Psyllid ID: psy758
Local Sequence Feature Prediction
| Prediction and (Method) | Result |
|---|
|
|
Close Homologs for Annotation Transfer
Close Homologs in SWISS-PROT Database Detected by BLAST 
Original result of BLAST against SWISS-PROT Database
| ID | Alignment graph | Length |
Definition |
RBH(Q2H) |
RBH(H2Q) |
Q cover |
H cover |
Identity |
E-value |
| Query | 292 | 2.2.26 [Sep-21-2011] | |||||||
| Q00532 | 357 | Cyclin-dependent kinase-l | yes | N/A | 0.883 | 0.722 | 0.5 | 4e-71 | |
| Q8CEQ0 | 352 | Cyclin-dependent kinase-l | yes | N/A | 0.866 | 0.718 | 0.478 | 3e-70 | |
| Q66HE7 | 352 | Cyclin-dependent kinase-l | yes | N/A | 0.890 | 0.738 | 0.482 | 3e-69 | |
| Q6AXJ9 | 350 | Cyclin-dependent kinase-l | yes | N/A | 0.890 | 0.742 | 0.482 | 4e-69 | |
| Q5MAI5 | 315 | Cyclin-dependent kinase-l | no | N/A | 0.890 | 0.825 | 0.450 | 5e-65 | |
| Q3TZA2 | 342 | Cyclin-dependent kinase-l | no | N/A | 0.890 | 0.760 | 0.454 | 6e-65 | |
| Q9QUK0 | 568 | Cyclin-dependent kinase-l | no | N/A | 0.989 | 0.508 | 0.396 | 7e-56 | |
| Q9TTK0 | 566 | Cyclin-dependent kinase-l | no | N/A | 0.931 | 0.480 | 0.404 | 9e-55 | |
| Q4R7T5 | 570 | Cyclin-dependent kinase-l | N/A | N/A | 0.931 | 0.477 | 0.404 | 2e-54 | |
| Q5R754 | 493 | Cyclin-dependent kinase-l | yes | N/A | 0.931 | 0.551 | 0.404 | 2e-54 |
| >sp|Q00532|CDKL1_HUMAN Cyclin-dependent kinase-like 1 OS=Homo sapiens GN=CDKL1 PE=1 SV=5 | Back alignment and function desciption |
|---|
Score = 268 bits (685), Expect = 4e-71, Method: Compositional matrix adjust.
Identities = 146/292 (50%), Positives = 188/292 (64%), Gaps = 34/292 (11%)
Query: 1 MERYEKIGKLGEGSYGVVFKCRNRDTGQVVAIKKFLESEEDPLIRKIALREIRLLKSLKH 60
ME+YEKIGK+GEGSYGVVFKCRNRDTGQ+VAIKKFLESE+DP+I+KIALREIR+LK LKH
Sbjct: 1 MEKYEKIGKIGEGSYGVVFKCRNRDTGQIVAIKKFLESEDDPVIKKIALREIRMLKQLKH 60
Query: 61 PNLVNLLEVFRRKKKLHLVFEFCDHTVLNELENHPHGLPWDLIKQITWQVLRGVSYCHRH 120
PNLVNLLEVFRRK++LHLVFE+CDHTVL+EL+ + G+P L+K ITWQ L+ V++CH+H
Sbjct: 61 PNLVNLLEVFRRKRRLHLVFEYCDHTVLHELDRYQRGVPEHLVKSITWQTLQAVNFCHKH 120
Query: 121 ACIHRDIKPENILLTANGVVKLCDFGFARLIRDLIPRHLHIFQTNEYFK----------- 169
CIHRD+KPENIL+T + V+KLCDFGFARL+ + T Y
Sbjct: 121 NCIHRDVKPENILITKHSVIKLCDFGFARLLAGPSDYYTDYVATRWYRSPELLVGDTQYG 180
Query: 170 ------GVSLPHAENVVPLEIKIGKPAATNIYLIDFLKRCLDKDPLRRWSCDQLLRHPYF 223
+ AE + + + GK +YLI L + +S +Q YF
Sbjct: 181 PPVDVWAIGCVFAELLSGVPLWPGKSDVDQLYLIRKTLGDLIPRHQQVFSTNQ-----YF 235
Query: 224 NGYYFEVPDEMQYEEIT------------QRCLDKDPLRRWSCDQLLRHPYF 263
+G P++M+ E+ + CL DP +R +C+QLL HPYF
Sbjct: 236 SGVKIPDPEDMEPLELKFPNISYPALGLLKGCLHMDPTQRLTCEQLLHHPYF 287
|
Homo sapiens (taxid: 9606) EC: 2EC: .EC: 7EC: .EC: 1EC: 1EC: .EC: 2EC: 2 |
| >sp|Q8CEQ0|CDKL1_MOUSE Cyclin-dependent kinase-like 1 OS=Mus musculus GN=Cdkl1 PE=2 SV=1 | Back alignment and function description |
|---|
Score = 265 bits (677), Expect = 3e-70, Method: Compositional matrix adjust.
Identities = 144/301 (47%), Positives = 187/301 (62%), Gaps = 48/301 (15%)
Query: 1 MERYEKIGKLGEGSYGVVFKCRNRDTGQVVAIKKFLESEEDPLIRKIALREIRLLKSLKH 60
ME+YEKIGK+GEGSYGVVFKCRNRDTGQ+VAIK+FLE+E+DP+I+KIALREIR+LK LKH
Sbjct: 1 MEKYEKIGKIGEGSYGVVFKCRNRDTGQIVAIKRFLETEDDPVIKKIALREIRMLKQLKH 60
Query: 61 PNLVNLLEVFRRKKKLHLVFEFCDHTVLNELENHPHGLPWDLIKQITWQVLRGVSYCHRH 120
PNLVNLLEVFRRK++LHLVFE+CDHTVL+EL+ + G+P L+K ITWQ L+ V++CH+H
Sbjct: 61 PNLVNLLEVFRRKRRLHLVFEYCDHTVLHELDRYQRGVPEPLVKNITWQTLQAVNFCHKH 120
Query: 121 ACIHRDIKPENILLTANGVVKLCDFGFARLIRDLIPRHLHIFQTNEYFK----------- 169
CIHRD+KPENIL+T +KLCDFGFARL+ + T Y
Sbjct: 121 NCIHRDVKPENILITKQSAIKLCDFGFARLLTGPGDYYTDYVATRWYRSPELLVGDTQYG 180
Query: 170 ------GVSLPHAENVVPLEIKIGKPAATNIYLIDFLKRCLDKDPLRRWSCDQLLRH--- 220
+ AE + + + GK +YLI R+ D + RH
Sbjct: 181 PPVDVWAIGCVFAELLSGVPLWPGKSDVDQLYLI------------RKTLGDLIPRHQQV 228
Query: 221 ----PYFNGYYFEVPDEMQYEEIT------------QRCLDKDPLRRWSCDQLLRHPYFN 264
YF+G P++M+ E+ + CL DP R +C+QLL+HPYF+
Sbjct: 229 FSMNQYFSGVKIPDPEDMETLELKFPNISYSALGFLKGCLHMDPAERLTCEQLLQHPYFD 288
Query: 265 G 265
Sbjct: 289 S 289
|
Mus musculus (taxid: 10090) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 2 EC: 2 |
| >sp|Q66HE7|CDKL1_RAT Cyclin-dependent kinase-like 1 OS=Rattus norvegicus GN=Cdkl1 PE=2 SV=1 | Back alignment and function description |
|---|
Score = 261 bits (668), Expect = 3e-69, Method: Compositional matrix adjust.
Identities = 142/294 (48%), Positives = 188/294 (63%), Gaps = 34/294 (11%)
Query: 1 MERYEKIGKLGEGSYGVVFKCRNRDTGQVVAIKKFLESEEDPLIRKIALREIRLLKSLKH 60
ME+YEKIGK+GEGSYGVVFKCRNRDTGQ+VAIK+FLE+E+DP+I+KIALREIR+LK LKH
Sbjct: 1 MEKYEKIGKIGEGSYGVVFKCRNRDTGQIVAIKRFLETEDDPVIKKIALREIRMLKQLKH 60
Query: 61 PNLVNLLEVFRRKKKLHLVFEFCDHTVLNELENHPHGLPWDLIKQITWQVLRGVSYCHRH 120
PNLV+LLEVFRRK++LHLVFE+C HTVL+EL+ + G+P L+K ITWQ L+ V++CH+H
Sbjct: 61 PNLVSLLEVFRRKRRLHLVFEYCHHTVLHELDRYQRGVPEPLVKNITWQTLQAVNFCHKH 120
Query: 121 ACIHRDIKPENILLTANGVVKLCDFGFARLIRDLIPRHLHIFQTNEYFK----------- 169
CIHRD+KPENIL+T + V+KLCDFGFARL+ + T Y
Sbjct: 121 NCIHRDVKPENILITKHSVIKLCDFGFARLLTGPGDYYTDYVATRWYRSPELLVGDTQYG 180
Query: 170 ------GVSLPHAENVVPLEIKIGKPAATNIYLIDFLKRCLDKDPLRRWSCDQLLRHPYF 223
+ AE + + + GK +YLI L + +S +Q YF
Sbjct: 181 PPVDVWAIGCVFAELLSGVPLWPGKSDVDQLYLIRKTLGDLIPRHQQVFSMNQ-----YF 235
Query: 224 NGYYFEVPDEMQYEEIT------------QRCLDKDPLRRWSCDQLLRHPYFNG 265
+G P++M+ E+ + CL DP R +C+QLL+HPYF+
Sbjct: 236 SGVKIPDPEDMETLELKFPNISYSALGFLKGCLHMDPAERLTCEQLLQHPYFDS 289
|
Rattus norvegicus (taxid: 10116) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 2 EC: 2 |
| >sp|Q6AXJ9|CDKL1_DANRE Cyclin-dependent kinase-like 1 OS=Danio rerio GN=cdkl1 PE=2 SV=1 | Back alignment and function description |
|---|
Score = 261 bits (667), Expect = 4e-69, Method: Compositional matrix adjust.
Identities = 142/294 (48%), Positives = 182/294 (61%), Gaps = 34/294 (11%)
Query: 1 MERYEKIGKLGEGSYGVVFKCRNRDTGQVVAIKKFLESEEDPLIRKIALREIRLLKSLKH 60
ME+YEKI K+GEGSYGVVFKCRN+DTGQ+VAIKKF+ESE+DP+I+KIALREIR+LK LKH
Sbjct: 1 MEKYEKISKIGEGSYGVVFKCRNKDTGQIVAIKKFVESEDDPIIKKIALREIRMLKQLKH 60
Query: 61 PNLVNLLEVFRRKKKLHLVFEFCDHTVLNELENHPHGLPWDLIKQITWQVLRGVSYCHRH 120
PNLVNL+EVFRRK+KLHLVFE+CDHTVLNEL+ +P G+P ++K I WQ L+ V++CH+
Sbjct: 61 PNLVNLMEVFRRKRKLHLVFEYCDHTVLNELDRYPRGVPEHMVKSIIWQTLQAVNFCHKQ 120
Query: 121 ACIHRDIKPENILLTANGVVKLCDFGFARLIRDLIPRHLHIFQTNEYFK----------- 169
CIHRD+KPENIL+T + V+KLCDFGFAR++ + T Y
Sbjct: 121 NCIHRDVKPENILITKHQVIKLCDFGFARILTGPCDYYTDCVATRWYRAPELLVGDTQYG 180
Query: 170 ------GVSLPHAENVVPLEIKIGKPAATNIYLIDFLKRCLDKDPLRRWSCDQLLRHPYF 223
V AE + + GK +YLI L + +S +Q +F
Sbjct: 181 PPVDVWAVGCVFAELLSGAPLWPGKSDVDQLYLIRKTLGELIPRHQQVFSTNQ-----FF 235
Query: 224 NGYYFEVPDEM------------QYEEITQRCLDKDPLRRWSCDQLLRHPYFNG 265
+G P EM Q + + CL DP R SC+QLL PYF+
Sbjct: 236 SGVCVPEPQEMEPLELKYPNLSYQALSLMKGCLRMDPAERLSCEQLLEQPYFDS 289
|
Danio rerio (taxid: 7955) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 2 EC: 2 |
| >sp|Q5MAI5|CDKL4_HUMAN Cyclin-dependent kinase-like 4 OS=Homo sapiens GN=CDKL4 PE=2 SV=1 | Back alignment and function description |
|---|
Score = 248 bits (632), Expect = 5e-65, Method: Compositional matrix adjust.
Identities = 133/295 (45%), Positives = 186/295 (63%), Gaps = 35/295 (11%)
Query: 1 MERYEKIGKLGEGSYGVVFKCRNRDTGQVVAIKKFLESEEDPLIRKIALREIRLLKSLKH 60
ME+YEK+ K GEGSYGVVFKCRN+ +GQVVA+KKF+ESE+DP+++KIALREIR+LK LKH
Sbjct: 1 MEKYEKLAKTGEGSYGVVFKCRNKTSGQVVAVKKFVESEDDPVVKKIALREIRMLKQLKH 60
Query: 61 PNLVNLLEVFRRKKKLHLVFEFCDHTVLNELENHPHGLPWDLIKQITWQVLRGVSYCHRH 120
PNLVNL+EVFRRK+K+HLVFE+CDHT+LNELE +P+G+ +IK + WQ L+ +++CH H
Sbjct: 61 PNLVNLIEVFRRKRKMHLVFEYCDHTLLNELERNPNGVADGVIKSVLWQTLQALNFCHIH 120
Query: 121 ACIHRDIKPENILLTANGVVKLCDFGFARLIRDLIPRHLH--------------IFQTNE 166
CIHRDIKPENIL+T G++K+CDFGFA++ LIP + + +
Sbjct: 121 NCIHRDIKPENILITKQGIIKICDFGFAQI---LIPGDAYTDYVATRWYRAPELLVGDTQ 177
Query: 167 YFKGVSLPHAENVVPLEIKIGK---PAATNIYLIDFLKRCLDKDPLRRWSCDQLLRHPYF 223
Y V + A V E+ G+ P +++ + + R L K R S + +F
Sbjct: 178 YGSSVDI-WAIGCVFAELLTGQPLWPGKSDVDQLYLIIRTLGKLIPRHQSI--FKSNGFF 234
Query: 224 NGYYFEVPDEMQYEE------------ITQRCLDKDPLRRWSCDQLLRHPYFNGY 266
+G P++M+ E + CL +P R +C QLL YF+ +
Sbjct: 235 HGISIPEPEDMETLEEKFSDVHPVALNFMKGCLKMNPDDRLTCSQLLESSYFDSF 289
|
Homo sapiens (taxid: 9606) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 2 EC: 2 |
| >sp|Q3TZA2|CDKL4_MOUSE Cyclin-dependent kinase-like 4 OS=Mus musculus GN=Cdkl4 PE=2 SV=1 | Back alignment and function description |
|---|
Score = 247 bits (631), Expect = 6e-65, Method: Compositional matrix adjust.
Identities = 134/295 (45%), Positives = 185/295 (62%), Gaps = 35/295 (11%)
Query: 1 MERYEKIGKLGEGSYGVVFKCRNRDTGQVVAIKKFLESEEDPLIRKIALREIRLLKSLKH 60
ME+YEK+ K+GEGSYGVVFKCRN+ +GQVVAIKKF+ESE+D ++RKIALREIR+LK LKH
Sbjct: 1 MEKYEKLAKIGEGSYGVVFKCRNKSSGQVVAIKKFVESEDDRVVRKIALREIRMLKQLKH 60
Query: 61 PNLVNLLEVFRRKKKLHLVFEFCDHTVLNELENHPHGLPWDLIKQITWQVLRGVSYCHRH 120
PNLVNL+EVFRRK+K+HLVFE+CDHT+LNELE +P+G+ +IK + WQ L+ +++CH+H
Sbjct: 61 PNLVNLIEVFRRKRKMHLVFEYCDHTLLNELERNPNGVSDGVIKSVLWQTLQALNFCHKH 120
Query: 121 ACIHRDIKPENILLTANGVVKLCDFGFARLIRDLIPRHLH--------------IFQTNE 166
CIHRD+KPENIL+T G++K+CDFGFAR+ LIP + + +
Sbjct: 121 NCIHRDVKPENILITKQGMIKICDFGFARI---LIPGDAYTDYVATRWYRAPELLVGDTK 177
Query: 167 YFKGVSLPHAENVVPLEIKIGK---PAATNIYLIDFLKRCLDKDPLRRWSCDQLLRHPYF 223
Y V + A V E+ G+ P +++ + + R L K R S + +F
Sbjct: 178 YGSSVDV-WAVGCVFAELLTGQPLWPGKSDVDQLYLIIRTLGKLIPRHQSI--FRSNQFF 234
Query: 224 NGYYFEVPDEMQYEE------------ITQRCLDKDPLRRWSCDQLLRHPYFNGY 266
G P++M+ E + CL +P R +C QLL YF +
Sbjct: 235 RGISIPEPEDMETLEEKFSNVQPVALSFMKGCLKMNPDERLTCAQLLDSAYFESF 289
|
Mus musculus (taxid: 10090) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 2 EC: 2 |
| >sp|Q9QUK0|CDKL2_MOUSE Cyclin-dependent kinase-like 2 OS=Mus musculus GN=Cdkl2 PE=2 SV=1 | Back alignment and function description |
|---|
Score = 217 bits (553), Expect = 7e-56, Method: Compositional matrix adjust.
Identities = 129/325 (39%), Positives = 198/325 (60%), Gaps = 36/325 (11%)
Query: 1 MERYEKIGKLGEGSYGVVFKCRNRDTGQVVAIKKFLESEEDPLIRKIALREIRLLKSLKH 60
ME+YE +G +GEGSYG+V KCRN+D+G++VAIKKFLES++D +++KIA+REI+LLK L+H
Sbjct: 1 MEKYENLGLVGEGSYGMVMKCRNKDSGRIVAIKKFLESDDDKMVKKIAMREIKLLKQLRH 60
Query: 61 PNLVNLLEVFRRKKKLHLVFEFCDHTVLNELENHPHGLPWDLIKQITWQVLRGVSYCHRH 120
NLVNLLEV ++KK+ +LVFEF DHT+L++L+ P+GL + ++++ +Q++ G+ +CH H
Sbjct: 61 ENLVNLLEVCKKKKRWYLVFEFVDHTILDDLKLFPNGLDYQVVQKYLFQIINGIGFCHSH 120
Query: 121 ACIHRDIKPENILLTANGVVKLCDFGFARLIRDLIPRHLHIFQTN------------EYF 168
IHRDIKPENIL++ +GVVKLCDFGFAR + + T +Y
Sbjct: 121 NIIHRDIKPENILVSQSGVVKLCDFGFARTLAAPGEVYTDYVATRWYRAPELLVGDVKYG 180
Query: 169 KGVSLPHAENVVPLEIKIGK---PAATNIYLIDFLKRCLDKDPLRRWSCDQLLRHPYFNG 225
K V + A + +E+ +G+ P ++I + + CL R + ++P F G
Sbjct: 181 KAVDI-WAIGCLVIEMLMGQPLFPGESDIDQLHHIMTCLGNLIPRHQ--ELFYKNPVFAG 237
Query: 226 YYF-EVPD------EMQYEE-------ITQRCLDKDPLRRWSCDQLLRHPYF--NGYYFE 269
EV D E +Y + + ++CL DP +R C LLRH +F +G+
Sbjct: 238 VRLPEVKDAEAEPLESRYPKLPEAVISLAKKCLHIDPDKRPFCADLLRHDFFQMDGFAER 297
Query: 270 VPDEMQY--EEITQVSRLPTKDKNK 292
E+Q E+ + + LP K +N+
Sbjct: 298 FSQELQLKIEKDARNNSLPKKSQNR 322
|
Mus musculus (taxid: 10090) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 2 EC: 2 |
| >sp|Q9TTK0|CDKL2_RABIT Cyclin-dependent kinase-like 2 OS=Oryctolagus cuniculus GN=CDKL2 PE=2 SV=1 | Back alignment and function description |
|---|
Score = 213 bits (543), Expect = 9e-55, Method: Compositional matrix adjust.
Identities = 123/304 (40%), Positives = 187/304 (61%), Gaps = 32/304 (10%)
Query: 1 MERYEKIGKLGEGSYGVVFKCRNRDTGQVVAIKKFLESEEDPLIRKIALREIRLLKSLKH 60
ME+YE +G +GEGSYG+V KCRN+D+G++VAIKKFLES++D +++KIA+REI+LLK L+H
Sbjct: 1 MEKYENLGLVGEGSYGMVMKCRNKDSGRIVAIKKFLESDDDKMVKKIAMREIKLLKQLRH 60
Query: 61 PNLVNLLEVFRRKKKLHLVFEFCDHTVLNELENHPHGLPWDLIKQITWQVLRGVSYCHRH 120
NLVNLLEV ++KK+ +LVFEF DHT+L++LE P+GL ++++ +Q++ G+ +CH H
Sbjct: 61 ENLVNLLEVCKKKKRWYLVFEFVDHTILDDLELFPNGLDDQVVQKYLFQIINGIGFCHSH 120
Query: 121 ACIHRDIKPENILLTANGVVKLCDFGFARLI-------RDLIPRHLH-----IFQTNEYF 168
IHRDIKPENIL++ +GVVKLCDFGFAR + D + + + +Y
Sbjct: 121 NIIHRDIKPENILVSQSGVVKLCDFGFARTLAAPGEVYTDYVATRWYRAPELLVGDVKYG 180
Query: 169 KGVSLPHAENVVPLEIKIGK---PAATNIYLIDFLKRCLDKDPLRRWSCDQLLRHPYFNG 225
K V + A + E+ +G+ P ++I + + RCL R ++P F G
Sbjct: 181 KAVDV-WAIGCLVTEMLMGEPLFPGDSDIDQLYLIMRCLGNLIPRHQEL--FYKNPVFAG 237
Query: 226 YYF-----EVPDEMQYEEITQ-------RCLDKDPLRRWSCDQLLRHPYF--NGYYFEVP 271
P E +Y ++++ +CL DP +R C +LL H +F +G+
Sbjct: 238 VRLPEIKESEPLERRYPKLSEVVIDLAKKCLHVDPDKRPFCAELLHHDFFQMDGFAERFS 297
Query: 272 DEMQ 275
E+Q
Sbjct: 298 QELQ 301
|
Oryctolagus cuniculus (taxid: 9986) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 2 EC: 2 |
| >sp|Q4R7T5|CDKL2_MACFA Cyclin-dependent kinase-like 2 OS=Macaca fascicularis GN=CDKL2 PE=2 SV=1 | Back alignment and function description |
|---|
Score = 213 bits (541), Expect = 2e-54, Method: Compositional matrix adjust.
Identities = 123/304 (40%), Positives = 186/304 (61%), Gaps = 32/304 (10%)
Query: 1 MERYEKIGKLGEGSYGVVFKCRNRDTGQVVAIKKFLESEEDPLIRKIALREIRLLKSLKH 60
ME+YE +G +GEGSYG+V KCRN+DTG++VAIKKFLES++D +++KIA+REI+LLK L+H
Sbjct: 1 MEKYENLGLVGEGSYGMVVKCRNKDTGRIVAIKKFLESDDDKMVKKIAMREIKLLKQLRH 60
Query: 61 PNLVNLLEVFRRKKKLHLVFEFCDHTVLNELENHPHGLPWDLIKQITWQVLRGVSYCHRH 120
NLVNLLEV ++KK+ +LVFEF DHT+L++LE P+GL + ++++ +Q++ G+ +CH H
Sbjct: 61 ENLVNLLEVCKKKKRWYLVFEFVDHTILDDLELFPNGLDYQVVQKYLFQIINGIGFCHSH 120
Query: 121 ACIHRDIKPENILLTANGVVKLCDFGFARLIRDLIPRHLHIFQTN------------EYF 168
IHRDIKPENIL++ +GVVKLCDFGFAR + + T +Y
Sbjct: 121 NIIHRDIKPENILVSQSGVVKLCDFGFARTLAAPGEVYTDYVATRWYRAPELLVGDVKYG 180
Query: 169 KGVSLPHAENVVPLEIKIGK---PAATNIYLIDFLKRCLDKDPLRRWSCDQLLRHPYFNG 225
K V + A + E+ +G+ P ++I + + CL R + ++P F G
Sbjct: 181 KAVDV-WAIGCLVTEMFMGEPLFPGDSDIDQLYHIMMCLGNLIPRHQ--ELFYKNPVFAG 237
Query: 226 YYF-----EVPDEMQYEEITQ-------RCLDKDPLRRWSCDQLLRHPYF--NGYYFEVP 271
P E +Y ++++ +CL DP +R C +LL H +F +G+
Sbjct: 238 VRLPEIKEREPLERRYPKLSEVVIDLAKKCLHIDPDKRPFCSELLHHDFFQMDGFAERFS 297
Query: 272 DEMQ 275
E+Q
Sbjct: 298 QELQ 301
|
Macaca fascicularis (taxid: 9541) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 2 EC: 2 |
| >sp|Q5R754|CDKL2_PONAB Cyclin-dependent kinase-like 2 OS=Pongo abelii GN=CDKL2 PE=2 SV=1 | Back alignment and function description |
|---|
Score = 212 bits (540), Expect = 2e-54, Method: Compositional matrix adjust.
Identities = 123/304 (40%), Positives = 186/304 (61%), Gaps = 32/304 (10%)
Query: 1 MERYEKIGKLGEGSYGVVFKCRNRDTGQVVAIKKFLESEEDPLIRKIALREIRLLKSLKH 60
ME+YE +G +GEGSYG+V KCRN+DTG++VAIKKFLES++D +++KIA+REI+LLK L+H
Sbjct: 1 MEKYENLGLVGEGSYGMVMKCRNKDTGRIVAIKKFLESDDDKMVKKIAMREIKLLKQLRH 60
Query: 61 PNLVNLLEVFRRKKKLHLVFEFCDHTVLNELENHPHGLPWDLIKQITWQVLRGVSYCHRH 120
NLVNLLEV ++KK+ +LVFEF DHT+L++LE P+GL + ++++ +Q++ G+ +CH H
Sbjct: 61 ENLVNLLEVCKKKKRWYLVFEFVDHTILDDLELFPNGLDYQVVQKYLFQIINGIGFCHSH 120
Query: 121 ACIHRDIKPENILLTANGVVKLCDFGFARLIRDLIPRHLHIFQTN------------EYF 168
IHRDIKPENIL++ +GVVKLCDFGFAR + + T +Y
Sbjct: 121 NIIHRDIKPENILVSKSGVVKLCDFGFARTLAAPGEVYTDYVATRWYRAPELLVGDVKYG 180
Query: 169 KGVSLPHAENVVPLEIKIGK---PAATNIYLIDFLKRCLDKDPLRRWSCDQLLRHPYFNG 225
K V + A + E+ +G+ P ++I + + CL R + ++P F G
Sbjct: 181 KAVDV-WAIGCLVTEMFMGEPLFPGDSDIDQLYHIMMCLGNLIPRHQ--ELFYKNPVFAG 237
Query: 226 YYF-----EVPDEMQYEEITQ-------RCLDKDPLRRWSCDQLLRHPYF--NGYYFEVP 271
P E +Y ++++ +CL DP +R C +LL H +F +G+
Sbjct: 238 VRLPEIKEREPLERRYPKLSEVVIDLAKKCLHIDPDKRPFCAELLHHDFFQMDGFAERFS 297
Query: 272 DEMQ 275
E+Q
Sbjct: 298 QELQ 301
|
Pongo abelii (taxid: 9601) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 2 EC: 2 |
Close Homologs in the Non-Redundant Database Detected by BLAST
Original result of BLAST against Nonredundant Database
| GI | Alignment Graph | Length |
Definition |
Q cover |
H cover |
Identity |
E-value |
| Query | 292 | ||||||
| 328714070 | 388 | PREDICTED: cyclin-dependent kinase-like | 0.941 | 0.708 | 0.514 | 1e-75 | |
| 270009928 | 346 | hypothetical protein TcasGA2_TC009252 [T | 0.952 | 0.803 | 0.519 | 1e-75 | |
| 321475433 | 329 | hypothetical protein DAPPUDRAFT_44967 [D | 0.787 | 0.699 | 0.513 | 3e-74 | |
| 242017241 | 351 | mitogen-activated protein kinase ERK-A, | 0.910 | 0.757 | 0.517 | 8e-74 | |
| 156542367 | 388 | PREDICTED: cyclin-dependent kinase-like | 0.952 | 0.716 | 0.466 | 3e-73 | |
| 345492622 | 394 | PREDICTED: cyclin-dependent kinase-like | 0.952 | 0.705 | 0.466 | 4e-73 | |
| 357630311 | 369 | putative cdkl1/4 [Danaus plexippus] | 0.880 | 0.696 | 0.498 | 7e-73 | |
| 383849185 | 392 | PREDICTED: cyclin-dependent kinase-like | 0.986 | 0.734 | 0.478 | 6e-72 | |
| 363734885 | 352 | PREDICTED: cyclin-dependent kinase-like | 0.866 | 0.718 | 0.495 | 2e-71 | |
| 332018915 | 320 | Cyclin-dependent kinase-like 1 [Acromyrm | 0.962 | 0.878 | 0.479 | 2e-71 |
| >gi|328714070|ref|XP_001949199.2| PREDICTED: cyclin-dependent kinase-like 1-like [Acyrthosiphon pisum] | Back alignment and taxonomy information |
|---|
Score = 289 bits (739), Expect = 1e-75, Method: Compositional matrix adjust.
Identities = 157/305 (51%), Positives = 196/305 (64%), Gaps = 30/305 (9%)
Query: 1 MERYEKIGKLGEGSYGVVFKCRNRDTGQVVAIKKFLESEEDPLIRKIALREIRLLKSLKH 60
MERYE++GKLGEGSYG+VFKCRNR+ G +VAIKKF+ESE+DPLIRKIALREIR+LK+LKH
Sbjct: 33 MERYERLGKLGEGSYGMVFKCRNRENGHIVAIKKFVESEDDPLIRKIALREIRMLKTLKH 92
Query: 61 PNLVNLLEVFRRKKKLHLVFEFCDHTVLNELENHPHGLPWDLIKQITWQVLRGVSYCHRH 120
PNLVNLLEVFRRK+KLHLVFEFC+HTVL+ELE HP+G P KQI WQ L+ V+YCHRH
Sbjct: 93 PNLVNLLEVFRRKRKLHLVFEFCEHTVLHELERHPYGCPEIFTKQIIWQTLQAVAYCHRH 152
Query: 121 ACIHRDIKPENILLTANGVVKLCDFGFARLIRDLIPRHLHIFQTNEYFKGVSLPHAENVV 180
CIHRDIKPENILLT+ GVVKLCDFGFARL+ + + +++ L + +
Sbjct: 153 NCIHRDIKPENILLTSQGVVKLCDFGFARLMNP--GENYTDYVATRWYRSPELLVGDTLY 210
Query: 181 PLEIKIGKPAATNIYLI---DFLKRCLDKDPL---RRWSCDQLLRH-------PYFNGYY 227
+ + LI D D L R D + RH +F G
Sbjct: 211 GPSVDVWAIGCVGAELIRGEALWPGKSDVDQLYLIRSTLGDLIARHMHIFKMNEFFRGMS 270
Query: 228 FEVPDEMQYEE---------------ITQRCLDKDPLRRWSCDQLLRHPYFNGYYFEVPD 272
P+ ++ E + CL+KDPLRRW+CDQLLRHP+F+ + F+ P+
Sbjct: 271 LPQPETIEPLEKKLPKQTLSIPHLLDFLKMCLEKDPLRRWTCDQLLRHPFFDNFSFKYPE 330
Query: 273 EMQYE 277
YE
Sbjct: 331 GDLYE 335
|
Source: Acyrthosiphon pisum Species: Acyrthosiphon pisum Genus: Acyrthosiphon Family: Aphididae Order: Hemiptera Class: Insecta Phylum: Arthropoda Superkingdom: Eukaryota |
| >gi|270009928|gb|EFA06376.1| hypothetical protein TcasGA2_TC009252 [Tribolium castaneum] | Back alignment and taxonomy information |
|---|
Score = 288 bits (738), Expect = 1e-75, Method: Compositional matrix adjust.
Identities = 162/312 (51%), Positives = 200/312 (64%), Gaps = 34/312 (10%)
Query: 1 MERYEKIGKLGEGSYGVVFKCRNRDTGQVVAIKKFLESEEDPLIRKIALREIRLLKSLKH 60
MERYEK+ KLGEGSYG+V+KCRNRDTG++VAIKKF ESE+DPLIRKIALREIRLLK+LKH
Sbjct: 1 MERYEKLAKLGEGSYGIVYKCRNRDTGEIVAIKKFAESEDDPLIRKIALREIRLLKNLKH 60
Query: 61 PNLVNLLEVFRRKKKLHLVFEFCDHTVLNELENHPHGLPWDLIKQITWQVLRGVSYCHRH 120
PNLVNLLEVFRRK++LHLVFEFC+ TVLNELE +P G P L +QI WQ L+ V+YCH H
Sbjct: 61 PNLVNLLEVFRRKRRLHLVFEFCERTVLNELERYPRGCPHLLTQQIIWQTLQAVAYCHHH 120
Query: 121 ACIHRDIKPENILLTANGVVKLCDFGFARLIR------DLIPRHLH-----IFQTNEYFK 169
CIHRDIKPENILLT +GVVKLCDFGFAR++ D + + + +Y
Sbjct: 121 GCIHRDIKPENILLTGSGVVKLCDFGFARMLSPGENYTDYVATRWYRAPELLVGDTQYGT 180
Query: 170 GVSLPH-----AENVVPLEIKIGKPAATNIYLIDFLKRCLDKDPLRRWSCDQLLRHPYFN 224
V + AE V + GK +YLI R D L+R + +F
Sbjct: 181 PVDVWAIGCVLAELVKGEALWPGKSDVDQLYLI----RSTVGDLLQR-HMQAFKNNDFFQ 235
Query: 225 GYYFEVPDEMQYEEIT------------QRCLDKDPLRRWSCDQLLRHPYFNGYYFEVPD 272
G VP +M E+ ++CLDKDPL+RW+CD LL H YF + F+V D
Sbjct: 236 GVILPVPQQMVPLEVKLPMCNQTTIDFLKKCLDKDPLKRWTCDMLLTHDYFENFNFKV-D 294
Query: 273 EMQYEEITQVSR 284
E + ++SR
Sbjct: 295 ETDSQNFEKLSR 306
|
Source: Tribolium castaneum Species: Tribolium castaneum Genus: Tribolium Family: Tenebrionidae Order: Coleoptera Class: Insecta Phylum: Arthropoda Superkingdom: Eukaryota |
| >gi|321475433|gb|EFX86396.1| hypothetical protein DAPPUDRAFT_44967 [Daphnia pulex] | Back alignment and taxonomy information |
|---|
Score = 284 bits (727), Expect = 3e-74, Method: Compositional matrix adjust.
Identities = 153/298 (51%), Positives = 189/298 (63%), Gaps = 68/298 (22%)
Query: 1 MERYEKIGKLGEGSYGVVFKCRNRDTGQVVAIKKFLESEEDPLIRKIALREIRLLKSLKH 60
MERYEKI ++GEGSYGVV+KCRNR+TGQ+VAIKKF+ESEEDPLI+KIALREIR+LK LKH
Sbjct: 1 MERYEKICRMGEGSYGVVYKCRNRETGQIVAIKKFVESEEDPLIKKIALREIRMLKQLKH 60
Query: 61 PNLVNLLEVFRRKKKLHLVFEFCDHTVLNELENHPHGLPWDLIKQITWQVLRGVSYCHRH 120
PNLVNL+EVFRRKKKLHLVFE+CD TVLNELE HP G+P L K+I WQ L+ V YCH H
Sbjct: 61 PNLVNLIEVFRRKKKLHLVFEYCDLTVLNELEKHPRGVPEVLTKRIIWQTLQAVGYCHAH 120
Query: 121 ACIHRDIKPENILLTAN--------GVVKLCDFG-------------------------- 146
CIHRD+KPENILLT G +L + G
Sbjct: 121 NCIHRDVKPENILLTKEGVVKLCDFGFARLLNPGENYTDYVATRWYRAPELLVGDTQYGP 180
Query: 147 ----------FARLIR----------------------DLIPRHLHIFQTNEYFKGVSLP 174
FA L+R DLIPRH+ +F+ NE+F G+S+P
Sbjct: 181 GVDVWAIGCVFAELVRGEALWPGKSDVDQLFLIRKTLGDLIPRHMKVFKNNEFFAGLSIP 240
Query: 175 HAENVVPLEIKIGKPAATNIYLIDFLKRCLDKDPLRRWSCDQLLRHPYFNGYYFEVPD 232
+ +E K+ P +I +DFLK+CLD+DP +R++CDQLLRHPYF + F +P+
Sbjct: 241 EPDVRESIESKM--PRDFSIDGMDFLKKCLDRDPSKRYTCDQLLRHPYFANFNFRLPE 296
|
Source: Daphnia pulex Species: Daphnia pulex Genus: Daphnia Family: Daphniidae Order: Diplostraca Class: Branchiopoda Phylum: Arthropoda Superkingdom: Eukaryota |
| >gi|242017241|ref|XP_002429100.1| mitogen-activated protein kinase ERK-A, putative [Pediculus humanus corporis] gi|212513964|gb|EEB16362.1| mitogen-activated protein kinase ERK-A, putative [Pediculus humanus corporis] | Back alignment and taxonomy information |
|---|
Score = 283 bits (723), Expect = 8e-74, Method: Compositional matrix adjust.
Identities = 150/290 (51%), Positives = 199/290 (68%), Gaps = 24/290 (8%)
Query: 1 MERYEKIGKLGEGSYGVVFKCRNRDTGQVVAIKKFLESEEDPLIRKIALREIRLLKSLKH 60
MERYEK+GKLGEGSYG+VFKCRN++TGQ+VAIKKF+ESE+DP+IRKIALREIR+LK+LKH
Sbjct: 1 MERYEKLGKLGEGSYGLVFKCRNKETGQIVAIKKFVESEDDPIIRKIALREIRMLKNLKH 60
Query: 61 PNLVNLLEVFRRKKKLHLVFEFCDHTVLNELENHPHGLPWDLIKQITWQVLRGVSYCHRH 120
PNLVNLLEVFRRKKK+HLVFE+CDHTVL+ELE +P G P L + ITWQ+L+G++YCH+H
Sbjct: 61 PNLVNLLEVFRRKKKIHLVFEYCDHTVLHELEKYPKGCPEQLTQYITWQILQGIAYCHQH 120
Query: 121 ACIHRDIKPENILLTANGVVKLCDFGFARLIR------DLIPR------HLHIFQTNEYF 168
+CIHRDIKPENILLT+ G+VKLCDFGFAR++ D + L + TN
Sbjct: 121 SCIHRDIKPENILLTSQGIVKLCDFGFARMLNPGENYTDYVATRWYRAPELLVGDTNYGT 180
Query: 169 K----GVSLPHAENVVPLEIKIGKPAATNIYLI-----DFLKRCLDKDPLRRWSCDQLLR 219
+ AE + + GK +YLI D + R + + +L
Sbjct: 181 PVDVWAIGCVFAELIRGEAVWPGKSDVDQLYLIRATLGDLIPRHMQIFKSNEFFAGVILP 240
Query: 220 HPY-FNGYYFEVPDEMQYEEIT--QRCLDKDPLRRWSCDQLLRHPYFNGY 266
P+ F ++P + + ++C+DKDP +RW+C+QLL+HPYF+ +
Sbjct: 241 VPHTFEPIEEKLPKQQNIYSLDFFKKCVDKDPSKRWTCEQLLQHPYFDNF 290
|
Source: Pediculus humanus corporis Species: Pediculus humanus Genus: Pediculus Family: Pediculidae Order: Phthiraptera Class: Insecta Phylum: Arthropoda Superkingdom: Eukaryota |
| >gi|156542367|ref|XP_001600503.1| PREDICTED: cyclin-dependent kinase-like 1-like isoform 1 [Nasonia vitripennis] | Back alignment and taxonomy information |
|---|
Score = 281 bits (718), Expect = 3e-73, Method: Compositional matrix adjust.
Identities = 153/328 (46%), Positives = 210/328 (64%), Gaps = 50/328 (15%)
Query: 1 MERYEKIGKLGEGSYGVVFKCRNRDTGQVVAIKKFLESEEDPLIRKIALREIRLLKSLKH 60
MERYE++G+LGEGSYGVVF+CR+R TG++VA+KKF ++E+DPLIRKIALREIRLLK+LKH
Sbjct: 25 MERYERLGRLGEGSYGVVFQCRDRQTGRLVAVKKFQQTEDDPLIRKIALREIRLLKNLKH 84
Query: 61 PNLVNLLEVFRRKKKLHLVFEFCDHTVLNELENHPHGLPWDLIKQITWQVLRGVSYCHRH 120
PNLVNLLEVFRRK+KLHLVFE+C+HT+L+E+E +PHG P + KQ+TWQ+L+GV+YCHR
Sbjct: 85 PNLVNLLEVFRRKRKLHLVFEYCEHTLLHEMEKYPHGCPELMTKQLTWQILQGVAYCHRL 144
Query: 121 ACIHRDIKPENILLTANGVVKLCDFGFARLIRDLIPRHLHI----FQTNEYFKG------ 170
C+HRD+KPENILLTA+GVVKLCDFGFAR++ ++ ++ E G
Sbjct: 145 GCVHRDVKPENILLTADGVVKLCDFGFARMLSPGENYTEYVATRWYRAPELLVGDTQYGT 204
Query: 171 ------VSLPHAENVVPLEIKIGKPAATNIYLIDFLKRCLDKDPLRRWSCDQLLRH---- 220
+ +AE + + GK +YLI RR D L RH
Sbjct: 205 PVDVWAIGCVYAELIRGEALWPGKSDVDQLYLI------------RRTLGDLLPRHMAIF 252
Query: 221 ---PYFNGYYFEVPDEMQYEEIT--------------QRCLDKDPLRRWSCDQLLRHPYF 263
+F G P + E ++CLDK+P +RW+CDQLL+H YF
Sbjct: 253 QQNEFFAGISLPTPQTLTPLETVLPETSSSTLQMDFLKKCLDKEPDQRWTCDQLLQHVYF 312
Query: 264 NGYYFEVPDEMQYEEITQVSRLPTKDKN 291
++F++P E++ EE ++ L + ++
Sbjct: 313 ENFHFKMP-EVETEEFEKLRNLRERSRH 339
|
Source: Nasonia vitripennis Species: Nasonia vitripennis Genus: Nasonia Family: Pteromalidae Order: Hymenoptera Class: Insecta Phylum: Arthropoda Superkingdom: Eukaryota |
| >gi|345492622|ref|XP_003426895.1| PREDICTED: cyclin-dependent kinase-like 1-like isoform 2 [Nasonia vitripennis] | Back alignment and taxonomy information |
|---|
Score = 281 bits (718), Expect = 4e-73, Method: Compositional matrix adjust.
Identities = 153/328 (46%), Positives = 210/328 (64%), Gaps = 50/328 (15%)
Query: 1 MERYEKIGKLGEGSYGVVFKCRNRDTGQVVAIKKFLESEEDPLIRKIALREIRLLKSLKH 60
MERYE++G+LGEGSYGVVF+CR+R TG++VA+KKF ++E+DPLIRKIALREIRLLK+LKH
Sbjct: 31 MERYERLGRLGEGSYGVVFQCRDRQTGRLVAVKKFQQTEDDPLIRKIALREIRLLKNLKH 90
Query: 61 PNLVNLLEVFRRKKKLHLVFEFCDHTVLNELENHPHGLPWDLIKQITWQVLRGVSYCHRH 120
PNLVNLLEVFRRK+KLHLVFE+C+HT+L+E+E +PHG P + KQ+TWQ+L+GV+YCHR
Sbjct: 91 PNLVNLLEVFRRKRKLHLVFEYCEHTLLHEMEKYPHGCPELMTKQLTWQILQGVAYCHRL 150
Query: 121 ACIHRDIKPENILLTANGVVKLCDFGFARLIRDLIPRHLHI----FQTNEYFKG------ 170
C+HRD+KPENILLTA+GVVKLCDFGFAR++ ++ ++ E G
Sbjct: 151 GCVHRDVKPENILLTADGVVKLCDFGFARMLSPGENYTEYVATRWYRAPELLVGDTQYGT 210
Query: 171 ------VSLPHAENVVPLEIKIGKPAATNIYLIDFLKRCLDKDPLRRWSCDQLLRH---- 220
+ +AE + + GK +YLI RR D L RH
Sbjct: 211 PVDVWAIGCVYAELIRGEALWPGKSDVDQLYLI------------RRTLGDLLPRHMAIF 258
Query: 221 ---PYFNGYYFEVPDEMQYEEIT--------------QRCLDKDPLRRWSCDQLLRHPYF 263
+F G P + E ++CLDK+P +RW+CDQLL+H YF
Sbjct: 259 QQNEFFAGISLPTPQTLTPLETVLPETSSSTLQMDFLKKCLDKEPDQRWTCDQLLQHVYF 318
Query: 264 NGYYFEVPDEMQYEEITQVSRLPTKDKN 291
++F++P E++ EE ++ L + ++
Sbjct: 319 ENFHFKMP-EVETEEFEKLRNLRERSRH 345
|
Source: Nasonia vitripennis Species: Nasonia vitripennis Genus: Nasonia Family: Pteromalidae Order: Hymenoptera Class: Insecta Phylum: Arthropoda Superkingdom: Eukaryota |
| >gi|357630311|gb|EHJ78519.1| putative cdkl1/4 [Danaus plexippus] | Back alignment and taxonomy information |
|---|
Score = 280 bits (715), Expect = 7e-73, Method: Compositional matrix adjust.
Identities = 155/311 (49%), Positives = 196/311 (63%), Gaps = 54/311 (17%)
Query: 1 MERYEKIGKLGEGSYGVVFKCRNRDTGQVVAIKKFLESEEDPLIRKIALREIRLLKSLKH 60
MERYEK+ KLGEGSYG+V+KCRNR+TG+VVA+KKF+E+E+DPLIRKIALREIR+LK+LKH
Sbjct: 26 MERYEKLAKLGEGSYGLVYKCRNRETGEVVAVKKFVENEDDPLIRKIALREIRMLKNLKH 85
Query: 61 PNLVNLLEVFRRKKKLHLVFEFCDHTVLNELENHPHGLPWDLIKQITWQVLRGVSYCHRH 120
PNLVNL+EVFRRK+KLHLVFE+CDHTVL+ELE +P G P L KQI WQ L+GV+YCHRH
Sbjct: 86 PNLVNLIEVFRRKRKLHLVFEYCDHTVLHELEKYPAGCPELLSKQIIWQTLQGVAYCHRH 145
Query: 121 ACIHRDIKPENILLTANGVVKLCDFGFARLIR------DLIPRHLH----------IFQT 164
CIHRD+KPENILLT++GVVKLCDFGFAR+I D + + ++ T
Sbjct: 146 NCIHRDVKPENILLTSDGVVKLCDFGFARMISPGESYTDYVATRWYRAPELLVGDTLYST 205
Query: 165 NEYFKGVSLPHAENVVPLEIKIGKPAATNIYLIDFLKRCLDKDPLRRWSCDQLLRH---- 220
+ AE + + GK +YLI R+ D L RH
Sbjct: 206 PVDVWAIGCVFAELLSSEALWPGKSDLDQLYLI------------RKTLGDLLPRHMTIF 253
Query: 221 ---PYFNGYYFEVPDEMQYE-----------------EITQRCLDKDPLRRWSCDQLLRH 260
+F G E+P+ E + ++CLDKDPL R +C+QLLRH
Sbjct: 254 SQNTFFQG--MELPEPTSLEPLEKKIPPRYANNDLVLDFLKKCLDKDPLARATCEQLLRH 311
Query: 261 PYFNGYYFEVP 271
F + + VP
Sbjct: 312 AIFENFLYAVP 322
|
Source: Danaus plexippus Species: Danaus plexippus Genus: Danaus Family: Nymphalidae Order: Lepidoptera Class: Insecta Phylum: Arthropoda Superkingdom: Eukaryota |
| >gi|383849185|ref|XP_003700226.1| PREDICTED: cyclin-dependent kinase-like 4-like [Megachile rotundata] | Back alignment and taxonomy information |
|---|
Score = 276 bits (707), Expect = 6e-72, Method: Compositional matrix adjust.
Identities = 153/320 (47%), Positives = 207/320 (64%), Gaps = 32/320 (10%)
Query: 1 MERYEKIGKLGEGSYGVVFKCRNRDTGQVVAIKKFLESEEDPLIRKIALREIRLLKSLKH 60
MERYE++ +LGEGSYGVVF+CR+R TG++VA+KKF ++E+DPLIRKIALREIRLLK+LKH
Sbjct: 31 MERYERLARLGEGSYGVVFQCRDRQTGRLVAVKKFQQTEDDPLIRKIALREIRLLKNLKH 90
Query: 61 PNLVNLLEVFRRKKKLHLVFEFCDHTVLNELENHPHGLPWDLIKQITWQVLRGVSYCHRH 120
PNLVNLLEVFRRK+KLHLVFE+C++T+LNE+E +PHG P KQ+TWQ+L+GV+YCHR
Sbjct: 91 PNLVNLLEVFRRKRKLHLVFEYCEYTLLNEMERYPHGCPEITTKQLTWQILQGVAYCHRL 150
Query: 121 ACIHRDIKPENILLTANGVVKLCDFGFARLIRDLIPRHLHI-FQTNEYFKGVSL--PHAE 177
C+HRD+KPENIL+TA GVVKLCDFGFAR+ L P + + +++ L +
Sbjct: 151 CCVHRDVKPENILITAEGVVKLCDFGFARI---LSPGENYTEYVATRWYRAPELLVGDTQ 207
Query: 178 NVVPLEI-KIGKPAATNIYLIDFLKRCLDKDPL---RRWSCDQLLRH-------PYFNGY 226
P+++ IG A I D D L RR D L RH +F G
Sbjct: 208 YGTPVDVWAIGCVFAELIRGEALWPGKSDVDQLYLIRRTIGDLLPRHIAIFQQNEFFAGI 267
Query: 227 YFEVPDEMQ--------------YEEITQRCLDKDPLRRWSCDQLLRHPYFNGYYFEVPD 272
P + + ++CLDKDP +RWSC+QLL+H YF ++F++P
Sbjct: 268 TLPTPQTLTPLDEALPNRGNVILQLDFLKKCLDKDPDKRWSCEQLLQHSYFENFHFKMP- 326
Query: 273 EMQYEEITQVSRLPTKDKNK 292
E + EE ++ + + +N
Sbjct: 327 EAEMEEFEKLKKYRDRSRNS 346
|
Source: Megachile rotundata Species: Megachile rotundata Genus: Megachile Family: Megachilidae Order: Hymenoptera Class: Insecta Phylum: Arthropoda Superkingdom: Eukaryota |
| >gi|363734885|ref|XP_421464.3| PREDICTED: cyclin-dependent kinase-like 1 [Gallus gallus] | Back alignment and taxonomy information |
|---|
Score = 275 bits (702), Expect = 2e-71, Method: Compositional matrix adjust.
Identities = 149/301 (49%), Positives = 191/301 (63%), Gaps = 48/301 (15%)
Query: 1 MERYEKIGKLGEGSYGVVFKCRNRDTGQVVAIKKFLESEEDPLIRKIALREIRLLKSLKH 60
MERYEK+GK+GEGSYGVVFKCRNR+TGQ+VAIKKFLESEEDP+IRKIALRE+R+LK LKH
Sbjct: 1 MERYEKLGKVGEGSYGVVFKCRNRETGQIVAIKKFLESEEDPVIRKIALREVRMLKQLKH 60
Query: 61 PNLVNLLEVFRRKKKLHLVFEFCDHTVLNELENHPHGLPWDLIKQITWQVLRGVSYCHRH 120
PNLVNLLEVFRRK+KLHLVFE+CDHTVL+EL+ HP G+P L++ ITWQ L+ V++CH+H
Sbjct: 61 PNLVNLLEVFRRKRKLHLVFEYCDHTVLHELDKHPRGVPEQLVRSITWQTLQAVNFCHKH 120
Query: 121 ACIHRDIKPENILLTANGVVKLCDFGFARLIRDLIPRHLHIFQTNEYFK----------- 169
CIHRD+KPENIL+T + V+KLCDFGFAR++ + T Y
Sbjct: 121 NCIHRDVKPENILITKHSVIKLCDFGFARMLTGPGDYYTDYVATRWYRSPELLVGDTQYG 180
Query: 170 ------GVSLPHAENVVPLEIKIGKPAATNIYLIDFLKRCLDKDPLRRWSCDQLLRH--- 220
+ AE + + + GK +YLI RR D + RH
Sbjct: 181 PPVDVWAIGCVFAELLSGVPLWPGKSDVDQLYLI------------RRTLGDLIPRHQQV 228
Query: 221 ----PYFNGYYFEVPD-----EMQYEEIT-------QRCLDKDPLRRWSCDQLLRHPYFN 264
+F+G P+ EM++ I+ + CL DP R +C+QLL+HPYF+
Sbjct: 229 FSTNQFFSGVTIPDPESMEPLEMKFPSISYPALALMKGCLHMDPAERQTCEQLLQHPYFD 288
Query: 265 G 265
Sbjct: 289 S 289
|
Source: Gallus gallus Species: Gallus gallus Genus: Gallus Family: Phasianidae Order: Galliformes Class: Aves Phylum: Chordata Superkingdom: Eukaryota |
| >gi|332018915|gb|EGI59461.1| Cyclin-dependent kinase-like 1 [Acromyrmex echinatior] | Back alignment and taxonomy information |
|---|
Score = 275 bits (702), Expect = 2e-71, Method: Compositional matrix adjust.
Identities = 149/311 (47%), Positives = 205/311 (65%), Gaps = 30/311 (9%)
Query: 1 MERYEKIGKLGEGSYGVVFKCRNRDTGQVVAIKKFLESEEDPLIRKIALREIRLLKSLKH 60
MERYE++ +LGEGSYGVVF+CR+R TG++VA+KKF ++E+DPLIRKIALREIRLLK+LKH
Sbjct: 1 MERYERLARLGEGSYGVVFQCRDRQTGKLVAVKKFQQTEDDPLIRKIALREIRLLKNLKH 60
Query: 61 PNLVNLLEVFRRKKKLHLVFEFCDHTVLNELENHPHGLPWDLIKQITWQVLRGVSYCHRH 120
PNLVNLLEVFRRK+KLHLVFE+C++T+LNE+E +P G P +QITWQ+L+G++YCHR
Sbjct: 61 PNLVNLLEVFRRKRKLHLVFEYCENTLLNEMEKYPSGCPDLTTRQITWQILQGIAYCHRL 120
Query: 121 ACIHRDIKPENILLTANGVVKLCDFGFARLIRDLIPRHLHIFQTNEYFKGVSL--PHAEN 178
C+HRD+KPENIL+T+ GVVKLCDFGFAR++ + + +++ L +
Sbjct: 121 GCVHRDVKPENILITSEGVVKLCDFGFARMLSP--GENYTEYVATRWYRAPELLVGDTQY 178
Query: 179 VVPLEI-KIGKPAATNIYLIDFLKRCLDKDPL---RRWSCDQLLRH-------PYFNGYY 227
P+++ IG A I D D L RR D L RH +F+G
Sbjct: 179 GTPVDVWAIGCVFAELIRGEALWPGKSDVDQLYLIRRTLGDLLPRHMAIFQQNEFFSGIT 238
Query: 228 FEVPDEMQYEEIT--------------QRCLDKDPLRRWSCDQLLRHPYFNGYYFEVPDE 273
P + E T ++CLDKDP RW+C+QLLRH YF+ ++F++PD
Sbjct: 239 LPTPQTLTPLENTLPRGNGSTLQLDFLKKCLDKDPNERWTCEQLLRHSYFDNFHFKMPD- 297
Query: 274 MQYEEITQVSR 284
++ EE ++ +
Sbjct: 298 VETEEFEKLKK 308
|
Source: Acromyrmex echinatior Species: Acromyrmex echinatior Genus: Acromyrmex Family: Formicidae Order: Hymenoptera Class: Insecta Phylum: Arthropoda Superkingdom: Eukaryota |
Prediction of Gene Ontology (GO) Terms
Close Homologs with Gene Ontology terms Detected by BLAST
Original result of BLAST against Gene Ontology (AMIGO)
| ID |
Alignment graph |
Length |
Definition |
Q cover |
H cover |
Identity |
E-value |
| Query | 292 | ||||||
| UNIPROTKB|E1C5K5 | 352 | CDKL1 "Uncharacterized protein | 0.517 | 0.428 | 0.768 | 5.1e-83 | |
| UNIPROTKB|A6QLF0 | 352 | CDKL1 "Uncharacterized protein | 0.517 | 0.428 | 0.761 | 6.5e-83 | |
| UNIPROTKB|Q00532 | 357 | CDKL1 "Cyclin-dependent kinase | 0.517 | 0.422 | 0.761 | 2.2e-82 | |
| FB|FBgn0031730 | 501 | CG7236 [Drosophila melanogaste | 0.517 | 0.301 | 0.735 | 4.5e-82 | |
| UNIPROTKB|E2RRC1 | 358 | CDKL1 "Uncharacterized protein | 0.517 | 0.421 | 0.768 | 4e-81 | |
| ZFIN|ZDB-GENE-040808-34 | 350 | cdkl1 "cyclin-dependent kinase | 0.517 | 0.431 | 0.728 | 1.2e-77 | |
| UNIPROTKB|E2QUJ9 | 336 | CDKL4 "Uncharacterized protein | 0.517 | 0.449 | 0.695 | 1.1e-74 | |
| UNIPROTKB|E2R1T0 | 342 | CDKL4 "Uncharacterized protein | 0.517 | 0.441 | 0.695 | 1.1e-74 | |
| UNIPROTKB|F1MB23 | 315 | CDKL4 "Uncharacterized protein | 0.517 | 0.479 | 0.688 | 2.3e-74 | |
| UNIPROTKB|J3KMW1 | 276 | CDKL1 "Cyclin-dependent kinase | 0.517 | 0.547 | 0.761 | 2.9e-74 |
| UNIPROTKB|E1C5K5 CDKL1 "Uncharacterized protein" [Gallus gallus (taxid:9031)] | Back alignment and assigned GO terms |
|---|
Score = 669 (240.6 bits), Expect = 5.1e-83, Sum P(2) = 5.1e-83
Identities = 116/151 (76%), Positives = 140/151 (92%)
Query: 1 MERYEKIGKLGEGSYGVVFKCRNRDTGQVVAIKKFLESEEDPLIRKIALREIRLLKSLKH 60
MERYEK+GK+GEGSYGVVFKCRNR+TGQ+VAIKKFLESEEDP+IRKIALRE+R+LK LKH
Sbjct: 1 MERYEKLGKVGEGSYGVVFKCRNRETGQIVAIKKFLESEEDPVIRKIALREVRMLKQLKH 60
Query: 61 PNLVNLLEVFRRKKKLHLVFEFCDHTVLNELENHPHGLPWDLIKQITWQVLRGVSYCHRH 120
PNLVNLLEVFRRK+KLHLVFE+CDHTVL+EL+ HP G+P L++ ITWQ L+ V++CH+H
Sbjct: 61 PNLVNLLEVFRRKRKLHLVFEYCDHTVLHELDKHPRGVPEQLVRSITWQTLQAVNFCHKH 120
Query: 121 ACIHRDIKPENILLTANGVVKLCDFGFARLI 151
CIHRD+KPENIL+T + V+KLCDFGFAR++
Sbjct: 121 NCIHRDVKPENILITKHSVIKLCDFGFARML 151
|
|
| UNIPROTKB|A6QLF0 CDKL1 "Uncharacterized protein" [Bos taurus (taxid:9913)] | Back alignment and assigned GO terms |
|---|
Score = 660 (237.4 bits), Expect = 6.5e-83, Sum P(2) = 6.5e-83
Identities = 115/151 (76%), Positives = 139/151 (92%)
Query: 1 MERYEKIGKLGEGSYGVVFKCRNRDTGQVVAIKKFLESEEDPLIRKIALREIRLLKSLKH 60
ME+YEKIGK+GEGSYGVVFKCRNRDTGQ+VAIKKFLESE+DP+I+KIALREIR+LK LKH
Sbjct: 1 MEKYEKIGKIGEGSYGVVFKCRNRDTGQIVAIKKFLESEDDPVIKKIALREIRMLKQLKH 60
Query: 61 PNLVNLLEVFRRKKKLHLVFEFCDHTVLNELENHPHGLPWDLIKQITWQVLRGVSYCHRH 120
PNLVNL+EVFRRK++LHLVFE+CDHTVL+EL+ H G+P L+K ITWQ L+ V++CH+H
Sbjct: 61 PNLVNLIEVFRRKRRLHLVFEYCDHTVLHELDRHQRGVPEHLVKSITWQTLQAVNFCHKH 120
Query: 121 ACIHRDIKPENILLTANGVVKLCDFGFARLI 151
+CIHRD+KPENIL+T V+KLCDFGFARL+
Sbjct: 121 SCIHRDVKPENILVTKQSVIKLCDFGFARLL 151
|
|
| UNIPROTKB|Q00532 CDKL1 "Cyclin-dependent kinase-like 1" [Homo sapiens (taxid:9606)] | Back alignment and assigned GO terms |
|---|
Score = 655 (235.6 bits), Expect = 2.2e-82, Sum P(2) = 2.2e-82
Identities = 115/151 (76%), Positives = 139/151 (92%)
Query: 1 MERYEKIGKLGEGSYGVVFKCRNRDTGQVVAIKKFLESEEDPLIRKIALREIRLLKSLKH 60
ME+YEKIGK+GEGSYGVVFKCRNRDTGQ+VAIKKFLESE+DP+I+KIALREIR+LK LKH
Sbjct: 1 MEKYEKIGKIGEGSYGVVFKCRNRDTGQIVAIKKFLESEDDPVIKKIALREIRMLKQLKH 60
Query: 61 PNLVNLLEVFRRKKKLHLVFEFCDHTVLNELENHPHGLPWDLIKQITWQVLRGVSYCHRH 120
PNLVNLLEVFRRK++LHLVFE+CDHTVL+EL+ + G+P L+K ITWQ L+ V++CH+H
Sbjct: 61 PNLVNLLEVFRRKRRLHLVFEYCDHTVLHELDRYQRGVPEHLVKSITWQTLQAVNFCHKH 120
Query: 121 ACIHRDIKPENILLTANGVVKLCDFGFARLI 151
CIHRD+KPENIL+T + V+KLCDFGFARL+
Sbjct: 121 NCIHRDVKPENILITKHSVIKLCDFGFARLL 151
|
|
| FB|FBgn0031730 CG7236 [Drosophila melanogaster (taxid:7227)] | Back alignment and assigned GO terms |
|---|
Score = 612 (220.5 bits), Expect = 4.5e-82, Sum P(2) = 4.5e-82
Identities = 111/151 (73%), Positives = 134/151 (88%)
Query: 1 MERYEKIGKLGEGSYGVVFKCRNRDTGQVVAIKKFLESEEDPLIRKIALREIRLLKSLKH 60
M+RYEK+ +LGEGSYGVV+KCR+R+TG +VA+K+F+ESE+DP IRKIALREIRLLK+LKH
Sbjct: 110 MDRYEKLSRLGEGSYGVVYKCRDRETGALVAVKRFVESEDDPAIRKIALREIRLLKNLKH 169
Query: 61 PNLVNLLEVFRRKKKLHLVFEFCDHTVLNELENHPHGLPWDLIKQITWQVLRGVSYCHRH 120
PNLV+LLEVFRRK++LHLVFEFC+ TVL+ELE HP G P L KQI +Q L GV+YCH+
Sbjct: 170 PNLVSLLEVFRRKRRLHLVFEFCELTVLHELERHPQGCPEHLTKQICYQTLLGVAYCHKQ 229
Query: 121 ACIHRDIKPENILLTANGVVKLCDFGFARLI 151
C+HRDIKPENILLTA G VKLCDFGFAR++
Sbjct: 230 GCLHRDIKPENILLTAQGQVKLCDFGFARML 260
|
|
| UNIPROTKB|E2RRC1 CDKL1 "Uncharacterized protein" [Canis lupus familiaris (taxid:9615)] | Back alignment and assigned GO terms |
|---|
Score = 661 (237.7 bits), Expect = 4.0e-81, Sum P(2) = 4.0e-81
Identities = 116/151 (76%), Positives = 139/151 (92%)
Query: 1 MERYEKIGKLGEGSYGVVFKCRNRDTGQVVAIKKFLESEEDPLIRKIALREIRLLKSLKH 60
ME+YEKIGK+GEGSYGVVFKCRNRDTGQ+VAIK+FLESE+DP+I+KIALREIR+LK LKH
Sbjct: 2 MEKYEKIGKIGEGSYGVVFKCRNRDTGQIVAIKRFLESEDDPVIKKIALREIRMLKQLKH 61
Query: 61 PNLVNLLEVFRRKKKLHLVFEFCDHTVLNELENHPHGLPWDLIKQITWQVLRGVSYCHRH 120
PNLVNLLEVFRRK+KLHLVFE+CDHTVL+EL+ H G+P L+K ITWQ L+ V++CH+H
Sbjct: 62 PNLVNLLEVFRRKRKLHLVFEYCDHTVLHELDRHQRGVPEHLVKNITWQTLQAVNFCHKH 121
Query: 121 ACIHRDIKPENILLTANGVVKLCDFGFARLI 151
CIHRD+KPENIL+T + V+KLCDFGFARL+
Sbjct: 122 DCIHRDVKPENILITKHSVIKLCDFGFARLL 152
|
|
| ZFIN|ZDB-GENE-040808-34 cdkl1 "cyclin-dependent kinase-like 1 (CDC2-related kinase)" [Danio rerio (taxid:7955)] | Back alignment and assigned GO terms |
|---|
Score = 638 (229.6 bits), Expect = 1.2e-77, Sum P(2) = 1.2e-77
Identities = 110/151 (72%), Positives = 137/151 (90%)
Query: 1 MERYEKIGKLGEGSYGVVFKCRNRDTGQVVAIKKFLESEEDPLIRKIALREIRLLKSLKH 60
ME+YEKI K+GEGSYGVVFKCRN+DTGQ+VAIKKF+ESE+DP+I+KIALREIR+LK LKH
Sbjct: 1 MEKYEKISKIGEGSYGVVFKCRNKDTGQIVAIKKFVESEDDPIIKKIALREIRMLKQLKH 60
Query: 61 PNLVNLLEVFRRKKKLHLVFEFCDHTVLNELENHPHGLPWDLIKQITWQVLRGVSYCHRH 120
PNLVNL+EVFRRK+KLHLVFE+CDHTVLNEL+ +P G+P ++K I WQ L+ V++CH+
Sbjct: 61 PNLVNLMEVFRRKRKLHLVFEYCDHTVLNELDRYPRGVPEHMVKSIIWQTLQAVNFCHKQ 120
Query: 121 ACIHRDIKPENILLTANGVVKLCDFGFARLI 151
CIHRD+KPENIL+T + V+KLCDFGFAR++
Sbjct: 121 NCIHRDVKPENILITKHQVIKLCDFGFARIL 151
|
|
| UNIPROTKB|E2QUJ9 CDKL4 "Uncharacterized protein" [Canis lupus familiaris (taxid:9615)] | Back alignment and assigned GO terms |
|---|
Score = 620 (223.3 bits), Expect = 1.1e-74, Sum P(2) = 1.1e-74
Identities = 105/151 (69%), Positives = 136/151 (90%)
Query: 1 MERYEKIGKLGEGSYGVVFKCRNRDTGQVVAIKKFLESEEDPLIRKIALREIRLLKSLKH 60
ME+YEK+ K+GEGSYGVVFKCRN+ +GQVVAIKKF+ESE+DP+I+KIALREIR+LK LKH
Sbjct: 1 MEKYEKLAKIGEGSYGVVFKCRNKTSGQVVAIKKFVESEDDPVIKKIALREIRMLKQLKH 60
Query: 61 PNLVNLLEVFRRKKKLHLVFEFCDHTVLNELENHPHGLPWDLIKQITWQVLRGVSYCHRH 120
PNLVNL+EVFRRK+K+HLVFE+CDHT+LNELE +P G+ +IK + WQ L+ +++CH+H
Sbjct: 61 PNLVNLIEVFRRKRKMHLVFEYCDHTLLNELERNPKGVADGVIKSVLWQTLQALNFCHKH 120
Query: 121 ACIHRDIKPENILLTANGVVKLCDFGFARLI 151
CIHRD+KPENIL+T G++K+CDFGFAR++
Sbjct: 121 NCIHRDVKPENILITKQGIIKICDFGFARIL 151
|
|
| UNIPROTKB|E2R1T0 CDKL4 "Uncharacterized protein" [Canis lupus familiaris (taxid:9615)] | Back alignment and assigned GO terms |
|---|
Score = 620 (223.3 bits), Expect = 1.1e-74, Sum P(2) = 1.1e-74
Identities = 105/151 (69%), Positives = 136/151 (90%)
Query: 1 MERYEKIGKLGEGSYGVVFKCRNRDTGQVVAIKKFLESEEDPLIRKIALREIRLLKSLKH 60
ME+YEK+ K+GEGSYGVVFKCRN+ +GQVVAIKKF+ESE+DP+I+KIALREIR+LK LKH
Sbjct: 1 MEKYEKLAKIGEGSYGVVFKCRNKTSGQVVAIKKFVESEDDPVIKKIALREIRMLKQLKH 60
Query: 61 PNLVNLLEVFRRKKKLHLVFEFCDHTVLNELENHPHGLPWDLIKQITWQVLRGVSYCHRH 120
PNLVNL+EVFRRK+K+HLVFE+CDHT+LNELE +P G+ +IK + WQ L+ +++CH+H
Sbjct: 61 PNLVNLIEVFRRKRKMHLVFEYCDHTLLNELERNPKGVADGVIKSVLWQTLQALNFCHKH 120
Query: 121 ACIHRDIKPENILLTANGVVKLCDFGFARLI 151
CIHRD+KPENIL+T G++K+CDFGFAR++
Sbjct: 121 NCIHRDVKPENILITKQGIIKICDFGFARIL 151
|
|
| UNIPROTKB|F1MB23 CDKL4 "Uncharacterized protein" [Bos taurus (taxid:9913)] | Back alignment and assigned GO terms |
|---|
Score = 621 (223.7 bits), Expect = 2.3e-74, Sum P(2) = 2.3e-74
Identities = 104/151 (68%), Positives = 137/151 (90%)
Query: 1 MERYEKIGKLGEGSYGVVFKCRNRDTGQVVAIKKFLESEEDPLIRKIALREIRLLKSLKH 60
ME+YEK+ K+GEGSYGVVFKCRN+ +GQVVAIKKF+ESE+DP+++KIALREIR+LK LKH
Sbjct: 1 MEKYEKLAKIGEGSYGVVFKCRNKTSGQVVAIKKFVESEDDPVVKKIALREIRMLKQLKH 60
Query: 61 PNLVNLLEVFRRKKKLHLVFEFCDHTVLNELENHPHGLPWDLIKQITWQVLRGVSYCHRH 120
PNLVNL+EVFRRK+K+HLVFE+CDHT+LNELE +P+G+ +IK + WQ L+ +++CH+H
Sbjct: 61 PNLVNLIEVFRRKRKMHLVFEYCDHTLLNELERNPNGVADGVIKSVLWQTLQALNFCHKH 120
Query: 121 ACIHRDIKPENILLTANGVVKLCDFGFARLI 151
CIHRD+KPENIL+T G++K+CDFGFAR++
Sbjct: 121 NCIHRDVKPENILITKQGIIKICDFGFARIL 151
|
|
| UNIPROTKB|J3KMW1 CDKL1 "Cyclin-dependent kinase-like 1" [Homo sapiens (taxid:9606)] | Back alignment and assigned GO terms |
|---|
Score = 655 (235.6 bits), Expect = 2.9e-74, Sum P(2) = 2.9e-74
Identities = 115/151 (76%), Positives = 139/151 (92%)
Query: 1 MERYEKIGKLGEGSYGVVFKCRNRDTGQVVAIKKFLESEEDPLIRKIALREIRLLKSLKH 60
ME+YEKIGK+GEGSYGVVFKCRNRDTGQ+VAIKKFLESE+DP+I+KIALREIR+LK LKH
Sbjct: 2 MEKYEKIGKIGEGSYGVVFKCRNRDTGQIVAIKKFLESEDDPVIKKIALREIRMLKQLKH 61
Query: 61 PNLVNLLEVFRRKKKLHLVFEFCDHTVLNELENHPHGLPWDLIKQITWQVLRGVSYCHRH 120
PNLVNLLEVFRRK++LHLVFE+CDHTVL+EL+ + G+P L+K ITWQ L+ V++CH+H
Sbjct: 62 PNLVNLLEVFRRKRRLHLVFEYCDHTVLHELDRYQRGVPEHLVKSITWQTLQAVNFCHKH 121
Query: 121 ACIHRDIKPENILLTANGVVKLCDFGFARLI 151
CIHRD+KPENIL+T + V+KLCDFGFARL+
Sbjct: 122 NCIHRDVKPENILITKHSVIKLCDFGFARLL 152
|
|
Prediction of Enzyme Commission (EC) Number
EC Number Prediction by Annotation Transfer from SWISS-PROT Entries
Original result of BLAST against SWISS-PROT
| ID | Name | Annotated EC number | Identity | Query coverage | Hit coverage | RBH(Q2H) | RBH(H2Q) |
| Q27032 | CDC2H_THEPA | 2, ., 7, ., 1, 1, ., 2, 3 | 0.3469 | 0.8664 | 0.8489 | yes | N/A |
| Q26671 | CDC2H_THEAN | 2, ., 7, ., 1, 1, ., 2, 3 | 0.3469 | 0.8664 | 0.8489 | yes | N/A |
| Q66HE7 | CDKL1_RAT | 2, ., 7, ., 1, 1, ., 2, 2 | 0.4829 | 0.8904 | 0.7386 | yes | N/A |
| Q00532 | CDKL1_HUMAN | 2, ., 7, ., 1, 1, ., 2, 2 | 0.5 | 0.8835 | 0.7226 | yes | N/A |
| Q6AXJ9 | CDKL1_DANRE | 2, ., 7, ., 1, 1, ., 2, 2 | 0.4829 | 0.8904 | 0.7428 | yes | N/A |
| Q8CEQ0 | CDKL1_MOUSE | 2, ., 7, ., 1, 1, ., 2, 2 | 0.4784 | 0.8664 | 0.7187 | yes | N/A |
EC Number Prediction by EFICAz Software
| Prediction Level | EC number | Confidence of Prediction |
| 4th Layer | 2.7.11.1 | 0.737 |
| 3rd Layer | 2.7.11 | 0.921 |
Prediction of Functionally Associated Proteins
Conserved Domains and Related Protein Families
Conserved Domains Detected by RPS-BLAST
Original result of RPS-BLAST against CDD database
| ID | Alignment Graph | Length |
Definition |
E-value |
| Query | 292 | |||
| cd07847 | 286 | cd07847, STKc_CDKL1_4, Catalytic domain of the Ser | 1e-105 | |
| cd07833 | 288 | cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dep | 3e-90 | |
| cd07846 | 286 | cd07846, STKc_CDKL2_3, Catalytic domain of the Ser | 1e-84 | |
| cd05118 | 283 | cd05118, STKc_CMGC, Catalytic domain of CMGC famil | 1e-70 | |
| smart00220 | 254 | smart00220, S_TKc, Serine/Threonine protein kinase | 2e-67 | |
| cd07829 | 282 | cd07829, STKc_CDK_like, Catalytic domain of Cyclin | 8e-67 | |
| pfam00069 | 260 | pfam00069, Pkinase, Protein kinase domain | 4e-66 | |
| cd00180 | 215 | cd00180, PKc, Catalytic domain of Protein Kinases | 4e-56 | |
| cd07848 | 287 | cd07848, STKc_CDKL5, Catalytic domain of the Serin | 2e-50 | |
| cd07835 | 283 | cd07835, STKc_CDK1_like, Catalytic domain of Cycli | 4e-50 | |
| cd07830 | 283 | cd07830, STKc_MAK_like, Catalytic domain of Male g | 6e-50 | |
| cd07841 | 298 | cd07841, STKc_CDK7, Catalytic domain of the Serine | 3e-48 | |
| cd07839 | 284 | cd07839, STKc_CDK5, Catalytic domain of the Serine | 3e-48 | |
| cd07860 | 284 | cd07860, STKc_CDK2_3, Catalytic domain of the Seri | 1e-47 | |
| cd07840 | 287 | cd07840, STKc_CDK9_like, Catalytic domain of Cycli | 1e-47 | |
| cd07861 | 285 | cd07861, STKc_CDK1_euk, Catalytic domain of the Se | 3e-47 | |
| cd06606 | 260 | cd06606, STKc_MAPKKK, Catalytic domain of the Prot | 1e-46 | |
| cd05122 | 253 | cd05122, PKc_STE, Catalytic domain of STE family P | 2e-45 | |
| cd07845 | 309 | cd07845, STKc_CDK10, Catalytic domain of the Serin | 1e-44 | |
| cd07838 | 287 | cd07838, STKc_CDK4_6_like, Catalytic domain of Cyc | 4e-43 | |
| cd07832 | 286 | cd07832, STKc_CCRK, Catalytic domain of the Serine | 6e-43 | |
| cd07844 | 291 | cd07844, STKc_PCTAIRE_like, Catalytic domain of PC | 3e-42 | |
| cd07865 | 310 | cd07865, STKc_CDK9, Catalytic domain of the Serine | 4e-42 | |
| cd07836 | 284 | cd07836, STKc_Pho85, Catalytic domain of the Serin | 8e-42 | |
| cd06611 | 280 | cd06611, STKc_SLK_like, Catalytic domain of Ste20- | 2e-41 | |
| PLN00009 | 294 | PLN00009, PLN00009, cyclin-dependent kinase A; Pro | 7e-41 | |
| cd07834 | 330 | cd07834, STKc_MAPK, Catalytic domain of the Serine | 1e-40 | |
| cd07866 | 311 | cd07866, STKc_BUR1, Catalytic domain of the Serine | 7e-39 | |
| cd08215 | 258 | cd08215, STKc_Nek, Catalytic domain of the Protein | 8e-39 | |
| cd07842 | 316 | cd07842, STKc_CDK8_like, Catalytic domain of Cycli | 6e-38 | |
| cd06627 | 254 | cd06627, STKc_Cdc7_like, Catalytic domain of Cell | 1e-37 | |
| cd07843 | 293 | cd07843, STKc_CDC2L1, Catalytic domain of the Seri | 4e-37 | |
| smart00219 | 257 | smart00219, TyrKc, Tyrosine kinase, catalytic doma | 4e-36 | |
| cd06623 | 264 | cd06623, PKc_MAPKK_plant_like, Catalytic domain of | 6e-36 | |
| smart00221 | 258 | smart00221, STYKc, Protein kinase; unclassified sp | 9e-36 | |
| cd06626 | 264 | cd06626, STKc_MEKK4, Catalytic domain of the Prote | 2e-35 | |
| cd07837 | 295 | cd07837, STKc_CdkB_plant, Catalytic domain of the | 3e-35 | |
| cd06605 | 265 | cd06605, PKc_MAPKK, Catalytic domain of the dual-s | 3e-35 | |
| cd06614 | 286 | cd06614, STKc_PAK, Catalytic domain of the Protein | 8e-35 | |
| COG0515 | 384 | COG0515, SPS1, Serine/threonine protein kinase [Ge | 9e-35 | |
| cd07871 | 288 | cd07871, STKc_PCTAIRE3, Catalytic domain of the Se | 1e-34 | |
| cd06613 | 262 | cd06613, STKc_MAP4K3_like, Catalytic domain of Mit | 2e-34 | |
| cd07852 | 337 | cd07852, STKc_MAPK15, Catalytic domain of the Seri | 2e-34 | |
| pfam07714 | 258 | pfam07714, Pkinase_Tyr, Protein tyrosine kinase | 2e-34 | |
| cd07864 | 302 | cd07864, STKc_CDK12, Catalytic domain of the Serin | 1e-33 | |
| cd07869 | 303 | cd07869, STKc_PFTAIRE1, Catalytic domain of the Se | 2e-33 | |
| cd07863 | 288 | cd07863, STKc_CDK4, Catalytic domain of the Serine | 4e-33 | |
| cd07862 | 290 | cd07862, STKc_CDK6, Catalytic domain of the Serine | 6e-33 | |
| cd00192 | 262 | cd00192, PTKc, Catalytic domain of Protein Tyrosin | 1e-32 | |
| cd07872 | 309 | cd07872, STKc_PCTAIRE2, Catalytic domain of the Se | 2e-32 | |
| cd06612 | 256 | cd06612, STKc_MST1_2, Catalytic domain of the Prot | 2e-32 | |
| cd07873 | 301 | cd07873, STKc_PCTAIRE1, Catalytic domain of the Se | 9e-32 | |
| cd07831 | 282 | cd07831, STKc_MOK, Catalytic domain of the Serine/ | 2e-31 | |
| cd06609 | 274 | cd06609, STKc_MST3_like, Catalytic domain of Mamma | 1e-30 | |
| cd08217 | 265 | cd08217, STKc_Nek2, Catalytic domain of the Protei | 2e-30 | |
| cd06632 | 258 | cd06632, STKc_MEKK1_plant, Catalytic domain of the | 3e-30 | |
| cd06643 | 282 | cd06643, STKc_SLK, Catalytic domain of the Protein | 3e-30 | |
| cd07870 | 291 | cd07870, STKc_PFTAIRE2, Catalytic domain of the Se | 7e-30 | |
| cd06608 | 275 | cd06608, STKc_myosinIII_like, Catalytic domain of | 9e-30 | |
| cd06607 | 307 | cd06607, STKc_TAO, Catalytic domain of the Protein | 2e-29 | |
| cd08529 | 256 | cd08529, STKc_FA2-like, Catalytic domain of the Pr | 5e-29 | |
| cd07849 | 336 | cd07849, STKc_ERK1_2_like, Catalytic domain of Ext | 1e-28 | |
| cd07855 | 334 | cd07855, STKc_ERK5, Catalytic domain of the Serine | 2e-28 | |
| cd06644 | 292 | cd06644, STKc_STK10_LOK, Catalytic domain of the P | 2e-28 | |
| cd06648 | 285 | cd06648, STKc_PAK_II, Catalytic domain of the Prot | 2e-28 | |
| cd05123 | 250 | cd05123, STKc_AGC, Catalytic domain of AGC family | 2e-28 | |
| cd06645 | 267 | cd06645, STKc_MAP4K3, Catalytic domain of the Prot | 3e-28 | |
| cd06621 | 287 | cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of | 3e-27 | |
| cd05581 | 280 | cd05581, STKc_PDK1, Catalytic domain of the Protei | 4e-27 | |
| cd07856 | 328 | cd07856, STKc_Sty1_Hog1, Catalytic domain of the S | 4e-27 | |
| cd05579 | 265 | cd05579, STKc_MAST_like, Catalytic domain of Micro | 8e-27 | |
| cd07858 | 337 | cd07858, STKc_TEY_MAPK_plant, Catalytic domain of | 3e-26 | |
| cd08218 | 256 | cd08218, STKc_Nek1, Catalytic domain of the Protei | 4e-26 | |
| cd08224 | 267 | cd08224, STKc_Nek6_Nek7, Catalytic domain of the P | 4e-26 | |
| cd07851 | 343 | cd07851, STKc_p38, Catalytic domain of the Serine/ | 1e-25 | |
| cd08530 | 256 | cd08530, STKc_CNK2-like, Catalytic domain of the P | 1e-25 | |
| PTZ00024 | 335 | PTZ00024, PTZ00024, cyclin-dependent protein kinas | 2e-25 | |
| cd06625 | 263 | cd06625, STKc_MEKK3_like, Catalytic domain of MAP/ | 5e-25 | |
| cd06631 | 265 | cd06631, STKc_YSK4, Catalytic domain of the Protei | 9e-25 | |
| PLN00034 | 353 | PLN00034, PLN00034, mitogen-activated protein kina | 4e-24 | |
| cd06647 | 293 | cd06647, STKc_PAK_I, Catalytic domain of the Prote | 7e-24 | |
| cd07880 | 343 | cd07880, STKc_p38gamma_MAPK12, Catalytic domain of | 1e-23 | |
| cd05580 | 290 | cd05580, STKc_PKA, Catalytic domain of the Protein | 2e-23 | |
| cd06629 | 272 | cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain o | 3e-23 | |
| cd07853 | 372 | cd07853, STKc_NLK, Catalytic domain of the Serine/ | 4e-23 | |
| cd06636 | 282 | cd06636, STKc_MAP4K4_6, Catalytic domain of the Pr | 4e-23 | |
| cd06610 | 267 | cd06610, STKc_OSR1_SPAK, Catalytic domain of the P | 5e-23 | |
| cd06635 | 317 | cd06635, STKc_TAO1, Catalytic domain of the Protei | 6e-23 | |
| cd06615 | 308 | cd06615, PKc_MEK, Catalytic domain of the dual-spe | 6e-23 | |
| cd08221 | 256 | cd08221, STKc_Nek9, Catalytic domain of the Protei | 7e-23 | |
| cd07859 | 338 | cd07859, STKc_TDY_MAPK_plant, Catalytic domain of | 1e-22 | |
| cd06633 | 313 | cd06633, STKc_TAO3, Catalytic domain of the Protei | 2e-22 | |
| cd06649 | 331 | cd06649, PKc_MEK2, Catalytic domain of the dual-sp | 4e-22 | |
| cd06650 | 333 | cd06650, PKc_MEK1, Catalytic domain of the dual-sp | 4e-22 | |
| cd07854 | 342 | cd07854, STKc_MAPK4_6, Catalytic domain of the Ser | 5e-22 | |
| cd06622 | 286 | cd06622, PKc_MAPKK_PBS2_like, Catalytic domain of | 7e-22 | |
| cd07850 | 353 | cd07850, STKc_JNK, Catalytic domain of the Serine/ | 8e-22 | |
| cd08225 | 257 | cd08225, STKc_Nek5, Catalytic domain of the Protei | 1e-21 | |
| cd06917 | 277 | cd06917, STKc_NAK1_like, Catalytic domain of Funga | 1e-21 | |
| cd07847 | 286 | cd07847, STKc_CDKL1_4, Catalytic domain of the Ser | 2e-21 | |
| cd06634 | 308 | cd06634, STKc_TAO2, Catalytic domain of the Protei | 2e-21 | |
| cd06657 | 292 | cd06657, STKc_PAK4, Catalytic domain of the Protei | 2e-21 | |
| cd06655 | 296 | cd06655, STKc_PAK2, Catalytic domain of the Protei | 2e-21 | |
| cd06646 | 267 | cd06646, STKc_MAP4K5, Catalytic domain of the Prot | 2e-21 | |
| cd06656 | 297 | cd06656, STKc_PAK3, Catalytic domain of the Protei | 2e-21 | |
| cd07867 | 317 | cd07867, STKc_CDC2L6, Catalytic domain of Serine/T | 3e-21 | |
| cd07857 | 332 | cd07857, STKc_MPK1, Catalytic domain of the Serine | 3e-21 | |
| cd07879 | 342 | cd07879, STKc_p38delta_MAPK13, Catalytic domain of | 4e-21 | |
| cd05053 | 293 | cd05053, PTKc_FGFR, Catalytic domain of the Protei | 6e-21 | |
| cd06637 | 272 | cd06637, STKc_TNIK, Catalytic domain of the Protei | 7e-21 | |
| cd06658 | 292 | cd06658, STKc_PAK5, Catalytic domain of the Protei | 7e-21 | |
| cd07868 | 317 | cd07868, STKc_CDK8, Catalytic domain of the Serine | 1e-20 | |
| cd06620 | 284 | cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of | 1e-20 | |
| cd07877 | 345 | cd07877, STKc_p38alpha_MAPK14, Catalytic domain of | 2e-20 | |
| cd06654 | 296 | cd06654, STKc_PAK1, Catalytic domain of the Protei | 2e-20 | |
| cd06659 | 297 | cd06659, STKc_PAK6, Catalytic domain of the Protei | 2e-20 | |
| cd08220 | 256 | cd08220, STKc_Nek8, Catalytic domain of the Protei | 3e-20 | |
| cd05052 | 263 | cd05052, PTKc_Abl, Catalytic domain of the Protein | 9e-20 | |
| cd05578 | 258 | cd05578, STKc_Yank1, Catalytic domain of the Prote | 2e-19 | |
| PTZ00036 | 440 | PTZ00036, PTZ00036, glycogen synthase kinase; Prov | 2e-19 | |
| cd05574 | 316 | cd05574, STKc_phototropin_like, Catalytic domain o | 2e-19 | |
| cd05573 | 350 | cd05573, STKc_ROCK_NDR_like, Catalytic domain of R | 3e-19 | |
| cd06618 | 296 | cd06618, PKc_MKK7, Catalytic domain of the dual-sp | 3e-19 | |
| cd08216 | 314 | cd08216, PK_STRAD, Pseudokinase domain of STE20-re | 4e-19 | |
| cd06628 | 267 | cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain o | 6e-19 | |
| PTZ00263 | 329 | PTZ00263, PTZ00263, protein kinase A catalytic sub | 6e-19 | |
| cd08219 | 255 | cd08219, STKc_Nek3, Catalytic domain of the Protei | 7e-19 | |
| cd06640 | 277 | cd06640, STKc_MST4, Catalytic domain of the Protei | 1e-18 | |
| cd06641 | 277 | cd06641, STKc_MST3, Catalytic domain of the Protei | 1e-18 | |
| cd05059 | 256 | cd05059, PTKc_Tec_like, Catalytic domain of Tec-li | 2e-18 | |
| cd05611 | 260 | cd05611, STKc_Rim15_like, Catalytic domain of fung | 3e-18 | |
| cd05572 | 262 | cd05572, STKc_cGK_PKG, Catalytic domain of the Pro | 4e-18 | |
| cd07878 | 343 | cd07878, STKc_p38beta_MAPK11, Catalytic domain of | 6e-18 | |
| cd06642 | 277 | cd06642, STKc_STK25-YSK1, Catalytic domain of the | 6e-18 | |
| cd05081 | 284 | cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2) | 7e-18 | |
| cd05114 | 256 | cd05114, PTKc_Tec_Rlk, Catalytic domain of the Pro | 9e-18 | |
| cd05034 | 261 | cd05034, PTKc_Src_like, Catalytic domain of Src ki | 9e-18 | |
| cd05048 | 283 | cd05048, PTKc_Ror, Catalytic Domain of the Protein | 1e-17 | |
| cd06617 | 283 | cd06617, PKc_MKK3_6, Catalytic domain of the dual- | 1e-17 | |
| cd07876 | 359 | cd07876, STKc_JNK2, Catalytic domain of the Serine | 2e-17 | |
| cd07874 | 355 | cd07874, STKc_JNK3, Catalytic domain of the Serine | 2e-17 | |
| cd07875 | 364 | cd07875, STKc_JNK1, Catalytic domain of the Serine | 3e-17 | |
| cd05600 | 333 | cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fun | 4e-17 | |
| cd06653 | 264 | cd06653, STKc_MEKK3_like_1, Catalytic domain of MA | 4e-17 | |
| cd05148 | 261 | cd05148, PTKc_Srm_Brk, Catalytic domain of the Pro | 5e-17 | |
| cd06630 | 268 | cd06630, STKc_MEKK1, Catalytic domain of the Prote | 6e-17 | |
| cd06652 | 265 | cd06652, STKc_MEKK2, Catalytic domain of the Prote | 7e-17 | |
| cd08228 | 267 | cd08228, STKc_Nek6, Catalytic domain of the Protei | 1e-16 | |
| cd08223 | 257 | cd08223, STKc_Nek4, Catalytic domain of the Protei | 2e-16 | |
| cd06624 | 268 | cd06624, STKc_ASK, Catalytic domain of the Protein | 5e-16 | |
| cd05041 | 251 | cd05041, PTKc_Fes_like, Catalytic domain of Fes-li | 6e-16 | |
| cd06638 | 286 | cd06638, STKc_myosinIIIA, Catalytic domain of the | 7e-16 | |
| cd08229 | 267 | cd08229, STKc_Nek7, Catalytic domain of the Protei | 9e-16 | |
| cd05068 | 261 | cd05068, PTKc_Frk_like, Catalytic domain of Fyn-re | 1e-15 | |
| cd05038 | 284 | cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domai | 1e-15 | |
| cd06651 | 266 | cd06651, STKc_MEKK3, Catalytic domain of the Prote | 2e-15 | |
| cd06639 | 291 | cd06639, STKc_myosinIIIB, Catalytic domain of the | 3e-15 | |
| cd05612 | 291 | cd05612, STKc_PRKX_like, Catalytic domain of PRKX- | 4e-15 | |
| cd05084 | 252 | cd05084, PTKc_Fes, Catalytic domain of the Protein | 5e-15 | |
| cd05040 | 257 | cd05040, PTKc_Ack_like, Catalytic domain of the Pr | 6e-15 | |
| cd05055 | 302 | cd05055, PTKc_PDGFR, Catalytic domain of the Prote | 6e-15 | |
| cd08528 | 269 | cd08528, STKc_Nek10, Catalytic domain of the Prote | 7e-15 | |
| cd05609 | 305 | cd05609, STKc_MAST, Catalytic domain of the Protei | 1e-14 | |
| cd05112 | 256 | cd05112, PTKc_Itk, Catalytic domain of the Protein | 1e-14 | |
| cd05049 | 280 | cd05049, PTKc_Trk, Catalytic domain of the Protein | 2e-14 | |
| cd05599 | 364 | cd05599, STKc_NDR_like, Catalytic domain of Nuclea | 3e-14 | |
| cd05067 | 260 | cd05067, PTKc_Lck_Blk, Catalytic domain of the Pro | 4e-14 | |
| cd05584 | 323 | cd05584, STKc_p70S6K, Catalytic domain of the Prot | 5e-14 | |
| cd06616 | 288 | cd06616, PKc_MKK4, Catalytic domain of the dual-sp | 8e-14 | |
| cd05586 | 330 | cd05586, STKc_Sck1_like, Catalytic domain of Suppr | 1e-13 | |
| cd05080 | 283 | cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) doma | 1e-13 | |
| TIGR03903 | 1266 | TIGR03903, TOMM_kin_cyc, TOMM system kinase/cyclas | 1e-13 | |
| cd05608 | 280 | cd05608, STKc_GRK1, Catalytic domain of the Protei | 2e-13 | |
| PTZ00266 | 1021 | PTZ00266, PTZ00266, NIMA-related protein kinase; P | 4e-13 | |
| PHA03209 | 357 | PHA03209, PHA03209, serine/threonine kinase US3; P | 4e-13 | |
| cd05099 | 314 | cd05099, PTKc_FGFR4, Catalytic domain of the Prote | 5e-13 | |
| cd05113 | 256 | cd05113, PTKc_Btk_Bmx, Catalytic domain of the Pro | 6e-13 | |
| cd05071 | 262 | cd05071, PTKc_Src, Catalytic domain of the Protein | 7e-13 | |
| cd05050 | 288 | cd05050, PTKc_Musk, Catalytic domain of the Protei | 7e-13 | |
| cd05032 | 277 | cd05032, PTKc_InsR_like, Catalytic domain of Insul | 1e-12 | |
| cd05575 | 323 | cd05575, STKc_SGK, Catalytic domain of the Protein | 1e-12 | |
| cd07846 | 286 | cd07846, STKc_CDKL2_3, Catalytic domain of the Ser | 2e-12 | |
| cd08222 | 260 | cd08222, STKc_Nek11, Catalytic domain of the Prote | 2e-12 | |
| cd05057 | 279 | cd05057, PTKc_EGFR_like, Catalytic domain of Epide | 2e-12 | |
| cd05613 | 290 | cd05613, STKc_MSK1_N, N-terminal catalytic domain | 3e-12 | |
| cd05577 | 277 | cd05577, STKc_GRK, Catalytic domain of the Protein | 3e-12 | |
| PTZ00426 | 340 | PTZ00426, PTZ00426, cAMP-dependent protein kinase | 3e-12 | |
| cd05085 | 250 | cd05085, PTKc_Fer, Catalytic domain of the Protein | 5e-12 | |
| cd05605 | 285 | cd05605, STKc_GRK4_like, Catalytic domain of G pro | 6e-12 | |
| cd06619 | 279 | cd06619, PKc_MKK5, Catalytic domain of the dual-sp | 6e-12 | |
| PRK13184 | 932 | PRK13184, pknD, serine/threonine-protein kinase; R | 1e-11 | |
| cd05629 | 377 | cd05629, STKc_NDR_like_fungal, Catalytic domain of | 1e-11 | |
| cd05585 | 312 | cd05585, STKc_YPK1_like, Catalytic domain of Yeast | 1e-11 | |
| cd05070 | 260 | cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Pro | 1e-11 | |
| cd05060 | 257 | cd05060, PTKc_Syk_like, Catalytic domain of Spleen | 1e-11 | |
| cd05582 | 318 | cd05582, STKc_RSK_N, N-terminal catalytic domain o | 1e-11 | |
| cd05072 | 261 | cd05072, PTKc_Lyn, Catalytic domain of the Protein | 1e-11 | |
| cd05604 | 325 | cd05604, STKc_SGK3, Catalytic domain of the Protei | 2e-11 | |
| cd05101 | 304 | cd05101, PTKc_FGFR2, Catalytic domain of the Prote | 2e-11 | |
| cd05033 | 266 | cd05033, PTKc_EphR, Catalytic domain of Ephrin Rec | 4e-11 | |
| cd05056 | 270 | cd05056, PTKc_FAK, Catalytic domain of the Protein | 4e-11 | |
| cd05073 | 260 | cd05073, PTKc_Hck, Catalytic domain of the Protein | 4e-11 | |
| cd05069 | 260 | cd05069, PTKc_Yes, Catalytic domain of the Protein | 5e-11 | |
| cd05571 | 323 | cd05571, STKc_PKB, Catalytic domain of the Protein | 5e-11 | |
| cd05098 | 307 | cd05098, PTKc_FGFR1, Catalytic domain of the Prote | 5e-11 | |
| cd05088 | 303 | cd05088, PTKc_Tie2, Catalytic domain of the Protei | 7e-11 | |
| cd05570 | 318 | cd05570, STKc_PKC, Catalytic domain of the Protein | 7e-11 | |
| cd05583 | 288 | cd05583, STKc_MSK_N, N-terminal catalytic domain o | 8e-11 | |
| PHA03207 | 392 | PHA03207, PHA03207, serine/threonine kinase US3; P | 9e-11 | |
| cd05603 | 321 | cd05603, STKc_SGK2, Catalytic domain of the Protei | 1e-10 | |
| cd08226 | 328 | cd08226, PK_STRAD_beta, Pseudokinase domain of STE | 1e-10 | |
| cd05607 | 277 | cd05607, STKc_GRK7, Catalytic domain of the Protei | 1e-10 | |
| cd05627 | 360 | cd05627, STKc_NDR2, Catalytic domain of the Protei | 1e-10 | |
| cd05093 | 288 | cd05093, PTKc_TrkB, Catalytic domain of the Protei | 1e-10 | |
| cd05100 | 334 | cd05100, PTKc_FGFR3, Catalytic domain of the Prote | 1e-10 | |
| cd05601 | 330 | cd05601, STKc_CRIK, Catalytic domain of the Protei | 1e-10 | |
| cd05593 | 328 | cd05593, STKc_PKB_gamma, Catalytic domain of the P | 2e-10 | |
| cd05097 | 295 | cd05097, PTKc_DDR_like, Catalytic domain of Discoi | 2e-10 | |
| cd05110 | 303 | cd05110, PTKc_HER4, Catalytic domain of the Protei | 2e-10 | |
| cd05091 | 283 | cd05091, PTKc_Ror2, Catalytic domain of the Protei | 2e-10 | |
| cd05039 | 256 | cd05039, PTKc_Csk_like, Catalytic domain of C-term | 2e-10 | |
| cd05116 | 257 | cd05116, PTKc_Syk, Catalytic domain of the Protein | 2e-10 | |
| cd05632 | 285 | cd05632, STKc_GRK5, Catalytic domain of the Protei | 2e-10 | |
| cd05628 | 363 | cd05628, STKc_NDR1, Catalytic domain of the Protei | 3e-10 | |
| cd05092 | 280 | cd05092, PTKc_TrkA, Catalytic domain of the Protei | 3e-10 | |
| cd05625 | 382 | cd05625, STKc_LATS1, Catalytic domain of the Prote | 4e-10 | |
| cd05083 | 254 | cd05083, PTKc_Chk, Catalytic domain of the Protein | 4e-10 | |
| cd05589 | 324 | cd05589, STKc_PKN, Catalytic domain of the Protein | 5e-10 | |
| PTZ00283 | 496 | PTZ00283, PTZ00283, serine/threonine protein kinas | 6e-10 | |
| cd05598 | 376 | cd05598, STKc_LATS, Catalytic domain of the Protei | 7e-10 | |
| cd05051 | 296 | cd05051, PTKc_DDR, Catalytic domain of the Protein | 8e-10 | |
| cd05610 | 669 | cd05610, STKc_MASTL, Catalytic domain of the Prote | 9e-10 | |
| cd05054 | 337 | cd05054, PTKc_VEGFR, Catalytic domain of the Prote | 9e-10 | |
| cd05591 | 321 | cd05591, STKc_nPKC_epsilon, Catalytic domain of th | 9e-10 | |
| PHA03211 | 461 | PHA03211, PHA03211, serine/threonine kinase US3; P | 1e-09 | |
| PHA03210 | 501 | PHA03210, PHA03210, serine/threonine kinase US3; P | 1e-09 | |
| cd05621 | 370 | cd05621, STKc_ROCK2, Catalytic domain of the Prote | 1e-09 | |
| cd05045 | 290 | cd05045, PTKc_RET, Catalytic domain of the Protein | 1e-09 | |
| cd05102 | 338 | cd05102, PTKc_VEGFR3, Catalytic domain of the Prot | 2e-09 | |
| cd05622 | 371 | cd05622, STKc_ROCK1, Catalytic domain of the Prote | 2e-09 | |
| cd05597 | 331 | cd05597, STKc_DMPK_like, Catalytic domain of Myoto | 2e-09 | |
| cd05596 | 370 | cd05596, STKc_ROCK, Catalytic domain of the Protei | 2e-09 | |
| cd05094 | 291 | cd05094, PTKc_TrkC, Catalytic domain of the Protei | 4e-09 | |
| cd05595 | 323 | cd05595, STKc_PKB_beta, Catalytic domain of the Pr | 4e-09 | |
| cd05614 | 332 | cd05614, STKc_MSK2_N, N-terminal catalytic domain | 4e-09 | |
| PLN03224 | 507 | PLN03224, PLN03224, probable serine/threonine prot | 5e-09 | |
| cd05079 | 284 | cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) doma | 5e-09 | |
| cd05618 | 329 | cd05618, STKc_aPKC_iota, Catalytic domain of the P | 5e-09 | |
| cd05602 | 325 | cd05602, STKc_SGK1, Catalytic domain of the Protei | 5e-09 | |
| cd05631 | 285 | cd05631, STKc_GRK4, Catalytic domain of the Protei | 6e-09 | |
| cd05066 | 267 | cd05066, PTKc_EphR_A, Catalytic domain of the Prot | 6e-09 | |
| cd05106 | 374 | cd05106, PTKc_CSF-1R, Catalytic domain of the Prot | 6e-09 | |
| cd05630 | 285 | cd05630, STKc_GRK6, Catalytic domain of the Protei | 7e-09 | |
| cd05103 | 343 | cd05103, PTKc_VEGFR2, Catalytic domain of the Prot | 7e-09 | |
| cd05095 | 296 | cd05095, PTKc_DDR2, Catalytic domain of the Protei | 7e-09 | |
| cd05046 | 275 | cd05046, PTK_CCK4, Pseudokinase domain of the Prot | 8e-09 | |
| cd05104 | 375 | cd05104, PTKc_Kit, Catalytic domain of the Protein | 8e-09 | |
| cd05065 | 269 | cd05065, PTKc_EphR_B, Catalytic domain of the Prot | 1e-08 | |
| cd05624 | 331 | cd05624, STKc_MRCK_beta, Catalytic domain of the P | 1e-08 | |
| cd05042 | 269 | cd05042, PTKc_Aatyk, Catalytic domain of the Prote | 2e-08 | |
| cd05623 | 332 | cd05623, STKc_MRCK_alpha, Catalytic domain of the | 2e-08 | |
| cd05619 | 316 | cd05619, STKc_nPKC_theta, Catalytic domain of the | 2e-08 | |
| cd05626 | 381 | cd05626, STKc_LATS2, Catalytic domain of the Prote | 3e-08 | |
| PHA03212 | 391 | PHA03212, PHA03212, serine/threonine kinase US3; P | 3e-08 | |
| cd05606 | 278 | cd05606, STKc_beta_ARK, Catalytic domain of the Pr | 3e-08 | |
| cd05090 | 283 | cd05090, PTKc_Ror1, Catalytic domain of the Protei | 4e-08 | |
| cd05105 | 400 | cd05105, PTKc_PDGFR_alpha, Catalytic domain of the | 8e-08 | |
| cd05617 | 327 | cd05617, STKc_aPKC_zeta, Catalytic domain of the P | 8e-08 | |
| cd05592 | 316 | cd05592, STKc_nPKC_theta_delta, Catalytic domain o | 9e-08 | |
| cd05036 | 277 | cd05036, PTKc_ALK_LTK, Catalytic domain of the Pro | 1e-07 | |
| cd05633 | 279 | cd05633, STKc_GRK3, Catalytic domain of the Protei | 1e-07 | |
| cd05089 | 297 | cd05089, PTKc_Tie1, Catalytic domain of the Protei | 1e-07 | |
| cd05061 | 288 | cd05061, PTKc_InsR, Catalytic domain of the Protei | 1e-07 | |
| cd05115 | 257 | cd05115, PTKc_Zap-70, Catalytic domain of the Prot | 1e-07 | |
| cd05058 | 262 | cd05058, PTKc_Met_Ron, Catalytic domain of the Pro | 2e-07 | |
| cd05588 | 329 | cd05588, STKc_aPKC, Catalytic domain of the Protei | 2e-07 | |
| cd05074 | 273 | cd05074, PTKc_Tyro3, Catalytic domain of the Prote | 2e-07 | |
| cd05096 | 304 | cd05096, PTKc_DDR1, Catalytic domain of the Protei | 3e-07 | |
| cd05108 | 316 | cd05108, PTKc_EGFR, Catalytic domain of the Protei | 3e-07 | |
| cd05594 | 325 | cd05594, STKc_PKB_alpha, Catalytic domain of the P | 3e-07 | |
| cd05590 | 320 | cd05590, STKc_nPKC_eta, Catalytic domain of the Pr | 4e-07 | |
| cd05087 | 269 | cd05087, PTKc_Aatyk1_Aatyk3, Catalytic domain of t | 7e-07 | |
| cd06623 | 264 | cd06623, PKc_MAPKK_plant_like, Catalytic domain of | 8e-07 | |
| cd05063 | 268 | cd05063, PTKc_EphR_A2, Catalytic domain of the Pro | 9e-07 | |
| cd06614 | 286 | cd06614, STKc_PAK, Catalytic domain of the Protein | 1e-06 | |
| cd05047 | 270 | cd05047, PTKc_Tie, Catalytic domain of Tie Protein | 1e-06 | |
| cd05044 | 269 | cd05044, PTKc_c-ros, Catalytic domain of the Prote | 2e-06 | |
| PTZ00267 | 478 | PTZ00267, PTZ00267, NIMA-related protein kinase; P | 2e-06 | |
| cd05107 | 401 | cd05107, PTKc_PDGFR_beta, Catalytic domain of the | 4e-06 | |
| PHA03390 | 267 | PHA03390, pk1, serine/threonine-protein kinase 1; | 4e-06 | |
| cd05111 | 279 | cd05111, PTK_HER3, Pseudokinase domain of the Prot | 4e-06 | |
| cd05043 | 280 | cd05043, PTK_Ryk, Pseudokinase domain of Ryk (Rece | 5e-06 | |
| cd05062 | 277 | cd05062, PTKc_IGF-1R, Catalytic domain of the Prot | 8e-06 | |
| cd05109 | 279 | cd05109, PTKc_HER2, Catalytic domain of the Protei | 8e-06 | |
| cd05616 | 323 | cd05616, STKc_cPKC_beta, Catalytic domain of the P | 1e-05 | |
| cd05620 | 316 | cd05620, STKc_nPKC_delta, Catalytic domain of the | 1e-05 | |
| cd05035 | 273 | cd05035, PTKc_Axl_like, Catalytic Domain of Axl-li | 2e-05 | |
| cd05587 | 324 | cd05587, STKc_cPKC, Catalytic domain of the Protei | 2e-05 | |
| cd05086 | 268 | cd05086, PTKc_Aatyk2, Catalytic domain of the Prot | 2e-05 | |
| cd05075 | 272 | cd05075, PTKc_Axl, Catalytic domain of the Protein | 2e-05 | |
| cd07841 | 298 | cd07841, STKc_CDK7, Catalytic domain of the Serine | 3e-05 | |
| cd05082 | 256 | cd05082, PTKc_Csk, Catalytic domain of the Protein | 3e-05 | |
| cd07834 | 330 | cd07834, STKc_MAPK, Catalytic domain of the Serine | 4e-05 | |
| cd05615 | 323 | cd05615, STKc_cPKC_alpha, Catalytic domain of the | 4e-05 | |
| PLN00034 | 353 | PLN00034, PLN00034, mitogen-activated protein kina | 6e-05 | |
| PHA02882 | 294 | PHA02882, PHA02882, putative serine/threonine kina | 6e-05 | |
| cd06612 | 256 | cd06612, STKc_MST1_2, Catalytic domain of the Prot | 2e-04 | |
| cd06609 | 274 | cd06609, STKc_MST3_like, Catalytic domain of Mamma | 2e-04 | |
| cd06623 | 264 | cd06623, PKc_MAPKK_plant_like, Catalytic domain of | 3e-04 | |
| cd08227 | 327 | cd08227, PK_STRAD_alpha, Pseudokinase domain of ST | 4e-04 | |
| PLN00113 | 968 | PLN00113, PLN00113, leucine-rich repeat receptor-l | 5e-04 | |
| cd06614 | 286 | cd06614, STKc_PAK, Catalytic domain of the Protein | 6e-04 | |
| cd06606 | 260 | cd06606, STKc_MAPKKK, Catalytic domain of the Prot | 9e-04 | |
| cd08216 | 314 | cd08216, PK_STRAD, Pseudokinase domain of STE20-re | 0.001 | |
| PLN00034 | 353 | PLN00034, PLN00034, mitogen-activated protein kina | 0.002 | |
| PLN03225 | 566 | PLN03225, PLN03225, Serine/threonine-protein kinas | 0.002 | |
| cd07830 | 283 | cd07830, STKc_MAK_like, Catalytic domain of Male g | 0.004 | |
| cd08216 | 314 | cd08216, PK_STRAD, Pseudokinase domain of STE20-re | 0.004 |
| >gnl|CDD|173744 cd07847, STKc_CDKL1_4, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4 | Back alignment and domain information |
|---|
Score = 308 bits (790), Expect = e-105
Identities = 112/150 (74%), Positives = 137/150 (91%)
Query: 2 ERYEKIGKLGEGSYGVVFKCRNRDTGQVVAIKKFLESEEDPLIRKIALREIRLLKSLKHP 61
E+YEK+ K+GEGSYGVVFKCRNR+TGQ+VAIKKF+ESE+DP+I+KIALREIR+LK LKHP
Sbjct: 1 EKYEKLSKIGEGSYGVVFKCRNRETGQIVAIKKFVESEDDPVIKKIALREIRMLKQLKHP 60
Query: 62 NLVNLLEVFRRKKKLHLVFEFCDHTVLNELENHPHGLPWDLIKQITWQVLRGVSYCHRHA 121
NLVNL+EVFRRK+KLHLVFE+CDHTVLNELE +P G+P LIK+I WQ L+ V++CH+H
Sbjct: 61 NLVNLIEVFRRKRKLHLVFEYCDHTVLNELEKNPRGVPEHLIKKIIWQTLQAVNFCHKHN 120
Query: 122 CIHRDIKPENILLTANGVVKLCDFGFARLI 151
CIHRD+KPENIL+T G +KLCDFGFAR++
Sbjct: 121 CIHRDVKPENILITKQGQIKLCDFGFARIL 150
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The function of CDKL4 is unknown. Length = 286 |
| >gnl|CDD|143338 cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 269 bits (690), Expect = 3e-90
Identities = 120/294 (40%), Positives = 169/294 (57%), Gaps = 38/294 (12%)
Query: 2 ERYEKIGKLGEGSYGVVFKCRNRDTGQVVAIKKFLESEEDPLIRKIALREIRLLKSLKHP 61
+YE +G +GEG+YGVV KCRN+ TG++VAIKKF ESE+D ++K ALRE+++L+ L+H
Sbjct: 1 NKYEVLGVVGEGAYGVVLKCRNKATGEIVAIKKFKESEDDEDVKKTALREVKVLRQLRHE 60
Query: 62 NLVNLLEVFRRKKKLHLVFEFCDHTVLNELENHPHGLPWDLIKQITWQVLRGVSYCHRHA 121
N+VNL E FRRK +L+LVFE+ + T+L LE P GLP D ++ WQ+L+ ++YCH H
Sbjct: 61 NIVNLKEAFRRKGRLYLVFEYVERTLLELLEASPGGLPPDAVRSYIWQLLQAIAYCHSHN 120
Query: 122 CIHRDIKPENILLTANGVVKLCDFGFARLIRDLIPRHLH-------------IFQTNEYF 168
IHRDIKPENIL++ +GV+KLCDFGFAR +R L + Y
Sbjct: 121 IIHRDIKPENILVSESGVLKLCDFGFARALRARPASPLTDYVATRWYRAPELLVGDTNYG 180
Query: 169 KGVSLPHAENVVPLEIKIGKP--AATN----IYLIDFLKRCLDKDPLRRWSCDQLLRHPY 222
K V + A + E+ G+P + +YLI ++CL P +P
Sbjct: 181 KPVDV-WAIGCIMAELLDGEPLFPGDSDIDQLYLI---QKCLGPLPPSHQE--LFSSNPR 234
Query: 223 FNGYYFEVPDEMQ-----YE--------EITQRCLDKDPLRRWSCDQLLRHPYF 263
F G F P + + Y + + CL DP R +CD+LL+HPYF
Sbjct: 235 FAGVAFPEPSQPESLERRYPGKVSSPALDFLKACLRMDPKERLTCDELLQHPYF 288
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning and memory. Length = 288 |
| >gnl|CDD|173743 cd07846, STKc_CDKL2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3 | Back alignment and domain information |
|---|
Score = 255 bits (653), Expect = 1e-84
Identities = 96/150 (64%), Positives = 130/150 (86%)
Query: 2 ERYEKIGKLGEGSYGVVFKCRNRDTGQVVAIKKFLESEEDPLIRKIALREIRLLKSLKHP 61
E+YE +G +GEGSYG+V KC++++TGQ+VAIKKFLESE+D +++KIA+REIR+LK L+H
Sbjct: 1 EKYENLGLVGEGSYGMVMKCKHKETGQIVAIKKFLESEDDKMVKKIAMREIRMLKQLRHE 60
Query: 62 NLVNLLEVFRRKKKLHLVFEFCDHTVLNELENHPHGLPWDLIKQITWQVLRGVSYCHRHA 121
NLVNL+EVFRRKK+L+LVFEF DHTVL++LE +P+GL +++ +Q+LRG+ +CH H
Sbjct: 61 NLVNLIEVFRRKKRLYLVFEFVDHTVLDDLEKYPNGLDESRVRKYLFQILRGIEFCHSHN 120
Query: 122 CIHRDIKPENILLTANGVVKLCDFGFARLI 151
IHRDIKPENIL++ +GVVKLCDFGFAR +
Sbjct: 121 IIHRDIKPENILVSQSGVVKLCDFGFARTL 150
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKIAMRE (NKIATRE in rat), by translocation is associated with mild mental retardation. It has been reported that CDKL3 is lost in leukemic cells having a chromosome arm 5q deletion, and may contribute to the transformed phenotype. Length = 286 |
| >gnl|CDD|143333 cd05118, STKc_CMGC, Catalytic domain of CMGC family Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 219 bits (560), Expect = 1e-70
Identities = 100/286 (34%), Positives = 145/286 (50%), Gaps = 29/286 (10%)
Query: 4 YEKIGKLGEGSYGVVFKCRNRDTGQVVAIKKFLESEEDPLIRKIALREIRLLKSLKHPNL 63
Y+K+GK+GEG+YGVV+K R++ TG++VAIKK E I K ALREI+LLK L HPN+
Sbjct: 1 YQKLGKIGEGTYGVVYKARDKLTGEIVAIKKIKLRFESEGIPKTALREIKLLKELNHPNI 60
Query: 64 VNLLEVFRRKKKLHLVFEFCDHTVLNELENHPHGLPWDLIKQITWQVLRGVSYCHRHACI 123
+ LL+VFR K L+LVFEF D + +++ GLP LIK +Q+L+G+++CH H +
Sbjct: 61 IKLLDVFRHKGDLYLVFEFMDTDLYKLIKDRQRGLPESLIKSYLYQLLQGLAFCHSHGIL 120
Query: 124 HRDIKPENILLTANGVVKLCDFGFARLIRDLIPRHLH------------IFQTNEYFKGV 171
HRD+KPEN+L+ GV+KL DFG AR + + H + Y V
Sbjct: 121 HRDLKPENLLINTEGVLKLADFGLARSFGSPVRPYTHYVVTRWYRAPELLLGDKGYSTPV 180
Query: 172 SLPHAENVVPLEIKIGKPAATNIYLIDFLKRCLDK--DPLRR-WSCDQLLRHPYFNGYYF 228
+ + + E+ +P ID L + P W L + F
Sbjct: 181 DI-WSVGCIFAELLSRRPLFPGKSEIDQLFKIFRTLGTPDPEVWPKFTSL--ARNYKFSF 237
Query: 229 EVPDEMQYEEIT-----------QRCLDKDPLRRWSCDQLLRHPYF 263
M ++ + L DP +R + +Q L HPYF
Sbjct: 238 PKKAGMPLPKLFPNASPQALDLLSQMLHYDPHKRITAEQALAHPYF 283
|
Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Length = 283 |
| >gnl|CDD|214567 smart00220, S_TKc, Serine/Threonine protein kinases, catalytic domain | Back alignment and domain information |
|---|
Score = 210 bits (536), Expect = 2e-67
Identities = 88/257 (34%), Positives = 129/257 (50%), Gaps = 40/257 (15%)
Query: 4 YEKIGKLGEGSYGVVFKCRNRDTGQVVAIKKFLESEEDPLIRKIALREIRLLKSLKHPNL 63
YE + KLGEGS+G V+ R++ TG++VAIK ++ ++ R+ LREI++LK LKHPN+
Sbjct: 1 YEILEKLGEGSFGKVYLARDKKTGKLVAIKV-IKKKKIKKDRERILREIKILKKLKHPNI 59
Query: 64 VNLLEVFRRKKKLHLVFEFCDHTVLNELENHPHGLPWDLIKQITWQVLRGVSYCHRHACI 123
V L +VF + KL+LV E+C+ L +L L D + Q+L + Y H +
Sbjct: 60 VRLYDVFEDEDKLYLVMEYCEGGDLFDLLKKRGRLSEDEARFYLRQILSALEYLHSKGIV 119
Query: 124 HRDIKPENILLTANGVVKLCDFGFARLIRDLIPRHLH------------IFQTNEY-FK- 169
HRD+KPENILL +G VKL DFG AR + L + Y
Sbjct: 120 HRDLKPENILLDEDGHVKLADFGLARQLDP--GEKLTTFVGTPEYMAPEVLLGKGYGKAV 177
Query: 170 -----GVSL----------PHAENVVPLEIKIGKPAATNIY--------LIDFLKRCLDK 206
GV L P + ++ L KIGKP D +++ L K
Sbjct: 178 DIWSLGVILYELLTGKPPFPGDDQLLELFKKIGKPKPPFPPPEWDISPEAKDLIRKLLVK 237
Query: 207 DPLRRWSCDQLLRHPYF 223
DP +R + ++ L+HP+F
Sbjct: 238 DPEKRLTAEEALQHPFF 254
|
Phosphotransferases. Serine or threonine-specific kinase subfamily. Length = 254 |
| >gnl|CDD|173733 cd07829, STKc_CDK_like, Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 209 bits (535), Expect = 8e-67
Identities = 81/147 (55%), Positives = 111/147 (75%), Gaps = 2/147 (1%)
Query: 4 YEKIGKLGEGSYGVVFKCRNRDTGQVVAIKKF-LESEEDPLIRKIALREIRLLKSLKHPN 62
YEK+ KLGEG+YGVV+K R++ TG++VA+KK L++EE+ I ALREI LLK LKHPN
Sbjct: 1 YEKLEKLGEGTYGVVYKARDKKTGEIVALKKIRLDNEEEG-IPSTALREISLLKELKHPN 59
Query: 63 LVNLLEVFRRKKKLHLVFEFCDHTVLNELENHPHGLPWDLIKQITWQVLRGVSYCHRHAC 122
+V LL+V ++KL+LVFE+CD + L+ P L +LIK I +Q+LRG++YCH H
Sbjct: 60 IVKLLDVIHTERKLYLVFEYCDMDLKKYLDKRPGPLSPNLIKSIMYQLLRGLAYCHSHRI 119
Query: 123 IHRDIKPENILLTANGVVKLCDFGFAR 149
+HRD+KP+NIL+ +GV+KL DFG AR
Sbjct: 120 LHRDLKPQNILINRDGVLKLADFGLAR 146
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the early G1 phase by CDK4 or CDK6, the G1/S phase transition by CDK2, or the entry of mitosis by CDK1. They also exhibit overlapping cyclin specificity and functions in certain conditions. Knockout mice with a single CDK deleted remain viable with specific phenotypes, showing that some CDKs can compensate for each other. For example, CDK4 can compensate for the loss of CDK6, however, double knockout mice with both CDK4 and CDK6 deleted die in utero. CDK8 and CDK9 are mainly involved in transcription while CDK5 is implicated in neuronal function. CDK7 plays essential roles in both the cell cycle as a CDK-Activating Kinase (CAK) and in transcription as a component of the general transcription factor TFIIH. Length = 282 |
| >gnl|CDD|215690 pfam00069, Pkinase, Protein kinase domain | Back alignment and domain information |
|---|
Score = 207 bits (528), Expect = 4e-66
Identities = 87/260 (33%), Positives = 131/260 (50%), Gaps = 40/260 (15%)
Query: 4 YEKIGKLGEGSYGVVFKCRNRDTGQVVAIKKFLESEEDPLIRKIALREIRLLKSLKHPNL 63
YE + KLG GS+G V+K +++ TG++VA+K + E + A REIR+L+ L HPN+
Sbjct: 1 YELLRKLGSGSFGTVYKAKHKGTGKIVAVKILKKRSEKSKKDQTARREIRILRRLSHPNI 60
Query: 64 VNLLEVFRRKKKLHLVFEFCDHTVLNELENHPHGLPWDLIKQITWQVLRGVSYCHRHACI 123
V L++ F K L+LV E+C+ L + + L D K+I Q+LRG+ Y H + I
Sbjct: 61 VRLIDAFEDKDHLYLVMEYCEGGDLFDYLSRGGPLSEDEAKKIALQILRGLEYLHSNGII 120
Query: 124 HRDIKPENILLTANGVVKLCDFGFARLIRDLIPRHLHIFQTNEY---------------- 167
HRD+KPENILL NGVVK+ DFG A+ + T Y
Sbjct: 121 HRDLKPENILLDENGVVKIADFGLAKKLLKSSSSLTTFVGTPWYMAPEVLLGGNGYGPKV 180
Query: 168 ------------FKGVSLPHAENVV------------PLEIKIGKPAATNIYLIDFLKRC 203
G EN++ PLE K ++ + D +K+C
Sbjct: 181 DVWSLGVILYELLTGKPPFSGENILDQLQLIRRILGPPLEFDEPKWSSGSEEAKDLIKKC 240
Query: 204 LDKDPLRRWSCDQLLRHPYF 223
L+KDP +R + +++L+HP+F
Sbjct: 241 LNKDPSKRPTAEEILQHPWF 260
|
Length = 260 |
| >gnl|CDD|173623 cd00180, PKc, Catalytic domain of Protein Kinases | Back alignment and domain information |
|---|
Score = 180 bits (458), Expect = 4e-56
Identities = 80/228 (35%), Positives = 121/228 (53%), Gaps = 29/228 (12%)
Query: 10 LGEGSYGVVFKCRNRDTGQVVAIKKFLESEEDPLIRKIALREIRLLKSLKHPNLVNLLEV 69
LGEG +G V+ R++ TG+ VAIK + + L+ ++ LREI +LK L HPN+V L V
Sbjct: 1 LGEGGFGTVYLARDKKTGKKVAIKIIKKEDSSSLLEEL-LREIEILKKLNHPNIVKLYGV 59
Query: 70 FRRKKKLHLVFEFCDH-TVLNELENHPHGLPWDLIKQITWQVLRGVSYCHRHACIHRDIK 128
F + L+LV E+C+ ++ + L+ + L D I +I Q+L G+ Y H + IHRD+K
Sbjct: 60 FEDENHLYLVMEYCEGGSLKDLLKENEGKLSEDEILRILLQILEGLEYLHSNGIIHRDLK 119
Query: 129 PENILLTA-NGVVKLCDFGFARLIRDLIPRHLHIFQTNEYFKGVSLPHAENVVPLEIKIG 187
PENILL + NG VKL DFG ++L+ I T Y + E+ +G
Sbjct: 120 PENILLDSDNGKVKLADFGLSKLLTSDKSLLKTIVGTPAY------------MAPEVLLG 167
Query: 188 KPAATN---IY-----------LIDFLKRCLDKDPLRRWSCDQLLRHP 221
K + I+ L D +++ L KDP +R S ++L H
Sbjct: 168 KGYYSEKSDIWSLGVILYELPELKDLIRKMLQKDPEKRPSAKEILEHL 215
|
Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which one kinase activates a second kinase, which in turn, may act on other kinases; this sequential action transmits a signal from the cell surface to target proteins, which results in cellular responses. The PK family is one of the largest known protein families with more than 100 homologous yeast enzymes and 550 human proteins. A fraction of PK family members are pseudokinases that lack crucial residues for catalytic activity. The mutiplicity of kinases allows for specific regulation according to substrate, tissue distribution, and cellular localization. PKs regulate many cellular processes including proliferation, division, differentiation, motility, survival, metabolism, cell-cycle progression, cytoskeletal rearrangement, immunity, and neuronal functions. Many kinases are implicated in the development of various human diseases including different types of cancer. Length = 215 |
| >gnl|CDD|173745 cd07848, STKc_CDKL5, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5 | Back alignment and domain information |
|---|
Score = 167 bits (424), Expect = 2e-50
Identities = 70/147 (47%), Positives = 114/147 (77%)
Query: 3 RYEKIGKLGEGSYGVVFKCRNRDTGQVVAIKKFLESEEDPLIRKIALREIRLLKSLKHPN 62
++E +G +GEG+YGVV KCR+++T ++VAIKKF +SEE+ +++ LRE+++L++LK N
Sbjct: 2 KFEVLGVVGEGAYGVVLKCRHKETKEIVAIKKFKDSEENEEVKETTLRELKMLRTLKQEN 61
Query: 63 LVNLLEVFRRKKKLHLVFEFCDHTVLNELENHPHGLPWDLIKQITWQVLRGVSYCHRHAC 122
+V L E FRR+ KL+LVFE+ + +L LE P+G+P + ++ +Q+++ + +CH++
Sbjct: 62 IVELKEAFRRRGKLYLVFEYVEKNMLELLEEMPNGVPPEKVRSYIYQLIKAIHWCHKNDI 121
Query: 123 IHRDIKPENILLTANGVVKLCDFGFAR 149
+HRDIKPEN+L++ N V+KLCDFGFAR
Sbjct: 122 VHRDIKPENLLISHNDVLKLCDFGFAR 148
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes cause a phenotype similar to Rett syndrome (RTT), a progressive neurodevelopmental disorder. These pathogenic mutations are located in the N-terminal portion of the protein within the kinase domain. Length = 287 |
| >gnl|CDD|173738 cd07835, STKc_CDK1_like, Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 166 bits (423), Expect = 4e-50
Identities = 72/148 (48%), Positives = 106/148 (71%), Gaps = 3/148 (2%)
Query: 4 YEKIGKLGEGSYGVVFKCRNRDTGQVVAIKKF-LESEEDPLIRKIALREIRLLKSLKHPN 62
Y+K+ K+GEG+YGVV+K R++ TG++VA+KK LE+E++ + A+REI LLK L HPN
Sbjct: 1 YQKVEKIGEGTYGVVYKARDKLTGEIVALKKIRLETEDEG-VPSTAIREISLLKELNHPN 59
Query: 63 LVNLLEVFRRKKKLHLVFEFCDHTVLNELENHPH-GLPWDLIKQITWQVLRGVSYCHRHA 121
+V LL+V + KL+LVFEF D + +++ P GL LIK +Q+L+G++YCH H
Sbjct: 60 IVRLLDVVHSENKLYLVFEFLDLDLKKYMDSSPLTGLDPPLIKSYLYQLLQGIAYCHSHR 119
Query: 122 CIHRDIKPENILLTANGVVKLCDFGFAR 149
+HRD+KP+N+L+ G +KL DFG AR
Sbjct: 120 VLHRDLKPQNLLIDREGALKLADFGLAR 147
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression while the CDK1/cyclin B complex is critical for G2 to M phase transition. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. Studies in knockout mice revealed that CDK1 can compensate for the loss of the cdk2 gene as it can also bind cyclin E and drive G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 283 |
| >gnl|CDD|173734 cd07830, STKc_MAK_like, Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 166 bits (422), Expect = 6e-50
Identities = 61/154 (39%), Positives = 99/154 (64%), Gaps = 9/154 (5%)
Query: 4 YEKIGKLGEGSYGVVFKCRNRDTGQVVAIKKF---LESEEDPLIRKIALREIRLLKSLK- 59
Y+ I +LG+G++G V+ RN++TG++VAIKK S E+ + LRE++ L+ L
Sbjct: 1 YKVIKQLGDGTFGSVYLARNKETGELVAIKKMKKKFYSWEECM----NLREVKSLRKLNE 56
Query: 60 HPNLVNLLEVFRRKKKLHLVFEFCDHTVLNELENHPHG-LPWDLIKQITWQVLRGVSYCH 118
HPN+V L EVFR +L+ VFE+ + + +++ +I+ I +Q+L+G+++ H
Sbjct: 57 HPNIVKLKEVFRENDELYFVFEYMEGNLYQLMKDRKGKPFSESVIRSIIYQILQGLAHIH 116
Query: 119 RHACIHRDIKPENILLTANGVVKLCDFGFARLIR 152
+H HRD+KPEN+L++ VVK+ DFG AR IR
Sbjct: 117 KHGFFHRDLKPENLLVSGPEVVKIADFGLAREIR 150
|
Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertility. It functions as a coactivator of the androgen receptor in prostate cells. MRK, also called Intestinal Cell Kinase (ICK), is expressed ubiquitously, with highest expression in the ovary and uterus. A missense mutation in MRK causes endocrine-cerebro-osteodysplasia (ECO), suggesting that this protein plays an important role in the development of many organs. MAK and MRK may be involved in regulating cell cycle and cell fate. Ime2p is a meiosis-specific kinase that is important during meiotic initiation and during the later stages of meiosis. Mde3 functions downstream of the transcription factor Mei-4 which is essential for meiotic prophase I. Length = 283 |
| >gnl|CDD|143346 cd07841, STKc_CDK7, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7 | Back alignment and domain information |
|---|
Score = 162 bits (412), Expect = 3e-48
Identities = 70/165 (42%), Positives = 94/165 (56%), Gaps = 33/165 (20%)
Query: 3 RYEKIGKLGEGSYGVVFKCRNRDTGQVVAIKKF---LESEEDPLIRKIALREIRLLKSLK 59
RYEK KLGEG+Y VV+K R+++TG++VAIKK E I ALREI+LL+ LK
Sbjct: 1 RYEKGKKLGEGTYAVVYKARDKETGRIVAIKKIKLGERKEAKDGINFTALREIKLLQELK 60
Query: 60 HPNLVNLLEVFRRKKKLHLVFEFCDHTVLNELENHPHGLPWDL---------------IK 104
HPN++ LL+VF K ++LVFEF + DL IK
Sbjct: 61 HPNIIGLLDVFGHKSNINLVFEFME---------------TDLEKVIKDKSIVLTPADIK 105
Query: 105 QITWQVLRGVSYCHRHACIHRDIKPENILLTANGVVKLCDFGFAR 149
LRG+ Y H + +HRD+KP N+L+ ++GV+KL DFG AR
Sbjct: 106 SYMLMTLRGLEYLHSNWILHRDLKPNNLLIASDGVLKLADFGLAR 150
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is also a component of the general transcription factor TFIIH, which phosphorylates the C-terminal domain (CTD) of RNA polymerase II when it is bound with unphosphorylated DNA, as present in the pre-initiation complex. Following phosphorylation, the CTD dissociates from the DNA which allows transcription initiation. Length = 298 |
| >gnl|CDD|143344 cd07839, STKc_CDK5, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5 | Back alignment and domain information |
|---|
Score = 161 bits (410), Expect = 3e-48
Identities = 66/147 (44%), Positives = 101/147 (68%)
Query: 3 RYEKIGKLGEGSYGVVFKCRNRDTGQVVAIKKFLESEEDPLIRKIALREIRLLKSLKHPN 62
+YEK+ K+GEG+YG VFK +NR+T ++VA+K+ ++D + ALREI LLK LKH N
Sbjct: 1 KYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKN 60
Query: 63 LVNLLEVFRRKKKLHLVFEFCDHTVLNELENHPHGLPWDLIKQITWQVLRGVSYCHRHAC 122
+V L +V KKL LVFE+CD + ++ + +++K +Q+L+G+++CH H
Sbjct: 61 IVRLYDVLHSDKKLTLVFEYCDQDLKKYFDSCNGDIDPEIVKSFMFQLLKGLAFCHSHNV 120
Query: 123 IHRDIKPENILLTANGVVKLCDFGFAR 149
+HRD+KP+N+L+ NG +KL DFG AR
Sbjct: 121 LHRDLKPQNLLINKNGELKLADFGLAR 147
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also important in synaptic plasticity and learning. CDK5 also participates in protecting against cell death and promoting angiogenesis. Impaired CDK5 activity is implicated in Alzheimer's disease, amyotrophic lateral sclerosis, Parkinson's disease, Huntington's disease and acute neuronal injury. Length = 284 |
| >gnl|CDD|173751 cd07860, STKc_CDK2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3 | Back alignment and domain information |
|---|
Score = 160 bits (406), Expect = 1e-47
Identities = 69/147 (46%), Positives = 100/147 (68%), Gaps = 1/147 (0%)
Query: 4 YEKIGKLGEGSYGVVFKCRNRDTGQVVAIKKFLESEEDPLIRKIALREIRLLKSLKHPNL 63
++K+ K+GEG+YGVV+K RN+ TG+VVA+KK E + A+REI LLK L HPN+
Sbjct: 2 FQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNI 61
Query: 64 VNLLEVFRRKKKLHLVFEFCDHTVLNELENHP-HGLPWDLIKQITWQVLRGVSYCHRHAC 122
V LL+V + KL+LVFEF + ++ P G+P LIK +Q+L+G+++CH H
Sbjct: 62 VKLLDVIHTENKLYLVFEFLHQDLKKFMDASPLSGIPLPLIKSYLFQLLQGLAFCHSHRV 121
Query: 123 IHRDIKPENILLTANGVVKLCDFGFAR 149
+HRD+KP+N+L+ G +KL DFG AR
Sbjct: 122 LHRDLKPQNLLINTEGAIKLADFGLAR 148
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. CDK2, together with CDK4, also regulates embryonic cell proliferation. Despite these important roles, mice deleted for the cdk2 gene are viable and normal except for being sterile. This may be due to compensation provided by CDK1 (also called Cdc2), which can also bind cyclin E and drive the G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 284 |
| >gnl|CDD|143345 cd07840, STKc_CDK9_like, Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 160 bits (407), Expect = 1e-47
Identities = 65/150 (43%), Positives = 93/150 (62%), Gaps = 2/150 (1%)
Query: 4 YEKIGKLGEGSYGVVFKCRNRDTGQVVAIKKFLESEEDPLIRKIALREIRLLKSLKHPNL 63
YEKI ++GEG+YG V+K RN+ TG++VA+KK E A+REI+LL+ L+HPN+
Sbjct: 1 YEKIAQIGEGTYGQVYKARNKKTGELVALKKIRMENEKEGFPITAIREIKLLQKLRHPNI 60
Query: 64 VNLLEVFRRKKK--LHLVFEFCDHTVLNELENHPHGLPWDLIKQITWQVLRGVSYCHRHA 121
V L E+ K K +++VFE+ DH + L++ IK Q+L G+ Y H +
Sbjct: 61 VRLKEIVTSKGKGSIYMVFEYMDHDLTGLLDSPEVKFTESQIKCYMKQLLEGLQYLHSNG 120
Query: 122 CIHRDIKPENILLTANGVVKLCDFGFARLI 151
+HRDIK NIL+ +GV+KL DFG AR
Sbjct: 121 ILHRDIKGSNILINNDGVLKLADFGLARPY 150
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA polymerase II and participate in regulating mutliple steps of gene expression including transcription elongation and RNA processing. CDK9 and CdkC associate with T-type cyclins while BUR1 associates with the cyclin BUR2. CDK12 is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 interacts with cyclins L1 and L2, and participates in regulating transcription and alternative splicing. Length = 287 |
| >gnl|CDD|173752 cd07861, STKc_CDK1_euk, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like | Back alignment and domain information |
|---|
Score = 159 bits (404), Expect = 3e-47
Identities = 71/149 (47%), Positives = 105/149 (70%), Gaps = 4/149 (2%)
Query: 4 YEKIGKLGEGSYGVVFKCRNRDTGQVVAIKKF-LESEEDPLIRKIALREIRLLKSLKHPN 62
Y KI K+GEG+YGVV+K RN+ TGQ+VA+KK LESEE+ + A+REI LLK L+HPN
Sbjct: 2 YTKIEKIGEGTYGVVYKGRNKKTGQIVAMKKIRLESEEEG-VPSTAIREISLLKELQHPN 60
Query: 63 LVNLLEVFRRKKKLHLVFEFCDHTVLNELENHPHG--LPWDLIKQITWQVLRGVSYCHRH 120
+V L +V ++ +L+L+FEF + L++ P G + +L+K +Q+L+G+ +CH
Sbjct: 61 IVCLQDVLMQESRLYLIFEFLSMDLKKYLDSLPKGQYMDAELVKSYLYQILQGILFCHSR 120
Query: 121 ACIHRDIKPENILLTANGVVKLCDFGFAR 149
+HRD+KP+N+L+ GV+KL DFG AR
Sbjct: 121 RVLHRDLKPQNLLIDNKGVIKLADFGLAR 149
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression. CDK1/cyclin A2 has also been implicated as an important regulator of S phase events. The CDK1/cyclin B complex is critical for G2 to M phase transition. It induces mitosis by activating nuclear enzymes that regulate chromatin condensation, nuclear membrane degradation, mitosis-specific microtubule and cytoskeletal reorganization. CDK1 also associates with cyclin E and plays a role in the entry into S phase. CDK1 transcription is stable throughout the cell cycle but is modulated in some pathological conditions. It may play a role in regulating apoptosis under these conditions. In breast cancer cells, HER2 can mediate apoptosis by inactivating CDK1. Activation of CDK1 may contribute to HIV-1 induced apoptosis and neuronal apoptosis in neurodegenerative diseases. Length = 285 |
| >gnl|CDD|173724 cd06606, STKc_MAPKKK, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase | Back alignment and domain information |
|---|
Score = 156 bits (398), Expect = 1e-46
Identities = 77/262 (29%), Positives = 126/262 (48%), Gaps = 43/262 (16%)
Query: 3 RYEKIGKLGEGSYGVVFKCRNRDTGQVVAIKKFLESEEDP-LIRKIALREIRLLKSLKHP 61
+ + LG GS+G V+ ++DTG+++A+K S + + + REIR+L SL+HP
Sbjct: 1 EWTRGELLGRGSFGSVYLALDKDTGELMAVKSVELSGDSEEELEAL-EREIRILSSLQHP 59
Query: 62 NLVNLL--EVFRRKKKLHLVFEFCDH-TVLNELENHPHGLPWDLIKQITWQVLRGVSYCH 118
N+V E K L++ E+ ++ + L+ LP +I++ T Q+L G++Y H
Sbjct: 60 NIVRYYGSERDEEKNTLNIFLEYVSGGSLSSLLKKFG-KLPEPVIRKYTRQILEGLAYLH 118
Query: 119 RHACIHRDIKPENILLTANGVVKLCDFGFARLIRDLIPRH-LHIFQ------------TN 165
+ +HRDIK NIL+ ++GVVKL DFG A+ + D+ +
Sbjct: 119 SNGIVHRDIKGANILVDSDGVVKLADFGCAKRLGDIETGEGTGSVRGTPYWMAPEVIRGE 178
Query: 166 EYFKGV---SL--------------PHAENVVPLEIKIGK-------PAATNIYLIDFLK 201
EY + SL N + KIG P + DFL+
Sbjct: 179 EYGRAADIWSLGCTVIEMATGKPPWSELGNPMAALYKIGSSGEPPEIPEHLSEEAKDFLR 238
Query: 202 RCLDKDPLRRWSCDQLLRHPYF 223
+CL +DP +R + D+LL+HP+
Sbjct: 239 KCLRRDPKKRPTADELLQHPFL 260
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKKK5) and ASK2 (or MAPKKK6), MEKK1, MEKK2, MEKK3, MEKK4, as well as plant and fungal MAPKKKs. Also included in this subfamily are the cell division control proteins Schizosaccharomyces pombe Cdc7 and Saccharomyces cerevisiae Cdc15. Length = 260 |
| >gnl|CDD|173659 cd05122, PKc_STE, Catalytic domain of STE family Protein Kinases | Back alignment and domain information |
|---|
Score = 153 bits (389), Expect = 2e-45
Identities = 82/257 (31%), Positives = 132/257 (51%), Gaps = 43/257 (16%)
Query: 4 YEKIGKLGEGSYGVVFKCRNRDTGQVVAIKKF-LESEEDPLIRKIALREIRLLKSLKHPN 62
+E + K+G+G +G V+K R++ TG+ VAIK LES+E KI + EI++LK KHPN
Sbjct: 2 FEILEKIGKGGFGEVYKARHKRTGKEVAIKVIKLESKEK--KEKI-INEIQILKKCKHPN 58
Query: 63 LVNLLEVFRRKKKLHLVFEFCDH-TVLNELENHPHGLPWDLIKQITWQVLRGVSYCHRHA 121
+V + +K +L +V EFC ++ + L++ L I + ++L+G+ Y H +
Sbjct: 59 IVKYYGSYLKKDELWIVMEFCSGGSLKDLLKSTNQTLTESQIAYVCKELLKGLEYLHSNG 118
Query: 122 CIHRDIKPENILLTANGVVKLCDFGFARLIRDLIPRHLH-----------IFQTNEYFK- 169
IHRDIK NILLT++G VKL DFG + + D R+ I +K
Sbjct: 119 IIHRDIKAANILLTSDGEVKLIDFGLSAQLSDTKARNTMVGTPYWMAPEVINGKPYDYKA 178
Query: 170 -----GVSL--------PHAE-----------NVVPLEIKIGKPAATNIYLIDFLKRCLD 205
G++ P++E P ++ + + DFLK+CL
Sbjct: 179 DIWSLGITAIELAEGKPPYSELPPMKALFKIATNGPPGLRNPEKWSDEFK--DFLKKCLQ 236
Query: 206 KDPLRRWSCDQLLRHPY 222
K+P +R + +QLL+HP+
Sbjct: 237 KNPEKRPTAEQLLKHPF 253
|
Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPKK, which itself is phosphorylated and activated by a MAPKKK. Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAPKKK to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. Other STE family members include p21-activated kinases (PAKs) and class III myosins, among others. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain, which can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, as well as autophosphorylate the C-terminal motor domain. They play an important role in maintaining the structural integrity of photoreceptor cell microvilli. Length = 253 |
| >gnl|CDD|173742 cd07845, STKc_CDK10, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10 | Back alignment and domain information |
|---|
Score = 153 bits (388), Expect = 1e-44
Identities = 61/153 (39%), Positives = 98/153 (64%), Gaps = 8/153 (5%)
Query: 4 YEKIGKLGEGSYGVVFKCRNRDTGQVVAIKKF-LESEED--PLIRKIALREIRLLKSLKH 60
+EK+ ++GEG+YG+V++ R+ +G++VA+KK +++E D P+ +LREI LL +L+H
Sbjct: 9 FEKLNRIGEGTYGIVYRARDTTSGEIVALKKVRMDNERDGIPIS---SLREITLLLNLRH 65
Query: 61 PNLVNLLEVF--RRKKKLHLVFEFCDHTVLNELENHPHGLPWDLIKQITWQVLRGVSYCH 118
PN+V L EV + + LV E+C+ + + L+N P +K + Q+LRG+ Y H
Sbjct: 66 PNIVELKEVVVGKHLDSIFLVMEYCEQDLASLLDNMPTPFSESQVKCLMLQLLRGLQYLH 125
Query: 119 RHACIHRDIKPENILLTANGVVKLCDFGFARLI 151
+ IHRD+K N+LLT G +K+ DFG AR
Sbjct: 126 ENFIIHRDLKVSNLLLTDKGCLKIADFGLARTY 158
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing increases the transcription of c-RAF and the activation of the p42/p44 MAPK pathway, which leads to antiestrogen resistance. Patients who express low levels of CDK10 relapse early on tamoxifen. Length = 309 |
| >gnl|CDD|173739 cd07838, STKc_CDK4_6_like, Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 148 bits (377), Expect = 4e-43
Identities = 71/156 (45%), Positives = 99/156 (63%), Gaps = 9/156 (5%)
Query: 4 YEKIGKLGEGSYGVVFKCRNRDTGQVVAIKKFLESEEDPLIRKIALREIRLLKSLK---H 60
YE++ ++GEG+YG V+K R+ +TG+ VA+KK + I LREI LLK L+ H
Sbjct: 1 YEELAEIGEGAYGTVYKARDLNTGRFVALKKVRVPLSEEGIPLSTLREIALLKQLESFEH 60
Query: 61 PNLVNLLEVF-----RRKKKLHLVFEFCDHTVLNELENHPH-GLPWDLIKQITWQVLRGV 114
PN+V LL+V R+ KL LVFE D + L P GLP + IK + Q+LRGV
Sbjct: 61 PNIVRLLDVCHGPRTDRELKLTLVFEHVDQDLATYLSKCPKPGLPPETIKDLMRQLLRGV 120
Query: 115 SYCHRHACIHRDIKPENILLTANGVVKLCDFGFARL 150
+ H H +HRD+KP+NIL+T++G VK+ DFG AR+
Sbjct: 121 DFLHSHRIVHRDLKPQNILVTSDGQVKIADFGLARI 156
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both expressed ubiquitously, associate with all three D cyclins (D1, D2 and D3), and phosphorylate the retinoblastoma (pRb) protein. They are also regulated by the INK4 family of inhibitors which associate with either the CDK alone or the CDK/cyclin complex. CDK4 and CDK6 show differences in subcellular localization, sensitivity to some inhibitors, timing in activation, tumor selectivity, and possibly substrate profiles. Although CDK4 and CDK6 seem to show some redundancy, they also have discrete, nonoverlapping functions. CDK6 plays an important role in cell differentiation. Length = 287 |
| >gnl|CDD|173736 cd07832, STKc_CCRK, Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase | Back alignment and domain information |
|---|
Score = 148 bits (375), Expect = 6e-43
Identities = 62/155 (40%), Positives = 98/155 (63%)
Query: 3 RYEKIGKLGEGSYGVVFKCRNRDTGQVVAIKKFLESEEDPLIRKIALREIRLLKSLKHPN 62
RY+ +G++GEG++G+VFK ++R+TG+ VA+KK + I ALREI+ L++ +HP
Sbjct: 1 RYKILGRIGEGAHGIVFKAKDRETGETVALKKVALRRLEGGIPNQALREIKALQACQHPY 60
Query: 63 LVNLLEVFRRKKKLHLVFEFCDHTVLNELENHPHGLPWDLIKQITWQVLRGVSYCHRHAC 122
+V LL+VF LV E+ + L + LP +K +L+GV+Y H +
Sbjct: 61 VVKLLDVFPHGSGFVLVMEYMPSDLSEVLRDEERPLPEAQVKSYMRMLLKGVAYMHANGI 120
Query: 123 IHRDIKPENILLTANGVVKLCDFGFARLIRDLIPR 157
+HRD+KP N+L++A+GV+K+ DFG ARL + PR
Sbjct: 121 MHRDLKPANLLISADGVLKIADFGLARLFSEEEPR 155
|
Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of heart failure. Length = 286 |
| >gnl|CDD|143349 cd07844, STKc_PCTAIRE_like, Catalytic domain of PCTAIRE-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 146 bits (370), Expect = 3e-42
Identities = 68/151 (45%), Positives = 100/151 (66%), Gaps = 5/151 (3%)
Query: 1 MERYEKIGKLGEGSYGVVFKCRNRDTGQVVAIKKF-LESEED-PLIRKIALREIRLLKSL 58
+E Y+K+ KLGEGSY V+K R++ TGQ+VA+K+ LE EE P A+RE LLK L
Sbjct: 4 LETYKKLDKLGEGSYATVYKGRSKLTGQLVALKEIRLEHEEGAPFT---AIREASLLKDL 60
Query: 59 KHPNLVNLLEVFRRKKKLHLVFEFCDHTVLNELENHPHGLPWDLIKQITWQVLRGVSYCH 118
KH N+V L ++ KK L LVFE+ D + +++ GL ++ +Q+LRG++YCH
Sbjct: 61 KHANIVTLHDIIHTKKTLTLVFEYLDTDLKQYMDDCGGGLSMHNVRLFLFQLLRGLAYCH 120
Query: 119 RHACIHRDIKPENILLTANGVVKLCDFGFAR 149
+ +HRD+KP+N+L++ G +KL DFG AR
Sbjct: 121 QRRVLHRDLKPQNLLISERGELKLADFGLAR 151
|
Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the membrane-associated cyclin Y. PCTAIRE-like proteins show unusual expression patterns with high levels in post-mitotic tissues, suggesting that they may be involved in regulating post-mitotic cellular events. Length = 291 |
| >gnl|CDD|173754 cd07865, STKc_CDK9, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9 | Back alignment and domain information |
|---|
Score = 146 bits (371), Expect = 4e-42
Identities = 69/158 (43%), Positives = 100/158 (63%), Gaps = 14/158 (8%)
Query: 3 RYEKIGKLGEGSYGVVFKCRNRDTGQVVAIKKFL---ESEEDPLIRKIALREIRLLKSLK 59
+YEK+ K+G+G++G VFK R++ T Q+VA+KK L E E P+ ALREI++L+ LK
Sbjct: 13 KYEKLAKIGQGTFGEVFKARHKKTKQIVALKKVLMENEKEGFPIT---ALREIKILQLLK 69
Query: 60 HPNLVNLLEVFRRKKK--------LHLVFEFCDHTVLNELENHPHGLPWDLIKQITWQVL 111
H N+VNL+E+ R K +LVFEFC+H + L N IK++ +L
Sbjct: 70 HENVVNLIEICRTKATPYNRYKGSFYLVFEFCEHDLAGLLSNKNVKFTLSEIKKVMKMLL 129
Query: 112 RGVSYCHRHACIHRDIKPENILLTANGVVKLCDFGFAR 149
G+ Y HR+ +HRD+K NIL+T +G++KL DFG AR
Sbjct: 130 NGLYYIHRNKILHRDMKAANILITKDGILKLADFGLAR 167
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multiple steps of gene expression including transcription elongation, mRNA synthesis, processing, export, and translation. It also plays a role in mediating cytokine induced transcription networks such as IL6-induced STAT3 signaling. In addition, the CDK9/cyclin T2a complex promotes muscle differentiation and enhances the function of some myogenic regulatory factors. Length = 310 |
| >gnl|CDD|143341 cd07836, STKc_Pho85, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85 | Back alignment and domain information |
|---|
Score = 145 bits (367), Expect = 8e-42
Identities = 63/149 (42%), Positives = 99/149 (66%), Gaps = 5/149 (3%)
Query: 4 YEKIGKLGEGSYGVVFKCRNRDTGQVVAIKKF-LESEEDPLIRKIALREIRLLKSLKHPN 62
++++ KLGEG+Y V+K RNR TG++VA+K+ L++EE A+REI L+K LKH N
Sbjct: 2 FKQLEKLGEGTYATVYKGRNRTTGEIVALKEIHLDAEEG--TPSTAIREISLMKELKHEN 59
Query: 63 LVNLLEVFRRKKKLHLVFEFCDHTVLNELENHPH--GLPWDLIKQITWQVLRGVSYCHRH 120
+V L +V + KL LVFE+ D + ++ H L + +K T+Q+L+G+++CH +
Sbjct: 60 IVRLHDVIHTENKLMLVFEYMDKDLKKYMDTHGVRGALDPNTVKSFTYQLLKGIAFCHEN 119
Query: 121 ACIHRDIKPENILLTANGVVKLCDFGFAR 149
+HRD+KP+N+L+ G +KL DFG AR
Sbjct: 120 RVLHRDLKPQNLLINKRGELKLADFGLAR 148
|
Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment. It is not essential for yeast viability and is the functional homolog of mammalian CDK5, which plays a role in central nervous system development. Length = 284 |
| >gnl|CDD|132942 cd06611, STKc_SLK_like, Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 144 bits (365), Expect = 2e-41
Identities = 90/267 (33%), Positives = 136/267 (50%), Gaps = 49/267 (18%)
Query: 2 ERYEKIGKLGEGSYGVVFKCRNRDTGQVVAIKKFLESEEDPLIRKIALREIRLLKSLKHP 61
+ +E IG+LG+G++G V+K ++++TG A K E+ L + + EI +L KHP
Sbjct: 5 DIWEIIGELGDGAFGKVYKAQHKETGLFAAAKIIQIESEEEL--EDFMVEIDILSECKHP 62
Query: 62 NLVNLLEVFRRKKKLHLVFEFCD----HTVLNELENHPHGLPWDLIKQITWQVLRGVSYC 117
N+V L E + + KL ++ EFCD +++ ELE GL I+ + Q+L +++
Sbjct: 63 NIVGLYEAYFYENKLWILIEFCDGGALDSIMLELE---RGLTEPQIRYVCRQMLEALNFL 119
Query: 118 HRHACIHRDIKPENILLTANGVVKLCDFGF-ARLIRDLIPRHLHI--------------- 161
H H IHRD+K NILLT +G VKL DFG A+ L R I
Sbjct: 120 HSHKVIHRDLKAGNILLTLDGDVKLADFGVSAKNKSTLQKRDTFIGTPYWMAPEVVACET 179
Query: 162 FQTNEY-FK------GVSL--------PHAE-NVVPLEIKIGK--------PAATNIYLI 197
F+ N Y +K G++L PH E N + + +KI K P+ +
Sbjct: 180 FKDNPYDYKADIWSLGITLIELAQMEPPHHELNPMRVLLKILKSEPPTLDQPSKWSSSFN 239
Query: 198 DFLKRCLDKDPLRRWSCDQLLRHPYFN 224
DFLK CL KDP R + +LL+HP+ +
Sbjct: 240 DFLKSCLVKDPDDRPTAAELLKHPFVS 266
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. SmSLK is capable of activating the MAPK Jun N-terminal kinase (JNK) pathway in human embryonic kidney (HEK) cells as well as in Xenopus oocytes. It may participate in regulating MAPK cascades during host-parasite interactions. Length = 280 |
| >gnl|CDD|177649 PLN00009, PLN00009, cyclin-dependent kinase A; Provisional | Back alignment and domain information |
|---|
Score = 143 bits (361), Expect = 7e-41
Identities = 66/151 (43%), Positives = 101/151 (66%), Gaps = 2/151 (1%)
Query: 1 MERYEKIGKLGEGSYGVVFKCRNRDTGQVVAIKKFLESEEDPLIRKIALREIRLLKSLKH 60
M++YEK+ K+GEG+YGVV+K R+R T + +A+KK +ED + A+REI LLK ++H
Sbjct: 1 MDQYEKVEKIGEGTYGVVYKARDRVTNETIALKKIRLEQEDEGVPSTAIREISLLKEMQH 60
Query: 61 PNLVNLLEVFRRKKKLHLVFEFCDHTVLNELENHPH-GLPWDLIKQITWQVLRGVSYCHR 119
N+V L +V +K+L+LVFE+ D + +++ P LIK +Q+LRG++YCH
Sbjct: 61 GNIVRLQDVVHSEKRLYLVFEYLDLDLKKHMDSSPDFAKNPRLIKTYLYQILRGIAYCHS 120
Query: 120 HACIHRDIKPENILLT-ANGVVKLCDFGFAR 149
H +HRD+KP+N+L+ +KL DFG AR
Sbjct: 121 HRVLHRDLKPQNLLIDRRTNALKLADFGLAR 151
|
Length = 294 |
| >gnl|CDD|173737 cd07834, STKc_MAPK, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 143 bits (363), Expect = 1e-40
Identities = 61/154 (39%), Positives = 93/154 (60%), Gaps = 6/154 (3%)
Query: 3 RYEKIGKLGEGSYGVVFKCRNRDTGQVVAIKKFLESEEDPLIRKIALREIRLLKSLKHPN 62
RYE + +G G+YGVV ++ TG+ VAIKK +D + K LREI+LL+ L+H N
Sbjct: 1 RYELLKPIGSGAYGVVCSAVDKRTGRKVAIKKISNVFDDLIDAKRILREIKLLRHLRHEN 60
Query: 63 LVNLLEVFRRKKK-----LHLVFEFCDHTVLNELENHPHGLPWDLIKQITWQVLRGVSYC 117
++ LL++ R +++V E + T L+++ P L D I+ +Q+LRG+ Y
Sbjct: 61 IIGLLDILRPPSPEDFNDVYIVTELME-TDLHKVIKSPQPLTDDHIQYFLYQILRGLKYL 119
Query: 118 HRHACIHRDIKPENILLTANGVVKLCDFGFARLI 151
H IHRD+KP NIL+ +N +K+CDFG AR +
Sbjct: 120 HSANVIHRDLKPSNILVNSNCDLKICDFGLARGV 153
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPK kinase (MAP2K or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAP3K or MKKK). Each cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. There are three main typical MAPK subfamilies: Extracellular signal-Regulated Kinase (ERK), c-Jun N-terminal Kinase (JNK), and p38. Some MAPKs are atypical in that they are not regulated by MAP2Ks. These include MAPK4, MAPK6, NLK, and ERK7. Length = 330 |
| >gnl|CDD|143371 cd07866, STKc_BUR1, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins | Back alignment and domain information |
|---|
Score = 138 bits (349), Expect = 7e-39
Identities = 65/170 (38%), Positives = 94/170 (55%), Gaps = 20/170 (11%)
Query: 1 MERYEKIGKLGEGSYGVVFKCRNRDTGQVVAIKKFLESEEDPLIRKIALREIRLLKSLKH 60
+ YE +GKLGEG++G V+K R TG+VVA+KK L E ALREI++LK LKH
Sbjct: 7 LRDYEILGKLGEGTFGEVYKARQIKTGRVVALKKILMHNEKDGFPITALREIKILKKLKH 66
Query: 61 PNLVNLLEVF--------RRKKKLHLVFEFCDHTVLNELEN------HPHGLPWDLIKQI 106
PN+V L+++ R++ +++V + DH + LEN IK
Sbjct: 67 PNVVPLIDMAVERPDKSKRKRGSVYMVTPYMDHDLSGLLENPSVKLTESQ------IKCY 120
Query: 107 TWQVLRGVSYCHRHACIHRDIKPENILLTANGVVKLCDFGFARLIRDLIP 156
Q+L G++Y H + +HRDIK NIL+ G++K+ DFG AR P
Sbjct: 121 MLQLLEGINYLHENHILHRDIKAANILIDNQGILKIADFGLARPYDGPPP 170
|
Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic screen as factors involved in general transcription. The BUR1/BUR2 complex phosphorylates the C-terminal domain of RNA polymerase II. In addition, this complex regulates histone modification by phosporylating Rad6 and mediating the association of the Paf1 complex with chromatin. Length = 311 |
| >gnl|CDD|173755 cd08215, STKc_Nek, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase | Back alignment and domain information |
|---|
Score = 136 bits (345), Expect = 8e-39
Identities = 54/151 (35%), Positives = 86/151 (56%), Gaps = 4/151 (2%)
Query: 3 RYEKIGKLGEGSYGVVFKCRNRDTGQVVAIKKFLESEEDPLIRKIALREIRLLKSLKHPN 62
+YE I ++G+GS+G V+ R + G++ +K+ S R+ AL E+++LK L HPN
Sbjct: 1 KYEIIKQIGKGSFGKVYLVRRKSDGKLYVLKEIDLSNMSEKEREDALNEVKILKKLNHPN 60
Query: 63 LVNLLEVFRRKKKLHLVFEFCDHTVLNE-LENHPHG---LPWDLIKQITWQVLRGVSYCH 118
++ E F K KL +V E+ D L++ ++ P + I Q+ + Y H
Sbjct: 61 IIKYYESFEEKGKLCIVMEYADGGDLSQKIKKQKKEGKPFPEEQILDWFVQLCLALKYLH 120
Query: 119 RHACIHRDIKPENILLTANGVVKLCDFGFAR 149
+HRDIKP+NI LT+NG+VKL DFG ++
Sbjct: 121 SRKILHRDIKPQNIFLTSNGLVKLGDFGISK 151
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Length = 258 |
| >gnl|CDD|173740 cd07842, STKc_CDK8_like, Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 135 bits (343), Expect = 6e-38
Identities = 64/164 (39%), Positives = 95/164 (57%), Gaps = 13/164 (7%)
Query: 3 RYEKIGKLGEGSYGVVFKCR--NRDTGQVVAIKKFLESEEDPL-IRKIALREIRLLKSLK 59
+YE G +G G+YG V+K + N G+ AIKKF +E I + A REI LL+ LK
Sbjct: 1 KYEIEGCIGRGTYGRVYKAKRKNGKDGKEYAIKKFKGDKEQYTGISQSACREIALLRELK 60
Query: 60 HPNLVNLLEVF--RRKKKLHLVFEFCDHTVLNELENHPHG----LPWDLIKQITWQVLRG 113
H N+V+L+EVF K ++L+F++ +H + ++ H +P ++K + WQ+L G
Sbjct: 61 HENVVSLVEVFLEHADKSVYLLFDYAEHDLWQIIKFHRQAKRVSIPPSMVKSLLWQILNG 120
Query: 114 VSYCHRHACIHRDIKPENILLTAN----GVVKLCDFGFARLIRD 153
V Y H + +HRD+KP NIL+ GVVK+ D G ARL
Sbjct: 121 VHYLHSNWVLHRDLKPANILVMGEGPERGVVKIGDLGLARLFNA 164
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA polymerase II (RNAP II)-dependent transcription. CDC2L6 also associates with Mediator in complexes lacking CDK8. In VP16-dependent transcriptional activation, CDK8 and CDC2L6 exerts opposing effects by positive and negative regulation, respectively, in similar conditions. Length = 316 |
| >gnl|CDD|173731 cd06627, STKc_Cdc7_like, Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 133 bits (336), Expect = 1e-37
Identities = 85/285 (29%), Positives = 132/285 (46%), Gaps = 55/285 (19%)
Query: 3 RYEKIGKLGEGSYGVVFKCRNRDTGQVVAIKKFLESEEDPL--IRKIALREIRLLKSLKH 60
Y+ +G G++GVV+K N +TG VAIK+ + E+ ++ I ++EI LLK+LKH
Sbjct: 1 NYQLGDLIGRGAFGVVYKGLNLETGDFVAIKQ-ISLEKIKEEALKSI-MQEIDLLKNLKH 58
Query: 61 PNLVNLLEVFRRKKKLHLVFEFCDHTVLNELENHPHGLPWDLIKQITWQVLRGVSYCHRH 120
PN+V + L+++ E+ ++ L ++ P L+ +QVL+G++Y H
Sbjct: 59 PNIVKYIGSIETSDSLYIILEYAENGSLRQIIKKFGPFPESLVAVYVYQVLQGLAYLHEQ 118
Query: 121 ACIHRDIKPENILLTANGVVKLCDFGFARLIRDLIPRHLHIFQTNEYFKGVSLPH--AEN 178
IHRDIK NIL T +GVVKL DFG A + D + + V P+ A
Sbjct: 119 GVIHRDIKAANILTTKDGVVKLADFGVATKLND---------VSKDDASVVGTPYWMAPE 169
Query: 179 VVPLEIKIGKPAATNIYLIDFLKRCLDKDPLRRWS----CDQLL--RHPYFNG-----YY 227
V+ + G A++I WS +LL PY++ +
Sbjct: 170 VIEMS---GASTASDI-----------------WSLGCTVIELLTGNPPYYDLNPMAALF 209
Query: 228 FEVPDEMQY--EEITQRCLD-------KDPLRRWSCDQLLRHPYF 263
V D+ E I+ D KDP R + QLL+HP+
Sbjct: 210 RIVQDDHPPLPEGISPELKDFLMQCFQKDPNLRPTAKQLLKHPWI 254
|
Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Cdc7 is essential for cell division by playing a key role in the initiation of septum formation and cytokinesis. Budding yeast Cdc15 functions to coordinate mitotic exit with cytokinesis. Arabidopsis MAPKKK epsilon is required for pollen development in the plasma membrane. Length = 254 |
| >gnl|CDD|173741 cd07843, STKc_CDC2L1, Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1 | Back alignment and domain information |
|---|
Score = 133 bits (336), Expect = 4e-37
Identities = 83/293 (28%), Positives = 134/293 (45%), Gaps = 75/293 (25%)
Query: 2 ERYEKIGKLGEGSYGVVFKCRNRDTGQVVAIKKF-LESEED--PLIRKIALREIRLLKSL 58
+ YEK+ ++ EG+YGVV++ R++ TG++VA+KK +E E++ P+ +LREI +L L
Sbjct: 5 DEYEKLNRIEEGTYGVVYRARDKKTGEIVALKKLKMEKEKEGFPIT---SLREINILLKL 61
Query: 59 KHPNLVNLLEVF--RRKKKLHLVFEFCDHTVLNELENHPHGLPWDLIKQITWQVLRGVSY 116
+HPN+V + EV K+++V E+ +H + + +E +K + Q+L GV++
Sbjct: 62 QHPNIVTVKEVVVGSNLDKIYMVMEYVEHDLKSLMETMKQPFLQSEVKCLMLQLLSGVAH 121
Query: 117 CHRHACIHRDIKPENILLTANGVVKLCDFG------------------------------ 146
H + +HRD+K N+LL G++K+CDFG
Sbjct: 122 LHDNWILHRDLKTSNLLLNNRGILKICDFGLAREYGSPLKPYTQLVVTLWYRAPELLLGA 181
Query: 147 ---------------FARLIRD--LIPRHLHIFQTNEYFKGV------------SLPHAE 177
FA L+ L P I Q N+ FK + LP A+
Sbjct: 182 KEYSTAIDMWSVGCIFAELLTKKPLFPGKSEIDQLNKIFKLLGTPTEKIWPGFSELPGAK 241
Query: 178 NVVP-------LEIKIGKPAATNIYLIDFLKRCLDKDPLRRWSCDQLLRHPYF 223
L K + ++ D L R L DP +R S + L+HPYF
Sbjct: 242 KKTFTKYPYNQLRKKFPALSLSDNGF-DLLNRLLTYDPAKRISAEDALKHPYF 293
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the major isoform, associates with cyclin L and is expressed throughout the cell cycle. It is involved in RNA processing and the regulation of transcription. CDK11(p58) associates with cyclin D3 and is expressed during the G2/M phase of the cell cycle. It plays roles in spindle morphogenesis, centrosome maturation, sister chromatid cohesion, and the completion of mitosis. CDK11(p46) is formed from the larger isoforms by caspases during TNFalpha- and Fas-induced apoptosis. It functions as a downstream effector kinase in apoptotic signaling pathways and interacts with eukaryotic initiation factor 3f (eIF3f), p21-activated kinase (PAK1), and Ran-binding protein (RanBPM). Length = 293 |
| >gnl|CDD|197581 smart00219, TyrKc, Tyrosine kinase, catalytic domain | Back alignment and domain information |
|---|
Score = 129 bits (327), Expect = 4e-36
Identities = 50/150 (33%), Positives = 76/150 (50%), Gaps = 6/150 (4%)
Query: 9 KLGEGSYGVVFKCR----NRDTGQVVAIKKFLESEEDPLIRKIALREIRLLKSLKHPNLV 64
KLGEG++G V+K + VA+K E + I + LRE R+++ L HPN+V
Sbjct: 6 KLGEGAFGEVYKGKLKGKGGKKKVEVAVKTLKEDASEQQIEEF-LREARIMRKLDHPNVV 64
Query: 65 NLLEVFRRKKKLHLVFEFCDHTVLNE-LENHPHGLPWDLIKQITWQVLRGVSYCHRHACI 123
LL V ++ L++V E+ + L L + L + Q+ RG+ Y I
Sbjct: 65 KLLGVCTEEEPLYIVMEYMEGGDLLSYLRKNRPKLSLSDLLSFALQIARGMEYLESKNFI 124
Query: 124 HRDIKPENILLTANGVVKLCDFGFARLIRD 153
HRD+ N L+ N VVK+ DFG +R + D
Sbjct: 125 HRDLAARNCLVGENLVVKISDFGLSRDLYD 154
|
Phosphotransferases. Tyrosine-specific kinase subfamily. Length = 257 |
| >gnl|CDD|132954 cd06623, PKc_MAPKK_plant_like, Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins | Back alignment and domain information |
|---|
Score = 129 bits (326), Expect = 6e-36
Identities = 53/150 (35%), Positives = 89/150 (59%), Gaps = 2/150 (1%)
Query: 5 EKIGKLGEGSYGVVFKCRNRDTGQVVAIKKFLESEEDPLIRKIALREIRLLKSLKHPNLV 64
E++ LG+GS GVV+K R++ TG++ A+KK D RK LRE++ L+S + P +V
Sbjct: 4 ERVKVLGQGSSGVVYKVRHKPTGKIYALKKIHVDG-DEEFRKQLLRELKTLRSCESPYVV 62
Query: 65 NLLEVFRRKKKLHLVFEFCDHTVLNELENHPHGLPWDLIKQITWQVLRGVSYCHR-HACI 123
F ++ ++ +V E+ D L +L +P ++ I Q+L+G+ Y H I
Sbjct: 63 KCYGAFYKEGEISIVLEYMDGGSLADLLKKVGKIPEPVLAYIARQILKGLDYLHTKRHII 122
Query: 124 HRDIKPENILLTANGVVKLCDFGFARLIRD 153
HRDIKP N+L+ + G VK+ DFG ++++ +
Sbjct: 123 HRDIKPSNLLINSKGEVKIADFGISKVLEN 152
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include MAPKKs from plants, kinetoplastids, alveolates, and mycetozoa. The MAPKK, LmxPK4, from Leishmania mexicana, is important in differentiation and virulence. Dictyostelium discoideum MEK1 is required for proper chemotaxis. MEK1 null mutants display severe defects in cell polarization and directional movement. Plants contain multiple MAPKKs like other eukaryotes. The Arabidopsis genome encodes for 10 MAPKKs while poplar and rice contain 13 MAPKKs each. The functions of these proteins have not been fully elucidated. There is evidence to suggest that MAPK cascades are involved in plant stress responses. In Arabidopsis, MKK3 plays a role in pathogen signaling, MKK2 is involved in cold and salt stress signaling, MKK4/MKK5 participates in innate immunity, and MKK7 regulates basal and systemic acquired resistance. Length = 264 |
| >gnl|CDD|214568 smart00221, STYKc, Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Score = 128 bits (324), Expect = 9e-36
Identities = 51/151 (33%), Positives = 75/151 (49%), Gaps = 7/151 (4%)
Query: 9 KLGEGSYGVVFKCR----NRDTGQVVAIKKFLESEEDPLIRKIALREIRLLKSLKHPNLV 64
KLGEG++G V+K VA+K E + I + LRE R+++ L HPN+V
Sbjct: 6 KLGEGAFGEVYKGTLKGKGDGKEVEVAVKTLKEDASEQQIEEF-LREARIMRKLDHPNIV 64
Query: 65 NLLEVFRRKKKLHLVFEFCDHTVLNE--LENHPHGLPWDLIKQITWQVLRGVSYCHRHAC 122
LL V ++ L +V E+ L + +N P L + Q+ RG+ Y
Sbjct: 65 KLLGVCTEEEPLMIVMEYMPGGDLLDYLRKNRPKELSLSDLLSFALQIARGMEYLESKNF 124
Query: 123 IHRDIKPENILLTANGVVKLCDFGFARLIRD 153
IHRD+ N L+ N VVK+ DFG +R + D
Sbjct: 125 IHRDLAARNCLVGENLVVKISDFGLSRDLYD 155
|
Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase. Length = 258 |
| >gnl|CDD|132957 cd06626, STKc_MEKK4, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4 | Back alignment and domain information |
|---|
Score = 127 bits (322), Expect = 2e-35
Identities = 90/273 (32%), Positives = 145/273 (53%), Gaps = 23/273 (8%)
Query: 3 RYEKIGKLGEGSYGVVFKCRNRDTGQVVAIKKF-LESEEDPLIRKIALREIRLLKSLKHP 61
R+++ K+G G++G V+ N DTG+++A+K+ ++ + I++IA E+++L+ LKHP
Sbjct: 1 RWQRGNKIGGGTFGKVYTAVNLDTGELMAVKEIRIQDNDPKTIKEIA-DEMKVLELLKHP 59
Query: 62 NLVNL--LEVFRRKKKLHLVFEFCDHTVLNELENHPHGLPWDLIKQITWQVLRGVSYCHR 119
NLV +EV R +K+++ E+C L EL H L +I+ T Q+L G++Y H
Sbjct: 60 NLVKYYGVEVHR--EKVYIFMEYCSGGTLEELLEHGRILDEHVIRVYTLQLLEGLAYLHS 117
Query: 120 HACIHRDIKPENILLTANGVVKLCDFGFARLIRDLIPRHLHIFQTNEYFKGVSLPHAENV 179
H +HRDIKP NI L NGV+KL DFG A +++ Q+ G A V
Sbjct: 118 HGIVHRDIKPANIFLDHNGVIKLGDFGCAVKLKNNTTTMGEEVQSLA---GTPAYMAPEV 174
Query: 180 VPLEIKIGKPAATNIYLID--FLKRCLDKDPLRRWS-CD---QLLRHPYFNGYYFEVPDE 233
+ G A +I+ + L+ K P WS D Q++ H G+ +PD
Sbjct: 175 ITGGKGKGHGRAADIWSLGCVVLEMATGKRP---WSELDNEFQIMFHVGA-GHKPPIPDS 230
Query: 234 MQYE----EITQRCLDKDPLRRWSCDQLLRHPY 262
+Q + RCL+ DP +R + +LL+HP+
Sbjct: 231 LQLSPEGKDFLDRCLESDPKKRPTASELLQHPF 263
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. MEKK4 also plays roles in the re-polarization of the actin cytoskeleton in response to osmotic stress, in the proper closure of the neural tube, in cardiovascular development, and in immune responses. Length = 264 |
| >gnl|CDD|143342 cd07837, STKc_CdkB_plant, Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase | Back alignment and domain information |
|---|
Score = 128 bits (323), Expect = 3e-35
Identities = 61/159 (38%), Positives = 100/159 (62%), Gaps = 11/159 (6%)
Query: 2 ERYEKIGKLGEGSYGVVFKCRNRDTGQVVAIKKFLESEEDPLIRKIALREIRLLKSLKH- 60
+ YEK+ K+GEG+YG V+K R+++TG++VA+KK ++ I ALREI LL+ L
Sbjct: 1 DAYEKLEKIGEGTYGKVYKARDKNTGKLVALKKTRLEMDEEGIPPTALREISLLQMLSES 60
Query: 61 PNLVNLLEVFRRKKK-----LHLVFEFCDHTVLNELENH----PHGLPWDLIKQITWQVL 111
+V LL+V ++K L+LVFE+ D + ++++ LP IK +Q+L
Sbjct: 61 IYIVRLLDVEHVEEKNGKPSLYLVFEYLDSDLKKFMDSNGRGPGRPLPAKTIKSFMYQLL 120
Query: 112 RGVSYCHRHACIHRDIKPENILL-TANGVVKLCDFGFAR 149
+GV++CH+H +HRD+KP+N+L+ G++K+ D G R
Sbjct: 121 KGVAHCHKHGVMHRDLKPQNLLVDKQKGLLKIADLGLGR 159
|
Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developmental pathways, such as stomata and leaf development. CdkB has been shown to associate with both cyclin B, which controls G2/M transition, and cyclin D, which acts as a mediator in linking extracellular signals to the cell cycle. Length = 295 |
| >gnl|CDD|173723 cd06605, PKc_MAPKK, Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase | Back alignment and domain information |
|---|
Score = 127 bits (321), Expect = 3e-35
Identities = 79/288 (27%), Positives = 130/288 (45%), Gaps = 54/288 (18%)
Query: 5 EKIGKLGEGSYGVVFKCRNRDTGQVVAIKKFLESEEDPLIRKIALREIRLLKSLKHPNLV 64
E +G+LG G+ GVV K +R TG+++A K + E + I+K LRE+ +L P +V
Sbjct: 4 EYLGELGAGNSGVVSKVLHRPTGKIMA-VKTIRLEINEAIQKQILRELDILHKCNSPYIV 62
Query: 65 NLLEVFRRKKKLHLVFEFCDHTVLNE-LENHPHGLPWDLIKQITWQVLRGVSYCHR-HAC 122
F + + E+ D L++ L+ +P ++ +I VL+G++Y H H
Sbjct: 63 GFYGAFYNNGDISICMEYMDGGSLDKILKEVQGRIPERILGKIAVAVLKGLTYLHEKHKI 122
Query: 123 IHRDIKPENILLTANGVVKLCDFGFA-RLIRDLI-----------PRHLHIFQTNEY--- 167
IHRD+KP NIL+ + G +KLCDFG + +L+ L P + Q N+Y
Sbjct: 123 IHRDVKPSNILVNSRGQIKLCDFGVSGQLVNSLAKTFVGTSSYMAPERI---QGNDYSVK 179
Query: 168 ----FKGVSLPHAENVVPLEIKIGK-----PAATNIYLIDFLKRCLDKDPLRRWSCDQLL 218
G+SL +E+ G+ + + L+ +++ P +L
Sbjct: 180 SDIWSLGLSL--------IELATGRFPYPPENDPPDGIFELLQYIVNEPP------PRLP 225
Query: 219 RHPYFNGYYFEVPDEMQYEEITQRCLDKDPLRRWSCDQLLRHPYFNGY 266
+ + Q + CL KDP R S +LL HP+ Y
Sbjct: 226 SGKF--------SPDFQ--DFVNLCLIKDPRERPSYKELLEHPFIKKY 263
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity PKs that phosphorylate their downstream targets, MAPKs, at specific threonine and tyrosine residues. There are three MAPK subfamilies: extracellular signal-regulated kinase (ERK), c-Jun N-terminal kinase (JNK), and p38. In mammalian cells, there are seven MAPKKs (named MKK1-7) and 20 MAPKKKs. Each MAPK subfamily can be activated by at least two cognate MAPKKs and by multiple MAPKKKs. Length = 265 |
| >gnl|CDD|173728 cd06614, STKc_PAK, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase | Back alignment and domain information |
|---|
Score = 126 bits (320), Expect = 8e-35
Identities = 55/148 (37%), Positives = 89/148 (60%), Gaps = 4/148 (2%)
Query: 2 ERYEKIGKLGEGSYGVVFKCRNRDTGQVVAIKKFLESEEDPLIRKIALREIRLLKSLKHP 61
E Y+ + K+GEG+ G V+K +R TG+ VAIKK +++ +++ + EI ++K KHP
Sbjct: 19 ELYKNLEKIGEGASGEVYKATDRATGKEVAIKKMRLRKQN---KELIINEILIMKDCKHP 75
Query: 62 NLVNLLEVFRRKKKLHLVFEFCDHTVLNE-LENHPHGLPWDLIKQITWQVLRGVSYCHRH 120
N+V+ + + +L +V E+ D L + + + + I + +VL+G+ Y H
Sbjct: 76 NIVDYYDSYLVGDELWVVMEYMDGGSLTDIITQNFVRMNEPQIAYVCREVLQGLEYLHSQ 135
Query: 121 ACIHRDIKPENILLTANGVVKLCDFGFA 148
IHRDIK +NILL+ +G VKL DFGFA
Sbjct: 136 NVIHRDIKSDNILLSKDGSVKLADFGFA 163
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). Group II PAKs contain a PBD and a catalytic domain, but lack other motifs found in group I PAKs. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. Group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX; no such binding has been demonstrated for group II PAKs. Length = 286 |
| >gnl|CDD|223589 COG0515, SPS1, Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair] | Back alignment and domain information |
|---|
Score = 129 bits (323), Expect = 9e-35
Identities = 81/290 (27%), Positives = 118/290 (40%), Gaps = 25/290 (8%)
Query: 4 YEKIGKLGEGSYGVVFKCRNRDTGQVVAIKKFL-ESEEDPLIRKIALREIRLLKSLKHP- 61
Y + KLGEGS+G V+ R+R ++VA+K + E + LREI++L SL HP
Sbjct: 2 YRILRKLGEGSFGEVYLARDR---KLVALKVLAKKLESKSKEVERFLREIQILASLNHPP 58
Query: 62 NLVNLLEVFRRKKKLHLVFEFCDHTVLNELENHPH---GLPWDLIKQITWQVLRGVSYCH 118
N+V L + F+ + L+LV E+ D L +L L I Q+L + Y H
Sbjct: 59 NIVKLYDFFQDEGSLYLVMEYVDGGSLEDLLKKIGRKGPLSESEALFILAQILSALEYLH 118
Query: 119 RHACIHRDIKPENILLTANG-VVKLCDFGFARLIRDLIPRHLHIFQTNEYFKGVSLPHAE 177
IHRDIKPENILL +G VVKL DFG A+L+ D + G A
Sbjct: 119 SKGIIHRDIKPENILLDRDGRVVKLIDFGLAKLLPDPGSTSSIPALPST-SVGTPGYMAP 177
Query: 178 NVVPLEIKIGKPAATNIYL--IDFLKRCLDKDPLRRWSC----DQLLRHPYFNGY----- 226
V+ ++++I+ I + P Q L+
Sbjct: 178 EVLLGLSLAYASSSSDIWSLGITLYELLTGLPPFEGEKNSSATSQTLKIILELPTPSLAS 237
Query: 227 ----YFEVPDEMQYEEITQRCLDKDPLRRWSCDQLLRHPYFNGYYFEVPD 272
++ ++ L KDP R S L H + D
Sbjct: 238 PLSPSNPELISKAASDLLKKLLAKDPKNRLSSSSDLSHDLLAHLKLKESD 287
|
Length = 384 |
| >gnl|CDD|143376 cd07871, STKc_PCTAIRE3, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase | Back alignment and domain information |
|---|
Score = 126 bits (318), Expect = 1e-34
Identities = 65/150 (43%), Positives = 97/150 (64%), Gaps = 3/150 (2%)
Query: 1 MERYEKIGKLGEGSYGVVFKCRNRDTGQVVAIKKF-LESEEDPLIRKIALREIRLLKSLK 59
+E Y K+ KLGEG+Y VFK R++ T +VA+K+ LE EE A+RE+ LLK+LK
Sbjct: 4 LETYVKLDKLGEGTYATVFKGRSKLTENLVALKEIRLEHEEGAPC--TAIREVSLLKNLK 61
Query: 60 HPNLVNLLEVFRRKKKLHLVFEFCDHTVLNELENHPHGLPWDLIKQITWQVLRGVSYCHR 119
H N+V L ++ ++ L LVFE+ D + L+N + + +K +Q+LRG+SYCH+
Sbjct: 62 HANIVTLHDIIHTERCLTLVFEYLDSDLKQYLDNCGNLMSMHNVKIFMFQLLRGLSYCHK 121
Query: 120 HACIHRDIKPENILLTANGVVKLCDFGFAR 149
+HRD+KP+N+L+ G +KL DFG AR
Sbjct: 122 RKILHRDLKPQNLLINEKGELKLADFGLAR 151
|
Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filaments (PHFs) and stimulate Tau phosphorylation. As AD progresses, phosphorylated Tau aggregates and forms PHFs, which leads to the formation of neurofibrillary tangles (NFTs). In human glioma cells, PCTAIRE-3 induces cell cycle arrest and cell death. Length = 288 |
| >gnl|CDD|173727 cd06613, STKc_MAP4K3_like, Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 125 bits (316), Expect = 2e-34
Identities = 59/151 (39%), Positives = 85/151 (56%), Gaps = 3/151 (1%)
Query: 2 ERYEKIGKLGEGSYGVVFKCRNRDTGQVVAIKKFLESEEDPLIRKIALREIRLLKSLKHP 61
E YE I ++G G+YG V+K R+ TG++VAIK D +I +EI +LK +HP
Sbjct: 3 EDYELIQRIGSGTYGDVYKARDIATGELVAIKVIKLEPGDDF--EIIQQEISMLKECRHP 60
Query: 62 NLVNLLEVFRRKKKLHLVFEFCDHTVLNELENHPHG-LPWDLIKQITWQVLRGVSYCHRH 120
N+V + R+ KL +V E+C L ++ G L I + + L+G++Y H
Sbjct: 61 NIVAYFGSYLRRDKLWIVMEYCGGGSLQDIYQVTRGPLSELQIAYVCRETLKGLAYLHET 120
Query: 121 ACIHRDIKPENILLTANGVVKLCDFGFARLI 151
IHRDIK NILLT +G VKL DFG + +
Sbjct: 121 GKIHRDIKGANILLTEDGDVKLADFGVSAQL 151
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K1, also called haematopoietic progenitor kinase 1 (HPK1), is a hematopoietic-specific STK involved in many cellular signaling cascades including MAPK, antigen receptor, apoptosis, growth factor, and cytokine signaling. It participates in the regulation of T cell receptor signaling and T cell-mediated immune responses. MAP4K2 was referred to as germinal center (GC) kinase because of its preferred location in GC B cells. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. It is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). Length = 262 |
| >gnl|CDD|173747 cd07852, STKc_MAPK15, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15 | Back alignment and domain information |
|---|
Score = 127 bits (321), Expect = 2e-34
Identities = 62/161 (38%), Positives = 97/161 (60%), Gaps = 13/161 (8%)
Query: 1 MERYEKIGKLGEGSYGVVFKCRNRDTGQVVAIKKFLESEEDPLIRKIALREIRLLKSLK- 59
+ +YE + KLG+G+YG+V+K +R T +VVA+KK ++ + + REI L+ L
Sbjct: 6 LRKYEILQKLGKGAYGIVWKAIDRRTKEVVALKKIFDAFRNATDAQRTFREIMFLQELGD 65
Query: 60 HPNLVNLLEVFRRK--KKLHLVFEFCD---HTVLNELENHPHGLPWDLIKQ-ITWQVLRG 113
HPN+V LL V + + K ++LVFE+ + H V+ + D+ K+ I +Q+L+
Sbjct: 66 HPNIVKLLNVIKAENDKDIYLVFEYMETDLHAVIR------ANILEDVHKRYIMYQLLKA 119
Query: 114 VSYCHRHACIHRDIKPENILLTANGVVKLCDFGFARLIRDL 154
+ Y H IHRD+KP NILL ++ VKL DFG AR + +L
Sbjct: 120 LKYIHSGNVIHRDLKPSNILLNSDCRVKLADFGLARSLSEL 160
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimuli whereas ERK8 shows low basal activity and is activated by DNA-damaging agents. ERK7 and ERK8 also have different substrate profiles. Genome analysis shows that they are orthologs with similar gene structures. ERK7 and ERK 8 may be involved in the signaling of some nuclear receptor transcription factors. ERK7 regulates hormone-dependent degradation of estrogen receptor alpha while ERK8 down-regulates the transcriptional co-activation androgen and glucocorticoid receptors. Length = 337 |
| >gnl|CDD|219530 pfam07714, Pkinase_Tyr, Protein tyrosine kinase | Back alignment and domain information |
|---|
Score = 124 bits (315), Expect = 2e-34
Identities = 51/154 (33%), Positives = 77/154 (50%), Gaps = 6/154 (3%)
Query: 5 EKIGKLGEGSYGVVFKCR----NRDTGQVVAIKKFLESEEDPLIRKIALREIRLLKSLKH 60
E KLGEG++G V+K T VA+K E + + L E ++K L H
Sbjct: 2 ELGKKLGEGAFGEVYKGTLKGDGEGTETKVAVKTLKEGASEEEREEF-LEEASIMKKLSH 60
Query: 61 PNLVNLLEVFRRKKKLHLVFEFCDHTVLNE-LENHPHGLPWDLIKQITWQVLRGVSYCHR 119
PN+V LL V + + L++V E+ L + L H L + Q+ Q+ +G+ Y
Sbjct: 61 PNIVRLLGVCTQGEPLYIVTEYMPGGDLLDFLRKHGEKLTLKDLLQMALQIAKGMEYLES 120
Query: 120 HACIHRDIKPENILLTANGVVKLCDFGFARLIRD 153
+HRD+ N L+T N VVK+ DFG +R I +
Sbjct: 121 KNFVHRDLAARNCLVTENLVVKISDFGLSRDIYE 154
|
Length = 258 |
| >gnl|CDD|173753 cd07864, STKc_CDK12, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12 | Back alignment and domain information |
|---|
Score = 124 bits (312), Expect = 1e-33
Identities = 68/163 (41%), Positives = 105/163 (64%), Gaps = 16/163 (9%)
Query: 1 MERYEKIGKLGEGSYGVVFKCRNRDTGQVVAIKKF-LESEED--PLIRKIALREIRLLKS 57
+++++ IG++GEG+YG V+K R++DTG++VA+KK L++E++ P+ A+REI++L+
Sbjct: 6 VDKFDIIGQIGEGTYGQVYKARDKDTGELVALKKVRLDNEKEGFPIT---AIREIKILRQ 62
Query: 58 LKHPNLVNLLEVF----------RRKKKLHLVFEFCDHTVLNELENHPHGLPWDLIKQIT 107
L H N+VNL E+ + K +LVFE+ DH ++ LE+ D IK
Sbjct: 63 LNHRNIVNLKEIVTDKQDALDFKKDKGAFYLVFEYMDHDLMGLLESGLVHFSEDHIKSFM 122
Query: 108 WQVLRGVSYCHRHACIHRDIKPENILLTANGVVKLCDFGFARL 150
Q+L G++YCH+ +HRDIK NILL G +KL DFG ARL
Sbjct: 123 KQLLEGLNYCHKKNFLHRDIKCSNILLNNKGQIKLADFGLARL 165
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely expressed in tissues. It interacts with cyclins L1 and L2, and plays roles in regulating transcription and alternative splicing. Length = 302 |
| >gnl|CDD|143374 cd07869, STKc_PFTAIRE1, Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase | Back alignment and domain information |
|---|
Score = 123 bits (310), Expect = 2e-33
Identities = 66/161 (40%), Positives = 100/161 (62%), Gaps = 7/161 (4%)
Query: 2 ERYEKIGKLGEGSYGVVFKCRNRDTGQVVAIK--KFLESEEDPLIRKIALREIRLLKSLK 59
+ YEK+ KLGEGSY V+K +++ G++VA+K + E E P A+RE LLK LK
Sbjct: 5 DSYEKLEKLGEGSYATVYKGKSKVNGKLVALKVIRLQEEEGTPFT---AIREASLLKGLK 61
Query: 60 HPNLVNLLEVFRRKKKLHLVFEFCDHTVLNELENHPHGLPWDLIKQITWQVLRGVSYCHR 119
H N+V L ++ K+ L LVFE+ + ++ HP GL + +K +Q+LRG+SY H+
Sbjct: 62 HANIVLLHDIIHTKETLTLVFEYVHTDLCQYMDKHPGGLHPENVKLFLFQLLRGLSYIHQ 121
Query: 120 HACIHRDIKPENILLTANGVVKLCDFGFARLIRDLIPRHLH 160
+HRD+KP+N+L++ G +KL DFG AR +P H +
Sbjct: 122 RYILHRDLKPQNLLISDTGELKLADFGLAR--AKSVPSHTY 160
|
Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 and is inhibited by the p21 cell cycle inhibitor. It has also been shown to interact with the membrane-associated cyclin Y, which recruits the protein to the plasma membrane. Length = 303 |
| >gnl|CDD|143368 cd07863, STKc_CDK4, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4 | Back alignment and domain information |
|---|
Score = 122 bits (308), Expect = 4e-33
Identities = 64/159 (40%), Positives = 100/159 (62%), Gaps = 13/159 (8%)
Query: 3 RYEKIGKLGEGSYGVVFKCRNRDTGQVVAIKKF-LESEEDPL----IRKIALREIRLLKS 57
+YE + ++G G+YG V+K R+ +G VA+K +++ ED L +R++AL ++ L++
Sbjct: 1 QYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVQTNEDGLPLSTVREVAL--LKRLEA 58
Query: 58 LKHPNLVNLLEV-----FRRKKKLHLVFEFCDHTVLNELENHPH-GLPWDLIKQITWQVL 111
HPN+V L++V R+ K+ LVFE D + L+ P GLP + IK + Q L
Sbjct: 59 FDHPNIVRLMDVCATSRTDRETKVTLVFEHVDQDLRTYLDKVPPPGLPAETIKDLMRQFL 118
Query: 112 RGVSYCHRHACIHRDIKPENILLTANGVVKLCDFGFARL 150
RG+ + H + +HRD+KPENIL+T+ G VKL DFG AR+
Sbjct: 119 RGLDFLHANCIVHRDLKPENILVTSGGQVKLADFGLARI 157
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the nucleus. CDK4 also shows kinase activity towards Smad3, a signal transducer of transforming growth factor (TGF)-beta signaling which modulates transcription and plays a role in cell proliferation and apoptosis. CDK4 is inhibited by the p21 inhibitor and is specifically mutated in human melanoma. Length = 288 |
| >gnl|CDD|143367 cd07862, STKc_CDK6, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6 | Back alignment and domain information |
|---|
Score = 122 bits (306), Expect = 6e-33
Identities = 66/161 (40%), Positives = 109/161 (67%), Gaps = 14/161 (8%)
Query: 2 ERYEKIGKLGEGSYGVVFKCRN-RDTGQVVAIKKF-LESEED--PL--IRKIALREIRLL 55
++YE + ++GEG+YG VFK R+ ++ G+ VA+K+ +++ E+ PL IR++A+ +R L
Sbjct: 1 QQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAV--LRHL 58
Query: 56 KSLKHPNLVNLLEVFR-----RKKKLHLVFEFCDHTVLNELENHPH-GLPWDLIKQITWQ 109
++ +HPN+V L +V R+ KL LVFE D + L+ P G+P + IK + +Q
Sbjct: 59 ETFEHPNVVRLFDVCTVSRTDRETKLTLVFEHVDQDLTTYLDKVPEPGVPTETIKDMMFQ 118
Query: 110 VLRGVSYCHRHACIHRDIKPENILLTANGVVKLCDFGFARL 150
+LRG+ + H H +HRD+KP+NIL+T++G +KL DFG AR+
Sbjct: 119 LLRGLDFLHSHRVVHRDLKPQNILVTSSGQIKLADFGLARI 159
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytoplasm. It is also present in the ruffling edge of spreading fibroblasts and may play a role in cell spreading. It binds to the p21 inhibitor without any effect on its own activity and it is overexpressed in squamous cell carcinomas and neuroblastomas. CDK6 has also been shown to inhibit cell differentiation in many cell types. Length = 290 |
| >gnl|CDD|173624 cd00192, PTKc, Catalytic domain of Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 120 bits (304), Expect = 1e-32
Identities = 47/157 (29%), Positives = 76/157 (48%), Gaps = 13/157 (8%)
Query: 9 KLGEGSYGVVFKCR---NRDTGQVVAIKKFLESEEDPLIRKIALREIRLLKSLKHPNLVN 65
KLGEG++G V+K + VA+K E + + L+E R++K L HPN+V
Sbjct: 2 KLGEGAFGEVYKGKLKGKDGKTTEVAVKTLKEDASEEERKDF-LKEARVMKKLGHPNVVR 60
Query: 66 LLEVFRRKKKLHLVFEFCDHTVLNE-LENHPHGLPWDLIKQIT--------WQVLRGVSY 116
LL V ++ L+LV E+ + L + L P ++ Q+ +G+ Y
Sbjct: 61 LLGVCTEEEPLYLVLEYMEGGDLLDYLRKSRPVFPSPEKSTLSLKDLLSFAIQIAKGMEY 120
Query: 117 CHRHACIHRDIKPENILLTANGVVKLCDFGFARLIRD 153
+HRD+ N L+ + VVK+ DFG +R + D
Sbjct: 121 LASKKFVHRDLAARNCLVGEDLVVKISDFGLSRDVYD 157
|
Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain, leading to intracellular signaling. Some RTKs are orphan receptors with no known ligands. Non-receptor (or cytoplasmic) tyr kinases are distributed in different intracellular compartments and are usually multi-domain proteins containing a catalytic tyr kinase domain as well as various regulatory domains such as SH3 and SH2. PTKs are usually autoinhibited and require a mechanism for activation. In many PTKs, the phosphorylation of tyr residues in the activation loop is essential for optimal activity. Aberrant expression of PTKs is associated with many development abnormalities and cancers. Length = 262 |
| >gnl|CDD|143377 cd07872, STKc_PCTAIRE2, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase | Back alignment and domain information |
|---|
Score = 121 bits (304), Expect = 2e-32
Identities = 65/150 (43%), Positives = 95/150 (63%), Gaps = 3/150 (2%)
Query: 1 MERYEKIGKLGEGSYGVVFKCRNRDTGQVVAIKKF-LESEEDPLIRKIALREIRLLKSLK 59
ME Y K+ KLGEG+Y VFK R++ T +VA+K+ LE EE A+RE+ LLK LK
Sbjct: 5 METYIKLEKLGEGTYATVFKGRSKLTENLVALKEIRLEHEEGAPC--TAIREVSLLKDLK 62
Query: 60 HPNLVNLLEVFRRKKKLHLVFEFCDHTVLNELENHPHGLPWDLIKQITWQVLRGVSYCHR 119
H N+V L ++ K L LVFE+ D + +++ + + +K +Q+LRG++YCHR
Sbjct: 63 HANIVTLHDIVHTDKSLTLVFEYLDKDLKQYMDDCGNIMSMHNVKIFLYQILRGLAYCHR 122
Query: 120 HACIHRDIKPENILLTANGVVKLCDFGFAR 149
+HRD+KP+N+L+ G +KL DFG AR
Sbjct: 123 RKVLHRDLKPQNLLINERGELKLADFGLAR 152
|
Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play a role in regulating mitochondrial function in neurons. Length = 309 |
| >gnl|CDD|132943 cd06612, STKc_MST1_2, Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2 | Back alignment and domain information |
|---|
Score = 119 bits (301), Expect = 2e-32
Identities = 57/148 (38%), Positives = 81/148 (54%), Gaps = 5/148 (3%)
Query: 2 ERYEKIGKLGEGSYGVVFKCRNRDTGQVVAIKKFLESEEDPLIRKIALREIRLLKSLKHP 61
E ++ + KLGEGSYG V+K +++TGQVVAIK E+ I K EI +LK P
Sbjct: 3 EVFDILEKLGEGSYGSVYKAIHKETGQVVAIKVVPVEEDLQEIIK----EISILKQCDSP 58
Query: 62 NLVNLLEVFRRKKKLHLVFEFCD-HTVLNELENHPHGLPWDLIKQITWQVLRGVSYCHRH 120
+V + + L +V E+C +V + ++ L + I I +Q L+G+ Y H +
Sbjct: 59 YIVKYYGSYFKNTDLWIVMEYCGAGSVSDIMKITNKTLTEEEIAAILYQTLKGLEYLHSN 118
Query: 121 ACIHRDIKPENILLTANGVVKLCDFGFA 148
IHRDIK NILL G KL DFG +
Sbjct: 119 KKIHRDIKAGNILLNEEGQAKLADFGVS 146
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a MAPK kinase) and MEKK1 (a MAPK kinase kinase) by acting as a MAPK kinase kinase kinase (MAPKKKK). Activation of JNK by MST1 leads to caspase activation and apoptosis. MST1 has also been implicated in cell proliferation and differentiation. Krs1 may regulate cell growth arrest and apoptosis in response to cellular stress. Length = 256 |
| >gnl|CDD|143378 cd07873, STKc_PCTAIRE1, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase | Back alignment and domain information |
|---|
Score = 119 bits (299), Expect = 9e-32
Identities = 64/150 (42%), Positives = 96/150 (64%), Gaps = 3/150 (2%)
Query: 1 MERYEKIGKLGEGSYGVVFKCRNRDTGQVVAIKKF-LESEEDPLIRKIALREIRLLKSLK 59
+E Y K+ KLGEG+Y V+K R++ T +VA+K+ LE EE A+RE+ LLK LK
Sbjct: 5 LETYIKLDKLGEGTYATVYKGRSKLTDNLVALKEIRLEHEEGAPC--TAIREVSLLKDLK 62
Query: 60 HPNLVNLLEVFRRKKKLHLVFEFCDHTVLNELENHPHGLPWDLIKQITWQVLRGVSYCHR 119
H N+V L ++ +K L LVFE+ D + L++ + + +K +Q+LRG++YCHR
Sbjct: 63 HANIVTLHDIIHTEKSLTLVFEYLDKDLKQYLDDCGNSINMHNVKLFLFQLLRGLNYCHR 122
Query: 120 HACIHRDIKPENILLTANGVVKLCDFGFAR 149
+HRD+KP+N+L+ G +KL DFG AR
Sbjct: 123 RKVLHRDLKPQNLLINERGELKLADFGLAR 152
|
Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may play a role in regulating neurite outgrowth. It can also associate with Trap (Tudor repeat associator with PCTAIRE-2), a physiological partner of PCTAIRE-2; with p11, a small dimeric protein with similarity to S100; and with 14-3-3 proteins, mediators of phosphorylation-dependent interactions in many different proteins. Length = 301 |
| >gnl|CDD|173735 cd07831, STKc_MOK, Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase | Back alignment and domain information |
|---|
Score = 117 bits (296), Expect = 2e-31
Identities = 58/151 (38%), Positives = 90/151 (59%), Gaps = 5/151 (3%)
Query: 4 YEKIGKLGEGSYGVVFKCRNRDTGQVVAIKKFLESEEDPLIRKIALREIRLLKSLK-HPN 62
Y+ +GK+GEG++ V K ++R TG+ AIK ++ L + LREI+ L+ L HPN
Sbjct: 1 YKILGKIGEGTFSEVLKAQSRKTGKYYAIKC-MKKHFKSLEQVNNLREIQALRRLSPHPN 59
Query: 63 LVNLLEVF--RRKKKLHLVFEFCDHTVLNELENHPHGLPWDLIKQITWQVLRGVSYCHRH 120
++ L+EV R+ +L LVFE D + ++ LP +K +Q+L+ + + HR+
Sbjct: 60 ILRLIEVLFDRKTGRLALVFELMDMNLYELIKGRKRPLPEKRVKSYMYQLLKSLDHMHRN 119
Query: 121 ACIHRDIKPENILLTANGVVKLCDFGFARLI 151
HRDIKPENIL+ + ++KL DFG R I
Sbjct: 120 GIFHRDIKPENILIKDD-ILKLADFGSCRGI 149
|
Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation. Length = 282 |
| >gnl|CDD|132940 cd06609, STKc_MST3_like, Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 115 bits (290), Expect = 1e-30
Identities = 57/149 (38%), Positives = 80/149 (53%), Gaps = 6/149 (4%)
Query: 2 ERYEKIGKLGEGSYGVVFKCRNRDTGQVVAIKKF-LESEEDPLIRKIALREIRLLKSLKH 60
E + + +G+GS+G V+K ++ T QVVAIK LE ED I I +EI+ L +
Sbjct: 1 ELFTLLECIGKGSFGEVYKAIDKRTNQVVAIKVIDLEEAEDE-IEDIQ-QEIQFLSQCRS 58
Query: 61 PNLVNLLEVFRRKKKLHLVFEFCDH-TVLNELENHPHGLPWDLIKQITWQVLRGVSYCHR 119
P + F + KL ++ E+C + L+ L+ P L I I +VL G+ Y H
Sbjct: 59 PYITKYYGSFLKGSKLWIIMEYCGGGSCLDLLK--PGKLDETYIAFILREVLLGLEYLHE 116
Query: 120 HACIHRDIKPENILLTANGVVKLCDFGFA 148
IHRDIK NILL+ G VKL DFG +
Sbjct: 117 EGKIHRDIKAANILLSEEGDVKLADFGVS 145
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN) signaling pathway, and plays a role in cytokinesis. SPS1 plays a role in regulating proteins required for spore wall formation. MST4 plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. STK25 may play a role in the regulation of cell migration and polarization. Length = 274 |
| >gnl|CDD|173757 cd08217, STKc_Nek2, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2 | Back alignment and domain information |
|---|
Score = 115 bits (289), Expect = 2e-30
Identities = 69/294 (23%), Positives = 116/294 (39%), Gaps = 66/294 (22%)
Query: 4 YEKIGKLGEGSYGVVFKCRNRDTGQVVAIKKFLESEEDPLIRKIALREIRLLKSLKHPNL 63
YE + +G+GS+G V K R + G+++ K+ ++ + E+ +L+ LKHPN+
Sbjct: 2 YEVLETIGKGSFGTVRKVRRKSDGKILVWKEIDYGNMTEKEKQQLVSEVNILRELKHPNI 61
Query: 64 VNLL--EVFRRKKKLHLVFEFCDHTVLNEL------ENHPHGLPWDLIKQITWQVLRGVS 115
V + R + L++V E+C+ L +L E + + I +I Q+L +
Sbjct: 62 VRYYDRIIDRSNQTLYIVMEYCEGGDLAQLIQKCKKERKY--IEEEFIWRILTQLLLALY 119
Query: 116 YCHR-----HACIHRDIKPENILLTANGVVKLCDFGFARLIRDLIPRHLHIFQTNEYFKG 170
CH + +HRD+KP NI L AN VKL DFG A+++ Y
Sbjct: 120 ECHNRSDPGNTVLHRDLKPANIFLDANNNVKLGDFGLAKILGH------DSSFAKTY--- 170
Query: 171 VSLPHAENVVPLEIKIGKP--AATNIYLIDFLKRCLDKDPLRRWSCDQLL-----RHPYF 223
V P+ + E ++I WS L+ P F
Sbjct: 171 VGTPY---YMSPEQLNHMSYDEKSDI-----------------WSLGCLIYELCALSPPF 210
Query: 224 NGYYFEVPDEM-----------QYEE----ITQRCLDKDPLRRWSCDQLLRHPY 262
+Y + + L+ DP +R S ++LL+ P
Sbjct: 211 TARNQLQLASKIKEGKFRRIPYRYSSELNEVIKSMLNVDPDKRPSTEELLQLPL 264
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exit. NIMA is involved in nuclear membrane fission. Vertebrate Nek2 is a cell cycle-regulated STK, localized in centrosomes and kinetochores, that regulates centrosome splitting at the G2/M phase. It also interacts with other mitotic kinases such as Polo-like kinase 1 and may play a role in spindle checkpoint. An increase in the expression of the human NEK2 gene is strongly associated with the progression of non-Hodgkin lymphoma. Length = 265 |
| >gnl|CDD|132963 cd06632, STKc_MEKK1_plant, Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Score = 114 bits (286), Expect = 3e-30
Identities = 76/266 (28%), Positives = 116/266 (43%), Gaps = 55/266 (20%)
Query: 3 RYEKIGKLGEGSYGVVFKCRNRDTGQVVAIKKFLESEEDPL----IRKIALREIRLLKSL 58
R+ K LG GS+G V++ N D G A+K+ +++ ++++ +EI LL L
Sbjct: 1 RWRKGELLGSGSFGSVYEGLNLDDGDFFAVKEVSLADDGQTGQEAVKQLE-QEIALLSKL 59
Query: 59 KHPNLVNLLEVFRRKKKLHLVFEFCDHTVLNELENHPHGLPWDLIKQITWQVLRGVSYCH 118
+HPN+V L R + L++ E L +L P +I+ T Q+L G+ Y H
Sbjct: 60 QHPNIVQYLGTEREEDNLYIFLELVPGGSLAKLLKKYGSFPEPVIRLYTRQILLGLEYLH 119
Query: 119 RHACIHRDIKPENILLTANGVVKLCDFGFARLIRDLIPRHLHIFQTNEYFKGVSLPHAEN 178
+HRDIK NIL+ NGVVKL DFG A + + F + FKG A
Sbjct: 120 DRNTVHRDIKGANILVDTNGVVKLADFGMA--------KQVVEFSFAKSFKGSPYWMAPE 171
Query: 179 VVP------------------LEIKIGKPAATNIYLI----------------------- 197
V+ LE+ GKP + + +
Sbjct: 172 VIAQQGGYGLAADIWSLGCTVLEMATGKPPWSQLEGVAAVFKIGRSKELPPIPDHLSDEA 231
Query: 198 -DFLKRCLDKDPLRRWSCDQLLRHPY 222
DF+ +CL +DP R + +LL HP+
Sbjct: 232 KDFILKCLQRDPSLRPTAAELLEHPF 257
|
Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidopsis thaliana MEKK1 activates MPK4, a MAPK that regulates systemic acquired resistance. MEKK1 also participates in the regulation of temperature-sensitive and tissue-specific cell death. Length = 258 |
| >gnl|CDD|132974 cd06643, STKc_SLK, Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase | Back alignment and domain information |
|---|
Score = 114 bits (287), Expect = 3e-30
Identities = 85/265 (32%), Positives = 132/265 (49%), Gaps = 49/265 (18%)
Query: 2 ERYEKIGKLGEGSYGVVFKCRNRDTGQVVAIKKFLESEEDPLIRKIALREIRLLKSLKHP 61
E +E IG+LG+G++G V+K +N++TG + A K E+ L + + EI +L S HP
Sbjct: 5 EFWEIIGELGDGAFGKVYKAQNKETGVLAAAKVIDTKSEEEL--EDYMVEIDILASCDHP 62
Query: 62 NLVNLLEVFRRKKKLHLVFEFCD----HTVLNELENHPHGLPWDLIKQITWQVLRGVSYC 117
N+V LL+ F + L ++ EFC V+ ELE L I+ + Q L ++Y
Sbjct: 63 NIVKLLDAFYYENNLWILIEFCAGGAVDAVMLELE---RPLTEPQIRVVCKQTLEALNYL 119
Query: 118 HRHACIHRDIKPENILLTANGVVKLCDFGF-ARLIRDLIPRHLHI--------------- 161
H + IHRD+K NIL T +G +KL DFG A+ R + R I
Sbjct: 120 HENKIIHRDLKAGNILFTLDGDIKLADFGVSAKNTRTIQRRDSFIGTPYWMAPEVVMCET 179
Query: 162 -------FQTNEYFKGVSL--------PHAE-NVVPLEIKIGK--------PAATNIYLI 197
++ + + G++L PH E N + + +KI K P+ +
Sbjct: 180 SKDRPYDYKADVWSLGITLIEMAQIEPPHHELNPMRVLLKIAKSEPPTLAQPSRWSSEFK 239
Query: 198 DFLKRCLDKDPLRRWSCDQLLRHPY 222
DFLK+CL+K+ RW+ QLL+HP+
Sbjct: 240 DFLKKCLEKNVDARWTTTQLLQHPF 264
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration. Length = 282 |
| >gnl|CDD|143375 cd07870, STKc_PFTAIRE2, Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase | Back alignment and domain information |
|---|
Score = 113 bits (285), Expect = 7e-30
Identities = 60/147 (40%), Positives = 90/147 (61%), Gaps = 3/147 (2%)
Query: 4 YEKIGKLGEGSYGVVFKCRNRDTGQVVAIKKF-LESEEDPLIRKIALREIRLLKSLKHPN 62
Y + KLGEGSY V+K +R GQ+VA+K +++EE + A+RE LLK LKH N
Sbjct: 7 YLNLEKLGEGSYATVYKGISRINGQLVALKVISMKTEEG--VPFTAIREASLLKGLKHAN 64
Query: 63 LVNLLEVFRRKKKLHLVFEFCDHTVLNELENHPHGLPWDLIKQITWQVLRGVSYCHRHAC 122
+V L ++ K+ L VFE+ + + HP GL ++ +Q+LRG++Y H
Sbjct: 65 IVLLHDIIHTKETLTFVFEYMHTDLAQYMIQHPGGLHPYNVRLFMFQLLRGLAYIHGQHI 124
Query: 123 IHRDIKPENILLTANGVVKLCDFGFAR 149
+HRD+KP+N+L++ G +KL DFG AR
Sbjct: 125 LHRDLKPQNLLISYLGELKLADFGLAR 151
|
Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recessive form of juvenile ALS. The function of PFTAIRE-2 is not yet known. Length = 291 |
| >gnl|CDD|173725 cd06608, STKc_myosinIII_like, Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 113 bits (284), Expect = 9e-30
Identities = 58/159 (36%), Positives = 83/159 (52%), Gaps = 14/159 (8%)
Query: 2 ERYEKIGKLGEGSYGVVFKCRNRDTGQVVAIKKFLESEEDPLIRKIALREIRLLKSL-KH 60
+E + +GEG+YG V+K R++ TGQ+VAIK ++ ED +I E +L+ H
Sbjct: 6 GIFELVEVIGEGTYGKVYKARHKKTGQLVAIK-IMDIIED-EEEEIKE-EYNILRKYSNH 62
Query: 61 PNLVNLLEVFRRKK------KLHLVFEFCDH----TVLNELENHPHGLPWDLIKQITWQV 110
PN+ F +K +L LV E C ++ L L + I I +
Sbjct: 63 PNIATFYGAFIKKNPPGNDDQLWLVMELCGGGSVTDLVKGLRKKGKRLKEEWIAYILRET 122
Query: 111 LRGVSYCHRHACIHRDIKPENILLTANGVVKLCDFGFAR 149
LRG++Y H + IHRDIK +NILLT N VKL DFG +
Sbjct: 123 LRGLAYLHENKVIHRDIKGQNILLTKNAEVKLVDFGVSA 161
|
Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin III may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. It may also function as a cargo carrier during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. The Drosophila class III myosin, called NinaC (Neither inactivation nor afterpotential protein C), is critical in normal adaptation and termination of photoresponse. Vertebrates contain two isoforms of class III myosin, IIIA and IIIB. This subfamily also includes mammalian NIK-like embryo-specific kinase (NESK), Traf2- and Nck-interacting kinase (TNIK), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6). MAP4Ks are involved in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Length = 275 |
| >gnl|CDD|132938 cd06607, STKc_TAO, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins | Back alignment and domain information |
|---|
Score = 113 bits (284), Expect = 2e-29
Identities = 57/151 (37%), Positives = 84/151 (55%), Gaps = 1/151 (0%)
Query: 2 ERYEKIGKLGEGSYGVVFKCRNRDTGQVVAIKKFLESEEDPLIR-KIALREIRLLKSLKH 60
+ + + ++G GS+G V+ R+ T +VVAIKK S + + + ++E+R L+ L+H
Sbjct: 15 KLFTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQQLRH 74
Query: 61 PNLVNLLEVFRRKKKLHLVFEFCDHTVLNELENHPHGLPWDLIKQITWQVLRGVSYCHRH 120
PN + + R+ LV E+C + + LE H L I I L+G++Y H H
Sbjct: 75 PNTIEYKGCYLREHTAWLVMEYCLGSASDILEVHKKPLQEVEIAAICHGALQGLAYLHSH 134
Query: 121 ACIHRDIKPENILLTANGVVKLCDFGFARLI 151
IHRDIK NILLT G VKL DFG A L+
Sbjct: 135 ERIHRDIKAGNILLTEPGTVKLADFGSASLV 165
|
Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily members, named TAO1, TAO2, and TAO3. Length = 307 |
| >gnl|CDD|173771 cd08529, STKc_FA2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains | Back alignment and domain information |
|---|
Score = 111 bits (278), Expect = 5e-29
Identities = 74/253 (29%), Positives = 115/253 (45%), Gaps = 35/253 (13%)
Query: 4 YEKIGKLGEGSYGVVFKCRNRDTGQVVAIKKFLESEEDPLIRKIALREIRLLKSLKHPNL 63
+E + K+G+GS+GVVFK + +V A+K+ S+ + R+ A+ E R+L L +
Sbjct: 2 FEILNKIGKGSFGVVFKVVRKADKRVYAMKQIDLSKMNRREREEAIDEARVLAKLDSSYI 61
Query: 64 VNLLEVFRRKKKLHLVFEFCDHTVLNELENHPHG--LPWDLIKQITWQVLRGVSYCHRHA 121
+ E F K KL++V E+ ++ L++L G LP D + + Q+L G+++ H
Sbjct: 62 IRYYESFLDKGKLNIVMEYAENGDLHKLLKMQRGRPLPEDQVWRFFIQILLGLAHLHSKK 121
Query: 122 CIHRDIKPENILLTANGVVKLCDFGFARLIRDLIPRHLHIFQTNEYFK------------ 169
+HRDIK N+ L A VK+ D G A+L+ D I T Y
Sbjct: 122 ILHRDIKSLNLFLDAYDNVKIGDLGVAKLLSDNTNFANTIVGTPYYLSPELCEDKPYNEK 181
Query: 170 ------GVSLPH---------AENVVPLEIKIGK------PAATNIYLIDFLKRCLDKDP 208
GV L A N L +KI + + L + +CL KD
Sbjct: 182 SDVWALGVVLYECCTGKHPFDANNQGALILKIIRGVFPPVSQMYSQQLAQLIDQCLTKDY 241
Query: 209 LRRWSCDQLLRHP 221
+R QLLR+P
Sbjct: 242 RQRPDTFQLLRNP 254
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cycle progression. No cellular function has yet been ascribed to CNK4. Length = 256 |
| >gnl|CDD|143354 cd07849, STKc_ERK1_2_like, Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 112 bits (281), Expect = 1e-28
Identities = 59/176 (33%), Positives = 93/176 (52%), Gaps = 21/176 (11%)
Query: 2 ERYEKIGKLGEGSYGVVFKCRNRDTGQVVAIKKFLESEEDPLIRKIALREIRLLKSLKHP 61
RY+ + +GEG+YG+V ++ TG VAIKK + E + LREI++L+ KH
Sbjct: 5 PRYQNLSYIGEGAYGMVCSATHKPTGVKVAIKK-ISPFEHQTFCQRTLREIKILRRFKHE 63
Query: 62 NLVNLLEVFRRK-----KKLHLVFEFCD---HTVL--NELENHPHGLPWDLIKQITWQVL 111
N++ +L++ R +++V E + + ++ L N D I+ +Q+L
Sbjct: 64 NIIGILDIIRPPSFESFNDVYIVQELMETDLYKLIKTQHLSN-------DHIQYFLYQIL 116
Query: 112 RGVSYCHRHACIHRDIKPENILLTANGVVKLCDFGFARLIRDLIPRHLHIFQTNEY 167
RG+ Y H +HRD+KP N+LL N +K+CDFG AR+ P H H EY
Sbjct: 117 RGLKYIHSANVLHRDLKPSNLLLNTNCDLKICDFGLARIA---DPEHDHTGFLTEY 169
|
Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase kinase from the Raf family. ERK1/2 have numerous substrates, many of which are nuclear and participate in transcriptional regulation of many cellular processes. They regulate cell growth, cell proliferation, and cell cycle progression from G1 to S phase. Although the distinct roles of ERK1 and ERK2 have not been fully determined, it is known that ERK2 can maintain most functions in the absence of ERK1, and that the deletion of ERK2 is embryonically lethal. The MAPK, Fus3, regulates yeast mating processes including mating-specific gene expression, G1 arrest, mating projection, and cell fusion. Length = 336 |
| >gnl|CDD|173749 cd07855, STKc_ERK5, Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5 | Back alignment and domain information |
|---|
Score = 111 bits (279), Expect = 2e-28
Identities = 51/158 (32%), Positives = 88/158 (55%), Gaps = 13/158 (8%)
Query: 2 ERYEKIGKLGEGSYGVVFKCRNRDTGQVVAIKKFLESEEDPLIRKIALREIRLLKSLKHP 61
RY+ I +G G+YGVV + +G+ VAIKK + + P + K LRE+++L+ KH
Sbjct: 5 SRYKPIENIGSGAYGVVCSAIDTRSGKKVAIKKIPHAFDVPTLAKRTLRELKILRHFKHD 64
Query: 62 NLVNLLEVFRRKKKLHLVFEFCD-HTVLNELENHPH-------GLPWDLIKQITWQVLRG 113
N++ + ++ R +F D + V++ +E+ H L + I+ +Q+LRG
Sbjct: 65 NIIAIRDILRPPGA-----DFKDVYVVMDLMESDLHHIIHSDQPLTEEHIRYFLYQLLRG 119
Query: 114 VSYCHRHACIHRDIKPENILLTANGVVKLCDFGFARLI 151
+ Y H IHRD+KP N+L+ + +++ DFG AR +
Sbjct: 120 LKYIHSANVIHRDLKPSNLLVNEDCELRIGDFGMARGL 157
|
Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the MAP2K MEK5, which in turn is regulated by the MAP3Ks MEKK2 and MEKK3. Activated ERK5 phosphorylates its targets including myocyte enhancer factor 2 (MEF2), Sap1a, c-Myc, and RSK. It plays a role in EGF-induced cell proliferation during the G1/S phase transition. Studies on knockout mice revealed that ERK5 is essential for cardiovascular development and plays an important role in angiogenesis. It is also critical for neural differentiation and survival. The ERK5 pathway has been implicated in the pathogenesis of many diseases including cancer, cardiac hypertrophy, and atherosclerosis. Length = 334 |
| >gnl|CDD|132975 cd06644, STKc_STK10_LOK, Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase | Back alignment and domain information |
|---|
Score = 110 bits (275), Expect = 2e-28
Identities = 87/266 (32%), Positives = 129/266 (48%), Gaps = 51/266 (19%)
Query: 2 ERYEKIGKLGEGSYGVVFKCRNRDTGQVVAIKKFLESEEDPLIRKIALREIRLLKSLKHP 61
E +E IG+LG+G++G V+K +N++TG + A K E+ L + EI +L + HP
Sbjct: 12 EVWEIIGELGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYMV--EIEILATCNHP 69
Query: 62 NLVNLLEVFRRKKKLHLVFEFC-----DHTVLNELENHPHGLPWDLIKQITWQVLRGVSY 116
+V LL F KL ++ EFC D +L EL+ GL I+ I Q+L + Y
Sbjct: 70 YIVKLLGAFYWDGKLWIMIEFCPGGAVDAIML-ELD---RGLTEPQIQVICRQMLEALQY 125
Query: 117 CHRHACIHRDIKPENILLTANGVVKLCDFGF-ARLIRDLIPRHLHI-------------- 161
H IHRD+K N+LLT +G +KL DFG A+ ++ L R I
Sbjct: 126 LHSMKIIHRDLKAGNVLLTLDGDIKLADFGVSAKNVKTLQRRDSFIGTPYWMAPEVVMCE 185
Query: 162 --------FQTNEYFKGVSL--------PHAE-NVVPLEIKIGK--------PAATNIYL 196
++ + + G++L PH E N + + +KI K P+ ++
Sbjct: 186 TMKDTPYDYKADIWSLGITLIEMAQIEPPHHELNPMRVLLKIAKSEPPTLSQPSKWSMEF 245
Query: 197 IDFLKRCLDKDPLRRWSCDQLLRHPY 222
DFLK LDK P R S QLL HP+
Sbjct: 246 RDFLKTALDKHPETRPSAAQLLEHPF 271
|
Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types. Length = 292 |
| >gnl|CDD|132979 cd06648, STKc_PAK_II, Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase | Back alignment and domain information |
|---|
Score = 109 bits (275), Expect = 2e-28
Identities = 75/274 (27%), Positives = 132/274 (48%), Gaps = 32/274 (11%)
Query: 2 ERYEKIGKLGEGSYGVVFKCRNRDTGQVVAIKKF-LESEEDPLIRKIALREIRLLKSLKH 60
+ K+GEGS G+V ++ TG+ VA+KK L ++ R++ E+ +++ +H
Sbjct: 19 SYLDNFVKIGEGSTGIVCIATDKSTGRQVAVKKMDLRKQQR---RELLFNEVVIMRDYQH 75
Query: 61 PNLVNLLEVFRRKKKLHLVFEFCDHTVLNELENHPHGLPWDLIKQITWQVLRGVSYCHRH 120
PN+V + + +L +V EF + L ++ H + + I + VL+ +S+ H
Sbjct: 76 PNIVEMYSSYLVGDELWVVMEFLEGGALTDIVTHTR-MNEEQIATVCLAVLKALSFLHAQ 134
Query: 121 ACIHRDIKPENILLTANGVVKLCDFGFARLIRDLIPRHLHIFQTNEYFKG----VSLPHA 176
IHRDIK ++ILLT++G VKL DFGF + +PR + T Y+ LP+
Sbjct: 135 GVIHRDIKSDSILLTSDGRVKLSDFGFCAQVSKEVPRRKSLVGT-PYWMAPEVISRLPYG 193
Query: 177 ENV-------VPLEIKIGKPAATNIYLIDFLKRCLDKDPLRRWSCDQLLRHPYFNGYYFE 229
V + +E+ G+P N + +KR D P + L++ + +
Sbjct: 194 TEVDIWSLGIMVIEMVDGEPPYFNEPPLQAMKRIRDNLPPK-------LKNLH------K 240
Query: 230 VPDEMQYEEITQRCLDKDPLRRWSCDQLLRHPYF 263
V ++ R L +DP +R + +LL HP+
Sbjct: 241 VSPRLR--SFLDRMLVRDPAQRATAAELLNHPFL 272
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs found in group I PAKs, such as an AID (autoinhibitory domain) and SH3 binding sites. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. While group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX, no such binding has been demonstrated for group II PAKs. Some known substrates of group II PAKs are also substrates of group I PAKs such as Raf, BAD, LIMK and GEFH1. Unique group II substrates include MARK/Par-1 and PDZ-RhoGEF. Group II PAKs play important roles in filopodia formation, neuron extension, cytoskeletal organization, and cell survival. Length = 285 |
| >gnl|CDD|173660 cd05123, STKc_AGC, Catalytic domain of AGC family Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 108 bits (273), Expect = 2e-28
Identities = 67/259 (25%), Positives = 108/259 (41%), Gaps = 54/259 (20%)
Query: 10 LGEGSYGVVFKCRNRDTGQVVAIK---KFLESEEDPLIRKIALREIRLLKSLKHPNLVNL 66
LG+GS+G V R +DTG++ A+K K + + L E +L + HP +V L
Sbjct: 1 LGKGSFGKVLLVRKKDTGKLYAMKVLKKKKIIKRKEVEH--TLTERNILSRINHPFIVKL 58
Query: 67 LEVFRRKKKLHLVFEFCD----HTVLNELENHPHGLPWDLIKQITWQVLRGVSYCHRHAC 122
F+ ++KL+LV E+ + L++ + + +++ + Y H
Sbjct: 59 HYAFQTEEKLYLVLEYAPGGELFSHLSKE----GRFSEERARFYAAEIVLALEYLHSLGI 114
Query: 123 IHRDIKPENILLTANGVVKLCDFGFARLIRDLIPRHLHIFQ---TNEY------------ 167
I+RD+KPENILL A+G +KL DFG A ++L T EY
Sbjct: 115 IYRDLKPENILLDADGHIKLTDFGLA---KELSSEGSRTNTFCGTPEYLAPEVLLGKGYG 171
Query: 168 ---------------FKGVSLPHAENVVPLEIKIGK-----PAATNIYLIDFLKRCLDKD 207
G +AE+ + KI K P + D + L KD
Sbjct: 172 KAVDWWSLGVLLYEMLTGKPPFYAEDRKEIYEKILKDPLRFPEFLSPEARDLISGLLQKD 231
Query: 208 PLRRWSC---DQLLRHPYF 223
P +R +++ HP+F
Sbjct: 232 PTKRLGSGGAEEIKAHPFF 250
|
Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the turn motif. Phosphorylation at the A-loop is required of most AGC kinases, which results in a disorder-to-order transition of the A-loop. The ordered conformation results in the access of substrates and ATP to the active site. A subset of AGC kinases with C-terminal extensions containing the HM also requires phosphorylation at this site. Phosphorylation at the HM allows the C-terminal extension to form an ordered structure that packs into the hydrophobic pocket of the catalytic domain, which then reconfigures the kinase into an active bi-lobed state. In addition, growth factor-activated AGC kinases such as PKB, p70S6K, RSK, MSK, PKC, and SGK, require phosphorylation at the turn motif (also called tail or zipper site), located N-terminal to the HM at the C-terminal extension. AGC kinases regulate many cellular processes including division, growth, survival, metabolism, motility, and differentiation. Many are implicated in the development of various human diseases. Length = 250 |
| >gnl|CDD|132976 cd06645, STKc_MAP4K3, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3 | Back alignment and domain information |
|---|
Score = 109 bits (273), Expect = 3e-28
Identities = 85/274 (31%), Positives = 129/274 (47%), Gaps = 28/274 (10%)
Query: 2 ERYEKIGKLGEGSYGVVFKCRNRDTGQVVAIKKF-LESEEDPLIRKIALREIRLLKSLKH 60
E +E I ++G G+YG V+K RN +TG++ AIK LE ED + +EI ++K KH
Sbjct: 9 EDFELIQRIGSGTYGDVYKARNVNTGELAAIKVIKLEPGED---FAVVQQEIIMMKDCKH 65
Query: 61 PNLVNLLEVFRRKKKLHLVFEFCDHTVLNELENHPHGLPWDLIKQITWQVLRGVSYCHRH 120
N+V + R+ KL + EFC L ++ + L I ++ + L+G+ Y H
Sbjct: 66 SNIVAYFGSYLRRDKLWICMEFCGGGSLQDIYHVTGPLSESQIAYVSRETLQGLYYLHSK 125
Query: 121 ACIHRDIKPENILLTANGVVKLCDFGFARLIRDLIPRHLHIFQTNEYFKGVSLPHAENVV 180
+HRDIK NILLT NG VKL DFG + I I + + F G A V
Sbjct: 126 GKMHRDIKGANILLTDNGHVKLADFGVSAQITATIAKR-------KSFIGTPYWMAPEVA 178
Query: 181 PLEIKIG--------KPAATNIYLIDFLKRCLDKDPLRRWSCDQLLRHPYFNGYYFEVPD 232
+E K G T I L + D P+R L N ++ D
Sbjct: 179 AVERKGGYNQLCDIWAVGITAIELAELQPPMFDLHPMR-----ALFLMTKSNFQPPKLKD 233
Query: 233 EMQ----YEEITQRCLDKDPLRRWSCDQLLRHPY 262
+M+ + + L K+P +R + ++LL+HP+
Sbjct: 234 KMKWSNSFHHFVKMALTKNPKKRPTAEKLLQHPF 267
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. MAP4K3 is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. mTOR regulates ribosome biogenesis and protein translation, and is frequently deregulated in cancer. Length = 267 |
| >gnl|CDD|132952 cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 107 bits (268), Expect = 3e-27
Identities = 54/151 (35%), Positives = 87/151 (57%), Gaps = 7/151 (4%)
Query: 2 ERYEKIGKLGEGSYGVVFKCRNRDTGQVVAIKKFLESEEDPLIRKIALREIRLLKSLKHP 61
E+ ++ +LGEG+ G V KCR ++TG + A K + ++ +P ++K LRE+ + KS K P
Sbjct: 1 EKIVELSRLGEGAGGSVTKCRLKNTGMIFA-LKTITTDPNPDLQKQILRELEINKSCKSP 59
Query: 62 NLVNLLEVFRRKKK--LHLVFEFCD----HTVLNELENHPHGLPWDLIKQITWQVLRGVS 115
+V F + + + E+C+ ++ +++ + ++ +I VL+G+S
Sbjct: 60 YIVKYYGAFLDESSSSIGIAMEYCEGGSLDSIYKKVKKRGGRIGEKVLGKIAESVLKGLS 119
Query: 116 YCHRHACIHRDIKPENILLTANGVVKLCDFG 146
Y H IHRDIKP NILLT G VKLCDFG
Sbjct: 120 YLHSRKIIHRDIKPSNILLTRKGQVKLCDFG 150
|
Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Pek1/Skh1 from Schizosaccharomyces pombe and MKK2 from Saccharomyces cerevisiae, and related proteins. Both fission yeast Pek1 and baker's yeast MKK2 are components of the cell integrity MAPK pathway. In fission yeast, Pek1 phosphorylates and activates the MAPK Pmk1/Spm1 and is regulated by the MAPKKK Mkh1. In baker's yeast, the pathway involves the MAPK Slt2, the MAPKKs MKK1 and MKK2, and the MAPKKK Bck1. The cell integrity MAPK cascade is activated by multiple stress conditions, and is essential in cell wall construction, morphogenesis, cytokinesis, and ion homeostasis. Length = 287 |
| >gnl|CDD|173672 cd05581, STKc_PDK1, Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1 | Back alignment and domain information |
|---|
Score = 106 bits (267), Expect = 4e-27
Identities = 72/298 (24%), Positives = 119/298 (39%), Gaps = 61/298 (20%)
Query: 6 KIGK-LGEGSYGVVFKCRNRDTGQVVAIK----KFLESEEDPLIRKI--ALREIRLLKSL 58
K GK +GEGS+ V + ++T + AIK + L E +K+ E +L L
Sbjct: 4 KFGKIIGEGSFSTVVLAKEKETNKEYAIKILDKRQLIKE-----KKVKYVKIEKEVLTRL 58
Query: 59 K-HPNLVNLLEVFRRKKKLHLVFEFCDHTVLNELENHPHGLPWDLIKQITWQVLRGVSYC 117
HP ++ L F+ ++ L+ V E+ + L + L + ++L + Y
Sbjct: 59 NGHPGIIKLYYTFQDEENLYFVLEYAPNGELLQYIRKYGSLDEKCTRFYAAEILLALEYL 118
Query: 118 HRHACIHRDIKPENILLTANGVVKLCDFGFARLI-RDLIPRHLHIFQTNEYFKGVSLPH- 175
H IHRD+KPENILL + +K+ DFG A+++ + P TN +
Sbjct: 119 HSKGIIHRDLKPENILLDKDMHIKITDFGTAKVLDPNSSPESNKGDATNIDSQIEKNRRR 178
Query: 176 -------AENVVPLEIKIGKPAATNIYLIDFLKRCLDKDPLRRWS----CDQLL--RHPY 222
AE V P E+ KPA D W+ Q+L + P+
Sbjct: 179 FASFVGTAEYVSP-ELLNEKPAG---KSSDL------------WALGCIIYQMLTGKPPF 222
Query: 223 FNGYYFEVPD---EMQYE----------EITQRCLDKDPLRR----WSCDQLLRHPYF 263
+ +++Y ++ ++ L DP R D+L HP+F
Sbjct: 223 RGSNEYLTFQKILKLEYSFPPNFPPDAKDLIEKLLVLDPQDRLGVNEGYDELKAHPFF 280
|
Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to autophosphorylate and is constitutively active in mammalian cells. PDK1 is essential for normal embryo development and is important in regulating cell volume. Length = 280 |
| >gnl|CDD|143361 cd07856, STKc_Sty1_Hog1, Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1 | Back alignment and domain information |
|---|
Score = 107 bits (268), Expect = 4e-27
Identities = 55/150 (36%), Positives = 89/150 (59%), Gaps = 3/150 (2%)
Query: 2 ERYEKIGKLGEGSYGVVFKCRNRDTGQVVAIKKFLESEEDPLIRKIALREIRLLKSLKHP 61
RY + +G G++G+V R++ TGQ VAIKK ++ P++ K RE++LLK L+H
Sbjct: 10 NRYVDLQPVGMGAFGLVCSARDQLTGQNVAIKKIMKPFSTPVLAKRTYRELKLLKHLRHE 69
Query: 62 NLVNLLEVF-RRKKKLHLVFEFCDHTVLNELENHPHGLPWDLIKQITWQVLRGVSYCHRH 120
N+++L ++F + ++ V E + L + P L I+ +Q+LRG+ Y H
Sbjct: 70 NIISLSDIFISPLEDIYFVTELLGTDLHRLLTSRP--LEKQFIQYFLYQILRGLKYVHSA 127
Query: 121 ACIHRDIKPENILLTANGVVKLCDFGFARL 150
+HRD+KP NIL+ N +K+CDFG AR+
Sbjct: 128 GVVHRDLKPSNILINENCDLKICDFGLARI 157
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and UV radiation. Sty1 is regulated by the MAP2K Wis1, which is activated by the MAP3Ks Wis4 and Win1, which receive signals of the stress condition from membrane-spanning histidine kinases Mak1-3. Activated Sty1 stabilizes the Atf1 transcription factor and induces transcription of Atf1-dependent genes of the core environmetal stress response (CESR). Hog1 is the key element in the high osmolarity glycerol (HOG) pathway and is activated upon hyperosmotic stress. Activated Hog1 accumulates in the nucleus and regulates stress-induced transcription. The HOG pathway is mediated by two transmembrane osmosensors, Sln1 and Sho1. Length = 328 |
| >gnl|CDD|173670 cd05579, STKc_MAST_like, Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins | Back alignment and domain information |
|---|
Score = 105 bits (263), Expect = 8e-27
Identities = 72/264 (27%), Positives = 114/264 (43%), Gaps = 56/264 (21%)
Query: 13 GSYGVVFKCRNRDTGQVVAIKKFLESEEDPLIRKI----ALREIRLLKSLKHPNLVNLLE 68
G+YG VF + + TG + AIK +++ +IRK L E +L + P +V L
Sbjct: 4 GAYGRVFLAKKKSTGDIYAIKVIKKAD---MIRKNQVDQVLTERDILSQAQSPYVVKLYY 60
Query: 69 VFRRKKKLHLVFEFCDHTVLNELENHPHGLPWDLIKQITWQVLRGVSYCHRHACIHRDIK 128
F+ KK L+LV E+ L L + L D+ + +++ + Y H + IHRD+K
Sbjct: 61 SFQGKKNLYLVMEYLPGGDLASLLENVGSLDEDVARIYIAEIVLALEYLHSNGIIHRDLK 120
Query: 129 PENILLTANGVVKLCDFGFAR--LIRDLIPRHLHIFQTN--------------------- 165
P+NIL+ +NG +KL DFG ++ L+R I + +
Sbjct: 121 PDNILIDSNGHLKLTDFGLSKVGLVRRQINLNDDEKEDKRIVGTPDYIAPEVILGQGHSK 180
Query: 166 ------------EYFKGVSLPHAENVVPLEI-------KIGKPAATNIY--LIDFLKRCL 204
E+ G+ H E P EI KI P + ID + + L
Sbjct: 181 TVDWWSLGCILYEFLVGIPPFHGET--PEEIFQNILNGKIEWPEDVEVSDEAIDLISKLL 238
Query: 205 DKDPLRR---WSCDQLLRHPYFNG 225
DP +R S +++ HP+F G
Sbjct: 239 VPDPEKRLGAKSIEEIKNHPFFKG 262
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert relative to other kinases. The fungal kinases in this subfamily harbor other domains in addition to a central catalytic domain, which also contains an insert relative to MAST kinases like MASTL. Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. MAST kinases are cytoskeletal associated kinases of unknown function that are also expressed at neuromuscular junctions and postsynaptic densities. The fungal proteins Rim15 and cek1 are involved in the regulation of meiosis and mitosis, respectively. Length = 265 |
| >gnl|CDD|143363 cd07858, STKc_TEY_MAPK_plant, Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Score = 105 bits (263), Expect = 3e-26
Identities = 54/152 (35%), Positives = 88/152 (57%), Gaps = 6/152 (3%)
Query: 3 RYEKIGKLGEGSYGVVFKCRNRDTGQVVAIKKFLESEEDPLIRKIALREIRLLKSLKHPN 62
+Y I +G G+YG+V +N +T + VAIKK + ++ + K LREI+LL+ L H N
Sbjct: 6 KYVPIKPIGRGAYGIVCSAKNSETNEKVAIKKIANAFDNRIDAKRTLREIKLLRHLDHEN 65
Query: 63 LVNLLEVF-----RRKKKLHLVFEFCDHTVLNELENHPHGLPWDLIKQITWQVLRGVSYC 117
++ + ++ +++V+E D T L+++ L D + +Q+LRG+ Y
Sbjct: 66 VIAIKDIMPPPHREAFNDVYIVYELMD-TDLHQIIRSSQTLSDDHCQYFLYQLLRGLKYI 124
Query: 118 HRHACIHRDIKPENILLTANGVVKLCDFGFAR 149
H +HRD+KP N+LL AN +K+CDFG AR
Sbjct: 125 HSANVLHRDLKPSNLLLNANCDLKICDFGLAR 156
|
Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activation loop, TEY and TDY. This subfamily represents the TEY subtype and is further subdivided into three groups (A, B, and C). Group A is represented by AtMPK3, AtMPK6, Nicotiana tabacum BTF4 (NtNTF4), among others. They are mostly involved in environmental and hormonal responses. AtMPK3 and AtMPK6 are also key regulators for stomatal development and patterning. Group B is represented by AtMPK4, AtMPK13, and NtNTF6, among others. They may be involved in both cell division and environmental stress response. AtMPK4 also participates in regulating innate immunity. Group C is represented by AtMPK1, AtMPK2, NtNTF3, Oryza sativa MAPK4 (OsMAPK4), among others. They may also be involved in stress responses. AtMPK1 and AtMPK2 are activated following mechanical injury and in the presence of stress chemicals such as jasmonic acid, hydrogen peroxide and abscisic acid. OsMAPK4 is also called OsMSRMK3 for Multiple Stress-Responsive MAPK3. Length = 337 |
| >gnl|CDD|173758 cd08218, STKc_Nek1, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1 | Back alignment and domain information |
|---|
Score = 103 bits (258), Expect = 4e-26
Identities = 49/151 (32%), Positives = 87/151 (57%), Gaps = 2/151 (1%)
Query: 3 RYEKIGKLGEGSYGVVFKCRNRDTGQVVAIKKFLESEEDPLIRKIALREIRLLKSLKHPN 62
+Y K+ K+GEGS+G ++++ G+ IK+ S+ P R+ + +E+ +L ++KHPN
Sbjct: 1 KYVKVKKIGEGSFGKAILVKSKEDGKQYVIKEINISKMSPKEREESRKEVAVLSNMKHPN 60
Query: 63 LVNLLEVFRRKKKLHLVFEFCDHTVLNELENHPHGLPWDLIKQITW--QVLRGVSYCHRH 120
+V E F L++V ++C+ L + N G+ + + + W Q+ + + H
Sbjct: 61 IVQYQESFEENGNLYIVMDYCEGGDLYKKINAQRGVLFPEDQILDWFVQICLALKHVHDR 120
Query: 121 ACIHRDIKPENILLTANGVVKLCDFGFARLI 151
+HRDIK +NI LT +G +KL DFG AR++
Sbjct: 121 KILHRDIKSQNIFLTKDGTIKLGDFGIARVL 151
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycystic kidney disease, which is characterized by benign polycystic tumors formed by abnormal overgrowth of renal epithelial cells. It appears also to be involved in DNA damage response, and may be important for both correct DNA damage checkpoint activation and DNA repair. Length = 256 |
| >gnl|CDD|173764 cd08224, STKc_Nek6_Nek7, Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7 | Back alignment and domain information |
|---|
Score = 103 bits (258), Expect = 4e-26
Identities = 54/150 (36%), Positives = 75/150 (50%), Gaps = 13/150 (8%)
Query: 9 KLGEGSYGVVFKCRNRDTGQVVAIKKFLESE-EDPLIRKIALREIRLLKSLKHPNLVNLL 67
K+G+G + VV+K G+VVA+KK E D R+ L+EI LLK L HPN++ L
Sbjct: 9 KIGKGQFSVVYKAICLLDGRVVALKKVQIFEMMDAKARQDCLKEIDLLKQLDHPNVIKYL 68
Query: 68 EVFRRKKKLHLVFEFCDHTVLNELENH--------PHGLPWDLIKQITWQVLRGVSYCHR 119
F +L++V E D L+ + H P W Q+ + + H
Sbjct: 69 ASFIENNELNIVLELADAGDLSRMIKHFKKQKRLIPERTIWKYFVQLC----SALEHMHS 124
Query: 120 HACIHRDIKPENILLTANGVVKLCDFGFAR 149
+HRDIKP N+ +TA GVVKL D G R
Sbjct: 125 KRIMHRDIKPANVFITATGVVKLGDLGLGR 154
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may also be regulators of the p70 ribosomal S6 kinase. Length = 267 |
| >gnl|CDD|143356 cd07851, STKc_p38, Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 103 bits (260), Expect = 1e-25
Identities = 54/155 (34%), Positives = 82/155 (52%), Gaps = 8/155 (5%)
Query: 2 ERYEKIGKLGEGSYGVVFKCRNRDTGQVVAIKKFLESEEDPLIRKIALREIRLLKSLKHP 61
+RY+ + +G G+YG V + TG+ VAIKK + + K RE+RLLK + H
Sbjct: 15 DRYQNLSPVGSGAYGQVCSAFDTKTGRKVAIKKLSRPFQSAIHAKRTYRELRLLKHMDHE 74
Query: 62 NLVNLLEVFRRKKKL------HLVFEFCDHTVLNELENHPHGLPWDLIKQITWQVLRGVS 115
N++ LL+VF L +LV + N ++ L D I+ + +Q+LRG+
Sbjct: 75 NVIGLLDVFTPASSLEDFQDVYLVTHLMGADLNNIVKCQK--LSDDHIQFLVYQILRGLK 132
Query: 116 YCHRHACIHRDIKPENILLTANGVVKLCDFGFARL 150
Y H IHRD+KP NI + + +K+ DFG AR
Sbjct: 133 YIHSAGIIHRDLKPSNIAVNEDCELKILDFGLARH 167
|
Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. p38 substrates include other protein kinases and factors that regulate transcription, nuclear export, mRNA stability and translation. p38 kinases are drug targets for the inflammatory diseases psoriasis, rheumatoid arthritis, and chronic pulmonary disease. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta, which show varying substrate specificity and expression patterns. p38alpha and p38beta are ubiquitously expressed, p38gamma is predominantly found in skeletal muscle, and p38delta is found in the heart, lung, testis, pancreas, and small intestine. Length = 343 |
| >gnl|CDD|173772 cd08530, STKc_CNK2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains | Back alignment and domain information |
|---|
Score = 101 bits (254), Expect = 1e-25
Identities = 72/254 (28%), Positives = 121/254 (47%), Gaps = 35/254 (13%)
Query: 3 RYEKIGKLGEGSYGVVFKCRNRDTGQVVAIKKFLESEEDPLIRKIALREIRLLKSLKHPN 62
++ + KLG+GSYG V+K + Q A+K+ R+ A+ EIR+L S+ HPN
Sbjct: 1 DFKVLKKLGKGSYGSVYKVKRLSDNQFYALKEVDLGSMSQKEREDAVNEIRILASVNHPN 60
Query: 63 LVNLLEVFRRKKKLHLVFEFCD----HTVLNELENHPHGLPWDLIKQITWQVLRGVSYCH 118
+++ E F KL +V E+ +++ + +P I +I Q+LRG+ H
Sbjct: 61 IISYKEAFLDGNKLCIVMEYAPFGDLSKAISKRKKKRKLIPEQEIWRIFIQLLRGLQALH 120
Query: 119 RHACIHRDIKPENILLTANGVVKLCDFGFARLIRDLI-------PRHL--HIFQTNEY-F 168
+HRD+K NILL AN +VK+ D G +++++ + P ++ +++ Y +
Sbjct: 121 EQKILHRDLKSANILLVANDLVKIGDLGISKVLKKNMAKTQIGTPHYMAPEVWKGRPYSY 180
Query: 169 K------GVSL-PHAENVVPLE----------IKIGK-PAATNIY---LIDFLKRCLDKD 207
K G L A P E ++ GK P IY L +F++ L
Sbjct: 181 KSDIWSLGCLLYEMATFAPPFEARSMQDLRYKVQRGKYPPIPPIYSQDLQNFIRSMLQVK 240
Query: 208 PLRRWSCDQLLRHP 221
P R +CD++L P
Sbjct: 241 PKLRPNCDKILASP 254
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, and it regulates cell size, through influencing the size threshold at which cells commit to mitosis. Length = 256 |
| >gnl|CDD|240233 PTZ00024, PTZ00024, cyclin-dependent protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 103 bits (258), Expect = 2e-25
Identities = 50/161 (31%), Positives = 87/161 (54%), Gaps = 14/161 (8%)
Query: 2 ERYEKIGK-LGEGSYGVVFKCRNRDTGQVVAIKKF----LESEEDPLIRKI--------A 48
ERY + G LGEG+YG V K + TG++VAIKK + ++ + +
Sbjct: 8 ERYIQKGAHLGEGTYGKVEKAYDTLTGKIVAIKKVKIIEISNDVTKDRQLVGMCGIHFTT 67
Query: 49 LREIRLLKSLKHPNLVNLLEVFRRKKKLHLVFEFCDHTVLNELENHPHGLPWDLIKQITW 108
LRE++++ +KH N++ L++V+ ++LV + L ++ + L +K I
Sbjct: 68 LRELKIMNEIKHENIMGLVDVYVEGDFINLVMDIMASD-LKKVVDRKIRLTESQVKCILL 126
Query: 109 QVLRGVSYCHRHACIHRDIKPENILLTANGVVKLCDFGFAR 149
Q+L G++ H+ +HRD+ P NI + + G+ K+ DFG AR
Sbjct: 127 QILNGLNVLHKWYFMHRDLSPANIFINSKGICKIADFGLAR 167
|
Length = 335 |
| >gnl|CDD|132956 cd06625, STKc_MEKK3_like, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 100 bits (251), Expect = 5e-25
Identities = 68/260 (26%), Positives = 122/260 (46%), Gaps = 43/260 (16%)
Query: 6 KIGK-LGEGSYGVVFKCRNRDTGQVVAIKKFLESEEDPLIRK--IALR-EIRLLKSLKHP 61
+ GK LG+G++G V+ C + DTG+ +A+K+ + P +K AL EI+LLK+L+H
Sbjct: 5 RRGKLLGQGAFGRVYLCYDVDTGRELAVKQVPFDPDSPETKKEVNALECEIQLLKNLQHE 64
Query: 62 NLVNLLEVFRRKKKLHLVFEFCDH-TVLNELENHPHGLPWDLIKQITWQVLRGVSYCHRH 120
+V R + L + E+ +V ++L+ + L + ++ T Q+L GV Y H +
Sbjct: 65 RIVQYYGCLRDDETLSIFMEYMPGGSVKDQLKAY-GALTETVTRKYTRQILEGVEYLHSN 123
Query: 121 ACIHRDIKPENILLTANGVVKLCDFGFARLIR---------------------DLIPRHL 159
+HRDIK NIL + G VKL DFG ++ ++ ++I
Sbjct: 124 MIVHRDIKGANILRDSAGNVKLGDFGASKRLQTICSSGTGMKSVTGTPYWMSPEVISGEG 183
Query: 160 HIFQTNEYFKGVSL-------PHAENVVPLEI--KIGK-------PAATNIYLIDFLKRC 203
+ + + + G ++ P + KI P+ + +FL+R
Sbjct: 184 YGRKADVWSVGCTVVEMLTEKPPWAEFEAMAAIFKIATQPTNPQLPSHVSPDARNFLRRT 243
Query: 204 LDKDPLRRWSCDQLLRHPYF 223
++ +R S ++LLRH +
Sbjct: 244 FVENAKKRPSAEELLRHFFV 263
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 263 |
| >gnl|CDD|132962 cd06631, STKc_YSK4, Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4 | Back alignment and domain information |
|---|
Score = 99.6 bits (248), Expect = 9e-25
Identities = 76/261 (29%), Positives = 113/261 (43%), Gaps = 52/261 (19%)
Query: 10 LGEGSYGVVFKCRNRDTGQVVAIKKFLESEEDPLIRKIALR----EIRLLKSLKHPNLVN 65
LG+G+YG V+ C + GQ++A+K+ + L + E+ LLKSLKH N+V
Sbjct: 8 LGKGAYGTVY-CGLTNQGQLIAVKQVELDTSNVLAAEKEYEKLQEEVDLLKSLKHVNIVQ 66
Query: 66 LLEVFRRKKKLHLVFEFCDHTVLNELENHPHGLPWDLIKQITWQVLRGVSYCHRHACIHR 125
L + + EF ++ + N LP + + T Q+L GV+Y H + +HR
Sbjct: 67 YLGTCLDDNTISIFMEFVPGGSISSILNRFGPLPEPVFCKYTKQILDGVAYLHNNCVVHR 126
Query: 126 DIKPENILLTANGVVKLCDFGFARLIRDLIPRHLHIFQTN--EYFKGVSLPHAENVVP-- 181
DIK N++L NG++KL DFG A R L LH +N + G A V+
Sbjct: 127 DIKGNNVMLMPNGIIKLIDFGCA---RRLAWVGLHGTHSNMLKSMHGTPYWMAPEVINES 183
Query: 182 ---------------LEIKIGKPAATNI-------YL------------------IDFLK 201
E+ GKP ++ Y+ IDF+
Sbjct: 184 GYGRKSDIWSIGCTVFEMATGKPPLASMDRLAAMFYIGAHRGLMPRLPDSFSAAAIDFVT 243
Query: 202 RCLDKDPLRRWSCDQLLRHPY 222
CL +D R S QLLRH +
Sbjct: 244 SCLTRDQHERPSALQLLRHDF 264
|
Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Length = 265 |
| >gnl|CDD|215036 PLN00034, PLN00034, mitogen-activated protein kinase kinase; Provisional | Back alignment and domain information |
|---|
Score = 99.5 bits (248), Expect = 4e-24
Identities = 50/147 (34%), Positives = 86/147 (58%), Gaps = 5/147 (3%)
Query: 5 EKIGKLGEGSYGVVFKCRNRDTGQVVAIKKFLESEEDPLIRKIALREIRLLKSLKHPNLV 64
E++ ++G G+ G V+K +R TG++ A+K + ED + R+I REI +L+ + HPN+V
Sbjct: 77 ERVNRIGSGAGGTVYKVIHRPTGRLYALKVIYGNHEDTVRRQIC-REIEILRDVNHPNVV 135
Query: 65 NLLEVFRRKKKLHLVFEFCDHTVLNELENHPHGLPWDLIKQITWQVLRGVSYCHRHACIH 124
++F ++ ++ EF D LE H + + Q+L G++Y HR +H
Sbjct: 136 KCHDMFDHNGEIQVLLEFMDG---GSLEGT-HIADEQFLADVARQILSGIAYLHRRHIVH 191
Query: 125 RDIKPENILLTANGVVKLCDFGFARLI 151
RDIKP N+L+ + VK+ DFG +R++
Sbjct: 192 RDIKPSNLLINSAKNVKIADFGVSRIL 218
|
Length = 353 |
| >gnl|CDD|132978 cd06647, STKc_PAK_I, Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase | Back alignment and domain information |
|---|
Score = 98.1 bits (244), Expect = 7e-24
Identities = 71/258 (27%), Positives = 123/258 (47%), Gaps = 40/258 (15%)
Query: 2 ERYEKIGKLGEGSYGVVFKCRNRDTGQVVAIKKFLESEEDPLIRKIALREIRLLKSLKHP 61
++Y + K+G+G+ G V+ + TGQ VAIK+ ++ +++ + EI +++ KHP
Sbjct: 19 KKYTRFEKIGQGASGTVYTAIDVATGQEVAIKQMNLQQQPK--KELIINEILVMRENKHP 76
Query: 62 NLVNLLEVFRRKKKLHLVFEFCDHTVLNELENHPHGLPWDLIKQITWQVLRGVSYCHRHA 121
N+VN L+ + +L +V E+ L ++ + I + + L+ + + H +
Sbjct: 77 NIVNYLDSYLVGDELWVVMEYLAGGSLTDVVTETC-MDEGQIAAVCRECLQALEFLHSNQ 135
Query: 122 CIHRDIKPENILLTANGVVKLCDFGF-ARLIRDLIPRHL----------HIFQTNEYFKG 170
IHRDIK +NILL +G VKL DFGF A++ + R + Y
Sbjct: 136 VIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSTMVGTPYWMAPEVVTRKAYGPK 195
Query: 171 VSLPHAENVVPLEIKIGKPAATN------IYLI-------------------DFLKRCLD 205
V + + ++ +E+ G+P N +YLI DFL RCL+
Sbjct: 196 VDI-WSLGIMAIEMVEGEPPYLNENPLRALYLIATNGTPELQNPEKLSAIFRDFLNRCLE 254
Query: 206 KDPLRRWSCDQLLRHPYF 223
D +R S +LL+HP+
Sbjct: 255 MDVEKRGSAKELLQHPFL 272
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs, also called conventional PAKs, include PAK1, PAK2, and PAK3. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). They interact with the SH3 domain containing proteins Nck, Grb2 and PIX. Binding of group I PAKs to activated GTPases leads to conformational changes that destabilize the AID, allowing autophosphorylation and full activation of the kinase domain. Known group I PAK substrates include MLCK, Bad, Raf, MEK1, LIMK, Merlin, Vimentin, Myc, Stat5a, and Aurora A, among others. Length = 293 |
| >gnl|CDD|143385 cd07880, STKc_p38gamma_MAPK12, Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 98.1 bits (244), Expect = 1e-23
Identities = 60/154 (38%), Positives = 86/154 (55%), Gaps = 8/154 (5%)
Query: 2 ERYEKIGKLGEGSYGVVFKCRNRDTGQVVAIKKFLESEEDPLIRKIALREIRLLKSLKHP 61
+RY + ++G G+YG V +R TG VAIKK + L K A RE+RLLK +KH
Sbjct: 15 DRYRDLKQVGSGAYGTVCSALDRRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMKHE 74
Query: 62 NLVNLLEVFRRKKKL------HLVFEFCDHTVLNELENHPHGLPWDLIKQITWQVLRGVS 115
N++ LL+VF L +LV F T L +L H L D I+ + +Q+L+G+
Sbjct: 75 NVIGLLDVFTPDLSLDRFHDFYLVMPFMG-TDLGKLMKHEK-LSEDRIQFLVYQMLKGLK 132
Query: 116 YCHRHACIHRDIKPENILLTANGVVKLCDFGFAR 149
Y H IHRD+KP N+ + + +K+ DFG AR
Sbjct: 133 YIHAAGIIHRDLKPGNLAVNEDCELKILDFGLAR 166
|
Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12, is predominantly expressed in skeletal muscle. Unlike p38alpha and p38beta, p38gamma is insensitive to pyridinylimidazoles. It displays an antagonizing function compared to p38alpha. p38gamma inhibits, while p38alpha stimulates, c-Jun phosphorylation and AP-1 mediated transcription. p38gamma also plays a role in the signaling between Ras and the estrogen receptor and has been implicated to increase cell invasion and breast cancer progression. In Xenopus, p38gamma is critical in the meiotic maturation of oocytes. Length = 343 |
| >gnl|CDD|173671 cd05580, STKc_PKA, Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase | Back alignment and domain information |
|---|
Score = 96.8 bits (242), Expect = 2e-23
Identities = 49/154 (31%), Positives = 83/154 (53%), Gaps = 7/154 (4%)
Query: 4 YEKIGKLGEGSYGVVFKCRNRDTGQVVAIKKFLESEEDPLIR----KIALREIRLLKSLK 59
+E I LG GS+G V R++ +G+ A+K + +++ + L E R+L+S++
Sbjct: 3 FEFIKTLGTGSFGRVMLVRHKGSGKYYALKIL---SKAKIVKLKQVEHVLNEKRILQSIR 59
Query: 60 HPNLVNLLEVFRRKKKLHLVFEFCDHTVLNELENHPHGLPWDLIKQITWQVLRGVSYCHR 119
HP LVNL F+ L+LV E+ L P + + QV+ + Y H
Sbjct: 60 HPFLVNLYGSFQDDSNLYLVMEYVPGGELFSHLRKSGRFPEPVARFYAAQVVLALEYLHS 119
Query: 120 HACIHRDIKPENILLTANGVVKLCDFGFARLIRD 153
++RD+KPEN+LL ++G +K+ DFGFA+ ++
Sbjct: 120 LDIVYRDLKPENLLLDSDGYIKITDFGFAKRVKG 153
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubiquitously in cells and interacts with many different downstream targets. It plays a role in the regulation of diverse processes such as growth, development, memory, metabolism, gene expression, immunity, and lipolysis. Length = 290 |
| >gnl|CDD|132960 cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Score = 95.6 bits (238), Expect = 3e-23
Identities = 66/263 (25%), Positives = 110/263 (41%), Gaps = 50/263 (19%)
Query: 10 LGEGSYGVVFKCRNRDTGQVVAIK-----KFLESEEDPLIRKI--ALR-EIRLLKSLKHP 61
+G+G+YG V+ N TG+++A+K + D + + ALR EI LK L H
Sbjct: 9 IGKGTYGRVYLALNVTTGEMMAVKQVELPATIAGRHDSRQKDMVKALRSEIETLKDLDHL 68
Query: 62 NLVNLLEVFRRKKKLHLVFEFCDHTVLNELENHPHGLPWDLIKQITWQVLRGVSYCHRHA 121
N+V L ++ L + E+ + L++ T QVL G++Y H
Sbjct: 69 NIVQYLGFETTEEYLSIFLEYVPGGSIGSCLRTYGRFEEQLVRFFTEQVLEGLAYLHSKG 128
Query: 122 CIHRDIKPENILLTANGVVKLCDFGFARLIRD----------------LIPRHLHIFQTN 165
+HRD+K +N+L+ A+G+ K+ DFG ++ D + P +H +
Sbjct: 129 ILHRDLKADNLLVDADGICKISDFGISKKSDDIYDNDQNMSMQGSVFWMAPEVIHSYSQG 188
Query: 166 ---------------EYFKGVSLPHAENVVPLEIKIGK-------PAATNIYL----IDF 199
E F G E + K+G P ++ L +DF
Sbjct: 189 YSAKVDIWSLGCVVLEMFAGRRPWSDEEAIAAMFKLGNKRSAPPIPPDVSMNLSPVALDF 248
Query: 200 LKRCLDKDPLRRWSCDQLLRHPY 222
L C +P R + +LL+HP+
Sbjct: 249 LNACFTINPDNRPTARELLQHPF 271
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell integrity MAPK pathway, which is activated by stresses and aggressions to the cell wall. The MAPKKK Bck1, MAPKKs Mkk1 and Mkk2, and the MAPK Slt2 make up the cascade that is important in the maintenance of cell wall homeostasis. Fission yeast Mkh1 is involved in MAPK cascades regulating cell morphology, cell wall integrity, salt resistance, and filamentous growth in response to stress. Length = 272 |
| >gnl|CDD|173748 cd07853, STKc_NLK, Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase | Back alignment and domain information |
|---|
Score = 97.1 bits (242), Expect = 4e-23
Identities = 78/290 (26%), Positives = 131/290 (45%), Gaps = 38/290 (13%)
Query: 10 LGEGSYGVVFKCRNRDTGQVVAIKKFLESEEDPLIRKIALREIRLLKSLKHPNLVNLLEV 69
+G G++GVV+ + G+ VA+KK ++ + K RE+++L KH N+++ L++
Sbjct: 8 IGYGAFGVVWSVTDPRDGKRVALKKMPNVFQNLVSCKRVFRELKMLCFFKHDNVLSALDI 67
Query: 70 FRRKKKLHLVFEFCDHTVLNEL---ENH-----PHGLPWDLIKQITWQVLRGVSYCHRHA 121
+ H+ F + V+ EL + H P L D +K +Q+LRG+ Y H
Sbjct: 68 L---QPPHIDP-FEEIYVVTELMQSDLHKIIVSPQPLSSDHVKVFLYQILRGLKYLHSAG 123
Query: 122 CIHRDIKPENILLTANGVVKLCDFGFARLIRDLIPRHLHIFQTNEYFKGVSL----PHAE 177
+HRDIKP N+L+ +N V+K+CDFG AR+ +H+ +Y++ + H
Sbjct: 124 ILHRDIKPGNLLVNSNCVLKICDFGLARVEEPDESKHMTQEVVTQYYRAPEILMGSRHYT 183
Query: 178 NVVP-----------LEIKIGKPAATNIYLIDFLKRCLDKDPLR--RWSCD----QLLRH 220
+ V L +I A + I +D + L L R +C+ +LR
Sbjct: 184 SAVDIWSVGCIFAELLGRRILFQAQSPIQQLDLITDLLGTPSLEAMRSACEGARAHILRG 243
Query: 221 PY----FNG-YYFEVPDEMQYEEITQRCLDKDPLRRWSCDQLLRHPYFNG 265
P+ Y + + R L DP +R S L HPY +
Sbjct: 244 PHKPPSLPVLYTLSSQATHEAVHLLCRMLVFDPDKRISAADALAHPYLDE 293
|
Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription factors from the TCF/LEF family, inhibiting their ability to activate the transcription of target genes. In prostate cancer cells, NLK is involved in regulating androgen receptor-mediated transcription and its expression is altered during cancer progression. Length = 372 |
| >gnl|CDD|132967 cd06636, STKc_MAP4K4_6, Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6 | Back alignment and domain information |
|---|
Score = 95.5 bits (237), Expect = 4e-23
Identities = 79/268 (29%), Positives = 120/268 (44%), Gaps = 53/268 (19%)
Query: 4 YEKIGKLGEGSYGVVFKCRNRDTGQVVAIK--KFLESEEDPLIRKIALREIRLLKSLKHP 61
+E + +G G+YG V+K R+ TGQ+ AIK E EE+ + +I + L K H
Sbjct: 18 FELVEVVGNGTYGQVYKGRHVKTGQLAAIKVMDVTEDEEEEIKLEINM----LKKYSHHR 73
Query: 62 NLVNLLEVFRRKK------KLHLVFEFCDHTVLNELENHPHG--LPWDLIKQITWQVLRG 113
N+ F +K +L LV EFC + +L + G L D I I ++LRG
Sbjct: 74 NIATYYGAFIKKSPPGHDDQLWLVMEFCGAGSVTDLVKNTKGNALKEDWIAYICREILRG 133
Query: 114 VSYCHRHACIHRDIKPENILLTANGVVKLCDFGFARLIRDLIPRHLHIFQTNEYFKGVSL 173
+++ H H IHRDIK +N+LLT N VKL DFG + + + R T + +
Sbjct: 134 LAHLHAHKVIHRDIKGQNVLLTENAEVKLVDFGVSAQLDRTVGRRNTFIGTPYWMAPEVI 193
Query: 174 PHAEN---------------VVPLEIKIGKPAATNIY----------------------- 195
EN + +E+ G P +++
Sbjct: 194 ACDENPDATYDYRSDIWSLGITAIEMAEGAPPLCDMHPMRALFLIPRNPPPKLKSKKWSK 253
Query: 196 -LIDFLKRCLDKDPLRRWSCDQLLRHPY 222
IDF++ CL K+ L R S +QLL+HP+
Sbjct: 254 KFIDFIEGCLVKNYLSRPSTEQLLKHPF 281
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K4 is also called Nck Interacting kinase (NIK). It facilitates the activation of the MAPKs, extracellular signal-regulated kinase (ERK) 1, ERK2, and c-Jun N-terminal kinase (JNK), by phosphorylating and activating MEKK1. MAP4K4 plays a role in tumor necrosis factor (TNF) alpha-induced insulin resistance. MAP4K4 silencing in skeletal muscle cells from type II diabetic patients restores insulin-mediated glucose uptake. MAP4K4, through JNK, also plays a broad role in cell motility, which impacts inflammation, homeostasis, as well as the invasion and spread of cancer. MAP4K4 is found to be highly expressed in most tumor cell lines relative to normal tissue. MAP4K6 (also called MINK for Misshapen/NIKs-related kinase) is activated after Ras induction and mediates activation of p38 MAPK. MAP4K6 plays a role in cell cycle arrest, cytoskeleton organization, cell adhesion, and cell motility. Length = 282 |
| >gnl|CDD|173726 cd06610, STKc_OSR1_SPAK, Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase | Back alignment and domain information |
|---|
Score = 95.1 bits (237), Expect = 5e-23
Identities = 46/146 (31%), Positives = 71/146 (48%), Gaps = 4/146 (2%)
Query: 4 YEKIGKLGEGSYGVVFKCRNRDTGQVVAIKKFLESEEDPLIRKIALREIRLLKSLKHPNL 63
YE I +G G+ VV+ + VAIK+ ++ E+ +E++ + HPN+
Sbjct: 3 YELIEVIGVGATAVVYAAICLPNNEKVAIKR-IDLEKCQTSVDELRKEVQAMSQCNHPNV 61
Query: 64 VNLLEVFRRKKKLHLVFEFCDHTVLNELENH---PHGLPWDLIKQITWQVLRGVSYCHRH 120
V F +L LV + L ++ GL +I + +VL+G+ Y H +
Sbjct: 62 VKYYTSFVVGDELWLVMPYLSGGSLLDIMKSSYPRGGLDEAIIATVLKEVLKGLEYLHSN 121
Query: 121 ACIHRDIKPENILLTANGVVKLCDFG 146
IHRDIK NILL +G VK+ DFG
Sbjct: 122 GQIHRDIKAGNILLGEDGSVKIADFG 147
|
Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1 and SPAK contain a conserved C-terminal (CCT) domain, which recognizes a unique motif ([RK]FX[VI]) present in their activating kinases (WNK1/WNK4) and their substrates. Length = 267 |
| >gnl|CDD|132966 cd06635, STKc_TAO1, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1 | Back alignment and domain information |
|---|
Score = 95.9 bits (238), Expect = 6e-23
Identities = 73/254 (28%), Positives = 116/254 (45%), Gaps = 36/254 (14%)
Query: 4 YEKIGKLGEGSYGVVFKCRNRDTGQVVAIKKFLESEEDPLIR-KIALREIRLLKSLKHPN 62
+ + ++G GS+G V+ R+ T +VVAIKK S + + + ++E++ L+ +KHPN
Sbjct: 27 FTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVKFLQRIKHPN 86
Query: 63 LVNLLEVFRRKKKLHLVFEFCDHTVLNELENHPHGLPWDLIKQITWQVLRGVSYCHRHAC 122
+ + R+ LV E+C + + LE H L I IT L+G++Y H H
Sbjct: 87 SIEYKGCYLREHTAWLVMEYCLGSASDLLEVHKKPLQEVEIAAITHGALQGLAYLHSHNM 146
Query: 123 IHRDIKPENILLTANGVVKLCDFGFARLIRD----------LIPRHLHIFQTNEYFKGVS 172
IHRDIK NILLT G VKL DFG A + + P + +Y V
Sbjct: 147 IHRDIKAGNILLTEPGQVKLADFGSASIASPANSFVGTPYWMAPEVILAMDEGQYDGKVD 206
Query: 173 LPHAENVVPLEIKIGKPAATNI------------------------YLIDFLKRCLDKDP 208
+ + + +E+ KP N+ Y +F+ CL K P
Sbjct: 207 V-WSLGITCIELAERKPPLFNMNAMSALYHIAQNESPTLQSNEWSDYFRNFVDSCLQKIP 265
Query: 209 LRRWSCDQLLRHPY 222
R + ++LL+H +
Sbjct: 266 QDRPTSEELLKHMF 279
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuronal apoptosis. TAO1 interacts with the checkpoint proteins BubR1 and Mad2, and plays an important role in regulating mitotic progression, which is required for both chromosome congression and checkpoint-induced anaphase delay. TAO1 may play a role in protecting genomic stability. Length = 317 |
| >gnl|CDD|132946 cd06615, PKc_MEK, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase | Back alignment and domain information |
|---|
Score = 95.6 bits (238), Expect = 6e-23
Identities = 50/146 (34%), Positives = 86/146 (58%), Gaps = 2/146 (1%)
Query: 2 ERYEKIGKLGEGSYGVVFKCRNRDTGQVVAIKKFLESEEDPLIRKIALREIRLLKSLKHP 61
+ +EK+G+LG G+ GVV K +R +G ++A +K + E P IR +RE+++L P
Sbjct: 1 DDFEKLGELGAGNGGVVTKVLHRPSGLIMA-RKLIHLEIKPAIRNQIIRELKVLHECNSP 59
Query: 62 NLVNLLEVFRRKKKLHLVFEFCDHTVLNELENHPHGLPWDLIKQITWQVLRGVSYCH-RH 120
+V F ++ + E D L+++ +P +++ +I+ VLRG++Y +H
Sbjct: 60 YIVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGRIPENILGKISIAVLRGLTYLREKH 119
Query: 121 ACIHRDIKPENILLTANGVVKLCDFG 146
+HRD+KP NIL+ + G +KLCDFG
Sbjct: 120 KIMHRDVKPSNILVNSRGEIKLCDFG 145
|
Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the downstream targets, ERK(extracellular signal-regulated kinase) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK1/2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. This cascade has also been implicated in synaptic plasticity, migration, morphological determination, and stress response immunological reactions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK1/2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 308 |
| >gnl|CDD|173761 cd08221, STKc_Nek9, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9 | Back alignment and domain information |
|---|
Score = 94.4 bits (235), Expect = 7e-23
Identities = 65/268 (24%), Positives = 109/268 (40%), Gaps = 23/268 (8%)
Query: 3 RYEKIGKLGEGSYGVVFKCRNRDTGQVVAIKKFLESEEDPLIRKIALREIRLLKSLKHPN 62
Y I LG+G++G R + +V K+ + R+ AL EI +L L+HPN
Sbjct: 1 HYIPIRVLGKGAFGEATLYRRTEDDSLVVWKEVNLTRLSEKERRDALNEIVILSLLQHPN 60
Query: 63 LVNLLEVFRRKKKLHLVFEFCDHTVLNELENHPHG--LPWDLIKQITWQVLRGVSYCHRH 120
++ F L + E+ + L + G +++ +Q++ VSY H+
Sbjct: 61 IIAYYNHFMDDNTLLIEMEYANGGTLYDKIVRQKGQLFEEEMVLWYLFQIVSAVSYIHKA 120
Query: 121 ACIHRDIKPENILLTANGVVKLCDFGFARLIRDLIPRHLHIFQTNEYF-----KGVSLPH 175
+HRDIK NI LT G++KL DFG ++++ + T Y +GV
Sbjct: 121 GILHRDIKTLNIFLTKAGLIKLGDFGISKILGSEYSMAETVVGTPYYMSPELCQGVKYNF 180
Query: 176 AENVVPLEIKIGKPAATNIYLIDFLKRCLDKDPLRR--WSCDQLLRHPYFNGYYFEVPDE 233
++ L +Y + LKR D Q P + Y E+
Sbjct: 181 KSDIWAL--------GCVLYELLTLKRTFDATNPLNLVVKIVQGNYTPVVSVYSSEL--- 229
Query: 234 MQYEEITQRCLDKDPLRRWSCDQLLRHP 261
+ L +DP +R + D++L P
Sbjct: 230 ---ISLVHSLLQQDPEKRPTADEVLDQP 254
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associates with FACT (FAcilitates Chromatin Transcription) and modulates interphase progression. It also interacts with Nek6, and Nek7, during mitosis, resulting in their activation. Length = 256 |
| >gnl|CDD|143364 cd07859, STKc_TDY_MAPK_plant, Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Score = 95.2 bits (237), Expect = 1e-22
Identities = 56/155 (36%), Positives = 86/155 (55%), Gaps = 12/155 (7%)
Query: 3 RYEKIGKLGEGSYGVVFKCRNRDTGQVVAIKKFLESEEDPLIRKIALREIRLLKSLKHPN 62
RY+ +G+GSYGVV + TG+ VAIKK + E LREI+LL+ L+HP+
Sbjct: 1 RYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKINDVFEHVSDATRILREIKLLRLLRHPD 60
Query: 63 LVNLLEVF-----RRKKKLHLVFEFCD---HTVLNELENHPHGLPWDLIKQITWQVLRGV 114
+V + + R K +++VFE + H V+ ++ L + + +Q+LR +
Sbjct: 61 IVEIKHIMLPPSRREFKDIYVVFELMESDLHQVIKANDD----LTPEHHQFFLYQLLRAL 116
Query: 115 SYCHRHACIHRDIKPENILLTANGVVKLCDFGFAR 149
Y H HRD+KP+NIL A+ +K+CDFG AR
Sbjct: 117 KYIHTANVFHRDLKPKNILANADCKLKICDFGLAR 151
|
Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activation loop, TEY and TDY. Arabidopsis thaliana contains more TEY-type MAPKs than TDY-type, whereas the reverse is true for Oryza sativa. This subfamily represents the TDY subtype and is composed of Group D plant MAPKs including Arabidopsis thaliana MPK18 (AtMPK18), Oryza sativa Blast- and Wound-induced MAPK1 (OsBWMK1), OsWJUMK1 (Wound- and JA-Uninducible MAPK1), Zea mays MPK6, and the Medicago sativa TDY1 gene product. OsBWMK1 enhances resistance to pathogenic infections. It mediates stress-activated defense responses by activating a transcription factor that affects the expression of stress-related genes. AtMPK18 is involved in microtubule-related functions. Length = 338 |
| >gnl|CDD|132964 cd06633, STKc_TAO3, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3 | Back alignment and domain information |
|---|
Score = 94.3 bits (234), Expect = 2e-22
Identities = 55/141 (39%), Positives = 79/141 (56%), Gaps = 1/141 (0%)
Query: 9 KLGEGSYGVVFKCRNRDTGQVVAIKKFLESEEDPLIR-KIALREIRLLKSLKHPNLVNLL 67
++G GS+G V+ N T +VVA+KK S + + + ++E++ L+ LKHPN +
Sbjct: 28 EIGHGSFGAVYFATNSHTNEVVAVKKMSYSGKQTNEKWQDIIKEVKFLQQLKHPNTIEYK 87
Query: 68 EVFRRKKKLHLVFEFCDHTVLNELENHPHGLPWDLIKQITWQVLRGVSYCHRHACIHRDI 127
+ ++ LV E+C + + LE H L I IT L+G++Y H H IHRDI
Sbjct: 88 GCYLKEHTAWLVMEYCLGSASDLLEVHKKPLQEVEIAAITHGALQGLAYLHSHNMIHRDI 147
Query: 128 KPENILLTANGVVKLCDFGFA 148
K NILLT G VKL DFG A
Sbjct: 148 KAGNILLTEPGQVKLADFGSA 168
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a component of the RAM (regulation of Ace2p activity and cellular morphogenesis) signaling pathway. TAO3 is upregulated in retinal ganglion cells after axotomy, and may play a role in apoptosis. Length = 313 |
| >gnl|CDD|132980 cd06649, PKc_MEK2, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2 | Back alignment and domain information |
|---|
Score = 94.0 bits (233), Expect = 4e-22
Identities = 47/148 (31%), Positives = 87/148 (58%), Gaps = 2/148 (1%)
Query: 2 ERYEKIGKLGEGSYGVVFKCRNRDTGQVVAIKKFLESEEDPLIRKIALREIRLLKSLKHP 61
+ +E+I +LG G+ GVV K +++ +G ++A +K + E P IR +RE+++L P
Sbjct: 5 DDFERISELGAGNGGVVTKVQHKPSGLIMA-RKLIHLEIKPAIRNQIIRELQVLHECNSP 63
Query: 62 NLVNLLEVFRRKKKLHLVFEFCDHTVLNELENHPHGLPWDLIKQITWQVLRGVSYC-HRH 120
+V F ++ + E D L+++ +P +++ +++ VLRG++Y +H
Sbjct: 64 YIVGFYGAFYSDGEISICMEHMDGGSLDQVLKEAKRIPEEILGKVSIAVLRGLAYLREKH 123
Query: 121 ACIHRDIKPENILLTANGVVKLCDFGFA 148
+HRD+KP NIL+ + G +KLCDFG +
Sbjct: 124 QIMHRDVKPSNILVNSRGEIKLCDFGVS 151
|
Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 331 |
| >gnl|CDD|132981 cd06650, PKc_MEK1, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1 | Back alignment and domain information |
|---|
Score = 93.6 bits (232), Expect = 4e-22
Identities = 47/146 (32%), Positives = 85/146 (58%), Gaps = 2/146 (1%)
Query: 4 YEKIGKLGEGSYGVVFKCRNRDTGQVVAIKKFLESEEDPLIRKIALREIRLLKSLKHPNL 63
+EKI +LG G+ GVVFK ++ +G ++A +K + E P IR +RE+++L P +
Sbjct: 7 FEKISELGAGNGGVVFKVSHKPSGLIMA-RKLIHLEIKPAIRNQIIRELQVLHECNSPYI 65
Query: 64 VNLLEVFRRKKKLHLVFEFCDHTVLNELENHPHGLPWDLIKQITWQVLRGVSYC-HRHAC 122
V F ++ + E D L+++ +P ++ +++ V++G++Y +H
Sbjct: 66 VGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGRIPEQILGKVSIAVIKGLTYLREKHKI 125
Query: 123 IHRDIKPENILLTANGVVKLCDFGFA 148
+HRD+KP NIL+ + G +KLCDFG +
Sbjct: 126 MHRDVKPSNILVNSRGEIKLCDFGVS 151
|
Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK1, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK1, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. MEK1 also plays a role in cell cycle control. Length = 333 |
| >gnl|CDD|143359 cd07854, STKc_MAPK4_6, Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6 | Back alignment and domain information |
|---|
Score = 93.7 bits (233), Expect = 5e-22
Identities = 83/311 (26%), Positives = 139/311 (44%), Gaps = 53/311 (17%)
Query: 3 RYEKIGKLGEGSYGVVFKCRNRDTGQVVAIKKFLESEEDPLIRKIALREIRLLKSLKHPN 62
RY + LG GS G+VF + D + VA+KK + + DP K ALREI++++ L H N
Sbjct: 6 RYMDLRPLGCGSNGLVFSAVDSDCDKRVAVKKIVLT--DPQSVKHALREIKIIRRLDHDN 63
Query: 63 LVNLLEVFRRK--------------KKLHLVFEFCDHTVLNELENHPHGLPWDLIKQITW 108
+V + EV +++V E+ + + N LE P L + + +
Sbjct: 64 IVKVYEVLGPSGSDLTEDVGSLTELNSVYIVQEYMETDLANVLEQGP--LSEEHARLFMY 121
Query: 109 QVLRGVSYCHRHACIHRDIKPENILL-TANGVVKLCDFGFARLIRDLIPRHLH------- 160
Q+LRG+ Y H +HRD+KP N+ + T + V+K+ DFG AR++ P + H
Sbjct: 122 QLLRGLKYIHSANVLHRDLKPANVFINTEDLVLKIGDFGLARIVD---PHYSHKGYLSEG 178
Query: 161 -----------IFQTNEYFKGVSLPHAENVVPLEIKIGKPAATNIYLIDFLKRCLDKDPL 209
+ N Y K + + A + E+ GKP + ++ ++ L+ P+
Sbjct: 179 LVTKWYRSPRLLLSPNNYTKAIDM-WAAGCIFAEMLTGKPLFAGAHELEQMQLILESVPV 237
Query: 210 -RRWSCDQLLR-HPYF---NGYYFEVPDEMQYEEITQRCLDK-------DPLRRWSCDQL 257
R ++LL P F +G P + LD +P+ R + ++
Sbjct: 238 VREEDRNELLNVIPSFVRNDGGEPRRPLRDLLPGVNPEALDFLEQILTFNPMDRLTAEEA 297
Query: 258 LRHPYFNGYYF 268
L HPY + Y
Sbjct: 298 LMHPYMSCYSC 308
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progression in certain conditions. It may also play a role in glucose-induced insulin secretion. MAPK6 and MAPK4 cooperate to regulate the activity of MAPK-activated protein kinase 5 (MK5), leading to its relocation to the cytoplasm and exclusion from the nucleus. The MAPK6/MK5 and MAPK4/MK5 pathways may play critical roles in embryonic and post-natal development. Length = 342 |
| >gnl|CDD|132953 cd06622, PKc_MAPKK_PBS2_like, Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 92.2 bits (229), Expect = 7e-22
Identities = 79/290 (27%), Positives = 130/290 (44%), Gaps = 53/290 (18%)
Query: 5 EKIGKLGEGSYGVVFKCRNRDTGQVVAIKKFLESEEDPLIRKIALREIRLLKSLKHPNLV 64
E + +LG+G+YG V+K +R TG +A+K+ ++ +I + E+ +L P +V
Sbjct: 4 EVLDELGKGNYGSVYKVLHRPTGVTMAMKEIRLELDESKFNQI-IMELDILHKAVSPYIV 62
Query: 65 NLLEVFRRKKKLHLVFEFCDHTVLNEL---ENHPHGLPWDLIKQITWQVLRGVSYC-HRH 120
+ F + +++ E+ D L++L G+P D++++IT+ V++G+ + H
Sbjct: 63 DFYGAFFIEGAVYMCMEYMDAGSLDKLYAGGVATEGIPEDVLRRITYAVVKGLKFLKEEH 122
Query: 121 ACIHRDIKPENILLTANGVVKLCDFGFA-RLIRDLIPRHLHIFQTNEYFKGVSLPHAENV 179
IHRD+KP N+L+ NG VKLCDFG + L+ L +TN + +
Sbjct: 123 NIIHRDVKPTNVLVNGNGQVKLCDFGVSGNLVASLA-------KTN-------IGCQSYM 168
Query: 180 VPLEIKIGKPAATNIYLIDFLKRCLDKDPLRRWSCD------QLLRHPYFNGYYFEV--- 230
P IK G P Y + D WS L R+PY Y +
Sbjct: 169 APERIKSGGPNQNPTYTV-------QSDV---WSLGLSILEMALGRYPYPPETYANIFAQ 218
Query: 231 ------------PDEMQYE--EITQRCLDKDPLRRWSCDQLLRHPYFNGY 266
P + + +CL+K P RR + QLL HP+ Y
Sbjct: 219 LSAIVDGDPPTLPSGYSDDAQDFVAKCLNKIPNRRPTYAQLLEHPWLVKY 268
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Polymyxin B resistance protein 2 (PBS2) from Saccharomyces cerevisiae, Wis1 from Schizosaccharomyces pombe, and related proteins. PBS2 and Wis1 are components of stress-activated MAPK cascades in budding and fission yeast, respectively. PBS2 is the specific activator of the MAPK Hog1, which plays a central role in the response of budding yeast to stress including exposure to arsenite and hyperosmotic environments. Wis1 phosphorylates and activates the MAPK Sty1 (also called Spc1 or Phh1), which stimulates a transcriptional response to a wide range of cellular insults through the bZip transcription factors Atf1, Pcr1, and Pap1. Length = 286 |
| >gnl|CDD|173746 cd07850, STKc_JNK, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase | Back alignment and domain information |
|---|
Score = 93.2 bits (232), Expect = 8e-22
Identities = 86/349 (24%), Positives = 136/349 (38%), Gaps = 107/349 (30%)
Query: 3 RYEKIGKLGEGSYGVVFKCRNRDTGQVVAIKKFLESEEDPLIRKIALREIRLLKSLKHPN 62
RY+ + +G G+ G+V + TGQ VAIKK ++ K A RE+ L+K + H N
Sbjct: 17 RYQNLKPIGSGAQGIVCAAYDTVTGQNVAIKKLSRPFQNVTHAKRAYRELVLMKLVNHKN 76
Query: 63 LVNLLEVFRRKKKL------HLVFEFCDHT---VLNELENHPHGLPWDLIKQITWQVLRG 113
++ LL VF +K L +LV E D V+ +H + + + +Q+L G
Sbjct: 77 IIGLLNVFTPQKSLEEFQDVYLVMELMDANLCQVIQMDLDH------ERMSYLLYQMLCG 130
Query: 114 VSYCHRHACIHRDIKPENILLTANGVVKLCDFG--------------------------- 146
+ + H IHRD+KP NI++ ++ +K+ DFG
Sbjct: 131 IKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMTPYVVTRYYRAPEVIL 190
Query: 147 ----------------FARLIRD--LIPRHLHIFQTNEYFKGVSLPHAENVVPLEIKIGK 188
+IR L P HI Q N+ + ++G
Sbjct: 191 GMGYKENVDIWSVGCIMGEMIRGTVLFPGTDHIDQWNKIIE---------------QLGT 235
Query: 189 PAATNIYLIDFLKRCLDKDPLRRWSCDQLLRHPYFNGYYFEV--PDEM------------ 234
P+ +F+ R P R + ++ GY FE PD +
Sbjct: 236 PSD------EFMSRL---QPTVRNYVENRPKYA---GYSFEELFPDVLFPPDSESHNKLK 283
Query: 235 --QYEEITQRCLDKDPLRRWSCDQLLRHPYFNGYY----FEVPDEMQYE 277
Q ++ + L DP +R S D L+HPY N +Y E P Y+
Sbjct: 284 ASQARDLLSKMLVIDPEKRISVDDALQHPYINVWYDPSEVEAPPPAPYD 332
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3) that are alternatively spliced to produce at least 10 isoforms. JNKs are specifically activated by the MAPK kinases MKK4 and MKK7, which are in turn activated by upstream MAPK kinase kinases as a result of different stimuli including stresses such as ultraviolet (UV) irradiation, hyperosmolarity, heat shock, or cytokines. JNKs activate a large number of different substrates based on specific stimulus, cell type, and cellular condition, and may be implicated in seemingly contradictory functions. Length = 353 |
| >gnl|CDD|173765 cd08225, STKc_Nek5, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5 | Back alignment and domain information |
|---|
Score = 91.2 bits (226), Expect = 1e-21
Identities = 55/155 (35%), Positives = 89/155 (57%), Gaps = 5/155 (3%)
Query: 3 RYEKIGKLGEGSYGVVFKCRNRDTGQVVAIKKFLESEEDPLIRKIALR-EIRLLKSLKHP 61
RYE I K+GEGS+G ++ + + + IK+ ++ + P+ K A + E+ LL +KHP
Sbjct: 1 RYEIIKKIGEGSFGKIYLAKAKSDSEHCVIKE-IDLTKMPVKEKEASKKEVILLAKMKHP 59
Query: 62 NLVNLLEVFRRKKKLHLVFEFCDHTVLNELENHPHGLPWDLIKQITW--QVLRGVSYCHR 119
N+V F+ +L +V E+CD L + N G+ + + ++W Q+ G+ + H
Sbjct: 60 NIVTFFASFQENGRLFIVMEYCDGGDLMKRINRQRGVLFSEDQILSWFVQISLGLKHIHD 119
Query: 120 HACIHRDIKPENILLTANGVV-KLCDFGFARLIRD 153
+HRDIK +NI L+ NG+V KL DFG AR + D
Sbjct: 120 RKILHRDIKSQNIFLSKNGMVAKLGDFGIARQLND 154
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown. Length = 257 |
| >gnl|CDD|132991 cd06917, STKc_NAK1_like, Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 91.3 bits (227), Expect = 1e-21
Identities = 72/257 (28%), Positives = 117/257 (45%), Gaps = 47/257 (18%)
Query: 3 RYEKIGKLGEGSYGVVFKCRNRDTGQVVAIKKF-LESEEDPLIRKIALREIRLLKSLKH- 60
R E IG+ G+YG V++ ++ TG+VVA+K L++ +D + I RE+ LL L+
Sbjct: 5 RLELIGR---GAYGAVYRGKHVPTGRVVALKIINLDTPDDD-VSDIQ-REVALLSQLRQS 59
Query: 61 --PNLVNLLEVFRRKKKLHLVFEFCDH-TVLNELENHPHGLPWDLIKQITWQVLRGVSYC 117
PN+ + + +L ++ E+ + +V ++ P + I I +VL + Y
Sbjct: 60 QPPNITKYYGSYLKGPRLWIIMEYAEGGSVRTLMKAGPIAEKY--ISVIIREVLVALKYI 117
Query: 118 HRHACIHRDIKPENILLTANGVVKLCDFGFARLIRDLIPRHLHIFQTNEYF------KGV 171
H+ IHRDIK NIL+T G VKLCDFG A L+ + T + +G
Sbjct: 118 HKVGVIHRDIKAANILVTNTGNVKLCDFGVAALLNQNSSKRSTFVGTPYWMAPEVITEGK 177
Query: 172 SLPHAENVVPL-----EIKIGKP------AATNIYLI------------------DFLKR 202
++ L E+ G P A + LI +F+
Sbjct: 178 YYDTKADIWSLGITIYEMATGNPPYSDVDAFRAMMLIPKSKPPRLEDNGYSKLLREFVAA 237
Query: 203 CLDKDPLRRWSCDQLLR 219
CLD++P R S ++LL+
Sbjct: 238 CLDEEPKERLSAEELLK 254
|
Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of centrin, and phosphorylates substrates in a Cdc31p-dependent manner. Length = 277 |
| >gnl|CDD|173744 cd07847, STKc_CDKL1_4, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4 | Back alignment and domain information |
|---|
Score = 90.9 bits (226), Expect = 2e-21
Identities = 38/71 (53%), Positives = 46/71 (64%), Gaps = 3/71 (4%)
Query: 153 DLIPRHLHIFQTNEYFKGVSLPHAENVVPLEIKIGKPAATNIYLIDFLKRCLDKDPLRRW 212
DLIPRH IF TN++FKG+S+P E PLE K P ++ L FLK CL DP R
Sbjct: 219 DLIPRHQQIFSTNQFFKGLSIPEPETREPLESKF--PNISSPAL-SFLKGCLQMDPTERL 275
Query: 213 SCDQLLRHPYF 223
SC++LL HPYF
Sbjct: 276 SCEELLEHPYF 286
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The function of CDKL4 is unknown. Length = 286 |
| >gnl|CDD|132965 cd06634, STKc_TAO2, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2 | Back alignment and domain information |
|---|
Score = 91.7 bits (227), Expect = 2e-21
Identities = 53/149 (35%), Positives = 84/149 (56%), Gaps = 1/149 (0%)
Query: 4 YEKIGKLGEGSYGVVFKCRNRDTGQVVAIKKFLESEEDPLIR-KIALREIRLLKSLKHPN 62
+ + ++G GS+G V+ R+ +VVAIKK S + + + ++E+R L+ L+HPN
Sbjct: 17 FSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPN 76
Query: 63 LVNLLEVFRRKKKLHLVFEFCDHTVLNELENHPHGLPWDLIKQITWQVLRGVSYCHRHAC 122
+ + R+ LV E+C + + LE H L I +T L+G++Y H H
Sbjct: 77 TIQYRGCYLREHTAWLVMEYCLGSASDLLEVHKKPLQEVEIAAVTHGALQGLAYLHSHNM 136
Query: 123 IHRDIKPENILLTANGVVKLCDFGFARLI 151
IHRD+K NILL+ G+VKL DFG A ++
Sbjct: 137 IHRDVKAGNILLSEPGLVKLGDFGSASIM 165
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. TAO2 contains a long C-terminal extension with autoinhibitory segments. It is activated by the release of this inhibition and the phosphorylation of its activation loop serine. TAO2 functions as a regulator of actin cytoskeletal and microtubule organization. In addition, it regulates the transforming growth factor-activated kinase 1 (TAK1), which is a MAPKKK that plays an essential role in the signaling pathways of tumor necrosis factor (TNF), interleukin 1 (IL-1), and Toll-like receptor (TLR). Length = 308 |
| >gnl|CDD|132988 cd06657, STKc_PAK4, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4 | Back alignment and domain information |
|---|
Score = 91.6 bits (227), Expect = 2e-21
Identities = 71/266 (26%), Positives = 125/266 (46%), Gaps = 30/266 (11%)
Query: 9 KLGEGSYGVVFKCRNRDTGQVVAIKKF-LESEEDPLIRKIALREIRLLKSLKHPNLVNLL 67
K+GEGS G+V + +G++VA+KK L ++ R++ E+ +++ +H N+V +
Sbjct: 27 KIGEGSTGIVCIATVKSSGKLVAVKKMDLRKQQR---RELLFNEVVIMRDYQHENVVEMY 83
Query: 68 EVFRRKKKLHLVFEFCDHTVLNELENHPHGLPWDLIKQITWQVLRGVSYCHRHACIHRDI 127
+ +L +V EF + L ++ H + + I + VL+ +S H IHRDI
Sbjct: 84 NSYLVGDELWVVMEFLEGGALTDIVTHTR-MNEEQIAAVCLAVLKALSVLHAQGVIHRDI 142
Query: 128 KPENILLTANGVVKLCDFGFARLIRDLIPRHLHIFQTNEYFKG---VSLPHAENV----- 179
K ++ILLT +G VKL DFGF + +PR + T + LP+ V
Sbjct: 143 KSDSILLTHDGRVKLSDFGFCAQVSKEVPRRKSLVGTPYWMAPELISRLPYGPEVDIWSL 202
Query: 180 --VPLEIKIGKPAATNIYLIDFLKRCLDKDPLRRWSCDQLLRHPYFNGYYFEVPDEMQYE 237
+ +E+ G+P N + +K D P + + ++ P G+
Sbjct: 203 GIMVIEMVDGEPPYFNEPPLKAMKMIRDNLPPKLKNLHKV--SPSLKGFL---------- 250
Query: 238 EITQRCLDKDPLRRWSCDQLLRHPYF 263
R L +DP +R + +LL+HP+
Sbjct: 251 ---DRLLVRDPAQRATAAELLKHPFL 273
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell morphology and cytoskeletal organization. It is essential for embryonic viability and proper neural development. Mice lacking PAK4 die due to defects in the fetal heart. In addition, their spinal cord motor neurons showed failure to differentiate and migrate. PAK4 also plays a role in cell survival and tumorigenesis. It is overexpressed in many primary tumors including colon, esophageal, and mammary tumors. PAK4 has also been implicated in viral and bacterial infection pathways. Length = 292 |
| >gnl|CDD|132986 cd06655, STKc_PAK2, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2 | Back alignment and domain information |
|---|
Score = 91.3 bits (226), Expect = 2e-21
Identities = 73/257 (28%), Positives = 124/257 (48%), Gaps = 38/257 (14%)
Query: 2 ERYEKIGKLGEGSYGVVFKCRNRDTGQVVAIKKFLESEEDPLIRKIALREIRLLKSLKHP 61
++Y + K+G+G+ G VF + TGQ VAIK+ + ++ P +++ + EI ++K LK+P
Sbjct: 19 KKYTRYEKIGQGASGTVFTAIDVATGQEVAIKQ-INLQKQPK-KELIINEILVMKELKNP 76
Query: 62 NLVNLLEVFRRKKKLHLVFEFCDHTVLNELENHPHGLPWDLIKQITWQVLRGVSYCHRHA 121
N+VN L+ F +L +V E+ L ++ + I + + L+ + + H +
Sbjct: 77 NIVNFLDSFLVGDELFVVMEYLAGGSLTDVVTET-CMDEAQIAAVCRECLQALEFLHANQ 135
Query: 122 CIHRDIKPENILLTANGVVKLCDFGFARLIRDLIPRHLHIFQTNEYF------KGVSLPH 175
IHRDIK +N+LL +G VKL DFGF I + + T + + P
Sbjct: 136 VIHRDIKSDNVLLGMDGSVKLTDFGFCAQITPEQSKRSTMVGTPYWMAPEVVTRKAYGPK 195
Query: 176 AE----NVVPLEIKIGKPAATN------IYLI-------------------DFLKRCLDK 206
+ ++ +E+ G+P N +YLI DFL RCL+
Sbjct: 196 VDIWSLGIMAIEMVEGEPPYLNENPLRALYLIATNGTPELQNPEKLSPIFRDFLNRCLEM 255
Query: 207 DPLRRWSCDQLLRHPYF 223
D +R S +LL+HP+
Sbjct: 256 DVEKRGSAKELLQHPFL 272
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK2 plays a role in pro-apoptotic signaling. It is cleaved and activated by caspases leading to morphological changes during apoptosis. PAK2 is also activated in response to a variety of stresses including DNA damage, hyperosmolarity, serum starvation, and contact inhibition, and may play a role in coordinating the stress response. PAK2 also contributes to cancer cell invasion through a mechanism distinct from that of PAK1. Length = 296 |
| >gnl|CDD|132977 cd06646, STKc_MAP4K5, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5 | Back alignment and domain information |
|---|
Score = 90.9 bits (225), Expect = 2e-21
Identities = 57/156 (36%), Positives = 86/156 (55%), Gaps = 6/156 (3%)
Query: 4 YEKIGKLGEGSYGVVFKCRNRDTGQVVAIK--KFLESEEDPLIRKIALREIRLLKSLKHP 61
YE I ++G G+YG V+K RN TG++ A+K K ++ LI++ EI ++K KH
Sbjct: 11 YELIQRVGSGTYGDVYKARNLHTGELAAVKIIKLEPGDDFSLIQQ----EIFMVKECKHC 66
Query: 62 NLVNLLEVFRRKKKLHLVFEFCDHTVLNELENHPHGLPWDLIKQITWQVLRGVSYCHRHA 121
N+V + ++KL + E+C L ++ + L I + + L+G++Y H
Sbjct: 67 NIVAYFGSYLSREKLWICMEYCGGGSLQDIYHVTGPLSELQIAYVCRETLQGLAYLHSKG 126
Query: 122 CIHRDIKPENILLTANGVVKLCDFGFARLIRDLIPR 157
+HRDIK NILLT NG VKL DFG A I I +
Sbjct: 127 KMHRDIKGANILLTDNGDVKLADFGVAAKITATIAK 162
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). MAP4K5 also facilitates Wnt signaling in B cells, and may therefore be implicated in the control of cell fate, proliferation, and polarity. Length = 267 |
| >gnl|CDD|132987 cd06656, STKc_PAK3, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3 | Back alignment and domain information |
|---|
Score = 91.3 bits (226), Expect = 2e-21
Identities = 71/257 (27%), Positives = 123/257 (47%), Gaps = 38/257 (14%)
Query: 2 ERYEKIGKLGEGSYGVVFKCRNRDTGQVVAIKKFLESEEDPLIRKIALREIRLLKSLKHP 61
++Y + K+G+G+ G V+ + TGQ VAIK+ + ++ P +++ + EI +++ K+P
Sbjct: 19 KKYTRFEKIGQGASGTVYTAIDIATGQEVAIKQ-MNLQQQPK-KELIINEILVMRENKNP 76
Query: 62 NLVNLLEVFRRKKKLHLVFEFCDHTVLNELENHPHGLPWDLIKQITWQVLRGVSYCHRHA 121
N+VN L+ + +L +V E+ L ++ + I + + L+ + + H +
Sbjct: 77 NIVNYLDSYLVGDELWVVMEYLAGGSLTDVVTET-CMDEGQIAAVCRECLQALDFLHSNQ 135
Query: 122 CIHRDIKPENILLTANGVVKLCDFGFARLIRDLIPRHLHIFQTNEYF------KGVSLPH 175
IHRDIK +NILL +G VKL DFGF I + + T + + P
Sbjct: 136 VIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSTMVGTPYWMAPEVVTRKAYGPK 195
Query: 176 AE----NVVPLEIKIGKPAATN------IYLI-------------------DFLKRCLDK 206
+ ++ +E+ G+P N +YLI DFL RCL+
Sbjct: 196 VDIWSLGIMAIEMVEGEPPYLNENPLRALYLIATNGTPELQNPERLSAVFRDFLNRCLEM 255
Query: 207 DPLRRWSCDQLLRHPYF 223
D RR S +LL+HP+
Sbjct: 256 DVDRRGSAKELLQHPFL 272
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK3 is highly expressed in the brain. It is implicated in neuronal plasticity, synapse formation, dendritic spine morphogenesis, cell cycle progression, neuronal migration, and apoptosis. Inactivating mutations in the PAK3 gene cause X-linked non-syndromic mental retardation, the severity of which depends on the site of the mutation. Length = 297 |
| >gnl|CDD|143372 cd07867, STKc_CDC2L6, Catalytic domain of Serine/Threonine Kinase, Cell Division Cycle 2-like 6 | Back alignment and domain information |
|---|
Score = 91.3 bits (226), Expect = 3e-21
Identities = 57/157 (36%), Positives = 90/157 (57%), Gaps = 18/157 (11%)
Query: 9 KLGEGSYGVVFKCRNRDTGQVVAIKKF-LESEEDPLIRKIALREIRLLKSLKHPNLVNLL 67
K+G G+YG V+K + +D K++ L+ E I A REI LL+ LKHPN++ L
Sbjct: 8 KVGRGTYGHVYKAKRKDGKDE---KEYALKQIEGTGISMSACREIALLRELKHPNVIALQ 64
Query: 68 EVF--RRKKKLHLVFEFCDHTVLNELENH--------PHGLPWDLIKQITWQVLRGVSYC 117
+VF +K+ L+F++ +H + + ++ H P LP ++K + +Q+L G+ Y
Sbjct: 65 KVFLSHSDRKVWLLFDYAEHDLWHIIKFHRASKANKKPMQLPRSMVKSLLYQILDGIHYL 124
Query: 118 HRHACIHRDIKPENILLTANGV----VKLCDFGFARL 150
H + +HRD+KP NIL+ G VK+ D GFARL
Sbjct: 125 HANWVLHRDLKPANILVMGEGPERGRVKIADMGFARL 161
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 6 (CDC2L6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L6 is also called CDK8-like and was previously referred to as CDK11. However, this is a confusing nomenclature as CDC2L6 is distinct from CDC2L1, which is represented by the two protein products from its gene, called CDK11(p110) and CDK11(p58), as well as the caspase-processed CDK11(p46). CDK11(p110), CDK11(p58), and CDK11(p46)do not belong to this subfamily. CDC2L6 is an associated protein of Mediator, a multiprotein complex that provides a platform to connect transcriptional and chromatin regulators and cofactors, in order to activate and mediate RNA polymerase II transcription. CDC2L6 is localized mainly in the nucleus amd exerts an opposing effect to CDK8 in VP16-dependent transcriptional activation by being a negative regulator. Length = 317 |
| >gnl|CDD|173750 cd07857, STKc_MPK1, Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1 | Back alignment and domain information |
|---|
Score = 91.3 bits (227), Expect = 3e-21
Identities = 56/156 (35%), Positives = 86/156 (55%), Gaps = 12/156 (7%)
Query: 3 RYEKIGKLGEGSYGVVFKCRNRDT--GQVVAIKKFLESEEDPLIRKIALREIRLLKSLK- 59
RYE I +LG+G+YG+V RN +T + VAIKK ++ K ALRE++LL+ +
Sbjct: 1 RYELIKELGQGAYGIVCSARNAETSEEETVAIKKITNVFSKKILAKRALRELKLLRHFRG 60
Query: 60 HPNLVNLLE---VFRRK-KKLHLVFEF--CDHTVLNELENHPHGLPWDLIKQITWQVLRG 113
H N+ L + VF +L+L E D L+++ L + +Q+L G
Sbjct: 61 HKNITCLYDMDIVFPGNFNELYLYEELMEAD---LHQIIRSGQPLTDAHFQSFIYQILCG 117
Query: 114 VSYCHRHACIHRDIKPENILLTANGVVKLCDFGFAR 149
+ Y H +HRD+KP N+L+ A+ +K+CDFG AR
Sbjct: 118 LKYIHSANVLHRDLKPGNLLVNADCELKICDFGLAR 153
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall construction, morphogenesis, and ion homeostasis. MPK1 is activated in response to cell wall stress including heat stimulation, osmotic shock, UV irradiation, and any agents that interfere with cell wall biogenesis such as chitin antagonists, caffeine, or zymolase. MPK1 is regulated by the MAP2Ks Mkk1/2, which are regulated by the MAP3K Bck1. Pmk1 is also activated by multiple stresses including elevated temperatures, hyper- or hypotonic stress, glucose deprivation, exposure to cell-wall damaging compounds, and oxidative stress. It is regulated by the MAP2K Pek1, which is regulated by the MAP3K Mkh1. Length = 332 |
| >gnl|CDD|143384 cd07879, STKc_p38delta_MAPK13, Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 91.1 bits (226), Expect = 4e-21
Identities = 54/154 (35%), Positives = 84/154 (54%), Gaps = 9/154 (5%)
Query: 2 ERYEKIGKLGEGSYGVVFKCRNRDTGQVVAIKKFLESEEDPLIRKIALREIRLLKSLKHP 61
ERY + ++G G+YG V ++ TG+ VAIKK + + K A RE+ LLK ++H
Sbjct: 15 ERYTSLKQVGSGAYGSVCSAIDKRTGEKVAIKKLSRPFQSEIFAKRAYRELTLLKHMQHE 74
Query: 62 NLVNLLEVFRRKKKLH------LVFEFCDHTVLNELENHPHGLPWDLIKQITWQVLRGVS 115
N++ LL+VF LV + T L ++ HP L D ++ + +Q+L G+
Sbjct: 75 NVIGLLDVFTSAVSGDEFQDFYLVMPYM-QTDLQKIMGHP--LSEDKVQYLVYQMLCGLK 131
Query: 116 YCHRHACIHRDIKPENILLTANGVVKLCDFGFAR 149
Y H IHRD+KP N+ + + +K+ DFG AR
Sbjct: 132 YIHSAGIIHRDLKPGNLAVNEDCELKILDFGLAR 165
|
Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13, is found in skeletal muscle, heart, lung, testis, pancreas, and small intestine. It regulates microtubule function by phosphorylating Tau. It activates the c-jun promoter and plays a role in G2 cell cycle arrest. It also controls the degration of c-Myb, which is associated with myeloid leukemia and poor prognosis in colorectal cancer. p38delta is the main isoform involved in regulating the differentiation and apoptosis of keratinocytes. Length = 342 |
| >gnl|CDD|173634 cd05053, PTKc_FGFR, Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors | Back alignment and domain information |
|---|
Score = 89.8 bits (223), Expect = 6e-21
Identities = 50/175 (28%), Positives = 84/175 (48%), Gaps = 23/175 (13%)
Query: 2 ERYEKIGKLGEGSYGVVFK-----CRNRDTGQVVAIKKFLESEEDPLIRKIALREIRLLK 56
+R LGEG++G V K N + VA+K + + + + + E+ ++K
Sbjct: 12 DRLTLGKPLGEGAFGQVVKAEAVGLDNPNETSTVAVKMLKDDATEKDLSDL-VSEMEMMK 70
Query: 57 SL-KHPNLVNLLEVFRRKKKLHLVFEFCDHTVLNEL--ENHPHG------LPWDLIKQIT 107
+ KH N++NLL V ++ L++V E+ H L + P G P + +T
Sbjct: 71 MIGKHKNIINLLGVCTQEGPLYVVVEYAAHGNLRDFLRARRPPGEYASPDDPRPPEETLT 130
Query: 108 --------WQVLRGVSYCHRHACIHRDIKPENILLTANGVVKLCDFGFARLIRDL 154
+QV RG+ + CIHRD+ N+L+T + V+K+ DFG AR I +
Sbjct: 131 QKDLVSFAYQVARGMEFLASKKCIHRDLAARNVLVTEDHVMKIADFGLARDIHHI 185
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation, and intracellular signaling. There are at least 23 FGFs and four types of FGFRs. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. FGF/FGFR signaling is important in the regulation of embryonic development, homeostasis, and regenerative processes. Depending on the cell type and stage, FGFR signaling produces diverse cellular responses including proliferation, growth arrest, differentiation, and apoptosis. Aberrant signaling leads to many human diseases such as skeletal, olfactory, and metabolic disorders, as well as cancer. Length = 293 |
| >gnl|CDD|132968 cd06637, STKc_TNIK, Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase | Back alignment and domain information |
|---|
Score = 89.4 bits (221), Expect = 7e-21
Identities = 76/268 (28%), Positives = 123/268 (45%), Gaps = 53/268 (19%)
Query: 4 YEKIGKLGEGSYGVVFKCRNRDTGQVVAIKKF-LESEEDPLIRKIALREIRLLKSLKH-P 61
+E + +G G+YG V+K R+ TGQ+ AIK + +E+ I++ EI +LK H
Sbjct: 8 FELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTGDEEEEIKQ----EINMLKKYSHHR 63
Query: 62 NLVNLLEVFRRKK------KLHLVFEFCDHTVLNELENHPHG--LPWDLIKQITWQVLRG 113
N+ F +K +L LV EFC + +L + G L + I I ++LRG
Sbjct: 64 NIATYYGAFIKKNPPGMDDQLWLVMEFCGAGSVTDLIKNTKGNTLKEEWIAYICREILRG 123
Query: 114 VSYCHRHACIHRDIKPENILLTANGVVKLCDFGFARLIRDLIPRHLHIFQTNEYFKGVSL 173
+S+ H+H IHRDIK +N+LLT N VKL DFG + + + R T + +
Sbjct: 124 LSHLHQHKVIHRDIKGQNVLLTENAEVKLVDFGVSAQLDRTVGRRNTFIGTPYWMAPEVI 183
Query: 174 PHAEN---------------VVPLEIKIGKPAATN------IYLI--------------- 197
EN + +E+ G P + ++LI
Sbjct: 184 ACDENPDATYDFKSDLWSLGITAIEMAEGAPPLCDMHPMRALFLIPRNPAPRLKSKKWSK 243
Query: 198 ---DFLKRCLDKDPLRRWSCDQLLRHPY 222
F++ CL K+ +R + +QL++HP+
Sbjct: 244 KFQSFIESCLVKNHSQRPTTEQLMKHPF 271
|
Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activates the c-Jun N-terminal kinase (JNK) pathway and plays a role in regulating the actin cytoskeleton. Length = 272 |
| >gnl|CDD|132989 cd06658, STKc_PAK5, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5 | Back alignment and domain information |
|---|
Score = 89.7 bits (222), Expect = 7e-21
Identities = 72/270 (26%), Positives = 126/270 (46%), Gaps = 38/270 (14%)
Query: 9 KLGEGSYGVVFKCRNRDTGQVVAIKKF-LESEEDPLIRKIALREIRLLKSLKHPNLVNLL 67
K+GEGS G+V + TG+ VA+KK L ++ R++ E+ +++ H N+V++
Sbjct: 29 KIGEGSTGIVCIATEKHTGKQVAVKKMDLRKQQR---RELLFNEVVIMRDYHHENVVDMY 85
Query: 68 EVFRRKKKLHLVFEFCDHTVLNELENHPHGLPWDLIKQITWQVLRGVSYCHRHACIHRDI 127
+ +L +V EF + L ++ H + + I + VLR +SY H IHRDI
Sbjct: 86 NSYLVGDELWVVMEFLEGGALTDIVTHTR-MNEEQIATVCLSVLRALSYLHNQGVIHRDI 144
Query: 128 KPENILLTANGVVKLCDFGFARLIRDLIPRHLHIFQTNEYFKG---VSLPHAENV----- 179
K ++ILLT++G +KL DFGF + +P+ + T + LP+ V
Sbjct: 145 KSDSILLTSDGRIKLSDFGFCAQVSKEVPKRKSLVGTPYWMAPEVISRLPYGTEVDIWSL 204
Query: 180 --VPLEIKIGKPAATNIYLIDFLKRCLDKDPLRRWSCDQLLRHPYFNGYYFEVPDEMQYE 237
+ +E+ G+P N + ++R D P R V D +
Sbjct: 205 GIMVIEMIDGEPPYFNEPPLQAMRRIRDNLPPR-------------------VKDSHKVS 245
Query: 238 EITQRCLD----KDPLRRWSCDQLLRHPYF 263
+ + LD ++P +R + +LL+HP+
Sbjct: 246 SVLRGFLDLMLVREPSQRATAQELLQHPFL 275
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly expressed in the brain. It is not required for viability, but together with PAK6, it is required for normal levels of locomotion and activity, and for learning and memory. PAK5 cooperates with Inca (induced in neural crest by AP2) in the regulation of cell adhesion and cytoskeletal organization in the embryo and in neural crest cells during craniofacial development. PAK5 may also play a role in controlling the signaling of Raf-1, an effector of Ras, at the mitochondria. Length = 292 |
| >gnl|CDD|143373 cd07868, STKc_CDK8, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 8 | Back alignment and domain information |
|---|
Score = 89.7 bits (222), Expect = 1e-20
Identities = 57/158 (36%), Positives = 91/158 (57%), Gaps = 20/158 (12%)
Query: 9 KLGEGSYGVVFKCRNRD--TGQVVAIKKFLESEEDPLIRKIALREIRLLKSLKHPNLVNL 66
K+G G+YG V+K + +D + A+K+ E I A REI LL+ LKHPN+++L
Sbjct: 8 KVGRGTYGHVYKAKRKDGKDDRDYALKQI----EGTGISMSACREIALLRELKHPNVISL 63
Query: 67 LEVF--RRKKKLHLVFEFCDHTVLNELENH--------PHGLPWDLIKQITWQVLRGVSY 116
+VF +K+ L+F++ +H + + ++ H P LP ++K + +Q+L G+ Y
Sbjct: 64 QKVFLSHADRKVWLLFDYAEHDLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHY 123
Query: 117 CHRHACIHRDIKPENILLTANGV----VKLCDFGFARL 150
H + +HRD+KP NIL+ G VK+ D GFARL
Sbjct: 124 LHANWVLHRDLKPANILVMGEGPERGRVKIADMGFARL 161
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK8 can act as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA polymerase II (RNAP II)-dependent transcription. CDK8 phosphorylates cyclin H, a subunit of the general transcription factor TFIIH, which results in the inhibition of TFIIH-dependent phosphorylation of the C-terminal domain (CTD) of RNAP II, facilitating the inhibition of transcription. It has also been shown to promote transcription by a mechanism that is likely to involve RNAP II phosphorylation. CDK8 also functions as a stimulus-specific positive coregulator of p53 transcriptional responses. Length = 317 |
| >gnl|CDD|132951 cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 88.7 bits (220), Expect = 1e-20
Identities = 75/287 (26%), Positives = 131/287 (45%), Gaps = 53/287 (18%)
Query: 5 EKIGKLGEGSYGVVFKCRNRDTGQVVAIKKFLESEEDPLIRKIALREIRLLKSLKHPNLV 64
E I LG G+ G V K ++ TG V+A KK + +RK LRE++++ + P +V
Sbjct: 8 ETISDLGAGNGGSVSKVKHIPTGTVMA-KKVVHIGAKSSVRKQILRELQIMHECRSPYIV 66
Query: 65 NLLEVFRRKKKLHLVFEFCDHTVLNELENHPHGLPWDLIKQITWQVLRGVSYCH-RHACI 123
+ F + + + EF D L+ + +P +++ +I V+ G++Y + H +
Sbjct: 67 SFYGAFLNENNICMCMEFMDCGSLDRIYKKGGPIPVEILGKIAVAVVEGLTYLYNVHRIM 126
Query: 124 HRDIKPENILLTANGVVKLCDFGFA-RLIRDL---------------IPRHLHIFQTNEY 167
HRDIKP NIL+ + G +KLCDFG + LI + I + +++ +
Sbjct: 127 HRDIKPSNILVNSRGQIKLCDFGVSGELINSIADTFVGTSTYMSPERIQGGKYTVKSDVW 186
Query: 168 FKGVSLPHAENVVPLEIKIGK-PAATN----------IYLIDFLKRCLDKDPLRRWSCDQ 216
G+S+ +E+ +GK P A + + ++D L++ + + P R S D
Sbjct: 187 SLGISI--------IELALGKFPFAFSNIDDDGQDDPMGILDLLQQIVQEPPPRLPSSD- 237
Query: 217 LLRHPYFNGYYFEVPDEMQYEEITQRCLDKDPLRRWSCDQLLRHPYF 263
P+++ + CL KDP R + QL P F
Sbjct: 238 -------------FPEDL--RDFVDACLLKDPTERPTPQQLCAMPPF 269
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Byr1 from Schizosaccharomyces pombe, FUZ7 from Ustilago maydis, and related proteins. Byr1 phosphorylates its downstream target, the MAPK Spk1, and is regulated by the MAPKKK Byr2. The Spk1 cascade is pheromone-responsive and is essential for sporulation and sexual differentiation in fission yeast. FUZ7 phosphorylates and activates its target, the MAPK Crk1, which is required in mating and virulence in U. maydis. Length = 284 |
| >gnl|CDD|143382 cd07877, STKc_p38alpha_MAPK14, Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 89.3 bits (221), Expect = 2e-20
Identities = 56/155 (36%), Positives = 84/155 (54%), Gaps = 10/155 (6%)
Query: 2 ERYEKIGKLGEGSYGVVFKCRNRDTGQVVAIKKFLESEEDPLIRKIALREIRLLKSLKHP 61
ERY+ + +G G+YG V + TG VA+KK + + K RE+RLLK +KH
Sbjct: 17 ERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHE 76
Query: 62 NLVNLLEVFRRKKKLHLVFEFCD-----HTVLNELEN--HPHGLPWDLIKQITWQVLRGV 114
N++ LL+VF + L EF D H + +L N L D ++ + +Q+LRG+
Sbjct: 77 NVIGLLDVFTPARSLE---EFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGL 133
Query: 115 SYCHRHACIHRDIKPENILLTANGVVKLCDFGFAR 149
Y H IHRD+KP N+ + + +K+ DFG AR
Sbjct: 134 KYIHSADIIHRDLKPSNLAVNEDCELKILDFGLAR 168
|
Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14, is expressed in most tissues and is the major isoform involved in the immune and inflammatory response. It is the central p38 MAPK involved in myogenesis. It plays a role in regulating cell cycle check-point transition and promoting cell differentiation. p38alpha also regulates cell proliferation and death through crosstalk with the JNK pathway. Its substrates include MAPK activated protein kinase 2 (MK2), MK5, and the transcription factors ATF2 and Mitf. Length = 345 |
| >gnl|CDD|132985 cd06654, STKc_PAK1, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1 | Back alignment and domain information |
|---|
Score = 88.6 bits (219), Expect = 2e-20
Identities = 69/257 (26%), Positives = 122/257 (47%), Gaps = 38/257 (14%)
Query: 2 ERYEKIGKLGEGSYGVVFKCRNRDTGQVVAIKKFLESEEDPLIRKIALREIRLLKSLKHP 61
++Y + K+G+G+ G V+ + TGQ VAI++ + ++ P +++ + EI +++ K+P
Sbjct: 20 KKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQ-MNLQQQPK-KELIINEILVMRENKNP 77
Query: 62 NLVNLLEVFRRKKKLHLVFEFCDHTVLNELENHPHGLPWDLIKQITWQVLRGVSYCHRHA 121
N+VN L+ + +L +V E+ L ++ + I + + L+ + + H +
Sbjct: 78 NIVNYLDSYLVGDELWVVMEYLAGGSLTDVVTET-CMDEGQIAAVCRECLQALEFLHSNQ 136
Query: 122 CIHRDIKPENILLTANGVVKLCDFGFARLIRDLIPRHLHIFQTNEYF------KGVSLPH 175
IHRDIK +NILL +G VKL DFGF I + + T + + P
Sbjct: 137 VIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSTMVGTPYWMAPEVVTRKAYGPK 196
Query: 176 AE----NVVPLEIKIGKPAATN------IYLI-------------------DFLKRCLDK 206
+ ++ +E+ G+P N +YLI DFL RCLD
Sbjct: 197 VDIWSLGIMAIEMIEGEPPYLNENPLRALYLIATNGTPELQNPEKLSAIFRDFLNRCLDM 256
Query: 207 DPLRRWSCDQLLRHPYF 223
D +R S +LL+H +
Sbjct: 257 DVEKRGSAKELLQHQFL 273
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK1 is important in the regulation of many cellular processes including cytoskeletal dynamics, cell motility, growth, and proliferation. Although PAK1 has been regarded mainly as a cytosolic protein, recent reports indicate that PAK1 also exists in significant amounts in the nucleus, where it is involved in transcription modulation and in cell cycle regulatory events. PAK1 is also involved in transformation and tumorigenesis. Its overexpression, hyperactivation and increased nuclear accumulation is correlated to breast cancer invasiveness and progression. Nuclear accumulation is also linked to tamoxifen resistance in breast cancer cells. Length = 296 |
| >gnl|CDD|132990 cd06659, STKc_PAK6, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6 | Back alignment and domain information |
|---|
Score = 88.2 bits (218), Expect = 2e-20
Identities = 72/274 (26%), Positives = 122/274 (44%), Gaps = 43/274 (15%)
Query: 9 KLGEGSYGVVFKCRNRDTGQVVAIKKF-LESEEDPLIRKIALREIRLLKSLKHPNLVNLL 67
K+GEGS G+V R + +G+ VA+K L ++ R++ E+ +++ +H N+V +
Sbjct: 28 KIGEGSTGIVCIAREKHSGRQVAVKMMDLRKQQR---RELLFNEVVIMRDYQHQNVVEMY 84
Query: 68 EVFRRKKKLHLVFEFCDHTVLNELENHPHGLPWDLIKQITWQVLRGVSYCHRHACIHRDI 127
+ + ++L ++ EF L ++ + L + I + VL+ + Y H IHRDI
Sbjct: 85 KSYLVGEELWVLMEFLQGGALTDIVSQTR-LNEEQIATVCESVLQALCYLHSQGVIHRDI 143
Query: 128 KPENILLTANGVVKLCDFGFARLIRDLIPRHLHIFQTNEYFKG---VSLPHAENV----- 179
K ++ILLT +G VKL DFGF I +P+ + T + P+ V
Sbjct: 144 KSDSILLTLDGRVKLSDFGFCAQISKDVPKRKSLVGTPYWMAPEVISRTPYGTEVDIWSL 203
Query: 180 --VPLEIKIGKP-------------------------AATNIYLIDFLKRCLDKDPLRRW 212
+ +E+ G+P + L DFL+R L ++P R
Sbjct: 204 GIMVIEMVDGEPPYFSDSPVQAMKRLRDSPPPKLKNAHKISPVLRDFLERMLTREPQERA 263
Query: 213 SCDQLLRHPYFNGYYFE---VPDEMQYEEITQRC 243
+ +LL HP+ VP QY + T C
Sbjct: 264 TAQELLDHPFLLQTGLPECLVPLIQQYRKRTSTC 297
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role in stress responses through its activation by the mitogen-activated protein kinase (MAPK) p38 and MAPK kinase 6 (MKK6) pathway. PAK6 is highly expressed in the brain. It is not required for viability, but together with PAK5, it is required for normal levels of locomotion and activity, and for learning and memory. Increased expression of PAK6 is found in primary and metastatic prostate cancer. PAK6 may play a role in the regulation of motility. Length = 297 |
| >gnl|CDD|173760 cd08220, STKc_Nek8, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8 | Back alignment and domain information |
|---|
Score = 87.2 bits (216), Expect = 3e-20
Identities = 50/152 (32%), Positives = 78/152 (51%), Gaps = 3/152 (1%)
Query: 3 RYEKIGKLGEGSYGVVFKCRNRDTGQVVAIKKFLESEEDPLIRKIALREIRLLKSLKHPN 62
+YEKI +G G++G+V CR + ++V IK+ + R A E ++LK L HPN
Sbjct: 1 KYEKIRVVGRGAFGIVHLCRRKADQKLVIIKQIPVEQMTKDERLAAQNECQVLKLLSHPN 60
Query: 63 LVNLLEVFRRKKKLHLVFEFCDHTVLNELENHPHG--LPWDLIKQITWQVLRGVSYCHRH 120
++ E F K L +V E+ L E L D I Q+L + + H
Sbjct: 61 IIEYYENFLEDKALMIVMEYAPGGTLAEYIQKRCNSLLDEDTILHFFVQILLALHHVHTK 120
Query: 121 ACIHRDIKPENILLTANG-VVKLCDFGFARLI 151
+HRD+K +NILL + VVK+ DFG ++++
Sbjct: 121 LILHRDLKTQNILLDKHKMVVKIGDFGISKIL 152
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with a rare form of juvenile renal cystic disease, nephronophthisis type 9. It has been suggested that a defect in the ciliary localization of Nek8 contributes to the development of cysts manifested by these diseases. Length = 256 |
| >gnl|CDD|173633 cd05052, PTKc_Abl, Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase | Back alignment and domain information |
|---|
Score = 86.1 bits (213), Expect = 9e-20
Identities = 48/157 (30%), Positives = 80/157 (50%), Gaps = 7/157 (4%)
Query: 1 MERYEKI--GKLGEGSYGVVFKCRNRDTGQVVAIKKFLESEEDPLIRKIALREIRLLKSL 58
MER + KLG G YG V++ + VA+K +ED + + L+E ++K +
Sbjct: 3 MERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTL---KEDTMEVEEFLKEAAVMKEI 59
Query: 59 KHPNLVNLLEVFRRKKKLHLVFEFCDHTVLNEL--ENHPHGLPWDLIKQITWQVLRGVSY 116
KHPNLV LL V R+ +++ EF + L + E + + ++ + Q+ + Y
Sbjct: 60 KHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEY 119
Query: 117 CHRHACIHRDIKPENILLTANGVVKLCDFGFARLIRD 153
+ IHRD+ N L+ N +VK+ DFG +RL+
Sbjct: 120 LEKKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTG 156
|
Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays a role in cell proliferation and survival. In response to DNA damage or oxidative stress, Abl is transported to the nucleus where it induces apoptosis. In chronic myelogenous leukemia (CML) patients, an aberrant translocation results in the replacement of the first exon of Abl with the BCR (breakpoint cluster region) gene. The resulting BCR-Abl fusion protein is constitutively active and associates into tetramers, resulting in a hyperactive kinase sending a continuous signal. This leads to uncontrolled proliferation, morphological transformation and anti-apoptotic effects. BCR-Abl is the target of selective inhibitors, such as imatinib (Gleevec), used in the treatment of CML. Abl2, also known as ARG (Abelson-related gene), is thought to play a cooperative role with Abl in the proper development of the nervous system. The Tel-ARG fusion protein, resulting from reciprocal translocation between chromosomes 1 and 12, is associated with acute myeloid leukemia (AML). The TEL gene is a frequent fusion partner of other tyr kinase oncogenes, including Tel/Abl, Tel/PDGFRbeta, and Tel/Jak2, found in patients with leukemia and myeloproliferative disorders. Length = 263 |
| >gnl|CDD|173669 cd05578, STKc_Yank1, Catalytic domain of the Protein Serine/Threonine Kinase, Yank1 | Back alignment and domain information |
|---|
Score = 85.1 bits (211), Expect = 2e-19
Identities = 66/270 (24%), Positives = 103/270 (38%), Gaps = 77/270 (28%)
Query: 11 GEGSYGVVFKCRNRDTGQVVAIK-----KFLESEEDPLIRKIALREIRLLKSLKHPNLVN 65
G+G++G V + RDT ++ A+K K +E +R + L E R+L+ L HP LVN
Sbjct: 9 GKGAFGKVCIVQKRDTKKMFAMKYMNKQKCVEKGS---VRNV-LNERRILQELNHPFLVN 64
Query: 66 LLEVFRRKKKLHLVFEFC---DHTVLNELENHPHGLPWDLIKQITWQ----------VLR 112
L F+ ++ ++LV + D L + L +++ + ++
Sbjct: 65 LWYSFQDEENMYLVVDLLLGGD-------------LRYHLSQKVKFSEEQVKFWICEIVL 111
Query: 113 GVSYCHRHACIHRDIKPENILLTANGVVKLCDFGFARLIRD-------------LIPRHL 159
+ Y H IHRDIKP+NILL G V + DF A + + P
Sbjct: 112 ALEYLHSKGIIHRDIKPDNILLDEQGHVHITDFNIATKVTPDTLTTSTSGTPGYMAPE-- 169
Query: 160 HIFQTNEYFKGV---SL-----PHAENVVPLEIKIGK----------------PAATNIY 195
+ Y V SL P PA +
Sbjct: 170 -VLCRQGYSVAVDWWSLGVTAYECLRGKRPYRGHSRTIRDQIRAKQETADVLYPATWSTE 228
Query: 196 LIDFLKRCLDKDPLRRWSC--DQLLRHPYF 223
ID + + L++DP +R L HPYF
Sbjct: 229 AIDAINKLLERDPQKRLGDNLKDLKNHPYF 258
|
Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A. Length = 258 |
| >gnl|CDD|173333 PTZ00036, PTZ00036, glycogen synthase kinase; Provisional | Back alignment and domain information |
|---|
Score = 87.0 bits (215), Expect = 2e-19
Identities = 58/160 (36%), Positives = 94/160 (58%), Gaps = 19/160 (11%)
Query: 3 RYEKIGKL-GEGSYGVVFKCRNRDTGQVVAIKKFLESEEDPLIRKIALREIRLLKSLKHP 61
+ K+G + G GS+GVV++ DT + VAIKK L+ DP + RE+ ++K+L H
Sbjct: 66 KSYKLGNIIGNGSFGVVYEAICIDTSEKVAIKKVLQ---DPQYKN---RELLIMKNLNHI 119
Query: 62 NLVNL-----LEVFRRKKK---LHLVFEFCDHTVLNELENHP---HGLPWDLIKQITWQV 110
N++ L E F++ +K L++V EF TV ++++ H LP L+K ++Q+
Sbjct: 120 NIIFLKDYYYTECFKKNEKNIFLNVVMEFIPQTVHKYMKHYARNNHALPLFLVKLYSYQL 179
Query: 111 LRGVSYCHRHACIHRDIKPENILLTANG-VVKLCDFGFAR 149
R ++Y H HRD+KP+N+L+ N +KLCDFG A+
Sbjct: 180 CRALAYIHSKFICHRDLKPQNLLIDPNTHTLKLCDFGSAK 219
|
Length = 440 |
| >gnl|CDD|173665 cd05574, STKc_phototropin_like, Catalytic domain of Phototropin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 85.8 bits (213), Expect = 2e-19
Identities = 49/148 (33%), Positives = 76/148 (51%), Gaps = 7/148 (4%)
Query: 3 RYEKIGKLGEGSYGVVFKCRNRDTGQVVAIK---KFLESEEDPLIRKIALREIRLLKSLK 59
++KI LG+G G VF R + TG++ A+K K + + + R L E +L +L
Sbjct: 2 HFKKIKLLGKGDVGRVFLVRLKGTGKLFALKVLDKKEMIKRNKVKR--VLTEQEILATLD 59
Query: 60 HPNLVNLLEVFRRKKKLHLVFEFCDHTVLNE-LENHPHG-LPWDLIKQITWQVLRGVSYC 117
HP L L F+ + L LV ++C L L+ P L ++ + +VL + Y
Sbjct: 60 HPFLPTLYASFQTETYLCLVMDYCPGGELFRLLQRQPGKCLSEEVARFYAAEVLLALEYL 119
Query: 118 HRHACIHRDIKPENILLTANGVVKLCDF 145
H ++RD+KPENILL +G + L DF
Sbjct: 120 HLLGIVYRDLKPENILLHESGHIMLSDF 147
|
Serine/Threonine Kinases (STKs), Phototropin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The phototropin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Included in this subfamily are plant phototropins and predominantly uncharacterized fungal STKs whose catalytic domains resemble the phototropin kinase domain. One protein from Neurospora crassa is called nrc-2. Phototropins are blue-light receptors that control responses such as phototropism, stromatal opening, and chloroplast movement in order to optimize the photosynthetic efficiency of plants. They are light-activated STKs that contain an N-terminal photosensory domain and a C-terminal catalytic domain. The N-terminal domain contains two LOV (Light, Oxygen or Voltage) domains that binds FMN. Photoexcitation of the LOV domains results in autophosphorylation at multiple sites and activation of the catalytic domain. Neurospora crassa nrc-2 plays a role in growth and development by controlling entry into the conidiation program. Length = 316 |
| >gnl|CDD|173664 cd05573, STKc_ROCK_NDR_like, Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 85.8 bits (213), Expect = 3e-19
Identities = 49/156 (31%), Positives = 84/156 (53%), Gaps = 7/156 (4%)
Query: 2 ERYEKIGKLGEGSYGVVFKCRNRDTGQVVAIKKFLESEEDPLIRK--IAL-REIRLLKSL 58
+ +E I +G G++G V+ R++DTGQV A+K +S+ +I++ IA R R + +
Sbjct: 1 DDFEVIKVIGRGAFGEVWLVRDKDTGQVYAMKVLRKSD---MIKRNQIAHVRAERDILAD 57
Query: 59 KH-PNLVNLLEVFRRKKKLHLVFEFCDHTVLNELENHPHGLPWDLIKQITWQVLRGVSYC 117
P +V L F+ ++ L+LV E+ L L P + + +++ +
Sbjct: 58 ADSPWIVKLYYSFQDEEHLYLVMEYMPGGDLMNLLIRKDVFPEETARFYIAELVLALDSV 117
Query: 118 HRHACIHRDIKPENILLTANGVVKLCDFGFARLIRD 153
H+ IHRDIKP+NIL+ A+G +KL DFG + +
Sbjct: 118 HKLGFIHRDIKPDNILIDADGHIKLADFGLCKKMNK 153
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Proteins in this subfamily are involved in regulating many cellular functions including contraction, motility, division, proliferation, apoptosis, morphogenesis, and cytokinesis. Length = 350 |
| >gnl|CDD|132949 cd06618, PKc_MKK7, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7 | Back alignment and domain information |
|---|
Score = 85.1 bits (211), Expect = 3e-19
Identities = 51/151 (33%), Positives = 85/151 (56%), Gaps = 6/151 (3%)
Query: 5 EKIGKLGEGSYGVVFKCRNRDTGQVVAIKKFLESEEDPLIRKIALREIR-LLKSLKHPNL 63
E +G++G G+ G V+K R + TG V+A+K+ + ++I L ++ +LKS P +
Sbjct: 18 ENLGEIGSGTCGQVYKMRFKKTGHVMAVKQMRRTGNKEENKRI-LMDLDVVLKSHDCPYI 76
Query: 64 VNLLEVFRRKKKLHLVFEFCDHTVLNELENH-PHGLPWDLIKQITWQVLRGVSYC-HRHA 121
V F + + E T L++L +P D++ ++T +++ + Y +H
Sbjct: 77 VKCYGYFITDSDVFICME-LMSTCLDKLLKRIQGPIPEDILGKMTVAIVKALHYLKEKHG 135
Query: 122 CIHRDIKPENILLTANGVVKLCDFGFA-RLI 151
IHRD+KP NILL A+G VKLCDFG + RL+
Sbjct: 136 VIHRDVKPSNILLDASGNVKLCDFGISGRLV 166
|
Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates its downstream target, c-Jun N-terminal kinase (JNK), on specific threonine and tyrosine residues. Although MKK7 is capable of dual phosphorylation, it prefers to phosphorylate the threonine residue of JNK. Thus, optimal activation of JNK requires both MKK4 (not included in this subfamily) and MKK7. MKK7 is primarily activated by cytokines. MKK7 is essential for liver formation during embryogenesis. It plays roles in G2/M cell cycle arrest and cell growth. In addition, it is involved in the control of programmed cell death, which is crucial in oncogenesis, cancer chemoresistance, and antagonism to TNFalpha-induced killing, through its inhibition by Gadd45beta and the subsequent suppression of the JNK cascade. Length = 296 |
| >gnl|CDD|173756 cd08216, PK_STRAD, Pseudokinase domain of STE20-related kinase adapter protein | Back alignment and domain information |
|---|
Score = 85.1 bits (211), Expect = 4e-19
Identities = 43/147 (29%), Positives = 69/147 (46%), Gaps = 9/147 (6%)
Query: 4 YEKIGKLGEGSYGVVFKCRNRDTGQVVAIKKF-LESEEDPLIRKIALREIRLLKSLKHPN 62
IGK +V +++ T +VA+KK L+S ++ + +EI + L+HPN
Sbjct: 3 LTLIGK-CFEDLMIVHLAKHKPTNTLVAVKKINLDSCSKEDLKLLQ-QEIITSRQLQHPN 60
Query: 63 LVNLLEVFRRKKKLHLVFEFCDH---TVLNELENH-PHGLPWDLIKQITWQVLRGVSYCH 118
++ + F +L++V + L L+ H P GLP I I VL + Y H
Sbjct: 61 ILPYVTSFIVDSELYVVSPLMAYGSCEDL--LKTHFPEGLPELAIAFILKDVLNALDYIH 118
Query: 119 RHACIHRDIKPENILLTANGVVKLCDF 145
IHR +K +ILL+ +G V L
Sbjct: 119 SKGFIHRSVKASHILLSGDGKVVLSGL 145
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) subfamily, pseudokinase domain. The STRAD subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buccal mucosa. There are two forms of STRAD, alpha and beta, that complex with LKB1 and MO25. The structure of STRAD-alpha is available and shows that this protein binds ATP, has an ordered activation loop, and adopts a closed conformation typical of fully active protein kinases. It does not possess activity due to nonconservative substitutions of essential catalytic residues. ATP binding enhances the affinity of STRAD for MO25. The conformation of STRAD-alpha stabilized through ATP and MO25 may be needed to activate LKB1. Length = 314 |
| >gnl|CDD|173732 cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Score = 83.7 bits (207), Expect = 6e-19
Identities = 46/147 (31%), Positives = 75/147 (51%), Gaps = 7/147 (4%)
Query: 10 LGEGSYGVVFKCRNRDTGQVVAIKKFLES--EEDPLIRKIAL-----REIRLLKSLKHPN 62
+G GS+G V+ N +G+++A+K+ RK ++ REI LLK L+H N
Sbjct: 8 IGSGSFGSVYLGMNASSGELMAVKQVELPSVSASSKDRKRSMLDALAREIALLKELQHEN 67
Query: 63 LVNLLEVFRRKKKLHLVFEFCDHTVLNELENHPHGLPWDLIKQITWQVLRGVSYCHRHAC 122
+V L L++ E+ + L N+ L++ Q+L+G++Y H
Sbjct: 68 IVQYLGSSLDADHLNIFLEYVPGGSVAALLNNYGAFEETLVRNFVRQILKGLNYLHNRGI 127
Query: 123 IHRDIKPENILLTANGVVKLCDFGFAR 149
IHRDIK NIL+ G +K+ DFG ++
Sbjct: 128 IHRDIKGANILVDNKGGIKISDFGISK 154
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Byr2 is regulated by Ras1. It responds to pheromone signaling and controls mating through the MAPK pathway. Budding yeast Ste11 functions in MAPK cascades that regulate mating, high osmolarity glycerol, and filamentous growth responses. Length = 267 |
| >gnl|CDD|140289 PTZ00263, PTZ00263, protein kinase A catalytic subunit; Provisional | Back alignment and domain information |
|---|
Score = 84.9 bits (210), Expect = 6e-19
Identities = 50/149 (33%), Positives = 81/149 (54%), Gaps = 9/149 (6%)
Query: 10 LGEGSYGVVFKCRNRDTGQVVAIKKFLESEEDPLIRKI--ALREIRLLKSLKHPNLVNLL 67
LG GS+G V +++ TG+ AIK L+ E ++++ +E +L L HP +VN++
Sbjct: 26 LGTGSFGRVRIAKHKGTGEYYAIK-CLKKREILKMKQVQHVAQEKSILMELSHPFIVNMM 84
Query: 68 EVFRRKKKLHLVFEFCDHTVLNELENHPHG---LPWDLIKQITWQVLRGVSYCHRHACIH 124
F+ + +++ + EF V EL H P D+ K +++ Y H I+
Sbjct: 85 CSFQDENRVYFLLEF---VVGGELFTHLRKAGRFPNDVAKFYHAELVLAFEYLHSKDIIY 141
Query: 125 RDIKPENILLTANGVVKLCDFGFARLIRD 153
RD+KPEN+LL G VK+ DFGFA+ + D
Sbjct: 142 RDLKPENLLLDNKGHVKVTDFGFAKKVPD 170
|
Length = 329 |
| >gnl|CDD|173759 cd08219, STKc_Nek3, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3 | Back alignment and domain information |
|---|
Score = 83.5 bits (206), Expect = 7e-19
Identities = 54/151 (35%), Positives = 79/151 (52%), Gaps = 3/151 (1%)
Query: 3 RYEKIGKLGEGSYGVVFKCRNRDTGQVVAIKKFLESEEDPLIRKIALREIRLLKSLKHPN 62
+Y + +GEGS+G ++ ++ Q A+K+ + + + +E LL +KHPN
Sbjct: 1 QYNVLRVVGEGSFGRALLVQHVNSDQKYAMKEIRLPKSSSAVED-SRKEAVLLAKMKHPN 59
Query: 63 LVNLLEVFRRKKKLHLVFEFCDHTVLNELENHPHG--LPWDLIKQITWQVLRGVSYCHRH 120
+V E F L++V E+CD L + G P D I Q Q+ GV + H
Sbjct: 60 IVAFKESFEADGHLYIVMEYCDGGDLMQKIKLQRGKLFPEDTILQWFVQMCLGVQHIHEK 119
Query: 121 ACIHRDIKPENILLTANGVVKLCDFGFARLI 151
+HRDIK +NI LT NG VKL DFG ARL+
Sbjct: 120 RVLHRDIKSKNIFLTQNGKVKLGDFGSARLL 150
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activation of Vav2 and contributes to prolactin-mediated motility of breast cancer cells. Length = 255 |
| >gnl|CDD|132971 cd06640, STKc_MST4, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4 | Back alignment and domain information |
|---|
Score = 83.2 bits (205), Expect = 1e-18
Identities = 78/276 (28%), Positives = 125/276 (45%), Gaps = 39/276 (14%)
Query: 2 ERYEKIGKLGEGSYGVVFKCRNRDTGQVVAIKKF-LESEEDPLIRKIALREIRLLKSLKH 60
E + K+ ++G+GS+G VFK + T QVVAIK LE ED I I +EI +L
Sbjct: 4 ELFTKLERIGKGSFGEVFKGIDNRTQQVVAIKIIDLEEAEDE-IEDIQ-QEITVLSQCDS 61
Query: 61 PNLVNLLEVFRRKKKLHLVFEFCDH-TVLNELENHPHGLPWD--LIKQITWQVLRGVSYC 117
P + + + KL ++ E+ + L+ L P+D I + ++L+G+ Y
Sbjct: 62 PYVTKYYGSYLKGTKLWIIMEYLGGGSALDLLR----AGPFDEFQIATMLKEILKGLDYL 117
Query: 118 HRHACIHRDIKPENILLTANGVVKLCDFGFARLIRDL-IPRHL----------HIFQTNE 166
H IHRDIK N+LL+ G VKL DFG A + D I R+ + Q +
Sbjct: 118 HSEKKIHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQIKRNTFVGTPFWMAPEVIQQSA 177
Query: 167 YFKGVSLPHAENVVPLEIKIGKPAATNIYLIDFLKRCLDKDPLRRWSCDQLLRHPYFNGY 226
Y + + + +E+ G+P ++++ P+R L P N
Sbjct: 178 YDSKADI-WSLGITAIELAKGEPPNSDMH------------PMR-----VLFLIPKNNPP 219
Query: 227 YFEVPDEMQYEEITQRCLDKDPLRRWSCDQLLRHPY 262
++E CL+KDP R + +LL+H +
Sbjct: 220 TLTGEFSKPFKEFIDACLNKDPSFRPTAKELLKHKF 255
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by interacting with the Golgi matrix protein GM130 and may play a role in cell migration. Length = 277 |
| >gnl|CDD|132972 cd06641, STKc_MST3, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3 | Back alignment and domain information |
|---|
Score = 83.2 bits (205), Expect = 1e-18
Identities = 76/272 (27%), Positives = 124/272 (45%), Gaps = 31/272 (11%)
Query: 2 ERYEKIGKLGEGSYGVVFKCRNRDTGQVVAIKKFLESEEDPLIRKIALREIRLLKSLKHP 61
E + K+ K+G+GS+G VFK + T +VVAIK E + I I +EI +L P
Sbjct: 4 ELFTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQ-QEITVLSQCDSP 62
Query: 62 NLVNLLEVFRRKKKLHLVFEFCDH-TVLNELENHPHGLPWDLIKQITWQVLRGVSYCHRH 120
+ + + KL ++ E+ + L+ LE P L I I ++L+G+ Y H
Sbjct: 63 YVTKYYGSYLKDTKLWIIMEYLGGGSALDLLEPGP--LDETQIATILREILKGLDYLHSE 120
Query: 121 ACIHRDIKPENILLTANGVVKLCDFGFARLIRDL-IPRHLHI----FQTNEYFKGVSLPH 175
IHRDIK N+LL+ +G VKL DFG A + D I R+ + + E K +
Sbjct: 121 KKIHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQIKRNTFVGTPFWMAPEVIKQSAYDS 180
Query: 176 AEN-----VVPLEIKIGKPAATNIYLIDFLKRCLDKDPLRRWSCDQLLRHPYFNGYYFEV 230
+ + +E+ G+P + ++ + L +P P G Y
Sbjct: 181 KADIWSLGITAIELAKGEPPHSELHPMKVLFLIPKNNP------------PTLEGNY--- 225
Query: 231 PDEMQYEEITQRCLDKDPLRRWSCDQLLRHPY 262
+E + CL+K+P R + +LL+H +
Sbjct: 226 --SKPLKEFVEACLNKEPSFRPTAKELLKHKF 255
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and intrauterine growth retardation. Length = 277 |
| >gnl|CDD|173637 cd05059, PTKc_Tec_like, Catalytic domain of Tec-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 82.5 bits (204), Expect = 2e-18
Identities = 44/147 (29%), Positives = 72/147 (48%), Gaps = 9/147 (6%)
Query: 10 LGEGSYGVVF--KCRNRDTGQVVAIKKFLESEEDPLIRKIALREIRLLKSLKHPNLVNLL 67
LG G +GVV K R + + I++ SE+D + E +++ L HPNLV L
Sbjct: 12 LGSGQFGVVHLGKWRGKIDVAIKMIREGAMSEDD------FIEEAKVMMKLSHPNLVQLY 65
Query: 68 EVFRRKKKLHLVFEFCDH-TVLNELENHPHGLPWDLIKQITWQVLRGVSYCHRHACIHRD 126
V +++ + +V E+ + +LN L L + + + V + Y + IHRD
Sbjct: 66 GVCTKQRPIFIVTEYMANGCLLNYLRERKGKLGTEWLLDMCSDVCEAMEYLESNGFIHRD 125
Query: 127 IKPENILLTANGVVKLCDFGFARLIRD 153
+ N L+ + VVK+ DFG AR + D
Sbjct: 126 LAARNCLVGEDNVVKVSDFGLARYVLD 152
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, some members contain the Tec homology (TH) domain, which contains proline-rich and zinc-binding regions. Tec kinases form the second largest subfamily of nRTKs and are expressed mainly by haematopoietic cells, although Tec and Bmx are also found in endothelial cells. B-cells express Btk and Tec, while T-cells express Itk, Txk, and Tec. Collectively, Tec kinases are expressed in a variety of myeloid cells such as mast cells, platelets, macrophages, and dendritic cells. Each Tec kinase shows a distinct cell-type pattern of expression. The function of Tec kinases in lymphoid cells have been studied extensively. They play important roles in the development, differentiation, maturation, regulation, survival, and function of B-cells and T-cells. Mutations in Btk cause the severe B-cell immunodeficiency, X-linked agammaglobulinaemia (XLA). Length = 256 |
| >gnl|CDD|173702 cd05611, STKc_Rim15_like, Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 81.8 bits (202), Expect = 3e-18
Identities = 48/142 (33%), Positives = 73/142 (51%), Gaps = 8/142 (5%)
Query: 13 GSYGVVFKCRNRDTGQVVAIKKFLESEEDPLIRKIALREIRLLKSLKH-----PNLVNLL 67
G++G V+ + R TG AIK +S+ +I K + ++ +++ P + L
Sbjct: 7 GAFGSVYLAKKRSTGDYFAIKVLKKSD---MIAKNQVTNVKAERAIMMIQGESPYVAKLY 63
Query: 68 EVFRRKKKLHLVFEFCDHTVLNELENHPHGLPWDLIKQITWQVLRGVSYCHRHACIHRDI 127
F+ K L+LV E+ + L GLP D KQ +V+ GV H+ IHRDI
Sbjct: 64 YSFQSKDYLYLVMEYLNGGDCASLIKTLGGLPEDWAKQYIAEVVLGVEDLHQRGIIHRDI 123
Query: 128 KPENILLTANGVVKLCDFGFAR 149
KPEN+L+ G +KL DFG +R
Sbjct: 124 KPENLLIDQTGHLKLTDFGLSR 145
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a downstream effector of PKA and regulates entry into stationary phase (G0). Thus, it plays a crucial role in regulating yeast proliferation, differentiation, and aging. Cek1 may facilitate progression of mitotic anaphase. Length = 260 |
| >gnl|CDD|173663 cd05572, STKc_cGK_PKG, Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase | Back alignment and domain information |
|---|
Score = 81.5 bits (202), Expect = 4e-18
Identities = 42/145 (28%), Positives = 69/145 (47%), Gaps = 9/145 (6%)
Query: 10 LGEGSYGVVFKCRNRDTGQVVAIKKFLESE-EDPLIRKIALREIRLLKSLKHPNLVNLLE 68
LG G +G V + + + A+K + + ++ E +L+ HP +V L
Sbjct: 1 LGVGGFGRVELVKVKSKNRTFALKCVKKRHIVETGQQEHIFSEKEILEECNHPFIVKLYR 60
Query: 69 VFRRKKKLHLVFEFCD----HTVLNELENHPHGLPWDLIKQITWQVLRGVSYCHRHACIH 124
F+ KK ++++ E+C T+L + + V+ Y H I+
Sbjct: 61 TFKDKKYIYMLMEYCLGGELWTILRDRGL----FDEYTARFYIACVVLAFEYLHNRGIIY 116
Query: 125 RDIKPENILLTANGVVKLCDFGFAR 149
RD+KPEN+LL +NG VKL DFGFA+
Sbjct: 117 RDLKPENLLLDSNGYVKLVDFGFAK 141
|
Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowing autophosphorylation and activation of the kinase. cGKI is a soluble protein expressed in all smooth muscles, platelets, cerebellum, and kidney. It is also expressed at lower concentrations in other tissues. cGKII is a membrane-bound protein that is most abundantly expressed in the intestine. It is also present in the brain nuclei, adrenal cortex, kidney, lung, and prostate. cGKI is involved in the regulation of smooth muscle tone, smooth cell proliferation, and platelet activation. cGKII plays a role in the regulation of secretion, such as renin secretion by the kidney and aldosterone secretion by the adrenal. It also regulates bone growth and the circadian rhythm. Length = 262 |
| >gnl|CDD|143383 cd07878, STKc_p38beta_MAPK11, Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 82.4 bits (203), Expect = 6e-18
Identities = 51/156 (32%), Positives = 81/156 (51%), Gaps = 4/156 (2%)
Query: 2 ERYEKIGKLGEGSYGVVFKCRNRDTGQVVAIKKFLESEEDPLIRKIALREIRLLKSLKHP 61
ERY+ + +G G+YG V + Q VA+KK + + + RE+RLLK +KH
Sbjct: 15 ERYQNLTPVGSGAYGSVCSAYDTRLRQKVAVKKLSRPFQSLIHARRTYRELRLLKHMKHE 74
Query: 62 NLVNLLEVFRRKKKLHLVFEFCDHTVL--NELEN--HPHGLPWDLIKQITWQVLRGVSYC 117
N++ LL+VF + E T L +L N L + ++ + +Q+LRG+ Y
Sbjct: 75 NVIGLLDVFTPATSIENFNEVYLVTNLMGADLNNIVKCQKLSDEHVQFLIYQLLRGLKYI 134
Query: 118 HRHACIHRDIKPENILLTANGVVKLCDFGFARLIRD 153
H IHRD+KP N+ + + +++ DFG AR D
Sbjct: 135 HSAGIIHRDLKPSNVAVNEDCELRILDFGLARQADD 170
|
Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is widely expressed in tissues and shows more similarity with p38alpha than with the other isoforms. Both are sensitive to pyridinylimidazoles and share some common substrates such as MAPK activated protein kinase 2 (MK2) and the transcription factors ATF2, c-Fos and, ELK-1. p38beta is involved in regulating the activation of the cyclooxygenase-2 promoter and the expression of TGFbeta-induced alpha-smooth muscle cell actin. Length = 343 |
| >gnl|CDD|132973 cd06642, STKc_STK25-YSK1, Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1 | Back alignment and domain information |
|---|
Score = 81.2 bits (200), Expect = 6e-18
Identities = 78/277 (28%), Positives = 127/277 (45%), Gaps = 33/277 (11%)
Query: 2 ERYEKIGKLGEGSYGVVFKCRNRDTGQVVAIKKF-LESEEDPLIRKIALREIRLLKSLKH 60
E + K+ ++G+GS+G V+K + T +VVAIK LE ED I I +EI +L
Sbjct: 4 ELFTKLERIGKGSFGEVYKGIDNRTKEVVAIKIIDLEEAEDE-IEDIQ-QEITVLSQCDS 61
Query: 61 PNLVNLLEVFRRKKKLHLVFEFCDH-TVLNELENHPHGLPWDLIKQITWQVLRGVSYCHR 119
P + + + KL ++ E+ + L+ L+ P L I I ++L+G+ Y H
Sbjct: 62 PYITRYYGSYLKGTKLWIIMEYLGGGSALDLLKPGP--LEETYIATILREILKGLDYLHS 119
Query: 120 HACIHRDIKPENILLTANGVVKLCDFGFARLIRDL-IPRHLHI----FQTNEYFKGVSLP 174
IHRDIK N+LL+ G VKL DFG A + D I R+ + + E K +
Sbjct: 120 ERKIHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQIKRNTFVGTPFWMAPEVIKQSAYD 179
Query: 175 HAEN-----VVPLEIKIGKPAATNIYLIDFLKRCLDKDPLRRWSCDQLLRHPYFNGYYFE 229
+ + +E+ G+P ++++ + L P P G Y
Sbjct: 180 FKADIWSLGITAIELAKGEPPNSDLHPMRVLFLIPKNSP------------PTLEGQY-- 225
Query: 230 VPDEMQYEEITQRCLDKDPLRRWSCDQLLRHPYFNGY 266
++E + CL+KDP R + +LL+H + Y
Sbjct: 226 ---SKPFKEFVEACLNKDPRFRPTAKELLKHKFITRY 259
|
Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25 is a candidate gene responsible for pseudopseudohypoparathyroidism (PPHP), a disease that shares features with the Albright hereditary osteodystrophy (AHO) phenotype. Length = 277 |
| >gnl|CDD|133212 cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Score = 81.0 bits (200), Expect = 7e-18
Identities = 54/158 (34%), Positives = 84/158 (53%), Gaps = 10/158 (6%)
Query: 2 ERYEK-IGKLGEGSYGVVFKCR----NRDTGQVVAIKKFLESEEDPLIRKIALREIRLLK 56
ER+ K I +LG+G++G V CR +TG+VVA+KK S + L R REI +LK
Sbjct: 3 ERHLKFIQQLGKGNFGSVELCRYDPLQDNTGEVVAVKKLQHSTAEHL-RDFE-REIEILK 60
Query: 57 SLKHPNLVNLLEVF--RRKKKLHLVFEFCDHTVLNE-LENHPHGLPWDLIKQITWQVLRG 113
SL+H N+V V ++ L LV E+ + L + L+ H L + Q+ +G
Sbjct: 61 SLQHDNIVKYKGVCYSAGRRNLRLVMEYLPYGSLRDYLQKHRERLDHRKLLLYASQICKG 120
Query: 114 VSYCHRHACIHRDIKPENILLTANGVVKLCDFGFARLI 151
+ Y +HRD+ NIL+ + VK+ DFG +++
Sbjct: 121 MEYLGSKRYVHRDLATRNILVESENRVKIGDFGLTKVL 158
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak2 is widely expressed in many tissues while Jak3 is expressed only in hematopoietic cells. Jak2 is essential for the signaling of hormone-like cytokines such as growth hormone, erythropoietin, thrombopoietin, and prolactin, as well as some IFNs and cytokines that signal through the IL-3 and gp130 receptors. Jak3 binds the shared receptor subunit common gamma chain and thus, is essential in the signaling of cytokines that use it such as IL-2, IL-4, IL-7, IL-9, IL-15, and IL-21. Disruption of Jak2 in mice results in an embryonic lethal phenotype with multiple defects including erythropoietic and cardiac abnormalities. It is the only Jak gene that results in a lethal phenotype when disrupted in mice. A mutation in the pseudokinase domain of Jak2, V617F, is present in many myeloproliferative diseases, including almost all patients with polycythemia vera, and 50% of patients with essential thrombocytosis and myelofibrosis. Jak3 is important in lymphoid development and myeloid cell differentiation. Inactivating mutations in Jak3 have been reported in humans with severe combined immunodeficiency (SCID). Length = 284 |
| >gnl|CDD|173658 cd05114, PTKc_Tec_Rlk, Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase | Back alignment and domain information |
|---|
Score = 80.3 bits (198), Expect = 9e-18
Identities = 53/151 (35%), Positives = 81/151 (53%), Gaps = 11/151 (7%)
Query: 7 IGKLGEGSYGVVFKCRNRDTGQVVAIKKFLE---SEEDPLIRKIALREIRLLKSLKHPNL 63
+ +LG G +GVV + R +V AIK E SEED + E +++ L HP L
Sbjct: 9 MKELGSGQFGVVHLGKWRAQIKV-AIKAINEGAMSEED------FIEEAKVMMKLSHPKL 61
Query: 64 VNLLEVFRRKKKLHLVFEFCDH-TVLNELENHPHGLPWDLIKQITWQVLRGVSYCHRHAC 122
V L V ++K L++V EF ++ +LN L L D++ + V G+ Y R++
Sbjct: 62 VQLYGVCTQQKPLYIVTEFMENGCLLNYLRQRQGKLSKDMLLSMCQDVCEGMEYLERNSF 121
Query: 123 IHRDIKPENILLTANGVVKLCDFGFARLIRD 153
IHRD+ N L+++ GVVK+ DFG R + D
Sbjct: 122 IHRDLAARNCLVSSTGVVKVSDFGMTRYVLD 152
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. Instead of PH, Rlk contains an N-terminal cysteine-rich region. In addition to PH, Tec also contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Tec is more widely-expressed than other Tec subfamily kinases. It is found in endothelial cells, both B- and T-cells, and a variety of myeloid cells including mast cells, erythroid cells, platelets, macrophages and neutrophils. Rlk is expressed in T-cells and mast cell lines. Tec and Rlk are both key components of T-cell receptor (TCR) signaling. They are important in TCR-stimulated proliferation, IL-2 production and phopholipase C-gamma1 activation. Length = 256 |
| >gnl|CDD|173626 cd05034, PTKc_Src_like, Catalytic domain of Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 80.4 bits (199), Expect = 9e-18
Identities = 46/147 (31%), Positives = 71/147 (48%), Gaps = 6/147 (4%)
Query: 9 KLGEGSYGVVFKCRNRDTGQVVAIKKFLESEEDPLIRKIALREIRLLKSLKHPNLVNLLE 68
KLG G +G V+ T +V A+K P + L+E +++K L+H LV L
Sbjct: 13 KLGAGQFGEVWMGTWNGTTKV-AVKTLKPGTMSP---EAFLQEAQIMKKLRHDKLVQLYA 68
Query: 69 VFRRKKKLHLVFEFCDHTVLNELENHPHGLPWDLIKQI--TWQVLRGVSYCHRHACIHRD 126
V ++ +++V E+ L + G L + + Q+ G++Y IHRD
Sbjct: 69 VCSEEEPIYIVTEYMSKGSLLDFLKSGEGKKLRLPQLVDMAAQIAEGMAYLESRNYIHRD 128
Query: 127 IKPENILLTANGVVKLCDFGFARLIRD 153
+ NIL+ N V K+ DFG ARLI D
Sbjct: 129 LAARNILVGENLVCKIADFGLARLIED 155
|
Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. They were identified as the first proto-oncogene products, and they regulate cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Src kinases are overexpressed in a variety of human cancers, making them attractive targets for therapy. They are also implicated in acute inflammatory responses and osteoclast function. Src, Fyn, Yes, and Yrk are widely expressed, while Blk, Lck, Hck, Fgr, and Lyn show a limited expression pattern. Length = 261 |
| >gnl|CDD|133179 cd05048, PTKc_Ror, Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors | Back alignment and domain information |
|---|
Score = 81.0 bits (200), Expect = 1e-17
Identities = 51/163 (31%), Positives = 78/163 (47%), Gaps = 22/163 (13%)
Query: 10 LGEGSYGVVFKCR-----NRDTGQVVAIKKFLESEEDPLIRKIALREIRLLKSLKHPNLV 64
LGEG++G V+K R + VAIK E+ E P +++ +E L+ L+HPN+V
Sbjct: 13 LGEGAFGKVYKGELTGPNERLSATSVAIKTLKENAE-PKVQQEFRQEAELMSDLQHPNIV 71
Query: 65 NLLEVFRRKKKLHLVFEFCDHTVLNE--LENHPHG--------------LPWDLIKQITW 108
LL V +++ ++FE+ H L+E + N PH L I
Sbjct: 72 CLLGVCTKEQPTCMLFEYLAHGDLHEFLVRNSPHSDVGAESGDETVKSSLDCSDFLHIAI 131
Query: 109 QVLRGVSYCHRHACIHRDIKPENILLTANGVVKLCDFGFARLI 151
Q+ G+ Y H +HRD+ N L+ VK+ DFG +R I
Sbjct: 132 QIAAGMEYLSSHHFVHRDLAARNCLVGEGLTVKISDFGLSRDI 174
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror kinases are expressed in many tissues during development. They play important roles in bone and heart formation. Mutations in human Ror2 result in two different bone development genetic disorders, recessive Robinow syndrome and brachydactyly type B. Drosophila Ror is expressed only in the developing nervous system during neurite outgrowth and neuronal differentiation, suggesting a role for Drosophila Ror in neural development. More recently, mouse Ror1 and Ror2 have also been found to play an important role in regulating neurite growth in central neurons. Ror1 and Ror2 are believed to have some overlapping and redundant functions. Length = 283 |
| >gnl|CDD|173729 cd06617, PKc_MKK3_6, Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6 | Back alignment and domain information |
|---|
Score = 80.2 bits (198), Expect = 1e-17
Identities = 49/151 (32%), Positives = 83/151 (54%), Gaps = 14/151 (9%)
Query: 5 EKIGKLGEGSYGVVFKCRNRDTGQVVAIKKF---LESEEDPLIRKIALREIRL-LKSLKH 60
E I +LG G+YGVV K R+ TG ++A+K+ + S+E K L ++ + ++S+
Sbjct: 4 EVIEELGRGAYGVVDKMRHVPTGTIMAVKRIRATVNSQEQ----KRLLMDLDISMRSVDC 59
Query: 61 PNLVNLLEVFRRKKKLHLVFEFCDHTVLNEL----ENHPHGLPWDLIKQITWQVLRGVSY 116
P V R+ + + E D T L++ + +P D++ +I +++ + Y
Sbjct: 60 PYTVTFYGALFREGDVWICMEVMD-TSLDKFYKKVYDKGLTIPEDILGKIAVSIVKALEY 118
Query: 117 CH-RHACIHRDIKPENILLTANGVVKLCDFG 146
H + + IHRD+KP N+L+ NG VKLCDFG
Sbjct: 119 LHSKLSVIHRDVKPSNVLINRNGQVKLCDFG 149
|
Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs that phosphorylate and activate their downstream target, p38 MAPK, on specific threonine and tyrosine residues. MKK3/6 plays roles in the regulation of cell cycle progression, cytokine- and stress-induced apoptosis, oncogenic transformation, and adult tissue regeneration. In addition, MKK6 plays a critical role in osteoclast survival in inflammatory disease while MKK3 is associated with tumor invasion, progression, and poor patient survival in glioma. Length = 283 |
| >gnl|CDD|143381 cd07876, STKc_JNK2, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2 | Back alignment and domain information |
|---|
Score = 80.8 bits (199), Expect = 2e-17
Identities = 49/155 (31%), Positives = 84/155 (54%), Gaps = 9/155 (5%)
Query: 1 MERYEKIGKLGEGSYGVVFKCRNRDTGQVVAIKKFLESEEDPLIRKIALREIRLLKSLKH 60
++RY+++ +G G+ G+V + G VA+KK ++ K A RE+ LLK + H
Sbjct: 20 LKRYQQLKPIGSGAQGIVCAAFDTVLGINVAVKKLSRPFQNQTHAKRAYRELVLLKCVNH 79
Query: 61 PNLVNLLEVFRRKKKL------HLVFEFCDHTVLNELENHPHGLPWDLIKQITWQVLRGV 114
N+++LL VF +K L +LV E D + + L + + + +Q+L G+
Sbjct: 80 KNIISLLNVFTPQKSLEEFQDVYLVMELMDANLCQVIHME---LDHERMSYLLYQMLCGI 136
Query: 115 SYCHRHACIHRDIKPENILLTANGVVKLCDFGFAR 149
+ H IHRD+KP NI++ ++ +K+ DFG AR
Sbjct: 137 KHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLAR 171
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jnk1 or Jnk2) could survive but disruption of both genes resulted in lethality. However, recent studies have shown that JNK1 and JNK2 perform distinct functions through specific binding partners and substrates. JNK2 is specifically translocated to the mitochondria during dopaminergic cell death. Specific substrates include the microtubule-associated proteins DCX and Tau, as well as TIF-IA which is involved in ribosomal RNA synthesis regulation. Mice deficient in Jnk2 show protection against arthritis, type 1 diabetes, atherosclerosis, abdominal aortic aneurysm, cardiac cell death, TNF-induced liver damage, and tumor growth, indicating that JNK2 may play roles in the pathogenesis of these diseases. Length = 359 |
| >gnl|CDD|143379 cd07874, STKc_JNK3, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 3 | Back alignment and domain information |
|---|
Score = 80.9 bits (199), Expect = 2e-17
Identities = 74/316 (23%), Positives = 138/316 (43%), Gaps = 62/316 (19%)
Query: 1 MERYEKIGKLGEGSYGVVFKCRNRDTGQVVAIKKFLESEEDPLIRKIALREIRLLKSLKH 60
++RY+ + +G G+ G+V + + VAIKK ++ K A RE+ L+K + H
Sbjct: 16 LKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNH 75
Query: 61 PNLVNLLEVFRRKKKL------HLVFEFCDHTVLNELENHPHGLPWDLIKQITWQVLRGV 114
N+++LL VF +K L +LV E D + ++ L + + + +Q+L G+
Sbjct: 76 KNIISLLNVFTPQKSLEEFQDVYLVMELMDANLCQVIQME---LDHERMSYLLYQMLCGI 132
Query: 115 SYCHRHACIHRDIKPENILLTANGVVKLCDFGFAR-------LIRDLIPRHLHIFQTNEY 167
+ H IHRD+KP NI++ ++ +K+ DFG AR + ++ R+ ++ E
Sbjct: 133 KHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMTPYVVTRY---YRAPEV 189
Query: 168 FKGVSLPHAENVVPLEIKIGKPAATNIYLIDFLKRCLDKDPLRRWS---------CDQLL 218
G+ ++ + +G+ I +D + +W+ C + +
Sbjct: 190 ILGMGYKENVDIWSVGCIMGEMVRHKILFP-------GRDYIDQWNKVIEQLGTPCPEFM 242
Query: 219 R------------HPYFNGYYFE--VPDEM-------------QYEEITQRCLDKDPLRR 251
+ P + G F PD + Q ++ + L DP +R
Sbjct: 243 KKLQPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKR 302
Query: 252 WSCDQLLRHPYFNGYY 267
S D+ L+HPY N +Y
Sbjct: 303 ISVDEALQHPYINVWY 318
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 3 (JNK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK3 is expressed primarily in the brain, and to a lesser extent in the heart and testis. Mice deficient in Jnk3 are protected against kainic acid-induced seizures, stroke, sciatic axotomy neural death, and neuronal death due to NGF deprivation, oxidative stress, or exposure to beta-amyloid peptide. This suggests that JNK3 may play roles in the pathogenesis of these diseases. Length = 355 |
| >gnl|CDD|143380 cd07875, STKc_JNK1, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 1 | Back alignment and domain information |
|---|
Score = 80.5 bits (198), Expect = 3e-17
Identities = 73/316 (23%), Positives = 137/316 (43%), Gaps = 62/316 (19%)
Query: 1 MERYEKIGKLGEGSYGVVFKCRNRDTGQVVAIKKFLESEEDPLIRKIALREIRLLKSLKH 60
++RY+ + +G G+ G+V + + VAIKK ++ K A RE+ L+K + H
Sbjct: 23 LKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNH 82
Query: 61 PNLVNLLEVFRRKKKL------HLVFEFCDHTVLNELENHPHGLPWDLIKQITWQVLRGV 114
N++ LL VF +K L ++V E D + ++ L + + + +Q+L G+
Sbjct: 83 KNIIGLLNVFTPQKSLEEFQDVYIVMELMDANLCQVIQME---LDHERMSYLLYQMLCGI 139
Query: 115 SYCHRHACIHRDIKPENILLTANGVVKLCDFGFAR-------LIRDLIPRHLHIFQTNEY 167
+ H IHRD+KP NI++ ++ +K+ DFG AR + ++ R+ ++ E
Sbjct: 140 KHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMTPYVVTRY---YRAPEV 196
Query: 168 FKGVSLPHAENVVPLEIKIGKPAATNIYLIDFLKRCLDKDPLRRWS---------CDQLL 218
G+ ++ + +G+ + D + +W+ C + +
Sbjct: 197 ILGMGYKENVDIWSVGCIMGEMIKGGVLFP-------GTDHIDQWNKVIEQLGTPCPEFM 249
Query: 219 R------------HPYFNGYYFE--VPDEM-------------QYEEITQRCLDKDPLRR 251
+ P + GY FE PD + Q ++ + L D +R
Sbjct: 250 KKLQPTVRTYVENRPKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKR 309
Query: 252 WSCDQLLRHPYFNGYY 267
S D+ L+HPY N +Y
Sbjct: 310 ISVDEALQHPYINVWY 325
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 1 (JNK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jnk1 or Jnk2) could survive but disruption of both genes resulted in lethality. However, recent studies have shown that JNK1 and JNK2 perform distinct functions through specific binding partners and substrates. JNK1 specifically binds with JAMP (JNK1-associated membrane protein), which regulates the duration of JNK1 activity in response to stimuli. Specific JNK1 substrates include Itch and SG10, which are implicated in Th2 responses and airway inflammation, and microtubule dynamics and axodendritic length, respectively. Mice deficient in Jnk1 are protected against arthritis, obesity, type 2 diabetes, cardiac cell death, and non-alcoholic liver disease, suggesting that JNK1 may play roles in the pathogenesis of these diseases. Length = 364 |
| >gnl|CDD|173691 cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 79.8 bits (197), Expect = 4e-17
Identities = 47/146 (32%), Positives = 73/146 (50%), Gaps = 7/146 (4%)
Query: 7 IGKLGEGSYGVVFKCRNRDTGQVVAIK----KFLESEEDPLIRKIALREIRLLKSLKHPN 62
+ ++G+G YG VF + +DTG++VA+K L + + L E +L + K
Sbjct: 6 LTQVGQGGYGQVFLAKKKDTGEIVALKRMKKSLLFKLNE---VRHVLTERDILTTTKSEW 62
Query: 63 LVNLLEVFRRKKKLHLVFEFCDHTVLNELENHPHGLPWDLIKQITWQVLRGVSYCHRHAC 122
LV LL F+ + L+L E+ L N+ L D + ++ V H
Sbjct: 63 LVKLLYAFQDDEYLYLAMEYVPGGDFRTLLNNLGVLSEDHARFYMAEMFEAVDALHELGY 122
Query: 123 IHRDIKPENILLTANGVVKLCDFGFA 148
IHRD+KPEN L+ A+G +KL DFG +
Sbjct: 123 IHRDLKPENFLIDASGHIKLTDFGLS 148
|
Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis. Dbf2p is important in regulating the mitotic exit network (MEN) and in cytokinesis. Length = 333 |
| >gnl|CDD|132984 cd06653, STKc_MEKK3_like_1, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 78.9 bits (194), Expect = 4e-17
Identities = 54/155 (34%), Positives = 88/155 (56%), Gaps = 6/155 (3%)
Query: 6 KIGKL-GEGSYGVVFKCRNRDTGQVVAIKK--FLESEEDPLIRKIALR-EIRLLKSLKHP 61
++GKL G G++G V+ C + DTG+ +A+K+ F ++ AL EI+LLK+L+H
Sbjct: 5 RLGKLLGRGAFGEVYLCYDADTGRELAVKQVPFDPDSQETSKEVNALECEIQLLKNLRHD 64
Query: 62 NLVNLLEVFR--RKKKLHLVFEFCDHTVLNELENHPHGLPWDLIKQITWQVLRGVSYCHR 119
+V R +KKL + E+ + + L ++ ++ T Q+L+GVSY H
Sbjct: 65 RIVQYYGCLRDPEEKKLSIFVEYMPGGSIKDQLKAYGALTENVTRRYTRQILQGVSYLHS 124
Query: 120 HACIHRDIKPENILLTANGVVKLCDFGFARLIRDL 154
+ +HRDIK NIL + G VKL DFG ++ I+ +
Sbjct: 125 NMIVHRDIKGANILRDSAGNVKLGDFGASKRIQTI 159
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 264 |
| >gnl|CDD|133248 cd05148, PTKc_Srm_Brk, Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk | Back alignment and domain information |
|---|
Score = 78.2 bits (193), Expect = 5e-17
Identities = 46/147 (31%), Positives = 78/147 (53%), Gaps = 5/147 (3%)
Query: 9 KLGEGSYGVVFKCRNRDTGQVVAIKKFLESEEDPLIRKIALREIRLLKSLKHPNLVNLLE 68
KLG G +G V++ ++ +V AIK +D L ++ +E++ LK L+H +L++L
Sbjct: 13 KLGSGYFGEVWEGLWKNRVRV-AIKIL--KSDDLLKQQDFQKEVQALKRLRHKHLISLFA 69
Query: 69 VFRRKKKLHLVFEFCDHTVLNELENHPHG--LPWDLIKQITWQVLRGVSYCHRHACIHRD 126
V + ++++ E + L P G LP + + QV G++Y IHRD
Sbjct: 70 VCSVGEPVYIITELMEKGSLLAFLRSPEGQVLPVASLIDMACQVAEGMAYLEEQNSIHRD 129
Query: 127 IKPENILLTANGVVKLCDFGFARLIRD 153
+ NIL+ + V K+ DFG ARLI++
Sbjct: 130 LAARNILVGEDLVCKVADFGLARLIKE 156
|
Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Srm and Brk however, lack the N-terminal myristylation sites. Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Brk has been found to be overexpressed in a majority of breast tumors. Length = 261 |
| >gnl|CDD|132961 cd06630, STKc_MEKK1, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Score = 78.4 bits (193), Expect = 6e-17
Identities = 66/261 (25%), Positives = 111/261 (42%), Gaps = 48/261 (18%)
Query: 10 LGEGSYGVVFKCRNRDTGQVVAIKKF-----LESEEDPLIRKIALREIRLLKSLKHPNLV 64
LG G++ ++ R+ TG ++A+K+ SE++ ++ + +EIRL+ L HP+++
Sbjct: 8 LGTGAFSSCYQARDVKTGTLMAVKQVTYVRNTSSEQEEVVEAL-RKEIRLMARLNHPHII 66
Query: 65 NLLEVFRRKKKLHLVFEFCDHTVLNELENHPHGLPWDLIKQITWQVLRGVSYCHRHACIH 124
+L +L E+ ++ L + +I T Q+LRG+SY H + IH
Sbjct: 67 RMLGATCEDSHFNLFVEWMAGGSVSHLLSKYGAFKEAVIINYTEQLLRGLSYLHENQIIH 126
Query: 125 RDIKPENILLTANG-VVKLCDFGFA-RLIRDLIPRHLH--------IFQTNEYFKGVSLP 174
RD+K N+L+ + G +++ DFG A RL F E +G
Sbjct: 127 RDVKGANLLIDSTGQRLRIADFGAAARLAAKGTGAGEFQGQLLGTIAFMAPEVLRGEQYG 186
Query: 175 HAENV-----VPLEIKIGKPA--ATN-------IYLI------------------DFLKR 202
+ +V V +E+ KP A I+ I D R
Sbjct: 187 RSCDVWSVGCVIIEMATAKPPWNAEKHSNHLALIFKIASATTAPSIPEHLSPGLRDVTLR 246
Query: 203 CLDKDPLRRWSCDQLLRHPYF 223
CL+ P R +LL+HP F
Sbjct: 247 CLELQPEDRPPSRELLKHPVF 267
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their respective MAPKKs, MEK1/2 and MKK4/MKK7, respectively. MEKK1 is important in regulating cell survival and apoptosis. MEKK1 also plays a role in cell migration, tissue maintenance and homeostasis, and wound healing. Length = 268 |
| >gnl|CDD|132983 cd06652, STKc_MEKK2, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2 | Back alignment and domain information |
|---|
Score = 78.2 bits (192), Expect = 7e-17
Identities = 53/155 (34%), Positives = 85/155 (54%), Gaps = 6/155 (3%)
Query: 6 KIGKL-GEGSYGVVFKCRNRDTGQVVAIKKFLESEEDPLIRK--IALR-EIRLLKSLKHP 61
++GKL G+G++G V+ C + DTG+ +A+K+ E P K AL EI+LLK+L H
Sbjct: 5 RLGKLLGQGAFGRVYLCYDADTGRELAVKQVQFDPESPETSKEVNALECEIQLLKNLLHE 64
Query: 62 NLVNLLEVFR--RKKKLHLVFEFCDHTVLNELENHPHGLPWDLIKQITWQVLRGVSYCHR 119
+V R ++ L + E + + L ++ ++ T Q+L GVSY H
Sbjct: 65 RIVQYYGCLRDPMERTLSIFMEHMPGGSIKDQLKSYGALTENVTRKYTRQILEGVSYLHS 124
Query: 120 HACIHRDIKPENILLTANGVVKLCDFGFARLIRDL 154
+ +HRDIK NIL + G VKL DFG ++ ++ +
Sbjct: 125 NMIVHRDIKGANILRDSVGNVKLGDFGASKRLQTI 159
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their respective MAPKKs MEK1/2, JNK-activating kinase 2 (JNKK2), and MKK3/6. MEKK2 plays roles in T cell receptor signaling, immune synapse formation, cytokine gene expression, as well as in EGF and FGF receptor signaling. Length = 265 |
| >gnl|CDD|173768 cd08228, STKc_Nek6, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6 | Back alignment and domain information |
|---|
Score = 77.8 bits (191), Expect = 1e-16
Identities = 48/147 (32%), Positives = 75/147 (51%), Gaps = 5/147 (3%)
Query: 9 KLGEGSYGVVFKCRNRDTGQVVAIKKFLESEE-DPLIRKIALREIRLLKSLKHPNLVNLL 67
K+G G + V++ + VA+KK E D R+ ++EI LLK L HPN++ L
Sbjct: 9 KIGRGQFSEVYRATCLLDRKPVALKKVQIFEMMDAKARQDCVKEIDLLKQLNHPNVIKYL 68
Query: 68 EVFRRKKKLHLVFEFCDHTVLNELENHPHGLPWDLIKQITW----QVLRGVSYCHRHACI 123
+ F +L++V E D L+++ + + ++ W Q+ V + H +
Sbjct: 69 DSFIEDNELNIVLELADAGDLSQMIKYFKKQKRLIPERTVWKYFVQLCSAVEHMHSRRVM 128
Query: 124 HRDIKPENILLTANGVVKLCDFGFARL 150
HRDIKP N+ +TA GVVKL D G R
Sbjct: 129 HRDIKPANVFITATGVVKLGDLGLGRF 155
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase and anaphase, and to the midbody during cytokinesis. Length = 267 |
| >gnl|CDD|173763 cd08223, STKc_Nek4, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4 | Back alignment and domain information |
|---|
Score = 76.6 bits (188), Expect = 2e-16
Identities = 71/249 (28%), Positives = 110/249 (44%), Gaps = 36/249 (14%)
Query: 10 LGEGSYGVVFKCRNRDTGQVVAIKKFLESEEDPLIRKIALREIRLLKSLKHPNLVNLLEV 69
+G+GSYG V R+R G+ IKK RK A +E +LL LKHPN+V E
Sbjct: 8 VGKGSYGEVSLVRHRTDGKQYVIKKLNLRNASRRERKAAEQEAQLLSQLKHPNIVAYRES 67
Query: 70 FRRKK-KLHLVFEFCDHTVLNELENHPHG--LPWDLIKQITWQVLRGVSYCHRHACIHRD 126
+ + L++V FC+ L G LP + + + Q+ + Y H +HRD
Sbjct: 68 WEGEDGLLYIVMGFCEGGDLYHKLKEQKGKLLPENQVVEWFVQIAMALQYLHEKHILHRD 127
Query: 127 IKPENILLTANGVVKLCDFGFARLIRD-------LI--PRHL--HIFQTNEY-------- 167
+K +N+ LT ++K+ D G AR++ + LI P ++ +F Y
Sbjct: 128 LKTQNVFLTRTNIIKVGDLGIARVLENQCDMASTLIGTPYYMSPELFSNKPYNYKSDVWA 187
Query: 168 -----FKGVSLPHAENVVPL-----EIKIGK----PAATNIYLIDFLKRCLDKDPLRRWS 213
++ +L HA N + I GK P + L + + L K P +R S
Sbjct: 188 LGCCVYEMATLKHAFNAKDMNSLVYRIIEGKLPPMPKDYSPELGELIATMLSKRPEKRPS 247
Query: 214 CDQLLRHPY 222
+LR PY
Sbjct: 248 VKSILRQPY 256
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown. Length = 257 |
| >gnl|CDD|173730 cd06624, STKc_ASK, Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase | Back alignment and domain information |
|---|
Score = 75.6 bits (186), Expect = 5e-16
Identities = 75/271 (27%), Positives = 110/271 (40%), Gaps = 37/271 (13%)
Query: 10 LGEGSYGVVFKCRNRDTGQVVAIKKFLES---EEDPLIRKIALREIRLLKSLKHPNLVNL 66
LG+G+YG+V+ R+ T +AIK+ E PL +IAL LKH N+V
Sbjct: 16 LGKGTYGIVYAARDLSTQVRIAIKEIPERDSRYVQPLHEEIALH-----SYLKHRNIVQY 70
Query: 67 LEVFRRKKKLHLVFEFCDHTVLNELENH---PHGLPWDLIKQITWQVLRGVSYCHRHACI 123
L + E L+ L P I T Q+L G+ Y H + +
Sbjct: 71 LGSDSENGFFKIFMEQVPGGSLSALLRSKWGPLKDNEQTIIFYTKQILEGLKYLHDNQIV 130
Query: 124 HRDIKPENILL-TANGVVKLCDFGFARLIRDLIPRHLHIFQTNEYFKGVSLPHAENVVPL 182
HRDIK +N+L+ T +GVVK+ DFG ++ + + P E F G A V+
Sbjct: 131 HRDIKGDNVLVNTYSGVVKISDFGTSKRLAGINP-------CTETFTGTLQYMAPEVIDK 183
Query: 183 EIK-IGKPAATNIYLIDFLKRCLDKDPLRRWSCDQ--------LLRHPYFNGYYFEVPDE 233
+ G PA ++ K P Q HP E+P+
Sbjct: 184 GPRGYGAPADIWSLGCTIVEMATGKPPFIELGEPQAAMFKVGMFKIHP-------EIPES 236
Query: 234 MQYE--EITQRCLDKDPLRRWSCDQLLRHPY 262
+ E RC + DP +R S LL+ P+
Sbjct: 237 LSAEAKNFILRCFEPDPDKRASAHDLLQDPF 267
|
Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. It plays important roles in cytokine and stress responses, as well as in reactive oxygen species (ROS)-mediated cellular responses. ASK1 is implicated in various diseases mediated by oxidative stress including inschemic heart disease, hypertension, vessel injury, brain ischemia, Fanconi anemia, asthma, and pulmonary edema, among others. ASK2 (also called MAPKKK6) functions only in a heteromeric complex with ASK1, and can activate ASK1 by direct phosphorylation. The function of MAPKKK15 is still unknown. Length = 268 |
| >gnl|CDD|173629 cd05041, PTKc_Fes_like, Catalytic domain of Fes-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 75.2 bits (185), Expect = 6e-16
Identities = 45/142 (31%), Positives = 75/142 (52%), Gaps = 3/142 (2%)
Query: 9 KLGEGSYGVVFKCRNRDTGQVVAIKKFLESEEDPLIRKIALREIRLLKSLKHPNLVNLLE 68
K+G+G++G V+K + +V A+K + L RK L+E +LK HPN+V L+
Sbjct: 2 KIGKGNFGDVYKGVLKGNTEV-AVKTCRSTLPPDLKRKF-LQEAEILKQYDHPNIVKLIG 59
Query: 69 VFRRKKKLHLVFEFC-DHTVLNELENHPHGLPWDLIKQITWQVLRGVSYCHRHACIHRDI 127
V +K+ +++V E ++L L + L + Q++ G+ Y CIHRD+
Sbjct: 60 VCVQKQPIYIVMELVPGGSLLTFLRKKKNRLTVKKLLQMSLDAAAGMEYLESKNCIHRDL 119
Query: 128 KPENILLTANGVVKLCDFGFAR 149
N L+ N V+K+ DFG +R
Sbjct: 120 AARNCLVGENNVLKISDFGMSR 141
|
Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes and Fer kinases play roles in haematopoiesis, inflammation and immunity, growth factor signaling, cytoskeletal regulation, cell migration and adhesion, and the regulation of cell-cell interactions. Fes and Fer show redundancy in their biological functions. Length = 251 |
| >gnl|CDD|132969 cd06638, STKc_myosinIIIA, Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin | Back alignment and domain information |
|---|
Score = 75.8 bits (186), Expect = 7e-16
Identities = 53/159 (33%), Positives = 80/159 (50%), Gaps = 17/159 (10%)
Query: 2 ERYEKIGKLGEGSYGVVFKCRNRDTGQVVAIKKFLESEEDPL--IRKIALREIRLLKSLK 59
+ +E I +G+G+YG VFK N+ G A+K DP+ I + E +LK+L
Sbjct: 18 DTWEIIETIGKGTYGKVFKVLNKKNGSKAAVKIL-----DPIHDIDEEIEAEYNILKALS 72
Query: 60 -HPNLVNLLEVFRRKK-----KLHLVFEFCDHTVLNELEN----HPHGLPWDLIKQITWQ 109
HPN+V ++ +K +L LV E C+ + +L + +I I +
Sbjct: 73 DHPNVVKFYGMYYKKDVKNGDQLWLVLELCNGGSVTDLVKGFLKRGERMEEPIIAYILHE 132
Query: 110 VLRGVSYCHRHACIHRDIKPENILLTANGVVKLCDFGFA 148
L G+ + H + IHRD+K NILLT G VKL DFG +
Sbjct: 133 ALMGLQHLHVNKTIHRDVKGNNILLTTEGGVKLVDFGVS 171
|
Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear hair cells. It is localized to the distal ends of actin-bundled structures. Mutations in human myosin IIIA are responsible for progressive nonsyndromic hearing loss. Human myosin IIIA possesses ATPase and kinase activities, and the ability to move actin filaments in a motility assay. It may function as a cellular transporter capable of moving along actin bundles in sensory cells. Length = 286 |
| >gnl|CDD|173769 cd08229, STKc_Nek7, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7 | Back alignment and domain information |
|---|
Score = 75.1 bits (184), Expect = 9e-16
Identities = 47/147 (31%), Positives = 71/147 (48%), Gaps = 5/147 (3%)
Query: 9 KLGEGSYGVVFKCRNRDTGQVVAIKKF-LESEEDPLIRKIALREIRLLKSLKHPNLVNLL 67
K+G G + V++ G VA+KK + D R ++EI LLK L HPN++
Sbjct: 9 KIGRGQFSEVYRATCLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPNVIKYY 68
Query: 68 EVFRRKKKLHLVFEFCDHTVLNELENHPHGLPWDLIKQITW----QVLRGVSYCHRHACI 123
F +L++V E D L+ + H + ++ W Q+ + + H +
Sbjct: 69 ASFIEDNELNIVLELADAGDLSRMIKHFKKQKRLIPEKTVWKYFVQLCSALEHMHSRRVM 128
Query: 124 HRDIKPENILLTANGVVKLCDFGFARL 150
HRDIKP N+ +TA GVVKL D G R
Sbjct: 129 HRDIKPANVFITATGVVKLGDLGLGRF 155
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase. Length = 267 |
| >gnl|CDD|133199 cd05068, PTKc_Frk_like, Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 74.4 bits (183), Expect = 1e-15
Identities = 47/147 (31%), Positives = 74/147 (50%), Gaps = 6/147 (4%)
Query: 9 KLGEGSYGVVFKCRNRDTGQVVAIKKFLESEEDPLIRKIALREIRLLKSLKHPNLVNLLE 68
KLG G +G V++ +T V A+K DP K L E +++K L+HP L+ L
Sbjct: 13 KLGAGQFGEVWEGLWNNTTPV-AVKTLKPGTMDP---KDFLAEAQIMKKLRHPKLIQLYA 68
Query: 69 VFRRKKKLHLVFEFCDHTVLNELENHPHGLPWDLIKQI--TWQVLRGVSYCHRHACIHRD 126
V ++ +++V E + L E G L + I QV G++Y IHRD
Sbjct: 69 VCTLEEPIYIVTELMKYGSLLEYLQGGAGRALKLPQLIDMAAQVASGMAYLEAQNYIHRD 128
Query: 127 IKPENILLTANGVVKLCDFGFARLIRD 153
+ N+L+ N + K+ DFG AR+I++
Sbjct: 129 LAARNVLVGENNICKVADFGLARVIKE 155
|
Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Frk, also known as Rak, is specifically expressed in liver, lung, kidney, intestine, mammary glands, and the islets of Langerhans. Rodent homologs were previously referred to as GTK (gastrointestinal tyr kinase), BSK (beta-cell Src-like kinase), or IYK (intestinal tyr kinase). Studies in mice reveal that Frk is not essential for viability. It plays a role in the signaling that leads to cytokine-induced beta-cell death in Type I diabetes. It also regulates beta-cell number during embryogenesis and early in life. Length = 261 |
| >gnl|CDD|173628 cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Score = 74.7 bits (184), Expect = 1e-15
Identities = 48/153 (31%), Positives = 76/153 (49%), Gaps = 8/153 (5%)
Query: 6 KIGKLGEGSYGVVFKCR---NRD-TGQVVAIKKFLESEEDPLIRKIALREIRLLKSLKHP 61
I +LGEG +G V CR D TG+ VA+K S E+ REI +L++L H
Sbjct: 8 FIKQLGEGHFGKVELCRYDPLGDNTGEQVAVKSLNHSGEEQHRSDFE-REIEILRTLDHE 66
Query: 62 NLVNLLEVF--RRKKKLHLVFEFCDHTVLNE-LENHPHGLPWDLIKQITWQVLRGVSYCH 118
N+V V + L L+ E+ L + L+ H + + + Q+ +G+ Y
Sbjct: 67 NIVKYKGVCEKPGGRSLRLIMEYLPSGSLRDYLQRHRDQINLKRLLLFSSQICKGMDYLG 126
Query: 119 RHACIHRDIKPENILLTANGVVKLCDFGFARLI 151
IHRD+ NIL+ + +VK+ DFG A+++
Sbjct: 127 SQRYIHRDLAARNILVESEDLVKISDFGLAKVL 159
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jaks are also involved in regulating the surface expression of some cytokine receptors. The Jak-STAT pathway is involved in many biological processes including hematopoiesis, immunoregulation, host defense, fertility, lactation, growth, and embryogenesis. Length = 284 |
| >gnl|CDD|132982 cd06651, STKc_MEKK3, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3 | Back alignment and domain information |
|---|
Score = 74.3 bits (182), Expect = 2e-15
Identities = 51/150 (34%), Positives = 81/150 (54%), Gaps = 5/150 (3%)
Query: 10 LGEGSYGVVFKCRNRDTGQVVAIKKFLESEEDPLIRK--IALR-EIRLLKSLKHPNLVNL 66
LG+G++G V+ C + DTG+ +A K+ E P K AL EI+LLK+L+H +V
Sbjct: 10 LGQGAFGRVYLCYDVDTGRELAAKQVQFDPESPETSKEVSALECEIQLLKNLQHERIVQY 69
Query: 67 LEVFRRK--KKLHLVFEFCDHTVLNELENHPHGLPWDLIKQITWQVLRGVSYCHRHACIH 124
R + K L + E+ + + L + ++ T Q+L G+SY H + +H
Sbjct: 70 YGCLRDRAEKTLTIFMEYMPGGSVKDQLKAYGALTESVTRKYTRQILEGMSYLHSNMIVH 129
Query: 125 RDIKPENILLTANGVVKLCDFGFARLIRDL 154
RDIK NIL + G VKL DFG ++ ++ +
Sbjct: 130 RDIKGANILRDSAGNVKLGDFGASKRLQTI 159
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. In addition, MEKK3 is involved in interleukin-1 receptor and Toll-like receptor 4 signaling. It is also a specific regulator of the proinflammatory cytokines IL-6 and GM-CSF in some immune cells. MEKK3 also regulates calcineurin, which plays a critical role in T cell activation, apoptosis, skeletal myocyte differentiation, and cardiac hypertrophy. Length = 266 |
| >gnl|CDD|132970 cd06639, STKc_myosinIIIB, Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin | Back alignment and domain information |
|---|
Score = 73.9 bits (181), Expect = 3e-15
Identities = 74/271 (27%), Positives = 114/271 (42%), Gaps = 57/271 (21%)
Query: 4 YEKIGKLGEGSYGVVFKCRNRDTGQVVAIKKFLESEEDPL--IRKIALREIRLLKSL-KH 60
+E I +G+G+YG V+K N+ G + A+K DP+ + + E +L+SL H
Sbjct: 24 WEIIETIGKGTYGKVYKVTNKKDGSLAAVKIL-----DPISDVDEEIEAEYNILQSLPNH 78
Query: 61 PNLVNLLEVFRRKKK-----LHLVFEFCDHTVLNELEN----HPHGLPWDLIKQITWQVL 111
PN+V +F + K L LV E C+ + EL L +I I + L
Sbjct: 79 PNVVKFYGMFYKADKLVGGQLWLVLELCNGGSVTELVKGLLICGQRLDEAMISYILYGAL 138
Query: 112 RGVSYCHRHACIHRDIKPENILLTANGVVKLCDFGF------ARLIRD--------LIPR 157
G+ + H + IHRD+K NILLT G VKL DFG RL R+ + P
Sbjct: 139 LGLQHLHNNRIIHRDVKGNNILLTTEGGVKLVDFGVSAQLTSTRLRRNTSVGTPFWMAPE 198
Query: 158 HLHIFQTNEY-FKGVSLPHAENVVPLEIKIGKPAATNIYLID------------------ 198
+ Q +Y + + + +E+ G P +++ +
Sbjct: 199 VIACEQQYDYSYDARCDVWSLGITAIELGDGDPPLFDMHPVKTLFKIPRNPPPTLLHPEK 258
Query: 199 -------FLKRCLDKDPLRRWSCDQLLRHPY 222
F+ +CL KD R S LL HP+
Sbjct: 259 WCRSFNHFISQCLIKDFEARPSVTHLLEHPF 289
|
Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also present in the brain and testis. The human class IIIB myosin gene maps to a region that overlaps the locus for Bardet-Biedl syndrome, which is characterized by dysmorphic extremities, retinal dystrophy, obesity, male hypogenitalism, and renal abnormalities. Length = 291 |
| >gnl|CDD|173703 cd05612, STKc_PRKX_like, Catalytic domain of PRKX-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 73.2 bits (180), Expect = 4e-15
Identities = 46/165 (27%), Positives = 80/165 (48%), Gaps = 25/165 (15%)
Query: 2 ERYEKIGKLGEGSYGVVFKCRNRDTGQVVAIKKFLESEEDPLIRKIALREI-------RL 54
+ E+I +G G++G V R+R + A+K E I L++ R+
Sbjct: 1 DDLERIKTVGTGTFGRVHLVRDRISEHYYALKVMAIPE------VIRLKQEQHVHNEKRV 54
Query: 55 LKSLKHPNLVNLLEVFRRKKKLHLVFEF-CDHTVLNELEN-----HPHGLPWDLIKQITW 108
LK + HP ++ L ++ L+++ E+ + + L N + GL +
Sbjct: 55 LKEVSHPFIIRLFWTEHDQRFLYMLMEYVPGGELFSYLRNSGRFSNSTGLFY------AS 108
Query: 109 QVLRGVSYCHRHACIHRDIKPENILLTANGVVKLCDFGFARLIRD 153
+++ + Y H ++RD+KPENILL G +KL DFGFA+ +RD
Sbjct: 109 EIVCALEYLHSKEIVYRDLKPENILLDKEGHIKLTDFGFAKKLRD 153
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyte/macrophage lineage differentiation, renal cell epithelial migration, and tubular morphogenesis in the developing kidney. Length = 291 |
| >gnl|CDD|173645 cd05084, PTKc_Fes, Catalytic domain of the Protein Tyrosine Kinase, Fes | Back alignment and domain information |
|---|
Score = 72.7 bits (178), Expect = 5e-15
Identities = 47/142 (33%), Positives = 70/142 (49%), Gaps = 2/142 (1%)
Query: 9 KLGEGSYGVVFKCRNRDTGQVVAIKKFLESEEDPLIRKIALREIRLLKSLKHPNLVNLLE 68
++G G++G VF R R VA+K E+ L K L+E R+LK HPN+V L+
Sbjct: 2 RIGRGNFGEVFSGRLRADNTPVAVKSCRETLPPDLKAKF-LQEARILKQYSHPNIVRLIG 60
Query: 69 VFRRKKKLHLVFEFCDH-TVLNELENHPHGLPWDLIKQITWQVLRGVSYCHRHACIHRDI 127
V +K+ +++V E L L L + Q+ G+ Y CIHRD+
Sbjct: 61 VCTQKQPIYIVMELVQGGDFLTFLRTEGPRLKVKELIQMVENAAAGMEYLESKHCIHRDL 120
Query: 128 KPENILLTANGVVKLCDFGFAR 149
N L+T V+K+ DFG +R
Sbjct: 121 AARNCLVTEKNVLKISDFGMSR 142
|
Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular endothelial, epithelial, and neuronal cells. It plays important roles in cell growth and differentiation, angiogenesis, inflammation and immunity, and cytoskeletal regulation. A recent study implicates Fes kinase as a tumor suppressor in colorectal cancer. Length = 252 |
| >gnl|CDD|133172 cd05040, PTKc_Ack_like, Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase | Back alignment and domain information |
|---|
Score = 72.4 bits (178), Expect = 6e-15
Identities = 46/146 (31%), Positives = 70/146 (47%), Gaps = 7/146 (4%)
Query: 9 KLGEGSYGVVFKCR-NRDTGQV--VAIKKFLESEEDPLIRKIALREIRLLKSLKHPNLVN 65
KLG+GS+GVV + + G+V VA+K L+S++ I L+E ++ SL H NL+
Sbjct: 2 KLGDGSFGVVRRGEWSTSGGKVIPVAVK-CLKSDKLSDIMDDFLKEAAIMHSLDHENLIR 60
Query: 66 LLEVFRRKKKLHLVFEFCDHTVLNEL--ENHPHGLPWDLIKQITWQVLRGVSYCHRHACI 123
L V L +V E L + ++ + Q+ G+ Y I
Sbjct: 61 LYGVVL-THPLMMVTELAPLGSLLDRLRKDALGHFLISTLCDYAVQIANGMRYLESKRFI 119
Query: 124 HRDIKPENILLTANGVVKLCDFGFAR 149
HRD+ NILL ++ VK+ DFG R
Sbjct: 120 HRDLAARNILLASDDKVKIGDFGLMR 145
|
Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with androgen-independent prostate cancer progression. Tnk1 regulates TNFalpha signaling and may play an important role in cell death. Length = 257 |
| >gnl|CDD|133186 cd05055, PTKc_PDGFR, Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors | Back alignment and domain information |
|---|
Score = 73.3 bits (180), Expect = 6e-15
Identities = 47/151 (31%), Positives = 76/151 (50%), Gaps = 11/151 (7%)
Query: 10 LGEGSYGVV-----FKCRNRDTGQVVAIKKFLESEEDPLIRKIALREIRLLKSL-KHPNL 63
LG G++G V + D VA+K L+ R+ + E++++ L H N+
Sbjct: 43 LGAGAFGKVVEATAYGLSKSDAVMKVAVK-MLKPTAHSSEREALMSELKIMSHLGNHENI 101
Query: 64 VNLLEVFRRKKKLHLVFEFCDH-TVLNELENHPHGL--PWDLIKQITWQVLRGVSYCHRH 120
VNLL + ++ E+C + +LN L DL+ ++QV +G+++
Sbjct: 102 VNLLGACTIGGPILVITEYCCYGDLLNFLRRKRESFLTLEDLL-SFSYQVAKGMAFLASK 160
Query: 121 ACIHRDIKPENILLTANGVVKLCDFGFARLI 151
CIHRD+ N+LLT +VK+CDFG AR I
Sbjct: 161 NCIHRDLAARNVLLTHGKIVKICDFGLARDI 191
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR subfamily receptors are important in the development of a variety of cells. PDGFRs are expressed in a many cells including fibroblasts, neurons, endometrial cells, mammary epithelial cells, and vascular smooth muscle cells. PDGFR signaling is critical in normal embryonic development, angiogenesis, and wound healing. PDGFRs transduce mitogenic signals for connective tissue cells and are important for cell shape and motility. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem cells, the interstitial cells of Cajal, and the pacemaker cells of the GI tract. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. Mammalian FLT3 plays an important role in the survival, proliferation, and differentiation of stem cells. Length = 302 |
| >gnl|CDD|173770 cd08528, STKc_Nek10, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10 | Back alignment and domain information |
|---|
Score = 72.5 bits (178), Expect = 7e-15
Identities = 47/162 (29%), Positives = 81/162 (50%), Gaps = 17/162 (10%)
Query: 4 YEKIGKLGEGSYGVVFKCRNRDTGQ-VVAIKKF---------LESEEDPLIRKIALREIR 53
Y + LG G++G V+K R ++ GQ ++A+K+ + E D I I + E+
Sbjct: 2 YAVLEHLGSGAFGCVYKVRKKNNGQNLLALKEINVHNPAFGKDKRERDKSIGDI-VSEVT 60
Query: 54 LLK-SLKHPNLVNLLEVFRRKKKLHLVFEFCDHTVLNE----LENHPHGLPWDLIKQITW 108
++K L+HPN+V + F +L++V + + L E L+ + I I
Sbjct: 61 IIKEQLRHPNIVRYYKTFLENDRLYIVMDLIEGAPLGEHFNSLKEKKQRFTEERIWNIFV 120
Query: 109 QVLRGVSYCHRHACI-HRDIKPENILLTANGVVKLCDFGFAR 149
Q++ + Y H+ I HRD+ P NI+L + V + DFG A+
Sbjct: 121 QMVLALRYLHKEKRIVHRDLTPNNIMLGEDDKVTITDFGLAK 162
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24. Length = 269 |
| >gnl|CDD|173700 cd05609, STKc_MAST, Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine kinase | Back alignment and domain information |
|---|
Score = 72.5 bits (178), Expect = 1e-14
Identities = 43/152 (28%), Positives = 85/152 (55%), Gaps = 5/152 (3%)
Query: 2 ERYEKIGKLGEGSYGVVFKCRNRDTGQVVAIKKFLESEEDPLIR---KIALREIRLLKSL 58
E +E I + G+YG V+ R+++T Q A+KK ++++ ++R + E +L
Sbjct: 1 EDFETIKLISNGAYGAVYLVRHKETRQRFAMKKI--NKQNLILRNQIQQVFVERDILTFA 58
Query: 59 KHPNLVNLLEVFRRKKKLHLVFEFCDHTVLNELENHPHGLPWDLIKQITWQVLRGVSYCH 118
++P +V++ F K+ L +V E+ + L + LP D+ + + + + Y H
Sbjct: 59 ENPFVVSMFCSFETKRHLCMVMEYVEGGDCATLLKNIGALPVDMARMYFAETVLALEYLH 118
Query: 119 RHACIHRDIKPENILLTANGVVKLCDFGFARL 150
+ +HRD+KP+N+L+T+ G +KL DFG +++
Sbjct: 119 NYGIVHRDLKPDNLLITSMGHIKLTDFGLSKI 150
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. There are four mammalian MAST kinases, named MAST1-MAST4. MAST1 is also referred to as syntrophin-associated STK (SAST), while MAST2 is also called MAST205. MAST kinases are cytoskeletal associated kinases of unknown function that are also expressed at neuromuscular junctions and postsynaptic densities. MAST1, MAST2, and MAST3 bind and phosphorylate the tumor suppressor PTEN, and may contribute to the regulation and stabilization of PTEN. MAST2 is involved in the regulation of the Fc-gamma receptor of the innate immune response in macrophages, and may also be involved in the regulation of the Na+/H+ exchanger NHE3. Length = 305 |
| >gnl|CDD|133243 cd05112, PTKc_Itk, Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase | Back alignment and domain information |
|---|
Score = 71.9 bits (176), Expect = 1e-14
Identities = 43/148 (29%), Positives = 70/148 (47%), Gaps = 9/148 (6%)
Query: 9 KLGEGSYGVVFK--CRNRDTGQVVAIKKFLESEEDPLIRKIALREIRLLKSLKHPNLVNL 66
++G G +G+V+ + + I++ SEED + E +++ L HP LV L
Sbjct: 11 EIGSGQFGLVWLGYWLEKRKVAIKTIREGAMSEED------FIEEAQVMMKLSHPKLVQL 64
Query: 67 LEVFRRKKKLHLVFEFCDHTVLNELENHPHG-LPWDLIKQITWQVLRGVSYCHRHACIHR 125
V + + LVFEF +H L++ G + + + V G++Y IHR
Sbjct: 65 YGVCTERSPICLVFEFMEHGCLSDYLRAQRGKFSQETLLGMCLDVCEGMAYLESSNVIHR 124
Query: 126 DIKPENILLTANGVVKLCDFGFARLIRD 153
D+ N L+ N VVK+ DFG R + D
Sbjct: 125 DLAARNCLVGENQVVKVSDFGMTRFVLD 152
|
Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Itk contains the Tec homology (TH) domain containing one proline-rich region and a zinc-binding region. Tec kinases are expressed mainly by haematopoietic cells. Itk is expressed in T-cells and mast cells, and is important in their development and differentiation. Of the three Tec kinases expressed in T-cells, Itk plays the predominant role in T-cell receptor (TCR) signaling. It is activated by phosphorylation upon TCR crosslinking and is involved in the pathway resulting in phospholipase C-gamma1 activation and actin polymerization. It also plays a role in the downstream signaling of the T-cell costimulatory receptor CD28, the T-cell surface receptor CD2, and the chemokine receptor CXCR4. In addition, Itk is crucial for the development of T-helper(Th)2 effector responses. Length = 256 |
| >gnl|CDD|133180 cd05049, PTKc_Trk, Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases | Back alignment and domain information |
|---|
Score = 71.3 bits (175), Expect = 2e-14
Identities = 48/162 (29%), Positives = 74/162 (45%), Gaps = 20/162 (12%)
Query: 7 IGKLGEGSYGVVFK--CRNRDTGQ---VVAIKKFLESEEDPLIRKIALREIRLLKSLKHP 61
+LGEG++G VF C + + +VA+K E+ + RK RE LL + +H
Sbjct: 10 KRELGEGAFGKVFLGECYHLEPENDKELVAVKTLKETASNDA-RKDFEREAELLTNFQHE 68
Query: 62 NLVNLLEVFRRKKKLHLVFEFCDHTVLNEL-------------ENHPHG-LPWDLIKQIT 107
N+V V +VFE+ +H LN+ + P G L + QI
Sbjct: 69 NIVKFYGVCTEGDPPIMVFEYMEHGDLNKFLRSHGPDAAFLKSPDSPMGELTLSQLLQIA 128
Query: 108 WQVLRGVSYCHRHACIHRDIKPENILLTANGVVKLCDFGFAR 149
Q+ G+ Y +HRD+ N L+ + VVK+ DFG +R
Sbjct: 129 VQIASGMVYLASQHFVHRDLATRNCLVGYDLVVKIGDFGMSR 170
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalytic domain. Trk receptors are mainly expressed in the peripheral and central nervous systems. They play important roles in cell fate determination, neuronal survival and differentiation, as well as in the regulation of synaptic plasticity. Altered expression of Trk receptors is associated with many human diseases. Length = 280 |
| >gnl|CDD|173690 cd05599, STKc_NDR_like, Catalytic domain of Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 71.6 bits (176), Expect = 3e-14
Identities = 47/160 (29%), Positives = 78/160 (48%), Gaps = 33/160 (20%)
Query: 4 YEKIGKLGEGSYGVVFKCRNRDTGQVVAIKKFLESEEDPLIRKIALREIR----LLKSLK 59
+E I +G G++G V + +DTG + A+KK +SE ++ K + +R +L
Sbjct: 3 FESIKVIGRGAFGEVRLVQKKDTGHIYAMKKLRKSE---MLEKEQVAHVRAERDILAEAD 59
Query: 60 HPNLVNLLEVFRRKKKLHLVFEFC---DHTVLNELENHPHGLPWDLIKQITW-------- 108
+P +V L F+ + L+L+ E+ D L L+K+ T+
Sbjct: 60 NPWVVKLYYSFQDENYLYLIMEYLPGGDMMTL-------------LMKKDTFTEEETRFY 106
Query: 109 --QVLRGVSYCHRHACIHRDIKPENILLTANGVVKLCDFG 146
+ + + H+ IHRDIKP+N+LL A G +KL DFG
Sbjct: 107 IAETILAIDSIHKLGYIHRDIKPDNLLLDAKGHIKLSDFG 146
|
Serine/Threonine Kinases (STKs), Nuclear Dbf2-Related (NDR) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. NDR kinases regulate mitosis, cell growth, embryonic development, and neurological processes. They are also required for proper centrosome duplication. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. This subfamily also contains fungal NDR-like kinases. Length = 364 |
| >gnl|CDD|173640 cd05067, PTKc_Lck_Blk, Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk | Back alignment and domain information |
|---|
Score = 70.3 bits (172), Expect = 4e-14
Identities = 47/147 (31%), Positives = 74/147 (50%), Gaps = 7/147 (4%)
Query: 9 KLGEGSYGVVFKCRNRDTGQVVAIKKFLESEEDPLIRKIALREIRLLKSLKHPNLVNLLE 68
KLG G +G V+ VAIK + P + L E L+K L+HP LV L
Sbjct: 13 KLGAGQFGEVWMGYYNGH-TKVAIKSLKQGSMSP---EAFLAEANLMKQLQHPRLVRLYA 68
Query: 69 VFRRKKKLHLVFEFCDHTVLNELENHPHGLPWDLIKQI--TWQVLRGVSYCHRHACIHRD 126
V ++ ++++ E+ ++ L + P G+ + K I Q+ G+++ R IHRD
Sbjct: 69 VVT-QEPIYIITEYMENGSLVDFLKTPEGIKLTINKLIDMAAQIAEGMAFIERKNYIHRD 127
Query: 127 IKPENILLTANGVVKLCDFGFARLIRD 153
++ NIL++ K+ DFG ARLI D
Sbjct: 128 LRAANILVSETLCCKIADFGLARLIED 154
|
Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lck is expressed in T-cells and natural killer (NK) cells. It plays a critical role in T-cell maturation, activation, and T-cell receptor (TCR) signaling. Lck phosphorylates ITAM (immunoreceptor tyr activation motif) sequences on several subunits of TCRs, leading to the activation of different second messenger cascades. Phosphorylated ITAMs serve as binding sites for other signaling factor such as Syk and ZAP-70, leading to their activation and propagation of downstream events. In addition, Lck regulates drug-induced apoptosis by interfering with the mitochondrial death pathway. The apototic role of Lck is independent of its primary function in T-cell signaling. Blk is expressed specifically in B-cells. It is involved in pre-BCR (B-cell receptor) signaling. Length = 260 |
| >gnl|CDD|173675 cd05584, STKc_p70S6K, Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Score = 70.6 bits (173), Expect = 5e-14
Identities = 52/149 (34%), Positives = 80/149 (53%), Gaps = 13/149 (8%)
Query: 10 LGEGSYGVVFKCRN---RDTGQVVAIK-----KFLESEEDPLIRKIALREIRLLKSLKHP 61
LG+G YG VF+ R DTG++ A+K + +++D K A R I L+++KHP
Sbjct: 4 LGKGGYGKVFQVRKVTGADTGKIFAMKVLKKATIVRNQKDTAHTK-AERNI--LEAVKHP 60
Query: 62 NLVNLLEVFRRKKKLHLVFEFCDHTVL-NELENHPHGLPWDLIKQITWQVLRGVSYCHRH 120
+V+L+ F+ KL+L+ E+ L LE + D ++ + + H+
Sbjct: 61 FIVDLIYAFQTGGKLYLILEYLSGGELFMHLEREGIFME-DTACFYLSEISLALEHLHQQ 119
Query: 121 ACIHRDIKPENILLTANGVVKLCDFGFAR 149
I+RD+KPENILL A G VKL DFG +
Sbjct: 120 GIIYRDLKPENILLDAQGHVKLTDFGLCK 148
|
Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the insulin receptor substrate IRS-1, among others. Mammals contain two isoforms of p70S6K, named S6K1 and S6K2 (or S6K-beta). Length = 323 |
| >gnl|CDD|132947 cd06616, PKc_MKK4, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4 | Back alignment and domain information |
|---|
Score = 69.7 bits (171), Expect = 8e-14
Identities = 41/149 (27%), Positives = 79/149 (53%), Gaps = 9/149 (6%)
Query: 5 EKIGKLGEGSYGVVFKCRNRDTGQVVAIKKFLESEEDPLIRKIALREIR-LLKSLKHPNL 63
+ +G++G G++G V K ++ +G ++A+K+ + S D +K L ++ +++S P +
Sbjct: 7 KDLGEIGRGAFGTVNKMLHKPSGTIMAVKR-IRSTVDEKEQKRLLMDLDVVMRSSDCPYI 65
Query: 64 VNLLEVFRRKKKLHLVFEFCDHTVLNELENHPHG-----LPWDLIKQITWQVLRGVSYCH 118
V R+ + E D L++ + + +P +++ +I ++ ++Y
Sbjct: 66 VKFYGALFREGDCWICMELMD-ISLDKFYKYVYEVLKSVIPEEILGKIAVATVKALNYLK 124
Query: 119 R-HACIHRDIKPENILLTANGVVKLCDFG 146
IHRD+KP NILL NG +KLCDFG
Sbjct: 125 EELKIIHRDVKPSNILLDRNGNIKLCDFG 153
|
Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates the downstream targets, c-Jun N-terminal kinase (JNK) and p38 MAPK, on specific threonine and tyrosine residues. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. Their activation is associated with the induction of cell death. Mice deficient in MKK4 die during embryogenesis and display anemia, severe liver hemorrhage, and abnormal hepatogenesis. MKK4 may also play roles in the immune system and in cardiac hypertrophy. It plays a major role in cancer as a tumor and metastasis suppressor. Under certain conditions, MKK4 is pro-oncogenic. Length = 288 |
| >gnl|CDD|173677 cd05586, STKc_Sck1_like, Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 69.6 bits (170), Expect = 1e-13
Identities = 42/147 (28%), Positives = 74/147 (50%), Gaps = 10/147 (6%)
Query: 10 LGEGSYGVVFKCRNRDTGQVVAIKKFLESEEDPLIRK------IALREIRLLKSLKH-PN 62
+G+G++G V++ R +DT ++ A+K + E ++ K I R I + L P
Sbjct: 1 IGKGTFGQVYQVRKKDTRRIYAMKVLSKKE---IVAKKEVAHTIGERNILVRTLLDESPF 57
Query: 63 LVNLLEVFRRKKKLHLVFEFCDHTVLNELENHPHGLPWDLIKQITWQVLRGVSYCHRHAC 122
+V L F+ L+LV ++ L D K +++ + + H++
Sbjct: 58 IVGLKFSFQTDSDLYLVTDYMSGGELFWHLQKEGRFSEDRAKFYIAELVLALEHLHKYDI 117
Query: 123 IHRDIKPENILLTANGVVKLCDFGFAR 149
++RD+KPENILL A G + LCDFG ++
Sbjct: 118 VYRDLKPENILLDATGHIALCDFGLSK 144
|
Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of yeast to environmental changes. Length = 330 |
| >gnl|CDD|133211 cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Score = 69.2 bits (169), Expect = 1e-13
Identities = 51/158 (32%), Positives = 80/158 (50%), Gaps = 11/158 (6%)
Query: 2 ERY-EKIGKLGEGSYGVV----FKCRNRDTGQVVAIKKFLESEEDPLIRKIALREIRLLK 56
+RY +KI LGEG +G V + N TG++VA+K L+ E +EI +LK
Sbjct: 3 KRYLKKIRVLGEGHFGKVSLYCYDPANDGTGEMVAVKT-LKRECGQQNTSGWKKEINILK 61
Query: 57 SLKHPNLVNLLEVFRRK--KKLHLVFEFCD-HTVLNELENHPHGLPWDLIKQITWQVLRG 113
+L H N+V + K L L+ E+ ++ + L H L L+ Q+ G
Sbjct: 62 TLYHENIVKYKGCCSEQGGKGLQLIMEYVPLGSLRDYLPKHKLNLAQLLL--FAQQICEG 119
Query: 114 VSYCHRHACIHRDIKPENILLTANGVVKLCDFGFARLI 151
++Y H IHRD+ N+LL + +VK+ DFG A+ +
Sbjct: 120 MAYLHSQHYIHRDLAARNVLLDNDRLVKIGDFGLAKAV 157
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Tyk2 is widely expressed in many tissues. It is involved in signaling via the cytokine receptors IFN-alphabeta, IL-6, IL-10, IL-12, IL-13, and IL-23. It mediates cell surface urokinase receptor (uPAR) signaling and plays a role in modulating vascular smooth muscle cell (VSMC) functional behavior in response to injury. Tyk2 is also important in dendritic cell function and T helper (Th)1 cell differentiation. A homozygous mutation of Tyk2 was found in a patient with hyper-IgE syndrome (HIES), a primary immunodeficiency characterized by recurrent skin abscesses, pneumonia, and elevated serum IgE. This suggests that Tyk2 may play important roles in multiple cytokine signaling involved in innate and adaptive immunity. Length = 283 |
| >gnl|CDD|234389 TIGR03903, TOMM_kin_cyc, TOMM system kinase/cyclase fusion protein | Back alignment and domain information |
|---|
Score = 70.6 bits (173), Expect = 1e-13
Identities = 44/134 (32%), Positives = 62/134 (46%), Gaps = 5/134 (3%)
Query: 25 DTGQVVAIKKFLE-SEEDPLIRKIALREIRLLKSLKHPNLVNLLEVFRRK-KKLHLVFEF 82
TG VAIK + E+ R RE L L HPN+V LL+ L VFE+
Sbjct: 1 MTGHEVAIKLLRTDAPEEEHQRARFRRETALCARLYHPNIVALLDSGEAPPGLLFAVFEY 60
Query: 83 CDHTVLNELENHPHGLPWDLIKQITWQVLRGVSYCHRHACIHRDIKPENILLTANGV--- 139
L E+ LP ++ QVL ++ H +HRD+KP+NI+++ GV
Sbjct: 61 VPGRTLREVLAADGALPAGETGRLMLQVLDALACAHNQGIVHRDLKPQNIMVSQTGVRPH 120
Query: 140 VKLCDFGFARLIRD 153
K+ DFG L+
Sbjct: 121 AKVLDFGIGTLLPG 134
|
This model represents proteins of 1350 in length, in multiple species of Burkholderia, in Acidovorax avenae subsp. citrulli AAC00-1 and Delftia acidovorans SPH-1, and in multiple copies in Sorangium cellulosum, in genomic neighborhoods that include a cyclodehydratase/docking scaffold fusion protein (TIGR03882) and a member of the thiazole/oxazole modified metabolite (TOMM) precursor family TIGR03795. It has a kinase domain in the N-terminal 300 amino acids, followed by a cyclase homology domain, followed by regions without named domain definitions. It is a probable bacteriocin-like metabolite biosynthesis protein [Cellular processes, Toxin production and resistance]. Length = 1266 |
| >gnl|CDD|173699 cd05608, STKc_GRK1, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1 | Back alignment and domain information |
|---|
Score = 68.3 bits (167), Expect = 2e-13
Identities = 72/265 (27%), Positives = 114/265 (43%), Gaps = 52/265 (19%)
Query: 10 LGEGSYGVVFKCRNRDTGQVVAIKKFLESEEDPLIRK---IALREIRLLKSLKHPNLVNL 66
LG+G +G V C+ R TG++ A KK +++ RK A+ E R+L + +V+L
Sbjct: 1 LGKGGFGEVSACQMRATGKLYACKKL--NKKRLKKRKGYEGAMVEKRILAKVHSRFIVSL 58
Query: 67 LEVFRRKKKLHLVFEFCD-----HTVLNELENHPHGLPWDLIKQITWQVLRGVSYCHRHA 121
F+ K L LV + + + N E +P G P T Q++ G+ + H+
Sbjct: 59 AYAFQTKTDLCLVMTIMNGGDLRYHIYNVDEENP-GFPEPRACFYTAQIISGLEHLHQRR 117
Query: 122 CIHRDIKPENILLTANGVVKLCDFGFARLIRD--------------LIPRHL----HIFQ 163
I+RD+KPEN+LL +G V++ D G A ++D + P L + F
Sbjct: 118 IIYRDLKPENVLLDNDGNVRISDLGLAVELKDGQSKTKGYAGTPGFMAPELLQGEEYDFS 177
Query: 164 TNEYFKGVSL-----------PHAENVVPLEIK-------IGKPAATNIYLIDFLKRCLD 205
+ + GV+L E V E+K + P + F + L
Sbjct: 178 VDYFALGVTLYEMIAARGPFRARGEKVENKELKQRILNDSVTYPDKFSPASKSFCEALLA 237
Query: 206 KDPLRRW-----SCDQLLRHPYFNG 225
KDP +R +CD L HP F
Sbjct: 238 KDPEKRLGFRDGNCDGLRTHPLFRD 262
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual group of GRKs and is expressed in retinal cells. It phosphorylates rhodopsin in rod cells, which leads to termination of the phototransduction cascade. Mutations in GRK1 are associated to a recessively inherited form of stationary nightblindness called Oguchi disease. Length = 280 |
| >gnl|CDD|173502 PTZ00266, PTZ00266, NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 69.4 bits (169), Expect = 4e-13
Identities = 52/193 (26%), Positives = 90/193 (46%), Gaps = 54/193 (27%)
Query: 1 MERYEKIGKLGEGSYGVVFKCRNRDTGQ-----VVAIKKFLESEEDPLIRKIALREIRLL 55
+ YE I K+G G +G VF +++ T + ++ + E E+ L+ E+ ++
Sbjct: 12 LNEYEVIKKIGNGRFGEVFLVKHKRTQEFFCWKAISYRGLKEREKSQLVI-----EVNVM 66
Query: 56 KSLKHPNLVNLLEVFRRK--KKLHLVFEFCD-----------HTVLNELENHPHGLPWDL 102
+ LKH N+V ++ F K +KL+++ EFCD + + ++E H
Sbjct: 67 RELKHKNIVRYIDRFLNKANQKLYILMEFCDAGDLSRNIQKCYKMFGKIEEHA------- 119
Query: 103 IKQITWQVLRGVSYCHR-------HACIHRDIKPENILLTA---------------NG-- 138
I IT Q+L ++YCH +HRD+KP+NI L+ NG
Sbjct: 120 IVDITRQLLHALAYCHNLKDGPNGERVLHRDLKPQNIFLSTGIRHIGKITAQANNLNGRP 179
Query: 139 VVKLCDFGFARLI 151
+ K+ DFG ++ I
Sbjct: 180 IAKIGDFGLSKNI 192
|
Length = 1021 |
| >gnl|CDD|177557 PHA03209, PHA03209, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 68.4 bits (167), Expect = 4e-13
Identities = 44/151 (29%), Positives = 63/151 (41%), Gaps = 18/151 (11%)
Query: 4 YEKIGKLGEGSYGVVFKCRNRDTGQVVAIKKFLESEEDPLIRKIA-----LREIRLLKSL 58
Y I L GS G VF VA K + DP++ KI L E LL+++
Sbjct: 68 YTVIKTLTPGSEGRVF----------VATK---PGQPDPVVLKIGQKGTTLIEAMLLQNV 114
Query: 59 KHPNLVNLLEVFRRKKKLHLVFEFCDHTVLNELENHPHGLPWDLIKQITWQVLRGVSYCH 118
HP+++ + + +V + L LP D I Q+L G+ Y H
Sbjct: 115 NHPSVIRMKDTLVSGAITCMVLPHYSSDLYTYLTKRSRPLPIDQALIIEKQILEGLRYLH 174
Query: 119 RHACIHRDIKPENILLTANGVVKLCDFGFAR 149
IHRD+K ENI + V + D G A+
Sbjct: 175 AQRIIHRDVKTENIFINDVDQVCIGDLGAAQ 205
|
Length = 357 |
| >gnl|CDD|133230 cd05099, PTKc_FGFR4, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4 | Back alignment and domain information |
|---|
Score = 67.7 bits (165), Expect = 5e-13
Identities = 49/173 (28%), Positives = 82/173 (47%), Gaps = 26/173 (15%)
Query: 7 IGK-LGEGSYGVVFKCR-------NRDTGQVVAIKKFLESEEDPLIRKIALREIRLLKSL 58
+GK LGEG +G V + D VA+K ++ D + + + E+ L+K +
Sbjct: 16 LGKPLGEGCFGQVVRAEAYGIDKSRPDQTVTVAVKMLKDNATDKDLADL-ISEMELMKLI 74
Query: 59 -KHPNLVNLLEVFRRKKKLHLVFEFCDHTVLNEL----------------ENHPHGLPWD 101
KH N++NLL V ++ L+++ E+ L E + L +
Sbjct: 75 GKHKNIINLLGVCTQEGPLYVIVEYAAKGNLREFLRARRPPGPDYTFDITKVPEEQLSFK 134
Query: 102 LIKQITWQVLRGVSYCHRHACIHRDIKPENILLTANGVVKLCDFGFARLIRDL 154
+ +QV RG+ Y CIHRD+ N+L+T + V+K+ DFG AR + D+
Sbjct: 135 DLVSCAYQVARGMEYLESRRCIHRDLAARNVLVTEDNVMKIADFGLARGVHDI 187
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Unlike other FGFRs, there is only one splice form of FGFR4. It binds FGF1, FGF2, FGF6, FGF19, and FGF23. FGF19 is a selective ligand for FGFR4. Although disruption of FGFR4 in mice causes no obvious phenotype, in vivo inhibition of FGFR4 in cultured skeletal muscle cells resulted in an arrest of muscle progenitor differentiation. FGF6 and FGFR4 are uniquely expressed in myofibers and satellite cells. FGF6/FGFR4 signaling appears to play a key role in the regulation of muscle regeneration. A polymorphism in FGFR4 is found in head and neck squamous cell carcinoma. Length = 314 |
| >gnl|CDD|173657 cd05113, PTKc_Btk_Bmx, Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome | Back alignment and domain information |
|---|
Score = 66.8 bits (163), Expect = 6e-13
Identities = 47/151 (31%), Positives = 73/151 (48%), Gaps = 11/151 (7%)
Query: 7 IGKLGEGSYGVVFKCRNRDTGQV-VAIKKFLESE--EDPLIRKIALREIRLLKSLKHPNL 63
+ +LG G +GVV + R GQ VAIK E ED I E +++ L H L
Sbjct: 9 LKELGTGQFGVVKYGKWR--GQYDVAIKMIKEGSMSEDEFIE-----EAKVMMKLSHEKL 61
Query: 64 VNLLEVFRRKKKLHLVFEF-CDHTVLNELENHPHGLPWDLIKQITWQVLRGVSYCHRHAC 122
V L V +++ +++V E+ + +LN L H + ++ V G++Y
Sbjct: 62 VQLYGVCTKQRPIYIVTEYMSNGCLLNYLREHGKRFQPSQLLEMCKDVCEGMAYLESKQF 121
Query: 123 IHRDIKPENILLTANGVVKLCDFGFARLIRD 153
IHRD+ N L+ G VK+ DFG +R + D
Sbjct: 122 IHRDLAARNCLVDDQGCVKVSDFGLSRYVLD 152
|
Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Btk contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Btk is expressed in B-cells, and a variety of myeloid cells including mast cells, platelets, neutrophils, and dendrictic cells. It interacts with a variety of partners, from cytosolic proteins to nuclear transcription factors, suggesting a diversity of functions. Stimulation of a diverse array of cell surface receptors, including antigen engagement of the B-cell receptor (BCR), leads to PH-mediated membrane translocation of Btk and subsequent phosphorylation by Src kinase and activation. Btk plays an important role in the life cycle of B-cells including their development, differentiation, proliferation, survival, and apoptosis. Mutations in Btk cause the primary immunodeficiency disease, X-linked agammaglobulinaemia (XLA) in humans. Bmx is primarily expressed in bone marrow and the arterial endothelium, and plays an important role in ischemia-induced angiogenesis. It facilitates arterial growth, capillary formation, vessel maturation, and bone marrow-derived endothelial progenitor cell mobilization. Length = 256 |
| >gnl|CDD|133202 cd05071, PTKc_Src, Catalytic domain of the Protein Tyrosine Kinase, Src | Back alignment and domain information |
|---|
Score = 67.0 bits (163), Expect = 7e-13
Identities = 47/147 (31%), Positives = 74/147 (50%), Gaps = 7/147 (4%)
Query: 9 KLGEGSYGVVFKCRNRDTGQVVAIKKFLESEEDPLIRKIALREIRLLKSLKHPNLVNLLE 68
KLG+G +G V+ T +V AIK P + L+E +++K L+H LV L
Sbjct: 13 KLGQGCFGEVWMGTWNGTTRV-AIKTLKPGTMSP---EAFLQEAQVMKKLRHEKLVQLYA 68
Query: 69 VFRRKKKLHLVFEFCDHTVLNELENHPHGLPWDLIKQITW--QVLRGVSYCHRHACIHRD 126
V ++ +++V E+ L + G L + + Q+ G++Y R +HRD
Sbjct: 69 VVS-EEPIYIVTEYMSKGSLLDFLKGEMGKYLRLPQLVDMAAQIASGMAYVERMNYVHRD 127
Query: 127 IKPENILLTANGVVKLCDFGFARLIRD 153
++ NIL+ N V K+ DFG ARLI D
Sbjct: 128 LRAANILVGENLVCKVADFGLARLIED 154
|
Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Src also play a role in regulating cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Elevated levels of Src kinase activity have been reported in a variety of human cancers. Several inhibitors of Src have been developed as anti-cancer drugs. Src is also implicated in acute inflammatory responses and osteoclast function. Length = 262 |
| >gnl|CDD|133181 cd05050, PTKc_Musk, Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase | Back alignment and domain information |
|---|
Score = 67.2 bits (164), Expect = 7e-13
Identities = 50/173 (28%), Positives = 73/173 (42%), Gaps = 26/173 (15%)
Query: 5 EKIGKLGEGSYGVVFKCRN----RDTGQVVAIKKFLESEEDPLIRKIALREIRLLKSLKH 60
E + +G+G++G VF+ R + K L+ E ++ RE L+ H
Sbjct: 8 EYVRDIGQGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDH 67
Query: 61 PNLVNLLEVFRRKKKLHLVFEFCDHTVLNELENH--PHGL----------------PWDL 102
PN+V LL V K + L+FE+ + LNE H P P L
Sbjct: 68 PNIVKLLGVCAVGKPMCLLFEYMAYGDLNEFLRHRSPRAQCSLSHSTSSARKCGLNPLPL 127
Query: 103 IK----QITWQVLRGVSYCHRHACIHRDIKPENILLTANGVVKLCDFGFARLI 151
I QV G++Y +HRD+ N L+ N VVK+ DFG +R I
Sbjct: 128 SCTEQLCIAKQVAAGMAYLSERKFVHRDLATRNCLVGENMVVKIADFGLSRNI 180
|
Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates Musk autophosphorylation and activation, leading to the clustering of acetylcholine receptors (AChRs). To date, there is no evidence to suggest that agrin binds directly to Musk. Mutations in AChR, Musk and other partners are responsible for diseases of the NMJ, such as the autoimmune syndrome myasthenia gravis. Length = 288 |
| >gnl|CDD|173625 cd05032, PTKc_InsR_like, Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 66.2 bits (162), Expect = 1e-12
Identities = 48/185 (25%), Positives = 78/185 (42%), Gaps = 26/185 (14%)
Query: 1 MERYEKIGKLGEGSYGVVFK-----CRNRDTGQVVAIKKFLESEEDPLIRKIALREIRLL 55
E+ I +LG+GS+G+V++ + VAIK E+ + L E ++
Sbjct: 5 REKITLIRELGQGSFGMVYEGLAKGVVKGEPETRVAIKTVNENASMRERIEF-LNEASVM 63
Query: 56 KSLKHPNLVNLLEVFRRKKKLHLVFEFCDHTVLN--------ELENHPHGLPWDLIKQIT 107
K ++V LL V + +V E L E EN+P P L K I
Sbjct: 64 KEFNCHHVVRLLGVVSTGQPTLVVMELMAKGDLKSYLRSRRPEAENNPGLGPPTLQKFIQ 123
Query: 108 W--QVLRGVSYCHRHACIHRDIKPENILLTANGVVKLCDFGFARLIRDLIPRHLHIFQTN 165
++ G++Y +HRD+ N ++ + VK+ DFG R I++T+
Sbjct: 124 MAAEIADGMAYLAAKKFVHRDLAARNCMVAEDLTVKIGDFGMTRD----------IYETD 173
Query: 166 EYFKG 170
Y KG
Sbjct: 174 YYRKG 178
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR and IGF-1R, which share 84% sequence identity in their kinase domains, display physiologically distinct yet overlapping functions in cell growth, differentiation, and metabolism. InsR activation leads primarily to metabolic effects while IGF-1R activation stimulates mitogenic pathways. In cells expressing both receptors, InsR/IGF-1R hybrids are found together with classical receptors. Both receptors can interact with common adaptor molecules such as IRS-1 and IRS-2. Length = 277 |
| >gnl|CDD|173666 cd05575, STKc_SGK, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase | Back alignment and domain information |
|---|
Score = 66.7 bits (163), Expect = 1e-12
Identities = 48/150 (32%), Positives = 72/150 (48%), Gaps = 18/150 (12%)
Query: 10 LGEGSYGVVFKCRNRDTGQVVAIKKFLESEEDPLIRK-------IALREIRLLKSLKHPN 62
+G+GS+G V +++ G+ A+K + I K +A R + LLK++KHP
Sbjct: 3 IGKGSFGKVLLAKHKADGKFYAVKVLQKKA----ILKKKEQKHIMAERNV-LLKNVKHPF 57
Query: 63 LVNLLEVFRRKKKLHLVFEFCDHTVLNELENH---PHGLPWDLIKQITWQVLRGVSYCHR 119
LV L F+ KL+ V D+ EL H P + ++ + Y H
Sbjct: 58 LVGLHYSFQTADKLYFVL---DYVNGGELFFHLQRERSFPEPRARFYAAEIASALGYLHS 114
Query: 120 HACIHRDIKPENILLTANGVVKLCDFGFAR 149
I+RD+KPENILL + G V L DFG +
Sbjct: 115 LNIIYRDLKPENILLDSQGHVVLTDFGLCK 144
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell proliferation, and apoptosis. Length = 323 |
| >gnl|CDD|173743 cd07846, STKc_CDKL2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3 | Back alignment and domain information |
|---|
Score = 65.9 bits (161), Expect = 2e-12
Identities = 30/71 (42%), Positives = 40/71 (56%), Gaps = 3/71 (4%)
Query: 153 DLIPRHLHIFQTNEYFKGVSLPHAENVVPLEIKIGKPAATNIYLIDFLKRCLDKDPLRRW 212
+LIPRH IFQ N F G+ LP + + PLE + K + ++D K+CL DP R
Sbjct: 219 NLIPRHQEIFQKNPLFAGMRLPEVKEIEPLEKRFPK---LSGLVLDLAKQCLRIDPDDRP 275
Query: 213 SCDQLLRHPYF 223
S QLL H +F
Sbjct: 276 SSSQLLHHEFF 286
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKIAMRE (NKIATRE in rat), by translocation is associated with mild mental retardation. It has been reported that CDKL3 is lost in leukemic cells having a chromosome arm 5q deletion, and may contribute to the transformed phenotype. Length = 286 |
| >gnl|CDD|173762 cd08222, STKc_Nek11, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11 | Back alignment and domain information |
|---|
Score = 65.7 bits (160), Expect = 2e-12
Identities = 48/165 (29%), Positives = 82/165 (49%), Gaps = 26/165 (15%)
Query: 3 RYEKIGKLGEGSYGVVFKCRNRDTGQVVAIKKFLESEEDPLIRKI------------ALR 50
RY +LG+GS+G V+ +V KK + E ++++I A +
Sbjct: 1 RYILQQRLGKGSFGTVY---------LVKDKKAVAEERLKVLKEIPVGELNPNETVQANQ 51
Query: 51 EIRLLKSLKHPNLVNLLEVFRRKKKLHLVFEFCDHTVLN----ELENHPHGLPWDLIKQI 106
E +LL L HP +V F + ++ E+C+ L+ EL++ L + + +
Sbjct: 52 EAQLLSKLDHPAIVKFHASFLERDAFCIITEYCEGRDLDCKLEELKHTGKTLSENQVCEW 111
Query: 107 TWQVLRGVSYCHRHACIHRDIKPENILLTANGVVKLCDFGFARLI 151
Q+L GV Y H+ +HRD+K +NI L N ++K+ DFG +RL+
Sbjct: 112 FIQLLLGVHYMHQRRILHRDLKAKNIFLKNN-LLKIGDFGVSRLL 155
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M checkpoint. Nek11 may also play a role in the S-phase checkpoint as well as in DNA replication and genotoxic stress responses. Length = 260 |
| >gnl|CDD|173636 cd05057, PTKc_EGFR_like, Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 65.9 bits (161), Expect = 2e-12
Identities = 45/155 (29%), Positives = 74/155 (47%), Gaps = 5/155 (3%)
Query: 1 MERYEKIGKLGEGSYGVVFKCRNRDTGQVVAIK---KFLESEEDPLIRKIALREIRLLKS 57
EKI LG G++G V+K G+ V I K L E P K L E ++ S
Sbjct: 6 ETELEKIKVLGSGAFGTVYKGVWIPEGEKVKIPVAIKVLREETSPKANKEILDEAYVMAS 65
Query: 58 LKHPNLVNLLEVFRRKKKLHLVFEFCDH-TVLNELENHPHGLPWDLIKQITWQVLRGVSY 116
+ HP++V LL + ++ L+ + +L+ + NH + + Q+ +G+SY
Sbjct: 66 VDHPHVVRLLGICL-SSQVQLITQLMPLGCLLDYVRNHKDNIGSQYLLNWCVQIAKGMSY 124
Query: 117 CHRHACIHRDIKPENILLTANGVVKLCDFGFARLI 151
+HRD+ N+L+ VK+ DFG A+L+
Sbjct: 125 LEEKRLVHRDLAARNVLVKTPQHVKITDFGLAKLL 159
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, resulting in the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Collectively, they can recognize a variety of ligands including EGF, TGFalpha, and neuregulins, among others. All four subfamily members can form homo- or heterodimers. HER3 contains an impaired kinase domain and depends on its heterodimerization partner for activation. EGFR subfamily members are involved in signaling pathways leading to a broad range of cellular responses including cell proliferation, differentiation, migration, growth inhibition, and apoptosis. Gain of function alterations, through their overexpression, deletions, or point mutations in their kinase domains, have been implicated in various cancers. These receptors are targets of many small molecule inhibitors and monoclonal antibodies used in cancer therapy. Length = 279 |
| >gnl|CDD|173704 cd05613, STKc_MSK1_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1 | Back alignment and domain information |
|---|
Score = 65.4 bits (159), Expect = 3e-12
Identities = 77/295 (26%), Positives = 123/295 (41%), Gaps = 60/295 (20%)
Query: 4 YEKIGKLGEGSYGVVF---KCRNRDTGQVVAIK--------KFLESEEDPLIRKIALREI 52
+E + LG G+YG VF K D+G++ A+K + ++ E + L I
Sbjct: 2 FELLKVLGTGAYGKVFLVRKVSGHDSGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHI 61
Query: 53 RLLKSLKHPNLVNLLEVFRRKKKLHLVFEFCDHTVLNELENHPHGLPWDLIKQITWQVLR 112
R + P LV L F+ KLHL+ ++ + L + ++ + +++
Sbjct: 62 R-----QSPFLVTLHYAFQTDTKLHLILDYINGGELFTHLSQRERFKEQEVQIYSGEIVL 116
Query: 113 GVSYCHRHACIHRDIKPENILLTANGVVKLCDFGFAR-LIRDLIPRHLHIFQTNEYF--- 168
+ + H+ I+RDIK ENILL +NG V L DFG ++ D + R T EY
Sbjct: 117 ALEHLHKLGIIYRDIKLENILLDSNGHVVLTDFGLSKEFHEDEVERAYSFCGTIEYMAPD 176
Query: 169 --KGVSLPHAE-------NVVPLEIKIGKPAAT----NIYLIDFLKRCLDKDPLRRWSCD 215
+G H + V+ E+ G T + +R L +P
Sbjct: 177 IVRGGDGGHDKAVDWWSMGVLMYELLTGASPFTVDGEKNSQAEISRRILKSEP------- 229
Query: 216 QLLRHPYFNGYYFEVPDEMQ--YEEITQRCLDKDPLRRWSC-----DQLLRHPYF 263
PY P EM ++I QR L KDP +R C D++ +HP+F
Sbjct: 230 -----PY--------PQEMSALAKDIIQRLLMKDPKKRLGCGPSDADEIKKHPFF 271
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSK1 plays a role in the regulation of translational control and transcriptional activation. It phosphorylates the transcription factors, CREB and NFkappaB. It also phosphorylates the nucleosomal proteins H3 and HMG-14. Increased phosphorylation of MEK1 is associated with the development of cerebral ischemic/hypoxic preconditioning. Length = 290 |
| >gnl|CDD|173668 cd05577, STKc_GRK, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase | Back alignment and domain information |
|---|
Score = 65.2 bits (159), Expect = 3e-12
Identities = 44/151 (29%), Positives = 75/151 (49%), Gaps = 21/151 (13%)
Query: 10 LGEGSYGVVFKCRNRDTGQVVAIKKFLESEEDPLIRK-----IALREIRLLKSLKHPNLV 64
LG+G +G V C+ + TG++ A KK + ++K +AL E ++L+ + +V
Sbjct: 1 LGKGGFGEVCACQVKATGKMYACKKL----DKKRLKKRKGEQMALNEKKILEKVSSRFIV 56
Query: 65 NLLEVFRRKKKLHLVFEFCDHTVLNELENHPH-------GLPWDLIKQITWQVLRGVSYC 117
+L F K L LV T++N + H G P Q++ G+ +
Sbjct: 57 SLAYAFETKDDLCLVM-----TLMNGGDLKYHIYNVGEPGFPEARAIFYAAQIICGLEHL 111
Query: 118 HRHACIHRDIKPENILLTANGVVKLCDFGFA 148
H+ ++RD+KPEN+LL +G V++ D G A
Sbjct: 112 HQRRIVYRDLKPENVLLDDHGNVRISDLGLA 142
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of G protein signaling) homology (RH) domain and several motifs. The C-terminus diverges among different groups of GRKs. There are seven types of GRKs, named GRK1 to GRK7. They are subdivided into three main groups: visual (GRK1/7); beta-adrenergic receptor kinases (GRK2/3); and GRK4-like (GRK4/5/6). Expression of GRK2/3/5/6 is widespread while GRK1/4/7 show a limited tissue distribution. The substrate spectrum of the widely expressed GRKs partially overlaps. GRKs play important roles in the cardiovascular, immune, respiratory, skeletal, and nervous systems. Length = 277 |
| >gnl|CDD|173616 PTZ00426, PTZ00426, cAMP-dependent protein kinase catalytic subunit; Provisional | Back alignment and domain information |
|---|
Score = 65.8 bits (160), Expect = 3e-12
Identities = 47/155 (30%), Positives = 75/155 (48%), Gaps = 8/155 (5%)
Query: 2 ERYEKIGKLGEGSYGVVFKCRNRDTG-QVVAIKKFLESEEDPLIRKI----ALREIRLLK 56
E + I LG GS+G V ++ VAIK+F E+ +I++ E ++L
Sbjct: 30 EDFNFIRTLGTGSFGRVILATYKNEDFPPVAIKRF---EKSKIIKQKQVDHVFSERKILN 86
Query: 57 SLKHPNLVNLLEVFRRKKKLHLVFEFCDHTVLNELENHPHGLPWDLIKQITWQVLRGVSY 116
+ HP VNL F+ + L+LV EF P D+ Q++ Y
Sbjct: 87 YINHPFCVNLYGSFKDESYLYLVLEFVIGGEFFTFLRRNKRFPNDVGCFYAAQIVLIFEY 146
Query: 117 CHRHACIHRDIKPENILLTANGVVKLCDFGFARLI 151
++RD+KPEN+LL +G +K+ DFGFA+++
Sbjct: 147 LQSLNIVYRDLKPENLLLDKDGFIKMTDFGFAKVV 181
|
Length = 340 |
| >gnl|CDD|133216 cd05085, PTKc_Fer, Catalytic domain of the Protein Tyrosine Kinase, Fer | Back alignment and domain information |
|---|
Score = 64.2 bits (156), Expect = 5e-12
Identities = 46/141 (32%), Positives = 70/141 (49%), Gaps = 3/141 (2%)
Query: 10 LGEGSYGVVFKCRNRDTGQVVAIKKFLESEEDPLIRKIALREIRLLKSLKHPNLVNLLEV 69
LG+G++G VFK +D V A+K E L K L E R+LK HPN+V L+ V
Sbjct: 3 LGKGNFGEVFKGTLKDKTPV-AVKTCKEDLPQELKIKF-LSEARILKQYDHPNIVKLIGV 60
Query: 70 FRRKKKLHLVFEFCDH-TVLNELENHPHGLPWDLIKQITWQVLRGVSYCHRHACIHRDIK 128
+++ +++V E L+ L L + + G++Y CIHRD+
Sbjct: 61 CTQRQPIYIVMELVPGGDFLSFLRKKKDELKTKQLVKFALDAAAGMAYLESKNCIHRDLA 120
Query: 129 PENILLTANGVVKLCDFGFAR 149
N L+ N V+K+ DFG +R
Sbjct: 121 ARNCLVGENNVLKISDFGMSR 141
|
Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-cell interactions mediated by adherens junctions and focal adhesions. Fer kinase also regulates cell cycle progression in malignant cells. Length = 250 |
| >gnl|CDD|173696 cd05605, STKc_GRK4_like, Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 64.5 bits (157), Expect = 6e-12
Identities = 47/156 (30%), Positives = 77/156 (49%), Gaps = 21/156 (13%)
Query: 10 LGEGSYGVVFKCRNRDTGQVVAIKKFLESEEDPLIRK-----IALREIRLLKSLKHPNLV 64
LG+G +G V C+ R TG++ A KK E I+K +AL E ++L+ + +V
Sbjct: 8 LGKGGFGEVCACQVRATGKMYACKKL----EKKRIKKRKGEAMALNEKQILEKVNSRFVV 63
Query: 65 NLLEVFRRKKKLHLVFEFCDHTVLN--ELENHPH-----GLPWDLIKQITWQVLRGVSYC 117
+L + K L LV T++N +L+ H + G + ++ G+
Sbjct: 64 SLAYAYETKDALCLVL-----TLMNGGDLKFHIYNMGNPGFDEERAVFYAAEITCGLEDL 118
Query: 118 HRHACIHRDIKPENILLTANGVVKLCDFGFARLIRD 153
HR ++RD+KPENILL G +++ D G A I +
Sbjct: 119 HRERIVYRDLKPENILLDDYGHIRISDLGLAVEIPE 154
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5, GRK6, and similar GRKs. GRKs in this group contain an N-terminal RGS homology (RH) domain and a catalytic domain, but lack a G protein betagamma-subunit binding domain. They are localized to the plasma membrane through post-translational lipid modification or direct binding to PIP2. Length = 285 |
| >gnl|CDD|132950 cd06619, PKc_MKK5, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5 | Back alignment and domain information |
|---|
Score = 64.1 bits (156), Expect = 6e-12
Identities = 39/140 (27%), Positives = 71/140 (50%), Gaps = 5/140 (3%)
Query: 10 LGEGSYGVVFKCRNRDTGQVVAIKKFLESEEDPLIRKIALREIRLLKSLKHPNLVNLLEV 69
LG G+ G V+K + T +++A+K L ++I + E+ +L P ++
Sbjct: 9 LGHGNGGTVYKAYHLLTRRILAVKVIPLDITVELQKQI-MSELEILYKCDSPYIIGFYGA 67
Query: 70 FRRKKKLHLVFEFCDHTVLNELENHPHGLPWDLIKQITWQVLRGVSYCHRHACIHRDIKP 129
F + ++ + EF D L+ +P ++ +I V++G++Y +HRD+KP
Sbjct: 68 FFVENRISICTEFMDGGSLDVYRK----IPEHVLGRIAVAVVKGLTYLWSLKILHRDVKP 123
Query: 130 ENILLTANGVVKLCDFGFAR 149
N+L+ G VKLCDFG +
Sbjct: 124 SNMLVNTRGQVKLCDFGVST 143
|
Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that phosphorylates its downstream target, extracellular signal-regulated kinase 5 (ERK5), on specific threonine and tyrosine residues. MKK5 is activated by MEKK2 and MEKK3 in response to mitogenic and stress stimuli. The ERK5 cascade promotes cell proliferation, differentiation, neuronal survival, and neuroprotection. This cascade plays an essential role in heart development. Mice deficient in either ERK5 or MKK5 die around embryonic day 10 due to cardiovascular defects including underdevelopment of the myocardium. In addition, MKK5 is associated with metastasis and unfavorable prognosis in prostate cancer. Length = 279 |
| >gnl|CDD|183880 PRK13184, pknD, serine/threonine-protein kinase; Reviewed | Back alignment and domain information |
|---|
Score = 65.2 bits (159), Expect = 1e-11
Identities = 45/163 (27%), Positives = 76/163 (46%), Gaps = 12/163 (7%)
Query: 1 MERYEKIGKLGEGSYGVVFKCRNRDTGQVVAIKKFLES-EEDPLIRKIALREIRLLKSLK 59
M+RY+ I +G+G G V+ + + VA+KK E E+PL++K LRE ++ L
Sbjct: 1 MQRYDIIRLIGKGGMGEVYLAYDPVCSRRVALKKIREDLSENPLLKKRFLREAKIAADLI 60
Query: 60 HPNLVNLLEVFRRKKKLHLVFEFCDHTVLNELEN---HPHGLPWDLIKQ--------ITW 108
HP +V + + ++ + + L L L +L ++ I
Sbjct: 61 HPGIVPVYSICSDGDPVYYTMPYIEGYTLKSLLKSVWQKESLSKELAEKTSVGAFLSIFH 120
Query: 109 QVLRGVSYCHRHACIHRDIKPENILLTANGVVKLCDFGFARLI 151
++ + Y H +HRD+KP+NILL G V + D+G A
Sbjct: 121 KICATIEYVHSKGVLHRDLKPDNILLGLFGEVVILDWGAAIFK 163
|
Length = 932 |
| >gnl|CDD|173718 cd05629, STKc_NDR_like_fungal, Catalytic domain of Fungal Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 64.5 bits (157), Expect = 1e-11
Identities = 45/150 (30%), Positives = 77/150 (51%), Gaps = 5/150 (3%)
Query: 2 ERYEKIGKLGEGSYGVVFKCRNRDTGQVVAIKKFLESE---EDPLIRKIALREIRLLKSL 58
E + + +G+G++G V + +DTG++ A+K L+SE +D L A R++ L
Sbjct: 1 EDFHTVKVIGKGAFGEVRLVQKKDTGKIYAMKTLLKSEMFKKDQLAHVKAERDV--LAES 58
Query: 59 KHPNLVNLLEVFRRKKKLHLVFEFCDHTVLNELENHPHGLPWDLIKQITWQVLRGVSYCH 118
P +V+L F+ + L+L+ EF L + D+ + + + + H
Sbjct: 59 DSPWVVSLYYSFQDAQYLYLIMEFLPGGDLMTMLIKYDTFSEDVTRFYMAECVLAIEAVH 118
Query: 119 RHACIHRDIKPENILLTANGVVKLCDFGFA 148
+ IHRDIKP+NIL+ G +KL DFG +
Sbjct: 119 KLGFIHRDIKPDNILIDRGGHIKLSDFGLS 148
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, fungal NDR-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group is composed of fungal NDR-like proteins including Saccharomyces cerevisiae CBK1 (or CBK1p), Schizosaccharomyces pombe Orb6 (or Orb6p), Ustilago maydis Ukc1 (or Ukc1p), and Neurospora crassa Cot1. Like NDR kinase, group members contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. CBK1 is an essential component in the RAM (regulation of Ace2p activity and cellular morphogenesis) network. CBK1 and Orb6 play similar roles in coordinating cell morphology with cell cycle progression. Ukc1 is involved in morphogenesis, pathogenicity, and pigment formation. Cot1 plays a role in polar tip extension. Length = 377 |
| >gnl|CDD|173676 cd05585, STKc_YPK1_like, Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 63.8 bits (155), Expect = 1e-11
Identities = 48/147 (32%), Positives = 77/147 (52%), Gaps = 11/147 (7%)
Query: 10 LGEGSYGVVFKCRNRDTGQVVAIKKFLES---EEDPLIRKIALREIRLLKSLKHPNLVNL 66
+G+GS+G V + R RDT ++ A+K ++ + +A R + L + P +V L
Sbjct: 1 IGKGSFGKVMQVRKRDTQRIYALKTIRKAHIVSRSEVTHTLAERTV--LAQVNCPFIVPL 58
Query: 67 LEVFRRKKKLHLVFEFCDHTVLNELENHPHGL-PWDLIKQ--ITWQVLRGVSYCHRHACI 123
F+ +KL+LV F + EL +H +DL + T ++L + H+ I
Sbjct: 59 KFSFQSPEKLYLVLAFING---GELFHHLQREGRFDLSRARFYTAELLCALENLHKFNVI 115
Query: 124 HRDIKPENILLTANGVVKLCDFGFARL 150
+RD+KPENILL G + LCDFG +L
Sbjct: 116 YRDLKPENILLDYQGHIALCDFGLCKL 142
|
Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It plays a role in cell growth and sexual development. Length = 312 |
| >gnl|CDD|133201 cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk | Back alignment and domain information |
|---|
Score = 63.1 bits (153), Expect = 1e-11
Identities = 48/154 (31%), Positives = 72/154 (46%), Gaps = 7/154 (4%)
Query: 2 ERYEKIGKLGEGSYGVVFKCRNRDTGQVVAIKKFLESEEDPLIRKIALREIRLLKSLKHP 61
E + I KLG G +G V+ +V A+K P + L E +++K L+H
Sbjct: 6 ESLQLIKKLGNGQFGEVWMGTWNGNTKV-AVKTLKPGTMSP---ESFLEEAQIMKKLRHD 61
Query: 62 NLVNLLEVFRRKKKLHLVFEFCDHTVLNELENHPHGLPWDL--IKQITWQVLRGVSYCHR 119
LV L V + +++V E+ L + G L + + QV G++Y R
Sbjct: 62 KLVQLYAVVSEEP-IYIVTEYMSKGSLLDFLKDGEGRALKLPNLVDMAAQVAAGMAYIER 120
Query: 120 HACIHRDIKPENILLTANGVVKLCDFGFARLIRD 153
IHRD++ NIL+ V K+ DFG ARLI D
Sbjct: 121 MNYIHRDLRSANILVGDGLVCKIADFGLARLIED 154
|
Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Fyn, together with Lck, plays a critical role in T-cell signal transduction by phosphorylating ITAM (immunoreceptor tyr activation motif) sequences on T-cell receptors, ultimately leading to the proliferation and differentiation of T-cells. In addition, Fyn is involved in the myelination of neurons, and is implicated in Alzheimer's and Parkinson's diseases. Yrk has been detected only in chickens. It is primarily found in neuronal and epithelial cells and in macrophages. It may play a role in inflammation and in response to injury. Length = 260 |
| >gnl|CDD|133191 cd05060, PTKc_Syk_like, Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 63.1 bits (154), Expect = 1e-11
Identities = 42/149 (28%), Positives = 71/149 (47%), Gaps = 7/149 (4%)
Query: 8 GKLGEGSYGVVFK--CRNRDTGQV-VAIKKFLESEEDPLIRKIALREIRLLKSLKHPNLV 64
+LG G++G V K + +V VA+K + ++ LRE ++ L HP +V
Sbjct: 1 KELGHGNFGSVVKGVYLMKSGKEVEVAVKTLKQEHIAAGKKEF-LREASVMAQLDHPCIV 59
Query: 65 NLLEVFRRKKKLHLVFEFCDHTVLNE-LENHPHGLPWDLIKQITWQVLRGVSYCHRHACI 123
L+ V + + L LV E L + L+ +P +K++ QV G++Y +
Sbjct: 60 RLIGVCK-GEPLMLVMELAPLGPLLKYLKKRRE-IPVSDLKELAHQVAMGMAYLESKHFV 117
Query: 124 HRDIKPENILLTANGVVKLCDFGFARLIR 152
HRD+ N+LL K+ DFG +R +
Sbjct: 118 HRDLAARNVLLVNRHQAKISDFGMSRALG 146
|
Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, migration, and phagocytosis. Syk is important in B-cell receptor (BCR) signaling, while Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Syk also plays a central role in Fc receptor-mediated phagocytosis in the adaptive immune system. Shark is exclusively expressed in ectodermally derived epithelia, and is localized preferentially to the apical surface of the epithelial cells, it may play a role in a signaling pathway for epithelial cell polarity. Length = 257 |
| >gnl|CDD|173673 cd05582, STKc_RSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Score = 63.7 bits (155), Expect = 1e-11
Identities = 44/143 (30%), Positives = 70/143 (48%), Gaps = 3/143 (2%)
Query: 10 LGEGSYGVVF---KCRNRDTGQVVAIKKFLESEEDPLIRKIALREIRLLKSLKHPNLVNL 66
LG+GS+G VF K D GQ+ A+K ++ R E +L + HP +V L
Sbjct: 4 LGQGSFGKVFLVRKITGPDAGQLYAMKVLKKATLKVRDRVRTKMERDILAEVNHPFIVKL 63
Query: 67 LEVFRRKKKLHLVFEFCDHTVLNELENHPHGLPWDLIKQITWQVLRGVSYCHRHACIHRD 126
F+ + KL+L+ +F L + + +K ++ + + H I+RD
Sbjct: 64 HYAFQTEGKLYLILDFLRGGDLFTRLSKEVMFTEEDVKFYLAELALALDHLHSLGIIYRD 123
Query: 127 IKPENILLTANGVVKLCDFGFAR 149
+KPENILL G +KL DFG ++
Sbjct: 124 LKPENILLDEEGHIKLTDFGLSK 146
|
Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylates all known RSK substrates. RSKs act as downstream effectors of mitogen-activated protein kinase (MAPK) and play key roles in mitogen-activated cell growth, differentiation, and survival. Mammals possess four RSK isoforms (RSK1-4) from distinct genes. RSK proteins are also referred to as MAP kinase-activated protein kinases (MAPKAPKs), p90-RSKs, or p90S6Ks. Length = 318 |
| >gnl|CDD|173641 cd05072, PTKc_Lyn, Catalytic domain of the Protein Tyrosine Kinase, Lyn | Back alignment and domain information |
|---|
Score = 63.1 bits (153), Expect = 1e-11
Identities = 44/154 (28%), Positives = 80/154 (51%), Gaps = 6/154 (3%)
Query: 2 ERYEKIGKLGEGSYGVVFKCRNRDTGQVVAIKKFLESEEDPLIRKIALREIRLLKSLKHP 61
E + + KLG G +G V+ ++ +V A+K + + + L E L+K+L+H
Sbjct: 6 ESIKLVKKLGAGQFGEVWMGYYNNSTKV-AVKTL---KPGTMSVQAFLEEANLMKTLQHD 61
Query: 62 NLVNLLEVFRRKKKLHLVFEFCDHTVLNELENHPHGLPWDLIKQITW--QVLRGVSYCHR 119
LV L V +++ ++++ E+ L + G L K I + Q+ G++Y R
Sbjct: 62 KLVRLYAVVTKEEPIYIITEYMAKGSLLDFLKSDEGGKVLLPKLIDFSAQIAEGMAYIER 121
Query: 120 HACIHRDIKPENILLTANGVVKLCDFGFARLIRD 153
IHRD++ N+L++ + + K+ DFG AR+I D
Sbjct: 122 KNYIHRDLRAANVLVSESLMCKIADFGLARVIED 155
|
Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lyn is expressed in B lymphocytes and myeloid cells. It exhibits both positive and negative regulatory roles in B cell receptor (BCR) signaling. Lyn, as well as Fyn and Blk, promotes B cell activation by phosphorylating ITAMs (immunoreceptor tyr activation motifs) in CD19 and in Ig components of BCR. It negatively regulates signaling by its unique ability to phosphorylate ITIMs (immunoreceptor tyr inhibition motifs) in cell surface receptors like CD22 and CD5. Lyn also plays an important role in G-CSF receptor signaling by phosphorylating a variety of adaptor molecules. Length = 261 |
| >gnl|CDD|173695 cd05604, STKc_SGK3, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3 | Back alignment and domain information |
|---|
Score = 63.1 bits (153), Expect = 2e-11
Identities = 46/145 (31%), Positives = 72/145 (49%), Gaps = 8/145 (5%)
Query: 10 LGEGSYGVVFKCRNRDTGQVVAIKKF-----LESEEDPLIRKIALREIRLLKSLKHPNLV 64
+G+GS+G V + + G+ A+K L +E I +A R + LLK++KHP LV
Sbjct: 3 IGKGSFGKVLLAKRKLDGKCYAVKVLQKKIVLNRKEQKHI--MAERNV-LLKNVKHPFLV 59
Query: 65 NLLEVFRRKKKLHLVFEFCDHTVLNELENHPHGLPWDLIKQITWQVLRGVSYCHRHACIH 124
L F+ +KL+ V +F + L P + ++ + Y H ++
Sbjct: 60 GLHYSFQTTEKLYFVLDFVNGGELFFHLQRERSFPEPRARFYAAEIASALGYLHSINIVY 119
Query: 125 RDIKPENILLTANGVVKLCDFGFAR 149
RD+KPENILL + G V L DFG +
Sbjct: 120 RDLKPENILLDSQGHVVLTDFGLCK 144
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels, and receptors. It plays a critical role in hair follicle morphogenesis and hair cycling. Length = 325 |
| >gnl|CDD|133232 cd05101, PTKc_FGFR2, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Score = 62.7 bits (152), Expect = 2e-11
Identities = 49/173 (28%), Positives = 81/173 (46%), Gaps = 26/173 (15%)
Query: 7 IGK-LGEGSYGVVFKC------RNRDTGQVVAIKKFLESEEDPLIRKIALREIRLLKSL- 58
+GK LGEG +G V +++ V K L+ + + E+ ++K +
Sbjct: 19 LGKPLGEGCFGQVVMAEALGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIG 78
Query: 59 KHPNLVNLLEVFRRKKKLHLVFEFCDHTVLNEL--ENHPHGLPW---------------D 101
KH N++NLL + L+++ E+ L E P G+ + D
Sbjct: 79 KHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDIARVPDEQMTFKD 138
Query: 102 LIKQITWQVLRGVSYCHRHACIHRDIKPENILLTANGVVKLCDFGFARLIRDL 154
L+ T+QV RG+ Y CIHRD+ N+L+T N V+K+ DFG AR + ++
Sbjct: 139 LV-SCTYQVARGMEYLASQKCIHRDLAARNVLVTENNVMKIADFGLARDVNNI 190
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. There are many splice variants of FGFR2 which show differential expression and binding to FGF ligands. Disruption of either FGFR2 or FGFR2b is lethal in mice, due to defects in the placenta or severe impairment of tissue development including lung, limb, and thyroid, respectively. Disruption of FGFR2c in mice results in defective bone and skull development. Genetic alterations of FGFR2 are associated with many human skeletal disorders including Apert syndrome, Crouzon syndrome, Jackson-Weiss syndrome, and Pfeiffer syndrome. Length = 304 |
| >gnl|CDD|133165 cd05033, PTKc_EphR, Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 62.0 bits (151), Expect = 4e-11
Identities = 38/148 (25%), Positives = 71/148 (47%), Gaps = 5/148 (3%)
Query: 10 LGEGSYGVVFKCRNRDTGQ---VVAIKKFLESEEDPLIRKIALREIRLLKSLKHPNLVNL 66
+G G +G V + R + G+ VAIK L++ R L E ++ HPN++ L
Sbjct: 12 IGGGEFGEVCRGRLKLPGKKEIDVAIKT-LKAGSSDKQRLDFLTEASIMGQFDHPNIIRL 70
Query: 67 LEVFRRKKKLHLVFEFCDHTVLNE-LENHPHGLPWDLIKQITWQVLRGVSYCHRHACIHR 125
V + + + ++ E+ ++ L++ L + + + + G+ Y +HR
Sbjct: 71 EGVVTKSRPVMIITEYMENGSLDKFLRENDGKFTVGQLVGMLRGIASGMKYLSEMNYVHR 130
Query: 126 DIKPENILLTANGVVKLCDFGFARLIRD 153
D+ NIL+ +N V K+ DFG +R + D
Sbjct: 131 DLAARNILVNSNLVCKVSDFGLSRRLED 158
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. This allows ephrin/EphR dimers to form, leading to the activation of the intracellular tyr kinase domain. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). The main effect of ephrin/EphR interaction is cell-cell repulsion or adhesion. Ephrin/EphR signaling is important in neural development and plasticity, cell morphogenesis and proliferation, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. Length = 266 |
| >gnl|CDD|133187 cd05056, PTKc_FAK, Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase | Back alignment and domain information |
|---|
Score = 62.1 bits (151), Expect = 4e-11
Identities = 38/149 (25%), Positives = 74/149 (49%), Gaps = 6/149 (4%)
Query: 9 KLGEGSYGVVFK---CRNRDTGQVVAIKKFLESEEDPLIRKIALREIRLLKSLKHPNLVN 65
+GEG +G V++ + VA+K ++ P +R+ L+E +++ HP++V
Sbjct: 13 CIGEGQFGDVYQGVYMSPENEKIAVAVKTC-KNCTSPSVREKFLQEAYIMRQFDHPHIVK 71
Query: 66 LLEVFRRKKKLHLVFEFCDHTVLNE-LENHPHGLPWDLIKQITWQVLRGVSYCHRHACIH 124
L+ V + + +V E L L+ + + L + ++Q+ ++Y +H
Sbjct: 72 LIGVIT-ENPVWIVMELAPLGELRSYLQVNKYSLDLASLILYSYQLSTALAYLESKRFVH 130
Query: 125 RDIKPENILLTANGVVKLCDFGFARLIRD 153
RDI N+L+++ VKL DFG +R + D
Sbjct: 131 RDIAARNVLVSSPDCVKLGDFGLSRYLED 159
|
Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions and at growth factor receptors. Through diverse molecular interactions, FAK functions as a biosensor or integrator to control cell motility. It is a key regulator of cell survival, proliferation, migration and invasion, and thus plays an important role in the development and progression of cancer. Src binds to autophosphorylated FAK forming the FAK-Src dual kinase complex, which is activated in a wide variety of tumor cells and generates signals promoting growth and metastasis. FAK is being developed as a target for cancer therapy. Length = 270 |
| >gnl|CDD|133204 cd05073, PTKc_Hck, Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase | Back alignment and domain information |
|---|
Score = 61.6 bits (149), Expect = 4e-11
Identities = 46/148 (31%), Positives = 77/148 (52%), Gaps = 9/148 (6%)
Query: 9 KLGEGSYGVVFKCR-NRDTGQVVAIKKFLESEEDPLIRKIALREIRLLKSLKHPNLVNLL 67
KLG G +G V+ N+ T VA+K + + + L E ++K+L+H LV L
Sbjct: 13 KLGAGQFGEVWMATYNKHTK--VAVKTM---KPGSMSVEAFLAEANVMKTLQHDKLVKLH 67
Query: 68 EVFRRKKKLHLVFEFCDHTVLNELENHPHGLPWDLIKQITW--QVLRGVSYCHRHACIHR 125
V ++ ++++ EF L + G L K I + Q+ G+++ + IHR
Sbjct: 68 AVVTKEP-IYIITEFMAKGSLLDFLKSDEGSKQPLPKLIDFSAQIAEGMAFIEQRNYIHR 126
Query: 126 DIKPENILLTANGVVKLCDFGFARLIRD 153
D++ NIL++A+ V K+ DFG AR+I D
Sbjct: 127 DLRAANILVSASLVCKIADFGLARVIED 154
|
Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Hck is present in myeloid and lymphoid cells that play a role in the development of cancer. It may be important in the oncogenic signaling of the protein Tel-Abl, which induces a chronic myelogenous leukemia (CML)-like disease. Hck also acts as a negative regulator of granulocyte colony-stimulating factor (G-CSF)-induced proliferation of granulocytic precursors, suggesting a possible role in the development of acute myeloid leukemia (AML). In addition, Hck is essential in regulating the degranulation of polymorphonuclear leukocytes (PMNs). Genetic polymorphisms affect the expression level of Hck, which affects PMN mediator release and influences the development of chronic obstructive pulmonary disease (COPD). Length = 260 |
| >gnl|CDD|133200 cd05069, PTKc_Yes, Catalytic domain of the Protein Tyrosine Kinase, Yes | Back alignment and domain information |
|---|
Score = 61.6 bits (149), Expect = 5e-11
Identities = 49/147 (33%), Positives = 74/147 (50%), Gaps = 7/147 (4%)
Query: 9 KLGEGSYGVVFKCRNRDTGQVVAIKKFLESEEDPLIRKIALREIRLLKSLKHPNLVNLLE 68
KLG+G +G V+ T +V AIK P + L+E +++K L+H LV L
Sbjct: 13 KLGQGCFGEVWMGTWNGTTKV-AIKTLKPGTMMP---EAFLQEAQIMKKLRHDKLVPLYA 68
Query: 69 VFRRKKKLHLVFEFCDHTVLNELENHPHG--LPWDLIKQITWQVLRGVSYCHRHACIHRD 126
V ++ +++V EF L + G L + + Q+ G++Y R IHRD
Sbjct: 69 VVS-EEPIYIVTEFMGKGSLLDFLKEGDGKYLKLPQLVDMAAQIADGMAYIERMNYIHRD 127
Query: 127 IKPENILLTANGVVKLCDFGFARLIRD 153
++ NIL+ N V K+ DFG ARLI D
Sbjct: 128 LRAANILVGDNLVCKIADFGLARLIED 154
|
Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. c-Yes kinase is the cellular homolog of the oncogenic protein (v-Yes) encoded by the Yamaguchi 73 and Esh sarcoma viruses. It displays functional overlap with other Src subfamily members, particularly Src. It also shows some unique functions such as binding to occludins, transmembrane proteins that regulate extracellular interactions in tight junctions. Yes also associates with a number of proteins in different cell types that Src does not interact with, like JAK2 and gp130 in pre-adipocytes, and Pyk2 in treated pulmonary vein endothelial cells. Although the biological function of Yes remains unclear, it appears to have a role in regulating cell-cell interactions and vesicle trafficking in polarized cells. Length = 260 |
| >gnl|CDD|173662 cd05571, STKc_PKB, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B | Back alignment and domain information |
|---|
Score = 61.8 bits (150), Expect = 5e-11
Identities = 40/144 (27%), Positives = 74/144 (51%), Gaps = 7/144 (4%)
Query: 10 LGEGSYGVVFKCRNRDTGQVVAIKKFLESEEDPLIRK--IA--LREIRLLKSLKHPNLVN 65
LG+G++G V R + TG+ A+K +++ +I K +A L E R+L++ +HP L
Sbjct: 3 LGKGTFGKVILVREKATGKYYAMKIL---KKEVIIAKDEVAHTLTESRVLQNTRHPFLTA 59
Query: 66 LLEVFRRKKKLHLVFEFCDHTVLNELENHPHGLPWDLIKQITWQVLRGVSYCHRHACIHR 125
L F+ +L V E+ + L + D + +++ + Y H ++R
Sbjct: 60 LKYSFQTHDRLCFVMEYANGGELFFHLSRERVFSEDRARFYGAEIVSALGYLHSCDVVYR 119
Query: 126 DIKPENILLTANGVVKLCDFGFAR 149
D+K EN++L +G +K+ DFG +
Sbjct: 120 DLKLENLMLDKDGHIKITDFGLCK 143
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having been implicated in tumor initiation, progression, and metastasis. Length = 323 |
| >gnl|CDD|133229 cd05098, PTKc_FGFR1, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1 | Back alignment and domain information |
|---|
Score = 62.0 bits (150), Expect = 5e-11
Identities = 52/173 (30%), Positives = 80/173 (46%), Gaps = 32/173 (18%)
Query: 7 IGK-LGEGSYGVVFKCR---------NRDTGQVVAIKKFLESEEDPLIRKIALREIRLLK 56
+GK LGEG +G V NR T V + K +E+D + E+ ++K
Sbjct: 22 LGKPLGEGCFGQVVMAEAIGLDKEKPNRVTKVAVKMLKSDATEKD---LSDLISEMEMMK 78
Query: 57 SL-KHPNLVNLLEVFRRKKKLHLVFEFCDHTVLNEL--ENHPHGLPW------------- 100
+ KH N++NLL + L+++ E+ L E P G+ +
Sbjct: 79 MIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYCYNPTQVPEEQLS 138
Query: 101 --DLIKQITWQVLRGVSYCHRHACIHRDIKPENILLTANGVVKLCDFGFARLI 151
DL+ +QV RG+ Y CIHRD+ N+L+T + V+K+ DFG AR I
Sbjct: 139 FKDLV-SCAYQVARGMEYLASKKCIHRDLAARNVLVTEDNVMKIADFGLARDI 190
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Alternative splicing of FGFR1 transcripts produces a variety of isoforms, which are differentially expressed in cells. FGFR1 binds the ligands, FGF1 and FGF2, with high affinity and has also been reported to bind FGF4, FGF6, and FGF9. FGFR1 signaling is critical in the control of cell migration during embryo development. It promotes cell proliferation in fibroblasts. Nuclear FGFR1 plays a role in the regulation of transcription. Mutations, insertions or deletions of FGFR1 have been identified in patients with Kallman's syndrome (KS), an inherited disorder characterized by hypogonadotropic hypogonadism and loss of olfaction. Aberrant FGFR1 expression has been found in some human cancers including 8P11 myeloproliferative syndrome (EMS), breast cancer, and pancreatic adenocarcinoma. Length = 307 |
| >gnl|CDD|133219 cd05088, PTKc_Tie2, Catalytic domain of the Protein Tyrosine Kinase, Tie2 | Back alignment and domain information |
|---|
Score = 61.6 bits (149), Expect = 7e-11
Identities = 68/280 (24%), Positives = 106/280 (37%), Gaps = 60/280 (21%)
Query: 10 LGEGSYGVVFKCRNRDTG--QVVAIKKFLESEEDPLIRKIALREIRLLKSLKHPNLVNLL 67
+GEG++G V K R + G AIK+ E R A L K HPN++NLL
Sbjct: 15 IGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLL 74
Query: 68 EVFRRKKKLHLVFEFCDHTVLNE-------LENHP-----HGLPWDLIKQ----ITWQVL 111
+ L+L E+ H L + LE P + L Q V
Sbjct: 75 GACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVA 134
Query: 112 RGVSYCHRHACIHRDIKPENILLTANGVVKLCDFGFAR----LIRDLIPR---------- 157
RG+ Y + IHRD+ NIL+ N V K+ DFG +R ++ + R
Sbjct: 135 RGMDYLSQKQFIHRDLAARNILVGENYVAKIADFGLSRGQEVYVKKTMGRLPVRWMAIES 194
Query: 158 -HLHIFQTNE------------------YFKGVSLPHAENVVPLEIKIGKPAATNIYLID 198
+ ++ TN + G++ +P ++ KP + + D
Sbjct: 195 LNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAELYEKLPQGYRLEKPLNCDDEVYD 254
Query: 199 FLKRCLDKDPLRRWSCDQLL---------RHPYFNGYYFE 229
+++C + P R S Q+L R Y N +E
Sbjct: 255 LMRQCWREKPYERPSFAQILVSLNRMLEERKTYVNTTLYE 294
|
Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of Ang-1 to Tie2 leads to receptor autophosphorylation and activation, promoting cell migration and survival. In contrast, Ang-2 binding to Tie2 does not result in the same response, suggesting that Ang-2 may function as an antagonist. Tie2 signaling plays key regulatory roles in vascular integrity and quiescence, and in inflammation. Length = 303 |
| >gnl|CDD|173661 cd05570, STKc_PKC, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C | Back alignment and domain information |
|---|
Score = 61.6 bits (150), Expect = 7e-11
Identities = 39/141 (27%), Positives = 70/141 (49%), Gaps = 6/141 (4%)
Query: 10 LGEGSYGVVFKCRNRDTGQVVAIK---KFLESEEDPLIRKIALREIRLLK-SLKHPNLVN 65
LG+GS+G V + T ++ A+K K + ++D + + + E R+L + KHP L
Sbjct: 3 LGKGSFGKVLLAELKGTDELYAVKVLKKDVILQDDDV--ECTMTEKRVLALAGKHPFLTQ 60
Query: 66 LLEVFRRKKKLHLVFEFCDHTVLNELENHPHGLPWDLIKQITWQVLRGVSYCHRHACIHR 125
L F+ K +L V E+ + L + +++ G+ + H I+R
Sbjct: 61 LHSCFQTKDRLFFVMEYVNGGDLMFHIQRSGRFDEPRARFYAAEIVLGLQFLHERGIIYR 120
Query: 126 DIKPENILLTANGVVKLCDFG 146
D+K +N+LL + G +K+ DFG
Sbjct: 121 DLKLDNVLLDSEGHIKIADFG 141
|
Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only require PS. PKCs phosphorylate and modify the activities of a wide variety of cellular proteins including receptors, enzymes, cytoskeletal proteins, transcription factors, and other kinases. They play a central role in signal transduction pathways that regulate cell migration and polarity, proliferation, differentiation, and apoptosis. Also included in this subfamily are the PKC-like proteins, called PKNs. Length = 318 |
| >gnl|CDD|173674 cd05583, STKc_MSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase | Back alignment and domain information |
|---|
Score = 61.0 bits (148), Expect = 8e-11
Identities = 66/281 (23%), Positives = 111/281 (39%), Gaps = 70/281 (24%)
Query: 4 YEKIGKLGEGSYGVVFKCR---NRDTGQVVAIKKFLESEEDPLIRKIALREIRLLKSLKH 60
+E + LG G+YG VF R D G++ A+K +++K + + K+ +H
Sbjct: 2 FELLRVLGTGAYGKVFLVRKVGGHDAGKLYAMK---------VLKKATIVQKA--KTAEH 50
Query: 61 --------------PNLVNLLEVFRRKKKLHLVFEFCDHTVLNELENHPHGLPWDLIKQI 106
P LV L F+ KLHL+ ++ + L ++
Sbjct: 51 TRTERQVLEAVRRCPFLVTLHYAFQTDTKLHLILDYVNGGELFTHLYQREHFTESEVRVY 110
Query: 107 TWQVLRGVSYCHRHACIHRDIKPENILLTANGVVKLCDFGFAR-LIRDLIPRHLHIFQTN 165
+++ + + H+ I+RDIK ENILL + G V L DFG ++ + + R T
Sbjct: 111 IAEIVLALDHLHQLGIIYRDIKLENILLDSEGHVVLTDFGLSKEFLAEEEERAYSFCGTI 170
Query: 166 EYF-----KGVSLPHAE-------NVVPLEIKIGK------------------------- 188
EY +G S H + V+ E+ G
Sbjct: 171 EYMAPEVIRGGSGGHDKAVDWWSLGVLTFELLTGASPFTVDGEQNSQSEISRRILKSKPP 230
Query: 189 -PAATNIYLIDFLKRCLDKDPLRRWSC---DQLLRHPYFNG 225
P + DF+++ L+KDP +R D++ HP+F G
Sbjct: 231 FPKTMSAEARDFIQKLLEKDPKKRLGANGADEIKNHPFFQG 271
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines. This triggers phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) in the C-terminal extension of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSKs are predominantly nuclear proteins. They are widely expressed in many tissues including heart, brain, lung, liver, kidney, and pancreas. There are two isoforms of MSK, called MSK1 and MSK2. Length = 288 |
| >gnl|CDD|165473 PHA03207, PHA03207, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 61.4 bits (149), Expect = 9e-11
Identities = 43/147 (29%), Positives = 68/147 (46%), Gaps = 8/147 (5%)
Query: 3 RYEKIGKLGEGSYGVVFKC-RNRDTGQVVAIKKFLESEEDPLIRKIALREIRLLKSLKHP 61
+Y + L GS G VF C ++ D + I K + + P REI +LK++ H
Sbjct: 93 QYNILSSLTPGSEGEVFVCTKHGDEQRKKVIVKAVTGGKTPG------REIDILKTISHR 146
Query: 62 NLVNLLEVFRRKKKLHLVFEFCDHTVLNELENHPHGLPWDLIKQITWQVLRGVSYCHRHA 121
++NL+ +R K + +V + ++ LP + I ++L ++Y H
Sbjct: 147 AIINLIHAYRWKSTVCMVMPKYKCDLFTYVDRS-GPLPLEQAITIQRRLLEALAYLHGRG 205
Query: 122 CIHRDIKPENILLTANGVVKLCDFGFA 148
IHRD+K ENI L L DFG A
Sbjct: 206 IIHRDVKTENIFLDEPENAVLGDFGAA 232
|
Length = 392 |
| >gnl|CDD|173694 cd05603, STKc_SGK2, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2 | Back alignment and domain information |
|---|
Score = 61.1 bits (148), Expect = 1e-10
Identities = 47/145 (32%), Positives = 71/145 (48%), Gaps = 8/145 (5%)
Query: 10 LGEGSYGVVFKCRNRDTGQVVAIK-----KFLESEEDPLIRKIALREIRLLKSLKHPNLV 64
+G+GS+G V + + G A+K L+ +E I +A R + LLK+LKHP LV
Sbjct: 3 IGKGSFGKVLLAKRKSDGSFYAVKVLQKKTILKKKEQNHI--MAERNV-LLKNLKHPFLV 59
Query: 65 NLLEVFRRKKKLHLVFEFCDHTVLNELENHPHGLPWDLIKQITWQVLRGVSYCHRHACIH 124
L F+ +KL+ V ++ + L + +V + Y H I+
Sbjct: 60 GLHYSFQTAEKLYFVLDYVNGGELFFHLQRERCFLEPRARFYAAEVASAIGYLHSLNIIY 119
Query: 125 RDIKPENILLTANGVVKLCDFGFAR 149
RD+KPENILL + G V L DFG +
Sbjct: 120 RDLKPENILLDSQGHVVLTDFGLCK 144
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1. Length = 321 |
| >gnl|CDD|173766 cd08226, PK_STRAD_beta, Pseudokinase domain of STE20-related kinase adapter protein beta | Back alignment and domain information |
|---|
Score = 61.1 bits (148), Expect = 1e-10
Identities = 39/128 (30%), Positives = 66/128 (51%), Gaps = 4/128 (3%)
Query: 18 VFKCRNRDTGQVVAIK-KFLESEEDPLIRKIALREIRLLKSLKHPNLVNLLEVFRRKKKL 76
V+ R+ TG +V ++ LE+ + + K E+ L +HPN++ VF L
Sbjct: 16 VYLARHTPTGTLVTVRITDLENCTEEHL-KALQNEVVLSHFFRHPNIMTSWTVFTTGSWL 74
Query: 77 HLVFEFCDHTVLNEL--ENHPHGLPWDLIKQITWQVLRGVSYCHRHACIHRDIKPENILL 134
++ F + N L P G+ LI I + LRG++Y H++ IHR+IK +IL+
Sbjct: 75 WVISPFMAYGSANSLLKTYFPEGMSEALIGNILFGALRGLNYLHQNGYIHRNIKASHILI 134
Query: 135 TANGVVKL 142
+ +G+V L
Sbjct: 135 SGDGLVSL 142
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) beta subfamily, pseudokinase domain. The STRAD-beta subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buccal mucosa. There are two forms of STRAD, alpha and beta, that complex with LKB1 and MO25. STRAD-beta is also referred to as ALS2CR2 (Amyotrophic lateral sclerosis 2 chromosomal region candidate gene 2 protein), since the human gene encoding it is located within the juvenile ALS2 critical region on chromosome 2q33-q34. It is not linked to the development of ALS2. Length = 328 |
| >gnl|CDD|173698 cd05607, STKc_GRK7, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7 | Back alignment and domain information |
|---|
Score = 60.7 bits (147), Expect = 1e-10
Identities = 46/152 (30%), Positives = 79/152 (51%), Gaps = 13/152 (8%)
Query: 10 LGEGSYGVVFKCRNRDTGQVVAIKKFLESE-EDPLIRKIALREIRLLKSLKHPNLVNLLE 68
LG+G +G V + ++TG++ A KK + + K+AL E +L+ + P +VNL
Sbjct: 1 LGKGGFGEVCAVQVKNTGKMYACKKLDKKRLKKKSGEKMALLEKEILEKVNSPFIVNLAY 60
Query: 69 VFRRKKKLHLVFEFCDHTVLN--ELENHPH-----GLPWDLIKQITWQVLRGVSYCHRHA 121
F K L LV +++N +L+ H + GL + + + Q+ G+ + H
Sbjct: 61 AFESKTHLCLVM-----SLMNGGDLKYHIYNVGERGLEMERVIHYSAQITCGILHLHSMD 115
Query: 122 CIHRDIKPENILLTANGVVKLCDFGFARLIRD 153
++RD+KPEN+LL G +L D G A ++D
Sbjct: 116 IVYRDMKPENVLLDDQGNCRLSDLGLAVELKD 147
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual group of GRKs. It is primarily found in the retina and plays a role in the regulation of opsin light receptors. GRK7 is located in retinal cone outer segments and plays an important role in regulating photoresponse of the cones. Length = 277 |
| >gnl|CDD|173716 cd05627, STKc_NDR2, Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 2 | Back alignment and domain information |
|---|
Score = 61.2 bits (148), Expect = 1e-10
Identities = 47/149 (31%), Positives = 73/149 (48%), Gaps = 9/149 (6%)
Query: 4 YEKIGKLGEGSYGVVFKCRNRDTGQVVAIK-----KFLESEEDPLIRKIALREIRLLKSL 58
+E + +G G++G V + +DTG + A+K LE E+ IR A R+I L
Sbjct: 3 FESLKVIGRGAFGEVRLVQKKDTGHIYAMKILRKADMLEKEQVAHIR--AERDI--LVEA 58
Query: 59 KHPNLVNLLEVFRRKKKLHLVFEFCDHTVLNELENHPHGLPWDLIKQITWQVLRGVSYCH 118
+V + F+ K+ L+L+ EF + L L + + + + + H
Sbjct: 59 DGAWVVKMFYSFQDKRNLYLIMEFLPGGDMMTLLMKKDTLSEEATQFYIAETVLAIDAIH 118
Query: 119 RHACIHRDIKPENILLTANGVVKLCDFGF 147
+ IHRDIKP+N+LL A G VKL DFG
Sbjct: 119 QLGFIHRDIKPDNLLLDAKGHVKLSDFGL 147
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. In addition, NDR2 plays a role in regulating neuronal growth and differentiation, as well as in facilitating neurite outgrowth. It is also implicated in fear conditioning as it contributes to the coupling of neuronal morphological changes with fear-memory consolidation. NDR2 is also referred to as STK38-like. Length = 360 |
| >gnl|CDD|173649 cd05093, PTKc_TrkB, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B | Back alignment and domain information |
|---|
Score = 60.5 bits (146), Expect = 1e-10
Identities = 49/159 (30%), Positives = 75/159 (47%), Gaps = 20/159 (12%)
Query: 9 KLGEGSYGVVF--KCRNRDTGQ---VVAIKKFLESEEDPLIRKIALREIRLLKSLKHPNL 63
+LGEG++G VF +C N Q +VA+K ++ ++ RK RE LL +L+H ++
Sbjct: 12 ELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDASDNA--RKDFHREAELLTNLQHEHI 69
Query: 64 VNLLEVFRRKKKLHLVFEFCDHTVLNEL-------------ENHPHGLPWDLIKQITWQV 110
V V L +VFE+ H LN+ N P L + I Q+
Sbjct: 70 VKFYGVCVEGDPLIMVFEYMKHGDLNKFLRAHGPDAVLMAEGNRPAELTQSQMLHIAQQI 129
Query: 111 LRGVSYCHRHACIHRDIKPENILLTANGVVKLCDFGFAR 149
G+ Y +HRD+ N L+ N +VK+ DFG +R
Sbjct: 130 AAGMVYLASQHFVHRDLATRNCLVGENLLVKIGDFGMSR 168
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly expressed in the nervous system and in some non-neural tissues. It plays important roles in cell proliferation, differentiation, and survival. BDNF/Trk signaling plays a key role in regulating activity-dependent synaptic plasticity. TrkB also contributes to protection against gp120-induced neuronal cell death. TrkB overexpression is associated with poor prognosis in neuroblastoma (NB) and other human cancers. It acts as a suppressor of anoikis (detachment-induced apoptosis) and contributes to tumor metastasis. Length = 288 |
| >gnl|CDD|173652 cd05100, PTKc_FGFR3, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Score = 60.8 bits (147), Expect = 1e-10
Identities = 49/174 (28%), Positives = 84/174 (48%), Gaps = 28/174 (16%)
Query: 7 IGK-LGEGSYGVVFKC------RNRDTGQV-VAIKKFLESEEDPLIRKIALREIRLLKSL 58
+GK LGEG +G V +++ V VA+K + D + + + E+ ++K +
Sbjct: 16 LGKPLGEGCFGQVVMAEAIGIDKDKPNKPVTVAVKMLKDDATDKDLSDL-VSEMEMMKMI 74
Query: 59 -KHPNLVNLLEVFRRKKKLHLVFEFCDHTVLNEL--ENHPHGLPW--------------- 100
KH N++NLL + L+++ E+ L E P G+ +
Sbjct: 75 GKHKNIINLLGACTQDGPLYVLVEYASKGNLREYLRARRPPGMDYSFDTCKLPEEQLTFK 134
Query: 101 DLIKQITWQVLRGVSYCHRHACIHRDIKPENILLTANGVVKLCDFGFARLIRDL 154
DL+ +QV RG+ Y CIHRD+ N+L+T + V+K+ DFG AR + ++
Sbjct: 135 DLV-SCAYQVARGMEYLASQKCIHRDLAARNVLVTEDNVMKIADFGLARDVHNI 187
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Many FGFR3 splice variants have been reported with the IIIb and IIIc isoforms being the predominant forms. FGFR3 IIIc is the isoform expressed in chondrocytes, the cells affected in dwarfism, while IIIb is expressed in epithelial cells. FGFR3 ligands include FGF1, FGF2, FGF4, FGF8, FGF9, and FGF23. It is a negative regulator of long bone growth. In the cochlear duct and in the lens, FGFR3 is involved in differentiation while it appears to have a role in cell proliferation in epithelial cells. Germline mutations in FGFR3 are associated with skeletal disorders including several forms of dwarfism. Some missense mutations are associated with multiple myeloma and carcinomas of the bladder and cervix. Overexpression of FGFR3 is found in thyroid carcinoma. Length = 334 |
| >gnl|CDD|173692 cd05601, STKc_CRIK, Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase | Back alignment and domain information |
|---|
Score = 60.6 bits (147), Expect = 1e-10
Identities = 43/147 (29%), Positives = 71/147 (48%), Gaps = 3/147 (2%)
Query: 10 LGEGSYGVVFKCRNRDTGQVVAIKKFLESEEDPLIRKIALREIRLLKSLKH-PNLVNLLE 68
+G G +G V R + TG + A+K +S E R + S+ + P + L
Sbjct: 9 VGRGHFGEVQVVREKATGDIYAMKVMKKSVLLAQETVSFFEEERDILSISNSPWIPQLQY 68
Query: 69 VFRRKKKLHLVFEFC-DHTVLNELENHPHGLPWDLIKQITWQVLRGVSYCHRHACIHRDI 127
F+ K L+LV E+ +L+ L + D+ + +++ + H+ +HRDI
Sbjct: 69 AFQDKDNLYLVMEYQPGGDLLSLLNRYEDQFDEDMAQFYLAELVLAIHSVHQMGYVHRDI 128
Query: 128 KPENILLTANGVVKLCDFG-FARLIRD 153
KPEN+L+ G +KL DFG ARL +
Sbjct: 129 KPENVLIDRTGHIKLADFGSAARLTAN 155
|
Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnormal cytokinesis and massive apoptosis in neuronal precursors. A Down syndrome critical region protein TTC3 interacts with CRIK and inhibits CRIK-dependent neuronal differentiation and neurite extension. Length = 330 |
| >gnl|CDD|173684 cd05593, STKc_PKB_gamma, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma | Back alignment and domain information |
|---|
Score = 60.5 bits (146), Expect = 2e-10
Identities = 41/142 (28%), Positives = 74/142 (52%), Gaps = 3/142 (2%)
Query: 10 LGEGSYGVVFKCRNRDTGQVVAIKKFLESEEDPLIRKIA--LREIRLLKSLKHPNLVNLL 67
LG+G++G V R + +G+ A+K L+ E ++A L E R+LK+ +HP L +L
Sbjct: 3 LGKGTFGKVILVREKASGKYYAMK-ILKKEVIIAKDEVAHTLTESRVLKNTRHPFLTSLK 61
Query: 68 EVFRRKKKLHLVFEFCDHTVLNELENHPHGLPWDLIKQITWQVLRGVSYCHRHACIHRDI 127
F+ K +L V E+ + L + D + +++ + Y H ++RD+
Sbjct: 62 YSFQTKDRLCFVMEYVNGGELFFHLSRERVFSEDRTRFYGAEIVSALDYLHSGKIVYRDL 121
Query: 128 KPENILLTANGVVKLCDFGFAR 149
K EN++L +G +K+ DFG +
Sbjct: 122 KLENLMLDKDGHIKITDFGLCK 143
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulated in estrogen-deficient breast cancer cells, androgen-independent prostate cancer cells, and primary ovarian tumors. It acts as a key mediator in the genesis of ovarian cancer. Length = 328 |
| >gnl|CDD|133228 cd05097, PTKc_DDR_like, Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 60.0 bits (145), Expect = 2e-10
Identities = 46/166 (27%), Positives = 77/166 (46%), Gaps = 25/166 (15%)
Query: 9 KLGEGSYGVVFKCR------------NRDTGQVVAIK-KFLESEEDPLIRKIALREIRLL 55
KLGEG +G V C GQ V + K L ++ R L+EI+++
Sbjct: 12 KLGEGQFGEVHLCEAEGLAEFLGEGAPEFDGQPVLVAVKMLRADVTKTARNDFLKEIKIM 71
Query: 56 KSLKHPNLVNLLEVFRRKKKLHLVFEFCDHTVLN------ELEN---HPHGLPWDLIKQI 106
LK+PN++ LL V L ++ E+ ++ LN E+E+ H + +P I +
Sbjct: 72 SRLKNPNIIRLLGVCVSDDPLCMITEYMENGDLNQFLSQREIESTFTHANNIPSVSIANL 131
Query: 107 TW---QVLRGVSYCHRHACIHRDIKPENILLTANGVVKLCDFGFAR 149
+ Q+ G+ Y +HRD+ N L+ + +K+ DFG +R
Sbjct: 132 LYMAVQIASGMKYLASLNFVHRDLATRNCLVGNHYTIKIADFGMSR 177
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including breast, colon, ovarian, brain, and lung. There is no evidence showing that DDRs act as transforming oncogenes. They are more likely to play a role in the regulation of tumor growth and metastasis. Length = 295 |
| >gnl|CDD|173655 cd05110, PTKc_HER4, Catalytic domain of the Protein Tyrosine Kinase, HER4 | Back alignment and domain information |
|---|
Score = 60.1 bits (145), Expect = 2e-10
Identities = 43/151 (28%), Positives = 71/151 (47%), Gaps = 5/151 (3%)
Query: 5 EKIGKLGEGSYGVVFKCRNRDTGQVVAIK---KFLESEEDPLIRKIALREIRLLKSLKHP 61
+++ LG G++G V+K G+ V I K L P + E ++ S+ HP
Sbjct: 10 KRVKVLGSGAFGTVYKGIWVPEGETVKIPVAIKILNETTGPKANVEFMDEALIMASMDHP 69
Query: 62 NLVNLLEVFRRKKKLHLVFEFCDHTVLNE-LENHPHGLPWDLIKQITWQVLRGVSYCHRH 120
+LV LL V + LV + H L + + H + L+ Q+ +G+ Y
Sbjct: 70 HLVRLLGVCL-SPTIQLVTQLMPHGCLLDYVHEHKDNIGSQLLLNWCVQIAKGMMYLEER 128
Query: 121 ACIHRDIKPENILLTANGVVKLCDFGFARLI 151
+HRD+ N+L+ + VK+ DFG ARL+
Sbjct: 129 RLVHRDLAARNVLVKSPNHVKITDFGLARLL 159
|
Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Ligands that bind HER4 fall into two groups, the neuregulins (or heregulins) and some EGFR (HER1) ligands including betacellulin, HBEGF, and epiregulin. All four neuregulins (NRG1-4) interact with HER4. Upon ligand binding, HER4 forms homo- or heterodimers with other HER proteins. HER4 is essential in embryonic development. It is implicated in mammary gland, cardiac, and neural development. As a postsynaptic receptor of NRG1, HER4 plays an important role in synaptic plasticity and maturation. The impairment of NRG1/HER4 signaling may contribute to schizophrenia. Length = 303 |
| >gnl|CDD|173647 cd05091, PTKc_Ror2, Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 2 | Back alignment and domain information |
|---|
Score = 59.7 bits (144), Expect = 2e-10
Identities = 48/163 (29%), Positives = 76/163 (46%), Gaps = 24/163 (14%)
Query: 9 KLGEGSYGVVFKCRNRDTG-----QVVAIKKFLESEEDPLIRKIALREIRLLKSLKHPNL 63
+LGE +G V+K T Q VAIK + E PL R+ E + L+HPN+
Sbjct: 12 ELGEDRFGKVYKGHLFGTAPGEQTQAVAIKTLKDKAEGPL-REEFKHEAMMRSRLQHPNI 70
Query: 64 VNLLEVFRRKKKLHLVFEFCDHTVLNE--LENHPHG---------------LPWDLIKQI 106
V LL V +++ L ++F +C H+ L+E + PH P D + +
Sbjct: 71 VCLLGVVTKEQPLSMIFSYCSHSDLHEFLVMRSPHSDVGSTDDDKTVKSTLEPADFVHIV 130
Query: 107 TWQVLRGVSYCHRHACIHRDIKPENILLTANGVVKLCDFGFAR 149
T Q+ G+ + H +H+D+ N+L+ VK+ D G R
Sbjct: 131 T-QIAAGMEFLSSHHVVHKDLATRNVLVFDKLNVKISDLGLFR 172
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 2 (Ror2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror2 plays important roles in skeletal and heart formation. Ror2-deficient mice show widespread bone abnormalities, ventricular defects in the heart, and respiratory dysfunction. Mutations in human Ror2 result in two different bone development genetic disorders, recessive Robinow syndrome and brachydactyly type B. Ror2 is also implicated in neural development. Length = 283 |
| >gnl|CDD|133171 cd05039, PTKc_Csk_like, Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 59.3 bits (144), Expect = 2e-10
Identities = 40/142 (28%), Positives = 66/142 (46%), Gaps = 7/142 (4%)
Query: 10 LGEGSYGVVFKCRNRDTGQVVAIKKFLESEEDPLIRKIALREIRLLKSLKHPNLVNLLEV 69
+G+G +G V R GQ VA+K ++D + L E ++ +L+HPNLV LL V
Sbjct: 14 IGKGEFGDVMLGDYR--GQKVAVKC---LKDDSTAAQAFLAEASVMTTLRHPNLVQLLGV 68
Query: 70 FRRKKKLHLVFEFCDHTVLNEL--ENHPHGLPWDLIKQITWQVLRGVSYCHRHACIHRDI 127
+ L++V E+ L + + V G+ Y +HRD+
Sbjct: 69 VLQGNPLYIVTEYMAKGSLVDYLRSRGRAVITLAQQLGFALDVCEGMEYLEEKNFVHRDL 128
Query: 128 KPENILLTANGVVKLCDFGFAR 149
N+L++ + V K+ DFG A+
Sbjct: 129 AARNVLVSEDLVAKVSDFGLAK 150
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As negative regulators of Src kinases, Csk and Chk play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Length = 256 |
| >gnl|CDD|133247 cd05116, PTKc_Syk, Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase | Back alignment and domain information |
|---|
Score = 59.2 bits (143), Expect = 2e-10
Identities = 38/147 (25%), Positives = 70/147 (47%), Gaps = 3/147 (2%)
Query: 8 GKLGEGSYGVVFK--CRNRDTGQVVAIKKFLESEEDPLIRKIALREIRLLKSLKHPNLVN 65
G+LG G++G V K + + + + VA+K DP ++ LRE +++ L +P +V
Sbjct: 1 GELGSGNFGTVKKGMYKMKKSEKTVAVKILKNDNNDPALKDELLREANVMQQLDNPYIVR 60
Query: 66 LLEVFRRKKKLHLVFEFCDHTVLNELENHPHGLPWDLIKQITWQVLRGVSYCHRHACIHR 125
++ + + LV E + LN+ + I ++ QV G+ Y +HR
Sbjct: 61 MIGICE-AESWMLVMELAELGPLNKFLQKNKHVTEKNITELVHQVSMGMKYLEETNFVHR 119
Query: 126 DIKPENILLTANGVVKLCDFGFARLIR 152
D+ N+LL K+ DFG ++ +
Sbjct: 120 DLAARNVLLVTQHYAKISDFGLSKALG 146
|
Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, migration, and phagocytosis. More recently, Syk expression has been detected in other cell types (including epithelial cells, vascular endothelial cells, neurons, hepatocytes, and melanocytes), suggesting a variety of biological functions in non-immune cells. Syk plays a critical role in maintaining vascular integrity and in wound healing during embryogenesis. It also regulates Vav3, which is important in osteoclast function including bone development. In breast epithelial cells, where Syk acts as a negative regulator for epidermal growth factor receptor (EGFR) signaling, loss of Syk expression is associated with abnormal proliferation during cancer development suggesting a potential role as a tumor suppressor. In mice, Syk has been shown to inhibit malignant transformation of mammary epithelial cells induced with murine mammary tumor virus (MMTV). Length = 257 |
| >gnl|CDD|173721 cd05632, STKc_GRK5, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5 | Back alignment and domain information |
|---|
Score = 59.6 bits (144), Expect = 2e-10
Identities = 47/151 (31%), Positives = 76/151 (50%), Gaps = 21/151 (13%)
Query: 10 LGEGSYGVVFKCRNRDTGQVVAIKKFLESEEDPLIRK-----IALREIRLLKSLKHPNLV 64
LG+G +G V C+ R TG++ A K+ E I+K +AL E ++L+ + +V
Sbjct: 8 LGKGGFGEVCACQVRATGKMYACKRL----EKKRIKKRKGESMALNEKQILEKVNSQFVV 63
Query: 65 NLLEVFRRKKKLHLVFEFCDHTVLN--ELENHPH-----GLPWDLIKQITWQVLRGVSYC 117
NL + K L LV T++N +L+ H + G + ++L G+
Sbjct: 64 NLAYAYETKDALCLVL-----TIMNGGDLKFHIYNMGNPGFEEERALFYAAEILCGLEDL 118
Query: 118 HRHACIHRDIKPENILLTANGVVKLCDFGFA 148
HR ++RD+KPENILL G +++ D G A
Sbjct: 119 HRENTVYRDLKPENILLDDYGHIRISDLGLA 149
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with the membrane though an N-terminal PIP2 binding domain and also binds phospholipids via its C-terminus. GRK5 deficiency is associated with early Alzheimer's disease in humans and mouse models. GRK5 also plays a crucial role in the pathogenesis of sporadic Parkinson's disease. It participates in the regulation and desensitization of PDGFRbeta, a receptor tyrosine kinase involved in a variety of downstream cellular effects including cell growth, chemotaxis, apoptosis, and angiogenesis. GRK5 also regulates Toll-like receptor 4, which is involved in innate and adaptive immunity. Length = 285 |
| >gnl|CDD|173717 cd05628, STKc_NDR1, Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 1 | Back alignment and domain information |
|---|
Score = 60.1 bits (145), Expect = 3e-10
Identities = 48/151 (31%), Positives = 73/151 (48%), Gaps = 9/151 (5%)
Query: 2 ERYEKIGKLGEGSYGVVFKCRNRDTGQVVAIK-----KFLESEEDPLIRKIALREIRLLK 56
E +E + +G G++G V + +DTG V A+K LE E+ IR A R+I L
Sbjct: 1 EDFESLKVIGRGAFGEVRLVQKKDTGHVYAMKILRKADMLEKEQVGHIR--AERDI--LV 56
Query: 57 SLKHPNLVNLLEVFRRKKKLHLVFEFCDHTVLNELENHPHGLPWDLIKQITWQVLRGVSY 116
+V + F+ K L+L+ EF + L L + + + + +
Sbjct: 57 EADSLWVVKMFYSFQDKLNLYLIMEFLPGGDMMTLLMKKDTLTEEETQFYIAETVLAIDS 116
Query: 117 CHRHACIHRDIKPENILLTANGVVKLCDFGF 147
H+ IHRDIKP+N+LL + G VKL DFG
Sbjct: 117 IHQLGFIHRDIKPDNLLLDSKGHVKLSDFGL 147
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. NDR1 is highly expressed in thymus, muscle, lung and spleen. It is not an essential protein because mice deficient of NDR1 remain viable and fertile. However, these mice develop T-cell lymphomas and appear to be hypersenstive to carcinogenic treatment. NDR1 appears to act as a tumor suppressor. NDR1 is also called STK38. Length = 363 |
| >gnl|CDD|173648 cd05092, PTKc_TrkA, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A | Back alignment and domain information |
|---|
Score = 59.2 bits (143), Expect = 3e-10
Identities = 52/165 (31%), Positives = 74/165 (44%), Gaps = 26/165 (15%)
Query: 9 KLGEGSYGVVF--KCRNRDTGQ---VVAIKKFLESEEDPLIRKIALREIRLLKSLKHPNL 63
+LGEG++G VF +C N Q +VA+K E+ E R+ RE LL L+H ++
Sbjct: 12 ELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESA--RQDFQREAELLTVLQHQHI 69
Query: 64 VNLLEVFRRKKKLHLVFEFCDHTVLNE-LENH----------------PHGLPWDLIKQI 106
V V + L +VFE+ H LN L +H L L I
Sbjct: 70 VRFYGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKILAGGEDVAPGQLTLGQML--AI 127
Query: 107 TWQVLRGVSYCHRHACIHRDIKPENILLTANGVVKLCDFGFARLI 151
Q+ G+ Y +HRD+ N L+ VVK+ DFG +R I
Sbjct: 128 ASQIASGMVYLASLHFVHRDLATRNCLVGQGLVVKIGDFGMSRDI 172
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory and sympathetic neurons of the peripheral nervous system, and in basal forebrain cholinergic neurons of the central nervous system. It is critical for neuronal growth, differentiation and survival. Alternative TrkA splicing has been implicated as a pivotal regulator of neuroblastoma (NB) behavior. Normal TrkA expression is associated with better NB prognosis, while the hypoxia-regulated TrkAIII splice variant promotes NB pathogenesis and progression. Aberrant TrkA expression has also been demonstrated in non-neural tumors including prostate, breast, lung, and pancreatic cancers. Length = 280 |
| >gnl|CDD|173714 cd05625, STKc_LATS1, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 1 | Back alignment and domain information |
|---|
Score = 59.6 bits (144), Expect = 4e-10
Identities = 45/147 (30%), Positives = 69/147 (46%), Gaps = 5/147 (3%)
Query: 4 YEKIGKLGEGSYGVVFKCRNRDTGQVVAIKKFLESEEDPLIRKIALR---EIRLLKSLKH 60
+ KI LG G++G V R DT + A+K ++D L+R E +L +
Sbjct: 3 FVKIKTLGIGAFGEVCLARKVDTKALYAMKTL--RKKDVLLRNQVAHVKAERDILAEADN 60
Query: 61 PNLVNLLEVFRRKKKLHLVFEFCDHTVLNELENHPHGLPWDLIKQITWQVLRGVSYCHRH 120
+V L F+ K L+ V ++ + L P DL + ++ V H+
Sbjct: 61 EWVVRLYYSFQDKDNLYFVMDYIPGGDMMSLLIRMGIFPEDLARFYIAELTCAVESVHKM 120
Query: 121 ACIHRDIKPENILLTANGVVKLCDFGF 147
IHRDIKP+NIL+ +G +KL DFG
Sbjct: 121 GFIHRDIKPDNILIDRDGHIKLTDFGL 147
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. Promoter methylation, loss of heterozygosity, and missense mutations targeting the LATS1 gene have also been found in human sarcomas and ovarian cancers. In addition, decreased expression of LATS1 is associated with an aggressive phenotype and poor prognosis. LATS1 induces G2 arrest and promotes cytokinesis. It may be a component of the mitotic exit network in higher eukaryotes. Length = 382 |
| >gnl|CDD|133214 cd05083, PTKc_Chk, Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase | Back alignment and domain information |
|---|
Score = 58.8 bits (142), Expect = 4e-10
Identities = 45/143 (31%), Positives = 67/143 (46%), Gaps = 9/143 (6%)
Query: 9 KLGEGSYGVVFKCRNRDTGQVVAIKKFLESEEDPLIRKIALREIRLLKSLKHPNLVNLLE 68
+GEG +G V + TGQ VA+K + + + L E ++ L H NLV LL
Sbjct: 13 IIGEGEFGAVLQ--GEYTGQKVAVKNI----KCDVTAQAFLEETAVMTKLHHKNLVRLLG 66
Query: 69 VFRRKKKLHLVFEFCDH-TVLNELENHPHGL-PWDLIKQITWQVLRGVSYCHRHACIHRD 126
V L++V E ++N L L + Q + V G+ Y +HRD
Sbjct: 67 VILHNG-LYIVMELMSKGNLVNFLRTRGRALVSVIQLLQFSLDVAEGMEYLESKKLVHRD 125
Query: 127 IKPENILLTANGVVKLCDFGFAR 149
+ NIL++ +GV K+ DFG AR
Sbjct: 126 LAARNILVSEDGVAKVSDFGLAR 148
|
Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As a negative regulator of Src kinases, Chk may play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Chk is expressed in brain and hematopoietic cells. Studies in mice reveal that Chk is not functionally redundant with Csk and that it plays an important role as a regulator of immune responses. Chk also plays a role in neural differentiation in a manner independent of Src by enhancing Mapk activation via Ras-mediated signaling. Length = 254 |
| >gnl|CDD|173680 cd05589, STKc_PKN, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N | Back alignment and domain information |
|---|
Score = 58.9 bits (143), Expect = 5e-10
Identities = 43/149 (28%), Positives = 68/149 (45%), Gaps = 21/149 (14%)
Query: 10 LGEGSYGVVFKCRNRDTGQVVAIKKFLESEEDPLIRKIALREIRLLKSLK---------- 59
LG G +G V + TG++ AIK + D + R E+ L K
Sbjct: 7 LGRGHFGKVLLAEYKKTGELYAIKAL--KKGDIIARD----EVESLMCEKRIFETANSER 60
Query: 60 HPNLVNLLEVFRRKKKLHLVFEFCDHTVLNELENHPHGLPWDLIKQITW--QVLRGVSYC 117
HP LVNL F+ + + V E+ +L H H + + + + V+ G+ Y
Sbjct: 61 HPFLVNLFACFQTEDHVCFVMEY---AAGGDLMMHIHTDVFSEPRAVFYAACVVLGLQYL 117
Query: 118 HRHACIHRDIKPENILLTANGVVKLCDFG 146
H + ++RD+K +N+LL G VK+ DFG
Sbjct: 118 HENKIVYRDLKLDNLLLDTEGFVKIADFG 146
|
Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved in many biological processes including cytokeletal regulation, cell adhesion, vesicle transport, glucose transport, regulation of meiotic maturation and embryonic cell cycles, signaling to the nucleus, and tumorigenesis. Length = 324 |
| >gnl|CDD|240344 PTZ00283, PTZ00283, serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 59.1 bits (143), Expect = 6e-10
Identities = 55/168 (32%), Positives = 73/168 (43%), Gaps = 35/168 (20%)
Query: 109 QVLRGVSYCHRHACIHRDIKPENILLTANGVVKLCDFGFARL----IRDLIPRHLHIFQT 164
QVL V + H IHRDIK NILL +NG+VKL DFGF+++ + D + R F
Sbjct: 151 QVLLAVHHVHSKHMIHRDIKSANILLCSNGLVKLGDFGFSKMYAATVSDDVGR---TFCG 207
Query: 165 NEYFKGVSLPHAENVVPLEIKIGKPAATN---------IYLIDFLKRCLDKDPLRRWSCD 215
Y+ V P EI KP + +Y + LKR D + +
Sbjct: 208 TPYY----------VAP-EIWRRKPYSKKADMFSLGVLLYELLTLKRPFDGENMEE---- 252
Query: 216 QLLRHPYFNGYYFEVPDEMQYE--EITQRCLDKDPLRRWSCDQLLRHP 261
+ H G Y +P + E EI L DP RR S +LL P
Sbjct: 253 --VMHKTLAGRYDPLPPSISPEMQEIVTALLSSDPKRRPSSSKLLNMP 298
|
Length = 496 |
| >gnl|CDD|173689 cd05598, STKc_LATS, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor | Back alignment and domain information |
|---|
Score = 58.7 bits (142), Expect = 7e-10
Identities = 43/146 (29%), Positives = 69/146 (47%), Gaps = 5/146 (3%)
Query: 4 YEKIGKLGEGSYGVVFKCRNRDTGQVVAIKKFLESEEDPLIRKIALR---EIRLLKSLKH 60
+ KI +G G++G V R DT + A+K ++ D L+R A E +L +
Sbjct: 3 FVKIKTIGIGAFGEVCLVRKVDTNALYAMKTLRKA--DVLMRNQAAHVKAERDILAEADN 60
Query: 61 PNLVNLLEVFRRKKKLHLVFEFCDHTVLNELENHPHGLPWDLIKQITWQVLRGVSYCHRH 120
+V L F+ K L+ V ++ + L DL + ++ + H+
Sbjct: 61 EWVVKLYYSFQDKDNLYFVMDYIPGGDMMSLLIRLGIFEEDLARFYIAELTCAIESVHKM 120
Query: 121 ACIHRDIKPENILLTANGVVKLCDFG 146
IHRDIKP+NIL+ +G +KL DFG
Sbjct: 121 GFIHRDIKPDNILIDRDGHIKLTDFG 146
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS was originally identified in Drosophila using a screen for genes whose inactivation led to overproliferation of cells. In tetrapods, there are two LATS isoforms, LATS1 and LATS2. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Length = 376 |
| >gnl|CDD|173632 cd05051, PTKc_DDR, Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors | Back alignment and domain information |
|---|
Score = 58.1 bits (141), Expect = 8e-10
Identities = 46/169 (27%), Positives = 73/169 (43%), Gaps = 30/169 (17%)
Query: 9 KLGEGSYGVVFKCRN----------------RDTGQVVAIKKFLESEEDPLIRKIALREI 52
KLGEG +G V C D +VA+K D R+ L+E+
Sbjct: 12 KLGEGQFGEVHLCEADGLQDFSEKAFAENDNADAPVLVAVKVLRPDASDNA-REDFLKEV 70
Query: 53 RLLKSLKHPNLVNLLEVFRRKKKLHLVFEFCDHTVLNE-LENH---PHGLPWDLIKQITW 108
++L L PN+ LL V L ++ E+ ++ LN+ L+ H GL + K +++
Sbjct: 71 KILSRLSDPNIARLLGVCTVDPPLCMIMEYMENGDLNQFLQKHVAETSGLACN-SKSLSF 129
Query: 109 QVL--------RGVSYCHRHACIHRDIKPENILLTANGVVKLCDFGFAR 149
L G+ Y +HRD+ N L+ N +K+ DFG +R
Sbjct: 130 STLLYMATQIASGMRYLESLNFVHRDLATRNCLVGKNYTIKIADFGMSR 178
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including breast, colon, ovarian, brain, and lung. There is no evidence showing that DDRs act as transforming oncogenes. They are more likely to play a role in the regulation of tumor growth and metastasis. Length = 296 |
| >gnl|CDD|173701 cd05610, STKc_MASTL, Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase | Back alignment and domain information |
|---|
Score = 58.7 bits (142), Expect = 9e-10
Identities = 44/151 (29%), Positives = 82/151 (54%), Gaps = 15/151 (9%)
Query: 13 GSYGVVFKCRNRDTGQVVAIKKFLESEEDPLIRKIALREIRL----LKSLKHPNLVNLLE 68
G++G V+ R ++ ++ A+K +++ +I K + +++ L K P +V+L
Sbjct: 15 GAFGKVYLGRKKNNSKLYAVKVVKKAD---MINKNMVHQVQAERDALALSKSPFIVHLYY 71
Query: 69 VFRRKKKLHLVFEFCDHTVLNELENHPHGLPWD---LIKQITWQVLRGVSYCHRHACIHR 125
+ ++LV E+ + L H +G +D +K I+ +V + Y HRH IHR
Sbjct: 72 SLQSANNVYLVMEYLIGGDVKSLL-HIYGY-FDEEMAVKYIS-EVALALDYLHRHGIIHR 128
Query: 126 DIKPENILLTANGVVKLCDFGFAR--LIRDL 154
D+KP+N+L++ G +KL DFG ++ L R+L
Sbjct: 129 DLKPDNMLISNEGHIKLTDFGLSKVTLNREL 159
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ14813 is associated with autosomal dominant thrombocytopenia. To date, the function of MASTL is unknown. Length = 669 |
| >gnl|CDD|173635 cd05054, PTKc_VEGFR, Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors | Back alignment and domain information |
|---|
Score = 58.3 bits (141), Expect = 9e-10
Identities = 27/51 (52%), Positives = 34/51 (66%), Gaps = 1/51 (1%)
Query: 101 DLIKQITWQVLRGVSYCHRHACIHRDIKPENILLTANGVVKLCDFGFARLI 151
DLI ++QV RG+ + CIHRD+ NILL+ N VVK+CDFG AR I
Sbjct: 174 DLI-SYSFQVARGMEFLASRKCIHRDLAARNILLSENNVVKICDFGLARDI 223
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. There are five VEGF ligands in mammals, which bind, in an overlapping pattern to the three VEGFRs, which can form homo or heterodimers. VEGFRs regulate the cardiovascular system. They are critical for vascular development during embryogenesis and blood vessel formation in adults. They induce cellular functions common to other growth factor receptors such as cell migration, survival, and proliferation. VEGFR1 binds VEGFA, VEGFB, and placenta growth factor (PLGF). It regulates monocyte and macrophage migration, vascular permeability, haematopoiesis, and the recruitment of haematopietic progenitor cells from the bone marrow. Length = 337 |
| >gnl|CDD|173682 cd05591, STKc_nPKC_epsilon, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon | Back alignment and domain information |
|---|
Score = 58.3 bits (141), Expect = 9e-10
Identities = 78/301 (25%), Positives = 125/301 (41%), Gaps = 88/301 (29%)
Query: 10 LGEGSYGVVFKCRNRDTGQVVAIKKFLESEEDPLIR----KIALREIRLLK-SLKHPNLV 64
LG+GS+G V + T +V AIK ++D +++ + E R+L + KHP L
Sbjct: 3 LGKGSFGKVMLAELKGTDEVYAIKVL---KKDVILQDDDVDCTMTEKRILALAAKHPFLT 59
Query: 65 NLLEVFRRKKKLHLVFEFCDHTVLNELENHPHGLPWDLIKQI--------------TWQV 110
L F+ K +L V E+ + DL+ QI +V
Sbjct: 60 ALHCCFQTKDRLFFVMEYVNGG--------------DLMFQIQRSRKFDEPRSRFYAAEV 105
Query: 111 LRGVSYCHRHACIHRDIKPENILLTANGVVKLCDFGFAR--LIRDLI-------PRHL-- 159
+ + HRH I+RD+K +NILL A G KL DFG + ++ + P ++
Sbjct: 106 TLALMFLHRHGVIYRDLKLDNILLDAEGHCKLADFGMCKEGILNGVTTTTFCGTPDYIAP 165
Query: 160 HIFQTNEYFKGVSLP-HAENVVPLEIKIGKPA--ATN----------------IYL---- 196
I Q EY G S+ A V+ E+ G+P A N ++L
Sbjct: 166 EILQELEY--GPSVDWWALGVLMYEMMAGQPPFEADNEDDLFESILHDDVLYPVWLSKEA 223
Query: 197 IDFLKRCLDKDPLRRWSC-------DQLLRHPYFNGYYFEVPDEMQYEEITQRCLDKDPL 249
+ LK + K+P +R C D + +HP+F E+ + + QR + K P
Sbjct: 224 VSILKAFMTKNPNKRLGCVASQGGEDAIKQHPFFK--------EIDWVLLEQRKI-KPPF 274
Query: 250 R 250
+
Sbjct: 275 K 275
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to neoplastic transformation depending on the cell type. It contributes to oncogenesis by inducing disordered cell growth and inhibiting cell death. It also plays a role in tumor invasion and metastasis. PKC-epsilon has also been found to confer cardioprotection against ischemia and reperfusion-mediated damage. Other cellular functions include the regulation of gene expression, cell adhesion, and cell motility. Length = 321 |
| >gnl|CDD|223009 PHA03211, PHA03211, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 58.4 bits (141), Expect = 1e-09
Identities = 43/145 (29%), Positives = 61/145 (42%), Gaps = 8/145 (5%)
Query: 8 GKLGEGSYGVVFKCRNRDTGQVVAIKKFLESEEDPLIRKIALREIRLLKSLKHPNLVNLL 67
L GS G VF+ + D Q V +K + ++ E RLL+ L HP ++ LL
Sbjct: 175 RALTPGSEGCVFESSHPDYPQRVVVKAGWYAS--------SVHEARLLRRLSHPAVLALL 226
Query: 68 EVFRRKKKLHLVFEFCDHTVLNELENHPHGLPWDLIKQITWQVLRGVSYCHRHACIHRDI 127
+V LV + L L + + Q+L + Y H IHRDI
Sbjct: 227 DVRVVGGLTCLVLPKYRSDLYTYLGARLRPLGLAQVTAVARQLLSAIDYIHGEGIIHRDI 286
Query: 128 KPENILLTANGVVKLCDFGFARLIR 152
K EN+L+ + L DFG A R
Sbjct: 287 KTENVLVNGPEDICLGDFGAACFAR 311
|
Length = 461 |
| >gnl|CDD|165476 PHA03210, PHA03210, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 58.6 bits (141), Expect = 1e-09
Identities = 47/170 (27%), Positives = 74/170 (43%), Gaps = 24/170 (14%)
Query: 1 MERYEKIGKLGEGSYGVVFKCRNRDTGQVVAIKKFLESEEDPLI---RKIALR------- 50
+ + I L G++G +F C R + + ++ + S R IA R
Sbjct: 147 LAHFRVIDDLPAGAFGKIFICALRASTEEAEARRGVNSTNQGKPKCERLIAKRVKAGSRA 206
Query: 51 ------EIRLLKSLKHPNLVNLLEVFRRKKKLHLVFEFCDHTVLNELENHPHGLPWD--- 101
EI L L H N++ + E+ R + +++ + D + + + + W
Sbjct: 207 AIQLENEILALGRLNHENILKIEEILRSEANTYMITQKYDFDLYSFM--YDEAFDWKDRP 264
Query: 102 LIKQ---ITWQVLRGVSYCHRHACIHRDIKPENILLTANGVVKLCDFGFA 148
L+KQ I Q+L V Y H IHRDIK ENI L +G + L DFG A
Sbjct: 265 LLKQTRAIMKQLLCAVEYIHDKKLIHRDIKLENIFLNCDGKIVLGDFGTA 314
|
Length = 501 |
| >gnl|CDD|173711 cd05621, STKc_ROCK2, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2 | Back alignment and domain information |
|---|
Score = 58.1 bits (140), Expect = 1e-09
Identities = 43/149 (28%), Positives = 76/149 (51%), Gaps = 8/149 (5%)
Query: 2 ERYEKIGKLGEGSYGVVFKCRNRDTGQVVAIKKFLESEEDPLIRK----IALREIRLLKS 57
E Y+ + +G G++G V R++ + +V A+K + E +I++ E ++
Sbjct: 43 EDYDVVKVIGRGAFGEVQLVRHKSSQKVYAMKLLSKFE---MIKRSDSAFFWEERDIMAF 99
Query: 58 LKHPNLVNLLEVFRRKKKLHLVFEFCDHTVLNELENHPHGLPWDLIKQITWQVLRGVSYC 117
P +V L F+ K L++V E+ L L ++ + +P K T +V+ +
Sbjct: 100 ANSPWVVQLFCAFQDDKYLYMVMEYMPGGDLVNLMSN-YDVPEKWAKFYTAEVVLALDAI 158
Query: 118 HRHACIHRDIKPENILLTANGVVKLCDFG 146
H IHRD+KP+N+LL +G +KL DFG
Sbjct: 159 HSMGLIHRDVKPDNMLLDKHGHLKLADFG 187
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found to play a role in stress fiber and focal adhesion formation. It is prominently expressed in the brain, heart, and skeletal muscles. It is implicated in vascular and neurological disorders, such as hypertension and vasospasm of the coronary and cerebral arteries. ROCK2 is also activated by caspase-2 cleavage, resulting in thrombin-induced microparticle generation in response to cell activation. Mice deficient in ROCK2 show intrauterine growth retardation and embryonic lethality because of placental dysfunction. Length = 370 |
| >gnl|CDD|173631 cd05045, PTKc_RET, Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein | Back alignment and domain information |
|---|
Score = 57.7 bits (139), Expect = 1e-09
Identities = 42/169 (24%), Positives = 71/169 (42%), Gaps = 30/169 (17%)
Query: 10 LGEGSYGVV-----FKCRNRDTGQVVAIKKFLESEEDPLIRKIALREIRLLKSLKHPNLV 64
LGEG +G V F+ + R VA+K E+ +R + L E LLK + HP+++
Sbjct: 8 LGEGEFGKVVKATAFRLKGRAGYTTVAVKMLKENASSSELRDL-LSEFNLLKQVNHPHVI 66
Query: 65 NLLEVFRRKKKLHLVFEFCDHTVL----------------------NELENHPHGLPWDL 102
L + L L+ E+ + L + ++P +
Sbjct: 67 KLYGACSQDGPLLLIVEYAKYGSLRSFLRESRKVGPSYLGSDGNRNSSYLDNPDERALTM 126
Query: 103 IKQIT--WQVLRGVSYCHRHACIHRDIKPENILLTANGVVKLCDFGFAR 149
I+ WQ+ RG+ Y +HRD+ N+L+ +K+ DFG +R
Sbjct: 127 GDLISFAWQISRGMQYLAEMKLVHRDLAARNVLVAEGRKMKISDFGLSR 175
|
Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leading to autophosphorylation, activation, and intracellular signaling. RET is essential for the development of the sympathetic, parasympathetic and enteric nervous systems, and the kidney. RET disruption by germline mutations causes diseases in humans including congenital aganglionosis of the gastrointestinal tract (Hirschsprung's disease) and three related inherited cancers: multiple endocrine neoplasia type 2A (MEN2A), MEN2B, and familial medullary thyroid carcinoma (FMTC). Length = 290 |
| >gnl|CDD|133233 cd05102, PTKc_VEGFR3, Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Score = 57.3 bits (138), Expect = 2e-09
Identities = 24/45 (53%), Positives = 31/45 (68%)
Query: 107 TWQVLRGVSYCHRHACIHRDIKPENILLTANGVVKLCDFGFARLI 151
++QV RG+ + CIHRD+ NILL+ N VVK+CDFG AR I
Sbjct: 180 SFQVARGMEFLASRKCIHRDLAARNILLSENNVVKICDFGLARDI 224
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. VEGFR3 preferentially binds the ligands VEGFC and VEGFD. VEGFR3 is essential for lymphatic endothelial cell (EC) development and function. It has been shown to regulate adaptive immunity during corneal transplantation. VEGFR3 is upregulated on blood vascular ECs in pathological conditions such as vascular tumors and the periphery of solid tumors. It plays a role in cancer progression and lymph node metastasis. Missense mutations in the VEGFR3 gene are associated with primary human lymphedema. Length = 338 |
| >gnl|CDD|173712 cd05622, STKc_ROCK1, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 1 | Back alignment and domain information |
|---|
Score = 57.3 bits (138), Expect = 2e-09
Identities = 43/149 (28%), Positives = 76/149 (51%), Gaps = 8/149 (5%)
Query: 2 ERYEKIGKLGEGSYGVVFKCRNRDTGQVVAIKKFLESEEDPLIRK----IALREIRLLKS 57
E YE + +G G++G V R++ T +V A+K + E +I++ E ++
Sbjct: 43 EDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFE---MIKRSDSAFFWEERDIMAF 99
Query: 58 LKHPNLVNLLEVFRRKKKLHLVFEFCDHTVLNELENHPHGLPWDLIKQITWQVLRGVSYC 117
P +V L F+ + L++V E+ L L ++ + +P + T +V+ +
Sbjct: 100 ANSPWVVQLFYAFQDDRYLYMVMEYMPGGDLVNLMSN-YDVPEKWARFYTAEVVLALDAI 158
Query: 118 HRHACIHRDIKPENILLTANGVVKLCDFG 146
H IHRD+KP+N+LL +G +KL DFG
Sbjct: 159 HSMGFIHRDVKPDNMLLDKSGHLKLADFG 187
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK1 (or ROK-beta) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK1 is preferentially expressed in the liver, lung, spleen, testes, and kidney. It mediates signaling from Rho to the actin cytoskeleton. It is implicated in the development of cardiac fibrosis, cardiomyocyte apoptosis, and hyperglycemia. Mice deficient with ROCK1 display eyelids open at birth (EOB) and omphalocele phenotypes due to the disorganization of actin filaments in the eyelids and the umbilical ring. Length = 371 |
| >gnl|CDD|173688 cd05597, STKc_DMPK_like, Catalytic domain of Myotonic Dystrophy protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 57.1 bits (138), Expect = 2e-09
Identities = 44/150 (29%), Positives = 79/150 (52%), Gaps = 8/150 (5%)
Query: 2 ERYEKIGKLGEGSYGVVFKCRNRDTGQVVAIKKFLESEEDPLIRKIALREIR-LLKSLKH 60
+ +E + +G G++G V + ++TGQV A+K + E RE R +L +
Sbjct: 1 DDFEILKVIGRGAFGEVAVVKMKNTGQVYAMKILNKWEMLKRAETACFREERDVLVNGDR 60
Query: 61 PNLVNLLEVFRRKKKLHLVFEFCDH----TVLNELENHPHGLPWDLIKQITWQVLRGVSY 116
+ NL F+ + L+LV ++ T+L++ E+ LP D+ + +++ +
Sbjct: 61 RWITNLHYAFQDENNLYLVMDYYVGGDLLTLLSKFEDR---LPEDMARFYLAEMVLAIDS 117
Query: 117 CHRHACIHRDIKPENILLTANGVVKLCDFG 146
H+ +HRDIKP+N+LL NG ++L DFG
Sbjct: 118 VHQLGYVHRDIKPDNVLLDKNGHIRLADFG 147
|
Serine/Threonine Kinases (STKs), Myotonic Dystrophy protein kinase (DMPK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The DMPK-like subfamily is composed of DMPK and DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK). Three isoforms of MRCK are known, named alpha, beta and gamma. The DMPK gene is implicated in myotonic dystrophy 1 (DM1), an inherited multisystemic disorder with symptoms that include muscle hyperexcitability, progressive muscle weakness and wasting, cataract development, testicular atrophy, and cardiac conduction defects. The genetic basis for DM1 is the mutational expansion of a CTG repeat in the 3'-UTR of DMPK. DMPK is expressed in skeletal and cardiac muscles, and in central nervous tissues. The functional role of DMPK is not fully understood. It may play a role in the signal transduction and homeostasis of calcium. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKgamma is expressed in heart and skeletal muscles, unlike MRCKalpha and MRCKbeta, which are expressed ubiquitously. Length = 331 |
| >gnl|CDD|173687 cd05596, STKc_ROCK, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase | Back alignment and domain information |
|---|
Score = 57.1 bits (138), Expect = 2e-09
Identities = 42/150 (28%), Positives = 76/150 (50%), Gaps = 10/150 (6%)
Query: 2 ERYEKIGKLGEGSYGVVFKCRNRDTGQVVAIKKFLESEEDPLIRK----IALREIRLLKS 57
E ++ I +G G++G V R++ + QV A+K + E +I++ E ++
Sbjct: 43 EDFDVIKVIGRGAFGEVQLVRHKSSKQVYAMKLLSKFE---MIKRSDSAFFWEERDIMAH 99
Query: 58 LKHPNLVNLLEVFRRKKKLHLVFEFC-DHTVLNELENHPHGLPWDLIKQITWQVLRGVSY 116
+V L F+ K L++V E+ ++N + N+ +P + T +V+ +
Sbjct: 100 ANSEWIVQLHYAFQDDKYLYMVMEYMPGGDLVNLMSNYD--IPEKWARFYTAEVVLALDA 157
Query: 117 CHRHACIHRDIKPENILLTANGVVKLCDFG 146
H IHRD+KP+N+LL +G +KL DFG
Sbjct: 158 IHSMGFIHRDVKPDNMLLDKSGHLKLADFG 187
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via interaction with Rho GTPases and is involved in many cellular functions including contraction, adhesion, migration, motility, proliferation, and apoptosis. The ROCK subfamily consists of two isoforms, ROCK1 and ROCK2, which may be functionally redundant in some systems, but exhibit different tissue distributions. Both isoforms are ubiquitously expressed in most tissues, but ROCK2 is more prominent in brain and skeletal muscle while ROCK1 is more pronounced in the liver, testes, and kidney. Studies in knockout mice result in different phenotypes, suggesting that the two isoforms do not compensate for each other during embryonic development. Length = 370 |
| >gnl|CDD|173650 cd05094, PTKc_TrkC, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C | Back alignment and domain information |
|---|
Score = 56.2 bits (135), Expect = 4e-09
Identities = 50/164 (30%), Positives = 77/164 (46%), Gaps = 27/164 (16%)
Query: 9 KLGEGSYGVVF--KCRN---RDTGQVVAIKKFLESEEDPLI--RKIALREIRLLKSLKHP 61
+LGEG++G VF +C N +VA+K +DP + RK RE LL +L+H
Sbjct: 12 ELGEGAFGKVFLAECYNLSPTKDKMLVAVKAL----KDPTLAARKDFQREAELLTNLQHE 67
Query: 62 NLVNLLEVFRRKKKLHLVFEFCDHTVLNE------------LENHPHGLPWDL----IKQ 105
++V V L +VFE+ H LN+ ++ P +L +
Sbjct: 68 HIVKFYGVCGDGDPLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLH 127
Query: 106 ITWQVLRGVSYCHRHACIHRDIKPENILLTANGVVKLCDFGFAR 149
I Q+ G+ Y +HRD+ N L+ AN +VK+ DFG +R
Sbjct: 128 IASQIASGMVYLASQHFVHRDLATRNCLVGANLLVKIGDFGMSR 171
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some non-neural tissues including the developing heart. NT3/TrkC signaling plays an important role in the innervation of the cardiac conducting system and the development of smooth muscle cells. Mice deficient with NT3 and TrkC have multiple heart defects. NT3/TrkC signaling is also critical for the development and maintenance of enteric neurons that are important for the control of gut peristalsis. Length = 291 |
| >gnl|CDD|173686 cd05595, STKc_PKB_beta, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta | Back alignment and domain information |
|---|
Score = 56.6 bits (136), Expect = 4e-09
Identities = 39/142 (27%), Positives = 71/142 (50%), Gaps = 3/142 (2%)
Query: 10 LGEGSYGVVFKCRNRDTGQVVAIKKFLESEEDPLIRKIA--LREIRLLKSLKHPNLVNLL 67
LG+G++G V R + TG+ A+K L E ++A + E R+L++ +HP L L
Sbjct: 3 LGKGTFGKVILVREKATGRYYAMK-ILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALK 61
Query: 68 EVFRRKKKLHLVFEFCDHTVLNELENHPHGLPWDLIKQITWQVLRGVSYCHRHACIHRDI 127
F+ +L V E+ + L + + + +++ + Y H ++RDI
Sbjct: 62 YAFQTHDRLCFVMEYANGGELFFHLSRERVFTEERARFYGAEIVSALEYLHSRDVVYRDI 121
Query: 128 KPENILLTANGVVKLCDFGFAR 149
K EN++L +G +K+ DFG +
Sbjct: 122 KLENLMLDKDGHIKITDFGLCK 143
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in PKB-beta display normal growth weights but exhibit severe insulin resistance and diabetes, accompanied by lipoatrophy and B-cell failure. Length = 323 |
| >gnl|CDD|173705 cd05614, STKc_MSK2_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2 | Back alignment and domain information |
|---|
Score = 56.1 bits (135), Expect = 4e-09
Identities = 46/160 (28%), Positives = 78/160 (48%), Gaps = 22/160 (13%)
Query: 4 YEKIGKLGEGSYGVVF---KCRNRDTGQVVAIK--------KFLESEEDPLIRKIALREI 52
+E + LG G+YG VF K DTG++ A+K + ++ E + L +
Sbjct: 2 FELLKVLGTGAYGKVFLVRKVTGHDTGKLYAMKVLQKAALVQKAKTVEHTRTERNVLEHV 61
Query: 53 RLLKSLKHPNLVNLLEVFRRKKKLHLVFEFCDHTVLNELENHPH---GLPWDLIKQITWQ 109
R + P LV L F+ + KLHL+ D+ E+ H + D ++ + +
Sbjct: 62 R-----QSPFLVTLHYAFQTEAKLHLIL---DYVSGGEMFTHLYQRDNFSEDEVRFYSGE 113
Query: 110 VLRGVSYCHRHACIHRDIKPENILLTANGVVKLCDFGFAR 149
++ + + H+ ++RDIK ENILL + G V L DFG ++
Sbjct: 114 IILALEHLHKLGIVYRDIKLENILLDSEGHVVLTDFGLSK 153
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSK2 and MSK1 play nonredundant roles in activating histone H3 kinases, which play pivotal roles in compaction of the chromatin fiber. MSK2 is the required H3 kinase in response to stress stimuli and activation of the p38 MAPK pathway. MSK2 also plays a role in the pathogenesis of psoriasis. Length = 332 |
| >gnl|CDD|178763 PLN03224, PLN03224, probable serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 56.6 bits (136), Expect = 5e-09
Identities = 25/48 (52%), Positives = 34/48 (70%)
Query: 101 DLIKQITWQVLRGVSYCHRHACIHRDIKPENILLTANGVVKLCDFGFA 148
++IK + QVL G+ HR +HRDIKPEN+L+T +G VK+ DFG A
Sbjct: 309 NVIKGVMRQVLTGLRKLHRIGIVHRDIKPENLLVTVDGQVKIIDFGAA 356
|
Length = 507 |
| >gnl|CDD|173644 cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Score = 55.7 bits (134), Expect = 5e-09
Identities = 42/156 (26%), Positives = 71/156 (45%), Gaps = 8/156 (5%)
Query: 5 EKIGKLGEGSYGVVFKCR----NRDTGQVVAIKKFLESEEDPLIRKIALREIRLLKSLKH 60
++I LGEG +G V CR +TG+ VA+K I + +EI +L++L H
Sbjct: 7 KRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLK-KEIEILRNLYH 65
Query: 61 PNLVNLLEVFRRK--KKLHLVFEFCDHTVLNE-LENHPHGLPWDLIKQITWQVLRGVSYC 117
N+V + + L+ EF L E L + + + + Q+ +G+ Y
Sbjct: 66 ENIVKYKGICTEDGGNGIKLIMEFLPSGSLKEYLPRNKNKINLKQQLKYAVQICKGMDYL 125
Query: 118 HRHACIHRDIKPENILLTANGVVKLCDFGFARLIRD 153
+HRD+ N+L+ + VK+ DFG + I
Sbjct: 126 GSRQYVHRDLAARNVLVESEHQVKIGDFGLTKAIET 161
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak1 is widely expressed in many tissues. Many cytokines are dependent on Jak1 for signaling, including those that use the shared receptor subunits common gamma chain (IL-2, IL-4, IL-7, IL-9, IL-15, IL-21) and gp130 (IL-6, IL-11, oncostatin M, G-CSF, and IFNs, among others). The many varied interactions of Jak1 and its ubiquitous expression suggest many biological roles. Jak1 is important in neurological development, as well as in lymphoid development and function. It also plays a role in the pathophysiology of cardiac hypertrophy and heart failure. A mutation in the ATP-binding site of Jak1 was identified in a human uterine leiomyosarcoma cell line, resulting in defective cytokine induction and antigen presentation, thus allowing the tumor to evade the immune system. Length = 284 |
| >gnl|CDD|88519 cd05618, STKc_aPKC_iota, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota | Back alignment and domain information |
|---|
Score = 55.8 bits (134), Expect = 5e-09
Identities = 38/144 (26%), Positives = 70/144 (48%), Gaps = 6/144 (4%)
Query: 10 LGEGSYGVVFKCRNRDTGQVVAIK----KFLESEEDPLIRKIALREIRLLKSLKHPNLVN 65
+G GSY V R + T ++ A+K + + +ED I + + ++ HP LV
Sbjct: 3 IGRGSYAKVLLVRLKKTERIYAMKVVKKELVNDDED--IDWVQTEKHVFEQASNHPFLVG 60
Query: 66 LLEVFRRKKKLHLVFEFCDHTVLNELENHPHGLPWDLIKQITWQVLRGVSYCHRHACIHR 125
L F+ + +L V E+ + L LP + + + ++ ++Y H I+R
Sbjct: 61 LHSCFQTESRLFFVIEYVNGGDLMFHMQRQRKLPEEHARFYSAEISLALNYLHERGIIYR 120
Query: 126 DIKPENILLTANGVVKLCDFGFAR 149
D+K +N+LL + G +KL D+G +
Sbjct: 121 DLKLDNVLLDSEGHIKLTDYGMCK 144
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target of tumor-specific gene amplification in many human cancers, and has been identified as a human oncogene. In addition to its role in transformed growth, PKC-iota also promotes invasion, chemoresistance, and tumor cell survival. Expression profiling of PKC-iota is a prognostic marker of poor clinical outcome in several human cancers. PKC-iota also plays a role in establishing cell polarity, and has critical embryonic functions. Length = 329 |
| >gnl|CDD|173693 cd05602, STKc_SGK1, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1 | Back alignment and domain information |
|---|
Score = 55.8 bits (134), Expect = 5e-09
Identities = 42/145 (28%), Positives = 72/145 (49%), Gaps = 8/145 (5%)
Query: 10 LGEGSYGVVFKCRNRDTGQVVAIK-----KFLESEEDPLIRKIALREIRLLKSLKHPNLV 64
+G+GS+G V R++ + A+K L+ +E+ I ++ R + LLK++KHP LV
Sbjct: 3 IGKGSFGKVLLARHKAEEKFYAVKVLQKKAILKKKEEKHI--MSERNV-LLKNVKHPFLV 59
Query: 65 NLLEVFRRKKKLHLVFEFCDHTVLNELENHPHGLPWDLIKQITWQVLRGVSYCHRHACIH 124
L F+ KL+ V ++ + L + ++ + Y H ++
Sbjct: 60 GLHFSFQTADKLYFVLDYINGGELFYHLQRERCFLEPRARFYAAEIASALGYLHSLNIVY 119
Query: 125 RDIKPENILLTANGVVKLCDFGFAR 149
RD+KPENILL + G + L DFG +
Sbjct: 120 RDLKPENILLDSQGHIVLTDFGLCK 144
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt sensitivity, memory consolidation, and cardiac repolarization. A common SGK1 variant is associated with increased blood pressure and body weight. SGK1 may also contribute to tumor growth, neurodegeneration, fibrosing disease, and ischemia. Length = 325 |
| >gnl|CDD|173720 cd05631, STKc_GRK4, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4 | Back alignment and domain information |
|---|
Score = 55.4 bits (133), Expect = 6e-09
Identities = 47/151 (31%), Positives = 78/151 (51%), Gaps = 21/151 (13%)
Query: 10 LGEGSYGVVFKCRNRDTGQVVAIKKFLESEEDPLIRK-----IALREIRLLKSLKHPNLV 64
LG+G +G V C+ R TG++ A KK E I+K +AL E R+L+ + +V
Sbjct: 8 LGKGGFGEVCACQVRATGKMYACKKL----EKKRIKKRKGEAMALNEKRILEKVNSRFVV 63
Query: 65 NLLEVFRRKKKLHLVFEFCDHTVLN--ELENHPHGLP---WDLIKQITW--QVLRGVSYC 117
+L + K L LV T++N +L+ H + + +D + I + ++ G+
Sbjct: 64 SLAYAYETKDALCLVL-----TIMNGGDLKFHIYNMGNPGFDEQRAIFYAAELCCGLEDL 118
Query: 118 HRHACIHRDIKPENILLTANGVVKLCDFGFA 148
R ++RD+KPENILL G +++ D G A
Sbjct: 119 QRERIVYRDLKPENILLDDRGHIRISDLGLA 149
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found in the testis, but is also present in the cerebellum and kidney. It is expressed as multiple splice variants with different domain architectures. It is post-translationally palmitoylated and localized in the membrane. GRK4 polymorphisms are associated with hypertension and salt sensitivity, as they cause hyperphosphorylation, desensitization, and internalization of the dopamine 1 (D1) receptor while increasing the expression of the angiotensin II type 1 receptor. GRK4 plays a crucial role in the D1 receptor regulation of sodium excretion and blood pressure. Length = 285 |
| >gnl|CDD|173639 cd05066, PTKc_EphR_A, Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors | Back alignment and domain information |
|---|
Score = 55.3 bits (133), Expect = 6e-09
Identities = 45/158 (28%), Positives = 81/158 (51%), Gaps = 13/158 (8%)
Query: 3 RYEKIGKLGEGSYGVVFKCRNRDTGQ---VVAIKKFLESEEDPLIRKIALREIRLLKSLK 59
+ EK+ +G G +G V R + G+ VAIK L++ R+ L E ++
Sbjct: 7 KIEKV--IGAGEFGEVCSGRLKLPGKREIPVAIKT-LKAGYTEKQRRDFLSEASIMGQFD 63
Query: 60 HPNLVNLLEVFRRKKKLHLVFEFCDHTVLNELENHPHGLPWDLIKQITWQVLRGVS---- 115
HPN+++L V + K + +V E+ ++ L+ H + +I+ + +LRG++
Sbjct: 64 HPNIIHLEGVVTKSKPVMIVTEYMENGSLDAFLRK-HDGQFTVIQLVG--MLRGIASGMK 120
Query: 116 YCHRHACIHRDIKPENILLTANGVVKLCDFGFARLIRD 153
Y +HRD+ NIL+ +N V K+ DFG +R++ D
Sbjct: 121 YLSDMGYVHRDLAARNILVNSNLVCKVSDFGLSRVLED 158
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. EphARs and ephrin-A ligands are expressed in multiple areas of the developing brain, especially in the retina and tectum. They are part of a system controlling retinotectal mapping. Length = 267 |
| >gnl|CDD|133237 cd05106, PTKc_CSF-1R, Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor | Back alignment and domain information |
|---|
Score = 56.0 bits (135), Expect = 6e-09
Identities = 23/52 (44%), Positives = 32/52 (61%), Gaps = 1/52 (1%)
Query: 100 WDLIKQITWQVLRGVSYCHRHACIHRDIKPENILLTANGVVKLCDFGFARLI 151
DL+ + + QV +G+ + CIHRD+ N+LLT V K+CDFG AR I
Sbjct: 212 DDLL-RFSSQVAQGMDFLASKNCIHRDVAARNVLLTDGRVAKICDFGLARDI 262
|
Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. It leads to increases in gene transcription and protein translation, and induces cytoskeletal remodeling. CSF-1R signaling leads to a variety of cellular responses including survival, proliferation, and differentiation of target cells. It plays an important role in innate immunity, tissue development and function, and the pathogenesis of some diseases including atherosclerosis and cancer. CSF-1R signaling is also implicated in mammary gland development during pregnancy and lactation. Aberrant CSF-1/CSF-1R expression correlates with tumor cell invasiveness, poor clinical prognosis, and bone metastasis in breast cancer. Although the structure of the human CSF-1R catalytic domain is known, it is excluded from this specific alignment model because it contains a deletion in its sequence. Length = 374 |
| >gnl|CDD|173719 cd05630, STKc_GRK6, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6 | Back alignment and domain information |
|---|
Score = 55.4 bits (133), Expect = 7e-09
Identities = 45/151 (29%), Positives = 75/151 (49%), Gaps = 21/151 (13%)
Query: 10 LGEGSYGVVFKCRNRDTGQVVAIKKFLESEEDPLIRK-----IALREIRLLKSLKHPNLV 64
LG+G +G V C+ R TG++ A KK E I+K +AL E ++L+ + +V
Sbjct: 8 LGKGGFGEVCACQVRATGKMYACKKL----EKKRIKKRKGESMALNEKQILEKVNSRFVV 63
Query: 65 NLLEVFRRKKKLHLVFEFCDHTVLN--ELENHPH-----GLPWDLIKQITWQVLRGVSYC 117
+L + K L LV T++N +L+ H + G ++ G+
Sbjct: 64 SLAYAYETKDALCLVL-----TLMNGGDLKFHIYHMGEAGFEEGRAVFYAAEICCGLEDL 118
Query: 118 HRHACIHRDIKPENILLTANGVVKLCDFGFA 148
H+ ++RD+KPENILL +G +++ D G A
Sbjct: 119 HQERIVYRDLKPENILLDDHGHIRISDLGLA 149
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as multiple splice variants with different domain architectures. It is post-translationally palmitoylated and localized in the membrane. GRK6 plays important roles in the regulation of dopamine, M3 muscarinic, opioid, and chemokine receptor signaling. It also plays maladaptive roles in addiction and Parkinson's disease. GRK6-deficient mice exhibit altered dopamine receptor regulation, decreased lymphocyte chemotaxis, and increased acute inflammation and neutrophil chemotaxis. Length = 285 |
| >gnl|CDD|133234 cd05103, PTKc_VEGFR2, Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Score = 55.4 bits (133), Expect = 7e-09
Identities = 23/45 (51%), Positives = 31/45 (68%)
Query: 107 TWQVLRGVSYCHRHACIHRDIKPENILLTANGVVKLCDFGFARLI 151
++QV +G+ + CIHRD+ NILL+ N VVK+CDFG AR I
Sbjct: 185 SFQVAKGMEFLASRKCIHRDLAARNILLSENNVVKICDFGLARDI 229
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosphorylation and activation. VEGFR2 binds the ligands VEGFA, VEGFC, VEGFD and VEGFE. VEGFR2 signaling is implicated in all aspects of normal and pathological vascular endothelial cell biology. It induces a variety of cellular effects including migration, survival, and proliferation. It is critical in regulating embryonic vascular development and angiogenesis. VEGFR2 is the major signal transducer in pathological angiogenesis including cancer and diabetic retinopathy, and is a target for inhibition in cancer therapy. Length = 343 |
| >gnl|CDD|173651 cd05095, PTKc_DDR2, Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 2 | Back alignment and domain information |
|---|
Score = 55.3 bits (133), Expect = 7e-09
Identities = 44/173 (25%), Positives = 74/173 (42%), Gaps = 38/173 (21%)
Query: 9 KLGEGSYGVVFKCRNRDTGQVVAIKKFLE-------SEEDPLI--------------RKI 47
KLGEG +G V C + ++KF++ S P++ R
Sbjct: 12 KLGEGQFGEVHLC------EAEGMEKFMDKDFSLDVSGNQPVLVAVKMLREDANKNARND 65
Query: 48 ALREIRLLKSLKHPNLVNLLEVFRRKKKLHLVFEFCDHTVLNE-LENH-PHGLPWDL--- 102
L+EI+++ LK PN++ LL V L ++ E+ ++ LN+ L H P
Sbjct: 66 FLKEIKIMSRLKDPNIIRLLAVCITSDPLCMITEYMENGDLNQFLSRHEPQEAAEKADVV 125
Query: 103 ------IKQITWQVLRGVSYCHRHACIHRDIKPENILLTANGVVKLCDFGFAR 149
+ + Q+ G+ Y +HRD+ N L+ N +K+ DFG +R
Sbjct: 126 TISYSTLIFMATQIASGMKYLSSLNFVHRDLATRNCLVGKNYTIKIADFGMSR 178
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 2 (DDR2) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR2 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR2 binds mostly to fibrillar collagens. More recently, it has been reported to also bind collagen X. DDR2 is widely expressed in many tissues with the highest levels found in skeletal muscle, skin, kidney and lung. It is important in cell proliferation and development. Mice, with a deletion of DDR2, suffer from dwarfism and delayed healing of epidermal wounds. DDR2 also contributes to collagen (type I) regulation by inhibiting fibrillogenesis and altering the morphology of collagen fibers. It is also expressed in immature dendritic cells (DCs), where it plays a role in DC activation and function. Length = 296 |
| >gnl|CDD|133178 cd05046, PTK_CCK4, Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4 | Back alignment and domain information |
|---|
Score = 55.2 bits (133), Expect = 8e-09
Identities = 35/161 (21%), Positives = 69/161 (42%), Gaps = 18/161 (11%)
Query: 7 IGKLGEGSYGVVFKCRNR-----DTGQVVAIKKFLESEEDPLIRKIALREIRLLKSLKHP 61
I LG G +G VF + + +V +K +++++ L + RE+ + + L H
Sbjct: 10 ITTLGRGEFGEVFLAKAKGIEEEGGETLVLVKALQKTKDENLQSEFR-RELDMFRKLSHK 68
Query: 62 NLVNLLEVFRRKKKLHLVFEFCDHTVLNEL---------ENHPHGLPWDLIKQITWQVLR 112
N+V LL + R + +++ E+ D L + + P L + Q+
Sbjct: 69 NVVRLLGLCREAEPHYMILEYTDLGDLKQFLRATKSKDEKLKPPPLSTKQKVALCTQIAL 128
Query: 113 GVSYCHRHACIHRDIKPENILLTANGVVKLCDFGFARLIRD 153
G+ + +HRD+ N L+++ VK+ L +D
Sbjct: 129 GMDHLSNARFVHRDLAARNCLVSSQREVKV---SLLSLSKD 166
|
Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is still unknown. Other pseudokinases such as HER3 rely on the activity of partner RTKs. Length = 275 |
| >gnl|CDD|133235 cd05104, PTKc_Kit, Catalytic domain of the Protein Tyrosine Kinase, Kit | Back alignment and domain information |
|---|
Score = 55.7 bits (134), Expect = 8e-09
Identities = 25/53 (47%), Positives = 35/53 (66%), Gaps = 1/53 (1%)
Query: 101 DLIKQITWQVLRGVSYCHRHACIHRDIKPENILLTANGVVKLCDFGFARLIRD 153
DL+ ++QV +G+S+ CIHRD+ NILLT + K+CDFG AR IR+
Sbjct: 215 DLL-SFSYQVAKGMSFLASKNCIHRDLAARNILLTHGRITKICDFGLARDIRN 266
|
Protein Tyrosine Kinase (PTK) family; Kit (or c-Kit); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Kit is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of Kit to its ligand, the stem-cell factor (SCF), leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem cells, the interstitial cells of Cajal, and the pacemaker cells of the GI tract. Kit signaling is involved in major cellular functions including cell survival, proliferation, differentiation, adhesion, and chemotaxis. Mutations in Kit, which result in constitutive ligand-independent activation, are found in human cancers such as gastrointestinal stromal tumor (GIST) and testicular germ cell tumor (TGCT). The aberrant expression of Kit and/or SCF is associated with other tumor types such as systemic mastocytosis and cancers of the breast, neurons, lung, prostate, colon, and rectum. Although the structure of the human Kit catalytic domain is known, it is excluded from this specific alignment model because it contains a deletion in its sequence. Length = 375 |
| >gnl|CDD|173638 cd05065, PTKc_EphR_B, Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors | Back alignment and domain information |
|---|
Score = 54.9 bits (132), Expect = 1e-08
Identities = 43/151 (28%), Positives = 76/151 (50%), Gaps = 11/151 (7%)
Query: 10 LGEGSYGVVFKCRNRDTG---QVVAIKKFLESEEDPLIRKIALREIRLLKSLKHPNLVNL 66
+G G +G V + R + G VAIK L+S R+ L E ++ HPN+++L
Sbjct: 12 IGAGEFGEVCRGRLKLPGKREIFVAIKT-LKSGYTEKQRRDFLSEASIMGQFDHPNIIHL 70
Query: 67 LEVFRRKKKLHLVFEFCDHTVLNELENHPHGLPWDLIKQITWQVLRGVS----YCHRHAC 122
V + + + ++ EF ++ L+ G + +I+ + +LRG++ Y
Sbjct: 71 EGVVTKSRPVMIITEFMENGALDSFLRQNDG-QFTVIQLVG--MLRGIAAGMKYLSEMNY 127
Query: 123 IHRDIKPENILLTANGVVKLCDFGFARLIRD 153
+HRD+ NIL+ +N V K+ DFG +R + D
Sbjct: 128 VHRDLAARNILVNSNLVCKVSDFGLSRFLED 158
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion. EphBRs play important roles in synapse formation and plasticity, spine morphogenesis, axon guidance, and angiogenesis. In the intestinal epithelium, EphBRs are Wnt signaling target genes that control cell compartmentalization. They function as suppressors of color cancer progression. Length = 269 |
| >gnl|CDD|173713 cd05624, STKc_MRCK_beta, Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase beta | Back alignment and domain information |
|---|
Score = 55.0 bits (132), Expect = 1e-08
Identities = 40/147 (27%), Positives = 72/147 (48%), Gaps = 2/147 (1%)
Query: 2 ERYEKIGKLGEGSYGVVFKCRNRDTGQVVAIKKFLESEEDPLIRKIALREIR-LLKSLKH 60
+ +E I +G G++G V + + T ++ A+K + E RE R +L +
Sbjct: 1 DDFEIIKVIGRGAFGEVAVVKMKHTERIYAMKILNKWEMLKRAETACFREERNVLVNGDC 60
Query: 61 PNLVNLLEVFRRKKKLHLVFEF-CDHTVLNELENHPHGLPWDLIKQITWQVLRGVSYCHR 119
+ L F+ + L+LV ++ +L L LP D+ + +++ + H+
Sbjct: 61 QWITTLHYAFQDENYLYLVMDYYVGGDLLTLLSKFEDRLPEDMARFYIAEMVLAIHSIHQ 120
Query: 120 HACIHRDIKPENILLTANGVVKLCDFG 146
+HRDIKP+N+LL NG ++L DFG
Sbjct: 121 LHYVHRDIKPDNVLLDMNGHIRLADFG 147
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) beta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKbeta is expressed ubiquitously in many tissues. Length = 331 |
| >gnl|CDD|133174 cd05042, PTKc_Aatyk, Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases | Back alignment and domain information |
|---|
Score = 53.7 bits (129), Expect = 2e-08
Identities = 37/146 (25%), Positives = 66/146 (45%), Gaps = 6/146 (4%)
Query: 9 KLGEGSYGVVFKCR-NRDTGQVVAIKKFLESEEDPLIRKIALREIRLLKSLKHPNLVNLL 67
++G G +G V +R + + K L + P + + L+E++ + L HPN++ L
Sbjct: 2 EIGNGWFGKVLLGEAHRGMSKARVVVKELRASATPDEQLLFLQEVQPYRELNHPNVLQCL 61
Query: 68 EVFRRKKKLHLVFEFCDH----TVLNELENHPHGLPW-DLIKQITWQVLRGVSYCHRHAC 122
LV EFC L + D+++++ +V G+ + H+
Sbjct: 62 GQCIESIPYLLVLEFCPLGDLKNYLRSNRGMVAQMAQKDVLQRMACEVASGLLWLHQADF 121
Query: 123 IHRDIKPENILLTANGVVKLCDFGFA 148
IH D+ N LTA+ VK+ D+G A
Sbjct: 122 IHSDLALRNCQLTADLSVKIGDYGLA 147
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase (Aatyk) subfamily; catalytic (c) domain. The Aatyk subfamily is also referred to as the lemur tyrosine kinase (Lmtk) subfamily. It consists of Aatyk1 (Lmtk1), Aatyk2 (Lmtk2, Brek), Aatyk3 (Lmtk3), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk proteins are mostly receptor tyr kinases (RTKs) containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 does not contain a transmembrane segment and is a cytoplasmic (or nonreceptor) kinase. Aatyk proteins are classified as tyr kinases based on overall sequence similarity and the phylogenetic tree. However, analysis of catalytic residues suggests that Aatyk proteins may be multispecific kinases, functioning also as serine/threonine kinases. They are involved in neural differentiation, nerve growth factor (NGF) signaling, apoptosis, and spermatogenesis. Length = 269 |
| >gnl|CDD|88524 cd05623, STKc_MRCK_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase alpha | Back alignment and domain information |
|---|
Score = 53.9 bits (129), Expect = 2e-08
Identities = 40/147 (27%), Positives = 73/147 (49%), Gaps = 2/147 (1%)
Query: 2 ERYEKIGKLGEGSYGVVFKCRNRDTGQVVAIKKFLESEEDPLIRKIALREIR-LLKSLKH 60
E +E + +G G++G V + ++ +V A+K + E RE R +L + +
Sbjct: 1 EDFEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDN 60
Query: 61 PNLVNLLEVFRRKKKLHLVFEF-CDHTVLNELENHPHGLPWDLIKQITWQVLRGVSYCHR 119
+ L F+ + L+LV ++ +L L LP D+ + +++ + H+
Sbjct: 61 QWITTLHYAFQDENNLYLVMDYYVGGDLLTLLSKFEDRLPEDMARFYLAEMVIAIDSVHQ 120
Query: 120 HACIHRDIKPENILLTANGVVKLCDFG 146
+HRDIKP+NIL+ NG ++L DFG
Sbjct: 121 LHYVHRDIKPDNILMDMNGHIRLADFG 147
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKalpha is expressed ubiquitously in many tissues. It plays a role in the regulation of peripheral actin reorganization and neurite outgrowth. It may also play a role in the transferrin iron uptake pathway. Length = 332 |
| >gnl|CDD|173709 cd05619, STKc_nPKC_theta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta | Back alignment and domain information |
|---|
Score = 53.8 bits (129), Expect = 2e-08
Identities = 43/147 (29%), Positives = 76/147 (51%), Gaps = 12/147 (8%)
Query: 10 LGEGSYGVVFKCRNRDTGQVVAIKKFLESEEDPLIR----KIALREIRLLK-SLKHPNLV 64
LG+GS+G VF + T Q AIK ++D ++ + + E R+L + +HP L
Sbjct: 3 LGKGSFGKVFLAELKGTNQFFAIKAL---KKDVVLMDDDVECTMVEKRVLSLAWEHPFLT 59
Query: 65 NLLEVFRRKKKLHLVFEFCDHTVLNELENHPHGLPWDLIKQITW--QVLRGVSYCHRHAC 122
+L F+ K+ L V E+ + L H +DL + + +++ G+ + H
Sbjct: 60 HLYCTFQTKENLFFVMEYLNGGDLMFHIQSCH--KFDLPRATFYAAEIICGLQFLHSKGI 117
Query: 123 IHRDIKPENILLTANGVVKLCDFGFAR 149
++RD+K +NILL +G +K+ DFG +
Sbjct: 118 VYRDLKLDNILLDTDGHIKIADFGMCK 144
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. Although T-cells also express other PKC isoforms, PKC-theta is unique in that upon antigen stimulation, it is translocated to the plasma membrane at the immunological synapse, where it mediates signals essential for T-cell activation. It is essential for TCR-induced proliferation, cytokine production, T-cell survival, and the differentiation and effector function of T-helper (Th) cells, particularly Th2 and Th17. PKC-theta is being developed as a therapeutic target for Th2-mediated allergic inflammation and Th17-mediated autoimmune diseases. Length = 316 |
| >gnl|CDD|173715 cd05626, STKc_LATS2, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 2 | Back alignment and domain information |
|---|
Score = 53.9 bits (129), Expect = 3e-08
Identities = 45/151 (29%), Positives = 70/151 (46%), Gaps = 13/151 (8%)
Query: 4 YEKIGKLGEGSYGVVFKCRNRDTGQVVAIKKFLESEEDPLIRKIALR---EIRLLKSLKH 60
+ KI LG G++G V DT + A+K ++D L R E +L +
Sbjct: 3 FVKIKTLGIGAFGEVCLACKVDTHALYAMKTL--RKKDVLNRNQVAHVKAERDILAEADN 60
Query: 61 PNLVNLLEVFRRKKKLHLVFEFCD----HTVLNELENHPHGLPWDLIKQITWQVLRGVSY 116
+V L F+ K L+ V ++ ++L +E P L I ++T +
Sbjct: 61 EWVVKLYYSFQDKDNLYFVMDYIPGGDMMSLLIRMEVFPEVLARFYIAELTL----AIES 116
Query: 117 CHRHACIHRDIKPENILLTANGVVKLCDFGF 147
H+ IHRDIKP+NIL+ +G +KL DFG
Sbjct: 117 VHKMGFIHRDIKPDNILIDLDGHIKLTDFGL 147
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. LATS2 is an essential mitotic regulator responsible for coordinating accurate cytokinesis completion and governing the stabilization of other mitotic regulators. It is also critical in the maintenance of proper chromosome number, genomic stability, mitotic fidelity, and the integrity of centrosome duplication. Downregulation of LATS2 is associated with poor prognosis in acute lymphoblastic leukemia and breast cancer. Length = 381 |
| >gnl|CDD|165478 PHA03212, PHA03212, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 53.8 bits (129), Expect = 3e-08
Identities = 41/136 (30%), Positives = 57/136 (41%), Gaps = 9/136 (6%)
Query: 13 GSYGVVFKCRNRDTGQVVAIKKFLESEEDPLIRKIALREIRLLKSLKHPNLVNLLEVFRR 72
G+ G F C + T + V IK R E +L+++ HP+++ L F
Sbjct: 103 GAEGFAFACIDNKTCEHVVIKAGQ--------RGGTATEAHILRAINHPSIIQLKGTFTY 154
Query: 73 KKKLHLVFEFCDHTVLNELENHPHGLPWDLIKQITWQVLRGVSYCHRHACIHRDIKPENI 132
K L+ + L + I I VLR + Y H + IHRDIK ENI
Sbjct: 155 NKFTCLILPRYKTDLYCYLAAK-RNIAICDILAIERSVLRAIQYLHENRIIHRDIKAENI 213
Query: 133 LLTANGVVKLCDFGFA 148
+ G V L DFG A
Sbjct: 214 FINHPGDVCLGDFGAA 229
|
Length = 391 |
| >gnl|CDD|173697 cd05606, STKc_beta_ARK, Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase | Back alignment and domain information |
|---|
Score = 53.0 bits (127), Expect = 3e-08
Identities = 41/156 (26%), Positives = 70/156 (44%), Gaps = 30/156 (19%)
Query: 10 LGEGSYGVVFKCRNRDTGQVVAIK-------KFLESEEDPLIRKIALREIRLLKSLKHPN 62
+G G +G V+ CR DTG++ A+K K + E L +I L L+ + P
Sbjct: 2 IGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLS---LVSTGDCPF 58
Query: 63 LVNLLEVFRRKKKLHLVFEFCD----------HTVLNELENHPHGLPWDLIKQITWQVLR 112
+V + F KL + + + H V +E E ++ +++
Sbjct: 59 IVCMSYAFHTPDKLSFILDLMNGGDLHYHLSQHGVFSEAE----------MRFYAAEIIL 108
Query: 113 GVSYCHRHACIHRDIKPENILLTANGVVKLCDFGFA 148
G+ + H ++RD+KP NILL +G V++ D G A
Sbjct: 109 GLEHMHNRFVVYRDLKPANILLDEHGHVRISDLGLA 144
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is composed of GRK2, GRK3, and similar proteins. GRK2 and GRK3 are both widely expressed in many tissues, although GRK2 is present at higher levels. They contain an N-terminal RGS homology (RH) domain, a central catalytic domain, and C-terminal pleckstrin homology (PH) domain that mediates PIP2 and G protein betagamma-subunit translocation to the membrane. GRK2 (also called beta-ARK or beta-ARK1) is important in regulating several cardiac receptor responses. It plays a role in cardiac development and in hypertension. Deletion of GRK2 in mice results in embryonic lethality, caused by hypoplasia of the ventricular myocardium. GRK2 also plays important roles in the liver (as a regulator of portal blood pressure), in immune cells, and in the nervous system. Altered GRK2 expression has been reported in several disorders including major depression, schizophrenia, bipolar disorder, and Parkinsonism. Length = 278 |
| >gnl|CDD|133221 cd05090, PTKc_Ror1, Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 1 | Back alignment and domain information |
|---|
Score = 52.7 bits (126), Expect = 4e-08
Identities = 46/164 (28%), Positives = 75/164 (45%), Gaps = 22/164 (13%)
Query: 9 KLGEGSYGVVFKCR----NRDTGQVVAIKKFLESEEDPLIRKIALREIRLLKSLKHPNLV 64
+LGE ++G ++K D Q+VAIK L+ +P +E L+ L HPN+V
Sbjct: 12 ELGECAFGKIYKGHLYLPGMDHAQLVAIKT-LKDINNPQQWGEFQQEASLMAELHHPNIV 70
Query: 65 NLLEVFRRKKKLHLVFEFCDHTVLNE--LENHPHG---------------LPWDLIKQIT 107
LL V +++ + ++FE+ + L+E + PH L I
Sbjct: 71 CLLGVVTQEQPVCMLFEYLNQGDLHEFLIMRSPHSDVGCSSDEDGTVKSSLDHGDFLHIA 130
Query: 108 WQVLRGVSYCHRHACIHRDIKPENILLTANGVVKLCDFGFARLI 151
Q+ G+ Y H +H+D+ NIL+ VK+ D G +R I
Sbjct: 131 IQIAAGMEYLSSHFFVHKDLAARNILIGEQLHVKISDLGLSREI 174
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 1 (Ror1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror kinases are expressed in many tissues during development. Avian Ror1 was found to be involved in late limb development. Studies in mice reveal that Ror1 is important in the regulation of neurite growth in central neurons, as well as in respiratory development. Loss of Ror1 also enhances the heart and skeletal abnormalities found in Ror2-deficient mice. Length = 283 |
| >gnl|CDD|173653 cd05105, PTKc_PDGFR_alpha, Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor alpha | Back alignment and domain information |
|---|
Score = 52.7 bits (126), Expect = 8e-08
Identities = 23/60 (38%), Positives = 34/60 (56%)
Query: 92 ENHPHGLPWDLIKQITWQVLRGVSYCHRHACIHRDIKPENILLTANGVVKLCDFGFARLI 151
++ GL + T+QV RG+ + C+HRD+ N+LL +VK+CDFG AR I
Sbjct: 228 DDGSEGLTTLDLLSFTYQVARGMEFLASKNCVHRDLAARNVLLAQGKIVKICDFGLARDI 287
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) alpha; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR alpha is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR alpha forms homodimers or heterodimers with PDGFR beta, depending on the nature of the PDGF ligand. PDGF-AA, PDGF-AB, and PDGF-CC induce PDGFR alpha homodimerization. PDGFR signaling plays many roles in normal embryonic development and adult physiology. PDGFR alpha signaling is important in the formation of lung alveoli, intestinal villi, mesenchymal dermis, and hair follicles, as well as in the development of oligodendrocytes, retinal astrocytes, neural crest cells, and testicular cells. Aberrant PDGFR alpha expression is associated with some human cancers. Mutations in PDGFR alpha have been found within a subset of gastrointestinal stromal tumors (GISTs). An active fusion protein FIP1L1-PDGFR alpha, derived from interstitial deletion, is associated with idiopathic hypereosinophilic syndrome (HES) and chronic eosinophilic leukemia (CEL). Length = 400 |
| >gnl|CDD|173708 cd05617, STKc_aPKC_zeta, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta | Back alignment and domain information |
|---|
Score = 52.3 bits (125), Expect = 8e-08
Identities = 38/144 (26%), Positives = 69/144 (47%), Gaps = 6/144 (4%)
Query: 10 LGEGSYGVVFKCRNRDTGQVVAIK----KFLESEEDPLIRKIALREIRLLKSLKHPNLVN 65
+G GSY V R + Q+ A+K + + +ED I + + ++ +P LV
Sbjct: 3 IGRGSYAKVLLVRLKKNDQIYAMKVVKKELVHDDED--IDWVQTEKHVFEQASSNPFLVG 60
Query: 66 LLEVFRRKKKLHLVFEFCDHTVLNELENHPHGLPWDLIKQITWQVLRGVSYCHRHACIHR 125
L F+ +L LV E+ + L LP + + ++ +++ H I+R
Sbjct: 61 LHSCFQTTSRLFLVIEYVNGGDLMFHMQRQRKLPEEHARFYAAEICIALNFLHERGIIYR 120
Query: 126 DIKPENILLTANGVVKLCDFGFAR 149
D+K +N+LL A+G +KL D+G +
Sbjct: 121 DLKLDNVLLDADGHIKLTDYGMCK 144
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways. PKC-zeta also plays a central role in maintaining cell polarity in yeast and mammalian cells. In addition, it affects actin remodeling in muscle cells. Length = 327 |
| >gnl|CDD|173683 cd05592, STKc_nPKC_theta_delta, Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta | Back alignment and domain information |
|---|
Score = 52.1 bits (125), Expect = 9e-08
Identities = 43/149 (28%), Positives = 75/149 (50%), Gaps = 14/149 (9%)
Query: 10 LGEGSYGVVFKCRNRDTGQVVAIK---KFLESEEDPLIRKIALREIRLLKSLKHPNLVNL 66
LG+GS+G V + T + AIK K + E+D + + R + L +HP L +L
Sbjct: 3 LGKGSFGKVMLAELKGTNEFFAIKALKKDVVLEDDDVECTMVERRVLALAW-EHPFLTHL 61
Query: 67 LEVFRRKKKLHLVFEFCDHTVLN--ELENH-PHGLPWDLIKQITW--QVLRGVSYCHRHA 121
F+ K+ L V E+ LN +L H +D + + +++ G+ + H+
Sbjct: 62 FCTFQTKEHLFFVMEY-----LNGGDLMFHIQSSGRFDEARARFYAAEIICGLQFLHKKG 116
Query: 122 CIHRDIKPENILLTANGVVKLCDFGFARL 150
I+RD+K +N+LL +G +K+ DFG +
Sbjct: 117 IIYRDLKLDNVLLDKDGHIKIADFGMCKE 145
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. Length = 316 |
| >gnl|CDD|133168 cd05036, PTKc_ALK_LTK, Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase | Back alignment and domain information |
|---|
Score = 51.7 bits (124), Expect = 1e-07
Identities = 46/157 (29%), Positives = 60/157 (38%), Gaps = 17/157 (10%)
Query: 8 GKLGEGSYGVVFKCRNRDTGQVVAIK--KFLESEEDPLIRKIALREIRLLKSLKHPNLVN 65
G GE G+ VA+K SE+D L E ++ H N+V
Sbjct: 17 GAFGEVYEGLYRGRDGDAVELQVAVKTLPESCSEQDESD---FLMEALIMSKFNHQNIVR 73
Query: 66 LLEVFRRKKKLHLVFEFCDHTVLNEL--ENHPH-GLPW-----DLIKQITWQVLRGVSYC 117
L+ V + ++ E L EN P P DL+ V +G Y
Sbjct: 74 LIGVSFERLPRFILLELMAGGDLKSFLRENRPRPERPSSLTMKDLLF-CARDVAKGCKYL 132
Query: 118 HRHACIHRDIKPENILLTANG---VVKLCDFGFARLI 151
+ IHRDI N LLT G V K+ DFG AR I
Sbjct: 133 EENHFIHRDIAARNCLLTCKGPGRVAKIADFGMARDI 169
|
Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well as visceral muscle differentiation in Drosophila. ALK is aberrantly expressed as fusion proteins, due to chromosomal translocations, in about 60% of anaplastic large cell lymphomas (ALCLs). ALK fusion proteins are also found in rare cases of diffuse large B cell lymphomas (DLBCLs). LTK is mainly expressed in B lymphocytes and neuronal tissues. It is important in cell proliferation and survival. Transgenic mice expressing TLK display retarded growth and high mortality rate. In addition, a polymorphism in mouse and human LTK is implicated in the pathogenesis of systemic lupus erythematosus. Length = 277 |
| >gnl|CDD|173722 cd05633, STKc_GRK3, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3 | Back alignment and domain information |
|---|
Score = 51.5 bits (123), Expect = 1e-07
Identities = 41/156 (26%), Positives = 70/156 (44%), Gaps = 30/156 (19%)
Query: 10 LGEGSYGVVFKCRNRDTGQVVAIK-------KFLESEEDPLIRKIALREIRLLKSLKHPN 62
+G G +G V+ CR DTG++ A+K K + E L +I L L+ + P
Sbjct: 2 IGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLS---LVSTGDCPF 58
Query: 63 LVNLLEVFRRKKKLHLVFEFCD----------HTVLNELENHPHGLPWDLIKQITWQVLR 112
+V + F KL + + + H V +E E ++ +++
Sbjct: 59 IVCMTYAFHTPDKLCFILDLMNGGDLHYHLSQHGVFSEKE----------MRFYATEIIL 108
Query: 113 GVSYCHRHACIHRDIKPENILLTANGVVKLCDFGFA 148
G+ + H ++RD+KP NILL +G V++ D G A
Sbjct: 109 GLEHMHNRFVVYRDLKPANILLDEHGHVRISDLGLA 144
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is widely expressed in many tissues. GRK3-deficient mice show a lack of olfactory receptor desensitization and altered regulation of the M2 muscarinic airway. GRK3 is involved in modulating the cholinergic response of airway smooth muscles. It also plays a role in dopamine receptor regulation. GRK3 promoter polymorphisms may be associated with bipolar disorder. Length = 279 |
| >gnl|CDD|133220 cd05089, PTKc_Tie1, Catalytic domain of the Protein Tyrosine Kinase, Tie1 | Back alignment and domain information |
|---|
Score = 51.5 bits (123), Expect = 1e-07
Identities = 46/161 (28%), Positives = 69/161 (42%), Gaps = 24/161 (14%)
Query: 10 LGEGSYGVVFKCRNRDTGQVV--AIKKFLESEEDPLIRKIALREIRLLKSLKHPNLVNLL 67
+GEG++G V + + G + AIK E + R A L K HPN++NLL
Sbjct: 10 IGEGNFGQVIRAMIKKDGLKMNAAIKMLKEFASENDHRDFAGELEVLCKLGHHPNIINLL 69
Query: 68 EVFRRKKKLHLVFEFCDHTVLNE-------LENHP-----HGLPWDLIKQITWQVLR--- 112
+ L++ E+ + L + LE P HG L Q Q+L+
Sbjct: 70 GACENRGYLYIAIEYAPYGNLLDFLRKSRVLETDPAFAKEHGTASTLTSQ---QLLQFAS 126
Query: 113 ----GVSYCHRHACIHRDIKPENILLTANGVVKLCDFGFAR 149
G+ Y IHRD+ N+L+ N K+ DFG +R
Sbjct: 127 DVATGMQYLSEKQFIHRDLAARNVLVGENLASKIADFGLSR 167
|
Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations. In vivo studies of Tie1 show that it is critical in vascular development. Length = 297 |
| >gnl|CDD|133192 cd05061, PTKc_InsR, Catalytic domain of the Protein Tyrosine Kinase, Insulin Receptor | Back alignment and domain information |
|---|
Score = 51.5 bits (123), Expect = 1e-07
Identities = 52/185 (28%), Positives = 87/185 (47%), Gaps = 28/185 (15%)
Query: 2 ERYEKIGKLGEGSYGVVFKCRNRD--TGQV---VAIKKFLESEEDPLIRKIA-LREIRLL 55
E+ + +LG+GS+G+V++ RD G+ VA+K ES L +I L E ++
Sbjct: 6 EKITLLRELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESAS--LRERIEFLNEASVM 63
Query: 56 KSLKHPNLVNLLEVFRRKKKLHLVFEFCDHTVLN--------ELENHPHGLPWDL--IKQ 105
K ++V LL V + + +V E H L E EN+P P L + Q
Sbjct: 64 KGFTCHHVVRLLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQ 123
Query: 106 ITWQVLRGVSYCHRHACIHRDIKPENILLTANGVVKLCDFGFARLIRDLIPRHLHIFQTN 165
+ ++ G++Y + +HRD+ N ++ + VK+ DFG R I++T+
Sbjct: 124 MAAEIADGMAYLNAKKFVHRDLAARNCMVAHDFTVKIGDFGMTR----------DIYETD 173
Query: 166 EYFKG 170
Y KG
Sbjct: 174 YYRKG 178
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR is a receptor tyr kinase (RTK) that is composed of two alphabeta heterodimers. Binding of the insulin ligand to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR signaling plays an important role in many cellular processes including glucose homeostasis, glycogen synthesis, lipid and protein metabolism, ion and amino acid transport, cell cycle and proliferation, cell differentiation, gene transcription, and nitric oxide synthesis. Insulin resistance, caused by abnormalities in InsR signaling, has been described in diabetes, hypertension, cardiovascular disease, metabolic syndrome, heart failure, and female infertility. Length = 288 |
| >gnl|CDD|133246 cd05115, PTKc_Zap-70, Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa | Back alignment and domain information |
|---|
Score = 51.1 bits (122), Expect = 1e-07
Identities = 41/146 (28%), Positives = 70/146 (47%), Gaps = 9/146 (6%)
Query: 9 KLGEGSYGVV----FKCRNRDTGQVVAIKKFLESEEDPLIRKIALREIRLLKSLKHPNLV 64
+LG G++G V +K R + VAIK L++E + +R +RE ++ L +P +V
Sbjct: 2 ELGSGNFGCVKKGVYKMRKKQID--VAIK-VLKNENEKSVRDEMMREAEIMHQLDNPYIV 58
Query: 65 NLLEVFRRKKKLHLVFEFCDHTVLNE-LENHPHGLPWDLIKQITWQVLRGVSYCHRHACI 123
++ V + L LV E LN+ L + + ++ QV G+ Y +
Sbjct: 59 RMIGVCE-AEALMLVMEMASGGPLNKFLSGKKDEITVSNVVELMHQVSMGMKYLEGKNFV 117
Query: 124 HRDIKPENILLTANGVVKLCDFGFAR 149
HRD+ N+LL K+ DFG ++
Sbjct: 118 HRDLAARNVLLVNQHYAKISDFGLSK 143
|
Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its phosphorylation and activation. It then phosphorylates target proteins, which propagate the signals to downstream pathways. Zap-70 is hardly detected in normal peripheral B-cells, but is present in some B-cell malignancies. It is used as a diagnostic marker for chronic lymphocytic leukemia (CLL) as it is associated with the more aggressive subtype of the disease. Length = 257 |
| >gnl|CDD|133189 cd05058, PTKc_Met_Ron, Catalytic domain of the Protein Tyrosine Kinases, Met and Ron | Back alignment and domain information |
|---|
Score = 50.9 bits (122), Expect = 2e-07
Identities = 40/150 (26%), Positives = 66/150 (44%), Gaps = 8/150 (5%)
Query: 10 LGEGSYGVVFKCRNRDTGQV---VAIKKFLESEEDPLIRKIALREIRLLKSLKHPNLVNL 66
+G+G +G V+ D+ A+K + + + L+E ++K HPN+++L
Sbjct: 3 IGKGHFGCVYHGTLIDSDGQKIHCAVKSLNRITDLEEVEQF-LKEGIIMKDFSHPNVLSL 61
Query: 67 LEVFRRKKKL-HLVFEFCDHTVLNELENHPHGLPW--DLIKQITWQVLRGVSYCHRHACI 123
L + + +V + H L P DLI QV +G+ Y +
Sbjct: 62 LGICLPSEGSPLVVLPYMKHGDLRNFIRSETHNPTVKDLIG-FGLQVAKGMEYLASKKFV 120
Query: 124 HRDIKPENILLTANGVVKLCDFGFARLIRD 153
HRD+ N +L + VK+ DFG AR I D
Sbjct: 121 HRDLAARNCMLDESFTVKVADFGLARDIYD 150
|
Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also called the HGF receptor. HGF/Met signaling plays a role in growth, transformation, cell motility, invasion, metastasis, angiogenesis, wound healing, and tissue regeneration. Aberrant expression of Met through mutations or gene amplification is associated with many human cancers including hereditary papillary renal and gastric carcinomas. The ligand for Ron is macrophage stimulating protein (MSP). Ron signaling is important in regulating cell motility, adhesion, proliferation, and apoptosis. Aberrant Ron expression is implicated in tumorigenesis and metastasis. Length = 262 |
| >gnl|CDD|173679 cd05588, STKc_aPKC, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C | Back alignment and domain information |
|---|
Score = 51.4 bits (123), Expect = 2e-07
Identities = 38/144 (26%), Positives = 67/144 (46%), Gaps = 6/144 (4%)
Query: 10 LGEGSYGVVFKCRNRDTGQVVAIK----KFLESEEDPLIRKIALREIRLLKSLKHPNLVN 65
+G GSY V + T ++ A+K + + +ED I + + + HP LV
Sbjct: 3 IGRGSYAKVLLVELKKTRRIYAMKVIKKELVNDDED--IDWVQTEKHVFETASNHPFLVG 60
Query: 66 LLEVFRRKKKLHLVFEFCDHTVLNELENHPHGLPWDLIKQITWQVLRGVSYCHRHACIHR 125
L F+ + +L V EF L LP + + + ++ +++ H I+R
Sbjct: 61 LHSCFQTESRLFFVIEFVSGGDLMFHMQRQRKLPEEHARFYSAEISLALNFLHERGIIYR 120
Query: 126 DIKPENILLTANGVVKLCDFGFAR 149
D+K +N+LL A G +KL D+G +
Sbjct: 121 DLKLDNVLLDAEGHIKLTDYGMCK 144
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions including proliferation, migration, apoptosis, polarity maintenance and cytoskeletal regulation. They also play a critical role in the regulation of glucose metabolism and in the pathogenesis of type 2 diabetes. Length = 329 |
| >gnl|CDD|133205 cd05074, PTKc_Tyro3, Catalytic domain of the Protein Tyrosine Kinase, Tyro3 | Back alignment and domain information |
|---|
Score = 50.7 bits (121), Expect = 2e-07
Identities = 43/160 (26%), Positives = 68/160 (42%), Gaps = 21/160 (13%)
Query: 10 LGEGSYGVV---FKCRNRDTGQVVAIKKF---LESEEDPLIRKIALREIRLLKSLKHPNL 63
LG+G +G V + Q VA+K + S D I + LRE +K HPN+
Sbjct: 7 LGKGEFGSVREAQLKSEDGSFQKVAVKMLKADIFSSSD--IEEF-LREAACMKEFDHPNV 63
Query: 64 VNLLEV-FRRKKKLHL-----VFEFCDH------TVLNELENHPHGLPWDLIKQITWQVL 111
+ L+ V R + K L + F H +++ + P LP + + +
Sbjct: 64 IKLIGVSLRSRAKGRLPIPMVILPFMKHGDLHTFLLMSRIGEEPFTLPLQTLVRFMIDIA 123
Query: 112 RGVSYCHRHACIHRDIKPENILLTANGVVKLCDFGFARLI 151
G+ Y IHRD+ N +L N V + DFG ++ I
Sbjct: 124 SGMEYLSSKNFIHRDLAARNCMLNENMTVCVADFGLSKKI 163
|
Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic factor. It is also expressed in osteoclasts and has a role in bone resorption. Length = 273 |
| >gnl|CDD|133227 cd05096, PTKc_DDR1, Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 1 | Back alignment and domain information |
|---|
Score = 50.7 bits (121), Expect = 3e-07
Identities = 45/176 (25%), Positives = 75/176 (42%), Gaps = 36/176 (20%)
Query: 9 KLGEGSYGVVFKCR--------------NRDTGQ--VVAIKKFLESEEDPLIRKIALREI 52
KLGEG +G V C N G+ +VA+K L + + R L+E+
Sbjct: 12 KLGEGQFGEVHLCEVVNPQDLPTLQFPFNVRKGRPLLVAVK-ILRPDANKNARNDFLKEV 70
Query: 53 RLLKSLKHPNLVNLLEVFRRKKKLHLVFEFCDHTVLNELENHPH-------GLPWD---- 101
++L LK PN++ LL V + L ++ E+ ++ LN+ + H G
Sbjct: 71 KILSRLKDPNIIRLLGVCVDEDPLCMITEYMENGDLNQFLSSHHLDDKEENGNDAVPPAH 130
Query: 102 --------LIKQITWQVLRGVSYCHRHACIHRDIKPENILLTANGVVKLCDFGFAR 149
+ + Q+ G+ Y +HRD+ N L+ N +K+ DFG +R
Sbjct: 131 CLPAISYSSLLHVALQIASGMKYLSSLNFVHRDLATRNCLVGENLTIKIADFGMSR 186
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 1 (DDR1) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR1 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR1 binds to all collagens tested to date (types I-IV). It is widely expressed in many tissues. It is abundant in the brain and is also found in keratinocytes, colonic mucosa epithelium, lung epithelium, thyroid follicles, and the islets of Langerhans. During embryonic development, it is found in the developing neuroectoderm. DDR1 is a key regulator of cell morphogenesis, differentiation and proliferation. It is important in the development of the mammary gland, the vasculator and the kidney. DDR1 is also found in human leukocytes, where it facilitates cell adhesion, migration, maturation, and cytokine production. Length = 304 |
| >gnl|CDD|173654 cd05108, PTKc_EGFR, Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor | Back alignment and domain information |
|---|
Score = 50.4 bits (120), Expect = 3e-07
Identities = 43/164 (26%), Positives = 72/164 (43%), Gaps = 29/164 (17%)
Query: 4 YEKIGKLGEGSYGVVFKCRNRDTGQVVAIK---KFLESEEDPLIRKIALREIRLLKSLKH 60
++KI LG G++G V+K G+ V I K L P K L E ++ S+ +
Sbjct: 9 FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDN 68
Query: 61 PNLVNLLEVFRRKKKLHLVFEFC-DHTVLNELENHPHGLPWDLIKQ----------ITW- 108
P++ LL + C TV + P G D +++ + W
Sbjct: 69 PHVCRLLGI-------------CLTSTVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWC 115
Query: 109 -QVLRGVSYCHRHACIHRDIKPENILLTANGVVKLCDFGFARLI 151
Q+ +G++Y +HRD+ N+L+ VK+ DFG A+L+
Sbjct: 116 VQIAKGMNYLEERRLVHRDLAARNVLVKTPQHVKITDFGLAKLL 159
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Ligands for EGFR include EGF, heparin binding EGF-like growth factor (HBEGF), epiregulin, amphiregulin, TGFalpha, and betacellulin. Upon ligand binding, EGFR can form homo- or heterodimers with other EGFR subfamily members. The EGFR signaling pathway is one of the most important pathways regulating cell proliferation, differentiation, survival, and growth. Overexpression and mutation in the kinase domain of EGFR have been implicated in the development and progression of a variety of cancers. A number of monoclonal antibodies and small molecule inhibitors have been developed that target EGFR, including the antibodies Cetuximab and Panitumumab, which are used in combination with other therapies for the treatment of colorectal cancer and non-small cell lung carcinoma (NSCLC). The small molecule inhibitors Gefitinib (Iressa) and Erlotinib (Tarceva), already used for NSCLC, are undergoing clinical trials for other types of cancer including gastrointestinal, breast, head and neck, and bladder. Length = 316 |
| >gnl|CDD|173685 cd05594, STKc_PKB_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha | Back alignment and domain information |
|---|
Score = 50.4 bits (120), Expect = 3e-07
Identities = 39/143 (27%), Positives = 72/143 (50%), Gaps = 4/143 (2%)
Query: 10 LGEGSYGVVFKCRNRDTGQVVAIKKFLESEEDPLIRKIA--LREIRLLKSLKHPNLVNLL 67
LG+G++G V + + TG+ A+K L+ E ++A L E R+L++ +HP L L
Sbjct: 3 LGKGTFGKVILVKEKATGRYYAMK-ILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALK 61
Query: 68 EVFRRKKKLHLVFEFCDHTVLNELENHPHGLPWDLIKQITWQVLRGVSYCH-RHACIHRD 126
F+ +L V E+ + L + D + +++ + Y H ++RD
Sbjct: 62 YSFQTHDRLCFVMEYANGGELFFHLSRERVFSEDRARFYGAEIVSALDYLHSEKNVVYRD 121
Query: 127 IKPENILLTANGVVKLCDFGFAR 149
+K EN++L +G +K+ DFG +
Sbjct: 122 LKLENLMLDKDGHIKITDFGLCK 144
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficient in PKB-alpha exhibit perinatal morbidity, growth retardation, reduction in body weight accompanied by reduced sizes of multiple organs, and enhanced apoptosis in some cell types. PKB-alpha activity has been reported to be frequently elevated in breast and prostate cancers. In some cancer cells, PKB-alpha may act as a suppressor of metastasis. Length = 325 |
| >gnl|CDD|173681 cd05590, STKc_nPKC_eta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta | Back alignment and domain information |
|---|
Score = 50.3 bits (120), Expect = 4e-07
Identities = 39/144 (27%), Positives = 68/144 (47%), Gaps = 6/144 (4%)
Query: 10 LGEGSYGVVFKCRNRDTGQVVAIK---KFLESEEDPLIRKIALREIRLLK-SLKHPNLVN 65
LG+GS+G V R +++G++ A+K K + ++D + + + E R+L + HP L
Sbjct: 3 LGKGSFGKVMLARLKESGRLYAVKVLKKDVILQDDDV--ECTMTEKRILSLARNHPFLTQ 60
Query: 66 LLEVFRRKKKLHLVFEFCDHTVLNELENHPHGLPWDLIKQITWQVLRGVSYCHRHACIHR 125
L F+ +L V EF + L + ++ + + H I+R
Sbjct: 61 LYCCFQTPDRLFFVMEFVNGGDLMFHIQKSRRFDEARARFYAAEITSALMFLHDKGIIYR 120
Query: 126 DIKPENILLTANGVVKLCDFGFAR 149
D+K +N+LL G KL DFG +
Sbjct: 121 DLKLDNVLLDHEGHCKLADFGMCK 144
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signaling of cell-type specific differentiation. It is also expressed in pro-B cells and early-stage thymocytes, and acts as a key regulator in early B-cell development. PKC-eta increases glioblastoma multiforme (GBM) proliferation and resistance to radiation, and is being developed as a therapeutic target for the management of GBM. Length = 320 |
| >gnl|CDD|173646 cd05087, PTKc_Aatyk1_Aatyk3, Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases 1 and 3 | Back alignment and domain information |
|---|
Score = 49.2 bits (117), Expect = 7e-07
Identities = 37/151 (24%), Positives = 65/151 (43%), Gaps = 12/151 (7%)
Query: 9 KLGEGSYGVVFKCR-NRDTGQVVAIKKFLESEEDPLIRKIALREIRLLKSLKHPNLVNLL 67
++G G +G V N + K L + L E + +SL+H NL+ L
Sbjct: 2 EIGNGWFGKVILGEVNSGYTPAQVVVKELRVSASVQEQMKFLEEAQPYRSLQHSNLLQCL 61
Query: 68 EVFRRKKKLHLVFEFCDHTVLNELENH------PHGLPWDL--IKQITWQVLRGVSYCHR 119
LV EFC L +L+ + + D ++++ ++ G+ + H+
Sbjct: 62 GQCTEVTPYLLVMEFCP---LGDLKGYLRSCRKAELMTPDPTTLQRMACEIALGLLHLHK 118
Query: 120 HACIHRDIKPENILLTANGVVKLCDFGFARL 150
+ IH D+ N LLTA+ VK+ D+G +
Sbjct: 119 NNFIHSDLALRNCLLTADLTVKIGDYGLSHN 149
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 1 (Aatyk1) and Aatyk3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk1 and Aatyk3 are members of the Aatyk subfamily of proteins. Aatyk3 is a receptor kinase containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 has a similar domain arrangement but without the transmembrane segment and is thus, a cytoplasmic (or nonreceptor) kinase. The expression of Aatyk1 (also referred simply as Aatyk) is upregulated during growth arrest and apoptosis in myeloid cells. Aatyk1 has been implicated in neural differentiation, and is a regulator of the Na-K-2Cl cotransporter, a membrane protein involved in cell proliferation and survival, epithelial transport, and blood pressure control. The function of Aatyk3 is still unknown. Length = 269 |
| >gnl|CDD|132954 cd06623, PKc_MAPKK_plant_like, Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins | Back alignment and domain information |
|---|
Score = 49.1 bits (118), Expect = 8e-07
Identities = 13/31 (41%), Positives = 18/31 (58%)
Query: 196 LIDFLKRCLDKDPLRRWSCDQLLRHPYFNGY 226
DF+ CL KDP +R S +LL+HP+
Sbjct: 232 FRDFISACLQKDPKKRPSAAELLQHPFIKKA 262
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include MAPKKs from plants, kinetoplastids, alveolates, and mycetozoa. The MAPKK, LmxPK4, from Leishmania mexicana, is important in differentiation and virulence. Dictyostelium discoideum MEK1 is required for proper chemotaxis. MEK1 null mutants display severe defects in cell polarization and directional movement. Plants contain multiple MAPKKs like other eukaryotes. The Arabidopsis genome encodes for 10 MAPKKs while poplar and rice contain 13 MAPKKs each. The functions of these proteins have not been fully elucidated. There is evidence to suggest that MAPK cascades are involved in plant stress responses. In Arabidopsis, MKK3 plays a role in pathogen signaling, MKK2 is involved in cold and salt stress signaling, MKK4/MKK5 participates in innate immunity, and MKK7 regulates basal and systemic acquired resistance. Length = 264 |
| >gnl|CDD|133194 cd05063, PTKc_EphR_A2, Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2 | Back alignment and domain information |
|---|
Score = 48.8 bits (116), Expect = 9e-07
Identities = 37/149 (24%), Positives = 71/149 (47%), Gaps = 7/149 (4%)
Query: 10 LGEGSYGVVFKCRNRDTGQ---VVAIKKFLESEEDPLIRKIALREIRLLKSLKHPNLVNL 66
+G G +G VF+ + G+ VAIK L+ R+ L E ++ H N++ L
Sbjct: 13 IGAGEFGEVFRGILKMPGRKEVAVAIKT-LKPGYTEKQRQDFLSEASIMGQFSHHNIIRL 71
Query: 67 LEVFRRKKKLHLVFEFCDHTVLNEL--ENHPHGLPWDLIKQITWQVLRGVSYCHRHACIH 124
V + K ++ E+ ++ L++ ++ + L+ + + G+ Y +H
Sbjct: 72 EGVVTKFKPAMIITEYMENGALDKYLRDHDGEFSSYQLVGMLR-GIAAGMKYLSDMNYVH 130
Query: 125 RDIKPENILLTANGVVKLCDFGFARLIRD 153
RD+ NIL+ +N K+ DFG +R++ D
Sbjct: 131 RDLAARNILVNSNLECKVSDFGLSRVLED 159
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. The EphA2 receptor is overexpressed in tumor cells and tumor blood vessels in a variety of cancers including breast, prostate, lung, and colon. As a result, it is an attractive target for drug design since its inhibition could affect several aspects of tumor progression. Length = 268 |
| >gnl|CDD|173728 cd06614, STKc_PAK, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase | Back alignment and domain information |
|---|
Score = 48.7 bits (117), Expect = 1e-06
Identities = 14/29 (48%), Positives = 20/29 (68%)
Query: 196 LIDFLKRCLDKDPLRRWSCDQLLRHPYFN 224
DFL +CL KDP +R S ++LL+HP+
Sbjct: 246 FKDFLNKCLVKDPEKRPSAEELLQHPFLK 274
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). Group II PAKs contain a PBD and a catalytic domain, but lack other motifs found in group I PAKs. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. Group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX; no such binding has been demonstrated for group II PAKs. Length = 286 |
| >gnl|CDD|88330 cd05047, PTKc_Tie, Catalytic domain of Tie Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 48.5 bits (115), Expect = 1e-06
Identities = 50/161 (31%), Positives = 69/161 (42%), Gaps = 24/161 (14%)
Query: 10 LGEGSYGVVFKCRNRDTG--QVVAIKKFLESEEDPLIRKIALREIRLLKSLKHPNLVNLL 67
+GEG++G V K R + G AIK+ E R A L K HPN++NLL
Sbjct: 3 IGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLL 62
Query: 68 EVFRRKKKLHLVFEFCDHTVLNE-------LENHP-----HGLPWDLIKQITWQVLR--- 112
+ L+L E+ H L + LE P + L Q Q+L
Sbjct: 63 GACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQ---QLLHFAA 119
Query: 113 ----GVSYCHRHACIHRDIKPENILLTANGVVKLCDFGFAR 149
G+ Y + IHRD+ NIL+ N V K+ DFG +R
Sbjct: 120 DVARGMDYLSQKQFIHRDLAARNILVGENYVAKIADFGLSR 160
|
Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific ligand has been identified for Tie1. The binding of Ang-1 to Tie2 leads to receptor autophosphorylation and activation, promoting cell migration and survival. In contrast, Ang-2 binding to Tie2 does not result in the same response, suggesting that Ang-2 may function as an antagonist. In vivo studies of Tie1 show that it is critical in vascular development. Length = 270 |
| >gnl|CDD|173630 cd05044, PTKc_c-ros, Catalytic domain of the Protein Tyrosine Kinase, C-ros | Back alignment and domain information |
|---|
Score = 47.9 bits (114), Expect = 2e-06
Identities = 46/160 (28%), Positives = 75/160 (46%), Gaps = 19/160 (11%)
Query: 10 LGEGSYGVVFKCRNRD-----TGQV-VAIKKFLESEEDPLIRKIALREIRLLKSLKHPNL 63
LG G++G V++ D +G + VA+K + D ++ L+E L+ + HPN+
Sbjct: 3 LGSGAFGEVYEGTATDILGPGSGPIRVAVKTLRKGATDQEKKEF-LKEAHLMSNFNHPNI 61
Query: 64 VNLLEVFRRKKKLHLVFEFCDH-TVLNELEN------HPHGLPWDLIKQITWQVLRGVSY 116
V LL V + +++ E + +L+ L + P L + I V +G Y
Sbjct: 62 VKLLGVCLLNEPQYIIMELMEGGDLLSYLRDARVERFGPPLLTLKELLDICLDVAKGCVY 121
Query: 117 CHRHACIHRDIKPENILLTANG-----VVKLCDFGFARLI 151
+ IHRD+ N L++ G VVK+ DFG AR I
Sbjct: 122 LEQMHFIHRDLAARNCLVSEKGYDADRVVKIGDFGLARDI 161
|
Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male mice bearing inactive mutations of c-ros lack the initial segment of the epididymis and are infertile. The Drosophila protein, Sevenless, is required for the specification of the R7 photoreceptor cell during eye development. Length = 269 |
| >gnl|CDD|140293 PTZ00267, PTZ00267, NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 48.1 bits (114), Expect = 2e-06
Identities = 33/113 (29%), Positives = 55/113 (48%), Gaps = 10/113 (8%)
Query: 48 ALREIRLLKSLKHPNLVNLLEVFRRKKKLHLVFEFCDHTVLNE-----LENHPHGLPWDL 102
A E+ L + H +V + F+ KL L+ E+ LN+ L+ H LP+
Sbjct: 112 ARSELHCLAACDHFGIVKHFDDFKSDDKLLLIMEYGSGGDLNKQIKQRLKEH---LPFQE 168
Query: 103 --IKQITWQVLRGVSYCHRHACIHRDIKPENILLTANGVVKLCDFGFARLIRD 153
+ + +Q++ + H +HRD+K NI L G++KL DFGF++ D
Sbjct: 169 YEVGLLFYQIVLALDEVHSRKMMHRDLKSANIFLMPTGIIKLGDFGFSKQYSD 221
|
Length = 478 |
| >gnl|CDD|133238 cd05107, PTKc_PDGFR_beta, Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor beta | Back alignment and domain information |
|---|
Score = 47.3 bits (112), Expect = 4e-06
Identities = 20/57 (35%), Positives = 34/57 (59%), Gaps = 1/57 (1%)
Query: 98 LPWDLIKQITWQVLRGVSYCHRHACIHRDIKPENILLTANGVVKLCDFGFAR-LIRD 153
L + + ++QV G+ + C+HRD+ N+L+ +VK+CDFG AR ++RD
Sbjct: 236 LSYMDLVGFSYQVANGMEFLASKNCVHRDLAARNVLICEGKLVKICDFGLARDIMRD 292
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) beta; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR beta is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR beta forms homodimers or heterodimers with PDGFR alpha, depending on the nature of the PDGF ligand. PDGF-BB and PDGF-DD induce PDGFR beta homodimerization. PDGFR signaling plays many roles in normal embryonic development and adult physiology. PDGFR beta signaling leads to a variety of cellular effects including the stimulation of cell growth and chemotaxis, as well as the inhibition of apoptosis and GAP junctional communication. It is critical in normal angiogenesis as it is involved in the recruitment of pericytes and smooth muscle cells essential for vessel stability. Aberrant PDGFR beta expression is associated with some human cancers. The continuously-active fusion proteins of PDGFR beta with COL1A1 and TEL are associated with dermatofibrosarcoma protuberans (DFSP) and a subset of chronic myelomonocytic leukemia (CMML), respectively. Length = 401 |
| >gnl|CDD|223069 PHA03390, pk1, serine/threonine-protein kinase 1; Provisional | Back alignment and domain information |
|---|
Score = 46.8 bits (112), Expect = 4e-06
Identities = 39/149 (26%), Positives = 69/149 (46%), Gaps = 17/149 (11%)
Query: 9 KLGEGSYGVVFKCRNRDTGQV-----VAIKKFLESEEDPLIRKIALREIRLLKSLKHPNL 63
KL +G +G V +++ T ++ + K F E P++ + L+K +PN
Sbjct: 23 KLIDGKFGKVSVLKHKPTQKLFVQKIIKAKNFNAIE--PMVHQ-------LMK--DNPNF 71
Query: 64 VNLLEVFRRKKKLHLVFEFCDHTVLNELENHPHGLPWDLIKQITWQVLRGVSYCHRHACI 123
+ L K L+ ++ L +L L +K+I Q++ ++ H+H I
Sbjct: 72 IKLYYSVTTLKGHVLIMDYIKDGDLFDLLKKEGKLSEAEVKKIIRQLVEALNDLHKHNII 131
Query: 124 HRDIKPENILLT-ANGVVKLCDFGFARLI 151
H DIK EN+L A + LCD+G ++I
Sbjct: 132 HNDIKLENVLYDRAKDRIYLCDYGLCKII 160
|
Length = 267 |
| >gnl|CDD|173656 cd05111, PTK_HER3, Pseudokinase domain of the Protein Tyrosine Kinase, HER3 | Back alignment and domain information |
|---|
Score = 46.9 bits (111), Expect = 4e-06
Identities = 41/152 (26%), Positives = 71/152 (46%), Gaps = 7/152 (4%)
Query: 5 EKIGKLGEGSYGVVFKCRNRDTGQVVAIKKFLESEEDPLIRKIALREIR----LLKSLKH 60
K+ LG G +G V K G + I +++ +D R+ +EI + SL H
Sbjct: 10 RKLKLLGSGVFGTVHKGIWIPEGDSIKIPVAIKTIQDRSGRQ-TFQEITDHMLAMGSLDH 68
Query: 61 PNLVNLLEVFRRKKKLHLVFEFCDH-TVLNELENHPHGLPWDLIKQITWQVLRGVSYCHR 119
+V LL + L LV + ++L+ + H L + Q+ +G+ Y
Sbjct: 69 AYIVRLLGICP-GASLQLVTQLSPLGSLLDHVRQHRDSLDPQRLLNWCVQIAKGMYYLEE 127
Query: 120 HACIHRDIKPENILLTANGVVKLCDFGFARLI 151
H +HR++ NILL ++ +V++ DFG A L+
Sbjct: 128 HRMVHRNLAARNILLKSDSIVQIADFGVADLL 159
|
Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. HER3 binds the neuregulin ligands, NRG1 and NRG2. HER3 contains an impaired tyr kinase domain and relies on its heterodimerization partners for activity following ligand binding. The HER2-HER3 heterodimer constitutes a high affinity co-receptor capable of potent mitogenic signaling. HER3 participates in a signaling pathway involved in the proliferation, survival, adhesion, and motility of tumor cells. Length = 279 |
| >gnl|CDD|133175 cd05043, PTK_Ryk, Pseudokinase domain of Ryk (Receptor related to tyrosine kinase) | Back alignment and domain information |
|---|
Score = 46.6 bits (111), Expect = 5e-06
Identities = 43/180 (23%), Positives = 68/180 (37%), Gaps = 39/180 (21%)
Query: 12 EGSYGVVFKCRNRDTGQVVAIKKFLESEEDPLIRKIA-----------LREIRLLKSLKH 60
EG++G +F + I + EE+ ++ + L+E LL L H
Sbjct: 16 EGTFGRIF--------YGILIDEKPGKEEEVFVKTVKDHASEIQVTLLLQESCLLYGLSH 67
Query: 61 PNLVNLLEV-------------FRRKKKLHLVFEFCDHTVLNELENHPHGLPWDLIKQIT 107
N++ +L V + L L + C N+P L + +
Sbjct: 68 QNILPILHVCIEDGEPPFVLYPYMNWGNLKLFLQQCRLGE----ANNPQALSTQQLVHMA 123
Query: 108 WQVLRGVSYCHRHACIHRDIKPENILLTANGVVKLCDFGFARLIRDLIPRHLHIFQTNEY 167
Q+ G+SY H+ IH+DI N ++ VK+ D L RDL P H NE
Sbjct: 124 IQIACGMSYLHKRGVIHKDIAARNCVIDEELQVKITD---NALSRDLFPMDYHCLGDNEN 180
|
Protein Tyrosine Kinase (PTK) family; Receptor related to tyrosine kinase (Ryk); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ryk is a receptor tyr kinase (RTK) containing an extracellular region with two leucine-rich motifs, a transmembrane segment, and an intracellular inactive pseudokinase domain. The extracellular region of Ryk shows homology to the N-terminal domain of Wnt inhibitory factor-1 (WIF) and serves as the ligand (Wnt) binding domain of Ryk. Ryk is expressed in many different tissues both during development and in adults, suggesting a widespread function. It acts as a chemorepulsive axon guidance receptor of Wnt glycoproteins and is responsible for the establishment of axon tracts during the development of the central nervous system. In addition, studies in mice reveal that Ryk is essential in skeletal, craniofacial, and cardiac development. Thus, it appears Ryk is involved in signal transduction despite its lack of kinase activity. Ryk may function as an accessory protein that modulates the signals coming from catalytically active partner RTKs such as the Eph receptors. Length = 280 |
| >gnl|CDD|133193 cd05062, PTKc_IGF-1R, Catalytic domain of the Protein Tyrosine Kinase, Insulin-like Growth Factor-1 Receptor | Back alignment and domain information |
|---|
Score = 46.2 bits (109), Expect = 8e-06
Identities = 48/178 (26%), Positives = 84/178 (47%), Gaps = 28/178 (15%)
Query: 9 KLGEGSYGVVF----KCRNRDTGQV-VAIKKFLESEEDPLIRKIA-LREIRLLKSLKHPN 62
+LG+GS+G+V+ K +D + VAIK E+ + +I L E ++K +
Sbjct: 13 ELGQGSFGMVYEGIAKGVVKDEPETRVAIKTVNEAAS--MRERIEFLNEASVMKEFNCHH 70
Query: 63 LVNLLEVFRRKKKLHLVFEFCDHTVLN--------ELENHPHGLPWDLIK--QITWQVLR 112
+V LL V + + ++ E L E+EN+P P L K Q+ ++
Sbjct: 71 VVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVQAPPSLKKMIQMAGEIAD 130
Query: 113 GVSYCHRHACIHRDIKPENILLTANGVVKLCDFGFARLIRDLIPRHLHIFQTNEYFKG 170
G++Y + + +HRD+ N ++ + VK+ DFG R I++T+ Y KG
Sbjct: 131 GMAYLNANKFVHRDLAARNCMVAEDFTVKIGDFGMTR----------DIYETDYYRKG 178
|
Protein Tyrosine Kinase (PTK) family; Insulin-like Growth Factor-1 Receptor (IGF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. IGF-1R is a receptor tyr kinases (RTK) that is composed of two alphabeta heterodimers. Binding of the ligand (IGF-1 or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, which stimulates downstream kinase activities and biological function. IGF-1R signaling is important in the differentiation, growth, and survival of normal cells. In cancer cells, where it is frequently overexpressed, IGF-1R is implicated in proliferation, the suppression of apoptosis, invasion, and metastasis. IGF-1R is being developed as a therapeutic target in cancer treatment. Length = 277 |
| >gnl|CDD|133240 cd05109, PTKc_HER2, Catalytic domain of the Protein Tyrosine Kinase, HER2 | Back alignment and domain information |
|---|
Score = 46.2 bits (109), Expect = 8e-06
Identities = 42/162 (25%), Positives = 70/162 (43%), Gaps = 27/162 (16%)
Query: 5 EKIGKLGEGSYGVVFKCRNRDTGQVVAIK---KFLESEEDPLIRKIALREIRLLKSLKHP 61
+K+ LG G++G V+K G+ V I K L P K L E ++ + P
Sbjct: 10 KKVKVLGSGAFGTVYKGIWIPDGENVKIPVAIKVLRENTSPKANKEILDEAYVMAGVGSP 69
Query: 62 NLVNLLEVFRRKKKLHLVFEFCDHTVLNELENHPHGLPWDLIKQ----------ITW--Q 109
+ LL + + LV + P+G D +++ + W Q
Sbjct: 70 YVCRLLGICL-TSTVQLVTQLM-----------PYGCLLDYVRENKDRIGSQDLLNWCVQ 117
Query: 110 VLRGVSYCHRHACIHRDIKPENILLTANGVVKLCDFGFARLI 151
+ +G+SY +HRD+ N+L+ + VK+ DFG ARL+
Sbjct: 118 IAKGMSYLEEVRLVHRDLAARNVLVKSPNHVKITDFGLARLL 159
|
Protein Tyrosine Kinase (PTK) family; HER2 (ErbB2, HER2/neu); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER2 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. HER2 does not bind to any known EGFR subfamily ligands, but contributes to the kinase activity of all possible heterodimers. It acts as the preferred partner with other ligand-bound EGFR proteins and functions as a signal amplifier, with the HER2-HER3 heterodimer being the most potent pair in mitogenic signaling. HER2 plays an important role in cell development, proliferation, survival and motility. Overexpression of HER2 results in its activation and downstream signaling, even in the absence of ligand. HER2 overexpression, mainly due to gene amplification, has been shown in a variety of human cancers. Its role in breast cancer is especially well-documented. HER2 is up-regulated in about 25% of breast tumors and is associated with increases in tumor aggressiveness, recurrence and mortality. HER2 is a target for monoclonal antibodies and small molecule inhibitors, which are being developed as treatments for cancer. The first humanized antibody approved for clinical use is Trastuzumab (Herceptin), which is being used in combination with other therapies to improve the survival rates of patients with HER2-overexpressing breast cancer. Length = 279 |
| >gnl|CDD|173707 cd05616, STKc_cPKC_beta, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta | Back alignment and domain information |
|---|
Score = 45.8 bits (108), Expect = 1e-05
Identities = 39/151 (25%), Positives = 76/151 (50%), Gaps = 20/151 (13%)
Query: 10 LGEGSYGVVFKCRNRDTGQVVAIKKFLESEEDPLIR----KIALREIRLLK-SLKHPNLV 64
LG+GS+G V + T ++ AIK ++D +I+ + + E R+L S K P L
Sbjct: 8 LGKGSFGKVMLAERKGTDELYAIKIL---KKDVVIQDDDVECTMVEKRVLALSGKPPFLT 64
Query: 65 NLLEVFRRKKKLHLVFEFCDH-TVLNELEN-----HPHGLPWDLIKQITWQVLRGVSYCH 118
L F+ +L+ V E+ + ++ +++ PH + + ++ G+ + H
Sbjct: 65 QLHSCFQTMDRLYFVMEYVNGGDLMYQIQQVGRFKEPHAVFY------AAEIAIGLFFLH 118
Query: 119 RHACIHRDIKPENILLTANGVVKLCDFGFAR 149
I+RD+K +N++L + G +K+ DFG +
Sbjct: 119 SKGIIYRDLKLDNVMLDSEGHIKIADFGMCK 149
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. The PKC beta isoforms (I and II), generated by alternative splicing of a single gene, are preferentially activated by hyperglycemia-induced DAG in retinal tissues. This is implicated in diabetic microangiopathy such as ischemia, neovascularization, and abnormal vasodilator function. PKC-beta also plays an important role in VEGF signaling. In addition, glucose regulates proliferation in retinal endothelial cells via PKC-betaI. PKC-beta is also being explored as a therapeutic target in cancer. It contributes to tumor formation and is involved in the tumor host mechanisms of inflammation and angiogenesis. Length = 323 |
| >gnl|CDD|173710 cd05620, STKc_nPKC_delta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta | Back alignment and domain information |
|---|
Score = 45.3 bits (107), Expect = 1e-05
Identities = 38/147 (25%), Positives = 73/147 (49%), Gaps = 12/147 (8%)
Query: 10 LGEGSYGVVFKCRNRDTGQVVAIKKFLES----EEDPLIRKIALREIRLLKSLKHPNLVN 65
LG+GS+G V + G+ A+K + ++D + R + L + ++P L +
Sbjct: 3 LGKGSFGKVLLAELKGKGEYFAVKALKKDVVLIDDDVECTMVEKRVLAL--AWENPFLTH 60
Query: 66 LLEVFRRKKKLHLVFEFCDHTVLNELENHPHGL-PWDLIKQITW--QVLRGVSYCHRHAC 122
L F+ K+ L V EF + +L H +DL + + +++ G+ + H
Sbjct: 61 LYCTFQTKEHLFFVMEFLNG---GDLMFHIQDKGRFDLYRATFYAAEIVCGLQFLHSKGI 117
Query: 123 IHRDIKPENILLTANGVVKLCDFGFAR 149
I+RD+K +N++L +G +K+ DFG +
Sbjct: 118 IYRDLKLDNVMLDRDGHIKIADFGMCK 144
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. It slows down cell proliferation, inducing cell cycle arrest and enhancing cell differentiation. PKC-delta is also involved in the regulation of transcription as well as immune and inflammatory responses. It plays a central role in the genotoxic stress response that leads to DNA damaged-induced apoptosis. Length = 316 |
| >gnl|CDD|133167 cd05035, PTKc_Axl_like, Catalytic Domain of Axl-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 45.2 bits (107), Expect = 2e-05
Identities = 45/167 (26%), Positives = 70/167 (41%), Gaps = 26/167 (15%)
Query: 6 KIGK-LGEGSYGVVFKCR-NRDTG--QVVAIKK-----FLESEEDPLIRKIALREIRLLK 56
K+GK LGEG +G V + + ++D G VA+K SE + L E +K
Sbjct: 2 KLGKILGEGEFGSVMEGQLSQDDGSQLKVAVKTMKLDIHTYSEIEEF-----LSEAACMK 56
Query: 57 SLKHPNLVNLLEVFRRKKKLH------LVFEFCDHTVLN------ELENHPHGLPWDLIK 104
HPN++ L+ V L ++ F H L+ L P LP +
Sbjct: 57 DFDHPNVMKLIGVCFEASSLQKIPKPMVILPFMKHGDLHSFLLYSRLGGLPEKLPLQTLL 116
Query: 105 QITWQVLRGVSYCHRHACIHRDIKPENILLTANGVVKLCDFGFARLI 151
+ + G+ Y IHRD+ N +L + V + DFG ++ I
Sbjct: 117 KFMVDIALGMEYLSNRNFIHRDLAARNCMLREDMTVCVADFGLSKKI 163
|
Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellular effects including survival, proliferation, migration, and phagocytosis. They are also associated with several types of cancer as well as inflammatory, autoimmune, vascular, and kidney diseases. Mer is named after its original reported expression pattern (monocytes, epithelial, and reproductive tissues). It is required for the ingestion of apoptotic cells by phagocytes such as macrophages, retinal pigment epithelial cells, and dendritic cells. Mer is also important in maintaining immune homeostasis. Length = 273 |
| >gnl|CDD|173678 cd05587, STKc_cPKC, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C | Back alignment and domain information |
|---|
Score = 45.2 bits (107), Expect = 2e-05
Identities = 40/159 (25%), Positives = 70/159 (44%), Gaps = 36/159 (22%)
Query: 10 LGEGSYGVVFKCRNRDTGQVVAIKKFLESEEDPLIR----KIALREIRLLK-SLKHPNLV 64
LG+GS+G V + T ++ AIK ++D +I+ + + E R+L K P L
Sbjct: 8 LGKGSFGKVMLAERKGTDELYAIKIL---KKDVIIQDDDVECTMVEKRVLALPGKPPFLT 64
Query: 65 NLLEVFRRKKKLHLVFEFCDHTVLNELENHPHGLPWDLIKQI--------------TWQV 110
L F+ +L+ V E+ + DL+ I ++
Sbjct: 65 QLHSCFQTMDRLYFVMEYVNGG--------------DLMYHIQQVGKFKEPHAVFYAAEI 110
Query: 111 LRGVSYCHRHACIHRDIKPENILLTANGVVKLCDFGFAR 149
G+ + H I+RD+K +N++L A G +K+ DFG +
Sbjct: 111 AIGLFFLHSKGIIYRDLKLDNVMLDAEGHIKIADFGMCK 149
|
Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory domain. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. cPKCs are potent kinases for histones, myelin basic protein, and protamine. PKC-gamma is mainly expressed in neuronal tissues. It plays a role in protection from ischemia. Length = 324 |
| >gnl|CDD|133217 cd05086, PTKc_Aatyk2, Catalytic domain of the Protein Tyrosine Kinase, Apoptosis-associated tyrosine kinase 2 | Back alignment and domain information |
|---|
Score = 44.9 bits (106), Expect = 2e-05
Identities = 35/137 (25%), Positives = 67/137 (48%), Gaps = 6/137 (4%)
Query: 25 DTGQVVAIKKFLESEEDPLIRKIALREIRLLKSLKHPNLVNLLEVFRRKKKLHLVFEFCD 84
DTG + K L++ + L++ + L+HPN++ L LVFE+C+
Sbjct: 19 DTGVARVVVKELKANASSKEQNEFLQQGDPYRILQHPNILQCLGQCVEAIPYLLVFEYCE 78
Query: 85 ----HTVLNELENHPHGLPWDLIKQITWQVLRGVSYCHRHACIHRDIKPENILLTANGVV 140
+ L++ + H L++++ ++ GV++ H+H +H D+ N LT++ V
Sbjct: 79 LGDLKSYLSQEQWHRRNSQLLLLQRMACEIAAGVTHMHKHNFLHSDLALRNCFLTSDLTV 138
Query: 141 KLCDF--GFARLIRDLI 155
K+ D+ G +R D I
Sbjct: 139 KVGDYGIGPSRYKEDYI 155
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 2 (Aatyk2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk2 is a member of the Aatyk subfamily of proteins, which are receptor kinases containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk2 is also called lemur tyrosine kinase 2 (Lmtk2) or brain-enriched kinase (Brek). It is expressed at high levels in early postnatal brain, and has been shown to play a role in nerve growth factor (NGF) signaling. Studies with knockout mice reveal that Aatyk2 is essential for late stage spermatogenesis. Although it is classified as a tyr kinase based on sequence similarity and the phylogenetic tree, Aatyk2 has been characterized as a serine/threonine kinase. Length = 268 |
| >gnl|CDD|173642 cd05075, PTKc_Axl, Catalytic domain of the Protein Tyrosine Kinase, Axl | Back alignment and domain information |
|---|
Score = 44.6 bits (105), Expect = 2e-05
Identities = 44/165 (26%), Positives = 73/165 (44%), Gaps = 25/165 (15%)
Query: 7 IGK-LGEGSYGVVFKCR-NRDTGQV-VAIKKF-----LESEEDPLIRKIALREIRLLKSL 58
+GK LGEG +G V + + N+D + VA+K SE + L E +K
Sbjct: 3 LGKTLGEGEFGSVMEGQLNQDDSILKVAVKTMKIAICTRSEMEDF-----LSEAVCMKEF 57
Query: 59 KHPNLVNLLEVFRRKKKLH------LVFEFCDHTVL------NELENHPHGLPWDLIKQI 106
HPN++ L+ V + + ++ F H L + L + P LP ++ +
Sbjct: 58 DHPNVMRLIGVCLQTVESEGYPSPVVILPFMKHGDLHSFLLYSRLGDCPQYLPTQMLVKF 117
Query: 107 TWQVLRGVSYCHRHACIHRDIKPENILLTANGVVKLCDFGFARLI 151
+ G+ Y + IHRD+ N +L N V + DFG ++ I
Sbjct: 118 MTDIASGMEYLSSKSFIHRDLAARNCMLNENMNVCVADFGLSKKI 162
|
Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transformed cells. Axl signaling is important in many cellular functions such as survival, anti-apoptosis, proliferation, migration, and adhesion. Axl was originally isolated from patients with chronic myelogenous leukemia and a chronic myeloproliferative disorder. Axl is overexpressed in many human cancers including colon, squamous cell, thyroid, breast, and lung carcinomas. Length = 272 |
| >gnl|CDD|143346 cd07841, STKc_CDK7, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7 | Back alignment and domain information |
|---|
Score = 44.5 bits (106), Expect = 3e-05
Identities = 15/35 (42%), Positives = 22/35 (62%), Gaps = 1/35 (2%)
Query: 189 PAATNIYLIDFLKRCLDKDPLRRWSCDQLLRHPYF 223
PAA++ +D L+R L +P +R + Q L HPYF
Sbjct: 252 PAASD-DALDLLQRLLTLNPNKRITARQALEHPYF 285
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is also a component of the general transcription factor TFIIH, which phosphorylates the C-terminal domain (CTD) of RNA polymerase II when it is bound with unphosphorylated DNA, as present in the pre-initiation complex. Following phosphorylation, the CTD dissociates from the DNA which allows transcription initiation. Length = 298 |
| >gnl|CDD|133213 cd05082, PTKc_Csk, Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase | Back alignment and domain information |
|---|
Score = 44.2 bits (104), Expect = 3e-05
Identities = 39/152 (25%), Positives = 73/152 (48%), Gaps = 9/152 (5%)
Query: 1 MERYEKIGKLGEGSYGVVFKCRNRDTGQVVAIKKFLESEEDPLIRKIALREIRLLKSLKH 60
M+ + + +G+G +G V R G VA+K ++ + L E ++ L+H
Sbjct: 5 MKELKLLQTIGKGEFGDVMLGDYR--GNKVAVKCI----KNDATAQAFLAEASVMTQLRH 58
Query: 61 PNLVNLLEVF-RRKKKLHLVFEF-CDHTVLNELENHPHG-LPWDLIKQITWQVLRGVSYC 117
NLV LL V K L++V E+ ++++ L + L D + + + V + Y
Sbjct: 59 SNLVQLLGVIVEEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYL 118
Query: 118 HRHACIHRDIKPENILLTANGVVKLCDFGFAR 149
+ +HRD+ N+L++ + V K+ DFG +
Sbjct: 119 EANNFVHRDLAARNVLVSEDNVAKVSDFGLTK 150
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Csk is expressed in a wide variety of tissues. As a negative regulator of Src, Csk plays a role in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. In addition, Csk also shows Src-independent functions. It is a critical component in G-protein signaling, and plays a role in cytoskeletal reorganization and cell migration. Length = 256 |
| >gnl|CDD|173737 cd07834, STKc_MAPK, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 44.1 bits (105), Expect = 4e-05
Identities = 14/42 (33%), Positives = 21/42 (50%), Gaps = 1/42 (2%)
Query: 197 IDFLKRCLDKDPLRRWSCDQLLRHPYFNGYYFEVPDEMQYEE 238
ID L++ L DP +R + D+ L HPY + DE +
Sbjct: 266 IDLLEKMLVFDPKKRITADEALAHPYLAQLHDPE-DEPVAKP 306
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPK kinase (MAP2K or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAP3K or MKKK). Each cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. There are three main typical MAPK subfamilies: Extracellular signal-Regulated Kinase (ERK), c-Jun N-terminal Kinase (JNK), and p38. Some MAPKs are atypical in that they are not regulated by MAP2Ks. These include MAPK4, MAPK6, NLK, and ERK7. Length = 330 |
| >gnl|CDD|173706 cd05615, STKc_cPKC_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha | Back alignment and domain information |
|---|
Score = 44.2 bits (104), Expect = 4e-05
Identities = 40/148 (27%), Positives = 73/148 (49%), Gaps = 14/148 (9%)
Query: 10 LGEGSYGVVFKCRNRDTGQVVAIKKFLESEEDPLIR----KIALREIRLLKSL-KHPNLV 64
LG+GS+G V + T ++ AIK ++D +I+ + + E R+L K P L
Sbjct: 8 LGKGSFGKVMLAERKGTDELYAIKIL---KKDVVIQDDDVECTMVEKRVLALQDKPPFLT 64
Query: 65 NLLEVFRRKKKLHLVFEFCDHTVLNELENHPHGLPWDLIKQITW---QVLRGVSYCHRHA 121
L F+ +L+ V E+ + +L H + Q + ++ G+ + HR
Sbjct: 65 QLHSCFQTVDRLYFVMEYVNG---GDLMYHIQQVGKFKEPQAVFYAAEISVGLFFLHRRG 121
Query: 122 CIHRDIKPENILLTANGVVKLCDFGFAR 149
I+RD+K +N++L + G +K+ DFG +
Sbjct: 122 IIYRDLKLDNVMLDSEGHIKIADFGMCK 149
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. PKC-alpha is expressed in many tissues and is associated with cell proliferation, apoptosis, and cell motility. It plays a role in the signaling of the growth factors PDGF, VEGF, EGF, and FGF. Abnormal levels of PKC-alpha have been detected in many transformed cell lines and several human tumors. In addition, PKC-alpha is required for HER2 dependent breast cancer invasion. Length = 323 |
| >gnl|CDD|215036 PLN00034, PLN00034, mitogen-activated protein kinase kinase; Provisional | Back alignment and domain information |
|---|
Score = 43.7 bits (103), Expect = 6e-05
Identities = 14/34 (41%), Positives = 21/34 (61%)
Query: 189 PAATNIYLIDFLKRCLDKDPLRRWSCDQLLRHPY 222
PA + F+ CL ++P +RWS QLL+HP+
Sbjct: 297 PATASREFRHFISCCLQREPAKRWSAMQLLQHPF 330
|
Length = 353 |
| >gnl|CDD|165211 PHA02882, PHA02882, putative serine/threonine kinase; Provisional | Back alignment and domain information |
|---|
Score = 43.4 bits (102), Expect = 6e-05
Identities = 21/60 (35%), Positives = 28/60 (46%)
Query: 89 NELENHPHGLPWDLIKQITWQVLRGVSYCHRHACIHRDIKPENILLTANGVVKLCDFGFA 148
E+ LIK I +L + Y H H H DIKPENI++ N + D+G A
Sbjct: 114 KEIFKRIKCKNKKLIKNIMKDMLTTLEYIHEHGISHGDIKPENIMVDGNNRGYIIDYGIA 173
|
Length = 294 |
| >gnl|CDD|132943 cd06612, STKc_MST1_2, Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2 | Back alignment and domain information |
|---|
Score = 41.5 bits (98), Expect = 2e-04
Identities = 15/28 (53%), Positives = 19/28 (67%)
Query: 196 LIDFLKRCLDKDPLRRWSCDQLLRHPYF 223
DF+K+CL KDP R S QLL+HP+
Sbjct: 229 FNDFVKKCLVKDPEERPSAIQLLQHPFI 256
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a MAPK kinase) and MEKK1 (a MAPK kinase kinase) by acting as a MAPK kinase kinase kinase (MAPKKKK). Activation of JNK by MST1 leads to caspase activation and apoptosis. MST1 has also been implicated in cell proliferation and differentiation. Krs1 may regulate cell growth arrest and apoptosis in response to cellular stress. Length = 256 |
| >gnl|CDD|132940 cd06609, STKc_MST3_like, Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 41.4 bits (98), Expect = 2e-04
Identities = 12/25 (48%), Positives = 17/25 (68%)
Query: 198 DFLKRCLDKDPLRRWSCDQLLRHPY 222
DF+ CL+KDP R S +LL+H +
Sbjct: 229 DFVSLCLNKDPKERPSAKELLKHKF 253
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN) signaling pathway, and plays a role in cytokinesis. SPS1 plays a role in regulating proteins required for spore wall formation. MST4 plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. STK25 may play a role in the regulation of cell migration and polarization. Length = 274 |
| >gnl|CDD|132954 cd06623, PKc_MAPKK_plant_like, Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins | Back alignment and domain information |
|---|
Score = 41.0 bits (97), Expect = 3e-04
Identities = 11/26 (42%), Positives = 15/26 (57%)
Query: 241 QRCLDKDPLRRWSCDQLLRHPYFNGY 266
CL KDP +R S +LL+HP+
Sbjct: 237 SACLQKDPKKRPSAAELLQHPFIKKA 262
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include MAPKKs from plants, kinetoplastids, alveolates, and mycetozoa. The MAPKK, LmxPK4, from Leishmania mexicana, is important in differentiation and virulence. Dictyostelium discoideum MEK1 is required for proper chemotaxis. MEK1 null mutants display severe defects in cell polarization and directional movement. Plants contain multiple MAPKKs like other eukaryotes. The Arabidopsis genome encodes for 10 MAPKKs while poplar and rice contain 13 MAPKKs each. The functions of these proteins have not been fully elucidated. There is evidence to suggest that MAPK cascades are involved in plant stress responses. In Arabidopsis, MKK3 plays a role in pathogen signaling, MKK2 is involved in cold and salt stress signaling, MKK4/MKK5 participates in innate immunity, and MKK7 regulates basal and systemic acquired resistance. Length = 264 |
| >gnl|CDD|173767 cd08227, PK_STRAD_alpha, Pseudokinase domain of STE20-related kinase adapter protein alpha | Back alignment and domain information |
|---|
Score = 41.1 bits (96), Expect = 4e-04
Identities = 32/124 (25%), Positives = 59/124 (47%), Gaps = 4/124 (3%)
Query: 22 RNRDTGQVVAIKKF-LESEEDPLIRKIALREIRLLKSLKHPNLVNLLEVFRRKKKLHLVF 80
R + TG+ V +++ LE+ + ++ + E+ + K HPN+V F +L +V
Sbjct: 20 RYKPTGEYVTVRRINLEACTNEMVTFLQG-ELHVSKLFNHPNIVPYRATFIADNELWVVT 78
Query: 81 EFCDHTVLNEL--ENHPHGLPWDLIKQITWQVLRGVSYCHRHACIHRDIKPENILLTANG 138
F + +L + G+ I I VL+ + Y H +HR +K +IL++ +G
Sbjct: 79 SFMAYGSAKDLICTHFMDGMSELAIAYILQGVLKALDYIHHMGYVHRSVKASHILISVDG 138
Query: 139 VVKL 142
V L
Sbjct: 139 KVYL 142
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) alpha subfamily, pseudokinase domain. The STRAD alpha subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buccal mucosa. There are two forms of STRAD, alpha and beta, that complex with LKB1 and MO25. The structure of STRAD-alpha is available and shows that this protein binds ATP, has an ordered activation loop, and adopts a closed conformation typical of fully active protein kinases. It does not possess activity due to nonconservative substitutions of essential catalytic residues. ATP binding enhances the affinity of STRAD for MO25. The conformation of STRAD-alpha, stabilized through ATP and MO25, may be needed to activate LKB1. A mutation which results in a truncation of a C-terminal part of the human STRAD-alpha pseudokinase domain and disrupts its association with LKB1, leads to PMSE (polyhydramnios, megalencephaly, symptomatic epilepsy) syndrome. Several splice variants of STRAD-alpha exist which exhibit different effects on the localization and activation of LKB1. Length = 327 |
| >gnl|CDD|215061 PLN00113, PLN00113, leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 41.4 bits (97), Expect = 5e-04
Identities = 29/137 (21%), Positives = 60/137 (43%), Gaps = 12/137 (8%)
Query: 10 LGEGSYGVVFKCRNRDTGQVVAIKKFLESEEDPLIRKIALREIRLLKSLKHPNLVNLLEV 69
+ G G +K ++ G +K+ + I EI + L+HPN+V L+ +
Sbjct: 698 ISRGKKGASYKGKSIKNGMQFVVKEINDVNS------IPSSEIADMGKLQHPNIVKLIGL 751
Query: 70 FRRKKKLHLVFEFCDHTVLNELENHPHGLPWDLIKQITWQVLRGVSYCHRH---ACIHRD 126
R +K +L+ E+ + L+E+ L W+ ++I + + + + H A + +
Sbjct: 752 CRSEKGAYLIHEYIEGKNLSEVLR---NLSWERRRKIAIGIAKALRFLHCRCSPAVVVGN 808
Query: 127 IKPENILLTANGVVKLC 143
+ PE I++ L
Sbjct: 809 LSPEKIIIDGKDEPHLR 825
|
Length = 968 |
| >gnl|CDD|173728 cd06614, STKc_PAK, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase | Back alignment and domain information |
|---|
Score = 40.3 bits (95), Expect = 6e-04
Identities = 11/23 (47%), Positives = 17/23 (73%)
Query: 242 RCLDKDPLRRWSCDQLLRHPYFN 264
+CL KDP +R S ++LL+HP+
Sbjct: 252 KCLVKDPEKRPSAEELLQHPFLK 274
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). Group II PAKs contain a PBD and a catalytic domain, but lack other motifs found in group I PAKs. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. Group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX; no such binding has been demonstrated for group II PAKs. Length = 286 |
| >gnl|CDD|173724 cd06606, STKc_MAPKKK, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase | Back alignment and domain information |
|---|
Score = 39.8 bits (94), Expect = 9e-04
Identities = 10/23 (43%), Positives = 18/23 (78%)
Query: 241 QRCLDKDPLRRWSCDQLLRHPYF 263
++CL +DP +R + D+LL+HP+
Sbjct: 238 RKCLRRDPKKRPTADELLQHPFL 260
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKKK5) and ASK2 (or MAPKKK6), MEKK1, MEKK2, MEKK3, MEKK4, as well as plant and fungal MAPKKKs. Also included in this subfamily are the cell division control proteins Schizosaccharomyces pombe Cdc7 and Saccharomyces cerevisiae Cdc15. Length = 260 |
| >gnl|CDD|173756 cd08216, PK_STRAD, Pseudokinase domain of STE20-related kinase adapter protein | Back alignment and domain information |
|---|
Score = 39.3 bits (92), Expect = 0.001
Identities = 12/27 (44%), Positives = 16/27 (59%)
Query: 198 DFLKRCLDKDPLRRWSCDQLLRHPYFN 224
F++ CL +DP R S QLL H +F
Sbjct: 273 QFVELCLQRDPESRPSASQLLNHSFFK 299
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) subfamily, pseudokinase domain. The STRAD subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buccal mucosa. There are two forms of STRAD, alpha and beta, that complex with LKB1 and MO25. The structure of STRAD-alpha is available and shows that this protein binds ATP, has an ordered activation loop, and adopts a closed conformation typical of fully active protein kinases. It does not possess activity due to nonconservative substitutions of essential catalytic residues. ATP binding enhances the affinity of STRAD for MO25. The conformation of STRAD-alpha stabilized through ATP and MO25 may be needed to activate LKB1. Length = 314 |
| >gnl|CDD|215036 PLN00034, PLN00034, mitogen-activated protein kinase kinase; Provisional | Back alignment and domain information |
|---|
Score = 39.0 bits (91), Expect = 0.002
Identities = 11/21 (52%), Positives = 16/21 (76%)
Query: 242 RCLDKDPLRRWSCDQLLRHPY 262
CL ++P +RWS QLL+HP+
Sbjct: 310 CCLQREPAKRWSAMQLLQHPF 330
|
Length = 353 |
| >gnl|CDD|215638 PLN03225, PLN03225, Serine/threonine-protein kinase SNT7; Provisional | Back alignment and domain information |
|---|
Score = 39.0 bits (91), Expect = 0.002
Identities = 47/180 (26%), Positives = 78/180 (43%), Gaps = 47/180 (26%)
Query: 9 KLGEGSYGVVFKCRNRDTGQVVAIKKFLESEEDPLIRK--------IALREIRLLKSLKH 60
KLGEG++GVV+K + K + E +++K I + E R+ ++
Sbjct: 139 KLGEGAFGVVYK--------ASLVNKQSKKEGKYVLKKATEYGAVEIWMNE-RVRRAC-- 187
Query: 61 PN-----LVNLLEVFRRKKK--LHLVFEFCDHTVLNEL---ENHPH-----------GLP 99
PN + LE KK+ LV+ + + L +L + P+ LP
Sbjct: 188 PNSCADFVYGFLEPVSSKKEDEYWLVWRYEGESTLADLMQSKEFPYNVEPYLLGKVQDLP 247
Query: 100 WDL------IKQITWQVLRGVSYCHRHACIHRDIKPENILLT-ANGVVKLCDFGFARLIR 152
L I+ I Q+L + H +HRD+KP+NI+ + +G K+ D G A +R
Sbjct: 248 KGLERENKIIQTIMRQILFALDGLHSTGIVHRDVKPQNIIFSEGSGSFKIIDLGAAADLR 307
|
Length = 566 |
| >gnl|CDD|173734 cd07830, STKc_MAK_like, Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 37.5 bits (88), Expect = 0.004
Identities = 13/28 (46%), Positives = 17/28 (60%)
Query: 196 LIDFLKRCLDKDPLRRWSCDQLLRHPYF 223
ID +K L DP +R + Q L+HPYF
Sbjct: 256 AIDLIKDMLRWDPKKRPTASQALQHPYF 283
|
Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertility. It functions as a coactivator of the androgen receptor in prostate cells. MRK, also called Intestinal Cell Kinase (ICK), is expressed ubiquitously, with highest expression in the ovary and uterus. A missense mutation in MRK causes endocrine-cerebro-osteodysplasia (ECO), suggesting that this protein plays an important role in the development of many organs. MAK and MRK may be involved in regulating cell cycle and cell fate. Ime2p is a meiosis-specific kinase that is important during meiotic initiation and during the later stages of meiosis. Mde3 functions downstream of the transcription factor Mei-4 which is essential for meiotic prophase I. Length = 283 |
| >gnl|CDD|173756 cd08216, PK_STRAD, Pseudokinase domain of STE20-related kinase adapter protein | Back alignment and domain information |
|---|
Score = 37.7 bits (88), Expect = 0.004
Identities = 11/26 (42%), Positives = 14/26 (53%)
Query: 239 ITQRCLDKDPLRRWSCDQLLRHPYFN 264
+ CL +DP R S QLL H +F
Sbjct: 274 FVELCLQRDPESRPSASQLLNHSFFK 299
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) subfamily, pseudokinase domain. The STRAD subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buccal mucosa. There are two forms of STRAD, alpha and beta, that complex with LKB1 and MO25. The structure of STRAD-alpha is available and shows that this protein binds ATP, has an ordered activation loop, and adopts a closed conformation typical of fully active protein kinases. It does not possess activity due to nonconservative substitutions of essential catalytic residues. ATP binding enhances the affinity of STRAD for MO25. The conformation of STRAD-alpha stabilized through ATP and MO25 may be needed to activate LKB1. Length = 314 |
Conserved Domains Detected by HHsearch
Original result of HHsearch against CDD database
| ID | Alignment Graph | Length |
Definition |
Probability |
| Query | 292 | |||
| KOG0575|consensus | 592 | 100.0 | ||
| KOG0615|consensus | 475 | 100.0 | ||
| KOG0593|consensus | 396 | 100.0 | ||
| KOG0581|consensus | 364 | 100.0 | ||
| KOG0598|consensus | 357 | 100.0 | ||
| KOG0592|consensus | 604 | 100.0 | ||
| KOG0616|consensus | 355 | 100.0 | ||
| KOG0659|consensus | 318 | 100.0 | ||
| KOG0661|consensus | 538 | 100.0 | ||
| KOG0605|consensus | 550 | 100.0 | ||
| KOG0583|consensus | 370 | 100.0 | ||
| KOG0597|consensus | 808 | 100.0 | ||
| KOG0595|consensus | 429 | 100.0 | ||
| KOG0600|consensus | 560 | 100.0 | ||
| KOG0198|consensus | 313 | 100.0 | ||
| KOG0578|consensus | 550 | 100.0 | ||
| cd05612 | 291 | STKc_PRKX_like Catalytic domain of PRKX-like Prote | 100.0 | |
| KOG0610|consensus | 459 | 100.0 | ||
| KOG0585|consensus | 576 | 100.0 | ||
| PTZ00263 | 329 | protein kinase A catalytic subunit; Provisional | 100.0 | |
| KOG0588|consensus | 786 | 100.0 | ||
| KOG0591|consensus | 375 | 100.0 | ||
| cd05571 | 323 | STKc_PKB Catalytic domain of the Protein Serine/Th | 100.0 | |
| KOG0582|consensus | 516 | 100.0 | ||
| KOG0694|consensus | 694 | 100.0 | ||
| cd07848 | 287 | STKc_CDKL5 Catalytic domain of the Serine/Threonin | 100.0 | |
| KOG0611|consensus | 668 | 100.0 | ||
| PTZ00426 | 340 | cAMP-dependent protein kinase catalytic subunit; P | 100.0 | |
| KOG0580|consensus | 281 | 100.0 | ||
| cd05573 | 350 | STKc_ROCK_NDR_like Catalytic domain of ROCK- and N | 100.0 | |
| cd05593 | 328 | STKc_PKB_gamma Catalytic domain of the Protein Ser | 100.0 | |
| KOG0660|consensus | 359 | 100.0 | ||
| cd05595 | 323 | STKc_PKB_beta Catalytic domain of the Protein Seri | 100.0 | |
| cd05600 | 333 | STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p- | 100.0 | |
| cd05601 | 330 | STKc_CRIK Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07869 | 303 | STKc_PFTAIRE1 Catalytic domain of the Serine/Threo | 100.0 | |
| cd05594 | 325 | STKc_PKB_alpha Catalytic domain of the Protein Ser | 100.0 | |
| cd07871 | 288 | STKc_PCTAIRE3 Catalytic domain of the Serine/Threo | 100.0 | |
| KOG0033|consensus | 355 | 100.0 | ||
| cd05585 | 312 | STKc_YPK1_like Catalytic domain of Yeast Protein K | 100.0 | |
| cd05599 | 364 | STKc_NDR_like Catalytic domain of Nuclear Dbf2-Rel | 100.0 | |
| KOG0599|consensus | 411 | 100.0 | ||
| KOG0663|consensus | 419 | 100.0 | ||
| cd05590 | 320 | STKc_nPKC_eta Catalytic domain of the Protein Seri | 100.0 | |
| cd05628 | 363 | STKc_NDR1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07859 | 338 | STKc_TDY_MAPK_plant Catalytic domain of the Serine | 100.0 | |
| cd05631 | 285 | STKc_GRK4 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0032|consensus | 382 | 100.0 | ||
| cd05629 | 377 | STKc_NDR_like_fungal Catalytic domain of Fungal Nu | 100.0 | |
| cd05596 | 370 | STKc_ROCK Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05582 | 318 | STKc_RSK_N N-terminal catalytic domain of the Prot | 100.0 | |
| cd05589 | 324 | STKc_PKN Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05591 | 321 | STKc_nPKC_epsilon Catalytic domain of the Protein | 100.0 | |
| cd05587 | 324 | STKc_cPKC Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05626 | 381 | STKc_LATS2 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05614 | 332 | STKc_MSK2_N N-terminal catalytic domain of the Pro | 100.0 | |
| cd05627 | 360 | STKc_NDR2 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0690|consensus | 516 | 100.0 | ||
| cd07876 | 359 | STKc_JNK2 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd06649 | 331 | PKc_MEK2 Catalytic domain of the dual-specificity | 100.0 | |
| cd05570 | 318 | STKc_PKC Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd06650 | 333 | PKc_MEK1 Catalytic domain of the dual-specificity | 100.0 | |
| cd05588 | 329 | STKc_aPKC Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05598 | 376 | STKc_LATS Catalytic domain of the Protein Serine/T | 100.0 | |
| PHA03212 | 391 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd05575 | 323 | STKc_SGK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05618 | 329 | STKc_aPKC_iota Catalytic domain of the Protein Ser | 100.0 | |
| cd05584 | 323 | STKc_p70S6K Catalytic domain of the Protein Serine | 100.0 | |
| cd05625 | 382 | STKc_LATS1 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05592 | 316 | STKc_nPKC_theta_delta Catalytic domain of the Prot | 100.0 | |
| cd07839 | 284 | STKc_CDK5 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd07853 | 372 | STKc_NLK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05620 | 316 | STKc_nPKC_delta Catalytic domain of the Protein Se | 100.0 | |
| KOG0594|consensus | 323 | 100.0 | ||
| KOG0586|consensus | 596 | 100.0 | ||
| cd07875 | 364 | STKc_JNK1 Catalytic domain of the Serine/Threonine | 100.0 | |
| KOG0589|consensus | 426 | 100.0 | ||
| cd05616 | 323 | STKc_cPKC_beta Catalytic domain of the Protein Ser | 100.0 | |
| cd05619 | 316 | STKc_nPKC_theta Catalytic domain of the Protein Se | 100.0 | |
| cd05621 | 370 | STKc_ROCK2 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd07878 | 343 | STKc_p38beta_MAPK11 Catalytic domain of the Serine | 100.0 | |
| cd05608 | 280 | STKc_GRK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05597 | 331 | STKc_DMPK_like Catalytic domain of Myotonic Dystro | 100.0 | |
| KOG0192|consensus | 362 | 100.0 | ||
| cd05615 | 323 | STKc_cPKC_alpha Catalytic domain of the Protein Se | 100.0 | |
| cd07874 | 355 | STKc_JNK3 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd07872 | 309 | STKc_PCTAIRE2 Catalytic domain of the Serine/Threo | 100.0 | |
| cd05605 | 285 | STKc_GRK4_like Catalytic domain of G protein-coupl | 100.0 | |
| cd05580 | 290 | STKc_PKA Catalytic domain of the Protein Serine/Th | 100.0 | |
| PF00069 | 260 | Pkinase: Protein kinase domain Protein kinase; unc | 100.0 | |
| PLN00034 | 353 | mitogen-activated protein kinase kinase; Provision | 100.0 | |
| KOG0658|consensus | 364 | 100.0 | ||
| cd07873 | 301 | STKc_PCTAIRE1 Catalytic domain of the Serine/Threo | 100.0 | |
| cd05622 | 371 | STKc_ROCK1 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05604 | 325 | STKc_SGK3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05603 | 321 | STKc_SGK2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05586 | 330 | STKc_Sck1_like Catalytic domain of Suppressor of l | 100.0 | |
| cd05617 | 327 | STKc_aPKC_zeta Catalytic domain of the Protein Ser | 100.0 | |
| cd06625 | 263 | STKc_MEKK3_like Catalytic domain of MAP/ERK kinase | 100.0 | |
| cd05602 | 325 | STKc_SGK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07847 | 286 | STKc_CDKL1_4 Catalytic domain of the Serine/Threon | 100.0 | |
| PTZ00036 | 440 | glycogen synthase kinase; Provisional | 100.0 | |
| KOG0201|consensus | 467 | 100.0 | ||
| cd05574 | 316 | STKc_phototropin_like Catalytic domain of Phototro | 100.0 | |
| cd07862 | 290 | STKc_CDK6 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd07863 | 288 | STKc_CDK4 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd07841 | 298 | STKc_CDK7 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05624 | 331 | STKc_MRCK_beta Catalytic domain of the Protein Ser | 100.0 | |
| cd05578 | 258 | STKc_Yank1 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd07846 | 286 | STKc_CDKL2_3 Catalytic domain of the Serine/Threon | 100.0 | |
| cd08227 | 327 | PK_STRAD_alpha Pseudokinase domain of STE20-relate | 100.0 | |
| cd08223 | 257 | STKc_Nek4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd08529 | 256 | STKc_FA2-like Catalytic domain of the Protein Seri | 100.0 | |
| cd05623 | 332 | STKc_MRCK_alpha Catalytic domain of the Protein Se | 100.0 | |
| KOG0667|consensus | 586 | 100.0 | ||
| cd06615 | 308 | PKc_MEK Catalytic domain of the dual-specificity P | 100.0 | |
| PHA03209 | 357 | serine/threonine kinase US3; Provisional | 100.0 | |
| PTZ00283 | 496 | serine/threonine protein kinase; Provisional | 100.0 | |
| cd06610 | 267 | STKc_OSR1_SPAK Catalytic domain of the Protein Ser | 100.0 | |
| cd07833 | 288 | STKc_CDKL Catalytic domain of Cyclin-Dependent pro | 100.0 | |
| cd06644 | 292 | STKc_STK10_LOK Catalytic domain of the Protein Ser | 100.0 | |
| cd08218 | 256 | STKc_Nek1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06611 | 280 | STKc_SLK_like Catalytic domain of Ste20-like kinas | 100.0 | |
| KOG4717|consensus | 864 | 100.0 | ||
| cd07845 | 309 | STKc_CDK10 Catalytic domain of the Serine/Threonin | 100.0 | |
| cd05607 | 277 | STKc_GRK7 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05572 | 262 | STKc_cGK_PKG Catalytic domain of the Protein Serin | 100.0 | |
| cd07832 | 286 | STKc_CCRK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd06628 | 267 | STKc_MAPKKK_Byr2_like Catalytic domain of fungal B | 100.0 | |
| PTZ00267 | 478 | NIMA-related protein kinase; Provisional | 100.0 | |
| cd06609 | 274 | STKc_MST3_like Catalytic domain of Mammalian Ste20 | 100.0 | |
| cd05609 | 305 | STKc_MAST Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06626 | 264 | STKc_MEKK4 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd07861 | 285 | STKc_CDK1_euk Catalytic domain of the Serine/Threo | 100.0 | |
| KOG0197|consensus | 468 | 100.0 | ||
| cd07850 | 353 | STKc_JNK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd06643 | 282 | STKc_SLK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd06622 | 286 | PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS | 100.0 | |
| cd05581 | 280 | STKc_PDK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05579 | 265 | STKc_MAST_like Catalytic domain of Microtubule-ass | 100.0 | |
| KOG0612|consensus | 1317 | 100.0 | ||
| cd05630 | 285 | STKc_GRK6 Catalytic domain of the Protein Serine/T | 100.0 | |
| PHA03207 | 392 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd07870 | 291 | STKc_PFTAIRE2 Catalytic domain of the Serine/Threo | 100.0 | |
| PHA03211 | 461 | serine/threonine kinase US3; Provisional | 100.0 | |
| KOG0579|consensus | 1187 | 100.0 | ||
| cd07834 | 330 | STKc_MAPK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd08221 | 256 | STKc_Nek9 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07843 | 293 | STKc_CDC2L1 Catalytic domain of the Serine/Threoni | 100.0 | |
| cd07844 | 291 | STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like | 100.0 | |
| cd06605 | 265 | PKc_MAPKK Catalytic domain of the dual-specificity | 100.0 | |
| cd07855 | 334 | STKc_ERK5 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd06654 | 296 | STKc_PAK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07831 | 282 | STKc_MOK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd07865 | 310 | STKc_CDK9 Catalytic domain of the Serine/Threonine | 100.0 | |
| KOG0662|consensus | 292 | 100.0 | ||
| cd07860 | 284 | STKc_CDK2_3 Catalytic domain of the Serine/Threoni | 100.0 | |
| cd06608 | 275 | STKc_myosinIII_like Catalytic domain of Class III | 100.0 | |
| cd05577 | 277 | STKc_GRK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd06645 | 267 | STKc_MAP4K3 Catalytic domain of the Protein Serine | 100.0 | |
| PTZ00266 | 1021 | NIMA-related protein kinase; Provisional | 100.0 | |
| cd06656 | 297 | STKc_PAK3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06631 | 265 | STKc_YSK4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06612 | 256 | STKc_MST1_2 Catalytic domain of the Protein Serine | 100.0 | |
| PTZ00284 | 467 | protein kinase; Provisional | 100.0 | |
| cd06619 | 279 | PKc_MKK5 Catalytic domain of the dual-specificity | 100.0 | |
| cd06630 | 268 | STKc_MEKK1 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd07858 | 337 | STKc_TEY_MAPK_plant Catalytic domain of the Serine | 100.0 | |
| cd06646 | 267 | STKc_MAP4K5 Catalytic domain of the Protein Serine | 100.0 | |
| cd06651 | 266 | STKc_MEKK3 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd07864 | 302 | STKc_CDK12 Catalytic domain of the Serine/Threonin | 100.0 | |
| cd06613 | 262 | STKc_MAP4K3_like Catalytic domain of Mitogen-activ | 100.0 | |
| cd06629 | 272 | STKc_MAPKKK_Bck1_like Catalytic domain of fungal B | 100.0 | |
| cd06655 | 296 | STKc_PAK2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05632 | 285 | STKc_GRK5 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG2345|consensus | 302 | 100.0 | ||
| PLN00009 | 294 | cyclin-dependent kinase A; Provisional | 100.0 | |
| cd08220 | 256 | STKc_Nek8 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05118 | 283 | STKc_CMGC Catalytic domain of CMGC family Serine/T | 100.0 | |
| cd06623 | 264 | PKc_MAPKK_plant_like Catalytic domain of Plant dua | 100.0 | |
| cd07866 | 311 | STKc_BUR1 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05102 | 338 | PTKc_VEGFR3 Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd08217 | 265 | STKc_Nek2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd08215 | 258 | STKc_Nek Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd06658 | 292 | STKc_PAK5 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG1989|consensus | 738 | 100.0 | ||
| cd05611 | 260 | STKc_Rim15_like Catalytic domain of fungal Rim15-l | 100.0 | |
| cd06642 | 277 | STKc_STK25-YSK1 Catalytic domain of the Protein Se | 100.0 | |
| cd06632 | 258 | STKc_MEKK1_plant Catalytic domain of the Protein S | 100.0 | |
| KOG0574|consensus | 502 | 100.0 | ||
| cd06607 | 307 | STKc_TAO Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd08225 | 257 | STKc_Nek5 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06637 | 272 | STKc_TNIK Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07851 | 343 | STKc_p38 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05633 | 279 | STKc_GRK3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07837 | 295 | STKc_CdkB_plant Catalytic domain of the Serine/Thr | 100.0 | |
| cd07880 | 343 | STKc_p38gamma_MAPK12 Catalytic domain of the Serin | 100.0 | |
| cd07854 | 342 | STKc_MAPK4_6 Catalytic domain of the Serine/Threon | 100.0 | |
| cd07835 | 283 | STKc_CDK1_like Catalytic domain of Cyclin-Dependen | 100.0 | |
| cd07842 | 316 | STKc_CDK8_like Catalytic domain of Cyclin-Dependen | 100.0 | |
| cd06627 | 254 | STKc_Cdc7_like Catalytic domain of Cell division c | 100.0 | |
| cd07849 | 336 | STKc_ERK1_2_like Catalytic domain of Extracellular | 100.0 | |
| cd07868 | 317 | STKc_CDK8 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05096 | 304 | PTKc_DDR1 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd08226 | 328 | PK_STRAD_beta Pseudokinase domain of STE20-related | 100.0 | |
| cd06617 | 283 | PKc_MKK3_6 Catalytic domain of the dual-specificit | 100.0 | |
| cd06606 | 260 | STKc_MAPKKK Catalytic domain of the Protein Serine | 100.0 | |
| PHA02988 | 283 | hypothetical protein; Provisional | 100.0 | |
| cd05104 | 375 | PTKc_Kit Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd07852 | 337 | STKc_MAPK15 Catalytic domain of the Serine/Threoni | 100.0 | |
| KOG4236|consensus | 888 | 100.0 | ||
| cd06652 | 265 | STKc_MEKK2 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05123 | 250 | STKc_AGC Catalytic domain of AGC family Protein Se | 100.0 | |
| cd06639 | 291 | STKc_myosinIIIB Catalytic domain of the Protein Se | 100.0 | |
| KOG0607|consensus | 463 | 100.0 | ||
| cd06647 | 293 | STKc_PAK_I Catalytic domain of the Protein Serine/ | 100.0 | |
| cd06640 | 277 | STKc_MST4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06641 | 277 | STKc_MST3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07836 | 284 | STKc_Pho85 Catalytic domain of the Serine/Threonin | 100.0 | |
| cd07829 | 282 | STKc_CDK_like Catalytic domain of Cyclin-Dependent | 100.0 | |
| cd06917 | 277 | STKc_NAK1_like Catalytic domain of Fungal Nak1-lik | 100.0 | |
| cd08530 | 256 | STKc_CNK2-like Catalytic domain of the Protein Ser | 100.0 | |
| cd07840 | 287 | STKc_CDK9_like Catalytic domain of Cyclin-Dependen | 100.0 | |
| cd06638 | 286 | STKc_myosinIIIA Catalytic domain of the Protein Se | 100.0 | |
| cd05061 | 288 | PTKc_InsR Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06636 | 282 | STKc_MAP4K4_6 Catalytic domain of the Protein Seri | 100.0 | |
| cd06620 | 284 | PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr | 100.0 | |
| cd06659 | 297 | STKc_PAK6 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd08228 | 267 | STKc_Nek6 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0604|consensus | 400 | 100.0 | ||
| cd07879 | 342 | STKc_p38delta_MAPK13 Catalytic domain of the Serin | 100.0 | |
| cd05606 | 278 | STKc_beta_ARK Catalytic domain of the Protein Seri | 100.0 | |
| KOG0666|consensus | 438 | 100.0 | ||
| PHA03390 | 267 | pk1 serine/threonine-protein kinase 1; Provisional | 100.0 | |
| cd06614 | 286 | STKc_PAK Catalytic domain of the Protein Serine/Th | 100.0 | |
| KOG0614|consensus | 732 | 100.0 | ||
| cd06621 | 287 | PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek | 100.0 | |
| cd07877 | 345 | STKc_p38alpha_MAPK14 Catalytic domain of the Serin | 100.0 | |
| cd08219 | 255 | STKc_Nek3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06648 | 285 | STKc_PAK_II Catalytic domain of the Protein Serine | 100.0 | |
| PTZ00024 | 335 | cyclin-dependent protein kinase; Provisional | 100.0 | |
| cd05613 | 290 | STKc_MSK1_N N-terminal catalytic domain of the Pro | 100.0 | |
| cd05106 | 374 | PTKc_CSF-1R Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05088 | 303 | PTKc_Tie2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05064 | 266 | PTKc_EphR_A10 Catalytic domain of the Protein Tyro | 100.0 | |
| cd06616 | 288 | PKc_MKK4 Catalytic domain of the dual-specificity | 100.0 | |
| KOG0577|consensus | 948 | 100.0 | ||
| cd08229 | 267 | STKc_Nek7 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07867 | 317 | STKc_CDC2L6 Catalytic domain of Serine/Threonine K | 100.0 | |
| cd05122 | 253 | PKc_STE Catalytic domain of STE family Protein Kin | 100.0 | |
| cd06624 | 268 | STKc_ASK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05583 | 288 | STKc_MSK_N N-terminal catalytic domain of the Prot | 100.0 | |
| cd05052 | 263 | PTKc_Abl Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd07830 | 283 | STKc_MAK_like Catalytic domain of Male germ cell-A | 100.0 | |
| cd06633 | 313 | STKc_TAO3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05084 | 252 | PTKc_Fes Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05048 | 283 | PTKc_Ror Catalytic Domain of the Protein Tyrosine | 100.0 | |
| cd06618 | 296 | PKc_MKK7 Catalytic domain of the dual-specificity | 100.0 | |
| cd06634 | 308 | STKc_TAO2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd08216 | 314 | PK_STRAD Pseudokinase domain of STE20-related kina | 100.0 | |
| cd08224 | 267 | STKc_Nek6_Nek7 Catalytic domain of the Protein Ser | 100.0 | |
| PRK13184 | 932 | pknD serine/threonine-protein kinase; Reviewed | 100.0 | |
| cd06653 | 264 | STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kina | 100.0 | |
| cd07857 | 332 | STKc_MPK1 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd07856 | 328 | STKc_Sty1_Hog1 Catalytic domain of the Serine/Thre | 100.0 | |
| KOG1187|consensus | 361 | 100.0 | ||
| cd05114 | 256 | PTKc_Tec_Rlk Catalytic domain of the Protein Tyros | 100.0 | |
| cd06657 | 292 | STKc_PAK4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05035 | 273 | PTKc_Axl_like Catalytic Domain of Axl-like Protein | 100.0 | |
| cd05079 | 284 | PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the | 100.0 | |
| cd06635 | 317 | STKc_TAO1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05039 | 256 | PTKc_Csk_like Catalytic domain of C-terminal Src k | 100.0 | |
| cd07838 | 287 | STKc_CDK4_6_like Catalytic domain of Cyclin-Depend | 100.0 | |
| PHA03210 | 501 | serine/threonine kinase US3; Provisional | 100.0 | |
| KOG4279|consensus | 1226 | 100.0 | ||
| KOG0194|consensus | 474 | 100.0 | ||
| cd05090 | 283 | PTKc_Ror1 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05059 | 256 | PTKc_Tec_like Catalytic domain of Tec-like Protein | 100.0 | |
| cd05033 | 266 | PTKc_EphR Catalytic domain of Ephrin Receptor Prot | 100.0 | |
| cd05053 | 293 | PTKc_FGFR Catalytic domain of the Protein Tyrosine | 100.0 | |
| PF07714 | 259 | Pkinase_Tyr: Protein tyrosine kinase Protein kinas | 100.0 | |
| cd05093 | 288 | PTKc_TrkB Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05062 | 277 | PTKc_IGF-1R Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05054 | 337 | PTKc_VEGFR Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05113 | 256 | PTKc_Btk_Bmx Catalytic domain of the Protein Tyros | 100.0 | |
| cd05068 | 261 | PTKc_Frk_like Catalytic domain of Fyn-related kina | 100.0 | |
| cd00192 | 262 | PTKc Catalytic domain of Protein Tyrosine Kinases. | 100.0 | |
| cd05051 | 296 | PTKc_DDR Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05089 | 297 | PTKc_Tie1 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd08222 | 260 | STKc_Nek11 Catalytic domain of the Protein Serine/ | 100.0 | |
| KOG4645|consensus | 1509 | 100.0 | ||
| cd05049 | 280 | PTKc_Trk Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG0986|consensus | 591 | 100.0 | ||
| cd05097 | 295 | PTKc_DDR_like Catalytic domain of Discoidin Domain | 100.0 | |
| cd05080 | 283 | PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the | 100.0 | |
| cd05116 | 257 | PTKc_Syk Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG0596|consensus | 677 | 100.0 | ||
| cd05075 | 272 | PTKc_Axl Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05108 | 316 | PTKc_EGFR Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05148 | 261 | PTKc_Srm_Brk Catalytic domain of the Protein Tyros | 100.0 | |
| cd05066 | 267 | PTKc_EphR_A Catalytic domain of the Protein Tyrosi | 100.0 | |
| KOG0983|consensus | 391 | 100.0 | ||
| cd05060 | 257 | PTKc_Syk_like Catalytic domain of Spleen Tyrosine | 100.0 | |
| cd05032 | 277 | PTKc_InsR_like Catalytic domain of Insulin Recepto | 100.0 | |
| cd05036 | 277 | PTKc_ALK_LTK Catalytic domain of the Protein Tyros | 100.0 | |
| cd05072 | 261 | PTKc_Lyn Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05095 | 296 | PTKc_DDR2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05055 | 302 | PTKc_PDGFR Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05103 | 343 | PTKc_VEGFR2 Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05576 | 237 | STKc_RPK118_like Catalytic domain of the Protein S | 100.0 | |
| cd05091 | 283 | PTKc_Ror2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG1035|consensus | 1351 | 100.0 | ||
| cd05046 | 275 | PTK_CCK4 Pseudokinase domain of the Protein Tyrosi | 100.0 | |
| cd05105 | 400 | PTKc_PDGFR_alpha Catalytic domain of the Protein T | 100.0 | |
| cd05098 | 307 | PTKc_FGFR1 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05065 | 269 | PTKc_EphR_B Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05081 | 284 | PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of | 100.0 | |
| cd05070 | 260 | PTKc_Fyn_Yrk Catalytic domain of the Protein Tyros | 100.0 | |
| cd05034 | 261 | PTKc_Src_like Catalytic domain of Src kinase-like | 100.0 | |
| cd05094 | 291 | PTKc_TrkC Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05071 | 262 | PTKc_Src Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05038 | 284 | PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the P | 100.0 | |
| cd05099 | 314 | PTKc_FGFR4 Catalytic domain of the Protein Tyrosin | 100.0 | |
| smart00219 | 258 | TyrKc Tyrosine kinase, catalytic domain. Phosphotr | 100.0 | |
| cd05082 | 256 | PTKc_Csk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05050 | 288 | PTKc_Musk Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG0671|consensus | 415 | 100.0 | ||
| cd05063 | 268 | PTKc_EphR_A2 Catalytic domain of the Protein Tyros | 100.0 | |
| cd05040 | 257 | PTKc_Ack_like Catalytic domain of the Protein Tyro | 100.0 | |
| KOG0695|consensus | 593 | 100.0 | ||
| cd05101 | 304 | PTKc_FGFR2 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05045 | 290 | PTKc_RET Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG0584|consensus | 632 | 100.0 | ||
| cd05100 | 334 | PTKc_FGFR3 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05037 | 259 | PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the | 100.0 | |
| cd05043 | 280 | PTK_Ryk Pseudokinase domain of Ryk (Receptor relat | 100.0 | |
| cd05047 | 270 | PTKc_Tie Catalytic domain of Tie Protein Tyrosine | 100.0 | |
| cd05109 | 279 | PTKc_HER2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05041 | 251 | PTKc_Fes_like Catalytic domain of Fes-like Protein | 100.0 | |
| cd05057 | 279 | PTKc_EGFR_like Catalytic domain of Epidermal Growt | 100.0 | |
| cd05092 | 280 | PTKc_TrkA Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05107 | 401 | PTKc_PDGFR_beta Catalytic domain of the Protein Ty | 100.0 | |
| cd05115 | 257 | PTKc_Zap-70 Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05069 | 260 | PTKc_Yes Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05112 | 256 | PTKc_Itk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05056 | 270 | PTKc_FAK Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG0603|consensus | 612 | 100.0 | ||
| cd05067 | 260 | PTKc_Lck_Blk Catalytic domain of the Protein Tyros | 100.0 | |
| cd05610 | 669 | STKc_MASTL Catalytic domain of the Protein Serine/ | 100.0 | |
| KOG0696|consensus | 683 | 100.0 | ||
| cd05083 | 254 | PTKc_Chk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05111 | 279 | PTK_HER3 Pseudokinase domain of the Protein Tyrosi | 100.0 | |
| cd05073 | 260 | PTKc_Hck Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05085 | 250 | PTKc_Fer Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05077 | 262 | PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of th | 100.0 | |
| PLN03225 | 566 | Serine/threonine-protein kinase SNT7; Provisional | 100.0 | |
| cd05076 | 274 | PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of th | 100.0 | |
| KOG0193|consensus | 678 | 100.0 | ||
| cd08528 | 269 | STKc_Nek10 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05042 | 269 | PTKc_Aatyk Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05078 | 258 | PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain | 100.0 | |
| KOG0608|consensus | 1034 | 100.0 | ||
| KOG0669|consensus | 376 | 100.0 | ||
| KOG4721|consensus | 904 | 100.0 | ||
| cd05058 | 262 | PTKc_Met_Ron Catalytic domain of the Protein Tyros | 100.0 | |
| cd05110 | 303 | PTKc_HER4 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05074 | 273 | PTKc_Tyro3 Catalytic domain of the Protein Tyrosin | 100.0 | |
| KOG0668|consensus | 338 | 100.0 | ||
| cd05044 | 269 | PTKc_c-ros Catalytic domain of the Protein Tyrosin | 100.0 | |
| KOG4250|consensus | 732 | 100.0 | ||
| cd05087 | 269 | PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein | 100.0 | |
| KOG1026|consensus | 774 | 100.0 | ||
| smart00220 | 244 | S_TKc Serine/Threonine protein kinases, catalytic | 100.0 | |
| KOG0670|consensus | 752 | 100.0 | ||
| cd05086 | 268 | PTKc_Aatyk2 Catalytic domain of the Protein Tyrosi | 100.0 | |
| KOG0587|consensus | 953 | 100.0 | ||
| KOG0576|consensus | 829 | 100.0 | ||
| KOG4257|consensus | 974 | 100.0 | ||
| KOG1290|consensus | 590 | 100.0 | ||
| KOG1151|consensus | 775 | 100.0 | ||
| KOG1095|consensus | 1025 | 100.0 | ||
| PLN03224 | 507 | probable serine/threonine protein kinase; Provisio | 100.0 | |
| KOG1006|consensus | 361 | 99.98 | ||
| KOG0665|consensus | 369 | 99.97 | ||
| KOG1094|consensus | 807 | 99.97 | ||
| PHA02882 | 294 | putative serine/threonine kinase; Provisional | 99.97 | |
| KOG0199|consensus | 1039 | 99.97 | ||
| KOG0196|consensus | 996 | 99.97 | ||
| KOG0664|consensus | 449 | 99.97 | ||
| KOG1027|consensus | 903 | 99.97 | ||
| KOG1152|consensus | 772 | 99.97 | ||
| PLN00113 | 968 | leucine-rich repeat receptor-like protein kinase; | 99.97 | |
| cd00180 | 215 | PKc Catalytic domain of Protein Kinases. Protein K | 99.97 | |
| KOG4278|consensus | 1157 | 99.96 | ||
| KOG1167|consensus | 418 | 99.96 | ||
| KOG3653|consensus | 534 | 99.96 | ||
| KOG0200|consensus | 609 | 99.95 | ||
| KOG2052|consensus | 513 | 99.95 | ||
| KOG1345|consensus | 378 | 99.95 | ||
| PRK09188 | 365 | serine/threonine protein kinase; Provisional | 99.95 | |
| KOG1025|consensus | 1177 | 99.95 | ||
| cd05147 | 190 | RIO1_euk RIO kinase family; eukaryotic RIO1, catal | 99.94 | |
| KOG0984|consensus | 282 | 99.93 | ||
| KOG0590|consensus | 601 | 99.93 | ||
| smart00221 | 225 | STYKc Protein kinase; unclassified specificity. Ph | 99.93 | |
| cd05145 | 190 | RIO1_like RIO kinase family; RIO1, RIO3 and simila | 99.92 | |
| PLN00181 | 793 | protein SPA1-RELATED; Provisional | 99.91 | |
| KOG1024|consensus | 563 | 99.89 | ||
| PRK10359 | 232 | lipopolysaccharide core biosynthesis protein; Prov | 99.89 | |
| KOG1163|consensus | 341 | 99.89 | ||
| smart00090 | 237 | RIO RIO-like kinase. | 99.89 | |
| PRK10345 | 210 | hypothetical protein; Provisional | 99.88 | |
| KOG1164|consensus | 322 | 99.86 | ||
| PRK14879 | 211 | serine/threonine protein kinase; Provisional | 99.85 | |
| PRK12274 | 218 | serine/threonine protein kinase; Provisional | 99.85 | |
| COG0515 | 384 | SPS1 Serine/threonine protein kinase [General func | 99.85 | |
| smart00750 | 176 | KIND kinase non-catalytic C-lobe domain. It is an | 99.85 | |
| cd05144 | 198 | RIO2_C RIO kinase family; RIO2, C-terminal catalyt | 99.84 | |
| TIGR03724 | 199 | arch_bud32 Kae1-associated kinase Bud32. Members o | 99.83 | |
| KOG1165|consensus | 449 | 99.83 | ||
| KOG1240|consensus | 1431 | 99.82 | ||
| PRK09605 | 535 | bifunctional UGMP family protein/serine/threonine | 99.81 | |
| cd05119 | 187 | RIO RIO kinase family, catalytic domain. The RIO k | 99.8 | |
| KOG0603|consensus | 612 | 99.8 | ||
| PRK01723 | 239 | 3-deoxy-D-manno-octulosonic-acid kinase; Reviewed | 99.78 | |
| KOG1166|consensus | 974 | 99.77 | ||
| KOG4158|consensus | 598 | 99.77 | ||
| PF14531 | 288 | Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_ | 99.76 | |
| KOG0606|consensus | 1205 | 99.76 | ||
| KOG0195|consensus | 448 | 99.76 | ||
| cd05120 | 155 | APH_ChoK_like Aminoglycoside 3'-phosphotransferase | 99.76 | |
| KOG0590|consensus | 601 | 99.68 | ||
| PRK04750 | 537 | ubiB putative ubiquinone biosynthesis protein UbiB | 99.65 | |
| KOG1023|consensus | 484 | 99.64 | ||
| cd05146 | 197 | RIO3_euk RIO kinase family; eukaryotic RIO3, catal | 99.62 | |
| TIGR01982 | 437 | UbiB 2-polyprenylphenol 6-hydroxylase. This model | 99.58 | |
| cd05151 | 170 | ChoK Choline Kinase (ChoK). The ChoK subfamily is | 99.55 | |
| COG3642 | 204 | Mn2+-dependent serine/threonine protein kinase [Si | 99.51 | |
| KOG0601|consensus | 524 | 99.48 | ||
| KOG1266|consensus | 458 | 99.45 | ||
| KOG1243|consensus | 690 | 99.44 | ||
| KOG3087|consensus | 229 | 99.41 | ||
| KOG1033|consensus | 516 | 99.4 | ||
| cd05154 | 223 | ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 an | 99.39 | |
| PRK15123 | 268 | lipopolysaccharide core heptose(I) kinase RfaP; Pr | 99.36 | |
| PF01163 | 188 | RIO1: RIO1 family; InterPro: IPR018934 Protein pho | 99.33 | |
| KOG0606|consensus | 1205 | 99.33 | ||
| KOG0601|consensus | 524 | 99.31 | ||
| KOG3741|consensus | 655 | 99.28 | ||
| COG0478 | 304 | RIO-like serine/threonine protein kinase fused to | 99.27 | |
| PRK09902 | 216 | hypothetical protein; Provisional | 99.13 | |
| PF06176 | 229 | WaaY: Lipopolysaccharide core biosynthesis protein | 99.13 | |
| PF06293 | 206 | Kdo: Lipopolysaccharide kinase (Kdo/WaaP) family; | 99.11 | |
| COG1718 | 268 | RIO1 Serine/threonine protein kinase involved in c | 98.99 | |
| TIGR02172 | 226 | Fb_sc_TIGR02172 Fibrobacter succinogenes paralogou | 98.86 | |
| PF01636 | 239 | APH: Phosphotransferase enzyme family This family | 98.76 | |
| KOG2137|consensus | 700 | 98.74 | ||
| COG0661 | 517 | AarF Predicted unusual protein kinase [General fun | 98.71 | |
| cd05150 | 244 | APH Aminoglycoside 3'-phosphotransferase (APH). Th | 98.64 | |
| KOG1235|consensus | 538 | 98.53 | ||
| PLN02876 | 822 | acyl-CoA dehydrogenase | 98.5 | |
| PF10707 | 199 | YrbL-PhoP_reg: PhoP regulatory network protein Yrb | 98.42 | |
| COG2112 | 201 | Predicted Ser/Thr protein kinase [Signal transduct | 98.39 | |
| cd05155 | 235 | APH_ChoK_like_1 Uncharacterized bacterial proteins | 98.34 | |
| PF12260 | 188 | PIP49_C: Protein-kinase domain of FAM69; InterPro: | 98.28 | |
| cd05153 | 296 | HomoserineK_II Homoserine Kinase, type II. Homoser | 98.27 | |
| cd05157 | 235 | ETNK_euk Ethanolamine kinase (ETNK) in eukaryotes. | 98.21 | |
| TIGR02721 | 256 | ycfN_thiK thiamine kinase. Members of this family | 98.15 | |
| PRK05231 | 319 | homoserine kinase; Provisional | 98.13 | |
| PRK10593 | 297 | hypothetical protein; Provisional | 98.13 | |
| TIGR00938 | 307 | thrB_alt homoserine kinase, Neisseria type. Homose | 98.11 | |
| COG3173 | 321 | Predicted aminoglycoside phosphotransferase [Gener | 98.11 | |
| PRK09550 | 401 | mtnK methylthioribose kinase; Reviewed | 98.06 | |
| PF13095 | 207 | FTA2: Kinetochore Sim4 complex subunit FTA2 | 97.93 | |
| KOG2268|consensus | 465 | 97.92 | ||
| cd05156 | 302 | ChoK_euk Choline Kinase (ChoK) in eukaryotes. The | 97.85 | |
| KOG0576|consensus | 829 | 97.82 | ||
| KOG1035|consensus | 1351 | 97.81 | ||
| KOG2270|consensus | 520 | 97.75 | ||
| PLN02756 | 418 | S-methyl-5-thioribose kinase | 97.67 | |
| TIGR01767 | 370 | MTRK 5-methylthioribose kinase. This enzyme is inv | 97.67 | |
| PRK12396 | 409 | 5-methylribose kinase; Reviewed | 97.58 | |
| PLN02236 | 344 | choline kinase | 97.54 | |
| PLN02421 | 330 | phosphotransferase, alcohol group as acceptor/kina | 97.52 | |
| TIGR02904 | 309 | spore_ysxE spore coat protein YsxE. Members of thi | 97.46 | |
| cd05152 | 276 | MPH2' Macrolide 2'-Phosphotransferase (MPH2'). MPH | 97.36 | |
| KOG0575|consensus | 592 | 97.34 | ||
| PF07387 | 308 | Seadorna_VP7: Seadornavirus VP7; InterPro: IPR0099 | 97.22 | |
| COG2334 | 331 | Putative homoserine kinase type II (protein kinase | 97.2 | |
| PF01633 | 211 | Choline_kinase: Choline/ethanolamine kinase; Inter | 97.09 | |
| KOG0201|consensus | 467 | 97.08 | ||
| COG4248 | 637 | Uncharacterized protein with protein kinase and he | 97.01 | |
| cd05610 | 669 | STKc_MASTL Catalytic domain of the Protein Serine/ | 96.92 | |
| COG5072 | 488 | ALK1 Serine/threonine kinase of the haspin family | 96.84 | |
| PRK06148 | 1013 | hypothetical protein; Provisional | 96.82 | |
| KOG0581|consensus | 364 | 96.82 | ||
| PTZ00384 | 383 | choline kinase; Provisional | 96.64 | |
| PF03881 | 288 | Fructosamin_kin: Fructosamine kinase; InterPro: IP | 96.53 | |
| PRK11768 | 325 | serine/threonine protein kinase; Provisional | 96.44 | |
| KOG0588|consensus | 786 | 96.42 |
| >KOG0575|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.8e-53 Score=349.33 Aligned_cols=257 Identities=26% Similarity=0.399 Sum_probs=221.7
Q ss_pred ccceeeeecccCceEEEEEEEcCCCcEEEEEEeccCC-CChHHHHHHHHHHHHHHhCCCCCcchhhhhhhcCCeEEEEEe
Q psy758 3 RYEKIGKLGEGSYGVVFKCRNRDTGQVVAIKKFLESE-EDPLIRKIALREIRLLKSLKHPNLVNLLEVFRRKKKLHLVFE 81 (292)
Q Consensus 3 ~y~~~~~l~~g~~~~v~~~~~~~~~~~v~iK~~~~~~-~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~iv~e 81 (292)
+|..++.||+|+|+++|.+++..+|+.||+|++++.. ......+.+.+|+++.++|+|||||+++++|++.+++|+|+|
T Consensus 19 ~Y~~g~~LGkGgFA~cYe~~~~~tge~~A~KvVpk~~l~k~~~reKv~~EIeIHr~L~HpnIV~f~~~FEDs~nVYivLE 98 (592)
T KOG0575|consen 19 RYKRGRFLGKGGFARCYEARDLDTGEVVAVKVVPKKLLKKPKQREKVLNEIEIHRSLKHPNIVQFYHFFEDSNNVYIVLE 98 (592)
T ss_pred eeeeeeeeccCcceEEEEEEEcCCCcEEEEEEeehHHhcCcchHHHHHHHHHHHHhcCCCcEEeeeeEeecCCceEEEEE
Confidence 6999999999999999999999999999999998765 444567889999999999999999999999999999999999
Q ss_pred cCCCccHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEEccCCcEEEeecCchhhhhccccccccc
Q psy758 82 FCDHTVLNELENHPHGLPWDLIKQITWQVLRGVSYCHRHACIHRDIKPENILLTANGVVKLCDFGFARLIRDLIPRHLHI 161 (292)
Q Consensus 82 ~~~~~~L~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~givH~dl~p~Nilv~~~~~~kl~dfg~~~~~~~~~~~~~~~ 161 (292)
+|..++|..++++.+.++|..++.++.||+.||.|||+++|+|||||..|+|++++.++||+|||+|+.+..........
T Consensus 99 LC~~~sL~el~Krrk~ltEpEary~l~QIv~GlkYLH~~~IiHRDLKLGNlfL~~~~~VKIgDFGLAt~le~~~Erk~Tl 178 (592)
T KOG0575|consen 99 LCHRGSLMELLKRRKPLTEPEARYFLRQIVEGLKYLHSLGIIHRDLKLGNLFLNENMNVKIGDFGLATQLEYDGERKKTL 178 (592)
T ss_pred ecCCccHHHHHHhcCCCCcHHHHHHHHHHHHHHHHHHhcCceecccchhheeecCcCcEEecccceeeeecCccccccee
Confidence 99999999999998999999999999999999999999999999999999999999999999999999998776677777
Q ss_pred cccccccccCCCCCCCcccceeeecCCCCCCchHHHHHHHhhcccCCCCCCChhhhhhccCcCCCCCCCCCccchHHHHh
Q psy758 162 FQTNEYFKGVSLPHAENVVPLEIKIGKPAATNIYLIDFLKRCLDKDPLRRWSCDQLLRHPYFNGYYFEVPDEMQYEEITQ 241 (292)
Q Consensus 162 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~ 241 (292)
+++|.|.+++.+... -.+...++|+.++.++..+.+..|++..+..+.+...-...+..|...+.+.++||.
T Consensus 179 CGTPNYIAPEVl~k~--------gHsfEvDiWSlGcvmYtLL~G~PPFetk~vkety~~Ik~~~Y~~P~~ls~~A~dLI~ 250 (592)
T KOG0575|consen 179 CGTPNYIAPEVLNKS--------GHSFEVDIWSLGCVMYTLLVGRPPFETKTVKETYNKIKLNEYSMPSHLSAEAKDLIR 250 (592)
T ss_pred cCCCcccChhHhccC--------CCCCchhhhhhhhHHHhhhhCCCCcccchHHHHHHHHHhcCcccccccCHHHHHHHH
Confidence 888888877665311 111112223444445555666667777777777777777788888888999999999
Q ss_pred cccCcCCCCCCChhhhhhCCccccee
Q psy758 242 RCLDKDPLRRWSCDQLLRHPYFNGYY 267 (292)
Q Consensus 242 ~~l~~dP~~Rpt~~~il~h~w~~~~~ 267 (292)
+||+.||.+|||+++||.|+||++..
T Consensus 251 ~lL~~~P~~Rpsl~~vL~h~Ff~~g~ 276 (592)
T KOG0575|consen 251 KLLRPNPSERPSLDEVLDHPFFKSGF 276 (592)
T ss_pred HHhcCCcccCCCHHHHhcCHhhhCCC
Confidence 99999999999999999999996644
|
|
| >KOG0615|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-52 Score=332.03 Aligned_cols=254 Identities=28% Similarity=0.328 Sum_probs=205.4
Q ss_pred cccceeeeecccCceEEEEEEEcCCCcEEEEEEeccCCCCh-----HHHHHHHHHHHHHHhCCCCCcchhhhhhhcCCeE
Q psy758 2 ERYEKIGKLGEGSYGVVFKCRNRDTGQVVAIKKFLESEEDP-----LIRKIALREIRLLKSLKHPNLVNLLEVFRRKKKL 76 (292)
Q Consensus 2 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~v~iK~~~~~~~~~-----~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~ 76 (292)
+.|.+.+.||+|+||.|-+|....||+.||||++.+..... .....+.+|+++|++|+||+|++++++|+.+++.
T Consensus 172 d~yii~~~LGsGafg~Vkla~e~~tgk~vAiKIi~krk~~~~s~~~~~~~~v~~EieILkkL~HP~IV~~~d~f~~~ds~ 251 (475)
T KOG0615|consen 172 DYYIISKTLGSGAFGLVKLAYEKKTGKQVAIKIINKRKSTGCSRAIAKTRDVQNEIEILKKLSHPNIVRIKDFFEVPDSS 251 (475)
T ss_pred ceeEeeeeecCCceeEEEEEEEcccCcEEEeeeeehhhcccccccccchhhhHHHHHHHHhcCCCCEEEEeeeeecCCce
Confidence 46889999999999999999999999999999997665322 1233467999999999999999999999999999
Q ss_pred EEEEecCCCccHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEEccC---CcEEEeecCchhhhhc
Q psy758 77 HLVFEFCDHTVLNELENHPHGLPWDLIKQITWQVLRGVSYCHRHACIHRDIKPENILLTAN---GVVKLCDFGFARLIRD 153 (292)
Q Consensus 77 ~iv~e~~~~~~L~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~givH~dl~p~Nilv~~~---~~~kl~dfg~~~~~~~ 153 (292)
|+||||++||.|.+.+-.++.+.+..-..++.|++.|+.|||++||+||||||+|||++.+ ..+||+|||+++..++
T Consensus 252 YmVlE~v~GGeLfd~vv~nk~l~ed~~K~~f~Qll~avkYLH~~GI~HRDiKPeNILl~~~~e~~llKItDFGlAK~~g~ 331 (475)
T KOG0615|consen 252 YMVLEYVEGGELFDKVVANKYLREDLGKLLFKQLLTAVKYLHSQGIIHRDIKPENILLSNDAEDCLLKITDFGLAKVSGE 331 (475)
T ss_pred EEEEEEecCccHHHHHHhccccccchhHHHHHHHHHHHHHHHHcCcccccCCcceEEeccCCcceEEEecccchhhcccc
Confidence 9999999999999999988899999999999999999999999999999999999999877 6799999999998864
Q ss_pred cc----cccccccccccccccCC--------CCCCCcccceeeecCCCCCCchHHHHHHHhhcccCCCCCCCh-hhhhhc
Q psy758 154 LI----PRHLHIFQTNEYFKGVS--------LPHAENVVPLEIKIGKPAATNIYLIDFLKRCLDKDPLRRWSC-DQLLRH 220 (292)
Q Consensus 154 ~~----~~~~~~~~~~~~~~~~~--------~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~-~~~~~~ 220 (292)
.. .-+++.|.+||...+.. ..|++|+..|-+++|.+|+.....- ++. +++.+-
T Consensus 332 ~sfm~TlCGTpsYvAPEVl~~kg~~~~~~kVDiWSlGcvLfvcLsG~pPFS~~~~~--------------~sl~eQI~~G 397 (475)
T KOG0615|consen 332 GSFMKTLCGTPSYVAPEVLASKGVEYYPSKVDIWSLGCVLFVCLSGYPPFSEEYTD--------------PSLKEQILKG 397 (475)
T ss_pred ceehhhhcCCccccChhheecCCeecccchheeeeccceEEEEeccCCCcccccCC--------------ccHHHHHhcC
Confidence 32 23345566666654322 3588888888888888876433221 212 222222
Q ss_pred cCcCCCCCCCCCccchHHHHhcccCcCCCCCCChhhhhhCCcccceecc
Q psy758 221 PYFNGYYFEVPDEMQYEEITQRCLDKDPLRRWSCDQLLRHPYFNGYYFE 269 (292)
Q Consensus 221 ~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~~il~h~w~~~~~~~ 269 (292)
.+--+-.....++.+..+||.+||..||++|||++|+|+||||++.+..
T Consensus 398 ~y~f~p~~w~~Iseea~dlI~~mL~VdP~~R~s~~eaL~hpW~~~~~~~ 446 (475)
T KOG0615|consen 398 RYAFGPLQWDRISEEALDLINWMLVVDPENRPSADEALNHPWFKDAPCL 446 (475)
T ss_pred cccccChhhhhhhHHHHHHHHHhhEeCcccCcCHHHHhcChhhhccccc
Confidence 2222222334557889999999999999999999999999999986533
|
|
| >KOG0593|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-51 Score=312.38 Aligned_cols=263 Identities=52% Similarity=0.917 Sum_probs=221.6
Q ss_pred CcccceeeeecccCceEEEEEEEcCCCcEEEEEEeccCCCChHHHHHHHHHHHHHHhCCCCCcchhhhhhhcCCeEEEEE
Q psy758 1 MERYEKIGKLGEGSYGVVFKCRNRDTGQVVAIKKFLESEEDPLIRKIALREIRLLKSLKHPNLVNLLEVFRRKKKLHLVF 80 (292)
Q Consensus 1 ~~~y~~~~~l~~g~~~~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~iv~ 80 (292)
|++|+....+|+|+||.|++++++.||+.||||.+-.++.+....+..++|++++++|+|+|+|.++++|......++|+
T Consensus 1 MekYE~LgkvGEGSYGvV~KCrnk~TgqIVAIKkF~Esedd~~VkKIAlREIrmLKqLkH~NLVnLiEVFrrkrklhLVF 80 (396)
T KOG0593|consen 1 MEKYEKLGKVGEGSYGVVMKCRNKDTGQIVAIKKFVESEDDPVVKKIALREIRMLKQLKHENLVNLIEVFRRKRKLHLVF 80 (396)
T ss_pred CcHHhhhhccccCcceEEEEeccCCcccEEEEEeeccCCccHHHHHHHHHHHHHHHhcccchHHHHHHHHHhcceeEEEe
Confidence 68999999999999999999999999999999999999999999999999999999999999999999999999999999
Q ss_pred ecCCCccHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEEccCCcEEEeecCchhhhhccc-----
Q psy758 81 EFCDHTVLNELENHPHGLPWDLIKQITWQVLRGVSYCHRHACIHRDIKPENILLTANGVVKLCDFGFARLIRDLI----- 155 (292)
Q Consensus 81 e~~~~~~L~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~givH~dl~p~Nilv~~~~~~kl~dfg~~~~~~~~~----- 155 (292)
|||....|.++-..+..++.+.+..++.|++.|+.|+|+++++||||||+|||++.+|.+||||||+++.+....
T Consensus 81 E~~dhTvL~eLe~~p~G~~~~~vk~~l~Q~l~ai~~cHk~n~IHRDIKPENILit~~gvvKLCDFGFAR~L~~pgd~YTD 160 (396)
T KOG0593|consen 81 EYCDHTVLHELERYPNGVPSELVKKYLYQLLKAIHFCHKNNCIHRDIKPENILITQNGVVKLCDFGFARTLSAPGDNYTD 160 (396)
T ss_pred eecchHHHHHHHhccCCCCHHHHHHHHHHHHHHhhhhhhcCeecccCChhheEEecCCcEEeccchhhHhhcCCcchhhh
Confidence 999999999999888899999999999999999999999999999999999999999999999999999886422
Q ss_pred cccccccccccccccC-C-----CCCCCcccceeeecCCCCCCchHHHHH---HHhhcccCCCCCCChhhhh-hccCcCC
Q psy758 156 PRHLHIFQTNEYFKGV-S-----LPHAENVVPLEIKIGKPAATNIYLIDF---LKRCLDKDPLRRWSCDQLL-RHPYFNG 225 (292)
Q Consensus 156 ~~~~~~~~~~~~~~~~-~-----~~~~~~~~~~~~~~~~~~~~~~~~~~~---~~~~~~~~p~~~~~~~~~~-~~~~~~~ 225 (292)
...+..|.+||...|- . ..|+.|++..++.+|.+.+-+..-.+. +...++.-+ +...+++ .+++|.+
T Consensus 161 YVATRWYRaPELLvGDtqYG~pVDiWAiGCv~aEl~~G~pL~PG~SDiDQLy~I~ktLG~L~---prhq~iF~~N~~F~G 237 (396)
T KOG0593|consen 161 YVATRWYRAPELLVGDTQYGKPVDIWAIGCVFAELLTGEPLWPGRSDIDQLYLIRKTLGNLI---PRHQSIFSSNPFFHG 237 (396)
T ss_pred hhhhhhccChhhhcccCcCCCcccchhhhHHHHHHhcCCcCCCCcchHHHHHHHHHHHcccC---HHHHHHhccCCceee
Confidence 2234568888888872 2 346777777777888877655444333 333333221 2233333 4678888
Q ss_pred CCCCCCC------------ccchHHHHhcccCcCCCCCCChhhhhhCCcccce
Q psy758 226 YYFEVPD------------EMQYEEITQRCLDKDPLRRWSCDQLLRHPYFNGY 266 (292)
Q Consensus 226 ~~~~~~~------------~~~l~~li~~~l~~dP~~Rpt~~~il~h~w~~~~ 266 (292)
..+|.+. +.-+.+|++.||..||.+|++.+|++.||||.++
T Consensus 238 v~lP~~~~~epLe~k~p~~s~~~ld~~k~cL~~dP~~R~sc~qll~H~yFd~~ 290 (396)
T KOG0593|consen 238 VRLPEPEHPEPLERKYPKISNVLLDLLKKCLKMDPDDRLSCEQLLHHPYFDGF 290 (396)
T ss_pred eecCCCCCccchhhhcccchHHHHHHHHHHhcCCccccccHHHHhcChHHHHH
Confidence 7776554 3346799999999999999999999999999663
|
|
| >KOG0581|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.9e-50 Score=313.32 Aligned_cols=250 Identities=30% Similarity=0.527 Sum_probs=207.9
Q ss_pred cccceeeeecccCceEEEEEEEcCCCcEEEEEEeccCCCChHHHHHHHHHHHHHHhCCCCCcchhhhhhhcCC-eEEEEE
Q psy758 2 ERYEKIGKLGEGSYGVVFKCRNRDTGQVVAIKKFLESEEDPLIRKIALREIRLLKSLKHPNLVNLLEVFRRKK-KLHLVF 80 (292)
Q Consensus 2 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~-~~~iv~ 80 (292)
++.+.++.||+|..|+||+++++.|++.+|+|++ ....+....+++.+|+++++..+||+||++||.|.+++ .++++|
T Consensus 79 ~dle~~~~lG~G~gG~V~kv~Hk~t~~i~AlK~I-~~~~~~~~~~Qi~rEl~il~~~~spyIV~~ygaF~~~~~~isI~m 157 (364)
T KOG0581|consen 79 SDLERLGVLGSGNGGTVYKVRHKPTGKIYALKVI-LLNIDPALQKQILRELEILRSCQSPYIVGFYGAFYSNGEEISICM 157 (364)
T ss_pred HHhhhhhhcccCCCcEEEEEEEcCCCeEEEEEee-cccCCHHHHHHHHHHHHHHhhCCCCCeeeEeEEEEeCCceEEeeh
Confidence 3566788999999999999999999999999999 44566678899999999999999999999999999988 599999
Q ss_pred ecCCCccHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHh-CCccccCCCCCceEEccCCcEEEeecCchhhhhcc---cc
Q psy758 81 EFCDHTVLNELENHPHGLPWDLIKQITWQVLRGVSYCHR-HACIHRDIKPENILLTANGVVKLCDFGFARLIRDL---IP 156 (292)
Q Consensus 81 e~~~~~~L~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~-~givH~dl~p~Nilv~~~~~~kl~dfg~~~~~~~~---~~ 156 (292)
|||.||+|+.+++..++++|.....++.+|++||.|||+ ++|+||||||+|||++..|.+||+|||.++.+.+. ..
T Consensus 158 EYMDgGSLd~~~k~~g~i~E~~L~~ia~~VL~GL~YLh~~~~IIHRDIKPsNlLvNskGeVKicDFGVS~~lvnS~a~tf 237 (364)
T KOG0581|consen 158 EYMDGGSLDDILKRVGRIPEPVLGKIARAVLRGLSYLHEERKIIHRDIKPSNLLVNSKGEVKICDFGVSGILVNSIANTF 237 (364)
T ss_pred hhcCCCCHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhccCeeeccCCHHHeeeccCCCEEeccccccHHhhhhhcccc
Confidence 999999999999988899999999999999999999995 99999999999999999999999999999887653 23
Q ss_pred ccccccccccccccCCCC-----CCCcccceeeecCCCCCCch-----HHHHHHHhhcccCCCCCCChhhhhhccCcCCC
Q psy758 157 RHLHIFQTNEYFKGVSLP-----HAENVVPLEIKIGKPAATNI-----YLIDFLKRCLDKDPLRRWSCDQLLRHPYFNGY 226 (292)
Q Consensus 157 ~~~~~~~~~~~~~~~~~~-----~~~~~~~~~~~~~~~~~~~~-----~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~ 226 (292)
.++..|.+||-..|..+. |++|+..+++.+|..+.... ...+++..++...|..
T Consensus 238 vGT~~YMsPERi~g~~Ys~~sDIWSLGLsllE~a~GrfP~~~~~~~~~~~~~Ll~~Iv~~ppP~---------------- 301 (364)
T KOG0581|consen 238 VGTSAYMSPERISGESYSVKSDIWSLGLSLLELAIGRFPYPPPNPPYLDIFELLCAIVDEPPPR---------------- 301 (364)
T ss_pred cccccccChhhhcCCcCCcccceecccHHHHHHhhCCCCCCCcCCCCCCHHHHHHHHhcCCCCC----------------
Confidence 456678888888776654 55555555666676555432 3444555544433311
Q ss_pred CCCC-CCccchHHHHhcccCcCCCCCCChhhhhhCCcccceecc
Q psy758 227 YFEV-PDEMQYEEITQRCLDKDPLRRWSCDQLLRHPYFNGYYFE 269 (292)
Q Consensus 227 ~~~~-~~~~~l~~li~~~l~~dP~~Rpt~~~il~h~w~~~~~~~ 269 (292)
.+. .-++++++||..||+.||.+|||++|+++|||++.....
T Consensus 302 -lP~~~fS~ef~~FV~~CL~Kdp~~R~s~~qLl~Hpfi~~~~~~ 344 (364)
T KOG0581|consen 302 -LPEGEFSPEFRSFVSCCLRKDPSERPSAKQLLQHPFIKKFEDP 344 (364)
T ss_pred -CCcccCCHHHHHHHHHHhcCCcccCCCHHHHhcCHHHhhcccc
Confidence 122 247789999999999999999999999999999985543
|
|
| >KOG0598|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.7e-50 Score=313.53 Aligned_cols=251 Identities=25% Similarity=0.377 Sum_probs=214.4
Q ss_pred cccceeeeecccCceEEEEEEEcCCCcEEEEEEeccCCCC-hHHHHHHHHHHHHHHhCCCCCcchhhhhhhcCCeEEEEE
Q psy758 2 ERYEKIGKLGEGSYGVVFKCRNRDTGQVVAIKKFLESEED-PLIRKIALREIRLLKSLKHPNLVNLLEVFRRKKKLHLVF 80 (292)
Q Consensus 2 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~v~iK~~~~~~~~-~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~iv~ 80 (292)
++|++++.||+|+||.|+.++...+++.||+|++.+.... ....+....|..++..++||+|++++..|++++.+|+|+
T Consensus 25 ~dF~~lkviGkG~fGkV~~Vrk~dt~kiYAmKvl~K~~iv~~~e~~~~~~Er~IL~~v~hPFiv~l~ysFQt~~kLylVl 104 (357)
T KOG0598|consen 25 DDFEILKVIGKGSFGKVFQVRKKDTGKIYAMKVLKKKKIVEKKEVRHTKAERNILSKIKHPFIVKLIYSFQTEEKLYLVL 104 (357)
T ss_pred hheeeeeeeeccCCceEEEEEEcccCceeehhhhhhhHhhhhhhHHHHHHHHHHHHhCCCCcEeeeEEecccCCeEEEEE
Confidence 6799999999999999999999999999999999877633 346777889999999999999999999999999999999
Q ss_pred ecCCCccHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEEccCCcEEEeecCchhhhhcccccccc
Q psy758 81 EFCDHTVLNELENHPHGLPWDLIKQITWQVLRGVSYCHRHACIHRDIKPENILLTANGVVKLCDFGFARLIRDLIPRHLH 160 (292)
Q Consensus 81 e~~~~~~L~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~givH~dl~p~Nilv~~~~~~kl~dfg~~~~~~~~~~~~~~ 160 (292)
||+.||.|...+++.+.+++..++.++.+|+.||.|||++||+||||||+|||+|.+|+++|+|||+++..-........
T Consensus 105 d~~~GGeLf~hL~~eg~F~E~~arfYlaEi~lAL~~LH~~gIiyRDlKPENILLd~~GHi~LtDFgL~k~~~~~~~~t~t 184 (357)
T KOG0598|consen 105 DYLNGGELFYHLQREGRFSEDRARFYLAEIVLALGYLHSKGIIYRDLKPENILLDEQGHIKLTDFGLCKEDLKDGDATRT 184 (357)
T ss_pred eccCCccHHHHHHhcCCcchhHHHHHHHHHHHHHHHHHhCCeeeccCCHHHeeecCCCcEEEeccccchhcccCCCcccc
Confidence 99999999999999999999999999999999999999999999999999999999999999999999876554444444
Q ss_pred ccccccccccCCC----------CCCCcccceeeecCCCCCCchHHHHHHHhhcccCCCCCCChhhhhhccCcCCCCCCC
Q psy758 161 IFQTNEYFKGVSL----------PHAENVVPLEIKIGKPAATNIYLIDFLKRCLDKDPLRRWSCDQLLRHPYFNGYYFEV 230 (292)
Q Consensus 161 ~~~~~~~~~~~~~----------~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~ 230 (292)
++++++|.+++.+ .|++|+..|++++|.+++.......+...++... ....+.
T Consensus 185 fcGT~eYmAPEil~~~gy~~~vDWWsLGillYeML~G~pPF~~~~~~~~~~~I~~~k-----------------~~~~p~ 247 (357)
T KOG0598|consen 185 FCGTPEYMAPEILLGKGYDKAVDWWSLGILLYEMLTGKPPFYAEDVKKMYDKILKGK-----------------LPLPPG 247 (357)
T ss_pred ccCCccccChHHHhcCCCCcccchHhHHHHHHHHhhCCCCCcCccHHHHHHHHhcCc-----------------CCCCCc
Confidence 5666666665433 4677777777777877777666666666655433 012223
Q ss_pred CCccchHHHHhcccCcCCCCCC----ChhhhhhCCcccceecc
Q psy758 231 PDEMQYEEITQRCLDKDPLRRW----SCDQLLRHPYFNGYYFE 269 (292)
Q Consensus 231 ~~~~~l~~li~~~l~~dP~~Rp----t~~~il~h~w~~~~~~~ 269 (292)
..+...+++|+++|+.||++|. ++.+|-+||||.++.|+
T Consensus 248 ~ls~~ardll~~LL~rdp~~RLg~~~d~~~ik~HpfF~~inW~ 290 (357)
T KOG0598|consen 248 YLSEEARDLLKKLLKRDPRQRLGGPGDAEEIKRHPFFKGINWE 290 (357)
T ss_pred cCCHHHHHHHHHHhccCHHHhcCCCCChHHhhcCcccccCCHH
Confidence 3577899999999999999996 89999999999999998
|
|
| >KOG0592|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-50 Score=328.55 Aligned_cols=263 Identities=24% Similarity=0.340 Sum_probs=212.2
Q ss_pred cccceeeeecccCceEEEEEEEcCCCcEEEEEEeccCC-CChHHHHHHHHHHHHHHhC-CCCCcchhhhhhhcCCeEEEE
Q psy758 2 ERYEKIGKLGEGSYGVVFKCRNRDTGQVVAIKKFLESE-EDPLIRKIALREIRLLKSL-KHPNLVNLLEVFRRKKKLHLV 79 (292)
Q Consensus 2 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~v~iK~~~~~~-~~~~~~~~~~~e~~~~~~l-~~~~i~~~~~~~~~~~~~~iv 79 (292)
++|.+++.||.|+|++|++|++..+++.||||++.+.. ..+...+.+.+|-+.|..| .||+|++++-.|+|+..+|+|
T Consensus 73 ~DF~Fg~~lGeGSYStV~~A~~~~t~keYAiKVl~K~~Iike~KvkYV~~Ek~~l~~L~~hPgivkLy~TFQD~~sLYFv 152 (604)
T KOG0592|consen 73 NDFKFGKILGEGSYSTVVLAREKATGKEYAIKVLDKRYIIKEKKVKYVTREKEALTQLSGHPGIVKLYFTFQDEESLYFV 152 (604)
T ss_pred hhcchhheeccccceeEEEeeecCCCceeeHhhhhHHHHHhhcccchhhHHHHHHHHhhCCCCeEEEEEEeecccceEEE
Confidence 57999999999999999999999999999999997665 3334567888999999999 799999999999999999999
Q ss_pred EecCCCccHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEEccCCcEEEeecCchhhhhccccc--
Q psy758 80 FEFCDHTVLNELENHPHGLPWDLIKQITWQVLRGVSYCHRHACIHRDIKPENILLTANGVVKLCDFGFARLIRDLIPR-- 157 (292)
Q Consensus 80 ~e~~~~~~L~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~givH~dl~p~Nilv~~~~~~kl~dfg~~~~~~~~~~~-- 157 (292)
+||+++|.|..+++..+.+++..++.++.||+.||+|||++|||||||||+|||+|.||+++|+|||.++.+++....
T Consensus 153 Le~A~nGdll~~i~K~Gsfde~caR~YAAeIldAleylH~~GIIHRDlKPENILLd~dmhikITDFGsAK~l~~~~~~~~ 232 (604)
T KOG0592|consen 153 LEYAPNGDLLDLIKKYGSFDETCARFYAAEILDALEYLHSNGIIHRDLKPENILLDKDGHIKITDFGSAKILSPSQKSQE 232 (604)
T ss_pred EEecCCCcHHHHHHHhCcchHHHHHHHHHHHHHHHHHHHhcCceeccCChhheeEcCCCcEEEeeccccccCChhhcccc
Confidence 999999999999999999999999999999999999999999999999999999999999999999999987642211
Q ss_pred ----------------cccccccccccccCCC-----CCCCcccceeeecCCCCCCchHHHHHHHhhcccCCCCCCChhh
Q psy758 158 ----------------HLHIFQTNEYFKGVSL-----PHAENVVPLEIKIGKPAATNIYLIDFLKRCLDKDPLRRWSCDQ 216 (292)
Q Consensus 158 ----------------~~~~~~~~~~~~~~~~-----~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~ 216 (292)
++..|.+||.+..... .|++|++.|.++.|.+++....-+-++..+
T Consensus 233 ~~~~~~~a~s~~~SFVGTAeYVSPElL~~~~~~~~sDiWAlGCilyQmlaG~PPFra~NeyliFqkI------------- 299 (604)
T KOG0592|consen 233 NPVDPNQASSRRSSFVGTAEYVSPELLNDSPAGPSSDLWALGCILYQMLAGQPPFRAANEYLIFQKI------------- 299 (604)
T ss_pred CccCcccccCcccceeeeecccCHHHhcCCCCCcccchHHHHHHHHHHhcCCCCCccccHHHHHHHH-------------
Confidence 1223444444433322 344444444444444444333333333222
Q ss_pred hhhccCcCCCCCCCCCccchHHHHhcccCcCCCCCCChhhhhhCCcccceeccCCChhHHHHHhhh
Q psy758 217 LLRHPYFNGYYFEVPDEMQYEEITQRCLDKDPLRRWSCDQLLRHPYFNGYYFEVPDEMQYEEITQV 282 (292)
Q Consensus 217 ~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~~il~h~w~~~~~~~~~~~~~~~~~~~~ 282 (292)
.--.+.++...++.+++||+++|..||++|+|++||.+||||+++.|+..-+++.+.+.++
T Consensus 300 -----~~l~y~fp~~fp~~a~dLv~KLLv~dp~~Rlt~~qIk~HpFF~~Vdw~nlw~~~PP~l~py 360 (604)
T KOG0592|consen 300 -----QALDYEFPEGFPEDARDLIKKLLVRDPSDRLTSQQIKAHPFFEGVDWENLWQQTPPKLQPY 360 (604)
T ss_pred -----HHhcccCCCCCCHHHHHHHHHHHccCccccccHHHHhhCcccccCChhhhhhcCCCcccCC
Confidence 2234455666678999999999999999999999999999999999998777777777665
|
|
| >KOG0616|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.8e-48 Score=293.24 Aligned_cols=249 Identities=25% Similarity=0.399 Sum_probs=213.3
Q ss_pred CcccceeeeecccCceEEEEEEEcCCCcEEEEEEeccCC-CChHHHHHHHHHHHHHHhCCCCCcchhhhhhhcCCeEEEE
Q psy758 1 MERYEKIGKLGEGSYGVVFKCRNRDTGQVVAIKKFLESE-EDPLIRKIALREIRLLKSLKHPNLVNLLEVFRRKKKLHLV 79 (292)
Q Consensus 1 ~~~y~~~~~l~~g~~~~v~~~~~~~~~~~v~iK~~~~~~-~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~iv 79 (292)
+++|++.+.||.|+||+|.+++.+.+|..+|+|++.+.. ......+...+|..+++.+.||+++++++.+.+.+.+|+|
T Consensus 43 l~dfe~~~tlGtGSFGrV~LVr~k~~g~yYAmKvL~k~~vVklKQveH~~nEk~vL~~v~~PFlv~l~~t~~d~~~lymv 122 (355)
T KOG0616|consen 43 LQDFERLKTLGTGSFGRVHLVREKHSGNYYAMKVLDKQKVVKLKQVEHTHNEKRVLKAVSHPFLVKLYGTFKDNSNLYMV 122 (355)
T ss_pred hhhhhheeeeccCccceEEEEEEccCCceeehhhcCHHHHHHHHHHHHHhhHHHHHhhccCceeEEEEEeeccCCeEEEE
Confidence 578999999999999999999999999999999998776 3344567788999999999999999999999999999999
Q ss_pred EecCCCccHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEEccCCcEEEeecCchhhhhccccccc
Q psy758 80 FEFCDHTVLNELENHPHGLPWDLIKQITWQVLRGVSYCHRHACIHRDIKPENILLTANGVVKLCDFGFARLIRDLIPRHL 159 (292)
Q Consensus 80 ~e~~~~~~L~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~givH~dl~p~Nilv~~~~~~kl~dfg~~~~~~~~~~~~~ 159 (292)
|||.+||.|..++++.+++++..++.++.||+.||+|||+.+|++|||||+|||+|.+|++||+|||+++.... ...
T Consensus 123 meyv~GGElFS~Lrk~~rF~e~~arFYAAeivlAleylH~~~iiYRDLKPENiLlD~~G~iKitDFGFAK~v~~---rT~ 199 (355)
T KOG0616|consen 123 MEYVPGGELFSYLRKSGRFSEPHARFYAAEIVLALEYLHSLDIIYRDLKPENLLLDQNGHIKITDFGFAKRVSG---RTW 199 (355)
T ss_pred EeccCCccHHHHHHhcCCCCchhHHHHHHHHHHHHHHHHhcCeeeccCChHHeeeccCCcEEEEeccceEEecC---cEE
Confidence 99999999999999999999999999999999999999999999999999999999999999999999987654 355
Q ss_pred cccccccccccCCC----------CCCCcccceeeecCCCCCCchHHHHHHHhhcccCCCCCCChhhhhhccCcCCCCCC
Q psy758 160 HIFQTNEYFKGVSL----------PHAENVVPLEIKIGKPAATNIYLIDFLKRCLDKDPLRRWSCDQLLRHPYFNGYYFE 229 (292)
Q Consensus 160 ~~~~~~~~~~~~~~----------~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~ 229 (292)
..+++|+|.+++.+ .|++|+..++++.|.+++.+.....++.++ .-....+|
T Consensus 200 TlCGTPeYLAPEii~sk~ynkavDWWalGVLIYEMlaG~pPF~~~~~~~iY~KI------------------~~~~v~fP 261 (355)
T KOG0616|consen 200 TLCGTPEYLAPEIIQSKGYNKAVDWWALGVLIYEMLAGYPPFYDDNPIQIYEKI------------------LEGKVKFP 261 (355)
T ss_pred EecCCccccChHHhhcCCCCcchhHHHHHHHHHHHHcCCCCCcCCChHHHHHHH------------------HhCcccCC
Confidence 66788888877655 355555555666666655544444444444 34455667
Q ss_pred CCCccchHHHHhcccCcCCCCCC-----ChhhhhhCCcccceeccC
Q psy758 230 VPDEMQYEEITQRCLDKDPLRRW-----SCDQLLRHPYFNGYYFEV 270 (292)
Q Consensus 230 ~~~~~~l~~li~~~l~~dP~~Rp-----t~~~il~h~w~~~~~~~~ 270 (292)
...+..+++||+++|+.|-++|. ...+|.+||||+++.|+.
T Consensus 262 ~~fs~~~kdLl~~LL~vD~t~R~gnlknG~~dIk~H~wF~~v~W~~ 307 (355)
T KOG0616|consen 262 SYFSSDAKDLLKKLLQVDLTKRFGNLKNGVEDIKNHPWFKGVDWEA 307 (355)
T ss_pred cccCHHHHHHHHHHHhhhhHhhhcCcCCCccccccCcccccccHHH
Confidence 77788999999999999999994 677999999999999883
|
|
| >KOG0659|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.2e-47 Score=284.65 Aligned_cols=268 Identities=33% Similarity=0.510 Sum_probs=212.8
Q ss_pred CcccceeeeecccCceEEEEEEEcCCCcEEEEEEeccCCCChHHHHHHHHHHHHHHhCCCCCcchhhhhhhcCCeEEEEE
Q psy758 1 MERYEKIGKLGEGSYGVVFKCRNRDTGQVVAIKKFLESEEDPLIRKIALREIRLLKSLKHPNLVNLLEVFRRKKKLHLVF 80 (292)
Q Consensus 1 ~~~y~~~~~l~~g~~~~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~iv~ 80 (292)
..||...+.||+|.||.||+|++..||+.||||.+......+-......+|+..++.++|+||+.++++|.+.+.+.+|+
T Consensus 1 ~~rY~~~~~lGEG~~gvVyka~d~~t~~~VAIKKIkl~~~kdGi~~talREIK~Lqel~h~nIi~LiD~F~~~~~l~lVf 80 (318)
T KOG0659|consen 1 MDRYEKLEKLGEGTYGVVYKARDTETGKRVAIKKIKLGNAKDGINRTALREIKLLQELKHPNIIELIDVFPHKSNLSLVF 80 (318)
T ss_pred CchhhhhhhhcCcceEEEEEEEecCCCcEEEEEEeeccccccCccHHHHHHHHHHHHccCcchhhhhhhccCCCceEEEE
Confidence 46899999999999999999999999999999999888766666677889999999999999999999999999999999
Q ss_pred ecCCCccHHHHhc-CCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEEccCCcEEEeecCchhhhhcccccc-
Q psy758 81 EFCDHTVLNELEN-HPHGLPWDLIKQITWQVLRGVSYCHRHACIHRDIKPENILLTANGVVKLCDFGFARLIRDLIPRH- 158 (292)
Q Consensus 81 e~~~~~~L~~~~~-~~~~~~~~~~~~i~~qi~~aL~~LH~~givH~dl~p~Nilv~~~~~~kl~dfg~~~~~~~~~~~~- 158 (292)
||++.. |...++ +.-.++...+..++.++++||+|||++.|+||||||.|+|++++|.+||+|||+++.+.+.....
T Consensus 81 Efm~td-Le~vIkd~~i~l~pa~iK~y~~m~LkGl~y~H~~~IlHRDlKPnNLLis~~g~lKiADFGLAr~f~~p~~~~~ 159 (318)
T KOG0659|consen 81 EFMPTD-LEVVIKDKNIILSPADIKSYMLMTLKGLAYCHSKWILHRDLKPNNLLISSDGQLKIADFGLARFFGSPNRIQT 159 (318)
T ss_pred Eecccc-HHHHhcccccccCHHHHHHHHHHHHHHHHHHHhhhhhcccCCccceEEcCCCcEEeecccchhccCCCCcccc
Confidence 999865 555554 44568999999999999999999999999999999999999999999999999999987654443
Q ss_pred ----ccccccccccccCCC------CCCCcccceeeecCCCCCCchHHHH---HHHhhc-ccCCCCCCChhhhhhccCcC
Q psy758 159 ----LHIFQTNEYFKGVSL------PHAENVVPLEIKIGKPAATNIYLID---FLKRCL-DKDPLRRWSCDQLLRHPYFN 224 (292)
Q Consensus 159 ----~~~~~~~~~~~~~~~------~~~~~~~~~~~~~~~~~~~~~~~~~---~~~~~~-~~~p~~~~~~~~~~~~~~~~ 224 (292)
+..|.+||...|... .|+.|++..++..+.+..-+..-.+ .+-..+ ...+.+.+...++-...-+.
T Consensus 160 ~~V~TRWYRAPELLfGsr~Yg~~VDmWavGCI~AELllr~P~fpG~sDidQL~~If~~LGTP~~~~WP~~~~lpdY~~~~ 239 (318)
T KOG0659|consen 160 HQVVTRWYRAPELLFGSRQYGTGVDMWAVGCIFAELLLRVPFFPGDSDIDQLSKIFRALGTPTPDQWPEMTSLPDYVKIQ 239 (318)
T ss_pred cceeeeeccChHHhccchhcCCcchhhhHHHHHHHHHccCCCCCCCchHHHHHHHHHHcCCCCcccCccccccccHHHHh
Confidence 356888887766543 4777777777777776554433222 233333 34555665554443322222
Q ss_pred CCCC------CCCCccchHHHHhcccCcCCCCCCChhhhhhCCcccceecc
Q psy758 225 GYYF------EVPDEMQYEEITQRCLDKDPLRRWSCDQLLRHPYFNGYYFE 269 (292)
Q Consensus 225 ~~~~------~~~~~~~l~~li~~~l~~dP~~Rpt~~~il~h~w~~~~~~~ 269 (292)
.++. -...+..+.+|+.+||.+||.+|+|+.|+++|+||++.+..
T Consensus 240 ~~P~~~~~~lf~aas~d~ldLl~~m~~ynP~~Rita~qaL~~~yf~~~P~p 290 (318)
T KOG0659|consen 240 QFPKPPLNNLFPAASSDALDLLSKMLTYNPKKRITASQALKHPYFKSLPLP 290 (318)
T ss_pred cCCCCccccccccccHHHHHHHHhhhccCchhcccHHHHhcchhhhcCCCC
Confidence 1111 12236667899999999999999999999999999986544
|
|
| >KOG0661|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.6e-48 Score=309.79 Aligned_cols=266 Identities=31% Similarity=0.488 Sum_probs=205.7
Q ss_pred CcccceeeeecccCceEEEEEEEcCCCcEEEEEEeccCCCChHHHHHHHHHHHHHHhCC-CCCcchhhhhhhcCC-eEEE
Q psy758 1 MERYEKIGKLGEGSYGVVFKCRNRDTGQVVAIKKFLESEEDPLIRKIALREIRLLKSLK-HPNLVNLLEVFRRKK-KLHL 78 (292)
Q Consensus 1 ~~~y~~~~~l~~g~~~~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~e~~~~~~l~-~~~i~~~~~~~~~~~-~~~i 78 (292)
++||++++.||.|+||.||+|+...+++.||||.+...-..-+ .-.-.+|+..+++|+ ||||+++.+++.+.+ .+|+
T Consensus 9 m~RY~~i~klGDGTfGsV~la~~~~~~~~VAIK~MK~Kf~s~e-e~~nLREvksL~kln~hpniikL~Evi~d~~~~L~f 87 (538)
T KOG0661|consen 9 MDRYTVIRKLGDGTFGSVYLAKSKETGELVAIKKMKKKFYSWE-ECMNLREVKSLRKLNPHPNIIKLKEVIRDNDRILYF 87 (538)
T ss_pred HHHHHHHHHhcCCcceeEEEeeecCCCceeeHHHHHhhhccHH-HHHHHHHHHHHHhcCCCCcchhhHHHhhccCceEee
Confidence 4799999999999999999999999999999999876655433 233468999999999 999999999999887 9999
Q ss_pred EEecCCCccHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEEccCCcEEEeecCchhhhhcccc--
Q psy758 79 VFEFCDHTVLNELENHPHGLPWDLIKQITWQVLRGVSYCHRHACIHRDIKPENILLTANGVVKLCDFGFARLIRDLIP-- 156 (292)
Q Consensus 79 v~e~~~~~~L~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~givH~dl~p~Nilv~~~~~~kl~dfg~~~~~~~~~~-- 156 (292)
|||||..+.-.-+..+++.+++..++.|+.||++||+|+|.+|+.|||+||+|||+..+..+||+|||+|+...+..+
T Consensus 88 VfE~Md~NLYqLmK~R~r~fse~~irnim~QilqGL~hiHk~GfFHRDlKPENiLi~~~~~iKiaDFGLARev~SkpPYT 167 (538)
T KOG0661|consen 88 VFEFMDCNLYQLMKDRNRLFSESDIRNIMYQILQGLAHIHKHGFFHRDLKPENILISGNDVIKIADFGLAREVRSKPPYT 167 (538)
T ss_pred eHHhhhhhHHHHHhhcCCcCCHHHHHHHHHHHHHHHHHHHhcCcccccCChhheEecccceeEecccccccccccCCCcc
Confidence 999999775555555667799999999999999999999999999999999999999999999999999998765333
Q ss_pred --ccccccccccccccCC------CCCCCcccceeeecCCCCCCchHHHHHHHhhc--ccCCCCC-CChhhhh------h
Q psy758 157 --RHLHIFQTNEYFKGVS------LPHAENVVPLEIKIGKPAATNIYLIDFLKRCL--DKDPLRR-WSCDQLL------R 219 (292)
Q Consensus 157 --~~~~~~~~~~~~~~~~------~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~p~~~-~~~~~~~------~ 219 (292)
..+..|.+||...... +.|+.|++.+++..-.+.+-+..-.+-+.+++ -..|..+ +.....+ .
T Consensus 168 eYVSTRWYRAPEvLLrs~~Ys~pvD~wA~GcI~aEl~sLrPLFPG~sE~Dqi~KIc~VLGtP~~~~~~eg~~La~~mnf~ 247 (538)
T KOG0661|consen 168 EYVSTRWYRAPEVLLRSGYYSSPVDMWAVGCIMAELYSLRPLFPGASEIDQIYKICEVLGTPDKDSWPEGYNLASAMNFR 247 (538)
T ss_pred hhhhcccccchHHhhhccccCCchHHHHHHHHHHHHHHhcccCCCCcHHHHHHHHHHHhCCCccccchhHHHHHHHhccC
Confidence 3456688888765443 34777777777777666665554444333332 1233322 2221222 2
Q ss_pred ccCcCCCCCC---CCCccchHHHHhcccCcCCCCCCChhhhhhCCccccee
Q psy758 220 HPYFNGYYFE---VPDEMQYEEITQRCLDKDPLRRWSCDQLLRHPYFNGYY 267 (292)
Q Consensus 220 ~~~~~~~~~~---~~~~~~l~~li~~~l~~dP~~Rpt~~~il~h~w~~~~~ 267 (292)
.+.+.+..+. ...+.++.++|.+||++||.+||||+|+|+||||+...
T Consensus 248 ~P~~~~~~l~~L~p~~s~~~~~li~~ll~WDP~kRpTA~~al~~pffq~~~ 298 (538)
T KOG0661|consen 248 FPQVKPSPLKDLLPNASSEAASLIERLLAWDPDKRPTASQALQHPFFQVGR 298 (538)
T ss_pred CCcCCCCChHHhCcccCHHHHHHHHHHhcCCCccCccHHHHhcCccccccc
Confidence 2333333221 12477788999999999999999999999999999744
|
|
| >KOG0605|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-47 Score=311.18 Aligned_cols=266 Identities=24% Similarity=0.347 Sum_probs=202.0
Q ss_pred CcccceeeeecccCceEEEEEEEcCCCcEEEEEEeccCC-CChHHHHHHHHHHHHHHhCCCCCcchhhhhhhcCCeEEEE
Q psy758 1 MERYEKIGKLGEGSYGVVFKCRNRDTGQVVAIKKFLESE-EDPLIRKIALREIRLLKSLKHPNLVNLLEVFRRKKKLHLV 79 (292)
Q Consensus 1 ~~~y~~~~~l~~g~~~~v~~~~~~~~~~~v~iK~~~~~~-~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~iv 79 (292)
+++|++++.||+|+||.||+|+.+.||+.+|+|+++++. ........+.-|-.+|....+|.||++|.+|++..++|+|
T Consensus 140 ~~DFe~Lk~IgkGAfGeVrLarKk~Tg~iyAmK~LkKS~M~~~~Qv~hV~aERdiL~~~ds~~vVKLyYsFQD~~~LYLi 219 (550)
T KOG0605|consen 140 LDDFELLKVIGKGAFGEVRLARKKDTGEIYAMKILKKSEMLKKNQVEHVRAERDILAEVDSPWVVKLYYSFQDKEYLYLI 219 (550)
T ss_pred cccchhheeeccccceeEEEEEEccCCcEEeeecccHHHHHhhhhHHHHHHHHHHhhhcCCCcEEEEEEEecCCCeeEEE
Confidence 578999999999999999999999999999999998886 4444567788899999999999999999999999999999
Q ss_pred EecCCCccHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEEccCCcEEEeecCchhhhhcc-----
Q psy758 80 FEFCDHTVLNELENHPHGLPWDLIKQITWQVLRGVSYCHRHACIHRDIKPENILLTANGVVKLCDFGFARLIRDL----- 154 (292)
Q Consensus 80 ~e~~~~~~L~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~givH~dl~p~Nilv~~~~~~kl~dfg~~~~~~~~----- 154 (292)
|||++||++..++.+.+.++++.++.++.+++.|+..||+.|++|+||||+|+|||..|++||+|||+++.+...
T Consensus 220 MEylPGGD~mTLL~~~~~L~e~~arfYiaE~vlAI~~iH~~gyIHRDIKPdNlLiD~~GHiKLSDFGLs~gl~~~~~~~~ 299 (550)
T KOG0605|consen 220 MEYLPGGDMMTLLMRKDTLTEDWARFYIAETVLAIESIHQLGYIHRDIKPDNLLIDAKGHIKLSDFGLSTGLDKKHRIES 299 (550)
T ss_pred EEecCCccHHHHHHhcCcCchHHHHHHHHHHHHHHHHHHHcCcccccCChhheeecCCCCEeeccccccchhhhhhhhhh
Confidence 999999999999999999999999999999999999999999999999999999999999999999998654210
Q ss_pred ------------------cc-----ccc-------------------cccccccccccCCCCCCCcccceeeecCCCCCC
Q psy758 155 ------------------IP-----RHL-------------------HIFQTNEYFKGVSLPHAENVVPLEIKIGKPAAT 192 (292)
Q Consensus 155 ------------------~~-----~~~-------------------~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 192 (292)
.+ ..+ ...++|.|.+++.+. +--++...+.
T Consensus 300 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~w~~nrr~~a~StVGTPDYiAPEVll--------~kgY~~~cDw 371 (550)
T KOG0605|consen 300 YRLDEQMQINLSEAKPSDFPKFNTPRSTMSRREQLQTWKRNRRQLAYSTVGTPDYIAPEVLL--------GKGYGKECDW 371 (550)
T ss_pred hcchhhhhhhhccCCCccccccccccchhhHHHHHHHHHhhhhhhhhcccCCccccchHHHh--------cCCCCccccH
Confidence 00 000 012233333222210 0001111222
Q ss_pred chHHHHHHHhhcccCCCCCCChhhhhhcc--CcCC--CCCCCCCccchHHHHhcccCcCCCCCC---ChhhhhhCCcccc
Q psy758 193 NIYLIDFLKRCLDKDPLRRWSCDQLLRHP--YFNG--YYFEVPDEMQYEEITQRCLDKDPLRRW---SCDQLLRHPYFNG 265 (292)
Q Consensus 193 ~~~~~~~~~~~~~~~p~~~~~~~~~~~~~--~~~~--~~~~~~~~~~l~~li~~~l~~dP~~Rp---t~~~il~h~w~~~ 265 (292)
++.++-+++.+.+..|+..-+..+..+.. |-.. ++.....+.+..+||.+||+ ||.+|. .++||.+||||++
T Consensus 372 WSLG~ImyEmLvGyPPF~s~tp~~T~rkI~nwr~~l~fP~~~~~s~eA~DLI~rll~-d~~~RLG~~G~~EIK~HPfF~~ 450 (550)
T KOG0605|consen 372 WSLGCIMYEMLVGYPPFCSETPQETYRKIVNWRETLKFPEEVDLSDEAKDLITRLLC-DPENRLGSKGAEEIKKHPFFKG 450 (550)
T ss_pred HHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhhhccCCCcCcccHHHHHHHHHHhc-CHHHhcCcccHHHHhcCCcccc
Confidence 33334444444455555444444444331 2222 23334446789999999999 999999 5999999999999
Q ss_pred eeccCCChhH
Q psy758 266 YYFEVPDEMQ 275 (292)
Q Consensus 266 ~~~~~~~~~~ 275 (292)
+.|+..-++.
T Consensus 451 v~W~~l~~~~ 460 (550)
T KOG0605|consen 451 VDWDHLREMP 460 (550)
T ss_pred CCcchhhcCC
Confidence 9999655544
|
|
| >KOG0583|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-46 Score=309.98 Aligned_cols=254 Identities=29% Similarity=0.429 Sum_probs=210.5
Q ss_pred CcccceeeeecccCceEEEEEEEcCCCcEEEEEEeccCCCC---hHHHHHHHHHHHHHHhCC-CCCcchhhhhhhcCCeE
Q psy758 1 MERYEKIGKLGEGSYGVVFKCRNRDTGQVVAIKKFLESEED---PLIRKIALREIRLLKSLK-HPNLVNLLEVFRRKKKL 76 (292)
Q Consensus 1 ~~~y~~~~~l~~g~~~~v~~~~~~~~~~~v~iK~~~~~~~~---~~~~~~~~~e~~~~~~l~-~~~i~~~~~~~~~~~~~ 76 (292)
.++|.+++.||+|+||+|+.|.+..++..||+|++...... ....+.+.+|+.+++.++ ||||+++++++.....+
T Consensus 16 ~g~y~~~~~lG~GsfgkV~~a~~~~t~~~vAiKii~~~~~~~~~~~~~~~i~rEi~~~~~~~~HpnI~~l~ev~~t~~~~ 95 (370)
T KOG0583|consen 16 IGKYELGRTLGSGSFGKVKLAKHRLTGEKVAIKIIDRKKVSSKSQKLDELIKREISILRRLRSHPNIIRLLEVFATPTKI 95 (370)
T ss_pred cCceeeeeeecCCCCeeEEEeeeccCCCeEEEEEechhcccccccccchhhHHHHHHHHHhccCCCEeEEEEEEecCCeE
Confidence 36899999999999999999999999999999977664211 234566778999999999 99999999999999999
Q ss_pred EEEEecCCCccHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEEccC-CcEEEeecCchhhhh-c-
Q psy758 77 HLVFEFCDHTVLNELENHPHGLPWDLIKQITWQVLRGVSYCHRHACIHRDIKPENILLTAN-GVVKLCDFGFARLIR-D- 153 (292)
Q Consensus 77 ~iv~e~~~~~~L~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~givH~dl~p~Nilv~~~-~~~kl~dfg~~~~~~-~- 153 (292)
|+||||+.||.|.+++...++++|..++.++.||+.|++|||++||+||||||+||+++.+ +++||+|||++.... .
T Consensus 96 ~ivmEy~~gGdL~~~i~~~g~l~E~~ar~~F~Qlisav~y~H~~gi~HRDLK~ENilld~~~~~~Kl~DFG~s~~~~~~~ 175 (370)
T KOG0583|consen 96 YIVMEYCSGGDLFDYIVNKGRLKEDEARKYFRQLISAVAYCHSRGIVHRDLKPENILLDGNEGNLKLSDFGLSAISPGED 175 (370)
T ss_pred EEEEEecCCccHHHHHHHcCCCChHHHHHHHHHHHHHHHHHHhCCEeeCCCCHHHEEecCCCCCEEEeccccccccCCCC
Confidence 9999999999999999888899999999999999999999999999999999999999999 999999999998773 2
Q ss_pred ---cccccccccccccccccCCCCCCCcccceeeecCCCCCCchHHHHHHHhhcccCCCCCCChhhhhhccCcCCCCCCC
Q psy758 154 ---LIPRHLHIFQTNEYFKGVSLPHAENVVPLEIKIGKPAATNIYLIDFLKRCLDKDPLRRWSCDQLLRHPYFNGYYFEV 230 (292)
Q Consensus 154 ---~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~ 230 (292)
....++..|.+||+..+... ..|...++|+...-++..+.+..|+.......+.....-..+..+.
T Consensus 176 ~~l~t~cGsp~Y~aPEvl~~~~~-----------Y~g~~aDvWS~GViLy~ml~G~~PF~d~~~~~l~~ki~~~~~~~p~ 244 (370)
T KOG0583|consen 176 GLLKTFCGSPAYAAPEVLSGKGT-----------YSGKAADVWSLGVILYVLLCGRLPFDDSNVPNLYRKIRKGEFKIPS 244 (370)
T ss_pred CcccCCCCCcccCCHHHhCCCCC-----------cCCchhhhhhhHHHHHHHHhCCCCCCCccHHHHHHHHhcCCccCCC
Confidence 12233445666666555331 1244445555566666667777777776666666665555566676
Q ss_pred CC-ccchHHHHhcccCcCCCCCCChhhhhhCCcccc
Q psy758 231 PD-EMQYEEITQRCLDKDPLRRWSCDQLLRHPYFNG 265 (292)
Q Consensus 231 ~~-~~~l~~li~~~l~~dP~~Rpt~~~il~h~w~~~ 265 (292)
.. +.++++|+.+||..||.+|+|+.+|++||||+.
T Consensus 245 ~~~S~~~~~Li~~mL~~~P~~R~t~~~i~~h~w~~~ 280 (370)
T KOG0583|consen 245 YLLSPEARSLIEKMLVPDPSTRITLLEILEHPWFQK 280 (370)
T ss_pred CcCCHHHHHHHHHHcCCCcccCCCHHHHhhChhhcc
Confidence 66 899999999999999999999999999999996
|
|
| >KOG0597|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-47 Score=312.99 Aligned_cols=273 Identities=30% Similarity=0.447 Sum_probs=230.1
Q ss_pred CcccceeeeecccCceEEEEEEEcCCCcEEEEEEeccCCCChHHHHHHHHHHHHHHhCCCCCcchhhhhhhcCCeEEEEE
Q psy758 1 MERYEKIGKLGEGSYGVVFKCRNRDTGQVVAIKKFLESEEDPLIRKIALREIRLLKSLKHPNLVNLLEVFRRKKKLHLVF 80 (292)
Q Consensus 1 ~~~y~~~~~l~~g~~~~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~iv~ 80 (292)
|++|.+.+.||+|.||.||+|+.+.+.+.||+|.+.+....+...+.+.+|+++++.++||||+.++++|+...++|+|.
T Consensus 1 me~yhv~e~iG~Gsfg~VYKgrrK~t~~~vAik~i~K~gr~~k~l~~l~~ev~i~r~lkHpniv~m~esfEt~~~~~vVt 80 (808)
T KOG0597|consen 1 MEQYHVYEMIGEGSFGRVYKGRRKYTIQVVAIKFIDKSGRNEKELKNLRQEVRILRSLKHPNIVEMLESFETSAHLWVVT 80 (808)
T ss_pred CcchhHHHHhcCCccceeeecccccceeEEEEEEehhcCCchHHHHHHHHHHHHHHhcCCcchhhHHHhhcccceEEEEe
Confidence 68999999999999999999999999999999999999988888899999999999999999999999999999999999
Q ss_pred ecCCCccHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEEccCCcEEEeecCchhhhhcccc----
Q psy758 81 EFCDHTVLNELENHPHGLPWDLIKQITWQVLRGVSYCHRHACIHRDIKPENILLTANGVVKLCDFGFARLIRDLIP---- 156 (292)
Q Consensus 81 e~~~~~~L~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~givH~dl~p~Nilv~~~~~~kl~dfg~~~~~~~~~~---- 156 (292)
|||.| +|..++...+.++|+.++.++.+++.||.|||+.+|.|+|+||.||+++.+|.+|++|||+++.......
T Consensus 81 e~a~g-~L~~il~~d~~lpEe~v~~~a~~LVsaL~yLhs~rilhrd~kPqniLl~~~~~~KlcdFg~Ar~m~~~t~vlts 159 (808)
T KOG0597|consen 81 EYAVG-DLFTILEQDGKLPEEQVRAIAYDLVSALYYLHSNRILHRDMKPQNILLEKGGTLKLCDFGLARAMSTNTSVLTS 159 (808)
T ss_pred hhhhh-hHHHHHHhccCCCHHHHHHHHHHHHHHHHHHHhcCcccccCCcceeeecCCCceeechhhhhhhcccCceeeee
Confidence 99998 8999999999999999999999999999999999999999999999999999999999999988765322
Q ss_pred -ccccccccccccccCCC-----CCCCcccceeeecCCCCCCchHHHHHHHhhcccCCCCCCChhhhhhccCcCCCCCCC
Q psy758 157 -RHLHIFQTNEYFKGVSL-----PHAENVVPLEIKIGKPAATNIYLIDFLKRCLDKDPLRRWSCDQLLRHPYFNGYYFEV 230 (292)
Q Consensus 157 -~~~~~~~~~~~~~~~~~-----~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~ 230 (292)
.+++.|.+||...+..+ .|+.|++.|++..|.+++....+..++..++..++ .++.
T Consensus 160 ikGtPlYmAPElv~e~pyd~~sDlWslGcilYE~~~G~PPF~a~si~~Lv~~I~~d~v------------------~~p~ 221 (808)
T KOG0597|consen 160 IKGTPLYMAPELVEEQPYDHTSDLWSLGCILYELYVGQPPFYARSITQLVKSILKDPV------------------KPPS 221 (808)
T ss_pred ccCcccccCHHHHcCCCccchhhHHHHHHHHHHHhcCCCCchHHHHHHHHHHHhcCCC------------------CCcc
Confidence 34556677776665544 47777888888888888877777777777665443 3344
Q ss_pred CCccchHHHHhcccCcCCCCCCChhhhhhCCcccceeccCCChhHHHHHhhhc-CCCCcCCCC
Q psy758 231 PDEMQYEEITQRCLDKDPLRRWSCDQLLRHPYFNGYYFEVPDEMQYEEITQVS-RLPTKDKNK 292 (292)
Q Consensus 231 ~~~~~l~~li~~~l~~dP~~Rpt~~~il~h~w~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~ 292 (292)
..+..+.+|+..+|..||.+|.|..+++.|||+++-....-...+..-..++. ++|++-|+|
T Consensus 222 ~~S~~f~nfl~gLL~kdP~~RltW~~Ll~HpF~k~~~~~~~~~~~~a~~spftn~~Ppe~kek 284 (808)
T KOG0597|consen 222 TASSSFVNFLQGLLIKDPAQRLTWTDLLGHPFWKGKINIAELPAQVAFDSPFTNNTPPEYKEK 284 (808)
T ss_pred cccHHHHHHHHHHhhcChhhcccHHHHhcChHHhhhhhhhcccccccccCccccCCChHHHHh
Confidence 55778999999999999999999999999999998655433333333233332 346665553
|
|
| >KOG0595|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-45 Score=292.73 Aligned_cols=258 Identities=26% Similarity=0.399 Sum_probs=207.5
Q ss_pred CcccceeeeecccCceEEEEEEEcCCCcEEEEEEeccCCCChHHHHHHHHHHHHHHhCCCCCcchhhhhhhcCCeEEEEE
Q psy758 1 MERYEKIGKLGEGSYGVVFKCRNRDTGQVVAIKKFLESEEDPLIRKIALREIRLLKSLKHPNLVNLLEVFRRKKKLHLVF 80 (292)
Q Consensus 1 ~~~y~~~~~l~~g~~~~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~iv~ 80 (292)
+++|.+.+.||+|+||.||+|++..++..||||.+.+........+.+..|+.+++.++||||+.+++++++++.+|+||
T Consensus 9 ~~~y~~~~~iG~GsfavVykg~h~~~~~~VAIK~i~~~~l~~k~~e~L~~Ei~iLkel~H~nIV~l~d~~~~~~~i~lVM 88 (429)
T KOG0595|consen 9 VGDYELSREIGSGSFAVVYKGRHKKSGTEVAIKCIAKKKLNKKLVELLLSEIKILKELKHPNIVRLLDCIEDDDFIYLVM 88 (429)
T ss_pred cccceehhhccCcceEEEEEeEeccCCceEEeeeehhhccCHHHHHHHHHHHHHHHhcCCcceeeEEEEEecCCeEEEEE
Confidence 47899999999999999999999999999999999888878888899999999999999999999999999999999999
Q ss_pred ecCCCccHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEEccC------CcEEEeecCchhhhhcc
Q psy758 81 EFCDHTVLNELENHPHGLPWDLIKQITWQVLRGVSYCHRHACIHRDIKPENILLTAN------GVVKLCDFGFARLIRDL 154 (292)
Q Consensus 81 e~~~~~~L~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~givH~dl~p~Nilv~~~------~~~kl~dfg~~~~~~~~ 154 (292)
|||.||+|..++++.+.+++.+++.++.||+.||++||+++|+||||||.|||++.+ -.+||+|||+++.+.+.
T Consensus 89 EyC~gGDLs~yi~~~~~l~e~t~r~Fm~QLA~alq~L~~~~IiHRDLKPQNiLLs~~~~~~~~~~LKIADFGfAR~L~~~ 168 (429)
T KOG0595|consen 89 EYCNGGDLSDYIRRRGRLPEATARHFMQQLASALQFLHENNIIHRDLKPQNILLSTTARNDTSPVLKIADFGFARFLQPG 168 (429)
T ss_pred EeCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeeeccCCcceEEeccCCCCCCCceEEecccchhhhCCch
Confidence 999999999999999999999999999999999999999999999999999999875 46899999999988753
Q ss_pred ccccccccccccccccCCCCCCCcccceeeecCCCCCCchHHHHHHHhhcccCCCCCCChhhhhhccCcCCCC---CCCC
Q psy758 155 IPRHLHIFQTNEYFKGVSLPHAENVVPLEIKIGKPAATNIYLIDFLKRCLDKDPLRRWSCDQLLRHPYFNGYY---FEVP 231 (292)
Q Consensus 155 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~---~~~~ 231 (292)
.... ..+++|-|++++.+ . ...+....+.|+.+.-+++.+.++.|+...+..+++...-..... .+..
T Consensus 169 ~~a~-tlcGSplYMAPEV~-------~-~~~YdAKADLWSiG~Ilyq~l~g~~Pf~a~t~~eL~~~~~k~~~~~~~~~~~ 239 (429)
T KOG0595|consen 169 SMAE-TLCGSPLYMAPEVI-------M-SQQYDAKADLWSIGTILYQCLTGKPPFDAETPKELLLYIKKGNEIVPVLPAE 239 (429)
T ss_pred hHHH-HhhCCccccCHHHH-------H-hccccchhhHHHHHHHHHHHHhCCCCccccCHHHHHHHHhccccccCchhhh
Confidence 3222 12344444444332 1 111222233345555566666677777777777776532222111 1222
Q ss_pred CccchHHHHhcccCcCCCCCCChhhhhhCCccccee
Q psy758 232 DEMQYEEITQRCLDKDPLRRWSCDQLLRHPYFNGYY 267 (292)
Q Consensus 232 ~~~~l~~li~~~l~~dP~~Rpt~~~il~h~w~~~~~ 267 (292)
.+..+.+|+...|..||.+|.+..+-..|+++..-.
T Consensus 240 ~s~~~~~Ll~~ll~~~~~~~~~~~~~~~~~~l~~~p 275 (429)
T KOG0595|consen 240 LSNPLRELLISLLQRNPKDRISFEDFFDHPFLAANP 275 (429)
T ss_pred ccCchhhhhhHHHhcCccccCchHHhhhhhhcccCc
Confidence 355677999999999999999999999999998755
|
|
| >KOG0600|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.8e-46 Score=301.15 Aligned_cols=263 Identities=30% Similarity=0.463 Sum_probs=210.1
Q ss_pred cccceeeeecccCceEEEEEEEcCCCcEEEEEEeccCCCChHHHHHHHHHHHHHHhCCCCCcchhhhhhhcC--CeEEEE
Q psy758 2 ERYEKIGKLGEGSYGVVFKCRNRDTGQVVAIKKFLESEEDPLIRKIALREIRLLKSLKHPNLVNLLEVFRRK--KKLHLV 79 (292)
Q Consensus 2 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~--~~~~iv 79 (292)
+.|+.++.||+|+||.||+|++..+|+.||+|.+......+.......+|+.++++|.||||+++.+...+. +.+|+|
T Consensus 117 ~~feki~kIGeGTyg~VYkAr~~~tgkivALKKvr~d~~~~~~~~t~~REI~ILr~l~HpNIikL~eivt~~~~~siYlV 196 (560)
T KOG0600|consen 117 DSFEKIEKIGEGTYGQVYKARDLETGKIVALKKVRFDNEKEGFPITAIREIKILRRLDHPNIIKLEEIVTSKLSGSIYLV 196 (560)
T ss_pred HHHHHHHHhcCcchhheeEeeecccCcEEEEEEeecccCCCcchHHHHHHHHHHHhcCCCcccceeeEEEecCCceEEEE
Confidence 468889999999999999999999999999999988877777778889999999999999999999998765 789999
Q ss_pred EecCCCccHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEEccCCcEEEeecCchhhhhcccc---
Q psy758 80 FEFCDHTVLNELENHPHGLPWDLIKQITWQVLRGVSYCHRHACIHRDIKPENILLTANGVVKLCDFGFARLIRDLIP--- 156 (292)
Q Consensus 80 ~e~~~~~~L~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~givH~dl~p~Nilv~~~~~~kl~dfg~~~~~~~~~~--- 156 (292)
+|||+..+..-+....-.+++.++..++.||+.||+|||++|++|||||.+|||||.+|.+||+|||+++.+.....
T Consensus 197 FeYMdhDL~GLl~~p~vkft~~qIKc~mkQLl~Gl~~cH~~gvlHRDIK~SNiLidn~G~LKiaDFGLAr~y~~~~~~~~ 276 (560)
T KOG0600|consen 197 FEYMDHDLSGLLSSPGVKFTEPQIKCYMKQLLEGLEYCHSRGVLHRDIKGSNILIDNNGVLKIADFGLARFYTPSGSAPY 276 (560)
T ss_pred EecccchhhhhhcCCCcccChHHHHHHHHHHHHHHHHHhhcCeeeccccccceEEcCCCCEEeccccceeeccCCCCccc
Confidence 99999876555555456799999999999999999999999999999999999999999999999999997654332
Q ss_pred ---ccccccccccccccCCC------CCCCcccceeeecCCCCCCchHHHH---HHHhhcccCCCCCCChhhhhhccCcC
Q psy758 157 ---RHLHIFQTNEYFKGVSL------PHAENVVPLEIKIGKPAATNIYLID---FLKRCLDKDPLRRWSCDQLLRHPYFN 224 (292)
Q Consensus 157 ---~~~~~~~~~~~~~~~~~------~~~~~~~~~~~~~~~~~~~~~~~~~---~~~~~~~~~p~~~~~~~~~~~~~~~~ 224 (292)
..+-.|.+||.++|..- .|+.|++..++..|.+...+..-.+ .+..+++......|.. ..-+++.
T Consensus 277 T~rVvTLWYRpPELLLG~t~Yg~aVDlWS~GCIl~El~~gkPI~~G~tEveQl~kIfklcGSP~e~~W~~---~kLP~~~ 353 (560)
T KOG0600|consen 277 TSRVVTLWYRPPELLLGATSYGTAVDLWSVGCILAELFLGKPILQGRTEVEQLHKIFKLCGSPTEDYWPV---SKLPHAT 353 (560)
T ss_pred ccceEEeeccChHHhcCCcccccceeehhhhHHHHHHHcCCCCcCCccHHHHHHHHHHHhCCCChhcccc---ccCCccc
Confidence 22456899999998765 3777777777777877655443332 3444445444444442 2223333
Q ss_pred CCCCCC-----------CCccchHHHHhcccCcCCCCCCChhhhhhCCccccee
Q psy758 225 GYYFEV-----------PDEMQYEEITQRCLDKDPLRRWSCDQLLRHPYFNGYY 267 (292)
Q Consensus 225 ~~~~~~-----------~~~~~l~~li~~~l~~dP~~Rpt~~~il~h~w~~~~~ 267 (292)
.+.... ..+....+|+..||+.||.+|.||.++|+|+||....
T Consensus 354 ~~kp~~~y~r~l~E~~~~~~~~~l~Ll~~lL~ldP~kR~tA~~aL~seyF~t~p 407 (560)
T KOG0600|consen 354 IFKPQQPYKRRLRETFKDFPASALDLLEKLLSLDPDKRGTASSALQSEYFTTEP 407 (560)
T ss_pred ccCCCCcccchHHHHhccCCHHHHHHHHHHhccCccccccHHHHhcCcccccCC
Confidence 322221 2266778999999999999999999999999995533
|
|
| >KOG0198|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.8e-45 Score=290.78 Aligned_cols=247 Identities=28% Similarity=0.451 Sum_probs=198.4
Q ss_pred ccceeeeecccCceEEEEEEEcCCCcEEEEEEeccCCCChHHHHHHHHHHHHHHhCCCCCcchhhhhhhcCC--eEEEEE
Q psy758 3 RYEKIGKLGEGSYGVVFKCRNRDTGQVVAIKKFLESEEDPLIRKIALREIRLLKSLKHPNLVNLLEVFRRKK--KLHLVF 80 (292)
Q Consensus 3 ~y~~~~~l~~g~~~~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~--~~~iv~ 80 (292)
++..++.||+|+||.||++.+..+|...|+|........ ..+.+.+|+.+++.++|||||+++|...... .++++|
T Consensus 18 ~~~~~~~lG~Gs~G~V~l~~~~~~g~~~AvK~v~~~~~~--~~~~l~~Ei~iL~~l~~p~IV~~~G~~~~~~~~~~~i~m 95 (313)
T KOG0198|consen 18 NWSKGKLLGRGSFGSVYLATNKKTGELMAVKSVELEDSP--TSESLEREIRILSRLNHPNIVQYYGSSSSRENDEYNIFM 95 (313)
T ss_pred hhhhhccccCccceEEEEEEecCCCcceeeeeeecccch--hHHHHHHHHHHHHhCCCCCEEeeCCccccccCeeeEeee
Confidence 577889999999999999999999999999998766322 2677899999999999999999999854433 799999
Q ss_pred ecCCCccHHHHhcCCC-CCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEEcc-CCcEEEeecCchhhhhc-----
Q psy758 81 EFCDHTVLNELENHPH-GLPWDLIKQITWQVLRGVSYCHRHACIHRDIKPENILLTA-NGVVKLCDFGFARLIRD----- 153 (292)
Q Consensus 81 e~~~~~~L~~~~~~~~-~~~~~~~~~i~~qi~~aL~~LH~~givH~dl~p~Nilv~~-~~~~kl~dfg~~~~~~~----- 153 (292)
||+++|+|.+++...+ .+++..++.+..||++||+|||++|++|+||||+|||++. ++.+||+|||++.....
T Consensus 96 Ey~~~GsL~~~~~~~g~~l~E~~v~~ytr~iL~GL~ylHs~g~vH~DiK~~NiLl~~~~~~~KlaDFG~a~~~~~~~~~~ 175 (313)
T KOG0198|consen 96 EYAPGGSLSDLIKRYGGKLPEPLVRRYTRQILEGLAYLHSKGIVHCDIKPANILLDPSNGDVKLADFGLAKKLESKGTKS 175 (313)
T ss_pred eccCCCcHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCEeccCcccceEEEeCCCCeEEeccCccccccccccccc
Confidence 9999999999998876 7999999999999999999999999999999999999999 79999999999887652
Q ss_pred ---cccccccccccccccc-c-----CCCCCCCcccceeeecCCCCCCch-HHHHHHHhhcccCCCCCCChhhhhhccCc
Q psy758 154 ---LIPRHLHIFQTNEYFK-G-----VSLPHAENVVPLEIKIGKPAATNI-YLIDFLKRCLDKDPLRRWSCDQLLRHPYF 223 (292)
Q Consensus 154 ---~~~~~~~~~~~~~~~~-~-----~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~p~~~~~~~~~~~~~~~ 223 (292)
....++..|.+||... | ..+.|+.|+...++.+|.+++... .....+.......
T Consensus 176 ~~~~~~~Gtp~~maPEvi~~g~~~~~~sDiWSlGCtVvEM~Tg~~PW~~~~~~~~~~~~ig~~~---------------- 239 (313)
T KOG0198|consen 176 DSELSVQGTPNYMAPEVIRNGEVARRESDIWSLGCTVVEMLTGKPPWSEFFEEAEALLLIGRED---------------- 239 (313)
T ss_pred cccccccCCccccCchhhcCCCcCCccchhhhcCCEEEeccCCCCcchhhcchHHHHHHHhccC----------------
Confidence 2234455677777766 3 345688888888888887775431 1111111111111
Q ss_pred CCCCCCCCCccchHHHHhcccCcCCCCCCChhhhhhCCccccee
Q psy758 224 NGYYFEVPDEMQYEEITQRCLDKDPLRRWSCDQLLRHPYFNGYY 267 (292)
Q Consensus 224 ~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~~il~h~w~~~~~ 267 (292)
....++...+...++||.+|+..||++||||+++|+|||+.+..
T Consensus 240 ~~P~ip~~ls~~a~~Fl~~C~~~~p~~Rpta~eLL~hpf~~~~~ 283 (313)
T KOG0198|consen 240 SLPEIPDSLSDEAKDFLRKCFKRDPEKRPTAEELLEHPFLKQNS 283 (313)
T ss_pred CCCCCCcccCHHHHHHHHHHhhcCcccCcCHHHHhhChhhhccc
Confidence 00134455688999999999999999999999999999998744
|
|
| >KOG0578|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-45 Score=303.90 Aligned_cols=247 Identities=28% Similarity=0.450 Sum_probs=212.0
Q ss_pred cccceeeeecccCceEEEEEEEcCCCcEEEEEEeccCCCChHHHHHHHHHHHHHHhCCCCCcchhhhhhhcCCeEEEEEe
Q psy758 2 ERYEKIGKLGEGSYGVVFKCRNRDTGQVVAIKKFLESEEDPLIRKIALREIRLLKSLKHPNLVNLLEVFRRKKKLHLVFE 81 (292)
Q Consensus 2 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~iv~e 81 (292)
..|+....||+|+.|.||.|....+++.||+|.+....... .+.+.+|+.+++..+|+||+.+++.|...+.+|+|||
T Consensus 273 ~~y~~~~kigqgaSG~vy~A~~~~~~~~VaiK~m~l~~Q~~--keLilnEi~Vm~~~~H~NiVnfl~Sylv~deLWVVME 350 (550)
T KOG0578|consen 273 SKYTDFKKIGQGATGGVYVARKISTKQEVAIKRMDLRKQPK--KELLLNEILVMRDLHHPNIVNFLDSYLVGDELWVVME 350 (550)
T ss_pred hhhcchhhhccccccceeeeeeccCCceEEEEEEEeccCCc--hhhhHHHHHHHHhccchHHHHHHHHhcccceeEEEEe
Confidence 46888999999999999999999999999999997765443 4668899999999999999999999999999999999
Q ss_pred cCCCccHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEEccCCcEEEeecCchhhhhccccccccc
Q psy758 82 FCDHTVLNELENHPHGLPWDLIKQITWQVLRGVSYCHRHACIHRDIKPENILLTANGVVKLCDFGFARLIRDLIPRHLHI 161 (292)
Q Consensus 82 ~~~~~~L~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~givH~dl~p~Nilv~~~~~~kl~dfg~~~~~~~~~~~~~~~ 161 (292)
|++||+|.+.+... .++|.++..++.++++||+|||.+||+|+|||.+|||++.+|.+||+|||+|..+..........
T Consensus 351 ym~ggsLTDvVt~~-~~~E~qIA~Icre~l~aL~fLH~~gIiHrDIKSDnILL~~~g~vKltDFGFcaqi~~~~~KR~Tm 429 (550)
T KOG0578|consen 351 YMEGGSLTDVVTKT-RMTEGQIAAICREILQGLKFLHARGIIHRDIKSDNILLTMDGSVKLTDFGFCAQISEEQSKRSTM 429 (550)
T ss_pred ecCCCchhhhhhcc-cccHHHHHHHHHHHHHHHHHHHhcceeeeccccceeEeccCCcEEEeeeeeeeccccccCccccc
Confidence 99999999998875 59999999999999999999999999999999999999999999999999999998888788888
Q ss_pred cccccccccCCC----------CCCCcccceeeecCCCCCCchH-HHHHHHhhcccCCCCCCChhhhhhccCcCCCCCCC
Q psy758 162 FQTNEYFKGVSL----------PHAENVVPLEIKIGKPAATNIY-LIDFLKRCLDKDPLRRWSCDQLLRHPYFNGYYFEV 230 (292)
Q Consensus 162 ~~~~~~~~~~~~----------~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~ 230 (292)
.++|.|.+++.. .|++|++..++.-|++++.... +..+..-.....| ....+.
T Consensus 430 VGTPYWMAPEVvtrk~YG~KVDIWSLGIMaIEMveGEPPYlnE~PlrAlyLIa~ng~P----------------~lk~~~ 493 (550)
T KOG0578|consen 430 VGTPYWMAPEVVTRKPYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYLIATNGTP----------------KLKNPE 493 (550)
T ss_pred cCCCCccchhhhhhcccCccccchhhhhHHHHHhcCCCCccCCChHHHHHHHhhcCCC----------------CcCCcc
Confidence 899999887654 6888888888888888876432 2333222222222 123344
Q ss_pred CCccchHHHHhcccCcCCCCCCChhhhhhCCccccee
Q psy758 231 PDEMQYEEITQRCLDKDPLRRWSCDQLLRHPYFNGYY 267 (292)
Q Consensus 231 ~~~~~l~~li~~~l~~dP~~Rpt~~~il~h~w~~~~~ 267 (292)
..++.+++|+.+||+.||.+|++|.|+|+||||+...
T Consensus 494 klS~~~kdFL~~cL~~dv~~RasA~eLL~HpFl~~a~ 530 (550)
T KOG0578|consen 494 KLSPELKDFLDRCLVVDVEQRASAKELLEHPFLKMAK 530 (550)
T ss_pred ccCHHHHHHHHHHhhcchhcCCCHHHHhcChhhhhcC
Confidence 5588999999999999999999999999999996543
|
|
| >cd05612 STKc_PRKX_like Catalytic domain of PRKX-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.7e-45 Score=297.47 Aligned_cols=255 Identities=21% Similarity=0.271 Sum_probs=201.3
Q ss_pred cccceeeeecccCceEEEEEEEcCCCcEEEEEEeccCCC-ChHHHHHHHHHHHHHHhCCCCCcchhhhhhhcCCeEEEEE
Q psy758 2 ERYEKIGKLGEGSYGVVFKCRNRDTGQVVAIKKFLESEE-DPLIRKIALREIRLLKSLKHPNLVNLLEVFRRKKKLHLVF 80 (292)
Q Consensus 2 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~v~iK~~~~~~~-~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~iv~ 80 (292)
++|++.+.||+|+||.||+|.+..+++.||+|++..... .....+.+.+|+.+++.++||||+++++++.+.+.+++||
T Consensus 1 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~ 80 (291)
T cd05612 1 DDLERIKTVGTGTFGRVHLVRDRISEHYYALKVMAIPEVIRLKQEQHVHNEKRVLKEVSHPFIIRLFWTEHDQRFLYMLM 80 (291)
T ss_pred CCceeeeeeecCCCeEEEEEEEcCCCCEEEEEEEEHHHHhhhHHHHHHHHHHHHHHhCCCCcHhhhHhhhccCCeEEEEE
Confidence 579999999999999999999999999999999875432 2234566889999999999999999999999999999999
Q ss_pred ecCCCccHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEEccCCcEEEeecCchhhhhccc--ccc
Q psy758 81 EFCDHTVLNELENHPHGLPWDLIKQITWQVLRGVSYCHRHACIHRDIKPENILLTANGVVKLCDFGFARLIRDLI--PRH 158 (292)
Q Consensus 81 e~~~~~~L~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~givH~dl~p~Nilv~~~~~~kl~dfg~~~~~~~~~--~~~ 158 (292)
||+++++|.+++...+.+++..+..++.||+.||+|||++|++||||+|+||+++.++.++|+|||++....... ..+
T Consensus 81 e~~~~~~L~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~NIli~~~~~~kl~Dfg~~~~~~~~~~~~~g 160 (291)
T cd05612 81 EYVPGGELFSYLRNSGRFSNSTGLFYASEIVCALEYLHSKEIVYRDLKPENILLDKEGHIKLTDFGFAKKLRDRTWTLCG 160 (291)
T ss_pred eCCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCHHHeEECCCCCEEEEecCcchhccCCcccccC
Confidence 999999999999887789999999999999999999999999999999999999999999999999987654321 123
Q ss_pred ccccccccccccCCCCCCCcccceeeecCCCCCCchHHHHHHHhhcccCCCCCCChhhhhhccCcCCCCCCCCCccchHH
Q psy758 159 LHIFQTNEYFKGVSLPHAENVVPLEIKIGKPAATNIYLIDFLKRCLDKDPLRRWSCDQLLRHPYFNGYYFEVPDEMQYEE 238 (292)
Q Consensus 159 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ 238 (292)
+..|.+||...+.......++ ++.+..++..+.+..|+...+..++..........++...+..+++
T Consensus 161 t~~y~aPE~~~~~~~~~~~Di-------------wSlG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~ 227 (291)
T cd05612 161 TPEYLAPEVIQSKGHNKAVDW-------------WALGILIYEMLVGYPPFFDDNPFGIYEKILAGKLEFPRHLDLYAKD 227 (291)
T ss_pred ChhhcCHHHHcCCCCCchhhH-------------HHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCcCCCccCCHHHHH
Confidence 445667776654433222222 2233334444445555544444443333222233445556778999
Q ss_pred HHhcccCcCCCCCCC-----hhhhhhCCcccceecc
Q psy758 239 ITQRCLDKDPLRRWS-----CDQLLRHPYFNGYYFE 269 (292)
Q Consensus 239 li~~~l~~dP~~Rpt-----~~~il~h~w~~~~~~~ 269 (292)
||++||+.||.+||+ ++++++||||+.+.|.
T Consensus 228 li~~~l~~dp~~R~~~~~~~~~~~l~h~~~~~~~~~ 263 (291)
T cd05612 228 LIKKLLVVDRTRRLGNMKNGADDVKNHRWFKSVDWD 263 (291)
T ss_pred HHHHHcCCCHHHccCCccCCHHHHhcCccccCCCHH
Confidence 999999999999995 9999999999987765
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyt |
| >KOG0610|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-45 Score=291.32 Aligned_cols=272 Identities=23% Similarity=0.308 Sum_probs=206.8
Q ss_pred CcccceeeeecccCceEEEEEEEcCCCcEEEEEEeccCCCC-hHHHHHHHHHHHHHHhCCCCCcchhhhhhhcCCeEEEE
Q psy758 1 MERYEKIGKLGEGSYGVVFKCRNRDTGQVVAIKKFLESEED-PLIRKIALREIRLLKSLKHPNLVNLLEVFRRKKKLHLV 79 (292)
Q Consensus 1 ~~~y~~~~~l~~g~~~~v~~~~~~~~~~~v~iK~~~~~~~~-~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~iv 79 (292)
++.|++++.||+|.-|+||+|....++..+|+|++.+.... .........|.+|++.+.||.++.+|..|+.++..|++
T Consensus 76 l~~f~llk~LG~GdiG~VyL~~l~~t~~~fAmKVmdK~~l~~rkKl~Ra~tE~eIL~~lDHPFlPTLYa~fet~~~~cl~ 155 (459)
T KOG0610|consen 76 LRHFRLLKRLGCGDIGTVYLVELRGTNCLFAMKVMDKESLASRKKLKRAQTEREILSLLDHPFLPTLYASFETDKYSCLV 155 (459)
T ss_pred HHHHHHHHHcCCCCceeEEEEEecCCCceEEEEEecHHHHhhhhHHHHHHHHHHHHHhcCCCccchhhheeeccceeEEE
Confidence 35688999999999999999999999999999999877633 44567778899999999999999999999999999999
Q ss_pred EecCCCccHHHHhcCC--CCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEEccCCcEEEeecCchhhhhcccc-
Q psy758 80 FEFCDHTVLNELENHP--HGLPWDLIKQITWQVLRGVSYCHRHACIHRDIKPENILLTANGVVKLCDFGFARLIRDLIP- 156 (292)
Q Consensus 80 ~e~~~~~~L~~~~~~~--~~~~~~~~~~i~~qi~~aL~~LH~~givH~dl~p~Nilv~~~~~~kl~dfg~~~~~~~~~~- 156 (292)
||||+||+|..+++++ +.++++.++.++.+++.||+|||-.|||+|||||+||||-++|++.|+||.++........
T Consensus 156 meyCpGGdL~~LrqkQp~~~fse~~aRFYaAEvl~ALEYLHmlGivYRDLKPENILvredGHIMLsDFDLS~~~~~~Pt~ 235 (459)
T KOG0610|consen 156 MEYCPGGDLHSLRQKQPGKRFSESAARFYAAEVLLALEYLHMLGIVYRDLKPENILVREDGHIMLSDFDLSLRCPVSPTL 235 (459)
T ss_pred EecCCCccHHHHHhhCCCCccchhhHHHHHHHHHHHHHHHHhhceeeccCCcceeEEecCCcEEeeeccccccCCCCCee
Confidence 9999999999988764 4699999999999999999999999999999999999999999999999998765421000
Q ss_pred --c-----------c----ccccccc--------------------ccccc------CCCCCCCcccceeeecCCCC---
Q psy758 157 --R-----------H----LHIFQTN--------------------EYFKG------VSLPHAENVVPLEIKIGKPA--- 190 (292)
Q Consensus 157 --~-----------~----~~~~~~~--------------------~~~~~------~~~~~~~~~~~~~~~~~~~~--- 190 (292)
. . ...+... +..+. ..+.-...+.+.++..|.-.
T Consensus 236 ~~s~~~~~~~~~~~~~~~~~s~f~~r~~~~~~~~~k~~~~~~~~~p~~~aep~~~RSnSFVGThEYlAPEvI~G~GHgsA 315 (459)
T KOG0610|consen 236 VKSSSPRSSGSQPSCRSRQPSCFSPRCLSSSKKRKKKDESASRSLPELVAEPTGARSNSFVGTHEYLAPEVIRGEGHGSA 315 (459)
T ss_pred eccCCCCCCCCCcccccccccccccchhccccccccccccccccchhhhcCCCCccccccccccccccceeeecCCCCch
Confidence 0 0 0000000 00000 00001112233333333321
Q ss_pred -CCchHHHHHHHhhcccCCCCCCChhhhhhccCcCCCCCCC--CCccchHHHHhcccCcCCCCCCC----hhhhhhCCcc
Q psy758 191 -ATNIYLIDFLKRCLDKDPLRRWSCDQLLRHPYFNGYYFEV--PDEMQYEEITQRCLDKDPLRRWS----CDQLLRHPYF 263 (292)
Q Consensus 191 -~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~--~~~~~l~~li~~~l~~dP~~Rpt----~~~il~h~w~ 263 (292)
+.|....-+++.+.+..|+...+.++.+.+...+...++. .++..++|||+++|..||++|.. |+||.+||||
T Consensus 316 VDWWtfGIflYEmLyG~TPFKG~~~~~Tl~NIv~~~l~Fp~~~~vs~~akDLIr~LLvKdP~kRlg~~rGA~eIK~HpFF 395 (459)
T KOG0610|consen 316 VDWWTFGIFLYEMLYGTTPFKGSNNKETLRNIVGQPLKFPEEPEVSSAAKDLIRKLLVKDPSKRLGSKRGAAEIKRHPFF 395 (459)
T ss_pred hhHHHHHHHHHHHHhCCCCcCCCCchhhHHHHhcCCCcCCCCCcchhHHHHHHHHHhccChhhhhccccchHHhhcCccc
Confidence 1133334456777788888888777777766655544443 44788999999999999999998 9999999999
Q ss_pred cceeccCCC
Q psy758 264 NGYYFEVPD 272 (292)
Q Consensus 264 ~~~~~~~~~ 272 (292)
+++.|.+.-
T Consensus 396 ~gVnWaLir 404 (459)
T KOG0610|consen 396 EGVNWALIR 404 (459)
T ss_pred cCCChhhee
Confidence 999998433
|
|
| >KOG0585|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-45 Score=294.64 Aligned_cols=250 Identities=28% Similarity=0.415 Sum_probs=204.3
Q ss_pred CcccceeeeecccCceEEEEEEEcCCCcEEEEEEeccCCCC------------hHHHHHHHHHHHHHHhCCCCCcchhhh
Q psy758 1 MERYEKIGKLGEGSYGVVFKCRNRDTGQVVAIKKFLESEED------------PLIRKIALREIRLLKSLKHPNLVNLLE 68 (292)
Q Consensus 1 ~~~y~~~~~l~~g~~~~v~~~~~~~~~~~v~iK~~~~~~~~------------~~~~~~~~~e~~~~~~l~~~~i~~~~~ 68 (292)
||+|++.+.||+|.||.|-+|++..+++.||||++++.... ....+..++|+.+++++.|||||++++
T Consensus 96 lNqy~l~~eiG~G~yGkVkLar~~~~~~l~AiKil~K~~~~~~~~~~~~~a~~~~~~ekv~~EIailKkl~H~nVV~LiE 175 (576)
T KOG0585|consen 96 LNQYELIKEIGSGQYGKVKLARDEVDGKLYAIKILPKKELRRQYGFPRQPAMKLMPIEKVRREIAILKKLHHPNVVKLIE 175 (576)
T ss_pred hhheehhhhhcCCccceEEEEeecCCCcEEEEEeechhhhhhhcccccccccccCcHHHHHHHHHHHHhcCCcCeeEEEE
Confidence 68999999999999999999999999999999999754311 112357889999999999999999999
Q ss_pred hhhc--CCeEEEEEecCCCccHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEEccCCcEEEeecC
Q psy758 69 VFRR--KKKLHLVFEFCDHTVLNELENHPHGLPWDLIKQITWQVLRGVSYCHRHACIHRDIKPENILLTANGVVKLCDFG 146 (292)
Q Consensus 69 ~~~~--~~~~~iv~e~~~~~~L~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~givH~dl~p~Nilv~~~~~~kl~dfg 146 (292)
+..+ .+.+|+|+|||..|.+..--.....+++.++++++.+++.||.|||.+||+||||||+|+|++++|++||+|||
T Consensus 176 vLDDP~s~~~YlVley~s~G~v~w~p~d~~els~~~Ar~ylrDvv~GLEYLH~QgiiHRDIKPsNLLl~~~g~VKIsDFG 255 (576)
T KOG0585|consen 176 VLDDPESDKLYLVLEYCSKGEVKWCPPDKPELSEQQARKYLRDVVLGLEYLHYQGIIHRDIKPSNLLLSSDGTVKISDFG 255 (576)
T ss_pred eecCcccCceEEEEEeccCCccccCCCCcccccHHHHHHHHHHHHHHHHHHHhcCeeccccchhheEEcCCCcEEeeccc
Confidence 9886 46799999999988876654443339999999999999999999999999999999999999999999999999
Q ss_pred chhhhhc----------cccccccccccccccccCC---------CCCCCcccceeeecCCCCCCchHHHHHHHhhcccC
Q psy758 147 FARLIRD----------LIPRHLHIFQTNEYFKGVS---------LPHAENVVPLEIKIGKPAATNIYLIDFLKRCLDKD 207 (292)
Q Consensus 147 ~~~~~~~----------~~~~~~~~~~~~~~~~~~~---------~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 207 (292)
.+..+.. ....+++.|.+||...+.. ..|+.|+..|.+++|..++.+.....+..++....
T Consensus 256 Vs~~~~~~~~~~~d~~L~~tvGTPAF~APE~c~~~~~~~~~g~a~DiWalGVTLYCllfG~~PF~~~~~~~l~~KIvn~p 335 (576)
T KOG0585|consen 256 VSNEFPQGSDEGSDDQLSRTVGTPAFFAPELCSGGNSFSYSGFALDIWALGVTLYCLLFGQLPFFDDFELELFDKIVNDP 335 (576)
T ss_pred eeeecccCCccccHHHHhhcCCCccccchHhhcCCCCccccchhhhhhhhhhhHHHhhhccCCcccchHHHHHHHHhcCc
Confidence 9876521 1234455666776665522 35788888888888888888888887777765432
Q ss_pred CCCCCChhhhhhccCcCCCCCCCCCccchHHHHhcccCcCCCCCCChhhhhhCCcccce
Q psy758 208 PLRRWSCDQLLRHPYFNGYYFEVPDEMQYEEITQRCLDKDPLRRWSCDQLLRHPYFNGY 266 (292)
Q Consensus 208 p~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~~il~h~w~~~~ 266 (292)
..- +......+.+++||.+||+.||.+|++..+|..|||....
T Consensus 336 -L~f---------------P~~pe~~e~~kDli~~lL~KdP~~Ri~l~~ik~Hpwvt~~ 378 (576)
T KOG0585|consen 336 -LEF---------------PENPEINEDLKDLIKRLLEKDPEQRITLPDIKLHPWVTRD 378 (576)
T ss_pred -ccC---------------CCcccccHHHHHHHHHHhhcChhheeehhhheecceeccC
Confidence 111 1111346789999999999999999999999999999874
|
|
| >PTZ00263 protein kinase A catalytic subunit; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-44 Score=299.59 Aligned_cols=251 Identities=25% Similarity=0.345 Sum_probs=198.0
Q ss_pred CcccceeeeecccCceEEEEEEEcCCCcEEEEEEeccCC-CChHHHHHHHHHHHHHHhCCCCCcchhhhhhhcCCeEEEE
Q psy758 1 MERYEKIGKLGEGSYGVVFKCRNRDTGQVVAIKKFLESE-EDPLIRKIALREIRLLKSLKHPNLVNLLEVFRRKKKLHLV 79 (292)
Q Consensus 1 ~~~y~~~~~l~~g~~~~v~~~~~~~~~~~v~iK~~~~~~-~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~iv 79 (292)
+++|++.+.||+|++|.||+|++..+++.||+|++.... ......+.+.+|+.+++.++||||+++++++.+++..|+|
T Consensus 17 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv 96 (329)
T PTZ00263 17 LSDFEMGETLGTGSFGRVRIAKHKGTGEYYAIKCLKKREILKMKQVQHVAQEKSILMELSHPFIVNMMCSFQDENRVYFL 96 (329)
T ss_pred chheEEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCCCcEEEEEEcCCEEEEE
Confidence 478999999999999999999999999999999987543 2223456688999999999999999999999999999999
Q ss_pred EecCCCccHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEEccCCcEEEeecCchhhhhccc--cc
Q psy758 80 FEFCDHTVLNELENHPHGLPWDLIKQITWQVLRGVSYCHRHACIHRDIKPENILLTANGVVKLCDFGFARLIRDLI--PR 157 (292)
Q Consensus 80 ~e~~~~~~L~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~givH~dl~p~Nilv~~~~~~kl~dfg~~~~~~~~~--~~ 157 (292)
|||+.+++|..++...+.+++..+..++.||+.||+|||++|++||||||+||+++.++.++|+|||++....... ..
T Consensus 97 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivH~dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~~~~~ 176 (329)
T PTZ00263 97 LEFVVGGELFTHLRKAGRFPNDVAKFYHAELVLAFEYLHSKDIIYRDLKPENLLLDNKGHVKVTDFGFAKKVPDRTFTLC 176 (329)
T ss_pred EcCCCCChHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCHHHEEECCCCCEEEeeccCceEcCCCcceec
Confidence 9999999999999887889999999999999999999999999999999999999999999999999987654322 12
Q ss_pred cccccccccccccCCC-----CCCCcccceeeecCCCCCCchHHHHHHHhhcccCCCCCCChhhhhhccCcCCCCCCCCC
Q psy758 158 HLHIFQTNEYFKGVSL-----PHAENVVPLEIKIGKPAATNIYLIDFLKRCLDKDPLRRWSCDQLLRHPYFNGYYFEVPD 232 (292)
Q Consensus 158 ~~~~~~~~~~~~~~~~-----~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~ 232 (292)
++..|.+||...+... .|+.|+..+++.+|..++.......+..... -.....+...
T Consensus 177 gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~------------------~~~~~~p~~~ 238 (329)
T PTZ00263 177 GTPEYLAPEVIQSKGHGKAVDWWTMGVLLYEFIAGYPPFFDDTPFRIYEKIL------------------AGRLKFPNWF 238 (329)
T ss_pred CChhhcCHHHHcCCCCCCcceeechHHHHHHHHcCCCCCCCCCHHHHHHHHh------------------cCCcCCCCCC
Confidence 3345667776654433 3444444445555554443322222222221 1112233345
Q ss_pred ccchHHHHhcccCcCCCCCCC-----hhhhhhCCcccceecc
Q psy758 233 EMQYEEITQRCLDKDPLRRWS-----CDQLLRHPYFNGYYFE 269 (292)
Q Consensus 233 ~~~l~~li~~~l~~dP~~Rpt-----~~~il~h~w~~~~~~~ 269 (292)
+..+++||.+||+.||.+||+ ++++++||||.+..|+
T Consensus 239 ~~~~~~li~~~L~~dP~~R~~~~~~~~~~ll~hp~f~~~~~~ 280 (329)
T PTZ00263 239 DGRARDLVKGLLQTDHTKRLGTLKGGVADVKNHPYFHGANWD 280 (329)
T ss_pred CHHHHHHHHHHhhcCHHHcCCCCCCCHHHHhcCCccCCCCHH
Confidence 678999999999999999997 7999999999987666
|
|
| >KOG0588|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-44 Score=302.32 Aligned_cols=254 Identities=28% Similarity=0.395 Sum_probs=211.4
Q ss_pred cccceeeeecccCceEEEEEEEcCCCcEEEEEEeccC-CCChHHHHHHHHHHHHHHhCCCCCcchhhhhhhcCCeEEEEE
Q psy758 2 ERYEKIGKLGEGSYGVVFKCRNRDTGQVVAIKKFLES-EEDPLIRKIALREIRLLKSLKHPNLVNLLEVFRRKKKLHLVF 80 (292)
Q Consensus 2 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~v~iK~~~~~-~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~iv~ 80 (292)
+=|.+++.||.|+.|.|-+|++..||+..|||++.+. ...+.....+.+|+-+|+.+.|||++++|+++++..++|+|.
T Consensus 12 GpwkLgkTLG~Gstg~vrlakh~~TGqlaaiKii~k~~~~s~s~~~~IerEIviMkLi~HpnVl~LydVwe~~~~lylvl 91 (786)
T KOG0588|consen 12 GPWKLGKTLGKGSTGCVRLAKHAETGQLAAIKIIPKRSELSSSQPAGIEREIVIMKLIEHPNVLRLYDVWENKQHLYLVL 91 (786)
T ss_pred cceeccccccCCCCceehhhhcccccceeEEEeeccccccccccccchhhhhHHHHHhcCCCeeeeeeeeccCceEEEEE
Confidence 5588999999999999999999999999999999877 455556677889999999999999999999999999999999
Q ss_pred ecCCCccHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEEccCCcEEEeecCchhhhhccccc---
Q psy758 81 EFCDHTVLNELENHPHGLPWDLIKQITWQVLRGVSYCHRHACIHRDIKPENILLTANGVVKLCDFGFARLIRDLIPR--- 157 (292)
Q Consensus 81 e~~~~~~L~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~givH~dl~p~Nilv~~~~~~kl~dfg~~~~~~~~~~~--- 157 (292)
||++||.|.+++-..+++++..+.+++.||+.|+.|||..+|+|+||||+|+|+|..+++||+|||+|..-.+..--
T Consensus 92 Eyv~gGELFdylv~kG~l~e~eaa~ff~QIi~gv~yCH~~~icHRDLKpENlLLd~~~nIKIADFGMAsLe~~gklLeTS 171 (786)
T KOG0588|consen 92 EYVPGGELFDYLVRKGPLPEREAAHFFRQILDGVSYCHAFNICHRDLKPENLLLDVKNNIKIADFGMASLEVPGKLLETS 171 (786)
T ss_pred EecCCchhHHHHHhhCCCCCHHHHHHHHHHHHHHHHHhhhcceeccCCchhhhhhcccCEeeeccceeecccCCcccccc
Confidence 99999999999988899999999999999999999999999999999999999999999999999999765432211
Q ss_pred -cccccccccccccCCCCCCCcccceeeecCCCCCCchHHHHHHHhhcccCCCCCCChhhhhhccCcCCCCCCCCCccch
Q psy758 158 -HLHIFQTNEYFKGVSLPHAENVVPLEIKIGKPAATNIYLIDFLKRCLDKDPLRRWSCDQLLRHPYFNGYYFEVPDEMQY 236 (292)
Q Consensus 158 -~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~l 236 (292)
+.+-|.+||...|..+ -|.+.++|+.+.-++..+.+.-|++..+.+.++.......+.+|..++.++
T Consensus 172 CGSPHYA~PEIV~G~pY------------dG~~sDVWSCGVILfALLtG~LPFdDdNir~LLlKV~~G~f~MPs~Is~ea 239 (786)
T KOG0588|consen 172 CGSPHYAAPEIVSGRPY------------DGRPSDVWSCGVILFALLTGKLPFDDDNIRVLLLKVQRGVFEMPSNISSEA 239 (786)
T ss_pred CCCcccCCchhhcCCCC------------CCCccccchhHHHHHHHHhCCCCCCCccHHHHHHHHHcCcccCCCcCCHHH
Confidence 1233455554444332 233333344444445555555566666666666666666777888889999
Q ss_pred HHHHhcccCcCCCCCCChhhhhhCCccccee
Q psy758 237 EEITQRCLDKDPLRRWSCDQLLRHPYFNGYY 267 (292)
Q Consensus 237 ~~li~~~l~~dP~~Rpt~~~il~h~w~~~~~ 267 (292)
++||.+||.+||+.|.|++||+.|||+.+..
T Consensus 240 QdLLr~ml~VDp~~RiT~~eI~kHP~l~g~~ 270 (786)
T KOG0588|consen 240 QDLLRRMLDVDPSTRITTEEILKHPFLSGYT 270 (786)
T ss_pred HHHHHHHhccCccccccHHHHhhCchhhcCC
Confidence 9999999999999999999999999999854
|
|
| >KOG0591|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-45 Score=278.47 Aligned_cols=248 Identities=29% Similarity=0.452 Sum_probs=194.1
Q ss_pred cccceeeeecccCceEEEEEEEcCCCcEEEEEEeccCCCChHHHHHHHHHHHHHHhCCCCCcchhhh-hhhcCCe-EEEE
Q psy758 2 ERYEKIGKLGEGSYGVVFKCRNRDTGQVVAIKKFLESEEDPLIRKIALREIRLLKSLKHPNLVNLLE-VFRRKKK-LHLV 79 (292)
Q Consensus 2 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~-~~~~~~~-~~iv 79 (292)
..|++.+.||.|.||.||++++..+|+.||.|.+.-...+....+.+..|+.++++|+||||+++++ .|.+++. +++|
T Consensus 19 ~~y~Il~~IG~GsFg~vykv~~~~~g~l~a~K~i~f~~md~k~rq~~v~Ei~lLkQL~HpNIVqYy~~~f~~~~evlniv 98 (375)
T KOG0591|consen 19 ADYQILKKIGRGSFGEVYKVQCLLDGKLVALKKIQFGMMDAKARQDCVKEISLLKQLNHPNIVQYYAHSFIEDNEVLNIV 98 (375)
T ss_pred HHHHHHHHHcCCcchheEEeeeccCcchhhhhhcchhhccHHHHHHHHHHHHHHHhcCCchHHHHHHHhhhccchhhHHH
Confidence 4699999999999999999999999999999999977788888999999999999999999999999 5555555 8999
Q ss_pred EecCCCccHHHHhcC----CCCCCHHHHHHHHHHHHHHHHHHHh--CC--ccccCCCCCceEEccCCcEEEeecCchhhh
Q psy758 80 FEFCDHTVLNELENH----PHGLPWDLIKQITWQVLRGVSYCHR--HA--CIHRDIKPENILLTANGVVKLCDFGFARLI 151 (292)
Q Consensus 80 ~e~~~~~~L~~~~~~----~~~~~~~~~~~i~~qi~~aL~~LH~--~g--ivH~dl~p~Nilv~~~~~~kl~dfg~~~~~ 151 (292)
||||.+|+|..+++. .+.++|..+|+++.|++.||.++|+ .. +.||||||.|||++.+|.+||+|||+++.+
T Consensus 99 mE~c~~GDLsqmIk~~K~qkr~ipE~~Vwk~f~QL~~AL~~cH~~~~r~~VmHRDIKPaNIFl~~~gvvKLGDfGL~r~l 178 (375)
T KOG0591|consen 99 MELCDAGDLSQMIKHFKKQKRLIPEKTVWKYFVQLCRALYHCHSKIPRGTVMHRDIKPANIFLTANGVVKLGDFGLGRFL 178 (375)
T ss_pred HHhhcccCHHHHHHHHHhccccCchHHHHHHHHHHHHHHHHHhccccccceeeccCcchheEEcCCCceeeccchhHhHh
Confidence 999999999998753 4569999999999999999999999 44 899999999999999999999999999998
Q ss_pred hccccccccccccccccccCCC-----CCCCcccceeeecCCCCCCchHHHHHHHhhcccCCCCCCChhhhhhccCcCCC
Q psy758 152 RDLIPRHLHIFQTNEYFKGVSL-----PHAENVVPLEIKIGKPAATNIYLIDFLKRCLDKDPLRRWSCDQLLRHPYFNGY 226 (292)
Q Consensus 152 ~~~~~~~~~~~~~~~~~~~~~~-----~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~ 226 (292)
.+.........++|.|..++.+ .+..++|++ ++-+++.|.-..|+...+..++.+..-...+
T Consensus 179 ~s~~tfA~S~VGTPyYMSPE~i~~~~Y~~kSDiWsl-------------GCllyEMcaL~~PF~g~n~~~L~~KI~qgd~ 245 (375)
T KOG0591|consen 179 SSKTTFAHSLVGTPYYMSPERIHESGYNFKSDIWSL-------------GCLLYEMCALQSPFYGDNLLSLCKKIEQGDY 245 (375)
T ss_pred cchhHHHHhhcCCCcccCHHHHhcCCCCcchhHHHH-------------HHHHHHHHhcCCCcccccHHHHHHHHHcCCC
Confidence 7765554455566666555433 233333333 3334444444555555555554444332222
Q ss_pred C-CC-CCCccchHHHHhcccCcCCCCCCChhhhhhCCccccee
Q psy758 227 Y-FE-VPDEMQYEEITQRCLDKDPLRRWSCDQLLRHPYFNGYY 267 (292)
Q Consensus 227 ~-~~-~~~~~~l~~li~~~l~~dP~~Rpt~~~il~h~w~~~~~ 267 (292)
+ .+ ...+..+..||..|+++||..||+. +|++.++.
T Consensus 246 ~~~p~~~YS~~l~~li~~ci~vd~~~RP~t-----~~~v~di~ 283 (375)
T KOG0591|consen 246 PPLPDEHYSTDLRELINMCIAVDPEQRPDT-----VPYVQDIQ 283 (375)
T ss_pred CCCcHHHhhhHHHHHHHHHccCCcccCCCc-----chHHHHHH
Confidence 2 22 2347889999999999999999987 55555543
|
|
| >cd05571 STKc_PKB Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-43 Score=294.08 Aligned_cols=244 Identities=21% Similarity=0.267 Sum_probs=194.6
Q ss_pred eeecccCceEEEEEEEcCCCcEEEEEEeccCC-CChHHHHHHHHHHHHHHhCCCCCcchhhhhhhcCCeEEEEEecCCCc
Q psy758 8 GKLGEGSYGVVFKCRNRDTGQVVAIKKFLESE-EDPLIRKIALREIRLLKSLKHPNLVNLLEVFRRKKKLHLVFEFCDHT 86 (292)
Q Consensus 8 ~~l~~g~~~~v~~~~~~~~~~~v~iK~~~~~~-~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~iv~e~~~~~ 86 (292)
+.||+|+||.||+|.+..+|+.||+|++.... ........+.+|+.+++.++||||+++++++..++..|+||||++++
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~lv~e~~~~~ 80 (323)
T cd05571 1 KLLGKGTFGKVILVREKATGKYYAMKILKKEVIIAKDEVAHTLTESRVLQNTRHPFLTALKYSFQTHDRLCFVMEYANGG 80 (323)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCCCEEEEEEcCCEEEEEEeCCCCC
Confidence 46999999999999999999999999987543 22334456778999999999999999999999999999999999999
Q ss_pred cHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEEccCCcEEEeecCchhhhhccc-----cccccc
Q psy758 87 VLNELENHPHGLPWDLIKQITWQVLRGVSYCHRHACIHRDIKPENILLTANGVVKLCDFGFARLIRDLI-----PRHLHI 161 (292)
Q Consensus 87 ~L~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~givH~dl~p~Nilv~~~~~~kl~dfg~~~~~~~~~-----~~~~~~ 161 (292)
+|..++...+.+++..+..++.||+.||+|||++||+||||||+||+++.++.++|+|||+++...... ..++..
T Consensus 81 ~L~~~l~~~~~~~~~~~~~~~~qi~~~L~~lH~~~ivHrDlkp~NIll~~~~~~kl~DfG~a~~~~~~~~~~~~~~gt~~ 160 (323)
T cd05571 81 ELFFHLSRERVFSEDRARFYGAEIVSALGYLHSCDVVYRDLKLENLMLDKDGHIKITDFGLCKEGISDGATMKTFCGTPE 160 (323)
T ss_pred cHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCeEeCCCCHHHEEECCCCCEEEeeCCCCcccccCCCcccceecCcc
Confidence 999998887889999999999999999999999999999999999999999999999999987532211 123455
Q ss_pred cccccccccC-----CCCCCCcccceeeecCCCCCCchHHHHHHHhhcccCCCCCCChhhhhhccCcCCCCCCCCCccch
Q psy758 162 FQTNEYFKGV-----SLPHAENVVPLEIKIGKPAATNIYLIDFLKRCLDKDPLRRWSCDQLLRHPYFNGYYFEVPDEMQY 236 (292)
Q Consensus 162 ~~~~~~~~~~-----~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~l 236 (292)
|.+||...+. ...|+.|+..+++.+|..++.......+.... .......+...+..+
T Consensus 161 y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~Pf~~~~~~~~~~~~------------------~~~~~~~p~~~~~~~ 222 (323)
T cd05571 161 YLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELI------------------LMEEIRFPRTLSPEA 222 (323)
T ss_pred ccChhhhcCCCCCccccCcccchhhhhhhcCCCCCCCCCHHHHHHHH------------------HcCCCCCCCCCCHHH
Confidence 7777776554 34566666666666666554333222222222 122223344567899
Q ss_pred HHHHhcccCcCCCCCC-----ChhhhhhCCcccceecc
Q psy758 237 EEITQRCLDKDPLRRW-----SCDQLLRHPYFNGYYFE 269 (292)
Q Consensus 237 ~~li~~~l~~dP~~Rp-----t~~~il~h~w~~~~~~~ 269 (292)
.+||.+||+.||++|| ++.++++||||.+..|+
T Consensus 223 ~~li~~~L~~dP~~R~~~~~~~~~~ll~h~~f~~~~~~ 260 (323)
T cd05571 223 KSLLAGLLKKDPKQRLGGGPEDAKEIMEHRFFASINWQ 260 (323)
T ss_pred HHHHHHHccCCHHHcCCCCCCCHHHHHcCCCcCCCCHH
Confidence 9999999999999999 89999999999987655
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having be |
| >KOG0582|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-44 Score=286.53 Aligned_cols=256 Identities=26% Similarity=0.332 Sum_probs=206.2
Q ss_pred cccceeeeecccCceEEEEEEEcCCCcEEEEEEeccCCCChHHHHHHHHHHHHHHhCCCCCcchhhhhhhcCCeEEEEEe
Q psy758 2 ERYEKIGKLGEGSYGVVFKCRNRDTGQVVAIKKFLESEEDPLIRKIALREIRLLKSLKHPNLVNLLEVFRRKKKLHLVFE 81 (292)
Q Consensus 2 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~iv~e 81 (292)
+.|++...||.|..+.||+|++..+++.||||++....-+.. .+.+.+|+..++.++||||++++.+|..+..+|+||.
T Consensus 26 ~~YeL~e~IG~G~sa~V~~A~c~p~~e~VAIK~inLEkc~~~-ld~l~kE~~~msl~~HPNIv~~~~sFvv~~~LWvVmp 104 (516)
T KOG0582|consen 26 KDYELQEVIGVGASAVVYLARCIPTNEVVAIKIINLEKCNND-LDALRKEVQTMSLIDHPNIVTYHCSFVVDSELWVVMP 104 (516)
T ss_pred cceeEEEEEeccceeEeeeeeecccCCEEEEEEeehhhhhhh-HHHHHHHHHHhhhcCCCCcceEEEEEEecceeEEeeh
Confidence 579999999999999999999999999999999976654443 7889999999999999999999999999999999999
Q ss_pred cCCCccHHHHhcCC--CCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEEccCCcEEEeecCchhhhhcccccc-
Q psy758 82 FCDHTVLNELENHP--HGLPWDLIKQITWQVLRGVSYCHRHACIHRDIKPENILLTANGVVKLCDFGFARLIRDLIPRH- 158 (292)
Q Consensus 82 ~~~~~~L~~~~~~~--~~~~~~~~~~i~~qi~~aL~~LH~~givH~dl~p~Nilv~~~~~~kl~dfg~~~~~~~~~~~~- 158 (292)
++.+|++.++++.. ..++|..+..++.++++||.|||++|.+|||||+.||||+++|.++|+|||.+..+.....+.
T Consensus 105 fMa~GS~ldIik~~~~~Gl~E~~Ia~iLre~LkaL~YLH~~G~IHRdvKAgnILi~~dG~VkLadFgvsa~l~~~G~R~~ 184 (516)
T KOG0582|consen 105 FMAGGSLLDIIKTYYPDGLEEASIATILREVLKALDYLHQNGHIHRDVKAGNILIDSDGTVKLADFGVSASLFDSGDRQV 184 (516)
T ss_pred hhcCCcHHHHHHHHccccccHHHHHHHHHHHHHHHHHHHhcCceecccccccEEEcCCCcEEEcCceeeeeecccCceee
Confidence 99999999998753 359999999999999999999999999999999999999999999999999876554322211
Q ss_pred ---ccccccccccccCC------------CCCCCcccceeeecCCCCCCchHHHHHHHhhcccCCC-CCCChhhhhhccC
Q psy758 159 ---LHIFQTNEYFKGVS------------LPHAENVVPLEIKIGKPAATNIYLIDFLKRCLDKDPL-RRWSCDQLLRHPY 222 (292)
Q Consensus 159 ---~~~~~~~~~~~~~~------------~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~p~-~~~~~~~~~~~~~ 222 (292)
..+.++|.|..++. ..|++|+..+++..|..++-......++..-++..|. ...+...
T Consensus 185 ~rf~tfvgtp~wmAPEvl~q~~~GYdfKaDIwSfGITA~ELA~G~aPf~k~pPmkvLl~tLqn~pp~~~t~~~~------ 258 (516)
T KOG0582|consen 185 TRFNTFVGTPCWMAPEVLMQQLHGYDFKADIWSFGITACELAHGHAPFSKYPPMKVLLLTLQNDPPTLLTSGLD------ 258 (516)
T ss_pred EeeccccCcccccChHHhhhcccCccchhhhhhhhHHHHHHhcCCCCcccCChHHHHHHHhcCCCCCcccccCC------
Confidence 23355666666654 4688899999999998877655544444444444432 2110000
Q ss_pred cCCCCCCCCCccchHHHHhcccCcCCCCCCChhhhhhCCccccee
Q psy758 223 FNGYYFEVPDEMQYEEITQRCLDKDPLRRWSCDQLLRHPYFNGYY 267 (292)
Q Consensus 223 ~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~~il~h~w~~~~~ 267 (292)
.......+.+++.+|..||..||.+||||.++|.|+||+...
T Consensus 259 ---~d~~k~~~ksf~e~i~~CL~kDP~kRptAskLlkh~FFk~~k 300 (516)
T KOG0582|consen 259 ---KDEDKKFSKSFREMIALCLVKDPSKRPTASKLLKHAFFKKAK 300 (516)
T ss_pred ---hHHhhhhcHHHHHHHHHHhhcCcccCCCHHHHhccHHHhhcc
Confidence 000111255899999999999999999999999999999854
|
|
| >KOG0694|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-43 Score=298.11 Aligned_cols=259 Identities=22% Similarity=0.305 Sum_probs=221.6
Q ss_pred CcccceeeeecccCceEEEEEEEcCCCcEEEEEEeccCC-CChHHHHHHHHHHHHHHhCC-CCCcchhhhhhhcCCeEEE
Q psy758 1 MERYEKIGKLGEGSYGVVFKCRNRDTGQVVAIKKFLESE-EDPLIRKIALREIRLLKSLK-HPNLVNLLEVFRRKKKLHL 78 (292)
Q Consensus 1 ~~~y~~~~~l~~g~~~~v~~~~~~~~~~~v~iK~~~~~~-~~~~~~~~~~~e~~~~~~l~-~~~i~~~~~~~~~~~~~~i 78 (292)
+++|++.+.||+|.||+|++|..+.+++.+|||++++.. ..+...+..+.|.+++.... ||.++.++..|++.+++|+
T Consensus 367 l~~F~~l~vLGkGsFGkV~lae~k~~~e~yAIK~LKK~~Il~~d~Ve~~~~EkrI~~la~~HPFL~~L~~~fQT~~~l~f 446 (694)
T KOG0694|consen 367 LDDFRLLAVLGRGSFGKVLLAELKGTNEYYAIKVLKKGDILQRDEVESLMCEKRIFELANRHPFLVNLFSCFQTKEHLFF 446 (694)
T ss_pred ccceEEEEEeccCcCceEEEEEEcCCCcEEEEEEeeccceeccccHHHHHHHHHHHHHhccCCeEeecccccccCCeEEE
Confidence 578999999999999999999999999999999998886 44556778889999998885 9999999999999999999
Q ss_pred EEecCCCccHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEEccCCcEEEeecCchhhhhcccccc
Q psy758 79 VFEFCDHTVLNELENHPHGLPWDLIKQITWQVLRGVSYCHRHACIHRDIKPENILLTANGVVKLCDFGFARLIRDLIPRH 158 (292)
Q Consensus 79 v~e~~~~~~L~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~givH~dl~p~Nilv~~~~~~kl~dfg~~~~~~~~~~~~ 158 (292)
||||+.||++..+.+. +.+++..+..++.+|+.||.|||++||+|||||.+|||+|.+|++||+|||+++..-......
T Consensus 447 vmey~~Ggdm~~~~~~-~~F~e~rarfyaAev~l~L~fLH~~~IIYRDlKLdNiLLD~eGh~kiADFGlcKe~m~~g~~T 525 (694)
T KOG0694|consen 447 VMEYVAGGDLMHHIHT-DVFSEPRARFYAAEVVLGLQFLHENGIIYRDLKLDNLLLDTEGHVKIADFGLCKEGMGQGDRT 525 (694)
T ss_pred EEEecCCCcEEEEEec-ccccHHHHHHHHHHHHHHHHHHHhcCceeeecchhheEEcccCcEEecccccccccCCCCCcc
Confidence 9999999996555554 579999999999999999999999999999999999999999999999999998766555566
Q ss_pred ccccccccccccCCC-----CCCCcccceeeecCCCCCCchHHHHHHHhhcccCCCCCCChhhhhhccCcCCCCCCCCCc
Q psy758 159 LHIFQTNEYFKGVSL-----PHAENVVPLEIKIGKPAATNIYLIDFLKRCLDKDPLRRWSCDQLLRHPYFNGYYFEVPDE 233 (292)
Q Consensus 159 ~~~~~~~~~~~~~~~-----~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 233 (292)
+.++++|+|.+++.+ ..+.++|.+ +.-+++.+.+..|+..-+.+++..........+|.-.+
T Consensus 526 sTfCGTpey~aPEil~e~~Yt~aVDWW~l-------------GVLlyeML~Gq~PF~gddEee~FdsI~~d~~~yP~~ls 592 (694)
T KOG0694|consen 526 STFCGTPEFLAPEVLTEQSYTRAVDWWGL-------------GVLLYEMLVGESPFPGDDEEEVFDSIVNDEVRYPRFLS 592 (694)
T ss_pred ccccCChhhcChhhhccCcccchhhHHHH-------------HHHHHHHHcCCCCCCCCCHHHHHHHHhcCCCCCCCccc
Confidence 667777777776655 334444443 33455667777788878888888888888888888889
Q ss_pred cchHHHHhcccCcCCCCCCC-----hhhhhhCCcccceeccCCCh
Q psy758 234 MQYEEITQRCLDKDPLRRWS-----CDQLLRHPYFNGYYFEVPDE 273 (292)
Q Consensus 234 ~~l~~li~~~l~~dP~~Rpt-----~~~il~h~w~~~~~~~~~~~ 273 (292)
.+..++++++|..||++|.. +.+|..||||.++.|+...+
T Consensus 593 ~ea~~il~~ll~k~p~kRLG~~e~d~~~i~~hpFFr~i~w~~L~~ 637 (694)
T KOG0694|consen 593 KEAIAIMRRLLRKNPEKRLGSGERDAEDIKKHPFFRSIDWDDLLN 637 (694)
T ss_pred HHHHHHHHHHhccCcccccCCCCCCchhhhhCCccccCCHHHHhh
Confidence 99999999999999999994 68999999999999984433
|
|
| >cd07848 STKc_CDKL5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-43 Score=288.37 Aligned_cols=260 Identities=35% Similarity=0.642 Sum_probs=197.3
Q ss_pred cccceeeeecccCceEEEEEEEcCCCcEEEEEEeccCCCChHHHHHHHHHHHHHHhCCCCCcchhhhhhhcCCeEEEEEe
Q psy758 2 ERYEKIGKLGEGSYGVVFKCRNRDTGQVVAIKKFLESEEDPLIRKIALREIRLLKSLKHPNLVNLLEVFRRKKKLHLVFE 81 (292)
Q Consensus 2 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~iv~e 81 (292)
++|++.+.||+|++|.||+|++..+++.||+|++..........+.+.+|+.+++.++||||+++++++..++..++|||
T Consensus 1 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 80 (287)
T cd07848 1 NKFEVLGVVGEGAYGVVLKCRHKETKEIVAIKKFKDSEENEEVKETTLRELKMLRTLKQENIVELKEAFRRRGKLYLVFE 80 (287)
T ss_pred CCceEEEEecccCCEEEEEEEECCCCcEEEEEEEecccccccchhhHHHHHHHHHhCCCccccchhhhEecCCEEEEEEe
Confidence 58999999999999999999999999999999997665555556778899999999999999999999999999999999
Q ss_pred cCCCccHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEEccCCcEEEeecCchhhhhccc------
Q psy758 82 FCDHTVLNELENHPHGLPWDLIKQITWQVLRGVSYCHRHACIHRDIKPENILLTANGVVKLCDFGFARLIRDLI------ 155 (292)
Q Consensus 82 ~~~~~~L~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~givH~dl~p~Nilv~~~~~~kl~dfg~~~~~~~~~------ 155 (292)
|++++++..+......+++..++.++.||+.||.|||+.|++|+||+|+||+++.++.++|+|||++.......
T Consensus 81 ~~~~~~l~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~ 160 (287)
T cd07848 81 YVEKNMLELLEEMPNGVPPEKVRSYIYQLIKAIHWCHKNDIVHRDIKPENLLISHNDVLKLCDFGFARNLSEGSNANYTE 160 (287)
T ss_pred cCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEEcCCCcEEEeeccCcccccccccccccc
Confidence 99999888877666679999999999999999999999999999999999999999999999999987654221
Q ss_pred cccccccccccccccCC-----CCCCCcccceeeecCCCCCCchHHHHH---HHhhcccCCCCCCChhhhhhccCcCCC-
Q psy758 156 PRHLHIFQTNEYFKGVS-----LPHAENVVPLEIKIGKPAATNIYLIDF---LKRCLDKDPLRRWSCDQLLRHPYFNGY- 226 (292)
Q Consensus 156 ~~~~~~~~~~~~~~~~~-----~~~~~~~~~~~~~~~~~~~~~~~~~~~---~~~~~~~~p~~~~~~~~~~~~~~~~~~- 226 (292)
...+..|.+||...+.. ..|+.|+..+++.+|.+++......+. +..+.+..|... .......+.+...
T Consensus 161 ~~~~~~y~aPE~~~~~~~~~~~DiwslGvil~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~ 238 (287)
T cd07848 161 YVATRWYRSPELLLGAPYGKAVDMWSVGCILGELSDGQPLFPGESEIDQLFTIQKVLGPLPAEQ--MKLFYSNPRFHGLR 238 (287)
T ss_pred cccccccCCcHHHcCCCCCCchhHHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhhCCCCHHH--HHhhhccchhcccc
Confidence 12344577888765543 345666666667777766543222111 111211111000 0000000000000
Q ss_pred ------------CCCCCCccchHHHHhcccCcCCCCCCChhhhhhCCcc
Q psy758 227 ------------YFEVPDEMQYEEITQRCLDKDPLRRWSCDQLLRHPYF 263 (292)
Q Consensus 227 ------------~~~~~~~~~l~~li~~~l~~dP~~Rpt~~~il~h~w~ 263 (292)
......+..+.+||.+||++||++|||++++++||||
T Consensus 239 ~~~~~~~~~~~~~~~~~~s~~~~dll~~~L~~~P~~R~s~~~~l~hp~f 287 (287)
T cd07848 239 FPAVNHPQSLERRYLGILSGVLLDLMKNLLKLNPTDRYLTEQCLNHPAF 287 (287)
T ss_pred cCcccCcccHHHhhhcccCHHHHHHHHHHccCCcccCCCHHHHhcCCCC
Confidence 0112246679999999999999999999999999998
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes |
| >KOG0611|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.2e-44 Score=282.59 Aligned_cols=243 Identities=27% Similarity=0.405 Sum_probs=200.3
Q ss_pred ccceeeeecccCceEEEEEEEcCCCcEEEEEEeccCC-CChHHHHHHHHHHHHHHhCCCCCcchhhhhhhcCCeEEEEEe
Q psy758 3 RYEKIGKLGEGSYGVVFKCRNRDTGQVVAIKKFLESE-EDPLIRKIALREIRLLKSLKHPNLVNLLEVFRRKKKLHLVFE 81 (292)
Q Consensus 3 ~y~~~~~l~~g~~~~v~~~~~~~~~~~v~iK~~~~~~-~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~iv~e 81 (292)
||++.+.||+|+||.|-+|.....|+.||||.|.+.. .+....-.+++|+++++.|+||||+.+|++|+..+.+.+|||
T Consensus 54 RyE~~etLGkGTYGKVk~A~e~~sgR~VAiKsIrKdkIkdeqDlvhIRREIeIMSsLNHPhII~IyEVFENkdKIvivME 133 (668)
T KOG0611|consen 54 RYEITETLGKGTYGKVKLAYEHKSGREVAIKSIRKDKIKDEQDLVHIRREIEIMSSLNHPHIIQIYEVFENKDKIVIVME 133 (668)
T ss_pred HHHHHHHhcCCcccceeehhhccCCcEeehhhhhhhhcccHHHHHHHHHHHHHHhhcCCCceeehhhhhcCCceEEEEEE
Confidence 7999999999999999999999999999999998876 334456678999999999999999999999999999999999
Q ss_pred cCCCccHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEEccCCcEEEeecCchhhhhccccc----
Q psy758 82 FCDHTVLNELENHPHGLPWDLIKQITWQVLRGVSYCHRHACIHRDIKPENILLTANGVVKLCDFGFARLIRDLIPR---- 157 (292)
Q Consensus 82 ~~~~~~L~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~givH~dl~p~Nilv~~~~~~kl~dfg~~~~~~~~~~~---- 157 (292)
|..+|.|.+++...+.+++..++.++.||+.|+.|+|+++++|+|||.+|||+|.|+++||.|||++..+......
T Consensus 134 YaS~GeLYDYiSer~~LsErEaRhfFRQIvSAVhYCHknrVvHRDLKLENILLD~N~NiKIADFGLSNly~~~kfLqTFC 213 (668)
T KOG0611|consen 134 YASGGELYDYISERGSLSEREARHFFRQIVSAVHYCHKNRVVHRDLKLENILLDQNNNIKIADFGLSNLYADKKFLQTFC 213 (668)
T ss_pred ecCCccHHHHHHHhccccHHHHHHHHHHHHHHHHHHhhccceecccchhheeecCCCCeeeeccchhhhhccccHHHHhc
Confidence 9999999999999999999999999999999999999999999999999999999999999999999877643322
Q ss_pred ccccccccccccc------CCCCCCCcccceeeecCCCCCCchHHHHHHHhhcccCCCCCCChhhhhhccCcCCCCCCCC
Q psy758 158 HLHIFQTNEYFKG------VSLPHAENVVPLEIKIGKPAATNIYLIDFLKRCLDKDPLRRWSCDQLLRHPYFNGYYFEVP 231 (292)
Q Consensus 158 ~~~~~~~~~~~~~------~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~ 231 (292)
+.+.|.+||...| +...|++|+..|.+.+|..++.+.....++.++. .+...+.+
T Consensus 214 GSPLYASPEIvNG~PY~GPEVDsWsLGvLLYtLVyGtMPFDG~Dhk~lvrQIs-------------------~GaYrEP~ 274 (668)
T KOG0611|consen 214 GSPLYASPEIVNGTPYKGPEVDSWSLGVLLYTLVYGTMPFDGRDHKRLVRQIS-------------------RGAYREPE 274 (668)
T ss_pred CCcccCCccccCCCCCCCCccchhhHHHHHHHHhhcccccCCchHHHHHHHhh-------------------cccccCCC
Confidence 2234555554443 2334666666666666666554444444443332 22333445
Q ss_pred CccchHHHHhcccCcCCCCCCChhhhhhCCccc
Q psy758 232 DEMQYEEITQRCLDKDPLRRWSCDQLLRHPYFN 264 (292)
Q Consensus 232 ~~~~l~~li~~~l~~dP~~Rpt~~~il~h~w~~ 264 (292)
.+....-||++||-+||.+|.|+.+|.+|=|++
T Consensus 275 ~PSdA~gLIRwmLmVNP~RRATieDiAsHWWvN 307 (668)
T KOG0611|consen 275 TPSDASGLIRWMLMVNPERRATIEDIASHWWVN 307 (668)
T ss_pred CCchHHHHHHHHHhcCcccchhHHHHhhhheee
Confidence 567788999999999999999999999997766
|
|
| >PTZ00426 cAMP-dependent protein kinase catalytic subunit; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-43 Score=293.73 Aligned_cols=251 Identities=24% Similarity=0.341 Sum_probs=197.7
Q ss_pred CcccceeeeecccCceEEEEEEEcCCC-cEEEEEEeccCC-CChHHHHHHHHHHHHHHhCCCCCcchhhhhhhcCCeEEE
Q psy758 1 MERYEKIGKLGEGSYGVVFKCRNRDTG-QVVAIKKFLESE-EDPLIRKIALREIRLLKSLKHPNLVNLLEVFRRKKKLHL 78 (292)
Q Consensus 1 ~~~y~~~~~l~~g~~~~v~~~~~~~~~-~~v~iK~~~~~~-~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~i 78 (292)
+++|++.+.||+|+||.||+|.+..++ ..||+|.+.... ......+.+.+|+.+++.++||||+++++++.+++..|+
T Consensus 29 ~~~y~~~~~ig~G~~g~Vy~a~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~~~~l 108 (340)
T PTZ00426 29 YEDFNFIRTLGTGSFGRVILATYKNEDFPPVAIKRFEKSKIIKQKQVDHVFSERKILNYINHPFCVNLYGSFKDESYLYL 108 (340)
T ss_pred hhhcEEEEEEeecCCeEEEEEEEECCCCeEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCCcceEEEEEeCCEEEE
Confidence 368999999999999999999876654 689999986543 223345667889999999999999999999999999999
Q ss_pred EEecCCCccHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEEccCCcEEEeecCchhhhhccc--c
Q psy758 79 VFEFCDHTVLNELENHPHGLPWDLIKQITWQVLRGVSYCHRHACIHRDIKPENILLTANGVVKLCDFGFARLIRDLI--P 156 (292)
Q Consensus 79 v~e~~~~~~L~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~givH~dl~p~Nilv~~~~~~kl~dfg~~~~~~~~~--~ 156 (292)
||||+++|+|..++.....+++..+..++.||+.||.|||++|++||||||+||+++.++.++|+|||++....... .
T Consensus 109 v~Ey~~~g~L~~~i~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDLkp~NILl~~~~~ikL~DFG~a~~~~~~~~~~ 188 (340)
T PTZ00426 109 VLEFVIGGEFFTFLRRNKRFPNDVGCFYAAQIVLIFEYLQSLNIVYRDLKPENLLLDKDGFIKMTDFGFAKVVDTRTYTL 188 (340)
T ss_pred EEeCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEccCCCHHHEEECCCCCEEEecCCCCeecCCCccee
Confidence 99999999999999888889999999999999999999999999999999999999999999999999987654321 2
Q ss_pred ccccccccccccccC-----CCCCCCcccceeeecCCCCCCchHHHHHHHhhcccCCCCCCChhhhhhccCcCCCCCCCC
Q psy758 157 RHLHIFQTNEYFKGV-----SLPHAENVVPLEIKIGKPAATNIYLIDFLKRCLDKDPLRRWSCDQLLRHPYFNGYYFEVP 231 (292)
Q Consensus 157 ~~~~~~~~~~~~~~~-----~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~ 231 (292)
.++..|.+||...+. ...|+.|+..+++.+|..++.......+..... ......+..
T Consensus 189 ~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ell~G~~Pf~~~~~~~~~~~i~------------------~~~~~~p~~ 250 (340)
T PTZ00426 189 CGTPEYIAPEILLNVGHGKAADWWTLGIFIYEILVGCPPFYANEPLLIYQKIL------------------EGIIYFPKF 250 (340)
T ss_pred cCChhhcCHHHHhCCCCCccccccchhhHHHHHhcCCCCCCCCCHHHHHHHHh------------------cCCCCCCCC
Confidence 234457777776543 334555555566666655543322222222221 112223444
Q ss_pred CccchHHHHhcccCcCCCCCC-----ChhhhhhCCcccceecc
Q psy758 232 DEMQYEEITQRCLDKDPLRRW-----SCDQLLRHPYFNGYYFE 269 (292)
Q Consensus 232 ~~~~l~~li~~~l~~dP~~Rp-----t~~~il~h~w~~~~~~~ 269 (292)
.+..+.++|++||+.||.+|+ |++++++||||.++.|.
T Consensus 251 ~~~~~~~li~~~l~~dp~~R~~~~~~~~~~~~~hp~f~~~~~~ 293 (340)
T PTZ00426 251 LDNNCKHLMKKLLSHDLTKRYGNLKKGAQNVKEHPWFGNIDWV 293 (340)
T ss_pred CCHHHHHHHHHHcccCHHHcCCCCCCCHHHHHcCCCcCCCCHH
Confidence 577899999999999999995 89999999999987664
|
|
| >KOG0580|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.1e-45 Score=270.01 Aligned_cols=246 Identities=24% Similarity=0.398 Sum_probs=199.3
Q ss_pred CcccceeeeecccCceEEEEEEEcCCCcEEEEEEeccCC-CChHHHHHHHHHHHHHHhCCCCCcchhhhhhhcCCeEEEE
Q psy758 1 MERYEKIGKLGEGSYGVVFKCRNRDTGQVVAIKKFLESE-EDPLIRKIALREIRLLKSLKHPNLVNLLEVFRRKKKLHLV 79 (292)
Q Consensus 1 ~~~y~~~~~l~~g~~~~v~~~~~~~~~~~v~iK~~~~~~-~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~iv 79 (292)
+++|++++.||.|.||.||+|+...++-.||+|++.++. .......++.+|+++.+.|+||||+++|++|-+...+|++
T Consensus 21 l~dfeigr~LgkgkFG~vYlarekks~~IvalKVlfKsqi~~~~v~~qlrREiEIqs~L~hpnilrlY~~fhd~~riyLi 100 (281)
T KOG0580|consen 21 LDDFEIGRPLGKGKFGNVYLAREKKSLFIVALKVLFKSQILKTQVEHQLRREIEIQSHLRHPNILRLYGYFHDSKRIYLI 100 (281)
T ss_pred hhhccccccccCCccccEeEeeeccCCcEEEEeeeeHHHHHHhcchhhhhheeEeecccCCccHHhhhhheeccceeEEE
Confidence 578999999999999999999999999999999997665 3334567889999999999999999999999999999999
Q ss_pred EecCCCccHHHHhc--CCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEEccCCcEEEeecCchhhhhccccc
Q psy758 80 FEFCDHTVLNELEN--HPHGLPWDLIKQITWQVLRGVSYCHRHACIHRDIKPENILLTANGVVKLCDFGFARLIRDLIPR 157 (292)
Q Consensus 80 ~e~~~~~~L~~~~~--~~~~~~~~~~~~i~~qi~~aL~~LH~~givH~dl~p~Nilv~~~~~~kl~dfg~~~~~~~~~~~ 157 (292)
+||.++|.+...+. ....+++..++.++.|++.||.|+|.++++||||||+|+|++.++.+||+|||.+...+. ..+
T Consensus 101 lEya~~gel~k~L~~~~~~~f~e~~~a~Yi~q~A~Al~y~h~k~VIhRdiKpenlLlg~~~~lkiAdfGwsV~~p~-~kR 179 (281)
T KOG0580|consen 101 LEYAPRGELYKDLQEGRMKRFDEQRAATYIKQLANALLYCHLKRVIHRDIKPENLLLGSAGELKIADFGWSVHAPS-NKR 179 (281)
T ss_pred EEecCCchHHHHHHhcccccccccchhHHHHHHHHHHHHhccCCcccCCCCHHHhccCCCCCeeccCCCceeecCC-CCc
Confidence 99999999999888 666799999999999999999999999999999999999999999999999999865542 222
Q ss_pred c----ccccccccccccCCCC-----CCCcccceeeecCCCCCCchHHHHHHHhhcccCCCCCCChhhhhhccCcCCCCC
Q psy758 158 H----LHIFQTNEYFKGVSLP-----HAENVVPLEIKIGKPAATNIYLIDFLKRCLDKDPLRRWSCDQLLRHPYFNGYYF 228 (292)
Q Consensus 158 ~----~~~~~~~~~~~~~~~~-----~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~ 228 (292)
. +..|-+||...|.... |+.++..++.+.|.++ ++.-+..+.++...-....+
T Consensus 180 ~tlcgt~dyl~pEmv~~~~hd~~Vd~w~lgvl~yeflvg~pp------------------Fes~~~~etYkrI~k~~~~~ 241 (281)
T KOG0580|consen 180 KTLCGTLDYLPPEMVEGRGHDKFVDLWSLGVLCYEFLVGLPP------------------FESQSHSETYKRIRKVDLKF 241 (281)
T ss_pred eeeecccccCCHhhcCCCCccchhhHHHHHHHHHHHHhcCCc------------------hhhhhhHHHHHHHHHccccC
Confidence 1 2234455554444333 4444444444444444 44434444444333334556
Q ss_pred CCCCccchHHHHhcccCcCCCCCCChhhhhhCCcccc
Q psy758 229 EVPDEMQYEEITQRCLDKDPLRRWSCDQLLRHPYFNG 265 (292)
Q Consensus 229 ~~~~~~~l~~li~~~l~~dP~~Rpt~~~il~h~w~~~ 265 (292)
+..++..++++|.+||..+|.+|.+..|+++|||+..
T Consensus 242 p~~is~~a~dlI~~ll~~~p~~r~~l~~v~~hpwI~a 278 (281)
T KOG0580|consen 242 PSTISGGAADLISRLLVKNPIERLALTEVMDHPWIVA 278 (281)
T ss_pred CcccChhHHHHHHHHhccCccccccHHHHhhhHHHHh
Confidence 6788999999999999999999999999999999874
|
|
| >cd05573 STKc_ROCK_NDR_like Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-43 Score=295.81 Aligned_cols=252 Identities=26% Similarity=0.383 Sum_probs=200.5
Q ss_pred cccceeeeecccCceEEEEEEEcCCCcEEEEEEeccCCC-ChHHHHHHHHHHHHHHhCCCCCcchhhhhhhcCCeEEEEE
Q psy758 2 ERYEKIGKLGEGSYGVVFKCRNRDTGQVVAIKKFLESEE-DPLIRKIALREIRLLKSLKHPNLVNLLEVFRRKKKLHLVF 80 (292)
Q Consensus 2 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~v~iK~~~~~~~-~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~iv~ 80 (292)
++|++++.||+|++|.||+|.+..+++.||+|++..... .......+..|+.++..++||||+++++++.+++..|+||
T Consensus 1 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (350)
T cd05573 1 DDFEVIKVIGRGAFGEVWLVRDKDTGQVYAMKVLRKSDMIKRNQIAHVRAERDILADADSPWIVKLYYSFQDEEHLYLVM 80 (350)
T ss_pred CCceEEEEEEeCCcEEEEEEEECCCCCEEEEEEEEHHHHhhccHHHHHHHHHHHHHhcCCCCccchhhheecCCeEEEEE
Confidence 589999999999999999999999999999999975532 2234567888999999999999999999999999999999
Q ss_pred ecCCCccHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEEccCCcEEEeecCchhhhhccc-----
Q psy758 81 EFCDHTVLNELENHPHGLPWDLIKQITWQVLRGVSYCHRHACIHRDIKPENILLTANGVVKLCDFGFARLIRDLI----- 155 (292)
Q Consensus 81 e~~~~~~L~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~givH~dl~p~Nilv~~~~~~kl~dfg~~~~~~~~~----- 155 (292)
||+++++|..++...+.+++..++.++.||+.||+|||++|++||||||+||+++.++.++|+|||++.......
T Consensus 81 e~~~~~~L~~~l~~~~~l~~~~~~~i~~qi~~aL~~LH~~giiH~Dlkp~NIll~~~~~~kL~Dfg~~~~~~~~~~~~~~ 160 (350)
T cd05573 81 EYMPGGDLMNLLIRKDVFPEETARFYIAELVLALDSVHKLGFIHRDIKPDNILIDADGHIKLADFGLCKKMNKAKDREYY 160 (350)
T ss_pred cCCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHeEECCCCCEEeecCCCCccCcccCccccc
Confidence 999999999999877789999999999999999999999999999999999999999999999999987654322
Q ss_pred -----------------------------cccccccccccccccCCC-----CCCCcccceeeecCCCCCCchHHHHHHH
Q psy758 156 -----------------------------PRHLHIFQTNEYFKGVSL-----PHAENVVPLEIKIGKPAATNIYLIDFLK 201 (292)
Q Consensus 156 -----------------------------~~~~~~~~~~~~~~~~~~-----~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 201 (292)
..++..|.+||...+... .|+.|+..+++.+|..++..........
T Consensus 161 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~Pf~~~~~~~~~~ 240 (350)
T cd05573 161 LNDSHNLLFRDNVLVRRRDHKQRRVRANSTVGTPDYIAPEVLRGTPYGLECDWWSLGVILYEMLYGFPPFYSDTLQETYN 240 (350)
T ss_pred ccccccccccccccccccccccccccccccccCccccCHHHHcCCCCCCceeeEecchhhhhhccCCCCCCCCCHHHHHH
Confidence 123445677777655433 4566666666666666544333222222
Q ss_pred hhcccCCCCCCChhhhhhccCcCCCCCC--CCCccchHHHHhcccCcCCCCCCC-hhhhhhCCcccceeccC
Q psy758 202 RCLDKDPLRRWSCDQLLRHPYFNGYYFE--VPDEMQYEEITQRCLDKDPLRRWS-CDQLLRHPYFNGYYFEV 270 (292)
Q Consensus 202 ~~~~~~p~~~~~~~~~~~~~~~~~~~~~--~~~~~~l~~li~~~l~~dP~~Rpt-~~~il~h~w~~~~~~~~ 270 (292)
..... ......+ ...+..+.+||.+||. ||.+||+ ++++++||||++..|+.
T Consensus 241 ~i~~~----------------~~~~~~p~~~~~~~~~~~li~~ll~-dp~~R~~s~~~ll~hp~~~~~~~~~ 295 (350)
T cd05573 241 KIINW----------------KESLRFPPDPPVSPEAIDLICRLLC-DPEDRLGSFEEIKSHPFFKGIDWEN 295 (350)
T ss_pred HHhcc----------------CCcccCCCCCCCCHHHHHHHHHHcc-ChhhcCCCHHHHhcCCCcCCCCHHH
Confidence 22210 0111111 1247889999999998 9999999 99999999999987763
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the |
| >cd05593 STKc_PKB_gamma Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.7e-43 Score=288.66 Aligned_cols=249 Identities=21% Similarity=0.294 Sum_probs=192.8
Q ss_pred eeecccCceEEEEEEEcCCCcEEEEEEeccCC-CChHHHHHHHHHHHHHHhCCCCCcchhhhhhhcCCeEEEEEecCCCc
Q psy758 8 GKLGEGSYGVVFKCRNRDTGQVVAIKKFLESE-EDPLIRKIALREIRLLKSLKHPNLVNLLEVFRRKKKLHLVFEFCDHT 86 (292)
Q Consensus 8 ~~l~~g~~~~v~~~~~~~~~~~v~iK~~~~~~-~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~iv~e~~~~~ 86 (292)
+.||+|+||.||+|.+..+++.||+|++.... ........+.+|+.+++.++||||+++++++.+++..|+||||++++
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~Ey~~~g 80 (328)
T cd05593 1 KLLGKGTFGKVILVREKASGKYYAMKILKKEVIIAKDEVAHTLTESRVLKNTRHPFLTSLKYSFQTKDRLCFVMEYVNGG 80 (328)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceEEEEEcCCEEEEEEeCCCCC
Confidence 46899999999999999999999999997543 22334567788999999999999999999999999999999999999
Q ss_pred cHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEEccCCcEEEeecCchhhhhccc-----cccccc
Q psy758 87 VLNELENHPHGLPWDLIKQITWQVLRGVSYCHRHACIHRDIKPENILLTANGVVKLCDFGFARLIRDLI-----PRHLHI 161 (292)
Q Consensus 87 ~L~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~givH~dl~p~Nilv~~~~~~kl~dfg~~~~~~~~~-----~~~~~~ 161 (292)
+|..++.....+++..+..++.||+.||+|||++||+|+||||+||+++.++.++|+|||++....... ..++..
T Consensus 81 ~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~LH~~~ivHrDikp~NIll~~~~~~kL~DfG~~~~~~~~~~~~~~~~gt~~ 160 (328)
T cd05593 81 ELFFHLSRERVFSEDRTRFYGAEIVSALDYLHSGKIVYRDLKLENLMLDKDGHIKITDFGLCKEGITDAATMKTFCGTPE 160 (328)
T ss_pred CHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeEecccCHHHeEECCCCcEEEecCcCCccCCCcccccccccCCcC
Confidence 999998877789999999999999999999999999999999999999999999999999986532211 123345
Q ss_pred cccccccccCCCCCCCcccceeeecCCCCCCchHHHHHHHhhcccCCCCCCChhhhhhccCcCCCCCCCCCccchHHHHh
Q psy758 162 FQTNEYFKGVSLPHAENVVPLEIKIGKPAATNIYLIDFLKRCLDKDPLRRWSCDQLLRHPYFNGYYFEVPDEMQYEEITQ 241 (292)
Q Consensus 162 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~ 241 (292)
|.+||...+.......++|++ +..++..+.+..|+...+..+............+...+..+.+||.
T Consensus 161 y~aPE~~~~~~~~~~~Diwsl-------------Gvil~elltG~~Pf~~~~~~~~~~~~~~~~~~~p~~~~~~~~~li~ 227 (328)
T cd05593 161 YLAPEVLEDNDYGRAVDWWGL-------------GVVMYEMMCGRLPFYNQDHEKLFELILMEDIKFPRTLSADAKSLLS 227 (328)
T ss_pred ccChhhhcCCCCCccCCcccc-------------chHHHHHhhCCCCCCCCCHHHHHHHhccCCccCCCCCCHHHHHHHH
Confidence 666776554333222222222 2223333334444444444444333333344455566889999999
Q ss_pred cccCcCCCCCC-----ChhhhhhCCcccceecc
Q psy758 242 RCLDKDPLRRW-----SCDQLLRHPYFNGYYFE 269 (292)
Q Consensus 242 ~~l~~dP~~Rp-----t~~~il~h~w~~~~~~~ 269 (292)
+||+.||++|| ++.++++||||.+..|.
T Consensus 228 ~~L~~dP~~R~~~~~~~~~~il~h~~~~~~~~~ 260 (328)
T cd05593 228 GLLIKDPNKRLGGGPDDAKEIMRHSFFTGVNWQ 260 (328)
T ss_pred HHcCCCHHHcCCCCCCCHHHHhcCCCcCCCCHH
Confidence 99999999997 89999999999987654
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulate |
| >KOG0660|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-44 Score=280.81 Aligned_cols=262 Identities=30% Similarity=0.488 Sum_probs=207.6
Q ss_pred ccceeeeecccCceEEEEEEEcCCCcEEEEEEeccCCCChHHHHHHHHHHHHHHhCCCCCcchhhhhhhc-----CCeEE
Q psy758 3 RYEKIGKLGEGSYGVVFKCRNRDTGQVVAIKKFLESEEDPLIRKIALREIRLLKSLKHPNLVNLLEVFRR-----KKKLH 77 (292)
Q Consensus 3 ~y~~~~~l~~g~~~~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~-----~~~~~ 77 (292)
+|...+.||.|++|.|+.|.+..+|+.||||.+...-......+...+|+.+++.++|+||+.+++++.. -+.+|
T Consensus 23 ~y~~~~~iG~GAyGvVcsA~~~~t~~~VAIKKi~~~F~~~~~akRtlRElklLr~~~HeNIi~l~di~~p~~~~~f~DvY 102 (359)
T KOG0660|consen 23 YYVLIEPIGRGAYGVVCSAKDKRTGEKVAIKKILNPFENQIDAKRTLRELKLLRHLRHENIIGLLDIFRPPSRDKFNDVY 102 (359)
T ss_pred eecccccccCcceeeEEEEEEcCCCCEeehhhhhhhhhchHHHHHHHHHHHHHHHhcCCCcceEEeecccccccccceeE
Confidence 4566789999999999999999999999999998777777888999999999999999999999999864 34699
Q ss_pred EEEecCCCccHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEEccCCcEEEeecCchhhhhcc---
Q psy758 78 LVFEFCDHTVLNELENHPHGLPWDLIKQITWQVLRGVSYCHRHACIHRDIKPENILLTANGVVKLCDFGFARLIRDL--- 154 (292)
Q Consensus 78 iv~e~~~~~~L~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~givH~dl~p~Nilv~~~~~~kl~dfg~~~~~~~~--- 154 (292)
+|+|++ +.+|...++.+..+++..+..++.||+.||+|+|+.|++||||||+|++++.+..+||+|||+++...+.
T Consensus 103 iV~elM-etDL~~iik~~~~L~d~H~q~f~YQiLrgLKyiHSAnViHRDLKPsNll~n~~c~lKI~DFGLAR~~~~~~~~ 181 (359)
T KOG0660|consen 103 LVFELM-ETDLHQIIKSQQDLTDDHAQYFLYQILRGLKYIHSANVIHRDLKPSNLLLNADCDLKICDFGLARYLDKFFED 181 (359)
T ss_pred EehhHH-hhHHHHHHHcCccccHHHHHHHHHHHHHhcchhhcccccccccchhheeeccCCCEEeccccceeeccccCcc
Confidence 999999 5789999998877999999999999999999999999999999999999999999999999999887532
Q ss_pred ----ccccccccccccccccC------CCCCCCcccceeeecCCCCCCchHHHHHHHhhc---ccCCCCCC---Chhhhh
Q psy758 155 ----IPRHLHIFQTNEYFKGV------SLPHAENVVPLEIKIGKPAATNIYLIDFLKRCL---DKDPLRRW---SCDQLL 218 (292)
Q Consensus 155 ----~~~~~~~~~~~~~~~~~------~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~---~~~p~~~~---~~~~~~ 218 (292)
....+..|.+||..... ...|+.|++..+++.+.+.+.+....+-+..++ +..+.+.. +.....
T Consensus 182 ~~mTeYVaTRWYRAPElll~~~~Yt~aiDiWSvGCI~AEmL~gkplFpG~d~v~Ql~lI~~~lGtP~~e~l~~i~s~~ar 261 (359)
T KOG0660|consen 182 GFMTEYVATRWYRAPELLLNSSEYTKAIDIWSVGCILAEMLTGKPLFPGKDYVHQLQLILELLGTPSEEDLQKIRSEKAR 261 (359)
T ss_pred cchhcceeeeeecCHHHHhccccccchhhhhhhhHHHHHHHcCCCCCCCCchHHHHHHHHHhcCCCCHHHHHHhccHHHH
Confidence 12234557777765433 345888888888899998877766555444433 33221111 100011
Q ss_pred hccCcCCCCCC---------CCCccchHHHHhcccCcCCCCCCChhhhhhCCccccee
Q psy758 219 RHPYFNGYYFE---------VPDEMQYEEITQRCLDKDPLRRWSCDQLLRHPYFNGYY 267 (292)
Q Consensus 219 ~~~~~~~~~~~---------~~~~~~l~~li~~~l~~dP~~Rpt~~~il~h~w~~~~~ 267 (292)
.+..+.+.. ...++...+|+.+||..||.+|+|++|+|+||||+.+.
T Consensus 262 --~yi~slp~~p~~~f~~~fp~a~p~AidLlekmL~fdP~kRita~eAL~hPYl~~~h 317 (359)
T KOG0660|consen 262 --PYIKSLPQIPKQPFSSIFPNANPLAIDLLEKMLVFDPKKRITAEEALAHPYLAPYH 317 (359)
T ss_pred --HHHHhCCCCCCCCHHHHcCCCCHHHHHHHHHHhccCccccCCHHHHhcChhhhhhc
Confidence 111111110 13367788999999999999999999999999999843
|
|
| >cd05595 STKc_PKB_beta Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-42 Score=287.55 Aligned_cols=249 Identities=19% Similarity=0.256 Sum_probs=193.7
Q ss_pred eeecccCceEEEEEEEcCCCcEEEEEEeccCC-CChHHHHHHHHHHHHHHhCCCCCcchhhhhhhcCCeEEEEEecCCCc
Q psy758 8 GKLGEGSYGVVFKCRNRDTGQVVAIKKFLESE-EDPLIRKIALREIRLLKSLKHPNLVNLLEVFRRKKKLHLVFEFCDHT 86 (292)
Q Consensus 8 ~~l~~g~~~~v~~~~~~~~~~~v~iK~~~~~~-~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~iv~e~~~~~ 86 (292)
+.||+|+||.||++.+..+|+.||+|++.... ........+.+|+.+++.++||||+++++++.+++..|+||||++++
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~i~~~~~~~~~~~~~~lv~E~~~~~ 80 (323)
T cd05595 1 KLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLCFVMEYANGG 80 (323)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCcceeeEEecCCEEEEEEeCCCCC
Confidence 46999999999999999999999999987543 22334556778999999999999999999999999999999999999
Q ss_pred cHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEEccCCcEEEeecCchhhhhccc-----cccccc
Q psy758 87 VLNELENHPHGLPWDLIKQITWQVLRGVSYCHRHACIHRDIKPENILLTANGVVKLCDFGFARLIRDLI-----PRHLHI 161 (292)
Q Consensus 87 ~L~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~givH~dl~p~Nilv~~~~~~kl~dfg~~~~~~~~~-----~~~~~~ 161 (292)
+|..++.....+++..++.++.||+.||+|||++|++||||||+||+++.++.++|+|||++....... ..++..
T Consensus 81 ~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~kL~Dfg~~~~~~~~~~~~~~~~gt~~ 160 (323)
T cd05595 81 ELFFHLSRERVFTEERARFYGAEIVSALEYLHSRDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGATMKTFCGTPE 160 (323)
T ss_pred cHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHEEEcCCCCEEecccHHhccccCCCCccccccCCcC
Confidence 999988877789999999999999999999999999999999999999999999999999886532211 122344
Q ss_pred cccccccccCCCCCCCcccceeeecCCCCCCchHHHHHHHhhcccCCCCCCChhhhhhccCcCCCCCCCCCccchHHHHh
Q psy758 162 FQTNEYFKGVSLPHAENVVPLEIKIGKPAATNIYLIDFLKRCLDKDPLRRWSCDQLLRHPYFNGYYFEVPDEMQYEEITQ 241 (292)
Q Consensus 162 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~ 241 (292)
|.+||...+.......++ ++.+.-++..+.+..|+...+..+............+...+..+.++|.
T Consensus 161 y~aPE~~~~~~~~~~~Di-------------wSlGvil~ell~g~~Pf~~~~~~~~~~~~~~~~~~~p~~~~~~~~~li~ 227 (323)
T cd05595 161 YLAPEVLEDNDYGRAVDW-------------WGLGVVMYEMMCGRLPFYNQDHERLFELILMEEIRFPRTLSPEAKSLLA 227 (323)
T ss_pred cCCcccccCCCCCchhch-------------hhhHHHHHHHHhCCCCCCCCCHHHHHHHHhcCCCCCCCCCCHHHHHHHH
Confidence 666666544332222222 2333333444444555544444444433333344455667889999999
Q ss_pred cccCcCCCCCC-----ChhhhhhCCcccceecc
Q psy758 242 RCLDKDPLRRW-----SCDQLLRHPYFNGYYFE 269 (292)
Q Consensus 242 ~~l~~dP~~Rp-----t~~~il~h~w~~~~~~~ 269 (292)
+||+.||.+|| ++.++++||||.+..|.
T Consensus 228 ~~L~~dP~~R~~~~~~~~~~~l~h~~~~~~~~~ 260 (323)
T cd05595 228 GLLKKDPKQRLGGGPSDAKEVMEHRFFLSINWQ 260 (323)
T ss_pred HHccCCHHHhCCCCCCCHHHHHcCCCcCCCCHH
Confidence 99999999998 99999999999987654
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in |
| >cd05600 STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-42 Score=289.26 Aligned_cols=258 Identities=23% Similarity=0.317 Sum_probs=199.8
Q ss_pred cccceeeeecccCceEEEEEEEcCCCcEEEEEEeccCCC-ChHHHHHHHHHHHHHHhCCCCCcchhhhhhhcCCeEEEEE
Q psy758 2 ERYEKIGKLGEGSYGVVFKCRNRDTGQVVAIKKFLESEE-DPLIRKIALREIRLLKSLKHPNLVNLLEVFRRKKKLHLVF 80 (292)
Q Consensus 2 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~v~iK~~~~~~~-~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~iv~ 80 (292)
++|++.+.||+|++|.||+|.+..+++.||+|++..... .......+.+|+.++..++||||+++++++.+++..|+||
T Consensus 1 ~~y~~~~~ig~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~iv~~~~~~~~~~~~~lv~ 80 (333)
T cd05600 1 KDFQILTQVGQGGYGQVFLAKKKDTGEIVALKRMKKSLLFKLNEVRHVLTERDILTTTKSEWLVKLLYAFQDDEYLYLAM 80 (333)
T ss_pred CCcEEEEEEeecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhCCCCCCccEEEEEEcCCEEEEEE
Confidence 579999999999999999999999999999999975532 2234566788999999999999999999999999999999
Q ss_pred ecCCCccHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEEccCCcEEEeecCchhhhhcc--cccc
Q psy758 81 EFCDHTVLNELENHPHGLPWDLIKQITWQVLRGVSYCHRHACIHRDIKPENILLTANGVVKLCDFGFARLIRDL--IPRH 158 (292)
Q Consensus 81 e~~~~~~L~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~givH~dl~p~Nilv~~~~~~kl~dfg~~~~~~~~--~~~~ 158 (292)
||++|++|..++...+.+++..++.++.||+.||.|||++|++||||||+||+++.++.++|+|||++...... ...+
T Consensus 81 e~~~g~~L~~~l~~~~~l~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~kL~Dfg~a~~~~~~~~~~~g 160 (333)
T cd05600 81 EYVPGGDFRTLLNNLGVLSEDHARFYMAEMFEAVDALHELGYIHRDLKPENFLIDASGHIKLTDFGLSKGIVTYANSVVG 160 (333)
T ss_pred eCCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEECCCCCEEEEeCcCCcccccccCCccc
Confidence 99999999999988778999999999999999999999999999999999999999999999999998765431 1233
Q ss_pred ccccccccccccCCC-----CCCCcccceeeecCCCCCCchHHHHHHHhhcccCCCCCCChhhhhhccCcCCCCCCCCCc
Q psy758 159 LHIFQTNEYFKGVSL-----PHAENVVPLEIKIGKPAATNIYLIDFLKRCLDKDPLRRWSCDQLLRHPYFNGYYFEVPDE 233 (292)
Q Consensus 159 ~~~~~~~~~~~~~~~-----~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 233 (292)
+..|.+||...+... .|+.|+..+++.+|..++........+........ .+..+... ......+
T Consensus 161 t~~y~aPE~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~--------~~~~~~~~--~~~~~~s 230 (333)
T cd05600 161 SPDYMAPEVLRGKGYDFTVDYWSLGCMLYEFLCGFPPFSGSTPNETWENLKYWKE--------TLQRPVYD--DPRFNLS 230 (333)
T ss_pred CccccChhHhcCCCCCCccceecchHHHhhhhhCCCCCCCCCHHHHHHHHHhccc--------cccCCCCC--ccccccC
Confidence 456778887665443 45555555556666555433332222222211000 00000000 0002346
Q ss_pred cchHHHHhcccCcCCCCCCChhhhhhCCcccceecc
Q psy758 234 MQYEEITQRCLDKDPLRRWSCDQLLRHPYFNGYYFE 269 (292)
Q Consensus 234 ~~l~~li~~~l~~dP~~Rpt~~~il~h~w~~~~~~~ 269 (292)
..+.+||.+||..+|.+|||++++++||||.+..|+
T Consensus 231 ~~~~~li~~~l~~~~~rr~s~~~ll~h~~~~~~~~~ 266 (333)
T cd05600 231 DEAWDLITKLINDPSRRFGSLEDIKNHPFFKEVDWN 266 (333)
T ss_pred HHHHHHHHHHhhChhhhcCCHHHHHhCcccCCCCHH
Confidence 789999999999999999999999999999987654
|
Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis. |
| >cd05601 STKc_CRIK Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-42 Score=287.38 Aligned_cols=254 Identities=21% Similarity=0.262 Sum_probs=203.8
Q ss_pred cccceeeeecccCceEEEEEEEcCCCcEEEEEEeccCCC-ChHHHHHHHHHHHHHHhCCCCCcchhhhhhhcCCeEEEEE
Q psy758 2 ERYEKIGKLGEGSYGVVFKCRNRDTGQVVAIKKFLESEE-DPLIRKIALREIRLLKSLKHPNLVNLLEVFRRKKKLHLVF 80 (292)
Q Consensus 2 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~v~iK~~~~~~~-~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~iv~ 80 (292)
++|++.+.||+|+||.||+|.+..+++.||+|++..... .....+.+.+|+.+++.++||||+++++++.+.+..++||
T Consensus 1 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~i~~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (330)
T cd05601 1 KDFDVKSLVGRGHFGEVQVVREKATGDIYAMKVMKKSVLLAQETVSFFEEERDILSISNSPWIPQLQYAFQDKDNLYLVM 80 (330)
T ss_pred CCceEEEEEEeccCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceeeEEecCCeEEEEE
Confidence 579999999999999999999999999999999976543 3345567888999999999999999999999999999999
Q ss_pred ecCCCccHHHHhcCC-CCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEEccCCcEEEeecCchhhhhccc----
Q psy758 81 EFCDHTVLNELENHP-HGLPWDLIKQITWQVLRGVSYCHRHACIHRDIKPENILLTANGVVKLCDFGFARLIRDLI---- 155 (292)
Q Consensus 81 e~~~~~~L~~~~~~~-~~~~~~~~~~i~~qi~~aL~~LH~~givH~dl~p~Nilv~~~~~~kl~dfg~~~~~~~~~---- 155 (292)
||+++++|.+++... ..+++..++.++.||+.||.|||++||+||||||+||+++.++.++|+|||++.......
T Consensus 81 e~~~~~~L~~~l~~~~~~l~~~~~~~~~~qi~~aL~~lH~~~i~H~Dlkp~NIll~~~~~~kL~Dfg~a~~~~~~~~~~~ 160 (330)
T cd05601 81 EYQPGGDLLSLLNRYEDQFDEDMAQFYLAELVLAIHSVHQMGYVHRDIKPENVLIDRTGHIKLADFGSAARLTANKMVNS 160 (330)
T ss_pred CCCCCCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeEcccCchHheEECCCCCEEeccCCCCeECCCCCceee
Confidence 999999999998765 579999999999999999999999999999999999999999999999999987654221
Q ss_pred --cccccccccccccc-----------cCCCCCCCcccceeeecCCCCCCchHHHHHHHhhcccCCCCCCChhhhhhccC
Q psy758 156 --PRHLHIFQTNEYFK-----------GVSLPHAENVVPLEIKIGKPAATNIYLIDFLKRCLDKDPLRRWSCDQLLRHPY 222 (292)
Q Consensus 156 --~~~~~~~~~~~~~~-----------~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~ 222 (292)
...+..|.+||... .....|+.|+..+++.+|..++........+...+... -
T Consensus 161 ~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~~~~~~~~~i~~~~--------------~ 226 (330)
T cd05601 161 KLPVGTPDYIAPEVLTTMNGDGKGTYGVECDWWSLGVIAYEMIYGRSPFHEGTSAKTYNNIMNFQ--------------R 226 (330)
T ss_pred ecccCCccccCHHHhccccccccCCCCCcceeecccceeeeeccCCCCCCCCCHHHHHHHHHcCC--------------C
Confidence 12345677888764 23456888888888888877654333333333322211 0
Q ss_pred cCCCCCCCCCccchHHHHhcccCcCCCCCCChhhhhhCCcccceeccC
Q psy758 223 FNGYYFEVPDEMQYEEITQRCLDKDPLRRWSCDQLLRHPYFNGYYFEV 270 (292)
Q Consensus 223 ~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~~il~h~w~~~~~~~~ 270 (292)
..........+..+.+||.+||+ ||.+|||++++++||||....|+.
T Consensus 227 ~~~~~~~~~~~~~~~~li~~ll~-~p~~R~t~~~l~~h~~~~~~~~~~ 273 (330)
T cd05601 227 FLKFPEDPKVSSDFLDLIQSLLC-GQKERLGYEGLCCHPFFSKIDWNN 273 (330)
T ss_pred ccCCCCCCCCCHHHHHHHHHHcc-ChhhCCCHHHHhCCCCcCCCCHHH
Confidence 01111222357789999999998 999999999999999999876653
|
Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnor |
| >cd07869 STKc_PFTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.7e-43 Score=286.69 Aligned_cols=266 Identities=30% Similarity=0.455 Sum_probs=193.1
Q ss_pred cccceeeeecccCceEEEEEEEcCCCcEEEEEEeccCCCChHHHHHHHHHHHHHHhCCCCCcchhhhhhhcCCeEEEEEe
Q psy758 2 ERYEKIGKLGEGSYGVVFKCRNRDTGQVVAIKKFLESEEDPLIRKIALREIRLLKSLKHPNLVNLLEVFRRKKKLHLVFE 81 (292)
Q Consensus 2 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~iv~e 81 (292)
++|++.+.||+|++|.||+|.+..+++.||+|++....... ....+.+|+.+++.++||||+++++++.++...++|||
T Consensus 5 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~-~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e 83 (303)
T cd07869 5 DSYEKLEKLGEGSYATVYKGKSKVNGKLVALKVIRLQEEEG-TPFTAIREASLLKGLKHANIVLLHDIIHTKETLTLVFE 83 (303)
T ss_pred ccceEeeeEEecCCEEEEEEEECCCCCEEEEEEeccccccc-cchhHHHHHHHHhhCCCCCcCeEEEEEecCCeEEEEEE
Confidence 68999999999999999999999999999999987554322 23446789999999999999999999999999999999
Q ss_pred cCCCccHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEEccCCcEEEeecCchhhhhcc-----cc
Q psy758 82 FCDHTVLNELENHPHGLPWDLIKQITWQVLRGVSYCHRHACIHRDIKPENILLTANGVVKLCDFGFARLIRDL-----IP 156 (292)
Q Consensus 82 ~~~~~~L~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~givH~dl~p~Nilv~~~~~~kl~dfg~~~~~~~~-----~~ 156 (292)
|++++.+..+....+.+++..++.++.||+.||+|||++||+|+||||+||+++.++.++|+|||++...... ..
T Consensus 84 ~~~~~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~ 163 (303)
T cd07869 84 YVHTDLCQYMDKHPGGLHPENVKLFLFQLLRGLSYIHQRYILHRDLKPQNLLISDTGELKLADFGLARAKSVPSHTYSNE 163 (303)
T ss_pred CCCcCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEECCCCCEEECCCCcceeccCCCccCCCC
Confidence 9987666655555567999999999999999999999999999999999999999999999999998654321 12
Q ss_pred ccccccccccccccCC------CCCCCcccceeeecCCCCCCch-HHHHHHHh---hcccCCCC-CCChhhhh---hccC
Q psy758 157 RHLHIFQTNEYFKGVS------LPHAENVVPLEIKIGKPAATNI-YLIDFLKR---CLDKDPLR-RWSCDQLL---RHPY 222 (292)
Q Consensus 157 ~~~~~~~~~~~~~~~~------~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~---~~~~~p~~-~~~~~~~~---~~~~ 222 (292)
..+..|.+||...+.. ..|+.|+..+++.+|..++... .....+.. .+...... .+...... ...+
T Consensus 164 ~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 243 (303)
T cd07869 164 VVTLWYRPPDVLLGSTEYSTCLDMWGVGCIFVEMIQGVAAFPGMKDIQDQLERIFLVLGTPNEDTWPGVHSLPHFKPERF 243 (303)
T ss_pred cccCCCCChHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCccHHHHHHHHHHHhCCCChhhccchhhccccccccc
Confidence 2234577787654422 3466677777777777665432 11111111 11111111 11100000 0000
Q ss_pred c--CCC-----CCCCCCccchHHHHhcccCcCCCCCCChhhhhhCCcccceec
Q psy758 223 F--NGY-----YFEVPDEMQYEEITQRCLDKDPLRRWSCDQLLRHPYFNGYYF 268 (292)
Q Consensus 223 ~--~~~-----~~~~~~~~~l~~li~~~l~~dP~~Rpt~~~il~h~w~~~~~~ 268 (292)
. ... ......+..+.+||.+||+.||++|||+.|+++||||+++.+
T Consensus 244 ~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~dp~~R~s~~~~l~h~~f~~~~~ 296 (303)
T cd07869 244 TLYSPKNLRQAWNKLSYVNHAEDLASKLLQCFPKNRLSAQAALSHEYFSDLPP 296 (303)
T ss_pred cccCCccHHHHhhccCCChHHHHHHHHHhccCchhccCHHHHhcCcccccCCh
Confidence 0 000 001122457889999999999999999999999999998653
|
Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 an |
| >cd05594 STKc_PKB_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-42 Score=286.64 Aligned_cols=244 Identities=21% Similarity=0.282 Sum_probs=195.4
Q ss_pred eeecccCceEEEEEEEcCCCcEEEEEEeccCC-CChHHHHHHHHHHHHHHhCCCCCcchhhhhhhcCCeEEEEEecCCCc
Q psy758 8 GKLGEGSYGVVFKCRNRDTGQVVAIKKFLESE-EDPLIRKIALREIRLLKSLKHPNLVNLLEVFRRKKKLHLVFEFCDHT 86 (292)
Q Consensus 8 ~~l~~g~~~~v~~~~~~~~~~~v~iK~~~~~~-~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~iv~e~~~~~ 86 (292)
+.||+|+||.||+|.+..+++.||+|++.... ........+.+|+.+++.++||||+++++++.+++..|+||||++++
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~~~hp~i~~~~~~~~~~~~~~lv~E~~~~~ 80 (325)
T cd05594 1 KLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALKYSFQTHDRLCFVMEYANGG 80 (325)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCCceEEEEEcCCEEEEEEeCCCCC
Confidence 46999999999999999999999999997543 22234456678999999999999999999999999999999999999
Q ss_pred cHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHh-CCccccCCCCCceEEccCCcEEEeecCchhhhhcc-----cccccc
Q psy758 87 VLNELENHPHGLPWDLIKQITWQVLRGVSYCHR-HACIHRDIKPENILLTANGVVKLCDFGFARLIRDL-----IPRHLH 160 (292)
Q Consensus 87 ~L~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~-~givH~dl~p~Nilv~~~~~~kl~dfg~~~~~~~~-----~~~~~~ 160 (292)
+|..++.....+++..++.++.||+.||+|||+ +|++||||||+||+++.++.++|+|||++...... ...++.
T Consensus 81 ~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~lH~~~~ivHrDikp~NIll~~~~~~kL~Dfg~~~~~~~~~~~~~~~~gt~ 160 (325)
T cd05594 81 ELFFHLSRERVFSEDRARFYGAEIVSALDYLHSEKNVVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDGATMKTFCGTP 160 (325)
T ss_pred cHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCCEEecCCCCCeEEECCCCCEEEecCCCCeecCCCCcccccccCCc
Confidence 999998877789999999999999999999997 79999999999999999999999999998643211 112345
Q ss_pred ccccccccccC-----CCCCCCcccceeeecCCCCCCchHHHHHHHhhcccCCCCCCChhhhhhccCcCCCCCCCCCccc
Q psy758 161 IFQTNEYFKGV-----SLPHAENVVPLEIKIGKPAATNIYLIDFLKRCLDKDPLRRWSCDQLLRHPYFNGYYFEVPDEMQ 235 (292)
Q Consensus 161 ~~~~~~~~~~~-----~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 235 (292)
.|.+||...+. ...|+.|+..+++.+|..++.......+.... .......+...+..
T Consensus 161 ~y~aPE~~~~~~~~~~~DiwslG~il~el~tG~~Pf~~~~~~~~~~~i------------------~~~~~~~p~~~~~~ 222 (325)
T cd05594 161 EYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELI------------------LMEEIRFPRTLSPE 222 (325)
T ss_pred ccCCHHHHccCCCCCccccccccceeeeeccCCCCCCCCCHHHHHHHH------------------hcCCCCCCCCCCHH
Confidence 67788776544 34577777777777777665433322222222 11222334456788
Q ss_pred hHHHHhcccCcCCCCCC-----ChhhhhhCCcccceecc
Q psy758 236 YEEITQRCLDKDPLRRW-----SCDQLLRHPYFNGYYFE 269 (292)
Q Consensus 236 l~~li~~~l~~dP~~Rp-----t~~~il~h~w~~~~~~~ 269 (292)
+.+||.+||+.||++|+ ++.++++||||.+..|.
T Consensus 223 ~~~li~~~L~~dP~~R~~~~~~~~~~il~h~~~~~~~~~ 261 (325)
T cd05594 223 AKSLLSGLLKKDPKQRLGGGPDDAKEIMQHKFFAGIVWQ 261 (325)
T ss_pred HHHHHHHHhhcCHHHhCCCCCCCHHHHhcCCCcCCCCHH
Confidence 99999999999999997 99999999999987655
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficien |
| >cd07871 STKc_PCTAIRE3 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.5e-43 Score=284.66 Aligned_cols=261 Identities=30% Similarity=0.483 Sum_probs=194.0
Q ss_pred CcccceeeeecccCceEEEEEEEcCCCcEEEEEEeccCCCChHHHHHHHHHHHHHHhCCCCCcchhhhhhhcCCeEEEEE
Q psy758 1 MERYEKIGKLGEGSYGVVFKCRNRDTGQVVAIKKFLESEEDPLIRKIALREIRLLKSLKHPNLVNLLEVFRRKKKLHLVF 80 (292)
Q Consensus 1 ~~~y~~~~~l~~g~~~~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~iv~ 80 (292)
+++|++.+.||+|++|.||+|.+..++..||+|.+....... ....+.+|+.+++.++||||+++++++.+++..++|+
T Consensus 4 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~-~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~ 82 (288)
T cd07871 4 LETYVKLDKLGEGTYATVFKGRSKLTENLVALKEIRLEHEEG-APCTAIREVSLLKNLKHANIVTLHDIIHTERCLTLVF 82 (288)
T ss_pred cccceEeeEEecCCCEEEEEEEECCCCCEEEEEEecccccCC-cchhHHHHHHHHHhCCCCCEeeEEEEEcCCCeEEEEE
Confidence 578999999999999999999999999999999986543221 2345678999999999999999999999999999999
Q ss_pred ecCCCccHHHHhcC-CCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEEccCCcEEEeecCchhhhhcc-----
Q psy758 81 EFCDHTVLNELENH-PHGLPWDLIKQITWQVLRGVSYCHRHACIHRDIKPENILLTANGVVKLCDFGFARLIRDL----- 154 (292)
Q Consensus 81 e~~~~~~L~~~~~~-~~~~~~~~~~~i~~qi~~aL~~LH~~givH~dl~p~Nilv~~~~~~kl~dfg~~~~~~~~----- 154 (292)
||+++ +|..++.. ...+++..+..++.||+.||+|||++||+||||||+||+++.++.+||+|||++......
T Consensus 83 e~~~~-~l~~~l~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivH~dlkp~Nil~~~~~~~kl~DfG~~~~~~~~~~~~~ 161 (288)
T cd07871 83 EYLDS-DLKQYLDNCGNLMSMHNVKIFMFQLLRGLSYCHKRKILHRDLKPQNLLINEKGELKLADFGLARAKSVPTKTYS 161 (288)
T ss_pred eCCCc-CHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEECCCCCEEECcCcceeeccCCCcccc
Confidence 99987 56666543 345799999999999999999999999999999999999999999999999998654321
Q ss_pred ccccccccccccccccC------CCCCCCcccceeeecCCCCCCchHHHHHHHh---hcccCCCCCCC-h--hhhhhccC
Q psy758 155 IPRHLHIFQTNEYFKGV------SLPHAENVVPLEIKIGKPAATNIYLIDFLKR---CLDKDPLRRWS-C--DQLLRHPY 222 (292)
Q Consensus 155 ~~~~~~~~~~~~~~~~~------~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~---~~~~~p~~~~~-~--~~~~~~~~ 222 (292)
....+..|.+||...+. ...|+.|+..+++.+|.+++........+.. .++..+...+. . .+......
T Consensus 162 ~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 241 (288)
T cd07871 162 NEVVTLWYRPPDVLLGSTEYSTPIDMWGVGCILYEMATGRPMFPGSTVKEELHLIFRLLGTPTEETWPGITSNEEFRSYL 241 (288)
T ss_pred CceecccccChHHhcCCcccCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChHHhhccccchhhhccc
Confidence 12234557888876542 2346777777778888776654443333222 22222221111 0 00000001
Q ss_pred cCCC------CCCCCCccchHHHHhcccCcCCCCCCChhhhhhCCcc
Q psy758 223 FNGY------YFEVPDEMQYEEITQRCLDKDPLRRWSCDQLLRHPYF 263 (292)
Q Consensus 223 ~~~~------~~~~~~~~~l~~li~~~l~~dP~~Rpt~~~il~h~w~ 263 (292)
+... ......+..+.+||.+||++||.+|||++|+++||||
T Consensus 242 ~~~~~~~~~~~~~~~~~~~~~dll~~mL~~dp~~R~t~~~~l~hp~f 288 (288)
T cd07871 242 FPQYRAQPLINHAPRLDTDGIDLLSSLLLYETKSRISAEAALRHSYF 288 (288)
T ss_pred cCccCCCchHHhCCCCCHHHHHHHHHhcCcCcccCCCHHHHhcCCCC
Confidence 1111 0112346678999999999999999999999999998
|
Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filament |
| >KOG0033|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.1e-45 Score=270.51 Aligned_cols=250 Identities=25% Similarity=0.327 Sum_probs=191.9
Q ss_pred cccceeeeecccCceEEEEEEEcCCCcEEEEEEeccCCCChHHHHHHHHHHHHHHhCCCCCcchhhhhhhcCCeEEEEEe
Q psy758 2 ERYEKIGKLGEGSYGVVFKCRNRDTGQVVAIKKFLESEEDPLIRKIALREIRLLKSLKHPNLVNLLEVFRRKKKLHLVFE 81 (292)
Q Consensus 2 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~iv~e 81 (292)
+.|.+.+.||+|.|+.|+++.+..+|+.+++|++..........+.+.+|+++.+.|+||||+++.+.+.+.+..|+|+|
T Consensus 11 d~y~l~e~igkG~FSvVrRc~~~~tg~~fa~kiin~~k~~~~~~e~l~rEarIC~~LqHP~IvrL~~ti~~~~~~ylvFe 90 (355)
T KOG0033|consen 11 DNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEESFHYLVFD 90 (355)
T ss_pred hhhhHHHHHccCchHHHHHHHhccchHHHHHHHhhhhhhccccHHHHHHHHHHHHhcCCCcEeehhhhhcccceeEEEEe
Confidence 46889999999999999999999999999999998777666677888999999999999999999999999999999999
Q ss_pred cCCCccHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEEccC---CcEEEeecCchhhhhcccc--
Q psy758 82 FCDHTVLNELENHPHGLPWDLIKQITWQVLRGVSYCHRHACIHRDIKPENILLTAN---GVVKLCDFGFARLIRDLIP-- 156 (292)
Q Consensus 82 ~~~~~~L~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~givH~dl~p~Nilv~~~---~~~kl~dfg~~~~~~~~~~-- 156 (292)
++.|+.|..-+-...-++|..+..++.||+.||.|+|.+||||||+||.|+++.+. .-+||+|||++..++....
T Consensus 91 ~m~G~dl~~eIV~R~~ySEa~aSH~~rQiLeal~yCH~n~IvHRDvkP~nllLASK~~~A~vKL~~FGvAi~l~~g~~~~ 170 (355)
T KOG0033|consen 91 LVTGGELFEDIVAREFYSEADASHCIQQILEALAYCHSNGIVHRDLKPENLLLASKAKGAAVKLADFGLAIEVNDGEAWH 170 (355)
T ss_pred cccchHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHhcCceeccCChhheeeeeccCCCceeecccceEEEeCCccccc
Confidence 99998887655444568999999999999999999999999999999999999654 3599999999987763222
Q ss_pred --ccccccccccccccCCCC-----CCCcccceeeecCCCCCCchHHHHHHHhhcccCCCCCCChhhhhhccCcCCCCCC
Q psy758 157 --RHLHIFQTNEYFKGVSLP-----HAENVVPLEIKIGKPAATNIYLIDFLKRCLDKDPLRRWSCDQLLRHPYFNGYYFE 229 (292)
Q Consensus 157 --~~~~~~~~~~~~~~~~~~-----~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~ 229 (292)
.+++.|.+||........ |+.|+..+-++.|.+++.+..--.+++.+.... +--..+..
T Consensus 171 G~~GtP~fmaPEvvrkdpy~kpvDiW~cGViLfiLL~G~~PF~~~~~~rlye~I~~g~--------------yd~~~~~w 236 (355)
T KOG0033|consen 171 GFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWDEDQHRLYEQIKAGA--------------YDYPSPEW 236 (355)
T ss_pred cccCCCcccCHHHhhcCCCCCcchhhhhhHHHHHHHhCCCCCCCccHHHHHHHHhccc--------------cCCCCccc
Confidence 223444555544333332 344444444444554443333333333332211 00011122
Q ss_pred CCCccchHHHHhcccCcCCCCCCChhhhhhCCcccc
Q psy758 230 VPDEMQYEEITQRCLDKDPLRRWSCDQLLRHPYFNG 265 (292)
Q Consensus 230 ~~~~~~l~~li~~~l~~dP~~Rpt~~~il~h~w~~~ 265 (292)
..++++.++||++||..||++|+|+.|+|+|||+.+
T Consensus 237 ~~is~~Ak~LvrrML~~dP~kRIta~EAL~HpWi~~ 272 (355)
T KOG0033|consen 237 DTVTPEAKSLIRRMLTVNPKKRITADEALKHPWICN 272 (355)
T ss_pred CcCCHHHHHHHHHHhccChhhhccHHHHhCCchhcc
Confidence 355889999999999999999999999999999987
|
|
| >cd05585 STKc_YPK1_like Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-42 Score=284.52 Aligned_cols=241 Identities=25% Similarity=0.363 Sum_probs=189.5
Q ss_pred ecccCceEEEEEEEcCCCcEEEEEEeccCC-CChHHHHHHHHHHHHHHhCCCCCcchhhhhhhcCCeEEEEEecCCCccH
Q psy758 10 LGEGSYGVVFKCRNRDTGQVVAIKKFLESE-EDPLIRKIALREIRLLKSLKHPNLVNLLEVFRRKKKLHLVFEFCDHTVL 88 (292)
Q Consensus 10 l~~g~~~~v~~~~~~~~~~~v~iK~~~~~~-~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~iv~e~~~~~~L 88 (292)
||+|+||.||+|.+..+++.||+|.+.... ........+.+|+.+++.++||||+++++++.+++..|+||||+++++|
T Consensus 1 lg~G~~g~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~g~L 80 (312)
T cd05585 1 IGKGSFGKVMQVRKRDTQRIYALKTIRKAHIVSRSEVTHTLAERTVLAQVNCPFIVPLKFSFQSPEKLYLVLAFINGGEL 80 (312)
T ss_pred CCcCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCcEeceeeEEecCCeEEEEEcCCCCCcH
Confidence 699999999999999999999999986543 2333456678899999999999999999999999999999999999999
Q ss_pred HHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEEccCCcEEEeecCchhhhhccc-----cccccccc
Q psy758 89 NELENHPHGLPWDLIKQITWQVLRGVSYCHRHACIHRDIKPENILLTANGVVKLCDFGFARLIRDLI-----PRHLHIFQ 163 (292)
Q Consensus 89 ~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~givH~dl~p~Nilv~~~~~~kl~dfg~~~~~~~~~-----~~~~~~~~ 163 (292)
..++...+.+++..+..++.||+.||.|||++||+||||||+||+++.++.++|+|||++....... ..++..|.
T Consensus 81 ~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~HrDlkp~Nili~~~~~~kl~Dfg~~~~~~~~~~~~~~~~gt~~y~ 160 (312)
T cd05585 81 FHHLQREGRFDLSRARFYTAELLCALENLHKFNVIYRDLKPENILLDYQGHIALCDFGLCKLNMKDDDKTNTFCGTPEYL 160 (312)
T ss_pred HHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeEeCCCCHHHeEECCCCcEEEEECcccccCccCCCccccccCCcccC
Confidence 9999877789999999999999999999999999999999999999999999999999987532211 12344567
Q ss_pred cccccccCCC-----CCCCcccceeeecCCCCCCchHHHHHHHhhcccCCCCCCChhhhhhccCcCCCCCCCCCccchHH
Q psy758 164 TNEYFKGVSL-----PHAENVVPLEIKIGKPAATNIYLIDFLKRCLDKDPLRRWSCDQLLRHPYFNGYYFEVPDEMQYEE 238 (292)
Q Consensus 164 ~~~~~~~~~~-----~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ 238 (292)
+||...+... .|+.|+..+++.+|.. |+...+..+............+...+..+.+
T Consensus 161 aPE~~~~~~~~~~~DvwslGvil~el~tg~~------------------pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 222 (312)
T cd05585 161 APELLLGHGYTKAVDWWTLGVLLYEMLTGLP------------------PFYDENVNEMYRKILQEPLRFPDGFDRDAKD 222 (312)
T ss_pred CHHHHcCCCCCCccceechhHHHHHHHhCCC------------------CcCCCCHHHHHHHHHcCCCCCCCcCCHHHHH
Confidence 7776655433 3444444444444444 4433333333333222333445556789999
Q ss_pred HHhcccCcCCCCCC---ChhhhhhCCcccceec
Q psy758 239 ITQRCLDKDPLRRW---SCDQLLRHPYFNGYYF 268 (292)
Q Consensus 239 li~~~l~~dP~~Rp---t~~~il~h~w~~~~~~ 268 (292)
+|.+||+.||.+|| ++.++++||||.+..+
T Consensus 223 li~~~L~~dp~~R~~~~~~~e~l~hp~~~~~~~ 255 (312)
T cd05585 223 LLIGLLSRDPTRRLGYNGAQEIKNHPFFSQLSW 255 (312)
T ss_pred HHHHHcCCCHHHcCCCCCHHHHHcCCCcCCCCH
Confidence 99999999999997 5799999999998654
|
Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It pl |
| >cd05599 STKc_NDR_like Catalytic domain of Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6e-43 Score=294.45 Aligned_cols=253 Identities=23% Similarity=0.338 Sum_probs=195.7
Q ss_pred cccceeeeecccCceEEEEEEEcCCCcEEEEEEeccCC-CChHHHHHHHHHHHHHHhCCCCCcchhhhhhhcCCeEEEEE
Q psy758 2 ERYEKIGKLGEGSYGVVFKCRNRDTGQVVAIKKFLESE-EDPLIRKIALREIRLLKSLKHPNLVNLLEVFRRKKKLHLVF 80 (292)
Q Consensus 2 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~v~iK~~~~~~-~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~iv~ 80 (292)
++|++.+.||+|+||.||+|++..+++.||+|++.... ........+.+|+.+++.++||||+++++++.+++.+|+||
T Consensus 1 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~~~~~~~~~~~~~lv~ 80 (364)
T cd05599 1 DDFESIKVIGRGAFGEVRLVQKKDTGHIYAMKKLRKSEMLEKEQVAHVRAERDILAEADNPWVVKLYYSFQDENYLYLIM 80 (364)
T ss_pred CCceEEEEEEecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceEEEEEcCCeEEEEE
Confidence 57999999999999999999999999999999997543 22334566788999999999999999999999999999999
Q ss_pred ecCCCccHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEEccCCcEEEeecCchhhhhccc-----
Q psy758 81 EFCDHTVLNELENHPHGLPWDLIKQITWQVLRGVSYCHRHACIHRDIKPENILLTANGVVKLCDFGFARLIRDLI----- 155 (292)
Q Consensus 81 e~~~~~~L~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~givH~dl~p~Nilv~~~~~~kl~dfg~~~~~~~~~----- 155 (292)
||+++|+|.+++...+.+++..++.++.||+.||+|||++|++||||||+||+++.++.++|+|||++..+....
T Consensus 81 E~~~~g~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~lH~~~ivH~Dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~~~~~~~ 160 (364)
T cd05599 81 EYLPGGDMMTLLMKKDTFTEEETRFYIAETILAIDSIHKLGYIHRDIKPDNLLLDAKGHIKLSDFGLCTGLKKSHRTEFY 160 (364)
T ss_pred CCCCCcHHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEeccCCHHHeEECCCCCEEEeecccceecccccccccc
Confidence 999999999999877789999999999999999999999999999999999999999999999999986542110
Q ss_pred --------------------------------------cccccccccccccccCC-----CCCCCcccceeeecCCCCCC
Q psy758 156 --------------------------------------PRHLHIFQTNEYFKGVS-----LPHAENVVPLEIKIGKPAAT 192 (292)
Q Consensus 156 --------------------------------------~~~~~~~~~~~~~~~~~-----~~~~~~~~~~~~~~~~~~~~ 192 (292)
..++..|.+||...+.. ..|+.|+..+++.+|..++.
T Consensus 161 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~~G~~Pf~ 240 (364)
T cd05599 161 RILSHALPSNFLDFISKPMSSKRKAETWKRNRRALAYSTVGTPDYIAPEVFLQTGYNKECDWWSLGVIMYEMLVGYPPFC 240 (364)
T ss_pred ccccccccccccccccccccccccccchhhcccccccccccCccccCHHHHcCCCCCCeeeeecchhHHHHhhcCCCCCC
Confidence 01233456666554432 34555555555666655543
Q ss_pred chHHHHHHHhhcccCCCCCCChhhhhhccCcCCCCCCCCCccchHHHHhcccCcCCCCCCC---hhhhhhCCcccceecc
Q psy758 193 NIYLIDFLKRCLDKDPLRRWSCDQLLRHPYFNGYYFEVPDEMQYEEITQRCLDKDPLRRWS---CDQLLRHPYFNGYYFE 269 (292)
Q Consensus 193 ~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt---~~~il~h~w~~~~~~~ 269 (292)
.......+........ ..........+..+.+||.+||. ||.+|++ ++++++||||++..|+
T Consensus 241 ~~~~~~~~~~i~~~~~--------------~~~~~~~~~~s~~~~~li~~ll~-~p~~R~~~~~~~~ll~h~~~~~~~~~ 305 (364)
T cd05599 241 SDNPQETYRKIINWKE--------------TLQFPDEVPLSPEAKDLIKRLCC-EAERRLGNNGVNEIKSHPFFKGVDWE 305 (364)
T ss_pred CCCHHHHHHHHHcCCC--------------ccCCCCCCCCCHHHHHHHHHHcc-CHhhcCCCCCHHHHhcCCCcCCCCHH
Confidence 3322222222211100 00111112346789999999997 9999998 9999999999998765
|
Serine/Threonine Kinases (STKs), Nuclear Dbf2-Related (NDR) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. NDR kinases regulate mitosis, cell growth, embryonic development, and neurological processes. They are also required for proper centrosome duplica |
| >KOG0599|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.8e-44 Score=269.73 Aligned_cols=251 Identities=26% Similarity=0.381 Sum_probs=201.6
Q ss_pred cccceeeeecccCceEEEEEEEcCCCcEEEEEEeccCC------CChHHHHHHHHHHHHHHhCC-CCCcchhhhhhhcCC
Q psy758 2 ERYEKIGKLGEGSYGVVFKCRNRDTGQVVAIKKFLESE------EDPLIRKIALREIRLLKSLK-HPNLVNLLEVFRRKK 74 (292)
Q Consensus 2 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~v~iK~~~~~~------~~~~~~~~~~~e~~~~~~l~-~~~i~~~~~~~~~~~ 74 (292)
+.|.-.++||.|..+.|.++.+..+|+.+++|++.... ...+..+.-.+|+.+++++. ||+|+++.++|+.+.
T Consensus 17 ~~y~pkeilgrgvss~vrRci~k~t~~e~a~kii~~~at~~~~e~~~~~~EaT~~Ev~ILRqv~GHP~II~l~D~yes~s 96 (411)
T KOG0599|consen 17 AKYEPKEILGRGVSSVVRRCIHKETGKEFAVKIIDVTATTESGETPYEMREATRQEISILRQVMGHPYIIDLQDVYESDA 96 (411)
T ss_pred hhcChHHHhcccchhhhhhhhhcccccceeEEEEEecccccCCccHHHHHHHHHHHHHHHHHhcCCCcEEEeeeeccCcc
Confidence 46778889999999999999999999999999985332 22334556678999999985 999999999999999
Q ss_pred eEEEEEecCCCccHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEEccCCcEEEeecCchhhhhcc
Q psy758 75 KLHLVFEFCDHTVLNELENHPHGLPWDLIKQITWQVLRGVSYCHRHACIHRDIKPENILLTANGVVKLCDFGFARLIRDL 154 (292)
Q Consensus 75 ~~~iv~e~~~~~~L~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~givH~dl~p~Nilv~~~~~~kl~dfg~~~~~~~~ 154 (292)
.+++|+|.|+.|.|.+++.....+++...+.|+.|++.|+.|||.++|||+||||+|||+|++.+++|+|||+++.+.+.
T Consensus 97 F~FlVFdl~prGELFDyLts~VtlSEK~tR~iMrqlfegVeylHa~~IVHRDLKpENILlddn~~i~isDFGFa~~l~~G 176 (411)
T KOG0599|consen 97 FVFLVFDLMPRGELFDYLTSKVTLSEKETRRIMRQLFEGVEYLHARNIVHRDLKPENILLDDNMNIKISDFGFACQLEPG 176 (411)
T ss_pred hhhhhhhhcccchHHHHhhhheeecHHHHHHHHHHHHHHHHHHHHhhhhhcccChhheeeccccceEEeccceeeccCCc
Confidence 99999999999999999999889999999999999999999999999999999999999999999999999999987643
Q ss_pred ccccccccccccccccCCC----------------CCCCcccceeeecCCCCCCchHHHHHHHhhcccCCCCCCChhhhh
Q psy758 155 IPRHLHIFQTNEYFKGVSL----------------PHAENVVPLEIKIGKPAATNIYLIDFLKRCLDKDPLRRWSCDQLL 218 (292)
Q Consensus 155 ~~~~~~~~~~~~~~~~~~~----------------~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~ 218 (292)
. .-...+++|.|.+++.+ .|+.|++.+.++.|.+++.+..-.-++..++...-..+
T Consensus 177 e-kLrelCGTPgYLAPEtikC~m~e~~pGYs~EVD~Wa~GVImyTLLaGcpPFwHRkQmlMLR~ImeGkyqF~------- 248 (411)
T KOG0599|consen 177 E-KLRELCGTPGYLAPETIKCSMYENHPGYSKEVDEWACGVIMYTLLAGCPPFWHRKQMLMLRMIMEGKYQFR------- 248 (411)
T ss_pred h-hHHHhcCCCcccChhheeeecccCCCCccchhhHHHHHHHHHHHHcCCCchhHHHHHHHHHHHHhcccccC-------
Confidence 2 22334556666555443 36666666667777776555544444554443331111
Q ss_pred hccCcCCCCCCCCCccchHHHHhcccCcCCCCCCChhhhhhCCccccee
Q psy758 219 RHPYFNGYYFEVPDEMQYEEITQRCLDKDPLRRWSCDQLLRHPYFNGYY 267 (292)
Q Consensus 219 ~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~~il~h~w~~~~~ 267 (292)
.+.....+...++||.+||+.||.+|.|++|+|+||||.++-
T Consensus 249 -------speWadis~~~KdLIsrlLqVdp~~Ritake~LaHpff~q~~ 290 (411)
T KOG0599|consen 249 -------SPEWADISATVKDLISRLLQVDPTKRITAKEALAHPFFIQIA 290 (411)
T ss_pred -------CcchhhccccHHHHHHHHHeeCchhcccHHHHhcChHHHHHH
Confidence 122234577899999999999999999999999999997643
|
|
| >KOG0663|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-43 Score=271.99 Aligned_cols=268 Identities=26% Similarity=0.400 Sum_probs=199.5
Q ss_pred CcccceeeeecccCceEEEEEEEcCCCcEEEEEEeccCCCChHHHHHHHHHHHHHHhCCCCCcchhhhhhhc--CCeEEE
Q psy758 1 MERYEKIGKLGEGSYGVVFKCRNRDTGQVVAIKKFLESEEDPLIRKIALREIRLLKSLKHPNLVNLLEVFRR--KKKLHL 78 (292)
Q Consensus 1 ~~~y~~~~~l~~g~~~~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~--~~~~~i 78 (292)
+++|+.+..|++|+||.||+|++..|++.||+|.++......-.--...+|+.++.+.+||||+.+-++... -+.+|+
T Consensus 75 v~efe~lnrI~EGtyGiVYRakdk~t~eIVALKr~kmekek~GFPItsLREIniLl~~~H~NIV~vkEVVvG~~~d~iy~ 154 (419)
T KOG0663|consen 75 VEEFEKLNRIEEGTYGVVYRAKDKKTDEIVALKRLKMEKEKEGFPITSLREINILLKARHPNIVEVKEVVVGSNMDKIYI 154 (419)
T ss_pred HHHHHHHhhcccCcceeEEEeccCCcceeEEeeecccccccCCCcchhHHHHHHHHhcCCCCeeeeEEEEeccccceeee
Confidence 467999999999999999999999999999999997665443333445789999999999999999888764 456999
Q ss_pred EEecCCCccHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEEccCCcEEEeecCchhhhhcccccc
Q psy758 79 VFEFCDHTVLNELENHPHGLPWDLIKQITWQVLRGVSYCHRHACIHRDIKPENILLTANGVVKLCDFGFARLIRDLIPRH 158 (292)
Q Consensus 79 v~e~~~~~~L~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~givH~dl~p~Nilv~~~~~~kl~dfg~~~~~~~~~~~~ 158 (292)
|||||+...-.-+-.-..++...++..++.|++.|++|||.+.|+|||||++|+|++..|.+||+|||+|+.+++....-
T Consensus 155 VMe~~EhDLksl~d~m~q~F~~~evK~L~~QlL~glk~lH~~wilHRDLK~SNLLm~~~G~lKiaDFGLAR~ygsp~k~~ 234 (419)
T KOG0663|consen 155 VMEYVEHDLKSLMETMKQPFLPGEVKTLMLQLLRGLKHLHDNWILHRDLKTSNLLLSHKGILKIADFGLAREYGSPLKPY 234 (419)
T ss_pred eHHHHHhhHHHHHHhccCCCchHHHHHHHHHHHHHHHHHhhceeEecccchhheeeccCCcEEecccchhhhhcCCcccC
Confidence 99999975433333334589999999999999999999999999999999999999999999999999999988754333
Q ss_pred -----ccccccccccccCCCC------CCCcccceeeecCCCCCCchHH---HHHHHhhcccCCCCC-CChhhhhhc--c
Q psy758 159 -----LHIFQTNEYFKGVSLP------HAENVVPLEIKIGKPAATNIYL---IDFLKRCLDKDPLRR-WSCDQLLRH--P 221 (292)
Q Consensus 159 -----~~~~~~~~~~~~~~~~------~~~~~~~~~~~~~~~~~~~~~~---~~~~~~~~~~~p~~~-~~~~~~~~~--~ 221 (292)
+-.|.+||...|..-+ |+.|++..+++.+.+.+.+..- .+.+-.+++.....- +...++-.. .
T Consensus 235 T~lVVTLWYRaPELLLG~~tyst~iDMWSvGCI~aE~l~~kPlf~G~sE~dQl~~If~llGtPte~iwpg~~~lp~~k~~ 314 (419)
T KOG0663|consen 235 TPLVVTLWYRAPELLLGAKTYSTAVDMWSVGCIFAELLTQKPLFPGKSEIDQLDKIFKLLGTPSEAIWPGYSELPAVKKM 314 (419)
T ss_pred cceEEEeeecCHHHhcCCcccCcchhhhhHHHHHHHHHhcCCCCCCCchHHHHHHHHHHhCCCccccCCCccccchhhcc
Confidence 3458899988876543 5566665566666665543332 223344444433222 222221100 0
Q ss_pred CcCCCC-------CCC-CCccchHHHHhcccCcCCCCCCChhhhhhCCcccceec
Q psy758 222 YFNGYY-------FEV-PDEMQYEEITQRCLDKDPLRRWSCDQLLRHPYFNGYYF 268 (292)
Q Consensus 222 ~~~~~~-------~~~-~~~~~l~~li~~~l~~dP~~Rpt~~~il~h~w~~~~~~ 268 (292)
-+...+ ++. ..+..-.+|++.+|.+||.+|.||.|.|.|+||.+.+-
T Consensus 315 ~f~~~pyn~lr~kF~~~~lse~g~~Lln~llt~dP~kR~tA~~~L~h~~F~e~P~ 369 (419)
T KOG0663|consen 315 TFSEHPYNNLRKKFGALSLSEQGFDLLNKLLTYDPGKRITAEDGLKHEYFRETPL 369 (419)
T ss_pred ccCCCCchhhhhhccccccchhHHHHHHHHhccCccccccHHHhhcccccccCCC
Confidence 011100 111 14567889999999999999999999999999998443
|
|
| >cd05590 STKc_nPKC_eta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-42 Score=284.57 Aligned_cols=249 Identities=20% Similarity=0.259 Sum_probs=188.5
Q ss_pred eeecccCceEEEEEEEcCCCcEEEEEEeccCC-CChHHHHHHHHHHHHHHhC-CCCCcchhhhhhhcCCeEEEEEecCCC
Q psy758 8 GKLGEGSYGVVFKCRNRDTGQVVAIKKFLESE-EDPLIRKIALREIRLLKSL-KHPNLVNLLEVFRRKKKLHLVFEFCDH 85 (292)
Q Consensus 8 ~~l~~g~~~~v~~~~~~~~~~~v~iK~~~~~~-~~~~~~~~~~~e~~~~~~l-~~~~i~~~~~~~~~~~~~~iv~e~~~~ 85 (292)
+.||+|+||.||+|.+..+++.||+|++.... ........+..|..++..+ +||||+++++++.+.+.+|+||||+++
T Consensus 1 ~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~h~~iv~~~~~~~~~~~~~iv~Ey~~~ 80 (320)
T cd05590 1 RVLGKGSFGKVMLARLKESGRLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQLYCCFQTPDRLFFVMEFVNG 80 (320)
T ss_pred CeeeeCCCeEEEEEEEcCCCCEEEEEEEEHHHHhhccHHHHHHHHHHHHHhccCCCchhceeeEEEcCCEEEEEEcCCCC
Confidence 46999999999999999999999999987543 2223445667788888776 699999999999999999999999999
Q ss_pred ccHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEEccCCcEEEeecCchhhhhccc-----ccccc
Q psy758 86 TVLNELENHPHGLPWDLIKQITWQVLRGVSYCHRHACIHRDIKPENILLTANGVVKLCDFGFARLIRDLI-----PRHLH 160 (292)
Q Consensus 86 ~~L~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~givH~dl~p~Nilv~~~~~~kl~dfg~~~~~~~~~-----~~~~~ 160 (292)
++|..++.....+++..++.++.|++.||.|||++|++||||||+||+++.++.++|+|||++....... ..++.
T Consensus 81 g~L~~~i~~~~~l~~~~~~~~~~ql~~~L~~lH~~~ivH~dlkp~NIli~~~~~~kL~DfG~~~~~~~~~~~~~~~~gt~ 160 (320)
T cd05590 81 GDLMFHIQKSRRFDEARARFYAAEITSALMFLHDKGIIYRDLKLDNVLLDHEGHCKLADFGMCKEGIFNGKTTSTFCGTP 160 (320)
T ss_pred chHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEeCCCCHHHeEECCCCcEEEeeCCCCeecCcCCCcccccccCc
Confidence 9999998877789999999999999999999999999999999999999999999999999986532111 11234
Q ss_pred ccccccccccCCCCCCCcccceeeecCCCCCCchHHHHHHHhhcccCCCCCCChhhhhhccCcCCCCCCCCCccchHHHH
Q psy758 161 IFQTNEYFKGVSLPHAENVVPLEIKIGKPAATNIYLIDFLKRCLDKDPLRRWSCDQLLRHPYFNGYYFEVPDEMQYEEIT 240 (292)
Q Consensus 161 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li 240 (292)
.|.+||...+.......++ ++.+..++..+.+..|+...+..++.....-.....+...+..+.++|
T Consensus 161 ~y~aPE~~~~~~~~~~~Di-------------wslG~il~el~~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~li 227 (320)
T cd05590 161 DYIAPEILQEMLYGPSVDW-------------WAMGVLLYEMLCGHAPFEAENEDDLFEAILNDEVVYPTWLSQDAVDIL 227 (320)
T ss_pred cccCHHHHcCCCCCCccch-------------hhhHHHHHHHhhCCCCCCCCCHHHHHHHHhcCCCCCCCCCCHHHHHHH
Confidence 4666665544332222222 222333333344444444444444333322222233444577899999
Q ss_pred hcccCcCCCCCCCh------hhhhhCCcccceecc
Q psy758 241 QRCLDKDPLRRWSC------DQLLRHPYFNGYYFE 269 (292)
Q Consensus 241 ~~~l~~dP~~Rpt~------~~il~h~w~~~~~~~ 269 (292)
.+||+.||.+||++ +++++||||.++.|+
T Consensus 228 ~~~L~~dP~~R~~~~~~~~~~~~~~h~~f~~~~~~ 262 (320)
T cd05590 228 KAFMTKNPTMRLGSLTLGGEEAILRHPFFKELDWE 262 (320)
T ss_pred HHHcccCHHHCCCCCCCCCHHHHHcCCCcCCCCHH
Confidence 99999999999998 899999999997765
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signal |
| >cd05628 STKc_NDR1 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-42 Score=289.19 Aligned_cols=255 Identities=20% Similarity=0.254 Sum_probs=190.4
Q ss_pred cccceeeeecccCceEEEEEEEcCCCcEEEEEEeccCC-CChHHHHHHHHHHHHHHhCCCCCcchhhhhhhcCCeEEEEE
Q psy758 2 ERYEKIGKLGEGSYGVVFKCRNRDTGQVVAIKKFLESE-EDPLIRKIALREIRLLKSLKHPNLVNLLEVFRRKKKLHLVF 80 (292)
Q Consensus 2 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~v~iK~~~~~~-~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~iv~ 80 (292)
++|++.+.||+|+||.||+|.+..+++.||+|++.... ........+..|+.++..++||+|+++++.+.++..+|+||
T Consensus 1 ~~y~~~~~LG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~~~~~~iv~~~~~~~~~~~~~lv~ 80 (363)
T cd05628 1 EDFESLKVIGRGAFGEVRLVQKKDTGHVYAMKILRKADMLEKEQVGHIRAERDILVEADSLWVVKMFYSFQDKLNLYLIM 80 (363)
T ss_pred CCceEeEEEEeCCCEEEEEEEECCCCCEEEEEEEEHHHHHHhhHHHHHHHHHHHHHhCCCCCcceEEEEEecCCeEEEEE
Confidence 57999999999999999999999999999999997543 22334567788999999999999999999999999999999
Q ss_pred ecCCCccHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEEccCCcEEEeecCchhhhhccc-----
Q psy758 81 EFCDHTVLNELENHPHGLPWDLIKQITWQVLRGVSYCHRHACIHRDIKPENILLTANGVVKLCDFGFARLIRDLI----- 155 (292)
Q Consensus 81 e~~~~~~L~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~givH~dl~p~Nilv~~~~~~kl~dfg~~~~~~~~~----- 155 (292)
||++||+|..++...+.+++..+..++.|++.||+|||++||+||||||+||+++.++.++|+|||+++......
T Consensus 81 E~~~gg~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~lH~~givHrDlKp~NILi~~~~~vkL~DFGla~~~~~~~~~~~~ 160 (363)
T cd05628 81 EFLPGGDMMTLLMKKDTLTEEETQFYIAETVLAIDSIHQLGFIHRDIKPDNLLLDSKGHVKLSDFGLCTGLKKAHRTEFY 160 (363)
T ss_pred cCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeEecCCCHHHeEECCCCCEEEeeccCccccccccccccc
Confidence 999999999999887889999999999999999999999999999999999999999999999999987543210
Q ss_pred -----------------------------------cccccccccccccccCCCCCCCcccceeeecCCCCCCchHHHHHH
Q psy758 156 -----------------------------------PRHLHIFQTNEYFKGVSLPHAENVVPLEIKIGKPAATNIYLIDFL 200 (292)
Q Consensus 156 -----------------------------------~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 200 (292)
..++..|.+||...+...... .+.++.+..++
T Consensus 161 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~~~~-------------~DvwSlGvil~ 227 (363)
T cd05628 161 RNLNHSLPSDFTFQNMNSKRKAETWKRNRRQLAFSTVGTPDYIAPEVFMQTGYNKL-------------CDWWSLGVIMY 227 (363)
T ss_pred ccccccccccccccccccccccchhhhccccccccccCCccccCHHHHcCCCCCCc-------------hhhhhhHHHHH
Confidence 012233555555443322111 12222233333
Q ss_pred HhhcccCCCCCCChhhhhhccCc--CC--CCCCCCCccchHHHHhcccCcCCC---CCCChhhhhhCCcccceeccC
Q psy758 201 KRCLDKDPLRRWSCDQLLRHPYF--NG--YYFEVPDEMQYEEITQRCLDKDPL---RRWSCDQLLRHPYFNGYYFEV 270 (292)
Q Consensus 201 ~~~~~~~p~~~~~~~~~~~~~~~--~~--~~~~~~~~~~l~~li~~~l~~dP~---~Rpt~~~il~h~w~~~~~~~~ 270 (292)
+.+.+..|+...+..+....... .. ++...+.+..++++|.+|+. +|. .||+++||++||||++..|+.
T Consensus 228 ell~G~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~~~s~~~~~li~~l~~-~~~~r~~r~~~~ei~~hp~f~~~~~~~ 303 (363)
T cd05628 228 EMLIGYPPFCSETPQETYKKVMNWKETLIFPPEVPISEKAKDLILRFCC-EWEHRIGAPGVEEIKTNPFFEGVDWEH 303 (363)
T ss_pred HHHhCCCCCCCCCHHHHHHHHHcCcCcccCCCcCCCCHHHHHHHHHHcC-ChhhcCCCCCHHHHhCCCCCCCCCHHH
Confidence 44444444443333333222110 11 11122457789999999775 444 468999999999999987764
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. NDR1 is highly expressed in thymus, mus |
| >cd07859 STKc_TDY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-42 Score=287.86 Aligned_cols=264 Identities=27% Similarity=0.386 Sum_probs=193.5
Q ss_pred ccceeeeecccCceEEEEEEEcCCCcEEEEEEeccCCCChHHHHHHHHHHHHHHhCCCCCcchhhhhhhcC-----CeEE
Q psy758 3 RYEKIGKLGEGSYGVVFKCRNRDTGQVVAIKKFLESEEDPLIRKIALREIRLLKSLKHPNLVNLLEVFRRK-----KKLH 77 (292)
Q Consensus 3 ~y~~~~~l~~g~~~~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~-----~~~~ 77 (292)
+|++.+.||+|++|.||+|.+..++..||+|.+............+.+|+.+++.++||||+++++++... ..+|
T Consensus 1 ry~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~~ 80 (338)
T cd07859 1 RYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKINDVFEHVSDATRILREIKLLRLLRHPDIVEIKHIMLPPSRREFKDIY 80 (338)
T ss_pred CeEEEEEEeecCCeEEEEEEECCCCCEEEEEEechhhccchhHHHHHHHHHHHHhCCCCCEeeecceEeccCCCCCceEE
Confidence 69999999999999999999999999999999875443334455678999999999999999999987532 3589
Q ss_pred EEEecCCCccHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEEccCCcEEEeecCchhhhhccc--
Q psy758 78 LVFEFCDHTVLNELENHPHGLPWDLIKQITWQVLRGVSYCHRHACIHRDIKPENILLTANGVVKLCDFGFARLIRDLI-- 155 (292)
Q Consensus 78 iv~e~~~~~~L~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~givH~dl~p~Nilv~~~~~~kl~dfg~~~~~~~~~-- 155 (292)
+||||++ ++|..++.....+++..++.++.||+.||.|||++||+|+||||+||+++.++.++|+|||++.......
T Consensus 81 lv~e~~~-~~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~dlkp~NIll~~~~~~kL~Dfg~~~~~~~~~~~ 159 (338)
T cd07859 81 VVFELME-SDLHQVIKANDDLTPEHHQFFLYQLLRALKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVAFNDTPT 159 (338)
T ss_pred EEEecCC-CCHHHHHHhcccCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEECCCCcEEEccCccccccccccCc
Confidence 9999996 4677777776789999999999999999999999999999999999999999999999999987543211
Q ss_pred ------ccccccccccccccc-------CCCCCCCcccceeeecCCCCCCchHHHH---HHHhhcccCCCCCCC------
Q psy758 156 ------PRHLHIFQTNEYFKG-------VSLPHAENVVPLEIKIGKPAATNIYLID---FLKRCLDKDPLRRWS------ 213 (292)
Q Consensus 156 ------~~~~~~~~~~~~~~~-------~~~~~~~~~~~~~~~~~~~~~~~~~~~~---~~~~~~~~~p~~~~~------ 213 (292)
...+..|.+||...+ ....|+.|+..+++.+|.+++....... .+....+..+.....
T Consensus 160 ~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~DvwSlGvvl~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~ 239 (338)
T cd07859 160 AIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLITDLLGTPSPETISRVRNEK 239 (338)
T ss_pred cccccCCCCCCCcCCHHHHhccccccCchhHHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHHhCCCCHHHHHHhhhhh
Confidence 123445777876543 2345667777777777776654332222 222222222111000
Q ss_pred hhhhhhccCcCCCC-----CCCCCccchHHHHhcccCcCCCCCCChhhhhhCCcccceec
Q psy758 214 CDQLLRHPYFNGYY-----FEVPDEMQYEEITQRCLDKDPLRRWSCDQLLRHPYFNGYYF 268 (292)
Q Consensus 214 ~~~~~~~~~~~~~~-----~~~~~~~~l~~li~~~l~~dP~~Rpt~~~il~h~w~~~~~~ 268 (292)
....+.. ...... .-...+..+.++|.+||+.||++|||++++++||||++...
T Consensus 240 ~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~e~l~hp~f~~~~~ 298 (338)
T cd07859 240 ARRYLSS-MRKKQPVPFSQKFPNADPLALRLLERLLAFDPKDRPTAEEALADPYFKGLAK 298 (338)
T ss_pred HHHHHHh-hcccCCCchHHhcCCCChHHHHHHHHHcCcCcccCCCHHHHhcCchhhhcCc
Confidence 0000000 000000 00123567899999999999999999999999999998554
|
Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phos |
| >cd05631 STKc_GRK4 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.5e-42 Score=277.76 Aligned_cols=256 Identities=21% Similarity=0.257 Sum_probs=191.1
Q ss_pred ccceeeeecccCceEEEEEEEcCCCcEEEEEEeccCCCC-hHHHHHHHHHHHHHHhCCCCCcchhhhhhhcCCeEEEEEe
Q psy758 3 RYEKIGKLGEGSYGVVFKCRNRDTGQVVAIKKFLESEED-PLIRKIALREIRLLKSLKHPNLVNLLEVFRRKKKLHLVFE 81 (292)
Q Consensus 3 ~y~~~~~l~~g~~~~v~~~~~~~~~~~v~iK~~~~~~~~-~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~iv~e 81 (292)
.|++.+.||+|+||.||+|.+..+++.||+|.+...... ......+.+|+.+++.++|++|+++++++.+++..++|+|
T Consensus 1 ~f~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~iv~~~~~~~~~~~~~lv~e 80 (285)
T cd05631 1 TFRHYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKRILEKVNSRFVVSLAYAYETKDALCLVLT 80 (285)
T ss_pred CceEEEEEecCCCEEEEEEEEecCCceEEEEEeeHhhhhhhhhHHHHHHHHHHHHhcCCCcEEEEEEEEccCCeEEEEEE
Confidence 488999999999999999999999999999998755422 2234557789999999999999999999999999999999
Q ss_pred cCCCccHHHHhcC--CCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEEccCCcEEEeecCchhhhhccc----
Q psy758 82 FCDHTVLNELENH--PHGLPWDLIKQITWQVLRGVSYCHRHACIHRDIKPENILLTANGVVKLCDFGFARLIRDLI---- 155 (292)
Q Consensus 82 ~~~~~~L~~~~~~--~~~~~~~~~~~i~~qi~~aL~~LH~~givH~dl~p~Nilv~~~~~~kl~dfg~~~~~~~~~---- 155 (292)
|+++++|...+.. ...+++..+..++.|++.||.|||++|++||||||+||++++++.++|+|||++.......
T Consensus 81 ~~~~g~L~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~iiH~dikp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~ 160 (285)
T cd05631 81 IMNGGDLKFHIYNMGNPGFDEQRAIFYAAELCCGLEDLQRERIVYRDLKPENILLDDRGHIRISDLGLAVQIPEGETVRG 160 (285)
T ss_pred ecCCCcHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCEEeCCCCHHHEEECCCCCEEEeeCCCcEEcCCCCeecC
Confidence 9999999877643 3358999999999999999999999999999999999999999999999999987643211
Q ss_pred cccccccccccccccCCCCCCCcccceeeecCCCCCCchHHHHHHHhhcccCCCCCCCh----hhhhhccCcCCCCCCCC
Q psy758 156 PRHLHIFQTNEYFKGVSLPHAENVVPLEIKIGKPAATNIYLIDFLKRCLDKDPLRRWSC----DQLLRHPYFNGYYFEVP 231 (292)
Q Consensus 156 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~----~~~~~~~~~~~~~~~~~ 231 (292)
..++..|.+||...+.......++ ++.+..++..+.+..|+..... ..+.....-.....+..
T Consensus 161 ~~g~~~y~aPE~~~~~~~~~~~Dv-------------wslGvil~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 227 (285)
T cd05631 161 RVGTVGYMAPEVINNEKYTFSPDW-------------WGLGCLIYEMIQGQSPFRKRKERVKREEVDRRVKEDQEEYSEK 227 (285)
T ss_pred CCCCCCccCHhhhcCCCCCcccCc-------------hhHHHHHHHHHhCCCCCCCCCcchhHHHHHHHhhcccccCCcc
Confidence 123445667776654433222222 2223333333334444332211 11111110111223344
Q ss_pred CccchHHHHhcccCcCCCCCCC-----hhhhhhCCcccceeccCC
Q psy758 232 DEMQYEEITQRCLDKDPLRRWS-----CDQLLRHPYFNGYYFEVP 271 (292)
Q Consensus 232 ~~~~l~~li~~~l~~dP~~Rpt-----~~~il~h~w~~~~~~~~~ 271 (292)
.+..+.+||++||+.||.+||+ ++++++||||.+..|+..
T Consensus 228 ~s~~~~~li~~~l~~~P~~R~~~~~~~~~~~~~h~~~~~~~~~~~ 272 (285)
T cd05631 228 FSEDAKSICRMLLTKNPKERLGCRGNGAAGVKQHPIFKNINFKRL 272 (285)
T ss_pred CCHHHHHHHHHHhhcCHHHhcCCCCCCHHHHhcCHhhcCCCHHHH
Confidence 5778999999999999999997 899999999999876643
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found i |
| >KOG0032|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-41 Score=281.06 Aligned_cols=249 Identities=30% Similarity=0.434 Sum_probs=194.5
Q ss_pred cccceeeeecccCceEEEEEEEcCCCcEEEEEEeccCCCC-hHHHHHHHHHHHHHHhCC-CCCcchhhhhhhcCCeEEEE
Q psy758 2 ERYEKIGKLGEGSYGVVFKCRNRDTGQVVAIKKFLESEED-PLIRKIALREIRLLKSLK-HPNLVNLLEVFRRKKKLHLV 79 (292)
Q Consensus 2 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~v~iK~~~~~~~~-~~~~~~~~~e~~~~~~l~-~~~i~~~~~~~~~~~~~~iv 79 (292)
+.|++.+.||+|.||.||.++...+|+.+|+|.+.+.... ......+.+|+.+++.++ ||||+.++++|++...+++|
T Consensus 35 ~~Y~l~~~lG~G~Fg~v~~~~~~~tg~~~A~K~i~k~~~~~~~~~~~v~~Ev~il~~l~~hpniv~l~~~~e~~~~~~lv 114 (382)
T KOG0032|consen 35 EKYELGRELGRGQFGVVYLCREKSTGKEVACKVIPKRKLRGKEDREDVRREVAILQQLSGHPNIVQLKDAFEDPDSVYLV 114 (382)
T ss_pred ccEEehhhhCCCCceEEEEEEecCCCceeEEEEeehhhccccccHHHHHHHHHHHHhccCCCCEEEEEEEEEcCCeEEEE
Confidence 4699999999999999999999999999999999877643 234567889999999998 99999999999999999999
Q ss_pred EecCCCccHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEEccC----CcEEEeecCchhhhhccc
Q psy758 80 FEFCDHTVLNELENHPHGLPWDLIKQITWQVLRGVSYCHRHACIHRDIKPENILLTAN----GVVKLCDFGFARLIRDLI 155 (292)
Q Consensus 80 ~e~~~~~~L~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~givH~dl~p~Nilv~~~----~~~kl~dfg~~~~~~~~~ 155 (292)
||+|.||.|.+.+... .+++..+..++.|++.|++|||+.|++|+||||+|+|+... +.++++|||++..... .
T Consensus 115 mEL~~GGeLfd~i~~~-~~sE~da~~~~~~il~av~~lH~~gvvHrDlKpEN~L~~~~~~~~~~ik~~DFGla~~~~~-~ 192 (382)
T KOG0032|consen 115 MELCEGGELFDRIVKK-HYSERDAAGIIRQILEAVKYLHSLGVVHRDLKPENLLLASKDEGSGRIKLIDFGLAKFIKP-G 192 (382)
T ss_pred EEecCCchHHHHHHHc-cCCHHHHHHHHHHHHHHHHHHHhCCceeccCCHHHeeeccccCCCCcEEEeeCCCceEccC-C
Confidence 9999999999887765 49999999999999999999999999999999999999754 4799999999988766 3
Q ss_pred cccccccccccccccCCC----------CCCCcccceeeecCCCCCCchHHHHHHHhhcccCCCCCCChhhhhhccCcCC
Q psy758 156 PRHLHIFQTNEYFKGVSL----------PHAENVVPLEIKIGKPAATNIYLIDFLKRCLDKDPLRRWSCDQLLRHPYFNG 225 (292)
Q Consensus 156 ~~~~~~~~~~~~~~~~~~----------~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~ 225 (292)
.......++|+|.+++.. .|+.|+..+-++.|.+++....-......++..+. -|..
T Consensus 193 ~~~~~~~Gtp~y~APEvl~~~~y~~~~DiWS~Gvi~yiLL~G~~PF~~~~~~~~~~~i~~~~~-------------~f~~ 259 (382)
T KOG0032|consen 193 ERLHTIVGTPEYVAPEVLGGRPYGDEVDVWSIGVILYILLSGVPPFWGETEFEIFLAILRGDF-------------DFTS 259 (382)
T ss_pred ceEeeecCCccccCchhhcCCCCCcccchhHHHHHHHHHhhCCCCCcCCChhHHHHHHHcCCC-------------CCCC
Confidence 333344555555554433 24444444555555554433332222222222211 1111
Q ss_pred CCCCCCCccchHHHHhcccCcCCCCCCChhhhhhCCcccce
Q psy758 226 YYFEVPDEMQYEEITQRCLDKDPLRRWSCDQLLRHPYFNGY 266 (292)
Q Consensus 226 ~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~~il~h~w~~~~ 266 (292)
......+..++++|++||..||.+|+|+.++|+|||+++.
T Consensus 260 -~~w~~is~~akd~i~~ll~~dp~~R~ta~~~L~HpWi~~~ 299 (382)
T KOG0032|consen 260 -EPWDDISESAKDFIRKLLEFDPRKRLTAAQALQHPWIKSI 299 (382)
T ss_pred -CCccccCHHHHHHHHHhcccCcccCCCHHHHhcCccccCC
Confidence 1223447899999999999999999999999999999985
|
|
| >cd05629 STKc_NDR_like_fungal Catalytic domain of Fungal Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.3e-42 Score=289.76 Aligned_cols=253 Identities=23% Similarity=0.329 Sum_probs=195.4
Q ss_pred cccceeeeecccCceEEEEEEEcCCCcEEEEEEeccCC-CChHHHHHHHHHHHHHHhCCCCCcchhhhhhhcCCeEEEEE
Q psy758 2 ERYEKIGKLGEGSYGVVFKCRNRDTGQVVAIKKFLESE-EDPLIRKIALREIRLLKSLKHPNLVNLLEVFRRKKKLHLVF 80 (292)
Q Consensus 2 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~v~iK~~~~~~-~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~iv~ 80 (292)
++|++++.||+|+||.||+|.+..+++.||+|++.... ......+.+.+|+.+++.++||||+++++++.+++.+|+||
T Consensus 1 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~~~~~~~~~~~~~lv~ 80 (377)
T cd05629 1 EDFHTVKVIGKGAFGEVRLVQKKDTGKIYAMKTLLKSEMFKKDQLAHVKAERDVLAESDSPWVVSLYYSFQDAQYLYLIM 80 (377)
T ss_pred CCceEeEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHHHHhHHHHHHHHHHHHHHhCCCCCcceEEEEEEcCCeeEEEE
Confidence 57999999999999999999999999999999986543 23334567888999999999999999999999999999999
Q ss_pred ecCCCccHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEEccCCcEEEeecCchhhhhcc------
Q psy758 81 EFCDHTVLNELENHPHGLPWDLIKQITWQVLRGVSYCHRHACIHRDIKPENILLTANGVVKLCDFGFARLIRDL------ 154 (292)
Q Consensus 81 e~~~~~~L~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~givH~dl~p~Nilv~~~~~~kl~dfg~~~~~~~~------ 154 (292)
||++|++|..++...+.+++..++.++.|++.||+|||++||+||||||+||+++.++.++|+|||+++.....
T Consensus 81 E~~~gg~L~~~l~~~~~~~~~~~~~~~~ql~~aL~~LH~~givHrDlkp~NIll~~~~~~kl~DfGla~~~~~~~~~~~~ 160 (377)
T cd05629 81 EFLPGGDLMTMLIKYDTFSEDVTRFYMAECVLAIEAVHKLGFIHRDIKPDNILIDRGGHIKLSDFGLSTGFHKQHDSAYY 160 (377)
T ss_pred eCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHEEECCCCCEEEeecccccccccccccccc
Confidence 99999999999987778999999999999999999999999999999999999999999999999998532110
Q ss_pred ----------------------------------------------ccccccccccccccccCC-----CCCCCccccee
Q psy758 155 ----------------------------------------------IPRHLHIFQTNEYFKGVS-----LPHAENVVPLE 183 (292)
Q Consensus 155 ----------------------------------------------~~~~~~~~~~~~~~~~~~-----~~~~~~~~~~~ 183 (292)
...++..|.+||...+.. ..|+.|+..++
T Consensus 161 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~e 240 (377)
T cd05629 161 QKLLQGKSNKNRIDNRNSVAVDSINLTMSSKDQIATWKKNRRLMAYSTVGTPDYIAPEIFLQQGYGQECDWWSLGAIMFE 240 (377)
T ss_pred cccccccccccccccccccccccccccccchhhhhhhhhcccccccccCCCccccCHHHHccCCCCCceeeEecchhhhh
Confidence 011334466776654433 34566666666
Q ss_pred eecCCCCCCchHHHHHHHhhcccCCCCCCChhhhhhccCcCCCCCC--CCCccchHHHHhcccCcCCCCC---CChhhhh
Q psy758 184 IKIGKPAATNIYLIDFLKRCLDKDPLRRWSCDQLLRHPYFNGYYFE--VPDEMQYEEITQRCLDKDPLRR---WSCDQLL 258 (292)
Q Consensus 184 ~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~--~~~~~~l~~li~~~l~~dP~~R---pt~~~il 258 (292)
+.+|.+++........+...... ......+ ...+..+++||.+||. +|.+| +|+.+++
T Consensus 241 lltG~~Pf~~~~~~~~~~~i~~~----------------~~~~~~p~~~~~s~~~~dli~~lL~-~~~~r~~r~~~~~~l 303 (377)
T cd05629 241 CLIGWPPFCSENSHETYRKIINW----------------RETLYFPDDIHLSVEAEDLIRRLIT-NAENRLGRGGAHEIK 303 (377)
T ss_pred hhcCCCCCCCCCHHHHHHHHHcc----------------CCccCCCCCCCCCHHHHHHHHHHhc-CHhhcCCCCCHHHHh
Confidence 66666655433322222222110 0011111 2346789999999998 77775 5999999
Q ss_pred hCCcccceeccCC
Q psy758 259 RHPYFNGYYFEVP 271 (292)
Q Consensus 259 ~h~w~~~~~~~~~ 271 (292)
+||||.+..|+..
T Consensus 304 ~hp~~~~~~~~~~ 316 (377)
T cd05629 304 SHPFFRGVDWDTI 316 (377)
T ss_pred cCCCcCCCCHHHH
Confidence 9999998776543
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, fungal NDR-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group is composed of fungal NDR-like proteins including Saccharomyces cerevisiae CBK1 (or CBK1p), Schizosaccharomyces pombe Orb6 (or Orb6p), Ustilago maydis Ukc1 (or Ukc1p), and Neurospora crassa Cot1. Like NDR kinase, group members contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. CBK1 is an essential component in the RAM (regulation of |
| >cd05596 STKc_ROCK Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.7e-42 Score=288.25 Aligned_cols=253 Identities=22% Similarity=0.282 Sum_probs=197.2
Q ss_pred cccceeeeecccCceEEEEEEEcCCCcEEEEEEeccCC-CChHHHHHHHHHHHHHHhCCCCCcchhhhhhhcCCeEEEEE
Q psy758 2 ERYEKIGKLGEGSYGVVFKCRNRDTGQVVAIKKFLESE-EDPLIRKIALREIRLLKSLKHPNLVNLLEVFRRKKKLHLVF 80 (292)
Q Consensus 2 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~v~iK~~~~~~-~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~iv~ 80 (292)
++|++.+.||+|+||.||+|.+..+++.||+|.+.... ........+.+|+.+++.++||||+++++++.+++.+|+||
T Consensus 43 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~h~~iv~~~~~~~~~~~~~lv~ 122 (370)
T cd05596 43 EDFDVIKVIGRGAFGEVQLVRHKSSKQVYAMKLLSKFEMIKRSDSAFFWEERDIMAHANSEWIVQLHYAFQDDKYLYMVM 122 (370)
T ss_pred HHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCcceEEEEEecCCEEEEEE
Confidence 57999999999999999999999999999999996543 22233455778999999999999999999999999999999
Q ss_pred ecCCCccHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEEccCCcEEEeecCchhhhhccc-----
Q psy758 81 EFCDHTVLNELENHPHGLPWDLIKQITWQVLRGVSYCHRHACIHRDIKPENILLTANGVVKLCDFGFARLIRDLI----- 155 (292)
Q Consensus 81 e~~~~~~L~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~givH~dl~p~Nilv~~~~~~kl~dfg~~~~~~~~~----- 155 (292)
||++||+|..++... .+++..+..++.||+.||+|||++||+||||||+|||++.++.++|+|||++.......
T Consensus 123 Ey~~gg~L~~~l~~~-~l~~~~~~~~~~qi~~aL~~LH~~~ivHrDLkp~NILl~~~~~~kL~DfG~~~~~~~~~~~~~~ 201 (370)
T cd05596 123 EYMPGGDLVNLMSNY-DIPEKWARFYTAEVVLALDAIHSMGFIHRDVKPDNMLLDKSGHLKLADFGTCMKMDANGMVRCD 201 (370)
T ss_pred cCCCCCcHHHHHHhc-CCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHEEEcCCCCEEEEeccceeeccCCCcccCC
Confidence 999999999988754 68999999999999999999999999999999999999999999999999987653221
Q ss_pred -ccccccccccccccc---------CCCCCCCcccceeeecCCCCCCchHHHHHHHhhcccCCCCCCChhhhhhccCcCC
Q psy758 156 -PRHLHIFQTNEYFKG---------VSLPHAENVVPLEIKIGKPAATNIYLIDFLKRCLDKDPLRRWSCDQLLRHPYFNG 225 (292)
Q Consensus 156 -~~~~~~~~~~~~~~~---------~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~ 225 (292)
..++..|.+||...+ ....|+.|+..+++.+|..++........+........ .-.
T Consensus 202 ~~~gt~~y~aPE~~~~~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~~~~~~i~~~~~--------------~~~ 267 (370)
T cd05596 202 TAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLVGTYSKIMDHKN--------------SLT 267 (370)
T ss_pred CCCCCcCeECHHHhccCCCCCCCCCceeeeehhHHHHHHHhCCCCcCCCCHHHHHHHHHcCCC--------------cCC
Confidence 123445666765433 23456666666666666665544333333333222110 001
Q ss_pred CCCCCCCccchHHHHhcccCcCCCC--CCChhhhhhCCcccceecc
Q psy758 226 YYFEVPDEMQYEEITQRCLDKDPLR--RWSCDQLLRHPYFNGYYFE 269 (292)
Q Consensus 226 ~~~~~~~~~~l~~li~~~l~~dP~~--Rpt~~~il~h~w~~~~~~~ 269 (292)
.+.....+..+.+||.+||+.+|.+ |+|++++++||||.+..|.
T Consensus 268 ~~~~~~~s~~~~~li~~~L~~~p~r~~R~s~~ell~h~~~~~~~~~ 313 (370)
T cd05596 268 FPDDIEISKQAKDLICAFLTDREVRLGRNGVDEIKSHPFFKNDQWT 313 (370)
T ss_pred CCCcCCCCHHHHHHHHHHccChhhccCCCCHHHHhcCcccCCCChh
Confidence 1112245778999999999999988 9999999999999986654
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via in |
| >cd05582 STKc_RSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.6e-42 Score=281.92 Aligned_cols=245 Identities=23% Similarity=0.272 Sum_probs=192.8
Q ss_pred eeeecccCceEEEEEEEc---CCCcEEEEEEeccCCCChHHHHHHHHHHHHHHhCCCCCcchhhhhhhcCCeEEEEEecC
Q psy758 7 IGKLGEGSYGVVFKCRNR---DTGQVVAIKKFLESEEDPLIRKIALREIRLLKSLKHPNLVNLLEVFRRKKKLHLVFEFC 83 (292)
Q Consensus 7 ~~~l~~g~~~~v~~~~~~---~~~~~v~iK~~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~iv~e~~ 83 (292)
++.||+|+||.||++.+. .+|+.||+|++............+.+|+.+++.++||||+++++++.+++..|+||||+
T Consensus 1 l~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~ 80 (318)
T cd05582 1 LKVLGQGSFGKVFLVRKITGPDAGQLYAMKVLKKATLKVRDRVRTKMERDILAEVNHPFIVKLHYAFQTEGKLYLILDFL 80 (318)
T ss_pred CceeeeCCCEEEEEEEEeccCCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHhCCCCCcccEEEEEEcCCEEEEEEcCC
Confidence 367999999999999863 57889999999765444344556778999999999999999999999999999999999
Q ss_pred CCccHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEEccCCcEEEeecCchhhhhccc-----ccc
Q psy758 84 DHTVLNELENHPHGLPWDLIKQITWQVLRGVSYCHRHACIHRDIKPENILLTANGVVKLCDFGFARLIRDLI-----PRH 158 (292)
Q Consensus 84 ~~~~L~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~givH~dl~p~Nilv~~~~~~kl~dfg~~~~~~~~~-----~~~ 158 (292)
++++|..++.....+++..++.++.||+.||.|||++|++||||+|+||+++.++.++|+|||++....... ..+
T Consensus 81 ~~~~L~~~l~~~~~l~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~kL~Dfg~~~~~~~~~~~~~~~~g 160 (318)
T cd05582 81 RGGDLFTRLSKEVMFTEEDVKFYLAELALALDHLHSLGIIYRDLKPENILLDEEGHIKLTDFGLSKESIDHEKKAYSFCG 160 (318)
T ss_pred CCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCEecCCCCHHHeEECCCCcEEEeeccCCcccCCCCCceecccC
Confidence 999999998877789999999999999999999999999999999999999999999999999987643321 122
Q ss_pred ccccccccccccC-----CCCCCCcccceeeecCCCCCCchHHHHHHHhhcccCCCCCCChhhhhhccCcCCCCCCCCCc
Q psy758 159 LHIFQTNEYFKGV-----SLPHAENVVPLEIKIGKPAATNIYLIDFLKRCLDKDPLRRWSCDQLLRHPYFNGYYFEVPDE 233 (292)
Q Consensus 159 ~~~~~~~~~~~~~-----~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 233 (292)
+..|.+||...+. ...|+.|+..+++.+|..++........+..... .....+...+
T Consensus 161 ~~~y~aPE~~~~~~~~~~~DiwslG~il~el~tg~~p~~~~~~~~~~~~i~~------------------~~~~~p~~~~ 222 (318)
T cd05582 161 TVEYMAPEVVNRRGHTQSADWWSFGVLMFEMLTGSLPFQGKDRKETMTMILK------------------AKLGMPQFLS 222 (318)
T ss_pred ChhhcCHHHHcCCCCCCccceeccceEeeeeccCCCCCCCCCHHHHHHHHHc------------------CCCCCCCCCC
Confidence 3456777765543 3456667777777777665443322222222211 1122334457
Q ss_pred cchHHHHhcccCcCCCCCCC-----hhhhhhCCcccceecc
Q psy758 234 MQYEEITQRCLDKDPLRRWS-----CDQLLRHPYFNGYYFE 269 (292)
Q Consensus 234 ~~l~~li~~~l~~dP~~Rpt-----~~~il~h~w~~~~~~~ 269 (292)
..+.+||++||+.||.+||| ++++++||||.+..|.
T Consensus 223 ~~~~~li~~~l~~~P~~R~~a~~~~~~~~~~~~~~~~~~~~ 263 (318)
T cd05582 223 PEAQSLLRALFKRNPANRLGAGPDGVEEIKRHPFFSTIDWN 263 (318)
T ss_pred HHHHHHHHHHhhcCHhHcCCCCCCCHHHHhCCCCcCCCCHH
Confidence 78999999999999999999 5669999999987654
|
Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylate |
| >cd05589 STKc_PKN Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-41 Score=281.13 Aligned_cols=252 Identities=21% Similarity=0.291 Sum_probs=189.2
Q ss_pred cceeeeecccCceEEEEEEEcCCCcEEEEEEeccCC-CChHHHHHHHHHHHHH---HhCCCCCcchhhhhhhcCCeEEEE
Q psy758 4 YEKIGKLGEGSYGVVFKCRNRDTGQVVAIKKFLESE-EDPLIRKIALREIRLL---KSLKHPNLVNLLEVFRRKKKLHLV 79 (292)
Q Consensus 4 y~~~~~l~~g~~~~v~~~~~~~~~~~v~iK~~~~~~-~~~~~~~~~~~e~~~~---~~l~~~~i~~~~~~~~~~~~~~iv 79 (292)
|++.+.||+|++|.||+|.+..+++.||+|++.... ......+.+.+|..++ +.++||||+++++++.+.+..|+|
T Consensus 1 y~i~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~l~~e~~~~~~~~~l~hp~i~~~~~~~~~~~~~~lv 80 (324)
T cd05589 1 FRCLAVLGRGHFGKVLLAEYKKTGELYAIKALKKGDIIARDEVESLMCEKRIFETANSERHPFLVNLFACFQTEDHVCFV 80 (324)
T ss_pred CeEEEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccccCCCChhceeeEEEcCCEEEEE
Confidence 788999999999999999999999999999997543 2222345566666655 466799999999999999999999
Q ss_pred EecCCCccHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEEccCCcEEEeecCchhhhhcccc---
Q psy758 80 FEFCDHTVLNELENHPHGLPWDLIKQITWQVLRGVSYCHRHACIHRDIKPENILLTANGVVKLCDFGFARLIRDLIP--- 156 (292)
Q Consensus 80 ~e~~~~~~L~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~givH~dl~p~Nilv~~~~~~kl~dfg~~~~~~~~~~--- 156 (292)
|||+++++|...+.. +.+++..++.++.||+.||.|||++|++||||||+||++++++.++|+|||++........
T Consensus 81 ~E~~~~~~L~~~~~~-~~l~~~~~~~~~~qi~~al~~lH~~~ivHrdlkp~Nill~~~~~~kL~Dfg~~~~~~~~~~~~~ 159 (324)
T cd05589 81 MEYAAGGDLMMHIHT-DVFSEPRAVFYAACVVLGLQYLHENKIVYRDLKLDNLLLDTEGFVKIADFGLCKEGMGFGDRTS 159 (324)
T ss_pred EcCCCCCcHHHHhhc-CCCCHHHHHHHHHHHHHHHHHHHhCCeEecCCCHHHeEECCCCcEEeCcccCCccCCCCCCccc
Confidence 999999999988865 4799999999999999999999999999999999999999999999999998865322111
Q ss_pred --ccccccccccccccCCCCCCCcccceeeecCCCCCCchHHHHHHHhhcccCCCCCCChhhhhhccCcCCCCCCCCCcc
Q psy758 157 --RHLHIFQTNEYFKGVSLPHAENVVPLEIKIGKPAATNIYLIDFLKRCLDKDPLRRWSCDQLLRHPYFNGYYFEVPDEM 234 (292)
Q Consensus 157 --~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 234 (292)
.++..|.+||...+.......++ ++.+..++..+.+..|+...+..+............+...+.
T Consensus 160 ~~~g~~~y~aPE~~~~~~~~~~~Di-------------wslG~il~el~~G~~pf~~~~~~~~~~~i~~~~~~~p~~~~~ 226 (324)
T cd05589 160 TFCGTPEFLAPEVLTETSYTRAVDW-------------WGLGVLIYEMLVGESPFPGDDEEEVFDSIVNDEVRYPRFLSR 226 (324)
T ss_pred ccccCccccCHhHhcCCCCCcccch-------------hhHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCCCCCCH
Confidence 12334556665544332222222 333333344444455544444443333222222334445678
Q ss_pred chHHHHhcccCcCCCCCC-----ChhhhhhCCcccceecc
Q psy758 235 QYEEITQRCLDKDPLRRW-----SCDQLLRHPYFNGYYFE 269 (292)
Q Consensus 235 ~l~~li~~~l~~dP~~Rp-----t~~~il~h~w~~~~~~~ 269 (292)
.+.++|.+||+.||.+|| ++.++++||||.+..|+
T Consensus 227 ~~~~li~~~L~~dP~~R~~~~~~~~~~l~~~~~f~~~~~~ 266 (324)
T cd05589 227 EAISIMRRLLRRNPERRLGSGEKDAEDVKKQPFFRDINWD 266 (324)
T ss_pred HHHHHHHHHhhcCHhHcCCCCCCCHHHHhhCCCcCCCCHH
Confidence 899999999999999999 79999999999986554
|
Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved |
| >cd05591 STKc_nPKC_epsilon Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-41 Score=281.51 Aligned_cols=244 Identities=25% Similarity=0.305 Sum_probs=188.8
Q ss_pred eeecccCceEEEEEEEcCCCcEEEEEEeccCC-CChHHHHHHHHHHHHHHhC-CCCCcchhhhhhhcCCeEEEEEecCCC
Q psy758 8 GKLGEGSYGVVFKCRNRDTGQVVAIKKFLESE-EDPLIRKIALREIRLLKSL-KHPNLVNLLEVFRRKKKLHLVFEFCDH 85 (292)
Q Consensus 8 ~~l~~g~~~~v~~~~~~~~~~~v~iK~~~~~~-~~~~~~~~~~~e~~~~~~l-~~~~i~~~~~~~~~~~~~~iv~e~~~~ 85 (292)
+.||+|+||.||+|.+..+++.||+|++.... ........+..|.+++..+ +||+|+++++++.+++.+|+||||+++
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~~hp~i~~~~~~~~~~~~~~lv~E~~~~ 80 (321)
T cd05591 1 KVLGKGSFGKVMLAELKGTDEVYAIKVLKKDVILQDDDVDCTMTEKRILALAAKHPFLTALHCCFQTKDRLFFVMEYVNG 80 (321)
T ss_pred CccccCCCeEEEEEEECCCCCEEEEEEEeHHHhhhhhHHHHHHHHHHHHHhccCCCCccceeeEEEcCCeEEEEEeCCCC
Confidence 46999999999999999999999999987543 2233445567788888866 799999999999999999999999999
Q ss_pred ccHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEEccCCcEEEeecCchhhhhccc-----ccccc
Q psy758 86 TVLNELENHPHGLPWDLIKQITWQVLRGVSYCHRHACIHRDIKPENILLTANGVVKLCDFGFARLIRDLI-----PRHLH 160 (292)
Q Consensus 86 ~~L~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~givH~dl~p~Nilv~~~~~~kl~dfg~~~~~~~~~-----~~~~~ 160 (292)
++|...+...+.+++..+..++.||+.||.|||++|++||||||+||+++.++.++|+|||++....... ..++.
T Consensus 81 ~~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDikp~Nill~~~~~~kL~Dfg~~~~~~~~~~~~~~~~gt~ 160 (321)
T cd05591 81 GDLMFQIQRSRKFDEPRSRFYAAEVTLALMFLHRHGVIYRDLKLDNILLDAEGHCKLADFGMCKEGILNGVTTTTFCGTP 160 (321)
T ss_pred CcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHeEECCCCCEEEeecccceecccCCccccccccCc
Confidence 9999988877789999999999999999999999999999999999999999999999999886532211 11234
Q ss_pred ccccccccccCCC-----CCCCcccceeeecCCCCCCchHHHHHHHhhcccCCCCCCChhhhhhccCcCCCCCCCCCccc
Q psy758 161 IFQTNEYFKGVSL-----PHAENVVPLEIKIGKPAATNIYLIDFLKRCLDKDPLRRWSCDQLLRHPYFNGYYFEVPDEMQ 235 (292)
Q Consensus 161 ~~~~~~~~~~~~~-----~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 235 (292)
.|.+||...+... .|+.|+..+++.+|.. |+...+..+.+..........+...+..
T Consensus 161 ~y~aPE~~~~~~~~~~~DvwslG~il~el~tg~~------------------Pf~~~~~~~~~~~i~~~~~~~p~~~~~~ 222 (321)
T cd05591 161 DYIAPEILQELEYGPSVDWWALGVLMYEMMAGQP------------------PFEADNEDDLFESILHDDVLYPVWLSKE 222 (321)
T ss_pred cccCHHHHcCCCCCCccceechhHHHHHHhcCCC------------------CCCCCCHHHHHHHHHcCCCCCCCCCCHH
Confidence 5666766544332 3444444444444444 4443333333333222222334445778
Q ss_pred hHHHHhcccCcCCCCCC-------ChhhhhhCCcccceecc
Q psy758 236 YEEITQRCLDKDPLRRW-------SCDQLLRHPYFNGYYFE 269 (292)
Q Consensus 236 l~~li~~~l~~dP~~Rp-------t~~~il~h~w~~~~~~~ 269 (292)
+.++|.+||+.||++|| +++++++||||.+..|+
T Consensus 223 ~~~ll~~~L~~dp~~R~~~~~~~~~~~~~~~hp~~~~~~~~ 263 (321)
T cd05591 223 AVSILKAFMTKNPNKRLGCVASQGGEDAIKQHPFFKEIDWV 263 (321)
T ss_pred HHHHHHHHhccCHHHcCCCCCCCCCHHHHhcCCccCCCCHH
Confidence 99999999999999999 89999999999987765
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to |
| >cd05587 STKc_cPKC Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-41 Score=280.58 Aligned_cols=254 Identities=19% Similarity=0.222 Sum_probs=192.5
Q ss_pred ccceeeeecccCceEEEEEEEcCCCcEEEEEEeccCC-CChHHHHHHHHHHHHHHhCCCC-CcchhhhhhhcCCeEEEEE
Q psy758 3 RYEKIGKLGEGSYGVVFKCRNRDTGQVVAIKKFLESE-EDPLIRKIALREIRLLKSLKHP-NLVNLLEVFRRKKKLHLVF 80 (292)
Q Consensus 3 ~y~~~~~l~~g~~~~v~~~~~~~~~~~v~iK~~~~~~-~~~~~~~~~~~e~~~~~~l~~~-~i~~~~~~~~~~~~~~iv~ 80 (292)
+|++.+.||+|+||.||+|.+..+++.||+|++.... ......+.+..|..++..+.|+ +|+++++++.+.+.+|+||
T Consensus 1 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (324)
T cd05587 1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVIIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDRLYFVM 80 (324)
T ss_pred CceEEEEEeeccCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhcCCCCceeeeEEEEEcCCEEEEEE
Confidence 5899999999999999999999999999999987543 2233456677899999999765 5888999999999999999
Q ss_pred ecCCCccHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEEccCCcEEEeecCchhhhhccc-----
Q psy758 81 EFCDHTVLNELENHPHGLPWDLIKQITWQVLRGVSYCHRHACIHRDIKPENILLTANGVVKLCDFGFARLIRDLI----- 155 (292)
Q Consensus 81 e~~~~~~L~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~givH~dl~p~Nilv~~~~~~kl~dfg~~~~~~~~~----- 155 (292)
||+++++|..++.....+++..+..++.||+.||.|||++||+||||||+||+++.++.++|+|||++.......
T Consensus 81 E~~~~g~L~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~ivH~dlkp~Nill~~~~~~kL~Dfg~~~~~~~~~~~~~~ 160 (324)
T cd05587 81 EYVNGGDLMYHIQQVGKFKEPHAVFYAAEIAIGLFFLHSKGIIYRDLKLDNVMLDAEGHIKIADFGMCKENIFGGKTTRT 160 (324)
T ss_pred cCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHeEEcCCCCEEEeecCcceecCCCCCceee
Confidence 999999999998877789999999999999999999999999999999999999999999999999886432111
Q ss_pred cccccccccccccccCCCCCCCcccceeeecCCCCCCchHHHHHHHhhcccCCCCCCChhhhhhccCcCCCCCCCCCccc
Q psy758 156 PRHLHIFQTNEYFKGVSLPHAENVVPLEIKIGKPAATNIYLIDFLKRCLDKDPLRRWSCDQLLRHPYFNGYYFEVPDEMQ 235 (292)
Q Consensus 156 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 235 (292)
..++..|.+||...+.......++ ++.+..++..+.+..|+......+......-.....+...+..
T Consensus 161 ~~gt~~y~aPE~~~~~~~~~~~Di-------------wslGvil~elltG~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~ 227 (324)
T cd05587 161 FCGTPDYIAPEIIAYQPYGKSVDW-------------WAFGVLLYEMLAGQPPFDGEDEDELFQSIMEHNVSYPKSLSKE 227 (324)
T ss_pred ecCCccccChhhhcCCCCCcccch-------------hhhHHHHHHHHhCCCCCCCCCHHHHHHHHHcCCCCCCCCCCHH
Confidence 123345667776654332212222 2222333333334444444443333332222223344556778
Q ss_pred hHHHHhcccCcCCCCCCCh-----hhhhhCCcccceecc
Q psy758 236 YEEITQRCLDKDPLRRWSC-----DQLLRHPYFNGYYFE 269 (292)
Q Consensus 236 l~~li~~~l~~dP~~Rpt~-----~~il~h~w~~~~~~~ 269 (292)
+.+++.+||..||.+|++. +++++||||....|+
T Consensus 228 ~~~li~~~l~~~P~~R~~~~~~~~~~~~~hp~~~~~~~~ 266 (324)
T cd05587 228 AVSICKGLLTKHPAKRLGCGPTGERDIREHAFFRRIDWE 266 (324)
T ss_pred HHHHHHHHhhcCHHHcCCCCCCCHHHHhcCCCcCCCCHH
Confidence 9999999999999999987 899999999987764
|
Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory |
| >cd05626 STKc_LATS2 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-41 Score=284.99 Aligned_cols=250 Identities=22% Similarity=0.265 Sum_probs=189.1
Q ss_pred cccceeeeecccCceEEEEEEEcCCCcEEEEEEeccCC-CChHHHHHHHHHHHHHHhCCCCCcchhhhhhhcCCeEEEEE
Q psy758 2 ERYEKIGKLGEGSYGVVFKCRNRDTGQVVAIKKFLESE-EDPLIRKIALREIRLLKSLKHPNLVNLLEVFRRKKKLHLVF 80 (292)
Q Consensus 2 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~v~iK~~~~~~-~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~iv~ 80 (292)
+.|++++.||+|+||.||+|++..+++.||+|++.... ........+.+|+.+++.++||||+++++++.+.+.+|+||
T Consensus 1 ~~f~~~~~LG~G~~g~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~l~~~~~~~~~~~lv~ 80 (381)
T cd05626 1 SMFVKIKTLGIGAFGEVCLACKVDTHALYAMKTLRKKDVLNRNQVAHVKAERDILAEADNEWVVKLYYSFQDKDNLYFVM 80 (381)
T ss_pred CCceEEEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhcCCCCeeeeEEEEecCCEEEEEE
Confidence 46999999999999999999999999999999997654 33345667889999999999999999999999999999999
Q ss_pred ecCCCccHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEEccCCcEEEeecCchhhhhcc------
Q psy758 81 EFCDHTVLNELENHPHGLPWDLIKQITWQVLRGVSYCHRHACIHRDIKPENILLTANGVVKLCDFGFARLIRDL------ 154 (292)
Q Consensus 81 e~~~~~~L~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~givH~dl~p~Nilv~~~~~~kl~dfg~~~~~~~~------ 154 (292)
||++||+|..++...+.+++..++.++.||+.||.|||+.||+||||||+||+++.+++++|+|||++......
T Consensus 81 E~~~gg~L~~~l~~~~~~~e~~~~~~~~qi~~aL~~LH~~givHrDlKp~Nili~~~~~~kL~DFGl~~~~~~~~~~~~~ 160 (381)
T cd05626 81 DYIPGGDMMSLLIRMEVFPEVLARFYIAELTLAIESVHKMGFIHRDIKPDNILIDLDGHIKLTDFGLCTGFRWTHNSKYY 160 (381)
T ss_pred ecCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCcHHHEEECCCCCEEEeeCcCCcccccccccccc
Confidence 99999999999988778999999999999999999999999999999999999999999999999987532100
Q ss_pred ----------------------------------------------ccccccccccccccccCC-----CCCCCccccee
Q psy758 155 ----------------------------------------------IPRHLHIFQTNEYFKGVS-----LPHAENVVPLE 183 (292)
Q Consensus 155 ----------------------------------------------~~~~~~~~~~~~~~~~~~-----~~~~~~~~~~~ 183 (292)
...++..|.+||...+.. ..|+.|+..++
T Consensus 161 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~DiwSlG~il~e 240 (381)
T cd05626 161 QKGSHIRQDSMEPSDLWDDVSNCRCGDRLKTLEQRATKQHQRCLAHSLVGTPNYIAPEVLLRKGYTQLCDWWSVGVILFE 240 (381)
T ss_pred cccccccccccCcccccccccccccccccchhhccccccccccccccccCCccccCHHHHcCCCCCCccceeehhhHHHH
Confidence 001223455555543322 23444444444
Q ss_pred eecCCCCCCchHHHHHHHhhcccCCCCCCChhhhhhcc--CcC--CCCCCCCCccchHHHHhccc--CcCCCCCCChhhh
Q psy758 184 IKIGKPAATNIYLIDFLKRCLDKDPLRRWSCDQLLRHP--YFN--GYYFEVPDEMQYEEITQRCL--DKDPLRRWSCDQL 257 (292)
Q Consensus 184 ~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~--~~~--~~~~~~~~~~~l~~li~~~l--~~dP~~Rpt~~~i 257 (292)
+.+|.. |+...+..+..... +-. ........+.++.+||.+|+ ..+|..||+++++
T Consensus 241 lltG~~------------------Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~dli~~ll~~~~~~~~R~~~~~~ 302 (381)
T cd05626 241 MLVGQP------------------PFLAPTPTETQLKVINWENTLHIPPQVKLSPEAVDLITKLCCSAEERLGRNGADDI 302 (381)
T ss_pred HHhCCC------------------CCcCCCHHHHHHHHHccccccCCCCCCCCCHHHHHHHHHHccCcccccCCCCHHHH
Confidence 444444 44333322211110 001 11112235778999999955 5566669999999
Q ss_pred hhCCcccceecc
Q psy758 258 LRHPYFNGYYFE 269 (292)
Q Consensus 258 l~h~w~~~~~~~ 269 (292)
++||||+++.|.
T Consensus 303 l~hp~f~~~~~~ 314 (381)
T cd05626 303 KAHPFFSEVDFS 314 (381)
T ss_pred hcCcccCCCChh
Confidence 999999987664
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. LATS2 is an essential mitotic regulator responsible for coordinating accurate cytokinesis completion and governing the stabilization of other mitotic regulators. It is also critical in the maintenance of proper chromosome number, genomic stability, mitotic fidelity, and the integrity of centrosome duplication. Downregulation of LATS2 is associated with po |
| >cd05614 STKc_MSK2_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-41 Score=281.19 Aligned_cols=253 Identities=24% Similarity=0.334 Sum_probs=193.7
Q ss_pred ccceeeeecccCceEEEEEEEc---CCCcEEEEEEeccCC--CChHHHHHHHHHHHHHHhCC-CCCcchhhhhhhcCCeE
Q psy758 3 RYEKIGKLGEGSYGVVFKCRNR---DTGQVVAIKKFLESE--EDPLIRKIALREIRLLKSLK-HPNLVNLLEVFRRKKKL 76 (292)
Q Consensus 3 ~y~~~~~l~~g~~~~v~~~~~~---~~~~~v~iK~~~~~~--~~~~~~~~~~~e~~~~~~l~-~~~i~~~~~~~~~~~~~ 76 (292)
+|++.+.||+|+||.||+|++. .+++.||+|++.... ......+.+..|+.+++.++ ||+|+++++++.+++.+
T Consensus 1 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~ 80 (332)
T cd05614 1 NFELLKVLGTGAYGKVFLVRKVTGHDTGKLYAMKVLQKAALVQKAKTVEHTRTERNVLEHVRQSPFLVTLHYAFQTEAKL 80 (332)
T ss_pred CceEEEEEeecCCEEEEEEEEcccCCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHHhccCCCCcccEEEEEecCCEE
Confidence 5899999999999999999874 468899999986543 22234566788999999995 89999999999999999
Q ss_pred EEEEecCCCccHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEEccCCcEEEeecCchhhhhccc-
Q psy758 77 HLVFEFCDHTVLNELENHPHGLPWDLIKQITWQVLRGVSYCHRHACIHRDIKPENILLTANGVVKLCDFGFARLIRDLI- 155 (292)
Q Consensus 77 ~iv~e~~~~~~L~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~givH~dl~p~Nilv~~~~~~kl~dfg~~~~~~~~~- 155 (292)
++||||+++++|..++.....+++..++.++.||+.||+|||++|++||||||+|||++.++.++|+|||++.......
T Consensus 81 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivHrDlkp~Nili~~~~~~kl~DfG~~~~~~~~~~ 160 (332)
T cd05614 81 HLILDYVSGGEMFTHLYQRDNFSEDEVRFYSGEIILALEHLHKLGIVYRDIKLENILLDSEGHVVLTDFGLSKEFLSEEK 160 (332)
T ss_pred EEEEeCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCHHHeEECCCCCEEEeeCcCCccccccCC
Confidence 9999999999999998777789999999999999999999999999999999999999999999999999987543211
Q ss_pred -----cccccccccccccccC------CCCCCCcccceeeecCCCCCCchHHHHHHHhhcccCCCCCCChhhhhhccCcC
Q psy758 156 -----PRHLHIFQTNEYFKGV------SLPHAENVVPLEIKIGKPAATNIYLIDFLKRCLDKDPLRRWSCDQLLRHPYFN 224 (292)
Q Consensus 156 -----~~~~~~~~~~~~~~~~------~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~ 224 (292)
..++..|.+||...+. ...|+.|+..+++.+|..++... ..+....++.....-.
T Consensus 161 ~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~--------------~~~~~~~~~~~~~~~~ 226 (332)
T cd05614 161 ERTYSFCGTIEYMAPEIIRGKGGHGKAVDWWSLGILIFELLTGASPFTLE--------------GERNTQSEVSRRILKC 226 (332)
T ss_pred CccccccCCccccCHHHhcCCCCCCCccccccchhhhhhhhcCCCCCCCC--------------CCCCCHHHHHHHHhcC
Confidence 1234557777766542 34566666666666666553210 0011111111111111
Q ss_pred CCCCCCCCccchHHHHhcccCcCCCCCC-----ChhhhhhCCcccceecc
Q psy758 225 GYYFEVPDEMQYEEITQRCLDKDPLRRW-----SCDQLLRHPYFNGYYFE 269 (292)
Q Consensus 225 ~~~~~~~~~~~l~~li~~~l~~dP~~Rp-----t~~~il~h~w~~~~~~~ 269 (292)
....+...+..+.++|.+||+.||++|| +++++++||||++..|+
T Consensus 227 ~~~~~~~~~~~~~~li~~~l~~dp~~R~~~~~~~~~~~l~h~~~~~~~~~ 276 (332)
T cd05614 227 DPPFPSFIGPEAQDLLHKLLRKDPKKRLGAGPQGASEIKEHPFFKGLDWE 276 (332)
T ss_pred CCCCCCCCCHHHHHHHHHHcCCCHHHcCCCCCCCHHHHHcCCCcCCCCHH
Confidence 1223344577899999999999999999 78899999999987654
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph |
| >cd05627 STKc_NDR2 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-41 Score=283.52 Aligned_cols=254 Identities=22% Similarity=0.315 Sum_probs=199.8
Q ss_pred cccceeeeecccCceEEEEEEEcCCCcEEEEEEeccCC-CChHHHHHHHHHHHHHHhCCCCCcchhhhhhhcCCeEEEEE
Q psy758 2 ERYEKIGKLGEGSYGVVFKCRNRDTGQVVAIKKFLESE-EDPLIRKIALREIRLLKSLKHPNLVNLLEVFRRKKKLHLVF 80 (292)
Q Consensus 2 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~v~iK~~~~~~-~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~iv~ 80 (292)
++|++.+.||+|+||.||+|.+..+++.||+|++.... ........+..|+.++..++||+|+++++.+.+++.+|+||
T Consensus 1 ~~f~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~~~~~lv~ 80 (360)
T cd05627 1 DDFESLKVIGRGAFGEVRLVQKKDTGHIYAMKILRKADMLEKEQVAHIRAERDILVEADGAWVVKMFYSFQDKRNLYLIM 80 (360)
T ss_pred CCceEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCEEEEEE
Confidence 57999999999999999999999999999999997543 22334567788999999999999999999999999999999
Q ss_pred ecCCCccHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEEccCCcEEEeecCchhhhhcc------
Q psy758 81 EFCDHTVLNELENHPHGLPWDLIKQITWQVLRGVSYCHRHACIHRDIKPENILLTANGVVKLCDFGFARLIRDL------ 154 (292)
Q Consensus 81 e~~~~~~L~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~givH~dl~p~Nilv~~~~~~kl~dfg~~~~~~~~------ 154 (292)
||++|++|..++...+.+++..++.++.|++.||.|||++||+||||||+||+++.++.++|+|||++......
T Consensus 81 E~~~gg~L~~~l~~~~~l~~~~~~~~~~qi~~~L~~lH~~givHrDLkp~NIli~~~~~vkL~DfG~~~~~~~~~~~~~~ 160 (360)
T cd05627 81 EFLPGGDMMTLLMKKDTLSEEATQFYIAETVLAIDAIHQLGFIHRDIKPDNLLLDAKGHVKLSDFGLCTGLKKAHRTEFY 160 (360)
T ss_pred eCCCCccHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeEccCCCHHHEEECCCCCEEEeeccCCcccccccccccc
Confidence 99999999999987778999999999999999999999999999999999999999999999999998654211
Q ss_pred ----------------------------------ccccccccccccccccC-----CCCCCCcccceeeecCCCCCCchH
Q psy758 155 ----------------------------------IPRHLHIFQTNEYFKGV-----SLPHAENVVPLEIKIGKPAATNIY 195 (292)
Q Consensus 155 ----------------------------------~~~~~~~~~~~~~~~~~-----~~~~~~~~~~~~~~~~~~~~~~~~ 195 (292)
...++..|.+||...+. ...|+.|+..+++.+|..++....
T Consensus 161 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~~~~~DiwSlGvilyel~tG~~Pf~~~~ 240 (360)
T cd05627 161 RNLTHNPPSDFSFQNMNSKRKAETWKKNRRQLAYSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMYEMLIGYPPFCSET 240 (360)
T ss_pred cccccCCcccccccccccccccccccccccccccccCCCccccCHHHHcCCCCCCcceeccccceeeecccCCCCCCCCC
Confidence 01123456677765443 346777777778888777654433
Q ss_pred HHHHHHhhcccCCCCCCChhhhhhccCcCCCCCCCCCccchHHHHhcccCcCCCCCCC---hhhhhhCCcccceeccC
Q psy758 196 LIDFLKRCLDKDPLRRWSCDQLLRHPYFNGYYFEVPDEMQYEEITQRCLDKDPLRRWS---CDQLLRHPYFNGYYFEV 270 (292)
Q Consensus 196 ~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt---~~~il~h~w~~~~~~~~ 270 (292)
....+........ ....+...+.+..+++||.+|+ .||.+|++ ++++++||||+++.|+.
T Consensus 241 ~~~~~~~i~~~~~--------------~~~~p~~~~~s~~~~~li~~l~-~~p~~R~~~~~~~ei~~hp~f~~~~~~~ 303 (360)
T cd05627 241 PQETYRKVMNWKE--------------TLVFPPEVPISEKAKDLILRFC-TDSENRIGSNGVEEIKSHPFFEGVDWGH 303 (360)
T ss_pred HHHHHHHHHcCCC--------------ceecCCCCCCCHHHHHHHHHhc-cChhhcCCCCCHHHHhcCCCCCCCCHHH
Confidence 3333332221100 0011112235678999999977 49999994 79999999999987763
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. In addition, NDR2 plays a role in regul |
| >KOG0690|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-42 Score=267.72 Aligned_cols=261 Identities=23% Similarity=0.331 Sum_probs=218.1
Q ss_pred CcccceeeeecccCceEEEEEEEcCCCcEEEEEEeccCC-CChHHHHHHHHHHHHHHhCCCCCcchhhhhhhcCCeEEEE
Q psy758 1 MERYEKIGKLGEGSYGVVFKCRNRDTGQVVAIKKFLESE-EDPLIRKIALREIRLLKSLKHPNLVNLLEVFRRKKKLHLV 79 (292)
Q Consensus 1 ~~~y~~~~~l~~g~~~~v~~~~~~~~~~~v~iK~~~~~~-~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~iv 79 (292)
|++|..++.||+|+||.|.+++.+.+++.+|+|++++.- ........-..|-++++..+||.+..+--.|+..+.+|+|
T Consensus 167 m~dFdfLKvLGkGTFGKVIL~rEKat~k~YAiKIlkKeviiakdEVAHTlTE~RVL~~~~HPFLt~LKYsFQt~drlCFV 246 (516)
T KOG0690|consen 167 MEDFDFLKVLGKGTFGKVILCREKATGKLYAIKILKKEVIIAKDEVAHTLTENRVLQNCRHPFLTSLKYSFQTQDRLCFV 246 (516)
T ss_pred cchhhHHHHhcCCccceEEEEeecccCceeehhhhhhhheeehHHhhhhhhHHHHHHhccCcHHHHhhhhhccCceEEEE
Confidence 578999999999999999999999999999999997765 3444556667899999999999999999999999999999
Q ss_pred EecCCCccHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEEccCCcEEEeecCchhhhhccccccc
Q psy758 80 FEFCDHTVLNELENHPHGLPWDLIKQITWQVLRGVSYCHRHACIHRDIKPENILLTANGVVKLCDFGFARLIRDLIPRHL 159 (292)
Q Consensus 80 ~e~~~~~~L~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~givH~dl~p~Nilv~~~~~~kl~dfg~~~~~~~~~~~~~ 159 (292)
|||+.||.|...+.+.+.+++..++.+-..|+.||.|||+++||+||||.+|+++|.+|++||+|||+|+..-.......
T Consensus 247 MeyanGGeLf~HLsrer~FsE~RtRFYGaEIvsAL~YLHs~~ivYRDlKLENLlLDkDGHIKitDFGLCKE~I~~g~t~k 326 (516)
T KOG0690|consen 247 MEYANGGELFFHLSRERVFSEDRTRFYGAEIVSALGYLHSRNIVYRDLKLENLLLDKDGHIKITDFGLCKEEIKYGDTTK 326 (516)
T ss_pred EEEccCceEeeehhhhhcccchhhhhhhHHHHHHhhhhhhCCeeeeechhhhheeccCCceEeeecccchhcccccceec
Confidence 99999999999999988999999999999999999999999999999999999999999999999999987666666667
Q ss_pred cccccccccccCCCCCCCcccceeeecCCCCCCchHHHHHHHhhcccCCCCCCChhhhhhccCcCCCCCCCCCccchHHH
Q psy758 160 HIFQTNEYFKGVSLPHAENVVPLEIKIGKPAATNIYLIDFLKRCLDKDPLRRWSCDQLLRHPYFNGYYFEVPDEMQYEEI 239 (292)
Q Consensus 160 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l 239 (292)
.++++|||.+++.+.. .-+|...+.+-....+++.++++-|+.......++.-.......+|...+++.+.|
T Consensus 327 TFCGTPEYLAPEVleD--------nDYgraVDWWG~GVVMYEMmCGRLPFyn~dh~kLFeLIl~ed~kFPr~ls~eAktL 398 (516)
T KOG0690|consen 327 TFCGTPEYLAPEVLED--------NDYGRAVDWWGVGVVMYEMMCGRLPFYNKDHEKLFELILMEDLKFPRTLSPEAKTL 398 (516)
T ss_pred cccCChhhcCchhhcc--------ccccceeehhhhhHHHHHHHhccCcccccchhHHHHHHHhhhccCCccCCHHHHHH
Confidence 7889999998876621 11111111122223344445555555555555555555566678888899999999
Q ss_pred HhcccCcCCCCCC-----ChhhhhhCCcccceecc
Q psy758 240 TQRCLDKDPLRRW-----SCDQLLRHPYFNGYYFE 269 (292)
Q Consensus 240 i~~~l~~dP~~Rp-----t~~~il~h~w~~~~~~~ 269 (292)
+..+|..||.+|. .|.||++|+||.++.|+
T Consensus 399 LsGLL~kdP~kRLGgGpdDakEi~~h~FF~~v~W~ 433 (516)
T KOG0690|consen 399 LSGLLKKDPKKRLGGGPDDAKEIMRHRFFASVDWE 433 (516)
T ss_pred HHHHhhcChHhhcCCCchhHHHHHhhhhhccCCHH
Confidence 9999999999998 79999999999999986
|
|
| >cd07876 STKc_JNK2 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-41 Score=284.14 Aligned_cols=264 Identities=27% Similarity=0.406 Sum_probs=191.8
Q ss_pred CcccceeeeecccCceEEEEEEEcCCCcEEEEEEeccCCCChHHHHHHHHHHHHHHhCCCCCcchhhhhhhcC------C
Q psy758 1 MERYEKIGKLGEGSYGVVFKCRNRDTGQVVAIKKFLESEEDPLIRKIALREIRLLKSLKHPNLVNLLEVFRRK------K 74 (292)
Q Consensus 1 ~~~y~~~~~l~~g~~~~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~------~ 74 (292)
+++|++.+.||+|+||.||+|.+..+|+.||+|.+............+.+|+.+++.++||||+++++++... .
T Consensus 20 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~ 99 (359)
T cd07876 20 LKRYQQLKPIGSGAQGIVCAAFDTVLGINVAVKKLSRPFQNQTHAKRAYRELVLLKCVNHKNIISLLNVFTPQKSLEEFQ 99 (359)
T ss_pred hhceEEEEEeecCCCEEEEEEEEcCCCceeEEEEecccccchhHHHHHHHHHHHHHhCCCCCEeeeeeeeccCCCccccc
Confidence 4789999999999999999999999999999999976655555567788999999999999999999988643 3
Q ss_pred eEEEEEecCCCccHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEEccCCcEEEeecCchhhhhcc
Q psy758 75 KLHLVFEFCDHTVLNELENHPHGLPWDLIKQITWQVLRGVSYCHRHACIHRDIKPENILLTANGVVKLCDFGFARLIRDL 154 (292)
Q Consensus 75 ~~~iv~e~~~~~~L~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~givH~dl~p~Nilv~~~~~~kl~dfg~~~~~~~~ 154 (292)
.+|+||||++++.+..+ .. .+++..+..++.||+.||.|||++||+||||||+||+++.++.++|+|||++......
T Consensus 100 ~~~lv~e~~~~~l~~~~-~~--~~~~~~~~~~~~qi~~~L~~LH~~~ivHrDlkp~NIl~~~~~~~kl~Dfg~a~~~~~~ 176 (359)
T cd07876 100 DVYLVMELMDANLCQVI-HM--ELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTACTN 176 (359)
T ss_pred eeEEEEeCCCcCHHHHH-hc--cCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEECCCCCEEEecCCCccccccC
Confidence 57999999987655443 32 4899999999999999999999999999999999999999999999999998754321
Q ss_pred c----cccccccccccccccCC-----CCCCCcccceeeecCCCCCCchHHHHHHHhhccc-------------------
Q psy758 155 I----PRHLHIFQTNEYFKGVS-----LPHAENVVPLEIKIGKPAATNIYLIDFLKRCLDK------------------- 206 (292)
Q Consensus 155 ~----~~~~~~~~~~~~~~~~~-----~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~------------------- 206 (292)
. ...+..|.+||...+.. ..|+.|+..+++.+|..++........+......
T Consensus 177 ~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 256 (359)
T cd07876 177 FMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGELVKGSVIFQGTDHIDQWNKVIEQLGTPSAEFMNRLQPTVRNY 256 (359)
T ss_pred ccCCCCcccCCCCCchhccCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCcHHHHHHHHHHHHHH
Confidence 1 12344578888776543 3466666666777777665433222211111110
Q ss_pred ---CCCC-CCChhhhhhccCcC-CCCCCCCCccchHHHHhcccCcCCCCCCChhhhhhCCccccee
Q psy758 207 ---DPLR-RWSCDQLLRHPYFN-GYYFEVPDEMQYEEITQRCLDKDPLRRWSCDQLLRHPYFNGYY 267 (292)
Q Consensus 207 ---~p~~-~~~~~~~~~~~~~~-~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~~il~h~w~~~~~ 267 (292)
.|.. .....+....-.+. ........+..+++||.+||+.||++|||++|+++||||..+.
T Consensus 257 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R~t~~e~l~hp~~~~~~ 322 (359)
T cd07876 257 VENRPQYPGISFEELFPDWIFPSESERDKLKTSQARDLLSKMLVIDPDKRISVDEALRHPYITVWY 322 (359)
T ss_pred HhhCCCCCCcchhhhccccccccccccccccchhHHHHHHHHhccCcccCCCHHHHhcCchhhhhc
Confidence 0100 00111111000000 0011112356789999999999999999999999999998633
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn |
| >cd06649 PKc_MEK2 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-40 Score=277.07 Aligned_cols=268 Identities=24% Similarity=0.395 Sum_probs=201.3
Q ss_pred cccceeeeecccCceEEEEEEEcCCCcEEEEEEeccCCCChHHHHHHHHHHHHHHhCCCCCcchhhhhhhcCCeEEEEEe
Q psy758 2 ERYEKIGKLGEGSYGVVFKCRNRDTGQVVAIKKFLESEEDPLIRKIALREIRLLKSLKHPNLVNLLEVFRRKKKLHLVFE 81 (292)
Q Consensus 2 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~iv~e 81 (292)
++|++.+.||+|++|.||++++..++..||+|.+.... .......+.+|+++++.++||||+++++++.+++..++|||
T Consensus 5 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~a~k~~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 83 (331)
T cd06649 5 DDFERISELGAGNGGVVTKVQHKPSGLIMARKLIHLEI-KPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICME 83 (331)
T ss_pred ccceEEEeecCCCCEEEEEEEECCCCcEEEEEEeeccc-CHHHHHHHHHHHHHHHHCCCCCCCeEEEEEEECCEEEEEee
Confidence 68999999999999999999999999999999987543 33456678899999999999999999999999999999999
Q ss_pred cCCCccHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhC-CccccCCCCCceEEccCCcEEEeecCchhhhhccc---cc
Q psy758 82 FCDHTVLNELENHPHGLPWDLIKQITWQVLRGVSYCHRH-ACIHRDIKPENILLTANGVVKLCDFGFARLIRDLI---PR 157 (292)
Q Consensus 82 ~~~~~~L~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~-givH~dl~p~Nilv~~~~~~kl~dfg~~~~~~~~~---~~ 157 (292)
|+++++|.+++.....+++..+..++.|++.||.|||++ +++|+||||+||+++.++.++|+|||++....... ..
T Consensus 84 ~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~ 163 (331)
T cd06649 84 HMDGGSLDQVLKEAKRIPEEILGKVSIAVLRGLAYLREKHQIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSMANSFV 163 (331)
T ss_pred cCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHhhcCCEEcCCCChhhEEEcCCCcEEEccCcccccccccccccCC
Confidence 999999999998877899999999999999999999986 69999999999999999999999999987653321 12
Q ss_pred cccccccccccccCCC-----CCCCcccceeeecCCCCCCchHHHHHHHhhcccCCC-------------CCCC------
Q psy758 158 HLHIFQTNEYFKGVSL-----PHAENVVPLEIKIGKPAATNIYLIDFLKRCLDKDPL-------------RRWS------ 213 (292)
Q Consensus 158 ~~~~~~~~~~~~~~~~-----~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~p~-------------~~~~------ 213 (292)
.+..|.+||...+... .|+.|+..+++.+|..++.......+... +..... .++.
T Consensus 164 g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~tg~~p~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 242 (331)
T cd06649 164 GTRSYMSPERLQGTHYSVQSDIWSMGLSLVELAIGRYPIPPPDAKELEAI-FGRPVVDGEEGEPHSISPRPRPPGRPVSG 242 (331)
T ss_pred CCcCcCCHhHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCCHHHHHHH-hcccccccccCCccccCcccccccccccc
Confidence 3456777877665433 45566666667777766543333222211 111000 0000
Q ss_pred ----------hhhhhhccCcC--CCCCCCCCccchHHHHhcccCcCCCCCCChhhhhhCCcccceeccCC
Q psy758 214 ----------CDQLLRHPYFN--GYYFEVPDEMQYEEITQRCLDKDPLRRWSCDQLLRHPYFNGYYFEVP 271 (292)
Q Consensus 214 ----------~~~~~~~~~~~--~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~~il~h~w~~~~~~~~~ 271 (292)
..+......-. ........+..+++||.+||..||++|||++++++||||+.......
T Consensus 243 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~~P~~Rpt~~ell~h~~~~~~~~~~~ 312 (331)
T cd06649 243 HGMDSRPAMAIFELLDYIVNEPPPKLPNGVFTPDFQEFVNKCLIKNPAERADLKMLMNHTFIKRSEVEEV 312 (331)
T ss_pred cccccccchhHHHHHHHHHhCCCcCCCCccccHHHHHHHHHHccCCcccCCCHHHHhcChHHhhcccccc
Confidence 00000000000 00001124678999999999999999999999999999998655444
|
Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downst |
| >cd05570 STKc_PKC Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-41 Score=279.51 Aligned_cols=249 Identities=20% Similarity=0.261 Sum_probs=190.0
Q ss_pred eeecccCceEEEEEEEcCCCcEEEEEEeccCC-CChHHHHHHHHHHHHHHhC-CCCCcchhhhhhhcCCeEEEEEecCCC
Q psy758 8 GKLGEGSYGVVFKCRNRDTGQVVAIKKFLESE-EDPLIRKIALREIRLLKSL-KHPNLVNLLEVFRRKKKLHLVFEFCDH 85 (292)
Q Consensus 8 ~~l~~g~~~~v~~~~~~~~~~~v~iK~~~~~~-~~~~~~~~~~~e~~~~~~l-~~~~i~~~~~~~~~~~~~~iv~e~~~~ 85 (292)
+.||+|+||.||+|.+..+++.||+|++.... ........+.+|..+++.+ +||||+++++++.+.+.+|+||||++|
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~ 80 (318)
T cd05570 1 KVLGKGSFGKVLLAELKGTDELYAVKVLKKDVILQDDDVECTMTEKRVLALAGKHPFLTQLHSCFQTKDRLFFVMEYVNG 80 (318)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhccCCCCccceeeEEEcCCEEEEEEcCCCC
Confidence 46999999999999999999999999997553 2223455667888888888 699999999999999999999999999
Q ss_pred ccHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEEccCCcEEEeecCchhhhhccc-----ccccc
Q psy758 86 TVLNELENHPHGLPWDLIKQITWQVLRGVSYCHRHACIHRDIKPENILLTANGVVKLCDFGFARLIRDLI-----PRHLH 160 (292)
Q Consensus 86 ~~L~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~givH~dl~p~Nilv~~~~~~kl~dfg~~~~~~~~~-----~~~~~ 160 (292)
++|...+.....+++..+..++.||+.||.|||++|++|+||+|+||++++++.++|+|||++....... ..++.
T Consensus 81 ~~L~~~~~~~~~l~~~~~~~~~~qi~~~l~~LH~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~g~~ 160 (318)
T cd05570 81 GDLMFHIQRSGRFDEPRARFYAAEIVLGLQFLHERGIIYRDLKLDNVLLDSEGHIKIADFGMCKEGILGGVTTSTFCGTP 160 (318)
T ss_pred CCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCeEccCCCHHHeEECCCCcEEecccCCCeecCcCCCcccceecCc
Confidence 9999998877789999999999999999999999999999999999999999999999999886422111 11234
Q ss_pred ccccccccccCCCCCCCcccceeeecCCCCCCchHHHHHHHhhcccCCCCCCChhhhhhccCcCCCCCCCCCccchHHHH
Q psy758 161 IFQTNEYFKGVSLPHAENVVPLEIKIGKPAATNIYLIDFLKRCLDKDPLRRWSCDQLLRHPYFNGYYFEVPDEMQYEEIT 240 (292)
Q Consensus 161 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li 240 (292)
.|.+||...+.......++| +.+.-++..+.+..|+...+..+............+...+..+.+||
T Consensus 161 ~y~aPE~~~~~~~~~~~Diw-------------slGvil~~l~~G~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~li 227 (318)
T cd05570 161 DYIAPEILSYQPYGPAVDWW-------------ALGVLLYEMLAGQSPFEGDDEDELFQSILEDEVRYPRWLSKEAKSIL 227 (318)
T ss_pred cccCHHHhcCCCCCcchhhh-------------hHHHHHHHHhhCCCCCCCCCHHHHHHHHHcCCCCCCCcCCHHHHHHH
Confidence 56667666544332222222 22223333344444544444333333222222334445678899999
Q ss_pred hcccCcCCCCCCCh-----hhhhhCCcccceecc
Q psy758 241 QRCLDKDPLRRWSC-----DQLLRHPYFNGYYFE 269 (292)
Q Consensus 241 ~~~l~~dP~~Rpt~-----~~il~h~w~~~~~~~ 269 (292)
++||+.||++|||+ .++++||||....|+
T Consensus 228 ~~~l~~dP~~R~s~~~~~~~~ll~~~~~~~~~~~ 261 (318)
T cd05570 228 KSFLTKNPEKRLGCLPTGEQDIKGHPFFREIDWD 261 (318)
T ss_pred HHHccCCHHHcCCCCCCCHHHHhcCCCcCCCCHH
Confidence 99999999999999 999999999997664
|
Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only re |
| >cd06650 PKc_MEK1 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-41 Score=280.66 Aligned_cols=266 Identities=25% Similarity=0.419 Sum_probs=199.9
Q ss_pred cccceeeeecccCceEEEEEEEcCCCcEEEEEEeccCCCChHHHHHHHHHHHHHHhCCCCCcchhhhhhhcCCeEEEEEe
Q psy758 2 ERYEKIGKLGEGSYGVVFKCRNRDTGQVVAIKKFLESEEDPLIRKIALREIRLLKSLKHPNLVNLLEVFRRKKKLHLVFE 81 (292)
Q Consensus 2 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~iv~e 81 (292)
++|++.+.||+|+||.||++.+..++..+++|.+.... .......+.+|+++++.++||||+++++++.+++..++|||
T Consensus 5 ~~y~~~~~lg~g~~g~V~~~~~~~~~~~~a~k~~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 83 (333)
T cd06650 5 DDFEKISELGAGNGGVVFKVSHKPSGLIMARKLIHLEI-KPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICME 83 (333)
T ss_pred hhhheeccccCCCCEEEEEEEECCCCcEEEEEEeeccc-CHHHHHHHHHHHHHHHHCCCCcccceeEEEEECCEEEEEEe
Confidence 68999999999999999999999999999999886543 33455678899999999999999999999999999999999
Q ss_pred cCCCccHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhC-CccccCCCCCceEEccCCcEEEeecCchhhhhccc---cc
Q psy758 82 FCDHTVLNELENHPHGLPWDLIKQITWQVLRGVSYCHRH-ACIHRDIKPENILLTANGVVKLCDFGFARLIRDLI---PR 157 (292)
Q Consensus 82 ~~~~~~L~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~-givH~dl~p~Nilv~~~~~~kl~dfg~~~~~~~~~---~~ 157 (292)
|+.+++|.+++...+.+++..+..++.|++.||.|||++ +++|+||||+||+++.++.++|+|||++....... ..
T Consensus 84 ~~~~~~L~~~l~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~ivH~dlkp~Nili~~~~~~kL~Dfg~~~~~~~~~~~~~~ 163 (333)
T cd06650 84 HMDGGSLDQVLKKAGRIPEQILGKVSIAVIKGLTYLREKHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSMANSFV 163 (333)
T ss_pred cCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhcCCEEecCCChhhEEEcCCCCEEEeeCCcchhhhhhccccCC
Confidence 999999999998777899999999999999999999985 79999999999999999999999999987654321 22
Q ss_pred cccccccccccccCCC-----CCCCcccceeeecCCCCCCchHHHHHHHh---hcccC---------------------C
Q psy758 158 HLHIFQTNEYFKGVSL-----PHAENVVPLEIKIGKPAATNIYLIDFLKR---CLDKD---------------------P 208 (292)
Q Consensus 158 ~~~~~~~~~~~~~~~~-----~~~~~~~~~~~~~~~~~~~~~~~~~~~~~---~~~~~---------------------p 208 (292)
.+..|.+||...+... .|+.|+..+++.+|..++.......+... ..... |
T Consensus 164 ~~~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 243 (333)
T cd06650 164 GTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAIGRYPIPPPDAKELELMFGCPVEGDPAESETSPRPRPPGRPLSSYGP 243 (333)
T ss_pred CCccccCHHHhcCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcchhHHHHHhcCcccCCccccccCcccCCccchhhhhcc
Confidence 3456788888766443 35555556666677665543333222111 11111 1
Q ss_pred CCCCChh--hhhhccCcCCCC---CCCCCccchHHHHhcccCcCCCCCCChhhhhhCCcccceecc
Q psy758 209 LRRWSCD--QLLRHPYFNGYY---FEVPDEMQYEEITQRCLDKDPLRRWSCDQLLRHPYFNGYYFE 269 (292)
Q Consensus 209 ~~~~~~~--~~~~~~~~~~~~---~~~~~~~~l~~li~~~l~~dP~~Rpt~~~il~h~w~~~~~~~ 269 (292)
..+++.. .+.... ..... .....+.++++||.+||+.||++|||+.|++.||||+...-+
T Consensus 244 ~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~li~~~L~~~P~~Rpt~~ell~h~~~~~~~~~ 308 (333)
T cd06650 244 DSRPPMAIFELLDYI-VNEPPPKLPSGVFGAEFQDFVNKCLIKNPAERADLKQLMVHAFIKRSEAE 308 (333)
T ss_pred cccccccHHHHHHHH-hcCCCccCCCCCcCHHHHHHHHHhccCCcccCcCHHHHhhCHHHhcCccc
Confidence 1111110 000000 00000 011235678999999999999999999999999999975533
|
Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downst |
| >cd05588 STKc_aPKC Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-41 Score=280.44 Aligned_cols=253 Identities=21% Similarity=0.296 Sum_probs=189.1
Q ss_pred eeecccCceEEEEEEEcCCCcEEEEEEeccCC-CChHHHHHHHHHHHHHHhC-CCCCcchhhhhhhcCCeEEEEEecCCC
Q psy758 8 GKLGEGSYGVVFKCRNRDTGQVVAIKKFLESE-EDPLIRKIALREIRLLKSL-KHPNLVNLLEVFRRKKKLHLVFEFCDH 85 (292)
Q Consensus 8 ~~l~~g~~~~v~~~~~~~~~~~v~iK~~~~~~-~~~~~~~~~~~e~~~~~~l-~~~~i~~~~~~~~~~~~~~iv~e~~~~ 85 (292)
+.||+|+||.||+|.+..+++.||+|++.... ......+.+..|..+++.+ +||||+++++++.+.+.+|+||||+++
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~e~~il~~~~~hp~Iv~~~~~~~~~~~~~lv~e~~~~ 80 (329)
T cd05588 1 RVIGRGSYAKVLLVELKKTRRIYAMKVIKKELVNDDEDIDWVQTEKHVFETASNHPFLVGLHSCFQTESRLFFVIEFVSG 80 (329)
T ss_pred CeEeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCCCCceEEEEEcCCEEEEEEeCCCC
Confidence 46999999999999999999999999997653 2333456678899999998 699999999999999999999999999
Q ss_pred ccHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEEccCCcEEEeecCchhhhhccc-----ccccc
Q psy758 86 TVLNELENHPHGLPWDLIKQITWQVLRGVSYCHRHACIHRDIKPENILLTANGVVKLCDFGFARLIRDLI-----PRHLH 160 (292)
Q Consensus 86 ~~L~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~givH~dl~p~Nilv~~~~~~kl~dfg~~~~~~~~~-----~~~~~ 160 (292)
++|..++...+.+++..++.++.||+.||.|||++|++||||||+||+++.++.++|+|||++....... ..++.
T Consensus 81 g~L~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nili~~~~~~kL~Dfg~~~~~~~~~~~~~~~~gt~ 160 (329)
T cd05588 81 GDLMFHMQRQRKLPEEHARFYSAEISLALNFLHERGIIYRDLKLDNVLLDAEGHIKLTDYGMCKEGIRPGDTTSTFCGTP 160 (329)
T ss_pred CCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHeEECCCCCEEECcCccccccccCCCccccccCCc
Confidence 9999988777789999999999999999999999999999999999999999999999999986432111 12234
Q ss_pred ccccccccccCCC-----CCCCcccceeeecCCCCCCchHHHHHHHhhcccCCCCCCChhhhhhccCcCCCCCCCCCccc
Q psy758 161 IFQTNEYFKGVSL-----PHAENVVPLEIKIGKPAATNIYLIDFLKRCLDKDPLRRWSCDQLLRHPYFNGYYFEVPDEMQ 235 (292)
Q Consensus 161 ~~~~~~~~~~~~~-----~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 235 (292)
.|.+||...+... .|+.|+..+++.+|..++.... ....|... ....+.....-.....+...+..
T Consensus 161 ~y~aPE~~~~~~~~~~~DiwslG~~l~el~~g~~Pf~~~~--------~~~~~~~~-~~~~~~~~~~~~~~~~p~~~~~~ 231 (329)
T cd05588 161 NYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVG--------MSDNPDQN-TEDYLFQVILEKQIRIPRSLSVK 231 (329)
T ss_pred cccCHHHHcCCCCCCccceechHHHHHHHHHCCCCccccc--------cccccccc-chHHHHHHHHcCCCCCCCCCCHH
Confidence 5677776655433 3444444444555544431000 00000000 00111111111222344556778
Q ss_pred hHHHHhcccCcCCCCCCC------hhhhhhCCcccceecc
Q psy758 236 YEEITQRCLDKDPLRRWS------CDQLLRHPYFNGYYFE 269 (292)
Q Consensus 236 l~~li~~~l~~dP~~Rpt------~~~il~h~w~~~~~~~ 269 (292)
+.++|++||+.||.+||| ++++++||||.+..|+
T Consensus 232 ~~~li~~~L~~dP~~R~~~~~~~~~~~i~~hp~~~~~~~~ 271 (329)
T cd05588 232 ASSVLKGFLNKDPKERLGCHPQTGFRDIKSHPFFRNIDWD 271 (329)
T ss_pred HHHHHHHHhccCHHHcCCCCCCCCHHHHhcCCCCCCCCHH
Confidence 999999999999999997 6899999999987775
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions incl |
| >cd05598 STKc_LATS Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-41 Score=284.75 Aligned_cols=253 Identities=21% Similarity=0.247 Sum_probs=196.7
Q ss_pred cccceeeeecccCceEEEEEEEcCCCcEEEEEEeccCCC-ChHHHHHHHHHHHHHHhCCCCCcchhhhhhhcCCeEEEEE
Q psy758 2 ERYEKIGKLGEGSYGVVFKCRNRDTGQVVAIKKFLESEE-DPLIRKIALREIRLLKSLKHPNLVNLLEVFRRKKKLHLVF 80 (292)
Q Consensus 2 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~v~iK~~~~~~~-~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~iv~ 80 (292)
++|++.+.||+|++|.||+|++..+++.||+|++..... .......+.+|+.+++.++||||+++++.+.+++.+|+||
T Consensus 1 ~~y~~~~~lG~G~~g~V~~a~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~~~~~~~~~~~~~lv~ 80 (376)
T cd05598 1 SMFVKIKTIGIGAFGEVCLVRKVDTNALYAMKTLRKADVLMRNQAAHVKAERDILAEADNEWVVKLYYSFQDKDNLYFVM 80 (376)
T ss_pred CCceEEEEEEeCCCeEEEEEEECCCCCEEEEEEEcHHHHHhhhhHHHHHHHHHHHHhCCCCCcceEEEEEEcCCEEEEEE
Confidence 579999999999999999999999999999999865432 2233466778999999999999999999999999999999
Q ss_pred ecCCCccHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEEccCCcEEEeecCchhhhhcc------
Q psy758 81 EFCDHTVLNELENHPHGLPWDLIKQITWQVLRGVSYCHRHACIHRDIKPENILLTANGVVKLCDFGFARLIRDL------ 154 (292)
Q Consensus 81 e~~~~~~L~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~givH~dl~p~Nilv~~~~~~kl~dfg~~~~~~~~------ 154 (292)
||+++++|.+++...+.+++..++.++.||+.||+|||++||+||||||+||+++.++.++|+|||++..+...
T Consensus 81 E~~~~g~L~~~i~~~~~~~~~~~~~~~~qi~~al~~lH~~~ivHrDlkp~Nill~~~~~ikL~DFG~a~~~~~~~~~~~~ 160 (376)
T cd05598 81 DYIPGGDMMSLLIRLGIFEEDLARFYIAELTCAIESVHKMGFIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTHDSKYY 160 (376)
T ss_pred eCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeEeCCCCHHHEEECCCCCEEEEeCCCCcccccccccccc
Confidence 99999999999988778999999999999999999999999999999999999999999999999987432100
Q ss_pred ------------------------------------------ccccccccccccccccC-----CCCCCCcccceeeecC
Q psy758 155 ------------------------------------------IPRHLHIFQTNEYFKGV-----SLPHAENVVPLEIKIG 187 (292)
Q Consensus 155 ------------------------------------------~~~~~~~~~~~~~~~~~-----~~~~~~~~~~~~~~~~ 187 (292)
...++..|.+||...+. ...|+.|++.+++++|
T Consensus 161 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvilyell~G 240 (376)
T cd05598 161 QKGDHHRQDSMEPSEEWSEIDRCRLKPLERRRKRQHQRCLAHSLVGTPNYIAPEVLLRTGYTQLCDWWSVGVILYEMLVG 240 (376)
T ss_pred ccccccccccccccccccccccccccchhhhhhhhcccccccccCCCccccCHHHHcCCCCCcceeeeeccceeeehhhC
Confidence 01133456677665443 3467777777777777
Q ss_pred CCCCCchHHHHHHHhhcccCCCCCCChhhhhhccCcCCCCCCCCCccchHHHHhcccCcCCCCCC---ChhhhhhCCccc
Q psy758 188 KPAATNIYLIDFLKRCLDKDPLRRWSCDQLLRHPYFNGYYFEVPDEMQYEEITQRCLDKDPLRRW---SCDQLLRHPYFN 264 (292)
Q Consensus 188 ~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rp---t~~~il~h~w~~ 264 (292)
..++................. ..........+..+.++|.+|+ .+|.+|+ |+.++++||||+
T Consensus 241 ~~Pf~~~~~~~~~~~i~~~~~--------------~~~~~~~~~~s~~~~~li~~l~-~~p~~R~~~~t~~ell~h~~~~ 305 (376)
T cd05598 241 QPPFLADTPAETQLKVINWET--------------TLHIPSQAKLSREASDLILRLC-CGAEDRLGKNGADEIKAHPFFK 305 (376)
T ss_pred CCCCCCCCHHHHHHHHhccCc--------------cccCCCCCCCCHHHHHHHHHHh-cCHhhcCCCCCHHHHhCCCCcC
Confidence 776544333222222111100 0011112234678899999976 5999999 999999999999
Q ss_pred ceecc
Q psy758 265 GYYFE 269 (292)
Q Consensus 265 ~~~~~ 269 (292)
++.+.
T Consensus 306 ~~~~~ 310 (376)
T cd05598 306 GIDFA 310 (376)
T ss_pred CCCHH
Confidence 86544
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS was originally identified in Drosophila using a screen for genes whose inactivation led to overproliferation of cells. In tetrapods, there are two LATS isoforms, LATS1 and LATS2. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. |
| >PHA03212 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-41 Score=284.51 Aligned_cols=259 Identities=22% Similarity=0.217 Sum_probs=189.9
Q ss_pred cccceeeeecccCceEEEEEEEcCCCcEEEEEEeccCCCChHHHHHHHHHHHHHHhCCCCCcchhhhhhhcCCeEEEEEe
Q psy758 2 ERYEKIGKLGEGSYGVVFKCRNRDTGQVVAIKKFLESEEDPLIRKIALREIRLLKSLKHPNLVNLLEVFRRKKKLHLVFE 81 (292)
Q Consensus 2 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~iv~e 81 (292)
++|++.+.||+|++|.||+|.+..+++.||+|... ...+.+|+.+++.++||||+++++++..+...++++|
T Consensus 92 ~~y~~~~~lg~G~~g~V~~~~d~~~~~~vaiK~~~--------~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~lv~e 163 (391)
T PHA03212 92 AGFSILETFTPGAEGFAFACIDNKTCEHVVIKAGQ--------RGGTATEAHILRAINHPSIIQLKGTFTYNKFTCLILP 163 (391)
T ss_pred CCcEEEEEEcCCCCeEEEEEEECCCCCEEEEechh--------hhhhHHHHHHHHhCCCCCCCCEeEEEEECCeeEEEEe
Confidence 57999999999999999999999999999999643 2345689999999999999999999999999999999
Q ss_pred cCCCccHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEEccCCcEEEeecCchhhhhcc------c
Q psy758 82 FCDHTVLNELENHPHGLPWDLIKQITWQVLRGVSYCHRHACIHRDIKPENILLTANGVVKLCDFGFARLIRDL------I 155 (292)
Q Consensus 82 ~~~~~~L~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~givH~dl~p~Nilv~~~~~~kl~dfg~~~~~~~~------~ 155 (292)
++.+ +|..++.....+++..++.++.||+.||.|||++||+||||||+||+++.++.++|+|||++...... .
T Consensus 164 ~~~~-~L~~~l~~~~~l~~~~~~~i~~qi~~aL~ylH~~~IvHrDiKP~NIll~~~~~vkL~DFG~a~~~~~~~~~~~~~ 242 (391)
T PHA03212 164 RYKT-DLYCYLAAKRNIAICDILAIERSVLRAIQYLHENRIIHRDIKAENIFINHPGDVCLGDFGAACFPVDINANKYYG 242 (391)
T ss_pred cCCC-CHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCChHhEEEcCCCCEEEEeCCccccccccccccccc
Confidence 9974 56666666667999999999999999999999999999999999999999999999999998653221 1
Q ss_pred cccccccccccccccCCC-----CCCCcccceeeecCCCCCCc----------hHHHHHHHhhcccCCCCCCC-----hh
Q psy758 156 PRHLHIFQTNEYFKGVSL-----PHAENVVPLEIKIGKPAATN----------IYLIDFLKRCLDKDPLRRWS-----CD 215 (292)
Q Consensus 156 ~~~~~~~~~~~~~~~~~~-----~~~~~~~~~~~~~~~~~~~~----------~~~~~~~~~~~~~~p~~~~~-----~~ 215 (292)
..++..|.+||...+... .|+.|+..+++.+|..+... ......+...++..|...+. ..
T Consensus 243 ~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~elltg~~p~~~~~~~~~~~~~~~~l~~i~~~~g~~p~~~~~~~~~~~~ 322 (391)
T PHA03212 243 WAGTIATNAPELLARDPYGPAVDIWSAGIVLFEMATCHDSLFEKDGLDGDCDSDRQIKLIIRRSGTHPNEFPIDAQANLD 322 (391)
T ss_pred ccCccCCCChhhhcCCCCCcHHHHHHHHHHHHHHHHCCCCcCCcccccccCchhHHHHHHHHHhcCChhhcCcchhHHHH
Confidence 123456777887655443 45666666666666543211 11112222222333322211 11
Q ss_pred hhh----hccCcCCCCC-----CCCCccchHHHHhcccCcCCCCCCChhhhhhCCcccceecc
Q psy758 216 QLL----RHPYFNGYYF-----EVPDEMQYEEITQRCLDKDPLRRWSCDQLLRHPYFNGYYFE 269 (292)
Q Consensus 216 ~~~----~~~~~~~~~~-----~~~~~~~l~~li~~~l~~dP~~Rpt~~~il~h~w~~~~~~~ 269 (292)
+.. .......... ....+.++.+||.+||++||.+|||++|+|+||||.++...
T Consensus 323 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~Li~~mL~~dP~~Rpta~elL~hp~f~~~~~~ 385 (391)
T PHA03212 323 EIYIGLAKKSSRKPGSRPLWTNLYELPIDLEYLICKMLAFDAHHRPSAEALLDFAAFQDIPDP 385 (391)
T ss_pred HHHHHHHhccCCCCCCCCCHHHHhhhhhhHHHHHHHHhcCChhhCCCHHHHhcChhhccCCCC
Confidence 111 0000000000 01235678999999999999999999999999999985533
|
|
| >cd05575 STKc_SGK Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-41 Score=278.76 Aligned_cols=244 Identities=23% Similarity=0.303 Sum_probs=187.3
Q ss_pred eeecccCceEEEEEEEcCCCcEEEEEEeccCCC-ChHHHHHHHHHHH-HHHhCCCCCcchhhhhhhcCCeEEEEEecCCC
Q psy758 8 GKLGEGSYGVVFKCRNRDTGQVVAIKKFLESEE-DPLIRKIALREIR-LLKSLKHPNLVNLLEVFRRKKKLHLVFEFCDH 85 (292)
Q Consensus 8 ~~l~~g~~~~v~~~~~~~~~~~v~iK~~~~~~~-~~~~~~~~~~e~~-~~~~l~~~~i~~~~~~~~~~~~~~iv~e~~~~ 85 (292)
+.||+|++|.||+|.+..+|+.||+|++..... .......+..|.. +++.++||||+++++.+.+.+..|+||||+++
T Consensus 1 ~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~~~~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~ 80 (323)
T cd05575 1 KVIGKGSFGKVLLAKHKADGKFYAVKVLQKKAILKKKEQKHIMAERNVLLKNVKHPFLVGLHYSFQTADKLYFVLDYVNG 80 (323)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhhCCCCCCCCeeEEEEeCCEEEEEEcCCCC
Confidence 469999999999999999999999999875432 2222334444544 56789999999999999999999999999999
Q ss_pred ccHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEEccCCcEEEeecCchhhhhccc-----ccccc
Q psy758 86 TVLNELENHPHGLPWDLIKQITWQVLRGVSYCHRHACIHRDIKPENILLTANGVVKLCDFGFARLIRDLI-----PRHLH 160 (292)
Q Consensus 86 ~~L~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~givH~dl~p~Nilv~~~~~~kl~dfg~~~~~~~~~-----~~~~~ 160 (292)
++|..++.....+++..+..++.||+.||.|||++|++||||||+||+++.++.++|+|||++....... ..++.
T Consensus 81 g~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~givH~dikp~NIll~~~~~~kl~Dfg~~~~~~~~~~~~~~~~gt~ 160 (323)
T cd05575 81 GELFFHLQRERSFPEPRARFYAAEIASALGYLHSLNIIYRDLKPENILLDSQGHVVLTDFGLCKEGIEHSKTTSTFCGTP 160 (323)
T ss_pred CCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeEeCCCCHHHeEECCCCcEEEeccCCCcccccCCCccccccCCh
Confidence 9999998887789999999999999999999999999999999999999999999999999986532211 12344
Q ss_pred ccccccccccCC-----CCCCCcccceeeecCCCCCCchHHHHHHHhhcccCCCCCCChhhhhhccCcCCCCCCCCCccc
Q psy758 161 IFQTNEYFKGVS-----LPHAENVVPLEIKIGKPAATNIYLIDFLKRCLDKDPLRRWSCDQLLRHPYFNGYYFEVPDEMQ 235 (292)
Q Consensus 161 ~~~~~~~~~~~~-----~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 235 (292)
.|.+||...+.. ..|+.|+..+++.+|..++.......+....+. .....+...+..
T Consensus 161 ~y~aPE~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~i~~------------------~~~~~~~~~~~~ 222 (323)
T cd05575 161 EYLAPEVLRKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRDTAEMYDNILN------------------KPLRLKPNISVS 222 (323)
T ss_pred hhcChhhhcCCCCCccccccccchhhhhhhcCCCCCCCCCHHHHHHHHHc------------------CCCCCCCCCCHH
Confidence 567777665543 345555555556666555443333333322221 112223345778
Q ss_pred hHHHHhcccCcCCCCCCCh----hhhhhCCcccceecc
Q psy758 236 YEEITQRCLDKDPLRRWSC----DQLLRHPYFNGYYFE 269 (292)
Q Consensus 236 l~~li~~~l~~dP~~Rpt~----~~il~h~w~~~~~~~ 269 (292)
+.++|.+||+.||.+||++ .++++||||.+..|+
T Consensus 223 ~~~li~~~l~~~p~~R~~~~~~~~~il~~~~~~~~~~~ 260 (323)
T cd05575 223 ARHLLEGLLQKDRTKRLGAKDDFLEIKNHVFFSSINWD 260 (323)
T ss_pred HHHHHHHHhhcCHHhCCCCCCCHHHHHcCCCcCCCCHH
Confidence 9999999999999999998 599999999987664
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell pr |
| >cd05618 STKc_aPKC_iota Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.1e-41 Score=278.50 Aligned_cols=253 Identities=22% Similarity=0.311 Sum_probs=190.0
Q ss_pred eeecccCceEEEEEEEcCCCcEEEEEEeccCC-CChHHHHHHHHHHHHHHhC-CCCCcchhhhhhhcCCeEEEEEecCCC
Q psy758 8 GKLGEGSYGVVFKCRNRDTGQVVAIKKFLESE-EDPLIRKIALREIRLLKSL-KHPNLVNLLEVFRRKKKLHLVFEFCDH 85 (292)
Q Consensus 8 ~~l~~g~~~~v~~~~~~~~~~~v~iK~~~~~~-~~~~~~~~~~~e~~~~~~l-~~~~i~~~~~~~~~~~~~~iv~e~~~~ 85 (292)
+.||+|+||.||+|.+..+++.||+|++.... ......+.+..|..++..+ +||||+++++++.+++.+++||||+++
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~~~~~~~~~~~~~lv~E~~~~ 80 (329)
T cd05618 1 RVIGRGSYAKVLLVRLKKTERIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRLFFVIEYVNG 80 (329)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEhhHhcchhHHHHHHHHHHHHHhcCCCCcCCceeeEEEeCCEEEEEEeCCCC
Confidence 47999999999999999999999999997653 2334456677888888777 799999999999999999999999999
Q ss_pred ccHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEEccCCcEEEeecCchhhhhccc-----ccccc
Q psy758 86 TVLNELENHPHGLPWDLIKQITWQVLRGVSYCHRHACIHRDIKPENILLTANGVVKLCDFGFARLIRDLI-----PRHLH 160 (292)
Q Consensus 86 ~~L~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~givH~dl~p~Nilv~~~~~~kl~dfg~~~~~~~~~-----~~~~~ 160 (292)
++|..++...+.+++..++.++.||+.||.|||++|++||||||+||+++.++.++|+|||++....... ..++.
T Consensus 81 ~~L~~~~~~~~~l~~~~~~~i~~qi~~~l~~lH~~~ivH~Dikp~Nili~~~~~~kL~DfG~~~~~~~~~~~~~~~~gt~ 160 (329)
T cd05618 81 GDLMFHMQRQRKLPEEHARFYSAEISLALNYLHERGIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGDTTSTFCGTP 160 (329)
T ss_pred CCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeeeCCCCHHHEEECCCCCEEEeeCCccccccCCCCccccccCCc
Confidence 9999988877789999999999999999999999999999999999999999999999999986532111 12344
Q ss_pred ccccccccccCCC-----CCCCcccceeeecCCCCCCchHHHHHHHhhcccCCCCCCChhhhhhccCcCCCCCCCCCccc
Q psy758 161 IFQTNEYFKGVSL-----PHAENVVPLEIKIGKPAATNIYLIDFLKRCLDKDPLRRWSCDQLLRHPYFNGYYFEVPDEMQ 235 (292)
Q Consensus 161 ~~~~~~~~~~~~~-----~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 235 (292)
.|.+||...+... .|+.|+..+++.+|..++.... ....+ .......+.....-.....+...+..
T Consensus 161 ~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~~--------~~~~~-~~~~~~~~~~~i~~~~~~~p~~~~~~ 231 (329)
T cd05618 161 NYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVG--------SSDNP-DQNTEDYLFQVILEKQIRIPRSLSVK 231 (329)
T ss_pred cccCHHHHcCCCCCCccceecccHHHHHHhhCCCCCccCC--------CcCCc-ccccHHHHHHHHhcCCCCCCCCCCHH
Confidence 5777777655433 3455555555555554431000 00000 00011111111111223445566788
Q ss_pred hHHHHhcccCcCCCCCCCh------hhhhhCCcccceecc
Q psy758 236 YEEITQRCLDKDPLRRWSC------DQLLRHPYFNGYYFE 269 (292)
Q Consensus 236 l~~li~~~l~~dP~~Rpt~------~~il~h~w~~~~~~~ 269 (292)
+.++|.+||+.||.+|||+ +++++||||.+..|+
T Consensus 232 ~~~ll~~~L~~dP~~R~~~~~~~~~~~i~~hp~f~~~~~~ 271 (329)
T cd05618 232 AASVLKSFLNKDPKERLGCHPQTGFADIQGHPFFRNVDWD 271 (329)
T ss_pred HHHHHHHHhcCCHHHcCCCCCCCCHHHHhcCCCCCCCCHH
Confidence 9999999999999999985 799999999998775
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target o |
| >cd05584 STKc_p70S6K Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.8e-41 Score=277.25 Aligned_cols=244 Identities=23% Similarity=0.294 Sum_probs=188.0
Q ss_pred eeeecccCceEEEEEEEc---CCCcEEEEEEeccCCC--ChHHHHHHHHHHHHHHhCCCCCcchhhhhhhcCCeEEEEEe
Q psy758 7 IGKLGEGSYGVVFKCRNR---DTGQVVAIKKFLESEE--DPLIRKIALREIRLLKSLKHPNLVNLLEVFRRKKKLHLVFE 81 (292)
Q Consensus 7 ~~~l~~g~~~~v~~~~~~---~~~~~v~iK~~~~~~~--~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~iv~e 81 (292)
++.||+|+||.||+|.+. .+++.||+|++..... .......+..|+.+++.++||||+++++++.+++..|+|||
T Consensus 1 ~~~lg~G~~g~V~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~~~~~~~~~~~~~lv~e 80 (323)
T cd05584 1 LKVLGKGGYGKVFQVRKVTGADTGKIFAMKVLKKATIVRNQKDTAHTKAERNILEAVKHPFIVDLIYAFQTGGKLYLILE 80 (323)
T ss_pred CceeeecCCeEEEEEEEcccCCCCCEEEEEEEEHHHHHhhhhhHHHHHHHHHHHHhCCCCchhceeeEEecCCeEEEEEe
Confidence 368999999999999864 4688999999875431 22334556789999999999999999999999999999999
Q ss_pred cCCCccHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEEccCCcEEEeecCchhhhhccc-----c
Q psy758 82 FCDHTVLNELENHPHGLPWDLIKQITWQVLRGVSYCHRHACIHRDIKPENILLTANGVVKLCDFGFARLIRDLI-----P 156 (292)
Q Consensus 82 ~~~~~~L~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~givH~dl~p~Nilv~~~~~~kl~dfg~~~~~~~~~-----~ 156 (292)
|+++++|..++...+.+++..+..++.||+.||.|||++|++|+||||+||+++.++.++|+|||++....... .
T Consensus 81 ~~~~~~L~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~ 160 (323)
T cd05584 81 YLSGGELFMHLEREGIFMEDTACFYLSEISLALEHLHQQGIIYRDLKPENILLDAQGHVKLTDFGLCKESIHEGTVTHTF 160 (323)
T ss_pred CCCCchHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEECCCCCEEEeeCcCCeecccCCCccccc
Confidence 99999999999887789999999999999999999999999999999999999999999999999986432211 1
Q ss_pred ccccccccccccccCC-----CCCCCcccceeeecCCCCCCchHHHHHHHhhcccCCCCCCChhhhhhccCcCCCCCCCC
Q psy758 157 RHLHIFQTNEYFKGVS-----LPHAENVVPLEIKIGKPAATNIYLIDFLKRCLDKDPLRRWSCDQLLRHPYFNGYYFEVP 231 (292)
Q Consensus 157 ~~~~~~~~~~~~~~~~-----~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~ 231 (292)
.++..|.+||...+.. ..|+.|+..+++.+|..++........+.... ......+..
T Consensus 161 ~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~pf~~~~~~~~~~~~~------------------~~~~~~~~~ 222 (323)
T cd05584 161 CGTIEYMAPEILMRSGHGKAVDWWSLGALMYDMLTGAPPFTAENRKKTIDKIL------------------KGKLNLPPY 222 (323)
T ss_pred CCCccccChhhccCCCCCCcceecccHHHHHHHhcCCCCCCCCCHHHHHHHHH------------------cCCCCCCCC
Confidence 2334567777665433 33455555555555555443222222222211 112233444
Q ss_pred CccchHHHHhcccCcCCCCCC-----ChhhhhhCCcccceec
Q psy758 232 DEMQYEEITQRCLDKDPLRRW-----SCDQLLRHPYFNGYYF 268 (292)
Q Consensus 232 ~~~~l~~li~~~l~~dP~~Rp-----t~~~il~h~w~~~~~~ 268 (292)
.+..+.++|.+||+.||++|| +++++++||||....|
T Consensus 223 ~~~~~~~li~~~l~~~p~~R~~~~~~~~~~l~~h~~~~~~~~ 264 (323)
T cd05584 223 LTPEARDLLKKLLKRNPSSRLGAGPGDAAEVQSHPFFRHVNW 264 (323)
T ss_pred CCHHHHHHHHHHcccCHhHcCCCCCCCHHHHhcCCCcCCCCH
Confidence 577899999999999999999 8999999999988655
|
Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the in |
| >cd05625 STKc_LATS1 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-41 Score=285.25 Aligned_cols=249 Identities=22% Similarity=0.267 Sum_probs=189.3
Q ss_pred cccceeeeecccCceEEEEEEEcCCCcEEEEEEeccCC-CChHHHHHHHHHHHHHHhCCCCCcchhhhhhhcCCeEEEEE
Q psy758 2 ERYEKIGKLGEGSYGVVFKCRNRDTGQVVAIKKFLESE-EDPLIRKIALREIRLLKSLKHPNLVNLLEVFRRKKKLHLVF 80 (292)
Q Consensus 2 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~v~iK~~~~~~-~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~iv~ 80 (292)
++|++++.||+|+||.||+|++..+++.||+|++.... ........+.+|+.+++.++||||+++++.+.+++.+|+||
T Consensus 1 ~~f~~~~~LG~G~~g~Vy~a~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~il~~~~h~~iv~~~~~~~~~~~~~lv~ 80 (382)
T cd05625 1 SMFVKIKTLGIGAFGEVCLARKVDTKALYAMKTLRKKDVLLRNQVAHVKAERDILAEADNEWVVRLYYSFQDKDNLYFVM 80 (382)
T ss_pred CCcEEEEEEEeCCCEEEEEEEECCCCCEEEEEEEeHHHhhhHHHHHHHHHHHHHHHhCCCCcCCeEEEEEEeCCEEEEEE
Confidence 47999999999999999999999999999999987543 23344567889999999999999999999999999999999
Q ss_pred ecCCCccHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEEccCCcEEEeecCchhhhhcc------
Q psy758 81 EFCDHTVLNELENHPHGLPWDLIKQITWQVLRGVSYCHRHACIHRDIKPENILLTANGVVKLCDFGFARLIRDL------ 154 (292)
Q Consensus 81 e~~~~~~L~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~givH~dl~p~Nilv~~~~~~kl~dfg~~~~~~~~------ 154 (292)
||+++|+|..++...+.+++..++.++.||+.||+|||++||+||||||+|||++.++.++|+|||++..+...
T Consensus 81 E~~~gg~L~~~l~~~~~~~e~~~~~~~~qi~~al~~lH~~~ivHrDlKp~NILl~~~g~~kL~DFGla~~~~~~~~~~~~ 160 (382)
T cd05625 81 DYIPGGDMMSLLIRMGIFPEDLARFYIAELTCAVESVHKMGFIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTHDSKYY 160 (382)
T ss_pred eCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEECCCCCEEEeECCCCcccccccccccc
Confidence 99999999999887778999999999999999999999999999999999999999999999999987532100
Q ss_pred ----------------------------------------------ccccccccccccccccCCC-----CCCCccccee
Q psy758 155 ----------------------------------------------IPRHLHIFQTNEYFKGVSL-----PHAENVVPLE 183 (292)
Q Consensus 155 ----------------------------------------------~~~~~~~~~~~~~~~~~~~-----~~~~~~~~~~ 183 (292)
...++..|.+||...+... .|+.|+..++
T Consensus 161 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~DiwSlGvil~e 240 (382)
T cd05625 161 QSGDHVRQDSMDFSNEWGDPANCRCGDRLKPLERRAARQHQRCLAHSLVGTPNYIAPEVLLRTGYTQLCDWWSVGVILYE 240 (382)
T ss_pred ccccccccccccccccccccccccccccccchhhhhccccccccccccccCcccCCHHHhcCCCCCCeeeEEechHHHHH
Confidence 0012234556665544332 3444444444
Q ss_pred eecCCCCCCchHHHHHHHhhcccCCCCCCChhhhhhcc--CcC--CCCCCCCCccchHHHHhcccCcCCCCCCC---hhh
Q psy758 184 IKIGKPAATNIYLIDFLKRCLDKDPLRRWSCDQLLRHP--YFN--GYYFEVPDEMQYEEITQRCLDKDPLRRWS---CDQ 256 (292)
Q Consensus 184 ~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~--~~~--~~~~~~~~~~~l~~li~~~l~~dP~~Rpt---~~~ 256 (292)
+.+|.++ +...+..+..... +.. ..+.....++.+.++|.+|+ .||.+|++ +++
T Consensus 241 lltG~~P------------------f~~~~~~~~~~~i~~~~~~~~~p~~~~~s~~~~~li~~l~-~~p~~R~~~~~~~e 301 (382)
T cd05625 241 MLVGQPP------------------FLAQTPLETQMKVINWQTSLHIPPQAKLSPEASDLIIKLC-RGPEDRLGKNGADE 301 (382)
T ss_pred HHhCCCC------------------CCCCCHHHHHHHHHccCCCcCCCCcccCCHHHHHHHHHHc-cCHhHcCCCCCHHH
Confidence 4444444 3332222211110 001 11112345778999999976 59999997 999
Q ss_pred hhhCCcccceecc
Q psy758 257 LLRHPYFNGYYFE 269 (292)
Q Consensus 257 il~h~w~~~~~~~ 269 (292)
+++||||.+..|.
T Consensus 302 i~~hp~f~~~~~~ 314 (382)
T cd05625 302 IKAHPFFKTIDFS 314 (382)
T ss_pred HhcCCCcCCcChH
Confidence 9999999987654
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. Promoter methylation, loss of heterozygosity, and missense mutations targeting the LATS1 gene have also been found in human sarcomas and ovarian cancers. In addition, decreased expression of LATS1 is associated with an aggressive phenotype an |
| >cd05592 STKc_nPKC_theta_delta Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.3e-41 Score=276.55 Aligned_cols=249 Identities=21% Similarity=0.313 Sum_probs=184.9
Q ss_pred eeecccCceEEEEEEEcCCCcEEEEEEeccCCC-ChHHHHHHHHHHHHHHhC-CCCCcchhhhhhhcCCeEEEEEecCCC
Q psy758 8 GKLGEGSYGVVFKCRNRDTGQVVAIKKFLESEE-DPLIRKIALREIRLLKSL-KHPNLVNLLEVFRRKKKLHLVFEFCDH 85 (292)
Q Consensus 8 ~~l~~g~~~~v~~~~~~~~~~~v~iK~~~~~~~-~~~~~~~~~~e~~~~~~l-~~~~i~~~~~~~~~~~~~~iv~e~~~~ 85 (292)
+.||+|+||.||+|.+..+++.||+|++..... .....+....|..++..+ +||||+++++++..++.+|+||||++|
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~hp~i~~~~~~~~~~~~~~lv~e~~~g 80 (316)
T cd05592 1 KVLGKGSFGKVMLAELKGTNEFFAIKALKKDVVLEDDDVECTMVERRVLALAWEHPFLTHLFCTFQTKEHLFFVMEYLNG 80 (316)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhccCCCCccceeeEEEcCCEEEEEEcCCCC
Confidence 469999999999999999999999999875431 222334455666666654 799999999999999999999999999
Q ss_pred ccHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEEccCCcEEEeecCchhhhhcccc-----cccc
Q psy758 86 TVLNELENHPHGLPWDLIKQITWQVLRGVSYCHRHACIHRDIKPENILLTANGVVKLCDFGFARLIRDLIP-----RHLH 160 (292)
Q Consensus 86 ~~L~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~givH~dl~p~Nilv~~~~~~kl~dfg~~~~~~~~~~-----~~~~ 160 (292)
++|..++...+.+++..++.++.||+.||.|||++||+||||||+||+++.++.++|+|||++........ .++.
T Consensus 81 g~L~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~ivH~dlkp~Nill~~~~~~kL~Dfg~a~~~~~~~~~~~~~~gt~ 160 (316)
T cd05592 81 GDLMFHIQSSGRFDEARARFYAAEIICGLQFLHKKGIIYRDLKLDNVLLDKDGHIKIADFGMCKENMNGEGKASTFCGTP 160 (316)
T ss_pred CcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCEEeCCCCHHHeEECCCCCEEEccCcCCeECCCCCCccccccCCc
Confidence 99999988777899999999999999999999999999999999999999999999999999875422111 1234
Q ss_pred ccccccccccCCCCCCCcccceeeecCCCCCCchHHHHHHHhhcccCCCCCCChhhhhhccCcCCCCCCCCCccchHHHH
Q psy758 161 IFQTNEYFKGVSLPHAENVVPLEIKIGKPAATNIYLIDFLKRCLDKDPLRRWSCDQLLRHPYFNGYYFEVPDEMQYEEIT 240 (292)
Q Consensus 161 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li 240 (292)
.|.+||...+.......+ .++.+..++..+.+..|+...+..++...........+...+..+.++|
T Consensus 161 ~y~aPE~~~~~~~~~~~D-------------vwslG~il~ell~G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~ll 227 (316)
T cd05592 161 DYIAPEILKGQKYNESVD-------------WWSFGVLLYEMLIGQSPFHGEDEDELFDSILNDRPHFPRWISKEAKDCL 227 (316)
T ss_pred cccCHHHHcCCCCCCccc-------------chhHHHHHHHHHhCCCCCCCCCHHHHHHHHHcCCCCCCCCCCHHHHHHH
Confidence 466666554433222222 2333333344444444544444333332221112223444577899999
Q ss_pred hcccCcCCCCCCChh-hhhhCCcccceecc
Q psy758 241 QRCLDKDPLRRWSCD-QLLRHPYFNGYYFE 269 (292)
Q Consensus 241 ~~~l~~dP~~Rpt~~-~il~h~w~~~~~~~ 269 (292)
.+||+.||.+||++. ++++||||....|+
T Consensus 228 ~~~l~~~P~~R~~~~~~l~~h~~~~~~~~~ 257 (316)
T cd05592 228 SKLFERDPTKRLGVDGDIRQHPFFRGIDWE 257 (316)
T ss_pred HHHccCCHHHcCCChHHHHcCcccCCCCHH
Confidence 999999999999864 88899999987765
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an imp |
| >cd07839 STKc_CDK5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-41 Score=274.12 Aligned_cols=261 Identities=32% Similarity=0.528 Sum_probs=189.9
Q ss_pred ccceeeeecccCceEEEEEEEcCCCcEEEEEEeccCCCChHHHHHHHHHHHHHHhCCCCCcchhhhhhhcCCeEEEEEec
Q psy758 3 RYEKIGKLGEGSYGVVFKCRNRDTGQVVAIKKFLESEEDPLIRKIALREIRLLKSLKHPNLVNLLEVFRRKKKLHLVFEF 82 (292)
Q Consensus 3 ~y~~~~~l~~g~~~~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~iv~e~ 82 (292)
+|++.+.||+|++|.||+|.+..+|+.|++|.+............+.+|+.+++.++||||+++++++.+.+..++++||
T Consensus 1 ~y~~~~~l~~g~~~~vy~~~~~~~g~~~~~k~~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 80 (284)
T cd07839 1 KYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLYDVLHSDKKLTLVFEY 80 (284)
T ss_pred CceeEEEecccCCeEEEEEEECCCCcEEEEEEeecccccccCccchhHHHHHHHhcCCCCeeeHHHHhccCCceEEEEec
Confidence 69999999999999999999999999999999976544444445677899999999999999999999999999999999
Q ss_pred CCCccHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEEccCCcEEEeecCchhhhhccc-----cc
Q psy758 83 CDHTVLNELENHPHGLPWDLIKQITWQVLRGVSYCHRHACIHRDIKPENILLTANGVVKLCDFGFARLIRDLI-----PR 157 (292)
Q Consensus 83 ~~~~~L~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~givH~dl~p~Nilv~~~~~~kl~dfg~~~~~~~~~-----~~ 157 (292)
++++.+..+......+++..++.++.||++||.|||++|++|+||+|+||+++.++.++|+|||++....... ..
T Consensus 81 ~~~~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~i~H~dl~~~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~ 160 (284)
T cd07839 81 CDQDLKKYFDSCNGDIDPEIVKSFMFQLLKGLAFCHSHNVLHRDLKPQNLLINKNGELKLADFGLARAFGIPVRCYSAEV 160 (284)
T ss_pred CCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCEecCCCCHHHEEEcCCCcEEECccchhhccCCCCCCcCCCc
Confidence 9876555454445679999999999999999999999999999999999999999999999999987654321 12
Q ss_pred cccccccccccccCC------CCCCCcccceeeecCCCCC-CchHHHH---HHHhhcccCCCCC-CChhhhhhccCcCCC
Q psy758 158 HLHIFQTNEYFKGVS------LPHAENVVPLEIKIGKPAA-TNIYLID---FLKRCLDKDPLRR-WSCDQLLRHPYFNGY 226 (292)
Q Consensus 158 ~~~~~~~~~~~~~~~------~~~~~~~~~~~~~~~~~~~-~~~~~~~---~~~~~~~~~p~~~-~~~~~~~~~~~~~~~ 226 (292)
....|.+||...+.. ..|+.|+..+++.++..+. ....... .+...+...+... +...+......+...
T Consensus 161 ~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 240 (284)
T cd07839 161 VTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEESWPGVSKLPDYKPYPMY 240 (284)
T ss_pred cccCCcChHHHhCCcccCcHHHHHHHHHHHHHHHhcCCCCcCCCCHHHHHHHHHHHhCCCChHHhHHhhhcccccccCCC
Confidence 234577888765432 3455666666666654432 1111111 1111111111111 111111111111111
Q ss_pred C-------CCCCCccchHHHHhcccCcCCCCCCChhhhhhCCcc
Q psy758 227 Y-------FEVPDEMQYEEITQRCLDKDPLRRWSCDQLLRHPYF 263 (292)
Q Consensus 227 ~-------~~~~~~~~l~~li~~~l~~dP~~Rpt~~~il~h~w~ 263 (292)
. .....+..++++|.+||+.||.+|||++++++||||
T Consensus 241 ~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~~il~h~~f 284 (284)
T cd07839 241 PATTSLVNVVPKLNSTGRDLLQNLLVCNPVQRISAEEALQHPYF 284 (284)
T ss_pred CCcchhhhhcccCCHHHHHHHHHHhcCChhhcCCHHHHhcCCCC
Confidence 1 011246788999999999999999999999999998
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also |
| >cd07853 STKc_NLK Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.1e-41 Score=282.41 Aligned_cols=264 Identities=27% Similarity=0.383 Sum_probs=196.6
Q ss_pred ccceeeeecccCceEEEEEEEcCCCcEEEEEEeccCCCChHHHHHHHHHHHHHHhCCCCCcchhhhhhhcCC-----eEE
Q psy758 3 RYEKIGKLGEGSYGVVFKCRNRDTGQVVAIKKFLESEEDPLIRKIALREIRLLKSLKHPNLVNLLEVFRRKK-----KLH 77 (292)
Q Consensus 3 ~y~~~~~l~~g~~~~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~-----~~~ 77 (292)
+|++.+.||+|+||.||+|.+..+++.||+|.+..........+.+.+|+.+++.++||||+++++++...+ ..|
T Consensus 1 ~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~ 80 (372)
T cd07853 1 DVEPDRPIGYGAFGVVWSVTDPRDGKRVALKKMPNVFQNLVSCKRVFRELKMLCFFKHDNVLSALDILQPPHIDPFEEIY 80 (372)
T ss_pred CCcccceeeeCCCEEEEEEEECCCCCEEEEEeccccccchHHHHHHHHHHHHHHhCCCCCcCCHhheecCCCccccceEE
Confidence 478999999999999999999999999999998765444445667889999999999999999999998766 789
Q ss_pred EEEecCCCccHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEEccCCcEEEeecCchhhhhccc--
Q psy758 78 LVFEFCDHTVLNELENHPHGLPWDLIKQITWQVLRGVSYCHRHACIHRDIKPENILLTANGVVKLCDFGFARLIRDLI-- 155 (292)
Q Consensus 78 iv~e~~~~~~L~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~givH~dl~p~Nilv~~~~~~kl~dfg~~~~~~~~~-- 155 (292)
+|+||+.+ .|...+.....+++..++.++.||+.||.|||++|++||||||+||+++.++.++|+|||++.......
T Consensus 81 lv~e~~~~-~l~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~ivH~dlkp~Nili~~~~~~kL~Dfg~a~~~~~~~~~ 159 (372)
T cd07853 81 VVTELMQS-DLHKIIVSPQPLSSDHVKVFLYQILRGLKYLHSAGILHRDIKPGNLLVNSNCVLKICDFGLARVEEPDESK 159 (372)
T ss_pred EEeecccc-CHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCChHHEEECCCCCEEeccccceeecccCccc
Confidence 99999985 566666666689999999999999999999999999999999999999999999999999987543211
Q ss_pred ----cccccccccccccccC------CCCCCCcccceeeecCCCCCCchHHHHHH---HhhcccCCCCCCC-----h-hh
Q psy758 156 ----PRHLHIFQTNEYFKGV------SLPHAENVVPLEIKIGKPAATNIYLIDFL---KRCLDKDPLRRWS-----C-DQ 216 (292)
Q Consensus 156 ----~~~~~~~~~~~~~~~~------~~~~~~~~~~~~~~~~~~~~~~~~~~~~~---~~~~~~~p~~~~~-----~-~~ 216 (292)
...+..|.+||...+. ...|+.|+..+++.+|..++........+ ...++..+..... . ..
T Consensus 160 ~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~~~~~ 239 (372)
T cd07853 160 HMTQEVVTQYYRAPEILMGSRHYTSAVDIWSVGCIFAELLGRRILFQAQSPIQQLDLITDLLGTPSLEAMRSACEGARAH 239 (372)
T ss_pred cCCCCCcCCCcCCHHHHcCCCCCCcHHHHHhHHHHHHHHHcCCCCCCCCCHHHHHHHHHHHcCCCCHHHHHHhhHHHHHH
Confidence 1223457788876553 24577777777777887765443332222 2222221110000 0 00
Q ss_pred hhhccCcC-----CCCCCCCCccchHHHHhcccCcCCCCCCChhhhhhCCccccee
Q psy758 217 LLRHPYFN-----GYYFEVPDEMQYEEITQRCLDKDPLRRWSCDQLLRHPYFNGYY 267 (292)
Q Consensus 217 ~~~~~~~~-----~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~~il~h~w~~~~~ 267 (292)
+...+... ........+..+.+||.+||+.||.+|||+.++++||||.+..
T Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R~t~~e~l~hp~~~~~~ 295 (372)
T cd07853 240 ILRGPHKPPSLPVLYTLSSQATHEAVHLLCRMLVFDPDKRISAADALAHPYLDEGR 295 (372)
T ss_pred HHhCCCCCCchHHhcccCCCCCHHHHHHHHHhCCCChhhCcCHHHHhcCHhhCCCc
Confidence 00000000 0012223467889999999999999999999999999999854
|
Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription |
| >cd05620 STKc_nPKC_delta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta | Back alignment and domain information |
|---|
Probab=100.00 E-value=6e-41 Score=276.65 Aligned_cols=249 Identities=19% Similarity=0.274 Sum_probs=185.9
Q ss_pred eeecccCceEEEEEEEcCCCcEEEEEEeccCCC-ChHHHHHHHHHHHHHHhC-CCCCcchhhhhhhcCCeEEEEEecCCC
Q psy758 8 GKLGEGSYGVVFKCRNRDTGQVVAIKKFLESEE-DPLIRKIALREIRLLKSL-KHPNLVNLLEVFRRKKKLHLVFEFCDH 85 (292)
Q Consensus 8 ~~l~~g~~~~v~~~~~~~~~~~v~iK~~~~~~~-~~~~~~~~~~e~~~~~~l-~~~~i~~~~~~~~~~~~~~iv~e~~~~ 85 (292)
+.||+|+||.||+|.+..+++.||+|.+..... ..........|..++..+ +||+|+++++++.+.+.+|+||||+.+
T Consensus 1 ~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~E~~~~ 80 (316)
T cd05620 1 KVLGKGSFGKVLLAELKGKGEYFAVKALKKDVVLIDDDVECTMVEKRVLALAWENPFLTHLYCTFQTKEHLFFVMEFLNG 80 (316)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhcchHHHHHHHHHHHHhccCCCCccCeeEEEEeCCEEEEEECCCCC
Confidence 469999999999999999999999999875431 122334556677777654 899999999999999999999999999
Q ss_pred ccHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEEccCCcEEEeecCchhhhhcc-----cccccc
Q psy758 86 TVLNELENHPHGLPWDLIKQITWQVLRGVSYCHRHACIHRDIKPENILLTANGVVKLCDFGFARLIRDL-----IPRHLH 160 (292)
Q Consensus 86 ~~L~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~givH~dl~p~Nilv~~~~~~kl~dfg~~~~~~~~-----~~~~~~ 160 (292)
++|..++.....+++..+..++.||+.||+|||++|++||||||+||+++.++.++|+|||++...... ...++.
T Consensus 81 g~L~~~i~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivHrDlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~gt~ 160 (316)
T cd05620 81 GDLMFHIQDKGRFDLYRATFYAAEIVCGLQFLHSKGIIYRDLKLDNVMLDRDGHIKIADFGMCKENVFGDNRASTFCGTP 160 (316)
T ss_pred CcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHeEECCCCCEEeCccCCCeecccCCCceeccCCCc
Confidence 999998887778999999999999999999999999999999999999999999999999988643211 112244
Q ss_pred ccccccccccCCCCCCCcccceeeecCCCCCCchHHHHHHHhhcccCCCCCCChhhhhhccCcCCCCCCCCCccchHHHH
Q psy758 161 IFQTNEYFKGVSLPHAENVVPLEIKIGKPAATNIYLIDFLKRCLDKDPLRRWSCDQLLRHPYFNGYYFEVPDEMQYEEIT 240 (292)
Q Consensus 161 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li 240 (292)
.|.+||...+.......++ ++.+..++..+.+..|+...+..++...........+...+..++++|
T Consensus 161 ~y~aPE~~~~~~~~~~~Di-------------wslGvil~el~~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li 227 (316)
T cd05620 161 DYIAPEILQGLKYTFSVDW-------------WSFGVLLYEMLIGQSPFHGDDEDELFESIRVDTPHYPRWITKESKDIL 227 (316)
T ss_pred CccCHHHHcCCCCCcccch-------------hhhHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCCCCCCHHHHHHH
Confidence 5667776654433222222 222333333444444444433333332222222223344577899999
Q ss_pred hcccCcCCCCCCCh-hhhhhCCcccceecc
Q psy758 241 QRCLDKDPLRRWSC-DQLLRHPYFNGYYFE 269 (292)
Q Consensus 241 ~~~l~~dP~~Rpt~-~~il~h~w~~~~~~~ 269 (292)
.+||+.||++||++ +++++||||++..|.
T Consensus 228 ~~~l~~dP~~R~~~~~~~~~h~~f~~~~~~ 257 (316)
T cd05620 228 EKLFERDPTRRLGVVGNIRGHPFFKTINWT 257 (316)
T ss_pred HHHccCCHHHcCCChHHHHcCCCcCCCCHH
Confidence 99999999999998 589999999987654
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. I |
| >KOG0594|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-41 Score=265.87 Aligned_cols=265 Identities=35% Similarity=0.498 Sum_probs=195.7
Q ss_pred cccceeeeecccCceEEEEEEEcCCCcEEEEEEeccCCCChHHHHHHHHHHHHHHhCCCCC-cchhhhhhhcCC------
Q psy758 2 ERYEKIGKLGEGSYGVVFKCRNRDTGQVVAIKKFLESEEDPLIRKIALREIRLLKSLKHPN-LVNLLEVFRRKK------ 74 (292)
Q Consensus 2 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~e~~~~~~l~~~~-i~~~~~~~~~~~------ 74 (292)
..|+.++.||+|+||.||.|+...+|+.||+|.+......+-.-....+|+.+++.++|+| |+.+++++.+.+
T Consensus 11 ~~~~~~eklGeGtyg~Vykar~~~~g~~VALKkirl~~~~EG~P~taiREisllk~L~~~~~iv~L~dv~~~~~~~~~~~ 90 (323)
T KOG0594|consen 11 FDYEKVEKLGEGTYGVVYKARSKRTGKFVALKKIRLEFEEEGVPSTAIREISLLKRLSHANHIVRLHDVIHTSNNHRGIG 90 (323)
T ss_pred HHHHHHHHhCCCCceEEEEEEEecCCCEEEEEEEeccccccCCCchhhHHHHHHHHhCCCcceEEEEeeeeecccccccc
Confidence 4588889999999999999999999999999999766543333355678999999999999 999999998766
Q ss_pred eEEEEEecCCCccHHHHhcCC----CCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEEccCCcEEEeecCchhh
Q psy758 75 KLHLVFEFCDHTVLNELENHP----HGLPWDLIKQITWQVLRGVSYCHRHACIHRDIKPENILLTANGVVKLCDFGFARL 150 (292)
Q Consensus 75 ~~~iv~e~~~~~~L~~~~~~~----~~~~~~~~~~i~~qi~~aL~~LH~~givH~dl~p~Nilv~~~~~~kl~dfg~~~~ 150 (292)
..++|+||.... |..++... ..++...++.++.||+.||+|||++||+||||||.||+|+++|.+||+|||+++.
T Consensus 91 ~l~lvfe~~d~D-L~~ymd~~~~~~~g~~~~~ik~~m~Qll~gl~~~H~~~IlHRDLKPQNlLi~~~G~lKlaDFGlAra 169 (323)
T KOG0594|consen 91 KLYLVFEFLDRD-LKKYMDSLPKKPQGLPPRLIKSFMRQLLRGLAFLHSHGILHRDLKPQNLLISSSGVLKLADFGLARA 169 (323)
T ss_pred eEEEEEEeeccc-HHHHHHhccccccCCCHHHHHHHHHHHHHHHHHHHhCCeecccCCcceEEECCCCcEeeeccchHHH
Confidence 899999999864 44444332 2578899999999999999999999999999999999999999999999999987
Q ss_pred hhccc-----cccccccccccccccCCC------CCCCcccceeeecCCCCCCchHHHHHH---HhhcccCCCCC-CChh
Q psy758 151 IRDLI-----PRHLHIFQTNEYFKGVSL------PHAENVVPLEIKIGKPAATNIYLIDFL---KRCLDKDPLRR-WSCD 215 (292)
Q Consensus 151 ~~~~~-----~~~~~~~~~~~~~~~~~~------~~~~~~~~~~~~~~~~~~~~~~~~~~~---~~~~~~~p~~~-~~~~ 215 (292)
..-+. ...+-.|.+||...|... .|+.|++..++..+.+.+.+..-.+.+ -..++....+. +...
T Consensus 170 ~~ip~~~yt~evvTlWYRaPEvLlGs~~Ys~~vDiWs~GcIfaEm~~~~~LFpG~se~~ql~~If~~lGtP~e~~Wp~v~ 249 (323)
T KOG0594|consen 170 FSIPMRTYTPEVVTLWYRAPEVLLGSTSYSTSVDIWSLGCIFAEMFTRRPLFPGDSEIDQLFRIFRLLGTPNEKDWPGVS 249 (323)
T ss_pred hcCCcccccccEEEeeccCHHHhcCCCcCCCCcchHhHHHHHHHHHhCCCCCCCCcHHHHHHHHHHHcCCCCccCCCCcc
Confidence 65211 122345889988887733 355555555666666655443333332 23334333333 3332
Q ss_pred hhhhcc-CcCCCCCCC-------CCccchHHHHhcccCcCCCCCCChhhhhhCCccccee
Q psy758 216 QLLRHP-YFNGYYFEV-------PDEMQYEEITQRCLDKDPLRRWSCDQLLRHPYFNGYY 267 (292)
Q Consensus 216 ~~~~~~-~~~~~~~~~-------~~~~~l~~li~~~l~~dP~~Rpt~~~il~h~w~~~~~ 267 (292)
...... -+.....+. .......+++.+||+++|.+|.||+.+|+||||.+..
T Consensus 250 ~~~~~k~~f~~~~~~~~l~~~~~~~~~~~~dll~~~L~y~p~~R~Sa~~al~h~yf~~~~ 309 (323)
T KOG0594|consen 250 SLPDYKAPFPKWPGPKDLSSILPKLDPDGIELLSKLLQYDPAKRISAKGALTHPYFSELP 309 (323)
T ss_pred ccccccccCcCCCCccchHHhccccCccHHHHHHHHhccCcccCcCHHHHhcChhhcccc
Confidence 222211 111111111 1135788999999999999999999999999999865
|
|
| >KOG0586|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-41 Score=279.58 Aligned_cols=250 Identities=27% Similarity=0.379 Sum_probs=215.8
Q ss_pred cccceeeeecccCceEEEEEEEcCCCcEEEEEEeccCCCChHHHHHHHHHHHHHHhCCCCCcchhhhhhhcCCeEEEEEe
Q psy758 2 ERYEKIGKLGEGSYGVVFKCRNRDTGQVVAIKKFLESEEDPLIRKIALREIRLLKSLKHPNLVNLLEVFRRKKKLHLVFE 81 (292)
Q Consensus 2 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~iv~e 81 (292)
+-|.+.+.||+|.|+.|.+|++..++..||||.+.+...+......+.+|++++..++||||++++.+......+|+|||
T Consensus 56 g~y~i~~tig~g~f~~V~La~~~~t~~~VaiK~idkt~ln~~~~~k~~rev~imk~l~HPnIvkl~~v~~t~~~lylV~e 135 (596)
T KOG0586|consen 56 GLYVIIKTIGKGNFAKVKLARHILTGTEVAIKIIDKTQLNPSKRQKLGREVDIMKSLNHPNIVKLFSVIETEATLYLVME 135 (596)
T ss_pred cceeeeeeeccceeEEEEeeEecCCCceEEEEEehhcccChHHHHHHHHHHHHHHhcCCcceeeeeeeeeecceeEEEEE
Confidence 56899999999999999999999999999999999988877777779999999999999999999999999999999999
Q ss_pred cCCCccHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEEccCCcEEEeecCchhhhhccccc----
Q psy758 82 FCDHTVLNELENHPHGLPWDLIKQITWQVLRGVSYCHRHACIHRDIKPENILLTANGVVKLCDFGFARLIRDLIPR---- 157 (292)
Q Consensus 82 ~~~~~~L~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~givH~dl~p~Nilv~~~~~~kl~dfg~~~~~~~~~~~---- 157 (292)
|+.+|.+.+++.+.++..+..+..++.|++.|++|||+++|+|+|||++||+++.+.++||+|||++..+......
T Consensus 136 ya~~ge~~~yl~~~gr~~e~~ar~~F~q~vsaveYcH~k~ivHrdLk~eNilL~~~mnikIaDfgfS~~~~~~~~lqt~c 215 (596)
T KOG0586|consen 136 YASGGELFDYLVKHGRMKEKEARAKFRQIVSAVEYCHSKNIVHRDLKAENILLDENMNIKIADFGFSTFFDYGLMLQTFC 215 (596)
T ss_pred eccCchhHHHHHhcccchhhhhhhhhHHHHHHHHHHhhcceeccccchhhcccccccceeeeccccceeecccccccccC
Confidence 9999999999999999999999999999999999999999999999999999999999999999999988743332
Q ss_pred cccccccccccccCC------CCCCCcccceeeecCCCCCCchHHHHHHHhhcccCCCCCCChhhhhhccCcCCCCCCCC
Q psy758 158 HLHIFQTNEYFKGVS------LPHAENVVPLEIKIGKPAATNIYLIDFLKRCLDKDPLRRWSCDQLLRHPYFNGYYFEVP 231 (292)
Q Consensus 158 ~~~~~~~~~~~~~~~------~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~ 231 (292)
+...|.+||.+.|.. ..|+.++..|.+..|.. |++.-+..++-.......++.+..
T Consensus 216 gsppyAaPEl~~g~~y~gpe~D~Wslgvvly~LV~GsL------------------PFDG~~lk~Lr~rvl~gk~rIp~~ 277 (596)
T KOG0586|consen 216 GSPPYAAPELFNGKKYDGPEVDIWSLGVVLYALVEGSL------------------PFDGQNLKELRPRVLRGKYRIPFY 277 (596)
T ss_pred CCCCccChHhhcCcccCCcceehhhhhhhheeeeeccc------------------ccCCcccccccchheeeeecccce
Confidence 234566666665543 34555555555555444 445555566666667777888888
Q ss_pred CccchHHHHhcccCcCCCCCCChhhhhhCCcccceecc
Q psy758 232 DEMQYEEITQRCLDKDPLRRWSCDQLLRHPYFNGYYFE 269 (292)
Q Consensus 232 ~~~~l~~li~~~l~~dP~~Rpt~~~il~h~w~~~~~~~ 269 (292)
.+.++++||+++|..+|.+|++.++++.|.|++...-+
T Consensus 278 ms~dce~lLrk~lvl~Pskr~~~dqim~~~W~n~~~~~ 315 (596)
T KOG0586|consen 278 MSCDCEDLLRKFLVLNPSKRGPCDQIMKDRWRNDLLEA 315 (596)
T ss_pred eechhHHHHHHhhccCccccCCHHHhhhhcccchhhhh
Confidence 99999999999999999999999999999999986644
|
|
| >cd07875 STKc_JNK1 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-40 Score=280.81 Aligned_cols=263 Identities=25% Similarity=0.391 Sum_probs=192.5
Q ss_pred CcccceeeeecccCceEEEEEEEcCCCcEEEEEEeccCCCChHHHHHHHHHHHHHHhCCCCCcchhhhhhhcC------C
Q psy758 1 MERYEKIGKLGEGSYGVVFKCRNRDTGQVVAIKKFLESEEDPLIRKIALREIRLLKSLKHPNLVNLLEVFRRK------K 74 (292)
Q Consensus 1 ~~~y~~~~~l~~g~~~~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~------~ 74 (292)
+++|++.+.||+|+||.||.|.+..+++.||+|.+............+.+|+.+++.++||||+++++++... .
T Consensus 23 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~ii~~~~~~~~~~~~~~~~ 102 (364)
T cd07875 23 LKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLLNVFTPQKSLEEFQ 102 (364)
T ss_pred hcceeEEEEeecCCCeEEEEEEECCCCcEEEEEEeCccccCchhHHHHHHHHHHHHhcCCCCccccceeecccccccccC
Confidence 4789999999999999999999999999999999976655555567788999999999999999999987543 3
Q ss_pred eEEEEEecCCCccHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEEccCCcEEEeecCchhhhhcc
Q psy758 75 KLHLVFEFCDHTVLNELENHPHGLPWDLIKQITWQVLRGVSYCHRHACIHRDIKPENILLTANGVVKLCDFGFARLIRDL 154 (292)
Q Consensus 75 ~~~iv~e~~~~~~L~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~givH~dl~p~Nilv~~~~~~kl~dfg~~~~~~~~ 154 (292)
.+|+||||++++.. ..+.. .+++..++.++.|++.||+|||++||+||||||+||+++.++.++|+|||++......
T Consensus 103 ~~~lv~e~~~~~l~-~~~~~--~~~~~~~~~~~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~kL~DfG~a~~~~~~ 179 (364)
T cd07875 103 DVYIVMELMDANLC-QVIQM--ELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTS 179 (364)
T ss_pred eEEEEEeCCCCCHH-HHHHh--cCCHHHHHHHHHHHHHHHHHHhhCCeecCCCCHHHEEECCCCcEEEEeCCCccccCCC
Confidence 58999999987544 44443 4889999999999999999999999999999999999999999999999999765432
Q ss_pred ----ccccccccccccccccCCC-----CCCCcccceeeecCCCCCCchHHHHHHHhhcccCCC----------------
Q psy758 155 ----IPRHLHIFQTNEYFKGVSL-----PHAENVVPLEIKIGKPAATNIYLIDFLKRCLDKDPL---------------- 209 (292)
Q Consensus 155 ----~~~~~~~~~~~~~~~~~~~-----~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~p~---------------- 209 (292)
....+..|.+||...+... .|+.|+..+++.+|..++........+...+..-..
T Consensus 180 ~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 259 (364)
T cd07875 180 FMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKGGVLFPGTDHIDQWNKVIEQLGTPCPEFMKKLQPTVRTY 259 (364)
T ss_pred CcccCCcccCCcCCHHHHhCCCCCchhhHHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHHHHHhhhHHHHHH
Confidence 1233456788887765443 466666667777777665433322222222111000
Q ss_pred --CC-----CChhhhhhccCcCC-CCCCCCCccchHHHHhcccCcCCCCCCChhhhhhCCcccce
Q psy758 210 --RR-----WSCDQLLRHPYFNG-YYFEVPDEMQYEEITQRCLDKDPLRRWSCDQLLRHPYFNGY 266 (292)
Q Consensus 210 --~~-----~~~~~~~~~~~~~~-~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~~il~h~w~~~~ 266 (292)
.+ ...........+.. .......+..+++||.+||+.||.+|||++++|+||||..+
T Consensus 260 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~dP~~R~t~~e~L~hp~~~~~ 324 (364)
T cd07875 260 VENRPKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKRISVDEALQHPYINVW 324 (364)
T ss_pred HhhCCCcCCCChHhhCccccccccccccccccHHHHHHHHHhcCcCcccCCCHHHHhcCcccccc
Confidence 00 01111111000000 00111234578999999999999999999999999999863
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 1 (JNK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn |
| >KOG0589|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-41 Score=277.33 Aligned_cols=250 Identities=25% Similarity=0.374 Sum_probs=203.2
Q ss_pred CcccceeeeecccCceEEEEEEEcCCCcEEEEEEeccCCCChHHHHHHHHHHHHHHhCCCCCcchhhhhhhcCCe-EEEE
Q psy758 1 MERYEKIGKLGEGSYGVVFKCRNRDTGQVVAIKKFLESEEDPLIRKIALREIRLLKSLKHPNLVNLLEVFRRKKK-LHLV 79 (292)
Q Consensus 1 ~~~y~~~~~l~~g~~~~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~-~~iv 79 (292)
+++|..++.+|.|+||.+++++++..++.+|+|.+..........+...+|+.+++++.||||+.+.++|..++. ++||
T Consensus 3 m~~Ye~~~~iG~GafG~a~lvrhk~~~~~~vlK~I~l~~~t~~~r~~A~~E~~lis~~~hP~iv~y~ds~~~~~~~l~Iv 82 (426)
T KOG0589|consen 3 MDNYEVLRQVGRGAFGSALLVRHKSDDKLYVLKKINLEKLTEPERRSAIQEMDLLSKLLHPNIVEYKDSFEEDGQLLCIV 82 (426)
T ss_pred cchhhhhhhcCccccchhhhhhhccCCceEEEEEEeccccCchhhHHHHHHHHHHHhccCCCeeeeccchhcCCceEEEE
Confidence 578999999999999999999999999999999998888777777889999999999999999999999998887 9999
Q ss_pred EecCCCccHHHHhcCCC--CCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEEccCCcEEEeecCchhhhhccc--
Q psy758 80 FEFCDHTVLNELENHPH--GLPWDLIKQITWQVLRGVSYCHRHACIHRDIKPENILLTANGVVKLCDFGFARLIRDLI-- 155 (292)
Q Consensus 80 ~e~~~~~~L~~~~~~~~--~~~~~~~~~i~~qi~~aL~~LH~~givH~dl~p~Nilv~~~~~~kl~dfg~~~~~~~~~-- 155 (292)
|+||+||++.+.+...+ -++++.++.++.|++.|+.|||+++|+|||||+.|||++.++.++|+|||+++...+..
T Consensus 83 m~Y~eGg~l~~~i~~~k~~~f~E~~i~~~~~Q~~~av~ylH~~~iLHRDlK~~Nifltk~~~VkLgDfGlaK~l~~~~~~ 162 (426)
T KOG0589|consen 83 MEYCEGGDLAQLIKEQKGVLFPEERILKWFVQILLAVNYLHENRVLHRDLKCANIFLTKDKKVKLGDFGLAKILNPEDSL 162 (426)
T ss_pred EeecCCCCHHHHHHHHhhccccHHHHHHHHHHHHHHHHHHHhhhhhcccchhhhhhccccCceeecchhhhhhcCCchhh
Confidence 99999999999886543 58999999999999999999999999999999999999999999999999999988765
Q ss_pred ---cccccccccccccccCCCC-----CCCcccceeeecCCCCCCchHHHHHHHhhcccCCCCCCChhhhhhccCcCCCC
Q psy758 156 ---PRHLHIFQTNEYFKGVSLP-----HAENVVPLEIKIGKPAATNIYLIDFLKRCLDKDPLRRWSCDQLLRHPYFNGYY 227 (292)
Q Consensus 156 ---~~~~~~~~~~~~~~~~~~~-----~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~ 227 (292)
..+++.|..||...+..+. |++|+..+++..-.+.+....+..++....... ..+
T Consensus 163 a~tvvGTp~YmcPEil~d~pYn~KSDiWsLGC~~yEm~~lk~aF~a~~m~~Li~ki~~~~-----------------~~P 225 (426)
T KOG0589|consen 163 ASTVVGTPYYMCPEILSDIPYNEKSDIWSLGCCLYEMCTLKPAFKASNMSELILKINRGL-----------------YSP 225 (426)
T ss_pred hheecCCCcccCHHHhCCCCCCccCcchhhcchHHHHHhcccccCccchHHHHHHHhhcc-----------------CCC
Confidence 2333445555555444433 444444444444444443333333333332111 235
Q ss_pred CCCCCccchHHHHhcccCcCCCCCCChhhhhhCCccccee
Q psy758 228 FEVPDEMQYEEITQRCLDKDPLRRWSCDQLLRHPYFNGYY 267 (292)
Q Consensus 228 ~~~~~~~~l~~li~~~l~~dP~~Rpt~~~il~h~w~~~~~ 267 (292)
.+...+.+++.+|+.||..+|..||++.++|.+|.++..-
T Consensus 226 lp~~ys~el~~lv~~~l~~~P~~RPsa~~LL~~P~l~~~~ 265 (426)
T KOG0589|consen 226 LPSMYSSELRSLVKSMLRKNPEHRPSALELLRRPHLLRYL 265 (426)
T ss_pred CCccccHHHHHHHHHHhhcCCccCCCHHHHhhChhhhhHH
Confidence 5666788999999999999999999999999999988543
|
|
| >cd05616 STKc_cPKC_beta Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-40 Score=275.75 Aligned_cols=249 Identities=20% Similarity=0.241 Sum_probs=192.0
Q ss_pred ccceeeeecccCceEEEEEEEcCCCcEEEEEEeccCCC-ChHHHHHHHHHHHHHHhC-CCCCcchhhhhhhcCCeEEEEE
Q psy758 3 RYEKIGKLGEGSYGVVFKCRNRDTGQVVAIKKFLESEE-DPLIRKIALREIRLLKSL-KHPNLVNLLEVFRRKKKLHLVF 80 (292)
Q Consensus 3 ~y~~~~~l~~g~~~~v~~~~~~~~~~~v~iK~~~~~~~-~~~~~~~~~~e~~~~~~l-~~~~i~~~~~~~~~~~~~~iv~ 80 (292)
+|++.+.||+|+||.||+|.+..+++.||+|++..... ..........|..++..+ .|++|+++++++.+.+..++||
T Consensus 1 df~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (323)
T cd05616 1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALSGKPPFLTQLHSCFQTMDRLYFVM 80 (323)
T ss_pred CceEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCeEeeEEEEEecCCEEEEEE
Confidence 58999999999999999999999999999999875432 222344566778888777 4789999999999999999999
Q ss_pred ecCCCccHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEEccCCcEEEeecCchhhhhccc-----
Q psy758 81 EFCDHTVLNELENHPHGLPWDLIKQITWQVLRGVSYCHRHACIHRDIKPENILLTANGVVKLCDFGFARLIRDLI----- 155 (292)
Q Consensus 81 e~~~~~~L~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~givH~dl~p~Nilv~~~~~~kl~dfg~~~~~~~~~----- 155 (292)
||+++|+|...+...+.+++..+..++.||+.||+|||++||+||||||+||+++.++.++|+|||++.......
T Consensus 81 E~~~~g~L~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~Nill~~~~~~kL~DfG~~~~~~~~~~~~~~ 160 (323)
T cd05616 81 EYVNGGDLMYQIQQVGRFKEPHAVFYAAEIAIGLFFLHSKGIIYRDLKLDNVMLDSEGHIKIADFGMCKENMWDGVTTKT 160 (323)
T ss_pred cCCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCEEecCCCHHHeEECCCCcEEEccCCCceecCCCCCcccc
Confidence 999999999998877789999999999999999999999999999999999999999999999999986432111
Q ss_pred cccccccccccccccCCC-----CCCCcccceeeecCCCCCCchHHHHHHHhhcccCCCCCCChhhhhhccCcCCCCCCC
Q psy758 156 PRHLHIFQTNEYFKGVSL-----PHAENVVPLEIKIGKPAATNIYLIDFLKRCLDKDPLRRWSCDQLLRHPYFNGYYFEV 230 (292)
Q Consensus 156 ~~~~~~~~~~~~~~~~~~-----~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~ 230 (292)
..++..|.+||...+... .|+.|+..+++.+|. .|+...+..++.....-.....+.
T Consensus 161 ~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~elltg~------------------~Pf~~~~~~~~~~~i~~~~~~~p~ 222 (323)
T cd05616 161 FCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQ------------------APFEGEDEDELFQSIMEHNVAYPK 222 (323)
T ss_pred CCCChhhcCHHHhcCCCCCCccchhchhHHHHHHHhCC------------------CCCCCCCHHHHHHHHHhCCCCCCC
Confidence 122345667776654433 333444444444444 444443333333322222233445
Q ss_pred CCccchHHHHhcccCcCCCCCCCh-----hhhhhCCcccceecc
Q psy758 231 PDEMQYEEITQRCLDKDPLRRWSC-----DQLLRHPYFNGYYFE 269 (292)
Q Consensus 231 ~~~~~l~~li~~~l~~dP~~Rpt~-----~~il~h~w~~~~~~~ 269 (292)
..+..+.+++.+||+.||.+|+++ .++++||||....|+
T Consensus 223 ~~s~~~~~li~~~l~~~p~~R~~~~~~~~~~i~~h~~~~~~~~~ 266 (323)
T cd05616 223 SMSKEAVAICKGLMTKHPGKRLGCGPEGERDIKEHAFFRYIDWE 266 (323)
T ss_pred cCCHHHHHHHHHHcccCHHhcCCCCCCCHHHHhcCCCcCCCCHH
Confidence 567899999999999999999985 899999999987765
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and |
| >cd05619 STKc_nPKC_theta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta | Back alignment and domain information |
|---|
Probab=100.00 E-value=9e-41 Score=275.51 Aligned_cols=249 Identities=20% Similarity=0.277 Sum_probs=187.2
Q ss_pred eeecccCceEEEEEEEcCCCcEEEEEEeccCCC-ChHHHHHHHHHHHHHHh-CCCCCcchhhhhhhcCCeEEEEEecCCC
Q psy758 8 GKLGEGSYGVVFKCRNRDTGQVVAIKKFLESEE-DPLIRKIALREIRLLKS-LKHPNLVNLLEVFRRKKKLHLVFEFCDH 85 (292)
Q Consensus 8 ~~l~~g~~~~v~~~~~~~~~~~v~iK~~~~~~~-~~~~~~~~~~e~~~~~~-l~~~~i~~~~~~~~~~~~~~iv~e~~~~ 85 (292)
+.||+|+||.||+|++..+++.||+|++..... ..........|..++.. ++||||+++++++.+.+.+++||||+++
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~hp~iv~~~~~~~~~~~~~lv~ey~~~ 80 (316)
T cd05619 1 KMLGKGSFGKVFLAELKGTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHLYCTFQTKENLFFVMEYLNG 80 (316)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhcchHHHHHHHHHHHHhccCCCcCcceEEEEEeCCEEEEEEeCCCC
Confidence 469999999999999999999999999875431 12223445667777775 4899999999999999999999999999
Q ss_pred ccHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEEccCCcEEEeecCchhhhhccc-----ccccc
Q psy758 86 TVLNELENHPHGLPWDLIKQITWQVLRGVSYCHRHACIHRDIKPENILLTANGVVKLCDFGFARLIRDLI-----PRHLH 160 (292)
Q Consensus 86 ~~L~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~givH~dl~p~Nilv~~~~~~kl~dfg~~~~~~~~~-----~~~~~ 160 (292)
++|..++.....+++..+..++.|++.||.|||++|++|+||||+||+++.++.++|+|||++....... ..++.
T Consensus 81 g~L~~~l~~~~~~~~~~~~~~~~qi~~al~~LH~~~ivHrdikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~gt~ 160 (316)
T cd05619 81 GDLMFHIQSCHKFDLPRATFYAAEIICGLQFLHSKGIVYRDLKLDNILLDTDGHIKIADFGMCKENMLGDAKTCTFCGTP 160 (316)
T ss_pred CcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCeEeCCCCHHHEEECCCCCEEEccCCcceECCCCCCceeeecCCc
Confidence 9999999877789999999999999999999999999999999999999999999999999986432111 11234
Q ss_pred ccccccccccCCCCCCCcccceeeecCCCCCCchHHHHHHHhhcccCCCCCCChhhhhhccCcCCCCCCCCCccchHHHH
Q psy758 161 IFQTNEYFKGVSLPHAENVVPLEIKIGKPAATNIYLIDFLKRCLDKDPLRRWSCDQLLRHPYFNGYYFEVPDEMQYEEIT 240 (292)
Q Consensus 161 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li 240 (292)
.|.+||...+....... +.++.+..++..+.+..|+...+..++...........+...+..+.++|
T Consensus 161 ~y~aPE~~~~~~~~~~~-------------DvwslG~il~el~~G~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~li 227 (316)
T cd05619 161 DYIAPEILLGQKYNTSV-------------DWWSFGVLLYEMLIGQSPFHGHDEEELFQSIRMDNPCYPRWLTREAKDIL 227 (316)
T ss_pred cccCHHHHcCCCCCchh-------------hhhhHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCCccCCHHHHHHH
Confidence 46666665443322222 22333333444444555554444444433222222223334567899999
Q ss_pred hcccCcCCCCCCChh-hhhhCCcccceecc
Q psy758 241 QRCLDKDPLRRWSCD-QLLRHPYFNGYYFE 269 (292)
Q Consensus 241 ~~~l~~dP~~Rpt~~-~il~h~w~~~~~~~ 269 (292)
.+||+.||.+||++. ++++||||.+..|.
T Consensus 228 ~~~l~~~P~~R~~~~~~l~~h~~~~~~~~~ 257 (316)
T cd05619 228 VKLFVREPERRLGVKGDIRQHPFFREIDWS 257 (316)
T ss_pred HHHhccCHhhcCCChHHHHcCcccCCCCHH
Confidence 999999999999996 89999999997764
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in |
| >cd05621 STKc_ROCK2 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.1e-41 Score=280.65 Aligned_cols=253 Identities=22% Similarity=0.299 Sum_probs=192.4
Q ss_pred cccceeeeecccCceEEEEEEEcCCCcEEEEEEeccCC-CChHHHHHHHHHHHHHHhCCCCCcchhhhhhhcCCeEEEEE
Q psy758 2 ERYEKIGKLGEGSYGVVFKCRNRDTGQVVAIKKFLESE-EDPLIRKIALREIRLLKSLKHPNLVNLLEVFRRKKKLHLVF 80 (292)
Q Consensus 2 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~v~iK~~~~~~-~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~iv~ 80 (292)
++|++.+.||+|+||.||+|.+..+++.||+|++.... ........+.+|+.+++.++||||+++++++.+++.+|+||
T Consensus 43 ~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~i~~~~~hp~iv~~~~~~~~~~~~~lv~ 122 (370)
T cd05621 43 EDYDVVKVIGRGAFGEVQLVRHKSSQKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFCAFQDDKYLYMVM 122 (370)
T ss_pred HHCeEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCEEEEEE
Confidence 57999999999999999999999999999999986533 22233456788999999999999999999999999999999
Q ss_pred ecCCCccHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEEccCCcEEEeecCchhhhhccc-----
Q psy758 81 EFCDHTVLNELENHPHGLPWDLIKQITWQVLRGVSYCHRHACIHRDIKPENILLTANGVVKLCDFGFARLIRDLI----- 155 (292)
Q Consensus 81 e~~~~~~L~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~givH~dl~p~Nilv~~~~~~kl~dfg~~~~~~~~~----- 155 (292)
||+++|+|.+++... .+++..+..++.||+.||+|||++||+||||||+||+++.++.+||+|||++.......
T Consensus 123 Ey~~gg~L~~~l~~~-~~~~~~~~~~~~qil~aL~~LH~~~IvHrDLKp~NILl~~~~~~kL~DFG~a~~~~~~~~~~~~ 201 (370)
T cd05621 123 EYMPGGDLVNLMSNY-DVPEKWAKFYTAEVVLALDAIHSMGLIHRDVKPDNMLLDKHGHLKLADFGTCMKMDETGMVRCD 201 (370)
T ss_pred cCCCCCcHHHHHHhc-CCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHEEECCCCCEEEEecccceecccCCceecc
Confidence 999999999998764 68999999999999999999999999999999999999999999999999987654221
Q ss_pred -ccccccccccccccc---------CCCCCCCcccceeeecCCCCCCchHHHHHHHhhcccCCCCCCChhhhhhccCcCC
Q psy758 156 -PRHLHIFQTNEYFKG---------VSLPHAENVVPLEIKIGKPAATNIYLIDFLKRCLDKDPLRRWSCDQLLRHPYFNG 225 (292)
Q Consensus 156 -~~~~~~~~~~~~~~~---------~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~ 225 (292)
..++..|.+||...+ ....|+.|+..+++.+|..++........+...... ...-.
T Consensus 202 ~~~gt~~Y~aPE~~~~~~~~~~~~~~~DiwSlG~ilyell~G~~Pf~~~~~~~~~~~i~~~--------------~~~~~ 267 (370)
T cd05621 202 TAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLFEMLVGDTPFYADSLVGTYSKIMDH--------------KNSLN 267 (370)
T ss_pred cCCCCcccCCHHHHhccCCCCCCCcccCEEeehHHHHHHHhCCCCCCCCCHHHHHHHHHhC--------------CcccC
Confidence 123445667765533 233455555555555565554333222222222111 00001
Q ss_pred CCCCCCCccchHHHHhcccCcCCCC--CCChhhhhhCCcccceecc
Q psy758 226 YYFEVPDEMQYEEITQRCLDKDPLR--RWSCDQLLRHPYFNGYYFE 269 (292)
Q Consensus 226 ~~~~~~~~~~l~~li~~~l~~dP~~--Rpt~~~il~h~w~~~~~~~ 269 (292)
.+.....+..++++|.+||..+|.+ |+|+.++++||||++..|+
T Consensus 268 ~p~~~~~s~~~~~li~~~L~~~~~r~~R~~~~e~l~hp~~~~~~~~ 313 (370)
T cd05621 268 FPEDVEISKHAKNLICAFLTDREVRLGRNGVEEIKQHPFFKNDQWN 313 (370)
T ss_pred CCCcccCCHHHHHHHHHHccCchhccCCCCHHHHhcCcccCCCCcC
Confidence 1112234778999999999865543 8999999999999986554
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found |
| >cd07878 STKc_p38beta_MAPK11 Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.5e-41 Score=280.31 Aligned_cols=263 Identities=27% Similarity=0.393 Sum_probs=192.7
Q ss_pred cccceeeeecccCceEEEEEEEcCCCcEEEEEEeccCCCChHHHHHHHHHHHHHHhCCCCCcchhhhhhhcC------Ce
Q psy758 2 ERYEKIGKLGEGSYGVVFKCRNRDTGQVVAIKKFLESEEDPLIRKIALREIRLLKSLKHPNLVNLLEVFRRK------KK 75 (292)
Q Consensus 2 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~------~~ 75 (292)
++|++.+.||+|+||.||+|.+..+++.||+|.+............+.+|+.+++.++||||+++++++... ..
T Consensus 15 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~ 94 (343)
T cd07878 15 ERYQNLTPVGSGAYGSVCSAYDTRLRQKVAVKKLSRPFQSLIHARRTYRELRLLKHMKHENVIGLLDVFTPATSIENFNE 94 (343)
T ss_pred hhhhhheecccCCCeEEEEEEECCCCCEEEEEEeCchhhhhHHHHHHHHHHHHHHhcCCCchhhhhhhhcccccccccCc
Confidence 689999999999999999999999999999999876544444556677899999999999999999988643 35
Q ss_pred EEEEEecCCCccHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEEccCCcEEEeecCchhhhhccc
Q psy758 76 LHLVFEFCDHTVLNELENHPHGLPWDLIKQITWQVLRGVSYCHRHACIHRDIKPENILLTANGVVKLCDFGFARLIRDLI 155 (292)
Q Consensus 76 ~~iv~e~~~~~~L~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~givH~dl~p~Nilv~~~~~~kl~dfg~~~~~~~~~ 155 (292)
.|++++++ +++|..++.. ..+++..++.++.||+.||.|||++||+|+||||+||+++.++.++|+|||++.......
T Consensus 95 ~~~~~~~~-~~~l~~~~~~-~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrdikp~Nil~~~~~~~kl~Dfg~~~~~~~~~ 172 (343)
T cd07878 95 VYLVTNLM-GADLNNIVKC-QKLSDEHVQFLIYQLLRGLKYIHSAGIIHRDLKPSNVAVNEDCELRILDFGLARQADDEM 172 (343)
T ss_pred EEEEeecC-CCCHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCeecccCChhhEEECCCCCEEEcCCccceecCCCc
Confidence 78999988 5677777764 469999999999999999999999999999999999999999999999999987654321
Q ss_pred --cccccccccccccccC------CCCCCCcccceeeecCCCCCCchHHHHHHHhhcccCCCCCCC------h---hhhh
Q psy758 156 --PRHLHIFQTNEYFKGV------SLPHAENVVPLEIKIGKPAATNIYLIDFLKRCLDKDPLRRWS------C---DQLL 218 (292)
Q Consensus 156 --~~~~~~~~~~~~~~~~------~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~------~---~~~~ 218 (292)
...+..|.+||...+. ...|+.|+..+++.+|..++......+.+..+.......... . ....
T Consensus 173 ~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 252 (343)
T cd07878 173 TGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLKGKALFPGNDYIDQLKRIMEVVGTPSPEVLKKISSEHARKYI 252 (343)
T ss_pred CCccccccccCchHhcCCccCCchhhhHhHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHhcchhhHHHHh
Confidence 2234567788876542 345667777777777776654433333222221111000000 0 0000
Q ss_pred h-ccCcCCC---CCCCCCccchHHHHhcccCcCCCCCCChhhhhhCCcccce
Q psy758 219 R-HPYFNGY---YFEVPDEMQYEEITQRCLDKDPLRRWSCDQLLRHPYFNGY 266 (292)
Q Consensus 219 ~-~~~~~~~---~~~~~~~~~l~~li~~~l~~dP~~Rpt~~~il~h~w~~~~ 266 (292)
. .+..... ......++.+.+||.+||+.||.+|||+.|+++||||...
T Consensus 253 ~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dp~~R~s~~ell~hp~~~~~ 304 (343)
T cd07878 253 QSLPHMPQQDLKKIFRGANPLAIDLLEKMLVLDSDKRISASEALAHPYFSQY 304 (343)
T ss_pred hccccccchhHHHhccCCCHHHHHHHHHHcCCChhhCCCHHHHhcCcchhcc
Confidence 0 0000000 0011235568899999999999999999999999999974
|
Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is |
| >cd05608 STKc_GRK1 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-40 Score=269.87 Aligned_cols=248 Identities=25% Similarity=0.342 Sum_probs=185.9
Q ss_pred ecccCceEEEEEEEcCCCcEEEEEEeccCCCC-hHHHHHHHHHHHHHHhCCCCCcchhhhhhhcCCeEEEEEecCCCccH
Q psy758 10 LGEGSYGVVFKCRNRDTGQVVAIKKFLESEED-PLIRKIALREIRLLKSLKHPNLVNLLEVFRRKKKLHLVFEFCDHTVL 88 (292)
Q Consensus 10 l~~g~~~~v~~~~~~~~~~~v~iK~~~~~~~~-~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~iv~e~~~~~~L 88 (292)
||+|+||.||++.+..+++.||+|.+...... ....+.+..|+.+++.++||||+++++++..++..++||||+++++|
T Consensus 1 lg~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~g~L 80 (280)
T cd05608 1 LGKGGFGEVSACQMRATGKLYACKKLNKKRLKKRKGYEGAMVEKRILAKVHSRFIVSLAYAFQTKTDLCLVMTIMNGGDL 80 (280)
T ss_pred CCCCCceeEEEEEEccCCcEEEEEeeeHHHHhhhHHHHHHHHHHHHHHhCCCCcEeeeeEEEcCCCeEEEEEeCCCCCCH
Confidence 69999999999999999999999998654322 22345677899999999999999999999999999999999999999
Q ss_pred HHHhc----CCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEEccCCcEEEeecCchhhhhcccc-----ccc
Q psy758 89 NELEN----HPHGLPWDLIKQITWQVLRGVSYCHRHACIHRDIKPENILLTANGVVKLCDFGFARLIRDLIP-----RHL 159 (292)
Q Consensus 89 ~~~~~----~~~~~~~~~~~~i~~qi~~aL~~LH~~givH~dl~p~Nilv~~~~~~kl~dfg~~~~~~~~~~-----~~~ 159 (292)
...+. ....+++..+..++.||+.||.|||++|++|+||+|+||+++.++.++|+|||++........ .++
T Consensus 81 ~~~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~~~~~~~~~~~g~ 160 (280)
T cd05608 81 RYHIYNVDEENPGFPEPRACFYTAQIISGLEHLHQRRIIYRDLKPENVLLDNDGNVRISDLGLAVELKDGQSKTKGYAGT 160 (280)
T ss_pred HHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCCEEEeeCccceecCCCCccccccCCC
Confidence 87763 334689999999999999999999999999999999999999999999999999875543221 223
Q ss_pred cccccccccccCCCCCCCcccceeeecCCCCCCchHHHHHHHhhcccCCCCCCC----hhhhhhccCcCCCCCCCCCccc
Q psy758 160 HIFQTNEYFKGVSLPHAENVVPLEIKIGKPAATNIYLIDFLKRCLDKDPLRRWS----CDQLLRHPYFNGYYFEVPDEMQ 235 (292)
Q Consensus 160 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~----~~~~~~~~~~~~~~~~~~~~~~ 235 (292)
..|.+||...+.......++ ++.+..++..+.+..|+.... ..++...........+...+..
T Consensus 161 ~~y~aPE~~~~~~~~~~~Dv-------------wslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 227 (280)
T cd05608 161 PGFMAPELLQGEEYDFSVDY-------------FALGVTLYEMIAARGPFRARGEKVENKELKQRILNDSVTYPDKFSPA 227 (280)
T ss_pred cCccCHHHhcCCCCCccccH-------------HHHHHHHHHHHhCCCCCCCCCcchhHHHHHHhhcccCCCCcccCCHH
Confidence 34666666654433222222 222333334444444443221 1222222222222334456788
Q ss_pred hHHHHhcccCcCCCCCC-----ChhhhhhCCcccceeccC
Q psy758 236 YEEITQRCLDKDPLRRW-----SCDQLLRHPYFNGYYFEV 270 (292)
Q Consensus 236 l~~li~~~l~~dP~~Rp-----t~~~il~h~w~~~~~~~~ 270 (292)
+.+++.+||+.||++|| |++++++||||++..|+.
T Consensus 228 ~~~li~~~l~~~P~~R~~~~~~~~~~~l~h~~~~~~~~~~ 267 (280)
T cd05608 228 SKSFCEALLAKDPEKRLGFRDGNCDGLRTHPLFRDLNWRQ 267 (280)
T ss_pred HHHHHHHHhcCCHHHhcCCCCCCHHHHhcChhhhcCCHhH
Confidence 99999999999999999 889999999999977664
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual g |
| >cd05597 STKc_DMPK_like Catalytic domain of Myotonic Dystrophy protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-40 Score=276.14 Aligned_cols=257 Identities=21% Similarity=0.262 Sum_probs=194.8
Q ss_pred cccceeeeecccCceEEEEEEEcCCCcEEEEEEeccCC-CChHHHHHHHHHHHHHHhCCCCCcchhhhhhhcCCeEEEEE
Q psy758 2 ERYEKIGKLGEGSYGVVFKCRNRDTGQVVAIKKFLESE-EDPLIRKIALREIRLLKSLKHPNLVNLLEVFRRKKKLHLVF 80 (292)
Q Consensus 2 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~v~iK~~~~~~-~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~iv~ 80 (292)
++|++.+.||+|+||.||.+.+..+++.||+|++.... ......+.+.+|..+++.++|+||+++++++.+++.+|+||
T Consensus 1 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (331)
T cd05597 1 DDFEILKVIGRGAFGEVAVVKMKNTGQVYAMKILNKWEMLKRAETACFREERDVLVNGDRRWITNLHYAFQDENNLYLVM 80 (331)
T ss_pred CCceEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCCCceEEEEecCCeEEEEE
Confidence 58999999999999999999999999999999987533 22334566788999999999999999999999999999999
Q ss_pred ecCCCccHHHHhcC-CCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEEccCCcEEEeecCchhhhhccc----
Q psy758 81 EFCDHTVLNELENH-PHGLPWDLIKQITWQVLRGVSYCHRHACIHRDIKPENILLTANGVVKLCDFGFARLIRDLI---- 155 (292)
Q Consensus 81 e~~~~~~L~~~~~~-~~~~~~~~~~~i~~qi~~aL~~LH~~givH~dl~p~Nilv~~~~~~kl~dfg~~~~~~~~~---- 155 (292)
||++|++|..++.. ...+++..+..++.||+.||+|||++|++||||||+||+++.++.++|+|||++.......
T Consensus 81 e~~~g~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~ 160 (331)
T cd05597 81 DYYVGGDLLTLLSKFEDRLPEDMARFYLAEMVLAIDSVHQLGYVHRDIKPDNVLLDKNGHIRLADFGSCLRLLADGTVQS 160 (331)
T ss_pred ecCCCCcHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeEECCCCHHHEEECCCCCEEEEECCceeecCCCCCccc
Confidence 99999999999865 4579999999999999999999999999999999999999999999999999986543221
Q ss_pred --ccccccccccccccc----------CCCCCCCcccceeeecCCCCCCchHHHHHHHhhcccCCCCCCChhhhhhccCc
Q psy758 156 --PRHLHIFQTNEYFKG----------VSLPHAENVVPLEIKIGKPAATNIYLIDFLKRCLDKDPLRRWSCDQLLRHPYF 223 (292)
Q Consensus 156 --~~~~~~~~~~~~~~~----------~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~ 223 (292)
..++..|.+||...+ ....|+.|+..+++.+|..++........+......... +
T Consensus 161 ~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~~l~el~~g~~Pf~~~~~~~~~~~i~~~~~~-------------~ 227 (331)
T cd05597 161 NVAVGTPDYISPEILQAMEDGKGRYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMNHKEH-------------F 227 (331)
T ss_pred cceeccccccCHHHHhhccccccCCCCcceeehhhhHHHHHhhCCCCCCCCCHHHHHHHHHcCCCc-------------c
Confidence 123445667766542 234566666666666666554333222222222211100 0
Q ss_pred CCCCCCCCCccchHHHHhcccCcCCCC--CCChhhhhhCCcccceeccCC
Q psy758 224 NGYYFEVPDEMQYEEITQRCLDKDPLR--RWSCDQLLRHPYFNGYYFEVP 271 (292)
Q Consensus 224 ~~~~~~~~~~~~l~~li~~~l~~dP~~--Rpt~~~il~h~w~~~~~~~~~ 271 (292)
.-.......+..++++|++||+.++++ |++++++++||||.+..|+..
T Consensus 228 ~~~~~~~~~~~~~~~li~~ll~~~~~r~~r~~~~~~l~hp~~~~~~~~~~ 277 (331)
T cd05597 228 QFPPDVTDVSEEAKDLIRRLICSPETRLGRNGLQDFKDHPFFEGIDWDNI 277 (331)
T ss_pred cCCCccCCCCHHHHHHHHHHccCcccccCCCCHHHHhcCCCCCCCCHHHH
Confidence 000111224778999999988764444 789999999999999776543
|
Serine/Threonine Kinases (STKs), Myotonic Dystrophy protein kinase (DMPK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The DMPK-like subfamily is composed of DMPK and DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK). Three isoforms of MRCK are known, named alpha, beta and gamma. The DMPK gene is implicated in myotonic dystrophy 1 (DM1), an inherited multisystemic disorder with symptoms that include muscle hyperexcitability, progressive muscle weakness and wasting, cataract development, testicular atrophy, |
| >KOG0192|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-40 Score=271.26 Aligned_cols=241 Identities=26% Similarity=0.349 Sum_probs=187.0
Q ss_pred cceeeeecccCceEEEEEEEcCCCcE-EEEEEeccCCCChHHHHHHHHHHHHHHhCCCCCcchhhhhhhcCC-eEEEEEe
Q psy758 4 YEKIGKLGEGSYGVVFKCRNRDTGQV-VAIKKFLESEEDPLIRKIALREIRLLKSLKHPNLVNLLEVFRRKK-KLHLVFE 81 (292)
Q Consensus 4 y~~~~~l~~g~~~~v~~~~~~~~~~~-v~iK~~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~-~~~iv~e 81 (292)
..+.+.||+|+||+||.+... |.. ||+|++..........+.+.+|+.+++.++||||++++|++.++. ..++|||
T Consensus 43 l~~~~~iG~G~~g~V~~~~~~--g~~~vavK~~~~~~~~~~~~~~f~~E~~il~~l~HpNIV~f~G~~~~~~~~~~iVtE 120 (362)
T KOG0192|consen 43 LPIEEVLGSGSFGTVYKGKWR--GTDVVAVKIISDPDFDDESRKAFRREASLLSRLRHPNIVQFYGACTSPPGSLCIVTE 120 (362)
T ss_pred hhhhhhcccCCceeEEEEEeC--CceeEEEEEecchhcChHHHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCCceEEEEE
Confidence 345566999999999999987 566 999999887766655889999999999999999999999999877 7999999
Q ss_pred cCCCccHHHHhcC--CCCCCHHHHHHHHHHHHHHHHHHHhCC-ccccCCCCCceEEccCC-cEEEeecCchhhhhccc--
Q psy758 82 FCDHTVLNELENH--PHGLPWDLIKQITWQVLRGVSYCHRHA-CIHRDIKPENILLTANG-VVKLCDFGFARLIRDLI-- 155 (292)
Q Consensus 82 ~~~~~~L~~~~~~--~~~~~~~~~~~i~~qi~~aL~~LH~~g-ivH~dl~p~Nilv~~~~-~~kl~dfg~~~~~~~~~-- 155 (292)
|+++|+|..++.. ...++...+..++.||+.|+.|||+++ |+|+||||+|||++.++ ++||+|||+++......
T Consensus 121 y~~~GsL~~~l~~~~~~~l~~~~~l~~aldiArGm~YLH~~~~iIHrDLK~~NiLv~~~~~~~KI~DFGlsr~~~~~~~~ 200 (362)
T KOG0192|consen 121 YMPGGSLSVLLHKKRKRKLPLKVRLRIALDIARGMEYLHSEGPIIHRDLKSDNILVDLKGKTLKIADFGLSREKVISKTS 200 (362)
T ss_pred eCCCCcHHHHHhhcccCCCCHHHHHHHHHHHHHHHHHHhcCCCeeecccChhhEEEcCCCCEEEECCCccceeecccccc
Confidence 9999999999976 578999999999999999999999999 99999999999999998 99999999997654321
Q ss_pred ---cccccccccccccccC--CCCCCCcccceeeecCCCCCCchHHHHHHHhhcccCCCCCCChhhhhhccCcCCCCC--
Q psy758 156 ---PRHLHIFQTNEYFKGV--SLPHAENVVPLEIKIGKPAATNIYLIDFLKRCLDKDPLRRWSCDQLLRHPYFNGYYF-- 228 (292)
Q Consensus 156 ---~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~-- 228 (292)
..++..|.+||.+.+. .+.... ++.+.+.-+.+.+.+..|+......++.......+.+.
T Consensus 201 ~~~~~GT~~wMAPEv~~~~~~~~~~K~-------------DvySFgIvlWEl~t~~~Pf~~~~~~~~~~~v~~~~~Rp~~ 267 (362)
T KOG0192|consen 201 MTSVAGTYRWMAPEVLRGEKSPYTEKS-------------DVYSFGIVLWELLTGEIPFEDLAPVQVASAVVVGGLRPPI 267 (362)
T ss_pred ccCCCCCccccChhhhcCCCCcCCccc-------------hhhhHHHHHHHHHHCCCCCCCCCHHHHHHHHHhcCCCCCC
Confidence 2334455666665533 222222 22333333444444555655555433333322222222
Q ss_pred CCCCccchHHHHhcccCcCCCCCCChhhhhh
Q psy758 229 EVPDEMQYEEITQRCLDKDPLRRWSCDQLLR 259 (292)
Q Consensus 229 ~~~~~~~l~~li~~~l~~dP~~Rpt~~~il~ 259 (292)
+...+..+..||.+||+.||.+||+..+++.
T Consensus 268 p~~~~~~l~~l~~~CW~~dp~~RP~f~ei~~ 298 (362)
T KOG0192|consen 268 PKECPPHLSSLMERCWLVDPSRRPSFLEIVS 298 (362)
T ss_pred CccCCHHHHHHHHHhCCCCCCcCCCHHHHHH
Confidence 2335788999999999999999999999976
|
|
| >cd05615 STKc_cPKC_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-40 Score=274.24 Aligned_cols=254 Identities=19% Similarity=0.226 Sum_probs=192.7
Q ss_pred ccceeeeecccCceEEEEEEEcCCCcEEEEEEeccCC-CChHHHHHHHHHHHHHHhCC-CCCcchhhhhhhcCCeEEEEE
Q psy758 3 RYEKIGKLGEGSYGVVFKCRNRDTGQVVAIKKFLESE-EDPLIRKIALREIRLLKSLK-HPNLVNLLEVFRRKKKLHLVF 80 (292)
Q Consensus 3 ~y~~~~~l~~g~~~~v~~~~~~~~~~~v~iK~~~~~~-~~~~~~~~~~~e~~~~~~l~-~~~i~~~~~~~~~~~~~~iv~ 80 (292)
+|++.+.||+|+||.||+|.+..+++.||+|++.... ........+..|..+++.+. |++|+++++++.+.+.+|+||
T Consensus 1 ~f~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (323)
T cd05615 1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALQDKPPFLTQLHSCFQTVDRLYFVM 80 (323)
T ss_pred CceEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCchhheeeEEecCCEEEEEE
Confidence 4889999999999999999999999999999987543 22233456677888888886 567888999999999999999
Q ss_pred ecCCCccHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEEccCCcEEEeecCchhhhhccc-----
Q psy758 81 EFCDHTVLNELENHPHGLPWDLIKQITWQVLRGVSYCHRHACIHRDIKPENILLTANGVVKLCDFGFARLIRDLI----- 155 (292)
Q Consensus 81 e~~~~~~L~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~givH~dl~p~Nilv~~~~~~kl~dfg~~~~~~~~~----- 155 (292)
||++|++|..++...+.+++..++.++.||+.||.|||++|++||||||+||+++.++.++|+|||++.......
T Consensus 81 Ey~~~g~L~~~i~~~~~l~~~~~~~i~~qi~~al~~lH~~~ivHrDikp~Nill~~~~~ikL~Dfg~~~~~~~~~~~~~~ 160 (323)
T cd05615 81 EYVNGGDLMYHIQQVGKFKEPQAVFYAAEISVGLFFLHRRGIIYRDLKLDNVMLDSEGHIKIADFGMCKEHMVDGVTTRT 160 (323)
T ss_pred cCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHeEECCCCCEEEeccccccccCCCCccccC
Confidence 999999999999887789999999999999999999999999999999999999999999999999986532211
Q ss_pred cccccccccccccccCCCCCCCcccceeeecCCCCCCchHHHHHHHhhcccCCCCCCChhhhhhccCcCCCCCCCCCccc
Q psy758 156 PRHLHIFQTNEYFKGVSLPHAENVVPLEIKIGKPAATNIYLIDFLKRCLDKDPLRRWSCDQLLRHPYFNGYYFEVPDEMQ 235 (292)
Q Consensus 156 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 235 (292)
..++..|.+||...+....... +.++.+..++..+.+..|....+..++...........+...+..
T Consensus 161 ~~gt~~y~aPE~~~~~~~~~~~-------------DiwslGvil~elltG~~pf~~~~~~~~~~~i~~~~~~~p~~~~~~ 227 (323)
T cd05615 161 FCGTPDYIAPEIIAYQPYGKSV-------------DWWAYGVLLYEMLAGQPPFDGEDEDELFQSIMEHNVSYPKSLSKE 227 (323)
T ss_pred ccCCccccCHHHHcCCCCCCcc-------------chhhhHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCCccCCHH
Confidence 1123446666665443222222 223333334444445555544444433333222233344456778
Q ss_pred hHHHHhcccCcCCCCCCCh-----hhhhhCCcccceecc
Q psy758 236 YEEITQRCLDKDPLRRWSC-----DQLLRHPYFNGYYFE 269 (292)
Q Consensus 236 l~~li~~~l~~dP~~Rpt~-----~~il~h~w~~~~~~~ 269 (292)
+.+++.+||+.||.+|+++ +++++||||....|+
T Consensus 228 ~~~li~~~l~~~p~~R~~~~~~~~~~i~~h~~f~~~~~~ 266 (323)
T cd05615 228 AVSICKGLMTKHPSKRLGCGPEGERDIREHAFFRRIDWD 266 (323)
T ss_pred HHHHHHHHcccCHhhCCCCCCCCHHHHhcCcccCCCCHH
Confidence 9999999999999999974 789999999997765
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, a |
| >cd07874 STKc_JNK3 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-40 Score=279.97 Aligned_cols=264 Identities=26% Similarity=0.410 Sum_probs=191.4
Q ss_pred CcccceeeeecccCceEEEEEEEcCCCcEEEEEEeccCCCChHHHHHHHHHHHHHHhCCCCCcchhhhhhhcC------C
Q psy758 1 MERYEKIGKLGEGSYGVVFKCRNRDTGQVVAIKKFLESEEDPLIRKIALREIRLLKSLKHPNLVNLLEVFRRK------K 74 (292)
Q Consensus 1 ~~~y~~~~~l~~g~~~~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~------~ 74 (292)
+++|++.+.||+|+||.||+|.+..+++.||+|.+............+.+|+.+++.++||||+++++++... .
T Consensus 16 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~ 95 (355)
T cd07874 16 LKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKSLEEFQ 95 (355)
T ss_pred hhceeEEEEeeecCCEEEEEEEecCCCceEEEEEeCCcccChHHHHHHHHHHHHHHHhCCCchhceeeeeeccccccccc
Confidence 4789999999999999999999999999999999976655555667788999999999999999999987543 3
Q ss_pred eEEEEEecCCCccHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEEccCCcEEEeecCchhhhhcc
Q psy758 75 KLHLVFEFCDHTVLNELENHPHGLPWDLIKQITWQVLRGVSYCHRHACIHRDIKPENILLTANGVVKLCDFGFARLIRDL 154 (292)
Q Consensus 75 ~~~iv~e~~~~~~L~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~givH~dl~p~Nilv~~~~~~kl~dfg~~~~~~~~ 154 (292)
..|+||||++++.. ..+.. .+++..++.++.|++.||.|||++|++||||||+||+++.++.++|+|||++......
T Consensus 96 ~~~lv~e~~~~~l~-~~~~~--~l~~~~~~~~~~qi~~aL~~LH~~givHrDikp~Nill~~~~~~kl~Dfg~~~~~~~~ 172 (355)
T cd07874 96 DVYLVMELMDANLC-QVIQM--ELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTS 172 (355)
T ss_pred eeEEEhhhhcccHH-HHHhh--cCCHHHHHHHHHHHHHHHHHHHhCCcccCCCChHHEEECCCCCEEEeeCcccccCCCc
Confidence 57999999987644 44432 5899999999999999999999999999999999999999999999999999765432
Q ss_pred c----cccccccccccccccCCC-----CCCCcccceeeecCCCCCCchHHHHHHHhhccc----CCC------------
Q psy758 155 I----PRHLHIFQTNEYFKGVSL-----PHAENVVPLEIKIGKPAATNIYLIDFLKRCLDK----DPL------------ 209 (292)
Q Consensus 155 ~----~~~~~~~~~~~~~~~~~~-----~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~----~p~------------ 209 (292)
. ...+..|.+||...+... .|+.|+..+++.++..++......+.+...... .|.
T Consensus 173 ~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 252 (355)
T cd07874 173 FMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQPTVRNY 252 (355)
T ss_pred cccCCccccCCccCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHhhcHHHHHH
Confidence 1 223456788887765443 455666666666776655433222221111110 000
Q ss_pred --CCC-----ChhhhhhccCcC-CCCCCCCCccchHHHHhcccCcCCCCCCChhhhhhCCccccee
Q psy758 210 --RRW-----SCDQLLRHPYFN-GYYFEVPDEMQYEEITQRCLDKDPLRRWSCDQLLRHPYFNGYY 267 (292)
Q Consensus 210 --~~~-----~~~~~~~~~~~~-~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~~il~h~w~~~~~ 267 (292)
.++ ..........+. ........+..+++||.+||+.||++|||+.|+++||||+..+
T Consensus 253 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~Rps~~ell~hp~~~~~~ 318 (355)
T cd07874 253 VENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDEALQHPYINVWY 318 (355)
T ss_pred HhcCCccccccchhhccccccccccccccccchHHHHHHHHHhcCCchhcCCHHHHhcCcchhccc
Confidence 000 000000000000 0011122355789999999999999999999999999998543
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 3 (JNK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK3 is expressed primarily in the brain, and to a lesser extent in the heart and testis. Mice deficient in Jnk3 are protected against kainic acid-induced seizures, strok |
| >cd07872 STKc_PCTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.1e-41 Score=275.78 Aligned_cols=266 Identities=30% Similarity=0.496 Sum_probs=194.5
Q ss_pred CcccceeeeecccCceEEEEEEEcCCCcEEEEEEeccCCCChHHHHHHHHHHHHHHhCCCCCcchhhhhhhcCCeEEEEE
Q psy758 1 MERYEKIGKLGEGSYGVVFKCRNRDTGQVVAIKKFLESEEDPLIRKIALREIRLLKSLKHPNLVNLLEVFRRKKKLHLVF 80 (292)
Q Consensus 1 ~~~y~~~~~l~~g~~~~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~iv~ 80 (292)
+++|++.+.||+|+||.||+|.+..+++.||+|.+....... ....+.+|+.+++.++||||+++++++..++..++||
T Consensus 5 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~-~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ 83 (309)
T cd07872 5 METYIKLEKLGEGTYATVFKGRSKLTENLVALKEIRLEHEEG-APCTAIREVSLLKDLKHANIVTLHDIVHTDKSLTLVF 83 (309)
T ss_pred CCceEEEEEecccCCEEEEEEEecCCCCeEEEEEeeccccCC-cchhHHHHHHHHHhCCCCCcceEEEEEeeCCeEEEEE
Confidence 578999999999999999999999999999999986543222 2334668999999999999999999999999999999
Q ss_pred ecCCCccHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEEccCCcEEEeecCchhhhhccc-----
Q psy758 81 EFCDHTVLNELENHPHGLPWDLIKQITWQVLRGVSYCHRHACIHRDIKPENILLTANGVVKLCDFGFARLIRDLI----- 155 (292)
Q Consensus 81 e~~~~~~L~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~givH~dl~p~Nilv~~~~~~kl~dfg~~~~~~~~~----- 155 (292)
||++++.+..+......+++..++.++.||+.||+|||++|++||||+|+||+++.++.++|+|||++.......
T Consensus 84 e~~~~~l~~~~~~~~~~~~~~~~~~~~~qi~~aL~~lH~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~ 163 (309)
T cd07872 84 EYLDKDLKQYMDDCGNIMSMHNVKIFLYQILRGLAYCHRRKVLHRDLKPQNLLINERGELKLADFGLARAKSVPTKTYSN 163 (309)
T ss_pred eCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEECCCCCEEECccccceecCCCcccccc
Confidence 999975444444444568999999999999999999999999999999999999999999999999986543211
Q ss_pred cccccccccccccccC------CCCCCCcccceeeecCCCCCCchHHHHH---HHhhcccCCCCCC-Ch---hhh--hhc
Q psy758 156 PRHLHIFQTNEYFKGV------SLPHAENVVPLEIKIGKPAATNIYLIDF---LKRCLDKDPLRRW-SC---DQL--LRH 220 (292)
Q Consensus 156 ~~~~~~~~~~~~~~~~------~~~~~~~~~~~~~~~~~~~~~~~~~~~~---~~~~~~~~p~~~~-~~---~~~--~~~ 220 (292)
...+..|.+||...+. ...|+.|+..+++.+|.+++......+. +...++..+...+ .. .+. ...
T Consensus 164 ~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 243 (309)
T cd07872 164 EVVTLWYRPPDVLLGSSEYSTQIDMWGVGCIFFEMASGRPLFPGSTVEDELHLIFRLLGTPTEETWPGISSNDEFKNYNF 243 (309)
T ss_pred ccccccccCCHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhhcchhhhhhhhc
Confidence 1224457778766442 2346677777777778776544333222 2222222221111 00 000 000
Q ss_pred cCcCC---CCCCCCCccchHHHHhcccCcCCCCCCChhhhhhCCccccee
Q psy758 221 PYFNG---YYFEVPDEMQYEEITQRCLDKDPLRRWSCDQLLRHPYFNGYY 267 (292)
Q Consensus 221 ~~~~~---~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~~il~h~w~~~~~ 267 (292)
+.... .......+..+.+||.+||+.||.+|||++|+++||||.+..
T Consensus 244 ~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~h~~~~~~~ 293 (309)
T cd07872 244 PKYKPQPLINHAPRLDTEGIELLTKFLQYESKKRISAEEAMKHAYFRSLG 293 (309)
T ss_pred CccCCCchhhhccCCCHHHHHHHHHhccCChhhCCCHHHHhcChhhhhcc
Confidence 00000 001123467889999999999999999999999999999854
|
Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play |
| >cd05605 STKc_GRK4_like Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-40 Score=268.90 Aligned_cols=249 Identities=23% Similarity=0.297 Sum_probs=188.4
Q ss_pred ccceeeeecccCceEEEEEEEcCCCcEEEEEEeccCCCC-hHHHHHHHHHHHHHHhCCCCCcchhhhhhhcCCeEEEEEe
Q psy758 3 RYEKIGKLGEGSYGVVFKCRNRDTGQVVAIKKFLESEED-PLIRKIALREIRLLKSLKHPNLVNLLEVFRRKKKLHLVFE 81 (292)
Q Consensus 3 ~y~~~~~l~~g~~~~v~~~~~~~~~~~v~iK~~~~~~~~-~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~iv~e 81 (292)
.|++.+.||+|++|.||++.+..+++.||+|.+...... ......+.+|+.+++.++||||+++++.+.+++..++|||
T Consensus 1 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 80 (285)
T cd05605 1 TFRHYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRFVVSLAYAYETKDALCLVLT 80 (285)
T ss_pred CceEEEEEecCCCeEEEEEEEcCCCceEEEEEEehhhhhhhhhHHHHHHHHHHHHhcCCCCEeeeeeeecCCCeEEEEEe
Confidence 589999999999999999999999999999998754422 2234556789999999999999999999999999999999
Q ss_pred cCCCccHHHHhcC--CCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEEccCCcEEEeecCchhhhhcccc---
Q psy758 82 FCDHTVLNELENH--PHGLPWDLIKQITWQVLRGVSYCHRHACIHRDIKPENILLTANGVVKLCDFGFARLIRDLIP--- 156 (292)
Q Consensus 82 ~~~~~~L~~~~~~--~~~~~~~~~~~i~~qi~~aL~~LH~~givH~dl~p~Nilv~~~~~~kl~dfg~~~~~~~~~~--- 156 (292)
|+.+++|..++.. ...+++..+..++.|++.||.|||+.|++|+||+|+||++++++.++|+|||++........
T Consensus 81 ~~~~~~L~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~~l~Dfg~~~~~~~~~~~~~ 160 (285)
T cd05605 81 LMNGGDLKFHIYNMGNPGFDEERAVFYAAEITCGLEDLHRERIVYRDLKPENILLDDYGHIRISDLGLAVEIPEGETIRG 160 (285)
T ss_pred ccCCCcHHHHHHhcCcCCCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCHHHEEECCCCCEEEeeCCCceecCCCCcccc
Confidence 9999999887643 24589999999999999999999999999999999999999999999999999876532111
Q ss_pred -ccccccccccccccCCC-----CCCCcccceeeecCCCCCCchHHHHHHHhhcccCCCCCCChh----hhhhccCcCCC
Q psy758 157 -RHLHIFQTNEYFKGVSL-----PHAENVVPLEIKIGKPAATNIYLIDFLKRCLDKDPLRRWSCD----QLLRHPYFNGY 226 (292)
Q Consensus 157 -~~~~~~~~~~~~~~~~~-----~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~----~~~~~~~~~~~ 226 (292)
.++..|.+||...+... .|+.|+..+++.+|..+ +...... ++.....-...
T Consensus 161 ~~~~~~y~aPE~~~~~~~~~~~Diws~G~~l~el~~g~~p------------------f~~~~~~~~~~~~~~~~~~~~~ 222 (285)
T cd05605 161 RVGTVGYMAPEVVKNERYTFSPDWWGLGCLIYEMIEGKSP------------------FRQRKEKVKREEVERRVKEDQE 222 (285)
T ss_pred ccCCCCccCcHHhcCCCCCccccchhHHHHHHHHHHCCCC------------------CCCCchhhHHHHHHHHhhhccc
Confidence 22344666666544332 33333333444444433 3221111 11111000111
Q ss_pred CCCCCCccchHHHHhcccCcCCCCCC-----ChhhhhhCCcccceecc
Q psy758 227 YFEVPDEMQYEEITQRCLDKDPLRRW-----SCDQLLRHPYFNGYYFE 269 (292)
Q Consensus 227 ~~~~~~~~~l~~li~~~l~~dP~~Rp-----t~~~il~h~w~~~~~~~ 269 (292)
..+...+..+.+||.+||+.||.+|| +++++++||||....|+
T Consensus 223 ~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~~~~~l~~~~~~~~~~~~ 270 (285)
T cd05605 223 EYSEKFSEAARSICRQLLTKDPGFRLGCRGEGAEEVKAHPFFRTANFK 270 (285)
T ss_pred ccCcccCHHHHHHHHHHccCCHHHhcCCCCCCHHHHhcCcCccCCCHH
Confidence 22334577899999999999999999 89999999999986665
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5, |
| >cd05580 STKc_PKA Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.9e-40 Score=267.96 Aligned_cols=255 Identities=24% Similarity=0.323 Sum_probs=196.6
Q ss_pred cccceeeeecccCceEEEEEEEcCCCcEEEEEEeccCCC-ChHHHHHHHHHHHHHHhCCCCCcchhhhhhhcCCeEEEEE
Q psy758 2 ERYEKIGKLGEGSYGVVFKCRNRDTGQVVAIKKFLESEE-DPLIRKIALREIRLLKSLKHPNLVNLLEVFRRKKKLHLVF 80 (292)
Q Consensus 2 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~v~iK~~~~~~~-~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~iv~ 80 (292)
++|++.+.||+|++|.||++.+..+++.|++|.+..... .....+.+.+|+++++.++||||+++++++.+++.+++|+
T Consensus 1 ~~y~~~~~ig~g~~~~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~ 80 (290)
T cd05580 1 DDFEFIKTLGTGSFGRVMLVRHKGSGKYYALKILSKAKIVKLKQVEHVLNEKRILQSIRHPFLVNLYGSFQDDSNLYLVM 80 (290)
T ss_pred CceEEEEEeecCCCeEEEEEEEcCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCccceeeEEEcCCeEEEEE
Confidence 579999999999999999999999999999999865442 2344577889999999999999999999999999999999
Q ss_pred ecCCCccHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEEccCCcEEEeecCchhhhhcccc--cc
Q psy758 81 EFCDHTVLNELENHPHGLPWDLIKQITWQVLRGVSYCHRHACIHRDIKPENILLTANGVVKLCDFGFARLIRDLIP--RH 158 (292)
Q Consensus 81 e~~~~~~L~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~givH~dl~p~Nilv~~~~~~kl~dfg~~~~~~~~~~--~~ 158 (292)
||+++++|.+++.....+++..+..++.||+.||.|||++|++|+||+|+||+++.++.++|+|||++........ ..
T Consensus 81 e~~~~~~L~~~~~~~~~l~~~~~~~~~~qil~~l~~lH~~~i~H~dl~p~nili~~~~~~kl~dfg~~~~~~~~~~~~~~ 160 (290)
T cd05580 81 EYVPGGELFSHLRKSGRFPEPVARFYAAQVVLALEYLHSLDIVYRDLKPENLLLDSDGYIKITDFGFAKRVKGRTYTLCG 160 (290)
T ss_pred ecCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCEecCCCCHHHEEECCCCCEEEeeCCCccccCCCCCCCCC
Confidence 9999999999998778899999999999999999999999999999999999999999999999999876543311 12
Q ss_pred ccccccccccccCCCCCCCcccceeeecCCCCCCchHHHHHHHhhcccCCCCCCChhhhhhccCcCCCCCCCCCccchHH
Q psy758 159 LHIFQTNEYFKGVSLPHAENVVPLEIKIGKPAATNIYLIDFLKRCLDKDPLRRWSCDQLLRHPYFNGYYFEVPDEMQYEE 238 (292)
Q Consensus 159 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ 238 (292)
...|.+||...+....... +.++.+..++..+.+..|.......+............+...+..+.+
T Consensus 161 ~~~y~aPE~~~~~~~~~~~-------------Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ 227 (290)
T cd05580 161 TPEYLAPEIILSKGYGKAV-------------DWWALGILIYEMLAGYPPFFDDNPIQIYEKILEGKVRFPSFFSPDAKD 227 (290)
T ss_pred CccccChhhhcCCCCCccc-------------cHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcCCccCCccCCHHHHH
Confidence 2335555544332221112 223333333444444445443333322222222222344455789999
Q ss_pred HHhcccCcCCCCCC-----ChhhhhhCCcccceecc
Q psy758 239 ITQRCLDKDPLRRW-----SCDQLLRHPYFNGYYFE 269 (292)
Q Consensus 239 li~~~l~~dP~~Rp-----t~~~il~h~w~~~~~~~ 269 (292)
+|.+||+.||.+|+ +++++++||||.+..|.
T Consensus 228 li~~~l~~~p~~R~~~~~~~~~~l~~~~~~~~~~~~ 263 (290)
T cd05580 228 LIRNLLQVDLTKRLGNLKNGVNDIKNHPWFAGIDWI 263 (290)
T ss_pred HHHHHccCCHHHccCcccCCHHHHHcCcccccCCHH
Confidence 99999999999999 99999999999987654
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubi |
| >PF00069 Pkinase: Protein kinase domain Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-41 Score=272.71 Aligned_cols=247 Identities=32% Similarity=0.532 Sum_probs=188.8
Q ss_pred cceeeeecccCceEEEEEEEcCCCcEEEEEEeccCCCChHHHHHHHHHHHHHHhCCCCCcchhhhhhhcCCeEEEEEecC
Q psy758 4 YEKIGKLGEGSYGVVFKCRNRDTGQVVAIKKFLESEEDPLIRKIALREIRLLKSLKHPNLVNLLEVFRRKKKLHLVFEFC 83 (292)
Q Consensus 4 y~~~~~l~~g~~~~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~iv~e~~ 83 (292)
|++++.||+|++|.||++.+..+++.||+|.+..............+|+.+++.++||||+++++++.+....++++|++
T Consensus 1 y~~~~~lg~G~~g~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~~v~~~~ 80 (260)
T PF00069_consen 1 YRLVKKLGSGGFGTVYKAKNKKNGQKVAVKIIDKSEIEEEEREENIREIKILRRLRHPNIVQILDVFQDDNYLYIVMEYC 80 (260)
T ss_dssp EEEEEEEEEESSEEEEEEEETTTTEEEEEEEEESTTHHHHHHHHHHHHHHHHHHHTBTTBCHEEEEEEESSEEEEEEEEE
T ss_pred CEEeEEEEeCCCEEEEEEEECCCCeEEEEEEeccccccccccchhhhhhhcccccccccccccccccccccccccccccc
Confidence 88999999999999999999999999999999888766555555567999999999999999999999999999999999
Q ss_pred CCccHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEEccCCcEEEeecCchhhhhc-----ccccc
Q psy758 84 DHTVLNELENHPHGLPWDLIKQITWQVLRGVSYCHRHACIHRDIKPENILLTANGVVKLCDFGFARLIRD-----LIPRH 158 (292)
Q Consensus 84 ~~~~L~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~givH~dl~p~Nilv~~~~~~kl~dfg~~~~~~~-----~~~~~ 158 (292)
.+++|..++.....+++..++.++.||+.||++||++|++|+||+|+||+++.++.++|+|||.+..... .....
T Consensus 81 ~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~L~~Lh~~~i~H~dikp~NIl~~~~~~~~l~Dfg~~~~~~~~~~~~~~~~~ 160 (260)
T PF00069_consen 81 PGGSLQDYLQKNKPLSEEEILKIAYQILEALAYLHSKGIVHRDIKPENILLDENGEVKLIDFGSSVKLSENNENFNPFVG 160 (260)
T ss_dssp TTEBHHHHHHHHSSBBHHHHHHHHHHHHHHHHHHHHTTEEESSBSGGGEEESTTSEEEESSGTTTEESTSTTSEBSSSSS
T ss_pred cccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccc
Confidence 9999999988666899999999999999999999999999999999999999999999999999864211 12233
Q ss_pred ccccccccccc-cCCCCCCCcccceeeecCCCCCCchHHHHHHHhhcccCCCCCCC---hhhhhh----ccCcCCCCCCC
Q psy758 159 LHIFQTNEYFK-GVSLPHAENVVPLEIKIGKPAATNIYLIDFLKRCLDKDPLRRWS---CDQLLR----HPYFNGYYFEV 230 (292)
Q Consensus 159 ~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~---~~~~~~----~~~~~~~~~~~ 230 (292)
+..|.+||... +.......++|++++ .++..+.+..|..... ....+. ...........
T Consensus 161 ~~~y~aPE~~~~~~~~~~~~Di~slG~-------------il~~l~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 227 (260)
T PF00069_consen 161 TPEYMAPEVLQQGKKYTRKSDIWSLGI-------------ILYELLTGKLPFEESNSDDQLEIIEKILKRPLPSSSQQSR 227 (260)
T ss_dssp SGGGSCHHHHTTTSSBSTHHHHHHHHH-------------HHHHHHHSSSSSTTSSHHHHHHHHHHHHHTHHHHHTTSHT
T ss_pred ccccccccccccccccccccccccccc-------------ccccccccccccccccchhhhhhhhhcccccccccccccc
Confidence 44577777765 444443333333322 2222333333333321 111110 00000111111
Q ss_pred CCccchHHHHhcccCcCCCCCCChhhhhhCCcc
Q psy758 231 PDEMQYEEITQRCLDKDPLRRWSCDQLLRHPYF 263 (292)
Q Consensus 231 ~~~~~l~~li~~~l~~dP~~Rpt~~~il~h~w~ 263 (292)
..+..+.++|.+||+.||++|||+.++++||||
T Consensus 228 ~~~~~l~~li~~~l~~~p~~R~~~~~l~~~~~~ 260 (260)
T PF00069_consen 228 EKSEELRDLIKKMLSKDPEQRPSAEELLKHPWF 260 (260)
T ss_dssp TSHHHHHHHHHHHSSSSGGGSTTHHHHHTSGGG
T ss_pred hhHHHHHHHHHHHccCChhHCcCHHHHhcCCCC
Confidence 223789999999999999999999999999998
|
Serine/Threonine protein kinases, catalytic domain Tyrosine kinase, catalytic domain; InterPro: IPR017442 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Eukaryotic protein kinases [, , , , ] are enzymes that belong to a very extensive family of proteins which share a conserved catalytic core common with both serine/threonine and tyrosine protein kinases. There are a number of conserved regions in the catalytic domain of protein kinases. In the N-terminal extremity of the catalytic domain there is a glycine-rich stretch of residues in the vicinity of a lysine residue, which has been shown to be involved in ATP binding. In the central part of the catalytic domain there is a conserved aspartic acid residue which is important for the catalytic activity of the enzyme []. This entry includes protein kinases from eukaryotes and viruses and may include some bacterial hits too.; GO: 0004672 protein kinase activity, 0005524 ATP binding, 0006468 protein phosphorylation; PDB: 3GC7_A 3ZYA_A 3MPT_A 3NEW_A 3MVM_A 1R3C_A 2FST_X 3E93_A 3HV5_B 3OCG_A .... |
| >PLN00034 mitogen-activated protein kinase kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-40 Score=276.90 Aligned_cols=253 Identities=25% Similarity=0.440 Sum_probs=183.4
Q ss_pred cccceeeeecccCceEEEEEEEcCCCcEEEEEEeccCCCChHHHHHHHHHHHHHHhCCCCCcchhhhhhhcCCeEEEEEe
Q psy758 2 ERYEKIGKLGEGSYGVVFKCRNRDTGQVVAIKKFLESEEDPLIRKIALREIRLLKSLKHPNLVNLLEVFRRKKKLHLVFE 81 (292)
Q Consensus 2 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~iv~e 81 (292)
++|++.+.||+|++|.||+|.+..+++.||+|++.... .......+.+|+.+++.++|+||+++++++.+++.+++|+|
T Consensus 74 ~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 152 (353)
T PLN00034 74 SELERVNRIGSGAGGTVYKVIHRPTGRLYALKVIYGNH-EDTVRRQICREIEILRDVNHPNVVKCHDMFDHNGEIQVLLE 152 (353)
T ss_pred HHHhhhhhccCCCCeEEEEEEECCCCCEEEEEEEecCC-cHHHHHHHHHHHHHHHhCCCCCcceeeeEeccCCeEEEEEe
Confidence 56888999999999999999999999999999986443 33455678899999999999999999999999999999999
Q ss_pred cCCCccHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEEccCCcEEEeecCchhhhhcccc-----
Q psy758 82 FCDHTVLNELENHPHGLPWDLIKQITWQVLRGVSYCHRHACIHRDIKPENILLTANGVVKLCDFGFARLIRDLIP----- 156 (292)
Q Consensus 82 ~~~~~~L~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~givH~dl~p~Nilv~~~~~~kl~dfg~~~~~~~~~~----- 156 (292)
|+.+++|... ...++..+..++.||+.||.|||++|++||||||+||++++++.++|+|||++........
T Consensus 153 ~~~~~~L~~~----~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~~~~kL~DfG~~~~~~~~~~~~~~~ 228 (353)
T PLN00034 153 FMDGGSLEGT----HIADEQFLADVARQILSGIAYLHRRHIVHRDIKPSNLLINSAKNVKIADFGVSRILAQTMDPCNSS 228 (353)
T ss_pred cCCCCccccc----ccCCHHHHHHHHHHHHHHHHHHHHCCEeecCCCHHHEEEcCCCCEEEcccccceeccccccccccc
Confidence 9999988653 2467888899999999999999999999999999999999999999999999876543211
Q ss_pred ccccccccccccccCCCCCCCcccceeeecCCCCCCchHHHHHHHhhcccCCCCCCC---hhhhhhcc-CcCCCCCCCCC
Q psy758 157 RHLHIFQTNEYFKGVSLPHAENVVPLEIKIGKPAATNIYLIDFLKRCLDKDPLRRWS---CDQLLRHP-YFNGYYFEVPD 232 (292)
Q Consensus 157 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~---~~~~~~~~-~~~~~~~~~~~ 232 (292)
.++..|.+||....... .+...+...++++.+.-+++.+.+..|+.... ...+.... .......+...
T Consensus 229 ~gt~~y~aPE~~~~~~~--------~~~~~~~~~DvwslGvil~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 300 (353)
T PLN00034 229 VGTIAYMSPERINTDLN--------HGAYDGYAGDIWSLGVSILEFYLGRFPFGVGRQGDWASLMCAICMSQPPEAPATA 300 (353)
T ss_pred ccCccccCccccccccc--------cCcCCCcchhHHHHHHHHHHHHhCCCCCCCCCCccHHHHHHHHhccCCCCCCCcc
Confidence 22334555554321100 00000111222333333344444444433111 11111100 00111223345
Q ss_pred ccchHHHHhcccCcCCCCCCChhhhhhCCccccee
Q psy758 233 EMQYEEITQRCLDKDPLRRWSCDQLLRHPYFNGYY 267 (292)
Q Consensus 233 ~~~l~~li~~~l~~dP~~Rpt~~~il~h~w~~~~~ 267 (292)
+..+.+||.+||+.||++|||+.|+++||||.+-.
T Consensus 301 ~~~l~~li~~~l~~~P~~Rpt~~ell~hp~~~~~~ 335 (353)
T PLN00034 301 SREFRHFISCCLQREPAKRWSAMQLLQHPFILRAQ 335 (353)
T ss_pred CHHHHHHHHHHccCChhhCcCHHHHhcCcccccCC
Confidence 77899999999999999999999999999999854
|
|
| >KOG0658|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.4e-42 Score=268.98 Aligned_cols=258 Identities=30% Similarity=0.517 Sum_probs=199.0
Q ss_pred ccceeeeecccCceEEEEEEEcCCCcEEEEEEeccCCCChHHHHHHHHHHHHHHhCCCCCcchhhhhhhc--CC---eEE
Q psy758 3 RYEKIGKLGEGSYGVVFKCRNRDTGQVVAIKKFLESEEDPLIRKIALREIRLLKSLKHPNLVNLLEVFRR--KK---KLH 77 (292)
Q Consensus 3 ~y~~~~~l~~g~~~~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~--~~---~~~ 77 (292)
.|+-.+.+|+|+||.||.|....+++.||||...... +.-.+|+.+++.+.||||+++.-+|.. +. +..
T Consensus 25 ~~~~~~liG~GsFg~Vyq~~~~e~~~~vAIKKv~~d~------r~knrEl~im~~l~HpNIV~L~~~f~~~~~~d~~~ln 98 (364)
T KOG0658|consen 25 SYEAVRLIGSGSFGVVYQAKLRETEEEVAIKKVLQDK------RYKNRELQIMRKLDHPNIVRLLYFFSSSTESDEVYLN 98 (364)
T ss_pred EEEeeEEEeecccceEEEEEEcCCCceeEEEEecCCC------CcCcHHHHHHHhcCCcCeeeEEEEEEecCCCchhHHH
Confidence 4777899999999999999999999999999875443 223479999999999999999888753 22 456
Q ss_pred EEEecCCCccHHHHh---cCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEEccC-CcEEEeecCchhhhhc
Q psy758 78 LVFEFCDHTVLNELE---NHPHGLPWDLIKQITWQVLRGVSYCHRHACIHRDIKPENILLTAN-GVVKLCDFGFARLIRD 153 (292)
Q Consensus 78 iv~e~~~~~~L~~~~---~~~~~~~~~~~~~i~~qi~~aL~~LH~~givH~dl~p~Nilv~~~-~~~kl~dfg~~~~~~~ 153 (292)
+||||++.+....+. ..+..++.-.++-+..||++||+|||+.||+||||||.|+|+|.+ |.+||+|||+|+.+..
T Consensus 99 lVleymP~tL~~~~r~~~~~~~~mp~~~iKLYt~Qlfrgl~yLh~~~IcHRDIKPqNlLvD~~tg~LKicDFGSAK~L~~ 178 (364)
T KOG0658|consen 99 LVLEYMPETLYRVIRHYTRANQRMPLLEIKLYTYQLFRGLAYLHSHGICHRDIKPQNLLVDPDTGVLKICDFGSAKVLVK 178 (364)
T ss_pred HHHHhchHHHHHHHHHHhhcCCCCceeeeHHHHHHHHHHHHHHHhcCcccCCCChheEEEcCCCCeEEeccCCcceeecc
Confidence 899999975443332 235679999999999999999999999999999999999999987 8999999999999876
Q ss_pred ccccc----ccccccccccccCCC------CCCCcccceeeecCCCCCCchHHHHH---HHhhcccCCCCCCC-------
Q psy758 154 LIPRH----LHIFQTNEYFKGVSL------PHAENVVPLEIKIGKPAATNIYLIDF---LKRCLDKDPLRRWS------- 213 (292)
Q Consensus 154 ~~~~~----~~~~~~~~~~~~~~~------~~~~~~~~~~~~~~~~~~~~~~~~~~---~~~~~~~~p~~~~~------- 213 (292)
..++. +..|.+||...|... .|+.|+...++..|.+.+.+....+. +.++++....+...
T Consensus 179 ~epniSYicSRyYRaPELifga~~Yt~~IDiWSaGCV~aELl~g~plFpG~s~~dQL~eIik~lG~Pt~e~I~~mn~~y~ 258 (364)
T KOG0658|consen 179 GEPNISYICSRYYRAPELIFGATEYTTSIDIWSAGCVMAELLKGQPLFPGDSSVDQLVEIIKVLGTPTREDIKSMNPNYT 258 (364)
T ss_pred CCCceeEEEeccccCHHHHcCccccCceeEEhhhhHHHHHHhcCCcccCCCCHHHHHHHHHHHhCCCCHHHHhhcCcccc
Confidence 55554 456899999888765 47777777778888877766655543 44555554322211
Q ss_pred ---hhhhhhccCcCCCCCCCCCccchHHHHhcccCcCCCCCCChhhhhhCCcccceec
Q psy758 214 ---CDQLLRHPYFNGYYFEVPDEMQYEEITQRCLDKDPLRRWSCDQLLRHPYFNGYYF 268 (292)
Q Consensus 214 ---~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~~il~h~w~~~~~~ 268 (292)
..++..++|.. -+....+++..+|+.++|.++|.+|.++.|++.||||....-
T Consensus 259 ~~~~p~ik~~~~~~--~~~~~~~~d~~dll~~~L~Y~P~~R~~~~~~l~h~fFdelr~ 314 (364)
T KOG0658|consen 259 EFKFPQIKAHPWHK--VFFKRLPPDALDLLSKLLQYSPSKRLSALEALAHPFFDELRD 314 (364)
T ss_pred cccCccccccccee--ecccCCCHHHHHHHHHHhccChhhcCCHHHHhcchhhHHhhC
Confidence 11222222211 133455788999999999999999999999999999998653
|
|
| >cd07873 STKc_PCTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-40 Score=272.33 Aligned_cols=263 Identities=30% Similarity=0.508 Sum_probs=194.3
Q ss_pred CcccceeeeecccCceEEEEEEEcCCCcEEEEEEeccCCCChHHHHHHHHHHHHHHhCCCCCcchhhhhhhcCCeEEEEE
Q psy758 1 MERYEKIGKLGEGSYGVVFKCRNRDTGQVVAIKKFLESEEDPLIRKIALREIRLLKSLKHPNLVNLLEVFRRKKKLHLVF 80 (292)
Q Consensus 1 ~~~y~~~~~l~~g~~~~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~iv~ 80 (292)
+++|++.+.||+|++|.||+|.+..+++.||+|.+....... ....+.+|+.+++.++||||+++++++.+++..++|+
T Consensus 5 ~~~y~~~~~lg~g~~g~vy~~~~~~~~~~vaiK~~~~~~~~~-~~~~~~~E~~~l~~l~h~nI~~~~~~~~~~~~~~lv~ 83 (301)
T cd07873 5 LETYIKLDKLGEGTYATVYKGRSKLTDNLVALKEIRLEHEEG-APCTAIREVSLLKDLKHANIVTLHDIIHTEKSLTLVF 83 (301)
T ss_pred ccceEEeeEeccCcCEEEEEEEEcCCCcEEEEEEEecccccC-chhHHHHHHHHHHhcCCCCcceEEEEEecCCeEEEEE
Confidence 578999999999999999999999999999999986543222 2234668999999999999999999999999999999
Q ss_pred ecCCCccHHHHh-cCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEEccCCcEEEeecCchhhhhccc----
Q psy758 81 EFCDHTVLNELE-NHPHGLPWDLIKQITWQVLRGVSYCHRHACIHRDIKPENILLTANGVVKLCDFGFARLIRDLI---- 155 (292)
Q Consensus 81 e~~~~~~L~~~~-~~~~~~~~~~~~~i~~qi~~aL~~LH~~givH~dl~p~Nilv~~~~~~kl~dfg~~~~~~~~~---- 155 (292)
||+++ +|..++ .....+++..++.++.||+.||.|||++|++|+||+|+||+++.++.++|+|||++.......
T Consensus 84 e~~~~-~l~~~l~~~~~~~~~~~~~~~~~qi~~aL~~lH~~~i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~ 162 (301)
T cd07873 84 EYLDK-DLKQYLDDCGNSINMHNVKLFLFQLLRGLNYCHRRKVLHRDLKPQNLLINERGELKLADFGLARAKSIPTKTYS 162 (301)
T ss_pred ecccc-CHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCCHHHEEECCCCcEEECcCcchhccCCCCCccc
Confidence 99986 555554 344568999999999999999999999999999999999999999999999999987543211
Q ss_pred -cccccccccccccccC------CCCCCCcccceeeecCCCCCCchHHHHHH---HhhcccCCCCCCChhhhhhccCcCC
Q psy758 156 -PRHLHIFQTNEYFKGV------SLPHAENVVPLEIKIGKPAATNIYLIDFL---KRCLDKDPLRRWSCDQLLRHPYFNG 225 (292)
Q Consensus 156 -~~~~~~~~~~~~~~~~------~~~~~~~~~~~~~~~~~~~~~~~~~~~~~---~~~~~~~p~~~~~~~~~~~~~~~~~ 225 (292)
...+..|.+||...+. ...|+.|+..+++.+|.+++........+ ...+...+...+ ........+..
T Consensus 163 ~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~el~tg~~~f~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~ 240 (301)
T cd07873 163 NEVVTLWYRPPDILLGSTDYSTQIDMWGVGCIFYEMSTGRPLFPGSTVEEQLHFIFRILGTPTEETW--PGILSNEEFKS 240 (301)
T ss_pred ccceeecccCcHHHhCCCCCccHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCChhhc--hhhhccccccc
Confidence 1223457777765442 23566777777777787665443332222 222222211111 01111111111
Q ss_pred CC-----------CCCCCccchHHHHhcccCcCCCCCCChhhhhhCCccccee
Q psy758 226 YY-----------FEVPDEMQYEEITQRCLDKDPLRRWSCDQLLRHPYFNGYY 267 (292)
Q Consensus 226 ~~-----------~~~~~~~~l~~li~~~l~~dP~~Rpt~~~il~h~w~~~~~ 267 (292)
.. .....+..+++||.+||+.||.+|||++++++||||....
T Consensus 241 ~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~R~t~~eil~h~~f~~~~ 293 (301)
T cd07873 241 YNYPKYRADCLHNHAPRLDSDGAELLSKLLQFEGRKRISAEEAMKHPYFHCLG 293 (301)
T ss_pred cccCccccccHHhhcCCCCHHHHHHHHHHhcCCcccCcCHHHHhcCccccccc
Confidence 01 1123466889999999999999999999999999998644
|
Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may pl |
| >cd05622 STKc_ROCK1 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-40 Score=277.31 Aligned_cols=253 Identities=21% Similarity=0.273 Sum_probs=192.1
Q ss_pred cccceeeeecccCceEEEEEEEcCCCcEEEEEEeccCC-CChHHHHHHHHHHHHHHhCCCCCcchhhhhhhcCCeEEEEE
Q psy758 2 ERYEKIGKLGEGSYGVVFKCRNRDTGQVVAIKKFLESE-EDPLIRKIALREIRLLKSLKHPNLVNLLEVFRRKKKLHLVF 80 (292)
Q Consensus 2 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~v~iK~~~~~~-~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~iv~ 80 (292)
++|++.+.||+|+||.||+|.+..+++.||+|++.... ........+.+|..+++.++||||+++++.+.+++..|+||
T Consensus 43 ~~y~i~~~lG~G~fg~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~e~~i~~~~~hp~iv~~~~~~~~~~~~~lv~ 122 (371)
T cd05622 43 EDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFYAFQDDRYLYMVM 122 (371)
T ss_pred hhcEEEEEEeecCCeEEEEEEECCCCcEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCCeEEEEEEcCCEEEEEE
Confidence 68999999999999999999999999999999986543 22233456788999999999999999999999999999999
Q ss_pred ecCCCccHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEEccCCcEEEeecCchhhhhccc-----
Q psy758 81 EFCDHTVLNELENHPHGLPWDLIKQITWQVLRGVSYCHRHACIHRDIKPENILLTANGVVKLCDFGFARLIRDLI----- 155 (292)
Q Consensus 81 e~~~~~~L~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~givH~dl~p~Nilv~~~~~~kl~dfg~~~~~~~~~----- 155 (292)
||++|++|..++... .+++..+..++.||+.||.|||++||+||||||+||+++.++.++|+|||++.......
T Consensus 123 Ey~~gg~L~~~~~~~-~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDLkp~NIll~~~~~ikL~DfG~a~~~~~~~~~~~~ 201 (371)
T cd05622 123 EYMPGGDLVNLMSNY-DVPEKWARFYTAEVVLALDAIHSMGFIHRDVKPDNMLLDKSGHLKLADFGTCMKMNKEGMVRCD 201 (371)
T ss_pred cCCCCCcHHHHHHhc-CCCHHHHHHHHHHHHHHHHHHHHCCEEeCCCCHHHEEECCCCCEEEEeCCceeEcCcCCccccc
Confidence 999999999998764 68999999999999999999999999999999999999999999999999987654221
Q ss_pred -ccccccccccccccc---------CCCCCCCcccceeeecCCCCCCchHHHHHHHhhcccCCCCCCChhhhhhccCcCC
Q psy758 156 -PRHLHIFQTNEYFKG---------VSLPHAENVVPLEIKIGKPAATNIYLIDFLKRCLDKDPLRRWSCDQLLRHPYFNG 225 (292)
Q Consensus 156 -~~~~~~~~~~~~~~~---------~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~ 225 (292)
..++..|.+||...+ ....|+.|+..+++.+|..++............+... ....
T Consensus 202 ~~~gt~~y~aPE~l~~~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~~~~~~i~~~~--------------~~~~ 267 (371)
T cd05622 202 TAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLVGTYSKIMNHK--------------NSLT 267 (371)
T ss_pred CcccCccccCHHHHhccCCCccCCCccceeehhHHHHHHHhCCCCCCCCCHHHHHHHHHcCC--------------Cccc
Confidence 123445667766533 2334555555555555555543333222222222111 0011
Q ss_pred CCCCCCCccchHHHHhcccCcCCCC--CCChhhhhhCCcccceecc
Q psy758 226 YYFEVPDEMQYEEITQRCLDKDPLR--RWSCDQLLRHPYFNGYYFE 269 (292)
Q Consensus 226 ~~~~~~~~~~l~~li~~~l~~dP~~--Rpt~~~il~h~w~~~~~~~ 269 (292)
.+.....+..++++|.+||..+|.+ |++++++++||||++..|+
T Consensus 268 ~~~~~~~s~~~~~li~~~L~~~~~r~~r~~~~ei~~h~~~~~~~~~ 313 (371)
T cd05622 268 FPDDNDISKEAKNLICAFLTDREVRLGRNGVEEIKRHLFFKNDQWA 313 (371)
T ss_pred CCCcCCCCHHHHHHHHHHcCChhhhcCCCCHHHHhcCcccCCCChh
Confidence 1122345778999999999844433 7899999999999986654
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK1 (or ROK-beta) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK1 is preferentially expressed in the liver, lung, spleen, testes, an |
| >cd05604 STKc_SGK3 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-40 Score=273.75 Aligned_cols=243 Identities=24% Similarity=0.317 Sum_probs=188.5
Q ss_pred eeecccCceEEEEEEEcCCCcEEEEEEeccCCC-ChHHHHHHHHHHH-HHHhCCCCCcchhhhhhhcCCeEEEEEecCCC
Q psy758 8 GKLGEGSYGVVFKCRNRDTGQVVAIKKFLESEE-DPLIRKIALREIR-LLKSLKHPNLVNLLEVFRRKKKLHLVFEFCDH 85 (292)
Q Consensus 8 ~~l~~g~~~~v~~~~~~~~~~~v~iK~~~~~~~-~~~~~~~~~~e~~-~~~~l~~~~i~~~~~~~~~~~~~~iv~e~~~~ 85 (292)
+.||+|+||.||+|.+..+|+.||+|++..... .......+..|.. +++.++||||+++++++..++..|+||||+++
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~hp~iv~~~~~~~~~~~~~lv~e~~~~ 80 (325)
T cd05604 1 KVIGKGSFGKVLLAKRKLDGKCYAVKVLQKKIVLNRKEQKHIMAERNVLLKNVKHPFLVGLHYSFQTTEKLYFVLDFVNG 80 (325)
T ss_pred CceeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHHhCCCCCCccEEEEEecCCEEEEEEcCCCC
Confidence 469999999999999999999999999865432 2223344455554 46778999999999999999999999999999
Q ss_pred ccHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEEccCCcEEEeecCchhhhhccc-----ccccc
Q psy758 86 TVLNELENHPHGLPWDLIKQITWQVLRGVSYCHRHACIHRDIKPENILLTANGVVKLCDFGFARLIRDLI-----PRHLH 160 (292)
Q Consensus 86 ~~L~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~givH~dl~p~Nilv~~~~~~kl~dfg~~~~~~~~~-----~~~~~ 160 (292)
++|..++.....+++..+..++.||+.||+|||++|++||||||+||+++.++.++|+|||++....... ..++.
T Consensus 81 ~~L~~~l~~~~~~~~~~~~~~~~qi~~al~~lH~~givH~Dlkp~NIll~~~~~~kL~DfG~~~~~~~~~~~~~~~~gt~ 160 (325)
T cd05604 81 GELFFHLQRERSFPEPRARFYAAEIASALGYLHSINIVYRDLKPENILLDSQGHVVLTDFGLCKEGIAQSDTTTTFCGTP 160 (325)
T ss_pred CCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCHHHeEECCCCCEEEeecCCcccCCCCCCCcccccCCh
Confidence 9999988887789999999999999999999999999999999999999999999999999986532211 12344
Q ss_pred ccccccccccC-----CCCCCCcccceeeecCCCCCCchHHHHHHHhhcccCCCCCCChhhhhhccCcCCCCCCCCCccc
Q psy758 161 IFQTNEYFKGV-----SLPHAENVVPLEIKIGKPAATNIYLIDFLKRCLDKDPLRRWSCDQLLRHPYFNGYYFEVPDEMQ 235 (292)
Q Consensus 161 ~~~~~~~~~~~-----~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 235 (292)
.|.+||...+. ...|+.|+..+++.+|..++.......++...+.. ........+..
T Consensus 161 ~y~aPE~~~~~~~~~~~DvwslG~il~el~~G~~pf~~~~~~~~~~~~~~~------------------~~~~~~~~~~~ 222 (325)
T cd05604 161 EYLAPEVIRKQPYDNTVDWWCLGAVLYEMLYGLPPFYCRDVAEMYDNILHK------------------PLVLRPGASLT 222 (325)
T ss_pred hhCCHHHHcCCCCCCcCccccccceehhhhcCCCCCCCCCHHHHHHHHHcC------------------CccCCCCCCHH
Confidence 57777776554 34566666666666776665444333333333221 11122234678
Q ss_pred hHHHHhcccCcCCCCCCChh----hhhhCCcccceec
Q psy758 236 YEEITQRCLDKDPLRRWSCD----QLLRHPYFNGYYF 268 (292)
Q Consensus 236 l~~li~~~l~~dP~~Rpt~~----~il~h~w~~~~~~ 268 (292)
+.++|++||..||.+||++. ++++||||++..|
T Consensus 223 ~~~ll~~ll~~~p~~R~~~~~~~~~i~~h~~f~~~~~ 259 (325)
T cd05604 223 AWSILEELLEKDRQRRLGAKEDFLEIQEHPFFESLSW 259 (325)
T ss_pred HHHHHHHHhccCHHhcCCCCCCHHHHhcCCCcCCCCH
Confidence 89999999999999999874 8999999998655
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels, |
| >cd05603 STKc_SGK2 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5e-40 Score=272.05 Aligned_cols=244 Identities=23% Similarity=0.277 Sum_probs=187.0
Q ss_pred eeecccCceEEEEEEEcCCCcEEEEEEeccCCC-ChHHHHHHHHHH-HHHHhCCCCCcchhhhhhhcCCeEEEEEecCCC
Q psy758 8 GKLGEGSYGVVFKCRNRDTGQVVAIKKFLESEE-DPLIRKIALREI-RLLKSLKHPNLVNLLEVFRRKKKLHLVFEFCDH 85 (292)
Q Consensus 8 ~~l~~g~~~~v~~~~~~~~~~~v~iK~~~~~~~-~~~~~~~~~~e~-~~~~~l~~~~i~~~~~~~~~~~~~~iv~e~~~~ 85 (292)
+.||+|+||.||+|++..+++.||+|++..... .......+..|. .+++.++||||+++++++.+.+..|+||||+++
T Consensus 1 ~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~h~~iv~~~~~~~~~~~~~lv~e~~~~ 80 (321)
T cd05603 1 KVIGKGSFGKVLLAKRKSDGSFYAVKVLQKKTILKKKEQNHIMAERNVLLKNLKHPFLVGLHYSFQTAEKLYFVLDYVNG 80 (321)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHHHHhhHHHHHHHHHHHHHHhCCCCCccceeeEEEcCCEEEEEEcCCCC
Confidence 469999999999999999999999999865432 222233444454 467889999999999999999999999999999
Q ss_pred ccHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEEccCCcEEEeecCchhhhhccc-----ccccc
Q psy758 86 TVLNELENHPHGLPWDLIKQITWQVLRGVSYCHRHACIHRDIKPENILLTANGVVKLCDFGFARLIRDLI-----PRHLH 160 (292)
Q Consensus 86 ~~L~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~givH~dl~p~Nilv~~~~~~kl~dfg~~~~~~~~~-----~~~~~ 160 (292)
++|...+.....+++..+..++.||+.||.|||++|++||||||+||+++.++.++|+|||++....... ..++.
T Consensus 81 ~~L~~~l~~~~~~~~~~~~~~~~qi~~~L~~lH~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~~~~~~~~gt~ 160 (321)
T cd05603 81 GELFFHLQRERCFLEPRARFYAAEVASAIGYLHSLNIIYRDLKPENILLDSQGHVVLTDFGLCKEGVEPEETTSTFCGTP 160 (321)
T ss_pred CCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEeccCCHHHeEECCCCCEEEccCCCCccCCCCCCccccccCCc
Confidence 9999888777789999999999999999999999999999999999999999999999999986532211 11234
Q ss_pred ccccccccccC-----CCCCCCcccceeeecCCCCCCchHHHHHHHhhcccCCCCCCChhhhhhccCcCCCCCCCCCccc
Q psy758 161 IFQTNEYFKGV-----SLPHAENVVPLEIKIGKPAATNIYLIDFLKRCLDKDPLRRWSCDQLLRHPYFNGYYFEVPDEMQ 235 (292)
Q Consensus 161 ~~~~~~~~~~~-----~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 235 (292)
.|.+||...+. ...|+.|+..+++.+|..++.......+....+. .....+...+..
T Consensus 161 ~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~------------------~~~~~~~~~~~~ 222 (321)
T cd05603 161 EYLAPEVLRKEPYDRTVDWWCLGAVLYEMLYGLPPFYSRDVSQMYDNILH------------------KPLQLPGGKTVA 222 (321)
T ss_pred ccCCHHHhcCCCCCCcCcccccchhhhhhhcCCCCCCCCCHHHHHHHHhc------------------CCCCCCCCCCHH
Confidence 56777765443 3446666666666666665443333333222221 122333445678
Q ss_pred hHHHHhcccCcCCCCCCChh----hhhhCCcccceecc
Q psy758 236 YEEITQRCLDKDPLRRWSCD----QLLRHPYFNGYYFE 269 (292)
Q Consensus 236 l~~li~~~l~~dP~~Rpt~~----~il~h~w~~~~~~~ 269 (292)
+.++|.+||+.||.+||++. ++++|+||....|+
T Consensus 223 ~~~li~~~l~~~p~~R~~~~~~~~~~~~~~~~~~~~~~ 260 (321)
T cd05603 223 ACDLLVGLLHKDQRRRLGAKADFLEIKNHVFFSPINWD 260 (321)
T ss_pred HHHHHHHHccCCHhhcCCCCCCHHHHhCCCCcCCCCHH
Confidence 99999999999999999875 99999999987664
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1. |
| >cd05586 STKc_Sck1_like Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-40 Score=273.67 Aligned_cols=242 Identities=21% Similarity=0.258 Sum_probs=188.7
Q ss_pred ecccCceEEEEEEEcCCCcEEEEEEeccCCC-ChHHHHHHHHHHHHHHhC---CCCCcchhhhhhhcCCeEEEEEecCCC
Q psy758 10 LGEGSYGVVFKCRNRDTGQVVAIKKFLESEE-DPLIRKIALREIRLLKSL---KHPNLVNLLEVFRRKKKLHLVFEFCDH 85 (292)
Q Consensus 10 l~~g~~~~v~~~~~~~~~~~v~iK~~~~~~~-~~~~~~~~~~e~~~~~~l---~~~~i~~~~~~~~~~~~~~iv~e~~~~ 85 (292)
||+|+||.||+|++..+++.||+|++..... ..........|..++..+ .||+|+++++++.+.+.+|+||||+++
T Consensus 1 lG~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~p~i~~~~~~~~~~~~~~lv~e~~~~ 80 (330)
T cd05586 1 IGKGTFGQVYQVRKKDTRRIYAMKVLSKKEIVAKKEVAHTIGERNILVRTLLDESPFIVGLKFSFQTDSDLYLVTDYMSG 80 (330)
T ss_pred CCCCCceEEEEEEECCCCCEEEEEEEeHHHHhhhhHHHHHHHHHHHHHHhccCCCCcCcceEEEEecCCeEEEEEcCCCC
Confidence 7999999999999999999999999865432 222333445566666655 699999999999999999999999999
Q ss_pred ccHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEEccCCcEEEeecCchhhhhccc-----ccccc
Q psy758 86 TVLNELENHPHGLPWDLIKQITWQVLRGVSYCHRHACIHRDIKPENILLTANGVVKLCDFGFARLIRDLI-----PRHLH 160 (292)
Q Consensus 86 ~~L~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~givH~dl~p~Nilv~~~~~~kl~dfg~~~~~~~~~-----~~~~~ 160 (292)
++|..++...+.+++..++.++.||+.||+|||++||+||||||+||+++.++.++|+|||++....... ..++.
T Consensus 81 g~L~~~l~~~~~~~~~~~~~~~~qil~al~~LH~~~ivHrDlkp~Nili~~~~~~kl~Dfg~a~~~~~~~~~~~~~~gt~ 160 (330)
T cd05586 81 GELFWHLQKEGRFSEDRAKFYIAELVLALEHLHKYDIVYRDLKPENILLDATGHIALCDFGLSKANLTDNKTTNTFCGTT 160 (330)
T ss_pred ChHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeEeccCCHHHeEECCCCCEEEecCCcCcCCCCCCCCccCccCCc
Confidence 9999988887889999999999999999999999999999999999999999999999999986532211 12345
Q ss_pred ccccccccccC------CCCCCCcccceeeecCCCCCCchHHHHHHHhhcccCCCCCCChhhhhhccCcCCCCCC-CCCc
Q psy758 161 IFQTNEYFKGV------SLPHAENVVPLEIKIGKPAATNIYLIDFLKRCLDKDPLRRWSCDQLLRHPYFNGYYFE-VPDE 233 (292)
Q Consensus 161 ~~~~~~~~~~~------~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~-~~~~ 233 (292)
.|.+||...+. ...|+.|+..+++.+|..++.......++..... .....+ ...+
T Consensus 161 ~y~aPE~~~~~~~~~~~~DvwslGvil~elltG~~Pf~~~~~~~~~~~i~~------------------~~~~~~~~~~~ 222 (330)
T cd05586 161 EYLAPEVLLDEKGYTKHVDFWSLGVLVFEMCCGWSPFYAEDTQQMYRNIAF------------------GKVRFPKNVLS 222 (330)
T ss_pred cccCHHHHcCCCCCCCccceeccccEEEEeccCCCCCCCCCHHHHHHHHHc------------------CCCCCCCccCC
Confidence 57788865432 4567778888888888776544333333322221 111111 1246
Q ss_pred cchHHHHhcccCcCCCCCC----ChhhhhhCCcccceecc
Q psy758 234 MQYEEITQRCLDKDPLRRW----SCDQLLRHPYFNGYYFE 269 (292)
Q Consensus 234 ~~l~~li~~~l~~dP~~Rp----t~~~il~h~w~~~~~~~ 269 (292)
..+.++|++||+.||.+|| ++.++++||||.+..|+
T Consensus 223 ~~~~~li~~~L~~~P~~R~~~~~~~~~ll~h~~~~~~~~~ 262 (330)
T cd05586 223 DEGRQFVKGLLNRNPQHRLGAHRDAVELKEHPFFADIDWD 262 (330)
T ss_pred HHHHHHHHHHcCCCHHHCCCCCCCHHHHhcCccccCCCHH
Confidence 7899999999999999998 78999999999986544
|
Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of |
| >cd05617 STKc_aPKC_zeta Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-40 Score=272.99 Aligned_cols=252 Identities=22% Similarity=0.299 Sum_probs=189.4
Q ss_pred eeecccCceEEEEEEEcCCCcEEEEEEeccCCC-ChHHHHHHHHHHHHHHhC-CCCCcchhhhhhhcCCeEEEEEecCCC
Q psy758 8 GKLGEGSYGVVFKCRNRDTGQVVAIKKFLESEE-DPLIRKIALREIRLLKSL-KHPNLVNLLEVFRRKKKLHLVFEFCDH 85 (292)
Q Consensus 8 ~~l~~g~~~~v~~~~~~~~~~~v~iK~~~~~~~-~~~~~~~~~~e~~~~~~l-~~~~i~~~~~~~~~~~~~~iv~e~~~~ 85 (292)
+.||+|+||.||+|.+..+++.||+|++..... .....+.+.+|..++..+ .||+|+++++++.+.+.+|+||||+++
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~ 80 (327)
T cd05617 1 RVIGRGSYAKVLLVRLKKNDQIYAMKVVKKELVHDDEDIDWVQTEKHVFEQASSNPFLVGLHSCFQTTSRLFLVIEYVNG 80 (327)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhhcCCCCEeeEEEEEEeCCEEEEEEeCCCC
Confidence 479999999999999999999999999976542 234456678899999888 599999999999999999999999999
Q ss_pred ccHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEEccCCcEEEeecCchhhhhcc-----cccccc
Q psy758 86 TVLNELENHPHGLPWDLIKQITWQVLRGVSYCHRHACIHRDIKPENILLTANGVVKLCDFGFARLIRDL-----IPRHLH 160 (292)
Q Consensus 86 ~~L~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~givH~dl~p~Nilv~~~~~~kl~dfg~~~~~~~~-----~~~~~~ 160 (292)
++|..++...+.+++..++.++.||+.||+|||++|++||||||+||+++.++.++|+|||++...... ...++.
T Consensus 81 ~~L~~~~~~~~~l~~~~~~~~~~qi~~al~~lH~~~ivHrDlkp~Nili~~~~~~kl~Dfg~~~~~~~~~~~~~~~~gt~ 160 (327)
T cd05617 81 GDLMFHMQRQRKLPEEHARFYAAEICIALNFLHERGIIYRDLKLDNVLLDADGHIKLTDYGMCKEGLGPGDTTSTFCGTP 160 (327)
T ss_pred CcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHEEEeCCCCEEEeccccceeccCCCCceecccCCc
Confidence 999998877778999999999999999999999999999999999999999999999999998643211 112344
Q ss_pred ccccccccccCCC-----CCCCcccceeeecCCCCCCchHHHHHHHhhcccCCCCCCChhhhhhccCcCCCCCCCCCccc
Q psy758 161 IFQTNEYFKGVSL-----PHAENVVPLEIKIGKPAATNIYLIDFLKRCLDKDPLRRWSCDQLLRHPYFNGYYFEVPDEMQ 235 (292)
Q Consensus 161 ~~~~~~~~~~~~~-----~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 235 (292)
.|.+||...+... .|+.|+..+++.+|..++... ..++ .......+...........+...+..
T Consensus 161 ~y~aPE~~~~~~~~~~~DiwslGvil~ell~g~~pf~~~----------~~~~-~~~~~~~~~~~~~~~~~~~p~~~~~~ 229 (327)
T cd05617 161 NYIAPEILRGEEYGFSVDWWALGVLMFEMMAGRSPFDII----------TDNP-DMNTEDYLFQVILEKPIRIPRFLSVK 229 (327)
T ss_pred ccCCHHHHCCCCCCchheeehhHHHHHHHHhCCCCCCcc----------CCCc-ccccHHHHHHHHHhCCCCCCCCCCHH
Confidence 5667776655433 344444444445554443100 0000 00011111111111223344556778
Q ss_pred hHHHHhcccCcCCCCCCCh------hhhhhCCcccceeccC
Q psy758 236 YEEITQRCLDKDPLRRWSC------DQLLRHPYFNGYYFEV 270 (292)
Q Consensus 236 l~~li~~~l~~dP~~Rpt~------~~il~h~w~~~~~~~~ 270 (292)
+.++|.+||+.||.+|+++ .++++||||.++.|+.
T Consensus 230 ~~~li~~~L~~dP~~R~~~~~~~~~~~i~~h~~f~~~~~~~ 270 (327)
T cd05617 230 ASHVLKGFLNKDPKERLGCQPQTGFSDIKSHTFFRSIDWDL 270 (327)
T ss_pred HHHHHHHHhccCHHHcCCCCCCCCHHHHHcCCCCCCCCHHH
Confidence 9999999999999999985 6999999999988773
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways |
| >cd06625 STKc_MEKK3_like Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-39 Score=262.85 Aligned_cols=249 Identities=23% Similarity=0.331 Sum_probs=191.6
Q ss_pred cccceeeeecccCceEEEEEEEcCCCcEEEEEEeccCCCC---hHHHHHHHHHHHHHHhCCCCCcchhhhhhhcCCeEEE
Q psy758 2 ERYEKIGKLGEGSYGVVFKCRNRDTGQVVAIKKFLESEED---PLIRKIALREIRLLKSLKHPNLVNLLEVFRRKKKLHL 78 (292)
Q Consensus 2 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~v~iK~~~~~~~~---~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~i 78 (292)
+.|++.+.||+|++|.||.|.+..+++.|++|.+...... ....+.+.+|+.+++.++||||+++++++.+++..++
T Consensus 2 ~~~~~~~~lg~g~~~~vy~~~~~~~~~~~~lk~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~ 81 (263)
T cd06625 2 TNWRRGKLLGQGAFGRVYLCYDVDTGRELAVKQVPFDPDSPETKKEVNALECEIQLLKNLQHERIVQYYGCLRDDETLSI 81 (263)
T ss_pred CcccccceecCCCceEEEEEEEcCCCcEEEEEEEeecccchhhHHHHHHHHHHHHHHHhCCCCCeeeeEEEEccCCeEEE
Confidence 5799999999999999999999999999999998755422 2234668889999999999999999999999999999
Q ss_pred EEecCCCccHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEEccCCcEEEeecCchhhhhccc---
Q psy758 79 VFEFCDHTVLNELENHPHGLPWDLIKQITWQVLRGVSYCHRHACIHRDIKPENILLTANGVVKLCDFGFARLIRDLI--- 155 (292)
Q Consensus 79 v~e~~~~~~L~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~givH~dl~p~Nilv~~~~~~kl~dfg~~~~~~~~~--- 155 (292)
++||+++++|.+++...+.+++..+..++.|++.||.+||+.|++|+||+|+||++++++.++|+|||.+.......
T Consensus 82 v~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~i~H~dl~p~nilv~~~~~~~l~dfg~~~~~~~~~~~~ 161 (263)
T cd06625 82 FMEYMPGGSVKDQLKAYGALTETVTRKYTRQILEGVEYLHSNMIVHRDIKGANILRDSAGNVKLGDFGASKRLQTICSSG 161 (263)
T ss_pred EEEECCCCcHHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCCEEEeecccceecccccccc
Confidence 99999999999998877789999999999999999999999999999999999999999999999999987553311
Q ss_pred -----cccccccccccccccCCCCCCCcccceeeecCCCCCCchHHHHHHHhhcccCCCCCCChhhhhhccCc--CCCCC
Q psy758 156 -----PRHLHIFQTNEYFKGVSLPHAENVVPLEIKIGKPAATNIYLIDFLKRCLDKDPLRRWSCDQLLRHPYF--NGYYF 228 (292)
Q Consensus 156 -----~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~--~~~~~ 228 (292)
......|.+||...+.......++ ++.+.-+++.+.+..|+...+..+....... .....
T Consensus 162 ~~~~~~~~~~~y~aPE~~~~~~~~~~~Di-------------~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~ 228 (263)
T cd06625 162 TGMKSVTGTPYWMSPEVISGEGYGRKADV-------------WSVGCTVVEMLTEKPPWAEFEAMAAIFKIATQPTNPQL 228 (263)
T ss_pred ccccCCCcCccccCcceeccCCCCchhhh-------------HHHHHHHHHHHhCCCCccccchHHHHHHHhccCCCCCC
Confidence 112234666666554433222222 3333334444444455444333222211111 11223
Q ss_pred CCCCccchHHHHhcccCcCCCCCCChhhhhhCCcc
Q psy758 229 EVPDEMQYEEITQRCLDKDPLRRWSCDQLLRHPYF 263 (292)
Q Consensus 229 ~~~~~~~l~~li~~~l~~dP~~Rpt~~~il~h~w~ 263 (292)
+...+..+.++|.+||..||.+|||+.++++||||
T Consensus 229 ~~~~~~~~~~li~~~l~~~p~~Rpt~~~ll~~~~~ 263 (263)
T cd06625 229 PSHVSPDARNFLRRTFVENAKKRPSAEELLRHFFV 263 (263)
T ss_pred CccCCHHHHHHHHHHhhcCcccCCCHHHHhhCCCC
Confidence 44557789999999999999999999999999997
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades t |
| >cd05602 STKc_SGK1 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.8e-40 Score=272.54 Aligned_cols=244 Identities=21% Similarity=0.261 Sum_probs=185.2
Q ss_pred eeecccCceEEEEEEEcCCCcEEEEEEeccCCC-ChHHHHHHHHHH-HHHHhCCCCCcchhhhhhhcCCeEEEEEecCCC
Q psy758 8 GKLGEGSYGVVFKCRNRDTGQVVAIKKFLESEE-DPLIRKIALREI-RLLKSLKHPNLVNLLEVFRRKKKLHLVFEFCDH 85 (292)
Q Consensus 8 ~~l~~g~~~~v~~~~~~~~~~~v~iK~~~~~~~-~~~~~~~~~~e~-~~~~~l~~~~i~~~~~~~~~~~~~~iv~e~~~~ 85 (292)
+.||+|+||.||+|++..+++.||+|++..... .......+..|. .+++.++||||+++++++.+++..|+||||+++
T Consensus 1 ~~lg~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~h~~Iv~~~~~~~~~~~~~lv~e~~~~ 80 (325)
T cd05602 1 KVIGKGSFGKVLLARHKAEEKFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGLHFSFQTADKLYFVLDYING 80 (325)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHHhhhHHHHHHHHHHHHHHhCCCCCCCceeEEEEcCCeEEEEEeCCCC
Confidence 469999999999999999999999999875432 112223333443 456788999999999999999999999999999
Q ss_pred ccHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEEccCCcEEEeecCchhhhhccc-----ccccc
Q psy758 86 TVLNELENHPHGLPWDLIKQITWQVLRGVSYCHRHACIHRDIKPENILLTANGVVKLCDFGFARLIRDLI-----PRHLH 160 (292)
Q Consensus 86 ~~L~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~givH~dl~p~Nilv~~~~~~kl~dfg~~~~~~~~~-----~~~~~ 160 (292)
++|..++...+.+++..+..++.||+.||.|||++|++||||||+||+++.++.++|+|||++....... ..++.
T Consensus 81 ~~L~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~giiHrDlkp~Nili~~~~~~kl~DfG~a~~~~~~~~~~~~~~gt~ 160 (325)
T cd05602 81 GELFYHLQRERCFLEPRARFYAAEIASALGYLHSLNIVYRDLKPENILLDSQGHIVLTDFGLCKENIEHNGTTSTFCGTP 160 (325)
T ss_pred CcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHeEECCCCCEEEccCCCCcccccCCCCcccccCCc
Confidence 9999999887789999999999999999999999999999999999999999999999999986532211 12344
Q ss_pred ccccccccccCC-----CCCCCcccceeeecCCCCCCchHHHHHHHhhcccCCCCCCChhhhhhccCcCCCCCCCCCccc
Q psy758 161 IFQTNEYFKGVS-----LPHAENVVPLEIKIGKPAATNIYLIDFLKRCLDKDPLRRWSCDQLLRHPYFNGYYFEVPDEMQ 235 (292)
Q Consensus 161 ~~~~~~~~~~~~-----~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 235 (292)
.|.+||...+.. ..|+.|+..+++.+|..++.......++.... ..........+..
T Consensus 161 ~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~------------------~~~~~~~~~~~~~ 222 (325)
T cd05602 161 EYLAPEVLHKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRNTAEMYDNIL------------------NKPLQLKPNITNS 222 (325)
T ss_pred cccCHHHHcCCCCCCccccccccHHHHHHhcCCCCCCCCCHHHHHHHHH------------------hCCcCCCCCCCHH
Confidence 577777665543 34555555555555555443322222222221 1112223345778
Q ss_pred hHHHHhcccCcCCCCCCChh----hhhhCCcccceecc
Q psy758 236 YEEITQRCLDKDPLRRWSCD----QLLRHPYFNGYYFE 269 (292)
Q Consensus 236 l~~li~~~l~~dP~~Rpt~~----~il~h~w~~~~~~~ 269 (292)
+.++|.+||+.||.+||++. ++++|+||....|+
T Consensus 223 ~~~li~~~l~~~p~~R~~~~~~~~~i~~~~~~~~~~~~ 260 (325)
T cd05602 223 ARHLLEGLLQKDRTKRLGAKDDFMEIKNHIFFSPINWD 260 (325)
T ss_pred HHHHHHHHcccCHHHCCCCCCCHHHHhcCcccCCCCHH
Confidence 99999999999999999887 89999999987664
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt |
| >cd07847 STKc_CDKL1_4 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-40 Score=268.19 Aligned_cols=259 Identities=53% Similarity=0.912 Sum_probs=192.3
Q ss_pred cccceeeeecccCceEEEEEEEcCCCcEEEEEEeccCCCChHHHHHHHHHHHHHHhCCCCCcchhhhhhhcCCeEEEEEe
Q psy758 2 ERYEKIGKLGEGSYGVVFKCRNRDTGQVVAIKKFLESEEDPLIRKIALREIRLLKSLKHPNLVNLLEVFRRKKKLHLVFE 81 (292)
Q Consensus 2 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~iv~e 81 (292)
++|++.+.||+|++|.||+|.+..+++.|++|.+..........+.+.+|+.+++.++|||++++++++......++|+|
T Consensus 1 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~v~e 80 (286)
T cd07847 1 EKYEKLSKIGEGSYGVVFKCRNRETGQIVAIKKFVESEDDPVIKKIALREIRMLKQLKHPNLVNLIEVFRRKRKLHLVFE 80 (286)
T ss_pred CceeeeeeecccCCeEEEEEEECCCCcEEEEEEEeecccCccccHHHHHHHHHHHhCCCCCEeeeeeEEeeCCEEEEEEe
Confidence 58999999999999999999999999999999987654433345667889999999999999999999999999999999
Q ss_pred cCCCccHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEEccCCcEEEeecCchhhhhccc-----c
Q psy758 82 FCDHTVLNELENHPHGLPWDLIKQITWQVLRGVSYCHRHACIHRDIKPENILLTANGVVKLCDFGFARLIRDLI-----P 156 (292)
Q Consensus 82 ~~~~~~L~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~givH~dl~p~Nilv~~~~~~kl~dfg~~~~~~~~~-----~ 156 (292)
|++++++..+......+++..++.++.||+.||.|||+.|++|+||+|+||+++.++.++|+|||++....... .
T Consensus 81 ~~~~~~l~~~~~~~~~~~~~~~~~~~~ql~~~l~~LH~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~ 160 (286)
T cd07847 81 YCDHTVLNELEKNPRGVPEHLIKKIIWQTLQAVNFCHKHNCIHRDVKPENILITKQGQIKLCDFGFARILTGPGDDYTDY 160 (286)
T ss_pred ccCccHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCChhhEEEcCCCcEEECccccceecCCCcccccCc
Confidence 99999999988777789999999999999999999999999999999999999999999999999987664322 1
Q ss_pred ccccccccccccccC------CCCCCCcccceeeecCCCCCCchHHHHH---HHhhcccCCCCCCChhhhh-hccCcCCC
Q psy758 157 RHLHIFQTNEYFKGV------SLPHAENVVPLEIKIGKPAATNIYLIDF---LKRCLDKDPLRRWSCDQLL-RHPYFNGY 226 (292)
Q Consensus 157 ~~~~~~~~~~~~~~~------~~~~~~~~~~~~~~~~~~~~~~~~~~~~---~~~~~~~~p~~~~~~~~~~-~~~~~~~~ 226 (292)
.....|.+||...+. ...|+.|+..+++.+|.+++......+. +.......... ..+.. ...+....
T Consensus 161 ~~~~~~~aPE~~~~~~~~~~~~Di~slG~i~~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~---~~~~~~~~~~~~~~ 237 (286)
T cd07847 161 VATRWYRAPELLVGDTQYGPPVDVWAIGCVFAELLTGQPLWPGKSDVDQLYLIRKTLGDLIPR---HQQIFSTNQFFKGL 237 (286)
T ss_pred ccccccCCHHHHhCCCCcCchhhhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChH---Hhhhcccccccccc
Confidence 123446677765432 2345555555666666655432211111 11111100000 00000 00010000
Q ss_pred CC------------CCCCccchHHHHhcccCcCCCCCCChhhhhhCCcc
Q psy758 227 YF------------EVPDEMQYEEITQRCLDKDPLRRWSCDQLLRHPYF 263 (292)
Q Consensus 227 ~~------------~~~~~~~l~~li~~~l~~dP~~Rpt~~~il~h~w~ 263 (292)
.. ....+..+.+||.+||+.||++|||+.+++.||||
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~eil~~~~f 286 (286)
T cd07847 238 SIPEPETREPLESKFPNISSPALSFLKGCLQMDPTERLSCEELLEHPYF 286 (286)
T ss_pred cCCCcccccCHHHHhccCCHHHHHHHHHHhcCCccccCCHHHHhcCCCC
Confidence 00 01236778999999999999999999999999998
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The functio |
| >PTZ00036 glycogen synthase kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-40 Score=284.08 Aligned_cols=256 Identities=29% Similarity=0.433 Sum_probs=186.1
Q ss_pred cccceeeeecccCceEEEEEEEcCCCcEEEEEEeccCCCChHHHHHHHHHHHHHHhCCCCCcchhhhhhhc--------C
Q psy758 2 ERYEKIGKLGEGSYGVVFKCRNRDTGQVVAIKKFLESEEDPLIRKIALREIRLLKSLKHPNLVNLLEVFRR--------K 73 (292)
Q Consensus 2 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~--------~ 73 (292)
++|++++.||+|+||.||+|.+..+++.||+|.+.... ....+|+.+++.++||||+++++++.. .
T Consensus 66 ~~y~~~~~LG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~------~~~~~Ei~il~~l~h~niv~l~~~~~~~~~~~~~~~ 139 (440)
T PTZ00036 66 KSYKLGNIIGNGSFGVVYEAICIDTSEKVAIKKVLQDP------QYKNRELLIMKNLNHINIIFLKDYYYTECFKKNEKN 139 (440)
T ss_pred CeEEEeEEEEeCCCEEEEEEEECCCCCEEEEEEEecCc------chHHHHHHHHHhcCCCCCcceeeeEeecccccCCCc
Confidence 47999999999999999999999999999999885432 223469999999999999999887632 2
Q ss_pred CeEEEEEecCCCccHHHH---hcCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEEccCC-cEEEeecCchh
Q psy758 74 KKLHLVFEFCDHTVLNEL---ENHPHGLPWDLIKQITWQVLRGVSYCHRHACIHRDIKPENILLTANG-VVKLCDFGFAR 149 (292)
Q Consensus 74 ~~~~iv~e~~~~~~L~~~---~~~~~~~~~~~~~~i~~qi~~aL~~LH~~givH~dl~p~Nilv~~~~-~~kl~dfg~~~ 149 (292)
..+++||||++++....+ ......+++..++.++.||+.||+|||++||+||||||+||+++.++ .+||+|||+++
T Consensus 140 ~~l~lvmE~~~~~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~gL~yLH~~~IiHrDLKp~NILl~~~~~~vkL~DFGla~ 219 (440)
T PTZ00036 140 IFLNVVMEFIPQTVHKYMKHYARNNHALPLFLVKLYSYQLCRALAYIHSKFICHRDLKPQNLLIDPNTHTLKLCDFGSAK 219 (440)
T ss_pred eEEEEEEecCCccHHHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHHCCEecCCcCHHHEEEcCCCCceeeeccccch
Confidence 257799999997643322 23455799999999999999999999999999999999999999765 69999999998
Q ss_pred hhhccc----cccccccccccccccC------CCCCCCcccceeeecCCCCCCchHHHHHHHhh---cccCCCCCCChhh
Q psy758 150 LIRDLI----PRHLHIFQTNEYFKGV------SLPHAENVVPLEIKIGKPAATNIYLIDFLKRC---LDKDPLRRWSCDQ 216 (292)
Q Consensus 150 ~~~~~~----~~~~~~~~~~~~~~~~------~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~---~~~~p~~~~~~~~ 216 (292)
...... ...+..|.+||...+. ...|+.|+..+++.+|.+++.+....+.+... ++..+ ..+
T Consensus 220 ~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~elltG~~pf~~~~~~~~~~~i~~~~~~p~-----~~~ 294 (440)
T PTZ00036 220 NLLAGQRSVSYICSRFYRAPELMLGATNYTTHIDLWSLGCIIAEMILGYPIFSGQSSVDQLVRIIQVLGTPT-----EDQ 294 (440)
T ss_pred hccCCCCcccCCCCcCccCHHHhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCC-----HHH
Confidence 654321 2234457788876543 23467777777788887776543322222221 11111 010
Q ss_pred hhh-ccCcCCC------------CCCCCCccchHHHHhcccCcCCCCCCChhhhhhCCcccceec
Q psy758 217 LLR-HPYFNGY------------YFEVPDEMQYEEITQRCLDKDPLRRWSCDQLLRHPYFNGYYF 268 (292)
Q Consensus 217 ~~~-~~~~~~~------------~~~~~~~~~l~~li~~~l~~dP~~Rpt~~~il~h~w~~~~~~ 268 (292)
... .+.+... .++...+.++.+||.+||.+||.+|||+.|+++||||.+...
T Consensus 295 ~~~~~~~~~~~~~~~~~~~~l~~~~p~~~~~~~~~li~~~L~~dP~~R~ta~e~l~hp~f~~~~~ 359 (440)
T PTZ00036 295 LKEMNPNYADIKFPDVKPKDLKKVFPKGTPDDAINFISQFLKYEPLKRLNPIEALADPFFDDLRD 359 (440)
T ss_pred HHHhchhhhcccCCccCchhHHHHhccCCCHHHHHHHHHHCCCChhHCcCHHHHhCChhHHhhhc
Confidence 000 0000000 112234678999999999999999999999999999987643
|
|
| >KOG0201|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-41 Score=269.02 Aligned_cols=245 Identities=28% Similarity=0.417 Sum_probs=200.8
Q ss_pred ccceeeeecccCceEEEEEEEcCCCcEEEEEEeccCCCChHHHHHHHHHHHHHHhCCCCCcchhhhhhhcCCeEEEEEec
Q psy758 3 RYEKIGKLGEGSYGVVFKCRNRDTGQVVAIKKFLESEEDPLIRKIALREIRLLKSLKHPNLVNLLEVFRRKKKLHLVFEF 82 (292)
Q Consensus 3 ~y~~~~~l~~g~~~~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~iv~e~ 82 (292)
.|+..+.||+|.||.||+|.+..+++.||+|++......++ ...+.+|+.++.+++++||.++|+.|..+..++++|||
T Consensus 14 ~~~~~~~IgrGsfG~Vyk~~d~~t~k~vAiKii~Le~~~de-Iediqqei~~Ls~~~~~~it~yygsyl~g~~LwiiMey 92 (467)
T KOG0201|consen 14 LYTKLELIGRGSFGEVYKAIDNKTKKVVAIKIIDLEEAEDE-IEDIQQEISVLSQCDSPNITEYYGSYLKGTKLWIIMEY 92 (467)
T ss_pred ccccchhccccccceeeeeeeccccceEEEEEechhhcchh-hHHHHHHHHHHHhcCcchHHhhhhheeecccHHHHHHH
Confidence 58888999999999999999999999999999987665543 44578899999999999999999999999999999999
Q ss_pred CCCccHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEEccCCcEEEeecCchhhhhcccccccccc
Q psy758 83 CDHTVLNELENHPHGLPWDLIKQITWQVLRGVSYCHRHACIHRDIKPENILLTANGVVKLCDFGFARLIRDLIPRHLHIF 162 (292)
Q Consensus 83 ~~~~~L~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~givH~dl~p~Nilv~~~~~~kl~dfg~~~~~~~~~~~~~~~~ 162 (292)
|.||++.+.++....+++..+..++.+++.||.|||+++.+|+|||+.||++..+|.+||+|||.+............+.
T Consensus 93 ~~gGsv~~lL~~~~~~~E~~i~~ilre~l~~l~ylH~~~kiHrDIKaanil~s~~g~vkl~DfgVa~ql~~~~~rr~tfv 172 (467)
T KOG0201|consen 93 CGGGSVLDLLKSGNILDEFEIAVILREVLKGLDYLHSEKKIHRDIKAANILLSESGDVKLADFGVAGQLTNTVKRRKTFV 172 (467)
T ss_pred hcCcchhhhhccCCCCccceeeeehHHHHHHhhhhhhcceecccccccceeEeccCcEEEEecceeeeeechhhcccccc
Confidence 99999999999887779999999999999999999999999999999999999999999999999988776555555566
Q ss_pred ccccccccCCC----------CCCCcccceeeecCCCCCCchHHHHHHHhhcccCCCCCCChhhhhhccCcCCCCCCCCC
Q psy758 163 QTNEYFKGVSL----------PHAENVVPLEIKIGKPAATNIYLIDFLKRCLDKDPLRRWSCDQLLRHPYFNGYYFEVPD 232 (292)
Q Consensus 163 ~~~~~~~~~~~----------~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~ 232 (292)
++|.|++++.+ .|++|+..+++..|.++......... +-.-|.. ..-......
T Consensus 173 GTPfwMAPEVI~~~~Y~~KADIWSLGITaiEla~GePP~s~~hPmrv----lflIpk~-------------~PP~L~~~~ 235 (467)
T KOG0201|consen 173 GTPFWMAPEVIKQSGYDTKADIWSLGITAIELAKGEPPHSKLHPMRV----LFLIPKS-------------APPRLDGDF 235 (467)
T ss_pred ccccccchhhhccccccchhhhhhhhHHHHHHhcCCCCCcccCcceE----EEeccCC-------------CCCcccccc
Confidence 66666665443 47777777777777776432222000 0000100 011122244
Q ss_pred ccchHHHHhcccCcCCCCCCChhhhhhCCcccc
Q psy758 233 EMQYEEITQRCLDKDPLRRWSCDQLLRHPYFNG 265 (292)
Q Consensus 233 ~~~l~~li~~~l~~dP~~Rpt~~~il~h~w~~~ 265 (292)
++.+++||..||+.||+.||||.++|.|+|++.
T Consensus 236 S~~~kEFV~~CL~k~P~~RpsA~~LLKh~FIk~ 268 (467)
T KOG0201|consen 236 SPPFKEFVEACLDKNPEFRPSAKELLKHKFIKR 268 (467)
T ss_pred CHHHHHHHHHHhhcCcccCcCHHHHhhhHHHHh
Confidence 778999999999999999999999999999998
|
|
| >cd05574 STKc_phototropin_like Catalytic domain of Phototropin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-39 Score=269.35 Aligned_cols=259 Identities=25% Similarity=0.362 Sum_probs=194.0
Q ss_pred cccceeeeecccCceEEEEEEEcCCCcEEEEEEeccCCCCh-HHHHHHHHHHHHHHhCCCCCcchhhhhhhcCCeEEEEE
Q psy758 2 ERYEKIGKLGEGSYGVVFKCRNRDTGQVVAIKKFLESEEDP-LIRKIALREIRLLKSLKHPNLVNLLEVFRRKKKLHLVF 80 (292)
Q Consensus 2 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~v~iK~~~~~~~~~-~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~iv~ 80 (292)
++|++.+.||+|++|.||+|.+..+++.|++|.+....... ...+.+..|+..++.++||||+++++.+.+++..|+++
T Consensus 1 ~~y~~~~~ig~g~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~ 80 (316)
T cd05574 1 KHFKKIKLLGKGDVGRVFLVRLKGTGKLFALKVLDKKEMIKRNKVKRVLTEQEILATLDHPFLPTLYASFQTETYLCLVM 80 (316)
T ss_pred CceEEeeeecCCccEEEEEEEEcCCCcEEEEEEEeccccchHHHHHHHHHHHHHHHhCCCCCchhheeeeecCCEEEEEE
Confidence 47999999999999999999999999999999997665432 45667889999999999999999999999999999999
Q ss_pred ecCCCccHHHHhcCC--CCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEEccCCcEEEeecCchhhhhcccc--
Q psy758 81 EFCDHTVLNELENHP--HGLPWDLIKQITWQVLRGVSYCHRHACIHRDIKPENILLTANGVVKLCDFGFARLIRDLIP-- 156 (292)
Q Consensus 81 e~~~~~~L~~~~~~~--~~~~~~~~~~i~~qi~~aL~~LH~~givH~dl~p~Nilv~~~~~~kl~dfg~~~~~~~~~~-- 156 (292)
||+.+++|.+++... ..+++..++.++.|++.||+|||++|++|+||+|+||+++.++.++|+|||++........
T Consensus 81 e~~~~~~L~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~~~~~~~ 160 (316)
T cd05574 81 DYCPGGELFRLLQRQPGKCLSEEVARFYAAEVLLALEYLHLLGIVYRDLKPENILLHESGHIMLSDFDLSKQSDVEPPPV 160 (316)
T ss_pred EecCCCCHHHHHHhCCCCccCHHHHHHHHHHHHHHHHHHHHCCeeccCCChHHeEEcCCCCEEEeecchhhccccccccc
Confidence 999999999988653 4689999999999999999999999999999999999999999999999999875432111
Q ss_pred --------------------------------ccccccccccccccCCCCCCCcccceeeecCCCCCCchHHHHHHHhhc
Q psy758 157 --------------------------------RHLHIFQTNEYFKGVSLPHAENVVPLEIKIGKPAATNIYLIDFLKRCL 204 (292)
Q Consensus 157 --------------------------------~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 204 (292)
.++..|.+||...+.......++ ++.+.-++..+.
T Consensus 161 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Di-------------~slG~ll~~l~~ 227 (316)
T cd05574 161 SKALRKGSRRSSVNSIPSETFSEEPSFRSNSFVGTEEYIAPEVISGDGHGSAVDW-------------WTLGILLYEMLY 227 (316)
T ss_pred ccccccccccccccccchhhhcccccCCCCCCcCccCCcCHHHHcCCCCCchHHH-------------HHHHHHHHHHhh
Confidence 01122444444433322211222 222223334444
Q ss_pred ccCCCCCCChhhhhhccCcCCCCCCC--CCccchHHHHhcccCcCCCCCCC----hhhhhhCCcccceeccCCCh
Q psy758 205 DKDPLRRWSCDQLLRHPYFNGYYFEV--PDEMQYEEITQRCLDKDPLRRWS----CDQLLRHPYFNGYYFEVPDE 273 (292)
Q Consensus 205 ~~~p~~~~~~~~~~~~~~~~~~~~~~--~~~~~l~~li~~~l~~dP~~Rpt----~~~il~h~w~~~~~~~~~~~ 273 (292)
+..|.......+.+..........+. ..+..+.++|.+||+.||++||| ++++++||||++..|.....
T Consensus 228 g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~s~~~~~~~ll~~~~~~~~~~~~~~~ 302 (316)
T cd05574 228 GTTPFKGSNRDETFSNILKKEVTFPGSPPVSSSARDLIRKLLVKDPSKRLGSKRGAAEIKQHPFFRGVNWALIRH 302 (316)
T ss_pred CCCCCCCCchHHHHHHHhcCCccCCCccccCHHHHHHHHHHccCCHhHCCCchhhHHHHHcCchhhcCChhhccc
Confidence 44444333322222211111111121 24778999999999999999999 99999999999987765544
|
Serine/Threonine Kinases (STKs), Phototropin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The phototropin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Included in this subfamily are plant phototropins and predominantly uncharacterized fungal STKs whose catalytic domains resemble the phototropin kinase domain. One protein from Neurospora crassa is called nrc-2. Phototropins are blue-light receptors that control responses such as phototropism, stromatal opening, and chloroplast movement in order to optimize the photosynthetic efficiency of plants. They are light-activated STKs that contain an N-termin |
| >cd07862 STKc_CDK6 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-40 Score=269.49 Aligned_cols=260 Identities=32% Similarity=0.501 Sum_probs=183.9
Q ss_pred cccceeeeecccCceEEEEEEEcC-CCcEEEEEEeccCCCChHHHHHHHHHHHHHHhC---CCCCcchhhhhhh-----c
Q psy758 2 ERYEKIGKLGEGSYGVVFKCRNRD-TGQVVAIKKFLESEEDPLIRKIALREIRLLKSL---KHPNLVNLLEVFR-----R 72 (292)
Q Consensus 2 ~~y~~~~~l~~g~~~~v~~~~~~~-~~~~v~iK~~~~~~~~~~~~~~~~~e~~~~~~l---~~~~i~~~~~~~~-----~ 72 (292)
++|++.+.||+|+||.||+|.+.. ++..||+|.+............+.+|+.+++.+ +||||+++++++. .
T Consensus 1 ~~Y~~~~~lg~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~hpniv~~~~~~~~~~~~~ 80 (290)
T cd07862 1 QQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRTDR 80 (290)
T ss_pred CCcceeeEeccCCCeEEEEEEEcCCCCeEEEEEEEecccCCCCchHHHHHHHHHHHhhcccCCCCcceEEEEEecccCCC
Confidence 589999999999999999999864 467899999876543333334455677777665 6999999999874 3
Q ss_pred CCeEEEEEecCCCccHHHHhcC--CCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEEccCCcEEEeecCchhh
Q psy758 73 KKKLHLVFEFCDHTVLNELENH--PHGLPWDLIKQITWQVLRGVSYCHRHACIHRDIKPENILLTANGVVKLCDFGFARL 150 (292)
Q Consensus 73 ~~~~~iv~e~~~~~~L~~~~~~--~~~~~~~~~~~i~~qi~~aL~~LH~~givH~dl~p~Nilv~~~~~~kl~dfg~~~~ 150 (292)
....++|+||+++ +|..++.. ...+++..++.++.||+.||.|||++|++|+||||+||+++.++.++|+|||++..
T Consensus 81 ~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~lH~~~iiH~dlkp~Nil~~~~~~~kl~Dfg~~~~ 159 (290)
T cd07862 81 ETKLTLVFEHVDQ-DLTTYLDKVPEPGVPTETIKDMMFQLLRGLDFLHSHRVVHRDLKPQNILVTSSGQIKLADFGLARI 159 (290)
T ss_pred CCcEEEEEccCCC-CHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeeCCCCHHHEEEcCCCCEEEccccceEe
Confidence 4568999999985 56666543 23589999999999999999999999999999999999999999999999999875
Q ss_pred hhccc----cccccccccccccccCC-----CCCCCcccceeeecCCCCCCchHHHHHHHhhc----ccCCCCCCChhhh
Q psy758 151 IRDLI----PRHLHIFQTNEYFKGVS-----LPHAENVVPLEIKIGKPAATNIYLIDFLKRCL----DKDPLRRWSCDQL 217 (292)
Q Consensus 151 ~~~~~----~~~~~~~~~~~~~~~~~-----~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~----~~~p~~~~~~~~~ 217 (292)
..... ...+..|.+||...+.. ..|+.|+..+++.++.+++......+.+..+. ...+...+.....
T Consensus 160 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~~f~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~ 239 (290)
T cd07862 160 YSFQMALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLPGEEDWPRDVAL 239 (290)
T ss_pred ccCCcccccccccccccChHHHhCCCCCCccchHHHHHHHHHHHcCCCCcCCCCHHHHHHHHHHHhCCCChhhchhhhcc
Confidence 54221 12244577777664433 44666666667777777654433333222222 1112111111111
Q ss_pred hhccCcCCC------CCCCCCccchHHHHhcccCcCCCCCCChhhhhhCCcc
Q psy758 218 LRHPYFNGY------YFEVPDEMQYEEITQRCLDKDPLRRWSCDQLLRHPYF 263 (292)
Q Consensus 218 ~~~~~~~~~------~~~~~~~~~l~~li~~~l~~dP~~Rpt~~~il~h~w~ 263 (292)
.... +... ......+..+.+||.+||+.||++|||+.++++||||
T Consensus 240 ~~~~-~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~~~~l~hp~f 290 (290)
T cd07862 240 PRQA-FHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALSHPYF 290 (290)
T ss_pred cchh-ccCCCCCCHHHHccCCCHHHHHHHHHHhccCchhcCCHHHHhcCCCC
Confidence 0000 0000 0112346678999999999999999999999999997
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytopla |
| >cd07863 STKc_CDK4 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.9e-40 Score=267.42 Aligned_cols=260 Identities=31% Similarity=0.476 Sum_probs=181.6
Q ss_pred ccceeeeecccCceEEEEEEEcCCCcEEEEEEeccCCCChHHHHHHHHHHHHHHhC---CCCCcchhhhhhhc-----CC
Q psy758 3 RYEKIGKLGEGSYGVVFKCRNRDTGQVVAIKKFLESEEDPLIRKIALREIRLLKSL---KHPNLVNLLEVFRR-----KK 74 (292)
Q Consensus 3 ~y~~~~~l~~g~~~~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~e~~~~~~l---~~~~i~~~~~~~~~-----~~ 74 (292)
+|++.+.||+|++|.||+|.+..+++.||+|.+..............+|+.+++.+ +||||+++++++.+ ..
T Consensus 1 ~y~~~~~lg~g~~g~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~ni~~~~~~~~~~~~~~~~ 80 (288)
T cd07863 1 QYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVQTNEDGLPLSTVREVALLKRLEAFDHPNIVRLMDVCATSRTDRET 80 (288)
T ss_pred CceEeeEEeecCCeEEEEEEECCCCcEEEEEEeccCcCCCCCchHHHHHHHHHHHhhhcCCCCeeeeeeeeccccCCCCc
Confidence 69999999999999999999999999999999875443322223344566666655 69999999998764 34
Q ss_pred eEEEEEecCCCccHHHHhcCC--CCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEEccCCcEEEeecCchhhhh
Q psy758 75 KLHLVFEFCDHTVLNELENHP--HGLPWDLIKQITWQVLRGVSYCHRHACIHRDIKPENILLTANGVVKLCDFGFARLIR 152 (292)
Q Consensus 75 ~~~iv~e~~~~~~L~~~~~~~--~~~~~~~~~~i~~qi~~aL~~LH~~givH~dl~p~Nilv~~~~~~kl~dfg~~~~~~ 152 (292)
.+++++||+++ +|..++... ..+++..++.++.||+.||.|||++|++|+||||+||+++.++.++|+|||++....
T Consensus 81 ~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~ivH~dikp~Nili~~~~~~kl~dfg~~~~~~ 159 (288)
T cd07863 81 KVTLVFEHVDQ-DLRTYLDKVPPPGLPAETIKDLMRQFLRGLDFLHANCIVHRDLKPENILVTSGGQVKLADFGLARIYS 159 (288)
T ss_pred eEEEEEccccc-CHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEECCCCCEEECccCcccccc
Confidence 68999999996 566665432 348999999999999999999999999999999999999999999999999987654
Q ss_pred ccc----cccccccccccccccCC-----CCCCCcccceeeecCCCCCCchHHHHHHHhhc---ccCCCCCCChhhhhhc
Q psy758 153 DLI----PRHLHIFQTNEYFKGVS-----LPHAENVVPLEIKIGKPAATNIYLIDFLKRCL---DKDPLRRWSCDQLLRH 220 (292)
Q Consensus 153 ~~~----~~~~~~~~~~~~~~~~~-----~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~---~~~p~~~~~~~~~~~~ 220 (292)
... ...+..|.+||...+.. ..|+.|+..+++.++.+++......+.+.... .......+........
T Consensus 160 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 239 (288)
T cd07863 160 CQMALTPVVVTLWYRAPEVLLQSTYATPVDMWSVGCIFAEMFRRKPLFCGNSEADQLGKIFDLIGLPPEDDWPRDVTLPR 239 (288)
T ss_pred CcccCCCccccccccCchHhhCCCCCCcchhhhHHHHHHHHHhCCcCcCCCCHHHHHHHHHHHhCCCChhhCcccccccc
Confidence 321 12244577888765544 34555555556666666554332222222211 1111111100000000
Q ss_pred cCcCCC------CCCCCCccchHHHHhcccCcCCCCCCChhhhhhCCcc
Q psy758 221 PYFNGY------YFEVPDEMQYEEITQRCLDKDPLRRWSCDQLLRHPYF 263 (292)
Q Consensus 221 ~~~~~~------~~~~~~~~~l~~li~~~l~~dP~~Rpt~~~il~h~w~ 263 (292)
..+... ......+..+.++|.+||++||.+|||+.+++.||||
T Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~~~l~hp~f 288 (288)
T cd07863 240 GAFSPRGPRPVQSVVPEIEESGAQLLLEMLTFNPHKRISAFRALQHPFF 288 (288)
T ss_pred cccCCCCCCchHHhCcCcCHHHHHHHHHHhccCcccCCCHHHHhcCCCC
Confidence 001000 0112346678999999999999999999999999998
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitou |
| >cd07841 STKc_CDK7 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.5e-40 Score=268.16 Aligned_cols=268 Identities=34% Similarity=0.484 Sum_probs=195.9
Q ss_pred ccceeeeecccCceEEEEEEEcCCCcEEEEEEeccCCCC---hHHHHHHHHHHHHHHhCCCCCcchhhhhhhcCCeEEEE
Q psy758 3 RYEKIGKLGEGSYGVVFKCRNRDTGQVVAIKKFLESEED---PLIRKIALREIRLLKSLKHPNLVNLLEVFRRKKKLHLV 79 (292)
Q Consensus 3 ~y~~~~~l~~g~~~~v~~~~~~~~~~~v~iK~~~~~~~~---~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~iv 79 (292)
+|++.+.||+|++|.||+|.+..+++.|++|.+...... ......+..|+.+++.++|+||+++++++.+++..++|
T Consensus 1 ~y~~~~~lg~g~~~~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv 80 (298)
T cd07841 1 RYEKGKKLGEGTYAVVYKARDKETGRIVAIKKIKLGERKEAKDGINFTALREIKLLQELKHPNIIGLLDVFGHKSNINLV 80 (298)
T ss_pred CceeeeeeeeccccEEEEEEECCCCcEEEEEEEeccccccccchhhHHHHHHHHHHhhcCCCCChhhhheeecCCEEEEE
Confidence 689999999999999999999999999999999766533 34456677899999999999999999999999999999
Q ss_pred EecCCCccHHHHhcCCC-CCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEEccCCcEEEeecCchhhhhccccc-
Q psy758 80 FEFCDHTVLNELENHPH-GLPWDLIKQITWQVLRGVSYCHRHACIHRDIKPENILLTANGVVKLCDFGFARLIRDLIPR- 157 (292)
Q Consensus 80 ~e~~~~~~L~~~~~~~~-~~~~~~~~~i~~qi~~aL~~LH~~givH~dl~p~Nilv~~~~~~kl~dfg~~~~~~~~~~~- 157 (292)
+||+ +++|..++.... .+++..++.++.||++||.|||++|++|+||+|+||+++.++.++|+|||++.........
T Consensus 81 ~e~~-~~~L~~~i~~~~~~~~~~~~~~~~~qi~~al~~lH~~~i~H~dl~p~nill~~~~~~~l~dfg~~~~~~~~~~~~ 159 (298)
T cd07841 81 FEFM-ETDLEKVIKDKSIVLTPADIKSYMLMTLRGLEYLHSNWILHRDLKPNNLLIASDGVLKLADFGLARSFGSPNRKM 159 (298)
T ss_pred Eccc-CCCHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCChhhEEEcCCCCEEEccceeeeeccCCCccc
Confidence 9999 889999987765 7999999999999999999999999999999999999999999999999998766432211
Q ss_pred ----cccccccccccccC------CCCCCCcccceeeecCCCCCCchHHHHHHHhhcc---cCCC-CCCChhhhhhccCc
Q psy758 158 ----HLHIFQTNEYFKGV------SLPHAENVVPLEIKIGKPAATNIYLIDFLKRCLD---KDPL-RRWSCDQLLRHPYF 223 (292)
Q Consensus 158 ----~~~~~~~~~~~~~~------~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~---~~p~-~~~~~~~~~~~~~~ 223 (292)
....|.+||...+. ...|+.|+..+++.++.+++........+..... .... ..+...........
T Consensus 160 ~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~e~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 239 (298)
T cd07841 160 THQVVTRWYRAPELLFGARHYGVGVDMWSVGCIFAELLLRVPFLPGDSDIDQLGKIFEALGTPTEENWPGVTSLPDYVEF 239 (298)
T ss_pred cccccceeeeCHHHHhCCCCCCcHHHHHHHHHHHHHHHcCCccccCCccHHHHHHHHHHcCCCchhhhhhcccccccccc
Confidence 12346677755332 2345566666666666554332222222222211 1100 00000000000000
Q ss_pred C---CC---CCCCCCccchHHHHhcccCcCCCCCCChhhhhhCCcccceeccCC
Q psy758 224 N---GY---YFEVPDEMQYEEITQRCLDKDPLRRWSCDQLLRHPYFNGYYFEVP 271 (292)
Q Consensus 224 ~---~~---~~~~~~~~~l~~li~~~l~~dP~~Rpt~~~il~h~w~~~~~~~~~ 271 (292)
. .. ......+..+.++|.+||++||++|||++++++||||.+..-.++
T Consensus 240 ~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~~e~l~~~~~~~~~~~~~ 293 (298)
T cd07841 240 KPFPPTPLKQIFPAASDDALDLLQRLLTLNPNKRITARQALEHPYFSNDPAPTP 293 (298)
T ss_pred cccCCcchhhhcccccHHHHHHHHHHhcCCcccCcCHHHHhhCccccCCCCCCC
Confidence 0 00 011223667899999999999999999999999999999654443
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is |
| >cd05624 STKc_MRCK_beta Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.7e-40 Score=271.17 Aligned_cols=256 Identities=20% Similarity=0.271 Sum_probs=196.1
Q ss_pred cccceeeeecccCceEEEEEEEcCCCcEEEEEEeccCC-CChHHHHHHHHHHHHHHhCCCCCcchhhhhhhcCCeEEEEE
Q psy758 2 ERYEKIGKLGEGSYGVVFKCRNRDTGQVVAIKKFLESE-EDPLIRKIALREIRLLKSLKHPNLVNLLEVFRRKKKLHLVF 80 (292)
Q Consensus 2 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~v~iK~~~~~~-~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~iv~ 80 (292)
++|++.+.||+|+||.||++.+..+++.||+|++.... ........+..|..++..++|++|+++++++.+++..|+||
T Consensus 1 d~y~i~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~l~~~~~~~~~~~lv~ 80 (331)
T cd05624 1 DDFEIIKVIGRGAFGEVAVVKMKHTERIYAMKILNKWEMLKRAETACFREERNVLVNGDCQWITTLHYAFQDENYLYLVM 80 (331)
T ss_pred CCceEEEEEeeCCCeEEEEEEECCCCCEEEEEEEeHHHHHhhHHHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCEEEEEE
Confidence 58999999999999999999999999999999986533 22334556788999999999999999999999999999999
Q ss_pred ecCCCccHHHHhcC-CCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEEccCCcEEEeecCchhhhhccc----
Q psy758 81 EFCDHTVLNELENH-PHGLPWDLIKQITWQVLRGVSYCHRHACIHRDIKPENILLTANGVVKLCDFGFARLIRDLI---- 155 (292)
Q Consensus 81 e~~~~~~L~~~~~~-~~~~~~~~~~~i~~qi~~aL~~LH~~givH~dl~p~Nilv~~~~~~kl~dfg~~~~~~~~~---- 155 (292)
||+.||+|..++.. ...+++..+..++.|++.||+|||++||+|+||||+||+++.++.++|+|||++.......
T Consensus 81 Ey~~gg~L~~~l~~~~~~l~~~~~~~~~~qi~~~L~~lH~~~iiHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~~~~~~ 160 (331)
T cd05624 81 DYYVGGDLLTLLSKFEDRLPEDMARFYIAEMVLAIHSIHQLHYVHRDIKPDNVLLDMNGHIRLADFGSCLKMNQDGTVQS 160 (331)
T ss_pred eCCCCCcHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeeeccCchHHEEEcCCCCEEEEeccceeeccCCCceee
Confidence 99999999999876 4578999999999999999999999999999999999999999999999999986654321
Q ss_pred --ccccccccccccccc----------CCCCCCCcccceeeecCCCCCCchHHHHHHHhhcccCCCCCCChhhhhhccCc
Q psy758 156 --PRHLHIFQTNEYFKG----------VSLPHAENVVPLEIKIGKPAATNIYLIDFLKRCLDKDPLRRWSCDQLLRHPYF 223 (292)
Q Consensus 156 --~~~~~~~~~~~~~~~----------~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~ 223 (292)
..++..|.+||...+ ....|+.|+..+++.+|..++........+........ +.. +
T Consensus 161 ~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwSlGvil~ell~g~~Pf~~~~~~~~~~~i~~~~~--~~~--------~- 229 (331)
T cd05624 161 SVAVGTPDYISPEILQAMEDGMGKYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMNHEE--RFQ--------F- 229 (331)
T ss_pred ccccCCcccCCHHHHhccccCCCCCCCcccEEeeehhhhhhhhCCCCccCCCHHHHHHHHHcCCC--ccc--------C-
Confidence 123445777776543 23456666666666677666543333333332221110 000 0
Q ss_pred CCCCCCCCCccchHHHHhcccCcCCCC--CCChhhhhhCCcccceeccC
Q psy758 224 NGYYFEVPDEMQYEEITQRCLDKDPLR--RWSCDQLLRHPYFNGYYFEV 270 (292)
Q Consensus 224 ~~~~~~~~~~~~l~~li~~~l~~dP~~--Rpt~~~il~h~w~~~~~~~~ 270 (292)
. ......+..++++|.+||+.++.+ |++++++++||||.+..|+.
T Consensus 230 p--~~~~~~~~~~~~li~~ll~~~~~~~~~~~~~~~~~h~~f~~~~~~~ 276 (331)
T cd05624 230 P--SHITDVSEEAKDLIQRLICSRERRLGQNGIEDFKKHAFFEGIDWEN 276 (331)
T ss_pred C--CccccCCHHHHHHHHHHccCchhhcCCCCHHHHhcCCCcCCCCHHH
Confidence 0 001234678999999999976654 56999999999999877653
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) beta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKbeta is expressed ubiquitously in many tissues. |
| >cd05578 STKc_Yank1 Catalytic domain of the Protein Serine/Threonine Kinase, Yank1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.3e-39 Score=256.93 Aligned_cols=248 Identities=25% Similarity=0.342 Sum_probs=190.3
Q ss_pred ccceeeeecccCceEEEEEEEcCCCcEEEEEEeccCCC-ChHHHHHHHHHHHHHHhCCCCCcchhhhhhhcCCeEEEEEe
Q psy758 3 RYEKIGKLGEGSYGVVFKCRNRDTGQVVAIKKFLESEE-DPLIRKIALREIRLLKSLKHPNLVNLLEVFRRKKKLHLVFE 81 (292)
Q Consensus 3 ~y~~~~~l~~g~~~~v~~~~~~~~~~~v~iK~~~~~~~-~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~iv~e 81 (292)
+|++.+.||+|++|.||+|.+..+++.|++|.+..... .....+.+.+|+.+++.++||||+++++.+.+++..++|+|
T Consensus 1 ~y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 80 (258)
T cd05578 1 HFELLRVIGKGAFGKVCIVQKRDTKKMFAMKYMNKQKCVEKGSVRNVLNERRILQELNHPFLVNLWYSFQDEENMYLVVD 80 (258)
T ss_pred CceEEEEeccCCCceEEEEEEccCCcEEEEEEEehhhhcchhHHHHHHHHHHHHHhCCCCChHHHHHhhcCCCeEEEEEe
Confidence 58999999999999999999999999999999976543 22456788999999999999999999999999999999999
Q ss_pred cCCCccHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEEccCCcEEEeecCchhhhhcc----ccc
Q psy758 82 FCDHTVLNELENHPHGLPWDLIKQITWQVLRGVSYCHRHACIHRDIKPENILLTANGVVKLCDFGFARLIRDL----IPR 157 (292)
Q Consensus 82 ~~~~~~L~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~givH~dl~p~Nilv~~~~~~kl~dfg~~~~~~~~----~~~ 157 (292)
|+.|++|..++.....+++..+..++.||++||.|||++|++|+||+|+||++++++.++|+|||.+...... ...
T Consensus 81 ~~~~~~L~~~l~~~~~l~~~~~~~~~~~i~~~l~~lh~~~i~h~dl~~~nil~~~~~~~~l~d~~~~~~~~~~~~~~~~~ 160 (258)
T cd05578 81 LLLGGDLRYHLSQKVKFSEEQVKFWICEIVLALEYLHSKGIIHRDIKPDNILLDEQGHVHITDFNIATKVTPDTLTTSTS 160 (258)
T ss_pred CCCCCCHHHHHHhcCCcCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHeEEcCCCCEEEeecccccccCCCccccccC
Confidence 9999999999987778999999999999999999999999999999999999999999999999998765432 122
Q ss_pred cccccccccccccCCCCCCCcccceeeecCCCCCCchHHHHHHHhhcccCCCCCCC---hhhhhhccCcCCCCCCCCCcc
Q psy758 158 HLHIFQTNEYFKGVSLPHAENVVPLEIKIGKPAATNIYLIDFLKRCLDKDPLRRWS---CDQLLRHPYFNGYYFEVPDEM 234 (292)
Q Consensus 158 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~---~~~~~~~~~~~~~~~~~~~~~ 234 (292)
....|.+||...+.......++|++ +.-++..+.+..|....+ ..+............+...+.
T Consensus 161 ~~~~y~~PE~~~~~~~~~~~Di~sl-------------G~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 227 (258)
T cd05578 161 GTPGYMAPEVLCRQGYSVAVDWWSL-------------GVTAYECLRGKRPYRGHSRTIRDQIRAKQETADVLYPATWST 227 (258)
T ss_pred CChhhcCHHHHcccCCCCcccchhh-------------HHHHHHHHhCCCCCCCCCccHHHHHHHHhccccccCcccCcH
Confidence 2334556666544332222222222 222233333333433222 122211111112223334568
Q ss_pred chHHHHhcccCcCCCCCCCh--hhhhhCCcc
Q psy758 235 QYEEITQRCLDKDPLRRWSC--DQLLRHPYF 263 (292)
Q Consensus 235 ~l~~li~~~l~~dP~~Rpt~--~~il~h~w~ 263 (292)
.+.++|.+||..||.+||++ +++++||||
T Consensus 228 ~~~~~i~~~l~~~p~~R~~~~~~~l~~~~~~ 258 (258)
T cd05578 228 EAIDAINKLLERDPQKRLGDNLKDLKNHPYF 258 (258)
T ss_pred HHHHHHHHHccCChhHcCCccHHHHhcCCCC
Confidence 99999999999999999999 999999998
|
Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A. |
| >cd07846 STKc_CDKL2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-39 Score=264.45 Aligned_cols=262 Identities=45% Similarity=0.726 Sum_probs=193.1
Q ss_pred cccceeeeecccCceEEEEEEEcCCCcEEEEEEeccCCCChHHHHHHHHHHHHHHhCCCCCcchhhhhhhcCCeEEEEEe
Q psy758 2 ERYEKIGKLGEGSYGVVFKCRNRDTGQVVAIKKFLESEEDPLIRKIALREIRLLKSLKHPNLVNLLEVFRRKKKLHLVFE 81 (292)
Q Consensus 2 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~iv~e 81 (292)
++|++.+.||+|++|.||+|.+..+++.||+|.+..........+.+.+|+++++.++||||+++++++.+++..++|+|
T Consensus 1 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 80 (286)
T cd07846 1 EKYENLGLVGEGSYGMVMKCKHKETGQIVAIKKFLESEDDKMVKKIAMREIRMLKQLRHENLVNLIEVFRRKKRLYLVFE 80 (286)
T ss_pred CceeEeeeeccCCCeEEEEEEECCCCCEEEEEeHhhccCcchhhHHHHHHHHHHHhcCCcchhhHHHhcccCCeEEEEEe
Confidence 57999999999999999999999889999999987655444456678889999999999999999999999999999999
Q ss_pred cCCCccHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEEccCCcEEEeecCchhhhhcccc-----
Q psy758 82 FCDHTVLNELENHPHGLPWDLIKQITWQVLRGVSYCHRHACIHRDIKPENILLTANGVVKLCDFGFARLIRDLIP----- 156 (292)
Q Consensus 82 ~~~~~~L~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~givH~dl~p~Nilv~~~~~~kl~dfg~~~~~~~~~~----- 156 (292)
|++++++..+......+++..++.++.||+.||+|||+.|++|+||+|+||++++++.++|+|||++........
T Consensus 81 ~~~~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~h~~l~p~ni~~~~~~~~~l~dfg~~~~~~~~~~~~~~~ 160 (286)
T cd07846 81 FVDHTVLDDLEKYPNGLDESRVRKYLFQILRGIEFCHSHNIIHRDIKPENILVSQSGVVKLCDFGFARTLAAPGEVYTDY 160 (286)
T ss_pred cCCccHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEECCCCcEEEEeeeeeeeccCCccccCcc
Confidence 999999999887766799999999999999999999999999999999999999999999999999876533211
Q ss_pred ccccccccccccccC------CCCCCCcccceeeecCCCCCCchHHHHHHHhhcccCCCCCCChhhhh-hccCcCCC---
Q psy758 157 RHLHIFQTNEYFKGV------SLPHAENVVPLEIKIGKPAATNIYLIDFLKRCLDKDPLRRWSCDQLL-RHPYFNGY--- 226 (292)
Q Consensus 157 ~~~~~~~~~~~~~~~------~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~-~~~~~~~~--- 226 (292)
.....|.+||+..+. ...|+.|+..+++.+|.+++........+.................. ..+.....
T Consensus 161 ~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~el~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 240 (286)
T cd07846 161 VATRWYRAPELLVGDTKYGRAVDIWAVGCLVTEMLTGEPLFPGDSDIDQLYHIIKCLGNLIPRHQEIFQKNPLFAGMRLP 240 (286)
T ss_pred cceeeccCcHHhccccccCchHhHHHHHHHHHHHHcCCCCCCCCchHHHHHHHHHHhCCCchhhHHHhccchHhhccccc
Confidence 123446677765432 23455555556666665544322211111111100000000000000 00000000
Q ss_pred ---------CCCCCCccchHHHHhcccCcCCCCCCChhhhhhCCcc
Q psy758 227 ---------YFEVPDEMQYEEITQRCLDKDPLRRWSCDQLLRHPYF 263 (292)
Q Consensus 227 ---------~~~~~~~~~l~~li~~~l~~dP~~Rpt~~~il~h~w~ 263 (292)
......+..+.+|+.+||+.||.+|||+.++++||||
T Consensus 241 ~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~~~~~ 286 (286)
T cd07846 241 EVKEIEPLEKRFPKLSGLVLDLAKQCLRIDPDDRPSSSQLLHHEFF 286 (286)
T ss_pred cccCcchHHHhCCCcCHHHHHHHHHHhcCCcccchhHHHHhcCCCC
Confidence 0012346779999999999999999999999999998
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKI |
| >cd08227 PK_STRAD_alpha Pseudokinase domain of STE20-related kinase adapter protein alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-39 Score=268.25 Aligned_cols=264 Identities=19% Similarity=0.271 Sum_probs=191.0
Q ss_pred eeeeeccc--CceEEEEEEEcCCCcEEEEEEeccCCCChHHHHHHHHHHHHHHhCCCCCcchhhhhhhcCCeEEEEEecC
Q psy758 6 KIGKLGEG--SYGVVFKCRNRDTGQVVAIKKFLESEEDPLIRKIALREIRLLKSLKHPNLVNLLEVFRRKKKLHLVFEFC 83 (292)
Q Consensus 6 ~~~~l~~g--~~~~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~iv~e~~ 83 (292)
+++.||+| +++.||++.+..+|+.||+|.+............+.+|+.+++.++||||+++++++..++..++|+||+
T Consensus 2 ~~~~ig~G~~~~~~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~~ 81 (327)
T cd08227 2 LLTVIGRGFEDLMTVNLARYKPTGEYVTVRRINLEACTNEMVTFLQGELHVSKLFNHPNIVPYRATFIADNELWVVTSFM 81 (327)
T ss_pred hhhhccccccceEEEEEEeecccCcEEEEEEechhhccHHHHHHHHHHHHHHHhcCCCCeeeEEEEEEECCEEEEEEecc
Confidence 56789999 6889999999999999999999776655566777888999999999999999999999999999999999
Q ss_pred CCccHHHHhcC--CCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEEccCCcEEEeecCchhhhhcc-------
Q psy758 84 DHTVLNELENH--PHGLPWDLIKQITWQVLRGVSYCHRHACIHRDIKPENILLTANGVVKLCDFGFARLIRDL------- 154 (292)
Q Consensus 84 ~~~~L~~~~~~--~~~~~~~~~~~i~~qi~~aL~~LH~~givH~dl~p~Nilv~~~~~~kl~dfg~~~~~~~~------- 154 (292)
++++|.+++.. ...+++..++.++.|++.||+|||++|++|+||||+||+++.++.++++||+........
T Consensus 82 ~~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~iiH~dlkp~Nil~~~~~~~~l~~~~~~~~~~~~~~~~~~~ 161 (327)
T cd08227 82 AYGSAKDLICTHFMDGMSELAIAYILQGVLKALDYIHHMGYVHRSVKASHILISVDGKVYLSGLRSNLSMINHGQRLRVV 161 (327)
T ss_pred CCCcHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCCEecCCCChhhEEEecCCcEEEcccchhhcccccccccccc
Confidence 99999998854 345899999999999999999999999999999999999999999999999765432211
Q ss_pred -----ccccccccccccccccC-------CCCCCCcccceeeecCCCCCCchHHHHHHHhhcc-cCCCC----CCChhhh
Q psy758 155 -----IPRHLHIFQTNEYFKGV-------SLPHAENVVPLEIKIGKPAATNIYLIDFLKRCLD-KDPLR----RWSCDQL 217 (292)
Q Consensus 155 -----~~~~~~~~~~~~~~~~~-------~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~p~~----~~~~~~~ 217 (292)
.......|.+||...+. ...|+.|+..+++.+|..++.............. ..|.. .....+.
T Consensus 162 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 241 (327)
T cd08227 162 HDFPKYSVKVLPWLSPEVLQQNLQGYDAKSDIYSVGITACELANGHVPFKDMPATQMLLEKLNGTVPCLLDTTTIPAEEL 241 (327)
T ss_pred ccccccccceecccChHHhhcccCCCCchhhHHHHHHHHHHHHHCCCCCCCcchhHHHHHHhcCCccccccccchhhhhc
Confidence 01122346777766432 2346666666667777766543222221111111 11100 0000000
Q ss_pred hhccC-------c-CC---------------CCCCCCCccchHHHHhcccCcCCCCCCChhhhhhCCcccceecc
Q psy758 218 LRHPY-------F-NG---------------YYFEVPDEMQYEEITQRCLDKDPLRRWSCDQLLRHPYFNGYYFE 269 (292)
Q Consensus 218 ~~~~~-------~-~~---------------~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~~il~h~w~~~~~~~ 269 (292)
..... . .. .......++.+.+||.+||+.||++|||++++++||||++...+
T Consensus 242 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~ell~~p~f~~~~~~ 316 (327)
T cd08227 242 TMKPSRSGANSGLGESTTVSTPRPSNGESSSHPYNRTFSPHFHHFVEQCLQRNPDARPSASTLLNHSFFKQIKRR 316 (327)
T ss_pred ccCCcccCCcCCCCcccccCCcCccccCCcccccccccCHHHHHHHHHHHhhCchhcCCHHHHhcChhhhhcchh
Confidence 00000 0 00 00112235678999999999999999999999999999986533
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) alpha subfamily, pseudokinase domain. The STRAD alpha subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hype |
| >cd08223 STKc_Nek4 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-38 Score=256.30 Aligned_cols=247 Identities=26% Similarity=0.360 Sum_probs=186.5
Q ss_pred ccceeeeecccCceEEEEEEEcCCCcEEEEEEeccCCCChHHHHHHHHHHHHHHhCCCCCcchhhhhhhc-CCeEEEEEe
Q psy758 3 RYEKIGKLGEGSYGVVFKCRNRDTGQVVAIKKFLESEEDPLIRKIALREIRLLKSLKHPNLVNLLEVFRR-KKKLHLVFE 81 (292)
Q Consensus 3 ~y~~~~~l~~g~~~~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~-~~~~~iv~e 81 (292)
+|++.+.||.|++|.||.+.+..+++.|++|.+..........+.+.+|+.+++.++|+|++++++.+.. +..+++++|
T Consensus 1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~lv~e 80 (257)
T cd08223 1 AYCFVRVVGKGSYGEVSLVRHRTDGKQYVIKKLNLRNASRRERKAAEQEAQLLSQLKHPNIVAYRESWEGEDGLLYIVMG 80 (257)
T ss_pred CceEEEEecCCCCeEEEEEEEcCCCcEEEEEEEehhhcCHHHHHHHHHHHHHHHhCCCCCeeeeeeeecCCCCEEEEEec
Confidence 5899999999999999999999999999999997766555566778899999999999999999988764 557899999
Q ss_pred cCCCccHHHHhcC--CCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEEccCCcEEEeecCchhhhhcccc---
Q psy758 82 FCDHTVLNELENH--PHGLPWDLIKQITWQVLRGVSYCHRHACIHRDIKPENILLTANGVVKLCDFGFARLIRDLIP--- 156 (292)
Q Consensus 82 ~~~~~~L~~~~~~--~~~~~~~~~~~i~~qi~~aL~~LH~~givH~dl~p~Nilv~~~~~~kl~dfg~~~~~~~~~~--- 156 (292)
|+++++|.+++.. ...+++.+++.++.|++.||.+||+.|++|+||+|+||+++.++.++|+|||.+........
T Consensus 81 ~~~~~~l~~~l~~~~~~~l~~~~~~~~~~~l~~~l~~lH~~~i~H~di~p~nil~~~~~~~~l~df~~~~~~~~~~~~~~ 160 (257)
T cd08223 81 FCEGGDLYHKLKEQKGKLLPENQVVEWFVQIAMALQYLHEKHILHRDLKTQNVFLTRTNIIKVGDLGIARVLENQCDMAS 160 (257)
T ss_pred ccCCCcHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCchhEEEecCCcEEEecccceEEecccCCccc
Confidence 9999999988764 34589999999999999999999999999999999999999999999999999876533211
Q ss_pred --ccccccccccccccCCCCCCCcccceeeecCCCCCCchHHHHHHHhhcccCCCCCCChhhhhhccCcCCC--CCCCCC
Q psy758 157 --RHLHIFQTNEYFKGVSLPHAENVVPLEIKIGKPAATNIYLIDFLKRCLDKDPLRRWSCDQLLRHPYFNGY--YFEVPD 232 (292)
Q Consensus 157 --~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~--~~~~~~ 232 (292)
.....|.+||...+.......++|+ .+.-++..+.+..|............. ..+. ..+...
T Consensus 161 ~~~~~~~y~aPE~~~~~~~~~~~Dv~s-------------lG~il~~l~~g~~~~~~~~~~~~~~~~-~~~~~~~~~~~~ 226 (257)
T cd08223 161 TLIGTPYYMSPELFSNKPYNYKSDVWA-------------LGCCVYEMATLKHAFNAKDMNSLVYRI-IEGKLPPMPKDY 226 (257)
T ss_pred cccCCcCccChhHhcCCCCCchhhhHH-------------HHHHHHHHHcCCCCCCCCCHHHHHHHH-HhcCCCCCcccc
Confidence 1223456666554433322222222 222333333344443333322221110 0111 123345
Q ss_pred ccchHHHHhcccCcCCCCCCChhhhhhCCcc
Q psy758 233 EMQYEEITQRCLDKDPLRRWSCDQLLRHPYF 263 (292)
Q Consensus 233 ~~~l~~li~~~l~~dP~~Rpt~~~il~h~w~ 263 (292)
+..+.+++.+||+.||.+|||+.++++||||
T Consensus 227 ~~~~~~li~~~l~~~p~~Rp~~~~~l~~~~~ 257 (257)
T cd08223 227 SPELGELIATMLSKRPEKRPSVKSILRQPYI 257 (257)
T ss_pred CHHHHHHHHHHhccCcccCCCHHHHhcCCCC
Confidence 7789999999999999999999999999997
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown. |
| >cd08529 STKc_FA2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-38 Score=255.47 Aligned_cols=248 Identities=27% Similarity=0.387 Sum_probs=191.4
Q ss_pred ccceeeeecccCceEEEEEEEcCCCcEEEEEEeccCCCChHHHHHHHHHHHHHHhCCCCCcchhhhhhhcCCeEEEEEec
Q psy758 3 RYEKIGKLGEGSYGVVFKCRNRDTGQVVAIKKFLESEEDPLIRKIALREIRLLKSLKHPNLVNLLEVFRRKKKLHLVFEF 82 (292)
Q Consensus 3 ~y~~~~~l~~g~~~~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~iv~e~ 82 (292)
+|++.+.||+|++|.||+|.+..+++.|++|.+............+.+|+.+++.++|||++++++++.+.+..++|+||
T Consensus 1 ~~~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 80 (256)
T cd08529 1 DFEILNKIGKGSFGVVFKVVRKADKRVYAMKQIDLSKMNRREREEAIDEARVLAKLDSSYIIRYYESFLDKGKLNIVMEY 80 (256)
T ss_pred CceEeEEecCCCCeEEEEEEEcCCCcEEEEEEeehhhCCHHHHHHHHHHHHHHHhcCCCCeehheeeeccCCEEEEEEEe
Confidence 58899999999999999999999999999999977665566677889999999999999999999999999999999999
Q ss_pred CCCccHHHHhcCC--CCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEEccCCcEEEeecCchhhhhcccc----
Q psy758 83 CDHTVLNELENHP--HGLPWDLIKQITWQVLRGVSYCHRHACIHRDIKPENILLTANGVVKLCDFGFARLIRDLIP---- 156 (292)
Q Consensus 83 ~~~~~L~~~~~~~--~~~~~~~~~~i~~qi~~aL~~LH~~givH~dl~p~Nilv~~~~~~kl~dfg~~~~~~~~~~---- 156 (292)
+++++|.+++... ..+++..++.++.|++.||.|||+.|++|+||+|+||++++++.++|+|||++........
T Consensus 81 ~~~~~L~~~l~~~~~~~~~~~~~~~i~~~l~~al~~lH~~~i~h~dl~~~nili~~~~~~~l~df~~~~~~~~~~~~~~~ 160 (256)
T cd08529 81 AENGDLHKLLKMQRGRPLPEDQVWRFFIQILLGLAHLHSKKILHRDIKSLNLFLDAYDNVKIGDLGVAKLLSDNTNFANT 160 (256)
T ss_pred CCCCcHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCcceEEEeCCCCEEEcccccceeccCccchhhc
Confidence 9999999988653 5689999999999999999999999999999999999999999999999998876543221
Q ss_pred -ccccccccccccccCCCCCCCcccceeeecCCCCCCchHHHHHHHhhcccCCCCCCChhhhhhccCcCCC-CCCCCCcc
Q psy758 157 -RHLHIFQTNEYFKGVSLPHAENVVPLEIKIGKPAATNIYLIDFLKRCLDKDPLRRWSCDQLLRHPYFNGY-YFEVPDEM 234 (292)
Q Consensus 157 -~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~-~~~~~~~~ 234 (292)
.....|.+||+..+.......++|+ .+.-++..+.+..|....+..+.......... ..+...+.
T Consensus 161 ~~~~~~y~aPE~~~~~~~~~~~Di~s-------------lG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 227 (256)
T cd08529 161 IVGTPYYLSPELCEDKPYNEKSDVWA-------------LGVVLYECCTGKHPFDANNQGALILKIIRGVFPPVSQMYSQ 227 (256)
T ss_pred cccCccccCHHHhcCCCCCCccchHH-------------HHHHHHHHHhCCCCCCCCCHHHHHHHHHcCCCCCCccccCH
Confidence 1223466666655443322222222 22233334444445444433332221111111 12224567
Q ss_pred chHHHHhcccCcCCCCCCChhhhhhCCcc
Q psy758 235 QYEEITQRCLDKDPLRRWSCDQLLRHPYF 263 (292)
Q Consensus 235 ~l~~li~~~l~~dP~~Rpt~~~il~h~w~ 263 (292)
.+.++|.+||+.+|++||++.++++|||+
T Consensus 228 ~~~~~i~~~l~~~p~~Rp~~~~ll~~~~~ 256 (256)
T cd08529 228 QLAQLIDQCLTKDYRQRPDTFQLLRNPSL 256 (256)
T ss_pred HHHHHHHHHccCCcccCcCHHHHhhCCCC
Confidence 89999999999999999999999999996
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cyc |
| >cd05623 STKc_MRCK_alpha Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.1e-40 Score=271.54 Aligned_cols=256 Identities=19% Similarity=0.259 Sum_probs=194.0
Q ss_pred cccceeeeecccCceEEEEEEEcCCCcEEEEEEeccCC-CChHHHHHHHHHHHHHHhCCCCCcchhhhhhhcCCeEEEEE
Q psy758 2 ERYEKIGKLGEGSYGVVFKCRNRDTGQVVAIKKFLESE-EDPLIRKIALREIRLLKSLKHPNLVNLLEVFRRKKKLHLVF 80 (292)
Q Consensus 2 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~v~iK~~~~~~-~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~iv~ 80 (292)
++|++.+.||+|+||.||++.+..+++.||+|++.... ........+..|..++..++|++|+++++.+.+++..|+||
T Consensus 1 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (332)
T cd05623 1 EDFEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDNQWITTLHYAFQDENNLYLVM 80 (332)
T ss_pred CCceEEEEEEeCCCeEEEEEEECCCCCEEEEEEEeHHHHHHhhHHHHHHHHHHHHhhCCCCCEeeEEEEEecCCEEEEEE
Confidence 57999999999999999999999999999999986532 22233455788999999999999999999999999999999
Q ss_pred ecCCCccHHHHhcC-CCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEEccCCcEEEeecCchhhhhccc----
Q psy758 81 EFCDHTVLNELENH-PHGLPWDLIKQITWQVLRGVSYCHRHACIHRDIKPENILLTANGVVKLCDFGFARLIRDLI---- 155 (292)
Q Consensus 81 e~~~~~~L~~~~~~-~~~~~~~~~~~i~~qi~~aL~~LH~~givH~dl~p~Nilv~~~~~~kl~dfg~~~~~~~~~---- 155 (292)
||+++|+|.+++.. ...+++..++.++.||+.||.|||++|++||||||+||+++.++.++|+|||++.......
T Consensus 81 ey~~~g~L~~~l~~~~~~l~~~~~~~~~~qi~~al~~lH~~~iiHrDlkp~Nili~~~~~~kL~DfG~a~~~~~~~~~~~ 160 (332)
T cd05623 81 DYYVGGDLLTLLSKFEDRLPEDMARFYLAEMVIAIDSVHQLHYVHRDIKPDNILMDMNGHIRLADFGSCLKLMEDGTVQS 160 (332)
T ss_pred eccCCCcHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHEEECCCCCEEEeecchheecccCCccee
Confidence 99999999999876 4578999999999999999999999999999999999999999999999999986543211
Q ss_pred --ccccccccccccccc----------CCCCCCCcccceeeecCCCCCCchHHHHHHHhhcccCCCCCCChhhhhhccCc
Q psy758 156 --PRHLHIFQTNEYFKG----------VSLPHAENVVPLEIKIGKPAATNIYLIDFLKRCLDKDPLRRWSCDQLLRHPYF 223 (292)
Q Consensus 156 --~~~~~~~~~~~~~~~----------~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~ 223 (292)
..++..|.+||...+ ....|+.|+..+++.+|..++........+........... +
T Consensus 161 ~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwSlGvil~ell~g~~Pf~~~~~~~~~~~i~~~~~~~~----------~- 229 (332)
T cd05623 161 SVAVGTPDYISPEILQAMEDGKGKYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMNHKERFQ----------F- 229 (332)
T ss_pred cccccCccccCHHHHhccccCCCCCCCcCCEEeeHHHHHHHhcCCCCCCCCCHHHHHHHHhCCCcccc----------C-
Confidence 123445677776532 23445556656666666655543333333333221110000 0
Q ss_pred CCCCCCCCCccchHHHHhcccCcCCCC--CCChhhhhhCCcccceeccC
Q psy758 224 NGYYFEVPDEMQYEEITQRCLDKDPLR--RWSCDQLLRHPYFNGYYFEV 270 (292)
Q Consensus 224 ~~~~~~~~~~~~l~~li~~~l~~dP~~--Rpt~~~il~h~w~~~~~~~~ 270 (292)
.......+..+++||++||+.+|.+ |++++++++||||.+..|+.
T Consensus 230 --p~~~~~~s~~~~~li~~ll~~~~~r~~r~~~~~~~~h~~f~~~~~~~ 276 (332)
T cd05623 230 --PAQVTDVSEDAKDLIRRLICSREHRLGQNGIEDFKQHPFFTGIDWDN 276 (332)
T ss_pred --CCccccCCHHHHHHHHHHccChhhhcCCCCHHHHhCCCCcCCCCHHH
Confidence 0011234778999999999765544 78999999999999987753
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKalpha is expressed ubiquitously in many tissues. It plays a role in the regulation of peripheral actin reorganization and neurite outgrowth. It may also play a role in the transferrin iron uptake pathw |
| >KOG0667|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.4e-40 Score=273.90 Aligned_cols=262 Identities=30% Similarity=0.460 Sum_probs=199.3
Q ss_pred ccceeeeecccCceEEEEEEEcCCCcEEEEEEeccCCCChHHHHHHHHHHHHHHhCC-C-----CCcchhhhhhhcCCeE
Q psy758 3 RYEKIGKLGEGSYGVVFKCRNRDTGQVVAIKKFLESEEDPLIRKIALREIRLLKSLK-H-----PNLVNLLEVFRRKKKL 76 (292)
Q Consensus 3 ~y~~~~~l~~g~~~~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~e~~~~~~l~-~-----~~i~~~~~~~~~~~~~ 76 (292)
||++.+.||+|+||.|.+|.+..|++.||||++++.. ....+...|+.++..|+ | -|+++++++|...++.
T Consensus 187 rY~V~e~LGkGtFGQVvk~~d~~T~e~VAIKIiKN~k---~f~~Q~~~Ei~iL~~ln~~d~~~~~n~Vrm~d~F~fr~Hl 263 (586)
T KOG0667|consen 187 RYEVLEVLGKGSFGQVVKAYDHKTGEIVAIKIIKNKK---RFLRQAQIEIRILELLNKHDPDDKYNIVRMLDYFYFRNHL 263 (586)
T ss_pred EEEEEEEecccccceeEEEEecCCCcEEEEEeeccCh---HHHHHHHHHHHHHHHHhccCCCCCeeEEEeeeccccccce
Confidence 7999999999999999999999999999999997654 34556677999999997 3 4899999999999999
Q ss_pred EEEEecCCCccHHHHhcCC--CCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEEccCC--cEEEeecCchhhhh
Q psy758 77 HLVFEFCDHTVLNELENHP--HGLPWDLIKQITWQVLRGVSYCHRHACIHRDIKPENILLTANG--VVKLCDFGFARLIR 152 (292)
Q Consensus 77 ~iv~e~~~~~~L~~~~~~~--~~~~~~~~~~i~~qi~~aL~~LH~~givH~dl~p~Nilv~~~~--~~kl~dfg~~~~~~ 152 (292)
|||+|.++. +|.++++.+ ..++...++.++.||+.||.+||+.||+|+||||+|||+.+.+ .+||+|||+++...
T Consensus 264 ciVfELL~~-NLYellK~n~f~Glsl~~ir~~~~Qil~~L~~L~~l~IIHcDLKPENILL~~~~r~~vKVIDFGSSc~~~ 342 (586)
T KOG0667|consen 264 CIVFELLST-NLYELLKNNKFRGLSLPLVRKFAQQILTALLFLHELGIIHCDLKPENILLKDPKRSRIKVIDFGSSCFES 342 (586)
T ss_pred eeeehhhhh-hHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCChhheeeccCCcCceeEEecccccccC
Confidence 999999975 577777654 3588999999999999999999999999999999999997654 69999999998776
Q ss_pred cc--ccccccccccccccccCCC-----CCCCcccceeeecCCCCCCchHHHHHHH---hhcccCCCCCCChhhhhhccC
Q psy758 153 DL--IPRHLHIFQTNEYFKGVSL-----PHAENVVPLEIKIGKPAATNIYLIDFLK---RCLDKDPLRRWSCDQLLRHPY 222 (292)
Q Consensus 153 ~~--~~~~~~~~~~~~~~~~~~~-----~~~~~~~~~~~~~~~~~~~~~~~~~~~~---~~~~~~p~~~~~~~~~~~~~~ 222 (292)
.. ..-++..|.+||..+|..+ .|++|++..++.+|.+.+.+..-.+.+. ..++..|..-.....- .+.+
T Consensus 343 q~vytYiQSRfYRAPEVILGlpY~~~IDmWSLGCIlAEL~tG~PLfpG~ne~DQl~~I~e~lG~Pp~~mL~~~~~-~~kf 421 (586)
T KOG0667|consen 343 QRVYTYIQSRFYRAPEVILGLPYDTAIDMWSLGCILAELFTGEPLFPGDNEYDQLARIIEVLGLPPPKMLDTAKK-AHKF 421 (586)
T ss_pred CcceeeeeccccccchhhccCCCCCccceeehhhhHHhHhcCccccCCCCHHHHHHHHHHHhCCCCHHHHHhccc-ccee
Confidence 43 3445678999999998765 4667777777888888776665544332 3333322110000000 0001
Q ss_pred cCC--------------------------------CCCC-----------CCCccchHHHHhcccCcCCCCCCChhhhhh
Q psy758 223 FNG--------------------------------YYFE-----------VPDEMQYEEITQRCLDKDPLRRWSCDQLLR 259 (292)
Q Consensus 223 ~~~--------------------------------~~~~-----------~~~~~~l~~li~~~l~~dP~~Rpt~~~il~ 259 (292)
|.. ...+ ......+.++|++||.+||.+|+|+.++|+
T Consensus 422 f~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~P~~~~~l~~~~~~~~~~~F~dflk~~L~~dP~~R~tp~qal~ 501 (586)
T KOG0667|consen 422 FTSLKGFPRLCVETSAPRGTKSPEVRKYYRKARLERRGPPGSRSLESGLPKADDKLFIDFLKRCLEWDPAERITPAQALN 501 (586)
T ss_pred hhccCCceeeeeeecccccccchhhhhhhhhhcccccCCCCCcccchhcccccHHHHHHHHHHHhccCchhcCCHHHHhc
Confidence 100 0011 011334679999999999999999999999
Q ss_pred CCcccceecc
Q psy758 260 HPYFNGYYFE 269 (292)
Q Consensus 260 h~w~~~~~~~ 269 (292)
||||.+....
T Consensus 502 Hpfl~~~~~~ 511 (586)
T KOG0667|consen 502 HPFLTGTSLE 511 (586)
T ss_pred Cccccccccc
Confidence 9999964433
|
|
| >cd06615 PKc_MEK Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.2e-39 Score=264.00 Aligned_cols=261 Identities=25% Similarity=0.436 Sum_probs=193.2
Q ss_pred cccceeeeecccCceEEEEEEEcCCCcEEEEEEeccCCCChHHHHHHHHHHHHHHhCCCCCcchhhhhhhcCCeEEEEEe
Q psy758 2 ERYEKIGKLGEGSYGVVFKCRNRDTGQVVAIKKFLESEEDPLIRKIALREIRLLKSLKHPNLVNLLEVFRRKKKLHLVFE 81 (292)
Q Consensus 2 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~iv~e 81 (292)
++|++.+.||+|++|.||++.+..++..+++|.+.... .......+.+|+++++.++||||+++++++.+++.+++++|
T Consensus 1 ~~~~~~~~lg~G~~g~v~~~~~~~~~~~~a~k~~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 79 (308)
T cd06615 1 DDFEKLGELGAGNGGVVTKVLHRPSGLIMARKLIHLEI-KPAIRNQIIRELKVLHECNSPYIVGFYGAFYSDGEISICME 79 (308)
T ss_pred CCceEEeeccCCCCeEEEEEEEcCCCeEEEEEEecccc-CHHHHHHHHHHHHHHHhCCCCCCCeEEEEEeeCCEEEEEee
Confidence 57999999999999999999999999999999886442 33455668899999999999999999999999999999999
Q ss_pred cCCCccHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHh-CCccccCCCCCceEEccCCcEEEeecCchhhhhccc---cc
Q psy758 82 FCDHTVLNELENHPHGLPWDLIKQITWQVLRGVSYCHR-HACIHRDIKPENILLTANGVVKLCDFGFARLIRDLI---PR 157 (292)
Q Consensus 82 ~~~~~~L~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~-~givH~dl~p~Nilv~~~~~~kl~dfg~~~~~~~~~---~~ 157 (292)
|+++++|.+++...+.+++..+..++.|++.||.|||+ .|++|+||+|+||++++++.++|+|||++....... ..
T Consensus 80 y~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~ 159 (308)
T cd06615 80 HMDGGSLDQVLKKAGRIPENILGKISIAVLRGLTYLREKHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSMANSFV 159 (308)
T ss_pred ccCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhhCCEEECCCChHHEEEecCCcEEEccCCCcccccccccccCC
Confidence 99999999999877789999999999999999999998 599999999999999999999999999886543221 12
Q ss_pred cccccccccccccCCC-----CCCCcccceeeecCCCCCCchHHHHHHHhhcccCCCCCC-------------------C
Q psy758 158 HLHIFQTNEYFKGVSL-----PHAENVVPLEIKIGKPAATNIYLIDFLKRCLDKDPLRRW-------------------S 213 (292)
Q Consensus 158 ~~~~~~~~~~~~~~~~-----~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~-------------------~ 213 (292)
....|.+||...+... .|+.|+..+++.+|..++.......+. ..+...+.... .
T Consensus 160 ~~~~~~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~p~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (308)
T cd06615 160 GTRSYMSPERLQGTHYTVQSDIWSLGLSLVEMAIGRYPIPPPDAKELE-AMFGRPVSEGEAKESHRPVSGHPPDSPRPMA 238 (308)
T ss_pred CCcCccChhHhcCCCCCccchHHHHHHHHHHHHhCCCCCCCcchhhHH-HhhcCccccccccCCcccccCCCCCccchhh
Confidence 2345677776655433 345555555666666554322222111 11111100000 0
Q ss_pred hhhhhhccCcCCCC---CCCCCccchHHHHhcccCcCCCCCCChhhhhhCCcccc
Q psy758 214 CDQLLRHPYFNGYY---FEVPDEMQYEEITQRCLDKDPLRRWSCDQLLRHPYFNG 265 (292)
Q Consensus 214 ~~~~~~~~~~~~~~---~~~~~~~~l~~li~~~l~~dP~~Rpt~~~il~h~w~~~ 265 (292)
..+..... ..... .....+..+.+||.+||..||++|||+.++++||||.+
T Consensus 239 ~~~~~~~~-~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~~~~~~~ 292 (308)
T cd06615 239 IFELLDYI-VNEPPPKLPSGAFSDEFQDFVDKCLKKNPKERADLKELTKHPFIKR 292 (308)
T ss_pred HHHHHHHH-hcCCCccCcCcccCHHHHHHHHHHccCChhhCcCHHHHhcChhhhh
Confidence 00000000 00000 01123567999999999999999999999999999987
|
Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the down |
| >PHA03209 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-39 Score=273.50 Aligned_cols=256 Identities=22% Similarity=0.259 Sum_probs=181.7
Q ss_pred cccceeeeecccCceEEEEEEEcCCCcEEEEEEeccCCCChHHHHHHHHHHHHHHhCCCCCcchhhhhhhcCCeEEEEEe
Q psy758 2 ERYEKIGKLGEGSYGVVFKCRNRDTGQVVAIKKFLESEEDPLIRKIALREIRLLKSLKHPNLVNLLEVFRRKKKLHLVFE 81 (292)
Q Consensus 2 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~iv~e 81 (292)
.+|++.+.||+|++|.||+|.+..+++.||+|+..... ...|+.+++.++||||+++++++.+.+..++|+|
T Consensus 66 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~valK~~~~~~--------~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 137 (357)
T PHA03209 66 LGYTVIKTLTPGSEGRVFVATKPGQPDPVVLKIGQKGT--------TLIEAMLLQNVNHPSVIRMKDTLVSGAITCMVLP 137 (357)
T ss_pred cCcEEEEEecCCCCeEEEEEEECCCCceEEEEeCCccc--------cHHHHHHHHhCCCCCCcChhheEEeCCeeEEEEE
Confidence 36999999999999999999999999999999754322 2468999999999999999999999999999999
Q ss_pred cCCCccHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEEccCCcEEEeecCchhhhhcc----ccc
Q psy758 82 FCDHTVLNELENHPHGLPWDLIKQITWQVLRGVSYCHRHACIHRDIKPENILLTANGVVKLCDFGFARLIRDL----IPR 157 (292)
Q Consensus 82 ~~~~~~L~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~givH~dl~p~Nilv~~~~~~kl~dfg~~~~~~~~----~~~ 157 (292)
++.++.+..+......+++..++.++.||+.||.|||++||+||||||+||+++.++.++|+|||++...... ...
T Consensus 138 ~~~~~l~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~~~~~~~~ 217 (357)
T PHA03209 138 HYSSDLYTYLTKRSRPLPIDQALIIEKQILEGLRYLHAQRIIHRDVKTENIFINDVDQVCIGDLGAAQFPVVAPAFLGLA 217 (357)
T ss_pred ccCCcHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEECCCCCEEEecCccccccccCccccccc
Confidence 9987655555555567999999999999999999999999999999999999999999999999998643221 122
Q ss_pred cccccccccccccCCCC-----CCCcccceeeecCCC-CCCc-------------hHHHHHHHhhcccCCCCCC--Chhh
Q psy758 158 HLHIFQTNEYFKGVSLP-----HAENVVPLEIKIGKP-AATN-------------IYLIDFLKRCLDKDPLRRW--SCDQ 216 (292)
Q Consensus 158 ~~~~~~~~~~~~~~~~~-----~~~~~~~~~~~~~~~-~~~~-------------~~~~~~~~~~~~~~p~~~~--~~~~ 216 (292)
++..|.+||...+.... |+.|+..+++..+.. .+.. ..+..++ ..++..|...+ ....
T Consensus 218 gt~~y~aPE~~~~~~~~~~~DiwSlGvvl~ell~~~~~~f~~~~~~~~~~~~~~~~~l~~~~-~~~~~~~~~~~~~~~~~ 296 (357)
T PHA03209 218 GTVETNAPEVLARDKYNSKADIWSAGIVLFEMLAYPSTIFEDPPSTPEEYVKSCHSHLLKII-STLKVHPEEFPRDPGSR 296 (357)
T ss_pred ccccccCCeecCCCCCCchhhHHHHHHHHHHHHHcCCccccCCCCcHHHHHHHHHHHHHHHH-HHhccChhhcCCCCccH
Confidence 34567788877665544 444444444443221 1110 0111111 11222222211 0000
Q ss_pred h----hhc------cCcCCC-CCCCCCccchHHHHhcccCcCCCCCCChhhhhhCCcccce
Q psy758 217 L----LRH------PYFNGY-YFEVPDEMQYEEITQRCLDKDPLRRWSCDQLLRHPYFNGY 266 (292)
Q Consensus 217 ~----~~~------~~~~~~-~~~~~~~~~l~~li~~~l~~dP~~Rpt~~~il~h~w~~~~ 266 (292)
. ... ++.... ......+..+.+||.+||+.||.+|||+.|+|+||||+++
T Consensus 297 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~Rpta~e~l~hp~f~~~ 357 (357)
T PHA03209 297 LVRGFIEYASLERQPYTRYPCFQRVNLPIDGEFLVHKMLTFDAAMRPSAEEILNYPMFAQL 357 (357)
T ss_pred HHHHHHhhcccCCCcccccHHHhccCCCchHHHHHHHHHcCCcccCcCHHHHhcCchhccC
Confidence 0 000 000000 0011335677889999999999999999999999999863
|
|
| >PTZ00283 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-39 Score=280.07 Aligned_cols=252 Identities=23% Similarity=0.269 Sum_probs=191.2
Q ss_pred cccceeeeecccCceEEEEEEEcCCCcEEEEEEeccCCCChHHHHHHHHHHHHHHhCCCCCcchhhhhhhcCC-------
Q psy758 2 ERYEKIGKLGEGSYGVVFKCRNRDTGQVVAIKKFLESEEDPLIRKIALREIRLLKSLKHPNLVNLLEVFRRKK------- 74 (292)
Q Consensus 2 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~------- 74 (292)
++|++.+.||+|+||.||+|.+..+++.||+|.+............+.+|+..+..++|+|++++++.+....
T Consensus 32 ~rY~i~~~LG~G~fG~Vy~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~Ei~~l~~~~h~~iv~~~~~~~~~~~~~~~~~ 111 (496)
T PTZ00283 32 KKYWISRVLGSGATGTVLCAKRVSDGEPFAVKVVDMEGMSEADKNRAQAEVCCLLNCDFFSIVKCHEDFAKKDPRNPENV 111 (496)
T ss_pred CCEEEEEEEecCCCEEEEEEEEcCCCCEEEEEEEecccCCHHHHHHHHHHHHHHhcCCCCcEEEeecceecccccCcccc
Confidence 6899999999999999999999999999999999877666666777889999999999999999887765321
Q ss_pred -eEEEEEecCCCccHHHHhcC----CCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEEccCCcEEEeecCchh
Q psy758 75 -KLHLVFEFCDHTVLNELENH----PHGLPWDLIKQITWQVLRGVSYCHRHACIHRDIKPENILLTANGVVKLCDFGFAR 149 (292)
Q Consensus 75 -~~~iv~e~~~~~~L~~~~~~----~~~~~~~~~~~i~~qi~~aL~~LH~~givH~dl~p~Nilv~~~~~~kl~dfg~~~ 149 (292)
.+++||||+++|+|.+++.. ...+++..++.++.|++.||.|||++||+||||||+||+++.++.++|+|||+++
T Consensus 112 ~~i~lV~Ey~~~gsL~~~l~~~~~~~~~l~e~~~~~i~~qll~aL~~lH~~~IiHrDLKP~NILl~~~~~vkL~DFGls~ 191 (496)
T PTZ00283 112 LMIALVLDYANAGDLRQEIKSRAKTNRTFREHEAGLLFIQVLLAVHHVHSKHMIHRDIKSANILLCSNGLVKLGDFGFSK 191 (496)
T ss_pred eEEEEEEeCCCCCcHHHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEEeCCCCEEEEecccCe
Confidence 47899999999999988753 3468999999999999999999999999999999999999999999999999987
Q ss_pred hhhccc-------cccccccccccccccCCCCCCCcccceeeecCCCCCCchHHHHHHHhhcccCCCCCCChhhhhhccC
Q psy758 150 LIRDLI-------PRHLHIFQTNEYFKGVSLPHAENVVPLEIKIGKPAATNIYLIDFLKRCLDKDPLRRWSCDQLLRHPY 222 (292)
Q Consensus 150 ~~~~~~-------~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~ 222 (292)
...... ..++..|.+||...+.......++ ++.+.-++..+.+..|+...+..+++....
T Consensus 192 ~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~s~k~DV-------------wSlGvilyeLltG~~Pf~~~~~~~~~~~~~ 258 (496)
T PTZ00283 192 MYAATVSDDVGRTFCGTPYYVAPEIWRRKPYSKKADM-------------FSLGVLLYELLTLKRPFDGENMEEVMHKTL 258 (496)
T ss_pred eccccccccccccccCCcceeCHHHhCCCCCCcHHHH-------------HHHHHHHHHHHHCCCCCCCCCHHHHHHHHh
Confidence 653211 112344666666554433222222 222333333444444544444433332221
Q ss_pred cCC-CCCCCCCccchHHHHhcccCcCCCCCCChhhhhhCCcccce
Q psy758 223 FNG-YYFEVPDEMQYEEITQRCLDKDPLRRWSCDQLLRHPYFNGY 266 (292)
Q Consensus 223 ~~~-~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~~il~h~w~~~~ 266 (292)
... ...+...+..+.+++.+||+.||.+|||+.++++|||++..
T Consensus 259 ~~~~~~~~~~~~~~l~~li~~~L~~dP~~RPs~~ell~~p~~~~~ 303 (496)
T PTZ00283 259 AGRYDPLPPSISPEMQEIVTALLSSDPKRRPSSSKLLNMPICKLF 303 (496)
T ss_pred cCCCCCCCCCCCHHHHHHHHHHcccChhhCcCHHHHHhCHHHHHh
Confidence 111 12334557889999999999999999999999999998763
|
|
| >cd06610 STKc_OSR1_SPAK Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-39 Score=260.23 Aligned_cols=249 Identities=27% Similarity=0.399 Sum_probs=186.1
Q ss_pred cccceeeeecccCceEEEEEEEcCCCcEEEEEEeccCCCChHHHHHHHHHHHHHHhCCCCCcchhhhhhhcCCeEEEEEe
Q psy758 2 ERYEKIGKLGEGSYGVVFKCRNRDTGQVVAIKKFLESEEDPLIRKIALREIRLLKSLKHPNLVNLLEVFRRKKKLHLVFE 81 (292)
Q Consensus 2 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~iv~e 81 (292)
++|++.+.||.|++|.||+|....++..+++|++....... ..+.+.+|+..++.++|+|++++++.+..++..++++|
T Consensus 1 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~-~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~iv~e 79 (267)
T cd06610 1 DDYELIEVIGVGATAVVYAAICLPNNEKVAIKRIDLEKCQT-SVDELRKEVQAMSQCNHPNVVKYYTSFVVGDELWLVMP 79 (267)
T ss_pred CcceeeeeecCCCCeEEEEEEEcCCCcEEEEEEeccCCcch-HHHHHHHHHHHHHhcCCCCEEEEEEEEeeCCEEEEEEe
Confidence 57999999999999999999998889999999987654443 56778899999999999999999999999999999999
Q ss_pred cCCCccHHHHhcCC---CCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEEccCCcEEEeecCchhhhhccccc-
Q psy758 82 FCDHTVLNELENHP---HGLPWDLIKQITWQVLRGVSYCHRHACIHRDIKPENILLTANGVVKLCDFGFARLIRDLIPR- 157 (292)
Q Consensus 82 ~~~~~~L~~~~~~~---~~~~~~~~~~i~~qi~~aL~~LH~~givH~dl~p~Nilv~~~~~~kl~dfg~~~~~~~~~~~- 157 (292)
++++++|..++... ..+++..++.++.|++.||.+||++|++|+||+|+||++++++.++|+|||++.........
T Consensus 80 ~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~lh~~~i~h~~l~p~ni~~~~~~~~~l~df~~~~~~~~~~~~~ 159 (267)
T cd06610 80 YLSGGSLLDIMKSSYPRGGLDEAIIATVLKEVLKGLEYLHSNGQIHRDIKAGNILLGEDGSVKIADFGVSASLADGGDRT 159 (267)
T ss_pred ccCCCcHHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHhEEEcCCCCEEEcccchHHHhccCcccc
Confidence 99999999998653 45899999999999999999999999999999999999999999999999998776542211
Q ss_pred --------cccccccccccccC------CCCCCCcccceeeecCCCCCCchHHHHHHHhhcccCCCCCCChhhhhhccCc
Q psy758 158 --------HLHIFQTNEYFKGV------SLPHAENVVPLEIKIGKPAATNIYLIDFLKRCLDKDPLRRWSCDQLLRHPYF 223 (292)
Q Consensus 158 --------~~~~~~~~~~~~~~------~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~ 223 (292)
....|.+|+..... ...|+.++..+++.+|..++........+.......+ +.+
T Consensus 160 ~~~~~~~~~~~~y~~Pe~~~~~~~~~~~~Dv~slG~i~~~l~~g~~p~~~~~~~~~~~~~~~~~~------------~~~ 227 (267)
T cd06610 160 RKVRKTFVGTPCWMAPEVMEQVHGYDFKADIWSFGITAIELATGAAPYSKYPPMKVLMLTLQNDP------------PSL 227 (267)
T ss_pred ccccccccCChhhcChHHHccccCcCcccchHhHhHHHHHHHhCCCCccccChhhhHHHHhcCCC------------CCc
Confidence 12335555544332 2233344444444444443321111111111111100 000
Q ss_pred CCCCCCCCCccchHHHHhcccCcCCCCCCChhhhhhCCcc
Q psy758 224 NGYYFEVPDEMQYEEITQRCLDKDPLRRWSCDQLLRHPYF 263 (292)
Q Consensus 224 ~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~~il~h~w~ 263 (292)
.........+..+.+++.+||..||.+|||+.++++||||
T Consensus 228 ~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~ll~~p~~ 267 (267)
T cd06610 228 ETGADYKKYSKSFRKMISLCLQKDPSKRPTAEELLKHKFF 267 (267)
T ss_pred CCccccccccHHHHHHHHHHcCCChhhCcCHHHHhhCCCC
Confidence 0000112346788999999999999999999999999997
|
Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1 |
| >cd07833 STKc_CDKL Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-39 Score=263.98 Aligned_cols=260 Identities=44% Similarity=0.776 Sum_probs=194.4
Q ss_pred cccceeeeecccCceEEEEEEEcCCCcEEEEEEeccCCCChHHHHHHHHHHHHHHhCCCCCcchhhhhhhcCCeEEEEEe
Q psy758 2 ERYEKIGKLGEGSYGVVFKCRNRDTGQVVAIKKFLESEEDPLIRKIALREIRLLKSLKHPNLVNLLEVFRRKKKLHLVFE 81 (292)
Q Consensus 2 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~iv~e 81 (292)
++|++.+.||+|++|.||+|.+..+++.|++|.+..........+.+.+|+.+++.++|+||+++++++.+++..++++|
T Consensus 1 ~~y~~~~~i~~g~~~~v~~~~~~~~~~~v~vK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~iv~e 80 (288)
T cd07833 1 NKYEVLGVVGEGAYGVVLKCRNKATGEIVAIKKFKESEDDEDVKKTALREVKVLRQLRHENIVNLKEAFRRKGRLYLVFE 80 (288)
T ss_pred CceeEEEEecccCCeeEEEEEeCCCCcEEEEehhhhhcccccchhHHHHHHHHHHhcCCCCeeehhheEEECCEEEEEEe
Confidence 58999999999999999999999999999999987665555556788899999999999999999999999999999999
Q ss_pred cCCCccHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEEccCCcEEEeecCchhhhhcccc-----
Q psy758 82 FCDHTVLNELENHPHGLPWDLIKQITWQVLRGVSYCHRHACIHRDIKPENILLTANGVVKLCDFGFARLIRDLIP----- 156 (292)
Q Consensus 82 ~~~~~~L~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~givH~dl~p~Nilv~~~~~~kl~dfg~~~~~~~~~~----- 156 (292)
|++++++..+......+++..++.++.||+.||.|||++|++|+||+|+||++++++.++|+|||.+........
T Consensus 81 ~~~~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~H~dl~~~ni~~~~~~~~kl~d~g~~~~~~~~~~~~~~~ 160 (288)
T cd07833 81 YVERTLLELLEASPGGLPPDAVRSYIWQLLQAIAYCHSHNIIHRDIKPENILVSESGVLKLCDFGFARALRARPASPLTD 160 (288)
T ss_pred cCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEECCCCCEEEEeeecccccCCCccccccC
Confidence 999999988887777799999999999999999999999999999999999999999999999999876554321
Q ss_pred -ccccccccccccccC-C-----CCCCCcccceeeecCCCCCCchHHHHHH---HhhcccCCCCCCChhhhhhccCcCC-
Q psy758 157 -RHLHIFQTNEYFKGV-S-----LPHAENVVPLEIKIGKPAATNIYLIDFL---KRCLDKDPLRRWSCDQLLRHPYFNG- 225 (292)
Q Consensus 157 -~~~~~~~~~~~~~~~-~-----~~~~~~~~~~~~~~~~~~~~~~~~~~~~---~~~~~~~p~~~~~~~~~~~~~~~~~- 225 (292)
.....|.+||+..+. . ..|+.|+..+++.+|.+++......+.+ ..++...+... .........+..
T Consensus 161 ~~~~~~~~~PE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~ 238 (288)
T cd07833 161 YVATRWYRAPELLVGDTNYGKPVDVWAIGCIMAELLDGEPLFPGDSDIDQLYLIQKCLGPLPPSH--QELFSSNPRFAGV 238 (288)
T ss_pred cccccCCcCCchhcCCCCcCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHH--hhhcccCcccccc
Confidence 112346677766554 2 3355555555566665543322111111 11111111000 000000000000
Q ss_pred ------------CCCCCCCccchHHHHhcccCcCCCCCCChhhhhhCCcc
Q psy758 226 ------------YYFEVPDEMQYEEITQRCLDKDPLRRWSCDQLLRHPYF 263 (292)
Q Consensus 226 ------------~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~~il~h~w~ 263 (292)
...+...+..+.+||++||..||++|||++++++||||
T Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~~~f 288 (288)
T cd07833 239 AFPEPSQPESLERRYPGKVSSPALDFLKACLRMDPKERLTCDELLQHPYF 288 (288)
T ss_pred ccCCCCCcHHHHHhcCCccchHHHHHHHHHhccCchhcccHHHHhcCCCC
Confidence 01122337789999999999999999999999999997
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning |
| >cd06644 STKc_STK10_LOK Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.3e-39 Score=262.19 Aligned_cols=252 Identities=27% Similarity=0.381 Sum_probs=190.8
Q ss_pred cccceeeeecccCceEEEEEEEcCCCcEEEEEEeccCCCChHHHHHHHHHHHHHHhCCCCCcchhhhhhhcCCeEEEEEe
Q psy758 2 ERYEKIGKLGEGSYGVVFKCRNRDTGQVVAIKKFLESEEDPLIRKIALREIRLLKSLKHPNLVNLLEVFRRKKKLHLVFE 81 (292)
Q Consensus 2 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~iv~e 81 (292)
+.|++++.||+|++|.||+|.+..+++.|++|.+... .......+.+|+.+++.++||||+++++.+..++..++|||
T Consensus 12 ~~y~i~~~lg~g~~g~vy~~~~~~~~~~~~~k~~~~~--~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 89 (292)
T cd06644 12 EVWEIIGELGDGAFGKVYKAKNKETGALAAAKVIETK--SEEELEDYMVEIEILATCNHPYIVKLLGAFYWDGKLWIMIE 89 (292)
T ss_pred hhhhhhheecCCCCeEEEEEEECCCCceEEEEEeccC--CHHHHHHHHHHHHHHHhCCCCcEeeeEEEEEeCCeEEEEEe
Confidence 4699999999999999999999999999999998654 33446668889999999999999999999999999999999
Q ss_pred cCCCccHHHHhcC-CCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEEccCCcEEEeecCchhhhhccc-----
Q psy758 82 FCDHTVLNELENH-PHGLPWDLIKQITWQVLRGVSYCHRHACIHRDIKPENILLTANGVVKLCDFGFARLIRDLI----- 155 (292)
Q Consensus 82 ~~~~~~L~~~~~~-~~~~~~~~~~~i~~qi~~aL~~LH~~givH~dl~p~Nilv~~~~~~kl~dfg~~~~~~~~~----- 155 (292)
|+++++|..++.. ...+++..++.++.|++.||.|||++|++|+||+|+||+++.++.++|+|||++.......
T Consensus 90 ~~~~~~l~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lH~~~i~H~dlkp~Nili~~~~~~kl~dfg~~~~~~~~~~~~~~ 169 (292)
T cd06644 90 FCPGGAVDAIMLELDRGLTEPQIQVICRQMLEALQYLHSMKIIHRDLKAGNVLLTLDGDIKLADFGVSAKNVKTLQRRDS 169 (292)
T ss_pred cCCCCcHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhcCCeeecCCCcceEEEcCCCCEEEccCccceeccccccccce
Confidence 9999999887643 4568999999999999999999999999999999999999999999999999876533211
Q ss_pred cccccccccccccccC----------CCCCCCcccceeeecCCCCCCchHHHHHHHhhcccCCCCCCChhhhhhccC---
Q psy758 156 PRHLHIFQTNEYFKGV----------SLPHAENVVPLEIKIGKPAATNIYLIDFLKRCLDKDPLRRWSCDQLLRHPY--- 222 (292)
Q Consensus 156 ~~~~~~~~~~~~~~~~----------~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~--- 222 (292)
......|.+||+..+. ...|+.|+..+++.++..+ ....+..+......
T Consensus 170 ~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~il~el~~g~~p------------------~~~~~~~~~~~~~~~~~ 231 (292)
T cd06644 170 FIGTPYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQIEPP------------------HHELNPMRVLLKIAKSE 231 (292)
T ss_pred ecCCccccCceeeccccccCCCCCchhhhHhHHHHHHHHhcCCCC------------------CccccHHHHHHHHhcCC
Confidence 1223456777765432 2233344444444444433 22222111111100
Q ss_pred cCCCCCCCCCccchHHHHhcccCcCCCCCCChhhhhhCCcccceeccCCCh
Q psy758 223 FNGYYFEVPDEMQYEEITQRCLDKDPLRRWSCDQLLRHPYFNGYYFEVPDE 273 (292)
Q Consensus 223 ~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~~il~h~w~~~~~~~~~~~ 273 (292)
......+...+..+.++|.+||..||++||++.++++||||..+.+..+.+
T Consensus 232 ~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~~~~~~~~~~~~~~ 282 (292)
T cd06644 232 PPTLSQPSKWSMEFRDFLKTALDKHPETRPSAAQLLEHPFVSSVTSNRPLR 282 (292)
T ss_pred CccCCCCcccCHHHHHHHHHHhcCCcccCcCHHHHhcCccccccccchhHH
Confidence 001111234466889999999999999999999999999999877666443
|
Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types. |
| >cd08218 STKc_Nek1 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-38 Score=255.26 Aligned_cols=248 Identities=24% Similarity=0.395 Sum_probs=188.9
Q ss_pred ccceeeeecccCceEEEEEEEcCCCcEEEEEEeccCCCChHHHHHHHHHHHHHHhCCCCCcchhhhhhhcCCeEEEEEec
Q psy758 3 RYEKIGKLGEGSYGVVFKCRNRDTGQVVAIKKFLESEEDPLIRKIALREIRLLKSLKHPNLVNLLEVFRRKKKLHLVFEF 82 (292)
Q Consensus 3 ~y~~~~~l~~g~~~~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~iv~e~ 82 (292)
+|++.+.||+|++|.+|.+.+..+++.|++|.+..........+.+.+|+.+++.++||||+++++++...+..++|+||
T Consensus 1 ~y~~~~~lg~g~~g~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~ 80 (256)
T cd08218 1 KYVKVKKIGEGSFGKAILVKSKEDGKQYVIKEINISKMSPKEREESRKEVAVLSNMKHPNIVQYQESFEENGNLYIVMDY 80 (256)
T ss_pred CceEEEEeccCCceEEEEEEEcCCCCEEEEEEEEhHhCChHHHHHHHHHHHHHHhCCCCCeeeeEeeecCCCeEEEEEec
Confidence 69999999999999999999999999999999876554445566788999999999999999999999999999999999
Q ss_pred CCCccHHHHhcCC--CCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEEccCCcEEEeecCchhhhhcccc----
Q psy758 83 CDHTVLNELENHP--HGLPWDLIKQITWQVLRGVSYCHRHACIHRDIKPENILLTANGVVKLCDFGFARLIRDLIP---- 156 (292)
Q Consensus 83 ~~~~~L~~~~~~~--~~~~~~~~~~i~~qi~~aL~~LH~~givH~dl~p~Nilv~~~~~~kl~dfg~~~~~~~~~~---- 156 (292)
+.+++|.+.+... ..+++..++.++.|++.||.+||++|++|+||+|+||+++.++.++|+|||.+........
T Consensus 81 ~~~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~i~h~~l~~~nil~~~~~~~~l~d~~~~~~~~~~~~~~~~ 160 (256)
T cd08218 81 CEGGDLYKKINAQRGVLFPEDQILDWFVQICLALKHVHDRKILHRDIKSQNIFLTKDGTIKLGDFGIARVLNSTVELART 160 (256)
T ss_pred CCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEEcCCCCEEEeeccceeecCcchhhhhh
Confidence 9999998887643 3579999999999999999999999999999999999999999999999999876543221
Q ss_pred -ccccccccccccccCCCCCCCcccceeeecCCCCCCchHHHHHHHhhcccCCCCCCChhhhhhccCcCCC-CCCCCCcc
Q psy758 157 -RHLHIFQTNEYFKGVSLPHAENVVPLEIKIGKPAATNIYLIDFLKRCLDKDPLRRWSCDQLLRHPYFNGY-YFEVPDEM 234 (292)
Q Consensus 157 -~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~-~~~~~~~~ 234 (292)
.....|.+||+..+.......++|+ .+.-++..+.+..|.......+.......... ..+...+.
T Consensus 161 ~~~~~~~~~pe~~~~~~~~~~~Dv~s-------------lG~i~~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 227 (256)
T cd08218 161 CIGTPYYLSPEICENRPYNNKSDIWA-------------LGCVLYEMCTLKHAFEAGNMKNLVLKIIRGSYPPVSSHYSY 227 (256)
T ss_pred ccCCccccCHHHhCCCCCCCccchhH-------------HHHHHHHHHcCCCCccCCCHHHHHHHHhcCCCCCCcccCCH
Confidence 1223456666654433322222222 22333333344444333333322221111111 12334477
Q ss_pred chHHHHhcccCcCCCCCCChhhhhhCCcc
Q psy758 235 QYEEITQRCLDKDPLRRWSCDQLLRHPYF 263 (292)
Q Consensus 235 ~l~~li~~~l~~dP~~Rpt~~~il~h~w~ 263 (292)
.+.++|.+||+.+|.+||++.++++||||
T Consensus 228 ~~~~li~~~l~~~p~~Rp~~~~vl~~~~~ 256 (256)
T cd08218 228 DLRNLVSQLFKRNPRDRPSVNSILEKNFI 256 (256)
T ss_pred HHHHHHHHHhhCChhhCcCHHHHhhCcCC
Confidence 89999999999999999999999999997
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycysti |
| >cd06611 STKc_SLK_like Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-39 Score=263.10 Aligned_cols=245 Identities=28% Similarity=0.436 Sum_probs=187.1
Q ss_pred cccceeeeecccCceEEEEEEEcCCCcEEEEEEeccCCCChHHHHHHHHHHHHHHhCCCCCcchhhhhhhcCCeEEEEEe
Q psy758 2 ERYEKIGKLGEGSYGVVFKCRNRDTGQVVAIKKFLESEEDPLIRKIALREIRLLKSLKHPNLVNLLEVFRRKKKLHLVFE 81 (292)
Q Consensus 2 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~iv~e 81 (292)
++|++.+.||+|++|.||++.+..++..+++|.+... .....+.+.+|+.+++.++||||+++++++.+++..++|||
T Consensus 5 ~~~~i~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~--~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 82 (280)
T cd06611 5 DIWEIIGELGDGAFGKVYKAQHKETGLFAAAKIIQIE--SEEELEDFMVEIDILSECKHPNIVGLYEAYFYENKLWILIE 82 (280)
T ss_pred hHHHHHHHhcCCCCceEEEEEEcCCCcEEEEEEEeeC--CHHHHHHHHHHHHHHHhCCCCceeEEEEEEecCCeEEEEee
Confidence 5799999999999999999999889999999998644 33345668889999999999999999999999999999999
Q ss_pred cCCCccHHHHhcC-CCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEEccCCcEEEeecCchhhhhcccc----
Q psy758 82 FCDHTVLNELENH-PHGLPWDLIKQITWQVLRGVSYCHRHACIHRDIKPENILLTANGVVKLCDFGFARLIRDLIP---- 156 (292)
Q Consensus 82 ~~~~~~L~~~~~~-~~~~~~~~~~~i~~qi~~aL~~LH~~givH~dl~p~Nilv~~~~~~kl~dfg~~~~~~~~~~---- 156 (292)
|+++++|..++.. ...+++..++.++.|++.||.|||++|++|+||+|+||+++.++.++|+|||.+........
T Consensus 83 ~~~~~~L~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lh~~~i~h~dl~p~nili~~~~~~~l~d~g~~~~~~~~~~~~~~ 162 (280)
T cd06611 83 FCDGGALDSIMLELERGLTEPQIRYVCRQMLEALNFLHSHKVIHRDLKAGNILLTLDGDVKLADFGVSAKNKSTLQKRDT 162 (280)
T ss_pred ccCCCcHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCChhhEEECCCCCEEEccCccchhhcccccccce
Confidence 9999999998865 34699999999999999999999999999999999999999999999999998765543221
Q ss_pred -ccccccccccccccC----------CCCCCCcccceeeecCCCCCCchHHHHHHHhhcccCCCCCCChhhhhhccCc--
Q psy758 157 -RHLHIFQTNEYFKGV----------SLPHAENVVPLEIKIGKPAATNIYLIDFLKRCLDKDPLRRWSCDQLLRHPYF-- 223 (292)
Q Consensus 157 -~~~~~~~~~~~~~~~----------~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~-- 223 (292)
..+..|.+||...+. ...|+.|+..+++.+|.. |.......+.+.....
T Consensus 163 ~~~~~~y~~PE~~~~~~~~~~~~~~~sDi~slG~il~~l~~g~~------------------p~~~~~~~~~~~~~~~~~ 224 (280)
T cd06611 163 FIGTPYWMAPEVVACETFKDNPYDYKADIWSLGITLIELAQMEP------------------PHHELNPMRVLLKILKSE 224 (280)
T ss_pred eecchhhcCHHHHhhcccCCCCCCccccHHHHHHHHHHHHhCCC------------------CcccCCHHHHHHHHhcCC
Confidence 123345566554321 222333444444444443 3332222221111100
Q ss_pred -CCCCCCCCCccchHHHHhcccCcCCCCCCChhhhhhCCcccce
Q psy758 224 -NGYYFEVPDEMQYEEITQRCLDKDPLRRWSCDQLLRHPYFNGY 266 (292)
Q Consensus 224 -~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~~il~h~w~~~~ 266 (292)
.....+...+..+.++|.+||+.||.+|||+.++++||||.+.
T Consensus 225 ~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~~~~~~~ 268 (280)
T cd06611 225 PPTLDQPSKWSSSFNDFLKSCLVKDPDDRPTAAELLKHPFVSDQ 268 (280)
T ss_pred CCCcCCcccCCHHHHHHHHHHhccChhhCcCHHHHhcChhhccc
Confidence 0111122346689999999999999999999999999999975
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated anti |
| >KOG4717|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-40 Score=268.33 Aligned_cols=254 Identities=27% Similarity=0.378 Sum_probs=207.2
Q ss_pred ccceeeeecccCceEEEEEEEcCCCcEEEEEEeccCCCChHHHHHHHHHHHHHHhCCCCCcchhhhhhhcCCeEEEEEec
Q psy758 3 RYEKIGKLGEGSYGVVFKCRNRDTGQVVAIKKFLESEEDPLIRKIALREIRLLKSLKHPNLVNLLEVFRRKKKLHLVFEF 82 (292)
Q Consensus 3 ~y~~~~~l~~g~~~~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~iv~e~ 82 (292)
-|.+.+.||+|-|+.|-+|++.-||+.||+|++.+...+......+.+|++.|+.++||||+++|++......+|+|+|+
T Consensus 19 LYDLekTlG~GHFAVVKLArHVFTGekVAVKviDKTKlD~~st~hlfqEVRCMKLVQHpNiVRLYEViDTQTKlyLiLEL 98 (864)
T KOG4717|consen 19 LYDLEKTLGRGHFAVVKLARHVFTGEKVAVKVIDKTKLDTLSTGHLFQEVRCMKLVQHPNIVRLYEVIDTQTKLYLILEL 98 (864)
T ss_pred eehhhhhhcCCceehhhhhhhhcccceeEEEEecccccchhhhhHHHHHHHHHHHhcCcCeeeeeehhcccceEEEEEEe
Confidence 47888999999999999999999999999999999988887888899999999999999999999999999999999999
Q ss_pred CCCccHHHHhcC-CCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEEc-cCCcEEEeecCchhhhhcccccc--
Q psy758 83 CDHTVLNELENH-PHGLPWDLIKQITWQVLRGVSYCHRHACIHRDIKPENILLT-ANGVVKLCDFGFARLIRDLIPRH-- 158 (292)
Q Consensus 83 ~~~~~L~~~~~~-~~~~~~~~~~~i~~qi~~aL~~LH~~givH~dl~p~Nilv~-~~~~~kl~dfg~~~~~~~~~~~~-- 158 (292)
-.+|+|.+++.. ...+.|+.+.+++.||+.|+.|+|+-.+||+||||+|+.+. .-|-+||+|||++..+.+.....
T Consensus 99 GD~GDl~DyImKHe~Gl~E~La~kYF~QI~~AI~YCHqLHVVHRDLKPENVVFFEKlGlVKLTDFGFSNkf~PG~kL~Ts 178 (864)
T KOG4717|consen 99 GDGGDLFDYIMKHEEGLNEDLAKKYFAQIVHAISYCHQLHVVHRDLKPENVVFFEKLGLVKLTDFGFSNKFQPGKKLTTS 178 (864)
T ss_pred cCCchHHHHHHhhhccccHHHHHHHHHHHHHHHHHHhhhhhhcccCCcceeEEeeecCceEeeeccccccCCCcchhhcc
Confidence 999999988754 45699999999999999999999999999999999998775 56899999999998876543322
Q ss_pred --ccccccccccccCCCC-CCCcccceeeecCCCCCCchHHHHHHHhhcccCCCCCCChhhhhhccCcCCCCCCCCCccc
Q psy758 159 --LHIFQTNEYFKGVSLP-HAENVVPLEIKIGKPAATNIYLIDFLKRCLDKDPLRRWSCDQLLRHPYFNGYYFEVPDEMQ 235 (292)
Q Consensus 159 --~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 235 (292)
.-.|.+||...|-.+- .+.++|++++ -++...++..|++..+..+.+....-=.+..|..++.+
T Consensus 179 CGSLAYSAPEILLGDsYDAPAVDiWSLGV-------------ILyMLVCGq~PFqeANDSETLTmImDCKYtvPshvS~e 245 (864)
T KOG4717|consen 179 CGSLAYSAPEILLGDSYDAPAVDIWSLGV-------------ILYMLVCGQPPFQEANDSETLTMIMDCKYTVPSHVSKE 245 (864)
T ss_pred cchhhccCchhhhcCccCCcchhhhHHHH-------------HHHHHHhCCCccccccchhhhhhhhcccccCchhhhHH
Confidence 2346677766664432 2233333322 22233344555555555555554444456778888999
Q ss_pred hHHHHhcccCcCCCCCCChhhhhhCCcccceecc
Q psy758 236 YEEITQRCLDKDPLRRWSCDQLLRHPYFNGYYFE 269 (292)
Q Consensus 236 l~~li~~~l~~dP~~Rpt~~~il~h~w~~~~~~~ 269 (292)
+++||.+||..||.+|.|.++|..|+|++.+...
T Consensus 246 CrdLI~sMLvRdPkkRAslEeI~s~~Wlq~~D~~ 279 (864)
T KOG4717|consen 246 CRDLIQSMLVRDPKKRASLEEIVSTSWLQAGDRG 279 (864)
T ss_pred HHHHHHHHHhcCchhhccHHHHhccccccCCCCC
Confidence 9999999999999999999999999999986644
|
|
| >cd07845 STKc_CDK10 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-39 Score=265.94 Aligned_cols=266 Identities=30% Similarity=0.459 Sum_probs=193.4
Q ss_pred CcccceeeeecccCceEEEEEEEcCCCcEEEEEEeccCCCChHHHHHHHHHHHHHHhCCCCCcchhhhhhhcC--CeEEE
Q psy758 1 MERYEKIGKLGEGSYGVVFKCRNRDTGQVVAIKKFLESEEDPLIRKIALREIRLLKSLKHPNLVNLLEVFRRK--KKLHL 78 (292)
Q Consensus 1 ~~~y~~~~~l~~g~~~~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~--~~~~i 78 (292)
+++|++.+.||.|++|.||+|.+..+|+.||+|.+............+.+|+.+++.++|+||+++++++.+. +..++
T Consensus 6 ~~~y~~~~~ig~g~~~~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~l 85 (309)
T cd07845 6 VTEFEKLNRIGEGTYGIVYRARDTTSGEIVALKKVRMDNERDGIPISSLREITLLLNLRHPNIVELKEVVVGKHLDSIFL 85 (309)
T ss_pred ccceeEeeeeeecCCEEEEEEEECCCCcEEEEEEEEeccCCCCCcchhhHHHHHHHhCCCCCCcceEEEEecCCCCeEEE
Confidence 4789999999999999999999999999999999875543333333456799999999999999999998654 56899
Q ss_pred EEecCCCccHHHHhc-CCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEEccCCcEEEeecCchhhhhccccc
Q psy758 79 VFEFCDHTVLNELEN-HPHGLPWDLIKQITWQVLRGVSYCHRHACIHRDIKPENILLTANGVVKLCDFGFARLIRDLIPR 157 (292)
Q Consensus 79 v~e~~~~~~L~~~~~-~~~~~~~~~~~~i~~qi~~aL~~LH~~givH~dl~p~Nilv~~~~~~kl~dfg~~~~~~~~~~~ 157 (292)
|+||+.++ |..++. ....+++..++.++.||+.||+|||++|++|+||+|+||++++++.++|+|||.+.........
T Consensus 86 v~e~~~~~-l~~~l~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~nil~~~~~~~kL~dfg~~~~~~~~~~~ 164 (309)
T cd07845 86 VMEYCEQD-LASLLDNMPTPFSESQVKCLMLQLLRGLQYLHENFIIHRDLKVSNLLLTDKGCLKIADFGLARTYGLPAKP 164 (309)
T ss_pred EEecCCCC-HHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEECCCCCEEECccceeeecCCccCC
Confidence 99999874 555544 3457899999999999999999999999999999999999999999999999998765432111
Q ss_pred -----cccccccccccccC------CCCCCCcccceeeecCCCCCCchHHHHHHHh---hcccCCCCCC-ChhhhhhccC
Q psy758 158 -----HLHIFQTNEYFKGV------SLPHAENVVPLEIKIGKPAATNIYLIDFLKR---CLDKDPLRRW-SCDQLLRHPY 222 (292)
Q Consensus 158 -----~~~~~~~~~~~~~~------~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~---~~~~~p~~~~-~~~~~~~~~~ 222 (292)
....|.+||...+. ...|+.|+..+++.++.+++........+.. .++..+...+ ..... +.
T Consensus 165 ~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~---~~ 241 (309)
T cd07845 165 MTPKVVTLWYRAPELLLGCTTYTTAIDMWAVGCILAELLAHKPLLPGKSEIEQLDLIIQLLGTPNESIWPGFSDL---PL 241 (309)
T ss_pred CCcccccccccChhhhcCCCCcCchHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCChhhchhhhcc---cc
Confidence 12347777766442 2346666667777777766544433333222 2222111110 00000 00
Q ss_pred cCCCCC-----------CCCCccchHHHHhcccCcCCCCCCChhhhhhCCcccceeccC
Q psy758 223 FNGYYF-----------EVPDEMQYEEITQRCLDKDPLRRWSCDQLLRHPYFNGYYFEV 270 (292)
Q Consensus 223 ~~~~~~-----------~~~~~~~l~~li~~~l~~dP~~Rpt~~~il~h~w~~~~~~~~ 270 (292)
...... ....+..+.++|.+||++||++|||+.++++||||.+.....
T Consensus 242 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~R~t~~~il~h~~f~~~~~~~ 300 (309)
T cd07845 242 VGKFTLPKQPYNNLKHKFPWLSEAGLRLLNFLLMYDPKKRATAEEALESSYFKEKPLPC 300 (309)
T ss_pred cccccccCCCCCchHHhccccCHHHHHHHHHHhcCChhhCcCHHHHhcChhhccCCCCC
Confidence 000000 011367789999999999999999999999999999755443
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing |
| >cd05607 STKc_GRK7 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.1e-39 Score=260.64 Aligned_cols=246 Identities=25% Similarity=0.335 Sum_probs=179.9
Q ss_pred ecccCceEEEEEEEcCCCcEEEEEEeccCCCC-hHHHHHHHHHHHHHHhCCCCCcchhhhhhhcCCeEEEEEecCCCccH
Q psy758 10 LGEGSYGVVFKCRNRDTGQVVAIKKFLESEED-PLIRKIALREIRLLKSLKHPNLVNLLEVFRRKKKLHLVFEFCDHTVL 88 (292)
Q Consensus 10 l~~g~~~~v~~~~~~~~~~~v~iK~~~~~~~~-~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~iv~e~~~~~~L 88 (292)
||+|+||.||++.+..+|+.|++|.+...... .........|+++++.++||||+++++++.++...++||||++|++|
T Consensus 1 lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~E~~il~~l~hp~i~~~~~~~~~~~~~~lv~e~~~g~~L 80 (277)
T cd05607 1 LGKGGFGEVCAVQVKNTGKMYACKKLDKKRLKKKSGEKMALLEKEILEKVNSPFIVNLAYAFESKTHLCLVMSLMNGGDL 80 (277)
T ss_pred CCCCCceEEEEEEEccCCcEEEEEEEcHHHhhcchhhHHHHHHHHHHHhcCCCcEEEEEEEEecCCeEEEEEecCCCCCH
Confidence 69999999999999999999999998654322 22334556799999999999999999999999999999999999999
Q ss_pred HHHhcCC--CCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEEccCCcEEEeecCchhhhhccc----ccccccc
Q psy758 89 NELENHP--HGLPWDLIKQITWQVLRGVSYCHRHACIHRDIKPENILLTANGVVKLCDFGFARLIRDLI----PRHLHIF 162 (292)
Q Consensus 89 ~~~~~~~--~~~~~~~~~~i~~qi~~aL~~LH~~givH~dl~p~Nilv~~~~~~kl~dfg~~~~~~~~~----~~~~~~~ 162 (292)
..++... ..+++..+..++.||+.||+|||+.|++|+||+|+||++++++.++|+|||++....... ...+..|
T Consensus 81 ~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~ivH~dikp~Nili~~~~~~~l~Dfg~~~~~~~~~~~~~~~~~~~y 160 (277)
T cd05607 81 KYHIYNVGERGLEMERVIHYSAQITCGILHLHSMDIVYRDMKPENVLLDDQGNCRLSDLGLAVELKDGKTITQRAGTNGY 160 (277)
T ss_pred HHHHHhccccCCCHHHHHHHHHHHHHHHHHHHHCCEEEccCChHhEEEcCCCCEEEeeceeeeecCCCceeeccCCCCCc
Confidence 8877432 358899999999999999999999999999999999999999999999999987654321 2233456
Q ss_pred ccccccccCCCC-----CCCcccceeeecCCCCCCchHHHHHHHhhcccCCCCCCChhhhhhccCcCCCCC-CCCCccch
Q psy758 163 QTNEYFKGVSLP-----HAENVVPLEIKIGKPAATNIYLIDFLKRCLDKDPLRRWSCDQLLRHPYFNGYYF-EVPDEMQY 236 (292)
Q Consensus 163 ~~~~~~~~~~~~-----~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~-~~~~~~~l 236 (292)
.+||+..+.... |+.|+..+++.+|..++.... ...+..++........... ....+.++
T Consensus 161 ~aPE~~~~~~~~~~~DvwslGv~l~el~~g~~p~~~~~--------------~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 226 (277)
T cd05607 161 MAPEILKEEPYSYPVDWFAMGCSIYEMVAGRTPFKDHK--------------EKVAKEELKRRTLEDEVKFEHQNFTEES 226 (277)
T ss_pred cCHHHHccCCCCCchhHHHHHHHHHHHHhCCCCCCCCc--------------chhhHHHHHHHhhccccccccccCCHHH
Confidence 677765544332 333333334444443321100 0001112211111111111 12347789
Q ss_pred HHHHhcccCcCCCCCCCh----hhhhhCCcccceecc
Q psy758 237 EEITQRCLDKDPLRRWSC----DQLLRHPYFNGYYFE 269 (292)
Q Consensus 237 ~~li~~~l~~dP~~Rpt~----~~il~h~w~~~~~~~ 269 (292)
++||.+||+.||.+||++ ++++.||||+++.|.
T Consensus 227 ~~li~~~L~~~P~~R~~~~~~~~~~~~h~~f~~~~~~ 263 (277)
T cd05607 227 KDICRLFLAKKPEDRLGSREKNDDPRKHEFFKTINFP 263 (277)
T ss_pred HHHHHHHhccCHhhCCCCccchhhhhcChhhcCCCHH
Confidence 999999999999999999 667899999987664
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual gr |
| >cd05572 STKc_cGK_PKG Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-38 Score=255.67 Aligned_cols=242 Identities=22% Similarity=0.324 Sum_probs=186.6
Q ss_pred ecccCceEEEEEEEcCCCcEEEEEEeccCCC-ChHHHHHHHHHHHHHHhCCCCCcchhhhhhhcCCeEEEEEecCCCccH
Q psy758 10 LGEGSYGVVFKCRNRDTGQVVAIKKFLESEE-DPLIRKIALREIRLLKSLKHPNLVNLLEVFRRKKKLHLVFEFCDHTVL 88 (292)
Q Consensus 10 l~~g~~~~v~~~~~~~~~~~v~iK~~~~~~~-~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~iv~e~~~~~~L 88 (292)
||.|++|.||+|.+..+++.|++|.+..... .....+.+.+|+.+++.++||||+++++.+.+++..++++||+++++|
T Consensus 1 lg~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L 80 (262)
T cd05572 1 LGVGGFGRVELVKVKSKNRTFALKCVKKRHIVETGQQEHIFSEKEILEECNHPFIVKLYRTFKDKKYIYMLMEYCLGGEL 80 (262)
T ss_pred CCCCCceEEEEEEECCCCcEEEEEEEehhcchhhhHHHHHHHHHHHHHhCCCCCEeeeeeeEEcCCccEEEEecCCCCcH
Confidence 6899999999999999999999999976543 334567788999999999999999999999999999999999999999
Q ss_pred HHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEEccCCcEEEeecCchhhhhccc----ccccccccc
Q psy758 89 NELENHPHGLPWDLIKQITWQVLRGVSYCHRHACIHRDIKPENILLTANGVVKLCDFGFARLIRDLI----PRHLHIFQT 164 (292)
Q Consensus 89 ~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~givH~dl~p~Nilv~~~~~~kl~dfg~~~~~~~~~----~~~~~~~~~ 164 (292)
.+++.....+++..+..++.||+.||+|||++|++|+||+|+||+++.++.++|+|||.+....... ......|.+
T Consensus 81 ~~~l~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~h~dl~~~nilv~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~ 160 (262)
T cd05572 81 WTILRDRGLFDEYTARFYIACVVLAFEYLHNRGIIYRDLKPENLLLDSNGYVKLVDFGFAKKLKSGQKTWTFCGTPEYVA 160 (262)
T ss_pred HHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhCCcccCCCCHHHEEEcCCCCEEEeeCCcccccCcccccccccCCcCccC
Confidence 9999877779999999999999999999999999999999999999999999999999987665421 112234555
Q ss_pred ccccccCC-----CCCCCcccceeeecCCCCCCchHHHHHHHhhcccCCCCCCC--hhhhhhccC--cCCCCCCCCCccc
Q psy758 165 NEYFKGVS-----LPHAENVVPLEIKIGKPAATNIYLIDFLKRCLDKDPLRRWS--CDQLLRHPY--FNGYYFEVPDEMQ 235 (292)
Q Consensus 165 ~~~~~~~~-----~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~--~~~~~~~~~--~~~~~~~~~~~~~ 235 (292)
||...+.. ..|+.|+..+++.+|. .|..... ..+...... ......+...+..
T Consensus 161 PE~~~~~~~~~~~Di~slG~il~~l~~g~------------------~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 222 (262)
T cd05572 161 PEIILNKGYDFSVDYWSLGILLYELLTGR------------------PPFGEDDEDPMEIYNDILKGNGKLEFPNYIDKA 222 (262)
T ss_pred hhHhcCCCCCChhhhhhhHHHHHHHHhCC------------------CCcCCCCCCHHHHHHHHhccCCCCCCCcccCHH
Confidence 65543322 2233333333333333 3333222 122221111 1122333344779
Q ss_pred hHHHHhcccCcCCCCCCC-----hhhhhhCCcccceecc
Q psy758 236 YEEITQRCLDKDPLRRWS-----CDQLLRHPYFNGYYFE 269 (292)
Q Consensus 236 l~~li~~~l~~dP~~Rpt-----~~~il~h~w~~~~~~~ 269 (292)
+.++|.+||+.||.+||+ ++|+++||||++..|+
T Consensus 223 ~~~~i~~~l~~~p~~R~~~~~~~~~~l~~~~~~~~~~~~ 261 (262)
T cd05572 223 AKDLIKQLLRRNPEERLGNLKGGIKDIKKHKWFNGFDWE 261 (262)
T ss_pred HHHHHHHHccCChhhCcCCcccCHHHHhcChhhhCCCCC
Confidence 999999999999999999 9999999999987664
|
Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowi |
| >cd07832 STKc_CCRK Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-39 Score=262.41 Aligned_cols=261 Identities=31% Similarity=0.477 Sum_probs=191.8
Q ss_pred ccceeeeecccCceEEEEEEEcCCCcEEEEEEeccCCCChHHHHHHHHHHHHHHhCCCCCcchhhhhhhcCCeEEEEEec
Q psy758 3 RYEKIGKLGEGSYGVVFKCRNRDTGQVVAIKKFLESEEDPLIRKIALREIRLLKSLKHPNLVNLLEVFRRKKKLHLVFEF 82 (292)
Q Consensus 3 ~y~~~~~l~~g~~~~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~iv~e~ 82 (292)
+|++.+.||+|++|.||+|.+..+|..|++|.+............+.+|+.+++.++||||+++++++.+++..++|+||
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~~v~e~ 80 (286)
T cd07832 1 RYKILGRIGEGAHGIVFKAKDRETGETVALKKVALRRLEGGIPNQALREIKALQACQHPYVVKLLDVFPHGSGFVLVMEY 80 (286)
T ss_pred CceEEeecccCCCcEEEEEEECCCCceEEEEEEEcccccchhhHHHHHHHHHHHhCCCCCCcceeeEEecCCeeEEEecc
Confidence 69999999999999999999999999999999987665455567788999999999999999999999999999999999
Q ss_pred CCCccHHHHhcC-CCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEEccCCcEEEeecCchhhhhccc------
Q psy758 83 CDHTVLNELENH-PHGLPWDLIKQITWQVLRGVSYCHRHACIHRDIKPENILLTANGVVKLCDFGFARLIRDLI------ 155 (292)
Q Consensus 83 ~~~~~L~~~~~~-~~~~~~~~~~~i~~qi~~aL~~LH~~givH~dl~p~Nilv~~~~~~kl~dfg~~~~~~~~~------ 155 (292)
+ +++|.+++.. ...+++..++.++.||+.||+|||+.|++|+||+|+||++++++.++|+|||.+.......
T Consensus 81 ~-~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~ni~~~~~~~~~l~dfg~~~~~~~~~~~~~~~ 159 (286)
T cd07832 81 M-PSDLSEVLRDEERPLPEAQVKSYMRMLLKGVAYMHANGIMHRDLKPANLLISADGVLKIADFGLARLFSEEEPRLYSH 159 (286)
T ss_pred c-CCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCcCHHHEEEcCCCcEEEeeeeecccccCCCCCcccc
Confidence 9 8888887753 4568999999999999999999999999999999999999999999999999987664322
Q ss_pred cccccccccccccccC------CCCCCCcccceeeecCCCCCCchHHHHHHHhhc---cc-CCCCCCChhhhhh--ccCc
Q psy758 156 PRHLHIFQTNEYFKGV------SLPHAENVVPLEIKIGKPAATNIYLIDFLKRCL---DK-DPLRRWSCDQLLR--HPYF 223 (292)
Q Consensus 156 ~~~~~~~~~~~~~~~~------~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~---~~-~p~~~~~~~~~~~--~~~~ 223 (292)
......|.+||...+. ...|+.|+..+++.++.+++........+...+ +. .+...+...+... ...+
T Consensus 160 ~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 239 (286)
T cd07832 160 QVATRWYRAPELLYGARKYDPGVDLWAVGCIFAELLNGSPLFPGENDIEQLAIVFRTLGTPNEETWPGLTSLPDYNKITF 239 (286)
T ss_pred ccCcccccCceeeeccccCCchhHHHHHHHHHHHHHcCCcCcCCCCHHHHHHHHHHHcCCCChHHHhhccCcchhhcccC
Confidence 1223456777765432 223555555566666655433222111111111 11 1101111000000 0000
Q ss_pred C-CC-----CCCCCCccchHHHHhcccCcCCCCCCChhhhhhCCccc
Q psy758 224 N-GY-----YFEVPDEMQYEEITQRCLDKDPLRRWSCDQLLRHPYFN 264 (292)
Q Consensus 224 ~-~~-----~~~~~~~~~l~~li~~~l~~dP~~Rpt~~~il~h~w~~ 264 (292)
. .. ......+..+.++|.+||+.||.+|||++++++||||.
T Consensus 240 ~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~l~h~~~~ 286 (286)
T cd07832 240 PESKPIPLEEIFPDASPEALDLLKGLLVYDPSKRLSAAEALRHPYFT 286 (286)
T ss_pred CCCCcchHHHhCCCccHHHHHHHHHHhccChhhCCCHHHHhhCcCcC
Confidence 0 00 00113357889999999999999999999999999984
|
Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of hea |
| >cd06628 STKc_MAPKKK_Byr2_like Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-38 Score=257.46 Aligned_cols=248 Identities=23% Similarity=0.324 Sum_probs=187.2
Q ss_pred ccceeeeecccCceEEEEEEEcCCCcEEEEEEeccCCCC-------hHHHHHHHHHHHHHHhCCCCCcchhhhhhhcCCe
Q psy758 3 RYEKIGKLGEGSYGVVFKCRNRDTGQVVAIKKFLESEED-------PLIRKIALREIRLLKSLKHPNLVNLLEVFRRKKK 75 (292)
Q Consensus 3 ~y~~~~~l~~g~~~~v~~~~~~~~~~~v~iK~~~~~~~~-------~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~ 75 (292)
+|++.+.||+|++|.||.|.+..+++.|++|.+...... ....+.+.+|+.+++.++||||+++++++.+.+.
T Consensus 1 ~~~~~~~ig~g~~~~v~~a~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~ 80 (267)
T cd06628 1 KWIKGALIGSGSFGSVYLGMNASSGELMAVKQVELPSVSASSKDRKRSMLDALAREIALLKELQHENIVQYLGSSLDADH 80 (267)
T ss_pred CccccceeecCCCeEEEEEEecCCCcEEEEEEecCCCcccchhHHHHHHHHHHHHHHHHHHhcCCCCeeeEEEEEEeCCc
Confidence 588999999999999999999988999999988655322 1234667889999999999999999999999999
Q ss_pred EEEEEecCCCccHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEEccCCcEEEeecCchhhhhccc
Q psy758 76 LHLVFEFCDHTVLNELENHPHGLPWDLIKQITWQVLRGVSYCHRHACIHRDIKPENILLTANGVVKLCDFGFARLIRDLI 155 (292)
Q Consensus 76 ~~iv~e~~~~~~L~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~givH~dl~p~Nilv~~~~~~kl~dfg~~~~~~~~~ 155 (292)
.++++||+++++|..++...+.+++..+..++.|++.||.+||++|++|+||+|+||++++++.++|+|||.+.......
T Consensus 81 ~~lv~e~~~~~~L~~~l~~~~~l~~~~~~~~~~~l~~~l~~lH~~~ivH~di~p~nil~~~~~~~~l~dfg~~~~~~~~~ 160 (267)
T cd06628 81 LNIFLEYVPGGSVAALLNNYGAFEETLVRNFVRQILKGLNYLHNRGIIHRDIKGANILVDNKGGIKISDFGISKKLEANS 160 (267)
T ss_pred cEEEEEecCCCCHHHHHHhccCccHHHHHHHHHHHHHHHHHHHhcCcccccCCHHHEEEcCCCCEEecccCCCccccccc
Confidence 99999999999999999887789999999999999999999999999999999999999999999999999987664211
Q ss_pred c-----------ccccccccccccccCCCCCCCcccceeeecCCCCCCchHHHHHHHhhcccCCCCCCChhhhhhc-cCc
Q psy758 156 P-----------RHLHIFQTNEYFKGVSLPHAENVVPLEIKIGKPAATNIYLIDFLKRCLDKDPLRRWSCDQLLRH-PYF 223 (292)
Q Consensus 156 ~-----------~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~-~~~ 223 (292)
. .....|.+||...+....... +.++.+.-++..+.+..|....+....... .-.
T Consensus 161 ~~~~~~~~~~~~~~~~~y~~pe~~~~~~~~~~~-------------Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~ 227 (267)
T cd06628 161 LSTKTNGARPSLQGSVFWMAPEVVKQTSYTRKA-------------DIWSLGCLVVEMLTGKHPFPDCTQLQAIFKIGEN 227 (267)
T ss_pred ccCCccccccccCCCcCccChhHhccCCCCchh-------------hhHHHHHHHHHHhhCCCCCCCccHHHHHHHHhcc
Confidence 0 112234555544332222112 222333333444444445443322221111 001
Q ss_pred CCCCCCCCCccchHHHHhcccCcCCCCCCChhhhhhCCcc
Q psy758 224 NGYYFEVPDEMQYEEITQRCLDKDPLRRWSCDQLLRHPYF 263 (292)
Q Consensus 224 ~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~~il~h~w~ 263 (292)
.....+...+..+.++|++||+.||.+||++.++++||||
T Consensus 228 ~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~~~~ 267 (267)
T cd06628 228 ASPEIPSNISSEAIDFLEKTFEIDHNKRPTAAELLKHPFL 267 (267)
T ss_pred CCCcCCcccCHHHHHHHHHHccCCchhCcCHHHHhhCCCC
Confidence 1112334457789999999999999999999999999997
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate |
| >PTZ00267 NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.2e-39 Score=277.98 Aligned_cols=248 Identities=19% Similarity=0.282 Sum_probs=189.1
Q ss_pred ccceeeeecccCceEEEEEEEcCC-CcEEEEEEeccCCCChHHHHHHHHHHHHHHhCCCCCcchhhhhhhcCCeEEEEEe
Q psy758 3 RYEKIGKLGEGSYGVVFKCRNRDT-GQVVAIKKFLESEEDPLIRKIALREIRLLKSLKHPNLVNLLEVFRRKKKLHLVFE 81 (292)
Q Consensus 3 ~y~~~~~l~~g~~~~v~~~~~~~~-~~~v~iK~~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~iv~e 81 (292)
.|.+.+.||+|++|.||.|.+..+ +..||+|.+... .......+.+|+.+++.++||||+++++++..++..|+|||
T Consensus 68 ~y~~~~~lg~G~~g~vy~a~~~~~~~~~vv~K~~~~~--~~~~~~~~~~E~~~l~~l~Hpniv~~~~~~~~~~~~~lv~E 145 (478)
T PTZ00267 68 MYVLTTLVGRNPTTAAFVATRGSDPKEKVVAKFVMLN--DERQAAYARSELHCLAACDHFGIVKHFDDFKSDDKLLLIME 145 (478)
T ss_pred eEEEEEEEEeCCCcEEEEEEEcCCCCeEEEEEEcccC--CHHHHHHHHHHHHHHHhCCCCCEeEEEEEEEECCEEEEEEE
Confidence 489999999999999999998887 778899876433 23344667889999999999999999999999999999999
Q ss_pred cCCCccHHHHhcC----CCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEEccCCcEEEeecCchhhhhcccc-
Q psy758 82 FCDHTVLNELENH----PHGLPWDLIKQITWQVLRGVSYCHRHACIHRDIKPENILLTANGVVKLCDFGFARLIRDLIP- 156 (292)
Q Consensus 82 ~~~~~~L~~~~~~----~~~~~~~~~~~i~~qi~~aL~~LH~~givH~dl~p~Nilv~~~~~~kl~dfg~~~~~~~~~~- 156 (292)
|++||+|..++.. ...+++..+..++.||+.||.|||++||+||||||+||++++++.++|+|||++........
T Consensus 146 ~~~gg~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~ivHrDlkp~NIll~~~~~~kL~DFgla~~~~~~~~~ 225 (478)
T PTZ00267 146 YGSGGDLNKQIKQRLKEHLPFQEYEVGLLFYQIVLALDEVHSRKMMHRDLKSANIFLMPTGIIKLGDFGFSKQYSDSVSL 225 (478)
T ss_pred CCCCCCHHHHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCCEEECCcCHHhEEECCCCcEEEEeCcCceecCCcccc
Confidence 9999999886642 34689999999999999999999999999999999999999999999999999976543211
Q ss_pred ------ccccccccccccccCCCCCCCcccceeeecCCCCCCchHHHHHHHhhcccCCCCCCChhhhhhccCcCCC-CCC
Q psy758 157 ------RHLHIFQTNEYFKGVSLPHAENVVPLEIKIGKPAATNIYLIDFLKRCLDKDPLRRWSCDQLLRHPYFNGY-YFE 229 (292)
Q Consensus 157 ------~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~-~~~ 229 (292)
.++..|.+||...+.......++ ++.++.++..+.+..|....+..+++........ ..+
T Consensus 226 ~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv-------------~slG~~l~el~tg~~Pf~~~~~~~~~~~~~~~~~~~~~ 292 (478)
T PTZ00267 226 DVASSFCGTPYYLAPELWERKRYSKKADM-------------WSLGVILYELLTLHRPFKGPSQREIMQQVLYGKYDPFP 292 (478)
T ss_pred ccccccCCCccccCHhHhCCCCCCcHHhH-------------HHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCCC
Confidence 12334556665544333222222 2333334444445555554444444333222211 223
Q ss_pred CCCccchHHHHhcccCcCCCCCCChhhhhhCCcccc
Q psy758 230 VPDEMQYEEITQRCLDKDPLRRWSCDQLLRHPYFNG 265 (292)
Q Consensus 230 ~~~~~~l~~li~~~l~~dP~~Rpt~~~il~h~w~~~ 265 (292)
...+..+.++|.+||..||++|||+++++.|+|++.
T Consensus 293 ~~~s~~~~~li~~~L~~dP~~Rps~~~~l~~~~~~~ 328 (478)
T PTZ00267 293 CPVSSGMKALLDPLLSKNPALRPTTQQLLHTEFLKY 328 (478)
T ss_pred ccCCHHHHHHHHHHhccChhhCcCHHHHHhCHHHHH
Confidence 445778999999999999999999999999999975
|
|
| >cd06609 STKc_MST3_like Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-38 Score=256.58 Aligned_cols=246 Identities=28% Similarity=0.385 Sum_probs=189.8
Q ss_pred cccceeeeecccCceEEEEEEEcCCCcEEEEEEeccCCCChHHHHHHHHHHHHHHhCCCCCcchhhhhhhcCCeEEEEEe
Q psy758 2 ERYEKIGKLGEGSYGVVFKCRNRDTGQVVAIKKFLESEEDPLIRKIALREIRLLKSLKHPNLVNLLEVFRRKKKLHLVFE 81 (292)
Q Consensus 2 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~iv~e 81 (292)
++|++.+.||+|++|.||+|.+..+++.|++|.+..... ......+.+|+.+++.++|+|++++++++.++...++|+|
T Consensus 1 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e 79 (274)
T cd06609 1 ELFTLLECIGKGSFGEVYKAIDKRTNQVVAIKVIDLEEA-EDEIEDIQQEIQFLSQCRSPYITKYYGSFLKGSKLWIIME 79 (274)
T ss_pred ChhhhhhhhcCCCCeEEEEEEECCCCeEEEEEEeecccc-chHHHHHHHHHHHHHHcCCCCeeeeeEEEEECCeEEEEEE
Confidence 589999999999999999999999999999999875542 3344567899999999999999999999999999999999
Q ss_pred cCCCccHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEEccCCcEEEeecCchhhhhccc-----c
Q psy758 82 FCDHTVLNELENHPHGLPWDLIKQITWQVLRGVSYCHRHACIHRDIKPENILLTANGVVKLCDFGFARLIRDLI-----P 156 (292)
Q Consensus 82 ~~~~~~L~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~givH~dl~p~Nilv~~~~~~kl~dfg~~~~~~~~~-----~ 156 (292)
|+++++|.+++... .+++..++.++.|++.||.|||++|++|+||+|+||++++++.++|+|||.+....... .
T Consensus 80 ~~~~~~L~~~~~~~-~~~~~~~~~~~~ql~~~l~~lh~~~i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~~~~~~~~~ 158 (274)
T cd06609 80 YCGGGSCLDLLKPG-KLDETYIAFILREVLLGLEYLHEEGKIHRDIKAANILLSEEGDVKLADFGVSGQLTSTMSKRNTF 158 (274)
T ss_pred eeCCCcHHHHHhhc-CCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEECCCCCEEEcccccceeecccccccccc
Confidence 99999999998875 79999999999999999999999999999999999999999999999999987765432 1
Q ss_pred ccccccccccccccCCC-----CCCCcccceeeecCCCCCCchHHHHHHHhhcccCCCCCCChhhhhhccC-cCCCCCCC
Q psy758 157 RHLHIFQTNEYFKGVSL-----PHAENVVPLEIKIGKPAATNIYLIDFLKRCLDKDPLRRWSCDQLLRHPY-FNGYYFEV 230 (292)
Q Consensus 157 ~~~~~~~~~~~~~~~~~-----~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~-~~~~~~~~ 230 (292)
.....|.+||...+... .|+.|+..+++.+|..+ .......+...... ......+.
T Consensus 159 ~~~~~y~~PE~~~~~~~~~~sDv~slG~il~~l~tg~~p------------------~~~~~~~~~~~~~~~~~~~~~~~ 220 (274)
T cd06609 159 VGTPFWMAPEVIKQSGYDEKADIWSLGITAIELAKGEPP------------------LSDLHPMRVLFLIPKNNPPSLEG 220 (274)
T ss_pred cCCccccChhhhccCCCCchhhHHHHHHHHHHHHhCCCC------------------cccCchHHHHHHhhhcCCCCCcc
Confidence 22234667776655433 23333333444444443 32222211111100 00001111
Q ss_pred C-CccchHHHHhcccCcCCCCCCChhhhhhCCccccee
Q psy758 231 P-DEMQYEEITQRCLDKDPLRRWSCDQLLRHPYFNGYY 267 (292)
Q Consensus 231 ~-~~~~l~~li~~~l~~dP~~Rpt~~~il~h~w~~~~~ 267 (292)
. .+..+.+++.+||..||.+|||++++++||||++..
T Consensus 221 ~~~~~~~~~~l~~~l~~~p~~Rpt~~~il~~~~~~~~~ 258 (274)
T cd06609 221 NKFSKPFKDFVSLCLNKDPKERPSAKELLKHKFIKKAK 258 (274)
T ss_pred cccCHHHHHHHHHHhhCChhhCcCHHHHhhChhhcCCC
Confidence 1 466899999999999999999999999999999844
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN) |
| >cd05609 STKc_MAST Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-38 Score=260.73 Aligned_cols=258 Identities=21% Similarity=0.300 Sum_probs=194.9
Q ss_pred cccceeeeecccCceEEEEEEEcCCCcEEEEEEeccCCC-ChHHHHHHHHHHHHHHhCCCCCcchhhhhhhcCCeEEEEE
Q psy758 2 ERYEKIGKLGEGSYGVVFKCRNRDTGQVVAIKKFLESEE-DPLIRKIALREIRLLKSLKHPNLVNLLEVFRRKKKLHLVF 80 (292)
Q Consensus 2 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~v~iK~~~~~~~-~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~iv~ 80 (292)
++|++.+.||+|++|.||++.+..+++.|++|.+..... .......+.+|+.+++.++||||+++++.+.+++..++|+
T Consensus 1 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (305)
T cd05609 1 EDFETIKLISNGAYGAVYLVRHKETRQRFAMKKINKQNLILRNQIQQVFVERDILTFAENPFVVSMFCSFETKRHLCMVM 80 (305)
T ss_pred CCceEeeEeecCCCeeEEEEEECCCCcEEEEEEeehhhhhhHHHHHHHHHHHHHHHhCCCCCeeeeEEEEecCCEEEEEE
Confidence 579999999999999999999999999999999876542 2234567788999999999999999999999999999999
Q ss_pred ecCCCccHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEEccCCcEEEeecCchhhhhccc-----
Q psy758 81 EFCDHTVLNELENHPHGLPWDLIKQITWQVLRGVSYCHRHACIHRDIKPENILLTANGVVKLCDFGFARLIRDLI----- 155 (292)
Q Consensus 81 e~~~~~~L~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~givH~dl~p~Nilv~~~~~~kl~dfg~~~~~~~~~----- 155 (292)
||++|++|..++...+.+++..+..++.|++.||.|||++|++|+||+|+||+++.++.++|+|||+++......
T Consensus 81 e~~~g~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~NIll~~~~~~~l~dfg~~~~~~~~~~~~~~ 160 (305)
T cd05609 81 EYVEGGDCATLLKNIGALPVDMARMYFAETVLALEYLHNYGIVHRDLKPDNLLITSMGHIKLTDFGLSKIGLMSLTTNLY 160 (305)
T ss_pred ecCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCchHHEEECCCCCEEEeeCCCccccCcCcccccc
Confidence 999999999999887789999999999999999999999999999999999999999999999999876321000
Q ss_pred ---------------cccccccccccccccCCCCCCCcccceeeecCCCCCCchHHHHHHHhhcccCCCCCCChhhhhhc
Q psy758 156 ---------------PRHLHIFQTNEYFKGVSLPHAENVVPLEIKIGKPAATNIYLIDFLKRCLDKDPLRRWSCDQLLRH 220 (292)
Q Consensus 156 ---------------~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~ 220 (292)
......|.+||...+..... ..+.++.+..++..+.+..|....+..++...
T Consensus 161 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~-------------~~Di~slG~vl~el~~g~~pf~~~~~~~~~~~ 227 (305)
T cd05609 161 EGHIEKDTREFLDKQVCGTPEYIAPEVILRQGYGK-------------PVDWWAMGIILYEFLVGCVPFFGDTPEELFGQ 227 (305)
T ss_pred ccccccchhhccccCCccCccccCchhccCCCCCc-------------hhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHH
Confidence 01112244444433222211 12223333344555555556554444444433
Q ss_pred cCcCCCCCC---CCCccchHHHHhcccCcCCCCCCC---hhhhhhCCcccceeccCCC
Q psy758 221 PYFNGYYFE---VPDEMQYEEITQRCLDKDPLRRWS---CDQLLRHPYFNGYYFEVPD 272 (292)
Q Consensus 221 ~~~~~~~~~---~~~~~~l~~li~~~l~~dP~~Rpt---~~~il~h~w~~~~~~~~~~ 272 (292)
........+ ...+..+.++|.+||+.||.+||+ +.++++||||....|..+.
T Consensus 228 ~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~~~ll~~~~~~~~~~~~~~ 285 (305)
T cd05609 228 VISDDIEWPEGDEALPADAQDLISRLLRQNPLERLGTGGAFEVKQHRFFLGLDWNGLL 285 (305)
T ss_pred HHhcccCCCCccccCCHHHHHHHHHHhccChhhccCccCHHHHHhCccccCCCHHHHh
Confidence 222211111 134678999999999999999997 7999999999887666544
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. There are four mammalian MAST kinases, named MAST1-MAST4. MAST1 is also referred to as syntrophin-associated STK (SAST), while MAST2 is also called MAST205. MAST kinases are cytoskeletal associated kinases of unknown function that a |
| >cd06626 STKc_MEKK4 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-38 Score=255.29 Aligned_cols=248 Identities=31% Similarity=0.479 Sum_probs=189.2
Q ss_pred ccceeeeecccCceEEEEEEEcCCCcEEEEEEeccCCCChHHHHHHHHHHHHHHhCCCCCcchhhhhhhcCCeEEEEEec
Q psy758 3 RYEKIGKLGEGSYGVVFKCRNRDTGQVVAIKKFLESEEDPLIRKIALREIRLLKSLKHPNLVNLLEVFRRKKKLHLVFEF 82 (292)
Q Consensus 3 ~y~~~~~l~~g~~~~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~iv~e~ 82 (292)
||++.+.||+|++|.||++.+..+++.|++|.+..........+.+.+|+.+++.++|+||+++++.+.+.+.+++|+||
T Consensus 1 ~y~~~~~lg~G~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~lv~e~ 80 (264)
T cd06626 1 RWQRGNKIGGGTFGKVYTAVNLDTGELMAVKEIRIQDNDPKTIKEIADEMKVLELLKHPNLVKYYGVEVHREKVYIFMEY 80 (264)
T ss_pred CceeeeEeecCCCcEEEEEEECCCCcEEEEEEEECcccchHHHHHHHHHHHHHHhCCCCChhheeeeEecCCEEEEEEec
Confidence 69999999999999999999998999999999987765556678899999999999999999999999889999999999
Q ss_pred CCCccHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEEccCCcEEEeecCchhhhhccccc-----
Q psy758 83 CDHTVLNELENHPHGLPWDLIKQITWQVLRGVSYCHRHACIHRDIKPENILLTANGVVKLCDFGFARLIRDLIPR----- 157 (292)
Q Consensus 83 ~~~~~L~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~givH~dl~p~Nilv~~~~~~kl~dfg~~~~~~~~~~~----- 157 (292)
+++++|.+++.....+++..++.++.|++.||.|||+.|++|+||+|+||++++++.++|+|||.+.........
T Consensus 81 ~~~~~L~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~i~H~dl~~~nil~~~~~~~kl~d~g~~~~~~~~~~~~~~~~ 160 (264)
T cd06626 81 CSGGTLEELLEHGRILDEHVIRVYTLQLLEGLAYLHSHGIVHRDIKPANIFLDHNGVIKLGDFGCAVKLKNNTTTMGEEV 160 (264)
T ss_pred CCCCcHHHHHhhcCCCChHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCCEEEcccccccccCCCCCcccccc
Confidence 999999999988777999999999999999999999999999999999999999999999999998776432221
Q ss_pred ----cccccccccccccCC---CCCCCcccceeeecCCCCCCchHHHHHHHhhcccCCCCCCC-hhhhhhc-cC--cCCC
Q psy758 158 ----HLHIFQTNEYFKGVS---LPHAENVVPLEIKIGKPAATNIYLIDFLKRCLDKDPLRRWS-CDQLLRH-PY--FNGY 226 (292)
Q Consensus 158 ----~~~~~~~~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~-~~~~~~~-~~--~~~~ 226 (292)
....|.+||+..+.. .... .+.++.+..++..+.+..|+.... ....... .. ....
T Consensus 161 ~~~~~~~~~~~PE~~~~~~~~~~~~~-------------~Dv~s~G~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~ 227 (264)
T cd06626 161 QSLAGTPAYMAPEVITGGKGKGHGRA-------------ADIWSLGCVVLEMATGKRPWSELDNEFQIMFHVGAGHKPPI 227 (264)
T ss_pred cCCcCCcCccChhhccCCCCCCCCcc-------------cchHHHHHHHHHHHhCCCCccCCcchHHHHHHHhcCCCCCC
Confidence 123455555554333 1111 122222333334444444433221 1111100 00 0011
Q ss_pred CCCCCCccchHHHHhcccCcCCCCCCChhhhhhCCcc
Q psy758 227 YFEVPDEMQYEEITQRCLDKDPLRRWSCDQLLRHPYF 263 (292)
Q Consensus 227 ~~~~~~~~~l~~li~~~l~~dP~~Rpt~~~il~h~w~ 263 (292)
+.....+..+.++|.+||+.||.+|||+.+++.|||+
T Consensus 228 ~~~~~~~~~~~~li~~~l~~~p~~R~~~~~i~~~~~~ 264 (264)
T cd06626 228 PDSLQLSPEGKDFLDRCLESDPKKRPTASELLQHPFV 264 (264)
T ss_pred CcccccCHHHHHHHHHHccCCcccCCCHHHHhcCCCC
Confidence 1112236788999999999999999999999999997
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4 |
| >cd07861 STKc_CDK1_euk Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-38 Score=259.06 Aligned_cols=260 Identities=32% Similarity=0.483 Sum_probs=187.4
Q ss_pred ccceeeeecccCceEEEEEEEcCCCcEEEEEEeccCCCChHHHHHHHHHHHHHHhCCCCCcchhhhhhhcCCeEEEEEec
Q psy758 3 RYEKIGKLGEGSYGVVFKCRNRDTGQVVAIKKFLESEEDPLIRKIALREIRLLKSLKHPNLVNLLEVFRRKKKLHLVFEF 82 (292)
Q Consensus 3 ~y~~~~~l~~g~~~~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~iv~e~ 82 (292)
+|++.+.||+|++|.||+|.+..+++.|++|.+............+.+|+.+++.++||||+++++++.+++.+++|+||
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~ 80 (285)
T cd07861 1 DYTKIEKIGEGTYGVVYKGRNKKTGQIVAMKKIRLESEEEGVPSTAIREISLLKELQHPNIVCLQDVLMQESRLYLIFEF 80 (285)
T ss_pred CceEeeEecccCceEEEEEEECCCCcEEEEEEeccccccCCchHHHHHHHHHHHhcCCCCEeeeEEEEeeCCeEEEEEec
Confidence 58999999999999999999999999999999876544444456678899999999999999999999999999999999
Q ss_pred CCCccHHHHhcC---CCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEEccCCcEEEeecCchhhhhccc----
Q psy758 83 CDHTVLNELENH---PHGLPWDLIKQITWQVLRGVSYCHRHACIHRDIKPENILLTANGVVKLCDFGFARLIRDLI---- 155 (292)
Q Consensus 83 ~~~~~L~~~~~~---~~~~~~~~~~~i~~qi~~aL~~LH~~givH~dl~p~Nilv~~~~~~kl~dfg~~~~~~~~~---- 155 (292)
+++ +|..++.. ...+++..++.++.||+.||+|||++|++|+||+|+||++++++.++|+|||++.......
T Consensus 81 ~~~-~l~~~~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~~~~~ 159 (285)
T cd07861 81 LSM-DLKKYLDSLPKGQYMDAELVKSYLYQILQGILFCHSRRVLHRDLKPQNLLIDNKGVIKLADFGLARAFGIPVRVYT 159 (285)
T ss_pred CCC-CHHHHHhcCCCCCcCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCHHHEEEcCCCcEEECcccceeecCCCccccc
Confidence 985 56555533 2468999999999999999999999999999999999999999999999999986543221
Q ss_pred -cccccccccccccccCC------CCCCCcccceeeecCCCCCCchHHHH----HHHhhcccCCCCCCChh--hhhhcc-
Q psy758 156 -PRHLHIFQTNEYFKGVS------LPHAENVVPLEIKIGKPAATNIYLID----FLKRCLDKDPLRRWSCD--QLLRHP- 221 (292)
Q Consensus 156 -~~~~~~~~~~~~~~~~~------~~~~~~~~~~~~~~~~~~~~~~~~~~----~~~~~~~~~p~~~~~~~--~~~~~~- 221 (292)
......|.+||...+.. ..|+.|+..+++.++.+++......+ .+............... ......
T Consensus 160 ~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~~l~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 239 (285)
T cd07861 160 HEVVTLWYRAPEVLLGSPRYSTPVDIWSIGTIFAEMATKKPLFHGDSEIDQLFRIFRILGTPTEDVWPGVTSLPDYKNTF 239 (285)
T ss_pred CCcccccccChHHhcCCCCcCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHhCCCChhhhhcchhhHHHHhhc
Confidence 11234567777654422 34556666666666665543222111 11111110000000000 000000
Q ss_pred -CcCC---CCCCCCCccchHHHHhcccCcCCCCCCChhhhhhCCcc
Q psy758 222 -YFNG---YYFEVPDEMQYEEITQRCLDKDPLRRWSCDQLLRHPYF 263 (292)
Q Consensus 222 -~~~~---~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~~il~h~w~ 263 (292)
-... .......+.++.++|.+||+.||.+|||+.++++||||
T Consensus 240 ~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~~ll~~~~~ 285 (285)
T cd07861 240 PKWKKGSLRSAVKNLDEDGLDLLEKMLIYDPAKRISAKKALNHPYF 285 (285)
T ss_pred cccCcchhHHhcCCCCHHHHHHHHHHhcCChhhCCCHHHHhcCCCC
Confidence 0000 01122357788999999999999999999999999997
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 |
| >KOG0197|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-39 Score=265.51 Aligned_cols=240 Identities=25% Similarity=0.351 Sum_probs=194.3
Q ss_pred ccceeeeecccCceEEEEEEEcCCCcEEEEEEeccCCCChHHHHHHHHHHHHHHhCCCCCcchhhhhhhcCCeEEEEEec
Q psy758 3 RYEKIGKLGEGSYGVVFKCRNRDTGQVVAIKKFLESEEDPLIRKIALREIRLLKSLKHPNLVNLLEVFRRKKKLHLVFEF 82 (292)
Q Consensus 3 ~y~~~~~l~~g~~~~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~iv~e~ 82 (292)
.+++.+.||+|.||.||.+.... ...|++|.+...... .+.|.+|+.+|++|+|++|+++++++..++.+||||||
T Consensus 207 ~l~l~~~LG~G~FG~V~~g~~~~-~~~vavk~ik~~~m~---~~~f~~Ea~iMk~L~H~~lV~l~gV~~~~~piyIVtE~ 282 (468)
T KOG0197|consen 207 ELKLIRELGSGQFGEVWLGKWNG-STKVAVKTIKEGSMS---PEAFLREAQIMKKLRHEKLVKLYGVCTKQEPIYIVTEY 282 (468)
T ss_pred HHHHHHHhcCCccceEEEEEEcC-CCcccceEEeccccC---hhHHHHHHHHHHhCcccCeEEEEEEEecCCceEEEEEe
Confidence 35678899999999999999874 347999998765433 24566999999999999999999999988899999999
Q ss_pred CCCccHHHHhcC--CCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEEccCCcEEEeecCchhhhhcccccc--
Q psy758 83 CDHTVLNELENH--PHGLPWDLIKQITWQVLRGVSYCHRHACIHRDIKPENILLTANGVVKLCDFGFARLIRDLIPRH-- 158 (292)
Q Consensus 83 ~~~~~L~~~~~~--~~~~~~~~~~~i~~qi~~aL~~LH~~givH~dl~p~Nilv~~~~~~kl~dfg~~~~~~~~~~~~-- 158 (292)
++.|+|.++++. ...+...+...++.|||+|++||+++++|||||.++||||++++.+||+|||+++...+.....
T Consensus 283 m~~GsLl~yLr~~~~~~l~~~~Ll~~a~qIaeGM~YLes~~~IHRDLAARNiLV~~~~~vKIsDFGLAr~~~d~~Y~~~~ 362 (468)
T KOG0197|consen 283 MPKGSLLDYLRTREGGLLNLPQLLDFAAQIAEGMAYLESKNYIHRDLAARNILVDEDLVVKISDFGLARLIGDDEYTASE 362 (468)
T ss_pred cccCcHHHHhhhcCCCccchHHHHHHHHHHHHHHHHHHhCCccchhhhhhheeeccCceEEEcccccccccCCCceeecC
Confidence 999999999986 5578999999999999999999999999999999999999999999999999999544322211
Q ss_pred ----ccccccccccccCCCCCCCcccceeeecCCCCCCchHHHHHHHhhcccCCCCCCChhhhhhccCcCCCCCCCCC--
Q psy758 159 ----LHIFQTNEYFKGVSLPHAENVVPLEIKIGKPAATNIYLIDFLKRCLDKDPLRRWSCDQLLRHPYFNGYYFEVPD-- 232 (292)
Q Consensus 159 ----~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~-- 232 (292)
.--+.+||...-..+.-..++|++++...+... .+..|....+..+++... -.+++.+.+.
T Consensus 363 ~~kfPIkWtAPEa~~~~~FS~kSDVWSFGVlL~E~fT------------~G~~py~~msn~ev~~~l-e~GyRlp~P~~C 429 (468)
T KOG0197|consen 363 GGKFPIKWTAPEALNYGKFSSKSDVWSFGVLLWELFT------------YGRVPYPGMSNEEVLELL-ERGYRLPRPEGC 429 (468)
T ss_pred CCCCCceecCHHHHhhCCcccccceeehhhhHHHHhc------------cCCCCCCCCCHHHHHHHH-hccCcCCCCCCC
Confidence 123566666666666666777777665444322 167787888888887654 2455555544
Q ss_pred ccchHHHHhcccCcCCCCCCChhhhhh
Q psy758 233 EMQYEEITQRCLDKDPLRRWSCDQLLR 259 (292)
Q Consensus 233 ~~~l~~li~~~l~~dP~~Rpt~~~il~ 259 (292)
|..+.+++..||+.+|++|||++.+..
T Consensus 430 P~~vY~lM~~CW~~~P~~RPtF~~L~~ 456 (468)
T KOG0197|consen 430 PDEVYELMKSCWHEDPEDRPTFETLRE 456 (468)
T ss_pred CHHHHHHHHHHhhCCcccCCCHHHHHH
Confidence 889999999999999999999996654
|
|
| >cd07850 STKc_JNK Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-38 Score=267.10 Aligned_cols=264 Identities=28% Similarity=0.413 Sum_probs=190.1
Q ss_pred cccceeeeecccCceEEEEEEEcCCCcEEEEEEeccCCCChHHHHHHHHHHHHHHhCCCCCcchhhhhhhcC------Ce
Q psy758 2 ERYEKIGKLGEGSYGVVFKCRNRDTGQVVAIKKFLESEEDPLIRKIALREIRLLKSLKHPNLVNLLEVFRRK------KK 75 (292)
Q Consensus 2 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~------~~ 75 (292)
++|++.+.||+|++|.||+|.+..+++.||+|.+............+.+|+.+++.++||||+++++++... ..
T Consensus 16 ~~y~~~~~lg~g~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~ 95 (353)
T cd07850 16 KRYQNLKPIGSGAQGIVCAAYDTVTGQNVAIKKLSRPFQNVTHAKRAYRELVLMKLVNHKNIIGLLNVFTPQKSLEEFQD 95 (353)
T ss_pred cceEEEEEeccCCCEEEEEEEECCCCCEEEEEecCccccChhHHHHHHHHHHHHHhcCCCCCcceeeeeccCCCccccCc
Confidence 689999999999999999999999999999999876554555556678899999999999999999987643 35
Q ss_pred EEEEEecCCCccHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEEccCCcEEEeecCchhhhhccc
Q psy758 76 LHLVFEFCDHTVLNELENHPHGLPWDLIKQITWQVLRGVSYCHRHACIHRDIKPENILLTANGVVKLCDFGFARLIRDLI 155 (292)
Q Consensus 76 ~~iv~e~~~~~~L~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~givH~dl~p~Nilv~~~~~~kl~dfg~~~~~~~~~ 155 (292)
.|+|+||+.+ +|...+... +++..+..++.|++.||+|||++|++|+||||+||+++.++.++|+|||++.......
T Consensus 96 ~~lv~e~~~~-~l~~~~~~~--l~~~~~~~~~~ql~~aL~~LH~~gi~H~dlkp~Nil~~~~~~~kL~Dfg~~~~~~~~~ 172 (353)
T cd07850 96 VYLVMELMDA-NLCQVIQMD--LDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSF 172 (353)
T ss_pred EEEEEeccCC-CHHHHHhhc--CCHHHHHHHHHHHHHHHHHHHhCCeeeCCCCHHHEEECCCCCEEEccCccceeCCCCC
Confidence 7999999986 555555543 8999999999999999999999999999999999999999999999999997654322
Q ss_pred c----ccccccccccccccCCC-----CCCCcccceeeecCCCCCCchHHHHHHHhh---cccCCC--------------
Q psy758 156 P----RHLHIFQTNEYFKGVSL-----PHAENVVPLEIKIGKPAATNIYLIDFLKRC---LDKDPL-------------- 209 (292)
Q Consensus 156 ~----~~~~~~~~~~~~~~~~~-----~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~---~~~~p~-------------- 209 (292)
. ..+..|.+||...+... .|+.|+..+.+.+|..++........+..+ ++..+.
T Consensus 173 ~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 252 (353)
T cd07850 173 MMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIRGTVLFPGTDHIDQWNKIIEQLGTPSDEFMSRLQPTVRNYV 252 (353)
T ss_pred CCCCCcccccccCHHHHhCCCCCCchhhHhHHHHHHHHHHCCCCCCCCCHHHHHHHHHHhcCCCCHHHHHHhhhhhhHHh
Confidence 1 12345777877655443 455566666666666554322221111111 111110
Q ss_pred -CC-----CChhhhhhccCcCCCC--CCCCCccchHHHHhcccCcCCCCCCChhhhhhCCcccceec
Q psy758 210 -RR-----WSCDQLLRHPYFNGYY--FEVPDEMQYEEITQRCLDKDPLRRWSCDQLLRHPYFNGYYF 268 (292)
Q Consensus 210 -~~-----~~~~~~~~~~~~~~~~--~~~~~~~~l~~li~~~l~~dP~~Rpt~~~il~h~w~~~~~~ 268 (292)
.+ ....+......+.... .+...+..++++|.+||+.||++|||+.|+|+||||..++.
T Consensus 253 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~eiL~~~~~~~~~~ 319 (353)
T cd07850 253 ENRPKYAGYSFEELFPDVLFPPDSESHNKLKASQARDLLSKMLVIDPEKRISVDDALQHPYINVWYD 319 (353)
T ss_pred hcCCCCCCcchhhhCcccccCcccccccccchhHHHHHHHHHcCCChhhCcCHHHHhcChhHhhccC
Confidence 00 0111111111000000 01123557899999999999999999999999999986554
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK |
| >cd06643 STKc_SLK Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-38 Score=258.12 Aligned_cols=255 Identities=26% Similarity=0.376 Sum_probs=185.5
Q ss_pred ccceeeeecccCceEEEEEEEcCCCcEEEEEEeccCCCChHHHHHHHHHHHHHHhCCCCCcchhhhhhhcCCeEEEEEec
Q psy758 3 RYEKIGKLGEGSYGVVFKCRNRDTGQVVAIKKFLESEEDPLIRKIALREIRLLKSLKHPNLVNLLEVFRRKKKLHLVFEF 82 (292)
Q Consensus 3 ~y~~~~~l~~g~~~~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~iv~e~ 82 (292)
-|++.+.||+|++|.||++.+..++..+++|.+.... ......+.+|+.+++.++|||++++++++..++..++|+||
T Consensus 6 ~~~i~~~lg~g~~g~v~~~~~~~~~~~~~~k~~~~~~--~~~~~~~~~e~~~l~~l~h~~ii~~~~~~~~~~~~~~v~e~ 83 (282)
T cd06643 6 FWEIIGELGDGAFGKVYKAQNKETGVLAAAKVIDTKS--EEELEDYMVEIDILASCDHPNIVKLLDAFYYENNLWILIEF 83 (282)
T ss_pred HHHHHhhcccCCCeEEEEEEECCCCeEEEEEEeCCCC--HHHHHHHHHHHHHHHHCCCCCeeeEEEEEeeCCEEEEEEEe
Confidence 4688899999999999999999999999999985443 33456678899999999999999999999999999999999
Q ss_pred CCCccHHHHhcC-CCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEEccCCcEEEeecCchhhhhccc-----c
Q psy758 83 CDHTVLNELENH-PHGLPWDLIKQITWQVLRGVSYCHRHACIHRDIKPENILLTANGVVKLCDFGFARLIRDLI-----P 156 (292)
Q Consensus 83 ~~~~~L~~~~~~-~~~~~~~~~~~i~~qi~~aL~~LH~~givH~dl~p~Nilv~~~~~~kl~dfg~~~~~~~~~-----~ 156 (292)
+++++|..++.. ...+++..++.++.|++.||.|||+.|++|+||+|+||+++.++.++|+|||++....... .
T Consensus 84 ~~~~~l~~~~~~~~~~l~~~~~~~~~~qi~~~L~~LH~~~i~H~dlkp~nili~~~~~~kl~dfg~~~~~~~~~~~~~~~ 163 (282)
T cd06643 84 CAGGAVDAVMLELERPLTEPQIRVVCKQTLEALNYLHENKIIHRDLKAGNILFTLDGDIKLADFGVSAKNTRTIQRRDSF 163 (282)
T ss_pred cCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCcccEEEccCCCEEEccccccccccccccccccc
Confidence 999999887643 4568999999999999999999999999999999999999999999999999986543221 1
Q ss_pred ccccccccccccccCCCCCCCcccceeeecCCCCCCchHHHHHHHhhcccCCCCCCChhhhhhccC---cCCCCCCCCCc
Q psy758 157 RHLHIFQTNEYFKGVSLPHAENVVPLEIKIGKPAATNIYLIDFLKRCLDKDPLRRWSCDQLLRHPY---FNGYYFEVPDE 233 (292)
Q Consensus 157 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~---~~~~~~~~~~~ 233 (292)
..+..|.+||...+.... ........+.++.+.-++..+.+..|+...+..+...... ......+...+
T Consensus 164 ~~~~~y~aPE~~~~~~~~--------~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 235 (282)
T cd06643 164 IGTPYWMAPEVVMCETSK--------DRPYDYKADVWSLGITLIEMAQIEPPHHELNPMRVLLKIAKSEPPTLAQPSRWS 235 (282)
T ss_pred cccccccCHhhccccCCC--------CCCCCccchhhhHHHHHHHHccCCCCccccCHHHHHHHHhhcCCCCCCCccccC
Confidence 223345566654211000 0000011122222333333333444443333222211110 00111223346
Q ss_pred cchHHHHhcccCcCCCCCCChhhhhhCCccccee
Q psy758 234 MQYEEITQRCLDKDPLRRWSCDQLLRHPYFNGYY 267 (292)
Q Consensus 234 ~~l~~li~~~l~~dP~~Rpt~~~il~h~w~~~~~ 267 (292)
..+.++|.+||+.||.+|||++++++||||....
T Consensus 236 ~~~~~li~~~l~~~p~~Rp~~~~il~~~~~~~~~ 269 (282)
T cd06643 236 SEFKDFLKKCLEKNVDARWTTTQLLQHPFVTVNS 269 (282)
T ss_pred HHHHHHHHHHccCChhhCcCHHHHhcCCCEeccC
Confidence 7899999999999999999999999999999743
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration. |
| >cd06622 PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-38 Score=259.04 Aligned_cols=258 Identities=25% Similarity=0.409 Sum_probs=187.8
Q ss_pred cccceeeeecccCceEEEEEEEcCCCcEEEEEEeccCCCChHHHHHHHHHHHHHHhCCCCCcchhhhhhhcCCeEEEEEe
Q psy758 2 ERYEKIGKLGEGSYGVVFKCRNRDTGQVVAIKKFLESEEDPLIRKIALREIRLLKSLKHPNLVNLLEVFRRKKKLHLVFE 81 (292)
Q Consensus 2 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~iv~e 81 (292)
++|++++.||+|++|.||+|.+..++..|++|.+.... .......+.+|+.+++.++||||+++++.+..++..++|+|
T Consensus 1 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~~a~k~~~~~~-~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e 79 (286)
T cd06622 1 DEIEVLDELGKGNYGSVYKVLHRPTGVTMAMKEIRLEL-DESKFNQIIMELDILHKAVSPYIVDFYGAFFIEGAVYMCME 79 (286)
T ss_pred ChhhhhhhhcccCCeEEEEEEEcCCCcEEEEEEeeccc-CHHHHHHHHHHHHHHHhcCCCcHHhhhhheecCCeEEEEEe
Confidence 57999999999999999999999999999999886542 33345678899999999999999999999999999999999
Q ss_pred cCCCccHHHHhcCC---CCCCHHHHHHHHHHHHHHHHHHHh-CCccccCCCCCceEEccCCcEEEeecCchhhhhcccc-
Q psy758 82 FCDHTVLNELENHP---HGLPWDLIKQITWQVLRGVSYCHR-HACIHRDIKPENILLTANGVVKLCDFGFARLIRDLIP- 156 (292)
Q Consensus 82 ~~~~~~L~~~~~~~---~~~~~~~~~~i~~qi~~aL~~LH~-~givH~dl~p~Nilv~~~~~~kl~dfg~~~~~~~~~~- 156 (292)
|+++++|..++... ..+++..+..++.||+.||.|||+ .|++|+||+|+||+++.++.++|+|||.+........
T Consensus 80 ~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~~~ 159 (286)
T cd06622 80 YMDAGSLDKLYAGGVATEGIPEDVLRRITYAVVKGLKFLKEEHNIIHRDVKPTNVLVNGNGQVKLCDFGVSGNLVASLAK 159 (286)
T ss_pred ecCCCCHHHHHHhccccCCCCHHHHHHHHHHHHHHHHHHHhcCCEeeCCCCHHHEEECCCCCEEEeecCCcccccCCccc
Confidence 99999999988763 368999999999999999999997 5999999999999999999999999999875532211
Q ss_pred --ccccccccccccccCCCCCCCcccceeeecCCCCCCchHHHHHHHhhcccCCCCCCChhhhhhc---c-CcCCCCCCC
Q psy758 157 --RHLHIFQTNEYFKGVSLPHAENVVPLEIKIGKPAATNIYLIDFLKRCLDKDPLRRWSCDQLLRH---P-YFNGYYFEV 230 (292)
Q Consensus 157 --~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~---~-~~~~~~~~~ 230 (292)
.....|.+||...+.... .........+.++.+..++..+.+..|+........... . .......+.
T Consensus 160 ~~~~~~~y~aPE~~~~~~~~-------~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~ 232 (286)
T cd06622 160 TNIGCQSYMAPERIKSGGPN-------QNPTYTVQSDVWSLGLSILEMALGRYPYPPETYANIFAQLSAIVDGDPPTLPS 232 (286)
T ss_pred cCCCccCccCcchhcCCCCC-------ccCCCCcccchHhHHHHHHHHHhCCCCCCCcchhhHHHHHHHHhhcCCCCCCc
Confidence 122345566654322110 000001111222223333333334444332222111110 0 000112233
Q ss_pred CCccchHHHHhcccCcCCCCCCChhhhhhCCccccee
Q psy758 231 PDEMQYEEITQRCLDKDPLRRWSCDQLLRHPYFNGYY 267 (292)
Q Consensus 231 ~~~~~l~~li~~~l~~dP~~Rpt~~~il~h~w~~~~~ 267 (292)
..+..+.++|.+||..||.+||+++++++||||....
T Consensus 233 ~~~~~~~~li~~~l~~~p~~Rp~~~~l~~~~~~~~~~ 269 (286)
T cd06622 233 GYSDDAQDFVAKCLNKIPNRRPTYAQLLEHPWLVKYK 269 (286)
T ss_pred ccCHHHHHHHHHHcccCcccCCCHHHHhcChhhhhcc
Confidence 3577899999999999999999999999999998754
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >cd05581 STKc_PDK1 Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-38 Score=255.84 Aligned_cols=249 Identities=23% Similarity=0.320 Sum_probs=193.5
Q ss_pred cccceeeeecccCceEEEEEEEcCCCcEEEEEEeccCC-CChHHHHHHHHHHHHHHhCC-CCCcchhhhhhhcCCeEEEE
Q psy758 2 ERYEKIGKLGEGSYGVVFKCRNRDTGQVVAIKKFLESE-EDPLIRKIALREIRLLKSLK-HPNLVNLLEVFRRKKKLHLV 79 (292)
Q Consensus 2 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~v~iK~~~~~~-~~~~~~~~~~~e~~~~~~l~-~~~i~~~~~~~~~~~~~~iv 79 (292)
++|.+.+.||+|++|.||+|.+..+++.|++|++.... ......+.+.+|..+++.+. ||||+++++++.+.+..+++
T Consensus 1 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~~~lv 80 (280)
T cd05581 1 DDFKFGKIIGEGSFSTVVLAKEKETNKEYAIKILDKRQLIKEKKVKYVKIEKEVLTRLNGHPGIIKLYYTFQDEENLYFV 80 (280)
T ss_pred CCceEeeeecCCCceEEEEEEEcCCCCEEEEEEechHhccchHHHHHHHHHHHHHHhcccCCCchhHHHHhcCCceEEEE
Confidence 57999999999999999999999999999999987643 23344567888999999998 99999999999999999999
Q ss_pred EecCCCccHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEEccCCcEEEeecCchhhhhcccccc-
Q psy758 80 FEFCDHTVLNELENHPHGLPWDLIKQITWQVLRGVSYCHRHACIHRDIKPENILLTANGVVKLCDFGFARLIRDLIPRH- 158 (292)
Q Consensus 80 ~e~~~~~~L~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~givH~dl~p~Nilv~~~~~~kl~dfg~~~~~~~~~~~~- 158 (292)
||++.+++|.+++...+.+++..++.++.|++.||.+||+.|++|+||+|+||+++.++.++|+|||.+..........
T Consensus 81 ~e~~~~~~L~~~l~~~~~l~~~~~~~i~~ql~~~l~~Lh~~~~~H~dl~~~ni~i~~~~~~~l~df~~~~~~~~~~~~~~ 160 (280)
T cd05581 81 LEYAPNGELLQYIRKYGSLDEKCTRFYAAEILLALEYLHSKGIIHRDLKPENILLDKDMHIKITDFGTAKVLDPNSSPES 160 (280)
T ss_pred EcCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCHHHeEECCCCCEEecCCccccccCCcccccc
Confidence 9999999999999887789999999999999999999999999999999999999999999999999987664422110
Q ss_pred ------------------------ccccccccccccCCCCCCCcccceeeecCCCCCCchHHHHHHHhhcccCCCCCCCh
Q psy758 159 ------------------------LHIFQTNEYFKGVSLPHAENVVPLEIKIGKPAATNIYLIDFLKRCLDKDPLRRWSC 214 (292)
Q Consensus 159 ------------------------~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~ 214 (292)
...|.+|+...+... ....+.++.+..++..+.+..|....+.
T Consensus 161 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~-------------~~~~Di~slG~~l~~l~~g~~p~~~~~~ 227 (280)
T cd05581 161 NKGDATNIDSQIEKNRRRFASFVGTAEYVSPELLNEKPA-------------GKSSDLWALGCIIYQMLTGKPPFRGSNE 227 (280)
T ss_pred CCCCCccccccccccccccccccCCccccCHHHhCCCCC-------------ChhhhHHHHHHHHHHHHhCCCCCCCccH
Confidence 111223332222111 1122233334445555666666665554
Q ss_pred hhhhhccCcCCCCCCCCCccchHHHHhcccCcCCCCCCCh----hhhhhCCcc
Q psy758 215 DQLLRHPYFNGYYFEVPDEMQYEEITQRCLDKDPLRRWSC----DQLLRHPYF 263 (292)
Q Consensus 215 ~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~----~~il~h~w~ 263 (292)
...+....-.....+...+..+.++|.+||+.||.+|||+ +++++||||
T Consensus 228 ~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~ll~~~~~ 280 (280)
T cd05581 228 YLTFQKILKLEYSFPPNFPPDAKDLIEKLLVLDPQDRLGVNEGYDELKAHPFF 280 (280)
T ss_pred HHHHHHHHhcCCCCCCccCHHHHHHHHHHhcCCHhhCCCcccCHHHHhcCCCC
Confidence 3333222222333444557889999999999999999999 999999997
|
Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to auto |
| >cd05579 STKc_MAST_like Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.9e-38 Score=253.30 Aligned_cols=246 Identities=23% Similarity=0.338 Sum_probs=186.2
Q ss_pred ecccCceEEEEEEEcCCCcEEEEEEeccCCC-ChHHHHHHHHHHHHHHhCCCCCcchhhhhhhcCCeEEEEEecCCCccH
Q psy758 10 LGEGSYGVVFKCRNRDTGQVVAIKKFLESEE-DPLIRKIALREIRLLKSLKHPNLVNLLEVFRRKKKLHLVFEFCDHTVL 88 (292)
Q Consensus 10 l~~g~~~~v~~~~~~~~~~~v~iK~~~~~~~-~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~iv~e~~~~~~L 88 (292)
||+|++|.||++.+..+++.+++|.+..... .......+.+|+++++.++||||+++++.+..+...|+++||+.+++|
T Consensus 1 lg~g~~~~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L 80 (265)
T cd05579 1 ISKGAYGRVFLAKKKSTGDIYAIKVIKKADMIRKNQVDQVLTERDILSQAQSPYVVKLYYSFQGKKNLYLVMEYLPGGDL 80 (265)
T ss_pred CCCCCceEEEEEEECCCCCEEEEEEecchhhhhhhHHHHHHHHHHHHHhCCCcchhHHHHheecCcEEEEEEecCCCCcH
Confidence 6899999999999999999999999865542 234567788999999999999999999999999999999999999999
Q ss_pred HHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEEccCCcEEEeecCchhhhhcccc------------
Q psy758 89 NELENHPHGLPWDLIKQITWQVLRGVSYCHRHACIHRDIKPENILLTANGVVKLCDFGFARLIRDLIP------------ 156 (292)
Q Consensus 89 ~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~givH~dl~p~Nilv~~~~~~kl~dfg~~~~~~~~~~------------ 156 (292)
..++...+.+++..++.++.||+.||.|||++|++|+||+|+||++++++.++|+|||++........
T Consensus 81 ~~~l~~~~~~~~~~~~~i~~qi~~~L~~lH~~~i~H~di~~~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~ 160 (265)
T cd05579 81 ASLLENVGSLDEDVARIYIAEIVLALEYLHSNGIIHRDLKPDNILIDSNGHLKLTDFGLSKVGLVRRQINLNDDEKEDKR 160 (265)
T ss_pred HHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHcCeecCCCCHHHeEEcCCCCEEEEecccchhcccCcccccccccccccC
Confidence 99998766899999999999999999999999999999999999999999999999998875432211
Q ss_pred -ccccccccccccccCCCCCCCcccceeeecCCCCCCchHHHHHHHhhcccCCCCCCChhhhhhccCcCCCCCCCC--Cc
Q psy758 157 -RHLHIFQTNEYFKGVSLPHAENVVPLEIKIGKPAATNIYLIDFLKRCLDKDPLRRWSCDQLLRHPYFNGYYFEVP--DE 233 (292)
Q Consensus 157 -~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~--~~ 233 (292)
.....|.+|+...+.......++ ++.+.-++..+.+..|.......+............+.. .+
T Consensus 161 ~~~~~~~~~Pe~~~~~~~~~~~Dv-------------~slG~~~~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 227 (265)
T cd05579 161 IVGTPDYIAPEVILGQGHSKTVDW-------------WSLGCILYEFLVGIPPFHGETPEEIFQNILNGKIEWPEDVEVS 227 (265)
T ss_pred cccCccccCHHHhcCCCCCcchhh-------------HHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcCCcCCCccccCC
Confidence 11123444444433322222222 222333333444445544444443332221112222222 27
Q ss_pred cchHHHHhcccCcCCCCCCCh---hhhhhCCcccceec
Q psy758 234 MQYEEITQRCLDKDPLRRWSC---DQLLRHPYFNGYYF 268 (292)
Q Consensus 234 ~~l~~li~~~l~~dP~~Rpt~---~~il~h~w~~~~~~ 268 (292)
..+.+++.+||+.+|.+|||+ .++++||||+++.|
T Consensus 228 ~~~~~~i~~~l~~~p~~Rpt~~~~~~~l~~~~~~~~~~ 265 (265)
T cd05579 228 DEAIDLISKLLVPDPEKRLGAKSIEEIKNHPFFKGIDW 265 (265)
T ss_pred HHHHHHHHHHhcCCHhhcCCCccHHHHhcCccccCCCC
Confidence 789999999999999999999 99999999998765
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert re |
| >KOG0612|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-40 Score=289.62 Aligned_cols=258 Identities=21% Similarity=0.263 Sum_probs=210.9
Q ss_pred cccceeeeecccCceEEEEEEEcCCCcEEEEEEeccCC-CChHHHHHHHHHHHHHHhCCCCCcchhhhhhhcCCeEEEEE
Q psy758 2 ERYEKIGKLGEGSYGVVFKCRNRDTGQVVAIKKFLESE-EDPLIRKIALREIRLLKSLKHPNLVNLLEVFRRKKKLHLVF 80 (292)
Q Consensus 2 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~v~iK~~~~~~-~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~iv~ 80 (292)
++|.+++.||+|+||.|.+++.+.+++.||+|++.+-. ........|..|-+++..-+.+=|+.++-.|++++++|+||
T Consensus 75 ~DfeilKvIGrGaFGEV~lVr~k~t~~VYAMK~lnK~eMlKr~~tA~F~EERDimv~~ns~Wiv~LhyAFQD~~~LYlVM 154 (1317)
T KOG0612|consen 75 EDFEILKVIGRGAFGEVALVRHKSTEKVYAMKILNKWEMLKRAETACFREERDIMVFGNSEWIVQLHYAFQDERYLYLVM 154 (1317)
T ss_pred HhhHHHHHhcccccceeEEEEeeccccchhHHHhhHHHHhhchhHHHHHHHhHHHHcCCcHHHHHHHHHhcCccceEEEE
Confidence 57999999999999999999999999999999997643 22334567888999999989999999999999999999999
Q ss_pred ecCCCccHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEEccCCcEEEeecCchhhhhc------c
Q psy758 81 EFCDHTVLNELENHPHGLPWDLIKQITWQVLRGVSYCHRHACIHRDIKPENILLTANGVVKLCDFGFARLIRD------L 154 (292)
Q Consensus 81 e~~~~~~L~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~givH~dl~p~Nilv~~~~~~kl~dfg~~~~~~~------~ 154 (292)
||++||+|-.++.....+|+..++.++..|+.||.-||+.|+|||||||+|||+|..|++||+|||.|-.... .
T Consensus 155 dY~pGGDlltLlSk~~~~pE~~ArFY~aEiVlAldslH~mgyVHRDiKPDNvLld~~GHikLADFGsClkm~~dG~V~s~ 234 (1317)
T KOG0612|consen 155 DYMPGGDLLTLLSKFDRLPEDWARFYTAEIVLALDSLHSMGYVHRDIKPDNVLLDKSGHIKLADFGSCLKMDADGTVRSS 234 (1317)
T ss_pred ecccCchHHHHHhhcCCChHHHHHHHHHHHHHHHHHHHhccceeccCCcceeEecccCcEeeccchhHHhcCCCCcEEec
Confidence 9999999999999888899999999999999999999999999999999999999999999999999877763 2
Q ss_pred cccccccccccccccc----------CCCCCCCcccceeeecCCCCCCchHHHHHHHhhcccCCCCCCChhhhhhccCcC
Q psy758 155 IPRHLHIFQTNEYFKG----------VSLPHAENVVPLEIKIGKPAATNIYLIDFLKRCLDKDPLRRWSCDQLLRHPYFN 224 (292)
Q Consensus 155 ~~~~~~~~~~~~~~~~----------~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~ 224 (292)
.+.+++.|.+|+.... +..+|+.|++.|++++|..|+........+.+++. |.-.-
T Consensus 235 ~aVGTPDYISPEvLqs~~~~~g~yG~ecDwWSlGV~~YEMlyG~TPFYadslveTY~KIm~--------------hk~~l 300 (1317)
T KOG0612|consen 235 VAVGTPDYISPEVLQSQGDGKGEYGRECDWWSLGVFMYEMLYGETPFYADSLVETYGKIMN--------------HKESL 300 (1317)
T ss_pred cccCCCCccCHHHHHhhcCCccccCCccchhhhHHHHHHHHcCCCcchHHHHHHHHHHHhc--------------hhhhc
Confidence 3344455555554321 23357777888888888777766666666555543 22222
Q ss_pred CCCCCCCCccchHHHHhcccCcCCCCCCC---hhhhhhCCcccceeccCCChh
Q psy758 225 GYYFEVPDEMQYEEITQRCLDKDPLRRWS---CDQLLRHPYFNGYYFEVPDEM 274 (292)
Q Consensus 225 ~~~~~~~~~~~l~~li~~~l~~dP~~Rpt---~~~il~h~w~~~~~~~~~~~~ 274 (292)
+++....++.+.++||.++++. |..|.. ++++.+||||.++.|+..-+.
T Consensus 301 ~FP~~~~VSeeakdLI~~ll~~-~e~RLgrngiedik~HpFF~g~~W~~iR~~ 352 (1317)
T KOG0612|consen 301 SFPDETDVSEEAKDLIEALLCD-REVRLGRNGIEDIKNHPFFEGIDWDNIRES 352 (1317)
T ss_pred CCCcccccCHHHHHHHHHHhcC-hhhhcccccHHHHHhCccccCCChhhhhhc
Confidence 2333355799999999999986 889998 999999999999999744333
|
|
| >cd05630 STKc_GRK6 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-38 Score=258.30 Aligned_cols=249 Identities=22% Similarity=0.279 Sum_probs=187.2
Q ss_pred ccceeeeecccCceEEEEEEEcCCCcEEEEEEeccCCCC-hHHHHHHHHHHHHHHhCCCCCcchhhhhhhcCCeEEEEEe
Q psy758 3 RYEKIGKLGEGSYGVVFKCRNRDTGQVVAIKKFLESEED-PLIRKIALREIRLLKSLKHPNLVNLLEVFRRKKKLHLVFE 81 (292)
Q Consensus 3 ~y~~~~~l~~g~~~~v~~~~~~~~~~~v~iK~~~~~~~~-~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~iv~e 81 (292)
.|++.+.||+|+||.||.+.+..+++.||+|.+...... ......+.+|+.+++.++|++++++++.+.+.+..++|||
T Consensus 1 ~f~~~~~ig~G~~g~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv~e 80 (285)
T cd05630 1 TFRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMALNEKQILEKVNSRFVVSLAYAYETKDALCLVLT 80 (285)
T ss_pred CceeeEEeecCCCeEEEEEEEcCCCceEEEEEEehhhccchHHHHHHHHHHHHHHhCCCCCeeeeeEEEecCCEEEEEEE
Confidence 488899999999999999999999999999998755432 2334566789999999999999999999999999999999
Q ss_pred cCCCccHHHHhcCC--CCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEEccCCcEEEeecCchhhhhccc----
Q psy758 82 FCDHTVLNELENHP--HGLPWDLIKQITWQVLRGVSYCHRHACIHRDIKPENILLTANGVVKLCDFGFARLIRDLI---- 155 (292)
Q Consensus 82 ~~~~~~L~~~~~~~--~~~~~~~~~~i~~qi~~aL~~LH~~givH~dl~p~Nilv~~~~~~kl~dfg~~~~~~~~~---- 155 (292)
|+++++|..++... ..+++..+..++.|++.||.|||+.|++|+||+|+||++++++.++|+|||++.......
T Consensus 81 ~~~g~~L~~~l~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~iiH~dikp~Nil~~~~~~~~l~Dfg~~~~~~~~~~~~~ 160 (285)
T cd05630 81 LMNGGDLKFHIYHMGEAGFEEGRAVFYAAEICCGLEDLHQERIVYRDLKPENILLDDHGHIRISDLGLAVHVPEGQTIKG 160 (285)
T ss_pred ecCCCcHHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCCEEeCCCCHHHEEECCCCCEEEeeccceeecCCCccccC
Confidence 99999998887432 358999999999999999999999999999999999999999999999999886543211
Q ss_pred cccccccccccccccCCC-----CCCCcccceeeecCCCCCCchHHHHHHHhhcccCCCCCCCh---hhhhhccCc-CCC
Q psy758 156 PRHLHIFQTNEYFKGVSL-----PHAENVVPLEIKIGKPAATNIYLIDFLKRCLDKDPLRRWSC---DQLLRHPYF-NGY 226 (292)
Q Consensus 156 ~~~~~~~~~~~~~~~~~~-----~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~---~~~~~~~~~-~~~ 226 (292)
...+..|.+||...+... .|+.|+..+++.+|..+ +..... .+....... ...
T Consensus 161 ~~g~~~y~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~P------------------f~~~~~~~~~~~~~~~~~~~~~ 222 (285)
T cd05630 161 RVGTVGYMAPEVVKNERYTFSPDWWALGCLLYEMIAGQSP------------------FQQRKKKIKREEVERLVKEVQE 222 (285)
T ss_pred CCCCccccChHHHcCCCCCCccccHHHHHHHHHHHhCCCC------------------CCCCCccchHHHHHhhhhhhhh
Confidence 122344666666554332 33333333444444443 321110 000000000 001
Q ss_pred CCCCCCccchHHHHhcccCcCCCCCCC-----hhhhhhCCcccceecc
Q psy758 227 YFEVPDEMQYEEITQRCLDKDPLRRWS-----CDQLLRHPYFNGYYFE 269 (292)
Q Consensus 227 ~~~~~~~~~l~~li~~~l~~dP~~Rpt-----~~~il~h~w~~~~~~~ 269 (292)
..+...+..+.+|+.+||+.||.+||| ++|+++||||++..++
T Consensus 223 ~~~~~~~~~~~~li~~~l~~~p~~R~s~~~~~~~~~~~h~~~~~~~~~ 270 (285)
T cd05630 223 EYSEKFSPDARSLCKMLLCKDPKERLGCQGGGAREVKEHPLFKQINFK 270 (285)
T ss_pred hcCccCCHHHHHHHHHHhhcCHHHccCCCCCchHHHHcChhhhccCHH
Confidence 122345678999999999999999999 8999999999987666
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as |
| >PHA03207 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-39 Score=273.34 Aligned_cols=262 Identities=23% Similarity=0.286 Sum_probs=190.3
Q ss_pred cccceeeeecccCceEEEEEEEc--CCCcEEEEEEeccCCCChHHHHHHHHHHHHHHhCCCCCcchhhhhhhcCCeEEEE
Q psy758 2 ERYEKIGKLGEGSYGVVFKCRNR--DTGQVVAIKKFLESEEDPLIRKIALREIRLLKSLKHPNLVNLLEVFRRKKKLHLV 79 (292)
Q Consensus 2 ~~y~~~~~l~~g~~~~v~~~~~~--~~~~~v~iK~~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~iv 79 (292)
.+|.+++.||.|++|.||+|... .++..|++|.+.... ...+|+.+++.++||||+++++++...+..|++
T Consensus 92 ~~y~i~~~Lg~G~~g~Vy~~~~~~~~~~~~v~vK~~~~~~-------~~~~E~~il~~l~h~~iv~~~~~~~~~~~~~lv 164 (392)
T PHA03207 92 MQYNILSSLTPGSEGEVFVCTKHGDEQRKKVIVKAVTGGK-------TPGREIDILKTISHRAIINLIHAYRWKSTVCMV 164 (392)
T ss_pred CceEEEEeecCCCCeEEEEEEEcCCccceeEEEEeccccc-------cHHHHHHHHHhcCCCCccceeeeEeeCCEEEEE
Confidence 36999999999999999999754 346789999875432 245799999999999999999999999999999
Q ss_pred EecCCCccHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEEccCCcEEEeecCchhhhhccc----
Q psy758 80 FEFCDHTVLNELENHPHGLPWDLIKQITWQVLRGVSYCHRHACIHRDIKPENILLTANGVVKLCDFGFARLIRDLI---- 155 (292)
Q Consensus 80 ~e~~~~~~L~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~givH~dl~p~Nilv~~~~~~kl~dfg~~~~~~~~~---- 155 (292)
||++.+ .|..++.....+++..++.++.||+.||.|||++||+||||||+||+++.++.++|+|||++.......
T Consensus 165 ~e~~~~-~l~~~l~~~~~l~~~~~~~i~~ql~~aL~~LH~~givHrDlkp~Nill~~~~~~~l~DfG~a~~~~~~~~~~~ 243 (392)
T PHA03207 165 MPKYKC-DLFTYVDRSGPLPLEQAITIQRRLLEALAYLHGRGIIHRDVKTENIFLDEPENAVLGDFGAACKLDAHPDTPQ 243 (392)
T ss_pred ehhcCC-CHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEEcCCCCEEEccCccccccCccccccc
Confidence 999975 556666666689999999999999999999999999999999999999999999999999987654321
Q ss_pred ---cccccccccccccccCC-----CCCCCcccceeeecCCCCCCch------HHHHHHHhhcccCCCCCCChh-----h
Q psy758 156 ---PRHLHIFQTNEYFKGVS-----LPHAENVVPLEIKIGKPAATNI------YLIDFLKRCLDKDPLRRWSCD-----Q 216 (292)
Q Consensus 156 ---~~~~~~~~~~~~~~~~~-----~~~~~~~~~~~~~~~~~~~~~~------~~~~~~~~~~~~~p~~~~~~~-----~ 216 (292)
..++..|.+||...+.. ..|+.|+..+++.+|..++... ....-+..+++..|...+... .
T Consensus 244 ~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~~~~~~~~l~~i~~~~~~~~~~~~~~~~~~~~~ 323 (392)
T PHA03207 244 CYGWSGTLETNSPELLALDPYCAKTDIWSAGLVLFEMSVKNVTLFGKQVKSSSSQLRSIIRCMQVHPLEFPQNGSTNLCK 323 (392)
T ss_pred ccccccccCccCHhHhcCCCCCchhhHHHHHHHHHHHHHCCCCCCCCCCCCcHHHHHHHHHHhccCccccCCccchhHHH
Confidence 12345567777765543 3466666666676666554321 111122223333333222110 0
Q ss_pred hhhcc---CcCCCCC-----CCCCccchHHHHhcccCcCCCCCCChhhhhhCCcccceeccCC
Q psy758 217 LLRHP---YFNGYYF-----EVPDEMQYEEITQRCLDKDPLRRWSCDQLLRHPYFNGYYFEVP 271 (292)
Q Consensus 217 ~~~~~---~~~~~~~-----~~~~~~~l~~li~~~l~~dP~~Rpt~~~il~h~w~~~~~~~~~ 271 (292)
.+... ....+.. ....+..+.++|.+||..||.+|||+.++|+||||....++..
T Consensus 324 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~Rpsa~e~l~~p~f~~~~~~~~ 386 (392)
T PHA03207 324 HFKQYAIVLRPPYTIPPVIRKYGMHMDVEYLIAKMLTFDQEFRPSAQDILSLPLFTKEPINLL 386 (392)
T ss_pred HHHhhcccccCCccccchhhccCcchhHHHHHHHHhccChhhCCCHHHHhhCchhhccchhhh
Confidence 00000 0000011 1123567889999999999999999999999999998766543
|
|
| >cd07870 STKc_PFTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-38 Score=259.98 Aligned_cols=261 Identities=29% Similarity=0.453 Sum_probs=187.9
Q ss_pred cccceeeeecccCceEEEEEEEcCCCcEEEEEEeccCCCChHHHHHHHHHHHHHHhCCCCCcchhhhhhhcCCeEEEEEe
Q psy758 2 ERYEKIGKLGEGSYGVVFKCRNRDTGQVVAIKKFLESEEDPLIRKIALREIRLLKSLKHPNLVNLLEVFRRKKKLHLVFE 81 (292)
Q Consensus 2 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~iv~e 81 (292)
++|++.+.||+|++|.||.|.+..+++.|++|.+....... ....+.+|+.+++.++|+||+++++++.+++..|+|+|
T Consensus 5 ~~y~~~~~ig~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~-~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~lv~e 83 (291)
T cd07870 5 TSYLNLEKLGEGSYATVYKGISRINGQLVALKVISMKTEEG-VPFTAIREASLLKGLKHANIVLLHDIIHTKETLTFVFE 83 (291)
T ss_pred ceeEEEEEEEecCCEEEEEEEEcCCCcEEEEEEecccCcCC-CcHHHHHHHHHHHhcCCCCEeEEEEEEecCCeEEEEEe
Confidence 67999999999999999999999999999999986554221 22345689999999999999999999999999999999
Q ss_pred cCCCccHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEEccCCcEEEeecCchhhhhccc-----c
Q psy758 82 FCDHTVLNELENHPHGLPWDLIKQITWQVLRGVSYCHRHACIHRDIKPENILLTANGVVKLCDFGFARLIRDLI-----P 156 (292)
Q Consensus 82 ~~~~~~L~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~givH~dl~p~Nilv~~~~~~kl~dfg~~~~~~~~~-----~ 156 (292)
|+.++.+..+......+++..+..++.|++.||.|||++|++|+||+|+||+++.++.++|+|||++....... .
T Consensus 84 ~~~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~dlkp~Nil~~~~~~~~l~Dfg~~~~~~~~~~~~~~~ 163 (291)
T cd07870 84 YMHTDLAQYMIQHPGGLHPYNVRLFMFQLLRGLAYIHGQHILHRDLKPQNLLISYLGELKLADFGLARAKSIPSQTYSSE 163 (291)
T ss_pred cccCCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCChHHEEEcCCCcEEEeccccccccCCCCCCCCCc
Confidence 99866666555555568899999999999999999999999999999999999999999999999886543211 1
Q ss_pred ccccccccccccccC------CCCCCCcccceeeecCCCCCCch-HHHHHHHhhc---ccCCCCCC-Ch-------hhhh
Q psy758 157 RHLHIFQTNEYFKGV------SLPHAENVVPLEIKIGKPAATNI-YLIDFLKRCL---DKDPLRRW-SC-------DQLL 218 (292)
Q Consensus 157 ~~~~~~~~~~~~~~~------~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~---~~~p~~~~-~~-------~~~~ 218 (292)
.....|.+||+..+. ...|+.|+..+++.+|..++... .....+...+ +..+.... .. .+..
T Consensus 164 ~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 243 (291)
T cd07870 164 VVTLWYRPPDVLLGATDYSSALDIWGAGCIFIEMLQGQPAFPGVSDVFEQLEKIWTVLGVPTEDTWPGVSKLPNYKPEWF 243 (291)
T ss_pred cccccccCCceeecCCCCCcHHHHHHHHHHHHHHHhCCCCCCCchhHHHHHHHHHHHcCCCChhhhhhhhhcccccchhc
Confidence 223457778876542 24566677777777776654321 1112222211 11100000 00 0000
Q ss_pred hcc---CcCCCCCCCCCccchHHHHhcccCcCCCCCCChhhhhhCCcc
Q psy758 219 RHP---YFNGYYFEVPDEMQYEEITQRCLDKDPLRRWSCDQLLRHPYF 263 (292)
Q Consensus 219 ~~~---~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~~il~h~w~ 263 (292)
... .+.........+..+.+++.+||..||++|||++|++.||||
T Consensus 244 ~~~~~~~~~~~~~~~~~~~~~~~ll~~~l~~dp~~R~t~~~~l~h~~~ 291 (291)
T cd07870 244 LPCKPQQLRVVWKRLSRPPKAEDLASQMLMMFPKDRISAQDALLHPYF 291 (291)
T ss_pred cccCCcchhhhccccCCChHHHHHHHHHhCcCcccCcCHHHHhcCCCC
Confidence 000 000000011235688999999999999999999999999997
|
Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recess |
| >PHA03211 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-38 Score=272.73 Aligned_cols=256 Identities=24% Similarity=0.302 Sum_probs=180.3
Q ss_pred cccceeeeecccCceEEEEEEEcCCCcEEEEEEeccCCCChHHHHHHHHHHHHHHhCCCCCcchhhhhhhcCCeEEEEEe
Q psy758 2 ERYEKIGKLGEGSYGVVFKCRNRDTGQVVAIKKFLESEEDPLIRKIALREIRLLKSLKHPNLVNLLEVFRRKKKLHLVFE 81 (292)
Q Consensus 2 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~iv~e 81 (292)
.+|.+.+.||+|++|.||+|.+..+++.|++|.... ..+.+|+++++.++|+||+++++++..++..++|+|
T Consensus 169 ~gy~i~~~Lg~G~~G~Vy~a~~~~~~~~vavK~~~~--------~~~~~E~~iL~~L~HpnIv~l~~~~~~~~~~~lv~e 240 (461)
T PHA03211 169 LGFAIHRALTPGSEGCVFESSHPDYPQRVVVKAGWY--------ASSVHEARLLRRLSHPAVLALLDVRVVGGLTCLVLP 240 (461)
T ss_pred CCeEEEEEEccCCCeEEEEEEECCCCCEEEEecccc--------cCHHHHHHHHHHCCCCCCCcEEEEEEECCEEEEEEE
Confidence 369999999999999999999999999999995321 234679999999999999999999999999999999
Q ss_pred cCCCccHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEEccCCcEEEeecCchhhhhccc------
Q psy758 82 FCDHTVLNELENHPHGLPWDLIKQITWQVLRGVSYCHRHACIHRDIKPENILLTANGVVKLCDFGFARLIRDLI------ 155 (292)
Q Consensus 82 ~~~~~~L~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~givH~dl~p~Nilv~~~~~~kl~dfg~~~~~~~~~------ 155 (292)
++.++.+..+......+++..++.++.||+.||.|||++||+|+||||+|||++.++.++|+|||+++......
T Consensus 241 ~~~~~L~~~l~~~~~~l~~~~~~~i~~qi~~aL~yLH~~gIvHrDLKP~NILl~~~~~vkL~DFGla~~~~~~~~~~~~~ 320 (461)
T PHA03211 241 KYRSDLYTYLGARLRPLGLAQVTAVARQLLSAIDYIHGEGIIHRDIKTENVLVNGPEDICLGDFGAACFARGSWSTPFHY 320 (461)
T ss_pred ccCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCEEECcCCHHHEEECCCCCEEEcccCCceeccccccccccc
Confidence 99765444444444579999999999999999999999999999999999999999999999999987653211
Q ss_pred -cccccccccccccccCCCC-----CCCcccceeeecCCCCCC-----------chHHHHHHHhhcccCC-CCCCChhhh
Q psy758 156 -PRHLHIFQTNEYFKGVSLP-----HAENVVPLEIKIGKPAAT-----------NIYLIDFLKRCLDKDP-LRRWSCDQL 217 (292)
Q Consensus 156 -~~~~~~~~~~~~~~~~~~~-----~~~~~~~~~~~~~~~~~~-----------~~~~~~~~~~~~~~~p-~~~~~~~~~ 217 (292)
..++..|.+||...+.... |++|+..+++.++..+.. ......++...-...+ ........+
T Consensus 321 ~~~GT~~Y~APE~~~~~~~~~~sDvwSlGviL~El~~g~~~lf~~~~~~~~~~~~~~l~~~i~~~~~~~~~~~~~~~~~l 400 (461)
T PHA03211 321 GIAGTVDTNAPEVLAGDPYTPSVDIWSAGLVIFEAAVHTASLFSASRGDERRPYDAQILRIIRQAQVHVDEFPQHAGSRL 400 (461)
T ss_pred ccCCCcCCcCHHHHcCCCCCchHHHHHHHHHHHHHHHcCCCcccCCcccccCCcHHHHHHHHHhhccccccCCCCcchHH
Confidence 1234567778877665443 445555555544332110 0111222222111000 000000000
Q ss_pred ---hh-------ccCcCCCCCC--CCCccchHHHHhcccCcCCCCCCChhhhhhCCcccc
Q psy758 218 ---LR-------HPYFNGYYFE--VPDEMQYEEITQRCLDKDPLRRWSCDQLLRHPYFNG 265 (292)
Q Consensus 218 ---~~-------~~~~~~~~~~--~~~~~~l~~li~~~l~~dP~~Rpt~~~il~h~w~~~ 265 (292)
+. .+.+....+. ...+..+.+||.+||+.||.+|||+.|+|+||||++
T Consensus 401 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~DP~~RPsa~elL~hp~f~~ 460 (461)
T PHA03211 401 VSQYRHRAARNRRPAYTRPAWTRYYKLDLDVEYLVCRALTFDGARRPSAAELLRLPLFQS 460 (461)
T ss_pred HHHHHhhhhcccCCccCCcchhhhccccchHHHHHHHHcccChhhCcCHHHHhhCcccCC
Confidence 00 0000000000 123557899999999999999999999999999975
|
|
| >KOG0579|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.6e-40 Score=272.76 Aligned_cols=256 Identities=26% Similarity=0.360 Sum_probs=200.2
Q ss_pred ccceeeeecccCceEEEEEEEcCCCcEEEEEEeccCCCChHHHHHHHHHHHHHHhCCCCCcchhhhhhhcCCeEEEEEec
Q psy758 3 RYEKIGKLGEGSYGVVFKCRNRDTGQVVAIKKFLESEEDPLIRKIALREIRLLKSLKHPNLVNLLEVFRRKKKLHLVFEF 82 (292)
Q Consensus 3 ~y~~~~~l~~g~~~~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~iv~e~ 82 (292)
-|.+++.||.|+||.||.|....++-.-|.|+|.... .+....+.-|++++..+.||+|+++++.|..++.++++.|+
T Consensus 33 ~WeIiGELGDGAFGKVyKA~nket~~lAAaKvIetks--eEELEDylVEIeILa~CdHP~ivkLl~ayy~enkLwiliEF 110 (1187)
T KOG0579|consen 33 HWEIIGELGDGAFGKVYKAVNKETKLLAAAKVIETKS--EEELEDYLVEIEILAECDHPVIVKLLSAYYFENKLWILIEF 110 (1187)
T ss_pred HHHHHhhhcCccchhhhhhhcccchhhhhhhhhcccc--hhHHhhhhhhhhhhhcCCChHHHHHHHHHhccCceEEEEee
Confidence 4678899999999999999999888888999886543 33456677899999999999999999999999999999999
Q ss_pred CCCccHHHH-hcCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEEccCCcEEEeecCchhhhhccccccccc
Q psy758 83 CDHTVLNEL-ENHPHGLPWDLIKQITWQVLRGVSYCHRHACIHRDIKPENILLTANGVVKLCDFGFARLIRDLIPRHLHI 161 (292)
Q Consensus 83 ~~~~~L~~~-~~~~~~~~~~~~~~i~~qi~~aL~~LH~~givH~dl~p~Nilv~~~~~~kl~dfg~~~~~~~~~~~~~~~ 161 (292)
|+||-++.+ +.-...+++.++..++.|++.||.|||+++|+|+|||+.|||++-+|.++|.|||.+............+
T Consensus 111 C~GGAVDaimlEL~r~LtE~QIqvvc~q~ldALn~LHs~~iIHRDLKAGNiL~TldGdirLADFGVSAKn~~t~qkRDsF 190 (1187)
T KOG0579|consen 111 CGGGAVDAIMLELGRVLTEDQIQVVCYQVLDALNWLHSQNIIHRDLKAGNILLTLDGDIRLADFGVSAKNKSTRQKRDSF 190 (1187)
T ss_pred cCCchHhHHHHHhccccchHHHHHHHHHHHHHHHHHhhcchhhhhccccceEEEecCcEeeecccccccchhHHhhhccc
Confidence 999998875 4556679999999999999999999999999999999999999999999999999987766555555667
Q ss_pred cccccccccCCCCCCCcccceeeec----CCCCCCchHHHHHHHhhcccCCCCCCChhhhhhccCcCC-CC--CCCCCcc
Q psy758 162 FQTNEYFKGVSLPHAENVVPLEIKI----GKPAATNIYLIDFLKRCLDKDPLRRWSCDQLLRHPYFNG-YY--FEVPDEM 234 (292)
Q Consensus 162 ~~~~~~~~~~~~~~~~~~~~~~~~~----~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~-~~--~~~~~~~ 234 (292)
.++|.|.+++.. .++..- .+..++|+.+..++...-...|....+.-.++-...-+. -. -|...+.
T Consensus 191 IGTPYWMAPEVv-------mCET~KD~PYDykaDiWSlGITLIEMAqiEPPHhelnpMRVllKiaKSePPTLlqPS~Ws~ 263 (1187)
T KOG0579|consen 191 IGTPYWMAPEVV-------MCETFKDQPYDYKADIWSLGITLIEMAQIEPPHHELNPMRVLLKIAKSEPPTLLQPSHWSR 263 (1187)
T ss_pred cCCcccccchhe-------eeccccCCCchhhhhHHhhhhHHHHHhccCCCccccchHHHHHHHhhcCCCcccCcchhhh
Confidence 788888877544 111111 122333455555666665666665555444432211111 11 1222356
Q ss_pred chHHHHhcccCcCCCCCCChhhhhhCCccccee
Q psy758 235 QYEEITQRCLDKDPLRRWSCDQLLRHPYFNGYY 267 (292)
Q Consensus 235 ~l~~li~~~l~~dP~~Rpt~~~il~h~w~~~~~ 267 (292)
.+.+++++||..||..||+++++++|||++++.
T Consensus 264 ~F~DfLk~cL~Knp~~Rp~aaqll~Hpfv~~~~ 296 (1187)
T KOG0579|consen 264 SFSDFLKRCLVKNPRNRPPAAQLLKHPFVQNAP 296 (1187)
T ss_pred HHHHHHHHHHhcCCccCCCHHHHhhCcccccCC
Confidence 789999999999999999999999999999755
|
|
| >cd07834 STKc_MAPK Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.5e-39 Score=265.59 Aligned_cols=264 Identities=30% Similarity=0.432 Sum_probs=197.1
Q ss_pred ccceeeeecccCceEEEEEEEcCCCcEEEEEEeccCCCChHHHHHHHHHHHHHHhCCCCCcchhhhhhhcCC-----eEE
Q psy758 3 RYEKIGKLGEGSYGVVFKCRNRDTGQVVAIKKFLESEEDPLIRKIALREIRLLKSLKHPNLVNLLEVFRRKK-----KLH 77 (292)
Q Consensus 3 ~y~~~~~l~~g~~~~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~-----~~~ 77 (292)
+|++.+.||+|++|.||+|.+..+++.|++|.+..........+.+.+|+.+++.++||||+++++++.+.. ..|
T Consensus 1 ~y~i~~~ig~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~~~~ 80 (330)
T cd07834 1 RYELLKPIGSGAYGVVCSAVDKRTGRKVAIKKISNVFDDLIDAKRILREIKLLRHLRHENIIGLLDILRPPSPEDFNDVY 80 (330)
T ss_pred CceeeeeecCCCCeEEEEEEeCCCCcEEEEEeeccccccchhhhhHHHHHHHHHhcCCcchhhhhhhhcccCcccccceE
Confidence 699999999999999999999999999999998765544555677889999999999999999999988765 789
Q ss_pred EEEecCCCccHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEEccCCcEEEeecCchhhhhccc--
Q psy758 78 LVFEFCDHTVLNELENHPHGLPWDLIKQITWQVLRGVSYCHRHACIHRDIKPENILLTANGVVKLCDFGFARLIRDLI-- 155 (292)
Q Consensus 78 iv~e~~~~~~L~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~givH~dl~p~Nilv~~~~~~kl~dfg~~~~~~~~~-- 155 (292)
+++||+++ +|..++.....+++..++.++.||+.||++||++|++|+||+|+||+++.++.++|+|||.+.......
T Consensus 81 lv~e~~~~-~l~~~l~~~~~l~~~~~~~i~~~l~~~l~~LH~~gi~H~dlkp~nili~~~~~~~L~dfg~~~~~~~~~~~ 159 (330)
T cd07834 81 IVTELMET-DLHKVIKSPQPLTDDHIQYFLYQILRGLKYLHSANVIHRDLKPSNILVNSNCDLKICDFGLARGVDPDEDE 159 (330)
T ss_pred EEecchhh-hHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCCEEEcccCceEeecccccc
Confidence 99999985 677777776789999999999999999999999999999999999999999999999999987664432
Q ss_pred ------cccccccccccccccC------CCCCCCcccceeeecCCCCCCchHHHHHHHhhc---ccCCCCCCC------h
Q psy758 156 ------PRHLHIFQTNEYFKGV------SLPHAENVVPLEIKIGKPAATNIYLIDFLKRCL---DKDPLRRWS------C 214 (292)
Q Consensus 156 ------~~~~~~~~~~~~~~~~------~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~---~~~p~~~~~------~ 214 (292)
...+..|.+||...+. ...|+.|+..+.+.+|.+++........+.... +..+..... .
T Consensus 160 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~ 239 (330)
T cd07834 160 KGFLTEYVVTRWYRAPELLLSSSRYTKAIDIWSVGCIFAELLTRKPLFPGRDYIDQLNLIVEVLGTPSEEDLKFITSEKA 239 (330)
T ss_pred cccccccccccCcCCceeeecccCCCcchhHHHHHHHHHHHHcCCCCcCCCCHHHHHHHHHHhcCCCChhHhhhccccch
Confidence 1123346777776554 334556666666667766654443333222222 111111100 0
Q ss_pred hhhhh-ccCcCCCC---CCCCCccchHHHHhcccCcCCCCCCChhhhhhCCccccee
Q psy758 215 DQLLR-HPYFNGYY---FEVPDEMQYEEITQRCLDKDPLRRWSCDQLLRHPYFNGYY 267 (292)
Q Consensus 215 ~~~~~-~~~~~~~~---~~~~~~~~l~~li~~~l~~dP~~Rpt~~~il~h~w~~~~~ 267 (292)
...+. ........ .....+..+.++|.+||+.||.+|||++++++||||++..
T Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~~~~~~~~~ 296 (330)
T cd07834 240 RNYLKSLPKKPKKPLSKLFPGASPEAIDLLEKMLVFDPKKRITADEALAHPYLAQLH 296 (330)
T ss_pred hhHHhhcccCCcchhHHhcccCCHHHHHHHHHHccCChhhCCCHHHHHhCccHHhhc
Confidence 00000 00000000 1122467889999999999999999999999999999855
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and |
| >cd08221 STKc_Nek9 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.3e-38 Score=250.86 Aligned_cols=248 Identities=23% Similarity=0.323 Sum_probs=190.0
Q ss_pred ccceeeeecccCceEEEEEEEcCCCcEEEEEEeccCCCChHHHHHHHHHHHHHHhCCCCCcchhhhhhhcCCeEEEEEec
Q psy758 3 RYEKIGKLGEGSYGVVFKCRNRDTGQVVAIKKFLESEEDPLIRKIALREIRLLKSLKHPNLVNLLEVFRRKKKLHLVFEF 82 (292)
Q Consensus 3 ~y~~~~~l~~g~~~~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~iv~e~ 82 (292)
+|++.+.||.|++|.||.+++..+++.+++|.+..........+.+.+|+.+++.++|+||+++++++.+++..++++||
T Consensus 1 ~y~~~~~ig~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~~~e~ 80 (256)
T cd08221 1 HYIPIRVLGKGAFGEATLYRRTEDDSLVVWKEVNLTRLSEKERRDALNEIVILSLLQHPNIIAYYNHFMDDNTLLIEMEY 80 (256)
T ss_pred CceEeeEecccCCceEEEEEEcCCCcEEEEEEEeecccchhHHHHHHHHHHHHHhCCCCCeeEEEeEEecCCeEEEEEEe
Confidence 69999999999999999999999999999999877665566677788999999999999999999999999999999999
Q ss_pred CCCccHHHHhcCC--CCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEEccCCcEEEeecCchhhhhccc-----
Q psy758 83 CDHTVLNELENHP--HGLPWDLIKQITWQVLRGVSYCHRHACIHRDIKPENILLTANGVVKLCDFGFARLIRDLI----- 155 (292)
Q Consensus 83 ~~~~~L~~~~~~~--~~~~~~~~~~i~~qi~~aL~~LH~~givH~dl~p~Nilv~~~~~~kl~dfg~~~~~~~~~----- 155 (292)
+++++|.+++... ..+++..+..++.|++.||.|||+.|++|+||+|+||+++.++.++|+|||++.......
T Consensus 81 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~i~h~dl~p~ni~~~~~~~~kl~d~~~~~~~~~~~~~~~~ 160 (256)
T cd08221 81 ANGGTLYDKIVRQKGQLFEEEMVLWYLFQIVSAVSYIHKAGILHRDIKTLNIFLTKAGLIKLGDFGISKILGSEYSMAET 160 (256)
T ss_pred cCCCcHHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHhCCccccCCChHhEEEeCCCCEEECcCcceEEcccccccccc
Confidence 9999999988754 458999999999999999999999999999999999999999999999999987654322
Q ss_pred cccccccccccccccCCCCCCCcccceeeecCCCCCCchHHHHHHHhhcccCCCCCCChhhhhhccCcCCC-CCCCCCcc
Q psy758 156 PRHLHIFQTNEYFKGVSLPHAENVVPLEIKIGKPAATNIYLIDFLKRCLDKDPLRRWSCDQLLRHPYFNGY-YFEVPDEM 234 (292)
Q Consensus 156 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~-~~~~~~~~ 234 (292)
......|.+|+...+.......++ ++.+.-++..+.+..|.......+.......... ..+...+.
T Consensus 161 ~~~~~~y~ape~~~~~~~~~~~Dv-------------~slG~i~~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 227 (256)
T cd08221 161 VVGTPYYMSPELCQGVKYNFKSDI-------------WALGCVLYELLTLKRTFDATNPLNLVVKIVQGNYTPVVSVYSS 227 (256)
T ss_pred cCCCccccCHhhcCCCCCCCcchh-------------HHHHHHHHHHHHCCCCCCCCCHHHHHHHHHcCCCCCCccccCH
Confidence 122334555555443322222222 2222333333334444433333332221111111 11233467
Q ss_pred chHHHHhcccCcCCCCCCChhhhhhCCcc
Q psy758 235 QYEEITQRCLDKDPLRRWSCDQLLRHPYF 263 (292)
Q Consensus 235 ~l~~li~~~l~~dP~~Rpt~~~il~h~w~ 263 (292)
.+.++|.+||..||.+|||+.++++|||+
T Consensus 228 ~~~~~i~~~l~~~p~~R~s~~~ll~~~~l 256 (256)
T cd08221 228 ELISLVHSLLQQDPEKRPTADEVLDQPLL 256 (256)
T ss_pred HHHHHHHHHcccCcccCCCHHHHhhCcCC
Confidence 89999999999999999999999999996
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associa |
| >cd07843 STKc_CDC2L1 Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.9e-39 Score=262.11 Aligned_cols=262 Identities=30% Similarity=0.469 Sum_probs=187.5
Q ss_pred CcccceeeeecccCceEEEEEEEcCCCcEEEEEEeccCCCChHHHHHHHHHHHHHHhCCCCCcchhhhhhhcC--CeEEE
Q psy758 1 MERYEKIGKLGEGSYGVVFKCRNRDTGQVVAIKKFLESEEDPLIRKIALREIRLLKSLKHPNLVNLLEVFRRK--KKLHL 78 (292)
Q Consensus 1 ~~~y~~~~~l~~g~~~~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~--~~~~i 78 (292)
+++|++.+.||+|++|.||+|.+..+++.+++|.+............+.+|+.+++.++||||+++++++... +..|+
T Consensus 4 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~~~l 83 (293)
T cd07843 4 VDEYEKLNRIEEGTYGVVYRARDKKTGEIVALKKLKMEKEKEGFPITSLREINILLKLQHPNIVTVKEVVVGSNLDKIYM 83 (293)
T ss_pred hhhhhhhhhhcCCCCeEEEEEEECCCCcEEEEEEEeeccccccchhhHHHHHHHHHhcCCCCEEEEEEEEEecCCCcEEE
Confidence 4689999999999999999999999999999999976554444445567899999999999999999998766 88999
Q ss_pred EEecCCCccHHHHhcC-CCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEEccCCcEEEeecCchhhhhcccc-
Q psy758 79 VFEFCDHTVLNELENH-PHGLPWDLIKQITWQVLRGVSYCHRHACIHRDIKPENILLTANGVVKLCDFGFARLIRDLIP- 156 (292)
Q Consensus 79 v~e~~~~~~L~~~~~~-~~~~~~~~~~~i~~qi~~aL~~LH~~givH~dl~p~Nilv~~~~~~kl~dfg~~~~~~~~~~- 156 (292)
|+||+++ +|..++.. ...+++..++.++.||+.||+|||++|++|+||+|+||+++.++.++|+|||.+........
T Consensus 84 v~e~~~~-~L~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~i~H~dl~p~nili~~~~~~~l~d~g~~~~~~~~~~~ 162 (293)
T cd07843 84 VMEYVEH-DLKSLMETMKQPFLQSEVKCLMLQLLSGVAHLHDNWILHRDLKTSNLLLNNRGILKICDFGLAREYGSPLKP 162 (293)
T ss_pred EehhcCc-CHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCeeeccCCHHHEEECCCCcEEEeecCceeeccCCccc
Confidence 9999986 66666654 34589999999999999999999999999999999999999999999999998876544321
Q ss_pred ----ccccccccccccccC------CCCCCCcccceeeecCCCCCCchHHHHHHHhhc---ccCCCC-CCChhhhh----
Q psy758 157 ----RHLHIFQTNEYFKGV------SLPHAENVVPLEIKIGKPAATNIYLIDFLKRCL---DKDPLR-RWSCDQLL---- 218 (292)
Q Consensus 157 ----~~~~~~~~~~~~~~~------~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~---~~~p~~-~~~~~~~~---- 218 (292)
.....|.+||...+. ...|+.|+..+++.+|.+++........+.... ...+.. .....++.
T Consensus 163 ~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 242 (293)
T cd07843 163 YTQLVVTLWYRAPELLLGAKEYSTAIDMWSVGCIFAELLTKKPLFPGKSEIDQLNKIFKLLGTPTEKIWPGFSELPGAKK 242 (293)
T ss_pred cccccccccccCchhhcCCccccchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCchHHHHHhhccchhcc
Confidence 122346667665432 234555555556666655543322222221111 110000 00000000
Q ss_pred -h--ccCcC--CCCCCCC-CccchHHHHhcccCcCCCCCCChhhhhhCCcc
Q psy758 219 -R--HPYFN--GYYFEVP-DEMQYEEITQRCLDKDPLRRWSCDQLLRHPYF 263 (292)
Q Consensus 219 -~--~~~~~--~~~~~~~-~~~~l~~li~~~l~~dP~~Rpt~~~il~h~w~ 263 (292)
. ..... ...++.. .+..+.++|++||+.||++|||+.|+++||||
T Consensus 243 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~t~~ell~~~~f 293 (293)
T cd07843 243 KTFTKYPYNQLRKKFPALSLSDNGFDLLNRLLTYDPAKRISAEDALKHPYF 293 (293)
T ss_pred cccccccchhhhccccccCCChHHHHHHHHHhccCccccCCHHHHhcCCCC
Confidence 0 00000 0011111 46778999999999999999999999999998
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the |
| >cd07844 STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-38 Score=258.96 Aligned_cols=261 Identities=32% Similarity=0.537 Sum_probs=187.6
Q ss_pred CcccceeeeecccCceEEEEEEEcCCCcEEEEEEeccCCCChHHHHHHHHHHHHHHhCCCCCcchhhhhhhcCCeEEEEE
Q psy758 1 MERYEKIGKLGEGSYGVVFKCRNRDTGQVVAIKKFLESEEDPLIRKIALREIRLLKSLKHPNLVNLLEVFRRKKKLHLVF 80 (292)
Q Consensus 1 ~~~y~~~~~l~~g~~~~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~iv~ 80 (292)
+++|++.+.||+|++|.||+|.+..+++.|++|.+....... ....+.+|+.+++.++||||+++++++.+++..++|+
T Consensus 4 ~~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~-~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 82 (291)
T cd07844 4 LETYKKLDKLGEGSYATVYKGRSKLTGQLVALKEIRLEHEEG-APFTAIREASLLKDLKHANIVTLHDIIHTKKTLTLVF 82 (291)
T ss_pred ccceeEEEEEeecCCeEEEEEEEcCCCcEEEEEEEecccccC-CchhHHHHHHHHhhCCCcceeeEEEEEecCCeEEEEE
Confidence 578999999999999999999999899999999986543221 1234568999999999999999999999999999999
Q ss_pred ecCCCccHHHHhcC-CCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEEccCCcEEEeecCchhhhhccc----
Q psy758 81 EFCDHTVLNELENH-PHGLPWDLIKQITWQVLRGVSYCHRHACIHRDIKPENILLTANGVVKLCDFGFARLIRDLI---- 155 (292)
Q Consensus 81 e~~~~~~L~~~~~~-~~~~~~~~~~~i~~qi~~aL~~LH~~givH~dl~p~Nilv~~~~~~kl~dfg~~~~~~~~~---- 155 (292)
||+.+ +|..++.. ...+++..++.++.|++.||.|||++|++|+||+|+||++++++.++|+|||.+.......
T Consensus 83 e~~~~-~L~~~~~~~~~~~~~~~~~~~~~ql~~al~~lH~~~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~~~~~~ 161 (291)
T cd07844 83 EYLDT-DLKQYMDDCGGGLSMHNVRLFLFQLLRGLAYCHQRRVLHRDLKPQNLLISERGELKLADFGLARAKSVPSKTYS 161 (291)
T ss_pred ecCCC-CHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecccCCHHHEEEcCCCCEEECccccccccCCCCcccc
Confidence 99996 67666643 3468999999999999999999999999999999999999999999999999886543211
Q ss_pred -cccccccccccccccC------CCCCCCcccceeeecCCCCCCchH-HHHH---HHhhcccCCCCCC-Chhhhh-----
Q psy758 156 -PRHLHIFQTNEYFKGV------SLPHAENVVPLEIKIGKPAATNIY-LIDF---LKRCLDKDPLRRW-SCDQLL----- 218 (292)
Q Consensus 156 -~~~~~~~~~~~~~~~~------~~~~~~~~~~~~~~~~~~~~~~~~-~~~~---~~~~~~~~p~~~~-~~~~~~----- 218 (292)
......|.+||...+. ...|+.|+..+++.+|..++.... ..+. +...+.......+ ......
T Consensus 162 ~~~~~~~~~aPE~~~~~~~~~~~~Dv~slG~il~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 241 (291)
T cd07844 162 NEVVTLWYRPPDVLLGSTEYSTSLDMWGVGCIFYEMATGRPLFPGSTDVEDQLHKIFRVLGTPTEETWPGVSSNPEFKPY 241 (291)
T ss_pred ccccccccCCcHHhhcCcccCcHHHHHHHHHHHHHHHhCCCCCCCCccHHHHHHHHHHhcCCCChhhhhhhhhccccccc
Confidence 1123446777765442 235666777777777776553222 1111 1122221111110 100000
Q ss_pred hccCcCCC-----CCCCCCccchHHHHhcccCcCCCCCCChhhhhhCCcc
Q psy758 219 RHPYFNGY-----YFEVPDEMQYEEITQRCLDKDPLRRWSCDQLLRHPYF 263 (292)
Q Consensus 219 ~~~~~~~~-----~~~~~~~~~l~~li~~~l~~dP~~Rpt~~~il~h~w~ 263 (292)
........ .........+.+++.+||+.||.+|||+.++++||||
T Consensus 242 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~~p~~Rps~~e~l~~~~f 291 (291)
T cd07844 242 SFPFYPPRPLINHAPRLDRIPHGEELALKFLQYEPKKRISAAEAMKHPYF 291 (291)
T ss_pred cccccCChhHHHhCcCCCCchhHHHHHHHHhccCcccccCHHHHhcCCCC
Confidence 00000000 0011112678899999999999999999999999998
|
Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the |
| >cd06605 PKc_MAPKK Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-38 Score=253.95 Aligned_cols=251 Identities=27% Similarity=0.466 Sum_probs=190.3
Q ss_pred cccceeeeecccCceEEEEEEEcCCCcEEEEEEeccCCCChHHHHHHHHHHHHHHhCCCCCcchhhhhhhcCCeEEEEEe
Q psy758 2 ERYEKIGKLGEGSYGVVFKCRNRDTGQVVAIKKFLESEEDPLIRKIALREIRLLKSLKHPNLVNLLEVFRRKKKLHLVFE 81 (292)
Q Consensus 2 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~iv~e 81 (292)
++|++.+.||+|++|.||+|.+..+++.|++|.+...... .....+.+|+++++.++||||+++++.+..++.+++++|
T Consensus 1 ~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~-~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e 79 (265)
T cd06605 1 DDLEYLGELGAGNSGVVSKVLHRPTGKIMAVKTIRLEINE-AIQKQILRELDILHKCNSPYIVGFYGAFYNNGDISICME 79 (265)
T ss_pred CcchHHHHhcCCCCeEEEEEEEcCCCcEEEEEEEecccCh-HHHHHHHHHHHHHHHCCCCchhhhheeeecCCEEEEEEE
Confidence 5789999999999999999999999999999998765433 455678899999999999999999999999999999999
Q ss_pred cCCCccHHHHhcCC-CCCCHHHHHHHHHHHHHHHHHHHh-CCccccCCCCCceEEccCCcEEEeecCchhhhhccc---c
Q psy758 82 FCDHTVLNELENHP-HGLPWDLIKQITWQVLRGVSYCHR-HACIHRDIKPENILLTANGVVKLCDFGFARLIRDLI---P 156 (292)
Q Consensus 82 ~~~~~~L~~~~~~~-~~~~~~~~~~i~~qi~~aL~~LH~-~givH~dl~p~Nilv~~~~~~kl~dfg~~~~~~~~~---~ 156 (292)
|+++++|.+++... ..+++..++.++.|++.||++||+ .|++|+||+|+||++++++.++|+|||.+....... .
T Consensus 80 ~~~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~i~H~dl~~~ni~~~~~~~~~l~d~g~~~~~~~~~~~~~ 159 (265)
T cd06605 80 YMDGGSLDKILKEVQGRIPERILGKIAVAVLKGLTYLHEKHKIIHRDVKPSNILVNSRGQIKLCDFGVSGQLVNSLAKTF 159 (265)
T ss_pred ecCCCcHHHHHHHccCCCCHHHHHHHHHHHHHHHHHHcCCCCeecCCCCHHHEEECCCCCEEEeecccchhhHHHHhhcc
Confidence 99999999998765 679999999999999999999999 999999999999999999999999999987654321 2
Q ss_pred ccccccccccccccCCCCCCCcccceeeecCCCCCCchHHHHHHHhhcccCCCCCC-----ChhhhhhccCcC-CCCCCC
Q psy758 157 RHLHIFQTNEYFKGVSLPHAENVVPLEIKIGKPAATNIYLIDFLKRCLDKDPLRRW-----SCDQLLRHPYFN-GYYFEV 230 (292)
Q Consensus 157 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~-----~~~~~~~~~~~~-~~~~~~ 230 (292)
.....|.+||+..+.......++|++ +..++..+.+..|.... ...+........ ....+.
T Consensus 160 ~~~~~y~~PE~~~~~~~~~~~Dv~sl-------------G~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 226 (265)
T cd06605 160 VGTSSYMAPERIQGNDYSVKSDIWSL-------------GLSLIELATGRFPYPPENDPPDGIFELLQYIVNEPPPRLPS 226 (265)
T ss_pred cCChhccCHHHHcCCCCCchhhHHHH-------------HHHHHHHHhCCCCCCccccccccHHHHHHHHhcCCCCCCCh
Confidence 23345667776655433323333332 22223333333333221 111111110000 001111
Q ss_pred C-CccchHHHHhcccCcCCCCCCChhhhhhCCcccce
Q psy758 231 P-DEMQYEEITQRCLDKDPLRRWSCDQLLRHPYFNGY 266 (292)
Q Consensus 231 ~-~~~~l~~li~~~l~~dP~~Rpt~~~il~h~w~~~~ 266 (292)
. .+..+.++|.+||..||.+|||+.+++.||||+.+
T Consensus 227 ~~~~~~~~~li~~~l~~~p~~Rpt~~~ll~~~~~~~~ 263 (265)
T cd06605 227 GKFSPDFQDFVNLCLIKDPRERPSYKELLEHPFIKKY 263 (265)
T ss_pred hhcCHHHHHHHHHHcCCCchhCcCHHHHhhCchhhcc
Confidence 1 46789999999999999999999999999999864
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity |
| >cd07855 STKc_ERK5 Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.8e-39 Score=265.75 Aligned_cols=265 Identities=24% Similarity=0.397 Sum_probs=195.7
Q ss_pred cccceeeeecccCceEEEEEEEcCCCcEEEEEEeccCCCChHHHHHHHHHHHHHHhCCCCCcchhhhhhhc----CCeEE
Q psy758 2 ERYEKIGKLGEGSYGVVFKCRNRDTGQVVAIKKFLESEEDPLIRKIALREIRLLKSLKHPNLVNLLEVFRR----KKKLH 77 (292)
Q Consensus 2 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~----~~~~~ 77 (292)
++|++.+.||+|++|.||+|.+..+++.|++|.+..........+.+.+|+.+++.++||||+++++++.. ....+
T Consensus 5 ~~y~~~~~lg~g~~g~v~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~ 84 (334)
T cd07855 5 SRYKPIENIGSGAYGVVCSAIDTRSGKKVAIKKIPHAFDVPTLAKRTLRELKILRHFKHDNIIAIRDILRPPGADFKDVY 84 (334)
T ss_pred hceeeeeeeecCCCeEEEEEEEcCCCCEEEEEEeccccccccchHHHHHHHHHHHhcCCCCccCHHHhccccCCCCceEE
Confidence 47999999999999999999999999999999987654444456677889999999999999999998763 35789
Q ss_pred EEEecCCCccHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEEccCCcEEEeecCchhhhhccc--
Q psy758 78 LVFEFCDHTVLNELENHPHGLPWDLIKQITWQVLRGVSYCHRHACIHRDIKPENILLTANGVVKLCDFGFARLIRDLI-- 155 (292)
Q Consensus 78 iv~e~~~~~~L~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~givH~dl~p~Nilv~~~~~~kl~dfg~~~~~~~~~-- 155 (292)
+|+||+.+ +|..++.....+++..++.++.||+.||.|||++|++|+||+|+||++++++.++|+|||++.......
T Consensus 85 lv~e~~~~-~l~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~dlkp~Nil~~~~~~~kl~dfg~~~~~~~~~~~ 163 (334)
T cd07855 85 VVMDLMES-DLHHIIHSDQPLTEEHIRYFLYQLLRGLKYIHSANVIHRDLKPSNLLVNEDCELRIGDFGMARGLSSSPTE 163 (334)
T ss_pred EEEehhhh-hHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEEcCCCcEEecccccceeecccCcC
Confidence 99999975 788888777779999999999999999999999999999999999999999999999999986543211
Q ss_pred -------ccccccccccccccc------CCCCCCCcccceeeecCCCCCCchHHH---HHHHhhcccCCCCCCC---hhh
Q psy758 156 -------PRHLHIFQTNEYFKG------VSLPHAENVVPLEIKIGKPAATNIYLI---DFLKRCLDKDPLRRWS---CDQ 216 (292)
Q Consensus 156 -------~~~~~~~~~~~~~~~------~~~~~~~~~~~~~~~~~~~~~~~~~~~---~~~~~~~~~~p~~~~~---~~~ 216 (292)
...+..|.+||+..+ ....|+.|+..+++.++.+++...... ..+...++..|..... ...
T Consensus 164 ~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~l~el~~g~~pf~~~~~~~~~~~~~~~~g~~~~~~~~~~~~~~ 243 (334)
T cd07855 164 HKYFMTEYVATRWYRAPELLLSLPEYTTAIDMWSVGCIFAEMLGRRQLFPGKNYVHQLKLILSVLGSPSEEVLNRIGSDR 243 (334)
T ss_pred CCcccccccccccccChHHhcCCcccccccchHHHHHHHHHHHcCCCccCCCChHHHHHHHHHHhCCChhHhhhhhchhh
Confidence 122334667776533 234566666666677777665433222 2233333333222110 000
Q ss_pred ---hhh-ccCcCCCC---CCCCCccchHHHHhcccCcCCCCCCChhhhhhCCccccee
Q psy758 217 ---LLR-HPYFNGYY---FEVPDEMQYEEITQRCLDKDPLRRWSCDQLLRHPYFNGYY 267 (292)
Q Consensus 217 ---~~~-~~~~~~~~---~~~~~~~~l~~li~~~l~~dP~~Rpt~~~il~h~w~~~~~ 267 (292)
... .+...... .....+..+.++|++||+.||.+|||++++++||||.+..
T Consensus 244 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~~l~~~~~~~~~ 301 (334)
T cd07855 244 VRKYIQNLPRKQPVPWSKIFPKASPEALDLLSQMLQFDPEERITVEQALQHPFLAQYH 301 (334)
T ss_pred HHHHHhhcccCCCCCHHHHcccCCHHHHHHHHHHccCChhhCcCHHHHHhChhhhhcc
Confidence 000 00000111 0123477899999999999999999999999999998744
|
Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the |
| >cd06654 STKc_PAK1 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.5e-38 Score=256.52 Aligned_cols=248 Identities=25% Similarity=0.361 Sum_probs=187.3
Q ss_pred cccceeeeecccCceEEEEEEEcCCCcEEEEEEeccCCCChHHHHHHHHHHHHHHhCCCCCcchhhhhhhcCCeEEEEEe
Q psy758 2 ERYEKIGKLGEGSYGVVFKCRNRDTGQVVAIKKFLESEEDPLIRKIALREIRLLKSLKHPNLVNLLEVFRRKKKLHLVFE 81 (292)
Q Consensus 2 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~iv~e 81 (292)
.+|++.+.||+|++|.||++.+..++..|++|.+...... ....+.+|+.+++.++|||++++++.+..+...|+|+|
T Consensus 20 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~v~ik~~~~~~~~--~~~~~~~e~~~l~~~~h~~v~~~~~~~~~~~~~~lv~e 97 (296)
T cd06654 20 KKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQP--KKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVME 97 (296)
T ss_pred cceeeEEEecCCCCeEEEEEEECCCCcEEEEEEEecCCcc--hHHHHHHHHHHHHhCCCCCEeeEEEEEEeCCEEEEeec
Confidence 5899999999999999999999999999999998765433 24667889999999999999999999999999999999
Q ss_pred cCCCccHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEEccCCcEEEeecCchhhhhccc-----c
Q psy758 82 FCDHTVLNELENHPHGLPWDLIKQITWQVLRGVSYCHRHACIHRDIKPENILLTANGVVKLCDFGFARLIRDLI-----P 156 (292)
Q Consensus 82 ~~~~~~L~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~givH~dl~p~Nilv~~~~~~kl~dfg~~~~~~~~~-----~ 156 (292)
|+++++|..++... .+++.++..++.|++.||.|||+.|++|+||+|+||+++.++.++|+|||.+....... .
T Consensus 98 ~~~~~~L~~~~~~~-~~~~~~~~~i~~ql~~aL~~LH~~gi~H~dLkp~Nill~~~~~~kl~dfg~~~~~~~~~~~~~~~ 176 (296)
T cd06654 98 YLAGGSLTDVVTET-CMDEGQIAAVCRECLQALEFLHSNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSTM 176 (296)
T ss_pred ccCCCCHHHHHHhc-CCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEEcCCCCEEECccccchhccccccccCcc
Confidence 99999999998653 68999999999999999999999999999999999999999999999999887543221 1
Q ss_pred ccccccccccccccCCCCCCCcccceeeecCCCCCCchHHHHHHHhhcccCCCCCCChhhhhhccCcC---CCCCCCCCc
Q psy758 157 RHLHIFQTNEYFKGVSLPHAENVVPLEIKIGKPAATNIYLIDFLKRCLDKDPLRRWSCDQLLRHPYFN---GYYFEVPDE 233 (292)
Q Consensus 157 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~---~~~~~~~~~ 233 (292)
.....|.+||...+.......++|+ .+.-++..+.+..|+............... ....+...+
T Consensus 177 ~~~~~y~aPE~~~~~~~~~~~Dv~s-------------~Gvil~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 243 (296)
T cd06654 177 VGTPYWMAPEVVTRKAYGPKVDIWS-------------LGIMAIEMIEGEPPYLNENPLRALYLIATNGTPELQNPEKLS 243 (296)
T ss_pred cCCccccCHHHHcCCCCCccchHHH-------------HHHHHHHHHhCCCCCCCCCHHHhHHHHhcCCCCCCCCccccC
Confidence 2233466666654433322222222 222233333444443333221111110000 111123346
Q ss_pred cchHHHHhcccCcCCCCCCChhhhhhCCcccc
Q psy758 234 MQYEEITQRCLDKDPLRRWSCDQLLRHPYFNG 265 (292)
Q Consensus 234 ~~l~~li~~~l~~dP~~Rpt~~~il~h~w~~~ 265 (292)
..+.++|.+||..||.+|||+.++++||||..
T Consensus 244 ~~l~~li~~~l~~~p~~Rpt~~eil~~~~~~~ 275 (296)
T cd06654 244 AIFRDFLNRCLDMDVEKRGSAKELLQHQFLKI 275 (296)
T ss_pred HHHHHHHHHHCcCCcccCcCHHHHhhChhhhc
Confidence 67899999999999999999999999999986
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >cd07831 STKc_MOK Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-38 Score=258.02 Aligned_cols=255 Identities=31% Similarity=0.451 Sum_probs=181.5
Q ss_pred cceeeeecccCceEEEEEEEcCCCcEEEEEEeccCCCChHHHHHHHHHHHHHHhCC-CCCcchhhhhhhcC--CeEEEEE
Q psy758 4 YEKIGKLGEGSYGVVFKCRNRDTGQVVAIKKFLESEEDPLIRKIALREIRLLKSLK-HPNLVNLLEVFRRK--KKLHLVF 80 (292)
Q Consensus 4 y~~~~~l~~g~~~~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~e~~~~~~l~-~~~i~~~~~~~~~~--~~~~iv~ 80 (292)
|++.+.||+|++|.||+|.+..+++.|++|.+......... ....+|+..++.+. |+|++++++++.++ +..++|+
T Consensus 1 y~~~~~lg~g~~~~v~~~~~~~~~~~~aik~~~~~~~~~~~-~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~~~lv~ 79 (282)
T cd07831 1 YKILGKIGEGTFSEVLKAQSRKTGKYYAIKCMKKHFKSLEQ-VNNLREIQALRRLSPHPNILRLIEVLFDRKTGRLALVF 79 (282)
T ss_pred CceEeeccccccceEEEEEEcCCCcEEEEEEehhccCCchh-hhHHHHHHHHhhcCCCCCccceEEEEecCCCCcEEEEE
Confidence 78899999999999999999999999999998765433222 23457888888885 99999999999877 8899999
Q ss_pred ecCCCccHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEEccCCcEEEeecCchhhhhcccc----
Q psy758 81 EFCDHTVLNELENHPHGLPWDLIKQITWQVLRGVSYCHRHACIHRDIKPENILLTANGVVKLCDFGFARLIRDLIP---- 156 (292)
Q Consensus 81 e~~~~~~L~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~givH~dl~p~Nilv~~~~~~kl~dfg~~~~~~~~~~---- 156 (292)
||++++.+..+......+++..++.++.|++.||.|||+.|++|+||+|+||++++ +.++|+|||.+........
T Consensus 80 e~~~~~l~~~l~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~i~H~dl~p~ni~l~~-~~~kl~dfg~~~~~~~~~~~~~~ 158 (282)
T cd07831 80 ELMDMNLYELIKGRKRPLPEKRVKSYMYQLLKSLDHMHRNGIFHRDIKPENILIKD-DILKLADFGSCRGIYSKPPYTEY 158 (282)
T ss_pred ecCCccHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCceecccCHHHEEEcC-CCeEEEecccccccccCCCcCCC
Confidence 99997655555544457899999999999999999999999999999999999999 9999999999876543222
Q ss_pred cccccccccccccc------CCCCCCCcccceeeecCCCCCCchHHHHHHHh---hcccCCCCCCChhhhhhccCcCCCC
Q psy758 157 RHLHIFQTNEYFKG------VSLPHAENVVPLEIKIGKPAATNIYLIDFLKR---CLDKDPLRRWSCDQLLRHPYFNGYY 227 (292)
Q Consensus 157 ~~~~~~~~~~~~~~------~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~---~~~~~p~~~~~~~~~~~~~~~~~~~ 227 (292)
..+..|.+||...+ ....|+.|+..+++.++.+++......+.+.. .++..+. . ..+...........
T Consensus 159 ~~~~~y~aPE~~~~~~~~~~~~Di~slGv~l~el~~~~~p~~~~~~~~~~~~~~~~~~~~~~-~--~~~~~~~~~~~~~~ 235 (282)
T cd07831 159 ISTRWYRAPECLLTDGYYGPKMDIWAVGCVFFEILSLFPLFPGTNELDQIAKIHDVLGTPDA-E--VLKKFRKSRHMNYN 235 (282)
T ss_pred CCCcccCChhHhhcCCCCCcchhHHHHHHHHHHHHcCCcCCCCCCHHHHHHHHHHHcCCCCH-H--HHHhhccccccccc
Confidence 12344667775422 22345555555556666555433322222211 1111110 0 00000000000000
Q ss_pred C-----------CCCCccchHHHHhcccCcCCCCCCChhhhhhCCcc
Q psy758 228 F-----------EVPDEMQYEEITQRCLDKDPLRRWSCDQLLRHPYF 263 (292)
Q Consensus 228 ~-----------~~~~~~~l~~li~~~l~~dP~~Rpt~~~il~h~w~ 263 (292)
. ....+..+.++|.+||++||++|||++++++||||
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~l~~~~~ 282 (282)
T cd07831 236 FPSKKGTGLRKLLPNASAEGLDLLKKLLAYDPDERITAKQALRHPYF 282 (282)
T ss_pred CcccccccHHHHcccccHHHHHHHHHHhccCcccccCHHHHhhCCCC
Confidence 0 12346789999999999999999999999999997
|
Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation. |
| >cd07865 STKc_CDK9 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-38 Score=261.84 Aligned_cols=263 Identities=32% Similarity=0.511 Sum_probs=185.9
Q ss_pred CcccceeeeecccCceEEEEEEEcCCCcEEEEEEeccCCCChHHHHHHHHHHHHHHhCCCCCcchhhhhhhcC-------
Q psy758 1 MERYEKIGKLGEGSYGVVFKCRNRDTGQVVAIKKFLESEEDPLIRKIALREIRLLKSLKHPNLVNLLEVFRRK------- 73 (292)
Q Consensus 1 ~~~y~~~~~l~~g~~~~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~------- 73 (292)
+++|++.+.||+|++|.||+|.+..+++.||+|.+............+.+|+.+++.++||||+++++++...
T Consensus 11 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 90 (310)
T cd07865 11 VSKYEKLAKIGQGTFGEVFKARHKKTKQIVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKATPYNRY 90 (310)
T ss_pred hhheEEEEEeecCCCEEEEEEEECCCCcEEEEEEEeccCCcCCchhHHHHHHHHHHhCCCCCccceEEEEecccccccCC
Confidence 4789999999999999999999999999999999865543333344566899999999999999999987543
Q ss_pred -CeEEEEEecCCCccHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEEccCCcEEEeecCchhhhh
Q psy758 74 -KKLHLVFEFCDHTVLNELENHPHGLPWDLIKQITWQVLRGVSYCHRHACIHRDIKPENILLTANGVVKLCDFGFARLIR 152 (292)
Q Consensus 74 -~~~~iv~e~~~~~~L~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~givH~dl~p~Nilv~~~~~~kl~dfg~~~~~~ 152 (292)
...++|+||++++....+......+++..++.++.||+.||.|||++|++|+||+|+||+++.++.++|+|||++....
T Consensus 91 ~~~~~lv~e~~~~~l~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~~~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~ 170 (310)
T cd07865 91 KGSFYLVFEFCEHDLAGLLSNKNVKFTLSEIKKVMKMLLNGLYYIHRNKILHRDMKAANILITKDGILKLADFGLARAFS 170 (310)
T ss_pred CceEEEEEcCCCcCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHEEECCCCcEEECcCCCccccc
Confidence 3469999999875444444444468999999999999999999999999999999999999999999999999987653
Q ss_pred cccc---------ccccccccccccccC------CCCCCCcccceeeecCCCCCCchH---HHHHHHhhcccCCCCCC-C
Q psy758 153 DLIP---------RHLHIFQTNEYFKGV------SLPHAENVVPLEIKIGKPAATNIY---LIDFLKRCLDKDPLRRW-S 213 (292)
Q Consensus 153 ~~~~---------~~~~~~~~~~~~~~~------~~~~~~~~~~~~~~~~~~~~~~~~---~~~~~~~~~~~~p~~~~-~ 213 (292)
.... .....|.+||...+. ...|+.|+..+++.++.+++.... ....+..+.+..|.... .
T Consensus 171 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~el~t~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 250 (310)
T cd07865 171 LSKNSKPNRYTNRVVTLWYRPPELLLGERDYGPPIDMWGAGCIMAEMWTRSPIMQGNTEQHQLTLISQLCGSITPEVWPG 250 (310)
T ss_pred CCcccCCCCccCcccCccccCcHHhcCCcccCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChhhccc
Confidence 3211 122347778865442 334666666666666665443222 22233333332221110 0
Q ss_pred hhh--hhhc-cCcCC-------CCCCCCCccchHHHHhcccCcCCCCCCChhhhhhCCcc
Q psy758 214 CDQ--LLRH-PYFNG-------YYFEVPDEMQYEEITQRCLDKDPLRRWSCDQLLRHPYF 263 (292)
Q Consensus 214 ~~~--~~~~-~~~~~-------~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~~il~h~w~ 263 (292)
... .... ..... .......+..+.+||.+||..||.+|||++++++||||
T Consensus 251 ~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~dli~~~l~~~P~~R~t~~e~l~h~~f 310 (310)
T cd07865 251 VDKLELFKKMELPQGQKRKVKERLKPYVKDPHALDLIDKLLVLDPAKRIDADTALNHDFF 310 (310)
T ss_pred ccchhhhhhccCCCccchhhHHhcccccCCHHHHHHHHHHhcCChhhccCHHHHhcCCCC
Confidence 000 0000 00000 00011124567899999999999999999999999998
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multipl |
| >KOG0662|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-38 Score=226.92 Aligned_cols=267 Identities=33% Similarity=0.542 Sum_probs=202.2
Q ss_pred CcccceeeeecccCceEEEEEEEcCCCcEEEEEEeccCCCChHHHHHHHHHHHHHHhCCCCCcchhhhhhhcCCeEEEEE
Q psy758 1 MERYEKIGKLGEGSYGVVFKCRNRDTGQVVAIKKFLESEEDPLIRKIALREIRLLKSLKHPNLVNLLEVFRRKKKLHLVF 80 (292)
Q Consensus 1 ~~~y~~~~~l~~g~~~~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~iv~ 80 (292)
+.+|.-.+.||+|++|+||+|+...+++.||+|..+..+.++-.-....+|+-+++.++|.||++++++...++.+.+|+
T Consensus 1 m~~ydkmekigegtygtvfkarn~~t~eivalkrvrlddddegvpssalreicllkelkhknivrl~dvlhsdkkltlvf 80 (292)
T KOG0662|consen 1 MQKYDKMEKIGEGTYGTVFKARNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLHSDKKLTLVF 80 (292)
T ss_pred CcchHHHHhhcCCcceeeEecccCCccceEEEEEEeccCCCCCCcHHHHHHHHHHHHhhhcceeehhhhhccCceeEEeH
Confidence 46788889999999999999999999999999999888877777778899999999999999999999999999999999
Q ss_pred ecCCCccHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEEccCCcEEEeecCchhhhhcccc----
Q psy758 81 EFCDHTVLNELENHPHGLPWDLIKQITWQVLRGVSYCHRHACIHRDIKPENILLTANGVVKLCDFGFARLIRDLIP---- 156 (292)
Q Consensus 81 e~~~~~~L~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~givH~dl~p~Nilv~~~~~~kl~dfg~~~~~~~~~~---- 156 (292)
|||....-..+-..++.++.+.++.++.|++.||.++|++++.|+|+||.|.+|..+|.+||.|||+++.++-+..
T Consensus 81 e~cdqdlkkyfdslng~~d~~~~rsfmlqllrgl~fchshnvlhrdlkpqnllin~ngelkladfglarafgipvrcysa 160 (292)
T KOG0662|consen 81 EFCDQDLKKYFDSLNGDLDPEIVRSFMLQLLRGLGFCHSHNVLHRDLKPQNLLINRNGELKLADFGLARAFGIPVRCYSA 160 (292)
T ss_pred HHhhHHHHHHHHhcCCcCCHHHHHHHHHHHHhhhhhhhhhhhhhccCCcceEEeccCCcEEecccchhhhcCCceEeeec
Confidence 9999876666666678899999999999999999999999999999999999999999999999999988763221
Q ss_pred -ccccccccccccccCCCC------CCCcccceeee-cCCCCCCchHHHHHH----HhhcccCCCCCCChhhhhhccCcC
Q psy758 157 -RHLHIFQTNEYFKGVSLP------HAENVVPLEIK-IGKPAATNIYLIDFL----KRCLDKDPLRRWSCDQLLRHPYFN 224 (292)
Q Consensus 157 -~~~~~~~~~~~~~~~~~~------~~~~~~~~~~~-~~~~~~~~~~~~~~~----~~~~~~~p~~~~~~~~~~~~~~~~ 224 (292)
..+-.|..|....|..++ |+.+++..++. .|.+.+-+...-+.+ ..+-.......++...+-....+.
T Consensus 161 evvtlwyrppdvlfgakly~tsidmwsagcifaelanagrplfpg~dvddqlkrif~~lg~p~ed~wps~t~lpdyk~yp 240 (292)
T KOG0662|consen 161 EVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEDQWPSMTKLPDYKPYP 240 (292)
T ss_pred eeeeeeccCcceeeeeehhccchHhhhcchHHHHHhhcCCCCCCCCcHHHHHHHHHHHhCCCccccCCccccCCCCcccC
Confidence 123345666665555443 44444333332 244444444433333 332233334445544443222221
Q ss_pred CCCC-------CCCCccchHHHHhcccCcCCCCCCChhhhhhCCccccee
Q psy758 225 GYYF-------EVPDEMQYEEITQRCLDKDPLRRWSCDQLLRHPYFNGYY 267 (292)
Q Consensus 225 ~~~~-------~~~~~~~l~~li~~~l~~dP~~Rpt~~~il~h~w~~~~~ 267 (292)
.++. ....+..-++|++++|.-+|.+|++|++.++||||.+..
T Consensus 241 ~ypattswsqivp~lns~grdllqkll~cnp~qrisaeaalqhpyf~d~s 290 (292)
T KOG0662|consen 241 IYPATTSWSQIVPKLNSTGRDLLQKLLKCNPAQRISAEAALQHPYFSDFS 290 (292)
T ss_pred CccccchHHHHhhhhcchhHHHHHHHhccCcccccCHHHHhcCccccccC
Confidence 1111 111244568999999999999999999999999999853
|
|
| >cd07860 STKc_CDK2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-38 Score=258.79 Aligned_cols=260 Identities=33% Similarity=0.532 Sum_probs=188.2
Q ss_pred ccceeeeecccCceEEEEEEEcCCCcEEEEEEeccCCCChHHHHHHHHHHHHHHhCCCCCcchhhhhhhcCCeEEEEEec
Q psy758 3 RYEKIGKLGEGSYGVVFKCRNRDTGQVVAIKKFLESEEDPLIRKIALREIRLLKSLKHPNLVNLLEVFRRKKKLHLVFEF 82 (292)
Q Consensus 3 ~y~~~~~l~~g~~~~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~iv~e~ 82 (292)
.|+..+.||+|++|.||+|.+..+++.|++|.+............+.+|+++++.++||||+++++++.+++..++|+||
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~ 80 (284)
T cd07860 1 NFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFEF 80 (284)
T ss_pred CceeeeeecCCCceEEEEEEECCCCCEEEEEEccccccccccchHHHHHHHHHHhcCCCCCcchhhhcccCCcEEEEeec
Confidence 48899999999999999999999999999999876554444456788899999999999999999999999999999999
Q ss_pred CCCccHHHHhcC--CCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEEccCCcEEEeecCchhhhhcccc----
Q psy758 83 CDHTVLNELENH--PHGLPWDLIKQITWQVLRGVSYCHRHACIHRDIKPENILLTANGVVKLCDFGFARLIRDLIP---- 156 (292)
Q Consensus 83 ~~~~~L~~~~~~--~~~~~~~~~~~i~~qi~~aL~~LH~~givH~dl~p~Nilv~~~~~~kl~dfg~~~~~~~~~~---- 156 (292)
+.+ .|..++.. ...+++..++.++.|++.||+|||+.|++|+||+|+||++++++.++|+|||++........
T Consensus 81 ~~~-~l~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~i~H~~l~p~nill~~~~~~~l~dfg~~~~~~~~~~~~~~ 159 (284)
T cd07860 81 LHQ-DLKKFMDASPLSGIPLPLIKSYLFQLLQGLAFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTH 159 (284)
T ss_pred ccc-CHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEECCCCCEEEeeccchhhcccCcccccc
Confidence 975 56666543 34689999999999999999999999999999999999999999999999999876543211
Q ss_pred -ccccccccccccccC------CCCCCCcccceeeecCCCCCCchHHHHHHHhhc---ccCCCCC-CChhhhh--hccCc
Q psy758 157 -RHLHIFQTNEYFKGV------SLPHAENVVPLEIKIGKPAATNIYLIDFLKRCL---DKDPLRR-WSCDQLL--RHPYF 223 (292)
Q Consensus 157 -~~~~~~~~~~~~~~~------~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~---~~~p~~~-~~~~~~~--~~~~~ 223 (292)
.....|.+||...+. ...|+.|+..+++.+|..++........+.... ...+... +....+. ...+.
T Consensus 160 ~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 239 (284)
T cd07860 160 EVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSLPDYKPSFP 239 (284)
T ss_pred ccccccccCCeEEecCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHhCCCChhhhhhhhHHHHHHhhcc
Confidence 112346777765442 234666666667777765543222211111111 1111000 0000000 00000
Q ss_pred C---C--CCCCCCCccchHHHHhcccCcCCCCCCChhhhhhCCcc
Q psy758 224 N---G--YYFEVPDEMQYEEITQRCLDKDPLRRWSCDQLLRHPYF 263 (292)
Q Consensus 224 ~---~--~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~~il~h~w~ 263 (292)
. . .......+..++++|.+||+.||.+|||++++++||||
T Consensus 240 ~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~~l~~~~f 284 (284)
T cd07860 240 KWARQDFSKVVPPLDEDGRDLLSQMLHYDPNKRISAKAALAHPFF 284 (284)
T ss_pred cccccCHHHHcccCCHHHHHHHHHhcCCCcccCCCHHHHhcCCCC
Confidence 0 0 00112346678999999999999999999999999998
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex |
| >cd06608 STKc_myosinIII_like Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-38 Score=256.99 Aligned_cols=244 Identities=30% Similarity=0.442 Sum_probs=181.6
Q ss_pred cccceeeeecccCceEEEEEEEcCCCcEEEEEEeccCCCChHHHHHHHHHHHHHHhC-CCCCcchhhhhhhcC------C
Q psy758 2 ERYEKIGKLGEGSYGVVFKCRNRDTGQVVAIKKFLESEEDPLIRKIALREIRLLKSL-KHPNLVNLLEVFRRK------K 74 (292)
Q Consensus 2 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~e~~~~~~l-~~~~i~~~~~~~~~~------~ 74 (292)
++|++.+.||+|++|.||+|.+..+++.+++|++..... ..+.+.+|+.+++.+ .|+||+++++++.+. .
T Consensus 6 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~---~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~~~~ 82 (275)
T cd06608 6 GIFELVEVIGEGTYGKVYKARHKKTGQLVAIKIMDIIED---EEEEIKEEYNILRKYSNHPNIATFYGAFIKKNPPGNDD 82 (275)
T ss_pred hheeheeeecCCCCeEEEEEEECCCCcEEEEEEEecCch---hHHHHHHHHHHHHHhcCCCChheEEEEEEecCCCCcce
Confidence 689999999999999999999998899999999865543 235678999999999 699999999998653 4
Q ss_pred eEEEEEecCCCccHHHHhcC----CCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEEccCCcEEEeecCchhh
Q psy758 75 KLHLVFEFCDHTVLNELENH----PHGLPWDLIKQITWQVLRGVSYCHRHACIHRDIKPENILLTANGVVKLCDFGFARL 150 (292)
Q Consensus 75 ~~~iv~e~~~~~~L~~~~~~----~~~~~~~~~~~i~~qi~~aL~~LH~~givH~dl~p~Nilv~~~~~~kl~dfg~~~~ 150 (292)
.+++|+||+++++|.+++.. ...+++..++.++.|++.||.|||++|++|+||+|+||+++.++.++|+|||++..
T Consensus 83 ~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~lH~~~i~H~~l~p~ni~~~~~~~~~l~d~~~~~~ 162 (275)
T cd06608 83 QLWLVMELCGGGSVTDLVKGLRKKGKRLKEEWIAYILRETLRGLAYLHENKVIHRDIKGQNILLTKNAEVKLVDFGVSAQ 162 (275)
T ss_pred EEEEEEEcCCCCcHHHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHhcCCcccCCCCHHHEEEccCCeEEECCCcccee
Confidence 58999999999999888754 34789999999999999999999999999999999999999999999999998865
Q ss_pred hhcccc-----ccccccccccccccC----------CCCCCCcccceeeecCCCCCCchHHHHHHHhhcccCCCCCCChh
Q psy758 151 IRDLIP-----RHLHIFQTNEYFKGV----------SLPHAENVVPLEIKIGKPAATNIYLIDFLKRCLDKDPLRRWSCD 215 (292)
Q Consensus 151 ~~~~~~-----~~~~~~~~~~~~~~~----------~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~ 215 (292)
...... .....|.+||...+. ...|+.|+..+++.++..++........+......
T Consensus 163 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~--------- 233 (275)
T cd06608 163 LDSTLGRRNTFIGTPYWMAPEVIACDEQPDASYDARSDVWSLGITAIELADGKPPLCDMHPMRALFKIPRN--------- 233 (275)
T ss_pred cccchhhhcCccccccccCHhHhcccccccCCccccccHHHhHHHHHHHHhCCCCccccchHHHHHHhhcc---------
Confidence 433221 123345666654322 23344444444444454443221111111111100
Q ss_pred hhhhccCcCCCCCCCCCccchHHHHhcccCcCCCCCCChhhhhhCCcc
Q psy758 216 QLLRHPYFNGYYFEVPDEMQYEEITQRCLDKDPLRRWSCDQLLRHPYF 263 (292)
Q Consensus 216 ~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~~il~h~w~ 263 (292)
. ......+...+..+++||.+||..||++|||+.++++|||+
T Consensus 234 -----~-~~~~~~~~~~~~~~~~li~~~l~~dp~~Rpt~~~ll~~~~~ 275 (275)
T cd06608 234 -----P-PPTLKSPENWSKKFNDFISECLIKNYEQRPFMEELLEHPFI 275 (275)
T ss_pred -----C-CCCCCchhhcCHHHHHHHHHHhhcChhhCcCHHHHhcCCCC
Confidence 0 00111122235689999999999999999999999999996
|
Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin I |
| >cd05577 STKc_GRK Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-38 Score=256.21 Aligned_cols=250 Identities=23% Similarity=0.342 Sum_probs=187.1
Q ss_pred ecccCceEEEEEEEcCCCcEEEEEEeccCCCC-hHHHHHHHHHHHHHHhCCCCCcchhhhhhhcCCeEEEEEecCCCccH
Q psy758 10 LGEGSYGVVFKCRNRDTGQVVAIKKFLESEED-PLIRKIALREIRLLKSLKHPNLVNLLEVFRRKKKLHLVFEFCDHTVL 88 (292)
Q Consensus 10 l~~g~~~~v~~~~~~~~~~~v~iK~~~~~~~~-~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~iv~e~~~~~~L 88 (292)
||+|++|.||+|.+..+|+.|++|.+...... ......+.+|+.+++.++||||+++++++...+..|+|+||+++++|
T Consensus 1 lg~g~~g~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L 80 (277)
T cd05577 1 LGKGGFGEVCACQVKATGKMYACKKLDKKRLKKRKGEQMALNEKKILEKVSSRFIVSLAYAFETKDDLCLVMTLMNGGDL 80 (277)
T ss_pred CCCCCceeEEEEEEcCCCcEEEEEEEehhhhhhhhhhHHHHHHHHHHHhCCCCCEeeeeeEEecCCeEEEEEecCCCCcH
Confidence 68999999999999999999999998754322 22345567899999999999999999999999999999999999999
Q ss_pred HHHhcCCC--CCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEEccCCcEEEeecCchhhhhccc----ccccccc
Q psy758 89 NELENHPH--GLPWDLIKQITWQVLRGVSYCHRHACIHRDIKPENILLTANGVVKLCDFGFARLIRDLI----PRHLHIF 162 (292)
Q Consensus 89 ~~~~~~~~--~~~~~~~~~i~~qi~~aL~~LH~~givH~dl~p~Nilv~~~~~~kl~dfg~~~~~~~~~----~~~~~~~ 162 (292)
.+++.... .+++..+..++.|++.||.|||++|++|+||+|+||++++++.++|+|||.+....... ......|
T Consensus 81 ~~~l~~~~~~~~~~~~~~~~~~ql~~~l~~lH~~~i~H~di~p~Nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~y 160 (277)
T cd05577 81 KYHIYNVGEPGFPEARAIFYAAQIICGLEHLHQRRIVYRDLKPENVLLDDHGNVRISDLGLAVELKGGKKIKGRAGTPGY 160 (277)
T ss_pred HHHHHHcCcCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEECCCCCEEEccCcchhhhccCCccccccCCCCc
Confidence 99886544 68999999999999999999999999999999999999999999999999887654211 1222346
Q ss_pred ccccccccCCCCCCCcccceeeecCCCCCCchHHHHHHHhhcccCCCCCCC----hhhhhhccCcCCCCCCCCCccchHH
Q psy758 163 QTNEYFKGVSLPHAENVVPLEIKIGKPAATNIYLIDFLKRCLDKDPLRRWS----CDQLLRHPYFNGYYFEVPDEMQYEE 238 (292)
Q Consensus 163 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~----~~~~~~~~~~~~~~~~~~~~~~l~~ 238 (292)
.+||+..+.......++|++ +.-+...+.+..|..... ..++...........+...+..+.+
T Consensus 161 ~~PE~~~~~~~~~~~Di~sl-------------G~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 227 (277)
T cd05577 161 MAPEVLQGEVYDFSVDWFAL-------------GCTLYEMIAGRSPFRQRKEKVEKEELKRRTLEMAVEYPDKFSPEAKD 227 (277)
T ss_pred CCHHHhcCCCCCchhhhHHH-------------HHHHHHHhhCCCCCCCCcccccHHHHHhccccccccCCccCCHHHHH
Confidence 66666554433222333322 222333333444432221 1222222221222333445788999
Q ss_pred HHhcccCcCCCCCC-----ChhhhhhCCcccceeccCCC
Q psy758 239 ITQRCLDKDPLRRW-----SCDQLLRHPYFNGYYFEVPD 272 (292)
Q Consensus 239 li~~~l~~dP~~Rp-----t~~~il~h~w~~~~~~~~~~ 272 (292)
+|.+||+.||.+|| ++.++++||||.+..|+...
T Consensus 228 li~~~l~~~p~~R~~~~~~~~~~ll~h~~~~~~~~~~~~ 266 (277)
T cd05577 228 LCEALLQKDPEKRLGCRGGSADEVREHPLFKDLNWRRLE 266 (277)
T ss_pred HHHHHccCChhHccCCCcccHHHHHhChhhhcCChhhhh
Confidence 99999999999999 88889999999998877654
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of |
| >cd06645 STKc_MAP4K3 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-38 Score=254.07 Aligned_cols=246 Identities=28% Similarity=0.403 Sum_probs=181.3
Q ss_pred cccceeeeecccCceEEEEEEEcCCCcEEEEEEeccCCCChHHHHHHHHHHHHHHhCCCCCcchhhhhhhcCCeEEEEEe
Q psy758 2 ERYEKIGKLGEGSYGVVFKCRNRDTGQVVAIKKFLESEEDPLIRKIALREIRLLKSLKHPNLVNLLEVFRRKKKLHLVFE 81 (292)
Q Consensus 2 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~iv~e 81 (292)
++|++.+.||+|++|.||.|.+..+++.|++|.+..... .....+.+|+.+++.++||||+++++++.+.+.+++++|
T Consensus 9 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~--~~~~~~~~e~~~~~~l~h~~ii~~~~~~~~~~~~~lv~e 86 (267)
T cd06645 9 EDFELIQRIGSGTYGDVYKARNVNTGELAAIKVIKLEPG--EDFAVVQQEIIMMKDCKHSNIVAYFGSYLRRDKLWICME 86 (267)
T ss_pred HHHHHHHHhCCCCCeEEEEEEEcCCCcEEEEEEEecCch--hHHHHHHHHHHHHHhCCCCCeeeEEEEEEeCCEEEEEEe
Confidence 578999999999999999999999999999999865532 233457789999999999999999999999999999999
Q ss_pred cCCCccHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEEccCCcEEEeecCchhhhhcccc-----
Q psy758 82 FCDHTVLNELENHPHGLPWDLIKQITWQVLRGVSYCHRHACIHRDIKPENILLTANGVVKLCDFGFARLIRDLIP----- 156 (292)
Q Consensus 82 ~~~~~~L~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~givH~dl~p~Nilv~~~~~~kl~dfg~~~~~~~~~~----- 156 (292)
|+++++|.+++...+.+++..++.++.|++.||.|||+.|++|+||+|+||+++.++.++|+|||.+........
T Consensus 87 ~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~nili~~~~~~~l~dfg~~~~~~~~~~~~~~~ 166 (267)
T cd06645 87 FCGGGSLQDIYHVTGPLSESQIAYVSRETLQGLYYLHSKGKMHRDIKGANILLTDNGHVKLADFGVSAQITATIAKRKSF 166 (267)
T ss_pred ccCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEECCCCCEEECcceeeeEccCcccccccc
Confidence 999999999988777899999999999999999999999999999999999999999999999999865432211
Q ss_pred ccccccccccccc---cCCCCCCCcccceeeecCCCCCCchHHHHHHHhhcccCCCCCCChhhhhhc---cCcC--CCCC
Q psy758 157 RHLHIFQTNEYFK---GVSLPHAENVVPLEIKIGKPAATNIYLIDFLKRCLDKDPLRRWSCDQLLRH---PYFN--GYYF 228 (292)
Q Consensus 157 ~~~~~~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~---~~~~--~~~~ 228 (292)
.+...|.+||... ........++ ++.+..++..+....|.........+.. ..+. ....
T Consensus 167 ~~~~~y~aPE~~~~~~~~~~~~~~Dv-------------wSlG~il~~l~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 233 (267)
T cd06645 167 IGTPYWMAPEVAAVERKGGYNQLCDI-------------WAVGITAIELAELQPPMFDLHPMRALFLMTKSNFQPPKLKD 233 (267)
T ss_pred cCcccccChhhhccccCCCCCchhhh-------------HHHHHHHHHHhcCCCCcccccchhhHHhhhccCCCCCcccc
Confidence 2233455566542 1111111222 2222223333333333221111111000 0000 0011
Q ss_pred CCCCccchHHHHhcccCcCCCCCCChhhhhhCCc
Q psy758 229 EVPDEMQYEEITQRCLDKDPLRRWSCDQLLRHPY 262 (292)
Q Consensus 229 ~~~~~~~l~~li~~~l~~dP~~Rpt~~~il~h~w 262 (292)
....+..+.++|.+||+.||++|||++++++|||
T Consensus 234 ~~~~~~~~~~li~~~l~~~P~~R~~~~~ll~~~~ 267 (267)
T cd06645 234 KMKWSNSFHHFVKMALTKNPKKRPTAEKLLQHPF 267 (267)
T ss_pred cCCCCHHHHHHHHHHccCCchhCcCHHHHhcCCC
Confidence 1234567899999999999999999999999998
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated |
| >PTZ00266 NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-38 Score=286.46 Aligned_cols=249 Identities=24% Similarity=0.335 Sum_probs=188.2
Q ss_pred CcccceeeeecccCceEEEEEEEcCCCcEEEEEEeccCCCChHHHHHHHHHHHHHHhCCCCCcchhhhhhhc--CCeEEE
Q psy758 1 MERYEKIGKLGEGSYGVVFKCRNRDTGQVVAIKKFLESEEDPLIRKIALREIRLLKSLKHPNLVNLLEVFRR--KKKLHL 78 (292)
Q Consensus 1 ~~~y~~~~~l~~g~~~~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~--~~~~~i 78 (292)
+++|++++.||+|+||.||+|.+..++..|++|.+............+..|+.+++.++||||++++++|.+ ...+|+
T Consensus 12 l~~YeIl~kLG~GgFGtVYLAkdk~tg~~vAlKvIk~~~l~e~~~~~~~~EI~IL~~L~HPNIVrl~d~f~de~~~~lyI 91 (1021)
T PTZ00266 12 LNEYEVIKKIGNGRFGEVFLVKHKRTQEFFCWKAISYRGLKEREKSQLVIEVNVMRELKHKNIVRYIDRFLNKANQKLYI 91 (1021)
T ss_pred cCCEEEEEEEecCCCeEEEEEEECCCCeEEEEEEEeccccCHHHHHHHHHHHHHHHHcCCCCcCeEEEEEEecCCCEEEE
Confidence 478999999999999999999999999999999998776666667788999999999999999999998854 467999
Q ss_pred EEecCCCccHHHHhcC----CCCCCHHHHHHHHHHHHHHHHHHHhC-------CccccCCCCCceEEccC----------
Q psy758 79 VFEFCDHTVLNELENH----PHGLPWDLIKQITWQVLRGVSYCHRH-------ACIHRDIKPENILLTAN---------- 137 (292)
Q Consensus 79 v~e~~~~~~L~~~~~~----~~~~~~~~~~~i~~qi~~aL~~LH~~-------givH~dl~p~Nilv~~~---------- 137 (292)
||||+++++|..++.. ...+++..++.|+.||+.||.|||+. +|+|+||||+|||++.+
T Consensus 92 VMEY~~gGSL~~lL~k~~~~~g~L~E~~Il~Ia~QIL~ALaYLHs~g~~~~~k~IVHRDLKPeNILL~s~~~~lg~i~~~ 171 (1021)
T PTZ00266 92 LMEFCDAGDLSRNIQKCYKMFGKIEEHAIVDITRQLLHALAYCHNLKDGPNGERVLHRDLKPQNIFLSTGIRHIGKITAQ 171 (1021)
T ss_pred EEeCCCCCcHHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhcccccccCCceeccCcHHHeEeecCcccccccccc
Confidence 9999999999988754 24699999999999999999999984 49999999999999642
Q ss_pred -------CcEEEeecCchhhhhccc----cccccccccccccccCC-------CCCCCcccceeeecCCCCCCchHHHHH
Q psy758 138 -------GVVKLCDFGFARLIRDLI----PRHLHIFQTNEYFKGVS-------LPHAENVVPLEIKIGKPAATNIYLIDF 199 (292)
Q Consensus 138 -------~~~kl~dfg~~~~~~~~~----~~~~~~~~~~~~~~~~~-------~~~~~~~~~~~~~~~~~~~~~~~~~~~ 199 (292)
+.++|+|||++....... ...+..|.+||...+.. ..|+++++.++++++..
T Consensus 172 ~~n~ng~~iVKLsDFGlAr~l~~~s~~~s~vGTp~YmAPEvL~ge~~~~s~KSDVWSLG~ILYELLTGk~---------- 241 (1021)
T PTZ00266 172 ANNLNGRPIAKIGDFGLSKNIGIESMAHSCVGTPYYWSPELLLHETKSYDDKSDMWALGCIIYELCSGKT---------- 241 (1021)
T ss_pred ccccCCCCceEEccCCccccccccccccccCCCccccCHHHHhccCCCCCchhHHHHHHHHHHHHHHCCC----------
Confidence 358999999987653221 12344566777654321 23444444444444444
Q ss_pred HHhhcccCCCCCCC-hhhhhhccCcCCCCC-CCCCccchHHHHhcccCcCCCCCCChhhhhhCCcccceec
Q psy758 200 LKRCLDKDPLRRWS-CDQLLRHPYFNGYYF-EVPDEMQYEEITQRCLDKDPLRRWSCDQLLRHPYFNGYYF 268 (292)
Q Consensus 200 ~~~~~~~~p~~~~~-~~~~~~~~~~~~~~~-~~~~~~~l~~li~~~l~~dP~~Rpt~~~il~h~w~~~~~~ 268 (292)
|+.... ..+++... ...... ....+..+.+||..||..+|.+|||+.|+|.||||+.+..
T Consensus 242 --------PF~~~~~~~qli~~l-k~~p~lpi~~~S~eL~dLI~~~L~~dPeeRPSa~QlL~h~~ik~i~~ 303 (1021)
T PTZ00266 242 --------PFHKANNFSQLISEL-KRGPDLPIKGKSKELNILIKNLLNLSAKERPSALQCLGYQIIKNVGP 303 (1021)
T ss_pred --------CCCcCCcHHHHHHHH-hcCCCCCcCCCCHHHHHHHHHHhcCChhHCcCHHHHhccHHHhhcCC
Confidence 332221 11111110 000111 1223678999999999999999999999999999987654
|
|
| >cd06656 STKc_PAK3 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.4e-38 Score=256.31 Aligned_cols=250 Identities=26% Similarity=0.371 Sum_probs=186.8
Q ss_pred cccceeeeecccCceEEEEEEEcCCCcEEEEEEeccCCCChHHHHHHHHHHHHHHhCCCCCcchhhhhhhcCCeEEEEEe
Q psy758 2 ERYEKIGKLGEGSYGVVFKCRNRDTGQVVAIKKFLESEEDPLIRKIALREIRLLKSLKHPNLVNLLEVFRRKKKLHLVFE 81 (292)
Q Consensus 2 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~iv~e 81 (292)
++|++++.||+|++|.||++.+..+++.|++|.+...... ..+.+.+|+.+++.++||||+++++++..++..++|+|
T Consensus 19 ~~y~~~~~lg~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~--~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e 96 (297)
T cd06656 19 KKYTRFEKIGQGASGTVYTAIDIATGQEVAIKQMNLQQQP--KKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVME 96 (297)
T ss_pred hhceeeeeeccCCCeEEEEEEECCCCCEEEEEEEecCccc--hHHHHHHHHHHHHhCCCCCEeeEEEEEecCCEEEEeec
Confidence 5899999999999999999999999999999998654433 24567889999999999999999999999999999999
Q ss_pred cCCCccHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEEccCCcEEEeecCchhhhhcccc-----
Q psy758 82 FCDHTVLNELENHPHGLPWDLIKQITWQVLRGVSYCHRHACIHRDIKPENILLTANGVVKLCDFGFARLIRDLIP----- 156 (292)
Q Consensus 82 ~~~~~~L~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~givH~dl~p~Nilv~~~~~~kl~dfg~~~~~~~~~~----- 156 (292)
|+++++|..++... .+++..+..++.|++.||.|||+.|++|+||+|+||+++.++.++|+|||.+........
T Consensus 97 ~~~~~~L~~~~~~~-~~~~~~~~~~~~~l~~~L~~LH~~~i~H~dL~p~Nili~~~~~~~l~Dfg~~~~~~~~~~~~~~~ 175 (297)
T cd06656 97 YLAGGSLTDVVTET-CMDEGQIAAVCRECLQALDFLHSNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSTM 175 (297)
T ss_pred ccCCCCHHHHHHhC-CCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCCEEECcCccceEccCCccCcCcc
Confidence 99999999998653 689999999999999999999999999999999999999999999999998865433211
Q ss_pred ccccccccccccccCCCCCCCcccceeeecCCCCCCchHHHHHHHhhcccCCCCCCChhhhhhccCcC---CCCCCCCCc
Q psy758 157 RHLHIFQTNEYFKGVSLPHAENVVPLEIKIGKPAATNIYLIDFLKRCLDKDPLRRWSCDQLLRHPYFN---GYYFEVPDE 233 (292)
Q Consensus 157 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~---~~~~~~~~~ 233 (292)
.....|.+||...+.......++|++ +.-++..+.+..|+............... ....+...+
T Consensus 176 ~~~~~y~aPE~~~~~~~~~~~Di~sl-------------Gvil~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 242 (297)
T cd06656 176 VGTPYWMAPEVVTRKAYGPKVDIWSL-------------GIMAIEMVEGEPPYLNENPLRALYLIATNGTPELQNPERLS 242 (297)
T ss_pred cCCccccCHHHHcCCCCCcHHHHHHH-------------HHHHHHHHhCCCCCCCCCcchheeeeccCCCCCCCCccccC
Confidence 12234555665544333222222222 22233333344443322211111111100 111223346
Q ss_pred cchHHHHhcccCcCCCCCCChhhhhhCCccccee
Q psy758 234 MQYEEITQRCLDKDPLRRWSCDQLLRHPYFNGYY 267 (292)
Q Consensus 234 ~~l~~li~~~l~~dP~~Rpt~~~il~h~w~~~~~ 267 (292)
..+.++|.+||..||.+|||++++++||||....
T Consensus 243 ~~~~~li~~~l~~~p~~Rps~~~il~~~~~~~~~ 276 (297)
T cd06656 243 AVFRDFLNRCLEMDVDRRGSAKELLQHPFLKLAK 276 (297)
T ss_pred HHHHHHHHHHccCChhhCcCHHHHhcCchhcccc
Confidence 6789999999999999999999999999998644
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >cd06631 STKc_YSK4 Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.4e-38 Score=251.81 Aligned_cols=247 Identities=26% Similarity=0.325 Sum_probs=184.7
Q ss_pred ccceeeeecccCceEEEEEEEcCCCcEEEEEEeccCCC----ChHHHHHHHHHHHHHHhCCCCCcchhhhhhhcCCeEEE
Q psy758 3 RYEKIGKLGEGSYGVVFKCRNRDTGQVVAIKKFLESEE----DPLIRKIALREIRLLKSLKHPNLVNLLEVFRRKKKLHL 78 (292)
Q Consensus 3 ~y~~~~~l~~g~~~~v~~~~~~~~~~~v~iK~~~~~~~----~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~i 78 (292)
+|++.+.||+|+||.||+|.+. +++.+++|.+..... .......+.+|+++++.++|+||+++++++.+.+..++
T Consensus 1 ~~~~~~~ig~g~~~~v~~~~~~-~~~~~avk~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~l 79 (265)
T cd06631 1 EWTKGEVLGKGAYGTVYCGLTN-QGQLIAVKQVELDTSNVLAAEKEYEKLQEEVDLLKSLKHVNIVQYLGTCLDDNTISI 79 (265)
T ss_pred CccccceEeccCCeEEEEEEEc-CCCeEEEEEeecCccchhhHHHHHHHHHHHHHHHHhcCCCCEeeEeeEeecCCeEEE
Confidence 5899999999999999999874 688999998865432 22344668899999999999999999999999999999
Q ss_pred EEecCCCccHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEEccCCcEEEeecCchhhhhccc---
Q psy758 79 VFEFCDHTVLNELENHPHGLPWDLIKQITWQVLRGVSYCHRHACIHRDIKPENILLTANGVVKLCDFGFARLIRDLI--- 155 (292)
Q Consensus 79 v~e~~~~~~L~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~givH~dl~p~Nilv~~~~~~kl~dfg~~~~~~~~~--- 155 (292)
++||+++++|.+++.....+++..++.++.|++.||+|||+.|++|+||+|+||++++++.++|+|||++.......
T Consensus 80 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~~~~ 159 (265)
T cd06631 80 FMEFVPGGSISSILNRFGPLPEPVFCKYTKQILDGVAYLHNNCVVHRDIKGNNVMLMPNGIIKLIDFGCARRLAWVGLHG 159 (265)
T ss_pred EEecCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCcCHHhEEECCCCeEEeccchhhHhhhhccccc
Confidence 99999999999999877789999999999999999999999999999999999999999999999999987653211
Q ss_pred --------cccccccccccccccCCCCCCCcccceeeecCCCCCCchHHHHHHHhhcccCCCCCCChhhhhhccC-c--C
Q psy758 156 --------PRHLHIFQTNEYFKGVSLPHAENVVPLEIKIGKPAATNIYLIDFLKRCLDKDPLRRWSCDQLLRHPY-F--N 224 (292)
Q Consensus 156 --------~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~-~--~ 224 (292)
......|.+||...+.......++ ++.+.-++..+.+..|.............. . .
T Consensus 160 ~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv-------------~slG~~~~~l~~g~~p~~~~~~~~~~~~~~~~~~~ 226 (265)
T cd06631 160 THSNMLKSMHGTPYWMAPEVINESGYGRKSDI-------------WSIGCTVFEMATGKPPLASMDRLAAMFYIGAHRGL 226 (265)
T ss_pred cccccccccCCCccccChhhhcCCCCcchhhH-------------HHHHHHHHHHHhCCCccccCChHHHHHHhhhccCC
Confidence 111223555555543332222222 222333344444444443322211111000 0 0
Q ss_pred CCCCCCCCccchHHHHhcccCcCCCCCCChhhhhhCCcc
Q psy758 225 GYYFEVPDEMQYEEITQRCLDKDPLRRWSCDQLLRHPYF 263 (292)
Q Consensus 225 ~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~~il~h~w~ 263 (292)
....+...+..+.++|++||..||.+|||+.++++||||
T Consensus 227 ~~~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~~l~~~~~ 265 (265)
T cd06631 227 MPRLPDSFSAAAIDFVTSCLTRDQHERPSALQLLRHDFL 265 (265)
T ss_pred CCCCCCCCCHHHHHHHHHHhcCCcccCCCHHHHhcCCCC
Confidence 112333457789999999999999999999999999997
|
Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. |
| >cd06612 STKc_MST1_2 Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-38 Score=252.60 Aligned_cols=245 Identities=29% Similarity=0.459 Sum_probs=186.1
Q ss_pred cccceeeeecccCceEEEEEEEcCCCcEEEEEEeccCCCChHHHHHHHHHHHHHHhCCCCCcchhhhhhhcCCeEEEEEe
Q psy758 2 ERYEKIGKLGEGSYGVVFKCRNRDTGQVVAIKKFLESEEDPLIRKIALREIRLLKSLKHPNLVNLLEVFRRKKKLHLVFE 81 (292)
Q Consensus 2 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~iv~e 81 (292)
++|++.+.||+|++|.||+|....+++.|++|.+..... .+.+.+|+++++.++||||+++++.+.++...|+++|
T Consensus 3 ~~y~~~~~i~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~----~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~l~~e 78 (256)
T cd06612 3 EVFDILEKLGEGSYGSVYKAIHKETGQVVAIKVVPVEED----LQEIIKEISILKQCDSPYIVKYYGSYFKNTDLWIVME 78 (256)
T ss_pred ccchhhhhhcCCCCeEEEEEEEcCCCcEEEEEEeecHHH----HHHHHHHHHHHHhCCCCcEeeeeeeeecCCcEEEEEe
Confidence 689999999999999999999998899999999865432 5678899999999999999999999999999999999
Q ss_pred cCCCccHHHHhcC-CCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEEccCCcEEEeecCchhhhhccccc---
Q psy758 82 FCDHTVLNELENH-PHGLPWDLIKQITWQVLRGVSYCHRHACIHRDIKPENILLTANGVVKLCDFGFARLIRDLIPR--- 157 (292)
Q Consensus 82 ~~~~~~L~~~~~~-~~~~~~~~~~~i~~qi~~aL~~LH~~givH~dl~p~Nilv~~~~~~kl~dfg~~~~~~~~~~~--- 157 (292)
|+++++|.+++.. ...+++..++.++.|++.||.|||+.|++|+||+|+||++++++.++|+|||++.........
T Consensus 79 ~~~~~~L~~~l~~~~~~l~~~~~~~~~~~l~~~l~~lh~~~i~H~dl~~~ni~~~~~~~~~l~dfg~~~~~~~~~~~~~~ 158 (256)
T cd06612 79 YCGAGSVSDIMKITNKTLTEEEIAAILYQTLKGLEYLHSNKKIHRDIKAGNILLNEEGQAKLADFGVSGQLTDTMAKRNT 158 (256)
T ss_pred cCCCCcHHHHHHhCccCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCcceEEECCCCcEEEcccccchhcccCcccccc
Confidence 9999999998864 456899999999999999999999999999999999999999999999999998776543211
Q ss_pred --cccccccccccccCCCCCCCcccceeeecCCCCCCchHHHHHHHhhcccCCCCCCChhhhhhc---cCcCCCCCCCCC
Q psy758 158 --HLHIFQTNEYFKGVSLPHAENVVPLEIKIGKPAATNIYLIDFLKRCLDKDPLRRWSCDQLLRH---PYFNGYYFEVPD 232 (292)
Q Consensus 158 --~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~---~~~~~~~~~~~~ 232 (292)
....|.+||...+.......++|+ .+.-++..+.+..|.......+.... ........+...
T Consensus 159 ~~~~~~y~~PE~~~~~~~~~~~Di~s-------------~G~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 225 (256)
T cd06612 159 VIGTPFWMAPEVIQEIGYNNKADIWS-------------LGITAIEMAEGKPPYSDIHPMRAIFMIPNKPPPTLSDPEKW 225 (256)
T ss_pred ccCCccccCHHHHhcCCCCchhhHHH-------------HHHHHHHHHhCCCCCCCcchhhhhhhhccCCCCCCCchhhc
Confidence 223456666554433222222222 22223333344444333222221111 001111122234
Q ss_pred ccchHHHHhcccCcCCCCCCChhhhhhCCcc
Q psy758 233 EMQYEEITQRCLDKDPLRRWSCDQLLRHPYF 263 (292)
Q Consensus 233 ~~~l~~li~~~l~~dP~~Rpt~~~il~h~w~ 263 (292)
+..+.++|.+||+.||++|||+.++++||||
T Consensus 226 ~~~~~~~i~~~l~~~P~~Rps~~~il~~~~~ 256 (256)
T cd06612 226 SPEFNDFVKKCLVKDPEERPSAIQLLQHPFI 256 (256)
T ss_pred CHHHHHHHHHHHhcChhhCcCHHHHhcCCCC
Confidence 5689999999999999999999999999997
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a |
| >PTZ00284 protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-38 Score=274.79 Aligned_cols=272 Identities=21% Similarity=0.296 Sum_probs=189.1
Q ss_pred cccceeeeecccCceEEEEEEEcCCCcEEEEEEeccCCCChHHHHHHHHHHHHHHhCCC------CCcchhhhhhhc-CC
Q psy758 2 ERYEKIGKLGEGSYGVVFKCRNRDTGQVVAIKKFLESEEDPLIRKIALREIRLLKSLKH------PNLVNLLEVFRR-KK 74 (292)
Q Consensus 2 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~e~~~~~~l~~------~~i~~~~~~~~~-~~ 74 (292)
++|++.+.||+|+||.||+|.+..+++.||+|++.... ........|+.+++.++| .+++.+++++.. .+
T Consensus 129 ~~y~i~~~lG~G~fg~V~~a~~~~~~~~vAvK~i~~~~---~~~~~~~~e~~~l~~l~~~~~~~~~~i~~i~~~~~~~~~ 205 (467)
T PTZ00284 129 QRFKILSLLGEGTFGKVVEAWDRKRKEYCAVKIVRNVP---KYTRDAKIEIQFMEKVRQADPADRFPLMKIQRYFQNETG 205 (467)
T ss_pred CcEEEEEEEEeccCEEEEEEEEcCCCeEEEEEEEecch---hhHHHHHHHHHHHHHHhhcCcccCcceeeeEEEEEcCCc
Confidence 57999999999999999999999999999999986432 122334557777766654 457888888765 45
Q ss_pred eEEEEEecCCCccHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHh-CCccccCCCCCceEEccCC---------------
Q psy758 75 KLHLVFEFCDHTVLNELENHPHGLPWDLIKQITWQVLRGVSYCHR-HACIHRDIKPENILLTANG--------------- 138 (292)
Q Consensus 75 ~~~iv~e~~~~~~L~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~-~givH~dl~p~Nilv~~~~--------------- 138 (292)
.+|+|+|++++ .|.+++...+.+++..++.++.||+.||.|||+ .||+||||||+|||++.++
T Consensus 206 ~~~iv~~~~g~-~l~~~l~~~~~l~~~~~~~i~~qi~~aL~yLH~~~gIiHrDlKP~NILl~~~~~~~~~~~~~~~~~~~ 284 (467)
T PTZ00284 206 HMCIVMPKYGP-CLLDWIMKHGPFSHRHLAQIIFQTGVALDYFHTELHLMHTDLKPENILMETSDTVVDPVTNRALPPDP 284 (467)
T ss_pred eEEEEEeccCC-CHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhcCCeecCCCCHHHEEEecCCcccccccccccCCCC
Confidence 78999999854 555555555689999999999999999999998 5999999999999998765
Q ss_pred -cEEEeecCchhhhhcc--ccccccccccccccccCC-----CCCCCcccceeeecCCCCCCchHH---HHHHHhhcccC
Q psy758 139 -VVKLCDFGFARLIRDL--IPRHLHIFQTNEYFKGVS-----LPHAENVVPLEIKIGKPAATNIYL---IDFLKRCLDKD 207 (292)
Q Consensus 139 -~~kl~dfg~~~~~~~~--~~~~~~~~~~~~~~~~~~-----~~~~~~~~~~~~~~~~~~~~~~~~---~~~~~~~~~~~ 207 (292)
.+||+|||.+...... ...++..|.+||...+.. ..|++|+..+++++|.+++....- ...+...++..
T Consensus 285 ~~vkl~DfG~~~~~~~~~~~~~gt~~Y~APE~~~~~~~~~~~DiwSlGvil~elltG~~pf~~~~~~~~~~~i~~~~g~~ 364 (467)
T PTZ00284 285 CRVRICDLGGCCDERHSRTAIVSTRHYRSPEVVLGLGWMYSTDMWSMGCIIYELYTGKLLYDTHDNLEHLHLMEKTLGRL 364 (467)
T ss_pred ceEEECCCCccccCccccccccCCccccCcHHhhcCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHcCCC
Confidence 4999999987543221 123345678888776654 457777777788888887643322 22333333332
Q ss_pred CCCCCC------hhhhhhc-----c---------CcCCCC-CCCCCccchHHHHhcccCcCCCCCCChhhhhhCCcccce
Q psy758 208 PLRRWS------CDQLLRH-----P---------YFNGYY-FEVPDEMQYEEITQRCLDKDPLRRWSCDQLLRHPYFNGY 266 (292)
Q Consensus 208 p~~~~~------~~~~~~~-----~---------~~~~~~-~~~~~~~~l~~li~~~l~~dP~~Rpt~~~il~h~w~~~~ 266 (292)
|..... ..++... + +..... ........+.+||.+||++||.+|||++|+|+||||...
T Consensus 365 p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~dP~~R~ta~e~L~Hp~~~~~ 444 (467)
T PTZ00284 365 PSEWAGRCGTEEARLLYNSAGQLRPCTDPKHLARIARARPVREVIRDDLLCDLIYGLLHYDRQKRLNARQMTTHPYVLKY 444 (467)
T ss_pred CHHHHhhccchhHHHHhhhcccccccCCHHHHHhhhcccchhhhhchHHHHHHHHHhCCcChhhCCCHHHHhcCcccccc
Confidence 211000 0000000 0 000000 001124567899999999999999999999999999997
Q ss_pred eccCCChhHHH
Q psy758 267 YFEVPDEMQYE 277 (292)
Q Consensus 267 ~~~~~~~~~~~ 277 (292)
+.+-.+...|.
T Consensus 445 ~~~~~~~~~~~ 455 (467)
T PTZ00284 445 YPECRQHPNYP 455 (467)
T ss_pred CCccccCCCCC
Confidence 76554444443
|
|
| >cd06619 PKc_MKK5 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.8e-38 Score=254.05 Aligned_cols=247 Identities=23% Similarity=0.367 Sum_probs=183.6
Q ss_pred cccceeeeecccCceEEEEEEEcCCCcEEEEEEeccCCCChHHHHHHHHHHHHHHhCCCCCcchhhhhhhcCCeEEEEEe
Q psy758 2 ERYEKIGKLGEGSYGVVFKCRNRDTGQVVAIKKFLESEEDPLIRKIALREIRLLKSLKHPNLVNLLEVFRRKKKLHLVFE 81 (292)
Q Consensus 2 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~iv~e 81 (292)
++|++++.||+|++|.||+|.+..+++.|++|.+.... .......+.+|+.+++.++||||+++++.+...+..++|+|
T Consensus 1 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~aiK~~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 79 (279)
T cd06619 1 QDIQYQEILGHGNGGTVYKAYHLLTRRILAVKVIPLDI-TVELQKQIMSELEILYKCDSPYIIGFYGAFFVENRISICTE 79 (279)
T ss_pred CcchheeeeccCCCeEEEEEEEcCCCcEEEEEEEecCC-ChHHHHHHHHHHHHHHhCCCCCeeeEEEEEEECCEEEEEEe
Confidence 47899999999999999999999999999999986543 23345668899999999999999999999999999999999
Q ss_pred cCCCccHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEEccCCcEEEeecCchhhhhccc---ccc
Q psy758 82 FCDHTVLNELENHPHGLPWDLIKQITWQVLRGVSYCHRHACIHRDIKPENILLTANGVVKLCDFGFARLIRDLI---PRH 158 (292)
Q Consensus 82 ~~~~~~L~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~givH~dl~p~Nilv~~~~~~kl~dfg~~~~~~~~~---~~~ 158 (292)
|+++++|..+. .+++..+..++.|++.||.|||+.|++|+||+|+||+++.++.++|+|||++....... ...
T Consensus 80 ~~~~~~l~~~~----~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nill~~~~~~~l~dfg~~~~~~~~~~~~~~~ 155 (279)
T cd06619 80 FMDGGSLDVYR----KIPEHVLGRIAVAVVKGLTYLWSLKILHRDVKPSNMLVNTRGQVKLCDFGVSTQLVNSIAKTYVG 155 (279)
T ss_pred cCCCCChHHhh----cCCHHHHHHHHHHHHHHHHHHHHCCEeeCCCCHHHEEECCCCCEEEeeCCcceecccccccCCCC
Confidence 99999997653 47899999999999999999999999999999999999999999999999987553321 122
Q ss_pred ccccccccccccCCCCCCCcccceeeecCCCCCCchHHHHHHHhhcccCCCCCCC-------hhhhhhccC--cCCCCCC
Q psy758 159 LHIFQTNEYFKGVSLPHAENVVPLEIKIGKPAATNIYLIDFLKRCLDKDPLRRWS-------CDQLLRHPY--FNGYYFE 229 (292)
Q Consensus 159 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~-------~~~~~~~~~--~~~~~~~ 229 (292)
+..|.+||...+.......++|+ .+..++..+.+..|..... ..+...... .......
T Consensus 156 ~~~y~aPE~~~~~~~~~~~Dvws-------------lG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 222 (279)
T cd06619 156 TNAYMAPERISGEQYGIHSDVWS-------------LGISFMELALGRFPYPQIQKNQGSLMPLQLLQCIVDEDPPVLPV 222 (279)
T ss_pred ChhhcCceeecCCCCCCcchHHH-------------HHHHHHHHHhCCCCchhhcccccccchHHHHHHHhccCCCCCCC
Confidence 34566677665443322222222 2222233333333322110 011110000 0000112
Q ss_pred CCCccchHHHHhcccCcCCCCCCChhhhhhCCcccce
Q psy758 230 VPDEMQYEEITQRCLDKDPLRRWSCDQLLRHPYFNGY 266 (292)
Q Consensus 230 ~~~~~~l~~li~~~l~~dP~~Rpt~~~il~h~w~~~~ 266 (292)
...+..+.++|.+||+.||.+||+++++++||||...
T Consensus 223 ~~~~~~~~~li~~~l~~~P~~Rp~~~eil~~~~~~~~ 259 (279)
T cd06619 223 GQFSEKFVHFITQCMRKQPKERPAPENLMDHPFIVQY 259 (279)
T ss_pred CcCCHHHHHHHHHHhhCChhhCCCHHHHhcCcccccc
Confidence 2346689999999999999999999999999999875
|
Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that p |
| >cd06630 STKc_MEKK1 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-37 Score=251.49 Aligned_cols=249 Identities=24% Similarity=0.348 Sum_probs=186.5
Q ss_pred ccceeeeecccCceEEEEEEEcCCCcEEEEEEeccCCC----ChHHHHHHHHHHHHHHhCCCCCcchhhhhhhcCCeEEE
Q psy758 3 RYEKIGKLGEGSYGVVFKCRNRDTGQVVAIKKFLESEE----DPLIRKIALREIRLLKSLKHPNLVNLLEVFRRKKKLHL 78 (292)
Q Consensus 3 ~y~~~~~l~~g~~~~v~~~~~~~~~~~v~iK~~~~~~~----~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~i 78 (292)
+|+..+.||+|++|.||.+.+..+++.|++|.+..... .....+.+.+|+..++.++|+||+++++++.+++..++
T Consensus 1 ~~~~~~~lg~g~~~~v~~~~~~~~~~~~alk~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~ 80 (268)
T cd06630 1 EWLKGQQLGTGAFSSCYQARDVKTGTLMAVKQVTYVRNTSSEQEEVVEALRKEIRLMARLNHPHIIRMLGATCEDSHFNL 80 (268)
T ss_pred CccccceecCcCceEEEEEEEcCCCcEEEEEEeecccCCchhHHHHHHHHHHHHHHHHHcCCCceehhhceeccCCeEEE
Confidence 58899999999999999999999999999999865432 12346778899999999999999999999999999999
Q ss_pred EEecCCCccHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEEccCC-cEEEeecCchhhhhcccc-
Q psy758 79 VFEFCDHTVLNELENHPHGLPWDLIKQITWQVLRGVSYCHRHACIHRDIKPENILLTANG-VVKLCDFGFARLIRDLIP- 156 (292)
Q Consensus 79 v~e~~~~~~L~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~givH~dl~p~Nilv~~~~-~~kl~dfg~~~~~~~~~~- 156 (292)
|+||+.+++|.+++...+.+++..++.++.||+.||.+||++|++|+||+|+||+++.++ .++|+|||.+........
T Consensus 81 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~ql~~al~~LH~~~i~H~~i~~~nil~~~~~~~~~l~dfg~~~~~~~~~~~ 160 (268)
T cd06630 81 FVEWMAGGSVSHLLSKYGAFKEAVIINYTEQLLRGLSYLHENQIIHRDVKGANLLIDSTGQRLRIADFGAAARLAAKGTG 160 (268)
T ss_pred EEeccCCCcHHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCCEEEEccccccccccccccc
Confidence 999999999999998777899999999999999999999999999999999999998776 599999999876643211
Q ss_pred --------ccccccccccccccCCCCCCCcccceeeecCCCCCCchHHHHHHHhhcccCCCCCCCh---hhhhhcc--Cc
Q psy758 157 --------RHLHIFQTNEYFKGVSLPHAENVVPLEIKIGKPAATNIYLIDFLKRCLDKDPLRRWSC---DQLLRHP--YF 223 (292)
Q Consensus 157 --------~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~---~~~~~~~--~~ 223 (292)
..+..|.+||...+.......++ ++.+..++..+.+..|...... ....... ..
T Consensus 161 ~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Dv-------------~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~ 227 (268)
T cd06630 161 AGEFQGQLLGTIAFMAPEVLRGEQYGRSCDV-------------WSVGCVIIEMATAKPPWNAEKHSNHLALIFKIASAT 227 (268)
T ss_pred CCccccccccccceeCHhHhccCCCCcccch-------------HHHHHHHHHHHhCCCCCCCCCCcchHHHHHHHhccC
Confidence 11234555655443322222222 2333333344444444322111 1111000 01
Q ss_pred CCCCCCCCCccchHHHHhcccCcCCCCCCChhhhhhCCccc
Q psy758 224 NGYYFEVPDEMQYEEITQRCLDKDPLRRWSCDQLLRHPYFN 264 (292)
Q Consensus 224 ~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~~il~h~w~~ 264 (292)
.....+...+..+.+++.+||..||.+|||+.++++||||.
T Consensus 228 ~~~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~ll~~~~~~ 268 (268)
T cd06630 228 TAPSIPEHLSPGLRDVTLRCLELQPEDRPPSRELLKHPVFR 268 (268)
T ss_pred CCCCCchhhCHHHHHHHHHHcCCCcccCcCHHHHhcCcccC
Confidence 11122333467899999999999999999999999999984
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their |
| >cd07858 STKc_TEY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-38 Score=264.06 Aligned_cols=265 Identities=26% Similarity=0.430 Sum_probs=192.5
Q ss_pred cccceeeeecccCceEEEEEEEcCCCcEEEEEEeccCCCChHHHHHHHHHHHHHHhCCCCCcchhhhhhhcC-----CeE
Q psy758 2 ERYEKIGKLGEGSYGVVFKCRNRDTGQVVAIKKFLESEEDPLIRKIALREIRLLKSLKHPNLVNLLEVFRRK-----KKL 76 (292)
Q Consensus 2 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~-----~~~ 76 (292)
++|.+.+.||.|++|.||+|.+..+++.|++|.+............+.+|+.+++.++|+||+++++++... ...
T Consensus 5 ~~y~~~~~lg~G~~~~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~ni~~~~~~~~~~~~~~~~~~ 84 (337)
T cd07858 5 TKYVPIKPIGRGAYGIVCSAKNSETNEKVAIKKIANAFDNRIDAKRTLREIKLLRHLDHENVIAIKDIMPPPHREAFNDV 84 (337)
T ss_pred cceeEEEEeccCCCeEEEEEEecCCCCeEEEEEecccccccchhHHHHHHHHHHHhcCCCCccchHHheecccccccCcE
Confidence 589999999999999999999999999999999875443333455677899999999999999999988643 358
Q ss_pred EEEEecCCCccHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEEccCCcEEEeecCchhhhhccc-
Q psy758 77 HLVFEFCDHTVLNELENHPHGLPWDLIKQITWQVLRGVSYCHRHACIHRDIKPENILLTANGVVKLCDFGFARLIRDLI- 155 (292)
Q Consensus 77 ~iv~e~~~~~~L~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~givH~dl~p~Nilv~~~~~~kl~dfg~~~~~~~~~- 155 (292)
|+++||+. +.|..++...+.+++..+..++.|++.||.|||++|++|+||+|+||+++.++.++|+|||++.......
T Consensus 85 ~lv~e~~~-~~L~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~i~H~dlkp~Nil~~~~~~~kL~Dfg~~~~~~~~~~ 163 (337)
T cd07858 85 YIVYELMD-TDLHQIIRSSQTLSDDHCQYFLYQLLRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLARTTSEKGD 163 (337)
T ss_pred EEEEeCCC-CCHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEEcCCCCEEECcCccccccCCCcc
Confidence 99999997 4677777777789999999999999999999999999999999999999999999999999987654321
Q ss_pred ----ccccccccccccccc------CCCCCCCcccceeeecCCCCCCchHH---HHHHHhhcccCCCCCCC------hhh
Q psy758 156 ----PRHLHIFQTNEYFKG------VSLPHAENVVPLEIKIGKPAATNIYL---IDFLKRCLDKDPLRRWS------CDQ 216 (292)
Q Consensus 156 ----~~~~~~~~~~~~~~~------~~~~~~~~~~~~~~~~~~~~~~~~~~---~~~~~~~~~~~p~~~~~------~~~ 216 (292)
...+..|.+||...+ ....|+.|+..+++.+|.+++..... ...+..+++..+..... ...
T Consensus 164 ~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 243 (337)
T cd07858 164 FMTEYVVTRWYRAPELLLNCSEYTTAIDVWSVGCIFAELLGRKPLFPGKDYVHQLKLITELLGSPSEEDLGFIRNEKARR 243 (337)
T ss_pred cccccccccCccChHHHhcCCCCCCcccHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHHhCCCChHHhhhcCchhhhH
Confidence 122344667775543 23346666666666667665433221 11222222221111100 000
Q ss_pred hhhc-cCcCC---CCCCCCCccchHHHHhcccCcCCCCCCChhhhhhCCccccee
Q psy758 217 LLRH-PYFNG---YYFEVPDEMQYEEITQRCLDKDPLRRWSCDQLLRHPYFNGYY 267 (292)
Q Consensus 217 ~~~~-~~~~~---~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~~il~h~w~~~~~ 267 (292)
.... +.... .......+..+.++|.+||+.||++|||++++++||||..+.
T Consensus 244 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rps~~ell~h~~~~~~~ 298 (337)
T cd07858 244 YIRSLPYTPRQSFARLFPHANPLAIDLLEKMLVFDPSKRITVEEALAHPYLASLH 298 (337)
T ss_pred HHHhcCcccccCHHHHcccCCHHHHHHHHHHhcCChhhccCHHHHHcCcchhhhc
Confidence 0000 00000 001123567889999999999999999999999999999864
|
Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activati |
| >cd06646 STKc_MAP4K5 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.3e-38 Score=252.09 Aligned_cols=246 Identities=27% Similarity=0.369 Sum_probs=182.0
Q ss_pred cccceeeeecccCceEEEEEEEcCCCcEEEEEEeccCCCChHHHHHHHHHHHHHHhCCCCCcchhhhhhhcCCeEEEEEe
Q psy758 2 ERYEKIGKLGEGSYGVVFKCRNRDTGQVVAIKKFLESEEDPLIRKIALREIRLLKSLKHPNLVNLLEVFRRKKKLHLVFE 81 (292)
Q Consensus 2 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~iv~e 81 (292)
++|++.+.||+|++|.||+|.+..+++.|++|++...... ....+.+|+.+++.++||||+++++++..++..++|+|
T Consensus 9 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~~aik~~~~~~~~--~~~~~~~e~~~l~~~~h~~ii~~~~~~~~~~~~~iv~e 86 (267)
T cd06646 9 HDYELIQRVGSGTYGDVYKARNLHTGELAAVKIIKLEPGD--DFSLIQQEIFMVKECKHCNIVAYFGSYLSREKLWICME 86 (267)
T ss_pred hhcchhheeecCCCeEEEEEEECCCCeEEEEEEEecCccc--hHHHHHHHHHHHHhcCCCCeeeeeEEEEeCCEEEEEEe
Confidence 5799999999999999999999999999999998654332 23457789999999999999999999999999999999
Q ss_pred cCCCccHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEEccCCcEEEeecCchhhhhcccc-----
Q psy758 82 FCDHTVLNELENHPHGLPWDLIKQITWQVLRGVSYCHRHACIHRDIKPENILLTANGVVKLCDFGFARLIRDLIP----- 156 (292)
Q Consensus 82 ~~~~~~L~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~givH~dl~p~Nilv~~~~~~kl~dfg~~~~~~~~~~----- 156 (292)
|+++++|.+++...+.+++..+..++.|++.||.|||++|++|+||+|+||+++.++.++|+|||++........
T Consensus 87 ~~~~~~L~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~nill~~~~~~~l~dfg~~~~~~~~~~~~~~~ 166 (267)
T cd06646 87 YCGGGSLQDIYHVTGPLSELQIAYVCRETLQGLAYLHSKGKMHRDIKGANILLTDNGDVKLADFGVAAKITATIAKRKSF 166 (267)
T ss_pred CCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEECCCCCEEECcCccceeecccccccCcc
Confidence 999999999887777899999999999999999999999999999999999999999999999999876532211
Q ss_pred ccccccccccccccCC---CCCCCcccceeeecCCCCCCchHHHHHHHhhcccCCCCCCChhhhhh---ccCcC--CCCC
Q psy758 157 RHLHIFQTNEYFKGVS---LPHAENVVPLEIKIGKPAATNIYLIDFLKRCLDKDPLRRWSCDQLLR---HPYFN--GYYF 228 (292)
Q Consensus 157 ~~~~~~~~~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~---~~~~~--~~~~ 228 (292)
.....|.+||...+.. .....++ ++.+.-++..+.+..|.......+... ...+. ....
T Consensus 167 ~~~~~y~~PE~~~~~~~~~~~~~~Dv-------------ws~G~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 233 (267)
T cd06646 167 IGTPYWMAPEVAAVEKNGGYNQLCDI-------------WAVGITAIELAELQPPMFDLHPMRALFLMSKSNFQPPKLKD 233 (267)
T ss_pred ccCccccCHhHcccccCCCCcchhhH-------------HHHHHHHHHHHhCCCCccccchhhhheeeecCCCCCCCCcc
Confidence 1223455666542211 1111222 222222333333333322111111100 00000 0111
Q ss_pred CCCCccchHHHHhcccCcCCCCCCChhhhhhCCc
Q psy758 229 EVPDEMQYEEITQRCLDKDPLRRWSCDQLLRHPY 262 (292)
Q Consensus 229 ~~~~~~~l~~li~~~l~~dP~~Rpt~~~il~h~w 262 (292)
....+..+.++|++||+.||++|||++++++|+|
T Consensus 234 ~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~~l~ 267 (267)
T cd06646 234 KTKWSSTFHNFVKISLTKNPKKRPTAERLLTHLF 267 (267)
T ss_pred ccccCHHHHHHHHHHhhCChhhCcCHHHHhcCCC
Confidence 2234678999999999999999999999999998
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated |
| >cd06651 STKc_MEKK3 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.2e-38 Score=252.28 Aligned_cols=249 Identities=24% Similarity=0.349 Sum_probs=183.4
Q ss_pred cccceeeeecccCceEEEEEEEcCCCcEEEEEEeccCCC---ChHHHHHHHHHHHHHHhCCCCCcchhhhhhhc--CCeE
Q psy758 2 ERYEKIGKLGEGSYGVVFKCRNRDTGQVVAIKKFLESEE---DPLIRKIALREIRLLKSLKHPNLVNLLEVFRR--KKKL 76 (292)
Q Consensus 2 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~v~iK~~~~~~~---~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~--~~~~ 76 (292)
..|+..+.||+|++|.||+|.+..++..|++|.+..... .......+.+|+.+++.++||||+++++++.+ ++..
T Consensus 2 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~ 81 (266)
T cd06651 2 INWRRGKLLGQGAFGRVYLCYDVDTGRELAAKQVQFDPESPETSKEVSALECEIQLLKNLQHERIVQYYGCLRDRAEKTL 81 (266)
T ss_pred CCccccceecCCCCEEEEEEEEcCCCcEEEEEEeecCcCCchhHHHHHHHHHHHHHHHHcCCCCeeeEEEEEEcCCCCEE
Confidence 368999999999999999999999999999998865432 22345678889999999999999999998765 4678
Q ss_pred EEEEecCCCccHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEEccCCcEEEeecCchhhhhccc-
Q psy758 77 HLVFEFCDHTVLNELENHPHGLPWDLIKQITWQVLRGVSYCHRHACIHRDIKPENILLTANGVVKLCDFGFARLIRDLI- 155 (292)
Q Consensus 77 ~iv~e~~~~~~L~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~givH~dl~p~Nilv~~~~~~kl~dfg~~~~~~~~~- 155 (292)
++++||+++++|..++.....+++..++.++.|++.||++||++|++|+||+|+||++++++.++|+|||++.......
T Consensus 82 ~l~~e~~~~~~L~~~l~~~~~l~~~~~~~~~~qi~~~l~~LH~~~i~H~~l~p~nil~~~~~~~~l~dfg~~~~~~~~~~ 161 (266)
T cd06651 82 TIFMEYMPGGSVKDQLKAYGALTESVTRKYTRQILEGMSYLHSNMIVHRDIKGANILRDSAGNVKLGDFGASKRLQTICM 161 (266)
T ss_pred EEEEeCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCeeeCCCCHHHEEECCCCCEEEccCCCccccccccc
Confidence 9999999999999998877779999999999999999999999999999999999999999999999999986543211
Q ss_pred -------cccccccccccccccCCCCCCCcccceeeecCCCCCCchHHHHHHHhhcccCCCCCCChhhhhhccCcC--CC
Q psy758 156 -------PRHLHIFQTNEYFKGVSLPHAENVVPLEIKIGKPAATNIYLIDFLKRCLDKDPLRRWSCDQLLRHPYFN--GY 226 (292)
Q Consensus 156 -------~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~--~~ 226 (292)
......|.+||...+.......++|+ .+..+++.+.+..|.......+........ ..
T Consensus 162 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~s-------------lG~i~~el~~g~~pf~~~~~~~~~~~~~~~~~~~ 228 (266)
T cd06651 162 SGTGIRSVTGTPYWMSPEVISGEGYGRKADVWS-------------LGCTVVEMLTEKPPWAEYEAMAAIFKIATQPTNP 228 (266)
T ss_pred cCCccccCCccccccCHHHhCCCCCCchhhhHH-------------HHHHHHHHHHCCCCccccchHHHHHHHhcCCCCC
Confidence 11233456666655443322222222 222233333333443332222211111111 11
Q ss_pred CCCCCCccchHHHHhcccCcCCCCCCChhhhhhCCccc
Q psy758 227 YFEVPDEMQYEEITQRCLDKDPLRRWSCDQLLRHPYFN 264 (292)
Q Consensus 227 ~~~~~~~~~l~~li~~~l~~dP~~Rpt~~~il~h~w~~ 264 (292)
..+...+..++++| +||..||++|||++|+++||||+
T Consensus 229 ~~~~~~~~~~~~li-~~~~~~p~~Rp~~~eil~hp~~~ 265 (266)
T cd06651 229 QLPSHISEHARDFL-GCIFVEARHRPSAEELLRHPFAQ 265 (266)
T ss_pred CCchhcCHHHHHHH-HHhcCChhhCcCHHHHhcCcccc
Confidence 12333466788898 67778999999999999999986
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development |
| >cd07864 STKc_CDK12 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-38 Score=259.03 Aligned_cols=263 Identities=30% Similarity=0.447 Sum_probs=190.8
Q ss_pred CcccceeeeecccCceEEEEEEEcCCCcEEEEEEeccCCCChHHHHHHHHHHHHHHhCCCCCcchhhhhhhcCC------
Q psy758 1 MERYEKIGKLGEGSYGVVFKCRNRDTGQVVAIKKFLESEEDPLIRKIALREIRLLKSLKHPNLVNLLEVFRRKK------ 74 (292)
Q Consensus 1 ~~~y~~~~~l~~g~~~~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~------ 74 (292)
+++|++.+.||+|++|.||+|.+..+++.|++|.+............+.+|+.+++.++|||++++++++.+..
T Consensus 6 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~e~~~~~~l~h~~i~~~~~~~~~~~~~~~~~ 85 (302)
T cd07864 6 VDKFDIIGQIGEGTYGQVYKARDKDTGELVALKKVRLDNEKEGFPITAIREIKILRQLNHRNIVNLKEIVTDKQDALDFK 85 (302)
T ss_pred hhhhheeeeecccCCEEEEEEEECCCCcEEEEEEEeecccccCchHHHHHHHHHHHhCCCCCeeeeeheecCcchhhhcc
Confidence 36899999999999999999999999999999998765433333455678999999999999999999887544
Q ss_pred ----eEEEEEecCCCccHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEEccCCcEEEeecCchhh
Q psy758 75 ----KLHLVFEFCDHTVLNELENHPHGLPWDLIKQITWQVLRGVSYCHRHACIHRDIKPENILLTANGVVKLCDFGFARL 150 (292)
Q Consensus 75 ----~~~iv~e~~~~~~L~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~givH~dl~p~Nilv~~~~~~kl~dfg~~~~ 150 (292)
.+++++||++++.+..+......+++..++.++.||+.||+|||+.|++|+||+|+||++++++.++|+|||.+..
T Consensus 86 ~~~~~~~lv~e~~~~~l~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~i~H~dl~p~nili~~~~~~kl~dfg~~~~ 165 (302)
T cd07864 86 KDKGAFYLVFEYMDHDLMGLLESGLVHFSEDHIKSFMKQLLEGLNYCHKKNFLHRDIKCSNILLNNKGQIKLADFGLARL 165 (302)
T ss_pred ccCCcEEEEEcccCccHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEECCCCcEEeCccccccc
Confidence 7999999999865555554445799999999999999999999999999999999999999999999999999876
Q ss_pred hhcccc------ccccccccccccccC------CCCCCCcccceeeecCCCCCCchHHHH----HHHhhcccCCCCCCCh
Q psy758 151 IRDLIP------RHLHIFQTNEYFKGV------SLPHAENVVPLEIKIGKPAATNIYLID----FLKRCLDKDPLRRWSC 214 (292)
Q Consensus 151 ~~~~~~------~~~~~~~~~~~~~~~------~~~~~~~~~~~~~~~~~~~~~~~~~~~----~~~~~~~~~p~~~~~~ 214 (292)
...... .....|.+||...+. ...|+.|+..+++.+|.+++....... +...+....+..++..
T Consensus 166 ~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~~~el~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 245 (302)
T cd07864 166 YNSEESRPYTNKVITLWYRPPELLLGEERYGPAIDVWSCGCILGELFTKKPIFQANQELAQLELISRLCGSPCPAVWPDV 245 (302)
T ss_pred ccCCcccccccceeccCccChHHhcCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChhhcccc
Confidence 543221 113346777765432 234555666666666766554322222 2222222233222222
Q ss_pred hhhhhccCcCC--------CCCCCCCccchHHHHhcccCcCCCCCCChhhhhhCCcc
Q psy758 215 DQLLRHPYFNG--------YYFEVPDEMQYEEITQRCLDKDPLRRWSCDQLLRHPYF 263 (292)
Q Consensus 215 ~~~~~~~~~~~--------~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~~il~h~w~ 263 (292)
.+......... .......+..+.++|.+||+.||.+|||+.++++||||
T Consensus 246 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~~~~~ 302 (302)
T cd07864 246 IKLPYFNTMKPKKQYRRRLREEFSFIPTPALDLLDHMLTLDPSKRCTAEEALNSPWL 302 (302)
T ss_pred cccccccccccccccccchhhhcCCCCHHHHHHHHHHccCChhhCCCHHHHhcCCCC
Confidence 22111000000 00111247789999999999999999999999999997
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely |
| >cd06613 STKc_MAP4K3_like Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-37 Score=249.93 Aligned_cols=241 Identities=31% Similarity=0.445 Sum_probs=185.7
Q ss_pred cccceeeeecccCceEEEEEEEcCCCcEEEEEEeccCCCChHHHHHHHHHHHHHHhCCCCCcchhhhhhhcCCeEEEEEe
Q psy758 2 ERYEKIGKLGEGSYGVVFKCRNRDTGQVVAIKKFLESEEDPLIRKIALREIRLLKSLKHPNLVNLLEVFRRKKKLHLVFE 81 (292)
Q Consensus 2 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~iv~e 81 (292)
++|++.+.||+|++|.||+|.+..+++.+++|.+...... ..+.+.+|+.+++.++||||+++++++.+++.+|++||
T Consensus 3 ~~~~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~--~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~l~~e 80 (262)
T cd06613 3 EDYELIQRIGSGTYGDVYKARDIATGELVAIKVIKLEPGD--DFEIIQQEISMLKECRHPNIVAYFGSYLRRDKLWIVME 80 (262)
T ss_pred cceEEEEEecCCCceEEEEeEecCCCCEEEEEEEEcCchh--hHHHHHHHHHHHHhCCCCChhceEEEEEeCCEEEEEEe
Confidence 6899999999999999999999999999999999765433 45778899999999999999999999999999999999
Q ss_pred cCCCccHHHHhcCC-CCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEEccCCcEEEeecCchhhhhcccc----
Q psy758 82 FCDHTVLNELENHP-HGLPWDLIKQITWQVLRGVSYCHRHACIHRDIKPENILLTANGVVKLCDFGFARLIRDLIP---- 156 (292)
Q Consensus 82 ~~~~~~L~~~~~~~-~~~~~~~~~~i~~qi~~aL~~LH~~givH~dl~p~Nilv~~~~~~kl~dfg~~~~~~~~~~---- 156 (292)
|+++++|..++... ..+++..++.++.|++.||.|||++|++|+||+|+||+++.++.++|+|||++........
T Consensus 81 ~~~~~~l~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lh~~~i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~~~~~~~~ 160 (262)
T cd06613 81 YCGGGSLQDIYQVTRGPLSELQIAYVCRETLKGLAYLHETGKIHRDIKGANILLTEDGDVKLADFGVSAQLTATIAKRKS 160 (262)
T ss_pred CCCCCcHHHHHHhhccCCCHHHHHHHHHHHHHHHHHHHhCCceecCCChhhEEECCCCCEEECccccchhhhhhhhcccc
Confidence 99999999988765 6799999999999999999999999999999999999999999999999999876543221
Q ss_pred -ccccccccccccccC---CC-----CCCCcccceeeecCCCCCCchHHHHHHHhhcccCCCCCCChhhhhhccCcC---
Q psy758 157 -RHLHIFQTNEYFKGV---SL-----PHAENVVPLEIKIGKPAATNIYLIDFLKRCLDKDPLRRWSCDQLLRHPYFN--- 224 (292)
Q Consensus 157 -~~~~~~~~~~~~~~~---~~-----~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~--- 224 (292)
.....|.+||...+. .. .|+.|+..+++.+|..++ ...+..+........
T Consensus 161 ~~~~~~y~~Pe~~~~~~~~~~~~~~Di~slG~~l~~~~tg~~p~------------------~~~~~~~~~~~~~~~~~~ 222 (262)
T cd06613 161 FIGTPYWMAPEVAAVERKGGYDGKCDIWALGITAIELAELQPPM------------------FDLHPMRALFLISKSNFP 222 (262)
T ss_pred ccCCccccCchhhcccccCCcCchhhhHHHHHHHHHHHhCCCCC------------------CCCCHHHHHHHHHhccCC
Confidence 223346677765544 22 233333344444444432 221111110000000
Q ss_pred --CCCCCCCCccchHHHHhcccCcCCCCCCChhhhhhCCc
Q psy758 225 --GYYFEVPDEMQYEEITQRCLDKDPLRRWSCDQLLRHPY 262 (292)
Q Consensus 225 --~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~~il~h~w 262 (292)
........+..+.++|.+||..||.+|||+.+++.|+|
T Consensus 223 ~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~~~~ 262 (262)
T cd06613 223 PPKLKDKEKWSPVFHDFIKKCLTKDPKKRPTATKLLQHPF 262 (262)
T ss_pred CccccchhhhhHHHHHHHHHHcCCChhhCCCHHHHhcCCC
Confidence 00112233567899999999999999999999999998
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activ |
| >cd06629 STKc_MAPKKK_Bck1_like Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.5e-38 Score=253.32 Aligned_cols=243 Identities=23% Similarity=0.333 Sum_probs=182.6
Q ss_pred ccceeeeecccCceEEEEEEEcCCCcEEEEEEeccCCC--------ChHHHHHHHHHHHHHHhCCCCCcchhhhhhhcCC
Q psy758 3 RYEKIGKLGEGSYGVVFKCRNRDTGQVVAIKKFLESEE--------DPLIRKIALREIRLLKSLKHPNLVNLLEVFRRKK 74 (292)
Q Consensus 3 ~y~~~~~l~~g~~~~v~~~~~~~~~~~v~iK~~~~~~~--------~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~ 74 (292)
+|.+.+.||+|++|.||+|.+..+++.|++|.+..... .....+.+.+|+.+++.++|||++++++++...+
T Consensus 2 ~~~~~~~lg~g~~~~vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~ 81 (272)
T cd06629 2 KWVKGELIGKGTYGRVYLALNVTTGEMMAVKQVELPATIAGRHDSRQKDMVKALRSEIETLKDLDHLNIVQYLGFETTEE 81 (272)
T ss_pred ceeecceecccCceEEEEEeecCCCceeeeeeeechhhhhcccchHHHHHHHHHHHHHHHHHhcCCCCcceEEEEeccCC
Confidence 68899999999999999999998999999998854321 1123456788999999999999999999999999
Q ss_pred eEEEEEecCCCccHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEEccCCcEEEeecCchhhhhcc
Q psy758 75 KLHLVFEFCDHTVLNELENHPHGLPWDLIKQITWQVLRGVSYCHRHACIHRDIKPENILLTANGVVKLCDFGFARLIRDL 154 (292)
Q Consensus 75 ~~~iv~e~~~~~~L~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~givH~dl~p~Nilv~~~~~~kl~dfg~~~~~~~~ 154 (292)
..++|+||+++++|.+++...+.+++..+..++.||+.||.+||++|++|+||+|+||+++.++.++|+|||++......
T Consensus 82 ~~~lv~e~~~~~~L~~~l~~~~~l~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~~~nil~~~~~~~~l~d~~~~~~~~~~ 161 (272)
T cd06629 82 YLSIFLEYVPGGSIGSCLRTYGRFEEQLVRFFTEQVLEGLAYLHSKGILHRDLKADNLLVDADGICKISDFGISKKSDDI 161 (272)
T ss_pred ceEEEEecCCCCcHHHHHhhccCCCHHHHHHHHHHHHHHHHHHhhCCeeecCCChhhEEEcCCCeEEEeecccccccccc
Confidence 99999999999999999988778999999999999999999999999999999999999999999999999998754321
Q ss_pred c-------cccccccccccccccCC-------CCCCCcccceeeecCCCCCCchHHHHHHHhhcccCCCCCCChhhhhhc
Q psy758 155 I-------PRHLHIFQTNEYFKGVS-------LPHAENVVPLEIKIGKPAATNIYLIDFLKRCLDKDPLRRWSCDQLLRH 220 (292)
Q Consensus 155 ~-------~~~~~~~~~~~~~~~~~-------~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~ 220 (292)
. ......|.+||...+.. ..|+.++..+++.+|..+ .......+.+..
T Consensus 162 ~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~~Dv~slG~~l~~l~~g~~p------------------~~~~~~~~~~~~ 223 (272)
T cd06629 162 YDNDQNMSMQGSVFWMAPEVIHSYSQGYSAKVDIWSLGCVVLEMFAGRRP------------------WSDEEAIAAMFK 223 (272)
T ss_pred ccccccccccCCccccCHHHhccccCCCCccchhHHHHHHHHHHHhCCCC------------------CcCcchHHHHHH
Confidence 1 11223455665543322 223333333444444433 222111111100
Q ss_pred cCcC--CC----CCCCCCccchHHHHhcccCcCCCCCCChhhhhhCCcc
Q psy758 221 PYFN--GY----YFEVPDEMQYEEITQRCLDKDPLRRWSCDQLLRHPYF 263 (292)
Q Consensus 221 ~~~~--~~----~~~~~~~~~l~~li~~~l~~dP~~Rpt~~~il~h~w~ 263 (292)
.... .. ......+..+.++|.+||.+||.+|||++++++||||
T Consensus 224 ~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~~~~ 272 (272)
T cd06629 224 LGNKRSAPPIPPDVSMNLSPVALDFLNACFTINPDNRPTARELLQHPFI 272 (272)
T ss_pred hhccccCCcCCccccccCCHHHHHHHHHHhcCChhhCCCHHHHhhCCCC
Confidence 0000 00 1112346789999999999999999999999999997
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell inte |
| >cd06655 STKc_PAK2 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-37 Score=254.80 Aligned_cols=248 Identities=26% Similarity=0.378 Sum_probs=187.4
Q ss_pred cccceeeeecccCceEEEEEEEcCCCcEEEEEEeccCCCChHHHHHHHHHHHHHHhCCCCCcchhhhhhhcCCeEEEEEe
Q psy758 2 ERYEKIGKLGEGSYGVVFKCRNRDTGQVVAIKKFLESEEDPLIRKIALREIRLLKSLKHPNLVNLLEVFRRKKKLHLVFE 81 (292)
Q Consensus 2 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~iv~e 81 (292)
.+|++.+.||.|++|.||++.+..+++.|++|.+...... ..+.+.+|+.+++.++|||++++++++..++..++|+|
T Consensus 19 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~iK~~~~~~~~--~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 96 (296)
T cd06655 19 KKYTRYEKIGQGASGTVFTAIDVATGQEVAIKQINLQKQP--KKELIINEILVMKELKNPNIVNFLDSFLVGDELFVVME 96 (296)
T ss_pred ceEEEEEEEecCCCeEEEEEEEcCCCcEEEEEEEecccCc--hHHHHHHHHHHHHhcCCCceeeeeeeEecCceEEEEEE
Confidence 4699999999999999999999999999999998655433 24567889999999999999999999999999999999
Q ss_pred cCCCccHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEEccCCcEEEeecCchhhhhcccc-----
Q psy758 82 FCDHTVLNELENHPHGLPWDLIKQITWQVLRGVSYCHRHACIHRDIKPENILLTANGVVKLCDFGFARLIRDLIP----- 156 (292)
Q Consensus 82 ~~~~~~L~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~givH~dl~p~Nilv~~~~~~kl~dfg~~~~~~~~~~----- 156 (292)
|+++++|..++... .+++.++..++.|++.||.+||++|++|+||+|+||+++.++.++|+|||++........
T Consensus 97 ~~~~~~L~~~~~~~-~l~~~~~~~i~~~l~~al~~LH~~~i~H~dL~p~Nili~~~~~~kl~dfg~~~~~~~~~~~~~~~ 175 (296)
T cd06655 97 YLAGGSLTDVVTET-CMDEAQIAAVCRECLQALEFLHANQVIHRDIKSDNVLLGMDGSVKLTDFGFCAQITPEQSKRSTM 175 (296)
T ss_pred ecCCCcHHHHHHhc-CCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCCEEEccCccchhcccccccCCCc
Confidence 99999999988754 689999999999999999999999999999999999999999999999998876543221
Q ss_pred ccccccccccccccCCCCCCCcccceeeecCCCCCCchHHHHHHHhhcccCCCCCCChhhhhhc---cCcCCCCCCCCCc
Q psy758 157 RHLHIFQTNEYFKGVSLPHAENVVPLEIKIGKPAATNIYLIDFLKRCLDKDPLRRWSCDQLLRH---PYFNGYYFEVPDE 233 (292)
Q Consensus 157 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~---~~~~~~~~~~~~~ 233 (292)
.....|.+||...+.......++|+ .+.-++..+.+..|+......+.... ........+...+
T Consensus 176 ~~~~~y~aPE~~~~~~~~~~~Dv~s-------------lGvil~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 242 (296)
T cd06655 176 VGTPYWMAPEVVTRKAYGPKVDIWS-------------LGIMAIEMVEGEPPYLNENPLRALYLIATNGTPELQNPEKLS 242 (296)
T ss_pred CCCccccCcchhcCCCCCchhhHHH-------------HHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCcccCCcccCC
Confidence 1223456666554433322222222 22223333333344333222111100 0011112233456
Q ss_pred cchHHHHhcccCcCCCCCCChhhhhhCCcccc
Q psy758 234 MQYEEITQRCLDKDPLRRWSCDQLLRHPYFNG 265 (292)
Q Consensus 234 ~~l~~li~~~l~~dP~~Rpt~~~il~h~w~~~ 265 (292)
..+.++|.+||..||.+|||+.+++.||||..
T Consensus 243 ~~~~~li~~~l~~dp~~Rpt~~~il~~~~~~~ 274 (296)
T cd06655 243 PIFRDFLNRCLEMDVEKRGSAKELLQHPFLKL 274 (296)
T ss_pred HHHHHHHHHHhhcChhhCCCHHHHhhChHhhh
Confidence 78999999999999999999999999999986
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >cd05632 STKc_GRK5 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.6e-38 Score=254.81 Aligned_cols=254 Identities=23% Similarity=0.311 Sum_probs=187.0
Q ss_pred ccceeeeecccCceEEEEEEEcCCCcEEEEEEeccCCCC-hHHHHHHHHHHHHHHhCCCCCcchhhhhhhcCCeEEEEEe
Q psy758 3 RYEKIGKLGEGSYGVVFKCRNRDTGQVVAIKKFLESEED-PLIRKIALREIRLLKSLKHPNLVNLLEVFRRKKKLHLVFE 81 (292)
Q Consensus 3 ~y~~~~~l~~g~~~~v~~~~~~~~~~~v~iK~~~~~~~~-~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~iv~e 81 (292)
.|+..+.||+|+||.||.|.+..+++.||+|.+...... ......+.+|+.+++.++|++++++++.+.+++..++++|
T Consensus 1 ~~~~~~~lg~G~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv~e 80 (285)
T cd05632 1 TFRQYRVLGKGGFGEVCACQVRATGKMYACKRLEKKRIKKRKGESMALNEKQILEKVNSQFVVNLAYAYETKDALCLVLT 80 (285)
T ss_pred CceEEEEEecCCCeEEEEEEECCCCcEEEEEEeehhhhhhhhHHHHHHHHHHHHHHcCCcCceeEEEEEecCCEEEEEEE
Confidence 488899999999999999999999999999998655432 2234556789999999999999999999999999999999
Q ss_pred cCCCccHHHHhcC--CCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEEccCCcEEEeecCchhhhhccc----
Q psy758 82 FCDHTVLNELENH--PHGLPWDLIKQITWQVLRGVSYCHRHACIHRDIKPENILLTANGVVKLCDFGFARLIRDLI---- 155 (292)
Q Consensus 82 ~~~~~~L~~~~~~--~~~~~~~~~~~i~~qi~~aL~~LH~~givH~dl~p~Nilv~~~~~~kl~dfg~~~~~~~~~---- 155 (292)
|+.+++|..++.. ...+++..+..++.|++.||.|||++||+|+||+|+||++++++.++|+|||++.......
T Consensus 81 ~~~~~~L~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~lH~~~iiH~dikp~Nili~~~~~~kl~Dfg~~~~~~~~~~~~~ 160 (285)
T cd05632 81 IMNGGDLKFHIYNMGNPGFEEERALFYAAEILCGLEDLHRENTVYRDLKPENILLDDYGHIRISDLGLAVKIPEGESIRG 160 (285)
T ss_pred eccCccHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCHHHEEECCCCCEEEecCCcceecCCCCcccC
Confidence 9999999887743 2369999999999999999999999999999999999999999999999999886543211
Q ss_pred cccccccccccccccCCCCCCCcccceeeecCCCCCCchHHHHHHHhhcccCCCCCCChh----hhhhccCcCCCCCCCC
Q psy758 156 PRHLHIFQTNEYFKGVSLPHAENVVPLEIKIGKPAATNIYLIDFLKRCLDKDPLRRWSCD----QLLRHPYFNGYYFEVP 231 (292)
Q Consensus 156 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~----~~~~~~~~~~~~~~~~ 231 (292)
...+..|.+||...+.......++|++ +..++..+.+..|+...... .+.....-.....+..
T Consensus 161 ~~g~~~~~aPE~~~~~~~~~~~Di~sl-------------G~~l~~l~~g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~ 227 (285)
T cd05632 161 RVGTVGYMAPEVLNNQRYTLSPDYWGL-------------GCLIYEMIEGQSPFRGRKEKVKREEVDRRVLETEEVYSAK 227 (285)
T ss_pred CCCCcCccChHHhcCCCCCcccchHHH-------------HHHHHHHHhCCCCCCCCCHHHHHHHHHHhhhccccccCcc
Confidence 122344666666544333222222222 22223333333333221111 1110000001112233
Q ss_pred CccchHHHHhcccCcCCCCCCC-----hhhhhhCCcccceecc
Q psy758 232 DEMQYEEITQRCLDKDPLRRWS-----CDQLLRHPYFNGYYFE 269 (292)
Q Consensus 232 ~~~~l~~li~~~l~~dP~~Rpt-----~~~il~h~w~~~~~~~ 269 (292)
.+..+.+|+.+||+.||.+||| ++++++|+||.+..++
T Consensus 228 ~~~~~~~li~~~l~~~P~~R~~~~~~~~~~l~~~~~~~~~~~~ 270 (285)
T cd05632 228 FSEEAKSICKMLLTKDPKQRLGCQEEGAGEVKRHPFFRNMNFK 270 (285)
T ss_pred CCHHHHHHHHHHccCCHhHcCCCcccChHHHHcChhhhcCCHH
Confidence 4678899999999999999999 8899999999997665
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with |
| >KOG2345|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.4e-38 Score=233.23 Aligned_cols=247 Identities=23% Similarity=0.251 Sum_probs=188.7
Q ss_pred cccceeeeecccCceEEEEEEEcCCCcEEEEEEeccCCCChHHHHHHHHHHHHHHhCCCCCcchhhhhhhcC-----CeE
Q psy758 2 ERYEKIGKLGEGSYGVVFKCRNRDTGQVVAIKKFLESEEDPLIRKIALREIRLLKSLKHPNLVNLLEVFRRK-----KKL 76 (292)
Q Consensus 2 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~-----~~~ 76 (292)
+||++++.||.|||+-||+++...+++.||+|.+.... .+..+..++|++..+.++|||+++++++...+ ...
T Consensus 21 ~Ryri~~~LgeGGfsfv~LV~~~s~~~~YAlKkI~c~~--~~~~e~~~rEid~~rkf~s~~vl~l~dh~l~~~~D~~~~~ 98 (302)
T KOG2345|consen 21 KRYRIQRLLGEGGFSFVDLVKGLSTGHLYALKKILCHS--QEDIEEALREIDNHRKFNSPNVLRLVDHQLREEKDGKHEA 98 (302)
T ss_pred ceEEEeeeecCCCceeeeeecccCcccchhhheeeccc--hHHHHHHHHHHHHHHhhCCcchHHHHHHHHHhhccCceeE
Confidence 58999999999999999999999999999999997766 34567788999999999999999999987543 349
Q ss_pred EEEEecCCCccHHHHhcC----CCCCCHHHHHHHHHHHHHHHHHHHhCC--ccccCCCCCceEEccCCcEEEeecCchhh
Q psy758 77 HLVFEFCDHTVLNELENH----PHGLPWDLIKQITWQVLRGVSYCHRHA--CIHRDIKPENILLTANGVVKLCDFGFARL 150 (292)
Q Consensus 77 ~iv~e~~~~~~L~~~~~~----~~~~~~~~~~~i~~qi~~aL~~LH~~g--ivH~dl~p~Nilv~~~~~~kl~dfg~~~~ 150 (292)
|++++|+..|+|.+.+.. +..+++.++..++.+|++||++||+.. ++|+||||.||++++.+.++|.|||+++.
T Consensus 99 yll~Pyy~~Gsl~d~i~~~k~kg~~~sE~~iL~if~gic~gL~~lH~~~~~yAH~DiKP~NILls~~~~~vl~D~GS~~~ 178 (302)
T KOG2345|consen 99 YLLLPYYKRGSLLDEIERLKIKGNFVSEAQILWIFLGICRGLEALHEKEPPYAHRDIKPANILLSDSGLPVLMDLGSATQ 178 (302)
T ss_pred EEEeehhccccHHHHHHHHhhcCCccCHHHHHHHHHHHHHHHHHHhccCCcccccCCCcceeEecCCCceEEEeccCccc
Confidence 999999999988887643 336899999999999999999999998 99999999999999999999999999876
Q ss_pred hhc--------------cccccccccccccccccCCCCCCCcccceeeecCCCCCCchHHHHHHHhhcccCCCCCCChh-
Q psy758 151 IRD--------------LIPRHLHIFQTNEYFKGVSLPHAENVVPLEIKIGKPAATNIYLIDFLKRCLDKDPLRRWSCD- 215 (292)
Q Consensus 151 ~~~--------------~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~- 215 (292)
..- .....+..|.+||.+.-.. ...+....++++.++.++..|+...|+++.-..
T Consensus 179 a~i~i~~~~~a~~lQe~a~e~Ct~pyRAPELf~vk~----------~~ti~ertDIWSLGCtLYa~mf~~sPfe~~~~~G 248 (302)
T KOG2345|consen 179 APIQIEGSRQALRLQEWAEERCTIPYRAPELFNVKS----------HCTITERTDIWSLGCTLYAMMFGESPFERIYQQG 248 (302)
T ss_pred cceEeechHHHHHHHHHHHHhCCCcccCchheeccc----------CcccccccchhhhhHHHHHHHHcCCcchHHhhcC
Confidence 531 2234456677777653211 112222333344455566666777776653110
Q ss_pred hhhhccCc-CCC--CCCCCCccchHHHHhcccCcCCCCCCChhhhhhC
Q psy758 216 QLLRHPYF-NGY--YFEVPDEMQYEEITQRCLDKDPLRRWSCDQLLRH 260 (292)
Q Consensus 216 ~~~~~~~~-~~~--~~~~~~~~~l~~li~~~l~~dP~~Rpt~~~il~h 260 (292)
.-+.-... .++ +...+.++.+.++|+.||++||.+||++.+++++
T Consensus 249 gSlaLAv~n~q~s~P~~~~yse~l~~lik~mlqvdP~qRP~i~~ll~~ 296 (302)
T KOG2345|consen 249 GSLALAVQNAQISIPNSSRYSEALHQLIKSMLQVDPNQRPTIPELLSK 296 (302)
T ss_pred CeEEEeeeccccccCCCCCccHHHHHHHHHHhcCCcccCCCHHHHHHH
Confidence 00000000 112 2223468889999999999999999999999874
|
|
| >PLN00009 cyclin-dependent kinase A; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-38 Score=257.55 Aligned_cols=266 Identities=32% Similarity=0.490 Sum_probs=191.2
Q ss_pred CcccceeeeecccCceEEEEEEEcCCCcEEEEEEeccCCCChHHHHHHHHHHHHHHhCCCCCcchhhhhhhcCCeEEEEE
Q psy758 1 MERYEKIGKLGEGSYGVVFKCRNRDTGQVVAIKKFLESEEDPLIRKIALREIRLLKSLKHPNLVNLLEVFRRKKKLHLVF 80 (292)
Q Consensus 1 ~~~y~~~~~l~~g~~~~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~iv~ 80 (292)
+++|++.+.||+|++|.||+|.+..+++.|++|.+..........+.+.+|+.+++.++||||+++++++.+++..++|+
T Consensus 1 ~~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 80 (294)
T PLN00009 1 MDQYEKVEKIGEGTYGVVYKARDRVTNETIALKKIRLEQEDEGVPSTAIREISLLKEMQHGNIVRLQDVVHSEKRLYLVF 80 (294)
T ss_pred CCceEEEEEecCCCCEEEEEEEecCCCcEEEEEehhhccccccchHHHHHHHHHHHhccCCCEeeEEEEEecCCeEEEEE
Confidence 68999999999999999999999999999999998765544444566788999999999999999999999999999999
Q ss_pred ecCCCccHHHHhcCCC--CCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEEcc-CCcEEEeecCchhhhhccc--
Q psy758 81 EFCDHTVLNELENHPH--GLPWDLIKQITWQVLRGVSYCHRHACIHRDIKPENILLTA-NGVVKLCDFGFARLIRDLI-- 155 (292)
Q Consensus 81 e~~~~~~L~~~~~~~~--~~~~~~~~~i~~qi~~aL~~LH~~givH~dl~p~Nilv~~-~~~~kl~dfg~~~~~~~~~-- 155 (292)
||++++ +...+.... .+++..++.++.||+.||+|||++|++|+||+|+||+++. ++.++|+|||++.......
T Consensus 81 e~~~~~-l~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~i~H~dl~p~nill~~~~~~~kl~dfg~~~~~~~~~~~ 159 (294)
T PLN00009 81 EYLDLD-LKKHMDSSPDFAKNPRLIKTYLYQILRGIAYCHSHRVLHRDLKPQNLLIDRRTNALKLADFGLARAFGIPVRT 159 (294)
T ss_pred eccccc-HHHHHHhCCCCCcCHHHHHHHHHHHHHHHHHHHhCCeeCCCCCcceEEEECCCCEEEEcccccccccCCCccc
Confidence 999865 444443322 3588899999999999999999999999999999999985 4579999999987543221
Q ss_pred ---cccccccccccccccC------CCCCCCcccceeeecCCCCCCchHHHHHHHhhc---ccCCCCCCCh----hhhh-
Q psy758 156 ---PRHLHIFQTNEYFKGV------SLPHAENVVPLEIKIGKPAATNIYLIDFLKRCL---DKDPLRRWSC----DQLL- 218 (292)
Q Consensus 156 ---~~~~~~~~~~~~~~~~------~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~---~~~p~~~~~~----~~~~- 218 (292)
......|.+||+..+. ...|+.|+..+++.+|.+++......+.+...+ ...+...+.. .+..
T Consensus 160 ~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~i~~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 239 (294)
T PLN00009 160 FTHEVVTLWYRAPEILLGSRHYSTPVDIWSVGCIFAEMVNQKPLFPGDSEIDELFKIFRILGTPNEETWPGVTSLPDYKS 239 (294)
T ss_pred cccCceeecccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChhhccccccchhhhh
Confidence 1123456777765442 224666666667777766654332222222211 1111111100 0000
Q ss_pred hccCcCCC---CCCCCCccchHHHHhcccCcCCCCCCChhhhhhCCccccee
Q psy758 219 RHPYFNGY---YFEVPDEMQYEEITQRCLDKDPLRRWSCDQLLRHPYFNGYY 267 (292)
Q Consensus 219 ~~~~~~~~---~~~~~~~~~l~~li~~~l~~dP~~Rpt~~~il~h~w~~~~~ 267 (292)
..+.+... ......+..+.++|.+||+.||++||++.++++||||.++.
T Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rps~~~~l~~~~~~~~~ 291 (294)
T PLN00009 240 AFPKWPPKDLATVVPTLEPAGVDLLSKMLRLDPSKRITARAALEHEYFKDLG 291 (294)
T ss_pred hcccCCCCCHHHhCcCCChHHHHHHHHHccCChhhCcCHHHHhcCchHhHHh
Confidence 00000000 01123467789999999999999999999999999999853
|
|
| >cd08220 STKc_Nek8 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-37 Score=247.61 Aligned_cols=248 Identities=24% Similarity=0.316 Sum_probs=189.2
Q ss_pred ccceeeeecccCceEEEEEEEcCCCcEEEEEEeccCCCChHHHHHHHHHHHHHHhCCCCCcchhhhhhhcCCeEEEEEec
Q psy758 3 RYEKIGKLGEGSYGVVFKCRNRDTGQVVAIKKFLESEEDPLIRKIALREIRLLKSLKHPNLVNLLEVFRRKKKLHLVFEF 82 (292)
Q Consensus 3 ~y~~~~~l~~g~~~~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~iv~e~ 82 (292)
+|++.+.||+|++|.||.|.+..+++.+++|.+............+.+|+.+++.++|||++++++.+..++..++|+||
T Consensus 1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~ 80 (256)
T cd08220 1 KYEKIRVVGRGAFGIVHLCRRKADQKLVIIKQIPVEQMTKDERLAAQNECQVLKLLSHPNIIEYYENFLEDKALMIVMEY 80 (256)
T ss_pred CceEEEEecccCceEEEEEEEcCCCcEEEEEEEeccccccHHHHHHHHHHHHHhhCCCCchhheeeeEecCCEEEEEEec
Confidence 69999999999999999999999999999999987665555677888999999999999999999999999999999999
Q ss_pred CCCccHHHHhcCC--CCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEEccC-CcEEEeecCchhhhhcccc---
Q psy758 83 CDHTVLNELENHP--HGLPWDLIKQITWQVLRGVSYCHRHACIHRDIKPENILLTAN-GVVKLCDFGFARLIRDLIP--- 156 (292)
Q Consensus 83 ~~~~~L~~~~~~~--~~~~~~~~~~i~~qi~~aL~~LH~~givH~dl~p~Nilv~~~-~~~kl~dfg~~~~~~~~~~--- 156 (292)
+++++|.+++... ..+++..++.++.|++.||++||++|++|+||+|+||+++++ +.++|+|||.+........
T Consensus 81 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~~i~h~dl~~~nil~~~~~~~~~l~d~~~~~~~~~~~~~~~ 160 (256)
T cd08220 81 APGGTLAEYIQKRCNSLLDEDTILHFFVQILLALHHVHTKLILHRDLKTQNILLDKHKMVVKIGDFGISKILSSKSKAYT 160 (256)
T ss_pred CCCCCHHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCCEEEEccCCCceecCCCccccc
Confidence 9999999988653 348999999999999999999999999999999999999865 4689999999876643221
Q ss_pred -ccccccccccccccCCCCCCCcccceeeecCCCCCCchHHHHHHHhhcccCCCCCCChhhhhhccCcC-CCCCCCCCcc
Q psy758 157 -RHLHIFQTNEYFKGVSLPHAENVVPLEIKIGKPAATNIYLIDFLKRCLDKDPLRRWSCDQLLRHPYFN-GYYFEVPDEM 234 (292)
Q Consensus 157 -~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~-~~~~~~~~~~ 234 (292)
.....|.+||...+.......+ .++.+.-++..+.+..|....+........... ....+...+.
T Consensus 161 ~~~~~~y~aPE~~~~~~~~~~~D-------------v~slG~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 227 (256)
T cd08220 161 VVGTPCYISPELCEGKPYNQKSD-------------IWALGCVLYELASLKRAFEAANLPALVLKIMSGTFAPISDRYSP 227 (256)
T ss_pred cccCCcccCchhccCCCCCcccc-------------hHHHHHHHHHHHhCCCCcccCchHHHHHHHHhcCCCCCCCCcCH
Confidence 1223455565554332222222 233333344444444444433332222221111 1123334577
Q ss_pred chHHHHhcccCcCCCCCCChhhhhhCCcc
Q psy758 235 QYEEITQRCLDKDPLRRWSCDQLLRHPYF 263 (292)
Q Consensus 235 ~l~~li~~~l~~dP~~Rpt~~~il~h~w~ 263 (292)
.+.+++.+||+.||.+|||+.++++||||
T Consensus 228 ~l~~li~~~l~~~p~~Rpt~~~ll~~p~~ 256 (256)
T cd08220 228 DLRQLILSMLNLDPSKRPQLSQIMAQPIC 256 (256)
T ss_pred HHHHHHHHHccCChhhCCCHHHHhhCCCC
Confidence 89999999999999999999999999997
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with |
| >cd05118 STKc_CMGC Catalytic domain of CMGC family Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-38 Score=257.41 Aligned_cols=260 Identities=38% Similarity=0.606 Sum_probs=190.0
Q ss_pred cceeeeecccCceEEEEEEEcCCCcEEEEEEeccCCCChHHHHHHHHHHHHHHhCCCCCcchhhhhhhcCCeEEEEEecC
Q psy758 4 YEKIGKLGEGSYGVVFKCRNRDTGQVVAIKKFLESEEDPLIRKIALREIRLLKSLKHPNLVNLLEVFRRKKKLHLVFEFC 83 (292)
Q Consensus 4 y~~~~~l~~g~~~~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~iv~e~~ 83 (292)
|++.+.||+|++|.||+|.+..+++.+++|.+............+.+|+.+++.++|++|+++++++.+++..++++||+
T Consensus 1 y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~ 80 (283)
T cd05118 1 YQKLGKIGEGTYGVVYKARDKLTGEIVAIKKIKLRFESEGIPKTALREIKLLKELNHPNIIKLLDVFRHKGDLYLVFEFM 80 (283)
T ss_pred CccceeeecCCCceEEEEEcCCCCcEEEEEEeccccccchhHHHHHHHHHHHHHhcCCCcchHHHhhccCCCEEEEEecc
Confidence 67889999999999999999999999999998766655455677888999999999999999999999999999999999
Q ss_pred CCccHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEEccCCcEEEeecCchhhhhccc-----ccc
Q psy758 84 DHTVLNELENHPHGLPWDLIKQITWQVLRGVSYCHRHACIHRDIKPENILLTANGVVKLCDFGFARLIRDLI-----PRH 158 (292)
Q Consensus 84 ~~~~L~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~givH~dl~p~Nilv~~~~~~kl~dfg~~~~~~~~~-----~~~ 158 (292)
+++....+......+++..++.++.||+.||.+||++|++|+||+|+||+++.++.++|+|||.+....... ...
T Consensus 81 ~~~l~~~l~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~H~dl~p~nili~~~~~~~l~df~~~~~~~~~~~~~~~~~~ 160 (283)
T cd05118 81 DTDLYKLIKDRQRGLPESLIKSYLYQLLQGLAFCHSHGILHRDLKPENLLINTEGVLKLADFGLARSFGSPVRPYTHYVV 160 (283)
T ss_pred CCCHHHHHHhhcccCCHHHHHHHHHHHHHHHHHHHHCCeeecCcCHHHEEECCCCcEEEeeeeeeEecCCCcccccCccC
Confidence 875444444444679999999999999999999999999999999999999999999999999987664432 122
Q ss_pred ccccccccccccC------CCCCCCcccceeeecCCCCCCchHHHHHHHhhc----ccCCCCCCChhhhhhc---cCcCC
Q psy758 159 LHIFQTNEYFKGV------SLPHAENVVPLEIKIGKPAATNIYLIDFLKRCL----DKDPLRRWSCDQLLRH---PYFNG 225 (292)
Q Consensus 159 ~~~~~~~~~~~~~------~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~----~~~p~~~~~~~~~~~~---~~~~~ 225 (292)
...|.+||...+. ...|+.|+..+.+.+|..++......+.+.... ...+.......+.... .+-..
T Consensus 161 ~~~~~~PE~~~~~~~~~~~~Di~slG~~l~~l~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 240 (283)
T cd05118 161 TRWYRAPELLLGDKGYSTPVDIWSVGCIFAELLSRRPLFPGKSEIDQLFKIFRTLGTPDPEVWPKFTSLARNYKFSFPKK 240 (283)
T ss_pred cccccCcHHHhcCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCchHhcccchhhhhhhhhhhccc
Confidence 3346677766544 234555666666666665543332222222211 1111111111110000 00000
Q ss_pred C-----CCCCCCccchHHHHhcccCcCCCCCCChhhhhhCCcc
Q psy758 226 Y-----YFEVPDEMQYEEITQRCLDKDPLRRWSCDQLLRHPYF 263 (292)
Q Consensus 226 ~-----~~~~~~~~~l~~li~~~l~~dP~~Rpt~~~il~h~w~ 263 (292)
. ......+..+.++|.+||++||.+||++.+++.||||
T Consensus 241 ~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~ll~~~~~ 283 (283)
T cd05118 241 AGMPLPKLFPNASPQALDLLSQMLHYDPHKRITAEQALAHPYF 283 (283)
T ss_pred cccCHHHhhhhhCHHHHHHHHHHhccCcccCcCHHHHhhCCCC
Confidence 0 0111246789999999999999999999999999997
|
Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They |
| >cd06623 PKc_MAPKK_plant_like Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-37 Score=250.23 Aligned_cols=251 Identities=29% Similarity=0.496 Sum_probs=191.4
Q ss_pred cccceeeeecccCceEEEEEEEcCCCcEEEEEEeccCCCChHHHHHHHHHHHHHHhCCCCCcchhhhhhhcCCeEEEEEe
Q psy758 2 ERYEKIGKLGEGSYGVVFKCRNRDTGQVVAIKKFLESEEDPLIRKIALREIRLLKSLKHPNLVNLLEVFRRKKKLHLVFE 81 (292)
Q Consensus 2 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~iv~e 81 (292)
++|.+.+.||+|++|.||+|.+..+++.|++|.+...... .....+.+|+..++.++|+|++++++++..++..++++|
T Consensus 1 ~~~~~~~~i~~g~~~~v~~~~~~~~~~~~~vk~~~~~~~~-~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e 79 (264)
T cd06623 1 SDLERVKVLGQGSSGVVYKVRHKPTGKIYALKKIHVDGDE-EFRKQLLRELKTLRSCESPYVVKCYGAFYKEGEISIVLE 79 (264)
T ss_pred CcceeeeeeeecCCeEEEEEEEcCCCcEEEEEEeccCcch-HHHHHHHHHHHHHHhcCCCCeeeEEEEEccCCeEEEEEE
Confidence 4789999999999999999999999999999998765543 456778899999999999999999999999999999999
Q ss_pred cCCCccHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHh-CCccccCCCCCceEEccCCcEEEeecCchhhhhccccc---
Q psy758 82 FCDHTVLNELENHPHGLPWDLIKQITWQVLRGVSYCHR-HACIHRDIKPENILLTANGVVKLCDFGFARLIRDLIPR--- 157 (292)
Q Consensus 82 ~~~~~~L~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~-~givH~dl~p~Nilv~~~~~~kl~dfg~~~~~~~~~~~--- 157 (292)
|+++++|.+++.....+++..++.++.|++.||.+||+ .|++|+||+|+||++++++.++|+|||.+.........
T Consensus 80 ~~~~~~L~~~l~~~~~l~~~~~~~~~~~l~~~l~~lh~~~~~~H~~l~~~ni~~~~~~~~~l~df~~~~~~~~~~~~~~~ 159 (264)
T cd06623 80 YMDGGSLADLLKKVGKIPEPVLAYIARQILKGLDYLHTKRHIIHRDIKPSNLLINSKGEVKIADFGISKVLENTLDQCNT 159 (264)
T ss_pred ecCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHhccCCCccCCCCHHHEEECCCCCEEEccCccceecccCCCcccc
Confidence 99999999999877789999999999999999999999 99999999999999999999999999998765432222
Q ss_pred --cccccccccccccCCCCCCCcccceeeecCCCCCCchHHHHHHHhhcccCCCCCC---ChhhhhhccCcC-CCCCCCC
Q psy758 158 --HLHIFQTNEYFKGVSLPHAENVVPLEIKIGKPAATNIYLIDFLKRCLDKDPLRRW---SCDQLLRHPYFN-GYYFEVP 231 (292)
Q Consensus 158 --~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~---~~~~~~~~~~~~-~~~~~~~ 231 (292)
....|.+||...+.......++ ++.+.-++..+.+..|.... ...+........ ....+..
T Consensus 160 ~~~~~~y~~pE~~~~~~~~~~~Dv-------------~slG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 226 (264)
T cd06623 160 FVGTVTYMSPERIQGESYSYAADI-------------WSLGLTLLECALGKFPFLPPGQPSFFELMQAICDGPPPSLPAE 226 (264)
T ss_pred eeecccccCHhhhCCCCCCchhhH-------------HHHHHHHHHHHhCCCCCccccccCHHHHHHHHhcCCCCCCCcc
Confidence 2233555665544322222222 22222233333333333222 222222211111 1112222
Q ss_pred -CccchHHHHhcccCcCCCCCCChhhhhhCCcccce
Q psy758 232 -DEMQYEEITQRCLDKDPLRRWSCDQLLRHPYFNGY 266 (292)
Q Consensus 232 -~~~~l~~li~~~l~~dP~~Rpt~~~il~h~w~~~~ 266 (292)
.+..+.++|.+||+.+|++|||+.++++||||++.
T Consensus 227 ~~~~~l~~li~~~l~~~p~~R~~~~~ll~~~~~~~~ 262 (264)
T cd06623 227 EFSPEFRDFISACLQKDPKKRPSAAELLQHPFIKKA 262 (264)
T ss_pred cCCHHHHHHHHHHccCChhhCCCHHHHHhCHHHHhc
Confidence 56789999999999999999999999999999864
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of |
| >cd07866 STKc_BUR1 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.4e-38 Score=258.55 Aligned_cols=263 Identities=32% Similarity=0.455 Sum_probs=187.5
Q ss_pred CcccceeeeecccCceEEEEEEEcCCCcEEEEEEeccCCCChHHHHHHHHHHHHHHhCCCCCcchhhhhhhcC-------
Q psy758 1 MERYEKIGKLGEGSYGVVFKCRNRDTGQVVAIKKFLESEEDPLIRKIALREIRLLKSLKHPNLVNLLEVFRRK------- 73 (292)
Q Consensus 1 ~~~y~~~~~l~~g~~~~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~------- 73 (292)
+++|++.+.||+|++|.||+|.+..+++.+++|.+............+.+|+++++.++||||+++++++.+.
T Consensus 7 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~~ 86 (311)
T cd07866 7 LRDYEILGKLGEGTFGEVYKARQIKTGRVVALKKILMHNEKDGFPITALREIKILKKLKHPNVVPLIDMAVERPDKSKRK 86 (311)
T ss_pred cccEEEEEEeccCCCEEEEEEEECCCCcEEEEEEEEeccCCCCcchhHHHHHHHHHhcCCCCccchhhheeccccccccc
Confidence 4789999999999999999999999999999999865543333334566899999999999999999987532
Q ss_pred -CeEEEEEecCCCccHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEEccCCcEEEeecCchhhhh
Q psy758 74 -KKLHLVFEFCDHTVLNELENHPHGLPWDLIKQITWQVLRGVSYCHRHACIHRDIKPENILLTANGVVKLCDFGFARLIR 152 (292)
Q Consensus 74 -~~~~iv~e~~~~~~L~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~givH~dl~p~Nilv~~~~~~kl~dfg~~~~~~ 152 (292)
..+++++||+.+..+..+......+++..++.++.||++||.|||++|++|+||+|+||++++++.++|+|||++....
T Consensus 87 ~~~~~lv~~~~~~~l~~~~~~~~~~~~~~~~~~i~~~l~~al~~lH~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~ 166 (311)
T cd07866 87 RGSVYMVTPYMDHDLSGLLENPSVKLTESQIKCYMLQLLEGINYLHENHILHRDIKAANILIDNQGILKIADFGLARPYD 166 (311)
T ss_pred CceEEEEEecCCcCHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEECCCCCEEECcCccchhcc
Confidence 3579999999876555555555679999999999999999999999999999999999999999999999999987654
Q ss_pred ccccc----------------cccccccccccccC------CCCCCCcccceeeecCCCCCCchHHHHHHHhhc----cc
Q psy758 153 DLIPR----------------HLHIFQTNEYFKGV------SLPHAENVVPLEIKIGKPAATNIYLIDFLKRCL----DK 206 (292)
Q Consensus 153 ~~~~~----------------~~~~~~~~~~~~~~------~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~----~~ 206 (292)
..... ....|.+||...+. ...|+.|+..+++.+|.+++............. ..
T Consensus 167 ~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~~g~~~~~~~~~~~~~~~~~~~~~~~ 246 (311)
T cd07866 167 GPPPNPKGGGGGGTRKYTNLVVTRWYRPPELLLGERRYTTAVDIWGIGCVFAEMFTRRPILQGKSDIDQLHLIFKLCGTP 246 (311)
T ss_pred CCCcccccCCcccccccccceeccCcCChHHhhCCCccCchhHhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCC
Confidence 32211 12236777765432 334666666677777776654333222222211 11
Q ss_pred CCCCCCChhhhhhc---cCcCCCC-----CCCCCccchHHHHhcccCcCCCCCCChhhhhhCCcc
Q psy758 207 DPLRRWSCDQLLRH---PYFNGYY-----FEVPDEMQYEEITQRCLDKDPLRRWSCDQLLRHPYF 263 (292)
Q Consensus 207 ~p~~~~~~~~~~~~---~~~~~~~-----~~~~~~~~l~~li~~~l~~dP~~Rpt~~~il~h~w~ 263 (292)
.+...+....+... ....... .-......+.++|.+||..||.+|||+.++++||||
T Consensus 247 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~t~~ell~~~~f 311 (311)
T cd07866 247 TEETWPGWRSLPGCEGVHSFTNYPRTLEERFGKLGPEGLDLLSKLLSLDPYKRLTASDALEHPYF 311 (311)
T ss_pred ChhhchhhhhcccccccccCCCCCccHHHHcccCChhHHHHHHHHcccCcccCcCHHHHhcCCCC
Confidence 11111110000000 0000000 001224678899999999999999999999999998
|
Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic |
| >cd05102 PTKc_VEGFR3 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.3e-38 Score=260.40 Aligned_cols=244 Identities=25% Similarity=0.358 Sum_probs=175.2
Q ss_pred cccceeeeecccCceEEEEEEE-----cCCCcEEEEEEeccCCCChHHHHHHHHHHHHHHhC-CCCCcchhhhhhhc-CC
Q psy758 2 ERYEKIGKLGEGSYGVVFKCRN-----RDTGQVVAIKKFLESEEDPLIRKIALREIRLLKSL-KHPNLVNLLEVFRR-KK 74 (292)
Q Consensus 2 ~~y~~~~~l~~g~~~~v~~~~~-----~~~~~~v~iK~~~~~~~~~~~~~~~~~e~~~~~~l-~~~~i~~~~~~~~~-~~ 74 (292)
++|++.+.||+|+||.||+|.+ ..++..||+|++.... .......+.+|+.+++.+ +||||+++++++.. ++
T Consensus 7 ~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~~ 85 (338)
T cd05102 7 DRLRLGKVLGHGAFGKVVEASAFGIDKKSSCNTVAVKMLKEGA-TASEHKALMSELKILIHIGNHLNVVNLLGACTKPNG 85 (338)
T ss_pred hHceeeeEeccCCcceEEEEEEeccCCcccchhhheecccccc-chHHHHHHHHHHHHHHHhccCcceeeEEeEecCCCC
Confidence 5899999999999999999975 2345689999986443 333456788999999999 89999999998775 45
Q ss_pred eEEEEEecCCCccHHHHhcCC-----------------------------------------------------------
Q psy758 75 KLHLVFEFCDHTVLNELENHP----------------------------------------------------------- 95 (292)
Q Consensus 75 ~~~iv~e~~~~~~L~~~~~~~----------------------------------------------------------- 95 (292)
.++++|||+++|+|.+++...
T Consensus 86 ~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 165 (338)
T cd05102 86 PLMVIVEFCKYGNLSNFLRAKREFFSPYREKSPKQRGRFRAMVEQSRVDRRIEAGQASVLFSRFQPSTSGSTNPPQETDD 165 (338)
T ss_pred ceEEEEecCCCCcHHHHHHhcchhcccccccchhhhhhhhhhhhhhccccccccccCCccccccccccCcccccchhccc
Confidence 689999999999999887642
Q ss_pred ---CCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEEccCCcEEEeecCchhhhhccc-------cccccccccc
Q psy758 96 ---HGLPWDLIKQITWQVLRGVSYCHRHACIHRDIKPENILLTANGVVKLCDFGFARLIRDLI-------PRHLHIFQTN 165 (292)
Q Consensus 96 ---~~~~~~~~~~i~~qi~~aL~~LH~~givH~dl~p~Nilv~~~~~~kl~dfg~~~~~~~~~-------~~~~~~~~~~ 165 (292)
..+++..+..++.||+.||+|||++||+|+||||+||+++.++.++|+|||+++...... ...+..|.+|
T Consensus 166 ~~~~~l~~~~~~~~~~qi~~aL~~LH~~~ivHrDiKp~Nil~~~~~~~kl~DfG~a~~~~~~~~~~~~~~~~~~~~y~aP 245 (338)
T cd05102 166 LWKSPLTMEDLICYSFQVARGMEFLASRKCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGSARLPLKWMAP 245 (338)
T ss_pred cccCCCCHHHHHHHHHHHHHHHHHHHHCCEECCCCccceEEEcCCCcEEEeecccccccccCcchhcccCCCCCccccCc
Confidence 237788889999999999999999999999999999999999999999999987543211 1112346667
Q ss_pred cccccCCCCCCCcccceeeecCCCCCCchHHHHHHHhh-cccCCCCCCChhhhhhccCcC--CCCCCCCCccchHHHHhc
Q psy758 166 EYFKGVSLPHAENVVPLEIKIGKPAATNIYLIDFLKRC-LDKDPLRRWSCDQLLRHPYFN--GYYFEVPDEMQYEEITQR 242 (292)
Q Consensus 166 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~p~~~~~~~~~~~~~~~~--~~~~~~~~~~~l~~li~~ 242 (292)
|...+.......++|++ +..+++.+ .+..|+......+.+...... ....+...+..+.+|+.+
T Consensus 246 E~~~~~~~~~~sDiwsl-------------G~il~el~~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~ 312 (338)
T cd05102 246 ESIFDKVYTTQSDVWSF-------------GVLLWEIFSLGASPYPGVQINEEFCQRLKDGTRMRAPENATPEIYRIMLA 312 (338)
T ss_pred HHhhcCCCCcccCHHHH-------------HHHHHHHHhCCCCCCCCCCccHHHHHHHhcCCCCCCCCCCCHHHHHHHHH
Confidence 66554433333333333 22222222 133333322211111111111 112233457789999999
Q ss_pred ccCcCCCCCCChhhhhh
Q psy758 243 CLDKDPLRRWSCDQLLR 259 (292)
Q Consensus 243 ~l~~dP~~Rpt~~~il~ 259 (292)
||+.||.+|||+.++++
T Consensus 313 cl~~dp~~RPs~~el~~ 329 (338)
T cd05102 313 CWQGDPKERPTFSALVE 329 (338)
T ss_pred HccCChhhCcCHHHHHH
Confidence 99999999999999987
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. V |
| >cd08217 STKc_Nek2 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-37 Score=249.23 Aligned_cols=248 Identities=26% Similarity=0.397 Sum_probs=186.5
Q ss_pred ccceeeeecccCceEEEEEEEcCCCcEEEEEEeccCCCChHHHHHHHHHHHHHHhCCCCCcchhhhhhh--cCCeEEEEE
Q psy758 3 RYEKIGKLGEGSYGVVFKCRNRDTGQVVAIKKFLESEEDPLIRKIALREIRLLKSLKHPNLVNLLEVFR--RKKKLHLVF 80 (292)
Q Consensus 3 ~y~~~~~l~~g~~~~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~--~~~~~~iv~ 80 (292)
+|++.+.||+|++|.||+|.+..++..|++|.+..........+.+..|+.+++.++||||+++++.+. .+...++++
T Consensus 1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~~~~ 80 (265)
T cd08217 1 DYEVLETIGKGSFGTVRKVRRKSDGKILVWKEIDYGNMTEKEKQQLVSEVNILRELKHPNIVRYYDRIIDRSNQTLYIVM 80 (265)
T ss_pred CceeeeeeccCCCeEEEEeeecCCCCEEEEEEEecccCCHHHHHHHHHHHHHHHhcCCCccceeeeeeecCCCCEEEEEe
Confidence 589999999999999999999999999999999776666666778889999999999999999999765 355789999
Q ss_pred ecCCCccHHHHhcC----CCCCCHHHHHHHHHHHHHHHHHHH-----hCCccccCCCCCceEEccCCcEEEeecCchhhh
Q psy758 81 EFCDHTVLNELENH----PHGLPWDLIKQITWQVLRGVSYCH-----RHACIHRDIKPENILLTANGVVKLCDFGFARLI 151 (292)
Q Consensus 81 e~~~~~~L~~~~~~----~~~~~~~~~~~i~~qi~~aL~~LH-----~~givH~dl~p~Nilv~~~~~~kl~dfg~~~~~ 151 (292)
||+++++|..++.. ...+++..++.++.||+.||.+|| +.+++|+||+|+||++++++.++|+|||++...
T Consensus 81 e~~~~~~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~~~~i~h~dl~p~nili~~~~~~kl~d~g~~~~~ 160 (265)
T cd08217 81 EYCEGGDLAQLIQKCKKERKYIEEEFIWRILTQLLLALYECHNRSDPGNTVLHRDLKPANIFLDANNNVKLGDFGLAKIL 160 (265)
T ss_pred hhccCCCHHHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHhcCccccCcceecCCCHHHEEEecCCCEEEecccccccc
Confidence 99999999988754 357899999999999999999999 899999999999999999999999999998876
Q ss_pred hcccc-----ccccccccccccccCCCCCCCcccceeeecCCCCCCchHHHHHHHhhcccCCCCCCChhhhhhccCcCC-
Q psy758 152 RDLIP-----RHLHIFQTNEYFKGVSLPHAENVVPLEIKIGKPAATNIYLIDFLKRCLDKDPLRRWSCDQLLRHPYFNG- 225 (292)
Q Consensus 152 ~~~~~-----~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~- 225 (292)
..... .....|.+||...+.......++|++ +.-++..+.+..|.......+......-..
T Consensus 161 ~~~~~~~~~~~~~~~~~~pE~~~~~~~~~~~Dv~sl-------------G~il~~l~~g~~p~~~~~~~~~~~~~~~~~~ 227 (265)
T cd08217 161 GHDSSFAKTYVGTPYYMSPEQLNHMSYDEKSDIWSL-------------GCLIYELCALSPPFTARNQLQLASKIKEGKF 227 (265)
T ss_pred cCCcccccccccCCCccChhhhcCCCCCchhHHHHH-------------HHHHHHHHHCCCcccCcCHHHHHHHHhcCCC
Confidence 43221 22334555665544332222222222 222233333333433332222221111000
Q ss_pred CCCCCCCccchHHHHhcccCcCCCCCCChhhhhhCCcc
Q psy758 226 YYFEVPDEMQYEEITQRCLDKDPLRRWSCDQLLRHPYF 263 (292)
Q Consensus 226 ~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~~il~h~w~ 263 (292)
...+...+..+.+++.+||+.||++|||+.+|++|||+
T Consensus 228 ~~~~~~~~~~~~~l~~~~l~~~p~~Rp~~~~il~~~~~ 265 (265)
T cd08217 228 RRIPYRYSSELNEVIKSMLNVDPDKRPSTEELLQLPLI 265 (265)
T ss_pred CCCccccCHHHHHHHHHHccCCcccCCCHHHHhhCCCC
Confidence 12233456789999999999999999999999999996
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exi |
| >cd08215 STKc_Nek Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-37 Score=247.33 Aligned_cols=248 Identities=27% Similarity=0.420 Sum_probs=192.4
Q ss_pred ccceeeeecccCceEEEEEEEcCCCcEEEEEEeccCCCChHHHHHHHHHHHHHHhCCCCCcchhhhhhhcCCeEEEEEec
Q psy758 3 RYEKIGKLGEGSYGVVFKCRNRDTGQVVAIKKFLESEEDPLIRKIALREIRLLKSLKHPNLVNLLEVFRRKKKLHLVFEF 82 (292)
Q Consensus 3 ~y~~~~~l~~g~~~~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~iv~e~ 82 (292)
+|.+.+.||+|++|.||++.+..++..|++|.+..........+.+.+|+++++.++|||++++++.+..++..++++|+
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~~~~~lv~e~ 80 (258)
T cd08215 1 KYEIIKQIGKGSFGKVYLVRRKSDGKLYVLKEIDLSNMSEKEREDALNEVKILKKLNHPNIIKYYESFEEKGKLCIVMEY 80 (258)
T ss_pred CceEEeeeccCCCeEEEEEEEcCCCcEEEEEEeecccCChHHHHHHHHHHHHHHhcCCCChhheEEEEecCCEEEEEEEe
Confidence 68999999999999999999999999999999987766666677888999999999999999999999989999999999
Q ss_pred CCCccHHHHhcCC----CCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEEccCCcEEEeecCchhhhhccc---
Q psy758 83 CDHTVLNELENHP----HGLPWDLIKQITWQVLRGVSYCHRHACIHRDIKPENILLTANGVVKLCDFGFARLIRDLI--- 155 (292)
Q Consensus 83 ~~~~~L~~~~~~~----~~~~~~~~~~i~~qi~~aL~~LH~~givH~dl~p~Nilv~~~~~~kl~dfg~~~~~~~~~--- 155 (292)
+++++|...+... ..+++..+..++.|++.||.+||++|++|+||+|+||++++++.++|+|||.+.......
T Consensus 81 ~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~H~dl~~~nil~~~~~~~~l~d~~~~~~~~~~~~~~ 160 (258)
T cd08215 81 ADGGDLSQKIKKQKKEGKPFPEEQILDWFVQLCLALKYLHSRKILHRDIKPQNIFLTSNGLVKLGDFGISKVLSSTVDLA 160 (258)
T ss_pred cCCCcHHHHHHHhhccCCCcCHHHHHHHHHHHHHHHHHHHhCCEecccCChHHeEEcCCCcEEECCccceeecccCccee
Confidence 9999999888653 679999999999999999999999999999999999999999999999999987654432
Q ss_pred --cccccccccccccccCCCCCCCcccceeeecCCCCCCchHHHHHHHhhcccCCCCCCChhhhhhccCcC-CCCCCCCC
Q psy758 156 --PRHLHIFQTNEYFKGVSLPHAENVVPLEIKIGKPAATNIYLIDFLKRCLDKDPLRRWSCDQLLRHPYFN-GYYFEVPD 232 (292)
Q Consensus 156 --~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~-~~~~~~~~ 232 (292)
......|.+|+...+.......++|. .+.-++..+.+..|.......++....... ....+...
T Consensus 161 ~~~~~~~~y~~pe~~~~~~~~~~~Dv~s-------------lG~~~~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 227 (258)
T cd08215 161 KTVVGTPYYLSPELCQNKPYNYKSDIWS-------------LGCVLYELCTLKHPFEGENLLELALKILKGQYPPIPSQY 227 (258)
T ss_pred cceeeeecccChhHhccCCCCccccHHH-------------HHHHHHHHHcCCCCCCCCcHHHHHHHHhcCCCCCCCCCC
Confidence 11223355555544433333333332 222233334444454444333333221111 11223345
Q ss_pred ccchHHHHhcccCcCCCCCCChhhhhhCCcc
Q psy758 233 EMQYEEITQRCLDKDPLRRWSCDQLLRHPYF 263 (292)
Q Consensus 233 ~~~l~~li~~~l~~dP~~Rpt~~~il~h~w~ 263 (292)
+..+.+++.+||..||.+|||+.++++||||
T Consensus 228 ~~~~~~~i~~~l~~~p~~Rp~~~~ll~~~~~ 258 (258)
T cd08215 228 SSELRNLVSSLLQKDPEERPSIAQILQSPFI 258 (258)
T ss_pred CHHHHHHHHHHcCCChhhCcCHHHHhcCCCC
Confidence 7789999999999999999999999999997
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They |
| >cd06658 STKc_PAK5 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-37 Score=253.12 Aligned_cols=249 Identities=24% Similarity=0.365 Sum_probs=186.2
Q ss_pred ccceeeeecccCceEEEEEEEcCCCcEEEEEEeccCCCChHHHHHHHHHHHHHHhCCCCCcchhhhhhhcCCeEEEEEec
Q psy758 3 RYEKIGKLGEGSYGVVFKCRNRDTGQVVAIKKFLESEEDPLIRKIALREIRLLKSLKHPNLVNLLEVFRRKKKLHLVFEF 82 (292)
Q Consensus 3 ~y~~~~~l~~g~~~~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~iv~e~ 82 (292)
.|.....||+|++|.||.+.+..++..|++|.+.... ....+.+.+|+..++.++||||+++++.+..++..++|+||
T Consensus 23 ~~~~~~~lg~g~~g~v~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~e~~~l~~l~h~~ii~~~~~~~~~~~~~lv~e~ 100 (292)
T cd06658 23 YLDSFIKIGEGSTGIVCIATEKHTGKQVAVKKMDLRK--QQRRELLFNEVVIMRDYHHENVVDMYNSYLVGDELWVVMEF 100 (292)
T ss_pred HHhhhhcccCCCCeEEEEEEECCCCCEEEEEEEecch--HHHHHHHHHHHHHHHhCCCCcHHHHHHheecCCeEEEEEeC
Confidence 4556678999999999999999999999999886533 23456688999999999999999999999999999999999
Q ss_pred CCCccHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEEccCCcEEEeecCchhhhhccccc-----
Q psy758 83 CDHTVLNELENHPHGLPWDLIKQITWQVLRGVSYCHRHACIHRDIKPENILLTANGVVKLCDFGFARLIRDLIPR----- 157 (292)
Q Consensus 83 ~~~~~L~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~givH~dl~p~Nilv~~~~~~kl~dfg~~~~~~~~~~~----- 157 (292)
+++++|..++... .+++..++.++.||+.||.|||++|++|+||+|+||++++++.++|+|||++.........
T Consensus 101 ~~~~~L~~~~~~~-~l~~~~~~~~~~qi~~~l~~LH~~~ivH~dlkp~Nill~~~~~~kL~dfg~~~~~~~~~~~~~~~~ 179 (292)
T cd06658 101 LEGGALTDIVTHT-RMNEEQIATVCLSVLRALSYLHNQGVIHRDIKSDSILLTSDGRIKLSDFGFCAQVSKEVPKRKSLV 179 (292)
T ss_pred CCCCcHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHHCCEeecCCCHHHEEEcCCCCEEEccCcchhhcccccccCceee
Confidence 9999999988653 6899999999999999999999999999999999999999999999999998754332221
Q ss_pred cccccccccccccCCCCCCCcccceeeecCCCCCCchHHHHHHHhhcccCCCCCCChhhhhhc---cCcCCCCCCCCCcc
Q psy758 158 HLHIFQTNEYFKGVSLPHAENVVPLEIKIGKPAATNIYLIDFLKRCLDKDPLRRWSCDQLLRH---PYFNGYYFEVPDEM 234 (292)
Q Consensus 158 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~---~~~~~~~~~~~~~~ 234 (292)
.+..|.+||...+...... .+.++.+..+++.+.+..|.......+.+.. ..-.........+.
T Consensus 180 ~~~~y~aPE~~~~~~~~~~-------------~Dv~slGvil~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 246 (292)
T cd06658 180 GTPYWMAPEVISRLPYGTE-------------VDIWSLGIMVIEMIDGEPPYFNEPPLQAMRRIRDNLPPRVKDSHKVSS 246 (292)
T ss_pred cCccccCHHHHccCCCCch-------------hhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCCccccccccCH
Confidence 2233555555433222211 2223333334444444445433322222111 11111111223466
Q ss_pred chHHHHhcccCcCCCCCCChhhhhhCCccccee
Q psy758 235 QYEEITQRCLDKDPLRRWSCDQLLRHPYFNGYY 267 (292)
Q Consensus 235 ~l~~li~~~l~~dP~~Rpt~~~il~h~w~~~~~ 267 (292)
.+.+++.+||..||++|||++++++||||....
T Consensus 247 ~~~~li~~~l~~~P~~Rpt~~~il~~~~~~~~~ 279 (292)
T cd06658 247 VLRGFLDLMLVREPSQRATAQELLQHPFLKLAG 279 (292)
T ss_pred HHHHHHHHHccCChhHCcCHHHHhhChhhhccC
Confidence 899999999999999999999999999999744
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly express |
| >KOG1989|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-38 Score=272.55 Aligned_cols=248 Identities=24% Similarity=0.321 Sum_probs=191.7
Q ss_pred ccceeeeecccCceEEEEEEEcCCCcEEEEEEeccCCCChHHHHHHHHHHHHHHhCC-CCCcchhhhh-hhc------CC
Q psy758 3 RYEKIGKLGEGSYGVVFKCRNRDTGQVVAIKKFLESEEDPLIRKIALREIRLLKSLK-HPNLVNLLEV-FRR------KK 74 (292)
Q Consensus 3 ~y~~~~~l~~g~~~~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~e~~~~~~l~-~~~i~~~~~~-~~~------~~ 74 (292)
++++.+.|.+|||+.||+|++...+..||+|++-.. +......+.+|+++++.|+ |+|||.+++. ... ..
T Consensus 38 ~v~V~~vLAEGGFa~VYla~~~~~~~~~AlKrm~~~--de~~L~~v~~EI~~MK~L~gh~nIV~yidss~~~~~~~~~~~ 115 (738)
T KOG1989|consen 38 RVTVEKVLAEGGFAQVYLAQDVKGGKKYALKRMYVN--DEEALNAVKREIDIMKLLSGHKNIVSYIDSSAINRSSNNGVW 115 (738)
T ss_pred EEEEEEEEccCCcEEEEEEEecCCCceeeeeeeecC--CHHHHHHHHHHHHHHHHhcCCCceeeEeccccccccCCCcee
Confidence 567899999999999999999998899999987554 5566788899999999997 9999999994 321 13
Q ss_pred eEEEEEecCCCccHHHHhc--CCCCCCHHHHHHHHHHHHHHHHHHHhCC--ccccCCCCCceEEccCCcEEEeecCchhh
Q psy758 75 KLHLVFEFCDHTVLNELEN--HPHGLPWDLIKQITWQVLRGVSYCHRHA--CIHRDIKPENILLTANGVVKLCDFGFARL 150 (292)
Q Consensus 75 ~~~iv~e~~~~~~L~~~~~--~~~~~~~~~~~~i~~qi~~aL~~LH~~g--ivH~dl~p~Nilv~~~~~~kl~dfg~~~~ 150 (292)
.++++||||.||.|-++++ ...+|++.++++|+.|+++|+.+||... |+|||||.+|||++.+|++||||||.++-
T Consensus 116 EvllLmEyC~gg~Lvd~mn~Rlq~~lte~eVLkIf~dv~~AVa~mH~~~pPiIHRDLKiENvLls~~g~~KLCDFGSatt 195 (738)
T KOG1989|consen 116 EVLLLMEYCKGGSLVDFMNTRLQTRLTEDEVLKIFYDVCEAVAAMHYLKPPIIHRDLKIENVLLSADGNYKLCDFGSATT 195 (738)
T ss_pred EEEeehhhccCCcHHHHHHHHHhccCChHHHHHHHHHHHHHHHHHhcCCCccchhhhhhhheEEcCCCCEEeCccccccc
Confidence 5899999999888888776 2346999999999999999999999997 99999999999999999999999999864
Q ss_pred hh--------------cccccccccccccccc---ccCCCCCCCcccceeeecCCCCCCchHHHHHHHhhcccCCCCCCC
Q psy758 151 IR--------------DLIPRHLHIFQTNEYF---KGVSLPHAENVVPLEIKIGKPAATNIYLIDFLKRCLDKDPLRRWS 213 (292)
Q Consensus 151 ~~--------------~~~~~~~~~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~ 213 (292)
-. +.....+..|++||.. .|..+.. ..++|..++-++..|+...|++.-.
T Consensus 196 ~~~~~~~~~e~~~ve~eI~k~TTp~YRsPEMIDlysg~pI~e-------------KsDIWALGclLYkLCy~t~PFe~sg 262 (738)
T KOG1989|consen 196 KILSPTSAQEVNYVEEEIEKYTTPQYRSPEMIDLYSGLPIGE-------------KSDIWALGCLLYKLCYFTTPFEESG 262 (738)
T ss_pred ccCCCccHHHHHHHHHHHHhhCCccccChHHHhhhcCCCCcc-------------hhHHHHHHHHHHHHHHhCCCcCcCc
Confidence 21 1233445567777654 2333333 3333444445666777888887765
Q ss_pred hhhhhhccCcCCCCCCCCCccchHHHHhcccCcCCCCCCChhhhhhC--------Cccccee
Q psy758 214 CDQLLRHPYFNGYYFEVPDEMQYEEITQRCLDKDPLRRWSCDQLLRH--------PYFNGYY 267 (292)
Q Consensus 214 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~~il~h--------~w~~~~~ 267 (292)
...++.-.| .++.....+..+.+||+.||++||.+||++-|++.+ +|+.+++
T Consensus 263 ~laIlng~Y--~~P~~p~ys~~l~~LI~~mL~~nP~~RPnI~Qv~~~~~~l~~~~~~~~~~~ 322 (738)
T KOG1989|consen 263 KLAILNGNY--SFPPFPNYSDRLKDLIRTMLQPNPDERPNIYQVLEEIFELANKPCPIPDIY 322 (738)
T ss_pred ceeEEeccc--cCCCCccHHHHHHHHHHHHhccCcccCCCHHHHHHHHHHHhcCCCCccccc
Confidence 555554433 112223557889999999999999999999999875 5555555
|
|
| >cd05611 STKc_Rim15_like Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-37 Score=250.79 Aligned_cols=249 Identities=24% Similarity=0.295 Sum_probs=179.6
Q ss_pred eeecccCceEEEEEEEcCCCcEEEEEEeccCCCC-hHHHHHHHHHHHHH-HhCCCCCcchhhhhhhcCCeEEEEEecCCC
Q psy758 8 GKLGEGSYGVVFKCRNRDTGQVVAIKKFLESEED-PLIRKIALREIRLL-KSLKHPNLVNLLEVFRRKKKLHLVFEFCDH 85 (292)
Q Consensus 8 ~~l~~g~~~~v~~~~~~~~~~~v~iK~~~~~~~~-~~~~~~~~~e~~~~-~~l~~~~i~~~~~~~~~~~~~~iv~e~~~~ 85 (292)
+.||+|++|.||+|.+..+++.||+|.+...... ......+..|..++ ...+|+|++++++++..++..|+++||+++
T Consensus 2 ~~l~~g~~~~v~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~ 81 (260)
T cd05611 2 KPISKGAFGSVYLAKKRSTGDYFAIKVLKKSDMIAKNQVTNVKAERAIMMIQGESPYVAKLYYSFQSKDYLYLVMEYLNG 81 (260)
T ss_pred ccCCcCCCeeEEEEEecCCCCeEEEEEecchhhhHHHHHHHHHHHHHHHhhcCCCCCeeeeeeeEEcCCeEEEEEeccCC
Confidence 5799999999999999999999999998755422 22223334454443 445899999999999999999999999999
Q ss_pred ccHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEEccCCcEEEeecCchhhhhcc-cccccccccc
Q psy758 86 TVLNELENHPHGLPWDLIKQITWQVLRGVSYCHRHACIHRDIKPENILLTANGVVKLCDFGFARLIRDL-IPRHLHIFQT 164 (292)
Q Consensus 86 ~~L~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~givH~dl~p~Nilv~~~~~~kl~dfg~~~~~~~~-~~~~~~~~~~ 164 (292)
++|..++.....+++..+..++.|++.||.|||+.|++|+||+|+||+++.++.++|+|||++...... .......|.+
T Consensus 82 ~~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~lH~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~y~~ 161 (260)
T cd05611 82 GDCASLIKTLGGLPEDWAKQYIAEVVLGVEDLHQRGIIHRDIKPENLLIDQTGHLKLTDFGLSRNGLENKKFVGTPDYLA 161 (260)
T ss_pred CCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEECCCCcEEEeecccceeccccccCCCCcCccC
Confidence 999999987778999999999999999999999999999999999999999999999999988654321 1222344666
Q ss_pred ccccccCCCCCCCcccceeeecCCCCCCchHHHHHHHhhcccCCCCCCChhhhhhccCcCC----CCCCCCCccchHHHH
Q psy758 165 NEYFKGVSLPHAENVVPLEIKIGKPAATNIYLIDFLKRCLDKDPLRRWSCDQLLRHPYFNG----YYFEVPDEMQYEEIT 240 (292)
Q Consensus 165 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~----~~~~~~~~~~l~~li 240 (292)
|+...+.......++| +.+.-++..+.+..|....+..+......... .......+..+.++|
T Consensus 162 pe~~~~~~~~~~~Dv~-------------slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i 228 (260)
T cd05611 162 PETILGVGDDKMSDWW-------------SLGCVIFEFLFGYPPFHAETPDAVFDNILSRRINWPEEVKEFCSPEAVDLI 228 (260)
T ss_pred hhhhcCCCCcchhhhH-------------HHHHHHHHHHHCCCCCCCCCHHHHHHHHHhcccCCCCcccccCCHHHHHHH
Confidence 6665443322222222 22222333333333433333222221110000 011123477899999
Q ss_pred hcccCcCCCCCCCh---hhhhhCCcccceecc
Q psy758 241 QRCLDKDPLRRWSC---DQLLRHPYFNGYYFE 269 (292)
Q Consensus 241 ~~~l~~dP~~Rpt~---~~il~h~w~~~~~~~ 269 (292)
.+||+.||++|||+ +|+++||||++..||
T Consensus 229 ~~~l~~~p~~R~~~~~~~~~l~~~~~~~~~~~ 260 (260)
T cd05611 229 NRLLCMDPAKRLGANGYQEIKSHPFFKSINWD 260 (260)
T ss_pred HHHccCCHHHccCCCcHHHHHcChHhhcCCCC
Confidence 99999999999955 799999999998775
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a do |
| >cd06642 STKc_STK25-YSK1 Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-37 Score=253.04 Aligned_cols=252 Identities=26% Similarity=0.354 Sum_probs=187.9
Q ss_pred cccceeeeecccCceEEEEEEEcCCCcEEEEEEeccCCCChHHHHHHHHHHHHHHhCCCCCcchhhhhhhcCCeEEEEEe
Q psy758 2 ERYEKIGKLGEGSYGVVFKCRNRDTGQVVAIKKFLESEEDPLIRKIALREIRLLKSLKHPNLVNLLEVFRRKKKLHLVFE 81 (292)
Q Consensus 2 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~iv~e 81 (292)
+.|+..+.||+|++|.||+|.+..++..||+|.+...... ...+.+.+|+.+++.++||||+++++.+..++..++|+|
T Consensus 4 ~~y~~~~~l~~g~~~~vy~~~~~~~~~~vaiK~~~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 82 (277)
T cd06642 4 ELFTKLERIGKGSFGEVYKGIDNRTKEVVAIKIIDLEEAE-DEIEDIQQEITVLSQCDSPYITRYYGSYLKGTKLWIIME 82 (277)
T ss_pred HHHHHHHHhcCCCCeeEEEEEEcCCCeEEEEEEeccccch-HHHHHHHHHHHHHHcCCCCccHhhhcccccCCceEEEEE
Confidence 3588889999999999999999998999999988654433 345678899999999999999999999999999999999
Q ss_pred cCCCccHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEEccCCcEEEeecCchhhhhcccc-----
Q psy758 82 FCDHTVLNELENHPHGLPWDLIKQITWQVLRGVSYCHRHACIHRDIKPENILLTANGVVKLCDFGFARLIRDLIP----- 156 (292)
Q Consensus 82 ~~~~~~L~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~givH~dl~p~Nilv~~~~~~kl~dfg~~~~~~~~~~----- 156 (292)
|+++++|..++.. ..+++..++.++.|++.||.|||++|++|+||+|+||++++++.++|+|||++........
T Consensus 83 ~~~~~~L~~~~~~-~~~~~~~~~~~~~~i~~~l~~lH~~~ivH~dl~p~ni~i~~~~~~~l~dfg~~~~~~~~~~~~~~~ 161 (277)
T cd06642 83 YLGGGSALDLLKP-GPLEETYIATILREILKGLDYLHSERKIHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQIKRNTF 161 (277)
T ss_pred ccCCCcHHHHhhc-CCCCHHHHHHHHHHHHHHHHHHhcCCeeccCCChheEEEeCCCCEEEccccccccccCcchhhhcc
Confidence 9999999998865 4689999999999999999999999999999999999999999999999999876543211
Q ss_pred ccccccccccccccCCCCCCCcccceeeecCCCCCCchHHHHHHHhhcccCCCCCCChhhhhhccC-cCCCCCCCCCccc
Q psy758 157 RHLHIFQTNEYFKGVSLPHAENVVPLEIKIGKPAATNIYLIDFLKRCLDKDPLRRWSCDQLLRHPY-FNGYYFEVPDEMQ 235 (292)
Q Consensus 157 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~-~~~~~~~~~~~~~ 235 (292)
.....|.+||...+.......++|++ +.-+++.+.+..|.............- ..........+..
T Consensus 162 ~~~~~y~aPE~~~~~~~~~~~Dv~sl-------------G~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 228 (277)
T cd06642 162 VGTPFWMAPEVIKQSAYDFKADIWSL-------------GITAIELAKGEPPNSDLHPMRVLFLIPKNSPPTLEGQYSKP 228 (277)
T ss_pred cCcccccCHHHhCcCCCchhhhHHHH-------------HHHHHHHHhCCCCCcccchhhHHhhhhcCCCCCCCcccCHH
Confidence 12334666666554433222222222 222233333333332221111111000 0001122234678
Q ss_pred hHHHHhcccCcCCCCCCChhhhhhCCcccceec
Q psy758 236 YEEITQRCLDKDPLRRWSCDQLLRHPYFNGYYF 268 (292)
Q Consensus 236 l~~li~~~l~~dP~~Rpt~~~il~h~w~~~~~~ 268 (292)
+.++|.+||+.+|.+|||+.++++||||.....
T Consensus 229 ~~~li~~~l~~~p~~Rp~~~~il~~~~~~~~~~ 261 (277)
T cd06642 229 FKEFVEACLNKDPRFRPTAKELLKHKFITRYTK 261 (277)
T ss_pred HHHHHHHHccCCcccCcCHHHHHHhHHHHHHhh
Confidence 999999999999999999999999999987553
|
Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25 |
| >cd06632 STKc_MEKK1_plant Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-37 Score=247.23 Aligned_cols=248 Identities=28% Similarity=0.385 Sum_probs=186.6
Q ss_pred ccceeeeecccCceEEEEEEEcCCCcEEEEEEeccCC---CChHHHHHHHHHHHHHHhCCCCCcchhhhhhhcCCeEEEE
Q psy758 3 RYEKIGKLGEGSYGVVFKCRNRDTGQVVAIKKFLESE---EDPLIRKIALREIRLLKSLKHPNLVNLLEVFRRKKKLHLV 79 (292)
Q Consensus 3 ~y~~~~~l~~g~~~~v~~~~~~~~~~~v~iK~~~~~~---~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~iv 79 (292)
+|+..+.||+|++|.||+|.+..+++.|++|.+.... ......+.+.+|+.+++.++|+||+++++++.++..++++
T Consensus 1 ~~~~~~~ig~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv 80 (258)
T cd06632 1 RWRKGELLGSGSFGSVYEGLNLDDGDFFAVKEVSLADDGQTGQEAVKQLEQEIALLSKLQHPNIVQYLGTEREEDNLYIF 80 (258)
T ss_pred CccccceeeecCCceEEEEEEcCCCcEEEEEEEEEccccccchHHHHHHHHHHHHHHhcCCCCchheeeeEecCCeEEEE
Confidence 6889999999999999999999889999999986544 2234567788999999999999999999999999999999
Q ss_pred EecCCCccHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEEccCCcEEEeecCchhhhhccc----
Q psy758 80 FEFCDHTVLNELENHPHGLPWDLIKQITWQVLRGVSYCHRHACIHRDIKPENILLTANGVVKLCDFGFARLIRDLI---- 155 (292)
Q Consensus 80 ~e~~~~~~L~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~givH~dl~p~Nilv~~~~~~kl~dfg~~~~~~~~~---- 155 (292)
+||+++++|.+++.....+++..++.++.||+.||++||+.|++|+||+|+||+++.++.++|+|||.+.......
T Consensus 81 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~~~ni~~~~~~~~kl~d~~~~~~~~~~~~~~~ 160 (258)
T cd06632 81 LELVPGGSLAKLLKKYGSFPEPVIRLYTRQILLGLEYLHDRNTVHRDIKGANILVDTNGVVKLADFGMAKQVVEFSFAKS 160 (258)
T ss_pred EEecCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCCEEEccCccceeccccccccc
Confidence 9999999999999877779999999999999999999999999999999999999999999999999887654322
Q ss_pred cccccccccccccccCC-CCCCCcccceeeecCCCCCCchHHHHHHHhhcccCCCCCCChhhhh-hccC-cCCCCCCCCC
Q psy758 156 PRHLHIFQTNEYFKGVS-LPHAENVVPLEIKIGKPAATNIYLIDFLKRCLDKDPLRRWSCDQLL-RHPY-FNGYYFEVPD 232 (292)
Q Consensus 156 ~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~-~~~~-~~~~~~~~~~ 232 (292)
......|.+|++..... .....++ ++.+.-++..+.+..|.......+.. .... ......+...
T Consensus 161 ~~~~~~y~~pe~~~~~~~~~~~~D~-------------~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~ 227 (258)
T cd06632 161 FKGSPYWMAPEVIAQQGGYGLAADI-------------WSLGCTVLEMATGKPPWSQLEGVAAVFKIGRSKELPPIPDHL 227 (258)
T ss_pred cCCCcceeCHHHhcCCCCCCchhhh-------------HHHHHHHHHHHhCCCCcccCcHHHHHHHHHhcccCCCcCCCc
Confidence 11223345555543322 1111222 22222233333344443332211111 1111 0111223345
Q ss_pred ccchHHHHhcccCcCCCCCCChhhhhhCCcc
Q psy758 233 EMQYEEITQRCLDKDPLRRWSCDQLLRHPYF 263 (292)
Q Consensus 233 ~~~l~~li~~~l~~dP~~Rpt~~~il~h~w~ 263 (292)
+..+.+++.+||+.||.+|||+.+++.||||
T Consensus 228 ~~~~~~li~~~l~~~p~~Rp~~~~~l~~~~~ 258 (258)
T cd06632 228 SDEAKDFILKCLQRDPSLRPTAAELLEHPFV 258 (258)
T ss_pred CHHHHHHHHHHhhcCcccCcCHHHHhcCCCC
Confidence 7789999999999999999999999999997
|
Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidops |
| >KOG0574|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-40 Score=252.09 Aligned_cols=247 Identities=26% Similarity=0.443 Sum_probs=201.4
Q ss_pred cceeeeecccCceEEEEEEEcCCCcEEEEEEeccCCCChHHHHHHHHHHHHHHhCCCCCcchhhhhhhcCCeEEEEEecC
Q psy758 4 YEKIGKLGEGSYGVVFKCRNRDTGQVVAIKKFLESEEDPLIRKIALREIRLLKSLKHPNLVNLLEVFRRKKKLHLVFEFC 83 (292)
Q Consensus 4 y~~~~~l~~g~~~~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~iv~e~~ 83 (292)
|.+++.||.|+||.||+|.++.+|..+|||..+...+ .+.+.+|+.++++..+|+++++||.|.....+|+|||||
T Consensus 35 FDi~~KLGEGSYGSV~KAIH~EsG~v~AIK~VPV~sD----LQEIIKEISIMQQC~S~yVVKYYGSYFK~sDLWIVMEYC 110 (502)
T KOG0574|consen 35 FDIVGKLGEGSYGSVHKAIHRESGHVLAIKKVPVDTD----LQEIIKEISIMQQCKSKYVVKYYGSYFKHSDLWIVMEYC 110 (502)
T ss_pred HHHHHHhcCCcchHHHHHHHhccCcEEEEEecCccch----HHHHHHHHHHHHHcCCchhhhhhhhhccCCceEeehhhc
Confidence 6788999999999999999999999999998876543 466788999999999999999999999999999999999
Q ss_pred CCccHHHHhcC-CCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEEccCCcEEEeecCchhhhhcccccccccc
Q psy758 84 DHTVLNELENH-PHGLPWDLIKQITWQVLRGVSYCHRHACIHRDIKPENILLTANGVVKLCDFGFARLIRDLIPRHLHIF 162 (292)
Q Consensus 84 ~~~~L~~~~~~-~~~~~~~~~~~i~~qi~~aL~~LH~~givH~dl~p~Nilv~~~~~~kl~dfg~~~~~~~~~~~~~~~~ 162 (292)
+.|+..++++. ++.++++.+..++..-++||+|||...-+|||||..|||++.+|+.||.|||.+..+...-.......
T Consensus 111 GAGSiSDI~R~R~K~L~E~EIs~iL~~TLKGL~YLH~~~KIHRDIKAGNILLNT~G~AKLADFGVAGQLTDTMAKRNTVI 190 (502)
T KOG0574|consen 111 GAGSISDIMRARRKPLSEQEISAVLRDTLKGLQYLHDLKKIHRDIKAGNILLNTDGIAKLADFGVAGQLTDTMAKRNTVI 190 (502)
T ss_pred CCCcHHHHHHHhcCCccHHHHHHHHHHHHhHHHHHHHHHHHHhhcccccEEEcccchhhhhhccccchhhhhHHhhCccc
Confidence 99999998764 45799999999999999999999999999999999999999999999999999988876555555556
Q ss_pred ccccccccCC----------CCCCCcccceeeecCCCCCCchHHHHHHHhhcccCCCCCCChhhhhhccCcCCCCCCCCC
Q psy758 163 QTNEYFKGVS----------LPHAENVVPLEIKIGKPAATNIYLIDFLKRCLDKDPLRRWSCDQLLRHPYFNGYYFEVPD 232 (292)
Q Consensus 163 ~~~~~~~~~~----------~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~ 232 (292)
++|-|.+++. ..|++++...++.-|.+++.+.....-+-. ...+|. + .+..+..-
T Consensus 191 GTPFWMAPEVI~EIGY~~~ADIWSLGITaIEMAEG~PPYsDIHPMRAIFM-IPT~PP-----------P---TF~KPE~W 255 (502)
T KOG0574|consen 191 GTPFWMAPEVIEEIGYDTKADIWSLGITAIEMAEGRPPYSDIHPMRAIFM-IPTKPP-----------P---TFKKPEEW 255 (502)
T ss_pred cCcccccHHHHHHhccchhhhHhhhcchhhhhhcCCCCcccccccceeEe-ccCCCC-----------C---CCCChHhh
Confidence 6676666543 368888888888888887654432211111 111110 0 11112233
Q ss_pred ccchHHHHhcccCcCCCCCCChhhhhhCCcccceecc
Q psy758 233 EMQYEEITQRCLDKDPLRRWSCDQLLRHPYFNGYYFE 269 (292)
Q Consensus 233 ~~~l~~li~~~l~~dP~~Rpt~~~il~h~w~~~~~~~ 269 (292)
+..+.++|++||..+|++|-||.++++|||+++....
T Consensus 256 S~~F~DFi~~CLiK~PE~R~TA~~L~~H~FiknA~g~ 292 (502)
T KOG0574|consen 256 SSEFNDFIRSCLIKKPEERKTALRLCEHTFIKNAPGC 292 (502)
T ss_pred hhHHHHHHHHHhcCCHHHHHHHHHHhhhhhhcCCCcc
Confidence 6678999999999999999999999999999986543
|
|
| >cd06607 STKc_TAO Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-37 Score=255.10 Aligned_cols=249 Identities=29% Similarity=0.404 Sum_probs=184.4
Q ss_pred cccceeeeecccCceEEEEEEEcCCCcEEEEEEeccCC-CChHHHHHHHHHHHHHHhCCCCCcchhhhhhhcCCeEEEEE
Q psy758 2 ERYEKIGKLGEGSYGVVFKCRNRDTGQVVAIKKFLESE-EDPLIRKIALREIRLLKSLKHPNLVNLLEVFRRKKKLHLVF 80 (292)
Q Consensus 2 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~v~iK~~~~~~-~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~iv~ 80 (292)
++|.+.+.||+|++|.||+|.+..+++.|++|.+.... ......+.+.+|+.+++.++||||+++++++.+++..++|+
T Consensus 15 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~~~~~~~~~~~~~lv~ 94 (307)
T cd06607 15 KLFTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQQLRHPNTIEYKGCYLREHTAWLVM 94 (307)
T ss_pred hhhhhheeecCCCCeEEEEEEEcCCCcEEEEEEEeccccCcHHHHHHHHHHHHHHHhCCCCCEEEEEEEEEeCCeEEEEH
Confidence 46899999999999999999999899999999986543 33445567889999999999999999999999999999999
Q ss_pred ecCCCccHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEEccCCcEEEeecCchhhhhccc-cccc
Q psy758 81 EFCDHTVLNELENHPHGLPWDLIKQITWQVLRGVSYCHRHACIHRDIKPENILLTANGVVKLCDFGFARLIRDLI-PRHL 159 (292)
Q Consensus 81 e~~~~~~L~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~givH~dl~p~Nilv~~~~~~kl~dfg~~~~~~~~~-~~~~ 159 (292)
||+.|+.+..+......+++..+..++.|++.||.|||+.|++|+||+|+||++++++.++|+|||++....... ....
T Consensus 95 e~~~g~l~~~~~~~~~~l~~~~~~~~~~ql~~~L~~LH~~~i~H~dl~p~nIl~~~~~~~kL~dfg~~~~~~~~~~~~~~ 174 (307)
T cd06607 95 EYCLGSASDILEVHKKPLQEVEIAAICHGALQGLAYLHSHERIHRDIKAGNILLTEPGTVKLADFGSASLVSPANSFVGT 174 (307)
T ss_pred HhhCCCHHHHHHHcccCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCcccEEECCCCCEEEeecCcceecCCCCCccCC
Confidence 999876555554445579999999999999999999999999999999999999999999999999886543221 1222
Q ss_pred ccccccccccc--------CCCCCCCcccceeeecCCCCCCchHHHHHHHhhcccCCCCCCChhhhhhccCcCCCCCCCC
Q psy758 160 HIFQTNEYFKG--------VSLPHAENVVPLEIKIGKPAATNIYLIDFLKRCLDKDPLRRWSCDQLLRHPYFNGYYFEVP 231 (292)
Q Consensus 160 ~~~~~~~~~~~--------~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~ 231 (292)
..|.+||...+ ....|+.|+..+++.+|..++................+ ....+..
T Consensus 175 ~~y~aPE~~~~~~~~~~~~~sDv~s~G~il~el~tg~~p~~~~~~~~~~~~~~~~~~----------------~~~~~~~ 238 (307)
T cd06607 175 PYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNDS----------------PTLSSND 238 (307)
T ss_pred ccccCceeeeccCCCCCCcccchHHHHHHHHHHHcCCCCCCCccHHHHHHHHhcCCC----------------CCCCchh
Confidence 34556665421 12234444444444444444322221111111110000 0000112
Q ss_pred CccchHHHHhcccCcCCCCCCChhhhhhCCcccce
Q psy758 232 DEMQYEEITQRCLDKDPLRRWSCDQLLRHPYFNGY 266 (292)
Q Consensus 232 ~~~~l~~li~~~l~~dP~~Rpt~~~il~h~w~~~~ 266 (292)
.+..+.++|.+||+.||.+|||+.+++.||||...
T Consensus 239 ~~~~~~~li~~~l~~~p~~Rp~~~~il~~~~~~~~ 273 (307)
T cd06607 239 WSDYFRNFVDSCLQKIPQDRPSSEELLKHRFVLRE 273 (307)
T ss_pred hCHHHHHHHHHHhcCChhhCcCHHHHhcChhhccc
Confidence 35678999999999999999999999999999863
|
Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily |
| >cd08225 STKc_Nek5 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-37 Score=246.73 Aligned_cols=248 Identities=26% Similarity=0.399 Sum_probs=184.8
Q ss_pred ccceeeeecccCceEEEEEEEcCCCcEEEEEEeccCCCChHHHHHHHHHHHHHHhCCCCCcchhhhhhhcCCeEEEEEec
Q psy758 3 RYEKIGKLGEGSYGVVFKCRNRDTGQVVAIKKFLESEEDPLIRKIALREIRLLKSLKHPNLVNLLEVFRRKKKLHLVFEF 82 (292)
Q Consensus 3 ~y~~~~~l~~g~~~~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~iv~e~ 82 (292)
+|++.+.||+|++|.||++.+..++..+++|.+..........+.+.+|+.+++.++|+||+++++.+.+.+..++++||
T Consensus 1 ~~~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~ 80 (257)
T cd08225 1 RYEIIKKIGEGSFGKIYLAKAKSDSEHCVIKEIDLTKMPVKEKEASKKEVILLAKMKHPNIVTFFASFQENGRLFIVMEY 80 (257)
T ss_pred CceEEEEecCCCcceEEEEEEcCCCceEEEEEeeHhhccchhhHHHHHHHHHHHhCCCCChhhhhheeccCCeEEEEEec
Confidence 68999999999999999999999999999999876544444456778999999999999999999999999999999999
Q ss_pred CCCccHHHHhcCCC--CCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEEccCC-cEEEeecCchhhhhcccc---
Q psy758 83 CDHTVLNELENHPH--GLPWDLIKQITWQVLRGVSYCHRHACIHRDIKPENILLTANG-VVKLCDFGFARLIRDLIP--- 156 (292)
Q Consensus 83 ~~~~~L~~~~~~~~--~~~~~~~~~i~~qi~~aL~~LH~~givH~dl~p~Nilv~~~~-~~kl~dfg~~~~~~~~~~--- 156 (292)
+++++|.+++.... .+++..+..++.|++.||.|||++|++|+||+|+||++++++ .++|+|||.+........
T Consensus 81 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~i~H~dl~~~nil~~~~~~~~~l~d~~~~~~~~~~~~~~~ 160 (257)
T cd08225 81 CDGGDLMKRINRQRGVLFSEDQILSWFVQISLGLKHIHDRKILHRDIKSQNIFLSKNGMVAKLGDFGIARQLNDSMELAY 160 (257)
T ss_pred CCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCHHHEEEcCCCCeEEecccccchhccCCccccc
Confidence 99999999886533 479999999999999999999999999999999999999886 469999998876643221
Q ss_pred --ccccccccccccccCCCCCCCcccceeeecCCCCCCchHHHHHHHhhcccCCCCCCChhhhhhccCcCCC-CCCCCCc
Q psy758 157 --RHLHIFQTNEYFKGVSLPHAENVVPLEIKIGKPAATNIYLIDFLKRCLDKDPLRRWSCDQLLRHPYFNGY-YFEVPDE 233 (292)
Q Consensus 157 --~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~-~~~~~~~ 233 (292)
.....|.+||+..+.......++|++ +.-++..+.+..|....+..+.......... ......+
T Consensus 161 ~~~~~~~~~ape~~~~~~~~~~~Dv~sl-------------G~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 227 (257)
T cd08225 161 TCVGTPYYLSPEICQNRPYNNKTDIWSL-------------GCVLYELCTLKHPFEGNNLHQLVLKICQGYFAPISPNFS 227 (257)
T ss_pred ccCCCccccCHHHHcCCCCCchhhHHHH-------------HHHHHHHHhCCCCCCCccHHHHHHHHhcccCCCCCCCCC
Confidence 12234556665543332222222222 2222333333334332222222211110000 1122346
Q ss_pred cchHHHHhcccCcCCCCCCChhhhhhCCcc
Q psy758 234 MQYEEITQRCLDKDPLRRWSCDQLLRHPYF 263 (292)
Q Consensus 234 ~~l~~li~~~l~~dP~~Rpt~~~il~h~w~ 263 (292)
..+.++|.+||..+|++|||+.++++||||
T Consensus 228 ~~~~~~i~~~l~~~p~~Rpt~~~ll~~~~~ 257 (257)
T cd08225 228 RDLRSLISQLFKVSPRDRPSITSILKRPFL 257 (257)
T ss_pred HHHHHHHHHHhccChhhCcCHHHHhhCCCC
Confidence 789999999999999999999999999997
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown. |
| >cd06637 STKc_TNIK Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-37 Score=249.70 Aligned_cols=251 Identities=27% Similarity=0.390 Sum_probs=179.1
Q ss_pred cccceeeeecccCceEEEEEEEcCCCcEEEEEEeccCCCChHHHHHHHHHHHHHHhC-CCCCcchhhhhhhc------CC
Q psy758 2 ERYEKIGKLGEGSYGVVFKCRNRDTGQVVAIKKFLESEEDPLIRKIALREIRLLKSL-KHPNLVNLLEVFRR------KK 74 (292)
Q Consensus 2 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~e~~~~~~l-~~~~i~~~~~~~~~------~~ 74 (292)
++|++.+.||+|++|.||.|.+..+++.|++|.+...... ...+.+|+.+++.+ +||||+++++++.. ..
T Consensus 6 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~~aik~~~~~~~~---~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~~~~ 82 (272)
T cd06637 6 GIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTGDE---EEEIKQEINMLKKYSHHRNIATYYGAFIKKNPPGMDD 82 (272)
T ss_pred hhhhHHHheeecCCeEEEEEEEcCCCcEEEEEEEEcCCcc---HHHHHHHHHHHHHhcCCCCeeeEeeEEeecCCCCCCc
Confidence 4689999999999999999999999999999998655432 34567899999998 69999999999864 24
Q ss_pred eEEEEEecCCCccHHHHhcCC--CCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEEccCCcEEEeecCchhhhh
Q psy758 75 KLHLVFEFCDHTVLNELENHP--HGLPWDLIKQITWQVLRGVSYCHRHACIHRDIKPENILLTANGVVKLCDFGFARLIR 152 (292)
Q Consensus 75 ~~~iv~e~~~~~~L~~~~~~~--~~~~~~~~~~i~~qi~~aL~~LH~~givH~dl~p~Nilv~~~~~~kl~dfg~~~~~~ 152 (292)
.+++++||+++++|..++... ..+++..+..++.|++.||+|||++|++|+||+|+||++++++.++|+|||++....
T Consensus 83 ~~~iv~e~~~~~~L~~~l~~~~~~~l~~~~~~~~~~qi~~~l~~LH~~~ivh~dl~~~nili~~~~~~~l~Dfg~~~~~~ 162 (272)
T cd06637 83 QLWLVMEFCGAGSVTDLIKNTKGNTLKEEWIAYICREILRGLSHLHQHKVIHRDIKGQNVLLTENAEVKLVDFGVSAQLD 162 (272)
T ss_pred EEEEEEEcCCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCCccCCCCHHHEEECCCCCEEEccCCCceecc
Confidence 689999999999999988753 358999999999999999999999999999999999999999999999999987543
Q ss_pred cccc-----ccccccccccccccCCCCCCCcccceeeecCCCCCCchHHHHHHHhhcccCCCCCCChhhhhhccCcCC--
Q psy758 153 DLIP-----RHLHIFQTNEYFKGVSLPHAENVVPLEIKIGKPAATNIYLIDFLKRCLDKDPLRRWSCDQLLRHPYFNG-- 225 (292)
Q Consensus 153 ~~~~-----~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~-- 225 (292)
.... .....|.+||+..+.... ........+.++.+..+++.+.+..|.................
T Consensus 163 ~~~~~~~~~~g~~~y~aPE~~~~~~~~--------~~~~~~~~Dv~slGv~l~el~~g~~p~~~~~~~~~~~~~~~~~~~ 234 (272)
T cd06637 163 RTVGRRNTFIGTPYWMAPEVIACDENP--------DATYDFKSDLWSLGITAIEMAEGAPPLCDMHPMRALFLIPRNPAP 234 (272)
T ss_pred cccccCCcccccccccCHhHhccccCc--------CCCCCchhhHHHHHHHHHHHHhCCCCccccCHHHHHHHHhcCCCC
Confidence 2211 122345666655321100 0000011122222333333333444433222111111000000
Q ss_pred CCCCCCCccchHHHHhcccCcCCCCCCChhhhhhCCcc
Q psy758 226 YYFEVPDEMQYEEITQRCLDKDPLRRWSCDQLLRHPYF 263 (292)
Q Consensus 226 ~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~~il~h~w~ 263 (292)
.......+..+.+||.+||..||.+|||+.+++.||||
T Consensus 235 ~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~~~~~ 272 (272)
T cd06637 235 RLKSKKWSKKFQSFIESCLVKNHSQRPTTEQLMKHPFI 272 (272)
T ss_pred CCCCCCcCHHHHHHHHHHcCCChhhCCCHHHHhhCCCC
Confidence 01112346789999999999999999999999999997
|
Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activ |
| >cd07851 STKc_p38 Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.4e-38 Score=261.25 Aligned_cols=264 Identities=28% Similarity=0.412 Sum_probs=191.8
Q ss_pred cccceeeeecccCceEEEEEEEcCCCcEEEEEEeccCCCChHHHHHHHHHHHHHHhCCCCCcchhhhhhhcCCe------
Q psy758 2 ERYEKIGKLGEGSYGVVFKCRNRDTGQVVAIKKFLESEEDPLIRKIALREIRLLKSLKHPNLVNLLEVFRRKKK------ 75 (292)
Q Consensus 2 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~------ 75 (292)
++|++.+.||+|++|.||+|.+..+++.|++|.+............+.+|+.+++.++|||++++++++...+.
T Consensus 15 ~~y~~~~~ig~g~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~ 94 (343)
T cd07851 15 DRYQNLSPVGSGAYGQVCSAFDTKTGRKVAIKKLSRPFQSAIHAKRTYRELRLLKHMDHENVIGLLDVFTPASSLEDFQD 94 (343)
T ss_pred CceEEEEEeccCCceEEEEEEECCCCcEEEEEecccccchhhHHHHHHHHHHHHHhccCCCHHHHHHHhhcccccccccc
Confidence 57999999999999999999999999999999987654444455667889999999999999999998876554
Q ss_pred EEEEEecCCCccHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEEccCCcEEEeecCchhhhhccc
Q psy758 76 LHLVFEFCDHTVLNELENHPHGLPWDLIKQITWQVLRGVSYCHRHACIHRDIKPENILLTANGVVKLCDFGFARLIRDLI 155 (292)
Q Consensus 76 ~~iv~e~~~~~~L~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~givH~dl~p~Nilv~~~~~~kl~dfg~~~~~~~~~ 155 (292)
.++|+||++ ++|.+++.. ..+++..++.++.|++.||.+||+.|++|+||+|+||++++++.++|+|||++.......
T Consensus 95 ~~lv~e~~~-~~L~~~~~~-~~l~~~~~~~~~~ql~~aL~~LH~~gi~H~dlkp~Nill~~~~~~kL~dfg~~~~~~~~~ 172 (343)
T cd07851 95 VYLVTHLMG-ADLNNIVKC-QKLSDDHIQFLVYQILRGLKYIHSAGIIHRDLKPSNIAVNEDCELKILDFGLARHTDDEM 172 (343)
T ss_pred EEEEEecCC-CCHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEECCCCCEEEccccccccccccc
Confidence 899999995 578888765 469999999999999999999999999999999999999999999999999987654321
Q ss_pred --cccccccccccccccC------CCCCCCcccceeeecCCCCCCchHHHHHHHhhccc---CCC---CCCC---hhhhh
Q psy758 156 --PRHLHIFQTNEYFKGV------SLPHAENVVPLEIKIGKPAATNIYLIDFLKRCLDK---DPL---RRWS---CDQLL 218 (292)
Q Consensus 156 --~~~~~~~~~~~~~~~~------~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~---~p~---~~~~---~~~~~ 218 (292)
...+..|.+|+...+. ...|+.|+..+++.+|..++........+...... .+. .+.. ....+
T Consensus 173 ~~~~~~~~y~aPE~~~~~~~~~~~~DvwslGv~l~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~ 252 (343)
T cd07851 173 TGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGKTLFPGSDHIDQLKRIMNLVGTPDEELLQKISSESARNYI 252 (343)
T ss_pred cCCcccccccCHHHHhCCCCCCchHhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCHHHHhhccchhHHHHH
Confidence 1223346667665332 33455666666666676654333322222222111 110 0000 00000
Q ss_pred hcc-CcCCC---CCCCCCccchHHHHhcccCcCCCCCCChhhhhhCCccccee
Q psy758 219 RHP-YFNGY---YFEVPDEMQYEEITQRCLDKDPLRRWSCDQLLRHPYFNGYY 267 (292)
Q Consensus 219 ~~~-~~~~~---~~~~~~~~~l~~li~~~l~~dP~~Rpt~~~il~h~w~~~~~ 267 (292)
... ..... ......+..+.++|.+||+.||.+|||+.+|++||||..+.
T Consensus 253 ~~~~~~~~~~~~~~~~~~s~~l~dli~~~l~~~P~~Rpt~~ell~h~~~~~~~ 305 (343)
T cd07851 253 QSLPQMPKKDFKEVFSGANPLAIDLLEKMLVLDPDKRITAAEALAHPYLAEYH 305 (343)
T ss_pred HhccccCCCCHHHHhccCCHHHHHHHHHhCCCChhhCCCHHHHhcCCCccccC
Confidence 000 00000 00112367899999999999999999999999999999854
|
Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK |
| >cd05633 STKc_GRK3 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-37 Score=251.27 Aligned_cols=249 Identities=20% Similarity=0.284 Sum_probs=178.0
Q ss_pred eecccCceEEEEEEEcCCCcEEEEEEeccCCCC-hHHHHHHHHHHHHHH---hCCCCCcchhhhhhhcCCeEEEEEecCC
Q psy758 9 KLGEGSYGVVFKCRNRDTGQVVAIKKFLESEED-PLIRKIALREIRLLK---SLKHPNLVNLLEVFRRKKKLHLVFEFCD 84 (292)
Q Consensus 9 ~l~~g~~~~v~~~~~~~~~~~v~iK~~~~~~~~-~~~~~~~~~e~~~~~---~l~~~~i~~~~~~~~~~~~~~iv~e~~~ 84 (292)
.||+|+||.||++.+..+++.+|+|.+...... ........+|..+++ ...||+++.+++++..++..++||||++
T Consensus 1 ~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~ 80 (279)
T cd05633 1 IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMTYAFHTPDKLCFILDLMN 80 (279)
T ss_pred CcccCCCeEEEEEEECCCCcEEEEEEEEccccccchHHHHHHHHHHHHHHHhhCCCCcEeEEEEEEecCCeEEEEEecCC
Confidence 489999999999999999999999998655422 111222334443333 3479999999999998999999999999
Q ss_pred CccHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEEccCCcEEEeecCchhhhhccc---cccccc
Q psy758 85 HTVLNELENHPHGLPWDLIKQITWQVLRGVSYCHRHACIHRDIKPENILLTANGVVKLCDFGFARLIRDLI---PRHLHI 161 (292)
Q Consensus 85 ~~~L~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~givH~dl~p~Nilv~~~~~~kl~dfg~~~~~~~~~---~~~~~~ 161 (292)
+++|..++...+.+++..+..++.|++.||.|||++|++|+||+|+||+++.++.++|+|||++....... ...+..
T Consensus 81 ~~~L~~~i~~~~~l~~~~~~~i~~qi~~al~~lH~~~ivH~dikp~Nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~ 160 (279)
T cd05633 81 GGDLHYHLSQHGVFSEKEMRFYATEIILGLEHMHNRFVVYRDLKPANILLDEHGHVRISDLGLACDFSKKKPHASVGTHG 160 (279)
T ss_pred CCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCcCCCCCCHHHEEECCCCCEEEccCCcceeccccCccCcCCCcC
Confidence 99999998877789999999999999999999999999999999999999999999999999986543211 122334
Q ss_pred ccccccccc-CCCCCCCcccceeeecCCCCCCchHHHHHHHhhcccCCCCCCC---hhhhhhccCcCCCCCCCCCccchH
Q psy758 162 FQTNEYFKG-VSLPHAENVVPLEIKIGKPAATNIYLIDFLKRCLDKDPLRRWS---CDQLLRHPYFNGYYFEVPDEMQYE 237 (292)
Q Consensus 162 ~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~---~~~~~~~~~~~~~~~~~~~~~~l~ 237 (292)
|.+||...+ ...... .+.++.+..++..+.+..|+.... ...+...........+...+..+.
T Consensus 161 y~aPE~~~~~~~~~~~-------------~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 227 (279)
T cd05633 161 YMAPEVLQKGTAYDSS-------------ADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTLTVNVELPDSFSPELK 227 (279)
T ss_pred ccCHHHhcCCCCCCch-------------hhhHHHHHHHHHHHhCCCCcCCCCCcCHHHHHHHhhcCCcCCccccCHHHH
Confidence 555555432 111111 122333333344444444432211 111111111111223344577899
Q ss_pred HHHhcccCcCCCCCC-----ChhhhhhCCcccceeccC
Q psy758 238 EITQRCLDKDPLRRW-----SCDQLLRHPYFNGYYFEV 270 (292)
Q Consensus 238 ~li~~~l~~dP~~Rp-----t~~~il~h~w~~~~~~~~ 270 (292)
++|.+||..||++|| |++++++||||+++.|..
T Consensus 228 ~li~~~l~~~p~~R~~~~~~~~~~~~~h~~~~~~~~~~ 265 (279)
T cd05633 228 SLLEGLLQRDVSKRLGCLGRGAQEVKEHVFFKGIDWQQ 265 (279)
T ss_pred HHHHHHhcCCHHHhcCCCCCCHHHHHhCccccCCCHhH
Confidence 999999999999999 699999999999977653
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is wi |
| >cd07837 STKc_CdkB_plant Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.3e-38 Score=256.71 Aligned_cols=262 Identities=31% Similarity=0.491 Sum_probs=184.6
Q ss_pred cccceeeeecccCceEEEEEEEcCCCcEEEEEEeccCCCChHHHHHHHHHHHHHHhCC-CCCcchhhhhhhcCCe-----
Q psy758 2 ERYEKIGKLGEGSYGVVFKCRNRDTGQVVAIKKFLESEEDPLIRKIALREIRLLKSLK-HPNLVNLLEVFRRKKK----- 75 (292)
Q Consensus 2 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~e~~~~~~l~-~~~i~~~~~~~~~~~~----- 75 (292)
++|++.+.||+|++|.||+|.+..+++.|++|.+............+.+|+.+++.++ ||||+++++++...+.
T Consensus 1 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~lK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~~~~ 80 (295)
T cd07837 1 DAYEKLEKIGEGTYGKVYKARDKNTGKLVALKKTRLEMDEEGIPPTALREISLLQMLSESIYIVRLLDVEHVEEKNGKPS 80 (295)
T ss_pred CCceEeeEecccCCeEEEEEEECCCCcEEEEEeehhhccccCCchHHHHHHHHHHHccCCCCccceeeeEeecCCCCCce
Confidence 5799999999999999999999999999999998665443334456778999999995 6999999998876554
Q ss_pred EEEEEecCCCccHHHHhcC-----CCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEEcc-CCcEEEeecCchh
Q psy758 76 LHLVFEFCDHTVLNELENH-----PHGLPWDLIKQITWQVLRGVSYCHRHACIHRDIKPENILLTA-NGVVKLCDFGFAR 149 (292)
Q Consensus 76 ~~iv~e~~~~~~L~~~~~~-----~~~~~~~~~~~i~~qi~~aL~~LH~~givH~dl~p~Nilv~~-~~~~kl~dfg~~~ 149 (292)
.|+++||++++ +..++.. ...+++..++.++.||+.||.|||++|++|+||+|+||+++. ++.++|+|||.+.
T Consensus 81 ~~lv~e~~~~~-l~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~i~H~dl~~~nil~~~~~~~~kl~dfg~~~ 159 (295)
T cd07837 81 LYLVFEYLDSD-LKKFMDSNGRGPGRPLPAKTIKSFMYQLLKGVAHCHKHGVMHRDLKPQNLLVDKQKGLLKIADLGLGR 159 (295)
T ss_pred EEEEeeccCcC-HHHHHHHhcccCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCChHHEEEecCCCeEEEeecccce
Confidence 89999999974 5555432 235799999999999999999999999999999999999998 8899999999887
Q ss_pred hhhccc-----cccccccccccccccC------CCCCCCcccceeeecCCCCCCchHHHHHHHhhcc--cCCCCCC--Ch
Q psy758 150 LIRDLI-----PRHLHIFQTNEYFKGV------SLPHAENVVPLEIKIGKPAATNIYLIDFLKRCLD--KDPLRRW--SC 214 (292)
Q Consensus 150 ~~~~~~-----~~~~~~~~~~~~~~~~------~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~p~~~~--~~ 214 (292)
...... ......|.+||+..+. ...|+.|+..+++.+|..++........+..+.. ..|.... ..
T Consensus 160 ~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 239 (295)
T cd07837 160 AFSIPVKSYTHEIVTLWYRAPEVLLGSTHYSTPVDIWSVGCIFAEMSRKQPLFPGDSELQQLLHIFKLLGTPTEQVWPGV 239 (295)
T ss_pred ecCCCccccCCcccccCCCChHHhhCCCCCCchHHHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHHHhCCCChhhCcch
Confidence 543211 1123446777766432 2345666666666667655432221111111110 0111100 00
Q ss_pred hhh---hhccCcCCC---CCCCCCccchHHHHhcccCcCCCCCCChhhhhhCCccc
Q psy758 215 DQL---LRHPYFNGY---YFEVPDEMQYEEITQRCLDKDPLRRWSCDQLLRHPYFN 264 (292)
Q Consensus 215 ~~~---~~~~~~~~~---~~~~~~~~~l~~li~~~l~~dP~~Rpt~~~il~h~w~~ 264 (292)
... ...+.+... ......+..+.++|.+||.+||.+|||+++++.||||+
T Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~R~~~~eil~~~~~~ 295 (295)
T cd07837 240 SKLRDWHEFPQWKPQDLSRAVPDLSPEGLDLLQKMLRYDPAKRISAKAALTHPYFD 295 (295)
T ss_pred hhccchhhcCcccchhHHHhccccCHHHHHHHHHHccCChhhcCCHHHHhcCCCcC
Confidence 000 000000000 00123467899999999999999999999999999985
|
Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developm |
| >cd07880 STKc_p38gamma_MAPK12 Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-38 Score=262.47 Aligned_cols=264 Identities=29% Similarity=0.429 Sum_probs=191.9
Q ss_pred cccceeeeecccCceEEEEEEEcCCCcEEEEEEeccCCCChHHHHHHHHHHHHHHhCCCCCcchhhhhhhcCC------e
Q psy758 2 ERYEKIGKLGEGSYGVVFKCRNRDTGQVVAIKKFLESEEDPLIRKIALREIRLLKSLKHPNLVNLLEVFRRKK------K 75 (292)
Q Consensus 2 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~------~ 75 (292)
++|++.+.||+|++|.||+|.+..++..||+|.+............+.+|+.+++.++||||+++++++..+. .
T Consensus 15 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~ 94 (343)
T cd07880 15 DRYRDLKQVGSGAYGTVCSALDRRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMKHENVIGLLDVFTPDLSLDRFHD 94 (343)
T ss_pred cceEEEEEeeecCCeEEEEEEECCCCcEEEEEEecccccchHHHHHHHHHHHHHHhcCCCCccceeeeecCCccccccce
Confidence 5899999999999999999999999999999998655444445567889999999999999999999987543 4
Q ss_pred EEEEEecCCCccHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEEccCCcEEEeecCchhhhhccc
Q psy758 76 LHLVFEFCDHTVLNELENHPHGLPWDLIKQITWQVLRGVSYCHRHACIHRDIKPENILLTANGVVKLCDFGFARLIRDLI 155 (292)
Q Consensus 76 ~~iv~e~~~~~~L~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~givH~dl~p~Nilv~~~~~~kl~dfg~~~~~~~~~ 155 (292)
+++|+||+ +++|..++.. ..+++..++.++.||+.||.|||+.|++|+||+|+||++++++.++|+|||++.......
T Consensus 95 ~~lv~e~~-~~~l~~~~~~-~~l~~~~~~~i~~qi~~al~~LH~~gi~H~dlkp~Nill~~~~~~kl~dfg~~~~~~~~~ 172 (343)
T cd07880 95 FYLVMPFM-GTDLGKLMKH-EKLSEDRIQFLVYQMLKGLKYIHAAGIIHRDLKPGNLAVNEDCELKILDFGLARQTDSEM 172 (343)
T ss_pred EEEEEecC-CCCHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCCEEEeecccccccccCc
Confidence 68999998 6678877764 479999999999999999999999999999999999999999999999999987654322
Q ss_pred --cccccccccccccccC------CCCCCCcccceeeecCCCCCCchHHHHHHHhhcccCCCCCCChh---------hhh
Q psy758 156 --PRHLHIFQTNEYFKGV------SLPHAENVVPLEIKIGKPAATNIYLIDFLKRCLDKDPLRRWSCD---------QLL 218 (292)
Q Consensus 156 --~~~~~~~~~~~~~~~~------~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~---------~~~ 218 (292)
......|.+|+...+. ...|+.|+..+.+.+|..++........+...+...+....... ...
T Consensus 173 ~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 252 (343)
T cd07880 173 TGYVVTRWYRAPEVILNWMHYTQTVDIWSVGCIMAEMLTGKPLFKGHDHLDQLMEIMKVTGTPSKEFVQKLQSEDAKNYV 252 (343)
T ss_pred cccccCCcccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHHHHHhhcchhHHHHH
Confidence 1223446677765442 23455666666666676655433322222222111110000000 000
Q ss_pred hc-cCcCC---CCCCCCCccchHHHHhcccCcCCCCCCChhhhhhCCccccee
Q psy758 219 RH-PYFNG---YYFEVPDEMQYEEITQRCLDKDPLRRWSCDQLLRHPYFNGYY 267 (292)
Q Consensus 219 ~~-~~~~~---~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~~il~h~w~~~~~ 267 (292)
.. +.+.. .......+..+.++|.+||+.||++|||+.++++||||+...
T Consensus 253 ~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~R~t~~~~l~~~~~~~~~ 305 (343)
T cd07880 253 KKLPRFRKKDFRSLLPNANPLAVNVLEKMLVLDAESRITAAEALAHPYFEEFH 305 (343)
T ss_pred HhccccCcchHHHhccCCChHHHHHHHHHcCCChhhCCCHHHHhcCccHhhhc
Confidence 00 00000 001123466789999999999999999999999999999854
|
Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12 |
| >cd07854 STKc_MAPK4_6 Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-37 Score=259.77 Aligned_cols=261 Identities=25% Similarity=0.397 Sum_probs=189.2
Q ss_pred cccceeeeecccCceEEEEEEEcCCCcEEEEEEeccCCCChHHHHHHHHHHHHHHhCCCCCcchhhhhhhcC--------
Q psy758 2 ERYEKIGKLGEGSYGVVFKCRNRDTGQVVAIKKFLESEEDPLIRKIALREIRLLKSLKHPNLVNLLEVFRRK-------- 73 (292)
Q Consensus 2 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~-------- 73 (292)
++|++.+.||.|++|.||+|.+..+++.|++|.+..... ...+.+.+|+.+++.++||||+++++++...
T Consensus 5 ~~y~~~~~Lg~g~~g~vy~~~~~~~~~~v~iK~i~~~~~--~~~~~~~~Ei~~l~~l~h~~i~~~~~~~~~~~~~~~~~~ 82 (342)
T cd07854 5 SRYMDLRPLGCGSNGLVFSAVDSDCDKRVAVKKIVLTDP--QSVKHALREIKIIRRLDHDNIVKVYEVLGPSGSDLTEDV 82 (342)
T ss_pred cceEEEEEecCCCCEEEEEEEECCCCcEEEEEEEecCCC--chHHHHHHHHHHHHhcCCCcchhhHhhhccccccccccc
Confidence 589999999999999999999999999999999866543 2346677899999999999999999887653
Q ss_pred ------CeEEEEEecCCCccHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEEcc-CCcEEEeecC
Q psy758 74 ------KKLHLVFEFCDHTVLNELENHPHGLPWDLIKQITWQVLRGVSYCHRHACIHRDIKPENILLTA-NGVVKLCDFG 146 (292)
Q Consensus 74 ------~~~~iv~e~~~~~~L~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~givH~dl~p~Nilv~~-~~~~kl~dfg 146 (292)
...|+++||+++ +|..++.. ..+++..++.++.||+.||.|||+.|++|+||+|+||+++. ++.++|+|||
T Consensus 83 ~~~~~~~~~~lv~e~~~~-~L~~~~~~-~~l~~~~~~~~~~qi~~aL~~LH~~givH~dikp~Nili~~~~~~~kl~dfg 160 (342)
T cd07854 83 GSLTELNSVYIVQEYMET-DLANVLEQ-GPLSEEHARLFMYQLLRGLKYIHSANVLHRDLKPANVFINTEDLVLKIGDFG 160 (342)
T ss_pred ccccccceEEEEeecccc-cHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEEcCCCceEEECCcc
Confidence 357999999985 67777754 36899999999999999999999999999999999999984 5678999999
Q ss_pred chhhhhcccc--------cccccccccccccc------CCCCCCCcccceeeecCCCCCCchHHHHHHHhhcccCCCCCC
Q psy758 147 FARLIRDLIP--------RHLHIFQTNEYFKG------VSLPHAENVVPLEIKIGKPAATNIYLIDFLKRCLDKDPLRRW 212 (292)
Q Consensus 147 ~~~~~~~~~~--------~~~~~~~~~~~~~~------~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~ 212 (292)
.+........ ..+..|.+||...+ ....|+.|+..+++.++..++............+...|..+.
T Consensus 161 ~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~ 240 (342)
T cd07854 161 LARIVDPHYSHKGYLSEGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKPLFAGAHELEQMQLILESVPVVRE 240 (342)
T ss_pred cceecCCccccccccccccccccccCHHHHhCccccCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCh
Confidence 9875532111 12335677775432 234566666666677777665433333333333333232222
Q ss_pred Chhhhh----hccCc-----CCC---CCCCCCccchHHHHhcccCcCCCCCCChhhhhhCCcccce
Q psy758 213 SCDQLL----RHPYF-----NGY---YFEVPDEMQYEEITQRCLDKDPLRRWSCDQLLRHPYFNGY 266 (292)
Q Consensus 213 ~~~~~~----~~~~~-----~~~---~~~~~~~~~l~~li~~~l~~dP~~Rpt~~~il~h~w~~~~ 266 (292)
...... ..... ... ......+..+.+||.+||+.||.+|||+.++++||||+.+
T Consensus 241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~ell~h~~~~~~ 306 (342)
T cd07854 241 EDRNELLNVIPSFVRNDGGEPRRPLRDLLPGVNPEALDFLEQILTFNPMDRLTAEEALMHPYMSCY 306 (342)
T ss_pred HHhhhhhhhhhhhhhhcccccCCCHHHHccCCCHHHHHHHHHHhCCCchhccCHHHHhCCCccccc
Confidence 111000 00000 000 0011346678899999999999999999999999999864
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progressi |
| >cd07835 STKc_CDK1_like Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-37 Score=252.63 Aligned_cols=259 Identities=35% Similarity=0.526 Sum_probs=188.4
Q ss_pred cceeeeecccCceEEEEEEEcCCCcEEEEEEeccCCCChHHHHHHHHHHHHHHhCCCCCcchhhhhhhcCCeEEEEEecC
Q psy758 4 YEKIGKLGEGSYGVVFKCRNRDTGQVVAIKKFLESEEDPLIRKIALREIRLLKSLKHPNLVNLLEVFRRKKKLHLVFEFC 83 (292)
Q Consensus 4 y~~~~~l~~g~~~~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~iv~e~~ 83 (292)
|++.+.||.|++|.||+|.+..+|..|++|++............+.+|+..++.++|||++++++++.+++..++++||+
T Consensus 1 y~~~~~l~~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~l~~~~iv~~~~~~~~~~~~~iv~e~~ 80 (283)
T cd07835 1 YQKVEKIGEGTYGVVYKARDKLTGEIVALKKIRLETEDEGVPSTAIREISLLKELNHPNIVRLLDVVHSENKLYLVFEFL 80 (283)
T ss_pred CchheEecCCCCeEEEEEEEcCCCCEEEEEEeecccccccchhHHHHHHHHHHhcCCCCccCHhheeccCCeEEEEEecc
Confidence 78899999999999999999999999999998765544444456778999999999999999999999999999999999
Q ss_pred CCccHHHHhcCCC--CCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEEccCCcEEEeecCchhhhhccc-----c
Q psy758 84 DHTVLNELENHPH--GLPWDLIKQITWQVLRGVSYCHRHACIHRDIKPENILLTANGVVKLCDFGFARLIRDLI-----P 156 (292)
Q Consensus 84 ~~~~L~~~~~~~~--~~~~~~~~~i~~qi~~aL~~LH~~givH~dl~p~Nilv~~~~~~kl~dfg~~~~~~~~~-----~ 156 (292)
+ ++|..++.... .+++..++.++.|++.||+|||++|++||||+|+||++++++.++|+|||.+....... .
T Consensus 81 ~-~~l~~~~~~~~~~~~~~~~~~~~~~~i~~~L~~lH~~~~~H~dl~p~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~ 159 (283)
T cd07835 81 D-LDLKKYMDSSPLTGLDPPLIKSYLYQLLQGIAYCHSHRVLHRDLKPQNLLIDREGALKLADFGLARAFGVPVRTYTHE 159 (283)
T ss_pred C-cCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeCCCCCHHHEEEcCCCcEEEeecccccccCCCccccCcc
Confidence 6 46777776544 68999999999999999999999999999999999999999999999999987543211 1
Q ss_pred ccccccccccccccC------CCCCCCcccceeeecCCCCCCchHHHHHHHhhcc--cCCCCCC--------Chhhhhh-
Q psy758 157 RHLHIFQTNEYFKGV------SLPHAENVVPLEIKIGKPAATNIYLIDFLKRCLD--KDPLRRW--------SCDQLLR- 219 (292)
Q Consensus 157 ~~~~~~~~~~~~~~~------~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~p~~~~--------~~~~~~~- 219 (292)
.....|.+||...+. ...|+.|+..+++.+|.+++........+..... ..|.... .......
T Consensus 160 ~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 239 (283)
T cd07835 160 VVTLWYRAPEILLGSRQYSTPVDIWSIGCIFAEMVNRRPLFPGDSEIDQLFRIFRTLGTPDEDVWPGVTSLPDYKPTFPK 239 (283)
T ss_pred ccccCCCCCceeecCcccCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChHHhhhhhhchhhhhhccc
Confidence 123446777765432 2246666666677777665432222111111111 0010000 0000000
Q ss_pred ccCcCCCCCCCCCccchHHHHhcccCcCCCCCCChhhhhhCCcc
Q psy758 220 HPYFNGYYFEVPDEMQYEEITQRCLDKDPLRRWSCDQLLRHPYF 263 (292)
Q Consensus 220 ~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~~il~h~w~ 263 (292)
.............+..+.++|.+||+.||.+|||++++++||||
T Consensus 240 ~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~il~~~~~ 283 (283)
T cd07835 240 WARQDLSKVVPNLDEDGLDLLSKMLVYDPAKRISAKAALQHPYF 283 (283)
T ss_pred ccccchhhhcCCCCHHHHHHHHHHhcCChhhCcCHHHHhcCCCC
Confidence 00000001122346789999999999999999999999999998
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyc |
| >cd07842 STKc_CDK8_like Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=7e-38 Score=258.91 Aligned_cols=261 Identities=30% Similarity=0.484 Sum_probs=184.2
Q ss_pred ccceeeeecccCceEEEEEEEcC--CCcEEEEEEeccCC-CChHHHHHHHHHHHHHHhCCCCCcchhhhhhhcC--CeEE
Q psy758 3 RYEKIGKLGEGSYGVVFKCRNRD--TGQVVAIKKFLESE-EDPLIRKIALREIRLLKSLKHPNLVNLLEVFRRK--KKLH 77 (292)
Q Consensus 3 ~y~~~~~l~~g~~~~v~~~~~~~--~~~~v~iK~~~~~~-~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~--~~~~ 77 (292)
+|.+.+.||+|++|.||+|.+.. +++.||+|.+.... ........+.+|+.+++.++||||+++++++.+. +.++
T Consensus 1 ~y~~~~~ig~g~~g~v~~~~~~~~~~~~~~alK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~ 80 (316)
T cd07842 1 KYEIEGCIGRGTYGRVYKAKRKNGKDGKEYAIKKFKGDKEQYTGISQSACREIALLRELKHENVVSLVEVFLEHADKSVY 80 (316)
T ss_pred CceEEEEeccCCcEEEEEEEecCCCCCCeEEEEEeccccccccCccHHHHHHHHHHHhcCCCCccceEEEEeCCCCceEE
Confidence 68999999999999999999988 89999999987643 2222335567899999999999999999999887 8899
Q ss_pred EEEecCCCccHHHHhc---C-CCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEEcc----CCcEEEeecCchh
Q psy758 78 LVFEFCDHTVLNELEN---H-PHGLPWDLIKQITWQVLRGVSYCHRHACIHRDIKPENILLTA----NGVVKLCDFGFAR 149 (292)
Q Consensus 78 iv~e~~~~~~L~~~~~---~-~~~~~~~~~~~i~~qi~~aL~~LH~~givH~dl~p~Nilv~~----~~~~kl~dfg~~~ 149 (292)
+|+||++++.+..+.. . ...+++..++.++.||+.||.|||+.|++|+||+|+||+++. ++.++|+|||++.
T Consensus 81 lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~h~dlkp~Nil~~~~~~~~~~~kl~Dfg~~~ 160 (316)
T cd07842 81 LLFDYAEHDLWQIIKFHRQAKRVSIPPSMVKSLLWQILNGVHYLHSNWVLHRDLKPANILVMGEGPERGVVKIGDLGLAR 160 (316)
T ss_pred EEEeCCCcCHHHHHHhhccCCCcCcCHHHHHHHHHHHHHHHHHHHhCCEeeCCCCHHHEEEcCCCCccceEEECCCcccc
Confidence 9999998755443321 1 236899999999999999999999999999999999999999 8999999999987
Q ss_pred hhhcccc--------ccccccccccccccC------CCCCCCcccceeeecCCCCCCch-------------HHHHHHHh
Q psy758 150 LIRDLIP--------RHLHIFQTNEYFKGV------SLPHAENVVPLEIKIGKPAATNI-------------YLIDFLKR 202 (292)
Q Consensus 150 ~~~~~~~--------~~~~~~~~~~~~~~~------~~~~~~~~~~~~~~~~~~~~~~~-------------~~~~~~~~ 202 (292)
....... ..+..|.+||...+. ...|+.|+..+++.++.+++... ....++..
T Consensus 161 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 240 (316)
T cd07842 161 LFNAPLKPLADLDPVVVTIWYRAPELLLGARHYTKAIDIWAIGCIFAELLTLEPIFKGREAKIKKSNPFQRDQLERIFEV 240 (316)
T ss_pred ccCCCcccccccCCccccccccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhcCCCCcCCcccccccchhHHHHHHHHHHH
Confidence 6543211 123346778765443 23466666666666666554211 11112222
Q ss_pred hcccCCCCCCChhhhhh------ccCcCCCC-------CC--CCCccchHHHHhcccCcCCCCCCChhhhhhCCcc
Q psy758 203 CLDKDPLRRWSCDQLLR------HPYFNGYY-------FE--VPDEMQYEEITQRCLDKDPLRRWSCDQLLRHPYF 263 (292)
Q Consensus 203 ~~~~~p~~~~~~~~~~~------~~~~~~~~-------~~--~~~~~~l~~li~~~l~~dP~~Rpt~~~il~h~w~ 263 (292)
+-...+..+....+... ........ .+ ...+..+.++|.+||+.||++|||+.|+++||||
T Consensus 241 l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rps~~eil~~~~f 316 (316)
T cd07842 241 LGTPTEKDWPDIKKMPEYDTLMKDFKTKTYPSNSLAKWMEKHKKPDSQGFDLLRKLLEYDPTKRITAEEALEHPYF 316 (316)
T ss_pred hCCCchhHHHHHhhcccchhhhhhccCCCCCCccHHHHHHhccCCCHHHHHHHHHHhcCCcccCcCHHHHhcCCCC
Confidence 21111111100000000 00000000 00 1446678999999999999999999999999998
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the |
| >cd06627 STKc_Cdc7_like Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.8e-37 Score=244.82 Aligned_cols=248 Identities=29% Similarity=0.421 Sum_probs=191.6
Q ss_pred ccceeeeecccCceEEEEEEEcCCCcEEEEEEeccCCCChHHHHHHHHHHHHHHhCCCCCcchhhhhhhcCCeEEEEEec
Q psy758 3 RYEKIGKLGEGSYGVVFKCRNRDTGQVVAIKKFLESEEDPLIRKIALREIRLLKSLKHPNLVNLLEVFRRKKKLHLVFEF 82 (292)
Q Consensus 3 ~y~~~~~l~~g~~~~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~iv~e~ 82 (292)
+|++.+.||+|++|.||++.+..+++.|++|.+..........+.+.+|+++++.++|||++++++++.+++..++++|+
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~ 80 (254)
T cd06627 1 NYQLGDLIGRGAFGVVYKGLNLETGDFVAIKQISLEKIKEEALKSIMQEIDLLKNLKHPNIVKYIGSIETSDSLYIILEY 80 (254)
T ss_pred CceeeeEEcccCCeEEEEEEEcCCCcEEEEEEecccccCHHHHHHHHHHHHHHHhCCCCCccEEEEEEEeCCEEEEEEec
Confidence 68999999999999999999999999999999987765555667899999999999999999999999999999999999
Q ss_pred CCCccHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEEccCCcEEEeecCchhhhhcccc-----c
Q psy758 83 CDHTVLNELENHPHGLPWDLIKQITWQVLRGVSYCHRHACIHRDIKPENILLTANGVVKLCDFGFARLIRDLIP-----R 157 (292)
Q Consensus 83 ~~~~~L~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~givH~dl~p~Nilv~~~~~~kl~dfg~~~~~~~~~~-----~ 157 (292)
+++++|.+++.....+++..++.++.|++.||.+||+.|++|+||+|+||+++.++.++|+|||.+........ .
T Consensus 81 ~~~~~L~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~~~~~~~ 160 (254)
T cd06627 81 AENGSLRQIIKKFGPFPESLVAVYVYQVLQGLAYLHEQGVIHRDIKAANILTTKDGVVKLADFGVATKLNDVSKDDASVV 160 (254)
T ss_pred CCCCcHHHHHHhccCCCHHHHHHHHHHHHHHHHHHhhCCcccCCCCHHHEEECCCCCEEEeccccceecCCCcccccccc
Confidence 99999999998777899999999999999999999999999999999999999999999999999876654332 1
Q ss_pred cccccccccccccCCCCCCCcccceeeecCCCCCCchHHHHHHHhhcccCCCCCCChhhhhhc-cCcCCCCCCCCCccch
Q psy758 158 HLHIFQTNEYFKGVSLPHAENVVPLEIKIGKPAATNIYLIDFLKRCLDKDPLRRWSCDQLLRH-PYFNGYYFEVPDEMQY 236 (292)
Q Consensus 158 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~-~~~~~~~~~~~~~~~l 236 (292)
....|.+||...+.......++ ...+..++..+.+..|............ ..-.....+...+..+
T Consensus 161 ~~~~y~~pe~~~~~~~~~~~Dv-------------~~lG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 227 (254)
T cd06627 161 GTPYWMAPEVIEMSGASTASDI-------------WSLGCTVIELLTGNPPYYDLNPMAALFRIVQDDHPPLPEGISPEL 227 (254)
T ss_pred cchhhcCHhhhcCCCCCcchhH-------------HHHHHHHHHHHhCCCCCCCccHHHHHHHHhccCCCCCCCCCCHHH
Confidence 2233555555433322222222 2222333333444444433222111111 1111122334557789
Q ss_pred HHHHhcccCcCCCCCCChhhhhhCCcc
Q psy758 237 EEITQRCLDKDPLRRWSCDQLLRHPYF 263 (292)
Q Consensus 237 ~~li~~~l~~dP~~Rpt~~~il~h~w~ 263 (292)
.+++.+||..||++|||+.+++.||||
T Consensus 228 ~~~i~~~l~~~p~~R~~~~~~l~~~~~ 254 (254)
T cd06627 228 KDFLMQCFQKDPNLRPTAKQLLKHPWI 254 (254)
T ss_pred HHHHHHHHhCChhhCcCHHHHhcCCCC
Confidence 999999999999999999999999997
|
Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast |
| >cd07849 STKc_ERK1_2_like Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-37 Score=259.51 Aligned_cols=263 Identities=26% Similarity=0.448 Sum_probs=188.1
Q ss_pred cccceeeeecccCceEEEEEEEcCCCcEEEEEEeccCCCChHHHHHHHHHHHHHHhCCCCCcchhhhhhhcC-----CeE
Q psy758 2 ERYEKIGKLGEGSYGVVFKCRNRDTGQVVAIKKFLESEEDPLIRKIALREIRLLKSLKHPNLVNLLEVFRRK-----KKL 76 (292)
Q Consensus 2 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~-----~~~ 76 (292)
++|++.+.||+|++|.||+|.+..+|+.||+|.+..... ......+.+|+.+++.++||||+++++++... ...
T Consensus 5 ~~y~i~~~lg~G~~g~vy~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~ 83 (336)
T cd07849 5 PRYQNLSYIGEGAYGMVCSATHKPTGVKVAIKKISPFEH-QTFCQRTLREIKILRRFKHENIIGILDIIRPPSFESFNDV 83 (336)
T ss_pred cceEEEEEEEecCCeEEEEEEEcCCCCeEEEEEeccccc-chhHHHHHHHHHHHHhCCCCCcCchhheeecccccccceE
Confidence 689999999999999999999999999999999864322 23455677899999999999999999886543 458
Q ss_pred EEEEecCCCccHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEEccCCcEEEeecCchhhhhcccc
Q psy758 77 HLVFEFCDHTVLNELENHPHGLPWDLIKQITWQVLRGVSYCHRHACIHRDIKPENILLTANGVVKLCDFGFARLIRDLIP 156 (292)
Q Consensus 77 ~iv~e~~~~~~L~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~givH~dl~p~Nilv~~~~~~kl~dfg~~~~~~~~~~ 156 (292)
++++||+.+ ++...+.. ..+++..++.++.|++.||.+||++|++|+||+|+||+++.++.++|+|||++........
T Consensus 84 ~lv~e~~~~-~l~~~~~~-~~l~~~~~~~i~~ql~~aL~~LH~~~ivH~dlkp~Nill~~~~~~kl~dfg~~~~~~~~~~ 161 (336)
T cd07849 84 YIVQELMET-DLYKLIKT-QHLSNDHIQYFLYQILRGLKYIHSANVLHRDLKPSNLLLNTNCDLKICDFGLARIADPEHD 161 (336)
T ss_pred EEEehhccc-CHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHEEECCCCCEEECcccceeecccccc
Confidence 999999986 55555544 4699999999999999999999999999999999999999999999999999876532211
Q ss_pred --------ccccccccccccccC------CCCCCCcccceeeecCCCCCCchHHHHHH---HhhcccCCCCCCC------
Q psy758 157 --------RHLHIFQTNEYFKGV------SLPHAENVVPLEIKIGKPAATNIYLIDFL---KRCLDKDPLRRWS------ 213 (292)
Q Consensus 157 --------~~~~~~~~~~~~~~~------~~~~~~~~~~~~~~~~~~~~~~~~~~~~~---~~~~~~~p~~~~~------ 213 (292)
..+..|.+||...+. ...|+.|+..+++.+|.+++........+ ...++..+.+...
T Consensus 162 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslGvil~el~~G~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 241 (336)
T cd07849 162 HTGFLTEYVATRWYRAPEIMLNSKGYTKAIDIWSVGCILAEMLSNRPLFPGKDYLHQLNLILGVLGTPSQEDLNCIISLR 241 (336)
T ss_pred ccCCcCCcCcCCCccChHHhhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCCHHHHHHhhchh
Confidence 123346677764331 23466666667777777655433222211 1112211111000
Q ss_pred hhhhhhc-cCcCCCC---CCCCCccchHHHHhcccCcCCCCCCChhhhhhCCccccee
Q psy758 214 CDQLLRH-PYFNGYY---FEVPDEMQYEEITQRCLDKDPLRRWSCDQLLRHPYFNGYY 267 (292)
Q Consensus 214 ~~~~~~~-~~~~~~~---~~~~~~~~l~~li~~~l~~dP~~Rpt~~~il~h~w~~~~~ 267 (292)
..+.... +...... .....+..+.++|.+||+.||.+|||+.++++||||+.+.
T Consensus 242 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~e~l~hp~~~~~~ 299 (336)
T cd07849 242 ARNYIKSLPFKPKVPWNKLFPNADPKALDLLDKMLTFNPHKRITVEEALAHPYLEQYH 299 (336)
T ss_pred hhhHHhhcCcCCcccHHHHhcccCcHHHHHHHHHcCCChhhCcCHHHHhcCccccccC
Confidence 0000000 0000000 0112367899999999999999999999999999999865
|
Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase |
| >cd07868 STKc_CDK8 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 8 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-37 Score=257.45 Aligned_cols=252 Identities=29% Similarity=0.505 Sum_probs=173.8
Q ss_pred eeeecccCceEEEEEEEc--CCCcEEEEEEeccCCCChHHHHHHHHHHHHHHhCCCCCcchhhhhhhc--CCeEEEEEec
Q psy758 7 IGKLGEGSYGVVFKCRNR--DTGQVVAIKKFLESEEDPLIRKIALREIRLLKSLKHPNLVNLLEVFRR--KKKLHLVFEF 82 (292)
Q Consensus 7 ~~~l~~g~~~~v~~~~~~--~~~~~v~iK~~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~--~~~~~iv~e~ 82 (292)
.+.||+|+||.||+|.+. .+++.||+|.+...... ..+.+|+.+++.++||||+++++++.. +..+++++||
T Consensus 6 ~~~lG~G~~g~Vy~~~~~~~~~~~~~aiK~~~~~~~~----~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~lv~e~ 81 (317)
T cd07868 6 GCKVGRGTYGHVYKAKRKDGKDDRDYALKQIEGTGIS----MSACREIALLRELKHPNVISLQKVFLSHADRKVWLLFDY 81 (317)
T ss_pred ccccccCCCeEEEEEEEccCCCCceEEEEEECCCCCc----HHHHHHHHHHHhcCCCCCcceeeeEecCCCcEEEEEEec
Confidence 568999999999999965 46789999998655432 335689999999999999999998853 5678999999
Q ss_pred CCCccHHHHhcC---------CCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEEc----cCCcEEEeecCchh
Q psy758 83 CDHTVLNELENH---------PHGLPWDLIKQITWQVLRGVSYCHRHACIHRDIKPENILLT----ANGVVKLCDFGFAR 149 (292)
Q Consensus 83 ~~~~~L~~~~~~---------~~~~~~~~~~~i~~qi~~aL~~LH~~givH~dl~p~Nilv~----~~~~~kl~dfg~~~ 149 (292)
+++ +|..++.. ...+++..++.++.||+.||.|||++||+|+||||+||+++ .++.+||+|||++.
T Consensus 82 ~~~-~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~ivHrDlkp~Nil~~~~~~~~~~~kl~DfG~a~ 160 (317)
T cd07868 82 AEH-DLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLHANWVLHRDLKPANILVMGEGPERGRVKIADMGFAR 160 (317)
T ss_pred cCC-CHHHHHHhcccccccCCcccCCHHHHHHHHHHHHHHHHHHHhCCEEcCCCCHHHEEEecCCCCcCcEEEeecCcee
Confidence 986 45554431 22589999999999999999999999999999999999994 55789999999997
Q ss_pred hhhccc--------cccccccccccccccC------CCCCCCcccceeeecCCCCCCch------------HHHHHHHhh
Q psy758 150 LIRDLI--------PRHLHIFQTNEYFKGV------SLPHAENVVPLEIKIGKPAATNI------------YLIDFLKRC 203 (292)
Q Consensus 150 ~~~~~~--------~~~~~~~~~~~~~~~~------~~~~~~~~~~~~~~~~~~~~~~~------------~~~~~~~~~ 203 (292)
...... ...+..|.+||...+. ...|+.|+..+++.+|.+++... .....+...
T Consensus 161 ~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~~f~~~~~~~~~~~~~~~~~~~~~~~~ 240 (317)
T cd07868 161 LFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIKTSNPYHHDQLDRIFNV 240 (317)
T ss_pred ccCCCCccccccCCccccccccCCHHHcCCCCcCchhhHHHHHHHHHHHHhCCCCccCCcccccccccccHHHHHHHHHh
Confidence 654321 1223457888876553 23466666666777776654211 111111111
Q ss_pred cccCCCCCCCh-----------hhhhhccCcCC-----C-CCCCCCccchHHHHhcccCcCCCCCCChhhhhhCCcc
Q psy758 204 LDKDPLRRWSC-----------DQLLRHPYFNG-----Y-YFEVPDEMQYEEITQRCLDKDPLRRWSCDQLLRHPYF 263 (292)
Q Consensus 204 ~~~~p~~~~~~-----------~~~~~~~~~~~-----~-~~~~~~~~~l~~li~~~l~~dP~~Rpt~~~il~h~w~ 263 (292)
++..+...+.. .......+... . ......+..+.+||.+||++||.+|||++|+|+||||
T Consensus 241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~dP~~R~t~~e~l~hp~f 317 (317)
T cd07868 241 MGFPADKDWEDIKKMPEHSTLMKDFRRNTYTNCSLIKYMEKHKVKPDSKAFHLLQKLLTMDPIKRITSEQAMQDPYF 317 (317)
T ss_pred cCCCChHHhHHHhhccchhhhhhhhhccccCcccccchHHhcCCCCChHHHHHHHHHhccCcccCCCHHHHhcCCCC
Confidence 22111111100 00000000000 0 0011224568899999999999999999999999998
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK8 can act as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA p |
| >cd05096 PTKc_DDR1 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-37 Score=253.39 Aligned_cols=244 Identities=21% Similarity=0.306 Sum_probs=176.3
Q ss_pred cccceeeeecccCceEEEEEEEcC----------------CCcEEEEEEeccCCCChHHHHHHHHHHHHHHhCCCCCcch
Q psy758 2 ERYEKIGKLGEGSYGVVFKCRNRD----------------TGQVVAIKKFLESEEDPLIRKIALREIRLLKSLKHPNLVN 65 (292)
Q Consensus 2 ~~y~~~~~l~~g~~~~v~~~~~~~----------------~~~~v~iK~~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~ 65 (292)
++|++.+.||+|+||.||+|.+.. ++..||+|.+.... .......+.+|+.++..++||||++
T Consensus 5 ~~~~~~~~lg~G~fg~V~~~~~~~~~~~~~~~~~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~ 83 (304)
T cd05096 5 GHLLFKEKLGEGQFGEVHLCEVVNPQDLPTLQFPFNVRKGRPLLVAVKILRPDA-NKNARNDFLKEVKILSRLKDPNIIR 83 (304)
T ss_pred hhCeeeeEecccCCeEEEEEEeccCcccccccccccccCCcceEEEEEEecCCC-CHHHHHHHHHHHHHHhhcCCCCeeE
Confidence 589999999999999999998643 33479999886543 3344567889999999999999999
Q ss_pred hhhhhhcCCeEEEEEecCCCccHHHHhcCC-------------------CCCCHHHHHHHHHHHHHHHHHHHhCCccccC
Q psy758 66 LLEVFRRKKKLHLVFEFCDHTVLNELENHP-------------------HGLPWDLIKQITWQVLRGVSYCHRHACIHRD 126 (292)
Q Consensus 66 ~~~~~~~~~~~~iv~e~~~~~~L~~~~~~~-------------------~~~~~~~~~~i~~qi~~aL~~LH~~givH~d 126 (292)
+++++.+.+..++||||+++++|.+++... ..++...++.++.||+.||.|||++|++|+|
T Consensus 84 ~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~ivH~d 163 (304)
T cd05096 84 LLGVCVDEDPLCMITEYMENGDLNQFLSSHHLDDKEENGNDAVPPAHCLPAISYSSLLHVALQIASGMKYLSSLNFVHRD 163 (304)
T ss_pred EEEEEecCCceEEEEecCCCCcHHHHHHhccccccccccccccccccccccccHHHHHHHHHHHHHHHHHHHHCCccccC
Confidence 999999989999999999999999887542 1367788999999999999999999999999
Q ss_pred CCCCceEEccCCcEEEeecCchhhhhcccc-------ccccccccccccccCCCCCCCcccceeeecCCCCCCchHHHHH
Q psy758 127 IKPENILLTANGVVKLCDFGFARLIRDLIP-------RHLHIFQTNEYFKGVSLPHAENVVPLEIKIGKPAATNIYLIDF 199 (292)
Q Consensus 127 l~p~Nilv~~~~~~kl~dfg~~~~~~~~~~-------~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 199 (292)
|||+||+++.++.++|+|||++........ ..+..|.+||...+.......++|++++ .+
T Consensus 164 lkp~Nill~~~~~~kl~DfG~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~-------------~l 230 (304)
T cd05096 164 LATRNCLVGENLTIKIADFGMSRNLYAGDYYRIQGRAVLPIRWMAWECILMGKFTTASDVWAFGV-------------TL 230 (304)
T ss_pred cchhheEEcCCccEEECCCccceecccCceeEecCcCCCCccccCHHHHhcCCCCchhhhHHHHH-------------HH
Confidence 999999999999999999999875432111 1123456666554433333333333322 22
Q ss_pred HHhhc--ccCCCCCCChhhhhhcc--------CcCCCCCCCCCccchHHHHhcccCcCCCCCCChhhhhh
Q psy758 200 LKRCL--DKDPLRRWSCDQLLRHP--------YFNGYYFEVPDEMQYEEITQRCLDKDPLRRWSCDQLLR 259 (292)
Q Consensus 200 ~~~~~--~~~p~~~~~~~~~~~~~--------~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~~il~ 259 (292)
++.+. ...|....+..+..... .......+...+..+.+||.+||+.||.+|||+.+|.+
T Consensus 231 ~el~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~RPs~~~i~~ 300 (304)
T cd05096 231 WEILMLCKEQPYGELTDEQVIENAGEFFRDQGRQVYLFRPPPCPQGLYELMLQCWSRDCRERPSFSDIHA 300 (304)
T ss_pred HHHHHccCCCCCCcCCHHHHHHHHHHHhhhccccccccCCCCCCHHHHHHHHHHccCCchhCcCHHHHHH
Confidence 22211 23343333333322110 00001122345678999999999999999999999954
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 1 (DDR1) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR1 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR1 binds to all collagens tested to date (types I-IV). It is widely expressed in many tissues. It is abundant in the brain and is also found in k |
| >cd08226 PK_STRAD_beta Pseudokinase domain of STE20-related kinase adapter protein beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-37 Score=255.87 Aligned_cols=262 Identities=21% Similarity=0.297 Sum_probs=188.8
Q ss_pred eeeeccc--CceEEEEEEEcCCCcEEEEEEeccCCCChHHHHHHHHHHHHHHhCCCCCcchhhhhhhcCCeEEEEEecCC
Q psy758 7 IGKLGEG--SYGVVFKCRNRDTGQVVAIKKFLESEEDPLIRKIALREIRLLKSLKHPNLVNLLEVFRRKKKLHLVFEFCD 84 (292)
Q Consensus 7 ~~~l~~g--~~~~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~iv~e~~~ 84 (292)
...||.| ++|+||.|.+..+|+.||+|++..........+.+.+|+.+++.++||||+++++++..++..++|+||+.
T Consensus 3 ~~~ig~g~~~~~~v~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~~~~l~h~niv~~~~~~~~~~~~~~v~e~~~ 82 (328)
T cd08226 3 QVEIGRGFCNLTSVYLARHTPTGTLVTVRITDLENCTEEHLKALQNEVVLSHFFRHPNIMTSWTVFTTGSWLWVISPFMA 82 (328)
T ss_pred HHHhCCcccCceeEEEEEEcCCCcEEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCcceEeeeEecCCceEEEEeccc
Confidence 3457776 89999999999999999999987766555666888999999999999999999999999999999999999
Q ss_pred CccHHHHhcCC--CCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEEccCCcEEEeecCchhhhhccc-------
Q psy758 85 HTVLNELENHP--HGLPWDLIKQITWQVLRGVSYCHRHACIHRDIKPENILLTANGVVKLCDFGFARLIRDLI------- 155 (292)
Q Consensus 85 ~~~L~~~~~~~--~~~~~~~~~~i~~qi~~aL~~LH~~givH~dl~p~Nilv~~~~~~kl~dfg~~~~~~~~~------- 155 (292)
++++..++... ..+++..+..++.||+.||+|||++|++|+||||+||+++.++.++++||+.+.......
T Consensus 83 ~~~l~~~l~~~~~~~~~~~~~~~~~~qi~~aL~~lH~~~ivHrDlkp~Nill~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 162 (328)
T cd08226 83 YGSANSLLKTYFPEGMSEALIGNILFGALRGLNYLHQNGYIHRNIKASHILISGDGLVSLSGLSHLYSLVRNGQKAKVVY 162 (328)
T ss_pred CCCHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEeCCCcEEEechHHHhhhhccCccccccc
Confidence 99999988753 348999999999999999999999999999999999999999999999997543322110
Q ss_pred -----cccccccccccccccC-------CCCCCCcccceeeecCCCCCCchHHHHHHHhhcccCCCCCCChh--------
Q psy758 156 -----PRHLHIFQTNEYFKGV-------SLPHAENVVPLEIKIGKPAATNIYLIDFLKRCLDKDPLRRWSCD-------- 215 (292)
Q Consensus 156 -----~~~~~~~~~~~~~~~~-------~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~-------- 215 (292)
......|.+||+..+. ...|+.++..+++.+|..++........+...+...+.......
T Consensus 163 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 242 (328)
T cd08226 163 DFPQFSTSVLPWLSPELLRQDLYGYNVKSDIYSVGITACELATGRVPFQDMLRTQMLLQKLKGPPYSPLDITTFPCEESR 242 (328)
T ss_pred cccccccCccCccChhhhcCCCCCCCchhhHHHHHHHHHHHHhCCCCCCCcChHHHHHHHhcCCCCCCccccccchhhhh
Confidence 0112336777766442 24466666666666666665433222222222222111110000
Q ss_pred --------------hhhhcc---CcC----CCCCCCCCccchHHHHhcccCcCCCCCCChhhhhhCCcccceec
Q psy758 216 --------------QLLRHP---YFN----GYYFEVPDEMQYEEITQRCLDKDPLRRWSCDQLLRHPYFNGYYF 268 (292)
Q Consensus 216 --------------~~~~~~---~~~----~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~~il~h~w~~~~~~ 268 (292)
...... ... ........+..+.+||++||+.||++|||++++++||||.+..-
T Consensus 243 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpta~e~l~~~~~~~~~~ 316 (328)
T cd08226 243 MKNSQSGVDSGIGESVVAAGMTQTMTSERLRTPSSKTFSPAFQNLVELCLQQDPEKRPSASSLLSHAFFKQVKE 316 (328)
T ss_pred hccchhhhhcccccchhccccccccccccccchhhhhhhHHHHHHHHHHccCCcccCCCHHHHhhCHHHHHHHH
Confidence 000000 000 00011223567899999999999999999999999999987553
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) beta subfamily, pseudokinase domain. The STRAD-beta subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpig |
| >cd06617 PKc_MKK3_6 Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.6e-37 Score=248.54 Aligned_cols=255 Identities=24% Similarity=0.412 Sum_probs=178.2
Q ss_pred cccceeeeecccCceEEEEEEEcCCCcEEEEEEeccCCCChHHHHHHHHHHHH-HHhCCCCCcchhhhhhhcCCeEEEEE
Q psy758 2 ERYEKIGKLGEGSYGVVFKCRNRDTGQVVAIKKFLESEEDPLIRKIALREIRL-LKSLKHPNLVNLLEVFRRKKKLHLVF 80 (292)
Q Consensus 2 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~e~~~-~~~l~~~~i~~~~~~~~~~~~~~iv~ 80 (292)
++|++.+.||+|+||.||+|.+..+|+.||+|.+.......... .+..|... ++.+.||||+++++++..++..|+++
T Consensus 1 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~-~~~~e~~~~~~~~~~~~iv~~~~~~~~~~~~~lv~ 79 (283)
T cd06617 1 DDLEVIEELGRGAYGVVDKMRHVPTGTIMAVKRIRATVNSQEQK-RLLMDLDISMRSVDCPYTVTFYGALFREGDVWICM 79 (283)
T ss_pred CCceEEEEecccCCeEEEEEEEcCCCcEEEEEEEecCCCcHHHH-HHHHHHHHHHHHcCCCCeeeeeEEEecCCcEEEEh
Confidence 57999999999999999999999999999999987654433333 34445554 66678999999999999899999999
Q ss_pred ecCCCccHHHHhc----CCCCCCHHHHHHHHHHHHHHHHHHHhC-CccccCCCCCceEEccCCcEEEeecCchhhhhccc
Q psy758 81 EFCDHTVLNELEN----HPHGLPWDLIKQITWQVLRGVSYCHRH-ACIHRDIKPENILLTANGVVKLCDFGFARLIRDLI 155 (292)
Q Consensus 81 e~~~~~~L~~~~~----~~~~~~~~~~~~i~~qi~~aL~~LH~~-givH~dl~p~Nilv~~~~~~kl~dfg~~~~~~~~~ 155 (292)
||+++ +|..++. ....+++..++.++.||+.||+|||++ +++|+||+|+||+++.++.++|+|||.+.......
T Consensus 80 e~~~~-~l~~~l~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~~i~h~dlkp~nil~~~~~~~kl~dfg~~~~~~~~~ 158 (283)
T cd06617 80 EVMDT-SLDKFYKKVYDKGLTIPEDILGKIAVSIVKALEYLHSKLSVIHRDVKPSNVLINRNGQVKLCDFGISGYLVDSV 158 (283)
T ss_pred hhhcc-cHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhhcCCeecCCCCHHHEEECCCCCEEEeeccccccccccc
Confidence 99985 4444432 334689999999999999999999998 99999999999999999999999999987653321
Q ss_pred ----cccccccccccccccCCCCCCCcccceeeecCCCCCCchHHHHHHHhhcccCCCCCCC-hhhhhhccCcC-CCCC-
Q psy758 156 ----PRHLHIFQTNEYFKGVSLPHAENVVPLEIKIGKPAATNIYLIDFLKRCLDKDPLRRWS-CDQLLRHPYFN-GYYF- 228 (292)
Q Consensus 156 ----~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~-~~~~~~~~~~~-~~~~- 228 (292)
......|.+||...+.... ...+...+.++.+..++..+.+..|..... ..+.+...... ....
T Consensus 159 ~~~~~~~~~~y~aPE~~~~~~~~---------~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~ 229 (283)
T cd06617 159 AKTIDAGCKPYMAPERINPELNQ---------KGYDVKSDVWSLGITMIELATGRFPYDSWKTPFQQLKQVVEEPSPQLP 229 (283)
T ss_pred ccccccCCccccChhhcCCcccc---------cccCccccchhhHHHHHHHHhCCCCCCccccCHHHHHHHHhcCCCCCC
Confidence 1223345666655431110 000011122222333333333444433211 11111110000 0011
Q ss_pred CCCCccchHHHHhcccCcCCCCCCChhhhhhCCccccee
Q psy758 229 EVPDEMQYEEITQRCLDKDPLRRWSCDQLLRHPYFNGYY 267 (292)
Q Consensus 229 ~~~~~~~l~~li~~~l~~dP~~Rpt~~~il~h~w~~~~~ 267 (292)
....+..+.++|.+||..+|.+|||++++++||||....
T Consensus 230 ~~~~~~~l~~li~~~l~~~p~~Rp~~~~il~~~~~~~~~ 268 (283)
T cd06617 230 AEKFSPEFQDFVNKCLKKNYKERPNYPELLQHPFFELHL 268 (283)
T ss_pred ccccCHHHHHHHHHHccCChhhCcCHHHHhcCchhhhcc
Confidence 123467899999999999999999999999999999854
|
Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs |
| >cd06606 STKc_MAPKKK Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-36 Score=243.58 Aligned_cols=248 Identities=29% Similarity=0.455 Sum_probs=191.9
Q ss_pred ccceeeeecccCceEEEEEEEcCCCcEEEEEEeccCCCChHHHHHHHHHHHHHHhCCCCCcchhhhhhhcC--CeEEEEE
Q psy758 3 RYEKIGKLGEGSYGVVFKCRNRDTGQVVAIKKFLESEEDPLIRKIALREIRLLKSLKHPNLVNLLEVFRRK--KKLHLVF 80 (292)
Q Consensus 3 ~y~~~~~l~~g~~~~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~--~~~~iv~ 80 (292)
+|.+.+.||+|++|.||+|.+..+++.|++|.+..........+.+.+|+..++.++||||+++++.+.+. +.+++++
T Consensus 1 ~~~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~lv~ 80 (260)
T cd06606 1 EWTRGELLGRGSFGSVYLALDKDTGELMAVKSVELSGDSEEELEALEREIRILSSLQHPNIVRYYGSERDEEKNTLNIFL 80 (260)
T ss_pred CceeeeEeeecCceEEEEEEECCCCcEEEEEEeeccccchHHHHHHHHHHHHHHHcCCCCEeeEEEEEecCCCCeEEEEE
Confidence 58899999999999999999998999999999977665556678889999999999999999999999887 8999999
Q ss_pred ecCCCccHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEEccCCcEEEeecCchhhhhcccc----
Q psy758 81 EFCDHTVLNELENHPHGLPWDLIKQITWQVLRGVSYCHRHACIHRDIKPENILLTANGVVKLCDFGFARLIRDLIP---- 156 (292)
Q Consensus 81 e~~~~~~L~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~givH~dl~p~Nilv~~~~~~kl~dfg~~~~~~~~~~---- 156 (292)
|++++++|.+++.....+++..++.++.|++.||+|||+.|++|+||+|+||++++++.++|+|||.+........
T Consensus 81 e~~~~~~L~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~~h~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~~~~~ 160 (260)
T cd06606 81 EYVSGGSLSSLLKKFGKLPEPVIRKYTRQILEGLAYLHSNGIVHRDIKGANILVDSDGVVKLADFGCAKRLGDIETGEGT 160 (260)
T ss_pred EecCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEEcCCCCEEEcccccEEecccccccccc
Confidence 9999999999988777899999999999999999999999999999999999999999999999999876654322
Q ss_pred ---ccccccccccccccCCCCCCCcccceeeecCCCCCCchHHHHHHHhhcccCCCCCCC-hhhhhhccCc--CCCCCCC
Q psy758 157 ---RHLHIFQTNEYFKGVSLPHAENVVPLEIKIGKPAATNIYLIDFLKRCLDKDPLRRWS-CDQLLRHPYF--NGYYFEV 230 (292)
Q Consensus 157 ---~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~-~~~~~~~~~~--~~~~~~~ 230 (292)
.....|.+||...+.......++|. .+.-++..+.+..|..... .......... .....+.
T Consensus 161 ~~~~~~~~y~~pE~~~~~~~~~~~Dv~s-------------lG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 227 (260)
T cd06606 161 GSVRGTPYWMAPEVIRGEEYGRAADIWS-------------LGCTVIEMATGKPPWSELGNPMAALYKIGSSGEPPEIPE 227 (260)
T ss_pred cCCCCCccccCHhhhcCCCCCchhhHHH-------------HHHHHHHHHhCCCCCCCCCchHHHHHhccccCCCcCCCc
Confidence 2233455666554443322222222 2223333344444433322 1111111110 1112333
Q ss_pred CCccchHHHHhcccCcCCCCCCChhhhhhCCcc
Q psy758 231 PDEMQYEEITQRCLDKDPLRRWSCDQLLRHPYF 263 (292)
Q Consensus 231 ~~~~~l~~li~~~l~~dP~~Rpt~~~il~h~w~ 263 (292)
..+..+.++|.+||+.||.+||++.+++.||||
T Consensus 228 ~~~~~l~~~i~~~l~~~p~~Rp~~~~ll~~~~~ 260 (260)
T cd06606 228 HLSEEAKDFLRKCLRRDPKKRPTADELLQHPFL 260 (260)
T ss_pred ccCHHHHHHHHHhCcCChhhCCCHHHHhhCCCC
Confidence 447789999999999999999999999999997
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKK |
| >PHA02988 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-37 Score=250.21 Aligned_cols=237 Identities=13% Similarity=0.220 Sum_probs=179.6
Q ss_pred eeecccCceEEEEEEEcCCCcEEEEEEeccCCC-ChHHHHHHHHHHHHHHhCCCCCcchhhhhhhc----CCeEEEEEec
Q psy758 8 GKLGEGSYGVVFKCRNRDTGQVVAIKKFLESEE-DPLIRKIALREIRLLKSLKHPNLVNLLEVFRR----KKKLHLVFEF 82 (292)
Q Consensus 8 ~~l~~g~~~~v~~~~~~~~~~~v~iK~~~~~~~-~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~----~~~~~iv~e~ 82 (292)
..|++|+++.||+|.. +|+.||+|.+..... .....+.+.+|+.+++.++||||+++++++.+ ....++||||
T Consensus 26 ~~i~~g~~~~v~~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~~~g~~~~~~~~~~~~~lv~Ey 103 (283)
T PHA02988 26 VLIKENDQNSIYKGIF--NNKEVIIRTFKKFHKGHKVLIDITENEIKNLRRIDSNNILKIYGFIIDIVDDLPRLSLILEY 103 (283)
T ss_pred eEEeeCCceEEEEEEE--CCEEEEEEeccccccccHHHHHHHHHHHHHHHhcCCCCEEEEeeeEEecccCCCceEEEEEe
Confidence 5689999999999987 488999999976543 33345778899999999999999999999866 4578999999
Q ss_pred CCCccHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhC-CccccCCCCCceEEccCCcEEEeecCchhhhhccc--cccc
Q psy758 83 CDHTVLNELENHPHGLPWDLIKQITWQVLRGVSYCHRH-ACIHRDIKPENILLTANGVVKLCDFGFARLIRDLI--PRHL 159 (292)
Q Consensus 83 ~~~~~L~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~-givH~dl~p~Nilv~~~~~~kl~dfg~~~~~~~~~--~~~~ 159 (292)
+++|+|.+++.....+++.....++.|++.||.+||+. +++|+||+|+||++++++.+||+|||++....... ...+
T Consensus 104 ~~~g~L~~~l~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~Hrdlkp~nill~~~~~~kl~dfg~~~~~~~~~~~~~~~ 183 (283)
T PHA02988 104 CTRGYLREVLDKEKDLSFKTKLDMAIDCCKGLYNLYKYTNKPYKNLTSVSFLVTENYKLKIICHGLEKILSSPPFKNVNF 183 (283)
T ss_pred CCCCcHHHHHhhCCCCChhHHHHHHHHHHHHHHHHHhcCCCCCCcCChhhEEECCCCcEEEcccchHhhhccccccccCc
Confidence 99999999998877899999999999999999999985 99999999999999999999999999987654321 1223
Q ss_pred ccccccccccc--CCCCCCCcccceeeecCCCCCCchHHHHHHHhhcccCCCCCCChhhhhhccCcCC--CCCCCCCccc
Q psy758 160 HIFQTNEYFKG--VSLPHAENVVPLEIKIGKPAATNIYLIDFLKRCLDKDPLRRWSCDQLLRHPYFNG--YYFEVPDEMQ 235 (292)
Q Consensus 160 ~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~--~~~~~~~~~~ 235 (292)
..|.+||+..+ ..... ..++++.+.-+++.+.+..|+...+..++........ ...+...+..
T Consensus 184 ~~y~aPE~~~~~~~~~~~-------------k~Di~SlGvil~el~~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~ 250 (283)
T PHA02988 184 MVYFSYKMLNDIFSEYTI-------------KDDIYSLGVVLWEIFTGKIPFENLTTKEIYDLIINKNNSLKLPLDCPLE 250 (283)
T ss_pred ccccCHHHhhhccccccc-------------hhhhhHHHHHHHHHHHCCCCCCCCCHHHHHHHHHhcCCCCCCCCcCcHH
Confidence 45667776654 11111 2222333333444444555555544444433221111 1223345778
Q ss_pred hHHHHhcccCcCCCCCCChhhhhh
Q psy758 236 YEEITQRCLDKDPLRRWSCDQLLR 259 (292)
Q Consensus 236 l~~li~~~l~~dP~~Rpt~~~il~ 259 (292)
+.+||.+||+.||++|||++++++
T Consensus 251 l~~li~~cl~~dp~~Rps~~ell~ 274 (283)
T PHA02988 251 IKCIVEACTSHDSIKRPNIKEILY 274 (283)
T ss_pred HHHHHHHHhcCCcccCcCHHHHHH
Confidence 999999999999999999999986
|
|
| >cd05104 PTKc_Kit Catalytic domain of the Protein Tyrosine Kinase, Kit | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-37 Score=260.71 Aligned_cols=245 Identities=26% Similarity=0.370 Sum_probs=177.6
Q ss_pred cccceeeeecccCceEEEEEEE-----cCCCcEEEEEEeccCCCChHHHHHHHHHHHHHHhC-CCCCcchhhhhhhcCCe
Q psy758 2 ERYEKIGKLGEGSYGVVFKCRN-----RDTGQVVAIKKFLESEEDPLIRKIALREIRLLKSL-KHPNLVNLLEVFRRKKK 75 (292)
Q Consensus 2 ~~y~~~~~l~~g~~~~v~~~~~-----~~~~~~v~iK~~~~~~~~~~~~~~~~~e~~~~~~l-~~~~i~~~~~~~~~~~~ 75 (292)
++|++.+.||+|+||.||+|.+ ..++..||+|++...... ...+.+.+|+.+++.+ +||||+++++++.+++.
T Consensus 35 ~~~~~~~~LG~G~fG~V~~~~~~~~~~~~~~~~vavK~l~~~~~~-~~~~~~~~Ei~il~~l~~HpnIv~l~~~~~~~~~ 113 (375)
T cd05104 35 NRLSFGKTLGAGAFGKVVEATAYGLFKSDAAMTVAVKMLKPSAHL-TEREALMSELKVLSYLGNHINIVNLLGACTVGGP 113 (375)
T ss_pred HHeehhheecCCccceEEEEEEeccccCccceeEEEEeccCCcCc-HHHHHHHHHHHHHHHhcCCcceeeeeeeeccCCc
Confidence 4799999999999999999974 345678999998654332 3456688999999999 89999999999999999
Q ss_pred EEEEEecCCCccHHHHhcCCC-----------------------------------------------------------
Q psy758 76 LHLVFEFCDHTVLNELENHPH----------------------------------------------------------- 96 (292)
Q Consensus 76 ~~iv~e~~~~~~L~~~~~~~~----------------------------------------------------------- 96 (292)
.++||||+++|+|..++....
T Consensus 114 ~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 193 (375)
T cd05104 114 TLVITEYCCYGDLLNFLRRKRDSFICPKHEDHAEAALYKNLLHQREMSCDSLNEYMDMKPGVSYVVPTKADKRRSVRSGS 193 (375)
T ss_pred ceeeehhccCCcHHHHHHhcccccccccccchhhhHHHHhhhhhhcccchhhhhhhhcCCCcccccccccccccccccce
Confidence 999999999999988875321
Q ss_pred ----------------CCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEEccCCcEEEeecCchhhhhcccc----
Q psy758 97 ----------------GLPWDLIKQITWQVLRGVSYCHRHACIHRDIKPENILLTANGVVKLCDFGFARLIRDLIP---- 156 (292)
Q Consensus 97 ----------------~~~~~~~~~i~~qi~~aL~~LH~~givH~dl~p~Nilv~~~~~~kl~dfg~~~~~~~~~~---- 156 (292)
.+++..+..++.||+.||+|||++|++||||||+||+++.++.++|+|||++........
T Consensus 194 ~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~ivH~Dlkp~Nill~~~~~~kl~DfG~a~~~~~~~~~~~~ 273 (375)
T cd05104 194 YIDQDVTSEILEEDELALDTEDLLSFSYQVAKGMSFLASKNCIHRDLAARNILLTHGRITKICDFGLARDIRNDSNYVVK 273 (375)
T ss_pred ecccccHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCchhhEEEECCCcEEEecCccceeccCccccccc
Confidence 367888999999999999999999999999999999999999999999999875532211
Q ss_pred ---ccccccccccccccCCCCCCCcccceeeecCCCCCCchHHHHHHHhhc-ccCCCCCCChhhhhhccCcCCC--CCCC
Q psy758 157 ---RHLHIFQTNEYFKGVSLPHAENVVPLEIKIGKPAATNIYLIDFLKRCL-DKDPLRRWSCDQLLRHPYFNGY--YFEV 230 (292)
Q Consensus 157 ---~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~p~~~~~~~~~~~~~~~~~~--~~~~ 230 (292)
.....|.+||...+.......++|++ +..+++.+. +..|................+. ..+.
T Consensus 274 ~~~~~~~~y~aPE~~~~~~~~~~sDi~sl-------------G~~l~ellt~g~~p~~~~~~~~~~~~~~~~~~~~~~~~ 340 (375)
T cd05104 274 GNARLPVKWMAPESIFNCVYTFESDVWSY-------------GILLWEIFSLGSSPYPGMPVDSKFYKMIKEGYRMLSPE 340 (375)
T ss_pred CCCCCCcceeChhHhcCCCCCCCCCHHHH-------------HHHHHHHHhcCCCCCCCCCchHHHHHHHHhCccCCCCC
Confidence 11123666666655443333333333 222233222 3334333222111111111111 1122
Q ss_pred CCccchHHHHhcccCcCCCCCCChhhhhhC
Q psy758 231 PDEMQYEEITQRCLDKDPLRRWSCDQLLRH 260 (292)
Q Consensus 231 ~~~~~l~~li~~~l~~dP~~Rpt~~~il~h 260 (292)
..+.++.+||.+||+.||++|||+.++++.
T Consensus 341 ~~~~~l~~li~~cl~~dP~~RPs~~eil~~ 370 (375)
T cd05104 341 CAPSEMYDIMKSCWDADPLKRPTFKQIVQL 370 (375)
T ss_pred CCCHHHHHHHHHHccCChhHCcCHHHHHHH
Confidence 346789999999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Kit (or c-Kit); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Kit is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of Kit to its ligand, the stem-cell factor (SCF), leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem ce |
| >cd07852 STKc_MAPK15 Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.4e-38 Score=260.23 Aligned_cols=263 Identities=29% Similarity=0.444 Sum_probs=187.4
Q ss_pred cccceeeeecccCceEEEEEEEcCCCcEEEEEEeccCCCChHHHHHHHHHHHHHHhC-CCCCcchhhhhhhc--CCeEEE
Q psy758 2 ERYEKIGKLGEGSYGVVFKCRNRDTGQVVAIKKFLESEEDPLIRKIALREIRLLKSL-KHPNLVNLLEVFRR--KKKLHL 78 (292)
Q Consensus 2 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~e~~~~~~l-~~~~i~~~~~~~~~--~~~~~i 78 (292)
++|++.+.||+|++|.||+|.+..+++.+++|.+............+.+|+.+++.+ +||||+++++++.. ....|+
T Consensus 7 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~E~~~l~~l~~h~ni~~~~~~~~~~~~~~~~l 86 (337)
T cd07852 7 RKYEILQKLGKGAYGIVWKAIDRRTKEVVALKKIFDAFRNATDAQRTFREIMFLQELGDHPNIVKLLNVIKAENDKDIYL 86 (337)
T ss_pred hHHHHhHhhcCCCCeeEEEEEEcCCCeEEEEEeeccccCcchhhhhhhHHHHHHHHhcCCCCccceeeeeccCCCceEEE
Confidence 689999999999999999999998999999998865433333445677899999999 99999999998764 346899
Q ss_pred EEecCCCccHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEEccCCcEEEeecCchhhhhcccc--
Q psy758 79 VFEFCDHTVLNELENHPHGLPWDLIKQITWQVLRGVSYCHRHACIHRDIKPENILLTANGVVKLCDFGFARLIRDLIP-- 156 (292)
Q Consensus 79 v~e~~~~~~L~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~givH~dl~p~Nilv~~~~~~kl~dfg~~~~~~~~~~-- 156 (292)
|+||+++ +|..++... .+++..++.++.||+.||.|||+.|++|+||+|+||+++.++.++|+|||.+........
T Consensus 87 v~e~~~~-~L~~~~~~~-~~~~~~~~~i~~qi~~~L~~LH~~~i~H~dl~p~nill~~~~~~kl~d~g~~~~~~~~~~~~ 164 (337)
T cd07852 87 VFEYMET-DLHAVIRAN-ILEDVHKRYIMYQLLKALKYIHSGNVIHRDLKPSNILLNSDCRVKLADFGLARSLSELEENP 164 (337)
T ss_pred Eeccccc-CHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEEcCCCcEEEeeccchhccccccccc
Confidence 9999985 777777655 789999999999999999999999999999999999999999999999999876543221
Q ss_pred --------cccccccccccccc------CCCCCCCcccceeeecCCCCCCchHHHHHHHhhcccCCCCCCC---------
Q psy758 157 --------RHLHIFQTNEYFKG------VSLPHAENVVPLEIKIGKPAATNIYLIDFLKRCLDKDPLRRWS--------- 213 (292)
Q Consensus 157 --------~~~~~~~~~~~~~~------~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~--------- 213 (292)
..+..|.+||...+ ....|+.|+..+++.+|..++........+.......+.....
T Consensus 165 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~~l~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 244 (337)
T cd07852 165 ENPVLTDYVATRWYRAPEILLGSTRYTKGVDMWSVGCILGEMLLGKPLFPGTSTLNQLEKIIEVIGPPSAEDIESIKSPF 244 (337)
T ss_pred cCcchhcccccccccCceeeeccccccccchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHHHHHhhh
Confidence 11234566665433 1334555655666666665543222222111111111000000
Q ss_pred hhhhhhc----cCcCCCCCCCCCccchHHHHhcccCcCCCCCCChhhhhhCCcccce
Q psy758 214 CDQLLRH----PYFNGYYFEVPDEMQYEEITQRCLDKDPLRRWSCDQLLRHPYFNGY 266 (292)
Q Consensus 214 ~~~~~~~----~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~~il~h~w~~~~ 266 (292)
...++.. ....-.......+..+.++|.+||+.||++|||+.++++||||++.
T Consensus 245 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~P~~Rps~~~il~~~~~~~~ 301 (337)
T cd07852 245 AATMLDSLPSRPRKPLDELLPKASDDALDLLKKLLVFNPNKRLTAEEALEHPYVAQF 301 (337)
T ss_pred HHHhhhhcccccccchhhhccCCCHHHHHHHHHhccCCcccccCHHHHhhChhhhhh
Confidence 0000000 0000000111246789999999999999999999999999999984
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimul |
| >KOG4236|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-38 Score=257.32 Aligned_cols=244 Identities=26% Similarity=0.386 Sum_probs=197.7
Q ss_pred eeeecccCceEEEEEEEcCCCcEEEEEEeccCCCChHHHHHHHHHHHHHHhCCCCCcchhhhhhhcCCeEEEEEecCCCc
Q psy758 7 IGKLGEGSYGVVFKCRNRDTGQVVAIKKFLESEEDPLIRKIALREIRLLKSLKHPNLVNLLEVFRRKKKLHLVFEFCDHT 86 (292)
Q Consensus 7 ~~~l~~g~~~~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~iv~e~~~~~ 86 (292)
.+.||+|.||+||.++++.+|+.||+|+|.+..........+++|+.+++.+.||+|+.+-..|+..+.+++|||-+.|.
T Consensus 569 devLGSGQFG~VYgg~hRktGrdVAvKvIdKlrFp~kqesqlR~EVaILq~l~HPGiV~le~M~ET~ervFVVMEKl~GD 648 (888)
T KOG4236|consen 569 DEVLGSGQFGTVYGGKHRKTGRDVAVKVIDKLRFPTKQESQLRNEVAILQNLHHPGIVNLECMFETPERVFVVMEKLHGD 648 (888)
T ss_pred HhhccCCcceeeecceecccCceeeeeeeecccCCCchHHHHHHHHHHHHhcCCCCeeEEEEeecCCceEEEEehhhcch
Confidence 46799999999999999999999999999888776667788999999999999999999999999999999999999999
Q ss_pred cHHHHhcC-CCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEEccCC---cEEEeecCchhhhhccccc----c
Q psy758 87 VLNELENH-PHGLPWDLIKQITWQVLRGVSYCHRHACIHRDIKPENILLTANG---VVKLCDFGFARLIRDLIPR----H 158 (292)
Q Consensus 87 ~L~~~~~~-~~~~~~~~~~~i~~qi~~aL~~LH~~givH~dl~p~Nilv~~~~---~~kl~dfg~~~~~~~~~~~----~ 158 (292)
.|.-++.. .+++++.....++.||+.||.|||-+||+|+||||+|||+.+.. .+||||||+++.+++...+ +
T Consensus 649 MLEMILSsEkgRL~er~TkFlvtQIL~ALr~LH~knIvHCDLKPENVLLas~~~FPQvKlCDFGfARiIgEksFRrsVVG 728 (888)
T KOG4236|consen 649 MLEMILSSEKGRLPERITKFLVTQILVALRYLHFKNIVHCDLKPENVLLASASPFPQVKLCDFGFARIIGEKSFRRSVVG 728 (888)
T ss_pred HHHHHHHhhcccchHHHHHHHHHHHHHHHHHhhhcceeeccCCchheeeccCCCCCceeeccccceeecchhhhhhhhcC
Confidence 99888865 46799999999999999999999999999999999999997653 6999999999998875433 3
Q ss_pred ccccccccccccCCCCCCCcccceeeec-----CCCCC-CchHHHHHHHhhcccCCCCCCChhhhhhccCcCCCCCCCCC
Q psy758 159 LHIFQTNEYFKGVSLPHAENVVPLEIKI-----GKPAA-TNIYLIDFLKRCLDKDPLRRWSCDQLLRHPYFNGYYFEVPD 232 (292)
Q Consensus 159 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~-----~~~~~-~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~ 232 (292)
++.|.+||......+-.+++.|+.++.+ |..++ .+..+. +++.+..|.-..+....+
T Consensus 729 TPAYLaPEVLrnkGyNrSLDMWSVGVIiYVsLSGTFPFNEdEdIn-----------------dQIQNAaFMyPp~PW~ei 791 (888)
T KOG4236|consen 729 TPAYLAPEVLRNKGYNRSLDMWSVGVIIYVSLSGTFPFNEDEDIN-----------------DQIQNAAFMYPPNPWSEI 791 (888)
T ss_pred CccccCHHHHhhccccccccceeeeEEEEEEecccccCCCccchh-----------------HHhhccccccCCCchhhc
Confidence 4567777777666666566666655443 33322 122222 233333332222333455
Q ss_pred ccchHHHHhcccCcCCCCCCChhhhhhCCccccee
Q psy758 233 EMQYEEITQRCLDKDPLRRWSCDQLLRHPYFNGYY 267 (292)
Q Consensus 233 ~~~l~~li~~~l~~dP~~Rpt~~~il~h~w~~~~~ 267 (292)
++...+||..+|+..-.+|.|.+..+.|||++++.
T Consensus 792 s~~AidlIn~LLqVkm~kRysvdk~lsh~Wlq~yq 826 (888)
T KOG4236|consen 792 SPEAIDLINNLLQVKMRKRYSVDKSLSHPWLQDYQ 826 (888)
T ss_pred CHHHHHHHHHHHHHHHHHhcchHhhccchhhhcch
Confidence 77889999999999999999999999999999853
|
|
| >cd06652 STKc_MEKK2 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-36 Score=245.78 Aligned_cols=249 Identities=24% Similarity=0.328 Sum_probs=184.1
Q ss_pred cccceeeeecccCceEEEEEEEcCCCcEEEEEEeccCC---CChHHHHHHHHHHHHHHhCCCCCcchhhhhhhc--CCeE
Q psy758 2 ERYEKIGKLGEGSYGVVFKCRNRDTGQVVAIKKFLESE---EDPLIRKIALREIRLLKSLKHPNLVNLLEVFRR--KKKL 76 (292)
Q Consensus 2 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~v~iK~~~~~~---~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~--~~~~ 76 (292)
..|++.+.||+|++|.||.+.+..++..|++|.+.... ........+.+|+.+++.+.||||+++++++.+ ...+
T Consensus 2 ~~~~~~~~l~~g~~g~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~ 81 (265)
T cd06652 2 TNWRLGKLLGQGAFGRVYLCYDADTGRELAVKQVQFDPESPETSKEVNALECEIQLLKNLLHERIVQYYGCLRDPMERTL 81 (265)
T ss_pred CcceEeeEEecCCceEEEEEEEcCCCcEEEEEEeecCcCCcccHHHHHHHHHHHHHHHhcCCCCeeeEEeEeccCCCceE
Confidence 57999999999999999999999999999999885432 223445678899999999999999999998865 3568
Q ss_pred EEEEecCCCccHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEEccCCcEEEeecCchhhhhccc-
Q psy758 77 HLVFEFCDHTVLNELENHPHGLPWDLIKQITWQVLRGVSYCHRHACIHRDIKPENILLTANGVVKLCDFGFARLIRDLI- 155 (292)
Q Consensus 77 ~iv~e~~~~~~L~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~givH~dl~p~Nilv~~~~~~kl~dfg~~~~~~~~~- 155 (292)
++++||+++++|.+++.....+++..+..++.|++.||.+||++|++|+||+|+||++++++.++|+|||.+.......
T Consensus 82 ~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~l~~~l~~lH~~~i~H~dl~p~nil~~~~~~~~l~Dfg~~~~~~~~~~ 161 (265)
T cd06652 82 SIFMEHMPGGSIKDQLKSYGALTENVTRKYTRQILEGVSYLHSNMIVHRDIKGANILRDSVGNVKLGDFGASKRLQTICL 161 (265)
T ss_pred EEEEEecCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEecCCCCEEECcCccccccccccc
Confidence 8999999999999998776678999999999999999999999999999999999999999999999999887543211
Q ss_pred -------cccccccccccccccCCCCCCCcccceeeecCCCCCCchHHHHHHHhhcccCCCCCCChhhhhhccCcCC--C
Q psy758 156 -------PRHLHIFQTNEYFKGVSLPHAENVVPLEIKIGKPAATNIYLIDFLKRCLDKDPLRRWSCDQLLRHPYFNG--Y 226 (292)
Q Consensus 156 -------~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~--~ 226 (292)
......|.+||...+.......++ ++.+..++..+.+..|................. .
T Consensus 162 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv-------------~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~ 228 (265)
T cd06652 162 SGTGMKSVTGTPYWMSPEVISGEGYGRKADI-------------WSVGCTVVEMLTEKPPWAEFEAMAAIFKIATQPTNP 228 (265)
T ss_pred cccccccCCCCccccChhhhcCCCCCcchhH-------------HHHHHHHHHHhhCCCCCCccchHHHHHHHhcCCCCC
Confidence 112234566665544332222222 222233334444444443332222221111111 1
Q ss_pred CCCCCCccchHHHHhcccCcCCCCCCChhhhhhCCccc
Q psy758 227 YFEVPDEMQYEEITQRCLDKDPLRRWSCDQLLRHPYFN 264 (292)
Q Consensus 227 ~~~~~~~~~l~~li~~~l~~dP~~Rpt~~~il~h~w~~ 264 (292)
..+...+..+.++|.+|+. +|++|||++++++|||+.
T Consensus 229 ~~~~~~~~~~~~~i~~~l~-~p~~Rp~~~~il~~~~~~ 265 (265)
T cd06652 229 VLPPHVSDHCRDFLKRIFV-EAKLRPSADELLRHTFVH 265 (265)
T ss_pred CCchhhCHHHHHHHHHHhc-ChhhCCCHHHHhcCcccC
Confidence 1223346678899999995 999999999999999974
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their re |
| >cd05123 STKc_AGC Catalytic domain of AGC family Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-36 Score=241.16 Aligned_cols=241 Identities=25% Similarity=0.338 Sum_probs=187.0
Q ss_pred ecccCceEEEEEEEcCCCcEEEEEEeccCCCC-hHHHHHHHHHHHHHHhCCCCCcchhhhhhhcCCeEEEEEecCCCccH
Q psy758 10 LGEGSYGVVFKCRNRDTGQVVAIKKFLESEED-PLIRKIALREIRLLKSLKHPNLVNLLEVFRRKKKLHLVFEFCDHTVL 88 (292)
Q Consensus 10 l~~g~~~~v~~~~~~~~~~~v~iK~~~~~~~~-~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~iv~e~~~~~~L 88 (292)
||.|++|.||.+.+..+++.+++|.+...... ....+.+..|+.+++.++||||+++++.+.+++.++++||++++++|
T Consensus 1 lg~G~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~~~~L 80 (250)
T cd05123 1 LGKGSFGKVLLVRKKDTGKLYAMKVLKKKKIIKRKEVEHTLTERNILSRINHPFIVKLHYAFQTEEKLYLVLEYAPGGEL 80 (250)
T ss_pred CCCCCceEEEEEEECCCCcEEEEEEeehhhhcchHHHHHHHHHHHHHHHcCCCcHHHHHHHeecCCeeEEEEecCCCCcH
Confidence 68999999999999988999999998765432 23566788999999999999999999999999999999999999999
Q ss_pred HHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEEccCCcEEEeecCchhhhhccc-----cccccccc
Q psy758 89 NELENHPHGLPWDLIKQITWQVLRGVSYCHRHACIHRDIKPENILLTANGVVKLCDFGFARLIRDLI-----PRHLHIFQ 163 (292)
Q Consensus 89 ~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~givH~dl~p~Nilv~~~~~~kl~dfg~~~~~~~~~-----~~~~~~~~ 163 (292)
.+++.....+++..++.++.|++.||.+||++|++|+||+|+||+++.++.++|+|||.+....... ......|.
T Consensus 81 ~~~l~~~~~l~~~~~~~~~~qi~~~l~~lh~~~~~H~~l~p~ni~~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~ 160 (250)
T cd05123 81 FSHLSKEGRFSEERARFYAAEIVLALEYLHSLGIIYRDLKPENILLDADGHIKLTDFGLAKELSSEGSRTNTFCGTPEYL 160 (250)
T ss_pred HHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCcceEEEcCCCcEEEeecCcceecccCCCcccCCcCCcccc
Confidence 9999877789999999999999999999999999999999999999999999999999987654321 12233455
Q ss_pred cccccccCCCCCCCcccceeeecCCCCCCchHHHHHHHhhcccCCCCCCChhhhhhccCcCCCCCCCCCccchHHHHhcc
Q psy758 164 TNEYFKGVSLPHAENVVPLEIKIGKPAATNIYLIDFLKRCLDKDPLRRWSCDQLLRHPYFNGYYFEVPDEMQYEEITQRC 243 (292)
Q Consensus 164 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~ 243 (292)
+|+...+.......++ +..+.-++..+.+..|.......+............+...+..+.++|++|
T Consensus 161 ~Pe~~~~~~~~~~~D~-------------~slG~~~~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~i~~~ 227 (250)
T cd05123 161 APEVLLGKGYGKAVDW-------------WSLGVLLYEMLTGKPPFYAEDRKEIYEKILKDPLRFPEFLSPEARDLISGL 227 (250)
T ss_pred ChHHhCCCCCCchhhH-------------HHHHHHHHHHHHCCCCCCCCCHHHHHHHHhcCCCCCCCCCCHHHHHHHHHH
Confidence 6665543322222222 222223344444555554444333333322234445555678999999999
Q ss_pred cCcCCCCCCCh---hhhhhCCcc
Q psy758 244 LDKDPLRRWSC---DQLLRHPYF 263 (292)
Q Consensus 244 l~~dP~~Rpt~---~~il~h~w~ 263 (292)
|..||.+|||+ +++++||||
T Consensus 228 l~~~p~~R~~~~~~~~l~~~~~f 250 (250)
T cd05123 228 LQKDPTKRLGSGGAEEIKAHPFF 250 (250)
T ss_pred hcCCHhhCCCcccHHHHHhCCCC
Confidence 99999999999 999999998
|
Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the |
| >cd06639 STKc_myosinIIIB Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-36 Score=247.11 Aligned_cols=242 Identities=28% Similarity=0.405 Sum_probs=179.7
Q ss_pred cccceeeeecccCceEEEEEEEcCCCcEEEEEEeccCCCChHHHHHHHHHHHHHHhC-CCCCcchhhhhhhcC-----Ce
Q psy758 2 ERYEKIGKLGEGSYGVVFKCRNRDTGQVVAIKKFLESEEDPLIRKIALREIRLLKSL-KHPNLVNLLEVFRRK-----KK 75 (292)
Q Consensus 2 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~e~~~~~~l-~~~~i~~~~~~~~~~-----~~ 75 (292)
++|.+.+.||+|++|.||+|.+..+++.+++|.+..... ....+.+|+.+++.+ +|||++++++++... +.
T Consensus 22 ~~y~~~~~l~~g~~~~vy~~~~~~~~~~~aik~~~~~~~---~~~~~~~e~~~l~~l~~h~ni~~~~~~~~~~~~~~~~~ 98 (291)
T cd06639 22 DTWEIIETIGKGTYGKVYKVTNKKDGSLAAVKILDPISD---VDEEIEAEYNILQSLPNHPNVVKFYGMFYKADKLVGGQ 98 (291)
T ss_pred CCeEEEEEeecCCCeEEEEEEECCCCCEEEEEEeccccc---HHHHHHHHHHHHHHhcCCCCeEEEEEEEEeccccCCCe
Confidence 579999999999999999999999999999999865432 234566789999998 799999999987643 46
Q ss_pred EEEEEecCCCccHHHHhc----CCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEEccCCcEEEeecCchhhh
Q psy758 76 LHLVFEFCDHTVLNELEN----HPHGLPWDLIKQITWQVLRGVSYCHRHACIHRDIKPENILLTANGVVKLCDFGFARLI 151 (292)
Q Consensus 76 ~~iv~e~~~~~~L~~~~~----~~~~~~~~~~~~i~~qi~~aL~~LH~~givH~dl~p~Nilv~~~~~~kl~dfg~~~~~ 151 (292)
.++|+||+++++|.++++ ....+++..++.++.|++.||.+||++|++|+||+|+||+++.++.++|+|||++...
T Consensus 99 ~~lv~ey~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~ivH~dlkp~nili~~~~~~kl~dfg~~~~~ 178 (291)
T cd06639 99 LWLVLELCNGGSVTELVKGLLICGQRLDEAMISYILYGALLGLQHLHNNRIIHRDVKGNNILLTTEGGVKLVDFGVSAQL 178 (291)
T ss_pred eEEEEEECCCCcHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHEEEcCCCCEEEeecccchhc
Confidence 899999999999998774 3456899999999999999999999999999999999999999999999999998765
Q ss_pred hccc-----cccccccccccccccC----------CCCCCCcccceeeecCCCCCCchHHHHHHHhhcccCCCCCCChhh
Q psy758 152 RDLI-----PRHLHIFQTNEYFKGV----------SLPHAENVVPLEIKIGKPAATNIYLIDFLKRCLDKDPLRRWSCDQ 216 (292)
Q Consensus 152 ~~~~-----~~~~~~~~~~~~~~~~----------~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~ 216 (292)
.... ......|.+||..... ...|+.|+..+++.+|. .|.......+
T Consensus 179 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slGvi~~el~~g~------------------~p~~~~~~~~ 240 (291)
T cd06639 179 TSTRLRRNTSVGTPFWMAPEVIACEQQYDYSYDARCDVWSLGITAIELGDGD------------------PPLFDMHPVK 240 (291)
T ss_pred ccccccccCccCCccccChhhhcCCCCcccccCCccchHHHHHHHHHHhhCC------------------CCCCCCcHHH
Confidence 4321 2223446667654321 22333333333344443 3333322211
Q ss_pred hhhc---cCcCCCCCCCCCccchHHHHhcccCcCCCCCCChhhhhhCCccc
Q psy758 217 LLRH---PYFNGYYFEVPDEMQYEEITQRCLDKDPLRRWSCDQLLRHPYFN 264 (292)
Q Consensus 217 ~~~~---~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~~il~h~w~~ 264 (292)
.+.. ........+...+..+.++|.+||+.||.+|||+.++++||||+
T Consensus 241 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~il~~~~~~ 291 (291)
T cd06639 241 TLFKIPRNPPPTLLHPEKWCRSFNHFISQCLIKDFEARPSVTHLLEHPFIK 291 (291)
T ss_pred HHHHHhcCCCCCCCcccccCHHHHHHHHHHhhcChhhCcCHHHHhcCcccC
Confidence 1111 00001111223456799999999999999999999999999984
|
Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also pre |
| >KOG0607|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-38 Score=245.26 Aligned_cols=253 Identities=23% Similarity=0.307 Sum_probs=187.3
Q ss_pred eeeecccCceEEEEEEEcCCCcEEEEEEeccCCCChHHHHHHHHHHHHHHhCC-CCCcchhhhhhhcCCeEEEEEecCCC
Q psy758 7 IGKLGEGSYGVVFKCRNRDTGQVVAIKKFLESEEDPLIRKIALREIRLLKSLK-HPNLVNLLEVFRRKKKLHLVFEFCDH 85 (292)
Q Consensus 7 ~~~l~~g~~~~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~e~~~~~~l~-~~~i~~~~~~~~~~~~~~iv~e~~~~ 85 (292)
.+.||+|+++.|-.+....++..||+|++.+... .....+.+|++++...+ |+||++++++|+++...|+|||-+.|
T Consensus 83 ~e~LGeGAyasVqtcv~i~t~~EYAVKiidKq~g--HsR~RvfREVe~f~~Cqgh~nilqLiefFEdd~~FYLVfEKm~G 160 (463)
T KOG0607|consen 83 SELLGEGAYASVQTCVSIQTGKEYAVKIIDKQPG--HSRSRVFREVETFYQCQGHKNILQLIEFFEDDTRFYLVFEKMRG 160 (463)
T ss_pred HHHhcCccceeeeeeeeeccchhhhhhhhhcCCc--hHHHHHHHHHHHHHHhcCCccHHHHHHHhcccceEEEEEecccC
Confidence 4569999999999999999999999999988754 34677889999999985 99999999999999999999999999
Q ss_pred ccHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEEccCCc---EEEeecCchhhhhccc---cccc
Q psy758 86 TVLNELENHPHGLPWDLIKQITWQVLRGVSYCHRHACIHRDIKPENILLTANGV---VKLCDFGFARLIRDLI---PRHL 159 (292)
Q Consensus 86 ~~L~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~givH~dl~p~Nilv~~~~~---~kl~dfg~~~~~~~~~---~~~~ 159 (292)
|.|...+....-+++..+..+..+|+.||.|||.+||.||||||+|||..+.++ +||+||.+..-..... +..+
T Consensus 161 GplLshI~~~~~F~E~EAs~vvkdia~aLdFlH~kgIAHRDlKPENiLC~~pn~vsPvKiCDfDLgSg~k~~~~~spast 240 (463)
T KOG0607|consen 161 GPLLSHIQKRKHFNEREASRVVKDIASALDFLHTKGIAHRDLKPENILCESPNKVSPVKICDFDLGSGIKLNNDCSPAST 240 (463)
T ss_pred chHHHHHHHhhhccHHHHHHHHHHHHHHHHHHhhcCcccccCCccceeecCCCCcCceeeeccccccccccCCCCCCCCC
Confidence 999998888888999999999999999999999999999999999999987654 8999998765432111 1111
Q ss_pred ----cccccccccccCCC---------------CCCCcccceeeecCCCCCCchHHHHHHHhhcccCCCCCCChhhhhhc
Q psy758 160 ----HIFQTNEYFKGVSL---------------PHAENVVPLEIKIGKPAATNIYLIDFLKRCLDKDPLRRWSCDQLLRH 220 (292)
Q Consensus 160 ----~~~~~~~~~~~~~~---------------~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~ 220 (292)
...++-||++++.. .|++|++.|-++.|++++.+-... .--.+|-..-...++
T Consensus 241 P~L~tPvGSAEfMAPEVVd~fv~qA~~YDKrCDlwSLGvIlYImLsGYpPFvG~Cg~--------dCGWdrGe~Cr~CQ~ 312 (463)
T KOG0607|consen 241 PELLTPVGSAEFMAPEVVDVFVDQATFYDKRCDLWSLGVILYIMLSGYPPFVGHCGA--------DCGWDRGEVCRVCQN 312 (463)
T ss_pred ccccCcccchhhcchhHHhhhccccccccccccHHHHHHHHHHHHhCCCCccCccCC--------cCCccCCCccHHHHH
Confidence 12233333333221 255555555555555554322110 001222222222222
Q ss_pred cCc----C-CCCCCC----CCccchHHHHhcccCcCCCCCCChhhhhhCCcccceecc
Q psy758 221 PYF----N-GYYFEV----PDEMQYEEITQRCLDKDPLRRWSCDQLLRHPYFNGYYFE 269 (292)
Q Consensus 221 ~~~----~-~~~~~~----~~~~~l~~li~~~l~~dP~~Rpt~~~il~h~w~~~~~~~ 269 (292)
.+| . .+.+|. .++.+.++||..+|..||.+|.+|.++++|||++....+
T Consensus 313 ~LFesIQEGkYeFPdkdWahIS~eakdlisnLlvrda~~rlsa~~vlnhPw~~~~~~e 370 (463)
T KOG0607|consen 313 KLFESIQEGKYEFPDKDWAHISSEAKDLISNLLVRDAKQRLSAAQVLNHPWVQRCAPE 370 (463)
T ss_pred HHHHHHhccCCcCChhhhHHhhHHHHHHHHHHHhccHHhhhhhhhccCCccccccchh
Confidence 222 1 122332 237778999999999999999999999999999986655
|
|
| >cd06647 STKc_PAK_I Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-36 Score=248.43 Aligned_cols=250 Identities=25% Similarity=0.370 Sum_probs=186.1
Q ss_pred cccceeeeecccCceEEEEEEEcCCCcEEEEEEeccCCCChHHHHHHHHHHHHHHhCCCCCcchhhhhhhcCCeEEEEEe
Q psy758 2 ERYEKIGKLGEGSYGVVFKCRNRDTGQVVAIKKFLESEEDPLIRKIALREIRLLKSLKHPNLVNLLEVFRRKKKLHLVFE 81 (292)
Q Consensus 2 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~iv~e 81 (292)
++|.+.+.||+|++|.||++.+..++..|++|.+...... ..+.+.+|+.+++.++|||++++++++...+..|+|+|
T Consensus 19 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~--~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~lv~e 96 (293)
T cd06647 19 KKYTRFEKIGQGASGTVYTAIDVATGQEVAIKQMNLQQQP--KKELIINEILVMRENKHPNIVNYLDSYLVGDELWVVME 96 (293)
T ss_pred hhceeeeEecCCCCeEEEEEEEcCCCCEEEEEEeccccch--HHHHHHHHHHHHhhcCCCCeeehhheeeeCCcEEEEEe
Confidence 5899999999999999999999888999999998644322 34667889999999999999999999999999999999
Q ss_pred cCCCccHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEEccCCcEEEeecCchhhhhcccccc---
Q psy758 82 FCDHTVLNELENHPHGLPWDLIKQITWQVLRGVSYCHRHACIHRDIKPENILLTANGVVKLCDFGFARLIRDLIPRH--- 158 (292)
Q Consensus 82 ~~~~~~L~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~givH~dl~p~Nilv~~~~~~kl~dfg~~~~~~~~~~~~--- 158 (292)
|+++++|.+++... .+++..+..++.|++.||.|||++|++|+||+|+||+++.++.++|+|||++..........
T Consensus 97 ~~~~~~L~~~~~~~-~l~~~~~~~i~~~l~~al~~LH~~gi~H~dL~p~Nili~~~~~~kL~dfg~~~~~~~~~~~~~~~ 175 (293)
T cd06647 97 YLAGGSLTDVVTET-CMDEGQIAAVCRECLQALEFLHSNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSTM 175 (293)
T ss_pred cCCCCcHHHHHhhc-CCCHHHHHHHHHHHHHHHHHHHhCCEeeccCCHHHEEEcCCCCEEEccCcceecccccccccccc
Confidence 99999999998764 58899999999999999999999999999999999999999999999999876544322211
Q ss_pred --ccccccccccccCCCCCCCcccceeeecCCCCCCchHHHHHHHhhcccCCCCCCChhhhhhccCc---CCCCCCCCCc
Q psy758 159 --LHIFQTNEYFKGVSLPHAENVVPLEIKIGKPAATNIYLIDFLKRCLDKDPLRRWSCDQLLRHPYF---NGYYFEVPDE 233 (292)
Q Consensus 159 --~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~---~~~~~~~~~~ 233 (292)
...|.+|+...+.......++ ++.+.-++..+.+..|+...+..+.+..... .....+...+
T Consensus 176 ~~~~~y~~PE~~~~~~~~~~~Dv-------------~slG~ll~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 242 (293)
T cd06647 176 VGTPYWMAPEVVTRKAYGPKVDI-------------WSLGIMAIEMVEGEPPYLNENPLRALYLIATNGTPELQNPEKLS 242 (293)
T ss_pred cCChhhcCchhhccCCCCchhhH-------------HHHHHHHHHHHhCCCCCCCCChhhheeehhcCCCCCCCCccccC
Confidence 122445554433222222222 2233333344444444433222111111100 0111122346
Q ss_pred cchHHHHhcccCcCCCCCCChhhhhhCCccccee
Q psy758 234 MQYEEITQRCLDKDPLRRWSCDQLLRHPYFNGYY 267 (292)
Q Consensus 234 ~~l~~li~~~l~~dP~~Rpt~~~il~h~w~~~~~ 267 (292)
..++++|.+||..||.+||++.+++.||||....
T Consensus 243 ~~l~~li~~~l~~~p~~Rp~~~~il~h~~~~~~~ 276 (293)
T cd06647 243 AIFRDFLNRCLEMDVEKRGSAKELLQHPFLKIAK 276 (293)
T ss_pred HHHHHHHHHHccCChhhCcCHHHHhcCHHHhcCc
Confidence 6799999999999999999999999999998755
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their bi |
| >cd06640 STKc_MST4 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.9e-37 Score=247.95 Aligned_cols=253 Identities=25% Similarity=0.306 Sum_probs=188.8
Q ss_pred cccceeeeecccCceEEEEEEEcCCCcEEEEEEeccCCCChHHHHHHHHHHHHHHhCCCCCcchhhhhhhcCCeEEEEEe
Q psy758 2 ERYEKIGKLGEGSYGVVFKCRNRDTGQVVAIKKFLESEEDPLIRKIALREIRLLKSLKHPNLVNLLEVFRRKKKLHLVFE 81 (292)
Q Consensus 2 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~iv~e 81 (292)
+.|+..+.||+|++|.||.|.+..++..|++|.+..... ......+.+|+.+++.++||||+++++++.+++..++|+|
T Consensus 4 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 82 (277)
T cd06640 4 ELFTKLERIGKGSFGEVFKGIDNRTQQVVAIKIIDLEEA-EDEIEDIQQEITVLSQCDSPYVTKYYGSYLKGTKLWIIME 82 (277)
T ss_pred HhhhhhhhcccCCCeEEEEEEEccCCEEEEEEEEecccc-HHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCEEEEEEe
Confidence 368889999999999999999999999999999875433 3345678899999999999999999999999999999999
Q ss_pred cCCCccHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEEccCCcEEEeecCchhhhhcccc-----
Q psy758 82 FCDHTVLNELENHPHGLPWDLIKQITWQVLRGVSYCHRHACIHRDIKPENILLTANGVVKLCDFGFARLIRDLIP----- 156 (292)
Q Consensus 82 ~~~~~~L~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~givH~dl~p~Nilv~~~~~~kl~dfg~~~~~~~~~~----- 156 (292)
|++|++|.+++.. +.+++..+..++.|++.||++||++|++|+||+|+||+++.++.++|+|||.+........
T Consensus 83 ~~~~~~L~~~i~~-~~l~~~~~~~~~~~l~~~l~~lh~~~ivH~dl~p~Nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~ 161 (277)
T cd06640 83 YLGGGSALDLLRA-GPFDEFQIATMLKEILKGLDYLHSEKKIHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQIKRNTF 161 (277)
T ss_pred cCCCCcHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCccCcCCChhhEEEcCCCCEEEcccccceeccCCccccccc
Confidence 9999999998875 4689999999999999999999999999999999999999999999999999865543221
Q ss_pred ccccccccccccccCCCCCCCcccceeeecCCCCCCchHHHHHHHhhcccCCCCCCChhhhhhcc-CcCCCCCCCCCccc
Q psy758 157 RHLHIFQTNEYFKGVSLPHAENVVPLEIKIGKPAATNIYLIDFLKRCLDKDPLRRWSCDQLLRHP-YFNGYYFEVPDEMQ 235 (292)
Q Consensus 157 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~-~~~~~~~~~~~~~~ 235 (292)
.....|.+||...+.......++ ++.+.-++..+.+..|............. ...........+..
T Consensus 162 ~~~~~y~apE~~~~~~~~~~~Dv-------------~slG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 228 (277)
T cd06640 162 VGTPFWMAPEVIQQSAYDSKADI-------------WSLGITAIELAKGEPPNSDMHPMRVLFLIPKNNPPTLTGEFSKP 228 (277)
T ss_pred cCcccccCHhHhccCCCccHHHH-------------HHHHHHHHHHHHCCCCCCCcChHhHhhhhhcCCCCCCchhhhHH
Confidence 11223556665443322222222 22222233333344443332222211110 00011122234678
Q ss_pred hHHHHhcccCcCCCCCCChhhhhhCCcccceecc
Q psy758 236 YEEITQRCLDKDPLRRWSCDQLLRHPYFNGYYFE 269 (292)
Q Consensus 236 l~~li~~~l~~dP~~Rpt~~~il~h~w~~~~~~~ 269 (292)
+.++|.+||+.||.+||++.++++||||.....+
T Consensus 229 ~~~li~~~l~~~p~~Rp~~~~il~~~~~~~~~~~ 262 (277)
T cd06640 229 FKEFIDACLNKDPSFRPTAKELLKHKFIVKNAKK 262 (277)
T ss_pred HHHHHHHHcccCcccCcCHHHHHhChHhhhcchh
Confidence 8999999999999999999999999999886544
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by inter |
| >cd06641 STKc_MST3 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-36 Score=246.98 Aligned_cols=250 Identities=26% Similarity=0.336 Sum_probs=187.6
Q ss_pred ccceeeeecccCceEEEEEEEcCCCcEEEEEEeccCCCChHHHHHHHHHHHHHHhCCCCCcchhhhhhhcCCeEEEEEec
Q psy758 3 RYEKIGKLGEGSYGVVFKCRNRDTGQVVAIKKFLESEEDPLIRKIALREIRLLKSLKHPNLVNLLEVFRRKKKLHLVFEF 82 (292)
Q Consensus 3 ~y~~~~~l~~g~~~~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~iv~e~ 82 (292)
-|++.+.||+|++|.||+|.+..++..||+|.+..... ....+.+.+|+.+++.++||||+++++.+.+++..++|+||
T Consensus 5 ~~~~~~~ig~G~~~~vy~~~~~~~~~~~aiK~~~~~~~-~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 83 (277)
T cd06641 5 LFTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEA-EDEIEDIQQEITVLSQCDSPYVTKYYGSYLKDTKLWIIMEY 83 (277)
T ss_pred hhhhheeEeecCCeEEEEEEECCCCcEEEEEEeccccc-hHHHHHHHHHHHHHHhcCCCCEeEEEEEEEeCCeEEEEEEe
Confidence 47889999999999999999998999999998865443 23456788999999999999999999999999999999999
Q ss_pred CCCccHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEEccCCcEEEeecCchhhhhcccc-----c
Q psy758 83 CDHTVLNELENHPHGLPWDLIKQITWQVLRGVSYCHRHACIHRDIKPENILLTANGVVKLCDFGFARLIRDLIP-----R 157 (292)
Q Consensus 83 ~~~~~L~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~givH~dl~p~Nilv~~~~~~kl~dfg~~~~~~~~~~-----~ 157 (292)
+++++|..++.. ..+++..+..++.|++.|+.+||++|++|+||+|+||+++.++.++|+|||++........ .
T Consensus 84 ~~~~~l~~~i~~-~~~~~~~~~~~~~~l~~~l~~lh~~~i~h~dl~p~Ni~i~~~~~~~l~dfg~~~~~~~~~~~~~~~~ 162 (277)
T cd06641 84 LGGGSALDLLEP-GPLDETQIATILREILKGLDYLHSEKKIHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQIKRNTFV 162 (277)
T ss_pred CCCCcHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHccCCeecCCCCHHhEEECCCCCEEEeecccceecccchhhhcccc
Confidence 999999998875 3689999999999999999999999999999999999999999999999998865433211 1
Q ss_pred cccccccccccccCCCCCCCcccceeeecCCCCCCchHHHHHHHhhcccCCCCCCChhhhhhccCcC-CCCCCCCCccch
Q psy758 158 HLHIFQTNEYFKGVSLPHAENVVPLEIKIGKPAATNIYLIDFLKRCLDKDPLRRWSCDQLLRHPYFN-GYYFEVPDEMQY 236 (292)
Q Consensus 158 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~-~~~~~~~~~~~l 236 (292)
....|.+|+...+.......++ ++.+..++..+.+..|................ ........+..+
T Consensus 163 ~~~~y~~PE~~~~~~~~~~~Dv-------------~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 229 (277)
T cd06641 163 GTPFWMAPEVIKQSAYDSKADI-------------WSLGITAIELAKGEPPHSELHPMKVLFLIPKNNPPTLEGNYSKPL 229 (277)
T ss_pred CCccccChhhhccCCCCchhhH-------------HHHHHHHHHHHcCCCCCCccchHHHHHHHhcCCCCCCCcccCHHH
Confidence 2233555655443322222222 22223333444444444333222222111000 111223456789
Q ss_pred HHHHhcccCcCCCCCCChhhhhhCCccccee
Q psy758 237 EEITQRCLDKDPLRRWSCDQLLRHPYFNGYY 267 (292)
Q Consensus 237 ~~li~~~l~~dP~~Rpt~~~il~h~w~~~~~ 267 (292)
.++|.+||..||.+||++.++++||||.+..
T Consensus 230 ~~~i~~~l~~~p~~Rp~~~~~l~~~~~~~~~ 260 (277)
T cd06641 230 KEFVEACLNKEPSFRPTAKELLKHKFIVRFA 260 (277)
T ss_pred HHHHHHHccCChhhCcCHHHHHhCHHHhhhh
Confidence 9999999999999999999999999999853
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and int |
| >cd07836 STKc_Pho85 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-37 Score=250.61 Aligned_cols=258 Identities=30% Similarity=0.498 Sum_probs=185.4
Q ss_pred ccceeeeecccCceEEEEEEEcCCCcEEEEEEeccCCCChHHHHHHHHHHHHHHhCCCCCcchhhhhhhcCCeEEEEEec
Q psy758 3 RYEKIGKLGEGSYGVVFKCRNRDTGQVVAIKKFLESEEDPLIRKIALREIRLLKSLKHPNLVNLLEVFRRKKKLHLVFEF 82 (292)
Q Consensus 3 ~y~~~~~l~~g~~~~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~iv~e~ 82 (292)
+|++.+.||.|++|.||+|.+..+|+.|++|.+...... .....+.+|+.+++.++||||+++++++.+.+..++|+||
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~-~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 79 (284)
T cd07836 1 NFKQLEKLGEGTYATVYKGRNRTTGEIVALKEIHLDAEE-GTPSTAIREISLMKELKHENIVRLHDVIHTENKLMLVFEY 79 (284)
T ss_pred CceEeeeeccCCceEEEEEEECCCCeEEEEEEecccccc-cchHHHHHHHHHHHhhcCCCEeeeeeeEeeCCcEEEEEec
Confidence 589999999999999999999999999999998755432 2235567899999999999999999999999999999999
Q ss_pred CCCccHHHHhcCC---CCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEEccCCcEEEeecCchhhhhccc----
Q psy758 83 CDHTVLNELENHP---HGLPWDLIKQITWQVLRGVSYCHRHACIHRDIKPENILLTANGVVKLCDFGFARLIRDLI---- 155 (292)
Q Consensus 83 ~~~~~L~~~~~~~---~~~~~~~~~~i~~qi~~aL~~LH~~givH~dl~p~Nilv~~~~~~kl~dfg~~~~~~~~~---- 155 (292)
+++ +|..++... ..+++..+..++.|++.||.|||+.|++|+||+|+||++++++.++|+|||.+.......
T Consensus 80 ~~~-~l~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~h~dl~p~ni~~~~~~~~~l~d~g~~~~~~~~~~~~~ 158 (284)
T cd07836 80 MDK-DLKKYMDTHGVRGALDPNTVKSFTYQLLKGIAFCHENRVLHRDLKPQNLLINKRGELKLADFGLARAFGIPVNTFS 158 (284)
T ss_pred CCc-cHHHHHHhcCCCCCcCHHHHHHHHHHHHHHHHHHHHCCeeeCCCCHHHEEECCCCcEEEeecchhhhhcCCccccc
Confidence 997 555555432 358999999999999999999999999999999999999999999999999987653321
Q ss_pred -cccccccccccccccC------CCCCCCcccceeeecCCCCCCchHHHHHHHhhccc--CCCCCCChhhhhh-ccCcCC
Q psy758 156 -PRHLHIFQTNEYFKGV------SLPHAENVVPLEIKIGKPAATNIYLIDFLKRCLDK--DPLRRWSCDQLLR-HPYFNG 225 (292)
Q Consensus 156 -~~~~~~~~~~~~~~~~------~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~p~~~~~~~~~~~-~~~~~~ 225 (292)
...+..|.+||...+. ...|+.|+..+++.+|..++........+...... .|.... ...+.. ..+...
T Consensus 159 ~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~ 237 (284)
T cd07836 159 NEVVTLWYRAPDVLLGSRTYSTSIDIWSVGCIMAEMITGRPLFPGTNNEDQLLKIFRIMGTPTEST-WPGISQLPEYKPT 237 (284)
T ss_pred cccccccccChHHhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCChhh-HHHHhcCchhccc
Confidence 1123346677765432 22456666666666666654333222221111110 000000 000000 000000
Q ss_pred C---------CCCCCCccchHHHHhcccCcCCCCCCChhhhhhCCcc
Q psy758 226 Y---------YFEVPDEMQYEEITQRCLDKDPLRRWSCDQLLRHPYF 263 (292)
Q Consensus 226 ~---------~~~~~~~~~l~~li~~~l~~dP~~Rpt~~~il~h~w~ 263 (292)
. ......+..+.++|.+||+.||.+|||+.++++||||
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~l~~~~f 284 (284)
T cd07836 238 FPRYPPQDLQQLFPHADPLGIDLLHRLLQLNPELRISAHDALQHPWF 284 (284)
T ss_pred ccCCChHHHHHHhhhcCcHHHHHHHHHhcCCcccCCCHHHHhcCCCC
Confidence 0 0111336788999999999999999999999999998
|
Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment. |
| >cd07829 STKc_CDK_like Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.7e-37 Score=249.45 Aligned_cols=259 Identities=38% Similarity=0.603 Sum_probs=188.1
Q ss_pred cceeeeecccCceEEEEEEEcCCCcEEEEEEeccCCCChHHHHHHHHHHHHHHhCCCCCcchhhhhhhcCCeEEEEEecC
Q psy758 4 YEKIGKLGEGSYGVVFKCRNRDTGQVVAIKKFLESEEDPLIRKIALREIRLLKSLKHPNLVNLLEVFRRKKKLHLVFEFC 83 (292)
Q Consensus 4 y~~~~~l~~g~~~~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~iv~e~~ 83 (292)
|++.+.||+|++|.||+|....+++.|++|.+..........+.+.+|+.+++.++|+|++++++++.+.+..++|+||+
T Consensus 1 y~~~~~ig~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~~v~e~~ 80 (282)
T cd07829 1 YEKLEKLGEGTYGVVYKARDKKTGEIVALKKIRLDNEEEGIPSTALREISLLKELKHPNIVKLLDVIHTERKLYLVFEYC 80 (282)
T ss_pred CeeehcccccCcceEEEeeecCCCcEEEEEEeccccccccccHHHHHHHHHHHhcCCCCHHHHHhhhhcCCceEEEecCc
Confidence 67889999999999999999999999999999776544444566778999999999999999999999999999999999
Q ss_pred CCccHHHHhcCC-CCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEEccCCcEEEeecCchhhhhcccc-----c
Q psy758 84 DHTVLNELENHP-HGLPWDLIKQITWQVLRGVSYCHRHACIHRDIKPENILLTANGVVKLCDFGFARLIRDLIP-----R 157 (292)
Q Consensus 84 ~~~~L~~~~~~~-~~~~~~~~~~i~~qi~~aL~~LH~~givH~dl~p~Nilv~~~~~~kl~dfg~~~~~~~~~~-----~ 157 (292)
++ +|..++... ..+++..++.++.|++.||.+||++|++||||+|+||++++++.++|+|||.+........ .
T Consensus 81 ~~-~l~~~i~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~H~~l~~~ni~~~~~~~~~l~d~g~~~~~~~~~~~~~~~~ 159 (282)
T cd07829 81 DM-DLKKYLDKRPGPLSPNLIKSIMYQLLRGLAYCHSHRILHRDLKPQNILINRDGVLKLADFGLARAFGIPLRTYTHEV 159 (282)
T ss_pred Cc-CHHHHHHhhccCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCChheEEEcCCCCEEEecCCcccccCCCccccCccc
Confidence 85 688877664 5799999999999999999999999999999999999999999999999999876543221 1
Q ss_pred cccccccccccccC------CCCCCCcccceeeecCCCCCCchHHHHHHHhhc----ccCCCCCCChhhhh-hccCcCCC
Q psy758 158 HLHIFQTNEYFKGV------SLPHAENVVPLEIKIGKPAATNIYLIDFLKRCL----DKDPLRRWSCDQLL-RHPYFNGY 226 (292)
Q Consensus 158 ~~~~~~~~~~~~~~------~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~----~~~p~~~~~~~~~~-~~~~~~~~ 226 (292)
....|.+||...+. ...|+.|+..+++.++.+++......+.+.... ...+........+. ....+...
T Consensus 160 ~~~~~~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 239 (282)
T cd07829 160 VTLWYRAPEILLGSKHYSTAVDIWSVGCIFAEMITGKPLFPGDSEIDQLFKIFQILGTPTEESWPGVTKLPDYKPTFPKF 239 (282)
T ss_pred cCcCcCChHHhcCCcCCCccccHHHHHHHHHHHHhCCCCCCCccHHHHHHHHHHHhCCCcHHHHHhhccccccccccccc
Confidence 12336677765443 233555555555666655543332222221111 11111000000000 00000000
Q ss_pred ------CCCCCCccchHHHHhcccCcCCCCCCChhhhhhCCcc
Q psy758 227 ------YFEVPDEMQYEEITQRCLDKDPLRRWSCDQLLRHPYF 263 (292)
Q Consensus 227 ------~~~~~~~~~l~~li~~~l~~dP~~Rpt~~~il~h~w~ 263 (292)
......+..+.++|.+||..||++||++.++++||||
T Consensus 240 ~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~~l~~p~~ 282 (282)
T cd07829 240 PPKDLEKVLPRLDPEGIDLLSKMLQYNPAKRISAKEALKHPYF 282 (282)
T ss_pred CccchHHhcccccHHHHHHHHHhhccCcccCCCHHHHhhCcCC
Confidence 0011226689999999999999999999999999998
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the |
| >cd06917 STKc_NAK1_like Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-36 Score=245.15 Aligned_cols=250 Identities=24% Similarity=0.364 Sum_probs=184.6
Q ss_pred ccceeeeecccCceEEEEEEEcCCCcEEEEEEeccCCCChHHHHHHHHHHHHHHhCC---CCCcchhhhhhhcCCeEEEE
Q psy758 3 RYEKIGKLGEGSYGVVFKCRNRDTGQVVAIKKFLESEEDPLIRKIALREIRLLKSLK---HPNLVNLLEVFRRKKKLHLV 79 (292)
Q Consensus 3 ~y~~~~~l~~g~~~~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~e~~~~~~l~---~~~i~~~~~~~~~~~~~~iv 79 (292)
.|++.+.||+|++|.||+|.+..+++.|++|.+..... ......+.+|+.+++.++ |||++++++++.++...+++
T Consensus 2 ~y~~~~~l~~g~~g~v~~~~~~~~~~~~~iK~~~~~~~-~~~~~~~~~e~~~l~~l~~~~~~~vi~~~~~~~~~~~~~lv 80 (277)
T cd06917 2 LYQRLELIGRGAYGAVYRGKHVPTGRVVALKIINLDTP-DDDVSDIQREVALLSQLRQSQPPNITKYYGSYLKGPRLWII 80 (277)
T ss_pred hhhhhhheeccCCceEEEEEEcCCCcEEEEEEecCCCC-chhHHHHHHHHHHHHHhccCCCCCeeeEeeeeeeCCEEEEE
Confidence 58899999999999999999999999999999865432 233456778999999996 99999999999999999999
Q ss_pred EecCCCccHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEEccCCcEEEeecCchhhhhcccc---
Q psy758 80 FEFCDHTVLNELENHPHGLPWDLIKQITWQVLRGVSYCHRHACIHRDIKPENILLTANGVVKLCDFGFARLIRDLIP--- 156 (292)
Q Consensus 80 ~e~~~~~~L~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~givH~dl~p~Nilv~~~~~~kl~dfg~~~~~~~~~~--- 156 (292)
+||+++++|.+++... .+++..++.++.|++.||.|||+.|++|+||+|+||++++++.++|+|||.+........
T Consensus 81 ~e~~~~~~L~~~~~~~-~l~~~~~~~i~~~i~~~l~~lh~~~i~H~dl~p~ni~i~~~~~~~l~dfg~~~~~~~~~~~~~ 159 (277)
T cd06917 81 MEYAEGGSVRTLMKAG-PIAEKYISVIIREVLVALKYIHKVGVIHRDIKAANILVTNTGNVKLCDFGVAALLNQNSSKRS 159 (277)
T ss_pred EecCCCCcHHHHHHcc-CCCHHHHHHHHHHHHHHHHHHHhCCcccCCcCHHHEEEcCCCCEEEccCCceeecCCCccccc
Confidence 9999999999998764 789999999999999999999999999999999999999999999999998876543221
Q ss_pred --ccccccccccccccCC-CCCCCcccceeeecCCCCCCchHHHHHHHhhcccCCCCCCChhhhhhccCc-CCCCCCC-C
Q psy758 157 --RHLHIFQTNEYFKGVS-LPHAENVVPLEIKIGKPAATNIYLIDFLKRCLDKDPLRRWSCDQLLRHPYF-NGYYFEV-P 231 (292)
Q Consensus 157 --~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~-~~~~~~~-~ 231 (292)
.....|.+||...+.. .....++ ++.+..+...+.+..|..............- ....... .
T Consensus 160 ~~~~~~~y~aPE~~~~~~~~~~~~Dv-------------~slG~~l~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 226 (277)
T cd06917 160 TFVGTPYWMAPEVITEGKYYDTKADI-------------WSLGITIYEMATGNPPYSDVDAFRAMMLIPKSKPPRLEDNG 226 (277)
T ss_pred cccCCcceeCHHHhccCCccccchhH-------------HHHHHHHHHHHhCCCCCCCCChhhhhhccccCCCCCCCccc
Confidence 1223355666543211 1111222 2222223333333334333222111110000 0001111 2
Q ss_pred CccchHHHHhcccCcCCCCCCChhhhhhCCccccee
Q psy758 232 DEMQYEEITQRCLDKDPLRRWSCDQLLRHPYFNGYY 267 (292)
Q Consensus 232 ~~~~l~~li~~~l~~dP~~Rpt~~~il~h~w~~~~~ 267 (292)
.+.++.+++.+||+.||.+|||+.++++||||.+..
T Consensus 227 ~~~~~~~~i~~~l~~~p~~R~~~~~il~~~~~~~~~ 262 (277)
T cd06917 227 YSKLLREFVAACLDEEPKERLSAEELLKSKWIKAHS 262 (277)
T ss_pred CCHHHHHHHHHHcCCCcccCcCHHHHhhChHhhccc
Confidence 467899999999999999999999999999998755
|
Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of cent |
| >cd08530 STKc_CNK2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-36 Score=241.26 Aligned_cols=248 Identities=26% Similarity=0.378 Sum_probs=190.5
Q ss_pred ccceeeeecccCceEEEEEEEcCCCcEEEEEEeccCCCChHHHHHHHHHHHHHHhCCCCCcchhhhhhhcCCeEEEEEec
Q psy758 3 RYEKIGKLGEGSYGVVFKCRNRDTGQVVAIKKFLESEEDPLIRKIALREIRLLKSLKHPNLVNLLEVFRRKKKLHLVFEF 82 (292)
Q Consensus 3 ~y~~~~~l~~g~~~~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~iv~e~ 82 (292)
+|++.+.||.|++|.||++.+..+++.+++|.+............+.+|+.+++.++|+||+++++++.+....++|+||
T Consensus 1 ~y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~ 80 (256)
T cd08530 1 DFKVLKKLGKGSYGSVYKVKRLSDNQFYALKEVDLGSMSQKEREDAVNEIRILASVNHPNIISYKEAFLDGNKLCIVMEY 80 (256)
T ss_pred CceEeeeecCCCceeEEEEEECCCCCEEEEEEEehhhccHHHHHHHHHHHHHHHhCCCCCchhhhhhhccCCEEEEEehh
Confidence 58999999999999999999999999999999876654555567778899999999999999999999999999999999
Q ss_pred CCCccHHHHhcC----CCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEEccCCcEEEeecCchhhhhcccc--
Q psy758 83 CDHTVLNELENH----PHGLPWDLIKQITWQVLRGVSYCHRHACIHRDIKPENILLTANGVVKLCDFGFARLIRDLIP-- 156 (292)
Q Consensus 83 ~~~~~L~~~~~~----~~~~~~~~~~~i~~qi~~aL~~LH~~givH~dl~p~Nilv~~~~~~kl~dfg~~~~~~~~~~-- 156 (292)
+++++|..++.. ...+++..++.++.|++.||.+||+.|++|+||+|+||++++++.++|+|||.+........
T Consensus 81 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lh~~~i~h~~l~~~ni~~~~~~~~kl~d~g~~~~~~~~~~~~ 160 (256)
T cd08530 81 APFGDLSKAISKRKKKRKLIPEQEIWRIFIQLLRGLQALHEQKILHRDLKSANILLVANDLVKIGDLGISKVLKKNMAKT 160 (256)
T ss_pred cCCCCHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhCCcccCCCCcceEEEecCCcEEEeeccchhhhccCCccc
Confidence 999999988755 34689999999999999999999999999999999999999999999999999877654311
Q ss_pred -ccccccccccccccCCCCCCCcccceeeecCCCCCCchHHHHHHHhhcccCCCCCCChhhhhhccCcCCC-CCCCCCcc
Q psy758 157 -RHLHIFQTNEYFKGVSLPHAENVVPLEIKIGKPAATNIYLIDFLKRCLDKDPLRRWSCDQLLRHPYFNGY-YFEVPDEM 234 (292)
Q Consensus 157 -~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~-~~~~~~~~ 234 (292)
.....|.+||+..+.......++ ++.+.-++..+.+..|....+..++......... ..+...+.
T Consensus 161 ~~~~~~~~~Pe~~~~~~~~~~~D~-------------~slG~~~~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 227 (256)
T cd08530 161 QIGTPHYMAPEVWKGRPYSYKSDI-------------WSLGCLLYEMATFAPPFEARSMQDLRYKVQRGKYPPIPPIYSQ 227 (256)
T ss_pred ccCCccccCHHHHCCCCCCchhhH-------------HHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcCCCCCCchhhCH
Confidence 12234555555443322222222 2333334444455555555444333222111111 12224467
Q ss_pred chHHHHhcccCcCCCCCCChhhhhhCCcc
Q psy758 235 QYEEITQRCLDKDPLRRWSCDQLLRHPYF 263 (292)
Q Consensus 235 ~l~~li~~~l~~dP~~Rpt~~~il~h~w~ 263 (292)
.+.+++.+||+.+|.+|||+.++++||++
T Consensus 228 ~~~~li~~~l~~~p~~Rp~~~~~l~~p~~ 256 (256)
T cd08530 228 DLQNFIRSMLQVKPKLRPNCDKILASPAV 256 (256)
T ss_pred HHHHHHHHHcCCCcccCCCHHHHhcCCCC
Confidence 89999999999999999999999999975
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, an |
| >cd07840 STKc_CDK9_like Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-37 Score=250.52 Aligned_cols=259 Identities=34% Similarity=0.507 Sum_probs=189.9
Q ss_pred cceeeeecccCceEEEEEEEcCCCcEEEEEEeccCCCChHHHHHHHHHHHHHHhCCCCCcchhhhhhhcC--CeEEEEEe
Q psy758 4 YEKIGKLGEGSYGVVFKCRNRDTGQVVAIKKFLESEEDPLIRKIALREIRLLKSLKHPNLVNLLEVFRRK--KKLHLVFE 81 (292)
Q Consensus 4 y~~~~~l~~g~~~~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~--~~~~iv~e 81 (292)
|++.+.||+|++|.||+|.+..+++.+++|.+............+.+|+.+++.++|||++++++++.+. +..++|+|
T Consensus 1 y~~~~~l~~g~~~~vy~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~lv~e 80 (287)
T cd07840 1 YEKIAQIGEGTYGQVYKARNKKTGELVALKKIRMENEKEGFPITAIREIKLLQKLRHPNIVRLKEIVTSKGKGSIYMVFE 80 (287)
T ss_pred CeeeEEeccCCCeEEEEEEECCCCeEEEEEEEecccccccchHHHHHHHHHHHhccCCCeeeheeeEecCCCCcEEEEec
Confidence 7889999999999999999999999999999987654444456678899999999999999999999887 89999999
Q ss_pred cCCCccHHHHhcCC-CCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEEccCCcEEEeecCchhhhhccc-----
Q psy758 82 FCDHTVLNELENHP-HGLPWDLIKQITWQVLRGVSYCHRHACIHRDIKPENILLTANGVVKLCDFGFARLIRDLI----- 155 (292)
Q Consensus 82 ~~~~~~L~~~~~~~-~~~~~~~~~~i~~qi~~aL~~LH~~givH~dl~p~Nilv~~~~~~kl~dfg~~~~~~~~~----- 155 (292)
|+++ +|..++... ..+++..++.++.||+.||++||+.|++|+||+|+||++++++.++|+|||.+.......
T Consensus 81 ~~~~-~l~~~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~~~~h~dl~p~nil~~~~~~~~l~d~g~~~~~~~~~~~~~~ 159 (287)
T cd07840 81 YMDH-DLTGLLDSPEVKFTESQIKCYMKQLLEGLQYLHSNGILHRDIKGSNILINNDGVLKLADFGLARPYTKRNSADYT 159 (287)
T ss_pred cccc-cHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCcHHHeEEcCCCCEEEccccceeeccCCCccccc
Confidence 9986 566666543 579999999999999999999999999999999999999999999999999987665432
Q ss_pred -cccccccccccccccC------CCCCCCcccceeeecCCCCCCchHHHHHH----HhhcccCCCCCCChhhhhhccCcC
Q psy758 156 -PRHLHIFQTNEYFKGV------SLPHAENVVPLEIKIGKPAATNIYLIDFL----KRCLDKDPLRRWSCDQLLRHPYFN 224 (292)
Q Consensus 156 -~~~~~~~~~~~~~~~~------~~~~~~~~~~~~~~~~~~~~~~~~~~~~~----~~~~~~~p~~~~~~~~~~~~~~~~ 224 (292)
......|.+||...+. ...|+.|+..+++.++..++........+ ..+-...+..++....+.......
T Consensus 160 ~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~el~t~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 239 (287)
T cd07840 160 NRVITLWYRPPELLLGATRYGPEVDMWSVGCILAELFLGKPIFQGSTELEQLEKIFELCGSPTDENWPGVSKLPWFENLK 239 (287)
T ss_pred ccccccccCCceeeEccccCChHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCchhhccccccchhhhhcc
Confidence 1123346777765432 23455666666666666554332222221 212122222222211110000000
Q ss_pred -CC--------CCCCCCccchHHHHhcccCcCCCCCCChhhhhhCCcc
Q psy758 225 -GY--------YFEVPDEMQYEEITQRCLDKDPLRRWSCDQLLRHPYF 263 (292)
Q Consensus 225 -~~--------~~~~~~~~~l~~li~~~l~~dP~~Rpt~~~il~h~w~ 263 (292)
.. ......+..+.++|.+||+.||.+|||+.++++||||
T Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~~l~~~~~ 287 (287)
T cd07840 240 PKKPYKRRLREFFKHLIDPSALDLLDKLLTLDPKKRISADQALQHEYF 287 (287)
T ss_pred ccccchhHHHHHhcccCCHHHHHHHHHHcCCChhhCcCHHHHhhCcCC
Confidence 00 0011136788999999999999999999999999997
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA po |
| >cd06638 STKc_myosinIIIA Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-36 Score=246.14 Aligned_cols=241 Identities=26% Similarity=0.396 Sum_probs=177.4
Q ss_pred cccceeeeecccCceEEEEEEEcCCCcEEEEEEeccCCCChHHHHHHHHHHHHHHhC-CCCCcchhhhhhh-----cCCe
Q psy758 2 ERYEKIGKLGEGSYGVVFKCRNRDTGQVVAIKKFLESEEDPLIRKIALREIRLLKSL-KHPNLVNLLEVFR-----RKKK 75 (292)
Q Consensus 2 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~e~~~~~~l-~~~~i~~~~~~~~-----~~~~ 75 (292)
++|++.+.||+|++|.||+|.+..+++.+++|.+...... ...+..|+.+++.+ +||||+++++++. .++.
T Consensus 18 ~~~~~~~~lg~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~---~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~~~~ 94 (286)
T cd06638 18 DTWEIIETIGKGTYGKVFKVLNKKNGSKAAVKILDPIHDI---DEEIEAEYNILKALSDHPNVVKFYGMYYKKDVKNGDQ 94 (286)
T ss_pred cceeeeeeeccCCCcEEEEEEECCCCceeEEEeeccccch---HHHHHHHHHHHHHHhcCCCeeeeeeeeeecccCCCCe
Confidence 6899999999999999999999999999999987643322 24566899999999 6999999999873 4567
Q ss_pred EEEEEecCCCccHHHHhc----CCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEEccCCcEEEeecCchhhh
Q psy758 76 LHLVFEFCDHTVLNELEN----HPHGLPWDLIKQITWQVLRGVSYCHRHACIHRDIKPENILLTANGVVKLCDFGFARLI 151 (292)
Q Consensus 76 ~~iv~e~~~~~~L~~~~~----~~~~~~~~~~~~i~~qi~~aL~~LH~~givH~dl~p~Nilv~~~~~~kl~dfg~~~~~ 151 (292)
.++||||+++++|.+++. ....+++..++.++.|++.||.|||+++++|+||+|+||++++++.++|+|||++...
T Consensus 95 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~nili~~~~~~kl~dfg~~~~~ 174 (286)
T cd06638 95 LWLVLELCNGGSVTDLVKGFLKRGERMEEPIIAYILHEALMGLQHLHVNKTIHRDVKGNNILLTTEGGVKLVDFGVSAQL 174 (286)
T ss_pred EEEEEeecCCCCHHHHHHHhhccCccccHHHHHHHHHHHHHHHHHHHhCCccccCCCHHhEEECCCCCEEEccCCceeec
Confidence 999999999999988764 3346899999999999999999999999999999999999999999999999998755
Q ss_pred hccc-----ccccccccccccccc----------CCCCCCCcccceeeecCCCCCCchHHHHHHHhhcccCCCCCCChhh
Q psy758 152 RDLI-----PRHLHIFQTNEYFKG----------VSLPHAENVVPLEIKIGKPAATNIYLIDFLKRCLDKDPLRRWSCDQ 216 (292)
Q Consensus 152 ~~~~-----~~~~~~~~~~~~~~~----------~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~ 216 (292)
.... ...+..|.+||...+ ....|+.++..+++.++..++ .......
T Consensus 175 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGvi~~el~~g~~p~------------------~~~~~~~ 236 (286)
T cd06638 175 TSTRLRRNTSVGTPFWMAPEVIACEQQLDSTYDARCDVWSLGITAIELGDGDPPL------------------ADLHPMR 236 (286)
T ss_pred ccCCCccccccCCCcccChhhhchhhhccccccchhhhhhHHHHHHHHhcCCCCC------------------CCCchhH
Confidence 3221 122334666665432 122344444444444444332 2221111
Q ss_pred hhhc-cCcC--CCCCCCCCccchHHHHhcccCcCCCCCCChhhhhhCCcc
Q psy758 217 LLRH-PYFN--GYYFEVPDEMQYEEITQRCLDKDPLRRWSCDQLLRHPYF 263 (292)
Q Consensus 217 ~~~~-~~~~--~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~~il~h~w~ 263 (292)
.+.. .... ....+...+..+.++|.+||+.||.+|||+.++++|+||
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~ell~~~~~ 286 (286)
T cd06638 237 ALFKIPRNPPPTLHQPELWSNEFNDFIRKCLTKDYEKRPTVSDLLQHVFI 286 (286)
T ss_pred HHhhccccCCCcccCCCCcCHHHHHHHHHHccCCcccCCCHHHHhhcccC
Confidence 1100 0000 001122235679999999999999999999999999997
|
Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear |
| >cd05061 PTKc_InsR Catalytic domain of the Protein Tyrosine Kinase, Insulin Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.6e-37 Score=248.79 Aligned_cols=253 Identities=21% Similarity=0.290 Sum_probs=183.4
Q ss_pred cccceeeeecccCceEEEEEEEcC-----CCcEEEEEEeccCCCChHHHHHHHHHHHHHHhCCCCCcchhhhhhhcCCeE
Q psy758 2 ERYEKIGKLGEGSYGVVFKCRNRD-----TGQVVAIKKFLESEEDPLIRKIALREIRLLKSLKHPNLVNLLEVFRRKKKL 76 (292)
Q Consensus 2 ~~y~~~~~l~~g~~~~v~~~~~~~-----~~~~v~iK~~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~ 76 (292)
++|++.+.||+|++|.||+|.... .+..|++|.+...... .....+.+|+.+++.++||||+++++++.+.+..
T Consensus 6 ~~~~i~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~-~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~ 84 (288)
T cd05061 6 EKITLLRELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASL-RERIEFLNEASVMKGFTCHHVVRLLGVVSKGQPT 84 (288)
T ss_pred HHceeeeeecCCCCcEEEEEEEeccCCCCcceEEEEEECCCcCCH-HHHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCCc
Confidence 589999999999999999997542 3457999988644332 2344577899999999999999999999988999
Q ss_pred EEEEecCCCccHHHHhcCC----------CCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEEccCCcEEEeecC
Q psy758 77 HLVFEFCDHTVLNELENHP----------HGLPWDLIKQITWQVLRGVSYCHRHACIHRDIKPENILLTANGVVKLCDFG 146 (292)
Q Consensus 77 ~iv~e~~~~~~L~~~~~~~----------~~~~~~~~~~i~~qi~~aL~~LH~~givH~dl~p~Nilv~~~~~~kl~dfg 146 (292)
++||||+++|+|.+++... ...+...+..++.|++.||.|||++|++|+||+|+||++++++.++|+|||
T Consensus 85 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~i~H~dikp~nili~~~~~~~L~Dfg 164 (288)
T cd05061 85 LVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADGMAYLNAKKFVHRDLAARNCMVAHDFTVKIGDFG 164 (288)
T ss_pred EEEEeCCCCCCHHHHHHHhccccccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCcCCCCChheEEEcCCCcEEECcCC
Confidence 9999999999999998642 234667889999999999999999999999999999999999999999999
Q ss_pred chhhhhcccc-------ccccccccccccccCCCCCCCcccceeeecCCCCCCchHHHHHHHhhc-ccCCCCCCChhhhh
Q psy758 147 FARLIRDLIP-------RHLHIFQTNEYFKGVSLPHAENVVPLEIKIGKPAATNIYLIDFLKRCL-DKDPLRRWSCDQLL 218 (292)
Q Consensus 147 ~~~~~~~~~~-------~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~p~~~~~~~~~~ 218 (292)
++........ .....|.+||...+.......++|+++ ..+++.+. +..|....+..+..
T Consensus 165 ~~~~~~~~~~~~~~~~~~~~~~y~~pE~~~~~~~~~~~DvwslG-------------~~l~el~~~~~~p~~~~~~~~~~ 231 (288)
T cd05061 165 MTRDIYETDYYRKGGKGLLPVRWMAPESLKDGVFTTSSDMWSFG-------------VVLWEITSLAEQPYQGLSNEQVL 231 (288)
T ss_pred ccccccccccccccCCCcccccccCHHHhccCCCChHhHHHHHH-------------HHHHHHHhCCCCCCCCCCHHHHH
Confidence 9875432111 111235566655443333233333332 22222222 33344433433333
Q ss_pred hccCcCC-CCCCCCCccchHHHHhcccCcCCCCCCChhhhhh------CCcccceec
Q psy758 219 RHPYFNG-YYFEVPDEMQYEEITQRCLDKDPLRRWSCDQLLR------HPYFNGYYF 268 (292)
Q Consensus 219 ~~~~~~~-~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~~il~------h~w~~~~~~ 268 (292)
....-.. ...+...+..+.+++.+||+.||.+|||+.++++ ||||.++.|
T Consensus 232 ~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~~l~~~~~~~~~~~~~ 288 (288)
T cd05061 232 KFVMDGGYLDQPDNCPERVTDLMRMCWQFNPKMRPTFLEIVNLLKDDLHPSFPEVSF 288 (288)
T ss_pred HHHHcCCCCCCCCCCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHhhcCCCCCCCCC
Confidence 2211111 1122344678999999999999999999999988 999998765
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR is a receptor tyr kinase (RTK) that is composed of two alphabeta heterodimers. Binding of the insulin ligand to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR signaling plays an important role in many cellular processes including glucose homeostasis, glycogen synthesis, lipid and protein meta |
| >cd06636 STKc_MAP4K4_6 Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-36 Score=244.70 Aligned_cols=241 Identities=31% Similarity=0.420 Sum_probs=178.2
Q ss_pred cccceeeeecccCceEEEEEEEcCCCcEEEEEEeccCCCChHHHHHHHHHHHHHHhC-CCCCcchhhhhhh------cCC
Q psy758 2 ERYEKIGKLGEGSYGVVFKCRNRDTGQVVAIKKFLESEEDPLIRKIALREIRLLKSL-KHPNLVNLLEVFR------RKK 74 (292)
Q Consensus 2 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~e~~~~~~l-~~~~i~~~~~~~~------~~~ 74 (292)
++|++.+.||+|++|.||+|.+..+++.+++|.+.... .....+..|+.+++.+ +|+||+++++++. ..+
T Consensus 16 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~a~K~~~~~~---~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~~~~ 92 (282)
T cd06636 16 GIFELVEVVGNGTYGQVYKGRHVKTGQLAAIKVMDVTE---DEEEEIKLEINMLKKYSHHRNIATYYGAFIKKSPPGHDD 92 (282)
T ss_pred hhhhhheeeccCCCeEEEEEEEcCCCcEEEEEEEecCh---HHHHHHHHHHHHHHHhcCCCcEEEEeeehhcccccCCCC
Confidence 57999999999999999999999999999999986543 2234577889999988 6999999999985 246
Q ss_pred eEEEEEecCCCccHHHHhcCC--CCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEEccCCcEEEeecCchhhhh
Q psy758 75 KLHLVFEFCDHTVLNELENHP--HGLPWDLIKQITWQVLRGVSYCHRHACIHRDIKPENILLTANGVVKLCDFGFARLIR 152 (292)
Q Consensus 75 ~~~iv~e~~~~~~L~~~~~~~--~~~~~~~~~~i~~qi~~aL~~LH~~givH~dl~p~Nilv~~~~~~kl~dfg~~~~~~ 152 (292)
.+|++|||+++++|..++... ..+++..++.++.||+.||.|||++|++|+||+|+||++++++.++|+|||++....
T Consensus 93 ~~~iv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~ivH~dl~~~nili~~~~~~~l~dfg~~~~~~ 172 (282)
T cd06636 93 QLWLVMEFCGAGSVTDLVKNTKGNALKEDWIAYICREILRGLAHLHAHKVIHRDIKGQNVLLTENAEVKLVDFGVSAQLD 172 (282)
T ss_pred EEEEEEEeCCCCcHHHHHHHccCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCCEEEeeCcchhhhh
Confidence 789999999999999988642 358899999999999999999999999999999999999999999999999987654
Q ss_pred ccc-----cccccccccccccccC----------CCCCCCcccceeeecCCCCCCchHHHHHHHhhcccCCCCCCChhhh
Q psy758 153 DLI-----PRHLHIFQTNEYFKGV----------SLPHAENVVPLEIKIGKPAATNIYLIDFLKRCLDKDPLRRWSCDQL 217 (292)
Q Consensus 153 ~~~-----~~~~~~~~~~~~~~~~----------~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~ 217 (292)
... ..+...|.+||..... ...|+.|+..+++.++. .|.......+.
T Consensus 173 ~~~~~~~~~~~~~~y~aPE~l~~~~~~~~~~~~~~DvwslG~~l~el~~g~------------------~p~~~~~~~~~ 234 (282)
T cd06636 173 RTVGRRNTFIGTPYWMAPEVIACDENPDATYDYRSDIWSLGITAIEMAEGA------------------PPLCDMHPMRA 234 (282)
T ss_pred ccccCCCcccccccccCHhhcCcccCcCcCCCcccchhHHHHHHHHHHhCC------------------CCccccCHHhh
Confidence 221 1123345666654321 22333333333344443 33322221111
Q ss_pred hhc-cCc-CCCCCCCCCccchHHHHhcccCcCCCCCCChhhhhhCCcc
Q psy758 218 LRH-PYF-NGYYFEVPDEMQYEEITQRCLDKDPLRRWSCDQLLRHPYF 263 (292)
Q Consensus 218 ~~~-~~~-~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~~il~h~w~ 263 (292)
... ... .........+..+.+||.+||+.||.+|||+.++++||||
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~ell~~~~~ 282 (282)
T cd06636 235 LFLIPRNPPPKLKSKKWSKKFIDFIEGCLVKNYLSRPSTEQLLKHPFI 282 (282)
T ss_pred hhhHhhCCCCCCcccccCHHHHHHHHHHhCCChhhCcCHHHHhcCCCC
Confidence 100 000 0001112346789999999999999999999999999997
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Ea |
| >cd06620 PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.8e-37 Score=248.87 Aligned_cols=257 Identities=26% Similarity=0.378 Sum_probs=187.5
Q ss_pred cccceeeeecccCceEEEEEEEcCCCcEEEEEEeccCCCChHHHHHHHHHHHHHHhCCCCCcchhhhhhhcCCeEEEEEe
Q psy758 2 ERYEKIGKLGEGSYGVVFKCRNRDTGQVVAIKKFLESEEDPLIRKIALREIRLLKSLKHPNLVNLLEVFRRKKKLHLVFE 81 (292)
Q Consensus 2 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~iv~e 81 (292)
++|++.+.||+|++|.||++.+..+++.|++|++.... .......+.+|+++++.++||||+++++.+...+.+++|+|
T Consensus 5 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~~a~k~~~~~~-~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 83 (284)
T cd06620 5 EDLETISDLGAGNGGSVSKVKHIPTGTVMAKKVVHIGA-KSSVRKQILRELQIMHECRSPYIVSFYGAFLNENNICMCME 83 (284)
T ss_pred HHHHHHHHcCCCCCeEEEEEEEcCCCcEEEEEEEEecC-cchHHHHHHHHHHHHHHcCCCCcceEeeeEecCCEEEEEEe
Confidence 57999999999999999999999999999999886543 23456778899999999999999999999999999999999
Q ss_pred cCCCccHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHh-CCccccCCCCCceEEccCCcEEEeecCchhhhhccc---cc
Q psy758 82 FCDHTVLNELENHPHGLPWDLIKQITWQVLRGVSYCHR-HACIHRDIKPENILLTANGVVKLCDFGFARLIRDLI---PR 157 (292)
Q Consensus 82 ~~~~~~L~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~-~givH~dl~p~Nilv~~~~~~kl~dfg~~~~~~~~~---~~ 157 (292)
|+++++|..++...+.+++..++.++.+++.||.|||+ .|++|+||+|+||++++++.++|+|||++....... ..
T Consensus 84 ~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~i~H~dl~p~nil~~~~~~~~l~d~gl~~~~~~~~~~~~~ 163 (284)
T cd06620 84 FMDCGSLDRIYKKGGPIPVEILGKIAVAVVEGLTYLYNVHRIMHRDIKPSNILVNSRGQIKLCDFGVSGELINSIADTFV 163 (284)
T ss_pred cCCCCCHHHHHHhccCCCHHHHHHHHHHHHHHHHHHHHhcCeeccCCCHHHEEECCCCcEEEccCCcccchhhhccCccc
Confidence 99999999998877789999999999999999999997 599999999999999999999999999876543211 12
Q ss_pred cccccccccccccCCCC-----CCCcccceeeecCCCCCCchHHHHHHHhhcccCCCCCCChhhhhhccCcC-CCCCC-C
Q psy758 158 HLHIFQTNEYFKGVSLP-----HAENVVPLEIKIGKPAATNIYLIDFLKRCLDKDPLRRWSCDQLLRHPYFN-GYYFE-V 230 (292)
Q Consensus 158 ~~~~~~~~~~~~~~~~~-----~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~-~~~~~-~ 230 (292)
.+..|.+||...+.... |+.++..+++.+|..++........ ......+..+........ ....+ .
T Consensus 164 ~~~~~~aPE~~~~~~~~~~~Di~slG~~l~~l~tg~~p~~~~~~~~~-------~~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (284)
T cd06620 164 GTSTYMSPERIQGGKYTVKSDVWSLGISIIELALGKFPFAFSNIDDD-------GQDDPMGILDLLQQIVQEPPPRLPSS 236 (284)
T ss_pred cCcccCCHHHHccCCCCccchHHHHHHHHHHHHhCCCCCcccchhhh-------hhhhhhHHHHHHHHHhhccCCCCCch
Confidence 33456667665443332 3333333344444443321110000 000000000111110000 00111 1
Q ss_pred CCccchHHHHhcccCcCCCCCCChhhhhhCCcccce
Q psy758 231 PDEMQYEEITQRCLDKDPLRRWSCDQLLRHPYFNGY 266 (292)
Q Consensus 231 ~~~~~l~~li~~~l~~dP~~Rpt~~~il~h~w~~~~ 266 (292)
..+..+.+||.+||+.||.+|||+.++++||||...
T Consensus 237 ~~~~~~~~li~~~l~~dp~~Rpt~~e~~~~~~~~~~ 272 (284)
T cd06620 237 DFPEDLRDFVDACLLKDPTERPTPQQLCAMPPFIQA 272 (284)
T ss_pred hcCHHHHHHHHHHhcCCcccCcCHHHHhcCcccccc
Confidence 245679999999999999999999999999999763
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >cd06659 STKc_PAK6 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-36 Score=247.72 Aligned_cols=248 Identities=25% Similarity=0.362 Sum_probs=184.8
Q ss_pred cceeeeecccCceEEEEEEEcCCCcEEEEEEeccCCCChHHHHHHHHHHHHHHhCCCCCcchhhhhhhcCCeEEEEEecC
Q psy758 4 YEKIGKLGEGSYGVVFKCRNRDTGQVVAIKKFLESEEDPLIRKIALREIRLLKSLKHPNLVNLLEVFRRKKKLHLVFEFC 83 (292)
Q Consensus 4 y~~~~~l~~g~~~~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~iv~e~~ 83 (292)
|.....||+|+||.||.|.+..+++.|++|.+...... ..+.+.+|+.+++.++|||++++++.+..++..++++||+
T Consensus 23 ~~~~~~ig~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~--~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~iv~e~~ 100 (297)
T cd06659 23 LENYIKIGEGSTGIVCIAREKHSGRQVAVKMMDLRKQQ--RRELLFNEVVIMRDYQHQNVVEMYKSYLVGEELWVLMEFL 100 (297)
T ss_pred HHhhhhcCCCCceeEEEEEEcCCCCEEEEEEEEecccc--hHHHHHHHHHHHHhCCCCchhhhhhheeeCCeEEEEEecC
Confidence 55566899999999999999989999999998654332 2456788999999999999999999999999999999999
Q ss_pred CCccHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEEccCCcEEEeecCchhhhhcccc-----cc
Q psy758 84 DHTVLNELENHPHGLPWDLIKQITWQVLRGVSYCHRHACIHRDIKPENILLTANGVVKLCDFGFARLIRDLIP-----RH 158 (292)
Q Consensus 84 ~~~~L~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~givH~dl~p~Nilv~~~~~~kl~dfg~~~~~~~~~~-----~~ 158 (292)
++++|..++.. ..+++..++.++.|++.||.+||++|++|+||+|+||+++.++.++|+|||++........ ..
T Consensus 101 ~~~~L~~~~~~-~~~~~~~~~~~~~qi~~~L~~LH~~~ivH~dl~p~Nill~~~~~~kL~dfg~~~~~~~~~~~~~~~~~ 179 (297)
T cd06659 101 QGGALTDIVSQ-TRLNEEQIATVCESVLQALCYLHSQGVIHRDIKSDSILLTLDGRVKLSDFGFCAQISKDVPKRKSLVG 179 (297)
T ss_pred CCCCHHHHHhh-cCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHeEEccCCcEEEeechhHhhcccccccccceec
Confidence 99999998765 4689999999999999999999999999999999999999999999999999865433221 12
Q ss_pred ccccccccccccCCCCCCCcccceeeecCCCCCCchHHHHHHHhhcccCCCCCCChhhhhhc---cCcCCCCCCCCCccc
Q psy758 159 LHIFQTNEYFKGVSLPHAENVVPLEIKIGKPAATNIYLIDFLKRCLDKDPLRRWSCDQLLRH---PYFNGYYFEVPDEMQ 235 (292)
Q Consensus 159 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~---~~~~~~~~~~~~~~~ 235 (292)
...|.+||+..+.......++ ++.+..+++.+.+..|.......+.+.. ............+..
T Consensus 180 ~~~y~aPE~~~~~~~~~~~Dv-------------~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 246 (297)
T cd06659 180 TPYWMAPEVISRTPYGTEVDI-------------WSLGIMVIEMVDGEPPYFSDSPVQAMKRLRDSPPPKLKNAHKISPV 246 (297)
T ss_pred CccccCHHHHccCCCCchhhH-------------HHHHHHHHHHHhCCCCCCCCCHHHHHHHHhccCCCCccccCCCCHH
Confidence 334566665544332222222 2222333333444444433222222111 000111112234667
Q ss_pred hHHHHhcccCcCCCCCCChhhhhhCCccccee
Q psy758 236 YEEITQRCLDKDPLRRWSCDQLLRHPYFNGYY 267 (292)
Q Consensus 236 l~~li~~~l~~dP~~Rpt~~~il~h~w~~~~~ 267 (292)
+.++|.+||+.||.+||++.++++||||.+..
T Consensus 247 l~~~i~~~l~~~P~~Rps~~~ll~~~~~~~~~ 278 (297)
T cd06659 247 LRDFLERMLTREPQERATAQELLDHPFLLQTG 278 (297)
T ss_pred HHHHHHHHhcCCcccCcCHHHHhhChhhccCC
Confidence 89999999999999999999999999999743
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role i |
| >cd08228 STKc_Nek6 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-36 Score=244.75 Aligned_cols=246 Identities=23% Similarity=0.313 Sum_probs=181.1
Q ss_pred CcccceeeeecccCceEEEEEEEcCCCcEEEEEEeccCC-CChHHHHHHHHHHHHHHhCCCCCcchhhhhhhcCCeEEEE
Q psy758 1 MERYEKIGKLGEGSYGVVFKCRNRDTGQVVAIKKFLESE-EDPLIRKIALREIRLLKSLKHPNLVNLLEVFRRKKKLHLV 79 (292)
Q Consensus 1 ~~~y~~~~~l~~g~~~~v~~~~~~~~~~~v~iK~~~~~~-~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~iv 79 (292)
+++|++.+.||+|++|.||+|.+..+++.|++|.+.... ........+.+|+.+++.++||||+++++++.+.+..+++
T Consensus 1 ~~~~~i~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v 80 (267)
T cd08228 1 LANFQIEKKIGRGQFSEVYRATCLLDRKPVALKKVQIFEMMDAKARQDCVKEIDLLKQLNHPNVIKYLDSFIEDNELNIV 80 (267)
T ss_pred CcceeeeeeeccCCCeeEEEEEEeCCCCEEEEEEeeccccCCHHHHHHHHHHHHHHHhCCCcceeeeeeeEEECCeEEEE
Confidence 578999999999999999999999999999999886543 3444566788999999999999999999999999999999
Q ss_pred EecCCCccHHHHhc----CCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEEccCCcEEEeecCchhhhhccc
Q psy758 80 FEFCDHTVLNELEN----HPHGLPWDLIKQITWQVLRGVSYCHRHACIHRDIKPENILLTANGVVKLCDFGFARLIRDLI 155 (292)
Q Consensus 80 ~e~~~~~~L~~~~~----~~~~~~~~~~~~i~~qi~~aL~~LH~~givH~dl~p~Nilv~~~~~~kl~dfg~~~~~~~~~ 155 (292)
+||+++++|..++. ....+++..++.++.|++.||.|||++|++|+||+|+||+++.++.++|+|||.+.......
T Consensus 81 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~H~dl~~~nil~~~~~~~~l~d~g~~~~~~~~~ 160 (267)
T cd08228 81 LELADAGDLSQMIKYFKKQKRLIPERTVWKYFVQLCSAVEHMHSRRVMHRDIKPANVFITATGVVKLGDLGLGRFFSSKT 160 (267)
T ss_pred EEecCCCcHHHHHHHhhhccCCCCHHHHHHHHHHHHHHHHHHhhCCeeCCCCCHHHEEEcCCCCEEECccccceeccchh
Confidence 99999999988774 23458999999999999999999999999999999999999999999999999887654322
Q ss_pred -----cccccccccccccccCCCCCCCcccceeeecCCCCCCchHHHHHHHhhcccCCCCCCC--hhhhhhccCcCCCC-
Q psy758 156 -----PRHLHIFQTNEYFKGVSLPHAENVVPLEIKIGKPAATNIYLIDFLKRCLDKDPLRRWS--CDQLLRHPYFNGYY- 227 (292)
Q Consensus 156 -----~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~--~~~~~~~~~~~~~~- 227 (292)
......|.+||...+.......++|+ .+.-++..+.+..|..... ..+.....-....+
T Consensus 161 ~~~~~~~~~~~~~aPE~~~~~~~~~~~Di~s-------------lG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~ 227 (267)
T cd08228 161 TAAHSLVGTPYYMSPERIHENGYNFKSDIWS-------------LGCLLYEMAALQSPFYGDKMNLFSLCQKIEQCDYPP 227 (267)
T ss_pred HHHhcCCCCccccChhhhccCCCCchhhHHH-------------HHHHHHHHhcCCCCCccccccHHHHHHHHhcCCCCC
Confidence 12233456666654433222222222 2222233333333322211 11111110000000
Q ss_pred -CCCCCccchHHHHhcccCcCCCCCCChhhhhh
Q psy758 228 -FEVPDEMQYEEITQRCLDKDPLRRWSCDQLLR 259 (292)
Q Consensus 228 -~~~~~~~~l~~li~~~l~~dP~~Rpt~~~il~ 259 (292)
.....+..+.++|.+||+.||++|||+.++++
T Consensus 228 ~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~vl~ 260 (267)
T cd08228 228 LPTEHYSEKLRELVSMCIYPDPDQRPDIGYVHQ 260 (267)
T ss_pred CChhhcCHHHHHHHHHHCCCCcccCcCHHHHHH
Confidence 11234567999999999999999999999997
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase |
| >KOG0604|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.8e-38 Score=238.93 Aligned_cols=245 Identities=25% Similarity=0.348 Sum_probs=183.9
Q ss_pred cccce-eeeecccCceEEEEEEEcCCCcEEEEEEeccCCCChHHHHHHHHHHHHHHhC-CCCCcchhhhhhhc----CCe
Q psy758 2 ERYEK-IGKLGEGSYGVVFKCRNRDTGQVVAIKKFLESEEDPLIRKIALREIRLLKSL-KHPNLVNLLEVFRR----KKK 75 (292)
Q Consensus 2 ~~y~~-~~~l~~g~~~~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~e~~~~~~l-~~~~i~~~~~~~~~----~~~ 75 (292)
++|++ -+.||-|-+|.|-.+.++.||+.+|+|++..+ ...++|+++--.. .|||||.++++|+. ...
T Consensus 61 edY~is~qvLG~GinGkV~~C~~k~T~ekfALKvL~Ds-------~KARrEVeLHw~~s~h~~iV~IidVyeNs~~~rkc 133 (400)
T KOG0604|consen 61 EDYSISWQVLGAGINGKVVQCVHKRTQEKFALKVLLDS-------PKARREVELHWMASGHPHIVSIIDVYENSYQGRKC 133 (400)
T ss_pred hhheehhhhhccccCCceEEEEeccchhhhHHHHHhcC-------HHHHhHhhhhhhhcCCCceEEeehhhhhhccCcee
Confidence 45666 35699999999999999999999999998544 4456787765554 59999999999874 456
Q ss_pred EEEEEecCCCccHHHHhcCCCC--CCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEEccC---CcEEEeecCchhh
Q psy758 76 LHLVFEFCDHTVLNELENHPHG--LPWDLIKQITWQVLRGVSYCHRHACIHRDIKPENILLTAN---GVVKLCDFGFARL 150 (292)
Q Consensus 76 ~~iv~e~~~~~~L~~~~~~~~~--~~~~~~~~i~~qi~~aL~~LH~~givH~dl~p~Nilv~~~---~~~kl~dfg~~~~ 150 (292)
+.+|||.++||.|...++..+. ++|.++..|+.||+.|+.|||+.+|.||||||+|+|...+ ..+||+|||+++.
T Consensus 134 LLiVmE~meGGeLfsriq~~g~~afTErea~eI~~qI~~Av~~lH~~nIAHRDlKpENLLyt~t~~na~lKLtDfGFAK~ 213 (400)
T KOG0604|consen 134 LLIVMECMEGGELFSRIQDRGDQAFTEREASEIMKQIGLAVRYLHSMNIAHRDLKPENLLYTTTSPNAPLKLTDFGFAKE 213 (400)
T ss_pred eEeeeecccchHHHHHHHHcccccchHHHHHHHHHHHHHHHHHHHhcchhhccCChhheeeecCCCCcceEecccccccc
Confidence 8899999999999998877654 9999999999999999999999999999999999999754 5799999999988
Q ss_pred hhcccccc----ccccccccccccCCC-----CCCCcccceeeecCCCCCCchHHHHHHHhhcccCCCCCCChhhhhhcc
Q psy758 151 IRDLIPRH----LHIFQTNEYFKGVSL-----PHAENVVPLEIKIGKPAATNIYLIDFLKRCLDKDPLRRWSCDQLLRHP 221 (292)
Q Consensus 151 ~~~~~~~~----~~~~~~~~~~~~~~~-----~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~ 221 (292)
..+...-. ++.|.+|+..-++.. .|+.++..|-+++|.+++.+.....+- +.... ..
T Consensus 214 t~~~~~L~TPc~TPyYvaPevlg~eKydkscdmwSlgVimYIlLCGyPPFYS~hg~ais-----------pgMk~---rI 279 (400)
T KOG0604|consen 214 TQEPGDLMTPCFTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAIS-----------PGMKR---RI 279 (400)
T ss_pred cCCCccccCCcccccccCHHHhCchhcCCCCCccchhHHHHHhhcCCCcccccCCccCC-----------hhHHh---Hh
Confidence 76433222 344555555544433 355555555566666665433221111 01111 11
Q ss_pred CcCCCCCCCC----CccchHHHHhcccCcCCCCCCChhhhhhCCccccee
Q psy758 222 YFNGYYFEVP----DEMQYEEITQRCLDKDPLRRWSCDQLLRHPYFNGYY 267 (292)
Q Consensus 222 ~~~~~~~~~~----~~~~l~~li~~~l~~dP~~Rpt~~~il~h~w~~~~~ 267 (292)
-...+.++.+ ++...+++|+.+|..+|++|.|+.++++|||+++..
T Consensus 280 ~~gqy~FP~pEWs~VSe~aKdlIR~LLkt~PteRlTI~~~m~hpwi~~~~ 329 (400)
T KOG0604|consen 280 RTGQYEFPEPEWSCVSEAAKDLIRKLLKTEPTERLTIEEVMDHPWINQYE 329 (400)
T ss_pred hccCccCCChhHhHHHHHHHHHHHHHhcCCchhheeHHHhhcCchhcccc
Confidence 1223344444 377889999999999999999999999999999843
|
|
| >cd07879 STKc_p38delta_MAPK13 Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-37 Score=256.85 Aligned_cols=263 Identities=27% Similarity=0.429 Sum_probs=191.7
Q ss_pred cccceeeeecccCceEEEEEEEcCCCcEEEEEEeccCCCChHHHHHHHHHHHHHHhCCCCCcchhhhhhhcC------Ce
Q psy758 2 ERYEKIGKLGEGSYGVVFKCRNRDTGQVVAIKKFLESEEDPLIRKIALREIRLLKSLKHPNLVNLLEVFRRK------KK 75 (292)
Q Consensus 2 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~------~~ 75 (292)
++|.+.+.||+|++|.||+|.+..+++.||+|.+............+.+|+.+++.++||||+++++++... ..
T Consensus 15 ~~y~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~ 94 (342)
T cd07879 15 ERYTSLKQVGSGAYGSVCSAIDKRTGEKVAIKKLSRPFQSEIFAKRAYRELTLLKHMQHENVIGLLDVFTSAVSGDEFQD 94 (342)
T ss_pred cceEEEEEeeecCCeEEEEEEeCCCCcEEEEEEecCccccccchhHHHHHHHHHHhcCCCCccchhheecccccCCCCce
Confidence 589999999999999999999999999999999876544444455678899999999999999999998653 34
Q ss_pred EEEEEecCCCccHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEEccCCcEEEeecCchhhhhccc
Q psy758 76 LHLVFEFCDHTVLNELENHPHGLPWDLIKQITWQVLRGVSYCHRHACIHRDIKPENILLTANGVVKLCDFGFARLIRDLI 155 (292)
Q Consensus 76 ~~iv~e~~~~~~L~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~givH~dl~p~Nilv~~~~~~kl~dfg~~~~~~~~~ 155 (292)
+++|+||+.. ++..+.. ..+++..++.++.|++.||+|||+.|++||||+|+||+++.++.++|+|||++.......
T Consensus 95 ~~lv~e~~~~-~l~~~~~--~~~~~~~~~~~~~qi~~aL~~LH~~~i~H~dlkp~NIll~~~~~~kL~dfg~~~~~~~~~ 171 (342)
T cd07879 95 FYLVMPYMQT-DLQKIMG--HPLSEDKVQYLVYQMLCGLKYIHSAGIIHRDLKPGNLAVNEDCELKILDFGLARHADAEM 171 (342)
T ss_pred EEEEeccccc-CHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCCEEEeeCCCCcCCCCCC
Confidence 6999999975 5666553 368999999999999999999999999999999999999999999999999987543221
Q ss_pred --ccccccccccccccc------CCCCCCCcccceeeecCCCCCCchHHHHHHHhhcccCCCCCCChhhhhhc-------
Q psy758 156 --PRHLHIFQTNEYFKG------VSLPHAENVVPLEIKIGKPAATNIYLIDFLKRCLDKDPLRRWSCDQLLRH------- 220 (292)
Q Consensus 156 --~~~~~~~~~~~~~~~------~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~------- 220 (292)
...+..|.+||...+ ....|+.|+..+++.+|..++........+...+...+..++...+.+..
T Consensus 172 ~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slGvil~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 251 (342)
T cd07879 172 TGYVVTRWYRAPEVILNWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQLTQILKVTGVPGPEFVQKLEDKAAKSYI 251 (342)
T ss_pred CCceeeecccChhhhcCccccCchHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHHHHHHhcccchHHHH
Confidence 122344677776543 23346667777777777766544333333332222211111111111100
Q ss_pred ---cCcCCCCC---CCCCccchHHHHhcccCcCCCCCCChhhhhhCCccccee
Q psy758 221 ---PYFNGYYF---EVPDEMQYEEITQRCLDKDPLRRWSCDQLLRHPYFNGYY 267 (292)
Q Consensus 221 ---~~~~~~~~---~~~~~~~l~~li~~~l~~dP~~Rpt~~~il~h~w~~~~~ 267 (292)
+.+..... ....+..+.+||.+||+.||.+|||+++++.||||.+..
T Consensus 252 ~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~R~~~~e~l~h~~f~~~~ 304 (342)
T cd07879 252 KSLPKYPRKDFSTLFPKASPQAVDLLEKMLELDVDKRLTATEALEHPYFDSFR 304 (342)
T ss_pred hhcCCcccchHHHHhcCCCHHHHHHHHHHcCCChhhCcCHHHHhcCcchhhcc
Confidence 00000000 012456789999999999999999999999999999865
|
Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13 |
| >cd05606 STKc_beta_ARK Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-36 Score=244.53 Aligned_cols=250 Identities=20% Similarity=0.288 Sum_probs=179.7
Q ss_pred eecccCceEEEEEEEcCCCcEEEEEEeccCCCCh-HHHHHHHHH---HHHHHhCCCCCcchhhhhhhcCCeEEEEEecCC
Q psy758 9 KLGEGSYGVVFKCRNRDTGQVVAIKKFLESEEDP-LIRKIALRE---IRLLKSLKHPNLVNLLEVFRRKKKLHLVFEFCD 84 (292)
Q Consensus 9 ~l~~g~~~~v~~~~~~~~~~~v~iK~~~~~~~~~-~~~~~~~~e---~~~~~~l~~~~i~~~~~~~~~~~~~~iv~e~~~ 84 (292)
.||+|++|.||+|.+..+++.||+|.+....... .....+..| ...++...||+|+++++++.+++..++|+||+.
T Consensus 1 ~ig~g~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~v~e~~~ 80 (278)
T cd05606 1 IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDKLSFILDLMN 80 (278)
T ss_pred CcccCCCeEEEEEEEecCCCEEEEEEeeccccccchhHHHHHHHHHHHHHHHhCCCCcEeeeeeeeecCCEEEEEEecCC
Confidence 4899999999999999999999999987654221 111222333 334455679999999999999999999999999
Q ss_pred CccHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEEccCCcEEEeecCchhhhhccc---cccccc
Q psy758 85 HTVLNELENHPHGLPWDLIKQITWQVLRGVSYCHRHACIHRDIKPENILLTANGVVKLCDFGFARLIRDLI---PRHLHI 161 (292)
Q Consensus 85 ~~~L~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~givH~dl~p~Nilv~~~~~~kl~dfg~~~~~~~~~---~~~~~~ 161 (292)
|++|..++...+.+++..+..++.|++.||.|||++|++|+||+|+||+++.++.++|+|||.+....... ...+..
T Consensus 81 g~~L~~~l~~~~~l~~~~~~~~~~ql~~~l~~lH~~~i~H~di~p~nili~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~ 160 (278)
T cd05606 81 GGDLHYHLSQHGVFSEAEMRFYAAEIILGLEHMHNRFVVYRDLKPANILLDEHGHVRISDLGLACDFSKKKPHASVGTHG 160 (278)
T ss_pred CCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCEEcCCCCHHHEEECCCCCEEEccCcCccccCccCCcCcCCCcC
Confidence 99999998877789999999999999999999999999999999999999999999999999986543221 122334
Q ss_pred cccccccccC-CCCCCCcccceeeecCCCCCCchHHHHHHHhhcccCCCCCC---ChhhhhhccCcCCCCCCCCCccchH
Q psy758 162 FQTNEYFKGV-SLPHAENVVPLEIKIGKPAATNIYLIDFLKRCLDKDPLRRW---SCDQLLRHPYFNGYYFEVPDEMQYE 237 (292)
Q Consensus 162 ~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~---~~~~~~~~~~~~~~~~~~~~~~~l~ 237 (292)
|.+||...+. ...... +.++.+..++..+.+..|+... ...+............+...+..+.
T Consensus 161 y~aPE~~~~~~~~~~~~-------------Di~s~G~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~ 227 (278)
T cd05606 161 YMAPEVLQKGVAYDSSA-------------DWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTLTMAVELPDSFSPELR 227 (278)
T ss_pred CcCcHHhcCCCCCCccc-------------chHhHHHHHHHHHhCCCCCCCCCccchHHHHHHhhccCCCCCCcCCHHHH
Confidence 5555554321 111111 2222333333444444444332 1111111111112233444578999
Q ss_pred HHHhcccCcCCCCCC-----ChhhhhhCCcccceeccCC
Q psy758 238 EITQRCLDKDPLRRW-----SCDQLLRHPYFNGYYFEVP 271 (292)
Q Consensus 238 ~li~~~l~~dP~~Rp-----t~~~il~h~w~~~~~~~~~ 271 (292)
+++.+||..||.+|| ++.++++||||.+..|...
T Consensus 228 ~li~~~l~~~p~~R~~~~~~~~~~ll~~~~~~~~~~~~~ 266 (278)
T cd05606 228 SLLEGLLQRDVNRRLGCLGRGAQEVKEHPFFRSLDWQMV 266 (278)
T ss_pred HHHHHHhhcCHHhccCCCCCCHHHHHhCccccCCCchHh
Confidence 999999999999999 9999999999999776543
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is co |
| >KOG0666|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-38 Score=242.21 Aligned_cols=266 Identities=32% Similarity=0.559 Sum_probs=194.6
Q ss_pred CcccceeeeecccCceEEEEEEEcCCCc----EEEEEEeccCCCChHHHHHHHHHHHHHHhCCCCCcchhhhhhhc-CCe
Q psy758 1 MERYEKIGKLGEGSYGVVFKCRNRDTGQ----VVAIKKFLESEEDPLIRKIALREIRLLKSLKHPNLVNLLEVFRR-KKK 75 (292)
Q Consensus 1 ~~~y~~~~~l~~g~~~~v~~~~~~~~~~----~v~iK~~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~-~~~ 75 (292)
+..|+..+.||+|++|.||+|...+++. .+|+|.+.......-......+|+.+++.++|||++.+..+|.. +..
T Consensus 23 l~~ye~ig~Ig~GTYG~VykA~~~~~n~kr~k~yAiKkfk~~kd~tGiS~SAcREiaL~REl~h~nvi~Lv~Vfl~~d~~ 102 (438)
T KOG0666|consen 23 LFEYEGIGKIGRGTYGKVYKAVRKNTNDKRTKEYAIKKFKGEKDGTGISMSACREIALLRELKHPNVISLVKVFLSHDKK 102 (438)
T ss_pred HHHhhccceecccccceeeEeeeccCCcccchhhHHHHHhccCCCCCcCHHHHHHHHHHHHhcCCcchhHHHHHhccCce
Confidence 3579999999999999999996655433 68999998776555556777899999999999999999999987 889
Q ss_pred EEEEEecCCCccHHHHh----cCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEEccC----CcEEEeecCc
Q psy758 76 LHLVFEFCDHTVLNELE----NHPHGLPWDLIKQITWQVLRGVSYCHRHACIHRDIKPENILLTAN----GVVKLCDFGF 147 (292)
Q Consensus 76 ~~iv~e~~~~~~L~~~~----~~~~~~~~~~~~~i~~qi~~aL~~LH~~givH~dl~p~Nilv~~~----~~~kl~dfg~ 147 (292)
+++++||.+...+.-+- ...+.++...+..|+.||+.|+.|||++=++||||||.||+|..+ |.+||+|||+
T Consensus 103 v~l~fdYAEhDL~~II~fHr~~~~~~lp~~mvKsilwQil~Gv~YLH~NWvlHRDLKPaNIlvmgdgperG~VKIaDlGl 182 (438)
T KOG0666|consen 103 VWLLFDYAEHDLWHIIKFHRASKAKQLPRSMVKSILWQILDGVHYLHSNWVLHRDLKPANILVMGDGPERGRVKIADLGL 182 (438)
T ss_pred EEEEehhhhhhHHHHHHHhccchhccCCHHHHHHHHHHHHhhhHHHhhhheeeccCCcceEEEeccCCccCeeEeecccH
Confidence 99999999986544332 122469999999999999999999999999999999999999988 8999999999
Q ss_pred hhhhhcccc--------ccccccccccccccCCCC------CCCcccceeeecCCCCCCchH------------HHHHHH
Q psy758 148 ARLIRDLIP--------RHLHIFQTNEYFKGVSLP------HAENVVPLEIKIGKPAATNIY------------LIDFLK 201 (292)
Q Consensus 148 ~~~~~~~~~--------~~~~~~~~~~~~~~~~~~------~~~~~~~~~~~~~~~~~~~~~------------~~~~~~ 201 (292)
++.+.+... ..+..|.+||...|...+ |+.|++-.++++..+.+.... -.+-+.
T Consensus 183 aR~~~~plkpl~s~d~VVVTiWYRAPELLLGa~hYT~AiDvWAiGCIfaElLtl~PlF~g~E~k~~~~~Pfq~dQl~rIf 262 (438)
T KOG0666|consen 183 ARLFNNPLKPLASLDPVVVTIWYRAPELLLGARHYTKAIDVWAIGCIFAELLTLEPLFKGREEKIKTKNPFQHDQLDRIF 262 (438)
T ss_pred HHHhhccccccccCCceEEEEEecChHHhcccccccchhhhHHHHHHHHHHHccCccccchhhhcccCCCchHHHHHHHH
Confidence 998865332 124568999998887653 555555555555444332211 112233
Q ss_pred hhcccCCCCCCC-hhhhhhc-----cCcCCCCCC----------CCCccchHHHHhcccCcCCCCCCChhhhhhCCcccc
Q psy758 202 RCLDKDPLRRWS-CDQLLRH-----PYFNGYYFE----------VPDEMQYEEITQRCLDKDPLRRWSCDQLLRHPYFNG 265 (292)
Q Consensus 202 ~~~~~~p~~~~~-~~~~~~~-----~~~~~~~~~----------~~~~~~l~~li~~~l~~dP~~Rpt~~~il~h~w~~~ 265 (292)
.+++....+++. ....-.+ .+-..+..+ ...+++..+|+.+||++||.+|.|++++|+|+||..
T Consensus 263 ~vLG~Pt~~~Wp~lkk~Pe~q~~ls~f~~~~~~n~sL~~~~~~~k~k~~~a~~LL~klL~yDP~kRIta~qAleh~yF~~ 342 (438)
T KOG0666|consen 263 EVLGTPTDKDWPDLKKMPEYQTLLSDFRRHYYDNVSLHKYYHKHKVKDPSALDLLQKLLTYDPIKRITAEQALEHPYFTE 342 (438)
T ss_pred HHcCCCccccchhhhhCcchHHHHHHhHHhhcCcchHHHHHHHhcCCCchHHHHHHHHhccCchhhccHHHHhccccccc
Confidence 344444333332 1111111 000011111 122455889999999999999999999999999997
Q ss_pred e
Q psy758 266 Y 266 (292)
Q Consensus 266 ~ 266 (292)
.
T Consensus 343 d 343 (438)
T KOG0666|consen 343 D 343 (438)
T ss_pred C
Confidence 4
|
|
| >PHA03390 pk1 serine/threonine-protein kinase 1; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.9e-37 Score=246.44 Aligned_cols=244 Identities=19% Similarity=0.249 Sum_probs=178.0
Q ss_pred cccceeeee--cccCceEEEEEEEcCCCcEEEEEEeccCCCChHHHHHHHHHHHHHHhC-CCCCcchhhhhhhcCCeEEE
Q psy758 2 ERYEKIGKL--GEGSYGVVFKCRNRDTGQVVAIKKFLESEEDPLIRKIALREIRLLKSL-KHPNLVNLLEVFRRKKKLHL 78 (292)
Q Consensus 2 ~~y~~~~~l--~~g~~~~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~e~~~~~~l-~~~~i~~~~~~~~~~~~~~i 78 (292)
++|++.+.+ |+|+||.||.+.+..++..+++|.+........ |......+ +|||++++++.+..++..++
T Consensus 14 ~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~-------e~~~~~~~~~h~~iv~~~~~~~~~~~~~i 86 (267)
T PHA03390 14 KNCEIVKKLKLIDGKFGKVSVLKHKPTQKLFVQKIIKAKNFNAI-------EPMVHQLMKDNPNFIKLYYSVTTLKGHVL 86 (267)
T ss_pred HhhccccceeecCCCceEEEEEEEcCCCcEEEEEEEehhhcchh-------hHHHHHHhhcCCCEEEEEEEEecCCeeEE
Confidence 467777776 999999999999999999999999865432211 22222222 69999999999999999999
Q ss_pred EEecCCCccHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEEccCC-cEEEeecCchhhhhccc-c
Q psy758 79 VFEFCDHTVLNELENHPHGLPWDLIKQITWQVLRGVSYCHRHACIHRDIKPENILLTANG-VVKLCDFGFARLIRDLI-P 156 (292)
Q Consensus 79 v~e~~~~~~L~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~givH~dl~p~Nilv~~~~-~~kl~dfg~~~~~~~~~-~ 156 (292)
||||+++++|..++.....+++..++.++.|++.||.+||+.|++|+||+|+||+++.++ .++|+|||.+....... .
T Consensus 87 v~e~~~~~~L~~~l~~~~~l~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~nil~~~~~~~~~l~dfg~~~~~~~~~~~ 166 (267)
T PHA03390 87 IMDYIKDGDLFDLLKKEGKLSEAEVKKIIRQLVEALNDLHKHNIIHNDIKLENVLYDRAKDRIYLCDYGLCKIIGTPSCY 166 (267)
T ss_pred EEEcCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeeeCCCCHHHEEEeCCCCeEEEecCccceecCCCccC
Confidence 999999999999998777899999999999999999999999999999999999999998 99999999887554321 2
Q ss_pred ccccccccccccccCCCCCCCcccceeeecCCCCCCchHHHHHHHhhcccCCCCCCChhh----hhhccCcCCCCCCCCC
Q psy758 157 RHLHIFQTNEYFKGVSLPHAENVVPLEIKIGKPAATNIYLIDFLKRCLDKDPLRRWSCDQ----LLRHPYFNGYYFEVPD 232 (292)
Q Consensus 157 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~----~~~~~~~~~~~~~~~~ 232 (292)
.....|.+||...+.......++ ++.+..++..+.+..|........ .+..............
T Consensus 167 ~~~~~y~aPE~~~~~~~~~~~Dv-------------wslG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 233 (267)
T PHA03390 167 DGTLDYFSPEKIKGHNYDVSFDW-------------WAVGVLTYELLTGKHPFKEDEDEELDLESLLKRQQKKLPFIKNV 233 (267)
T ss_pred CCCCcccChhhhcCCCCCchhhH-------------HHHHHHHHHHHHCCCCCCCCCcchhhHHHHHHhhcccCCccccc
Confidence 23344566665544332211222 233333444444444544322111 1111111222233346
Q ss_pred ccchHHHHhcccCcCCCCCCC-hhhhhhCCcccc
Q psy758 233 EMQYEEITQRCLDKDPLRRWS-CDQLLRHPYFNG 265 (292)
Q Consensus 233 ~~~l~~li~~~l~~dP~~Rpt-~~~il~h~w~~~ 265 (292)
+..+.++|.+||+.||.+||+ .+++++||||++
T Consensus 234 ~~~~~~li~~~l~~~p~~R~~~~~~~l~h~~~~~ 267 (267)
T PHA03390 234 SKNANDFVQSMLKYNINYRLTNYNEIIKHPFLKI 267 (267)
T ss_pred CHHHHHHHHHHhccChhhCCchHHHHhcCCcccC
Confidence 788999999999999999996 599999999974
|
|
| >cd06614 STKc_PAK Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-36 Score=246.81 Aligned_cols=250 Identities=29% Similarity=0.434 Sum_probs=188.9
Q ss_pred cccceeeeecccCceEEEEEEEcCCCcEEEEEEeccCCCChHHHHHHHHHHHHHHhCCCCCcchhhhhhhcCCeEEEEEe
Q psy758 2 ERYEKIGKLGEGSYGVVFKCRNRDTGQVVAIKKFLESEEDPLIRKIALREIRLLKSLKHPNLVNLLEVFRRKKKLHLVFE 81 (292)
Q Consensus 2 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~iv~e 81 (292)
+.|++.+.||+|++|.||.+.+..++..|++|++..... ....+.+|++.++.++|+|++++++.+..++..++++|
T Consensus 19 ~~~~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~---~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e 95 (286)
T cd06614 19 ELYKNLEKIGEGASGEVYKATDRATGKEVAIKKMRLRKQ---NKELIINEILIMKDCKHPNIVDYYDSYLVGDELWVVME 95 (286)
T ss_pred ccchHhHhccCCCCeEEEEEEEccCCcEEEEEEEecCch---hHHHHHHHHHHHHHCCCCCeeEEEEEEEECCEEEEEEe
Confidence 468888999999999999999998899999999875543 45667889999999999999999999999999999999
Q ss_pred cCCCccHHHHhcCCC-CCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEEccCCcEEEeecCchhhhhccccc---
Q psy758 82 FCDHTVLNELENHPH-GLPWDLIKQITWQVLRGVSYCHRHACIHRDIKPENILLTANGVVKLCDFGFARLIRDLIPR--- 157 (292)
Q Consensus 82 ~~~~~~L~~~~~~~~-~~~~~~~~~i~~qi~~aL~~LH~~givH~dl~p~Nilv~~~~~~kl~dfg~~~~~~~~~~~--- 157 (292)
|+++++|.+++.... .++...+..++.|++.||.+||+.|++|+||+|+||+++.++.++|+|||.+.........
T Consensus 96 ~~~~~~L~~~l~~~~~~l~~~~~~~i~~~i~~~L~~lH~~gi~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~~~~~ 175 (286)
T cd06614 96 YMDGGSLTDIITQNFVRMNEPQIAYVCREVLQGLEYLHSQNVIHRDIKSDNILLSKDGSVKLADFGFAAQLTKEKSKRNS 175 (286)
T ss_pred ccCCCcHHHHHHHhccCCCHHHHHHHHHHHHHHHHHHHhCCeeeCCCChhhEEEcCCCCEEECccchhhhhccchhhhcc
Confidence 999999999998765 7999999999999999999999999999999999999999999999999988655432111
Q ss_pred --cccccccccccccCCCCCCCcccceeeecCCCCCCchHHHHHHHhhcccCCCCCCChhhhhhc---cCcCCCCCCCCC
Q psy758 158 --HLHIFQTNEYFKGVSLPHAENVVPLEIKIGKPAATNIYLIDFLKRCLDKDPLRRWSCDQLLRH---PYFNGYYFEVPD 232 (292)
Q Consensus 158 --~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~---~~~~~~~~~~~~ 232 (292)
....|.+||...+...... .+.++.+.-++..+.+..|............ ............
T Consensus 176 ~~~~~~y~~PE~~~~~~~~~~-------------~Dv~slGvil~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 242 (286)
T cd06614 176 VVGTPYWMAPEVIKRKDYGPK-------------VDIWSLGIMCIEMAEGEPPYLREPPLRALFLITTKGIPPLKNPEKW 242 (286)
T ss_pred ccCCcccCCHhHhcCCCCCCc-------------cccHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCCCCcchhhC
Confidence 1223555555433222222 2223333333444444444433322211111 111111112224
Q ss_pred ccchHHHHhcccCcCCCCCCChhhhhhCCccccee
Q psy758 233 EMQYEEITQRCLDKDPLRRWSCDQLLRHPYFNGYY 267 (292)
Q Consensus 233 ~~~l~~li~~~l~~dP~~Rpt~~~il~h~w~~~~~ 267 (292)
+..+.++|.+||+.+|.+|||+.++++||||++..
T Consensus 243 ~~~l~~li~~~l~~~p~~Rpt~~~il~~~~~~~~~ 277 (286)
T cd06614 243 SPEFKDFLNKCLVKDPEKRPSAEELLQHPFLKKAC 277 (286)
T ss_pred CHHHHHHHHHHhccChhhCcCHHHHhhChHhhccC
Confidence 67899999999999999999999999999999854
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two grou |
| >KOG0614|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-39 Score=261.81 Aligned_cols=251 Identities=22% Similarity=0.334 Sum_probs=213.8
Q ss_pred cccceeeeecccCceEEEEEEEcCCCcEEEEEEeccCC-CChHHHHHHHHHHHHHHhCCCCCcchhhhhhhcCCeEEEEE
Q psy758 2 ERYEKIGKLGEGSYGVVFKCRNRDTGQVVAIKKFLESE-EDPLIRKIALREIRLLKSLKHPNLVNLLEVFRRKKKLHLVF 80 (292)
Q Consensus 2 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~v~iK~~~~~~-~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~iv~ 80 (292)
++..++..||-|+||.|-++..+.....+|+|++++.. .+....+.+..|-.++...++|.|+++|..|.++.++|++|
T Consensus 420 ~dl~~iaTLGvGgFGRVELV~~~~~~~~fAlKilkK~hIVdtkQqeHv~sEr~Im~~~~s~fIvrLYrTfrd~kyvYmLm 499 (732)
T KOG0614|consen 420 SDLKRIATLGVGGFGRVELVKVNSQKATFALKILKKKHIVDTKQQEHVFSERNIMMECRSDFIVRLYRTFRDSKYVYMLM 499 (732)
T ss_pred hhhhhhhhcccCccceEEEEEecccchHHHHHHHhHhhccchhHHHHHHhHHHHHHhcCchHHHHHHHHhccchhhhhhH
Confidence 45667788999999999999988766679999998776 44455677889999999999999999999999999999999
Q ss_pred ecCCCccHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEEccCCcEEEeecCchhhhhcccccccc
Q psy758 81 EFCDHTVLNELENHPHGLPWDLIKQITWQVLRGVSYCHRHACIHRDIKPENILLTANGVVKLCDFGFARLIRDLIPRHLH 160 (292)
Q Consensus 81 e~~~~~~L~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~givH~dl~p~Nilv~~~~~~kl~dfg~~~~~~~~~~~~~~ 160 (292)
|-|-||.++..++..+.+++.+++.++.++++|++|||++||++|||||+|.+++.+|.+||.|||+++.+... ...+.
T Consensus 500 EaClGGElWTiLrdRg~Fdd~tarF~~acv~EAfeYLH~k~iIYRDLKPENllLd~~Gy~KLVDFGFAKki~~g-~KTwT 578 (732)
T KOG0614|consen 500 EACLGGELWTILRDRGSFDDYTARFYVACVLEAFEYLHRKGIIYRDLKPENLLLDNRGYLKLVDFGFAKKIGSG-RKTWT 578 (732)
T ss_pred HhhcCchhhhhhhhcCCcccchhhhhHHHHHHHHHHHHhcCceeccCChhheeeccCCceEEeehhhHHHhccC-Cceee
Confidence 99999999999999999999999999999999999999999999999999999999999999999999988653 34556
Q ss_pred ccccccccccCCC----------CCCCcccceeeecCCCCCCchHHHHHHHhhcccCCCCCCChhhhhhccCcCCCCCCC
Q psy758 161 IFQTNEYFKGVSL----------PHAENVVPLEIKIGKPAATNIYLIDFLKRCLDKDPLRRWSCDQLLRHPYFNGYYFEV 230 (292)
Q Consensus 161 ~~~~~~~~~~~~~----------~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~ 230 (292)
++++|||.+++.+ +|++|+..+++++|.+++........+..++.. .....+|.
T Consensus 579 FcGTpEYVAPEIILnKGHD~avDyWaLGIli~ELL~G~pPFs~~dpmktYn~ILkG----------------id~i~~Pr 642 (732)
T KOG0614|consen 579 FCGTPEYVAPEIILNKGHDRAVDYWALGILIYELLTGSPPFSGVDPMKTYNLILKG----------------IDKIEFPR 642 (732)
T ss_pred ecCCcccccchhhhccCcchhhHHHHHHHHHHHHHcCCCCCCCCchHHHHHHHHhh----------------hhhhhccc
Confidence 7888998888765 577888888888888877665554444443322 12234556
Q ss_pred CCccchHHHHhcccCcCCCCCCC-----hhhhhhCCcccceecc
Q psy758 231 PDEMQYEEITQRCLDKDPLRRWS-----CDQLLRHPYFNGYYFE 269 (292)
Q Consensus 231 ~~~~~l~~li~~~l~~dP~~Rpt-----~~~il~h~w~~~~~~~ 269 (292)
.++....+||+++...+|.+|.. ..+|..|.||.+..|+
T Consensus 643 ~I~k~a~~Lik~LCr~~P~ERLG~~~~gI~DIkkH~Wf~gfdwe 686 (732)
T KOG0614|consen 643 RITKTATDLIKKLCRDNPTERLGYQKGGINDIKKHRWFEGFDWE 686 (732)
T ss_pred ccchhHHHHHHHHHhcCcHhhhccccCChHHHHhhhhhhcCChh
Confidence 66778999999999999999995 8899999999999988
|
|
| >cd06621 PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-36 Score=245.17 Aligned_cols=254 Identities=28% Similarity=0.433 Sum_probs=183.7
Q ss_pred cccceeeeecccCceEEEEEEEcCCCcEEEEEEeccCCCChHHHHHHHHHHHHHHhCCCCCcchhhhhhhc--CCeEEEE
Q psy758 2 ERYEKIGKLGEGSYGVVFKCRNRDTGQVVAIKKFLESEEDPLIRKIALREIRLLKSLKHPNLVNLLEVFRR--KKKLHLV 79 (292)
Q Consensus 2 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~--~~~~~iv 79 (292)
++|...+.||.|++|.||++.+..+++.+++|.+...... .....+.+|+++++.++||||+++++++.+ .+.+++|
T Consensus 1 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~-~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~lv 79 (287)
T cd06621 1 EKIVELSRLGEGAGGSVTKCRLKNTGMIFALKTITTDPNP-DLQKQILRELEINKSCKSPYIVKYYGAFLDESSSSIGIA 79 (287)
T ss_pred CceEEEEEeccCCceEEEEEEECCCCeEEEEEEEecCCch-HHHHHHHHHHHHHHhCCCCCeeeeeeEEEccCCCeEEEE
Confidence 5789999999999999999999999999999998755433 445678899999999999999999998754 4578999
Q ss_pred EecCCCccHHHHhc----CCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEEccCCcEEEeecCchhhhhccc
Q psy758 80 FEFCDHTVLNELEN----HPHGLPWDLIKQITWQVLRGVSYCHRHACIHRDIKPENILLTANGVVKLCDFGFARLIRDLI 155 (292)
Q Consensus 80 ~e~~~~~~L~~~~~----~~~~~~~~~~~~i~~qi~~aL~~LH~~givH~dl~p~Nilv~~~~~~kl~dfg~~~~~~~~~ 155 (292)
|||+++++|.+++. ....+++..+..++.||+.||.|||+.|++|+||+|+||+++.++.++|+|||++.......
T Consensus 80 ~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~lH~~~i~H~dl~~~nil~~~~~~~~l~dfg~~~~~~~~~ 159 (287)
T cd06621 80 MEYCEGGSLDSIYKKVKKRGGRIGEKVLGKIAESVLKGLSYLHSRKIIHRDIKPSNILLTRKGQVKLCDFGVSGELVNSL 159 (287)
T ss_pred EEecCCCCHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEEecCCeEEEeeccccccccccc
Confidence 99999999987653 24468999999999999999999999999999999999999999999999999986543221
Q ss_pred ---cccccccccccccccCCC-----CCCCcccceeeecCCCCCCchHHHHHHHhhcccCCCCCCChhhhhhccC-----
Q psy758 156 ---PRHLHIFQTNEYFKGVSL-----PHAENVVPLEIKIGKPAATNIYLIDFLKRCLDKDPLRRWSCDQLLRHPY----- 222 (292)
Q Consensus 156 ---~~~~~~~~~~~~~~~~~~-----~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~----- 222 (292)
......|.+||...+... .|+.|+..+++.+|..++..... .+....+......
T Consensus 160 ~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~-------------~~~~~~~~~~~~~~~~~~ 226 (287)
T cd06621 160 AGTFTGTSFYMAPERIQGKPYSITSDVWSLGLTLLEVAQNRFPFPPEGE-------------PPLGPIELLSYIVNMPNP 226 (287)
T ss_pred cccccCCccccCHHHhcCCCCCchhhHHHHHHHHHHHHhCCCCCCcccC-------------CCCChHHHHHHHhcCCch
Confidence 112334566665544322 23333333444444333211100 0001111111100
Q ss_pred -cCCC-CCCCCCccchHHHHhcccCcCCCCCCChhhhhhCCcccceecc
Q psy758 223 -FNGY-YFEVPDEMQYEEITQRCLDKDPLRRWSCDQLLRHPYFNGYYFE 269 (292)
Q Consensus 223 -~~~~-~~~~~~~~~l~~li~~~l~~dP~~Rpt~~~il~h~w~~~~~~~ 269 (292)
.... ......+..+.++|.+||..||.+|||+.|++.||||.+....
T Consensus 227 ~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~eil~~~~~~~~~~~ 275 (287)
T cd06621 227 ELKDEPGNGIKWSEEFKDFIKQCLEKDPTRRPTPWDMLEHPWIKAQMKK 275 (287)
T ss_pred hhccCCCCCCchHHHHHHHHHHHcCCCcccCCCHHHHHhCccccccccc
Confidence 0000 0011235678999999999999999999999999999875543
|
Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >cd07877 STKc_p38alpha_MAPK14 Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-37 Score=257.87 Aligned_cols=264 Identities=27% Similarity=0.388 Sum_probs=189.5
Q ss_pred cccceeeeecccCceEEEEEEEcCCCcEEEEEEeccCCCChHHHHHHHHHHHHHHhCCCCCcchhhhhhhcC------Ce
Q psy758 2 ERYEKIGKLGEGSYGVVFKCRNRDTGQVVAIKKFLESEEDPLIRKIALREIRLLKSLKHPNLVNLLEVFRRK------KK 75 (292)
Q Consensus 2 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~------~~ 75 (292)
++|++.+.||+|++|.||+|.+..+++.||+|.+..........+.+.+|+.+++.++||||+++++++... ..
T Consensus 17 ~~y~~~~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~~iv~~~~~~~~~~~~~~~~~ 96 (345)
T cd07877 17 ERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFND 96 (345)
T ss_pred CceEEEEEeeecCCeEEEEEEEcCCCeEEEEEEecCcchhhHHHHHHHHHHHHHHHcCCCcccceeeeeeeccccccccc
Confidence 689999999999999999999999999999999876544444556778899999999999999999987532 34
Q ss_pred EEEEEecCCCccHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEEccCCcEEEeecCchhhhhccc
Q psy758 76 LHLVFEFCDHTVLNELENHPHGLPWDLIKQITWQVLRGVSYCHRHACIHRDIKPENILLTANGVVKLCDFGFARLIRDLI 155 (292)
Q Consensus 76 ~~iv~e~~~~~~L~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~givH~dl~p~Nilv~~~~~~kl~dfg~~~~~~~~~ 155 (292)
.+++++++ +++|..+++.. .+++..++.++.|++.||+|||++|++|+||+|+||++++++.++|+|||++.......
T Consensus 97 ~~lv~~~~-~~~L~~~~~~~-~l~~~~~~~i~~qi~~aL~~LH~~~ivH~dlkp~NIll~~~~~~kl~dfg~~~~~~~~~ 174 (345)
T cd07877 97 VYLVTHLM-GADLNNIVKCQ-KLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEM 174 (345)
T ss_pred EEEEehhc-ccCHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHHCCeeecCCChHHEEEcCCCCEEEecccccccccccc
Confidence 78888877 66788877654 69999999999999999999999999999999999999999999999999987653321
Q ss_pred --ccccccccccccccc------CCCCCCCcccceeeecCCCCCCchHHHHHHHhhc---ccCCCCC------CChhhhh
Q psy758 156 --PRHLHIFQTNEYFKG------VSLPHAENVVPLEIKIGKPAATNIYLIDFLKRCL---DKDPLRR------WSCDQLL 218 (292)
Q Consensus 156 --~~~~~~~~~~~~~~~------~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~---~~~p~~~------~~~~~~~ 218 (292)
...+..|.+||...+ ....|+.|+..+++.+|..++........+.... ...+... .......
T Consensus 175 ~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 254 (345)
T cd07877 175 TGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARNYI 254 (345)
T ss_pred cccccCCCccCHHHHhCccCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHhhcccHhHHHHH
Confidence 122344677776544 2344666666666777766543322222111111 1110000 0000000
Q ss_pred h-ccCcCCCC---CCCCCccchHHHHhcccCcCCCCCCChhhhhhCCccccee
Q psy758 219 R-HPYFNGYY---FEVPDEMQYEEITQRCLDKDPLRRWSCDQLLRHPYFNGYY 267 (292)
Q Consensus 219 ~-~~~~~~~~---~~~~~~~~l~~li~~~l~~dP~~Rpt~~~il~h~w~~~~~ 267 (292)
. .+...... .....+..+.++|.+||+.||.+|||+.++++||||.+..
T Consensus 255 ~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~h~~f~~~~ 307 (345)
T cd07877 255 QSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQYH 307 (345)
T ss_pred HHhcccCCcchhhhcCCCCHHHHHHHHHHcCCChhhcCCHHHHhcChhhhhcC
Confidence 0 00000000 0113466889999999999999999999999999999743
|
Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14 |
| >cd08219 STKc_Nek3 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-36 Score=241.59 Aligned_cols=240 Identities=25% Similarity=0.333 Sum_probs=185.8
Q ss_pred ccceeeeecccCceEEEEEEEcCCCcEEEEEEeccCCCChHHHHHHHHHHHHHHhCCCCCcchhhhhhhcCCeEEEEEec
Q psy758 3 RYEKIGKLGEGSYGVVFKCRNRDTGQVVAIKKFLESEEDPLIRKIALREIRLLKSLKHPNLVNLLEVFRRKKKLHLVFEF 82 (292)
Q Consensus 3 ~y~~~~~l~~g~~~~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~iv~e~ 82 (292)
+|++.+.||.|++|.||.+.+..+++.|++|.+...... ...+.+.+|+.+++.++||||+++++.+.+++.+++++||
T Consensus 1 ~y~~~~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 79 (255)
T cd08219 1 QYNVLRVVGEGSFGRALLVQHVNSDQKYAMKEIRLPKSS-SAVEDSRKEAVLLAKMKHPNIVAFKESFEADGHLYIVMEY 79 (255)
T ss_pred CceEEEEeeccCCeEEEEEEEcCCCceEEEEEEEcCcch-HHHHHHHHHHHHHHhCCCCCcceEEEEEEECCEEEEEEee
Confidence 589999999999999999999999999999998654432 3456677899999999999999999999999999999999
Q ss_pred CCCccHHHHhcC--CCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEEccCCcEEEeecCchhhhhccc-----
Q psy758 83 CDHTVLNELENH--PHGLPWDLIKQITWQVLRGVSYCHRHACIHRDIKPENILLTANGVVKLCDFGFARLIRDLI----- 155 (292)
Q Consensus 83 ~~~~~L~~~~~~--~~~~~~~~~~~i~~qi~~aL~~LH~~givH~dl~p~Nilv~~~~~~kl~dfg~~~~~~~~~----- 155 (292)
+++++|..++.. ...+++..++.++.||+.||.+||++|++|+||+|+||++++++.++|+|||.+.......
T Consensus 80 ~~~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~~i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~~~~~~~~ 159 (255)
T cd08219 80 CDGGDLMQKIKLQRGKLFPEDTILQWFVQMCLGVQHIHEKRVLHRDIKSKNIFLTQNGKVKLGDFGSARLLTSPGAYACT 159 (255)
T ss_pred CCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHhhCCcccCCCCcceEEECCCCcEEEcccCcceeeccccccccc
Confidence 999999887753 3458999999999999999999999999999999999999999999999999987654322
Q ss_pred cccccccccccccccCC-----CCCCCcccceeeecCCCCCCchHHHHHHHhhcccCCCCCCChhhhhhccCcCCCCCCC
Q psy758 156 PRHLHIFQTNEYFKGVS-----LPHAENVVPLEIKIGKPAATNIYLIDFLKRCLDKDPLRRWSCDQLLRHPYFNGYYFEV 230 (292)
Q Consensus 156 ~~~~~~~~~~~~~~~~~-----~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~ 230 (292)
......|.+||...+.. ..|+.|+..+.+.++..++........+....... .. ..+.
T Consensus 160 ~~~~~~~~aPE~~~~~~~~~~~Dv~slG~i~~~l~~g~~p~~~~~~~~~~~~~~~~~---------------~~--~~~~ 222 (255)
T cd08219 160 YVGTPYYVPPEIWENMPYNNKSDIWSLGCILYELCTLKHPFQANSWKNLILKVCQGS---------------YK--PLPS 222 (255)
T ss_pred ccCCccccCHHHHccCCcCchhhhhhhchhheehhhccCCCCCCCHHHHHHHHhcCC---------------CC--CCCc
Confidence 12233466777655433 34555665666666655543332222222221110 00 1123
Q ss_pred CCccchHHHHhcccCcCCCCCCChhhhhhC
Q psy758 231 PDEMQYEEITQRCLDKDPLRRWSCDQLLRH 260 (292)
Q Consensus 231 ~~~~~l~~li~~~l~~dP~~Rpt~~~il~h 260 (292)
..+..+.++|.+||+.||.+|||+.++++-
T Consensus 223 ~~~~~~~~li~~~l~~~P~~Rp~~~~il~~ 252 (255)
T cd08219 223 HYSYELRSLIKQMFKRNPRSRPSATTILSR 252 (255)
T ss_pred ccCHHHHHHHHHHHhCCcccCCCHHHHhhc
Confidence 346678999999999999999999999874
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activati |
| >cd06648 STKc_PAK_II Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.9e-36 Score=243.70 Aligned_cols=249 Identities=25% Similarity=0.398 Sum_probs=184.6
Q ss_pred ccceeeeecccCceEEEEEEEcCCCcEEEEEEeccCCCChHHHHHHHHHHHHHHhCCCCCcchhhhhhhcCCeEEEEEec
Q psy758 3 RYEKIGKLGEGSYGVVFKCRNRDTGQVVAIKKFLESEEDPLIRKIALREIRLLKSLKHPNLVNLLEVFRRKKKLHLVFEF 82 (292)
Q Consensus 3 ~y~~~~~l~~g~~~~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~iv~e~ 82 (292)
+|...+.||+|++|.||++.+..+++.+++|.+..... ...+.+.+|+.+++.++|||++++++++..++..++++||
T Consensus 20 ~~~~~~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~~~--~~~~~~~~e~~~l~~~~h~~vv~~~~~~~~~~~~~~v~e~ 97 (285)
T cd06648 20 YLDNFVKIGEGSTGIVCIATDKSTGRQVAVKKMDLRKQ--QRRELLFNEVVIMRDYQHPNIVEMYSSYLVGDELWVVMEF 97 (285)
T ss_pred hhhcceEeccCCCeEEEEEEECCCCCEEEEEEEeccch--hHHHHHHHHHHHHHHcCCCChheEEEEEEcCCeEEEEEec
Confidence 45667799999999999999998999999998854332 3345678999999999999999999999999999999999
Q ss_pred CCCccHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEEccCCcEEEeecCchhhhhccccc-----
Q psy758 83 CDHTVLNELENHPHGLPWDLIKQITWQVLRGVSYCHRHACIHRDIKPENILLTANGVVKLCDFGFARLIRDLIPR----- 157 (292)
Q Consensus 83 ~~~~~L~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~givH~dl~p~Nilv~~~~~~kl~dfg~~~~~~~~~~~----- 157 (292)
+.+++|.+++.. ..+++..++.++.|++.||++||++|++||||+|+||+++.++.++|+|||.+.........
T Consensus 98 ~~~~~L~~~~~~-~~~~~~~~~~~~~ql~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~~l~d~g~~~~~~~~~~~~~~~~ 176 (285)
T cd06648 98 LEGGALTDIVTH-TRMNEEQIATVCLAVLKALSFLHAQGVIHRDIKSDSILLTSDGRVKLSDFGFCAQVSKEVPRRKSLV 176 (285)
T ss_pred cCCCCHHHHHHh-CCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCChhhEEEcCCCcEEEcccccchhhccCCccccccc
Confidence 999999999877 57899999999999999999999999999999999999999999999999987655432221
Q ss_pred cccccccccccccCCCCCCCcccceeeecCCCCCCchHHHHHHHhhcccCCCCCCChhhhhh---ccCcCCCCCCCCCcc
Q psy758 158 HLHIFQTNEYFKGVSLPHAENVVPLEIKIGKPAATNIYLIDFLKRCLDKDPLRRWSCDQLLR---HPYFNGYYFEVPDEM 234 (292)
Q Consensus 158 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~---~~~~~~~~~~~~~~~ 234 (292)
....|.+||...+.......++ ++.+.-++..+.+..|....+..+... .........+...+.
T Consensus 177 ~~~~y~aPE~~~~~~~~~~~Dv-------------~slGv~l~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 243 (285)
T cd06648 177 GTPYWMAPEVISRLPYGTEVDI-------------WSLGIMVIEMVDGEPPYFNEPPLQAMKRIRDNLPPKLKNLHKVSP 243 (285)
T ss_pred CCccccCHHHhcCCCCCCcccH-------------HHHHHHHHHHHhCCCCCcCCCHHHHHHHHHhcCCCCCcccccCCH
Confidence 2234555655543322222222 222233333333443432222111111 110011111223567
Q ss_pred chHHHHhcccCcCCCCCCChhhhhhCCccccee
Q psy758 235 QYEEITQRCLDKDPLRRWSCDQLLRHPYFNGYY 267 (292)
Q Consensus 235 ~l~~li~~~l~~dP~~Rpt~~~il~h~w~~~~~ 267 (292)
.+.++|.+||+.||++|||+.++++||||....
T Consensus 244 ~l~~li~~~l~~~p~~Rpt~~~il~~~~~~~~~ 276 (285)
T cd06648 244 RLRSFLDRMLVRDPAQRATAAELLNHPFLAKAG 276 (285)
T ss_pred HHHHHHHHHcccChhhCcCHHHHccCcccccCC
Confidence 899999999999999999999999999999743
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs foun |
| >PTZ00024 cyclin-dependent protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=6e-37 Score=255.25 Aligned_cols=267 Identities=28% Similarity=0.394 Sum_probs=189.1
Q ss_pred cccce-eeeecccCceEEEEEEEcCCCcEEEEEEeccCCCChH------------HHHHHHHHHHHHHhCCCCCcchhhh
Q psy758 2 ERYEK-IGKLGEGSYGVVFKCRNRDTGQVVAIKKFLESEEDPL------------IRKIALREIRLLKSLKHPNLVNLLE 68 (292)
Q Consensus 2 ~~y~~-~~~l~~g~~~~v~~~~~~~~~~~v~iK~~~~~~~~~~------------~~~~~~~e~~~~~~l~~~~i~~~~~ 68 (292)
+||.. .+.||+|++|.||+|.+..+++.||+|.+........ ....+.+|+.+++.++||||+++++
T Consensus 8 ~ry~~~~~~ig~G~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~ 87 (335)
T PTZ00024 8 ERYIQKGAHLGEGTYGKVEKAYDTLTGKIVAIKKVKIIEISNDVTKDRQLVGMCGIHFTTLRELKIMNEIKHENIMGLVD 87 (335)
T ss_pred cchhhhhhcccCCCceeEEEEEECCCCCeEEEEEeeccccccccccchhhhcccccchhHHHHHHHHHhCCCcceeeeeE
Confidence 57764 5779999999999999999999999999865432210 0124678999999999999999999
Q ss_pred hhhcCCeEEEEEecCCCccHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEEccCCcEEEeecCch
Q psy758 69 VFRRKKKLHLVFEFCDHTVLNELENHPHGLPWDLIKQITWQVLRGVSYCHRHACIHRDIKPENILLTANGVVKLCDFGFA 148 (292)
Q Consensus 69 ~~~~~~~~~iv~e~~~~~~L~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~givH~dl~p~Nilv~~~~~~kl~dfg~~ 148 (292)
++..++..+++|||+.+ +|..++.....+++..+..++.|++.||.+||++|++|+||+|+||+++.++.++|+|||.+
T Consensus 88 ~~~~~~~~~lv~e~~~~-~l~~~l~~~~~~~~~~~~~~~~ql~~aL~~LH~~~i~H~dl~~~nill~~~~~~kl~dfg~~ 166 (335)
T PTZ00024 88 VYVEGDFINLVMDIMAS-DLKKVVDRKIRLTESQVKCILLQILNGLNVLHKWYFMHRDLSPANIFINSKGICKIADFGLA 166 (335)
T ss_pred EEecCCcEEEEEecccc-CHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeecccccHHHeEECCCCCEEECCccce
Confidence 99999999999999985 67777777678999999999999999999999999999999999999999999999999988
Q ss_pred hhhhcc-------------------ccccccccccccccccCC------CCCCCcccceeeecCCCCCCchHHHHHHHh-
Q psy758 149 RLIRDL-------------------IPRHLHIFQTNEYFKGVS------LPHAENVVPLEIKIGKPAATNIYLIDFLKR- 202 (292)
Q Consensus 149 ~~~~~~-------------------~~~~~~~~~~~~~~~~~~------~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~- 202 (292)
...... .......|.+||...+.. ..|+.|+..+++.+|.+++........+..
T Consensus 167 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~el~tg~~p~~~~~~~~~~~~i 246 (335)
T PTZ00024 167 RRYGYPPYSDTLSKDETMQRREEMTSKVVTLWYRAPELLMGAEKYHFAVDMWSVGCIFAELLTGKPLFPGENEIDQLGRI 246 (335)
T ss_pred eecccccccccccccccccccccccccccccCCCCChhcccCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHH
Confidence 765410 011123466676654422 235555666666666655433322222211
Q ss_pred --hcccCCCCCC-Chhhhhhc-cCcCCC-----CCCCCCccchHHHHhcccCcCCCCCCChhhhhhCCcccceecc
Q psy758 203 --CLDKDPLRRW-SCDQLLRH-PYFNGY-----YFEVPDEMQYEEITQRCLDKDPLRRWSCDQLLRHPYFNGYYFE 269 (292)
Q Consensus 203 --~~~~~p~~~~-~~~~~~~~-~~~~~~-----~~~~~~~~~l~~li~~~l~~dP~~Rpt~~~il~h~w~~~~~~~ 269 (292)
.++..+...+ ....+... ++.... ......+..+.++|.+||+.||.+|||+++++.||||++....
T Consensus 247 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~~~~l~~~~~~~~~~~ 322 (335)
T PTZ00024 247 FELLGTPNEDNWPQAKKLPLYTEFTPRKPKDLKTIFPNASDDAIDLLQSLLKLNPLERISAKEALKHEYFKSDPLP 322 (335)
T ss_pred HHHhCCCchhhCcchhhcccccccCcCCcccHHHhCcCCChHHHHHHHHHcCCCchhccCHHHHhcCcccCCCCCC
Confidence 1111111100 00000000 000000 0011236678999999999999999999999999999975433
|
|
| >cd05613 STKc_MSK1_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.8e-37 Score=249.32 Aligned_cols=255 Identities=24% Similarity=0.334 Sum_probs=186.9
Q ss_pred ccceeeeecccCceEEEEEEEc---CCCcEEEEEEeccCCC--ChHHHHHHHHHHHHHHhC-CCCCcchhhhhhhcCCeE
Q psy758 3 RYEKIGKLGEGSYGVVFKCRNR---DTGQVVAIKKFLESEE--DPLIRKIALREIRLLKSL-KHPNLVNLLEVFRRKKKL 76 (292)
Q Consensus 3 ~y~~~~~l~~g~~~~v~~~~~~---~~~~~v~iK~~~~~~~--~~~~~~~~~~e~~~~~~l-~~~~i~~~~~~~~~~~~~ 76 (292)
.|++.+.||.|++|.||.|.+. .+|+.|++|++..... .....+.+.+|+.+++.+ +|++|+++++.+..++..
T Consensus 1 ~y~~~~~lg~G~~g~v~~~~~~~~~~~g~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~ 80 (290)
T cd05613 1 NFELLKVLGTGAYGKVFLVRKVSGHDSGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTDTKL 80 (290)
T ss_pred CceeeeeeccCCcceEEEEEeccCCCCCceEEEEEeehhhhhhcchHHHHHHHHHHHHHhcccCCChhceeeEeecCCeE
Confidence 4889999999999999999875 4788999999865432 223446677899999999 589999999999999999
Q ss_pred EEEEecCCCccHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEEccCCcEEEeecCchhhhhcccc
Q psy758 77 HLVFEFCDHTVLNELENHPHGLPWDLIKQITWQVLRGVSYCHRHACIHRDIKPENILLTANGVVKLCDFGFARLIRDLIP 156 (292)
Q Consensus 77 ~iv~e~~~~~~L~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~givH~dl~p~Nilv~~~~~~kl~dfg~~~~~~~~~~ 156 (292)
++|+||+++++|.+++.....+++..+..++.|++.||.|||+.|++|+||+|+||+++.++.++|+|||++........
T Consensus 81 ~lv~e~~~~~~L~~~l~~~~~l~~~~~~~~~~qi~~al~~lH~~~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~~~ 160 (290)
T cd05613 81 HLILDYINGGELFTHLSQRERFKEQEVQIYSGEIVLALEHLHKLGIIYRDIKLENILLDSNGHVVLTDFGLSKEFHEDEV 160 (290)
T ss_pred EEEEecCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHeEECCCCCEEEeeCccceecccccc
Confidence 99999999999999988777899999999999999999999999999999999999999999999999999876533211
Q ss_pred ------ccccccccccccccCC--CCCCCcccceeeecCCCCCCchHHHHHHHhhcccCCCC----CCChhhhhhccCcC
Q psy758 157 ------RHLHIFQTNEYFKGVS--LPHAENVVPLEIKIGKPAATNIYLIDFLKRCLDKDPLR----RWSCDQLLRHPYFN 224 (292)
Q Consensus 157 ------~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~p~~----~~~~~~~~~~~~~~ 224 (292)
.....|.+||...+.. .....++| +.+.-++..+.+..|.. ..+..++.......
T Consensus 161 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Dv~-------------slG~~l~~ll~g~~p~~~~~~~~~~~~~~~~~~~~ 227 (290)
T cd05613 161 ERAYSFCGTIEYMAPDIVRGGDGGHDKAVDWW-------------SMGVLMYELLTGASPFTVDGEKNSQAEISRRILKS 227 (290)
T ss_pred cccccccCCcccCChhhccCCCCCCCccccHH-------------HHHHHHHHHhcCCCCCCcCCccccHHHHHHHhhcc
Confidence 1223355565543211 11112222 22222233333333322 11112222111111
Q ss_pred CCCCCCCCccchHHHHhcccCcCCCCCC-----ChhhhhhCCcccceeccC
Q psy758 225 GYYFEVPDEMQYEEITQRCLDKDPLRRW-----SCDQLLRHPYFNGYYFEV 270 (292)
Q Consensus 225 ~~~~~~~~~~~l~~li~~~l~~dP~~Rp-----t~~~il~h~w~~~~~~~~ 270 (292)
....+...+..+.+++.+||..||.+|| +++++++||||+...|+-
T Consensus 228 ~~~~~~~~~~~~~~ll~~~l~~~p~~R~~~~~~~~~~l~~~~~~~~~~~~~ 278 (290)
T cd05613 228 EPPYPQEMSALAKDIIQRLLMKDPKKRLGCGPSDADEIKKHPFFQKINWDD 278 (290)
T ss_pred CCCCCccCCHHHHHHHHHHhcCCHHHhcCCCCCCHHHHHcCcccccCCHHH
Confidence 2223344567889999999999999997 899999999999988753
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph |
| >cd05106 PTKc_CSF-1R Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.6e-37 Score=257.79 Aligned_cols=244 Identities=23% Similarity=0.291 Sum_probs=176.5
Q ss_pred cccceeeeecccCceEEEEEEEcCC-----CcEEEEEEeccCCCChHHHHHHHHHHHHHHhC-CCCCcchhhhhhhcCCe
Q psy758 2 ERYEKIGKLGEGSYGVVFKCRNRDT-----GQVVAIKKFLESEEDPLIRKIALREIRLLKSL-KHPNLVNLLEVFRRKKK 75 (292)
Q Consensus 2 ~~y~~~~~l~~g~~~~v~~~~~~~~-----~~~v~iK~~~~~~~~~~~~~~~~~e~~~~~~l-~~~~i~~~~~~~~~~~~ 75 (292)
++|++++.||+|+||.||+|++..+ +..||+|.+...... .....+.+|+.+++.+ +|+||+++++++.+.+.
T Consensus 38 ~~~~~~~~LG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~~-~~~~~~~~E~~il~~l~~h~nIv~~~~~~~~~~~ 116 (374)
T cd05106 38 DNLQFGKTLGAGAFGKVVEATAFGLGKEDNVLRVAVKMLKASAHT-DEREALMSELKILSHLGQHKNIVNLLGACTHGGP 116 (374)
T ss_pred HHceehheecCCCcccEEEEEEecCCcccccceeEEEeccCCCCH-HHHHHHHHHHHHHHhhccCCceeeEeeEecCCCC
Confidence 4699999999999999999986443 357999998755433 3456688999999999 89999999999999999
Q ss_pred EEEEEecCCCccHHHHhcCC------------------------------------------------------------
Q psy758 76 LHLVFEFCDHTVLNELENHP------------------------------------------------------------ 95 (292)
Q Consensus 76 ~~iv~e~~~~~~L~~~~~~~------------------------------------------------------------ 95 (292)
+++||||+++|+|.+++...
T Consensus 117 ~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 196 (374)
T cd05106 117 VLVITEYCCYGDLLNFLRKKAETFLNFVMALPEISETSSDYKNITLEKKYIRSDSGFSSQGSDTYVEMRPVSSSSSQSSD 196 (374)
T ss_pred eEEeHhhccCCcHHHHHHhhhhhhccccccccccccccccccccchhcccccccccccccccccccccCCcccccccccc
Confidence 99999999999999887432
Q ss_pred ----------CCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEEccCCcEEEeecCchhhhhcccc-------cc
Q psy758 96 ----------HGLPWDLIKQITWQVLRGVSYCHRHACIHRDIKPENILLTANGVVKLCDFGFARLIRDLIP-------RH 158 (292)
Q Consensus 96 ----------~~~~~~~~~~i~~qi~~aL~~LH~~givH~dl~p~Nilv~~~~~~kl~dfg~~~~~~~~~~-------~~ 158 (292)
..+++..++.++.||+.||.|||++|++||||||+||++++++.++|+|||++........ ..
T Consensus 197 ~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~giiHrDLkp~Nil~~~~~~~kL~DfGla~~~~~~~~~~~~~~~~~ 276 (374)
T cd05106 197 SKDEEDTEDSWPLDLDDLLRFSSQVAQGMDFLASKNCIHRDVAARNVLLTDGRVAKICDFGLARDIMNDSNYVVKGNARL 276 (374)
T ss_pred ccchhccCCCCCcCHHHHHHHHHHHHHHHHHHHHCCEEeccCchheEEEeCCCeEEEeeceeeeeccCCcceeeccCCCC
Confidence 2378889999999999999999999999999999999999999999999999875432211 11
Q ss_pred ccccccccccccCCCCCCCcccceeeecCCCCCCchHHHHHHHhhc-ccCCCCCCChhhhhhccCcC--CCCCCCCCccc
Q psy758 159 LHIFQTNEYFKGVSLPHAENVVPLEIKIGKPAATNIYLIDFLKRCL-DKDPLRRWSCDQLLRHPYFN--GYYFEVPDEMQ 235 (292)
Q Consensus 159 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~p~~~~~~~~~~~~~~~~--~~~~~~~~~~~ 235 (292)
+..|.+||...+.......++| +.+..++..+. +..|+............... ....+...+..
T Consensus 277 ~~~y~aPE~~~~~~~~~~~Dvw-------------SlGvil~ellt~G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 343 (374)
T cd05106 277 PVKWMAPESIFDCVYTVQSDVW-------------SYGILLWEIFSLGKSPYPGILVNSKFYKMVKRGYQMSRPDFAPPE 343 (374)
T ss_pred ccceeCHHHhcCCCCCccccHH-------------HHHHHHHHHHhCCCCCCccccccHHHHHHHHcccCccCCCCCCHH
Confidence 1235666655443332223332 22333333332 44443332221111110001 11122334778
Q ss_pred hHHHHhcccCcCCCCCCChhhhhh
Q psy758 236 YEEITQRCLDKDPLRRWSCDQLLR 259 (292)
Q Consensus 236 l~~li~~~l~~dP~~Rpt~~~il~ 259 (292)
+.++|.+||+.||.+|||+.++++
T Consensus 344 l~~li~~cl~~dp~~RPs~~~l~~ 367 (374)
T cd05106 344 IYSIMKMCWNLEPTERPTFSQISQ 367 (374)
T ss_pred HHHHHHHHcCCChhhCcCHHHHHH
Confidence 999999999999999999999987
|
Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is criti |
| >cd05088 PTKc_Tie2 Catalytic domain of the Protein Tyrosine Kinase, Tie2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-36 Score=247.60 Aligned_cols=241 Identities=24% Similarity=0.326 Sum_probs=176.9
Q ss_pred CcccceeeeecccCceEEEEEEEcCCCcE--EEEEEeccCCCChHHHHHHHHHHHHHHhC-CCCCcchhhhhhhcCCeEE
Q psy758 1 MERYEKIGKLGEGSYGVVFKCRNRDTGQV--VAIKKFLESEEDPLIRKIALREIRLLKSL-KHPNLVNLLEVFRRKKKLH 77 (292)
Q Consensus 1 ~~~y~~~~~l~~g~~~~v~~~~~~~~~~~--v~iK~~~~~~~~~~~~~~~~~e~~~~~~l-~~~~i~~~~~~~~~~~~~~ 77 (292)
+++|++.+.||+|+||.||+|.+..++.. +++|.+... ........+.+|+.++..+ +||||+++++++.+++.++
T Consensus 6 ~~~~~~~~~lg~G~~g~V~~a~~~~~~~~~~~~ik~~~~~-~~~~~~~~~~~Ei~~l~~l~~h~~iv~~~~~~~~~~~~~ 84 (303)
T cd05088 6 WNDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEY-ASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLY 84 (303)
T ss_pred hhhceeeeeecCCCCceEEEEEEccCCceeeEEEEEeccc-CCHHHHHHHHHHHHHHHHhcCCCCcceEEEEECCCCCce
Confidence 46899999999999999999998877765 466665432 2334456788899999999 8999999999999999999
Q ss_pred EEEecCCCccHHHHhcCCC----------------CCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEEccCCcEE
Q psy758 78 LVFEFCDHTVLNELENHPH----------------GLPWDLIKQITWQVLRGVSYCHRHACIHRDIKPENILLTANGVVK 141 (292)
Q Consensus 78 iv~e~~~~~~L~~~~~~~~----------------~~~~~~~~~i~~qi~~aL~~LH~~givH~dl~p~Nilv~~~~~~k 141 (292)
+|+||+++++|..++.... .+++..++.++.||+.||+|||++|++||||+|+||+++.++.++
T Consensus 85 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~gi~H~dlkp~Nili~~~~~~k 164 (303)
T cd05088 85 LAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQFIHRDLAARNILVGENYVAK 164 (303)
T ss_pred EEEEeCCCCcHHHHHHhcccccccccccccccccCcCCHHHHHHHHHHHHHHHHHHHhCCccccccchheEEecCCCcEE
Confidence 9999999999999886432 478999999999999999999999999999999999999999999
Q ss_pred EeecCchhhhhccc----cccccccccccccccCCC-----CCCCcccceeeec-CCCCCCchHHHHHHHhhcccCCCCC
Q psy758 142 LCDFGFARLIRDLI----PRHLHIFQTNEYFKGVSL-----PHAENVVPLEIKI-GKPAATNIYLIDFLKRCLDKDPLRR 211 (292)
Q Consensus 142 l~dfg~~~~~~~~~----~~~~~~~~~~~~~~~~~~-----~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~p~~~ 211 (292)
|+|||++....... ......|.+||+..+... .|+.|+..+++.+ |..+ ...
T Consensus 165 l~dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p------------------~~~ 226 (303)
T cd05088 165 IADFGLSRGQEVYVKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTP------------------YCG 226 (303)
T ss_pred eCccccCcccchhhhcccCCCcccccCHHHHhccCCcccccchhhhhHHHHHHhcCCCC------------------ccc
Confidence 99999986432111 111233666665544332 3444444444433 3333 222
Q ss_pred CChhhhhhccCcC-CCCCCCCCccchHHHHhcccCcCCCCCCChhhhhhC
Q psy758 212 WSCDQLLRHPYFN-GYYFEVPDEMQYEEITQRCLDKDPLRRWSCDQLLRH 260 (292)
Q Consensus 212 ~~~~~~~~~~~~~-~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~~il~h 260 (292)
.+..+.....-.. ....+...+..+.+||.+||+.||.+|||+++++++
T Consensus 227 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~ 276 (303)
T cd05088 227 MTCAELYEKLPQGYRLEKPLNCDDEVYDLMRQCWREKPYERPSFAQILVS 276 (303)
T ss_pred CChHHHHHHHhcCCcCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence 2222222111000 011222346789999999999999999999999986
|
Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of A |
| >cd05064 PTKc_EphR_A10 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A10 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-36 Score=243.74 Aligned_cols=244 Identities=16% Similarity=0.157 Sum_probs=178.7
Q ss_pred cccceeeeecccCceEEEEEEEc---CCCcEEEEEEeccCCCChHHHHHHHHHHHHHHhCCCCCcchhhhhhhcCCeEEE
Q psy758 2 ERYEKIGKLGEGSYGVVFKCRNR---DTGQVVAIKKFLESEEDPLIRKIALREIRLLKSLKHPNLVNLLEVFRRKKKLHL 78 (292)
Q Consensus 2 ~~y~~~~~l~~g~~~~v~~~~~~---~~~~~v~iK~~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~i 78 (292)
++|++.+.||+|+||.||+|... ..+..|++|.+..... ......+.+|+..++.++||||+++++++..++..++
T Consensus 5 ~~~~~~~~ig~G~fg~V~~~~~~~~~~~~~~vaik~~~~~~~-~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~l 83 (266)
T cd05064 5 KSIKIERILGTGRFGELCRGCLKLPSKRELPVAIHTLRAGCS-DKQRRGFLAEALTLGQFDHSNIVRLEGVITRGNTMMI 83 (266)
T ss_pred HHeEEeeeecccCCCeEEEEEEecCCCceeeEEEEecCCCCC-HHHHHHHHHHHHHHhcCCCCCcCeEEEEEecCCCcEE
Confidence 47899999999999999999765 3456899999875433 3345678899999999999999999999999999999
Q ss_pred EEecCCCccHHHHhcCC-CCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEEccCCcEEEeecCchhhhhccc--
Q psy758 79 VFEFCDHTVLNELENHP-HGLPWDLIKQITWQVLRGVSYCHRHACIHRDIKPENILLTANGVVKLCDFGFARLIRDLI-- 155 (292)
Q Consensus 79 v~e~~~~~~L~~~~~~~-~~~~~~~~~~i~~qi~~aL~~LH~~givH~dl~p~Nilv~~~~~~kl~dfg~~~~~~~~~-- 155 (292)
||||+++++|..++... ..+++..++.++.||+.||+|||++|++|+||+|+||++++++.++++|||.+.......
T Consensus 84 v~e~~~~~~L~~~l~~~~~~l~~~~~~~~~~~i~~al~~lH~~~iiH~dikp~nili~~~~~~~l~dfg~~~~~~~~~~~ 163 (266)
T cd05064 84 VTEYMSNGALDSFLRKHEGQLVAGQLMGMLPGLASGMKYLSEMGYVHKGLAAHKVLVNSDLVCKISGFRRLQEDKSEAIY 163 (266)
T ss_pred EEEeCCCCcHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCEeeccccHhhEEEcCCCcEEECCCcccccccccchh
Confidence 99999999999988653 468999999999999999999999999999999999999999999999999765432211
Q ss_pred ----cccccccccccccccCCCCCCCcccceeeecCCCCCCchHHHHHHHhhc-ccCCCCCCChhhhhhccCc-CCCCCC
Q psy758 156 ----PRHLHIFQTNEYFKGVSLPHAENVVPLEIKIGKPAATNIYLIDFLKRCL-DKDPLRRWSCDQLLRHPYF-NGYYFE 229 (292)
Q Consensus 156 ----~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~p~~~~~~~~~~~~~~~-~~~~~~ 229 (292)
...+..|.+||...+.......++|++ +..+++.+. +..|....+..+.+...-- ...+.+
T Consensus 164 ~~~~~~~~~~y~aPE~~~~~~~~~~~Di~sl-------------G~~l~ell~~g~~p~~~~~~~~~~~~~~~~~~~~~~ 230 (266)
T cd05064 164 TTMSGKSPVLWAAPEAIQYHHFSSASDVWSF-------------GIVMWEVMSYGERPYWDMSGQDVIKAVEDGFRLPAP 230 (266)
T ss_pred cccCCCCceeecCHHHHhhCCccchhHHHHH-------------HHHHHHHhcCCCCCcCcCCHHHHHHHHHCCCCCCCC
Confidence 011123556665544333222333332 222233222 3444433333332221100 011223
Q ss_pred CCCccchHHHHhcccCcCCCCCCChhhhhh
Q psy758 230 VPDEMQYEEITQRCLDKDPLRRWSCDQLLR 259 (292)
Q Consensus 230 ~~~~~~l~~li~~~l~~dP~~Rpt~~~il~ 259 (292)
...+..+.+++.+||+.||.+|||+++|++
T Consensus 231 ~~~~~~~~~li~~c~~~~p~~RP~~~~i~~ 260 (266)
T cd05064 231 RNCPNLLHQLMLDCWQKERGERPRFSQIHS 260 (266)
T ss_pred CCCCHHHHHHHHHHcCCCchhCCCHHHHHH
Confidence 345778999999999999999999999976
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA10 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchor |
| >cd06616 PKc_MKK4 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.4e-37 Score=249.20 Aligned_cols=259 Identities=24% Similarity=0.401 Sum_probs=186.7
Q ss_pred cccceeeeecccCceEEEEEEEcCCCcEEEEEEeccCCCChHHHHHHHHHHHHHHhCC-CCCcchhhhhhhcCCeEEEEE
Q psy758 2 ERYEKIGKLGEGSYGVVFKCRNRDTGQVVAIKKFLESEEDPLIRKIALREIRLLKSLK-HPNLVNLLEVFRRKKKLHLVF 80 (292)
Q Consensus 2 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~e~~~~~~l~-~~~i~~~~~~~~~~~~~~iv~ 80 (292)
++|+..+.||+|++|.||++.+..+++.|++|.+...... .....+.+|+.++..+. ||||+++++++..++..++++
T Consensus 4 ~~~~~~~~lg~G~~g~vy~~~~~~~~~~~aiK~~~~~~~~-~~~~~~~~e~~~l~~~~~~~~iv~~~~~~~~~~~~~~~~ 82 (288)
T cd06616 4 EDLKDLGEIGRGAFGTVNKMLHKPSGTIMAVKRIRSTVDE-KEQKRLLMDLDVVMRSSDCPYIVKFYGALFREGDCWICM 82 (288)
T ss_pred HHhHHHHHhCCCCceEEEEEEECCCCCEEEEEEehhccCh-HHHHHHHHHHHHHHHhcCCCCEeeeeeEEecCCcEEEEE
Confidence 4678889999999999999999999999999998755433 44566788999999996 999999999999889999999
Q ss_pred ecCCCcc--HHHHh--cCCCCCCHHHHHHHHHHHHHHHHHHHhC-CccccCCCCCceEEccCCcEEEeecCchhhhhccc
Q psy758 81 EFCDHTV--LNELE--NHPHGLPWDLIKQITWQVLRGVSYCHRH-ACIHRDIKPENILLTANGVVKLCDFGFARLIRDLI 155 (292)
Q Consensus 81 e~~~~~~--L~~~~--~~~~~~~~~~~~~i~~qi~~aL~~LH~~-givH~dl~p~Nilv~~~~~~kl~dfg~~~~~~~~~ 155 (292)
||+.+.. +...+ .....+++..+..++.|++.||+|||+. |++||||+|+||+++.++.++|+|||++.......
T Consensus 83 e~~~~~l~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lh~~~~i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~~~~ 162 (288)
T cd06616 83 ELMDISLDKFYKYVYEVLKSVIPEEILGKIAVATVKALNYLKEELKIIHRDVKPSNILLDRNGNIKLCDFGISGQLVDSI 162 (288)
T ss_pred ecccCCHHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhcCCeeccCCCHHHEEEccCCcEEEeecchhHHhccCC
Confidence 9988632 22222 2235699999999999999999999975 99999999999999999999999999987654321
Q ss_pred ----cccccccccccccccC--------CCCCCCcccceeeecCCCCCCchH-HHHHHHhhcccCCCCCCChhhhhhccC
Q psy758 156 ----PRHLHIFQTNEYFKGV--------SLPHAENVVPLEIKIGKPAATNIY-LIDFLKRCLDKDPLRRWSCDQLLRHPY 222 (292)
Q Consensus 156 ----~~~~~~~~~~~~~~~~--------~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~p~~~~~~~~~~~~~~ 222 (292)
...+..|.+||...+. ...|+.|+..+++.+|..++.... ....+.......+ +.
T Consensus 163 ~~~~~~~~~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~------------~~ 230 (288)
T cd06616 163 AKTRDAGCRPYMAPERIDPSARDGYDVRSDVWSLGITLYEVATGKFPYPKWNSVFDQLTQVVKGDP------------PI 230 (288)
T ss_pred ccccccCccCccCHHHhccccccCCcchhhhhHHHHHHHHHHhCCCCchhcchHHHHHhhhcCCCC------------Cc
Confidence 1223446677765443 223444444445555554432110 0111111111000 00
Q ss_pred cCCCCCCCCCccchHHHHhcccCcCCCCCCChhhhhhCCcccceeccCCChh
Q psy758 223 FNGYYFEVPDEMQYEEITQRCLDKDPLRRWSCDQLLRHPYFNGYYFEVPDEM 274 (292)
Q Consensus 223 ~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~~il~h~w~~~~~~~~~~~~ 274 (292)
. ....+...+..+.+||.+||+.||++|||++++++||||.+..++.....
T Consensus 231 ~-~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~i~~~~~~~~~~~~~~~~~ 281 (288)
T cd06616 231 L-SNSEEREFSPSFVNFINLCLIKDESKRPKYKELLEHPFIKDYEERNVDVA 281 (288)
T ss_pred C-CCcCCCccCHHHHHHHHHHccCChhhCcCHHHHhcChhhhchhhcchhHH
Confidence 0 01111235678999999999999999999999999999998666555443
|
Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates |
| >KOG0577|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-37 Score=256.36 Aligned_cols=250 Identities=29% Similarity=0.429 Sum_probs=195.0
Q ss_pred ccceeeeecccCceEEEEEEEcCCCcEEEEEEeccCC-CChHHHHHHHHHHHHHHhCCCCCcchhhhhhhcCCeEEEEEe
Q psy758 3 RYEKIGKLGEGSYGVVFKCRNRDTGQVVAIKKFLESE-EDPLIRKIALREIRLLKSLKHPNLVNLLEVFRRKKKLHLVFE 81 (292)
Q Consensus 3 ~y~~~~~l~~g~~~~v~~~~~~~~~~~v~iK~~~~~~-~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~iv~e 81 (292)
.|.-++.||.|+||.||-|++..+.+.||||.++.+. ...+....+.+|+..+++++|||++.+-|.|..+...|+|||
T Consensus 27 lf~dLrEIGHGSFGAVYfArd~~n~evVAIKKMsySGKQs~EKWqDIlKEVrFL~~l~HPntieYkgCyLre~TaWLVME 106 (948)
T KOG0577|consen 27 LFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDILKEVRFLRQLRHPNTIEYKGCYLREHTAWLVME 106 (948)
T ss_pred HHHHHHHhcCCccceeEEeeccCccceeeeeeccccccccHHHHHHHHHHHHHHHhccCCCcccccceeeccchHHHHHH
Confidence 4667889999999999999999999999999998776 444567788999999999999999999999999999999999
Q ss_pred cCCCccHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEEccCCcEEEeecCchhhhhccccccccc
Q psy758 82 FCDHTVLNELENHPHGLPWDLIKQITWQVLRGVSYCHRHACIHRDIKPENILLTANGVVKLCDFGFARLIRDLIPRHLHI 161 (292)
Q Consensus 82 ~~~~~~L~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~givH~dl~p~Nilv~~~~~~kl~dfg~~~~~~~~~~~~~~~ 161 (292)
||-|.--+-+--..+++-+-.+..|+.+.+.||+|||+.+.+|+|||..|||+++.|.+||+|||.+....+.+ .+
T Consensus 107 YClGSAsDlleVhkKplqEvEIAAi~~gaL~gLaYLHS~~~IHRDiKAGNILLse~g~VKLaDFGSAsi~~PAn----sF 182 (948)
T KOG0577|consen 107 YCLGSASDLLEVHKKPLQEVEIAAITHGALQGLAYLHSHNRIHRDIKAGNILLSEPGLVKLADFGSASIMAPAN----SF 182 (948)
T ss_pred HHhccHHHHHHHHhccchHHHHHHHHHHHHHHHHHHHHhhHHhhhccccceEecCCCeeeeccccchhhcCchh----cc
Confidence 99874322222223479999999999999999999999999999999999999999999999999997765432 23
Q ss_pred cccccccccCC-------------CCCCCcccceeeecCCCCCCchHHHHHHHhhcccCCCCCCChhhhhhccCcCCCCC
Q psy758 162 FQTNEYFKGVS-------------LPHAENVVPLEIKIGKPAATNIYLIDFLKRCLDKDPLRRWSCDQLLRHPYFNGYYF 228 (292)
Q Consensus 162 ~~~~~~~~~~~-------------~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~ 228 (292)
.++|.|..++. ..|++|+...++.-..++-.+..+..-+..+-+.++ |+..
T Consensus 183 vGTPywMAPEVILAMDEGqYdgkvDvWSLGITCIELAERkPPlFnMNAMSALYHIAQNes---PtLq------------- 246 (948)
T KOG0577|consen 183 VGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNES---PTLQ------------- 246 (948)
T ss_pred cCCccccchhHheeccccccCCccceeeccchhhhhhhcCCCccCchHHHHHHHHHhcCC---CCCC-------------
Confidence 45555555443 356666666666666666555555554444433332 1111
Q ss_pred CCCCccchHHHHhcccCcCCCCCCChhhhhhCCcccceeccCCChhH
Q psy758 229 EVPDEMQYEEITQRCLDKDPLRRWSCDQLLRHPYFNGYYFEVPDEMQ 275 (292)
Q Consensus 229 ~~~~~~~l~~li~~~l~~dP~~Rpt~~~il~h~w~~~~~~~~~~~~~ 275 (292)
....+..+++|+..||..-|.+|||.++++.|+|+.. +.|+...
T Consensus 247 s~eWS~~F~~Fvd~CLqKipqeRptse~ll~H~fv~R---~Rp~tvi 290 (948)
T KOG0577|consen 247 SNEWSDYFRNFVDSCLQKIPQERPTSEELLKHRFVLR---ERPPTVI 290 (948)
T ss_pred CchhHHHHHHHHHHHHhhCcccCCcHHHHhhcchhcc---CCCchHH
Confidence 1122567899999999999999999999999999985 4454443
|
|
| >cd08229 STKc_Nek7 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5e-36 Score=242.01 Aligned_cols=246 Identities=22% Similarity=0.322 Sum_probs=180.8
Q ss_pred CcccceeeeecccCceEEEEEEEcCCCcEEEEEEeccCC-CChHHHHHHHHHHHHHHhCCCCCcchhhhhhhcCCeEEEE
Q psy758 1 MERYEKIGKLGEGSYGVVFKCRNRDTGQVVAIKKFLESE-EDPLIRKIALREIRLLKSLKHPNLVNLLEVFRRKKKLHLV 79 (292)
Q Consensus 1 ~~~y~~~~~l~~g~~~~v~~~~~~~~~~~v~iK~~~~~~-~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~iv 79 (292)
+++|++.+.||+|++|.||+|.+..+++.+++|.+.... ........+.+|+.+++.++||||+++++++.+++..+++
T Consensus 1 ~~~y~~~~~ig~g~~g~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~v 80 (267)
T cd08229 1 LANFRIEKKIGRGQFSEVYRATCLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPNVIKYYASFIEDNELNIV 80 (267)
T ss_pred CchhhhhhhhcccCCeEEEEEeecCCCceEEEEeeeehhhhhHHHHHHHHHHHHHHHHccCCchhhhhheeEeCCeEEEE
Confidence 578999999999999999999999999999999886544 3334456788999999999999999999999999999999
Q ss_pred EecCCCccHHHHhcC----CCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEEccCCcEEEeecCchhhhhccc
Q psy758 80 FEFCDHTVLNELENH----PHGLPWDLIKQITWQVLRGVSYCHRHACIHRDIKPENILLTANGVVKLCDFGFARLIRDLI 155 (292)
Q Consensus 80 ~e~~~~~~L~~~~~~----~~~~~~~~~~~i~~qi~~aL~~LH~~givH~dl~p~Nilv~~~~~~kl~dfg~~~~~~~~~ 155 (292)
+||+++++|.+++.. ...+++..++.++.||+.||.|||++|++|+||+|+||+++.++.++|+|||++.......
T Consensus 81 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~~~ 160 (267)
T cd08229 81 LELADAGDLSRMIKHFKKQKRLIPEKTVWKYFVQLCSALEHMHSRRVMHRDIKPANVFITATGVVKLGDLGLGRFFSSKT 160 (267)
T ss_pred EEecCCCCHHHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEEcCCCCEEECcchhhhccccCC
Confidence 999999999988752 3458999999999999999999999999999999999999999999999999887654322
Q ss_pred c-----ccccccccccccccCCCCCCCcccceeeecCCCCCCchHHHHHHHhhcccCCCCCCCh--hhhhhccCcCCCC-
Q psy758 156 P-----RHLHIFQTNEYFKGVSLPHAENVVPLEIKIGKPAATNIYLIDFLKRCLDKDPLRRWSC--DQLLRHPYFNGYY- 227 (292)
Q Consensus 156 ~-----~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~--~~~~~~~~~~~~~- 227 (292)
. .....|.+||+..+.......++| +.+.-++..+.+..|...... .+...........
T Consensus 161 ~~~~~~~~~~~~~ape~~~~~~~~~~~Dv~-------------slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~ 227 (267)
T cd08229 161 TAAHSLVGTPYYMSPERIHENGYNFKSDIW-------------SLGCLLYEMAALQSPFYGDKMNLYSLCKKIEQCDYPP 227 (267)
T ss_pred cccccccCCcCccCHHHhcCCCccchhhHH-------------HHHHHHHHHHhCCCCcccccchHHHHhhhhhcCCCCC
Confidence 1 222345566655443222222222 222223333333334322111 1111110000000
Q ss_pred -CCCCCccchHHHHhcccCcCCCCCCChhhhhh
Q psy758 228 -FEVPDEMQYEEITQRCLDKDPLRRWSCDQLLR 259 (292)
Q Consensus 228 -~~~~~~~~l~~li~~~l~~dP~~Rpt~~~il~ 259 (292)
.....+..+.++|.+||+.||.+|||+.+|++
T Consensus 228 ~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~i~~ 260 (267)
T cd08229 228 LPSDHYSEELRQLVNMCINPDPEKRPDITYVYD 260 (267)
T ss_pred CCcccccHHHHHHHHHhcCCCcccCCCHHHHHH
Confidence 11234668999999999999999999998875
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase. |
| >cd07867 STKc_CDC2L6 Catalytic domain of Serine/Threonine Kinase, Cell Division Cycle 2-like 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-36 Score=251.40 Aligned_cols=253 Identities=29% Similarity=0.500 Sum_probs=173.2
Q ss_pred eeeecccCceEEEEEEEcC--CCcEEEEEEeccCCCChHHHHHHHHHHHHHHhCCCCCcchhhhhhh--cCCeEEEEEec
Q psy758 7 IGKLGEGSYGVVFKCRNRD--TGQVVAIKKFLESEEDPLIRKIALREIRLLKSLKHPNLVNLLEVFR--RKKKLHLVFEF 82 (292)
Q Consensus 7 ~~~l~~g~~~~v~~~~~~~--~~~~v~iK~~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~--~~~~~~iv~e~ 82 (292)
...||+|+||.||+|.... ++..||+|.+...... ..+.+|+.+++.++||||+++++++. .+...++++||
T Consensus 6 g~~lG~G~~g~Vy~~~~~~~~~~~~~a~k~~~~~~~~----~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~lv~e~ 81 (317)
T cd07867 6 GCKVGRGTYGHVYKAKRKDGKDEKEYALKQIEGTGIS----MSACREIALLRELKHPNVIALQKVFLSHSDRKVWLLFDY 81 (317)
T ss_pred ceEeccCCCeeEEEEEecCCCccceEEEEEecCCCCc----HHHHHHHHHHHhCCCCCeeeEEEEEeccCCCeEEEEEee
Confidence 4679999999999998653 5678999988654432 34668999999999999999999874 45678999999
Q ss_pred CCCccHHHHhc--------CCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEE----ccCCcEEEeecCchhh
Q psy758 83 CDHTVLNELEN--------HPHGLPWDLIKQITWQVLRGVSYCHRHACIHRDIKPENILL----TANGVVKLCDFGFARL 150 (292)
Q Consensus 83 ~~~~~L~~~~~--------~~~~~~~~~~~~i~~qi~~aL~~LH~~givH~dl~p~Nilv----~~~~~~kl~dfg~~~~ 150 (292)
++++.+..+.. ....+++..++.++.||+.||.|||++|++|+||||+||++ +.++.++|+|||++..
T Consensus 82 ~~~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~ivH~Dlkp~Nil~~~~~~~~~~~kl~DfG~a~~ 161 (317)
T cd07867 82 AEHDLWHIIKFHRASKANKKPMQLPRSMVKSLLYQILDGIHYLHANWVLHRDLKPANILVMGEGPERGRVKIADMGFARL 161 (317)
T ss_pred eCCcHHHHHHhhhccccCCCCccCCHHHHHHHHHHHHHHHHHHHhCCEEcCCCCHHHEEEccCCCCCCcEEEeeccceec
Confidence 98754433321 12248899999999999999999999999999999999999 4567899999999976
Q ss_pred hhcccc--------ccccccccccccccC------CCCCCCcccceeeecCCCCCCchH------------HHHHHHhhc
Q psy758 151 IRDLIP--------RHLHIFQTNEYFKGV------SLPHAENVVPLEIKIGKPAATNIY------------LIDFLKRCL 204 (292)
Q Consensus 151 ~~~~~~--------~~~~~~~~~~~~~~~------~~~~~~~~~~~~~~~~~~~~~~~~------------~~~~~~~~~ 204 (292)
...... ..+..|.+||...+. ...|+.|+..+++.+|.+++.... ...-+...+
T Consensus 162 ~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~el~tg~~~f~~~~~~~~~~~~~~~~~~~~~~~~~ 241 (317)
T cd07867 162 FNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIKTSNPFHHDQLDRIFSVM 241 (317)
T ss_pred cCCCcccccccCcceecccccCcHHhcCCCccCcHHHHHhHHHHHHHHHhCCCCcccccccccccccccHHHHHHHHHhc
Confidence 543211 223457788876542 234666777777777776643110 011111111
Q ss_pred ccCCCCCCC----------hhhhhhccCcCC-------CCCCCCCccchHHHHhcccCcCCCCCCChhhhhhCCcc
Q psy758 205 DKDPLRRWS----------CDQLLRHPYFNG-------YYFEVPDEMQYEEITQRCLDKDPLRRWSCDQLLRHPYF 263 (292)
Q Consensus 205 ~~~p~~~~~----------~~~~~~~~~~~~-------~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~~il~h~w~ 263 (292)
+......+. ............ .......+..+.+||.+||+.||.+|||++|+|+||||
T Consensus 242 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~l~~dP~~R~t~~e~l~hp~f 317 (317)
T cd07867 242 GFPADKDWEDIRKMPEYPTLQKDFRRTTYANSSLIKYMEKHKVKPDSKVFLLLQKLLTMDPTKRITSEQALQDPYF 317 (317)
T ss_pred CCCChhhhhhhhhcccchhhhhhhcccccCCchhhhhhhcccCCCChHHHHHHHHHhccCcccccCHHHHhcCCCC
Confidence 111111100 000000000000 00011234568899999999999999999999999998
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 6 (CDC2L6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L6 is also called CDK8-like and was previously referred to as CDK11. However, this is a confusing nomenclature as CDC2L6 is distinct from CDC2L1, which is represented by the two protein products from its gene, called CDK11(p110) and CDK11(p58), as well as |
| >cd05122 PKc_STE Catalytic domain of STE family Protein Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.3e-36 Score=238.52 Aligned_cols=245 Identities=30% Similarity=0.470 Sum_probs=187.1
Q ss_pred ccceeeeecccCceEEEEEEEcCCCcEEEEEEeccCCCChHHHHHHHHHHHHHHhCCCCCcchhhhhhhcCCeEEEEEec
Q psy758 3 RYEKIGKLGEGSYGVVFKCRNRDTGQVVAIKKFLESEEDPLIRKIALREIRLLKSLKHPNLVNLLEVFRRKKKLHLVFEF 82 (292)
Q Consensus 3 ~y~~~~~l~~g~~~~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~iv~e~ 82 (292)
.|+..+.||+|++|.||++.+..+++.+++|.+..... .....+.+|+..++.++|++++++++.+...+..++++||
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~--~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~l~~e~ 78 (253)
T cd05122 1 LFEILEKIGKGGFGEVYKARHKRTGKEVAIKVIKLESK--EKKEKIINEIQILKKCKHPNIVKYYGSYLKKDELWIVMEF 78 (253)
T ss_pred CceeeeeeccCCceEEEEEEECCCCcEEEEEEecccch--hHHHHHHHHHHHHHhCCCCCEeEEEEEEecCCeEEEEEec
Confidence 48899999999999999999998999999999866543 3456788999999999999999999999999999999999
Q ss_pred CCCccHHHHhcCC-CCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEEccCCcEEEeecCchhhhhccc----cc
Q psy758 83 CDHTVLNELENHP-HGLPWDLIKQITWQVLRGVSYCHRHACIHRDIKPENILLTANGVVKLCDFGFARLIRDLI----PR 157 (292)
Q Consensus 83 ~~~~~L~~~~~~~-~~~~~~~~~~i~~qi~~aL~~LH~~givH~dl~p~Nilv~~~~~~kl~dfg~~~~~~~~~----~~ 157 (292)
+++++|.+++... ..+++..++.++.|++.||++||++|++||||+|+||++++++.++|+|||.+....... ..
T Consensus 79 ~~~~~L~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~i~h~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~~~~~~ 158 (253)
T cd05122 79 CSGGSLKDLLKSTNQTLTESQIAYVCKELLKGLEYLHSNGIIHRDIKAANILLTSDGEVKLIDFGLSAQLSDTKARNTMV 158 (253)
T ss_pred CCCCcHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHhhcCCEecCCCCHHHEEEccCCeEEEeecccccccccccccccee
Confidence 9999999988765 578999999999999999999999999999999999999999999999999987665432 22
Q ss_pred cccccccccccccCCCCCCCcccceeeecCCCCCCchHHHHHHHhhcccCCCCCCChhhhhhc---cCcCCCCCCCCCcc
Q psy758 158 HLHIFQTNEYFKGVSLPHAENVVPLEIKIGKPAATNIYLIDFLKRCLDKDPLRRWSCDQLLRH---PYFNGYYFEVPDEM 234 (292)
Q Consensus 158 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~---~~~~~~~~~~~~~~ 234 (292)
....|.+||...+.......+ .++.+.-++..+.+..|....+..+.... ............+.
T Consensus 159 ~~~~~~~PE~~~~~~~~~~~D-------------v~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 225 (253)
T cd05122 159 GTPYWMAPEVINGKPYDYKAD-------------IWSLGITAIELAEGKPPYSELPPMKALFKIATNGPPGLRNPEKWSD 225 (253)
T ss_pred cCCcccCHHHHcCCCCCcccc-------------HHHHHHHHHHHHhCCCCCCCCchHHHHHHHHhcCCCCcCcccccCH
Confidence 233455555544333222222 23333334444445555444322221111 11111111222267
Q ss_pred chHHHHhcccCcCCCCCCChhhhhhCCc
Q psy758 235 QYEEITQRCLDKDPLRRWSCDQLLRHPY 262 (292)
Q Consensus 235 ~l~~li~~~l~~dP~~Rpt~~~il~h~w 262 (292)
.+.++|.+||+.||++|||+.++++|||
T Consensus 226 ~~~~~i~~~l~~~p~~R~t~~~~l~~~~ 253 (253)
T cd05122 226 EFKDFLKKCLQKNPEKRPTAEQLLKHPF 253 (253)
T ss_pred HHHHHHHHHccCChhhCCCHHHHhcCCC
Confidence 8999999999999999999999999999
|
Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core |
| >cd06624 STKc_ASK Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-35 Score=239.97 Aligned_cols=246 Identities=26% Similarity=0.359 Sum_probs=177.7
Q ss_pred ceeeeecccCceEEEEEEEcCCCcEEEEEEeccCCCChHHHHHHHHHHHHHHhCCCCCcchhhhhhhcCCeEEEEEecCC
Q psy758 5 EKIGKLGEGSYGVVFKCRNRDTGQVVAIKKFLESEEDPLIRKIALREIRLLKSLKHPNLVNLLEVFRRKKKLHLVFEFCD 84 (292)
Q Consensus 5 ~~~~~l~~g~~~~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~iv~e~~~ 84 (292)
.....||+|++|.||+|.+..++..|++|.+.... ....+.+.+|+.+++.++|+||+++++++.+++..++++||++
T Consensus 11 ~~~~~lg~g~~g~v~~~~~~~~~~~v~~k~~~~~~--~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~ 88 (268)
T cd06624 11 GERVVLGKGTYGIVYAARDLSTQVRIAIKEIPERD--SRYVQPLHEEIALHSYLKHRNIVQYLGSDSENGFFKIFMEQVP 88 (268)
T ss_pred CceEEEecCCceEEEEeEecCCCcEEEEEEecCCC--HHHHHHHHHHHHHHHhcCCCCeeeeeeeeccCCEEEEEEecCC
Confidence 34567999999999999999889999999886543 2345678899999999999999999999999999999999999
Q ss_pred CccHHHHhcCC-CCC--CHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEEcc-CCcEEEeecCchhhhhcccc----
Q psy758 85 HTVLNELENHP-HGL--PWDLIKQITWQVLRGVSYCHRHACIHRDIKPENILLTA-NGVVKLCDFGFARLIRDLIP---- 156 (292)
Q Consensus 85 ~~~L~~~~~~~-~~~--~~~~~~~i~~qi~~aL~~LH~~givH~dl~p~Nilv~~-~~~~kl~dfg~~~~~~~~~~---- 156 (292)
+++|..++... ..+ ++..+..++.||+.||+|||++|++|+||+|+||+++. ++.++|+|||.+........
T Consensus 89 ~~~L~~~l~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~i~h~dl~p~nil~~~~~~~~~l~dfg~~~~~~~~~~~~~~ 168 (268)
T cd06624 89 GGSLSALLRSKWGPLKDNEQTIIFYTKQILEGLKYLHDNQIVHRDIKGDNVLVNTYSGVVKISDFGTSKRLAGINPCTET 168 (268)
T ss_pred CCCHHHHHHHhcccCCCcHHHHHHHHHHHHHHHHHHHHCCEeecCCCHHHEEEcCCCCeEEEecchhheecccCCCcccc
Confidence 99999988653 345 88899999999999999999999999999999999986 67999999998865432111
Q ss_pred -ccccccccccccccCCCCCCCcccceeeecCCCCCCchHHHHHHHhhcccCCCCCCCh--hhhhhccCcC-CCCCCCCC
Q psy758 157 -RHLHIFQTNEYFKGVSLPHAENVVPLEIKIGKPAATNIYLIDFLKRCLDKDPLRRWSC--DQLLRHPYFN-GYYFEVPD 232 (292)
Q Consensus 157 -~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~--~~~~~~~~~~-~~~~~~~~ 232 (292)
.....|.+||+..+.... .+...+.++.+..++..+.+..|...... .......... ....+...
T Consensus 169 ~~~~~~~~aPE~~~~~~~~-----------~~~~~Dv~slGvvl~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (268)
T cd06624 169 FTGTLQYMAPEVIDKGPRG-----------YGAPADIWSLGCTIVEMATGKPPFIELGEPQAAMFKVGMFKIHPEIPESL 237 (268)
T ss_pred CCCCccccChhhhcccccc-----------CCchhhhHHHHHHHHHHHhCCCCCccccChhhhHhhhhhhccCCCCCccc
Confidence 123345566654321100 01111222333333333444444322211 1111111111 11223345
Q ss_pred ccchHHHHhcccCcCCCCCCChhhhhhCCcc
Q psy758 233 EMQYEEITQRCLDKDPLRRWSCDQLLRHPYF 263 (292)
Q Consensus 233 ~~~l~~li~~~l~~dP~~Rpt~~~il~h~w~ 263 (292)
+..+.+++.+||+.+|.+|||+.++++||||
T Consensus 238 ~~~~~~li~~~l~~~p~~Rpt~~~ll~~~~~ 268 (268)
T cd06624 238 SAEAKNFILRCFEPDPDKRASAHDLLQDPFL 268 (268)
T ss_pred CHHHHHHHHHHcCCCchhCCCHHHHHhCCCC
Confidence 6789999999999999999999999999997
|
Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kina |
| >cd05583 STKc_MSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-36 Score=247.59 Aligned_cols=254 Identities=24% Similarity=0.340 Sum_probs=184.3
Q ss_pred ccceeeeecccCceEEEEEEEc---CCCcEEEEEEeccCC--CChHHHHHHHHHHHHHHhC-CCCCcchhhhhhhcCCeE
Q psy758 3 RYEKIGKLGEGSYGVVFKCRNR---DTGQVVAIKKFLESE--EDPLIRKIALREIRLLKSL-KHPNLVNLLEVFRRKKKL 76 (292)
Q Consensus 3 ~y~~~~~l~~g~~~~v~~~~~~---~~~~~v~iK~~~~~~--~~~~~~~~~~~e~~~~~~l-~~~~i~~~~~~~~~~~~~ 76 (292)
+|++.+.||+|++|.||++.+. .+++.|++|.+.... ......+.+.+|+.+++.+ +||+|+++++.+..++..
T Consensus 1 ~~~~~~~ig~G~~~~vy~~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~~~~~~~~~~~~ 80 (288)
T cd05583 1 NFELLRVLGTGAYGKVFLVRKVGGHDAGKLYAMKVLKKATIVQKAKTAEHTRTERQVLEAVRRCPFLVTLHYAFQTDTKL 80 (288)
T ss_pred CceEEEEeccCCCceEEEEEEeccccCCcEEEEEEEehHHHHhhhhHHHHHHHHHHHHHhccCCcchhhhheeeecCCEE
Confidence 4889999999999999999864 457889999986543 2223456678899999999 599999999999999999
Q ss_pred EEEEecCCCccHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEEccCCcEEEeecCchhhhhcccc
Q psy758 77 HLVFEFCDHTVLNELENHPHGLPWDLIKQITWQVLRGVSYCHRHACIHRDIKPENILLTANGVVKLCDFGFARLIRDLIP 156 (292)
Q Consensus 77 ~iv~e~~~~~~L~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~givH~dl~p~Nilv~~~~~~kl~dfg~~~~~~~~~~ 156 (292)
++|+||+.+++|..++.....+++..+..++.|++.||.|||+.|++|+||+|+||+++.++.++|+|||++........
T Consensus 81 ~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~ql~~~l~~lH~~~~~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~~ 160 (288)
T cd05583 81 HLILDYVNGGELFTHLYQREHFTESEVRVYIAEIVLALDHLHQLGIIYRDIKLENILLDSEGHVVLTDFGLSKEFLAEEE 160 (288)
T ss_pred EEEEecCCCCcHHHHHhhcCCcCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHeEECCCCCEEEEECccccccccccc
Confidence 99999999999999887766799999999999999999999999999999999999999999999999998866432211
Q ss_pred ------ccccccccccccccCC--CCCCCcccceeeecCCCCCCchHHHHHHHhhcccCCCCC----CChhhhhhccCcC
Q psy758 157 ------RHLHIFQTNEYFKGVS--LPHAENVVPLEIKIGKPAATNIYLIDFLKRCLDKDPLRR----WSCDQLLRHPYFN 224 (292)
Q Consensus 157 ------~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~p~~~----~~~~~~~~~~~~~ 224 (292)
.....|.+||...+.. .....++ ++.+..++..+.+..|... ....++.......
T Consensus 161 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Dv-------------~slG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~ 227 (288)
T cd05583 161 ERAYSFCGTIEYMAPEVIRGGSGGHDKAVDW-------------WSLGVLTFELLTGASPFTVDGEQNSQSEISRRILKS 227 (288)
T ss_pred cccccccCCccccCHHHhcCCCCCCcchhhh-------------HHHHHHHHHHHhCCCCcccCcccchHHHHHHHHHcc
Confidence 1223355555543322 1111122 2222223333333333211 1112211111111
Q ss_pred CCCCCCCCccchHHHHhcccCcCCCCCCC---hhhhhhCCcccceecc
Q psy758 225 GYYFEVPDEMQYEEITQRCLDKDPLRRWS---CDQLLRHPYFNGYYFE 269 (292)
Q Consensus 225 ~~~~~~~~~~~l~~li~~~l~~dP~~Rpt---~~~il~h~w~~~~~~~ 269 (292)
....+...+..+.++|.+||+.||++||| +.++++||||++..|+
T Consensus 228 ~~~~~~~~~~~l~~li~~~l~~~p~~R~t~~~~~~~l~~~~~~~~~~~ 275 (288)
T cd05583 228 KPPFPKTMSAEARDFIQKLLEKDPKKRLGANGADEIKNHPFFQGIDWD 275 (288)
T ss_pred CCCCCcccCHHHHHHHHHHhcCCHhhccCcchHHHHhcCcccccCCHH
Confidence 22233445678999999999999999998 4677999999998764
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines |
| >cd05052 PTKc_Abl Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-36 Score=241.77 Aligned_cols=243 Identities=21% Similarity=0.255 Sum_probs=180.4
Q ss_pred cccceeeeecccCceEEEEEEEcCCCcEEEEEEeccCCCChHHHHHHHHHHHHHHhCCCCCcchhhhhhhcCCeEEEEEe
Q psy758 2 ERYEKIGKLGEGSYGVVFKCRNRDTGQVVAIKKFLESEEDPLIRKIALREIRLLKSLKHPNLVNLLEVFRRKKKLHLVFE 81 (292)
Q Consensus 2 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~iv~e 81 (292)
.+|++.+.||+|++|.||+|.+..+++.|++|.+.... .....+.+|+.+++.++||||+++++++..++..++++|
T Consensus 6 ~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~~K~~~~~~---~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 82 (263)
T cd05052 6 TDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDT---MEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITE 82 (263)
T ss_pred HHeEEeeecCCcccceEEEEEEecCCceEEEEEecCCc---hHHHHHHHHHHHHHhCCCCChhheEEEEcCCCCcEEEEE
Confidence 46889999999999999999999999999999986432 234567889999999999999999999999999999999
Q ss_pred cCCCccHHHHhcCC--CCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEEccCCcEEEeecCchhhhhccccc--
Q psy758 82 FCDHTVLNELENHP--HGLPWDLIKQITWQVLRGVSYCHRHACIHRDIKPENILLTANGVVKLCDFGFARLIRDLIPR-- 157 (292)
Q Consensus 82 ~~~~~~L~~~~~~~--~~~~~~~~~~i~~qi~~aL~~LH~~givH~dl~p~Nilv~~~~~~kl~dfg~~~~~~~~~~~-- 157 (292)
|+++++|.+++... ..+++..++.++.|++.||+|||++|++|+||+|+||++++++.++|+|||.+.........
T Consensus 83 ~~~~~~L~~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lH~~~i~H~dlkp~nil~~~~~~~kl~df~~~~~~~~~~~~~~ 162 (263)
T cd05052 83 FMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLEKKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAH 162 (263)
T ss_pred eCCCCcHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCEeecccCcceEEEcCCCcEEeCCCccccccccceeecc
Confidence 99999999988643 35899999999999999999999999999999999999999999999999998765432111
Q ss_pred ----cccccccccccccCCCCCCCcccceeeecCCCCCCchHHHHHHHhhc-ccCCCCCCChhhhhhccCc-CCCCCCCC
Q psy758 158 ----HLHIFQTNEYFKGVSLPHAENVVPLEIKIGKPAATNIYLIDFLKRCL-DKDPLRRWSCDQLLRHPYF-NGYYFEVP 231 (292)
Q Consensus 158 ----~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~p~~~~~~~~~~~~~~~-~~~~~~~~ 231 (292)
....|.+||...+.......++|+++ ..+++.+. +..|.......+....... .....+..
T Consensus 163 ~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG-------------~il~el~t~g~~p~~~~~~~~~~~~~~~~~~~~~~~~ 229 (263)
T cd05052 163 AGAKFPIKWTAPESLAYNKFSIKSDVWAFG-------------VLLWEIATYGMSPYPGIDLSQVYELLEKGYRMERPEG 229 (263)
T ss_pred CCCCCccccCCHHHhccCCCCchhHHHHHH-------------HHHHHHHcCCCCCCCCCCHHHHHHHHHCCCCCCCCCC
Confidence 12246677766544333222332222 22222222 2333322222222111000 01122344
Q ss_pred CccchHHHHhcccCcCCCCCCChhhhhhC
Q psy758 232 DEMQYEEITQRCLDKDPLRRWSCDQLLRH 260 (292)
Q Consensus 232 ~~~~l~~li~~~l~~dP~~Rpt~~~il~h 260 (292)
.+.++.++|.+||+.||++|||+.++++.
T Consensus 230 ~~~~~~~li~~cl~~~p~~Rp~~~~l~~~ 258 (263)
T cd05052 230 CPPKVYELMRACWQWNPSDRPSFAEIHQA 258 (263)
T ss_pred CCHHHHHHHHHHccCCcccCCCHHHHHHH
Confidence 57889999999999999999999999863
|
Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays |
| >cd07830 STKc_MAK_like Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.2e-36 Score=242.47 Aligned_cols=258 Identities=32% Similarity=0.511 Sum_probs=184.5
Q ss_pred cceeeeecccCceEEEEEEEcCCCcEEEEEEeccCCCChHHHHHHHHHHHHHHhCC-CCCcchhhhhhhcCCeEEEEEec
Q psy758 4 YEKIGKLGEGSYGVVFKCRNRDTGQVVAIKKFLESEEDPLIRKIALREIRLLKSLK-HPNLVNLLEVFRRKKKLHLVFEF 82 (292)
Q Consensus 4 y~~~~~l~~g~~~~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~e~~~~~~l~-~~~i~~~~~~~~~~~~~~iv~e~ 82 (292)
|++.+.||+|++|.||+|....+++.|++|.+....... ......+|+..++.++ |||++++++++.+++..++||||
T Consensus 1 y~~~~~ig~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~-~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~lv~e~ 79 (283)
T cd07830 1 YKVIKQLGDGTFGSVYLARNKETGELVAIKKMKKKFYSW-EECMNLREVKSLRKLNEHPNIVKLKEVFRENDELYFVFEY 79 (283)
T ss_pred CeeheeeccCCceEEEEEEECCCCcEEEEEEehhhccch-hHHHHHHHHHHHHhccCCCCchhHHHHhhcCCcEEEEEec
Confidence 788999999999999999999889999999986554322 2233457899999999 99999999999999999999999
Q ss_pred CCCccHHHHhcCCC--CCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEEccCCcEEEeecCchhhhhcccc----
Q psy758 83 CDHTVLNELENHPH--GLPWDLIKQITWQVLRGVSYCHRHACIHRDIKPENILLTANGVVKLCDFGFARLIRDLIP---- 156 (292)
Q Consensus 83 ~~~~~L~~~~~~~~--~~~~~~~~~i~~qi~~aL~~LH~~givH~dl~p~Nilv~~~~~~kl~dfg~~~~~~~~~~---- 156 (292)
+ ++++...+.... .+++..+..++.|++.||.|||++|++|+||+|+||++++++.++|+|||.+........
T Consensus 80 ~-~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~Lh~~~i~H~dl~~~ni~i~~~~~~~l~d~~~~~~~~~~~~~~~~ 158 (283)
T cd07830 80 M-EGNLYQLMKDRKGKPFSESVIRSIIYQILQGLAHIHKHGFFHRDLKPENLLVSGPEVVKIADFGLAREIRSRPPYTDY 158 (283)
T ss_pred C-CCCHHHHHHhcccccCCHHHHHHHHHHHHHHHHHHHHCCcccCCCChhhEEEcCCCCEEEeecccceeccCCCCcCCC
Confidence 9 566666665443 689999999999999999999999999999999999999999999999999876543211
Q ss_pred cccccccccccccc------CCCCCCCcccceeeecCCCCCCchHHHHHHHh---hcccCCCCCCChhhhhhccC---cC
Q psy758 157 RHLHIFQTNEYFKG------VSLPHAENVVPLEIKIGKPAATNIYLIDFLKR---CLDKDPLRRWSCDQLLRHPY---FN 224 (292)
Q Consensus 157 ~~~~~~~~~~~~~~------~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~---~~~~~p~~~~~~~~~~~~~~---~~ 224 (292)
.....|.+||...+ ....|+.++..+++.++.+++......+.+.. .++..+...+.....+.... +.
T Consensus 159 ~~~~~~~aPE~~~~~~~~~~~~Di~s~G~~l~el~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (283)
T cd07830 159 VSTRWYRAPEILLRSTSYSSPVDIWALGCIMAELYTLRPLFPGSSEIDQLYKICSVLGTPTKQDWPEGYKLASKLGFRFP 238 (283)
T ss_pred CCcccccCceeeecCcCcCCccchhhHHHHHHHHHhCCCccCCCChHHHHHHHHHhcCCCChhhhhhHhhhhcccccccc
Confidence 12334667775532 23456666666677777655433322222111 11111111000000000000 00
Q ss_pred CC------CCCCCCccchHHHHhcccCcCCCCCCChhhhhhCCcc
Q psy758 225 GY------YFEVPDEMQYEEITQRCLDKDPLRRWSCDQLLRHPYF 263 (292)
Q Consensus 225 ~~------~~~~~~~~~l~~li~~~l~~dP~~Rpt~~~il~h~w~ 263 (292)
.. ......+..+.++|.+||+.||.+|||+.|+++||||
T Consensus 239 ~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~~~~~ 283 (283)
T cd07830 239 QFAPTSLHQLIPNASPEAIDLIKDMLRWDPKKRPTASQALQHPYF 283 (283)
T ss_pred ccccccHHHHcccCCHHHHHHHHHhcccCcccCCCHHHHhhCCCC
Confidence 00 0001125679999999999999999999999999997
|
Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertili |
| >cd06633 STKc_TAO3 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-36 Score=247.39 Aligned_cols=252 Identities=29% Similarity=0.360 Sum_probs=181.1
Q ss_pred ccceeeeecccCceEEEEEEEcCCCcEEEEEEeccCCC-ChHHHHHHHHHHHHHHhCCCCCcchhhhhhhcCCeEEEEEe
Q psy758 3 RYEKIGKLGEGSYGVVFKCRNRDTGQVVAIKKFLESEE-DPLIRKIALREIRLLKSLKHPNLVNLLEVFRRKKKLHLVFE 81 (292)
Q Consensus 3 ~y~~~~~l~~g~~~~v~~~~~~~~~~~v~iK~~~~~~~-~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~iv~e 81 (292)
.|...+.||+|++|.||+|.+..+++.|++|.+..... .......+.+|+.+++.++|||++++++++.+....|+|+|
T Consensus 22 ~~~~~~~lg~g~~g~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 101 (313)
T cd06633 22 IFVGLHEIGHGSFGAVYFATNSHTNEVVAVKKMSYSGKQTNEKWQDIIKEVKFLQQLKHPNTIEYKGCYLKEHTAWLVME 101 (313)
T ss_pred HhhcceeeccCCCeEEEEEEECCCCcEEEEEEEeccccCchHHHHHHHHHHHHHHhCCCCCCccEEEEEEeCCEEEEEEe
Confidence 35667889999999999999999999999999875543 33345667889999999999999999999999999999999
Q ss_pred cCCCccHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEEccCCcEEEeecCchhhhhccc-ccccc
Q psy758 82 FCDHTVLNELENHPHGLPWDLIKQITWQVLRGVSYCHRHACIHRDIKPENILLTANGVVKLCDFGFARLIRDLI-PRHLH 160 (292)
Q Consensus 82 ~~~~~~L~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~givH~dl~p~Nilv~~~~~~kl~dfg~~~~~~~~~-~~~~~ 160 (292)
|+.++.+..+......+++..++.++.||+.||.|||++|++|+||+|+||++++++.++|+|||++....... .....
T Consensus 102 ~~~~~l~~~l~~~~~~l~~~~~~~~~~qi~~al~~LH~~gi~H~dl~p~nili~~~~~~kL~dfg~~~~~~~~~~~~~~~ 181 (313)
T cd06633 102 YCLGSASDLLEVHKKPLQEVEIAAITHGALQGLAYLHSHNMIHRDIKAGNILLTEPGQVKLADFGSASKSSPANSFVGTP 181 (313)
T ss_pred cCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCChhhEEECCCCCEEEeecCCCcccCCCCCccccc
Confidence 99876555554445678999999999999999999999999999999999999999999999999876433211 12233
Q ss_pred cccccccccc---CCCCCCCcccceeeecCCCCCCchHHHHHHHhhcccCCCCCCChhhhhhccCcCCC--CCCCCCccc
Q psy758 161 IFQTNEYFKG---VSLPHAENVVPLEIKIGKPAATNIYLIDFLKRCLDKDPLRRWSCDQLLRHPYFNGY--YFEVPDEMQ 235 (292)
Q Consensus 161 ~~~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~--~~~~~~~~~ 235 (292)
.|.+||+..+ .......++ ++.+..++..+.+..|...........+...... ......+..
T Consensus 182 ~y~aPE~~~~~~~~~~~~~sDv-------------~slGvil~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 248 (313)
T cd06633 182 YWMAPEVILAMDEGQYDGKVDV-------------WSLGITCIELAERKPPLFNMNAMSALYHIAQNDSPTLQSNEWTDS 248 (313)
T ss_pred cccChhhccccCCCCCCchhhH-------------HHHHHHHHHHHhCCCCCCCCChHHHHHHHHhcCCCCCCccccCHH
Confidence 4666666531 111111111 2222223333333333333222111111100000 011223557
Q ss_pred hHHHHhcccCcCCCCCCChhhhhhCCccccee
Q psy758 236 YEEITQRCLDKDPLRRWSCDQLLRHPYFNGYY 267 (292)
Q Consensus 236 l~~li~~~l~~dP~~Rpt~~~il~h~w~~~~~ 267 (292)
+++|+.+||+.+|.+||++.++++||||....
T Consensus 249 l~~li~~~l~~~P~~Rp~~~~~l~~~~~~~~~ 280 (313)
T cd06633 249 FRGFVDYCLQKIPQERPASAELLRHDFVRRDR 280 (313)
T ss_pred HHHHHHHHccCChhhCcCHHHHhcCcccCCCc
Confidence 89999999999999999999999999999744
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a co |
| >cd05084 PTKc_Fes Catalytic domain of the Protein Tyrosine Kinase, Fes | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-36 Score=240.64 Aligned_cols=238 Identities=24% Similarity=0.299 Sum_probs=173.8
Q ss_pred eeecccCceEEEEEEEcCCCcEEEEEEeccCCCChHHHHHHHHHHHHHHhCCCCCcchhhhhhhcCCeEEEEEecCCCcc
Q psy758 8 GKLGEGSYGVVFKCRNRDTGQVVAIKKFLESEEDPLIRKIALREIRLLKSLKHPNLVNLLEVFRRKKKLHLVFEFCDHTV 87 (292)
Q Consensus 8 ~~l~~g~~~~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~iv~e~~~~~~ 87 (292)
+.||+|++|.||+|.+..+++.|++|.+.... .......+.+|+++++.++||||+++++++...+..++|+||+++++
T Consensus 1 ~~lg~g~~g~vy~~~~~~~~~~~a~k~~~~~~-~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~ 79 (252)
T cd05084 1 ERIGRGNFGEVFSGRLRADNTPVAVKSCRETL-PPDLKAKFLQEARILKQYSHPNIVRLIGVCTQKQPIYIVMELVQGGD 79 (252)
T ss_pred CccCcccCccEEEEEEecCCceEEEEecCccC-CHHHHHHHHHHHHHHHhCCCCCcceEEEEEcCCCCeEEEEeeccCCc
Confidence 46899999999999999999999999876433 34455678899999999999999999999999999999999999999
Q ss_pred HHHHhcCC-CCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEEccCCcEEEeecCchhhhhcccccc-------c
Q psy758 88 LNELENHP-HGLPWDLIKQITWQVLRGVSYCHRHACIHRDIKPENILLTANGVVKLCDFGFARLIRDLIPRH-------L 159 (292)
Q Consensus 88 L~~~~~~~-~~~~~~~~~~i~~qi~~aL~~LH~~givH~dl~p~Nilv~~~~~~kl~dfg~~~~~~~~~~~~-------~ 159 (292)
|.+++... ..+++..++.++.|++.||.|||++|++|+||+|+||+++.++.++|+|||.+.......... .
T Consensus 80 L~~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~ 159 (252)
T cd05084 80 FLTFLRTEGPRLKVKELIQMVENAAAGMEYLESKHCIHRDLAARNCLVTEKNVLKISDFGMSREEEDGVYASTGGMKQIP 159 (252)
T ss_pred HHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccccchheEEEcCCCcEEECccccCcccccccccccCCCCCCc
Confidence 99988653 358999999999999999999999999999999999999999999999999986543211110 1
Q ss_pred cccccccccccCCCCCCCcccceeeecCCCCCCchHHHHHHHhhc-ccCCCCCCChhhhhhccC-cCCCCCCCCCccchH
Q psy758 160 HIFQTNEYFKGVSLPHAENVVPLEIKIGKPAATNIYLIDFLKRCL-DKDPLRRWSCDQLLRHPY-FNGYYFEVPDEMQYE 237 (292)
Q Consensus 160 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~p~~~~~~~~~~~~~~-~~~~~~~~~~~~~l~ 237 (292)
..|.+||...+.......++|++ +.-+++.+. +..|....+..+...... ......+...+..+.
T Consensus 160 ~~y~aPE~~~~~~~~~~~Dv~sl-------------G~il~e~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 226 (252)
T cd05084 160 VKWTAPEALNYGRYSSESDVWSF-------------GILLWEAFSLGAVPYANLSNQQTREAIEQGVRLPCPELCPDAVY 226 (252)
T ss_pred eeecCchhhcCCCCChHHHHHHH-------------HHHHHHHHhCCCCCccccCHHHHHHHHHcCCCCCCcccCCHHHH
Confidence 22555555443332222222222 222222222 333333333222211110 011122334477899
Q ss_pred HHHhcccCcCCCCCCChhhhhh
Q psy758 238 EITQRCLDKDPLRRWSCDQLLR 259 (292)
Q Consensus 238 ~li~~~l~~dP~~Rpt~~~il~ 259 (292)
+++.+||+.||++|||+.++++
T Consensus 227 ~li~~~l~~~p~~Rps~~~~~~ 248 (252)
T cd05084 227 RLMERCWEYDPGQRPSFSTVHQ 248 (252)
T ss_pred HHHHHHcCCChhhCcCHHHHHH
Confidence 9999999999999999999975
|
Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular |
| >cd05048 PTKc_Ror Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-36 Score=245.52 Aligned_cols=246 Identities=22% Similarity=0.297 Sum_probs=181.2
Q ss_pred CcccceeeeecccCceEEEEEEEcCCC-----cEEEEEEeccCCCChHHHHHHHHHHHHHHhCCCCCcchhhhhhhcCCe
Q psy758 1 MERYEKIGKLGEGSYGVVFKCRNRDTG-----QVVAIKKFLESEEDPLIRKIALREIRLLKSLKHPNLVNLLEVFRRKKK 75 (292)
Q Consensus 1 ~~~y~~~~~l~~g~~~~v~~~~~~~~~-----~~v~iK~~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~ 75 (292)
+++|++.+.||+|++|.||+|.....+ ..|++|.+.... .......+.+|+.+++.++||||+++++++.+.+.
T Consensus 4 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~v~~K~~~~~~-~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~ 82 (283)
T cd05048 4 LSAVRFLEELGEGAFGKVYKGELTGPNERLSATSVAIKTLKENA-EPKVQQEFRQEAELMSDLQHPNIVCLLGVCTKEQP 82 (283)
T ss_pred hHHcchhhcccCccCCcEEEEEEecCCCCcceeeEEEEecccCC-CHHHHHHHHHHHHHHHhcCCcccceEEEEEcCCCc
Confidence 367999999999999999999876655 679999886443 33445668899999999999999999999998899
Q ss_pred EEEEEecCCCccHHHHhcCC----------------CCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEEccCCc
Q psy758 76 LHLVFEFCDHTVLNELENHP----------------HGLPWDLIKQITWQVLRGVSYCHRHACIHRDIKPENILLTANGV 139 (292)
Q Consensus 76 ~~iv~e~~~~~~L~~~~~~~----------------~~~~~~~~~~i~~qi~~aL~~LH~~givH~dl~p~Nilv~~~~~ 139 (292)
.++++||+++++|.+++... ..+++..++.++.|++.||.|||++|++|+||+|+||++++++.
T Consensus 83 ~~~~~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~al~~lH~~~i~H~dlkp~Nil~~~~~~ 162 (283)
T cd05048 83 TCMLFEYLAHGDLHEFLVRNSPHSDVGAESGDETVKSSLDCSDFLHIAIQIAAGMEYLSSHHFVHRDLAARNCLVGEGLT 162 (283)
T ss_pred eEEEEecCCCCcHHHHHHhcCCCcccccccccccccCCCCHHHHHHHHHHHHHHHHHHHhCCeeccccccceEEEcCCCc
Confidence 99999999999999988653 45788999999999999999999999999999999999999999
Q ss_pred EEEeecCchhhhhccc-------cccccccccccccccCCCCCCCcccceeeecCCCCCCchHHHHHHHhhc-ccCCCCC
Q psy758 140 VKLCDFGFARLIRDLI-------PRHLHIFQTNEYFKGVSLPHAENVVPLEIKIGKPAATNIYLIDFLKRCL-DKDPLRR 211 (292)
Q Consensus 140 ~kl~dfg~~~~~~~~~-------~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~p~~~ 211 (292)
++|+|||++....... ...+..|.+||...+.......++|++ +..+++.+. +..|+..
T Consensus 163 ~~L~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDv~sl-------------G~il~el~~~g~~p~~~ 229 (283)
T cd05048 163 VKISDFGLSRDIYSADYYRVQSKSLLPVRWMPPEAILYGKFTTESDIWSF-------------GVVLWEIFSYGLQPYYG 229 (283)
T ss_pred EEECCCcceeeccccccccccCCCcccccccCHHHhccCcCchhhhHHHH-------------HHHHHHHHcCCCCCCCC
Confidence 9999999986543211 111233666666544333222222222 222333322 3344433
Q ss_pred CChhhhhhccCcC-CCCCCCCCccchHHHHhcccCcCCCCCCChhhhhhC
Q psy758 212 WSCDQLLRHPYFN-GYYFEVPDEMQYEEITQRCLDKDPLRRWSCDQLLRH 260 (292)
Q Consensus 212 ~~~~~~~~~~~~~-~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~~il~h 260 (292)
.+..++.....-. ....+...+.++.+|+.+||+.||.+|||+++|+++
T Consensus 230 ~~~~~~~~~i~~~~~~~~~~~~~~~~~~l~~~c~~~~p~~Rp~~~~i~~~ 279 (283)
T cd05048 230 FSNQEVIEMIRSRQLLPCPEDCPARVYALMIECWNEIPARRPRFKDIHTR 279 (283)
T ss_pred CCHHHHHHHHHcCCcCCCcccCCHHHHHHHHHHccCChhhCcCHHHHHHH
Confidence 3333332211000 112234457899999999999999999999999884
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimer |
| >cd06618 PKc_MKK7 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.7e-36 Score=245.20 Aligned_cols=249 Identities=25% Similarity=0.425 Sum_probs=178.3
Q ss_pred CcccceeeeecccCceEEEEEEEcCCCcEEEEEEeccCCCChHHHHHHHHHHHHHHhC-CCCCcchhhhhhhcCCeEEEE
Q psy758 1 MERYEKIGKLGEGSYGVVFKCRNRDTGQVVAIKKFLESEEDPLIRKIALREIRLLKSL-KHPNLVNLLEVFRRKKKLHLV 79 (292)
Q Consensus 1 ~~~y~~~~~l~~g~~~~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~e~~~~~~l-~~~~i~~~~~~~~~~~~~~iv 79 (292)
+++|++.+.||+|++|.||+|.+..+++.|++|.+....... ....+..|+..+... .||||+++++++.+....|++
T Consensus 14 ~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~~~-~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~~v 92 (296)
T cd06618 14 LNDLENLGEIGSGTCGQVYKMRFKKTGHVMAVKQMRRTGNKE-ENKRILMDLDVVLKSHDCPYIVKCYGYFITDSDVFIC 92 (296)
T ss_pred cchheeeeEeeccCCeEEEEEEECCCCeEEEEEEEeccCChH-HHHHHHHHHHHHHhccCCCchHhhheeeecCCeEEEE
Confidence 468999999999999999999999999999999987654333 334455677666666 499999999999999999999
Q ss_pred EecCCCccHHHHhc-CCCCCCHHHHHHHHHHHHHHHHHHHh-CCccccCCCCCceEEccCCcEEEeecCchhhhhcccc-
Q psy758 80 FEFCDHTVLNELEN-HPHGLPWDLIKQITWQVLRGVSYCHR-HACIHRDIKPENILLTANGVVKLCDFGFARLIRDLIP- 156 (292)
Q Consensus 80 ~e~~~~~~L~~~~~-~~~~~~~~~~~~i~~qi~~aL~~LH~-~givH~dl~p~Nilv~~~~~~kl~dfg~~~~~~~~~~- 156 (292)
+||+++ ++..+.. ....+++..+..++.|++.||+|||+ .|++|+||+|+||++++++.++|+|||++........
T Consensus 93 ~e~~~~-~l~~l~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~i~H~dl~p~nill~~~~~~kL~dfg~~~~~~~~~~~ 171 (296)
T cd06618 93 MELMST-CLDKLLKRIQGPIPEDILGKMTVAIVKALHYLKEKHGVIHRDVKPSNILLDASGNVKLCDFGISGRLVDSKAK 171 (296)
T ss_pred eeccCc-CHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhhCCEecCCCcHHHEEEcCCCCEEECccccchhccCCCcc
Confidence 999876 4444443 34578999999999999999999997 5999999999999999999999999999876543211
Q ss_pred ---ccccccccccccccCC---------CCCCCcccceeeecCCCCCCch-HHHHHHHhhcccCCCCCCChhhhhhccCc
Q psy758 157 ---RHLHIFQTNEYFKGVS---------LPHAENVVPLEIKIGKPAATNI-YLIDFLKRCLDKDPLRRWSCDQLLRHPYF 223 (292)
Q Consensus 157 ---~~~~~~~~~~~~~~~~---------~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~p~~~~~~~~~~~~~~~ 223 (292)
.....|.+||...+.. ..|+.|+..+++.+|..++... .....+...+... .
T Consensus 172 ~~~~~~~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~---------------~ 236 (296)
T cd06618 172 TRSAGCAAYMAPERIDPPDPNPKYDIRADVWSLGISLVELATGQFPYKNCKTEFEVLTKILQEE---------------P 236 (296)
T ss_pred cCCCCCccccCHhhcCCCCCccccccchhHHHHHHHHHHHHhCCCCCCcchhHHHHHHHHhcCC---------------C
Confidence 1223456666654332 2233444444444444432210 0011111111110 0
Q ss_pred CCCCCCCCCccchHHHHhcccCcCCCCCCChhhhhhCCcccce
Q psy758 224 NGYYFEVPDEMQYEEITQRCLDKDPLRRWSCDQLLRHPYFNGY 266 (292)
Q Consensus 224 ~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~~il~h~w~~~~ 266 (292)
.........+.++.+||.+||+.||.+|||++++++||||...
T Consensus 237 ~~~~~~~~~~~~l~~li~~~l~~~p~~Rp~~~~il~~~~~~~~ 279 (296)
T cd06618 237 PSLPPNEGFSPDFCSFVDLCLTKDHRKRPKYRELLQHPFIRRY 279 (296)
T ss_pred CCCCCCCCCCHHHHHHHHHHccCChhhCCCHHHHhcChhhhcc
Confidence 0011111346789999999999999999999999999999963
|
Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates it |
| >cd06634 STKc_TAO2 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6e-36 Score=246.28 Aligned_cols=247 Identities=28% Similarity=0.399 Sum_probs=182.6
Q ss_pred cccceeeeecccCceEEEEEEEcCCCcEEEEEEeccCC-CChHHHHHHHHHHHHHHhCCCCCcchhhhhhhcCCeEEEEE
Q psy758 2 ERYEKIGKLGEGSYGVVFKCRNRDTGQVVAIKKFLESE-EDPLIRKIALREIRLLKSLKHPNLVNLLEVFRRKKKLHLVF 80 (292)
Q Consensus 2 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~v~iK~~~~~~-~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~iv~ 80 (292)
++|+..+.||+|++|.||+|++..+++.+++|.+.... ........+.+|+.+++.++|+|++++++++...+..++|+
T Consensus 15 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 94 (308)
T cd06634 15 KLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLVM 94 (308)
T ss_pred HHHHHHHheeeCCCEEEEEEEEcCCCcEEEEEEEecccccChHHHHHHHHHHHHHHhCCCCCcccEEEEEEcCCeeEEEE
Confidence 35788899999999999999999999999999986543 23344556778999999999999999999999999999999
Q ss_pred ecCCCccHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEEccCCcEEEeecCchhhhhccc-cccc
Q psy758 81 EFCDHTVLNELENHPHGLPWDLIKQITWQVLRGVSYCHRHACIHRDIKPENILLTANGVVKLCDFGFARLIRDLI-PRHL 159 (292)
Q Consensus 81 e~~~~~~L~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~givH~dl~p~Nilv~~~~~~kl~dfg~~~~~~~~~-~~~~ 159 (292)
||+.++.+..+......+++..+..++.|++.||.|||++|++|+||+|+||+++.++.++|+|||++....... ...+
T Consensus 95 e~~~~~l~~~~~~~~~~l~~~~~~~~~~~l~~~l~~LH~~~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~ 174 (308)
T cd06634 95 EYCLGSASDLLEVHKKPLQEVEIAAVTHGALQGLAYLHSHNMIHRDVKAGNILLSEPGLVKLGDFGSASIMAPANXFVGT 174 (308)
T ss_pred EccCCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHhEEECCCCcEEECCcccceeecCcccccCC
Confidence 999865444444445568999999999999999999999999999999999999999999999999886554321 1223
Q ss_pred ccccccccccc--------CCCCCCCcccceeeecCCCCCCchHHHHHHHhhcccCCCCCCChhhhhhccCcCC--CCCC
Q psy758 160 HIFQTNEYFKG--------VSLPHAENVVPLEIKIGKPAATNIYLIDFLKRCLDKDPLRRWSCDQLLRHPYFNG--YYFE 229 (292)
Q Consensus 160 ~~~~~~~~~~~--------~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~--~~~~ 229 (292)
..|.+||...+ ....|+.|+..+++.+|.. |.......+...+..... ....
T Consensus 175 ~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~------------------p~~~~~~~~~~~~~~~~~~~~~~~ 236 (308)
T cd06634 175 PYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKP------------------PLFNMNAMSALYHIAQNESPALQS 236 (308)
T ss_pred ccccCHHHHhhcccCCCCcccchHHHHHHHHHHHcCCC------------------CCccccHHHHHHHHhhcCCCCcCc
Confidence 44666666431 1223333433344444443 332222221111100000 0112
Q ss_pred CCCccchHHHHhcccCcCCCCCCChhhhhhCCcccce
Q psy758 230 VPDEMQYEEITQRCLDKDPLRRWSCDQLLRHPYFNGY 266 (292)
Q Consensus 230 ~~~~~~l~~li~~~l~~dP~~Rpt~~~il~h~w~~~~ 266 (292)
...+..+.+||.+||+.+|.+||+++++++|||+...
T Consensus 237 ~~~~~~~~~li~~cl~~~P~~Rp~~~~ll~~~~~~~~ 273 (308)
T cd06634 237 GHWSEYFRNFVDSCLQKIPQDRPTSEVLLKHRFVLRE 273 (308)
T ss_pred ccccHHHHHHHHHHhhCCcccCCCHHHHhhCcccccc
Confidence 2346789999999999999999999999999999983
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activatin |
| >cd08216 PK_STRAD Pseudokinase domain of STE20-related kinase adapter protein | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-35 Score=245.42 Aligned_cols=254 Identities=22% Similarity=0.266 Sum_probs=178.7
Q ss_pred CceEEEEEEEcCCCcEEEEEEeccCCCChHHHHHHHHHHHHHHhCCCCCcchhhhhhhcCCeEEEEEecCCCccHHHHhc
Q psy758 14 SYGVVFKCRNRDTGQVVAIKKFLESEEDPLIRKIALREIRLLKSLKHPNLVNLLEVFRRKKKLHLVFEFCDHTVLNELEN 93 (292)
Q Consensus 14 ~~~~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~iv~e~~~~~~L~~~~~ 93 (292)
+++.||.+++..+++.||+|++..........+.+.+|+.+++.++||||+++++++.+.+..++++||+++++|..++.
T Consensus 12 ~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~~i~~~~~~~~~~~~~~~~~e~~~~~~l~~~l~ 91 (314)
T cd08216 12 DLMIVHLAKHKPTNTLVAVKKINLDSCSKEDLKLLQQEIITSRQLQHPNILPYVTSFIVDSELYVVSPLMAYGSCEDLLK 91 (314)
T ss_pred CCceEEEEEecCCCCEEEEEEEeccccchhHHHHHHHHHHHHHhcCCcchhhhhheeecCCeEEEEEeccCCCCHHHHHH
Confidence 44667777777789999999998765555667789999999999999999999999999999999999999999999886
Q ss_pred C--CCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEEccCCcEEEeecCchhhhhcccc------------ccc
Q psy758 94 H--PHGLPWDLIKQITWQVLRGVSYCHRHACIHRDIKPENILLTANGVVKLCDFGFARLIRDLIP------------RHL 159 (292)
Q Consensus 94 ~--~~~~~~~~~~~i~~qi~~aL~~LH~~givH~dl~p~Nilv~~~~~~kl~dfg~~~~~~~~~~------------~~~ 159 (292)
. ...+++..+..++.|++.||+|||++||+|+||+|+||+++.++.++|+||+.+........ ...
T Consensus 92 ~~~~~~~~~~~~~~~~~~l~~~L~~LH~~~ivH~dlk~~Nili~~~~~~kl~d~~~~~~~~~~~~~~~~~~~~~~~~~~~ 171 (314)
T cd08216 92 THFPEGLPELAIAFILKDVLNALDYIHSKGFIHRSVKASHILLSGDGKVVLSGLRYSVSMIKHGKRQRVVHDFPKSSVKN 171 (314)
T ss_pred HhcccCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCcceEEEecCCceEEecCccceeecccccccccccccccccccc
Confidence 4 24589999999999999999999999999999999999999999999999998764432111 112
Q ss_pred cccccccccccC-------CCCCCCcccceeeecCCCCCCchHHH-HHHHhhcccCC---------CCCCChhhh-----
Q psy758 160 HIFQTNEYFKGV-------SLPHAENVVPLEIKIGKPAATNIYLI-DFLKRCLDKDP---------LRRWSCDQL----- 217 (292)
Q Consensus 160 ~~~~~~~~~~~~-------~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~p---------~~~~~~~~~----- 217 (292)
..|.+||...+. ...|+.|+..+++.+|..++...... ..+....+..+ .......+.
T Consensus 172 ~~y~aPE~~~~~~~~~~~~~Diws~G~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 251 (314)
T cd08216 172 LPWLSPEVLQQNLQGYNEKSDIYSVGITACELANGHVPFKDMPATQMLLEKVRGTVPCLLDKSTYPLYEDSMSQSRSSNE 251 (314)
T ss_pred ccccCHHHhcCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhccCccccccCchhhhcCCcCccccccc
Confidence 235666654331 23455555555566666554332211 11121111100 000000000
Q ss_pred -hhccCcCCCCCCCCCccchHHHHhcccCcCCCCCCChhhhhhCCccccee
Q psy758 218 -LRHPYFNGYYFEVPDEMQYEEITQRCLDKDPLRRWSCDQLLRHPYFNGYY 267 (292)
Q Consensus 218 -~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~~il~h~w~~~~~ 267 (292)
...............+..+.+|+.+||..||++|||++++++||||+...
T Consensus 252 ~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~~p~~~~~~ 302 (314)
T cd08216 252 HPNNRDSVDHPYTRTFSEHFHQFVELCLQRDPESRPSASQLLNHSFFKQCK 302 (314)
T ss_pred ccchhhhhhcchhhHHHHHHHHHHHHHhhcCCCcCcCHHHHhcCchHhhhc
Confidence 00000000011112245688999999999999999999999999999765
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) subfamily, pseudokinase domain. The STRAD subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buc |
| >cd08224 STKc_Nek6_Nek7 Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-35 Score=238.84 Aligned_cols=246 Identities=26% Similarity=0.367 Sum_probs=183.1
Q ss_pred CcccceeeeecccCceEEEEEEEcCCCcEEEEEEeccCC-CChHHHHHHHHHHHHHHhCCCCCcchhhhhhhcCCeEEEE
Q psy758 1 MERYEKIGKLGEGSYGVVFKCRNRDTGQVVAIKKFLESE-EDPLIRKIALREIRLLKSLKHPNLVNLLEVFRRKKKLHLV 79 (292)
Q Consensus 1 ~~~y~~~~~l~~g~~~~v~~~~~~~~~~~v~iK~~~~~~-~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~iv 79 (292)
+++|++.+.||+|++|.||+|.+..+|+.|++|.+.... ......+.+.+|+++++.++|++++++++++.+.+..+++
T Consensus 1 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~ei~~l~~~~~~~i~~~~~~~~~~~~~~lv 80 (267)
T cd08224 1 LGNFKIEKKIGKGQFSVVYKAICLLDGRVVALKKVQIFEMMDAKARQDCLKEIDLLKQLDHPNVIKYLASFIENNELNIV 80 (267)
T ss_pred CCceeeeeeeccCCceEEEEEEEcCCCCEEEEEEeecccccchhhHHHHHHHHHHHHhCCCCCeeeeeeeeecCCeEEEE
Confidence 478999999999999999999999899999999987544 3333467788999999999999999999999999999999
Q ss_pred EecCCCccHHHHhcC----CCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEEccCCcEEEeecCchhhhhccc
Q psy758 80 FEFCDHTVLNELENH----PHGLPWDLIKQITWQVLRGVSYCHRHACIHRDIKPENILLTANGVVKLCDFGFARLIRDLI 155 (292)
Q Consensus 80 ~e~~~~~~L~~~~~~----~~~~~~~~~~~i~~qi~~aL~~LH~~givH~dl~p~Nilv~~~~~~kl~dfg~~~~~~~~~ 155 (292)
+||+++++|..++.. ...+++..++.++.|++.||.+||+.|++|+||+|+||+++.++.++|+|||++.......
T Consensus 81 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~i~h~dl~p~nil~~~~~~~~l~d~~~~~~~~~~~ 160 (267)
T cd08224 81 LELADAGDLSRMIKHFKKQKRLIPERTIWKYFVQLCSALEHMHSKRIMHRDIKPANVFITATGVVKLGDLGLGRFFSSKT 160 (267)
T ss_pred EecCCCCCHHHHHHHhcccCCCcCHHHHHHHHHHHHHHHHHHHhCCEecCCcChhhEEECCCCcEEEeccceeeeccCCC
Confidence 999999999988743 3458999999999999999999999999999999999999999999999999986543221
Q ss_pred -----cccccccccccccccCCCCCCCcccceeeecCCCCCCchHHHHHHHhhcccCCCCCC--ChhhhhhccCcCC-CC
Q psy758 156 -----PRHLHIFQTNEYFKGVSLPHAENVVPLEIKIGKPAATNIYLIDFLKRCLDKDPLRRW--SCDQLLRHPYFNG-YY 227 (292)
Q Consensus 156 -----~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~--~~~~~~~~~~~~~-~~ 227 (292)
......|.+||...+.......++|++ +.-++..+.+..|.... +..+......... ..
T Consensus 161 ~~~~~~~~~~~y~apE~~~~~~~~~~~Di~sl-------------G~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~ 227 (267)
T cd08224 161 TAAHSLVGTPYYMSPERIHENGYNFKSDIWSL-------------GCLLYEMAALQSPFYGDKMNLYSLCKKIEKCDYPP 227 (267)
T ss_pred cccceecCCccccCHHHhccCCCCchhcHHHH-------------HHHHHHHHHCCCCcccCCccHHHHHhhhhcCCCCC
Confidence 122334666766555443333333333 22233333333333221 1111111110000 01
Q ss_pred CCC-CCccchHHHHhcccCcCCCCCCChhhhhh
Q psy758 228 FEV-PDEMQYEEITQRCLDKDPLRRWSCDQLLR 259 (292)
Q Consensus 228 ~~~-~~~~~l~~li~~~l~~dP~~Rpt~~~il~ 259 (292)
.+. ..+..+.++|.+||..+|++|||+.+|++
T Consensus 228 ~~~~~~~~~~~~~i~~cl~~~p~~Rp~~~~il~ 260 (267)
T cd08224 228 LPADHYSEELRDLVSRCINPDPEKRPDISYVLQ 260 (267)
T ss_pred CChhhcCHHHHHHHHHHcCCCcccCCCHHHHHH
Confidence 111 34668999999999999999999999886
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may a |
| >PRK13184 pknD serine/threonine-protein kinase; Reviewed | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-36 Score=269.38 Aligned_cols=246 Identities=23% Similarity=0.298 Sum_probs=178.8
Q ss_pred CcccceeeeecccCceEEEEEEEcCCCcEEEEEEeccCC-CChHHHHHHHHHHHHHHhCCCCCcchhhhhhhcCCeEEEE
Q psy758 1 MERYEKIGKLGEGSYGVVFKCRNRDTGQVVAIKKFLESE-EDPLIRKIALREIRLLKSLKHPNLVNLLEVFRRKKKLHLV 79 (292)
Q Consensus 1 ~~~y~~~~~l~~g~~~~v~~~~~~~~~~~v~iK~~~~~~-~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~iv 79 (292)
|++|++.+.||+|++|.||+|.+..+++.||+|++.... ......+.+.+|+.+++.++||||+++++++.+++..+++
T Consensus 1 igrYeIi~~LGkGgfG~VYlA~d~~tg~~VAIK~I~~~l~~~e~~~~rflrEi~ILs~L~HPNIVkl~~v~~d~~~lyLV 80 (932)
T PRK13184 1 MQRYDIIRLIGKGGMGEVYLAYDPVCSRRVALKKIREDLSENPLLKKRFLREAKIAADLIHPGIVPVYSICSDGDPVYYT 80 (932)
T ss_pred CCCeEEEEEEecCCCEEEEEEEECCCCcEEEEEEECcccccCHHHHHHHHHHHHHHHhCCCcCcCeEEEEEeeCCEEEEE
Confidence 689999999999999999999999999999999997543 3344567788999999999999999999999999999999
Q ss_pred EecCCCccHHHHhcCC-----------CCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEEccCCcEEEeecCch
Q psy758 80 FEFCDHTVLNELENHP-----------HGLPWDLIKQITWQVLRGVSYCHRHACIHRDIKPENILLTANGVVKLCDFGFA 148 (292)
Q Consensus 80 ~e~~~~~~L~~~~~~~-----------~~~~~~~~~~i~~qi~~aL~~LH~~givH~dl~p~Nilv~~~~~~kl~dfg~~ 148 (292)
|||++|++|.+++... ...+...+..++.||+.||+|||++||+||||||+||+++.++.++|+|||++
T Consensus 81 MEY~eGGSL~~lL~s~~~~~~l~e~~~~~lsv~~iL~I~~QIa~AL~yLHs~GIIHRDLKPeNILLd~dg~vKLiDFGLA 160 (932)
T PRK13184 81 MPYIEGYTLKSLLKSVWQKESLSKELAEKTSVGAFLSIFHKICATIEYVHSKGVLHRDLKPDNILLGLFGEVVILDWGAA 160 (932)
T ss_pred EEcCCCCCHHHHHHHhhhccccchhhhcccCHHHHHHHHHHHHHHHHHHHHCCccccCCchheEEEcCCCCEEEEecCcc
Confidence 9999999999987531 23456778899999999999999999999999999999999999999999998
Q ss_pred hhhhccc-----------------------cccccccccccccccCCCCCCCcccceeeecCCCCCCchHHHHHHHhhcc
Q psy758 149 RLIRDLI-----------------------PRHLHIFQTNEYFKGVSLPHAENVVPLEIKIGKPAATNIYLIDFLKRCLD 205 (292)
Q Consensus 149 ~~~~~~~-----------------------~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 205 (292)
....... ..++..|.+||...+.......|+ ++.+..+++.+.+
T Consensus 161 k~i~~~~~~~~~l~~~~~~s~~s~~t~~g~~vGT~~YmAPE~l~g~~~S~kSDI-------------WSLGVILyELLTG 227 (932)
T PRK13184 161 IFKKLEEEDLLDIDVDERNICYSSMTIPGKIVGTPDYMAPERLLGVPASESTDI-------------YALGVILYQMLTL 227 (932)
T ss_pred eecccccccccccccccccccccccccCCCCCCCCCCCCHHHhcCCCCCcHhHH-------------HHHHHHHHHHHHC
Confidence 7652100 012334555555444332222222 2223333444444
Q ss_pred cCCCCCCChhhhhhccCcC---CCCCCCCCccchHHHHhcccCcCCCCCCChhhhhh
Q psy758 206 KDPLRRWSCDQLLRHPYFN---GYYFEVPDEMQYEEITQRCLDKDPLRRWSCDQLLR 259 (292)
Q Consensus 206 ~~p~~~~~~~~~~~~~~~~---~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~~il~ 259 (292)
..|........+....... ........+..+.+++.+||+.||++||+..+.+.
T Consensus 228 ~~PF~~~~~~ki~~~~~i~~P~~~~p~~~iP~~L~~LI~rcL~~DP~kR~ss~eeLl 284 (932)
T PRK13184 228 SFPYRRKKGRKISYRDVILSPIEVAPYREIPPFLSQIAMKALAVDPAERYSSVQELK 284 (932)
T ss_pred CCCCCCcchhhhhhhhhccChhhccccccCCHHHHHHHHHHccCChhhCcCHHHHHH
Confidence 4444332222211111000 00111245678999999999999999987665554
|
|
| >cd06653 STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-35 Score=239.39 Aligned_cols=248 Identities=25% Similarity=0.350 Sum_probs=185.5
Q ss_pred cccceeeeecccCceEEEEEEEcCCCcEEEEEEeccCC---CChHHHHHHHHHHHHHHhCCCCCcchhhhhhhc--CCeE
Q psy758 2 ERYEKIGKLGEGSYGVVFKCRNRDTGQVVAIKKFLESE---EDPLIRKIALREIRLLKSLKHPNLVNLLEVFRR--KKKL 76 (292)
Q Consensus 2 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~v~iK~~~~~~---~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~--~~~~ 76 (292)
..|.+.+.||+|++|.||+|.+..+++.|++|.+.... ........+.+|+.+++.++|+||+++++.+.+ .+.+
T Consensus 2 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~~~~ 81 (264)
T cd06653 2 VNWRLGKLLGRGAFGEVYLCYDADTGRELAVKQVPFDPDSQETSKEVNALECEIQLLKNLRHDRIVQYYGCLRDPEEKKL 81 (264)
T ss_pred CceeeeeeEccCCCeEEEEEEEcCCCCEEEEEEEecCcccchhhHHHHHHHHHHHHHHHcCCCCcceEEEEEEcCCCCEE
Confidence 47999999999999999999999999999999875432 233455678899999999999999999998865 3568
Q ss_pred EEEEecCCCccHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEEccCCcEEEeecCchhhhhccc-
Q psy758 77 HLVFEFCDHTVLNELENHPHGLPWDLIKQITWQVLRGVSYCHRHACIHRDIKPENILLTANGVVKLCDFGFARLIRDLI- 155 (292)
Q Consensus 77 ~iv~e~~~~~~L~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~givH~dl~p~Nilv~~~~~~kl~dfg~~~~~~~~~- 155 (292)
++++||+++++|.+++...+.+++..+..++.|++.||.|||++|++|+||+|+||++++++.++|+|||++.......
T Consensus 82 ~~v~e~~~~~~L~~~~~~~~~l~~~~~~~~~~~i~~al~~LH~~~i~H~dl~p~ni~i~~~~~~~l~dfg~~~~~~~~~~ 161 (264)
T cd06653 82 SIFVEYMPGGSIKDQLKAYGALTENVTRRYTRQILQGVSYLHSNMIVHRDIKGANILRDSAGNVKLGDFGASKRIQTICM 161 (264)
T ss_pred EEEEEeCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEEcCCCCEEECccccccccccccc
Confidence 9999999999999988776678999999999999999999999999999999999999999999999999987653211
Q ss_pred -------cccccccccccccccCCCCCCCcccceeeecCCCCCCchHHHHHHHhhcccCCCCCCChhhhhhccCcCC--C
Q psy758 156 -------PRHLHIFQTNEYFKGVSLPHAENVVPLEIKIGKPAATNIYLIDFLKRCLDKDPLRRWSCDQLLRHPYFNG--Y 226 (292)
Q Consensus 156 -------~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~--~ 226 (292)
......|.+||+..+.......++ ++.+.-++..+.+..|.......+......... .
T Consensus 162 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di-------------~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~ 228 (264)
T cd06653 162 SGTGIKSVTGTPYWMSPEVISGEGYGRKADV-------------WSVACTVVEMLTEKPPWAEYEAMAAIFKIATQPTKP 228 (264)
T ss_pred cCccccccCCcccccCHhhhcCCCCCccccH-------------HHHHHHHHHHHhCCCCCCccCHHHHHHHHHcCCCCC
Confidence 112234566666544333222222 222223333344444444433222222211111 1
Q ss_pred CCCCCCccchHHHHhcccCcCCCCCCChhhhhhCCcc
Q psy758 227 YFEVPDEMQYEEITQRCLDKDPLRRWSCDQLLRHPYF 263 (292)
Q Consensus 227 ~~~~~~~~~l~~li~~~l~~dP~~Rpt~~~il~h~w~ 263 (292)
..+...+..+.++|.+||. +|..|||+.++++|||.
T Consensus 229 ~~p~~~~~~~~~~i~~~l~-~~~~r~~~~~~~~~~~~ 264 (264)
T cd06653 229 MLPDGVSDACRDFLKQIFV-EEKRRPTAEFLLRHPFV 264 (264)
T ss_pred CCCcccCHHHHHHHHHHhc-CcccCccHHHHhcCCCC
Confidence 2344557789999999999 57999999999999984
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phospho |
| >cd07857 STKc_MPK1 Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-36 Score=251.47 Aligned_cols=262 Identities=27% Similarity=0.400 Sum_probs=186.5
Q ss_pred ccceeeeecccCceEEEEEEEcCC--CcEEEEEEeccCCCChHHHHHHHHHHHHHHhC-CCCCcchhhhhhh----cCCe
Q psy758 3 RYEKIGKLGEGSYGVVFKCRNRDT--GQVVAIKKFLESEEDPLIRKIALREIRLLKSL-KHPNLVNLLEVFR----RKKK 75 (292)
Q Consensus 3 ~y~~~~~l~~g~~~~v~~~~~~~~--~~~v~iK~~~~~~~~~~~~~~~~~e~~~~~~l-~~~~i~~~~~~~~----~~~~ 75 (292)
+|++.+.||+|++|.||++.+..+ +..||+|.+..........+.+.+|+.+++.+ .||||+++++... ....
T Consensus 1 ~y~~~~~lg~G~~g~vy~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~~~ 80 (332)
T cd07857 1 RYELIKELGQGAYGIVCSARNAETSEEETVAIKKITNVFSKKILAKRALRELKLLRHFRGHKNITCLYDMDIVFPGNFNE 80 (332)
T ss_pred CceEEEEccccCCeEEEEEEeCCCCcCceEEEEEeccccccchhHHHHHHHHHHHHHhcCCCChheeeeeeeeccccCCc
Confidence 589999999999999999999888 88999999875544444456678899999999 5999999998643 2345
Q ss_pred EEEEEecCCCccHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEEccCCcEEEeecCchhhhhccc
Q psy758 76 LHLVFEFCDHTVLNELENHPHGLPWDLIKQITWQVLRGVSYCHRHACIHRDIKPENILLTANGVVKLCDFGFARLIRDLI 155 (292)
Q Consensus 76 ~~iv~e~~~~~~L~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~givH~dl~p~Nilv~~~~~~kl~dfg~~~~~~~~~ 155 (292)
++++++++++ +|..++.....+++..++.++.||+.||.|||++|++|+||+|+||++++++.++|+|||.+.......
T Consensus 81 ~~~~~e~~~~-~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~givH~dlkp~Nili~~~~~~kl~Dfg~a~~~~~~~ 159 (332)
T cd07857 81 LYLYEELMEA-DLHQIIRSGQPLTDAHFQSFIYQILCGLKYIHSANVLHRDLKPGNLLVNADCELKICDFGLARGFSENP 159 (332)
T ss_pred EEEEEecccC-CHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHeEEcCCCCEEeCcCCCceeccccc
Confidence 7889999874 677777766789999999999999999999999999999999999999999999999999987654211
Q ss_pred c---------ccccccccccccccC------CCCCCCcccceeeecCCCCCCchHHHHHHHhh---cccCCCCCC-----
Q psy758 156 P---------RHLHIFQTNEYFKGV------SLPHAENVVPLEIKIGKPAATNIYLIDFLKRC---LDKDPLRRW----- 212 (292)
Q Consensus 156 ~---------~~~~~~~~~~~~~~~------~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~---~~~~p~~~~----- 212 (292)
. .++..|.+||...+. ...|+.|+..+.+..+.+++........+... ++..+....
T Consensus 160 ~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~Di~slGv~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 239 (332)
T cd07857 160 GENAGFMTEYVATRWYRAPEIMLSFQSYTKAIDVWSVGCILAELLGRKPVFKGKDYVDQLNQILQVLGTPDEETLSRIGS 239 (332)
T ss_pred ccccccccCcccCccccCcHHHhCCCCCCcHHHHHHHHHHHHHHHhCCcCCCCCCHHHHHHHHHHHhCCCCHHHHHhhhh
Confidence 1 123446777765432 23456666666666666655433322222221 121111000
Q ss_pred -Chhhhhhc-cCcCCC---CCCCCCccchHHHHhcccCcCCCCCCChhhhhhCCcccc
Q psy758 213 -SCDQLLRH-PYFNGY---YFEVPDEMQYEEITQRCLDKDPLRRWSCDQLLRHPYFNG 265 (292)
Q Consensus 213 -~~~~~~~~-~~~~~~---~~~~~~~~~l~~li~~~l~~dP~~Rpt~~~il~h~w~~~ 265 (292)
........ ...... ......+..+.+++.+||+.||.+|||+.+++.||||..
T Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~~ll~~~~~~~ 297 (332)
T cd07857 240 PKAQNYIRSLPNIPKKPFESIFPNANPLALDLLEKLLAFDPTKRISVEEALEHPYLAI 297 (332)
T ss_pred hhHHHHHHhccccCCcchHhhCCCCCHHHHHHHHHHccCCcccCCCHHHHhcChhhhh
Confidence 00000000 000000 001123668999999999999999999999999999976
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall co |
| >cd07856 STKc_Sty1_Hog1 Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.8e-36 Score=247.74 Aligned_cols=264 Identities=28% Similarity=0.441 Sum_probs=190.1
Q ss_pred cccceeeeecccCceEEEEEEEcCCCcEEEEEEeccCCCChHHHHHHHHHHHHHHhCCCCCcchhhhhhhc-CCeEEEEE
Q psy758 2 ERYEKIGKLGEGSYGVVFKCRNRDTGQVVAIKKFLESEEDPLIRKIALREIRLLKSLKHPNLVNLLEVFRR-KKKLHLVF 80 (292)
Q Consensus 2 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~-~~~~~iv~ 80 (292)
++|++.+.||.|++|.||+|.+..+++.|++|.+..........+.+.+|+.+++.++||||+++++++.. .+..++++
T Consensus 10 ~~y~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~lv~ 89 (328)
T cd07856 10 NRYVDLQPVGMGAFGLVCSARDQLTGQNVAIKKIMKPFSTPVLAKRTYRELKLLKHLRHENIISLSDIFISPLEDIYFVT 89 (328)
T ss_pred cceEEEEeecccCCeEEEEEEECCCCCEEEEEEecccccccchhHHHHHHHHHHHhcCCCCeeeEeeeEecCCCcEEEEe
Confidence 58999999999999999999999999999999986554444455667789999999999999999999865 56789999
Q ss_pred ecCCCccHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEEccCCcEEEeecCchhhhhccc--ccc
Q psy758 81 EFCDHTVLNELENHPHGLPWDLIKQITWQVLRGVSYCHRHACIHRDIKPENILLTANGVVKLCDFGFARLIRDLI--PRH 158 (292)
Q Consensus 81 e~~~~~~L~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~givH~dl~p~Nilv~~~~~~kl~dfg~~~~~~~~~--~~~ 158 (292)
||++ ++|..+++.. .+++..+..++.|++.||.|||++|++|+||+|+||++++++.++|+|||.+....... ...
T Consensus 90 e~~~-~~L~~~~~~~-~~~~~~~~~~~~ql~~aL~~LH~~~iiH~dl~p~Nili~~~~~~~l~dfg~~~~~~~~~~~~~~ 167 (328)
T cd07856 90 ELLG-TDLHRLLTSR-PLEKQFIQYFLYQILRGLKYVHSAGVVHRDLKPSNILINENCDLKICDFGLARIQDPQMTGYVS 167 (328)
T ss_pred ehhc-cCHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEeECCCCCEEeCccccccccCCCcCCCcc
Confidence 9985 5677777653 68999999999999999999999999999999999999999999999999987543321 112
Q ss_pred cccccccccccc-C-----CCCCCCcccceeeecCCCCCCchH---HHHHHHhhcccCCCCCC------Chhhhhhc-cC
Q psy758 159 LHIFQTNEYFKG-V-----SLPHAENVVPLEIKIGKPAATNIY---LIDFLKRCLDKDPLRRW------SCDQLLRH-PY 222 (292)
Q Consensus 159 ~~~~~~~~~~~~-~-----~~~~~~~~~~~~~~~~~~~~~~~~---~~~~~~~~~~~~p~~~~------~~~~~~~~-~~ 222 (292)
...|.+||...+ . ...|+.|+..+++.+|.+++.... ....+...++..|.+-. ...+.... +.
T Consensus 168 ~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~tg~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 247 (328)
T cd07856 168 TRYYRAPEIMLTWQKYDVEVDIWSAGCIFAEMLEGKPLFPGKDHVNQFSIITDLLGTPPDDVINTICSENTLRFVQSLPK 247 (328)
T ss_pred cccccCceeeeccCCcCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHhccchhhHHHHhhccc
Confidence 334677776543 2 223555555666666665543221 12222233222221000 00000000 00
Q ss_pred cCCCC---CCCCCccchHHHHhcccCcCCCCCCChhhhhhCCccccee
Q psy758 223 FNGYY---FEVPDEMQYEEITQRCLDKDPLRRWSCDQLLRHPYFNGYY 267 (292)
Q Consensus 223 ~~~~~---~~~~~~~~l~~li~~~l~~dP~~Rpt~~~il~h~w~~~~~ 267 (292)
..... .....+..+.++|.+||+.||++|||+++++.||||....
T Consensus 248 ~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~ell~~~~~~~~~ 295 (328)
T cd07856 248 REPVPFSEKFKNADPSAIDLLEKMLVFDPQKRISAAEALAHPYLAPYH 295 (328)
T ss_pred cCCCcHHHHcCCCCHHHHHHHHHHcCCChhhCCCHHHHhcCCcccccc
Confidence 00000 0012367899999999999999999999999999998744
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and U |
| >KOG1187|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-36 Score=248.59 Aligned_cols=249 Identities=29% Similarity=0.427 Sum_probs=183.3
Q ss_pred cccceeeeecccCceEEEEEEEcCCCcEEEEEEeccCCCChHHHHHHHHHHHHHHhCCCCCcchhhhhhhcCC-eEEEEE
Q psy758 2 ERYEKIGKLGEGSYGVVFKCRNRDTGQVVAIKKFLESEEDPLIRKIALREIRLLKSLKHPNLVNLLEVFRRKK-KLHLVF 80 (292)
Q Consensus 2 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~-~~~iv~ 80 (292)
+.|.-...||+|+||.||+|.... +..||||.+....... ...|.+|+.++..++|||+++++|+|.+.+ ..++|+
T Consensus 75 ~~Fs~~~~ig~Ggfg~VYkG~l~~-~~~vAVK~~~~~~~~~--~~eF~~Ei~~ls~l~H~Nlv~LlGyC~e~~~~~~LVY 151 (361)
T KOG1187|consen 75 NNFSESNLIGEGGFGTVYKGVLSD-GTVVAVKRLSSNSGQG--EREFLNEVEILSRLRHPNLVKLLGYCLEGGEHRLLVY 151 (361)
T ss_pred hCCchhcceecCCCeEEEEEEECC-CCEEEEEEecCCCCcc--hhHHHHHHHHHhcCCCcCcccEEEEEecCCceEEEEE
Confidence 346666899999999999998865 4899999876655443 344999999999999999999999999888 599999
Q ss_pred ecCCCccHHHHhcCCC--CCCHHHHHHHHHHHHHHHHHHHhCC---ccccCCCCCceEEccCCcEEEeecCchhhhhc-c
Q psy758 81 EFCDHTVLNELENHPH--GLPWDLIKQITWQVLRGVSYCHRHA---CIHRDIKPENILLTANGVVKLCDFGFARLIRD-L 154 (292)
Q Consensus 81 e~~~~~~L~~~~~~~~--~~~~~~~~~i~~qi~~aL~~LH~~g---ivH~dl~p~Nilv~~~~~~kl~dfg~~~~~~~-~ 154 (292)
||+++|+|.+++.... .+++.++.+|+.++|+||+|||... |+||||||+|||+|.+..+||+|||+++.... .
T Consensus 152 Eym~nGsL~d~L~~~~~~~L~W~~R~kIa~g~A~gL~yLH~~~~~~iiHrDiKssNILLD~~~~aKlsDFGLa~~~~~~~ 231 (361)
T KOG1187|consen 152 EYMPNGSLEDHLHGKKGEPLDWETRLKIALGAARGLAYLHEGCPPPIIHRDIKSSNILLDEDFNAKLSDFGLAKLGPEGD 231 (361)
T ss_pred EccCCCCHHHHhCCCCCCCCCHHHHHHHHHHHHHHHHHHccCCCCCEecCCCCHHHeeECCCCCEEccCccCcccCCccc
Confidence 9999999999987755 7899999999999999999999954 99999999999999999999999999966543 2
Q ss_pred cc-----ccccccccccccccC-----CCCCCCcccceeeecCCCCCCch------HHHHHHHhhcccCCCCCCChhhhh
Q psy758 155 IP-----RHLHIFQTNEYFKGV-----SLPHAENVVPLEIKIGKPAATNI------YLIDFLKRCLDKDPLRRWSCDQLL 218 (292)
Q Consensus 155 ~~-----~~~~~~~~~~~~~~~-----~~~~~~~~~~~~~~~~~~~~~~~------~~~~~~~~~~~~~p~~~~~~~~~~ 218 (292)
.. .++..|.+|||.... ...+++|+..+++.+|..+.... .+.+....++... ...+++
T Consensus 232 ~~~~~~~~gt~gY~~PEy~~~g~lt~KsDVySFGVvllElitgr~~~d~~~~~~~~~l~~w~~~~~~~~-----~~~eii 306 (361)
T KOG1187|consen 232 TSVSTTVMGTFGYLAPEYASTGKLTEKSDVYSFGVVLLELITGRKAVDQSRPRGELSLVEWAKPLLEEG-----KLREIV 306 (361)
T ss_pred cceeeecCCCCccCChhhhccCCcCcccccccchHHHHHHHhCCcccCCCCCcccccHHHHHHHHHHCc-----chhhee
Confidence 21 455678899988653 34566666666666666422111 1222222222221 222222
Q ss_pred hccCcCCCCCCC-CCccchHHHHhcccCcCCCCCCChhhhhh
Q psy758 219 RHPYFNGYYFEV-PDEMQYEEITQRCLDKDPLRRWSCDQLLR 259 (292)
Q Consensus 219 ~~~~~~~~~~~~-~~~~~l~~li~~~l~~dP~~Rpt~~~il~ 259 (292)
...... ..... ..-..+..+..+|++.+|.+||++.||++
T Consensus 307 D~~l~~-~~~~~~~~~~~~~~~a~~C~~~~~~~RP~m~~Vv~ 347 (361)
T KOG1187|consen 307 DPRLKE-GEYPDEKEVKKLAELALRCLRPDPKERPTMSQVVK 347 (361)
T ss_pred CCCccC-CCCChHHHHHHHHHHHHHHcCcCCCcCcCHHHHHH
Confidence 221110 01110 11223567888999999999999999865
|
|
| >cd05114 PTKc_Tec_Rlk Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.8e-36 Score=238.82 Aligned_cols=241 Identities=26% Similarity=0.346 Sum_probs=176.1
Q ss_pred cccceeeeecccCceEEEEEEEcCCCcEEEEEEeccCCCChHHHHHHHHHHHHHHhCCCCCcchhhhhhhcCCeEEEEEe
Q psy758 2 ERYEKIGKLGEGSYGVVFKCRNRDTGQVVAIKKFLESEEDPLIRKIALREIRLLKSLKHPNLVNLLEVFRRKKKLHLVFE 81 (292)
Q Consensus 2 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~iv~e 81 (292)
++|++.+.||+|+||.||++.... +..+++|.+...... ...+.+|+.+++.++||||+++++++.+.+..+++||
T Consensus 4 ~~~~~~~~lg~G~~~~vy~~~~~~-~~~~a~K~~~~~~~~---~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~iv~e 79 (256)
T cd05114 4 SELTFMKELGSGQFGVVHLGKWRA-QIKVAIKAINEGAMS---EEDFIEEAKVMMKLSHPKLVQLYGVCTQQKPLYIVTE 79 (256)
T ss_pred HHcEEeeEecCCcCceEEEEEecc-CceEEEEecccCCcc---HHHHHHHHHHHHHCCCCCceeEEEEEccCCCEEEEEE
Confidence 579999999999999999998754 568999987644332 3457789999999999999999999999999999999
Q ss_pred cCCCccHHHHhcC-CCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEEccCCcEEEeecCchhhhhcccc----
Q psy758 82 FCDHTVLNELENH-PHGLPWDLIKQITWQVLRGVSYCHRHACIHRDIKPENILLTANGVVKLCDFGFARLIRDLIP---- 156 (292)
Q Consensus 82 ~~~~~~L~~~~~~-~~~~~~~~~~~i~~qi~~aL~~LH~~givH~dl~p~Nilv~~~~~~kl~dfg~~~~~~~~~~---- 156 (292)
|+++++|.+++.. .+.+++..++.++.|++.||+|||++|++|+||+|+||++++++.++|+|||.+........
T Consensus 80 ~~~~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~ni~i~~~~~~kl~d~g~~~~~~~~~~~~~~ 159 (256)
T cd05114 80 FMENGCLLNYLRQRQGKLSKDMLLSMCQDVCEGMEYLERNSFIHRDLAARNCLVSSTGVVKVSDFGMTRYVLDDEYTSSS 159 (256)
T ss_pred cCCCCcHHHHHHhCccCCCHHHHHHHHHHHHHHHHHHHHCCccccccCcceEEEcCCCeEEECCCCCccccCCCceeccC
Confidence 9999999998864 34689999999999999999999999999999999999999999999999998875432111
Q ss_pred --ccccccccccccccCCCCCCCcccceeeecCCCCCCchHHHHHHHhhc-ccCCCCCCChhhhhhccCc-CCCCCCCCC
Q psy758 157 --RHLHIFQTNEYFKGVSLPHAENVVPLEIKIGKPAATNIYLIDFLKRCL-DKDPLRRWSCDQLLRHPYF-NGYYFEVPD 232 (292)
Q Consensus 157 --~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~p~~~~~~~~~~~~~~~-~~~~~~~~~ 232 (292)
.....|.+||+..+.......++|++ +..++..+. +..|....+..+.+....- .....+...
T Consensus 160 ~~~~~~~y~aPE~~~~~~~~~~~Di~s~-------------G~~l~el~~~g~~p~~~~~~~~~~~~i~~~~~~~~~~~~ 226 (256)
T cd05114 160 GAKFPVKWSPPEVFNFSKYSSKSDVWSF-------------GVLMWEVFTEGKMPFEKKSNYEVVEMISRGFRLYRPKLA 226 (256)
T ss_pred CCCCchhhCChhhcccCccchhhhhHHH-------------HHHHHHHHcCCCCCCCCCCHHHHHHHHHCCCCCCCCCCC
Confidence 11123566666544333222222222 222223222 2333333222222211100 011123334
Q ss_pred ccchHHHHhcccCcCCCCCCChhhhhh
Q psy758 233 EMQYEEITQRCLDKDPLRRWSCDQLLR 259 (292)
Q Consensus 233 ~~~l~~li~~~l~~dP~~Rpt~~~il~ 259 (292)
+..+.+++.+||+.||.+|||++++++
T Consensus 227 ~~~~~~li~~c~~~~p~~Rps~~~l~~ 253 (256)
T cd05114 227 SMTVYEVMYSCWHEKPEGRPTFAELLR 253 (256)
T ss_pred CHHHHHHHHHHccCCcccCcCHHHHHH
Confidence 678999999999999999999999986
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin h |
| >cd06657 STKc_PAK4 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-35 Score=242.46 Aligned_cols=247 Identities=24% Similarity=0.367 Sum_probs=182.3
Q ss_pred ceeeeecccCceEEEEEEEcCCCcEEEEEEeccCCCChHHHHHHHHHHHHHHhCCCCCcchhhhhhhcCCeEEEEEecCC
Q psy758 5 EKIGKLGEGSYGVVFKCRNRDTGQVVAIKKFLESEEDPLIRKIALREIRLLKSLKHPNLVNLLEVFRRKKKLHLVFEFCD 84 (292)
Q Consensus 5 ~~~~~l~~g~~~~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~iv~e~~~ 84 (292)
+....||+|++|.||.+....+++.|++|.+.... ......+.+|+.+++.++|+|++++++.+..++..++++||++
T Consensus 23 ~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~--~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~ 100 (292)
T cd06657 23 DNFIKIGEGSTGIVCIATVKSSGKLVAVKKMDLRK--QQRRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVMEFLE 100 (292)
T ss_pred hhHHHcCCCCCeEEEEEEEcCCCeEEEEEEecccc--hhHHHHHHHHHHHHHhcCCcchhheeeEEEeCCEEEEEEecCC
Confidence 33457999999999999999999999999885433 2345668899999999999999999999999999999999999
Q ss_pred CccHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEEccCCcEEEeecCchhhhhcccc-----ccc
Q psy758 85 HTVLNELENHPHGLPWDLIKQITWQVLRGVSYCHRHACIHRDIKPENILLTANGVVKLCDFGFARLIRDLIP-----RHL 159 (292)
Q Consensus 85 ~~~L~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~givH~dl~p~Nilv~~~~~~kl~dfg~~~~~~~~~~-----~~~ 159 (292)
+++|.+++... .+++..++.++.|++.||+|||+.|++||||+|+||+++.++.++|+|||++........ ..+
T Consensus 101 ~~~L~~~~~~~-~~~~~~~~~~~~ql~~~l~~lH~~givH~dl~p~Nilv~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~ 179 (292)
T cd06657 101 GGALTDIVTHT-RMNEEQIAAVCLAVLKALSVLHAQGVIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEVPRRKSLVGT 179 (292)
T ss_pred CCcHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEECCCCCEEEcccccceecccccccccccccC
Confidence 99999987653 689999999999999999999999999999999999999999999999998765433221 122
Q ss_pred cccccccccccCCCCCCCcccceeeecCCCCCCchHHHHHHHhhcccCCCCCCChhhhh---hccCcCCCCCCCCCccch
Q psy758 160 HIFQTNEYFKGVSLPHAENVVPLEIKIGKPAATNIYLIDFLKRCLDKDPLRRWSCDQLL---RHPYFNGYYFEVPDEMQY 236 (292)
Q Consensus 160 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~---~~~~~~~~~~~~~~~~~l 236 (292)
..|.+||+..+.......++ ++.+.-++..+.+..|.......+.+ ..............+..+
T Consensus 180 ~~y~~pE~~~~~~~~~~~Dv-------------~slGvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 246 (292)
T cd06657 180 PYWMAPELISRLPYGPEVDI-------------WSLGIMVIEMVDGEPPYFNEPPLKAMKMIRDNLPPKLKNLHKVSPSL 246 (292)
T ss_pred ccccCHHHhcCCCCCchhhH-------------HHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhhCCcccCCcccCCHHH
Confidence 33556665543322222222 22222233333333333222211111 111111111122346789
Q ss_pred HHHHhcccCcCCCCCCChhhhhhCCccccee
Q psy758 237 EEITQRCLDKDPLRRWSCDQLLRHPYFNGYY 267 (292)
Q Consensus 237 ~~li~~~l~~dP~~Rpt~~~il~h~w~~~~~ 267 (292)
.+++.+||+.||.+||++.++++||||....
T Consensus 247 ~~li~~~l~~~P~~R~~~~~ll~~~~~~~~~ 277 (292)
T cd06657 247 KGFLDRLLVRDPAQRATAAELLKHPFLAKAG 277 (292)
T ss_pred HHHHHHHHhCCcccCcCHHHHhcChHHhccC
Confidence 9999999999999999999999999999866
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell mo |
| >cd05035 PTKc_Axl_like Catalytic Domain of Axl-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.6e-36 Score=241.39 Aligned_cols=244 Identities=19% Similarity=0.217 Sum_probs=176.3
Q ss_pred cceeeeecccCceEEEEEEEcCC---CcEEEEEEeccCCCChHHHHHHHHHHHHHHhCCCCCcchhhhhhhcCC------
Q psy758 4 YEKIGKLGEGSYGVVFKCRNRDT---GQVVAIKKFLESEEDPLIRKIALREIRLLKSLKHPNLVNLLEVFRRKK------ 74 (292)
Q Consensus 4 y~~~~~l~~g~~~~v~~~~~~~~---~~~v~iK~~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~------ 74 (292)
|.+++.||+|+||.||.|....+ +..||+|.+............+.+|+..++.++||||+++++++.+..
T Consensus 1 ~~~~~~lg~G~~g~v~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 80 (273)
T cd05035 1 LKLGKILGEGEFGSVMEGQLSQDDGSQLKVAVKTMKLDIHTYSEIEEFLSEAACMKDFDHPNVMKLIGVCFEASSLQKIP 80 (273)
T ss_pred CccccccCcCCCceEEEEEEecCCCCcceEEEEEeccCcCCHHHHHHHHHHHHHHHhCCCCCeeeEEeeeccCCccccCc
Confidence 67899999999999999987653 478999998766555556677899999999999999999999876544
Q ss_pred eEEEEEecCCCccHHHHhcC------CCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEEccCCcEEEeecCch
Q psy758 75 KLHLVFEFCDHTVLNELENH------PHGLPWDLIKQITWQVLRGVSYCHRHACIHRDIKPENILLTANGVVKLCDFGFA 148 (292)
Q Consensus 75 ~~~iv~e~~~~~~L~~~~~~------~~~~~~~~~~~i~~qi~~aL~~LH~~givH~dl~p~Nilv~~~~~~kl~dfg~~ 148 (292)
..++++||+++++|..++.. ...+++..++.++.|++.||.|||++|++|+||+|+||++++++.++|+|||++
T Consensus 81 ~~~~v~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~aL~~lH~~~i~H~dlkp~Nil~~~~~~~kl~dfg~~ 160 (273)
T cd05035 81 KPMVILPFMKHGDLHSFLLYSRLGGLPEKLPLQTLLKFMVDIALGMEYLSNRNFIHRDLAARNCMLREDMTVCVADFGLS 160 (273)
T ss_pred ccEEEEeccCCCCHHHHHHHhhccCCcccCCHHHHHHHHHHHHHHHHHHHhCCeeccccchheEEECCCCeEEECCccce
Confidence 38999999999999888732 235899999999999999999999999999999999999999999999999998
Q ss_pred hhhhcccc-------ccccccccccccccCCCCCCCcccceeeecCCCCCCchHHHHHHHhhc-ccCCCCCCChhhhhhc
Q psy758 149 RLIRDLIP-------RHLHIFQTNEYFKGVSLPHAENVVPLEIKIGKPAATNIYLIDFLKRCL-DKDPLRRWSCDQLLRH 220 (292)
Q Consensus 149 ~~~~~~~~-------~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~p~~~~~~~~~~~~ 220 (292)
+....... .....|.+|+...+.......++|++ +.-+++.+. +..|.......++...
T Consensus 161 ~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~Sl-------------G~il~el~~~g~~p~~~~~~~~~~~~ 227 (273)
T cd05035 161 KKIYSGDYYRQGRIAKMPVKWIAIESLADRVYTSKSDVWAF-------------GVTMWEIATRGQTPYPGVENHEIYDY 227 (273)
T ss_pred eeccccccccccccccCCccccCHhhcccCCCCcccchHHH-------------HHHHHHHHhCCCCCCCCCCHHHHHHH
Confidence 76532211 11123455555444333222333222 222223222 3333332222222221
Q ss_pred cCc-CCCCCCCCCccchHHHHhcccCcCCCCCCChhhhhhC
Q psy758 221 PYF-NGYYFEVPDEMQYEEITQRCLDKDPLRRWSCDQLLRH 260 (292)
Q Consensus 221 ~~~-~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~~il~h 260 (292)
..- .....+...+..+.+++.+||+.||++|||+.+++++
T Consensus 228 ~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~e~~~~ 268 (273)
T cd05035 228 LRHGNRLKQPEDCLDELYDLMYSCWRADPKDRPTFTKLREV 268 (273)
T ss_pred HHcCCCCCCCcCCCHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence 110 0112234457789999999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellu |
| >cd05079 PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.6e-36 Score=242.73 Aligned_cols=253 Identities=19% Similarity=0.259 Sum_probs=179.4
Q ss_pred ccceeeeecccCceEEEEEEE----cCCCcEEEEEEeccCCCChHHHHHHHHHHHHHHhCCCCCcchhhhhhhcC--CeE
Q psy758 3 RYEKIGKLGEGSYGVVFKCRN----RDTGQVVAIKKFLESEEDPLIRKIALREIRLLKSLKHPNLVNLLEVFRRK--KKL 76 (292)
Q Consensus 3 ~y~~~~~l~~g~~~~v~~~~~----~~~~~~v~iK~~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~--~~~ 76 (292)
-|++++.||+|++|.||.|.. ..++..|++|.+.... .......+.+|+.+++.++|||++++++++.+. ...
T Consensus 5 ~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~va~K~~~~~~-~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~ 83 (284)
T cd05079 5 FLKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPES-GGNHIADLKKEIEILRNLYHENIVKYKGICTEDGGNGI 83 (284)
T ss_pred hhhhceecCCCCceeEEEEEEccCCCCccceEEEEEcCccc-cHHHHHHHHHHHHHHHhCCCCCeeeeeeEEecCCCCce
Confidence 368899999999999999974 4568899999986443 334456788999999999999999999988764 578
Q ss_pred EEEEecCCCccHHHHhcCC-CCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEEccCCcEEEeecCchhhhhccc
Q psy758 77 HLVFEFCDHTVLNELENHP-HGLPWDLIKQITWQVLRGVSYCHRHACIHRDIKPENILLTANGVVKLCDFGFARLIRDLI 155 (292)
Q Consensus 77 ~iv~e~~~~~~L~~~~~~~-~~~~~~~~~~i~~qi~~aL~~LH~~givH~dl~p~Nilv~~~~~~kl~dfg~~~~~~~~~ 155 (292)
++|+||++|++|..++... ..+++..+..++.||+.||+|||++|++|+||+|+||+++.++.++|+|||++.......
T Consensus 84 ~lv~e~~~g~~L~~~l~~~~~~~~~~~~~~i~~~i~~aL~~lH~~gi~H~dlkp~Nil~~~~~~~~l~dfg~~~~~~~~~ 163 (284)
T cd05079 84 KLIMEFLPSGSLKEYLPRNKNKINLKQQLKYAVQICKGMDYLGSRQYVHRDLAARNVLVESEHQVKIGDFGLTKAIETDK 163 (284)
T ss_pred EEEEEccCCCCHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCeeecccchheEEEcCCCCEEECCCccccccccCc
Confidence 9999999999999998653 358999999999999999999999999999999999999999999999999987653211
Q ss_pred --------cccccccccccccccCC-----CCCCCcccceeeecCCCCCCchHHHHHHHhhcccCCCCCC--Chhhhhhc
Q psy758 156 --------PRHLHIFQTNEYFKGVS-----LPHAENVVPLEIKIGKPAATNIYLIDFLKRCLDKDPLRRW--SCDQLLRH 220 (292)
Q Consensus 156 --------~~~~~~~~~~~~~~~~~-----~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~--~~~~~~~~ 220 (292)
......|.+||+..+.. ..|+.|+..+++.++..+.... . ..........+.... .....+..
T Consensus 164 ~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~ellt~~~~~~~~-~-~~~~~~~~~~~~~~~~~~~~~~~~~ 241 (284)
T cd05079 164 EYYTVKDDLDSPVFWYAPECLIQSKFYIASDVWSFGVTLYELLTYCDSESSP-M-TLFLKMIGPTHGQMTVTRLVRVLEE 241 (284)
T ss_pred cceeecCCCCCCccccCHHHhccCCCCccccchhhhhhhhhhhcCCCCCccc-c-chhhhhcccccccccHHHHHHHHHc
Confidence 11223467777665443 3455555555554433221111 0 011111111111100 00111111
Q ss_pred cCcCCCCCCCCCccchHHHHhcccCcCCCCCCChhhhhhC
Q psy758 221 PYFNGYYFEVPDEMQYEEITQRCLDKDPLRRWSCDQLLRH 260 (292)
Q Consensus 221 ~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~~il~h 260 (292)
.. ....+...+..+.+|+.+||+.||.+|||++++++.
T Consensus 242 ~~--~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~~ 279 (284)
T cd05079 242 GK--RLPRPPNCPEEVYQLMRKCWEFQPSKRTTFQNLIEG 279 (284)
T ss_pred Cc--cCCCCCCCCHHHHHHHHHHccCCcccCcCHHHHHHH
Confidence 10 112233457789999999999999999999999873
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers a |
| >cd06635 STKc_TAO1 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-35 Score=244.86 Aligned_cols=251 Identities=29% Similarity=0.386 Sum_probs=184.5
Q ss_pred ccceeeeecccCceEEEEEEEcCCCcEEEEEEeccCC-CChHHHHHHHHHHHHHHhCCCCCcchhhhhhhcCCeEEEEEe
Q psy758 3 RYEKIGKLGEGSYGVVFKCRNRDTGQVVAIKKFLESE-EDPLIRKIALREIRLLKSLKHPNLVNLLEVFRRKKKLHLVFE 81 (292)
Q Consensus 3 ~y~~~~~l~~g~~~~v~~~~~~~~~~~v~iK~~~~~~-~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~iv~e 81 (292)
.|...+.||+|++|.||++.+..++..|++|.+.... ........+.+|+.+++.++|||++++++++.+++..++|+|
T Consensus 26 ~f~~~~~lg~G~~~~v~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 105 (317)
T cd06635 26 LFTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVKFLQRIKHPNSIEYKGCYLREHTAWLVME 105 (317)
T ss_pred hhhhhheeccCCCeEEEEEEEcCCCcEEEEEEEecCCCCchHHHHHHHHHHHHHHhCCCCCEEEEEEEEeeCCeEEEEEe
Confidence 4778889999999999999999999999999987553 233445678889999999999999999999999999999999
Q ss_pred cCCCccHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEEccCCcEEEeecCchhhhhccc-ccccc
Q psy758 82 FCDHTVLNELENHPHGLPWDLIKQITWQVLRGVSYCHRHACIHRDIKPENILLTANGVVKLCDFGFARLIRDLI-PRHLH 160 (292)
Q Consensus 82 ~~~~~~L~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~givH~dl~p~Nilv~~~~~~kl~dfg~~~~~~~~~-~~~~~ 160 (292)
|+.|+.+..+......+++..+..++.|++.||.|||++|++|+||+|+||+++.++.++|+|||++....... .....
T Consensus 106 ~~~g~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~i~H~dL~p~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~ 185 (317)
T cd06635 106 YCLGSASDLLEVHKKPLQEVEIAAITHGALQGLAYLHSHNMIHRDIKAGNILLTEPGQVKLADFGSASIASPANSFVGTP 185 (317)
T ss_pred CCCCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCcccEEECCCCCEEEecCCCccccCCcccccCCc
Confidence 99875554444445678999999999999999999999999999999999999999999999999886544321 12233
Q ss_pred cccccccccc---CC-----CCCCCcccceeeecCCCCCCchHHHHHHHhhcccCCCCCCChhhhhhccCcCC--CCCCC
Q psy758 161 IFQTNEYFKG---VS-----LPHAENVVPLEIKIGKPAATNIYLIDFLKRCLDKDPLRRWSCDQLLRHPYFNG--YYFEV 230 (292)
Q Consensus 161 ~~~~~~~~~~---~~-----~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~--~~~~~ 230 (292)
.|.+||+..+ .. ..|+.|+..+++.+|.. |................. .....
T Consensus 186 ~y~aPE~~~~~~~~~~~~~~Dv~slGvil~el~~g~~------------------p~~~~~~~~~~~~~~~~~~~~~~~~ 247 (317)
T cd06635 186 YWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKP------------------PLFNMNAMSALYHIAQNESPTLQSN 247 (317)
T ss_pred cccChhhhhcCCCCCCCccccHHHHHHHHHHHHhCCC------------------CCCCccHHHHHHHHHhccCCCCCCc
Confidence 4666666421 11 22333333333444443 322222111111100000 01112
Q ss_pred CCccchHHHHhcccCcCCCCCCChhhhhhCCcccceeccCC
Q psy758 231 PDEMQYEEITQRCLDKDPLRRWSCDQLLRHPYFNGYYFEVP 271 (292)
Q Consensus 231 ~~~~~l~~li~~~l~~dP~~Rpt~~~il~h~w~~~~~~~~~ 271 (292)
..+..+.++|.+||+.+|.+|||+.++++|+|+.....+..
T Consensus 248 ~~~~~l~~li~~~l~~~p~~Rpt~~~il~~~~~~~~~~~~~ 288 (317)
T cd06635 248 EWSDYFRNFVDSCLQKIPQDRPTSEELLKHMFVLRERPETV 288 (317)
T ss_pred cccHHHHHHHHHHccCCcccCcCHHHHHhChhhhccCcccc
Confidence 34567999999999999999999999999999987555443
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuron |
| >cd05039 PTKc_Csk_like Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-35 Score=238.32 Aligned_cols=240 Identities=21% Similarity=0.291 Sum_probs=181.5
Q ss_pred cccceeeeecccCceEEEEEEEcCCCcEEEEEEeccCCCChHHHHHHHHHHHHHHhCCCCCcchhhhhhhcCCeEEEEEe
Q psy758 2 ERYEKIGKLGEGSYGVVFKCRNRDTGQVVAIKKFLESEEDPLIRKIALREIRLLKSLKHPNLVNLLEVFRRKKKLHLVFE 81 (292)
Q Consensus 2 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~iv~e 81 (292)
++|++.+.||+|++|.||.|... |+.|++|.+..... ..+.+.+|+.+++.++|+||+++++++.+.+..++|+|
T Consensus 6 ~~~~~~~~ig~g~~g~v~~~~~~--~~~v~iK~~~~~~~---~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e 80 (256)
T cd05039 6 KELKLGATIGKGEFGDVMLGDYR--GQKVAVKCLKDDST---AAQAFLAEASVMTTLRHPNLVQLLGVVLQGNPLYIVTE 80 (256)
T ss_pred hhccceeeeecCCCceEEEEEec--CcEEEEEEeccchh---HHHHHHHHHHHHHhcCCcceeeeEEEEcCCCCeEEEEE
Confidence 57899999999999999999875 78999999865543 45678899999999999999999999998899999999
Q ss_pred cCCCccHHHHhcCCC--CCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEEccCCcEEEeecCchhhhhcccccc-
Q psy758 82 FCDHTVLNELENHPH--GLPWDLIKQITWQVLRGVSYCHRHACIHRDIKPENILLTANGVVKLCDFGFARLIRDLIPRH- 158 (292)
Q Consensus 82 ~~~~~~L~~~~~~~~--~~~~~~~~~i~~qi~~aL~~LH~~givH~dl~p~Nilv~~~~~~kl~dfg~~~~~~~~~~~~- 158 (292)
|+++++|.+++.... .+++..++.++.|++.||.|||++|++|+||+|+||+++.++.++|+|||.+..........
T Consensus 81 ~~~~~~L~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lh~~~i~H~di~p~Nili~~~~~~~l~d~g~~~~~~~~~~~~~ 160 (256)
T cd05039 81 YMAKGSLVDYLRSRGRAVITLAQQLGFALDVCEGMEYLEEKNFVHRDLAARNVLVSEDLVAKVSDFGLAKEASQGQDSGK 160 (256)
T ss_pred ecCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCccchhcccceEEEeCCCCEEEcccccccccccccccCC
Confidence 999999999987654 68999999999999999999999999999999999999999999999999987664322211
Q ss_pred -ccccccccccccCCCCCCCcccceeeecCCCCCCchHHHHHHHhhc-ccCCCCCCChhhhhhccCcC-CCCCCCCCccc
Q psy758 159 -LHIFQTNEYFKGVSLPHAENVVPLEIKIGKPAATNIYLIDFLKRCL-DKDPLRRWSCDQLLRHPYFN-GYYFEVPDEMQ 235 (292)
Q Consensus 159 -~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~p~~~~~~~~~~~~~~~~-~~~~~~~~~~~ 235 (292)
...|.+||+..+.......++|+ .+.-++..+. +..|....+..++.....-. ....+...+..
T Consensus 161 ~~~~~~ape~~~~~~~~~~~Di~s-------------lG~il~~l~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 227 (256)
T cd05039 161 LPVKWTAPEALREKKFSTKSDVWS-------------FGILLWEIYSFGRVPYPRIPLKDVVPHVEKGYRMEAPEGCPPE 227 (256)
T ss_pred CcccccCchhhcCCcCCcHHHHHH-------------HHHHHHHHHhcCCCCCCCCCHHHHHHHHhcCCCCCCccCCCHH
Confidence 22355666554332222222222 2222333332 44454444444433221100 11223345788
Q ss_pred hHHHHhcccCcCCCCCCChhhhhh
Q psy758 236 YEEITQRCLDKDPLRRWSCDQLLR 259 (292)
Q Consensus 236 l~~li~~~l~~dP~~Rpt~~~il~ 259 (292)
+.++|.+||..+|.+|||+.++++
T Consensus 228 ~~~li~~~l~~~p~~Rp~~~~l~~ 251 (256)
T cd05039 228 VYKVMKDCWELDPAKRPTFKQLRE 251 (256)
T ss_pred HHHHHHHHhccChhhCcCHHHHHH
Confidence 999999999999999999999987
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk |
| >cd07838 STKc_CDK4_6_like Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.1e-36 Score=244.43 Aligned_cols=259 Identities=34% Similarity=0.477 Sum_probs=180.3
Q ss_pred cceeeeecccCceEEEEEEEcCCCcEEEEEEeccCCCChHHHHHHHHHHHHHHhC---CCCCcchhhhhhhcCCe-----
Q psy758 4 YEKIGKLGEGSYGVVFKCRNRDTGQVVAIKKFLESEEDPLIRKIALREIRLLKSL---KHPNLVNLLEVFRRKKK----- 75 (292)
Q Consensus 4 y~~~~~l~~g~~~~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~e~~~~~~l---~~~~i~~~~~~~~~~~~----- 75 (292)
|++.+.||+|++|.||+|.+..+++.|++|.+............+.+|+.+++.+ +|||++++++++.+.+.
T Consensus 1 y~~~~~l~~g~~~~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~~i~~~~~~~~~~~~~~~~~ 80 (287)
T cd07838 1 YEELAEIGEGAYGTVYKARDLNTGRFVALKKVRVPLSEEGIPLSTLREIALLKQLESFEHPNIVRLLDVCHGPRTDRELK 80 (287)
T ss_pred CeEEEEecccCceEEEEEEECCCCCEEEEEEeccccccchhhhhHHHHHHHHHHhhccCCCCcceEEEEEeeccCCCCce
Confidence 7889999999999999999998899999999976554444445566787777666 59999999999987666
Q ss_pred EEEEEecCCCccHHHHhcCC--CCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEEccCCcEEEeecCchhhhhc
Q psy758 76 LHLVFEFCDHTVLNELENHP--HGLPWDLIKQITWQVLRGVSYCHRHACIHRDIKPENILLTANGVVKLCDFGFARLIRD 153 (292)
Q Consensus 76 ~~iv~e~~~~~~L~~~~~~~--~~~~~~~~~~i~~qi~~aL~~LH~~givH~dl~p~Nilv~~~~~~kl~dfg~~~~~~~ 153 (292)
.++++||+++ .|..++... ..+++..++.++.|++.||.+||+.|++|+||+|+||++++++.++|+|||.+.....
T Consensus 81 ~~l~~e~~~~-~l~~~l~~~~~~~l~~~~~~~~~~~i~~al~~LH~~~i~h~~l~~~nili~~~~~~~l~dfg~~~~~~~ 159 (287)
T cd07838 81 LTLVFEHVDQ-DLATYLSKCPKPGLPPETIKDLMRQLLRGVDFLHSHRIVHRDLKPQNILVTSDGQVKIADFGLARIYSF 159 (287)
T ss_pred eEEEehhccc-CHHHHHHHccCCCCCHHHHHHHHHHHHHHHHHHHHCCeeeccCChhhEEEccCCCEEEeccCcceeccC
Confidence 9999999986 566666542 2589999999999999999999999999999999999999999999999999876543
Q ss_pred ccc----ccccccccccccccCC-----CCCCCcccceeeecCCCCCCchHHHHHHHhhccc----CCCCCCChhhhhhc
Q psy758 154 LIP----RHLHIFQTNEYFKGVS-----LPHAENVVPLEIKIGKPAATNIYLIDFLKRCLDK----DPLRRWSCDQLLRH 220 (292)
Q Consensus 154 ~~~----~~~~~~~~~~~~~~~~-----~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~----~p~~~~~~~~~~~~ 220 (292)
... .....|.+||...+.. ..|+.|+..+++.++.+++......+.+...... .....+........
T Consensus 160 ~~~~~~~~~~~~~~~PE~~~~~~~~~~~Di~s~G~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 239 (287)
T cd07838 160 EMALTSVVVTLWYRAPEVLLQSSYATPVDMWSVGCIFAELFRRRPLFRGTSEADQLDKIFDVIGLPSEEEWPRNVSLPRS 239 (287)
T ss_pred CcccccccccccccChHHhccCCCCCcchhhhHHHHHHHHHhCCCcccCCChHHHHHHHHHHcCCCChHhcCCCcccchh
Confidence 211 1233466776655433 3455555555555555443322222211111110 00000000000000
Q ss_pred cCcCCCC-----CCCCCccchHHHHhcccCcCCCCCCChhhhhhCCcc
Q psy758 221 PYFNGYY-----FEVPDEMQYEEITQRCLDKDPLRRWSCDQLLRHPYF 263 (292)
Q Consensus 221 ~~~~~~~-----~~~~~~~~l~~li~~~l~~dP~~Rpt~~~il~h~w~ 263 (292)
.+..... .....+..+.++|.+||+.||.+||++.++++||||
T Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rp~~~~il~~~~~ 287 (287)
T cd07838 240 SFPSYTPRSFKSFVPEICEEGLDLLKKMLTFNPHKRISAFEALQHPYF 287 (287)
T ss_pred hcccccccchhhhhhhhhHHHHHHHHHHhccCCccCCCHHHHhcCcCC
Confidence 0000000 011235677899999999999999999999999997
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both |
| >PHA03210 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-36 Score=263.01 Aligned_cols=266 Identities=20% Similarity=0.184 Sum_probs=175.8
Q ss_pred cccceeeeecccCceEEEEEEEcCCCc-EEEEEEe--------------c-cCCCChHHHHHHHHHHHHHHhCCCCCcch
Q psy758 2 ERYEKIGKLGEGSYGVVFKCRNRDTGQ-VVAIKKF--------------L-ESEEDPLIRKIALREIRLLKSLKHPNLVN 65 (292)
Q Consensus 2 ~~y~~~~~l~~g~~~~v~~~~~~~~~~-~v~iK~~--------------~-~~~~~~~~~~~~~~e~~~~~~l~~~~i~~ 65 (292)
++|++++.||+|+||.||++....... ..+.|.+ . ...........+.+|+.+++.++||||++
T Consensus 148 ~~Y~ii~~LG~G~fG~Vyl~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~Ei~il~~l~HpnIv~ 227 (501)
T PHA03210 148 AHFRVIDDLPAGAFGKIFICALRASTEEAEARRGVNSTNQGKPKCERLIAKRVKAGSRAAIQLENEILALGRLNHENILK 227 (501)
T ss_pred hccEEEeEecCCCCcceEEEEEeccchhhhhhhccccccccchhhhhhHhHHhhcchHHHHHHHHHHHHHHhCCCCCcCc
Confidence 689999999999999999987643222 2222211 1 11122234566789999999999999999
Q ss_pred hhhhhhcCCeEEEEEecCCCccHHHHhcC----CCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEEccCCcEE
Q psy758 66 LLEVFRRKKKLHLVFEFCDHTVLNELENH----PHGLPWDLIKQITWQVLRGVSYCHRHACIHRDIKPENILLTANGVVK 141 (292)
Q Consensus 66 ~~~~~~~~~~~~iv~e~~~~~~L~~~~~~----~~~~~~~~~~~i~~qi~~aL~~LH~~givH~dl~p~Nilv~~~~~~k 141 (292)
+++++.+.+..|++++++.+..+..+... ........+..++.||+.||.|||++||+|+||||+|||++.++.+|
T Consensus 228 l~~~~~~~~~~~lv~e~~~~~l~~~l~~~~~~~~~~~~~~~~~~i~~ql~~aL~yLH~~gIiHrDLKP~NILl~~~~~vk 307 (501)
T PHA03210 228 IEEILRSEANTYMITQKYDFDLYSFMYDEAFDWKDRPLLKQTRAIMKQLLCAVEYIHDKKLIHRDIKLENIFLNCDGKIV 307 (501)
T ss_pred EeEEEEECCeeEEEEeccccCHHHHHhhccccccccccHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEECCCCCEE
Confidence 99999999999999999987655544332 12244667889999999999999999999999999999999999999
Q ss_pred EeecCchhhhhccc------cccccccccccccccCCC-----CCCCcccceeeecCCCCCC----chHHHHHHHhhc--
Q psy758 142 LCDFGFARLIRDLI------PRHLHIFQTNEYFKGVSL-----PHAENVVPLEIKIGKPAAT----NIYLIDFLKRCL-- 204 (292)
Q Consensus 142 l~dfg~~~~~~~~~------~~~~~~~~~~~~~~~~~~-----~~~~~~~~~~~~~~~~~~~----~~~~~~~~~~~~-- 204 (292)
|+|||++..+.... ..++..|.+||...+... .|+.|+..++++++..... ......+...+.
T Consensus 308 L~DFGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ell~~~~~p~~~~~~~~~~~~~~~~~~~ 387 (501)
T PHA03210 308 LGDFGTAMPFEKEREAFDYGWVGTVATNSPEILAGDGYCEITDIWSCGLILLDMLSHDFCPIGDGGGKPGKQLLKIIDSL 387 (501)
T ss_pred EEeCCCceecCcccccccccccCCcCCCCchhhcCCCCCcHHHHHHHHHHHHHHHHCCCCCccCCCCCHHHHHHHHHHhc
Confidence 99999997654321 123455777887766544 3555555555555432111 111122211111
Q ss_pred ccCCCCCCC-hhhhh---hccCcCC-------CCCCCCCccchHHHHhcccCcCCCCCCChhhhhhCCccccee
Q psy758 205 DKDPLRRWS-CDQLL---RHPYFNG-------YYFEVPDEMQYEEITQRCLDKDPLRRWSCDQLLRHPYFNGYY 267 (292)
Q Consensus 205 ~~~p~~~~~-~~~~~---~~~~~~~-------~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~~il~h~w~~~~~ 267 (292)
...+..-+. ...+. ....+.. .......+..+.++|.+||++||.+|||+.|+|+||||++..
T Consensus 388 ~~~~~~~p~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~li~kmL~~DP~~Rpsa~elL~hp~f~~~~ 461 (501)
T PHA03210 388 SVCDEEFPDPPCKLFDYIDSAEIDHAGHSVPPLIRNLGLPADFEYPLVKMLTFDWHLRPGAAELLALPLFSAEE 461 (501)
T ss_pred ccChhhcCCcHHHHHHHhhhhhcccCccchhhHHHhcCCChHHHHHHHHHhccCcccCcCHHHHhhChhhhcCC
Confidence 100110010 00111 0000000 001112355778899999999999999999999999998743
|
|
| >KOG4279|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-36 Score=253.31 Aligned_cols=238 Identities=25% Similarity=0.363 Sum_probs=191.1
Q ss_pred eecccCceEEEEEEEcCCCcEEEEEEeccCCCChHHHHHHHHHHHHHHhCCCCCcchhhhhhhcCCeEEEEEecCCCccH
Q psy758 9 KLGEGSYGVVFKCRNRDTGQVVAIKKFLESEEDPLIRKIALREIRLLKSLKHPNLVNLLEVFRRKKKLHLVFEFCDHTVL 88 (292)
Q Consensus 9 ~l~~g~~~~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~iv~e~~~~~~L 88 (292)
.||.|+||+||-|++..|+..+|||-++.... ...+-+..|+.+-+.|+|.||++++|.+..+++.-|.||.++||+|
T Consensus 582 VLGKGTYG~VYA~RD~~tqvrIaIKEIpekds--r~~QPLhEEIaLH~~LrHkNIVrYLGs~senGf~kIFMEqVPGGSL 659 (1226)
T KOG4279|consen 582 VLGKGTYGTVYAARDMDTQVRIAIKEIPEKDS--REVQPLHEEIALHSTLRHKNIVRYLGSVSENGFFKIFMEQVPGGSL 659 (1226)
T ss_pred EeecCceeEEEeeccccceeEEEeeecccccc--hhhccHHHHHHHHHHHhhHhHHHHhhccCCCCeEEEEeecCCCCcH
Confidence 59999999999999999999999999865543 3456677899999999999999999999999999999999999999
Q ss_pred HHHhcCC-CCC--CHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEEcc-CCcEEEeecCchhhhhcccccc-----c
Q psy758 89 NELENHP-HGL--PWDLIKQITWQVLRGVSYCHRHACIHRDIKPENILLTA-NGVVKLCDFGFARLIRDLIPRH-----L 159 (292)
Q Consensus 89 ~~~~~~~-~~~--~~~~~~~i~~qi~~aL~~LH~~givH~dl~p~Nilv~~-~~~~kl~dfg~~~~~~~~~~~~-----~ 159 (292)
..+++.. +++ .|.++..+..||++||+|||.+.|||||||-+|+||+. .|.+||+|||-++.+....+-. +
T Consensus 660 SsLLrskWGPlKDNEstm~fYtkQILeGLkYLHen~IVHRDIKGDNVLvNTySGvlKISDFGTsKRLAginP~TETFTGT 739 (1226)
T KOG4279|consen 660 SSLLRSKWGPLKDNESTMNFYTKQILEGLKYLHENKIVHRDIKGDNVLVNTYSGVLKISDFGTSKRLAGINPCTETFTGT 739 (1226)
T ss_pred HHHHHhccCCCccchhHHHHHHHHHHHHhhhhhhcceeeccccCCcEEEeeccceEEecccccchhhccCCccccccccc
Confidence 9999864 345 88999999999999999999999999999999999985 5899999999999886544432 3
Q ss_pred cccccccccc-------cCCCCCCCcccceeeecCCCCCC---chHHHHHHHhhcccCCCCCCChhhhhhccCcCCCCCC
Q psy758 160 HIFQTNEYFK-------GVSLPHAENVVPLEIKIGKPAAT---NIYLIDFLKRCLDKDPLRRWSCDQLLRHPYFNGYYFE 229 (292)
Q Consensus 160 ~~~~~~~~~~-------~~~~~~~~~~~~~~~~~~~~~~~---~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~ 229 (292)
-.|.+||..- .....|++|+...++.+|.+++. +..+..+-..+.... -+.|
T Consensus 740 LQYMAPEvIDqG~RGYG~aADIWS~GCT~vEMATGrPPF~ElgspqAAMFkVGmyKvH------------------P~iP 801 (1226)
T KOG4279|consen 740 LQYMAPEVIDQGPRGYGKAADIWSFGCTMVEMATGRPPFVELGSPQAAMFKVGMYKVH------------------PPIP 801 (1226)
T ss_pred hhhhChHhhccCCcCCCchhhhhhccceeEeeccCCCCeeecCChhHhhhhhcceecC------------------CCCc
Confidence 3455555532 12335777777778888888753 112222222222222 2445
Q ss_pred CCCccchHHHHhcccCcCCCCCCChhhhhhCCcccce
Q psy758 230 VPDEMQYEEITQRCLDKDPLRRWSCDQLLRHPYFNGY 266 (292)
Q Consensus 230 ~~~~~~l~~li~~~l~~dP~~Rpt~~~il~h~w~~~~ 266 (292)
...+.+++.+|.+|+.+||.+||+|.++|..||++.-
T Consensus 802 eelsaeak~FilrcFepd~~~R~sA~~LL~DpFlq~~ 838 (1226)
T KOG4279|consen 802 EELSAEAKNFILRCFEPDPCDRPSAKDLLQDPFLQHN 838 (1226)
T ss_pred HHHHHHHHHHHHHHcCCCcccCccHHHhccCcccccC
Confidence 5557789999999999999999999999999999986
|
|
| >KOG0194|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.4e-36 Score=249.12 Aligned_cols=250 Identities=26% Similarity=0.379 Sum_probs=195.7
Q ss_pred cceeeeecccCceEEEEEEEcCCCc---E-EEEEEeccC-CCChHHHHHHHHHHHHHHhCCCCCcchhhhhhhcCCeEEE
Q psy758 4 YEKIGKLGEGSYGVVFKCRNRDTGQ---V-VAIKKFLES-EEDPLIRKIALREIRLLKSLKHPNLVNLLEVFRRKKKLHL 78 (292)
Q Consensus 4 y~~~~~l~~g~~~~v~~~~~~~~~~---~-v~iK~~~~~-~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~i 78 (292)
-++.+.||+|+||.||.|.....+. . ||+|..... .........+.+|.++++.++||||+++||+......+++
T Consensus 159 v~l~kkLGeGaFGeV~~G~l~~~~~~~~~~VAvK~~k~~~~~~~~~~~e~m~EArvMr~l~H~NVVr~yGVa~~~~Pl~i 238 (474)
T KOG0194|consen 159 IELGKKLGEGAFGEVFKGKLKLKNGFKVVPVAVKTTKGSSELTKEQIKEFMKEARVMRQLNHPNVVRFYGVAVLEEPLML 238 (474)
T ss_pred ccccceeecccccEEEEEEEEecCCceeeeeEEEeecccccccHHHHHHHHHHHHHHHhCCCCCEEEEEEEEcCCCccEE
Confidence 3566899999999999998765432 3 899988753 3667788999999999999999999999999999999999
Q ss_pred EEecCCCccHHHHhcCCC-CCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEEccCCcEEEeecCchhhhhccccc
Q psy758 79 VFEFCDHTVLNELENHPH-GLPWDLIKQITWQVLRGVSYCHRHACIHRDIKPENILLTANGVVKLCDFGFARLIRDLIPR 157 (292)
Q Consensus 79 v~e~~~~~~L~~~~~~~~-~~~~~~~~~i~~qi~~aL~~LH~~givH~dl~p~Nilv~~~~~~kl~dfg~~~~~~~~~~~ 157 (292)
|||+|.||+|.++++..+ .++..+...++.+.+.||+|||+++++||||..+|+|++.++.+||+|||+++........
T Consensus 239 vmEl~~gGsL~~~L~k~~~~v~~~ek~~~~~~AA~Gl~YLh~k~~IHRDIAARNcL~~~~~~vKISDFGLs~~~~~~~~~ 318 (474)
T KOG0194|consen 239 VMELCNGGSLDDYLKKNKKSLPTLEKLRFCYDAARGLEYLHSKNCIHRDIAARNCLYSKKGVVKISDFGLSRAGSQYVMK 318 (474)
T ss_pred EEEecCCCcHHHHHHhCCCCCCHHHHHHHHHHHHhHHHHHHHCCCcchhHhHHHheecCCCeEEeCccccccCCcceeec
Confidence 999999999999998876 4999999999999999999999999999999999999999999999999998765421111
Q ss_pred -----cccccccccccccCCCCCCCcccceeeecCCCCCCchHHHHHHHhhcccCCCCCCChhhhhhccCcCCCCC--CC
Q psy758 158 -----HLHIFQTNEYFKGVSLPHAENVVPLEIKIGKPAATNIYLIDFLKRCLDKDPLRRWSCDQLLRHPYFNGYYF--EV 230 (292)
Q Consensus 158 -----~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~--~~ 230 (292)
-.-.|.+||-.....+....++|++++...+.... +..|....+..++.......+++. +.
T Consensus 319 ~~~~klPirWLAPEtl~~~~~s~kTDV~sfGV~~~Eif~~------------g~~Py~g~~~~~v~~kI~~~~~r~~~~~ 386 (474)
T KOG0194|consen 319 KFLKKLPIRWLAPETLNTGIFSFKTDVWSFGVLLWEIFEN------------GAEPYPGMKNYEVKAKIVKNGYRMPIPS 386 (474)
T ss_pred cccccCcceecChhhhccCccccccchhheeeeEEeeecc------------CCCCCCCCCHHHHHHHHHhcCccCCCCC
Confidence 12335566666555555666666666655444321 223555556555555543444333 33
Q ss_pred CCccchHHHHhcccCcCCCCCCChhhhhhCCccccee
Q psy758 231 PDEMQYEEITQRCLDKDPLRRWSCDQLLRHPYFNGYY 267 (292)
Q Consensus 231 ~~~~~l~~li~~~l~~dP~~Rpt~~~il~h~w~~~~~ 267 (292)
..|..+..++.+|+..||++|||+.++.+ +++...
T Consensus 387 ~~p~~~~~~~~~c~~~~p~~R~tm~~i~~--~l~~~~ 421 (474)
T KOG0194|consen 387 KTPKELAKVMKQCWKKDPEDRPTMSTIKK--KLEALE 421 (474)
T ss_pred CCHHHHHHHHHHhccCChhhccCHHHHHH--HHHHHH
Confidence 45778999999999999999999999987 555533
|
|
| >cd05090 PTKc_Ror1 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-35 Score=241.86 Aligned_cols=246 Identities=20% Similarity=0.278 Sum_probs=179.1
Q ss_pred CcccceeeeecccCceEEEEEEEc----CCCcEEEEEEeccCCCChHHHHHHHHHHHHHHhCCCCCcchhhhhhhcCCeE
Q psy758 1 MERYEKIGKLGEGSYGVVFKCRNR----DTGQVVAIKKFLESEEDPLIRKIALREIRLLKSLKHPNLVNLLEVFRRKKKL 76 (292)
Q Consensus 1 ~~~y~~~~~l~~g~~~~v~~~~~~----~~~~~v~iK~~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~ 76 (292)
+++|++.+.||+|+||.||+|... .++..|++|.+..... ......+.+|+.+++.++||||+++++++..++..
T Consensus 4 ~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~ik~~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~ 82 (283)
T cd05090 4 LSAVRFMEELGECAFGKIYKGHLYLPGMDHAQLVAIKTLKDINN-PQQWGEFQQEASLMAELHHPNIVCLLGVVTQEQPV 82 (283)
T ss_pred hhhceeeeeccccCCcceEEEEEecCCCCCcceEEEEeccCCCC-HHHHHHHHHHHHHHhhCCCCCeeeEEEEEecCCce
Confidence 467999999999999999999853 3567899998865433 34456788899999999999999999999999999
Q ss_pred EEEEecCCCccHHHHhcCC-----------------CCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEEccCCc
Q psy758 77 HLVFEFCDHTVLNELENHP-----------------HGLPWDLIKQITWQVLRGVSYCHRHACIHRDIKPENILLTANGV 139 (292)
Q Consensus 77 ~iv~e~~~~~~L~~~~~~~-----------------~~~~~~~~~~i~~qi~~aL~~LH~~givH~dl~p~Nilv~~~~~ 139 (292)
|++|||+++++|.+++... ..+++..+..++.|++.||.|||++|++|+||+|+||++++++.
T Consensus 83 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~i~H~dlkp~nili~~~~~ 162 (283)
T cd05090 83 CMLFEYLNQGDLHEFLIMRSPHSDVGCSSDEDGTVKSSLDHGDFLHIAIQIAAGMEYLSSHFFVHKDLAARNILIGEQLH 162 (283)
T ss_pred EEEEEcCCCCcHHHHHHhcCCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHhcCeehhccccceEEEcCCCc
Confidence 9999999999999987421 24788999999999999999999999999999999999999999
Q ss_pred EEEeecCchhhhhccc-------cccccccccccccccCCCCCCCcccceeeecCCCCCCchHHHHHHHhhc-ccCCCCC
Q psy758 140 VKLCDFGFARLIRDLI-------PRHLHIFQTNEYFKGVSLPHAENVVPLEIKIGKPAATNIYLIDFLKRCL-DKDPLRR 211 (292)
Q Consensus 140 ~kl~dfg~~~~~~~~~-------~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~p~~~ 211 (292)
++|+|||++....... ......|.+||+..+.......++|+++ ..+++.+. +..|+..
T Consensus 163 ~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG-------------~il~el~~~g~~p~~~ 229 (283)
T cd05090 163 VKISDLGLSREIYSADYYRVQPKSLLPIRWMPPEAIMYGKFSSDSDIWSFG-------------VVLWEIFSFGLQPYYG 229 (283)
T ss_pred EEeccccccccccCCcceecccCCCccceecChHHhccCCCCchhhhHHHH-------------HHHHHHHcCCCCCCCC
Confidence 9999999987653211 1112236677766544333333333322 22223222 3334333
Q ss_pred CChhhhhhccCcC-CCCCCCCCccchHHHHhcccCcCCCCCCChhhhhhC
Q psy758 212 WSCDQLLRHPYFN-GYYFEVPDEMQYEEITQRCLDKDPLRRWSCDQLLRH 260 (292)
Q Consensus 212 ~~~~~~~~~~~~~-~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~~il~h 260 (292)
.+..++....-.. ....+...+..+.+++.+||+.||.+||++.+|+++
T Consensus 230 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~i~~~ 279 (283)
T cd05090 230 FSNQEVIEMVRKRQLLPCSEDCPPRMYSLMTECWQEGPSRRPRFKDIHTR 279 (283)
T ss_pred CCHHHHHHHHHcCCcCCCCCCCCHHHHHHHHHHcccCcccCcCHHHHHHH
Confidence 2222222111000 012233457789999999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 1 (Ror1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly |
| >cd05059 PTKc_Tec_like Catalytic domain of Tec-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.9e-36 Score=239.36 Aligned_cols=242 Identities=23% Similarity=0.317 Sum_probs=178.3
Q ss_pred cccceeeeecccCceEEEEEEEcCCCcEEEEEEeccCCCChHHHHHHHHHHHHHHhCCCCCcchhhhhhhcCCeEEEEEe
Q psy758 2 ERYEKIGKLGEGSYGVVFKCRNRDTGQVVAIKKFLESEEDPLIRKIALREIRLLKSLKHPNLVNLLEVFRRKKKLHLVFE 81 (292)
Q Consensus 2 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~iv~e 81 (292)
.+|++.+.||+|++|.||++.+. ++..+++|.+...... ...+.+|+.+++.++||||+++++++.+.+..++|+|
T Consensus 4 ~~~~~~~~lg~G~~~~v~~~~~~-~~~~~~iK~~~~~~~~---~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e 79 (256)
T cd05059 4 SELTFLKELGSGQFGVVHLGKWR-GKIDVAIKMIREGAMS---EDDFIEEAKVMMKLSHPNLVQLYGVCTKQRPIFIVTE 79 (256)
T ss_pred HHcchhhhhccCCCceEEEeEec-CCccEEEEEeccCCCC---HHHHHHHHHHHHhCCCCCEEEEEEEEcCCCceEEEEe
Confidence 47899999999999999999876 4668999998654433 2356789999999999999999999999999999999
Q ss_pred cCCCccHHHHhcC-CCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEEccCCcEEEeecCchhhhhcccc----
Q psy758 82 FCDHTVLNELENH-PHGLPWDLIKQITWQVLRGVSYCHRHACIHRDIKPENILLTANGVVKLCDFGFARLIRDLIP---- 156 (292)
Q Consensus 82 ~~~~~~L~~~~~~-~~~~~~~~~~~i~~qi~~aL~~LH~~givH~dl~p~Nilv~~~~~~kl~dfg~~~~~~~~~~---- 156 (292)
|+++++|.+++.. ...+++..++.++.||+.||+|||++|++|+||+|+||++++++.++|+|||.+....+...
T Consensus 80 ~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dl~p~ni~i~~~~~~kl~dfg~~~~~~~~~~~~~~ 159 (256)
T cd05059 80 YMANGCLLNYLRERKGKLGTEWLLDMCSDVCEAMEYLESNGFIHRDLAARNCLVGEDNVVKVSDFGLARYVLDDQYTSSQ 159 (256)
T ss_pred cCCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCCcccccccHhhEEECCCCcEEECCcccceecccccccccC
Confidence 9999999998864 34689999999999999999999999999999999999999999999999998875432111
Q ss_pred --ccccccccccccccCCCCCCCcccceeeecCCCCCCchHHHHHHHhhc-ccCCCCCCChhhhhhccCcC-CCCCCCCC
Q psy758 157 --RHLHIFQTNEYFKGVSLPHAENVVPLEIKIGKPAATNIYLIDFLKRCL-DKDPLRRWSCDQLLRHPYFN-GYYFEVPD 232 (292)
Q Consensus 157 --~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~p~~~~~~~~~~~~~~~~-~~~~~~~~ 232 (292)
.....|.+||...+.......++|++ +.-++..+. +..|....+..+........ ....+...
T Consensus 160 ~~~~~~~y~~Pe~~~~~~~~~~~Di~sl-------------G~il~~l~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 226 (256)
T cd05059 160 GTKFPVKWAPPEVFDYSRFSSKSDVWSF-------------GVLMWEVFSEGKMPYERFSNSEVVESVSAGYRLYRPKLA 226 (256)
T ss_pred CCCCCccccCHHHhccCCCCchhhHHHH-------------HHHHHHHhccCCCCCCCCCHHHHHHHHHcCCcCCCCCCC
Confidence 11123566666554333322333332 222222222 33343333333322211100 11223345
Q ss_pred ccchHHHHhcccCcCCCCCCChhhhhhC
Q psy758 233 EMQYEEITQRCLDKDPLRRWSCDQLLRH 260 (292)
Q Consensus 233 ~~~l~~li~~~l~~dP~~Rpt~~~il~h 260 (292)
+..+.+++.+||+.+|++|||+.++++.
T Consensus 227 ~~~~~~li~~cl~~~p~~Rpt~~~~l~~ 254 (256)
T cd05059 227 PTEVYTIMYSCWHEKPEDRPAFKKLLSQ 254 (256)
T ss_pred CHHHHHHHHHHhcCChhhCcCHHHHHHH
Confidence 7889999999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows |
| >cd05033 PTKc_EphR Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.4e-35 Score=235.86 Aligned_cols=245 Identities=19% Similarity=0.242 Sum_probs=180.2
Q ss_pred cccceeeeecccCceEEEEEEEcCC---CcEEEEEEeccCCCChHHHHHHHHHHHHHHhCCCCCcchhhhhhhcCCeEEE
Q psy758 2 ERYEKIGKLGEGSYGVVFKCRNRDT---GQVVAIKKFLESEEDPLIRKIALREIRLLKSLKHPNLVNLLEVFRRKKKLHL 78 (292)
Q Consensus 2 ~~y~~~~~l~~g~~~~v~~~~~~~~---~~~v~iK~~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~i 78 (292)
++|++.+.||+|+||.||+|....+ ...|++|.+.... .......+.+|+.+++.++||||+++++++.+++..++
T Consensus 4 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~vaik~~~~~~-~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~i 82 (266)
T cd05033 4 SYVTIEKVIGGGEFGEVCRGRLKLPGKKEIDVAIKTLKAGS-SDKQRLDFLTEASIMGQFDHPNIIRLEGVVTKSRPVMI 82 (266)
T ss_pred HHceeeeEecCCccceEEEEEEccCCCCcceEEEEEcCCCC-ChHHHHHHHHHHHHHHhCCCCCcceEeEEEecCCceEE
Confidence 5799999999999999999988654 4579999886543 33445668889999999999999999999999999999
Q ss_pred EEecCCCccHHHHhcCC-CCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEEccCCcEEEeecCchhhhhcccc-
Q psy758 79 VFEFCDHTVLNELENHP-HGLPWDLIKQITWQVLRGVSYCHRHACIHRDIKPENILLTANGVVKLCDFGFARLIRDLIP- 156 (292)
Q Consensus 79 v~e~~~~~~L~~~~~~~-~~~~~~~~~~i~~qi~~aL~~LH~~givH~dl~p~Nilv~~~~~~kl~dfg~~~~~~~~~~- 156 (292)
++||+++++|.+++... +.+++..++.++.|++.||.|||++|++|+||+|+||++++++.++|+|||++........
T Consensus 83 v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~~l~~Lh~~~i~H~di~p~nili~~~~~~~l~dfg~~~~~~~~~~~ 162 (266)
T cd05033 83 ITEYMENGSLDKFLRENDGKFTVGQLVGMLRGIASGMKYLSEMNYVHRDLAARNILVNSNLVCKVSDFGLSRRLEDSEAT 162 (266)
T ss_pred EEEcCCCCCHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCcceEEEcCCCCEEECccchhhcccccccc
Confidence 99999999999988653 4689999999999999999999999999999999999999999999999999987641111
Q ss_pred ------ccccccccccccccCCCCCCCcccceeeecCCCCCCchHHHHHHHhhc-ccCCCCCCChhhhhhccCc-CCCCC
Q psy758 157 ------RHLHIFQTNEYFKGVSLPHAENVVPLEIKIGKPAATNIYLIDFLKRCL-DKDPLRRWSCDQLLRHPYF-NGYYF 228 (292)
Q Consensus 157 ------~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~p~~~~~~~~~~~~~~~-~~~~~ 228 (292)
.....|.+|+...+.......++|++ +.-++..+. +..|....+..++....-- .....
T Consensus 163 ~~~~~~~~~~~y~~Pe~~~~~~~~~~~Dv~sl-------------G~~l~~l~~~g~~p~~~~~~~~~~~~~~~~~~~~~ 229 (266)
T cd05033 163 YTTKGGKIPIRWTAPEAIAYRKFTSASDVWSF-------------GIVMWEVMSYGERPYWDMSNQDVIKAVEDGYRLPP 229 (266)
T ss_pred eeccCCCCCccccChhhhccCCCccccchHHH-------------HHHHHHHHccCCCCCCCCCHHHHHHHHHcCCCCCC
Confidence 11123555655544333222233222 222333232 3444433333322211100 01122
Q ss_pred CCCCccchHHHHhcccCcCCCCCCChhhhhhC
Q psy758 229 EVPDEMQYEEITQRCLDKDPLRRWSCDQLLRH 260 (292)
Q Consensus 229 ~~~~~~~l~~li~~~l~~dP~~Rpt~~~il~h 260 (292)
+...+..+.+++.+||+.||++||++.+++++
T Consensus 230 ~~~~~~~l~~li~~cl~~~p~~Rp~~~ei~~~ 261 (266)
T cd05033 230 PMDCPSALYQLMLDCWQKDRNERPTFSQIVST 261 (266)
T ss_pred CCCCCHHHHHHHHHHcCCCcccCcCHHHHHHH
Confidence 33447789999999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment |
| >cd05053 PTKc_FGFR Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-35 Score=240.90 Aligned_cols=240 Identities=25% Similarity=0.345 Sum_probs=178.2
Q ss_pred cccceeeeecccCceEEEEEEEcCC-----CcEEEEEEeccCCCChHHHHHHHHHHHHHHhC-CCCCcchhhhhhhcCCe
Q psy758 2 ERYEKIGKLGEGSYGVVFKCRNRDT-----GQVVAIKKFLESEEDPLIRKIALREIRLLKSL-KHPNLVNLLEVFRRKKK 75 (292)
Q Consensus 2 ~~y~~~~~l~~g~~~~v~~~~~~~~-----~~~v~iK~~~~~~~~~~~~~~~~~e~~~~~~l-~~~~i~~~~~~~~~~~~ 75 (292)
++|++.+.||+|++|.||++..... ...+++|.+..... ......+.+|+.+++.+ +|+||+++++++..++.
T Consensus 12 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~~~a~k~~~~~~~-~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~~ 90 (293)
T cd05053 12 DRLTLGKPLGEGAFGQVVKAEAVGLDNPNETSTVAVKMLKDDAT-EKDLSDLVSEMEMMKMIGKHKNIINLLGVCTQEGP 90 (293)
T ss_pred hHeEEeeEecccccccEEEEEEecCCCCCCceeEEEEEccCCCC-HHHHHHHHHHHHHHHhhcCCCCeeeEEEEEcCCCC
Confidence 5799999999999999999987643 36799998875433 33446688999999999 79999999999999999
Q ss_pred EEEEEecCCCccHHHHhcC----------------CCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEEccCCc
Q psy758 76 LHLVFEFCDHTVLNELENH----------------PHGLPWDLIKQITWQVLRGVSYCHRHACIHRDIKPENILLTANGV 139 (292)
Q Consensus 76 ~~iv~e~~~~~~L~~~~~~----------------~~~~~~~~~~~i~~qi~~aL~~LH~~givH~dl~p~Nilv~~~~~ 139 (292)
++++|||+++++|..++.. ...+++..++.++.|++.||+|||++|++|+||+|+||++++++.
T Consensus 91 ~~li~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~ivH~dlkp~Nil~~~~~~ 170 (293)
T cd05053 91 LYVVVEYAAHGNLRDFLRARRPPGEYASPDDPRPPEETLTQKDLVSFAYQVARGMEFLASKKCIHRDLAARNVLVTEDHV 170 (293)
T ss_pred eEEEEEeCCCCcHHHHHHhcCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHHCCccccccceeeEEEcCCCe
Confidence 9999999999999998843 345899999999999999999999999999999999999999999
Q ss_pred EEEeecCchhhhhccc-------cccccccccccccccCCC-----CCCCcccceeeec-CCCCCCchHHHHHHHhhccc
Q psy758 140 VKLCDFGFARLIRDLI-------PRHLHIFQTNEYFKGVSL-----PHAENVVPLEIKI-GKPAATNIYLIDFLKRCLDK 206 (292)
Q Consensus 140 ~kl~dfg~~~~~~~~~-------~~~~~~~~~~~~~~~~~~-----~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~ 206 (292)
++|+|||.+....... ......|.+||...+... .|+.|+..+++.+ |..
T Consensus 171 ~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~----------------- 233 (293)
T cd05053 171 MKIADFGLARDIHHIDYYRKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFTLGGS----------------- 233 (293)
T ss_pred EEeCccccccccccccceeccCCCCCCccccCHHHhccCCcCcccceeehhhHHHHHhcCCCC-----------------
Confidence 9999999987654321 111234667776554433 3444443333332 322
Q ss_pred CCCCCCChhhhhhccCcC-CCCCCCCCccchHHHHhcccCcCCCCCCChhhhhhC
Q psy758 207 DPLRRWSCDQLLRHPYFN-GYYFEVPDEMQYEEITQRCLDKDPLRRWSCDQLLRH 260 (292)
Q Consensus 207 ~p~~~~~~~~~~~~~~~~-~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~~il~h 260 (292)
|.......+........ ....+...+..+.+|+.+||..||++|||+.+++++
T Consensus 234 -p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~eil~~ 287 (293)
T cd05053 234 -PYPGIPVEELFKLLKEGYRMEKPQNCTQELYHLMRDCWHEVPSQRPTFKQLVED 287 (293)
T ss_pred -CCCCCCHHHHHHHHHcCCcCCCCCCCCHHHHHHHHHHcccCcccCcCHHHHHHH
Confidence 22222222221111000 111233446789999999999999999999999984
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation, |
| >PF07714 Pkinase_Tyr: Protein tyrosine kinase Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-36 Score=243.31 Aligned_cols=240 Identities=27% Similarity=0.415 Sum_probs=172.7
Q ss_pred ceeeeecccCceEEEEEEEc----CCCcEEEEEEeccCCCChHHHHHHHHHHHHHHhCCCCCcchhhhhhhcCCeEEEEE
Q psy758 5 EKIGKLGEGSYGVVFKCRNR----DTGQVVAIKKFLESEEDPLIRKIALREIRLLKSLKHPNLVNLLEVFRRKKKLHLVF 80 (292)
Q Consensus 5 ~~~~~l~~g~~~~v~~~~~~----~~~~~v~iK~~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~iv~ 80 (292)
++.+.||.|.||.||+|... ..+..|++|.+.. .......+.+.+|++.++.++||||++++|++...+..++|+
T Consensus 2 ~~~~~ig~G~fg~v~~~~~~~~~~~~~~~V~vk~~~~-~~~~~~~~~~~~e~~~l~~l~h~ni~~~~g~~~~~~~~~lv~ 80 (259)
T PF07714_consen 2 KLIKQIGEGSFGKVYRAEWKQKDNDKNQPVAVKILKP-SSSEEEEEEFLNEIQILRKLRHPNIVKLYGFCIENEPLFLVM 80 (259)
T ss_dssp EEEEEEEEESSEEEEEEEEESTTTSSEEEEEEEEEST-TSSHHHHHHHHHHHHHHHTHSBTTBE-EEEEEESSSSEEEEE
T ss_pred EEeeEEccCCCcEEEEEEEEcccCCCCEEEEEEEecc-ccccccceeeeecccccccccccccccccccccccccccccc
Confidence 46789999999999999887 3456799999954 344445788899999999999999999999999888899999
Q ss_pred ecCCCccHHHHhcCC--CCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEEccCCcEEEeecCchhhhhcc----
Q psy758 81 EFCDHTVLNELENHP--HGLPWDLIKQITWQVLRGVSYCHRHACIHRDIKPENILLTANGVVKLCDFGFARLIRDL---- 154 (292)
Q Consensus 81 e~~~~~~L~~~~~~~--~~~~~~~~~~i~~qi~~aL~~LH~~givH~dl~p~Nilv~~~~~~kl~dfg~~~~~~~~---- 154 (292)
||+++|+|.+++... ..++...++.++.||+.||.|||+++++|++|+++||+++.++.+||+|||++......
T Consensus 81 e~~~~g~L~~~L~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~iiH~~l~~~nill~~~~~~Kl~~f~~~~~~~~~~~~~ 160 (259)
T PF07714_consen 81 EYCPGGSLDDYLKSKNKEPLSEQQRLSIAIQIAEALSYLHSNNIIHGNLSPSNILLDSNGQVKLSDFGLSRPISEKSKYK 160 (259)
T ss_dssp E--TTEBHHHHHHHTCTTTSBHHHHHHHHHHHHHHHHHHHHTTEEEST-SGGGEEEETTTEEEEESTTTGEETTTSSSEE
T ss_pred cccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccc
Confidence 999999999988765 67999999999999999999999999999999999999999999999999998766211
Q ss_pred ---ccccccccccccccccCCCCCCCcccceeeecCCCCCCchHHHHHHHhhc-ccCCCCCCChhhhhhccCcCCC--CC
Q psy758 155 ---IPRHLHIFQTNEYFKGVSLPHAENVVPLEIKIGKPAATNIYLIDFLKRCL-DKDPLRRWSCDQLLRHPYFNGY--YF 228 (292)
Q Consensus 155 ---~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~p~~~~~~~~~~~~~~~~~~--~~ 228 (292)
.......|.+||...+.......|++++ +.-+++.+. +..|.......++.... ..+. ..
T Consensus 161 ~~~~~~~~~~~~aPE~~~~~~~~~ksDVysf-------------G~~l~ei~~~~~~p~~~~~~~~~~~~~-~~~~~~~~ 226 (259)
T PF07714_consen 161 NDSSQQLPLRYLAPEVLKDGEYTKKSDVYSF-------------GMLLYEILTLGKFPFSDYDNEEIIEKL-KQGQRLPI 226 (259)
T ss_dssp ESTTSESGGGGS-HHHHHHSEESHHHHHHHH-------------HHHHHHHHTTSSGTTTTSCHHHHHHHH-HTTEETTS
T ss_pred ccccccccccccccccccccccccccccccc-------------ccccccccccccccccccccccccccc-ccccccee
Confidence 1112223445555433332222222222 222333333 33455444444433322 1121 22
Q ss_pred CCCCccchHHHHhcccCcCCCCCCChhhhhh
Q psy758 229 EVPDEMQYEEITQRCLDKDPLRRWSCDQLLR 259 (292)
Q Consensus 229 ~~~~~~~l~~li~~~l~~dP~~Rpt~~~il~ 259 (292)
+...+..+.++|.+||+.||.+|||+.++++
T Consensus 227 ~~~~~~~~~~li~~C~~~~p~~RPs~~~i~~ 257 (259)
T PF07714_consen 227 PDNCPKDIYSLIQQCWSHDPEKRPSFQEILQ 257 (259)
T ss_dssp BTTSBHHHHHHHHHHT-SSGGGS--HHHHHH
T ss_pred ccchhHHHHHHHHHHcCCChhhCcCHHHHHh
Confidence 3345788999999999999999999999975
|
Tyrosine kinase, catalytic domain; InterPro: IPR001245 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Tyrosine-protein kinases can transfer a phosphate group from ATP to a tyrosine residue in a protein. These enzymes can be divided into two main groups []: Receptor tyrosine kinases (RTK), which are transmembrane proteins involved in signal transduction; they play key roles in growth, differentiation, metabolism, adhesion, motility, death and oncogenesis []. RTKs are composed of 3 domains: an extracellular domain (binds ligand), a transmembrane (TM) domain, and an intracellular catalytic domain (phosphorylates substrate). The TM domain plays an important role in the dimerisation process necessary for signal transduction []. Cytoplasmic / non-receptor tyrosine kinases, which act as regulatory proteins, playing key roles in cell differentiation, motility, proliferation, and survival. For example, the Src-family of protein-tyrosine kinases []. ; GO: 0004672 protein kinase activity, 0006468 protein phosphorylation; PDB: 2HYY_C 1OPL_A 2V7A_A 2G2H_B 2G1T_A 3PYY_A 3CS9_D 2HZI_A 2E2B_A 2HIW_A .... |
| >cd05093 PTKc_TrkB Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-35 Score=241.90 Aligned_cols=243 Identities=22% Similarity=0.278 Sum_probs=177.9
Q ss_pred cccceeeeecccCceEEEEEEEc-----CCCcEEEEEEeccCCCChHHHHHHHHHHHHHHhCCCCCcchhhhhhhcCCeE
Q psy758 2 ERYEKIGKLGEGSYGVVFKCRNR-----DTGQVVAIKKFLESEEDPLIRKIALREIRLLKSLKHPNLVNLLEVFRRKKKL 76 (292)
Q Consensus 2 ~~y~~~~~l~~g~~~~v~~~~~~-----~~~~~v~iK~~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~ 76 (292)
..|.+.+.||+|++|.||++.+. .++..+++|.+.... ......+.+|+.+++.++||||+++++++...+.+
T Consensus 5 ~~~~~~~~lg~G~~~~v~~~~~~~~~~~~~~~~~~ik~~~~~~--~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~ 82 (288)
T cd05093 5 HNIVLKRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDAS--DNARKDFHREAELLTNLQHEHIVKFYGVCVEGDPL 82 (288)
T ss_pred HHeeeccccCCcCCeeEEeeEeccCCCCCcceEEEEEecCCcC--HHHHHHHHHHHHHHHhCCCCCcceEEEEEecCCcc
Confidence 36889999999999999999853 345678999886443 34456788999999999999999999999999999
Q ss_pred EEEEecCCCccHHHHhcCCC-------------CCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEEccCCcEEEe
Q psy758 77 HLVFEFCDHTVLNELENHPH-------------GLPWDLIKQITWQVLRGVSYCHRHACIHRDIKPENILLTANGVVKLC 143 (292)
Q Consensus 77 ~iv~e~~~~~~L~~~~~~~~-------------~~~~~~~~~i~~qi~~aL~~LH~~givH~dl~p~Nilv~~~~~~kl~ 143 (292)
++++||+++++|.+++...+ .+++..++.++.|++.||+|||++|++||||+|+||++++++.++|+
T Consensus 83 ~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~l~~~~~~~~~~ql~~aL~~lH~~~i~H~dlkp~Nili~~~~~~kl~ 162 (288)
T cd05093 83 IMVFEYMKHGDLNKFLRAHGPDAVLMAEGNRPAELTQSQMLHIAQQIAAGMVYLASQHFVHRDLATRNCLVGENLLVKIG 162 (288)
T ss_pred EEEEEcCCCCCHHHHHHHcCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeecccCcceEEEccCCcEEec
Confidence 99999999999999886432 48999999999999999999999999999999999999999999999
Q ss_pred ecCchhhhhcccc-------ccccccccccccccCCCCCCCcccceeeecCCCCCCchHHHHHHHhhc-ccCCCCCCChh
Q psy758 144 DFGFARLIRDLIP-------RHLHIFQTNEYFKGVSLPHAENVVPLEIKIGKPAATNIYLIDFLKRCL-DKDPLRRWSCD 215 (292)
Q Consensus 144 dfg~~~~~~~~~~-------~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~p~~~~~~~ 215 (292)
|||++........ .....|.+||...+.......++|+++ .-++..+. +..|+......
T Consensus 163 dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDiwslG-------------~il~~l~t~g~~p~~~~~~~ 229 (288)
T cd05093 163 DFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSLG-------------VVLWEIFTYGKQPWYQLSNN 229 (288)
T ss_pred cCCccccccCCceeecCCCCCccccccCHHHhccCCCCchhhHHHHH-------------HHHHHHHhCCCCCCCCCCHH
Confidence 9999875432111 112246666665544333233333322 22223332 33344333333
Q ss_pred hhhhccCcCC-CCCCCCCccchHHHHhcccCcCCCCCCChhhhhh
Q psy758 216 QLLRHPYFNG-YYFEVPDEMQYEEITQRCLDKDPLRRWSCDQLLR 259 (292)
Q Consensus 216 ~~~~~~~~~~-~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~~il~ 259 (292)
+......... ...+...+..+.+|+.+||+.||.+|||+.++++
T Consensus 230 ~~~~~i~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~v~~ 274 (288)
T cd05093 230 EVIECITQGRVLQRPRTCPKEVYDLMLGCWQREPHMRLNIKEIHS 274 (288)
T ss_pred HHHHHHHcCCcCCCCCCCCHHHHHHHHHHccCChhhCCCHHHHHH
Confidence 2221110000 1123345678999999999999999999999976
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly |
| >cd05062 PTKc_IGF-1R Catalytic domain of the Protein Tyrosine Kinase, Insulin-like Growth Factor-1 Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-35 Score=240.91 Aligned_cols=245 Identities=20% Similarity=0.245 Sum_probs=177.9
Q ss_pred cccceeeeecccCceEEEEEEEcC-----CCcEEEEEEeccCCCChHHHHHHHHHHHHHHhCCCCCcchhhhhhhcCCeE
Q psy758 2 ERYEKIGKLGEGSYGVVFKCRNRD-----TGQVVAIKKFLESEEDPLIRKIALREIRLLKSLKHPNLVNLLEVFRRKKKL 76 (292)
Q Consensus 2 ~~y~~~~~l~~g~~~~v~~~~~~~-----~~~~v~iK~~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~ 76 (292)
++|++.+.||+|++|.||.|.+.. ++..|++|.+..... ......+.+|+.+++.++||||+++++++.+++..
T Consensus 6 ~~~~~~~~ig~G~~g~v~~~~~~~~~~~~~~~~~aik~~~~~~~-~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~~~~ 84 (277)
T cd05062 6 EKITMSRELGQGSFGMVYEGIAKGVVKDEPETRVAIKTVNEAAS-MRERIEFLNEASVMKEFNCHHVVRLLGVVSQGQPT 84 (277)
T ss_pred HHceeeeeeccccCCeEEEEEeccCCCCCceeEEEEEeccccCC-HHHHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCCe
Confidence 579999999999999999998642 356799998854332 23455688999999999999999999999999999
Q ss_pred EEEEecCCCccHHHHhcCCC----------CCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEEccCCcEEEeecC
Q psy758 77 HLVFEFCDHTVLNELENHPH----------GLPWDLIKQITWQVLRGVSYCHRHACIHRDIKPENILLTANGVVKLCDFG 146 (292)
Q Consensus 77 ~iv~e~~~~~~L~~~~~~~~----------~~~~~~~~~i~~qi~~aL~~LH~~givH~dl~p~Nilv~~~~~~kl~dfg 146 (292)
++|+||+++++|.+++.... .++...+..++.|++.||.|||++|++|+||||+||++++++.++|+|||
T Consensus 85 ~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~vH~dlkp~Nil~~~~~~~~l~dfg 164 (277)
T cd05062 85 LVIMELMTRGDLKSYLRSLRPEMENNPVQAPPSLKKMIQMAGEIADGMAYLNANKFVHRDLAARNCMVAEDFTVKIGDFG 164 (277)
T ss_pred EEEEecCCCCCHHHHHHHcCccccccccccCCCHHHHHHHHHHHHHHHHHHHHCCcccCCcchheEEEcCCCCEEECCCC
Confidence 99999999999999886422 35678899999999999999999999999999999999999999999999
Q ss_pred chhhhhcccc-------ccccccccccccccCCCCCCCcccceeeecCCCCCCchHHHHHHHhhc-ccCCCCCCChhhhh
Q psy758 147 FARLIRDLIP-------RHLHIFQTNEYFKGVSLPHAENVVPLEIKIGKPAATNIYLIDFLKRCL-DKDPLRRWSCDQLL 218 (292)
Q Consensus 147 ~~~~~~~~~~-------~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~p~~~~~~~~~~ 218 (292)
++........ .....|.+||...+.......++|++ +..+++.+. +..|....+..+..
T Consensus 165 ~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~sl-------------G~~l~el~~~~~~p~~~~~~~~~~ 231 (277)
T cd05062 165 MTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSF-------------GVVLWEIATLAEQPYQGMSNEQVL 231 (277)
T ss_pred CccccCCcceeecCCCCccCHhhcChhHhhcCCcCchhHHHHH-------------HHHHHHHHcCCCCCCCCCCHHHHH
Confidence 9865432111 11223666666544333222233332 222223332 23344333333333
Q ss_pred hccCcCC-CCCCCCCccchHHHHhcccCcCCCCCCChhhhhhC
Q psy758 219 RHPYFNG-YYFEVPDEMQYEEITQRCLDKDPLRRWSCDQLLRH 260 (292)
Q Consensus 219 ~~~~~~~-~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~~il~h 260 (292)
....... ...+...+..+.+++.+||+.||++|||+.+++++
T Consensus 232 ~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~ 274 (277)
T cd05062 232 RFVMEGGLLDKPDNCPDMLFELMRMCWQYNPKMRPSFLEIISS 274 (277)
T ss_pred HHHHcCCcCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence 2211111 12233456789999999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Insulin-like Growth Factor-1 Receptor (IGF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. IGF-1R is a receptor tyr kinases (RTK) that is composed of two alphabeta heterodimers. Binding of the ligand (IGF-1 or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, which stimulates downstream kinase activities and biological function. IGF-1R signaling is important in the differentiation, growth, and survival of normal cells. In cancer cells, wh |
| >cd05054 PTKc_VEGFR Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-35 Score=247.31 Aligned_cols=245 Identities=24% Similarity=0.341 Sum_probs=175.1
Q ss_pred cccceeeeecccCceEEEEEEEcC-----CCcEEEEEEeccCCCChHHHHHHHHHHHHHHhC-CCCCcchhhhhhhc-CC
Q psy758 2 ERYEKIGKLGEGSYGVVFKCRNRD-----TGQVVAIKKFLESEEDPLIRKIALREIRLLKSL-KHPNLVNLLEVFRR-KK 74 (292)
Q Consensus 2 ~~y~~~~~l~~g~~~~v~~~~~~~-----~~~~v~iK~~~~~~~~~~~~~~~~~e~~~~~~l-~~~~i~~~~~~~~~-~~ 74 (292)
++|++++.||.|+||.||.|.+.. +++.||+|++..... ....+.+.+|+.+++.+ +|+||+++++++.. +.
T Consensus 7 ~~~~i~~~lG~G~fg~Vy~a~~~~~~~~~~~~~va~K~~~~~~~-~~~~~~~~~E~~~~~~l~~h~niv~~~~~~~~~~~ 85 (337)
T cd05054 7 DRLKLGKPLGRGAFGKVIQASAFGIEKSASCRTVAVKMLKEGAT-ASEYKALMTELKILIHIGHHLNVVNLLGACTKPGG 85 (337)
T ss_pred HHhhhhcccccCcCceEEeccccccccccccceeeeeeccCCCC-HHHHHHHHHHHHHHHhhccCcchhheeeeEecCCC
Confidence 489999999999999999997543 457899999865433 33456678899999999 79999999998764 56
Q ss_pred eEEEEEecCCCccHHHHhcCC-----------------------------------------------------------
Q psy758 75 KLHLVFEFCDHTVLNELENHP----------------------------------------------------------- 95 (292)
Q Consensus 75 ~~~iv~e~~~~~~L~~~~~~~----------------------------------------------------------- 95 (292)
.+++++||+++++|..++...
T Consensus 86 ~~~~v~ey~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 165 (337)
T cd05054 86 PLMVIVEYCKFGNLSNYLRSKRECFSPYRNKSTRKREMKQKEGKKQRLDSVSSSQSSASSGFIEDKSLSDVEEDEEGDEL 165 (337)
T ss_pred CEEEEEecCCCCCHHHHHHhccccccccccccccccccccccccccccccCCccccccccccccCcchhhcccchhhhHH
Confidence 789999999999999887531
Q ss_pred --CCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEEccCCcEEEeecCchhhhhccc-------ccccccccccc
Q psy758 96 --HGLPWDLIKQITWQVLRGVSYCHRHACIHRDIKPENILLTANGVVKLCDFGFARLIRDLI-------PRHLHIFQTNE 166 (292)
Q Consensus 96 --~~~~~~~~~~i~~qi~~aL~~LH~~givH~dl~p~Nilv~~~~~~kl~dfg~~~~~~~~~-------~~~~~~~~~~~ 166 (292)
..+++..+..++.||+.||+|||++||+||||||+||++++++.++|+|||++..+.... ......|.+||
T Consensus 166 ~~~~l~~~~~~~~~~qi~~aL~~lH~~~ivHrDikp~Nill~~~~~vkL~DfG~a~~~~~~~~~~~~~~~~~~~~y~aPE 245 (337)
T cd05054 166 YKEPLTLEDLISYSFQVARGMEFLASRKCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPE 245 (337)
T ss_pred hhcCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCcceEEEeCCCcEEEeccccchhcccCcchhhccCCCCCccccCcH
Confidence 257889999999999999999999999999999999999999999999999997653211 11123467777
Q ss_pred ccccCCCCCCCcccceeeecCCCCCCchHHHHHHHhhc-ccCCCCCCChhhhhhccCcC--CCCCCCCCccchHHHHhcc
Q psy758 167 YFKGVSLPHAENVVPLEIKIGKPAATNIYLIDFLKRCL-DKDPLRRWSCDQLLRHPYFN--GYYFEVPDEMQYEEITQRC 243 (292)
Q Consensus 167 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~p~~~~~~~~~~~~~~~~--~~~~~~~~~~~l~~li~~~ 243 (292)
+..+.......++|++++ .+++.+. +..|.......+.+....-. ....+...+..+.+++.+|
T Consensus 246 ~~~~~~~~~~~Di~SlGv-------------~l~el~t~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~c 312 (337)
T cd05054 246 SIFDKVYTTQSDVWSFGV-------------LLWEIFSLGASPYPGVQIDEEFCRRLKEGTRMRAPEYATPEIYSIMLDC 312 (337)
T ss_pred HhcCCCCCccccHHHHHH-------------HHHHHHHcCCCCCCCCCccHHHHHHHhccCCCCCCccCCHHHHHHHHHH
Confidence 665544433334433322 2222221 22232211111111110000 0112233467899999999
Q ss_pred cCcCCCCCCChhhhhhC
Q psy758 244 LDKDPLRRWSCDQLLRH 260 (292)
Q Consensus 244 l~~dP~~Rpt~~~il~h 260 (292)
|+.+|++|||+.++++|
T Consensus 313 l~~~p~~RPs~~ell~~ 329 (337)
T cd05054 313 WHNNPEDRPTFSELVEI 329 (337)
T ss_pred ccCChhhCcCHHHHHHH
Confidence 99999999999999984
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to recepto |
| >cd05113 PTKc_Btk_Bmx Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-35 Score=238.14 Aligned_cols=242 Identities=21% Similarity=0.279 Sum_probs=176.9
Q ss_pred cccceeeeecccCceEEEEEEEcCCCcEEEEEEeccCCCChHHHHHHHHHHHHHHhCCCCCcchhhhhhhcCCeEEEEEe
Q psy758 2 ERYEKIGKLGEGSYGVVFKCRNRDTGQVVAIKKFLESEEDPLIRKIALREIRLLKSLKHPNLVNLLEVFRRKKKLHLVFE 81 (292)
Q Consensus 2 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~iv~e 81 (292)
++|++.+.||+|++|.||.+.... +..+++|.+...... .+.+.+|+.+++.++||||+++++++.+....+++||
T Consensus 4 ~~~~~~~~lg~G~~~~vy~~~~~~-~~~~aik~~~~~~~~---~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 79 (256)
T cd05113 4 KDLTFLKELGTGQFGVVKYGKWRG-QYDVAIKMIKEGSMS---EDEFIEEAKVMMKLSHEKLVQLYGVCTKQRPIYIVTE 79 (256)
T ss_pred HHeEEeeEecCcccceEEEEEecC-CCcEEEEEcCCCccc---HHHHHHHHHHHhcCCCCCeeeEEEEEccCCCcEEEEE
Confidence 579999999999999999998754 456999988654332 3457889999999999999999999998888999999
Q ss_pred cCCCccHHHHhcCC-CCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEEccCCcEEEeecCchhhhhcccc----
Q psy758 82 FCDHTVLNELENHP-HGLPWDLIKQITWQVLRGVSYCHRHACIHRDIKPENILLTANGVVKLCDFGFARLIRDLIP---- 156 (292)
Q Consensus 82 ~~~~~~L~~~~~~~-~~~~~~~~~~i~~qi~~aL~~LH~~givH~dl~p~Nilv~~~~~~kl~dfg~~~~~~~~~~---- 156 (292)
|+.+++|.+++... ..+++..++.++.||+.||.|||++|++|+||+|+||++++++.++|+|||.+........
T Consensus 80 ~~~~~~l~~~i~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~nili~~~~~~kl~d~g~~~~~~~~~~~~~~ 159 (256)
T cd05113 80 YMSNGCLLNYLREHGKRFQPSQLLEMCKDVCEGMAYLESKQFIHRDLAARNCLVDDQGCVKVSDFGLSRYVLDDEYTSSV 159 (256)
T ss_pred cCCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeccccCcceEEEcCCCCEEECCCccceecCCCceeecC
Confidence 99999999988653 3689999999999999999999999999999999999999999999999998865432111
Q ss_pred --ccccccccccccccCCCCCCCcccceeeecCCCCCCchHHHHHHHhhc-ccCCCCCCChhhhhhccCcC-CCCCCCCC
Q psy758 157 --RHLHIFQTNEYFKGVSLPHAENVVPLEIKIGKPAATNIYLIDFLKRCL-DKDPLRRWSCDQLLRHPYFN-GYYFEVPD 232 (292)
Q Consensus 157 --~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~p~~~~~~~~~~~~~~~~-~~~~~~~~ 232 (292)
.....|.+||...+.......++|++ +..++..+. +..|....+..+........ ....+...
T Consensus 160 ~~~~~~~y~~pe~~~~~~~~~~~Di~sl-------------G~~l~~l~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 226 (256)
T cd05113 160 GSKFPVRWSPPEVLLYSKFSSKSDVWAF-------------GVLMWEVYSLGKMPYERFNNSETVEKVSQGLRLYRPHLA 226 (256)
T ss_pred CCccChhhCCHHHHhcCcccchhHHHHH-------------HHHHHHHhcCCCCCcCcCCHHHHHHHHhcCCCCCCCCCC
Confidence 11123566666544333222222222 222222222 33344333332222111100 01122334
Q ss_pred ccchHHHHhcccCcCCCCCCChhhhhhC
Q psy758 233 EMQYEEITQRCLDKDPLRRWSCDQLLRH 260 (292)
Q Consensus 233 ~~~l~~li~~~l~~dP~~Rpt~~~il~h 260 (292)
+..+.+++.+||+.||.+|||+.+++++
T Consensus 227 ~~~~~~li~~cl~~~p~~Rp~~~~ll~~ 254 (256)
T cd05113 227 SEKVYAIMYSCWHEKAEERPTFQQLLSS 254 (256)
T ss_pred CHHHHHHHHHHcCCCcccCCCHHHHHHh
Confidence 6789999999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds |
| >cd05068 PTKc_Frk_like Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-35 Score=237.52 Aligned_cols=241 Identities=23% Similarity=0.295 Sum_probs=178.5
Q ss_pred cccceeeeecccCceEEEEEEEcCCCcEEEEEEeccCCCChHHHHHHHHHHHHHHhCCCCCcchhhhhhhcCCeEEEEEe
Q psy758 2 ERYEKIGKLGEGSYGVVFKCRNRDTGQVVAIKKFLESEEDPLIRKIALREIRLLKSLKHPNLVNLLEVFRRKKKLHLVFE 81 (292)
Q Consensus 2 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~iv~e 81 (292)
++|++.+.||+|++|.||+|.+.. ++.|++|.+...... .+.+.+|+.+++.++||||+++++++...+..++++|
T Consensus 6 ~~~~~~~~lg~g~~~~v~~~~~~~-~~~v~iK~~~~~~~~---~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 81 (261)
T cd05068 6 TSIQLLRKLGAGQFGEVWEGLWNN-TTPVAVKTLKPGTMD---PKDFLAEAQIMKKLRHPKLIQLYAVCTLEEPIYIVTE 81 (261)
T ss_pred hheeeEEEecccCCccEEEEEecC-CeEEEEEeeCCCccc---HHHHHHHHHHHHHCCCCCccceeEEEecCCCeeeeee
Confidence 578999999999999999998754 578999998654332 3557789999999999999999999999999999999
Q ss_pred cCCCccHHHHhcCCC--CCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEEccCCcEEEeecCchhhhhcccccc-
Q psy758 82 FCDHTVLNELENHPH--GLPWDLIKQITWQVLRGVSYCHRHACIHRDIKPENILLTANGVVKLCDFGFARLIRDLIPRH- 158 (292)
Q Consensus 82 ~~~~~~L~~~~~~~~--~~~~~~~~~i~~qi~~aL~~LH~~givH~dl~p~Nilv~~~~~~kl~dfg~~~~~~~~~~~~- 158 (292)
|+++++|.+++.... .+++..+..++.|++.||.+||++|++|+||+|+||++++++.++|+|||++..........
T Consensus 82 ~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~~l~dfg~~~~~~~~~~~~~ 161 (261)
T cd05068 82 LMKYGSLLEYLQGGAGRALKLPQLIDMAAQVASGMAYLEAQNYIHRDLAARNVLVGENNICKVADFGLARVIKEDIYEAR 161 (261)
T ss_pred cccCCcHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCCcceEEEcCCCCEEECCcceEEEccCCccccc
Confidence 999999999986543 68999999999999999999999999999999999999999999999999987654321111
Q ss_pred -----ccccccccccccCCCCCCCcccceeeecCCCCCCchHHHHHHHhhc-ccCCCCCCChhhhhhccCcC-CCCCCCC
Q psy758 159 -----LHIFQTNEYFKGVSLPHAENVVPLEIKIGKPAATNIYLIDFLKRCL-DKDPLRRWSCDQLLRHPYFN-GYYFEVP 231 (292)
Q Consensus 159 -----~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~p~~~~~~~~~~~~~~~~-~~~~~~~ 231 (292)
...|.+||+..+.......++|+ .+..++..+. +..|....+..++.....-. ....+..
T Consensus 162 ~~~~~~~~y~aPE~~~~~~~~~~~Di~s-------------lG~~l~el~t~g~~p~~~~~~~~~~~~~~~~~~~~~~~~ 228 (261)
T cd05068 162 EGAKFPIKWTAPEAALYNRFSIKSDVWS-------------FGILLTEIVTYGRMPYPGMTNAEVLQQVDQGYRMPCPPG 228 (261)
T ss_pred CCCcCceeccCccccccCCCCchhhHHH-------------HHHHHHHHHhcCCCCCCCCCHHHHHHHHHcCCCCCCCCc
Confidence 12356666554433322222222 2222333332 33343333333222211000 1122334
Q ss_pred CccchHHHHhcccCcCCCCCCChhhhhh
Q psy758 232 DEMQYEEITQRCLDKDPLRRWSCDQLLR 259 (292)
Q Consensus 232 ~~~~l~~li~~~l~~dP~~Rpt~~~il~ 259 (292)
.+..+.+++.+||+.||.+||++.++++
T Consensus 229 ~~~~~~~li~~~l~~~P~~Rp~~~~l~~ 256 (261)
T cd05068 229 CPKELYDIMLDCWKEDPDDRPTFETLQW 256 (261)
T ss_pred CCHHHHHHHHHHhhcCcccCCCHHHHHH
Confidence 5778999999999999999999999976
|
Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins a |
| >cd00192 PTKc Catalytic domain of Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.9e-35 Score=235.40 Aligned_cols=239 Identities=25% Similarity=0.322 Sum_probs=182.4
Q ss_pred eeecccCceEEEEEEEcCC---CcEEEEEEeccCCCChHHHHHHHHHHHHHHhCCCCCcchhhhhhhcCCeEEEEEecCC
Q psy758 8 GKLGEGSYGVVFKCRNRDT---GQVVAIKKFLESEEDPLIRKIALREIRLLKSLKHPNLVNLLEVFRRKKKLHLVFEFCD 84 (292)
Q Consensus 8 ~~l~~g~~~~v~~~~~~~~---~~~v~iK~~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~iv~e~~~ 84 (292)
+.||+|++|.||+|.+... +..|++|.+....... ..+.+.+|+..++.++|+|++++++++.+...+++++||++
T Consensus 1 ~~ig~g~~g~v~~~~~~~~~~~~~~~~ik~~~~~~~~~-~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~~~ 79 (262)
T cd00192 1 KKLGEGAFGEVYKGKLKGKDGKTTEVAVKTLKEDASEE-ERKDFLKEARVMKKLGHPNVVRLLGVCTEEEPLYLVLEYME 79 (262)
T ss_pred CccccCCceEEEEEEEecCCCCCceEEeEeeccccchh-HHHHHHHHHHHHhhcCCCChheeeeeecCCCceEEEEEecc
Confidence 4689999999999999866 8899999987665443 56778899999999999999999999999999999999999
Q ss_pred CccHHHHhcCC---------CCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEEccCCcEEEeecCchhhhhccc
Q psy758 85 HTVLNELENHP---------HGLPWDLIKQITWQVLRGVSYCHRHACIHRDIKPENILLTANGVVKLCDFGFARLIRDLI 155 (292)
Q Consensus 85 ~~~L~~~~~~~---------~~~~~~~~~~i~~qi~~aL~~LH~~givH~dl~p~Nilv~~~~~~kl~dfg~~~~~~~~~ 155 (292)
+++|.+++... ..+++..++.++.|++.||++||++|++|+||+|+||++++++.++|+|||.+.......
T Consensus 80 ~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~~~i~H~di~p~nili~~~~~~~l~dfg~~~~~~~~~ 159 (262)
T cd00192 80 GGDLLDYLRKSRPVFPSPEKSTLSLKDLLSFAIQIAKGMEYLASKKFVHRDLAARNCLVGEDLVVKISDFGLSRDVYDDD 159 (262)
T ss_pred CCcHHHHHhhccccccccccccCCHHHHHHHHHHHHHHHHHHHcCCcccCccCcceEEECCCCcEEEccccccccccccc
Confidence 99999998775 679999999999999999999999999999999999999999999999999997765422
Q ss_pred -------cccccccccccccccCCCCCCCcccceeeecCCCCCCchHHHHHHHhhc-ccCCCCCCChhhhhhccC-cCCC
Q psy758 156 -------PRHLHIFQTNEYFKGVSLPHAENVVPLEIKIGKPAATNIYLIDFLKRCL-DKDPLRRWSCDQLLRHPY-FNGY 226 (292)
Q Consensus 156 -------~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~p~~~~~~~~~~~~~~-~~~~ 226 (292)
......|.+||...+.......++|++ +..++..+. +..|....+..++..... ....
T Consensus 160 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~sl-------------G~il~~l~~~g~~p~~~~~~~~~~~~~~~~~~~ 226 (262)
T cd00192 160 YYRKKTGGKLPIRWMAPESLKDGIFTSKSDVWSF-------------GVLLWEIFTLGATPYPGLSNEEVLEYLRKGYRL 226 (262)
T ss_pred ccccccCCCcCccccCHHHhccCCcchhhccHHH-------------HHHHHHHHhcCCCCCCCCCHHHHHHHHHcCCCC
Confidence 112234566665544433333333332 222333332 244444444333332211 1112
Q ss_pred CCCCCCccchHHHHhcccCcCCCCCCChhhhhhC
Q psy758 227 YFEVPDEMQYEEITQRCLDKDPLRRWSCDQLLRH 260 (292)
Q Consensus 227 ~~~~~~~~~l~~li~~~l~~dP~~Rpt~~~il~h 260 (292)
..+...+..+.+++.+||+.||.+|||+.+++++
T Consensus 227 ~~~~~~~~~~~~li~~~l~~~p~~Rps~~~l~~~ 260 (262)
T cd00192 227 PKPEYCPDELYELMLSCWQLDPEDRPTFSELVER 260 (262)
T ss_pred CCCccCChHHHHHHHHHccCCcccCcCHHHHHHh
Confidence 2334457899999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligan |
| >cd05051 PTKc_DDR Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-35 Score=242.95 Aligned_cols=244 Identities=20% Similarity=0.293 Sum_probs=179.2
Q ss_pred cccceeeeecccCceEEEEEEEcCCC----------------cEEEEEEeccCCCChHHHHHHHHHHHHHHhCCCCCcch
Q psy758 2 ERYEKIGKLGEGSYGVVFKCRNRDTG----------------QVVAIKKFLESEEDPLIRKIALREIRLLKSLKHPNLVN 65 (292)
Q Consensus 2 ~~y~~~~~l~~g~~~~v~~~~~~~~~----------------~~v~iK~~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~ 65 (292)
++|++++.||+|+||.||+|.+..++ ..|++|.+...... ...+.+.+|+.+++.++||||++
T Consensus 5 ~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~va~K~~~~~~~~-~~~~~~~~e~~~l~~l~~~~i~~ 83 (296)
T cd05051 5 QPLNFVEKLGEGQFGEVHLCEADGLQDFSEKAFAENDNADAPVLVAVKVLRPDASD-NAREDFLKEVKILSRLSDPNIAR 83 (296)
T ss_pred hhCcccccccCCCCccEEEEEeccCCcccccccccccccCCceeEEEEEecCccCH-HHHHHHHHHHHHHHhcCCCCEeE
Confidence 58999999999999999999876543 45799988755433 45677889999999999999999
Q ss_pred hhhhhhcCCeEEEEEecCCCccHHHHhcCCC-----------CCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEE
Q psy758 66 LLEVFRRKKKLHLVFEFCDHTVLNELENHPH-----------GLPWDLIKQITWQVLRGVSYCHRHACIHRDIKPENILL 134 (292)
Q Consensus 66 ~~~~~~~~~~~~iv~e~~~~~~L~~~~~~~~-----------~~~~~~~~~i~~qi~~aL~~LH~~givH~dl~p~Nilv 134 (292)
+++++..++..++++|++.+++|..++.... .+++..++.++.|++.||+|||++|++|+||+|+||++
T Consensus 84 ~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~al~~LH~~~i~H~dlkp~Nili 163 (296)
T cd05051 84 LLGVCTVDPPLCMIMEYMENGDLNQFLQKHVAETSGLACNSKSLSFSTLLYMATQIASGMRYLESLNFVHRDLATRNCLV 163 (296)
T ss_pred EEEEEecCCCcEEEEecCCCCCHHHHHHhcccccccccccCCCCCHHHHHHHHHHHHHHHHHHHHcCccccccchhceee
Confidence 9999998899999999999999999987654 68999999999999999999999999999999999999
Q ss_pred ccCCcEEEeecCchhhhhccc-------cccccccccccccccCCCCCCCcccceeeecCCCCCCchHHHHHHHhhc--c
Q psy758 135 TANGVVKLCDFGFARLIRDLI-------PRHLHIFQTNEYFKGVSLPHAENVVPLEIKIGKPAATNIYLIDFLKRCL--D 205 (292)
Q Consensus 135 ~~~~~~kl~dfg~~~~~~~~~-------~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~ 205 (292)
++++.++|+|||.+....... ...+..|.+||...+.......++|++++ .++..+. +
T Consensus 164 ~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~-------------~l~el~~~~~ 230 (296)
T cd05051 164 GKNYTIKIADFGMSRNLYSSDYYRVQGRAPLPIRWMAWESVLLGKFTTKSDVWAFGV-------------TLWEILTLCR 230 (296)
T ss_pred cCCCceEEccccceeecccCcceeecCcCCCCceecCHHHhhcCCCCccchhhhhHH-------------HHHHHHhcCC
Confidence 999999999999987543211 11122356666554433333333333322 1222111 2
Q ss_pred cCCCCCCChhhhhhccC--c------CCCCCCCCCccchHHHHhcccCcCCCCCCChhhhhh
Q psy758 206 KDPLRRWSCDQLLRHPY--F------NGYYFEVPDEMQYEEITQRCLDKDPLRRWSCDQLLR 259 (292)
Q Consensus 206 ~~p~~~~~~~~~~~~~~--~------~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~~il~ 259 (292)
..|....+..+.+.... + .....+...+.++.+++.+||+.||.+|||+.+|++
T Consensus 231 ~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rpt~~el~~ 292 (296)
T cd05051 231 EQPYEHLTDQQVIENAGHFFRDDGRQIYLPRPPNCPKDIYELMLECWRRDEEDRPTFREIHL 292 (296)
T ss_pred CCCCCCcChHHHHHHHHhccccccccccCCCccCCCHHHHHHHHHHhccChhcCCCHHHHHH
Confidence 33333333333222110 0 001112234578999999999999999999999976
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linke |
| >cd05089 PTKc_Tie1 Catalytic domain of the Protein Tyrosine Kinase, Tie1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-35 Score=240.85 Aligned_cols=245 Identities=21% Similarity=0.265 Sum_probs=177.6
Q ss_pred cccceeeeecccCceEEEEEEEcCCCc--EEEEEEeccCCCChHHHHHHHHHHHHHHhC-CCCCcchhhhhhhcCCeEEE
Q psy758 2 ERYEKIGKLGEGSYGVVFKCRNRDTGQ--VVAIKKFLESEEDPLIRKIALREIRLLKSL-KHPNLVNLLEVFRRKKKLHL 78 (292)
Q Consensus 2 ~~y~~~~~l~~g~~~~v~~~~~~~~~~--~v~iK~~~~~~~~~~~~~~~~~e~~~~~~l-~~~~i~~~~~~~~~~~~~~i 78 (292)
++|++.+.||+|++|.||+|....++. .+++|.+... ......+.+.+|+.+++.+ +||||+++++++.+.+..++
T Consensus 2 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~ik~~~~~-~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~~~l 80 (297)
T cd05089 2 EDIKFEDVIGEGNFGQVIRAMIKKDGLKMNAAIKMLKEF-ASENDHRDFAGELEVLCKLGHHPNIINLLGACENRGYLYI 80 (297)
T ss_pred ccceeeeeecCCCcceEEEEEecCCCCcceeEEEEcccc-CCHHHHHHHHHHHHHHHhhcCCCchhheEEEEccCCcceE
Confidence 689999999999999999999877665 4688877532 2333456688899999999 69999999999998899999
Q ss_pred EEecCCCccHHHHhcCC----------------CCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEEccCCcEEE
Q psy758 79 VFEFCDHTVLNELENHP----------------HGLPWDLIKQITWQVLRGVSYCHRHACIHRDIKPENILLTANGVVKL 142 (292)
Q Consensus 79 v~e~~~~~~L~~~~~~~----------------~~~~~~~~~~i~~qi~~aL~~LH~~givH~dl~p~Nilv~~~~~~kl 142 (292)
++||+++++|.+++... ..+++..++.++.|++.||+|||++|++|+||||+||++++++.++|
T Consensus 81 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~lH~~~ivH~dlkp~Nill~~~~~~kl 160 (297)
T cd05089 81 AIEYAPYGNLLDFLRKSRVLETDPAFAKEHGTASTLTSQQLLQFASDVATGMQYLSEKQFIHRDLAARNVLVGENLASKI 160 (297)
T ss_pred EEEecCCCcHHHHHHhccccccccccccccCccCCCCHHHHHHHHHHHHHHHHHHHHCCcccCcCCcceEEECCCCeEEE
Confidence 99999999999988643 24788999999999999999999999999999999999999999999
Q ss_pred eecCchhhhhcccc----ccccccccccccccCCCCCCCcccceeeecCCCCCCchHHHHHHHhhc-ccCCCCCCChhhh
Q psy758 143 CDFGFARLIRDLIP----RHLHIFQTNEYFKGVSLPHAENVVPLEIKIGKPAATNIYLIDFLKRCL-DKDPLRRWSCDQL 217 (292)
Q Consensus 143 ~dfg~~~~~~~~~~----~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~p~~~~~~~~~ 217 (292)
+|||++........ .....|.+||...+.......++|+++ ..++..+. +..|+...+..+.
T Consensus 161 ~dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlG-------------~il~el~t~g~~pf~~~~~~~~ 227 (297)
T cd05089 161 ADFGLSRGEEVYVKKTMGRLPVRWMAIESLNYSVYTTKSDVWSFG-------------VLLWEIVSLGGTPYCGMTCAEL 227 (297)
T ss_pred CCcCCCccccceeccCCCCcCccccCchhhccCCCCchhhHHHHH-------------HHHHHHHcCCCCCCCCCCHHHH
Confidence 99999864322111 112236666665443332223332222 22222221 3334444333332
Q ss_pred hhccCcC-CCCCCCCCccchHHHHhcccCcCCCCCCChhhhhhC
Q psy758 218 LRHPYFN-GYYFEVPDEMQYEEITQRCLDKDPLRRWSCDQLLRH 260 (292)
Q Consensus 218 ~~~~~~~-~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~~il~h 260 (292)
....... ....+...+..+.+||.+||..||.+|||++++++.
T Consensus 228 ~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~ 271 (297)
T cd05089 228 YEKLPQGYRMEKPRNCDDEVYELMRQCWRDRPYERPPFAQISVQ 271 (297)
T ss_pred HHHHhcCCCCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence 2211100 111233456789999999999999999999999775
|
Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations. |
| >cd08222 STKc_Nek11 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-35 Score=235.91 Aligned_cols=247 Identities=24% Similarity=0.347 Sum_probs=175.2
Q ss_pred ccceeeeecccCceEEEEEEEcCCCcEEEEEEeccC---CCChHHHHHHHHHHHHHHhCCCCCcchhhhhhhcCCeEEEE
Q psy758 3 RYEKIGKLGEGSYGVVFKCRNRDTGQVVAIKKFLES---EEDPLIRKIALREIRLLKSLKHPNLVNLLEVFRRKKKLHLV 79 (292)
Q Consensus 3 ~y~~~~~l~~g~~~~v~~~~~~~~~~~v~iK~~~~~---~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~iv 79 (292)
||.+.+.||+|++|.||++.+..++..+++|+.... .........+..|..+++.++||||+++++.+.+....+++
T Consensus 1 ~y~i~~~ig~g~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 80 (260)
T cd08222 1 RYILQQRLGKGSFGTVYLVKDKKAVAEERLKVLKEIPVGELNPNETVQANQEAQLLSKLDHPAIVKFHASFLERDAFCII 80 (260)
T ss_pred CceeeeeecCCCCceEEEEEecCCCCcceEEEeccccccccCcchHHHHHHHHHHHHhCCCCcHHHHHHHHhcCCceEEE
Confidence 699999999999999999999887776666665432 22223344566789999999999999999999999999999
Q ss_pred EecCCCccHHHHhc----CCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEEccCCcEEEeecCchhhhhccc
Q psy758 80 FEFCDHTVLNELEN----HPHGLPWDLIKQITWQVLRGVSYCHRHACIHRDIKPENILLTANGVVKLCDFGFARLIRDLI 155 (292)
Q Consensus 80 ~e~~~~~~L~~~~~----~~~~~~~~~~~~i~~qi~~aL~~LH~~givH~dl~p~Nilv~~~~~~kl~dfg~~~~~~~~~ 155 (292)
+||+++++|..++. ....+++..++.++.|++.||.|||+.|++|+||+|+||++++ +.++|+|||.+.......
T Consensus 81 ~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~i~h~~l~~~nili~~-~~~~l~d~g~~~~~~~~~ 159 (260)
T cd08222 81 TEYCEGRDLDCKLEELKHTGKTLSENQVCEWFIQLLLGVHYMHQRRILHRDLKAKNIFLKN-NLLKIGDFGVSRLLMGSC 159 (260)
T ss_pred EEeCCCCCHHHHHHHHhhcccccCHHHHHHHHHHHHHHHHHHHHcCccccCCChhheEeec-CCEeecccCceeecCCCc
Confidence 99999999988764 3456899999999999999999999999999999999999975 569999999886553221
Q ss_pred c-----ccccccccccccccCCCCCCCcccceeeecCCCCCCchHHHHHHHhhcccCCCCCCChhhhhhccCcC-CCCCC
Q psy758 156 P-----RHLHIFQTNEYFKGVSLPHAENVVPLEIKIGKPAATNIYLIDFLKRCLDKDPLRRWSCDQLLRHPYFN-GYYFE 229 (292)
Q Consensus 156 ~-----~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~-~~~~~ 229 (292)
. .....|.+||...+.......++| +.+.-++..+....|.......+........ ....+
T Consensus 160 ~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~-------------slG~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 226 (260)
T cd08222 160 DLATTFTGTPYYMSPEALKHQGYDSKSDIW-------------SLGCILYEMCCLAHAFEGQNFLSVVLRIVEGPTPSLP 226 (260)
T ss_pred ccccCCCCCcCccCHHHHccCCCCchhhHH-------------HHHHHHHHHHhCCCCCCCccHHHHHHHHHcCCCCCCc
Confidence 1 122334555544332221112222 2222223333333333222222211111000 11122
Q ss_pred CCCccchHHHHhcccCcCCCCCCChhhhhhCCcc
Q psy758 230 VPDEMQYEEITQRCLDKDPLRRWSCDQLLRHPYF 263 (292)
Q Consensus 230 ~~~~~~l~~li~~~l~~dP~~Rpt~~~il~h~w~ 263 (292)
...+..+.++|.+||..||.+||++.++++||||
T Consensus 227 ~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~~~~ 260 (260)
T cd08222 227 ETYSRQLNSIMQSMLNKDPSLRPSAAEILRNPFI 260 (260)
T ss_pred chhcHHHHHHHHHHhcCChhhCcCHHHHhhCCCC
Confidence 3446789999999999999999999999999997
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M check |
| >KOG4645|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-37 Score=273.82 Aligned_cols=246 Identities=29% Similarity=0.458 Sum_probs=203.5
Q ss_pred ccceeeeecccCceEEEEEEEcCCCcEEEEEEeccCCCChHHHHHHHHHHHHHHhCCCCCcchhhhhhhcCCeEEEEEec
Q psy758 3 RYEKIGKLGEGSYGVVFKCRNRDTGQVVAIKKFLESEEDPLIRKIALREIRLLKSLKHPNLVNLLEVFRRKKKLHLVFEF 82 (292)
Q Consensus 3 ~y~~~~~l~~g~~~~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~iv~e~ 82 (292)
|+.....||.|.||.||.|.+..+|+..|+|-+..+.......+.+.+|..++..++|||++++||+-.+.+.++|.|||
T Consensus 1236 rWqrg~~Ig~G~fG~VYtavN~~tGellAvKEI~iq~~~~k~~~~i~eEm~vlE~lnHpNlV~YyGVEvHRekv~IFMEy 1315 (1509)
T KOG4645|consen 1236 RWQRGNFIGGGTFGKVYTAVNLDTGELLAVKEIKIQDSDHKTFKLIAEEMKVLEGLNHPNLVRYYGVEVHREKVYIFMEY 1315 (1509)
T ss_pred eeccccccCCcceeeeEEeecCCccchhhhhhhhcCccccccCcchHHHHHHHHhccCccccccCceeecHHHHHHHHHH
Confidence 45566789999999999999999999999999987776666778888999999999999999999999999999999999
Q ss_pred CCCccHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEEccCCcEEEeecCchhhhhccc-------
Q psy758 83 CDHTVLNELENHPHGLPWDLIKQITWQVLRGVSYCHRHACIHRDIKPENILLTANGVVKLCDFGFARLIRDLI------- 155 (292)
Q Consensus 83 ~~~~~L~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~givH~dl~p~Nilv~~~~~~kl~dfg~~~~~~~~~------- 155 (292)
|.+|+|.+++...+..++.....+..|++.|++|||++|||||||||.||+++.+|.+|++|||.+..+....
T Consensus 1316 C~~GsLa~ll~~gri~dE~vt~vyt~qll~gla~LH~~gIVHRDIK~aNI~Ld~~g~iK~~DFGsa~ki~~~~~~~~~el 1395 (1509)
T KOG4645|consen 1316 CEGGSLASLLEHGRIEDEMVTRVYTKQLLEGLAYLHEHGIVHRDIKPANILLDFNGLIKYGDFGSAVKIKNNAQTMPGEL 1395 (1509)
T ss_pred hccCcHHHHHHhcchhhhhHHHHHHHHHHHHHHHHHhcCceecCCCccceeeecCCcEEeecccceeEecCchhcCCHHH
Confidence 9999999999998888999999999999999999999999999999999999999999999999998765432
Q ss_pred --cccccccccccccccCC--------CCCCCcccceeeecCCCCCCc--hHHHHHHHhhcccCCCCCCChhhhhhccCc
Q psy758 156 --PRHLHIFQTNEYFKGVS--------LPHAENVVPLEIKIGKPAATN--IYLIDFLKRCLDKDPLRRWSCDQLLRHPYF 223 (292)
Q Consensus 156 --~~~~~~~~~~~~~~~~~--------~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~ 223 (292)
.-+++.|.+||...|.. ..|+.|+..+++.+|..+|.. ....-++....+..|
T Consensus 1396 ~~~~GT~~YMAPEvit~t~~kG~~~A~DiWslGCVVlEM~tGkrPW~~~dne~aIMy~V~~gh~P--------------- 1460 (1509)
T KOG4645|consen 1396 QSMMGTPMYMAPEVITGTKGKGHGGAADIWSLGCVVLEMATGKRPWAELDNEWAIMYHVAAGHKP--------------- 1460 (1509)
T ss_pred HhhcCCchhcCchhhcccccCCCCcchhhhcccceEEEeecCCCchhhccchhHHHhHHhccCCC---------------
Confidence 23345677777665433 468888888899999877531 111222222222222
Q ss_pred CCCCCCCCCccchHHHHhcccCcCCCCCCChhhhhhCCcccce
Q psy758 224 NGYYFEVPDEMQYEEITQRCLDKDPLRRWSCDQLLRHPYFNGY 266 (292)
Q Consensus 224 ~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~~il~h~w~~~~ 266 (292)
..|...+.+-+++|.+||..||++|.++.|+++|-|-+..
T Consensus 1461 ---q~P~~ls~~g~dFle~Cl~~dP~~Rw~~~qlle~~f~~~~ 1500 (1509)
T KOG4645|consen 1461 ---QIPERLSSEGRDFLEHCLEQDPKMRWTASQLLEHAFGKSC 1500 (1509)
T ss_pred ---CCchhhhHhHHHHHHHHHhcCchhhhHHHHHHHhhccccc
Confidence 2233357788999999999999999999999999987753
|
|
| >cd05049 PTKc_Trk Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-35 Score=240.08 Aligned_cols=244 Identities=23% Similarity=0.286 Sum_probs=181.5
Q ss_pred cccceeeeecccCceEEEEEEEcC-----CCcEEEEEEeccCCCChHHHHHHHHHHHHHHhCCCCCcchhhhhhhcCCeE
Q psy758 2 ERYEKIGKLGEGSYGVVFKCRNRD-----TGQVVAIKKFLESEEDPLIRKIALREIRLLKSLKHPNLVNLLEVFRRKKKL 76 (292)
Q Consensus 2 ~~y~~~~~l~~g~~~~v~~~~~~~-----~~~~v~iK~~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~ 76 (292)
++|++.+.||+|++|.||+|.+.. ++..|++|.+..... ....+.+.+|+++++.++||||+++++++...+..
T Consensus 5 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~ 83 (280)
T cd05049 5 DTIVLKRELGEGAFGKVFLGECYHLEPENDKELVAVKTLKETAS-NDARKDFEREAELLTNFQHENIVKFYGVCTEGDPP 83 (280)
T ss_pred HHhhHHhhccccCCceEeeeeeccccCcCCcceEEEEeecccCC-HHHHHHHHHHHHHHHhcCCCCchheeeEEecCCCe
Confidence 579999999999999999998743 357899999865433 33457788999999999999999999999999999
Q ss_pred EEEEecCCCccHHHHhcCC--------------CCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEEccCCcEEE
Q psy758 77 HLVFEFCDHTVLNELENHP--------------HGLPWDLIKQITWQVLRGVSYCHRHACIHRDIKPENILLTANGVVKL 142 (292)
Q Consensus 77 ~iv~e~~~~~~L~~~~~~~--------------~~~~~~~~~~i~~qi~~aL~~LH~~givH~dl~p~Nilv~~~~~~kl 142 (292)
+++|||+++++|.+++... ..+++..+..++.|++.||.+||++|++|+||+|+||+++.++.++|
T Consensus 84 ~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~i~h~dlkp~nili~~~~~~kl 163 (280)
T cd05049 84 IMVFEYMEHGDLNKFLRSHGPDAAFLKSPDSPMGELTLSQLLQIAVQIASGMVYLASQHFVHRDLATRNCLVGYDLVVKI 163 (280)
T ss_pred EEEEecCCCCCHHHHHHhcCCchhhhcccccccccccHHHHHHHHHHHHHHHHHHhhCCeeccccccceEEEcCCCeEEE
Confidence 9999999999999988643 24788999999999999999999999999999999999999999999
Q ss_pred eecCchhhhhccc-------cccccccccccccccCCCCCCCcccceeeecCCCCCCchHHHHHHHhhc-ccCCCCCCCh
Q psy758 143 CDFGFARLIRDLI-------PRHLHIFQTNEYFKGVSLPHAENVVPLEIKIGKPAATNIYLIDFLKRCL-DKDPLRRWSC 214 (292)
Q Consensus 143 ~dfg~~~~~~~~~-------~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~p~~~~~~ 214 (292)
+|||.+....... ......|.+||...+.......++|+++ ..+++.+. +..|......
T Consensus 164 ~d~g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG-------------~il~e~~~~g~~p~~~~~~ 230 (280)
T cd05049 164 GDFGMSRDVYTTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSFG-------------VVLWEIFTYGKQPWYGLSN 230 (280)
T ss_pred CCcccceecccCcceecCCCCcccceecChhhhccCCcchhhhHHHHH-------------HHHHHHHhcCCCCCCCCCH
Confidence 9999986542211 1112346677766544433333333332 22233332 4444433333
Q ss_pred hhhhhccCcCC-CCCCCCCccchHHHHhcccCcCCCCCCChhhhhh
Q psy758 215 DQLLRHPYFNG-YYFEVPDEMQYEEITQRCLDKDPLRRWSCDQLLR 259 (292)
Q Consensus 215 ~~~~~~~~~~~-~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~~il~ 259 (292)
.+......... ...+...+..+.+++.+||+.||.+|||+.|+++
T Consensus 231 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~eil~ 276 (280)
T cd05049 231 EEVIECITQGRLLQRPRTCPSEVYDIMLGCWKRDPQQRINIKDIHE 276 (280)
T ss_pred HHHHHHHHcCCcCCCCCCCCHHHHHHHHHHcCCCcccCCCHHHHHH
Confidence 33332211111 1123345778999999999999999999999986
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalyt |
| >KOG0986|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.6e-38 Score=251.12 Aligned_cols=260 Identities=22% Similarity=0.307 Sum_probs=202.9
Q ss_pred cccceeeeecccCceEEEEEEEcCCCcEEEEEEeccCCCC-hHHHHHHHHHHHHHHhCCCCCcchhhhhhhcCCeEEEEE
Q psy758 2 ERYEKIGKLGEGSYGVVFKCRNRDTGQVVAIKKFLESEED-PLIRKIALREIRLLKSLKHPNLVNLLEVFRRKKKLHLVF 80 (292)
Q Consensus 2 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~v~iK~~~~~~~~-~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~iv~ 80 (292)
+.|...+.||.|+||.|+-++...||+-||+|.+.+.... ..-.....+|-.+++.++.+.||.+--.|++.+.+|+|+
T Consensus 185 n~F~~~RvlGkGGFGEV~acqvraTGKMYAcKkL~KKRiKkr~ge~maLnEk~iL~kV~s~FiVslaYAfeTkd~LClVL 264 (591)
T KOG0986|consen 185 NTFRVYRVLGKGGFGEVCACQVRATGKMYACKKLDKKRIKKRKGETMALNEKQILEKVSSPFIVSLAYAFETKDALCLVL 264 (591)
T ss_pred cceeeeEEEecccccceeEEEEecchhhHHHHHHHHHHHHHhhhhHHhhHHHHHHHHhccCcEEEEeeeecCCCceEEEE
Confidence 5688899999999999999999999999999988654322 223455678999999999999999999999999999999
Q ss_pred ecCCCccHHHHhcCCC--CCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEEccCCcEEEeecCchhhhhcccc--
Q psy758 81 EFCDHTVLNELENHPH--GLPWDLIKQITWQVLRGVSYCHRHACIHRDIKPENILLTANGVVKLCDFGFARLIRDLIP-- 156 (292)
Q Consensus 81 e~~~~~~L~~~~~~~~--~~~~~~~~~i~~qi~~aL~~LH~~givH~dl~p~Nilv~~~~~~kl~dfg~~~~~~~~~~-- 156 (292)
..|+||+|...+-+-+ .++++.+..++.+|+.||.+||+.+||+|||||+|||+|+.|+++|+|+|++..+.+..+
T Consensus 265 tlMNGGDLkfHiyn~g~~gF~e~ra~FYAAEi~cGLehlH~~~iVYRDLKPeNILLDd~GhvRISDLGLAvei~~g~~~~ 344 (591)
T KOG0986|consen 265 TLMNGGDLKFHIYNHGNPGFDEQRARFYAAEIICGLEHLHRRRIVYRDLKPENILLDDHGHVRISDLGLAVEIPEGKPIR 344 (591)
T ss_pred EeecCCceeEEeeccCCCCCchHHHHHHHHHHHhhHHHHHhcceeeccCChhheeeccCCCeEeeccceEEecCCCCccc
Confidence 9999999999886654 799999999999999999999999999999999999999999999999999988765332
Q ss_pred --ccccccccccccccCCCCCCCcccceeeecCCCCCCchHHHHHHHhhcccCCCCCCChhhhhhccCcCCCCCCCCCcc
Q psy758 157 --RHLHIFQTNEYFKGVSLPHAENVVPLEIKIGKPAATNIYLIDFLKRCLDKDPLRRWSCDQLLRHPYFNGYYFEVPDEM 234 (292)
Q Consensus 157 --~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 234 (292)
.++..|.+||...++.+.++.++|.+++.+.+.....+.+.+--++. ..+++-+...-..-.++..-++
T Consensus 345 ~rvGT~GYMAPEvl~ne~Y~~s~Dwf~lGCllYemi~G~sPFr~~KeKv---------k~eEvdrr~~~~~~ey~~kFS~ 415 (591)
T KOG0986|consen 345 GRVGTVGYMAPEVLQNEVYDFSPDWFSLGCLLYEMIAGHSPFRQRKEKV---------KREEVDRRTLEDPEEYSDKFSE 415 (591)
T ss_pred cccCcccccCHHHHcCCcccCCccHHHHHhHHHHHHcccCchhhhhhhh---------hHHHHHHHHhcchhhcccccCH
Confidence 45677889999888887777777776654332222111111111110 1111111111111122334478
Q ss_pred chHHHHhcccCcCCCCCC-----ChhhhhhCCcccceeccC
Q psy758 235 QYEEITQRCLDKDPLRRW-----SCDQLLRHPYFNGYYFEV 270 (292)
Q Consensus 235 ~l~~li~~~l~~dP~~Rp-----t~~~il~h~w~~~~~~~~ 270 (292)
++++|.+.+|+.||++|. .++++.+||||+++.|..
T Consensus 416 eakslc~~LL~Kdp~~RLGcrg~ga~evk~HpfFk~lnw~r 456 (591)
T KOG0986|consen 416 EAKSLCEGLLTKDPEKRLGCRGEGAQEVKEHPFFKDLNWRR 456 (591)
T ss_pred HHHHHHHHHHccCHHHhccCCCcCcchhhhCcccccCCHhH
Confidence 999999999999999998 778999999999999873
|
|
| >cd05097 PTKc_DDR_like Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-35 Score=240.40 Aligned_cols=244 Identities=20% Similarity=0.300 Sum_probs=176.5
Q ss_pred cccceeeeecccCceEEEEEEEcCCC--------------cEEEEEEeccCCCChHHHHHHHHHHHHHHhCCCCCcchhh
Q psy758 2 ERYEKIGKLGEGSYGVVFKCRNRDTG--------------QVVAIKKFLESEEDPLIRKIALREIRLLKSLKHPNLVNLL 67 (292)
Q Consensus 2 ~~y~~~~~l~~g~~~~v~~~~~~~~~--------------~~v~iK~~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~ 67 (292)
++|++.+.||+|+||.||++.+..++ ..|++|.+.... .......+.+|+++++.++|||+++++
T Consensus 5 ~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~ei~~l~~l~h~~i~~~~ 83 (295)
T cd05097 5 QQLRLKEKLGEGQFGEVHLCEAEGLAEFLGEGAPEFDGQPVLVAVKMLRADV-TKTARNDFLKEIKIMSRLKNPNIIRLL 83 (295)
T ss_pred HhCeehhccCCCCCceEEecccccchhhccccCcccCCCceEEEEEecCCCC-CHHHHHHHHHHHHHHHhCCCCCcCeEE
Confidence 48999999999999999999875432 358999886543 334456788999999999999999999
Q ss_pred hhhhcCCeEEEEEecCCCccHHHHhcCCC------------CCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEEc
Q psy758 68 EVFRRKKKLHLVFEFCDHTVLNELENHPH------------GLPWDLIKQITWQVLRGVSYCHRHACIHRDIKPENILLT 135 (292)
Q Consensus 68 ~~~~~~~~~~iv~e~~~~~~L~~~~~~~~------------~~~~~~~~~i~~qi~~aL~~LH~~givH~dl~p~Nilv~ 135 (292)
+++...+..++||||+.+++|.+++.... .+++..++.++.|++.||.|||++|++|+||+|+||+++
T Consensus 84 ~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~i~H~dlkp~Nill~ 163 (295)
T cd05097 84 GVCVSDDPLCMITEYMENGDLNQFLSQREIESTFTHANNIPSVSIANLLYMAVQIASGMKYLASLNFVHRDLATRNCLVG 163 (295)
T ss_pred EEEcCCCccEEEEecCCCCcHHHHHHhccccccccccccCCcccHHHHHHHHHHHHHHHHHHHhcCeeccccChhhEEEc
Confidence 99999999999999999999999875421 368889999999999999999999999999999999999
Q ss_pred cCCcEEEeecCchhhhhcccc-------ccccccccccccccCCCCCCCcccceeeecCCCCCCchHHHHHHHhhc--cc
Q psy758 136 ANGVVKLCDFGFARLIRDLIP-------RHLHIFQTNEYFKGVSLPHAENVVPLEIKIGKPAATNIYLIDFLKRCL--DK 206 (292)
Q Consensus 136 ~~~~~kl~dfg~~~~~~~~~~-------~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~ 206 (292)
+++.++|+|||++........ .....|.+||...+.......++|+++ ..++..+. ..
T Consensus 164 ~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlG-------------~~l~el~~~~~~ 230 (295)
T cd05097 164 NHYTIKIADFGMSRNLYSGDYYRIQGRAVLPIRWMAWESILLGKFTTASDVWAFG-------------VTLWEMFTLCKE 230 (295)
T ss_pred CCCcEEecccccccccccCcceeccCcCcCceeecChhhhccCCcCchhhHHHHH-------------HHHHHHHHcCCC
Confidence 999999999999875432111 112235556655443333333333332 22222221 23
Q ss_pred CCCCCCChhhhhhcc--CcC------CCCCCCCCccchHHHHhcccCcCCCCCCChhhhhh
Q psy758 207 DPLRRWSCDQLLRHP--YFN------GYYFEVPDEMQYEEITQRCLDKDPLRRWSCDQLLR 259 (292)
Q Consensus 207 ~p~~~~~~~~~~~~~--~~~------~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~~il~ 259 (292)
.|....+..++.... ++. ....+...+..+.+|+.+||+.||.+|||+++|++
T Consensus 231 ~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~RPs~~~i~~ 291 (295)
T cd05097 231 QPYSLLSDEQVIENTGEFFRNQGRQIYLSQTPLCPSPVFKLMMRCWSRDIKDRPTFNKIHH 291 (295)
T ss_pred CCCcccChHHHHHHHHHhhhhccccccCCCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHH
Confidence 344443333332110 000 01122334678999999999999999999999976
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including |
| >cd05080 PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-35 Score=241.53 Aligned_cols=252 Identities=22% Similarity=0.262 Sum_probs=175.9
Q ss_pred ccc-ceeeeecccCceEEEEEE----EcCCCcEEEEEEeccCCCChHHHHHHHHHHHHHHhCCCCCcchhhhhhhc--CC
Q psy758 2 ERY-EKIGKLGEGSYGVVFKCR----NRDTGQVVAIKKFLESEEDPLIRKIALREIRLLKSLKHPNLVNLLEVFRR--KK 74 (292)
Q Consensus 2 ~~y-~~~~~l~~g~~~~v~~~~----~~~~~~~v~iK~~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~--~~ 74 (292)
+|| ++.+.||+|+||.||++. ...++..|++|.+..... ......+.+|+.+++.++||||+++++++.. ..
T Consensus 3 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~ 81 (283)
T cd05080 3 KRYLKKIRVLGEGHFGKVSLYCYDPANDGTGEMVAVKTLKRECG-QQNTSGWKKEINILKTLYHENIVKYKGCCSEQGGK 81 (283)
T ss_pred hhhceeceecccCCCcEEEEeeEccccCCCCceEEEEEeccccC-hHHHHHHHHHHHHHHhCCCCCEeeEEEEEecCCCc
Confidence 567 899999999999998765 345678899999865432 2345667889999999999999999998754 44
Q ss_pred eEEEEEecCCCccHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEEccCCcEEEeecCchhhhhcc
Q psy758 75 KLHLVFEFCDHTVLNELENHPHGLPWDLIKQITWQVLRGVSYCHRHACIHRDIKPENILLTANGVVKLCDFGFARLIRDL 154 (292)
Q Consensus 75 ~~~iv~e~~~~~~L~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~givH~dl~p~Nilv~~~~~~kl~dfg~~~~~~~~ 154 (292)
..+++|||+++++|.+++... .+++..++.++.|++.||.|||++|++|+||||+||++++++.++|+|||++......
T Consensus 82 ~~~lv~e~~~~~~l~~~~~~~-~l~~~~~~~i~~~l~~~l~~lH~~~i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~~~ 160 (283)
T cd05080 82 GLQLIMEYVPLGSLRDYLPKH-KLNLAQLLLFAQQICEGMAYLHSQHYIHRDLAARNVLLDNDRLVKIGDFGLAKAVPEG 160 (283)
T ss_pred eEEEEecCCCCCCHHHHHHHc-CCCHHHHHHHHHHHHHHHHHHHHCCeeccccChheEEEcCCCcEEEeecccccccCCc
Confidence 689999999999999998764 6999999999999999999999999999999999999999999999999998765431
Q ss_pred cc--------ccccccccccccccCC-----CCCCCcccceeeecCCCCCCchH--HHHHHHhhcccCCCCCCChhhhhh
Q psy758 155 IP--------RHLHIFQTNEYFKGVS-----LPHAENVVPLEIKIGKPAATNIY--LIDFLKRCLDKDPLRRWSCDQLLR 219 (292)
Q Consensus 155 ~~--------~~~~~~~~~~~~~~~~-----~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~p~~~~~~~~~~~ 219 (292)
.. .....|.+||...+.. ..|+.|+..+++.+|..++.... ...++....... ......+...
T Consensus 161 ~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Di~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~ 238 (283)
T cd05080 161 HEYYRVREDGDSPVFWYAVECLKENKFSYASDVWSFGVTLYELLTHCDSKQSPPKKFEEMIGPKQGQM--TVVRLIELLE 238 (283)
T ss_pred chhhccCCCCCCCceeeCHhHhcccCCCcccccHHHHHHHHHHHhCCCCCCCCcchhhhhhccccccc--chhhhhhhhh
Confidence 11 1122355666554333 23444444444444443321110 111111000000 0000111111
Q ss_pred ccCcCCCCCCCCCccchHHHHhcccCcCCCCCCChhhhhh
Q psy758 220 HPYFNGYYFEVPDEMQYEEITQRCLDKDPLRRWSCDQLLR 259 (292)
Q Consensus 220 ~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~~il~ 259 (292)
... ....+...+..+.+++.+||+.||++|||++++++
T Consensus 239 ~~~--~~~~~~~~~~~~~~li~~cl~~~p~~Rps~~~i~~ 276 (283)
T cd05080 239 RGM--RLPCPKNCPQEVYILMKNCWETEAKFRPTFRSLIP 276 (283)
T ss_pred cCC--CCCCCCCCCHHHHHHHHHHhccChhhCCCHHHHHH
Confidence 110 11223445778999999999999999999999987
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of sign |
| >cd05116 PTKc_Syk Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-35 Score=236.36 Aligned_cols=237 Identities=18% Similarity=0.269 Sum_probs=174.2
Q ss_pred eecccCceEEEEEEE--cCCCcEEEEEEeccCCCChHHHHHHHHHHHHHHhCCCCCcchhhhhhhcCCeEEEEEecCCCc
Q psy758 9 KLGEGSYGVVFKCRN--RDTGQVVAIKKFLESEEDPLIRKIALREIRLLKSLKHPNLVNLLEVFRRKKKLHLVFEFCDHT 86 (292)
Q Consensus 9 ~l~~g~~~~v~~~~~--~~~~~~v~iK~~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~iv~e~~~~~ 86 (292)
.||+|+||.||+|.. ..++..+++|++..........+.+.+|+.+++.+.||||+++++++. .+..++|+||++++
T Consensus 2 ~lg~G~~g~v~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~-~~~~~lv~e~~~~~ 80 (257)
T cd05116 2 ELGSGNFGTVKKGMYKMKKSEKTVAVKILKNDNNDPALKDELLREANVMQQLDNPYIVRMIGICE-AESWMLVMELAELG 80 (257)
T ss_pred cCCCcCCcceEEeEEecCCCceEEEEEEccCCCCcHHHHHHHHHHHHHHHhCCCCCcceEEEEEc-CCCcEEEEecCCCC
Confidence 689999999999964 456789999998766666666778899999999999999999999875 45678999999999
Q ss_pred cHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEEccCCcEEEeecCchhhhhccccc---c-----
Q psy758 87 VLNELENHPHGLPWDLIKQITWQVLRGVSYCHRHACIHRDIKPENILLTANGVVKLCDFGFARLIRDLIPR---H----- 158 (292)
Q Consensus 87 ~L~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~givH~dl~p~Nilv~~~~~~kl~dfg~~~~~~~~~~~---~----- 158 (292)
+|..++.....+++..+..++.|++.||++||++|++|+||+|+||++++++.++|+|||++......... .
T Consensus 81 ~L~~~l~~~~~~~~~~~~~i~~qi~~al~~lH~~~i~H~dlkp~nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~ 160 (257)
T cd05116 81 PLNKFLQKNKHVTEKNITELVHQVSMGMKYLEETNFVHRDLAARNVLLVTQHYAKISDFGLSKALGADENYYKAKTHGKW 160 (257)
T ss_pred cHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCEeecccchhhEEEcCCCeEEECCCccccccCCCCCeeeecCCCCC
Confidence 99999987778999999999999999999999999999999999999999999999999998765432110 0
Q ss_pred ccccccccccccCCCCCCCcccceeeecCCCCCCchHHHHHHHhhc-ccCCCCCCChhhhhhccCc-CCCCCCCCCccch
Q psy758 159 LHIFQTNEYFKGVSLPHAENVVPLEIKIGKPAATNIYLIDFLKRCL-DKDPLRRWSCDQLLRHPYF-NGYYFEVPDEMQY 236 (292)
Q Consensus 159 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~p~~~~~~~~~~~~~~~-~~~~~~~~~~~~l 236 (292)
...|.+||...+.......++ ++.+.-+++.+. +..|.......++....-. .....+...+..+
T Consensus 161 ~~~y~aPE~~~~~~~~~~~Di-------------~slG~~l~el~t~g~~p~~~~~~~~~~~~i~~~~~~~~~~~~~~~l 227 (257)
T cd05116 161 PVKWYAPECMNYYKFSSKSDV-------------WSFGVLMWEAFSYGQKPYKGMKGNEVTQMIESGERMECPQRCPPEM 227 (257)
T ss_pred CccccCHhHhccCCcCchhHH-------------HHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHCCCCCCCCCCCCHHH
Confidence 123445554433222222222 222222333332 4444443333222211110 0112334457889
Q ss_pred HHHHhcccCcCCCCCCChhhhhh
Q psy758 237 EEITQRCLDKDPLRRWSCDQLLR 259 (292)
Q Consensus 237 ~~li~~~l~~dP~~Rpt~~~il~ 259 (292)
.++|.+||+.||.+||++++|..
T Consensus 228 ~~li~~~~~~~p~~Rp~~~~i~~ 250 (257)
T cd05116 228 YDLMKLCWTYGVDERPGFAVVEL 250 (257)
T ss_pred HHHHHHHhccCchhCcCHHHHHH
Confidence 99999999999999999999976
|
Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferatio |
| >KOG0596|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.8e-36 Score=245.52 Aligned_cols=274 Identities=28% Similarity=0.370 Sum_probs=190.4
Q ss_pred ccceeeeecccCceEEEEEEEcCCCcEEEEEEeccCCCChHHHHHHHHHHHHHHhCC-CCCcchhhhhhhcCCeEEEEEe
Q psy758 3 RYEKIGKLGEGSYGVVFKCRNRDTGQVVAIKKFLESEEDPLIRKIALREIRLLKSLK-HPNLVNLLEVFRRKKKLHLVFE 81 (292)
Q Consensus 3 ~y~~~~~l~~g~~~~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~e~~~~~~l~-~~~i~~~~~~~~~~~~~~iv~e 81 (292)
.|++.+.||+||.+.||++.... ...||+|.+.....+....+.+.+|+.++.+|+ |.+|+++|++-..++++|+|||
T Consensus 362 ~Yeilk~iG~GGSSkV~kV~~s~-~~iyalkkv~~~~~D~qtl~gy~nEI~lL~KLkg~~~IIqL~DYEv~d~~lYmvmE 440 (677)
T KOG0596|consen 362 EYEILKQIGSGGSSKVFKVLNSD-KQIYALKKVVLLEADNQTLDGYRNEIALLNKLKGHDKIIQLYDYEVTDGYLYMVME 440 (677)
T ss_pred hhhHHHhhcCCCcceeeeeecCC-CcchhhhHHHHhhcCHHHHHHHHHHHHHHHHhcCCceEEEEeeeeccCceEEEEee
Confidence 69999999999999999998764 456788877777778888999999999999996 8999999999989999999999
Q ss_pred cCCCccHHHHhcCCCC-CCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEEccCCcEEEeecCchhhhhccccccc-
Q psy758 82 FCDHTVLNELENHPHG-LPWDLIKQITWQVLRGVSYCHRHACIHRDIKPENILLTANGVVKLCDFGFARLIRDLIPRHL- 159 (292)
Q Consensus 82 ~~~~~~L~~~~~~~~~-~~~~~~~~i~~qi~~aL~~LH~~givH~dl~p~Nilv~~~~~~kl~dfg~~~~~~~~~~~~~- 159 (292)
|-. .+|..++++... .+...++.+..|++.|++++|+.||||.||||.|+|+.. |.+||+|||++....+......
T Consensus 441 ~Gd-~DL~kiL~k~~~~~~~~~lk~ywkqML~aV~~IH~~gIVHSDLKPANFLlVk-G~LKLIDFGIA~aI~~DTTsI~k 518 (677)
T KOG0596|consen 441 CGD-IDLNKILKKKKSIDPDWFLKFYWKQMLLAVKTIHQHGIVHSDLKPANFLLVK-GRLKLIDFGIANAIQPDTTSIVK 518 (677)
T ss_pred ccc-ccHHHHHHhccCCCchHHHHHHHHHHHHHHHHHHHhceeecCCCcccEEEEe-eeEEeeeechhcccCccccceee
Confidence 865 568888876654 444688999999999999999999999999999999864 5899999999987765333221
Q ss_pred -cccccccccccCCCCCCCc---ccceeeecCCCCCCchHHHHHHHhhcccCCCCCCCh-hhhh---hccCcCCCCCCC-
Q psy758 160 -HIFQTNEYFKGVSLPHAEN---VVPLEIKIGKPAATNIYLIDFLKRCLDKDPLRRWSC-DQLL---RHPYFNGYYFEV- 230 (292)
Q Consensus 160 -~~~~~~~~~~~~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~-~~~~---~~~~~~~~~~~~- 230 (292)
...+++.|..++.+..... --.-.+.++.+.++|+.++-++....++.|+..... ..-+ ..+- ....++.
T Consensus 519 dsQvGT~NYMsPEAl~~~~s~~~~~~~k~Ki~r~SDvWSLGCILYqMvYgktPf~~~~n~~aKl~aI~~P~-~~Iefp~~ 597 (677)
T KOG0596|consen 519 DSQVGTVNYMSPEALTDMSSSRENGKSKIKISRKSDVWSLGCILYQMVYGKTPFGQIINQIAKLHAITDPN-HEIEFPDI 597 (677)
T ss_pred ccccCcccccCHHHHhhccccccCCCcceeecCccchhhhhhHHHHHHhcCCchHHHHHHHHHHHhhcCCC-ccccccCC
Confidence 2234444444333211000 000112233334444444444444444444332210 0000 0010 0111222
Q ss_pred CCccchHHHHhcccCcCCCCCCChhhhhhCCcccceeccCCChhHHHHHhhh
Q psy758 231 PDEMQYEEITQRCLDKDPLRRWSCDQLLRHPYFNGYYFEVPDEMQYEEITQV 282 (292)
Q Consensus 231 ~~~~~l~~li~~~l~~dP~~Rpt~~~il~h~w~~~~~~~~~~~~~~~~~~~~ 282 (292)
+.+.++.++++.||..||++|||..++|+|||++.. .+|-++...-++..
T Consensus 598 ~~~~~li~~mK~CL~rdPkkR~si~eLLqhpFl~~~--~i~~~~m~~~~~~~ 647 (677)
T KOG0596|consen 598 PENDELIDVMKCCLARDPKKRWSIPELLQHPFLQIQ--PIPVEQMAKLTTNE 647 (677)
T ss_pred CCchHHHHHHHHHHhcCcccCCCcHHHhcCcccccc--cccchHHHHHHHHH
Confidence 223349999999999999999999999999999973 36666666554443
|
|
| >cd05075 PTKc_Axl Catalytic domain of the Protein Tyrosine Kinase, Axl | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.2e-35 Score=236.24 Aligned_cols=244 Identities=18% Similarity=0.199 Sum_probs=172.5
Q ss_pred cceeeeecccCceEEEEEEEcCCCc--EEEEEEeccCCCChHHHHHHHHHHHHHHhCCCCCcchhhhhhhc------CCe
Q psy758 4 YEKIGKLGEGSYGVVFKCRNRDTGQ--VVAIKKFLESEEDPLIRKIALREIRLLKSLKHPNLVNLLEVFRR------KKK 75 (292)
Q Consensus 4 y~~~~~l~~g~~~~v~~~~~~~~~~--~v~iK~~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~------~~~ 75 (292)
|.+++.||+|++|.||+|....++. .|++|.+..........+.+.+|..+++.++||||+++++++.. ...
T Consensus 1 ~~i~~~ig~G~~g~V~~~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~ 80 (272)
T cd05075 1 LALGKTLGEGEFGSVMEGQLNQDDSILKVAVKTMKIAICTRSEMEDFLSEAVCMKEFDHPNVMRLIGVCLQTVESEGYPS 80 (272)
T ss_pred CccccccCcccCceEEEeEEccCCCeeeEEEEecccCcCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEccCCcccCCCC
Confidence 4678999999999999999887765 58999987665555667788899999999999999999987532 225
Q ss_pred EEEEEecCCCccHHHHhc------CCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEEccCCcEEEeecCchh
Q psy758 76 LHLVFEFCDHTVLNELEN------HPHGLPWDLIKQITWQVLRGVSYCHRHACIHRDIKPENILLTANGVVKLCDFGFAR 149 (292)
Q Consensus 76 ~~iv~e~~~~~~L~~~~~------~~~~~~~~~~~~i~~qi~~aL~~LH~~givH~dl~p~Nilv~~~~~~kl~dfg~~~ 149 (292)
.++++||+.+++|..++. ....+++..+..++.||+.||+|||++|++|+||||+||+++.++.++|+|||++.
T Consensus 81 ~~~v~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~ 160 (272)
T cd05075 81 PVVILPFMKHGDLHSFLLYSRLGDCPQYLPTQMLVKFMTDIASGMEYLSSKSFIHRDLAARNCMLNENMNVCVADFGLSK 160 (272)
T ss_pred cEEEEEeCCCCcHHHHHHHhcccCCcccCCHHHHHHHHHHHHHHHHHHHHCCeeccccchhheEEcCCCCEEECCCCccc
Confidence 789999999999988763 22348999999999999999999999999999999999999999999999999987
Q ss_pred hhhcccc-------ccccccccccccccCCCCCCCcccceeeecCCCCCCchHHHHHHHhhc-ccCCCCCCChhhhhhcc
Q psy758 150 LIRDLIP-------RHLHIFQTNEYFKGVSLPHAENVVPLEIKIGKPAATNIYLIDFLKRCL-DKDPLRRWSCDQLLRHP 221 (292)
Q Consensus 150 ~~~~~~~-------~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~p~~~~~~~~~~~~~ 221 (292)
....... .....|.+|+...+.......++|++ +..+++.+. +..|+......++....
T Consensus 161 ~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Di~sl-------------G~il~el~~~g~~p~~~~~~~~~~~~~ 227 (272)
T cd05075 161 KIYNGDYYRQGRIAKMPVKWIAIESLADRVYTTKSDVWSF-------------GVTMWEIATRGQTPYPGVENSEIYDYL 227 (272)
T ss_pred ccCcccceecCCcccCCcccCCHHHccCCCcChHHHHHHH-------------HHHHHHHHcCCCCCCCCCCHHHHHHHH
Confidence 6543211 11122444444433332222223222 222222222 22333322222222111
Q ss_pred CcC-CCCCCCCCccchHHHHhcccCcCCCCCCChhhhhhC
Q psy758 222 YFN-GYYFEVPDEMQYEEITQRCLDKDPLRRWSCDQLLRH 260 (292)
Q Consensus 222 ~~~-~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~~il~h 260 (292)
.-. ....+...+..+.++|.+||+.||.+|||+.+++++
T Consensus 228 ~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~l~~~ 267 (272)
T cd05075 228 RQGNRLKQPPDCLDGLYSLMSSCWLLNPKDRPSFETLRCE 267 (272)
T ss_pred HcCCCCCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHH
Confidence 000 011223346679999999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transfor |
| >cd05108 PTKc_EGFR Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-35 Score=242.71 Aligned_cols=244 Identities=20% Similarity=0.256 Sum_probs=176.3
Q ss_pred cccceeeeecccCceEEEEEEEcCCCcE----EEEEEeccCCCChHHHHHHHHHHHHHHhCCCCCcchhhhhhhcCCeEE
Q psy758 2 ERYEKIGKLGEGSYGVVFKCRNRDTGQV----VAIKKFLESEEDPLIRKIALREIRLLKSLKHPNLVNLLEVFRRKKKLH 77 (292)
Q Consensus 2 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~----v~iK~~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~ 77 (292)
++|++.+.||+|+||.||+|.+..+++. ||+|.+... ......+.+.+|+.+++.++||||+++++++... ..+
T Consensus 7 ~~f~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~vaiK~~~~~-~~~~~~~~~~~e~~~l~~l~h~niv~~~g~~~~~-~~~ 84 (316)
T cd05108 7 TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREA-TSPKANKEILDEAYVMASVDNPHVCRLLGICLTS-TVQ 84 (316)
T ss_pred hhceeeeeeecCCCceEEEEEEecCCCccceeEEEEecccc-CCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEcCC-Cce
Confidence 5799999999999999999998666554 899988643 2334456788999999999999999999988754 577
Q ss_pred EEEecCCCccHHHHhcC-CCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEEccCCcEEEeecCchhhhhcccc
Q psy758 78 LVFEFCDHTVLNELENH-PHGLPWDLIKQITWQVLRGVSYCHRHACIHRDIKPENILLTANGVVKLCDFGFARLIRDLIP 156 (292)
Q Consensus 78 iv~e~~~~~~L~~~~~~-~~~~~~~~~~~i~~qi~~aL~~LH~~givH~dl~p~Nilv~~~~~~kl~dfg~~~~~~~~~~ 156 (292)
+++||+.+|+|.+++.. ...++...++.++.||+.||+|||++|++|+||||+||+++.++.++|+|||++........
T Consensus 85 ~v~e~~~~g~l~~~l~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~iiH~dlkp~Nill~~~~~~kl~DfG~a~~~~~~~~ 164 (316)
T cd05108 85 LITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEERRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGADEK 164 (316)
T ss_pred eeeecCCCCCHHHHHHhccccCCHHHHHHHHHHHHHHHHHHHhcCeeccccchhheEecCCCcEEEccccccccccCCCc
Confidence 99999999999988865 34689999999999999999999999999999999999999999999999999986543211
Q ss_pred c-------cccccccccccccCCCCCCCcccceeeecCCCCCCchHHHHHHHhhc-ccCCCCCCChhhhhhcc-CcCCCC
Q psy758 157 R-------HLHIFQTNEYFKGVSLPHAENVVPLEIKIGKPAATNIYLIDFLKRCL-DKDPLRRWSCDQLLRHP-YFNGYY 227 (292)
Q Consensus 157 ~-------~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~p~~~~~~~~~~~~~-~~~~~~ 227 (292)
. .+..|.+|+...+.......++|++ +..+++.+. +..|.......++.... .-....
T Consensus 165 ~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~sl-------------Gv~l~el~t~g~~p~~~~~~~~~~~~~~~~~~~~ 231 (316)
T cd05108 165 EYHAEGGKVPIKWMALESILHRIYTHQSDVWSY-------------GVTVWELMTFGSKPYDGIPASEISSILEKGERLP 231 (316)
T ss_pred ceeccCCccceeecChHHhccCCCCchhhhHHH-------------HHHHHHHHcCCCCCCCCCCHHHHHHHHhCCCCCC
Confidence 1 1123556665544333222233222 222233222 34444333322221100 000112
Q ss_pred CCCCCccchHHHHhcccCcCCCCCCChhhhhhC
Q psy758 228 FEVPDEMQYEEITQRCLDKDPLRRWSCDQLLRH 260 (292)
Q Consensus 228 ~~~~~~~~l~~li~~~l~~dP~~Rpt~~~il~h 260 (292)
.+...+..+.+++.+||..||.+|||+.+++.+
T Consensus 232 ~~~~~~~~~~~li~~cl~~~p~~Rps~~~l~~~ 264 (316)
T cd05108 232 QPPICTIDVYMIMVKCWMIDADSRPKFRELIIE 264 (316)
T ss_pred CCCCCCHHHHHHHHHHccCChhhCcCHHHHHHH
Confidence 223346688999999999999999999999986
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphor |
| >cd05148 PTKc_Srm_Brk Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-35 Score=236.41 Aligned_cols=242 Identities=23% Similarity=0.304 Sum_probs=179.9
Q ss_pred cccceeeeecccCceEEEEEEEcCCCcEEEEEEeccCCCChHHHHHHHHHHHHHHhCCCCCcchhhhhhhcCCeEEEEEe
Q psy758 2 ERYEKIGKLGEGSYGVVFKCRNRDTGQVVAIKKFLESEEDPLIRKIALREIRLLKSLKHPNLVNLLEVFRRKKKLHLVFE 81 (292)
Q Consensus 2 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~iv~e 81 (292)
++|++.+.||+|++|.||+|.+.. +..+++|.+..... .....+.+|+.+++.++||||+++++++.+.+..++|+|
T Consensus 6 ~~y~~~~~ig~g~~~~vy~~~~~~-~~~~~~k~~~~~~~--~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e 82 (261)
T cd05148 6 EEFTLERKLGSGYFGEVWEGLWKN-RVRVAIKILKSDDL--LKQQDFQKEVQALKRLRHKHLISLFAVCSVGEPVYIITE 82 (261)
T ss_pred HHHHHhhhhccCCCccEEEeEecC-CCcEEEEeccccch--hhHHHHHHHHHHHhcCCCcchhheeeeEecCCCeEEEEe
Confidence 479999999999999999999987 88999999865432 234567889999999999999999999999999999999
Q ss_pred cCCCccHHHHhcCC--CCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEEccCCcEEEeecCchhhhhcccc---
Q psy758 82 FCDHTVLNELENHP--HGLPWDLIKQITWQVLRGVSYCHRHACIHRDIKPENILLTANGVVKLCDFGFARLIRDLIP--- 156 (292)
Q Consensus 82 ~~~~~~L~~~~~~~--~~~~~~~~~~i~~qi~~aL~~LH~~givH~dl~p~Nilv~~~~~~kl~dfg~~~~~~~~~~--- 156 (292)
|+++++|.+++... ..+++..++.++.||+.||.|||++|++|+||+|+||++++++.++|+|||.+........
T Consensus 83 ~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~~i~h~dl~~~nilv~~~~~~kl~d~g~~~~~~~~~~~~~ 162 (261)
T cd05148 83 LMEKGSLLAFLRSPEGQVLPVASLIDMACQVAEGMAYLEEQNSIHRDLAARNILVGEDLVCKVADFGLARLIKEDVYLSS 162 (261)
T ss_pred ecccCCHHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeccccCcceEEEcCCceEEEccccchhhcCCcccccc
Confidence 99999999998753 3589999999999999999999999999999999999999999999999999876543211
Q ss_pred --ccccccccccccccCCCCCCCcccceeeecCCCCCCchHHHHHHHhhc-ccCCCCCCChhhhhhccCcC-CCCCCCCC
Q psy758 157 --RHLHIFQTNEYFKGVSLPHAENVVPLEIKIGKPAATNIYLIDFLKRCL-DKDPLRRWSCDQLLRHPYFN-GYYFEVPD 232 (292)
Q Consensus 157 --~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~p~~~~~~~~~~~~~~~~-~~~~~~~~ 232 (292)
.....|.+||...+.......++|++ +..++..+. +..|.......+.+...... ....+...
T Consensus 163 ~~~~~~~~~~PE~~~~~~~~~~~Diwsl-------------G~~l~~l~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 229 (261)
T cd05148 163 DKKIPYKWTAPEAASHGTFSTKSDVWSF-------------GILLYEMFTYGQVPYPGMNNHEVYDQITAGYRMPCPAKC 229 (261)
T ss_pred CCCCceEecCHHHHccCCCCchhhHHHH-------------HHHHHHHHcCCCCCCCcCCHHHHHHHHHhCCcCCCCCCC
Confidence 11123555555433322222222222 222333332 33444333333322211100 11233455
Q ss_pred ccchHHHHhcccCcCCCCCCChhhhhh
Q psy758 233 EMQYEEITQRCLDKDPLRRWSCDQLLR 259 (292)
Q Consensus 233 ~~~l~~li~~~l~~dP~~Rpt~~~il~ 259 (292)
+..+.++|.+||+.||.+|||++++++
T Consensus 230 ~~~~~~~i~~~l~~~p~~Rpt~~~l~~ 256 (261)
T cd05148 230 PQEIYKIMLECWAAEPEDRPSFKALRE 256 (261)
T ss_pred CHHHHHHHHHHcCCCchhCcCHHHHHH
Confidence 778999999999999999999999986
|
Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase dom |
| >cd05066 PTKc_EphR_A Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-35 Score=237.95 Aligned_cols=243 Identities=21% Similarity=0.288 Sum_probs=177.5
Q ss_pred cccceeeeecccCceEEEEEEEcCCCc---EEEEEEeccCCCChHHHHHHHHHHHHHHhCCCCCcchhhhhhhcCCeEEE
Q psy758 2 ERYEKIGKLGEGSYGVVFKCRNRDTGQ---VVAIKKFLESEEDPLIRKIALREIRLLKSLKHPNLVNLLEVFRRKKKLHL 78 (292)
Q Consensus 2 ~~y~~~~~l~~g~~~~v~~~~~~~~~~---~v~iK~~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~i 78 (292)
++|++.+.||+|+||.||.|.+..++. .+++|.+.... .....+.+.+|+.+++.++||||+++++++.+++..++
T Consensus 4 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~ik~~~~~~-~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l 82 (267)
T cd05066 4 SCIKIEKVIGAGEFGEVCSGRLKLPGKREIPVAIKTLKAGY-TEKQRRDFLSEASIMGQFDHPNIIHLEGVVTKSKPVMI 82 (267)
T ss_pred HHeEeeeeecccCCCceEEEEEecCCCCceEEEEEECCCCC-CHHHHHHHHHHHHHHHhCCCCCcceEEEEEecCCccEE
Confidence 579999999999999999998865544 68999886543 33456678899999999999999999999999999999
Q ss_pred EEecCCCccHHHHhcCC-CCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEEccCCcEEEeecCchhhhhccccc
Q psy758 79 VFEFCDHTVLNELENHP-HGLPWDLIKQITWQVLRGVSYCHRHACIHRDIKPENILLTANGVVKLCDFGFARLIRDLIPR 157 (292)
Q Consensus 79 v~e~~~~~~L~~~~~~~-~~~~~~~~~~i~~qi~~aL~~LH~~givH~dl~p~Nilv~~~~~~kl~dfg~~~~~~~~~~~ 157 (292)
+|||+++++|.+++... ..++..+++.++.|++.||.+||++|++|+||+|+||+++.++.++|+|||.+.........
T Consensus 83 v~e~~~~~~L~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~i~h~dlkp~nili~~~~~~~l~dfg~~~~~~~~~~~ 162 (267)
T cd05066 83 VTEYMENGSLDAFLRKHDGQFTVIQLVGMLRGIASGMKYLSDMGYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEA 162 (267)
T ss_pred EEEcCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCEeehhhchhcEEECCCCeEEeCCCCcccccccccce
Confidence 99999999999998653 45899999999999999999999999999999999999999999999999998765432110
Q ss_pred c--------ccccccccccccCCCCCCCcccceeeecCCCCCCchHHHHHHHhhc-ccCCCCCCChhhhhhccCcCC--C
Q psy758 158 H--------LHIFQTNEYFKGVSLPHAENVVPLEIKIGKPAATNIYLIDFLKRCL-DKDPLRRWSCDQLLRHPYFNG--Y 226 (292)
Q Consensus 158 ~--------~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~p~~~~~~~~~~~~~~~~~--~ 226 (292)
. ...|.+|++..+.......++|+++ ..++..+. +..|.......+.... .... .
T Consensus 163 ~~~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG-------------~~l~ell~~g~~p~~~~~~~~~~~~-~~~~~~~ 228 (267)
T cd05066 163 AYTTRGGKIPIRWTAPEAIAYRKFTSASDVWSYG-------------IVMWEVMSYGERPYWEMSNQDVIKA-IEEGYRL 228 (267)
T ss_pred eeecCCCccceeecCHhHhccCccCchhhhHHHH-------------HHHHHHhcCCCCCcccCCHHHHHHH-HhCCCcC
Confidence 0 1235566655543332222332222 11222221 3333322222221111 0011 1
Q ss_pred CCCCCCccchHHHHhcccCcCCCCCCChhhhhh
Q psy758 227 YFEVPDEMQYEEITQRCLDKDPLRRWSCDQLLR 259 (292)
Q Consensus 227 ~~~~~~~~~l~~li~~~l~~dP~~Rpt~~~il~ 259 (292)
..+...+..+.+++.+||+.+|.+|||+.++++
T Consensus 229 ~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~ 261 (267)
T cd05066 229 PAPMDCPAALHQLMLDCWQKDRNERPKFEQIVS 261 (267)
T ss_pred CCCCCCCHHHHHHHHHHcccCchhCCCHHHHHH
Confidence 122334678999999999999999999999986
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellul |
| >KOG0983|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-36 Score=227.71 Aligned_cols=249 Identities=23% Similarity=0.416 Sum_probs=194.4
Q ss_pred cccceeeeecccCceEEEEEEEcCCCcEEEEEEeccCCCChHHHHHHHHHHHHHHhC-CCCCcchhhhhhhcCCeEEEEE
Q psy758 2 ERYEKIGKLGEGSYGVVFKCRNRDTGQVVAIKKFLESEEDPLIRKIALREIRLLKSL-KHPNLVNLLEVFRRKKKLHLVF 80 (292)
Q Consensus 2 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~e~~~~~~l-~~~~i~~~~~~~~~~~~~~iv~ 80 (292)
++...++.||+|+.|.||+++...+|...|+|.+...... +..+.+...++++..- .+|+|++.+|+|..+..+++.|
T Consensus 92 ndl~~l~dlGsGtcG~V~k~~~rs~~~iiAVK~M~rt~Nk-ee~kRILmDldvv~~s~dcpyIV~c~GyFi~n~dV~IcM 170 (391)
T KOG0983|consen 92 NDLENLGDLGSGTCGQVWKMRFRSTGHIIAVKQMRRTGNK-EENKRILMDLDVVLKSHDCPYIVQCFGYFITNTDVFICM 170 (391)
T ss_pred HHhhhHHhhcCCCccceEEEEEcccceEEEEEeecccCCH-HHHHHHHHhhhHHhhccCCCeeeeeeeEEeeCchHHHHH
Confidence 4566788899999999999999999999999999776654 4456677777776665 4899999999999999999999
Q ss_pred ecCCCccHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhC-CccccCCCCCceEEccCCcEEEeecCchhhhhcccc---
Q psy758 81 EFCDHTVLNELENHPHGLPWDLIKQITWQVLRGVSYCHRH-ACIHRDIKPENILLTANGVVKLCDFGFARLIRDLIP--- 156 (292)
Q Consensus 81 e~~~~~~L~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~-givH~dl~p~Nilv~~~~~~kl~dfg~~~~~~~~~~--- 156 (292)
|.+....-.-+..-.++++|..+-++...++.||.||..+ |++|||+||+|||+|+.|.+||||||++..+.+.-.
T Consensus 171 elMs~C~ekLlkrik~piPE~ilGk~tva~v~AL~YLKeKH~viHRDvKPSNILlDe~GniKlCDFGIsGrlvdSkAhtr 250 (391)
T KOG0983|consen 171 ELMSTCAEKLLKRIKGPIPERILGKMTVAIVKALYYLKEKHGVIHRDVKPSNILLDERGNIKLCDFGISGRLVDSKAHTR 250 (391)
T ss_pred HHHHHHHHHHHHHhcCCchHHhhhhhHHHHHHHHHHHHHhcceeecccCccceEEccCCCEEeecccccceeeccccccc
Confidence 9987643333333346799999999999999999999975 899999999999999999999999999987754322
Q ss_pred -ccccccccccccccCC--------CCCCCcccceeeecCCCCCCc-hHHHHHHHhhcccCCCCCCChhhhhhccCcCCC
Q psy758 157 -RHLHIFQTNEYFKGVS--------LPHAENVVPLEIKIGKPAATN-IYLIDFLKRCLDKDPLRRWSCDQLLRHPYFNGY 226 (292)
Q Consensus 157 -~~~~~~~~~~~~~~~~--------~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~ 226 (292)
.+...|.+||-..+.. ..|++|+..+++.+|..++.. ..-.+.+...++..| +....
T Consensus 251 sAGC~~YMaPERidp~~~~kYDiRaDVWSlGITlveLaTg~yPy~~c~tdFe~ltkvln~eP---P~L~~---------- 317 (391)
T KOG0983|consen 251 SAGCAAYMAPERIDPPDKPKYDIRADVWSLGITLVELATGQYPYKGCKTDFEVLTKVLNEEP---PLLPG---------- 317 (391)
T ss_pred ccCCccccCccccCCCCCCccchhhhhhhhccchhhhhcccCCCCCCCccHHHHHHHHhcCC---CCCCc----------
Confidence 2234466666655542 358889999999999877654 223455566665544 11111
Q ss_pred CCCCCCccchHHHHhcccCcCCCCCCChhhhhhCCcccce
Q psy758 227 YFEVPDEMQYEEITQRCLDKDPLRRWSCDQLLRHPYFNGY 266 (292)
Q Consensus 227 ~~~~~~~~~l~~li~~~l~~dP~~Rpt~~~il~h~w~~~~ 266 (292)
...-++.+.+|+..||..|+.+||...++|+|||+..+
T Consensus 318 --~~gFSp~F~~fv~~CL~kd~r~RP~Y~~Ll~h~Fi~~y 355 (391)
T KOG0983|consen 318 --HMGFSPDFQSFVKDCLTKDHRKRPKYNKLLEHPFIKRY 355 (391)
T ss_pred --ccCcCHHHHHHHHHHhhcCcccCcchHHHhcCcceeec
Confidence 11136689999999999999999999999999999874
|
|
| >cd05060 PTKc_Syk_like Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.6e-35 Score=234.56 Aligned_cols=237 Identities=21% Similarity=0.255 Sum_probs=175.4
Q ss_pred eeecccCceEEEEEEEcCCC---cEEEEEEeccCCCChHHHHHHHHHHHHHHhCCCCCcchhhhhhhcCCeEEEEEecCC
Q psy758 8 GKLGEGSYGVVFKCRNRDTG---QVVAIKKFLESEEDPLIRKIALREIRLLKSLKHPNLVNLLEVFRRKKKLHLVFEFCD 84 (292)
Q Consensus 8 ~~l~~g~~~~v~~~~~~~~~---~~v~iK~~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~iv~e~~~ 84 (292)
+.||+|++|.||+|....++ ..+++|.+...... ...+.+.+|+.+++.+.||||+++++++. .+..++++||+.
T Consensus 1 ~~ig~G~~g~v~~~~~~~~~~~~~~~~iK~~~~~~~~-~~~~~~~~e~~~l~~l~h~~iv~~~~~~~-~~~~~~v~e~~~ 78 (257)
T cd05060 1 KELGHGNFGSVVKGVYLMKSGKEVEVAVKTLKQEHIA-AGKKEFLREASVMAQLDHPCIVRLIGVCK-GEPLMLVMELAP 78 (257)
T ss_pred CccCccCceeEEEeEeeccCCCcceEEEEecccccch-HHHHHHHHHHHHHHhcCCCCeeeEEEEEc-CCceEEEEEeCC
Confidence 47999999999999876554 78999998766544 45567889999999999999999999875 456899999999
Q ss_pred CccHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEEccCCcEEEeecCchhhhhcccccc------
Q psy758 85 HTVLNELENHPHGLPWDLIKQITWQVLRGVSYCHRHACIHRDIKPENILLTANGVVKLCDFGFARLIRDLIPRH------ 158 (292)
Q Consensus 85 ~~~L~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~givH~dl~p~Nilv~~~~~~kl~dfg~~~~~~~~~~~~------ 158 (292)
+++|.+++.....+++..++.++.|++.||++||++|++|+||+|+||+++.++.++|+|||.+..........
T Consensus 79 ~~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lh~~~i~H~di~p~nili~~~~~~kl~df~~~~~~~~~~~~~~~~~~~ 158 (257)
T cd05060 79 LGPLLKYLKKRREIPVSDLKELAHQVAMGMAYLESKHFVHRDLAARNVLLVNRHQAKISDFGMSRALGAGSDYYRATTAG 158 (257)
T ss_pred CCcHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHhhcCeeccCcccceEEEcCCCcEEeccccccceeecCCcccccccCc
Confidence 99999999877789999999999999999999999999999999999999999999999999987653322110
Q ss_pred --ccccccccccccCCCCCCCcccceeeecCCCCCCchHHHHHHHhhc-ccCCCCCCChhhhhhccC-cCCCCCCCCCcc
Q psy758 159 --LHIFQTNEYFKGVSLPHAENVVPLEIKIGKPAATNIYLIDFLKRCL-DKDPLRRWSCDQLLRHPY-FNGYYFEVPDEM 234 (292)
Q Consensus 159 --~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~p~~~~~~~~~~~~~~-~~~~~~~~~~~~ 234 (292)
...|.+||...+.......++ ++.+.-++..+. +..|.......++..... ......+...+.
T Consensus 159 ~~~~~y~aPE~~~~~~~~~~~Di-------------~slG~~l~~~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 225 (257)
T cd05060 159 RWPLKWYAPECINYGKFSSKSDV-------------WSYGVTLWEAFSYGAKPYGEMKGAEVIAMLESGERLPRPEECPQ 225 (257)
T ss_pred cccccccCHHHhcCCCCCccchH-------------HHHHHHHHHHHcCCCCCcccCCHHHHHHHHHcCCcCCCCCCCCH
Confidence 123555665544333222222 222333333332 444544433333322111 011123344567
Q ss_pred chHHHHhcccCcCCCCCCChhhhhh
Q psy758 235 QYEEITQRCLDKDPLRRWSCDQLLR 259 (292)
Q Consensus 235 ~l~~li~~~l~~dP~~Rpt~~~il~ 259 (292)
.+.++|.+||+.||++|||+.++++
T Consensus 226 ~l~~li~~cl~~~p~~Rp~~~~l~~ 250 (257)
T cd05060 226 EIYSIMLSCWKYRPEDRPTFSELES 250 (257)
T ss_pred HHHHHHHHHhcCChhhCcCHHHHHH
Confidence 8999999999999999999999987
|
Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, mi |
| >cd05032 PTKc_InsR_like Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.4e-35 Score=236.44 Aligned_cols=244 Identities=20% Similarity=0.248 Sum_probs=178.6
Q ss_pred cccceeeeecccCceEEEEEEEcCC-----CcEEEEEEeccCCCChHHHHHHHHHHHHHHhCCCCCcchhhhhhhcCCeE
Q psy758 2 ERYEKIGKLGEGSYGVVFKCRNRDT-----GQVVAIKKFLESEEDPLIRKIALREIRLLKSLKHPNLVNLLEVFRRKKKL 76 (292)
Q Consensus 2 ~~y~~~~~l~~g~~~~v~~~~~~~~-----~~~v~iK~~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~ 76 (292)
++|++.+.||+|++|.||++.+... +..|++|.+..... ......+.+|+.+++.++||||+++++++...+..
T Consensus 6 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~aik~~~~~~~-~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~ 84 (277)
T cd05032 6 EKITLIRELGQGSFGMVYEGLAKGVVKGEPETRVAIKTVNENAS-MRERIEFLNEASVMKEFNCHHVVRLLGVVSTGQPT 84 (277)
T ss_pred HHeeEEeEecCCCCceEEEEEEeccCCCCcceeEEEEecCCccC-HHHHHHHHHHHHHHHhCCCCceeEEEEEEcCCCCc
Confidence 6899999999999999999988643 47899999864432 23345678899999999999999999999999999
Q ss_pred EEEEecCCCccHHHHhcCC----------CCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEEccCCcEEEeecC
Q psy758 77 HLVFEFCDHTVLNELENHP----------HGLPWDLIKQITWQVLRGVSYCHRHACIHRDIKPENILLTANGVVKLCDFG 146 (292)
Q Consensus 77 ~iv~e~~~~~~L~~~~~~~----------~~~~~~~~~~i~~qi~~aL~~LH~~givH~dl~p~Nilv~~~~~~kl~dfg 146 (292)
++|+||+++++|..++... ..+++..++.++.|++.||.|||++|++|+||+|+||+++.++.++|+|||
T Consensus 85 ~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~di~p~nill~~~~~~kl~dfg 164 (277)
T cd05032 85 LVVMELMAKGDLKSYLRSRRPEAENNPGLGPPTLQKFIQMAAEIADGMAYLAAKKFVHRDLAARNCMVAEDLTVKIGDFG 164 (277)
T ss_pred EEEEecCCCCCHHHHHHhcccchhhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccccChheEEEcCCCCEEECCcc
Confidence 9999999999999988542 236788999999999999999999999999999999999999999999999
Q ss_pred chhhhhcccc-------ccccccccccccccCCCCCCCcccceeeecCCCCCCchHHHHHHHhhc-ccCCCCCCChhhhh
Q psy758 147 FARLIRDLIP-------RHLHIFQTNEYFKGVSLPHAENVVPLEIKIGKPAATNIYLIDFLKRCL-DKDPLRRWSCDQLL 218 (292)
Q Consensus 147 ~~~~~~~~~~-------~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~p~~~~~~~~~~ 218 (292)
++........ ..+..|.+||...+.......++|+++ ..+++.+. +..|....+..+..
T Consensus 165 ~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG-------------~il~el~t~g~~p~~~~~~~~~~ 231 (277)
T cd05032 165 MTRDIYETDYYRKGGKGLLPVRWMAPESLKDGVFTTKSDVWSFG-------------VVLWEMATLAEQPYQGLSNEEVL 231 (277)
T ss_pred cchhhccCcccccCCCCCccccccCHHHHhcCCCCcccchHHHH-------------HHHHHhhccCCCCCccCCHHHHH
Confidence 9875532211 112345666655433332223333322 22222222 33333333333333
Q ss_pred hccCcC-CCCCCCCCccchHHHHhcccCcCCCCCCChhhhhh
Q psy758 219 RHPYFN-GYYFEVPDEMQYEEITQRCLDKDPLRRWSCDQLLR 259 (292)
Q Consensus 219 ~~~~~~-~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~~il~ 259 (292)
...... ....+...+..+.++|.+||+.+|++|||+.++++
T Consensus 232 ~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~l~~ 273 (277)
T cd05032 232 KFVIDGGHLDLPENCPDKLLELMRMCWQYNPKMRPTFLEIVS 273 (277)
T ss_pred HHHhcCCCCCCCCCCCHHHHHHHHHHcCCChhhCCCHHHHHH
Confidence 222111 11233445778999999999999999999999987
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological |
| >cd05036 PTKc_ALK_LTK Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-35 Score=238.07 Aligned_cols=245 Identities=21% Similarity=0.233 Sum_probs=178.8
Q ss_pred cccceeeeecccCceEEEEEEEcC-----CCcEEEEEEeccCCCChHHHHHHHHHHHHHHhCCCCCcchhhhhhhcCCeE
Q psy758 2 ERYEKIGKLGEGSYGVVFKCRNRD-----TGQVVAIKKFLESEEDPLIRKIALREIRLLKSLKHPNLVNLLEVFRRKKKL 76 (292)
Q Consensus 2 ~~y~~~~~l~~g~~~~v~~~~~~~-----~~~~v~iK~~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~ 76 (292)
++|++.+.||+|++|.||.|.+.. ++..|++|.+..... ......+.+|+.+++.++|+||+++++++.+.+..
T Consensus 6 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~v~ik~~~~~~~-~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~ 84 (277)
T cd05036 6 DSITLLRALGHGAFGEVYEGLYRGRDGDAVELQVAVKTLPESCS-EQDESDFLMEALIMSKFNHQNIVRLIGVSFERLPR 84 (277)
T ss_pred HHcEeeeECCCCCCCcEEEEEEecCCCCCCceeEEEEEcCCCCC-HHHHHHHHHHHHHHHhCCCCCEeeEEEEEccCCCc
Confidence 578999999999999999999977 678899998864433 33345678899999999999999999999888889
Q ss_pred EEEEecCCCccHHHHhcCCC-------CCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEEccCC---cEEEeecC
Q psy758 77 HLVFEFCDHTVLNELENHPH-------GLPWDLIKQITWQVLRGVSYCHRHACIHRDIKPENILLTANG---VVKLCDFG 146 (292)
Q Consensus 77 ~iv~e~~~~~~L~~~~~~~~-------~~~~~~~~~i~~qi~~aL~~LH~~givH~dl~p~Nilv~~~~---~~kl~dfg 146 (292)
++++||+.+++|.+++...+ .+++..+..++.||+.||.|||++|++|+||+|+||+++.++ .++|+|||
T Consensus 85 ~lv~e~~~g~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivH~dlkp~nil~~~~~~~~~~kl~dfg 164 (277)
T cd05036 85 FILLELMAGGDLKSFLRENRPRPERPSSLTMKDLLFCARDVAKGCKYLEENHFIHRDIAARNCLLTCKGPGRVAKIADFG 164 (277)
T ss_pred EEEEecCCCCCHHHHHHHhCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCEeecccchheEEEeccCCCcceEeccCc
Confidence 99999999999999886542 488999999999999999999999999999999999998765 59999999
Q ss_pred chhhhhcccc-------ccccccccccccccCCCCCCCcccceeeecCCCCCCchHHHHHHHhh-cccCCCCCCChhhhh
Q psy758 147 FARLIRDLIP-------RHLHIFQTNEYFKGVSLPHAENVVPLEIKIGKPAATNIYLIDFLKRC-LDKDPLRRWSCDQLL 218 (292)
Q Consensus 147 ~~~~~~~~~~-------~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~p~~~~~~~~~~ 218 (292)
++........ .....|.+||...+.......++|++++ -+++.+ .+..|+...+..++.
T Consensus 165 ~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~-------------il~el~~~g~~pf~~~~~~~~~ 231 (277)
T cd05036 165 MARDIYRASYYRKGGRAMLPIKWMPPEAFLDGIFTSKTDVWSFGV-------------LLWEIFSLGYMPYPGRTNQEVM 231 (277)
T ss_pred cccccCCccceecCCCCCccHhhCCHHHHhcCCcCchhHHHHHHH-------------HHHHHHcCCCCCCCCCCHHHHH
Confidence 9876532111 0112366677665444433333333322 122222 133333332222222
Q ss_pred hccCc-CCCCCCCCCccchHHHHhcccCcCCCCCCChhhhhhC
Q psy758 219 RHPYF-NGYYFEVPDEMQYEEITQRCLDKDPLRRWSCDQLLRH 260 (292)
Q Consensus 219 ~~~~~-~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~~il~h 260 (292)
..... .....+...+..+.+++.+||+.||++|||+.++++|
T Consensus 232 ~~~~~~~~~~~~~~~~~~~~~~i~~cl~~~p~~Rps~~~vl~~ 274 (277)
T cd05036 232 EFVTGGGRLDPPKGCPGPVYRIMTDCWQHTPEDRPNFATILER 274 (277)
T ss_pred HHHHcCCcCCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHH
Confidence 11100 0112233456789999999999999999999999986
|
Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well |
| >cd05072 PTKc_Lyn Catalytic domain of the Protein Tyrosine Kinase, Lyn | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-35 Score=236.38 Aligned_cols=235 Identities=23% Similarity=0.313 Sum_probs=176.1
Q ss_pred cccceeeeecccCceEEEEEEEcCCCcEEEEEEeccCCCChHHHHHHHHHHHHHHhCCCCCcchhhhhhhcCCeEEEEEe
Q psy758 2 ERYEKIGKLGEGSYGVVFKCRNRDTGQVVAIKKFLESEEDPLIRKIALREIRLLKSLKHPNLVNLLEVFRRKKKLHLVFE 81 (292)
Q Consensus 2 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~iv~e 81 (292)
++|++++.||+|++|.||+|... ++..|++|.+..... ..+.+.+|+.+++.++|+||+++++.+.+.+..++++|
T Consensus 6 ~~~~~~~~lg~g~~g~v~~~~~~-~~~~v~iK~~~~~~~---~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 81 (261)
T cd05072 6 ESIKLVKKLGAGQFGEVWMGYYN-NSTKVAVKTLKPGTM---SVQAFLEEANLMKTLQHDKLVRLYAVVTKEEPIYIITE 81 (261)
T ss_pred HHeEEeeecCCcCCceEEEEEec-CCceEEEEEccCCch---hHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCCcEEEEe
Confidence 57999999999999999999865 466799998754332 24668899999999999999999999999999999999
Q ss_pred cCCCccHHHHhcC--CCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEEccCCcEEEeecCchhhhhcccc---
Q psy758 82 FCDHTVLNELENH--PHGLPWDLIKQITWQVLRGVSYCHRHACIHRDIKPENILLTANGVVKLCDFGFARLIRDLIP--- 156 (292)
Q Consensus 82 ~~~~~~L~~~~~~--~~~~~~~~~~~i~~qi~~aL~~LH~~givH~dl~p~Nilv~~~~~~kl~dfg~~~~~~~~~~--- 156 (292)
|+++++|.+++.. ...++...++.++.|++.||+|||+.|++|+||+|+||++++++.++|+|||.+........
T Consensus 82 ~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~l~~~l~~LH~~~i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~~~~~~~ 161 (261)
T cd05072 82 YMAKGSLLDFLKSDEGGKVLLPKLIDFSAQIAEGMAYIERKNYIHRDLRAANVLVSESLMCKIADFGLARVIEDNEYTAR 161 (261)
T ss_pred cCCCCcHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeeccccchhhEEecCCCcEEECCCccceecCCCceecc
Confidence 9999999998854 34688999999999999999999999999999999999999999999999999976543111
Q ss_pred ---ccccccccccccccCCC-----CCCCcccceeeec-CCCCCCchHHHHHHHhhcccCCCCCCChhhhhhccCcCC--
Q psy758 157 ---RHLHIFQTNEYFKGVSL-----PHAENVVPLEIKI-GKPAATNIYLIDFLKRCLDKDPLRRWSCDQLLRHPYFNG-- 225 (292)
Q Consensus 157 ---~~~~~~~~~~~~~~~~~-----~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~-- 225 (292)
.....|.+||+..+... .|+.|+..+++.+ +.. |.......+..... ...
T Consensus 162 ~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~t~g~~------------------p~~~~~~~~~~~~~-~~~~~ 222 (261)
T cd05072 162 EGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLYEIVTYGKI------------------PYPGMSNSDVMSAL-QRGYR 222 (261)
T ss_pred CCCccceecCCHHHhccCCCChhhhhhhhHHHHHHHHccCCC------------------CCCCCCHHHHHHHH-HcCCC
Confidence 11234667776544332 3333333333333 333 32222222211110 001
Q ss_pred CCCCCCCccchHHHHhcccCcCCCCCCChhhhhh
Q psy758 226 YYFEVPDEMQYEEITQRCLDKDPLRRWSCDQLLR 259 (292)
Q Consensus 226 ~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~~il~ 259 (292)
.......+..+.+++.+||+.||++|||++++++
T Consensus 223 ~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~ 256 (261)
T cd05072 223 MPRMENCPDELYDIMKTCWKEKAEERPTFDYLQS 256 (261)
T ss_pred CCCCCCCCHHHHHHHHHHccCCcccCcCHHHHHH
Confidence 1112234678999999999999999999999976
|
Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth fa |
| >cd05095 PTKc_DDR2 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.5e-35 Score=239.38 Aligned_cols=244 Identities=21% Similarity=0.311 Sum_probs=173.7
Q ss_pred cccceeeeecccCceEEEEEEEcC----------------CCcEEEEEEeccCCCChHHHHHHHHHHHHHHhCCCCCcch
Q psy758 2 ERYEKIGKLGEGSYGVVFKCRNRD----------------TGQVVAIKKFLESEEDPLIRKIALREIRLLKSLKHPNLVN 65 (292)
Q Consensus 2 ~~y~~~~~l~~g~~~~v~~~~~~~----------------~~~~v~iK~~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~ 65 (292)
++|++.+.||+|+||.||++.+.. ++..|++|.+.... .......+.+|+.+++.++|+||++
T Consensus 5 ~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~a~K~~~~~~-~~~~~~~~~~E~~~l~~l~~~~i~~ 83 (296)
T cd05095 5 KRLTFKEKLGEGQFGEVHLCEAEGMEKFMDKDFSLDVSGNQPVLVAVKMLREDA-NKNARNDFLKEIKIMSRLKDPNIIR 83 (296)
T ss_pred hhceeeeeccCCCCCeEEecccccccccccccccccCCCCceeEEEEEeccccC-CHHHHHHHHHHHHHHHhCCCCCcce
Confidence 579999999999999999986432 34468999886543 3344567889999999999999999
Q ss_pred hhhhhhcCCeEEEEEecCCCccHHHHhcCCC-----------CCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEE
Q psy758 66 LLEVFRRKKKLHLVFEFCDHTVLNELENHPH-----------GLPWDLIKQITWQVLRGVSYCHRHACIHRDIKPENILL 134 (292)
Q Consensus 66 ~~~~~~~~~~~~iv~e~~~~~~L~~~~~~~~-----------~~~~~~~~~i~~qi~~aL~~LH~~givH~dl~p~Nilv 134 (292)
+++++.+.+..++++||+.+++|..++.... .+++..++.++.|++.||+|||++|++|+||||+||++
T Consensus 84 ~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~~i~H~dlkp~Nili 163 (296)
T cd05095 84 LLAVCITSDPLCMITEYMENGDLNQFLSRHEPQEAAEKADVVTISYSTLIFMATQIASGMKYLSSLNFVHRDLATRNCLV 163 (296)
T ss_pred EEEEEecCCccEEEEEeCCCCcHHHHHHhcCcccccccccccccCHHHHHHHHHHHHHHHHHHHHCCeecccCChheEEE
Confidence 9999999999999999999999999886532 36678899999999999999999999999999999999
Q ss_pred ccCCcEEEeecCchhhhhccccc--c-----ccccccccccccCCCCCCCcccceeeecCCCCCCchHHHHHHHhhc--c
Q psy758 135 TANGVVKLCDFGFARLIRDLIPR--H-----LHIFQTNEYFKGVSLPHAENVVPLEIKIGKPAATNIYLIDFLKRCL--D 205 (292)
Q Consensus 135 ~~~~~~kl~dfg~~~~~~~~~~~--~-----~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~ 205 (292)
+.++.++|+|||++......... . ...|.+|+...+.......++|++ +..+++.+. +
T Consensus 164 ~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~DiwSl-------------G~~l~el~~~~~ 230 (296)
T cd05095 164 GKNYTIKIADFGMSRNLYSGDYYRIQGRAVLPIRWMSWESILLGKFTTASDVWAF-------------GVTLWEILTLCK 230 (296)
T ss_pred cCCCCEEeccCcccccccCCcceeccCcCcCccccCCHHHHhcCCccchhhhhHH-------------HHHHHHHHHhCC
Confidence 99999999999998754322110 0 122344443333222222233332 222222221 3
Q ss_pred cCCCCCCChhhhhhcc--Cc------CCCCCCCCCccchHHHHhcccCcCCCCCCChhhhhh
Q psy758 206 KDPLRRWSCDQLLRHP--YF------NGYYFEVPDEMQYEEITQRCLDKDPLRRWSCDQLLR 259 (292)
Q Consensus 206 ~~p~~~~~~~~~~~~~--~~------~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~~il~ 259 (292)
..|....+..+..... ++ .....+...+..+.+|+.+||+.||.+|||+.+|++
T Consensus 231 ~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~i~~ 292 (296)
T cd05095 231 EQPYSQLSDEQVIENTGEFFRDQGRQVYLPKPALCPDSLYKLMLSCWRRNAKERPSFQEIHA 292 (296)
T ss_pred CCCccccChHHHHHHHHHHHhhccccccCCCCCCCCHHHHHHHHHHcCCCcccCCCHHHHHH
Confidence 3344333333322110 00 001122334678999999999999999999999975
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 2 (DDR2) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR2 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR2 binds mostly to fibrillar collagens. More recently, it has been reported to also bind collagen X. DDR2 is widely expressed in many tissues wit |
| >cd05055 PTKc_PDGFR Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=5e-35 Score=240.09 Aligned_cols=244 Identities=24% Similarity=0.367 Sum_probs=176.9
Q ss_pred cccceeeeecccCceEEEEEEE-----cCCCcEEEEEEeccCCCChHHHHHHHHHHHHHHhC-CCCCcchhhhhhhcCCe
Q psy758 2 ERYEKIGKLGEGSYGVVFKCRN-----RDTGQVVAIKKFLESEEDPLIRKIALREIRLLKSL-KHPNLVNLLEVFRRKKK 75 (292)
Q Consensus 2 ~~y~~~~~l~~g~~~~v~~~~~-----~~~~~~v~iK~~~~~~~~~~~~~~~~~e~~~~~~l-~~~~i~~~~~~~~~~~~ 75 (292)
++|.+.+.||+|++|.||++.+ ..++..||+|.+..... ....+.+.+|+.+++.+ +||||+++++++...+.
T Consensus 35 ~~~~~~~~ig~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~ 113 (302)
T cd05055 35 NNLSFGKTLGAGAFGKVVEATAYGLSKSDAVMKVAVKMLKPTAH-SSEREALMSELKIMSHLGNHENIVNLLGACTIGGP 113 (302)
T ss_pred HHeEEcceeeccCCeeEEEEEEecCCCCCceeEEEEEecCccCC-hHHHHHHHHHHHHHHhccCCCCcceEEEEEecCCc
Confidence 4788999999999999999975 23456799998865433 33456788999999999 79999999999999999
Q ss_pred EEEEEecCCCccHHHHhcCCC--CCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEEccCCcEEEeecCchhhhhc
Q psy758 76 LHLVFEFCDHTVLNELENHPH--GLPWDLIKQITWQVLRGVSYCHRHACIHRDIKPENILLTANGVVKLCDFGFARLIRD 153 (292)
Q Consensus 76 ~~iv~e~~~~~~L~~~~~~~~--~~~~~~~~~i~~qi~~aL~~LH~~givH~dl~p~Nilv~~~~~~kl~dfg~~~~~~~ 153 (292)
.++++||+++++|..++.... .+++.++..++.|++.||.|||++|++|+||+|+||+++.++.++|+|||++.....
T Consensus 114 ~~lv~e~~~~~~L~~~i~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~~l~dfg~~~~~~~ 193 (302)
T cd05055 114 ILVITEYCCYGDLLNFLRRKRESFLTLEDLLSFSYQVAKGMAFLASKNCIHRDLAARNVLLTHGKIVKICDFGLARDIMN 193 (302)
T ss_pred eEEEEEcCCCCcHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCeehhhhccceEEEcCCCeEEECCCcccccccC
Confidence 999999999999999886532 389999999999999999999999999999999999999999999999999875532
Q ss_pred ccc-------ccccccccccccccCCCCCCCcccceeeecCCCCCCchHHHHHHHhhc-ccCCCCCCChhhhhhccCcCC
Q psy758 154 LIP-------RHLHIFQTNEYFKGVSLPHAENVVPLEIKIGKPAATNIYLIDFLKRCL-DKDPLRRWSCDQLLRHPYFNG 225 (292)
Q Consensus 154 ~~~-------~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~p~~~~~~~~~~~~~~~~~ 225 (292)
... .....|.+||...+.......++|++ +.-+++.+. +..|.......+........+
T Consensus 194 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Diwsl-------------Gvil~el~t~g~~p~~~~~~~~~~~~~~~~~ 260 (302)
T cd05055 194 DSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSY-------------GILLWEIFSLGSNPYPGMPVDSKFYKLIKEG 260 (302)
T ss_pred CCceeecCCCCcccccCCHhhhccCCCCcHhHHHHH-------------HHHHHHHHhCCCCCcCCCCchHHHHHHHHcC
Confidence 211 11223556665544333222333332 222223232 333433322221111111011
Q ss_pred C--CCCCCCccchHHHHhcccCcCCCCCCChhhhhh
Q psy758 226 Y--YFEVPDEMQYEEITQRCLDKDPLRRWSCDQLLR 259 (292)
Q Consensus 226 ~--~~~~~~~~~l~~li~~~l~~dP~~Rpt~~~il~ 259 (292)
. ..+...+..+.+++.+||+.+|++|||+.++++
T Consensus 261 ~~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ell~ 296 (302)
T cd05055 261 YRMAQPEHAPAEIYDIMKTCWDADPLKRPTFKQIVQ 296 (302)
T ss_pred CcCCCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHH
Confidence 1 122334678999999999999999999999986
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to recept |
| >cd05103 PTKc_VEGFR2 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-34 Score=242.15 Aligned_cols=245 Identities=24% Similarity=0.364 Sum_probs=172.8
Q ss_pred cccceeeeecccCceEEEEEEE-----cCCCcEEEEEEeccCCCChHHHHHHHHHHHHHHhC-CCCCcchhhhhhhc-CC
Q psy758 2 ERYEKIGKLGEGSYGVVFKCRN-----RDTGQVVAIKKFLESEEDPLIRKIALREIRLLKSL-KHPNLVNLLEVFRR-KK 74 (292)
Q Consensus 2 ~~y~~~~~l~~g~~~~v~~~~~-----~~~~~~v~iK~~~~~~~~~~~~~~~~~e~~~~~~l-~~~~i~~~~~~~~~-~~ 74 (292)
++|++.+.||+|+||.||+|.+ ..+++.||+|.+..... ......+.+|+.++..+ +||||+++++++.. ++
T Consensus 7 ~~~~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~~ 85 (343)
T cd05103 7 DRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGAT-HSEHRALMSELKILIHIGHHLNVVNLLGACTKPGG 85 (343)
T ss_pred hHhcccccccCCccceEEEEeeccCCccccceeEEEEEeccCCC-hHHHHHHHHHHHHHHhccCCccHhhhcceeecCCC
Confidence 5899999999999999999984 34677899999865433 33456688899999999 68999999998764 45
Q ss_pred eEEEEEecCCCccHHHHhcCC-----------------------------------------------------------
Q psy758 75 KLHLVFEFCDHTVLNELENHP----------------------------------------------------------- 95 (292)
Q Consensus 75 ~~~iv~e~~~~~~L~~~~~~~----------------------------------------------------------- 95 (292)
..++++||+++|+|.+++...
T Consensus 86 ~~~lv~ey~~~g~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 165 (343)
T cd05103 86 PLMVIVEFCKFGNLSNYLRSKRGEFVPYKTKDARFRQGKSGYGDISEDLKRRLDSITSSQSSASSGFVEEKSLSDVEEEE 165 (343)
T ss_pred ceEEEEeccCCCcHHHHHHhcCCccccccccccccccccccccchhhhhhhhccccccccccccccccCCCccccchhhh
Confidence 689999999999999887532
Q ss_pred --------CCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEEccCCcEEEeecCchhhhhccc-------ccccc
Q psy758 96 --------HGLPWDLIKQITWQVLRGVSYCHRHACIHRDIKPENILLTANGVVKLCDFGFARLIRDLI-------PRHLH 160 (292)
Q Consensus 96 --------~~~~~~~~~~i~~qi~~aL~~LH~~givH~dl~p~Nilv~~~~~~kl~dfg~~~~~~~~~-------~~~~~ 160 (292)
..++...+..++.||+.||+|||++|++|+||||+||+++.++.++|+|||++....... .....
T Consensus 166 ~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~i~H~dikp~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~ 245 (343)
T cd05103 166 AEQEDLYKKVLTLEDLICYSFQVAKGMEFLASRKCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGDARLPL 245 (343)
T ss_pred hhhhhhhhccCCHHHHHHHHHHHHHHHHHHHhCCeecCCCccCeEEEcCCCcEEEEecccccccccCcchhhcCCCCCCc
Confidence 136778889999999999999999999999999999999999999999999987643211 11122
Q ss_pred ccccccccccCCCCCCCcccceeeecCCCCCCchHHHHHHHhh-cccCCCCCCChhhhhhccCcCC--CCCCCCCccchH
Q psy758 161 IFQTNEYFKGVSLPHAENVVPLEIKIGKPAATNIYLIDFLKRC-LDKDPLRRWSCDQLLRHPYFNG--YYFEVPDEMQYE 237 (292)
Q Consensus 161 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~p~~~~~~~~~~~~~~~~~--~~~~~~~~~~l~ 237 (292)
.|.+||...+.......++|+++ ..++..+ .+..|.......+........+ ...+...++.+.
T Consensus 246 ~y~aPE~~~~~~~~~~~Di~slG-------------~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 312 (343)
T cd05103 246 KWMAPETIFDRVYTIQSDVWSFG-------------VLLWEIFSLGASPYPGVKIDEEFCRRLKEGTRMRAPDYTTPEMY 312 (343)
T ss_pred ceECcHHhcCCCCCchhhHHHHH-------------HHHHHHHHCCCCCCCCccccHHHHHHHhccCCCCCCCCCCHHHH
Confidence 35666655444333333333322 2222222 1233332221111111100011 111223456899
Q ss_pred HHHhcccCcCCCCCCChhhhhhC
Q psy758 238 EITQRCLDKDPLRRWSCDQLLRH 260 (292)
Q Consensus 238 ~li~~~l~~dP~~Rpt~~~il~h 260 (292)
+++.+||+.||.+|||+.+|++|
T Consensus 313 ~~~~~cl~~~p~~Rps~~eil~~ 335 (343)
T cd05103 313 QTMLDCWHGEPSQRPTFSELVEH 335 (343)
T ss_pred HHHHHHccCChhhCcCHHHHHHH
Confidence 99999999999999999999986
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosp |
| >cd05576 STKc_RPK118_like Catalytic domain of the Protein Serine/Threonine Kinases, RPK118 and similar proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-35 Score=232.31 Aligned_cols=227 Identities=18% Similarity=0.179 Sum_probs=166.7
Q ss_pred cCceEEEEEEEcCCCcEEEEEEeccCCCChHHHHHHHHHHHHHHhCCCCCcchhhhhhhcCCeEEEEEecCCCccHHHHh
Q psy758 13 GSYGVVFKCRNRDTGQVVAIKKFLESEEDPLIRKIALREIRLLKSLKHPNLVNLLEVFRRKKKLHLVFEFCDHTVLNELE 92 (292)
Q Consensus 13 g~~~~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~iv~e~~~~~~L~~~~ 92 (292)
|.+|.||+|++..+++.||+|.+..... ..+|...+....||||+++++++.+.+..+++|||++|++|.+++
T Consensus 4 g~~~~v~~~~~~~~~~~~~~K~i~~~~~-------~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l 76 (237)
T cd05576 4 GVIDKVLLVMDTRTQQTFILKGLRKSSE-------YSRERLTIIPHCVPNMVCLHKYIVSEDSVFLVLQHAEGGKLWSHI 76 (237)
T ss_pred cccceEEEEEEccCCcEEEEEeecchhh-------hhhHHHHHHhcCCCceeehhhheecCCeEEEEEecCCCCCHHHHH
Confidence 8899999999999999999999866431 223444555567999999999999999999999999999999988
Q ss_pred cCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEEccCCcEEEeecCchhhhhccc--ccccccccccccccc
Q psy758 93 NHPHGLPWDLIKQITWQVLRGVSYCHRHACIHRDIKPENILLTANGVVKLCDFGFARLIRDLI--PRHLHIFQTNEYFKG 170 (292)
Q Consensus 93 ~~~~~~~~~~~~~i~~qi~~aL~~LH~~givH~dl~p~Nilv~~~~~~kl~dfg~~~~~~~~~--~~~~~~~~~~~~~~~ 170 (292)
.....+++..+..++.|++.||.|||++|++|+||+|+||+++.++.++++|||.+....... ......|.+||...+
T Consensus 77 ~~~~~l~~~~~~~~~~ql~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~y~aPE~~~~ 156 (237)
T cd05576 77 SKFLNIPEECVKRWAAEMVVALDALHREGIVCRDLNPNNILLDDRGHIQLTYFSRWSEVEDSCDGEAVENMYCAPEVGGI 156 (237)
T ss_pred HHhcCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHEEEcCCCCEEEecccchhccccccccCCcCccccCCcccCC
Confidence 776679999999999999999999999999999999999999999999999999876554321 122234666665543
Q ss_pred CCCCCCCcccceeeecCCCCCCchHHHHHHHhhcccCCCCCCChhhhhhccCcCCCCCCCCCccchHHHHhcccCcCCCC
Q psy758 171 VSLPHAENVVPLEIKIGKPAATNIYLIDFLKRCLDKDPLRRWSCDQLLRHPYFNGYYFEVPDEMQYEEITQRCLDKDPLR 250 (292)
Q Consensus 171 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~ 250 (292)
.......++|+ .+..++..+.+..+.... ...... ......+...+..++++|.+||+.||++
T Consensus 157 ~~~~~~~Dvws-------------lG~il~el~~g~~~~~~~-~~~~~~---~~~~~~~~~~~~~~~~li~~~l~~dp~~ 219 (237)
T cd05576 157 SEETEACDWWS-------------LGAILFELLTGKTLVECH-PSGINT---HTTLNIPEWVSEEARSLLQQLLQFNPTE 219 (237)
T ss_pred CCCCchhhHHH-------------HHHHHHHHHHCcchhhcC-chhccc---ccccCCcccCCHHHHHHHHHHccCCHHH
Confidence 32222222222 222233333333222111 000000 0112233445778999999999999999
Q ss_pred CCCh-----hhhhhCCcc
Q psy758 251 RWSC-----DQLLRHPYF 263 (292)
Q Consensus 251 Rpt~-----~~il~h~w~ 263 (292)
|||+ +++++||||
T Consensus 220 R~~~~~~~~~~~~~h~~~ 237 (237)
T cd05576 220 RLGAGVAGVEDIKSHPFF 237 (237)
T ss_pred hcCCCccchHHHHcCCCC
Confidence 9996 999999997
|
Serine/Threonine Kinases (STKs), RPK118-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RPK118-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily show similarity to human RPK118, which contains an N-terminal Phox homology (PX) domain, a Microtubule Interacting and Trafficking (MIT) domain, and a kinase domain containing a long insert. Also included in the family is human RPK60 (or ribosomal protein S6 kinase-like 1), which also contains MIT and kinase domains but lacks a PX domain. RPK118 binds sphingosine kinase, a key enzyme in the synthesis of sphingosine 1-phospha |
| >cd05091 PTKc_Ror2 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-35 Score=238.57 Aligned_cols=245 Identities=21% Similarity=0.253 Sum_probs=179.7
Q ss_pred cccceeeeecccCceEEEEEEEcCC-----CcEEEEEEeccCCCChHHHHHHHHHHHHHHhCCCCCcchhhhhhhcCCeE
Q psy758 2 ERYEKIGKLGEGSYGVVFKCRNRDT-----GQVVAIKKFLESEEDPLIRKIALREIRLLKSLKHPNLVNLLEVFRRKKKL 76 (292)
Q Consensus 2 ~~y~~~~~l~~g~~~~v~~~~~~~~-----~~~v~iK~~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~ 76 (292)
.+|.+.+.||+|++|.||+|.+..+ +..||+|.+..... ......+..|..++..++||||+++++++.+.+..
T Consensus 5 ~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~~~~~~ 83 (283)
T cd05091 5 STVRFMEELGEDRFGKVYKGHLFGTAPGEQTQAVAIKTLKDKAE-GPLREEFKHEAMMRSRLQHPNIVCLLGVVTKEQPL 83 (283)
T ss_pred HHHHHHHHhCCCCCCeEEEEEEecCCCCCceeEEEEEEccCCCC-HHHHHHHHHHHHHHhcCCCCCcCeEEEEEcCCCce
Confidence 5788999999999999999987543 57899999875432 33456688899999999999999999999998999
Q ss_pred EEEEecCCCccHHHHhcC----------------CCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEEccCCcE
Q psy758 77 HLVFEFCDHTVLNELENH----------------PHGLPWDLIKQITWQVLRGVSYCHRHACIHRDIKPENILLTANGVV 140 (292)
Q Consensus 77 ~iv~e~~~~~~L~~~~~~----------------~~~~~~~~~~~i~~qi~~aL~~LH~~givH~dl~p~Nilv~~~~~~ 140 (292)
++++||+.+++|..++.. ...++...++.++.|++.||.|||++|++||||||+||++++++.+
T Consensus 84 ~~~~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ql~~aL~~lH~~gi~H~dlkp~Nil~~~~~~~ 163 (283)
T cd05091 84 SMIFSYCSHSDLHEFLVMRSPHSDVGSTDDDKTVKSTLEPADFVHIVTQIAAGMEFLSSHHVVHKDLATRNVLVFDKLNV 163 (283)
T ss_pred EEEEEcCCCCcHHHHHHhcCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHHcCccccccchhheEecCCCce
Confidence 999999999999988742 1247888999999999999999999999999999999999999999
Q ss_pred EEeecCchhhhhcccc-------ccccccccccccccCCCCCCCcccceeeecCCCCCCchHHHHHHHhhc-ccCCCCCC
Q psy758 141 KLCDFGFARLIRDLIP-------RHLHIFQTNEYFKGVSLPHAENVVPLEIKIGKPAATNIYLIDFLKRCL-DKDPLRRW 212 (292)
Q Consensus 141 kl~dfg~~~~~~~~~~-------~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~p~~~~ 212 (292)
+|+|||++........ ..+..|.+||...+.......++ ++.+..+++.+. +..|....
T Consensus 164 kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv-------------~slG~~l~el~~~g~~p~~~~ 230 (283)
T cd05091 164 KISDLGLFREVYAADYYKLMGNSLLPIRWMSPEAIMYGKFSIDSDI-------------WSYGVVLWEVFSYGLQPYCGY 230 (283)
T ss_pred EecccccccccccchheeeccCccCCccccCHHHHhcCCCCcchhH-------------HHHHHHHHHHHcCCCCCCCCC
Confidence 9999999875432111 11234566665543333222222 222223333332 33344443
Q ss_pred ChhhhhhccCcC-CCCCCCCCccchHHHHhcccCcCCCCCCChhhhhhC
Q psy758 213 SCDQLLRHPYFN-GYYFEVPDEMQYEEITQRCLDKDPLRRWSCDQLLRH 260 (292)
Q Consensus 213 ~~~~~~~~~~~~-~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~~il~h 260 (292)
...++.....-. ....+...+..+.+|+.+||+.||.+||++++|++.
T Consensus 231 ~~~~~~~~i~~~~~~~~~~~~~~~~~~li~~cl~~~p~~RP~~~~i~~~ 279 (283)
T cd05091 231 SNQDVIEMIRNRQVLPCPDDCPAWVYTLMLECWNEFPSRRPRFKDIHSR 279 (283)
T ss_pred CHHHHHHHHHcCCcCCCCCCCCHHHHHHHHHHhCCCcccCCCHHHHHHH
Confidence 333333221111 112234557789999999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 2 (Ror2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly |
| >KOG1035|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.5e-36 Score=264.56 Aligned_cols=246 Identities=26% Similarity=0.410 Sum_probs=183.3
Q ss_pred cccceeeeecccCceEEEEEEEcCCCcEEEEEEeccCCCChHHHHHHHHHHHHHHhCCCCCcchhhhhhhcC--------
Q psy758 2 ERYEKIGKLGEGSYGVVFKCRNRDTGQVVAIKKFLESEEDPLIRKIALREIRLLKSLKHPNLVNLLEVFRRK-------- 73 (292)
Q Consensus 2 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~-------- 73 (292)
++|+..+.||+||||.||+++.+-+|..||||.|+... +......+.+|+..+.+|+||||++++..|.+.
T Consensus 479 ~DFEEL~lLGkGGFG~VvkVRNKlDGr~YAIKKIpl~~-s~~~~skI~rEVk~LArLnHpNVVRYysAWVEs~~~~~~~e 557 (1351)
T KOG1035|consen 479 NDFEELELLGKGGFGSVVKVRNKLDGREYAIKKIPLKA-SDKLYSKILREVKLLARLNHPNVVRYYSAWVESTAELTVLE 557 (1351)
T ss_pred hhhHHHHHhcCCCCceEEEEeecccchhhhhhhccCch-HHHHHHHHHHHHHHHhhcCCcceeeeehhhhccCCcccccc
Confidence 57888999999999999999999999999999998877 667778899999999999999999998765110
Q ss_pred --------------------------------------------------------------------------------
Q psy758 74 -------------------------------------------------------------------------------- 73 (292)
Q Consensus 74 -------------------------------------------------------------------------------- 73 (292)
T Consensus 558 i~~~~~~~~sQs~s~~~~~~~~~q~t~~p~~~~~~~~~~~~dd~sss~~~~~~~~~~~~d~e~~d~dedg~~~S~tS~~e 637 (1351)
T KOG1035|consen 558 IVASDSESRSQSASKYNGVDIRYQPTSSPSLTLSELDSEDEDDKSSSYTTRKASYESSTDEENDDSDEDGRNLSNTSDSE 637 (1351)
T ss_pred ccccchhhhcccCCCcccceeeeccCCCcccCcchhhccccCccccccccccccccccCCcccccccccccccccccccC
Confidence
Q ss_pred -------------------------------CeEEEEEecCCCccHHHHhcCCCCC-CHHHHHHHHHHHHHHHHHHHhCC
Q psy758 74 -------------------------------KKLHLVFEFCDHTVLNELENHPHGL-PWDLIKQITWQVLRGVSYCHRHA 121 (292)
Q Consensus 74 -------------------------------~~~~iv~e~~~~~~L~~~~~~~~~~-~~~~~~~i~~qi~~aL~~LH~~g 121 (292)
..+||=||||+..++.+++..+... ....+|.++.+|++||.|+|++|
T Consensus 638 ~~~~~d~~~ess~s~~~~~n~~e~~~~~q~~~~LYIQMEyCE~~ll~~iI~~N~~~~~~d~~wrLFreIlEGLaYIH~~g 717 (1351)
T KOG1035|consen 638 GSVILDDTSESSESIPKTENSSEPMVPVQKPLILYIQMEYCEKTLLRDIIRRNHFNSQRDEAWRLFREILEGLAYIHDQG 717 (1351)
T ss_pred CccccCcchhhhhhccccCCccccccccccceEEEEEHhhhhhhHHHHHHHhcccchhhHHHHHHHHHHHHHHHHHHhCc
Confidence 1257778999999999998876544 57889999999999999999999
Q ss_pred ccccCCCCCceEEccCCcEEEeecCchhhhh-----------------------ccccccccccccccccccCC---C--
Q psy758 122 CIHRDIKPENILLTANGVVKLCDFGFARLIR-----------------------DLIPRHLHIFQTNEYFKGVS---L-- 173 (292)
Q Consensus 122 ivH~dl~p~Nilv~~~~~~kl~dfg~~~~~~-----------------------~~~~~~~~~~~~~~~~~~~~---~-- 173 (292)
|+||||||.|||+++++.+||+|||+++... .....++..|.+||...+.. +
T Consensus 718 iIHRDLKP~NIFLd~~~~VKIGDFGLAt~~~~~~~~~d~~~~~~~~~~g~~~~~~Ts~VGTalYvAPEll~~~~~~~Yn~ 797 (1351)
T KOG1035|consen 718 IIHRDLKPRNIFLDSRNSVKIGDFGLATDLKENLESIDQDLSFSTNRAGSNDGDLTSQVGTALYVAPELLSDTSSNKYNS 797 (1351)
T ss_pred eeeccCCcceeEEcCCCCeeecccccchhhhhhhhhHhhccCccccccCCCCcccccccceeeeecHHHhcccccccccc
Confidence 9999999999999999999999999998722 01122345577777665544 1
Q ss_pred ---CCCCcccceeeecCCCCCCchHHHHHHHhhcccCCCCCCChhhhhhccCcCCCCCCCCCccchHHHHhcccCcCCCC
Q psy758 174 ---PHAENVVPLEIKIGKPAATNIYLIDFLKRCLDKDPLRRWSCDQLLRHPYFNGYYFEVPDEMQYEEITQRCLDKDPLR 250 (292)
Q Consensus 174 ---~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~ 250 (292)
.++.|+..++++.+ +.....-...+..+-...- ..+ ..+..+.-+.-..+|++||+.||++
T Consensus 798 KiDmYSLGIVlFEM~yP--F~TsMERa~iL~~LR~g~i----------P~~----~~f~~~~~~~e~slI~~Ll~hdP~k 861 (1351)
T KOG1035|consen 798 KIDMYSLGIVLFEMLYP--FGTSMERASILTNLRKGSI----------PEP----ADFFDPEHPEEASLIRWLLSHDPSK 861 (1351)
T ss_pred hhhhHHHHHHHHHHhcc--CCchHHHHHHHHhcccCCC----------CCC----cccccccchHHHHHHHHHhcCCCcc
Confidence 24444555555444 1112222223332221100 000 0111222345568999999999999
Q ss_pred CCChhhhhhCCccc
Q psy758 251 RWSCDQLLRHPYFN 264 (292)
Q Consensus 251 Rpt~~~il~h~w~~ 264 (292)
||||.|+|++.||-
T Consensus 862 RPtA~eLL~s~llp 875 (1351)
T KOG1035|consen 862 RPTATELLNSELLP 875 (1351)
T ss_pred CCCHHHHhhccCCC
Confidence 99999999999997
|
|
| >cd05046 PTK_CCK4 Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-34 Score=235.35 Aligned_cols=245 Identities=17% Similarity=0.247 Sum_probs=180.9
Q ss_pred cccceeeeecccCceEEEEEEEcC-----CCcEEEEEEeccCCCChHHHHHHHHHHHHHHhCCCCCcchhhhhhhcCCeE
Q psy758 2 ERYEKIGKLGEGSYGVVFKCRNRD-----TGQVVAIKKFLESEEDPLIRKIALREIRLLKSLKHPNLVNLLEVFRRKKKL 76 (292)
Q Consensus 2 ~~y~~~~~l~~g~~~~v~~~~~~~-----~~~~v~iK~~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~ 76 (292)
++|++.+.||+|+||.||+|+... +.+.|++|.+..... ....+.+.+|+++++.++||||+++++++.+.+..
T Consensus 5 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~~~k~~~~~~~-~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~ 83 (275)
T cd05046 5 SNLQEITTLGRGEFGEVFLAKAKGIEEEGGETLVLVKALQKTKD-ENLQSEFRRELDMFRKLSHKNVVRLLGLCREAEPH 83 (275)
T ss_pred HhceeeeeecccceeEEEEEEeccCCcCCCcceEEEEccCCccc-hHHHHHHHHHHHHHHhcCCcceeeeEEEECCCCcc
Confidence 578999999999999999999754 345789998765432 23556788999999999999999999999988999
Q ss_pred EEEEecCCCccHHHHhcCCC---------CCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEEccCCcEEEeecCc
Q psy758 77 HLVFEFCDHTVLNELENHPH---------GLPWDLIKQITWQVLRGVSYCHRHACIHRDIKPENILLTANGVVKLCDFGF 147 (292)
Q Consensus 77 ~iv~e~~~~~~L~~~~~~~~---------~~~~~~~~~i~~qi~~aL~~LH~~givH~dl~p~Nilv~~~~~~kl~dfg~ 147 (292)
++|+||+++++|.+++.... .+++..+..++.|++.||+|||++|++|+||+|+||+++.++.++|+|||+
T Consensus 84 ~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~l~~LH~~~i~H~dlkp~Nili~~~~~~~l~~~~~ 163 (275)
T cd05046 84 YMILEYTDLGDLKQFLRATKSKDEKLKPPPLSTKQKVALCTQIALGMDHLSNARFVHRDLAARNCLVSSQREVKVSLLSL 163 (275)
T ss_pred eEEEEecCCCcHHHHHHhcccccccccccCCCHHHHHHHHHHHHHHHHHhhhcCcccCcCccceEEEeCCCcEEEccccc
Confidence 99999999999999987655 689999999999999999999999999999999999999999999999998
Q ss_pred hhhhhccc------cccccccccccccccCCCCCCCcccceeeecCCCCCCchHHHHHHHhhc-ccCCCCCCChhhhhhc
Q psy758 148 ARLIRDLI------PRHLHIFQTNEYFKGVSLPHAENVVPLEIKIGKPAATNIYLIDFLKRCL-DKDPLRRWSCDQLLRH 220 (292)
Q Consensus 148 ~~~~~~~~------~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~p~~~~~~~~~~~~ 220 (292)
+....... ...+..|.+||+..+.......++|+++ ..++..+. +..|.......+.+..
T Consensus 164 ~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG-------------~~l~~l~~~~~~p~~~~~~~~~~~~ 230 (275)
T cd05046 164 SKDVYNSEYYKLRNALIPLRWLAPEAVQEDDFSTKSDVWSFG-------------VLMWEVFTQGELPFYGLSDEEVLNR 230 (275)
T ss_pred ccccCcccccccCCceeEEeecChhhhccCCCCchhhHHHHH-------------HHHHHHHhCCCCCccccchHHHHHH
Confidence 76432111 1112236667765444333333333332 22222222 3334333333333322
Q ss_pred cCcCC--CCCCCCCccchHHHHhcccCcCCCCCCChhhhhhC
Q psy758 221 PYFNG--YYFEVPDEMQYEEITQRCLDKDPLRRWSCDQLLRH 260 (292)
Q Consensus 221 ~~~~~--~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~~il~h 260 (292)
..... ...+...+..+.+++.+||+.||.+|||+.++++.
T Consensus 231 ~~~~~~~~~~~~~~~~~l~~~i~~~l~~~p~~Rp~~~~~l~~ 272 (275)
T cd05046 231 LQAGKLELPVPEGCPSRLYKLMTRCWAVNPKDRPSFSELVSA 272 (275)
T ss_pred HHcCCcCCCCCCCCCHHHHHHHHHHcCCCcccCCCHHHHHHH
Confidence 11111 12234557789999999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is s |
| >cd05105 PTKc_PDGFR_alpha Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.1e-35 Score=246.50 Aligned_cols=244 Identities=23% Similarity=0.294 Sum_probs=174.6
Q ss_pred cccceeeeecccCceEEEEEEEcCC-----CcEEEEEEeccCCCChHHHHHHHHHHHHHHhCC-CCCcchhhhhhhcCCe
Q psy758 2 ERYEKIGKLGEGSYGVVFKCRNRDT-----GQVVAIKKFLESEEDPLIRKIALREIRLLKSLK-HPNLVNLLEVFRRKKK 75 (292)
Q Consensus 2 ~~y~~~~~l~~g~~~~v~~~~~~~~-----~~~v~iK~~~~~~~~~~~~~~~~~e~~~~~~l~-~~~i~~~~~~~~~~~~ 75 (292)
++|++++.||+|+||.||.|.+... +..||+|++.... .....+.+.+|+.+++.+. ||||+++++++.+.+.
T Consensus 37 ~~~~~~~~LG~G~fG~Vy~~~~~~~~~~~~~~~vavK~l~~~~-~~~~~~~~~~Ei~~l~~l~~HpnIv~l~~~~~~~~~ 115 (400)
T cd05105 37 DGLVLGRILGSGAFGKVVEGTAYGLSRSQPVMKVAVKMLKPTA-RSSEKQALMSELKIMTHLGPHLNIVNLLGACTKSGP 115 (400)
T ss_pred cceehhheecCCCCceEEEEEEcccCCCCCceEEEEEecCCCC-ChHHHHHHHHHHHHHHhcCCCCCeeeEEEEEccCCc
Confidence 5788999999999999999986432 3469999986543 3344567889999999996 9999999999999999
Q ss_pred EEEEEecCCCccHHHHhcCC------------------------------------------------------------
Q psy758 76 LHLVFEFCDHTVLNELENHP------------------------------------------------------------ 95 (292)
Q Consensus 76 ~~iv~e~~~~~~L~~~~~~~------------------------------------------------------------ 95 (292)
+|+||||+++|+|.+++...
T Consensus 116 ~~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 195 (400)
T cd05105 116 IYIITEYCFYGDLVNYLHKNRDNFLSRHPEKPKKDLDIFGINPADESTRSYVILSFENKGDYMDMKQADTTQYVPMLEIK 195 (400)
T ss_pred eEEEEEecCCCcHHHHHHHhhhhhhccccccccccccccCCCcccccccchhhhhhcccccccccccccccccchhhhhh
Confidence 99999999999998876432
Q ss_pred ------------------------------------CCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEEccCCc
Q psy758 96 ------------------------------------HGLPWDLIKQITWQVLRGVSYCHRHACIHRDIKPENILLTANGV 139 (292)
Q Consensus 96 ------------------------------------~~~~~~~~~~i~~qi~~aL~~LH~~givH~dl~p~Nilv~~~~~ 139 (292)
..+++..+..++.||+.||+|||+.|++|+||+|+||++++++.
T Consensus 196 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~ivH~dikp~Nill~~~~~ 275 (400)
T cd05105 196 EASKYSDIQRSNYDRPASYKGSNDSEVKNLLSDDGSEGLTTLDLLSFTYQVARGMEFLASKNCVHRDLAARNVLLAQGKI 275 (400)
T ss_pred hhhhhhhcccCcccccccccCcchhhHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCChHhEEEeCCCE
Confidence 23678888999999999999999999999999999999999999
Q ss_pred EEEeecCchhhhhcccc-------ccccccccccccccCCCCCCCcccceeeecCCCCCCchHHHHHHHhh-cccCCCCC
Q psy758 140 VKLCDFGFARLIRDLIP-------RHLHIFQTNEYFKGVSLPHAENVVPLEIKIGKPAATNIYLIDFLKRC-LDKDPLRR 211 (292)
Q Consensus 140 ~kl~dfg~~~~~~~~~~-------~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~p~~~ 211 (292)
++|+|||++........ .....|.+||...+.......++|++ +..++..+ .+..|...
T Consensus 276 ~kL~DfGla~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwSl-------------Gvil~ellt~g~~P~~~ 342 (400)
T cd05105 276 VKICDFGLARDIMHDSNYVSKGSTFLPVKWMAPESIFDNLYTTLSDVWSY-------------GILLWEIFSLGGTPYPG 342 (400)
T ss_pred EEEEeCCcceeccccccccccCCcCCCcceEChhhhcCCCCCchhhHHHH-------------HHHHHHHHHCCCCCCcc
Confidence 99999999875432111 11123555665544333222333332 22223322 23344333
Q ss_pred CChhhhhhccCcCC--CCCCCCCccchHHHHhcccCcCCCCCCChhhhhh
Q psy758 212 WSCDQLLRHPYFNG--YYFEVPDEMQYEEITQRCLDKDPLRRWSCDQLLR 259 (292)
Q Consensus 212 ~~~~~~~~~~~~~~--~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~~il~ 259 (292)
.............+ ...+...+..+.+++.+||+.||++|||+.+|.+
T Consensus 343 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~~l~~ 392 (400)
T cd05105 343 MIVDSTFYNKIKSGYRMAKPDHATQEVYDIMVKCWNSEPEKRPSFLHLSD 392 (400)
T ss_pred cchhHHHHHHHhcCCCCCCCccCCHHHHHHHHHHCccCHhHCcCHHHHHH
Confidence 22211111111111 1122344678999999999999999999999877
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) alpha; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR alpha is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR alpha forms homodimers or heterodimers with PDGFR beta, depending on the nature of the PDGF ligand. PDGF-AA, PDGF- |
| >cd05098 PTKc_FGFR1 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.7e-35 Score=240.46 Aligned_cols=245 Identities=22% Similarity=0.304 Sum_probs=177.2
Q ss_pred cccceeeeecccCceEEEEEEEcC-------CCcEEEEEEeccCCCChHHHHHHHHHHHHHHhC-CCCCcchhhhhhhcC
Q psy758 2 ERYEKIGKLGEGSYGVVFKCRNRD-------TGQVVAIKKFLESEEDPLIRKIALREIRLLKSL-KHPNLVNLLEVFRRK 73 (292)
Q Consensus 2 ~~y~~~~~l~~g~~~~v~~~~~~~-------~~~~v~iK~~~~~~~~~~~~~~~~~e~~~~~~l-~~~~i~~~~~~~~~~ 73 (292)
++|.+.+.||+|+||.||.|.+.. +...+|+|.+.... .......+.+|+.+++.+ +||||+++++++...
T Consensus 18 ~~~~i~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~aiK~~~~~~-~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~ 96 (307)
T cd05098 18 DRLVLGKPLGEGCFGQVVMAEAIGLDKEKPNRVTKVAVKMLKSDA-TEKDLSDLISEMEMMKMIGKHKNIINLLGACTQD 96 (307)
T ss_pred HHeEEeeeeccCCCeeEEEeEEeccCCcccCccceEEEEeccCCC-ChHHHHHHHHHHHHHHHhcCCCCEeeEEEEEecC
Confidence 579999999999999999998643 23469999887543 233445678899999999 799999999999999
Q ss_pred CeEEEEEecCCCccHHHHhcCC----------------CCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEEccC
Q psy758 74 KKLHLVFEFCDHTVLNELENHP----------------HGLPWDLIKQITWQVLRGVSYCHRHACIHRDIKPENILLTAN 137 (292)
Q Consensus 74 ~~~~iv~e~~~~~~L~~~~~~~----------------~~~~~~~~~~i~~qi~~aL~~LH~~givH~dl~p~Nilv~~~ 137 (292)
+..|+|+||+++++|.+++... ..++...+..++.|++.||+|||++|++|+||+|+||+++++
T Consensus 97 ~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~~gi~H~dlkp~Nill~~~ 176 (307)
T cd05098 97 GPLYVIVEYASKGNLREYLRARRPPGMEYCYNPTQVPEEQLSFKDLVSCAYQVARGMEYLASKKCIHRDLAARNVLVTED 176 (307)
T ss_pred CceEEEEecCCCCcHHHHHHhcCCcccccccccccCccccCCHHHHHHHHHHHHHHHHHHHHCCcccccccHHheEEcCC
Confidence 9999999999999999998643 247889999999999999999999999999999999999999
Q ss_pred CcEEEeecCchhhhhcccc-------ccccccccccccccCCCCCCCcccceeeecCCCCCCchHHHHHHHhhc-ccCCC
Q psy758 138 GVVKLCDFGFARLIRDLIP-------RHLHIFQTNEYFKGVSLPHAENVVPLEIKIGKPAATNIYLIDFLKRCL-DKDPL 209 (292)
Q Consensus 138 ~~~kl~dfg~~~~~~~~~~-------~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~p~ 209 (292)
+.++|+|||.+........ .....|.+||...+.......++|++ +.-++..+. +..|.
T Consensus 177 ~~~kL~dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dvwsl-------------G~~l~el~~~g~~p~ 243 (307)
T cd05098 177 NVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSF-------------GVLLWEIFTLGGSPY 243 (307)
T ss_pred CcEEECCCcccccccccchhhccccCCCccceeChHHhccCCCCcHHHHHHH-------------HHHHHHHHcCCCCCC
Confidence 9999999999875532110 11124666665544333222222222 222222222 33333
Q ss_pred CCCChhhhhhccCcC-CCCCCCCCccchHHHHhcccCcCCCCCCChhhhhhC
Q psy758 210 RRWSCDQLLRHPYFN-GYYFEVPDEMQYEEITQRCLDKDPLRRWSCDQLLRH 260 (292)
Q Consensus 210 ~~~~~~~~~~~~~~~-~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~~il~h 260 (292)
......++....-.. ....+...+..+.+||.+||..+|.+|||+.+++++
T Consensus 244 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~evl~~ 295 (307)
T cd05098 244 PGVPVEELFKLLKEGHRMDKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVED 295 (307)
T ss_pred CcCCHHHHHHHHHcCCCCCCCCcCCHHHHHHHHHHcccChhhCcCHHHHHHH
Confidence 333333322111000 112233457789999999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd05065 PTKc_EphR_B Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-34 Score=234.48 Aligned_cols=246 Identities=20% Similarity=0.272 Sum_probs=179.0
Q ss_pred CcccceeeeecccCceEEEEEEEcCCCc---EEEEEEeccCCCChHHHHHHHHHHHHHHhCCCCCcchhhhhhhcCCeEE
Q psy758 1 MERYEKIGKLGEGSYGVVFKCRNRDTGQ---VVAIKKFLESEEDPLIRKIALREIRLLKSLKHPNLVNLLEVFRRKKKLH 77 (292)
Q Consensus 1 ~~~y~~~~~l~~g~~~~v~~~~~~~~~~---~v~iK~~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~ 77 (292)
+++|.+.+.||+|++|.||+|....+++ .|++|.+.... .......+..|+.+++.++||||+++++++.+++..+
T Consensus 3 ~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~ 81 (269)
T cd05065 3 VSCVKIEEVIGAGEFGEVCRGRLKLPGKREIFVAIKTLKSGY-TEKQRRDFLSEASIMGQFDHPNIIHLEGVVTKSRPVM 81 (269)
T ss_pred hHHeEEEeEecCCCCCeEEEEEEecCCCCceeEEEEEcCCCC-CHHHHHHHHHHHHHHHhCCCcCcceEEEEECCCCceE
Confidence 3679999999999999999999887665 59999886543 3445677889999999999999999999999999999
Q ss_pred EEEecCCCccHHHHhcC-CCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEEccCCcEEEeecCchhhhhcccc
Q psy758 78 LVFEFCDHTVLNELENH-PHGLPWDLIKQITWQVLRGVSYCHRHACIHRDIKPENILLTANGVVKLCDFGFARLIRDLIP 156 (292)
Q Consensus 78 iv~e~~~~~~L~~~~~~-~~~~~~~~~~~i~~qi~~aL~~LH~~givH~dl~p~Nilv~~~~~~kl~dfg~~~~~~~~~~ 156 (292)
+|+||+++++|..++.. .+.+++..++.++.|++.||.|||++|++|+||+|+||++++++.++|+|||++........
T Consensus 82 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~~l~~al~~lH~~g~~H~dl~p~nili~~~~~~kl~dfg~~~~~~~~~~ 161 (269)
T cd05065 82 IITEFMENGALDSFLRQNDGQFTVIQLVGMLRGIAAGMKYLSEMNYVHRDLAARNILVNSNLVCKVSDFGLSRFLEDDTS 161 (269)
T ss_pred EEEecCCCCcHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHHCCEeecccChheEEEcCCCcEEECCCccccccccCcc
Confidence 99999999999998865 34689999999999999999999999999999999999999999999999998865432111
Q ss_pred cc----------ccccccccccccCCCCCCCcccceeeecCCCCCCchHHHHHHHhh-cccCCCCCCChhhhhhccC-cC
Q psy758 157 RH----------LHIFQTNEYFKGVSLPHAENVVPLEIKIGKPAATNIYLIDFLKRC-LDKDPLRRWSCDQLLRHPY-FN 224 (292)
Q Consensus 157 ~~----------~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~p~~~~~~~~~~~~~~-~~ 224 (292)
.. ...|.+||...+.......++|+++ ..+++.+ .+..|.......+...... ..
T Consensus 162 ~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~DvwslG-------------~~l~e~l~~g~~p~~~~~~~~~~~~i~~~~ 228 (269)
T cd05065 162 DPTYTSSLGGKIPIRWTAPEAIAYRKFTSASDVWSYG-------------IVMWEVMSYGERPYWDMSNQDVINAIEQDY 228 (269)
T ss_pred ccccccccCCCcceeecCHhHhccCcccchhhhhhhH-------------HHHHHHhcCCCCCCCCCCHHHHHHHHHcCC
Confidence 00 1135566655443322222222222 2222222 1333333322222221110 00
Q ss_pred CCCCCCCCccchHHHHhcccCcCCCCCCChhhhhhC
Q psy758 225 GYYFEVPDEMQYEEITQRCLDKDPLRRWSCDQLLRH 260 (292)
Q Consensus 225 ~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~~il~h 260 (292)
....+...+..+.+++.+||..||.+||+++++++.
T Consensus 229 ~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~ 264 (269)
T cd05065 229 RLPPPMDCPTALHQLMLDCWQKDRNARPKFGQIVST 264 (269)
T ss_pred cCCCcccCCHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence 112223346789999999999999999999999863
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephr |
| >cd05081 PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-35 Score=238.46 Aligned_cols=252 Identities=25% Similarity=0.337 Sum_probs=175.5
Q ss_pred cccceeeeecccCceEEEEEE----EcCCCcEEEEEEeccCCCChHHHHHHHHHHHHHHhCCCCCcchhhhhhh--cCCe
Q psy758 2 ERYEKIGKLGEGSYGVVFKCR----NRDTGQVVAIKKFLESEEDPLIRKIALREIRLLKSLKHPNLVNLLEVFR--RKKK 75 (292)
Q Consensus 2 ~~y~~~~~l~~g~~~~v~~~~----~~~~~~~v~iK~~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~--~~~~ 75 (292)
++|++.+.||+|+||.||.+. +..++..|++|.+.... ....+.+.+|+.+++.++||||+++++++. +...
T Consensus 4 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~v~iK~~~~~~--~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~ 81 (284)
T cd05081 4 RHLKFIQQLGKGNFGSVELCRYDPLQDNTGEVVAVKKLQHST--AEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRN 81 (284)
T ss_pred ccceeeeeccCCCCceEEEEEecCCcCCCCcEEEEEEeccCC--HHHHHHHHHHHHHHHhCCCCCeeEEEEEEccCCCCc
Confidence 468899999999999999997 44578899999986443 334567889999999999999999998754 3457
Q ss_pred EEEEEecCCCccHHHHhcCC-CCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEEccCCcEEEeecCchhhhhcc
Q psy758 76 LHLVFEFCDHTVLNELENHP-HGLPWDLIKQITWQVLRGVSYCHRHACIHRDIKPENILLTANGVVKLCDFGFARLIRDL 154 (292)
Q Consensus 76 ~~iv~e~~~~~~L~~~~~~~-~~~~~~~~~~i~~qi~~aL~~LH~~givH~dl~p~Nilv~~~~~~kl~dfg~~~~~~~~ 154 (292)
+++|+||+++++|.+++... ..+++..++.++.|++.||+|||++|++|+||+|+||++++++.++|+|||++......
T Consensus 82 ~~lv~e~~~~~~L~~~l~~~~~~l~~~~~~~~~~~l~~aL~~LH~~~i~H~dlkp~nili~~~~~~~l~dfg~~~~~~~~ 161 (284)
T cd05081 82 LRLVMEYLPYGSLRDYLQKHRERLDHRKLLLYASQICKGMEYLGSKRYVHRDLATRNILVESENRVKIGDFGLTKVLPQD 161 (284)
T ss_pred eEEEEEecCCCCHHHHHHhcCcCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCHhhEEECCCCeEEECCCcccccccCC
Confidence 89999999999999988653 45899999999999999999999999999999999999999999999999998865432
Q ss_pred cc--------ccccccccccccccCCCC-----CCCcccceeeecCCCCCCchHHHHHHHhhcccCCCCCCC---hhhhh
Q psy758 155 IP--------RHLHIFQTNEYFKGVSLP-----HAENVVPLEIKIGKPAATNIYLIDFLKRCLDKDPLRRWS---CDQLL 218 (292)
Q Consensus 155 ~~--------~~~~~~~~~~~~~~~~~~-----~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~---~~~~~ 218 (292)
.. .....|.+||...+.... |+.|+..+++.++........ ..+... .......... ..+.+
T Consensus 162 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~~~~~~~~~-~~~~~~-~~~~~~~~~~~~~~~~~~ 239 (284)
T cd05081 162 KEYYKVREPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYSDKSCSPP-AEFMRM-MGNDKQGQMIVYHLIELL 239 (284)
T ss_pred CcceeecCCCCCceEeeCHHHhccCCcChHHHHHHHHHHHHHHhhcCCcCCCcc-hhhhhh-cccccccccchHHHHHHH
Confidence 11 111235667766554333 333333333333322111100 001111 0111000000 11111
Q ss_pred hccCcCCCCCCCCCccchHHHHhcccCcCCCCCCChhhhhh
Q psy758 219 RHPYFNGYYFEVPDEMQYEEITQRCLDKDPLRRWSCDQLLR 259 (292)
Q Consensus 219 ~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~~il~ 259 (292)
.... ....+...+..+.+||.+||+.+|++|||+.++++
T Consensus 240 ~~~~--~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~ 278 (284)
T cd05081 240 KNNG--RLPAPPGCPAEIYAIMKECWNNDPSQRPSFSELAL 278 (284)
T ss_pred hcCC--cCCCCCCCCHHHHHHHHHHccCChhhCCCHHHHHH
Confidence 1110 11222344678999999999999999999999987
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as th |
| >cd05070 PTKc_Fyn_Yrk Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.5e-35 Score=234.23 Aligned_cols=240 Identities=24% Similarity=0.311 Sum_probs=173.8
Q ss_pred cccceeeeecccCceEEEEEEEcCCCcEEEEEEeccCCCChHHHHHHHHHHHHHHhCCCCCcchhhhhhhcCCeEEEEEe
Q psy758 2 ERYEKIGKLGEGSYGVVFKCRNRDTGQVVAIKKFLESEEDPLIRKIALREIRLLKSLKHPNLVNLLEVFRRKKKLHLVFE 81 (292)
Q Consensus 2 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~iv~e 81 (292)
++|++.+.||+|++|.||+|.+. .+..+++|.+...... .+.+.+|+.+++.++|++++++++++. .+..+++||
T Consensus 6 ~~~~~~~~ig~g~~~~v~~~~~~-~~~~~~~k~~~~~~~~---~~~~~~E~~~l~~l~~~~i~~~~~~~~-~~~~~lv~e 80 (260)
T cd05070 6 ESLQLIKKLGNGQFGEVWMGTWN-GNTKVAVKTLKPGTMS---PESFLEEAQIMKKLRHDKLVQLYAVVS-EEPIYIVTE 80 (260)
T ss_pred HHhhhhheeccccCceEEEEEec-CCceeEEEEecCCCCC---HHHHHHHHHHHHhcCCCceEEEEeEEC-CCCcEEEEE
Confidence 68999999999999999999876 4667999998765443 245788999999999999999999875 456899999
Q ss_pred cCCCccHHHHhcCC--CCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEEccCCcEEEeecCchhhhhcccc---
Q psy758 82 FCDHTVLNELENHP--HGLPWDLIKQITWQVLRGVSYCHRHACIHRDIKPENILLTANGVVKLCDFGFARLIRDLIP--- 156 (292)
Q Consensus 82 ~~~~~~L~~~~~~~--~~~~~~~~~~i~~qi~~aL~~LH~~givH~dl~p~Nilv~~~~~~kl~dfg~~~~~~~~~~--- 156 (292)
|+++++|.+++... ..+++..++.++.|++.||.|||++|++|+||+|+||++++++.++|+|||.+........
T Consensus 81 ~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~~~i~H~di~p~Nili~~~~~~~l~dfg~~~~~~~~~~~~~ 160 (260)
T cd05070 81 YMSKGSLLDFLKDGEGRALKLPNLVDMAAQVAAGMAYIERMNYIHRDLRSANILVGDGLVCKIADFGLARLIEDNEYTAR 160 (260)
T ss_pred ecCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCccceEEEeCCceEEeCCceeeeeccCcccccc
Confidence 99999999988642 3589999999999999999999999999999999999999999999999999876532111
Q ss_pred ---ccccccccccccccCCCCCCCcccceeeecCCCCCCchHHHHHHHhhc-ccCCCCCCChhhhhhccCc-CCCCCCCC
Q psy758 157 ---RHLHIFQTNEYFKGVSLPHAENVVPLEIKIGKPAATNIYLIDFLKRCL-DKDPLRRWSCDQLLRHPYF-NGYYFEVP 231 (292)
Q Consensus 157 ---~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~p~~~~~~~~~~~~~~~-~~~~~~~~ 231 (292)
.....|.+||...+.......++|+++ ..++..+. +..|.......+......- .....+..
T Consensus 161 ~~~~~~~~y~aPE~~~~~~~~~~~Di~slG-------------~~l~~l~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~ 227 (260)
T cd05070 161 QGAKFPIKWTAPEAALYGRFTIKSDVWSFG-------------ILLTELVTKGRVPYPGMNNREVLEQVERGYRMPCPQD 227 (260)
T ss_pred cCCCCCccccChHHHhcCCCcchhhhHHHH-------------HHHHHHHhcCCCCCCCCCHHHHHHHHHcCCCCCCCCc
Confidence 112246677765443332233333322 12222222 2223222222222211100 01122334
Q ss_pred CccchHHHHhcccCcCCCCCCChhhhhh
Q psy758 232 DEMQYEEITQRCLDKDPLRRWSCDQLLR 259 (292)
Q Consensus 232 ~~~~l~~li~~~l~~dP~~Rpt~~~il~ 259 (292)
.+..+.+|+.+||+.||.+|||++++.+
T Consensus 228 ~~~~~~~li~~~l~~~p~~Rpt~~~l~~ 255 (260)
T cd05070 228 CPISLHELMLQCWKKDPEERPTFEYLQS 255 (260)
T ss_pred CCHHHHHHHHHHcccCcccCcCHHHHHH
Confidence 5778999999999999999999999986
|
Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that r |
| >cd05034 PTKc_Src_like Catalytic domain of Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-34 Score=232.54 Aligned_cols=241 Identities=23% Similarity=0.299 Sum_probs=178.6
Q ss_pred cccceeeeecccCceEEEEEEEcCCCcEEEEEEeccCCCChHHHHHHHHHHHHHHhCCCCCcchhhhhhhcCCeEEEEEe
Q psy758 2 ERYEKIGKLGEGSYGVVFKCRNRDTGQVVAIKKFLESEEDPLIRKIALREIRLLKSLKHPNLVNLLEVFRRKKKLHLVFE 81 (292)
Q Consensus 2 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~iv~e 81 (292)
++|++.+.||+|++|.||+|.+.. +..|++|.+...... .+.+.+|+.+++.++||||+++++++.+....++++|
T Consensus 6 ~~~~i~~~ig~g~~~~v~~~~~~~-~~~~~vK~~~~~~~~---~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e 81 (261)
T cd05034 6 ESLKLERKLGAGQFGEVWMGTWNG-TTKVAVKTLKPGTMS---PEAFLQEAQIMKKLRHDKLVQLYAVCSEEEPIYIVTE 81 (261)
T ss_pred hheeeeeeeccCcceEEEEEEEcC-CceEEEEEecCCccC---HHHHHHHHHHHhhCCCCCEeeeeeeeecCCceEEEEe
Confidence 689999999999999999999764 577999998754433 3457889999999999999999999988889999999
Q ss_pred cCCCccHHHHhcCC--CCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEEccCCcEEEeecCchhhhhccc----
Q psy758 82 FCDHTVLNELENHP--HGLPWDLIKQITWQVLRGVSYCHRHACIHRDIKPENILLTANGVVKLCDFGFARLIRDLI---- 155 (292)
Q Consensus 82 ~~~~~~L~~~~~~~--~~~~~~~~~~i~~qi~~aL~~LH~~givH~dl~p~Nilv~~~~~~kl~dfg~~~~~~~~~---- 155 (292)
|+++++|.+++... ..++...+..++.|++.||.|||++|++|+||+|+||++++++.++|+|||.+.......
T Consensus 82 ~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~i~~al~~lh~~~i~h~di~p~nili~~~~~~~l~d~g~~~~~~~~~~~~~ 161 (261)
T cd05034 82 YMSKGSLLDFLKSGEGKKLRLPQLVDMAAQIAEGMAYLESRNYIHRDLAARNILVGENLVCKIADFGLARLIEDDEYTAR 161 (261)
T ss_pred ccCCCCHHHHHhccccCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCcchheEEEcCCCCEEECccccceeccchhhhhh
Confidence 99999999988653 368999999999999999999999999999999999999999999999999987654211
Q ss_pred --cccccccccccccccCCCCCCCcccceeeecCCCCCCchHHHHHHHhhc-ccCCCCCCChhhhhhccCcC-CCCCCCC
Q psy758 156 --PRHLHIFQTNEYFKGVSLPHAENVVPLEIKIGKPAATNIYLIDFLKRCL-DKDPLRRWSCDQLLRHPYFN-GYYFEVP 231 (292)
Q Consensus 156 --~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~p~~~~~~~~~~~~~~~~-~~~~~~~ 231 (292)
......|.+||...+.......++|++++ .++..+. +..|....+....+...... ....+..
T Consensus 162 ~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~-------------il~~l~t~g~~p~~~~~~~~~~~~~~~~~~~~~~~~ 228 (261)
T cd05034 162 EGAKFPIKWTAPEAANYGRFTIKSDVWSFGI-------------LLTEIVTYGRVPYPGMTNREVLEQVERGYRMPRPPN 228 (261)
T ss_pred hccCCCccccCHHHhccCCcCchhHHHHHHH-------------HHHHHHhCCCCCCCCCCHHHHHHHHHcCCCCCCCCC
Confidence 11123466677665544333333333322 2222222 33333322222222211100 1122233
Q ss_pred CccchHHHHhcccCcCCCCCCChhhhhh
Q psy758 232 DEMQYEEITQRCLDKDPLRRWSCDQLLR 259 (292)
Q Consensus 232 ~~~~l~~li~~~l~~dP~~Rpt~~~il~ 259 (292)
.+..+.+++.+||+.||.+||+++++++
T Consensus 229 ~~~~~~~~i~~~l~~~p~~Rp~~~~l~~ 256 (261)
T cd05034 229 CPEELYDLMLQCWDKDPEERPTFEYLQS 256 (261)
T ss_pred CCHHHHHHHHHHcccCcccCCCHHHHHH
Confidence 4678999999999999999999999986
|
Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-t |
| >cd05094 PTKc_TrkC Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.8e-35 Score=237.30 Aligned_cols=243 Identities=22% Similarity=0.277 Sum_probs=176.8
Q ss_pred cccceeeeecccCceEEEEEEEcC-----CCcEEEEEEeccCCCChHHHHHHHHHHHHHHhCCCCCcchhhhhhhcCCeE
Q psy758 2 ERYEKIGKLGEGSYGVVFKCRNRD-----TGQVVAIKKFLESEEDPLIRKIALREIRLLKSLKHPNLVNLLEVFRRKKKL 76 (292)
Q Consensus 2 ~~y~~~~~l~~g~~~~v~~~~~~~-----~~~~v~iK~~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~ 76 (292)
.+|.+.+.||+|++|.||+|.+.. ++..+++|.+.... ....+.+.+|+.+++.++||||+++++++...+..
T Consensus 5 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~k~~~~~~--~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~ 82 (291)
T cd05094 5 RDIVLKRELGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPT--LAARKDFQREAELLTNLQHEHIVKFYGVCGDGDPL 82 (291)
T ss_pred HHeEEeeeecccCCCeEEEeEeeccCCCCcceeeEEEecCCcc--HHHHHHHHHHHHHHhcCCCCCcceEEEEEccCCce
Confidence 478999999999999999998543 45568888875433 33446688999999999999999999999999999
Q ss_pred EEEEecCCCccHHHHhcCC----------------CCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEEccCCcE
Q psy758 77 HLVFEFCDHTVLNELENHP----------------HGLPWDLIKQITWQVLRGVSYCHRHACIHRDIKPENILLTANGVV 140 (292)
Q Consensus 77 ~iv~e~~~~~~L~~~~~~~----------------~~~~~~~~~~i~~qi~~aL~~LH~~givH~dl~p~Nilv~~~~~~ 140 (292)
++||||+++++|.+++... ..+++..++.++.||+.||+|||++|++|+||+|+||++++++.+
T Consensus 83 ~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~i~H~dlkp~Nil~~~~~~~ 162 (291)
T cd05094 83 IMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHIASQIASGMVYLASQHFVHRDLATRNCLVGANLLV 162 (291)
T ss_pred EEEEecCCCCcHHHHHHhcCcccccccccccccCcCCCCHHHHHHHHHHHHHHHHHHHhCCeeecccCcceEEEccCCcE
Confidence 9999999999999998643 237899999999999999999999999999999999999999999
Q ss_pred EEeecCchhhhhcccc-------ccccccccccccccCCCCCCCcccceeeecCCCCCCchHHHHHHHhhc-ccCCCCCC
Q psy758 141 KLCDFGFARLIRDLIP-------RHLHIFQTNEYFKGVSLPHAENVVPLEIKIGKPAATNIYLIDFLKRCL-DKDPLRRW 212 (292)
Q Consensus 141 kl~dfg~~~~~~~~~~-------~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~p~~~~ 212 (292)
+|+|||++........ .....|.+||...+.......++|++ +.-+++.+. +..|....
T Consensus 163 ~l~dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~sl-------------G~il~el~t~g~~p~~~~ 229 (291)
T cd05094 163 KIGDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSF-------------GVILWEIFTYGKQPWFQL 229 (291)
T ss_pred EECCCCcccccCCCceeecCCCCCcceeecChHHhccCCCCchhhHHHH-------------HHHHHHHHhCCCCCCCCC
Confidence 9999999875432111 11234666666544433222333322 222233332 44443333
Q ss_pred ChhhhhhccCcCCC-CCCCCCccchHHHHhcccCcCCCCCCChhhhhh
Q psy758 213 SCDQLLRHPYFNGY-YFEVPDEMQYEEITQRCLDKDPLRRWSCDQLLR 259 (292)
Q Consensus 213 ~~~~~~~~~~~~~~-~~~~~~~~~l~~li~~~l~~dP~~Rpt~~~il~ 259 (292)
...+.......... ..+...+..+.+++.+||+.||++|||+.++++
T Consensus 230 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~v~~ 277 (291)
T cd05094 230 SNTEVIECITQGRVLERPRVCPKEVYDIMLGCWQREPQQRLNIKEIYK 277 (291)
T ss_pred CHHHHHHHHhCCCCCCCCccCCHHHHHHHHHHcccChhhCcCHHHHHH
Confidence 33222211100000 112334678999999999999999999999987
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some n |
| >cd05071 PTKc_Src Catalytic domain of the Protein Tyrosine Kinase, Src | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-34 Score=232.86 Aligned_cols=240 Identities=23% Similarity=0.288 Sum_probs=174.0
Q ss_pred cccceeeeecccCceEEEEEEEcCCCcEEEEEEeccCCCChHHHHHHHHHHHHHHhCCCCCcchhhhhhhcCCeEEEEEe
Q psy758 2 ERYEKIGKLGEGSYGVVFKCRNRDTGQVVAIKKFLESEEDPLIRKIALREIRLLKSLKHPNLVNLLEVFRRKKKLHLVFE 81 (292)
Q Consensus 2 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~iv~e 81 (292)
++|++.+.||+|++|.||+|.+..+ ..|++|.+...... ...+.+|+.+++.++||||+++++.+. .+..++|||
T Consensus 6 ~~~~~~~~lg~g~~~~v~~~~~~~~-~~valK~~~~~~~~---~~~~~~E~~~l~~l~~~~i~~~~~~~~-~~~~~lv~e 80 (262)
T cd05071 6 ESLRLEVKLGQGCFGEVWMGTWNGT-TRVAIKTLKPGTMS---PEAFLQEAQVMKKLRHEKLVQLYAVVS-EEPIYIVTE 80 (262)
T ss_pred HHeeEeeecCCCCCCcEEEEEecCC-ceEEEEecccCccC---HHHHHHHHHHHHhCCCCCcceEEEEEC-CCCcEEEEE
Confidence 6899999999999999999988765 46999998754432 245788999999999999999998875 456899999
Q ss_pred cCCCccHHHHhcCC--CCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEEccCCcEEEeecCchhhhhcccc---
Q psy758 82 FCDHTVLNELENHP--HGLPWDLIKQITWQVLRGVSYCHRHACIHRDIKPENILLTANGVVKLCDFGFARLIRDLIP--- 156 (292)
Q Consensus 82 ~~~~~~L~~~~~~~--~~~~~~~~~~i~~qi~~aL~~LH~~givH~dl~p~Nilv~~~~~~kl~dfg~~~~~~~~~~--- 156 (292)
|+++++|.+++... ..+++..+..++.|++.||++||++|++|+||+|+||++++++.++|+|||.+........
T Consensus 81 ~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~aL~~lH~~~i~H~dl~p~Nill~~~~~~~L~dfg~~~~~~~~~~~~~ 160 (262)
T cd05071 81 YMSKGSLLDFLKGEMGKYLRLPQLVDMAAQIASGMAYVERMNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTAR 160 (262)
T ss_pred cCCCCcHHHHHhhccccCCCHHHHHHHHHHHHHHHHHHHHCCccccccCcccEEEcCCCcEEeccCCceeeccccccccc
Confidence 99999999988642 3578999999999999999999999999999999999999999999999999875532211
Q ss_pred ---ccccccccccccccCCCCCCCcccceeeecCCCCCCchHHHHHHHhhc-ccCCCCCCChhhhhhccCcC-CCCCCCC
Q psy758 157 ---RHLHIFQTNEYFKGVSLPHAENVVPLEIKIGKPAATNIYLIDFLKRCL-DKDPLRRWSCDQLLRHPYFN-GYYFEVP 231 (292)
Q Consensus 157 ---~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~p~~~~~~~~~~~~~~~~-~~~~~~~ 231 (292)
.....|.+||...+.......++|+ .+..++..+. +..|.......+........ .......
T Consensus 161 ~~~~~~~~y~~PE~~~~~~~~~~~Dvws-------------lG~~l~ellt~g~~p~~~~~~~~~~~~~~~~~~~~~~~~ 227 (262)
T cd05071 161 QGAKFPIKWTAPEAALYGRFTIKSDVWS-------------FGILLTELTTKGRVPYPGMVNREVLDQVERGYRMPCPPE 227 (262)
T ss_pred cCCcccceecCHhHhccCCCCchhhHHH-------------HHHHHHHHHcCCCCCCCCCChHHHHHHHhcCCCCCCccc
Confidence 1122356666554433222222222 2222233332 23333333333322211100 1122334
Q ss_pred CccchHHHHhcccCcCCCCCCChhhhhh
Q psy758 232 DEMQYEEITQRCLDKDPLRRWSCDQLLR 259 (292)
Q Consensus 232 ~~~~l~~li~~~l~~dP~~Rpt~~~il~ 259 (292)
.+..+.++|.+||+.||.+|||+.++++
T Consensus 228 ~~~~l~~li~~~l~~~p~~Rp~~~~~~~ 255 (262)
T cd05071 228 CPESLHDLMCQCWRKEPEERPTFEYLQA 255 (262)
T ss_pred cCHHHHHHHHHHccCCcccCCCHHHHHH
Confidence 5778999999999999999999999987
|
Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is invo |
| >cd05038 PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.3e-35 Score=236.96 Aligned_cols=253 Identities=23% Similarity=0.317 Sum_probs=182.0
Q ss_pred cccceeeeecccCceEEEEEEEc----CCCcEEEEEEeccCCCChHHHHHHHHHHHHHHhCCCCCcchhhhhhhc--CCe
Q psy758 2 ERYEKIGKLGEGSYGVVFKCRNR----DTGQVVAIKKFLESEEDPLIRKIALREIRLLKSLKHPNLVNLLEVFRR--KKK 75 (292)
Q Consensus 2 ~~y~~~~~l~~g~~~~v~~~~~~----~~~~~v~iK~~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~--~~~ 75 (292)
.+|++.+.||+|++|.||.|... .+++.||+|.+...... .....+.+|+.+++.++||||+++++++.. +..
T Consensus 4 ~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~~~~avK~~~~~~~~-~~~~~~~~ei~~l~~l~~~~i~~~~~~~~~~~~~~ 82 (284)
T cd05038 4 RHLKFIKQLGEGHFGKVELCRYDPLGDNTGEQVAVKSLNHSGEE-QHRSDFEREIEILRTLDHENIVKYKGVCEKPGGRS 82 (284)
T ss_pred hhchhheeeccCCCeeEEEeeecCCCCCCceEEEEEEeccccch-HHHHHHHHHHHHHHhCCCCChheEEeeeecCCCCc
Confidence 46888999999999999999864 34789999998765543 456778999999999999999999998876 567
Q ss_pred EEEEEecCCCccHHHHhcCCC-CCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEEccCCcEEEeecCchhhhhcc
Q psy758 76 LHLVFEFCDHTVLNELENHPH-GLPWDLIKQITWQVLRGVSYCHRHACIHRDIKPENILLTANGVVKLCDFGFARLIRDL 154 (292)
Q Consensus 76 ~~iv~e~~~~~~L~~~~~~~~-~~~~~~~~~i~~qi~~aL~~LH~~givH~dl~p~Nilv~~~~~~kl~dfg~~~~~~~~ 154 (292)
.++++||+++++|.+++.... .+++..++.++.|++.||+|||++|++|+||+|+||+++.++.++|+|||.+......
T Consensus 83 ~~lv~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~l~~aL~~lH~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~ 162 (284)
T cd05038 83 LRLIMEYLPSGSLRDYLQRHRDQINLKRLLLFSSQICKGMDYLGSQRYIHRDLAARNILVESEDLVKISDFGLAKVLPED 162 (284)
T ss_pred eEEEEecCCCCCHHHHHHhCccccCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHhEEEcCCCCEEEcccccccccccC
Confidence 999999999999999886543 5899999999999999999999999999999999999999999999999998776521
Q ss_pred cc--------ccccccccccccccCCC-----CCCCcccceeeecCCCCCCchHHHHHHHhhcccCCCCC--CChhhhhh
Q psy758 155 IP--------RHLHIFQTNEYFKGVSL-----PHAENVVPLEIKIGKPAATNIYLIDFLKRCLDKDPLRR--WSCDQLLR 219 (292)
Q Consensus 155 ~~--------~~~~~~~~~~~~~~~~~-----~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~p~~~--~~~~~~~~ 219 (292)
.. .....|.+|+...+... .|+.|+..+++.++..++....... . .+....+..+ ....+.+.
T Consensus 163 ~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Di~slG~~l~el~tg~~p~~~~~~~~-~-~~~~~~~~~~~~~~~~~~~~ 240 (284)
T cd05038 163 KDYYYVKEPGESPIFWYAPECLRTSKFSSASDVWSFGVTLYELFTYGDPSQSPPAEF-L-RMIGIAQGQMIVTRLLELLK 240 (284)
T ss_pred CcceeccCCCCCcccccCcHHHccCCCCcccchHHHhhhhheeeccCCCcccccchh-c-cccccccccccHHHHHHHHH
Confidence 11 11223566666544433 4555555566666554432211110 0 0000000000 00111111
Q ss_pred ccCcCCCCCCCCCccchHHHHhcccCcCCCCCCChhhhhh
Q psy758 220 HPYFNGYYFEVPDEMQYEEITQRCLDKDPLRRWSCDQLLR 259 (292)
Q Consensus 220 ~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~~il~ 259 (292)
.. .....+...+.++.+++.+||+.||.+|||+.++++
T Consensus 241 ~~--~~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~ 278 (284)
T cd05038 241 EG--ERLPRPPSCPDEVYDLMKLCWEAEPQDRPSFADLIL 278 (284)
T ss_pred cC--CcCCCCccCCHHHHHHHHHHhccChhhCCCHHHHHH
Confidence 11 011222334678999999999999999999999987
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by aut |
| >cd05099 PTKc_FGFR4 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-34 Score=238.76 Aligned_cols=244 Identities=24% Similarity=0.342 Sum_probs=176.3
Q ss_pred cccceeeeecccCceEEEEEEEcC-------CCcEEEEEEeccCCCChHHHHHHHHHHHHHHhC-CCCCcchhhhhhhcC
Q psy758 2 ERYEKIGKLGEGSYGVVFKCRNRD-------TGQVVAIKKFLESEEDPLIRKIALREIRLLKSL-KHPNLVNLLEVFRRK 73 (292)
Q Consensus 2 ~~y~~~~~l~~g~~~~v~~~~~~~-------~~~~v~iK~~~~~~~~~~~~~~~~~e~~~~~~l-~~~~i~~~~~~~~~~ 73 (292)
++|.+.+.||+|++|.||+|.+.. ....+++|.+..... ......+.+|+.+++.+ +||||+++++++.+.
T Consensus 12 ~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~~~~~aiK~~~~~~~-~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~ 90 (314)
T cd05099 12 DRLVLGKPLGEGCFGQVVRAEAYGIDKSRPDQTVTVAVKMLKDNAT-DKDLADLISEMELMKLIGKHKNIINLLGVCTQE 90 (314)
T ss_pred HHeeeeeeecCCCcccEEEeeecccCCccCCcceEEEEEecCCCCC-hHHHHHHHHHHHHHHhccCCCCeeeEEEEEccC
Confidence 578999999999999999998632 345789998865433 33456678899999999 699999999999988
Q ss_pred CeEEEEEecCCCccHHHHhcCC----------------CCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEEccC
Q psy758 74 KKLHLVFEFCDHTVLNELENHP----------------HGLPWDLIKQITWQVLRGVSYCHRHACIHRDIKPENILLTAN 137 (292)
Q Consensus 74 ~~~~iv~e~~~~~~L~~~~~~~----------------~~~~~~~~~~i~~qi~~aL~~LH~~givH~dl~p~Nilv~~~ 137 (292)
+.+++++||+++++|..++... ..++...+..++.||+.||.|||++|++|+||+|+||+++.+
T Consensus 91 ~~~~lv~e~~~~g~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~~gi~H~dlkp~Nill~~~ 170 (314)
T cd05099 91 GPLYVIVEYAAKGNLREFLRARRPPGPDYTFDITKVPEEQLSFKDLVSCAYQVARGMEYLESRRCIHRDLAARNVLVTED 170 (314)
T ss_pred CceEEEEecCCCCcHHHHHHhcCCCcccccccccCCcccccCHHHHHHHHHHHHHHHHHHHHCCeeeccccceeEEEcCC
Confidence 9999999999999999988542 247889999999999999999999999999999999999999
Q ss_pred CcEEEeecCchhhhhcccc-------ccccccccccccccCCCCCCCcccceeeecCCCCCCchHHHHHHHhhc-ccCCC
Q psy758 138 GVVKLCDFGFARLIRDLIP-------RHLHIFQTNEYFKGVSLPHAENVVPLEIKIGKPAATNIYLIDFLKRCL-DKDPL 209 (292)
Q Consensus 138 ~~~kl~dfg~~~~~~~~~~-------~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~p~ 209 (292)
+.++|+|||.++....... .....|.+||...+.......++|++++ -++..+. +..|.
T Consensus 171 ~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~-------------~l~el~~~g~~p~ 237 (314)
T cd05099 171 NVMKIADFGLARGVHDIDYYKKTSNGRLPVKWMAPEALFDRVYTHQSDVWSFGI-------------LMWEIFTLGGSPY 237 (314)
T ss_pred CcEEEccccccccccccccccccccCCCCccccCHHHHccCCcCccchhhHHHH-------------HHHHHHhCCCCCC
Confidence 9999999999976532111 1112466777654443333333333322 1222221 22333
Q ss_pred CCCChhhhhhccCcC-CCCCCCCCccchHHHHhcccCcCCCCCCChhhhhh
Q psy758 210 RRWSCDQLLRHPYFN-GYYFEVPDEMQYEEITQRCLDKDPLRRWSCDQLLR 259 (292)
Q Consensus 210 ~~~~~~~~~~~~~~~-~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~~il~ 259 (292)
...+..++....... ....+...+..+.++|.+||+.||++|||+.++++
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~ll~ 288 (314)
T cd05099 238 PGIPVEELFKLLREGHRMDKPSNCTHELYMLMRECWHAVPTQRPTFKQLVE 288 (314)
T ss_pred CCCCHHHHHHHHHcCCCCCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHH
Confidence 332222222111000 11223344668999999999999999999999987
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >smart00219 TyrKc Tyrosine kinase, catalytic domain | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-34 Score=232.66 Aligned_cols=242 Identities=24% Similarity=0.325 Sum_probs=179.5
Q ss_pred cceeeeecccCceEEEEEEEcCCC----cEEEEEEeccCCCChHHHHHHHHHHHHHHhCCCCCcchhhhhhhcCCeEEEE
Q psy758 4 YEKIGKLGEGSYGVVFKCRNRDTG----QVVAIKKFLESEEDPLIRKIALREIRLLKSLKHPNLVNLLEVFRRKKKLHLV 79 (292)
Q Consensus 4 y~~~~~l~~g~~~~v~~~~~~~~~----~~v~iK~~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~iv 79 (292)
+++.+.||.|++|.||++.+..++ ..|++|.+...... ...+.+..|+..++.++|+||+++++++.+.+..+++
T Consensus 1 ~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~vaiK~~~~~~~~-~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~i 79 (258)
T smart00219 1 LTLGKKLGEGAFGEVYKGTLKGLSGEKEVEVAVKTLKEDADE-QQIEEFLREARIMRKLDHPNIVKLLGVCTEEEPLMIV 79 (258)
T ss_pred CcccceeccCCCcceEEEEecCCCCCCCceEEEEEccCCCCh-HHHHHHHHHHHHHHhcCCCchheEEEEEcCCCeeEEE
Confidence 467899999999999999998766 88999998654332 2567788999999999999999999999999999999
Q ss_pred EecCCCccHHHHhcCCCC--CCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEEccCCcEEEeecCchhhhhcccc-
Q psy758 80 FEFCDHTVLNELENHPHG--LPWDLIKQITWQVLRGVSYCHRHACIHRDIKPENILLTANGVVKLCDFGFARLIRDLIP- 156 (292)
Q Consensus 80 ~e~~~~~~L~~~~~~~~~--~~~~~~~~i~~qi~~aL~~LH~~givH~dl~p~Nilv~~~~~~kl~dfg~~~~~~~~~~- 156 (292)
+|++++++|.+++..... +++..++.++.|++.||++||+.|++|+||+|+||++++++.++|+|||++........
T Consensus 80 ~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~lh~~~~~h~dl~~~nil~~~~~~~~l~dfg~~~~~~~~~~~ 159 (258)
T smart00219 80 MEYMEGGDLLDYLRKNRPKELSLSDLLSFALQIARGMEYLESKNFIHRDLAARNCLVGENLVVKISDFGLSRDLYDDDYY 159 (258)
T ss_pred EeccCCCCHHHHHHhhhhccCCHHHHHHHHHHHHHHHHHHhcCCeeecccccceEEEccCCeEEEcccCCceeccccccc
Confidence 999999999999876444 89999999999999999999999999999999999999999999999999876653311
Q ss_pred -----ccccccccccccccCCCCCCCcccceeeecCCCCCCchHHHHHHHhhc-ccCCCCCCChhhhhhccCcC-CCCCC
Q psy758 157 -----RHLHIFQTNEYFKGVSLPHAENVVPLEIKIGKPAATNIYLIDFLKRCL-DKDPLRRWSCDQLLRHPYFN-GYYFE 229 (292)
Q Consensus 157 -----~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~p~~~~~~~~~~~~~~~~-~~~~~ 229 (292)
.....|.+|+...+.......++|+ .+.-++..+. +..|....+..+........ ....+
T Consensus 160 ~~~~~~~~~~y~~Pe~~~~~~~~~~~Di~s-------------lG~i~~~l~~~g~~p~~~~~~~~~~~~~~~~~~~~~~ 226 (258)
T smart00219 160 KKKGGKLPIRWMAPESLKDGKFTSKSDVWS-------------FGVLLWEIFTLGESPYPGMSNEEVLEYLKKGYRLPKP 226 (258)
T ss_pred ccccCCCcccccChHHhccCCCCcchhHHH-------------HHHHHHHHHhCCCCCCCCCCHHHHHHHHhcCCCCCCC
Confidence 1112344454443322222222222 2222333332 34444433333332221111 11223
Q ss_pred CCCccchHHHHhcccCcCCCCCCChhhhhh
Q psy758 230 VPDEMQYEEITQRCLDKDPLRRWSCDQLLR 259 (292)
Q Consensus 230 ~~~~~~l~~li~~~l~~dP~~Rpt~~~il~ 259 (292)
...+..+.+++.+||+.||.+|||+.++++
T Consensus 227 ~~~~~~~~~~i~~~l~~~p~~Rpt~~~ll~ 256 (258)
T smart00219 227 ENCPPEIYKLMLQCWAEDPEDRPTFSELVE 256 (258)
T ss_pred CcCCHHHHHHHHHHCcCChhhCcCHHHHHh
Confidence 335778999999999999999999999986
|
Phosphotransferases. Tyrosine-specific kinase subfamily. |
| >cd05082 PTKc_Csk Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-34 Score=232.55 Aligned_cols=239 Identities=21% Similarity=0.270 Sum_probs=176.3
Q ss_pred cccceeeeecccCceEEEEEEEcCCCcEEEEEEeccCCCChHHHHHHHHHHHHHHhCCCCCcchhhhhh-hcCCeEEEEE
Q psy758 2 ERYEKIGKLGEGSYGVVFKCRNRDTGQVVAIKKFLESEEDPLIRKIALREIRLLKSLKHPNLVNLLEVF-RRKKKLHLVF 80 (292)
Q Consensus 2 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~-~~~~~~~iv~ 80 (292)
++|++.+.||+|++|.||++... +..|++|.+.... ..+.+.+|+.+++.++|++++++++++ ..++..++++
T Consensus 6 ~~~~~~~~lg~g~~~~v~~~~~~--~~~~~~k~~~~~~----~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~lv~ 79 (256)
T cd05082 6 KELKLLQTIGKGEFGDVMLGDYR--GNKVAVKCIKNDA----TAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVT 79 (256)
T ss_pred HhCeeeeeecccCCCeEEEEEEc--CCcEEEEEeCCCc----hHHHHHHHHHHHHhCCCCCeeeEEEEEEcCCCceEEEE
Confidence 57999999999999999999765 7889999885432 245678899999999999999999875 4566799999
Q ss_pred ecCCCccHHHHhcCCC--CCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEEccCCcEEEeecCchhhhhcccc--
Q psy758 81 EFCDHTVLNELENHPH--GLPWDLIKQITWQVLRGVSYCHRHACIHRDIKPENILLTANGVVKLCDFGFARLIRDLIP-- 156 (292)
Q Consensus 81 e~~~~~~L~~~~~~~~--~~~~~~~~~i~~qi~~aL~~LH~~givH~dl~p~Nilv~~~~~~kl~dfg~~~~~~~~~~-- 156 (292)
||+++++|.+++.... .+++..++.++.|++.||+|||++|++|+||+|+||++++++.++|+|||++........
T Consensus 80 e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~nil~~~~~~~kl~dfg~~~~~~~~~~~~ 159 (256)
T cd05082 80 EYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEANNFVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQDTG 159 (256)
T ss_pred ECCCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCEeccccchheEEEcCCCcEEecCCccceeccccCCCC
Confidence 9999999999886533 478999999999999999999999999999999999999999999999999875433221
Q ss_pred ccccccccccccccCCCCCCCcccceeeecCCCCCCchHHHHHHHhhc-ccCCCCCCChhhhhhccCc-CCCCCCCCCcc
Q psy758 157 RHLHIFQTNEYFKGVSLPHAENVVPLEIKIGKPAATNIYLIDFLKRCL-DKDPLRRWSCDQLLRHPYF-NGYYFEVPDEM 234 (292)
Q Consensus 157 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~p~~~~~~~~~~~~~~~-~~~~~~~~~~~ 234 (292)
.....|.+||...+.......++|++++ -++..+. +..|.......++...... .....+...+.
T Consensus 160 ~~~~~y~aPE~~~~~~~~~~~Dv~slG~-------------i~~~l~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 226 (256)
T cd05082 160 KLPVKWTAPEALREKKFSTKSDVWSFGI-------------LLWEIYSFGRVPYPRIPLKDVVPRVEKGYKMDAPDGCPP 226 (256)
T ss_pred ccceeecCHHHHccCCCCchhhhHHHHH-------------HHHHHHhCCCCCCCCCCHHHHHHHHhcCCCCCCCCCCCH
Confidence 1223467777665544433333333322 2222221 3333333333333221100 01122334577
Q ss_pred chHHHHhcccCcCCCCCCChhhhhh
Q psy758 235 QYEEITQRCLDKDPLRRWSCDQLLR 259 (292)
Q Consensus 235 ~l~~li~~~l~~dP~~Rpt~~~il~ 259 (292)
.+.++|.+||+.||++|||+.++++
T Consensus 227 ~~~~li~~~l~~~p~~Rpt~~~l~~ 251 (256)
T cd05082 227 VVYDVMKQCWHLDAATRPSFLQLRE 251 (256)
T ss_pred HHHHHHHHHhcCChhhCcCHHHHHH
Confidence 8999999999999999999999986
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, re |
| >cd05050 PTKc_Musk Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.7e-35 Score=237.03 Aligned_cols=244 Identities=24% Similarity=0.292 Sum_probs=177.7
Q ss_pred cccceeeeecccCceEEEEEEEc-----CCCcEEEEEEeccCCCChHHHHHHHHHHHHHHhCCCCCcchhhhhhhcCCeE
Q psy758 2 ERYEKIGKLGEGSYGVVFKCRNR-----DTGQVVAIKKFLESEEDPLIRKIALREIRLLKSLKHPNLVNLLEVFRRKKKL 76 (292)
Q Consensus 2 ~~y~~~~~l~~g~~~~v~~~~~~-----~~~~~v~iK~~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~ 76 (292)
++|++.+.||+|++|.||+|.+. .++..|++|.+.... .......+.+|+.+++.++||||+++++++.++...
T Consensus 5 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~aiK~~~~~~-~~~~~~~~~~ei~~l~~l~h~~iv~~~~~~~~~~~~ 83 (288)
T cd05050 5 NNIEYVRDIGQGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEA-SADMQADFQREAALMAEFDHPNIVKLLGVCAVGKPM 83 (288)
T ss_pred HhceecccccccccccEEEEEEcccCCCCcceeEEEEecCCCc-CHHHHHHHHHHHHHHHhcCCCchheEEEEEcCCCcc
Confidence 57999999999999999999874 357789999886443 334456788999999999999999999999998999
Q ss_pred EEEEecCCCccHHHHhcCC----------------------CCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEE
Q psy758 77 HLVFEFCDHTVLNELENHP----------------------HGLPWDLIKQITWQVLRGVSYCHRHACIHRDIKPENILL 134 (292)
Q Consensus 77 ~iv~e~~~~~~L~~~~~~~----------------------~~~~~~~~~~i~~qi~~aL~~LH~~givH~dl~p~Nilv 134 (292)
++++||+++++|.+++... ..+++..++.++.|++.||.+||++|++|+||+|+||++
T Consensus 84 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~aL~~lH~~~i~H~dl~p~nil~ 163 (288)
T cd05050 84 CLLFEYMAYGDLNEFLRHRSPRAQCSLSHSTSSARKCGLNPLPLSCTEQLCIAKQVAAGMAYLSERKFVHRDLATRNCLV 163 (288)
T ss_pred EEEEecCCCCCHHHHHHHcCccccccccccccccccccccccccCHHHHHHHHHHHHHHHHHHHhCCeecccccHhheEe
Confidence 9999999999999988532 237888899999999999999999999999999999999
Q ss_pred ccCCcEEEeecCchhhhhccc-------cccccccccccccccCCCCCCCcccceeeecCCCCCCchHHHHHHHhh-ccc
Q psy758 135 TANGVVKLCDFGFARLIRDLI-------PRHLHIFQTNEYFKGVSLPHAENVVPLEIKIGKPAATNIYLIDFLKRC-LDK 206 (292)
Q Consensus 135 ~~~~~~kl~dfg~~~~~~~~~-------~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~ 206 (292)
++++.++|+|||.+....... ......|.+||...+.......++|+++ .-++..+ ++.
T Consensus 164 ~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG-------------~il~el~~~~~ 230 (288)
T cd05050 164 GENMVVKIADFGLSRNIYSADYYKASENDAIPIRWMPPESIFYNRYTTESDVWAYG-------------VVLWEIFSYGM 230 (288)
T ss_pred cCCCceEECccccceecccCccccccCCCccChhhcCHHHHhcCCCCchhHHHHHH-------------HHHHHHHhCCC
Confidence 999999999999986543211 0111235566655443332223333322 2222222 133
Q ss_pred CCCCCCChhhhhhccCcCC-CCCCCCCccchHHHHhcccCcCCCCCCChhhhhh
Q psy758 207 DPLRRWSCDQLLRHPYFNG-YYFEVPDEMQYEEITQRCLDKDPLRRWSCDQLLR 259 (292)
Q Consensus 207 ~p~~~~~~~~~~~~~~~~~-~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~~il~ 259 (292)
.|....+..+......-.. ...+...+.++.+||.+||+.||.+|||+.|+++
T Consensus 231 ~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~el~~ 284 (288)
T cd05050 231 QPYYGMAHEEVIYYVRDGNVLSCPDNCPLELYNLMRLCWSKLPSDRPSFASINR 284 (288)
T ss_pred CCCCCCCHHHHHHHHhcCCCCCCCCCCCHHHHHHHHHHcccCcccCCCHHHHHH
Confidence 3433333333332211011 1123345678999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates M |
| >KOG0671|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.6e-35 Score=230.35 Aligned_cols=262 Identities=26% Similarity=0.439 Sum_probs=193.9
Q ss_pred cccceeeeecccCceEEEEEEEcCCCcEEEEEEeccCCCChHHHHHHHHHHHHHHhCCC--C----CcchhhhhhhcCCe
Q psy758 2 ERYEKIGKLGEGSYGVVFKCRNRDTGQVVAIKKFLESEEDPLIRKIALREIRLLKSLKH--P----NLVNLLEVFRRKKK 75 (292)
Q Consensus 2 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~e~~~~~~l~~--~----~i~~~~~~~~~~~~ 75 (292)
+||++++.+|+|+||.|-.+.+..++..||+|+++.-. ...+...-|+++++++.+ | -++.+.++|...++
T Consensus 89 ~Ry~i~~~lGeGtFGkV~ec~D~~~~~~vAlKIik~V~---kYreAa~iEi~vLqki~~~DP~g~~rcv~m~~wFdyrgh 165 (415)
T KOG0671|consen 89 NRYEIVDLLGEGTFGKVVECWDRETKEHVALKIIKNVD---KYREAALIEIEVLQKINESDPNGKFRCVQMRDWFDYRGH 165 (415)
T ss_pred cceehhhhhcCCcccceEEEeecCCCceehHHHHHHHH---HHhhHHHHHHHHHHHHHhcCCCCceEEEeeehhhhccCc
Confidence 68999999999999999999999999999999986443 234445679999999942 2 36778888999999
Q ss_pred EEEEEecCCCccHHHHhcCC--CCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEEcc-----------------
Q psy758 76 LHLVFEFCDHTVLNELENHP--HGLPWDLIKQITWQVLRGVSYCHRHACIHRDIKPENILLTA----------------- 136 (292)
Q Consensus 76 ~~iv~e~~~~~~L~~~~~~~--~~~~~~~~~~i~~qi~~aL~~LH~~givH~dl~p~Nilv~~----------------- 136 (292)
.|+|+|.++- ++.+++..+ .+++...++.+..|+++++++||+.+++|.||||+||++.+
T Consensus 166 iCivfellG~-S~~dFlk~N~y~~fpi~~ir~m~~QL~~sv~fLh~~kl~HTDLKPENILfvss~~~~~~~~k~~~~~~r 244 (415)
T KOG0671|consen 166 ICIVFELLGL-STFDFLKENNYIPFPIDHIRHMGYQLLESVAFLHDLKLTHTDLKPENILFVSSEYFKTYNPKKKVCFIR 244 (415)
T ss_pred eEEEEeccCh-hHHHHhccCCccccchHHHHHHHHHHHHHHHHHHhcceeecCCChheEEEeccceEEEeccCCccceec
Confidence 9999999964 556666543 36899999999999999999999999999999999999953
Q ss_pred ---CCcEEEeecCchhhhhccc--cccccccccccccccCCCC-----CCCcccceeeecCCCCCC---chHHHHHHHhh
Q psy758 137 ---NGVVKLCDFGFARLIRDLI--PRHLHIFQTNEYFKGVSLP-----HAENVVPLEIKIGKPAAT---NIYLIDFLKRC 203 (292)
Q Consensus 137 ---~~~~kl~dfg~~~~~~~~~--~~~~~~~~~~~~~~~~~~~-----~~~~~~~~~~~~~~~~~~---~~~~~~~~~~~ 203 (292)
+..++++|||.++...+.. -..+.-|.+||...|-... |+.|++..++.+|...+. +..-..+++.+
T Consensus 245 ~~ks~~I~vIDFGsAtf~~e~hs~iVsTRHYRAPEViLgLGwS~pCDvWSiGCIL~ElytG~~LFqtHen~EHLaMMerI 324 (415)
T KOG0671|consen 245 PLKSTAIKVIDFGSATFDHEHHSTIVSTRHYRAPEVILGLGWSQPCDVWSIGCILVELYTGETLFQTHENLEHLAMMERI 324 (415)
T ss_pred cCCCcceEEEecCCcceeccCcceeeeccccCCchheeccCcCCccCceeeeeEEEEeeccceecccCCcHHHHHHHHHh
Confidence 2358999999998765433 2334569999999876654 556666666666765332 33555788888
Q ss_pred cccCCCCCCCh---hhhhhccCc----------------------CCCCCCCCCccchHHHHhcccCcCCCCCCChhhhh
Q psy758 204 LDKDPLRRWSC---DQLLRHPYF----------------------NGYYFEVPDEMQYEEITQRCLDKDPLRRWSCDQLL 258 (292)
Q Consensus 204 ~~~~p~~~~~~---~~~~~~~~~----------------------~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~~il 258 (292)
++.-|..-..- .....+.-+ ....-......++.+||++||.+||.+|+|+.|+|
T Consensus 325 lGp~P~~mi~r~~~~Kyf~~~rldw~e~~~~~~~k~v~~~ckpl~~~~~~~d~e~~~LfDLl~~mL~fDP~~RiTl~EAL 404 (415)
T KOG0671|consen 325 LGPIPSRMIKKTRKEKYFRRGRLDWPEVSSKGKSKYVFEPCKPLKKYMLQDDLEHVQLFDLLRRMLEFDPARRITLREAL 404 (415)
T ss_pred hCCCcHHHhhhhhhHhhhhcccccCccccccccchhhhcCCccHHHHhccCcHHHhHHHHHHHHHHccCccccccHHHHh
Confidence 88655322111 111111100 00001112244578999999999999999999999
Q ss_pred hCCccccee
Q psy758 259 RHPYFNGYY 267 (292)
Q Consensus 259 ~h~w~~~~~ 267 (292)
.||||+...
T Consensus 405 ~HpFF~~~~ 413 (415)
T KOG0671|consen 405 SHPFFARLT 413 (415)
T ss_pred cCHHhhcCC
Confidence 999999743
|
|
| >cd05063 PTKc_EphR_A2 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-34 Score=232.57 Aligned_cols=244 Identities=19% Similarity=0.242 Sum_probs=178.0
Q ss_pred cccceeeeecccCceEEEEEEEcCCCc---EEEEEEeccCCCChHHHHHHHHHHHHHHhCCCCCcchhhhhhhcCCeEEE
Q psy758 2 ERYEKIGKLGEGSYGVVFKCRNRDTGQ---VVAIKKFLESEEDPLIRKIALREIRLLKSLKHPNLVNLLEVFRRKKKLHL 78 (292)
Q Consensus 2 ~~y~~~~~l~~g~~~~v~~~~~~~~~~---~v~iK~~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~i 78 (292)
++|+..+.||+|++|.||+|.+..++. .+++|.+.... .....+.+.+|+.+++.++|||++++++++.+.+..++
T Consensus 5 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~ik~~~~~~-~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l 83 (268)
T cd05063 5 SHITKQKVIGAGEFGEVFRGILKMPGRKEVAVAIKTLKPGY-TEKQRQDFLSEASIMGQFSHHNIIRLEGVVTKFKPAMI 83 (268)
T ss_pred HHceEeeEecCCCCccEEEEEEecCCCCceEEEEEeccccC-CHHHHHHHHHHHHHHhcCCCCCeeEEEEEEccCCCcEE
Confidence 578999999999999999999876655 68999886543 23345678899999999999999999999999999999
Q ss_pred EEecCCCccHHHHhcC-CCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEEccCCcEEEeecCchhhhhccccc
Q psy758 79 VFEFCDHTVLNELENH-PHGLPWDLIKQITWQVLRGVSYCHRHACIHRDIKPENILLTANGVVKLCDFGFARLIRDLIPR 157 (292)
Q Consensus 79 v~e~~~~~~L~~~~~~-~~~~~~~~~~~i~~qi~~aL~~LH~~givH~dl~p~Nilv~~~~~~kl~dfg~~~~~~~~~~~ 157 (292)
||||+++++|..++.. .+.+++..+..++.|++.||+|||++|++|+||+|+||++++++.++|+|||++.........
T Consensus 84 v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~~~i~H~dlkp~Nili~~~~~~kl~dfg~~~~~~~~~~~ 163 (268)
T cd05063 84 ITEYMENGALDKYLRDHDGEFSSYQLVGMLRGIAAGMKYLSDMNYVHRDLAARNILVNSNLECKVSDFGLSRVLEDDPEG 163 (268)
T ss_pred EEEcCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeeccccchhhEEEcCCCcEEECCCccceeccccccc
Confidence 9999999999998865 356899999999999999999999999999999999999999999999999998765432111
Q ss_pred c--------ccccccccccccCCCCCCCcccceeeecCCCCCCchHHHHHHHhhc-ccCCCCCCChhhhhhccCc-CCCC
Q psy758 158 H--------LHIFQTNEYFKGVSLPHAENVVPLEIKIGKPAATNIYLIDFLKRCL-DKDPLRRWSCDQLLRHPYF-NGYY 227 (292)
Q Consensus 158 ~--------~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~p~~~~~~~~~~~~~~~-~~~~ 227 (292)
. ...|.+||...+.......++|++ +.-+++.+. +..|....+..+......- ....
T Consensus 164 ~~~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~sl-------------G~il~ell~~g~~p~~~~~~~~~~~~i~~~~~~~ 230 (268)
T cd05063 164 TYTTSGGKIPIRWTAPEAIAYRKFTSASDVWSF-------------GIVMWEVMSFGERPYWDMSNHEVMKAINDGFRLP 230 (268)
T ss_pred ceeccCCCcCceecCHHHhhcCCcChHhHHHHH-------------HHHHHHHHhCCCCCCCcCCHHHHHHHHhcCCCCC
Confidence 1 113555655443332222222222 222222222 3334332222222211100 0112
Q ss_pred CCCCCccchHHHHhcccCcCCCCCCChhhhhh
Q psy758 228 FEVPDEMQYEEITQRCLDKDPLRRWSCDQLLR 259 (292)
Q Consensus 228 ~~~~~~~~l~~li~~~l~~dP~~Rpt~~~il~ 259 (292)
.+...+..+.+++.+||+.||++||++.++++
T Consensus 231 ~~~~~~~~~~~li~~c~~~~p~~Rp~~~~i~~ 262 (268)
T cd05063 231 APMDCPSAVYQLMLQCWQQDRARRPRFVDIVN 262 (268)
T ss_pred CCCCCCHHHHHHHHHHcCCCcccCcCHHHHHH
Confidence 22344678999999999999999999999986
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored |
| >cd05040 PTKc_Ack_like Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-34 Score=231.25 Aligned_cols=237 Identities=23% Similarity=0.304 Sum_probs=176.1
Q ss_pred eeecccCceEEEEEEEcC-CCc--EEEEEEeccCCCChHHHHHHHHHHHHHHhCCCCCcchhhhhhhcCCeEEEEEecCC
Q psy758 8 GKLGEGSYGVVFKCRNRD-TGQ--VVAIKKFLESEEDPLIRKIALREIRLLKSLKHPNLVNLLEVFRRKKKLHLVFEFCD 84 (292)
Q Consensus 8 ~~l~~g~~~~v~~~~~~~-~~~--~v~iK~~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~iv~e~~~ 84 (292)
+.||+|++|.||+|.+.. .+. .|++|.+...... ...+.+.+|+..++.++||||+++++++.+ ...++++||++
T Consensus 1 ~~ig~g~~~~v~~~~~~~~~~~~~~vaiK~~~~~~~~-~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~-~~~~~v~e~~~ 78 (257)
T cd05040 1 KKLGDGSFGVVRRGEWSTSGGKVIPVAVKCLKSDKLS-DIMDDFLKEAAIMHSLDHENLIRLYGVVLT-HPLMMVTELAP 78 (257)
T ss_pred CcCCccCcccEEeeeEecCCCCceEEEEeecCCcccH-HHHHHHHHHHHHHhhcCCCCccceeEEEcC-CeEEEEEEecC
Confidence 468999999999999865 333 6899998766554 566788899999999999999999999888 88999999999
Q ss_pred CccHHHHhcCCC--CCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEEccCCcEEEeecCchhhhhccc-------
Q psy758 85 HTVLNELENHPH--GLPWDLIKQITWQVLRGVSYCHRHACIHRDIKPENILLTANGVVKLCDFGFARLIRDLI------- 155 (292)
Q Consensus 85 ~~~L~~~~~~~~--~~~~~~~~~i~~qi~~aL~~LH~~givH~dl~p~Nilv~~~~~~kl~dfg~~~~~~~~~------- 155 (292)
+++|..++.... .+++..++.++.|++.||.|||++|++|+||+|+||+++.++.++|+|||++.......
T Consensus 79 ~~~L~~~l~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~di~p~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~ 158 (257)
T cd05040 79 LGSLLDRLRKDALGHFLISTLCDYAVQIANGMRYLESKRFIHRDLAARNILLASDDKVKIGDFGLMRALPQNEDHYVMEE 158 (257)
T ss_pred CCcHHHHHHhcccccCcHHHHHHHHHHHHHHHHHHHhCCccccccCcccEEEecCCEEEeccccccccccccccceeccc
Confidence 999999886643 68999999999999999999999999999999999999999999999999987664311
Q ss_pred -cccccccccccccccCCCCCCCcccceeeecCCCCCCchHHHHHHHhhc-ccCCCCCCChhhhhhccCc--CCCCCCCC
Q psy758 156 -PRHLHIFQTNEYFKGVSLPHAENVVPLEIKIGKPAATNIYLIDFLKRCL-DKDPLRRWSCDQLLRHPYF--NGYYFEVP 231 (292)
Q Consensus 156 -~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~p~~~~~~~~~~~~~~~--~~~~~~~~ 231 (292)
......|.+||...+.......++ ++.+.-++..+. +..|....+..+....... .....+..
T Consensus 159 ~~~~~~~y~~pE~~~~~~~~~~~Di-------------~slG~~l~el~t~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 225 (257)
T cd05040 159 HLKVPFAWCAPESLRTRTFSHASDV-------------WMFGVTLWEMFTYGEEPWAGLSGSQILKKIDKEGERLERPEA 225 (257)
T ss_pred CCCCCceecCHHHhcccCcCchhhh-------------HHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHhcCCcCCCCcc
Confidence 111233555555443332222222 333333333332 5555544444443322111 11122334
Q ss_pred CccchHHHHhcccCcCCCCCCChhhhhh
Q psy758 232 DEMQYEEITQRCLDKDPLRRWSCDQLLR 259 (292)
Q Consensus 232 ~~~~l~~li~~~l~~dP~~Rpt~~~il~ 259 (292)
.+..+.+++.+||+.+|++|||++++++
T Consensus 226 ~~~~~~~li~~~l~~~p~~Rps~~~~~~ 253 (257)
T cd05040 226 CPQDIYNVMLQCWAHNPADRPTFAALRE 253 (257)
T ss_pred CCHHHHHHHHHHCCCCcccCCCHHHHHH
Confidence 5778999999999999999999999987
|
Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with and |
| >KOG0695|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-36 Score=234.17 Aligned_cols=259 Identities=19% Similarity=0.294 Sum_probs=206.3
Q ss_pred CcccceeeeecccCceEEEEEEEcCCCcEEEEEEeccCC-CChHHHHHHHHHHHHHHhC-CCCCcchhhhhhhcCCeEEE
Q psy758 1 MERYEKIGKLGEGSYGVVFKCRNRDTGQVVAIKKFLESE-EDPLIRKIALREIRLLKSL-KHPNLVNLLEVFRRKKKLHL 78 (292)
Q Consensus 1 ~~~y~~~~~l~~g~~~~v~~~~~~~~~~~v~iK~~~~~~-~~~~~~~~~~~e~~~~~~l-~~~~i~~~~~~~~~~~~~~i 78 (292)
|++|.+++.||+|++++|-+++..+|.+.||+|++++.. .+++..+....|..++... +||.++.+...|+.+..+++
T Consensus 249 l~df~ll~vigrgsyakvl~~~~~~t~qiyamkvvkkel~nddedidwvqtek~vfe~asn~pflvglhscfqtesrlff 328 (593)
T KOG0695|consen 249 LQDFDLLRVIGRGSYAKVLLVRLKKTDQIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNNPFLVGLHSCFQTESRLFF 328 (593)
T ss_pred cccceeeeeecCcchhhhhheehcccceeeehhhHHHHhcCCcccchhHHhhHHHHHhccCCCeEEehhhhhcccceEEE
Confidence 578999999999999999999999999999999997765 4555677778888888877 58999999999999999999
Q ss_pred EEecCCCccHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEEccCCcEEEeecCchhhhhcccccc
Q psy758 79 VFEFCDHTVLNELENHPHGLPWDLIKQITWQVLRGVSYCHRHACIHRDIKPENILLTANGVVKLCDFGFARLIRDLIPRH 158 (292)
Q Consensus 79 v~e~~~~~~L~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~givH~dl~p~Nilv~~~~~~kl~dfg~~~~~~~~~~~~ 158 (292)
|.||++||+|-...+++++++++.++.+...|+.||.|||++||+++|||.+|+|+|..|++||+|+|+++..-......
T Consensus 329 vieyv~ggdlmfhmqrqrklpeeharfys~ei~lal~flh~rgiiyrdlkldnvlldaeghikltdygmcke~l~~gd~t 408 (593)
T KOG0695|consen 329 VIEYVNGGDLMFHMQRQRKLPEEHARFYSAEICLALNFLHERGIIYRDLKLDNVLLDAEGHIKLTDYGMCKEGLGPGDTT 408 (593)
T ss_pred EEEEecCcceeeehhhhhcCcHHHhhhhhHHHHHHHHHHhhcCeeeeeccccceEEccCCceeecccchhhcCCCCCccc
Confidence 99999999999988888899999999999999999999999999999999999999999999999999998654433333
Q ss_pred ccccc-----cccccccCCCCCCCcccceeeecCCCCCCchHHHHHHHhhcccCCCCCCC-------hhhhh-hccCcCC
Q psy758 159 LHIFQ-----TNEYFKGVSLPHAENVVPLEIKIGKPAATNIYLIDFLKRCLDKDPLRRWS-------CDQLL-RHPYFNG 225 (292)
Q Consensus 159 ~~~~~-----~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~-------~~~~~-~~~~~~~ 225 (292)
+.+++ +||...|..+.++.++|.++++ +++.+.++.|++-.. .++.+ .-.+-.+
T Consensus 409 stfcgtpnyiapeilrgeeygfsvdwwalgvl-------------mfemmagrspfdivgm~n~d~ntedylfqvilekq 475 (593)
T KOG0695|consen 409 STFCGTPNYIAPEILRGEEYGFSVDWWALGVL-------------MFEMMAGRSPFDIVGMDNPDMNTEDYLFQVILEKQ 475 (593)
T ss_pred ccccCCCcccchhhhcccccCceehHHHHHHH-------------HHHHHcCCCCcceecCCCcccchhHHHHHHHhhhc
Confidence 44444 4455555555566666555332 233344444433221 12222 2222235
Q ss_pred CCCCCCCccchHHHHhcccCcCCCCCC------ChhhhhhCCcccceeccCCC
Q psy758 226 YYFEVPDEMQYEEITQRCLDKDPLRRW------SCDQLLRHPYFNGYYFEVPD 272 (292)
Q Consensus 226 ~~~~~~~~~~l~~li~~~l~~dP~~Rp------t~~~il~h~w~~~~~~~~~~ 272 (292)
.+.|.+.+.....+++..|+.||.+|. ..+++..|+||..+.|+...
T Consensus 476 iriprslsvkas~vlkgflnkdp~erlgc~~~~g~~dik~h~ffr~idwd~le 528 (593)
T KOG0695|consen 476 IRIPRSLSVKASHVLKGFLNKDPKERLGCRPQTGFSDIKSHAFFRSIDWDLLE 528 (593)
T ss_pred ccccceeehhhHHHHHHhhcCCcHHhcCCCcccchhhhhcchhhhhCCHHHHh
Confidence 567777777788999999999999998 57899999999999998544
|
|
| >cd05101 PTKc_FGFR2 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-34 Score=236.92 Aligned_cols=245 Identities=22% Similarity=0.322 Sum_probs=177.4
Q ss_pred cccceeeeecccCceEEEEEEEc-------CCCcEEEEEEeccCCCChHHHHHHHHHHHHHHhC-CCCCcchhhhhhhcC
Q psy758 2 ERYEKIGKLGEGSYGVVFKCRNR-------DTGQVVAIKKFLESEEDPLIRKIALREIRLLKSL-KHPNLVNLLEVFRRK 73 (292)
Q Consensus 2 ~~y~~~~~l~~g~~~~v~~~~~~-------~~~~~v~iK~~~~~~~~~~~~~~~~~e~~~~~~l-~~~~i~~~~~~~~~~ 73 (292)
++|++.+.||+|+||.||.|+.. .++..|++|.+.... .....+.+.+|+.+++.+ +||||+++++++...
T Consensus 15 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~v~iK~~~~~~-~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~ 93 (304)
T cd05101 15 DKLTLGKPLGEGCFGQVVMAEALGIDKDKPKEAVTVAVKMLKDDA-TEKDLSDLVSEMEMMKMIGKHKNIINLLGACTQD 93 (304)
T ss_pred HHeeecceeeccCCceEEEEEEeccCCCCCCcceeEEeeeccccc-chHHHHHHHHHHHHHHhhccCCCchheeEEEecC
Confidence 57899999999999999999753 234479999876432 233456688999999999 799999999999999
Q ss_pred CeEEEEEecCCCccHHHHhcCC----------------CCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEEccC
Q psy758 74 KKLHLVFEFCDHTVLNELENHP----------------HGLPWDLIKQITWQVLRGVSYCHRHACIHRDIKPENILLTAN 137 (292)
Q Consensus 74 ~~~~iv~e~~~~~~L~~~~~~~----------------~~~~~~~~~~i~~qi~~aL~~LH~~givH~dl~p~Nilv~~~ 137 (292)
+..+++|||+++++|.+++... ..++...+..++.||+.||.|||++|++|+||||+||+++++
T Consensus 94 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~givH~dlkp~Nili~~~ 173 (304)
T cd05101 94 GPLYVIVEYASKGNLREYLRARRPPGMEYSYDIARVPDEQMTFKDLVSCTYQVARGMEYLASQKCIHRDLAARNVLVTEN 173 (304)
T ss_pred CceEEEEecCCCCcHHHHHHhcCCcccccccccccCCcccccHHHHHHHHHHHHHHHHHHHHCCeeecccccceEEEcCC
Confidence 9999999999999999988653 236778899999999999999999999999999999999999
Q ss_pred CcEEEeecCchhhhhcccc-------ccccccccccccccCCCCCCCcccceeeecCCCCCCchHHHHHHHhhc-ccCCC
Q psy758 138 GVVKLCDFGFARLIRDLIP-------RHLHIFQTNEYFKGVSLPHAENVVPLEIKIGKPAATNIYLIDFLKRCL-DKDPL 209 (292)
Q Consensus 138 ~~~kl~dfg~~~~~~~~~~-------~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~p~ 209 (292)
+.++|+|||.+........ .....|.+||...+.......++|+++ ..++..+. +..|.
T Consensus 174 ~~~kl~D~g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG-------------~~l~el~~~g~~p~ 240 (304)
T cd05101 174 NVMKIADFGLARDVNNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFG-------------VLMWEIFTLGGSPY 240 (304)
T ss_pred CcEEECCCccceecccccccccccCCCCCceeeCchhhccCCCCchhhHHHHH-------------HHHHHHHcCCCCCc
Confidence 9999999999876543211 111235666655443332223333332 22222222 23333
Q ss_pred CCCChhhhhhccCcC-CCCCCCCCccchHHHHhcccCcCCCCCCChhhhhhC
Q psy758 210 RRWSCDQLLRHPYFN-GYYFEVPDEMQYEEITQRCLDKDPLRRWSCDQLLRH 260 (292)
Q Consensus 210 ~~~~~~~~~~~~~~~-~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~~il~h 260 (292)
...+..++....... ....+...+..+.+||.+||..+|.+|||+.++++.
T Consensus 241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rps~~e~l~~ 292 (304)
T cd05101 241 PGIPVEELFKLLKEGHRMDKPANCTNELYMMMRDCWHAIPSHRPTFKQLVED 292 (304)
T ss_pred ccCCHHHHHHHHHcCCcCCCCCCCCHHHHHHHHHHcccChhhCCCHHHHHHH
Confidence 333333333221111 111233457789999999999999999999999884
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd05045 PTKc_RET Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-34 Score=235.68 Aligned_cols=243 Identities=19% Similarity=0.273 Sum_probs=175.6
Q ss_pred ccceeeeecccCceEEEEEEEcC-----CCcEEEEEEeccCCCChHHHHHHHHHHHHHHhCCCCCcchhhhhhhcCCeEE
Q psy758 3 RYEKIGKLGEGSYGVVFKCRNRD-----TGQVVAIKKFLESEEDPLIRKIALREIRLLKSLKHPNLVNLLEVFRRKKKLH 77 (292)
Q Consensus 3 ~y~~~~~l~~g~~~~v~~~~~~~-----~~~~v~iK~~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~ 77 (292)
+|++.+.||+|+||.||+|.+.. ....+++|.+..... ......+.+|+.+++.++||||+++++.+...+..+
T Consensus 1 ~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~k~~~~~~~-~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~ 79 (290)
T cd05045 1 NLVLGKTLGEGEFGKVVKATAFRLKGRAGYTTVAVKMLKENAS-SSELRDLLSEFNLLKQVNHPHVIKLYGACSQDGPLL 79 (290)
T ss_pred CccccccccCcCCcceEEEEEecCCCCCcceeEEEEecCCCCC-HHHHHHHHHHHHHHhhCCCCCEeeEEEEEecCCCcE
Confidence 58899999999999999998753 234688888764433 334567889999999999999999999999999999
Q ss_pred EEEecCCCccHHHHhcCC------------------------CCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceE
Q psy758 78 LVFEFCDHTVLNELENHP------------------------HGLPWDLIKQITWQVLRGVSYCHRHACIHRDIKPENIL 133 (292)
Q Consensus 78 iv~e~~~~~~L~~~~~~~------------------------~~~~~~~~~~i~~qi~~aL~~LH~~givH~dl~p~Nil 133 (292)
+++||+.+++|..++... ..+++..++.++.|++.||.|||++|++||||+|+||+
T Consensus 80 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~ivH~dikp~nil 159 (290)
T cd05045 80 LIVEYAKYGSLRSFLRESRKVGPSYLGSDGNRNSSYLDNPDERALTMGDLISFAWQISRGMQYLAEMKLVHRDLAARNVL 159 (290)
T ss_pred EEEEecCCCCHHHHHHhcCCccccccccccccccccccCccccccCHHHHHHHHHHHHHHHHHHHHCCeehhhhhhheEE
Confidence 999999999999987532 24788999999999999999999999999999999999
Q ss_pred EccCCcEEEeecCchhhhhcccc-------ccccccccccccccCCCCCCCcccceeeecCCCCCCchHHHHHHHhhc-c
Q psy758 134 LTANGVVKLCDFGFARLIRDLIP-------RHLHIFQTNEYFKGVSLPHAENVVPLEIKIGKPAATNIYLIDFLKRCL-D 205 (292)
Q Consensus 134 v~~~~~~kl~dfg~~~~~~~~~~-------~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~ 205 (292)
+++++.++|+|||++........ .....|.+||...+.......++|+ .+..++..+. +
T Consensus 160 l~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~s-------------lG~~l~el~t~g 226 (290)
T cd05045 160 VAEGRKMKISDFGLSRDVYEEDSYVKRSKGRIPVKWMAIESLFDHIYTTQSDVWS-------------FGVLLWEIVTLG 226 (290)
T ss_pred EcCCCcEEeccccccccccCccchhcccCCCCCccccCHHHHccCCcchHhHHHH-------------HHHHHHHHHhcC
Confidence 99999999999999875432111 1122355555544333322222222 2222333332 4
Q ss_pred cCCCCCCChhhhhhccCc-CCCCCCCCCccchHHHHhcccCcCCCCCCChhhhhh
Q psy758 206 KDPLRRWSCDQLLRHPYF-NGYYFEVPDEMQYEEITQRCLDKDPLRRWSCDQLLR 259 (292)
Q Consensus 206 ~~p~~~~~~~~~~~~~~~-~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~~il~ 259 (292)
..|.......++....-. .....+...+..+.+++.+||+.||.+||+++++++
T Consensus 227 ~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~cl~~~P~~Rp~~~~i~~ 281 (290)
T cd05045 227 GNPYPGIAPERLFNLLKTGYRMERPENCSEEMYNLMLTCWKQEPDKRPTFADISK 281 (290)
T ss_pred CCCCCCCCHHHHHHHHhCCCCCCCCCCCCHHHHHHHHHHccCCcccCCCHHHHHH
Confidence 444433333332221000 011223345678999999999999999999999987
|
Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leadi |
| >KOG0584|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-35 Score=247.93 Aligned_cols=245 Identities=24% Similarity=0.403 Sum_probs=190.6
Q ss_pred eeeeecccCceEEEEEEEcCCCcEEEEEEeccCC--CChHHHHHHHHHHHHHHhCCCCCcchhhhhhhcCC--eEEEEEe
Q psy758 6 KIGKLGEGSYGVVFKCRNRDTGQVVAIKKFLESE--EDPLIRKIALREIRLLKSLKHPNLVNLLEVFRRKK--KLHLVFE 81 (292)
Q Consensus 6 ~~~~l~~g~~~~v~~~~~~~~~~~v~iK~~~~~~--~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~--~~~iv~e 81 (292)
....||+|+|-+||+|.|..+|..||--.+.... ......+.+..|+.+++.|+||||+++|++|.+.. .+-+|+|
T Consensus 44 ~~evLGrGafKtVYka~De~~giEVAWnqvk~~d~~q~~~~leR~~~Ev~lLKsL~H~NIirfy~SW~d~~n~~in~iTE 123 (632)
T KOG0584|consen 44 FDEVLGRGAFKTVYKAFDEEEGIEVAWNQVKIRDVTQSPEELERLYSEVHLLKSLKHPNIIRFYDSWVDTDNKTINFITE 123 (632)
T ss_pred hhhhcccccceeeeeccccccchhhHHHHHhHHHhhcChHHHHHHHHHHHHHccCCCCceeeeeeheecCCCceeeeeee
Confidence 3567999999999999999999998766554443 34445688999999999999999999999998754 4888999
Q ss_pred cCCCccHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCC--ccccCCCCCceEEccC-CcEEEeecCchhhhhcccccc
Q psy758 82 FCDHTVLNELENHPHGLPWDLIKQITWQVLRGVSYCHRHA--CIHRDIKPENILLTAN-GVVKLCDFGFARLIRDLIPRH 158 (292)
Q Consensus 82 ~~~~~~L~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~g--ivH~dl~p~Nilv~~~-~~~kl~dfg~~~~~~~~~~~~ 158 (292)
++..|+|..++++.+.++...+..|+.||++||.|||++. |+|||||-+||||+.+ |.+||+|+|+|+.........
T Consensus 124 L~TSGtLr~Y~kk~~~vn~kaik~W~RQILkGL~yLHs~~PPIIHRDLKCDNIFinG~~G~VKIGDLGLAtl~r~s~aks 203 (632)
T KOG0584|consen 124 LFTSGTLREYRKKHRRVNIKAIKSWCRQILKGLVYLHSQDPPIIHRDLKCDNIFVNGNLGEVKIGDLGLATLLRKSHAKS 203 (632)
T ss_pred cccCCcHHHHHHHhccCCHHHHHHHHHHHHHHhhhhhcCCCCccccccccceEEEcCCcCceeecchhHHHHhhccccce
Confidence 9999999999999999999999999999999999999985 9999999999999865 899999999999876544333
Q ss_pred ccccccccccccCCCC----CCCcccceeeecCCCCCCchHHHHHHHhhcccCCCCC-CChhhhhhccCcCC--CCCCCC
Q psy758 159 LHIFQTNEYFKGVSLP----HAENVVPLEIKIGKPAATNIYLIDFLKRCLDKDPLRR-WSCDQLLRHPYFNG--YYFEVP 231 (292)
Q Consensus 159 ~~~~~~~~~~~~~~~~----~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~p~~~-~~~~~~~~~~~~~~--~~~~~~ 231 (292)
..++||+++++.+- ...+++++++ -+++......|... .+..++++.....- ..+...
T Consensus 204 --vIGTPEFMAPEmYEE~YnE~VDVYaFGM-------------CmLEMvT~eYPYsEC~n~AQIYKKV~SGiKP~sl~kV 268 (632)
T KOG0584|consen 204 --VIGTPEFMAPEMYEENYNELVDVYAFGM-------------CMLEMVTSEYPYSECTNPAQIYKKVTSGIKPAALSKV 268 (632)
T ss_pred --eccCccccChHHHhhhcchhhhhhhhhH-------------HHHHHHhccCChhhhCCHHHHHHHHHcCCCHHHhhcc
Confidence 57888888876652 2223333222 23334444444333 24455554432211 112233
Q ss_pred CccchHHHHhcccCcCCCCCCChhhhhhCCcccce
Q psy758 232 DEMQYEEITQRCLDKDPLRRWSCDQLLRHPYFNGY 266 (292)
Q Consensus 232 ~~~~l~~li~~~l~~dP~~Rpt~~~il~h~w~~~~ 266 (292)
..+++++||.+||.. .++|||+.|+|.||||...
T Consensus 269 ~dPevr~fIekCl~~-~~~R~sa~eLL~d~Ff~~d 302 (632)
T KOG0584|consen 269 KDPEVREFIEKCLAT-KSERLSAKELLKDPFFDED 302 (632)
T ss_pred CCHHHHHHHHHHhcC-chhccCHHHHhhChhhccc
Confidence 467999999999999 9999999999999999974
|
|
| >cd05100 PTKc_FGFR3 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-34 Score=239.01 Aligned_cols=245 Identities=22% Similarity=0.319 Sum_probs=176.0
Q ss_pred cccceeeeecccCceEEEEEEEcCC-------CcEEEEEEeccCCCChHHHHHHHHHHHHHHhC-CCCCcchhhhhhhcC
Q psy758 2 ERYEKIGKLGEGSYGVVFKCRNRDT-------GQVVAIKKFLESEEDPLIRKIALREIRLLKSL-KHPNLVNLLEVFRRK 73 (292)
Q Consensus 2 ~~y~~~~~l~~g~~~~v~~~~~~~~-------~~~v~iK~~~~~~~~~~~~~~~~~e~~~~~~l-~~~~i~~~~~~~~~~ 73 (292)
.+|++++.||+|+||.||.|++... +..|++|.+... ......+.+.+|+.+++.+ +||||+++++++.++
T Consensus 12 ~~~~i~~~ig~G~~g~v~~~~~~~~~~~~~~~~~~vaiK~~~~~-~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~ 90 (334)
T cd05100 12 TRLTLGKPLGEGCFGQVVMAEAIGIDKDKPNKPVTVAVKMLKDD-ATDKDLSDLVSEMEMMKMIGKHKNIINLLGACTQD 90 (334)
T ss_pred hHeeecceeccccCCcEEEEEEeccCCccCCcceeEEEEEcccc-cCHHHHHHHHHHHHHHHhhcCCCCeeeeeEEEccC
Confidence 3799999999999999999986432 236899987643 2334456788999999999 799999999999999
Q ss_pred CeEEEEEecCCCccHHHHhcCC----------------CCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEEccC
Q psy758 74 KKLHLVFEFCDHTVLNELENHP----------------HGLPWDLIKQITWQVLRGVSYCHRHACIHRDIKPENILLTAN 137 (292)
Q Consensus 74 ~~~~iv~e~~~~~~L~~~~~~~----------------~~~~~~~~~~i~~qi~~aL~~LH~~givH~dl~p~Nilv~~~ 137 (292)
+..++++||+++++|.+++... ..++...+..++.|++.||.|||++|++|+||+|+||+++.+
T Consensus 91 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~givH~dlkp~Nill~~~ 170 (334)
T cd05100 91 GPLYVLVEYASKGNLREYLRARRPPGMDYSFDTCKLPEEQLTFKDLVSCAYQVARGMEYLASQKCIHRDLAARNVLVTED 170 (334)
T ss_pred CceEEEEecCCCCcHHHHHHhcCCcccccccccccCccccCCHHHHHHHHHHHHHHHHHHHHCCeeccccccceEEEcCC
Confidence 9999999999999999988642 236778899999999999999999999999999999999999
Q ss_pred CcEEEeecCchhhhhcccc-------ccccccccccccccCCCCCCCcccceeeecCCCCCCchHHHHHHHhhc-ccCCC
Q psy758 138 GVVKLCDFGFARLIRDLIP-------RHLHIFQTNEYFKGVSLPHAENVVPLEIKIGKPAATNIYLIDFLKRCL-DKDPL 209 (292)
Q Consensus 138 ~~~kl~dfg~~~~~~~~~~-------~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~p~ 209 (292)
+.++|+|||+++....... .....|.+||...+.......++|+++ .-+++.+. +..|.
T Consensus 171 ~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG-------------~il~el~~~g~~p~ 237 (334)
T cd05100 171 NVMKIADFGLARDVHNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFG-------------VLLWEIFTLGGSPY 237 (334)
T ss_pred CcEEECCcccceecccccccccccCCCcCceEcCHHHhccCCcCchhhhHHHH-------------HHHHHHHhcCCCCC
Confidence 9999999999875532111 111236666655443332222332222 22222221 23333
Q ss_pred CCCChhhhhhccCcC-CCCCCCCCccchHHHHhcccCcCCCCCCChhhhhhC
Q psy758 210 RRWSCDQLLRHPYFN-GYYFEVPDEMQYEEITQRCLDKDPLRRWSCDQLLRH 260 (292)
Q Consensus 210 ~~~~~~~~~~~~~~~-~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~~il~h 260 (292)
...+..+........ ....+...+..+.+++.+||+.+|.+|||+.+++++
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~ell~~ 289 (334)
T cd05100 238 PGIPVEELFKLLKEGHRMDKPANCTHELYMIMRECWHAVPSQRPTFKQLVED 289 (334)
T ss_pred CCCCHHHHHHHHHcCCCCCCCCCCCHHHHHHHHHHcccChhhCcCHHHHHHH
Confidence 332333322211100 111223446789999999999999999999999986
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd05037 PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-34 Score=231.11 Aligned_cols=234 Identities=21% Similarity=0.301 Sum_probs=169.4
Q ss_pred eeecccCceEEEEEEEcCCC----------cEEEEEEeccCCCChHHHHHHHHHHHHHHhCCCCCcchhhhhhhcCCeEE
Q psy758 8 GKLGEGSYGVVFKCRNRDTG----------QVVAIKKFLESEEDPLIRKIALREIRLLKSLKHPNLVNLLEVFRRKKKLH 77 (292)
Q Consensus 8 ~~l~~g~~~~v~~~~~~~~~----------~~v~iK~~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~ 77 (292)
+.||+|+||.||+|.+..++ ..+++|.+...... ...+.+|+.+++.++||||+++++++.. ...+
T Consensus 1 ~~lg~G~~~~v~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~~~---~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~~~~ 76 (259)
T cd05037 1 EHLGQGTFTNIYKGVLRVQSDLDIVGPGQEVSVVLKVLGSDHRD---SLAFFETASLMSQLSHKHLVKLYGVCVR-DENI 76 (259)
T ss_pred CcccccccceEEEEEEeccCCccccCCccceeeeeeccccchhh---HHHHHHHHHHHHcCCCcchhheeeEEec-CCcE
Confidence 46899999999999998766 35778876544322 5677889999999999999999999877 7789
Q ss_pred EEEecCCCccHHHHhcCCC-CCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEEccCC-------cEEEeecCchh
Q psy758 78 LVFEFCDHTVLNELENHPH-GLPWDLIKQITWQVLRGVSYCHRHACIHRDIKPENILLTANG-------VVKLCDFGFAR 149 (292)
Q Consensus 78 iv~e~~~~~~L~~~~~~~~-~~~~~~~~~i~~qi~~aL~~LH~~givH~dl~p~Nilv~~~~-------~~kl~dfg~~~ 149 (292)
+|+||+++++|..++.... .++...+..++.||+.||+|||++|++|+||||+||+++.++ .++|+|||++.
T Consensus 77 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~H~dlkp~Nill~~~~~~~~~~~~~kl~Dfg~a~ 156 (259)
T cd05037 77 MVEEYVKFGPLDVFLHREKNNVSLHWKLDVAKQLASALHYLEDKKLVHGNVCGKNILVARYGLNEGYVPFIKLSDPGIPI 156 (259)
T ss_pred EEEEcCCCCcHHHHHHhhccCCCHHHHHHHHHHHHHHHHHHhhCCeecccCccceEEEecCccccCCceeEEeCCCCccc
Confidence 9999999999999987655 689999999999999999999999999999999999999887 79999999987
Q ss_pred hhhcc-ccccccccccccccccC--CCCCCCcccceeeecCCCCCCchHHHHHHHhhc-ccCCCCCCChhhhhhccCcCC
Q psy758 150 LIRDL-IPRHLHIFQTNEYFKGV--SLPHAENVVPLEIKIGKPAATNIYLIDFLKRCL-DKDPLRRWSCDQLLRHPYFNG 225 (292)
Q Consensus 150 ~~~~~-~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~p~~~~~~~~~~~~~~~~~ 225 (292)
..... .......|.+||...+. ......++|+++ ..++..+. +..|....+..+.. ..+...
T Consensus 157 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG-------------~~~~~l~~~~~~p~~~~~~~~~~-~~~~~~ 222 (259)
T cd05037 157 TVLSREERVERIPWIAPECIRNGQASLTIAADKWSFG-------------TTLLEICSNGEEPLSTLSSSEKE-RFYQDQ 222 (259)
T ss_pred ccccccccccCCCccChhhhcCCCCCcchhhHHHHHH-------------HHHHHHHhCCCCCcccCCchhHH-HHHhcC
Confidence 65431 12223446677766554 222222232222 22222222 22333222211111 111112
Q ss_pred CCCCCCCccchHHHHhcccCcCCCCCCChhhhhh
Q psy758 226 YYFEVPDEMQYEEITQRCLDKDPLRRWSCDQLLR 259 (292)
Q Consensus 226 ~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~~il~ 259 (292)
...+.+....+.++|.+||..||.+|||+.++++
T Consensus 223 ~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~ 256 (259)
T cd05037 223 HRLPMPDCAELANLINQCWTYDPTKRPSFRAILR 256 (259)
T ss_pred CCCCCCCchHHHHHHHHHhccChhhCCCHHHHHH
Confidence 2233334478999999999999999999999986
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; pseudokinase domain (repeat1). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the ki |
| >cd05043 PTK_Ryk Pseudokinase domain of Ryk (Receptor related to tyrosine kinase) | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-34 Score=232.91 Aligned_cols=243 Identities=19% Similarity=0.250 Sum_probs=177.1
Q ss_pred cccceeeeecccCceEEEEEEEcC----CCcEEEEEEeccCCCChHHHHHHHHHHHHHHhCCCCCcchhhhhhhc-CCeE
Q psy758 2 ERYEKIGKLGEGSYGVVFKCRNRD----TGQVVAIKKFLESEEDPLIRKIALREIRLLKSLKHPNLVNLLEVFRR-KKKL 76 (292)
Q Consensus 2 ~~y~~~~~l~~g~~~~v~~~~~~~----~~~~v~iK~~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~-~~~~ 76 (292)
++|++.+.||+|+||.||.|.+.. ++..|++|.+... ........+.+|+.+++.++||||+++++++.. +...
T Consensus 6 ~~~~~~~~i~~g~~g~V~~~~~~~~~~~~~~~v~~k~~~~~-~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~ 84 (280)
T cd05043 6 DRVTLSDLLQEGTFGRIFYGILIDEKPGKEEEVFVKTVKDH-ASEIQVTLLLQESCLLYGLSHQNILPILHVCIEDGEPP 84 (280)
T ss_pred hheEEeeeecccCCceEEEEEEecCCCCceeEEEEEEccCC-CCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEecCCCCC
Confidence 589999999999999999999876 3577899987533 344456778899999999999999999998654 5778
Q ss_pred EEEEecCCCccHHHHhcCC--------CCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEEccCCcEEEeecCch
Q psy758 77 HLVFEFCDHTVLNELENHP--------HGLPWDLIKQITWQVLRGVSYCHRHACIHRDIKPENILLTANGVVKLCDFGFA 148 (292)
Q Consensus 77 ~iv~e~~~~~~L~~~~~~~--------~~~~~~~~~~i~~qi~~aL~~LH~~givH~dl~p~Nilv~~~~~~kl~dfg~~ 148 (292)
+++++|+++++|..++... ..+++..++.++.|++.||+|||++|++|+||+|+||++++++.++|+|||++
T Consensus 85 ~~~~~~~~~~~L~~~l~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~i~H~di~p~nil~~~~~~~kl~d~g~~ 164 (280)
T cd05043 85 FVLYPYMNWGNLKLFLQQCRLGEANNPQALSTQQLVHMAIQIACGMSYLHKRGVIHKDIAARNCVIDEELQVKITDNALS 164 (280)
T ss_pred EEEEEcCCCCcHHHHHHhccccccccccCCCHHHHHHHHHHHHHHHHHHHHCCEeecccCHhhEEEcCCCcEEECCCCCc
Confidence 9999999999999987542 35899999999999999999999999999999999999999999999999998
Q ss_pred hhhhccc-------cccccccccccccccCCCCCCCcccceeeecCCCCCCchHHHHHHHhhc-ccCCCCCCChhhhhhc
Q psy758 149 RLIRDLI-------PRHLHIFQTNEYFKGVSLPHAENVVPLEIKIGKPAATNIYLIDFLKRCL-DKDPLRRWSCDQLLRH 220 (292)
Q Consensus 149 ~~~~~~~-------~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~p~~~~~~~~~~~~ 220 (292)
+.+.... ......|.+||...+.......++|+++ ..+++.+. +..|.......++...
T Consensus 165 ~~~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG-------------~~l~el~~~g~~p~~~~~~~~~~~~ 231 (280)
T cd05043 165 RDLFPMDYHCLGDNENRPVKWMALESLVNKEYSSASDVWSFG-------------VLLWELMTLGQTPYVEIDPFEMAAY 231 (280)
T ss_pred ccccCCceEEeCCCCCcchhccCHHHHhcCCCCchhhHHHhH-------------HHHHHHhcCCCCCcCcCCHHHHHHH
Confidence 7553211 1122335666665444333333333322 22222222 3334333322222211
Q ss_pred cCcCCC--CCCCCCccchHHHHhcccCcCCCCCCChhhhhh
Q psy758 221 PYFNGY--YFEVPDEMQYEEITQRCLDKDPLRRWSCDQLLR 259 (292)
Q Consensus 221 ~~~~~~--~~~~~~~~~l~~li~~~l~~dP~~Rpt~~~il~ 259 (292)
...+. ......+.++.+++.+||..||++|||+.++++
T Consensus 232 -~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~~~ 271 (280)
T cd05043 232 -LKDGYRLAQPINCPDELFAVMACCWALDPEERPSFSQLVQ 271 (280)
T ss_pred -HHcCCCCCCCCcCCHHHHHHHHHHcCCChhhCCCHHHHHH
Confidence 00111 112234678999999999999999999999986
|
Protein Tyrosine Kinase (PTK) family; Receptor related to tyrosine kinase (Ryk); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ryk is a receptor tyr kinase (RTK) containing an extracellular region with two leucine-rich motifs, a transmembrane segment, and an intracellular inactive pseudokinase domain. The extracellular region of Ryk shows homology to the N-terminal domain of Wnt inhibitory factor-1 (WIF) and serves as the ligand (Wnt) binding domain of Ryk. Ryk is expressed in many different tissues both during development and in adults, suggesting a widespread function. It |
| >cd05047 PTKc_Tie Catalytic domain of Tie Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-34 Score=231.51 Aligned_cols=238 Identities=24% Similarity=0.342 Sum_probs=169.7
Q ss_pred eeecccCceEEEEEEEcCCCc--EEEEEEeccCCCChHHHHHHHHHHHHHHhC-CCCCcchhhhhhhcCCeEEEEEecCC
Q psy758 8 GKLGEGSYGVVFKCRNRDTGQ--VVAIKKFLESEEDPLIRKIALREIRLLKSL-KHPNLVNLLEVFRRKKKLHLVFEFCD 84 (292)
Q Consensus 8 ~~l~~g~~~~v~~~~~~~~~~--~v~iK~~~~~~~~~~~~~~~~~e~~~~~~l-~~~~i~~~~~~~~~~~~~~iv~e~~~ 84 (292)
+.||+|++|.||+|++..++. .+++|.+... ........+.+|+.+++.+ .||||+++++++...+..+++|||++
T Consensus 1 ~~lg~g~~g~v~~~~~~~~~~~~~~~~k~~~~~-~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~lv~e~~~ 79 (270)
T cd05047 1 DVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEY-ASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLAIEYAP 79 (270)
T ss_pred CcCCCCCCceEEEEEEcCCCCeeEEEEEEcccc-CCHHHHHHHHHHHHHHHhhccCCCeeeEEEEEecCCCceEEEEeCC
Confidence 468999999999999988776 4678877533 2334456678899999999 79999999999999899999999999
Q ss_pred CccHHHHhcCCC----------------CCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEEccCCcEEEeecCch
Q psy758 85 HTVLNELENHPH----------------GLPWDLIKQITWQVLRGVSYCHRHACIHRDIKPENILLTANGVVKLCDFGFA 148 (292)
Q Consensus 85 ~~~L~~~~~~~~----------------~~~~~~~~~i~~qi~~aL~~LH~~givH~dl~p~Nilv~~~~~~kl~dfg~~ 148 (292)
+++|.+++.... .+++..+..++.|++.||+|||++|++|+||+|+||++++++.++|+|||++
T Consensus 80 ~~~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~al~~lH~~~i~H~dikp~nili~~~~~~kl~dfgl~ 159 (270)
T cd05047 80 HGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQFIHRDLAARNILVGENYVAKIADFGLS 159 (270)
T ss_pred CCcHHHHHHhccccccccccccccCCcCCCCHHHHHHHHHHHHHHHHHHHHCCEeecccccceEEEcCCCeEEECCCCCc
Confidence 999999886432 4789999999999999999999999999999999999999999999999987
Q ss_pred hhhhccc----cccccccccccccccCCCCCCCcccceeeecCCCCCCchHHHHHHHhh-cccCCCCCCChhhhhhccCc
Q psy758 149 RLIRDLI----PRHLHIFQTNEYFKGVSLPHAENVVPLEIKIGKPAATNIYLIDFLKRC-LDKDPLRRWSCDQLLRHPYF 223 (292)
Q Consensus 149 ~~~~~~~----~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~p~~~~~~~~~~~~~~~ 223 (292)
....... ......|.+||+..+.......++|++++ .+++.+ .+..|+...+..+.....-.
T Consensus 160 ~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~-------------il~el~~~g~~pf~~~~~~~~~~~~~~ 226 (270)
T cd05047 160 RGQEVYVKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGV-------------LLWEIVSLGGTPYCGMTCAELYEKLPQ 226 (270)
T ss_pred cccchhhhccCCCCccccCChHHHccCCCCchhhHHHHHH-------------HHHHHHcCCCCCccccCHHHHHHHHhC
Confidence 5332111 11122366666654433332333333321 122222 13333333332222221100
Q ss_pred C-CCCCCCCCccchHHHHhcccCcCCCCCCChhhhhh
Q psy758 224 N-GYYFEVPDEMQYEEITQRCLDKDPLRRWSCDQLLR 259 (292)
Q Consensus 224 ~-~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~~il~ 259 (292)
. ....+...+..+.+++.+||+.||.+|||+.++++
T Consensus 227 ~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~ 263 (270)
T cd05047 227 GYRLEKPLNCDDEVYDLMRQCWREKPYERPSFAQILV 263 (270)
T ss_pred CCCCCCCCcCCHHHHHHHHHHcccChhhCCCHHHHHH
Confidence 0 11122334678999999999999999999999986
|
Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific l |
| >cd05109 PTKc_HER2 Catalytic domain of the Protein Tyrosine Kinase, HER2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-34 Score=232.18 Aligned_cols=243 Identities=21% Similarity=0.241 Sum_probs=175.3
Q ss_pred cccceeeeecccCceEEEEEEEcCCCc----EEEEEEeccCCCChHHHHHHHHHHHHHHhCCCCCcchhhhhhhcCCeEE
Q psy758 2 ERYEKIGKLGEGSYGVVFKCRNRDTGQ----VVAIKKFLESEEDPLIRKIALREIRLLKSLKHPNLVNLLEVFRRKKKLH 77 (292)
Q Consensus 2 ~~y~~~~~l~~g~~~~v~~~~~~~~~~----~v~iK~~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~ 77 (292)
++|++.+.||+|++|.||+|.+..++. .||+|.+.... .......+.+|..+++.+.||||+++++++.. ...+
T Consensus 7 ~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~va~K~~~~~~-~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~-~~~~ 84 (279)
T cd05109 7 TELKKVKVLGSGAFGTVYKGIWIPDGENVKIPVAIKVLRENT-SPKANKEILDEAYVMAGVGSPYVCRLLGICLT-STVQ 84 (279)
T ss_pred hheeeeeecCCCCCceEEEEEEecCCCccceEEEEEEecCCC-CHHHHHHHHHHHHHHHhcCCCCCceEEEEEcC-CCcE
Confidence 578999999999999999999877666 47999886543 33445668899999999999999999998765 4578
Q ss_pred EEEecCCCccHHHHhcC-CCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEEccCCcEEEeecCchhhhhcccc
Q psy758 78 LVFEFCDHTVLNELENH-PHGLPWDLIKQITWQVLRGVSYCHRHACIHRDIKPENILLTANGVVKLCDFGFARLIRDLIP 156 (292)
Q Consensus 78 iv~e~~~~~~L~~~~~~-~~~~~~~~~~~i~~qi~~aL~~LH~~givH~dl~p~Nilv~~~~~~kl~dfg~~~~~~~~~~ 156 (292)
+++||+++|+|.+++.. ...+++..+..++.||+.||+|||++|++|+||||+||++++++.++|+|||+++.......
T Consensus 85 l~~~~~~~g~l~~~l~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~iiH~dlkp~Nil~~~~~~~kL~dfG~~~~~~~~~~ 164 (279)
T cd05109 85 LVTQLMPYGCLLDYVRENKDRIGSQDLLNWCVQIAKGMSYLEEVRLVHRDLAARNVLVKSPNHVKITDFGLARLLDIDET 164 (279)
T ss_pred EEEEcCCCCCHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCCeeccccccceEEEcCCCcEEECCCCceeecccccc
Confidence 99999999999998865 34689999999999999999999999999999999999999999999999999876542111
Q ss_pred -------ccccccccccccccCCCCCCCcccceeeecCCCCCCchHHHHHHHhhc-ccCCCCCCChhhhhhccC-cCCCC
Q psy758 157 -------RHLHIFQTNEYFKGVSLPHAENVVPLEIKIGKPAATNIYLIDFLKRCL-DKDPLRRWSCDQLLRHPY-FNGYY 227 (292)
Q Consensus 157 -------~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~p~~~~~~~~~~~~~~-~~~~~ 227 (292)
.....|.+||...+.......++|+ .+..+++.+. +..|.......++....- .....
T Consensus 165 ~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~s-------------lG~~l~el~t~g~~p~~~~~~~~~~~~~~~~~~~~ 231 (279)
T cd05109 165 EYHADGGKVPIKWMALESILHRRFTHQSDVWS-------------YGVTVWELMTFGAKPYDGIPAREIPDLLEKGERLP 231 (279)
T ss_pred eeecCCCccchhhCCHHHhccCCCCchhHHHH-------------HHHHHHHHHcCCCCCCCCCCHHHHHHHHHCCCcCC
Confidence 1122355566554433222222222 2222333332 334433322222211000 00112
Q ss_pred CCCCCccchHHHHhcccCcCCCCCCChhhhhh
Q psy758 228 FEVPDEMQYEEITQRCLDKDPLRRWSCDQLLR 259 (292)
Q Consensus 228 ~~~~~~~~l~~li~~~l~~dP~~Rpt~~~il~ 259 (292)
.+...+..+.++|.+||+.||++|||+.++++
T Consensus 232 ~~~~~~~~~~~li~~~l~~dp~~Rp~~~~l~~ 263 (279)
T cd05109 232 QPPICTIDVYMIMVKCWMIDSECRPRFRELVD 263 (279)
T ss_pred CCccCCHHHHHHHHHHcCCChhhCcCHHHHHH
Confidence 22344678999999999999999999999986
|
Protein Tyrosine Kinase (PTK) family; HER2 (ErbB2, HER2/neu); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER2 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve |
| >cd05041 PTKc_Fes_like Catalytic domain of Fes-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-34 Score=228.60 Aligned_cols=237 Identities=22% Similarity=0.284 Sum_probs=174.7
Q ss_pred eeecccCceEEEEEEEcCCCcEEEEEEeccCCCChHHHHHHHHHHHHHHhCCCCCcchhhhhhhcCCeEEEEEecCCCcc
Q psy758 8 GKLGEGSYGVVFKCRNRDTGQVVAIKKFLESEEDPLIRKIALREIRLLKSLKHPNLVNLLEVFRRKKKLHLVFEFCDHTV 87 (292)
Q Consensus 8 ~~l~~g~~~~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~iv~e~~~~~~ 87 (292)
+.||.|++|.||+|.+.. ++.|++|.+...... .....+.+|+++++.++||||+++++++.+.+..++|+||+++++
T Consensus 1 ~~lg~g~~g~v~~~~~~~-~~~v~~K~~~~~~~~-~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~~~~~ 78 (251)
T cd05041 1 EKIGKGNFGDVYKGVLKG-NTEVAVKTCRSTLPP-DLKRKFLQEAEILKQYDHPNIVKLIGVCVQKQPIYIVMELVPGGS 78 (251)
T ss_pred CccccCCCceEEEEEEeC-CCcEEEEeccccCCH-HHHHHHHHHHHHHHhCCCCCeEEEEEEEecCCCeEEEEEcCCCCc
Confidence 468999999999999987 999999988765443 455678899999999999999999999999999999999999999
Q ss_pred HHHHhcC-CCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEEccCCcEEEeecCchhhhhcccc-------ccc
Q psy758 88 LNELENH-PHGLPWDLIKQITWQVLRGVSYCHRHACIHRDIKPENILLTANGVVKLCDFGFARLIRDLIP-------RHL 159 (292)
Q Consensus 88 L~~~~~~-~~~~~~~~~~~i~~qi~~aL~~LH~~givH~dl~p~Nilv~~~~~~kl~dfg~~~~~~~~~~-------~~~ 159 (292)
|.+++.. ...+++..+..++.+++.||++||++|++|+||+|+||+++.++.++|+|||.+........ ...
T Consensus 79 l~~~l~~~~~~~~~~~~~~~~~~~~~~l~~lH~~~i~h~di~p~nili~~~~~~~l~d~g~~~~~~~~~~~~~~~~~~~~ 158 (251)
T cd05041 79 LLTFLRKKKNRLTVKKLLQMSLDAAAGMEYLESKNCIHRDLAARNCLVGENNVLKISDFGMSREEEGGIYTVSDGLKQIP 158 (251)
T ss_pred HHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCEehhhcCcceEEEcCCCcEEEeeccccccccCCcceeccccCcce
Confidence 9998854 34689999999999999999999999999999999999999999999999999875432111 112
Q ss_pred cccccccccccCCCCCCCcccceeeecCCCCCCchHHHHHHHhhc-ccCCCCCCChhhhhhccCc-CCCCCCCCCccchH
Q psy758 160 HIFQTNEYFKGVSLPHAENVVPLEIKIGKPAATNIYLIDFLKRCL-DKDPLRRWSCDQLLRHPYF-NGYYFEVPDEMQYE 237 (292)
Q Consensus 160 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~p~~~~~~~~~~~~~~~-~~~~~~~~~~~~l~ 237 (292)
..|.+||...+.......++|++ +.-+++.+. +..|............... .....+...+..+.
T Consensus 159 ~~y~~PE~~~~~~~~~~~Di~sl-------------G~i~~~l~t~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 225 (251)
T cd05041 159 IKWTAPEALNYGRYTSESDVWSY-------------GILLWETFSLGDTPYPGMSNQQTRERIESGYRMPAPQLCPEEIY 225 (251)
T ss_pred eccCChHhhccCCCCcchhHHHH-------------HHHHHHHHhccCCCCccCCHHHHHHHHhcCCCCCCCccCCHHHH
Confidence 23666666544333222333332 222233232 2333332222211111000 01122334577899
Q ss_pred HHHhcccCcCCCCCCChhhhhh
Q psy758 238 EITQRCLDKDPLRRWSCDQLLR 259 (292)
Q Consensus 238 ~li~~~l~~dP~~Rpt~~~il~ 259 (292)
+++.+||+.+|.+|||+.++++
T Consensus 226 ~li~~~l~~~p~~Rp~~~ell~ 247 (251)
T cd05041 226 RLMLQCWAYDPENRPSFSEIYN 247 (251)
T ss_pred HHHHHHhccChhhCcCHHHHHH
Confidence 9999999999999999999987
|
Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr k |
| >cd05057 PTKc_EGFR_like Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-34 Score=232.54 Aligned_cols=243 Identities=21% Similarity=0.267 Sum_probs=177.8
Q ss_pred cccceeeeecccCceEEEEEEEcCCCc----EEEEEEeccCCCChHHHHHHHHHHHHHHhCCCCCcchhhhhhhcCCeEE
Q psy758 2 ERYEKIGKLGEGSYGVVFKCRNRDTGQ----VVAIKKFLESEEDPLIRKIALREIRLLKSLKHPNLVNLLEVFRRKKKLH 77 (292)
Q Consensus 2 ~~y~~~~~l~~g~~~~v~~~~~~~~~~----~v~iK~~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~ 77 (292)
++|++.+.||+|+||.||+|.+..+++ .|++|.+..... ......+.+|+..++.++||||+++++++.. ...+
T Consensus 7 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~~aik~~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~~~~ 84 (279)
T cd05057 7 TELEKIKVLGSGAFGTVYKGVWIPEGEKVKIPVAIKVLREETS-PKANKEILDEAYVMASVDHPHVVRLLGICLS-SQVQ 84 (279)
T ss_pred HHcEEcceecCCCCccEEEEEEecCCCCcceEEEEEeccCCCC-HHHHHHHHHHHHHHHhCCCCCcceEEEEEec-CceE
Confidence 578999999999999999999876665 589998765543 3455678899999999999999999998876 7899
Q ss_pred EEEecCCCccHHHHhcCC-CCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEEccCCcEEEeecCchhhhhcccc
Q psy758 78 LVFEFCDHTVLNELENHP-HGLPWDLIKQITWQVLRGVSYCHRHACIHRDIKPENILLTANGVVKLCDFGFARLIRDLIP 156 (292)
Q Consensus 78 iv~e~~~~~~L~~~~~~~-~~~~~~~~~~i~~qi~~aL~~LH~~givH~dl~p~Nilv~~~~~~kl~dfg~~~~~~~~~~ 156 (292)
+++||+++++|.+++... ..+++..+..++.||+.||+|||++|++|+||+|+||++++++.++|+|||.+........
T Consensus 85 ~v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~i~H~di~p~nil~~~~~~~kL~dfg~~~~~~~~~~ 164 (279)
T cd05057 85 LITQLMPLGCLLDYVRNHKDNIGSQYLLNWCVQIAKGMSYLEEKRLVHRDLAARNVLVKTPQHVKITDFGLAKLLDVDEK 164 (279)
T ss_pred EEEecCCCCcHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCCEEecccCcceEEEcCCCeEEECCCcccccccCccc
Confidence 999999999999988653 4689999999999999999999999999999999999999999999999999876542211
Q ss_pred cc-------ccccccccccccCCCCCCCcccceeeecCCCCCCchHHHHHHHhhc-ccCCCCCCChhhhhhccCc-CCCC
Q psy758 157 RH-------LHIFQTNEYFKGVSLPHAENVVPLEIKIGKPAATNIYLIDFLKRCL-DKDPLRRWSCDQLLRHPYF-NGYY 227 (292)
Q Consensus 157 ~~-------~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~p~~~~~~~~~~~~~~~-~~~~ 227 (292)
.. ...|.+||...+.......++ ++.+..+++.+. +..|.......++...... ....
T Consensus 165 ~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di-------------~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~~~ 231 (279)
T cd05057 165 EYHAEGGKVPIKWMALESILHRIYTHKSDV-------------WSYGVTVWELMTFGAKPYEGIPAVEIPDLLEKGERLP 231 (279)
T ss_pred ceecCCCcccccccCHHHhhcCCcCchhhH-------------HHHHHHHHHHhcCCCCCCCCCCHHHHHHHHhCCCCCC
Confidence 10 112444544332222111222 222333333332 4555544444433321111 1112
Q ss_pred CCCCCccchHHHHhcccCcCCCCCCChhhhhh
Q psy758 228 FEVPDEMQYEEITQRCLDKDPLRRWSCDQLLR 259 (292)
Q Consensus 228 ~~~~~~~~l~~li~~~l~~dP~~Rpt~~~il~ 259 (292)
.+...+..+.+++.+||..||++|||+.++++
T Consensus 232 ~~~~~~~~~~~~~~~~l~~~p~~Rp~~~~l~~ 263 (279)
T cd05057 232 QPPICTIDVYMVLVKCWMIDAESRPTFKELIN 263 (279)
T ss_pred CCCCCCHHHHHHHHHHcCCChhhCCCHHHHHH
Confidence 23334668899999999999999999999977
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instea |
| >cd05092 PTKc_TrkA Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-34 Score=233.13 Aligned_cols=243 Identities=22% Similarity=0.256 Sum_probs=176.0
Q ss_pred cccceeeeecccCceEEEEEEEc-----CCCcEEEEEEeccCCCChHHHHHHHHHHHHHHhCCCCCcchhhhhhhcCCeE
Q psy758 2 ERYEKIGKLGEGSYGVVFKCRNR-----DTGQVVAIKKFLESEEDPLIRKIALREIRLLKSLKHPNLVNLLEVFRRKKKL 76 (292)
Q Consensus 2 ~~y~~~~~l~~g~~~~v~~~~~~-----~~~~~v~iK~~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~ 76 (292)
.+|.+.+.||+|+||.||++... .++..+++|.+... .......+.+|+++++.++|+||+++++++.+.+..
T Consensus 5 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~~~k~~~~~--~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~ 82 (280)
T cd05092 5 RDIVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEA--SESARQDFQREAELLTVLQHQHIVRFYGVCTEGRPL 82 (280)
T ss_pred HhceeccccCCccCCeEEEeEEecCCCCCCceEEEEEecCcC--CHHHHHHHHHHHHHHhcCCCCCCceEEEEEecCCce
Confidence 36788999999999999999753 34667899987643 334456788999999999999999999999989999
Q ss_pred EEEEecCCCccHHHHhcCCC---------------CCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEEccCCcEE
Q psy758 77 HLVFEFCDHTVLNELENHPH---------------GLPWDLIKQITWQVLRGVSYCHRHACIHRDIKPENILLTANGVVK 141 (292)
Q Consensus 77 ~iv~e~~~~~~L~~~~~~~~---------------~~~~~~~~~i~~qi~~aL~~LH~~givH~dl~p~Nilv~~~~~~k 141 (292)
++++||+++++|.+++.... .+++..++.++.||+.||+|||++|++|+||+|+||++++++.++
T Consensus 83 ~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~~i~H~dlkp~nil~~~~~~~k 162 (280)
T cd05092 83 LMVFEYMRHGDLNRFLRSHGPDAKILAGGEDVAPGQLTLGQMLAIASQIASGMVYLASLHFVHRDLATRNCLVGQGLVVK 162 (280)
T ss_pred EEEEecCCCCCHHHHHHhcCcchhhhcccccCCccccCHHHHHHHHHHHHHHHHHHHHCCeecccccHhhEEEcCCCCEE
Confidence 99999999999999886532 478999999999999999999999999999999999999999999
Q ss_pred EeecCchhhhhcccc-------ccccccccccccccCCCCCCCcccceeeecCCCCCCchHHHHHHHhhc-ccCCCCCCC
Q psy758 142 LCDFGFARLIRDLIP-------RHLHIFQTNEYFKGVSLPHAENVVPLEIKIGKPAATNIYLIDFLKRCL-DKDPLRRWS 213 (292)
Q Consensus 142 l~dfg~~~~~~~~~~-------~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~p~~~~~ 213 (292)
|+|||++........ ..+..|.+||...+.......++|++ +.-+++.+. +..|+...+
T Consensus 163 L~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~sl-------------G~il~el~~~g~~p~~~~~ 229 (280)
T cd05092 163 IGDFGMSRDIYSTDYYRVGGRTMLPIRWMPPESILYRKFTTESDIWSF-------------GVVLWEIFTYGKQPWYQLS 229 (280)
T ss_pred ECCCCceeEcCCCceeecCCCccccccccCHHHhccCCcCchhhHHHH-------------HHHHHHHHcCCCCCCccCC
Confidence 999999864422110 11223566665544433322333322 222223222 333433322
Q ss_pred hhhhhhccC-cCCCCCCCCCccchHHHHhcccCcCCCCCCChhhhhh
Q psy758 214 CDQLLRHPY-FNGYYFEVPDEMQYEEITQRCLDKDPLRRWSCDQLLR 259 (292)
Q Consensus 214 ~~~~~~~~~-~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~~il~ 259 (292)
..+...... ......+...+..+.++|.+||+.||.+||++++|++
T Consensus 230 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~P~~Rp~~~~l~~ 276 (280)
T cd05092 230 NTEAIECITQGRELERPRTCPPEVYAIMQGCWQREPQQRMVIKDIHS 276 (280)
T ss_pred HHHHHHHHHcCccCCCCCCCCHHHHHHHHHHccCChhhCCCHHHHHH
Confidence 222221110 0111223345778999999999999999999999986
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory |
| >cd05107 PTKc_PDGFR_beta Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-34 Score=242.14 Aligned_cols=245 Identities=21% Similarity=0.321 Sum_probs=173.9
Q ss_pred cccceeeeecccCceEEEEEEEc-----CCCcEEEEEEeccCCCChHHHHHHHHHHHHHHhCC-CCCcchhhhhhhcCCe
Q psy758 2 ERYEKIGKLGEGSYGVVFKCRNR-----DTGQVVAIKKFLESEEDPLIRKIALREIRLLKSLK-HPNLVNLLEVFRRKKK 75 (292)
Q Consensus 2 ~~y~~~~~l~~g~~~~v~~~~~~-----~~~~~v~iK~~~~~~~~~~~~~~~~~e~~~~~~l~-~~~i~~~~~~~~~~~~ 75 (292)
++|.+.+.||+|+||.||+|.+. .+++.||+|++...... ...+.+.+|+.++..+. ||||+++++++..++.
T Consensus 37 ~~~~~~~~lG~G~fG~Vy~~~~~~~~~~~~~~~vavK~l~~~~~~-~~~~~~~~E~~~l~~l~~H~niv~~~~~~~~~~~ 115 (401)
T cd05107 37 DNLVLGRTLGSGAFGRVVEATAHGLSHSQSTMKVAVKMLKSTARS-SEKQALMSELKIMSHLGPHLNIVNLLGACTKGGP 115 (401)
T ss_pred HHeehhhhccCCCceeEEEEEEcCCCCCCCceEEEEEecCCCCCh-hHHHHHHHHHHHHHhcCCCCCeEEEEEEEccCCC
Confidence 46778899999999999999853 34568999999755333 33456889999999997 9999999999999999
Q ss_pred EEEEEecCCCccHHHHhcCC------------------------------------------------------------
Q psy758 76 LHLVFEFCDHTVLNELENHP------------------------------------------------------------ 95 (292)
Q Consensus 76 ~~iv~e~~~~~~L~~~~~~~------------------------------------------------------------ 95 (292)
.++|+||+++|+|.+++...
T Consensus 116 ~~iv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 195 (401)
T cd05107 116 IYIITEYCRYGDLVDYLHRNKHTFLQYYLDKNRDDGSLISGGSTPLSQRKSHVSLGSESDGGYMDMSKDESADYVPMQDM 195 (401)
T ss_pred cEEEEeccCCCcHHHHHHhccccchhhhcccccccccccccccccccccccchhhhhccCccccccCCccccCccchhcc
Confidence 99999999999999887532
Q ss_pred --------------------------------------CCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEEccC
Q psy758 96 --------------------------------------HGLPWDLIKQITWQVLRGVSYCHRHACIHRDIKPENILLTAN 137 (292)
Q Consensus 96 --------------------------------------~~~~~~~~~~i~~qi~~aL~~LH~~givH~dl~p~Nilv~~~ 137 (292)
..++...++.++.||+.||+|||+.|++|+||||+||+++++
T Consensus 196 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~ivHrdlkp~NiLl~~~ 275 (401)
T cd05107 196 KGTVKYADIESSNYESPYDQYLPSAPERTRRDTLINESPALSYMDLVGFSYQVANGMEFLASKNCVHRDLAARNVLICEG 275 (401)
T ss_pred hhhhhhhhhhccCcCCchhhhhcccCCCcchhhhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCcCcccCCcceEEEeCC
Confidence 135677788999999999999999999999999999999999
Q ss_pred CcEEEeecCchhhhhcccc--cc-----ccccccccccccCCCCCCCcccceeeecCCCCCCchHHHHHHHhhc-ccCCC
Q psy758 138 GVVKLCDFGFARLIRDLIP--RH-----LHIFQTNEYFKGVSLPHAENVVPLEIKIGKPAATNIYLIDFLKRCL-DKDPL 209 (292)
Q Consensus 138 ~~~kl~dfg~~~~~~~~~~--~~-----~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~p~ 209 (292)
+.++|+|||++........ .. +..|.+|+...+.......++ ++.+..+++.+. +..|.
T Consensus 276 ~~~kL~DfGla~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv-------------wslGvil~e~l~~g~~P~ 342 (401)
T cd05107 276 KLVKICDFGLARDIMRDSNYISKGSTFLPLKWMAPESIFNNLYTTLSDV-------------WSFGILLWEIFTLGGTPY 342 (401)
T ss_pred CEEEEEecCcceecccccccccCCCcCCCCceeChHHhcCCCCCcHhHH-------------HHHHHHHHHHHHcCCCCC
Confidence 9999999999875432111 11 122344443332222112222 222223333332 33443
Q ss_pred CCCChhhhhhccCcCCC--CCCCCCccchHHHHhcccCcCCCCCCChhhhhhC
Q psy758 210 RRWSCDQLLRHPYFNGY--YFEVPDEMQYEEITQRCLDKDPLRRWSCDQLLRH 260 (292)
Q Consensus 210 ~~~~~~~~~~~~~~~~~--~~~~~~~~~l~~li~~~l~~dP~~Rpt~~~il~h 260 (292)
......+........+. ..+...+..+.+|+.+||..||.+||++++|++.
T Consensus 343 ~~~~~~~~~~~~~~~~~~~~~p~~~~~~l~~li~~cl~~~P~~RPs~~ell~~ 395 (401)
T cd05107 343 PELPMNEQFYNAIKRGYRMAKPAHASDEIYEIMQKCWEEKFEIRPDFSQLVHL 395 (401)
T ss_pred CCCCchHHHHHHHHcCCCCCCCCCCCHHHHHHHHHHcCCChhHCcCHHHHHHH
Confidence 33222222211111111 1233457789999999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) beta; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR beta is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR beta forms homodimers or heterodimers with PDGFR alpha, depending on the nature of the PDGF ligand. PDGF-BB and PDGF-D |
| >cd05115 PTKc_Zap-70 Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.2e-34 Score=228.86 Aligned_cols=236 Identities=18% Similarity=0.261 Sum_probs=170.1
Q ss_pred eecccCceEEEEEEEc--CCCcEEEEEEeccCCCChHHHHHHHHHHHHHHhCCCCCcchhhhhhhcCCeEEEEEecCCCc
Q psy758 9 KLGEGSYGVVFKCRNR--DTGQVVAIKKFLESEEDPLIRKIALREIRLLKSLKHPNLVNLLEVFRRKKKLHLVFEFCDHT 86 (292)
Q Consensus 9 ~l~~g~~~~v~~~~~~--~~~~~v~iK~~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~iv~e~~~~~ 86 (292)
.||+|+||.||.|... .++..|++|++.... .....+.+.+|+.+++.++||||+++++++. ....++|+||++++
T Consensus 2 ~ig~G~~g~v~~~~~~~~~~~~~vavk~~~~~~-~~~~~~~~~~E~~~l~~l~h~~ii~~~~~~~-~~~~~lv~e~~~~~ 79 (257)
T cd05115 2 ELGSGNFGCVKKGVYKMRKKQIDVAIKVLKNEN-EKSVRDEMMREAEIMHQLDNPYIVRMIGVCE-AEALMLVMEMASGG 79 (257)
T ss_pred ccCCCCcccEEEEEEecCCCceeEEEEEccccc-ChHHHHHHHHHHHHHHhcCCCCeEEEEEEEc-CCCeEEEEEeCCCC
Confidence 4899999999999765 345579999886543 3445567889999999999999999999875 45789999999999
Q ss_pred cHHHHhcC-CCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEEccCCcEEEeecCchhhhhcccc--------c
Q psy758 87 VLNELENH-PHGLPWDLIKQITWQVLRGVSYCHRHACIHRDIKPENILLTANGVVKLCDFGFARLIRDLIP--------R 157 (292)
Q Consensus 87 ~L~~~~~~-~~~~~~~~~~~i~~qi~~aL~~LH~~givH~dl~p~Nilv~~~~~~kl~dfg~~~~~~~~~~--------~ 157 (292)
+|.+++.. ...+++..++.++.|++.||+|||++|++|+||+|+||+++.++.++|+|||++........ .
T Consensus 80 ~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~ 159 (257)
T cd05115 80 PLNKFLSGKKDEITVSNVVELMHQVSMGMKYLEGKNFVHRDLAARNVLLVNQHYAKISDFGLSKALGADDSYYKARSAGK 159 (257)
T ss_pred CHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhcCeeecccchheEEEcCCCcEEeccCCccccccCCccceeccCCCC
Confidence 99998864 45689999999999999999999999999999999999999999999999999875432111 0
Q ss_pred cccccccccccccCCCCCCCcccceeeecCCCCCCchHHHHHHHhh-cccCCCCCCChhhhhhccCc-CCCCCCCCCccc
Q psy758 158 HLHIFQTNEYFKGVSLPHAENVVPLEIKIGKPAATNIYLIDFLKRC-LDKDPLRRWSCDQLLRHPYF-NGYYFEVPDEMQ 235 (292)
Q Consensus 158 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~p~~~~~~~~~~~~~~~-~~~~~~~~~~~~ 235 (292)
....|.+||...+.......++|++ +.-++..+ .+..|.......++...... .....+...+.+
T Consensus 160 ~~~~y~aPE~~~~~~~~~~~Di~sl-------------G~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 226 (257)
T cd05115 160 WPLKWYAPECINFRKFSSRSDVWSY-------------GITMWEAFSYGQKPYKKMKGPEVMSFIEQGKRLDCPAECPPE 226 (257)
T ss_pred CCcccCCHHHHccCCCCchhhHHHH-------------HHHHHHHhcCCCCCcCcCCHHHHHHHHHCCCCCCCCCCCCHH
Confidence 0123556665543332222233222 22223323 14444444433333221100 011223345779
Q ss_pred hHHHHhcccCcCCCCCCChhhhhh
Q psy758 236 YEEITQRCLDKDPLRRWSCDQLLR 259 (292)
Q Consensus 236 l~~li~~~l~~dP~~Rpt~~~il~ 259 (292)
+.++|.+||..||++||++.+|++
T Consensus 227 l~~li~~c~~~~~~~Rp~~~~i~~ 250 (257)
T cd05115 227 MYALMKDCWIYKWEDRPNFAKVEE 250 (257)
T ss_pred HHHHHHHHcCCChhhCcCHHHHHH
Confidence 999999999999999999999976
|
Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its pho |
| >cd05069 PTKc_Yes Catalytic domain of the Protein Tyrosine Kinase, Yes | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.5e-34 Score=229.19 Aligned_cols=240 Identities=25% Similarity=0.284 Sum_probs=172.5
Q ss_pred cccceeeeecccCceEEEEEEEcCCCcEEEEEEeccCCCChHHHHHHHHHHHHHHhCCCCCcchhhhhhhcCCeEEEEEe
Q psy758 2 ERYEKIGKLGEGSYGVVFKCRNRDTGQVVAIKKFLESEEDPLIRKIALREIRLLKSLKHPNLVNLLEVFRRKKKLHLVFE 81 (292)
Q Consensus 2 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~iv~e 81 (292)
++|.+.+.||+|++|.||+|.+..+ ..+++|.+...... .+.+.+|+.+++.++|||++++++++. .+..+++||
T Consensus 6 ~~~~~~~~ig~g~~~~v~~~~~~~~-~~~~lK~~~~~~~~---~~~~~~E~~~l~~l~h~~i~~~~~~~~-~~~~~~v~e 80 (260)
T cd05069 6 ESLRLDVKLGQGCFGEVWMGTWNGT-TKVAIKTLKPGTMM---PEAFLQEAQIMKKLRHDKLVPLYAVVS-EEPIYIVTE 80 (260)
T ss_pred HHeeeeeeecCcCCCeEEEEEEcCC-ceEEEEEcccCCcc---HHHHHHHHHHHHhCCCCCeeeEEEEEc-CCCcEEEEE
Confidence 5799999999999999999988654 46899987654332 355778999999999999999998875 456889999
Q ss_pred cCCCccHHHHhcCC--CCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEEccCCcEEEeecCchhhhhcccc---
Q psy758 82 FCDHTVLNELENHP--HGLPWDLIKQITWQVLRGVSYCHRHACIHRDIKPENILLTANGVVKLCDFGFARLIRDLIP--- 156 (292)
Q Consensus 82 ~~~~~~L~~~~~~~--~~~~~~~~~~i~~qi~~aL~~LH~~givH~dl~p~Nilv~~~~~~kl~dfg~~~~~~~~~~--- 156 (292)
|+.+++|.+++... ..+++..+..++.|++.||.|||+.|++|+||+|+||++++++.++|+|||.+........
T Consensus 81 ~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~~~i~H~dl~~~Nill~~~~~~~l~dfg~~~~~~~~~~~~~ 160 (260)
T cd05069 81 FMGKGSLLDFLKEGDGKYLKLPQLVDMAAQIADGMAYIERMNYIHRDLRAANILVGDNLVCKIADFGLARLIEDNEYTAR 160 (260)
T ss_pred cCCCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCEeecccCcceEEEcCCCeEEECCCccceEccCCccccc
Confidence 99999999988653 2478999999999999999999999999999999999999999999999999875432111
Q ss_pred ---ccccccccccccccCCCCCCCcccceeeecCCCCCCchHHHHHHHhhc-ccCCCCCCChhhhhhccCcC-CCCCCCC
Q psy758 157 ---RHLHIFQTNEYFKGVSLPHAENVVPLEIKIGKPAATNIYLIDFLKRCL-DKDPLRRWSCDQLLRHPYFN-GYYFEVP 231 (292)
Q Consensus 157 ---~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~p~~~~~~~~~~~~~~~~-~~~~~~~ 231 (292)
.....|.+|+...+.......++|++ +..++..+. +..|.......+......-. ....+..
T Consensus 161 ~~~~~~~~y~~Pe~~~~~~~~~~~Di~sl-------------G~~l~el~t~g~~p~~~~~~~~~~~~~~~~~~~~~~~~ 227 (260)
T cd05069 161 QGAKFPIKWTAPEAALYGRFTIKSDVWSF-------------GILLTELVTKGRVPYPGMVNREVLEQVERGYRMPCPQG 227 (260)
T ss_pred CCCccchhhCCHHHhccCCcChHHHHHHH-------------HHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCCCCCcc
Confidence 11223666665544333322233222 222222222 23333332222222111000 0112234
Q ss_pred CccchHHHHhcccCcCCCCCCChhhhhh
Q psy758 232 DEMQYEEITQRCLDKDPLRRWSCDQLLR 259 (292)
Q Consensus 232 ~~~~l~~li~~~l~~dP~~Rpt~~~il~ 259 (292)
.+..+.+++.+||+.||.+||+++++++
T Consensus 228 ~~~~~~~li~~~l~~~p~~Rp~~~~i~~ 255 (260)
T cd05069 228 CPESLHELMKLCWKKDPDERPTFEYIQS 255 (260)
T ss_pred cCHHHHHHHHHHccCCcccCcCHHHHHH
Confidence 5778999999999999999999999987
|
Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine an |
| >cd05112 PTKc_Itk Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.3e-34 Score=228.36 Aligned_cols=242 Identities=24% Similarity=0.349 Sum_probs=177.6
Q ss_pred cccceeeeecccCceEEEEEEEcCCCcEEEEEEeccCCCChHHHHHHHHHHHHHHhCCCCCcchhhhhhhcCCeEEEEEe
Q psy758 2 ERYEKIGKLGEGSYGVVFKCRNRDTGQVVAIKKFLESEEDPLIRKIALREIRLLKSLKHPNLVNLLEVFRRKKKLHLVFE 81 (292)
Q Consensus 2 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~iv~e 81 (292)
++|++.+.||+|++|.||++.+.. +..+++|.+...... ...+.+|+++++.++||+++++++++......++++|
T Consensus 4 ~~~~~~~~ig~g~~g~v~~~~~~~-~~~~~~k~~~~~~~~---~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e 79 (256)
T cd05112 4 SELTLVQEIGSGQFGLVWLGYWLE-KRKVAIKTIREGAMS---EEDFIEEAQVMMKLSHPKLVQLYGVCTERSPICLVFE 79 (256)
T ss_pred hHeEEEeeecCcccceEEEEEEeC-CCeEEEEECCCCCCC---HHHHHHHHHHHHhCCCCCeeeEEEEEccCCceEEEEE
Confidence 579999999999999999998854 678999988655443 2457789999999999999999999998899999999
Q ss_pred cCCCccHHHHhcCC-CCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEEccCCcEEEeecCchhhhhcccc----
Q psy758 82 FCDHTVLNELENHP-HGLPWDLIKQITWQVLRGVSYCHRHACIHRDIKPENILLTANGVVKLCDFGFARLIRDLIP---- 156 (292)
Q Consensus 82 ~~~~~~L~~~~~~~-~~~~~~~~~~i~~qi~~aL~~LH~~givH~dl~p~Nilv~~~~~~kl~dfg~~~~~~~~~~---- 156 (292)
|+.+++|.+++... ..+++..++.++.|++.||++||++|++|+||+|+||+++.++.++|+|||.+........
T Consensus 80 ~~~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~~~~~~~~ 159 (256)
T cd05112 80 FMEHGCLSDYLRAQRGKFSQETLLGMCLDVCEGMAYLESSNVIHRDLAARNCLVGENQVVKVSDFGMTRFVLDDQYTSST 159 (256)
T ss_pred cCCCCcHHHHHHhCccCCCHHHHHHHHHHHHHHHHHHHHCCccccccccceEEEcCCCeEEECCCcceeecccCcccccC
Confidence 99999999988653 4589999999999999999999999999999999999999999999999998865432111
Q ss_pred --ccccccccccccccCCCCCCCcccceeeecCCCCCCchHHHHHHHhhc-ccCCCCCCChhhhhhccCcC-CCCCCCCC
Q psy758 157 --RHLHIFQTNEYFKGVSLPHAENVVPLEIKIGKPAATNIYLIDFLKRCL-DKDPLRRWSCDQLLRHPYFN-GYYFEVPD 232 (292)
Q Consensus 157 --~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~p~~~~~~~~~~~~~~~~-~~~~~~~~ 232 (292)
.....|.+|+...+.......++|+++ ..++..+. +..|.......+......-. ....+...
T Consensus 160 ~~~~~~~~~aPe~~~~~~~~~~~Dv~slG-------------~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 226 (256)
T cd05112 160 GTKFPVKWSSPEVFSFSKYSSKSDVWSFG-------------VLMWEVFSEGKTPYENRSNSEVVETINAGFRLYKPRLA 226 (256)
T ss_pred CCccchhhcCHhHhccCCcChHHHHHHHH-------------HHHHHHHcCCCCCCCcCCHHHHHHHHhCCCCCCCCCCC
Confidence 111235666665543333233333332 12222222 33343333322222211000 11112334
Q ss_pred ccchHHHHhcccCcCCCCCCChhhhhhC
Q psy758 233 EMQYEEITQRCLDKDPLRRWSCDQLLRH 260 (292)
Q Consensus 233 ~~~l~~li~~~l~~dP~~Rpt~~~il~h 260 (292)
+..+.+|+.+||+.+|++|||+.+++++
T Consensus 227 ~~~~~~l~~~~l~~~p~~Rp~~~~~l~~ 254 (256)
T cd05112 227 SQSVYELMQHCWKERPEDRPSFSLLLHQ 254 (256)
T ss_pred CHHHHHHHHHHcccChhhCCCHHHHHHh
Confidence 6789999999999999999999999873
|
Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activ |
| >cd05056 PTKc_FAK Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.7e-34 Score=229.30 Aligned_cols=243 Identities=20% Similarity=0.288 Sum_probs=176.7
Q ss_pred cccceeeeecccCceEEEEEEEcCC---CcEEEEEEeccCCCChHHHHHHHHHHHHHHhCCCCCcchhhhhhhcCCeEEE
Q psy758 2 ERYEKIGKLGEGSYGVVFKCRNRDT---GQVVAIKKFLESEEDPLIRKIALREIRLLKSLKHPNLVNLLEVFRRKKKLHL 78 (292)
Q Consensus 2 ~~y~~~~~l~~g~~~~v~~~~~~~~---~~~v~iK~~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~i 78 (292)
++|++.+.||+|++|.||+|.+... ...|++|....... ....+.+.+|+.+++.++||||+++++++.+ +..++
T Consensus 6 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~v~ik~~~~~~~-~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~-~~~~l 83 (270)
T cd05056 6 EDITLGRCIGEGQFGDVYQGVYMSPENEKIAVAVKTCKNCTS-PSVREKFLQEAYIMRQFDHPHIVKLIGVITE-NPVWI 83 (270)
T ss_pred hhceeeeeeCCccceeEEEEEEecCCCCCcceEEEecCCcCC-HHHHHHHHHHHHHHHhCCCCchhceeEEEcC-CCcEE
Confidence 4688999999999999999987544 34689998765433 3445678899999999999999999998875 45789
Q ss_pred EEecCCCccHHHHhcCC-CCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEEccCCcEEEeecCchhhhhcccc-
Q psy758 79 VFEFCDHTVLNELENHP-HGLPWDLIKQITWQVLRGVSYCHRHACIHRDIKPENILLTANGVVKLCDFGFARLIRDLIP- 156 (292)
Q Consensus 79 v~e~~~~~~L~~~~~~~-~~~~~~~~~~i~~qi~~aL~~LH~~givH~dl~p~Nilv~~~~~~kl~dfg~~~~~~~~~~- 156 (292)
|+||+++++|.+++... ..+++..++.++.|++.||+|||++|++|+||+|+||+++.++.++|+|||++........
T Consensus 84 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~~H~dl~p~nili~~~~~~~l~d~g~~~~~~~~~~~ 163 (270)
T cd05056 84 VMELAPLGELRSYLQVNKYSLDLASLILYSYQLSTALAYLESKRFVHRDIAARNVLVSSPDCVKLGDFGLSRYLEDESYY 163 (270)
T ss_pred EEEcCCCCcHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeccccChheEEEecCCCeEEccCceeeecccccce
Confidence 99999999999998754 3589999999999999999999999999999999999999999999999999875433211
Q ss_pred -----ccccccccccccccCCCCCCCcccceeeecCCCCCCchHHHHHHHhh-cccCCCCCCChhhhhhccCc-CCCCCC
Q psy758 157 -----RHLHIFQTNEYFKGVSLPHAENVVPLEIKIGKPAATNIYLIDFLKRC-LDKDPLRRWSCDQLLRHPYF-NGYYFE 229 (292)
Q Consensus 157 -----~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~p~~~~~~~~~~~~~~~-~~~~~~ 229 (292)
.....|.+||...+.......++ ++.+..+++.+ .+..|+...+..+....... .....+
T Consensus 164 ~~~~~~~~~~y~aPE~~~~~~~~~~~Di-------------~slG~il~el~~~g~~pf~~~~~~~~~~~~~~~~~~~~~ 230 (270)
T cd05056 164 KASKGKLPIKWMAPESINFRRFTSASDV-------------WMFGVCMWEILMLGVKPFQGVKNNDVIGRIENGERLPMP 230 (270)
T ss_pred ecCCCCccccccChhhhccCCCCchhhh-------------HHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHcCCcCCCC
Confidence 11123555555443332222222 22333333333 24445444333333221110 111223
Q ss_pred CCCccchHHHHhcccCcCCCCCCChhhhhh
Q psy758 230 VPDEMQYEEITQRCLDKDPLRRWSCDQLLR 259 (292)
Q Consensus 230 ~~~~~~l~~li~~~l~~dP~~Rpt~~~il~ 259 (292)
...+..+.++|.+||..+|.+|||+.++++
T Consensus 231 ~~~~~~~~~li~~~l~~~P~~Rpt~~~~~~ 260 (270)
T cd05056 231 PNCPPTLYSLMTKCWAYDPSKRPRFTELKA 260 (270)
T ss_pred CCCCHHHHHHHHHHcCCChhhCcCHHHHHH
Confidence 445778999999999999999999999987
|
Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions |
| >KOG0603|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.3e-35 Score=244.56 Aligned_cols=237 Identities=26% Similarity=0.344 Sum_probs=184.0
Q ss_pred cccceeeeecccCceEEEEEEEcCCCcEEEEEEeccCCCChHHHHHHHHHHHHHHhC-CCCCcchhhhhhhcCCeEEEEE
Q psy758 2 ERYEKIGKLGEGSYGVVFKCRNRDTGQVVAIKKFLESEEDPLIRKIALREIRLLKSL-KHPNLVNLLEVFRRKKKLHLVF 80 (292)
Q Consensus 2 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~e~~~~~~l-~~~~i~~~~~~~~~~~~~~iv~ 80 (292)
+.|++...+|.|+|+.|-.+.+..+++.+++|++.....+ ..+|+.++... +||||+++.+++.++...|+||
T Consensus 322 ~~y~~~~~~~~gs~s~~~~~~~~~t~~~~~vkii~~~~~~------~~~e~~~~~~~~~h~niv~~~~v~~~~~~~~~v~ 395 (612)
T KOG0603|consen 322 ESYEFREELGEGSFSAVKYCESSPTDQEPAVKIISKRADD------NQDEIPISLLVRDHPNIVKSHDVYEDGKEIYLVM 395 (612)
T ss_pred hhhccccccCCCCccceeeeeccccccchhheeccccccc------cccccchhhhhcCCCcceeecceecCCceeeeee
Confidence 4688899999999999999999999999999999877322 22455444444 6999999999999999999999
Q ss_pred ecCCCccHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEE-ccCCcEEEeecCchhhhhcc--ccc
Q psy758 81 EFCDHTVLNELENHPHGLPWDLIKQITWQVLRGVSYCHRHACIHRDIKPENILL-TANGVVKLCDFGFARLIRDL--IPR 157 (292)
Q Consensus 81 e~~~~~~L~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~givH~dl~p~Nilv-~~~~~~kl~dfg~~~~~~~~--~~~ 157 (292)
|.+.|+.+.+.+.....+. ..+..|+.+|+.|+.|||++|+|||||||+|||+ ++.++++|+|||.++..... .+.
T Consensus 396 e~l~g~ell~ri~~~~~~~-~e~~~w~~~lv~Av~~LH~~gvvhRDLkp~NIL~~~~~g~lrltyFG~a~~~~~~~~tp~ 474 (612)
T KOG0603|consen 396 ELLDGGELLRRIRSKPEFC-SEASQWAAELVSAVDYLHEQGVVHRDLKPGNILLDGSAGHLRLTYFGFWSELERSCDTPA 474 (612)
T ss_pred hhccccHHHHHHHhcchhH-HHHHHHHHHHHHHHHHHHhcCeeecCCChhheeecCCCCcEEEEEechhhhCchhhcccc
Confidence 9999988777666554444 7888999999999999999999999999999999 58899999999999887665 344
Q ss_pred cccccccccccccCCCCCCCcccce-----eeecCCCCCCchHHHHHHHhhcccCCCCCCChhhhhhccCcCCCCCCCCC
Q psy758 158 HLHIFQTNEYFKGVSLPHAENVVPL-----EIKIGKPAATNIYLIDFLKRCLDKDPLRRWSCDQLLRHPYFNGYYFEVPD 232 (292)
Q Consensus 158 ~~~~~~~~~~~~~~~~~~~~~~~~~-----~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~ 232 (292)
-+..|.+||.........+.++|++ ++++|..++..- +.-.++....... .+...+
T Consensus 475 ~t~~y~APEvl~~~~yt~acD~WSLGvlLy~ML~G~tp~~~~-----------------P~~~ei~~~i~~~--~~s~~v 535 (612)
T KOG0603|consen 475 LTLQYVAPEVLAIQEYTEACDWWSLGVLLYEMLTGRTLFAAH-----------------PAGIEIHTRIQMP--KFSECV 535 (612)
T ss_pred hhhcccChhhhccCCCCcchhhHHHHHHHHHHHhCCCccccC-----------------CchHHHHHhhcCC--cccccc
Confidence 5566888988876666555555554 444444432211 1112333222111 122566
Q ss_pred ccchHHHHhcccCcCCCCCCChhhhhhCCccc
Q psy758 233 EMQYEEITQRCLDKDPLRRWSCDQLLRHPYFN 264 (292)
Q Consensus 233 ~~~l~~li~~~l~~dP~~Rpt~~~il~h~w~~ 264 (292)
+...++||++||++||.+||++.++..||||.
T Consensus 536 S~~AKdLl~~LL~~dP~~Rl~~~~i~~h~w~~ 567 (612)
T KOG0603|consen 536 SDEAKDLLQQLLQVDPALRLGADEIGAHPWFL 567 (612)
T ss_pred CHHHHHHHHHhccCChhhCcChhhhccCcchh
Confidence 88999999999999999999999999999993
|
|
| >cd05067 PTKc_Lck_Blk Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-33 Score=227.26 Aligned_cols=240 Identities=22% Similarity=0.302 Sum_probs=174.7
Q ss_pred cccceeeeecccCceEEEEEEEcCCCcEEEEEEeccCCCChHHHHHHHHHHHHHHhCCCCCcchhhhhhhcCCeEEEEEe
Q psy758 2 ERYEKIGKLGEGSYGVVFKCRNRDTGQVVAIKKFLESEEDPLIRKIALREIRLLKSLKHPNLVNLLEVFRRKKKLHLVFE 81 (292)
Q Consensus 2 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~iv~e 81 (292)
++|++++.||+|++|.||+|... +++.|++|.+...... ...+.+|+.+++.++||||+++++++. .+..++++|
T Consensus 6 ~~~~~~~~ig~G~~g~v~~~~~~-~~~~~a~K~~~~~~~~---~~~~~~E~~~l~~l~h~~i~~~~~~~~-~~~~~~v~e 80 (260)
T cd05067 6 ETLKLVKKLGAGQFGEVWMGYYN-GHTKVAIKSLKQGSMS---PEAFLAEANLMKQLQHPRLVRLYAVVT-QEPIYIITE 80 (260)
T ss_pred HHceeeeeeccCccceEEeeecC-CCceEEEEEecCCCCc---HHHHHHHHHHHHhcCCcCeeeEEEEEc-cCCcEEEEE
Confidence 57999999999999999999865 4778999998755443 345778999999999999999999864 456899999
Q ss_pred cCCCccHHHHhcC--CCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEEccCCcEEEeecCchhhhhcccc---
Q psy758 82 FCDHTVLNELENH--PHGLPWDLIKQITWQVLRGVSYCHRHACIHRDIKPENILLTANGVVKLCDFGFARLIRDLIP--- 156 (292)
Q Consensus 82 ~~~~~~L~~~~~~--~~~~~~~~~~~i~~qi~~aL~~LH~~givH~dl~p~Nilv~~~~~~kl~dfg~~~~~~~~~~--- 156 (292)
|+.+++|.+++.. ...+++..+..++.|++.||+|||+.|++|+||+|+||++++++.++|+|||.+........
T Consensus 81 ~~~~~~L~~~~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~~i~H~dl~p~ni~i~~~~~~~l~dfg~~~~~~~~~~~~~ 160 (260)
T cd05067 81 YMENGSLVDFLKTPEGIKLTINKLIDMAAQIAEGMAFIERKNYIHRDLRAANILVSETLCCKIADFGLARLIEDNEYTAR 160 (260)
T ss_pred cCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCeecccccHHhEEEcCCCCEEEccCcceeecCCCCcccc
Confidence 9999999988754 33589999999999999999999999999999999999999999999999999866542111
Q ss_pred ---ccccccccccccccCCCCCCCcccceeeecCCCCCCchHHHHHHHhhc-ccCCCCCCChhhhhhccCc-CCCCCCCC
Q psy758 157 ---RHLHIFQTNEYFKGVSLPHAENVVPLEIKIGKPAATNIYLIDFLKRCL-DKDPLRRWSCDQLLRHPYF-NGYYFEVP 231 (292)
Q Consensus 157 ---~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~p~~~~~~~~~~~~~~~-~~~~~~~~ 231 (292)
.....|.+|+...+.......++| +.+..+++.+. +..|....+..+.....-- .....+..
T Consensus 161 ~~~~~~~~y~~pe~~~~~~~~~~~Di~-------------slG~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~ 227 (260)
T cd05067 161 EGAKFPIKWTAPEAINYGTFTIKSDVW-------------SFGILLTEIVTYGRIPYPGMTNPEVIQNLERGYRMPRPDN 227 (260)
T ss_pred cCCcccccccCHHHhccCCcCcccchH-------------HHHHHHHHHHhCCCCCCCCCChHHHHHHHHcCCCCCCCCC
Confidence 112345666655433322222222 22223333333 3344433333222211000 00112233
Q ss_pred CccchHHHHhcccCcCCCCCCChhhhhh
Q psy758 232 DEMQYEEITQRCLDKDPLRRWSCDQLLR 259 (292)
Q Consensus 232 ~~~~l~~li~~~l~~dP~~Rpt~~~il~ 259 (292)
.+.++.++|.+||+.||++|||++++++
T Consensus 228 ~~~~~~~li~~~l~~~p~~Rp~~~~l~~ 255 (260)
T cd05067 228 CPEELYELMRLCWKEKPEERPTFEYLRS 255 (260)
T ss_pred CCHHHHHHHHHHccCChhhCCCHHHHHH
Confidence 4678999999999999999999999987
|
Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Sr |
| >cd05610 STKc_MASTL Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-33 Score=253.57 Aligned_cols=150 Identities=24% Similarity=0.415 Sum_probs=138.6
Q ss_pred CcccceeeeecccCceEEEEEEEcCCCcEEEEEEeccCC-CChHHHHHHHHHHHHHHhCCCCCcchhhhhhhcCCeEEEE
Q psy758 1 MERYEKIGKLGEGSYGVVFKCRNRDTGQVVAIKKFLESE-EDPLIRKIALREIRLLKSLKHPNLVNLLEVFRRKKKLHLV 79 (292)
Q Consensus 1 ~~~y~~~~~l~~g~~~~v~~~~~~~~~~~v~iK~~~~~~-~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~iv 79 (292)
+++|++.+.||+|+||.||+|.+..+++.||+|++.... ........+..|+.++..++||||+++++++...+.+|+|
T Consensus 3 ~~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAiKvi~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~~~~lV 82 (669)
T cd05610 3 IEEFVIVKPISRGAFGKVYLGRKKNNSKLYAVKVVKKADMINKNMVHQVQAERDALALSKSPFIVHLYYSLQSANNVYLV 82 (669)
T ss_pred cCCEEEEEEEecCCCeEEEEEEECCCCcEEEEEEEehhhccCHHHHHHHHHHHHHHHhcCCCCcCeEEEEEEECCEEEEE
Confidence 578999999999999999999999999999999997544 3344567788999999999999999999999999999999
Q ss_pred EecCCCccHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEEccCCcEEEeecCchhh
Q psy758 80 FEFCDHTVLNELENHPHGLPWDLIKQITWQVLRGVSYCHRHACIHRDIKPENILLTANGVVKLCDFGFARL 150 (292)
Q Consensus 80 ~e~~~~~~L~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~givH~dl~p~Nilv~~~~~~kl~dfg~~~~ 150 (292)
|||+.|++|..++...+.+++..++.++.||+.||.|||++||+|+||||+|||++.++.++|+|||+++.
T Consensus 83 mEy~~g~~L~~li~~~~~l~~~~~~~i~~qil~aL~yLH~~gIiHrDLKP~NILl~~~g~vkL~DFGls~~ 153 (669)
T cd05610 83 MEYLIGGDVKSLLHIYGYFDEEMAVKYISEVALALDYLHRHGIIHRDLKPDNMLISNEGHIKLTDFGLSKV 153 (669)
T ss_pred EeCCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCEEeCCccHHHEEEcCCCCEEEEeCCCCcc
Confidence 99999999999998777899999999999999999999999999999999999999999999999999863
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ1481 |
| >KOG0696|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=7e-35 Score=232.45 Aligned_cols=263 Identities=20% Similarity=0.238 Sum_probs=212.4
Q ss_pred cccceeeeecccCceEEEEEEEcCCCcEEEEEEeccCC-CChHHHHHHHHHHHHHHhC-CCCCcchhhhhhhcCCeEEEE
Q psy758 2 ERYEKIGKLGEGSYGVVFKCRNRDTGQVVAIKKFLESE-EDPLIRKIALREIRLLKSL-KHPNLVNLLEVFRRKKKLHLV 79 (292)
Q Consensus 2 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~v~iK~~~~~~-~~~~~~~~~~~e~~~~~~l-~~~~i~~~~~~~~~~~~~~iv 79 (292)
.+|.++..||.|+||.|.+|..+.+.+.+|||++++.- .++...+--+.|-+++... +-|.+++++..|+.-+.+|+|
T Consensus 349 tDFnFl~VlGKGSFGKVlLaerkgtdELyAiKiLkKDViiQdDDvectm~EKrvLAL~~kppFL~qlHScFQTmDRLyFV 428 (683)
T KOG0696|consen 349 TDFNFLMVLGKGSFGKVLLAERKGTDELYAIKILKKDVIIQDDDVECTMVEKRVLALPGKPPFLVQLHSCFQTMDRLYFV 428 (683)
T ss_pred cccceEEEeccCccceeeeecccCcchhhhhhhhccceeeecCcccceehhhhheecCCCCchHHHHHHHhhhhhheeeE
Confidence 46889999999999999999999999999999987664 2222334445577777665 468899999999999999999
Q ss_pred EecCCCccHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEEccCCcEEEeecCchhhhhccccccc
Q psy758 80 FEFCDHTVLNELENHPHGLPWDLIKQITWQVLRGVSYCHRHACIHRDIKPENILLTANGVVKLCDFGFARLIRDLIPRHL 159 (292)
Q Consensus 80 ~e~~~~~~L~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~givH~dl~p~Nilv~~~~~~kl~dfg~~~~~~~~~~~~~ 159 (292)
|||+.||+|-..+++-+++.|..+..++.+|+.||-+||++||++||||.+||++|.+|++||+|||+++.---......
T Consensus 429 MEyvnGGDLMyhiQQ~GkFKEp~AvFYAaEiaigLFFLh~kgIiYRDLKLDNvmLd~eGHiKi~DFGmcKEni~~~~TTk 508 (683)
T KOG0696|consen 429 MEYVNGGDLMYHIQQVGKFKEPVAVFYAAEIAIGLFFLHSKGIIYRDLKLDNVMLDSEGHIKIADFGMCKENIFDGVTTK 508 (683)
T ss_pred EEEecCchhhhHHHHhcccCCchhhhhhHHHHHHhhhhhcCCeeeeeccccceEeccCCceEeeecccccccccCCccee
Confidence 99999999999999989999999999999999999999999999999999999999999999999999986443344445
Q ss_pred cccccccccccCCCCCCCcccceeeecCCCCCCchHHHHHHHhhcccCCCCCCChhhhhhccCcCCCCCCCCCccchHHH
Q psy758 160 HIFQTNEYFKGVSLPHAENVVPLEIKIGKPAATNIYLIDFLKRCLDKDPLRRWSCDQLLRHPYFNGYYFEVPDEMQYEEI 239 (292)
Q Consensus 160 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l 239 (292)
.++++|.|.+++.+.+.. +|...+.+++..-+++.+.+..|++.-..+++.+..--....++.+.+.+..++
T Consensus 509 TFCGTPdYiAPEIi~YqP--------YgksvDWWa~GVLLyEmlaGQpPFdGeDE~elF~aI~ehnvsyPKslSkEAv~i 580 (683)
T KOG0696|consen 509 TFCGTPDYIAPEIIAYQP--------YGKSVDWWAFGVLLYEMLAGQPPFDGEDEDELFQAIMEHNVSYPKSLSKEAVAI 580 (683)
T ss_pred eecCCCcccccceEEecc--------cccchhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHHccCcCcccccHHHHHH
Confidence 567888888776653211 222223344455556666677777777777777665555567778888999999
Q ss_pred HhcccCcCCCCCCC-----hhhhhhCCcccceeccCCC
Q psy758 240 TQRCLDKDPLRRWS-----CDQLLRHPYFNGYYFEVPD 272 (292)
Q Consensus 240 i~~~l~~dP~~Rpt-----~~~il~h~w~~~~~~~~~~ 272 (292)
.+..|...|.+|.. -.+|-+||||..+.|+...
T Consensus 581 ckg~ltK~P~kRLGcg~~ge~di~~H~FFR~iDWek~E 618 (683)
T KOG0696|consen 581 CKGLLTKHPGKRLGCGPEGERDIREHPFFRRIDWEKLE 618 (683)
T ss_pred HHHHhhcCCccccCCCCccccchhhCcchhhccHHHHh
Confidence 99999999999984 4689999999999998543
|
|
| >cd05083 PTKc_Chk Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.7e-34 Score=227.57 Aligned_cols=239 Identities=22% Similarity=0.286 Sum_probs=172.2
Q ss_pred CcccceeeeecccCceEEEEEEEcCCCcEEEEEEeccCCCChHHHHHHHHHHHHHHhCCCCCcchhhhhhhcCCeEEEEE
Q psy758 1 MERYEKIGKLGEGSYGVVFKCRNRDTGQVVAIKKFLESEEDPLIRKIALREIRLLKSLKHPNLVNLLEVFRRKKKLHLVF 80 (292)
Q Consensus 1 ~~~y~~~~~l~~g~~~~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~iv~ 80 (292)
+++|++.+.||+|++|.||.+.. +++.|++|.+.... ....+.+|+.+++.++|||++++++++..+ ..++++
T Consensus 5 ~~~~~~~~~lg~g~~g~v~~~~~--~~~~~~iK~~~~~~----~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~-~~~~v~ 77 (254)
T cd05083 5 LQKLTLGEIIGEGEFGAVLQGEY--TGQKVAVKNIKCDV----TAQAFLEETAVMTKLHHKNLVRLLGVILHN-GLYIVM 77 (254)
T ss_pred HHHceeeeeeccCCCCceEeccc--CCCceEEEeecCcc----hHHHHHHHHHHHHhCCCCCcCeEEEEEcCC-CcEEEE
Confidence 36899999999999999999864 58889999886432 235678899999999999999999988654 479999
Q ss_pred ecCCCccHHHHhcCCC--CCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEEccCCcEEEeecCchhhhhccc--c
Q psy758 81 EFCDHTVLNELENHPH--GLPWDLIKQITWQVLRGVSYCHRHACIHRDIKPENILLTANGVVKLCDFGFARLIRDLI--P 156 (292)
Q Consensus 81 e~~~~~~L~~~~~~~~--~~~~~~~~~i~~qi~~aL~~LH~~givH~dl~p~Nilv~~~~~~kl~dfg~~~~~~~~~--~ 156 (292)
||+.+++|..++.... .+++..++.++.|++.||.|||++|++||||+|+||+++.++.++|+|||++....... .
T Consensus 78 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~~~H~dl~p~nili~~~~~~kl~Dfg~~~~~~~~~~~~ 157 (254)
T cd05083 78 ELMSKGNLVNFLRTRGRALVSVIQLLQFSLDVAEGMEYLESKKLVHRDLAARNILVSEDGVAKVSDFGLARVGSMGVDNS 157 (254)
T ss_pred ECCCCCCHHHHHHhcCcCCCCHHHHHHHHHHHHHHHHHHHhCCeeccccCcceEEEcCCCcEEECCCccceeccccCCCC
Confidence 9999999999886533 47999999999999999999999999999999999999999999999999986543221 1
Q ss_pred ccccccccccccccCCCCCCCcccceeeecCCCCCCchHHHHHHHhhc-ccCCCCCCChhhhhhccCcC-CCCCCCCCcc
Q psy758 157 RHLHIFQTNEYFKGVSLPHAENVVPLEIKIGKPAATNIYLIDFLKRCL-DKDPLRRWSCDQLLRHPYFN-GYYFEVPDEM 234 (292)
Q Consensus 157 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~p~~~~~~~~~~~~~~~~-~~~~~~~~~~ 234 (292)
.....|.+||...+.......++|++ +.-++..+. +..|....+..+........ ....+...+.
T Consensus 158 ~~~~~y~~pe~~~~~~~~~~~Dv~sl-------------G~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 224 (254)
T cd05083 158 KLPVKWTAPEALKHKKFSSKSDVWSY-------------GVLLWEVFSYGRAPYPKMSLKEVKECVEKGYRMEPPEGCPA 224 (254)
T ss_pred CCCceecCHHHhccCCcCchhhHHHH-------------HHHHHHHHhCCCCCCccCCHHHHHHHHhCCCCCCCCCcCCH
Confidence 11234666666544332222222222 222222221 33333333322222111000 0112234467
Q ss_pred chHHHHhcccCcCCCCCCChhhhhh
Q psy758 235 QYEEITQRCLDKDPLRRWSCDQLLR 259 (292)
Q Consensus 235 ~l~~li~~~l~~dP~~Rpt~~~il~ 259 (292)
.+.+++.+||+.+|.+|||++++++
T Consensus 225 ~~~~li~~~l~~~p~~Rp~~~~l~~ 249 (254)
T cd05083 225 DVYVLMTSCWETEPKKRPSFHKLRE 249 (254)
T ss_pred HHHHHHHHHcCCChhhCcCHHHHHH
Confidence 8999999999999999999999986
|
Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src ki |
| >cd05111 PTK_HER3 Pseudokinase domain of the Protein Tyrosine Kinase, HER3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.8e-34 Score=230.93 Aligned_cols=241 Identities=20% Similarity=0.225 Sum_probs=170.4
Q ss_pred cccceeeeecccCceEEEEEEEcCCCc----EEEEEEeccCCCChHHHHHHHHHHHHHHhCCCCCcchhhhhhhcCCeEE
Q psy758 2 ERYEKIGKLGEGSYGVVFKCRNRDTGQ----VVAIKKFLESEEDPLIRKIALREIRLLKSLKHPNLVNLLEVFRRKKKLH 77 (292)
Q Consensus 2 ~~y~~~~~l~~g~~~~v~~~~~~~~~~----~v~iK~~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~ 77 (292)
++|++.+.||.|++|.||+|....++. .+++|.+.... .......+..|+..+..++||||+++++++. +...+
T Consensus 7 ~~~~~~~~lg~G~~~~vy~~~~~~~~~~~~~~~~~k~~~~~~-~~~~~~~~~~~~~~l~~l~h~~iv~~~~~~~-~~~~~ 84 (279)
T cd05111 7 TELRKLKLLGSGVFGTVHKGIWIPEGDSIKIPVAIKTIQDRS-GRQTFQEITDHMLAMGSLDHAYIVRLLGICP-GASLQ 84 (279)
T ss_pred hhceeccccCccCCcceEEEEEcCCCCceeeEEEEeeccccc-chHHHHHHHHHHHHHhcCCCCCcceEEEEEC-CCccE
Confidence 578999999999999999999877776 46777764332 2233456778888999999999999999875 45578
Q ss_pred EEEecCCCccHHHHhcC-CCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEEccCCcEEEeecCchhhhhcccc
Q psy758 78 LVFEFCDHTVLNELENH-PHGLPWDLIKQITWQVLRGVSYCHRHACIHRDIKPENILLTANGVVKLCDFGFARLIRDLIP 156 (292)
Q Consensus 78 iv~e~~~~~~L~~~~~~-~~~~~~~~~~~i~~qi~~aL~~LH~~givH~dl~p~Nilv~~~~~~kl~dfg~~~~~~~~~~ 156 (292)
+++||+++++|.+++.. .+.+++..+..++.||+.||.|||++|++|+||||+||+++.++.++|+|||.++.......
T Consensus 85 ~i~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~iiH~dlkp~nili~~~~~~kl~Dfg~~~~~~~~~~ 164 (279)
T cd05111 85 LVTQLSPLGSLLDHVRQHRDSLDPQRLLNWCVQIAKGMYYLEEHRMVHRNLAARNILLKSDSIVQIADFGVADLLYPDDK 164 (279)
T ss_pred EEEEeCCCCcHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCCEeccccCcceEEEcCCCcEEEcCCccceeccCCCc
Confidence 89999999999999864 45689999999999999999999999999999999999999999999999999876532111
Q ss_pred -------ccccccccccccccCCCCCCCcccceeeecCCCCCCchHHHHHHHhhc-ccCCCCCCChhh---hhhccCcCC
Q psy758 157 -------RHLHIFQTNEYFKGVSLPHAENVVPLEIKIGKPAATNIYLIDFLKRCL-DKDPLRRWSCDQ---LLRHPYFNG 225 (292)
Q Consensus 157 -------~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~p~~~~~~~~---~~~~~~~~~ 225 (292)
.....|.+||+..+.......++|++ +.-+++.+. +..|.......+ ++.... .
T Consensus 165 ~~~~~~~~~~~~y~~pE~~~~~~~~~~~Dv~sl-------------G~il~el~t~g~~p~~~~~~~~~~~~~~~~~--~ 229 (279)
T cd05111 165 KYFYSEHKTPIKWMALESILFGRYTHQSDVWSY-------------GVTVWEMMSYGAEPYAGMRPHEVPDLLEKGE--R 229 (279)
T ss_pred ccccCCCCCcccccCHHHhccCCcCchhhHHHH-------------HHHHHHHHcCCCCCCCCCCHHHHHHHHHCCC--c
Confidence 11223556665543332222222222 222222222 333332222211 111110 0
Q ss_pred CCCCCCCccchHHHHhcccCcCCCCCCChhhhhh
Q psy758 226 YYFEVPDEMQYEEITQRCLDKDPLRRWSCDQLLR 259 (292)
Q Consensus 226 ~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~~il~ 259 (292)
...+...+..+.+++.+||..||++|||+.++++
T Consensus 230 ~~~~~~~~~~~~~li~~c~~~~p~~Rps~~el~~ 263 (279)
T cd05111 230 LAQPQICTIDVYMVMVKCWMIDENVRPTFKELAN 263 (279)
T ss_pred CCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHH
Confidence 0111223557889999999999999999999977
|
Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr r |
| >cd05073 PTKc_Hck Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-33 Score=225.19 Aligned_cols=238 Identities=23% Similarity=0.322 Sum_probs=173.3
Q ss_pred cccceeeeecccCceEEEEEEEcCCCcEEEEEEeccCCCChHHHHHHHHHHHHHHhCCCCCcchhhhhhhcCCeEEEEEe
Q psy758 2 ERYEKIGKLGEGSYGVVFKCRNRDTGQVVAIKKFLESEEDPLIRKIALREIRLLKSLKHPNLVNLLEVFRRKKKLHLVFE 81 (292)
Q Consensus 2 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~iv~e 81 (292)
++|++.+.||+|++|.||++... .+..+++|.+.... ...+.+.+|+.+++.++|+||+++++.+.+ ...++++|
T Consensus 6 ~~~~~~~~lg~g~~~~vy~~~~~-~~~~~~iK~~~~~~---~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~-~~~~~v~e 80 (260)
T cd05073 6 ESLKLEKKLGAGQFGEVWMATYN-KHTKVAVKTMKPGS---MSVEAFLAEANVMKTLQHDKLVKLHAVVTK-EPIYIITE 80 (260)
T ss_pred cceeEEeEecCccceEEEEEEec-CCccEEEEecCCCh---hHHHHHHHHHHHHHhcCCCCcceEEEEEcC-CCeEEEEE
Confidence 68999999999999999999865 35679999876432 234667889999999999999999999887 77899999
Q ss_pred cCCCccHHHHhcC--CCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEEccCCcEEEeecCchhhhhcccc---
Q psy758 82 FCDHTVLNELENH--PHGLPWDLIKQITWQVLRGVSYCHRHACIHRDIKPENILLTANGVVKLCDFGFARLIRDLIP--- 156 (292)
Q Consensus 82 ~~~~~~L~~~~~~--~~~~~~~~~~~i~~qi~~aL~~LH~~givH~dl~p~Nilv~~~~~~kl~dfg~~~~~~~~~~--- 156 (292)
|+++++|.+++.. ...++...+..++.|++.||.+||++|++|+||+|+||+++.++.++|+|||.+........
T Consensus 81 ~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~aL~~lH~~~i~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~~~~ 160 (260)
T cd05073 81 FMAKGSLLDFLKSDEGSKQPLPKLIDFSAQIAEGMAFIEQRNYIHRDLRAANILVSASLVCKIADFGLARVIEDNEYTAR 160 (260)
T ss_pred eCCCCcHHHHHHhCCccccCHHHHHHHHHHHHHHHHHHHhCCccccccCcceEEEcCCCcEEECCCcceeeccCCCcccc
Confidence 9999999998865 33578889999999999999999999999999999999999999999999998865532111
Q ss_pred ---ccccccccccccccCCCCCCCcccceeeecCCCCCCchHHHHHHHhhc-ccCCCCCCChhhhhh---ccCcCCCCCC
Q psy758 157 ---RHLHIFQTNEYFKGVSLPHAENVVPLEIKIGKPAATNIYLIDFLKRCL-DKDPLRRWSCDQLLR---HPYFNGYYFE 229 (292)
Q Consensus 157 ---~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~p~~~~~~~~~~~---~~~~~~~~~~ 229 (292)
.....|.+||...+.......++ ++.+.-++..+. +..|....+..+... ..+ .....
T Consensus 161 ~~~~~~~~y~~PE~~~~~~~~~~~Di-------------~slG~~l~~l~t~g~~p~~~~~~~~~~~~~~~~~--~~~~~ 225 (260)
T cd05073 161 EGAKFPIKWTAPEAINFGSFTIKSDV-------------WSFGILLMEIVTYGRIPYPGMSNPEVIRALERGY--RMPRP 225 (260)
T ss_pred cCCcccccccCHhHhccCCcCccccc-------------hHHHHHHHHHHhcCCCCCCCCCHHHHHHHHhCCC--CCCCc
Confidence 11123556665543322222222 222222333332 333433333222221 111 11122
Q ss_pred CCCccchHHHHhcccCcCCCCCCChhhhhh
Q psy758 230 VPDEMQYEEITQRCLDKDPLRRWSCDQLLR 259 (292)
Q Consensus 230 ~~~~~~l~~li~~~l~~dP~~Rpt~~~il~ 259 (292)
...+.++.+++.+||+.||++||++.++++
T Consensus 226 ~~~~~~~~~~i~~~l~~~p~~Rp~~~~l~~ 255 (260)
T cd05073 226 ENCPEELYNIMMRCWKNRPEERPTFEYIQS 255 (260)
T ss_pred ccCCHHHHHHHHHHcccCcccCcCHHHHHH
Confidence 345778999999999999999999999876
|
Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pa |
| >cd05085 PTKc_Fer Catalytic domain of the Protein Tyrosine Kinase, Fer | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-33 Score=224.69 Aligned_cols=237 Identities=23% Similarity=0.301 Sum_probs=171.5
Q ss_pred eeecccCceEEEEEEEcCCCcEEEEEEeccCCCChHHHHHHHHHHHHHHhCCCCCcchhhhhhhcCCeEEEEEecCCCcc
Q psy758 8 GKLGEGSYGVVFKCRNRDTGQVVAIKKFLESEEDPLIRKIALREIRLLKSLKHPNLVNLLEVFRRKKKLHLVFEFCDHTV 87 (292)
Q Consensus 8 ~~l~~g~~~~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~iv~e~~~~~~ 87 (292)
+.||+|++|.||++... ++..+++|.+.... .......+.+|+.+++.++||||+++++++...+..++||||+++++
T Consensus 1 ~~ig~g~~g~vy~~~~~-~~~~~a~K~~~~~~-~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~ 78 (250)
T cd05085 1 ELLGKGNFGEVFKGTLK-DKTPVAVKTCKEDL-PQELKIKFLSEARILKQYDHPNIVKLIGVCTQRQPIYIVMELVPGGD 78 (250)
T ss_pred CccCCCCCceEEEEEec-CCcEEEEEecCCcC-CHHHHHHHHHHHHHHHhCCCCCcCeEEEEEecCCccEEEEECCCCCc
Confidence 46899999999999864 58899999886543 33344568899999999999999999999999999999999999999
Q ss_pred HHHHhcC-CCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEEccCCcEEEeecCchhhhhcccc------cccc
Q psy758 88 LNELENH-PHGLPWDLIKQITWQVLRGVSYCHRHACIHRDIKPENILLTANGVVKLCDFGFARLIRDLIP------RHLH 160 (292)
Q Consensus 88 L~~~~~~-~~~~~~~~~~~i~~qi~~aL~~LH~~givH~dl~p~Nilv~~~~~~kl~dfg~~~~~~~~~~------~~~~ 160 (292)
|..++.. ...+++..+..++.|++.||.|||++|++|+||+|+||++++++.++|+|||++........ ....
T Consensus 79 L~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~H~dl~p~nili~~~~~~~l~d~g~~~~~~~~~~~~~~~~~~~~ 158 (250)
T cd05085 79 FLSFLRKKKDELKTKQLVKFALDAAAGMAYLESKNCIHRDLAARNCLVGENNVLKISDFGMSRQEDDGIYSSSGLKQIPI 158 (250)
T ss_pred HHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeecccChheEEEcCCCeEEECCCccceeccccccccCCCCCCcc
Confidence 9998764 34579999999999999999999999999999999999999999999999998865332111 1122
Q ss_pred ccccccccccCCCCCCCcccceeeecCCCCCCchHHHHHHHhhc-ccCCCCCCChhhhhhccCcC-CCCCCCCCccchHH
Q psy758 161 IFQTNEYFKGVSLPHAENVVPLEIKIGKPAATNIYLIDFLKRCL-DKDPLRRWSCDQLLRHPYFN-GYYFEVPDEMQYEE 238 (292)
Q Consensus 161 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~p~~~~~~~~~~~~~~~~-~~~~~~~~~~~l~~ 238 (292)
.|.+||+..+.......++|+++ .-++..+. +..|................ ....+...+..+.+
T Consensus 159 ~y~aPE~~~~~~~~~~~Di~slG-------------~ll~~~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 225 (250)
T cd05085 159 KWTAPEALNYGRYSSESDVWSYG-------------ILLWETFSLGVCPYPGMTNQQAREQVEKGYRMSCPQKCPDDVYK 225 (250)
T ss_pred cccCHHHhccCCCCchhHHHHHH-------------HHHHHHhcCCCCCCCCCCHHHHHHHHHcCCCCCCCCCCCHHHHH
Confidence 36666665443332223333322 11222222 33343332222221110000 11223345788999
Q ss_pred HHhcccCcCCCCCCChhhhhh
Q psy758 239 ITQRCLDKDPLRRWSCDQLLR 259 (292)
Q Consensus 239 li~~~l~~dP~~Rpt~~~il~ 259 (292)
++.+||+.||++|||+.++++
T Consensus 226 li~~~l~~~p~~Rp~~~~l~~ 246 (250)
T cd05085 226 VMQRCWDYKPENRPKFSELQK 246 (250)
T ss_pred HHHHHcccCcccCCCHHHHHH
Confidence 999999999999999999976
|
Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-c |
| >cd05077 PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-33 Score=227.43 Aligned_cols=237 Identities=19% Similarity=0.242 Sum_probs=166.9
Q ss_pred eeecccCceEEEEEEEcC------------CCcEEEEEEeccCCCChHHHHHHHHHHHHHHhCCCCCcchhhhhhhcCCe
Q psy758 8 GKLGEGSYGVVFKCRNRD------------TGQVVAIKKFLESEEDPLIRKIALREIRLLKSLKHPNLVNLLEVFRRKKK 75 (292)
Q Consensus 8 ~~l~~g~~~~v~~~~~~~------------~~~~v~iK~~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~ 75 (292)
+.||+|++|.||.+.... ....|++|.+.... ......+..|..+++.++||||+++++++..+..
T Consensus 1 ~~lg~G~~~~vy~~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~--~~~~~~~~~~~~~l~~l~hp~iv~~~~~~~~~~~ 78 (262)
T cd05077 1 EHLGRGTRTQIYAGILNYKDDDEDDGYSYEKEIKVILKVLDPSH--RDISLAFFETASMMRQVSHKHIVLLYGVCVRDVE 78 (262)
T ss_pred CccccCCcceEeeeecccCCCccccccchhhceeEEEeecChhh--hhHHHHHHHHHHHHHhCCCCCEeeEEEEEecCCC
Confidence 468999999999997532 23358888875433 2344567788999999999999999999998888
Q ss_pred EEEEEecCCCccHHHHhcC-CCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEEccCCc-------EEEeecCc
Q psy758 76 LHLVFEFCDHTVLNELENH-PHGLPWDLIKQITWQVLRGVSYCHRHACIHRDIKPENILLTANGV-------VKLCDFGF 147 (292)
Q Consensus 76 ~~iv~e~~~~~~L~~~~~~-~~~~~~~~~~~i~~qi~~aL~~LH~~givH~dl~p~Nilv~~~~~-------~kl~dfg~ 147 (292)
.++++||+++++|..++.. ...+++..++.++.||+.||+|||++|++|+||+|+||+++.++. ++++|||.
T Consensus 79 ~~lv~e~~~~~~l~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~dlkp~Nill~~~~~~~~~~~~~~l~d~g~ 158 (262)
T cd05077 79 NIMVEEFVEFGPLDLFMHRKSDVLTTPWKFKVAKQLASALSYLEDKDLVHGNVCTKNILLAREGIDGECGPFIKLSDPGI 158 (262)
T ss_pred CEEEEecccCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHhhhCCeECCCCCcccEEEecCCccCCCCceeEeCCCCC
Confidence 9999999999999988864 346899999999999999999999999999999999999987664 89999998
Q ss_pred hhhhhccc-ccccccccccccccc-CCCCCCCcccceeeecCCCCCCchHHHHHHHhhc-ccCCCCCCChhhhhhccCcC
Q psy758 148 ARLIRDLI-PRHLHIFQTNEYFKG-VSLPHAENVVPLEIKIGKPAATNIYLIDFLKRCL-DKDPLRRWSCDQLLRHPYFN 224 (292)
Q Consensus 148 ~~~~~~~~-~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~p~~~~~~~~~~~~~~~~ 224 (292)
+....... ...+..|.+||...+ .......++|+++ ..++..+. +..|.......+.... .-.
T Consensus 159 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG-------------~~l~el~~~~~~p~~~~~~~~~~~~-~~~ 224 (262)
T cd05077 159 PITVLSRQECVERIPWIAPECVEDSKNLSIAADKWSFG-------------TTLWEICYNGEIPLKDKTLAEKERF-YEG 224 (262)
T ss_pred CccccCcccccccccccChhhhcCCCCCCchhHHHHHH-------------HHHHHHHhCCCCCCCCcchhHHHHH-Hhc
Confidence 86543321 223344677776542 2222223333322 22222221 2223222222111110 011
Q ss_pred CCCCCCCCccchHHHHhcccCcCCCCCCChhhhhhC
Q psy758 225 GYYFEVPDEMQYEEITQRCLDKDPLRRWSCDQLLRH 260 (292)
Q Consensus 225 ~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~~il~h 260 (292)
......+.+..+.+||.+||+.||.+||++.+|+++
T Consensus 225 ~~~~~~~~~~~~~~li~~cl~~dp~~Rp~~~~il~~ 260 (262)
T cd05077 225 QCMLVTPSCKELADLMTHCMNYDPNQRPFFRAIMRD 260 (262)
T ss_pred CccCCCCChHHHHHHHHHHcCCChhhCcCHHHHHHh
Confidence 112223345688999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic dom |
| >PLN03225 Serine/threonine-protein kinase SNT7; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-33 Score=247.41 Aligned_cols=263 Identities=20% Similarity=0.221 Sum_probs=157.1
Q ss_pred CcccceeeeecccCceEEEEEEEcCC----CcEEEEEEeccCCCChHHHHHHHHHHHHHHhCCCCCcchhhhhh------
Q psy758 1 MERYEKIGKLGEGSYGVVFKCRNRDT----GQVVAIKKFLESEEDPLIRKIALREIRLLKSLKHPNLVNLLEVF------ 70 (292)
Q Consensus 1 ~~~y~~~~~l~~g~~~~v~~~~~~~~----~~~v~iK~~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~------ 70 (292)
+++|.+.+.||+|+||.||+|.+..+ +..||+|.+....... ....+ .++...+.++..++..+
T Consensus 131 ~~~y~l~~~LG~G~FG~VYka~~~~~~~~~~~~vAvK~~~~~~~~e----~~~~e--~l~~~~~~~~~~~~~~~~~~~~~ 204 (566)
T PLN03225 131 KDDFVLGKKLGEGAFGVVYKASLVNKQSKKEGKYVLKKATEYGAVE----IWMNE--RVRRACPNSCADFVYGFLEPVSS 204 (566)
T ss_pred cCCeEEeEEEeeCCCeEEEEEEEcCCccccCcEEEEEEecccchhH----HHHHH--HHHhhchhhHHHHHHhhhccccc
Confidence 36899999999999999999999988 8999999875432211 11111 12222233344433332
Q ss_pred hcCCeEEEEEecCCCccHHHHhcCCCC--------------------CCHHHHHHHHHHHHHHHHHHHhCCccccCCCCC
Q psy758 71 RRKKKLHLVFEFCDHTVLNELENHPHG--------------------LPWDLIKQITWQVLRGVSYCHRHACIHRDIKPE 130 (292)
Q Consensus 71 ~~~~~~~iv~e~~~~~~L~~~~~~~~~--------------------~~~~~~~~i~~qi~~aL~~LH~~givH~dl~p~ 130 (292)
.++...++|+||+++++|.+++..... .....+..++.||+.||.|||++||+||||||+
T Consensus 205 ~~~~~~~LV~ey~~~gsL~~~l~~~~~~~~v~~~l~~~~~~l~~~~~r~~~~i~~i~~qll~aL~yLH~~gIiHRDLKP~ 284 (566)
T PLN03225 205 KKEDEYWLVWRYEGESTLADLMQSKEFPYNVEPYLLGKVQDLPKGLERENKIIQTIMRQILFALDGLHSTGIVHRDVKPQ 284 (566)
T ss_pred ccCCceEEEEEecCCCcHHHHHHhcCCchhHHHHhccchhhccccchhhHHHHHHHHHHHHHHHHHHHHCCEEeCcCCHH
Confidence 345679999999999999988764321 123456789999999999999999999999999
Q ss_pred ceEEcc-CCcEEEeecCchhhhhccc------cccccccccccccccCCCCCCCc------c---cceeeecCCCCCCch
Q psy758 131 NILLTA-NGVVKLCDFGFARLIRDLI------PRHLHIFQTNEYFKGVSLPHAEN------V---VPLEIKIGKPAATNI 194 (292)
Q Consensus 131 Nilv~~-~~~~kl~dfg~~~~~~~~~------~~~~~~~~~~~~~~~~~~~~~~~------~---~~~~~~~~~~~~~~~ 194 (292)
|||+++ ++.+||+|||+++.+.... ...+..|.+||.+.......... . ..+....+...++++
T Consensus 285 NILl~~~~~~~KL~DFGlA~~l~~~~~~~~~~~~~t~~Y~APE~~~~~~~~~~~~~~~~~~~~sp~l~~~~~~~k~DVwS 364 (566)
T PLN03225 285 NIIFSEGSGSFKIIDLGAAADLRVGINYIPKEFLLDPRYAAPEQYIMSTQTPSAPSAPVATALSPVLWQLNLPDRFDIYS 364 (566)
T ss_pred HEEEeCCCCcEEEEeCCCccccccccccCCcccccCCCccChHHhhccCCCCCCccccccccccchhccccCCCCcccHH
Confidence 999996 5799999999997543211 11223455565322111000000 0 000001111123333
Q ss_pred HHHHHHHhhcccCCCCCC-------------Chh---hhhhccC----cCCCCCCCCCccchHHHHhcccCcCCCCCCCh
Q psy758 195 YLIDFLKRCLDKDPLRRW-------------SCD---QLLRHPY----FNGYYFEVPDEMQYEEITQRCLDKDPLRRWSC 254 (292)
Q Consensus 195 ~~~~~~~~~~~~~p~~~~-------------~~~---~~~~~~~----~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~ 254 (292)
.++-+++.++..-+.... ... ....... ...+...........+||.+||+.||.+|||+
T Consensus 365 lGviL~el~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~dLi~~mL~~dP~kR~ta 444 (566)
T PLN03225 365 AGLIFLQMAFPNLRSDSNLIQFNRQLKRNDYDLVAWRKLVEPRASPDLRRGFEVLDLDGGAGWELLKSMMRFKGRQRISA 444 (566)
T ss_pred HHHHHHHHHhCcCCCchHHHHHHHHHHhcCCcHHHHHHhhccccchhhhhhhhhccccchHHHHHHHHHccCCcccCCCH
Confidence 333333333321111000 000 0000000 00011111223345589999999999999999
Q ss_pred hhhhhCCcccceecc
Q psy758 255 DQLLRHPYFNGYYFE 269 (292)
Q Consensus 255 ~~il~h~w~~~~~~~ 269 (292)
+++|+||||++....
T Consensus 445 ~e~L~Hpff~~~~~~ 459 (566)
T PLN03225 445 KAALAHPYFDREGLL 459 (566)
T ss_pred HHHhCCcCcCCCCcc
Confidence 999999999986543
|
|
| >cd05076 PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-33 Score=228.22 Aligned_cols=236 Identities=22% Similarity=0.264 Sum_probs=164.4
Q ss_pred eecccCceEEEEEEEcCC------------------------CcEEEEEEeccCCCChHHHHHHHHHHHHHHhCCCCCcc
Q psy758 9 KLGEGSYGVVFKCRNRDT------------------------GQVVAIKKFLESEEDPLIRKIALREIRLLKSLKHPNLV 64 (292)
Q Consensus 9 ~l~~g~~~~v~~~~~~~~------------------------~~~v~iK~~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~ 64 (292)
.||+|+||.||++....+ ...|++|.+.... ......+.+|..+++.++||||+
T Consensus 2 ~lG~G~~~~vy~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~--~~~~~~~~~~~~~~~~l~h~niv 79 (274)
T cd05076 2 HLGQGTRTNIYDGRLRVEGGGEPEEDEMEDEDPLVEGNNNGRELRVVLKVLDPSH--RDIALAFFETASLMSQVSHIHLA 79 (274)
T ss_pred CcCcccccceecceeEeccCCCCcccccccccccccccCCCeeeeEEEEecChHH--HHHHHHHHHHHHHHhcCCCCCee
Confidence 589999999999974321 2358888875432 23345678899999999999999
Q ss_pred hhhhhhhcCCeEEEEEecCCCccHHHHhcC-CCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEEccCC-----
Q psy758 65 NLLEVFRRKKKLHLVFEFCDHTVLNELENH-PHGLPWDLIKQITWQVLRGVSYCHRHACIHRDIKPENILLTANG----- 138 (292)
Q Consensus 65 ~~~~~~~~~~~~~iv~e~~~~~~L~~~~~~-~~~~~~~~~~~i~~qi~~aL~~LH~~givH~dl~p~Nilv~~~~----- 138 (292)
++++++.++...++||||+++++|..++.. .+.+++..+..++.||+.||+|||++|++|+||||+||+++..+
T Consensus 80 ~~~~~~~~~~~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~iiH~dlkp~Nill~~~~~~~~~ 159 (274)
T cd05076 80 FVHGVCVRGSENIMVEEFVEHGPLDVCLRKEKGRVPVAWKITVAQQLASALSYLEDKNLVHGNVCAKNILLARLGLAEGT 159 (274)
T ss_pred eEEEEEEeCCceEEEEecCCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHcCCccCCCCCcccEEEeccCcccCc
Confidence 999999999999999999999999998864 45689999999999999999999999999999999999998654
Q ss_pred --cEEEeecCchhhhhcc-ccccccccccccccccC-CCCCCCcccceeeecCCCCCCchHHHHHHHhhc-ccCCCCCCC
Q psy758 139 --VVKLCDFGFARLIRDL-IPRHLHIFQTNEYFKGV-SLPHAENVVPLEIKIGKPAATNIYLIDFLKRCL-DKDPLRRWS 213 (292)
Q Consensus 139 --~~kl~dfg~~~~~~~~-~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~p~~~~~ 213 (292)
.++++|||.+...... .......|.+||...+. ......++|++ +..++..++ +..|....+
T Consensus 160 ~~~~kl~d~g~~~~~~~~~~~~~~~~~~aPe~~~~~~~~~~~~Dv~sl-------------G~~l~el~~~g~~p~~~~~ 226 (274)
T cd05076 160 SPFIKLSDPGVSFTALSREERVERIPWIAPECVPGGNSLSTAADKWSF-------------GTTLLEICFDGEVPLKERT 226 (274)
T ss_pred cceeeecCCccccccccccccccCCcccCchhhcCCCCCCcHHHHHHH-------------HHHHHHHHhCCCCCccccC
Confidence 4899999987543221 11223345566654331 11122222222 222223222 333333222
Q ss_pred hhhhhhccCcCCCCCCCCCccchHHHHhcccCcCCCCCCChhhhhhC
Q psy758 214 CDQLLRHPYFNGYYFEVPDEMQYEEITQRCLDKDPLRRWSCDQLLRH 260 (292)
Q Consensus 214 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~~il~h 260 (292)
..+.... +......+.+.+..+.++|.+||+.+|.+|||+.+++++
T Consensus 227 ~~~~~~~-~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rps~~~il~~ 272 (274)
T cd05076 227 PSEKERF-YEKKHRLPEPSCKELATLISQCLTYEPTQRPSFRTILRD 272 (274)
T ss_pred hHHHHHH-HHhccCCCCCCChHHHHHHHHHcccChhhCcCHHHHHHh
Confidence 2221110 111122333345679999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalyt |
| >KOG0193|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.6e-34 Score=236.66 Aligned_cols=235 Identities=23% Similarity=0.305 Sum_probs=179.7
Q ss_pred cccceeeeecccCceEEEEEEEcCCCcEEEEEEeccCCCChHHHHHHHHHHHHHHhCCCCCcchhhhhhhcCCeEEEEEe
Q psy758 2 ERYEKIGKLGEGSYGVVFKCRNRDTGQVVAIKKFLESEEDPLIRKIALREIRLLKSLKHPNLVNLLEVFRRKKKLHLVFE 81 (292)
Q Consensus 2 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~iv~e 81 (292)
++..+...||+|.||+||+|.+.. .||||++.....+++..+.|.+|+..+++-+|-||+=+.|++..+.. .||+.
T Consensus 392 ~ev~l~~rIGsGsFGtV~Rg~whG---dVAVK~Lnv~~pt~~qlqaFKnEVa~lkkTRH~NIlLFMG~~~~p~~-AIiTq 467 (678)
T KOG0193|consen 392 EEVLLGERIGSGSFGTVYRGRWHG---DVAVKLLNVDDPTPEQLQAFKNEVAVLKKTRHENILLFMGACMNPPL-AIITQ 467 (678)
T ss_pred HHhhccceeccccccceeeccccc---ceEEEEEecCCCCHHHHHHHHHHHHHHhhcchhhheeeehhhcCCce-eeeeh
Confidence 456788899999999999999975 59999999998888899999999999999999999999999988776 99999
Q ss_pred cCCCccHHHHhcCC-CCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEEccCCcEEEeecCchhhhhc-------
Q psy758 82 FCDHTVLNELENHP-HGLPWDLIKQITWQVLRGVSYCHRHACIHRDIKPENILLTANGVVKLCDFGFARLIRD------- 153 (292)
Q Consensus 82 ~~~~~~L~~~~~~~-~~~~~~~~~~i~~qi~~aL~~LH~~givH~dl~p~Nilv~~~~~~kl~dfg~~~~~~~------- 153 (292)
+|+|.+|..++... .++...+...|+.||++|+.|||.++|+|+|||..|||+.++++|||+|||++..-.-
T Consensus 468 wCeGsSLY~hlHv~etkfdm~~~idIAqQiaqGM~YLHAK~IIHrDLKSnNIFl~~~~kVkIgDFGLatvk~~w~g~~q~ 547 (678)
T KOG0193|consen 468 WCEGSSLYTHLHVQETKFDMNTTIDIAQQIAQGMDYLHAKNIIHRDLKSNNIFLHEDLKVKIGDFGLATVKTRWSGEQQL 547 (678)
T ss_pred hccCchhhhhccchhhhhhHHHHHHHHHHHHHhhhhhhhhhhhhhhccccceEEccCCcEEEecccceeeeeeecccccc
Confidence 99999999988643 4689999999999999999999999999999999999999999999999999865431
Q ss_pred ccccccccccccccccc--------CCCCCCCcccceeeecCCCCCCchHHHHHHHhhcccCCCCCCChhhhhhccCcCC
Q psy758 154 LIPRHLHIFQTNEYFKG--------VSLPHAENVVPLEIKIGKPAATNIYLIDFLKRCLDKDPLRRWSCDQLLRHPYFNG 225 (292)
Q Consensus 154 ~~~~~~~~~~~~~~~~~--------~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~ 225 (292)
..+.....|.+||...- ..+.+++|+..|++++|. -|...-..++++...- .+
T Consensus 548 ~qp~gsilwmAPEvIRmqd~nPfS~qSDVYaFGiV~YELltg~------------------lPysi~~~dqIifmVG-rG 608 (678)
T KOG0193|consen 548 EQPHGSLLWMAPEVIRMQDDNPFSFQSDVYAFGIVWYELLTGE------------------LPYSIQNRDQIIFMVG-RG 608 (678)
T ss_pred CCCccchhhhcHHHHhhcccCCCCcccchhhhhHHHHHHHhCc------------------CCcCCCChhheEEEec-cc
Confidence 22333344556655431 112233333333333333 3433222233322111 11
Q ss_pred CCCC------CCCccchHHHHhcccCcCCCCCCChhhhhh
Q psy758 226 YYFE------VPDEMQYEEITQRCLDKDPLRRWSCDQLLR 259 (292)
Q Consensus 226 ~~~~------~~~~~~l~~li~~~l~~dP~~Rpt~~~il~ 259 (292)
+-.+ ..-+.++++|+..||+++|++||++.+||.
T Consensus 609 ~l~pd~s~~~s~~pk~mk~Ll~~C~~~~~~eRP~F~~il~ 648 (678)
T KOG0193|consen 609 YLMPDLSKIRSNCPKAMKRLLSDCWKFDREERPLFPQLLS 648 (678)
T ss_pred ccCccchhhhccCHHHHHHHHHHHHhcCcccCccHHHHHH
Confidence 1111 122668999999999999999999999988
|
|
| >cd08528 STKc_Nek10 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-33 Score=226.16 Aligned_cols=239 Identities=22% Similarity=0.341 Sum_probs=174.3
Q ss_pred ccceeeeecccCceEEEEEEEcC-CCcEEEEEEeccCC--------CChHHHHHHHHHHHHHHh-CCCCCcchhhhhhhc
Q psy758 3 RYEKIGKLGEGSYGVVFKCRNRD-TGQVVAIKKFLESE--------EDPLIRKIALREIRLLKS-LKHPNLVNLLEVFRR 72 (292)
Q Consensus 3 ~y~~~~~l~~g~~~~v~~~~~~~-~~~~v~iK~~~~~~--------~~~~~~~~~~~e~~~~~~-l~~~~i~~~~~~~~~ 72 (292)
.|++.+.||+|++|.||.+.+.. +++.+++|.+.... ........+.+|+.++.. ++||||+++++++.+
T Consensus 1 ~y~~~~~ig~G~~~~v~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~ 80 (269)
T cd08528 1 EYAVLEHLGSGAFGCVYKVRKKNNGQNLLALKEINVHNPAFGKDKRERDKSIGDIVSEVTIIKEQLRHPNIVRYYKTFLE 80 (269)
T ss_pred CchhhhhhcCCCCceEEEEEEcCCCCceeeeeEeeccccccccccccchHHHHHHHHHHHHHhhcCCCCCeeeEEeeEcc
Confidence 48899999999999999999987 67899999875332 223344556778888865 789999999999999
Q ss_pred CCeEEEEEecCCCccHHHHhc----CCCCCCHHHHHHHHHHHHHHHHHHHh-CCccccCCCCCceEEccCCcEEEeecCc
Q psy758 73 KKKLHLVFEFCDHTVLNELEN----HPHGLPWDLIKQITWQVLRGVSYCHR-HACIHRDIKPENILLTANGVVKLCDFGF 147 (292)
Q Consensus 73 ~~~~~iv~e~~~~~~L~~~~~----~~~~~~~~~~~~i~~qi~~aL~~LH~-~givH~dl~p~Nilv~~~~~~kl~dfg~ 147 (292)
++..++++||+++++|.+++. ....+++..++.++.|++.||.+||+ .|++|+||+|+||+++.++.++|+|||.
T Consensus 81 ~~~~~lv~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~i~H~dl~~~nil~~~~~~~~l~dfg~ 160 (269)
T cd08528 81 NDRLYIVMDLIEGAPLGEHFNSLKEKKQRFTEERIWNIFVQMVLALRYLHKEKRIVHRDLTPNNIMLGEDDKVTITDFGL 160 (269)
T ss_pred CCeEEEEEecCCCCcHHHHHHHHHhccCCCCHHHHHHHHHHHHHHHHHhccCCceeecCCCHHHEEECCCCcEEEecccc
Confidence 999999999999999988763 34468999999999999999999996 7899999999999999999999999999
Q ss_pred hhhhhccc----cccccccccccccccCCC-----CCCCcccceeeecCCCCCCchHHHHHHHhhcccCCCCCCChhhhh
Q psy758 148 ARLIRDLI----PRHLHIFQTNEYFKGVSL-----PHAENVVPLEIKIGKPAATNIYLIDFLKRCLDKDPLRRWSCDQLL 218 (292)
Q Consensus 148 ~~~~~~~~----~~~~~~~~~~~~~~~~~~-----~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~ 218 (292)
+....... ......|.+|+...+... .|+.++..+++.++.. |..........
T Consensus 161 ~~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Dv~slG~ll~~l~~g~~------------------p~~~~~~~~~~ 222 (269)
T cd08528 161 AKQKQPESKLTSVVGTILYSCPEIVKNEPYGEKADVWAFGCILYQMCTLQP------------------PFYSTNMLSLA 222 (269)
T ss_pred eeecccccccccccCcccCcChhhhcCCCCchHHHHHHHHHHHHHHHhCCC------------------cccccCHHHHH
Confidence 87654321 122334556665544332 2333333333443433 33222221111
Q ss_pred h---ccCcCCCCCCCCCccchHHHHhcccCcCCCCCCChhhhhhC
Q psy758 219 R---HPYFNGYYFEVPDEMQYEEITQRCLDKDPLRRWSCDQLLRH 260 (292)
Q Consensus 219 ~---~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~~il~h 260 (292)
. ...... ......+..+.++|.+||+.||++|||+.|+.++
T Consensus 223 ~~~~~~~~~~-~~~~~~~~~l~~li~~cl~~~p~~Rp~~~e~~~~ 266 (269)
T cd08528 223 TKIVEAVYEP-LPEGMYSEDVTDVITSCLTPDAEARPDIIQVSAM 266 (269)
T ss_pred HHHhhccCCc-CCcccCCHHHHHHHHHHCCCCCccCCCHHHHHHH
Confidence 1 110010 0112346789999999999999999999999874
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24. |
| >cd05042 PTKc_Aatyk Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-33 Score=228.59 Aligned_cols=245 Identities=20% Similarity=0.244 Sum_probs=165.5
Q ss_pred eeecccCceEEEEEEEcC--CCcEEEEEEeccCCCChHHHHHHHHHHHHHHhCCCCCcchhhhhhhcCCeEEEEEecCCC
Q psy758 8 GKLGEGSYGVVFKCRNRD--TGQVVAIKKFLESEEDPLIRKIALREIRLLKSLKHPNLVNLLEVFRRKKKLHLVFEFCDH 85 (292)
Q Consensus 8 ~~l~~g~~~~v~~~~~~~--~~~~v~iK~~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~iv~e~~~~ 85 (292)
+.||+|+||.||+|.... ....+++|.+.... .......+.+|+..++.++||||+++++.+.+....++||||+++
T Consensus 1 ~~lg~G~fg~v~~~~~~~~~~~~~~~~k~~~~~~-~~~~~~~~~~e~~~~~~l~h~nii~~~~~~~~~~~~~lv~e~~~~ 79 (269)
T cd05042 1 DEIGNGWFGKVLLGEAHRGMSKARVVVKELRASA-TPDEQLLFLQEVQPYRELNHPNVLQCLGQCIESIPYLLVLEFCPL 79 (269)
T ss_pred CcCCccCCceEEEEEEecCCCCeEEEEeecCccC-ChHHHHHHHHHHHHHHhCCCCCcceEEEEECCCCceEEEEEeCCC
Confidence 368999999999996533 34578888775433 344456678899999999999999999999999999999999999
Q ss_pred ccHHHHhcCCC-----CCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEEccCCcEEEeecCchhhhhccc-----
Q psy758 86 TVLNELENHPH-----GLPWDLIKQITWQVLRGVSYCHRHACIHRDIKPENILLTANGVVKLCDFGFARLIRDLI----- 155 (292)
Q Consensus 86 ~~L~~~~~~~~-----~~~~~~~~~i~~qi~~aL~~LH~~givH~dl~p~Nilv~~~~~~kl~dfg~~~~~~~~~----- 155 (292)
++|.+++.... ..++..+..++.||+.||+|||++|++|+||||+||+++.++.++|+|||++.......
T Consensus 80 g~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nill~~~~~~kl~dfg~~~~~~~~~~~~~~ 159 (269)
T cd05042 80 GDLKNYLRSNRGMVAQMAQKDVLQRMACEVASGLLWLHQADFIHSDLALRNCQLTADLSVKIGDYGLALEQYPEDYYITK 159 (269)
T ss_pred CcHHHHHHhccccccccccHHHHHHHHHHHHHHHHHHHhcCEecccccHhheEecCCCcEEEeccccccccccchheecc
Confidence 99999886532 24678889999999999999999999999999999999999999999999986432111
Q ss_pred --cccccccccccccccCCCCCCCcccceeeecCCCCCCchHHHHHHHhhc-ccCCCCCCChhhhhhccCcC------CC
Q psy758 156 --PRHLHIFQTNEYFKGVSLPHAENVVPLEIKIGKPAATNIYLIDFLKRCL-DKDPLRRWSCDQLLRHPYFN------GY 226 (292)
Q Consensus 156 --~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~p~~~~~~~~~~~~~~~~------~~ 226 (292)
......|.+||......... .........+.++.+..+++.+. +..|.......+.+...... ..
T Consensus 160 ~~~~~~~~y~aPE~~~~~~~~~------~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~ 233 (269)
T cd05042 160 DCHAVPLRWLAPELVEIRGQDL------LPKDQTKKSNIWSLGVTMWELFTAADQPYPDLSDEQVLKQVVREQDIKLPKP 233 (269)
T ss_pred CCCCCcccccCHHHHhhccccc------cccccchhhHHHHHHHHHHHHHhCCCCCCCcCCHHHHHHHHhhccCccCCCC
Confidence 11112355565542211000 00001111222233333333333 33344333333322211111 11
Q ss_pred CCCCCCccchHHHHhcccCcCCCCCCChhhhhhC
Q psy758 227 YFEVPDEMQYEEITQRCLDKDPLRRWSCDQLLRH 260 (292)
Q Consensus 227 ~~~~~~~~~l~~li~~~l~~dP~~Rpt~~~il~h 260 (292)
..+...+..+.+++..|+ .||.+|||+++|++.
T Consensus 234 ~~~~~~~~~~~~~~~~~~-~dp~~Rpt~~~v~~~ 266 (269)
T cd05042 234 QLDLKYSDRWYEVMQFCW-LDPETRPTAEEVHEL 266 (269)
T ss_pred cccccCCHHHHHHHHHHh-cCcccccCHHHHHHH
Confidence 122334667888999998 599999999999873
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase (Aatyk) subfamily; catalytic (c) domain. The Aatyk subfamily is also referred to as the lemur tyrosine kinase (Lmtk) subfamily. It consists of Aatyk1 (Lmtk1), Aatyk2 (Lmtk2, Brek), Aatyk3 (Lmtk3), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk proteins are mostly receptor tyr kinases (RTKs) containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 does not contain a transmembrane segment and is a cytoplasmic (or nonreceptor) kinase. Aatyk proteins are classified as tyr kina |
| >cd05078 PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-33 Score=227.32 Aligned_cols=237 Identities=17% Similarity=0.218 Sum_probs=167.2
Q ss_pred eeecccCceEEEEEEEcCCCc-------EEEEEEeccCCCChHHHHHHHHHHHHHHhCCCCCcchhhhhhhcCCeEEEEE
Q psy758 8 GKLGEGSYGVVFKCRNRDTGQ-------VVAIKKFLESEEDPLIRKIALREIRLLKSLKHPNLVNLLEVFRRKKKLHLVF 80 (292)
Q Consensus 8 ~~l~~g~~~~v~~~~~~~~~~-------~v~iK~~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~iv~ 80 (292)
+.||+|+||.||+|.+..++. .+++|.+.... ....+.+..|..+++.++|||++++++++..+...++||
T Consensus 1 ~~lg~G~~~~Vy~~~~~~~~~~~~~~~~~~~~k~~~~~~--~~~~~~~~~e~~~l~~~~h~~iv~~~~~~~~~~~~~lv~ 78 (258)
T cd05078 1 ESLGQGTFTKIFKGIRREVGDYGELHKTEVLLKVLDKSH--RNYSESFFEAASMMSQLSHKHLVLNYGVCVCGDESIMVQ 78 (258)
T ss_pred CCCCcccchhheeeeecccccccccccchhhHHhhcchh--HHHHHHHHHHHHHHHhCCCCChhheeeEEEeCCCcEEEE
Confidence 468999999999998865443 38888764332 334566788999999999999999999999888999999
Q ss_pred ecCCCccHHHHhcCC-CCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEEccCCc--------EEEeecCchhhh
Q psy758 81 EFCDHTVLNELENHP-HGLPWDLIKQITWQVLRGVSYCHRHACIHRDIKPENILLTANGV--------VKLCDFGFARLI 151 (292)
Q Consensus 81 e~~~~~~L~~~~~~~-~~~~~~~~~~i~~qi~~aL~~LH~~givH~dl~p~Nilv~~~~~--------~kl~dfg~~~~~ 151 (292)
||+++|+|..++... ..+++..+..++.||+.||+|||++|++|+||||+||+++.++. ++++|||.+...
T Consensus 79 e~~~~g~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~iiH~dlkp~nili~~~~~~~~~~~~~~~l~d~g~~~~~ 158 (258)
T cd05078 79 EYVKFGSLDTYLKKNKNLINISWKLEVAKQLAWALHFLEDKGLTHGNVCAKNVLLIREEDRKTGNPPFIKLSDPGISITV 158 (258)
T ss_pred ecCCCCcHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCccceEEEecccccccCCCceEEeccccccccc
Confidence 999999999998654 35899999999999999999999999999999999999987764 699999987654
Q ss_pred hccc-cccccccccccccccC-CCCCCCcccceeeecCCCCCCchHHHHHHHhhccc-CCCCCCChhhhhhccCcCCCCC
Q psy758 152 RDLI-PRHLHIFQTNEYFKGV-SLPHAENVVPLEIKIGKPAATNIYLIDFLKRCLDK-DPLRRWSCDQLLRHPYFNGYYF 228 (292)
Q Consensus 152 ~~~~-~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~p~~~~~~~~~~~~~~~~~~~~ 228 (292)
.... ...+..|.+||...+. ......++|++ +..++..+.+. .|........... ..-.....
T Consensus 159 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~Diwsl-------------G~~l~~l~~g~~~~~~~~~~~~~~~-~~~~~~~~ 224 (258)
T cd05078 159 LPKEILLERIPWVPPECIENPQNLSLAADKWSF-------------GTTLWEIFSGGDKPLSALDSQKKLQ-FYEDRHQL 224 (258)
T ss_pred CCchhccccCCccCchhccCCCCCCchhhHHHH-------------HHHHHHHHcCCCCChhhccHHHHHH-HHHccccC
Confidence 3221 2223446677665432 11112222222 22222222221 1211111111110 00111233
Q ss_pred CCCCccchHHHHhcccCcCCCCCCChhhhhhC
Q psy758 229 EVPDEMQYEEITQRCLDKDPLRRWSCDQLLRH 260 (292)
Q Consensus 229 ~~~~~~~l~~li~~~l~~dP~~Rpt~~~il~h 260 (292)
+.+.+..+.+||.+||+.||.+|||++++++.
T Consensus 225 ~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~ 256 (258)
T cd05078 225 PAPKWTELANLINQCMDYEPDFRPSFRAIIRD 256 (258)
T ss_pred CCCCcHHHHHHHHHHhccChhhCCCHHHHHHh
Confidence 44456789999999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity |
| >KOG0608|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-34 Score=241.46 Aligned_cols=287 Identities=21% Similarity=0.228 Sum_probs=198.2
Q ss_pred cceeeeecccCceEEEEEEEcCCCcEEEEEEeccCC-CChHHHHHHHHHHHHHHhCCCCCcchhhhhhhcCCeEEEEEec
Q psy758 4 YEKIGKLGEGSYGVVFKCRNRDTGQVVAIKKFLESE-EDPLIRKIALREIRLLKSLKHPNLVNLLEVFRRKKKLHLVFEF 82 (292)
Q Consensus 4 y~~~~~l~~g~~~~v~~~~~~~~~~~v~iK~~~~~~-~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~iv~e~ 82 (292)
|..++.||-|+||.|.+++...|...||+|.+.+.+ ..........-|-+||.....+-||++|-.|++.+.+|+||+|
T Consensus 631 Fvkik~iGvGAFGeV~Lv~KvDT~~lYAmKTLrKaDVl~rnQvaHVKAERDILAEADn~WVVrLyySFQDkdnLYFVMdY 710 (1034)
T KOG0608|consen 631 FVKIKTIGVGAFGEVCLVRKVDTRALYAMKTLRKADVLMRNQVAHVKAERDILAEADNEWVVRLYYSFQDKDNLYFVMDY 710 (1034)
T ss_pred eEEEeeecccccceeEEEeecchhhHHHHhhhHHHHHHhhhhhhhhhhhhhhHhhcCCcceEEEEEEeccCCceEEEEec
Confidence 667888999999999999999999999999997665 2233445556799999999999999999999999999999999
Q ss_pred CCCccHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEEccCCcEEEeecCchhhhh---------c
Q psy758 83 CDHTVLNELENHPHGLPWDLIKQITWQVLRGVSYCHRHACIHRDIKPENILLTANGVVKLCDFGFARLIR---------D 153 (292)
Q Consensus 83 ~~~~~L~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~givH~dl~p~Nilv~~~~~~kl~dfg~~~~~~---------~ 153 (292)
.+||++-.++-+.+-++|..++.++.++.+|+++.|+.|++||||||+|||||.+|+|||+|||+|+-+. +
T Consensus 711 IPGGDmMSLLIrmgIFeE~LARFYIAEltcAiesVHkmGFIHRDiKPDNILIDrdGHIKLTDFGLCTGfRWTHdskYYq~ 790 (1034)
T KOG0608|consen 711 IPGGDMMSLLIRMGIFEEDLARFYIAELTCAIESVHKMGFIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTHDSKYYQE 790 (1034)
T ss_pred cCCccHHHHHHHhccCHHHHHHHHHHHHHHHHHHHHhccceecccCccceEEccCCceeeeeccccccceeccccccccC
Confidence 9999999999888899999999999999999999999999999999999999999999999999997653 0
Q ss_pred cc-cccccccccccccccCCC--------------------CCCCcccceeee--cCC--CCCCchHHHHHHHhhcccCC
Q psy758 154 LI-PRHLHIFQTNEYFKGVSL--------------------PHAENVVPLEIK--IGK--PAATNIYLIDFLKRCLDKDP 208 (292)
Q Consensus 154 ~~-~~~~~~~~~~~~~~~~~~--------------------~~~~~~~~~~~~--~~~--~~~~~~~~~~~~~~~~~~~p 208 (292)
.. ......--.++|.....- .-...++..+++ .|. ..+.++...-+++.+++..|
T Consensus 791 gdH~RqDSmep~~e~~d~~~~lkvL~~ra~~~h~r~~ahslvgt~nyiapevl~r~g~~q~cdwws~gvil~em~~g~~p 870 (1034)
T KOG0608|consen 791 GDHHRQDSMEPSPEWADISKCLKVLERRAMRQHQRILAHSLVGTPNYIAPEVLARTGYTQLCDWWSVGVILYEMLVGQPP 870 (1034)
T ss_pred CCccccccCCCchhhccccccchHHHHHHHhhhhhhhhhhhcCCCcccChHHhcccCccccchhhHhhHHHHHHhhCCCC
Confidence 00 000000111122110000 000011111111 111 11223344445555666666
Q ss_pred CCCCChhhh----hhccCcCCCCCCCCCccchHHHHhcccCcCCCCCC---ChhhhhhCCcccceeccCCChhHHH----
Q psy758 209 LRRWSCDQL----LRHPYFNGYYFEVPDEMQYEEITQRCLDKDPLRRW---SCDQLLRHPYFNGYYFEVPDEMQYE---- 277 (292)
Q Consensus 209 ~~~~~~~~~----~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rp---t~~~il~h~w~~~~~~~~~~~~~~~---- 277 (292)
+...+..+. .+...+-.+......+.++.++|.++.+ +++.|. .+++|.+||||+++.|.-.-++...
T Consensus 871 f~~~tp~~tq~kv~nw~~~l~~~~~~~ls~e~~~li~kLc~-sad~RLGkng~d~vKaHpfFkgIDfsslRkq~ApYIP~ 949 (1034)
T KOG0608|consen 871 FLADTPGETQYKVINWRNFLHIPYQGNLSKEALDLIQKLCC-SADSRLGKNGADQVKAHPFFKGIDFSSLRKQRAPYIPR 949 (1034)
T ss_pred ccCCCCCcceeeeeehhhccccccccccCHHHHHHHHHHhc-ChhhhhcccchhhhhcCccccccchHhhhhccCCcCcc
Confidence 555443222 2222233344455668889999988654 477787 6788999999999988743333322
Q ss_pred --HHhhhcCCCCcCCC
Q psy758 278 --EITQVSRLPTKDKN 291 (292)
Q Consensus 278 --~~~~~~~~~~~~~~ 291 (292)
+=+-.|+|++-|-+
T Consensus 950 ItHptDTSNFdpvdpe 965 (1034)
T KOG0608|consen 950 ITHPTDTSNFDPVDPE 965 (1034)
T ss_pred ccCCCccccCCcCCcc
Confidence 12345666655443
|
|
| >KOG0669|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-35 Score=221.02 Aligned_cols=266 Identities=30% Similarity=0.467 Sum_probs=190.2
Q ss_pred cccceeeeecccCceEEEEEEEcCCCcEEEEEEeccCCCChHHHHHHHHHHHHHHhCCCCCcchhhhhhhc--------C
Q psy758 2 ERYEKIGKLGEGSYGVVFKCRNRDTGQVVAIKKFLESEEDPLIRKIALREIRLLKSLKHPNLVNLLEVFRR--------K 73 (292)
Q Consensus 2 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~--------~ 73 (292)
+.|.....+|+|.||.||+|+..++|+.|++|++-......-.-....+|+++++.|+|+|++.+++++.. .
T Consensus 17 ~~yek~~kigqGtfgeVFkAr~~n~~kkvalkkvlmeneKeGfpitalreikiL~~lkHenv~nliEic~tk~Tp~~r~r 96 (376)
T KOG0669|consen 17 SKYEKLAKIGQGTFGEVFKARSKNTGKKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKATPTNRDR 96 (376)
T ss_pred hHHHHHHhcCCchHHHHHHHhhcCccchhHHHHHHHhccccCCcHHHHHHHHHHHHhcchhHHHHHHHHhhccCCccccc
Confidence 56788889999999999999999999999998764322111122335689999999999999999998753 2
Q ss_pred CeEEEEEecCCCccHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEEccCCcEEEeecCchhhhhc
Q psy758 74 KKLHLVFEFCDHTVLNELENHPHGLPWDLIKQITWQVLRGVSYCHRHACIHRDIKPENILLTANGVVKLCDFGFARLIRD 153 (292)
Q Consensus 74 ~~~~iv~e~~~~~~L~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~givH~dl~p~Nilv~~~~~~kl~dfg~~~~~~~ 153 (292)
..+|+|+.+|+.....-+-....+++..++..++.+++.||.|+|...|+|||+||.|+||+.+|.++|+|||+++.+..
T Consensus 97 ~t~ylVf~~cehDLaGlLsn~~vr~sls~Ikk~Mk~Lm~GL~~iHr~kilHRDmKaaNvLIt~dgilklADFGlar~fs~ 176 (376)
T KOG0669|consen 97 ATFYLVFDFCEHDLAGLLSNRKVRFSLSEIKKVMKGLMNGLYYIHRNKILHRDMKAANVLITKDGILKLADFGLARAFST 176 (376)
T ss_pred ceeeeeHHHhhhhHHHHhcCccccccHHHHHHHHHHHHHHHHHHHHhhHHhhcccHhhEEEcCCceEEeeccccccceec
Confidence 35899999999754333333336799999999999999999999999999999999999999999999999999977653
Q ss_pred cccc---------cccccccccccccCCC------CCCCcccceeeecCCCCCC-chH--HHHHHHhhccc-CCCCCCCh
Q psy758 154 LIPR---------HLHIFQTNEYFKGVSL------PHAENVVPLEIKIGKPAAT-NIY--LIDFLKRCLDK-DPLRRWSC 214 (292)
Q Consensus 154 ~~~~---------~~~~~~~~~~~~~~~~------~~~~~~~~~~~~~~~~~~~-~~~--~~~~~~~~~~~-~p~~~~~~ 214 (292)
.... .+-.|.+||...|... .|..+++..+++++.+... +.. -..++..+++. .+.-.|..
T Consensus 177 ~~n~~kprytnrvvTLwYrppEllLG~r~yg~~iDiWgAgCimaeMwtrspimqgnteqqql~~Is~LcGs~tkevWP~~ 256 (376)
T KOG0669|consen 177 SKNVVKPRYTNRVVTLWYRPPELLLGDREYGPPIDIWGAGCIMAEMWTRSPIMQGNTEQQQLHLISQLCGSITKEVWPNV 256 (376)
T ss_pred ccccCCCCcccceeeeecCCHHHhhcccccCCcchhHhHHHHHHHHHccCccccCChHHHHHHHHHHHhccCCcccCCCc
Confidence 2211 1345777877776543 4566666666666655332 222 23345555543 44444443
Q ss_pred hhhhhcc------CcC-------CCCCCCCCccchHHHHhcccCcCCCCCCChhhhhhCCccccee
Q psy758 215 DQLLRHP------YFN-------GYYFEVPDEMQYEEITQRCLDKDPLRRWSCDQLLRHPYFNGYY 267 (292)
Q Consensus 215 ~~~~~~~------~~~-------~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~~il~h~w~~~~~ 267 (292)
+.+--.. .-. ....+........+|+.+||..||.+|++++++++|.||....
T Consensus 257 d~lpL~~sie~ePl~~~~~rkv~n~~kp~~kd~~a~dLle~ll~~DP~kR~~ad~alnh~~F~kdp 322 (376)
T KOG0669|consen 257 DNLPLYQSIELEPLPKGQKRKVKNRLKPYVKDDEALDLLEKLLKLDPTKRIDADQALNHDFFWKDP 322 (376)
T ss_pred ccchHHHhccCCCCCcchhhhhhhhcccccCChhHHHHHHHHhccCcccCcchHhhhchhhhhcCC
Confidence 3221100 000 0011222255678999999999999999999999999997644
|
|
| >KOG4721|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-34 Score=235.88 Aligned_cols=237 Identities=23% Similarity=0.349 Sum_probs=181.4
Q ss_pred ceeeeecccCceEEEEEEEcCCCcEEEEEEeccCCCChHHHHHHHHHHHHHHhCCCCCcchhhhhhhcCCeEEEEEecCC
Q psy758 5 EKIGKLGEGSYGVVFKCRNRDTGQVVAIKKFLESEEDPLIRKIALREIRLLKSLKHPNLVNLLEVFRRKKKLHLVFEFCD 84 (292)
Q Consensus 5 ~~~~~l~~g~~~~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~iv~e~~~ 84 (292)
.-++-||+|+.|.||+++.. ++.||||.+... -..+++-+++|+||||+.+.|++...-.+|||||||.
T Consensus 127 sELeWlGSGaQGAVF~Grl~--netVAVKKV~el---------kETdIKHLRkLkH~NII~FkGVCtqsPcyCIiMEfCa 195 (904)
T KOG4721|consen 127 SELEWLGSGAQGAVFLGRLH--NETVAVKKVREL---------KETDIKHLRKLKHPNIITFKGVCTQSPCYCIIMEFCA 195 (904)
T ss_pred hhhhhhccCcccceeeeecc--CceehhHHHhhh---------hhhhHHHHHhccCcceeeEeeeecCCceeEEeeeccc
Confidence 34567999999999999987 789999976432 3358899999999999999999999999999999999
Q ss_pred CccHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEEccCCcEEEeecCchhhhhcccc----cccc
Q psy758 85 HTVLNELENHPHGLPWDLIKQITWQVLRGVSYCHRHACIHRDIKPENILLTANGVVKLCDFGFARLIRDLIP----RHLH 160 (292)
Q Consensus 85 ~~~L~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~givH~dl~p~Nilv~~~~~~kl~dfg~~~~~~~~~~----~~~~ 160 (292)
.|-|...++....++......+..+|+.|+.|||.+.|+|||||.-||||+.+..+||+|||-++....... .++-
T Consensus 196 ~GqL~~VLka~~~itp~llv~Wsk~IA~GM~YLH~hKIIHRDLKSPNiLIs~~d~VKIsDFGTS~e~~~~STkMSFaGTV 275 (904)
T KOG4721|consen 196 QGQLYEVLKAGRPITPSLLVDWSKGIAGGMNYLHLHKIIHRDLKSPNILISYDDVVKISDFGTSKELSDKSTKMSFAGTV 275 (904)
T ss_pred cccHHHHHhccCccCHHHHHHHHHHhhhhhHHHHHhhHhhhccCCCceEeeccceEEeccccchHhhhhhhhhhhhhhhH
Confidence 999999999999999999999999999999999999999999999999999999999999999987765422 2233
Q ss_pred ccccccccccCCCCCCCcccceeeecCCCCCCchHHHHHHHhhcccCCCCCCChhhhhhccCcC--CCCCCCCCccchHH
Q psy758 161 IFQTNEYFKGVSLPHAENVVPLEIKIGKPAATNIYLIDFLKRCLDKDPLRRWSCDQLLRHPYFN--GYYFEVPDEMQYEE 238 (292)
Q Consensus 161 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~--~~~~~~~~~~~l~~ 238 (292)
.+.+||....+......++|+++ ..+.+.+.+..|........++.-.-.+ ....+..-|..++=
T Consensus 276 aWMAPEvIrnePcsEKVDIwSfG-------------VVLWEmLT~EiPYkdVdssAIIwGVGsNsL~LpvPstcP~Gfkl 342 (904)
T KOG4721|consen 276 AWMAPEVIRNEPCSEKVDIWSFG-------------VVLWEMLTGEIPYKDVDSSAIIWGVGSNSLHLPVPSTCPDGFKL 342 (904)
T ss_pred hhhCHHHhhcCCcccccceehhH-------------HHHHHHHhcCCCccccchheeEEeccCCcccccCcccCchHHHH
Confidence 34555555444333333333332 2233333344444444333333222111 23445556888999
Q ss_pred HHhcccCcCCCCCCChhhhhhCCcccc
Q psy758 239 ITQRCLDKDPLRRWSCDQLLRHPYFNG 265 (292)
Q Consensus 239 li~~~l~~dP~~Rpt~~~il~h~w~~~ 265 (292)
||++||+..|..||++.+++.|-=+..
T Consensus 343 L~Kqcw~sKpRNRPSFrqil~HldIa~ 369 (904)
T KOG4721|consen 343 LLKQCWNSKPRNRPSFRQILLHLDIAS 369 (904)
T ss_pred HHHHHHhcCCCCCccHHHHHHHHhhcC
Confidence 999999999999999999999954443
|
|
| >cd05058 PTKc_Met_Ron Catalytic domain of the Protein Tyrosine Kinases, Met and Ron | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.5e-33 Score=222.85 Aligned_cols=238 Identities=19% Similarity=0.230 Sum_probs=165.3
Q ss_pred eeecccCceEEEEEEEcC---CCcEEEEEEeccCCCChHHHHHHHHHHHHHHhCCCCCcchhhhhhh-cCCeEEEEEecC
Q psy758 8 GKLGEGSYGVVFKCRNRD---TGQVVAIKKFLESEEDPLIRKIALREIRLLKSLKHPNLVNLLEVFR-RKKKLHLVFEFC 83 (292)
Q Consensus 8 ~~l~~g~~~~v~~~~~~~---~~~~v~iK~~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~-~~~~~~iv~e~~ 83 (292)
+.||+|+||.||+|.+.. .+..|++|.+.... .....+.+.+|+.+++.++||||+++++++. .++..++++||+
T Consensus 1 ~~lg~g~~g~v~~~~~~~~~~~~~~~aiK~~~~~~-~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~lv~e~~ 79 (262)
T cd05058 1 RVIGKGHFGCVYHGTLIDSDGQKIHCAVKSLNRIT-DLEEVEQFLKEGIIMKDFSHPNVLSLLGICLPSEGSPLVVLPYM 79 (262)
T ss_pred CcccccCCceEEEEEEecCCCceEEEEEEecCccC-CHHHHHHHHHHHHHHccCCCCCcceEEEEeecCCCCcEEEEecC
Confidence 468999999999998653 34579999875332 3334567788999999999999999999765 466789999999
Q ss_pred CCccHHHHhcCC-CCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEEccCCcEEEeecCchhhhhccc-------
Q psy758 84 DHTVLNELENHP-HGLPWDLIKQITWQVLRGVSYCHRHACIHRDIKPENILLTANGVVKLCDFGFARLIRDLI------- 155 (292)
Q Consensus 84 ~~~~L~~~~~~~-~~~~~~~~~~i~~qi~~aL~~LH~~givH~dl~p~Nilv~~~~~~kl~dfg~~~~~~~~~------- 155 (292)
.+++|..++... ...+...+..++.|++.||.|||+.|++|+||+|+||++++++.++|+|||++.......
T Consensus 80 ~~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlk~~nili~~~~~~kl~dfg~~~~~~~~~~~~~~~~ 159 (262)
T cd05058 80 KHGDLRNFIRSETHNPTVKDLIGFGLQVAKGMEYLASKKFVHRDLAARNCMLDESFTVKVADFGLARDIYDKEYYSVHNH 159 (262)
T ss_pred CCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCccccccCcceEEEcCCCcEEECCccccccccCCcceeeccc
Confidence 999999998653 346778889999999999999999999999999999999999999999999987543211
Q ss_pred --cccccccccccccccCCCCCCCcccceeeecCCCCCCchHHHHHHHhhcc-cCCCCCCChhhhhhccCcC-CCCCCCC
Q psy758 156 --PRHLHIFQTNEYFKGVSLPHAENVVPLEIKIGKPAATNIYLIDFLKRCLD-KDPLRRWSCDQLLRHPYFN-GYYFEVP 231 (292)
Q Consensus 156 --~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~p~~~~~~~~~~~~~~~~-~~~~~~~ 231 (292)
......|.+||...+.......++|+++ ..+++.+.+ ..|.......+........ ....+..
T Consensus 160 ~~~~~~~~y~aPE~~~~~~~~~~~Di~slG-------------~~l~el~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 226 (262)
T cd05058 160 TGAKLPVKWMALESLQTQKFTTKSDVWSFG-------------VLLWELMTRGAPPYPDVDSFDITVYLLQGRRLLQPEY 226 (262)
T ss_pred ccCcCCccccChhHhccCccchHHHHHHHH-------------HHHHHHHcCCCCCCCCCCHHHHHHHHhcCCCCCCCCc
Confidence 1112235566655433332222222222 222222221 1222222222222211110 1111223
Q ss_pred CccchHHHHhcccCcCCCCCCChhhhhh
Q psy758 232 DEMQYEEITQRCLDKDPLRRWSCDQLLR 259 (292)
Q Consensus 232 ~~~~l~~li~~~l~~dP~~Rpt~~~il~ 259 (292)
.+..+.+++.+||..+|++||++.++++
T Consensus 227 ~~~~~~~li~~cl~~~p~~Rp~~~~il~ 254 (262)
T cd05058 227 CPDPLYEVMLSCWHPKPEMRPTFSELVS 254 (262)
T ss_pred CCHHHHHHHHHHcCCChhhCCCHHHHHH
Confidence 4678999999999999999999999987
|
Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also ca |
| >cd05110 PTKc_HER4 Catalytic domain of the Protein Tyrosine Kinase, HER4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.6e-33 Score=228.14 Aligned_cols=244 Identities=21% Similarity=0.274 Sum_probs=172.5
Q ss_pred cccceeeeecccCceEEEEEEEcCCCc----EEEEEEeccCCCChHHHHHHHHHHHHHHhCCCCCcchhhhhhhcCCeEE
Q psy758 2 ERYEKIGKLGEGSYGVVFKCRNRDTGQ----VVAIKKFLESEEDPLIRKIALREIRLLKSLKHPNLVNLLEVFRRKKKLH 77 (292)
Q Consensus 2 ~~y~~~~~l~~g~~~~v~~~~~~~~~~----~v~iK~~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~ 77 (292)
++|+..+.||+|++|.||+|.+..++. .|++|.+..... ......+.+|+.+++.++||||+++++++... ..+
T Consensus 7 ~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~e~~~~~~l~h~niv~~~~~~~~~-~~~ 84 (303)
T cd05110 7 TELKRVKVLGSGAFGTVYKGIWVPEGETVKIPVAIKILNETTG-PKANVEFMDEALIMASMDHPHLVRLLGVCLSP-TIQ 84 (303)
T ss_pred hhceeccccccCCCccEEEEEEecCCCcceeeEEEEeccccCC-HHHHHHHHHHHHHHHhCCCCCcccEEEEEcCC-Cce
Confidence 578889999999999999999887776 468888764433 33345678899999999999999999988654 467
Q ss_pred EEEecCCCccHHHHhcCC-CCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEEccCCcEEEeecCchhhhhcccc
Q psy758 78 LVFEFCDHTVLNELENHP-HGLPWDLIKQITWQVLRGVSYCHRHACIHRDIKPENILLTANGVVKLCDFGFARLIRDLIP 156 (292)
Q Consensus 78 iv~e~~~~~~L~~~~~~~-~~~~~~~~~~i~~qi~~aL~~LH~~givH~dl~p~Nilv~~~~~~kl~dfg~~~~~~~~~~ 156 (292)
+++||+++|+|.+++... ..+++..+..++.|++.||.|||++|++|+||+|+||++++++.+||+|||++........
T Consensus 85 ~v~e~~~~g~l~~~~~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~ivH~dikp~Nill~~~~~~kL~Dfg~~~~~~~~~~ 164 (303)
T cd05110 85 LVTQLMPHGCLLDYVHEHKDNIGSQLLLNWCVQIAKGMMYLEERRLVHRDLAARNVLVKSPNHVKITDFGLARLLEGDEK 164 (303)
T ss_pred eeehhcCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHhhcCeeccccccceeeecCCCceEEccccccccccCccc
Confidence 899999999999887653 3589999999999999999999999999999999999999999999999999976542111
Q ss_pred -------ccccccccccccccCCCCCCCcccceeeecCCCCCCchHHHHHHHhhc-ccCCCCCCChhhhhhccCc-CCCC
Q psy758 157 -------RHLHIFQTNEYFKGVSLPHAENVVPLEIKIGKPAATNIYLIDFLKRCL-DKDPLRRWSCDQLLRHPYF-NGYY 227 (292)
Q Consensus 157 -------~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~p~~~~~~~~~~~~~~~-~~~~ 227 (292)
..+..|.+|+...+.......++|++ +..+++.+. +..|.......+....... ....
T Consensus 165 ~~~~~~~~~~~~y~~PE~~~~~~~~~~~Diwsl-------------G~~l~el~t~g~~p~~~~~~~~~~~~~~~~~~~~ 231 (303)
T cd05110 165 EYNADGGKMPIKWMALECIHYRKFTHQSDVWSY-------------GVTIWELMTFGGKPYDGIPTREIPDLLEKGERLP 231 (303)
T ss_pred ccccCCCccccccCCHHHhccCCCChHHHHHHH-------------HHHHHHHHhCCCCCCCCCCHHHHHHHHHCCCCCC
Confidence 11123455555443332222222222 222222222 3334333222221111000 0111
Q ss_pred CCCCCccchHHHHhcccCcCCCCCCChhhhhhC
Q psy758 228 FEVPDEMQYEEITQRCLDKDPLRRWSCDQLLRH 260 (292)
Q Consensus 228 ~~~~~~~~l~~li~~~l~~dP~~Rpt~~~il~h 260 (292)
.+...+..+.+++.+||..||++||+++++++.
T Consensus 232 ~~~~~~~~~~~li~~c~~~~p~~Rp~~~~l~~~ 264 (303)
T cd05110 232 QPPICTIDVYMVMVKCWMIDADSRPKFKELAAE 264 (303)
T ss_pred CCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence 122346688999999999999999999999885
|
Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as bindin |
| >cd05074 PTKc_Tyro3 Catalytic domain of the Protein Tyrosine Kinase, Tyro3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.6e-33 Score=223.84 Aligned_cols=244 Identities=20% Similarity=0.237 Sum_probs=170.8
Q ss_pred cceeeeecccCceEEEEEEEc---CCCcEEEEEEeccCCCChHHHHHHHHHHHHHHhCCCCCcchhhhhhhcCC------
Q psy758 4 YEKIGKLGEGSYGVVFKCRNR---DTGQVVAIKKFLESEEDPLIRKIALREIRLLKSLKHPNLVNLLEVFRRKK------ 74 (292)
Q Consensus 4 y~~~~~l~~g~~~~v~~~~~~---~~~~~v~iK~~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~------ 74 (292)
|++.+.||+|++|.||+|... .++..|++|.+..........+.+.+|+.+++.++||||+++++++....
T Consensus 1 ~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~ 80 (273)
T cd05074 1 FTLGRMLGKGEFGSVREAQLKSEDGSFQKVAVKMLKADIFSSSDIEEFLREAACMKEFDHPNVIKLIGVSLRSRAKGRLP 80 (273)
T ss_pred CcchhcccCCCCCCEEeeEeeccCCCceEEEEEEeccccCChHHHHHHHHHHHHHhcCCCCCcceEEEEEccCCCCCccc
Confidence 678899999999999999864 35788999999776666666777889999999999999999999875432
Q ss_pred eEEEEEecCCCccHHHHhcC------CCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEEccCCcEEEeecCch
Q psy758 75 KLHLVFEFCDHTVLNELENH------PHGLPWDLIKQITWQVLRGVSYCHRHACIHRDIKPENILLTANGVVKLCDFGFA 148 (292)
Q Consensus 75 ~~~iv~e~~~~~~L~~~~~~------~~~~~~~~~~~i~~qi~~aL~~LH~~givH~dl~p~Nilv~~~~~~kl~dfg~~ 148 (292)
..+++++|+.+++|..++.. ...++...++.++.|++.||+|||++|++|+||+|+||++++++.++|+|||++
T Consensus 81 ~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~i~H~dikp~nili~~~~~~kl~dfg~~ 160 (273)
T cd05074 81 IPMVILPFMKHGDLHTFLLMSRIGEEPFTLPLQTLVRFMIDIASGMEYLSSKNFIHRDLAARNCMLNENMTVCVADFGLS 160 (273)
T ss_pred ceEEEEecCCCCcHHHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCEeecccchhhEEEcCCCCEEECccccc
Confidence 35789999999999877532 124789999999999999999999999999999999999999999999999998
Q ss_pred hhhhcccc--cc-----ccccccccccccCCCCCCCcccceeeecCCCCCCchHHHHHHHhhc-ccCCCCCCChhhhhhc
Q psy758 149 RLIRDLIP--RH-----LHIFQTNEYFKGVSLPHAENVVPLEIKIGKPAATNIYLIDFLKRCL-DKDPLRRWSCDQLLRH 220 (292)
Q Consensus 149 ~~~~~~~~--~~-----~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~p~~~~~~~~~~~~ 220 (292)
........ .. ...|.+|+...+.......++ ++.+..+++.+. +..|.......++...
T Consensus 161 ~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~sDi-------------~slG~il~el~~~g~~p~~~~~~~~~~~~ 227 (273)
T cd05074 161 KKIYSGDYYRQGCASKLPVKWLALESLADNVYTTHSDV-------------WAFGVTMWEIMTRGQTPYAGVENSEIYNY 227 (273)
T ss_pred ccccCCcceecCCCccCchhhcCHhHHhcCccchhhhh-------------HHHHHHHHHHhhCCCCCCCCCCHHHHHHH
Confidence 76532111 11 112333443322222111222 222222223222 2333332222222211
Q ss_pred cCc-CCCCCCCCCccchHHHHhcccCcCCCCCCChhhhhhC
Q psy758 221 PYF-NGYYFEVPDEMQYEEITQRCLDKDPLRRWSCDQLLRH 260 (292)
Q Consensus 221 ~~~-~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~~il~h 260 (292)
... .....+...+..+.+++.+||+.+|++|||+.+++++
T Consensus 228 ~~~~~~~~~~~~~~~~~~~l~~~~l~~~p~~Rps~~~~~~~ 268 (273)
T cd05074 228 LIKGNRLKQPPDCLEDVYELMCQCWSPEPKCRPSFQHLRDQ 268 (273)
T ss_pred HHcCCcCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence 110 0111223346789999999999999999999999873
|
Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic fac |
| >KOG0668|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-34 Score=212.61 Aligned_cols=259 Identities=22% Similarity=0.350 Sum_probs=184.0
Q ss_pred CcccceeeeecccCceEEEEEEEcCCCcEEEEEEeccCCCChHHHHHHHHHHHHHHhCC-CCCcchhhhhhhcC--CeEE
Q psy758 1 MERYEKIGKLGEGSYGVVFKCRNRDTGQVVAIKKFLESEEDPLIRKIALREIRLLKSLK-HPNLVNLLEVFRRK--KKLH 77 (292)
Q Consensus 1 ~~~y~~~~~l~~g~~~~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~e~~~~~~l~-~~~i~~~~~~~~~~--~~~~ 77 (292)
.++|++++.+|+|.+|.||.|....+++.++||+++.- ..+.+.+|+.+++.|+ ||||++++++..+. ...-
T Consensus 37 ~ddYeivrk~GRGKYSEVFeg~~~~~~eK~ViKiLKPV-----kkkKIkREikIL~nL~gg~NIi~L~DiV~Dp~Sktpa 111 (338)
T KOG0668|consen 37 QDDYEIVRKVGRGKYSEVFEGINITNNEKCVIKILKPV-----KKKKIKREIKILQNLRGGPNIIKLLDIVKDPESKTPS 111 (338)
T ss_pred cchHHHHHHHcCccHhhHhcccccCCCceEEEeeechH-----HHHHHHHHHHHHHhccCCCCeeehhhhhcCccccCch
Confidence 36899999999999999999999999999999998543 3577889999999997 99999999999864 4578
Q ss_pred EEEecCCCccHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEEccC-CcEEEeecCchhhhhccc-
Q psy758 78 LVFEFCDHTVLNELENHPHGLPWDLIKQITWQVLRGVSYCHRHACIHRDIKPENILLTAN-GVVKLCDFGFARLIRDLI- 155 (292)
Q Consensus 78 iv~e~~~~~~L~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~givH~dl~p~Nilv~~~-~~~kl~dfg~~~~~~~~~- 155 (292)
+|+||..+.+...+-. .++...++.++.+++.||.|+||.||.|||+||.|++||.. -.++|+|+|++.+..+..
T Consensus 112 LiFE~v~n~Dfk~ly~---tl~d~dIryY~~elLkALdyCHS~GImHRDVKPhNvmIdh~~rkLrlIDWGLAEFYHp~~e 188 (338)
T KOG0668|consen 112 LIFEYVNNTDFKQLYP---TLTDYDIRYYIYELLKALDYCHSMGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKE 188 (338)
T ss_pred hHhhhhccccHHHHhh---hhchhhHHHHHHHHHHHHhHHHhcCcccccCCcceeeechhhceeeeeecchHhhcCCCce
Confidence 9999999988877754 58899999999999999999999999999999999999976 479999999998775421
Q ss_pred ---cccccccccccccccCCC-CCCCcccceee-----ecCCCCCC-ch-HHHH--HHHhhcc----------cCCCCCC
Q psy758 156 ---PRHLHIFQTNEYFKGVSL-PHAENVVPLEI-----KIGKPAAT-NI-YLID--FLKRCLD----------KDPLRRW 212 (292)
Q Consensus 156 ---~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~-----~~~~~~~~-~~-~~~~--~~~~~~~----------~~p~~~~ 212 (292)
...+..|..||....... -+++++|++++ .+...++. +. ..-+ -+...++ ..-...+
T Consensus 189 YnVRVASRyfKGPELLVdy~~YDYSLD~WS~GcmlA~miFrkepFFhG~dN~DQLVkIakVLGt~el~~Yl~KY~i~Ldp 268 (338)
T KOG0668|consen 189 YNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVKIAKVLGTDELYAYLNKYQIDLDP 268 (338)
T ss_pred eeeeeehhhcCCchheeechhccccHHHHHHHHHHHHHHhccCcccCCCCCHHHHHHHHHHhChHHHHHHHHHHccCCCh
Confidence 112233555555544332 23444444443 33332221 11 0000 0111111 1111222
Q ss_pred Chhhhhh----ccCcCCCCC--CCCCccchHHHHhcccCcCCCCCCChhhhhhCCccccee
Q psy758 213 SCDQLLR----HPYFNGYYF--EVPDEMQYEEITQRCLDKDPLRRWSCDQLLRHPYFNGYY 267 (292)
Q Consensus 213 ~~~~~~~----~~~~~~~~~--~~~~~~~l~~li~~~l~~dP~~Rpt~~~il~h~w~~~~~ 267 (292)
....++. .+|..-.+. ..-.+++..+|+.++|.+|..+|+||+|++.||||....
T Consensus 269 ~~~~i~~~~~rk~w~~Fi~~~n~hl~~peaiDlldklLrYDHqeRlTakEam~HpyF~~~~ 329 (338)
T KOG0668|consen 269 QFEDILGRHSRKPWSRFINSENQHLVSPEAIDLLDKLLRYDHQERLTAKEAMAHPYFAPVR 329 (338)
T ss_pred hHhhHhhccccccHHHhCCccccccCChHHHHHHHHHHhhccccccchHHHhcCchHHHHH
Confidence 2233221 122111111 112367889999999999999999999999999998754
|
|
| >cd05044 PTKc_c-ros Catalytic domain of the Protein Tyrosine Kinase, C-ros | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.6e-33 Score=224.44 Aligned_cols=238 Identities=23% Similarity=0.299 Sum_probs=171.0
Q ss_pred eeecccCceEEEEEEEcCCC------cEEEEEEeccCCCChHHHHHHHHHHHHHHhCCCCCcchhhhhhhcCCeEEEEEe
Q psy758 8 GKLGEGSYGVVFKCRNRDTG------QVVAIKKFLESEEDPLIRKIALREIRLLKSLKHPNLVNLLEVFRRKKKLHLVFE 81 (292)
Q Consensus 8 ~~l~~g~~~~v~~~~~~~~~------~~v~iK~~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~iv~e 81 (292)
+.||+|++|.||+|...... +.+++|.+..... ......+.+|+.+++.++||||+++++++.+.+..++++|
T Consensus 1 ~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~iK~~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e 79 (269)
T cd05044 1 NFLGSGAFGEVYEGTATDILGPGSGPIRVAVKTLRKGAT-DQEKKEFLKEAHLMSNFNHPNIVKLLGVCLLNEPQYIIME 79 (269)
T ss_pred CccccccceeEEeeeecccccCcccceeehhhhhhcccc-hhhHHHHHHHHHHHHhcCCCCeeeEeeeecCCCCeEEEEe
Confidence 46899999999999876433 6799998765432 2335567889999999999999999999999999999999
Q ss_pred cCCCccHHHHhcC-------CCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEEccCC-----cEEEeecCchh
Q psy758 82 FCDHTVLNELENH-------PHGLPWDLIKQITWQVLRGVSYCHRHACIHRDIKPENILLTANG-----VVKLCDFGFAR 149 (292)
Q Consensus 82 ~~~~~~L~~~~~~-------~~~~~~~~~~~i~~qi~~aL~~LH~~givH~dl~p~Nilv~~~~-----~~kl~dfg~~~ 149 (292)
|+++++|.+++.. ...+++..+..++.|++.||.|||++|++|+||+|+||++++++ .++|+|||++.
T Consensus 80 ~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~i~H~dl~p~nil~~~~~~~~~~~~~l~dfg~~~ 159 (269)
T cd05044 80 LMEGGDLLSYLRDARVERFGPPLLTLKELLDICLDVAKGCVYLEQMHFIHRDLAARNCLVSEKGYDADRVVKIGDFGLAR 159 (269)
T ss_pred ccCCCcHHHHHHHhhhcccCCccccHHHHHHHHHHHHHHHHHHHhCCcccCCCChheEEEecCCCCCCcceEECCccccc
Confidence 9999999988753 23478899999999999999999999999999999999999887 89999999986
Q ss_pred hhhcccc-------ccccccccccccccCCCCCCCcccceeeecCCCCCCchHHHHHHHhhc-ccCCCCCCChhhhhhcc
Q psy758 150 LIRDLIP-------RHLHIFQTNEYFKGVSLPHAENVVPLEIKIGKPAATNIYLIDFLKRCL-DKDPLRRWSCDQLLRHP 221 (292)
Q Consensus 150 ~~~~~~~-------~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~p~~~~~~~~~~~~~ 221 (292)
....... .....|.+||+..+.......++|+ .+.-+++.+. +..|....+..+.....
T Consensus 160 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~s-------------lG~il~ellt~g~~p~~~~~~~~~~~~~ 226 (269)
T cd05044 160 DIYKSDYYRKEGEGLLPVRWMAPESLLDGKFTTQSDVWS-------------FGVLMWEILTLGQQPYPALNNQEVLQHV 226 (269)
T ss_pred ccccccccccCcccCCCccccCHHHHccCCcccchhHHH-------------HHHHHHHHHHcCCCCCcccCHHHHHHHH
Confidence 5432111 1123355666554433322222222 2222333332 34444333333332221
Q ss_pred CcC-CCCCCCCCccchHHHHhcccCcCCCCCCChhhhhh
Q psy758 222 YFN-GYYFEVPDEMQYEEITQRCLDKDPLRRWSCDQLLR 259 (292)
Q Consensus 222 ~~~-~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~~il~ 259 (292)
... ....+...+..+.++|.+||+.+|.+|||++++++
T Consensus 227 ~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~ 265 (269)
T cd05044 227 TAGGRLQKPENCPDKIYQLMTNCWAQDPSERPTFDRIQE 265 (269)
T ss_pred hcCCccCCcccchHHHHHHHHHHcCCCcccCCCHHHHHH
Confidence 110 11223345778999999999999999999999976
|
Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male |
| >KOG4250|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-34 Score=242.10 Aligned_cols=246 Identities=26% Similarity=0.358 Sum_probs=183.9
Q ss_pred ceeeeecccCceEEEEEEEcCCCcEEEEEEeccCCCChHHHHHHHHHHHHHHhCCCCCcchhhhhhhcCC------eEEE
Q psy758 5 EKIGKLGEGSYGVVFKCRNRDTGQVVAIKKFLESEEDPLIRKIALREIRLLKSLKHPNLVNLLEVFRRKK------KLHL 78 (292)
Q Consensus 5 ~~~~~l~~g~~~~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~------~~~i 78 (292)
...+.||.|+||.||+++++.+|+.||+|.+.... .....+...+|++++++|+|||||+++++-++.. ...+
T Consensus 16 ~~~e~LG~Ga~g~V~rgrnketG~~vAvK~~~~~~-~~r~~e~~~~EieilkKLnh~NIVk~f~iee~~~~~~~~~~~vl 94 (732)
T KOG4250|consen 16 EMDERLGKGAFGNVYRGRNKETGRLVAVKTFNKES-SLRPRERWCREIEILKKLNHPNIVKLFDIEETKFLGLVTRLPVL 94 (732)
T ss_pred eehhhhcCCccceeeeecccccccchhHHhhhhhc-ccchHHHHHHHHHHHHHcCchhhhhhcccCCccccCcccccceE
Confidence 44678999999999999999999999999997654 3345677889999999999999999999865433 4789
Q ss_pred EEecCCCccHHHHhcCC---CCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEEccC--C--cEEEeecCchhhh
Q psy758 79 VFEFCDHTVLNELENHP---HGLPWDLIKQITWQVLRGVSYCHRHACIHRDIKPENILLTAN--G--VVKLCDFGFARLI 151 (292)
Q Consensus 79 v~e~~~~~~L~~~~~~~---~~~~~~~~~~i~~qi~~aL~~LH~~givH~dl~p~Nilv~~~--~--~~kl~dfg~~~~~ 151 (292)
+||||.||+|...++.+ ..+++.....++.+++.||.|||++||+||||||.||++... | ..||+|||.++.+
T Consensus 95 vmEyC~gGsL~~~L~~PEN~~GLpE~e~l~lL~d~~~al~~LrEn~IvHRDlKP~NIvl~~Gedgq~IyKLtDfG~Arel 174 (732)
T KOG4250|consen 95 VMEYCSGGSLRKVLNSPENAYGLPESEFLDLLSDLVSALRHLRENGIVHRDLKPGNIVLQIGEDGQSIYKLTDFGAAREL 174 (732)
T ss_pred EEeecCCCcHHHHhcCcccccCCCHHHHHHHHHHHHHHHHHHHHcCceeccCCCCcEEEeecCCCceEEeeecccccccC
Confidence 99999999999999764 359999999999999999999999999999999999998643 3 5899999999988
Q ss_pred hccccccccccccccccccC-----------CCCCCCcccceeeecCCCCCCchHHH----HHHHhhcccCCCCCC-Chh
Q psy758 152 RDLIPRHLHIFQTNEYFKGV-----------SLPHAENVVPLEIKIGKPAATNIYLI----DFLKRCLDKDPLRRW-SCD 215 (292)
Q Consensus 152 ~~~~~~~~~~~~~~~~~~~~-----------~~~~~~~~~~~~~~~~~~~~~~~~~~----~~~~~~~~~~p~~~~-~~~ 215 (292)
.+.. .....+++++|+.|. .+.|+.|+..|++.+|..|+.+...- .+.-....++|..-. ...
T Consensus 175 ~d~s-~~~S~vGT~~YLhPel~E~q~~y~~tVDLWS~GvtlY~caTG~lPF~p~~~pk~~~~~~~~~~tkkp~~v~i~~~ 253 (732)
T KOG4250|consen 175 DDNS-LFTSLVGTEEYLHPELYERQKKYTATVDLWSFGVTLYECATGELPFIPFGGPKNNKEIMWHIITKKPSGVAIGAQ 253 (732)
T ss_pred CCCC-eeeeecCchhhcChHHHhhccCcCceeehhhhhhHHHHHhccCCCCCcCCCccccchhhhhhhccCCCceeEeee
Confidence 6544 444566777666553 33588999999999999887644322 233333333332221 111
Q ss_pred hhhhc--cCcCCCCCCCCCcc----chHHHHhcccCcCCCCCC
Q psy758 216 QLLRH--PYFNGYYFEVPDEM----QYEEITQRCLDKDPLRRW 252 (292)
Q Consensus 216 ~~~~~--~~~~~~~~~~~~~~----~l~~li~~~l~~dP~~Rp 252 (292)
+..+. .|....+.+...+. .+...+..+|..||.+|.
T Consensus 254 ~~eNgpv~~s~~lP~p~~Ls~~l~~~~~kwLa~~L~~~~~~~~ 296 (732)
T KOG4250|consen 254 EEENGPVEWSSTLPQPNHLSRGLATRLTKWLASMLEWNPRKRG 296 (732)
T ss_pred cccCCceeeeccCCCcccccHHHHhhhhHHHHHHHhhhHHHhC
Confidence 11111 22223333333332 345788899999999998
|
|
| >cd05087 PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases 1 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-32 Score=219.13 Aligned_cols=244 Identities=22% Similarity=0.217 Sum_probs=168.8
Q ss_pred eeecccCceEEEEEEEc--CCCcEEEEEEeccCCCChHHHHHHHHHHHHHHhCCCCCcchhhhhhhcCCeEEEEEecCCC
Q psy758 8 GKLGEGSYGVVFKCRNR--DTGQVVAIKKFLESEEDPLIRKIALREIRLLKSLKHPNLVNLLEVFRRKKKLHLVFEFCDH 85 (292)
Q Consensus 8 ~~l~~g~~~~v~~~~~~--~~~~~v~iK~~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~iv~e~~~~ 85 (292)
+.||+|+||.||+|... .++..+++|.+...... .....+.+|+.+++.++||||+++++.+.+....++||||+++
T Consensus 1 ~~lg~G~~g~Vy~~~~~~~~~~~~~~~k~~~~~~~~-~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~ 79 (269)
T cd05087 1 KEIGNGWFGKVILGEVNSGYTPAQVVVKELRVSASV-QEQMKFLEEAQPYRSLQHSNLLQCLGQCTEVTPYLLVMEFCPL 79 (269)
T ss_pred CcccccCCceEEEEEEcCCCCceEEEEEecCCCCCh-HHHHHHHHHHHHHHhCCCCCEeeEEEEEcCCCCcEEEEECCCC
Confidence 46899999999999764 34567999988655433 3345678899999999999999999999988899999999999
Q ss_pred ccHHHHhcCC-----CCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEEccCCcEEEeecCchhhhhcccc----
Q psy758 86 TVLNELENHP-----HGLPWDLIKQITWQVLRGVSYCHRHACIHRDIKPENILLTANGVVKLCDFGFARLIRDLIP---- 156 (292)
Q Consensus 86 ~~L~~~~~~~-----~~~~~~~~~~i~~qi~~aL~~LH~~givH~dl~p~Nilv~~~~~~kl~dfg~~~~~~~~~~---- 156 (292)
++|.+++... ...+...+..++.|++.||.|||++|++|+||||+||+++.++.++|+|||.+........
T Consensus 80 g~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~i~H~dlkp~nil~~~~~~~kL~dfg~~~~~~~~~~~~~~ 159 (269)
T cd05087 80 GDLKGYLRSCRKAELMTPDPTTLQRMACEIALGLLHLHKNNFIHSDLALRNCLLTADLTVKIGDYGLSHNKYKEDYYVTP 159 (269)
T ss_pred CcHHHHHHHhhhcccccccHHHHHHHHHHHHHHHHHHHHCCEeccccCcceEEEcCCCcEEECCccccccccCcceeecC
Confidence 9999988542 2356778889999999999999999999999999999999999999999999864332111
Q ss_pred ---ccccccccccccccCCCCCCCcccceeeecCCCCCCchHHHHHHHhh-cccCCCCCCChhhhhhccCcC------CC
Q psy758 157 ---RHLHIFQTNEYFKGVSLPHAENVVPLEIKIGKPAATNIYLIDFLKRC-LDKDPLRRWSCDQLLRHPYFN------GY 226 (292)
Q Consensus 157 ---~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~p~~~~~~~~~~~~~~~~------~~ 226 (292)
.....|.+||...+.... ......+...+.++.+..+++.+ .+..|+......+........ ..
T Consensus 160 ~~~~~~~~y~aPE~~~~~~~~------~~~~~~~~~~DiwslG~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~ 233 (269)
T cd05087 160 DQLWVPLRWIAPELVDEVHGN------LLVVDQTKESNVWSLGVTIWELFELGSQPYRHLSDEQVLTYTVREQQLKLPKP 233 (269)
T ss_pred CCcCCcccccCHhHhcccccc------ccccCCCccchhHHHHHHHHHHHhCCCCCCCCCChHHHHHHHhhcccCCCCCC
Confidence 111234555544221000 00001122233334444444444 255555444444333221111 11
Q ss_pred CCCCCCccchHHHHhcccCcCCCCCCChhhhhh
Q psy758 227 YFEVPDEMQYEEITQRCLDKDPLRRWSCDQLLR 259 (292)
Q Consensus 227 ~~~~~~~~~l~~li~~~l~~dP~~Rpt~~~il~ 259 (292)
......+..+.+++.+|+ .||++|||+++|+.
T Consensus 234 ~~~~~~~~~~~~l~~~c~-~~P~~Rpt~~~l~~ 265 (269)
T cd05087 234 RLKLPLSDRWYEVMQFCW-LQPEQRPSAEEVHL 265 (269)
T ss_pred ccCCCCChHHHHHHHHHh-cCcccCCCHHHHHH
Confidence 112234667889999998 68999999999985
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 1 (Aatyk1) and Aatyk3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk1 and Aatyk3 are members of the Aatyk subfamily of proteins. Aatyk3 is a receptor kinase containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 has a similar domain arrangement but without the transmembrane segment and is thus, a cytoplasmic (or nonreceptor) kinase. The expression of Aatyk1 (also referred simply as Aatyk) is upregulated during growth arrest and apoptosis in myeloid cells |
| >KOG1026|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.5e-34 Score=245.23 Aligned_cols=243 Identities=26% Similarity=0.345 Sum_probs=186.6
Q ss_pred cceeeeecccCceEEEEEEEcC-----CCcEEEEEEeccCCCChHHHHHHHHHHHHHHhCCCCCcchhhhhhhcCCeEEE
Q psy758 4 YEKIGKLGEGSYGVVFKCRNRD-----TGQVVAIKKFLESEEDPLIRKIALREIRLLKSLKHPNLVNLLEVFRRKKKLHL 78 (292)
Q Consensus 4 y~~~~~l~~g~~~~v~~~~~~~-----~~~~v~iK~~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~i 78 (292)
-.+.+.||+|+||.||+|+... ....||||.++.... ......|++|++++..|+|||||+++|++.+++..|+
T Consensus 488 i~~~~eLGegaFGkVf~a~~~~l~p~~~~~lVAVK~LKd~a~-~~~~~dF~REaeLla~l~H~nIVrLlGVC~~~~P~~M 566 (774)
T KOG1026|consen 488 IVFKEELGEGAFGKVFLAEAYGLLPGQDEQLVAVKALKDKAE-NQARQDFRREAELLAELQHPNIVRLLGVCREGDPLCM 566 (774)
T ss_pred eeehhhhcCchhhhhhhhhccCCCCCccceehhHhhhccccc-HHHHHHHHHHHHHHHhccCCCeEEEEEEEccCCeeEE
Confidence 3567889999999999998654 334799999865443 3357789999999999999999999999999999999
Q ss_pred EEecCCCccHHHHhcCCC--------------CCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEEccCCcEEEee
Q psy758 79 VFEFCDHTVLNELENHPH--------------GLPWDLIKQITWQVLRGVSYCHRHACIHRDIKPENILLTANGVVKLCD 144 (292)
Q Consensus 79 v~e~~~~~~L~~~~~~~~--------------~~~~~~~~~i~~qi~~aL~~LH~~givH~dl~p~Nilv~~~~~~kl~d 144 (292)
|+||+..|+|.+++.... .++..+...|+.|||.|+.||-++.+||+||..+|+||.++..+||+|
T Consensus 567 vFEYm~~GDL~eFLra~sP~a~~~~~g~~~~~~L~~~q~L~iA~QIAaGM~YLs~~~FVHRDLATRNCLVge~l~VKIsD 646 (774)
T KOG1026|consen 567 VFEYMDHGDLHEFLRARSPKADKLASGQDTPPPLSTSQFLHIATQIAAGMEYLSSHHFVHRDLATRNCLVGENLVVKISD 646 (774)
T ss_pred EEEecccccHHHHHHhhCCccccccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCcccccchhhhhceeccceEEEecc
Confidence 999999999999985422 288899999999999999999999999999999999999999999999
Q ss_pred cCchhhhhccc--cccccccccccccccC-----CCCCCCcccceeeecCCCCCCchHHHHHHHhhcccCCCCCCChhhh
Q psy758 145 FGFARLIRDLI--PRHLHIFQTNEYFKGV-----SLPHAENVVPLEIKIGKPAATNIYLIDFLKRCLDKDPLRRWSCDQL 217 (292)
Q Consensus 145 fg~~~~~~~~~--~~~~~~~~~~~~~~~~-----~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~ 217 (292)
||+++..-+.. ......+.+-.|+.++ .+.-..|+|++++...+.+. .+..|....+.+++
T Consensus 647 fGLsRdiYssDYYk~~~~t~lPIRWMppEsIly~kFTteSDVWs~GVvLWEIFs------------yG~QPy~glSn~EV 714 (774)
T KOG1026|consen 647 FGLSRDIYSSDYYKVRGNTLLPIRWMPPESILYGKFTTESDVWSFGVVLWEIFS------------YGKQPYYGLSNQEV 714 (774)
T ss_pred cccchhhhhhhhhcccCCceeeeecCCHHHhhcCcccchhhhhhhhhhhhhhhc------------cccCcccccchHHH
Confidence 99998653211 1111222333333333 33344555555554444331 24567777888887
Q ss_pred hhccCcCC-CCCCCCCccchHHHHhcccCcCCCCCCChhhhhh
Q psy758 218 LRHPYFNG-YYFEVPDEMQYEEITQRCLDKDPLRRWSCDQLLR 259 (292)
Q Consensus 218 ~~~~~~~~-~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~~il~ 259 (292)
+.-.--.. ...+..-|.++.+|+..||+.+|++||++.||-.
T Consensus 715 Ie~i~~g~lL~~Pe~CP~~vY~LM~~CW~~~P~~RPsF~eI~~ 757 (774)
T KOG1026|consen 715 IECIRAGQLLSCPENCPTEVYSLMLECWNENPKRRPSFKEIHS 757 (774)
T ss_pred HHHHHcCCcccCCCCCCHHHHHHHHHHhhcCcccCCCHHHHHH
Confidence 76432222 2344555889999999999999999999999854
|
|
| >smart00220 S_TKc Serine/Threonine protein kinases, catalytic domain | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-32 Score=216.79 Aligned_cols=236 Identities=34% Similarity=0.483 Sum_probs=175.7
Q ss_pred CceEEEEEEEcCCCcEEEEEEeccCCCChHHHHHHHHHHHHHHhCCCCCcchhhhhhhcCCeEEEEEecCCCccHHHHhc
Q psy758 14 SYGVVFKCRNRDTGQVVAIKKFLESEEDPLIRKIALREIRLLKSLKHPNLVNLLEVFRRKKKLHLVFEFCDHTVLNELEN 93 (292)
Q Consensus 14 ~~~~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~iv~e~~~~~~L~~~~~ 93 (292)
++|.||+|....+++.+++|++........ .+.+.+|+..++.++|++++++++.+......++++|++++++|..++.
T Consensus 1 ~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~-~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~l~~e~~~~~~L~~~~~ 79 (244)
T smart00220 1 SFGKVYLARDKKTGKLVAIKVIKKEKIKKK-RERILREISILKKLKHPNIVRLYDVFEDEDKLYLVMEYCDGGDLFDLLK 79 (244)
T ss_pred CceEEEEEEECCCCcEEEEEEecccccccH-HHHHHHHHHHHHhCCCCcHHHHHhheeeCCEEEEEEeCCCCCCHHHHHH
Confidence 579999999998899999999876554322 5778899999999999999999999998899999999999999999987
Q ss_pred CCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEEccCCcEEEeecCchhhhhccc----cccccccccccccc
Q psy758 94 HPHGLPWDLIKQITWQVLRGVSYCHRHACIHRDIKPENILLTANGVVKLCDFGFARLIRDLI----PRHLHIFQTNEYFK 169 (292)
Q Consensus 94 ~~~~~~~~~~~~i~~qi~~aL~~LH~~givH~dl~p~Nilv~~~~~~kl~dfg~~~~~~~~~----~~~~~~~~~~~~~~ 169 (292)
....++...++.++.+++.++.+||+.|++|+||+|+||++++++.++|+|||.+....... ......|.+||...
T Consensus 80 ~~~~~~~~~~~~~~~~l~~~l~~lh~~~i~h~~i~~~ni~~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~pE~~~ 159 (244)
T smart00220 80 KRGRLSEDEARFYARQILSALEYLHSNGIIHRDLKPENILLDEDGHVKLADFGLARQLDPGGLLTTFVGTPEYMAPEVLL 159 (244)
T ss_pred hccCCCHHHHHHHHHHHHHHHHHHHHcCeecCCcCHHHeEECCCCcEEEccccceeeeccccccccccCCcCCCCHHHHc
Confidence 76668999999999999999999999999999999999999999999999999987765421 11223345555444
Q ss_pred cCCCCCCCcccceeeecCCCCCCchHHHHHHHhhcccCCCCC-CChhhhhhccCcCCCCCCCC---CccchHHHHhcccC
Q psy758 170 GVSLPHAENVVPLEIKIGKPAATNIYLIDFLKRCLDKDPLRR-WSCDQLLRHPYFNGYYFEVP---DEMQYEEITQRCLD 245 (292)
Q Consensus 170 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~p~~~-~~~~~~~~~~~~~~~~~~~~---~~~~l~~li~~~l~ 245 (292)
+.......+++.+ +..++..+.+..|... .....+.....-........ .+..+.+++.+||.
T Consensus 160 ~~~~~~~~Di~sl-------------G~~l~~l~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~ 226 (244)
T smart00220 160 GKGYGKAVDVWSL-------------GVILYELLTGKPPFPGDDQLLELFKKIGKPKPPFPPPEWKISPEAKDLIRKLLV 226 (244)
T ss_pred cCCCCchhhHHHH-------------HHHHHHHHhCCCCCCCCCcHHHHHHHHhccCCCCccccccCCHHHHHHHHHHcc
Confidence 3222222333322 2223333334444433 22222222111111111111 56789999999999
Q ss_pred cCCCCCCChhhhhhCCcc
Q psy758 246 KDPLRRWSCDQLLRHPYF 263 (292)
Q Consensus 246 ~dP~~Rpt~~~il~h~w~ 263 (292)
.||++||++.++++||||
T Consensus 227 ~~p~~Rp~~~~~~~~~~~ 244 (244)
T smart00220 227 KDPEKRLTAEEALQHPFF 244 (244)
T ss_pred CCchhccCHHHHhhCCCC
Confidence 999999999999999997
|
Phosphotransferases. Serine or threonine-specific kinase subfamily. |
| >KOG0670|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-32 Score=225.14 Aligned_cols=260 Identities=25% Similarity=0.398 Sum_probs=195.9
Q ss_pred cccceeeeecccCceEEEEEEEcCCCcEEEEEEeccCCCChHHHHHHHHHHHHHHhCCC------CCcchhhhhhhcCCe
Q psy758 2 ERYEKIGKLGEGSYGVVFKCRNRDTGQVVAIKKFLESEEDPLIRKIALREIRLLKSLKH------PNLVNLLEVFRRKKK 75 (292)
Q Consensus 2 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~e~~~~~~l~~------~~i~~~~~~~~~~~~ 75 (292)
++|.+....|.|-||+|.+|.+..-|..||||+|.+.+. ..+.=..|+++|+.|+. -|.++++..|.+.++
T Consensus 432 ~RY~V~~~~GkGvFs~Vvra~D~~r~~~vAiKIIRnNE~---M~KtGl~EleiLkKL~~AD~Edk~Hclrl~r~F~hknH 508 (752)
T KOG0670|consen 432 SRYEVQGYTGKGVFSTVVRARDQARGQEVAIKIIRNNEV---MHKTGLKELEILKKLNDADPEDKFHCLRLFRHFKHKNH 508 (752)
T ss_pred ceeEEEeccccceeeeeeeccccCCCCeeEEEEeecchH---HhhhhhHHHHHHHHhhccCchhhhHHHHHHHHhhhcce
Confidence 589999999999999999999999999999999976542 23444679999999963 389999999999999
Q ss_pred EEEEEecCCCccHHHHhcCCC---CCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEEccC-CcEEEeecCchhhh
Q psy758 76 LHLVFEFCDHTVLNELENHPH---GLPWDLIKQITWQVLRGVSYCHRHACIHRDIKPENILLTAN-GVVKLCDFGFARLI 151 (292)
Q Consensus 76 ~~iv~e~~~~~~L~~~~~~~~---~~~~~~~~~i~~qi~~aL~~LH~~givH~dl~p~Nilv~~~-~~~kl~dfg~~~~~ 151 (292)
+|+|+|.+..+ |.+.++..+ .+....+..++.|++.||..|-+.|++|.||||+||||... +.+||||||.+...
T Consensus 509 LClVFE~LslN-LRevLKKyG~nvGL~ikaVRsYaqQLflALklLK~c~vlHaDIKPDNiLVNE~k~iLKLCDfGSA~~~ 587 (752)
T KOG0670|consen 509 LCLVFEPLSLN-LREVLKKYGRNVGLHIKAVRSYAQQLFLALKLLKKCGVLHADIKPDNILVNESKNILKLCDFGSASFA 587 (752)
T ss_pred eEEEehhhhch-HHHHHHHhCcccceeehHHHHHHHHHHHHHHHHHhcCeeecccCccceEeccCcceeeeccCcccccc
Confidence 99999998764 566665433 47889999999999999999999999999999999999866 57999999999877
Q ss_pred hccc---cccccccccccccccCCC-----CCCCcccceeeecCCCCCCchH---HHHHHHhhcccCCCCCCChhhhhhc
Q psy758 152 RDLI---PRHLHIFQTNEYFKGVSL-----PHAENVVPLEIKIGKPAATNIY---LIDFLKRCLDKDPLRRWSCDQLLRH 220 (292)
Q Consensus 152 ~~~~---~~~~~~~~~~~~~~~~~~-----~~~~~~~~~~~~~~~~~~~~~~---~~~~~~~~~~~~p~~~~~~~~~~~~ 220 (292)
++.. ...+.+|.+||...|..+ .|+.++..|++.+|...+-+.. +..+...+-+.-|..-.--.+....
T Consensus 588 ~eneitPYLVSRFYRaPEIiLG~~yd~~iD~WSvgctLYElYtGkIlFpG~TNN~MLrl~me~KGk~p~KmlRKgqF~dq 667 (752)
T KOG0670|consen 588 SENEITPYLVSRFYRAPEIILGLPYDYPIDTWSVGCTLYELYTGKILFPGRTNNQMLRLFMELKGKFPNKMLRKGQFKDQ 667 (752)
T ss_pred ccccccHHHHHHhccCcceeecCcccCCccceeeceeeEEeeccceecCCCCcHHHHHHHHHhcCCCcHHHhhhcchhhh
Confidence 6432 233467999999998765 5777777788888887665443 4444444444444322111111111
Q ss_pred cCcCC------------------------------------CCCCCCC---ccchHHHHhcccCcCCCCCCChhhhhhCC
Q psy758 221 PYFNG------------------------------------YYFEVPD---EMQYEEITQRCLDKDPLRRWSCDQLLRHP 261 (292)
Q Consensus 221 ~~~~~------------------------------------~~~~~~~---~~~l~~li~~~l~~dP~~Rpt~~~il~h~ 261 (292)
-|-.. .+.+... -.++++|+.+||..||++|.|..++|.||
T Consensus 668 HFD~d~nf~~~e~D~vT~r~~~~vm~~vkPtkdl~s~l~~~q~~~deq~~~~~~~rdLLdkml~LdP~KRit~nqAL~Hp 747 (752)
T KOG0670|consen 668 HFDQDLNFLYIEVDKVTEREKRTVMVNVKPTKDLGSELIAVQRLPDEQPKIVQQLRDLLDKMLILDPEKRITVNQALKHP 747 (752)
T ss_pred hcccccceEEEeccccccceeEEEecccCcchhHHHHHhccCCCCchhHHHHHHHHHHHHHHhccChhhcCCHHHHhcCC
Confidence 11000 0111111 23478999999999999999999999999
Q ss_pred cccc
Q psy758 262 YFNG 265 (292)
Q Consensus 262 w~~~ 265 (292)
||+.
T Consensus 748 Fi~~ 751 (752)
T KOG0670|consen 748 FITE 751 (752)
T ss_pred cccC
Confidence 9974
|
|
| >cd05086 PTKc_Aatyk2 Catalytic domain of the Protein Tyrosine Kinase, Apoptosis-associated tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-31 Score=216.86 Aligned_cols=244 Identities=19% Similarity=0.269 Sum_probs=163.7
Q ss_pred eeecccCceEEEEEEEcCC--CcEEEEEEeccCCCChHHHHHHHHHHHHHHhCCCCCcchhhhhhhcCCeEEEEEecCCC
Q psy758 8 GKLGEGSYGVVFKCRNRDT--GQVVAIKKFLESEEDPLIRKIALREIRLLKSLKHPNLVNLLEVFRRKKKLHLVFEFCDH 85 (292)
Q Consensus 8 ~~l~~g~~~~v~~~~~~~~--~~~v~iK~~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~iv~e~~~~ 85 (292)
+.||+|+||.||++..... ...+++|.+..... ....+.+.+|+..++.++||||+++++.+.+....|+||||+++
T Consensus 1 ~~lg~G~~g~v~~~~~~~~~~~~~~~~k~~~~~~~-~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~ 79 (268)
T cd05086 1 QEIGNGWFGKVLLSEIYTDTGVARVVVKELKANAS-SKEQNEFLQQGDPYRILQHPNILQCLGQCVEAIPYLLVFEYCEL 79 (268)
T ss_pred CcCCCCcCceEEEEEEEcCCCcceEEEEEecCCCC-hHHHHHHHHHHHHHhccCCcchhheEEEecCCCccEEEEecCCC
Confidence 3699999999999975433 23566776654332 33456788999999999999999999999999999999999999
Q ss_pred ccHHHHhcCC----CCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEEccCCcEEEeecCchhhhhcc-------
Q psy758 86 TVLNELENHP----HGLPWDLIKQITWQVLRGVSYCHRHACIHRDIKPENILLTANGVVKLCDFGFARLIRDL------- 154 (292)
Q Consensus 86 ~~L~~~~~~~----~~~~~~~~~~i~~qi~~aL~~LH~~givH~dl~p~Nilv~~~~~~kl~dfg~~~~~~~~------- 154 (292)
++|..++... ...++..++.++.||+.||+|||++|++|+||||+||+++.++.++|+|||++......
T Consensus 80 ~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~~i~H~dikp~nil~~~~~~~~l~Dfg~~~~~~~~~~~~~~~ 159 (268)
T cd05086 80 GDLKSYLSQEQWHRRNSQLLLLQRMACEIAAGVTHMHKHNFLHSDLALRNCFLTSDLTVKVGDYGIGPSRYKEDYIETED 159 (268)
T ss_pred CcHHHHHHhhhcccccccHHHHHHHHHHHHHHHHHHHHCCeeccCCccceEEEcCCccEEecccccccccCcchhhhccc
Confidence 9999988643 24677788899999999999999999999999999999999999999999987532111
Q ss_pred ccccccccccccccccCCCCCCCcccceeeecCCCCCCchHHHHHHHhhc-ccCCCCCCChhhhhhccCcC------CCC
Q psy758 155 IPRHLHIFQTNEYFKGVSLPHAENVVPLEIKIGKPAATNIYLIDFLKRCL-DKDPLRRWSCDQLLRHPYFN------GYY 227 (292)
Q Consensus 155 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~p~~~~~~~~~~~~~~~~------~~~ 227 (292)
.......|.+||+...... +. .........+.++.+..+++.+. ...|....+..+.+...... ...
T Consensus 160 ~~~~~~~y~aPE~~~~~~~----~~--~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 233 (268)
T cd05086 160 DKCVPLRWLAPELVGEFHG----GL--ITAEQTKPSNVWALGVTLWELFENAAQPYSHLSDREVLNHVIKDQQVKLFKPQ 233 (268)
T ss_pred CCcCcccccCchhcccccC----cc--ccCCCCCcchhHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHhhcccccCCCc
Confidence 1112233555655421100 00 00000111222333333333322 22343333333322221111 011
Q ss_pred CCCCCccchHHHHhcccCcCCCCCCChhhhhh
Q psy758 228 FEVPDEMQYEEITQRCLDKDPLRRWSCDQLLR 259 (292)
Q Consensus 228 ~~~~~~~~l~~li~~~l~~dP~~Rpt~~~il~ 259 (292)
.....+..+.+++..|| .+|.+|||+++|++
T Consensus 234 ~~~~~~~~~~~l~~~c~-~~P~~Rp~~~~i~~ 264 (268)
T cd05086 234 LELPYSERWYEVLQFCW-LSPEKRATAEEVHR 264 (268)
T ss_pred cCCCCcHHHHHHHHHHh-hCcccCCCHHHHHH
Confidence 22334677889999999 68999999999976
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 2 (Aatyk2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk2 is a member of the Aatyk subfamily of proteins, which are receptor kinases containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk2 is also called lemur tyrosine kinase 2 (Lmtk2) or brain-enriched kinase (Brek). It is expressed at high levels in early postnatal brain, and has been shown to play a role in nerve growth factor (NGF) signaling. Studies with knockout mice reveal that Aatyk2 is essential for late stage |
| >KOG0587|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.3e-32 Score=232.44 Aligned_cols=247 Identities=29% Similarity=0.435 Sum_probs=198.8
Q ss_pred cccceeeeecccCceEEEEEEEcCCCcEEEEEEeccCCCChHHHHHHHHHHHHHHhCC-CCCcchhhhhhh-----cCCe
Q psy758 2 ERYEKIGKLGEGSYGVVFKCRNRDTGQVVAIKKFLESEEDPLIRKIALREIRLLKSLK-HPNLVNLLEVFR-----RKKK 75 (292)
Q Consensus 2 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~e~~~~~~l~-~~~i~~~~~~~~-----~~~~ 75 (292)
+.|++.+.||.|.+|.||+++...+++..|+|+.....+.++ .+.-|.++++.+. |||++.++++|. .++.
T Consensus 19 d~~ei~evig~Gtygkv~k~k~~~~~~~aa~kI~~~~~d~de---EiE~eynil~~~~~hpnv~~fyg~~~k~~~~~~Dq 95 (953)
T KOG0587|consen 19 DIFEIIEVIGNGTYGKVYKGRHVKTGQLAAIKIMDPTEDEEE---EIELEYNMLKKYSHHPNVATFYGAFIKKDPGNGDQ 95 (953)
T ss_pred CccEEEEEEeeccceeEEEEeeeecCceeeeEeecCCccccH---HHHHHHHHHHhccCCCCcceEEEEEEEecCCCCCe
Confidence 457899999999999999999999999999999876654443 3445888888885 999999999985 3568
Q ss_pred EEEEEecCCCccHHHHhcC--CCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEEccCCcEEEeecCchhhhhc
Q psy758 76 LHLVFEFCDHTVLNELENH--PHGLPWDLIKQITWQVLRGVSYCHRHACIHRDIKPENILLTANGVVKLCDFGFARLIRD 153 (292)
Q Consensus 76 ~~iv~e~~~~~~L~~~~~~--~~~~~~~~~~~i~~qi~~aL~~LH~~givH~dl~p~Nilv~~~~~~kl~dfg~~~~~~~ 153 (292)
+|+|||||+||+..++++. ..++.|..+..|+..++.||.|||++.++|+|||-.|||++.++.+||+|||.+..+..
T Consensus 96 LWLVMEfC~gGSVTDLVKn~~g~rl~E~~IaYI~re~lrgl~HLH~nkviHRDikG~NiLLT~e~~VKLvDFGvSaQlds 175 (953)
T KOG0587|consen 96 LWLVMEFCGGGSVTDLVKNTKGNRLKEEWIAYILREILRGLAHLHNNKVIHRDIKGQNVLLTENAEVKLVDFGVSAQLDS 175 (953)
T ss_pred EEEEeeccCCccHHHHHhhhcccchhhHHHHHHHHHHHHHHHHHhhcceeeecccCceEEEeccCcEEEeeeeeeeeeec
Confidence 9999999999999998865 45789999999999999999999999999999999999999999999999999988877
Q ss_pred cccccccccccccccccCCC---------------CCCCcccceeeecCCCCCCchHHHHHHHhhcccCCCCCCChhhhh
Q psy758 154 LIPRHLHIFQTNEYFKGVSL---------------PHAENVVPLEIKIGKPAATNIYLIDFLKRCLDKDPLRRWSCDQLL 218 (292)
Q Consensus 154 ~~~~~~~~~~~~~~~~~~~~---------------~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~ 218 (292)
.......+.++|.|.+++.+ .|++++...++.-|.++..+....-.+-.. .+.-+++..
T Consensus 176 T~grRnT~iGtP~WMAPEViac~e~~d~tyd~R~D~WsLGITaIEladG~PPl~DmHPmraLF~I---pRNPPPkLk--- 249 (953)
T KOG0587|consen 176 TVGRRNTFIGTPYWMAPEVIACDESPDATYDYRSDLWSLGITAIEMAEGAPPLCDMHPMRALFLI---PRNPPPKLK--- 249 (953)
T ss_pred ccccccCcCCCcccccceeeecccCCCCCcccccchhhccceeehhcCCCCCccCcchhhhhccC---CCCCCcccc---
Confidence 66666667777777776544 588888888888888876655433222222 111111111
Q ss_pred hccCcCCCCCCCCCccchHHHHhcccCcCCCCCCChhhhhhCCcccce
Q psy758 219 RHPYFNGYYFEVPDEMQYEEITQRCLDKDPLRRWSCDQLLRHPYFNGY 266 (292)
Q Consensus 219 ~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~~il~h~w~~~~ 266 (292)
+ +..-+.++-++|..||..|-.+||+..++|+|||++..
T Consensus 250 r---------p~kWs~~FndFIs~cL~Kd~e~RP~~~~ll~hpFi~e~ 288 (953)
T KOG0587|consen 250 R---------PKKWSKKFNDFISTCLVKDYEQRPSTEELLKHPFITEQ 288 (953)
T ss_pred c---------hhhHHHHHHHHHHHHHhhccccCcchhhhccCCccccc
Confidence 0 11124578899999999999999999999999999943
|
|
| >KOG0576|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-33 Score=235.74 Aligned_cols=250 Identities=26% Similarity=0.421 Sum_probs=196.9
Q ss_pred cccceeeeecccCceEEEEEEEcCCCcEEEEEEeccCCCChHHHHHHHHHHHHHHhCCCCCcchhhhhhhcCCeEEEEEe
Q psy758 2 ERYEKIGKLGEGSYGVVFKCRNRDTGQVVAIKKFLESEEDPLIRKIALREIRLLKSLKHPNLVNLLEVFRRKKKLHLVFE 81 (292)
Q Consensus 2 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~iv~e 81 (292)
++|.++..+|+|++|.||+|++..+++..|+|+++....++ ...+.+|+-+++..+||||+.+++.|......+++||
T Consensus 15 ddyellqrvgsgTygdvyKaRd~~s~elaavkvVkLep~dd--~~~iqqei~~~~dc~h~nivay~gsylr~dklwicME 92 (829)
T KOG0576|consen 15 DDYELLQRVGSGTYGDVYKARDKRSGELAAVKVVKLEPGDD--FSGIQQEIGMLRDCRHPNIVAYFGSYLRRDKLWICME 92 (829)
T ss_pred cchhheeeecCCcccchhhhcccccCchhhheeeeccCCcc--ccccccceeeeecCCCcChHHHHhhhhhhcCcEEEEE
Confidence 57999999999999999999999999999999998766543 3556789999999999999999999999999999999
Q ss_pred cCCCccHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEEccCCcEEEeecCchhhhhccccccccc
Q psy758 82 FCDHTVLNELENHPHGLPWDLIKQITWQVLRGVSYCHRHACIHRDIKPENILLTANGVVKLCDFGFARLIRDLIPRHLHI 161 (292)
Q Consensus 82 ~~~~~~L~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~givH~dl~p~Nilv~~~~~~kl~dfg~~~~~~~~~~~~~~~ 161 (292)
||+||+|.+.-.-.+.+++.++...+...+++|+|||+.|-+|||||-.||++++.|.+|+.|||.+..+.........+
T Consensus 93 ycgggslQdiy~~TgplselqiayvcRetl~gl~ylhs~gk~hRdiKGanilltd~gDvklaDfgvsaqitati~Krksf 172 (829)
T KOG0576|consen 93 YCGGGSLQDIYHVTGPLSELQIAYVCRETLQGLKYLHSQGKIHRDIKGANILLTDEGDVKLADFGVSAQITATIAKRKSF 172 (829)
T ss_pred ecCCCcccceeeecccchhHHHHHHHhhhhccchhhhcCCcccccccccceeecccCceeecccCchhhhhhhhhhhhcc
Confidence 99999999998888899999999999999999999999999999999999999999999999999998887766666677
Q ss_pred cccccccccCCC-------------CCCCcccceeeecCCCCCCchHHHHHHHhhcccCCCCCCChhhhhhccCcCCCCC
Q psy758 162 FQTNEYFKGVSL-------------PHAENVVPLEIKIGKPAATNIYLIDFLKRCLDKDPLRRWSCDQLLRHPYFNGYYF 228 (292)
Q Consensus 162 ~~~~~~~~~~~~-------------~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~ 228 (292)
.++|.|..++.. .|+.++.+.++.--.++..+.....-+..+ .+.-++.++.+ .
T Consensus 173 iGtpywmapEvaaverkggynqlcdiwa~gitAiel~eLqpplfdlhpmr~l~Lm-TkS~~qpp~lk------------D 239 (829)
T KOG0576|consen 173 IGTPYWMAPEVAAVERKGGYNQLCDIWALGITAIELGELQPPLFDLHPMRALFLM-TKSGFQPPTLK------------D 239 (829)
T ss_pred cCCccccchhHHHHHhcccccccccccccccchhhhhhcCCcccccchHHHHHHh-hccCCCCCccc------------C
Confidence 788888776543 344444443332222221111111111111 11111111111 1
Q ss_pred CCCCccchHHHHhcccCcCCCCCCChhhhhhCCcccce
Q psy758 229 EVPDEMQYEEITQRCLDKDPLRRWSCDQLLRHPYFNGY 266 (292)
Q Consensus 229 ~~~~~~~l~~li~~~l~~dP~~Rpt~~~il~h~w~~~~ 266 (292)
+...++.+-+|++.+|..+|++|||++.+|.|||...-
T Consensus 240 k~kws~~fh~fvK~altknpKkRptaeklL~h~fvs~~ 277 (829)
T KOG0576|consen 240 KTKWSEFFHNFVKGALTKNPKKRPTAEKLLQHPFVSQT 277 (829)
T ss_pred CccchHHHHHHHHHHhcCCCccCCChhhheeceeeccc
Confidence 12225567899999999999999999999999999874
|
|
| >KOG4257|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.8e-33 Score=231.49 Aligned_cols=242 Identities=20% Similarity=0.316 Sum_probs=185.0
Q ss_pred cceeeeecccCceEEEEEEEcCC--Cc--EEEEEEeccCCCChHHHHHHHHHHHHHHhCCCCCcchhhhhhhcCCeEEEE
Q psy758 4 YEKIGKLGEGSYGVVFKCRNRDT--GQ--VVAIKKFLESEEDPLIRKIALREIRLLKSLKHPNLVNLLEVFRRKKKLHLV 79 (292)
Q Consensus 4 y~~~~~l~~g~~~~v~~~~~~~~--~~--~v~iK~~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~iv 79 (292)
.++.++||.|-||.||.|..... |+ .||||..+.....+. .+.|..|..+++.++||||++++|++. +...|+|
T Consensus 391 Itl~r~iG~GqFGdVy~gvYt~~~kge~iaVAvKtCK~d~t~d~-tekflqEa~iMrnfdHphIikLIGv~~-e~P~Wiv 468 (974)
T KOG4257|consen 391 ITLKRLIGEGQFGDVYKGVYTDPEKGERIAVAVKTCKTDCTPDD-TEKFLQEASIMRNFDHPHIIKLIGVCV-EQPMWIV 468 (974)
T ss_pred ccHHHhhcCCcccceeeeEecccccCcceeeeeehhccCCChhh-HHHHHHHHHHHHhCCCcchhheeeeee-ccceeEE
Confidence 34567899999999999987543 33 589999877554443 778999999999999999999999986 4568999
Q ss_pred EecCCCccHHHHhcCC-CCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEEccCCcEEEeecCchhhhhcccccc
Q psy758 80 FEFCDHTVLNELENHP-HGLPWDLIKQITWQVLRGVSYCHRHACIHRDIKPENILLTANGVVKLCDFGFARLIRDLIPRH 158 (292)
Q Consensus 80 ~e~~~~~~L~~~~~~~-~~~~~~~~~~i~~qi~~aL~~LH~~givH~dl~p~Nilv~~~~~~kl~dfg~~~~~~~~~~~~ 158 (292)
||+++-|.|..+++.+ ..++..+...++.||+.||+|||+..+|||||..+||||.+...+||+|||+++.+.....-.
T Consensus 469 mEL~~~GELr~yLq~nk~sL~l~tL~ly~~Qi~talaYLeSkrfVHRDIAaRNiLVsSp~CVKLaDFGLSR~~ed~~yYk 548 (974)
T KOG4257|consen 469 MELAPLGELREYLQQNKDSLPLRTLTLYCYQICTALAYLESKRFVHRDIAARNILVSSPQCVKLADFGLSRYLEDDAYYK 548 (974)
T ss_pred EecccchhHHHHHHhccccchHHHHHHHHHHHHHHHHHHHhhchhhhhhhhhheeecCcceeeecccchhhhccccchhh
Confidence 9999999999999765 368999999999999999999999999999999999999999999999999998776433211
Q ss_pred -ccccccccccccCCC-----CCCCcccceeeecCCCCCCchHHHHHHHhhcccCCCCCCChhhhhhccCcCC-CCCCCC
Q psy758 159 -LHIFQTNEYFKGVSL-----PHAENVVPLEIKIGKPAATNIYLIDFLKRCLDKDPLRRWSCDQLLRHPYFNG-YYFEVP 231 (292)
Q Consensus 159 -~~~~~~~~~~~~~~~-----~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~-~~~~~~ 231 (292)
+..-..-.|..++++ ..+.++|.+++ .++.+ .+++..|+......+++-+.--.. .+.|..
T Consensus 549 aS~~kLPIKWmaPESINfRrFTtASDVWMFgV----------CmWEI--l~lGvkPfqgvkNsDVI~~iEnGeRlP~P~n 616 (974)
T KOG4257|consen 549 ASRGKLPIKWMAPESINFRRFTTASDVWMFGV----------CMWEI--LSLGVKPFQGVKNSDVIGHIENGERLPCPPN 616 (974)
T ss_pred ccccccceeecCccccchhcccchhhHHHHHH----------HHHHH--HHhcCCccccccccceEEEecCCCCCCCCCC
Confidence 111122344444443 33444444422 22222 356788888887777765532221 234445
Q ss_pred CccchHHHHhcccCcCCCCCCChhhhhh
Q psy758 232 DEMQYEEITQRCLDKDPLRRWSCDQLLR 259 (292)
Q Consensus 232 ~~~~l~~li~~~l~~dP~~Rpt~~~il~ 259 (292)
-|+.+..|+.+||+++|.+||+..++..
T Consensus 617 CPp~LYslmskcWayeP~kRPrftei~~ 644 (974)
T KOG4257|consen 617 CPPALYSLMSKCWAYEPSKRPRFTEIKA 644 (974)
T ss_pred CChHHHHHHHHHhccCcccCCcHHHHHH
Confidence 5889999999999999999999888765
|
|
| >KOG1290|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-32 Score=219.98 Aligned_cols=130 Identities=35% Similarity=0.590 Sum_probs=112.9
Q ss_pred cccceeeeecccCceEEEEEEEcCCCcEEEEEEeccCCCChHHHHHHHHHHHHHHhCC-----C---CCcchhhhhhhc-
Q psy758 2 ERYEKIGKLGEGSYGVVFKCRNRDTGQVVAIKKFLESEEDPLIRKIALREIRLLKSLK-----H---PNLVNLLEVFRR- 72 (292)
Q Consensus 2 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~e~~~~~~l~-----~---~~i~~~~~~~~~- 72 (292)
+||.+++.||.|-|++||+|.+..+.+.||+|+.+... ...+....|+.++++++ + .+||++++.|..
T Consensus 78 gRY~v~rKLGWGHFSTVWLawDtq~~r~VAlKVvKSAq---hYtEaAlDEIklL~~v~~~Dp~~~~~~~VV~LlD~Fkhs 154 (590)
T KOG1290|consen 78 GRYHVQRKLGWGHFSTVWLAWDTQNKRYVALKVVKSAQ---HYTEAALDEIKLLQQVREGDPNDPGKKCVVQLLDHFKHS 154 (590)
T ss_pred ceEEEEEeccccccceeEEEeeccCCeEEEEEEEehhh---HHHHHHHHHHHHHHHHHhcCCCCCCCceeeeeeccceec
Confidence 58999999999999999999999999999999985432 34456678999999984 2 479999999974
Q ss_pred ---CCeEEEEEecCCCccHHHHhcCC-CCCCHHHHHHHHHHHHHHHHHHHhC-CccccCCCCCceEE
Q psy758 73 ---KKKLHLVFEFCDHTVLNELENHP-HGLPWDLIKQITWQVLRGVSYCHRH-ACIHRDIKPENILL 134 (292)
Q Consensus 73 ---~~~~~iv~e~~~~~~L~~~~~~~-~~~~~~~~~~i~~qi~~aL~~LH~~-givH~dl~p~Nilv 134 (292)
+.++|+|+|+.+...|..+.... +.++...+..|+.||+.||.|||.. ||+|.||||+|||+
T Consensus 155 GpNG~HVCMVfEvLGdnLLklI~~s~YrGlpl~~VK~I~~qvL~GLdYLH~ecgIIHTDlKPENvLl 221 (590)
T KOG1290|consen 155 GPNGQHVCMVFEVLGDNLLKLIKYSNYRGLPLSCVKEICRQVLTGLDYLHRECGIIHTDLKPENVLL 221 (590)
T ss_pred CCCCcEEEEEehhhhhHHHHHHHHhCCCCCcHHHHHHHHHHHHHHHHHHHHhcCccccCCCcceeee
Confidence 45899999999988887776543 4699999999999999999999975 99999999999999
|
|
| >KOG1151|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-33 Score=225.04 Aligned_cols=251 Identities=24% Similarity=0.333 Sum_probs=192.2
Q ss_pred cccceeeeecccCceEEEEEEEcCCCcEEEEEEeccCC-----CChHHHHHHHHHHHHHHhCCCCCcchhhhhhh-cCCe
Q psy758 2 ERYEKIGKLGEGSYGVVFKCRNRDTGQVVAIKKFLESE-----EDPLIRKIALREIRLLKSLKHPNLVNLLEVFR-RKKK 75 (292)
Q Consensus 2 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~v~iK~~~~~~-----~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~-~~~~ 75 (292)
+||.++.+||+|+|+.||+|.+...++.||+|+-.... ......+...+|.++-+.|.||.||++|++|. +.+.
T Consensus 463 ~RYLlLhLLGrGGFSEVyKAFDl~EqRYvAvKIHqlNK~WrdEKKeNYhKHAcREyrIHKeLDHpRIVKlYDyfslDtds 542 (775)
T KOG1151|consen 463 DRYLLLHLLGRGGFSEVYKAFDLTEQRYVAVKIHQLNKNWRDEKKENYHKHACREYRIHKELDHPRIVKLYDYFSLDTDS 542 (775)
T ss_pred HHHHHHHHhccccHHHHHHhcccchhheeeEeeehhccchhhHhhhhHHHHHHHHHhhhhccCcceeeeeeeeeeecccc
Confidence 58999999999999999999999999999999864332 22335677889999999999999999999986 6778
Q ss_pred EEEEEecCCCccHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhC--CccccCCCCCceEEccC---CcEEEeecCchhh
Q psy758 76 LHLVFEFCDHTVLNELENHPHGLPWDLIKQITWQVLRGVSYCHRH--ACIHRDIKPENILLTAN---GVVKLCDFGFARL 150 (292)
Q Consensus 76 ~~iv~e~~~~~~L~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~--givH~dl~p~Nilv~~~---~~~kl~dfg~~~~ 150 (292)
+|-|+|||+|++|+.+++..+.+++..++.|+.||+.||.||... .|+|-||||.|||+.+. |.+||+|||+++.
T Consensus 543 FCTVLEYceGNDLDFYLKQhklmSEKEARSIiMQiVnAL~YLNEikpPIIHYDLKPgNILLv~GtacGeIKITDFGLSKI 622 (775)
T KOG1151|consen 543 FCTVLEYCEGNDLDFYLKQHKLMSEKEARSIIMQIVNALKYLNEIKPPIIHYDLKPGNILLVNGTACGEIKITDFGLSKI 622 (775)
T ss_pred ceeeeeecCCCchhHHHHhhhhhhHHHHHHHHHHHHHHHHHHhccCCCeeeeccCCccEEEecCcccceeEeeecchhhh
Confidence 999999999999999999999999999999999999999999986 59999999999999754 6799999999998
Q ss_pred hhccccc------------cccccccccccc-c--------CCCCCCCcccceeeecCCCCCCchHHH-HHHHhhcccCC
Q psy758 151 IRDLIPR------------HLHIFQTNEYFK-G--------VSLPHAENVVPLEIKIGKPAATNIYLI-DFLKRCLDKDP 208 (292)
Q Consensus 151 ~~~~~~~------------~~~~~~~~~~~~-~--------~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~p 208 (292)
....... ++..|.+||.+. | ....|+.|++.|.+++|..++...... +++..-.-.
T Consensus 623 MdddSy~~vdGmeLTSQgAGTYWYLPPEcFvVgkePPKIsnKVDVWSvGVIFyQClYGrKPFGhnqsQQdILqeNTIl-- 700 (775)
T KOG1151|consen 623 MDDDSYNSVDGMELTSQGAGTYWYLPPECFVVGKEPPKISNKVDVWSVGVIFYQCLYGRKPFGHNQSQQDILQENTIL-- 700 (775)
T ss_pred ccCCccCcccceeeecccCceeeecCcceeecCCCCCccccceeeEeeehhhhhhhccCCCCCCchhHHHHHhhhchh--
Confidence 7643322 223344444332 1 122466666666666666655433221 122111000
Q ss_pred CCCCChhhhhhccCcCCCCCCCCCccchHHHHhcccCcCCCCCCChhhhhhCCcccc
Q psy758 209 LRRWSCDQLLRHPYFNGYYFEVPDEMQYEEITQRCLDKDPLRRWSCDQLLRHPYFNG 265 (292)
Q Consensus 209 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~~il~h~w~~~ 265 (292)
.+.+ -.++....++.+.+++|++||++.-.+|....++..||+|--
T Consensus 701 ----kAtE-------VqFP~KPvVsseAkaFIRRCLaYRKeDR~DV~qLA~dpyllP 746 (775)
T KOG1151|consen 701 ----KATE-------VQFPPKPVVSSEAKAFIRRCLAYRKEDRIDVQQLACDPYLLP 746 (775)
T ss_pred ----ccee-------ccCCCCCccCHHHHHHHHHHHHhhhhhhhhHHHHccCccccc
Confidence 0001 123334456888999999999999999999999999999975
|
|
| >KOG1095|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-32 Score=244.97 Aligned_cols=242 Identities=23% Similarity=0.312 Sum_probs=184.5
Q ss_pred cceeeeecccCceEEEEEEEcCCCc-----EEEEEEeccCCCChHHHHHHHHHHHHHHhCCCCCcchhhhhhhcCCeEEE
Q psy758 4 YEKIGKLGEGSYGVVFKCRNRDTGQ-----VVAIKKFLESEEDPLIRKIALREIRLLKSLKHPNLVNLLEVFRRKKKLHL 78 (292)
Q Consensus 4 y~~~~~l~~g~~~~v~~~~~~~~~~-----~v~iK~~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~i 78 (292)
-++.+.||+|.||.||.|....... .|++|.+..... ......|.+|..+++.++||||++++|++.+.+..+|
T Consensus 694 v~l~~~lG~G~FG~VY~g~~~~~~~~~~~~~vaiK~l~~~~~-~~~~~~Fl~Ea~~m~~f~HpNiv~liGv~l~~~~~~i 772 (1025)
T KOG1095|consen 694 VTLLRVLGKGAFGEVYEGTYSDVPGSVSPIQVAVKSLKRLSS-EQEVSDFLKEALLMSKFDHPNIVSLIGVCLDSGPPLI 772 (1025)
T ss_pred eEeeeeeccccccceEEEEEecCCCCccceEEEEEeccccCC-HHHHHHHHHHHHHHhcCCCcceeeEEEeecCCCCcEE
Confidence 4578899999999999998765333 388888765443 4456779999999999999999999999999999999
Q ss_pred EEecCCCccHHHHhcCC-------CCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEEccCCcEEEeecCchhhh
Q psy758 79 VFEFCDHTVLNELENHP-------HGLPWDLIKQITWQVLRGVSYCHRHACIHRDIKPENILLTANGVVKLCDFGFARLI 151 (292)
Q Consensus 79 v~e~~~~~~L~~~~~~~-------~~~~~~~~~~i~~qi~~aL~~LH~~givH~dl~p~Nilv~~~~~~kl~dfg~~~~~ 151 (292)
++|||.||+|..+++.. ..++......++.|||+|..||+++++|||||..+|+|++....+||+|||+++.+
T Consensus 773 ~leyM~gGDL~sflr~~r~~~~~~~~L~~~dLl~~a~dvA~G~~YLe~~~fvHRDLAaRNCLL~~~r~VKIaDFGlArDi 852 (1025)
T KOG1095|consen 773 LLEYMEGGDLLSFLRESRPAPFQPSNLSMRDLLAFALDVAKGMNYLESKHFVHRDLAARNCLLDERRVVKIADFGLARDI 852 (1025)
T ss_pred EehhcccCcHHHHHHhcccccCCCCCCCHHHHHHHHHHHhhhhHHHHhCCCcCcchhhhheeecccCcEEEcccchhHhh
Confidence 99999999999999765 35899999999999999999999999999999999999999999999999999854
Q ss_pred hccc--cccc-----cccccccccccCCCCCCCcccceeeecCCCCCCchHHHHHHHhhcccCCCCCCChhhhhhccCcC
Q psy758 152 RDLI--PRHL-----HIFQTNEYFKGVSLPHAENVVPLEIKIGKPAATNIYLIDFLKRCLDKDPLRRWSCDQLLRHPYFN 224 (292)
Q Consensus 152 ~~~~--~~~~-----~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~ 224 (292)
.... .... --+.+||.+....+.-..++|+++++..+.. -++..|....+..+++....-.
T Consensus 853 y~~~yyr~~~~a~lPvkWm~PEsl~d~iFtskSDvWsFGVllWEif------------slG~~PY~~~~n~~v~~~~~~g 920 (1025)
T KOG1095|consen 853 YDKDYYRKHGEAMLPVKWMPPESLKDGIFTSKSDVWSFGVLLWEIF------------SLGATPYPSRSNFEVLLDVLEG 920 (1025)
T ss_pred hhchheeccCccccceecCCHHHHhhcccccccchhhhHHHHHHHH------------hCCCCCCCCcchHHHHHHHHhC
Confidence 3211 1111 1245555555444444555555544332221 1344555555555555433222
Q ss_pred CCCCCCC--CccchHHHHhcccCcCCCCCCChhhhhh
Q psy758 225 GYYFEVP--DEMQYEEITQRCLDKDPLRRWSCDQLLR 259 (292)
Q Consensus 225 ~~~~~~~--~~~~l~~li~~~l~~dP~~Rpt~~~il~ 259 (292)
+ +.+.+ -+..+.++|..||+.+|++||++..|++
T Consensus 921 g-RL~~P~~CP~~ly~lM~~CW~~~pe~RP~F~~i~~ 956 (1025)
T KOG1095|consen 921 G-RLDPPSYCPEKLYQLMLQCWKHDPEDRPSFRTIVE 956 (1025)
T ss_pred C-ccCCCCCCChHHHHHHHHHccCChhhCccHHHHHh
Confidence 2 44333 3788999999999999999999999988
|
|
| >PLN03224 probable serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.5e-32 Score=230.37 Aligned_cols=265 Identities=22% Similarity=0.309 Sum_probs=166.4
Q ss_pred cccceeeeecccCceEEEEEEEc----------------CCCcEEEEEEeccCCCChH------------HHHHHHHHHH
Q psy758 2 ERYEKIGKLGEGSYGVVFKCRNR----------------DTGQVVAIKKFLESEEDPL------------IRKIALREIR 53 (292)
Q Consensus 2 ~~y~~~~~l~~g~~~~v~~~~~~----------------~~~~~v~iK~~~~~~~~~~------------~~~~~~~e~~ 53 (292)
++|.+.+.||+|+||.||+|... ..++.||+|.+........ ..+....|+.
T Consensus 145 d~F~i~~~LG~GgFG~VYkG~~~~~~~~~v~~~~~~~~~~~~r~VAVK~l~~~~~~~~~~fl~e~~~~~~~~e~~~vE~~ 224 (507)
T PLN03224 145 DDFQLRDKLGGGNFGITFEGLRLQADDQGVTQRSKLTAEQKKRRVVLKRVNMDRQGVRQDFLKTGTLAKGSAETGMVEAY 224 (507)
T ss_pred cCceEeeEeecCCCeEEEEEEecccccchhhhhccccccccCceEEEEEecccchhhHHHHHhhhhhhhcccchhHHHHH
Confidence 68999999999999999999752 2356799999864321100 1122334666
Q ss_pred HHHhCCCCCc-----chhhhhhhc--------CCeEEEEEecCCCccHHHHhcCC------------------------C
Q psy758 54 LLKSLKHPNL-----VNLLEVFRR--------KKKLHLVFEFCDHTVLNELENHP------------------------H 96 (292)
Q Consensus 54 ~~~~l~~~~i-----~~~~~~~~~--------~~~~~iv~e~~~~~~L~~~~~~~------------------------~ 96 (292)
.+..++|.++ +++++++.. .+..++|+||+++++|.+++... .
T Consensus 225 ~l~~l~~~~l~~~~~~~~lg~~~~~~~~g~~~~~~~~LV~Ey~~~gsL~~~L~~~~~~~~~~L~e~l~~g~~l~~~~~~~ 304 (507)
T PLN03224 225 MCAKIKRNPIAAASCAEYLGYFTSNTADGAFTKGSQWLVWKFESDATLGDALDGKLGPFPGCLEEFMMAGKKIPDNMPQD 304 (507)
T ss_pred HHHHhhcccchhhhhhhhhhhcccccccccccCCceEEEEEcCCCCcHHHHHhhccCCCcchHHHHHhcCCchhhhcccc
Confidence 7777766544 667776642 35689999999999998887532 1
Q ss_pred CCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEEccCCcEEEeecCchhhhhcccc-cc-----cccccccccccc
Q psy758 97 GLPWDLIKQITWQVLRGVSYCHRHACIHRDIKPENILLTANGVVKLCDFGFARLIRDLIP-RH-----LHIFQTNEYFKG 170 (292)
Q Consensus 97 ~~~~~~~~~i~~qi~~aL~~LH~~givH~dl~p~Nilv~~~~~~kl~dfg~~~~~~~~~~-~~-----~~~~~~~~~~~~ 170 (292)
.++...++.++.|++.||.|||++|++|+||||+||+++.++.++|+|||++........ .. +..|.+||....
T Consensus 305 ~~~~~~~~~i~~ql~~aL~~lH~~~ivHrDLKp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~g~~tp~Y~aPE~l~~ 384 (507)
T PLN03224 305 KRDINVIKGVMRQVLTGLRKLHRIGIVHRDIKPENLLVTVDGQVKIIDFGAAVDMCTGINFNPLYGMLDPRYSPPEELVM 384 (507)
T ss_pred cCCHHHHHHHHHHHHHHHHHHHHCCeecCCCchHhEEECCCCcEEEEeCcCccccccCCccCccccCCCcceeChhhhcC
Confidence 235677889999999999999999999999999999999999999999999865432111 11 223455554322
Q ss_pred CCCCCCC-------cccceeeecCCC--CCCchHHHHHHHhhcccC-CCCCCC-hh-hhhh-----ccC--c----CCCC
Q psy758 171 VSLPHAE-------NVVPLEIKIGKP--AATNIYLIDFLKRCLDKD-PLRRWS-CD-QLLR-----HPY--F----NGYY 227 (292)
Q Consensus 171 ~~~~~~~-------~~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~-p~~~~~-~~-~~~~-----~~~--~----~~~~ 227 (292)
....... .........+.+ .+.++...-++..+...- |..... .. +... ..| . ..+.
T Consensus 385 ~~~~~~~~~~~~~~~l~~~~~~yg~~~~~DvwSlGvil~em~~~~l~p~~~~~~f~~~~~~~~~~~~~~r~~~~~~~~~~ 464 (507)
T PLN03224 385 PQSCPRAPAPAMAALLSPFAWLYGRPDLFDSYTAGVLLMQMCVPELRPVANIRLFNTELRQYDNDLNRWRMYKGQKYDFS 464 (507)
T ss_pred CCCCCccchhhhhhhhhhhHHhcCCCCccchhhHHHHHHHHHhCCCCCccchhhhhhHHhhccchHHHHHhhcccCCCcc
Confidence 1110000 000011112222 244444544555444321 221110 00 0000 000 0 0112
Q ss_pred CCCCCccchHHHHhcccCcCC---CCCCChhhhhhCCcccce
Q psy758 228 FEVPDEMQYEEITQRCLDKDP---LRRWSCDQLLRHPYFNGY 266 (292)
Q Consensus 228 ~~~~~~~~l~~li~~~l~~dP---~~Rpt~~~il~h~w~~~~ 266 (292)
.....+....+|+.+||..+| .+|+|++|+|+||||...
T Consensus 465 ~~d~~s~~~~dLi~~LL~~~~~~~~~RlSa~eaL~Hp~f~~~ 506 (507)
T PLN03224 465 LLDRNKEAGWDLACKLITKRDQANRGRLSVGQALSHRFFLPE 506 (507)
T ss_pred cccccChHHHHHHHHHhccCCCCcccCCCHHHHhCCCCcCCC
Confidence 223457788999999999876 689999999999999753
|
|
| >KOG1006|consensus | Back alignment and domain information |
|---|
Probab=99.98 E-value=2e-32 Score=206.40 Aligned_cols=254 Identities=24% Similarity=0.372 Sum_probs=197.5
Q ss_pred ceeeeecccCceEEEEEEEcCCCcEEEEEEeccCCCChHHHHHHHHHHHHHHhC-CCCCcchhhhhhhcCCeEEEEEecC
Q psy758 5 EKIGKLGEGSYGVVFKCRNRDTGQVVAIKKFLESEEDPLIRKIALREIRLLKSL-KHPNLVNLLEVFRRKKKLHLVFEFC 83 (292)
Q Consensus 5 ~~~~~l~~g~~~~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~e~~~~~~l-~~~~i~~~~~~~~~~~~~~iv~e~~ 83 (292)
+-.+.||.|+||+|++..++.+|+..|+|.|+.... ....++++.|.+...+- ++|||+++||....++-.|+.||++
T Consensus 67 qdlg~iG~G~fG~V~KM~hk~sg~~mAVKrIr~~n~-~keq~rll~e~d~~mks~~cp~IVkfyGa~F~EGdcWiCMELM 145 (361)
T KOG1006|consen 67 QDLGEIGNGAFGTVNKMLHKPSGKLMAVKRIRSNNI-EKEQKRLLMEHDTVMKSSNCPNIVKFYGALFSEGDCWICMELM 145 (361)
T ss_pred HHHHHhcCCcchhhhhhhcCccCcEEEEEEeeeccc-hHHHHHHHHHHHHHHhhcCCcHHHHHhhhhhcCCceeeeHHHH
Confidence 345679999999999999999999999999976655 34456677777766555 6999999999999999999999999
Q ss_pred CCccHHHHh-----cCCCCCCHHHHHHHHHHHHHHHHHHHhC-CccccCCCCCceEEccCCcEEEeecCchhhhhcccc-
Q psy758 84 DHTVLNELE-----NHPHGLPWDLIKQITWQVLRGVSYCHRH-ACIHRDIKPENILLTANGVVKLCDFGFARLIRDLIP- 156 (292)
Q Consensus 84 ~~~~L~~~~-----~~~~~~~~~~~~~i~~qi~~aL~~LH~~-givH~dl~p~Nilv~~~~~~kl~dfg~~~~~~~~~~- 156 (292)
.-. ++.+- .+...++|...-.+....+.||.||... .|+|||+||+|||++..|.+||||||++..+.+...
T Consensus 146 d~S-lDklYk~vy~vq~~~ipE~Ilg~ItvatV~AL~yLK~~lkiIHRDvKPSNILldr~G~vKLCDFGIcGqLv~SiAk 224 (361)
T KOG1006|consen 146 DIS-LDKLYKRVYSVQKSRIPENILGHITVATVDALDYLKEELKIIHRDVKPSNILLDRHGDVKLCDFGICGQLVDSIAK 224 (361)
T ss_pred hhh-HHHHHHHHHHHHhccCcHhhhhheeeeehhHHHHHHHHhhhhhccCChhheEEecCCCEeeecccchHhHHHHHHh
Confidence 753 33321 2334699999999999999999999975 799999999999999999999999999988765332
Q ss_pred ---ccccccccccccccCCC-------CCCCcccceeeecCCCCCC-chHHHHHHHhhcccCCCCCCChhhhhhccCcCC
Q psy758 157 ---RHLHIFQTNEYFKGVSL-------PHAENVVPLEIKIGKPAAT-NIYLIDFLKRCLDKDPLRRWSCDQLLRHPYFNG 225 (292)
Q Consensus 157 ---~~~~~~~~~~~~~~~~~-------~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~ 225 (292)
.+...|.+||-..+... .|++|+..+++.+|..++. +....+-+......+|..-....+.
T Consensus 225 T~daGCrpYmAPERi~p~~~gyDiRSDvWSLGITL~EvAtG~fPyr~w~svfeql~~Vv~gdpp~l~~~~~~-------- 296 (361)
T KOG1006|consen 225 TVDAGCRPYMAPERIDPSDKGYDIRSDVWSLGITLYEVATGNFPYRKWDSVFEQLCQVVIGDPPILLFDKEC-------- 296 (361)
T ss_pred hhccCCccccChhccCCccCCcchhhhhhhhcceEeeeecCCCCcchHHHHHHHHHHHHcCCCCeecCcccc--------
Confidence 33345777776655433 5999999999999987653 4445555555555554322222221
Q ss_pred CCCCCCCccchHHHHhcccCcCCCCCCChhhhhhCCcccceeccCCC
Q psy758 226 YYFEVPDEMQYEEITQRCLDKDPLRRWSCDQLLRHPYFNGYYFEVPD 272 (292)
Q Consensus 226 ~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~~il~h~w~~~~~~~~~~ 272 (292)
...+..+..+|.-||..|-+.||+..+++.+||...+--+-|+
T Consensus 297 ----~~~s~~~~~fintCl~Kd~~~Rpky~~Lk~~~fyr~y~~~~~~ 339 (361)
T KOG1006|consen 297 ----VHYSFSMVRFINTCLIKDRSDRPKYDDLKKFPFYRMYAVEGPD 339 (361)
T ss_pred ----cccCHHHHHHHHHHhhcccccCcchhhhhcCchhhhhhhcCCc
Confidence 2236689999999999999999999999999999886655554
|
|
| >KOG0665|consensus | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.2e-32 Score=212.52 Aligned_cols=262 Identities=26% Similarity=0.418 Sum_probs=190.9
Q ss_pred cccceeeeecccCceEEEEEEEcCCCcEEEEEEeccCCCChHHHHHHHHHHHHHHhCCCCCcchhhhhhhcC------Ce
Q psy758 2 ERYEKIGKLGEGSYGVVFKCRNRDTGQVVAIKKFLESEEDPLIRKIALREIRLLKSLKHPNLVNLLEVFRRK------KK 75 (292)
Q Consensus 2 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~------~~ 75 (292)
.||.-++.++.|.- .|..|-+.-.++.|++|....+.......+...+|...+..++|+||++++.+|.-. ..
T Consensus 17 ~Ry~nL~p~~~g~~-~v~~a~D~v~~~~v~ikk~~~pf~n~~~akra~rel~l~~~v~~~nii~l~n~ftP~~~l~~~~e 95 (369)
T KOG0665|consen 17 KRYVNLKPIGSGAQ-IVVAAFDQVLGRPVAIKKLSRPFQNQTHAKRAYRELKLMKCVNHKNIISLLNVFTPQKTLEEFQE 95 (369)
T ss_pred eeeeeecccCCCCc-eEEecchhhccCceehhhhcCccccCccchhhhhhhhhhhhhcccceeeeeeccCccccHHHHHh
Confidence 46777888999988 788899999999999999876665566788899999999999999999999998633 35
Q ss_pred EEEEEecCCCccHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEEccCCcEEEeecCchhhhhcc-
Q psy758 76 LHLVFEFCDHTVLNELENHPHGLPWDLIKQITWQVLRGVSYCHRHACIHRDIKPENILLTANGVVKLCDFGFARLIRDL- 154 (292)
Q Consensus 76 ~~iv~e~~~~~~L~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~givH~dl~p~Nilv~~~~~~kl~dfg~~~~~~~~- 154 (292)
+|+|||++..+.-...+ -.++-.++..++.|+++|++|||+.||+||||||+||++..++.+||.|||++......
T Consensus 96 ~y~v~e~m~~nl~~vi~---~elDH~tis~i~yq~~~~ik~lhs~~IihRdLkPsnivv~~~~~lKi~dfg~ar~e~~~~ 172 (369)
T KOG0665|consen 96 VYLVMELMDANLCQVIL---MELDHETISYILYQMLCGIKHLHSAGIIHRDLKPSNIVVNSDCTLKILDFGLARTEDTDF 172 (369)
T ss_pred HHHHHHhhhhHHHHHHH---HhcchHHHHHHHHHHHHHHHHHHhcceeecccCcccceecchhheeeccchhhcccCccc
Confidence 89999999875444443 25888999999999999999999999999999999999999999999999999876543
Q ss_pred ---ccccccccccccccccCCCCCCCcccceeeecCC-----CCCCchHHHHH----HHh------------------hc
Q psy758 155 ---IPRHLHIFQTNEYFKGVSLPHAENVVPLEIKIGK-----PAATNIYLIDF----LKR------------------CL 204 (292)
Q Consensus 155 ---~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-----~~~~~~~~~~~----~~~------------------~~ 204 (292)
..-.+..|.+||...|-......++|+.++..|+ ..+.+....+- ++. ..
T Consensus 173 ~mtpyVvtRyyrapevil~~~~ke~vdiwSvGci~gEli~~~Vlf~g~d~idQ~~ki~~~lgtpd~~F~~qL~~~~r~yv 252 (369)
T KOG0665|consen 173 MMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGELILGTVLFPGKDHIDQWNKIIEQLGTPDPSFMKQLQPTVRNYV 252 (369)
T ss_pred ccCchhheeeccCchheeccCCcccchhhhhhhHHHHHhhceEEecCchHHHHHHHHHHHhcCCCHHHHHHhhHHHHHHh
Confidence 1222456888988888776655666666554443 22211111111 111 11
Q ss_pred ccCC-CCCCChhhhhhccCcCCCCC-CCCCccchHHHHhcccCcCCCCCCChhhhhhCCcccceec
Q psy758 205 DKDP-LRRWSCDQLLRHPYFNGYYF-EVPDEMQYEEITQRCLDKDPLRRWSCDQLLRHPYFNGYYF 268 (292)
Q Consensus 205 ~~~p-~~~~~~~~~~~~~~~~~~~~-~~~~~~~l~~li~~~l~~dP~~Rpt~~~il~h~w~~~~~~ 268 (292)
...| ....+..+++....|..-.. +......+++++.+||..||++|.|++++|+|||++ +|+
T Consensus 253 ~~~~~y~~~~f~~~fpD~~f~~~~e~~~~~~~~ardll~~MLvi~pe~Risv~daL~HPY~~-vw~ 317 (369)
T KOG0665|consen 253 ENRPQYQAISFSELFPDSLFPVVLEGSKLDCSLARDLLSKMLVIDPEKRISVDDALRHPYIK-VWY 317 (369)
T ss_pred hcChHhhccchhhhCCcccccccccCCccchHHHHHHHHHhhccChhhcccHHHHhcCCeee-eec
Confidence 1111 11123333333333322211 223356689999999999999999999999999999 444
|
|
| >KOG1094|consensus | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.1e-31 Score=222.15 Aligned_cols=244 Identities=24% Similarity=0.321 Sum_probs=184.1
Q ss_pred ccceeeeecccCceEEEEEEEcCCCcEEEEEEeccCCCChHHHHHHHHHHHHHHhCCCCCcchhhhhhhcCCeEEEEEec
Q psy758 3 RYEKIGKLGEGSYGVVFKCRNRDTGQVVAIKKFLESEEDPLIRKIALREIRLLKSLKHPNLVNLLEVFRRKKKLHLVFEF 82 (292)
Q Consensus 3 ~y~~~~~l~~g~~~~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~iv~e~ 82 (292)
+..+++.||+|.||.|.++.... +..||+|.++... .......|.+|++++.+|+||||+.++|++..++.+++|+||
T Consensus 539 ~L~~~ekiGeGqFGEVhLCeveg-~lkVAVK~Lr~~a-~~~~r~~F~kEIkiLsqLkhPNIveLvGVC~~DePicmI~EY 616 (807)
T KOG1094|consen 539 RLRFKEKIGEGQFGEVHLCEVEG-PLKVAVKILRPDA-TKNARNDFLKEIKILSRLKHPNIVELLGVCVQDDPLCMITEY 616 (807)
T ss_pred heehhhhhcCcccceeEEEEecC-ceEEEEeecCccc-chhHHHHHHHHHHHHhccCCCCeeEEEeeeecCCchHHHHHH
Confidence 45678999999999999998764 6889999986544 334467899999999999999999999999999999999999
Q ss_pred CCCccHHHHhcCCC--CCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEEccCCcEEEeecCchhhhhcccc--cc
Q psy758 83 CDHTVLNELENHPH--GLPWDLIKQITWQVLRGVSYCHRHACIHRDIKPENILLTANGVVKLCDFGFARLIRDLIP--RH 158 (292)
Q Consensus 83 ~~~~~L~~~~~~~~--~~~~~~~~~i~~qi~~aL~~LH~~givH~dl~p~Nilv~~~~~~kl~dfg~~~~~~~~~~--~~ 158 (292)
+++|+|.+++.... .........|+.||+.|++||.+.++|||||.+.|+|++.++++||+|||+++-+-.... .+
T Consensus 617 mEnGDLnqFl~aheapt~~t~~~vsi~tqiasgmaYLes~nfVHrd~a~rNcLv~~e~~iKiadfgmsR~lysg~yy~vq 696 (807)
T KOG1094|consen 617 MENGDLNQFLSAHELPTAETAPGVSICTQIASGMAYLESLNFVHRDLATRNCLVDGEFTIKIADFGMSRNLYSGDYYRVQ 696 (807)
T ss_pred HhcCcHHHHHHhccCcccccchhHHHHHHHHHHHHHHHhhchhhccccccceeecCcccEEecCcccccccccCCceeee
Confidence 99999999997752 234556677999999999999999999999999999999999999999999985432111 11
Q ss_pred c-----cccccccccccCCCCCCCcccceeeecCCCCCCchHHHHHHHhhcccCCCCCCChhhhhhc--cCcCCC-----
Q psy758 159 L-----HIFQTNEYFKGVSLPHAENVVPLEIKIGKPAATNIYLIDFLKRCLDKDPLRRWSCDQLLRH--PYFNGY----- 226 (292)
Q Consensus 159 ~-----~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~--~~~~~~----- 226 (292)
. -.|.++|...-..+.-+.+.|.+ ...++.++..| +..|....+.+++..+ .++...
T Consensus 697 gr~vlpiRwmawEsillgkFttaSDvWaf----------gvTlwE~~~~C-~e~Py~~lt~e~vven~~~~~~~~~~~~~ 765 (807)
T KOG1094|consen 697 GRAVLPIRWMAWESILLGKFTTASDVWAF----------GVTLWEVFMLC-REQPYSQLTDEQVVENAGEFFRDQGRQVV 765 (807)
T ss_pred cceeeeeeehhHHHHHhccccchhhhhhh----------HHHHHHHHHHH-hhCchhhhhHHHHHHhhhhhcCCCCccee
Confidence 1 12333333333334444444444 33334444444 5667777777777654 223221
Q ss_pred -CCCCCCccchHHHHhcccCcCCCCCCChhhhhh
Q psy758 227 -YFEVPDEMQYEEITQRCLDKDPLRRWSCDQLLR 259 (292)
Q Consensus 227 -~~~~~~~~~l~~li~~~l~~dP~~Rpt~~~il~ 259 (292)
..|.--+..+.++|.+||..|-.+|||++++..
T Consensus 766 l~~P~~cp~~lyelml~Cw~~es~~RPsFe~lh~ 799 (807)
T KOG1094|consen 766 LSRPPACPQGLYELMLRCWRRESEQRPSFEQLHL 799 (807)
T ss_pred ccCCCcCcHHHHHHHHHHhchhhhcCCCHHHHHH
Confidence 123334778899999999999999999999854
|
|
| >PHA02882 putative serine/threonine kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.8e-30 Score=212.25 Aligned_cols=243 Identities=16% Similarity=0.158 Sum_probs=158.4
Q ss_pred cccceeeeecccCceEEEEEEEcCC---CcEEEEEEeccCCCChHH---------HHHHHHHHHHHHhCCCCCcchhhhh
Q psy758 2 ERYEKIGKLGEGSYGVVFKCRNRDT---GQVVAIKKFLESEEDPLI---------RKIALREIRLLKSLKHPNLVNLLEV 69 (292)
Q Consensus 2 ~~y~~~~~l~~g~~~~v~~~~~~~~---~~~v~iK~~~~~~~~~~~---------~~~~~~e~~~~~~l~~~~i~~~~~~ 69 (292)
++|.+.+.||+|+||.||+|.+..+ +..+++|+.......... ......+...+..+.|++++++++.
T Consensus 12 ~~y~i~~~LG~G~fG~Vy~~~~~~~~~~~~~~~~k~~~~~~~~~~~e~~~~~~~~~~~~~~~~~~~~~~~h~~i~~~~~~ 91 (294)
T PHA02882 12 KEWKIDKLIGCGGFGCVYETQCASDHCINNQAVAKIENLENETIVMETLVYNNIYDIDKIALWKNIHNIDHLGIPKYYGC 91 (294)
T ss_pred CceEEeeEEecCCCceEEEEEEcCCcccccceEEEeccccCCchhhHHHHHHhhhhHHHHHHHHHhccCCCCCCCcEEEe
Confidence 4899999999999999999998877 667778764333221111 1112233445566789999999986
Q ss_pred hhcCC----eEEEEEecCCCccHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEEccCCcEEEeec
Q psy758 70 FRRKK----KLHLVFEFCDHTVLNELENHPHGLPWDLIKQITWQVLRGVSYCHRHACIHRDIKPENILLTANGVVKLCDF 145 (292)
Q Consensus 70 ~~~~~----~~~iv~e~~~~~~L~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~givH~dl~p~Nilv~~~~~~kl~df 145 (292)
..... ..+++++++... +...+......++..+..++.|++.||+|||++|++||||||+||++++++.++|+||
T Consensus 92 ~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~iiHrDiKp~Nill~~~~~~~l~DF 170 (294)
T PHA02882 92 GSFKRCRMYYRFILLEKLVEN-TKEIFKRIKCKNKKLIKNIMKDMLTTLEYIHEHGISHGDIKPENIMVDGNNRGYIIDY 170 (294)
T ss_pred eeEecCCceEEEEEEehhccC-HHHHHHhhccCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCcEEEEEc
Confidence 54332 457888887653 4445544445788999999999999999999999999999999999999999999999
Q ss_pred Cchhhhhccc------------cccccccccccccccCCCCCCCcccceeeecCCCCCCchHHHHHHHhhcccCCCCCCC
Q psy758 146 GFARLIRDLI------------PRHLHIFQTNEYFKGVSLPHAENVVPLEIKIGKPAATNIYLIDFLKRCLDKDPLRRWS 213 (292)
Q Consensus 146 g~~~~~~~~~------------~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~ 213 (292)
|+++...... ..++..|.+|+...+...... .++++.+..+++.+.+..|+...+
T Consensus 171 Gla~~~~~~~~~~~~~~~~~~~~~gt~~y~ape~~~~~~~~~~-------------~DiwSlG~~l~el~~g~~P~~~~~ 237 (294)
T PHA02882 171 GIASHFIIHGKHIEYSKEQKDLHRGTLYYAGLDAHNGACVTRR-------------GDLESLGYCMLKWAGIKLPWKGFG 237 (294)
T ss_pred CCceeeccCCcccccccccccccCCCccccCHHHhCCCCCCcH-------------HHHHHHHHHHHHHHhCCCCCCccc
Confidence 9987653211 112233444444433322222 222333333444444444443331
Q ss_pred hh-h--------hhhccCcCCCCCCCCCccchHHHHhcccCcCCCCCCChhhhhh
Q psy758 214 CD-Q--------LLRHPYFNGYYFEVPDEMQYEEITQRCLDKDPLRRWSCDQLLR 259 (292)
Q Consensus 214 ~~-~--------~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~~il~ 259 (292)
.. + ...... .+.......+..+.+++..|+..+|.+||+++++++
T Consensus 238 ~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~rp~~~~l~~ 291 (294)
T PHA02882 238 HNGNLIHAAKCDFIKRLH-EGKIKIKNANKFIYDFIECVTKLSYEEKPDYDALIK 291 (294)
T ss_pred cchHHHHHhHHHHHHHhh-hhhhccCCCCHHHHHHHHHHHhCCCCCCCCHHHHHH
Confidence 11 0 111110 110111233678999999999999999999999976
|
|
| >KOG0199|consensus | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.3e-31 Score=225.96 Aligned_cols=248 Identities=22% Similarity=0.295 Sum_probs=190.9
Q ss_pred ccceeeeecccCceEEEEEEEcCC-Cc--EEEEEEeccCCCChHHHHHHHHHHHHHHhCCCCCcchhhhhhhcCCeEEEE
Q psy758 3 RYEKIGKLGEGSYGVVFKCRNRDT-GQ--VVAIKKFLESEEDPLIRKIALREIRLLKSLKHPNLVNLLEVFRRKKKLHLV 79 (292)
Q Consensus 3 ~y~~~~~l~~g~~~~v~~~~~~~~-~~--~v~iK~~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~iv 79 (292)
+.++.+.||+|.||.|+++.+... |+ .||+|.+....... ..+.|++|+.+|.+|+|+|++++||++.+ ....+|
T Consensus 111 ~i~l~e~LG~GsFgvV~rg~Wt~psgk~V~VAVKclr~d~l~~-~mddflrEas~M~~L~H~hliRLyGvVl~-qp~mMV 188 (1039)
T KOG0199|consen 111 QIKLYELLGEGSFGVVKRGTWTQPSGKHVNVAVKCLRDDSLNA-IMDDFLREASHMLKLQHPHLIRLYGVVLD-QPAMMV 188 (1039)
T ss_pred HHHHHHHhcCcceeeEeeccccCCCCcEEeEEEEeccCCccch-hHHHHHHHHHHHHhccCcceeEEeeeecc-chhhHH
Confidence 456778999999999999987654 33 58999987655443 67889999999999999999999999987 678899
Q ss_pred EecCCCccHHHHhcC--CCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEEccCCcEEEeecCchhhhhccc--
Q psy758 80 FEFCDHTVLNELENH--PHGLPWDLIKQITWQVLRGVSYCHRHACIHRDIKPENILLTANGVVKLCDFGFARLIRDLI-- 155 (292)
Q Consensus 80 ~e~~~~~~L~~~~~~--~~~~~~~~~~~i~~qi~~aL~~LH~~givH~dl~p~Nilv~~~~~~kl~dfg~~~~~~~~~-- 155 (292)
+|++++|+|.+.+.. ...+.......++.||+.|+.||.++++|||||...|+++...-.+||+|||+.+.++...
T Consensus 189 ~ELaplGSLldrLrka~~~~llv~~Lcdya~QiA~aM~YLeskrlvHRDLAARNlllasprtVKI~DFGLmRaLg~ned~ 268 (1039)
T KOG0199|consen 189 FELAPLGSLLDRLRKAKKAILLVSRLCDYAMQIAKAMQYLESKRLVHRDLAARNLLLASPRTVKICDFGLMRALGENEDM 268 (1039)
T ss_pred hhhcccchHHHHHhhccccceeHHHHHHHHHHHHHHHHHHhhhhhhhhhhhhhhheecccceeeeecccceeccCCCCcc
Confidence 999999999888765 3458889999999999999999999999999999999999999999999999998876422
Q ss_pred ------cccccccccccccccCCCCCCCcccceeeecCCCCCCchHHHHHHHhhcccCCCCCCChhhhhhccCcCCCC--
Q psy758 156 ------PRHLHIFQTNEYFKGVSLPHAENVVPLEIKIGKPAATNIYLIDFLKRCLDKDPLRRWSCDQLLRHPYFNGYY-- 227 (292)
Q Consensus 156 ------~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~-- 227 (292)
......|++||...-..+..+.++|.|++.+.+.+. .+..|.......+++...- .+-.
T Consensus 269 Yvm~p~rkvPfAWCaPEsLrh~kFShaSDvWmyGVTiWEMFt------------yGEePW~G~~g~qIL~~iD-~~erLp 335 (1039)
T KOG0199|consen 269 YVMAPQRKVPFAWCAPESLRHRKFSHASDVWMYGVTIWEMFT------------YGEEPWVGCRGIQILKNID-AGERLP 335 (1039)
T ss_pred eEecCCCcCcccccCHhHhccccccccchhhhhhhhHHhhhc------------cCCCCCCCCCHHHHHHhcc-ccccCC
Confidence 222345777777766666666666666554333221 1334444444444544433 2222
Q ss_pred CCCCCccchHHHHhcccCcCCCCCCChhhhhhCCcccc
Q psy758 228 FEVPDEMQYEEITQRCLDKDPLRRWSCDQLLRHPYFNG 265 (292)
Q Consensus 228 ~~~~~~~~l~~li~~~l~~dP~~Rpt~~~il~h~w~~~ 265 (292)
.+...+..+.+++++||+.+|.+|||+..|.+.-++..
T Consensus 336 RPk~csedIY~imk~cWah~paDRptFsair~~~~l~e 373 (1039)
T KOG0199|consen 336 RPKYCSEDIYQIMKNCWAHNPADRPTFSAIREDLVLAE 373 (1039)
T ss_pred CCCCChHHHHHHHHHhccCCccccccHHHHHHhHHHHh
Confidence 23344788999999999999999999999976655544
|
|
| >KOG0196|consensus | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.9e-31 Score=227.31 Aligned_cols=243 Identities=21% Similarity=0.316 Sum_probs=194.2
Q ss_pred cceeeeecccCceEEEEEEEcCCCc---EEEEEEeccCCCChHHHHHHHHHHHHHHhCCCCCcchhhhhhhcCCeEEEEE
Q psy758 4 YEKIGKLGEGSYGVVFKCRNRDTGQ---VVAIKKFLESEEDPLIRKIALREIRLLKSLKHPNLVNLLEVFRRKKKLHLVF 80 (292)
Q Consensus 4 y~~~~~l~~g~~~~v~~~~~~~~~~---~v~iK~~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~iv~ 80 (292)
-.+.+.||.|.||.|++++.+..++ .||||.++.. ..+.....|+.|..||=+++||||+++.|+......++||.
T Consensus 631 i~Ie~VIGaGEFGEVc~GrLk~pgkre~~VAIKTLK~G-ytekqrrdFL~EAsIMGQFdHPNIIrLEGVVTks~PvMIiT 709 (996)
T KOG0196|consen 631 VKIEKVIGAGEFGEVCSGRLKLPGKREITVAIKTLKAG-YTEKQRRDFLSEASIMGQFDHPNIIRLEGVVTKSKPVMIIT 709 (996)
T ss_pred eEEEEEEecccccceecccccCCCCcceeEEEeeeccC-ccHHHHhhhhhhhhhcccCCCCcEEEEEEEEecCceeEEEh
Confidence 4578899999999999999987775 5999998644 45566777999999999999999999999999999999999
Q ss_pred ecCCCccHHHHhcC-CCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEEccCCcEEEeecCchhhhhccccccc
Q psy758 81 EFCDHTVLNELENH-PHGLPWDLIKQITWQVLRGVSYCHRHACIHRDIKPENILLTANGVVKLCDFGFARLIRDLIPRHL 159 (292)
Q Consensus 81 e~~~~~~L~~~~~~-~~~~~~~~~~~i~~qi~~aL~~LH~~givH~dl~p~Nilv~~~~~~kl~dfg~~~~~~~~~~~~~ 159 (292)
|||++|+|+.+++. .+.++..+...++..|+.|++||-+.|+|||||.+.||||+.+-..|++|||+++.+.+..+...
T Consensus 710 EyMENGsLDsFLR~~DGqftviQLVgMLrGIAsGMkYLsdm~YVHRDLAARNILVNsnLvCKVsDFGLSRvledd~~~~y 789 (996)
T KOG0196|consen 710 EYMENGSLDSFLRQNDGQFTVIQLVGMLRGIASGMKYLSDMNYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEAAY 789 (996)
T ss_pred hhhhCCcHHHHHhhcCCceEeehHHHHHHHHHHHhHHHhhcCchhhhhhhhheeeccceEEEeccccceeecccCCCccc
Confidence 99999999999875 45689999999999999999999999999999999999999999999999999997754332111
Q ss_pred --------cccccccccccCCCCCCCcccceeeecCCCCCCchHHHHHHHhhcccCCCCCCChhhhhhccCcCCCCCCCC
Q psy758 160 --------HIFQTNEYFKGVSLPHAENVVPLEIKIGKPAATNIYLIDFLKRCLDKDPLRRWSCDQLLRHPYFNGYYFEVP 231 (292)
Q Consensus 160 --------~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~ 231 (292)
-.+.+||-..-..+.-+.++|+|++...+... .+..|.=.++..++++.. -.++++|.+
T Consensus 790 tt~GGKIPiRWTAPEAIa~RKFTsASDVWSyGIVmWEVmS------------yGERPYWdmSNQdVIkaI-e~gyRLPpP 856 (996)
T KOG0196|consen 790 TTLGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMS------------YGERPYWDMSNQDVIKAI-EQGYRLPPP 856 (996)
T ss_pred cccCCccceeecChhHhhhcccCchhhccccceEEEEecc------------cCCCcccccchHHHHHHH-HhccCCCCC
Confidence 23566666555555566666666665544321 244455555666665432 234444443
Q ss_pred --CccchHHHHhcccCcCCCCCCChhhhhhC
Q psy758 232 --DEMQYEEITQRCLDKDPLRRWSCDQLLRH 260 (292)
Q Consensus 232 --~~~~l~~li~~~l~~dP~~Rpt~~~il~h 260 (292)
-|..+.+|+..||++|-.+||++.||+++
T Consensus 857 mDCP~aL~qLMldCWqkdR~~RP~F~qiV~~ 887 (996)
T KOG0196|consen 857 MDCPAALYQLMLDCWQKDRNRRPKFAQIVST 887 (996)
T ss_pred CCCcHHHHHHHHHHHHHHhhcCCCHHHHHHH
Confidence 48899999999999999999999999874
|
|
| >KOG0664|consensus | Back alignment and domain information |
|---|
Probab=99.97 E-value=5.1e-32 Score=205.39 Aligned_cols=262 Identities=25% Similarity=0.410 Sum_probs=192.5
Q ss_pred ceeeeecccCceEEEEEEEcCCCcEEEEEEeccCCCChHHHHHHHHHHHHHHhCCCCCcchhhhhhhcCC-----eEEEE
Q psy758 5 EKIGKLGEGSYGVVFKCRNRDTGQVVAIKKFLESEEDPLIRKIALREIRLLKSLKHPNLVNLLEVFRRKK-----KLHLV 79 (292)
Q Consensus 5 ~~~~~l~~g~~~~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~-----~~~iv 79 (292)
+-.+-||.|+||.||.+.+..+|+.|++|.+++-...-...+.+.+|+.++..++|.|++..+++.+-.+ .+|++
T Consensus 56 ~PDRPIGYGAFGVVWsVTDPRdgrrvalkK~pnvfq~L~s~krvFre~kmLcfFkHdNVLSaLDILQPph~dfFqEiYV~ 135 (449)
T KOG0664|consen 56 QPDRPIGYGAFGVVWSVTDPRSGKRVALKKMPNVFQNLASCKRVFREIKMLSSFRHDNVLSLLDILQPANPSFFQELYVL 135 (449)
T ss_pred CCCCcccccceeEEEeccCCCCccchhHhhcchHHHHHHHHHHHHHHHHHHHhhccccHHHHHHhcCCCCchHHHHHHHH
Confidence 3457899999999999999999999999999776655566788899999999999999999999876443 46788
Q ss_pred EecCCCccHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEEccCCcEEEeecCchhhhhccccc--
Q psy758 80 FEFCDHTVLNELENHPHGLPWDLIKQITWQVLRGVSYCHRHACIHRDIKPENILLTANGVVKLCDFGFARLIRDLIPR-- 157 (292)
Q Consensus 80 ~e~~~~~~L~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~givH~dl~p~Nilv~~~~~~kl~dfg~~~~~~~~~~~-- 157 (292)
+|++. .+|..++-....++...+.-++.||+.||+|||+.||.||||||.|+++++|..+||+|||+++........
T Consensus 136 TELmQ-SDLHKIIVSPQ~Ls~DHvKVFlYQILRGLKYLHsA~ILHRDIKPGNLLVNSNCvLKICDFGLARvee~d~~~hM 214 (449)
T KOG0664|consen 136 TELMQ-SDLHKIIVSPQALTPDHVKVFVYQILRGLKYLHTANILHRDIKPGNLLVNSNCILKICDFGLARTWDQRDRLNM 214 (449)
T ss_pred HHHHH-hhhhheeccCCCCCcchhhhhHHHHHhhhHHHhhcchhhccCCCccEEeccCceEEecccccccccchhhhhhh
Confidence 88886 456677777778999999999999999999999999999999999999999999999999999865432221
Q ss_pred ----cccccccccccccCCCC-CCCcccceeeecCCC-----CC---CchHHHHHHHhhcccCCCCCC--ChhhhhhccC
Q psy758 158 ----HLHIFQTNEYFKGVSLP-HAENVVPLEIKIGKP-----AA---TNIYLIDFLKRCLDKDPLRRW--SCDQLLRHPY 222 (292)
Q Consensus 158 ----~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~-----~~---~~~~~~~~~~~~~~~~p~~~~--~~~~~~~~~~ 222 (292)
.+..|.+||...|..-+ .+.++|+.++.+++. .+ ....-.+++..+++....+.. ..+..-.|..
T Consensus 215 TqEVVTQYYRAPEiLMGaRhYs~AvDiWSVGCIFaELLgRrILFQAq~PiqQL~lItdLLGTPs~EaMr~ACEGAk~H~L 294 (449)
T KOG0664|consen 215 THEVVTQYYRAPELLMGARRYTGAVDIWSVGCIFAELLQRKILFQAAGPIEQLQMIIDLLGTPSQEAMKYACEGAKNHVL 294 (449)
T ss_pred HHHHHHHHhccHHHhhcchhhcCccceehhhHHHHHHHhhhhhhhccChHHHHHHHHHHhCCCcHHHHHHHhhhhHHHhh
Confidence 13458899888776543 455666665544432 11 122334455555554322111 1111111211
Q ss_pred cCCC-----------CCCCCCccchHHHHhcccCcCCCCCCChhhhhhCCccccee
Q psy758 223 FNGY-----------YFEVPDEMQYEEITQRCLDKDPLRRWSCDQLLRHPYFNGYY 267 (292)
Q Consensus 223 ~~~~-----------~~~~~~~~~l~~li~~~l~~dP~~Rpt~~~il~h~w~~~~~ 267 (292)
..+. .-+.........++..||.+||.+|.+.++.+.|+++....
T Consensus 295 R~~~k~Ps~~vLYtlsS~~~~~heav~~~~~~l~~d~dkris~~~A~~~~~~~e~R 350 (449)
T KOG0664|consen 295 RAGLRAPDTQRLYKIASPDDKNHEAVDLLQKLLHFDPDKRISVEEALQHRYLEEGR 350 (449)
T ss_pred ccCCCCCCccceeeecCCcccchHHHHHHHHHhCCCCcccccHhhhcccccccccc
Confidence 1111 11122344567889999999999999999999999998754
|
|
| >KOG1027|consensus | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.1e-30 Score=224.27 Aligned_cols=234 Identities=26% Similarity=0.350 Sum_probs=168.0
Q ss_pred eeeecccCceE-EEEEEEcCCCcEEEEEEeccCCCChHHHHHHHHHHHHHHhC-CCCCcchhhhhhhcCCeEEEEEecCC
Q psy758 7 IGKLGEGSYGV-VFKCRNRDTGQVVAIKKFLESEEDPLIRKIALREIRLLKSL-KHPNLVNLLEVFRRKKKLHLVFEFCD 84 (292)
Q Consensus 7 ~~~l~~g~~~~-v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~e~~~~~~l-~~~~i~~~~~~~~~~~~~~iv~e~~~ 84 (292)
.+++|.|+.|+ ||++... |+.||||.+-. +..+...+|+..++.- +||||+++|+.-.+....||+.|.|.
T Consensus 514 ~eilG~Gs~Gt~Vf~G~ye--~R~VAVKrll~-----e~~~~A~rEi~lL~eSD~H~NviRyyc~E~d~qF~YIalELC~ 586 (903)
T KOG1027|consen 514 KEILGYGSNGTVVFRGVYE--GREVAVKRLLE-----EFFDFAQREIQLLQESDEHPNVIRYYCSEQDRQFLYIALELCA 586 (903)
T ss_pred HHHcccCCCCcEEEEEeeC--CceehHHHHhh-----HhHHHHHHHHHHHHhccCCCceEEEEeeccCCceEEEEehHhh
Confidence 35678888887 6888876 88999997743 3456778999999988 59999999999999999999999998
Q ss_pred CccHHHHhcCCC-C---CCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEEcc---CC--cEEEeecCchhhhhc--
Q psy758 85 HTVLNELENHPH-G---LPWDLIKQITWQVLRGVSYCHRHACIHRDIKPENILLTA---NG--VVKLCDFGFARLIRD-- 153 (292)
Q Consensus 85 ~~~L~~~~~~~~-~---~~~~~~~~i~~qi~~aL~~LH~~givH~dl~p~Nilv~~---~~--~~kl~dfg~~~~~~~-- 153 (292)
. +|.+++.... . ......+..+.|++.||+|||+.+||||||||.||||+. ++ .++|+|||+++.+..
T Consensus 587 ~-sL~dlie~~~~d~~~~~~i~~~~~l~q~~~GlaHLHsl~iVHRDLkPQNILI~~~~~~~~~ra~iSDfglsKkl~~~~ 665 (903)
T KOG1027|consen 587 C-SLQDLIESSGLDVEMQSDIDPISVLSQIASGLAHLHSLKIVHRDLKPQNILISVPSADGTLRAKISDFGLSKKLAGGK 665 (903)
T ss_pred h-hHHHHHhccccchhhcccccHHHHHHHHHHHHHHHHhcccccccCCCceEEEEccCCCcceeEEecccccccccCCCc
Confidence 5 5777776531 1 111445889999999999999999999999999999986 33 699999999998753
Q ss_pred ------cccccccccccccccccCCCCCCCcccceeeecC------CCCCCchHHHHHHHhhcccCCCCCCChhhhhhcc
Q psy758 154 ------LIPRHLHIFQTNEYFKGVSLPHAENVVPLEIKIG------KPAATNIYLIDFLKRCLDKDPLRRWSCDQLLRHP 221 (292)
Q Consensus 154 ------~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~------~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~ 221 (292)
....++..|.+||......-..+.++.++++.+. ..++.+....+ ..++...
T Consensus 666 sS~~r~s~~sGt~GW~APE~L~~~~~~~avDiFslGCvfyYvltgG~HpFGd~~~R~----------------~NIl~~~ 729 (903)
T KOG1027|consen 666 SSFSRLSGGSGTSGWQAPEQLREDRKTQAVDIFSLGCVFYYVLTGGSHPFGDSLERQ----------------ANILTGN 729 (903)
T ss_pred chhhcccCCCCcccccCHHHHhccccCcccchhhcCceEEEEecCCccCCCchHHhh----------------hhhhcCc
Confidence 2233455677777776655555566666555443 33333222211 1111111
Q ss_pred CcCCCCCCCCCccchHHHHhcccCcCCCCCCChhhhhhCCcccc
Q psy758 222 YFNGYYFEVPDEMQYEEITQRCLDKDPLRRWSCDQLLRHPYFNG 265 (292)
Q Consensus 222 ~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~~il~h~w~~~ 265 (292)
+- -............+||.+|+++||..||+|.+||.||+|=+
T Consensus 730 ~~-L~~L~~~~d~eA~dLI~~ml~~dP~~RPsa~~VL~HPlFW~ 772 (903)
T KOG1027|consen 730 YT-LVHLEPLPDCEAKDLISRMLNPDPQLRPSATDVLNHPLFWD 772 (903)
T ss_pred cc-eeeeccCchHHHHHHHHHhcCCCcccCCCHHHHhCCCccCC
Confidence 00 00001111117889999999999999999999999999954
|
|
| >KOG1152|consensus | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.8e-30 Score=214.72 Aligned_cols=189 Identities=26% Similarity=0.321 Sum_probs=159.4
Q ss_pred cccceeeeecccCceEEEEEEEcCCCcEEEEEEeccCCCC------hHHHHHHHHHHHHHHhCC---CCCcchhhhhhhc
Q psy758 2 ERYEKIGKLGEGSYGVVFKCRNRDTGQVVAIKKFLESEED------PLIRKIALREIRLLKSLK---HPNLVNLLEVFRR 72 (292)
Q Consensus 2 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~v~iK~~~~~~~~------~~~~~~~~~e~~~~~~l~---~~~i~~~~~~~~~ 72 (292)
..|+..+.||+|+||.|++|.++.+...|++|.|.+...- +...-.+-.|+.++..++ |+||++++++|++
T Consensus 561 s~yttlq~lG~GAyGkV~lai~K~n~~eVViK~I~KeRIL~DtWvrDrkLGtVp~EIqIla~l~~~sH~NIlKlLdfFEd 640 (772)
T KOG1152|consen 561 SDYTTLQPLGEGAYGKVNLAIHKENNYEVVIKMIFKERILVDTWVRDRKLGTVPSEIQILATLNKHSHENILKLLDFFED 640 (772)
T ss_pred ccceeeeeccccccceEEEeeecccceEEEeeehhhhhhhhhhhhcccccCccchhHHHHHHhhhcCccchhhhhheeec
Confidence 4699999999999999999999999999999998765311 111122345999999997 9999999999999
Q ss_pred CCeEEEEEecCC-CccHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEEccCCcEEEeecCchhhh
Q psy758 73 KKKLHLVFEFCD-HTVLNELENHPHGLPWDLIKQITWQVLRGVSYCHRHACIHRDIKPENILLTANGVVKLCDFGFARLI 151 (292)
Q Consensus 73 ~~~~~iv~e~~~-~~~L~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~givH~dl~p~Nilv~~~~~~kl~dfg~~~~~ 151 (292)
++++|+++|-.+ |-+|.+++....+++|..+..|+.|++.|+++||++||||||||-+|+.++.+|.+||+|||.+...
T Consensus 641 dd~yyl~te~hg~gIDLFd~IE~kp~m~E~eAk~IFkQV~agi~hlh~~~ivhrdikdenvivd~~g~~klidfgsaa~~ 720 (772)
T KOG1152|consen 641 DDYYYLETEVHGEGIDLFDFIEFKPRMDEPEAKLIFKQVVAGIKHLHDQGIVHRDIKDENVIVDSNGFVKLIDFGSAAYT 720 (772)
T ss_pred CCeeEEEecCCCCCcchhhhhhccCccchHHHHHHHHHHHhccccccccCceecccccccEEEecCCeEEEeeccchhhh
Confidence 999999999764 6779999998889999999999999999999999999999999999999999999999999998766
Q ss_pred hcc---ccccccccccccccccCCC------CCCCcccceeeecCCCC
Q psy758 152 RDL---IPRHLHIFQTNEYFKGVSL------PHAENVVPLEIKIGKPA 190 (292)
Q Consensus 152 ~~~---~~~~~~~~~~~~~~~~~~~------~~~~~~~~~~~~~~~~~ 190 (292)
.+. ...++..|.+||...|+.+ .|+.|+..|.+.+.+.+
T Consensus 721 ksgpfd~f~gtv~~aapevl~g~~y~gk~qdiwalgillytivykenp 768 (772)
T KOG1152|consen 721 KSGPFDVFVGTVDYAAPEVLGGEKYLGKPQDIWALGILLYTIVYKENP 768 (772)
T ss_pred cCCCcceeeeeccccchhhhCCCccCCCcchhhhhhheeeEEEeccCC
Confidence 542 2345677899998887655 57777777777665544
|
|
| >PLN00113 leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.6e-30 Score=242.70 Aligned_cols=248 Identities=17% Similarity=0.298 Sum_probs=170.1
Q ss_pred ccceeeeecccCceEEEEEEEcCCCcEEEEEEeccCCCChHHHHHHHHHHHHHHhCCCCCcchhhhhhhcCCeEEEEEec
Q psy758 3 RYEKIGKLGEGSYGVVFKCRNRDTGQVVAIKKFLESEEDPLIRKIALREIRLLKSLKHPNLVNLLEVFRRKKKLHLVFEF 82 (292)
Q Consensus 3 ~y~~~~~l~~g~~~~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~iv~e~ 82 (292)
.|...+.||+|+||.||+|.+..++..||+|.+....... ..|+..++.++||||+++++++.+++..++||||
T Consensus 691 ~~~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~------~~~~~~l~~l~HpnIv~~~~~~~~~~~~~lv~Ey 764 (968)
T PLN00113 691 SLKEENVISRGKKGASYKGKSIKNGMQFVVKEINDVNSIP------SSEIADMGKLQHPNIVKLIGLCRSEKGAYLIHEY 764 (968)
T ss_pred hCCcccEEccCCCeeEEEEEECCCCcEEEEEEccCCcccc------HHHHHHHhhCCCCCcceEEEEEEcCCCCEEEEeC
Confidence 4556678999999999999998899999999886443221 2457889999999999999999999999999999
Q ss_pred CCCccHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHH---hCCccccCCCCCceEEccCCcEEEeecCchhhhhc-ccccc
Q psy758 83 CDHTVLNELENHPHGLPWDLIKQITWQVLRGVSYCH---RHACIHRDIKPENILLTANGVVKLCDFGFARLIRD-LIPRH 158 (292)
Q Consensus 83 ~~~~~L~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH---~~givH~dl~p~Nilv~~~~~~kl~dfg~~~~~~~-~~~~~ 158 (292)
+++|+|.++++ .+++..+..++.|++.||+||| +.+++||||||+||+++.++..++. ++....... .....
T Consensus 765 ~~~g~L~~~l~---~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~dlkp~Nil~~~~~~~~~~-~~~~~~~~~~~~~~~ 840 (968)
T PLN00113 765 IEGKNLSEVLR---NLSWERRRKIAIGIAKALRFLHCRCSPAVVVGNLSPEKIIIDGKDEPHLR-LSLPGLLCTDTKCFI 840 (968)
T ss_pred CCCCcHHHHHh---cCCHHHHHHHHHHHHHHHHHhccCCCCCeecCCCCHHhEEECCCCceEEE-eccccccccCCCccc
Confidence 99999999996 4899999999999999999999 6699999999999999998887765 544432211 11223
Q ss_pred ccccccccccccCC-----CCCCCcccceeeecCCCCCCch-----HHHHHHHhhcccCCCCCCChhhhhhccCcCCCCC
Q psy758 159 LHIFQTNEYFKGVS-----LPHAENVVPLEIKIGKPAATNI-----YLIDFLKRCLDKDPLRRWSCDQLLRHPYFNGYYF 228 (292)
Q Consensus 159 ~~~~~~~~~~~~~~-----~~~~~~~~~~~~~~~~~~~~~~-----~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~ 228 (292)
+..|.+||+..+.. +.|+.|+..+++.++..++... ............. ................
T Consensus 841 t~~y~aPE~~~~~~~~~~sDv~S~Gvvl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~-----~~~~~~~~~~~~~~~~ 915 (968)
T PLN00113 841 SSAYVAPETRETKDITEKSDIYGFGLILIELLTGKSPADAEFGVHGSIVEWARYCYSDC-----HLDMWIDPSIRGDVSV 915 (968)
T ss_pred cccccCcccccCCCCCcccchhhHHHHHHHHHhCCCCCCcccCCCCcHHHHHHHhcCcc-----chhheeCccccCCCCc
Confidence 35577777765443 3455555555666665543110 0111111111000 0000000000000011
Q ss_pred CCCCccchHHHHhcccCcCCCCCCChhhhhhCCccccee
Q psy758 229 EVPDEMQYEEITQRCLDKDPLRRWSCDQLLRHPYFNGYY 267 (292)
Q Consensus 229 ~~~~~~~l~~li~~~l~~dP~~Rpt~~~il~h~w~~~~~ 267 (292)
+.....++.+++.+||+.||++|||++|+++. +....
T Consensus 916 ~~~~~~~~~~l~~~Cl~~~P~~RPt~~evl~~--L~~~~ 952 (968)
T PLN00113 916 NQNEIVEVMNLALHCTATDPTARPCANDVLKT--LESAS 952 (968)
T ss_pred cHHHHHHHHHHHHhhCcCCchhCcCHHHHHHH--HHHhh
Confidence 11123356789999999999999999999984 55443
|
|
| >cd00180 PKc Catalytic domain of Protein Kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.9e-29 Score=196.11 Aligned_cols=207 Identities=36% Similarity=0.591 Sum_probs=163.2
Q ss_pred ecccCceEEEEEEEcCCCcEEEEEEeccCCCChHHHHHHHHHHHHHHhCCCCCcchhhhhhhcCCeEEEEEecCCCccHH
Q psy758 10 LGEGSYGVVFKCRNRDTGQVVAIKKFLESEEDPLIRKIALREIRLLKSLKHPNLVNLLEVFRRKKKLHLVFEFCDHTVLN 89 (292)
Q Consensus 10 l~~g~~~~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~iv~e~~~~~~L~ 89 (292)
||+|.+|.||++....+++.+++|.+....... ..+.+.+|+..++.++|++++++++++......++++|++++++|.
T Consensus 1 l~~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~~-~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~~~~e~~~~~~l~ 79 (215)
T cd00180 1 LGEGGFGTVYLARDKKTGKKVAIKIIKKEDSSS-LLEELLREIEILKKLNHPNIVKLYGVFEDENHLYLVMEYCEGGSLK 79 (215)
T ss_pred CCcCCceEEEEEEecCCCcEEEEEEeccccchh-HHHHHHHHHHHHHhcCCCCeeeEeeeeecCCeEEEEEecCCCCcHH
Confidence 689999999999999889999999987654432 4567889999999999999999999999889999999999999999
Q ss_pred HHhcCC-CCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEEcc-CCcEEEeecCchhhhhccc-----ccccccc
Q psy758 90 ELENHP-HGLPWDLIKQITWQVLRGVSYCHRHACIHRDIKPENILLTA-NGVVKLCDFGFARLIRDLI-----PRHLHIF 162 (292)
Q Consensus 90 ~~~~~~-~~~~~~~~~~i~~qi~~aL~~LH~~givH~dl~p~Nilv~~-~~~~kl~dfg~~~~~~~~~-----~~~~~~~ 162 (292)
.++... ..++...++.++.+++.++++||+.|++|+||+|.||++++ ++.++|+||+.+....... ......|
T Consensus 80 ~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~~H~dl~~~ni~~~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~ 159 (215)
T cd00180 80 DLLKENEGKLSEDEILRILLQILEGLEYLHSNGIIHRDLKPENILLDSDNGKVKLADFGLSKLLTSDKSLLKTIVGTPAY 159 (215)
T ss_pred HHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHhhEEEeCCCCcEEEecCCceEEccCCcchhhcccCCCCc
Confidence 998765 46899999999999999999999999999999999999999 8999999999987654322 1122223
Q ss_pred ccccccccC-CCCCCCcccceeeecCCCCCCchHHHHHHHhhcccCCCCCCChhhhhhccCcCCCCCCCCCccchHHHHh
Q psy758 163 QTNEYFKGV-SLPHAENVVPLEIKIGKPAATNIYLIDFLKRCLDKDPLRRWSCDQLLRHPYFNGYYFEVPDEMQYEEITQ 241 (292)
Q Consensus 163 ~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~ 241 (292)
.+|+...+. ......+++.+ +..++. + ..+.+++.
T Consensus 160 ~~pe~~~~~~~~~~~~D~~~l-------------g~~~~~-l------------------------------~~~~~~l~ 195 (215)
T cd00180 160 MAPEVLLGKGYYSEKSDIWSL-------------GVILYE-L------------------------------PELKDLIR 195 (215)
T ss_pred cChhHhcccCCCCchhhhHHH-------------HHHHHH-H------------------------------HHHHHHHH
Confidence 333333221 11111111111 111111 1 48899999
Q ss_pred cccCcCCCCCCChhhhhhCC
Q psy758 242 RCLDKDPLRRWSCDQLLRHP 261 (292)
Q Consensus 242 ~~l~~dP~~Rpt~~~il~h~ 261 (292)
+|++.||.+||++.++++|+
T Consensus 196 ~~l~~~p~~R~~~~~l~~~~ 215 (215)
T cd00180 196 KMLQKDPEKRPSAKEILEHL 215 (215)
T ss_pred HHhhCCcccCcCHHHHhhCC
Confidence 99999999999999999875
|
Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which |
| >KOG4278|consensus | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.6e-29 Score=211.38 Aligned_cols=234 Identities=25% Similarity=0.320 Sum_probs=175.2
Q ss_pred cceeeeecccCceEEEEEEEcCCCcEEEEEEeccCCCChHHHHHHHHHHHHHHhCCCCCcchhhhhhhcCCeEEEEEecC
Q psy758 4 YEKIGKLGEGSYGVVFKCRNRDTGQVVAIKKFLESEEDPLIRKIALREIRLLKSLKHPNLVNLLEVFRRKKKLHLVFEFC 83 (292)
Q Consensus 4 y~~~~~l~~g~~~~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~iv~e~~ 83 (292)
.+....||-|.||.||.+.++.-.-.||+|.++... .....|+.|..+|+.+.|||+++++|+|..+...|||+|||
T Consensus 269 ItMkhKLGGGQYGeVYeGvWKkyslTvAVKtLKEDt---MeveEFLkEAAvMKeikHpNLVqLLGVCT~EpPFYIiTEfM 345 (1157)
T KOG4278|consen 269 ITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDT---MEVEEFLKEAAVMKEIKHPNLVQLLGVCTHEPPFYIITEFM 345 (1157)
T ss_pred eeeeeccCCCcccceeeeeeeccceeeehhhhhhcc---hhHHHHHHHHHHHHhhcCccHHHHhhhhccCCCeEEEEecc
Confidence 456778999999999999999888889999885443 34677999999999999999999999999999999999999
Q ss_pred CCccHHHHhcCCC--CCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEEccCCcEEEeecCchhhhhcccccc---
Q psy758 84 DHTVLNELENHPH--GLPWDLIKQITWQVLRGVSYCHRHACIHRDIKPENILLTANGVVKLCDFGFARLIRDLIPRH--- 158 (292)
Q Consensus 84 ~~~~L~~~~~~~~--~~~~~~~~~i~~qi~~aL~~LH~~givH~dl~p~Nilv~~~~~~kl~dfg~~~~~~~~~~~~--- 158 (292)
..|+|.++++.+. .++.-....++.||..|+.||..++++||||...|.||..+..+|+.|||+++.........
T Consensus 346 ~yGNLLdYLRecnr~ev~avvLlyMAtQIsSaMeYLEkknFIHRDLAARNCLVgEnhiVKvADFGLsRlMtgDTYTAHAG 425 (1157)
T KOG4278|consen 346 CYGNLLDYLRECNRSEVPAVVLLYMATQISSAMEYLEKKNFIHRDLAARNCLVGENHIVKVADFGLSRLMTGDTYTAHAG 425 (1157)
T ss_pred cCccHHHHHHHhchhhcchhHHHHHHHHHHHHHHHHHHhhhhhhhhhhhhccccccceEEeeccchhhhhcCCceecccC
Confidence 9999999987643 36777788999999999999999999999999999999999999999999998875422111
Q ss_pred ---ccccccccccccCCCC-----CCCcccceeeecC-CCCCCchHHHHHHHhhcccCCCCCCChhhhhhccCcCCCCC-
Q psy758 159 ---LHIFQTNEYFKGVSLP-----HAENVVPLEIKIG-KPAATNIYLIDFLKRCLDKDPLRRWSCDQLLRHPYFNGYYF- 228 (292)
Q Consensus 159 ---~~~~~~~~~~~~~~~~-----~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~- 228 (292)
..-|.+||.+.-..+. |++++..+++.+. ..++-+....+ .-+++.. ++++
T Consensus 426 AKFPIKWTAPEsLAyNtFSiKSDVWAFGVLLWEIATYGMsPYPGidlSq---------------VY~LLEk----gyRM~ 486 (1157)
T KOG4278|consen 426 AKFPIKWTAPESLAYNTFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQ---------------VYGLLEK----GYRMD 486 (1157)
T ss_pred ccCcccccCcccccccccccchhhHHHHHHHHHHHhcCCCCCCCccHHH---------------HHHHHhc----ccccc
Confidence 1124445444333332 4444444443332 12221222111 1222222 2233
Q ss_pred -CCCCccchHHHHhcccCcCCCCCCChhhhhh
Q psy758 229 -EVPDEMQYEEITQRCLDKDPLRRWSCDQLLR 259 (292)
Q Consensus 229 -~~~~~~~l~~li~~~l~~dP~~Rpt~~~il~ 259 (292)
+..-++.+.+|++.||+++|++||+++|+-+
T Consensus 487 ~PeGCPpkVYeLMraCW~WsPsDRPsFaeiHq 518 (1157)
T KOG4278|consen 487 GPEGCPPKVYELMRACWNWSPSDRPSFAEIHQ 518 (1157)
T ss_pred CCCCCCHHHHHHHHHHhcCCcccCccHHHHHH
Confidence 3334889999999999999999999999844
|
|
| >KOG1167|consensus | Back alignment and domain information |
|---|
Probab=99.96 E-value=3.6e-29 Score=200.01 Aligned_cols=259 Identities=20% Similarity=0.330 Sum_probs=185.2
Q ss_pred cccceeeeecccCceEEEEEEEcC---CCcEEEEEEeccCCCChHHHHHHHHHHHHHHhCC-CCCcchhhhhhhcCCeEE
Q psy758 2 ERYEKIGKLGEGSYGVVFKCRNRD---TGQVVAIKKFLESEEDPLIRKIALREIRLLKSLK-HPNLVNLLEVFRRKKKLH 77 (292)
Q Consensus 2 ~~y~~~~~l~~g~~~~v~~~~~~~---~~~~v~iK~~~~~~~~~~~~~~~~~e~~~~~~l~-~~~i~~~~~~~~~~~~~~ 77 (292)
+.|.++..||.|+|++||+|.+.. .++.||+|.+...... ..+..|++++..+. +.||+++.+.+..++.+.
T Consensus 36 ~~~~~v~kigeGsFssv~~a~~~~~~~~~~~valk~i~~ts~p----~ri~~El~~L~~~gG~~ni~~~~~~~rnnd~v~ 111 (418)
T KOG1167|consen 36 NAYKVVNKIGEGSFSSVYKATDIEQDTKRRYVALKAIYRTSSP----SRILNELEMLYRLGGSDNIIKLNGCFRNNDQVA 111 (418)
T ss_pred hhhhhhccccccchhhhhhhhHhhhccccceEeeeecccccCc----hHHHHHHHHHHHhccchhhhcchhhhccCCeeE
Confidence 468899999999999999999887 7889999998655433 44778999999995 889999999999999999
Q ss_pred EEEecCCCccHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEEccC-CcEEEeecCchhhhhc---
Q psy758 78 LVFEFCDHTVLNELENHPHGLPWDLIKQITWQVLRGVSYCHRHACIHRDIKPENILLTAN-GVVKLCDFGFARLIRD--- 153 (292)
Q Consensus 78 iv~e~~~~~~L~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~givH~dl~p~Nilv~~~-~~~kl~dfg~~~~~~~--- 153 (292)
+|+||++.....++.. .++...+..++..++.||+++|++|||||||||+|++.+.. +.-.|+|||++.....
T Consensus 112 ivlp~~~H~~f~~l~~---~l~~~~i~~Yl~~ll~Al~~~h~~GIvHRDiKpsNFL~n~~t~rg~LvDFgLA~~~d~~~~ 188 (418)
T KOG1167|consen 112 IVLPYFEHDRFRDLYR---SLSLAEIRWYLRNLLKALAHLHKNGIVHRDIKPSNFLYNRRTQRGVLVDFGLAQRYDGYQQ 188 (418)
T ss_pred EEecccCccCHHHHHh---cCCHHHHHHHHHHHHHHhhhhhccCccccCCCccccccccccCCceEEechhHHHHHhhhh
Confidence 9999999999998887 47899999999999999999999999999999999999865 6789999999973210
Q ss_pred ----------------------------------------------ccccccccccccccccc------CCCCCCCcccc
Q psy758 154 ----------------------------------------------LIPRHLHIFQTNEYFKG------VSLPHAENVVP 181 (292)
Q Consensus 154 ----------------------------------------------~~~~~~~~~~~~~~~~~------~~~~~~~~~~~ 181 (292)
....++..|.+||.... ....|+.|++.
T Consensus 189 ~~~s~~~~~~~~~~~~g~~~~~~~~~~~~~p~g~~~~~~~~r~~~~anrAGT~GfRaPEvL~k~~~QttaiDiws~GVI~ 268 (418)
T KOG1167|consen 189 TEHSRSYSGRHATPAMGKDVHCQSVATASKPAGYYRRCNDGRPSERANRAGTPGFRAPEVLFRCPRQTTAIDIWSAGVIL 268 (418)
T ss_pred hhhhhhhhcccCCccccCcccccccccccCCCCceeccCCCccceecccCCCCCCCchHHHhhccCcCCccceeecccee
Confidence 00111223444544432 23457777777
Q ss_pred eeeecCCCCCCch----H-HHH--------HHHh---hccc----CCCCCCChhhhhhc-------cCcC-------CCC
Q psy758 182 LEIKIGKPAATNI----Y-LID--------FLKR---CLDK----DPLRRWSCDQLLRH-------PYFN-------GYY 227 (292)
Q Consensus 182 ~~~~~~~~~~~~~----~-~~~--------~~~~---~~~~----~p~~~~~~~~~~~~-------~~~~-------~~~ 227 (292)
+.++.+..++... . ... -+.+ +.+. .+.+.++..++... .... ...
T Consensus 269 Lslls~~~PFf~a~dd~~al~ei~tifG~~~mrk~A~l~g~~~l~~ksn~~~~~e~~~~f~s~~~~~~~~~~q~n~~~~~ 348 (418)
T KOG1167|consen 269 LSLLSRRYPFFKAKDDADALAEIATIFGSAEMRKCAALPGRILLWQKSNIPTIPELRVNFETLHIESIYKSRQPNTEREI 348 (418)
T ss_pred ehhhccccccccCccccchHHHHHHHhChHHHHHHhhcCCceeeeccccccccHHHHhchhccChhhcccccccceeecc
Confidence 7776665543211 0 000 0111 1111 11222222222211 0000 011
Q ss_pred CCCCCccchHHHHhcccCcCCCCCCChhhhhhCCccccee
Q psy758 228 FEVPDEMQYEEITQRCLDKDPLRRWSCDQLLRHPYFNGYY 267 (292)
Q Consensus 228 ~~~~~~~~l~~li~~~l~~dP~~Rpt~~~il~h~w~~~~~ 267 (292)
+....+..+.+|+.+||..||.+|.||+++|.||||.+..
T Consensus 349 ~~d~~~~~~~dlLdk~le~np~kRitAEeALkHpFF~~~~ 388 (418)
T KOG1167|consen 349 GSDVFPALLLDLLDKCLELNPQKRITAEDALKHPFFDEAD 388 (418)
T ss_pred ccccccHHHHHHHHHHccCChhhcccHHHHhcCcCCcchh
Confidence 1122255788999999999999999999999999999643
|
|
| >KOG3653|consensus | Back alignment and domain information |
|---|
Probab=99.96 E-value=3e-29 Score=203.06 Aligned_cols=240 Identities=21% Similarity=0.352 Sum_probs=173.6
Q ss_pred ccceeeeecccCceEEEEEEEcCCCcEEEEEEeccCCCChHHHHHHHHHHHHHHhC--CCCCcchhhhhhhcCC----eE
Q psy758 3 RYEKIGKLGEGSYGVVFKCRNRDTGQVVAIKKFLESEEDPLIRKIALREIRLLKSL--KHPNLVNLLEVFRRKK----KL 76 (292)
Q Consensus 3 ~y~~~~~l~~g~~~~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~e~~~~~~l--~~~~i~~~~~~~~~~~----~~ 76 (292)
-.++.+.+|+|.||.||+|+.. ++.||||+++.. ..+.+..|.++++.. +|+||+++++.-.... .+
T Consensus 211 pl~l~eli~~Grfg~V~KaqL~--~~~VAVKifp~~-----~kqs~~~Ek~Iy~lp~m~h~nIl~Fi~~ekr~t~~~~ey 283 (534)
T KOG3653|consen 211 PLQLLELIGRGRFGCVWKAQLD--NRLVAVKIFPEQ-----EKQSFQNEKNIYSLPGMKHENILQFIGAEKRGTADRMEY 283 (534)
T ss_pred chhhHHHhhcCccceeehhhcc--CceeEEEecCHH-----HHHHHHhHHHHHhccCccchhHHHhhchhccCCccccce
Confidence 3467788999999999999876 689999999754 356677788887765 7999999999866444 79
Q ss_pred EEEEecCCCccHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhC---------CccccCCCCCceEEccCCcEEEeecCc
Q psy758 77 HLVFEFCDHTVLNELENHPHGLPWDLIKQITWQVLRGVSYCHRH---------ACIHRDIKPENILLTANGVVKLCDFGF 147 (292)
Q Consensus 77 ~iv~e~~~~~~L~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~---------givH~dl~p~Nilv~~~~~~kl~dfg~ 147 (292)
++|++|.+.|+|.++++.+ .++.....+++.-+++||+|||.- +|+|||||..||||.+|++..|+|||+
T Consensus 284 wLVt~fh~kGsL~dyL~~n-tisw~~~cria~SmarGLa~LHee~p~~d~~Kp~IaHRDlkSkNVLvK~DlTccIaDFGL 362 (534)
T KOG3653|consen 284 WLVTEFHPKGSLCDYLKAN-TISWNSLCRIAESMARGLAHLHEELPRGDHHKPPIAHRDLKSKNVLVKNDLTCCIADFGL 362 (534)
T ss_pred eEEeeeccCCcHHHHHHhc-cccHHHHHHHHHHHHHHHHHhcccCCcCCCCCCccccccccccceEEccCCcEEeeccce
Confidence 9999999999999999986 699999999999999999999972 599999999999999999999999999
Q ss_pred hhhhhccc-------cccccccccccccccCCCCCC------CcccceeeecCCCCCCchHHHHHHHhhcccCC----CC
Q psy758 148 ARLIRDLI-------PRHLHIFQTNEYFKGVSLPHA------ENVVPLEIKIGKPAATNIYLIDFLKRCLDKDP----LR 210 (292)
Q Consensus 148 ~~~~~~~~-------~~~~~~~~~~~~~~~~~~~~~------~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~p----~~ 210 (292)
+..+.... ..++..|.+||..-|.....- .++++. .-.++.++..|-...| ..
T Consensus 363 Al~~~p~~~~~d~~~qVGT~RYMAPEvLEgainl~d~~Afkr~DvYam----------gLVLWEi~SRC~~~~~~~vp~Y 432 (534)
T KOG3653|consen 363 ALRLEPGKPQGDTHGQVGTRRYMAPEVLEGAINLQDRDAFKRIDVYAM----------GLVLWEIASRCTDADPGPVPEY 432 (534)
T ss_pred eEEecCCCCCcchhhhhhhhhhcCHHHHhhhcccccHHHHHHHHHHHH----------HHHHHHHHhhcccccCCCCCcc
Confidence 98876322 233456777777766544320 111111 2223344444443322 11
Q ss_pred CCChh-hhhhccCcCCC----------------CCCCCCccchHHHHhcccCcCCCCCCChhhhhhC
Q psy758 211 RWSCD-QLLRHPYFNGY----------------YFEVPDEMQYEEITQRCLDKDPLRRWSCDQLLRH 260 (292)
Q Consensus 211 ~~~~~-~~~~~~~~~~~----------------~~~~~~~~~l~~li~~~l~~dP~~Rpt~~~il~h 260 (292)
.+.++ ++-.||-+... -..-.....+++.+..||..||+.|.||.=+-+.
T Consensus 433 qlpfe~evG~hPt~e~mq~~VV~kK~RP~~p~~W~~h~~~~~l~et~EeCWDhDaeARLTA~Cv~eR 499 (534)
T KOG3653|consen 433 QLPFEAEVGNHPTLEEMQELVVRKKQRPKIPDAWRKHAGMAVLCETIEECWDHDAEARLTAGCVEER 499 (534)
T ss_pred cCchhHHhcCCCCHHHHHHHHHhhccCCCChhhhhcCccHHHHHHHHHHHcCCchhhhhhhHHHHHH
Confidence 11222 33333332211 1111234567899999999999999999866553
|
|
| >KOG0200|consensus | Back alignment and domain information |
|---|
Probab=99.95 E-value=8e-28 Score=212.74 Aligned_cols=245 Identities=25% Similarity=0.376 Sum_probs=183.0
Q ss_pred ceeeeecccCceEEEEEEEcC-------CCcEEEEEEeccCCCChHHHHHHHHHHHHHHhCC-CCCcchhhhhhhcCCeE
Q psy758 5 EKIGKLGEGSYGVVFKCRNRD-------TGQVVAIKKFLESEEDPLIRKIALREIRLLKSLK-HPNLVNLLEVFRRKKKL 76 (292)
Q Consensus 5 ~~~~~l~~g~~~~v~~~~~~~-------~~~~v~iK~~~~~~~~~~~~~~~~~e~~~~~~l~-~~~i~~~~~~~~~~~~~ 76 (292)
.+.+.||+|.||.|++|.... ....||+|.+...... ...+.+..|+.+++.+. |+||+.++|.+...+.+
T Consensus 299 ~~~~~lg~g~fG~v~~~~~~~~~~~~~~~~~~VaVK~~k~~~~~-~~~~~~~~El~~m~~~g~H~niv~llG~~t~~~~~ 377 (609)
T KOG0200|consen 299 KLGKYLGEGAFGQVVKALLFGLSKALLSIYVTVAVKMLKENASS-SEKKDLMSELNVLKELGKHPNIVNLLGACTQDGPL 377 (609)
T ss_pred cccceeecccccceEeEEEeecccccccceEEEEEEecccccCc-HHHHHHHHHHHHHHHhcCCcchhhheeeeccCCce
Confidence 566799999999999997431 1346999998877666 66788999999999995 99999999999999999
Q ss_pred EEEEecCCCccHHHHhcCCC----------------CCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEEccCCcE
Q psy758 77 HLVFEFCDHTVLNELENHPH----------------GLPWDLIKQITWQVLRGVSYCHRHACIHRDIKPENILLTANGVV 140 (292)
Q Consensus 77 ~iv~e~~~~~~L~~~~~~~~----------------~~~~~~~~~i~~qi~~aL~~LH~~givH~dl~p~Nilv~~~~~~ 140 (292)
++|.||+..|+|..+++..+ .++......++.||+.|++||++.+++||||.++|||+..+..+
T Consensus 378 ~~v~Ey~~~G~L~~~Lr~~r~~~~~~~~~~~~~~~~~L~~~dLlsfa~QIa~GMe~L~~~~~vHRDLAaRNVLi~~~~~~ 457 (609)
T KOG0200|consen 378 YVIVEYAEHGDLLEFLRKKRVTESIDGSGVFPNERDALTTKDLLSFAYQIANGMEYLASVPCVHRDLAARNVLITKNKVI 457 (609)
T ss_pred EEEEEeccCCcHHHHHHhccccccccccCCCccccCCcCHHHHHHHHHHHHHHHHHHhhCCccchhhhhhhEEecCCCEE
Confidence 99999999999999998765 38889999999999999999999999999999999999999999
Q ss_pred EEeecCchhhhhcccc---cc-----ccccccccccccCCCCCCCcccceeeecCCCCCCchHHHHHHHhhcccCCCCCC
Q psy758 141 KLCDFGFARLIRDLIP---RH-----LHIFQTNEYFKGVSLPHAENVVPLEIKIGKPAATNIYLIDFLKRCLDKDPLRRW 212 (292)
Q Consensus 141 kl~dfg~~~~~~~~~~---~~-----~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~ 212 (292)
||+|||+++....... .. ..-+.+||-.....+....++|++++...+.. -++..|....
T Consensus 458 kIaDFGlar~~~~~~~y~~~~~~~~LP~kWmApEsl~~~~ft~kSDVWSfGI~L~Eif------------sLG~~PYp~~ 525 (609)
T KOG0200|consen 458 KIADFGLARDHYNKDYYRTKSSAGTLPVKWMAPESLFDRVFTSKSDVWSFGILLWEIF------------TLGGTPYPGI 525 (609)
T ss_pred EEccccceeccCCCCceEecCCCCccceeecCHHHhccCcccccchhhHHHHHHHHHh------------hCCCCCCCCC
Confidence 9999999985432111 11 11134444444433333444444443322221 2344555443
Q ss_pred C-hhhhhhccCcCCCCCCCCC--ccchHHHHhcccCcCCCCCCChhhhhhCCcccc
Q psy758 213 S-CDQLLRHPYFNGYYFEVPD--EMQYEEITQRCLDKDPLRRWSCDQLLRHPYFNG 265 (292)
Q Consensus 213 ~-~~~~~~~~~~~~~~~~~~~--~~~l~~li~~~l~~dP~~Rpt~~~il~h~w~~~ 265 (292)
. ..+++. ....+.+.+.+. +.++.++++.||+.+|.+||+..++.+ +|..
T Consensus 526 ~~~~~l~~-~l~~G~r~~~P~~c~~eiY~iM~~CW~~~p~~RP~F~~~~~--~~~~ 578 (609)
T KOG0200|consen 526 PPTEELLE-FLKEGNRMEQPEHCSDEIYDLMKSCWNADPEDRPTFSECVE--FFEK 578 (609)
T ss_pred CcHHHHHH-HHhcCCCCCCCCCCCHHHHHHHHHHhCCCcccCCCHHHHHH--HHHH
Confidence 3 444433 233344443333 778899999999999999999999988 5555
|
|
| >KOG2052|consensus | Back alignment and domain information |
|---|
Probab=99.95 E-value=7.9e-28 Score=193.54 Aligned_cols=143 Identities=25% Similarity=0.451 Sum_probs=125.6
Q ss_pred ccceeeeecccCceEEEEEEEcCCCcEEEEEEeccCCCChHHHHHHHHHHHHHHhC--CCCCcchhhhhhhcCC----eE
Q psy758 3 RYEKIGKLGEGSYGVVFKCRNRDTGQVVAIKKFLESEEDPLIRKIALREIRLLKSL--KHPNLVNLLEVFRRKK----KL 76 (292)
Q Consensus 3 ~y~~~~~l~~g~~~~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~e~~~~~~l--~~~~i~~~~~~~~~~~----~~ 76 (292)
+-++++.||+|.||.||+|.+. |+.||+|++...+ ++.+.+|.++.+.. +|+||+.+++.-..++ .+
T Consensus 212 qI~L~e~IGkGRyGEVwrG~wr--Ge~VAVKiF~srd-----E~SWfrEtEIYqTvmLRHENILgFIaaD~~~~gs~TQL 284 (513)
T KOG2052|consen 212 QIVLQEIIGKGRFGEVWRGRWR--GEDVAVKIFSSRD-----ERSWFRETEIYQTVMLRHENILGFIAADNKDNGSWTQL 284 (513)
T ss_pred eeEEEEEecCccccceeecccc--CCceEEEEecccc-----hhhhhhHHHHHHHHHhccchhhhhhhccccCCCceEEE
Confidence 4578999999999999999998 8999999996554 35677888888775 8999999998855332 58
Q ss_pred EEEEecCCCccHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhC--------CccccCCCCCceEEccCCcEEEeecCch
Q psy758 77 HLVFEFCDHTVLNELENHPHGLPWDLIKQITWQVLRGVSYCHRH--------ACIHRDIKPENILLTANGVVKLCDFGFA 148 (292)
Q Consensus 77 ~iv~e~~~~~~L~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~--------givH~dl~p~Nilv~~~~~~kl~dfg~~ 148 (292)
|+|++|.+.|+|.+++++. .++......++..++.||+|||.. .|.|||||..||||.+++...|+|+|++
T Consensus 285 wLvTdYHe~GSL~DyL~r~-tv~~~~ml~LalS~AsGLaHLH~eI~GTqgKPaIAHRDlKSKNILVKkn~~C~IADLGLA 363 (513)
T KOG2052|consen 285 WLVTDYHEHGSLYDYLNRN-TVTTEGMLKLALSIASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLA 363 (513)
T ss_pred EEeeecccCCcHHHHHhhc-cCCHHHHHHHHHHHhhhHHHHHHHHhcCCCCchhhccccccccEEEccCCcEEEeeceee
Confidence 9999999999999999984 799999999999999999999963 4999999999999999999999999999
Q ss_pred hhhhc
Q psy758 149 RLIRD 153 (292)
Q Consensus 149 ~~~~~ 153 (292)
....+
T Consensus 364 v~h~~ 368 (513)
T KOG2052|consen 364 VRHDS 368 (513)
T ss_pred EEecc
Confidence 77543
|
|
| >KOG1345|consensus | Back alignment and domain information |
|---|
Probab=99.95 E-value=1.4e-27 Score=180.93 Aligned_cols=245 Identities=20% Similarity=0.300 Sum_probs=185.6
Q ss_pred cccceeeeecccCceEEEEEEEcCCCcEEEEEEeccCCCChHHHHHHHHHHHHHHhCC-CCCcchhhhh-hhcCCeEEEE
Q psy758 2 ERYEKIGKLGEGSYGVVFKCRNRDTGQVVAIKKFLESEEDPLIRKIALREIRLLKSLK-HPNLVNLLEV-FRRKKKLHLV 79 (292)
Q Consensus 2 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~e~~~~~~l~-~~~i~~~~~~-~~~~~~~~iv 79 (292)
+.|++.+.||.|.||.+-++.++.++..+|+|.++.+-.. .+.|.+|...--.|+ |.||+..|++ |+..+.+.++
T Consensus 24 d~y~I~k~lgeG~FgkIlL~eHr~s~t~ivlKavp~p~tt---~~dF~rEfhY~~~Ls~H~hIi~tY~vaFqt~d~YvF~ 100 (378)
T KOG1345|consen 24 DVYTINKQLGEGRFGKILLAEHRQSKTRIVLKAVPRPQTT---QADFVREFHYSFFLSPHQHIIDTYEVAFQTSDAYVFV 100 (378)
T ss_pred hhhhHHHHhcccceeeEEeeeccCCceEEEeeccCcchhh---HHHHHHHhccceeeccchhhhHHHHHHhhcCceEEEe
Confidence 5799999999999999999999999999999999776543 466788888877776 8899998877 6788899999
Q ss_pred EecCCCccHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEEcc--CCcEEEeecCchhhhhccc--
Q psy758 80 FEFCDHTVLNELENHPHGLPWDLIKQITWQVLRGVSYCHRHACIHRDIKPENILLTA--NGVVKLCDFGFARLIRDLI-- 155 (292)
Q Consensus 80 ~e~~~~~~L~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~givH~dl~p~Nilv~~--~~~~kl~dfg~~~~~~~~~-- 155 (292)
+||++.|+|..-+... .+.|.....++.|+++|+.|+|++++||||||.+||||-. ...+||||||.....+...
T Consensus 101 qE~aP~gdL~snv~~~-GigE~~~K~v~~ql~SAi~fMHsknlVHRdlK~eNiLif~~df~rvKlcDFG~t~k~g~tV~~ 179 (378)
T KOG1345|consen 101 QEFAPRGDLRSNVEAA-GIGEANTKKVFAQLLSAIEFMHSKNLVHRDLKAENILIFDADFYRVKLCDFGLTRKVGTTVKY 179 (378)
T ss_pred eccCccchhhhhcCcc-cccHHHHHHHHHHHHHHHHHhhccchhhcccccceEEEecCCccEEEeeecccccccCceehh
Confidence 9999999999988764 5899999999999999999999999999999999999964 3589999999988765322
Q ss_pred ccccccccccccc----------ccCCCCCCCcccceeeecCCCCCCchH-----HHHHHHhhcccCCCCCCChhhhhhc
Q psy758 156 PRHLHIFQTNEYF----------KGVSLPHAENVVPLEIKIGKPAATNIY-----LIDFLKRCLDKDPLRRWSCDQLLRH 220 (292)
Q Consensus 156 ~~~~~~~~~~~~~----------~~~~~~~~~~~~~~~~~~~~~~~~~~~-----~~~~~~~~~~~~p~~~~~~~~~~~~ 220 (292)
......|.+|+.. .+....|.+|+..+-+++|.+++.... .+..+.-.-+.+|...
T Consensus 180 ~~~~~~y~~pe~~~~~~ne~~~~~ps~D~WqfGIi~f~cltG~~PWQka~~~d~~Y~~~~~w~~rk~~~~P--------- 250 (378)
T KOG1345|consen 180 LEYVNNYHAPELCDTVVNEKLVVNPSTDIWQFGIIFFYCLTGKFPWQKASIMDKPYWEWEQWLKRKNPALP--------- 250 (378)
T ss_pred hhhhcccCCcHHHhhccccceEecccccchheeeeeeeeecCCCcchhhhccCchHHHHHHHhcccCccCc---------
Confidence 1222334444432 355668999999999999998864222 1222222222222000
Q ss_pred cCcCCCCCCCCCccchHHHHhcccCcCCCCC---CChhhhhhCCcccc
Q psy758 221 PYFNGYYFEVPDEMQYEEITQRCLDKDPLRR---WSCDQLLRHPYFNG 265 (292)
Q Consensus 221 ~~~~~~~~~~~~~~~l~~li~~~l~~dP~~R---pt~~~il~h~w~~~ 265 (292)
..| .+.++.+..+.++-|..+|++| .+++......|...
T Consensus 251 ~~F------~~fs~~a~r~Fkk~lt~~~~drcki~~~kk~rk~~w~E~ 292 (378)
T KOG1345|consen 251 KKF------NPFSEKALRLFKKSLTPRFKDRCKIWTAKKMRKCLWKEK 292 (378)
T ss_pred hhh------cccCHHHHHHHHHhcCCcccccchhHHHHHHHHHHHHHh
Confidence 001 1225677889999999999999 56666666666653
|
|
| >PRK09188 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.95 E-value=7.6e-27 Score=192.06 Aligned_cols=140 Identities=26% Similarity=0.345 Sum_probs=115.3
Q ss_pred cccceeeeecccCceEEEEEEEcC-CCcEEEEEEeccCC---CChHHHHHHHHHHHHHHhCCCCCcch-hhhhhhcCCeE
Q psy758 2 ERYEKIGKLGEGSYGVVFKCRNRD-TGQVVAIKKFLESE---EDPLIRKIALREIRLLKSLKHPNLVN-LLEVFRRKKKL 76 (292)
Q Consensus 2 ~~y~~~~~l~~g~~~~v~~~~~~~-~~~~v~iK~~~~~~---~~~~~~~~~~~e~~~~~~l~~~~i~~-~~~~~~~~~~~ 76 (292)
++|++.+.||+|+||.||+|++.. +++.||+|.+.... ........+.+|+++++.++|+|+++ +++ .+..
T Consensus 18 ~~Y~~~~~IG~G~fg~Vy~a~~~~~~~~~vAiK~~~~~~~~~~~~~~~~~~~~E~~iL~~L~h~~iv~~l~~----~~~~ 93 (365)
T PRK09188 18 ARFVETAVLKRDVFSTVERGYFAGDPGTARAVRRRVSEVPWWSKPLARHLAAREIRALKTVRGIGVVPQLLA----TGKD 93 (365)
T ss_pred CCceEccEEeecCcEEEEEEEEcCCCCeEEEEEEecccccccccHHHHHHHHHHHHHHHhccCCCCCcEEEE----cCCc
Confidence 689999999999999999998876 67778999875331 13345667899999999999999985 443 2458
Q ss_pred EEEEecCCCccHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCC-CCCceEEccCCcEEEeecCchhhhh
Q psy758 77 HLVFEFCDHTVLNELENHPHGLPWDLIKQITWQVLRGVSYCHRHACIHRDI-KPENILLTANGVVKLCDFGFARLIR 152 (292)
Q Consensus 77 ~iv~e~~~~~~L~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~givH~dl-~p~Nilv~~~~~~kl~dfg~~~~~~ 152 (292)
|+||||++|++|... .. .. ...++.|+++||.|||++||+|||| ||+||+++.++.++|+|||+++...
T Consensus 94 ~LVmE~~~G~~L~~~-~~---~~---~~~~~~~i~~aL~~lH~~gIiHrDL~KP~NILv~~~~~ikLiDFGlA~~~~ 163 (365)
T PRK09188 94 GLVRGWTEGVPLHLA-RP---HG---DPAWFRSAHRALRDLHRAGITHNDLAKPQNWLMGPDGEAAVIDFQLASVFR 163 (365)
T ss_pred EEEEEccCCCCHHHh-Cc---cc---hHHHHHHHHHHHHHHHHCCCeeCCCCCcceEEEcCCCCEEEEECccceecc
Confidence 999999999999732 11 11 1467899999999999999999999 9999999999999999999998654
|
|
| >KOG1025|consensus | Back alignment and domain information |
|---|
Probab=99.95 E-value=2e-27 Score=204.08 Aligned_cols=239 Identities=21% Similarity=0.271 Sum_probs=175.9
Q ss_pred ceeeeecccCceEEEEEEEcCCCc----EEEEEEeccCCCChHHHHHHHHHHHHHHhCCCCCcchhhhhhhcCCeEEEEE
Q psy758 5 EKIGKLGEGSYGVVFKCRNRDTGQ----VVAIKKFLESEEDPLIRKIALREIRLLKSLKHPNLVNLLEVFRRKKKLHLVF 80 (292)
Q Consensus 5 ~~~~~l~~g~~~~v~~~~~~~~~~----~v~iK~~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~iv~ 80 (292)
...+.||+|+||+||++...-.|+ +|++|++...... .....+..|...+.+++|||++++++++.... +.+|+
T Consensus 699 kk~kvLGsgAfGtV~kGiw~Pege~vKipVaiKvl~~~t~~-~~s~e~LdeAl~masldHpnl~RLLgvc~~s~-~qlvt 776 (1177)
T KOG1025|consen 699 KKDKVLGSGAFGTVYKGIWIPEGENVKIPVAIKVLIEFTSP-KASIELLDEALRMASLDHPNLLRLLGVCMLST-LQLVT 776 (1177)
T ss_pred hhhceeccccceeEEeeeEecCCceecceeEEEEeeccCCc-hhhHHHHHHHHHHhcCCCchHHHHhhhcccch-HHHHH
Confidence 456789999999999998876665 5788887654433 34566889999999999999999999998655 88999
Q ss_pred ecCCCccHHHHhcCC-CCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEEccCCcEEEeecCchhhhhccccccc
Q psy758 81 EFCDHTVLNELENHP-HGLPWDLIKQITWQVLRGVSYCHRHACIHRDIKPENILLTANGVVKLCDFGFARLIRDLIPRHL 159 (292)
Q Consensus 81 e~~~~~~L~~~~~~~-~~~~~~~~~~i~~qi~~aL~~LH~~givH~dl~p~Nilv~~~~~~kl~dfg~~~~~~~~~~~~~ 159 (292)
+|+++|.|.++++.. ..+..+....|+.||++|+.|||.+++|||||..+||||..-..+||.|||+++.+......-.
T Consensus 777 q~mP~G~LlDyvr~hr~~igsq~lLnw~~QIAkgM~YLe~qrlVHrdLaaRNVLVksP~hvkitdfgla~ll~~d~~ey~ 856 (1177)
T KOG1025|consen 777 QLMPLGCLLDYVREHRDNIGSQDLLNWCYQIAKGMKYLEEQRLVHRDLAARNVLVKSPNHVKITDFGLAKLLAPDEKEYS 856 (1177)
T ss_pred HhcccchHHHHHHHhhccccHHHHHHHHHHHHHHHHHHHhcchhhhhhhhhheeecCCCeEEEEecchhhccCccccccc
Confidence 999999999988653 4688899999999999999999999999999999999999999999999999987754322111
Q ss_pred c--ccccccccccC-----CCCCCCcccceeeecCCCCCCchHHHHHHHh-hcccCCCCCCChhhhhhccCcCCCCCCC-
Q psy758 160 H--IFQTNEYFKGV-----SLPHAENVVPLEIKIGKPAATNIYLIDFLKR-CLDKDPLRRWSCDQLLRHPYFNGYYFEV- 230 (292)
Q Consensus 160 ~--~~~~~~~~~~~-----~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~p~~~~~~~~~~~~~~~~~~~~~~- 230 (292)
. .-.++.|.+-+ .+....++|++++ .+.+. .++..|..+.+.+++-...- .+-+.+.
T Consensus 857 ~~~gK~pikwmale~i~~~~~thqSDVWsfGV-------------tiWElmTFGa~Py~gi~~~eI~dlle-~geRLsqP 922 (1177)
T KOG1025|consen 857 APGGKVPIKWMALESIRIRKYTHQSDVWSFGV-------------TIWELMTFGAKPYDGIPAEEIPDLLE-KGERLSQP 922 (1177)
T ss_pred ccccccCcHHHHHHHhhccCCCchhhhhhhhh-------------hHHHHHhcCCCccCCCCHHHhhHHHh-ccccCCCC
Confidence 0 01112222111 1122333333322 22222 34777888888877743211 1222322
Q ss_pred -CCccchHHHHhcccCcCCCCCCChhhhhh
Q psy758 231 -PDEMQYEEITQRCLDKDPLRRWSCDQLLR 259 (292)
Q Consensus 231 -~~~~~l~~li~~~l~~dP~~Rpt~~~il~ 259 (292)
.-+..+.-++.+||..|+..||+++++.+
T Consensus 923 piCtiDVy~~mvkCwmid~~~rp~fkel~~ 952 (1177)
T KOG1025|consen 923 PICTIDVYMVMVKCWMIDADSRPTFKELAE 952 (1177)
T ss_pred CCccHHHHHHHHHHhccCcccCccHHHHHH
Confidence 23667889999999999999999998865
|
|
| >cd05147 RIO1_euk RIO kinase family; eukaryotic RIO1, catalytic domain | Back alignment and domain information |
|---|
Probab=99.94 E-value=1.5e-26 Score=175.67 Aligned_cols=142 Identities=20% Similarity=0.192 Sum_probs=111.3
Q ss_pred eeeecccCceEEEEEEEcCCCcEEEEEEeccCCCChH------------------------HHHHHHHHHHHHHhCCCCC
Q psy758 7 IGKLGEGSYGVVFKCRNRDTGQVVAIKKFLESEEDPL------------------------IRKIALREIRLLKSLKHPN 62 (292)
Q Consensus 7 ~~~l~~g~~~~v~~~~~~~~~~~v~iK~~~~~~~~~~------------------------~~~~~~~e~~~~~~l~~~~ 62 (292)
.+.||+|++|.||+|.+. +|+.||+|++........ ......+|...+..+.+++
T Consensus 2 ~~~ig~G~~~~Vy~a~~~-~g~~vAvKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~ 80 (190)
T cd05147 2 NGCISTGKEANVYHATTA-NGEERAIKIYKTSILVFKDRDRYVSGEFRFRHGYCKSNPRKMVRTWAEKEMRNLKRLVTAG 80 (190)
T ss_pred CCccccccceEEEEEECC-CCCEEEEEEEEecccccccHHHhhcCCchhhccccCCCHHHHHHHHHHHHHHHHHHHHHCC
Confidence 568999999999999997 899999999965421110 1123345999999998877
Q ss_pred cchhhhhhhcCCeEEEEEecCCCccHHHHhcCCCCCCHHHHHHHHHHHHHHHHHH-HhCCccccCCCCCceEEccCCcEE
Q psy758 63 LVNLLEVFRRKKKLHLVFEFCDHTVLNELENHPHGLPWDLIKQITWQVLRGVSYC-HRHACIHRDIKPENILLTANGVVK 141 (292)
Q Consensus 63 i~~~~~~~~~~~~~~iv~e~~~~~~L~~~~~~~~~~~~~~~~~i~~qi~~aL~~L-H~~givH~dl~p~Nilv~~~~~~k 141 (292)
+.....+.. ...++||||++|+++.........+++..+..++.|++.+|.++ |+.|++||||||+||+++ ++.++
T Consensus 81 v~~p~~~~~--~~~~iVmE~i~g~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~l~H~~giiHrDlkP~NIli~-~~~v~ 157 (190)
T cd05147 81 IPCPEPILL--KSHVLVMEFIGDDGWAAPRLKDAPLSESKARELYLQVIQIMRILYQDCRLVHADLSEYNLLYH-DGKLY 157 (190)
T ss_pred CCCCcEEEe--cCCEEEEEEeCCCCCcchhhhcCCCCHHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEEE-CCcEE
Confidence 644332222 22389999999987765533345799999999999999999999 799999999999999998 47899
Q ss_pred EeecCchhhhh
Q psy758 142 LCDFGFARLIR 152 (292)
Q Consensus 142 l~dfg~~~~~~ 152 (292)
|+|||++....
T Consensus 158 LiDFG~a~~~~ 168 (190)
T cd05147 158 IIDVSQSVEHD 168 (190)
T ss_pred EEEccccccCC
Confidence 99999997543
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. This subfamily is composed of RIO1 proteins from eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle progression and c |
| >KOG0984|consensus | Back alignment and domain information |
|---|
Probab=99.93 E-value=1.5e-25 Score=163.57 Aligned_cols=183 Identities=26% Similarity=0.449 Sum_probs=146.8
Q ss_pred eeeeecccCceEEEEEEEcCCCcEEEEEEeccCCCChHHHHHHHHHHHHHHhC-CCCCcchhhhhhhcCCeEEEEEecCC
Q psy758 6 KIGKLGEGSYGVVFKCRNRDTGQVVAIKKFLESEEDPLIRKIALREIRLLKSL-KHPNLVNLLEVFRRKKKLHLVFEFCD 84 (292)
Q Consensus 6 ~~~~l~~g~~~~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~e~~~~~~l-~~~~i~~~~~~~~~~~~~~iv~e~~~ 84 (292)
-+..||+|++|.|-..++..+|...|+|.+...-.+. ..++..+|+++.... .+|+++.+||.+..++.+++.||.+.
T Consensus 50 ~i~elGrGayG~vekmrh~~sg~imAvKri~~tvn~q-~q~r~L~dldi~~r~~~CPf~V~FyGa~~regdvwIcME~M~ 128 (282)
T KOG0984|consen 50 GIEELGRGAYGVVEKMRHIQSGTIMAVKRIRATVNSQ-EQKRLLMDLDIIMRTVDCPFTVHFYGALFREGDVWICMELMD 128 (282)
T ss_pred hhhhhcCCccchhhheeeccCCeEEEEeeehhhcChH-HHHHHHHhhhhhccCCCCCeEEEeehhhhccccEEEeHHHhh
Confidence 3567999999999999999999999999998766544 455667777776655 69999999999999999999999997
Q ss_pred CccHHH----HhcCCCCCCHHHHHHHHHHHHHHHHHHHhC-CccccCCCCCceEEccCCcEEEeecCchhhhhccc----
Q psy758 85 HTVLNE----LENHPHGLPWDLIKQITWQVLRGVSYCHRH-ACIHRDIKPENILLTANGVVKLCDFGFARLIRDLI---- 155 (292)
Q Consensus 85 ~~~L~~----~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~-givH~dl~p~Nilv~~~~~~kl~dfg~~~~~~~~~---- 155 (292)
.. |+. .++.++.++|.-+-+|+..++.||.|||++ .++|||+||+|||++.+|.+|+||||++..+.+..
T Consensus 129 tS-ldkfy~~v~~~g~~ipE~vlGkIa~Svv~al~~L~~kL~vIHRDvKPsNiLIn~~GqVKiCDFGIsG~L~dSiAkt~ 207 (282)
T KOG0984|consen 129 TS-LDKFYRKVLKKGGTIPEDVLGKIAVSVVHALEFLHSKLSVIHRDVKPSNILINYDGQVKICDFGISGYLVDSIAKTM 207 (282)
T ss_pred hh-HHHHHHHHHhcCCcCchHHhhHhHHHHHHHHHHHHHHhhhhhccCCcceEEEccCCcEEEcccccceeehhhhHHHH
Confidence 53 333 356677899999999999999999999997 79999999999999999999999999998775433
Q ss_pred cccccccccccccccCCC---------CCCCcccceeeecCCCC
Q psy758 156 PRHLHIFQTNEYFKGVSL---------PHAENVVPLEIKIGKPA 190 (292)
Q Consensus 156 ~~~~~~~~~~~~~~~~~~---------~~~~~~~~~~~~~~~~~ 190 (292)
..+...|.+||-..++.. .|++++...++.++..+
T Consensus 208 daGCkpYmaPEri~~e~n~~gY~vksDvWSLGItmiElA~lr~P 251 (282)
T KOG0984|consen 208 DAGCKPYMAPERINPELNQKGYSVKSDVWSLGITMIEMAILRFP 251 (282)
T ss_pred hcCCCccCChhhcCcccCcccceeehhhhhhhhhhhhhhhcccc
Confidence 233456777777655433 36666666666555443
|
|
| >KOG0590|consensus | Back alignment and domain information |
|---|
Probab=99.93 E-value=5.5e-26 Score=198.80 Aligned_cols=257 Identities=23% Similarity=0.260 Sum_probs=185.5
Q ss_pred eeeeecccCceEEEEEEEcCCCcEEEEEEec----cCCCChHHHHHHHHHHHHHHhCCCCCcchhhhhhhcCCeEEEEEe
Q psy758 6 KIGKLGEGSYGVVFKCRNRDTGQVVAIKKFL----ESEEDPLIRKIALREIRLLKSLKHPNLVNLLEVFRRKKKLHLVFE 81 (292)
Q Consensus 6 ~~~~l~~g~~~~v~~~~~~~~~~~v~iK~~~----~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~iv~e 81 (292)
....+|.|++|.++.+......+.+..|.+. ...........+..|+-+-..+.|||++..+..+.+.....-.||
T Consensus 322 ~~~~~g~ga~g~~~~~~~~~~~~~~~~~~~r~~~~~~~s~~~~~~~i~sE~~i~~~l~h~~~~e~l~~~~~~~~~~~~mE 401 (601)
T KOG0590|consen 322 PGRVLGSGAYGSVRIAKRRSDLKSFPEKEFRVRVKPTESERKYNYNITSEFCIGSSLSHPNIIETLDIVQEIDGILQSME 401 (601)
T ss_pred ccceeeecccCceEEEEecCCCccchhhhhhcccCCcccHHHHhhhhhhheeecccccCCchhhhHHHHhhcccchhhhh
Confidence 4678999999999988888777777777554 222222333336678888889999999999998887666666699
Q ss_pred cCCCccHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEEccCCcEEEeecCchhhhhcccc-----
Q psy758 82 FCDHTVLNELENHPHGLPWDLIKQITWQVLRGVSYCHRHACIHRDIKPENILLTANGVVKLCDFGFARLIRDLIP----- 156 (292)
Q Consensus 82 ~~~~~~L~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~givH~dl~p~Nilv~~~~~~kl~dfg~~~~~~~~~~----- 156 (292)
||++ +|..++...+.++...+..++.|++.|++|+|+.|+.|+|+||+|++++.+|.+||+|||.+..+.....
T Consensus 402 ~~~~-Dlf~~~~~~~~~~~~e~~c~fKqL~~Gv~y~h~~GiahrdlK~enll~~~~g~lki~Dfg~~~vf~~~~e~~~~~ 480 (601)
T KOG0590|consen 402 YCPY-DLFSLVMSNGKLTPLEADCFFKQLLRGVKYLHSMGLAHRDLKLENLLVTENGILKIIDFGAASVFRYPWEKNIHE 480 (601)
T ss_pred cccH-HHHHHHhcccccchhhhhHHHHHHHHHHHHHHhcCceeccCccccEEEecCCceEEeecCcceeeccCcchhhhh
Confidence 9999 9999998877899999999999999999999999999999999999999999999999999877653222
Q ss_pred ----ccccccccccccccCCC------CCCCcccceeeecCCCCCCchHHHHHHHhhcccCCCCCCChhhhhhccCcCCC
Q psy758 157 ----RHLHIFQTNEYFKGVSL------PHAENVVPLEIKIGKPAATNIYLIDFLKRCLDKDPLRRWSCDQLLRHPYFNGY 226 (292)
Q Consensus 157 ----~~~~~~~~~~~~~~~~~------~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~ 226 (292)
.+...|.+||...+..+ .|+.++....+.++..+|.-....+-.. ...+.... ........
T Consensus 481 ~~g~~gS~pY~apE~~~~~~ydpr~vDiwS~~ii~~~m~~~~~~Wk~a~~~~~~~------~~~~~~~~---~~~~~~~~ 551 (601)
T KOG0590|consen 481 SSGIVGSDPYLAPEVLTGKEYDPRAVDVWSCGIIYICMILGRFPWKVAKKSDNSF------KTNNYSDQ---RNIFEGPN 551 (601)
T ss_pred hcCcccCCcCcCcccccccccCcchhhhhhccceEEEEecCCCccccccccccch------hhhccccc---cccccChH
Confidence 22345666666655443 4666666666666655542111100000 00000000 00111112
Q ss_pred CCCCCCccchHHHHhcccCcCCCCCCChhhhhhCCcccceeccCCC
Q psy758 227 YFEVPDEMQYEEITQRCLDKDPLRRWSCDQLLRHPYFNGYYFEVPD 272 (292)
Q Consensus 227 ~~~~~~~~~l~~li~~~l~~dP~~Rpt~~~il~h~w~~~~~~~~~~ 272 (292)
......+...+.+|.+||++||.+|.|+++|++.+||+.+..+.-+
T Consensus 552 ~~~~~lp~~~~~~~~~~l~~~P~~R~ti~~i~~d~W~~~i~~c~v~ 597 (601)
T KOG0590|consen 552 RLLSLLPRETRIIIYRMLQLDPTKRITIEQILNDEWIRSIECCHVD 597 (601)
T ss_pred HHHHhchhhHHHHHHHHccCChhheecHHHHhhChHhhhcceEEec
Confidence 2233447788999999999999999999999999999998776543
|
|
| >smart00221 STYKc Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=99.93 E-value=1.2e-24 Score=170.92 Aligned_cols=149 Identities=43% Similarity=0.704 Sum_probs=135.5
Q ss_pred cceeeeecccCceEEEEEEEcCCCcEEEEEEeccCCCChHHHHHHHHHHHHHHhCCCCCcchhhhhhhcCCeEEEEEecC
Q psy758 4 YEKIGKLGEGSYGVVFKCRNRDTGQVVAIKKFLESEEDPLIRKIALREIRLLKSLKHPNLVNLLEVFRRKKKLHLVFEFC 83 (292)
Q Consensus 4 y~~~~~l~~g~~~~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~iv~e~~ 83 (292)
|.+.+.||+|++|.||++....+++.+++|.+...... ...+.+.+|+..++.++|+|++++++.+......++++|++
T Consensus 1 ~~~~~~i~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~-~~~~~~~~e~~~~~~~~~~~i~~~~~~~~~~~~~~~v~e~~ 79 (225)
T smart00221 1 YELGKKLGEGAFGKVYLARDKGTGELVAVKVLKKEKTE-KQREEFLREIRILKKLKHPNIVKLYGVFEDPEPLYLVMEYC 79 (225)
T ss_pred CceeeEeecCCCeEEEEEEEcCCCcEEEEEeeccccch-HHHHHHHHHHHHHHhCCCCChhhheeeeecCCceEEEEecc
Confidence 67889999999999999999988999999998765433 24577889999999999999999999998889999999999
Q ss_pred CCccHHHHhcCCCC-CCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEEccCCcEEEeecCchhhhhc
Q psy758 84 DHTVLNELENHPHG-LPWDLIKQITWQVLRGVSYCHRHACIHRDIKPENILLTANGVVKLCDFGFARLIRD 153 (292)
Q Consensus 84 ~~~~L~~~~~~~~~-~~~~~~~~i~~qi~~aL~~LH~~givH~dl~p~Nilv~~~~~~kl~dfg~~~~~~~ 153 (292)
++++|..++..... +++..++.++.+++.++.+||++|++|+||+|.||+++.++.++|+|||.+.....
T Consensus 80 ~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~i~h~di~~~ni~v~~~~~~~l~d~g~~~~~~~ 150 (225)
T smart00221 80 EGGDLFDYLRKKGGKLSEEEARFYLRQILEALEYLHSLGIVHRDLKPENILLGMDGLVKLADFGLARFIHR 150 (225)
T ss_pred CCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCCEEEeeCceeeEecC
Confidence 99999999887656 89999999999999999999999999999999999999999999999998876644
|
Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase. |
| >cd05145 RIO1_like RIO kinase family; RIO1, RIO3 and similar proteins, catalytic domain | Back alignment and domain information |
|---|
Probab=99.92 E-value=4.9e-25 Score=168.04 Aligned_cols=144 Identities=22% Similarity=0.198 Sum_probs=112.5
Q ss_pred eeeeecccCceEEEEEEEcCCCcEEEEEEeccCCCCh------------------------HHHHHHHHHHHHHHhCCCC
Q psy758 6 KIGKLGEGSYGVVFKCRNRDTGQVVAIKKFLESEEDP------------------------LIRKIALREIRLLKSLKHP 61 (292)
Q Consensus 6 ~~~~l~~g~~~~v~~~~~~~~~~~v~iK~~~~~~~~~------------------------~~~~~~~~e~~~~~~l~~~ 61 (292)
+.+.||+|++|.||+|.+. +|+.||+|++....... .......+|...+..+.++
T Consensus 1 ~~~~ig~G~~~~Vy~a~~~-~g~~vavKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~ 79 (190)
T cd05145 1 INGCISTGKEANVYHARTG-DGEELAVKIYKTSTLSFKDRDKYIEGDPRFRSRYSKSNPRKLVFAWAEKEFRNLKRLYEA 79 (190)
T ss_pred CCceeecCCCcEEEEEEcC-CCCEEEEEEEEcCcceEeeHHHHhcCCcccccccccCCHHHHHHHHHHHHHHHHHHHHhC
Confidence 3578999999999999987 89999999987553110 0122345788999999888
Q ss_pred CcchhhhhhhcCCeEEEEEecCCCccHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHh-CCccccCCCCCceEEccCCcE
Q psy758 62 NLVNLLEVFRRKKKLHLVFEFCDHTVLNELENHPHGLPWDLIKQITWQVLRGVSYCHR-HACIHRDIKPENILLTANGVV 140 (292)
Q Consensus 62 ~i~~~~~~~~~~~~~~iv~e~~~~~~L~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~-~givH~dl~p~Nilv~~~~~~ 140 (292)
++.....+... ..++||||++|+.+.........++...+..++.|++.++.++|+ +|++|+||||+||+++ ++.+
T Consensus 80 ~i~~p~~~~~~--~~~lVmE~~~g~~~~~~~l~~~~~~~~~~~~i~~~l~~~l~~lH~~~givHrDlkP~NIll~-~~~~ 156 (190)
T cd05145 80 GVPVPEPILLK--KNVLVMEFIGDDGSPAPRLKDVPLEEEEAEELYEQVVEQMRRLYQEAGLVHGDLSEYNILYH-DGKP 156 (190)
T ss_pred CCCCceEEEec--CCEEEEEEecCCCchhhhhhhccCCHHHHHHHHHHHHHHHHHHHHhCCEecCCCChhhEEEE-CCCE
Confidence 87443333222 248999999988544332233468889999999999999999999 9999999999999999 8899
Q ss_pred EEeecCchhhhhc
Q psy758 141 KLCDFGFARLIRD 153 (292)
Q Consensus 141 kl~dfg~~~~~~~ 153 (292)
+|+|||++.....
T Consensus 157 ~liDFG~a~~~~~ 169 (190)
T cd05145 157 YIIDVSQAVELDH 169 (190)
T ss_pred EEEEcccceecCC
Confidence 9999999976543
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. In addition, RIO3 is present in multicellular eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle pro |
| >PLN00181 protein SPA1-RELATED; Provisional | Back alignment and domain information |
|---|
Probab=99.91 E-value=6.9e-25 Score=201.23 Aligned_cols=194 Identities=16% Similarity=0.146 Sum_probs=119.0
Q ss_pred hCCC-CCcchhhhhhh-------cCCeEEEEEecCCCccHHHHhcC-CCCCCHHHHHHHHHHHHHHHHHHHhCCccccCC
Q psy758 57 SLKH-PNLVNLLEVFR-------RKKKLHLVFEFCDHTVLNELENH-PHGLPWDLIKQITWQVLRGVSYCHRHACIHRDI 127 (292)
Q Consensus 57 ~l~~-~~i~~~~~~~~-------~~~~~~iv~e~~~~~~L~~~~~~-~~~~~~~~~~~i~~qi~~aL~~LH~~givH~dl 127 (292)
.++| +||.++++++. +...++.++|++ +++|..++.. ...+++..++.++.||+.||+|||++||+||||
T Consensus 28 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~-~~~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~~gIvHrDl 106 (793)
T PLN00181 28 SLSHIDYVRSLLGSHKEGNLDGLDDDSIVRALECE-DVSLRQWLDNPDRSVDAFECFHVFRQIVEIVNAAHSQGIVVHNV 106 (793)
T ss_pred hhhHHHHHHHhhcccCCccccccccchhhhhhccC-CccHHHHHhcccccccHHHHHHHHHHHHHHHHHHHhCCeeeccC
Confidence 4455 57888888772 234567778877 4578888865 345999999999999999999999999999999
Q ss_pred CCCceEEccCCc-------------------EEEeecCchhhhhccc---------------------cccccccccccc
Q psy758 128 KPENILLTANGV-------------------VKLCDFGFARLIRDLI---------------------PRHLHIFQTNEY 167 (292)
Q Consensus 128 ~p~Nilv~~~~~-------------------~kl~dfg~~~~~~~~~---------------------~~~~~~~~~~~~ 167 (292)
||+|||++..+. +|++|||+++...... ...+..|.+||+
T Consensus 107 KP~NiLl~~~~~~k~~d~~~~~~~~~~~~~~~ki~DfG~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~ 186 (793)
T PLN00181 107 RPSCFVMSSFNHVSFIESASCSDSGSDEDATTKSREIGSSRREEILSERRIEKLEEVKKQPFPMKQILAMEMSWYTSPEE 186 (793)
T ss_pred CchhEEEcccCcEEEeeccccCcccccccCcccccccccccccccccccchhhhhccccCCCcccccccCCCcceEChhh
Confidence 999999965444 4555555554321000 011223666666
Q ss_pred cccCCCCCCCcccceeeecCCCCCCchHHHHHHHhhcccCCCCCCC-hhhhhhccCcCCCCCCCCCccchHHHHhcccCc
Q psy758 168 FKGVSLPHAENVVPLEIKIGKPAATNIYLIDFLKRCLDKDPLRRWS-CDQLLRHPYFNGYYFEVPDEMQYEEITQRCLDK 246 (292)
Q Consensus 168 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~-~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~ 246 (292)
..+.......++|++++. +++.+....|..... ....+....+... .........+++.+||++
T Consensus 187 ~~~~~~~~~sDVwSlGvi-------------L~ELl~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~L~~ 251 (793)
T PLN00181 187 DNGSSSNCASDVYRLGVL-------------LFELFCPVSSREEKSRTMSSLRHRVLPPQ--ILLNWPKEASFCLWLLHP 251 (793)
T ss_pred hccCCCCchhhhhhHHHH-------------HHHHhhCCCchhhHHHHHHHHHHhhcChh--hhhcCHHHHHHHHHhCCC
Confidence 555444333333333222 222222222211000 0000001000000 011234567899999999
Q ss_pred CCCCCCChhhhhhCCcccce
Q psy758 247 DPLRRWSCDQLLRHPYFNGY 266 (292)
Q Consensus 247 dP~~Rpt~~~il~h~w~~~~ 266 (292)
||.+|||+.|+++||||...
T Consensus 252 ~P~~Rps~~eil~h~~~~~~ 271 (793)
T PLN00181 252 EPSCRPSMSELLQSEFINEP 271 (793)
T ss_pred ChhhCcChHHHhhchhhhhh
Confidence 99999999999999999863
|
|
| >KOG1024|consensus | Back alignment and domain information |
|---|
Probab=99.89 E-value=4.2e-24 Score=169.87 Aligned_cols=243 Identities=20% Similarity=0.203 Sum_probs=173.6
Q ss_pred ccceeeeecccCceEEEEEEEcC-----CCcEEEEEEeccCCCChHHHHHHHHHHHHHHhCCCCCcchhhhhhh-cCCeE
Q psy758 3 RYEKIGKLGEGSYGVVFKCRNRD-----TGQVVAIKKFLESEEDPLIRKIALREIRLLKSLKHPNLVNLLEVFR-RKKKL 76 (292)
Q Consensus 3 ~y~~~~~l~~g~~~~v~~~~~~~-----~~~~v~iK~~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~-~~~~~ 76 (292)
|+++...+.+|+||.||.|.... +.+.|.+|.+.. ..++.....+..|.-.+..+.|||+.++.++.. +....
T Consensus 285 Rv~l~~llqEGtFGri~~gI~~eEdt~n~~q~v~vKTvk~-~AS~iQv~~~L~es~lly~~sH~nll~V~~V~ie~~~~P 363 (563)
T KOG1024|consen 285 RVRLSCLLQEGTFGRIYRGIWREEDTYNDCQEVLVKTVKQ-HASQIQVNLLLQESMLLYGASHPNLLSVLGVSIEDYATP 363 (563)
T ss_pred heechhhhhcCchhheeeeeecccCCcchHHHHHHHHHHh-cccHHHHHHHHHHHHHHhcCcCCCccceeEEEeeccCcc
Confidence 56667778899999999996653 233466666543 334456777889999999999999999999865 56679
Q ss_pred EEEEecCCCccHHHHhcC--------CCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEEccCCcEEEeecCch
Q psy758 77 HLVFEFCDHTVLNELENH--------PHGLPWDLIKQITWQVLRGVSYCHRHACIHRDIKPENILLTANGVVKLCDFGFA 148 (292)
Q Consensus 77 ~iv~e~~~~~~L~~~~~~--------~~~~~~~~~~~i~~qi~~aL~~LH~~givH~dl~p~Nilv~~~~~~kl~dfg~~ 148 (292)
++++.+.+-|+|..++.. .+.++..+...++.|++.|++|||++|++|.||..+|.+||+.-.+||+|=.++
T Consensus 364 ~V~y~~~~~gNLK~FL~~Cr~~~~~~aqtvtt~qlV~masQla~am~hlh~~~ViHkDiAaRNCvIdd~LqVkltDsaLS 443 (563)
T KOG1024|consen 364 FVLYPATGVGNLKSFLQICRGDDPSYAQTVTTIQLVLMASQLAMAMEHLHNHGVIHKDIAARNCVIDDQLQVKLTDSALS 443 (563)
T ss_pred eEEEeccCcchHHHHHHHhccCCCccccchhHHHHHHHHHHHHHHHHHHHhcCcccchhhhhcceehhheeEEeccchhc
Confidence 999999999999999872 234788888999999999999999999999999999999999999999998888
Q ss_pred hhhhcccc-------ccccccccccccccCCCCCCCcccceeeecCCCCCCchHHHHHHHhhcccCCCCCCChhhhhhcc
Q psy758 149 RLIRDLIP-------RHLHIFQTNEYFKGVSLPHAENVVPLEIKIGKPAATNIYLIDFLKRCLDKDPLRRWSCDQLLRHP 221 (292)
Q Consensus 149 ~~~~~~~~-------~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~ 221 (292)
+.+-+... +..--+.++|-.....+..+.++|+++... +.+ ..++..|.-...+.+.. +-
T Consensus 444 RDLFP~DYhcLGDnEnRPvkWMslEal~n~~yssasDvWsfGVll----------WEL--mtlg~~PyaeIDPfEm~-~y 510 (563)
T KOG1024|consen 444 RDLFPGDYHCLGDNENRPVKWMSLEALQNSHYSSASDVWSFGVLL----------WEL--MTLGKLPYAEIDPFEME-HY 510 (563)
T ss_pred cccCcccccccCCCCCCcccccCHHHHhhhhhcchhhhHHHHHHH----------HHH--HhcCCCCccccCHHHHH-HH
Confidence 75432111 111123344444444444555555553322 111 12345555555444432 22
Q ss_pred CcCCCCCCC--CCccchHHHHhcccCcCCCCCCChhhhhh
Q psy758 222 YFNGYYFEV--PDEMQYEEITQRCLDKDPLRRWSCDQLLR 259 (292)
Q Consensus 222 ~~~~~~~~~--~~~~~l~~li~~~l~~dP~~Rpt~~~il~ 259 (292)
...+++... .-|.++..++.-||+.+|++||+.+|+..
T Consensus 511 lkdGyRlaQP~NCPDeLf~vMacCWallpeeRPsf~Qlv~ 550 (563)
T KOG1024|consen 511 LKDGYRLAQPFNCPDELFTVMACCWALLPEERPSFSQLVI 550 (563)
T ss_pred HhccceecCCCCCcHHHHHHHHHHHhcCcccCCCHHHHHH
Confidence 233444333 33779999999999999999999999875
|
|
| >PRK10359 lipopolysaccharide core biosynthesis protein; Provisional | Back alignment and domain information |
|---|
Probab=99.89 E-value=1.1e-22 Score=156.08 Aligned_cols=140 Identities=14% Similarity=0.159 Sum_probs=114.4
Q ss_pred cccceeeeecccCceEEEEEEEcCCCcEEEEEEeccCCCCh-HHHHH------HHHHHHHHHhCCCCCcchhhhhhhcC-
Q psy758 2 ERYEKIGKLGEGSYGVVFKCRNRDTGQVVAIKKFLESEEDP-LIRKI------ALREIRLLKSLKHPNLVNLLEVFRRK- 73 (292)
Q Consensus 2 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~v~iK~~~~~~~~~-~~~~~------~~~e~~~~~~l~~~~i~~~~~~~~~~- 73 (292)
++|.+.+.+|.|+||.||++.. ++..+|+|.+....... ..... +.+|+..+.++.|++|..+.+++...
T Consensus 31 ~~y~~~~~l~~~~f~~v~l~~~--~~~~~iiKvf~~~~~~~~~~~~~f~~g~~~e~Ea~~l~rL~~~GI~~~~d~~~~~~ 108 (232)
T PRK10359 31 YNIKTIKVFRNIDDTKVSLIDT--DYGKYILKVFAPKVKRTERFLKSFVKGDYYENLIVQTDRVRSEGLASLNDFYLLAE 108 (232)
T ss_pred CceEEEEEecCCCceEEEEEec--CCCcEEEEEechhcCchHHHHHhhhhhHHHHHHHHHHHHHHHCCCCcceEeeeecc
Confidence 5899999999999999999755 36689999996554222 22222 57899999999999999998886532
Q ss_pred -------CeEEEEEecCCCccHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEEccCCcEEEeecC
Q psy758 74 -------KKLHLVFEFCDHTVLNELENHPHGLPWDLIKQITWQVLRGVSYCHRHACIHRDIKPENILLTANGVVKLCDFG 146 (292)
Q Consensus 74 -------~~~~iv~e~~~~~~L~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~givH~dl~p~Nilv~~~~~~kl~dfg 146 (292)
+..+++|||++|.+|.++.. +++ ....+++.+|..+|+.|++|||++|+||+++++| ++|+|||
T Consensus 109 ~~~~~~~~~~~lvmEyi~G~tL~~~~~----~~~----~~~~~i~~~l~~lH~~gi~H~Dikp~Nili~~~g-i~liDfg 179 (232)
T PRK10359 109 RKTLRYAHTYIMLIEYIEGVELNDMPE----ISE----DVKAKIKASIESLHQHGMVSGDPHKGNFIVSKNG-LRIIDLS 179 (232)
T ss_pred cccccccCCeEEEEEEECCccHHHhhh----ccH----HHHHHHHHHHHHHHHcCCccCCCChHHEEEeCCC-EEEEECC
Confidence 35899999999999988742 333 3466999999999999999999999999999999 9999999
Q ss_pred chhhhh
Q psy758 147 FARLIR 152 (292)
Q Consensus 147 ~~~~~~ 152 (292)
......
T Consensus 180 ~~~~~~ 185 (232)
T PRK10359 180 GKRCTA 185 (232)
T ss_pred Cccccc
Confidence 887653
|
|
| >KOG1163|consensus | Back alignment and domain information |
|---|
Probab=99.89 E-value=2.2e-22 Score=150.43 Aligned_cols=164 Identities=26% Similarity=0.402 Sum_probs=132.1
Q ss_pred cccceeeeecccCceEEEEEEEcCCCcEEEEEEeccCCCChHHHHHHHHHHHHHHhCCC-CCcchhhhhhhcCCeEEEEE
Q psy758 2 ERYEKIGKLGEGSYGVVFKCRNRDTGQVVAIKKFLESEEDPLIRKIALREIRLLKSLKH-PNLVNLLEVFRRKKKLHLVF 80 (292)
Q Consensus 2 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~e~~~~~~l~~-~~i~~~~~~~~~~~~~~iv~ 80 (292)
+.|.+++.||+|+||.+|.|....+|+.||||+-+..... ..+..|..+.+.|++ ..|..+..+..+..+-.+||
T Consensus 15 gky~lvrkiGsGSFGdIy~~~~i~~ge~VAiK~Es~~a~h----pqL~yEskvY~iL~~g~GiP~i~~y~~e~~ynvlVM 90 (341)
T KOG1163|consen 15 GKYKLVRKIGSGSFGDIYLGISITSGEEVAIKLESSKAKH----PQLLYESKVYRILQGGVGIPHIRHYGTEKDYNVLVM 90 (341)
T ss_pred cceEEEEeecCCchhheeeeeeccCCceEEEEeecccCCC----cchhHHHHHHHHhccCCCCchhhhhccccccceeee
Confidence 6899999999999999999999999999999986554433 335568888888874 67888888888888899999
Q ss_pred ecCCCccHHHHhc-CCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEEccC---CcEEEeecCchhhhhcccc
Q psy758 81 EFCDHTVLNELEN-HPHGLPWDLIKQITWQVLRGVSYCHRHACIHRDIKPENILLTAN---GVVKLCDFGFARLIRDLIP 156 (292)
Q Consensus 81 e~~~~~~L~~~~~-~~~~~~~~~~~~i~~qi~~aL~~LH~~givH~dl~p~Nilv~~~---~~~kl~dfg~~~~~~~~~~ 156 (292)
+..+.. |.++.+ ..+.++..++..++-|++.-++|+|.++++|+||||+|+|+.-+ +.+.|+|||+++.+-+...
T Consensus 91 dLLGPs-LEdLfnfC~R~ftmkTvLMLaDQml~RiEyvH~r~fiHRDIKPdNFLMGlgrh~~kl~LIDFGLaKky~d~~t 169 (341)
T KOG1163|consen 91 DLLGPS-LEDLFNFCSRRFTMKTVLMLADQMLSRIEYVHLRNFIHRDIKPDNFLMGLGRHCNKLYLIDFGLAKKYRDIRT 169 (341)
T ss_pred eccCcc-HHHHHHHHhhhhhHHhHHHHHHHHHHHHHHHHhhccccccCCccceeeccccccceEEEEeccchhhhccccc
Confidence 998654 444433 44579999999999999999999999999999999999999744 5699999999998876554
Q ss_pred cccccccccccccc
Q psy758 157 RHLHIFQTNEYFKG 170 (292)
Q Consensus 157 ~~~~~~~~~~~~~~ 170 (292)
...-.|..+.-+.|
T Consensus 170 ~~HIpyre~r~ltG 183 (341)
T KOG1163|consen 170 RQHIPYREDRNLTG 183 (341)
T ss_pred cccCccccCCccce
Confidence 44444444433333
|
|
| >smart00090 RIO RIO-like kinase | Back alignment and domain information |
|---|
Probab=99.89 E-value=1.4e-22 Score=158.91 Aligned_cols=144 Identities=19% Similarity=0.184 Sum_probs=114.2
Q ss_pred cceeeeecccCceEEEEEE-EcCCCcEEEEEEeccCCCC----------------------hHHHHHHHHHHHHHHhCCC
Q psy758 4 YEKIGKLGEGSYGVVFKCR-NRDTGQVVAIKKFLESEED----------------------PLIRKIALREIRLLKSLKH 60 (292)
Q Consensus 4 y~~~~~l~~g~~~~v~~~~-~~~~~~~v~iK~~~~~~~~----------------------~~~~~~~~~e~~~~~~l~~ 60 (292)
|.+.+.||+|++|.||+|. +..+|+.||+|++...... ......+.+|...+..+.+
T Consensus 30 ~~i~~~Lg~G~~g~Vy~a~~~~~~g~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~L~~L~~ 109 (237)
T smart00090 30 SAIGGCISTGKEANVYHALDFDGSGKERAVKIYRTGTLEFKRRDRYVDGDFRFKYRKINPRKLVRLWAEKEFRNLQRLYE 109 (237)
T ss_pred HHhCCeeccCcceeEEEEEecCCCCcEEEEEEEEcCcceecchhhhcccchhhccCCCCHHHHHHHHHHHHHHHHHHHHh
Confidence 7788999999999999999 6678999999998754311 0112345689999999975
Q ss_pred C--CcchhhhhhhcCCeEEEEEecCCCccHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCC-ccccCCCCCceEEccC
Q psy758 61 P--NLVNLLEVFRRKKKLHLVFEFCDHTVLNELENHPHGLPWDLIKQITWQVLRGVSYCHRHA-CIHRDIKPENILLTAN 137 (292)
Q Consensus 61 ~--~i~~~~~~~~~~~~~~iv~e~~~~~~L~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~g-ivH~dl~p~Nilv~~~ 137 (292)
. .+.++++. ...++||||++|+++..............+..++.||+.+|.+||+.| ++|+||+|+||+++ +
T Consensus 110 ~~i~~p~~~~~----~~~~lV~E~~~g~~L~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~g~iiH~Dikp~NIli~-~ 184 (237)
T smart00090 110 AGVPVPKPIAW----RRNVLVMEFIGGDGLPAPRLKDVEPEEEEEFELYDDILEEMRKLYKEGELVHGDLSEYNILVH-D 184 (237)
T ss_pred cCCCCCeeeEe----cCceEEEEEecCCcccccccccCCcchHHHHHHHHHHHHHHHHHHhcCCEEeCCCChhhEEEE-C
Confidence 3 23344432 235899999999888776544445777778899999999999999999 99999999999999 8
Q ss_pred CcEEEeecCchhhhh
Q psy758 138 GVVKLCDFGFARLIR 152 (292)
Q Consensus 138 ~~~kl~dfg~~~~~~ 152 (292)
+.++|+|||.+....
T Consensus 185 ~~i~LiDFg~a~~~~ 199 (237)
T smart00090 185 GKVVIIDVSQSVELD 199 (237)
T ss_pred CCEEEEEChhhhccC
Confidence 899999999987543
|
|
| >PRK10345 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=99.88 E-value=3.5e-22 Score=152.94 Aligned_cols=136 Identities=18% Similarity=0.247 Sum_probs=107.3
Q ss_pred ceeeeecccCceEEEEEEEcCCCcEEEEEEeccCCCChHHHHHHHHHHHHHHhC-----CCCCcchhhhhhhcCC---eE
Q psy758 5 EKIGKLGEGSYGVVFKCRNRDTGQVVAIKKFLESEEDPLIRKIALREIRLLKSL-----KHPNLVNLLEVFRRKK---KL 76 (292)
Q Consensus 5 ~~~~~l~~g~~~~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~e~~~~~~l-----~~~~i~~~~~~~~~~~---~~ 76 (292)
.-.+.||+|++|.||. +..++.. +||++...... ..+.+.+|+.+++.+ .||||++++|+++++. .+
T Consensus 5 ~~~~~LG~G~~~~Vy~--hp~~~~k-~IKv~~~~~~~--~~~~~~rEi~~l~~L~~~~~~h~nIvr~yg~~et~~g~g~v 79 (210)
T PRK10345 5 SEQSPLGTGRHRKCYA--HPEDAQR-CIKIVYHRGDG--GDKEIRRELKYYAHLSRRLIDWSGIPRYYGTVETDCGTGYV 79 (210)
T ss_pred CCcceecCCCceEEEE--CCCCcCe-EEEEEeccccc--hHHHHHHHHHHHHHhhccCCCCcccceeeEEEEeCCCCeEE
Confidence 4457899999999995 6665555 69988654322 345688999999999 5799999999998763 44
Q ss_pred E-EEEec--CCCccHHHHhcCCCCCCHHHHHHHHHHHHHHH-HHHHhCCccccCCCCCceEEccC----CcEEEeec-Cc
Q psy758 77 H-LVFEF--CDHTVLNELENHPHGLPWDLIKQITWQVLRGV-SYCHRHACIHRDIKPENILLTAN----GVVKLCDF-GF 147 (292)
Q Consensus 77 ~-iv~e~--~~~~~L~~~~~~~~~~~~~~~~~i~~qi~~aL-~~LH~~givH~dl~p~Nilv~~~----~~~kl~df-g~ 147 (292)
+ +|+|| +.+++|.++++.. .+++. ..++.|++.++ +|||+++|+|+||||+||+++.+ +.++|+|+ |.
T Consensus 80 ~~~I~e~~G~~~~tL~~~l~~~-~~~e~--~~~~~~~L~~l~~yLh~~~IvhrDlKp~NILl~~~~~~~~~~~LiDg~G~ 156 (210)
T PRK10345 80 YDVIADFDGKPSITLTEFAEQC-RYEED--VAQLRQLLKKLKRYLLDNRIVTMELKPQNILCQRISESEVIPVVCDNIGE 156 (210)
T ss_pred EEEEecCCCCcchhHHHHHHcc-cccHh--HHHHHHHHHHHHHHHHHCCEeecCCCHHHEEEeccCCCCCcEEEEECCCC
Confidence 4 78999 4589999999764 56666 35678888777 99999999999999999999743 37999994 54
Q ss_pred h
Q psy758 148 A 148 (292)
Q Consensus 148 ~ 148 (292)
.
T Consensus 157 ~ 157 (210)
T PRK10345 157 S 157 (210)
T ss_pred c
Confidence 4
|
|
| >KOG1164|consensus | Back alignment and domain information |
|---|
Probab=99.86 E-value=1.1e-20 Score=156.02 Aligned_cols=254 Identities=21% Similarity=0.238 Sum_probs=159.6
Q ss_pred ccceeeeecccCceEEEEEEEcCCC-cEEEEEEeccCCCChHHHHHHHHHHHHHHhCC----CCCcchhhhhh-hcCCeE
Q psy758 3 RYEKIGKLGEGSYGVVFKCRNRDTG-QVVAIKKFLESEEDPLIRKIALREIRLLKSLK----HPNLVNLLEVF-RRKKKL 76 (292)
Q Consensus 3 ~y~~~~~l~~g~~~~v~~~~~~~~~-~~v~iK~~~~~~~~~~~~~~~~~e~~~~~~l~----~~~i~~~~~~~-~~~~~~ 76 (292)
+|++.+.||+|+||.||.+.+..++ ..+|+|.-........ ..+..|..++..+. .+++..+++.. ..+...
T Consensus 19 ~~~i~~~iG~G~fG~V~~v~~~~~~~~~~a~K~e~~~~~~~~--~~l~~E~~vl~~l~~~~~~~~~~~~~~~G~~~~~~~ 96 (322)
T KOG1164|consen 19 RYKLGKKIGEGGFGAVYLVSDKSEKNKEYAKKLEKKELGSKP--SVLKIEIQVLKKLEKKNGPSHFPKLLDHGRSTEDFN 96 (322)
T ss_pred ceEEeeeccccCCceEEEEEecCCCCeeEEEEEEEecccCCC--ccchhHHHHHHHHhhhcCCCCCCEEEEeccCCCcee
Confidence 7999999999999999999998775 5788887765432211 14556777777776 36888988888 477889
Q ss_pred EEEEecCCCccHHHHhc-CC-CCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEEccC-----CcEEEeecCchh
Q psy758 77 HLVFEFCDHTVLNELEN-HP-HGLPWDLIKQITWQVLRGVSYCHRHACIHRDIKPENILLTAN-----GVVKLCDFGFAR 149 (292)
Q Consensus 77 ~iv~e~~~~~~L~~~~~-~~-~~~~~~~~~~i~~qi~~aL~~LH~~givH~dl~p~Nilv~~~-----~~~kl~dfg~~~ 149 (292)
|+||+.++. +|.++.. .. +.++..++..++.|++.+|++||+.|++||||||+|+.+... ..+.|.|||+++
T Consensus 97 ~iVM~l~G~-sL~dl~~~~~~~~fs~~T~l~ia~q~l~~l~~lH~~G~iHRDiKp~N~~~g~~~~~~~~~~~llDfGlar 175 (322)
T KOG1164|consen 97 FIVMSLLGP-SLEDLRKRNPPGRFSRKTVLRIAIQNLNALEDLHSKGFIHRDIKPENFVVGQSSRSEVRTLYLLDFGLAR 175 (322)
T ss_pred EEEEeccCc-cHHHHHHhCCCCCcCHhHHHHHHHHHHHHHHHHHhcCcccCCcCHHHeeecCCCCcccceEEEEecCCCc
Confidence 999999965 4555543 33 679999999999999999999999999999999999999865 369999999998
Q ss_pred hhhccccccc--ccccc-ccccccCCCCCCCcccceeeecCCCCCCchHHHHHHHhhcccCCCCCCChh---hhhhccCc
Q psy758 150 LIRDLIPRHL--HIFQT-NEYFKGVSLPHAENVVPLEIKIGKPAATNIYLIDFLKRCLDKDPLRRWSCD---QLLRHPYF 223 (292)
Q Consensus 150 ~~~~~~~~~~--~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~---~~~~~~~~ 223 (292)
.......... ..... +....|..-+.+.. .-.+.-.+...+..+++..++....+.-|....... ..+.....
T Consensus 176 ~~~~~~~~~~~~~~~r~~~~~~rGT~ry~S~~-~H~~~e~~r~DDles~~Y~l~el~~g~LPW~~~~~~~~~~~~~~~~~ 254 (322)
T KOG1164|consen 176 RFKYVGDSGGNLRPPRPQKGLFRGTLRYASIN-VHLGIEQGRRDDLESLFYMLLELLKGSLPWEALEMTDLKSKFEKDPR 254 (322)
T ss_pred cccccCCCCcccccCCCCccCCCCccccccHH-HhCCCccCCchhhhhHHHHHHHHhcCCCCCccccccchHHHHHHHhh
Confidence 3321111100 00000 01111111111111 111222233334444555555555454444332211 11110000
Q ss_pred CCCC--CCCCCccchHHHHhcccCcCCCCCCChhhhhhC
Q psy758 224 NGYY--FEVPDEMQYEEITQRCLDKDPLRRWSCDQLLRH 260 (292)
Q Consensus 224 ~~~~--~~~~~~~~l~~li~~~l~~dP~~Rpt~~~il~h 260 (292)
.... .....+..+.++..-+-..+..++|....+.+.
T Consensus 255 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Pdy~~~~~~ 293 (322)
T KOG1164|consen 255 KLLTDRFGDLKPEEFAKILEYIDSLDYEDKPDYEKLAEL 293 (322)
T ss_pred hhccccccCCChHHHHHHHHHhhccCCcCCCCHHHHHHH
Confidence 0000 122335567777777777899999988887664
|
|
| >PRK14879 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.85 E-value=8.3e-21 Score=147.74 Aligned_cols=136 Identities=21% Similarity=0.285 Sum_probs=113.6
Q ss_pred eeecccCceEEEEEEEcCCCcEEEEEEeccCCCCh------HHHHHHHHHHHHHHhCCCCCcchhhhhhhcCCeEEEEEe
Q psy758 8 GKLGEGSYGVVFKCRNRDTGQVVAIKKFLESEEDP------LIRKIALREIRLLKSLKHPNLVNLLEVFRRKKKLHLVFE 81 (292)
Q Consensus 8 ~~l~~g~~~~v~~~~~~~~~~~v~iK~~~~~~~~~------~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~iv~e 81 (292)
+.||+|++|.||+|.. .|..+++|......... .....+.+|+.++..+.|+++.....++.+.+..+++||
T Consensus 2 ~~l~~G~~~~vy~~~~--~~~~~~vK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~~~~lv~e 79 (211)
T PRK14879 2 KLIKRGAEAEIYLGDF--LGIKAVIKWRIPKRYRHPELDERIRRERTRREARIMSRARKAGVNVPAVYFVDPENFIIVME 79 (211)
T ss_pred cccccCceEEEEEEee--CCCceEEEEeCCcCCcChHHHHHHHHHHHHHHHHHHHHHHHCCCCCCeEEEEeCCCCEEEEE
Confidence 5799999999999987 47789999865433211 123457789999999999988777666666778899999
Q ss_pred cCCCccHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEEccCCcEEEeecCchhh
Q psy758 82 FCDHTVLNELENHPHGLPWDLIKQITWQVLRGVSYCHRHACIHRDIKPENILLTANGVVKLCDFGFARL 150 (292)
Q Consensus 82 ~~~~~~L~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~givH~dl~p~Nilv~~~~~~kl~dfg~~~~ 150 (292)
|++|++|.+++.... . ....++.+++.+|.++|+.|++|+|++|.||+++ ++.++|+|||.+..
T Consensus 80 ~~~G~~L~~~~~~~~---~-~~~~i~~~i~~~l~~lH~~~i~H~Dl~p~Nil~~-~~~~~liDf~~a~~ 143 (211)
T PRK14879 80 YIEGEPLKDLINSNG---M-EELELSREIGRLVGKLHSAGIIHGDLTTSNMILS-GGKIYLIDFGLAEF 143 (211)
T ss_pred EeCCcCHHHHHHhcc---H-HHHHHHHHHHHHHHHHHhCCcccCCCCcccEEEE-CCCEEEEECCcccC
Confidence 999999999887532 2 8889999999999999999999999999999999 78899999999865
|
|
| >PRK12274 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.85 E-value=1.1e-20 Score=141.98 Aligned_cols=135 Identities=19% Similarity=0.175 Sum_probs=107.8
Q ss_pred ceeeeecccCceEEEEEEEcCCCcEEEEEEeccCCC--ChHHHHHHHHHHHHHHhCC-CCCcchhhhhhhcCCeEEEEEe
Q psy758 5 EKIGKLGEGSYGVVFKCRNRDTGQVVAIKKFLESEE--DPLIRKIALREIRLLKSLK-HPNLVNLLEVFRRKKKLHLVFE 81 (292)
Q Consensus 5 ~~~~~l~~g~~~~v~~~~~~~~~~~v~iK~~~~~~~--~~~~~~~~~~e~~~~~~l~-~~~i~~~~~~~~~~~~~~iv~e 81 (292)
.++..|++|+||+|+.+.. .+..++.+.+....- .......+.+|+++++.|. ++++++++++ +..+++||
T Consensus 5 ~~~~~l~~~~f~~v~~~~~--~~~k~~~~~l~~~~~~~~~~~~~l~~rE~~iL~~L~~~~~vP~ll~~----~~~~lvme 78 (218)
T PRK12274 5 AVNEPLKSDTFGRILLVRG--GERKFVRRDLSAAPWWLRGVAWWLARREALALRQLDGLPRTPRLLHW----DGRHLDRS 78 (218)
T ss_pred ccceeecCCCcceEEEeec--CCceeeecccccchhhhhhHHHHHHHHHHHHHHhcCCCCCCCEEEEE----cCEEEEEe
Confidence 4678899999999997765 577888887755542 1222335789999999996 4778888875 34799999
Q ss_pred cCCCccHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCC-CCCceEEccCCcEEEeecCchhhhh
Q psy758 82 FCDHTVLNELENHPHGLPWDLIKQITWQVLRGVSYCHRHACIHRDI-KPENILLTANGVVKLCDFGFARLIR 152 (292)
Q Consensus 82 ~~~~~~L~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~givH~dl-~p~Nilv~~~~~~kl~dfg~~~~~~ 152 (292)
|+.|.+|...... . ...++.|++.+|.++|++||+|+|| +|+||+++.++.++|+|||++....
T Consensus 79 yI~G~~L~~~~~~------~-~~~~~~qi~~~L~~lH~~GIvHrDL~kp~NILv~~~g~i~LIDFG~A~~~~ 143 (218)
T PRK12274 79 YLAGAAMYQRPPR------G-DLAYFRAARRLLQQLHRCGVAHNDLAKEANWLVQEDGSPAVIDFQLAVRGN 143 (218)
T ss_pred eecCccHHhhhhh------h-hHHHHHHHHHHHHHHHHCcCccCCCCCcceEEEcCCCCEEEEECCCceecC
Confidence 9999998654321 1 2457889999999999999999999 7999999999999999999997543
|
|
| >COG0515 SPS1 Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair] | Back alignment and domain information |
|---|
Probab=99.85 E-value=6.1e-20 Score=152.86 Aligned_cols=247 Identities=32% Similarity=0.438 Sum_probs=182.2
Q ss_pred cceeeeecccCceEEEEEEEcCCCcEEEEEEeccCCCChH-HHHHHHHHHHHHHhCCCC-CcchhhhhhhcCCeEEEEEe
Q psy758 4 YEKIGKLGEGSYGVVFKCRNRDTGQVVAIKKFLESEEDPL-IRKIALREIRLLKSLKHP-NLVNLLEVFRRKKKLHLVFE 81 (292)
Q Consensus 4 y~~~~~l~~g~~~~v~~~~~~~~~~~v~iK~~~~~~~~~~-~~~~~~~e~~~~~~l~~~-~i~~~~~~~~~~~~~~iv~e 81 (292)
|++.+.||.|+|+.||.+.+. ..+++|.+........ ....+.+|...+..+.|+ +++++++.+...+..+++++
T Consensus 2 ~~~~~~l~~g~~~~v~~~~~~---~~~~~k~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~ 78 (384)
T COG0515 2 YRILRKLGEGSFGEVYLARDR---KLVALKVLAKKLESKSKEVERFLREIQILASLNHPPNIVKLYDFFQDEGSLYLVME 78 (384)
T ss_pred ceeEEeecCCCCeEEEEEEec---cEEEEEeechhhccchhHHHHHHHHHHHHHHccCCcceeeEEEEEecCCEEEEEEe
Confidence 778899999999999999987 7889999877665443 677888999999999988 79999999977777899999
Q ss_pred cCCCccHHHHhcCCC---CCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEEccCC-cEEEeecCchhhhhccc--
Q psy758 82 FCDHTVLNELENHPH---GLPWDLIKQITWQVLRGVSYCHRHACIHRDIKPENILLTANG-VVKLCDFGFARLIRDLI-- 155 (292)
Q Consensus 82 ~~~~~~L~~~~~~~~---~~~~~~~~~i~~qi~~aL~~LH~~givH~dl~p~Nilv~~~~-~~kl~dfg~~~~~~~~~-- 155 (292)
++.++.+..++.... .++...+..++.|++.++.++|+.|++|+|+||+||+++..+ .++++|||.+.......
T Consensus 79 ~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~H~~~~~hrd~kp~nil~~~~~~~~~l~dfg~~~~~~~~~~~ 158 (384)
T COG0515 79 YVDGGSLEDLLKKIGRKGPLSESEALFILAQILSALEYLHSKGIIHRDIKPENILLDRDGRVVKLIDFGLAKLLPDPGST 158 (384)
T ss_pred cCCCCcHHHHHHhcccccCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHeeecCCCCeEEEeccCcceecCCCCcc
Confidence 999999998777664 699999999999999999999999999999999999999998 79999999987544322
Q ss_pred ---------cccccccccccccccC---CCCCCCcccceeeecCCCCCCchHHHHHHHhhcccCCCCCCC----hhhhhh
Q psy758 156 ---------PRHLHIFQTNEYFKGV---SLPHAENVVPLEIKIGKPAATNIYLIDFLKRCLDKDPLRRWS----CDQLLR 219 (292)
Q Consensus 156 ---------~~~~~~~~~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~----~~~~~~ 219 (292)
...+..|.+|+...+. ......++|.++ ..+...+....|..... ..+...
T Consensus 159 ~~~~~~~~~~~~t~~~~~pe~~~~~~~~~~~~~~D~~s~g-------------~~~~~~~~~~~p~~~~~~~~~~~~~~~ 225 (384)
T COG0515 159 SSIPALPSTSVGTPGYMAPEVLLGLSLAYASSSSDIWSLG-------------ITLYELLTGLPPFEGEKNSSATSQTLK 225 (384)
T ss_pred ccccccccccccccccCCHHHhcCCCCCCCCchHhHHHHH-------------HHHHHHHhCCCCCCCCCccccHHHHHH
Confidence 1223445566655542 333333333221 23333444444533333 123322
Q ss_pred ccCcCCCC-C--CCCC------ccchHHHHhcccCcCCCCCCChhhhhhCCcccce
Q psy758 220 HPYFNGYY-F--EVPD------EMQYEEITQRCLDKDPLRRWSCDQLLRHPYFNGY 266 (292)
Q Consensus 220 ~~~~~~~~-~--~~~~------~~~l~~li~~~l~~dP~~Rpt~~~il~h~w~~~~ 266 (292)
........ . .... ...+.+++.+++..+|..|.+..+...++|....
T Consensus 226 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~r~~~~~~~~~~~~~~~ 281 (384)
T COG0515 226 IILELPTPSLASPLSPSNPELISKAASDLLKKLLAKDPKNRLSSSSDLSHDLLAHL 281 (384)
T ss_pred HHHhcCCcccccccCccccchhhHHHHHHHHHHHhcCchhcCCHHHHhhchHhhCc
Confidence 22222211 1 1111 1468899999999999999999999998666653
|
|
| >smart00750 KIND kinase non-catalytic C-lobe domain | Back alignment and domain information |
|---|
Probab=99.85 E-value=2.8e-21 Score=146.06 Aligned_cols=157 Identities=23% Similarity=0.194 Sum_probs=110.4
Q ss_pred ccHHHHhcC-CCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEEccCCcEEEeecCchhhhhcccccccccccc
Q psy758 86 TVLNELENH-PHGLPWDLIKQITWQVLRGVSYCHRHACIHRDIKPENILLTANGVVKLCDFGFARLIRDLIPRHLHIFQT 164 (292)
Q Consensus 86 ~~L~~~~~~-~~~~~~~~~~~i~~qi~~aL~~LH~~givH~dl~p~Nilv~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~ 164 (292)
|+|.+++.. ...+++..++.++.||+.||.|||+++ ||+||+++.++.+++ ||++..........+..|.+
T Consensus 1 GsL~~~l~~~~~~l~~~~~~~i~~qi~~~L~~lH~~~------kp~Nil~~~~~~~~~--fG~~~~~~~~~~~g~~~y~a 72 (176)
T smart00750 1 VSLADILEVRGRPLNEEEIWAVCLQCLRALRELHRQA------KSGNILLTWDGLLKL--DGSVAFKTPEQSRVDPYFMA 72 (176)
T ss_pred CcHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhcC------CcccEeEcCccceee--ccceEeeccccCCCcccccC
Confidence 567787765 445999999999999999999999999 999999999999999 99987765544455677888
Q ss_pred ccccccCCC-----CCCCcccceeeecCCCCCCchH-----HHHHHHhhcccCCCCCCChhhhhhccCcCCCCCCCCCc-
Q psy758 165 NEYFKGVSL-----PHAENVVPLEIKIGKPAATNIY-----LIDFLKRCLDKDPLRRWSCDQLLRHPYFNGYYFEVPDE- 233 (292)
Q Consensus 165 ~~~~~~~~~-----~~~~~~~~~~~~~~~~~~~~~~-----~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~- 233 (292)
||...+... .|+.|+..+++.++..++.... ...++..+....+..+.... ..+
T Consensus 73 PE~~~~~~~~~~~DiwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~---------------~~~~ 137 (176)
T smart00750 73 PEVIQGQSYTEKADIYSLGITLYEALDYELPYNEERELSAILEILLNGMPADDPRDRSNLE---------------SVSA 137 (176)
T ss_pred hHHhcCCCCcchhhHHHHHHHHHHHHhCCCCccccchhcHHHHHHHHHhccCCccccccHH---------------HHHh
Confidence 888766544 3445555555566665542211 11111122111111111111 112
Q ss_pred -cchHHHHhcccCcCCCCCCChhhhhhCCcccc
Q psy758 234 -MQYEEITQRCLDKDPLRRWSCDQLLRHPYFNG 265 (292)
Q Consensus 234 -~~l~~li~~~l~~dP~~Rpt~~~il~h~w~~~ 265 (292)
..+.++|.+||+.||.+|||+.++++|+|+..
T Consensus 138 ~~~~~~~i~~cl~~~p~~Rp~~~~ll~~~~~~~ 170 (176)
T smart00750 138 ARSFADFMRVCASRLPQRREAANHYLAHCRALF 170 (176)
T ss_pred hhhHHHHHHHHHhcccccccCHHHHHHHHHHHH
Confidence 26899999999999999999999999999874
|
It is an interaction domain identified as being similar to the C-terminal protein kinase catalytic fold (C lobe). Its presence at the N terminus of signalling proteins and the absence of the active-site residues in the catalytic and activation loops suggest that it folds independently and is likely to be non-catalytic. The occurrence of KIND only in metazoa implies that it has evolved from the catalytic protein kinase domain into an interaction domain possibly by keeping the substrate-binding features |
| >cd05144 RIO2_C RIO kinase family; RIO2, C-terminal catalytic domain | Back alignment and domain information |
|---|
Probab=99.84 E-value=1.4e-20 Score=144.71 Aligned_cols=138 Identities=20% Similarity=0.219 Sum_probs=108.9
Q ss_pred cceeeeecccCceEEEEEEEcCCCcEEEEEEeccCCCCh--------------------HHHHHHHHHHHHHHhCCCCC-
Q psy758 4 YEKIGKLGEGSYGVVFKCRNRDTGQVVAIKKFLESEEDP--------------------LIRKIALREIRLLKSLKHPN- 62 (292)
Q Consensus 4 y~~~~~l~~g~~~~v~~~~~~~~~~~v~iK~~~~~~~~~--------------------~~~~~~~~e~~~~~~l~~~~- 62 (292)
|.+.+.||+|++|.||.+... +|+.|++|++....... ........|..++..+.+++
T Consensus 17 ~~~~~~i~~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i 95 (198)
T cd05144 17 ESLGNQIGVGKESDVYLALDP-DGNPVALKFHRLGRTSFRKVKRKRDYLGDRKHASWLYLSRLAAQKEFAALKALYEEGF 95 (198)
T ss_pred hhcCCccccCcceEEEEEEcC-CCCEEEEEEEecccchhhhhcchHHHHhccccchhHHHhHHHHHHHHHHHHHHHHcCC
Confidence 778899999999999999875 79999999876433110 11123567888888887763
Q ss_pred -cchhhhhhhcCCeEEEEEecCCCccHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEEccCCcEE
Q psy758 63 -LVNLLEVFRRKKKLHLVFEFCDHTVLNELENHPHGLPWDLIKQITWQVLRGVSYCHRHACIHRDIKPENILLTANGVVK 141 (292)
Q Consensus 63 -i~~~~~~~~~~~~~~iv~e~~~~~~L~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~givH~dl~p~Nilv~~~~~~k 141 (292)
+...++ ....+++|||++|++|..+... .....++.+++.++.++|+.|++|+||+|+||++++++.++
T Consensus 96 ~v~~~~~----~~~~~lv~e~~~g~~L~~~~~~------~~~~~~~~~i~~~l~~lh~~gi~H~Dl~p~Nill~~~~~~~ 165 (198)
T cd05144 96 PVPKPID----WNRHAVVMEYIDGVELYRVRVL------EDPEEVLDEILEEIVKAYKHGIIHGDLSEFNILVDDDEKIY 165 (198)
T ss_pred CCCceee----cCCceEEEEEeCCcchhhcccc------ccHHHHHHHHHHHHHHHHHCCCCcCCCCcccEEEcCCCcEE
Confidence 444433 3456899999999998776431 34578889999999999999999999999999999999999
Q ss_pred EeecCchhhhh
Q psy758 142 LCDFGFARLIR 152 (292)
Q Consensus 142 l~dfg~~~~~~ 152 (292)
|+|||.+....
T Consensus 166 liDfg~~~~~~ 176 (198)
T cd05144 166 IIDWPQMVSTD 176 (198)
T ss_pred EEECCccccCC
Confidence 99999986554
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO2 is present in archaea and eukaryotes. It contains an N-terminal winged helix (wHTH) domain and a C-terminal RIO kinase catalytic domain. The wHTH domain is primarily seen in DNA-binding proteins, although some wHTH dom |
| >TIGR03724 arch_bud32 Kae1-associated kinase Bud32 | Back alignment and domain information |
|---|
Probab=99.83 E-value=2.7e-20 Score=143.46 Aligned_cols=133 Identities=17% Similarity=0.280 Sum_probs=106.9
Q ss_pred eecccCceEEEEEEEcCCCcEEEEEEeccCCCC------hHHHHHHHHHHHHHHhCCCCCcchhhhhhhcCCeEEEEEec
Q psy758 9 KLGEGSYGVVFKCRNRDTGQVVAIKKFLESEED------PLIRKIALREIRLLKSLKHPNLVNLLEVFRRKKKLHLVFEF 82 (292)
Q Consensus 9 ~l~~g~~~~v~~~~~~~~~~~v~iK~~~~~~~~------~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~iv~e~ 82 (292)
.||+|++|.||++.. ++..+++|........ ......+.+|..+++.+.++++.....++.+.+..+++|||
T Consensus 1 ~ig~G~~~~vy~~~~--~~~~~viK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~~~~lv~e~ 78 (199)
T TIGR03724 1 LIAKGAEAIIYLGDF--LGLKAVIKERVPKSYRHPELDERIRRERTRNEARLLSRARKAGVNTPVVYDVDPDNKTIVMEY 78 (199)
T ss_pred CCCCCceEEEEEeec--CCccEEEEEecCCcCcCchHHHHHHHHHHHHHHHHHHHHHHCCCCCCEEEEEECCCCEEEEEE
Confidence 489999999999984 4788999986543211 11235677899999999988765554444556677899999
Q ss_pred CCCccHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEEccCCcEEEeecCchhhh
Q psy758 83 CDHTVLNELENHPHGLPWDLIKQITWQVLRGVSYCHRHACIHRDIKPENILLTANGVVKLCDFGFARLI 151 (292)
Q Consensus 83 ~~~~~L~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~givH~dl~p~Nilv~~~~~~kl~dfg~~~~~ 151 (292)
++|++|...+..... .++.+++.+|.+||+.|++|||++|.||+++ ++.++++|||.+...
T Consensus 79 ~~g~~l~~~~~~~~~-------~~~~~i~~~l~~lH~~gi~H~Dl~~~Nil~~-~~~~~liDfg~a~~~ 139 (199)
T TIGR03724 79 IEGKPLKDVIEEGND-------ELLREIGRLVGKLHKAGIVHGDLTTSNIIVR-DDKLYLIDFGLGKYS 139 (199)
T ss_pred ECCccHHHHHhhcHH-------HHHHHHHHHHHHHHHCCeecCCCCcceEEEE-CCcEEEEECCCCcCC
Confidence 999999988764311 8899999999999999999999999999999 789999999998653
|
Members of this protein family are the Bud32 protein associated with Kae1 (kinase-associated endopeptidase 1) in the Archaea. In many Archaeal genomes, Kae1 and Bud32 are fused. The complex is homologous to the Kae1 and Bud32 subunits of the eukaryotic KEOPS complex, an apparently ancient protein kinase-containing molecular machine. |
| >KOG1165|consensus | Back alignment and domain information |
|---|
Probab=99.83 E-value=5.7e-20 Score=143.66 Aligned_cols=156 Identities=28% Similarity=0.358 Sum_probs=127.8
Q ss_pred ccceeeeecccCceEEEEEEEcCCCcEEEEEEeccCCCChHHHHHHHHHHHHHHhCC-CCCcchhhhhhhcCCeEEEEEe
Q psy758 3 RYEKIGKLGEGSYGVVFKCRNRDTGQVVAIKKFLESEEDPLIRKIALREIRLLKSLK-HPNLVNLLEVFRRKKKLHLVFE 81 (292)
Q Consensus 3 ~y~~~~~l~~g~~~~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~e~~~~~~l~-~~~i~~~~~~~~~~~~~~iv~e 81 (292)
.|.+++.||+|+||.++.+....+++.||||.-+..... ..+..|.+..+.|. .++|..+|-+-+++.+-.+|+|
T Consensus 29 hyrVGkKIGeGsFG~lf~G~Nl~nne~VAIKfEPrkS~A----PQLrdEYr~YKlL~g~~GIP~vYYFGqeG~~NiLVid 104 (449)
T KOG1165|consen 29 HYRVGKKIGEGSFGVLFLGKNLYNNEPVAIKFEPRKSEA----PQLRDEYRTYKLLGGTEGIPQVYYFGQEGKYNILVID 104 (449)
T ss_pred cceeccccccCcceeeecccccccCceEEEEeccccCCc----chHHHHHHHHHHHcCCCCCCceeeeccccchhhhhhh
Confidence 489999999999999999999999999999976655443 44566888888885 7899999877777888899999
Q ss_pred cCCCccHHHHh-cCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEEccC-----CcEEEeecCchhhhhccc
Q psy758 82 FCDHTVLNELE-NHPHGLPWDLIKQITWQVLRGVSYCHRHACIHRDIKPENILLTAN-----GVVKLCDFGFARLIRDLI 155 (292)
Q Consensus 82 ~~~~~~L~~~~-~~~~~~~~~~~~~i~~qi~~aL~~LH~~givH~dl~p~Nilv~~~-----~~~kl~dfg~~~~~~~~~ 155 (292)
+.+.. |.++. -..+.++..++..++.|++.-++++|++.+++|||||+|+||... +.+.++|||+++.+.++.
T Consensus 105 LLGPS-LEDLFD~CgR~FSvKTV~miA~Qmi~rie~vH~k~LIYRDIKPdNFLIGrp~~k~~n~IhiiDFGmAK~YrDp~ 183 (449)
T KOG1165|consen 105 LLGPS-LEDLFDLCGRRFSVKTVAMIAKQMITRIEYVHEKDLIYRDIKPDNFLIGRPGTKDANVIHIIDFGMAKEYRDPK 183 (449)
T ss_pred hhCcC-HHHHHHHhcCcccHHhHHHHHHHHHHHHHHHHhcceeecccCccceeecCCCCCCCceEEEEeccchhhhcCcc
Confidence 98753 33333 244579999999999999999999999999999999999999743 469999999999887655
Q ss_pred cccccccc
Q psy758 156 PRHLHIFQ 163 (292)
Q Consensus 156 ~~~~~~~~ 163 (292)
+.....|.
T Consensus 184 TkqHIPYr 191 (449)
T KOG1165|consen 184 TKQHIPYR 191 (449)
T ss_pred ccccCccc
Confidence 44443343
|
|
| >KOG1240|consensus | Back alignment and domain information |
|---|
Probab=99.82 E-value=5e-21 Score=169.83 Aligned_cols=250 Identities=23% Similarity=0.285 Sum_probs=171.9
Q ss_pred ccceeeeecccCceEEEEEEEcCCCcEEEEEEeccCCCC--hHHHHHHHHHHHHHHhCCCCCcchhhhhhhcCCeEEEEE
Q psy758 3 RYEKIGKLGEGSYGVVFKCRNRDTGQVVAIKKFLESEED--PLIRKIALREIRLLKSLKHPNLVNLLEVFRRKKKLHLVF 80 (292)
Q Consensus 3 ~y~~~~~l~~g~~~~v~~~~~~~~~~~v~iK~~~~~~~~--~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~iv~ 80 (292)
+|...+.||++.|=+|.+|++.. | .|++|++-+.... -....+...|++ ...+++||.+++.-+...+...|+|.
T Consensus 24 e~~~~~~LGstRFlKv~r~k~~e-G-~vVvKVFvk~~p~~sL~~~~qrL~~ik-~~l~~~pn~lPfqk~~~t~kAAylvR 100 (1431)
T KOG1240|consen 24 ECHYVENLGSTRFLKVARAKDRE-G-LVVVKVFVKQDPTISLRPFKQRLEEIK-FALMKAPNCLPFQKVLVTDKAAYLVR 100 (1431)
T ss_pred ceeeecccCchhhhhhhhccCCC-c-eEEEEEEeccCCCCCchHHHHHHHHHH-HHhhcCCcccchHHHHHhhHHHHHHH
Confidence 46678899999999999998874 4 4999998666522 223333445555 67779999999999888888899999
Q ss_pred ecCCCccHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEEccCCcEEEeecCchhhh--hcccccc
Q psy758 81 EFCDHTVLNELENHPHGLPWDLIKQITWQVLRGVSYCHRHACIHRDIKPENILLTANGVVKLCDFGFARLI--RDLIPRH 158 (292)
Q Consensus 81 e~~~~~~L~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~givH~dl~p~Nilv~~~~~~kl~dfg~~~~~--~~~~~~~ 158 (292)
+|...+ |.+.+..+.-+..-+.+.|+.||+.||..+|..||+|||||.+||||+.=+-+.|+||..-+.. .+.++..
T Consensus 101 qyvkhn-LyDRlSTRPFL~~iEKkWiaFQLL~al~qcH~~gVcHGDIKsENILiTSWNW~~LtDFAsFKPtYLPeDNPad 179 (1431)
T KOG1240|consen 101 QYVKHN-LYDRLSTRPFLVLIEKKWIAFQLLKALSQCHKLGVCHGDIKSENILITSWNWLYLTDFASFKPTYLPEDNPAD 179 (1431)
T ss_pred HHHhhh-hhhhhccchHHHHHHHHHHHHHHHHHHHHHHHcCccccccccceEEEeeechhhhhcccccCCccCCCCCccc
Confidence 999864 6666666667888999999999999999999999999999999999999999999999876542 2222221
Q ss_pred ----------ccccccccccccCCCCCCCcccceeeecCCCCCCchHHHHHHHhhcccCCCCCCChhhhhhccCcC----
Q psy758 159 ----------LHIFQTNEYFKGVSLPHAENVVPLEIKIGKPAATNIYLIDFLKRCLDKDPLRRWSCDQLLRHPYFN---- 224 (292)
Q Consensus 159 ----------~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~---- 224 (292)
..+|-+||-+....- ......-........++.+.++.+.+.++...|. .+..++++..--+
T Consensus 180 f~fFFDTSrRRtCYiAPERFv~~~~--~~~~~q~~~~L~paMDIFS~GCViaELf~Eg~Pl--F~LSQL~aYr~~~~~~~ 255 (1431)
T KOG1240|consen 180 FTFFFDTSRRRTCYIAPERFVSALG--KTSVGQDAPLLTPAMDIFSAGCVIAELFLEGRPL--FTLSQLLAYRSGNADDP 255 (1431)
T ss_pred ceEEEecCCceeeecChHhhhcccc--ccccCCcccccChhhhhhhhhHHHHHHHhcCCCc--ccHHHHHhHhccCccCH
Confidence 234556655543220 0000000110112223344555556666554442 2344444432211
Q ss_pred CCCCCCCCccchHHHHhcccCcCCCCCCChhhhhhC
Q psy758 225 GYYFEVPDEMQYEEITQRCLDKDPLRRWSCDQLLRH 260 (292)
Q Consensus 225 ~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~~il~h 260 (292)
+.-.+.-.+..++++|..|++.||++|.+|++.|+-
T Consensus 256 e~~Le~Ied~~~Rnlil~Mi~rdPs~RlSAedyL~~ 291 (1431)
T KOG1240|consen 256 EQLLEKIEDVSLRNLILSMIQRDPSKRLSAEDYLQK 291 (1431)
T ss_pred HHHHHhCcCccHHHHHHHHHccCchhccCHHHHHHh
Confidence 111223346689999999999999999999999986
|
|
| >PRK09605 bifunctional UGMP family protein/serine/threonine protein kinase; Validated | Back alignment and domain information |
|---|
Probab=99.81 E-value=2.2e-19 Score=157.90 Aligned_cols=137 Identities=17% Similarity=0.193 Sum_probs=110.1
Q ss_pred cceeeeecccCceEEEEEEEcCCCcEEEEEEeccCC-C-----ChHHHHHHHHHHHHHHhCCCCCcchhhhhhhcCCeEE
Q psy758 4 YEKIGKLGEGSYGVVFKCRNRDTGQVVAIKKFLESE-E-----DPLIRKIALREIRLLKSLKHPNLVNLLEVFRRKKKLH 77 (292)
Q Consensus 4 y~~~~~l~~g~~~~v~~~~~~~~~~~v~iK~~~~~~-~-----~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~ 77 (292)
|...+.||+|++|.||++.... ..+++|...... . .......+.+|.++++.++|++++....+..+....+
T Consensus 335 ~~~~~~iG~G~~g~Vy~~~~~~--~~~v~k~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~~~~ 412 (535)
T PRK09605 335 KIPDHLIGKGAEADIKKGEYLG--RDAVIKERVPKGYRHPELDERLRTERTRAEARLLSEARRAGVPTPVIYDVDPEEKT 412 (535)
T ss_pred cCccceeccCCcEEEEEEeecC--ccceeEEEecccccchhHHHHHHHHHHHHHHHHHHhhcccCCCeeEEEEEeCCCCE
Confidence 4567889999999999988753 344444432111 1 1123456789999999999999988766666667788
Q ss_pred EEEecCCCccHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEEccCCcEEEeecCchhhh
Q psy758 78 LVFEFCDHTVLNELENHPHGLPWDLIKQITWQVLRGVSYCHRHACIHRDIKPENILLTANGVVKLCDFGFARLI 151 (292)
Q Consensus 78 iv~e~~~~~~L~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~givH~dl~p~Nilv~~~~~~kl~dfg~~~~~ 151 (292)
+||||++|++|.+++. ....++.+++.+|.+||+.|++||||||+||++ +++.++|+|||+++..
T Consensus 413 lv~E~~~g~~L~~~l~--------~~~~~~~~i~~~L~~lH~~giiHrDlkp~NILl-~~~~~~liDFGla~~~ 477 (535)
T PRK09605 413 IVMEYIGGKDLKDVLE--------GNPELVRKVGEIVAKLHKAGIVHGDLTTSNFIV-RDDRLYLIDFGLGKYS 477 (535)
T ss_pred EEEEecCCCcHHHHHH--------HHHHHHHHHHHHHHHHHhCCCccCCCChHHEEE-ECCcEEEEeCcccccC
Confidence 9999999999998875 357899999999999999999999999999999 6779999999999754
|
|
| >cd05119 RIO RIO kinase family, catalytic domain | Back alignment and domain information |
|---|
Probab=99.80 E-value=3.2e-19 Score=136.14 Aligned_cols=139 Identities=24% Similarity=0.246 Sum_probs=97.0
Q ss_pred eeeeecccCceEEEEEEEcCCCcEEEEEEeccCCCChHHHHHH----------------------HHHHHHHHhCCCCC-
Q psy758 6 KIGKLGEGSYGVVFKCRNRDTGQVVAIKKFLESEEDPLIRKIA----------------------LREIRLLKSLKHPN- 62 (292)
Q Consensus 6 ~~~~l~~g~~~~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~----------------------~~e~~~~~~l~~~~- 62 (292)
+.+.||+|++|.||.|.+. +++.||+|++............. ..|...+..+.+.+
T Consensus 1 ~~~~lg~G~~g~Vy~a~~~-~~~~vavKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~ 79 (187)
T cd05119 1 VGGPIGTGKEADVYLALDG-DGEPVAVKIYRTGRTSFKKRKRYRTGDYRFGRKKSNWRYLSRLWAEKEFRNLKRLYEAGV 79 (187)
T ss_pred CCcccccccceeEEEEECC-CCCEEEEEEEecCccchhhhhhhhHHHHHhccCCcchhhhhhHHHHHHHHHHHHHHHcCC
Confidence 3578999999999999987 79999999986543221111111 23444444443222
Q ss_pred -cchhhhhhhcCCeEEEEEecCCCccHHH-HhcCCCCCCHHHHHHHHHHHHHHHHHHHh-CCccccCCCCCceEEccCCc
Q psy758 63 -LVNLLEVFRRKKKLHLVFEFCDHTVLNE-LENHPHGLPWDLIKQITWQVLRGVSYCHR-HACIHRDIKPENILLTANGV 139 (292)
Q Consensus 63 -i~~~~~~~~~~~~~~iv~e~~~~~~L~~-~~~~~~~~~~~~~~~i~~qi~~aL~~LH~-~givH~dl~p~Nilv~~~~~ 139 (292)
+.+.++. ...+++|||++++.+.. .+... ... ..+..++.+++.++.++|+ .|++|+||+|+||+++ ++.
T Consensus 80 ~~~~~~~~----~~~~lv~e~~~g~~~~~~~l~~~-~~~-~~~~~~~~~~~~~l~~lh~~~~ivH~Dl~p~Nili~-~~~ 152 (187)
T cd05119 80 PVPKPIDL----NRHVLVMEFIGGDGIPAPRLKDV-RLL-EDPEELYDQILELMRKLYREAGLVHGDLSEYNILVD-DGK 152 (187)
T ss_pred CCCceEec----CCCEEEEEEeCCCCccChhhhhh-hhc-ccHHHHHHHHHHHHHHHhhccCcCcCCCChhhEEEE-CCc
Confidence 3333322 24589999999943321 11111 111 6788999999999999999 9999999999999999 889
Q ss_pred EEEeecCchhhhh
Q psy758 140 VKLCDFGFARLIR 152 (292)
Q Consensus 140 ~kl~dfg~~~~~~ 152 (292)
++|+|||.+....
T Consensus 153 ~~liDfg~a~~~~ 165 (187)
T cd05119 153 VYIIDVPQAVEID 165 (187)
T ss_pred EEEEECccccccc
Confidence 9999999996554
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases present in archaea, bacteria and eukaryotes. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. RIO kinases contain a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. Most organisms contain at least two RIO kinases, RIO1 and RIO2. A third protein, RIO3, is present in multicellular eukaryotes. In yeast, RIO1 and RIO2 are essential for survival. They funct |
| >KOG0603|consensus | Back alignment and domain information |
|---|
Probab=99.80 E-value=5.2e-21 Score=161.13 Aligned_cols=238 Identities=21% Similarity=0.241 Sum_probs=183.2
Q ss_pred ecccCceEEEEEEE---cCCCcEEEEEEeccCCCChHHHHHHHHHHHHHHhCC-CCCcchhhhhhhcCCeEEEEEecCCC
Q psy758 10 LGEGSYGVVFKCRN---RDTGQVVAIKKFLESEEDPLIRKIALREIRLLKSLK-HPNLVNLLEVFRRKKKLHLVFEFCDH 85 (292)
Q Consensus 10 l~~g~~~~v~~~~~---~~~~~~v~iK~~~~~~~~~~~~~~~~~e~~~~~~l~-~~~i~~~~~~~~~~~~~~iv~e~~~~ 85 (292)
+|.|.+|.|++++. ...+..+++|+..+.............|..++...+ ||.++++.-.++.++..++++++..|
T Consensus 2 lg~g~~gkvfLvrk~~g~da~~~yamkvl~k~t~~~~~~~~t~~er~il~~~~~~~f~v~lhyafqt~~kl~l~ld~~rg 81 (612)
T KOG0603|consen 2 LGQGSYGKVFLVRKAGGADAGHLYAMKVLKKATLKVRDRTHTKQERIILAFVHNTPFLVKLHYAFQTDGKLYLILDFLRG 81 (612)
T ss_pred CCcCCCcchHHHHHhccccccchhhhhcccccccccccccccccHHHHHhhccCCCceeeeeeeeccccchhHhhhhccc
Confidence 78999999987754 334667889887655422222224456777788886 99999999999999999999999999
Q ss_pred ccHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEEccCCcEEEeecCchhhhhcccc-cccccccc
Q psy758 86 TVLNELENHPHGLPWDLIKQITWQVLRGVSYCHRHACIHRDIKPENILLTANGVVKLCDFGFARLIRDLIP-RHLHIFQT 164 (292)
Q Consensus 86 ~~L~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~givH~dl~p~Nilv~~~~~~kl~dfg~~~~~~~~~~-~~~~~~~~ 164 (292)
|.+...+.....+++.....+...++-|++++|+.|++|+|+|++||+++.+|++++.|||.++..-.... -++.-|.+
T Consensus 82 g~lft~l~~~~~f~~~~~~~~~aelaLald~lh~l~iiyrd~k~enilld~~Ghi~~tdfglske~v~~~~~cgt~eymA 161 (612)
T KOG0603|consen 82 GDLFTRLSKEVMFDELDVAFYLAELALALDHLHKLGIAYRDYKLENVLLLLEGHIKLTDFGLSKEAVKEKIACGTYEYRA 161 (612)
T ss_pred chhhhccccCCchHHHHHHHHHHHHHHHHhhcchhHHHHhcccccceeecccCccccCCchhhhHhHhhhhcccchhhhh
Confidence 99999998888899999999999999999999999999999999999999999999999999987654332 23445666
Q ss_pred ccccccC---CCCCCCcccceeeecCCCCCCchHHHHHHHhhcccCCCCCCChhhhhhccCcCCCCCCCCCccchHHHHh
Q psy758 165 NEYFKGV---SLPHAENVVPLEIKIGKPAATNIYLIDFLKRCLDKDPLRRWSCDQLLRHPYFNGYYFEVPDEMQYEEITQ 241 (292)
Q Consensus 165 ~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~ 241 (292)
|+...|. ...|+.++..+++.+|..++....+..+ .-.....+...+..+++++.
T Consensus 162 pEI~~gh~~a~D~ws~gvl~felltg~~pf~~~~~~~I----------------------l~~~~~~p~~l~~~a~~~~~ 219 (612)
T KOG0603|consen 162 PEIINGHLSAADWWSFGVLAFELLTGTLPFGGDTMKRI----------------------LKAELEMPRELSAEARSLFR 219 (612)
T ss_pred hHhhhccCCcccchhhhhhHHHHhhCCCCCchHHHHHH----------------------hhhccCCchhhhHHHHHHHH
Confidence 7666632 2345556666666666655443111111 11122344455668899999
Q ss_pred cccCcCCCCCCCh-----hhhhhCCcccceecc
Q psy758 242 RCLDKDPLRRWSC-----DQLLRHPYFNGYYFE 269 (292)
Q Consensus 242 ~~l~~dP~~Rpt~-----~~il~h~w~~~~~~~ 269 (292)
.++..+|..|.-+ .++++|+||+.+.|.
T Consensus 220 ~l~~r~p~nrLg~~~~~~~eik~h~f~~~i~~~ 252 (612)
T KOG0603|consen 220 QLFKRNPENRLGAGPDGVDEIKQHEFFQSIDWN 252 (612)
T ss_pred HHHhhCHHHHhccCcchhHHHhccchheeeeHh
Confidence 9999999999954 799999999999998
|
|
| >PRK01723 3-deoxy-D-manno-octulosonic-acid kinase; Reviewed | Back alignment and domain information |
|---|
Probab=99.78 E-value=2.5e-18 Score=135.20 Aligned_cols=137 Identities=20% Similarity=0.223 Sum_probs=105.7
Q ss_pred eeec-ccCceEEEEEEEcCCCcEEEEEEeccCC-----------CChHHHHHHHHHHHHHHhCCCCCc--chhhhhhhc-
Q psy758 8 GKLG-EGSYGVVFKCRNRDTGQVVAIKKFLESE-----------EDPLIRKIALREIRLLKSLKHPNL--VNLLEVFRR- 72 (292)
Q Consensus 8 ~~l~-~g~~~~v~~~~~~~~~~~v~iK~~~~~~-----------~~~~~~~~~~~e~~~~~~l~~~~i--~~~~~~~~~- 72 (292)
..|| .|+.|+||.+... +..+++|.+.... .+......+.+|+.++..|.|+++ ++.+++...
T Consensus 37 ~~lg~~~g~gtv~~v~~~--~~~~vlk~~~r~~~i~kv~~~~~~~~~~~~~r~~rE~~ll~~L~~~gi~vP~pl~~~~~~ 114 (239)
T PRK01723 37 RVVGSAKGRGTTWFVQTP--GVNWVLRHYRRGGLIGKLSKDRYLFTGLERTRAFAEFRLLAQLYEAGLPVPRPIAARVVR 114 (239)
T ss_pred ceeecCCCCccEEEEEeC--CceEEEEEeeEcchHHhhhhhcccccchhhhHHHHHHHHHHHHHhCCCCCceeEeeeeee
Confidence 4576 8889999998775 7789999885422 111234567889999999998775 566665332
Q ss_pred CC---eEEEEEecCCC-ccHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEEccCCcEEEeecCch
Q psy758 73 KK---KLHLVFEFCDH-TVLNELENHPHGLPWDLIKQITWQVLRGVSYCHRHACIHRDIKPENILLTANGVVKLCDFGFA 148 (292)
Q Consensus 73 ~~---~~~iv~e~~~~-~~L~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~givH~dl~p~Nilv~~~~~~kl~dfg~~ 148 (292)
.+ ..++|+|+++| .+|..++... .+++.. +.+|+.+|.+||++||+|+||+|.|||++.++.++|+|||.+
T Consensus 115 ~~~~~~~~lV~e~l~G~~~L~~~l~~~-~l~~~~----~~~i~~~l~~lH~~GI~HrDlkp~NILv~~~~~v~LIDfg~~ 189 (239)
T PRK01723 115 HGLFYRADILIERIEGARDLVALLQEA-PLSEEQ----WQAIGQLIARFHDAGVYHADLNAHNILLDPDGKFWLIDFDRG 189 (239)
T ss_pred cCcceeeeEEEEecCCCCCHHHHHhcC-CCCHHH----HHHHHHHHHHHHHCCCCCCCCCchhEEEcCCCCEEEEECCCc
Confidence 22 23599999997 6888887653 455543 678999999999999999999999999999999999999988
Q ss_pred hhh
Q psy758 149 RLI 151 (292)
Q Consensus 149 ~~~ 151 (292)
...
T Consensus 190 ~~~ 192 (239)
T PRK01723 190 ELR 192 (239)
T ss_pred ccC
Confidence 653
|
|
| >KOG1166|consensus | Back alignment and domain information |
|---|
Probab=99.77 E-value=2.4e-18 Score=154.61 Aligned_cols=145 Identities=28% Similarity=0.362 Sum_probs=118.4
Q ss_pred cccceeeeecccCceEEEEEEEcCCCcEEEEEEeccCCCChHHHHHHHHHHHHHHhCC---CCCcchhhhhhhcCCeEEE
Q psy758 2 ERYEKIGKLGEGSYGVVFKCRNRDTGQVVAIKKFLESEEDPLIRKIALREIRLLKSLK---HPNLVNLLEVFRRKKKLHL 78 (292)
Q Consensus 2 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~e~~~~~~l~---~~~i~~~~~~~~~~~~~~i 78 (292)
..|-+.+.||.|++|+||.|.... |+.||+|+-.....-+ |+--.+++.+|+ -+.|..+...+...+..++
T Consensus 698 ~~~~I~~e~G~g~y~~vy~a~~~~-~~~~alK~e~P~~~WE-----fYI~~q~~~RLk~~~~~~~~~~~~a~~~~~~S~l 771 (974)
T KOG1166|consen 698 EKFCISKEIGEGSYGSVYVATHSN-GKLVALKVEKPPNPWE-----FYICLQVMERLKPQMLPSIMHISSAHVFQNASVL 771 (974)
T ss_pred eeEEEEeeeccccceEEEEeecCC-CcEEEEEeecCCCcee-----eeehHHHHHhhchhhhcchHHHHHHHccCCccee
Confidence 468889999999999999999988 9999999865443221 111223333333 3567777777777888999
Q ss_pred EEecCCCccHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEEcc-------CCcEEEeecCchhhh
Q psy758 79 VFEFCDHTVLNELENHPHGLPWDLIKQITWQVLRGVSYCHRHACIHRDIKPENILLTA-------NGVVKLCDFGFARLI 151 (292)
Q Consensus 79 v~e~~~~~~L~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~givH~dl~p~Nilv~~-------~~~~kl~dfg~~~~~ 151 (292)
|+||.+.|+|.++++..+.+++..++.+..|++..+++||..|||||||||+|+++.. .--++|+|||.+-..
T Consensus 772 v~ey~~~Gtlld~~N~~~~m~e~lv~~~~~qml~ive~lH~~~IIHgDiKPDNfll~~~~~~~~~~~~l~lIDfG~siDm 851 (974)
T KOG1166|consen 772 VSEYSPYGTLLDLINTNKVMDEYLVMFFSCQMLRIVEHLHAMGIIHGDIKPDNFLLRREICADSDSKGLYLIDFGRSIDM 851 (974)
T ss_pred eeeccccccHHHhhccCCCCCchhhhHHHHHHHHHHHHHHhcceecccCCcceeEeecccCCCCcccceEEEecccceee
Confidence 9999999999999998889999999999999999999999999999999999999952 235999999998554
Q ss_pred h
Q psy758 152 R 152 (292)
Q Consensus 152 ~ 152 (292)
.
T Consensus 852 ~ 852 (974)
T KOG1166|consen 852 K 852 (974)
T ss_pred e
Confidence 3
|
|
| >KOG4158|consensus | Back alignment and domain information |
|---|
Probab=99.77 E-value=2.3e-18 Score=138.03 Aligned_cols=147 Identities=31% Similarity=0.437 Sum_probs=104.5
Q ss_pred CcccceeeeecccCceEEEEEEEcCCCc-----------------------------------EEEEEEeccCC---CCh
Q psy758 1 MERYEKIGKLGEGSYGVVFKCRNRDTGQ-----------------------------------VVAIKKFLESE---EDP 42 (292)
Q Consensus 1 ~~~y~~~~~l~~g~~~~v~~~~~~~~~~-----------------------------------~v~iK~~~~~~---~~~ 42 (292)
|++|+++..||+|....||.|....+|. +.|||.+-+-+ .+.
T Consensus 156 iddyeiG~~igkGC~AaVY~A~~~~dg~~le~~~~t~~~pgf~p~ts~p~e~~q~~~p~~~aFPLAiKmMfN~~~~s~~~ 235 (598)
T KOG4158|consen 156 IDDYEIGEFIGKGCNAAVYSARLANDGSDLESSGNTHYGPGFNPVTSIPAEIPQVSKPAQKAFPLAIKMMFNFEHDSGDA 235 (598)
T ss_pred hhhhcccchhhccchhhhhhhhcCCCcccccccCCCCcCCCcCCCcCCcccCCcccCccccccchHHHHhcccccCCchH
Confidence 5789999999999999999987654111 23455432222 222
Q ss_pred HHHHHHHHHH--------------HHHHhC--------CCCCcchhhhhhhcC---------------------------
Q psy758 43 LIRKIALREI--------------RLLKSL--------KHPNLVNLLEVFRRK--------------------------- 73 (292)
Q Consensus 43 ~~~~~~~~e~--------------~~~~~l--------~~~~i~~~~~~~~~~--------------------------- 73 (292)
...+...+|. ...+.+ +||||+++.++|.++
T Consensus 236 ~iL~sM~~ElvPa~~~a~~~e~~~~t~R~l~nqtvhLa~HPNIvri~~aF~dsv~~lPda~~~YPdalp~R~~p~g~g~~ 315 (598)
T KOG4158|consen 236 HILKSMGNELVPAPNAAKLLEGQMGTFRPLPNQTVHLAKHPNIVRIQTAFIDSVKVLPDAIERYPDALPARWYPSGAGEP 315 (598)
T ss_pred HHHHHhhhhccCcchhhhhcccccceeeeCCCCCcccCCCCCEEeehhhhhhhhccCCchhhhCcccccceecccccCCC
Confidence 2223333321 111112 499999999887442
Q ss_pred CeEEEEEecCCCccHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEEc--cCC--cEEEeecCchh
Q psy758 74 KKLHLVFEFCDHTVLNELENHPHGLPWDLIKQITWQVLRGVSYCHRHACIHRDIKPENILLT--ANG--VVKLCDFGFAR 149 (292)
Q Consensus 74 ~~~~iv~e~~~~~~L~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~givH~dl~p~Nilv~--~~~--~~kl~dfg~~~ 149 (292)
...|+||..+.. +|..++..+ ..+......++.|+++|+.|||++|+.|+|+|.+|||+. +|+ .+.+.|||++-
T Consensus 316 ~tlylvMkrY~~-tLr~yl~~~-~~s~r~~~~~laQlLEav~hL~~hgvAhRDlKSDNiL~ElddD~~P~LVvaDFGCcL 393 (598)
T KOG4158|consen 316 KTLYLVMKRYRQ-TLREYLWTR-HRSYRTGRVILAQLLEAVTHLHKHGVAHRDLKSDNILLELDDDEIPQLVVADFGCCL 393 (598)
T ss_pred ceEEEehhcchh-hHHHHHhcC-CCchHHHHHHHHHHHHHHHHHHHccchhhcccccceEEEecCCCCcEEEEcccceee
Confidence 358899988875 577777654 467788899999999999999999999999999999984 555 47889999874
|
|
| >PF14531 Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_A 3Q5Z_A 3Q60_A | Back alignment and domain information |
|---|
Probab=99.76 E-value=1.3e-18 Score=137.71 Aligned_cols=225 Identities=20% Similarity=0.218 Sum_probs=127.2
Q ss_pred cceeeeecccCceEEEEEEEcCCCcEEEEEEeccCCCC-hHHHHHHHHHHHHHHhCCC---C-------Ccchhhhhhhc
Q psy758 4 YEKIGKLGEGSYGVVFKCRNRDTGQVVAIKKFLESEED-PLIRKIALREIRLLKSLKH---P-------NLVNLLEVFRR 72 (292)
Q Consensus 4 y~~~~~l~~g~~~~v~~~~~~~~~~~v~iK~~~~~~~~-~~~~~~~~~e~~~~~~l~~---~-------~i~~~~~~~~~ 72 (292)
...++.||.|+++.||.+.+..||+.+++|++...... ....+.+.+|.-....+.+ | .++-.++...-
T Consensus 14 l~~~~~i~~g~~~~v~~v~d~~t~~~~avkvf~~~~~~~~~~~~~~~~e~l~~~~~~~~~~p~~a~~~~r~l~P~d~~~i 93 (288)
T PF14531_consen 14 LVRGRIIGKGGFSIVFEVTDVETGEEFAVKVFLLPADASANEYEQLKEEQLAITLFPGVKNPKEAYRHLRFLVPLDLLRI 93 (288)
T ss_dssp EEEEEEEEEETTEEEEEEEETTTTEEEEEEEEEESSTTHTTHHHHHHHHHHGGGGSTT--SHHHHHHHH-B---SEEEEE
T ss_pred EEEccccccCCceEEEEEEEccCCceEEEEEEecccccchHHHHHHHHHHHHhhhhccCCCHHHHHHhceEEeeeEEEEE
Confidence 45678899999999999999999999999998655422 2245556666555544332 1 22222222110
Q ss_pred ------------CC-----eEEEEEecCCCccHHHHhc---CCC----CCCHHHHHHHHHHHHHHHHHHHhCCccccCCC
Q psy758 73 ------------KK-----KLHLVFEFCDHTVLNELEN---HPH----GLPWDLIKQITWQVLRGVSYCHRHACIHRDIK 128 (292)
Q Consensus 73 ------------~~-----~~~iv~e~~~~~~L~~~~~---~~~----~~~~~~~~~i~~qi~~aL~~LH~~givH~dl~ 128 (292)
.. ..+++|+-+.+ +|..++. ... .+.......+..|+++.+++||+.|++|+||+
T Consensus 94 ~~~~~~~~~~~~~~~~~v~n~~~l~P~~~~-dL~~~~~~l~~~~~~~~~l~~~arl~lT~Q~I~lvA~Lh~~GlVHgdi~ 172 (288)
T PF14531_consen 94 PGKPPFFERGPGQSIYWVLNRFLLMPRAQG-DLQDLVEALFSRAQTHSPLAFAARLSLTVQMIRLVANLHSYGLVHGDIK 172 (288)
T ss_dssp TTS-SEEEECETTEEEEEESEEEEEE--SE-EHHHHHHHHHHHTTTSHHHHHHHHHHHHHHHHHHHHHHHHTTEEEST-S
T ss_pred cCCCcceecCCCCccceeehhhhccchhhh-cHHHHHHHHhhcccccchhHHHHHHHHHHHHHHHHHHHhhcceEecccc
Confidence 01 23667777754 4554432 111 12233345666899999999999999999999
Q ss_pred CCceEEccCCcEEEeecCchhhhhcccc--ccccccccccccccC-------------CCCCCCcccceeeecCCCCCCc
Q psy758 129 PENILLTANGVVKLCDFGFARLIRDLIP--RHLHIFQTNEYFKGV-------------SLPHAENVVPLEIKIGKPAATN 193 (292)
Q Consensus 129 p~Nilv~~~~~~kl~dfg~~~~~~~~~~--~~~~~~~~~~~~~~~-------------~~~~~~~~~~~~~~~~~~~~~~ 193 (292)
|+|++++.+|.++|+||+.....+.... .....+.+||..... ...|..|+..|.+++
T Consensus 173 ~~nfll~~~G~v~Lg~F~~~~r~g~~~~~~~~~~~~~PPe~~~~~~~~~~~~~~~t~~~DaW~LG~~ly~lWC------- 245 (288)
T PF14531_consen 173 PENFLLDQDGGVFLGDFSSLVRAGTRYRCSEFPVAFTPPELESCAGQFGQNNAPYTFATDAWQLGITLYSLWC------- 245 (288)
T ss_dssp GGGEEE-TTS-EEE--GGGEEETTEEEEGGGS-TTTS-HHHHHHHTSCHHSEEEE-HHHHHHHHHHHHHHHHH-------
T ss_pred eeeEEEcCCCCEEEcChHHHeecCceeeccCCCcccCChhhhhhhcccCcccceeeeccCHHHHHHHHHHHHH-------
Confidence 9999999999999999988776654332 122234444433211 112333333333333
Q ss_pred hHHHHHHHhhcccCCCCCCChhhhhhccCcCCCCCCCCCccchHHHHhcccCcCCCCC
Q psy758 194 IYLIDFLKRCLDKDPLRRWSCDQLLRHPYFNGYYFEVPDEMQYEEITQRCLDKDPLRR 251 (292)
Q Consensus 194 ~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~R 251 (292)
..-|+...+........| . ... ..|..++.||.++|++||.+|
T Consensus 246 -----------~~lPf~~~~~~~~~~~~f-~--~C~-~~Pe~v~~LI~~lL~~~~~~R 288 (288)
T PF14531_consen 246 -----------GRLPFGLSSPEADPEWDF-S--RCR-DMPEPVQFLIRGLLQRNPEDR 288 (288)
T ss_dssp -----------SS-STCCCGGGSTSGGGG-T--TSS----HHHHHHHHHHT-SSGGGS
T ss_pred -----------ccCCCCCCCccccccccc-h--hcC-CcCHHHHHHHHHHccCCcccC
Confidence 334444433322222222 1 222 668899999999999999988
|
|
| >KOG0606|consensus | Back alignment and domain information |
|---|
Probab=99.76 E-value=8.8e-19 Score=155.37 Aligned_cols=221 Identities=22% Similarity=0.315 Sum_probs=148.0
Q ss_pred cccceeeeecccCceEEEEEEEcCCCcEEEEEEeccCCCChHHHHHHHHHHHHHHhCCCCCcchhhhhhhcCCeEEEEEe
Q psy758 2 ERYEKIGKLGEGSYGVVFKCRNRDTGQVVAIKKFLESEEDPLIRKIALREIRLLKSLKHPNLVNLLEVFRRKKKLHLVFE 81 (292)
Q Consensus 2 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~iv~e 81 (292)
++|..++.+..|++|.||.+++..+.+.+|+| +.++..- +++ ++.....|. +|
T Consensus 83 ~df~~IklisngAygavylvrh~~trqrfa~k-iNkq~li------lRn---ilt~a~npf---------------vv-- 135 (1205)
T KOG0606|consen 83 SDFNTIKLISNGAYGAVYLVRHKETRQRFAMK-INKQNLI------LRN---ILTFAGNPF---------------VV-- 135 (1205)
T ss_pred cccceeEeeccCCCCceeeeeccccccchhhc-ccccchh------hhc---cccccCCcc---------------ee--
Confidence 46889999999999999999999999999995 3322110 001 222222333 33
Q ss_pred cCCCccHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEEccCCcEEEeecCchhhhhccc------
Q psy758 82 FCDHTVLNELENHPHGLPWDLIKQITWQVLRGVSYCHRHACIHRDIKPENILLTANGVVKLCDFGFARLIRDLI------ 155 (292)
Q Consensus 82 ~~~~~~L~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~givH~dl~p~Nilv~~~~~~kl~dfg~~~~~~~~~------ 155 (292)
|+-...++..+.++.+. +.|++|||+.||+|+|+||+|.+|+.-|++|++|||+.+......
T Consensus 136 ----gDc~tllk~~g~lPvdm--------vla~Eylh~ygivhrdlkpdnllIT~mGhiKlTDfgLsk~GLms~atnl~e 203 (1205)
T KOG0606|consen 136 ----GDCATLLKNIGPLPVDM--------VLAVEYLHSYGIVHRDLKPDNLLITSMGHIKLTDFGLSKKGLMSLATNLKE 203 (1205)
T ss_pred ----chhhhhcccCCCCcchh--------hHHhHhhccCCeecCCCCCCcceeeecccccccchhhhhhhhhhccchhhh
Confidence 55666677666676555 889999999999999999999999999999999999987643110
Q ss_pred ---------cccccccccccccccCCCCCCCcccceeeecCCCCCCchHHHHHHHhhcccCCCCCCChhhhhhccCcCCC
Q psy758 156 ---------PRHLHIFQTNEYFKGVSLPHAENVVPLEIKIGKPAATNIYLIDFLKRCLDKDPLRRWSCDQLLRHPYFNGY 226 (292)
Q Consensus 156 ---------~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~ 226 (292)
......+++|+|..++.+. .--+|++-+.+.-..-+.+-+.+..|+...+.++++.+......
T Consensus 204 g~I~k~t~Ef~dKqvcgTPeyiaPeVil--------rqgygkpvdwwamGiIlyeFLVgcvpffGdtpeelfg~visd~i 275 (1205)
T KOG0606|consen 204 GHIEKDTHEFQDKQVCGTPEYIAPEVIL--------RQGYGKPVDWWAMGIILYEFLVGCVPFFGDTPEELFGQVISDDI 275 (1205)
T ss_pred cchHHHHHHhhhccccCCccccChhhhh--------hhccCCCccHHHHHHHHHHHheeeeeccCCCHHHHHhhhhhhhc
Confidence 0111235666666655441 11122222212222222333344456666666666655443333
Q ss_pred CCCC---CCccchHHHHhcccCcCCCCCC---ChhhhhhCCcccceecc
Q psy758 227 YFEV---PDEMQYEEITQRCLDKDPLRRW---SCDQLLRHPYFNGYYFE 269 (292)
Q Consensus 227 ~~~~---~~~~~l~~li~~~l~~dP~~Rp---t~~~il~h~w~~~~~~~ 269 (292)
.++. ..+++++++|.++|..+|..|. .+-++.+|+||+...|.
T Consensus 276 ~wpE~dea~p~Ea~dli~~LL~qnp~~Rlgt~ga~evk~h~ff~~LDw~ 324 (1205)
T KOG0606|consen 276 EWPEEDEALPPEAQDLIEQLLRQNPLCRLGTGGALEVKQHGFFQLLDWK 324 (1205)
T ss_pred cccccCcCCCHHHHHHHHHHHHhChHhhcccchhhhhhhccceeecccc
Confidence 3332 3377899999999999999998 77889999999999887
|
|
| >KOG0195|consensus | Back alignment and domain information |
|---|
Probab=99.76 E-value=1.2e-18 Score=132.97 Aligned_cols=241 Identities=14% Similarity=0.195 Sum_probs=176.6
Q ss_pred cceeeeecccCceEEEEEEEcCCCcEEEEEEeccCCCChHHHHHHHHHHHHHHhCCCCCcchhhhhhhcCCeEEEEEecC
Q psy758 4 YEKIGKLGEGSYGVVFKCRNRDTGQVVAIKKFLESEEDPLIRKIALREIRLLKSLKHPNLVNLLEVFRRKKKLHLVFEFC 83 (292)
Q Consensus 4 y~~~~~l~~g~~~~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~iv~e~~ 83 (292)
..+...|.....|..|+++.. |..++.|++....-+....+.|..|.-.++-++||||+++++.+.....+.+++.|+
T Consensus 192 lnl~tkl~e~hsgelwrgrwq--gndivakil~vr~~t~risrdfneefp~lrifshpnilpvlgacnsppnlv~isq~m 269 (448)
T KOG0195|consen 192 LNLITKLAESHSGELWRGRWQ--GNDIVAKILNVREVTARISRDFNEEFPALRIFSHPNILPVLGACNSPPNLVIISQYM 269 (448)
T ss_pred hhhhhhhccCCCccccccccc--CcchhhhhhhhhhcchhhcchhhhhCcceeeecCCchhhhhhhccCCCCceEeeeec
Confidence 445667888899999999998 667889998877766666777888999999999999999999999999999999999
Q ss_pred CCccHHHHhcCCCC--CCHHHHHHHHHHHHHHHHHHHhCC--ccccCCCCCceEEccCCcEEEe--ecCchhhhhccccc
Q psy758 84 DHTVLNELENHPHG--LPWDLIKQITWQVLRGVSYCHRHA--CIHRDIKPENILLTANGVVKLC--DFGFARLIRDLIPR 157 (292)
Q Consensus 84 ~~~~L~~~~~~~~~--~~~~~~~~i~~qi~~aL~~LH~~g--ivH~dl~p~Nilv~~~~~~kl~--dfg~~~~~~~~~~~ 157 (292)
+-|+|...+..... .+..++.+++.+++.|++|||+-. |.--.|+...+++|++.+.+|. |-.++- .+...
T Consensus 270 p~gslynvlhe~t~vvvd~sqav~faldiargmaflhslep~ipr~~lns~hvmidedltarismad~kfsf--qe~gr- 346 (448)
T KOG0195|consen 270 PFGSLYNVLHEQTSVVVDHSQAVRFALDIARGMAFLHSLEPMIPRFYLNSKHVMIDEDLTARISMADTKFSF--QEVGR- 346 (448)
T ss_pred cchHHHHHHhcCccEEEecchHHHHHHHHHhhHHHHhhcchhhhhhhcccceEEecchhhhheecccceeee--ecccc-
Confidence 99999999976544 688999999999999999999975 4445689999999999776653 322221 11111
Q ss_pred cccccccccccccCCCCCCCcccceeeecCCCCCCchHHHHHHHhhcccCCCCCCChhhhhhccCcCCCCC--CCCCccc
Q psy758 158 HLHIFQTNEYFKGVSLPHAENVVPLEIKIGKPAATNIYLIDFLKRCLDKDPLRRWSCDQLLRHPYFNGYYF--EVPDEMQ 235 (292)
Q Consensus 158 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~--~~~~~~~ 235 (292)
.-+|.|..++.+.....-. .....+.++.+.-+.+.....-|+..++.-++-....+.+.+. +...+..
T Consensus 347 ----~y~pawmspealqrkped~-----n~raadmwsfaillwel~trevpfadlspmecgmkialeglrv~ippgis~h 417 (448)
T KOG0195|consen 347 ----AYSPAWMSPEALQRKPEDL-----NIRAADMWSFAILLWELNTREVPFADLSPMECGMKIALEGLRVHIPPGISRH 417 (448)
T ss_pred ----ccCcccCCHHHHhcCchhc-----chhhhhHHHHHHHHHHhhccccccccCCchhhhhhhhhccccccCCCCccHH
Confidence 1234444444332211110 0111122444444455556667777777777776766776654 4445788
Q ss_pred hHHHHhcccCcCCCCCCChhhhh
Q psy758 236 YEEITQRCLDKDPLRRWSCDQLL 258 (292)
Q Consensus 236 l~~li~~~l~~dP~~Rpt~~~il 258 (292)
+..|+.-|++.||.+||.++.|+
T Consensus 418 m~klm~icmnedpgkrpkfdmiv 440 (448)
T KOG0195|consen 418 MNKLMNICMNEDPGKRPKFDMIV 440 (448)
T ss_pred HHHHHHHHhcCCCCcCCCcceeh
Confidence 99999999999999999998775
|
|
| >cd05120 APH_ChoK_like Aminoglycoside 3'-phosphotransferase (APH) and Choline Kinase (ChoK) family | Back alignment and domain information |
|---|
Probab=99.76 E-value=7.7e-18 Score=124.05 Aligned_cols=132 Identities=20% Similarity=0.241 Sum_probs=112.6
Q ss_pred eeeeecccCceEEEEEEEcCCCcEEEEEEeccCCCChHHHHHHHHHHHHHHhCCC--CCcchhhhhhhcCCeEEEEEecC
Q psy758 6 KIGKLGEGSYGVVFKCRNRDTGQVVAIKKFLESEEDPLIRKIALREIRLLKSLKH--PNLVNLLEVFRRKKKLHLVFEFC 83 (292)
Q Consensus 6 ~~~~l~~g~~~~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~e~~~~~~l~~--~~i~~~~~~~~~~~~~~iv~e~~ 83 (292)
+++.|++|.++.||++.... ..+++|....... ...+..|...++.+++ .++++++++....+..++++||+
T Consensus 2 ~~~~i~~g~~~~v~~~~~~~--~~~~iK~~~~~~~----~~~~~~e~~~~~~l~~~~~~~p~~~~~~~~~~~~~~v~e~~ 75 (155)
T cd05120 2 SIKLLKGGLTNRVYLLGTKD--EDYVLKINPSREK----GADREREVAILQLLARKGLPVPKVLASGESDGWSYLLMEWI 75 (155)
T ss_pred cceecccccccceEEEEecC--CeEEEEecCCCCc----hhHHHHHHHHHHHHHHcCCCCCeEEEEcCCCCccEEEEEec
Confidence 46789999999999999853 7899998865443 3557789999999976 58888888888778899999999
Q ss_pred CCccHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhC---CccccCCCCCceEEccCCcEEEeecCchhh
Q psy758 84 DHTVLNELENHPHGLPWDLIKQITWQVLRGVSYCHRH---ACIHRDIKPENILLTANGVVKLCDFGFARL 150 (292)
Q Consensus 84 ~~~~L~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~---givH~dl~p~Nilv~~~~~~kl~dfg~~~~ 150 (292)
+|+.+..+ +......++.+++.+|+.+|.. +++|+|++|+||++++.+.++++||+.+..
T Consensus 76 ~g~~~~~~-------~~~~~~~~~~~~~~~l~~lh~~~~~~i~H~Dl~~~Nil~~~~~~~~l~Df~~~~~ 138 (155)
T cd05120 76 EGETLDEV-------SEEEKEDIAEQLAELLAKLHQLPLLVLCHGDLHPGNILVDDGKILGIIDWEYAGY 138 (155)
T ss_pred CCeecccC-------CHHHHHHHHHHHHHHHHHHhCCCceEEEecCCCcceEEEECCcEEEEEecccccC
Confidence 99877654 5567788899999999999985 799999999999999989999999998864
|
The APH/ChoK family is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). The family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides and macrolides, leads to their inactivation and to bacterial antibiotic resistance. Phosphorylation of choline, ethanolamine, and homoserine serves |
| >KOG0590|consensus | Back alignment and domain information |
|---|
Probab=99.68 E-value=1.1e-17 Score=146.97 Aligned_cols=245 Identities=20% Similarity=0.207 Sum_probs=182.9
Q ss_pred ccceeeeecccCceEEEEEEEcCC-CcEEEEEEeccCCCChHHHHHHHHHHHHHHhCC-CCCcchhhhhhhcCCeEEEEE
Q psy758 3 RYEKIGKLGEGSYGVVFKCRNRDT-GQVVAIKKFLESEEDPLIRKIALREIRLLKSLK-HPNLVNLLEVFRRKKKLHLVF 80 (292)
Q Consensus 3 ~y~~~~~l~~g~~~~v~~~~~~~~-~~~v~iK~~~~~~~~~~~~~~~~~e~~~~~~l~-~~~i~~~~~~~~~~~~~~iv~ 80 (292)
.|.+.+.||+|+++.+-.+....+ ...++.|.+...............|..+-..+. |+|++.+++...+.+..++++
T Consensus 21 ~~~~~~~ig~gs~~~~~~~~~~~~~~~~~a~~~~s~~~~~~~~~~~i~~e~~~~~~~s~h~n~~~~~~~~~~~~~~~~~~ 100 (601)
T KOG0590|consen 21 QYKLSRSIGKGSFSSSALASNSRDPESSSATKPISIPPKSEDSSEHIDTETDIQKKLSKHSNTVHMIEPSSSPRSYLLSL 100 (601)
T ss_pred cccccccccccccchhhhhhhcCCCcceeeccCCCCCCCccchhhhcCccccccccccccccccccCCccCCCccccccc
Confidence 578889999999999988877543 335677766555434444555666888888887 999999999999999999999
Q ss_pred ecCCCccHHHHh-cCCC-CCCHHHHHHHHHHHHHHHHHHH-hCCccccCCCCCceEEccCC-cEEEeecCchhhhhc-c-
Q psy758 81 EFCDHTVLNELE-NHPH-GLPWDLIKQITWQVLRGVSYCH-RHACIHRDIKPENILLTANG-VVKLCDFGFARLIRD-L- 154 (292)
Q Consensus 81 e~~~~~~L~~~~-~~~~-~~~~~~~~~i~~qi~~aL~~LH-~~givH~dl~p~Nilv~~~~-~~kl~dfg~~~~~~~-~- 154 (292)
+|..|+.+...+ .... ..+...+..++.|+..++.|+| ..++.|+|++|+|.+++..+ .+++.|||++..+.. .
T Consensus 101 ~~s~g~~~f~~i~~~~~~~~~~~~~~~~~~ql~s~l~~~H~~~~~~h~~ikP~n~~l~~s~~~l~~~df~~At~~~~~~g 180 (601)
T KOG0590|consen 101 SYSDGGSLFSKISHPDSTGTSSSSASRYLPQLNSGLSYLHPENGVTHRDIKPSNSLLDESGSALKIADFGLATAYRNKNG 180 (601)
T ss_pred CcccccccccccccCCccCCCCcchhhhhhhhccCccccCcccccccCCCCCccchhccCCCcccCCCchhhccccccCC
Confidence 999999998888 5544 6788999999999999999999 99999999999999999999 999999999987654 1
Q ss_pred ------cccc-ccccccccccccC------CCCCCCcccceeeecCCCCCCchHHHHHHHhhcccCCCCCCChhhhhhcc
Q psy758 155 ------IPRH-LHIFQTNEYFKGV------SLPHAENVVPLEIKIGKPAATNIYLIDFLKRCLDKDPLRRWSCDQLLRHP 221 (292)
Q Consensus 155 ------~~~~-~~~~~~~~~~~~~------~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~ 221 (292)
...+ ...|.++|+..+. ...|+.++....+..+..++. .+.........
T Consensus 181 ~~~~~~~~~g~s~~y~a~E~~~~~~~~~~~~d~~S~g~~l~~~~~g~~p~~------------------~~~~~~~~~~~ 242 (601)
T KOG0590|consen 181 AERSLKDRCGSSPPYGAPEHLSGKAYRGPSVDVWSLGIVLSAMLTGELPWD------------------FPSRKDGRYSS 242 (601)
T ss_pred cceeeecccCCCCCCCCcccccchhhcCCCcccccccccccccccCCCCcc------------------cccccccccee
Confidence 1122 4556677766652 223555555555555554432 22222111111
Q ss_pred CcC-----CCCCCCCCccchHHHHhcccCcCCCCCCChhhhhhCCcccc
Q psy758 222 YFN-----GYYFEVPDEMQYEEITQRCLDKDPLRRWSCDQLLRHPYFNG 265 (292)
Q Consensus 222 ~~~-----~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~~il~h~w~~~ 265 (292)
|.. ........+....+++.+++..+|..|.+.+++..+||+..
T Consensus 243 ~~~~~~~~~~~~~~~~~~~~~~~l~k~l~~~~~~r~s~~~~~~d~~~~~ 291 (601)
T KOG0590|consen 243 WKSNKGRFTQLPWNSISDQAHDLLHKILKENPSNRLSIEELKLDNWLSS 291 (601)
T ss_pred ecccccccccCccccCChhhhhcccccccCCchhccccccccccccccc
Confidence 111 12233344667889999999999999999999999999998
|
|
| >PRK04750 ubiB putative ubiquinone biosynthesis protein UbiB; Reviewed | Back alignment and domain information |
|---|
Probab=99.65 E-value=3.7e-16 Score=134.78 Aligned_cols=141 Identities=20% Similarity=0.229 Sum_probs=99.4
Q ss_pred ccceeeeecccCceEEEEEEEcCCCcEEEEEEeccCCCC--------------------------------hHHHHHHHH
Q psy758 3 RYEKIGKLGEGSYGVVFKCRNRDTGQVVAIKKFLESEED--------------------------------PLIRKIALR 50 (292)
Q Consensus 3 ~y~~~~~l~~g~~~~v~~~~~~~~~~~v~iK~~~~~~~~--------------------------------~~~~~~~~~ 50 (292)
.|.. +.||+|+.|.||.|+...+|+.||||+....... .+..+.+.+
T Consensus 121 ~fd~-~PlasaSiaQVh~A~l~~~G~~VAVKV~rP~i~~~I~~Dl~~l~~~a~~l~~~~~~~~~l~~~~~v~e~~~~l~~ 199 (537)
T PRK04750 121 DFDI-KPLASASIAQVHFARLKDNGREVVVKVLRPDILPVIDADLALMYRLARWVERLLPDGRRLKPREVVAEFEKTLHD 199 (537)
T ss_pred hcCh-hhhcCCCccEEEEEEECCCCCEEEEEEeCcchHHHHHHHHHHHHHHHHHHHHhCcccccCCHHHHHHHHHHHHHH
Confidence 4555 6799999999999999888999999998643110 123344555
Q ss_pred HHHHHHhCCCCCcchhhhhhhcCC-------------eEEEEEecCCCccHHHH--hcCCC----CCCHHHHHHHHHHHH
Q psy758 51 EIRLLKSLKHPNLVNLLEVFRRKK-------------KLHLVFEFCDHTVLNEL--ENHPH----GLPWDLIKQITWQVL 111 (292)
Q Consensus 51 e~~~~~~l~~~~i~~~~~~~~~~~-------------~~~iv~e~~~~~~L~~~--~~~~~----~~~~~~~~~i~~qi~ 111 (292)
|++..+.. +|+.++...|.+.. ..++||||+.|+.+.+. +...+ .+.+..+..++.|+
T Consensus 200 ElD~~~Ea--~N~~~~~~~f~~~~~v~VP~v~~d~st~~VLvmE~i~G~~l~d~~~l~~~g~d~~~la~~~v~~~~~Qi- 276 (537)
T PRK04750 200 ELDLMREA--ANASQLRRNFEDSDMLYVPEVYWDYCSETVMVMERMYGIPVSDVAALRAAGTDMKLLAERGVEVFFTQV- 276 (537)
T ss_pred hhCHHHHH--HHHHHHHHHccCCCCeecceeecccCCCceEEEeeecCccHHhHHHHHhcCCCHHHHHHHHHHHHHHHH-
Confidence 55555555 35666655554433 34599999999998774 22222 23344444455554
Q ss_pred HHHHHHHhCCccccCCCCCceEEccCC----cEEEeecCchhhhhc
Q psy758 112 RGVSYCHRHACIHRDIKPENILLTANG----VVKLCDFGFARLIRD 153 (292)
Q Consensus 112 ~aL~~LH~~givH~dl~p~Nilv~~~~----~~kl~dfg~~~~~~~ 153 (292)
...|++|+|++|.||+++.+| .++++|||++..+++
T Consensus 277 ------f~~GffHaDpHPGNIlv~~~g~~~~~i~llDFGivg~l~~ 316 (537)
T PRK04750 277 ------FRDGFFHADMHPGNIFVSYDPPENPRYIALDFGIVGSLNK 316 (537)
T ss_pred ------HhCCeeeCCCChHHeEEecCCCCCCeEEEEecceEEECCH
Confidence 459999999999999999988 999999999987653
|
|
| >KOG1023|consensus | Back alignment and domain information |
|---|
Probab=99.64 E-value=7.4e-16 Score=129.86 Aligned_cols=199 Identities=18% Similarity=0.298 Sum_probs=132.6
Q ss_pred HHhCCCCCcchhhhhhhcCCeEEEEEecCCCccHHHHhcC-CCCCCHHHHHHHHHHHHHHHHHHHhCCc-cccCCCCCce
Q psy758 55 LKSLKHPNLVNLLEVFRRKKKLHLVFEFCDHTVLNELENH-PHGLPWDLIKQITWQVLRGVSYCHRHAC-IHRDIKPENI 132 (292)
Q Consensus 55 ~~~l~~~~i~~~~~~~~~~~~~~iv~e~~~~~~L~~~~~~-~~~~~~~~~~~i~~qi~~aL~~LH~~gi-vH~dl~p~Ni 132 (292)
++.+.|.|+.+++|...++...++|.+||..|+|.+.+.. .-.++......++.+|+.||.|||+..| .||.++..|.
T Consensus 1 l~~l~h~n~~~f~g~~~~~~~~~~i~~~c~rGsl~D~i~~~~~~~d~~F~~s~~rdi~~Gl~ylh~s~i~~hg~l~s~nC 80 (484)
T KOG1023|consen 1 LRQLDHDNLNKFIGASVDGPEMIVIWEYCSRGSLLDILSNEDIKLDYFFILSFIRDISKGLAYLHNSPIGYHGALKSSNC 80 (484)
T ss_pred CcccchhhhhhheeeEecCCceEEEEeeecCccHHhHHhccccCccHHHHHHHHHHHHHHHHHHhcCcceeeeeeccccc
Confidence 3568899999999999999999999999999999998876 4568888899999999999999999876 9999999999
Q ss_pred EEccCCcEEEeecCchhhhhc--cccc-----cccccccccccccCCCCCCCcccceeeecCCCCCCchHHHHHHHhhcc
Q psy758 133 LLTANGVVKLCDFGFARLIRD--LIPR-----HLHIFQTNEYFKGVSLPHAENVVPLEIKIGKPAATNIYLIDFLKRCLD 205 (292)
Q Consensus 133 lv~~~~~~kl~dfg~~~~~~~--~~~~-----~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 205 (292)
++|..+.+||+|||+...... .... ....+.+|+...+...... ........+..+.+.-+.+.+..
T Consensus 81 lvd~~w~lklt~~Gl~~~~~~~~~~~~~~~~~~~~lw~aPellr~~~~~~~------~~~~~~~gdiYs~~ii~~ei~~r 154 (484)
T KOG1023|consen 81 LVDSRWVLKLTDFGLNSLLEETAEPEAHHPIRKALLWTAPELLRGALSQSL------ESALTQKGDIYSFGIIMYEILFR 154 (484)
T ss_pred eeeeeEEEEechhhhcccccccccccccchhHHHHhccCHHHhcccccccc------cccccccCCeehHHHHHHHHHhc
Confidence 999999999999999876632 0011 1123445554443211100 00111112223333333344444
Q ss_pred cCCCCCC----Chhhhhhcc-------CcCCCCCCCCCccchHHHHhcccCcCCCCCCChhhhhh
Q psy758 206 KDPLRRW----SCDQLLRHP-------YFNGYYFEVPDEMQYEEITQRCLDKDPLRRWSCDQLLR 259 (292)
Q Consensus 206 ~~p~~~~----~~~~~~~~~-------~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~~il~ 259 (292)
..|.... ...++.... +..........++.+..++++||..+|.+||+++++-.
T Consensus 155 ~~~~~~~~~~~~~~eii~~~~~~~~~~~rP~i~~~~e~~~~l~~l~~~cw~e~P~~rPs~~~i~~ 219 (484)
T KOG1023|consen 155 SGPFDLRNLVEDPDEIILRVKKGGSNPFRPSIELLNELPPELLLLVARCWEEIPEKRPSIEQIRS 219 (484)
T ss_pred cCccccccccCChHHHHHHHHhcCCCCcCcchhhhhhcchHHHHHHHHhcccChhhCccHHHHHh
Confidence 4443331 111222110 00000101123447889999999999999999999865
|
|
| >cd05146 RIO3_euk RIO kinase family; eukaryotic RIO3, catalytic domain | Back alignment and domain information |
|---|
Probab=99.62 E-value=3.6e-15 Score=112.25 Aligned_cols=140 Identities=23% Similarity=0.226 Sum_probs=101.2
Q ss_pred eeeecccCceEEEEEEEcC------CCcEEEEEEeccCCC-----------C---------hHHHHHH----HHHHHHHH
Q psy758 7 IGKLGEGSYGVVFKCRNRD------TGQVVAIKKFLESEE-----------D---------PLIRKIA----LREIRLLK 56 (292)
Q Consensus 7 ~~~l~~g~~~~v~~~~~~~------~~~~v~iK~~~~~~~-----------~---------~~~~~~~----~~e~~~~~ 56 (292)
...||.|.-+.||.|.... .+..+|+|++..... + ....+.+ .+|...++
T Consensus 2 ~g~i~~GKEa~V~~~~~~~~~~~~~~~~~~avKi~r~~~~~Fk~~~~y~~~~~rf~~~~~k~~~~~~~~~wa~kE~r~L~ 81 (197)
T cd05146 2 NGCISTGKESVVLHANGGSNETEQVIPTECAIKVFKTTLNEFKNRDKYIKDDYRFKDRFSKLNPRKIIRMWAEKEMHNLK 81 (197)
T ss_pred CCccccCcceEEEEEecCcccccccCCceEEEEEEeccceeEcChhhhccCCcccccCcCCCCHHHHHHHHHHHHHHHHH
Confidence 4679999999999998654 357899998753210 0 0112223 37888888
Q ss_pred hCCC--CCcchhhhhhhcCCeEEEEEecCCCccHHH-HhcCCCCCCHHHHHHHHHHHHHHHHHH-HhCCccccCCCCCce
Q psy758 57 SLKH--PNLVNLLEVFRRKKKLHLVFEFCDHTVLNE-LENHPHGLPWDLIKQITWQVLRGVSYC-HRHACIHRDIKPENI 132 (292)
Q Consensus 57 ~l~~--~~i~~~~~~~~~~~~~~iv~e~~~~~~L~~-~~~~~~~~~~~~~~~i~~qi~~aL~~L-H~~givH~dl~p~Ni 132 (292)
.+.. -+++.++++ ..-++||||++++.+.. .++. ..+++.....+..+++.+|..| |+.|++||||++.||
T Consensus 82 rl~~~Gv~vP~pi~~----~~~~lvME~Ig~~~~~~~~Lkd-~~~~~~~~~~i~~~i~~~l~~l~H~~glVHGDLs~~NI 156 (197)
T cd05146 82 RMQKAGIPCPEVVVL----KKHVLVMSFIGDDQVPAPKLKD-AKLNDEEMKNAYYQVLSMMKQLYKECNLVHADLSEYNM 156 (197)
T ss_pred HHHHcCCCCCeEEEe----cCCEEEEEEcCCCCccchhhhc-cccCHHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHE
Confidence 8853 345555543 45689999998754422 2322 2466677788899999999998 899999999999999
Q ss_pred EEccCCcEEEeecCchhhhh
Q psy758 133 LLTANGVVKLCDFGFARLIR 152 (292)
Q Consensus 133 lv~~~~~~kl~dfg~~~~~~ 152 (292)
+++ ++.+.|+|||.+....
T Consensus 157 L~~-~~~v~iIDF~qav~~~ 175 (197)
T cd05146 157 LWH-DGKVWFIDVSQSVEPT 175 (197)
T ss_pred EEE-CCcEEEEECCCceeCC
Confidence 997 4689999999886543
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO3 is present only in multicellular eukaryotes. Its function is still unknown. |
| >TIGR01982 UbiB 2-polyprenylphenol 6-hydroxylase | Back alignment and domain information |
|---|
Probab=99.58 E-value=8.2e-15 Score=125.05 Aligned_cols=142 Identities=25% Similarity=0.314 Sum_probs=93.5
Q ss_pred eeecccCceEEEEEEEcCCCcEEEEEEeccCCCCh--------------------------------HHHHH------HH
Q psy758 8 GKLGEGSYGVVFKCRNRDTGQVVAIKKFLESEEDP--------------------------------LIRKI------AL 49 (292)
Q Consensus 8 ~~l~~g~~~~v~~~~~~~~~~~v~iK~~~~~~~~~--------------------------------~~~~~------~~ 49 (292)
+.||+|+.|.||+|+.. +|+.||||+........ +.... +.
T Consensus 123 ~plasaSigQVh~A~l~-~G~~VaVKv~rp~i~~~i~~Dl~~l~~~~~~~~~~~~~~~~~~~~~~~~e~~~~l~~Eldf~ 201 (437)
T TIGR01982 123 KPLAAASIAQVHRARLV-DGKEVAVKVLRPGIEKTIAADIALLYRLARIVERLSPDSRRLRPTEVVKEFEKTLRRELDLR 201 (437)
T ss_pred cceeeeehhheEEEEec-CCCEEEEEeeCCCcHHHHHHHHHHHHHHHHHHHHhCccccccCHHHHHHHHHHHHHHHHCHH
Confidence 56999999999999875 69999999985332110 00011 12
Q ss_pred HHHHHHHhC----CCCCcchhhhhhh-cCCeEEEEEecCCCccHHHHhcCC-CCCCHHHHHHHHHHHHH-HHHHHHhCCc
Q psy758 50 REIRLLKSL----KHPNLVNLLEVFR-RKKKLHLVFEFCDHTVLNELENHP-HGLPWDLIKQITWQVLR-GVSYCHRHAC 122 (292)
Q Consensus 50 ~e~~~~~~l----~~~~i~~~~~~~~-~~~~~~iv~e~~~~~~L~~~~~~~-~~~~~~~~~~i~~qi~~-aL~~LH~~gi 122 (292)
+|...+..+ ++.+-+.+-.++. .....++||||++|+.+.+..... ... ....++.+++. .+..+|..|+
T Consensus 202 ~Ea~n~~~~~~~~~~~~~v~vP~v~~~~~~~~vLvmE~i~G~~L~~~~~~~~~~~---~~~~ia~~~~~~~l~ql~~~g~ 278 (437)
T TIGR01982 202 REAANASELGENFKNDPGVYVPEVYWDRTSERVLTMEWIDGIPLSDIAALDEAGL---DRKALAENLARSFLNQVLRDGF 278 (437)
T ss_pred HHHHHHHHHHHhcCCCCCEEeCCEehhhcCCceEEEEeECCcccccHHHHHhcCC---CHHHHHHHHHHHHHHHHHhCCc
Confidence 233333332 1221112111221 233468999999999988775421 112 23456666665 4788999999
Q ss_pred cccCCCCCceEEccCCcEEEeecCchhhhhc
Q psy758 123 IHRDIKPENILLTANGVVKLCDFGFARLIRD 153 (292)
Q Consensus 123 vH~dl~p~Nilv~~~~~~kl~dfg~~~~~~~ 153 (292)
+|+|++|.||++++++.++++|||++..+.+
T Consensus 279 ~H~D~hPgNilv~~~g~i~liDfG~~~~l~~ 309 (437)
T TIGR01982 279 FHADLHPGNIFVLKDGKIIALDFGIVGRLSE 309 (437)
T ss_pred eeCCCCcccEEECCCCcEEEEeCCCeeECCH
Confidence 9999999999999999999999999987653
|
This model represents the enzyme (UbiB) which catalyzes the first hydroxylation step in the ubiquinone biosynthetic pathway in bacteria. It is believed that the reaction is 2-polyprenylphenol - 6-hydroxy-2-polyprenylphenol. This model finds hits primarily in the proteobacteria. The gene is also known as AarF in certain species. |
| >cd05151 ChoK Choline Kinase (ChoK) | Back alignment and domain information |
|---|
Probab=99.55 E-value=1.9e-14 Score=107.97 Aligned_cols=128 Identities=17% Similarity=0.101 Sum_probs=95.2
Q ss_pred eeeecccCceEEEEEEEcCCCcEEEEEEeccCCCChHHHHHHHHHHHHHHhCCCCCc-chhhhhhhcCCeEEEEEecCCC
Q psy758 7 IGKLGEGSYGVVFKCRNRDTGQVVAIKKFLESEEDPLIRKIALREIRLLKSLKHPNL-VNLLEVFRRKKKLHLVFEFCDH 85 (292)
Q Consensus 7 ~~~l~~g~~~~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~e~~~~~~l~~~~i-~~~~~~~~~~~~~~iv~e~~~~ 85 (292)
++.|+.|.++.||++... +..|++|........ ...+.+|...++.+.+.++ .+++... ....++|||+++|
T Consensus 3 ~~~l~~G~~~~vy~~~~~--~~~~~lK~~~~~~~~---~~~~~~E~~~l~~l~~~~~~P~~~~~~--~~~~~lv~e~i~G 75 (170)
T cd05151 3 ISPLKGGMTNKNYRVEVA--NKKYVVRIPGNGTEL---LINRENEAENSKLAAEAGIGPKLYYFD--PETGVLITEFIEG 75 (170)
T ss_pred eeecCCcccCceEEEEEC--CeEEEEEeCCCCccc---ccCHHHHHHHHHHHHHhCCCCceEEEe--CCCCeEEEEecCC
Confidence 467899999999999865 788999987544321 1234578888888865443 3444433 2335799999999
Q ss_pred ccHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCc-----cccCCCCCceEEccCCcEEEeecCchhh
Q psy758 86 TVLNELENHPHGLPWDLIKQITWQVLRGVSYCHRHAC-----IHRDIKPENILLTANGVVKLCDFGFARL 150 (292)
Q Consensus 86 ~~L~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~gi-----vH~dl~p~Nilv~~~~~~kl~dfg~~~~ 150 (292)
..+... .......+.+++.+|+.||+.++ +|||++|.||+++ ++.++++||+.+..
T Consensus 76 ~~l~~~--------~~~~~~~~~~l~~~l~~LH~~~~~~~~~~HgD~~~~Nil~~-~~~~~liDf~~a~~ 136 (170)
T cd05151 76 SELLTE--------DFSDPENLEKIAKLLKKLHSSPLPDLVPCHNDLLPGNFLLD-DGRLWLIDWEYAGM 136 (170)
T ss_pred Cccccc--------cccCHHHHHHHHHHHHHHhCCCCCCceeecCCCCcCcEEEE-CCeEEEEecccccC
Confidence 877543 11123567899999999999985 9999999999999 66899999999864
|
The ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). It is composed of bacterial and eukaryotic choline kinases, as well as eukaryotic ethanolamine kinase. ChoK catalyzes the transfer of the gamma-phosphoryl group from ATP (or CTP) to its substrate, choline, producing phosphorylcholine (PCho), a precursor to the biosynthesis of two major membrane phospholipids, phosphatidylcholine (PC), and sphingomyelin (SM). Although choline is the preferred substrate, ChoK also shows substantial activity towards ethanolamine and its N-methylated derivatives. Bacterial ChoK is also referred to as licA protein. ETNK catalyzes the transfer of the gamma-phosphoryl group from CTP to ethanolamine (Etn), the first step in the CDP-Etn pathway for the formation of the major ph |
| >COG3642 Mn2+-dependent serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.51 E-value=2.7e-13 Score=98.76 Aligned_cols=135 Identities=19% Similarity=0.294 Sum_probs=102.0
Q ss_pred eeecccCceEEEEEEEcCCCcEEEEEEeccCCC-Ch-----HHHHHHHHHHHHHHhCCCCCcchhhhhhhcCCeEEEEEe
Q psy758 8 GKLGEGSYGVVFKCRNRDTGQVVAIKKFLESEE-DP-----LIRKIALREIRLLKSLKHPNLVNLLEVFRRKKKLHLVFE 81 (292)
Q Consensus 8 ~~l~~g~~~~v~~~~~~~~~~~v~iK~~~~~~~-~~-----~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~iv~e 81 (292)
..+++|+-+.++.+... |..+++|.-....+ .+ -....-.+|..++..+.--.|.-.+=+..+.....++||
T Consensus 2 ~~i~~GAEa~i~~~~~~--g~~av~K~Ri~K~YR~p~LD~klrr~Rt~~Earil~~a~~~GV~~P~v~dvD~~~~~I~me 79 (204)
T COG3642 2 DLIKQGAEAIIYLTDFL--GLPAVVKERIPKRYRHPELDEKLRRERTRREARILAKAREAGVPVPIVYDVDPDNGLIVME 79 (204)
T ss_pred chhhCCcceeEEeeecc--CcceEEEeecCcccCChHHHHHHHHHHHHHHHHHHHHHHHcCCCCCeEEEEcCCCCEEEEE
Confidence 35789999999998664 55577775432221 11 123455678999988875555544444556777889999
Q ss_pred cCCCccHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEEccCCcEEEeecCchhhhh
Q psy758 82 FCDHTVLNELENHPHGLPWDLIKQITWQVLRGVSYCHRHACIHRDIKPENILLTANGVVKLCDFGFARLIR 152 (292)
Q Consensus 82 ~~~~~~L~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~givH~dl~p~Nilv~~~~~~kl~dfg~~~~~~ 152 (292)
|.+|..|.+.+... ...++..+-.-+.-||..||+||||.++||++..++ +.++|||++....
T Consensus 80 ~I~G~~lkd~l~~~-------~~~~~r~vG~~vg~lH~~givHGDLTtsNiIl~~~~-i~~IDfGLg~~s~ 142 (204)
T COG3642 80 YIEGELLKDALEEA-------RPDLLREVGRLVGKLHKAGIVHGDLTTSNIILSGGR-IYFIDFGLGEFSD 142 (204)
T ss_pred EeCChhHHHHHHhc-------chHHHHHHHHHHHHHHhcCeecCCCccceEEEeCCc-EEEEECCcccccc
Confidence 99999999988764 266778888888999999999999999999998775 9999999987543
|
|
| >KOG0601|consensus | Back alignment and domain information |
|---|
Probab=99.48 E-value=4.2e-14 Score=119.58 Aligned_cols=246 Identities=27% Similarity=0.330 Sum_probs=164.9
Q ss_pred ccceeeeecc--cCceEEEEEEE--cCCCcEEEEEEeccCCCChHHHHHHHHHHHHHHhCC-CCCcchhhhhhhcCCeEE
Q psy758 3 RYEKIGKLGE--GSYGVVFKCRN--RDTGQVVAIKKFLESEEDPLIRKIALREIRLLKSLK-HPNLVNLLEVFRRKKKLH 77 (292)
Q Consensus 3 ~y~~~~~l~~--g~~~~v~~~~~--~~~~~~v~iK~~~~~~~~~~~~~~~~~e~~~~~~l~-~~~i~~~~~~~~~~~~~~ 77 (292)
.+.+.+.+|+ |.+|.+|.+.. ..++..+++|.-............-.+|......+. |++.++.+..++..+..+
T Consensus 115 ~~~~~~~~g~~~g~~~s~~~~~~~~~~s~~~~a~k~s~~p~s~p~~~~~k~~~~~s~~~i~~~~~~v~~~~~~e~~~~lf 194 (524)
T KOG0601|consen 115 RFPISSRTGSLPGSKGSVFKSRCTNSESPHKFAVKKSKIPFSPPLDSKRKLREFLSHHKIDSHENPVRDSPAWEGSGILF 194 (524)
T ss_pred hcccccccccCCCCCceeecccCCcccCCcccccccccCCCCCccccccccchhhcccccCccccccccCcccccCCcce
Confidence 4556778999 99999999998 888999999985444333333344456777666664 899999899999999999
Q ss_pred EEEecCCCccHHHHhcCCC-CCCHHHHHHHHHHHHH----HHHHHHhCCccccCCCCCceEEccC-CcEEEeecCchhhh
Q psy758 78 LVFEFCDHTVLNELENHPH-GLPWDLIKQITWQVLR----GVSYCHRHACIHRDIKPENILLTAN-GVVKLCDFGFARLI 151 (292)
Q Consensus 78 iv~e~~~~~~L~~~~~~~~-~~~~~~~~~i~~qi~~----aL~~LH~~givH~dl~p~Nilv~~~-~~~kl~dfg~~~~~ 151 (292)
+-+|+|+ .++..+..... .+++..++..+.+..+ ||.++|+.+++|-|++|.||+..++ ...+++|||....+
T Consensus 195 iqtE~~~-~sl~~~~~~~~~~~p~~~l~~~~~~~~~~~~~al~~~hs~~~~~~~~kp~~i~~~~~~~s~~~~df~~v~~i 273 (524)
T KOG0601|consen 195 IQTELCG-ESLQSYCHTPCNFLPDNLLWNSLRDWLSRDVTALSHLHSNNIVHDDLKPANIFTTSDWTSCKLTDFGLVSKI 273 (524)
T ss_pred eeecccc-chhHHhhhcccccCCchhhhhHHhhhhhcccccccccCCCcccccccchhheecccccceeecCCcceeEEc
Confidence 9999998 45555554433 4899999999999999 9999999999999999999999999 78999999998877
Q ss_pred hcccccc----------ccccccccccccCCCCCCCcccceeeecCCCCCCchHHHHHHHhhcccC-CCCC--CChhhhh
Q psy758 152 RDLIPRH----------LHIFQTNEYFKGVSLPHAENVVPLEIKIGKPAATNIYLIDFLKRCLDKD-PLRR--WSCDQLL 218 (292)
Q Consensus 152 ~~~~~~~----------~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-p~~~--~~~~~~~ 218 (292)
.+..... ...|.+++...+-.- ...++..+ ...++...++.. |..+ ....++
T Consensus 274 ~~~~~~~~~~~~~r~~~~~~Y~~ke~~~~l~~-~~~di~sl-------------~ev~l~~~l~~~~~~~g~~~~W~~~- 338 (524)
T KOG0601|consen 274 SDGNFSSVFKVSKRPEGDCIYAAKELLNGLAT-FASDIFSL-------------GEVILEAILGSHLPSVGKNSSWSQL- 338 (524)
T ss_pred cCCccccceeeeecCCCCceEeChhhhccccc-hHhhhcch-------------hhhhHhhHhhcccccCCCCCCcccc-
Confidence 6433221 122333333222111 11112111 111222222111 1111 111111
Q ss_pred hccCcCCCCCCCCCccchHHHHhcccCcCCCCCCChhhhhhCCcccc
Q psy758 219 RHPYFNGYYFEVPDEMQYEEITQRCLDKDPLRRWSCDQLLRHPYFNG 265 (292)
Q Consensus 219 ~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~~il~h~w~~~ 265 (292)
.+.+ ....+-...+.++...+..|+..+|..|++++.+++|+++..
T Consensus 339 r~~~-ip~e~~~~~s~~l~~~~~~~~d~~~~~~~~~q~~~~l~~i~s 384 (524)
T KOG0601|consen 339 RQGY-IPLEFCEGGSSSLRSVTSQMLDEDPRLRLTAQILTALNVIHS 384 (524)
T ss_pred cccc-CchhhhcCcchhhhhHHHHhcCcchhhhhHHHHHhccccccc
Confidence 1111 111111223556677999999999999999999999999985
|
|
| >KOG1266|consensus | Back alignment and domain information |
|---|
Probab=99.45 E-value=5.6e-13 Score=104.94 Aligned_cols=195 Identities=18% Similarity=0.238 Sum_probs=122.9
Q ss_pred HHHhCCCCCcchhhhhhhcCC-----eEEEEEecCCCccHHHHhcC----CCCCCHHHHHHHHHHHHHHHHHHHhCC--c
Q psy758 54 LLKSLKHPNLVNLLEVFRRKK-----KLHLVFEFCDHTVLNELENH----PHGLPWDLIKQITWQVLRGVSYCHRHA--C 122 (292)
Q Consensus 54 ~~~~l~~~~i~~~~~~~~~~~-----~~~iv~e~~~~~~L~~~~~~----~~~~~~~~~~~i~~qi~~aL~~LH~~g--i 122 (292)
-+-.+-|.||++++.++.+.. ...++.||+..|++..++++ ...+......+++.||+.||.|||+.. |
T Consensus 120 nllqlvHsnlvkfH~yw~d~K~~e~~rviFiteymssgs~~~fLkrt~~~~~a~~~~~wkkw~tqIlsal~yLhs~~Ppi 199 (458)
T KOG1266|consen 120 NLLQLVHSNLVKFHKYWTDKKYEEKPRVIFITEYMSSGSLKQFLKRTKKNQKALFQKAWKKWCTQILSALSYLHSCDPPI 199 (458)
T ss_pred HHHHHHHHHHHHHHHhhcccccccccceEEEEecccchhHHHHHHHHHHhhhhhhHHHHHHHHHHHHhhhhhhhccCCcc
Confidence 334456889999999987543 47899999999999998864 345888889999999999999999984 9
Q ss_pred cccCCCCCceEEccCCcEEEeecCchhhhh---------ccccccccccccccccccCCCCCCCcccceeeecCCCCCCc
Q psy758 123 IHRDIKPENILLTANGVVKLCDFGFARLIR---------DLIPRHLHIFQTNEYFKGVSLPHAENVVPLEIKIGKPAATN 193 (292)
Q Consensus 123 vH~dl~p~Nilv~~~~~~kl~dfg~~~~~~---------~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 193 (292)
+|+++..+.|++..+|-+|++--....... .........|.++++-.-.....+.++..++
T Consensus 200 ihgnlTc~tifiq~ngLIkig~~ap~s~h~s~~~~~~~Ek~~~~~~~g~~a~~sg~~tn~~~a~dIy~fg---------- 269 (458)
T KOG1266|consen 200 IHGNLTCDTIFIQHNGLIKIGSVAPDSTHPSVNSTREAEKSVNTSLPGFSAPESGTTTNTTGASDIYKFG---------- 269 (458)
T ss_pred ccCCcchhheeecCCceEEecccCccccchhhhhhhHhhhhccccCCccccCCcCcccccccchhhhhhh----------
Confidence 999999999999999988886422111100 0111112334444443222222222332221
Q ss_pred hHHHHHHHhhcccCCCCC---CChhhhhhccCcCCCCCCCCCccchHHHHhcccCcCCCCCCChhhhhhCCcccce
Q psy758 194 IYLIDFLKRCLDKDPLRR---WSCDQLLRHPYFNGYYFEVPDEMQYEEITQRCLDKDPLRRWSCDQLLRHPYFNGY 266 (292)
Q Consensus 194 ~~~~~~~~~~~~~~p~~~---~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~~il~h~w~~~~ 266 (292)
++.+-...+...+.+. ...++......+ ...+..-+++|.+||+..|..||+|.+++.||-+-++
T Consensus 270 --mcAlemailEiq~tnseS~~~~ee~ia~~i~------~len~lqr~~i~kcl~~eP~~rp~ar~llfHpllfeV 337 (458)
T KOG1266|consen 270 --MCALEMAILEIQSTNSESKVEVEENIANVII------GLENGLQRGSITKCLEGEPNGRPDARLLLFHPLLFEV 337 (458)
T ss_pred --HHHHHHHHheeccCCCcceeehhhhhhhhee------eccCccccCcCcccccCCCCCCcchhhhhcCceeeec
Confidence 1122222222222222 112222222111 1123344678999999999999999999999987653
|
|
| >KOG1243|consensus | Back alignment and domain information |
|---|
Probab=99.44 E-value=7.1e-13 Score=113.59 Aligned_cols=129 Identities=19% Similarity=0.326 Sum_probs=108.0
Q ss_pred EE-EEEEcCCCcEEEEEEeccCCCChHHHHHHHHHHHHHHhCCCCCcchhhhhhhcCCeEEEEEecCCCccHHHHhcCCC
Q psy758 18 VF-KCRNRDTGQVVAIKKFLESEEDPLIRKIALREIRLLKSLKHPNLVNLLEVFRRKKKLHLVFEFCDHTVLNELENHPH 96 (292)
Q Consensus 18 v~-~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~iv~e~~~~~~L~~~~~~~~ 96 (292)
+| .|..+.++.+|.+..+..... .......+.+..++.++||+|+++++.++.++..|+|+|.+.. |...++.
T Consensus 27 ~~~~~t~k~~~~~vsVF~~~~~~~--~~~~~~~~A~k~lKtlRHP~Il~yL~t~e~~~~~ylvTErV~P--l~~~lk~-- 100 (690)
T KOG1243|consen 27 LWPDGTRKADGGPVSVFVYKRSNG--EVTELAKRAVKRLKTLRHPNILSYLDTTEEEGTLYLVTERVRP--LETVLKE-- 100 (690)
T ss_pred cccccceeccCCceEEEEEeCCCc--hhhHHHHHHHHHhhhccCchhhhhhhhhcccCceEEEeecccc--HHHHHHH--
Confidence 44 456667788898888876655 5566778899999999999999999999999999999999863 5555553
Q ss_pred CCCHHHHHHHHHHHHHHHHHHH-hCCccccCCCCCceEEccCCcEEEeecCchhhhhc
Q psy758 97 GLPWDLIKQITWQVLRGVSYCH-RHACIHRDIKPENILLTANGVVKLCDFGFARLIRD 153 (292)
Q Consensus 97 ~~~~~~~~~i~~qi~~aL~~LH-~~givH~dl~p~Nilv~~~~~~kl~dfg~~~~~~~ 153 (292)
++...+...+.||+.||.||| +.+++|++|+.+.|+|+..|..||++|..+.....
T Consensus 101 -l~~~~v~~Gl~qIl~AL~FL~~d~~lvHgNv~~~SVfVn~~GeWkLggle~v~~~~~ 157 (690)
T KOG1243|consen 101 -LGKEEVCLGLFQILAALSFLNDDCNLVHGNVCKDSVFVNESGEWKLGGLELVSKASG 157 (690)
T ss_pred -hHHHHHHHHHHHHHHHHHHHhccCCeeeccEeeeeEEEcCCCcEEEeeeEEEecccc
Confidence 447888899999999999998 56799999999999999999999999988765443
|
|
| >KOG3087|consensus | Back alignment and domain information |
|---|
Probab=99.41 E-value=3.3e-12 Score=92.83 Aligned_cols=144 Identities=20% Similarity=0.270 Sum_probs=104.2
Q ss_pred eeeeecccCceEEEEEEEcCCCcEEEEEEeccC-----C-CChHHHHHHHHHHHHHHhCCCCCcchhhhhhhcCCeEEEE
Q psy758 6 KIGKLGEGSYGVVFKCRNRDTGQVVAIKKFLES-----E-EDPLIRKIALREIRLLKSLKHPNLVNLLEVFRRKKKLHLV 79 (292)
Q Consensus 6 ~~~~l~~g~~~~v~~~~~~~~~~~v~iK~~~~~-----~-~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~iv 79 (292)
....+.+|+-+.|+++... |+..+||.-... . +..-..+...+|.+.+.++.--.|.-.--++.+...-+++
T Consensus 11 ~l~likQGAEArv~~~~~~--Ge~~iIK~Rf~K~YRHP~LD~kLtr~Rt~~Ear~l~k~~~~GI~~P~l~~~D~~~~~i~ 88 (229)
T KOG3087|consen 11 SLELIKQGAEARVPRGSFS--GEAAIIKERFSKRYRHPALDQKLTRKRTKQEARLLAKCRALGIPAPRLIFIDTYGGQIY 88 (229)
T ss_pred cceeeeccceeeEeeeccC--CceeEEeecccccccchHHHHHHHHHHHHHHHHHHHHHHHhCCCCceEEEEecCCCeEE
Confidence 4567889999999988876 888778753222 2 2233456667899998888644554444445566777899
Q ss_pred EecCCC-ccHHHHhcC-CC-CCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEEccCC---cEEEeecCchhhh
Q psy758 80 FEFCDH-TVLNELENH-PH-GLPWDLIKQITWQVLRGVSYCHRHACIHRDIKPENILLTANG---VVKLCDFGFARLI 151 (292)
Q Consensus 80 ~e~~~~-~~L~~~~~~-~~-~~~~~~~~~i~~qi~~aL~~LH~~givH~dl~p~Nilv~~~~---~~kl~dfg~~~~~ 151 (292)
||+.+| .++.+++.. .. .....-...++.+|-+.+.-||.++|+||||..+||++.+++ .+.++|||++...
T Consensus 89 ME~~~g~~~vk~~i~~~~~~~~~d~~~~~~~~~iG~~igklH~ndiiHGDLTTSNill~~~~~~~~~~lIdfgls~~s 166 (229)
T KOG3087|consen 89 MEFIDGASTVKDFILSTMEDESEDEGLAELARRIGELIGKLHDNDIIHGDLTTSNILLRSDGNQITPILIDFGLSSVS 166 (229)
T ss_pred EEeccchhHHHHHHHHHccCcccchhHHHHHHHHHHHHHHhhhCCeecccccccceEEecCCCcCceEEEeecchhcc
Confidence 999998 455555432 11 233333378999999999999999999999999999998765 4689999998644
|
|
| >KOG1033|consensus | Back alignment and domain information |
|---|
Probab=99.40 E-value=3.5e-14 Score=118.07 Aligned_cols=173 Identities=19% Similarity=0.290 Sum_probs=119.3
Q ss_pred eEEEEEecCCCccHHHHhcCCC---CCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEEccCCcEEEeecCchhhh
Q psy758 75 KLHLVFEFCDHTVLNELENHPH---GLPWDLIKQITWQVLRGVSYCHRHACIHRDIKPENILLTANGVVKLCDFGFARLI 151 (292)
Q Consensus 75 ~~~iv~e~~~~~~L~~~~~~~~---~~~~~~~~~i~~qi~~aL~~LH~~givH~dl~p~Nilv~~~~~~kl~dfg~~~~~ 151 (292)
+.||.|++|..++|.+|+.... ..+......++.|++.|++| +|.+|+|++|.||++..+..++|+|||+....
T Consensus 330 ~lyI~Mn~c~~~tledWl~rr~~~e~~s~s~~~~~~~q~~~~~~y---k~~ihrdlkp~nif~~~d~q~kIgDFgl~ts~ 406 (516)
T KOG1033|consen 330 YLYIQMNLCEKETLEDWLRRRRTGEERSLSLMLDIFKQIAPAVEY---KGLIHRDLKPSNIFFSDDDQLKIGDFGLVTSQ 406 (516)
T ss_pred chhhhhhhhhhhhHHHHhhCCCcccccchhHHHHHHHhhccchhh---ccchhhhccccccccccchhhhhhhhhheeec
Confidence 5889999999999999997433 36777888999999999999 99999999999999999999999999998766
Q ss_pred hccc-----------cccccccccccccccCCCCCCCcccceeeecCCCCCCchHHHHHHHhhcccCCCCCCChhhhhhc
Q psy758 152 RDLI-----------PRHLHIFQTNEYFKGVSLPHAENVVPLEIKIGKPAATNIYLIDFLKRCLDKDPLRRWSCDQLLRH 220 (292)
Q Consensus 152 ~~~~-----------~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~ 220 (292)
.... ..++..|.+||-..|..+....+++.++++... ++..+ ..+.+|....+-+++
T Consensus 407 ~~~~~~~~~~a~~t~~~gt~~YmsPEQi~g~~y~~kvdIyaLGlil~E----------L~~~f--~T~~er~~t~~d~r~ 474 (516)
T KOG1033|consen 407 DKDETVAPAAASHTQQVGTLLYMSPEQIRGQQYSEKVDIYALGLILAE----------LLIQF--STQFERIATLTDIRD 474 (516)
T ss_pred ccCCcccchhhhhhhcccccccCCHHHHhhhhhhhhcchhhHHHHHHH----------HHHHh--ccHHHHHHhhhhhhc
Confidence 5432 122345777777777777666666666443221 11111 112222222222222
Q ss_pred cCcCCCCCCCCCccchHHHHhcccCcCCCCCCChhhhhhCCccc
Q psy758 221 PYFNGYYFEVPDEMQYEEITQRCLDKDPLRRWSCDQLLRHPYFN 264 (292)
Q Consensus 221 ~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~~il~h~w~~ 264 (292)
..+... -....+.-..|+.+||...|.+||++.+.--|+|++
T Consensus 475 g~ip~~--~~~d~p~e~~ll~~lls~~p~~RP~~~~~~~~~~~~ 516 (516)
T KOG1033|consen 475 GIIPPE--FLQDYPEEYTLLQQLLSPSPEERPSAIEVALHEFLQ 516 (516)
T ss_pred CCCChH--HhhcCcHHHHHHHHhcCCCcccCchHHHHhhhhhcC
Confidence 111100 011123455899999999999999888888888763
|
|
| >cd05154 ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 and 11, N-terminal domain, and similar proteins | Back alignment and domain information |
|---|
Probab=99.39 E-value=3.5e-12 Score=100.03 Aligned_cols=141 Identities=18% Similarity=0.223 Sum_probs=107.3
Q ss_pred eeeecccCceEEEEEEEcCCCcEEEEEEeccCCCChHHHHHHHHHHHHHHhCCCC--CcchhhhhhhcC---CeEEEEEe
Q psy758 7 IGKLGEGSYGVVFKCRNRDTGQVVAIKKFLESEEDPLIRKIALREIRLLKSLKHP--NLVNLLEVFRRK---KKLHLVFE 81 (292)
Q Consensus 7 ~~~l~~g~~~~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~e~~~~~~l~~~--~i~~~~~~~~~~---~~~~iv~e 81 (292)
.+.|+.|..+.+|++.... |+.+++|........ .....+.+|..+++.+.+. .+.+++.+.... +..++|||
T Consensus 3 ~~~l~~G~~n~~~~v~~~~-g~~~ilK~~~~~~~~-~~~~~~~~E~~~~~~l~~~~~~vp~~~~~~~~~~~~~~~~~v~e 80 (223)
T cd05154 3 VRQLSGGQSNLTYLLTAGG-GRRLVLRRPPPGALL-PSAHDVAREYRVLRALAGTGVPVPKVLALCEDPSVLGTPFYVME 80 (223)
T ss_pred ceecCCCccceEEEEEecC-CcceEEEeCCCcccC-cccccHHHHHHHHHHhhCCCCCCCCEEEECCCCCccCCceEEEE
Confidence 3568999999999998753 678999987554321 1234567899999998753 356666665543 36789999
Q ss_pred cCCCccHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHh------------------------------------------
Q psy758 82 FCDHTVLNELENHPHGLPWDLIKQITWQVLRGVSYCHR------------------------------------------ 119 (292)
Q Consensus 82 ~~~~~~L~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~------------------------------------------ 119 (292)
+++|..+...... ..+++.....++.+++.+|..||+
T Consensus 81 ~i~G~~l~~~~~~-~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 159 (223)
T cd05154 81 RVDGRVLRDRLLR-PELSPEERRALARALADTLAALHSVDPAAVGLGDLGRPGGYLERQVARWRRQYDASRTDEPPAMER 159 (223)
T ss_pred EeCCEecCCCCCC-CCCCHHHHHHHHHHHHHHHHHHhCCChhhcCCcccCCCCchHHHHHHHHHHHHHhhcccccHHHHH
Confidence 9999988776542 357778888888888888888884
Q ss_pred --------------CCccccCCCCCceEEcc--CCcEEEeecCchhh
Q psy758 120 --------------HACIHRDIKPENILLTA--NGVVKLCDFGFARL 150 (292)
Q Consensus 120 --------------~givH~dl~p~Nilv~~--~~~~kl~dfg~~~~ 150 (292)
..++|||+.|.||++++ ++.+.|+||+.+..
T Consensus 160 ~~~~~~~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~~~iID~e~~~~ 206 (223)
T cd05154 160 LLRWLEAHLPADSRPGLVHGDYRLGNVLFHPDEPRVVAVLDWELATL 206 (223)
T ss_pred HHHHHHhhCCCCCCcEEEECCCCcccEEEcCCCCcEEEEEecccccc
Confidence 23589999999999998 66789999998764
|
This subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This subfamily is composed of bacterial and eukaryotic proteins with similarity to the N-terminal domains of vertebrate ACAD10 and ACAD11. ACADs are a family of flavoproteins that are involved in the beta-oxidation of fatty acyl-CoA derivatives. ACAD deficiency can cause metabolic disorders including muscle fatigue, hypoglycemia, and hepatic lipidosis, among them. There are at least 11 distinct ACADs, some of which show distinct substrate specificities to either straight-chain or branched-chain fatty acids. ACAD10 is widely expressed in human tissues and is highly expressed in liver, kidney, pancreas, and spleen. ACAD10 and ACAD11 contain |
| >PRK15123 lipopolysaccharide core heptose(I) kinase RfaP; Provisional | Back alignment and domain information |
|---|
Probab=99.36 E-value=1.8e-11 Score=97.53 Aligned_cols=140 Identities=16% Similarity=0.070 Sum_probs=96.8
Q ss_pred eecccCceEEEEEEEcCCCcEEEEEEeccCCCChHH---------HHHHHHHHHHHHhCCCCCc--chhhhhhhc-----
Q psy758 9 KLGEGSYGVVFKCRNRDTGQVVAIKKFLESEEDPLI---------RKIALREIRLLKSLKHPNL--VNLLEVFRR----- 72 (292)
Q Consensus 9 ~l~~g~~~~v~~~~~~~~~~~v~iK~~~~~~~~~~~---------~~~~~~e~~~~~~l~~~~i--~~~~~~~~~----- 72 (292)
.+.......|.++.. .|+.|.+|......-.... ...+.+|...+..|..-+| +.++++.+.
T Consensus 29 ~v~~~~~rrvvr~~~--~g~~~~vKr~~~~~~~~~~k~l~~~~~p~~~a~rE~~~l~~L~~~GIptP~pVa~~e~~~~~~ 106 (268)
T PRK15123 29 VFRELEGRRTLRFEL--AGKSYFLKWHRGTGWGEIFKNLLSLRMPVLGADREWRAIHRLHEVGVDTMTGVAFGERGSNPA 106 (268)
T ss_pred EEecCCCceEEEEEE--CCEEEEEEEecCCcHHHHhhhhcccccccHHHHHHHHHHHHHHHcCCCCCCeeEEEEecCCCc
Confidence 344444455666544 4778999976433211100 1136688888887753333 233333322
Q ss_pred CCeEEEEEecCCCc-cHHHHhcC--CCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEEcc-------CCcEEE
Q psy758 73 KKKLHLVFEFCDHT-VLNELENH--PHGLPWDLIKQITWQVLRGVSYCHRHACIHRDIKPENILLTA-------NGVVKL 142 (292)
Q Consensus 73 ~~~~~iv~e~~~~~-~L~~~~~~--~~~~~~~~~~~i~~qi~~aL~~LH~~givH~dl~p~Nilv~~-------~~~~kl 142 (292)
....++|+|++++. +|.+++.. ....+......++.+++..+..||+.|++|+|+++.|||++. ++.+.|
T Consensus 107 ~~~s~LVte~l~~~~sL~~~~~~~~~~~~~~~~~~~ll~~la~~i~~LH~~Gi~HgDL~~~NiLl~~~~~~~~~~~~~~L 186 (268)
T PRK15123 107 TRTSFIITEDLAPTISLEDYCADWATNPPDPRLKRMLIKRVATMVRDMHAAGINHRDCYICHFLLHLPFPGREEDLKLSV 186 (268)
T ss_pred cceeEEEEeeCCCCccHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHHHCcCccCCCChhhEEEeccccCCCCCceEEE
Confidence 23578999999986 78888753 234667788899999999999999999999999999999985 467999
Q ss_pred eecCchhh
Q psy758 143 CDFGFARL 150 (292)
Q Consensus 143 ~dfg~~~~ 150 (292)
+||+.+..
T Consensus 187 IDl~r~~~ 194 (268)
T PRK15123 187 IDLHRAQI 194 (268)
T ss_pred EECCcccc
Confidence 99998753
|
|
| >PF01163 RIO1: RIO1 family; InterPro: IPR018934 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases | Back alignment and domain information |
|---|
Probab=99.33 E-value=1.1e-11 Score=93.07 Aligned_cols=128 Identities=26% Similarity=0.308 Sum_probs=85.8
Q ss_pred EEEEEEEcCCCcEEEEEEeccCC------------------------CChHHHHHHHHHHHHHHhCCCC--Ccchhhhhh
Q psy758 17 VVFKCRNRDTGQVVAIKKFLESE------------------------EDPLIRKIALREIRLLKSLKHP--NLVNLLEVF 70 (292)
Q Consensus 17 ~v~~~~~~~~~~~v~iK~~~~~~------------------------~~~~~~~~~~~e~~~~~~l~~~--~i~~~~~~~ 70 (292)
.||.|.... |..+|+|+..... ..........+|.+.|..+... ++++++++.
T Consensus 1 ~Vy~~~~~~-~~~~a~K~~r~~~~~Fk~~~~y~~~~~r~~~~~~~~~~~~~~~~~~~~E~~~L~~l~~~Gv~vP~p~~~~ 79 (188)
T PF01163_consen 1 DVYHAIDPD-GEEVAVKIYRTGRTSFKRRKKYRDYDYRFKKYRHKSSWRYLIREWAKKEFRNLKRLYEAGVPVPKPYDYN 79 (188)
T ss_dssp EEEEEEECT-TEEEEEEEE-S---SS-HHHHHTTTSTTSTTC--G--CHHHHHHHHHHHHHHHHHCCCTT-SS--EEEEE
T ss_pred CEEEEECCC-CCEEEEEEeccCceEEEEeeeeecccchhcccccccCHHHHHHHHHHHHHHHHHHHHHCCccCCcEEEEe
Confidence 488888744 7799999874221 1112345567899999999755 456665442
Q ss_pred hcCCeEEEEEecCC--CccHHHHhcCCCCCCHHHHHHHHHHHHHHHHH-HHhCCccccCCCCCceEEccCCcEEEeecCc
Q psy758 71 RRKKKLHLVFEFCD--HTVLNELENHPHGLPWDLIKQITWQVLRGVSY-CHRHACIHRDIKPENILLTANGVVKLCDFGF 147 (292)
Q Consensus 71 ~~~~~~~iv~e~~~--~~~L~~~~~~~~~~~~~~~~~i~~qi~~aL~~-LH~~givH~dl~p~Nilv~~~~~~kl~dfg~ 147 (292)
.-.+||||++ |..+..+.... ++......++.+++..+.. +|+.|++||||++.||+++++ .+.|+|||.
T Consensus 80 ----~~~ivME~I~~~G~~~~~l~~~~--~~~~~~~~~~~~il~~~~~~~~~~givHGDLs~~NIlv~~~-~~~iIDf~q 152 (188)
T PF01163_consen 80 ----RNVIVMEYIGEDGVPLPRLKDVD--LSPEEPKELLEEILEEIIKMLHKAGIVHGDLSEYNILVDDG-KVYIIDFGQ 152 (188)
T ss_dssp ----TTEEEEE--EETTEEGGCHHHCG--GGGSTHHHHHHHHHHHHHHHHHCTTEEESS-STTSEEEETT-CEEE--GTT
T ss_pred ----CCEEEEEecCCCccchhhHHhcc--ccchhHHHHHHHHHHHHHHHHHhcCceecCCChhhEEeecc-eEEEEecCc
Confidence 3469999999 77776665532 3355667888888885555 679999999999999999988 999999998
Q ss_pred hhhhh
Q psy758 148 ARLIR 152 (292)
Q Consensus 148 ~~~~~ 152 (292)
+....
T Consensus 153 av~~~ 157 (188)
T PF01163_consen 153 AVDSS 157 (188)
T ss_dssp EEETT
T ss_pred ceecC
Confidence 76543
|
Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. This entry represents RIO kinase, they exhibit little sequence similarity with eukaryotic protein kinases, and are classified as atypical protein kinases []. The conformation of ATP when bound to the RIO kinases is unique when compared with ePKs, such as serine/threonine kinases or the insulin receptor tyrosine kinase, suggesting that the detailed mechanism by which the catalytic aspartate of RIO kinases participates in phosphoryl transfer may not be identical to that employed in known serine/threonine ePKs. Representatives of the RIO family are present in organisms varying from Archaea to humans, although the RIO3 proteins have only been identified in multicellular eukaryotes, to date. Yeast Rio1 and Rio2 proteins are required for proper cell cycle progression and chromosome maintenance, and are necessary for survival of the cells. These proteins are involved in the processing of 20 S pre-rRNA via late 18 S rRNA processing. ; GO: 0003824 catalytic activity, 0005524 ATP binding; PDB: 1TQP_A 1ZAR_A 1TQI_A 1ZAO_A 1TQM_A 3RE4_A 1ZTH_B 1ZP9_A 1ZTF_A. |
| >KOG0606|consensus | Back alignment and domain information |
|---|
Probab=99.33 E-value=6.8e-13 Score=118.68 Aligned_cols=264 Identities=16% Similarity=0.191 Sum_probs=184.4
Q ss_pred cccceeeeecccCceEEEEEEEcCCCcEEEEEEeccCC-CChHHHHHHHHHHHHHHhCCCCCcchhhhhhhcCCeEEEEE
Q psy758 2 ERYEKIGKLGEGSYGVVFKCRNRDTGQVVAIKKFLESE-EDPLIRKIALREIRLLKSLKHPNLVNLLEVFRRKKKLHLVF 80 (292)
Q Consensus 2 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~v~iK~~~~~~-~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~iv~ 80 (292)
+.+.+.+-+.+|.++.++.+.-..+|...++|+..... ......+....+-.+.-.-.+|.++...-.+......++++
T Consensus 804 d~~~i~~p~qS~sp~ss~p~~pa~sgh~~~~~v~~~ap~i~~~~~~s~r~~s~~~i~p~~P~v~~~~~s~~~rsP~~L~~ 883 (1205)
T KOG0606|consen 804 DGFEITKPSQSGSPSSSFPASPAGSGHTRPSKVHGLAPKIRTNDYESIRSKSNILITPRSPAVVRSFPSFPCRSPLPLVG 883 (1205)
T ss_pred ccceecccccCCCCcccccCCccccccccchhhhccchhhccccccccCCccCccccCCCCceecccCCCCCCCCcchhh
Confidence 45667777889999999999888888666666543221 11111122223333333334566776665566677789999
Q ss_pred ecCCCccHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEEccCCcEEEeecCchhhhhcccccc--
Q psy758 81 EFCDHTVLNELENHPHGLPWDLIKQITWQVLRGVSYCHRHACIHRDIKPENILLTANGVVKLCDFGFARLIRDLIPRH-- 158 (292)
Q Consensus 81 e~~~~~~L~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~givH~dl~p~Nilv~~~~~~kl~dfg~~~~~~~~~~~~-- 158 (292)
+|++++.|...+...+..+++-++..+..+.+++++||+..+.|+|++|.|++...+++.++.+|+.....+...+..
T Consensus 884 ~~~~~~~~~Skl~~~~~~saepaRs~i~~~vqs~e~L~s~~r~h~~~~p~~~l~~~~gh~~l~~~~t~~~vg~~~p~~~~ 963 (1205)
T KOG0606|consen 884 HYLNGGDLPSKLHNSGCLSAEPARSPILERVQSLESLHSSLRKHRDLKPDSLLIAYDGHRPLTDFGTLSKVGLIPPTTDL 963 (1205)
T ss_pred HHhccCCchhhhhcCCCcccccccchhHHHHhhhhccccchhhcccccccchhhcccCCcccCccccccccccccCcCCc
Confidence 999999999999887778888999999999999999999999999999999999999999999998443322110000
Q ss_pred -----------------------------ccccccccccccCCCCCCCcccceeeecCCCCCCchHHHHHHHhhcccCCC
Q psy758 159 -----------------------------LHIFQTNEYFKGVSLPHAENVVPLEIKIGKPAATNIYLIDFLKRCLDKDPL 209 (292)
Q Consensus 159 -----------------------------~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~p~ 209 (292)
....+++.|..++. ..+..-+...+.+..+..++..+++..|+
T Consensus 964 sg~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~t~~~laPe~--------~lg~~hgs~ad~~~~g~~l~e~l~g~pp~ 1035 (1205)
T KOG0606|consen 964 SGPSSSGTPRRLSRSERRPQLSADEARRKHAVVGTPDYLAPEI--------LLGRRHGSAADWWSSGVCLFEVLTGIPPF 1035 (1205)
T ss_pred ccccccCccccccccccccccccchhhccccccCCCcccCCcc--------cccccCCCcchhhhhhhhhhhhhcCCCCC
Confidence 00111111111111 12222333334455666777888888888
Q ss_pred CCCChhhhhhccCcCCCCCCC---CCccchHHHHhcccCcCCCCCCChh---hhhhCCcccceeccCCCh
Q psy758 210 RRWSCDQLLRHPYFNGYYFEV---PDEMQYEEITQRCLDKDPLRRWSCD---QLLRHPYFNGYYFEVPDE 273 (292)
Q Consensus 210 ~~~~~~~~~~~~~~~~~~~~~---~~~~~l~~li~~~l~~dP~~Rpt~~---~il~h~w~~~~~~~~~~~ 273 (292)
+..+..+++.+..-....++. ..+...++++...|..+|.+|..+. ++-.|+||+++.|+..+.
T Consensus 1036 na~tpq~~f~ni~~~~~~~p~g~~~~s~~aq~~~~~ll~~~~~qr~~a~~~~e~k~~~~~~~~~~~~l~~ 1105 (1205)
T KOG0606|consen 1036 NAETPQQIFENILNRDIPWPEGPEEGSYEAQDLINRLLTEEPTQRLGAKGAAEVKGHPFFQDVDWENLAL 1105 (1205)
T ss_pred CCcchhhhhhccccCCCCCCCCccccChhhhhhhhhhhccCchhccCcccccccccCCccCCCCcccccc
Confidence 888888888766554444443 3377889999999999999999888 999999999999985443
|
|
| >KOG0601|consensus | Back alignment and domain information |
|---|
Probab=99.31 E-value=5.7e-12 Score=106.84 Aligned_cols=149 Identities=24% Similarity=0.321 Sum_probs=124.4
Q ss_pred cccceeeeecccCceEEEEEEEc-CCCcEEEEEEeccCCCChHHHHHHHHHHHHHHhC-CCCCcchhhhhhhcCCeEEEE
Q psy758 2 ERYEKIGKLGEGSYGVVFKCRNR-DTGQVVAIKKFLESEEDPLIRKIALREIRLLKSL-KHPNLVNLLEVFRRKKKLHLV 79 (292)
Q Consensus 2 ~~y~~~~~l~~g~~~~v~~~~~~-~~~~~v~iK~~~~~~~~~~~~~~~~~e~~~~~~l-~~~~i~~~~~~~~~~~~~~iv 79 (292)
.+|.++..||.|.++.++..... .++..|++|...+..........-..|+.+...+ .|.+++..+..|......|+=
T Consensus 265 ~df~~v~~i~~~~~~~~~~~~~r~~~~~~Y~~ke~~~~l~~~~~di~sl~ev~l~~~l~~~~~~~g~~~~W~~~r~~~ip 344 (524)
T KOG0601|consen 265 TDFGLVSKISDGNFSSVFKVSKRPEGDCIYAAKELLNGLATFASDIFSLGEVILEAILGSHLPSVGKNSSWSQLRQGYIP 344 (524)
T ss_pred CCcceeEEccCCccccceeeeecCCCCceEeChhhhccccchHhhhcchhhhhHhhHhhcccccCCCCCCccccccccCc
Confidence 57888999999999999987755 5677899998877665555555556777777777 488999988888877777788
Q ss_pred EecCCCccHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEEccC-CcEEEeecCchhh
Q psy758 80 FEFCDHTVLNELENHPHGLPWDLIKQITWQVLRGVSYCHRHACIHRDIKPENILLTAN-GVVKLCDFGFARL 150 (292)
Q Consensus 80 ~e~~~~~~L~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~givH~dl~p~Nilv~~~-~~~kl~dfg~~~~ 150 (292)
.|||.++++.........+++...+.+..|++.++.++|+..++|+|++|+||++..+ +.-+++||++.+.
T Consensus 345 ~e~~~~~s~~l~~~~~~~~d~~~~~~~~~q~~~~l~~i~s~~~~~~d~~psni~i~~~~~~~~~~~~~~~t~ 416 (524)
T KOG0601|consen 345 LEFCEGGSSSLRSVTSQMLDEDPRLRLTAQILTALNVIHSKLFVHLDVKPSNILISNDGFFSKLGDFGCWTR 416 (524)
T ss_pred hhhhcCcchhhhhHHHHhcCcchhhhhHHHHHhccccccchhhhcccccccceeeccchhhhhccccccccc
Confidence 9999998877766555568999999999999999999999999999999999999986 6788999998864
|
|
| >KOG3741|consensus | Back alignment and domain information |
|---|
Probab=99.28 E-value=5.4e-11 Score=99.43 Aligned_cols=138 Identities=17% Similarity=0.250 Sum_probs=110.1
Q ss_pred CceEEEEEEEcCCCcEEEEEEeccCCCChHHHHHHHHHHHHHHhCCCCCcchhhhhhh----cCCeEEEEEecCCC-ccH
Q psy758 14 SYGVVFKCRNRDTGQVVAIKKFLESEEDPLIRKIALREIRLLKSLKHPNLVNLLEVFR----RKKKLHLVFEFCDH-TVL 88 (292)
Q Consensus 14 ~~~~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~----~~~~~~iv~e~~~~-~~L 88 (292)
-..+.|++....+|..|++|++...... .......-++.++++.|+|++++-++|. .+..+++|++|+++ ++|
T Consensus 288 ~~~Ttyk~~s~~DG~~YvLkRlhg~r~~--~~nk~t~lve~wkkl~h~NvV~frevf~t~tF~D~SlvlvYDYyP~s~TL 365 (655)
T KOG3741|consen 288 FSITTYKATSNVDGNAYVLKRLHGDRDQ--STNKDTSLVEAWKKLCHTNVVPFREVFLTYTFGDLSLVLVYDYYPSSPTL 365 (655)
T ss_pred ccceeEeeeeccCCceeeeeeecccccc--CcccchHHHHHHHHhccCceeehhhhhhhhccCcceEEEEEecCCCCchH
Confidence 4567899999999999999999322211 1122345788999999999999999987 35679999999986 445
Q ss_pred HHH-hc--------------CCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEEccCCcEEEeecCchhhhhc
Q psy758 89 NEL-EN--------------HPHGLPWDLIKQITWQVLRGVSYCHRHACIHRDIKPENILLTANGVVKLCDFGFARLIRD 153 (292)
Q Consensus 89 ~~~-~~--------------~~~~~~~~~~~~i~~qi~~aL~~LH~~givH~dl~p~Nilv~~~~~~kl~dfg~~~~~~~ 153 (292)
.++ .. .+...+|...|.++.|+..||.++|+.|+.-+-|.|.+|+++.+.+++|...|+...+.+
T Consensus 366 ~d~~F~~~~~t~~~n~~~~~~~~~~~e~~lW~y~~QLtaaL~sIHssGLAck~L~~~kIlv~G~~RIriS~C~i~Dvl~~ 445 (655)
T KOG3741|consen 366 YDLYFANPPFTKRTNSFYPSQNLKAPEEVLWSYISQLTAALYSIHSSGLACKTLDLKKILVTGKMRIRISGCGIMDVLQE 445 (655)
T ss_pred HHHHccCCccccccccccccCCCCchHHHHHHHHHHHHHHHHHHHhcCceeecccHhHeEeeCcceEEEecccceeeecC
Confidence 443 21 223478999999999999999999999999999999999999999999998887766544
|
|
| >COG0478 RIO-like serine/threonine protein kinase fused to N-terminal HTH domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.27 E-value=7.1e-11 Score=91.45 Aligned_cols=137 Identities=24% Similarity=0.261 Sum_probs=104.2
Q ss_pred ceeeeecccCceEEEEEEEcCCCcEEEEEEeccCC------------------CC--hHHHHHHHHHHHHHHhCCCC--C
Q psy758 5 EKIGKLGEGSYGVVFKCRNRDTGQVVAIKKFLESE------------------ED--PLIRKIALREIRLLKSLKHP--N 62 (292)
Q Consensus 5 ~~~~~l~~g~~~~v~~~~~~~~~~~v~iK~~~~~~------------------~~--~~~~~~~~~e~~~~~~l~~~--~ 62 (292)
.++..||-|.-|.||.|.+. .|..+++|.=+... .+ ........+|.++|+.|... .
T Consensus 94 ~iG~~IGvGKEsdVY~~~~~-~g~~~~vKfHR~GrtsFrkvk~~R~y~~~~~h~sWl~~sRl~A~rEf~~L~~L~~~G~~ 172 (304)
T COG0478 94 AIGTKIGVGKESDVYVAIDP-KGRKVAVKFHRLGRTSFRKVKRNRDYLADKEHGSWLYVSRLAAEREFEALQRLYPEGVK 172 (304)
T ss_pred hhccccccCccceEEEEECC-CCCEEEEEEeecCchhhhhhcchhhhhccccCcchhhhHHHHHHHHHHHHHHhhhcCCC
Confidence 45678999999999999987 48899999432111 00 12345567899999999754 6
Q ss_pred cchhhhhhhcCCeEEEEEecCCCccHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEEccCCcEEE
Q psy758 63 LVNLLEVFRRKKKLHLVFEFCDHTVLNELENHPHGLPWDLIKQITWQVLRGVSYCHRHACIHRDIKPENILLTANGVVKL 142 (292)
Q Consensus 63 i~~~~~~~~~~~~~~iv~e~~~~~~L~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~givH~dl~p~Nilv~~~~~~kl 142 (292)
+.+.+++ +...+|||+..|..|.... ++.+....++..|++-+..+-..|+||||+++-||+++++|.+.+
T Consensus 173 VP~P~~~----nRHaVvMe~ieG~eL~~~r-----~~~en~~~il~~il~~~~~~~~~GiVHGDlSefNIlV~~dg~~~v 243 (304)
T COG0478 173 VPKPIAW----NRHAVVMEYIEGVELYRLR-----LDVENPDEILDKILEEVRKAYRRGIVHGDLSEFNILVTEDGDIVV 243 (304)
T ss_pred CCCcccc----ccceeeeehcccceeeccc-----CcccCHHHHHHHHHHHHHHHHHcCccccCCchheEEEecCCCEEE
Confidence 6766654 6678999999997765542 245556677777777777777999999999999999999999999
Q ss_pred eecCchhhh
Q psy758 143 CDFGFARLI 151 (292)
Q Consensus 143 ~dfg~~~~~ 151 (292)
+||--+...
T Consensus 244 IDwPQ~v~~ 252 (304)
T COG0478 244 IDWPQAVPI 252 (304)
T ss_pred EeCcccccC
Confidence 999766543
|
|
| >PRK09902 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=99.13 E-value=1.6e-09 Score=82.02 Aligned_cols=137 Identities=14% Similarity=0.113 Sum_probs=99.5
Q ss_pred cccCceEEEEEEEcCCCcEEEEEEeccCCC-C---hHHHHHHHHHHHHHHhCCCCC--cchhhhhhh---c--CCeEEEE
Q psy758 11 GEGSYGVVFKCRNRDTGQVVAIKKFLESEE-D---PLIRKIALREIRLLKSLKHPN--LVNLLEVFR---R--KKKLHLV 79 (292)
Q Consensus 11 ~~g~~~~v~~~~~~~~~~~v~iK~~~~~~~-~---~~~~~~~~~e~~~~~~l~~~~--i~~~~~~~~---~--~~~~~iv 79 (292)
+.||-|.|++.... |+.+-+|.-..... + +.-...+.+|...++.|..-+ ++++. ++. . ...-++|
T Consensus 27 ~rgG~SgV~r~~~~--g~~~ylKrq~nhl~~s~r~P~g~ptf~rE~~~L~~L~~~GvPVP~pv-f~~~~k~~~~~rA~LV 103 (216)
T PRK09902 27 RRNGMSGVQCVERN--GKKLYVKRMTHHLFHSVRYPFGRPTIVREVAVIKELERAGVIVPKIV-FGEAVKIEGEWRALLV 103 (216)
T ss_pred CCCCcceEEEEEeC--CcEEEEEeccCcccccccCCCCchHHHHHHHHHHHHHHcCCCCCccc-eeeeeccCCceEEEEE
Confidence 45888899987655 44688886541110 0 123466888999998885322 44444 222 1 2247899
Q ss_pred EecCCC-ccHHHHhcCC--CCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEEccCCc--EEEeecCchhh
Q psy758 80 FEFCDH-TVLNELENHP--HGLPWDLIKQITWQVLRGVSYCHRHACIHRDIKPENILLTANGV--VKLCDFGFARL 150 (292)
Q Consensus 80 ~e~~~~-~~L~~~~~~~--~~~~~~~~~~i~~qi~~aL~~LH~~givH~dl~p~Nilv~~~~~--~kl~dfg~~~~ 150 (292)
+|-++| .+|.+++... .+.++.....++.+++.++.-||+.|+.|+|+.+.||+++.++. +.++||.-++.
T Consensus 104 Te~L~g~~~L~~~l~~~~~~~~~~~~k~~il~~va~~ia~LH~~Gv~Hgdly~khIll~~~g~~~v~lIDlEk~r~ 179 (216)
T PRK09902 104 TEDMAGFISIADWYAQHAVSPYSDEVRQAMLKAVALAFKKMHSVNRQHGCCYVRHIYVKTEGKAEAGFLDLEKSRR 179 (216)
T ss_pred EEeCCCCccHHHHHhcCCcCCcchHHHHHHHHHHHHHHHHHHHCCCcCCCCCHhheeecCCCCeeEEEEEhhccch
Confidence 997765 7788887552 24578888999999999999999999999999999999987777 99999976654
|
|
| >PF06176 WaaY: Lipopolysaccharide core biosynthesis protein (WaaY); InterPro: IPR009330 This family consists of several bacterial lipopolysaccharide core biosynthesis proteins (WaaY or RfaY) | Back alignment and domain information |
|---|
Probab=99.13 E-value=1.4e-09 Score=82.55 Aligned_cols=138 Identities=19% Similarity=0.259 Sum_probs=88.6
Q ss_pred cccceeeeecccCceEEEEEEEcCCCcEEEEEEeccCCCChH-HHH------HHHHHHHHHHhCC---CCCcchhhhhhh
Q psy758 2 ERYEKIGKLGEGSYGVVFKCRNRDTGQVVAIKKFLESEEDPL-IRK------IALREIRLLKSLK---HPNLVNLLEVFR 71 (292)
Q Consensus 2 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~v~iK~~~~~~~~~~-~~~------~~~~e~~~~~~l~---~~~i~~~~~~~~ 71 (292)
++|...+.+.+.....|.+.. .+|+.+++|.........+ ... ...+.+.....+. ......++-+.+
T Consensus 31 ~~~~~~kv~k~~~r~~ValIe--i~~~kyIlK~pr~~~~r~er~~~sf~kg~~~~~l~~~~~~i~~~g~~~~~~~yl~~e 108 (229)
T PF06176_consen 31 NNYKIIKVFKNTKRNYVALIE--IDGKKYILKEPREENRRPERRFKSFFKGSEYSRLINNTDKIRNEGFTEPADPYLAAE 108 (229)
T ss_pred CCceEEEeecCCCccEEEEEE--ECCcEEEEeccchhhhhHHHHHHHHhccHHHHHHHHHHHHHHHcCccccccceeeee
Confidence 467778888887777666554 4488999998754331111 011 1122333333332 223333332222
Q ss_pred -----cCCeEEEEEecCCCccHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEEccCCcEEEeecC
Q psy758 72 -----RKKKLHLVFEFCDHTVLNELENHPHGLPWDLIKQITWQVLRGVSYCHRHACIHRDIKPENILLTANGVVKLCDFG 146 (292)
Q Consensus 72 -----~~~~~~iv~e~~~~~~L~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~givH~dl~p~Nilv~~~~~~kl~dfg 146 (292)
.....+++|||++|..|.+... +++ .+...+.+++..||+.|++|||..|.|+++++++ ++++||+
T Consensus 109 kk~~~~~~~~~ll~EYIeG~~l~d~~~----i~e----~~~~ki~~~ikqlH~~G~~HGD~hpgNFlv~~~~-i~iID~~ 179 (229)
T PF06176_consen 109 KKIFRYTSSYVLLMEYIEGVELNDIED----IDE----DLAEKIVEAIKQLHKHGFYHGDPHPGNFLVSNNG-IRIIDTQ 179 (229)
T ss_pred eeeccceeEEEEEEEEecCeecccchh----cCH----HHHHHHHHHHHHHHHcCCccCCCCcCcEEEECCc-EEEEECc
Confidence 2244678999999988776543 333 3446677889999999999999999999998665 8999997
Q ss_pred chhh
Q psy758 147 FARL 150 (292)
Q Consensus 147 ~~~~ 150 (292)
..+.
T Consensus 180 ~k~~ 183 (229)
T PF06176_consen 180 GKRM 183 (229)
T ss_pred cccc
Confidence 7654
|
The waaY, waaQ, and waaP genes are located in the central operon of the waa (formerly rfa) locus on the chromosome of Escherichia coli. This locus contains genes whose products are involved in the assembly of the core region of the lipopolysaccharide molecule. WaaY is the enzyme that phosphorylates HepII in this system [].; GO: 0009244 lipopolysaccharide core region biosynthetic process |
| >PF06293 Kdo: Lipopolysaccharide kinase (Kdo/WaaP) family; InterPro: IPR010440 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases | Back alignment and domain information |
|---|
Probab=99.11 E-value=5.7e-10 Score=86.11 Aligned_cols=105 Identities=22% Similarity=0.207 Sum_probs=82.1
Q ss_pred HHHHHHHHHHHhCCCCC--cchhhhhhhc----CCeEEEEEecCCC-ccHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHH
Q psy758 46 KIALREIRLLKSLKHPN--LVNLLEVFRR----KKKLHLVFEFCDH-TVLNELENHPHGLPWDLIKQITWQVLRGVSYCH 118 (292)
Q Consensus 46 ~~~~~e~~~~~~l~~~~--i~~~~~~~~~----~~~~~iv~e~~~~-~~L~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH 118 (292)
....+|...+..|..-+ .++.+++.+. ....++|+|++++ .+|.+++......+......++.+++..++-||
T Consensus 56 ~ra~~E~~~~~~L~~~Gi~tP~pva~~~~r~~~~~~s~lite~l~~~~~L~~~~~~~~~~~~~~~~~ll~~l~~~i~~lH 135 (206)
T PF06293_consen 56 SRAKREWRNLQRLREAGIPTPEPVAYGERRKGGGYRSYLITEALPGAQDLRDLLQQWEQLDPSQRRELLRALARLIAKLH 135 (206)
T ss_pred hHHHHHHHHHHHHHHcCCCCCcEEEEEEEcCCCceeEEEEEEeCCCcccHHHHHHhhcccchhhHHHHHHHHHHHHHHHH
Confidence 34667777777774322 3444444432 1346899999988 479998876445778888999999999999999
Q ss_pred hCCccccCCCCCceEEccCC---cEEEeecCchhh
Q psy758 119 RHACIHRDIKPENILLTANG---VVKLCDFGFARL 150 (292)
Q Consensus 119 ~~givH~dl~p~Nilv~~~~---~~kl~dfg~~~~ 150 (292)
.+|++|+|+++.|||++.++ .+.++||+-+..
T Consensus 136 ~~gi~H~Dl~~~NILv~~~~~~~~~~lIDld~~~~ 170 (206)
T PF06293_consen 136 DAGIYHGDLNPSNILVDPDDGQYRFYLIDLDRMRF 170 (206)
T ss_pred HCcCCCCCCCcccEEEeCCCCceeEEEEcchhcee
Confidence 99999999999999999887 899999987754
|
Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. This entry represents lipopolysaccharide kinases which are related to protein kinases IPR000719 from INTERPRO. This family includes waaP (rfaP) gene product is required for the addition of phosphate to O-4 of the first heptose residue of the lipopolysaccharide (LPS) inner core region. It has previously been shown that WaaP is necessary for resistance to hydrophobic and polycationic antimicrobials in E. coli and that it is required for virulence in invasive strains of Salmonella enterica [].; GO: 0005524 ATP binding, 0016773 phosphotransferase activity, alcohol group as acceptor, 0009103 lipopolysaccharide biosynthetic process, 0016020 membrane |
| >COG1718 RIO1 Serine/threonine protein kinase involved in cell cycle control [Signal transduction mechanisms / Cell division and chromosome partitioning] | Back alignment and domain information |
|---|
Probab=98.99 E-value=6.9e-09 Score=79.79 Aligned_cols=139 Identities=21% Similarity=0.216 Sum_probs=91.2
Q ss_pred eeeecccCceEEEEEEEcCCCcEEEEEEeccCCCChHHH----------------------HHHHHHHHHHHhCCC--CC
Q psy758 7 IGKLGEGSYGVVFKCRNRDTGQVVAIKKFLESEEDPLIR----------------------KIALREIRLLKSLKH--PN 62 (292)
Q Consensus 7 ~~~l~~g~~~~v~~~~~~~~~~~v~iK~~~~~~~~~~~~----------------------~~~~~e~~~~~~l~~--~~ 62 (292)
...|++|.-+.||.|.. .++..+|+|++......-... .-..+|..-|+.+.. -.
T Consensus 53 ~g~istGKEA~Vy~a~~-~~~~~~avKiyr~~t~~fk~~~~Yi~gd~Rf~~~~~~rr~lv~~W~~kEf~NL~R~~eAGVr 131 (268)
T COG1718 53 VGCISTGKEANVYLAET-GDGRYVAVKIYRTSTSEFKRIRRYIQGDPRFRNSRSNRRKLVFAWARKEFRNLKRAYEAGVR 131 (268)
T ss_pred EeeecCCcceEEEeecc-CCCceEEEEEEehhhhhhhhHHHHHhcChhhhcCCCCHHHHHHHHHHHHHHHHHHHHHcCCC
Confidence 45788899999999986 347899999986543221111 111223333333321 11
Q ss_pred cchhhhhhhcCCeEEEEEecCCCccHHH-HhcCCCCCCHHHHHHHHHHHHHHHHHHHh-CCccccCCCCCceEEccCCcE
Q psy758 63 LVNLLEVFRRKKKLHLVFEFCDHTVLNE-LENHPHGLPWDLIKQITWQVLRGVSYCHR-HACIHRDIKPENILLTANGVV 140 (292)
Q Consensus 63 i~~~~~~~~~~~~~~iv~e~~~~~~L~~-~~~~~~~~~~~~~~~i~~qi~~aL~~LH~-~givH~dl~p~Nilv~~~~~~ 140 (292)
+.+.+++ ..-.+|||+.+....-. .++. ..+....+..+..++++.+.-|-. .|+|||||+.-|||+. ++.+
T Consensus 132 vP~Pi~~----~~nVLvMEfIg~~g~pAP~LkD-v~~e~~e~~~~~~~~v~~~~~l~~~a~LVHgDLSEyNiL~~-~~~p 205 (268)
T COG1718 132 VPEPIAF----RNNVLVMEFIGDDGLPAPRLKD-VPLELEEAEGLYEDVVEYMRRLYKEAGLVHGDLSEYNILVH-DGEP 205 (268)
T ss_pred CCCceee----cCCeEEEEeccCCCCCCCCccc-CCcCchhHHHHHHHHHHHHHHHHHhcCcccccchhhheEEE-CCeE
Confidence 2222222 23468999998752211 1221 234444788899999999999888 8999999999999999 8899
Q ss_pred EEeecCchhhhh
Q psy758 141 KLCDFGFARLIR 152 (292)
Q Consensus 141 kl~dfg~~~~~~ 152 (292)
.++|++-+....
T Consensus 206 ~iID~~QaV~~~ 217 (268)
T COG1718 206 YIIDVSQAVTID 217 (268)
T ss_pred EEEECccccccC
Confidence 999999886554
|
|
| >TIGR02172 Fb_sc_TIGR02172 Fibrobacter succinogenes paralogous family TIGR02172 | Back alignment and domain information |
|---|
Probab=98.86 E-value=3.5e-08 Score=77.14 Aligned_cols=130 Identities=15% Similarity=0.200 Sum_probs=83.4
Q ss_pred eeecccCceEEEEEEEcCCCcEEEEEEeccCCCChHHHHHHHHHHHHHHhCCCCC--cchhhhhhhcCCeEEEEEecCCC
Q psy758 8 GKLGEGSYGVVFKCRNRDTGQVVAIKKFLESEEDPLIRKIALREIRLLKSLKHPN--LVNLLEVFRRKKKLHLVFEFCDH 85 (292)
Q Consensus 8 ~~l~~g~~~~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~e~~~~~~l~~~~--i~~~~~~~~~~~~~~iv~e~~~~ 85 (292)
..|++|..+.||+. .+..+++|..+..... ....+|.+.++.+..-+ +.+++++..+.+...+|||+++|
T Consensus 7 ~~i~~G~t~~~y~~----~~~~~VlR~~~~~~~~----~~i~~E~~~l~~l~~~glpvP~~~~~~~~~~~~glv~e~i~G 78 (226)
T TIGR02172 7 TQTGEGGNGESYTH----KTGKWMLKLYNPGFDK----ETIKREFDASRKVFSLGIPTPHPFDLVEDGGRLGLIYELIVG 78 (226)
T ss_pred eeecCCCCcceeEe----cCCCEEEEeCCCCCCH----HHHHHHHHHHHHHHHcCCCCCceEEEEecCCeeeeeeeecCC
Confidence 46899999999974 2556889987653322 23577999998886433 46677777777778899999999
Q ss_pred cc-HHHHhcCCCCCCHHHHHHHHHHHHHHHHHHH-----------------------------------------h--CC
Q psy758 86 TV-LNELENHPHGLPWDLIKQITWQVLRGVSYCH-----------------------------------------R--HA 121 (292)
Q Consensus 86 ~~-L~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH-----------------------------------------~--~g 121 (292)
.. +..... .+......++.++++.+.-|| . ..
T Consensus 79 ~~~~~~~~~----~~~~~~~~l~~~la~~l~~lH~~~~~~~~l~~~~~~~~~~l~~~~~~~~~~~~~l~~~l~~~~~~~~ 154 (226)
T TIGR02172 79 KRSFSRIIS----DNPSRLEEIAKIFAEMAKKLHSTKCDTSTFQSYKEKIRKFIEEKDFVPKDYKEKARAFIKEVPDTST 154 (226)
T ss_pred ccchhhhhc----CCHHHHHHHHHHHHHHHHHHhCCCCCCCcHHHHHHHHHHHHHhccCCCHHHHHHHHHHHHhCCCCCc
Confidence 63 222211 011111112222222222222 1 24
Q ss_pred ccccCCCCCceEEccCCcEEEeecCchhh
Q psy758 122 CIHRDIKPENILLTANGVVKLCDFGFARL 150 (292)
Q Consensus 122 ivH~dl~p~Nilv~~~~~~kl~dfg~~~~ 150 (292)
++|||+.|.||++++++ +.++||+.+..
T Consensus 155 ~~HgD~~~~Nii~~~~~-~~iIDwe~a~~ 182 (226)
T TIGR02172 155 CLHGDFQIGNLITSGKG-TYWIDLGDFGY 182 (226)
T ss_pred eEecCCCCCcEEEcCCC-cEEEechhcCc
Confidence 68999999999999988 99999998754
|
This model describes a paralogous family of five proteins, likely to be enzymes, in the rumen bacterium Fibrobacter succinogenes S85. Members show homology to proteins described by PFAM model pfam01636, a phosphotransferase enzyme family associated with resistance to aminoglycoside antibiotics. However, members of this family score below the current trusted and noise cutoffs for pfam01636. |
| >PF01636 APH: Phosphotransferase enzyme family This family is part of the larger protein kinase superfamily | Back alignment and domain information |
|---|
Probab=98.76 E-value=1.1e-07 Score=75.18 Aligned_cols=78 Identities=18% Similarity=0.181 Sum_probs=55.6
Q ss_pred eeeecccCceEEEEEEEcCCCcEEEEEEeccCCCChHHHHHHHHHHHHHHhCCCC--Ccchhhhhh---hcCCeEEEEEe
Q psy758 7 IGKLGEGSYGVVFKCRNRDTGQVVAIKKFLESEEDPLIRKIALREIRLLKSLKHP--NLVNLLEVF---RRKKKLHLVFE 81 (292)
Q Consensus 7 ~~~l~~g~~~~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~e~~~~~~l~~~--~i~~~~~~~---~~~~~~~iv~e 81 (292)
++.|+.|..+.+|.+.... ..+++|..... .....+.+|..+++.+... .+.+++... ......+++|+
T Consensus 2 i~~l~~G~~n~~~~v~~~~--~~~vlK~~~~~----~~~~~~~~e~~~~~~l~~~~~pvP~~~~~~~~~~~~~~~~~~~~ 75 (239)
T PF01636_consen 2 IRPLSGGFSNRVYRVTTDD--GRYVLKFYRPP----DAAERLRREAAVLRQLAEHGIPVPRVLAFDTSDEFNGFPYLLME 75 (239)
T ss_dssp EEEEEESSSSEEEEEEETT--SEEEEEEESSH----HHHHHHHHHHHHHHHHHHTTSBS--EEEEEEETEETSEEEEEEE
T ss_pred CccCCCCCeeeEEEEEECC--cEEEEEEeCCC----CCHHHHHHHHHHHHHHHhcCCCCceEEeecccccccccceEEEE
Confidence 4678999999999998765 58999986544 3455667888888887533 245555532 23446899999
Q ss_pred cCCCccHHH
Q psy758 82 FCDHTVLNE 90 (292)
Q Consensus 82 ~~~~~~L~~ 90 (292)
+++|..+..
T Consensus 76 ~i~g~~~~~ 84 (239)
T PF01636_consen 76 YIPGRPLDD 84 (239)
T ss_dssp EESSEEHHH
T ss_pred Eeccccccc
Confidence 999988777
|
; InterPro: IPR002575 This entry consists of bacterial antibiotic resistance proteins, which confer resistance to various aminoglycosides they include:- aminoglycoside 3'-phosphotransferase or kanamycin kinase / neomycin-kanamycin phosphotransferase and streptomycin 3''-kinase or streptomycin 3''-phosphotransferase. The aminoglycoside phosphotransferases inactivate aminoglycoside antibiotics via phosphorylation []. The proteins are found in a range of taxonomic groups.; PDB: 2PPQ_A 2Q83_B 3TDV_B 3TDW_A 3I0O_A 3I0Q_A 3I1A_B 3Q2M_A 3HAV_C 2PUI_B .... |
| >KOG2137|consensus | Back alignment and domain information |
|---|
Probab=98.74 E-value=8.2e-09 Score=89.48 Aligned_cols=153 Identities=24% Similarity=0.268 Sum_probs=99.5
Q ss_pred HHHHHHHHHHHHhC-CccccCCCCCceEEccCCcEEEeecCchhhhhcccc--------------ccccccccccccccC
Q psy758 107 TWQVLRGVSYCHRH-ACIHRDIKPENILLTANGVVKLCDFGFARLIRDLIP--------------RHLHIFQTNEYFKGV 171 (292)
Q Consensus 107 ~~qi~~aL~~LH~~-givH~dl~p~Nilv~~~~~~kl~dfg~~~~~~~~~~--------------~~~~~~~~~~~~~~~ 171 (292)
+.+++.|+.++|.. ++||++|.|++|.++.++.+||++|+++....+... .....|.+||+..+.
T Consensus 105 l~~v~dgl~flh~sAk~VH~ni~p~~i~~na~~~wkl~Gf~f~v~~~~~~~~p~~~yd~~lp~~~~~~~~f~apE~~~~~ 184 (700)
T KOG2137|consen 105 LGNVADGLAFLHRSAKVVHGNIQPEAIVVNANGDWKLAGFSFCVNANGPTEYPFSEYDPPLPLLLQPHLNFLAPEYLLGT 184 (700)
T ss_pred hhcccchhhhhccCcceeecccchhheeeccCcceeeccchhhhccCCCCccccccCCCCCChhhccCcccccchhhccc
Confidence 33455999999986 799999999999999999999999998865443110 112347778888776
Q ss_pred CCCCCCcccceeeecCCCCCCchHHHHHHHhhcccCCCCCCChhhhhhccCcCCCCCCCCCccchHHHHhcccCcCCCCC
Q psy758 172 SLPHAENVVPLEIKIGKPAATNIYLIDFLKRCLDKDPLRRWSCDQLLRHPYFNGYYFEVPDEMQYEEITQRCLDKDPLRR 251 (292)
Q Consensus 172 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~R 251 (292)
....+.+..++++.+......+.+....-...... .... ...-..........+.++++=+.++|..|+.-|
T Consensus 185 ~~~~~sd~fSlG~li~~i~~~gk~i~~a~~~~~~~------~~~~--~~~~~~~~~~s~~~p~el~~~l~k~l~~~~~~r 256 (700)
T KOG2137|consen 185 TNTPASDVFSLGVLIYTIYNGGKSIIAANGGLLSY------SFSR--NLLNAGAFGYSNNLPSELRESLKKLLNGDSAVR 256 (700)
T ss_pred cccccccceeeeeEEEEEecCCcchhhccCCcchh------hhhh--cccccccccccccCcHHHHHHHHHHhcCCcccC
Confidence 66666666666655444332222211100000000 0000 000011122235668899999999999999999
Q ss_pred CChhhhhhCCccccee
Q psy758 252 WSCDQLLRHPYFNGYY 267 (292)
Q Consensus 252 pt~~~il~h~w~~~~~ 267 (292)
|++.+++..|||.+..
T Consensus 257 p~~~~l~~~~ff~D~~ 272 (700)
T KOG2137|consen 257 PTLDLLLSIPFFSDPG 272 (700)
T ss_pred cchhhhhcccccCCch
Confidence 9999999999999843
|
|
| >COG0661 AarF Predicted unusual protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=98.71 E-value=9.3e-08 Score=82.76 Aligned_cols=141 Identities=18% Similarity=0.306 Sum_probs=86.7
Q ss_pred eeecccCceEEEEEEEcCCCcEEEEEEeccCCCC--------------------------------hHHHHHHHHHHHHH
Q psy758 8 GKLGEGSYGVVFKCRNRDTGQVVAIKKFLESEED--------------------------------PLIRKIALREIRLL 55 (292)
Q Consensus 8 ~~l~~g~~~~v~~~~~~~~~~~v~iK~~~~~~~~--------------------------------~~~~~~~~~e~~~~ 55 (292)
.-|++++-|.||.|.... |+.||||+....-.. ++..+.+..|++..
T Consensus 131 ~PiAsASIaQVH~A~L~s-G~~VAVKVqrPgi~~~i~~DL~il~~~a~~~~~~~~~~~~l~~~~vv~e~~~~l~~ElDy~ 209 (517)
T COG0661 131 EPIASASIAQVHRAVLKS-GEEVAVKVQRPGIRERIEADLKLLRRLARLIKRLPPGGRRLDLVEVVDEFEKRLREELDYR 209 (517)
T ss_pred CchhhhhHhhheeEEecC-CCEEEEEecCCChHHHHHHHHHHHHHHHHHHHHcCCccccCChHHHHHHHHHHHHHHhCHH
Confidence 458899999999999876 999999987432111 11111122222221
Q ss_pred ------HhCC-----CCCcchhhhhh-hcCCeEEEEEecCCCccHHHHh--cCCCCCCHHHHHHHHHHHHHHHHHHHhCC
Q psy758 56 ------KSLK-----HPNLVNLLEVF-RRKKKLHLVFEFCDHTVLNELE--NHPHGLPWDLIKQITWQVLRGVSYCHRHA 121 (292)
Q Consensus 56 ------~~l~-----~~~i~~~~~~~-~~~~~~~iv~e~~~~~~L~~~~--~~~~~~~~~~~~~i~~qi~~aL~~LH~~g 121 (292)
..++ .+++ .+=.+| +-.+.-.++|||+.|..+.+.. +. ...+...+...+.++ -+..+-..|
T Consensus 210 ~EA~n~~~~~~nf~~~~~v-~VP~V~we~t~~~VLtmE~i~Gi~i~d~~~l~~-~g~d~k~ia~~~~~~--f~~q~~~dg 285 (517)
T COG0661 210 REAANAERFRENFKDDPDV-YVPKVYWEYTTRRVLTMEWIDGIKISDIAALKS-AGIDRKELAELLVRA--FLRQLLRDG 285 (517)
T ss_pred HHHHHHHHHHHHcCCCCCe-EeceeehhccCCcEEEEEeeCCEecccHHHHHh-cCCCHHHHHHHHHHH--HHHHHHhcC
Confidence 1111 1111 111111 1234567899999998887763 33 234433333222221 244445589
Q ss_pred ccccCCCCCceEEccCCcEEEeecCchhhhhc
Q psy758 122 CIHRDIKPENILLTANGVVKLCDFGFARLIRD 153 (292)
Q Consensus 122 ivH~dl~p~Nilv~~~~~~kl~dfg~~~~~~~ 153 (292)
+.|+|..|.||+++.+|.+.+.|||+...+++
T Consensus 286 ffHaDpHpGNi~v~~~g~i~~lDfGi~g~l~~ 317 (517)
T COG0661 286 FFHADPHPGNILVRSDGRIVLLDFGIVGRLDP 317 (517)
T ss_pred ccccCCCccceEEecCCcEEEEcCcceecCCH
Confidence 99999999999999999999999999887654
|
|
| >cd05150 APH Aminoglycoside 3'-phosphotransferase (APH) | Back alignment and domain information |
|---|
Probab=98.64 E-value=3.3e-07 Score=72.89 Aligned_cols=135 Identities=12% Similarity=0.069 Sum_probs=81.4
Q ss_pred eecccCc-eEEEEEEEcCCCcEEEEEEeccCCCChHHHHHHHHHHHHHHhCC-CCCcchhhhhhhcCCeEEEEEecCCCc
Q psy758 9 KLGEGSY-GVVFKCRNRDTGQVVAIKKFLESEEDPLIRKIALREIRLLKSLK-HPNLVNLLEVFRRKKKLHLVFEFCDHT 86 (292)
Q Consensus 9 ~l~~g~~-~~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~e~~~~~~l~-~~~i~~~~~~~~~~~~~~iv~e~~~~~ 86 (292)
.|..|.+ +.||++... +..+++|..+... .....+|..+++.+. +-.+.+++++...++..++|||+++|.
T Consensus 5 ~~~~g~~~~~v~~~~~~--~~~~~vk~~~~~~-----~~~~~~E~~~l~~l~~~~~vP~v~~~~~~~~~~~lv~e~i~G~ 77 (244)
T cd05150 5 RVTEGQSGATVYRLDGK--NPGLYLKIAPSGP-----TYELEREAERLRWLAGKLPVPEVIDYGSDDGRAWLLTSAVPGV 77 (244)
T ss_pred ecCCCCCcCeEEEEcCC--CCcEEEEecCCCc-----ccchHHHHHHHHHHHhcCCCCeEEEEEecCCccEEEEEeeCCc
Confidence 3455554 778988653 4678899875543 223456888877774 334566677666666789999999997
Q ss_pred cHHHHhc-------------------CC----CCCCHH--HHH-HH----------------------HHHHHHHHHHH-
Q psy758 87 VLNELEN-------------------HP----HGLPWD--LIK-QI----------------------TWQVLRGVSYC- 117 (292)
Q Consensus 87 ~L~~~~~-------------------~~----~~~~~~--~~~-~i----------------------~~qi~~aL~~L- 117 (292)
.+..... .- ..+... ... .. ..++...|...
T Consensus 78 ~l~~~~~~~~~~~~~~~l~~~l~~lH~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~ 157 (244)
T cd05150 78 PAAALWEELEPERLVDALAEALRRLHALPVADCPFDRRLDRRLAEARARVENGLVDEDDFDDERRGWSAEELYAELEATR 157 (244)
T ss_pred cHhHhhcccCHHHHHHHHHHHHHHHhcCCcccCCcchhHHHHHHHHHHHHhcCCcChhhCcHhhcCCCHHHHHHHHHhhC
Confidence 7664321 00 001100 000 00 01111111111
Q ss_pred ---HhCCccccCCCCCceEEccCCcEEEeecCchhh
Q psy758 118 ---HRHACIHRDIKPENILLTANGVVKLCDFGFARL 150 (292)
Q Consensus 118 ---H~~givH~dl~p~Nilv~~~~~~kl~dfg~~~~ 150 (292)
....++|||+.|.||++++++.+.|+||+.+..
T Consensus 158 ~~~~~~~l~HgD~~~~Nil~~~~~~~~iIDwe~a~~ 193 (244)
T cd05150 158 PAEEDLVVTHGDACLPNIIVDPGKFSGFIDLGRLGV 193 (244)
T ss_pred CCcCceEEECCCCCCccEEEeCCcEEEEEEcccccc
Confidence 123489999999999999987788999998754
|
The APH subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). APH catalyzes the transfer of the gamma-phosphoryl group from ATP to aminoglycoside antibiotics such as kanamycin, streptomycin, neomycin, and gentamicin, among others. The aminoglycoside antibiotics target the 30S ribosome and promote miscoding, leading to the production of defective proteins which insert into the bacterial membrane, resulting in membrane damage and the ultimate demise of the bacterium. Phosphorylation of the aminoglycoside antibiotics results in their inactivation, leading to bacterial antibiotic resistance. The APH gene is found on transposons and plasmids and is thought to have originated as a self-defense mechanism used by microorganisms that produce the antibio |
| >KOG1235|consensus | Back alignment and domain information |
|---|
Probab=98.53 E-value=1.6e-06 Score=75.13 Aligned_cols=138 Identities=22% Similarity=0.299 Sum_probs=87.5
Q ss_pred eeecccCceEEEEEEEcCCCcEEEEEEeccCCCC-----------------------------hHHHHHHHHHHHHHHhC
Q psy758 8 GKLGEGSYGVVFKCRNRDTGQVVAIKKFLESEED-----------------------------PLIRKIALREIRLLKSL 58 (292)
Q Consensus 8 ~~l~~g~~~~v~~~~~~~~~~~v~iK~~~~~~~~-----------------------------~~~~~~~~~e~~~~~~l 58 (292)
+.|+..+.|.|++|+... |+.||+|+-...-.. ++..+.+..|++..+.-
T Consensus 167 ~piaaASlaQVhrA~L~~-G~~VaVKVQ~P~l~~~~~~Dl~~~~~~~~~l~k~~p~~~~~~lvdE~~~~L~~ELDF~~EA 245 (538)
T KOG1235|consen 167 EPIAAASLAQVHRARLKN-GEDVAVKVQHPGLEKLIMLDLRNLRLLAKVLQKFFPDFDLVWLVDEIAKSLPQELDFTKEA 245 (538)
T ss_pred chhhhcchhheEEEEecC-CCEEEEEecCcChHHHHHHHHHHHHHHHHHHHHhCcCCchhhHHHHHHhhhHhhcchHHHH
Confidence 468899999999999877 999999976432111 22233333344333332
Q ss_pred ----------CCCC------cchhhhhhhcCCeEEEEEecCCCccHHH---HhcCCCCCCHHHHHHHHHHHHHH-HHHHH
Q psy758 59 ----------KHPN------LVNLLEVFRRKKKLHLVFEFCDHTVLNE---LENHPHGLPWDLIKQITWQVLRG-VSYCH 118 (292)
Q Consensus 59 ----------~~~~------i~~~~~~~~~~~~~~iv~e~~~~~~L~~---~~~~~~~~~~~~~~~i~~qi~~a-L~~LH 118 (292)
.|-+ |.++|..+ ...-.++|||++|.-+.+ +-+. .++...+ +..+.++ +..+-
T Consensus 246 ~Nae~~~~~f~~~~~~~~V~VP~Vy~~~--st~RVLtME~~~G~~i~Dl~~i~~~--gi~~~~i---~~~l~~~~~~qIf 318 (538)
T KOG1235|consen 246 KNAERFRENFKDFSLLTYVLVPKVYWDL--STKRVLTMEYVDGIKINDLDAIDKR--GISPHDI---LNKLVEAYLEQIF 318 (538)
T ss_pred HhHHHHHHHHHhcccccceeCCeehhhc--CcceEEEEEecCCccCCCHHHHHHc--CCCHHHH---HHHHHHHHHHHHH
Confidence 2222 33333222 345679999999955444 3332 3565543 3333333 33445
Q ss_pred hCCccccCCCCCceEEcc----CCcEEEeecCchhhhhc
Q psy758 119 RHACIHRDIKPENILLTA----NGVVKLCDFGFARLIRD 153 (292)
Q Consensus 119 ~~givH~dl~p~Nilv~~----~~~~kl~dfg~~~~~~~ 153 (292)
..|++|+|-.|.||++.+ ++.+.+-|||+...+..
T Consensus 319 ~~GffHaDPHPGNilv~~~~~~~~~ivllDhGl~~~is~ 357 (538)
T KOG1235|consen 319 KTGFFHADPHPGNILVRPNPEGDEEIVLLDHGLYAVISH 357 (538)
T ss_pred hcCCccCCCCCCcEEEecCCCCCccEEEEcccccccccH
Confidence 678999999999999994 56799999999876653
|
|
| >PLN02876 acyl-CoA dehydrogenase | Back alignment and domain information |
|---|
Probab=98.50 E-value=1.6e-06 Score=80.66 Aligned_cols=80 Identities=14% Similarity=0.250 Sum_probs=55.9
Q ss_pred eeeecccCceEEEEEEEcCCC--cEEEEEEeccCCCChHHHHHHHHHHHHHHhCC-CCCc--chhhhhhhcC---CeEEE
Q psy758 7 IGKLGEGSYGVVFKCRNRDTG--QVVAIKKFLESEEDPLIRKIALREIRLLKSLK-HPNL--VNLLEVFRRK---KKLHL 78 (292)
Q Consensus 7 ~~~l~~g~~~~v~~~~~~~~~--~~v~iK~~~~~~~~~~~~~~~~~e~~~~~~l~-~~~i--~~~~~~~~~~---~~~~i 78 (292)
++.++.|.++.+|+......+ ..+++|+.+...... ....+.+|..+++.+. |+++ .+++.++.+. +..|+
T Consensus 43 v~~l~gG~sn~ty~l~~~~~~~~~~~VLR~~p~~~~~~-~~~~~~rE~~~l~~L~~~~~vpVP~v~~~~~d~~v~G~~fl 121 (822)
T PLN02876 43 VSQFGHGQSNPTFLLEVGNGGSVKRYVLRKKPPGKLLQ-SAHAVEREYQVLRALGEHTDVPVPKVYCLCTDASVIGTAFY 121 (822)
T ss_pred EEEeCCCCcCceEEEEECCCCcceeEEEEeCCCCccCc-cHHHHHHHHHHHHHHhhcCCCCCCcEEEEecCCCcCCCceE
Confidence 566888999999998765432 468888765433211 1345778999999995 5554 7777766553 56899
Q ss_pred EEecCCCcc
Q psy758 79 VFEFCDHTV 87 (292)
Q Consensus 79 v~e~~~~~~ 87 (292)
|||+++|..
T Consensus 122 VME~v~G~~ 130 (822)
T PLN02876 122 IMEYLEGRI 130 (822)
T ss_pred EEEecCCcc
Confidence 999999864
|
|
| >PF10707 YrbL-PhoP_reg: PhoP regulatory network protein YrbL; InterPro: IPR019647 This entry represents proteins that are activated by the protein PhoP | Back alignment and domain information |
|---|
Probab=98.42 E-value=5.3e-06 Score=63.10 Aligned_cols=135 Identities=19% Similarity=0.241 Sum_probs=94.4
Q ss_pred eeeecccCceEEEEEEEcCCCcEEEEEEeccCC--------------CChHHHHHHHHHHHHHHhCC------CCCcchh
Q psy758 7 IGKLGEGSYGVVFKCRNRDTGQVVAIKKFLESE--------------EDPLIRKIALREIRLLKSLK------HPNLVNL 66 (292)
Q Consensus 7 ~~~l~~g~~~~v~~~~~~~~~~~v~iK~~~~~~--------------~~~~~~~~~~~e~~~~~~l~------~~~i~~~ 66 (292)
...||+|+.-.||.- . .....+||+..... ......+...+|+.....+. +.+|.++
T Consensus 6 ~~~i~~G~~R~cy~H--P-~dp~~cIKV~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~E~~~y~~l~~~~~~~~~~i~r~ 82 (199)
T PF10707_consen 6 SDLIAQGGERDCYQH--P-DDPNLCIKVMRPDRGERRRPFKRWLKRLRPKSRYRQNRRELRYYKQLSLRRGVDWSHIPRF 82 (199)
T ss_pred CcccccCCCceEEEC--C-CCCCeEEEEEccccccccccchhHHHhhcccchhHHHHHHHHHHHHHhhccCCcccccccE
Confidence 356899999998843 2 24557899886554 01112355566777766666 7899999
Q ss_pred hhhhhcCCeEEEEEecCCC------ccHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEEccCC--
Q psy758 67 LEVFRRKKKLHLVFEFCDH------TVLNELENHPHGLPWDLIKQITWQVLRGVSYCHRHACIHRDIKPENILLTANG-- 138 (292)
Q Consensus 67 ~~~~~~~~~~~iv~e~~~~------~~L~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~givH~dl~p~Nilv~~~~-- 138 (292)
+|+.+++...-+|+|.... -+|.++++.. .+++ .+...+-+-..+|-+.+|+.+|++|.||++..+.
T Consensus 83 ~G~veT~~G~Glv~e~I~d~dG~~s~TL~~~l~~~-~~~~----~~~~~L~~f~~~l~~~~Iv~~dl~~~NIv~~~~~~~ 157 (199)
T PF10707_consen 83 YGFVETNLGLGLVVELIRDADGNISPTLEDYLKEG-GLTE----ELRQALDEFKRYLLDHHIVIRDLNPHNIVVQRRDSG 157 (199)
T ss_pred eEEEecCCceEEEEEEEECCCCCcCccHHHHHHcC-CccH----HHHHHHHHHHHHHHHcCCeecCCCcccEEEEecCCC
Confidence 9999998888899887542 4577888654 4555 3444444556778899999999999999997543
Q ss_pred --cEEEee-cCchh
Q psy758 139 --VVKLCD-FGFAR 149 (292)
Q Consensus 139 --~~kl~d-fg~~~ 149 (292)
.+.|+| ||...
T Consensus 158 ~~~lvlIDG~G~~~ 171 (199)
T PF10707_consen 158 EFRLVLIDGLGEKE 171 (199)
T ss_pred ceEEEEEeCCCCcc
Confidence 467776 55543
|
PhoP controls the expression of a large number of genes that mediate adaptation to low Mg2+ environments and/or virulence in several bacterial species. YbrL is proposed to be acting in a loop activity with PhoP and PrmA analogous to the multi-component loop in Salmonella sp., where the PhoP-dependent PmrD protein activates the regulatory protein PmrA, and the activated PmrA then represses transcription from the PmrD promoter which harbours binding sites for both the PhoP and PmrA proteins. Expression of YrbL is induced in low Mg2+ in a PhoP-dependent fashion and repressed by Fe3+ in a PmrA-dependent manner []. |
| >COG2112 Predicted Ser/Thr protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.39 E-value=3.4e-06 Score=61.66 Aligned_cols=128 Identities=22% Similarity=0.235 Sum_probs=92.0
Q ss_pred eeeeecccCceEEEEEEEcCCCcEEEEEEeccCCCChHHHHHHHHHHHHHHhCCCCCcch-hhhhhhcCCeEEEEEecCC
Q psy758 6 KIGKLGEGSYGVVFKCRNRDTGQVVAIKKFLESEEDPLIRKIALREIRLLKSLKHPNLVN-LLEVFRRKKKLHLVFEFCD 84 (292)
Q Consensus 6 ~~~~l~~g~~~~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~-~~~~~~~~~~~~iv~e~~~ 84 (292)
..+.|+.|++|.||++... |..+++|+-..... ...+..|.+++..+..-++.+ +|.+ +..++.|||..
T Consensus 26 v~~~L~KG~~s~Vyl~~~~--~~~~a~Kvrr~ds~----r~~l~kEakiLeil~g~~~~p~vy~y----g~~~i~me~i~ 95 (201)
T COG2112 26 VEKELAKGTTSVVYLGEWR--GGEVALKVRRRDSP----RRNLEKEAKILEILAGEGVTPEVYFY----GEDFIRMEYID 95 (201)
T ss_pred hhhhhhcccccEEEEeecc--CceEEEEEecCCcc----hhhHHHHHHHHHHhhhcCCCceEEEe----chhhhhhhhhc
Confidence 4567999999999999887 66899998654433 456778999999887655543 3333 22335599999
Q ss_pred CccHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCC-CCceEEccCCcEEEeecCchhh
Q psy758 85 HTVLNELENHPHGLPWDLIKQITWQVLRGVSYCHRHACIHRDIK-PENILLTANGVVKLCDFGFARL 150 (292)
Q Consensus 85 ~~~L~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~givH~dl~-p~Nilv~~~~~~kl~dfg~~~~ 150 (292)
|-.|..+-... + .+-+..++++---|-..||-|+.|+ |...++.+++.+.|+||..++.
T Consensus 96 G~~L~~~~~~~---~----rk~l~~vlE~a~~LD~~GI~H~El~~~~k~vlv~~~~~~iIDFd~At~ 155 (201)
T COG2112 96 GRPLGKLEIGG---D----RKHLLRVLEKAYKLDRLGIEHGELSRPWKNVLVNDRDVYIIDFDSATF 155 (201)
T ss_pred Ccchhhhhhcc---c----HHHHHHHHHHHHHHHHhccchhhhcCCceeEEecCCcEEEEEccchhh
Confidence 98887765421 2 3344556666566777899999986 6666666677999999999874
|
|
| >cd05155 APH_ChoK_like_1 Uncharacterized bacterial proteins with similarity to Aminoglycoside 3'-phosphotransferase (APH) and Choline kinase (ChoK) family members | Back alignment and domain information |
|---|
Probab=98.34 E-value=4.2e-06 Score=66.13 Aligned_cols=73 Identities=12% Similarity=0.097 Sum_probs=44.8
Q ss_pred eeecccCce-EEEEEEEcCCCcEEEEEEeccCCCChHHHHHHHHHHHHHHhCCCC---CcchhhhhhhcC---CeEEEEE
Q psy758 8 GKLGEGSYG-VVFKCRNRDTGQVVAIKKFLESEEDPLIRKIALREIRLLKSLKHP---NLVNLLEVFRRK---KKLHLVF 80 (292)
Q Consensus 8 ~~l~~g~~~-~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~e~~~~~~l~~~---~i~~~~~~~~~~---~~~~iv~ 80 (292)
+.|+.|+.+ .||+. +..+++|..+... ....+.+|...++.+... .+.++++..... +..+++|
T Consensus 3 ~~~~~gG~~n~vy~~-----~~~~VlR~~~~~~----~~~~~~~E~~~l~~L~~~~~v~vP~~~~~~~~~~~~~~~~~l~ 73 (235)
T cd05155 3 EPVDSGGTDNATFRL-----GDDMSVRLPSAAG----YAGQVRKEQRWLPRLAPHLPLPVPEPLGKGEPGEGYPWPWSVY 73 (235)
T ss_pred eeccCCCcccceEEc-----CCceEEEcCCccc----hHHHHHHHHHHHHHHhccCCCCCCceeecCCCccCCCcceEEE
Confidence 457766666 48876 2357788654322 234577899988887532 344444443322 2458899
Q ss_pred ecCCCccHH
Q psy758 81 EFCDHTVLN 89 (292)
Q Consensus 81 e~~~~~~L~ 89 (292)
++++|..+.
T Consensus 74 ~~i~G~~l~ 82 (235)
T cd05155 74 RWLEGETAT 82 (235)
T ss_pred EeecCCCCC
Confidence 999986653
|
The APH/ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates, such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides, and macrolides leads to their inactivation and to bacterial antibiotic resista |
| >PF12260 PIP49_C: Protein-kinase domain of FAM69; InterPro: IPR022049 Family with sequence similarity 69 has three members (A, B and C) | Back alignment and domain information |
|---|
Probab=98.28 E-value=2.8e-06 Score=64.33 Aligned_cols=99 Identities=21% Similarity=0.227 Sum_probs=78.9
Q ss_pred HHHHHHHHhCCC-CCcchhhhhhhcCCeEEEEEecCCCccHHHH---hcCCCCCCHHHHHHHHHHHHHHHHHHHh---CC
Q psy758 49 LREIRLLKSLKH-PNLVNLLEVFRRKKKLHLVFEFCDHTVLNEL---ENHPHGLPWDLIKQITWQVLRGVSYCHR---HA 121 (292)
Q Consensus 49 ~~e~~~~~~l~~-~~i~~~~~~~~~~~~~~iv~e~~~~~~L~~~---~~~~~~~~~~~~~~i~~qi~~aL~~LH~---~g 121 (292)
..|.-+++.+.+ +++++++|++. .+++.||.+.+.+... +..-...++..+..++.++++.+.+|+. ..
T Consensus 7 ~~E~lll~~l~~~~~~pk~lG~CG----~~~v~E~~~~~~~~~~~~~l~~~~~~~w~~R~~iA~~lL~~l~~l~~~~~~~ 82 (188)
T PF12260_consen 7 NNEPLLLQLLQGSEPFPKLLGSCG----RFYVVEYVGAGSLYGIYRPLSQFLQSPWEQRAKIALQLLELLEELDHGPLGF 82 (188)
T ss_pred ccHHHHHHHcCCCCCCCCeeeECC----CEEEEEeecCccccccccccccccccCHHHHHHHHHHHHHHHHHHhcCCCCc
Confidence 357888888875 69999999984 2678999997655321 1111246889999999999999999998 34
Q ss_pred ccccCCCCCceEEccCCcEEEeecCchhhh
Q psy758 122 CIHRDIKPENILLTANGVVKLCDFGFARLI 151 (292)
Q Consensus 122 ivH~dl~p~Nilv~~~~~~kl~dfg~~~~~ 151 (292)
+...|++|+|+.++++|++|++|...+...
T Consensus 83 ~~lcDv~~~nfgv~~~~~lk~iDld~v~~~ 112 (188)
T PF12260_consen 83 FYLCDVSPDNFGVNDDGRLKLIDLDDVFVE 112 (188)
T ss_pred EEEeecchHHeEEeCCCcEEEEechhcchh
Confidence 888999999999999999999999876544
|
Proteins in this uncharacterised family are described as transmembrane proteins. |
| >cd05153 HomoserineK_II Homoserine Kinase, type II | Back alignment and domain information |
|---|
Probab=98.27 E-value=1.3e-05 Score=65.78 Aligned_cols=137 Identities=15% Similarity=0.138 Sum_probs=80.7
Q ss_pred eeeecccCceEEEEEEEcCCCcEEEEEEeccCCCChHHHHHHHHHHHHHHhCCCC--Ccchhhhhh------hcCCeEEE
Q psy758 7 IGKLGEGSYGVVFKCRNRDTGQVVAIKKFLESEEDPLIRKIALREIRLLKSLKHP--NLVNLLEVF------RRKKKLHL 78 (292)
Q Consensus 7 ~~~l~~g~~~~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~e~~~~~~l~~~--~i~~~~~~~------~~~~~~~i 78 (292)
.+.|..|....+|++... +..+++|+.... . ...+..|..++..+... .+.+++... ..++..++
T Consensus 19 i~~i~~G~~n~~y~v~~~--~~~~vLr~~~~~--~---~~~~~~e~~~l~~L~~~g~~vp~~i~~~~g~~~~~~~~~~~~ 91 (296)
T cd05153 19 FEGISAGIENTNYFVTTD--SGRYVLTLFEKV--S---AEELPFFLALLDHLAERGLPVPRPIADRDGEYLSELAGKPAA 91 (296)
T ss_pred eecccCccccceEEEEeC--CCcEEEEEcCCC--C---hHhccHHHHHHHHHHHCCCCCCccccCCCCcEeeeeCCceEE
Confidence 455777877889987643 457899987641 1 23355577777776432 244544421 22456789
Q ss_pred EEecCCCccHHH-----H------hc----CCCCCC--------HHHHH------------HHHHHHHHHHHHHHh----
Q psy758 79 VFEFCDHTVLNE-----L------EN----HPHGLP--------WDLIK------------QITWQVLRGVSYCHR---- 119 (292)
Q Consensus 79 v~e~~~~~~L~~-----~------~~----~~~~~~--------~~~~~------------~i~~qi~~aL~~LH~---- 119 (292)
++++++|..+.. . +. ....+. ..... .....+..++.++.+
T Consensus 92 l~~~i~G~~~~~~~~~~~~~lg~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~l~~~~~~ 171 (296)
T cd05153 92 LVEFLAGEHLTRPTAAHCRQIGEALARLHLAAQSFPGERNNLRGLAWIRELGKDLLPLLSAEDRALLADELARQDAFDPS 171 (296)
T ss_pred EEEeCCCCCCCCCCHHHHHHHHHHHHHHHHHhccCCccCCCcCCcHHHHHHHHHhccccCHHHHHHHHHHHHHHHhhhhh
Confidence 999999865422 0 00 000000 00000 011112333444443
Q ss_pred ---CCccccCCCCCceEEccCCcEEEeecCchhh
Q psy758 120 ---HACIHRDIKPENILLTANGVVKLCDFGFARL 150 (292)
Q Consensus 120 ---~givH~dl~p~Nilv~~~~~~kl~dfg~~~~ 150 (292)
.+++|||+.|.||++++++.+.|+||+.+..
T Consensus 172 ~~~~~l~HgD~~~~Nil~~~~~~~~iIDfe~a~~ 205 (296)
T cd05153 172 DLPRGVIHADLFRDNVLFDGDELSGVIDFYFACT 205 (296)
T ss_pred cCCCcCCccCcCcccEEEeCCceEEEeehhhhcC
Confidence 4799999999999999987778999988754
|
Homoserine kinase is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This subfamily is composed of unusual homoserine kinases, from a subset of bacteria, which have a PK fold. These proteins do not bear any similarity to the GHMP family homoserine kinases present in most bacteria and eukaryotes. Homoserine kinase catalyzes the transfer of the gamma-phosphoryl group from ATP to L-homoserine producing L-homoserine phosphate, an intermediate in the production of the amino acids threonine, methionine, and isoleucine. |
| >cd05157 ETNK_euk Ethanolamine kinase (ETNK) in eukaryotes | Back alignment and domain information |
|---|
Probab=98.21 E-value=1.9e-05 Score=62.37 Aligned_cols=75 Identities=23% Similarity=0.339 Sum_probs=46.3
Q ss_pred eeeecccCceEEEEEEEcC-CCcEEEEEEeccCCCChHHHHHHHHHHHHHHhCCCCC-cchhhhhhhcCCeEEEEEecCC
Q psy758 7 IGKLGEGSYGVVFKCRNRD-TGQVVAIKKFLESEEDPLIRKIALREIRLLKSLKHPN-LVNLLEVFRRKKKLHLVFEFCD 84 (292)
Q Consensus 7 ~~~l~~g~~~~v~~~~~~~-~~~~v~iK~~~~~~~~~~~~~~~~~e~~~~~~l~~~~-i~~~~~~~~~~~~~~iv~e~~~ 84 (292)
++.|..|-...+|++.... .++.|++|+....... . -...+|..+++.+...+ .+++++... + .+++||++
T Consensus 3 i~~l~gG~tN~~~~v~~~~~~~~~~vlR~~~~~~~~--~-~d~~~E~~~~~~l~~~gl~P~v~~~~~-~---~~l~e~i~ 75 (235)
T cd05157 3 FKRFTGGITNKLVKVSNKEDNQDAVLVRVYGNKTEL--I-IDRERELRIHKLLSKHGLAPKLYATFQ-N---GLIYEFIP 75 (235)
T ss_pred EEEcCCcccceEEEEEcCCCCCCeEEEEEccCCccc--e-ecHHHHHHHHHHHHhCCCCCeEEEEeC-C---cEEEEeeC
Confidence 4567888888999986543 3568999976533211 0 11236888888875333 344444322 2 37999999
Q ss_pred CccH
Q psy758 85 HTVL 88 (292)
Q Consensus 85 ~~~L 88 (292)
|..+
T Consensus 76 G~~l 79 (235)
T cd05157 76 GRTL 79 (235)
T ss_pred CCcC
Confidence 8654
|
ETNK is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). ETNK catalyzes the transfer of the gamma-phosphoryl group from CTP to ethanolamine (Etn), the first step in the CDP-Etn pathway for the formation of the major phospholipid, phosphatidylethanolamine (PtdEtn). Unlike ChoK, ETNK shows specific activity for its substrate, and displays negligible activity towards N-methylated derivatives of Etn. The Drosophila ETNK is implicated in development and neuronal function. Mammals contain two ETNK proteins, ETNK1 and ETNK2. ETNK1 selectively increases Etn uptake and phosphorylation, as well as PtdEtn synthesis. ETNK2 is found primarily in the liver and reproductive tissues. It plays a critical role in regulating placental hemostasis to support late embryo |
| >TIGR02721 ycfN_thiK thiamine kinase | Back alignment and domain information |
|---|
Probab=98.15 E-value=1.1e-05 Score=64.68 Aligned_cols=134 Identities=20% Similarity=0.186 Sum_probs=75.6
Q ss_pred eecccCceEEEEEEEcCCCcEEEEEEeccCCCChHHHHHHHHHHHHHHhCCCCCc-chhhhhhhcCCeEEEEEecCCCcc
Q psy758 9 KLGEGSYGVVFKCRNRDTGQVVAIKKFLESEEDPLIRKIALREIRLLKSLKHPNL-VNLLEVFRRKKKLHLVFEFCDHTV 87 (292)
Q Consensus 9 ~l~~g~~~~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~e~~~~~~l~~~~i-~~~~~~~~~~~~~~iv~e~~~~~~ 87 (292)
.+..|-.+.+|+.. .+++.+++|........- .-...+|..+++.+...++ .+++... + -++|+||++|..
T Consensus 3 ~~~~G~tn~~y~~~--~~~~~~vlR~~~~~~~~~--~~~r~~E~~~l~~l~~~g~~P~~i~~~--~--~~~v~e~i~G~~ 74 (256)
T TIGR02721 3 TLSGGLTNRSWRIE--HPGISFVWRPQSPVCKAL--GVDRQREYQILQALSALGLAPKPILVN--E--HWLLVEWLEGEV 74 (256)
T ss_pred cCCCcCcCCeEEEE--eCCccEEEeeCCcccccc--cCcHHHHHHHHHHHHhcCCCCceEEEe--C--CEEEEEeccCcc
Confidence 45667788899886 346788899764332111 0113568888888864333 3333332 2 368999999866
Q ss_pred HHHH--------------h---cCC----CCCCH-HHHHHHHHHH---------HHHHHHHHh--------CCccccCCC
Q psy758 88 LNEL--------------E---NHP----HGLPW-DLIKQITWQV---------LRGVSYCHR--------HACIHRDIK 128 (292)
Q Consensus 88 L~~~--------------~---~~~----~~~~~-~~~~~i~~qi---------~~aL~~LH~--------~givH~dl~ 128 (292)
+... + ..- ..++. ..+..+..++ ...+..+-. ..++|+|+.
T Consensus 75 ~~~~~~~~~~~~~~la~~l~~lH~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~H~Dl~ 154 (256)
T TIGR02721 75 ITLDQFVALDLLLELAALLHQLHSQPRFGYPLSLKARIAHYWLQIDPARRTPEWLRLYKQFRSAPEPAPLPLAPLHMDVH 154 (256)
T ss_pred cccccccCchhHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHHhcccccCChHHHHHHHHHHhccCCCCCCCeeecCCCC
Confidence 5321 1 000 01111 1111211111 111222221 248999999
Q ss_pred CCceEEccCCcEEEeecCchhhh
Q psy758 129 PENILLTANGVVKLCDFGFARLI 151 (292)
Q Consensus 129 p~Nilv~~~~~~kl~dfg~~~~~ 151 (292)
|.||++++++ +.|+||..+...
T Consensus 155 ~~Nil~~~~~-~~lIDwE~a~~g 176 (256)
T TIGR02721 155 AYNLVVTPQG-LKLIDWEYASDG 176 (256)
T ss_pred cCcEEEeCCC-CEEEeccccCcC
Confidence 9999999887 789999888643
|
Members of this family are the ycfN gene product of Escherichia coli, now identified as the salvage enzyme thiamine kinase (thiK), and additional proteobacterial homologs taken to be orthologs with equivalent function. |
| >PRK05231 homoserine kinase; Provisional | Back alignment and domain information |
|---|
Probab=98.13 E-value=4.8e-05 Score=63.11 Aligned_cols=31 Identities=29% Similarity=0.469 Sum_probs=26.7
Q ss_pred CCccccCCCCCceEEccCCcEEEeecCchhh
Q psy758 120 HACIHRDIKPENILLTANGVVKLCDFGFARL 150 (292)
Q Consensus 120 ~givH~dl~p~Nilv~~~~~~kl~dfg~~~~ 150 (292)
.|++|||+.|.||+++++...-|+||+.+..
T Consensus 187 ~~liHgD~~~~Nil~~~~~~~~iIDf~~~~~ 217 (319)
T PRK05231 187 RGVIHADLFRDNVLFEGDRLSGFIDFYFACN 217 (319)
T ss_pred cccCCCCCCCCcEEEECCceEEEEecccccC
Confidence 4899999999999999776668999998753
|
|
| >PRK10593 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=98.13 E-value=6.1e-05 Score=61.62 Aligned_cols=76 Identities=13% Similarity=0.093 Sum_probs=53.1
Q ss_pred eeeecccCceEEEEEEEcCCCcEEEEEEeccCCCChHHHHHHHHHHHHHHhCCC---CCcchhhhhhhc---CCeEEEEE
Q psy758 7 IGKLGEGSYGVVFKCRNRDTGQVVAIKKFLESEEDPLIRKIALREIRLLKSLKH---PNLVNLLEVFRR---KKKLHLVF 80 (292)
Q Consensus 7 ~~~l~~g~~~~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~e~~~~~~l~~---~~i~~~~~~~~~---~~~~~iv~ 80 (292)
.+.|+.|..+.||...... + .+++|..+.... ...+..|...++.|.. -.+.++++++.+ .+..++||
T Consensus 19 ~~~i~~G~~~~vy~~~~~~-~-~~~~k~~~~~~~----~~~~~~Ea~~L~~L~~~~~vpVP~V~~~~~~~~~~g~~~LVm 92 (297)
T PRK10593 19 VECISEQPYAALWALYDSQ-G-NPMPLMARSFST----PGVAQQEAWKLSMLARSGTVRMPTVYGVMTHEQSPGPDVLLL 92 (297)
T ss_pred eeecCCccceeEEEEEcCC-C-CEEEEEeccccc----chHHHHHHHHHHHHccCCCCCcCcEEEEeccCCcCCCeEEEE
Confidence 5679999999999986542 3 467777533111 2456788888888853 357777876543 46789999
Q ss_pred ecCCCccH
Q psy758 81 EFCDHTVL 88 (292)
Q Consensus 81 e~~~~~~L 88 (292)
|+++|+.+
T Consensus 93 E~i~G~~~ 100 (297)
T PRK10593 93 ERLRGVSV 100 (297)
T ss_pred eccCCEec
Confidence 99998654
|
|
| >TIGR00938 thrB_alt homoserine kinase, Neisseria type | Back alignment and domain information |
|---|
Probab=98.11 E-value=7.9e-05 Score=61.43 Aligned_cols=138 Identities=15% Similarity=0.154 Sum_probs=78.5
Q ss_pred eeeecccCceEEEEEEEcCCCcEEEEEEeccCCCChHHHHHHHHHHHHHHhCCCCC--cchhhhhh------hcCCeEEE
Q psy758 7 IGKLGEGSYGVVFKCRNRDTGQVVAIKKFLESEEDPLIRKIALREIRLLKSLKHPN--LVNLLEVF------RRKKKLHL 78 (292)
Q Consensus 7 ~~~l~~g~~~~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~e~~~~~~l~~~~--i~~~~~~~------~~~~~~~i 78 (292)
.+.++.|....+|++... +..+++|+....... +.+..|..++..|...+ +.+++... ...+..++
T Consensus 27 i~~~~~G~~n~~y~v~t~--~~~~vLK~~~~~~~~----~~i~~e~~~l~~L~~~g~pvp~~i~t~~g~~~~~~~g~~~~ 100 (307)
T TIGR00938 27 LKGIAEGVENSNYLLTTD--VGRYILTLYEKRVKA----EELPFFLALTTHLAARGLPVPKPVKSRDGRQLSTLAGKPAC 100 (307)
T ss_pred ccccCCccccceEEEEeC--CCcEEEEEecCCCCH----HHHHHHHHHHHHHHHCCCCCCccccCCCCCeehhcCCeEEE
Confidence 455677777889988643 446888976542211 22345566666664222 34444321 12466889
Q ss_pred EEecCCCccHH-----------HHhc---C-CCCCC-------HHHHHH----------------HHHHHHHHHHHHHh-
Q psy758 79 VFEFCDHTVLN-----------ELEN---H-PHGLP-------WDLIKQ----------------ITWQVLRGVSYCHR- 119 (292)
Q Consensus 79 v~e~~~~~~L~-----------~~~~---~-~~~~~-------~~~~~~----------------i~~qi~~aL~~LH~- 119 (292)
++++++|..+. ..+. . ...++ ....|. ....+...++++..
T Consensus 101 l~e~i~G~~~~~~~~~~~~~~G~~LA~lH~~~~~~~~~~~~~~~~~~w~~~~~~~~~~~~~l~~~~~~~l~~~~~~l~~~ 180 (307)
T TIGR00938 101 LVEFLQGLSVGRPTAMHCRPVGEVLAWMHLAGAHFPENRKNSLRLEAWHILAEKCFEAAPQLEAHMGAELDKELDYLDKF 180 (307)
T ss_pred EEEeCCCCCCCCCCHHHHHHHHHHHHHHHhhhccCCCCCCCCCChHHHHHHHHhhhhcccccCHHHHHHHHHHHHHHHhh
Confidence 99999885431 0010 0 00000 001110 01122334544532
Q ss_pred ------CCccccCCCCCceEEccCCcEEEeecCchhh
Q psy758 120 ------HACIHRDIKPENILLTANGVVKLCDFGFARL 150 (292)
Q Consensus 120 ------~givH~dl~p~Nilv~~~~~~kl~dfg~~~~ 150 (292)
.+++|||+++.||++++++...|+||+.+..
T Consensus 181 ~~~~~~~~l~HgD~~~~Nvl~~~~~~~~vIDfd~~~~ 217 (307)
T TIGR00938 181 WPRDLPRGVIHADLFPDNVLFDGDSVKGVIDFYFACT 217 (307)
T ss_pred hhhcCCCccCCCCCCcCcEEEECCceEEEeecccccC
Confidence 6899999999999999988778999998753
|
Homoserine kinase is required in the biosynthesis of threonine from aspartate.The member of this family from Pseudomonas aeruginosa was shown by direct assay and complementation to act specifically as a homoserine kinase. |
| >COG3173 Predicted aminoglycoside phosphotransferase [General function prediction only] | Back alignment and domain information |
|---|
Probab=98.11 E-value=5.6e-05 Score=61.63 Aligned_cols=140 Identities=15% Similarity=0.169 Sum_probs=91.4
Q ss_pred eeeeecccCceEEEEEEEcCCCcEEEEEEeccCCCChHHHHHHHHHHHHHHhCCC--CCcchhhhhhhcCC--eEEEEEe
Q psy758 6 KIGKLGEGSYGVVFKCRNRDTGQVVAIKKFLESEEDPLIRKIALREIRLLKSLKH--PNLVNLLEVFRRKK--KLHLVFE 81 (292)
Q Consensus 6 ~~~~l~~g~~~~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~e~~~~~~l~~--~~i~~~~~~~~~~~--~~~iv~e 81 (292)
+++....|....+|..... ++.++++ .+.............+|..+++.+.- -.+...++.+.++. ..|.||+
T Consensus 29 ~v~~~~~G~sn~t~~~~~~--~~~~vlR-~P~~~~~~~~~~~~~re~~~i~~l~~~~vP~p~~~~~~~~~~~g~pf~v~~ 105 (321)
T COG3173 29 IVEEISGGWSNDTFRLGDT--GQKYVLR-KPPRGDPVESAHDEKREYRVIAALLDVDVPVPRAFGLCGEGYLGTPFYVME 105 (321)
T ss_pred eeeeccCCcccceEEEecC--CceEEEe-cCCccccchhhhHHHhHHHHHHHhcCCCCCCcccccccccCCCCCceEEEE
Confidence 4455555555556666554 7788888 44333333344556678888888753 34455666666554 7899999
Q ss_pred cCCCccHHHHhcCCCCCCHHHHHHHH-HHHHHHHHHHHh-----------------------------------------
Q psy758 82 FCDHTVLNELENHPHGLPWDLIKQIT-WQVLRGVSYCHR----------------------------------------- 119 (292)
Q Consensus 82 ~~~~~~L~~~~~~~~~~~~~~~~~i~-~qi~~aL~~LH~----------------------------------------- 119 (292)
++.|..+....... ..+ ..++ ..++..|+.||+
T Consensus 106 ~veGe~~~~~~~~~-~~~----~~~~~~~l~~~La~LH~ida~~~~~~g~~~~~~~rql~~~~~~~~~~~~~~~~~~p~~ 180 (321)
T COG3173 106 WVEGEVVWSALPPE-SLG----RQFALDALADFLAELHSIDAAGLPDPGKPNAYRGRQLARWDDEYRRAKKELGGRIPLA 180 (321)
T ss_pred EecceeccCcCCcc-cch----HHHHHHHHHHHHHHHhCCCCcCCCCCCccCccccchhhHHHHHHHHHHHhccCCCchH
Confidence 99997554443221 111 1222 356666666663
Q ss_pred -----------------CCccccCCCCCceEEccCCcEEEeecCchhhhhc
Q psy758 120 -----------------HACIHRDIKPENILLTANGVVKLCDFGFARLIRD 153 (292)
Q Consensus 120 -----------------~givH~dl~p~Nilv~~~~~~kl~dfg~~~~~~~ 153 (292)
..++|||+++.|+++++++-+=+.||+.+....+
T Consensus 181 ~~~~~Wl~~~~p~~~~~~~lvHGD~~~gNlii~~~~~~gVlDwe~~~lGDP 231 (321)
T COG3173 181 DRLIKWLEANRPPWAGPPVLVHGDYRPGNLIIDPGRPTGVLDWELATLGDP 231 (321)
T ss_pred HHHHHHHHhcCCCcCCCceeeeCCcccCCEEEeCCCeeEEEeccccccCCc
Confidence 2489999999999999998899999999876543
|
|
| >PRK09550 mtnK methylthioribose kinase; Reviewed | Back alignment and domain information |
|---|
Probab=98.06 E-value=0.00011 Score=62.13 Aligned_cols=78 Identities=21% Similarity=0.265 Sum_probs=52.7
Q ss_pred eeeecccCceEEEEEEEcCCCcEEEEEEeccCCC---C--hHHHHHHHHHHHHHHhCC---CCCcchhhhhhhcCCeEEE
Q psy758 7 IGKLGEGSYGVVFKCRNRDTGQVVAIKKFLESEE---D--PLIRKIALREIRLLKSLK---HPNLVNLLEVFRRKKKLHL 78 (292)
Q Consensus 7 ~~~l~~g~~~~v~~~~~~~~~~~v~iK~~~~~~~---~--~~~~~~~~~e~~~~~~l~---~~~i~~~~~~~~~~~~~~i 78 (292)
.+.||.|....||++.....++.|++|.-..... . ....+....|.+.++.+. ..++++++.+ +++..++
T Consensus 31 ~~elggGn~N~VyrV~~~~g~~svIVKqa~p~~r~~g~~wpl~~eR~~~Eae~L~~l~~~~p~~VPkV~~~--D~~~~~l 108 (401)
T PRK09550 31 AREIGDGNLNLVFRVSDTEGGKSVIVKQALPYVRVVGESWPLTLDRARIEAEALKIQAKYVPDLVPKVYHY--DEELAVT 108 (401)
T ss_pred eeEcCCCceEEEEEEEeCCCCeEEEEEecCcccccccccccccHHHHHHHHHHHHHHHhhCCCCCCeEEEE--CCCCCEE
Confidence 4679999999999999864335899997431110 0 122345666778887763 2456777766 4466789
Q ss_pred EEecCCCc
Q psy758 79 VFEFCDHT 86 (292)
Q Consensus 79 v~e~~~~~ 86 (292)
|||++++.
T Consensus 109 VME~L~~~ 116 (401)
T PRK09550 109 VMEDLSDH 116 (401)
T ss_pred EEecCCCc
Confidence 99998863
|
|
| >PF13095 FTA2: Kinetochore Sim4 complex subunit FTA2 | Back alignment and domain information |
|---|
Probab=97.93 E-value=0.00014 Score=55.02 Aligned_cols=127 Identities=28% Similarity=0.306 Sum_probs=83.7
Q ss_pred cccceeeeecccCc-eEEEEEEEcCCCcEEEEEEecc---CCC-------C---------hHHHHHHHHHHHHHHhCC--
Q psy758 2 ERYEKIGKLGEGSY-GVVFKCRNRDTGQVVAIKKFLE---SEE-------D---------PLIRKIALREIRLLKSLK-- 59 (292)
Q Consensus 2 ~~y~~~~~l~~g~~-~~v~~~~~~~~~~~v~iK~~~~---~~~-------~---------~~~~~~~~~e~~~~~~l~-- 59 (292)
..++..+.||.|.- |.||++... |+.||+|.+.. ... . ....+-|..|-+..-+|+
T Consensus 37 ~~I~flefLg~g~~~~~V~kv~I~--g~~YALKlf~~~~~~~~~~~~~~~~~~~~~~~~~~~y~~PF~~ECRAfgRLke~ 114 (207)
T PF13095_consen 37 DDIEFLEFLGHGSHDGYVFKVEID--GRIYALKLFRFWDYTEPDYTRERFAGHETSLSTPAHYADPFNCECRAFGRLKEA 114 (207)
T ss_pred CcEeeeeecCCCCceeEEEEEEEC--CeEEEEEEeeccccCCCccccccccccccccchhhhhcChHHHHHHhhHHHHhc
Confidence 35778899999999 999999876 78999999321 110 0 022334566666666654
Q ss_pred -CCCc--chhhhhhh-c-----------------CCeEEEEEecCCCccHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHH
Q psy758 60 -HPNL--VNLLEVFR-R-----------------KKKLHLVFEFCDHTVLNELENHPHGLPWDLIKQITWQVLRGVSYCH 118 (292)
Q Consensus 60 -~~~i--~~~~~~~~-~-----------------~~~~~iv~e~~~~~~L~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH 118 (292)
+.++ ++.+|+.. + .-..-||.|+.+... .++ ..-+.+|.+-+..+|
T Consensus 115 ~~e~~~Avkc~Gyl~L~~~~q~~~~~~~~~~~~~~~~~aIVKD~v~~~~---------~~~----~~~~~~~~~dl~~~~ 181 (207)
T PF13095_consen 115 GREGLWAVKCHGYLLLTEDQQFEQLRQRGSDHRPLPIRAIVKDFVPDDP---------PLQ----IRDIPQMLRDLKILH 181 (207)
T ss_pred cccCceEEEeeEEEEEchHHHHHHhhcccccCCCCccEEEEEeecCCcc---------ccc----hhHHHHHHHHHHHHH
Confidence 4445 77777651 1 001345666655432 123 344566777788899
Q ss_pred hCCccccCCCCCceEEccCCcEEEeecCch
Q psy758 119 RHACIHRDIKPENILLTANGVVKLCDFGFA 148 (292)
Q Consensus 119 ~~givH~dl~p~Nilv~~~~~~kl~dfg~~ 148 (292)
..||+-+|+++.|.. + -+|+|||.+
T Consensus 182 k~gI~~~Dv~~~ny~---~--G~lvDfs~~ 206 (207)
T PF13095_consen 182 KLGIVPRDVKPRNYR---G--GKLVDFSSS 206 (207)
T ss_pred HCCeeeccCcccccc---C--CEEEecccC
Confidence 999999999999986 2 378899864
|
|
| >KOG2268|consensus | Back alignment and domain information |
|---|
Probab=97.92 E-value=1.2e-05 Score=64.62 Aligned_cols=136 Identities=16% Similarity=0.196 Sum_probs=93.8
Q ss_pred cceeeeecccCceEEEEEEEcCCCcEEEEEEeccCCCCh--------------------HHHHHHHHHHHHHHhCCC--C
Q psy758 4 YEKIGKLGEGSYGVVFKCRNRDTGQVVAIKKFLESEEDP--------------------LIRKIALREIRLLKSLKH--P 61 (292)
Q Consensus 4 y~~~~~l~~g~~~~v~~~~~~~~~~~v~iK~~~~~~~~~--------------------~~~~~~~~e~~~~~~l~~--~ 61 (292)
+.++..||-|.-+.||.+-+.. |.+.++|.-.....+- -..-...+|...++.|.. =
T Consensus 94 ~svGnqIGVGKESDIY~v~d~~-G~~~~lK~HRLGRtSFR~Vk~kRDY~r~r~~~sWlyLSRlaa~kEfafmkaL~e~gf 172 (465)
T KOG2268|consen 94 ESVGNQIGVGKESDIYVVADEE-GNPLILKLHRLGRTSFRNVKNKRDYLRKRKSGSWLYLSRLAATKEFAFMKALYERGF 172 (465)
T ss_pred hhhccccccccccceEEEecCC-CCchhHHHHhhhhhhHHHhhhhhhhHhcCCccchhhhHHHHHHHHHHHHHHHHHcCC
Confidence 4567889999999999998865 8888888432211110 011223456666666642 1
Q ss_pred CcchhhhhhhcCCeEEEEEecCCCccHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEEccCCcEE
Q psy758 62 NLVNLLEVFRRKKKLHLVFEFCDHTVLNELENHPHGLPWDLIKQITWQVLRGVSYCHRHACIHRDIKPENILLTANGVVK 141 (292)
Q Consensus 62 ~i~~~~~~~~~~~~~~iv~e~~~~~~L~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~givH~dl~p~Nilv~~~~~~k 141 (292)
.+++.+ +.+..++|||++.|-.|.....- ..+..+...+..-+..|.++|++|||.+-=||++++++.++
T Consensus 173 pVPkpi----D~~RH~Vvmelv~g~Pl~~v~~v------~d~~~ly~~lm~~Iv~la~~GlIHgDFNEFNimv~dd~~i~ 242 (465)
T KOG2268|consen 173 PVPKPI----DHNRHCVVMELVDGYPLRQVRHV------EDPPTLYDDLMGLIVRLANHGLIHGDFNEFNIMVKDDDKIV 242 (465)
T ss_pred CCCCcc----cccceeeHHHhhcccceeeeeec------CChHHHHHHHHHHHHHHHHcCceecccchheeEEecCCCEE
Confidence 233333 34678999999998766554321 22345666677777888999999999999999999999999
Q ss_pred EeecCchhh
Q psy758 142 LCDFGFARL 150 (292)
Q Consensus 142 l~dfg~~~~ 150 (292)
++||--...
T Consensus 243 vIDFPQmvS 251 (465)
T KOG2268|consen 243 VIDFPQMVS 251 (465)
T ss_pred EeechHhhc
Confidence 999965543
|
|
| >cd05156 ChoK_euk Choline Kinase (ChoK) in eukaryotes | Back alignment and domain information |
|---|
Probab=97.85 E-value=0.00014 Score=59.75 Aligned_cols=76 Identities=24% Similarity=0.281 Sum_probs=46.1
Q ss_pred eeeecccCceEEEEEEEcC------CCcEEEEEEeccCCCChHHHHHHHHHHHHHHhCCCCCc-chhhhhhhcCCeEEEE
Q psy758 7 IGKLGEGSYGVVFKCRNRD------TGQVVAIKKFLESEEDPLIRKIALREIRLLKSLKHPNL-VNLLEVFRRKKKLHLV 79 (292)
Q Consensus 7 ~~~l~~g~~~~v~~~~~~~------~~~~v~iK~~~~~~~~~~~~~~~~~e~~~~~~l~~~~i-~~~~~~~~~~~~~~iv 79 (292)
++.|..|-...+|++.... +++.+++|+....... .....+|..+++.+...++ .++++.+. + ..|
T Consensus 3 i~~l~gGltN~~y~v~~~~~~~~~~~~~~~vlRi~~~~~~~---~~~r~~E~~~~~~l~~~g~~P~~~~~~~-~---~~v 75 (302)
T cd05156 3 VSKISGGLTNAVYKVSLPDEDALSDEPRKVLLRVYGQSVEL---LIDRERELVVFARLSERNLGPKLYGIFP-N---GRI 75 (302)
T ss_pred EEEecCcccceeEEEEcCCcccccCCCCeEEEEEecCCCcc---eechHHHHHHHHHHHhCCCCCceEEEeC-C---Cch
Confidence 4567777788899887543 2578999986543211 1224567777777753333 34444443 2 257
Q ss_pred EecCCCccHH
Q psy758 80 FEFCDHTVLN 89 (292)
Q Consensus 80 ~e~~~~~~L~ 89 (292)
+|+++|..+.
T Consensus 76 ~e~i~G~~l~ 85 (302)
T cd05156 76 EEFIPSRTLT 85 (302)
T ss_pred hheeCCCcCC
Confidence 8888876543
|
The ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). It is composed of bacterial and eukaryotic choline kinases, as well as eukaryotic ethanolamine kinase. ChoK catalyzes the transfer of the gamma-phosphoryl group from ATP (or CTP) to its substrate, choline, producing phosphorylcholine (PCho), a precursor to the biosynthesis of two major membrane phospholipids, phosphatidylcholine (PC) and sphingomyelin (SM). Although choline is the preferred substrate, ChoK also shows substantial activity towards ethanolamine and its N-methylated derivatives. ChoK plays an important role in cell signaling pathways and the regulation of cell growth. Along with PCho, it is involved in malignant transformation through Ras oncogenes in various human cancer |
| >KOG0576|consensus | Back alignment and domain information |
|---|
Probab=97.82 E-value=6.7e-06 Score=71.49 Aligned_cols=231 Identities=17% Similarity=0.122 Sum_probs=136.7
Q ss_pred eeeeecccCceEEEEEEEcCCCcEEEEEEeccCCCChHHHHHHHHHHHHHHhCCCCC-cchhhhhhhcCCeEEEEEecCC
Q psy758 6 KIGKLGEGSYGVVFKCRNRDTGQVVAIKKFLESEEDPLIRKIALREIRLLKSLKHPN-LVNLLEVFRRKKKLHLVFEFCD 84 (292)
Q Consensus 6 ~~~~l~~g~~~~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~e~~~~~~l~~~~-i~~~~~~~~~~~~~~iv~e~~~ 84 (292)
.....++++++++++.+...+...+ .+.+... ....-+++++.+++||| .+..++.++.+...++.++++.
T Consensus 246 ~fh~fvK~altknpKkRptaeklL~-h~fvs~~-------l~~rl~~eLLdK~n~P~~~v~~~~d~~~E~~~~i~~~i~s 317 (829)
T KOG0576|consen 246 FFHNFVKGALTKNPKKRPTAEKLLQ-HPFVSQT-------LSRRLAIELLDKVNNPNPVVRYLEDYDGEDYLWIPMRICS 317 (829)
T ss_pred HHHHHHHHHhcCCCccCCChhhhee-ceeeccc-------hhhHHHHHHHHHccCCCCcccccccCCcccccchhhhhhc
Confidence 3445667888888887776544444 5544333 33456899999999999 7777777888889999999999
Q ss_pred Cc--cHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEEccCCcEEEeecCchhhhhcccccccccc
Q psy758 85 HT--VLNELENHPHGLPWDLIKQITWQVLRGVSYCHRHACIHRDIKPENILLTANGVVKLCDFGFARLIRDLIPRHLHIF 162 (292)
Q Consensus 85 ~~--~L~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~givH~dl~p~Nilv~~~~~~kl~dfg~~~~~~~~~~~~~~~~ 162 (292)
++ .........-.+.+-+...++..-+.+|+++|+.--+|+| ||+..+ +..+..+|+....+.... ......
T Consensus 318 ~~rs~~~~~~~se~~~~~~~~~~~~r~et~~l~~l~~~~~~~~d----~~l~s~-~~~~~~~~~v~~~L~~~~-~~~t~~ 391 (829)
T KOG0576|consen 318 TGRSSALEMTVSEIALEQYQFAYPLRKETRPLAELHSSYKVHRD----NILGSE-EEVKLLDFAVPPQLTRTM-KPRTAI 391 (829)
T ss_pred CCccccccCChhhHhhhhhhhhhhhhhhcccccccccccccCcc----cccccc-cccccccccCCcccCccc-ccccCC
Confidence 87 2222222222355555667777788899999999888888 766655 578889998877665432 223334
Q ss_pred ccccccccCCC----------CCCCcccceeeecCCCCCCchHHHHHHHhhcccCCCCCCChhhhhhccCcCCCCCCCCC
Q psy758 163 QTNEYFKGVSL----------PHAENVVPLEIKIGKPAATNIYLIDFLKRCLDKDPLRRWSCDQLLRHPYFNGYYFEVPD 232 (292)
Q Consensus 163 ~~~~~~~~~~~----------~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~ 232 (292)
.++++..+... .|+.+..+..+.-+.++-...... ...+...++...+..+.. -.
T Consensus 392 ~~~~~~~pev~~~~~~~~~p~~~~~~~~~~~~ap~~pPr~~P~~~-------~~~~g~~p~s~~L~~~~a--------w~ 456 (829)
T KOG0576|consen 392 GTPEPLAPEVIQENTIDGCPDSGSLAVSAIQMAPGLPPRSSPPAV-------LPMIGNGPNSPMLTDKSA--------WS 456 (829)
T ss_pred CCCCCCCchhhcccccccCCCccCCCcchhhcCCCCCCCCCCccc-------cCCCCCCCCccccchhhh--------cC
Confidence 55555554422 222222111222222221110000 000000010011111000 00
Q ss_pred ccchHHHHhcccCcCCCCCCChhhhhhCCcccc
Q psy758 233 EMQYEEITQRCLDKDPLRRWSCDQLLRHPYFNG 265 (292)
Q Consensus 233 ~~~l~~li~~~l~~dP~~Rpt~~~il~h~w~~~ 265 (292)
+..-+++...|+..-|.-|+....++-|.+|++
T Consensus 457 ~~~~~~~~~~~~~g~P~~pkv~mgacfsKvfng 489 (829)
T KOG0576|consen 457 PVFHRDFPAPCLNGLPPTPKVHMGACFSKVFNG 489 (829)
T ss_pred cccccCCcccccCCCCCCCcchhhHHHHHHhcc
Confidence 111125778899999999999999999999998
|
|
| >KOG1035|consensus | Back alignment and domain information |
|---|
Probab=97.81 E-value=7.4e-05 Score=69.46 Aligned_cols=205 Identities=17% Similarity=0.223 Sum_probs=117.6
Q ss_pred HHHHHHHHHHHHhCCCCCcchhhhhhhcCC----eEEEEEecCCCccHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhC
Q psy758 45 RKIALREIRLLKSLKHPNLVNLLEVFRRKK----KLHLVFEFCDHTVLNELENHPHGLPWDLIKQITWQVLRGVSYCHRH 120 (292)
Q Consensus 45 ~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~----~~~iv~e~~~~~~L~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~ 120 (292)
.....-|...+....|+|+..++.+-.... ...+..++|++..+...+..-..++..+.+.+..++.+||+++|+.
T Consensus 226 i~~~E~e~~~l~k~~~~n~~~~~~~~le~~~~g~~~~v~~~~~s~~~~~~~~q~v~~i~~~~~r~~~~~~~~GL~~~h~~ 305 (1351)
T KOG1035|consen 226 IQTTEIELESLSKIAHDNLGGYFVYGLERLFRGIVLDVLQEICSKVELRSLLQSVGSIPLETLRILHQKLLEGLAYLHSL 305 (1351)
T ss_pred HHHHHHHHHHHHhhccccccceeEEeehhhcchHHHHHHHhhcCccchHHHHhhccccCHHHHHHHHHHHhhhHHHHHHh
Confidence 344455777778889999999987754322 2335568899988888888878899999999999999999999999
Q ss_pred CccccCCCCC---ceEEccCCcEEEe--ecCchhhhhccccccccccccccccccCCCCCCCcccceeeecCCCCCCchH
Q psy758 121 ACIHRDIKPE---NILLTANGVVKLC--DFGFARLIRDLIPRHLHIFQTNEYFKGVSLPHAENVVPLEIKIGKPAATNIY 195 (292)
Q Consensus 121 givH~dl~p~---Nilv~~~~~~kl~--dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 195 (292)
...|.-+..+ +.-++..+...++ ||+.+..+......... ..+..+............. ....+.+..
T Consensus 306 ~l~~v~L~~s~~~~~~~~~e~~~~~sl~~~~ss~~l~d~~~~~~~-~~~~~~~~~e~~~~~~~~~------~r~~dL~~l 378 (1351)
T KOG1035|consen 306 SLEHVVLSASSSKESTVDGEGVVAISLSDFDSSKPLPDNEKSFSD-LLAEIRNADEDLKENTAKK------SRLTDLWCL 378 (1351)
T ss_pred ccceeEEecccccccccCccceeecchhhhcccccCCCcccchhh-cCccccccccccccccchh------hhhhHHHHH
Confidence 6666655555 4444555566555 77776655432211111 1111111111110000000 000000111
Q ss_pred HHHHHHhhcccCCCCCCChhhhhhccCcCCCCCCCCCccchHHHHhcccCcCCCCCCChhhhhhCCcccc
Q psy758 196 LIDFLKRCLDKDPLRRWSCDQLLRHPYFNGYYFEVPDEMQYEEITQRCLDKDPLRRWSCDQLLRHPYFNG 265 (292)
Q Consensus 196 ~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~~il~h~w~~~ 265 (292)
....+............ .....+... .......+...+|+.-++++|+++.+++.|+|+.-
T Consensus 379 gll~~~~~~~~~i~~~~----~~~~~~l~~-----~~~~~~~d~~~~~~~~~~~~Rl~~~~ll~~~f~~~ 439 (1351)
T KOG1035|consen 379 GLLLLQLSQGEDISEKS----AVPVSLLDV-----LSTSELLDALPKCLDEDSEERLSALELLTHPFLRF 439 (1351)
T ss_pred HHHHhhhhhcCcccccc----cchhhhhcc-----ccchhhhhhhhhhcchhhhhccchhhhhhchhccc
Confidence 11111111111111111 111111111 01115778899999999999999999999999985
|
|
| >KOG2270|consensus | Back alignment and domain information |
|---|
Probab=97.75 E-value=0.00045 Score=56.91 Aligned_cols=141 Identities=20% Similarity=0.214 Sum_probs=92.0
Q ss_pred eeeeecccCceEEEEEEEcCCCcEEEEEEeccCCCC-----------------------h-HHHHHHHHHHHHHHhCCCC
Q psy758 6 KIGKLGEGSYGVVFKCRNRDTGQVVAIKKFLESEED-----------------------P-LIRKIALREIRLLKSLKHP 61 (292)
Q Consensus 6 ~~~~l~~g~~~~v~~~~~~~~~~~v~iK~~~~~~~~-----------------------~-~~~~~~~~e~~~~~~l~~~ 61 (292)
+-++|+.|.-+.||.|... +|..+|||++..+... . ...-....|++-+.++...
T Consensus 148 inGCiSTGKEANVYHat~~-dG~~~AIKIYKTSILvFKDRdRYV~GEfRFRhgyck~NPRKMVk~WAEKE~RNLkRl~~a 226 (520)
T KOG2270|consen 148 INGCISTGKEANVYHATEE-DGSEFAIKIYKTSILVFKDRDRYVSGEFRFRHGYCKHNPRKMVKTWAEKEMRNLKRLNNA 226 (520)
T ss_pred cccccccCccceeEeeecC-CCceEEEEEEeeeEEEEechhhhccceeeeecccccCCcHHHHHHHHHHHHHHHHHHHhc
Confidence 4567888999999998764 5888999988533210 0 1111223455555555433
Q ss_pred CcchhhhhhhcCCeEEEEEecCCCccHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHh-CCccccCCCCCceEEccCCcE
Q psy758 62 NLVNLLEVFRRKKKLHLVFEFCDHTVLNELENHPHGLPWDLIKQITWQVLRGVSYCHR-HACIHRDIKPENILLTANGVV 140 (292)
Q Consensus 62 ~i~~~~~~~~~~~~~~iv~e~~~~~~L~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~-~givH~dl~p~Nilv~~~~~~ 140 (292)
+|.-.--+. -....+||+++++.......-..-.++...+..+-.|++.-+.-|-+ .++||.||+--|+|+- +|.+
T Consensus 227 GIP~PePIl--Lk~hVLVM~FlGrdgw~aPkLKd~~ls~~ka~~~Y~~~v~~MR~lY~~c~LVHADLSEfN~Lyh-dG~l 303 (520)
T KOG2270|consen 227 GIPCPEPIL--LKNHVLVMEFLGRDGWAAPKLKDASLSTSKARELYQQCVRIMRRLYQKCRLVHADLSEFNLLYH-DGKL 303 (520)
T ss_pred CCCCCCcee--eecceEeeeeccCCCCcCcccccccCChHHHHHHHHHHHHHHHHHHHHhceeccchhhhhheEE-CCEE
Confidence 332111000 12346899999865444433333468888888888888888877754 6899999999999985 4588
Q ss_pred EEeecCchhh
Q psy758 141 KLCDFGFARL 150 (292)
Q Consensus 141 kl~dfg~~~~ 150 (292)
.++|.+-+..
T Consensus 304 yiIDVSQSVE 313 (520)
T KOG2270|consen 304 YIIDVSQSVE 313 (520)
T ss_pred EEEEcccccc
Confidence 8999876643
|
|
| >PLN02756 S-methyl-5-thioribose kinase | Back alignment and domain information |
|---|
Probab=97.67 E-value=0.0013 Score=55.59 Aligned_cols=83 Identities=17% Similarity=0.233 Sum_probs=51.9
Q ss_pred eeeeecccCceEEEEEEEcCCCcEEEEEEeccCCC--C---hHHHHHHHHHHHHHHhCC---CCCcchhhhhhhcCCeEE
Q psy758 6 KIGKLGEGSYGVVFKCRNRDTGQVVAIKKFLESEE--D---PLIRKIALREIRLLKSLK---HPNLVNLLEVFRRKKKLH 77 (292)
Q Consensus 6 ~~~~l~~g~~~~v~~~~~~~~~~~v~iK~~~~~~~--~---~~~~~~~~~e~~~~~~l~---~~~i~~~~~~~~~~~~~~ 77 (292)
..+.||.|....||++.+. +..++||.-..... . .........|...++.+. ..++++++.+.. +..+
T Consensus 36 ~~~eiggGn~N~VyrV~~~--~~svVVKqa~p~~r~vga~wpl~~~R~~~Ea~aL~~~~~~~p~~VPkVy~~de--d~~v 111 (418)
T PLN02756 36 KIKEVGDGNLNFVYIVVSS--SGSFVIKQALPYIRCIGESWPMTKERAYFEATALREHGRLCPDHVPEVYHFDR--TMAL 111 (418)
T ss_pred eEEEcCCCceeeEEEEEcC--CccEEEEeCCccccCCCccccCCccHHHHHHHHHHHhhhcCCCCCCeEEEECC--CCCE
Confidence 3567899999999998873 55799997541110 0 012233344566666553 246777887765 4467
Q ss_pred EEEecCCC--ccHHHHh
Q psy758 78 LVFEFCDH--TVLNELE 92 (292)
Q Consensus 78 iv~e~~~~--~~L~~~~ 92 (292)
++||++++ ..+..-+
T Consensus 112 lvME~L~~~~~ilr~~L 128 (418)
T PLN02756 112 IGMRYLEPPHIILRKGL 128 (418)
T ss_pred EEEeecCCcceehhhhh
Confidence 78999977 3455544
|
|
| >TIGR01767 MTRK 5-methylthioribose kinase | Back alignment and domain information |
|---|
Probab=97.67 E-value=0.00048 Score=57.13 Aligned_cols=83 Identities=19% Similarity=0.226 Sum_probs=50.9
Q ss_pred eeecccCceEEEEEEEcCCCcEEEEEEec----c-CCCChHHHHHHHHHHHHHHhCC--CC-CcchhhhhhhcCCeEEEE
Q psy758 8 GKLGEGSYGVVFKCRNRDTGQVVAIKKFL----E-SEEDPLIRKIALREIRLLKSLK--HP-NLVNLLEVFRRKKKLHLV 79 (292)
Q Consensus 8 ~~l~~g~~~~v~~~~~~~~~~~v~iK~~~----~-~~~~~~~~~~~~~e~~~~~~l~--~~-~i~~~~~~~~~~~~~~iv 79 (292)
+.||.|...-||++.....++.|+||.-. . ...-.-..++...|...++... .| .++++|.+ ++....+|
T Consensus 1 ~EigdGnlN~VfrV~~~~g~~svIVKQAlp~vRv~g~~wpl~~~R~~~E~~~L~~~~~~~P~~vP~vy~~--D~e~~~~v 78 (370)
T TIGR01767 1 QEVGDGNLNLVFHVYDQEGDRAAIVKQALPYVRVVGESWPLTLDRARIESSALIRQGEHVPHLVPRIFHF--DTEMAVTV 78 (370)
T ss_pred CcCCCCceEEEEEEEcCCCCeeEEEEEcCHHHhhcCCCCCCCccHHHHHHHHHHHhhccCccccCeEEEE--ccccceeh
Confidence 35899999999999975433689999532 1 1111222344456777777664 34 45555543 55667799
Q ss_pred EecCCC-ccHHHHh
Q psy758 80 FEFCDH-TVLNELE 92 (292)
Q Consensus 80 ~e~~~~-~~L~~~~ 92 (292)
||+++. ..+...+
T Consensus 79 MEdL~~~~ilR~~L 92 (370)
T TIGR01767 79 MEDLSHHKIARKGL 92 (370)
T ss_pred HhhCccchHHHHHH
Confidence 999864 3343443
|
This enzyme is involved in the methionine salvage pathway in certain bacteria. |
| >PRK12396 5-methylribose kinase; Reviewed | Back alignment and domain information |
|---|
Probab=97.58 E-value=0.00037 Score=58.50 Aligned_cols=84 Identities=19% Similarity=0.156 Sum_probs=53.0
Q ss_pred eeeecccCceEEEEEEEcCCCcEEEEEEec----cCCCChHHHHHHHHHHHHHHhCC--CC-CcchhhhhhhcCCeEEEE
Q psy758 7 IGKLGEGSYGVVFKCRNRDTGQVVAIKKFL----ESEEDPLIRKIALREIRLLKSLK--HP-NLVNLLEVFRRKKKLHLV 79 (292)
Q Consensus 7 ~~~l~~g~~~~v~~~~~~~~~~~v~iK~~~----~~~~~~~~~~~~~~e~~~~~~l~--~~-~i~~~~~~~~~~~~~~iv 79 (292)
.+.||.|...-||++.+...++.|+||.-. ....-.-..++...|.+.++.+. .| +++++|.+ ++....+|
T Consensus 34 ~~eigdGnlN~VfrV~~~~~~~svIVKQAlp~vRv~~swpL~~~R~~~E~~aL~~~~~~~P~~VP~vy~~--D~e~~~~v 111 (409)
T PRK12396 34 CKEIGDGNLNYVFRVWDEQKNISVIVKQAGDTARISDEFKLSTNRIRIESDVLQLEEELAPGLVPKVYLF--DSVMNCCV 111 (409)
T ss_pred eeEcCCCceEEEEEEeeCCCCceEEEEeccHhhccCCCCCCChHHHHHHHHHHHHHHhhCCCcCCeEEEE--CcHHhhHH
Confidence 567899999999999985445679998532 11111223455566777777764 34 45556544 55667788
Q ss_pred EecCCC-ccHHHHh
Q psy758 80 FEFCDH-TVLNELE 92 (292)
Q Consensus 80 ~e~~~~-~~L~~~~ 92 (292)
||+++. ..|...+
T Consensus 112 MEdL~~~~ilR~~L 125 (409)
T PRK12396 112 MEDLSDHTILRTAL 125 (409)
T ss_pred HHhCcccHHHHHHH
Confidence 888854 3344443
|
|
| >PLN02236 choline kinase | Back alignment and domain information |
|---|
Probab=97.54 E-value=0.00085 Score=56.17 Aligned_cols=138 Identities=19% Similarity=0.247 Sum_probs=77.6
Q ss_pred eeeecccCceEEEEEEEcC----CCcEEEEEEeccCCCChHHHHHHHHHHHHHHhCCCCCc-chhhhhhhcCCeEEEEEe
Q psy758 7 IGKLGEGSYGVVFKCRNRD----TGQVVAIKKFLESEEDPLIRKIALREIRLLKSLKHPNL-VNLLEVFRRKKKLHLVFE 81 (292)
Q Consensus 7 ~~~l~~g~~~~v~~~~~~~----~~~~v~iK~~~~~~~~~~~~~~~~~e~~~~~~l~~~~i-~~~~~~~~~~~~~~iv~e 81 (292)
+..|..|-...+|++.... +++.|++|+..... ....+ ..+|..+++.+...++ .++++.+.. + .|.+
T Consensus 41 i~~l~gGlTN~~y~v~~~~~~~~~~~~~v~Ri~g~~t--~~~id-R~~E~~~~~~l~~~gl~P~~~~~~~~-g---~v~e 113 (344)
T PLN02236 41 VIPLKGAMTNEVFQIKWPTKEGNLGRKVLVRIYGEGV--ELFFD-RDDEIRTFECMSRHGQGPRLLGRFPN-G---RVEE 113 (344)
T ss_pred EEEcCCcccceeEEEEeCCCCCCCCCeEEEEEccCCC--Ceeec-hHHHHHHHHHHHHcCCCCceEEEECC-c---eEEE
Confidence 4456667888899986432 34689999875432 11122 2468888888864333 344555432 2 4788
Q ss_pred cCCCccHHHH--------------h---cC---CC-C-C-CHHHHHHHHHHH-----------------H---HHHHH-H
Q psy758 82 FCDHTVLNEL--------------E---NH---PH-G-L-PWDLIKQITWQV-----------------L---RGVSY-C 117 (292)
Q Consensus 82 ~~~~~~L~~~--------------~---~~---~~-~-~-~~~~~~~i~~qi-----------------~---~aL~~-L 117 (292)
|+++..+... + .+ .. . . ....+..++.++ . ..|.. +
T Consensus 114 fi~g~~l~~~~l~~~~~~~~ia~~L~~lH~~~~~~~~~~~~~~~i~~~~~~~~~l~~~~~~~~~~~~~l~~~~~~L~~~~ 193 (344)
T PLN02236 114 FIHARTLSAADLRDPEISALIAAKLREFHSLDMPGPKNVLLWDRLRNWLKEAKNLCSPEEAKEFRLDSLEDEINLLEKEL 193 (344)
T ss_pred eeCCCCCCHHHcCChHHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHHHHHhhcCcchhhhcCHHHHHHHHHHHHHHh
Confidence 8877554321 0 00 00 0 1 112222222111 1 11111 1
Q ss_pred H----hCCccccCCCCCceEEcc-CCcEEEeecCchhhh
Q psy758 118 H----RHACIHRDIKPENILLTA-NGVVKLCDFGFARLI 151 (292)
Q Consensus 118 H----~~givH~dl~p~Nilv~~-~~~~kl~dfg~~~~~ 151 (292)
. ...++|+|+++.||++++ ++.+.++||..+...
T Consensus 194 ~~~~~~~~~cH~Dl~~~Nil~~~~~~~~~lID~Eya~~~ 232 (344)
T PLN02236 194 SGDDQEIGFCHNDLQYGNIMIDEETRAITIIDYEYASYN 232 (344)
T ss_pred cccCCCceEEeCCCCcCcEEEeCCCCcEEEEeehhcccc
Confidence 1 225899999999999986 467999999888643
|
|
| >PLN02421 phosphotransferase, alcohol group as acceptor/kinase | Back alignment and domain information |
|---|
Probab=97.52 E-value=0.0011 Score=55.14 Aligned_cols=75 Identities=19% Similarity=0.341 Sum_probs=44.1
Q ss_pred eeeecccCceEEEEEEEcCC---CcEEEEEEeccCCCChHHHHHHHHHHHHHHhCCCCCc-chhhhhhhcCCeEEEEEec
Q psy758 7 IGKLGEGSYGVVFKCRNRDT---GQVVAIKKFLESEEDPLIRKIALREIRLLKSLKHPNL-VNLLEVFRRKKKLHLVFEF 82 (292)
Q Consensus 7 ~~~l~~g~~~~v~~~~~~~~---~~~v~iK~~~~~~~~~~~~~~~~~e~~~~~~l~~~~i-~~~~~~~~~~~~~~iv~e~ 82 (292)
++.|..|=...+|++..... +..|++|+....... .. ...+|..+++.+..-++ .++++++. ++ +|.+|
T Consensus 19 i~~l~gGlTN~~~~v~~~~~~~~~~~~v~Ri~g~~t~~--~I-dR~~E~~il~~l~~~gl~P~~l~~~~-~G---~i~~f 91 (330)
T PLN02421 19 VERISGGITNLLLKVSVKEENGNEVSVTVRLFGPNTDY--VI-DRERELQAIKYLSAAGFGAKLLGVFG-NG---MIQSF 91 (330)
T ss_pred EEEeCCcccceEEEEEecCCCCCCceEEEEEecCCcCe--Ee-chHHHHHHHHHHHhcCCCCceeEEeC-Cc---Eeehh
Confidence 44566677778898865432 347999987543221 11 12467888888764444 34555442 33 47888
Q ss_pred CCCccH
Q psy758 83 CDHTVL 88 (292)
Q Consensus 83 ~~~~~L 88 (292)
++|..+
T Consensus 92 i~g~~l 97 (330)
T PLN02421 92 INARTL 97 (330)
T ss_pred hcCCCC
Confidence 877554
|
|
| >TIGR02904 spore_ysxE spore coat protein YsxE | Back alignment and domain information |
|---|
Probab=97.46 E-value=0.0025 Score=52.66 Aligned_cols=30 Identities=13% Similarity=0.171 Sum_probs=27.4
Q ss_pred CccccCCCCCceEEccCCcEEEeecCchhh
Q psy758 121 ACIHRDIKPENILLTANGVVKLCDFGFARL 150 (292)
Q Consensus 121 givH~dl~p~Nilv~~~~~~kl~dfg~~~~ 150 (292)
+++|||+.+.|+++++++.+.++||..+..
T Consensus 197 ~lcHgD~~~~Nvl~~~~~~~~iIDfd~~~~ 226 (309)
T TIGR02904 197 VLVHGKLSLSHFLYDETRGGYFINFEKASF 226 (309)
T ss_pred eeeCCCCcHHhEEEcCCCCEEEEEhhhccc
Confidence 799999999999999999999999988753
|
Members of this family are homologs of the Bacillus subtilis spore coat protein CotS. Members of this family, designated YsxE, are found only in the family Bacillaceae, from among the endospore-forming members of the Firmicutes branch of the Bacteria. As a rule, the ysxE gene is found immediately downstream of spoVID, a gene necessary for spore coat assembly. The protein has been shown to be part of the spore coat. |
| >cd05152 MPH2' Macrolide 2'-Phosphotransferase (MPH2') | Back alignment and domain information |
|---|
Probab=97.36 E-value=0.0035 Score=50.75 Aligned_cols=32 Identities=25% Similarity=0.433 Sum_probs=26.2
Q ss_pred CccccCCCCCceEEccCCc-EEEeecCchhhhh
Q psy758 121 ACIHRDIKPENILLTANGV-VKLCDFGFARLIR 152 (292)
Q Consensus 121 givH~dl~p~Nilv~~~~~-~kl~dfg~~~~~~ 152 (292)
.++|||++|.||++++++. .-|+||+.+....
T Consensus 186 ~lvHGD~~~~Nilv~~~~~~~gviDWe~a~iGD 218 (276)
T cd05152 186 VLVHGDLHPGHILIDEDARVTGLIDWTEAKVGD 218 (276)
T ss_pred eeEeCCCCCCcEEEeCCCCEEEEECcHhcccCC
Confidence 3799999999999998555 5699999886543
|
MPH2' is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). MPH2' catalyzes the transfer of the gamma-phosphoryl group from ATP to the 2'-hydroxyl of macrolide antibiotics such as erythromycin, clarithromycin, and azithromycin, among others. Macrolides penetrate the bacterial cell and bind to ribosomes, where it interrupts protein elongation, leading ultimately to the demise of the bacterium. Phosphorylation of macrolides leads to their inactivation. Based on substrate specificity and amino acid sequence, MPH2' is divided into types I and II, encoded by mphA and mphB genes, respectively. MPH2'I inactivates 14-membered ring macrolides while MPH2'II inactivates both 14- and 16-membered ring macrolides. Enzymatic inactivation of macrolides has been reported |
| >KOG0575|consensus | Back alignment and domain information |
|---|
Probab=97.34 E-value=0.00016 Score=62.36 Aligned_cols=72 Identities=19% Similarity=0.307 Sum_probs=54.7
Q ss_pred ccccccccccccC-----CCCCCCcccceeeecCCCCC----------------------CchHHHHHHHhhcccCCCCC
Q psy758 159 LHIFQTNEYFKGV-----SLPHAENVVPLEIKIGKPAA----------------------TNIYLIDFLKRCLDKDPLRR 211 (292)
Q Consensus 159 ~~~~~~~~~~~~~-----~~~~~~~~~~~~~~~~~~~~----------------------~~~~~~~~~~~~~~~~p~~~ 211 (292)
++-|.+||..... .+.|+.|++.|.+++|.+++ .+..+.+++..++..+|.+|
T Consensus 181 TPNYIAPEVl~k~gHsfEvDiWSlGcvmYtLL~G~PPFetk~vkety~~Ik~~~Y~~P~~ls~~A~dLI~~lL~~~P~~R 260 (592)
T KOG0575|consen 181 TPNYIAPEVLNKSGHSFEVDIWSLGCVMYTLLVGRPPFETKTVKETYNKIKLNEYSMPSHLSAEAKDLIRKLLRPNPSER 260 (592)
T ss_pred CCcccChhHhccCCCCCchhhhhhhhHHHhhhhCCCCcccchHHHHHHHHHhcCcccccccCHHHHHHHHHHhcCCcccC
Confidence 4456777776543 34577777777788888775 45567899999999999999
Q ss_pred CChhhhhhccCcCCCCCCC
Q psy758 212 WSCDQLLRHPYFNGYYFEV 230 (292)
Q Consensus 212 ~~~~~~~~~~~~~~~~~~~ 230 (292)
++.++++.|+||.....+.
T Consensus 261 psl~~vL~h~Ff~~g~~p~ 279 (592)
T KOG0575|consen 261 PSLDEVLDHPFFKSGFTPA 279 (592)
T ss_pred CCHHHHhcCHhhhCCCcCC
Confidence 9999999999995544443
|
|
| >PF07387 Seadorna_VP7: Seadornavirus VP7; InterPro: IPR009973 This family consists of several Seadornavirus specific VP7 proteins of around 305 residues in length | Back alignment and domain information |
|---|
Probab=97.22 E-value=0.0016 Score=49.94 Aligned_cols=116 Identities=16% Similarity=0.261 Sum_probs=71.0
Q ss_pred cCceEEEEEEEcCCCcEEEEEEeccCCCChHHHHHHHHHHHHHHhCCCCCcchhhhhhhcCCeEEEEEecCCCccHHHHh
Q psy758 13 GSYGVVFKCRNRDTGQVVAIKKFLESEEDPLIRKIALREIRLLKSLKHPNLVNLLEVFRRKKKLHLVFEFCDHTVLNELE 92 (292)
Q Consensus 13 g~~~~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~iv~e~~~~~~L~~~~ 92 (292)
++.++.-.+.... | ...+|.++...-.- ....+.++.+++.++. +|+++..- .+..+-++.|+|-.-
T Consensus 73 ~gNsTl~~~kt~i-G-~L~lKKi~slp~~~-~~~~y~nky~v~Armh--GilrL~ND--n~~~yGvIlE~Cy~~------ 139 (308)
T PF07387_consen 73 NGNSTLLIGKTKI-G-PLFLKKIRSLPCCI-NDALYFNKYRVFARMH--GILRLKND--NNYKYGVILERCYKI------ 139 (308)
T ss_pred CCceEEEEecccc-c-hhhhhhccCCCccc-chhhhhhhhhHHHHhh--heeEeecC--CCceeEEEEeeccCc------
Confidence 3344444333332 3 34455554333221 1234567788887765 66666632 445688999998632
Q ss_pred cCCCCCCHHHHHHHHHHHHHHHHHHHh--CCccccCCCCCceEEccCCcEEEeecCch
Q psy758 93 NHPHGLPWDLIKQITWQVLRGVSYCHR--HACIHRDIKPENILLTANGVVKLCDFGFA 148 (292)
Q Consensus 93 ~~~~~~~~~~~~~i~~qi~~aL~~LH~--~givH~dl~p~Nilv~~~~~~kl~dfg~~ 148 (292)
..-. .-++.-=+.+|.-.|+ .+.+|||..|+||+-|..|.+||.|-+..
T Consensus 140 ------~i~~-~N~i~agi~~L~~fH~~~~~~lHGD~np~NiM~D~~G~lKlVDP~~L 190 (308)
T PF07387_consen 140 ------KINF-SNFITAGIKDLMDFHSENQHCLHGDCNPDNIMCDKFGYLKLVDPVCL 190 (308)
T ss_pred ------ccch-hHHHHHhHHHHHHhhccCCCeecCCCChhheeecCCCCEEecChhhh
Confidence 1111 1222222567788884 46999999999999999999999997754
|
The function of this family is unknown. |
| >COG2334 Putative homoserine kinase type II (protein kinase fold) [General function prediction only] | Back alignment and domain information |
|---|
Probab=97.20 E-value=0.016 Score=48.01 Aligned_cols=133 Identities=22% Similarity=0.289 Sum_probs=76.9
Q ss_pred ecccCceEEEEEEEcCCCcEEEEEEeccCCCChHHHHHHHHHHHHHHhCCC---CC---cchhh----hhhhcCCeEEEE
Q psy758 10 LGEGSYGVVFKCRNRDTGQVVAIKKFLESEEDPLIRKIALREIRLLKSLKH---PN---LVNLL----EVFRRKKKLHLV 79 (292)
Q Consensus 10 l~~g~~~~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~e~~~~~~l~~---~~---i~~~~----~~~~~~~~~~iv 79 (292)
|.+ .-..+|...... ..+++|+.... ... ..+..|...++.|.- +- +...= ..+..+.+.+.+
T Consensus 34 l~s-~eN~~f~~~~~~--g~~iLki~~~~-~~~---~~i~~el~~l~~La~~~i~v~~Pl~~~dG~~l~~~~~~~r~a~l 106 (331)
T COG2334 34 LNS-EENSNFRVQTED--GRYILKIYRPG-WTR---AEIPFELALLQHLAERGIPVPAPLPSLDGELLEALSGGPRPAAL 106 (331)
T ss_pred ccc-ccCceEEEEecC--CCeEEEEecCC-CCH---HHHHHHHHHHHHHHHcCCCCCCCccCCCcchhhhccCCceeEEE
Confidence 444 445678777653 34489988765 222 334457777777732 11 22221 222222378899
Q ss_pred EecCCCccHHH-H-----------h-------cC-----CCCC---CHH----H---------HHHHHHHHHHHHHHHHh
Q psy758 80 FEFCDHTVLNE-L-----------E-------NH-----PHGL---PWD----L---------IKQITWQVLRGVSYCHR 119 (292)
Q Consensus 80 ~e~~~~~~L~~-~-----------~-------~~-----~~~~---~~~----~---------~~~i~~qi~~aL~~LH~ 119 (292)
++|++|..+.. . + +. ...+ ... . ......++...+..+.+
T Consensus 107 f~~l~G~~~~~~~~~~~~~~lG~~LgrlH~a~~~f~~~~p~~~~~~~w~~~~~~~~~~~~~~~~~~l~a~~~~~~~~~~~ 186 (331)
T COG2334 107 FEYLPGRPLERDDNAEQLEELGRMLGRLHLALRGFPFERPNALRRLEWDILEPRALLRLDLVEPEDLRAALLAALDRLLA 186 (331)
T ss_pred EEecCCcCcCCCCcHHHHHHHHHHHHHHHHHhCcCCccCCCcccccchhhhcchhhhhhcccCchhhHHHHHHHHHHHHh
Confidence 99999977762 1 0 00 0000 000 0 01133344455555554
Q ss_pred --------CC--ccccCCCCCceEEccCCc-EEEeecCchh
Q psy758 120 --------HA--CIHRDIKPENILLTANGV-VKLCDFGFAR 149 (292)
Q Consensus 120 --------~g--ivH~dl~p~Nilv~~~~~-~kl~dfg~~~ 149 (292)
-+ ++|+|+.|+||+++.+.. .-++||+-+.
T Consensus 187 ~~~~~lp~~~~~iIH~D~~~~NVl~d~~~~~~g~iDFdDa~ 227 (331)
T COG2334 187 RLPAHLPALGDQIIHGDLHPDNVLFDDDTDVSGFIDFDDAG 227 (331)
T ss_pred hchhhCCcccceeeecCCCccceeEcCCCCeeeEEEccccc
Confidence 23 999999999999999985 8899998875
|
|
| >PF01633 Choline_kinase: Choline/ethanolamine kinase; InterPro: IPR002573 Choline kinase, (ATP:choline phosphotransferase, 2 | Back alignment and domain information |
|---|
Probab=97.09 E-value=0.0015 Score=50.60 Aligned_cols=30 Identities=43% Similarity=0.757 Sum_probs=21.2
Q ss_pred CccccCCCCCceEE-ccCCcEEEeecCchhh
Q psy758 121 ACIHRDIKPENILL-TANGVVKLCDFGFARL 150 (292)
Q Consensus 121 givH~dl~p~Nilv-~~~~~~kl~dfg~~~~ 150 (292)
.++|+|+.|.||++ +.++.++|+||..+..
T Consensus 144 v~cHnDl~~~Nil~~~~~~~~~lIDfEya~~ 174 (211)
T PF01633_consen 144 VFCHNDLNPGNILINNKDGEVKLIDFEYAGY 174 (211)
T ss_dssp EEE-S--SGGGEEETSSSSCEEE--GTT-EE
T ss_pred eEeeccCccccEEeccCCCeEEEecHHHHhh
Confidence 47899999999999 7889999999998864
|
7.1.32 from EC) belongs to the choline/ethanolamine kinase family. Ethanolamine and choline are major membrane phospholipids, in the form of glycerophosphoethanolamine and glycerophosphocholine. Ethanolamine is also a component of the glycosylphosphatidylinositol (GPI) anchor, which is necessary for cell-surface protein attachment []. The de novo synthesis of these phospholipids begins with the creation of phosphoethanolamine and phosphocholine by ethanolamine and choline kinases in the first step of the CDP-ethanolamine pathway [, ]. There are two putative choline/ethanolamine kinases (C/EKs) in the Trypanosoma brucei genome. Ethanolamine kinase has no choline kinase activity [] and its activity is inhibited by ADP []. Inositol supplementation represses ethanolamine kinase, decreasing the incorporation of ethanolamine into the CDP-ethanolamine pathway and into phosphatidylethanolamine and phosphatidylcholine []. ; GO: 0016773 phosphotransferase activity, alcohol group as acceptor; PDB: 3C5I_A 2IG7_A 3LQ3_A 3FEG_A 2QG7_E 3FI8_A 1NW1_A 3MES_A 3G15_A 2CKP_B .... |
| >KOG0201|consensus | Back alignment and domain information |
|---|
Probab=97.08 E-value=0.00033 Score=58.29 Aligned_cols=85 Identities=21% Similarity=0.358 Sum_probs=53.7
Q ss_pred ccccccccccccccccCCCCC-------CCcccceeee--cC--CCC----CCchHHHHHHHhhcccCCCCCCChhhhhh
Q psy758 155 IPRHLHIFQTNEYFKGVSLPH-------AENVVPLEIK--IG--KPA----ATNIYLIDFLKRCLDKDPLRRWSCDQLLR 219 (292)
Q Consensus 155 ~~~~~~~~~~~~~~~~~~~~~-------~~~~~~~~~~--~~--~~~----~~~~~~~~~~~~~~~~~p~~~~~~~~~~~ 219 (292)
.........++.|++|.+.++ ..+.-+...+ +. .++ ..+..+.+++..|+.++|..|+++.++++
T Consensus 183 I~~~~Y~~KADIWSLGITaiEla~GePP~s~~hPmrvlflIpk~~PP~L~~~~S~~~kEFV~~CL~k~P~~RpsA~~LLK 262 (467)
T KOG0201|consen 183 IKQSGYDTKADIWSLGITAIELAKGEPPHSKLHPMRVLFLIPKSAPPRLDGDFSPPFKEFVEACLDKNPEFRPSAKELLK 262 (467)
T ss_pred hccccccchhhhhhhhHHHHHHhcCCCCCcccCcceEEEeccCCCCCccccccCHHHHHHHHHHhhcCcccCcCHHHHhh
Confidence 334455567888887755421 1222222221 11 111 23566899999999999999999999999
Q ss_pred ccCcCCCCCCCCCccchHHHHhcc
Q psy758 220 HPYFNGYYFEVPDEMQYEEITQRC 243 (292)
Q Consensus 220 ~~~~~~~~~~~~~~~~l~~li~~~ 243 (292)
|.|.... .....+.++|.+.
T Consensus 263 h~FIk~a----~k~s~L~~~i~r~ 282 (467)
T KOG0201|consen 263 HKFIKRA----KKTSELKELIDRY 282 (467)
T ss_pred hHHHHhc----CCchHHHHHHHHH
Confidence 9998762 2234566666554
|
|
| >COG4248 Uncharacterized protein with protein kinase and helix-hairpin-helix DNA-binding domains [General function prediction only] | Back alignment and domain information |
|---|
Probab=97.01 E-value=0.01 Score=49.94 Aligned_cols=133 Identities=13% Similarity=0.183 Sum_probs=86.4
Q ss_pred eeeeecccCceEEEEEEEcCCCcEEEEEEeccCCCChHHHHHHHHHHHHHHh-CCCCCcchhhhhh------hcCC-eEE
Q psy758 6 KIGKLGEGSYGVVFKCRNRDTGQVVAIKKFLESEEDPLIRKIALREIRLLKS-LKHPNLVNLLEVF------RRKK-KLH 77 (292)
Q Consensus 6 ~~~~l~~g~~~~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~e~~~~~~-l~~~~i~~~~~~~------~~~~-~~~ 77 (292)
..+.||+|+-+.+|..-.-. .-+.|++.......... -+..+.. -.||-+..-+.+= .+++ ..-
T Consensus 15 ~gr~LgqGgea~ly~l~e~~---d~VAKIYh~Pppa~~aq-----k~a~la~~p~~p~~~~rvaWPqa~L~G~~~~~~iG 86 (637)
T COG4248 15 PGRPLGQGGEADLYTLGEVR---DQVAKIYHAPPPAAQAQ-----KVAELAATPDAPLLNYRVAWPQATLHGGRRGKVIG 86 (637)
T ss_pred CCccccCCccceeeecchhh---chhheeecCCCchHHHH-----HHHHhccCCCCcchhhhhcccHHHhhCCCccceeE
Confidence 45679999999999764332 24678886654322111 1222222 2455433311111 1222 377
Q ss_pred EEEecCCCcc-HHHHh------cCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEEccCCcEEEeecC
Q psy758 78 LVFEFCDHTV-LNELE------NHPHGLPWDLIKQITWQVLRGVSYCHRHACIHRDIKPENILLTANGVVKLCDFG 146 (292)
Q Consensus 78 iv~e~~~~~~-L~~~~------~~~~~~~~~~~~~i~~qi~~aL~~LH~~givH~dl~p~Nilv~~~~~~kl~dfg 146 (292)
++|+..+|.- ...+. +...-............++.|.+.||..|.+-||++++|+||++++.+.|+|-.
T Consensus 87 flmP~v~g~~pI~~~y~p~tRRqs~P~~~w~fllrvaRnlA~aFA~lH~~Gh~vGDVn~~~~lVsd~~~V~LVdsD 162 (637)
T COG4248 87 FLMPKVSGKEPIHMIYSPATRRQSYPHCAWDFLLRVARNLASAFATLHEHGHVVGDVNQNSFLVSDDSKVVLVDSD 162 (637)
T ss_pred EecccCCCccchhhhcCchhhcccCCccccHHHHHHHHHHHHHHHHHHhcCCcccccCccceeeecCceEEEEccc
Confidence 8888887732 22222 122236778888999999999999999999999999999999999999998743
|
|
| >cd05610 STKc_MASTL Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase | Back alignment and domain information |
|---|
Probab=96.92 E-value=0.00058 Score=62.52 Aligned_cols=136 Identities=19% Similarity=0.210 Sum_probs=86.5
Q ss_pred cccCCCCC-ceEEccCCcEEEeecCchhhhhccc-------cccccccccccccccCCCC-----CCCcccceeeecCCC
Q psy758 123 IHRDIKPE-NILLTANGVVKLCDFGFARLIRDLI-------PRHLHIFQTNEYFKGVSLP-----HAENVVPLEIKIGKP 189 (292)
Q Consensus 123 vH~dl~p~-Nilv~~~~~~kl~dfg~~~~~~~~~-------~~~~~~~~~~~~~~~~~~~-----~~~~~~~~~~~~~~~ 189 (292)
.+++..|. |+++++++..++.||+.++...... ..++..|.+||...+.... |+.+++.+++++|..
T Consensus 499 ~~~~~~p~~~~~~~p~~~~~~~~~~~~~~~~~g~~~~~~~~~vGT~~Y~APE~l~~~~~~~~~DiwSlG~il~ElltG~~ 578 (669)
T cd05610 499 PTQKPRPHGNLYQTPKQVKIGTPYRTPKSVRRGAAPVEGERILGTPDYLAPELLLGKPHGPAVDWWALGVCLFEFLTGIP 578 (669)
T ss_pred CCCCCCCCCceeECCccccccccCCCchhhhcccccccCCceeeCccccCHHHcCCCCCCcHHHHHHHHHHHHHHHHCCC
Confidence 34566666 6777777778888999877654221 1335567788877665443 445555555555555
Q ss_pred CCCchHHHHHHHhhcccCCCCCCChhhhhhccCcCCCCCCCCCccchHHHHhcccCcCCCCCCChhhhhhCCcccceecc
Q psy758 190 AATNIYLIDFLKRCLDKDPLRRWSCDQLLRHPYFNGYYFEVPDEMQYEEITQRCLDKDPLRRWSCDQLLRHPYFNGYYFE 269 (292)
Q Consensus 190 ~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~~il~h~w~~~~~~~ 269 (292)
++.......++...+.... .+ .. .....+..+.+++.+||..||.+|||+.++++||||....|+
T Consensus 579 pf~~~~~~~~~~~il~~~~------------~~-p~--~~~~~~~~~~~~l~~lL~~dP~~R~ta~e~l~h~~~~~~~~~ 643 (669)
T cd05610 579 PFNDETPQQVFQNILNRDI------------PW-PE--GEEKLSVNAQNAIEILLTMDPTKRAGLKELKQHPLFHGVDWE 643 (669)
T ss_pred CCCCCCHHHHHHHHHhcCC------------CC-Cc--ccccCCHHHHHHHHHHcccChhHCcCHHHHHhCHhhcCCCHH
Confidence 5443333333333322111 00 00 112457799999999999999999999999999999998776
Q ss_pred CCCh
Q psy758 270 VPDE 273 (292)
Q Consensus 270 ~~~~ 273 (292)
.-..
T Consensus 644 ~~~~ 647 (669)
T cd05610 644 NLQN 647 (669)
T ss_pred Hhcc
Confidence 4443
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ1481 |
| >COG5072 ALK1 Serine/threonine kinase of the haspin family [Cell division and chromosome partitioning] | Back alignment and domain information |
|---|
Probab=96.84 E-value=0.0049 Score=50.94 Aligned_cols=72 Identities=22% Similarity=0.317 Sum_probs=56.0
Q ss_pred CCeEEEEEecCCCccHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhC-CccccCCCCCceEEccCCcEEEeecCchhh
Q psy758 73 KKKLHLVFEFCDHTVLNELENHPHGLPWDLIKQITWQVLRGVSYCHRH-ACIHRDIKPENILLTANGVVKLCDFGFARL 150 (292)
Q Consensus 73 ~~~~~iv~e~~~~~~L~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~-givH~dl~p~Nilv~~~~~~kl~dfg~~~~ 150 (292)
..+.|+++++..+... .. .....+++..++.+.+..++-+..+ ..-|+|+..+||+|+ +|.+-|+||.+++.
T Consensus 298 ~~y~yl~~kdhgt~is-~i----k~~~~~e~lsff~s~~sil~~lekkf~fehrnlt~~niLId-~GnvtLIDfklsRl 370 (488)
T COG5072 298 TLYLYLHFKDHGTPIS-II----KADRSEEELSFFWSCISILDILEKKFPFEHRNLTLDNILID-EGNVTLIDFKLSRL 370 (488)
T ss_pred ceEEEEEEecCCceee-ee----ecccHHHHHHHHHHHHHHHhhhhhcCCcccccccccceeee-cCceEEEEeeeeec
Confidence 4467788887765422 21 2345678888999888888888765 588999999999999 99999999999974
|
|
| >PRK06148 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=96.82 E-value=0.036 Score=53.32 Aligned_cols=31 Identities=39% Similarity=0.488 Sum_probs=26.1
Q ss_pred CCccccCCCCCceEEccCC--cEE-EeecCchhh
Q psy758 120 HACIHRDIKPENILLTANG--VVK-LCDFGFARL 150 (292)
Q Consensus 120 ~givH~dl~p~Nilv~~~~--~~k-l~dfg~~~~ 150 (292)
.+++|+|+++.||+++.++ .+. |+|||-+..
T Consensus 203 ~~vIHgDln~~NiLv~~~~~~~isGiIDFgDa~~ 236 (1013)
T PRK06148 203 AQVIHNDANDYNILVDADDGERISGLIDFGDAVH 236 (1013)
T ss_pred cceECCCCCcccEEEcCCCCcceEEEEECccccc
Confidence 5799999999999999875 555 999998754
|
|
| >KOG0581|consensus | Back alignment and domain information |
|---|
Probab=96.82 E-value=0.0015 Score=53.29 Aligned_cols=57 Identities=25% Similarity=0.377 Sum_probs=46.9
Q ss_pred CchHHHHHHHhhcccCCCCCCChhhhhhccCcCCCCCCCCCccchHHHHhcccCcCCCCC
Q psy758 192 TNIYLIDFLKRCLDKDPLRRWSCDQLLRHPYFNGYYFEVPDEMQYEEITQRCLDKDPLRR 251 (292)
Q Consensus 192 ~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~R 251 (292)
.+..+.+++..|++++|.+|++..+++.|+|+..+..+. ..+..++++++...+..|
T Consensus 307 fS~ef~~FV~~CL~Kdp~~R~s~~qLl~Hpfi~~~~~~~---vd~~~~~~~~~~~~~~~~ 363 (364)
T KOG0581|consen 307 FSPEFRSFVSCCLRKDPSERPSAKQLLQHPFIKKFEDPN---VDMASFVRKALSPPRSLP 363 (364)
T ss_pred CCHHHHHHHHHHhcCCcccCCCHHHHhcCHHHhhccccc---ccHHHHHHHhcccCCCCC
Confidence 467799999999999999999999999999999876553 346678888887765443
|
|
| >PTZ00384 choline kinase; Provisional | Back alignment and domain information |
|---|
Probab=96.64 E-value=0.02 Score=48.58 Aligned_cols=76 Identities=20% Similarity=0.243 Sum_probs=43.6
Q ss_pred eeeecccCceEEEEEEEcCC-Cc-----EEEEEEeccCCCChHHHHHHHHHHHHHHhCCCCCc-chhhhhhhcCCeEEEE
Q psy758 7 IGKLGEGSYGVVFKCRNRDT-GQ-----VVAIKKFLESEEDPLIRKIALREIRLLKSLKHPNL-VNLLEVFRRKKKLHLV 79 (292)
Q Consensus 7 ~~~l~~g~~~~v~~~~~~~~-~~-----~v~iK~~~~~~~~~~~~~~~~~e~~~~~~l~~~~i-~~~~~~~~~~~~~~iv 79 (292)
++.|..|-...+|++..... +. .|.++..... ..... ...+|..+++.+...++ .++++.+.. +++
T Consensus 55 i~~l~gGLTN~l~~v~~~~~~~~~~~~k~Vl~R~~g~~--~~l~I-dR~~E~~i~~~Ls~~glgP~l~~~f~~----g~l 127 (383)
T PTZ00384 55 IKKMNNGITNQVYQATLVDGDKDRYPIKSVCIKKSSTY--NSLVI-DNDLQYNIAKLLGDNNFGPKIIGRFGD----FTI 127 (383)
T ss_pred EEEeCCcccceEEEEEecCCCCCccccceEEEEeccCC--CceEe-ccHHHHHHHHHHHhCCCCCeEEEecCC----EEE
Confidence 45566688888998865432 12 2444443211 11111 12468888888865444 455555532 588
Q ss_pred EecCCCccHH
Q psy758 80 FEFCDHTVLN 89 (292)
Q Consensus 80 ~e~~~~~~L~ 89 (292)
.||++|..+.
T Consensus 128 ~efIeGr~l~ 137 (383)
T PTZ00384 128 QEWVEGNTMG 137 (383)
T ss_pred EEEeccccCC
Confidence 9999886653
|
|
| >PF03881 Fructosamin_kin: Fructosamine kinase; InterPro: IPR016477 Ketosamines derive from a non-enzymatic reaction between a sugar and a protein [] | Back alignment and domain information |
|---|
Probab=96.53 E-value=0.0098 Score=48.30 Aligned_cols=74 Identities=18% Similarity=0.177 Sum_probs=44.7
Q ss_pred eeeeecccCceEEEEEEEcCCCcEEEEEEeccCCCChHHHHHHHHHHHHHHhCC---CCCcchhhhhhhcCCeEEEEEec
Q psy758 6 KIGKLGEGSYGVVFKCRNRDTGQVVAIKKFLESEEDPLIRKIALREIRLLKSLK---HPNLVNLLEVFRRKKKLHLVFEF 82 (292)
Q Consensus 6 ~~~~l~~g~~~~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~e~~~~~~l~---~~~i~~~~~~~~~~~~~~iv~e~ 82 (292)
-.+.++.|.-+.+|+.. .+++.+.+|+-..... ..+..|..-++.|. .-.+++++++....+..++++|+
T Consensus 21 ~~~~v~GG~i~~a~~~~--~~~~~~FvK~~~~~~~-----~~f~~Ea~gL~~L~~~~~~~vP~vi~~G~~~~~~fLlle~ 93 (288)
T PF03881_consen 21 SIEPVSGGDINEAYRLD--TDGGSYFVKVNSESGR-----DMFEGEAEGLKALAEANPIRVPKVIAWGEYDDDAFLLLEF 93 (288)
T ss_dssp EEEEE--SSSSEEEEEE--TTS-EEEEEEEEGGGC-----CHHHHHHHHHHHHCHTTTSBS--EEEEEE-SSCCEEEEE-
T ss_pred eeEecCCCChhheEEEE--CCCccEEEEecChhhH-----HHHHHHHHHHHHHHhcCCCCCCeEEEEEeecCCceEEEEe
Confidence 35668889999999877 5588899998763222 34566777777773 34567777776666667999999
Q ss_pred CCCc
Q psy758 83 CDHT 86 (292)
Q Consensus 83 ~~~~ 86 (292)
.+.+
T Consensus 94 l~~~ 97 (288)
T PF03881_consen 94 LEMG 97 (288)
T ss_dssp ----
T ss_pred ecCC
Confidence 8765
|
Ketosamine-3-kinases (KT3K), of which fructosamine-3-kinase (FN3K) is the best-known example, catalyse the phosphorylation of the ketosamine moiety of glycated proteins. The instability of a phosphorylated ketosamine leads to its degradation, and KT3K is thus thought to be involved in protein repair []. The function of the prokaryotic members of this group has not been established. However, several lines of evidence indicate that they may function as fructosamine-3-kinases (FN3K). First, they are similar to characterised FN3K from mouse and human. Second, the Escherichia coli members are found in close proximity on the genome to fructose-6-phosphate kinase (PfkB). Last, FN3K activity has been found in a Anacystis montana (Gloeocapsa montana Kutzing 1843) [], indicating such activity-directly demonstrated in eukaryotes-is nonetheless not confined to eukaryotes. This family includes eukaryotic fructosamine-3-kinase enzymes [] which may initiate a process leading to the deglycation of fructoselysine and of glycated proteins and in the phosphorylation of 1-deoxy-1-morpholinofructose, fructoselysine, fructoseglycine, fructose and glycated lysozyme. The family also includes bacterial members that have not been characterised but probably have a similar or identical function. For additional information please see [].; PDB: 3JR1_B 3F7W_A. |
| >PRK11768 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=96.44 E-value=0.11 Score=43.26 Aligned_cols=29 Identities=31% Similarity=0.418 Sum_probs=24.3
Q ss_pred CCccccCCCCCceEEccCCcEEEeecCchhh
Q psy758 120 HACIHRDIKPENILLTANGVVKLCDFGFARL 150 (292)
Q Consensus 120 ~givH~dl~p~Nilv~~~~~~kl~dfg~~~~ 150 (292)
.+++|||+.+.||+++ + .+.|+||+-+..
T Consensus 196 ~~liHgD~h~~NvL~~-d-~~~iIDFDd~~~ 224 (325)
T PRK11768 196 LLRLHGDCHPGNILWR-D-GPHFVDLDDARM 224 (325)
T ss_pred ccceecCCCchhcccc-C-CcEEEeCCCCCC
Confidence 4789999999999995 4 577899998753
|
|
| >KOG0588|consensus | Back alignment and domain information |
|---|
Probab=96.42 E-value=0.0026 Score=55.97 Aligned_cols=65 Identities=28% Similarity=0.437 Sum_probs=48.6
Q ss_pred ccccccccCCCCCCCcccceeeecCCCC----------------------CCchHHHHHHHhhcccCCCCCCChhhhhhc
Q psy758 163 QTNEYFKGVSLPHAENVVPLEIKIGKPA----------------------ATNIYLIDFLKRCLDKDPLRRWSCDQLLRH 220 (292)
Q Consensus 163 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~----------------------~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~ 220 (292)
..-.|--+....|+.|++.+.+++|..+ .+...+.+++..|+.-+|..|.+.+++++|
T Consensus 184 ~G~pYdG~~sDVWSCGVILfALLtG~LPFdDdNir~LLlKV~~G~f~MPs~Is~eaQdLLr~ml~VDp~~RiT~~eI~kH 263 (786)
T KOG0588|consen 184 SGRPYDGRPSDVWSCGVILFALLTGKLPFDDDNIRVLLLKVQRGVFEMPSNISSEAQDLLRRMLDVDPSTRITTEEILKH 263 (786)
T ss_pred cCCCCCCCccccchhHHHHHHHHhCCCCCCCccHHHHHHHHHcCcccCCCcCCHHHHHHHHHHhccCccccccHHHHhhC
Confidence 3334444455556666666666666544 467778899999999999999999999999
Q ss_pred cCcCCCC
Q psy758 221 PYFNGYY 227 (292)
Q Consensus 221 ~~~~~~~ 227 (292)
+|+.++.
T Consensus 264 P~l~g~~ 270 (786)
T KOG0588|consen 264 PFLSGYT 270 (786)
T ss_pred chhhcCC
Confidence 9998864
|
|
Homologous Structure Templates
Structure Templates Detected by BLAST
Original result of BLAST against Protein Data Bank
| ID | Alignment Graph | Length |
Definition |
E-value | |
| Query | 292 | ||||
| 4agu_A | 311 | Crystal Structure Of The Human Cdkl1 Kinase Domain | 3e-71 | ||
| 4aaa_A | 331 | Crystal Structure Of The Human Cdkl2 Kinase Domain | 8e-55 | ||
| 4eoi_A | 299 | Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyc | 4e-36 | ||
| 4eom_A | 301 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Hum | 5e-36 | ||
| 4eon_A | 300 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Hum | 6e-36 | ||
| 4eop_A | 300 | Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 | 6e-36 | ||
| 4eoo_A | 299 | Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 | 6e-36 | ||
| 1oit_A | 299 | Imidazopyridines: A Potent And Selective Class Of C | 7e-36 | ||
| 4eoj_A | 302 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Huma | 7e-36 | ||
| 4eok_A | 300 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Huma | 7e-36 | ||
| 4erw_A | 306 | Cdk2 In Complex With Staurosporine Length = 306 | 1e-35 | ||
| 2iw6_A | 302 | Structure Of Human Thr160-Phospho Cdk2-Cyclin A Com | 1e-35 | ||
| 1gz8_A | 299 | Human Cyclin Dependent Kinase 2 Complexed With The | 1e-35 | ||
| 2jgz_A | 289 | Crystal Structure Of Phospho-Cdk2 In Complex With C | 1e-35 | ||
| 1e9h_A | 297 | Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex | 1e-35 | ||
| 1w98_A | 298 | The Structural Basis Of Cdk2 Activation By Cyclin E | 1e-35 | ||
| 2w17_A | 299 | Cdk2 In Complex With The Imidazole Pyrimidine Amide | 1e-35 | ||
| 1fin_A | 298 | Cyclin A-Cyclin-Dependent Kinase 2 Complex Length = | 1e-35 | ||
| 4eos_A | 300 | Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Co | 1e-35 | ||
| 4i3z_A | 296 | Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNES | 1e-35 | ||
| 1jst_A | 298 | Phosphorylated Cyclin-Dependent Kinase-2 Bound To C | 1e-35 | ||
| 1qmz_A | 299 | Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Com | 1e-35 | ||
| 2iw8_A | 302 | Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82 | 1e-35 | ||
| 4eoq_A | 301 | Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Co | 1e-35 | ||
| 4bcq_A | 301 | Structure Of Cdk2 In Complex With Cyclin A And A 2- | 1e-35 | ||
| 3ezr_A | 300 | Cdk-2 With Indazole Inhibitor 17 Bound At Its Activ | 1e-35 | ||
| 3pj8_A | 299 | Structure Of Cdk2 In Complex With A Pyrazolo[4,3-D] | 1e-35 | ||
| 3pxf_A | 306 | Cdk2 In Complex With Two Molecules Of 8-Anilino-1-N | 1e-35 | ||
| 3bht_A | 300 | Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN | 2e-35 | ||
| 3qhr_A | 298 | Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic | 2e-35 | ||
| 1h1p_A | 303 | Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMP | 2e-35 | ||
| 1ogu_A | 302 | Structure Of Human Thr160-phospho Cdk2/cyclin A Com | 2e-35 | ||
| 1vyw_A | 309 | Structure Of Cdk2CYCLIN A WITH PNU-292137 Length = | 2e-35 | ||
| 1ung_A | 292 | Structural Mechanism For The Inhibition Of Cdk5-P25 | 3e-35 | ||
| 1h4l_A | 292 | Structure And Regulation Of The Cdk5-P25(Nck5a) Com | 4e-35 | ||
| 1oir_A | 299 | Imidazopyridines: A Potent And Selective Class Of C | 5e-35 | ||
| 1h01_A | 298 | Cdk2 In Complex With A Disubstituted 2, 4-Bis Anili | 5e-35 | ||
| 1gii_A | 298 | Human Cyclin Dependent Kinase 2 Complexed With The | 5e-35 | ||
| 1pf8_A | 298 | Crystal Structure Of Human Cyclin-dependent Kinase | 7e-35 | ||
| 3niz_A | 311 | Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5 | 3e-34 | ||
| 2qkr_A | 313 | Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5 | 3e-34 | ||
| 4ec8_A | 373 | Structure Of Full Length Cdk9 In Complex With Cycli | 5e-31 | ||
| 3mi9_A | 351 | Crystal Structure Of Hiv-1 Tat Complexed With Human | 7e-31 | ||
| 3blh_A | 331 | Crystal Structure Of Human Cdk9CYCLINT1 Length = 33 | 7e-31 | ||
| 4bcf_A | 331 | Structure Of Cdk9 In Complex With Cyclin T And A 2- | 7e-31 | ||
| 2pk9_A | 317 | Structure Of The Pho85-pho80 Cdk-cyclin Complex Of | 2e-29 | ||
| 1ua2_A | 346 | Crystal Structure Of Human Cdk7 Length = 346 | 4e-29 | ||
| 1v0b_A | 288 | Crystal Structure Of The T198a Mutant Of Pfpk5 Leng | 1e-28 | ||
| 1v0o_A | 288 | Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulpho | 1e-28 | ||
| 3nup_A | 307 | Cdk6 (Monomeric) In Complex With Inhibitor Length = | 1e-28 | ||
| 1jow_B | 308 | Crystal Structure Of A Complex Of Human Cdk6 And A | 1e-28 | ||
| 1ob3_A | 288 | Structure Of P. Falciparum Pfpk5 Length = 288 | 2e-28 | ||
| 1bi8_A | 326 | Mechanism Of G1 Cyclin Dependent Kinase Inhibition | 2e-28 | ||
| 3mtl_A | 324 | Crystal Structure Of The Pctaire1 Kinase In Complex | 1e-27 | ||
| 3gbz_A | 329 | Structure Of The Cmgc Cdk Kinase From Giardia Lambl | 2e-27 | ||
| 2w99_B | 306 | Crystal Structure Of Cdk4 In Complex With A D-Type | 2e-26 | ||
| 2w96_B | 306 | Crystal Structure Of Cdk4 In Complex With A D-Type | 2e-26 | ||
| 2w9f_B | 306 | Crystal Structure Of Cdk4 In Complex With A D-Type | 2e-26 | ||
| 3g33_A | 308 | Crystal Structure Of Cdk4CYCLIN D3 Length = 308 | 2e-25 | ||
| 2j51_A | 325 | Crystal Structure Of Human Ste20-Like Kinase Bound | 1e-24 | ||
| 2jfl_A | 325 | Crystal Structure Of Human Ste20-Like Kinase ( Diph | 1e-24 | ||
| 2jfm_A | 325 | Crystal Structure Of Human Ste20-Like Kinase (Unlig | 2e-24 | ||
| 3com_A | 314 | Crystal Structure Of Mst1 Kinase Length = 314 | 2e-23 | ||
| 2j7t_A | 302 | Crystal Structure Of Human Serine Threonine Kinase- | 3e-23 | ||
| 4bc6_A | 293 | Crystal Structure Of Human Serine Threonine Kinase- | 4e-23 | ||
| 4an2_A | 301 | Crystal Structures Of Human Mek1 With Carboxamide-B | 1e-22 | ||
| 3sls_A | 304 | Crystal Structure Of Human Mek-1 Kinase In Complex | 3e-22 | ||
| 2uv2_A | 287 | Crystal Structure Of Human Ste20-Like Kinase Bound | 7e-22 | ||
| 3orn_A | 307 | Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In | 2e-21 | ||
| 3oz6_A | 388 | Crystal Structure Of Mapk From Cryptosporidium Parv | 5e-21 | ||
| 2cdz_A | 303 | Crystal Structure Of The Human P21-Activated Kinase | 1e-20 | ||
| 4fif_A | 346 | Catalytic Domain Of Human Pak4 With Rpkplvdp Peptid | 1e-20 | ||
| 2q0n_A | 301 | Structure Of Human P21 Activating Kinase 4 (Pak4) I | 1e-20 | ||
| 2bva_A | 292 | Crystal Structure Of The Human P21-Activated Kinase | 1e-20 | ||
| 2x4z_A | 296 | Crystal Structure Of The Human P21-Activated Kinase | 2e-20 | ||
| 1s9i_A | 354 | X-Ray Structure Of The Human Mitogen-Activated Prot | 2e-20 | ||
| 4fie_A | 423 | Full-Length Human Pak4 Length = 423 | 2e-20 | ||
| 2y4i_C | 395 | Ksr2-Mek1 Heterodimer Length = 395 | 2e-20 | ||
| 1s9j_A | 341 | X-Ray Structure Of The Human Mitogen-Activated Prot | 2e-20 | ||
| 2p55_A | 333 | X-Ray Structure Of The Human Mitogen-Activated Prot | 2e-20 | ||
| 3mbl_A | 328 | Crystal Structure Of The Human Mitogen-Activated Pr | 2e-20 | ||
| 3dv3_A | 322 | Mek1 With Pf-04622664 Bound Length = 322 | 2e-20 | ||
| 3eqc_A | 360 | X-Ray Structure Of The Human Mitogen-Activated Prot | 2e-20 | ||
| 1u5q_A | 348 | Crystal Structure Of The Tao2 Kinase Domain: Activa | 3e-20 | ||
| 2b9f_A | 353 | Crystal Structure Of Non-Phosphorylated Fus3 Length | 3e-20 | ||
| 2f9g_A | 353 | Crystal Structure Of Fus3 Phosphorylated On Tyr182 | 3e-20 | ||
| 2b9h_A | 353 | Crystal Structure Of Fus3 With A Docking Motif From | 3e-20 | ||
| 4b99_A | 398 | Crystal Structure Of Mapk7 (Erk5) With Inhibitor Le | 3e-20 | ||
| 3d83_A | 360 | Crystal Structure Of P38 Kinase In Complex With A B | 3e-20 | ||
| 2gcd_A | 309 | Tao2 Kinase Domain-Staurosporine Structure Length = | 3e-20 | ||
| 1ove_A | 366 | The Structure Of P38 Alpha In Complex With A Dihydr | 3e-20 | ||
| 3bhy_A | 283 | Crystal Structure Of Human Death Associated Protein | 3e-20 | ||
| 2y8o_A | 362 | Crystal Structure Of Human P38alpha Complexed With | 3e-20 | ||
| 4ic7_A | 442 | Crystal Structure Of The Erk5 Kinase Domain In Comp | 4e-20 | ||
| 3lij_A | 494 | Crystal Structure Of Full Length Cpcdpk3 (Cgd5_820) | 5e-20 | ||
| 3d7z_A | 360 | Crystal Structure Of P38 Kinase In Complex With A B | 5e-20 | ||
| 3p4k_A | 370 | The Third Conformation Of P38a Map Kinase Observed | 5e-20 | ||
| 4apc_A | 350 | Crystal Structure Of Human Nima-Related Kinase 1 (N | 5e-20 | ||
| 2baq_A | 365 | P38alpha Bound To Ro3201195 Length = 365 | 5e-20 | ||
| 1ywr_A | 360 | Crystal Structure Analysis Of Inactive P38 Kinase D | 5e-20 | ||
| 1yw2_A | 360 | Mutated Mus Musculus P38 Kinase (Mp38) Length = 360 | 5e-20 | ||
| 1lew_A | 360 | Crystal Structure Of Map Kinase P38 Complexed To Th | 6e-20 | ||
| 1yrp_A | 278 | Catalytic Domain Of Human Zip Kinase Phosphorylated | 6e-20 | ||
| 2bal_A | 365 | P38alpha Map Kinase Bound To Pyrazoloamine Length = | 6e-20 | ||
| 3e92_A | 371 | Crystal Structure Of P38 Kinase In Complex With A B | 6e-20 | ||
| 3py3_A | 380 | Crystal Structure Of Phosphorylated P38alpha Map Ki | 7e-20 | ||
| 3tg1_A | 380 | Crystal Structure Of P38alpha In Complex With A Map | 7e-20 | ||
| 2oza_B | 366 | Structure Of P38alpha Complex Length = 366 | 7e-20 | ||
| 4e5a_X | 360 | The W197a Mutant Of P38a Map Kinase Length = 360 | 7e-20 | ||
| 3fi4_A | 372 | P38 Kinase Crystal Structure In Complex With Ro4499 | 7e-20 | ||
| 2j90_A | 304 | Crystal Structure Of Human Zip Kinase In Complex Wi | 7e-20 | ||
| 3gcp_A | 360 | Human P38 Map Kinase In Complex With Sb203580 Lengt | 7e-20 | ||
| 3igo_A | 486 | Crystal Structure Of Cryptosporidium Parvum Cdpk1, | 7e-20 | ||
| 1bmk_A | 379 | The Complex Structure Of The Map Kinase P38SB218655 | 7e-20 | ||
| 2f57_A | 317 | Crystal Structure Of The Human P21-activated Kinase | 8e-20 | ||
| 2gtm_A | 348 | Mutated Mouse P38 Map Kinase Domain In Complex With | 8e-20 | ||
| 2fso_X | 367 | Mitogen Activated Protein Kinase P38alpha (D176a) A | 8e-20 | ||
| 2fsl_X | 367 | Mitogen Activated Protein Kinase P38alpha (D176a+f3 | 8e-20 | ||
| 2ghl_A | 348 | Mutant Mus Musculus P38 Kinase Domain In Complex Wi | 8e-20 | ||
| 3k3j_A | 362 | P38alpha Bound To Novel Dfg-Out Compound Pf-0041612 | 8e-20 | ||
| 2fst_X | 367 | Mitogen Activated Protein Kinase P38alpha (d176a+f3 | 8e-20 | ||
| 3od6_X | 360 | Crystal Structure Of P38alpha Y323t Active Mutant L | 9e-20 | ||
| 3hvc_A | 362 | Crystal Structure Of Human P38alpha Map Kinase Leng | 9e-20 | ||
| 3odz_X | 360 | Crystal Structure Of P38alpha Y323r Active Mutant L | 9e-20 | ||
| 2npq_A | 367 | A Novel Lipid Binding Site In The P38 Alpha Map Kin | 9e-20 | ||
| 3oef_X | 360 | Crystal Structure Of Y323f Inactive Mutant Of P38al | 9e-20 | ||
| 3zsg_A | 362 | X-Ray Structure Of P38alpha Bound To Tak-715 Length | 9e-20 | ||
| 3ody_X | 360 | Crystal Structure Of P38alpha Y323q Active Mutant L | 9e-20 | ||
| 2baj_A | 365 | P38alpha Bound To Pyrazolourea Length = 365 | 9e-20 | ||
| 3hrb_A | 359 | P38 Kinase Crystal Structure In Complex With Small | 9e-20 | ||
| 3gcu_A | 360 | Human P38 Map Kinase In Complex With Rl48 Length = | 9e-20 | ||
| 4ewq_A | 383 | Human P38 Alpha Mapk In Complex With A Pyridazine B | 9e-20 | ||
| 1di9_A | 360 | The Structure Of P38 Mitogen-Activated Protein Kina | 1e-19 | ||
| 1oz1_A | 372 | P38 Mitogen-Activated Kinase In Complex With 4-Azai | 1e-19 | ||
| 2gfs_A | 372 | P38 Kinase Crystal Structure In Complex With Ro3201 | 1e-19 | ||
| 1m7q_A | 366 | Crystal Structure Of P38 Map Kinase In Complex With | 1e-19 | ||
| 3mpt_A | 371 | Crystal Structure Of P38 Kinase In Complex With A P | 1e-19 | ||
| 3dt1_A | 383 | P38 Complexed With A Quinazoline Inhibitor Length = | 1e-19 | ||
| 1ian_A | 366 | Human P38 Map Kinase Inhibitor Complex Length = 366 | 1e-19 | ||
| 2lgc_A | 359 | Joint Nmr And X-Ray Refinement Reveals The Structur | 1e-19 | ||
| 1zzl_A | 351 | Crystal Structure Of P38 With Triazolopyridine Leng | 1e-19 | ||
| 3nnx_A | 354 | Crystal Structure Of Phosphorylated P38 Alpha In Co | 1e-19 | ||
| 3nnu_A | 354 | Crystal Structure Of P38 Alpha In Complex With Dp13 | 1e-19 | ||
| 3s3i_A | 349 | P38 Kinase Crystal Structure In Complex With Small | 1e-19 | ||
| 3hec_A | 348 | P38 In Complex With Imatinib Length = 348 | 1e-19 | ||
| 3kq7_A | 380 | Structure Of Human P38alpha With N-[4-Methyl-3-(6-{ | 1e-19 | ||
| 1bl6_A | 379 | The Complex Structure Of The Map Kinase P38SB216995 | 1e-19 | ||
| 3q5i_A | 504 | Crystal Structure Of Pbanka_031420 Length = 504 | 1e-19 | ||
| 3k3i_A | 350 | P38alpha Bound To Novel Dgf-Out Compound Pf-0021595 | 1e-19 | ||
| 2puu_A | 348 | Crystal Structure Of P38 Complex With 1-(5-Tert-But | 1e-19 | ||
| 2x7f_A | 326 | Crystal Structure Of The Kinase Domain Of Human Tra | 2e-19 | ||
| 1cm8_A | 367 | Phosphorylated Map Kinase P38-Gamma Length = 367 | 2e-19 | ||
| 3mh2_A | 360 | Mutagenesis Of P38 Map Kinase Establishes Key Roles | 2e-19 | ||
| 2wei_A | 287 | Crystal Structure Of The Kinase Domain Of Cryptospo | 3e-19 | ||
| 3dfa_A | 286 | Crystal Structure Of Kinase Domain Of Calcium-depen | 3e-19 | ||
| 3dxn_A | 287 | Crystal Structure Of The Calcium-dependent Kinase F | 3e-19 | ||
| 3hzt_A | 467 | Crystal Structure Of Toxoplasma Gondii Cdpk3, Tgme4 | 4e-19 | ||
| 3mfr_A | 351 | Cask-4m Cam Kinase Domain, Native Length = 351 | 4e-19 | ||
| 1yhv_A | 297 | Crystal Structure Of Pak1 Kinase Domain With Two Po | 5e-19 | ||
| 3o8p_A | 360 | Conformational Plasticity Of P38 Map Kinase Dfg Mot | 6e-19 | ||
| 1f3m_C | 297 | Crystal Structure Of Human SerineTHREONINE KINASE P | 7e-19 | ||
| 3gi3_A | 360 | Crystal Structure Of A N-Phenyl-N'-Naphthylurea Ana | 7e-19 | ||
| 3mh0_A | 360 | Mutagenesis Of P38 Map Kinase Eshtablishes Key Role | 7e-19 | ||
| 3mh1_A | 360 | Mutagenesis Of P38 Map Kinase Establishes Key Roles | 9e-19 | ||
| 3oht_A | 389 | Crystal Structure Of Salmo Salar P38alpha Length = | 9e-19 | ||
| 3vum_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M7 | 1e-18 | ||
| 3mh3_A | 360 | Mutagenesis Of P38 Map Kinase Establishes Key Roles | 1e-18 | ||
| 2qnj_A | 328 | Kinase And Ubiquitin-Associated Domains Of Mark3PAR | 2e-18 | ||
| 2y0a_A | 326 | Structure Of Dapk1 Construct Residues 1-304 Length | 2e-18 | ||
| 3vul_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M1 | 2e-18 | ||
| 3fxz_A | 297 | Crystal Structure Of Pak1 Kinase Domain With Ruthen | 3e-18 | ||
| 3fe3_A | 328 | Crystal Structure Of The Kinase Mark3PAR-1: T211a-S | 3e-18 | ||
| 2w4k_A | 302 | X-Ray Structure Of A Dap-Kinase 2-302 Length = 302 | 3e-18 | ||
| 2yak_A | 285 | Structure Of Death-Associated Protein Kinase 1 (Dap | 3e-18 | ||
| 2xzs_A | 312 | Death Associated Protein Kinase 1 Residues 1-312 Le | 3e-18 | ||
| 2w4j_A | 277 | X-Ray Structure Of A Dap-Kinase 2-277 Length = 277 | 3e-18 | ||
| 1wvw_A | 278 | Crystal Structures Of Kinase Domain Of Dap Kinase I | 3e-18 | ||
| 1p4f_A | 293 | Death Associated Protein Kinase Catalytic Domain Wi | 3e-18 | ||
| 3f5u_A | 295 | Crystal Structure Of The Death Associated Protein K | 3e-18 | ||
| 1ig1_A | 294 | 1.8a X-Ray Structure Of Ternary Complex Of A Cataly | 4e-18 | ||
| 2x0g_A | 334 | X-ray Structure Of A Dap-kinase Calmodulin Complex | 4e-18 | ||
| 3dfc_B | 295 | Crystal Structure Of A Glycine-Rich Loop Mutant Of | 4e-18 | ||
| 3i79_A | 484 | Calcium-Dependent Protein Kinase 1 From Toxoplasma | 4e-18 | ||
| 2c30_A | 321 | Crystal Structure Of The Human P21-Activated Kinase | 4e-18 | ||
| 3gu4_A | 295 | Crystal Structure Of Dapkq23v-Amppnp Length = 295 | 5e-18 | ||
| 3hx4_A | 508 | Crystal Structure Of Cdpk1 Of Toxoplasma Gondii, Tg | 5e-18 | ||
| 3ku2_A | 507 | Crystal Structure Of Inactivated Form Of Cdpk1 From | 5e-18 | ||
| 3q52_A | 306 | Structure Of Phosphorylated Pak1 Kinase Domain Leng | 5e-18 | ||
| 4e7w_A | 394 | Structure Of Gsk3 From Ustilago Maydis Length = 394 | 5e-18 | ||
| 3is5_A | 285 | Crystal Structure Of Cdpk Kinase Domain From Toxopl | 6e-18 | ||
| 3gu8_A | 295 | Crystal Structure Of Dapkl93g With N6-Cyclopentylad | 6e-18 | ||
| 3ma6_A | 298 | Crystal Structure Of Kinase Domain Of Tgcdpk1 In Pr | 7e-18 | ||
| 2hak_A | 328 | Catalytic And Ubiqutin-Associated Domains Of Mark1P | 9e-18 | ||
| 3e7o_A | 360 | Crystal Structure Of Jnk2 Length = 360 | 1e-17 | ||
| 3mn3_A | 271 | An Inhibited Conformation For The Protein Kinase Do | 1e-17 | ||
| 3i7c_A | 484 | Calcium-Dependent Protein Kinase 1 From Toxoplasma | 1e-17 | ||
| 3fi3_A | 364 | Crystal Structure Of Jnk3 With Indazole Inhibitor, | 1e-17 | ||
| 3vuk_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M5 | 1e-17 | ||
| 3rp9_A | 458 | Crystal Structure Of The Apo Mapk From Toxoplasma G | 1e-17 | ||
| 1h8f_A | 352 | Glycogen Synthase Kinase 3 Beta. Length = 352 | 1e-17 | ||
| 3dae_A | 283 | Crystal Structure Of Phosphorylated Snf1 Kinase Dom | 1e-17 | ||
| 2fh9_A | 274 | Structure And Dimerization Of The Kinase Domain Fro | 1e-17 | ||
| 3hyh_A | 275 | Crystal Structure Of The Protein Kinase Domain Of Y | 1e-17 | ||
| 1o9u_A | 350 | Glycogen Synthase Kinase 3 Beta Complexed With Axin | 1e-17 | ||
| 3q4z_A | 306 | Structure Of Unphosphorylated Pak1 Kinase Domain Le | 1e-17 | ||
| 2xs0_A | 386 | Linear Binding Motifs For Jnk And For Calcineurin A | 1e-17 | ||
| 3kvx_A | 364 | Jnk3 Bound To Aminopyrimidine Inhibitor, Sr-3562 Le | 1e-17 | ||
| 2r9s_A | 356 | C-Jun N-Terminal Kinase 3 With 3,5-Disubstituted Qu | 1e-17 | ||
| 3sd0_A | 350 | Identification Of A Glycogen Synthase Kinase-3b Inh | 2e-17 | ||
| 2ow3_A | 352 | Glycogen Synthase Kinase-3 Beta In Complex With Bis | 2e-17 | ||
| 3v3v_A | 379 | Structural And Functional Analysis Of Quercetagetin | 2e-17 | ||
| 2xuu_A | 334 | Crystal Structure Of A Dap-Kinase 1 Mutant Length = | 2e-17 | ||
| 3rgf_A | 405 | Crystal Structure Of Human Cdk8CYCC Length = 405 | 2e-17 | ||
| 2o5k_A | 372 | Crystal Structure Of Gsk3beta In Complex With A Ben | 2e-17 | ||
| 3vui_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M2 | 2e-17 | ||
| 1zmu_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 2e-17 | ||
| 3vuh_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M3 | 2e-17 | ||
| 1uv5_A | 350 | Glycogen Synthase Kinase 3 Beta Complexed With 6-Br | 2e-17 | ||
| 1q5k_A | 414 | Crystal Structure Of Glycogen Synthase Kinase 3 In | 2e-17 | ||
| 2r0i_A | 327 | Crystal Structure Of A Kinase Mark2PAR-1 Mutant Len | 2e-17 | ||
| 1r0e_A | 391 | Glycogen Synthase Kinase-3 Beta In Complex With 3-I | 2e-17 | ||
| 3gb2_A | 353 | Gsk3beta Inhibitor Complex Length = 353 | 2e-17 | ||
| 4afj_A | 367 | 5-Aryl-4-Carboxamide-1,3-Oxazoles: Potent And Selec | 2e-17 | ||
| 4dit_A | 382 | Crystal Structure Of Gsk3beta In Complex With A Imi | 2e-17 | ||
| 3zdi_A | 350 | Glycogen Synthase Kinase 3 Beta Complexed With Axin | 2e-17 | ||
| 1i09_A | 420 | Structure Of Glycogen Synthase Kinase-3 (Gsk3b) Len | 2e-17 | ||
| 3zrk_A | 371 | Identification Of 2-(4-Pyridyl)thienopyridinones As | 2e-17 | ||
| 3iec_A | 319 | Helicobacter Pylori Caga Inhibits Par1MARK FAMILY K | 2e-17 | ||
| 3f7z_A | 350 | X-ray Co-crystal Structure Of Glycogen Synthase Kin | 2e-17 | ||
| 1zmw_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 2e-17 | ||
| 1gng_A | 378 | Glycogen Synthase Kinase-3 Beta (Gsk3) Complex With | 2e-17 | ||
| 3npc_A | 364 | Crystal Structure Of Jnk2 Complexed With Birb796 Le | 2e-17 | ||
| 3say_A | 430 | Crystal Structure Of Human Glycogen Synthase Kinase | 2e-17 | ||
| 3f88_A | 349 | Glycogen Synthase Kinase 3beta Inhibitor Complex Le | 2e-17 | ||
| 4acc_A | 465 | Gsk3b In Complex With Inhibitor Length = 465 | 2e-17 | ||
| 1pyx_A | 422 | Gsk-3 Beta Complexed With Amp-Pnp Length = 422 | 2e-17 | ||
| 4h3q_A | 362 | Crystal Structure Of Human Erk2 Complexed With A Ma | 2e-17 | ||
| 3fv8_A | 355 | Jnk3 Bound To Piperazine Amide Inhibitor, Sr2774 Le | 2e-17 | ||
| 1q3d_A | 424 | Gsk-3 Beta Complexed With Staurosporine Length = 42 | 2e-17 | ||
| 3o17_A | 370 | Crystal Structure Of Jnk1-Alpha1 Isoform Length = 3 | 3e-17 | ||
| 2y94_A | 476 | Structure Of An Active Form Of Mammalian Ampk Lengt | 3e-17 | ||
| 1koa_A | 491 | Twitchin Kinase Fragment (C.Elegans), Autoregulated | 3e-17 | ||
| 3uto_A | 573 | Twitchin Kinase Region From C.Elegans (Fn31-Nl-Kin- | 3e-17 | ||
| 3fi2_A | 353 | Crystal Structure Of Jnk3 With Amino-Pyrazole Inhib | 3e-17 | ||
| 1kob_A | 387 | Twitchin Kinase Fragment (Aplysia), Autoregulated P | 4e-17 | ||
| 2xrw_A | 371 | Linear Binding Motifs For Jnk And For Calcineurin A | 4e-17 | ||
| 1zmv_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 4e-17 | ||
| 2wzj_A | 327 | Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82 | 4e-17 | ||
| 1ukh_A | 369 | Structural Basis For The Selective Inhibition Of Jn | 4e-17 | ||
| 3pze_A | 358 | Jnk1 In Complex With Inhibitor Length = 358 | 4e-17 | ||
| 2g01_A | 370 | Pyrazoloquinolones As Novel, Selective Jnk1 Inhibit | 4e-17 | ||
| 3elj_A | 369 | Jnk1 Complexed With A Bis-Anilino-Pyrrolopyrimidine | 4e-17 | ||
| 1pmn_A | 364 | Crystal Structure Of Jnk3 In Complex With An Imidaz | 5e-17 | ||
| 2ok1_A | 365 | Crystal Structure Of Jnk3 Bound To N-Benzyl-4-(4-(3 | 5e-17 | ||
| 3ttj_A | 464 | Crystal Structure Of Jnk3 Complexed With Cc-359, A | 5e-17 | ||
| 2o0u_A | 364 | Crystal Structure Of Human Jnk3 Complexed With N-{3 | 5e-17 | ||
| 3tei_A | 362 | Crystal Structure Of Human Erk2 Complexed With A Ma | 5e-17 | ||
| 3uc4_A | 362 | The Crystal Structure Of Snf1-Related Kinase 2.6 Le | 5e-17 | ||
| 3oxi_A | 362 | Design And Synthesis Of Disubstituted Thiophene And | 5e-17 | ||
| 3ptg_A | 363 | Design And Synthesis Of A Novel, Orally Efficacious | 5e-17 | ||
| 3vud_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M1 | 5e-17 | ||
| 4h36_A | 356 | Crystal Structure Of Jnk3 In Complex With Atf2 Pept | 5e-17 | ||
| 1jnk_A | 423 | The C-Jun N-Terminal Kinase (Jnk3s) Complexed With | 5e-17 | ||
| 4eqm_A | 294 | Structural Analysis Of Staphylococcus Aureus Serine | 5e-17 | ||
| 2b1p_A | 355 | Inhibitor Complex Of Jnk3 Length = 355 | 5e-17 | ||
| 3ujg_A | 361 | Crystal Structure Of Snrk2.6 In Complex With Hab1 L | 5e-17 | ||
| 2i6l_A | 320 | Crystal Structure Of Human Mitogen Activated Protei | 6e-17 | ||
| 3vug_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M2 | 6e-17 | ||
| 2exc_X | 356 | Inhibitor Complex Of Jnk3 Length = 356 | 6e-17 | ||
| 3n9x_A | 432 | Crystal Structure Of Map Kinase From Plasmodium Ber | 7e-17 | ||
| 3a7f_A | 303 | Human Mst3 Kinase Length = 303 | 8e-17 | ||
| 3ckx_A | 304 | Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3 | 8e-17 | ||
| 3ckw_A | 304 | Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3 | 8e-17 | ||
| 4fv7_A | 360 | Crystal Structure Of The Erk2 Complexed With E94 Le | 8e-17 | ||
| 3h4j_B | 336 | Crystal Structure Of Pombe Ampk Kdaid Fragment Leng | 8e-17 | ||
| 3zhp_C | 294 | Human Mst3 (stk24) In Complex With Mo25beta Length | 8e-17 | ||
| 2xik_A | 294 | Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related K | 8e-17 | ||
| 4fux_A | 360 | Crystal Structure Of The Erk2 Complexed With E75 Le | 8e-17 | ||
| 3coi_A | 353 | Crystal Structure Of P38delta Kinase Length = 353 | 9e-17 | ||
| 1y8g_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 9e-17 | ||
| 4gsb_A | 364 | Monoclinic Crystal Form Of The Apo-Erk2 Length = 36 | 9e-17 | ||
| 2y9q_A | 362 | Crystal Structure Of Human Erk2 Complexed With A Ma | 1e-16 | ||
| 3qyw_A | 364 | Crystal Structure Of Erk2 In Complex With An Inhibi | 1e-16 | ||
| 4fv6_A | 360 | Crystal Structure Of The Erk2 Complexed With E57 Le | 1e-16 | ||
| 1wzy_A | 368 | Crystal Structure Of Human Erk2 Complexed With A Py | 1e-16 | ||
| 1tvo_A | 368 | The Structure Of Erk2 In Complex With A Small Molec | 1e-16 | ||
| 2ya9_A | 361 | Crystal Structure Of The Autoinhibited Form Of Mous | 1e-16 | ||
| 2ojg_A | 380 | Crystal Structure Of Erk2 In Complex With N,n-dimet | 1e-16 | ||
| 4exu_A | 371 | Mapk13, Inactive Form Length = 371 | 1e-16 | ||
| 3o71_A | 358 | Crystal Structure Of Erk2DCC PEPTIDE COMPLEX Length | 1e-16 | ||
| 3zu7_A | 365 | Crystal Structure Of A Designed Selected Ankyrin Re | 1e-16 | ||
| 2z7l_A | 366 | Unphosphorylated Mitogen Activated Protein Kinase E | 1e-16 | ||
| 3c9w_A | 357 | Crystal Structure Of Erk-2 With Hypothemycin Covale | 1e-16 | ||
| 2fys_B | 364 | Crystal Structure Of Erk2 Complex With Kim Peptide | 1e-16 | ||
| 1pme_A | 380 | Structure Of Penta Mutant Human Erk2 Map Kinase Com | 2e-16 | ||
| 3r63_A | 358 | Structure Of Erk2 (Spe) Mutant (S246e) Length = 358 | 2e-16 | ||
| 3daj_A | 272 | Crystal Structure Of Aurora A Complexed With An Inh | 2e-16 | ||
| 3s95_A | 310 | Crystal Structure Of The Human Limk1 Kinase Domain | 2e-16 | ||
| 3d14_A | 272 | Crystal Structure Of Mouse Aurora A (Asn186->gly, L | 2e-16 | ||
| 3uc3_A | 361 | The Crystal Structure Of Snf1-Related Kinase 2.3 Le | 2e-16 | ||
| 3tac_A | 361 | Crystal Structure Of The Liprin-AlphaCASK COMPLEX L | 2e-16 | ||
| 4a4x_A | 279 | Nek2-Ede Bound To Cct248662 Length = 279 | 2e-16 | ||
| 3c0g_A | 351 | Cask Cam-kinase Domain- 3'-amp Complex, P1 Form Len | 2e-16 | ||
| 2gph_A | 364 | Docking Motif Interactions In The Map Kinase Erk2 L | 3e-16 | ||
| 2w5a_A | 279 | Human Nek2 Kinase Adp-Bound Length = 279 | 3e-16 | ||
| 2jav_A | 279 | Human Kinase With Pyrrole-Indolinone Ligand Length | 3e-16 | ||
| 1gol_A | 364 | Coordinates Of Rat Map Kinase Erk2 With An Arginine | 3e-16 | ||
| 3vn9_A | 340 | Rifined Crystal Structure Of Non-Phosphorylated Map | 3e-16 | ||
| 3gc9_A | 370 | The Structure Of P38beta C119s, C162s In Complex Wi | 3e-16 | ||
| 3zut_A | 362 | The Structure Of Ost1 (D160a) Kinase Length = 362 | 4e-16 | ||
| 3nie_A | 429 | Crystal Structure Of Pf11_0147 Length = 429 | 4e-16 | ||
| 3fme_A | 290 | Crystal Structure Of Human Mitogen-Activated Protei | 4e-16 | ||
| 3zuv_A | 364 | Crystal Structure Of A Designed Selected Ankyrin Re | 5e-16 | ||
| 2erk_A | 365 | Phosphorylated Map Kinase Erk2 Length = 365 | 5e-16 | ||
| 3zuu_A | 362 | The Structure Of Ost1 (D160a, S175d) Kinase In Comp | 5e-16 | ||
| 2dyl_A | 318 | Crystal Structure Of Human Mitogen-Activated Protei | 6e-16 | ||
| 3coh_A | 268 | Crystal Structure Of Aurora-A In Complex With A Pen | 7e-16 | ||
| 2w4o_A | 349 | Crystal Structure Of Human Camk4 In Complex With 4- | 7e-16 | ||
| 3uib_A | 362 | Map Kinase Lmampk10 From Leishmania Major In Comple | 8e-16 | ||
| 3pg1_A | 362 | Map Kinase Lmampk10 From Leishmania Major (1.95 Ang | 8e-16 | ||
| 3gc8_A | 370 | The Structure Of P38beta C162s In Complex With A Di | 8e-16 | ||
| 2yza_A | 276 | Crystal Structure Of Kinase Domain Of Human 5'-Amp- | 1e-15 | ||
| 2h6d_A | 276 | Protein Kinase Domain Of The Human 5'-Amp-Activated | 1e-15 | ||
| 3cok_A | 278 | Crystal Structure Of Plk4 Kinase Length = 278 | 1e-15 | ||
| 1wmk_A | 321 | Human Death-Associated Kinase Drp-1, Mutant S308d D | 1e-15 | ||
| 2bfy_A | 284 | Complex Of Aurora-B With Incenp And Hesperidin. Len | 1e-15 | ||
| 2bfx_B | 284 | Mechanism Of Aurora-B Activation By Incenp And Inhi | 1e-15 | ||
| 2vrx_A | 285 | Structure Of Aurora B Kinase In Complex With Zm4474 | 1e-15 | ||
| 1zy4_A | 303 | Crystal Structure Of Eif2alpha Protein Kinase Gcn2: | 1e-15 | ||
| 2a27_A | 321 | Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal | 1e-15 | ||
| 3sa0_A | 360 | Complex Of Erk2 With Norathyriol Length = 360 | 1e-15 | ||
| 2zoq_A | 382 | Structural Dissection Of Human Mitogen-Activated Ki | 1e-15 | ||
| 1zyc_A | 303 | Crystal Structure Of Eif2alpha Protein Kinase Gcn2: | 1e-15 | ||
| 1zws_A | 288 | Crystal Structure Of The Catalytic Domain Of Human | 1e-15 | ||
| 2a2a_A | 321 | High-resolution Crystallographic Analysis Of The Au | 1e-15 | ||
| 1z9x_A | 321 | Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal | 1e-15 | ||
| 2j4z_A | 306 | Structure Of Aurora-2 In Complex With Pha-680626 Le | 1e-15 | ||
| 3qbn_A | 281 | Structure Of Human Aurora A In Complex With A Diami | 2e-15 | ||
| 2bmc_A | 306 | Aurora-2 T287d T288d Complexed With Pha-680632 Leng | 2e-15 | ||
| 3o50_A | 267 | Crystal Structure Of Benzamide 9 Bound To Auroraa L | 2e-15 | ||
| 3e5a_A | 268 | Crystal Structure Of Aurora A In Complex With Vx-68 | 2e-15 | ||
| 2jam_A | 304 | Crystal Structure Of Human Calmodulin-Dependent Pro | 2e-15 | ||
| 3h0y_A | 268 | Aurora A In Complex With A Bisanilinopyrimidine Len | 2e-15 | ||
| 2w1d_A | 275 | Structure Determination Of Aurora Kinase In Complex | 2e-15 | ||
| 1muo_A | 297 | Crystal Structure Of Aurora-2, An Oncogenic Serine- | 2e-15 | ||
| 3ha6_A | 268 | Crystal Structure Of Aurora A In Complex With Tpx2 | 2e-15 | ||
| 2w1c_A | 275 | Structure Determination Of Aurora Kinase In Complex | 2e-15 | ||
| 2c6d_A | 275 | Aurora A Kinase Activated Mutant (T287d) In Complex | 2e-15 | ||
| 1ol5_A | 282 | Structure Of Aurora-A 122-403, Phosphorylated On Th | 2e-15 | ||
| 3r21_A | 271 | Design, Synthesis, And Biological Evaluation Of Pyr | 2e-15 | ||
| 3lau_A | 287 | Crystal Structure Of Aurora2 Kinase In Complex With | 2e-15 | ||
| 2xru_A | 280 | Aurora-A T288e Complexed With Pha-828300 Length = 2 | 2e-15 | ||
| 2x6d_A | 285 | Aurora-A Bound To An Inhibitor Length = 285 | 2e-15 | ||
| 2dwb_A | 285 | Aurora-A Kinase Complexed With Amppnp Length = 285 | 2e-15 | ||
| 2xng_A | 283 | Structure Of Aurora-A Bound To A Selective Imidazop | 2e-15 | ||
| 2j50_A | 280 | Structure Of Aurora-2 In Complex With Pha-739358 Le | 2e-15 | ||
| 3gp0_A | 348 | Crystal Structure Of Human Mitogen Activated Protei | 2e-15 | ||
| 2c6e_A | 283 | Aurora A Kinase Activated Mutant (T287d) In Complex | 2e-15 | ||
| 1mq4_A | 272 | Crystal Structure Of Aurora-A Protein Kinase Length | 2e-15 | ||
| 3unz_A | 279 | Aurora A In Complex With Rpm1679 Length = 279 | 2e-15 | ||
| 3nrm_A | 283 | Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibito | 2e-15 | ||
| 3fdn_A | 279 | Structure-Based Drug Design Of Novel Aurora Kinase | 2e-15 | ||
| 3e3p_A | 360 | Glycogen Synthase Kinase From Leishmania Major Leng | 2e-15 | ||
| 2y7j_A | 365 | Structure Of Human Phosphorylase Kinase, Gamma 2 Le | 3e-15 | ||
| 3udb_A | 317 | Crystal Structure Of Snrk2.6 Length = 317 | 3e-15 | ||
| 3ggf_A | 301 | Crystal Structure Of Human SerineTHREONINE-Protein | 3e-15 | ||
| 2wqe_A | 262 | Structure Of S155r Aurora-A Somatic Mutant Length = | 4e-15 | ||
| 2wtk_C | 305 | Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo2 | 4e-15 | ||
| 2wtv_A | 285 | Aurora-A Inhibitor Structure Length = 285 | 6e-15 | ||
| 2xne_A | 272 | Structure Of Aurora-A Bound To An Imidazopyrazine I | 6e-15 | ||
| 1ol6_A | 282 | Structure Of Unphosphorylated D274n Mutant Of Auror | 6e-15 | ||
| 2wtw_A | 285 | Aurora-A Inhibitor Structure (2nd Crystal Form) Len | 6e-15 | ||
| 4gs6_A | 315 | Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxoz | 1e-14 | ||
| 4e6d_A | 298 | Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex W | 1e-14 | ||
| 2eva_A | 307 | Structural Basis For The Interaction Of Tak1 Kinase | 1e-14 | ||
| 2wqm_A | 310 | Structure Of Apo Human Nek7 Length = 310 | 1e-14 | ||
| 1zxe_A | 303 | Crystal Structure Of Eif2alpha Protein Kinase Gcn2: | 1e-14 | ||
| 4eut_A | 396 | Structure Of Bx-795 Complexed With Unphosphorylated | 1e-14 | ||
| 3bkb_A | 377 | Crystal Structure Of Human Feline Sarcoma Viral Onc | 1e-14 | ||
| 3cd3_A | 377 | Crystal Structure Of Phosphorylated Human Feline Sa | 2e-14 | ||
| 1a06_A | 332 | Calmodulin-Dependent Protein Kinase From Rat Length | 2e-14 | ||
| 4euu_A | 319 | Structure Of Bx-795 Complexed With Human Tbk1 Kinas | 2e-14 | ||
| 3p1a_A | 311 | Structure Of Human Membrane-Associated Tyrosine- An | 3e-14 | ||
| 4fg7_A | 293 | Crystal Structure Of Human Calcium/calmodulin-depen | 4e-14 | ||
| 3vw6_A | 269 | Crystal Structure Of Human Apoptosis Signal-Regulat | 4e-14 | ||
| 2clq_A | 295 | Structure Of Mitogen-Activated Protein Kinase Kinas | 4e-14 | ||
| 4fg9_A | 320 | Crystal Structure Of Human Calcium/calmodulin-depen | 4e-14 | ||
| 4fg8_A | 315 | Crystal Structure Of Human Calcium/calmodulin-depen | 4e-14 | ||
| 1fot_A | 318 | Structure Of The Unliganded Camp-Dependent Protein | 4e-14 | ||
| 3tjc_A | 298 | Co-Crystal Structure Of Jak2 With Thienopyridine 8 | 5e-14 | ||
| 2w1i_A | 326 | Structure Determination Of Aurora Kinase In Complex | 5e-14 | ||
| 3ugc_A | 295 | Structural Basis Of Jak2 Inhibition By The Type Ii | 5e-14 | ||
| 3rvg_A | 303 | Crystals Structure Of Jak2 With A 1-Amino-5h-Pyrido | 5e-14 | ||
| 2b7a_A | 293 | The Structural Basis Of Janus Kinase 2 Inhibition B | 5e-14 | ||
| 4hge_A | 300 | Jak2 Kinase (Jh1 Domain) In Complex With Compound 8 | 5e-14 | ||
| 4e4m_A | 302 | Jak2 Kinase (Jh1 Domain) In Complex With Compound 3 | 5e-14 | ||
| 3e62_A | 293 | Fragment Based Discovery Of Jak-2 Inhibitors Length | 5e-14 | ||
| 4aqc_A | 301 | Triazolopyridine-Based Inhibitor Of Janus Kinase 2 | 5e-14 | ||
| 3q32_A | 301 | Structure Of Janus Kinase 2 With A Pyrrolotriazine | 5e-14 | ||
| 2xa4_A | 298 | Inhibitors Of Jak2 Kinase Domain Length = 298 | 5e-14 | ||
| 3lpb_A | 295 | Crystal Structure Of Jak2 Complexed With A Potent 2 | 6e-14 | ||
| 3io7_A | 313 | 2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Sel | 6e-14 | ||
| 3jy9_A | 311 | Janus Kinase 2 Inhibitors Length = 311 | 6e-14 | ||
| 3enm_A | 316 | The Structure Of The Map2k Mek6 Reveals An Autoinhi | 6e-14 | ||
| 1ql6_A | 298 | The Catalytic Mechanism Of Phosphorylase Kinase Pro | 7e-14 | ||
| 1phk_A | 298 | Two Structures Of The Catalytic Domain Of Phosphory | 7e-14 | ||
| 3l9m_A | 351 | Crystal Structure Of Pkab3 (Pka Triple Mutant V123a | 1e-13 | ||
| 1cdk_A | 350 | Camp-Dependent Protein Kinase Catalytic Subunit (E. | 1e-13 | ||
| 2jc6_A | 334 | Crystal Structure Of Human Calmodulin-Dependent Pro | 1e-13 | ||
| 2phk_A | 277 | The Crystal Structure Of A Phosphorylase Kinase Pep | 1e-13 | ||
| 1cmk_E | 350 | Crystal Structures Of The Myristylated Catalytic Su | 1e-13 | ||
| 1ctp_E | 350 | Structure Of The Mammalian Catalytic Subunit Of Cam | 2e-13 | ||
| 4bbe_A | 298 | Aminoalkylpyrimidine Inhibitor Complexes With Jak2 | 2e-13 | ||
| 4ae9_A | 343 | Structure And Function Of The Human Sperm-specific | 2e-13 | ||
| 4ae6_A | 343 | Structure And Function Of The Human Sperm-specific | 2e-13 | ||
| 3qa8_A | 676 | Crystal Structure Of Inhibitor Of Kappa B Kinase Be | 2e-13 | ||
| 3rzf_A | 677 | Crystal Structure Of Inhibitor Of Kappab Kinase Bet | 2e-13 | ||
| 3agm_A | 351 | Complex Of Pka With The Bisubstrate Protein Kinase | 2e-13 | ||
| 3nx8_A | 351 | Human Camp Dependent Protein Kinase In Complex With | 2e-13 | ||
| 3agl_A | 351 | Complex Of Pka With The Bisubstrate Protein Kinase | 2e-13 | ||
| 2wel_A | 327 | Crystal Structure Of Su6656-Bound CalciumCALMODULIN | 2e-13 | ||
| 3mvj_A | 371 | Human Cyclic Amp-Dependent Protein Kinase Pka Inhib | 3e-13 | ||
| 2ydj_A | 276 | Discovery Of Checkpoint Kinase Inhibitor Azd7762 By | 3e-13 | ||
| 2vn9_A | 301 | Crystal Structure Of Human Calcium Calmodulin Depen | 3e-13 | ||
| 4fsz_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 3e-13 | ||
| 1q61_A | 350 | Pka Triple Mutant Model Of Pkb Length = 350 | 3e-13 | ||
| 2qg5_A | 294 | Cryptosporidium Parvum Calcium Dependent Protein Ki | 3e-13 | ||
| 1szm_A | 350 | Dual Binding Mode Of Bisindolylmaleimide 2 To Prote | 3e-13 | ||
| 3ll6_A | 337 | Crystal Structure Of The Human Cyclin G Associated | 3e-13 | ||
| 3dls_A | 335 | Crystal Structure Of Human Pas Kinase Bound To Adp | 3e-13 | ||
| 3f3z_A | 277 | Crystal Structure Of Cryptosporidium Parvum Calcium | 3e-13 | ||
| 4fsy_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 3e-13 | ||
| 3kk9_A | 282 | Camkii Substrate Complex B Length = 282 | 3e-13 | ||
| 3kl8_A | 269 | Camkiintide Inhibitor Complex Length = 269 | 3e-13 | ||
| 2gnj_A | 350 | Pka Three Fold Mutant Model Of Rho-Kinase With Y-27 | 3e-13 | ||
| 3kk8_A | 284 | Camkii Substrate Complex A Length = 284 | 3e-13 | ||
| 2z60_A | 288 | Crystal Structure Of The T315i Mutant Of Abl Kinase | 3e-13 | ||
| 3oy3_A | 284 | Crystal Structure Of Abl T315i Mutant Kinase Domain | 4e-13 | ||
| 2gnf_A | 350 | Protein Kinase A Fivefold Mutant Model Of Rho-Kinas | 4e-13 | ||
| 2bdw_A | 362 | Crystal Structure Of The Auto-Inhibited Kinase Doma | 4e-13 | ||
| 3ama_A | 351 | Protein Kinase A Sixfold Mutant Model Of Aurora B W | 4e-13 | ||
| 2gng_A | 350 | Protein Kinase A Fivefold Mutant Model Of Rho-Kinas | 4e-13 | ||
| 3dk7_A | 277 | Crystal Structure Of Mutant Abl Kinase Domain In Co | 4e-13 | ||
| 3aln_A | 327 | Crystal Structure Of Human Non-Phosphorylated Mkk4 | 4e-13 | ||
| 1rjb_A | 344 | Crystal Structure Of Flt3 Length = 344 | 4e-13 | ||
| 1ydt_E | 350 | Structure Of Camp-Dependent Protein Kinase, Alpha-C | 4e-13 | ||
| 2uzt_A | 336 | Pka Structures Of Akt, Indazole-Pyridine Inhibitors | 4e-13 | ||
| 3oxz_A | 284 | Crystal Structure Of Abl Kinase Domain Bound With A | 5e-13 | ||
| 3qrj_A | 277 | The Crystal Structure Of Human Abl1 Kinase Domain T | 5e-13 | ||
| 2e9v_A | 268 | Structure Of H-Chk1 Complexed With A859017 Length = | 5e-13 | ||
| 2c1a_A | 351 | Structure Of Camp-Dependent Protein Kinase Complexe | 5e-13 | ||
| 3dnd_A | 350 | Camp-Dependent Protein Kinase Pka Catalytic Subunit | 5e-13 | ||
| 2zv2_A | 298 | Crystal Structure Of Human CalciumCALMODULIN-Depend | 5e-13 | ||
| 1svh_A | 350 | Crystal Structure Of Protein Kinase A In Complex Wi | 5e-13 | ||
| 1fpu_A | 293 | Crystal Structure Of Abl Kinase Domain In Complex W | 5e-13 | ||
| 2f7e_E | 351 | Pka Complexed With (S)-2-(1h-Indol-3-Yl)-1-(5-Isoqu | 5e-13 | ||
| 1stc_E | 350 | Camp-Dependent Protein Kinase, Alpha-Catalytic Subu | 5e-13 | ||
| 2jds_A | 351 | Structure Of Camp-Dependent Protein Kinase Complexe | 5e-13 | ||
| 1q8w_A | 350 | The Catalytic Subunit Of Camp-Dependent Protein Kin | 6e-13 | ||
| 2ghg_A | 269 | H-Chk1 Complexed With A431994 Length = 269 | 6e-13 | ||
| 2nry_A | 307 | Crystal Structure Of Irak-4 Length = 307 | 6e-13 | ||
| 2nru_A | 307 | Crystal Structure Of Irak-4 Length = 307 | 6e-13 | ||
| 2ayp_A | 269 | Crystal Structure Of Chk1 With An Indol Inhibitor L | 6e-13 | ||
| 4fst_A | 269 | Crystal Structure Of The Chk1 Length = 269 | 6e-13 | ||
| 3jvr_A | 271 | Characterization Of The Chk1 Allosteric Inhibitor B | 6e-13 | ||
| 2x8e_A | 276 | Discovery Of A Novel Class Of Triazolones As Checkp | 6e-13 | ||
| 1xh7_A | 350 | Crystal Structures Of Protein Kinase B Selective In | 6e-13 | ||
| 2oib_A | 301 | Crystal Structure Of Irak4 Kinase Domain Apo Form L | 6e-13 | ||
| 4fsn_A | 278 | Crystal Structure Of The Chk1 Length = 278 | 6e-13 | ||
| 4fsm_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 6e-13 | ||
| 2v7a_A | 286 | Crystal Structure Of The T315i Abl Mutant In Comple | 6e-13 | ||
| 2qoh_A | 288 | Crystal Structure Of Abl Kinase Bound With Ppy-a Le | 6e-13 | ||
| 4ft3_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 6e-13 | ||
| 3dk3_A | 293 | Crystal Structure Of Mutant Abl Kinase Domain In Co | 6e-13 | ||
| 1q24_A | 350 | Pka Double Mutant Model Of Pkb In Complex With Mgat | 6e-13 | ||
| 3ot3_A | 273 | X-Ray Crystal Structure Of Compound 22k Bound To Hu | 6e-13 | ||
| 2hog_A | 322 | Crystal Structure Of Chek1 In Complex With Inhibito | 6e-13 | ||
| 4fsw_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 6e-13 | ||
| 2r0u_A | 323 | Crystal Structure Of Chek1 In Complex With Inhibito | 6e-13 | ||
| 2br1_A | 297 | Structure-Based Design Of Novel Chk1 Inhibitors: In | 7e-13 | ||
| 1ia8_A | 289 | The 1.7 A Crystal Structure Of Human Cell Cycle Che | 7e-13 | ||
| 1zlt_A | 295 | Crystal Structure Of Chk1 Complexed With A Hymenald | 7e-13 | ||
| 3pyy_A | 298 | Discovery And Characterization Of A Cell-Permeable, | 7e-13 | ||
| 2vo0_A | 351 | Structure Of Pka-Pkb Chimera Complexed With C-(4-(4 | 7e-13 | ||
| 2uvy_A | 351 | Structure Of Pka-pkb Chimera Complexed With Methyl- | 8e-13 | ||
| 2f4j_A | 287 | Structure Of The Kinase Domain Of An Imatinib-Resis | 8e-13 | ||
| 2jdt_A | 351 | Structure Of Pka-Pkb Chimera Complexed With Isoquin | 8e-13 | ||
| 3qri_A | 277 | The Crystal Structure Of Human Abl1 Kinase Domain I | 8e-13 | ||
| 2hzi_A | 277 | Abl Kinase Domain In Complex With Pd180970 Length = | 8e-13 | ||
| 2hiw_A | 287 | Crystal Structure Of Inactive Conformation Abl Kina | 8e-13 | ||
| 3fhi_A | 350 | Crystal Structure Of A Complex Between The Catalyti | 9e-13 | ||
| 3qal_E | 350 | Crystal Structure Of Arg280ala Mutant Of Catalytic | 9e-13 | ||
| 2hyy_A | 273 | Human Abl Kinase Domain In Complex With Imatinib (S | 9e-13 | ||
| 2e2b_A | 293 | Crystal Structure Of The C-Abl Kinase Domain In Com | 9e-13 | ||
| 2g2f_A | 287 | A Src-Like Inactive Conformation In The Abl Tyrosin | 9e-13 | ||
| 1syk_A | 350 | Crystal Structure Of E230q Mutant Of Camp-Dependent | 9e-13 | ||
| 3pvb_A | 345 | Crystal Structure Of (73-244)ria:c Holoenzyme Of Ca | 9e-13 | ||
| 2erz_E | 351 | Crystal Structure Of C-amp Dependent Kinase (pka) B | 9e-13 | ||
| 1fmo_E | 350 | Crystal Structure Of A Polyhistidine-Tagged Recombi | 9e-13 | ||
| 1j3h_A | 350 | Crystal Structure Of Apoenzyme Camp-Dependent Prote | 9e-13 | ||
| 3qam_E | 350 | Crystal Structure Of Glu208ala Mutant Of Catalytic | 9e-13 | ||
| 3eb0_A | 383 | Crystal Structure Of Cgd4_240 From Cryptosporidium | 9e-13 | ||
| 2qur_A | 350 | Crystal Structure Of F327aK285P MUTANT OF CAMP-Depe | 9e-13 | ||
| 2hz0_A | 270 | Abl Kinase Domain In Complex With Nvp-Aeg082 Length | 9e-13 | ||
| 1jbp_E | 350 | Crystal Structure Of The Catalytic Subunit Of Camp- | 9e-13 | ||
| 2gqg_A | 278 | X-Ray Crystal Structure Of Dasatinib (Bms-354825) B | 9e-13 | ||
| 2qcs_A | 350 | A Complex Structure Between The Catalytic And Regul | 1e-12 | ||
| 2gu8_A | 337 | Discovery Of 2-pyrimidyl-5-amidothiophenes As Novel | 1e-12 | ||
| 1bkx_A | 350 | A Binary Complex Of The Catalytic Subunit Of Camp-D | 1e-12 | ||
| 2g1t_A | 287 | A Src-Like Inactive Conformation In The Abl Tyrosin | 1e-12 | ||
| 1apm_E | 350 | 2.0 Angstrom Refined Crystal Structure Of The Catal | 1e-12 | ||
| 1rdq_E | 350 | Hydrolysis Of Atp In The Crystal Of Y204a Mutant Of | 1e-12 | ||
| 3miy_A | 266 | X-Ray Crystal Structure Of Itk Complexed With Sunit | 1e-12 | ||
| 4dfy_A | 371 | Crystal Structure Of R194a Mutant Of Camp-Dependent | 1e-12 | ||
| 1l3r_E | 350 | Crystal Structure Of A Transition State Mimic Of Th | 1e-12 | ||
| 4dg3_E | 371 | Crystal Structure Of R336a Mutant Of Camp-dependent | 1e-12 | ||
| 2qr8_A | 342 | 2.0a X-ray Structure Of C-terminal Kinase Domain Of | 1e-12 | ||
| 2v7o_A | 336 | Crystal Structure Of Human Calcium-Calmodulin-Depen | 1e-12 | ||
| 4dfx_E | 350 | Crystal Structure Of Myristoylated K7c Catalytic Su | 1e-12 | ||
| 3lm0_A | 327 | Crystal Structure Of Human SerineTHREONINE KINASE 1 | 1e-12 | ||
| 3cly_A | 334 | Crystal Structure Of Fgf Receptor 2 (Fgfr2) Kinase | 1e-12 | ||
| 2pvy_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 1e-12 | ||
| 3kn5_A | 325 | Crystal Structure Of The C-Terminal Kinase Domain O | 2e-12 | ||
| 1sm2_A | 264 | Crystal Structure Of The Phosphorylated Interleukin | 2e-12 | ||
| 2pzp_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 2e-12 | ||
| 3o7l_B | 350 | Crystal Structure Of Phospholamban (1-19):pka C-Sub | 2e-12 | ||
| 3v5j_A | 266 | Crystal Structure Of Interleukin-2 Inducible T-Cell | 2e-12 | ||
| 3dk6_A | 293 | Crystal Structure Of Mutant Abl Kinase Domain In Co | 2e-12 | ||
| 1xh9_A | 350 | Crystal Structures Of Protein Kinase B Selective In | 2e-12 | ||
| 4hct_A | 269 | Crystal Structure Of Itk In Complex With Compound 5 | 2e-12 | ||
| 1zys_A | 273 | Co-Crystal Structure Of Checkpoint Kinase Chk1 With | 2e-12 | ||
| 3qgw_A | 286 | Crystal Structure Of Itk Kinase Bound To An Inhibit | 3e-12 | ||
| 2vz6_A | 313 | Structure Of Human Calcium Calmodulin Dependent Pro | 3e-12 | ||
| 2pzr_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 3e-12 | ||
| 1opk_A | 495 | Structural Basis For The Auto-Inhibition Of C-Abl T | 3e-12 | ||
| 2zv7_A | 279 | Lyn Tyrosine Kinase Domain, Apo Form Length = 279 | 3e-12 | ||
| 3lxk_A | 327 | Structural And Thermodynamic Characterization Of Th | 3e-12 | ||
| 2pvf_A | 334 | Crystal Structure Of Tyrosine Phosphorylated Activa | 3e-12 | ||
| 4hvd_A | 314 | Jak3 Kinase Domain In Complex With 2-cyclopropyl-5h | 3e-12 | ||
| 2qr7_A | 342 | 2.0a X-Ray Structure Of C-Terminal Kinase Domain Of | 3e-12 | ||
| 1gjo_A | 316 | The Fgfr2 Tyrosine Kinase Domain Length = 316 | 3e-12 | ||
| 4g3g_A | 350 | Crystal Structure Of Murine Nf-kappab Inducing Kina | 3e-12 | ||
| 2psq_A | 370 | Crystal Structure Of Unphosphorylated Unactivated W | 3e-12 | ||
| 3b2t_A | 311 | Structure Of Phosphotransferase Length = 311 | 3e-12 | ||
| 3ri1_A | 313 | Crystal Structure Of The Catalytic Domain Of Fgfr2 | 4e-12 | ||
| 3pjc_A | 315 | Crystal Structure Of Jak3 Complexed With A Potent A | 4e-12 | ||
| 1smh_A | 350 | Protein Kinase A Variant Complex With Completely Or | 4e-12 | ||
| 2fo0_A | 495 | Organization Of The Sh3-Sh2 Unit In Active And Inac | 5e-12 | ||
| 4fsu_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 5e-12 | ||
| 1opl_A | 537 | Structural Basis For The Auto-Inhibition Of C-Abl T | 5e-12 | ||
| 3beg_A | 381 | Crystal Structure Of Sr Protein Kinase 1 Complexed | 5e-12 | ||
| 2q0b_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 5e-12 | ||
| 1wbp_A | 397 | Srpk1 Bound To 9mer Docking Motif Peptide Length = | 6e-12 | ||
| 1vzo_A | 355 | The Structure Of The N-Terminal Kinase Domain Of Ms | 6e-12 | ||
| 3ppz_A | 309 | Crystal Structure Of Ctr1 Kinase Domain In Complex | 6e-12 | ||
| 2vwi_A | 303 | Structure Of The Osr1 Kinase, A Hypertension Drug T | 6e-12 | ||
| 2a19_B | 284 | Pkr Kinase Domain- Eif2alpha- Amp-Pnp Complex. Leng | 6e-12 | ||
| 2pz5_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 6e-12 | ||
| 3a4o_X | 286 | Lyn Kinase Domain Length = 286 | 7e-12 | ||
| 1yvj_A | 290 | Crystal Structure Of The Jak3 Kinase Domain In Comp | 7e-12 | ||
| 1yol_A | 283 | Crystal Structure Of Src Kinase Domain In Complex W | 7e-12 | ||
| 3dak_A | 290 | Crystal Structure Of Domain-Swapped Osr1 Kinase Dom | 7e-12 | ||
| 2pwl_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 8e-12 | ||
| 2py3_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 8e-12 | ||
| 1yoj_A | 283 | Crystal Structure Of Src Kinase Domain Length = 283 | 8e-12 | ||
| 3soa_A | 444 | Full-Length Human Camkii Length = 444 | 8e-12 | ||
| 2qq7_A | 286 | Crystal Structure Of Drug Resistant Src Kinase Doma | 9e-12 | ||
| 4g3c_A | 352 | Crystal Structure Of Apo Murine Nf-kappab Inducing | 9e-12 | ||
| 3g6h_A | 286 | Src Thr338ile Inhibited In The Dfg-Asp-Out Conforma | 9e-12 | ||
| 2oh4_A | 316 | Crystal Structure Of Vegfr2 With A Benzimidazole-Ur | 9e-12 | ||
| 3dqw_A | 286 | C-Src Kinase Domain Thr338ile Mutant In Complex Wit | 9e-12 | ||
| 3kxx_A | 317 | Structure Of The Mutant Fibroblast Growth Factor Re | 1e-11 | ||
| 4g3f_A | 336 | Crystal Structure Of Murine Nf-kappab Inducing Kina | 1e-11 | ||
| 3tt0_A | 382 | Co-Structure Of Fibroblast Growth Factor Receptor 1 | 1e-11 | ||
| 3js2_A | 317 | Crystal Structure Of Minimal Kinase Domain Of Fibro | 1e-11 | ||
| 1fgk_A | 310 | Crystal Structure Of The Tyrosine Kinase Domain Of | 1e-11 | ||
| 3rhx_B | 306 | Crystal Structure Of The Catalytic Domain Of Fgfr1 | 1e-11 | ||
| 3gql_A | 326 | Crystal Structure Of Activated Receptor Tyrosine Ki | 1e-11 | ||
| 3u4w_A | 275 | Src In Complex With Dna-Templated Macrocyclic Inhib | 1e-11 | ||
| 4f63_A | 309 | Crystal Structure Of Human Fibroblast Growth Factor | 1e-11 | ||
| 4af3_A | 292 | Human Aurora B Kinase In Complex With Incenp And Vx | 1e-11 | ||
| 3d7u_B | 277 | Structural Basis For The Recognition Of C-Src By It | 1e-11 | ||
| 3gvu_A | 292 | The Crystal Structure Of Human Abl2 In Complex With | 1e-11 | ||
| 2bdf_A | 279 | Src Kinase In Complex With Inhibitor Ap23451 Length | 1e-11 | ||
| 3c4f_A | 302 | Fgfr Tyrosine Kinase Domain In Complex With 3-(3- M | 1e-11 | ||
| 2oiq_A | 286 | Crystal Structure Of Chicken C-Src Kinase Domain In | 1e-11 | ||
| 1y57_A | 452 | Structure Of Unphosphorylated C-Src In Complex With | 1e-11 | ||
| 2hwo_A | 286 | Crystal Structure Of Src Kinase Domain In Complex W | 1e-11 | ||
| 1fmk_A | 452 | Crystal Structure Of Human Tyrosine-Protein Kinase | 1e-11 | ||
| 3uiu_A | 306 | Crystal Structure Of Apo-Pkr Kinase Domain Length = | 2e-11 | ||
| 4g31_A | 299 | Crystal Structure Of Gsk6414 Bound To Perk (R587-R1 | 2e-11 | ||
| 1ksw_A | 452 | Structure Of Human C-Src Tyrosine Kinase (Thr338gly | 2e-11 | ||
| 3t9t_A | 267 | Crystal Structure Of Btk Mutant (F435t,K596r) Compl | 2e-11 | ||
| 3svv_A | 286 | Crystal Structure Of T338c C-Src Covalently Bound T | 2e-11 | ||
| 3a60_A | 327 | Crystal Structure Of Unphosphorylated P70s6k1 (Form | 2e-11 | ||
| 3db6_A | 301 | Crystal Structure Of An Activated (Thr->asp) Polo-L | 2e-11 | ||
| 3gqi_A | 326 | Crystal Structure Of Activated Receptor Tyrosine Ki | 2e-11 | ||
| 3a62_A | 327 | Crystal Structure Of Phosphorylated P70s6k1 Length | 2e-11 | ||
| 2h8h_A | 535 | Src Kinase In Complex With A Quinazoline Inhibitor | 2e-11 | ||
| 3p86_A | 309 | Crystal Structure Of Ctr1 Kinase Domain Mutant D676 | 2e-11 | ||
| 2o8y_A | 298 | Apo Irak4 Kinase Domain Length = 298 | 2e-11 | ||
| 1luf_A | 343 | Crystal Structure Of The Musk Tyrosine Kinase: Insi | 2e-11 | ||
| 3geq_A | 286 | Structural Basis For The Chemical Rescue Of Src Kin | 2e-11 | ||
| 1tki_A | 321 | Autoinhibited Serine Kinase Domain Of The Giant Mus | 2e-11 | ||
| 3hko_A | 345 | Crystal Structure Of A Cdpk Kinase Domain From Cryp | 2e-11 | ||
| 3oez_A | 286 | Crystal Structure Of The L317i Mutant Of The Chicke | 3e-11 | ||
| 3zgw_A | 347 | Crystal Structure Of Maternal Embryonic Leucine Zip | 3e-11 | ||
| 4g3d_A | 371 | Crystal Structure Of Human Nf-kappab Inducing Kinas | 3e-11 | ||
| 3d5v_A | 317 | Crystal Structure Of An Activated (Thr->asp) Polo-L | 3e-11 | ||
| 1yi6_A | 276 | C-Term Tail Segment Of Human Tyrosine Kinase (258-5 | 3e-11 | ||
| 2xir_A | 316 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 3e-11 | ||
| 2z7q_A | 321 | Crystal Structure Of The N-Terminal Kinase Domain O | 3e-11 | ||
| 4dn5_A | 356 | Crystal Structure Of Nf-kb-inducing Kinase (nik) Le | 3e-11 | ||
| 2dq7_X | 283 | Crystal Structure Of Fyn Kinase Domain Complexed Wi | 3e-11 | ||
| 4agc_A | 353 | Crystal Structure Of Vegfr2 (Juxtamembrane And Kina | 3e-11 | ||
| 3dtc_A | 271 | Crystal Structure Of Mixed-Lineage Kinase Mlk1 Comp | 4e-11 | ||
| 4fr4_A | 384 | Crystal Structure Of Human SerineTHREONINE-Protein | 4e-11 | ||
| 3d5u_A | 317 | Crystal Structure Of A Wildtype Polo-Like Kinase 1 | 4e-11 | ||
| 3d5w_A | 317 | Crystal Structure Of A Phosphorylated Polo-Like Kin | 4e-11 | ||
| 3lxn_A | 318 | Structural And Thermodynamic Characterization Of Th | 4e-11 | ||
| 1vr2_A | 316 | Human Vascular Endothelial Growth Factor Receptor 2 | 4e-11 | ||
| 2p2i_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 4e-11 | ||
| 3hgk_A | 327 | Crystal Structure Of Effect Protein Avrptob Complex | 4e-11 | ||
| 2qkw_B | 321 | Structural Basis For Activation Of Plant Immunity B | 4e-11 | ||
| 1ywn_A | 316 | Vegfr2 In Complex With A Novel 4-amino-furo[2,3-d]p | 4e-11 | ||
| 3ewh_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 4e-11 | ||
| 3f69_A | 311 | Crystal Structure Of The Mycobacterium Tuberculosis | 4e-11 | ||
| 2ptk_A | 453 | Chicken Src Tyrosine Kinase Length = 453 | 5e-11 | ||
| 3u6j_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 5e-11 | ||
| 4e20_A | 290 | Structure Of Mouse Tyk-2 Complexed To A 3-Aminoinda | 5e-11 | ||
| 3vnt_A | 318 | Crystal Structure Of The Kinase Domain Of Human Veg | 5e-11 | ||
| 4e1z_A | 291 | Structure Of Mouse Tyk-2 Complexed To A 3-Aminoinda | 5e-11 | ||
| 3nyx_A | 302 | Non-Phosphorylated Tyk2 Jh1 Domain With Quinoline-T | 5e-11 | ||
| 2p2h_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 5e-11 | ||
| 3nz0_A | 302 | Non-Phosphorylated Tyk2 Kinase With Cmp6 Length = 3 | 6e-11 | ||
| 3bhh_A | 295 | Crystal Structure Of Human Calcium/calmodulin-depen | 6e-11 | ||
| 3ori_A | 311 | Mycobacterium Tuberculosis Pknb Kinase Domain L33d | 6e-11 | ||
| 2w0j_A | 323 | Crystal Structure Of Chk2 In Complex With Nsc 10955 | 6e-11 | ||
| 2ycf_A | 322 | Crystal Structure Of Checkpoint Kinase 2 In Complex | 7e-11 | ||
| 2ycr_A | 323 | Crystal Structure Of Checkpoint Kinase 2 In Complex | 7e-11 | ||
| 1o6y_A | 299 | Catalytic Domain Of Pknb Kinase From Mycobacterium | 7e-11 | ||
| 1qcf_A | 454 | Crystal Structure Of Hck In Complex With A Src Fami | 7e-11 | ||
| 2cn5_A | 329 | Crystal Structure Of Human Chk2 In Complex With Adp | 7e-11 | ||
| 2xk9_A | 322 | Structural Analysis Of Checkpoint Kinase 2 (Chk2) I | 8e-11 | ||
| 1na7_A | 329 | Crystal Structure Of The Catalytic Subunit Of Human | 8e-11 | ||
| 1mru_A | 311 | Intracellular SerTHR PROTEIN KINASE DOMAIN OF Mycob | 8e-11 | ||
| 3pwy_A | 311 | Crystal Structure Of An Extender (Spd28345)-Modifie | 8e-11 | ||
| 2hk5_A | 270 | Hck Kinase In Complex With Lck Targetted Inhibitor | 9e-11 | ||
| 3sxr_A | 268 | Crystal Structure Of Bmx Non-Receptor Tyrosine Kina | 9e-11 | ||
| 1uu9_A | 286 | Structure Of Human Pdk1 Kinase Domain In Complex Wi | 9e-11 | ||
| 3nay_A | 311 | Pdk1 In Complex With Inhibitor Mp6 Length = 311 | 9e-11 | ||
| 3nax_A | 311 | Pdk1 In Complex With Inhibitor Mp7 Length = 311 | 9e-11 | ||
| 3nus_A | 286 | Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fra | 9e-11 | ||
| 1h1w_A | 289 | High Resolution Crystal Structure Of The Human Pdk1 | 1e-10 | ||
| 1z5m_A | 286 | Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrr | 1e-10 | ||
| 3c4c_A | 280 | B-Raf Kinase In Complex With Plx4720 Length = 280 | 1e-10 | ||
| 3nun_A | 292 | Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lea | 1e-10 | ||
| 3bbt_B | 328 | Crystal Structure Of The Erbb4 Kinase In Complex Wi | 1e-10 | ||
| 2pl0_A | 289 | Lck Bound To Imatinib Length = 289 | 1e-10 | ||
| 1uu3_A | 310 | Structure Of Human Pdk1 Kinase Domain In Complex Wi | 1e-10 | ||
| 4fk3_A | 292 | B-Raf Kinase V600e Oncogenic Mutant In Complex With | 1e-10 | ||
| 2zm1_A | 285 | Crystal Structure Of Imidazo Pyrazin 1 Bound To The | 1e-10 | ||
| 3c4w_A | 543 | Crystal Structure Of G Protein Coupled Receptor Kin | 1e-10 | ||
| 2biy_A | 310 | Structure Of Pdk1-S241a Mutant Kinase Domain Length | 1e-10 | ||
| 3iop_A | 312 | Pdk-1 In Complex With The Inhibitor Compound-8i Len | 1e-10 | ||
| 3f61_A | 311 | Crystal Structure Of M. Tuberculosis Pknb Leu33aspV | 1e-10 | ||
| 3t8o_A | 543 | Rhodopsin Kinase (grk1) L166k Mutant At 2.5a Resolu | 1e-10 | ||
| 2xch_A | 309 | Crystal Structure Of Pdk1 In Complex With A Pyrazol | 1e-10 | ||
| 1qpe_A | 279 | Structural Analysis Of The Lymphocyte-Specific Kina | 1e-10 | ||
| 3kmm_A | 288 | Structure Of Human Lck Kinase With A Small Molecule | 1e-10 | ||
| 3c4x_A | 543 | Crystal Structure Of G Protein Coupled Receptor Kin | 1e-10 | ||
| 2og8_A | 265 | Crystal Structure Of Aminoquinazoline 36 Bound To L | 1e-10 | ||
| 1yhs_A | 273 | Crystal Structure Of Pim-1 Bound To Staurosporine L | 1e-10 | ||
| 3h9o_A | 311 | Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1) | 1e-10 | ||
| 3sc1_A | 311 | Novel Isoquinolone Pdk1 Inhibitors Discovered Throu | 1e-10 | ||
| 3qc9_A | 543 | Crystal Structure Of Cross-Linked Bovine Grk1 T8cN4 | 1e-10 | ||
| 3bys_A | 277 | Co-Crystal Structure Of Lck And Aminopyrimidine Ami | 1e-10 | ||
| 2r7b_A | 312 | Crystal Structure Of The Phosphoinositide-Dependent | 1e-10 | ||
| 3kxz_A | 287 | The Complex Crystal Structure Of Lck With A Probe M | 1e-10 | ||
| 3rwp_A | 311 | Discovery Of A Novel, Potent And Selective Inhibito | 1e-10 | ||
| 2ofv_A | 277 | Crystal Structure Of Aminoquinazoline 1 Bound To Lc | 1e-10 | ||
| 1fvr_A | 327 | Tie2 Kinase Domain Length = 327 | 1e-10 | ||
| 2r4b_A | 321 | Erbb4 Kinase Domain Complexed With A Thienopyrimidi | 1e-10 | ||
| 1yxs_A | 293 | Crystal Structure Of Kinase Pim1 With P123m Mutatio | 1e-10 | ||
| 3bym_A | 272 | X-Ray Co-Crystal Structure Aminobenzimidazole Triaz | 1e-10 | ||
| 2of2_A | 271 | Crystal Structure Of Furanopyrimidine 8 Bound To Lc | 1e-10 | ||
| 2oo8_X | 317 | Synthesis, Structural Analysis, And Sar Studies Of | 1e-10 | ||
| 2ofu_A | 273 | X-Ray Crystal Structure Of 2-Aminopyrimidine Carbam | 1e-10 | ||
| 4asz_A | 299 | Crystal Structure Of Apo Trkb Kinase Domain Length | 1e-10 | ||
| 3qc4_A | 314 | Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length = | 1e-10 | ||
| 4a07_A | 311 | Human Pdk1 Kinase Domain In Complex With Allosteric | 1e-10 | ||
| 3lck_A | 271 | The Kinase Domain Of Human Lymphocyte Kinase (Lck), | 2e-10 | ||
| 3g0f_A | 336 | Kit Kinase Domain Mutant D816h In Complex With Suni | 2e-10 | ||
| 3orm_A | 311 | Mycobacterium Tuberculosis Pknb Kinase Domain D76a | 2e-10 | ||
| 3g0e_A | 336 | Kit Kinase Domain In Complex With Sunitinib Length | 2e-10 | ||
| 4gt4_A | 308 | Structure Of Unliganded, Inactive Ror2 Kinase Domai | 2e-10 | ||
| 3uix_A | 298 | Crystal Structure Of Pim1 Kinase In Complex With Sm | 2e-10 | ||
| 1t45_A | 331 | Structural Basis For The Autoinhibition And Sti-571 | 2e-10 | ||
| 3hrc_A | 311 | Crystal Structure Of A Mutant Of Human Pdk1 Kinase | 2e-10 | ||
| 2rei_A | 318 | Kinase Domain Of Human Ephrin Type-a Receptor 7 (ep | 2e-10 | ||
| 3zzw_A | 289 | Crystal Structure Of The Kinase Domain Of Ror2 Leng | 2e-10 | ||
| 3i6w_A | 443 | Structure And Activation Mechanism Of The Chk2 Dna- | 2e-10 | ||
| 1t46_A | 313 | Structural Basis For The Autoinhibition And Sti-571 | 2e-10 | ||
| 1ywv_A | 293 | Crystal Structures Of Proto-Oncogene Kinase Pim1: A | 2e-10 | ||
| 3i6u_A | 419 | Structure And Activation Mechanism Of The Chk2 Dna- | 2e-10 | ||
| 3orx_A | 316 | Pdk1 Mutant Bound To Allosteric Disulfide Fragment | 2e-10 | ||
| 3jxw_A | 294 | Discovery Of 3h-Benzo[4,5]thieno[3,2-D]pyrimidin-4- | 2e-10 | ||
| 3f2a_A | 300 | Crystal Structure Of Human Pim-1 In Complex With Da | 2e-10 | ||
| 3r00_A | 299 | The Discovery Of Novel Benzofuran-2-Carboxylic Acid | 2e-10 | ||
| 2xj0_A | 301 | Protein Kinase Pim-1 In Complex With Fragment-4 Fro | 2e-10 | ||
| 1pkg_A | 329 | Structure Of A C-kit Kinase Product Complex Length | 2e-10 | ||
| 2xiy_A | 301 | Protein Kinase Pim-1 In Complex With Fragment-2 Fro | 2e-10 | ||
| 1xqz_A | 300 | Crystal Structure Of Hpim-1 Kinase At 2.1 A Resolut | 2e-10 | ||
| 4dtk_A | 276 | Novel And Selective Pan-Pim Kinase Inhibitor Length | 2e-10 | ||
| 2xix_A | 301 | Protein Kinase Pim-1 In Complex With Fragment-1 Fro | 2e-10 | ||
| 3a99_A | 320 | Structure Of Pim-1 Kinase Crystallized In The Prese | 2e-10 | ||
| 4alv_A | 328 | Benzofuropyrimidinone Inhibitors Of Pim-1 Length = | 2e-10 | ||
| 3c4e_A | 273 | Pim-1 Kinase Domain In Complex With 3-Aminophenyl-7 | 2e-10 | ||
| 2bil_B | 313 | The Human Protein Kinase Pim1 In Complex With Its C | 2e-10 | ||
| 4a7c_A | 308 | Crystal Structure Of Pim1 Kinase With Etp46546 Leng | 2e-10 | ||
| 3cy3_A | 314 | Crystal Structure Of Human Proto-Oncogene Serine Th | 2e-10 | ||
| 4as0_A | 273 | Cyclometalated Phthalimides As Protein Kinase Inhib | 2e-10 | ||
| 1xws_A | 313 | Crystal Structure Of The Human Pim1 Kinase Domain L | 2e-10 | ||
| 3cxw_A | 314 | Crystal Structure Of Human Proto-Oncogene Serine Th | 2e-10 | ||
| 3ma3_A | 313 | Crystal Structure Of Human Proto-Oncogene Serine Th | 2e-10 | ||
| 2j2i_B | 312 | Crystal Structure Of The Humab Pim1 In Complex With | 2e-10 | ||
| 4azf_A | 417 | Human Dyrk2 In Complex With Leucettine L41 Length = | 2e-10 | ||
| 3jpv_A | 313 | Crystal Structure Of Human Proto-Oncogene Serine Th | 2e-10 | ||
| 3dcv_A | 328 | Crystal Structure Of Human Pim1 Kinase Complexed Wi | 2e-10 | ||
| 2obj_A | 333 | Crystal Structure Of Human Pim-1 Kinase In Complex | 3e-10 | ||
| 3kvw_A | 429 | Crystal Structure Of Dual-Specificity Tyrosine Phos | 3e-10 | ||
| 2bik_B | 313 | Human Pim1 Phosphorylated On Ser261 Length = 313 | 3e-10 | ||
| 3v8s_A | 410 | Human Rho-Associated Protein Kinase 1 (Rock 1) In C | 3e-10 | ||
| 2v55_A | 406 | Mechanism Of Multi-site Phosphorylation From A Rock | 3e-10 | ||
| 3lcd_A | 329 | Inhibitor Bound To A Dfg-In Structure Of The Kinase | 3e-10 | ||
| 2esm_A | 415 | Crystal Structure Of Rock 1 Bound To Fasudil Length | 3e-10 | ||
| 2xck_A | 309 | Crystal Structure Of Pdk1 In Complex With A Pyrazol | 3e-10 | ||
| 3g51_A | 325 | Structural Diversity Of The Active Conformation Of | 3e-10 | ||
| 2fb8_A | 281 | Structure Of The B-Raf Kinase Domain Bound To Sb-59 | 3e-10 | ||
| 2ogv_A | 317 | Crystal Structure Of The Autoinhibited Human C-Fms | 3e-10 | ||
| 4dbn_A | 284 | Crystal Structure Of The Kinase Domain Of Human B-R | 3e-10 | ||
| 4h58_A | 275 | Braf In Complex With Compound 3 Length = 275 | 3e-10 | ||
| 3q96_A | 282 | B-Raf Kinase Domain In Complex With A Tetrahydronap | 4e-10 | ||
| 3og7_A | 289 | B-Raf Kinase V600e Oncogenic Mutant In Complex With | 4e-10 | ||
| 4aoj_A | 329 | Human Trka In Complex With The Inhibitor Az-23 Leng | 4e-10 | ||
| 3idp_A | 300 | B-Raf V600e Kinase Domain In Complex With An Aminoi | 4e-10 | ||
| 1qpd_A | 279 | Structural Analysis Of The Lymphocyte-specific Kina | 4e-10 | ||
| 1uwj_A | 276 | The Complex Of Mutant V599e B-raf And Bay439006 Len | 4e-10 | ||
| 3ii5_A | 306 | The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimi | 4e-10 | ||
| 3thb_A | 333 | Structure Of Plk1 Kinase Domain In Complex With A B | 4e-10 | ||
| 4gt5_A | 306 | Crystal Structure Of The Inactive Trka Kinase Domai | 4e-10 | ||
| 4el9_A | 305 | Structure Of N-Terminal Kinase Domain Of Rsk2 With | 4e-10 | ||
| 4g9r_A | 307 | B-Raf V600e Kinase Domain Bound To A Type Ii Dihydr | 4e-10 | ||
| 4f0i_A | 300 | Crystal Structure Of Apo Trka Length = 300 | 4e-10 | ||
| 3ubd_A | 304 | Structure Of N-Terminal Domain Of Rsk2 Kinase In Co | 4e-10 | ||
| 2rku_A | 294 | Structure Of Plk1 In Complex With Bi2536 Length = 2 | 4e-10 | ||
| 3d4q_A | 307 | Pyrazole-Based Inhibitors Of B-Raf Kinase Length = | 4e-10 | ||
| 2yac_A | 311 | Crystal Structure Of Polo-Like Kinase 1 In Complex | 4e-10 | ||
| 3pls_A | 298 | Ron In Complex With Ligand Amp-Pnp Length = 298 | 4e-10 | ||
| 3mpm_A | 267 | Lck Complexed With A Pyrazolopyrimidine Length = 26 | 4e-10 | ||
| 3kb7_A | 311 | Crystal Structure Of Polo-Like Kinase 1 In Complex | 4e-10 | ||
| 2ou7_A | 335 | Structure Of The Catalytic Domain Of Human Polo-Lik | 4e-10 | ||
| 2v5q_A | 315 | Crystal Structure Of Wild-type Plk-1 Kinase Domain | 5e-10 | ||
| 2wqb_A | 324 | Structure Of The Tie2 Kinase Domain In Complex With | 5e-10 | ||
| 2x4f_A | 373 | The Crystal Structure Of The Human Myosin Light Cha | 5e-10 | ||
| 2x7g_A | 389 | Structure Of Human Serine-Arginine-Rich Protein-Spe | 5e-10 | ||
| 3c7q_A | 316 | Structure Of Vegfr2 Kinase Domain In Complex With B | 5e-10 | ||
| 2jed_A | 352 | The Crystal Structure Of The Kinase Domain Of The P | 6e-10 | ||
| 3eta_A | 317 | Kinase Domain Of Insulin Receptor Complexed With A | 6e-10 | ||
| 1irk_A | 306 | Crystal Structure Of The Tyrosine Kinase Domain Of | 7e-10 | ||
| 2i0v_A | 335 | C-Fms Tyrosine Kinase In Complex With A Quinolone I | 8e-10 | ||
| 3v5q_A | 297 | Discovery Of A Selective Trk Inhibitor With Efficac | 9e-10 | ||
| 3k2l_A | 429 | Crystal Structure Of Dual-Specificity Tyrosine Phos | 1e-09 | ||
| 1xjd_A | 345 | Crystal Structure Of Pkc-Theta Complexed With Staur | 1e-09 | ||
| 2f2u_A | 402 | Crystal Structure Of The Rho-Kinase Kinase Domain L | 1e-09 | ||
| 1i44_A | 306 | Crystallographic Studies Of An Activation Loop Muta | 1e-09 | ||
| 3e87_A | 335 | Crystal Structures Of The Kinase Domain Of Akt2 In | 1e-09 | ||
| 1o6k_A | 336 | Structure Of Activated Form Of Pkb Kinase Domain S4 | 1e-09 | ||
| 1ad5_A | 438 | Src Family Kinase Hck-Amp-Pnp Complex Length = 438 | 1e-09 | ||
| 1uwh_A | 276 | The Complex Of Wild Type B-Raf And Bay439006 Length | 1e-09 | ||
| 1o6l_A | 337 | Crystal Structure Of An Activated Akt/protein Kinas | 1e-09 | ||
| 1mrv_A | 339 | Crystal Structure Of An Inactive Akt2 Kinase Domain | 1e-09 | ||
| 2jdo_A | 342 | Structure Of Pkb-Beta (Akt2) Complexed With Isoquin | 1e-09 | ||
| 1gzn_A | 335 | Structure Of Pkb Kinase Domain Length = 335 | 1e-09 | ||
| 1gzk_A | 315 | Molecular Mechanism For The Regulation Of Protein K | 1e-09 | ||
| 3bea_A | 333 | Cfms Tyrosine Kinase (Tie2 Kid) In Complex With A P | 2e-09 | ||
| 2i1m_A | 333 | Cfms Tyrosine Kinase (Tie2 Kid) In Complex With An | 2e-09 | ||
| 1p14_A | 306 | Crystal Structure Of A Catalytic-Loop Mutant Of The | 2e-09 | ||
| 2wnt_A | 330 | Crystal Structure Of The Human Ribosomal Protein S6 | 2e-09 | ||
| 3ekk_A | 307 | Insulin Receptor Kinase Complexed With An Inhibitor | 2e-09 | ||
| 2pml_X | 348 | Crystal Structure Of Pfpk7 In Complex With An Atp A | 3e-09 | ||
| 3rny_A | 346 | Crystal Structure Of Human Rsk1 C-Terminal Kinase D | 3e-09 | ||
| 3p23_A | 432 | Crystal Structure Of The Human Kinase And Rnase Dom | 3e-09 | ||
| 2iwi_A | 312 | Crystal Structure Of The Human Pim2 In Complex With | 3e-09 | ||
| 3lco_A | 324 | Inhibitor Bound To A Dfg-Out Structure Of The Kinas | 3e-09 | ||
| 1k2p_A | 263 | Crystal Structure Of Bruton's Tyrosine Kinase Domai | 3e-09 | ||
| 3p08_A | 267 | Crystal Structure Of The Human Btk Kinase Domain Le | 3e-09 | ||
| 2jkm_A | 276 | Focal Adhesion Kinase Catalytic Domain In Complex W | 3e-09 | ||
| 3ocs_A | 271 | Crystal Structure Of Bruton's Tyrosine Kinase In Co | 4e-09 | ||
| 3pix_A | 274 | Crystal Structure Of Btk Kinase Domain Complexed Wi | 4e-09 | ||
| 3cjg_A | 309 | Crystal Structure Of Vegfr2 In Complex With A 3,4,5 | 4e-09 | ||
| 3gen_A | 283 | The 1.6 A Crystal Structure Of Human Bruton's Tyros | 4e-09 | ||
| 1u46_A | 291 | Crystal Structure Of The Unphosphorylated Kinase Do | 4e-09 | ||
| 3oct_A | 265 | Crystal Structure Of Bruton's Tyrosine Kinase Mutan | 4e-09 | ||
| 2j0j_A | 656 | Crystal Structure Of A Fragment Of Focal Adhesion K | 4e-09 | ||
| 3eqp_B | 276 | Crystal Structure Of Ack1 With Compound T95 Length | 4e-09 | ||
| 1u54_A | 291 | Crystal Structures Of The Phosphorylated And Unphos | 4e-09 | ||
| 3k54_A | 283 | Structures Of Human Bruton's Tyrosine Kinase In Act | 4e-09 | ||
| 2hel_A | 306 | Crystal Structure Of A Mutant Epha4 Kinase Domain ( | 4e-09 | ||
| 2eu9_A | 355 | Crystal Structure Of Clk3 Length = 355 | 4e-09 | ||
| 2r2p_A | 295 | Kinase Domain Of Human Ephrin Type-A Receptor 5 (Ep | 4e-09 | ||
| 2j0l_A | 276 | Crystal Structure Of A The Active Conformation Of T | 4e-09 | ||
| 4hzs_A | 341 | Crystal Structure Of Ack1 Kinase Domain With C-term | 5e-09 | ||
| 4hzr_A | 277 | Crystal Structure Of Ack1 Kinase Domain Length = 27 | 5e-09 | ||
| 4ewh_B | 275 | Co-Crystal Structure Of Ack1 With Inhibitor Length | 5e-09 | ||
| 3qfv_A | 415 | Mrck Beta In Complex With Tpca-1 Length = 415 | 5e-09 | ||
| 1rqq_A | 306 | Crystal Structure Of The Insulin Receptor Kinase In | 5e-09 | ||
| 3a8w_A | 345 | Crystal Structure Of Pkciota Kinase Domain Length = | 5e-09 | ||
| 4id7_A | 273 | Ack1 Kinase In Complex With The Inhibitor Cis-3-[8- | 5e-09 | ||
| 2ivv_A | 314 | Crystal Structure Of Phosphorylated Ret Tyrosine Ki | 5e-09 | ||
| 1ir3_A | 306 | Phosphorylated Insulin Receptor Tyrosine Kinase In | 6e-09 | ||
| 3tku_A | 433 | Mrck Beta In Complex With Fasudil Length = 433 | 6e-09 | ||
| 3bz3_A | 276 | Crystal Structure Analysis Of Focal Adhesion Kinase | 6e-09 | ||
| 4ebw_A | 304 | Structure Of Focal Adhesion Kinase Catalytic Domain | 6e-09 | ||
| 2j0m_B | 276 | Crystal Structure A Two-Chain Complex Between The F | 6e-09 | ||
| 3pxk_A | 282 | Focal Adhesion Kinase Catalytic Domain In Complex W | 6e-09 | ||
| 3zh8_A | 349 | A Novel Small Molecule Apkc Inhibitor Length = 349 | 7e-09 | ||
| 2etm_A | 281 | Crystal Structure Of Focal Adhesion Kinase Domain C | 7e-09 | ||
| 2z8c_A | 303 | Phosphorylated Insulin Receptor Tyrosine Kinase In | 7e-09 | ||
| 1mp8_A | 281 | Crystal Structure Of Focal Adhesion Kinase (Fak) Le | 7e-09 | ||
| 2jkk_A | 276 | Focal Adhesion Kinase Catalytic Domain In Complex W | 7e-09 | ||
| 2j0k_A | 656 | Crystal Structure Of A Fragment Of Focal Adhesion K | 8e-09 | ||
| 3kul_A | 325 | Kinase Domain Of Human Ephrin Type-A Receptor 8 (Ep | 8e-09 | ||
| 1zrz_A | 364 | Crystal Structure Of The Catalytic Domain Of Atypic | 8e-09 | ||
| 4dgm_A | 326 | Crystal Structure Of Maize Ck2 In Complex With The | 8e-09 | ||
| 4f0f_A | 287 | Crystal Structure Of The Roco4 Kinase Domain Bound | 8e-09 | ||
| 3krw_A | 688 | Human Grk2 In Complex With Gbetgamma Subunits And B | 8e-09 | ||
| 3cqu_A | 342 | Crystal Structure Of Akt-1 Complexed With Substrate | 8e-09 | ||
| 4dc2_A | 396 | Structure Of Pkc In Complex With A Substrate Peptid | 9e-09 | ||
| 3cik_A | 689 | Human Grk2 In Complex With Gbetagamma Subunits Leng | 9e-09 | ||
| 2z2w_A | 285 | Humand Wee1 Kinase Complexed With Inhibitor Pf03357 | 9e-09 | ||
| 3kul_B | 325 | Kinase Domain Of Human Ephrin Type-A Receptor 8 (Ep | 9e-09 | ||
| 3ocb_A | 341 | Akt1 Kinase Domain With Pyrrolopyrimidine Inhibitor | 9e-09 | ||
| 3hng_A | 360 | Crystal Structure Of Vegfr1 In Complex With N-(4-ch | 9e-09 | ||
| 4gv1_A | 340 | Pkb Alpha In Complex With Azd5363 Length = 340 | 9e-09 | ||
| 1omw_A | 689 | Crystal Structure Of The Complex Between G Protein- | 9e-09 | ||
| 3psc_A | 695 | Bovine Grk2 In Complex With Gbetagamma Subunits Len | 9e-09 | ||
| 3bi6_A | 287 | Wee1 Kinase Complex With Inhibitor Pd352396 Length | 1e-08 | ||
| 2in6_A | 287 | Wee1 Kinase Complex With Inhibitor Pd311839 Length | 1e-08 | ||
| 1x8b_A | 289 | Structure Of Human Wee1a Kinase: Kinase Domain Comp | 1e-08 | ||
| 2ivt_A | 314 | Crystal Structure Of Phosphorylated Ret Tyrosine Ki | 1e-08 | ||
| 2ivs_A | 314 | Crystal Structure Of Non-Phosphorylated Ret Tyrosin | 1e-08 | ||
| 2y6m_A | 291 | Crystal Structure Of Epha4 Kinase Domain Length = 2 | 1e-08 | ||
| 2qok_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 1e-08 | ||
| 2xyu_A | 285 | Crystal Structure Of Epha4 Kinase Domain In Complex | 1e-08 | ||
| 2vd5_A | 412 | Structure Of Human Myotonic Dystrophy Protein Kinas | 1e-08 | ||
| 4alu_A | 328 | Benzofuropyrimidinone Inhibitors Of Pim-1 Length = | 1e-08 | ||
| 2wu6_A | 381 | Crystal Structure Of The Human Clk3 In Complex With | 1e-08 | ||
| 1jpa_A | 312 | Crystal Structure Of Unphosphorylated Ephb2 Recepto | 1e-08 | ||
| 2exe_A | 357 | Crystal Structure Of The Phosphorylated Clk3 Length | 1e-08 | ||
| 3tl8_A | 349 | The Avrptob-Bak1 Complex Reveals Two Structurally S | 1e-08 | ||
| 4ejn_A | 446 | Crystal Structure Of Autoinhibited Form Of Akt1 In | 1e-08 | ||
| 2r5t_A | 373 | Crystal Structure Of Inactive Serum And Glucocortic | 1e-08 | ||
| 3o96_A | 446 | Crystal Structure Of Human Akt1 With An Allosteric | 2e-08 | ||
| 4f1o_A | 287 | Crystal Structure Of The L1180t Mutant Roco4 Kinase | 2e-08 | ||
| 3uim_A | 326 | Structural Basis For The Impact Of Phosphorylation | 2e-08 | ||
| 3omv_A | 307 | Crystal Structure Of C-Raf (Raf-1) Length = 307 | 2e-08 | ||
| 3fxx_A | 371 | Human Epha3 Kinase And Juxtamembrane Region Bound T | 2e-08 | ||
| 2qc6_A | 332 | Protein Kinase Ck2 In Complex With Dbc Length = 332 | 2e-08 | ||
| 2gsf_A | 373 | The Human Epha3 Receptor Tyrosine Kinase And Juxtam | 2e-08 | ||
| 4dgn_A | 326 | Crystal Structure Of Maize Ck2 In Complex With The | 2e-08 | ||
| 4aw5_A | 291 | Complex Of The Ephb4 Kinase Domain With An Oxindole | 2e-08 | ||
| 2qof_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f | 2e-08 | ||
| 2qod_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y602f | 2e-08 | ||
| 3kxg_A | 327 | Crystal Structure Of Z. Mays Ck2 Kinase Alpha Subun | 2e-08 | ||
| 3cek_A | 313 | Crystal Structure Of Human Dual Specificity Protein | 2e-08 | ||
| 2qoo_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 2e-08 | ||
| 1ds5_A | 332 | Dimeric Crystal Structure Of The Alpha Subunit In C | 2e-08 | ||
| 1daw_A | 327 | Crystal Structure Of A Binary Complex Of Protein Ki | 2e-08 | ||
| 2qoi_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 2e-08 | ||
| 3pvg_A | 331 | Crystal Structure Of Z. Mays Ck2 Alpha Subunit In C | 2e-08 | ||
| 2x9e_A | 317 | Human Mps1 In Complex With Nms-P715 Length = 317 | 2e-08 | ||
| 1m2p_A | 325 | Crystal Structure Of 1,8-Di-Hydroxy-4-Nitro- Anthra | 2e-08 | ||
| 3txo_A | 353 | Pkc Eta Kinase In Complex With A Naphthyridine Leng | 3e-08 | ||
| 2pvh_A | 352 | Structure-Based Design Of Pyrazolo[1,5-A][1,3,5]tri | 3e-08 | ||
| 1q8y_A | 373 | The Structure Of The Yeast Sr Protein Kinase, Sky1p | 3e-08 | ||
| 1how_A | 373 | The X-Ray Crystal Structure Of Sky1p, An Sr Protein | 3e-08 | ||
| 2vwu_A | 302 | Ephb4 Kinase Domain Inhibitor Complex Length = 302 | 3e-08 | ||
| 3dzq_A | 361 | Human Epha3 Kinase Domain In Complex With Inhibitor | 3e-08 | ||
| 4anm_A | 335 | Complex Of Ck2 With A Cdc7 Inhibitor Length = 335 | 3e-08 | ||
| 2qoc_A | 344 | Human Epha3 Kinase Domain, Phosphorylated, Amp-Pnp | 3e-08 | ||
| 2qol_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596:y | 3e-08 | ||
| 3vqu_A | 320 | Crystal Structure Of Human Mps1 Catalytic Domain In | 3e-08 | ||
| 3hmn_A | 342 | Crystal Structure Of Human Mps1 Catalytic Domain In | 3e-08 | ||
| 3h9f_A | 313 | Crystal Structure Of Human Dual Specificity Protein | 3e-08 | ||
| 3dbq_A | 343 | Crystal Structure Of Ttk Kinase Domain Length = 343 | 3e-08 | ||
| 2vag_A | 339 | Crystal Structure Of Di-Phosphorylated Human Clk1 I | 4e-08 | ||
| 2qon_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 4e-08 | ||
| 1z57_A | 339 | Crystal Structure Of Human Clk1 In Complex With 10z | 4e-08 | ||
| 2zmd_A | 390 | Crystal Structure Of Human Mps1 Catalytic Domain T6 | 4e-08 | ||
| 2zmc_A | 390 | Crystal Structure Of Human Mitotic Checkpoint Kinas | 4e-08 | ||
| 4f1m_A | 287 | Crystal Structure Of The G1179s Roco4 Kinase Domain | 5e-08 | ||
| 2buj_A | 317 | Crystal Structure Of The Human Serine-Threonine Kin | 5e-08 | ||
| 4e4l_A | 302 | Jak1 Kinase (Jh1 Domain) In Complex With Compound 3 | 5e-08 | ||
| 3eyg_A | 290 | Crystal Structures Of Jak1 And Jak2 Inhibitor Compl | 5e-08 | ||
| 3cjf_A | 309 | Crystal Structure Of Vegfr2 In Complex With A 3,4,5 | 6e-08 | ||
| 1m7n_A | 322 | Crystal Structure Of Unactivated Apo Insulin-Like G | 6e-08 | ||
| 4aw2_A | 437 | Crystal Structure Of Cdc42 Binding Protein Kinase A | 6e-08 | ||
| 2qo7_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Dephos | 7e-08 | ||
| 3fpq_A | 290 | Crystal Structure Of The Kinase Domain Of Wnk1 Leng | 7e-08 | ||
| 2oj9_A | 307 | Structure Of Igf-1r Kinase Domain Complexed With A | 8e-08 | ||
| 3i81_A | 315 | Crystal Structure Of Insulin-Like Growth Factor 1 R | 9e-08 | ||
| 3r1n_A | 317 | Mk3 Kinase Bound To Compound 5b Length = 317 | 9e-08 | ||
| 3fhr_A | 336 | High Resolution Crystal Structure Of Mitogen-Activa | 9e-08 | ||
| 1jqh_A | 308 | Igf-1 Receptor Kinase Domain Length = 308 | 9e-08 | ||
| 2qob_A | 344 | Human Epha3 Kinase Domain, Base Structure Length = | 9e-08 | ||
| 3o23_A | 305 | Human Unphosphorylated Igf1-R Kinase Domain In Comp | 9e-08 | ||
| 3qqu_A | 301 | Cocrystal Structure Of Unphosphorylated Igf With Py | 1e-07 | ||
| 3lvp_A | 336 | Crystal Structure Of Bisphosphorylated Igf1-R Kinas | 1e-07 | ||
| 2jiv_A | 328 | Crystal Structure Of Egfr Kinase Domain T790m Mutat | 1e-07 | ||
| 3nyn_A | 576 | Crystal Structure Of G Protein-Coupled Receptor Kin | 1e-07 | ||
| 3ika_A | 331 | Crystal Structure Of Egfr 696-1022 T790m Mutant Cov | 1e-07 | ||
| 2acx_A | 576 | Crystal Structure Of G Protein Coupled Receptor Kin | 1e-07 | ||
| 2jit_A | 327 | Crystal Structure Of Egfr Kinase Domain T790m Mutat | 1e-07 | ||
| 2jiu_A | 328 | Crystal Structure Of Egfr Kinase Domain T790m Mutat | 1e-07 | ||
| 2hen_A | 286 | Crystal Structure Of The Ephb2 Receptor Kinase Doma | 1e-07 | ||
| 4i24_A | 329 | Structure Of T790m Egfr Kinase Domain Co-crystalliz | 1e-07 | ||
| 3cc6_A | 281 | Crystal Structure Of Kinase Domain Of Protein Tyros | 1e-07 | ||
| 3fzo_A | 277 | Crystal Structure Of Pyk2-Apo, Proline-Rich Tyrosin | 1e-07 | ||
| 4g5p_A | 330 | Crystal Structure Of Egfr Kinase T790m In Complex W | 1e-07 | ||
| 4h1j_A | 293 | Crystal Structure Of Pyk2 With The Pyrazole 13a Len | 1e-07 | ||
| 3nr9_A | 368 | Structure Of Human Cdc2-Like Kinase 2 (Clk2) Length | 1e-07 | ||
| 2ac5_A | 316 | Structure Of Human Mnk2 Kinase Domain Mutant D228g | 2e-07 | ||
| 1xkk_A | 352 | Egfr Kinase Domain Complexed With A Quinazoline Inh | 2e-07 | ||
| 2j5e_A | 327 | Crystal Structure Of Egfr Kinase Domain In Complex | 2e-07 | ||
| 4hjo_A | 337 | Crystal Structure Of The Inactive Egfr Tyrosine Kin | 2e-07 | ||
| 1mqb_A | 333 | Crystal Structure Of Ephrin A2 (Epha2) Receptor Pro | 2e-07 | ||
| 2j5f_A | 327 | Crystal Structure Of Egfr Kinase Domain In Complex | 2e-07 | ||
| 4i23_A | 329 | Crystal Structure Of The Wild-type Egfr Kinase Doma | 2e-07 | ||
| 4g5j_A | 330 | Crystal Structure Of Egfr Kinase In Complex With Bi | 2e-07 | ||
| 3bel_A | 315 | X-Ray Structure Of Egfr In Complex With Oxime Inhib | 2e-07 | ||
| 2gs2_A | 330 | Crystal Structure Of The Active Egfr Kinase Domain | 2e-07 | ||
| 2gs7_A | 330 | Crystal Structure Of The Inactive Egfr Kinase Domai | 2e-07 | ||
| 3d94_A | 301 | Crystal Structure Of The Insulin-Like Growth Factor | 2e-07 | ||
| 1m14_A | 333 | Tyrosine Kinase Domain From Epidermal Growth Factor | 2e-07 | ||
| 3vjo_A | 334 | Crystal Structure Of The Wild-Type Egfr Kinase Doma | 2e-07 | ||
| 3lmg_A | 344 | Crystal Structure Of The Erbb3 Kinase Domain In Com | 3e-07 | ||
| 3w2o_A | 331 | Egfr Kinase Domain T790m/l858r Mutant With Tak-285 | 3e-07 | ||
| 3lzb_A | 327 | Egfr Kinase Domain Complexed With An Imidazo[2,1-B] | 3e-07 | ||
| 2zm3_A | 308 | Complex Structure Of Insulin-Like Growth Factor Rec | 3e-07 | ||
| 2vx3_A | 382 | Crystal Structure Of The Human Dual Specificity Tyr | 3e-07 | ||
| 4i21_A | 329 | Crystal Structure Of L858r + T790m Egfr Kinase Doma | 3e-07 | ||
| 4i1z_A | 329 | Crystal Structure Of The Monomeric (v948r) Form Of | 3e-07 | ||
| 3kex_A | 325 | Crystal Structure Of The Catalytically Inactive Kin | 3e-07 | ||
| 1k3a_A | 299 | Structure Of The Insulin-Like Growth Factor 1 Recep | 4e-07 | ||
| 1y6a_A | 366 | Crystal Structure Of Vegfr2 In Complex With A 2-Ani | 4e-07 | ||
| 3vhk_A | 368 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 4e-07 | ||
| 3juh_A | 335 | Crystal Structure Of A Mutant Of Human Protein Kina | 4e-07 | ||
| 3vid_A | 356 | Crystal Structure Of Human Vegfr2 Kinase Domain Wit | 4e-07 | ||
| 3vhe_A | 359 | Crystal Structure Of Human Vegfr2 Kinase Domain Wit | 4e-07 | ||
| 3anq_A | 368 | Human Dyrk1aINHIBITOR COMPLEX Length = 368 | 4e-07 | ||
| 2rfd_A | 324 | Crystal Structure Of The Complex Between The Egfr K | 4e-07 | ||
| 3pp0_A | 338 | Crystal Structure Of The Kinase Domain Of Human Her | 4e-07 | ||
| 3tub_A | 293 | Crystal Structure Of Syk Kinase Domain With 1-(5-(6 | 5e-07 | ||
| 3vf8_A | 299 | Crystal Structure Of Spleen Tyrosine Kinase Syk Cat | 5e-07 | ||
| 4i20_A | 329 | Crystal Structure Of Monomeric (v948r) Primary Onco | 5e-07 | ||
| 4aze_A | 382 | Human Dyrk1a In Complex With Leucettine L41 Length | 5e-07 | ||
| 2itt_A | 327 | Crystal Structure Of Egfr Kinase Domain L858r Mutat | 5e-07 | ||
| 3emg_A | 291 | Discovery And Sar Of Novel 4-Thiazolyl-2- Phenylami | 6e-07 | ||
| 2eb3_A | 334 | Crystal Structure Of Mutated Egfr Kinase Domain (L8 | 6e-07 | ||
| 1k9a_A | 450 | Crystal Structure Analysis Of Full-Length Carboxyl- | 7e-07 | ||
| 3srv_B | 277 | Crystal Structure Of Spleen Tyrosine Kinase (Syk) I | 7e-07 | ||
| 3gop_A | 361 | Crystal Structure Of The Egf Receptor Juxtamembrane | 7e-07 | ||
| 3srv_A | 277 | Crystal Structure Of Spleen Tyrosine Kinase (Syk) I | 7e-07 | ||
| 1xba_A | 291 | Crystal Structure Of Apo Syk Tyrosine Kinase Domain | 7e-07 | ||
| 3ug1_A | 334 | Crystal Structure Of The Mutated Egfr Kinase Domain | 7e-07 | ||
| 4fl3_A | 635 | Structural And Biophysical Characterization Of The | 7e-07 | ||
| 3d7u_A | 263 | Structural Basis For The Recognition Of C-Src By It | 7e-07 | ||
| 4dfl_A | 274 | Crystal Structure Of Spleen Tyrosine Kinase Complex | 8e-07 | ||
| 4f4p_A | 273 | Syk In Complex With Ligand Lasw836 Length = 273 | 8e-07 | ||
| 1byg_A | 278 | Kinase Domain Of Human C-Terminal Src Kinase (Csk) | 8e-07 | ||
| 4fl2_A | 636 | Structural And Biophysical Characterization Of The | 8e-07 | ||
| 3d7t_A | 269 | Structural Basis For The Recognition Of C-Src By It | 8e-07 | ||
| 1p4o_A | 322 | Structure Of Apo Unactivated Igf-1r Kinase Domain A | 9e-07 | ||
| 3sdj_A | 448 | Structure Of Rnase-Inactive Point Mutant Of Oligome | 9e-07 | ||
| 2rio_A | 434 | Structure Of The Dual Enzyme Ire1 Reveals The Basis | 1e-06 | ||
| 3lj0_A | 434 | Ire1 Complexed With Adp And Quercetin Length = 434 | 1e-06 | ||
| 3fbv_A | 448 | Crystal Structure Of The Oligomer Formed By The Kin | 1e-06 | ||
| 2itn_A | 327 | Crystal Structure Of Egfr Kinase Domain G719s Mutat | 1e-06 | ||
| 3lw0_A | 304 | Igf-1rk In Complex With Ligand Msc1609119a-1 Length | 1e-06 | ||
| 2eb2_A | 334 | Crystal Structure Of Mutated Egfr Kinase Domain (G7 | 1e-06 | ||
| 2hw6_A | 307 | Crystal Structure Of Mnk1 Catalytic Domain Length = | 1e-06 | ||
| 1eh4_A | 298 | Binary Complex Of Casein Kinase-1 From S. Pombe Wit | 1e-06 | ||
| 2csn_A | 297 | Binary Complex Of Casein Kinase-1 With Cki7 Length | 1e-06 | ||
| 2ac3_A | 316 | Structure Of Human Mnk2 Kinase Domain Length = 316 | 2e-06 | ||
| 3i5n_A | 309 | Crystal Structure Of C-Met With Triazolopyridazine | 2e-06 | ||
| 3q6u_A | 308 | Structure Of The Apo Met Receptor Kinase In The Dua | 2e-06 | ||
| 3lq8_A | 302 | Structure Of The Kinase Domain Of C-Met Bound To Xl | 2e-06 | ||
| 2g15_A | 318 | Structural Characterization Of Autoinhibited C-Met | 2e-06 | ||
| 3f66_A | 298 | Human C-Met Kinase In Complex With Quinoxaline Inhi | 2e-06 |
| >pdb|4AGU|A Chain A, Crystal Structure Of The Human Cdkl1 Kinase Domain Length = 311 | Back alignment and structure |
|
| >pdb|4AAA|A Chain A, Crystal Structure Of The Human Cdkl2 Kinase Domain Length = 331 | Back alignment and structure |
|
| >pdb|4EOI|A Chain A, Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 299 | Back alignment and structure |
|
| >pdb|4EOM|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human Cyclin A3 Complex With Atp Length = 301 | Back alignment and structure |
|
| >pdb|4EON|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300 | Back alignment and structure |
|
| >pdb|4EOP|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300 | Back alignment and structure |
|
| >pdb|4EOO|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 Complex With Atp Length = 299 | Back alignment and structure |
|
| >pdb|1OIT|A Chain A, Imidazopyridines: A Potent And Selective Class Of Cyclin-dependent Kinase Inhibitors Identified Through Structure-based Hybridisation Length = 299 | Back alignment and structure |
|
| >pdb|4EOJ|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human Cyclin A3 Complex With Atp Length = 302 | Back alignment and structure |
|
| >pdb|4EOK|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human Cyclin A3 Complex With The Inhibitor Nu6102 Length = 300 | Back alignment and structure |
|
| >pdb|4ERW|A Chain A, Cdk2 In Complex With Staurosporine Length = 306 | Back alignment and structure |
|
| >pdb|2IW6|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A Complexed With A Bisanilinopyrimidine Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|1GZ8|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Inhibitor 2-Amino-6-(3'-Methyl-2'-Oxo)butoxypurine Length = 299 | Back alignment and structure |
|
| >pdb|2JGZ|A Chain A, Crystal Structure Of Phospho-Cdk2 In Complex With Cyclin B Length = 289 | Back alignment and structure |
|
| >pdb|1E9H|A Chain A, Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex With The Inhibitor Indirubin-5-Sulphonate Bound Length = 297 | Back alignment and structure |
|
| >pdb|1W98|A Chain A, The Structural Basis Of Cdk2 Activation By Cyclin E Length = 298 | Back alignment and structure |
|
| >pdb|2W17|A Chain A, Cdk2 In Complex With The Imidazole Pyrimidine Amide, Compound (S)-8b Length = 299 | Back alignment and structure |
|
| >pdb|1FIN|A Chain A, Cyclin A-Cyclin-Dependent Kinase 2 Complex Length = 298 | Back alignment and structure |
|
| >pdb|4EOS|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300 | Back alignment and structure |
|
| >pdb|4I3Z|A Chain A, Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNESIUM IONS Length = 296 | Back alignment and structure |
|
| >pdb|1JST|A Chain A, Phosphorylated Cyclin-Dependent Kinase-2 Bound To Cyclin A Length = 298 | Back alignment and structure |
|
| >pdb|1QMZ|A Chain A, Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Complex Length = 299 | Back alignment and structure |
|
| >pdb|2IW8|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82h-L83v- H84d Mutant With An O6-Cyclohexylmethylguanine Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|4EOQ|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex With Atp Length = 301 | Back alignment and structure |
|
| >pdb|4BCQ|A Chain A, Structure Of Cdk2 In Complex With Cyclin A And A 2-amino-4- Heteroaryl-pyrimidine Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|3EZR|A Chain A, Cdk-2 With Indazole Inhibitor 17 Bound At Its Active Site Length = 300 | Back alignment and structure |
|
| >pdb|3PJ8|A Chain A, Structure Of Cdk2 In Complex With A Pyrazolo[4,3-D]pyrimidine Bioisostere Of Roscovitine Length = 299 | Back alignment and structure |
|
| >pdb|3PXF|A Chain A, Cdk2 In Complex With Two Molecules Of 8-Anilino-1-Naphthalene Sulfonate Length = 306 | Back alignment and structure |
|
| >pdb|3BHT|A Chain A, Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN COMPLEX WITH THE Inhibitor Meriolin 3 Length = 300 | Back alignment and structure |
|
| >pdb|3QHR|A Chain A, Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic Length = 298 | Back alignment and structure |
|
| >pdb|1H1P|A Chain A, Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMPLEXED With The Inhibitor Nu2058 Length = 303 | Back alignment and structure |
|
| >pdb|1OGU|A Chain A, Structure Of Human Thr160-phospho Cdk2/cyclin A Complexed With A 2-arylamino-4-cyclohexylmethyl-5-nitroso-6- aminopyrimidine Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|1VYW|A Chain A, Structure Of Cdk2CYCLIN A WITH PNU-292137 Length = 309 | Back alignment and structure |
|
| >pdb|1UNG|A Chain A, Structural Mechanism For The Inhibition Of Cdk5-P25 By Roscovitine, Aloisine And Indirubin. Length = 292 | Back alignment and structure |
|
| >pdb|1H4L|A Chain A, Structure And Regulation Of The Cdk5-P25(Nck5a) Complex Length = 292 | Back alignment and structure |
|
| >pdb|1OIR|A Chain A, Imidazopyridines: A Potent And Selective Class Of Cyclin-Dependent Kinase Inhibitors Identified Through Structure-Based Hybridisation Length = 299 | Back alignment and structure |
|
| >pdb|1H01|A Chain A, Cdk2 In Complex With A Disubstituted 2, 4-Bis Anilino Pyrimidine Cdk4 Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|1GII|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Cdk4 Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|1PF8|A Chain A, Crystal Structure Of Human Cyclin-dependent Kinase 2 Complexed With A Nucleoside Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|3NIZ|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510 With Adp Bound Length = 311 | Back alignment and structure |
|
| >pdb|2QKR|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510 With Indirubin 3'-Monoxime Bound Length = 313 | Back alignment and structure |
|
| >pdb|4EC8|A Chain A, Structure Of Full Length Cdk9 In Complex With Cyclint And Drb Length = 373 | Back alignment and structure |
|
| >pdb|3MI9|A Chain A, Crystal Structure Of Hiv-1 Tat Complexed With Human P-Tefb Length = 351 | Back alignment and structure |
|
| >pdb|3BLH|A Chain A, Crystal Structure Of Human Cdk9CYCLINT1 Length = 331 | Back alignment and structure |
|
| >pdb|4BCF|A Chain A, Structure Of Cdk9 In Complex With Cyclin T And A 2-amino-4- Heteroaryl-pyrimidine Inhibitor Length = 331 | Back alignment and structure |
|
| >pdb|2PK9|A Chain A, Structure Of The Pho85-pho80 Cdk-cyclin Complex Of The Phosphate-responsive Signal Transduction Pathway Length = 317 | Back alignment and structure |
|
| >pdb|1UA2|A Chain A, Crystal Structure Of Human Cdk7 Length = 346 | Back alignment and structure |
|
| >pdb|1V0B|A Chain A, Crystal Structure Of The T198a Mutant Of Pfpk5 Length = 288 | Back alignment and structure |
|
| >pdb|1V0O|A Chain A, Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulphonate Ligand Complex Length = 288 | Back alignment and structure |
|
| >pdb|3NUP|A Chain A, Cdk6 (Monomeric) In Complex With Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|1JOW|B Chain B, Crystal Structure Of A Complex Of Human Cdk6 And A Viral Cyclin Length = 308 | Back alignment and structure |
|
| >pdb|1OB3|A Chain A, Structure Of P. Falciparum Pfpk5 Length = 288 | Back alignment and structure |
|
| >pdb|1BI8|A Chain A, Mechanism Of G1 Cyclin Dependent Kinase Inhibition From The Structures Cdk6-P19ink4d Inhibitor Complex Length = 326 | Back alignment and structure |
|
| >pdb|3MTL|A Chain A, Crystal Structure Of The Pctaire1 Kinase In Complex With Ind E804 Length = 324 | Back alignment and structure |
|
| >pdb|3GBZ|A Chain A, Structure Of The Cmgc Cdk Kinase From Giardia Lamblia Length = 329 | Back alignment and structure |
|
| >pdb|2W99|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306 | Back alignment and structure |
|
| >pdb|2W96|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306 | Back alignment and structure |
|
| >pdb|2W9F|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306 | Back alignment and structure |
|
| >pdb|3G33|A Chain A, Crystal Structure Of Cdk4CYCLIN D3 Length = 308 | Back alignment and structure |
|
| >pdb|2J51|A Chain A, Crystal Structure Of Human Ste20-Like Kinase Bound To 5- Amino-3-((4-(Aminosulfonyl)phenyl)amino)-N-(2,6- Difluorophenyl)-1h-1,2,4-Triazole-1-Carbothioamide Length = 325 | Back alignment and structure |
|
| >pdb|2JFL|A Chain A, Crystal Structure Of Human Ste20-Like Kinase ( Diphosphorylated Form) Bound To 5- Amino-3-((4-( Aminosulfonyl)phenyl)amino)-N-(2,6- Difluorophenyl)-1h-1,2, 4-Triazole-1-Carbothioamide Length = 325 | Back alignment and structure |
|
| >pdb|2JFM|A Chain A, Crystal Structure Of Human Ste20-Like Kinase (Unliganded Form) Length = 325 | Back alignment and structure |
|
| >pdb|3COM|A Chain A, Crystal Structure Of Mst1 Kinase Length = 314 | Back alignment and structure |
|
| >pdb|2J7T|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10 Bound To Su11274 Length = 302 | Back alignment and structure |
|
| >pdb|4BC6|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10 Bound To Novel Bosutinib Isoform 1, Previously Thought To Be Bosutinib Length = 293 | Back alignment and structure |
|
| >pdb|4AN2|A Chain A, Crystal Structures Of Human Mek1 With Carboxamide-Based Allosteric Inhibitor Xl518 (Gdc-0973), Or Related Analogs. Length = 301 | Back alignment and structure |
|
| >pdb|3SLS|A Chain A, Crystal Structure Of Human Mek-1 Kinase In Complex With Ucb1353770 And Amppnp Length = 304 | Back alignment and structure |
|
| >pdb|3ORN|A Chain A, Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In Complex With Ch4987655 And Mgamp-Pnp Length = 307 | Back alignment and structure |
|
| >pdb|3OZ6|A Chain A, Crystal Structure Of Mapk From Cryptosporidium Parvum, Cgd2_1960 Length = 388 | Back alignment and structure |
|
| >pdb|2CDZ|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In Complex With Cgp74514a Length = 303 | Back alignment and structure |
|
| >pdb|4FIF|A Chain A, Catalytic Domain Of Human Pak4 With Rpkplvdp Peptide Length = 346 | Back alignment and structure |
|
| >pdb|2Q0N|A Chain A, Structure Of Human P21 Activating Kinase 4 (Pak4) In Complex With A Consensus Peptide Length = 301 | Back alignment and structure |
|
| >pdb|2BVA|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 Length = 292 | Back alignment and structure |
|
| >pdb|2X4Z|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In Complex With Pf-03758309 Length = 296 | Back alignment and structure |
|
| >pdb|1S9I|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 2 (Mek2)in A Complex With Ligand And Mgatp Length = 354 | Back alignment and structure |
|
| >pdb|4FIE|A Chain A, Full-Length Human Pak4 Length = 423 | Back alignment and structure |
|
| >pdb|2Y4I|C Chain C, Ksr2-Mek1 Heterodimer Length = 395 | Back alignment and structure |
|
| >pdb|1S9J|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Complex With Ligand And Mgatp Length = 341 | Back alignment and structure |
|
| >pdb|2P55|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Complex With Ligand And Mgatp Length = 333 | Back alignment and structure |
|
| >pdb|3MBL|A Chain A, Crystal Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek 1) In Complex With Ligand And Mgadp Length = 328 | Back alignment and structure |
|
| >pdb|3DV3|A Chain A, Mek1 With Pf-04622664 Bound Length = 322 | Back alignment and structure |
|
| >pdb|3EQC|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Ternary Complex With Compound 1, Atp-Gs And Mg2p Length = 360 | Back alignment and structure |
|
| >pdb|1U5Q|A Chain A, Crystal Structure Of The Tao2 Kinase Domain: Activation And Specifity Of A Ste20p Map3k Length = 348 | Back alignment and structure |
|
| >pdb|2B9F|A Chain A, Crystal Structure Of Non-Phosphorylated Fus3 Length = 353 | Back alignment and structure |
|
| >pdb|2F9G|A Chain A, Crystal Structure Of Fus3 Phosphorylated On Tyr182 Length = 353 | Back alignment and structure |
|
| >pdb|2B9H|A Chain A, Crystal Structure Of Fus3 With A Docking Motif From Ste7 Length = 353 | Back alignment and structure |
|
| >pdb|4B99|A Chain A, Crystal Structure Of Mapk7 (Erk5) With Inhibitor Length = 398 | Back alignment and structure |
|
| >pdb|3D83|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biphenyl Amide Inhibitor Length = 360 | Back alignment and structure |
|
| >pdb|2GCD|A Chain A, Tao2 Kinase Domain-Staurosporine Structure Length = 309 | Back alignment and structure |
|
| >pdb|1OVE|A Chain A, The Structure Of P38 Alpha In Complex With A Dihydroquinolinone Length = 366 | Back alignment and structure |
|
| >pdb|3BHY|A Chain A, Crystal Structure Of Human Death Associated Protein Kinase 3 (Dapk3) In Complex With A Beta-Carboline Ligand Length = 283 | Back alignment and structure |
|
| >pdb|2Y8O|A Chain A, Crystal Structure Of Human P38alpha Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|4IC7|A Chain A, Crystal Structure Of The Erk5 Kinase Domain In Complex With An Mkk5 Binding Fragment Length = 442 | Back alignment and structure |
|
| >pdb|3LIJ|A Chain A, Crystal Structure Of Full Length Cpcdpk3 (Cgd5_820) In Complex With Ca2+ And Amppnp Length = 494 | Back alignment and structure |
|
| >pdb|3D7Z|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biphenyl Amide Inhibitor Length = 360 | Back alignment and structure |
|
| >pdb|3P4K|A Chain A, The Third Conformation Of P38a Map Kinase Observed In Phosphorylated P38a And In Solution Length = 370 | Back alignment and structure |
|
| >pdb|4APC|A Chain A, Crystal Structure Of Human Nima-Related Kinase 1 (Nek1) Length = 350 | Back alignment and structure |
|
| >pdb|2BAQ|A Chain A, P38alpha Bound To Ro3201195 Length = 365 | Back alignment and structure |
|
| >pdb|1YWR|A Chain A, Crystal Structure Analysis Of Inactive P38 Kinase Domain In Complex With A Monocyclic Pyrazolone Inhibitor Length = 360 | Back alignment and structure |
|
| >pdb|1YW2|A Chain A, Mutated Mus Musculus P38 Kinase (Mp38) Length = 360 | Back alignment and structure |
|
| >pdb|1LEW|A Chain A, Crystal Structure Of Map Kinase P38 Complexed To The Docking Site On Its Nuclear Substrate Mef2a Length = 360 | Back alignment and structure |
|
| >pdb|1YRP|A Chain A, Catalytic Domain Of Human Zip Kinase Phosphorylated At Thr265 Length = 278 | Back alignment and structure |
|
| >pdb|2BAL|A Chain A, P38alpha Map Kinase Bound To Pyrazoloamine Length = 365 | Back alignment and structure |
|
| >pdb|3E92|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biaryl Amide Inhibitor Length = 371 | Back alignment and structure |
|
| >pdb|3PY3|A Chain A, Crystal Structure Of Phosphorylated P38alpha Map Kinase Length = 380 | Back alignment and structure |
|
| >pdb|3TG1|A Chain A, Crystal Structure Of P38alpha In Complex With A Mapk Docking Partner Length = 380 | Back alignment and structure |
|
| >pdb|2OZA|B Chain B, Structure Of P38alpha Complex Length = 366 | Back alignment and structure |
|
| >pdb|4E5A|X Chain X, The W197a Mutant Of P38a Map Kinase Length = 360 | Back alignment and structure |
|
| >pdb|3FI4|A Chain A, P38 Kinase Crystal Structure In Complex With Ro4499 Length = 372 | Back alignment and structure |
|
| >pdb|2J90|A Chain A, Crystal Structure Of Human Zip Kinase In Complex With A Tetracyclic Pyridone Inhibitor (pyridone 6) Length = 304 | Back alignment and structure |
|
| >pdb|3GCP|A Chain A, Human P38 Map Kinase In Complex With Sb203580 Length = 360 | Back alignment and structure |
|
| >pdb|3IGO|A Chain A, Crystal Structure Of Cryptosporidium Parvum Cdpk1, Cgd3_920 Length = 486 | Back alignment and structure |
|
| >pdb|1BMK|A Chain A, The Complex Structure Of The Map Kinase P38SB218655 Length = 379 | Back alignment and structure |
|
| >pdb|2F57|A Chain A, Crystal Structure Of The Human P21-activated Kinase 5 Length = 317 | Back alignment and structure |
|
| >pdb|2GTM|A Chain A, Mutated Mouse P38 Map Kinase Domain In Complex With Inhibitor Pg-892579 Length = 348 | Back alignment and structure |
|
| >pdb|2FSO|X Chain X, Mitogen Activated Protein Kinase P38alpha (D176a) Activating Mutant Length = 367 | Back alignment and structure |
|
| >pdb|2FSL|X Chain X, Mitogen Activated Protein Kinase P38alpha (D176a+f327s) Activating Mutant Form-A Length = 367 | Back alignment and structure |
|
| >pdb|2GHL|A Chain A, Mutant Mus Musculus P38 Kinase Domain In Complex With Inhibitor Pg-874743 Length = 348 | Back alignment and structure |
|
| >pdb|3K3J|A Chain A, P38alpha Bound To Novel Dfg-Out Compound Pf-00416121 Length = 362 | Back alignment and structure |
|
| >pdb|2FST|X Chain X, Mitogen Activated Protein Kinase P38alpha (d176a+f327l) Activating Mutant Length = 367 | Back alignment and structure |
|
| >pdb|3OD6|X Chain X, Crystal Structure Of P38alpha Y323t Active Mutant Length = 360 | Back alignment and structure |
|
| >pdb|3HVC|A Chain A, Crystal Structure Of Human P38alpha Map Kinase Length = 362 | Back alignment and structure |
|
| >pdb|3ODZ|X Chain X, Crystal Structure Of P38alpha Y323r Active Mutant Length = 360 | Back alignment and structure |
|
| >pdb|2NPQ|A Chain A, A Novel Lipid Binding Site In The P38 Alpha Map Kinase Length = 367 | Back alignment and structure |
|
| >pdb|3OEF|X Chain X, Crystal Structure Of Y323f Inactive Mutant Of P38alpha Map Kinase Length = 360 | Back alignment and structure |
|
| >pdb|3ZSG|A Chain A, X-Ray Structure Of P38alpha Bound To Tak-715 Length = 362 | Back alignment and structure |
|
| >pdb|3ODY|X Chain X, Crystal Structure Of P38alpha Y323q Active Mutant Length = 360 | Back alignment and structure |
|
| >pdb|2BAJ|A Chain A, P38alpha Bound To Pyrazolourea Length = 365 | Back alignment and structure |
|
| >pdb|3HRB|A Chain A, P38 Kinase Crystal Structure In Complex With Small Molecule Inhibitor Length = 359 | Back alignment and structure |
|
| >pdb|3GCU|A Chain A, Human P38 Map Kinase In Complex With Rl48 Length = 360 | Back alignment and structure |
|
| >pdb|4EWQ|A Chain A, Human P38 Alpha Mapk In Complex With A Pyridazine Based Inhibitor Length = 383 | Back alignment and structure |
|
| >pdb|1DI9|A Chain A, The Structure Of P38 Mitogen-Activated Protein Kinase In Complex With 4-[3-Methylsulfanylanilino]-6,7- Dimethoxyquinazoline Length = 360 | Back alignment and structure |
|
| >pdb|1OZ1|A Chain A, P38 Mitogen-Activated Kinase In Complex With 4-Azaindole Inhibitor Length = 372 | Back alignment and structure |
|
| >pdb|2GFS|A Chain A, P38 Kinase Crystal Structure In Complex With Ro3201195 Length = 372 | Back alignment and structure |
|
| >pdb|1M7Q|A Chain A, Crystal Structure Of P38 Map Kinase In Complex With A Dihydroquinazolinone Inhibitor Length = 366 | Back alignment and structure |
|
| >pdb|3MPT|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Pyrrole-2- Carboxamide Inhibitor Length = 371 | Back alignment and structure |
|
| >pdb|3DT1|A Chain A, P38 Complexed With A Quinazoline Inhibitor Length = 383 | Back alignment and structure |
|
| >pdb|1IAN|A Chain A, Human P38 Map Kinase Inhibitor Complex Length = 366 | Back alignment and structure |
|
| >pdb|2LGC|A Chain A, Joint Nmr And X-Ray Refinement Reveals The Structure Of A Novel Dibenzo[a,D]cycloheptenone InhibitorP38 MAP KINASE COMPLEX IN Solution Length = 359 | Back alignment and structure |
|
| >pdb|1ZZL|A Chain A, Crystal Structure Of P38 With Triazolopyridine Length = 351 | Back alignment and structure |
|
| >pdb|3NNX|A Chain A, Crystal Structure Of Phosphorylated P38 Alpha In Complex With Dp802 Length = 354 | Back alignment and structure |
|
| >pdb|3NNU|A Chain A, Crystal Structure Of P38 Alpha In Complex With Dp1376 Length = 354 | Back alignment and structure |
|
| >pdb|3S3I|A Chain A, P38 Kinase Crystal Structure In Complex With Small Molecule Inhibitor Length = 349 | Back alignment and structure |
|
| >pdb|3HEC|A Chain A, P38 In Complex With Imatinib Length = 348 | Back alignment and structure |
|
| >pdb|3KQ7|A Chain A, Structure Of Human P38alpha With N-[4-Methyl-3-(6-{[2-(1- Methylpyrrolidin-2-Yl)ethyl]amino}pyridine-3- Amido)phenyl]- 2-(Morpholin-4-Yl)pyridine-4-Carboxamide Length = 380 | Back alignment and structure |
|
| >pdb|1BL6|A Chain A, The Complex Structure Of The Map Kinase P38SB216995 Length = 379 | Back alignment and structure |
|
| >pdb|3Q5I|A Chain A, Crystal Structure Of Pbanka_031420 Length = 504 | Back alignment and structure |
|
| >pdb|3K3I|A Chain A, P38alpha Bound To Novel Dgf-Out Compound Pf-00215955 Length = 350 | Back alignment and structure |
|
| >pdb|2PUU|A Chain A, Crystal Structure Of P38 Complex With 1-(5-Tert-Butyl-2-P- Tolyl-2h-Pyrazol-3-Yl)-3-[4-(6-Morpholin-4-Ylmethyl- Pyridin-3-Yl)naphthalen-1-Yl]urea Length = 348 | Back alignment and structure |
|
| >pdb|2X7F|A Chain A, Crystal Structure Of The Kinase Domain Of Human Traf2- And Nck-Interacting Kinase With Wee1chk1 Inhibitor Length = 326 | Back alignment and structure |
|
| >pdb|1CM8|A Chain A, Phosphorylated Map Kinase P38-Gamma Length = 367 | Back alignment and structure |
|
| >pdb|3MH2|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|2WEI|A Chain A, Crystal Structure Of The Kinase Domain Of Cryptosporidium Parvum Calcium Dependent Protein Kinase In Complex With 3- Mb-Pp1 Length = 287 | Back alignment and structure |
|
| >pdb|3DFA|A Chain A, Crystal Structure Of Kinase Domain Of Calcium-dependent Protein Kinase Cgd3_920 From Cryptosporidium Parvum Length = 286 | Back alignment and structure |
|
| >pdb|3DXN|A Chain A, Crystal Structure Of The Calcium-dependent Kinase From Toxoplasma Gondii, 541.m00134, Kinase Domain Length = 287 | Back alignment and structure |
|
| >pdb|3HZT|A Chain A, Crystal Structure Of Toxoplasma Gondii Cdpk3, Tgme49_105860 Length = 467 | Back alignment and structure |
|
| >pdb|3MFR|A Chain A, Cask-4m Cam Kinase Domain, Native Length = 351 | Back alignment and structure |
|
| >pdb|1YHV|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Two Point Mutations (K299r, T423e) Length = 297 | Back alignment and structure |
|
| >pdb|3O8P|A Chain A, Conformational Plasticity Of P38 Map Kinase Dfg Motif Mutants In Response To Inhibitor Binding Length = 360 | Back alignment and structure |
|
| >pdb|1F3M|C Chain C, Crystal Structure Of Human SerineTHREONINE KINASE PAK1 Length = 297 | Back alignment and structure |
|
| >pdb|3GI3|A Chain A, Crystal Structure Of A N-Phenyl-N'-Naphthylurea Analog In Complex With P38 Map Kinase Length = 360 | Back alignment and structure |
|
| >pdb|3MH0|A Chain A, Mutagenesis Of P38 Map Kinase Eshtablishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|3MH1|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|3OHT|A Chain A, Crystal Structure Of Salmo Salar P38alpha Length = 389 | Back alignment and structure |
|
| >pdb|3VUM|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M7 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3MH3|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|2QNJ|A Chain A, Kinase And Ubiquitin-Associated Domains Of Mark3PAR-1 Length = 328 | Back alignment and structure |
|
| >pdb|2Y0A|A Chain A, Structure Of Dapk1 Construct Residues 1-304 Length = 326 | Back alignment and structure |
|
| >pdb|3VUL|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M1 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3FXZ|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Ruthenium Complex Lambda-Fl172 Length = 297 | Back alignment and structure |
|
| >pdb|3FE3|A Chain A, Crystal Structure Of The Kinase Mark3PAR-1: T211a-S215a Double Mutant Length = 328 | Back alignment and structure |
|
| >pdb|2W4K|A Chain A, X-Ray Structure Of A Dap-Kinase 2-302 Length = 302 | Back alignment and structure |
|
| >pdb|2YAK|A Chain A, Structure Of Death-Associated Protein Kinase 1 (Dapk1) In Complex With A Ruthenium Octasporine Ligand (Osv) Length = 285 | Back alignment and structure |
|
| >pdb|2XZS|A Chain A, Death Associated Protein Kinase 1 Residues 1-312 Length = 312 | Back alignment and structure |
|
| >pdb|2W4J|A Chain A, X-Ray Structure Of A Dap-Kinase 2-277 Length = 277 | Back alignment and structure |
|
| >pdb|1WVW|A Chain A, Crystal Structures Of Kinase Domain Of Dap Kinase In Complex With Small Molecular Inhibitors Length = 278 | Back alignment and structure |
|
| >pdb|1P4F|A Chain A, Death Associated Protein Kinase Catalytic Domain With Bound Inhibitor Fragment Length = 293 | Back alignment and structure |
|
| >pdb|3F5U|A Chain A, Crystal Structure Of The Death Associated Protein Kinase In Complex With Amppnp And Mg2+ Length = 295 | Back alignment and structure |
|
| >pdb|1IG1|A Chain A, 1.8a X-Ray Structure Of Ternary Complex Of A Catalytic Domain Of Death-Associated Protein Kinase With Atp Analogue And Mn. Length = 294 | Back alignment and structure |
|
| >pdb|2X0G|A Chain A, X-ray Structure Of A Dap-kinase Calmodulin Complex Length = 334 | Back alignment and structure |
|
| >pdb|3DFC|B Chain B, Crystal Structure Of A Glycine-Rich Loop Mutant Of The Death Associated Protein Kinase Catalytic Domain With Amppnp Length = 295 | Back alignment and structure |
|
| >pdb|3I79|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii (Tgcdpk1) Length = 484 | Back alignment and structure |
|
| >pdb|2C30|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 6 Length = 321 | Back alignment and structure |
|
| >pdb|3GU4|A Chain A, Crystal Structure Of Dapkq23v-Amppnp Length = 295 | Back alignment and structure |
|
| >pdb|3HX4|A Chain A, Crystal Structure Of Cdpk1 Of Toxoplasma Gondii, Tgme49_101440, In Presence Of Calcium Length = 508 | Back alignment and structure |
|
| >pdb|3KU2|A Chain A, Crystal Structure Of Inactivated Form Of Cdpk1 From Toxoplasma Gondii, Tgme49.101440 Length = 507 | Back alignment and structure |
|
| >pdb|3Q52|A Chain A, Structure Of Phosphorylated Pak1 Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|4E7W|A Chain A, Structure Of Gsk3 From Ustilago Maydis Length = 394 | Back alignment and structure |
|
| >pdb|3IS5|A Chain A, Crystal Structure Of Cdpk Kinase Domain From Toxoplasma Gondii, Tgme49_018720 Length = 285 | Back alignment and structure |
|
| >pdb|3GU8|A Chain A, Crystal Structure Of Dapkl93g With N6-Cyclopentyladenosine Length = 295 | Back alignment and structure |
|
| >pdb|3MA6|A Chain A, Crystal Structure Of Kinase Domain Of Tgcdpk1 In Presence Of 3brb-Pp1 Length = 298 | Back alignment and structure |
|
| >pdb|2HAK|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark1PAR-1 Length = 328 | Back alignment and structure |
|
| >pdb|3E7O|A Chain A, Crystal Structure Of Jnk2 Length = 360 | Back alignment and structure |
|
| >pdb|3MN3|A Chain A, An Inhibited Conformation For The Protein Kinase Domain Of The Saccharomyces Cerevisiae Ampk Homolog Snf1 Length = 271 | Back alignment and structure |
|
| >pdb|3I7C|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii (Tgcdpk1) In Complex With Bumped Kinase Inhibitor Na-Pp2 Length = 484 | Back alignment and structure |
|
| >pdb|3FI3|A Chain A, Crystal Structure Of Jnk3 With Indazole Inhibitor, Sr-3737 Length = 364 | Back alignment and structure |
|
| >pdb|3VUK|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M5 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3RP9|A Chain A, Crystal Structure Of The Apo Mapk From Toxoplasma Gondii, 25.M01780 Or Tgme49_007820 Length = 458 | Back alignment and structure |
|
| >pdb|1H8F|A Chain A, Glycogen Synthase Kinase 3 Beta. Length = 352 | Back alignment and structure |
|
| >pdb|3DAE|A Chain A, Crystal Structure Of Phosphorylated Snf1 Kinase Domain Length = 283 | Back alignment and structure |
|
| >pdb|2FH9|A Chain A, Structure And Dimerization Of The Kinase Domain From Yeast Snf1 Length = 274 | Back alignment and structure |
|
| >pdb|3HYH|A Chain A, Crystal Structure Of The Protein Kinase Domain Of Yeast Amp-Activated Protein Kinase Snf1 Length = 275 | Back alignment and structure |
|
| >pdb|1O9U|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With Axin Peptide Length = 350 | Back alignment and structure |
|
| >pdb|3Q4Z|A Chain A, Structure Of Unphosphorylated Pak1 Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|2XS0|A Chain A, Linear Binding Motifs For Jnk And For Calcineurin Antagonistically Control The Nuclear Shuttling Of Nfat4 Length = 386 | Back alignment and structure |
|
| >pdb|3KVX|A Chain A, Jnk3 Bound To Aminopyrimidine Inhibitor, Sr-3562 Length = 364 | Back alignment and structure |
|
| >pdb|2R9S|A Chain A, C-Jun N-Terminal Kinase 3 With 3,5-Disubstituted Quinoline Inhibitor Length = 356 | Back alignment and structure |
|
| >pdb|3SD0|A Chain A, Identification Of A Glycogen Synthase Kinase-3b Inhibitor That Attenuates Hyperactivity In Clock Mutant Mice Length = 350 | Back alignment and structure |
|
| >pdb|2OW3|A Chain A, Glycogen Synthase Kinase-3 Beta In Complex With Bis- (Indole)maleimide Pyridinophane Inhibitor Length = 352 | Back alignment and structure |
|
| >pdb|3V3V|A Chain A, Structural And Functional Analysis Of Quercetagetin, A Natural Jnk1 Inhibitor Length = 379 | Back alignment and structure |
|
| >pdb|2XUU|A Chain A, Crystal Structure Of A Dap-Kinase 1 Mutant Length = 334 | Back alignment and structure |
|
| >pdb|3RGF|A Chain A, Crystal Structure Of Human Cdk8CYCC Length = 405 | Back alignment and structure |
|
| >pdb|2O5K|A Chain A, Crystal Structure Of Gsk3beta In Complex With A Benzoimidazol Inhibitor Length = 372 | Back alignment and structure |
|
| >pdb|3VUI|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M2 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|1ZMU|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: Wild Type Length = 327 | Back alignment and structure |
|
| >pdb|3VUH|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M3 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|1UV5|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With 6-Bromoindirubin-3'-Oxime Length = 350 | Back alignment and structure |
|
| >pdb|1Q5K|A Chain A, Crystal Structure Of Glycogen Synthase Kinase 3 In Complexed With Inhibitor Length = 414 | Back alignment and structure |
|
| >pdb|2R0I|A Chain A, Crystal Structure Of A Kinase Mark2PAR-1 Mutant Length = 327 | Back alignment and structure |
|
| >pdb|1R0E|A Chain A, Glycogen Synthase Kinase-3 Beta In Complex With 3-Indolyl-4- Arylmaleimide Inhibitor Length = 391 | Back alignment and structure |
|
| >pdb|3GB2|A Chain A, Gsk3beta Inhibitor Complex Length = 353 | Back alignment and structure |
|
| >pdb|4AFJ|A Chain A, 5-Aryl-4-Carboxamide-1,3-Oxazoles: Potent And Selective Gsk-3 Inhibitors Length = 367 | Back alignment and structure |
|
| >pdb|4DIT|A Chain A, Crystal Structure Of Gsk3beta In Complex With A Imidazopyridine Inhibitor Length = 382 | Back alignment and structure |
|
| >pdb|3ZDI|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With Axin Peptide And Inhibitor 7d Length = 350 | Back alignment and structure |
|
| >pdb|1I09|A Chain A, Structure Of Glycogen Synthase Kinase-3 (Gsk3b) Length = 420 | Back alignment and structure |
|
| >pdb|3ZRK|A Chain A, Identification Of 2-(4-Pyridyl)thienopyridinones As Gsk-3beta Inhibitors Length = 371 | Back alignment and structure |
|
| >pdb|3IEC|A Chain A, Helicobacter Pylori Caga Inhibits Par1MARK FAMILY KINASES BY Mimicking Host Substrates Length = 319 | Back alignment and structure |
|
| >pdb|3F7Z|A Chain A, X-ray Co-crystal Structure Of Glycogen Synthase Kinase 3beta In Complex With An Inhibitor Length = 350 | Back alignment and structure |
|
| >pdb|1ZMW|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: T208aS212A INACTIVE DOUBLE MUTANT Length = 327 | Back alignment and structure |
|
| >pdb|1GNG|A Chain A, Glycogen Synthase Kinase-3 Beta (Gsk3) Complex With Frattide Peptide Length = 378 | Back alignment and structure |
|
| >pdb|3NPC|A Chain A, Crystal Structure Of Jnk2 Complexed With Birb796 Length = 364 | Back alignment and structure |
|
| >pdb|3SAY|A Chain A, Crystal Structure Of Human Glycogen Synthase Kinase 3 Beta (Gsk3b) In Complex With Inhibitor 142 Length = 430 | Back alignment and structure |
|
| >pdb|3F88|A Chain A, Glycogen Synthase Kinase 3beta Inhibitor Complex Length = 349 | Back alignment and structure |
|
| >pdb|4ACC|A Chain A, Gsk3b In Complex With Inhibitor Length = 465 | Back alignment and structure |
|
| >pdb|1PYX|A Chain A, Gsk-3 Beta Complexed With Amp-Pnp Length = 422 | Back alignment and structure |
|
| >pdb|4H3Q|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|3FV8|A Chain A, Jnk3 Bound To Piperazine Amide Inhibitor, Sr2774 Length = 355 | Back alignment and structure |
|
| >pdb|1Q3D|A Chain A, Gsk-3 Beta Complexed With Staurosporine Length = 424 | Back alignment and structure |
|
| >pdb|3O17|A Chain A, Crystal Structure Of Jnk1-Alpha1 Isoform Length = 370 | Back alignment and structure |
|
| >pdb|2Y94|A Chain A, Structure Of An Active Form Of Mammalian Ampk Length = 476 | Back alignment and structure |
|
| >pdb|1KOA|A Chain A, Twitchin Kinase Fragment (C.Elegans), Autoregulated Protein Kinase And Immunoglobulin Domains Length = 491 | Back alignment and structure |
|
| >pdb|3UTO|A Chain A, Twitchin Kinase Region From C.Elegans (Fn31-Nl-Kin-Crd-Ig26) Length = 573 | Back alignment and structure |
|
| >pdb|3FI2|A Chain A, Crystal Structure Of Jnk3 With Amino-Pyrazole Inhibitor, Sr- 3451 Length = 353 | Back alignment and structure |
|
| >pdb|1KOB|A Chain A, Twitchin Kinase Fragment (Aplysia), Autoregulated Protein Kinase Domain Length = 387 | Back alignment and structure |
|
| >pdb|2XRW|A Chain A, Linear Binding Motifs For Jnk And For Calcineurin Antagonistically Control The Nuclear Shuttling Of Nfat4 Length = 371 | Back alignment and structure |
|
| >pdb|1ZMV|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: K82r Mutant Length = 327 | Back alignment and structure |
|
| >pdb|2WZJ|A Chain A, Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82r, T208e Double Mutant Length = 327 | Back alignment and structure |
|
| >pdb|1UKH|A Chain A, Structural Basis For The Selective Inhibition Of Jnk1 By The Scaffolding Protein Jip1 And Sp600125 Length = 369 | Back alignment and structure |
|
| >pdb|3PZE|A Chain A, Jnk1 In Complex With Inhibitor Length = 358 | Back alignment and structure |
|
| >pdb|2G01|A Chain A, Pyrazoloquinolones As Novel, Selective Jnk1 Inhibitors Length = 370 | Back alignment and structure |
|
| >pdb|3ELJ|A Chain A, Jnk1 Complexed With A Bis-Anilino-Pyrrolopyrimidine Inhibitor Length = 369 | Back alignment and structure |
|
| >pdb|1PMN|A Chain A, Crystal Structure Of Jnk3 In Complex With An Imidazole- Pyrimidine Inhibitor Length = 364 | Back alignment and structure |
|
| >pdb|2OK1|A Chain A, Crystal Structure Of Jnk3 Bound To N-Benzyl-4-(4-(3- Chlorophenyl)-1h-Pyrazol-3-Yl)-1h-Pyrrole-2-Carboxamide Length = 365 | Back alignment and structure |
|
| >pdb|3TTJ|A Chain A, Crystal Structure Of Jnk3 Complexed With Cc-359, A Jnk Inhibitor For The Prevention Of Ischemia-Reperfusion Injury Length = 464 | Back alignment and structure |
|
| >pdb|2O0U|A Chain A, Crystal Structure Of Human Jnk3 Complexed With N-{3-Cyano-6-[3-(1- Piperidinyl)propanoyl]-4,5,6,7-Tetrahydrothieno[2, 3-C]pyridin-2-Yl}- 1-Naphthalenecarboxamide Length = 364 | Back alignment and structure |
|
| >pdb|3TEI|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|3UC4|A Chain A, The Crystal Structure Of Snf1-Related Kinase 2.6 Length = 362 | Back alignment and structure |
|
| >pdb|3OXI|A Chain A, Design And Synthesis Of Disubstituted Thiophene And Thiazole Based Inhibitors Of Jnk For The Treatment Of Neurodegenerative Diseases Length = 362 | Back alignment and structure |
|
| >pdb|3PTG|A Chain A, Design And Synthesis Of A Novel, Orally Efficacious Tri-Substituted Thiophene Based Jnk Inhibitor Length = 363 | Back alignment and structure |
|
| >pdb|3VUD|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M1 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|4H36|A Chain A, Crystal Structure Of Jnk3 In Complex With Atf2 Peptide Length = 356 | Back alignment and structure |
|
| >pdb|1JNK|A Chain A, The C-Jun N-Terminal Kinase (Jnk3s) Complexed With Mgamp-Pnp Length = 423 | Back alignment and structure |
|
| >pdb|4EQM|A Chain A, Structural Analysis Of Staphylococcus Aureus SerineTHREONINE KINASE Pknb Length = 294 | Back alignment and structure |
|
| >pdb|2B1P|A Chain A, Inhibitor Complex Of Jnk3 Length = 355 | Back alignment and structure |
|
| >pdb|3UJG|A Chain A, Crystal Structure Of Snrk2.6 In Complex With Hab1 Length = 361 | Back alignment and structure |
|
| >pdb|2I6L|A Chain A, Crystal Structure Of Human Mitogen Activated Protein Kinase 6 (Mapk6) Length = 320 | Back alignment and structure |
|
| >pdb|3VUG|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M2 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|2EXC|X Chain X, Inhibitor Complex Of Jnk3 Length = 356 | Back alignment and structure |
|
| >pdb|3N9X|A Chain A, Crystal Structure Of Map Kinase From Plasmodium Berghei, Pb000659.00.0 Length = 432 | Back alignment and structure |
|
| >pdb|3A7F|A Chain A, Human Mst3 Kinase Length = 303 | Back alignment and structure |
|
| >pdb|3CKX|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) In Complex With Staurosporine Length = 304 | Back alignment and structure |
|
| >pdb|3CKW|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) Length = 304 | Back alignment and structure |
|
| >pdb|4FV7|A Chain A, Crystal Structure Of The Erk2 Complexed With E94 Length = 360 | Back alignment and structure |
|
| >pdb|3H4J|B Chain B, Crystal Structure Of Pombe Ampk Kdaid Fragment Length = 336 | Back alignment and structure |
|
| >pdb|3ZHP|C Chain C, Human Mst3 (stk24) In Complex With Mo25beta Length = 294 | Back alignment and structure |
|
| >pdb|2XIK|A Chain A, Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related Kinase 1) Length = 294 | Back alignment and structure |
|
| >pdb|4FUX|A Chain A, Crystal Structure Of The Erk2 Complexed With E75 Length = 360 | Back alignment and structure |
|
| >pdb|3COI|A Chain A, Crystal Structure Of P38delta Kinase Length = 353 | Back alignment and structure |
|
| >pdb|1Y8G|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: Inactive Double Mutant With Selenomethionine Length = 327 | Back alignment and structure |
|
| >pdb|4GSB|A Chain A, Monoclinic Crystal Form Of The Apo-Erk2 Length = 364 | Back alignment and structure |
|
| >pdb|2Y9Q|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|3QYW|A Chain A, Crystal Structure Of Erk2 In Complex With An Inhibitor Length = 364 | Back alignment and structure |
|
| >pdb|4FV6|A Chain A, Crystal Structure Of The Erk2 Complexed With E57 Length = 360 | Back alignment and structure |
|
| >pdb|1WZY|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Pyrazolopyridazine Derivative Length = 368 | Back alignment and structure |
|
| >pdb|1TVO|A Chain A, The Structure Of Erk2 In Complex With A Small Molecule Inhibitor Length = 368 | Back alignment and structure |
|
| >pdb|2YA9|A Chain A, Crystal Structure Of The Autoinhibited Form Of Mouse Dapk2 Length = 361 | Back alignment and structure |
|
| >pdb|2OJG|A Chain A, Crystal Structure Of Erk2 In Complex With N,n-dimethyl-4-(4- Phenyl-1h-pyrazol-3-yl)-1h-pyrrole-2-carboxamide Length = 380 | Back alignment and structure |
|
| >pdb|4EXU|A Chain A, Mapk13, Inactive Form Length = 371 | Back alignment and structure |
|
| >pdb|3O71|A Chain A, Crystal Structure Of Erk2DCC PEPTIDE COMPLEX Length = 358 | Back alignment and structure |
|
| >pdb|3ZU7|A Chain A, Crystal Structure Of A Designed Selected Ankyrin Repeat Protein In Complex With The Map Kinase Erk2 Length = 365 | Back alignment and structure |
|
| >pdb|2Z7L|A Chain A, Unphosphorylated Mitogen Activated Protein Kinase Erk2 In Complex With (4-{[5-Carbamoyl-4-(3-Methylanilino)pyrimidin 2-Yl]amino}phenyl)acetic Acid Length = 366 | Back alignment and structure |
|
| >pdb|3C9W|A Chain A, Crystal Structure Of Erk-2 With Hypothemycin Covalently Bound Length = 357 | Back alignment and structure |
|
| >pdb|2FYS|B Chain B, Crystal Structure Of Erk2 Complex With Kim Peptide Derived From Mkp3 Length = 364 | Back alignment and structure |
|
| >pdb|1PME|A Chain A, Structure Of Penta Mutant Human Erk2 Map Kinase Complexed With A Specific Inhibitor Of Human P38 Map Kinase Length = 380 | Back alignment and structure |
|
| >pdb|3R63|A Chain A, Structure Of Erk2 (Spe) Mutant (S246e) Length = 358 | Back alignment and structure |
|
| >pdb|3DAJ|A Chain A, Crystal Structure Of Aurora A Complexed With An Inhibitor Discovered Through Site-Directed Dynamic Tethering Length = 272 | Back alignment and structure |
|
| >pdb|3S95|A Chain A, Crystal Structure Of The Human Limk1 Kinase Domain In Complex With Staurosporine Length = 310 | Back alignment and structure |
|
| >pdb|3D14|A Chain A, Crystal Structure Of Mouse Aurora A (Asn186->gly, Lys240->arg, Met302- >leu) In Complex With 1-{5-[2-(Thieno[3,2-D]pyrimidin-4-Ylamino)- Ethyl]- Thiazol-2-Yl}-3-(3-Trifluoromethyl-Phenyl)-Urea Length = 272 | Back alignment and structure |
|
| >pdb|3UC3|A Chain A, The Crystal Structure Of Snf1-Related Kinase 2.3 Length = 361 | Back alignment and structure |
|
| >pdb|3TAC|A Chain A, Crystal Structure Of The Liprin-AlphaCASK COMPLEX Length = 361 | Back alignment and structure |
|
| >pdb|4A4X|A Chain A, Nek2-Ede Bound To Cct248662 Length = 279 | Back alignment and structure |
|
| >pdb|3C0G|A Chain A, Cask Cam-kinase Domain- 3'-amp Complex, P1 Form Length = 351 | Back alignment and structure |
|
| >pdb|2GPH|A Chain A, Docking Motif Interactions In The Map Kinase Erk2 Length = 364 | Back alignment and structure |
|
| >pdb|2W5A|A Chain A, Human Nek2 Kinase Adp-Bound Length = 279 | Back alignment and structure |
|
| >pdb|2JAV|A Chain A, Human Kinase With Pyrrole-Indolinone Ligand Length = 279 | Back alignment and structure |
|
| >pdb|1GOL|A Chain A, Coordinates Of Rat Map Kinase Erk2 With An Arginine Mutation At Position 52 Length = 364 | Back alignment and structure |
|
| >pdb|3VN9|A Chain A, Rifined Crystal Structure Of Non-Phosphorylated Map2k6 In A Putative Auto-Inhibition State Length = 340 | Back alignment and structure |
|
| >pdb|3GC9|A Chain A, The Structure Of P38beta C119s, C162s In Complex With A Dihydroquinazolinone Inhibitor Length = 370 | Back alignment and structure |
|
| >pdb|3ZUT|A Chain A, The Structure Of Ost1 (D160a) Kinase Length = 362 | Back alignment and structure |
|
| >pdb|3NIE|A Chain A, Crystal Structure Of Pf11_0147 Length = 429 | Back alignment and structure |
|
| >pdb|3FME|A Chain A, Crystal Structure Of Human Mitogen-Activated Protein Kinase Kinase 6 (Mek6) Activated Mutant (S207d, T211d) Length = 290 | Back alignment and structure |
|
| >pdb|3ZUV|A Chain A, Crystal Structure Of A Designed Selected Ankyrin Repeat Protein In Complex With The Phosphorylated Map Kinase Erk2 Length = 364 | Back alignment and structure |
|
| >pdb|2ERK|A Chain A, Phosphorylated Map Kinase Erk2 Length = 365 | Back alignment and structure |
|
| >pdb|3ZUU|A Chain A, The Structure Of Ost1 (D160a, S175d) Kinase In Complex With Gold Length = 362 | Back alignment and structure |
|
| >pdb|2DYL|A Chain A, Crystal Structure Of Human Mitogen-Activated Protein Kinase Kinase 7 Activated Mutant (S287d, T291d) Length = 318 | Back alignment and structure |
|
| >pdb|3COH|A Chain A, Crystal Structure Of Aurora-A In Complex With A Pentacyclic Inhibitor Length = 268 | Back alignment and structure |
|
| >pdb|2W4O|A Chain A, Crystal Structure Of Human Camk4 In Complex With 4-Amino( Sulfamoyl-Phenylamino)-Triazole-Carbothioic Acid (2,6- Difluoro-Phenyl)-Amide) Length = 349 | Back alignment and structure |
|
| >pdb|3UIB|A Chain A, Map Kinase Lmampk10 From Leishmania Major In Complex With Sb203580 Length = 362 | Back alignment and structure |
|
| >pdb|3PG1|A Chain A, Map Kinase Lmampk10 From Leishmania Major (1.95 Angs Resolution) Length = 362 | Back alignment and structure |
|
| >pdb|3GC8|A Chain A, The Structure Of P38beta C162s In Complex With A Dihydroquinazolinone Length = 370 | Back alignment and structure |
|
| >pdb|2YZA|A Chain A, Crystal Structure Of Kinase Domain Of Human 5'-Amp-Activated Protein Kinase Alpha-2 Subunit Mutant (T172d) Length = 276 | Back alignment and structure |
|
| >pdb|2H6D|A Chain A, Protein Kinase Domain Of The Human 5'-Amp-Activated Protein Kinase Catalytic Subunit Alpha-2 (Ampk Alpha-2 Chain) Length = 276 | Back alignment and structure |
|
| >pdb|3COK|A Chain A, Crystal Structure Of Plk4 Kinase Length = 278 | Back alignment and structure |
|
| >pdb|1WMK|A Chain A, Human Death-Associated Kinase Drp-1, Mutant S308d D40 Length = 321 | Back alignment and structure |
|
| >pdb|2BFY|A Chain A, Complex Of Aurora-B With Incenp And Hesperidin. Length = 284 | Back alignment and structure |
|
| >pdb|2VRX|A Chain A, Structure Of Aurora B Kinase In Complex With Zm447439 Length = 285 | Back alignment and structure |
|
| >pdb|1ZY4|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: R794g Hyperactivating Mutant In Apo Form. Length = 303 | Back alignment and structure |
|
| >pdb|2A27|A Chain A, Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal Form With 8 Monomers In The Asymmetric Unit Length = 321 | Back alignment and structure |
|
| >pdb|3SA0|A Chain A, Complex Of Erk2 With Norathyriol Length = 360 | Back alignment and structure |
|
| >pdb|2ZOQ|A Chain A, Structural Dissection Of Human Mitogen-Activated Kinase Erk1 Length = 382 | Back alignment and structure |
|
| >pdb|1ZYC|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: Wild- Type In Apo Form. Length = 303 | Back alignment and structure |
|
| >pdb|1ZWS|A Chain A, Crystal Structure Of The Catalytic Domain Of Human Drp-1 Kinase Length = 288 | Back alignment and structure |
|
| >pdb|2A2A|A Chain A, High-resolution Crystallographic Analysis Of The Autoinhibited Conformation Of A Human Death-associated Protein Kinase Length = 321 | Back alignment and structure |
|
| >pdb|1Z9X|A Chain A, Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal Form With 3 Monomers In The Asymmetric Unit Length = 321 | Back alignment and structure |
|
| >pdb|2J4Z|A Chain A, Structure Of Aurora-2 In Complex With Pha-680626 Length = 306 | Back alignment and structure |
|
| >pdb|3QBN|A Chain A, Structure Of Human Aurora A In Complex With A Diaminopyrimidine Length = 281 | Back alignment and structure |
|
| >pdb|2BMC|A Chain A, Aurora-2 T287d T288d Complexed With Pha-680632 Length = 306 | Back alignment and structure |
|
| >pdb|3O50|A Chain A, Crystal Structure Of Benzamide 9 Bound To Auroraa Length = 267 | Back alignment and structure |
|
| >pdb|3E5A|A Chain A, Crystal Structure Of Aurora A In Complex With Vx-680 And Tpx2 Length = 268 | Back alignment and structure |
|
| >pdb|2JAM|A Chain A, Crystal Structure Of Human Calmodulin-Dependent Protein Kinase I G Length = 304 | Back alignment and structure |
|
| >pdb|3H0Y|A Chain A, Aurora A In Complex With A Bisanilinopyrimidine Length = 268 | Back alignment and structure |
|
| >pdb|2W1D|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275 | Back alignment and structure |
|
| >pdb|1MUO|A Chain A, Crystal Structure Of Aurora-2, An Oncogenic Serine- Threonine Kinase Length = 297 | Back alignment and structure |
|
| >pdb|3HA6|A Chain A, Crystal Structure Of Aurora A In Complex With Tpx2 And Compound 10 Length = 268 | Back alignment and structure |
|
| >pdb|2W1C|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275 | Back alignment and structure |
|
| >pdb|2C6D|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With Adpnp Length = 275 | Back alignment and structure |
|
| >pdb|1OL5|A Chain A, Structure Of Aurora-A 122-403, Phosphorylated On Thr287, Thr288 And Bound To Tpx2 1-43 Length = 282 | Back alignment and structure |
|
| >pdb|3R21|A Chain A, Design, Synthesis, And Biological Evaluation Of Pyrazolopyridine- Sulfonamides As Potent Multiple-Mitotic Kinase (Mmk) Inhibitors (Part I) Length = 271 | Back alignment and structure |
|
| >pdb|3LAU|A Chain A, Crystal Structure Of Aurora2 Kinase In Complex With A Gsk3beta Inhibitor Length = 287 | Back alignment and structure |
|
| >pdb|2XRU|A Chain A, Aurora-A T288e Complexed With Pha-828300 Length = 280 | Back alignment and structure |
|
| >pdb|2X6D|A Chain A, Aurora-A Bound To An Inhibitor Length = 285 | Back alignment and structure |
|
| >pdb|2DWB|A Chain A, Aurora-A Kinase Complexed With Amppnp Length = 285 | Back alignment and structure |
|
| >pdb|2XNG|A Chain A, Structure Of Aurora-A Bound To A Selective Imidazopyrazine Inhibitor Length = 283 | Back alignment and structure |
|
| >pdb|2J50|A Chain A, Structure Of Aurora-2 In Complex With Pha-739358 Length = 280 | Back alignment and structure |
|
| >pdb|3GP0|A Chain A, Crystal Structure Of Human Mitogen Activated Protein Kinase 11 (p38 Beta) In Complex With Nilotinib Length = 348 | Back alignment and structure |
|
| >pdb|2C6E|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With A 5-Aminopyrimidinyl Quinazoline Inhibitor Length = 283 | Back alignment and structure |
|
| >pdb|1MQ4|A Chain A, Crystal Structure Of Aurora-A Protein Kinase Length = 272 | Back alignment and structure |
|
| >pdb|3UNZ|A Chain A, Aurora A In Complex With Rpm1679 Length = 279 | Back alignment and structure |
|
| >pdb|3NRM|A Chain A, Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibitors Length = 283 | Back alignment and structure |
|
| >pdb|3FDN|A Chain A, Structure-Based Drug Design Of Novel Aurora Kinase A Inhibitors: Structure Basis For Potency And Specificity Length = 279 | Back alignment and structure |
|
| >pdb|3E3P|A Chain A, Glycogen Synthase Kinase From Leishmania Major Length = 360 | Back alignment and structure |
|
| >pdb|2Y7J|A Chain A, Structure Of Human Phosphorylase Kinase, Gamma 2 Length = 365 | Back alignment and structure |
|
| >pdb|3UDB|A Chain A, Crystal Structure Of Snrk2.6 Length = 317 | Back alignment and structure |
|
| >pdb|3GGF|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase Mst4 In Complex With An Quinazolin Length = 301 | Back alignment and structure |
|
| >pdb|2WQE|A Chain A, Structure Of S155r Aurora-A Somatic Mutant Length = 262 | Back alignment and structure |
|
| >pdb|2WTK|C Chain C, Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo25alpha Complex Length = 305 | Back alignment and structure |
|
| >pdb|2WTV|A Chain A, Aurora-A Inhibitor Structure Length = 285 | Back alignment and structure |
|
| >pdb|2XNE|A Chain A, Structure Of Aurora-A Bound To An Imidazopyrazine Inhibitor Length = 272 | Back alignment and structure |
|
| >pdb|1OL6|A Chain A, Structure Of Unphosphorylated D274n Mutant Of Aurora-a Length = 282 | Back alignment and structure |
|
| >pdb|2WTW|A Chain A, Aurora-A Inhibitor Structure (2nd Crystal Form) Length = 285 | Back alignment and structure |
|
| >pdb|4GS6|A Chain A, Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxozeaenol Length = 315 | Back alignment and structure |
|
| >pdb|4E6D|A Chain A, Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex With Compound 7 Length = 298 | Back alignment and structure |
|
| >pdb|2EVA|A Chain A, Structural Basis For The Interaction Of Tak1 Kinase With Its Activating Protein Tab1 Length = 307 | Back alignment and structure |
|
| >pdb|2WQM|A Chain A, Structure Of Apo Human Nek7 Length = 310 | Back alignment and structure |
|
| >pdb|1ZXE|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: D835n Inactivating Mutant In Apo Form Length = 303 | Back alignment and structure |
|
| >pdb|4EUT|A Chain A, Structure Of Bx-795 Complexed With Unphosphorylated Human Tbk1 Kinase- Uld Domain Length = 396 | Back alignment and structure |
|
| >pdb|3BKB|A Chain A, Crystal Structure Of Human Feline Sarcoma Viral Oncogene Homologue (V- Fes) Length = 377 | Back alignment and structure |
|
| >pdb|3CD3|A Chain A, Crystal Structure Of Phosphorylated Human Feline Sarcoma Viral Oncogene Homologue (V-Fes) In Complex With Staurosporine And A Consensus Peptide Length = 377 | Back alignment and structure |
|
| >pdb|1A06|A Chain A, Calmodulin-Dependent Protein Kinase From Rat Length = 332 | Back alignment and structure |
|
| >pdb|4EUU|A Chain A, Structure Of Bx-795 Complexed With Human Tbk1 Kinase Domain Phosphorylated On Ser172 Length = 319 | Back alignment and structure |
|
| >pdb|3P1A|A Chain A, Structure Of Human Membrane-Associated Tyrosine- And Threonine- Specific Cdc2-Inhibitory Kinase Myt1 (Pkmyt1) Length = 311 | Back alignment and structure |
|
| >pdb|4FG7|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-293 In Complex With Atp Length = 293 | Back alignment and structure |
|
| >pdb|3VW6|A Chain A, Crystal Structure Of Human Apoptosis Signal-Regulating Kinase 1 (Ask1) With Imidazopyridine Inhibitor Length = 269 | Back alignment and structure |
|
| >pdb|2CLQ|A Chain A, Structure Of Mitogen-Activated Protein Kinase Kinase Kinase 5 Length = 295 | Back alignment and structure |
|
| >pdb|4FG9|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-320 In Complex With Atp Length = 320 | Back alignment and structure |
|
| >pdb|4FG8|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-315 In Complex With Atp Length = 315 | Back alignment and structure |
|
| >pdb|1FOT|A Chain A, Structure Of The Unliganded Camp-Dependent Protein Kinase Catalytic Subunit From Saccharomyces Cerevisiae Length = 318 | Back alignment and structure |
|
| >pdb|3TJC|A Chain A, Co-Crystal Structure Of Jak2 With Thienopyridine 8 Length = 298 | Back alignment and structure |
|
| >pdb|2W1I|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 326 | Back alignment and structure |
|
| >pdb|3UGC|A Chain A, Structural Basis Of Jak2 Inhibition By The Type Ii Inhibtor Nvp-Bbt594 Length = 295 | Back alignment and structure |
|
| >pdb|3RVG|A Chain A, Crystals Structure Of Jak2 With A 1-Amino-5h-Pyrido[4,3-B]indol-4- Carboxamide Inhibitor Length = 303 | Back alignment and structure |
|
| >pdb|2B7A|A Chain A, The Structural Basis Of Janus Kinase 2 Inhibition By A Potent And Specific Pan-Janus Kinase Inhibitor Length = 293 | Back alignment and structure |
|
| >pdb|4HGE|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 8 Length = 300 | Back alignment and structure |
|
| >pdb|4E4M|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 30 Length = 302 | Back alignment and structure |
|
| >pdb|3E62|A Chain A, Fragment Based Discovery Of Jak-2 Inhibitors Length = 293 | Back alignment and structure |
|
| >pdb|4AQC|A Chain A, Triazolopyridine-Based Inhibitor Of Janus Kinase 2 Length = 301 | Back alignment and structure |
|
| >pdb|3Q32|A Chain A, Structure Of Janus Kinase 2 With A Pyrrolotriazine Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|2XA4|A Chain A, Inhibitors Of Jak2 Kinase Domain Length = 298 | Back alignment and structure |
|
| >pdb|3LPB|A Chain A, Crystal Structure Of Jak2 Complexed With A Potent 2,8-Diaryl Quinoxaline Inhibitor Length = 295 | Back alignment and structure |
|
| >pdb|3IO7|A Chain A, 2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Selective Inhibitors Of Jak2 Length = 313 | Back alignment and structure |
|
| >pdb|3JY9|A Chain A, Janus Kinase 2 Inhibitors Length = 311 | Back alignment and structure |
|
| >pdb|3ENM|A Chain A, The Structure Of The Map2k Mek6 Reveals An Autoinhibitory Dimer Length = 316 | Back alignment and structure |
|
| >pdb|1QL6|A Chain A, The Catalytic Mechanism Of Phosphorylase Kinase Probed By Mutational Studies Length = 298 | Back alignment and structure |
|
| >pdb|1PHK|A Chain A, Two Structures Of The Catalytic Domain Of Phosphorylase, Kinase: An Active Protein Kinase Complexed With Nucleotide, Substrate-Analogue And Product Length = 298 | Back alignment and structure |
|
| >pdb|3L9M|A Chain A, Crystal Structure Of Pkab3 (Pka Triple Mutant V123a, L173m, Q181k) With Compound 18 Length = 351 | Back alignment and structure |
|
| >pdb|1CDK|A Chain A, Camp-Dependent Protein Kinase Catalytic Subunit (E.C.2.7.1.37) (Protein Kinase A) Complexed With Protein Kinase Inhibitor Peptide Fragment 5-24 (Pki(5-24) Isoelectric Variant Ca) And Mn2+ Adenylyl Imidodiphosphate (Mnamp-Pnp) At Ph 5.6 And 7c And 4c Length = 350 | Back alignment and structure |
|
| >pdb|2JC6|A Chain A, Crystal Structure Of Human Calmodulin-Dependent Protein Kinase 1d Length = 334 | Back alignment and structure |
|
| >pdb|2PHK|A Chain A, The Crystal Structure Of A Phosphorylase Kinase Peptide Substrate Complex: Kinase Substrate Recognition Length = 277 | Back alignment and structure |
|
| >pdb|1CMK|E Chain E, Crystal Structures Of The Myristylated Catalytic Subunit Of Camp- Dependent Protein Kinase Reveal Open And Closed Conformations Length = 350 | Back alignment and structure |
|
| >pdb|1CTP|E Chain E, Structure Of The Mammalian Catalytic Subunit Of Camp-Dependent Protein Kinase And An Inhibitor Peptide Displays An Open Conformation Length = 350 | Back alignment and structure |
|
| >pdb|4BBE|A Chain A, Aminoalkylpyrimidine Inhibitor Complexes With Jak2 Length = 298 | Back alignment and structure |
|
| >pdb|4AE9|A Chain A, Structure And Function Of The Human Sperm-specific Isoform Of Protein Kinase A (pka) Catalytic Subunit C Alpha 2 Length = 343 | Back alignment and structure |
|
| >pdb|4AE6|A Chain A, Structure And Function Of The Human Sperm-specific Isoform Of Protein Kinase A (pka) Catalytic Subunit Calpha 2 Length = 343 | Back alignment and structure |
|
| >pdb|3QA8|A Chain A, Crystal Structure Of Inhibitor Of Kappa B Kinase Beta Length = 676 | Back alignment and structure |
|
| >pdb|3RZF|A Chain A, Crystal Structure Of Inhibitor Of Kappab Kinase Beta (I4122) Length = 677 | Back alignment and structure |
|
| >pdb|3AGM|A Chain A, Complex Of Pka With The Bisubstrate Protein Kinase Inhibitor Arc-670 Length = 351 | Back alignment and structure |
|
| >pdb|3NX8|A Chain A, Human Camp Dependent Protein Kinase In Complex With Phenol Length = 351 | Back alignment and structure |
|
| >pdb|3AGL|A Chain A, Complex Of Pka With The Bisubstrate Protein Kinase Inhibitor Arc-1039 Length = 351 | Back alignment and structure |
|
| >pdb|2WEL|A Chain A, Crystal Structure Of Su6656-Bound CalciumCALMODULIN- Dependent Protein Kinase Ii Delta In Complex With Calmodulin Length = 327 | Back alignment and structure |
|
| >pdb|3MVJ|A Chain A, Human Cyclic Amp-Dependent Protein Kinase Pka Inhibitor Complex Length = 371 | Back alignment and structure |
|
| >pdb|2YDJ|A Chain A, Discovery Of Checkpoint Kinase Inhibitor Azd7762 By Structure Based Design And Optimization Of Thiophene Carboxamide Ureas Length = 276 | Back alignment and structure |
|
| >pdb|2VN9|A Chain A, Crystal Structure Of Human Calcium Calmodulin Dependent Protein Kinase Ii Delta Isoform 1, Camkd Length = 301 | Back alignment and structure |
|
| >pdb|4FSZ|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|1Q61|A Chain A, Pka Triple Mutant Model Of Pkb Length = 350 | Back alignment and structure |
|
| >pdb|2QG5|A Chain A, Cryptosporidium Parvum Calcium Dependent Protein Kinase Cgd7_1840 Length = 294 | Back alignment and structure |
|
| >pdb|1SZM|A Chain A, Dual Binding Mode Of Bisindolylmaleimide 2 To Protein Kinase A (Pka) Length = 350 | Back alignment and structure |
|
| >pdb|3LL6|A Chain A, Crystal Structure Of The Human Cyclin G Associated Kinase (gak) Length = 337 | Back alignment and structure |
|
| >pdb|3DLS|A Chain A, Crystal Structure Of Human Pas Kinase Bound To Adp Length = 335 | Back alignment and structure |
|
| >pdb|3F3Z|A Chain A, Crystal Structure Of Cryptosporidium Parvum Calcium Dependent Protein Kinase Cgd7_1840 In Presence Of Indirubin E804 Length = 277 | Back alignment and structure |
|
| >pdb|4FSY|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|3KK9|A Chain A, Camkii Substrate Complex B Length = 282 | Back alignment and structure |
|
| >pdb|3KL8|A Chain A, Camkiintide Inhibitor Complex Length = 269 | Back alignment and structure |
|
| >pdb|2GNJ|A Chain A, Pka Three Fold Mutant Model Of Rho-Kinase With Y-27632 Length = 350 | Back alignment and structure |
|
| >pdb|3KK8|A Chain A, Camkii Substrate Complex A Length = 284 | Back alignment and structure |
|
| >pdb|2Z60|A Chain A, Crystal Structure Of The T315i Mutant Of Abl Kinase Bound With Ppy-A Length = 288 | Back alignment and structure |
|
| >pdb|3OY3|A Chain A, Crystal Structure Of Abl T315i Mutant Kinase Domain Bound With A Dfg- Out Inhibitor Ap24589 Length = 284 | Back alignment and structure |
|
| >pdb|2GNF|A Chain A, Protein Kinase A Fivefold Mutant Model Of Rho-Kinase With Y- 27632 Length = 350 | Back alignment and structure |
|
| >pdb|2BDW|A Chain A, Crystal Structure Of The Auto-Inhibited Kinase Domain Of CalciumCALMODULIN ACTIVATED KINASE II Length = 362 | Back alignment and structure |
|
| >pdb|3AMA|A Chain A, Protein Kinase A Sixfold Mutant Model Of Aurora B With Inhibitor Jnj- 7706621 Length = 351 | Back alignment and structure |
|
| >pdb|2GNG|A Chain A, Protein Kinase A Fivefold Mutant Model Of Rho-Kinase Length = 350 | Back alignment and structure |
|
| >pdb|3DK7|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 277 | Back alignment and structure |
|
| >pdb|3ALN|A Chain A, Crystal Structure Of Human Non-Phosphorylated Mkk4 Kinase Domain Complexed With Amp-Pnp Length = 327 | Back alignment and structure |
|
| >pdb|1RJB|A Chain A, Crystal Structure Of Flt3 Length = 344 | Back alignment and structure |
|
| >pdb|1YDT|E Chain E, Structure Of Camp-Dependent Protein Kinase, Alpha-Catalytic Subunit In Complex With H89 Protein Kinase Inhibitor N-[2- (4-Bromocinnamylamino)ethyl]-5-Isoquinoline Length = 350 | Back alignment and structure |
|
| >pdb|2UZT|A Chain A, Pka Structures Of Akt, Indazole-Pyridine Inhibitors Length = 336 | Back alignment and structure |
|
| >pdb|3OXZ|A Chain A, Crystal Structure Of Abl Kinase Domain Bound With A Dfg-Out Inhibitor Ap24534 Length = 284 | Back alignment and structure |
|
| >pdb|3QRJ|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain T315i Mutant In Complex With Dcc-2036 Length = 277 | Back alignment and structure |
|
| >pdb|2E9V|A Chain A, Structure Of H-Chk1 Complexed With A859017 Length = 268 | Back alignment and structure |
|
| >pdb|2C1A|A Chain A, Structure Of Camp-Dependent Protein Kinase Complexed With Isoquinoline-5-Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl)amide Length = 351 | Back alignment and structure |
|
| >pdb|3DND|A Chain A, Camp-Dependent Protein Kinase Pka Catalytic Subunit With Pki-5-24 Length = 350 | Back alignment and structure |
|
| >pdb|2ZV2|A Chain A, Crystal Structure Of Human CalciumCALMODULIN-Dependent Protein Kinase Kinase 2, Beta, Camkk2 Kinase Domain In Complex With Sto-609 Length = 298 | Back alignment and structure |
|
| >pdb|1SVH|A Chain A, Crystal Structure Of Protein Kinase A In Complex With Azepane Derivative 8 Length = 350 | Back alignment and structure |
|
| >pdb|1FPU|A Chain A, Crystal Structure Of Abl Kinase Domain In Complex With A Small Molecule Inhibitor Length = 293 | Back alignment and structure |
|
| >pdb|2F7E|E Chain E, Pka Complexed With (S)-2-(1h-Indol-3-Yl)-1-(5-Isoquinolin-6- Yl-Pyridin-3-Yloxymethyl-Etylamine Length = 351 | Back alignment and structure |
|
| >pdb|1STC|E Chain E, Camp-Dependent Protein Kinase, Alpha-Catalytic Subunit In Complex With Staurosporine Length = 350 | Back alignment and structure |
|
| >pdb|2JDS|A Chain A, Structure Of Camp-Dependent Protein Kinase Complexed With A- 443654 Length = 351 | Back alignment and structure |
|
| >pdb|1Q8W|A Chain A, The Catalytic Subunit Of Camp-Dependent Protein Kinase In Complex With Rho-Kinase Inhibitor Fasudil (Ha-1077) Length = 350 | Back alignment and structure |
|
| >pdb|2GHG|A Chain A, H-Chk1 Complexed With A431994 Length = 269 | Back alignment and structure |
|
| >pdb|2NRY|A Chain A, Crystal Structure Of Irak-4 Length = 307 | Back alignment and structure |
|
| >pdb|2NRU|A Chain A, Crystal Structure Of Irak-4 Length = 307 | Back alignment and structure |
|
| >pdb|2AYP|A Chain A, Crystal Structure Of Chk1 With An Indol Inhibitor Length = 269 | Back alignment and structure |
|
| >pdb|4FST|A Chain A, Crystal Structure Of The Chk1 Length = 269 | Back alignment and structure |
|
| >pdb|3JVR|A Chain A, Characterization Of The Chk1 Allosteric Inhibitor Binding Site Length = 271 | Back alignment and structure |
|
| >pdb|2X8E|A Chain A, Discovery Of A Novel Class Of Triazolones As Checkpoint Kinase Inhibitors - Hit To Lead Exploration Length = 276 | Back alignment and structure |
|
| >pdb|1XH7|A Chain A, Crystal Structures Of Protein Kinase B Selective Inhibitors In Complex With Protein Kinase A And Mutants Length = 350 | Back alignment and structure |
|
| >pdb|2OIB|A Chain A, Crystal Structure Of Irak4 Kinase Domain Apo Form Length = 301 | Back alignment and structure |
|
| >pdb|4FSN|A Chain A, Crystal Structure Of The Chk1 Length = 278 | Back alignment and structure |
|
| >pdb|4FSM|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|2V7A|A Chain A, Crystal Structure Of The T315i Abl Mutant In Complex With The Inhibitor Pha-739358 Length = 286 | Back alignment and structure |
|
| >pdb|2QOH|A Chain A, Crystal Structure Of Abl Kinase Bound With Ppy-a Length = 288 | Back alignment and structure |
|
| >pdb|4FT3|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|3DK3|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 293 | Back alignment and structure |
|
| >pdb|1Q24|A Chain A, Pka Double Mutant Model Of Pkb In Complex With Mgatp Length = 350 | Back alignment and structure |
|
| >pdb|3OT3|A Chain A, X-Ray Crystal Structure Of Compound 22k Bound To Human Chk1 Kinase Domain Length = 273 | Back alignment and structure |
|
| >pdb|2HOG|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 20 Length = 322 | Back alignment and structure |
|
| >pdb|4FSW|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|2R0U|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 54 Length = 323 | Back alignment and structure |
|
| >pdb|2BR1|A Chain A, Structure-Based Design Of Novel Chk1 Inhibitors: Insights Into Hydrogen Bonding And Protein-Ligand Affinity Length = 297 | Back alignment and structure |
|
| >pdb|1IA8|A Chain A, The 1.7 A Crystal Structure Of Human Cell Cycle Checkpoint Kinase Chk1 Length = 289 | Back alignment and structure |
|
| >pdb|1ZLT|A Chain A, Crystal Structure Of Chk1 Complexed With A Hymenaldisine Analog Length = 295 | Back alignment and structure |
|
| >pdb|3PYY|A Chain A, Discovery And Characterization Of A Cell-Permeable, Small-Molecule C- Abl Kinase Activator That Binds To The Myristoyl Binding Site Length = 298 | Back alignment and structure |
|
| >pdb|2VO0|A Chain A, Structure Of Pka-Pkb Chimera Complexed With C-(4-(4- Chlorophenyl)-1-(7h-Pyrrolo(2, 3-D)pyrimidin-4-Yl)piperidin- 4-Yl)methylamine Length = 351 | Back alignment and structure |
|
| >pdb|2UVY|A Chain A, Structure Of Pka-pkb Chimera Complexed With Methyl-(4-(9h- Purin-6-yl)-benzyl)-amine Length = 351 | Back alignment and structure |
|
| >pdb|2F4J|A Chain A, Structure Of The Kinase Domain Of An Imatinib-Resistant Abl Mutant In Complex With The Aurora Kinase Inhibitor Vx-680 Length = 287 | Back alignment and structure |
|
| >pdb|2JDT|A Chain A, Structure Of Pka-Pkb Chimera Complexed With Isoquinoline-5- Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl) Amide Length = 351 | Back alignment and structure |
|
| >pdb|3QRI|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain In Complex With Dcc- 2036 Length = 277 | Back alignment and structure |
|
| >pdb|2HZI|A Chain A, Abl Kinase Domain In Complex With Pd180970 Length = 277 | Back alignment and structure |
|
| >pdb|2HIW|A Chain A, Crystal Structure Of Inactive Conformation Abl Kinase Catalytic Domain Complexed With Type Ii Inhibitor Length = 287 | Back alignment and structure |
|
| >pdb|3FHI|A Chain A, Crystal Structure Of A Complex Between The Catalytic And Regulatory (Ri{alpha}) Subunits Of Pka Length = 350 | Back alignment and structure |
|
| >pdb|3QAL|E Chain E, Crystal Structure Of Arg280ala Mutant Of Catalytic Subunit Of Camp- Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|2HYY|A Chain A, Human Abl Kinase Domain In Complex With Imatinib (Sti571, Glivec) Length = 273 | Back alignment and structure |
|
| >pdb|2E2B|A Chain A, Crystal Structure Of The C-Abl Kinase Domain In Complex With Inno-406 Length = 293 | Back alignment and structure |
|
| >pdb|2G2F|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine Kinase Domain Length = 287 | Back alignment and structure |
|
| >pdb|1SYK|A Chain A, Crystal Structure Of E230q Mutant Of Camp-Dependent Protein Kinase Reveals Unexpected Apoenzyme Conformation Length = 350 | Back alignment and structure |
|
| >pdb|3PVB|A Chain A, Crystal Structure Of (73-244)ria:c Holoenzyme Of Camp-Dependent Protein Kinase Length = 345 | Back alignment and structure |
|
| >pdb|2ERZ|E Chain E, Crystal Structure Of C-amp Dependent Kinase (pka) Bound To Hydroxyfasudil Length = 351 | Back alignment and structure |
|
| >pdb|1FMO|E Chain E, Crystal Structure Of A Polyhistidine-Tagged Recombinant Catalytic Subunit Of Camp-Dependent Protein Kinase Complexed With The Peptide Inhibitor Pki(5-24) And Adenosine Length = 350 | Back alignment and structure |
|
| >pdb|1J3H|A Chain A, Crystal Structure Of Apoenzyme Camp-Dependent Protein Kinase Catalytic Subunit Length = 350 | Back alignment and structure |
|
| >pdb|3QAM|E Chain E, Crystal Structure Of Glu208ala Mutant Of Catalytic Subunit Of Camp- Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|3EB0|A Chain A, Crystal Structure Of Cgd4_240 From Cryptosporidium Parvum In Complex With Indirubin E804 Length = 383 | Back alignment and structure |
|
| >pdb|2QUR|A Chain A, Crystal Structure Of F327aK285P MUTANT OF CAMP-Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|2HZ0|A Chain A, Abl Kinase Domain In Complex With Nvp-Aeg082 Length = 270 | Back alignment and structure |
|
| >pdb|1JBP|E Chain E, Crystal Structure Of The Catalytic Subunit Of Camp- Dependent Protein Kinase Complexed With A Substrate Peptide, Adp And Detergent Length = 350 | Back alignment and structure |
|
| >pdb|2GQG|A Chain A, X-Ray Crystal Structure Of Dasatinib (Bms-354825) Bound To Activated Abl Kinase Domain Length = 278 | Back alignment and structure |
|
| >pdb|2QCS|A Chain A, A Complex Structure Between The Catalytic And Regulatory Subunit Of Protein Kinase A That Represents The Inhibited State Length = 350 | Back alignment and structure |
|
| >pdb|2GU8|A Chain A, Discovery Of 2-pyrimidyl-5-amidothiophenes As Novel And Potent Inhibitors For Akt: Synthesis And Sar Studies Length = 337 | Back alignment and structure |
|
| >pdb|1BKX|A Chain A, A Binary Complex Of The Catalytic Subunit Of Camp-Dependent Protein Kinase And Adenosine Further Defines Conformational Flexibility Length = 350 | Back alignment and structure |
|
| >pdb|2G1T|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine Kinase Domain Length = 287 | Back alignment and structure |
|
| >pdb|1APM|E Chain E, 2.0 Angstrom Refined Crystal Structure Of The Catalytic Subunit Of Camp-Dependent Protein Kinase Complexed With A Peptide Inhibitor And Detergent Length = 350 | Back alignment and structure |
|
| >pdb|1RDQ|E Chain E, Hydrolysis Of Atp In The Crystal Of Y204a Mutant Of Camp-Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|3MIY|A Chain A, X-Ray Crystal Structure Of Itk Complexed With Sunitinib Length = 266 | Back alignment and structure |
|
| >pdb|4DFY|A Chain A, Crystal Structure Of R194a Mutant Of Camp-Dependent Protein Kinase With Unphosphorylated Activation Loop Length = 371 | Back alignment and structure |
|
| >pdb|1L3R|E Chain E, Crystal Structure Of A Transition State Mimic Of The Catalytic Subunit Of Camp-Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|4DG3|E Chain E, Crystal Structure Of R336a Mutant Of Camp-dependent Protein Kinase With Unphosphorylated Turn Motif Length = 371 | Back alignment and structure |
|
| >pdb|2QR8|A Chain A, 2.0a X-ray Structure Of C-terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2 (rsk2) Length = 342 | Back alignment and structure |
|
| >pdb|2V7O|A Chain A, Crystal Structure Of Human Calcium-Calmodulin-Dependent Protein Kinase Ii Gamma Length = 336 | Back alignment and structure |
|
| >pdb|4DFX|E Chain E, Crystal Structure Of Myristoylated K7c Catalytic Subunit Of Camp- Dependent Protein Kinase In Complex With Sp20 And Amp-Pnp Length = 350 | Back alignment and structure |
|
| >pdb|3LM0|A Chain A, Crystal Structure Of Human SerineTHREONINE KINASE 17B (STK17B) Length = 327 | Back alignment and structure |
|
| >pdb|3CLY|A Chain A, Crystal Structure Of Fgf Receptor 2 (Fgfr2) Kinase Domains Trapped In Trans-Phosphorylation Reaction Length = 334 | Back alignment and structure |
|
| >pdb|2PVY|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K659n Mutation Responsible For An Unclassified Craniosynostosis Syndrome. Length = 324 | Back alignment and structure |
|
| >pdb|3KN5|A Chain A, Crystal Structure Of The C-Terminal Kinase Domain Of Msk1 In With Amp-Pnp Length = 325 | Back alignment and structure |
|
| >pdb|1SM2|A Chain A, Crystal Structure Of The Phosphorylated Interleukin-2 Tyrosine Kinase Catalytic Domain Length = 264 | Back alignment and structure |
|
| >pdb|2PZP|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K526e Mutation Responsible For Crouzon Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|3O7L|B Chain B, Crystal Structure Of Phospholamban (1-19):pka C-Subunit:amp-Pnp:mg2+ Complex Length = 350 | Back alignment and structure |
|
| >pdb|3V5J|A Chain A, Crystal Structure Of Interleukin-2 Inducible T-Cell Kinase Itk Catalytic Domain With Thienopyrazolylindole Inhibitor 090 Length = 266 | Back alignment and structure |
|
| >pdb|3DK6|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 293 | Back alignment and structure |
|
| >pdb|1XH9|A Chain A, Crystal Structures Of Protein Kinase B Selective Inhibitors In Complex With Protein Kinase A And Mutants Length = 350 | Back alignment and structure |
|
| >pdb|4HCT|A Chain A, Crystal Structure Of Itk In Complex With Compound 52 Length = 269 | Back alignment and structure |
|
| >pdb|1ZYS|A Chain A, Co-Crystal Structure Of Checkpoint Kinase Chk1 With A Pyrrolo-Pyridine Inhibitor Length = 273 | Back alignment and structure |
|
| >pdb|3QGW|A Chain A, Crystal Structure Of Itk Kinase Bound To An Inhibitor Length = 286 | Back alignment and structure |
|
| >pdb|2VZ6|A Chain A, Structure Of Human Calcium Calmodulin Dependent Protein Kinase Type Ii Alpha (Camk2a) In Complex With Indirubin E804 Length = 313 | Back alignment and structure |
|
| >pdb|2PZR|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K641r Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|1OPK|A Chain A, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine Kinase Length = 495 | Back alignment and structure |
|
| >pdb|2ZV7|A Chain A, Lyn Tyrosine Kinase Domain, Apo Form Length = 279 | Back alignment and structure |
|
| >pdb|3LXK|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2 And Jak3 Kinase Domains In Complex With Cp-690550 And Cmp-6 Length = 327 | Back alignment and structure |
|
| >pdb|2PVF|A Chain A, Crystal Structure Of Tyrosine Phosphorylated Activated Fgf Receptor 2 (Fgfr2) Kinase Domain In Complex With Atp Analog And Substrate Peptide Length = 334 | Back alignment and structure |
|
| >pdb|4HVD|A Chain A, Jak3 Kinase Domain In Complex With 2-cyclopropyl-5h-pyrrolo[2,3- B]pyrazine-7-carboxylic Acid ((s)-1,2,2-trimethyl-propyl)-amide Length = 314 | Back alignment and structure |
|
| >pdb|2QR7|A Chain A, 2.0a X-Ray Structure Of C-Terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2: Se-Met Derivative Length = 342 | Back alignment and structure |
|
| >pdb|1GJO|A Chain A, The Fgfr2 Tyrosine Kinase Domain Length = 316 | Back alignment and structure |
|
| >pdb|4G3G|A Chain A, Crystal Structure Of Murine Nf-kappab Inducing Kinase (nik) V408l Bound To A 2-(aminothiazolyl)phenol (cmp3) Length = 350 | Back alignment and structure |
|
| >pdb|2PSQ|A Chain A, Crystal Structure Of Unphosphorylated Unactivated Wild Type Fgf Receptor 2 (Fgfr2) Kinase Domain Length = 370 | Back alignment and structure |
|
| >pdb|3B2T|A Chain A, Structure Of Phosphotransferase Length = 311 | Back alignment and structure |
|
| >pdb|3RI1|A Chain A, Crystal Structure Of The Catalytic Domain Of Fgfr2 Kinase In Complex With Arq 069 Length = 313 | Back alignment and structure |
|
| >pdb|3PJC|A Chain A, Crystal Structure Of Jak3 Complexed With A Potent Atp Site Inhibitor Showing High Selectivity Within The Janus Kinase Family Length = 315 | Back alignment and structure |
|
| >pdb|1SMH|A Chain A, Protein Kinase A Variant Complex With Completely Ordered N- Terminal Helix Length = 350 | Back alignment and structure |
|
| >pdb|4FSU|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|1OPL|A Chain A, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine Kinase Length = 537 | Back alignment and structure |
|
| >pdb|3BEG|A Chain A, Crystal Structure Of Sr Protein Kinase 1 Complexed To Its Substrate AsfSF2 Length = 381 | Back alignment and structure |
|
| >pdb|2Q0B|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic E565a Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|1WBP|A Chain A, Srpk1 Bound To 9mer Docking Motif Peptide Length = 397 | Back alignment and structure |
|
| >pdb|1VZO|A Chain A, The Structure Of The N-Terminal Kinase Domain Of Msk1 Reveals A Novel Autoinhibitory Conformation For A Dual Kinase Protein Length = 355 | Back alignment and structure |
|
| >pdb|3PPZ|A Chain A, Crystal Structure Of Ctr1 Kinase Domain In Complex With Staurosporine Length = 309 | Back alignment and structure |
|
| >pdb|2VWI|A Chain A, Structure Of The Osr1 Kinase, A Hypertension Drug Target Length = 303 | Back alignment and structure |
|
| >pdb|2A19|B Chain B, Pkr Kinase Domain- Eif2alpha- Amp-Pnp Complex. Length = 284 | Back alignment and structure |
|
| >pdb|2PZ5|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic N549t Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|3A4O|X Chain X, Lyn Kinase Domain Length = 286 | Back alignment and structure |
|
| >pdb|1YVJ|A Chain A, Crystal Structure Of The Jak3 Kinase Domain In Complex With A Staurosporine Analogue Length = 290 | Back alignment and structure |
|
| >pdb|1YOL|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With Cgp77675 Length = 283 | Back alignment and structure |
|
| >pdb|3DAK|A Chain A, Crystal Structure Of Domain-Swapped Osr1 Kinase Domain Length = 290 | Back alignment and structure |
|
| >pdb|2PWL|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic N549h Mutation Responsible For Crouzon Syndrome. Length = 324 | Back alignment and structure |
|
| >pdb|2PY3|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic E565g Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|1YOJ|A Chain A, Crystal Structure Of Src Kinase Domain Length = 283 | Back alignment and structure |
|
| >pdb|3SOA|A Chain A, Full-Length Human Camkii Length = 444 | Back alignment and structure |
|
| >pdb|2QQ7|A Chain A, Crystal Structure Of Drug Resistant Src Kinase Domain With Irreversible Inhibitor Length = 286 | Back alignment and structure |
|
| >pdb|4G3C|A Chain A, Crystal Structure Of Apo Murine Nf-kappab Inducing Kinase (nik) Length = 352 | Back alignment and structure |
|
| >pdb|3G6H|A Chain A, Src Thr338ile Inhibited In The Dfg-Asp-Out Conformation Length = 286 | Back alignment and structure |
|
| >pdb|2OH4|A Chain A, Crystal Structure Of Vegfr2 With A Benzimidazole-Urea Inhibitor Length = 316 | Back alignment and structure |
|
| >pdb|3DQW|A Chain A, C-Src Kinase Domain Thr338ile Mutant In Complex With Atpgs Length = 286 | Back alignment and structure |
|
| >pdb|3KXX|A Chain A, Structure Of The Mutant Fibroblast Growth Factor Receptor 1 Length = 317 | Back alignment and structure |
|
| >pdb|4G3F|A Chain A, Crystal Structure Of Murine Nf-kappab Inducing Kinase (nik) Bound To A 2-(aminothiazoly)phenol (cmp2) Length = 336 | Back alignment and structure |
|
| >pdb|3TT0|A Chain A, Co-Structure Of Fibroblast Growth Factor Receptor 1 Kinase Domain With 3-(2,6-Dichloro-3, 5-Dimethoxy-Phenyl)-1-{6-[4-(4-Ethyl-Piperazin-1- Yl)-Phenylamino]-Pyrimidin-4-Yl}-1-Methyl-Urea (Bgj398) Length = 382 | Back alignment and structure |
|
| >pdb|3JS2|A Chain A, Crystal Structure Of Minimal Kinase Domain Of Fibroblast Growth Factor Receptor 1 In Complex With 5-(2-Thienyl) Nicotinic Acid Length = 317 | Back alignment and structure |
|
| >pdb|1FGK|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of Fibroblast Growth Factor Receptor 1 Length = 310 | Back alignment and structure |
|
| >pdb|3RHX|B Chain B, Crystal Structure Of The Catalytic Domain Of Fgfr1 Kinase In Complex With Arq 069 Length = 306 | Back alignment and structure |
|
| >pdb|3GQL|A Chain A, Crystal Structure Of Activated Receptor Tyrosine Kinase In Complex With Substrates Length = 326 | Back alignment and structure |
|
| >pdb|3U4W|A Chain A, Src In Complex With Dna-Templated Macrocyclic Inhibitor Mc4b Length = 275 | Back alignment and structure |
|
| >pdb|4F63|A Chain A, Crystal Structure Of Human Fibroblast Growth Factor Receptor 1 Kinase Domain In Complex With Compound 1 Length = 309 | Back alignment and structure |
|
| >pdb|4AF3|A Chain A, Human Aurora B Kinase In Complex With Incenp And Vx-680 Length = 292 | Back alignment and structure |
|
| >pdb|3D7U|B Chain B, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 277 | Back alignment and structure |
|
| >pdb|3GVU|A Chain A, The Crystal Structure Of Human Abl2 In Complex With Gleevec Length = 292 | Back alignment and structure |
|
| >pdb|2BDF|A Chain A, Src Kinase In Complex With Inhibitor Ap23451 Length = 279 | Back alignment and structure |
|
| >pdb|3C4F|A Chain A, Fgfr Tyrosine Kinase Domain In Complex With 3-(3- Methoxybenzyl)-7-Azaindole Length = 302 | Back alignment and structure |
|
| >pdb|2OIQ|A Chain A, Crystal Structure Of Chicken C-Src Kinase Domain In Complex With The Cancer Drug Imatinib. Length = 286 | Back alignment and structure |
|
| >pdb|1Y57|A Chain A, Structure Of Unphosphorylated C-Src In Complex With An Inhibitor Length = 452 | Back alignment and structure |
|
| >pdb|2HWO|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With Covalent Inhibitor Length = 286 | Back alignment and structure |
|
| >pdb|1FMK|A Chain A, Crystal Structure Of Human Tyrosine-Protein Kinase C-Src Length = 452 | Back alignment and structure |
|
| >pdb|3UIU|A Chain A, Crystal Structure Of Apo-Pkr Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|4G31|A Chain A, Crystal Structure Of Gsk6414 Bound To Perk (R587-R1092, Delete A660- T867) At 2.28 A Resolution Length = 299 | Back alignment and structure |
|
| >pdb|1KSW|A Chain A, Structure Of Human C-Src Tyrosine Kinase (Thr338gly Mutant) In Complex With N6-Benzyl Adp Length = 452 | Back alignment and structure |
|
| >pdb|3T9T|A Chain A, Crystal Structure Of Btk Mutant (F435t,K596r) Complexed With Imidazo[1,5-A]quinoxaline Length = 267 | Back alignment and structure |
|
| >pdb|3SVV|A Chain A, Crystal Structure Of T338c C-Src Covalently Bound To Vinylsulfonamide- Pyrazolopyrimidine 9 Length = 286 | Back alignment and structure |
|
| >pdb|3A60|A Chain A, Crystal Structure Of Unphosphorylated P70s6k1 (Form I) Length = 327 | Back alignment and structure |
|
| >pdb|3DB6|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like Kinase 1 (Plk1) Catalytic Domain In Complex With Compound 902 Length = 301 | Back alignment and structure |
|
| >pdb|3GQI|A Chain A, Crystal Structure Of Activated Receptor Tyrosine Kinase In Complex With Substrates Length = 326 | Back alignment and structure |
|
| >pdb|3A62|A Chain A, Crystal Structure Of Phosphorylated P70s6k1 Length = 327 | Back alignment and structure |
|
| >pdb|2H8H|A Chain A, Src Kinase In Complex With A Quinazoline Inhibitor Length = 535 | Back alignment and structure |
|
| >pdb|3P86|A Chain A, Crystal Structure Of Ctr1 Kinase Domain Mutant D676n In Complex With Staurosporine Length = 309 | Back alignment and structure |
|
| >pdb|2O8Y|A Chain A, Apo Irak4 Kinase Domain Length = 298 | Back alignment and structure |
|
| >pdb|1LUF|A Chain A, Crystal Structure Of The Musk Tyrosine Kinase: Insights Into Receptor Autoregulation Length = 343 | Back alignment and structure |
|
| >pdb|3GEQ|A Chain A, Structural Basis For The Chemical Rescue Of Src Kinase Activity Length = 286 | Back alignment and structure |
|
| >pdb|1TKI|A Chain A, Autoinhibited Serine Kinase Domain Of The Giant Muscle Protein Titin Length = 321 | Back alignment and structure |
|
| >pdb|3HKO|A Chain A, Crystal Structure Of A Cdpk Kinase Domain From Cryptosporidium Parvum, Cgd7_40 Length = 345 | Back alignment and structure |
|
| >pdb|3OEZ|A Chain A, Crystal Structure Of The L317i Mutant Of The Chicken C-Src Tyrosine Kinase Domain Complexed With Imatinib Length = 286 | Back alignment and structure |
|
| >pdb|4G3D|A Chain A, Crystal Structure Of Human Nf-kappab Inducing Kinase (nik) Length = 371 | Back alignment and structure |
|
| >pdb|3D5V|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like Kinase 1 (Plk1) Catalytic Domain. Length = 317 | Back alignment and structure |
|
| >pdb|1YI6|A Chain A, C-Term Tail Segment Of Human Tyrosine Kinase (258-533) Length = 276 | Back alignment and structure |
|
| >pdb|2XIR|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With Pf-00337210 (N,2-Dimethyl-6-(7-(2-Morpholinoethoxy) Quinolin-4-Yloxy)benzofuran-3-Carboxamide) Length = 316 | Back alignment and structure |
|
| >pdb|2Z7Q|A Chain A, Crystal Structure Of The N-Terminal Kinase Domain Of Human Rsk-1 Bound To Amp-Pcp Length = 321 | Back alignment and structure |
|
| >pdb|4DN5|A Chain A, Crystal Structure Of Nf-kb-inducing Kinase (nik) Length = 356 | Back alignment and structure |
|
| >pdb|2DQ7|X Chain X, Crystal Structure Of Fyn Kinase Domain Complexed With Staurosporine Length = 283 | Back alignment and structure |
|
| >pdb|4AGC|A Chain A, Crystal Structure Of Vegfr2 (Juxtamembrane And Kinase Domains) In Complex With Axitinib (Ag-013736) (N-Methyl-2-( 3-((E)-2-Pyridin-2-Yl-Vinyl)-1h-Indazol-6-Ylsulfanyl)- Benzamide) Length = 353 | Back alignment and structure |
|
| >pdb|3DTC|A Chain A, Crystal Structure Of Mixed-Lineage Kinase Mlk1 Complexed With Compound 16 Length = 271 | Back alignment and structure |
|
| >pdb|4FR4|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase 32a (Yank1) Length = 384 | Back alignment and structure |
|
| >pdb|3D5U|A Chain A, Crystal Structure Of A Wildtype Polo-Like Kinase 1 (Plk1) Catalytic Domain Length = 317 | Back alignment and structure |
|
| >pdb|3D5W|A Chain A, Crystal Structure Of A Phosphorylated Polo-Like Kinase 1 (Plk1) Catalytic Domain In Complex With Adp Length = 317 | Back alignment and structure |
|
| >pdb|3LXN|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2 And Jak3 Kinase Domains In Complex With Cp-690550 And Cmp-6 Length = 318 | Back alignment and structure |
|
| >pdb|1VR2|A Chain A, Human Vascular Endothelial Growth Factor Receptor 2 (Kdr) Kinase Domain Length = 316 | Back alignment and structure |
|
| >pdb|2P2I|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Nicotinamide Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|3HGK|A Chain A, Crystal Structure Of Effect Protein Avrptob Complexed With Kinase Pto Length = 327 | Back alignment and structure |
|
| >pdb|2QKW|B Chain B, Structural Basis For Activation Of Plant Immunity By Bacterial Effector Protein Avrpto Length = 321 | Back alignment and structure |
|
| >pdb|1YWN|A Chain A, Vegfr2 In Complex With A Novel 4-amino-furo[2,3-d]pyrimidine Length = 316 | Back alignment and structure |
|
| >pdb|3EWH|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyridyl-Pyrimidine Benzimidazole Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|3F69|A Chain A, Crystal Structure Of The Mycobacterium Tuberculosis Pknb Mutant Kinase Domain In Complex With Kt5720 Length = 311 | Back alignment and structure |
|
| >pdb|2PTK|A Chain A, Chicken Src Tyrosine Kinase Length = 453 | Back alignment and structure |
|
| >pdb|3U6J|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyrazolone Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|4E20|A Chain A, Structure Of Mouse Tyk-2 Complexed To A 3-Aminoindazole Inhibitor Length = 290 | Back alignment and structure |
|
| >pdb|3VNT|A Chain A, Crystal Structure Of The Kinase Domain Of Human Vegfr2 With A [1, 3]thiazolo[5,4-B]pyridine Derivative Length = 318 | Back alignment and structure |
|
| >pdb|4E1Z|A Chain A, Structure Of Mouse Tyk-2 Complexed To A 3-Aminoindazole Inhibitor Length = 291 | Back alignment and structure |
|
| >pdb|3NYX|A Chain A, Non-Phosphorylated Tyk2 Jh1 Domain With Quinoline-Thiadiazole- Thiophene Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|2P2H|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyridinyl-Triazine Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|3NZ0|A Chain A, Non-Phosphorylated Tyk2 Kinase With Cmp6 Length = 302 | Back alignment and structure |
|
| >pdb|3BHH|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase Iib Isoform 1 (camk2b) Length = 295 | Back alignment and structure |
|
| >pdb|3ORI|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain L33d Mutant (Crystal Form 1) Length = 311 | Back alignment and structure |
|
| >pdb|2W0J|A Chain A, Crystal Structure Of Chk2 In Complex With Nsc 109555, A Specific Inhibitor Length = 323 | Back alignment and structure |
|
| >pdb|2YCF|A Chain A, Crystal Structure Of Checkpoint Kinase 2 In Complex With Inhibitor Pv1531 Length = 322 | Back alignment and structure |
|
| >pdb|2YCR|A Chain A, Crystal Structure Of Checkpoint Kinase 2 In Complex With Inhibitor Pv976 Length = 323 | Back alignment and structure |
|
| >pdb|1O6Y|A Chain A, Catalytic Domain Of Pknb Kinase From Mycobacterium Tuberculosis Length = 299 | Back alignment and structure |
|
| >pdb|1QCF|A Chain A, Crystal Structure Of Hck In Complex With A Src Family- Selective Tyrosine Kinase Inhibitor Length = 454 | Back alignment and structure |
|
| >pdb|2CN5|A Chain A, Crystal Structure Of Human Chk2 In Complex With Adp Length = 329 | Back alignment and structure |
|
| >pdb|2XK9|A Chain A, Structural Analysis Of Checkpoint Kinase 2 (Chk2) In Complex With Inhibitor Pv1533 Length = 322 | Back alignment and structure |
|
| >pdb|1NA7|A Chain A, Crystal Structure Of The Catalytic Subunit Of Human Protein Kinase Ck2 Length = 329 | Back alignment and structure |
|
| >pdb|1MRU|A Chain A, Intracellular SerTHR PROTEIN KINASE DOMAIN OF Mycobacterium Tuberculosis Pknb. Length = 311 | Back alignment and structure |
|
| >pdb|3PWY|A Chain A, Crystal Structure Of An Extender (Spd28345)-Modified Human Pdk1 Complex 2 Length = 311 | Back alignment and structure |
|
| >pdb|2HK5|A Chain A, Hck Kinase In Complex With Lck Targetted Inhibitor Pg- 1009247 Length = 270 | Back alignment and structure |
|
| >pdb|3SXR|A Chain A, Crystal Structure Of Bmx Non-Receptor Tyrosine Kinase Complex With Dasatinib Length = 268 | Back alignment and structure |
|
| >pdb|1UU9|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Bim-3 Length = 286 | Back alignment and structure |
|
| >pdb|3NAY|A Chain A, Pdk1 In Complex With Inhibitor Mp6 Length = 311 | Back alignment and structure |
|
| >pdb|3NAX|A Chain A, Pdk1 In Complex With Inhibitor Mp7 Length = 311 | Back alignment and structure |
|
| >pdb|3NUS|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fragment8 Length = 286 | Back alignment and structure |
|
| >pdb|1H1W|A Chain A, High Resolution Crystal Structure Of The Human Pdk1 Catalytic Domain Length = 289 | Back alignment and structure |
|
| >pdb|1Z5M|A Chain A, Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrrolidinylcarbonyl) Amino]phenyl]amino]-4-pyrimidinyl]amino]propyl]-2,2- Dimethylpropanediamide Complexed With Human Pdk1 Length = 286 | Back alignment and structure |
|
| >pdb|3C4C|A Chain A, B-Raf Kinase In Complex With Plx4720 Length = 280 | Back alignment and structure |
|
| >pdb|3NUN|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lead Compound Length = 292 | Back alignment and structure |
|
| >pdb|3BBT|B Chain B, Crystal Structure Of The Erbb4 Kinase In Complex With Lapatinib Length = 328 | Back alignment and structure |
|
| >pdb|2PL0|A Chain A, Lck Bound To Imatinib Length = 289 | Back alignment and structure |
|
| >pdb|1UU3|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Ly333531 Length = 310 | Back alignment and structure |
|
| >pdb|4FK3|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx3203 Length = 292 | Back alignment and structure |
|
| >pdb|2ZM1|A Chain A, Crystal Structure Of Imidazo Pyrazin 1 Bound To The Kinase Domain Of Human Lck, (Auto-Phosphorylated On Tyr394) Length = 285 | Back alignment and structure |
|
| >pdb|3C4W|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 1 Bound To Atp And Magnesium Chloride At 2.7a Length = 543 | Back alignment and structure |
|
| >pdb|2BIY|A Chain A, Structure Of Pdk1-S241a Mutant Kinase Domain Length = 310 | Back alignment and structure |
|
| >pdb|3IOP|A Chain A, Pdk-1 In Complex With The Inhibitor Compound-8i Length = 312 | Back alignment and structure |
|
| >pdb|3F61|A Chain A, Crystal Structure Of M. Tuberculosis Pknb Leu33aspVAL222ASP DOUBLE MUTANT IN COMPLEX WITH ADP Length = 311 | Back alignment and structure |
|
| >pdb|3T8O|A Chain A, Rhodopsin Kinase (grk1) L166k Mutant At 2.5a Resolution Length = 543 | Back alignment and structure |
|
| >pdb|2XCH|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309 | Back alignment and structure |
|
| >pdb|1QPE|A Chain A, Structural Analysis Of The Lymphocyte-Specific Kinase Lck In Complex With Non-Selective And Src Family Selective Kinase Inhibitors Length = 279 | Back alignment and structure |
|
| >pdb|3KMM|A Chain A, Structure Of Human Lck Kinase With A Small Molecule Inhibitor Length = 288 | Back alignment and structure |
|
| >pdb|3C4X|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 1 Bound To Atp And Magnesium Chloride At 2.9a Length = 543 | Back alignment and structure |
|
| >pdb|2OG8|A Chain A, Crystal Structure Of Aminoquinazoline 36 Bound To Lck Length = 265 | Back alignment and structure |
|
| >pdb|1YHS|A Chain A, Crystal Structure Of Pim-1 Bound To Staurosporine Length = 273 | Back alignment and structure |
|
| >pdb|3H9O|A Chain A, Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1) In Complex With Compound 9 Length = 311 | Back alignment and structure |
|
| >pdb|3SC1|A Chain A, Novel Isoquinolone Pdk1 Inhibitors Discovered Through Fragment-Based Lead Discovery Length = 311 | Back alignment and structure |
|
| >pdb|3QC9|A Chain A, Crystal Structure Of Cross-Linked Bovine Grk1 T8cN480C DOUBLE MUTANT Complexed With Adp And Mg Length = 543 | Back alignment and structure |
|
| >pdb|3BYS|A Chain A, Co-Crystal Structure Of Lck And Aminopyrimidine Amide 10b Length = 277 | Back alignment and structure |
|
| >pdb|2R7B|A Chain A, Crystal Structure Of The Phosphoinositide-Dependent Kinase- 1 (Pdk-1)catalytic Domain Bound To A Dibenzonaphthyridine Inhibitor Length = 312 | Back alignment and structure |
|
| >pdb|3KXZ|A Chain A, The Complex Crystal Structure Of Lck With A Probe Molecule W259 Length = 287 | Back alignment and structure |
|
| >pdb|3RWP|A Chain A, Discovery Of A Novel, Potent And Selective Inhibitor Of 3- Phosphoinositide Dependent Kinase (Pdk1) Length = 311 | Back alignment and structure |
|
| >pdb|2OFV|A Chain A, Crystal Structure Of Aminoquinazoline 1 Bound To Lck Length = 277 | Back alignment and structure |
|
| >pdb|1FVR|A Chain A, Tie2 Kinase Domain Length = 327 | Back alignment and structure |
|
| >pdb|2R4B|A Chain A, Erbb4 Kinase Domain Complexed With A Thienopyrimidine Inhibitor Length = 321 | Back alignment and structure |
|
| >pdb|1YXS|A Chain A, Crystal Structure Of Kinase Pim1 With P123m Mutation Length = 293 | Back alignment and structure |
|
| >pdb|3BYM|A Chain A, X-Ray Co-Crystal Structure Aminobenzimidazole Triazine 1 Bound To Lck Length = 272 | Back alignment and structure |
|
| >pdb|2OF2|A Chain A, Crystal Structure Of Furanopyrimidine 8 Bound To Lck Length = 271 | Back alignment and structure |
|
| >pdb|2OO8|X Chain X, Synthesis, Structural Analysis, And Sar Studies Of Triazine Derivatives As Potent, Selective Tie-2 Inhibitors Length = 317 | Back alignment and structure |
|
| >pdb|2OFU|A Chain A, X-Ray Crystal Structure Of 2-Aminopyrimidine Carbamate 43 Bound To Lck Length = 273 | Back alignment and structure |
|
| >pdb|4ASZ|A Chain A, Crystal Structure Of Apo Trkb Kinase Domain Length = 299 | Back alignment and structure |
|
| >pdb|3QC4|A Chain A, Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length = 314 | Back alignment and structure |
|
| >pdb|4A07|A Chain A, Human Pdk1 Kinase Domain In Complex With Allosteric Activator Ps171 Bound To The Pif-Pocket Length = 311 | Back alignment and structure |
|
| >pdb|3LCK|A Chain A, The Kinase Domain Of Human Lymphocyte Kinase (Lck), Activated Form (Auto-Phosphorylated On Tyr394) Length = 271 | Back alignment and structure |
|
| >pdb|3G0F|A Chain A, Kit Kinase Domain Mutant D816h In Complex With Sunitinib Length = 336 | Back alignment and structure |
|
| >pdb|3ORM|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain D76a Mutant Length = 311 | Back alignment and structure |
|
| >pdb|3G0E|A Chain A, Kit Kinase Domain In Complex With Sunitinib Length = 336 | Back alignment and structure |
|
| >pdb|4GT4|A Chain A, Structure Of Unliganded, Inactive Ror2 Kinase Domain Length = 308 | Back alignment and structure |
|
| >pdb|3UIX|A Chain A, Crystal Structure Of Pim1 Kinase In Complex With Small Molecule Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|1T45|A Chain A, Structural Basis For The Autoinhibition And Sti-571 Inhibition Of C- Kit Tyrosine Kinase Length = 331 | Back alignment and structure |
|
| >pdb|3HRC|A Chain A, Crystal Structure Of A Mutant Of Human Pdk1 Kinase Domain In Complex With Atp Length = 311 | Back alignment and structure |
|
| >pdb|2REI|A Chain A, Kinase Domain Of Human Ephrin Type-a Receptor 7 (epha7) Length = 318 | Back alignment and structure |
|
| >pdb|3ZZW|A Chain A, Crystal Structure Of The Kinase Domain Of Ror2 Length = 289 | Back alignment and structure |
|
| >pdb|3I6W|A Chain A, Structure And Activation Mechanism Of The Chk2 Dna-Damage Checkpoint Kinase Length = 443 | Back alignment and structure |
|
| >pdb|1T46|A Chain A, Structural Basis For The Autoinhibition And Sti-571 Inhibition Of C-kit Tyrosine Kinase Length = 313 | Back alignment and structure |
|
| >pdb|1YWV|A Chain A, Crystal Structures Of Proto-Oncogene Kinase Pim1: A Target Of Aberrant Somatic Hypermutations In Diffuse Large Cell Lymphoma Length = 293 | Back alignment and structure |
|
| >pdb|3I6U|A Chain A, Structure And Activation Mechanism Of The Chk2 Dna-Damage Checkpoint Kinase Length = 419 | Back alignment and structure |
|
| >pdb|3ORX|A Chain A, Pdk1 Mutant Bound To Allosteric Disulfide Fragment Inhibitor 1f8 Length = 316 | Back alignment and structure |
|
| >pdb|3JXW|A Chain A, Discovery Of 3h-Benzo[4,5]thieno[3,2-D]pyrimidin-4-Ones As Potent, Highly Selective And Orally Bioavailable Pim Kinases Inhibitors Length = 294 | Back alignment and structure |
|
| >pdb|3F2A|A Chain A, Crystal Structure Of Human Pim-1 In Complex With Dappa Length = 300 | Back alignment and structure |
|
| >pdb|3R00|A Chain A, The Discovery Of Novel Benzofuran-2-Carboxylic Acids As Potent Pim-1 Inhibitors Length = 299 | Back alignment and structure |
|
| >pdb|2XJ0|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-4 From Crystallographic Fragment Screen Length = 301 | Back alignment and structure |
|
| >pdb|1PKG|A Chain A, Structure Of A C-kit Kinase Product Complex Length = 329 | Back alignment and structure |
|
| >pdb|2XIY|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-2 From Crystallographic Fragment Screen Length = 301 | Back alignment and structure |
|
| >pdb|1XQZ|A Chain A, Crystal Structure Of Hpim-1 Kinase At 2.1 A Resolution Length = 300 | Back alignment and structure |
|
| >pdb|4DTK|A Chain A, Novel And Selective Pan-Pim Kinase Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|2XIX|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-1 From Crystallographic Fragment Screen Length = 301 | Back alignment and structure |
|
| >pdb|3A99|A Chain A, Structure Of Pim-1 Kinase Crystallized In The Presence Of P27kip1 Carboxy-Terminal Peptide Length = 320 | Back alignment and structure |
|
| >pdb|4ALV|A Chain A, Benzofuropyrimidinone Inhibitors Of Pim-1 Length = 328 | Back alignment and structure |
|
| >pdb|3C4E|A Chain A, Pim-1 Kinase Domain In Complex With 3-Aminophenyl-7- Azaindole Length = 273 | Back alignment and structure |
|
| >pdb|2BIL|B Chain B, The Human Protein Kinase Pim1 In Complex With Its Consensus Peptide Pimtide Length = 313 | Back alignment and structure |
|
| >pdb|4A7C|A Chain A, Crystal Structure Of Pim1 Kinase With Etp46546 Length = 308 | Back alignment and structure |
|
| >pdb|3CY3|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And The Jnk Inhibitor V Length = 314 | Back alignment and structure |
|
| >pdb|4AS0|A Chain A, Cyclometalated Phthalimides As Protein Kinase Inhibitors Length = 273 | Back alignment and structure |
|
| >pdb|1XWS|A Chain A, Crystal Structure Of The Human Pim1 Kinase Domain Length = 313 | Back alignment and structure |
|
| >pdb|3CXW|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Beta Carboline Ligand I Length = 314 | Back alignment and structure |
|
| >pdb|3MA3|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Naphtho-Difuran Ligand Length = 313 | Back alignment and structure |
|
| >pdb|2J2I|B Chain B, Crystal Structure Of The Humab Pim1 In Complex With Ly333531 Length = 312 | Back alignment and structure |
|
| >pdb|4AZF|A Chain A, Human Dyrk2 In Complex With Leucettine L41 Length = 417 | Back alignment and structure |
|
| >pdb|3JPV|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Pyrrolo[2,3- A]carbazole Ligand Length = 313 | Back alignment and structure |
|
| >pdb|3DCV|A Chain A, Crystal Structure Of Human Pim1 Kinase Complexed With 4-(4- Hydroxy-3-Methyl-Phenyl)-6-Phenylpyrimidin-2(1h)-One Length = 328 | Back alignment and structure |
|
| >pdb|2OBJ|A Chain A, Crystal Structure Of Human Pim-1 Kinase In Complex With Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|3KVW|A Chain A, Crystal Structure Of Dual-Specificity Tyrosine Phosphorylation Regulated Kinase 2 (Dyrk2) In Complex With An Indirubin Ligand Length = 429 | Back alignment and structure |
|
| >pdb|2BIK|B Chain B, Human Pim1 Phosphorylated On Ser261 Length = 313 | Back alignment and structure |
|
| >pdb|3V8S|A Chain A, Human Rho-Associated Protein Kinase 1 (Rock 1) In Complex With Indazole Derivative (Compound 18) Length = 410 | Back alignment and structure |
|
| >pdb|2V55|A Chain A, Mechanism Of Multi-site Phosphorylation From A Rock-i:rhoe Complex Structure Length = 406 | Back alignment and structure |
|
| >pdb|3LCD|A Chain A, Inhibitor Bound To A Dfg-In Structure Of The Kinase Domain Of Csf-1r Length = 329 | Back alignment and structure |
|
| >pdb|2ESM|A Chain A, Crystal Structure Of Rock 1 Bound To Fasudil Length = 415 | Back alignment and structure |
|
| >pdb|2XCK|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309 | Back alignment and structure |
|
| >pdb|3G51|A Chain A, Structural Diversity Of The Active Conformation Of The N- Terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2 Length = 325 | Back alignment and structure |
|
| >pdb|2FB8|A Chain A, Structure Of The B-Raf Kinase Domain Bound To Sb-590885 Length = 281 | Back alignment and structure |
|
| >pdb|2OGV|A Chain A, Crystal Structure Of The Autoinhibited Human C-Fms Kinase Domain Length = 317 | Back alignment and structure |
|
| >pdb|4DBN|A Chain A, Crystal Structure Of The Kinase Domain Of Human B-Raf With A [1, 3]thiazolo[5,4-B]pyridine Derivative Length = 284 | Back alignment and structure |
|
| >pdb|4H58|A Chain A, Braf In Complex With Compound 3 Length = 275 | Back alignment and structure |
|
| >pdb|3Q96|A Chain A, B-Raf Kinase Domain In Complex With A Tetrahydronaphthalene Inhibitor Length = 282 | Back alignment and structure |
|
| >pdb|3OG7|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx4032 Length = 289 | Back alignment and structure |
|
| >pdb|4AOJ|A Chain A, Human Trka In Complex With The Inhibitor Az-23 Length = 329 | Back alignment and structure |
|
| >pdb|3IDP|A Chain A, B-Raf V600e Kinase Domain In Complex With An Aminoisoquinoline Inhibitor Length = 300 | Back alignment and structure |
|
| >pdb|1QPD|A Chain A, Structural Analysis Of The Lymphocyte-specific Kinase Lck In Complex With Non-selective And Src Family Selective Kinase Inhibitors Length = 279 | Back alignment and structure |
|
| >pdb|1UWJ|A Chain A, The Complex Of Mutant V599e B-raf And Bay439006 Length = 276 | Back alignment and structure |
|
| >pdb|3II5|A Chain A, The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimidine Inhibitor Length = 306 | Back alignment and structure |
|
| >pdb|3THB|A Chain A, Structure Of Plk1 Kinase Domain In Complex With A Benzolactam-Derived Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|4GT5|A Chain A, Crystal Structure Of The Inactive Trka Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|4EL9|A Chain A, Structure Of N-Terminal Kinase Domain Of Rsk2 With Afzelin Length = 305 | Back alignment and structure |
|
| >pdb|4G9R|A Chain A, B-Raf V600e Kinase Domain Bound To A Type Ii Dihydroquinazoline Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|4F0I|A Chain A, Crystal Structure Of Apo Trka Length = 300 | Back alignment and structure |
|
| >pdb|3UBD|A Chain A, Structure Of N-Terminal Domain Of Rsk2 Kinase In Complex With Flavonoid Glycoside Sl0101 Length = 304 | Back alignment and structure |
|
| >pdb|2RKU|A Chain A, Structure Of Plk1 In Complex With Bi2536 Length = 294 | Back alignment and structure |
|
| >pdb|3D4Q|A Chain A, Pyrazole-Based Inhibitors Of B-Raf Kinase Length = 307 | Back alignment and structure |
|
| >pdb|2YAC|A Chain A, Crystal Structure Of Polo-Like Kinase 1 In Complex With Nms-P937 Length = 311 | Back alignment and structure |
|
| >pdb|3PLS|A Chain A, Ron In Complex With Ligand Amp-Pnp Length = 298 | Back alignment and structure |
|
| >pdb|3MPM|A Chain A, Lck Complexed With A Pyrazolopyrimidine Length = 267 | Back alignment and structure |
|
| >pdb|3KB7|A Chain A, Crystal Structure Of Polo-Like Kinase 1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 311 | Back alignment and structure |
|
| >pdb|2OU7|A Chain A, Structure Of The Catalytic Domain Of Human Polo-Like Kinase 1 Length = 335 | Back alignment and structure |
|
| >pdb|2V5Q|A Chain A, Crystal Structure Of Wild-type Plk-1 Kinase Domain In Complex With A Selective Darpin Length = 315 | Back alignment and structure |
|
| >pdb|2WQB|A Chain A, Structure Of The Tie2 Kinase Domain In Complex With A Thiazolopyrimidine Inhibitor Length = 324 | Back alignment and structure |
|
| >pdb|2X4F|A Chain A, The Crystal Structure Of The Human Myosin Light Chain Kinase Loc340156. Length = 373 | Back alignment and structure |
|
| >pdb|2X7G|A Chain A, Structure Of Human Serine-Arginine-Rich Protein-Specific Kinase 2 (Srpk2) Bound To Purvalanol B Length = 389 | Back alignment and structure |
|
| >pdb|3C7Q|A Chain A, Structure Of Vegfr2 Kinase Domain In Complex With Bibf1120 Length = 316 | Back alignment and structure |
|
| >pdb|2JED|A Chain A, The Crystal Structure Of The Kinase Domain Of The Protein Kinase C Theta In Complex With Nvp-Xaa228 At 2.32a Resolution. Length = 352 | Back alignment and structure |
|
| >pdb|3ETA|A Chain A, Kinase Domain Of Insulin Receptor Complexed With A Pyrrolo Pyridine Inhibitor Length = 317 | Back alignment and structure |
|
| >pdb|1IRK|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Human Insulin Receptor Length = 306 | Back alignment and structure |
|
| >pdb|2I0V|A Chain A, C-Fms Tyrosine Kinase In Complex With A Quinolone Inhibitor Length = 335 | Back alignment and structure |
|
| >pdb|3V5Q|A Chain A, Discovery Of A Selective Trk Inhibitor With Efficacy In Rodent Cancer Tumor Models Length = 297 | Back alignment and structure |
|
| >pdb|3K2L|A Chain A, Crystal Structure Of Dual-Specificity Tyrosine Phosphorylation Regulated Kinase 2 (Dyrk2) Length = 429 | Back alignment and structure |
|
| >pdb|1XJD|A Chain A, Crystal Structure Of Pkc-Theta Complexed With Staurosporine At 2a Resolution Length = 345 | Back alignment and structure |
|
| >pdb|2F2U|A Chain A, Crystal Structure Of The Rho-Kinase Kinase Domain Length = 402 | Back alignment and structure |
|
| >pdb|1I44|A Chain A, Crystallographic Studies Of An Activation Loop Mutant Of The Insulin Receptor Tyrosine Kinase Length = 306 | Back alignment and structure |
|
| >pdb|3E87|A Chain A, Crystal Structures Of The Kinase Domain Of Akt2 In Complex With Atp- Competitive Inhibitors Length = 335 | Back alignment and structure |
|
| >pdb|1O6K|A Chain A, Structure Of Activated Form Of Pkb Kinase Domain S474d With Gsk3 Peptide And Amp-Pnp Length = 336 | Back alignment and structure |
|
| >pdb|1AD5|A Chain A, Src Family Kinase Hck-Amp-Pnp Complex Length = 438 | Back alignment and structure |
|
| >pdb|1UWH|A Chain A, The Complex Of Wild Type B-Raf And Bay439006 Length = 276 | Back alignment and structure |
|
| >pdb|1O6L|A Chain A, Crystal Structure Of An Activated Akt/protein Kinase B (pkb-pif Chimera) Ternary Complex With Amp-pnp And Gsk3 Peptide Length = 337 | Back alignment and structure |
|
| >pdb|1MRV|A Chain A, Crystal Structure Of An Inactive Akt2 Kinase Domain Length = 339 | Back alignment and structure |
|
| >pdb|2JDO|A Chain A, Structure Of Pkb-Beta (Akt2) Complexed With Isoquinoline-5- Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl) Amide Length = 342 | Back alignment and structure |
|
| >pdb|1GZN|A Chain A, Structure Of Pkb Kinase Domain Length = 335 | Back alignment and structure |
|
| >pdb|1GZK|A Chain A, Molecular Mechanism For The Regulation Of Protein Kinase B Akt By Hydrophobic Motif Phosphorylation Length = 315 | Back alignment and structure |
|
| >pdb|3BEA|A Chain A, Cfms Tyrosine Kinase (Tie2 Kid) In Complex With A Pyrimidinopyridone Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|2I1M|A Chain A, Cfms Tyrosine Kinase (Tie2 Kid) In Complex With An Arylamide Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|1P14|A Chain A, Crystal Structure Of A Catalytic-Loop Mutant Of The Insulin Receptor Tyrosine Kinase Length = 306 | Back alignment and structure |
|
| >pdb|2WNT|A Chain A, Crystal Structure Of The Human Ribosomal Protein S6 Kinase Length = 330 | Back alignment and structure |
|
| >pdb|3EKK|A Chain A, Insulin Receptor Kinase Complexed With An Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|2PML|X Chain X, Crystal Structure Of Pfpk7 In Complex With An Atp Analogue Length = 348 | Back alignment and structure |
|
| >pdb|3RNY|A Chain A, Crystal Structure Of Human Rsk1 C-Terminal Kinase Domain Length = 346 | Back alignment and structure |
|
| >pdb|3P23|A Chain A, Crystal Structure Of The Human Kinase And Rnase Domains In Complex With Adp Length = 432 | Back alignment and structure |
|
| >pdb|2IWI|A Chain A, Crystal Structure Of The Human Pim2 In Complex With A Ruthenium Organometallic Ligand Ru1 Length = 312 | Back alignment and structure |
|
| >pdb|3LCO|A Chain A, Inhibitor Bound To A Dfg-Out Structure Of The Kinase Domain Of Csf-1r Length = 324 | Back alignment and structure |
|
| >pdb|1K2P|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase Domain Length = 263 | Back alignment and structure |
|
| >pdb|3P08|A Chain A, Crystal Structure Of The Human Btk Kinase Domain Length = 267 | Back alignment and structure |
|
| >pdb|2JKM|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Bis- Anilino Pyrimidine Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|3OCS|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase In Complex With Inhibitor Cgi1746 Length = 271 | Back alignment and structure |
|
| >pdb|3PIX|A Chain A, Crystal Structure Of Btk Kinase Domain Complexed With 2-Isopropyl-7- (4-Methyl-Piperazin-1-Yl)-4-(5-Methyl-2h-Pyrazol-3- Ylamino)-2h- Phthalazin-1-One Length = 274 | Back alignment and structure |
|
| >pdb|3CJG|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 3,4,5-Trimethoxy Aniline Containing Pyrimidine Length = 309 | Back alignment and structure |
|
| >pdb|3GEN|A Chain A, The 1.6 A Crystal Structure Of Human Bruton's Tyrosine Kinase Bound To A Pyrrolopyrimidine-Containing Compound Length = 283 | Back alignment and structure |
|
| >pdb|1U46|A Chain A, Crystal Structure Of The Unphosphorylated Kinase Domain Of The Tyrosine Kinase Ack1 Length = 291 | Back alignment and structure |
|
| >pdb|3OCT|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase Mutant V555r In Complex With Dasatinib Length = 265 | Back alignment and structure |
|
| >pdb|2J0J|A Chain A, Crystal Structure Of A Fragment Of Focal Adhesion Kinase Containing The Ferm And Kinase Domains Length = 656 | Back alignment and structure |
|
| >pdb|3EQP|B Chain B, Crystal Structure Of Ack1 With Compound T95 Length = 276 | Back alignment and structure |
|
| >pdb|1U54|A Chain A, Crystal Structures Of The Phosphorylated And Unphosphorylated Kinase Domains Of The Cdc42-Associated Tyrosine Kinase Ack1 Bound To Amp-Pcp Length = 291 | Back alignment and structure |
|
| >pdb|3K54|A Chain A, Structures Of Human Bruton's Tyrosine Kinase In Active And Inactive Conformations Suggests A Mechanism Of Activation For Tec Family Kinases Length = 283 | Back alignment and structure |
|
| >pdb|2HEL|A Chain A, Crystal Structure Of A Mutant Epha4 Kinase Domain (Y742a) Length = 306 | Back alignment and structure |
|
| >pdb|2EU9|A Chain A, Crystal Structure Of Clk3 Length = 355 | Back alignment and structure |
|
| >pdb|2R2P|A Chain A, Kinase Domain Of Human Ephrin Type-A Receptor 5 (Epha5) Length = 295 | Back alignment and structure |
|
| >pdb|2J0L|A Chain A, Crystal Structure Of A The Active Conformation Of The Kinase Domain Of Focal Adhesion Kinase With A Phosphorylated Activation Loop Length = 276 | Back alignment and structure |
|
| >pdb|4HZS|A Chain A, Crystal Structure Of Ack1 Kinase Domain With C-terminal Sh3 Domain Length = 341 | Back alignment and structure |
|
| >pdb|4HZR|A Chain A, Crystal Structure Of Ack1 Kinase Domain Length = 277 | Back alignment and structure |
|
| >pdb|4EWH|B Chain B, Co-Crystal Structure Of Ack1 With Inhibitor Length = 275 | Back alignment and structure |
|
| >pdb|3QFV|A Chain A, Mrck Beta In Complex With Tpca-1 Length = 415 | Back alignment and structure |
|
| >pdb|1RQQ|A Chain A, Crystal Structure Of The Insulin Receptor Kinase In Complex With The Sh2 Domain Of Aps Length = 306 | Back alignment and structure |
|
| >pdb|3A8W|A Chain A, Crystal Structure Of Pkciota Kinase Domain Length = 345 | Back alignment and structure |
|
| >pdb|4ID7|A Chain A, Ack1 Kinase In Complex With The Inhibitor Cis-3-[8-amino-1-(4- Phenoxyphenyl)imidazo[1,5-a]pyrazin-3-yl]cyclobutanol Length = 273 | Back alignment and structure |
|
| >pdb|2IVV|A Chain A, Crystal Structure Of Phosphorylated Ret Tyrosine Kinase Domain Complexed With The Inhibitor Pp1 Length = 314 | Back alignment and structure |
|
| >pdb|1IR3|A Chain A, Phosphorylated Insulin Receptor Tyrosine Kinase In Complex With Peptide Substrate And Atp Analog Length = 306 | Back alignment and structure |
|
| >pdb|3TKU|A Chain A, Mrck Beta In Complex With Fasudil Length = 433 | Back alignment and structure |
|
| >pdb|3BZ3|A Chain A, Crystal Structure Analysis Of Focal Adhesion Kinase With A Methanesulfonamide Diaminopyrimidine Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|4EBW|A Chain A, Structure Of Focal Adhesion Kinase Catalytic Domain In Complex With Novel Allosteric Inhibitor Length = 304 | Back alignment and structure |
|
| >pdb|2J0M|B Chain B, Crystal Structure A Two-Chain Complex Between The Ferm And Kinase Domains Of Focal Adhesion Kinase. Length = 276 | Back alignment and structure |
|
| >pdb|3PXK|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Pyrrolo[2,3- D]thiazole Length = 282 | Back alignment and structure |
|
| >pdb|3ZH8|A Chain A, A Novel Small Molecule Apkc Inhibitor Length = 349 | Back alignment and structure |
|
| >pdb|2ETM|A Chain A, Crystal Structure Of Focal Adhesion Kinase Domain Complexed With 7h-Pyrrolo [2,3-D] Pyrimidine Derivative Length = 281 | Back alignment and structure |
|
| >pdb|2Z8C|A Chain A, Phosphorylated Insulin Receptor Tyrosine Kinase In Complex With (4-{[5-Carbamoyl-4-(3-Methylanilino)pyrimidin-2- Yl]amino}phenyl)acetic Acid Length = 303 | Back alignment and structure |
|
| >pdb|1MP8|A Chain A, Crystal Structure Of Focal Adhesion Kinase (Fak) Length = 281 | Back alignment and structure |
|
| >pdb|2JKK|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Bis- Anilino Pyrimidine Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|2J0K|A Chain A, Crystal Structure Of A Fragment Of Focal Adhesion Kinase Containing The Ferm And Kinase Domains. Length = 656 | Back alignment and structure |
|
| >pdb|3KUL|A Chain A, Kinase Domain Of Human Ephrin Type-A Receptor 8 (Epha8) Length = 325 | Back alignment and structure |
|
| >pdb|1ZRZ|A Chain A, Crystal Structure Of The Catalytic Domain Of Atypical Protein Kinase C-Iota Length = 364 | Back alignment and structure |
|
| >pdb|4DGM|A Chain A, Crystal Structure Of Maize Ck2 In Complex With The Inhibitor Apigenin Length = 326 | Back alignment and structure |
|
| >pdb|4F0F|A Chain A, Crystal Structure Of The Roco4 Kinase Domain Bound To Appcp From D. Discoideum Length = 287 | Back alignment and structure |
|
| >pdb|3KRW|A Chain A, Human Grk2 In Complex With Gbetgamma Subunits And Balanol (Soak) Length = 688 | Back alignment and structure |
|
| >pdb|3CQU|A Chain A, Crystal Structure Of Akt-1 Complexed With Substrate Peptide And Inhibitor Length = 342 | Back alignment and structure |
|
| >pdb|4DC2|A Chain A, Structure Of Pkc In Complex With A Substrate Peptide From Par-3 Length = 396 | Back alignment and structure |
|
| >pdb|3CIK|A Chain A, Human Grk2 In Complex With Gbetagamma Subunits Length = 689 | Back alignment and structure |
|
| >pdb|2Z2W|A Chain A, Humand Wee1 Kinase Complexed With Inhibitor Pf0335770 Length = 285 | Back alignment and structure |
|
| >pdb|3KUL|B Chain B, Kinase Domain Of Human Ephrin Type-A Receptor 8 (Epha8) Length = 325 | Back alignment and structure |
|
| >pdb|3OCB|A Chain A, Akt1 Kinase Domain With Pyrrolopyrimidine Inhibitor Length = 341 | Back alignment and structure |
|
| >pdb|3HNG|A Chain A, Crystal Structure Of Vegfr1 In Complex With N-(4-chlorophenyl)-2- ((pyridin-4-ylmethyl)amino)benzamide Length = 360 | Back alignment and structure |
|
| >pdb|4GV1|A Chain A, Pkb Alpha In Complex With Azd5363 Length = 340 | Back alignment and structure |
|
| >pdb|1OMW|A Chain A, Crystal Structure Of The Complex Between G Protein-Coupled Receptor Kinase 2 And Heterotrimeric G Protein Beta 1 And Gamma 2 Subunits Length = 689 | Back alignment and structure |
|
| >pdb|3PSC|A Chain A, Bovine Grk2 In Complex With Gbetagamma Subunits Length = 695 | Back alignment and structure |
|
| >pdb|3BI6|A Chain A, Wee1 Kinase Complex With Inhibitor Pd352396 Length = 287 | Back alignment and structure |
|
| >pdb|2IN6|A Chain A, Wee1 Kinase Complex With Inhibitor Pd311839 Length = 287 | Back alignment and structure |
|
| >pdb|1X8B|A Chain A, Structure Of Human Wee1a Kinase: Kinase Domain Complexed With Inhibitor Pd0407824 Length = 289 | Back alignment and structure |
|
| >pdb|2IVT|A Chain A, Crystal Structure Of Phosphorylated Ret Tyrosine Kinase Domain Length = 314 | Back alignment and structure |
|
| >pdb|2IVS|A Chain A, Crystal Structure Of Non-Phosphorylated Ret Tyrosine Kinase Domain Length = 314 | Back alignment and structure |
|
| >pdb|2Y6M|A Chain A, Crystal Structure Of Epha4 Kinase Domain Length = 291 | Back alignment and structure |
|
| >pdb|2QOK|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:s768a Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2XYU|A Chain A, Crystal Structure Of Epha4 Kinase Domain In Complex With Vuf 12058 Length = 285 | Back alignment and structure |
|
| >pdb|2VD5|A Chain A, Structure Of Human Myotonic Dystrophy Protein Kinase In Complex With The Bisindoylmaleide Inhibitor Bim Viii Length = 412 | Back alignment and structure |
|
| >pdb|4ALU|A Chain A, Benzofuropyrimidinone Inhibitors Of Pim-1 Length = 328 | Back alignment and structure |
|
| >pdb|2WU6|A Chain A, Crystal Structure Of The Human Clk3 In Complex With Dki Length = 381 | Back alignment and structure |
|
| >pdb|1JPA|A Chain A, Crystal Structure Of Unphosphorylated Ephb2 Receptor Tyrosine Kinase And Juxtamembrane Region Length = 312 | Back alignment and structure |
|
| >pdb|2EXE|A Chain A, Crystal Structure Of The Phosphorylated Clk3 Length = 357 | Back alignment and structure |
|
| >pdb|3TL8|A Chain A, The Avrptob-Bak1 Complex Reveals Two Structurally Similar Kinaseinteracting Domains In A Single Type Iii Effector Length = 349 | Back alignment and structure |
|
| >pdb|4EJN|A Chain A, Crystal Structure Of Autoinhibited Form Of Akt1 In Complex With N-(4- (5-(3-Acetamidophenyl)-2-(2-Aminopyridin-3-Yl)-3h- Imidazo[4,5- B]pyridin-3-Yl)benzyl)-3-Fluorobenzamide Length = 446 | Back alignment and structure |
|
| >pdb|2R5T|A Chain A, Crystal Structure Of Inactive Serum And Glucocorticoid- Regulated Kinase 1 In Complex With Amp-Pnp Length = 373 | Back alignment and structure |
|
| >pdb|3O96|A Chain A, Crystal Structure Of Human Akt1 With An Allosteric Inhibitor Length = 446 | Back alignment and structure |
|
| >pdb|4F1O|A Chain A, Crystal Structure Of The L1180t Mutant Roco4 Kinase Domain From D. Discoideum Bound To Appcp Length = 287 | Back alignment and structure |
|
| >pdb|3UIM|A Chain A, Structural Basis For The Impact Of Phosphorylation On Plant Receptor- Like Kinase Bak1 Activation Length = 326 | Back alignment and structure |
|
| >pdb|3OMV|A Chain A, Crystal Structure Of C-Raf (Raf-1) Length = 307 | Back alignment and structure |
|
| >pdb|3FXX|A Chain A, Human Epha3 Kinase And Juxtamembrane Region Bound To Substrate Kqwdnye[ptyr]iw Length = 371 | Back alignment and structure |
|
| >pdb|2QC6|A Chain A, Protein Kinase Ck2 In Complex With Dbc Length = 332 | Back alignment and structure |
|
| >pdb|2GSF|A Chain A, The Human Epha3 Receptor Tyrosine Kinase And Juxtamembrane Region Length = 373 | Back alignment and structure |
|
| >pdb|4DGN|A Chain A, Crystal Structure Of Maize Ck2 In Complex With The Inhibitor Luteolin Length = 326 | Back alignment and structure |
|
| >pdb|4AW5|A Chain A, Complex Of The Ephb4 Kinase Domain With An Oxindole Inhibitor Length = 291 | Back alignment and structure |
|
| >pdb|2QOF|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2QOD|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y602f Mutant Length = 373 | Back alignment and structure |
|
| >pdb|3KXG|A Chain A, Crystal Structure Of Z. Mays Ck2 Kinase Alpha Subunit In Complex With The Inhibitor 3,4,5,6,7-Pentabromo-1h-Indazole (K64) Length = 327 | Back alignment and structure |
|
| >pdb|3CEK|A Chain A, Crystal Structure Of Human Dual Specificity Protein Kinase (ttk) Length = 313 | Back alignment and structure |
|
| >pdb|2QOO|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:y742f Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|1DS5|A Chain A, Dimeric Crystal Structure Of The Alpha Subunit In Complex With Two Beta Peptides Mimicking The Architecture Of The Tetrameric Protein Kinase Ck2 Holoenzyme. Length = 332 | Back alignment and structure |
|
| >pdb|1DAW|A Chain A, Crystal Structure Of A Binary Complex Of Protein Kinase Ck2 (Alpha-Subunit) And Mg-Amppnp Length = 327 | Back alignment and structure |
|
| >pdb|2QOI|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f Double Mutant Length = 373 | Back alignment and structure |
|
| >pdb|3PVG|A Chain A, Crystal Structure Of Z. Mays Ck2 Alpha Subunit In Complex With The Inhibitor 4,5,6,7-Tetrabromo-1-Carboxymethylbenzimidazole (K68) Length = 331 | Back alignment and structure |
|
| >pdb|2X9E|A Chain A, Human Mps1 In Complex With Nms-P715 Length = 317 | Back alignment and structure |
|
| >pdb|1M2P|A Chain A, Crystal Structure Of 1,8-Di-Hydroxy-4-Nitro- AnthraquinoneCK2 KINASE COMPLEX Length = 325 | Back alignment and structure |
|
| >pdb|3TXO|A Chain A, Pkc Eta Kinase In Complex With A Naphthyridine Length = 353 | Back alignment and structure |
|
| >pdb|2PVH|A Chain A, Structure-Based Design Of Pyrazolo[1,5-A][1,3,5]triazine Derivatives As Potent Inhibitors Of Protein Kinase Ck2 Length = 352 | Back alignment and structure |
|
| >pdb|1Q8Y|A Chain A, The Structure Of The Yeast Sr Protein Kinase, Sky1p, With Bound Adp Length = 373 | Back alignment and structure |
|
| >pdb|1HOW|A Chain A, The X-Ray Crystal Structure Of Sky1p, An Sr Protein Kinase In Yeast Length = 373 | Back alignment and structure |
|
| >pdb|2VWU|A Chain A, Ephb4 Kinase Domain Inhibitor Complex Length = 302 | Back alignment and structure |
|
| >pdb|3DZQ|A Chain A, Human Epha3 Kinase Domain In Complex With Inhibitor Awl-Ii- 38.3 Length = 361 | Back alignment and structure |
|
| >pdb|4ANM|A Chain A, Complex Of Ck2 With A Cdc7 Inhibitor Length = 335 | Back alignment and structure |
|
| >pdb|2QOC|A Chain A, Human Epha3 Kinase Domain, Phosphorylated, Amp-Pnp Bound Structure Length = 344 | Back alignment and structure |
|
| >pdb|2QOL|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596:y602:s768g Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|3VQU|A Chain A, Crystal Structure Of Human Mps1 Catalytic Domain In Complex With 4- [(4-Amino-5-Cyano-6-Ethoxypyridin-2- Yl)amino]benzamide Length = 320 | Back alignment and structure |
|
| >pdb|3HMN|A Chain A, Crystal Structure Of Human Mps1 Catalytic Domain In Complex With Atp Length = 342 | Back alignment and structure |
|
| >pdb|3H9F|A Chain A, Crystal Structure Of Human Dual Specificity Protein Kinase (Ttk) In Complex With A Pyrimido-Diazepin Ligand Length = 313 | Back alignment and structure |
|
| >pdb|3DBQ|A Chain A, Crystal Structure Of Ttk Kinase Domain Length = 343 | Back alignment and structure |
|
| >pdb|2VAG|A Chain A, Crystal Structure Of Di-Phosphorylated Human Clk1 In Complex With A Novel Substituted Indole Inhibitor Length = 339 | Back alignment and structure |
|
| >pdb|2QON|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:y742a Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|1Z57|A Chain A, Crystal Structure Of Human Clk1 In Complex With 10z-Hymenialdisine Length = 339 | Back alignment and structure |
|
| >pdb|2ZMD|A Chain A, Crystal Structure Of Human Mps1 Catalytic Domain T686a Mutant In Complex With Sp600125 Inhibitor Length = 390 | Back alignment and structure |
|
| >pdb|2ZMC|A Chain A, Crystal Structure Of Human Mitotic Checkpoint Kinase Mps1 Catalytic Domain Apo Form Length = 390 | Back alignment and structure |
|
| >pdb|4F1M|A Chain A, Crystal Structure Of The G1179s Roco4 Kinase Domain Bound To Appcp From D. Discoideum Length = 287 | Back alignment and structure |
|
| >pdb|2BUJ|A Chain A, Crystal Structure Of The Human Serine-Threonine Kinase 16 In Complex With Staurosporine Length = 317 | Back alignment and structure |
|
| >pdb|4E4L|A Chain A, Jak1 Kinase (Jh1 Domain) In Complex With Compound 30 Length = 302 | Back alignment and structure |
|
| >pdb|3EYG|A Chain A, Crystal Structures Of Jak1 And Jak2 Inhibitor Complexes Length = 290 | Back alignment and structure |
|
| >pdb|3CJF|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 3,4,5-Trimethoxy Aniline Containing Pyrimidine Length = 309 | Back alignment and structure |
|
| >pdb|1M7N|A Chain A, Crystal Structure Of Unactivated Apo Insulin-Like Growth Factor-1 Receptor Kinase Domain Length = 322 | Back alignment and structure |
|
| >pdb|4AW2|A Chain A, Crystal Structure Of Cdc42 Binding Protein Kinase Alpha (Mrck Alpha) Length = 437 | Back alignment and structure |
|
| >pdb|2QO7|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Dephosphorylated, Amp-Pnp Bound Length = 373 | Back alignment and structure |
|
| >pdb|3FPQ|A Chain A, Crystal Structure Of The Kinase Domain Of Wnk1 Length = 290 | Back alignment and structure |
|
| >pdb|2OJ9|A Chain A, Structure Of Igf-1r Kinase Domain Complexed With A Benzimidazole Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|3I81|A Chain A, Crystal Structure Of Insulin-Like Growth Factor 1 Receptor (Igf-1r-Wt) Complex With Bms-754807 [1-(4-((5-Cyclopropyl- 1h-Pyrazol-3-Yl)amino)pyrrolo[2,1-F][1,2, 4]triazin-2-Yl)-N- (6-Fluoro-3-Pyridinyl)-2-Methyl-L-Prolinamide] Length = 315 | Back alignment and structure |
|
| >pdb|3R1N|A Chain A, Mk3 Kinase Bound To Compound 5b Length = 317 | Back alignment and structure |
|
| >pdb|3FHR|A Chain A, High Resolution Crystal Structure Of Mitogen-Activated Protein Kinase-Activated Protein Kinase 3 (Mk3)-Inhibitor Complex Length = 336 | Back alignment and structure |
|
| >pdb|1JQH|A Chain A, Igf-1 Receptor Kinase Domain Length = 308 | Back alignment and structure |
|
| >pdb|2QOB|A Chain A, Human Epha3 Kinase Domain, Base Structure Length = 344 | Back alignment and structure |
|
| >pdb|3O23|A Chain A, Human Unphosphorylated Igf1-R Kinase Domain In Complex With An Hydantoin Inhibitor Length = 305 | Back alignment and structure |
|
| >pdb|3QQU|A Chain A, Cocrystal Structure Of Unphosphorylated Igf With Pyrimidine 8 Length = 301 | Back alignment and structure |
|
| >pdb|3LVP|A Chain A, Crystal Structure Of Bisphosphorylated Igf1-R Kinase Domain (2p) In Complex With A Bis-Azaindole Inhibitor Length = 336 | Back alignment and structure |
|
| >pdb|2JIV|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation In Compex With Hki-272 Length = 328 | Back alignment and structure |
|
| >pdb|3NYN|A Chain A, Crystal Structure Of G Protein-Coupled Receptor Kinase 6 In Complex With Sangivamycin Length = 576 | Back alignment and structure |
|
| >pdb|3IKA|A Chain A, Crystal Structure Of Egfr 696-1022 T790m Mutant Covalently Binding To Wz4002 Length = 331 | Back alignment and structure |
|
| >pdb|2ACX|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 6 Bound To Amppnp Length = 576 | Back alignment and structure |
|
| >pdb|2JIT|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation Length = 327 | Back alignment and structure |
|
| >pdb|2JIU|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation In Complex With Aee788 Length = 328 | Back alignment and structure |
|
| >pdb|2HEN|A Chain A, Crystal Structure Of The Ephb2 Receptor Kinase Domain In Complex With Adp Length = 286 | Back alignment and structure |
|
| >pdb|4I24|A Chain A, Structure Of T790m Egfr Kinase Domain Co-crystallized With Dacomitinib Length = 329 | Back alignment and structure |
|
| >pdb|3CC6|A Chain A, Crystal Structure Of Kinase Domain Of Protein Tyrosine Kinase 2 Beta (ptk2b) Length = 281 | Back alignment and structure |
|
| >pdb|3FZO|A Chain A, Crystal Structure Of Pyk2-Apo, Proline-Rich Tyrosine Kinase Length = 277 | Back alignment and structure |
|
| >pdb|4G5P|A Chain A, Crystal Structure Of Egfr Kinase T790m In Complex With Bibw2992 Length = 330 | Back alignment and structure |
|
| >pdb|4H1J|A Chain A, Crystal Structure Of Pyk2 With The Pyrazole 13a Length = 293 | Back alignment and structure |
|
| >pdb|3NR9|A Chain A, Structure Of Human Cdc2-Like Kinase 2 (Clk2) Length = 368 | Back alignment and structure |
|
| >pdb|2AC5|A Chain A, Structure Of Human Mnk2 Kinase Domain Mutant D228g Length = 316 | Back alignment and structure |
|
| >pdb|1XKK|A Chain A, Egfr Kinase Domain Complexed With A Quinazoline Inhibitor- Gw572016 Length = 352 | Back alignment and structure |
|
| >pdb|2J5E|A Chain A, Crystal Structure Of Egfr Kinase Domain In Complex With An Irreversible Inhibitor 13-Jab Length = 327 | Back alignment and structure |
|
| >pdb|4HJO|A Chain A, Crystal Structure Of The Inactive Egfr Tyrosine Kinase Domain With Erlotinib Length = 337 | Back alignment and structure |
|
| >pdb|1MQB|A Chain A, Crystal Structure Of Ephrin A2 (Epha2) Receptor Protein Kinase Length = 333 | Back alignment and structure |
|
| >pdb|2J5F|A Chain A, Crystal Structure Of Egfr Kinase Domain In Complex With An Irreversible Inhibitor 34-Jab Length = 327 | Back alignment and structure |
|
| >pdb|4I23|A Chain A, Crystal Structure Of The Wild-type Egfr Kinase Domain In Complex With Dacomitinib (soaked) Length = 329 | Back alignment and structure |
|
| >pdb|4G5J|A Chain A, Crystal Structure Of Egfr Kinase In Complex With Bibw2992 Length = 330 | Back alignment and structure |
|
| >pdb|3BEL|A Chain A, X-Ray Structure Of Egfr In Complex With Oxime Inhibitor Length = 315 | Back alignment and structure |
|
| >pdb|2GS2|A Chain A, Crystal Structure Of The Active Egfr Kinase Domain Length = 330 | Back alignment and structure |
|
| >pdb|2GS7|A Chain A, Crystal Structure Of The Inactive Egfr Kinase Domain In Complex With Amp-Pnp Length = 330 | Back alignment and structure |
|
| >pdb|3D94|A Chain A, Crystal Structure Of The Insulin-Like Growth Factor-1 Receptor Kinase In Complex With Pqip Length = 301 | Back alignment and structure |
|
| >pdb|1M14|A Chain A, Tyrosine Kinase Domain From Epidermal Growth Factor Receptor Length = 333 | Back alignment and structure |
|
| >pdb|3VJO|A Chain A, Crystal Structure Of The Wild-Type Egfr Kinase Domain In Complex With Amppnp Length = 334 | Back alignment and structure |
|
| >pdb|3LMG|A Chain A, Crystal Structure Of The Erbb3 Kinase Domain In Complex With Amp-Pnp Length = 344 | Back alignment and structure |
|
| >pdb|3W2O|A Chain A, Egfr Kinase Domain T790m/l858r Mutant With Tak-285 Length = 331 | Back alignment and structure |
|
| >pdb|3LZB|A Chain A, Egfr Kinase Domain Complexed With An Imidazo[2,1-B]thiazole Inhibitor Length = 327 | Back alignment and structure |
|
| >pdb|2ZM3|A Chain A, Complex Structure Of Insulin-Like Growth Factor Receptor And Isoquinolinedione Inhibitor Length = 308 | Back alignment and structure |
|
| >pdb|2VX3|A Chain A, Crystal Structure Of The Human Dual Specificity Tyrosine- Phosphorylation-Regulated Kinase 1a Length = 382 | Back alignment and structure |
|
| >pdb|4I21|A Chain A, Crystal Structure Of L858r + T790m Egfr Kinase Domain In Complex With Mig6 Peptide Length = 329 | Back alignment and structure |
|
| >pdb|4I1Z|A Chain A, Crystal Structure Of The Monomeric (v948r) Form Of The Gefitinib/erlotinib Resistant Egfr Kinase Domain L858r+t790m Length = 329 | Back alignment and structure |
|
| >pdb|3KEX|A Chain A, Crystal Structure Of The Catalytically Inactive Kinase Domain Of The Human Epidermal Growth Factor Receptor 3 (Her3) Length = 325 | Back alignment and structure |
|
| >pdb|1K3A|A Chain A, Structure Of The Insulin-Like Growth Factor 1 Receptor Kinase Length = 299 | Back alignment and structure |
|
| >pdb|1Y6A|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 2-Anilino-5-Aryl-Oxazole Inhibitor Length = 366 | Back alignment and structure |
|
| >pdb|3VHK|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Back Pocket Binder Length = 368 | Back alignment and structure |
|
| >pdb|3JUH|A Chain A, Crystal Structure Of A Mutant Of Human Protein Kinase Ck2alpha With Altered Cosubstrate Specificity Length = 335 | Back alignment and structure |
|
| >pdb|3VID|A Chain A, Crystal Structure Of Human Vegfr2 Kinase Domain With Compound A Length = 356 | Back alignment and structure |
|
| >pdb|3VHE|A Chain A, Crystal Structure Of Human Vegfr2 Kinase Domain With A Novel Pyrrolopyrimidine Inhibitor Length = 359 | Back alignment and structure |
|
| >pdb|3ANQ|A Chain A, Human Dyrk1aINHIBITOR COMPLEX Length = 368 | Back alignment and structure |
|
| >pdb|2RFD|A Chain A, Crystal Structure Of The Complex Between The Egfr Kinase Domain And A Mig6 Peptide Length = 324 | Back alignment and structure |
|
| >pdb|3PP0|A Chain A, Crystal Structure Of The Kinase Domain Of Human Her2 (Erbb2). Length = 338 | Back alignment and structure |
|
| >pdb|3TUB|A Chain A, Crystal Structure Of Syk Kinase Domain With 1-(5-(6,7- Dimethoxyquinolin-4-Yloxy)pyridin-2-Yl)-3-((1r,2s)-2- Phenylcyclopropyl)urea Length = 293 | Back alignment and structure |
|
| >pdb|3VF8|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase Syk Catalytic Domain With Pyrazolylbenzimidazole Inhibitor 416 Length = 299 | Back alignment and structure |
|
| >pdb|4I20|A Chain A, Crystal Structure Of Monomeric (v948r) Primary Oncogenic Mutant L858r Egfr Kinase Domain Length = 329 | Back alignment and structure |
|
| >pdb|4AZE|A Chain A, Human Dyrk1a In Complex With Leucettine L41 Length = 382 | Back alignment and structure |
|
| >pdb|2ITT|A Chain A, Crystal Structure Of Egfr Kinase Domain L858r Mutation In Complex With Aee788 Length = 327 | Back alignment and structure |
|
| >pdb|3EMG|A Chain A, Discovery And Sar Of Novel 4-Thiazolyl-2- Phenylaminopyrimidines As Potent Inhibitors Of Spleen Tyrosine Kinase (Syk) Length = 291 | Back alignment and structure |
|
| >pdb|2EB3|A Chain A, Crystal Structure Of Mutated Egfr Kinase Domain (L858r) In Complex With Amppnp Length = 334 | Back alignment and structure |
|
| >pdb|1K9A|A Chain A, Crystal Structure Analysis Of Full-Length Carboxyl-Terminal Src Kinase At 2.5 A Resolution Length = 450 | Back alignment and structure |
|
| >pdb|3SRV|B Chain B, Crystal Structure Of Spleen Tyrosine Kinase (Syk) In Complex With A Diaminopyrimidine Carboxamide Inhibitor Length = 277 | Back alignment and structure |
|
| >pdb|3GOP|A Chain A, Crystal Structure Of The Egf Receptor Juxtamembrane And Kinase Domains Length = 361 | Back alignment and structure |
|
| >pdb|3SRV|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase (Syk) In Complex With A Diaminopyrimidine Carboxamide Inhibitor Length = 277 | Back alignment and structure |
|
| >pdb|1XBA|A Chain A, Crystal Structure Of Apo Syk Tyrosine Kinase Domain Length = 291 | Back alignment and structure |
|
| >pdb|3UG1|A Chain A, Crystal Structure Of The Mutated Egfr Kinase Domain (G719sT790M) IN The Apo Form Length = 334 | Back alignment and structure |
|
| >pdb|4FL3|A Chain A, Structural And Biophysical Characterization Of The Syk Activation Switch Length = 635 | Back alignment and structure |
|
| >pdb|3D7U|A Chain A, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 263 | Back alignment and structure |
|
| >pdb|4DFL|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase Complexed With A Sulfonamidopyrazine Piperidine Inhibitor Length = 274 | Back alignment and structure |
|
| >pdb|4F4P|A Chain A, Syk In Complex With Ligand Lasw836 Length = 273 | Back alignment and structure |
|
| >pdb|1BYG|A Chain A, Kinase Domain Of Human C-Terminal Src Kinase (Csk) In Complex With Inhibitor Staurosporine Length = 278 | Back alignment and structure |
|
| >pdb|4FL2|A Chain A, Structural And Biophysical Characterization Of The Syk Activation Switch Length = 636 | Back alignment and structure |
|
| >pdb|3D7T|A Chain A, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 269 | Back alignment and structure |
|
| >pdb|1P4O|A Chain A, Structure Of Apo Unactivated Igf-1r Kinase Domain At 1.5a Resolution. Length = 322 | Back alignment and structure |
|
| >pdb|3SDJ|A Chain A, Structure Of Rnase-Inactive Point Mutant Of Oligomeric KinaseRNASE Ire1 Length = 448 | Back alignment and structure |
|
| >pdb|2RIO|A Chain A, Structure Of The Dual Enzyme Ire1 Reveals The Basis For Catalysis And Regulation Of Non-conventional Splicing Length = 434 | Back alignment and structure |
|
| >pdb|3LJ0|A Chain A, Ire1 Complexed With Adp And Quercetin Length = 434 | Back alignment and structure |
|
| >pdb|3FBV|A Chain A, Crystal Structure Of The Oligomer Formed By The Kinase-Ribonuclease Domain Of Ire1 Length = 448 | Back alignment and structure |
|
| >pdb|2ITN|A Chain A, Crystal Structure Of Egfr Kinase Domain G719s Mutation In Complex With Amp-Pnp Length = 327 | Back alignment and structure |
|
| >pdb|3LW0|A Chain A, Igf-1rk In Complex With Ligand Msc1609119a-1 Length = 304 | Back alignment and structure |
|
| >pdb|2EB2|A Chain A, Crystal Structure Of Mutated Egfr Kinase Domain (G719s) Length = 334 | Back alignment and structure |
|
| >pdb|2HW6|A Chain A, Crystal Structure Of Mnk1 Catalytic Domain Length = 307 | Back alignment and structure |
|
| >pdb|1EH4|A Chain A, Binary Complex Of Casein Kinase-1 From S. Pombe With An Atp Competitive Inhibitor, Ic261 Length = 298 | Back alignment and structure |
|
| >pdb|2CSN|A Chain A, Binary Complex Of Casein Kinase-1 With Cki7 Length = 297 | Back alignment and structure |
|
| >pdb|2AC3|A Chain A, Structure Of Human Mnk2 Kinase Domain Length = 316 | Back alignment and structure |
|
| >pdb|3I5N|A Chain A, Crystal Structure Of C-Met With Triazolopyridazine Inhibitor 13 Length = 309 | Back alignment and structure |
|
| >pdb|3Q6U|A Chain A, Structure Of The Apo Met Receptor Kinase In The Dually-Phosphorylated, Activated State Length = 308 | Back alignment and structure |
|
| >pdb|3LQ8|A Chain A, Structure Of The Kinase Domain Of C-Met Bound To Xl880 (Gsk1 Length = 302 | Back alignment and structure |
|
| >pdb|2G15|A Chain A, Structural Characterization Of Autoinhibited C-Met Kinase Length = 318 | Back alignment and structure |
|
| >pdb|3F66|A Chain A, Human C-Met Kinase In Complex With Quinoxaline Inhibitor Length = 298 | Back alignment and structure |
|
Structure Templates Detected by RPS-BLAST
Original result of RPS-BLAST against PDB70 database
| >4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens} Length = 311 | Back alignment and structure |
|---|
Score = 265 bits (681), Expect = 1e-88
Identities = 115/152 (75%), Positives = 139/152 (91%)
Query: 1 MERYEKIGKLGEGSYGVVFKCRNRDTGQVVAIKKFLESEEDPLIRKIALREIRLLKSLKH 60
ME+YEKIGK+GEGSYGVVFKCRNRDTGQ+VAIKKFLESE+DP+I+KIALREIR+LK LKH
Sbjct: 2 MEKYEKIGKIGEGSYGVVFKCRNRDTGQIVAIKKFLESEDDPVIKKIALREIRMLKQLKH 61
Query: 61 PNLVNLLEVFRRKKKLHLVFEFCDHTVLNELENHPHGLPWDLIKQITWQVLRGVSYCHRH 120
PNLVNLLEVFRRK++LHLVFE+CDHTVL+EL+ + G+P L+K ITWQ L+ V++CH+H
Sbjct: 62 PNLVNLLEVFRRKRRLHLVFEYCDHTVLHELDRYQRGVPEHLVKSITWQTLQAVNFCHKH 121
Query: 121 ACIHRDIKPENILLTANGVVKLCDFGFARLIR 152
CIHRD+KPENIL+T + V+KLCDFGFARL+
Sbjct: 122 NCIHRDVKPENILITKHSVIKLCDFGFARLLT 153
|
| >4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens} Length = 311 | Back alignment and structure |
|---|
Score = 66.0 bits (162), Expect = 1e-12
Identities = 35/94 (37%), Positives = 52/94 (55%), Gaps = 3/94 (3%)
Query: 149 RLIRDLIPRHLHIFQTNEYFKGVSLPHAENVVPLEIKIGKPAATNIYLIDFLKRCLDKDP 208
+ + DLIPRH +F TN+YF GV +P E++ PLE+K P + + LK CL DP
Sbjct: 217 KTLGDLIPRHQQVFSTNQYFSGVKIPDPEDMEPLELKF--PNISYP-ALGLLKGCLHMDP 273
Query: 209 LRRWSCDQLLRHPYFNGYYFEVPDEMQYEEITQR 242
R +C+QLL HPYF ++++ +
Sbjct: 274 TERLTCEQLLHHPYFENIREIEDLAKEHDKPAEN 307
|
| >4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} Length = 331 | Back alignment and structure |
|---|
Score = 264 bits (678), Expect = 5e-88
Identities = 92/153 (60%), Positives = 129/153 (84%)
Query: 1 MERYEKIGKLGEGSYGVVFKCRNRDTGQVVAIKKFLESEEDPLIRKIALREIRLLKSLKH 60
ME+YE +G +GEGSYG+V KCRN+DTG++VAIKKFLES++D +++KIA+REI+LLK L+H
Sbjct: 24 MEKYENLGLVGEGSYGMVMKCRNKDTGRIVAIKKFLESDDDKMVKKIAMREIKLLKQLRH 83
Query: 61 PNLVNLLEVFRRKKKLHLVFEFCDHTVLNELENHPHGLPWDLIKQITWQVLRGVSYCHRH 120
NLVNLLEV ++KK+ +LVFEF DHT+L++LE P+GL + ++++ +Q++ G+ +CH H
Sbjct: 84 ENLVNLLEVCKKKKRWYLVFEFVDHTILDDLELFPNGLDYQVVQKYLFQIINGIGFCHSH 143
Query: 121 ACIHRDIKPENILLTANGVVKLCDFGFARLIRD 153
IHRDIKPENIL++ +GVVKLCDFGFAR +
Sbjct: 144 NIIHRDIKPENILVSQSGVVKLCDFGFARTLAA 176
|
| >4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} Length = 331 | Back alignment and structure |
|---|
Score = 61.5 bits (150), Expect = 4e-11
Identities = 29/76 (38%), Positives = 41/76 (53%), Gaps = 3/76 (3%)
Query: 149 RLIRDLIPRHLHIFQTNEYFKGVSLPHAENVVPLEIKIGKPAATNIYLIDFLKRCLDKDP 208
+ +LIPRH +F N F GV LP + PLE + P + + +ID K+CL DP
Sbjct: 239 MCLGNLIPRHQELFNKNPVFAGVRLPEIKEREPLERRY--PKLSEV-VIDLAKKCLHIDP 295
Query: 209 LRRWSCDQLLRHPYFN 224
+R C +LL H +F
Sbjct: 296 DKRPFCAELLHHDFFQ 311
|
| >3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A Length = 292 | Back alignment and structure |
|---|
Score = 210 bits (537), Expect = 2e-67
Identities = 68/152 (44%), Positives = 103/152 (67%), Gaps = 6/152 (3%)
Query: 1 MERYEKIGKLGEGSYGVVFKCRNRDTGQVVAIKKF-LESEED--PLIRKIALREIRLLKS 57
M++YEK+ K+GEG+YG VFK +NR+T ++VA+K+ L+ +++ P ALREI LLK
Sbjct: 1 MQKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSS---ALREICLLKE 57
Query: 58 LKHPNLVNLLEVFRRKKKLHLVFEFCDHTVLNELENHPHGLPWDLIKQITWQVLRGVSYC 117
LKH N+V L +V KKL LVFEFCD + ++ L +++K +Q+L+G+ +C
Sbjct: 58 LKHKNIVRLHDVLHSDKKLTLVFEFCDQDLKKYFDSCNGDLDPEIVKSFLFQLLKGLGFC 117
Query: 118 HRHACIHRDIKPENILLTANGVVKLCDFGFAR 149
H +HRD+KP+N+L+ NG +KL +FG AR
Sbjct: 118 HSRNVLHRDLKPQNLLINRNGELKLANFGLAR 149
|
| >3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A Length = 292 | Back alignment and structure |
|---|
Score = 39.8 bits (94), Expect = 5e-04
Identities = 11/28 (39%), Positives = 19/28 (67%)
Query: 197 IDFLKRCLDKDPLRRWSCDQLLRHPYFN 224
D L+ L +P++R S ++ L+HPYF+
Sbjct: 260 RDLLQNLLKCNPVQRISAEEALQHPYFS 287
|
| >1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A Length = 288 | Back alignment and structure |
|---|
Score = 207 bits (530), Expect = 3e-66
Identities = 65/152 (42%), Positives = 92/152 (60%), Gaps = 7/152 (4%)
Query: 1 MERYEKIGKLGEGSYGVVFKCRNRDTGQVVAIKKF-LESEED--PLIRKIALREIRLLKS 57
ME+Y + K+GEG+YGVV+K +N G+ A+KK LE E++ P +REI +LK
Sbjct: 1 MEKYHGLEKIGEGTYGVVYKAQNN-YGETFALKKIRLEKEDEGIPST---TIREISILKE 56
Query: 58 LKHPNLVNLLEVFRRKKKLHLVFEFCDHTVLNELENHPHGLPWDLIKQITWQVLRGVSYC 117
LKH N+V L +V KK+L LVFE D + L+ GL K Q+L G++YC
Sbjct: 57 LKHSNIVKLYDVIHTKKRLVLVFEHLDQDLKKLLDVCEGGLESVTAKSFLLQLLNGIAYC 116
Query: 118 HRHACIHRDIKPENILLTANGVVKLCDFGFAR 149
H +HRD+KP+N+L+ G +K+ DFG AR
Sbjct: 117 HDRRVLHRDLKPQNLLINREGELKIADFGLAR 148
|
| >1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A Length = 288 | Back alignment and structure |
|---|
Score = 39.8 bits (94), Expect = 5e-04
Identities = 12/28 (42%), Positives = 15/28 (53%)
Query: 197 IDFLKRCLDKDPLRRWSCDQLLRHPYFN 224
ID L + L DP +R + Q L H YF
Sbjct: 258 IDLLSKMLKLDPNQRITAKQALEHAYFK 285
|
| >2r3i_A Cell division protein kinase 2; serine/threonine-protein kinase, cell cycle, inhibition, cyclin-dependent kinase, cancer, ATP-binding; HET: SCF; 1.28A {Homo sapiens} PDB: 2r3j_A* 2r3k_A* 2r3l_A* 2r3m_A* 2r3n_A* 2r3o_A* 2r3p_A* 2r3q_A* 1jvp_P* 1buh_A 1ckp_A* 1di8_A* 1dm2_A* 1f5q_A 1fin_A* 1fq1_B* 1fvt_A* 1fvv_A* 1g5s_A* 1gih_A* ... Length = 299 | Back alignment and structure |
|---|
Score = 207 bits (530), Expect = 4e-66
Identities = 72/153 (47%), Positives = 105/153 (68%), Gaps = 7/153 (4%)
Query: 1 MERYEKIGKLGEGSYGVVFKCRNRDTGQVVAIKKF-LESEED--PLIRKIALREIRLLKS 57
ME ++K+ K+GEG+YGVV+K RN+ TG+VVA+KK L++E + P A+REI LLK
Sbjct: 2 MENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPST---AIREISLLKE 58
Query: 58 LKHPNLVNLLEVFRRKKKLHLVFEFCDHTVLNELENHPH-GLPWDLIKQITWQVLRGVSY 116
L HPN+V LL+V + KL+LVFEF + ++ G+P LIK +Q+L+G+++
Sbjct: 59 LNHPNIVKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAF 118
Query: 117 CHRHACIHRDIKPENILLTANGVVKLCDFGFAR 149
CH H +HRD+KP+N+L+ G +KL DFG AR
Sbjct: 119 CHSHRVLHRDLKPQNLLINTEGAIKLADFGLAR 151
|
| >2r3i_A Cell division protein kinase 2; serine/threonine-protein kinase, cell cycle, inhibition, cyclin-dependent kinase, cancer, ATP-binding; HET: SCF; 1.28A {Homo sapiens} PDB: 2r3j_A* 2r3k_A* 2r3l_A* 2r3m_A* 2r3n_A* 2r3o_A* 2r3p_A* 2r3q_A* 1jvp_P* 1buh_A 1ckp_A* 1di8_A* 1dm2_A* 1f5q_A 1fin_A* 1fq1_B* 1fvt_A* 1fvv_A* 1g5s_A* 1gih_A* ... Length = 299 | Back alignment and structure |
|---|
Score = 39.4 bits (93), Expect = 6e-04
Identities = 10/28 (35%), Positives = 13/28 (46%)
Query: 197 IDFLKRCLDKDPLRRWSCDQLLRHPYFN 224
L + L DP +R S L HP+F
Sbjct: 261 RSLLSQMLHYDPNKRISAKAALAHPFFQ 288
|
| >3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} PDB: 2qkr_A* Length = 311 | Back alignment and structure |
|---|
Score = 204 bits (522), Expect = 9e-65
Identities = 68/152 (44%), Positives = 108/152 (71%), Gaps = 7/152 (4%)
Query: 1 MERYEKIGKLGEGSYGVVFKCRNRDTGQVVAIKKF-LESEED--PLIRKIALREIRLLKS 57
ME+Y+K+ K+GEG+YGVV+K ++ G++VA+K+ L++E++ P A+REI LLK
Sbjct: 20 MEKYQKLEKVGEGTYGVVYKAKDS-QGRIVALKRIRLDAEDEGIPST---AIREISLLKE 75
Query: 58 LKHPNLVNLLEVFRRKKKLHLVFEFCDHTVLNELENHPHGLPWDLIKQITWQVLRGVSYC 117
L HPN+V+L++V ++ L LVFEF + + L+ + GL IK +Q+LRGV++C
Sbjct: 76 LHHPNIVSLIDVIHSERCLTLVFEFMEKDLKKVLDENKTGLQDSQIKIYLYQLLRGVAHC 135
Query: 118 HRHACIHRDIKPENILLTANGVVKLCDFGFAR 149
H+H +HRD+KP+N+L+ ++G +KL DFG AR
Sbjct: 136 HQHRILHRDLKPQNLLINSDGALKLADFGLAR 167
|
| >3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} PDB: 2qkr_A* Length = 311 | Back alignment and structure |
|---|
Score = 40.6 bits (96), Expect = 4e-04
Identities = 12/38 (31%), Positives = 18/38 (47%), Gaps = 4/38 (10%)
Query: 197 IDFLKRCLDKDPLRRWSCDQLLRHPYFNGYYFEVPDEM 234
ID L L DP +R S + HPYF ++ ++
Sbjct: 278 IDLLSNMLCFDPNKRISARDAMNHPYFK----DLDPQI 311
|
| >3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens} Length = 324 | Back alignment and structure |
|---|
Score = 204 bits (522), Expect = 1e-64
Identities = 64/150 (42%), Positives = 96/150 (64%), Gaps = 3/150 (2%)
Query: 1 MERYEKIGKLGEGSYGVVFKCRNRDTGQVVAIKKF-LESEEDPLIRKIALREIRLLKSLK 59
ME Y K+ KLGEG+Y V+K +++ T +VA+K+ LE EE A+RE+ LLK LK
Sbjct: 1 METYIKLDKLGEGTYATVYKGKSKLTDNLVALKEIRLEHEEG--APCTAIREVSLLKDLK 58
Query: 60 HPNLVNLLEVFRRKKKLHLVFEFCDHTVLNELENHPHGLPWDLIKQITWQVLRGVSYCHR 119
H N+V L ++ +K L LVFE+ D + L++ + + +K +Q+LRG++YCHR
Sbjct: 59 HANIVTLHDIIHTEKSLTLVFEYLDKDLKQYLDDCGNIINMHNVKLFLFQLLRGLAYCHR 118
Query: 120 HACIHRDIKPENILLTANGVVKLCDFGFAR 149
+HRD+KP+N+L+ G +KL DFG AR
Sbjct: 119 QKVLHRDLKPQNLLINERGELKLADFGLAR 148
|
| >3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens} Length = 324 | Back alignment and structure |
|---|
Score = 42.2 bits (100), Expect = 1e-04
Identities = 13/60 (21%), Positives = 25/60 (41%), Gaps = 3/60 (5%)
Query: 197 IDFLKRCLDKDPLRRWSCDQLLRHPYFNGY---YFEVPDEMQYEEITQRCLDKDPLRRWS 253
D L + L + R S + ++HP+F ++PD + + L K+ R +
Sbjct: 259 ADLLTKLLQFEGRNRISAEDAMKHPFFLSLGERIHKLPDTTSIFALKEIQLQKEASLRSA 318
|
| >1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7 Length = 346 | Back alignment and structure |
|---|
Score = 204 bits (521), Expect = 3e-64
Identities = 64/152 (42%), Positives = 95/152 (62%), Gaps = 3/152 (1%)
Query: 1 MERYEKIGKLGEGSYGVVFKCRNRDTGQVVAIKKF-LESEEDPL--IRKIALREIRLLKS 57
+RYEK+ LGEG + V+K R+++T Q+VAIKK L + I + ALREI+LL+
Sbjct: 9 AKRYEKLDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQE 68
Query: 58 LKHPNLVNLLEVFRRKKKLHLVFEFCDHTVLNELENHPHGLPWDLIKQITWQVLRGVSYC 117
L HPN++ LL+ F K + LVF+F + + ++++ L IK L+G+ Y
Sbjct: 69 LSHPNIIGLLDAFGHKSNISLVFDFMETDLEVIIKDNSLVLTPSHIKAYMLMTLQGLEYL 128
Query: 118 HRHACIHRDIKPENILLTANGVVKLCDFGFAR 149
H+H +HRD+KP N+LL NGV+KL DFG A+
Sbjct: 129 HQHWILHRDLKPNNLLLDENGVLKLADFGLAK 160
|
| >1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7 Length = 346 | Back alignment and structure |
|---|
Score = 43.3 bits (103), Expect = 4e-05
Identities = 18/76 (23%), Positives = 30/76 (39%), Gaps = 14/76 (18%)
Query: 160 HIFQ-----TNEYFKGVS-LPHAENV-----VPLEIKIGKPAATNIYLIDFLKRCLDKDP 208
IF+ T E + + LP +PL AA + L+D ++ +P
Sbjct: 224 RIFETLGTPTEEQWPDMCSLPDYVTFKSFPGIPLHHIF--SAAGDD-LLDLIQGLFLFNP 280
Query: 209 LRRWSCDQLLRHPYFN 224
R + Q L+ YF+
Sbjct: 281 CARITATQALKMKYFS 296
|
| >2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A* Length = 317 | Back alignment and structure |
|---|
Score = 202 bits (517), Expect = 6e-64
Identities = 64/155 (41%), Positives = 99/155 (63%), Gaps = 8/155 (5%)
Query: 1 MERYEKIGKLGEGSYGVVFKCRNRDTGQVVAIKKF-LESEEDPLIRKIALREIRLLKSLK 59
+++++ KLG G+Y V+K N+ TG VA+K+ L+SEE A+REI L+K LK
Sbjct: 4 SSQFKQLEKLGNGTYATVYKGLNKTTGVYVALKEVKLDSEEG--TPSTAIREISLMKELK 61
Query: 60 HPNLVNLLEVFRRKKKLHLVFEFCDHTVLNELENH-----PHGLPWDLIKQITWQVLRGV 114
H N+V L +V + KL LVFEF D+ + +++ P GL +L+K WQ+L+G+
Sbjct: 62 HENIVRLYDVIHTENKLTLVFEFMDNDLKKYMDSRTVGNTPRGLELNLVKYFQWQLLQGL 121
Query: 115 SYCHRHACIHRDIKPENILLTANGVVKLCDFGFAR 149
++CH + +HRD+KP+N+L+ G +KL DFG AR
Sbjct: 122 AFCHENKILHRDLKPQNLLINKRGQLKLGDFGLAR 156
|
| >2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A* Length = 317 | Back alignment and structure |
|---|
Score = 40.3 bits (95), Expect = 4e-04
Identities = 19/79 (24%), Positives = 27/79 (34%), Gaps = 14/79 (17%)
Query: 160 HIFQ-----TNEYFKGVS-LPHAENVVP------LEIKIGKPAATNI--YLIDFLKRCLD 205
IF + V+ LP + L + + L+DFL L
Sbjct: 220 LIFDIMGTPNESLWPSVTKLPKYNPNIQQRPPRDLRQVLQPHTKEPLDGNLMDFLHGLLQ 279
Query: 206 KDPLRRWSCDQLLRHPYFN 224
+P R S Q L HP+F
Sbjct: 280 LNPDMRLSAKQALHHPWFA 298
|
| >3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A* Length = 329 | Back alignment and structure |
|---|
Score = 201 bits (514), Expect = 2e-63
Identities = 62/157 (39%), Positives = 100/157 (63%), Gaps = 12/157 (7%)
Query: 1 MERYEKIGKLGEGSYGVVFKCRNRDTGQVVAIKKF-LESEED--PLIRKIALREIRLLKS 57
++RY +I KLGEG+YG V+K + T + VAIK+ LE EE+ P A+RE+ LLK
Sbjct: 33 IDRYRRITKLGEGTYGEVYKAIDTVTNETVAIKRIRLEHEEEGVPGT---AIREVSLLKE 89
Query: 58 LKHPNLVNLLEVFRRKKKLHLVFEFCDHTVLNELENHPHGLPWDLIKQITWQVLRGVSYC 117
L+H N++ L V +LHL+FE+ ++ + ++ +P + +IK +Q++ GV++C
Sbjct: 90 LQHRNIIELKSVIHHNHRLHLIFEYAENDLKKYMDKNP-DVSMRVIKSFLYQLINGVNFC 148
Query: 118 HRHACIHRDIKPENILLTAN-----GVVKLCDFGFAR 149
H C+HRD+KP+N+LL+ + V+K+ DFG AR
Sbjct: 149 HSRRCLHRDLKPQNLLLSVSDASETPVLKIGDFGLAR 185
|
| >3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A* Length = 329 | Back alignment and structure |
|---|
Score = 40.7 bits (96), Expect = 3e-04
Identities = 20/75 (26%), Positives = 31/75 (41%), Gaps = 10/75 (13%)
Query: 160 HIFQ-----TNEYFKGVS-LPHAENVVPLEIKIG----KPAATNIYLIDFLKRCLDKDPL 209
IF+ + + GV+ LP + P A + +D L L+ DP+
Sbjct: 249 KIFEVLGLPDDTTWPGVTALPDWKQSFPKFRGKTLKRVLGALLDDEGLDLLTAMLEMDPV 308
Query: 210 RRWSCDQLLRHPYFN 224
+R S L HPYF+
Sbjct: 309 KRISAKNALEHPYFS 323
|
| >3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens} Length = 311 | Back alignment and structure |
|---|
Score = 198 bits (506), Expect = 2e-62
Identities = 61/253 (24%), Positives = 98/253 (38%), Gaps = 30/253 (11%)
Query: 1 MERYEKIGKLGEGSYGVVFKCRNRDTGQVVAIKKFLESEEDPLIRKIALREIRLLKSL-K 59
+ ++++ +LG GSYG VFK R+++ G++ A+K+ + P R L E+ + + +
Sbjct: 56 QQSFQRLSRLGHGSYGEVFKVRSKEDGRLYAVKRSMSPFRGPKDRARKLAEVGSHEKVGQ 115
Query: 60 HPNLVNLLEVFRRKKKLHLVFEFCDHTVLNELENHPHGLPWDLIKQITWQVLRGVSYCHR 119
HP V L + + L+L E C ++ E LP + L +++ H
Sbjct: 116 HPCCVRLEQAWEEGGILYLQTELCGPSLQQHCEAWGASLPEAQVWGYLRDTLLALAHLHS 175
Query: 120 HACIHRDIKPENILLTANGVVKLCDFGFARLIRDLIPRHLH----------IFQTN---- 165
+H D+KP NI L G KL DFG + + + Q +
Sbjct: 176 QGLVHLDVKPANIFLGPRGRCKLGDFGLLVELGTAGAGEVQEGDPRYMAPELLQGSYGTA 235
Query: 166 -----------EYFKGVSLPH-AENVVPLEIKIGKPAATNIY---LIDFLKRCLDKDPLR 210
E + LPH E L P T L L L+ DP
Sbjct: 236 ADVFSLGLTILEVACNMELPHGGEGWQQLRQGYLPPEFTAGLSSELRSVLVMMLEPDPKL 295
Query: 211 RWSCDQLLRHPYF 223
R + + LL P
Sbjct: 296 RATAEALLALPVL 308
|
| >3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens} Length = 308 | Back alignment and structure |
|---|
Score = 196 bits (501), Expect = 1e-61
Identities = 63/161 (39%), Positives = 94/161 (58%), Gaps = 12/161 (7%)
Query: 1 MERYEKIGKLGEGSYGVVFKCRNRDTGQVVAIKKF-LESEED--PLIRKIALREIRLLKS 57
RYE + ++G G+YG V+K R+ +G VA+K + + + +RE+ LL+
Sbjct: 8 TSRYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVPNGGGGGGGLPISTVREVALLRR 67
Query: 58 LK---HPNLVNLLEVF-----RRKKKLHLVFEFCDHTVLNELENHPH-GLPWDLIKQITW 108
L+ HPN+V L++V R+ K+ LVFE D + L+ P GLP + IK +
Sbjct: 68 LEAFEHPNVVRLMDVCATSRTDREIKVTLVFEHVDQDLRTYLDKAPPPGLPAETIKDLMR 127
Query: 109 QVLRGVSYCHRHACIHRDIKPENILLTANGVVKLCDFGFAR 149
Q LRG+ + H + +HRD+KPENIL+T+ G VKL DFG AR
Sbjct: 128 QFLRGLDFLHANCIVHRDLKPENILVTSGGTVKLADFGLAR 168
|
| >3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens} Length = 308 | Back alignment and structure |
|---|
Score = 39.5 bits (93), Expect = 7e-04
Identities = 8/28 (28%), Positives = 13/28 (46%)
Query: 197 IDFLKRCLDKDPLRRWSCDQLLRHPYFN 224
L L +P +R S + L+H Y +
Sbjct: 274 AQLLLEMLTFNPHKRISAFRALQHSYLH 301
|
| >1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B Length = 326 | Back alignment and structure |
|---|
Score = 193 bits (492), Expect = 4e-60
Identities = 65/162 (40%), Positives = 105/162 (64%), Gaps = 16/162 (9%)
Query: 1 MERYEKIGKLGEGSYGVVFKCRN-RDTGQVVAIKKF-LESEED--PLIRKIALREIRLLK 56
++YE + ++GEG+YG VFK R+ ++ G+ VA+K+ +++ E+ PL +RE+ +L+
Sbjct: 10 DQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLS---TIREVAVLR 66
Query: 57 SLK---HPNLVNLLEVF-----RRKKKLHLVFEFCDHTVLNELENHPH-GLPWDLIKQIT 107
L+ HPN+V L +V R+ KL LVFE D + L+ P G+P + IK +
Sbjct: 67 HLETFEHPNVVRLFDVCTVSRTDRETKLTLVFEHVDQDLTTYLDKVPEPGVPTETIKDMM 126
Query: 108 WQVLRGVSYCHRHACIHRDIKPENILLTANGVVKLCDFGFAR 149
+Q+LRG+ + H H +HRD+KP+NIL+T++G +KL DFG AR
Sbjct: 127 FQLLRGLDFLHSHRVVHRDLKPQNILVTSSGQIKLADFGLAR 168
|
| >3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* Length = 351 | Back alignment and structure |
|---|
Score = 192 bits (489), Expect = 2e-59
Identities = 70/175 (40%), Positives = 107/175 (61%), Gaps = 11/175 (6%)
Query: 1 MERYEKIGKLGEGSYGVVFKCRNRDTGQVVAIKKF-LESEEDPLIRKIALREIRLLKSLK 59
+ +YEK+ K+G+G++G VFK R+R TGQ VA+KK +E+E++ ALREI++L+ LK
Sbjct: 16 VSKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKE-GFPITALREIKILQLLK 74
Query: 60 HPNLVNLLEVF--------RRKKKLHLVFEFCDHTVLNELENHPHGLPWDLIKQITWQVL 111
H N+VNL+E+ R K ++LVF+FC+H + L N IK++ +L
Sbjct: 75 HENVVNLIEICRTKASPYNRCKGSIYLVFDFCEHDLAGLLSNVLVKFTLSEIKRVMQMLL 134
Query: 112 RGVSYCHRHACIHRDIKPENILLTANGVVKLCDFGFARLIRDLIPRHLHIFQTNE 166
G+ Y HR+ +HRD+K N+L+T +GV+KL DFG AR + + TN
Sbjct: 135 NGLYYIHRNKILHRDMKAANVLITRDGVLKLADFGLARAFSLAKNSQPNRY-TNR 188
|
| >2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A* Length = 310 | Back alignment and structure |
|---|
Score = 186 bits (474), Expect = 1e-57
Identities = 63/264 (23%), Positives = 99/264 (37%), Gaps = 43/264 (16%)
Query: 1 MERYEKIGKLGEGSYGVVFKCRNRDTGQVVAIKK-FLESEEDPLIRKIALREIRLLKSLK 59
+ + K+G G + V++ G VA+KK + D R ++EI LLK L
Sbjct: 31 LANFRIEKKIGRGQFSEVYRAACLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLN 90
Query: 60 HPNLVNLLEVFRRKKKLHLVFEFCD----HTVLNELENHPHGLPWDLIKQITWQVLRGVS 115
HPN++ F +L++V E D ++ + +P + + Q+ +
Sbjct: 91 HPNVIKYYASFIEDNELNIVLELADAGDLSRMIKHFKKQKRLIPERTVWKYFVQLCSALE 150
Query: 116 YCHRHACIHRDIKPENILLTANGVVKLCDFGFARLIRDLIPRHLH------------IFQ 163
+ H +HRDIKP N+ +TA GVVKL D G R H
Sbjct: 151 HMHSRRVMHRDIKPANVFITATGVVKLGDLGLGRFFSSKT-TAAHSLVGTPYYMSPERIH 209
Query: 164 TNEY-FK------GVSL-----------PHAENVVPLEIKIGK----PAATNIY---LID 198
N Y FK G L N+ L KI + P ++ Y L
Sbjct: 210 ENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLYSLCKKIEQCDYPPLPSDHYSEELRQ 269
Query: 199 FLKRCLDKDPLRRWSCDQLLRHPY 222
+ C++ DP +R +
Sbjct: 270 LVNMCINPDPEKRPDVTYVYDVAK 293
|
| >4apc_A Serine/threonine-protein kinase NEK1; transferase; 2.10A {Homo sapiens} Length = 350 | Back alignment and structure |
|---|
Score = 183 bits (467), Expect = 4e-56
Identities = 68/286 (23%), Positives = 119/286 (41%), Gaps = 40/286 (13%)
Query: 1 MERYEKIGKLGEGSYGVVFKCRNRDTGQVVAIKKFLESEEDPLIRKIALREIRLLKSLKH 60
ME+Y ++ K+GEGS+G ++ + G+ IK+ S R+ + RE+ +L ++KH
Sbjct: 23 MEKYVRLQKIGEGSFGKAILVKSTEDGRQYVIKEINISRMSSKEREESRREVAVLANMKH 82
Query: 61 PNLVNLLEVFRRKKKLHLVFEFCD----HTVLNELENHPHGLPWDLIKQITWQVLRGVSY 116
PN+V E F L++V ++C+ +N + D I Q+ + +
Sbjct: 83 PNIVQYRESFEENGSLYIVMDYCEGGDLFKRINAQKGVL--FQEDQILDWFVQICLALKH 140
Query: 117 CHRHACIHRDIKPENILLTANGVVKLCDFGFARLIRDLIPRHL-----------HIFQTN 165
H +HRDIK +NI LT +G V+L DFG AR++ + I +
Sbjct: 141 VHDRKILHRDIKSQNIFLTKDGTVQLGDFGIARVLNSTVELARACIGTPYYLSPEICENK 200
Query: 166 EY-FK------GVSL--------P-HAENVVPLEIKIGK---PAATNIY---LIDFLKRC 203
Y K G L A ++ L +KI P + Y L + +
Sbjct: 201 PYNNKSDIWALGCVLYELCTLKHAFEAGSMKNLVLKIISGSFPPVSLHYSYDLRSLVSQL 260
Query: 204 LDKDPLRRWSCDQLLRHPYFNGYYFE-VPDEMQYEEITQRCLDKDP 248
++P R S + +L + + + ++ EE + K
Sbjct: 261 FKRNPRDRPSVNSILEKGFIAKRIEKFLSPQLIAEEFCLKTFSKFG 306
|
| >3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A* Length = 313 | Back alignment and structure |
|---|
Score = 181 bits (462), Expect = 9e-56
Identities = 59/285 (20%), Positives = 97/285 (34%), Gaps = 53/285 (18%)
Query: 1 MERYEKIGKLGEGSYGVVFKCRNRDTGQVVAIKKFLESEEDPLIRKIALREIRLLKSLKH 60
Y + ++G G VF+ N + Q+ AIK E D EI L L+
Sbjct: 27 GRIYSILKQIGSGGSSKVFQVLN-EKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQ 85
Query: 61 PNL--VNLLEVFRRKKKLHLVFEFCDHTVLNELENHPHGLPWDLIKQITWQVLRGVSYCH 118
+ + L + + +++V E + + + L+ + K +L V H
Sbjct: 86 HSDKIIRLYDYEITDQYIYMVMECGNIDLNSWLKKK-KSIDPWERKSYWKNMLEAVHTIH 144
Query: 119 RHACIHRDIKPENILLTANGVVKLCDFGFARLIRD--------------------LIPRH 158
+H +H D+KP N L+ +G++KL DFG A ++ I
Sbjct: 145 QHGIVHSDLKPANFLIV-DGMLKLIDFGIANQMQPDTTSVVKDSQVGTVNYMPPEAIKDM 203
Query: 159 LHIFQTNEYFKGVSLP---------------------HAENVVPLEIKIGKPAATNIY-- 195
+ + +S N + I P +
Sbjct: 204 SSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQISKLHAIIDPNHEIEFPD 263
Query: 196 -----LIDFLKRCLDKDPLRRWSCDQLLRHPYFNGYYFEVPDEMQ 235
L D LK CL +DP +R S +LL HPY V +
Sbjct: 264 IPEKDLQDVLKCCLKRDPKQRISIPELLAHPYVQIQTHPVNQMAK 308
|
| >3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens} Length = 343 | Back alignment and structure |
|---|
Score = 180 bits (459), Expect = 5e-55
Identities = 59/285 (20%), Positives = 99/285 (34%), Gaps = 55/285 (19%)
Query: 2 ERYEKIGKLGEGSYGVVFKCRNRDTGQVVAIKK-FLESEEDPLIRKIALREIRLLKSLKH 60
Y + ++G G VF+ N Q+ AIK LE ++ + EI L L+
Sbjct: 9 RIYSILKQIGSGGSSKVFQVLNE-KKQIYAIKYVNLEEADNQTLDSY-RNEIAYLNKLQQ 66
Query: 61 PNL--VNLLEVFRRKKKLHLVFEFCDHTVLNELENHPHGLPWDLIKQITWQVLRGVSYCH 118
+ + L + + +++V E + + + L+ + K +L V H
Sbjct: 67 HSDKIIRLYDYEITDQYIYMVMECGNIDLNSWLKKK-KSIDPWERKSYWKNMLEAVHTIH 125
Query: 119 RHACIHRDIKPENILLTANGVVKLCDFGFARLIRD--------------------LIPRH 158
+H +H D+KP N L+ +G++KL DFG A ++ I
Sbjct: 126 QHGIVHSDLKPANFLIV-DGMLKLIDFGIANQMQPDTTSVVKDSQVGTVNYMPPEAIKDM 184
Query: 159 LHIFQTNEYFKGVSLP---------------------HAENVVPLEIKIGKPAATNIY-- 195
+ + +S N + I P +
Sbjct: 185 SSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQISKLHAIIDPNHEIEFPD 244
Query: 196 -----LIDFLKRCLDKDPLRRWSCDQLLRHPYFNGYYFEVPDEMQ 235
L D LK CL +DP +R S +LL HPY V +
Sbjct: 245 IPEKDLQDVLKCCLKRDPKQRISIPELLAHPYVQIQTHPVNQMAK 289
|
| >2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A* Length = 390 | Back alignment and structure |
|---|
Score = 180 bits (457), Expect = 3e-54
Identities = 59/285 (20%), Positives = 97/285 (34%), Gaps = 53/285 (18%)
Query: 1 MERYEKIGKLGEGSYGVVFKCRNRDTGQVVAIKKFLESEEDPLIRKIALREIRLLKSLKH 60
Y + ++G G VF+ N + Q+ AIK E D EI L L+
Sbjct: 55 GRIYSILKQIGSGGSSKVFQVLN-EKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQ 113
Query: 61 PNL--VNLLEVFRRKKKLHLVFEFCDHTVLNELENHPHGLPWDLIKQITWQVLRGVSYCH 118
+ + L + + +++V E + + + L+ + K +L V H
Sbjct: 114 HSDKIIRLYDYEITDQYIYMVMECGNIDLNSWLKKK-KSIDPWERKSYWKNMLEAVHTIH 172
Query: 119 RHACIHRDIKPENILLTANGVVKLCDFGFARLIRD--------------------LIPRH 158
+H +H D+KP N L+ +G++KL DFG A ++ I
Sbjct: 173 QHGIVHSDLKPANFLIV-DGMLKLIDFGIANQMQPDTTSVVKDSQVGAVNYMPPEAIKDM 231
Query: 159 LHIFQTNEYFKGVSLP---------------------HAENVVPLEIKIGKPAATNIY-- 195
+ + +S N + I P +
Sbjct: 232 SSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQISKLHAIIDPNHEIEFPD 291
Query: 196 -----LIDFLKRCLDKDPLRRWSCDQLLRHPYFNGYYFEVPDEMQ 235
L D LK CL +DP +R S +LL HPY V +
Sbjct: 292 IPEKDLQDVLKCCLKRDPKQRISIPELLAHPYVQIQTHPVNQMAK 336
|
| >1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A* Length = 289 | Back alignment and structure |
|---|
Score = 174 bits (442), Expect = 4e-53
Identities = 60/273 (21%), Positives = 99/273 (36%), Gaps = 53/273 (19%)
Query: 2 ERYEKIGKLGEGSYGVVFKCRNRDTGQVVAIKKFLESEEDPLIRKIALREIRLLKSL-KH 60
+ ++ K+G G +G VFKC R G + AIK+ + + + ALRE+ L +H
Sbjct: 11 TEFHELEKIGSGEFGSVFKCVKRLDGCIYAIKRSKKPLAGSVDEQNALREVYAHAVLGQH 70
Query: 61 PNLVNLLEVFRRKKKLHLVFEFCD----HTVLNELENHPHGLPWDLIKQITWQVLRGVSY 116
++V + + + E+C+ ++E +K + QV RG+ Y
Sbjct: 71 SHVVRYFSAWAEDDHMLIQNEYCNGGSLADAISENYRIMSYFKEAELKDLLLQVGRGLRY 130
Query: 117 CHRHACIHRDIKPENILLTANGV-------------------VKLCDFGFARLIRDLI-- 155
H + +H DIKP NI ++ + K+ D G I
Sbjct: 131 IHSMSLVHMDIKPSNIFISRTSIPNAASEEGDEDDWASNKVMFKIGDLGHVTRISSPQVE 190
Query: 156 ---PRHL--HIFQTN-----------------EYFKGVSLPHAENVVPLEIKIGK-PAAT 192
R L + Q N LP + EI+ G+ P
Sbjct: 191 EGDSRFLANEVLQENYTHLPKADIFALALTVVCAAGAEPLPRNGDQW-HEIRQGRLPRIP 249
Query: 193 NIY---LIDFLKRCLDKDPLRRWSCDQLLRHPY 222
+ + LK + DP RR S L++H
Sbjct: 250 QVLSQEFTELLKVMIHPDPERRPSAMALVKHSV 282
|
| >2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A* Length = 302 | Back alignment and structure |
|---|
Score = 173 bits (440), Expect = 1e-52
Identities = 75/265 (28%), Positives = 121/265 (45%), Gaps = 47/265 (17%)
Query: 2 ERYEKIGKLGEGSYGVVFKCRNRDTGQVVAIKKF-LESEEDPLIRKIALREIRLLKSLKH 60
E +E +G+LG+G++G V+K +N++TG + A K +SEE+ + + EI +L + H
Sbjct: 19 EVWEIVGELGDGAFGKVYKAKNKETGALAAAKVIETKSEEE--LEDY-IVEIEILATCDH 75
Query: 61 PNLVNLLEVFRRKKKLHLVFEFCDH-TVLNELENHPHGLPWDLIKQITWQVLRGVSYCHR 119
P +V LL + KL ++ EFC V + GL I+ + Q+L +++ H
Sbjct: 76 PYIVKLLGAYYHDGKLWIMIEFCPGGAVDAIMLELDRGLTEPQIQVVCRQMLEALNFLHS 135
Query: 120 HACIHRDIKPENILLTANGVVKLCDFGF-ARLIRDLIPRH---------------LHIFQ 163
IHRD+K N+L+T G ++L DFG A+ ++ L R +
Sbjct: 136 KRIIHRDLKAGNVLMTLEGDIRLADFGVSAKNLKTLQKRDSFIGTPYWMAPEVVMCETMK 195
Query: 164 TNEYFKGV---SL------------PHAENVVPLEI----------KIGKPAATNIYLID 198
Y SL PH + P+ + + P+ ++ D
Sbjct: 196 DTPYDYKADIWSLGITLIEMAQIEPPHH-ELNPMRVLLKIAKSDPPTLLTPSKWSVEFRD 254
Query: 199 FLKRCLDKDPLRRWSCDQLLRHPYF 223
FLK LDK+P R S QLL HP+
Sbjct: 255 FLKIALDKNPETRPSAAQLLEHPFV 279
|
| >2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A* Length = 279 | Back alignment and structure |
|---|
Score = 172 bits (437), Expect = 2e-52
Identities = 66/273 (24%), Positives = 110/273 (40%), Gaps = 50/273 (18%)
Query: 1 MERYEKIGKLGEGSYGVVFKCRNRDTGQVVAIKKFLESEEDPLIRKIALREIRLLKSLKH 60
E YE + +G GSYG K R + G+++ K+ +++ + E+ LL+ LKH
Sbjct: 5 AEDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKH 64
Query: 61 PNLVNLLEVF--RRKKKLHLVFEFCD----HTVLNELENHPHGLPWDLIKQITWQVLRGV 114
PN+V + R L++V E+C+ +V+ + L + + ++ Q+ +
Sbjct: 65 PNIVRYYDRIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLAL 124
Query: 115 SYCHR-----HACIHRDIKPENILLTANGVVKLCDFGFARLIRD--------------LI 155
CHR H +HRD+KP N+ L VKL DFG AR++ +
Sbjct: 125 KECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARILNHDTSFAKTFVGTPYYMS 184
Query: 156 PRHLHIFQTNEY-FK------GVSL--------P-HAENVVPLEIKIGK---PAATNIY- 195
P Y K G L P A + L KI + Y
Sbjct: 185 P---EQMNRMSYNEKSDIWSLGCLLYELCALMPPFTAFSQKELAGKIREGKFRRIPYRYS 241
Query: 196 --LIDFLKRCLDKDPLRRWSCDQLLRHPYFNGY 226
L + + R L+ R S +++L +P +
Sbjct: 242 DELNEIITRMLNLKDYHRPSVEEILENPLILEH 274
|
| >1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ... Length = 420 | Back alignment and structure |
|---|
Score = 176 bits (447), Expect = 2e-52
Identities = 53/165 (32%), Positives = 88/165 (53%), Gaps = 16/165 (9%)
Query: 2 ERYEKIGKLGEGSYGVVFKCRNRDTGQVVAIKKFLESEEDPLIRKIALREIRLLKSLKHP 61
Y +G GS+GVV++ + D+G++VAIKK L+ ++ RE+++++ L H
Sbjct: 54 VSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQD------KRFKNRELQIMRKLDHC 107
Query: 62 NLVNLLEVF------RRKKKLHLVFEFCDHTVLNELENHPHG---LPWDLIKQITWQVLR 112
N+V L F + + L+LV ++ TV ++ LP +K +Q+ R
Sbjct: 108 NIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFR 167
Query: 113 GVSYCHRHACIHRDIKPENILLTAN-GVVKLCDFGFARLIRDLIP 156
++Y H HRDIKP+N+LL + V+KLCDFG A+ + P
Sbjct: 168 SLAYIHSFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEP 212
|
| >1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ... Length = 420 | Back alignment and structure |
|---|
Score = 40.5 bits (95), Expect = 4e-04
Identities = 8/40 (20%), Positives = 16/40 (40%), Gaps = 3/40 (7%)
Query: 197 IDFLKRCLDKDPLRRWSCDQLLRHPYFNGYY---FEVPDE 233
I R L+ P R + + H +F+ ++P+
Sbjct: 314 IALCSRLLEYTPTARLTPLEACAHSFFDELRDPNVKLPNG 353
|
| >3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens} Length = 405 | Back alignment and structure |
|---|
Score = 174 bits (443), Expect = 5e-52
Identities = 57/166 (34%), Positives = 94/166 (56%), Gaps = 21/166 (12%)
Query: 2 ERYEKIG-KLGEGSYGVVFKCRNRD--TGQVVAIKKFLESEEDPLIRKIALREIRLLKSL 58
+ +E G K+G G+YG V+K + +D + A+K+ E + A REI LL+ L
Sbjct: 20 DLFEYEGCKVGRGTYGHVYKAKRKDGKDDKDYALKQI-EGTGISMS---ACREIALLREL 75
Query: 59 KHPNLVNLLEVF--RRKKKLHLVFEFCDHTVLNELENHPHG--------LPWDLIKQITW 108
KHPN+++L +VF +K+ L+F++ +H + + ++ H LP ++K + +
Sbjct: 76 KHPNVISLQKVFLSHADRKVWLLFDYAEHDLWHIIKFHRASKANKKPVQLPRGMVKSLLY 135
Query: 109 QVLRGVSYCHRHACIHRDIKPENILLTA----NGVVKLCDFGFARL 150
Q+L G+ Y H + +HRD+KP NIL+ G VK+ D GFARL
Sbjct: 136 QILDGIHYLHANWVLHRDLKPANILVMGEGPERGRVKIADMGFARL 181
|
| >2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B* Length = 284 | Back alignment and structure |
|---|
Score = 170 bits (433), Expect = 8e-52
Identities = 59/268 (22%), Positives = 101/268 (37%), Gaps = 51/268 (19%)
Query: 1 MERYEKIGKLGEGSYGVVFKCRNRDTGQVVAIKKFLESEEDPLIRKIALREIRLLKSLKH 60
+++I +G G +G VFK ++R G+ IK+ + A RE++ L L H
Sbjct: 10 GMDFKEIELIGSGGFGQVFKAKHRIDGKTYVIKRV------KYNNEKAEREVKALAKLDH 63
Query: 61 PNLVNLLEVF----------------RRKKKLHLVFEFCDHTVLNEL--ENHPHGLPWDL 102
N+V+ + + K L + EFCD L + + L L
Sbjct: 64 VNIVHYNGCWDGFDYDPETSSKNSSRSKTKCLFIQMEFCDKGTLEQWIEKRRGEKLDKVL 123
Query: 103 IKQITWQVLRGVSYCHRHACIHRDIKPENILLTANGVVKLCDFGFARLIRDLIPRHLH-- 160
++ Q+ +GV Y H I+RD+KP NI L VK+ DFG +++ R
Sbjct: 124 ALELFEQITKGVDYIHSKKLINRDLKPSNIFLVDTKQVKIGDFGLVTSLKNDGKRTRSKG 183
Query: 161 --------IFQTNEY-FK------GVSL-------PHAENVVPLEIKIGKPAATNIY--- 195
+ +Y + G+ L A + ++I+
Sbjct: 184 TLRYMSPEQISSQDYGKEVDLYALGLILAELLHVCDTAFETSKFFTDLRDGIISDIFDKK 243
Query: 196 LIDFLKRCLDKDPLRRWSCDQLLRHPYF 223
L++ L K P R + ++LR
Sbjct: 244 EKTLLQKLLSKKPEDRPNTSEILRTLTV 271
|
| >3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A* Length = 297 | Back alignment and structure |
|---|
Score = 169 bits (429), Expect = 5e-51
Identities = 69/259 (26%), Positives = 119/259 (45%), Gaps = 42/259 (16%)
Query: 2 ERYEKIGKLGEGSYGVVFKCRNRDTGQVVAIKKF-LESEEDPLIRKIALREIRLLKSLKH 60
++Y + K+G+G+ G V+ + TGQ VAI++ L+ + +++ + EI +++ K+
Sbjct: 20 KKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPK---KELIINEILVMRENKN 76
Query: 61 PNLVNLLEVFRRKKKLHLVFEFCDHTVLNELENHPHGLPWDLIKQITWQVLRGVSYCHRH 120
PN+VN L+ + +L +V E+ L ++ + I + + L+ + + H +
Sbjct: 77 PNIVNYLDSYLVGDELWVVMEYLAGGSLTDVV-TETCMDEGQIAAVCRECLQALEFLHSN 135
Query: 121 ACIHRDIKPENILLTANGVVKLCDFGF-ARLIRDLIPRHLHI----------FQTNEYFK 169
IHRDIK +NILL +G VKL DFGF A++ + R + Y
Sbjct: 136 QVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSTMVGTPYWMAPEVVTRKAYGP 195
Query: 170 GV---SL------------PHAENVVPLEI----------KIGKPAATNIYLIDFLKRCL 204
V SL P+ N PL ++ P + DFL RCL
Sbjct: 196 KVDIWSLGIMAIEMIEGEPPYL-NENPLRALYLIATNGTPELQNPEKLSAIFRDFLNRCL 254
Query: 205 DKDPLRRWSCDQLLRHPYF 223
+ D +R S +LL+H +
Sbjct: 255 EMDVEKRGSAKELLQHQFL 273
|
| >2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A* Length = 321 | Back alignment and structure |
|---|
Score = 168 bits (427), Expect = 1e-50
Identities = 70/268 (26%), Positives = 119/268 (44%), Gaps = 60/268 (22%)
Query: 2 ERYEKIGKLGEGSYGVVFKCRNRDTGQVVAIKKF-LESEEDPLIRKIALREIRLLKSLKH 60
+ K+GEGS G+V R + +G+ VA+K L ++ R++ E+ +++ +H
Sbjct: 45 LLLDSYVKIGEGSTGIVCLAREKHSGRQVAVKMMDLRKQQR---RELLFNEVVIMRDYQH 101
Query: 61 PNLVNLLEVFRRKKKLHLVFEFCD---------HTVLNELENHPHGLPWDLIKQITWQVL 111
N+V + + + ++L ++ EF LNE + I + VL
Sbjct: 102 FNVVEMYKSYLVGEELWVLMEFLQGGALTDIVSQVRLNEEQ----------IATVCEAVL 151
Query: 112 RGVSYCHRHACIHRDIKPENILLTANGVVKLCDFGF-ARLIRDLIPRHLHI--------- 161
+ ++Y H IHRDIK ++ILLT +G VKL DFGF A++ +D+ R +
Sbjct: 152 QALAYLHAQGVIHRDIKSDSILLTLDGRVKLSDFGFCAQISKDVPKRKSLVGTPYWMAPE 211
Query: 162 -FQTNEYFKGV---SL------------PHAENVVPLEI----------KIGKPAATNIY 195
+ Y V SL P+ + P++ K+ +
Sbjct: 212 VISRSLYATEVDIWSLGIMVIEMVDGEPPYF-SDSPVQAMKRLRDSPPPKLKNSHKVSPV 270
Query: 196 LIDFLKRCLDKDPLRRWSCDQLLRHPYF 223
L DFL+R L +DP R + +LL HP+
Sbjct: 271 LRDFLERMLVRDPQERATAQELLDHPFL 298
|
| >2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A* Length = 303 | Back alignment and structure |
|---|
Score = 164 bits (418), Expect = 2e-49
Identities = 69/279 (24%), Positives = 109/279 (39%), Gaps = 59/279 (21%)
Query: 2 ERYEKIGKLGEGSYGVVFKCRNRDTGQVVAIKKF-LESEEDPLIRKIALREIRLLKSLKH 60
+ YE +G G+ VV + VAIK+ LE + + L+EI+ + H
Sbjct: 15 DDYELQEVIGSGATAVVQAAYCAPKKEKVAIKRINLEKCQTSM--DELLKEIQAMSQCHH 72
Query: 61 PNLVNLLEVFRRKKKLHLVFEFCD--------HTVLNELENHPHGLPWDLIKQITWQVLR 112
PN+V+ F K +L LV + ++ + E+ L I I +VL
Sbjct: 73 PNIVSYYTSFVVKDELWLVMKLLSGGSVLDIIKHIVAKGEHKSGVLDESTIATILREVLE 132
Query: 113 GVSYCHRHACIHRDIKPENILLTANGVVKLCDFGFARLIRDLIPRHLH------------ 160
G+ Y H++ IHRD+K NILL +G V++ DFG + + +
Sbjct: 133 GLEYLHKNGQIHRDVKAGNILLGEDGSVQIADFGVSAFLATGGDITRNKVRKTFVGTPCW 192
Query: 161 -----IFQTNEY-FK------GVSL--------PHAE------------NVVP-LEIKIG 187
+ Q Y FK G++ P+ + N P LE +
Sbjct: 193 MAPEVMEQVRGYDFKADIWSFGITAIELATGAAPYHKYPPMKVLMLTLQNDPPSLETGVQ 252
Query: 188 KPAATNIY---LIDFLKRCLDKDPLRRWSCDQLLRHPYF 223
Y + CL KDP +R + +LLRH +F
Sbjct: 253 DKEMLKKYGKSFRKMISLCLQKDPEKRPTAAELLRHKFF 291
|
| >4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A* Length = 336 | Back alignment and structure |
|---|
Score = 165 bits (420), Expect = 3e-49
Identities = 60/266 (22%), Positives = 95/266 (35%), Gaps = 54/266 (20%)
Query: 1 MERYEKIGKLGEGSYGVVFKCRNRDTGQVVAIKKF-LESEEDPLIRKIALREIRLLKSLK 59
+ ++G GS+G V + +++ TG A+KK LE E+ L
Sbjct: 57 VHWMTHQPRVGRGSFGEVHRMKDKQTGFQCAVKKVRLEVFRV--------EELVACAGLS 108
Query: 60 HPNLVNLLEVFRRKKKLHLVFEFCDHTVLNELENHPHGLPWDLIKQITWQVLRGVSYCHR 119
P +V L R +++ E + L +L LP D Q L G+ Y H
Sbjct: 109 SPRIVPLYGAVREGPWVNIFMELLEGGSLGQLIKQMGCLPEDRALYYLGQALEGLEYLHT 168
Query: 120 HACIHRDIKPENILLTANGV-VKLCDFGFARLIRDLIPRHLHIFQTNEYFKG-------- 170
+H D+K +N+LL+++G LCDFG A ++ T +Y G
Sbjct: 169 RRILHGDVKADNVLLSSDGSRAALCDFGHALCLQPDGLGKSL--LTGDYIPGTETHMAPE 226
Query: 171 V-------------SL------------PHAE-NVVPLEIKIGK--------PAATNIYL 196
V S P + PL +KI P +
Sbjct: 227 VVMGKPCDAKVDIWSSCCMMLHMLNGCHPWTQYFRGPLCLKIASEPPPIREIPPSCAPLT 286
Query: 197 IDFLKRCLDKDPLRRWSCDQLLRHPY 222
++ L K+P+ R S +L R
Sbjct: 287 AQAIQEGLRKEPVHRASAMELRRKVG 312
|
| >4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis} Length = 394 | Back alignment and structure |
|---|
Score = 167 bits (424), Expect = 3e-49
Identities = 56/166 (33%), Positives = 90/166 (54%), Gaps = 17/166 (10%)
Query: 1 MERYEKIGKLGEGSYGVVFKCRNRDTGQVVAIKKFLESEEDPLIRKIALREIRLLKSLKH 60
Y +G GS+GVVF+ + ++ +V AIKK L+ + RE+++++ +KH
Sbjct: 39 EIAYTNCKVIGNGSFGVVFQAKLVESDEV-AIKKVLQDKRF------KNRELQIMRIVKH 91
Query: 61 PNLVNLLEVF------RRKKKLHLVFEFCDHTVLNELENHPH---GLPWDLIKQITWQVL 111
PN+V+L F + + L+LV E+ TV ++ +P LIK +Q+L
Sbjct: 92 PNVVDLKAFFYSNGDKKDEVFLNLVLEYVPETVYRASRHYAKLKQTMPMLLIKLYMYQLL 151
Query: 112 RGVSYCHRHACIHRDIKPENILLTAN-GVVKLCDFGFARLIRDLIP 156
R ++Y H HRDIKP+N+LL GV+KL DFG A+++ P
Sbjct: 152 RSLAYIHSIGICHRDIKPQNLLLDPPSGVLKLIDFGSAKILIAGEP 197
|
| >3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens} Length = 314 | Back alignment and structure |
|---|
Score = 163 bits (415), Expect = 8e-49
Identities = 79/260 (30%), Positives = 120/260 (46%), Gaps = 44/260 (16%)
Query: 2 ERYEKIGKLGEGSYGVVFKCRNRDTGQVVAIKKF-LESEEDPLIRKIALREIRLLKSLKH 60
E ++ + KLGEGSYG V+K +++TGQ+VAIK+ +ES+ +I+ EI +++
Sbjct: 29 EVFDVLEKLGEGSYGSVYKAIHKETGQIVAIKQVPVESDLQEIIK-----EISIMQQCDS 83
Query: 61 PNLVNLLEVFRRKKKLHLVFEFCDH-TVLNELENHPHGLPWDLIKQITWQVLRGVSYCHR 119
P++V + + L +V E+C +V + + L D I I L+G+ Y H
Sbjct: 84 PHVVKYYGSYFKNTDLWIVMEYCGAGSVSDIIRLRNKTLTEDEIATILQSTLKGLEYLHF 143
Query: 120 HACIHRDIKPENILLTANGVVKLCDFGF-ARLIRDLIPRHLHI----------FQTNEYF 168
IHRDIK NILL G KL DFG +L + R+ I Q Y
Sbjct: 144 MRKIHRDIKAGNILLNTEGHAKLADFGVAGQLTDTMAKRNTVIGTPFWMAPEVIQEIGYN 203
Query: 169 KGV---SL------------PHAENVVPLEI----------KIGKPAATNIYLIDFLKRC 203
SL P+A ++ P+ KP + DF+K+C
Sbjct: 204 CVADIWSLGITAIEMAEGKPPYA-DIHPMRAIFMIPTNPPPTFRKPELWSDNFTDFVKQC 262
Query: 204 LDKDPLRRWSCDQLLRHPYF 223
L K P +R + QLL+HP+
Sbjct: 263 LVKSPEQRATATQLLQHPFV 282
|
| >3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A* Length = 303 | Back alignment and structure |
|---|
Score = 162 bits (411), Expect = 2e-48
Identities = 73/266 (27%), Positives = 120/266 (45%), Gaps = 57/266 (21%)
Query: 2 ERYEKIGKLGEGSYGVVFKCRNRDTGQVVAIKKF-LESEEDPL--IRKIALREIRLLKSL 58
E + K+ K+G+GS+G VFK + T +VVAIK LE ED + I++ EI +L
Sbjct: 22 ELFTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQ----EITVLSQC 77
Query: 59 KHPNLVNLLEVFRRKKKLHLVFEFCDHTVLNELENHPHGLPWDLIKQITWQVLRGVSYCH 118
P + + + KL ++ E+ +L P L I I ++L+G+ Y H
Sbjct: 78 DSPYVTKYYGSYLKDTKLWIIMEYLGGGSALDLL-EPGPLDETQIATILREILKGLDYLH 136
Query: 119 RHACIHRDIKPENILLTANGVVKLCDFGF-ARLIRDLIPRHLHI----------FQTNEY 167
IHRDIK N+LL+ +G VKL DFG +L I R+ + + + Y
Sbjct: 137 SEKKIHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQIKRNTFVGTPFWMAPEVIKQSAY 196
Query: 168 -FK------GVSLPHAENVVPLEIKIGKPAATNI------YLI----------------- 197
K G++ +E+ G+P + + +LI
Sbjct: 197 DSKADIWSLGITA--------IELARGEPPHSELHPMKVLFLIPKNNPPTLEGNYSKPLK 248
Query: 198 DFLKRCLDKDPLRRWSCDQLLRHPYF 223
+F++ CL+K+P R + +LL+H +
Sbjct: 249 EFVEACLNKEPSFRPTAKELLKHKFI 274
|
| >3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A Length = 290 | Back alignment and structure |
|---|
Score = 160 bits (407), Expect = 6e-48
Identities = 58/269 (21%), Positives = 120/269 (44%), Gaps = 44/269 (16%)
Query: 1 MERYEKIGKLGEGSYGVVFKCRNRDTGQVVAIKKFLESEEDPLIRKIALREIR-LLKSLK 59
+ E I +LG G+YGVV K R+ +GQ++A+K+ + + + +K L ++ ++++
Sbjct: 6 ADDLEPIMELGRGAYGVVEKMRHVPSGQIMAVKR-IRATVNSQEQKRLLMDLDISMRTVD 64
Query: 60 HPNLVNLLEVFRRKKKLHLVFEFCD---HTVLNELENHPHGLPWDLIKQITWQVLRGVSY 116
P V R+ + + E D ++ + +P D++ +I +++ + +
Sbjct: 65 CPFTVTFYGALFREGDVWICMELMDTSLDKFYKQVIDKGQTIPEDILGKIAVSIVKALEH 124
Query: 117 CH-RHACIHRDIKPENILLTANGVVKLCDFGFARLIRDLIPRHLHI-------------- 161
H + + IHRD+KP N+L+ A G VK+CDFG + + D + + +
Sbjct: 125 LHSKLSVIHRDVKPSNVLINALGQVKMCDFGISGYLVDDVAKDIDAGCKPYMAPERINPE 184
Query: 162 FQTNEY-FK------GVSL--------PHAENVVPLE----IKIGKP--AATNIY---LI 197
Y K G+++ P+ P + + + + +
Sbjct: 185 LNQKGYSVKSDIWSLGITMIELAILRFPYDSWGTPFQQLKQVVEEPSPQLPADKFSAEFV 244
Query: 198 DFLKRCLDKDPLRRWSCDQLLRHPYFNGY 226
DF +CL K+ R + +L++HP+F +
Sbjct: 245 DFTSQCLKKNSKERPTYPELMQHPFFTLH 273
|
| >3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii} Length = 458 | Back alignment and structure |
|---|
Score = 164 bits (416), Expect = 1e-47
Identities = 58/155 (37%), Positives = 85/155 (54%), Gaps = 6/155 (3%)
Query: 2 ERYEKIGKLGEGSYGVVFKCRNRDTGQVVAIKKFLESEEDPLIRKIALREIRLLKSLKHP 61
+RYE +G GSYG V + ++ +VVAIKK L ED + K LREI +L L H
Sbjct: 53 DRYEIRHLIGTGSYGHVCEAYDKLEKRVVAIKKILRVFEDLIDCKRILREIAILNRLNHD 112
Query: 62 NLVNLLEVFRRK-----KKLHLVFEFCDHTVLNELENHPHGLPWDLIKQITWQVLRGVSY 116
++V +L++ K +L++V E D + +L P L IK + + +L GV Y
Sbjct: 113 HVVKVLDIVIPKDVEKFDELYVVLEIAD-SDFKKLFRTPVYLTELHIKTLLYNLLVGVKY 171
Query: 117 CHRHACIHRDIKPENILLTANGVVKLCDFGFARLI 151
H +HRD+KP N L+ + VK+CDFG AR +
Sbjct: 172 VHSAGILHRDLKPANCLVNQDCSVKVCDFGLARTV 206
|
| >3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii} Length = 458 | Back alignment and structure |
|---|
Score = 43.7 bits (103), Expect = 5e-05
Identities = 19/101 (18%), Positives = 35/101 (34%), Gaps = 24/101 (23%)
Query: 197 IDFLKRCLDKDPLRRWSCDQLLRHPYFNGYYFEVPDEMQYEEITQRCLDKDPLRRWSCDQ 256
I LKR L +P +R + ++ L HP+F + +
Sbjct: 374 IHLLKRMLVFNPNKRITINECLAHPFFKEVR-------------------IAEVETNATE 414
Query: 257 LLRHPYFNGYYFEVPD--EMQYEEIT---QVSRLPTKDKNK 292
+R P+ + + P +EI +LP + N+
Sbjct: 415 KVRLPFNDWMNMDEPQLRYAFVKEIQRYHPEIQLPRRSPNR 455
|
| >2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens} Length = 317 | Back alignment and structure |
|---|
Score = 159 bits (404), Expect = 4e-47
Identities = 54/278 (19%), Positives = 97/278 (34%), Gaps = 23/278 (8%)
Query: 2 ERYEKIGKLGEGSYGVVFKCRNRDTGQVVAIKK-FLESEEDPLIRKIALREIRLLKSLKH 60
+ Y I KLGEG + V G A+K+ ++D R+ A RE + + H
Sbjct: 29 KHYLFIQKLGEGGFSYVDLVEGLHDGHFYALKRILCHEQQD---REEAQREADMHRLFNH 85
Query: 61 PNLVNLLEVFRRKK----KLHLVFEFCD----HTVLNELENHPHGLPWDLIKQITWQVLR 112
PN++ L+ R++ + L+ F + L++ + L D I + + R
Sbjct: 86 PNILRLVAYCLRERGAKHEAWLLLPFFKRGTLWNEIERLKDKGNFLTEDQILWLLLGICR 145
Query: 113 GVSYCHRHACIHRDIKPENILLTANGVVKLCDFGFARLIRDLIPRHLHIFQTNEYFKGVS 172
G+ H HRD+KP NILL G L D G + ++
Sbjct: 146 GLEAIHAKGYAHRDLKPTNILLGDEGQPVLMDLGSMNQACIHVEGSRQALTLQDWAAQRC 205
Query: 173 LPH--AENVVPLEIKIGKPAATNI-------YLIDFLKRCLDKDPLRRWSCDQLLRHPYF 223
A + ++ T++ Y + F + D + S +++
Sbjct: 206 TISYRAPELFSVQSHCVIDERTDVWSLGCVLYAMMFGEGPYDMVFQKGDSVALAVQNQLS 265
Query: 224 NGYYFEVPDEMQYEEITQRCLDKDPLRRWSCDQLLRHP 261
+ ++ + DP +R LL
Sbjct: 266 IPQSPRHSSALW--QLLNSMMTVDPHQRPHIPLLLSQL 301
|
| >3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major} Length = 360 | Back alignment and structure |
|---|
Score = 160 bits (406), Expect = 6e-47
Identities = 54/162 (33%), Positives = 81/162 (50%), Gaps = 16/162 (9%)
Query: 1 MERYEKIGKLGEGSYGVVFKCRNRDTGQVVAIKKFLESEEDPLIRKIALREIRLLKSLKH 60
M+R++ G+G++G V + + TG VAIKK + +DP R L+ ++ L L H
Sbjct: 22 MDRFQVERMAGQGTFGTVQLGKEKSTGMSVAIKKVI---QDPRFRNRELQIMQDLAVLHH 78
Query: 61 PNLVNLLEVFR-------RKKKLHLVFEFCD---HTVLNELENHPHGLPWDLIKQITWQV 110
PN+V L F R L++V E+ H P LIK +Q+
Sbjct: 79 PNIVQLQSYFYTLGERDRRDIYLNVVMEYVPDTLHRCCRNYYRRQVAPPPILIKVFLFQL 138
Query: 111 LRGVSYCHRHAC--IHRDIKPENILL-TANGVVKLCDFGFAR 149
+R + H + HRDIKP N+L+ A+G +KLCDFG A+
Sbjct: 139 IRSIGCLHLPSVNVCHRDIKPHNVLVNEADGTLKLCDFGSAK 180
|
| >2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens} Length = 295 | Back alignment and structure |
|---|
Score = 157 bits (398), Expect = 2e-46
Identities = 64/262 (24%), Positives = 107/262 (40%), Gaps = 43/262 (16%)
Query: 2 ERYEKIGKLGEGSYGVVFKCRNRDTGQVVAIKKFLESEEDPLIRKIALREIRLLKSLKHP 61
+ LG+G+YG+V+ R+ +AIK+ + + + + EI L K LKH
Sbjct: 22 DENGDRVVLGKGTYGIVYAGRDLSNQVRIAIKE-IPERDSRYSQPLH-EEIALHKHLKHK 79
Query: 62 NLVNLLEVFRRKKKLHLVFEFCDH-TVLNELENHPHGLPWD--LIKQITWQVLRGVSYCH 118
N+V L F + + E ++ L + L + I T Q+L G+ Y H
Sbjct: 80 NIVQYLGSFSENGFIKIFMEQVPGGSLSALLRSKWGPLKDNEQTIGFYTKQILEGLKYLH 139
Query: 119 RHACIHRDIKPENILL-TANGVVKLCDFGFARLIRDLIPRHLH------------IFQTN 165
+ +HRDIK +N+L+ T +GV+K+ DFG ++ + + P I +
Sbjct: 140 DNQIVHRDIKGDNVLINTYSGVLKISDFGTSKRLAGINPCTETFTGTLQYMAPEIIDKGP 199
Query: 166 E-YFKGV---SL------------PHAENVVPLEI--KIGK-------PAATNIYLIDFL 200
Y K SL P E P K+G P + + F+
Sbjct: 200 RGYGKAADIWSLGCTIIEMATGKPPFYELGEPQAAMFKVGMFKVHPEIPESMSAEAKAFI 259
Query: 201 KRCLDKDPLRRWSCDQLLRHPY 222
+C + DP +R + LL +
Sbjct: 260 LKCFEPDPDKRACANDLLVDEF 281
|
| >4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A* Length = 299 | Back alignment and structure |
|---|
Score = 156 bits (396), Expect = 4e-46
Identities = 57/287 (19%), Positives = 95/287 (33%), Gaps = 59/287 (20%)
Query: 1 MERYEKIGKLGEGSYGVVFKCRNRDTGQVVAIKKFLESEEDPLIRKIALREIRLLKSLKH 60
+ +E I LG G +GVVF+ +N+ AIK+ + L R+ +RE++ L L+H
Sbjct: 4 LTDFEPIQCLGRGGFGVVFEAKNKVDDCNYAIKR-IRLPNRELAREKVMREVKALAKLEH 62
Query: 61 PNLVNLLEVF------------RRKKKLHLVFEFCDHTVLNEL---ENHPHGLPWDLIKQ 105
P +V + K L++ + C L + +
Sbjct: 63 PGIVRYFNAWLEKNTTEKLQPSSPKVYLYIQMQLCRKENLKDWMNGRCTIEERERSVCLH 122
Query: 106 ITWQVLRGVSYCHRHACIHRDIKPENILLTANGVVKLCDFG----------FARLIRDLI 155
I Q+ V + H +HRD+KP NI T + VVK+ DFG ++ +
Sbjct: 123 IFLQIAEAVEFLHSKGLMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTPMP 182
Query: 156 PRHLH-------------IFQTNEY-FK------GVSL------PHAENVVPLEIKI--- 186
H N Y K G+ L + +
Sbjct: 183 AYARHTGQVGTKLYMSPEQIHGNSYSHKVDIFSLGLILFELLYPFSTQMERVRTLTDVRN 242
Query: 187 GK-PAATNIY---LIDFLKRCLDKDPLRRWSCDQLLRHPYFNGYYFE 229
K P ++ L P+ R ++ + F F
Sbjct: 243 LKFPPLFTQKYPCEYVMVQDMLSPSPMERPEAINIIENAVFEDLDFP 289
|
| >1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A Length = 303 | Back alignment and structure |
|---|
Score = 156 bits (396), Expect = 5e-46
Identities = 49/166 (29%), Positives = 78/166 (46%), Gaps = 17/166 (10%)
Query: 2 ERYEKIGKLGEGSYGVVFKCRNRDTGQVVAIKKFLESEEDPLIRKIALREIRLLKSLKHP 61
+E+I LG+G++G V K RN + AIKK +EE L E+ LL SL H
Sbjct: 6 SDFEEIAVLGQGAFGQVVKARNALDSRYYAIKKIRHTEEK---LSTILSEVMLLASLNHQ 62
Query: 62 NLVNLLEVF-------------RRKKKLHLVFEFCD-HTVLNELENHPHGLPWDLIKQIT 107
+V + ++K L + E+C+ T+ + + + D ++
Sbjct: 63 YVVRYYAAWLERRNFVKPMTAVKKKSTLFIQMEYCENGTLYDLIHSENLNQQRDEYWRLF 122
Query: 108 WQVLRGVSYCHRHACIHRDIKPENILLTANGVVKLCDFGFARLIRD 153
Q+L +SY H IHRD+KP NI + + VK+ DFG A+ +
Sbjct: 123 RQILEALSYIHSQGIIHRDLKPMNIFIDESRNVKIGDFGLAKNVHR 168
|
| >1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A Length = 303 | Back alignment and structure |
|---|
Score = 41.5 bits (98), Expect = 2e-04
Identities = 6/32 (18%), Positives = 12/32 (37%)
Query: 196 LIDFLKRCLDKDPLRRWSCDQLLRHPYFNGYY 227
++ +D DP +R LL + +
Sbjct: 260 EKKIIRLLIDHDPNKRPGARTLLNSGWLPVKH 291
|
| >1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A* Length = 348 | Back alignment and structure |
|---|
Score = 156 bits (395), Expect = 1e-45
Identities = 52/148 (35%), Positives = 82/148 (55%), Gaps = 1/148 (0%)
Query: 2 ERYEKIGKLGEGSYGVVFKCRNRDTGQVVAIKKF-LESEEDPLIRKIALREIRLLKSLKH 60
+ + + ++G GS+G V+ R+ +VVAIKK ++ + ++E+R L+ L+H
Sbjct: 54 KLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRH 113
Query: 61 PNLVNLLEVFRRKKKLHLVFEFCDHTVLNELENHPHGLPWDLIKQITWQVLRGVSYCHRH 120
PN + + R+ LV E+C + + LE H L I +T L+G++Y H H
Sbjct: 114 PNTIQYRGCYLREHTAWLVMEYCLGSASDLLEVHKKPLQEVEIAAVTHGALQGLAYLHSH 173
Query: 121 ACIHRDIKPENILLTANGVVKLCDFGFA 148
IHRD+K NILL+ G+VKL DFG A
Sbjct: 174 NMIHRDVKAGNILLSEPGLVKLGDFGSA 201
|
| >1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A* Length = 348 | Back alignment and structure |
|---|
Score = 44.7 bits (106), Expect = 2e-05
Identities = 9/28 (32%), Positives = 15/28 (53%)
Query: 196 LIDFLKRCLDKDPLRRWSCDQLLRHPYF 223
+F+ CL K P R + + LL+H +
Sbjct: 282 FRNFVDSCLQKIPQDRPTSEVLLKHRFV 309
|
| >4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens} Length = 319 | Back alignment and structure |
|---|
Score = 154 bits (392), Expect = 2e-45
Identities = 69/312 (22%), Positives = 108/312 (34%), Gaps = 64/312 (20%)
Query: 2 ERYEKIGKLGEGSYGVVFKCRNRDTGQVVAIKKFLESEEDPLIRKIALREIRLLKSLKHP 61
+ LG+G+ VF+ R++ TG + AIK F + +RE +LK L H
Sbjct: 9 HLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQ-MREFEVLKKLNHK 67
Query: 62 NLVNLLEVF--RRKKKLHLVFEFCD----HTVLNELENHPHGLPWDLIKQITWQVLRGVS 115
N+V L + + L+ EFC +TVL E N +GLP + V+ G++
Sbjct: 68 NIVKLFAIEEETTTRHKVLIMEFCPCGSLYTVLEEPSN-AYGLPESEFLIVLRDVVGGMN 126
Query: 116 YCHRHACIHRDIKPENILLT----ANGVVKLCDFGFARLIRD-----------------L 154
+ + +HR+IKP NI+ V KL DFG AR + D +
Sbjct: 127 HLRENGIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARELEDDEQFVSLYGTEEYLHPDM 186
Query: 155 IPRHLHIFQTNEY-----------------------FKGVSLPHAENVVPLEIKIGKPAA 191
R + + F+ P V +I GKP+
Sbjct: 187 YERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPRRNKEVMYKIITGKPSG 246
Query: 192 TNIYLIDFLKRCLDKDPLRRWSCDQLLRHPYFNGYYFEVPDEMQYEEITQRCLDKDPLRR 251
+ +D WS D P + + + L+ D +
Sbjct: 247 AISGVQKAENGPID------WSGDM----PVSCSLSRGLQVLL--TPVLANILEADQEKC 294
Query: 252 WSCDQLLRHPYF 263
W DQ
Sbjct: 295 WGFDQFFAETSD 306
|
| >3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 3lau_A* 2wtv_A* ... Length = 279 | Back alignment and structure |
|---|
Score = 150 bits (382), Expect = 3e-44
Identities = 55/273 (20%), Positives = 108/273 (39%), Gaps = 33/273 (12%)
Query: 1 MERYEKIGKLGEGSYGVVFKCRNRDTGQVVAIKKFLESE--EDPLIRKIALREIRLLKSL 58
+E +E LG+G +G V+ R + + ++A+K +++ + + ++ RE+ + L
Sbjct: 8 LEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQL-RREVEIQSHL 66
Query: 59 KHPNLVNLLEVFRRKKKLHLVFEFCDHTVLNELENHPHGLPWDLIKQITWQVLRGVSYCH 118
+HPN++ L F +++L+ E+ + ++ +SYCH
Sbjct: 67 RHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCH 126
Query: 119 RHACIHRDIKPENILLTANGVVKLCDFGFARLIRDLIPRHL---------HIFQTNEYFK 169
IHRDIKPEN+LL + G +K+ DFG++ L + + + +
Sbjct: 127 SKRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRRTDLCGTLDYLPPEMIEGRMHDE 186
Query: 170 GV---------------SLP-HAENVVPLEIKIGK-----PAATNIYLIDFLKRCLDKDP 208
V P A +I + P D + R L +P
Sbjct: 187 KVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFTFPDFVTEGARDLISRLLKHNP 246
Query: 209 LRRWSCDQLLRHPYFNGYYFEVPDEMQYEEITQ 241
+R ++L HP+ + + E ++
Sbjct: 247 SQRPMLREVLEHPWITANSSKPSNCQNKESASK 279
|
| >2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens} Length = 305 | Back alignment and structure |
|---|
Score = 150 bits (381), Expect = 7e-44
Identities = 76/301 (25%), Positives = 120/301 (39%), Gaps = 52/301 (17%)
Query: 3 RYEKIGK-LGEGSYGVVFKCRNRDTGQVVAIK----KFLESEEDPLIRKIALREIRLLKS 57
+Y +G LGEGSYG V + + +T A+K K L + +EI+LL+
Sbjct: 6 KYL-MGDLLGEGSYGKVKEVLDSETLCRRAVKILKKKKLRRIPNGEAN--VKKEIQLLRR 62
Query: 58 LKHPNLVNLLEVFRR--KKKLHLVFEFCDHTVLNELENH-PHG-LPWDLIKQITWQVLRG 113
L+H N++ L++V K+K+++V E+C + E+ + P P Q++ G
Sbjct: 63 LRHKNVIQLVDVLYNEEKQKMYMVMEYCVC-GMQEMLDSVPEKRFPVCQAHGYFCQLIDG 121
Query: 114 VSYCHRHACIHRDIKPENILLTANGVVKLCDFGFARLIRDLIPRH-LH------------ 160
+ Y H +H+DIKP N+LLT G +K+ G A +
Sbjct: 122 LEYLHSQGIVHKDIKPGNLLLTTGGTLKISALGVAEALHPFAADDTCRTSQGSPAFQPPE 181
Query: 161 IFQTNEYFKGV-----------------SLP-HAENVVPLEIKIGK-----PAATNIYLI 197
I + F G P +N+ L IGK P L
Sbjct: 182 IANGLDTFSGFKVDIWSAGVTLYNITTGLYPFEGDNIYKLFENIGKGSYAIPGDCGPPLS 241
Query: 198 DFLKRCLDKDPLRRWSCDQLLRHPYFNGYYFEVPDEMQYEEITQRCLDKDPLRRWSCDQL 257
D LK L+ +P +R+S Q+ +H +F + P I KD R +
Sbjct: 242 DLLKGMLEYEPAKRFSIRQIRQHSWFRKKH---PPAEAPVPIPPSPDTKDRWRSMTVVPY 298
Query: 258 L 258
L
Sbjct: 299 L 299
|
| >3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens} Length = 278 | Back alignment and structure |
|---|
Score = 148 bits (377), Expect = 1e-43
Identities = 61/272 (22%), Positives = 113/272 (41%), Gaps = 44/272 (16%)
Query: 1 MERYEKIGKLGEGSYGVVFKCRNRDTGQVVAIK----KFLESEEDPLIRKIALREIRLLK 56
+E ++ LG+GS+ V++ + TG VAIK K + +++++ E+++
Sbjct: 10 IEDFKVGNLLGKGSFAGVYRAESIHTGLEVAIKMIDKKAMYKAG--MVQRV-QNEVKIHC 66
Query: 57 SLKHPNLVNLLEVFRRKKKLHLVFEFCDH-TVLNELENHPHGLPWDLIKQITWQVLRGVS 115
LKHP+++ L F ++LV E C + + L+N + + Q++ G+
Sbjct: 67 QLKHPSILELYNYFEDSNYVYLVLEMCHNGEMNRYLKNRVKPFSENEARHFMHQIITGML 126
Query: 116 YCHRHACIHRDIKPENILLTANGVVKLCDFGFARLIRDLIPRHLH-------------IF 162
Y H H +HRD+ N+LLT N +K+ DFG A ++ P H I
Sbjct: 127 YLHSHGILHRDLTLSNLLLTRNMNIKIADFGLATQLKM--PHEKHYTLCGTPNYISPEIA 184
Query: 163 QTNEY-FK------GV--------SLP-HAENVVPLEIKIGK-----PAATNIYLIDFLK 201
+ + + G P + V K+ P+ +I D +
Sbjct: 185 TRSAHGLESDVWSLGCMFYTLLIGRPPFDTDTVKNTLNKVVLADYEMPSFLSIEAKDLIH 244
Query: 202 RCLDKDPLRRWSCDQLLRHPYFNGYYFEVPDE 233
+ L ++P R S +L HP+ + +
Sbjct: 245 QLLRRNPADRLSLSSVLDHPFMSRNSSTKSKD 276
|
| >3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ... Length = 320 | Back alignment and structure |
|---|
Score = 149 bits (379), Expect = 2e-43
Identities = 63/268 (23%), Positives = 102/268 (38%), Gaps = 53/268 (19%)
Query: 3 RYEKIGKLGEGSYGVVFKCRNRDTGQVVAIK-----KFLESEEDPLIRKIALREIRLLKS 57
+Y+ LG G +G V+ VAIK + + E P ++ E+ LLK
Sbjct: 44 QYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVP-MEVVLLKK 102
Query: 58 LKH--PNLVNLLEVFRRKKKLHLVFEFCDHTVLNELENH--PHG-LPWDLIKQITWQVLR 112
+ ++ LL+ F R L+ E + +L + G L +L + WQVL
Sbjct: 103 VSSGFSGVIRLLDWFERPDSFVLILERPEPVQ--DLFDFITERGALQEELARSFFWQVLE 160
Query: 113 GVSYCHRHACIHRDIKPENILLTAN-GVVKLCDFGFARLIRDLIPRHLH----------- 160
V +CH +HRDIK ENIL+ N G +KL DFG L++D
Sbjct: 161 AVRHCHNCGVLHRDIKDENILIDLNRGELKLIDFGSGALLKD---TVYTDFDGTRVYSPP 217
Query: 161 -IFQTNEYFK--------GV--------SLP-HAENVVPLEIKIGK---PAATNIYLIDF 199
+ + Y G+ +P + EI G+ +
Sbjct: 218 EWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDE----EIIRGQVFFRQRVSSECQHL 273
Query: 200 LKRCLDKDPLRRWSCDQLLRHPYFNGYY 227
++ CL P R + +++ HP+
Sbjct: 274 IRWCLALRPSDRPTFEEIQNHPWMQDVL 301
|
| >3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A Length = 328 | Back alignment and structure |
|---|
Score = 149 bits (379), Expect = 2e-43
Identities = 73/285 (25%), Positives = 131/285 (45%), Gaps = 43/285 (15%)
Query: 3 RYEKIGKLGEGSYGVVFKCRNRDTGQVVAIKKFLESEEDPLIRKIALREIRLLKSLKHPN 62
Y + +G+G++ V R+ TG+ VAIK +++ +P + RE+R++K L HPN
Sbjct: 16 NYRLLKTIGKGNFAKVKLARHILTGREVAIKIIDKTQLNPTSLQKLFREVRIMKILNHPN 75
Query: 63 LVNLLEVFRRKKKLHLVFEFCDHTVLNELENH--PHG-LPWDLIKQITWQVLRGVSYCHR 119
+V L EV +K L+L+ E+ E+ ++ HG + + Q++ V YCH+
Sbjct: 76 IVKLFEVIETEKTLYLIMEYASG---GEVFDYLVAHGRMKEKEARSKFRQIVSAVQYCHQ 132
Query: 120 HACIHRDIKPENILLTANGVVKLCDFGFARLIRDLIPRHLH------------IFQTNEY 167
+HRD+K EN+LL A+ +K+ DFGF+ L +FQ +Y
Sbjct: 133 KRIVHRDLKAENLLLDADMNIKIADFGFSNEFTV--GGKLDAFCGAPPYAAPELFQGKKY 190
Query: 168 FK--------GV--------SLP-HAENVVPLEIKIGK-----PAATNIYLIDFLKRCLD 205
GV SLP +N+ L ++ + P + + LKR L
Sbjct: 191 DGPEVDVWSLGVILYTLVSGSLPFDGQNLKELRERVLRGKYRIPFYMSTDCENLLKRFLV 250
Query: 206 KDPLRRWSCDQLLRHPYFNGYYFEVPDEMQYEEITQRCLDKDPLR 250
+P++R + +Q+++ + N + E + + E D+ +
Sbjct: 251 LNPIKRGTLEQIMKDRWINAGH-EEDELKPFVEPELDISDQKRID 294
|
| >2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ... Length = 284 | Back alignment and structure |
|---|
Score = 148 bits (376), Expect = 3e-43
Identities = 55/267 (20%), Positives = 105/267 (39%), Gaps = 49/267 (18%)
Query: 1 MERYEKIGK-LGEGSYGVVFKCRNRDTGQVVAIK-----KFLESEEDPLIRKIALREIRL 54
++ ++ IG+ LG+G +G V+ R + ++A+K + + + +R REI +
Sbjct: 13 IDDFD-IGRPLGKGKFGNVYLAREKQNKFIMALKVLFKSQLEKEGVEHQLR----REIEI 67
Query: 55 LKSLKHPNLVNLLEVFRRKKKLHLVFEFCDHTVL-NELENHPHGLPWDLIKQITWQVLRG 113
L+HPN++ + F +K+++L+ EF L EL+ H ++
Sbjct: 68 QSHLRHPNILRMYNYFHDRKRIYLMLEFAPRGELYKELQKHGR-FDEQRSATFMEELADA 126
Query: 114 VSYCHRHACIHRDIKPENILLTANGVVKLCDFGFARLIRDLIPRHLH------------I 161
+ YCH IHRDIKPEN+L+ G +K+ DFG++ +
Sbjct: 127 LHYCHERKVIHRDIKPENLLMGYKGELKIADFGWSVHAPS---LRRRTMCGTLDYLPPEM 183
Query: 162 FQTNEYFKGV---------------SLP-HAENVVPLEIKIGK-----PAATNIYLIDFL 200
+ + + V P + + +I P + D +
Sbjct: 184 IEGKTHDEKVDLWCAGVLCYEFLVGMPPFDSPSHTETHRRIVNVDLKFPPFLSDGSKDLI 243
Query: 201 KRCLDKDPLRRWSCDQLLRHPYFNGYY 227
+ L P +R ++ HP+
Sbjct: 244 SKLLRYHPPQRLPLKGVMEHPWVKANS 270
|
| >3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B* Length = 389 | Back alignment and structure |
|---|
Score = 149 bits (377), Expect = 1e-42
Identities = 40/172 (23%), Positives = 71/172 (41%), Gaps = 5/172 (2%)
Query: 2 ERYEKIGKLGEGSYGVVFKCRNRDTGQVVAIKKF-LESEEDPLIRKIALREIRLLKSLKH 60
E IGK G V R + TG+ V +++ LE+ + ++ + E+ + K H
Sbjct: 28 ELLTVIGK-GFEDLMTVNLARYKPTGEYVTVRRINLEACSNEMVTFL-QGELHVSKLFNH 85
Query: 61 PNLVNLLEVFRRKKKLHLVFEFCDH-TVLNELENH-PHGLPWDLIKQITWQVLRGVSYCH 118
PN+V F +L +V F + + + + H G+ I I VL+ + Y H
Sbjct: 86 PNIVPYRATFIADNELWVVTSFMAYGSAKDLICTHFMDGMNELAIAYILQGVLKALDYIH 145
Query: 119 RHACIHRDIKPENILLTANGVVKLCDFGFARLIRDLIPRHLHIFQTNEYFKG 170
+HR +K +IL++ +G V L + R + +Y
Sbjct: 146 HMGYVHRSVKASHILISVDGKVYLSGLRSNLSMISHGQRQRVVHDFPKYSVK 197
|
| >3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B* Length = 389 | Back alignment and structure |
|---|
Score = 44.9 bits (106), Expect = 1e-05
Identities = 10/26 (38%), Positives = 16/26 (61%)
Query: 198 DFLKRCLDKDPLRRWSCDQLLRHPYF 223
F+++CL ++P R S LL H +F
Sbjct: 312 HFVEQCLQRNPDARPSASTLLNHSFF 337
|
| >3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens} Length = 337 | Back alignment and structure |
|---|
Score = 147 bits (374), Expect = 2e-42
Identities = 71/294 (24%), Positives = 114/294 (38%), Gaps = 54/294 (18%)
Query: 3 RYEKIGKLGEGSYGVVFKCRNRDTGQVVAIKKFLESEEDPLIRKIALREIRLLKSLK-HP 61
R L EG + V++ ++ +G+ A+K+ L +EE+ + ++E+ +K L HP
Sbjct: 29 RLRVRRVLAEGGFAFVYEAQDVGSGREYALKRLLSNEEEKN--RAIIQEVCFMKKLSGHP 86
Query: 62 NLVNLLEVFRRKKK--------LHLVFEFCDHTVLNELENHPHG--LPWDLIKQITWQVL 111
N+V K+ L+ E C ++ L+ L D + +I +Q
Sbjct: 87 NIVQFCSAASIGKEESDTGQAEFLLLTELCKGQLVEFLKKMESRGPLSCDTVLKIFYQTC 146
Query: 112 RGVSYCHRHAC--IHRDIKPENILLTANGVVKLCDFGFARLIRDLIPRHLHIFQTNEYFK 169
R V + HR IHRD+K EN+LL+ G +KLCDFG A I Y
Sbjct: 147 RAVQHMHRQKPPIIHRDLKVENLLLSNQGTIKLCDFGSATTISH-------------YPD 193
Query: 170 GVSLPHAENVVPLEI-KIGKPAATNIY----LIDFLKRCLDKDPLRRWSCDQLL------ 218
+V EI + P Y +ID + W+ +L
Sbjct: 194 YSWSAQRRALVEEEITRNTTPM----YRTPEIIDLYSNFPIGEKQDIWALGCILYLLCFR 249
Query: 219 RHPY--------FNGYYFEVPDEMQYEEITQ---RCLDKDPLRRWSCDQLLRHP 261
+HP+ NG Y P + QY L +P R S +++
Sbjct: 250 QHPFEDGAKLRIVNGKYSIPPHDTQYTVFHSLIRAMLQVNPEERLSIAEVVHQL 303
|
| >1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 3fpq_A Length = 290 | Back alignment and structure |
|---|
Score = 145 bits (369), Expect = 3e-42
Identities = 60/264 (22%), Positives = 102/264 (38%), Gaps = 46/264 (17%)
Query: 3 RYEKIGK-LGEGSYGVVFKCRNRDTGQVVAIKKFLESEEDPLIRKIALREIRLLKSLKHP 61
R+ K +G GS+ V+K + +T VA + + + R+ E +LK L+HP
Sbjct: 26 RFLKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHP 85
Query: 62 NLVNLLEVF----RRKKKLHLVFEFCDHTVLNELENHPHGLPWDLIKQITWQVLRGVSYC 117
N+V + + + KK + LV E L + +++ Q+L+G+ +
Sbjct: 86 NIVRFYDSWESTVKGKKCIVLVTELMTSGTLKTYLKRFKVMKIKVLRSWCRQILKGLQFL 145
Query: 118 HRH--ACIHRDIKPENILLTA-NGVVKLCDFGFARLIRDLIPRHLHIFQTNEYF---KGV 171
H IHRD+K +NI +T G VK+ D G A L R F +
Sbjct: 146 HTRTPPIIHRDLKCDNIFITGPTGSVKIGDLGLATLKRA---SFAKAVIGTPEFMAPEMY 202
Query: 172 SLPHAENV-------VPLEIKIGKP------AATNIYLI-------------------DF 199
+ E+V LE+ + A IY +
Sbjct: 203 EEKYDESVDVYAFGMCMLEMATSEYPYSECQNAAQIYRRVTSGVKPASFDKVAIPEVKEI 262
Query: 200 LKRCLDKDPLRRWSCDQLLRHPYF 223
++ C+ ++ R+S LL H +F
Sbjct: 263 IEGCIRQNKDERYSIKDLLNHAFF 286
|
| >4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens} Length = 396 | Back alignment and structure |
|---|
Score = 148 bits (375), Expect = 4e-42
Identities = 69/309 (22%), Positives = 108/309 (34%), Gaps = 64/309 (20%)
Query: 2 ERYEKIGKLGEGSYGVVFKCRNRDTGQVVAIKKFLESEEDPLIRKIALREIRLLKSLKHP 61
+ LG+G+ VF+ R++ TG + AIK F + +RE +LK L H
Sbjct: 9 HLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQ-MREFEVLKKLNHK 67
Query: 62 NLVNLLEVF--RRKKKLHLVFEFCD----HTVLNELENHPHGLPWDLIKQITWQVLRGVS 115
N+V L + + L+ EFC +TVL E N +GLP + V+ G++
Sbjct: 68 NIVKLFAIEEETTTRHKVLIMEFCPCGSLYTVLEEPSN-AYGLPESEFLIVLRDVVGGMN 126
Query: 116 YCHRHACIHRDIKPENILLT----ANGVVKLCDFGFARLIRD-----------------L 154
+ + +HR+IKP NI+ V KL DFG AR + D +
Sbjct: 127 HLRENGIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARELEDDEQFVSLYGTEEYLHPDM 186
Query: 155 IPRHLHIFQTNEY-----------------------FKGVSLPHAENVVPLEIKIGKPAA 191
R + + F+ P V +I GKP+
Sbjct: 187 YERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPRRNKEVMYKIITGKPSG 246
Query: 192 TNIYLIDFLKRCLDKDPLRRWSCDQLLRHPYFNGYYFEVPDEMQYEEITQRCLDKDPLRR 251
+ +D WS D P + + + L+ D +
Sbjct: 247 AISGVQKAENGPID------WSGDM----PVSCSLSRGLQVLL--TPVLANILEADQEKC 294
Query: 252 WSCDQLLRH 260
W DQ
Sbjct: 295 WGFDQFFAE 303
|
| >2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens} Length = 312 | Back alignment and structure |
|---|
Score = 145 bits (369), Expect = 4e-42
Identities = 64/274 (23%), Positives = 98/274 (35%), Gaps = 55/274 (20%)
Query: 3 RYEKIGKLGEGSYGVVFKCRNRDTGQVVAIK-----KFLESEEDPLIRKIALREIRLLKS 57
Y LG+G +G VF VAIK + L E+ LL
Sbjct: 32 EYRLGPLLGKGGFGTVFAGHRLTDRLQVAIKVIPRNRVLGWSPLSDSVTCP-LEVALLWK 90
Query: 58 L----KHPNLVNLLEVFRRKKKLHLVFEFCDHTVLNELENH--PHG-LPWDLIKQITWQV 110
+ HP ++ LL+ F ++ LV E +L ++ G L + QV
Sbjct: 91 VGAGGGHPGVIRLLDWFETQEGFMLVLERPLPAQ--DLFDYITEKGPLGEGPSRCFFGQV 148
Query: 111 LRGVSYCHRHACIHRDIKPENILL-TANGVVKLCDFGFARLIRDLIPRHLH--------- 160
+ + +CH +HRDIK ENIL+ G KL DFG L+ D
Sbjct: 149 VAAIQHCHSRGVVHRDIKDENILIDLRRGCAKLIDFGSGALLHD---EPYTDFDGTRVYS 205
Query: 161 ---IFQTNEYFK--------GV--------SLP-HAENVVPLEIKIGK---PAATNIYLI 197
++Y G+ +P + EI + PA +
Sbjct: 206 PPEWISRHQYHALPATVWSLGILLYDMVCGDIPFERDQ----EILEAELHFPAHVSPDCC 261
Query: 198 DFLKRCLDKDPLRRWSCDQLLRHPYFNGYYFEVP 231
++RCL P R S +++L P+ +VP
Sbjct: 262 ALIRRCLAPKPSSRPSLEEILLDPWMQTPAEDVP 295
|
| >2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A* Length = 335 | Back alignment and structure |
|---|
Score = 145 bits (368), Expect = 1e-41
Identities = 59/262 (22%), Positives = 94/262 (35%), Gaps = 43/262 (16%)
Query: 1 MERYEKIGKLGEGSYGVVFKCRNRDTGQVVAIK----KFLESEEDPLIRKIALREIRLLK 56
RY + LG+G + F+ + DT +V A K L K+ EI + +
Sbjct: 40 RRRYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPH--QREKM-SMEISIHR 96
Query: 57 SLKHPNLVNLLEVFRRKKKLHLVFEFCDHTVLNELENHPHGLPWDLIKQITWQVLRGVSY 116
SL H ++V F + +V E C L EL L + Q++ G Y
Sbjct: 97 SLAHQHVVGFHGFFEDNDFVFVVLELCRRRSLLELHKRRKALTEPEARYYLRQIVLGCQY 156
Query: 117 CHRHACIHRDIKPENILLTANGVVKLCDFGFARLIRDLIPRHLH-------------IFQ 163
HR+ IHRD+K N+ L + VK+ DFG A + +
Sbjct: 157 LHRNRVIHRDLKLGNLFLNEDLEVKIGDFGLATKVEY--DGERKKVLCGTPNYIAPEVLS 214
Query: 164 TNEY-FK------GV--------SLP-HAENVVPLEIKIGK-----PAATNIYLIDFLKR 202
+ F+ G P + ++I K P N +++
Sbjct: 215 KKGHSFEVDVWSIGCIMYTLLVGKPPFETSCLKETYLRIKKNEYSIPKHINPVAASLIQK 274
Query: 203 CLDKDPLRRWSCDQLLRHPYFN 224
L DP R + ++LL +F
Sbjct: 275 MLQTDPTARPTINELLNDEFFT 296
|
| >2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A* Length = 294 | Back alignment and structure |
|---|
Score = 144 bits (365), Expect = 1e-41
Identities = 60/266 (22%), Positives = 95/266 (35%), Gaps = 51/266 (19%)
Query: 1 MERYEKIGKLGEGSYGVVFKCRNRDTGQVVAIK----KFLESEEDPLIRKIALREIRLLK 56
RY + LG+G + F+ + DT +V A K L K+ EI + +
Sbjct: 14 RRRYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPH--QREKM-SMEISIHR 70
Query: 57 SLKHPNLVNLLEVFRRKKKLHLVFEFCDHTVLNELENHPHGLPWDLIKQITWQVLRGVSY 116
SL H ++V F + +V E C L EL L + Q++ G Y
Sbjct: 71 SLAHQHVVGFHGFFEDNDFVFVVLELCRRRSLLELHKRRKALTEPEARYYLRQIVLGCQY 130
Query: 117 CHRHACIHRDIKPENILLTANGVVKLCDFGFARLIRDLIPRHLH-------------IFQ 163
HR+ IHRD+K N+ L + VK+ DFG A + +
Sbjct: 131 LHRNRVIHRDLKLGNLFLNEDLEVKIGDFGLATKVEY--DGERKKVLCGTPNYIAPEVLS 188
Query: 164 TNEY-FK------GV--------SLP-HAENVVPLEIKIGKPAATNIYLI---------D 198
+ F+ G P + ++I K N Y I
Sbjct: 189 KKGHSFEVDVWSIGCIMYTLLVGKPPFETSCLKETYLRIKK----NEYSIPKHINPVAAS 244
Query: 199 FLKRCLDKDPLRRWSCDQLLRHPYFN 224
+++ L DP R + ++LL +F
Sbjct: 245 LIQKMLQTDPTARPTINELLNDEFFT 270
|
| >3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens} Length = 335 | Back alignment and structure |
|---|
Score = 145 bits (368), Expect = 1e-41
Identities = 64/311 (20%), Positives = 113/311 (36%), Gaps = 53/311 (17%)
Query: 1 MERYEKIGKLGEGSYGVVFKCRNRDTGQVVAIK-------KFLESEEDPLIRKIALREIR 53
++Y + LG G++G V+ +++ + V +K EDP + K+ EI
Sbjct: 23 SQKYSTMSPLGSGAFGFVWTAVDKEKNKEVVVKFIKKEKVLEDCWIEDPKLGKVT-LEIA 81
Query: 54 LLKSLKHPNLVNLLEVFRRKKKLHLVFEFCDHT--VLNELENHPHGLPWDLIKQITWQVL 111
+L ++H N++ +L++F + LV E + ++ HP L L I Q++
Sbjct: 82 ILSRVEHANIIKVLDIFENQGFFQLVMEKHGSGLDLFAFIDRHPR-LDEPLASYIFRQLV 140
Query: 112 RGVSYCHRHACIHRDIKPENILLTANGVVKLCDFGFARLIRDLIPRHLH----------- 160
V Y IHRDIK ENI++ + +KL DFG A + + +
Sbjct: 141 SAVGYLRLKDIIHRDIKDENIVIAEDFTIKLIDFGSAAYLER--GKLFYTFCGTIEYCAP 198
Query: 161 -IFQTNEYFK--------GV--------SLPHAENVVPLEIKIGK---PAATNIYLIDFL 200
+ N Y GV P E E P + L+ +
Sbjct: 199 EVLMGNPYRGPELEMWSLGVTLYTLVFEENPFCE---LEETVEAAIHPPYLVSKELMSLV 255
Query: 201 KRCLDKDPLRRWSCDQLLRHPYFNGYY----FEVPDEMQYEEITQRCLDKDPLR--RWSC 254
L P RR + ++L+ P+ + + + + L L S
Sbjct: 256 SGLLQPVPERRTTLEKLVTDPWVTQPVNLADYTWEEVFRVNKPESGVLSAASLEMGNRSL 315
Query: 255 DQLLRHPYFNG 265
+ + G
Sbjct: 316 SDVAQAQELCG 326
|
| >3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3mb7_A* 3mb6_A* 3owj_A* 3owk_A* ... Length = 330 | Back alignment and structure |
|---|
Score = 144 bits (365), Expect = 3e-41
Identities = 43/153 (28%), Positives = 80/153 (52%), Gaps = 12/153 (7%)
Query: 1 MERYEKIGKLGEGSYGVVFKCRNRDTGQVVAIKKFLESEEDPLIRKIALREIRLLKSLK- 59
+ Y+ + KLG G Y VF+ N + V +K P+ +K REI++L++L+
Sbjct: 35 QDDYQLVRKLGRGKYSEVFEAINITNNEKVVVKIL-----KPVKKKKIKREIKILENLRG 89
Query: 60 HPNLVNLLEVFR--RKKKLHLVFEFCDHTVLNELENHPHGLPWDLIKQITWQVLRGVSYC 117
PN++ L ++ + + LVFE ++T +L L I+ +++L+ + YC
Sbjct: 90 GPNIITLADIVKDPVSRTPALVFEHVNNTDFKQLYQT---LTDYDIRFYMYEILKALDYC 146
Query: 118 HRHACIHRDIKPENILL-TANGVVKLCDFGFAR 149
H +HRD+KP N+++ + ++L D+G A
Sbjct: 147 HSMGIMHRDVKPHNVMIDHEHRKLRLIDWGLAE 179
|
| >3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A* Length = 323 | Back alignment and structure |
|---|
Score = 143 bits (364), Expect = 4e-41
Identities = 65/292 (22%), Positives = 106/292 (36%), Gaps = 54/292 (18%)
Query: 1 MERYEKIGKLGEGSYGVVFKCRNRDTGQVVAIKKFLESEEDPLIRKIALREIRLLKSLKH 60
+E ++ + LGEG+YG V NR T + VA+K I +EI + K L H
Sbjct: 6 VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIK-KEICINKMLNH 64
Query: 61 PNLVNLLEVFRRKKKLHLVFEFCDHTVLNELENH--PHG-LPWDLIKQITWQVLRGVSYC 117
N+V R +L E+C EL + P +P ++ Q++ GV Y
Sbjct: 65 ENVVKFYGHRREGNIQYLFLEYCSG---GELFDRIEPDIGMPEPDAQRFFHQLMAGVVYL 121
Query: 118 HRHACIHRDIKPENILLTANGVVKLCDFGFARLIRDLIPRH-LH------------IFQT 164
H HRDIKPEN+LL +K+ DFG A + R L+ + +
Sbjct: 122 HGIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKR 181
Query: 165 NEYFK--------GV--------SLP--HAENVVPLEIKIGKPAATNIYLI--------- 197
E+ G+ LP + + YL
Sbjct: 182 REFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKE---KKTYLNPWKKIDSAP 238
Query: 198 -DFLKRCLDKDPLRRWSCDQLLRHPYFNGYYFEVPDEMQYEEITQRCLDKDP 248
L + L ++P R + + + ++N + +T + + P
Sbjct: 239 LALLHKILVENPSARITIPDIKKDRWYNKPL---KKGAKRPRVTSGGVSESP 287
|
| >3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* Length = 360 | Back alignment and structure |
|---|
Score = 144 bits (365), Expect = 4e-41
Identities = 48/149 (32%), Positives = 85/149 (57%), Gaps = 2/149 (1%)
Query: 1 MERYEKIGKLGEGSYGVVFKCRNRDTGQVVAIKKFLESEEDPLIRKIALREIRLLKSLKH 60
+ +EKI +LG G+ GVVFK ++ +G V+A K + E P IR +RE+++L
Sbjct: 32 DDDFEKISELGAGNGGVVFKVSHKPSGLVMARKL-IHLEIKPAIRNQIIRELQVLHECNS 90
Query: 61 PNLVNLLEVFRRKKKLHLVFEFCDHTVLNELENHPHGLPWDLIKQITWQVLRGVSYCH-R 119
P +V F ++ + E D L+++ +P ++ +++ V++G++Y +
Sbjct: 91 PYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGRIPEQILGKVSIAVIKGLTYLREK 150
Query: 120 HACIHRDIKPENILLTANGVVKLCDFGFA 148
H +HRD+KP NIL+ + G +KLCDFG +
Sbjct: 151 HKIMHRDVKPSNILVNSRGEIKLCDFGVS 179
|
| >3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* Length = 360 | Back alignment and structure |
|---|
Score = 41.8 bits (98), Expect = 1e-04
Identities = 10/31 (32%), Positives = 15/31 (48%)
Query: 196 LIDFLKRCLDKDPLRRWSCDQLLRHPYFNGY 226
DF+ +CL K+P R QL+ H +
Sbjct: 301 FQDFVNKCLIKNPAERADLKQLMVHAFIKRS 331
|
| >3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II} Length = 383 | Back alignment and structure |
|---|
Score = 144 bits (366), Expect = 5e-41
Identities = 47/191 (24%), Positives = 81/191 (42%), Gaps = 48/191 (25%)
Query: 1 MERYEKIGKLGEGSYGVVFKCRNRDTGQVVAIKKFLESEEDPLIRKIALREIRLLKSLKH 60
++Y LG GS+G+V + + ++G+ A+KK L+ + RE+ ++K L H
Sbjct: 6 SKKYSLGKTLGTGSFGIVCEVFDIESGKRFALKKVLQ------DPRYKNRELDIMKVLDH 59
Query: 61 PNLVNLLEVFRRKKK--------------------------------------LHLVFEF 82
N++ L++ F L+++ E+
Sbjct: 60 VNIIKLVDYFYTTGDEEPKPPQPPDDHNKLGGKNNGVNNHHKSVIVNPSQNKYLNVIMEY 119
Query: 83 CD---HTVLNELENHPHGLPWDLIKQITWQVLRGVSYCHRHACIHRDIKPENILLTAN-G 138
H VL +P +LI +Q+ R V + H HRDIKP+N+L+ +
Sbjct: 120 VPDTLHKVLKSFIRSGRSIPMNLISIYIYQLFRAVGFIHSLGICHRDIKPQNLLVNSKDN 179
Query: 139 VVKLCDFGFAR 149
+KLCDFG A+
Sbjct: 180 TLKLCDFGSAK 190
|
| >3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II} Length = 383 | Back alignment and structure |
|---|
Score = 41.6 bits (98), Expect = 1e-04
Identities = 11/39 (28%), Positives = 19/39 (48%)
Query: 189 PAATNIYLIDFLKRCLDKDPLRRWSCDQLLRHPYFNGYY 227
P T ID L++ L +P R + + + HP+F+
Sbjct: 291 PEGTPSLAIDLLEQILRYEPDLRINPYEAMAHPFFDHLR 329
|
| >2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 143 bits (362), Expect = 7e-41
Identities = 58/162 (35%), Positives = 88/162 (54%), Gaps = 14/162 (8%)
Query: 2 ERYEKIGKLGEGSYGVVFKCRNRDTGQVVAIKKF-LESEEDPLIRKIALREIRLLKSL-K 59
+E + +G G+YG V+K R+ TGQ+ AIK + +E+ I++ EI +LK
Sbjct: 24 GIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTGDEEEEIKQ----EINMLKKYSH 79
Query: 60 HPNLVNLLEVFRRKK------KLHLVFEFCDH-TVLNELENHPHG-LPWDLIKQITWQVL 111
H N+ F +K +L LV EFC +V + ++N L + I I ++L
Sbjct: 80 HRNIATYYGAFIKKNPPGMDDQLWLVMEFCGAGSVTDLIKNTKGNTLKEEWIAYICREIL 139
Query: 112 RGVSYCHRHACIHRDIKPENILLTANGVVKLCDFGFARLIRD 153
RG+S+ H+H IHRDIK +N+LLT N VKL DFG + +
Sbjct: 140 RGLSHLHQHKVIHRDIKGQNVLLTENAEVKLVDFGVSAQLDR 181
|
| >2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 43.5 bits (103), Expect = 3e-05
Identities = 9/26 (34%), Positives = 17/26 (65%)
Query: 196 LIDFLKRCLDKDPLRRWSCDQLLRHP 221
F++ CL K+ +R + +QL++HP
Sbjct: 263 FQSFIESCLVKNHSQRPATEQLMKHP 288
|
| >2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ... Length = 276 | Back alignment and structure |
|---|
Score = 141 bits (358), Expect = 1e-40
Identities = 63/265 (23%), Positives = 101/265 (38%), Gaps = 45/265 (16%)
Query: 1 MERYEKIGKLGEGSYGVVFKCRNRDTGQVVAIKKFLESEEDPLIRKIALREIRLLKSLKH 60
+E ++ + LGEG+YG V NR T + VA+K I +EI + K L H
Sbjct: 6 VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIK-KEICINKMLNH 64
Query: 61 PNLVNLLEVFRRKKKLHLVFEFCDHTVLNELENH--PHG-LPWDLIKQITWQVLRGVSYC 117
N+V R +L E+C EL + P +P ++ Q++ GV Y
Sbjct: 65 ENVVKFYGHRREGNIQYLFLEYCSG---GELFDRIEPDIGMPEPDAQRFFHQLMAGVVYL 121
Query: 118 HRHACIHRDIKPENILLTANGVVKLCDFGFARLIRDLIP-RHLH------------IFQT 164
H HRDIKPEN+LL +K+ DFG A + R R L+ + +
Sbjct: 122 HGIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKR 181
Query: 165 NEYFK--------GV--------SLP--HAENVVPLEIKIGK-----PAATNI--YLIDF 199
E+ G+ LP + + I +
Sbjct: 182 REFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKKTYLNPWKKIDSAPLAL 241
Query: 200 LKRCLDKDPLRRWSCDQLLRHPYFN 224
L + L ++P R + + + ++N
Sbjct: 242 LHKILVENPSARITIPDIKKDRWYN 266
|
| >3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A* Length = 371 | Back alignment and structure |
|---|
Score = 144 bits (363), Expect = 1e-40
Identities = 36/306 (11%), Positives = 79/306 (25%), Gaps = 73/306 (23%)
Query: 3 RYEKIGKLGEGSYGVVFKCRNRDTGQVVAIKKF-LESEEDPLIRKIALREIRLLKSLKHP 61
+ + + L G VVF R+ + + A+K F + +E + L
Sbjct: 63 KLKLVEPLRVGDRSVVFLVRDVERLEDFALKVFTMGAENSRSELERLHEATFAAARLLGE 122
Query: 62 NLVNLLEVFR--------------------------RKKKLHLVFEFCD------HTVLN 89
+ + R L+ + L+
Sbjct: 123 SPEEARDRRRLLLPSDAVAVQSQPPFAQLSPGQDDYAVANYLLLMPAASVDLELLFSTLD 182
Query: 90 ELENHPHGLPWDLIKQITWQVLRGVSYCHRHACIHRDIKPENILLTANGVVKLCDFGFAR 149
+ + +T Q++R + +H P+N+ + +G + L D
Sbjct: 183 FVYVFRGDEGILALHILTAQLIRLAANLQSKGLVHGHFTPDNLFIMPDGRLMLGDVSALW 242
Query: 150 LI----------RDLIPRHLHIFQTNEY----------------------FKGVSLPHAE 177
+ PR T + F V+
Sbjct: 243 KVGTRGPASSVPVTYAPREFLNASTATFTHALNAWQLGLSIYRVWCLFLPFGLVTPGIKG 302
Query: 178 NVVPLEIKIGKPAATNI--------YLIDFLKRCLDKDPLRRWSCDQLLRHPYFNGYYFE 229
+ +++ + ++ + R L+ D RR + + P F E
Sbjct: 303 SWKRPSLRVPGTDSLAFGSCTPLPDFVKTLIGRFLNFDRRRRLLPLEAMETPEFLQLQNE 362
Query: 230 VPDEMQ 235
+ +
Sbjct: 363 ISSSLS 368
|
| >2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ... Length = 371 | Back alignment and structure |
|---|
Score = 142 bits (360), Expect = 4e-40
Identities = 73/311 (23%), Positives = 126/311 (40%), Gaps = 52/311 (16%)
Query: 1 MERYEKIGKLGEGSYGVVFKCRNRDTGQVVAIKKFLESEEDPLIRKIALREIRLLKSLKH 60
++RY+ + +G G+ G+V + + VAIKK ++ K A RE+ L+K + H
Sbjct: 24 LKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNH 83
Query: 61 PNLVNLLEVFRRKKKLH------LVFEFCD---HTVLNELENHPHGLPWDLIKQITWQVL 111
N++ LL VF +K L +V E D V+ +H + + +Q+L
Sbjct: 84 KNIIGLLNVFTPQKSLEEFQDVYIVMELMDANLCQVIQMELDHER------MSYLLYQML 137
Query: 112 RGVSYCHRHACIHRDIKPENILLTANGVVKLCDFGFARLIRDLIP----------RHLHI 161
G+ + H IHRD+KP NI++ ++ +K+ DFG AR R +
Sbjct: 138 CGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMTPYVVTRYYRAPEV 197
Query: 162 FQTNEY----------------------FKGVSLPHAENVVPLEIKIGKPAATNIYLI-D 198
Y F G N V +E +G P + +
Sbjct: 198 ILGMGYKENVDIWSVGCIMGEMIKGGVLFPGTDHIDQWNKV-IEQ-LGTPCPEFMKKLQP 255
Query: 199 FLKRCLDKDPLR-RWSCDQLLRHPYFNGYYFEVPDE-MQYEEITQRCLDKDPLRRWSCDQ 256
++ ++ P +S ++L F + Q ++ + L D +R S D+
Sbjct: 256 TVRTYVENRPKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKRISVDE 315
Query: 257 LLRHPYFNGYY 267
L+HPY N +Y
Sbjct: 316 ALQHPYINVWY 326
|
| >2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A* Length = 276 | Back alignment and structure |
|---|
Score = 139 bits (353), Expect = 4e-40
Identities = 72/269 (26%), Positives = 111/269 (41%), Gaps = 51/269 (18%)
Query: 1 MERYEKIGKLGEGSYGVVFKCRNRDTGQVVAIK-----KFLESEEDPLIRKIALREIRLL 55
+ Y LG G++G V ++ TG VA+K K + I+ REI+ L
Sbjct: 10 IGHYVLGDTLGVGTFGKVKIGEHQLTGHKVAVKILNRQKIRSLDVVGKIK----REIQNL 65
Query: 56 KSLKHPNLVNLLEVFRRKKKLHLVFEFCDHTVLNELENH--PHG-LPWDLIKQITWQVLR 112
K +HP+++ L +V +V E+ EL ++ HG + +++ Q+L
Sbjct: 66 KLFRHPHIIKLYQVISTPTDFFMVMEYVSG---GELFDYICKHGRVEEMEARRLFQQILS 122
Query: 113 GVSYCHRHACIHRDIKPENILLTANGVVKLCDFGFARLIRDLIPRHLH------------ 160
V YCHRH +HRD+KPEN+LL A+ K+ DFG + ++ D L
Sbjct: 123 AVDYCHRHMVVHRDLKPENVLLDAHMNAKIADFGLSNMMSD--GEFLRTSCGSPNYAAPE 180
Query: 161 IFQTNEYFK--------GV--------SLP-HAENVVPLEIKIGK-----PAATNIYLID 198
+ Y GV +LP E+V L KI P N +
Sbjct: 181 VISGRLYAGPEVDIWSCGVILYALLCGTLPFDDEHVPTLFKKIRGGVFYIPEYLNRSVAT 240
Query: 199 FLKRCLDKDPLRRWSCDQLLRHPYFNGYY 227
L L DPL+R + + H +F
Sbjct: 241 LLMHMLQVDPLKRATIKDIREHEWFKQDL 269
|
| >2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens} Length = 318 | Back alignment and structure |
|---|
Score = 140 bits (355), Expect = 6e-40
Identities = 44/150 (29%), Positives = 75/150 (50%), Gaps = 3/150 (2%)
Query: 1 MERYEKIGKLGEGSYGVVFKCRNRDTGQVVAIKKFLESEEDPLIRKIALREIR-LLKSLK 59
+ E +G++G G+ G V+K R R TG V+A+K+ + + K L ++ +LKS
Sbjct: 24 INDLENLGEMGSGTCGQVWKMRFRKTGHVIAVKQ-MRRSGNKEENKRILMDLDVVLKSHD 82
Query: 60 HPNLVNLLEVFRRKKKLHLVFEFCDHTVLNELENHPHGLPWDLIKQITWQVLRGVSYCH- 118
P +V F + + E + +P ++ ++T +++ + Y
Sbjct: 83 CPYIVQCFGTFITNTDVFIAMELMGTCAEKLKKRMQGPIPERILGKMTVAIVKALYYLKE 142
Query: 119 RHACIHRDIKPENILLTANGVVKLCDFGFA 148
+H IHRD+KP NILL G +KLCDFG +
Sbjct: 143 KHGVIHRDVKPSNILLDERGQIKLCDFGIS 172
|
| >2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens} Length = 318 | Back alignment and structure |
|---|
Score = 45.1 bits (107), Expect = 1e-05
Identities = 11/31 (35%), Positives = 16/31 (51%)
Query: 196 LIDFLKRCLDKDPLRRWSCDQLLRHPYFNGY 226
F+K CL KD +R ++LL H + Y
Sbjct: 260 FQSFVKDCLTKDHRKRPKYNKLLEHSFIKRY 290
|
| >2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens} Length = 298 | Back alignment and structure |
|---|
Score = 140 bits (354), Expect = 6e-40
Identities = 69/287 (24%), Positives = 111/287 (38%), Gaps = 68/287 (23%)
Query: 3 RYEKIGKLGEGSYGVVFKCRNRDTGQVVAIK-------------------------KFLE 37
+Y ++G+GSYGVV N + A+K
Sbjct: 14 QYTLKDEIGKGSYGVVKLAYNENDNTYYAMKVLSKKKLIRQAGFPRRPPPRGTRPAPGGC 73
Query: 38 SEEDPLIRKIALREIRLLKSLKHPNLVNLLEVFRR--KKKLHLVFEFCDHTVLNELENHP 95
+ I ++ +EI +LK L HPN+V L+EV + L++VFE + + E+
Sbjct: 74 IQPRGPIEQVY-QEIAILKKLDHPNVVKLVEVLDDPNEDHLYMVFELVNQGPVMEVPTLK 132
Query: 96 HGLPWDLIKQITWQVLRGVSYCHRHACIHRDIKPENILLTANGVVKLCDFGFARLIRDLI 155
L D + +++G+ Y H IHRDIKP N+L+ +G +K+ DFG + +
Sbjct: 133 -PLSEDQARFYFQDLIKGIEYLHYQKIIHRDIKPSNLLVGEDGHIKIADFGVSNEFKG-S 190
Query: 156 PRHLH-------------IFQTNEYFKGV-----------------SLP-HAENVVPLEI 184
L + +T + F G P E ++ L
Sbjct: 191 DALLSNTVGTPAFMAPESLSETRKIFSGKALDVWAMGVTLYCFVFGQCPFMDERIMCLHS 250
Query: 185 KIGK-----PAATNI--YLIDFLKRCLDKDPLRRWSCDQLLRHPYFN 224
KI P +I L D + R LDK+P R ++ HP+
Sbjct: 251 KIKSQALEFPDQPDIAEDLKDLITRMLDKNPESRIVVPEIKLHPWVT 297
|
| >3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens} Length = 310 | Back alignment and structure |
|---|
Score = 140 bits (354), Expect = 7e-40
Identities = 42/146 (28%), Positives = 81/146 (55%), Gaps = 3/146 (2%)
Query: 9 KLGEGSYGVVFKCRNRDTGQVVAIKKFLESEEDPLIRKIALREIRLLKSLKHPNLVNLLE 68
LG+G +G K +R+TG+V+ +K+ + +E+ ++ L+E+++++ L+HPN++ +
Sbjct: 17 VLGKGCFGQAIKVTHRETGEVMVMKELIRFDEE--TQRTFLKEVKVMRCLEHPNVLKFIG 74
Query: 69 VFRRKKKLHLVFEFCDH-TVLNELENHPHGLPWDLIKQITWQVLRGVSYCHRHACIHRDI 127
V + K+L+ + E+ T+ +++ PW + G++Y H IHRD+
Sbjct: 75 VLYKDKRLNFITEYIKGGTLRGIIKSMDSQYPWSQRVSFAKDIASGMAYLHSMNIIHRDL 134
Query: 128 KPENILLTANGVVKLCDFGFARLIRD 153
N L+ N V + DFG ARL+ D
Sbjct: 135 NSHNCLVRENKNVVVADFGLARLMVD 160
|
| >3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A* Length = 432 | Back alignment and structure |
|---|
Score = 142 bits (360), Expect = 9e-40
Identities = 56/155 (36%), Positives = 82/155 (52%), Gaps = 6/155 (3%)
Query: 2 ERYEKIGKLGEGSYGVVFKCRNRDTGQVVAIKKFLESEEDPLIRKIALREIRLLKSLKHP 61
+ Y +G GSYG V+ +++T + VAIKK ED + K LREI +L LK
Sbjct: 26 DNYIIKHLIGRGSYGYVYLAYDKNTEKNVAIKKVNRMFEDLIDCKRILREITILNRLKSD 85
Query: 62 NLVNLLEVFRRK-----KKLHLVFEFCDHTVLNELENHPHGLPWDLIKQITWQVLRGVSY 116
++ L ++ +L++V E D + L +L P L + IK I + +L G ++
Sbjct: 86 YIIRLYDLIIPDDLLKFDELYIVLEIAD-SDLKKLFKTPIFLTEEHIKTILYNLLLGENF 144
Query: 117 CHRHACIHRDIKPENILLTANGVVKLCDFGFARLI 151
H IHRD+KP N LL + VK+CDFG AR I
Sbjct: 145 IHESGIIHRDLKPANCLLNQDCSVKVCDFGLARTI 179
|
| >3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A* Length = 432 | Back alignment and structure |
|---|
Score = 44.0 bits (104), Expect = 3e-05
Identities = 14/62 (22%), Positives = 24/62 (38%), Gaps = 9/62 (14%)
Query: 197 IDFLKRCLDKDPLRRWSCDQLLRHPYFNGYY-------FEVPDEMQYEEITQRCLDKDPL 249
I+ L+ L +P +R + DQ L HPY + +++ L + L
Sbjct: 339 INLLESMLKFNPNKRITIDQALDHPYLKDVRKKKLENFSTKKIILPFDDWMV--LSETQL 396
Query: 250 RR 251
R
Sbjct: 397 RY 398
|
| >3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe} Length = 336 | Back alignment and structure |
|---|
Score = 140 bits (355), Expect = 1e-39
Identities = 74/296 (25%), Positives = 122/296 (41%), Gaps = 64/296 (21%)
Query: 3 RYEKIGK-LGEGSYGVVFKCRNRDTGQVVAIK-----KFLESEEDPLIRKIALREIRLLK 56
Y I + LGEGS+G V + T Q VA+K +S+ + REI LK
Sbjct: 10 PYI-IRETLGEGSFGKVKLATHYKTQQKVALKFISRQLLKKSDMHMRVE----REISYLK 64
Query: 57 SLKHPNLVNLLEVFRRKKKLHLVFEFC-----DHTVLNELENHPHG-LPWDLIKQITWQV 110
L+HP+++ L +V + +V E+ D+ V + D ++ Q+
Sbjct: 65 LLRHPHIIKLYDVITTPTDIVMVIEYAGGELFDYIV-------EKKRMTEDEGRRFFQQI 117
Query: 111 LRGVSYCHRHACIHRDIKPENILLTANGVVKLCDFGFARLIRDLIPRHLH---------- 160
+ + YCHRH +HRD+KPEN+LL N VK+ DFG + ++ D L
Sbjct: 118 ICAIEYCHRHKIVHRDLKPENLLLDDNLNVKIADFGLSNIMTD--GNFLKTSCGSPNYAA 175
Query: 161 --IFQTNEYFK--------GV--------SLP-HAENVVPLEIKIGK-----PAATNIYL 196
+ Y G+ LP E + L K+ P +
Sbjct: 176 PEVINGKLYAGPEVDVWSCGIVLYVMLVGRLPFDDEFIPNLFKKVNSCVYVMPDFLSPGA 235
Query: 197 IDFLKRCLDKDPLRRWSCDQLLRHPYFNGYYFEVPDEMQ-YEEITQRCLDKDPLRR 251
++R + DP++R + ++ R P+FN PD ++ EE+ D + +
Sbjct: 236 QSLIRRMIVADPMQRITIQEIRRDPWFNVNL---PDYLRPMEEVQGSYADSRIVSK 288
|
| >3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A* Length = 327 | Back alignment and structure |
|---|
Score = 140 bits (354), Expect = 1e-39
Identities = 42/154 (27%), Positives = 77/154 (50%), Gaps = 7/154 (4%)
Query: 1 MERYEKIGKLGEGSYGVVFKCRNRDTGQVVAIKKFLESEEDPLIRKIALREIR-LLKSLK 59
E + +G++G G+YG V K ++ +GQ++A+K+ + S D +K L ++ +++S
Sbjct: 21 AEDLKDLGEIGRGAYGSVNKMVHKPSGQIMAVKR-IRSTVDEKEQKQLLMDLDVVMRSSD 79
Query: 60 HPNLVNLLEVFRRKKKLHLVFEFCD----HTVLNELENHPHGLPWDLIKQITWQVLRGVS 115
P +V R+ + E +P +++ +IT ++ ++
Sbjct: 80 CPYIVQFYGALFREGDCWICMELMSTSFDKFYKYVYSVLDDVIPEEILGKITLATVKALN 139
Query: 116 YCHR-HACIHRDIKPENILLTANGVVKLCDFGFA 148
+ IHRDIKP NILL +G +KLCDFG +
Sbjct: 140 HLKENLKIIHRDIKPSNILLDRSGNIKLCDFGIS 173
|
| >3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A* Length = 327 | Back alignment and structure |
|---|
Score = 45.4 bits (108), Expect = 1e-05
Identities = 12/31 (38%), Positives = 18/31 (58%)
Query: 196 LIDFLKRCLDKDPLRRWSCDQLLRHPYFNGY 226
I+F+ CL KD +R +LL+HP+ Y
Sbjct: 262 FINFVNLCLTKDESKRPKYKELLKHPFILMY 292
|
| >3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A* Length = 676 | Back alignment and structure |
|---|
Score = 145 bits (367), Expect = 1e-39
Identities = 66/307 (21%), Positives = 111/307 (36%), Gaps = 64/307 (20%)
Query: 3 RYEKIGKLGEGSYGVVFKCRNRDTGQVVAIKKFLESEEDPLIRKIALREIRLLKSLKHPN 62
+E +LG G +G V + ++DTG+ VAIK+ + + EI+++K L HPN
Sbjct: 15 PWEMKERLGTGGFGYVLRWIHQDTGEQVAIKQCRQELSPKNRERW-CLEIQIMKKLNHPN 73
Query: 63 LVNLLEVFRRKKKLH------LVFEFCD----HTVLNELENHPHGLPWDLIKQITWQVLR 112
+V+ EV +KL L E+C+ LN+ EN GL I+ + +
Sbjct: 74 VVSAREVPDGLQKLAPNDLPLLAMEYCEGGDLRKYLNQFEN-CCGLKEGPIRTLLSDISS 132
Query: 113 GVSYCHRHACIHRDIKPENILLTANG---VVKLCDFGFARLIRDLI--------PRHLH- 160
+ Y H + IHRD+KPENI+L + K+ D G+A+ + ++L
Sbjct: 133 ALRYLHENRIIHRDLKPENIVLQPGPQRLIHKIIDLGYAKELDQGELCTEFVGTLQYLAP 192
Query: 161 -IFQTNEYFK-------GV--------SLP--HAENVVPLEIKIGKPAATNIYLIDFLKR 202
+ + +Y G P V K+ + + +I + D L
Sbjct: 193 ELLEQKKYTVTVDYWSFGTLAFECITGFRPFLPNWQPVQWHGKVREKSNEHIVVYDDLTG 252
Query: 203 CLD-----KDPLRRWSCDQLLRHPYFNGYYFEVPDEMQYEEITQRCLDKDPLRRWSCDQL 257
+ P + Q L +R + Q
Sbjct: 253 AVKFSSVLPTPNHLSGILAGKLERWL-----------------QCMLMWHQRQRGTDPQN 295
Query: 258 LRHPYFN 264
F
Sbjct: 296 PNVGCFQ 302
|
| >3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ... Length = 283 | Back alignment and structure |
|---|
Score = 138 bits (349), Expect = 2e-39
Identities = 54/170 (31%), Positives = 79/170 (46%), Gaps = 28/170 (16%)
Query: 2 ERYEKIGKLGEGSYGVVFKCRNRDTGQVVAIK----KFLESEEDPLIRKIALREIRLLKS 57
+ YE +LG G + +V KCR + TG+ A K + L S + R+ RE+ +L+
Sbjct: 5 DHYEMGEELGSGQFAIVRKCRQKGTGKEYAAKFIKKRRLSSSRRGVSREEIEREVNILRE 64
Query: 58 LKHPNLVNLLEVFRRKKKLHLVFEFC----------DHTVLNELENHPHGLPWDLIKQIT 107
++HPN++ L ++F K + L+ E + L E E +KQI
Sbjct: 65 IRHPNIITLHDIFENKTDVVLILELVSGGELFDFLAEKESLTEDEAT------QFLKQI- 117
Query: 108 WQVLRGVSYCHRHACIHRDIKPENILLT----ANGVVKLCDFGFARLIRD 153
L GV Y H H D+KPENI+L N +KL DFG A I
Sbjct: 118 ---LDGVHYLHSKRIAHFDLKPENIMLLDKNVPNPRIKLIDFGIAHKIEA 164
|
| >2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus} Length = 476 | Back alignment and structure |
|---|
Score = 142 bits (359), Expect = 3e-39
Identities = 78/292 (26%), Positives = 120/292 (41%), Gaps = 55/292 (18%)
Query: 1 MERYEKIGKLGEGSYGVVFKCRNRDTGQVVAIK-----KFLESEEDPLIRKIALREIRLL 55
+ Y LG G++G V ++ TG VA+K K + IR REI+ L
Sbjct: 15 IGHYILGDTLGVGTFGKVKVGKHELTGHKVAVKILNRQKIRSLDVVGKIR----REIQNL 70
Query: 56 KSLKHPNLVNLLEVFRRKKKLHLVFEFCDHTVLNELENH--PHG-LPWDLIKQITWQVLR 112
K +HP+++ L +V + +V E+ EL ++ +G L +++ Q+L
Sbjct: 71 KLFRHPHIIKLYQVISTPSDIFMVMEYVSG---GELFDYICKNGRLDEKESRRLFQQILS 127
Query: 113 GVSYCHRHACIHRDIKPENILLTANGVVKLCDFGFARLIRDLIPRHLH------------ 160
GV YCHRH +HRD+KPEN+LL A+ K+ DFG + ++ D L
Sbjct: 128 GVDYCHRHMVVHRDLKPENVLLDAHMNAKIADFGLSNMMSD--GEFLRTSCGSPNYAAPE 185
Query: 161 IFQTNEYFK--------GV--------SLP-HAENVVPLEIKIGK-----PAATNIYLID 198
+ Y GV +LP ++V L KI P N +I
Sbjct: 186 VISGRLYAGPEVDIWSSGVILYALLCGTLPFDDDHVPTLFKKICDGIFYTPQYLNPSVIS 245
Query: 199 FLKRCLDKDPLRRWSCDQLLRHPYFN----GYYFEVPDEMQYEEITQRCLDK 246
LK L DP++R + + H +F Y F I L +
Sbjct: 246 LLKHMLQVDPMKRATIKDIREHEWFKQDLPKYLFPEDPSYSSTMIDDEALKE 297
|
| >3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens} Length = 432 | Back alignment and structure |
|---|
Score = 141 bits (356), Expect = 5e-39
Identities = 48/270 (17%), Positives = 97/270 (35%), Gaps = 56/270 (20%)
Query: 3 RYEKIGKLGEGSYG-VVFKCRNRDTGQVVAIKKFLESEEDPLIRKIALREIRLLKSL-KH 60
+ LG G+ G +V++ + VA+K+ L A RE++LL+ +H
Sbjct: 25 SFCPKDVLGHGAEGTIVYRGMF--DNRDVAVKRILPECFS-----FADREVQLLRESDEH 77
Query: 61 PNLVNLLEVFRRKKKLHLVFEFCDHTVLNELENHPHGLPWDLIKQITWQVLRGVSYCHRH 120
PN++ + ++ ++ E C T+ +E + Q G+++ H
Sbjct: 78 PNVIRYFCTEKDRQFQYIAIELCAATLQEYVEQKDFAHLGLEPITLLQQTTSGLAHLHSL 137
Query: 121 ACIHRDIKPENILLTANG-----VVKLCDFGFARLIRD---------------------L 154
+HRD+KP NIL++ + DFG + + +
Sbjct: 138 NIVHRDLKPHNILISMPNAHGKIKAMISDFGLCKKLAVGRHSFSRRSGVPGTEGWIAPEM 197
Query: 155 IPRHLHIFQTNE----------YF---KGVSLPHAENVVPLEIKIGKPAATNIYL----- 196
+ T Y+ +G I +G + ++
Sbjct: 198 LSEDCKENPTYTVDIFSAGCVFYYVISEGSHPFGKSLQRQANILLGACSLDCLHPEKHED 257
Query: 197 ---IDFLKRCLDKDPLRRWSCDQLLRHPYF 223
+ +++ + DP +R S +L+HP+F
Sbjct: 258 VIARELIEKMIAMDPQKRPSAKHVLKHPFF 287
|
| >3oz6_A Mitogen-activated protein kinase 1, serine/threon protein kinase; structural genomics consortium, SGC, transferase; 2.37A {Cryptosporidium parvum iowa II} Length = 388 | Back alignment and structure |
|---|
Score = 139 bits (353), Expect = 5e-39
Identities = 59/184 (32%), Positives = 97/184 (52%), Gaps = 15/184 (8%)
Query: 2 ERYEKIGKLGEGSYGVVFKCRNRDTGQVVAIKKFLESEEDPLIRKIALREIRLLKSLK-H 60
+YE + KLG+G+YG+V+K +R TG+VVA+KK ++ ++ + REI +L L H
Sbjct: 9 RKYELVKKLGKGAYGIVWKSIDRRTGEVVAVKKIFDAFQNSTDAQRTFREIMILTELSGH 68
Query: 61 PNLVNLLEVFRRK--KKLHLVFEFCD---HTVL--NELENHPHGLPWDLIKQITWQVLRG 113
N+VNLL V R + ++LVF++ + H V+ N LE + + +Q+++
Sbjct: 69 ENIVNLLNVLRADNDRDVYLVFDYMETDLHAVIRANILEP-------VHKQYVVYQLIKV 121
Query: 114 VSYCHRHACIHRDIKPENILLTANGVVKLCDFGFARLIRDLIPRHLHIFQTNEYFKGVSL 173
+ Y H +HRD+KP NILL A VK+ DFG +R ++ +I +
Sbjct: 122 IKYLHSGGLLHRDMKPSNILLNAECHVKVADFGLSRSFVNIRRVTNNIPLSINENTENFD 181
Query: 174 PHAE 177
Sbjct: 182 DDQP 185
|
| >3oz6_A Mitogen-activated protein kinase 1, serine/threon protein kinase; structural genomics consortium, SGC, transferase; 2.37A {Cryptosporidium parvum iowa II} Length = 388 | Back alignment and structure |
|---|
Score = 43.1 bits (102), Expect = 5e-05
Identities = 11/62 (17%), Positives = 25/62 (40%), Gaps = 9/62 (14%)
Query: 197 IDFLKRCLDKDPLRRWSCDQLLRHPYFNGYY-------FEVPDEMQYEEITQRCLDKDPL 249
+D L + L +P +R S + L+HP+ + ++ + + + + D
Sbjct: 306 LDLLDKLLQFNPNKRISANDALKHPFVSIFHNPNEEPNCDHIITIPINDNVK--HSIDDY 363
Query: 250 RR 251
R
Sbjct: 364 RN 365
|
| >2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 137 bits (348), Expect = 1e-38
Identities = 53/170 (31%), Positives = 78/170 (45%), Gaps = 28/170 (16%)
Query: 2 ERYEKIGKLGEGSYGVVFKCRNRDTGQVVAIK----KFLESEEDPLIRKIALREIRLLKS 57
+ Y+ +LG G + VV KCR + TG A K + +S + R+ RE+ +LK
Sbjct: 11 DYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKE 70
Query: 58 LKHPNLVNLLEVFRRKKKLHLVFEFC----------DHTVLNELENHPHGLPWDLIKQIT 107
++HPN++ L EV+ K + L+ E + L E E + +KQI
Sbjct: 71 IQHPNVITLHEVYENKTDVILILELVAGGELFDFLAEKESLTEEEAT------EFLKQI- 123
Query: 108 WQVLRGVSYCHRHACIHRDIKPENILLT----ANGVVKLCDFGFARLIRD 153
L GV Y H H D+KPENI+L +K+ DFG A I
Sbjct: 124 ---LNGVYYLHSLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDF 170
|
| >2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 39.5 bits (93), Expect = 8e-04
Identities = 13/55 (23%), Positives = 23/55 (41%)
Query: 198 DFLKRCLDKDPLRRWSCDQLLRHPYFNGYYFEVPDEMQYEEITQRCLDKDPLRRW 252
DF++R L KDP +R + L+HP+ + + + K R+
Sbjct: 250 DFIRRLLVKDPKKRMTIQDSLQHPWIKPKDTQQALSRKASAVNMEKFKKFAARKK 304
|
| >2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A* Length = 353 | Back alignment and structure |
|---|
Score = 138 bits (349), Expect = 1e-38
Identities = 56/162 (34%), Positives = 88/162 (54%), Gaps = 18/162 (11%)
Query: 2 ERYEKIGKLGEGSYGVVFKCRNRDTGQVVAIKKFLESEEDPLIRKIALREIRLLKSLKHP 61
++ LGEG+YGVV ++ TG++VAIKK +E + PL LREI++LK KH
Sbjct: 11 SDFQLKSLLGEGAYGVVCSATHKPTGEIVAIKK-IEPFDKPLFALRTLREIKILKHFKHE 69
Query: 62 NLVNLLEVFR-----RKKKLHLVFEFCD---HTVL--NELENHPHGLPWDLIKQITWQVL 111
N++ + + R +++++ E H V+ L + D I+ +Q L
Sbjct: 70 NIITIFNIQRPDSFENFNEVYIIQELMQTDLHRVISTQMLSD-------DHIQYFIYQTL 122
Query: 112 RGVSYCHRHACIHRDIKPENILLTANGVVKLCDFGFARLIRD 153
R V H IHRD+KP N+L+ +N +K+CDFG AR+I +
Sbjct: 123 RAVKVLHGSNVIHRDLKPSNLLINSNCDLKVCDFGLARIIDE 164
|
| >2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A* Length = 353 | Back alignment and structure |
|---|
Score = 45.7 bits (109), Expect = 7e-06
Identities = 18/51 (35%), Positives = 26/51 (50%), Gaps = 1/51 (1%)
Query: 197 IDFLKRCLDKDPLRRWSCDQLLRHPYFNGYYFEVPDEMQYEEITQRCLDKD 247
ID L+R L DP +R + + L HPY Y+ + DE + E I + D
Sbjct: 283 IDLLQRMLVFDPAKRITAKEALEHPYLQTYH-DPNDEPEGEPIPPSFFEFD 332
|
| >3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A Length = 361 | Back alignment and structure |
|---|
Score = 137 bits (348), Expect = 1e-38
Identities = 69/293 (23%), Positives = 107/293 (36%), Gaps = 56/293 (19%)
Query: 1 MERYEKIGKLGEGSYGVVFKCRNRDTGQVVAIKKFLESEEDPLIRKIALREIRLLKSLKH 60
+RY+ + +G G++GV R++ T ++VA+K ++E I + REI +SL+H
Sbjct: 19 SDRYDFVKDIGSGNFGVARLMRDKLTKELVAVK-YIERGA--AIDENVQREIINHRSLRH 75
Query: 61 PNLVNLLEVFRRKKKLHLVFEFCDHTVLNELENH--PHG-LPWDLIKQITWQVLRGVSYC 117
PN+V EV L ++ E+ EL G D + Q+L GVSYC
Sbjct: 76 PNIVRFKEVILTPTHLAIIMEYASG---GELYERICNAGRFSEDEARFFFQQLLSGVSYC 132
Query: 118 HRHACIHRDIKPENILLTANGV--VKLCDFGFARLIRDLIPRHLH------------IFQ 163
H HRD+K EN LL + +K+CDFG+++ +
Sbjct: 133 HSMQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSVL--HSQPKSTVGTPAYIAPEVLL 190
Query: 164 TNEY-----------------------FKGVSLPHAENVVPLEIKIGK---PAATNI--Y 195
EY F+ P I K P I
Sbjct: 191 RQEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPRDYRKTIQRILSVKYSIPDDIRISPE 250
Query: 196 LIDFLKRCLDKDPLRRWSCDQLLRHPYFNGYYFEVPDEMQYEEITQRCLDKDP 248
+ R DP R S ++ H +F P ++ E T +
Sbjct: 251 CCHLISRIFVADPATRISIPEIKTHSWFLKNL---PADLMNESNTGSQFQEPE 300
|
| >2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A* Length = 361 | Back alignment and structure |
|---|
Score = 137 bits (348), Expect = 2e-38
Identities = 48/170 (28%), Positives = 75/170 (44%), Gaps = 28/170 (16%)
Query: 2 ERYEKIGKLGEGSYGVVFKCRNRDTGQVVAIK----KFLESEEDPLIRKIALREIRLLKS 57
+ Y+ +LG G + +V KCR + TG A K + + + R+ RE+ +L+
Sbjct: 12 DFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVCREEIEREVSILRQ 71
Query: 58 LKHPNLVNLLEVFRRKKKLHLVFEFC----------DHTVLNELENHPHGLPWDLIKQIT 107
+ HPN++ L +V+ + + L+ E L+E E
Sbjct: 72 VLHPNIITLHDVYENRTDVVLILELVSGGELFDFLAQKESLSEEE----------ATSFI 121
Query: 108 WQVLRGVSYCHRHACIHRDIKPENILLTA----NGVVKLCDFGFARLIRD 153
Q+L GV+Y H H D+KPENI+L +KL DFG A I D
Sbjct: 122 KQILDGVNYLHTKKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIED 171
|
| >2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A* Length = 361 | Back alignment and structure |
|---|
Score = 41.6 bits (98), Expect = 2e-04
Identities = 12/54 (22%), Positives = 24/54 (44%)
Query: 198 DFLKRCLDKDPLRRWSCDQLLRHPYFNGYYFEVPDEMQYEEITQRCLDKDPLRR 251
DF+++ L K+ +R + + LRHP+ + + + K +RR
Sbjct: 251 DFIRKLLVKETRKRLTIQEALRHPWITPVDTQQAMVRRESVVNLENFKKQYVRR 304
|
| >3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 137 bits (346), Expect = 3e-38
Identities = 47/157 (29%), Positives = 78/157 (49%), Gaps = 15/157 (9%)
Query: 2 ERYEKIGKLGEGSYGVVFKCRNRDTGQVVAIKKFLESEEDPLIRKIALREIRLLKSLKHP 61
+ Y +G G+YG V ++ +G+ VAIKK + + K A RE+ LLK ++H
Sbjct: 24 KTYVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQSEIFAKRAYRELLLLKHMQHE 83
Query: 62 NLVNLLEVFRRKKKLH------LVFEFCD---HTVLNELENHPHGLPWDLIKQITWQVLR 112
N++ LL+VF L LV F ++ + I+ + +Q+L+
Sbjct: 84 NVIGLLDVFTPASSLRNFYDFYLVMPFMQTDLQKIMGLKFSEEK------IQYLVYQMLK 137
Query: 113 GVSYCHRHACIHRDIKPENILLTANGVVKLCDFGFAR 149
G+ Y H +HRD+KP N+ + + +K+ DFG AR
Sbjct: 138 GLKYIHSAGVVHRDLKPGNLAVNEDCELKILDFGLAR 174
|
| >3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 43.8 bits (104), Expect = 3e-05
Identities = 10/31 (32%), Positives = 17/31 (54%)
Query: 197 IDFLKRCLDKDPLRRWSCDQLLRHPYFNGYY 227
D L++ L+ D +R + Q L HP+F +
Sbjct: 283 ADLLEKMLELDVDKRLTAAQALTHPFFEPFR 313
|
| >3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens} Length = 444 | Back alignment and structure |
|---|
Score = 138 bits (351), Expect = 3e-38
Identities = 70/297 (23%), Positives = 113/297 (38%), Gaps = 74/297 (24%)
Query: 2 ERYEKIGKLGEGSYGVVFKCRNRDTGQVVAIKKFLESEEDPLIRKIALREIRLLKSLKHP 61
E Y+ +LG+G++ VV +C GQ A + + RE R+ + LKHP
Sbjct: 11 EEYQLFEELGKGAFSVVRRCVKVLAGQEYAAMIINTKKLSARDHQKLEREARICRLLKHP 70
Query: 62 NLVNLLEVFRRKKKLHLVFEFC----------DHTVLNELENHPHGLPWDLIKQITWQVL 111
N+V L + + +L+F+ +E + I+QI L
Sbjct: 71 NIVRLHDSISEEGHHYLIFDLVTGGELFEDIVAREYYSEADAS------HCIQQI----L 120
Query: 112 RGVSYCHRHACIHRDIKPENILLT---ANGVVKLCDFGFARLIRDLIPRHLH-------- 160
V +CH+ +HR++KPEN+LL VKL DFG A + +
Sbjct: 121 EAVLHCHQMGVVHRNLKPENLLLASKLKGAAVKLADFGLAIEVEG--EQQAWFGFAGTPG 178
Query: 161 -----IFQTNEYFK-------GVSL--------P-HAENVVPL--EIKIGK--------- 188
+ + + Y K GV L P E+ L +IK G
Sbjct: 179 YLSPEVLRKDPYGKPVDLWACGVILYILLVGYPPFWDEDQHRLYQQIKAGAYDFPSPEWD 238
Query: 189 ---PAATNIYLIDFLKRCLDKDPLRRWSCDQLLRHPYFNGYYFEVPDEMQYEEITQR 242
P A + LI+ + L +P +R + + L+HP+ + V M +E
Sbjct: 239 TVTPEAKD--LIN---KMLTINPSKRITAAEALKHPWISHRS-TVASCMHRQETVDC 289
|
| >2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A Length = 321 | Back alignment and structure |
|---|
Score = 136 bits (344), Expect = 3e-38
Identities = 50/170 (29%), Positives = 76/170 (44%), Gaps = 28/170 (16%)
Query: 2 ERYEKIGKLGEGSYGVVFKCRNRDTGQVVAIK----KFLESEEDPLIRKIALREIRLLKS 57
+ Y+ +LG G + +V KCR + TG A K + + + R+ RE+ +L+
Sbjct: 12 DFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVSILRQ 71
Query: 58 LKHPNLVNLLEVFRRKKKLHLVFEFC----------DHTVLNELENHPHGLPWDLIKQIT 107
+ H N++ L +V+ + + L+ E L+E E IKQI
Sbjct: 72 VLHHNVITLHDVYENRTDVVLILELVSGGELFDFLAQKESLSEEEAT------SFIKQI- 124
Query: 108 WQVLRGVSYCHRHACIHRDIKPENILLTA----NGVVKLCDFGFARLIRD 153
L GV+Y H H D+KPENI+L +KL DFG A I D
Sbjct: 125 ---LDGVNYLHTKKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIED 171
|
| >2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A Length = 321 | Back alignment and structure |
|---|
Score = 39.5 bits (93), Expect = 7e-04
Identities = 12/54 (22%), Positives = 24/54 (44%)
Query: 198 DFLKRCLDKDPLRRWSCDQLLRHPYFNGYYFEVPDEMQYEEITQRCLDKDPLRR 251
DF+++ L K+ +R + + LRHP+ + + + K +RR
Sbjct: 251 DFIRKLLVKETRKRLTIQEALRHPWITPVDNQQAMVRRESVVNLENFRKQYVRR 304
|
| >3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A* Length = 284 | Back alignment and structure |
|---|
Score = 134 bits (341), Expect = 4e-38
Identities = 47/169 (27%), Positives = 80/169 (47%), Gaps = 31/169 (18%)
Query: 2 ERYEKIGKLGEGSYGVVFKCRNRDTGQVVAIK----KFLESEEDPLIRKIALREIRLLKS 57
+ Y+ +LG+G++ VV +C ++ TG A K K L + + + RE R+ +
Sbjct: 6 DNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLE----REARICRK 61
Query: 58 LKHPNLVNLLEVFRRKKKLHLVFEFC----------DHTVLNELENHPHGLPWDLIKQIT 107
L+HPN+V L + + + +LVF+ +E +
Sbjct: 62 LQHPNIVRLHDSIQEESFHYLVFDLVTGGELFEDIVAREFYSEAD----------ASHCI 111
Query: 108 WQVLRGVSYCHRHACIHRDIKPENILLTA---NGVVKLCDFGFARLIRD 153
Q+L ++YCH + +HR++KPEN+LL + VKL DFG A + D
Sbjct: 112 QQILESIAYCHSNGIVHRNLKPENLLLASKAKGAAVKLADFGLAIEVND 160
|
| >3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A Length = 351 | Back alignment and structure |
|---|
Score = 135 bits (343), Expect = 9e-38
Identities = 53/166 (31%), Positives = 79/166 (47%), Gaps = 18/166 (10%)
Query: 2 ERYEKIGKLGEGSYGVVFKCRNRDTGQVVAIK---KFLESEEDPLIRKIALREIRLLKSL 58
+ YE +G+G + VV +C NR+TGQ A+K + L + RE + L
Sbjct: 24 DVYELCEVIGKGPFSVVRRCINRETGQQFAVKIVDVAKFTSSPGLSTEDLKREASICHML 83
Query: 59 KHPNLVNLLEVFRRKKKLHLVFEFCDHTVL-NELENHPHGLPW-------DLIKQITWQV 110
KHP++V LLE + L++VFEF D L E+ ++QI
Sbjct: 84 KHPHIVELLETYSSDGMLYMVFEFMDGADLCFEIVKRADAGFVYSEAVASHYMRQI---- 139
Query: 111 LRGVSYCHRHACIHRDIKPENILLTA---NGVVKLCDFGFARLIRD 153
L + YCH + IHRD+KP +LL + + VKL FG A + +
Sbjct: 140 LEALRYCHDNNIIHRDVKPHCVLLASKENSAPVKLGGFGVAIQLGE 185
|
| >1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A* Length = 298 | Back alignment and structure |
|---|
Score = 134 bits (339), Expect = 1e-37
Identities = 47/170 (27%), Positives = 78/170 (45%), Gaps = 28/170 (16%)
Query: 2 ERYEKIGKLGEGSYGVVFKCRNRDTGQVVAIK-------KFLESEEDPLIRKIALREIRL 54
E YE LG G VV +C ++ T + A+K +EE +R+ L+E+ +
Sbjct: 17 ENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDI 76
Query: 55 LKSLK-HPNLVNLLEVFRRKKKLHLVFEFC----------DHTVLNELENHPHGLPWDLI 103
L+ + HPN++ L + + LVF+ + L+E E
Sbjct: 77 LRKVSGHPNIIQLKDTYETNTFFFLVFDLMKKGELFDYLTEKVTLSEKE----------T 126
Query: 104 KQITWQVLRGVSYCHRHACIHRDIKPENILLTANGVVKLCDFGFARLIRD 153
++I +L + H+ +HRD+KPENILL + +KL DFGF+ +
Sbjct: 127 RKIMRALLEVICALHKLNIVHRDLKPENILLDDDMNIKLTDFGFSCQLDP 176
|
| >1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A* Length = 298 | Back alignment and structure |
|---|
Score = 39.9 bits (94), Expect = 5e-04
Identities = 10/29 (34%), Positives = 17/29 (58%)
Query: 198 DFLKRCLDKDPLRRWSCDQLLRHPYFNGY 226
D + R L P +R++ ++ L HP+F Y
Sbjct: 262 DLVSRFLVVQPQKRYTAEEALAHPFFQQY 290
|
| >2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B Length = 362 | Back alignment and structure |
|---|
Score = 135 bits (342), Expect = 1e-37
Identities = 49/169 (28%), Positives = 82/169 (48%), Gaps = 31/169 (18%)
Query: 2 ERYEKIGKLGEGSYGVVFKCRNRDTGQVVAIK----KFLESEEDPLIRKIALREIRLLKS 57
+ Y+ +LG+G++ VV +C ++ TG A K K L + + + RE R+ +
Sbjct: 29 DNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLE----REARICRK 84
Query: 58 LKHPNLVNLLEVFRRKKKLHLVFEFCD----------HTVLNELENHPHGLPWDLIKQIT 107
L+HPN+V L + + + +LVF+ +E + I+QI
Sbjct: 85 LQHPNIVRLHDSIQEESFHYLVFDLVTGGELFEDIVAREFYSEADAS------HCIQQI- 137
Query: 108 WQVLRGVSYCHRHACIHRDIKPENILLTA---NGVVKLCDFGFARLIRD 153
L ++YCH + +HR++KPEN+LL + VKL DFG A + D
Sbjct: 138 ---LESIAYCHSNGIVHRNLKPENLLLASKAKGAAVKLADFGLAIEVND 183
|
| >1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7 Length = 321 | Back alignment and structure |
|---|
Score = 134 bits (339), Expect = 1e-37
Identities = 43/165 (26%), Positives = 71/165 (43%), Gaps = 26/165 (15%)
Query: 2 ERYEKIGKLGEGSYGVVFKCRNRDTGQVVAIKKFLESEEDPLIRKIALREIRLLKSLKHP 61
E+Y LG G +G+V +C + + K D + + +EI +L +H
Sbjct: 5 EKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVKGTD---QVLVKKEISILNIARHR 61
Query: 62 NLVNLLEVFRRKKKLHLVFEFC-----------DHTVLNELENHPHGLPWDLIKQITWQV 110
N+++L E F ++L ++FEF LNE E I QV
Sbjct: 62 NILHLHESFESMEELVMIFEFISGLDIFERINTSAFELNERE----------IVSYVHQV 111
Query: 111 LRGVSYCHRHACIHRDIKPENILLTA--NGVVKLCDFGFARLIRD 153
+ + H H H DI+PENI+ + +K+ +FG AR ++
Sbjct: 112 CEALQFLHSHNIGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKP 156
|
| >3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A* Length = 464 | Back alignment and structure |
|---|
Score = 137 bits (346), Expect = 2e-37
Identities = 49/156 (31%), Positives = 82/156 (52%), Gaps = 9/156 (5%)
Query: 2 ERYEKIGKLGEGSYGVVFKCRNRDTGQVVAIKKFLESEEDPLIRKIALREIRLLKSLKHP 61
+RY+ + +G G+ G+V + + VAIKK ++ K A RE+ L+K + H
Sbjct: 62 KRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHK 121
Query: 62 NLVNLLEVFRRKKKLH------LVFEFCDHTVLNELENHPHGLPWDLIKQITWQVLRGVS 115
N+++LL VF +K L LV E D L ++ L + + + +Q+L G+
Sbjct: 122 NIISLLNVFTPQKTLEEFQDVYLVMELMD-ANLCQVIQME--LDHERMSYLLYQMLCGIK 178
Query: 116 YCHRHACIHRDIKPENILLTANGVVKLCDFGFARLI 151
+ H IHRD+KP NI++ ++ +K+ DFG AR
Sbjct: 179 HLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTA 214
|
| >3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A* Length = 464 | Back alignment and structure |
|---|
Score = 44.5 bits (105), Expect = 2e-05
Identities = 18/60 (30%), Positives = 28/60 (46%), Gaps = 5/60 (8%)
Query: 197 IDFLKRCLDKDPLRRWSCDQLLRHPYFNGYY----FEVPDEMQYE-EITQRCLDKDPLRR 251
D L + L DP +R S D L+HPY N +Y E P Y+ ++ +R + +
Sbjct: 333 RDLLSKMLVIDPAKRISVDDALQHPYINVWYDPAEVEAPPPQIYDKQLDEREHTIEEWKE 392
|
| >3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A* Length = 486 | Back alignment and structure |
|---|
Score = 136 bits (345), Expect = 3e-37
Identities = 52/169 (30%), Positives = 81/169 (47%), Gaps = 31/169 (18%)
Query: 2 ERYEKIGKLGEGSYGVVFKCRNRDTGQVVAIK----KFLESEEDPLIRKIALREIRLLKS 57
ERY + LG+GS+G V KC++R T Q A+K ++++ I RE+ LLK
Sbjct: 22 ERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTIL----REVELLKK 77
Query: 58 LKHPNLVNLLEVFRRKKKLHLVFEFC----------DHTVLNELENHPHGLPWDLIKQIT 107
L HPN++ L E+ ++V E +E + +I
Sbjct: 78 LDHPNIMKLFEILEDSSSFYIVGELYTGGELFDEIIKRKRFSEHD----------AARII 127
Query: 108 WQVLRGVSYCHRHACIHRDIKPENILLT---ANGVVKLCDFGFARLIRD 153
QV G++Y H+H +HRD+KPENILL + +K+ DFG + +
Sbjct: 128 KQVFSGITYMHKHNIVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQ 176
|
| >3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A* Length = 486 | Back alignment and structure |
|---|
Score = 41.2 bits (97), Expect = 3e-04
Identities = 11/35 (31%), Positives = 16/35 (45%)
Query: 198 DFLKRCLDKDPLRRWSCDQLLRHPYFNGYYFEVPD 232
D +++ L P R + Q L HP+ Y E P
Sbjct: 255 DLIRKMLTFHPSLRITATQCLEHPWIQKYSSETPT 289
|
| >2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A* Length = 287 | Back alignment and structure |
|---|
Score = 132 bits (334), Expect = 5e-37
Identities = 52/169 (30%), Positives = 82/169 (48%), Gaps = 31/169 (18%)
Query: 2 ERYEKIGKLGEGSYGVVFKCRNRDTGQVVAIK----KFLESEEDPLIRKIALREIRLLKS 57
ERY + LG+GS+G V KC++R T Q A+K ++++ I RE+ LLK
Sbjct: 22 ERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTIL----REVELLKK 77
Query: 58 LKHPNLVNLLEVFRRKKKLHLVFEFC----------DHTVLNELENHPHGLPWDLIKQIT 107
L HPN++ L E+ ++V E +E + +I
Sbjct: 78 LDHPNIMKLFEILEDSSSFYIVGELYTGGELFDEIIKRKRFSEHD----------AARII 127
Query: 108 WQVLRGVSYCHRHACIHRDIKPENILLTA---NGVVKLCDFGFARLIRD 153
QV G++Y H+H +HRD+KPENILL + + +K+ DFG + +
Sbjct: 128 KQVFSGITYMHKHNIVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQ 176
|
| >3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A* Length = 494 | Back alignment and structure |
|---|
Score = 136 bits (344), Expect = 5e-37
Identities = 52/169 (30%), Positives = 83/169 (49%), Gaps = 31/169 (18%)
Query: 2 ERYEKIGKLGEGSYGVVFKCRNRDTGQVVAIK----KFLESEEDPLIRKIALREIRLLKS 57
E Y+++ KLG G+YG V CR++ T AIK + + + + E+ +LK
Sbjct: 37 EMYQRVKKLGSGAYGEVLLCRDKVTHVERAIKIIRKTSVSTSSNSKLL----EEVAVLKL 92
Query: 58 LKHPNLVNLLEVFRRKKKLHLVFEFC----------DHTVLNELENHPHGLPWDLIKQIT 107
L HPN++ L + F K+ +LV E NE++ I
Sbjct: 93 LDHPNIMKLYDFFEDKRNYYLVMECYKGGELFDEIIHRMKFNEVD----------AAVII 142
Query: 108 WQVLRGVSYCHRHACIHRDIKPENILLT---ANGVVKLCDFGFARLIRD 153
QVL GV+Y H+H +HRD+KPEN+LL + ++K+ DFG + + +
Sbjct: 143 KQVLSGVTYLHKHNIVHRDLKPENLLLESKEKDALIKIVDFGLSAVFEN 191
|
| >3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A* Length = 494 | Back alignment and structure |
|---|
Score = 41.6 bits (98), Expect = 2e-04
Identities = 11/29 (37%), Positives = 14/29 (48%)
Query: 198 DFLKRCLDKDPLRRWSCDQLLRHPYFNGY 226
D +K+ L D RR S Q L HP+
Sbjct: 270 DLIKQMLQFDSQRRISAQQALEHPWIKEM 298
|
| >1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7 Length = 367 | Back alignment and structure |
|---|
Score = 133 bits (338), Expect = 6e-37
Identities = 53/161 (32%), Positives = 79/161 (49%), Gaps = 14/161 (8%)
Query: 2 ERYEKIGKLGEGSYGVVFKCRNRDTGQVVAIKKFLESEEDPLIRKIALREIRLLKSLKHP 61
Y + +G G+YG V + TG VAIKK + L K A RE+RLLK ++H
Sbjct: 25 AVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMRHE 84
Query: 62 NLVNLLEVFRRKKKLH------LVFEFCD---HTVLNELENHPHGLPWDLIKQITWQVLR 112
N++ LL+VF + L LV F ++ L D I+ + +Q+L+
Sbjct: 85 NVIGLLDVFTPDETLDDFTDFYLVMPFMGTDLGKLM-----KHEKLGEDRIQFLVYQMLK 139
Query: 113 GVSYCHRHACIHRDIKPENILLTANGVVKLCDFGFARLIRD 153
G+ Y H IHRD+KP N+ + + +K+ DFG AR
Sbjct: 140 GLRYIHAAGIIHRDLKPGNLAVNEDCELKILDFGLARQADS 180
|
| >1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7 Length = 367 | Back alignment and structure |
|---|
Score = 43.9 bits (104), Expect = 3e-05
Identities = 9/31 (29%), Positives = 17/31 (54%)
Query: 197 IDFLKRCLDKDPLRRWSCDQLLRHPYFNGYY 227
++ L++ L D +R + + L HPYF +
Sbjct: 285 VNLLEKMLVLDAEQRVTAGEALAHPYFESLH 315
|
| >3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A* Length = 484 | Back alignment and structure |
|---|
Score = 135 bits (341), Expect = 1e-36
Identities = 52/169 (30%), Positives = 88/169 (52%), Gaps = 30/169 (17%)
Query: 2 ERYEKIGKLGEGSYGVVFKCRNRDTGQVVAIK----KFLESEEDPLIRKIALREIRLLKS 57
+RY+ LG+GS+G V C+++ TGQ A+K + ++ + D ++ LRE++LLK
Sbjct: 26 DRYKGQRVLGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTD---KESLLREVQLLKQ 82
Query: 58 LKHPNLVNLLEVFRRKKKLHLVFEFC----------DHTVLNELENHPHGLPWDLIKQIT 107
L HPN++ L E F K +LV E +E++ +I
Sbjct: 83 LDHPNIMKLYEFFEDKGYFYLVGEVYTGGELFDEIISRKRFSEVD----------AARII 132
Query: 108 WQVLRGVSYCHRHACIHRDIKPENILLTA---NGVVKLCDFGFARLIRD 153
QVL G++Y H++ +HRD+KPEN+LL + + +++ DFG +
Sbjct: 133 RQVLSGITYMHKNKIVHRDLKPENLLLESKSKDANIRIIDFGLSTHFEA 181
|
| >3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A* Length = 484 | Back alignment and structure |
|---|
Score = 41.6 bits (98), Expect = 2e-04
Identities = 9/47 (19%), Positives = 14/47 (29%), Gaps = 2/47 (4%)
Query: 198 DFLKRCLDKDPLRRWSCDQLLRHPYFNGYY--FEVPDEMQYEEITQR 242
D +++ L P R S L H + Y D +
Sbjct: 260 DLIRKMLTYVPSMRISARDALDHEWIQTYTKEQISVDVPSLDNAILN 306
|
| >2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A* Length = 322 | Back alignment and structure |
|---|
Score = 132 bits (333), Expect = 1e-36
Identities = 46/171 (26%), Positives = 75/171 (43%), Gaps = 30/171 (17%)
Query: 2 ERYEKIGKLGEGSYGVVFKCRNRDTGQVVAIK-----KFLESEEDPLIRKIAL-REIRLL 55
+ Y LG G+ G V R T + VAIK KF + + EI +L
Sbjct: 10 DEYIMSKTLGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVETEIEIL 69
Query: 56 KSLKHPNLVNLLEVFRRKKKLHLVFEFC----------DHTVLNELENHPHGLPWDLIKQ 105
K L HP ++ + F + ++V E + L E K
Sbjct: 70 KKLNHPCIIKIKNFFD-AEDYYIVLELMEGGELFDKVVGNKRLKEAT----------CKL 118
Query: 106 ITWQVLRGVSYCHRHACIHRDIKPENILLTA---NGVVKLCDFGFARLIRD 153
+Q+L V Y H + IHRD+KPEN+LL++ + ++K+ DFG ++++ +
Sbjct: 119 YFYQMLLAVQYLHENGIIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGE 169
|
| >2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A* Length = 322 | Back alignment and structure |
|---|
Score = 39.6 bits (93), Expect = 8e-04
Identities = 10/29 (34%), Positives = 17/29 (58%)
Query: 198 DFLKRCLDKDPLRRWSCDQLLRHPYFNGY 226
D +K+ L DP R++ ++ LRHP+
Sbjct: 253 DLVKKLLVVDPKARFTTEEALRHPWLQDE 281
|
| >3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3o71_A 3r63_A 3c9w_A* 2y9q_A* 3sa0_A* 1wzy_A* 2e14_A* 1tvo_A* 2ojg_A* 2oji_A* ... Length = 364 | Back alignment and structure |
|---|
Score = 132 bits (335), Expect = 2e-36
Identities = 50/160 (31%), Positives = 81/160 (50%), Gaps = 18/160 (11%)
Query: 2 ERYEKIGKLGEGSYGVVFKCRNRDTGQVVAIKKFLESEEDPLIRKIALREIRLLKSLKHP 61
RY + +GEG+YG+V + VAIKK + E + LREI++L +H
Sbjct: 27 PRYTNLSYIGEGAYGMVCSAYDNLNKVRVAIKK-ISPFEHQTYCQRTLREIKILLRFRHE 85
Query: 62 NLVNLLEVFRRK-----KKLHLVFEFCD---HTVL--NELENHPHGLPWDLIKQITWQVL 111
N++ + ++ R K +++V + + + +L L N D I +Q+L
Sbjct: 86 NIIGINDIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSN-------DHICYFLYQIL 138
Query: 112 RGVSYCHRHACIHRDIKPENILLTANGVVKLCDFGFARLI 151
RG+ Y H +HRD+KP N+LL +K+CDFG AR+
Sbjct: 139 RGLKYIHSANVLHRDLKPSNLLLNTTCDLKICDFGLARVA 178
|
| >3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3o71_A 3r63_A 3c9w_A* 2y9q_A* 3sa0_A* 1wzy_A* 2e14_A* 1tvo_A* 2ojg_A* 2oji_A* ... Length = 364 | Back alignment and structure |
|---|
Score = 44.2 bits (105), Expect = 3e-05
Identities = 12/31 (38%), Positives = 17/31 (54%)
Query: 197 IDFLKRCLDKDPLRRWSCDQLLRHPYFNGYY 227
+D L + L +P +R +Q L HPY YY
Sbjct: 291 LDLLDKMLTFNPHKRIEVEQALAHPYLEQYY 321
|
| >3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A* Length = 327 | Back alignment and structure |
|---|
Score = 131 bits (332), Expect = 2e-36
Identities = 53/172 (30%), Positives = 81/172 (47%), Gaps = 33/172 (19%)
Query: 2 ERYEKIGK-LGEGSYGVVFKCRNRDTGQVVA---IKKFLESEEDPLIRKIALREIRLLKS 57
Y K LG G + VV +C ++ TGQ A +KK ++ R L EI +L+
Sbjct: 28 NFYILTSKELGRGKFAVVRQCISKSTGQEYAAKFLKKRRRGQDC---RAEILHEIAVLEL 84
Query: 58 LKH-PNLVNLLEVFRRKKKLHLVFEFC------------DHTVLNELENHPHGLPWDLIK 104
K P ++NL EV+ ++ L+ E+ +++E + LIK
Sbjct: 85 AKSCPRVINLHEVYENTSEIILILEYAAGGEIFSLCLPELAEMVSENDVI------RLIK 138
Query: 105 QITWQVLRGVSYCHRHACIHRDIKPENILL---TANGVVKLCDFGFARLIRD 153
QI L GV Y H++ +H D+KP+NILL G +K+ DFG +R I
Sbjct: 139 QI----LEGVYYLHQNNIVHLDLKPQNILLSSIYPLGDIKIVDFGMSRKIGH 186
|
| >3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A* Length = 327 | Back alignment and structure |
|---|
Score = 41.1 bits (97), Expect = 2e-04
Identities = 11/55 (20%), Positives = 22/55 (40%)
Query: 198 DFLKRCLDKDPLRRWSCDQLLRHPYFNGYYFEVPDEMQYEEITQRCLDKDPLRRW 252
DF++ L K+P +R + + L H + + FE + + + D
Sbjct: 266 DFIQSLLVKNPEKRPTAEICLSHSWLQQWDFENLFHPEETSSSSQTQDHSVRSSE 320
|
| >3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A Length = 419 | Back alignment and structure |
|---|
Score = 133 bits (337), Expect = 2e-36
Identities = 45/171 (26%), Positives = 75/171 (43%), Gaps = 30/171 (17%)
Query: 2 ERYEKIGKLGEGSYGVVFKCRNRDTGQVVAIK-----KFLESEEDPLIRKIAL-REIRLL 55
+ Y LG G+ G V R T + VAI+ KF + + EI +L
Sbjct: 135 DEYIMSKTLGSGACGEVKLAFERKTCKKVAIRIISKRKFAIGSAREADPALNVETEIEIL 194
Query: 56 KSLKHPNLVNLLEVFRRKKKLHLVFEFC----------DHTVLNELENHPHGLPWDLIKQ 105
K L HP ++ + F + ++V E + L E K
Sbjct: 195 KKLNHPCIIKIKNFFD-AEDYYIVLELMEGGELFDKVVGNKRLKEAT----------CKL 243
Query: 106 ITWQVLRGVSYCHRHACIHRDIKPENILLTA---NGVVKLCDFGFARLIRD 153
+Q+L V Y H + IHRD+KPEN+LL++ + ++K+ DFG ++++ +
Sbjct: 244 YFYQMLLAVQYLHENGIIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGE 294
|
| >2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A Length = 365 | Back alignment and structure |
|---|
Score = 132 bits (334), Expect = 2e-36
Identities = 47/169 (27%), Positives = 78/169 (46%), Gaps = 27/169 (15%)
Query: 2 ERYEKIGKLGEGSYGVVFKCRNRDTGQVVAIK-----KFLESEEDPLIRKIAL-REIRLL 55
++Y+ +G G VV +C +R TG A+K S E + A RE +L
Sbjct: 94 QKYDPKDVIGRGVSSVVRRCVHRATGHEFAVKIMEVTAERLSPEQLEEVREATRRETHIL 153
Query: 56 KSLK-HPNLVNLLEVFRRKKKLHLVFEFC----------DHTVLNELENHPHGLPWDLIK 104
+ + HP+++ L++ + + LVF+ + L+E E +
Sbjct: 154 RQVAGHPHIITLIDSYESSSFMFLVFDLMRKGELFDYLTEKVALSEKE----------TR 203
Query: 105 QITWQVLRGVSYCHRHACIHRDIKPENILLTANGVVKLCDFGFARLIRD 153
I +L VS+ H + +HRD+KPENILL N ++L DFGF+ +
Sbjct: 204 SIMRSLLEAVSFLHANNIVHRDLKPENILLDDNMQIRLSDFGFSCHLEP 252
|
| >3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II} Length = 345 | Back alignment and structure |
|---|
Score = 131 bits (332), Expect = 2e-36
Identities = 51/208 (24%), Positives = 78/208 (37%), Gaps = 45/208 (21%)
Query: 2 ERYEKIGKLGEGSYGVVFKCRNRDTGQVVAIK---KFLESEEDPLIRKIALREIRLLKSL 58
++Y G +G+GSYGVV T + AIK K + +P + E+RL+K L
Sbjct: 26 KKYHLKGAIGQGSYGVVRVAIENQTRAIRAIKIMNKNKIRQINPKDVERIKTEVRLMKKL 85
Query: 59 KHPNLVNLLEVFRRKKKLHLVFEFC------DHTVLNELENHPHGLPWDLI--------- 103
HPN+ L EV+ ++ + LV E C D + ++ +
Sbjct: 86 HHPNIARLYEVYEDEQYICLVMELCHGGHLLDKLNVFIDDSTGKCAMDVVKTQICPCPEC 145
Query: 104 -------------------------KQITWQVLRGVSYCHRHACIHRDIKPENILLTA-- 136
I Q+ + Y H HRDIKPEN L +
Sbjct: 146 NEEAINGSIHGFRESLDFVQREKLISNIMRQIFSALHYLHNQGICHRDIKPENFLFSTNK 205
Query: 137 NGVVKLCDFGFARLIRDLIPRHLHIFQT 164
+ +KL DFG ++ L + T
Sbjct: 206 SFEIKLVDFGLSKEFYKLNNGEYYGMTT 233
|
| >3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II} Length = 345 | Back alignment and structure |
|---|
Score = 40.6 bits (95), Expect = 3e-04
Identities = 7/29 (24%), Positives = 16/29 (55%)
Query: 198 DFLKRCLDKDPLRRWSCDQLLRHPYFNGY 226
D L L+++ R+ + L+HP+ + +
Sbjct: 309 DLLSNLLNRNVDERFDAMRALQHPWISQF 337
|
| >2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens} Length = 320 | Back alignment and structure |
|---|
Score = 131 bits (331), Expect = 2e-36
Identities = 51/172 (29%), Positives = 81/172 (47%), Gaps = 33/172 (19%)
Query: 2 ERYEKIGKLGEGSYGVVFKCRNRDTGQVVAIKK--FLESEEDPLIRKIALREIRLLKSLK 59
RY + LG G G+VF + D + VAIKK DP K ALREI++++ L
Sbjct: 11 SRYMDLKPLGCGGNGLVFSAVDNDCDKRVAIKKIVL----TDPQSVKHALREIKIIRRLD 66
Query: 60 HPNLVNLLEVFRRKKK--------------LHLVFEFCD---HTVL--NELENHPHGLPW 100
H N+V + E+ +++V E+ + VL L
Sbjct: 67 HDNIVKVFEILGPSGSQLTDDVGSLTELNSVYIVQEYMETDLANVLEQGPLLE------- 119
Query: 101 DLIKQITWQVLRGVSYCHRHACIHRDIKPENILLTA-NGVVKLCDFGFARLI 151
+ + +Q+LRG+ Y H +HRD+KP N+ + + V+K+ DFG AR++
Sbjct: 120 EHARLFMYQLLRGLKYIHSANVLHRDLKPANLFINTEDLVLKIGDFGLARIM 171
|
| >2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens} Length = 320 | Back alignment and structure |
|---|
Score = 44.6 bits (106), Expect = 2e-05
Identities = 11/31 (35%), Positives = 19/31 (61%)
Query: 197 IDFLKRCLDKDPLRRWSCDQLLRHPYFNGYY 227
+DFL++ L P+ R + ++ L HPY + Y
Sbjct: 283 VDFLEQILTFSPMDRLTAEEALSHPYMSIYS 313
|
| >2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A Length = 304 | Back alignment and structure |
|---|
Score = 130 bits (330), Expect = 3e-36
Identities = 43/168 (25%), Positives = 75/168 (44%), Gaps = 31/168 (18%)
Query: 2 ERYEKIGKLGEGSYGVVFKCRNRDTGQVVAIK---KFLESEEDPLIRKIALREIRLLKSL 58
+ + + LG G++ VF + R TG++ A+K K + L EI +LK +
Sbjct: 9 KTFIFMEVLGSGAFSEVFLVKQRLTGKLFALKCIKKSPAFRDSSL-----ENEIAVLKKI 63
Query: 59 KHPNLVNLLEVFRRKKKLHLVFEFC----------DHTVLNELENHPHGLPWDLIKQITW 108
KH N+V L +++ +LV + + V E + +
Sbjct: 64 KHENIVTLEDIYESTTHYYLVMQLVSGGELFDRILERGVYTEKD----------ASLVIQ 113
Query: 109 QVLRGVSYCHRHACIHRDIKPENILLT---ANGVVKLCDFGFARLIRD 153
QVL V Y H + +HRD+KPEN+L N + + DFG +++ ++
Sbjct: 114 QVLSAVKYLHENGIVHRDLKPENLLYLTPEENSKIMITDFGLSKMEQN 161
|
| >2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A Length = 304 | Back alignment and structure |
|---|
Score = 39.5 bits (93), Expect = 8e-04
Identities = 12/28 (42%), Positives = 20/28 (71%)
Query: 198 DFLKRCLDKDPLRRWSCDQLLRHPYFNG 225
DF+ L+KDP R++C++ L HP+ +G
Sbjct: 240 DFICHLLEKDPNERYTCEKALSHPWIDG 267
|
| >3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} Length = 362 | Back alignment and structure |
|---|
Score = 131 bits (332), Expect = 3e-36
Identities = 48/162 (29%), Positives = 69/162 (42%), Gaps = 15/162 (9%)
Query: 2 ERYEKIGKLGEGSYGVVFKCRNRDTGQVVAIKKFLESEEDPLIRKI---------ALREI 52
Y + GSYG V + G VAIK+ + D I LREI
Sbjct: 22 SPYTVQRFISSGSYGAVCAGVDS-EGIPVAIKRVFNTVSDGRTVNILSDSFLCKRVLREI 80
Query: 53 RLLKSLKHPNLVNLLEVFRRK-----KKLHLVFEFCDHTVLNELENHPHGLPWDLIKQIT 107
RLL HPN++ L ++F KL+LV E + + + + I+
Sbjct: 81 RLLNHFHHPNILGLRDIFVHFEEPAMHKLYLVTELMRTDLAQVIHDQRIVISPQHIQYFM 140
Query: 108 WQVLRGVSYCHRHACIHRDIKPENILLTANGVVKLCDFGFAR 149
+ +L G+ H +HRD+ P NILL N + +CDF AR
Sbjct: 141 YHILLGLHVLHEAGVVHRDLHPGNILLADNNDITICDFNLAR 182
|
| >3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} Length = 362 | Back alignment and structure |
|---|
Score = 43.4 bits (103), Expect = 4e-05
Identities = 13/31 (41%), Positives = 20/31 (64%)
Query: 197 IDFLKRCLDKDPLRRWSCDQLLRHPYFNGYY 227
+D + + L+ +P RR S +Q LRHPYF +
Sbjct: 294 LDLIAKMLEFNPQRRISTEQALRHPYFESLF 324
|
| >2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X* Length = 348 | Back alignment and structure |
|---|
Score = 131 bits (331), Expect = 4e-36
Identities = 39/177 (22%), Positives = 72/177 (40%), Gaps = 26/177 (14%)
Query: 1 MERYEKIGKLGEGSYGVVFKCRNRDTGQVVAIK----------KFLESEEDPLIRKIAL- 49
+ Y I L +G + + C + A+K + + I +
Sbjct: 30 INDYRIIRTLNQGKFNKIILCEK--DNKFYALKKYEKSLLEKKRDFTKSNNDKISIKSKY 87
Query: 50 ----REIRLLKSLKHPNLVNLLEVFRRKKKLHLVFEFC------DHTVLNEL--ENHPHG 97
E++++ +K+ + + ++++++E+ + +N+
Sbjct: 88 DDFKNELQIITDIKNEYCLTCEGIITNYDEVYIIYEYMENDSILKFDEYFFVLDKNYTCF 147
Query: 98 LPWDLIKQITWQVLRGVSYCHRHACI-HRDIKPENILLTANGVVKLCDFGFARLIRD 153
+P +IK I VL SY H I HRD+KP NIL+ NG VKL DFG + + D
Sbjct: 148 IPIQVIKCIIKSVLNSFSYIHNEKNICHRDVKPSNILMDKNGRVKLSDFGESEYMVD 204
|
| >3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A* Length = 277 | Back alignment and structure |
|---|
Score = 129 bits (326), Expect = 6e-36
Identities = 49/169 (28%), Positives = 70/169 (41%), Gaps = 33/169 (19%)
Query: 2 ERYEKIGKLGEGSYGVVFKCRNRDTGQVVAIK----KFLESEEDPLIRKIALREIRLLKS 57
+ Y +G GS+G V + T A K F+E + +EI ++KS
Sbjct: 9 QYYTLENTIGRGSWGEVKIAVQKGTRIRRAAKKIPKYFVEDVDR------FKQEIEIMKS 62
Query: 58 LKHPNLVNLLEVFRRKKKLHLVFEFC----------DHTVLNELENHPHGLPWDLIKQIT 107
L HPN++ L E F ++LV E C V E + +I
Sbjct: 63 LDHPNIIRLYETFEDNTDIYLVMELCTGGELFERVVHKRVFRESD----------AARIM 112
Query: 108 WQVLRGVSYCHRHACIHRDIKPENILLTA---NGVVKLCDFGFARLIRD 153
VL V+YCH+ HRD+KPEN L + +KL DFG A +
Sbjct: 113 KDVLSAVAYCHKLNVAHRDLKPENFLFLTDSPDSPLKLIDFGLAARFKP 161
|
| >3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A* Length = 277 | Back alignment and structure |
|---|
Score = 39.1 bits (92), Expect = 8e-04
Identities = 9/29 (31%), Positives = 14/29 (48%)
Query: 198 DFLKRCLDKDPLRRWSCDQLLRHPYFNGY 226
++R L K P +R + Q L H +F
Sbjct: 240 SLIRRLLTKSPKQRITSLQALEHEWFEKQ 268
|
| >2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ... Length = 367 | Back alignment and structure |
|---|
Score = 131 bits (331), Expect = 6e-36
Identities = 53/163 (32%), Positives = 84/163 (51%), Gaps = 18/163 (11%)
Query: 2 ERYEKIGKLGEGSYGVVFKCRNRDTGQVVAIKKFLESEEDPLIRKIALREIRLLKSLKHP 61
ERY+ + +G G+YG V + TG VA+KK + + K RE+RLLK +KH
Sbjct: 29 ERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHE 88
Query: 62 NLVNLLEVFRRKKKLH------LVFEFCD---HTVL--NELENHPHGLPWDLIKQITWQV 110
N++ LL+VF + L LV + ++ +L + D ++ + +Q+
Sbjct: 89 NVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTD-------DHVQFLIYQI 141
Query: 111 LRGVSYCHRHACIHRDIKPENILLTANGVVKLCDFGFARLIRD 153
LRG+ Y H IHRD+KP N+ + + +K+ DFG AR D
Sbjct: 142 LRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTAD 184
|
| >2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ... Length = 367 | Back alignment and structure |
|---|
Score = 43.9 bits (104), Expect = 3e-05
Identities = 15/64 (23%), Positives = 24/64 (37%), Gaps = 21/64 (32%)
Query: 197 IDFLKRCLDKDPLRRWSCDQLLRHPYFNGYY--------------FEVPD-------EMQ 235
+D L++ L D +R + Q L H YF Y+ E D +
Sbjct: 289 VDLLEKMLVLDSDKRITAAQALAHAYFAQYHDPDDEPVADPYDQSLESRDLLIDEWKSLT 348
Query: 236 YEEI 239
Y+E+
Sbjct: 349 YDEV 352
|
| >2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A Length = 316 | Back alignment and structure |
|---|
Score = 129 bits (326), Expect = 1e-35
Identities = 46/172 (26%), Positives = 69/172 (40%), Gaps = 37/172 (21%)
Query: 2 ERYEKIGK--LGEGSYGVVFKCRNRDTGQVVAIK----KFLESEEDPLIRKIALREIRLL 55
+ Y+ + + LGEG++ V C N T Q A+K + RE+ +L
Sbjct: 12 DVYQ-LQEDVLGEGAHARVQTCINLITSQEYAVKIIEKQPGHIRSR------VFREVEML 64
Query: 56 KSLK-HPNLVNLLEVFRRKKKLHLVFEFC------DHTV----LNELENHPHGLPWDLIK 104
+ H N++ L+E F + + +LVFE H NELE
Sbjct: 65 YQCQGHRNVLELIEFFEEEDRFYLVFEKMRGGSILSHIHKRRHFNELE----------AS 114
Query: 105 QITWQVLRGVSYCHRHACIHRDIKPENILLT---ANGVVKLCDFGFARLIRD 153
+ V + + H HRD+KPENIL VK+CDF I+
Sbjct: 115 VVVQDVASALDFLHNKGIAHRDLKPENILCEHPNQVSPVKICDFDLGSGIKL 166
|
| >3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A* Length = 299 | Back alignment and structure |
|---|
Score = 128 bits (324), Expect = 1e-35
Identities = 56/285 (19%), Positives = 102/285 (35%), Gaps = 98/285 (34%)
Query: 2 ERYEKIGK-LGEGSYGVVFKCRNRDTGQVVAIKKFLESEEDPLIRKIAL--REIRLLKSL 58
+ Y+ + LG G G V + N+ T + A+K ++ RE+ L
Sbjct: 17 DDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKM---------LQDCPKARREVELHWRA 67
Query: 59 -KHPNLVNLLEVF----RRKKKLHLVFEFCD------------HTVLNELENHPHGLPWD 101
+ P++V +++V+ +K L +V E D E E
Sbjct: 68 SQCPHIVRIVDVYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTERE--------- 118
Query: 102 LIKQITWQVLRGVSYCHRHACIHRDIKPENILLT---ANGVVKLCDFGFARLIRDLIPRH 158
+I + + Y H HRD+KPEN+L T N ++KL DFGFA+
Sbjct: 119 -ASEIMKSIGEAIQYLHSINIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTG----- 172
Query: 159 LHIFQTNEYFK-------GVSL--------P-HAENVVPLE------IKIGKPAATNIYL 196
+Y K GV + P ++ + + + I++G+
Sbjct: 173 ------EKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRMGQ-------- 218
Query: 197 IDF---------------LKRCLDKDPLRRWSCDQLLRHPYFNGY 226
+F ++ L +P +R + + + HP+
Sbjct: 219 YEFPNPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMNHPWIMQS 263
|
| >3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei} Length = 504 | Back alignment and structure |
|---|
Score = 132 bits (333), Expect = 2e-35
Identities = 57/176 (32%), Positives = 78/176 (44%), Gaps = 34/176 (19%)
Query: 2 ERYEKIGKLGEGSYGVVFKCRNRDTGQVVAIK----KFLESEEDPLIRKIA-------LR 50
E Y K+ KLG G+YG V C+ ++ AIK + K
Sbjct: 36 ESYFKVRKLGSGAYGEVLLCKEKNGHSEKAIKVIKKSQFDKGRYSDDNKNIEKFHEEIYN 95
Query: 51 EIRLLKSLKHPNLVNLLEVFRRKKKLHLVFEFCD----------HTVLNELENHPHGLPW 100
EI LLKSL HPN++ L +VF KK +LV EF + +E +
Sbjct: 96 EISLLKSLDHPNIIKLFDVFEDKKYFYLVTEFYEGGELFEQIINRHKFDECD-------- 147
Query: 101 DLIKQITWQVLRGVSYCHRHACIHRDIKPENILLT---ANGVVKLCDFGFARLIRD 153
I Q+L G+ Y H+H +HRDIKPENILL + +K+ DFG +
Sbjct: 148 --AANIMKQILSGICYLHKHNIVHRDIKPENILLENKNSLLNIKIVDFGLSSFFSK 201
|
| >3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei} Length = 504 | Back alignment and structure |
|---|
Score = 40.8 bits (96), Expect = 4e-04
Identities = 6/29 (20%), Positives = 13/29 (44%)
Query: 198 DFLKRCLDKDPLRRWSCDQLLRHPYFNGY 226
+ +K L D +R + ++ L + Y
Sbjct: 280 ELIKLMLTYDYNKRCTAEEALNSRWIKKY 308
|
| >1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7 Length = 387 | Back alignment and structure |
|---|
Score = 130 bits (328), Expect = 2e-35
Identities = 45/169 (26%), Positives = 74/169 (43%), Gaps = 33/169 (19%)
Query: 2 ERYEKIGKLGEGSYGVVFKCRNRDTGQVVAIK----KFLESEEDPLIRKIALREIRLLKS 57
+ Y+ + +LG G++GVV +C + TG+V K + + EI ++
Sbjct: 51 DYYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPYPLDKYT------VKNEISIMNQ 104
Query: 58 LKHPNLVNLLEVFRRKKKLHLVFEFC-----------DHTVLNELENHPHGLPWDLIKQI 106
L HP L+NL + F K ++ L+ EF + ++E E +
Sbjct: 105 LHHPKLINLHDAFEDKYEMVLILEFLSGGELFDRIAAEDYKMSEAE----------VINY 154
Query: 107 TWQVLRGVSYCHRHACIHRDIKPENILLTA--NGVVKLCDFGFARLIRD 153
Q G+ + H H+ +H DIKPENI+ VK+ DFG A +
Sbjct: 155 MRQACEGLKHMHEHSIVHLDIKPENIMCETKKASSVKIIDFGLATKLNP 203
|
| >3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii} Length = 285 | Back alignment and structure |
|---|
Score = 127 bits (322), Expect = 2e-35
Identities = 46/166 (27%), Positives = 75/166 (45%), Gaps = 22/166 (13%)
Query: 2 ERYEKIGKLGEGSYGVVFKCRNRDTGQVVAIK-----KFLESEEDPLIRKIALREIRLLK 56
+ + KLG G++G V R +G IK + E I EI +LK
Sbjct: 22 DLFIFKRKLGSGAFGDVHLVEERSSGLERVIKTINKDRSQVPMEQ--IE----AEIEVLK 75
Query: 57 SLKHPNLVNLLEVFRRKKKLHLVFEFC------DHTVLNELENHPHGLPWDLIKQITWQV 110
SL HPN++ + EVF +++V E C + V + L + ++ Q+
Sbjct: 76 SLDHPNIIKIFEVFEDYHNMYIVMETCEGGELLERIV--SAQARGKALSEGYVAELMKQM 133
Query: 111 LRGVSYCHRHACIHRDIKPENILLT---ANGVVKLCDFGFARLIRD 153
+ ++Y H +H+D+KPENIL + +K+ DFG A L +
Sbjct: 134 MNALAYFHSQHVVHKDLKPENILFQDTSPHSPIKIIDFGLAELFKS 179
|
| >3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A Length = 573 | Back alignment and structure |
|---|
Score = 131 bits (332), Expect = 5e-35
Identities = 45/169 (26%), Positives = 76/169 (44%), Gaps = 33/169 (19%)
Query: 2 ERYEKIGKLGEGSYGVVFKCRNRDTGQVVAIK----KFLESEEDPLIRKIALREIRLLKS 57
+ Y+ +LG G++GVV + R TG A K +E +EI+ +
Sbjct: 157 DHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKET------VRKEIQTMSV 210
Query: 58 LKHPNLVNLLEVFRRKKKLHLVFEFC-----------DHTVLNELENHPHGLPWDLIKQI 106
L+HP LVNL + F ++ +++EF +H ++E E +
Sbjct: 211 LRHPTLVNLHDAFEDDNEMVMIYEFMSGGELFEKVADEHNKMSEDE----------AVEY 260
Query: 107 TWQVLRGVSYCHRHACIHRDIKPENILLT--ANGVVKLCDFGFARLIRD 153
QV +G+ + H + +H D+KPENI+ T + +KL DFG +
Sbjct: 261 MRQVCKGLCHMHENNYVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDP 309
|
| >2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A Length = 342 | Back alignment and structure |
|---|
Score = 128 bits (323), Expect = 6e-35
Identities = 46/167 (27%), Positives = 75/167 (44%), Gaps = 31/167 (18%)
Query: 2 ERYEKIGKLGEGSYGVVFKCRNRDTGQVVAIKKFLESEEDPLIRKIALREIR-LLKSLKH 60
+ YE +G GSY V +C ++ T A+K +S+ DP EI LL+ +H
Sbjct: 22 DGYEVKEDIGVGSYSVCKRCIHKATNMEFAVKIIDKSKRDP------TEEIEILLRYGQH 75
Query: 61 PNLVNLLEVFRRKKKLHLVFEFC----------DHTVLNELENHPHGLPWDLIKQITWQV 110
PN++ L +V+ K +++V E +E E + + +
Sbjct: 76 PNIITLKDVYDDGKYVYVVTELMKGGELLDKILRQKFFSERE----------ASAVLFTI 125
Query: 111 LRGVSYCHRHACIHRDIKPENILLTANG----VVKLCDFGFARLIRD 153
+ V Y H +HRD+KP NIL +++CDFGFA+ +R
Sbjct: 126 TKTVEYLHAQGVVHRDLKPSNILYVDESGNPESIRICDFGFAKQLRA 172
|
| >2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens} Length = 373 | Back alignment and structure |
|---|
Score = 128 bits (323), Expect = 8e-35
Identities = 48/171 (28%), Positives = 72/171 (42%), Gaps = 35/171 (20%)
Query: 2 ERYE--KIGKLGEGSYGVVFKCRNRDTGQVVAIK----KFLESEEDPLIRKIALREIRLL 55
Y K LG G +G V KC TG +A K + ++ +E+ EI ++
Sbjct: 87 SFYTVSKTEILGGGRFGQVHKCEETATGLKLAAKIIKTRGMKDKEE------VKNEISVM 140
Query: 56 KSLKHPNLVNLLEVFRRKKKLHLVFEFC-----------DHTVLNELENHPHGLPWDLIK 104
L H NL+ L + F K + LV E+ + L EL+ +K
Sbjct: 141 NQLDHANLIQLYDAFESKNDIVLVMEYVDGGELFDRIIDESYNLTELDTI------LFMK 194
Query: 105 QITWQVLRGVSYCHRHACIHRDIKPENILLT--ANGVVKLCDFGFARLIRD 153
QI G+ + H+ +H D+KPENIL +K+ DFG AR +
Sbjct: 195 QI----CEGIRHMHQMYILHLDLKPENILCVNRDAKQIKIIDFGLARRYKP 241
|
| >3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A Length = 377 | Back alignment and structure |
|---|
Score = 127 bits (321), Expect = 1e-34
Identities = 46/297 (15%), Positives = 83/297 (27%), Gaps = 72/297 (24%)
Query: 6 KIGK-LGEGSYGVVFKCRNRDTGQVVAIK-----------------------KFLESEED 41
G LG+ + +++TG+ + + L ++
Sbjct: 76 VRGTVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKN 135
Query: 42 PLIRKIALREIR---LLKSLKHPNLVNLLEVFRRKKKLHLVFEF-----CDHTVLNELEN 93
K+ LR I L+K + ++ + R L F + T L +
Sbjct: 136 QKQAKVHLRFIFPFDLVKDPQKKKMIRVRLDERDMWVLSRFFLYPRMQSNLQTFGEVLLS 195
Query: 94 HP---HGLPWDLIKQITWQVLRGVSYCHRHACIHRDIKPENILLTANGVVKLCDFGFAR- 149
H L Q+T QV+R ++ H + +H ++P +I+L G V L F
Sbjct: 196 HSSTHKSLVHHARLQLTLQVIRLLASLHHYGLVHTYLRPVDIVLDQRGGVFLTGFEHLVR 255
Query: 150 -----------------LIRDLIPRHLHIFQTNEYFKGV---------------SLP-HA 176
L H + LP
Sbjct: 256 DGARVVSSVSRGFEPPELEARRATISYHRDRRTLMTFSFDAWALGLVIYWIWCADLPITK 315
Query: 177 ENVVPLEIKIGKPAATNI--YLIDFLKRCLDKDPLRRWSCDQLLRHPYFNGYYFEVP 231
+ + I + NI + L+ L R Q + P + E+
Sbjct: 316 DAALGGSEWIFRSCK-NIPQPVRALLEGFLRYPKEDRLLPLQAMETPEYEQLRTELS 371
|
| >3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A* Length = 309 | Back alignment and structure |
|---|
Score = 126 bits (318), Expect = 1e-34
Identities = 42/151 (27%), Positives = 73/151 (48%), Gaps = 9/151 (5%)
Query: 9 KLGEGSYGVVFKCRNRDTGQVVAIKKFLESEEDPLIRKIALREIRLLKSLKHPNLVNLLE 68
K+G GS+G V + G VA+K +E + LRE+ ++K L+HPN+V +
Sbjct: 44 KIGAGSFGTVHRAEWH--GSDVAVKILMEQDFHAERVNEFLREVAIMKRLRHPNIVLFMG 101
Query: 69 VFRRKKKLHLVFEFCD----HTVLNELENHPHGLPWDLIKQITWQVLRGVSYCHRHAC-- 122
+ L +V E+ + +L++ L + + V +G++Y H
Sbjct: 102 AVTQPPNLSIVTEYLSRGSLYRLLHKSGAREQ-LDERRRLSMAYDVAKGMNYLHNRNPPI 160
Query: 123 IHRDIKPENILLTANGVVKLCDFGFARLIRD 153
+HR++K N+L+ VK+CDFG +RL
Sbjct: 161 VHRNLKSPNLLVDKKYTVKVCDFGLSRLKAS 191
|
| >2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A* Length = 434 | Back alignment and structure |
|---|
Score = 127 bits (322), Expect = 3e-34
Identities = 63/318 (19%), Positives = 112/318 (35%), Gaps = 83/318 (26%)
Query: 2 ERYEKIGKLGEGSYGVVFKCRNRDTGQVVAIKKFLESEEDPLIRKIALREIRLL-KSLKH 60
LG GS G V + G+ VA+K+ L D IAL EI+LL +S H
Sbjct: 15 NLVVSEKILGYGSSGTV-VFQGSFQGRPVAVKRMLIDFCD-----IALMEIKLLTESDDH 68
Query: 61 PNLVNLLEVFRRKKKLHLVFEFCDHTVLNELENH------PHGLPWDLIKQITWQVLRGV 114
PN++ + L++ E C+ + + +E+ + Q+ GV
Sbjct: 69 PNVIRYYCSETTDRFLYIALELCNLNLQDLVESKNVSDENLKLQKEYNPISLLRQIASGV 128
Query: 115 SYCHRHACIHRDIKPENILLT-------------ANGVVKLCDFGFARLIRDLIPRHLHI 161
++ H IHRD+KP+NIL++ N + + DFG + +
Sbjct: 129 AHLHSLKIIHRDLKPQNILVSTSSRFTADQQTGAENLRILISDFGLCKKLDS-------- 180
Query: 162 FQTNEYFKGVSLPHAENVVPLEIKIGKPAATNIYLI-DFLKRCLDKDPLRR-------WS 213
+ P+ T+ + + L+ + RR +S
Sbjct: 181 ----------------GQSSFRTNLNNPSGTSGWRAPELLEESNNLQTKRRLTRSIDIFS 224
Query: 214 CDQLL-------RHPY----------FNGYY-FEVPDEMQYEEIT-------QRCLDKDP 248
+ +HP+ G + + + + + +D DP
Sbjct: 225 MGCVFYYILSKGKHPFGDKYSRESNIIRGIFSLDEMKCLHDRSLIAEATDLISQMIDHDP 284
Query: 249 LRRWSCDQLLRHPYFNGY 266
L+R + ++LRHP F
Sbjct: 285 LKRPTAMKVLRHPLFWPK 302
|
| >3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} PDB: 3c4c_A* 3c4d_A* 3idp_A* 3ii5_A* 3d4q_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 2fb8_A* 4dbn_A* 1uwj_A* 1uwh_A* 3q96_A* Length = 289 | Back alignment and structure |
|---|
Score = 123 bits (312), Expect = 6e-34
Identities = 38/146 (26%), Positives = 67/146 (45%), Gaps = 5/146 (3%)
Query: 9 KLGEGSYGVVFKCRNRDTGQVVAIKKFLESEEDPLIRKIALREIRLLKSLKHPNLVNLLE 68
++G GS+G V+K + VA+K + P + E+ +L+ +H N++ +
Sbjct: 31 RIGSGSFGTVYKGKWHGD---VAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMG 87
Query: 69 VFRRKKKLHLVFEFCDH-TVLNELENHPHGLPWDLIKQITWQVLRGVSYCHRHACIHRDI 127
+L +V ++C+ ++ + L + I Q RG+ Y H + IHRD+
Sbjct: 88 YST-APQLAIVTQWCEGSSLYHHLHASETKFEMKKLIDIARQTARGMDYLHAKSIIHRDL 146
Query: 128 KPENILLTANGVVKLCDFGFARLIRD 153
K NI L + VK+ DFG A
Sbjct: 147 KSNNIFLHEDNTVKIGDFGLATEKSR 172
|
| >2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens} Length = 349 | Back alignment and structure |
|---|
Score = 125 bits (316), Expect = 7e-34
Identities = 44/165 (26%), Positives = 82/165 (49%), Gaps = 27/165 (16%)
Query: 2 ERYEKIGKLGEGSYGVVFKCRNRDTGQVVAIKKFLESEEDPLIRKIALREIRLLKSLKHP 61
+ +E +LG G+ +V++C+ + T + A+K ++ + ++R EI +L L HP
Sbjct: 53 DFFEVESELGRGATSIVYRCKQKGTQKPYALKVLKKTVDKKIVR----TEIGVLLRLSHP 108
Query: 62 NLVNLLEVFRRKKKLHLVFEFC----------DHTVLNELENHPHGLPWDLIKQITWQVL 111
N++ L E+F ++ LV E + +E + D +KQI L
Sbjct: 109 NIIKLKEIFETPTEISLVLELVTGGELFDRIVEKGYYSERDAA------DAVKQI----L 158
Query: 112 RGVSYCHRHACIHRDIKPENILLT---ANGVVKLCDFGFARLIRD 153
V+Y H + +HRD+KPEN+L + +K+ DFG ++++
Sbjct: 159 EAVAYLHENGIVHRDLKPENLLYATPAPDAPLKIADFGLSKIVEH 203
|
| >2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens} Length = 349 | Back alignment and structure |
|---|
Score = 40.0 bits (94), Expect = 6e-04
Identities = 9/28 (32%), Positives = 17/28 (60%)
Query: 198 DFLKRCLDKDPLRRWSCDQLLRHPYFNG 225
D +++ + DP +R + Q L+HP+ G
Sbjct: 284 DLVRKLIVLDPKKRLTTFQALQHPWVTG 311
|
| >1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C Length = 400 | Back alignment and structure |
|---|
Score = 126 bits (318), Expect = 7e-34
Identities = 43/175 (24%), Positives = 71/175 (40%), Gaps = 42/175 (24%)
Query: 2 ERYEKIGK-LGEGSYGVVFKCRNRDTGQVVAIKKFLESEEDPLIRKIAL--REIRLLKSL 58
+ Y+ + LG G G V + N+ T + A+K +++ RE+ L
Sbjct: 61 DDYKVTSQVLGLGINGKVLQIFNKRTQEKFALK---------MLQDCPKARREVELHWRA 111
Query: 59 -KHPNLVNLLEVF----RRKKKLHLVFEFCD------------HTVLNELENHPHGLPWD 101
+ P++V +++V+ +K L +V E D E E
Sbjct: 112 SQCPHIVRIVDVYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTERE--------- 162
Query: 102 LIKQITWQVLRGVSYCHRHACIHRDIKPENILLT---ANGVVKLCDFGFARLIRD 153
+I + + Y H HRD+KPEN+L T N ++KL DFGFA+
Sbjct: 163 -ASEIMKSIGEAIQYLHSINIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTS 216
|
| >2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens} Length = 319 | Back alignment and structure |
|---|
Score = 124 bits (312), Expect = 1e-33
Identities = 34/159 (21%), Positives = 67/159 (42%), Gaps = 5/159 (3%)
Query: 9 KLGEGSYGVVFKCRNRDTGQVVAIKKFLESEEDPLIRKIALREIRLLKSLKHPNLVNLLE 68
+G+G +G V+ R VAI+ ++ K RE+ + +H N+V +
Sbjct: 40 LIGKGRFGQVYHGRWHGE---VAIRLIDIERDNEDQLKAFKREVMAYRQTRHENVVLFMG 96
Query: 69 VFRRKKKLHLVFEFCDH-TVLNELENHPHGLPWDLIKQITWQVLRGVSYCHRHACIHRDI 127
L ++ C T+ + + + L + +QI ++++G+ Y H +H+D+
Sbjct: 97 ACMSPPHLAIITSLCKGRTLYSVVRDAKIVLDVNKTRQIAQEIVKGMGYLHAKGILHKDL 156
Query: 128 KPENILLTANGVVKLCDFGFARLIRDLIPRHLHIFQTNE 166
K +N+ NG V + DFG + L +
Sbjct: 157 KSKNVFYD-NGKVVITDFGLFSISGVLQAGRREDKLRIQ 194
|
| >4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A* Length = 287 | Back alignment and structure |
|---|
Score = 122 bits (309), Expect = 2e-33
Identities = 38/155 (24%), Positives = 69/155 (44%), Gaps = 15/155 (9%)
Query: 9 KLGEGSYGVVFKCRNRDTGQVVAIKKFLESEEDPLIRKIAL-----REIRLLKSLKHPNL 63
++G+G +G+V K R VVAIK + + + I RE+ ++ +L HPN+
Sbjct: 26 QIGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKFQEFQREVFIMSNLNHPNI 85
Query: 64 VNLLEVFRRKKKLHLVFEFCDH-TVLNELENHPHGLPWDLIKQITWQVLRGVSYCHRHA- 121
V L + +V EF + + L + H + W + ++ + G+ Y
Sbjct: 86 VKLYGLM--HNPPRMVMEFVPCGDLYHRLLDKAHPIKWSVKLRLMLDIALGIEYMQNQNP 143
Query: 122 -CIHRDIKPENILLTANG-----VVKLCDFGFARL 150
+HRD++ NI L + K+ DFG ++
Sbjct: 144 PIVHRDLRSPNIFLQSLDENAPVCAKVADFGLSQQ 178
|
| >3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A Length = 325 | Back alignment and structure |
|---|
Score = 123 bits (310), Expect = 2e-33
Identities = 50/159 (31%), Positives = 72/159 (45%), Gaps = 29/159 (18%)
Query: 9 KLGEGSYGVVFKCRNRDTGQVVAIKKFLESEEDPLIRKIALREIRLLKSLK-HPNLVNLL 67
LGEGS+ + KC ++ + Q A+K + E +EI LK + HPN+V L
Sbjct: 18 PLGEGSFSICRKCVHKKSNQAFAVKIISKRMEANT-----QKEITALKLCEGHPNIVKLH 72
Query: 68 EVFRRKKKLHLVFEFC------DHTV----LNELENHPHGLPWDLIKQITWQVLRGVSYC 117
EVF + LV E + +E E I +++ VS+
Sbjct: 73 EVFHDQLHTFLVMELLNGGELFERIKKKKHFSETE----------ASYIMRKLVSAVSHM 122
Query: 118 HRHACIHRDIKPENILLT---ANGVVKLCDFGFARLIRD 153
H +HRD+KPEN+L T N +K+ DFGFARL
Sbjct: 123 HDVGVVHRDLKPENLLFTDENDNLEIKIIDFGFARLKPP 161
|
| >3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A Length = 325 | Back alignment and structure |
|---|
Score = 40.0 bits (94), Expect = 5e-04
Identities = 6/55 (10%), Positives = 13/55 (23%), Gaps = 1/55 (1%)
Query: 198 DFLKRCLDKDPLRRWSCDQLLRHPYFNGYYFEVPDEMQYEEITQRCLDKDPLRRW 252
D ++ L DP +R L + + ++
Sbjct: 249 DLIQGLLTVDPNKRLKMSGLRYNEWLQDGS-QLSSNPLMTPDILGSSGAAVHTCV 302
|
| >3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} Length = 413 | Back alignment and structure |
|---|
Score = 124 bits (312), Expect = 5e-33
Identities = 44/284 (15%), Positives = 85/284 (29%), Gaps = 70/284 (24%)
Query: 10 LGEGSYGVVFKCRNRDTGQVVAIK-----------------------KFLESEEDPLIRK 46
LG+ + +++TG+ + + L ++ K
Sbjct: 86 LGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAK 145
Query: 47 IALREIRLLKSLKHPNLVNLLEVFRRKKKLHLVFEF--------CDHTVLNELENHPHG- 97
+ LR I +K P ++ V ++ + ++ F T L +H
Sbjct: 146 VHLRFIFPFDLVKDPQKKKMIRVRLDERDMWVLSRFFLYPRMQSNLQTFGEVLLSHSSTH 205
Query: 98 --LPWDLIKQITWQVLRGVSYCHRHACIHRDIKPENILLTANGVVKLCDFGFARLIRD-- 153
L Q+T QV+R ++ H + +H ++P +I+L G V L F
Sbjct: 206 KSLVHHARLQLTLQVIRLLASLHHYGLVHTYLRPVDIVLDQRGGVFLTGFEHLVRDGASA 265
Query: 154 -------------LIPRHLHIFQTNEYFK---------GVSL--------P-HAENVVPL 182
R L Q + G+++ P + +
Sbjct: 266 VSPIGRGFAPPETTAERMLPFGQHHPTLMTFAFDTWTLGLAIYWIWCADLPNTDDAALGG 325
Query: 183 EIKIGKPAATNI--YLIDFLKRCLDKDPLRRWSCDQLLRHPYFN 224
I + NI + L+ L R Q + P +
Sbjct: 326 SEWIFRSCK-NIPQPVRALLEGFLRYPKEDRLLPLQAMETPEYE 368
|
| >2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens} Length = 307 | Back alignment and structure |
|---|
Score = 122 bits (307), Expect = 5e-33
Identities = 53/153 (34%), Positives = 76/153 (49%), Gaps = 17/153 (11%)
Query: 9 KLGEGSYGVVFKCRNRDTGQVVAIKKFLESEEDPLIRKIALREIRLLKSLKHPNLVNLLE 68
+G G++GVV K + R + VAIK+ E RK + E+R L + HPN+V L
Sbjct: 15 VVGRGAFGVVCKAKWR--AKDVAIKQIESESE----RKAFIVELRQLSRVNHPNIVKLYG 68
Query: 69 VFRRKKKLHLVFEFCD----HTVLNELENHPHGLPWDLIKQITWQVLRGVSYCHRHAC-- 122
+ LV E+ + + VL+ E P+ Q +GV+Y H
Sbjct: 69 AC--LNPVCLVMEYAEGGSLYNVLHGAEPLPY-YTAAHAMSWCLQCSQGVAYLHSMQPKA 125
Query: 123 -IHRDIKPENILLTANG-VVKLCDFGFARLIRD 153
IHRD+KP N+LL A G V+K+CDFG A I+
Sbjct: 126 LIHRDLKPPNLLLVAGGTVLKICDFGTACDIQT 158
|
| >3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A* Length = 336 | Back alignment and structure |
|---|
Score = 122 bits (307), Expect = 1e-32
Identities = 45/174 (25%), Positives = 72/174 (41%), Gaps = 40/174 (22%)
Query: 2 ERYEKIGK--LGEGSYGVVFKCRNRDTGQVVAIKKFLESEEDPLIRKIALREIRLLKSL- 58
+ Y+ + K LG G G V +C +R TGQ A+K + A +E+
Sbjct: 28 DDYQ-LSKQVLGLGVNGKVLECFHRRTGQKCALKLLYD-------SPKARQEVDHHWQAS 79
Query: 59 KHPNLVNLLEVF----RRKKKLHLVFEFCD------------HTVLNELENHPHGLPWDL 102
P++V +L+V+ K+ L ++ E + E E
Sbjct: 80 GGPHIVCILDVYENMHHGKRCLLIIMECMEGGELFSRIQERGDQAFTERE---------- 129
Query: 103 IKQITWQVLRGVSYCHRHACIHRDIKPENILLT---ANGVVKLCDFGFARLIRD 153
+I + + + H H HRD+KPEN+L T + V+KL DFGFA+
Sbjct: 130 AAEIMRDIGTAIQFLHSHNIAHRDVKPENLLYTSKEKDAVLKLTDFGFAKETTQ 183
|
| >3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} Length = 271 | Back alignment and structure |
|---|
Score = 118 bits (299), Expect = 3e-32
Identities = 48/158 (30%), Positives = 76/158 (48%), Gaps = 16/158 (10%)
Query: 9 KLGEGSYGVVFKCRNRDTGQVVAIKKFLESEEDPLIRKIA--LREIRLLKSLKHPNLVNL 66
+G G +G V++ G VA+K ++ + + I +E +L LKHPN++ L
Sbjct: 14 IIGIGGFGKVYRAFWI--GDEVAVKAARHDPDEDISQTIENVRQEAKLFAMLKHPNIIAL 71
Query: 67 LEVFRRKKKLHLVFEFCDHTVLNELENHPHGLPWDLIKQITWQVLRGVSYCHRHA---CI 123
V ++ L LV EF LN + +P D++ Q+ RG++Y H A I
Sbjct: 72 RGVCLKEPNLCLVMEFARGGPLNRVL-SGKRIPPDILVNWAVQIARGMNYLHDEAIVPII 130
Query: 124 HRDIKPENILLT--------ANGVVKLCDFGFARLIRD 153
HRD+K NIL+ +N ++K+ DFG AR
Sbjct: 131 HRDLKSSNILILQKVENGDLSNKILKITDFGLAREWHR 168
|
| >3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens} Length = 365 | Back alignment and structure |
|---|
Score = 120 bits (302), Expect = 6e-32
Identities = 34/190 (17%), Positives = 59/190 (31%), Gaps = 31/190 (16%)
Query: 2 ERYEKIGKLGEGSYGVVFKCRNRD-----TGQVVAIKKFLESEEDPLIRKIALREIRLLK 56
+ LGEG++ V++ D Q +K + +P I + + LK
Sbjct: 65 KLVYVHHLLGEGAFAQVYEATQGDLNDAKNKQKFVLKV--QKPANPWEFYIGTQLMERLK 122
Query: 57 SLKHPNLVNLLEVFRRKKKLHLVFEFCDHTVLNELENH-----PHGLPWDLIKQITWQVL 111
+ + LV E + L N +P L+ ++L
Sbjct: 123 PSMQHMFMKFYSAHLFQNGSVLVGELYSYGTLLNAINLYKNTPEKVMPQGLVISFAMRML 182
Query: 112 RGVSYCHRHACIHRDIKPENILLT-----------ANGVVKLCDFGFARLIRDLIPRHLH 160
+ H IH DIKP+N +L + + L D G + +
Sbjct: 183 YMIEQVHDCEIIHGDIKPDNFILGNGFLEQDDEDDLSAGLALIDLGQS--------IDMK 234
Query: 161 IFQTNEYFKG 170
+F F
Sbjct: 235 LFPKGTIFTA 244
|
| >1q8y_A SR protein kinase; transferase; HET: ADP ADE; 2.05A {Saccharomyces cerevisiae} SCOP: d.144.1.7 PDB: 1q8z_A 1q97_A* 1q99_A* 1how_A 2jd5_A Length = 373 | Back alignment and structure |
|---|
Score = 120 bits (303), Expect = 7e-32
Identities = 67/348 (19%), Positives = 119/348 (34%), Gaps = 77/348 (22%)
Query: 3 RYEKIGKLGEGSYGVVFKCRNRDTGQVVAIKKFLESEEDPLIRKIALREIRLLKSLK--- 59
RY + KLG G + V+ ++ VA+K + ++ + A EI+LL+ +
Sbjct: 20 RYILVRKLGWGHFSTVWLAKDMVNNTHVAMK-IVRGDKV--YTEAAEDEIKLLQRVNDAD 76
Query: 60 --------HPNLVNLLEVF--RRKKKLH--LVFEFCDHTVLNEL-ENHPHGLPWDLIKQI 106
+++ LL+ F + +H +VFE +L + + G+P +KQI
Sbjct: 77 NTKEDSMGANHILKLLDHFNHKGPNGVHVVMVFEVLGENLLALIKKYEHRGIPLIYVKQI 136
Query: 107 TWQVLRGVSYCHRHA-CIHRDIKPENILL------TANGVVKLCDFGFARLIRDLIPRHL 159
+ Q+L G+ Y HR IH DIKPEN+L+ +K+ D G A + +
Sbjct: 137 SKQLLLGLDYMHRRCGIIHTDIKPENVLMEIVDSPENLIQIKIADLGNACWYDE---HYT 193
Query: 160 HIFQTN---------------------------EYFKGVSL--PHAENVVPLEIK----- 185
+ QT E G L P + +
Sbjct: 194 NSIQTREYRSPEVLLGAPWGCGADIWSTACLIFELITGDFLFEPDEGHSYTKDDDHIAQI 253
Query: 186 ---IGKP-------AATNIYLIDFLKRCLDKDPLRRWSCDQLLRHPYFNGYYFEVPDEMQ 235
+G+ + + L+ W + +L Y F + +
Sbjct: 254 IELLGELPSYLLRNGKYTRTFFNSRGLLRNISKLKFWPLEDVLT----EKYKFSKDEAKE 309
Query: 236 YEEITQRCLDKDPLRRWSCDQLLRHPYFNGYYFEVPDEMQYEEITQVS 283
+ L DP +R L+ HP+ + E+
Sbjct: 310 ISDFLSPMLQLDPRKRADAGGLVNHPWLKDTLGMEEIRVPDRELYGSG 357
|
| >2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis} Length = 681 | Back alignment and structure |
|---|
Score = 122 bits (307), Expect = 2e-31
Identities = 61/267 (22%), Positives = 101/267 (37%), Gaps = 51/267 (19%)
Query: 3 RYEKIGKLGEGSYGVVFKCRNRDT---GQVVAIKKFLESEEDPLIRKIALREIRLLKSLK 59
+YE G + G G ++ D G+ V +K L D + +A+ E + L +
Sbjct: 81 QYEVKGCIAHGGLGWIYLAL--DRNVNGRPVVLK-GLVHSGDAEAQAMAMAERQFLAEVV 137
Query: 60 HPNLVNLLEV-----FRRKKKLHLVFEFCDHTVLNELENHPHGLPWDLIKQITWQVLRGV 114
HP++V + ++V E+ L + LP ++L +
Sbjct: 138 HPSIVQIFNFVEHTDRHGDPVGYIVMEYVGGQSLKRSKGQK--LPVAEAIAYLLEILPAL 195
Query: 115 SYCHRHACIHRDIKPENILLTANGVVKLCDFGFARLIRDLIPRHLHIFQTNEYFKGVSLP 174
SY H ++ D+KPENI+LT +KL D G I +++ T +
Sbjct: 196 SYLHSIGLVYNDLKPENIMLTEEQ-LKLIDLGAVSRINS----FGYLYGTPGFQ------ 244
Query: 175 HAENVVPLEIKIGKP-AATNIYLIDFLKRCLDKDPLRRWSCDQLLRHPYFNG-YYFEVPD 232
P EI P AT+IY + L L P NG Y +P+
Sbjct: 245 -----AP-EIVRTGPTVATDIYTVGRTLAAL------------TLDLPTRNGRYVDGLPE 286
Query: 233 EM-------QYEEITQRCLDKDPLRRW 252
+ Y + +R +D DP +R+
Sbjct: 287 DDPVLKTYDSYGRLLRRAIDPDPRQRF 313
|
| >3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 2qlu_A* Length = 322 | Back alignment and structure |
|---|
Score = 115 bits (291), Expect = 1e-30
Identities = 50/283 (17%), Positives = 91/283 (32%), Gaps = 50/283 (17%)
Query: 9 KLGEGSYGVVFKCRNRDTGQVVAIKKFLESEEDPLIRKIALREIRLLKSLKHPNLVNLL- 67
G +G V+K + + VA+K F ++ + E+ L +KH N++ +
Sbjct: 31 VKARGRFGCVWKAQLL--NEYVAVKIFPIQDKQSWQNE---YEVYSLPGMKHENILQFIG 85
Query: 68 ---EVFRRKKKLHLVFEFCDHTVLNELENHPHGLPWDLIKQITWQVLRGVSYCHRHAC-- 122
L L+ F + L++ + + W+ + I + RG++Y H
Sbjct: 86 AEKRGTSVDVDLWLITAFHEKGSLSDFL-KANVVSWNELCHIAETMARGLAYLHEDIPGL 144
Query: 123 --------IHRDIKPENILLTANGVVKLCDFGFARLIRDLIPRHLHIFQTN--------- 165
HRDIK +N+LL N + DFG A
Sbjct: 145 KDGHKPAISHRDIKSKNVLLKNNLTACIADFGLALK---FEAGKSAGDTHGQVGTRRYMA 201
Query: 166 -EYFKGVSLPHAEN----------VVPLEIKIGKPAATNIY------LIDFLKRCLDKDP 208
E +G + +V E+ AA + + + +
Sbjct: 202 PEVLEGAINFQRDAFLRIDMYAMGLVLWELASRCTAADGPVDEYMLPFEEEIGQHPSLED 261
Query: 209 LRRWSCDQLLRHPYFNGYYFEVPDEMQYEEITQRCLDKDPLRR 251
++ + R P Y+ + E + C D D R
Sbjct: 262 MQEVVVHKKKR-PVLRDYWQKHAGMAMLCETIEECWDHDAEAR 303
|
| >4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp} Length = 294 | Back alignment and structure |
|---|
Score = 115 bits (289), Expect = 2e-30
Identities = 48/154 (31%), Positives = 75/154 (48%), Gaps = 3/154 (1%)
Query: 2 ERYEKIGKLGEGSYGVVFKCRNRDTGQVVAIKKFLESE--EDPLIRKIALREIRLLKSLK 59
ERY+ + KLG G V+ + VAIK + E K RE+ L
Sbjct: 11 ERYKIVDKLGGGGMSTVYLAEDTILNIKVAIK-AIFIPPREKEETLKRFEREVHNSSQLS 69
Query: 60 HPNLVNLLEVFRRKKKLHLVFEFCDHTVLNELENHPHGLPWDLIKQITWQVLRGVSYCHR 119
H N+V++++V +LV E+ + L+E L D T Q+L G+ + H
Sbjct: 70 HQNIVSMIDVDEEDDCYYLVMEYIEGPTLSEYIESHGPLSVDTAINFTNQILDGIKHAHD 129
Query: 120 HACIHRDIKPENILLTANGVVKLCDFGFARLIRD 153
+HRDIKP+NIL+ +N +K+ DFG A+ + +
Sbjct: 130 MRIVHRDIKPQNILIDSNKTLKIFDFGIAKALSE 163
|
| >3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} PDB: 3kmw_A* 3rep_A* Length = 271 | Back alignment and structure |
|---|
Score = 113 bits (286), Expect = 3e-30
Identities = 22/149 (14%), Positives = 52/149 (34%), Gaps = 12/149 (8%)
Query: 9 KLGEGSYGVVFKCRNRDTGQVVAIKKFLESEEDPLIRKIALREIRLLKSLKHPNLVNLLE 68
KL E G ++K R + G + +K + + E L+ HPN++ +L
Sbjct: 17 KLNENHSGELWKGRWQ--GNDIVVKVLKVRDWSTRKSRDFNEECPRLRIFSHPNVLPVLG 74
Query: 69 VFRR--KKKLHLVFEFCD----HTVLNELENHPHGLPWDLIKQITWQVLRGVSYCHRHAC 122
+ L+ + + VL+E N + + + RG+++ H
Sbjct: 75 ACQSPPAPHPTLITHWMPYGSLYNVLHEGTNFV--VDQSQAVKFALDMARGMAFLHTLEP 132
Query: 123 --IHRDIKPENILLTANGVVKLCDFGFAR 149
+ ++++ + ++
Sbjct: 133 LIPRHALNSRSVMIDEDMTARISMADVKF 161
|
| >3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A* Length = 311 | Back alignment and structure |
|---|
Score = 113 bits (285), Expect = 8e-30
Identities = 45/158 (28%), Positives = 74/158 (46%), Gaps = 7/158 (4%)
Query: 2 ERYEKIGKLGEGSYGVVFKCRNRDTGQVVAIKKFLESE--EDPLIRKIALREIRLLKSLK 59
+RYE LG G V R+ + VA+K L ++ DP RE + +L
Sbjct: 12 DRYELGEILGFGGMSEVHLARDLRDHRDVAVK-VLRADLARDPSFYLRFRREAQNAAALN 70
Query: 60 HPNLVNLL---EVFRRKKKLH-LVFEFCDHTVLNELENHPHGLPWDLIKQITWQVLRGVS 115
HP +V + E L +V E+ D L ++ + + ++ + ++
Sbjct: 71 HPAIVAVYDTGEAETPAGPLPYIVMEYVDGVTLRDIVHTEGPMTPKRAIEVIADACQALN 130
Query: 116 YCHRHACIHRDIKPENILLTANGVVKLCDFGFARLIRD 153
+ H++ IHRD+KP NI+++A VK+ DFG AR I D
Sbjct: 131 FSHQNGIIHRDVKPANIMISATNAVKVMDFGIARAIAD 168
|
| >2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis} Length = 309 | Back alignment and structure |
|---|
Score = 112 bits (283), Expect = 2e-29
Identities = 39/153 (25%), Positives = 64/153 (41%), Gaps = 3/153 (1%)
Query: 3 RYEKIGKLGEGSYGVVFKCRNRDTGQVVAIKKFLESE--EDPLIRKIALREIRLLKSLKH 60
Y +G G G V++ + ++VA+K + DP+ R RE R L+
Sbjct: 35 PYRLRRLVGRGGMGDVYEAEDTVRERIVALK-LMSETLSSDPVFRTRMQREARTAGRLQE 93
Query: 61 PNLVNLLEVFRRKKKLHLVFEFCDHTVLNELENHPHGLPWDLIKQITWQVLRGVSYCHRH 120
P++V + + +L++ + L + L I Q+ + H
Sbjct: 94 PHVVPIHDFGEIDGQLYVDMRLINGVDLAAMLRRQGPLAPPRAVAIVRQIGSALDAAHAA 153
Query: 121 ACIHRDIKPENILLTANGVVKLCDFGFARLIRD 153
HRD+KPENIL++A+ L DFG A D
Sbjct: 154 GATHRDVKPENILVSADDFAYLVDFGIASATTD 186
|
| >3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 3q32_A* 3rvg_A* 3tjc_A* 3tjd_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* 3io7_A* 3kck_A* 3jy9_A* Length = 295 | Back alignment and structure |
|---|
Score = 110 bits (278), Expect = 7e-29
Identities = 50/156 (32%), Positives = 82/156 (52%), Gaps = 9/156 (5%)
Query: 5 EKIGKLGEGSYGVVFKCR----NRDTGQVVAIKKFLESEEDPLIRKIALREIRLLKSLKH 60
+ + +LG+G++G V CR +TG+VVA+KK S E+ + REI +LKSL+H
Sbjct: 13 KFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEH--LRDFEREIEILKSLQH 70
Query: 61 PNLVNLLEV--FRRKKKLHLVFEFCDHTVLNE-LENHPHGLPWDLIKQITWQVLRGVSYC 117
N+V V ++ L L+ E+ + L + L+ H + + Q T Q+ +G+ Y
Sbjct: 71 DNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKGMEYL 130
Query: 118 HRHACIHRDIKPENILLTANGVVKLCDFGFARLIRD 153
IHRD+ NIL+ VK+ DFG +++
Sbjct: 131 GTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQ 166
|
| >2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 111 bits (279), Expect = 8e-29
Identities = 50/156 (32%), Positives = 82/156 (52%), Gaps = 9/156 (5%)
Query: 5 EKIGKLGEGSYGVVFKCR----NRDTGQVVAIKKFLESEEDPLIRKIALREIRLLKSLKH 60
+ + +LG+G++G V CR +TG+VVA+KK S E+ + REI +LKSL+H
Sbjct: 44 KFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEH--LRDFEREIEILKSLQH 101
Query: 61 PNLVNLLEV--FRRKKKLHLVFEFCDHTVLNE-LENHPHGLPWDLIKQITWQVLRGVSYC 117
N+V V ++ L L+ E+ + L + L+ H + + Q T Q+ +G+ Y
Sbjct: 102 DNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKGMEYL 161
Query: 118 HRHACIHRDIKPENILLTANGVVKLCDFGFARLIRD 153
IHRD+ NIL+ VK+ DFG +++
Sbjct: 162 GTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQ 197
|
| >3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A* Length = 301 | Back alignment and structure |
|---|
Score = 110 bits (277), Expect = 1e-28
Identities = 35/154 (22%), Positives = 65/154 (42%), Gaps = 18/154 (11%)
Query: 9 KLGEGSYGVVFKCRNRDTGQVVAIKKFLESEEDPLIRKIALREIRLLKSLKHPNLVNLLE 68
+G+G YG V++ + G+ VA+K F +E R+ E+ L+H N++ +
Sbjct: 15 CVGKGRYGEVWRGSWQ--GENVAVKIFSSRDEKSWFRE---TELYNTVMLRHENILGFIA 69
Query: 69 VFRRKKKLH----LVFEFCDHTVLNELENHPHGLPWDLIKQITWQVLRGVSYCH------ 118
+ L+ + + L + L +I + G+++ H
Sbjct: 70 SDMTSRHSSTQLWLITHYHEMGSLYDYL-QLTTLDTVSCLRIVLSIASGLAHLHIEIFGT 128
Query: 119 --RHACIHRDIKPENILLTANGVVKLCDFGFARL 150
+ A HRD+K +NIL+ NG + D G A +
Sbjct: 129 QGKPAIAHRDLKSKNILVKKNGQCCIADLGLAVM 162
|
| >4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 3eyg_A* 3eyh_A* Length = 302 | Back alignment and structure |
|---|
Score = 110 bits (277), Expect = 1e-28
Identities = 43/159 (27%), Positives = 72/159 (45%), Gaps = 8/159 (5%)
Query: 2 ERYEKIGKLGEGSYGVVFKCR----NRDTGQVVAIKKFLESEEDPLIRKIALREIRLLKS 57
++I LGEG +G V CR +TG+ VA+K L+ E +EI +L++
Sbjct: 21 RFLKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKS-LKPESGGNHIADLKKEIEILRN 79
Query: 58 LKHPNLVNLLEVFRRKKK--LHLVFEFCDHTVLNE-LENHPHGLPWDLIKQITWQVLRGV 114
L H N+V + + L+ EF L E L + + + + Q+ +G+
Sbjct: 80 LYHENIVKYKGICTEDGGNGIKLIMEFLPSGSLKEYLPKNKNKINLKQQLKYAVQICKGM 139
Query: 115 SYCHRHACIHRDIKPENILLTANGVVKLCDFGFARLIRD 153
Y +HRD+ N+L+ + VK+ DFG + I
Sbjct: 140 DYLGSRQYVHRDLAARNVLVESEHQVKIGDFGLTKAIET 178
|
| >3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A* Length = 377 | Back alignment and structure |
|---|
Score = 111 bits (279), Expect = 2e-28
Identities = 47/146 (32%), Positives = 71/146 (48%), Gaps = 2/146 (1%)
Query: 9 KLGEGSYGVVFKCRNRDTGQVVAIKKFLESEEDPLIRKIALREIRLLKSLKHPNLVNLLE 68
++G G++G VF R R +VA+K E+ L K L+E R+LK HPN+V L+
Sbjct: 121 QIGRGNFGEVFSGRLRADNTLVAVKSCRETLPPDLKAKF-LQEARILKQYSHPNIVRLIG 179
Query: 69 VFRRKKKLHLVFEFCDHTVLNE-LENHPHGLPWDLIKQITWQVLRGVSYCHRHACIHRDI 127
V +K+ +++V E L L + Q+ G+ Y CIHRD+
Sbjct: 180 VCTQKQPIYIVMELVQGGDFLTFLRTEGARLRVKTLLQMVGDAAAGMEYLESKCCIHRDL 239
Query: 128 KPENILLTANGVVKLCDFGFARLIRD 153
N L+T V+K+ DFG +R D
Sbjct: 240 AARNCLVTEKNVLKISDFGMSREEAD 265
|
| >3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} Length = 337 | Back alignment and structure |
|---|
Score = 109 bits (274), Expect = 4e-28
Identities = 36/158 (22%), Positives = 73/158 (46%), Gaps = 20/158 (12%)
Query: 9 KLGEGSYGVVFKCRNRDTGQVVAIKKFLESEEDPLIRKIALREIRLLKSLKHPNLVNLLE 68
++G+G YG V+ + R G+ VA+K F +EE R+ EI ++H N++ +
Sbjct: 44 QIGKGRYGEVWMGKWR--GEKVAVKVFFTTEEASWFRE---TEIYQTVLMRHENILGFIA 98
Query: 69 VFRRKKKLH----LVFEFCDH-TVLNELENHPHGLPWDLIKQITWQVLRGVSYCH----- 118
+ L+ ++ ++ ++ + L++ L + ++ + + G+ + H
Sbjct: 99 ADIKGTGSWTQLYLITDYHENGSLYDYLKSTT--LDAKSMLKLAYSSVSGLCHLHTEIFS 156
Query: 119 ---RHACIHRDIKPENILLTANGVVKLCDFGFARLIRD 153
+ A HRD+K +NIL+ NG + D G A
Sbjct: 157 TQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVKFIS 194
|
| >3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* Length = 318 | Back alignment and structure |
|---|
Score = 108 bits (273), Expect = 6e-28
Identities = 49/159 (30%), Positives = 78/159 (49%), Gaps = 10/159 (6%)
Query: 2 ERYEKIGKLGEGSYGVVFKCR----NRDTGQVVAIKKFLESEEDPLIRKIALREIRLLKS 57
+KI LGEG +G V N TG++VA+K L+++ P R +EI +L++
Sbjct: 31 RYLKKIRDLGEGHFGKVSLYCYDPTNDGTGEMVAVKA-LKADAGPQHRSGWKQEIDILRT 89
Query: 58 LKHPNLVNLLEV--FRRKKKLHLVFEFCDHTVLNE-LENHPHGLPWDLIKQITWQVLRGV 114
L H +++ L LV E+ L + L H GL L+ Q+ G+
Sbjct: 90 LYHEHIIKYKGCCEDAGAASLQLVMEYVPLGSLRDYLPRHSIGLA-QLL-LFAQQICEGM 147
Query: 115 SYCHRHACIHRDIKPENILLTANGVVKLCDFGFARLIRD 153
+Y H IHRD+ N+LL + +VK+ DFG A+ + +
Sbjct: 148 AYLHAQHYIHRDLAARNVLLDNDRLVKIGDFGLAKAVPE 186
|
| >3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 3pjc_A* 1yvj_A* Length = 327 | Back alignment and structure |
|---|
Score = 108 bits (273), Expect = 6e-28
Identities = 48/156 (30%), Positives = 80/156 (51%), Gaps = 9/156 (5%)
Query: 5 EKIGKLGEGSYGVVFKCR----NRDTGQVVAIKKFLESEEDPLIRKIALREIRLLKSLKH 60
+ I +LG+G++G V CR +TG +VA+K+ S D ++ REI++LK+L
Sbjct: 26 KYISQLGKGNFGSVELCRYDPLGDNTGALVAVKQLQHSGPDQ--QRDFQREIQILKALHS 83
Query: 61 PNLVNLLEV--FRRKKKLHLVFEFCDHTVLNE-LENHPHGLPWDLIKQITWQVLRGVSYC 117
+V V ++ L LV E+ L + L+ H L + + Q+ +G+ Y
Sbjct: 84 DFIVKYRGVSYGPGRQSLRLVMEYLPSGCLRDFLQRHRARLDASRLLLYSSQICKGMEYL 143
Query: 118 HRHACIHRDIKPENILLTANGVVKLCDFGFARLIRD 153
C+HRD+ NIL+ + VK+ DFG A+L+
Sbjct: 144 GSRRCVHRDLAARNILVESEAHVKIADFGLAKLLPL 179
|
| >3kvw_A DYRK2, dual specificity tyrosine-phosphorylation-regulat 2; KI-(Y)-phosphorylation REG kinase 2, PSK-H2, kinase, structural genomics consortium; HET: SEP PTR IRB; 2.28A {Homo sapiens} PDB: 3k2l_A* Length = 429 | Back alignment and structure |
|---|
Score = 110 bits (276), Expect = 1e-27
Identities = 49/154 (31%), Positives = 81/154 (52%), Gaps = 14/154 (9%)
Query: 3 RYEKIGKLGEGSYGVVFKCRNRDTGQVVAIKKFLESEEDPLIRKIALREIRLLKSLKH-- 60
RYE + +G+GS+G V K + Q VA+K + +E+ + A EIR+L+ L+
Sbjct: 98 RYEVLKVIGKGSFGQVVKAYDHKVHQHVALK-MVRNEKR--FHRQAAEEIRILEHLRKQD 154
Query: 61 ----PNLVNLLEVFRRKKKLHLVFEFCDHTVLNEL--ENHPHGLPWDLIKQITWQVLRGV 114
N++++LE F + + + FE L EL +N G L+++ +L+ +
Sbjct: 155 KDNTMNVIHMLENFTFRNHICMTFELLSMN-LYELIKKNKFQGFSLPLVRKFAHSILQCL 213
Query: 115 SYCHRHACIHRDIKPENILLTANG--VVKLCDFG 146
H++ IH D+KPENILL G +K+ DFG
Sbjct: 214 DALHKNRIIHCDLKPENILLKQQGRSGIKVIDFG 247
|
| >3kvw_A DYRK2, dual specificity tyrosine-phosphorylation-regulat 2; KI-(Y)-phosphorylation REG kinase 2, PSK-H2, kinase, structural genomics consortium; HET: SEP PTR IRB; 2.28A {Homo sapiens} PDB: 3k2l_A* Length = 429 | Back alignment and structure |
|---|
Score = 50.9 bits (122), Expect = 2e-07
Identities = 15/37 (40%), Positives = 21/37 (56%)
Query: 196 LIDFLKRCLDKDPLRRWSCDQLLRHPYFNGYYFEVPD 232
+DFLK+CL+ DP R + Q LRHP+ + P
Sbjct: 385 FLDFLKQCLEWDPAVRMTPGQALRHPWLRRRLPKPPT 421
|
| >3kvw_A DYRK2, dual specificity tyrosine-phosphorylation-regulat 2; KI-(Y)-phosphorylation REG kinase 2, PSK-H2, kinase, structural genomics consortium; HET: SEP PTR IRB; 2.28A {Homo sapiens} PDB: 3k2l_A* Length = 429 | Back alignment and structure |
|---|
Score = 40.9 bits (96), Expect = 3e-04
Identities = 11/32 (34%), Positives = 17/32 (53%)
Query: 241 QRCLDKDPLRRWSCDQLLRHPYFNGYYFEVPD 272
++CL+ DP R + Q LRHP+ + P
Sbjct: 390 KQCLEWDPAVRMTPGQALRHPWLRRRLPKPPT 421
|
| >1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A* Length = 342 | Back alignment and structure |
|---|
Score = 107 bits (270), Expect = 2e-27
Identities = 37/154 (24%), Positives = 70/154 (45%), Gaps = 18/154 (11%)
Query: 9 KLGEGSYGVVFKCRNRDTGQVVAIKKFLESEEDPLIRKIALREIRLLKSLKHPNLVNLLE 68
+G+G +G V++ + R G+ VA+K F EE R+ EI L+H N++ +
Sbjct: 49 SIGKGRFGEVWRGKWR--GEEVAVKIFSSREERSWFRE---AEIYQTVMLRHENILGFIA 103
Query: 69 VFRRKKKLH----LVFEFCDHTVLNELENHPHGLPWDLIKQITWQVLRGVSYCH------ 118
+ LV ++ +H L + + + + + + ++ G+++ H
Sbjct: 104 ADNKDNGTWTQLWLVSDYHEHGSLFDYL-NRYTVTVEGMIKLALSTASGLAHLHMEIVGT 162
Query: 119 --RHACIHRDIKPENILLTANGVVKLCDFGFARL 150
+ A HRD+K +NIL+ NG + D G A
Sbjct: 163 QGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVR 196
|
| >3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ... Length = 288 | Back alignment and structure |
|---|
Score = 106 bits (266), Expect = 3e-27
Identities = 45/149 (30%), Positives = 74/149 (49%), Gaps = 9/149 (6%)
Query: 9 KLGEGSYGVVFKCRNRDTGQVVAIKKFLE--SEEDPLIRKIALREIRLLKSLKHPNLVNL 66
KLG G YG V++ + VA+K E E + L+E ++K +KHPNLV L
Sbjct: 20 KLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEF-----LKEAAVMKEIKHPNLVQL 74
Query: 67 LEVFRRKKKLHLVFEFCDHTVLNE--LENHPHGLPWDLIKQITWQVLRGVSYCHRHACIH 124
L V R+ +++ EF + L + E + + ++ + Q+ + Y + IH
Sbjct: 75 LGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKKNFIH 134
Query: 125 RDIKPENILLTANGVVKLCDFGFARLIRD 153
RD+ N L+ N +VK+ DFG +RL+
Sbjct: 135 RDLAARNCLVGENHLVKVADFGLSRLMTG 163
|
| >3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens} Length = 336 | Back alignment and structure |
|---|
Score = 106 bits (267), Expect = 4e-27
Identities = 36/156 (23%), Positives = 64/156 (41%), Gaps = 20/156 (12%)
Query: 9 KLGEGSYGVVFKCRNRDTGQVVAIKKFLESEEDPLIRKIALREIRLLKSLKHPNLVNLLE 68
+G G YG V+K + VA+K F + I + + I + ++H N+ +
Sbjct: 20 LIGRGRYGAVYKGSLD--ERPVAVKVFSFANRQNFINE---KNIYRVPLMEHDNIARFIV 74
Query: 69 VFRR-----KKKLHLVFEFCDHTVLNELENHPHGLPWDLIKQITWQVLRGVSYCH----- 118
R + + LV E+ + L + H W ++ V RG++Y H
Sbjct: 75 GDERVTADGRMEYLLVMEYYPNGSLXKYL-SLHTSDWVSSCRLAHSVTRGLAYLHTELPR 133
Query: 119 ----RHACIHRDIKPENILLTANGVVKLCDFGFARL 150
+ A HRD+ N+L+ +G + DFG +
Sbjct: 134 GDHYKPAISHRDLNSRNVLVKNDGTCVISDFGLSMR 169
|
| >1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A Length = 495 | Back alignment and structure |
|---|
Score = 108 bits (271), Expect = 7e-27
Identities = 44/149 (29%), Positives = 74/149 (49%), Gaps = 9/149 (6%)
Query: 9 KLGEGSYGVVFKCRNRDTGQVVAIK--KFLESEEDPLIRKIALREIRLLKSLKHPNLVNL 66
KLG G YG V++ + VA+K K E + L+E ++K +KHPNLV L
Sbjct: 227 KLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEF-----LKEAAVMKEIKHPNLVQL 281
Query: 67 LEVFRRKKKLHLVFEFCDHTVLNEL--ENHPHGLPWDLIKQITWQVLRGVSYCHRHACIH 124
L V R+ +++ EF + L + E + + ++ + Q+ + Y + IH
Sbjct: 282 LGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKKNFIH 341
Query: 125 RDIKPENILLTANGVVKLCDFGFARLIRD 153
R++ N L+ N +VK+ DFG +RL+
Sbjct: 342 RNLAARNCLVGENHLVKVADFGLSRLMTG 370
|
| >2vx3_A Dual specificity tyrosine-phosphorylation- regula kinase 1A; serine/threonine-protein kinase, minibrain homolog, nucleotide-binding, transferase; HET: PTR D15 P6G; 2.40A {Homo sapiens} PDB: 2wo6_A* 3anq_A* 3anr_A* Length = 382 | Back alignment and structure |
|---|
Score = 105 bits (265), Expect = 2e-26
Identities = 46/159 (28%), Positives = 77/159 (48%), Gaps = 16/159 (10%)
Query: 2 ERYEKIGKLGEGSYGVVFKCRNRDTGQVVAIKKFLESEEDPLIRKIALREIRLLKSLKHP 61
+RYE +G+GS+G V K +R + VAI K +++++ A E+RLL+ +
Sbjct: 54 DRYEIDSLIGKGSFGQVVKAYDRVEQEWVAI-KIIKNKKA--FLNQAQIEVRLLELMNKH 110
Query: 62 ------NLVNLLEVFRRKKKLHLVFEFCDHTVLNEL--ENHPHGLPWDLIKQITWQVLRG 113
+V+L F + L LVFE + L +L + G+ +L ++ Q+
Sbjct: 111 DTEMKYYIVHLKRHFMFRNHLCLVFEMLSYN-LYDLLRNTNFRGVSLNLTRKFAQQMCTA 169
Query: 114 VSYCHRHAC--IHRDIKPENILLT--ANGVVKLCDFGFA 148
+ + IH D+KPENILL +K+ DFG +
Sbjct: 170 LLFLATPELSIIHCDLKPENILLCNPKRSAIKIVDFGSS 208
|
| >2vx3_A Dual specificity tyrosine-phosphorylation- regula kinase 1A; serine/threonine-protein kinase, minibrain homolog, nucleotide-binding, transferase; HET: PTR D15 P6G; 2.40A {Homo sapiens} PDB: 2wo6_A* 3anq_A* 3anr_A* Length = 382 | Back alignment and structure |
|---|
Score = 47.8 bits (114), Expect = 2e-06
Identities = 10/28 (35%), Positives = 13/28 (46%)
Query: 196 LIDFLKRCLDKDPLRRWSCDQLLRHPYF 223
D + R LD DP R L+H +F
Sbjct: 349 FKDLILRMLDYDPKTRIQPYYALQHSFF 376
|
| >1uu3_A HPDK1, 3-phosphoinositide dependent protein kinase-1; PKB, inhibitor, LY333531, diabetes, cancer, transferase, serine/threonine-protein kinase; HET: SEP LY4; 1.7A {Homo sapiens} SCOP: d.144.1.7 PDB: 1okz_A* 1oky_A* 1uu7_A* 1uu8_A* 2biy_A* 3rwp_A* 2xch_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* ... Length = 310 | Back alignment and structure |
|---|
Score = 103 bits (259), Expect = 5e-26
Identities = 62/263 (23%), Positives = 98/263 (37%), Gaps = 53/263 (20%)
Query: 10 LGEGSYGVVFKCRNRDTGQVVAIKKFLESEEDPLIR--KIA--LREIRLLKSLKHPNLVN 65
LGEGS+ V R T + AIK E+ +I+ K+ RE ++ L HP V
Sbjct: 38 LGEGSFSTVVLARELATSREYAIKIL---EKRHIIKENKVPYVTRERDVMSRLDHPFFVK 94
Query: 66 LLEVFRRKKKLHLVFEFCDHTVLNELENH---PHGLPWDLIKQITWQVLRGVSYCHRHAC 122
L F+ +KL+ + + EL + + T +++ + Y H
Sbjct: 95 LYFTFQDDEKLYFGLSYAKN---GELLKYIRKIGSFDETCTRFYTAEIVSALEYLHGKGI 151
Query: 123 IHRDIKPENILLTANGVVKLCDFGFARLIRDLIPRHLH-------------IFQTNEYFK 169
IHRD+KPENILL + +++ DFG A+++ + + K
Sbjct: 152 IHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANSFVGTAQYVSPELLTEKSACK 211
Query: 170 GV---SL------------P-HAENVVPLEIKIGK-----PAATNIYLIDFLKRCLDKDP 208
+L P A N + KI K P D +++ L D
Sbjct: 212 SSDLWALGCIIYQLVAGLPPFRAGNEYLIFQKIIKLEYDFPEKFFPKARDLVEKLLVLDA 271
Query: 209 LRRWSC------DQLLRHPYFNG 225
+R C L HP+F
Sbjct: 272 TKRLGCEEMEGYGPLKAHPFFES 294
|
| >3llt_A Serine/threonine kinase-1, pflammer; lammer kinase, malaria, structural GE structural genomics consortium, SGC, transferase; HET: ANP; 2.50A {Plasmodium falciparum 3D7} Length = 360 | Back alignment and structure |
|---|
Score = 102 bits (255), Expect = 3e-25
Identities = 42/182 (23%), Positives = 75/182 (41%), Gaps = 46/182 (25%)
Query: 2 ERYEKIGKLGEGSYGVVFKCRNRDTGQVVAIKKFLESEEDPLIRKI------ALREIRLL 55
+ I K+G+G++G V C++ D + A+K ++R I A E +L
Sbjct: 35 NAFLVIRKMGDGTFGRVLLCQHIDNKKYYAVK---------VVRNIKKYTRSAKIEADIL 85
Query: 56 KSLKH-----PNLVNLLEVFRRKKKLHLVFEFCDHTVLNEL-ENHPHGLPWDLIKQITWQ 109
K +++ N+V F + L+FE ++ + N+ +G + IK +
Sbjct: 86 KKIQNDDINNNNIVKYHGKFMYYDHMCLIFEPLGPSLYEIITRNNYNGFHIEDIKLYCIE 145
Query: 110 VLRGVSYCHRHACIHRDIKPENILLTANGV-------------------------VKLCD 144
+L+ ++Y + + H D+KPENILL +KL D
Sbjct: 146 ILKALNYLRKMSLTHTDLKPENILLDDPYFEKSLITVRRVTDGKKIQIYRTKSTGIKLID 205
Query: 145 FG 146
FG
Sbjct: 206 FG 207
|
| >3llt_A Serine/threonine kinase-1, pflammer; lammer kinase, malaria, structural GE structural genomics consortium, SGC, transferase; HET: ANP; 2.50A {Plasmodium falciparum 3D7} Length = 360 | Back alignment and structure |
|---|
Score = 44.6 bits (106), Expect = 2e-05
Identities = 11/28 (39%), Positives = 14/28 (50%)
Query: 196 LIDFLKRCLDKDPLRRWSCDQLLRHPYF 223
DFL L DP R S +LL+H +
Sbjct: 332 FCDFLYSILQIDPTLRPSPAELLKHKFL 359
|
| >3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* Length = 267 | Back alignment and structure |
|---|
Score = 100 bits (251), Expect = 3e-25
Identities = 42/148 (28%), Positives = 67/148 (45%), Gaps = 9/148 (6%)
Query: 9 KLGEGSYGVVFKCRNRDTGQVVAIKKFLE--SEEDPLIRKIALREIRLLKSLKHPNLVNL 66
++G G +G+V + +V AIK E E+ + E ++ L HP LV L
Sbjct: 15 EIGSGQFGLVHLGYWLNKDKV-AIKTIREGAMSEEDF-----IEEAEVMMKLSHPKLVQL 68
Query: 67 LEVFRRKKKLHLVFEFCDHTVLNE-LENHPHGLPWDLIKQITWQVLRGVSYCHRHACIHR 125
V + + LV EF +H L++ L + + + V G++Y IHR
Sbjct: 69 YGVCLEQAPICLVTEFMEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLEEACVIHR 128
Query: 126 DIKPENILLTANGVVKLCDFGFARLIRD 153
D+ N L+ N V+K+ DFG R + D
Sbjct: 129 DLAARNCLVGENQVIKVSDFGMTRFVLD 156
|
| >1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A* Length = 313 | Back alignment and structure |
|---|
Score = 101 bits (253), Expect = 4e-25
Identities = 46/170 (27%), Positives = 75/170 (44%), Gaps = 27/170 (15%)
Query: 9 KLGEGSYGVVFKCR-----NRDTGQVVAIKKFLESEEDPLIRKIALREIRLLKSL-KHPN 62
LG G++G V + D VA+K L+ R+ + E+++L L H N
Sbjct: 30 TLGAGAFGKVVEATAYGLIKSDAAMTVAVKM-LKPSAHLTEREALMSELKVLSYLGNHMN 88
Query: 63 LVNLLEVFRRKKKLHLVFEFCDHTVLNE-------------------LENHPHGLPWDLI 103
+VNLL ++ E+C + L ++ DL+
Sbjct: 89 IVNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLL 148
Query: 104 KQITWQVLRGVSYCHRHACIHRDIKPENILLTANGVVKLCDFGFARLIRD 153
++QV +G+++ CIHRD+ NILLT + K+CDFG AR I++
Sbjct: 149 -SFSYQVAKGMAFLASKNCIHRDLAARNILLTHGRITKICDFGLARDIKN 197
|
| >3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A Length = 286 | Back alignment and structure |
|---|
Score = 100 bits (251), Expect = 4e-25
Identities = 21/149 (14%), Positives = 47/149 (31%), Gaps = 5/149 (3%)
Query: 3 RYEKIGKLGEGSYGVVFKCRNRDTGQVVAIKKFLESE--EDPLIRKIALREIRLLKSLKH 60
RY + G ++ + + VA+ F++ + + + L L +
Sbjct: 32 RYRLLIFHGGVPPLQFWQALDTALDRQVALT-FVDPQGVLPDDVLQETLSRTLRLSRIDK 90
Query: 61 PNLVNLLEVFRRKKKLHLVFEFCDHTVLNELENHPHGLPWDLIKQITWQVLRGVSYCHRH 120
P + +L+V + +V E+ L E+ + + + HR
Sbjct: 91 PGVARVLDVVHTRAGGLVVAEWIRGGSLQEVADT--SPSPVGAIRAMQSLAAAADAAHRA 148
Query: 121 ACIHRDIKPENILLTANGVVKLCDFGFAR 149
P + ++ +G V L
Sbjct: 149 GVALSIDHPSRVRVSIDGDVVLAYPATMP 177
|
| >3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens} Length = 327 | Back alignment and structure |
|---|
Score = 100 bits (252), Expect = 7e-25
Identities = 38/154 (24%), Positives = 71/154 (46%), Gaps = 7/154 (4%)
Query: 5 EKIGKLGEGSYGVVFKCR----NRDTGQVVAIKKFLESEEDPLIRKIALREIRLLKSLKH 60
+KI LG G++G V+K VAIK+ E+ ++I L E ++ S+ +
Sbjct: 18 KKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEI-LDEAYVMASVDN 76
Query: 61 PNLVNLLEVFRRKKKLHLVFEFCDHTVLNE-LENHPHGLPWDLIKQITWQVLRGVSYCHR 119
P++ LL + + L+ + L + + H + + Q+ +G++Y
Sbjct: 77 PHVCRLLGICL-TSTVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLED 135
Query: 120 HACIHRDIKPENILLTANGVVKLCDFGFARLIRD 153
+HRD+ N+L+ VK+ DFG A+L+
Sbjct: 136 RRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGA 169
|
| >3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} PDB: 3sxr_A* Length = 268 | Back alignment and structure |
|---|
Score = 99.2 bits (248), Expect = 8e-25
Identities = 42/148 (28%), Positives = 70/148 (47%), Gaps = 9/148 (6%)
Query: 9 KLGEGSYGVVFKCRNRDTGQVVAIK--KFLESEEDPLIRKIALREIRLLKSLKHPNLVNL 66
+LG G +GVV + + V A+K K ED +E + + L HP LV
Sbjct: 15 ELGSGQFGVVKLGKWKGQYDV-AVKMIKEGSMSEDEF-----FQEAQTMMKLSHPKLVKF 68
Query: 67 LEVFRRKKKLHLVFEFCDHTVLNE-LENHPHGLPWDLIKQITWQVLRGVSYCHRHACIHR 125
V ++ +++V E+ + L L +H GL + ++ + V G+++ H IHR
Sbjct: 69 YGVCSKEYPIYIVTEYISNGCLLNYLRSHGKGLEPSQLLEMCYDVCEGMAFLESHQFIHR 128
Query: 126 DIKPENILLTANGVVKLCDFGFARLIRD 153
D+ N L+ + VK+ DFG R + D
Sbjct: 129 DLAARNCLVDRDLCVKVSDFGMTRYVLD 156
|
| >3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens} Length = 325 | Back alignment and structure |
|---|
Score = 100 bits (250), Expect = 1e-24
Identities = 40/149 (26%), Positives = 64/149 (42%), Gaps = 5/149 (3%)
Query: 9 KLGEGSYGVVFK--CRNRDTGQV-VAIKKFLESEEDPLIRKIALREIRLLKSLKHPNLVN 65
+G G G V R V VAIK + R L E ++ HPN++
Sbjct: 56 IIGSGDSGEVCYGRLRVPGQRDVPVAIKALKAGYTERQRRDF-LSEASIMGQFDHPNIIR 114
Query: 66 LLEVFRRKKKLHLVFEFCDHTVLNE-LENHPHGLPWDLIKQITWQVLRGVSYCHRHACIH 124
L V R + +V E+ ++ L+ L H + + V G+ Y +H
Sbjct: 115 LEGVVTRGRLAMIVTEYMENGSLDTFLRTHDGQFTIMQLVGMLRGVGAGMRYLSDLGYVH 174
Query: 125 RDIKPENILLTANGVVKLCDFGFARLIRD 153
RD+ N+L+ +N V K+ DFG +R++ D
Sbjct: 175 RDLAARNVLVDSNLVCKVSDFGLSRVLED 203
|
| >3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A Length = 283 | Back alignment and structure |
|---|
Score = 98.8 bits (247), Expect = 2e-24
Identities = 41/148 (27%), Positives = 67/148 (45%), Gaps = 9/148 (6%)
Query: 9 KLGEGSYGVVFKCRNRDTGQVVAIK--KFLESEEDPLIRKIALREIRLLKSLKHPNLVNL 66
+LG G +GVV + R V AIK K ED + E +++ +L H LV L
Sbjct: 31 ELGTGQFGVVKYGKWRGQYDV-AIKMIKEGSMSEDEF-----IEEAKVMMNLSHEKLVQL 84
Query: 67 LEVFRRKKKLHLVFEFCDHTVLNE-LENHPHGLPWDLIKQITWQVLRGVSYCHRHACIHR 125
V +++ + ++ E+ + L L H + ++ V + Y +HR
Sbjct: 85 YGVCTKQRPIFIITEYMANGCLLNYLREMRHRFQTQQLLEMCKDVCEAMEYLESKQFLHR 144
Query: 126 DIKPENILLTANGVVKLCDFGFARLIRD 153
D+ N L+ GVVK+ DFG +R + D
Sbjct: 145 DLAARNCLVNDQGVVKVSDFGLSRYVLD 172
|
| >3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} Length = 298 | Back alignment and structure |
|---|
Score = 99.3 bits (248), Expect = 2e-24
Identities = 42/150 (28%), Positives = 67/150 (44%), Gaps = 6/150 (4%)
Query: 9 KLGEGSYGVVFKCRNRDTGQ---VVAIKKFLESEEDPLIRKIALREIRLLKSLKHPNLVN 65
+G+G +GVV+ D Q AIK E + LRE L++ L HPN++
Sbjct: 28 VIGKGHFGVVYHGEYIDQAQNRIQCAIKSLSRITEMQQVEAF-LREGLLMRGLNHPNVLA 86
Query: 66 LLEV-FRRKKKLHLVFEFCDHTVLNE-LENHPHGLPWDLIKQITWQVLRGVSYCHRHACI 123
L+ + + H++ + H L + + + + QV RG+ Y +
Sbjct: 87 LIGIMLPPEGLPHVLLPYMCHGDLLQFIRSPQRNPTVKDLISFGLQVARGMEYLAEQKFV 146
Query: 124 HRDIKPENILLTANGVVKLCDFGFARLIRD 153
HRD+ N +L + VK+ DFG AR I D
Sbjct: 147 HRDLAARNCMLDESFTVKVADFGLARDILD 176
|
| >3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 3q6w_A* 3r7o_A* 3q6u_A* 3cth_A* 3ce3_A* 3ctj_A* ... Length = 298 | Back alignment and structure |
|---|
Score = 98.5 bits (246), Expect = 3e-24
Identities = 38/150 (25%), Positives = 63/150 (42%), Gaps = 6/150 (4%)
Query: 9 KLGEGSYGVVFKCRNRDTGQV---VAIKKFLESEEDPLIRKIALREIRLLKSLKHPNLVN 65
+G G +G V+ D A+K + + + L E ++K HPN+++
Sbjct: 32 VIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQF-LTEGIIMKDFSHPNVLS 90
Query: 66 LLEV-FRRKKKLHLVFEFCDHTVLNE-LENHPHGLPWDLIKQITWQVLRGVSYCHRHACI 123
LL + R + +V + H L + N H + QV +G+ Y +
Sbjct: 91 LLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKYLASKKFV 150
Query: 124 HRDIKPENILLTANGVVKLCDFGFARLIRD 153
HRD+ N +L VK+ DFG AR + D
Sbjct: 151 HRDLAARNCMLDEKFTVKVADFGLARDMYD 180
|
| >4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens} Length = 384 | Back alignment and structure |
|---|
Score = 100 bits (250), Expect = 3e-24
Identities = 58/264 (21%), Positives = 109/264 (41%), Gaps = 57/264 (21%)
Query: 10 LGEGSYGVVFKCRNRDTGQVVAIK-----KFLESEEDPLIRKIALREIRLLKSLKHPNLV 64
+G+GS+G V + DT ++ A+K K +E E +R + +E+++++ L+HP LV
Sbjct: 23 IGKGSFGKVCIVQKNDTKKMYAMKYMNKQKCVERNE---VRNV-FKELQIMQGLEHPFLV 78
Query: 65 NLLEVFRRKKKLHLVFEFCDHTVLN--ELENH---PHGLPWDLIKQITWQVLRGVSYCHR 119
NL F+ ++ + +V + +L H + +K +++ + Y
Sbjct: 79 NLWYSFQDEEDMFMVVDLL-----LGGDLRYHLQQNVHFKEETVKLFICELVMALDYLQN 133
Query: 120 HACIHRDIKPENILLTANGVVKLCDFGFARLIRD-------------LIPRHLHIFQTNE 166
IHRD+KP+NILL +G V + DF A ++ + P +
Sbjct: 134 QRIIHRDMKPDNILLDEHGHVHITDFNIAAMLPRETQITTMAGTKPYMAPEMFSSRKGAG 193
Query: 167 YFKGV---SL----------------PHAENVVPLEIKIGK-----PAATNIYLIDFLKR 202
Y V SL + + + P+A + ++ LK+
Sbjct: 194 YSFAVDWWSLGVTAYELLRGRRPYHIRSSTSSKEIVHTFETTVVTYPSAWSQEMVSLLKK 253
Query: 203 CLDKDPLRRWSC-DQLLRHPYFNG 225
L+ +P +R+S + PY N
Sbjct: 254 LLEPNPDQRFSQLSDVQNFPYMND 277
|
| >2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ... Length = 373 | Back alignment and structure |
|---|
Score = 99.7 bits (249), Expect = 3e-24
Identities = 38/149 (25%), Positives = 66/149 (44%), Gaps = 5/149 (3%)
Query: 9 KLGEGSYGVVFK--CRNRDTGQV-VAIKKFLESEEDPLIRKIALREIRLLKSLKHPNLVN 65
+G G +G V + ++ VAIK + R L E ++ HPN++
Sbjct: 52 VVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDF-LGEASIMGQFDHPNIIR 110
Query: 66 LLEVFRRKKKLHLVFEFCDHTVLNE-LENHPHGLPWDLIKQITWQVLRGVSYCHRHACIH 124
L V + K + +V E+ ++ L+ L H + + + G+ Y +H
Sbjct: 111 LEGVVTKSKPVMIVTEYMENGSLDSFLRKHDAQFTVIQLVGMLRGIASGMKYLSDMGYVH 170
Query: 125 RDIKPENILLTANGVVKLCDFGFARLIRD 153
RD+ NIL+ +N V K+ DFG R++ D
Sbjct: 171 RDLAARNILINSNLVCKVSDFGLGRVLED 199
|
| >3v5q_A NT-3 growth factor receptor; kinase domain, kinase, phosphorylation, transferase-transfer inhibitor complex; HET: 0F4; 2.20A {Homo sapiens} Length = 297 | Back alignment and structure |
|---|
Score = 98.1 bits (245), Expect = 3e-24
Identities = 45/167 (26%), Positives = 72/167 (43%), Gaps = 25/167 (14%)
Query: 9 KLGEGSYGVVFKCRNRDTG-----QVVAIKKFLESEEDPLIRKIALREIRLLKSLKHPNL 63
+LGEG++G VF + +VA+K + RK RE LL +L+H ++
Sbjct: 22 ELGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPTLAA--RKDFQREAELLTNLQHEHI 79
Query: 64 VNLLEVFRRKKKLHLVFEFCDHTVLNEL--ENHPHGLPW---------------DLIKQI 106
V V L +VFE+ H LN+ + P + ++ I
Sbjct: 80 VKFYGVCGDGDPLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQML-HI 138
Query: 107 TWQVLRGVSYCHRHACIHRDIKPENILLTANGVVKLCDFGFARLIRD 153
Q+ G+ Y +HRD+ N L+ AN +VK+ DFG +R +
Sbjct: 139 ASQIASGMVYLASQHFVHRDLATRNCLVGANLLVKIGDFGMSRDVYS 185
|
| >1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ... Length = 322 | Back alignment and structure |
|---|
Score = 98.5 bits (246), Expect = 4e-24
Identities = 39/160 (24%), Positives = 72/160 (45%), Gaps = 16/160 (10%)
Query: 9 KLGEGSYGVVFKCR-----NRDTGQVVAIKKFLESEEDPLIRKIALREIRLLKSLKHPNL 63
+LG+GS+G+V++ + VAIK E+ + L E ++K ++
Sbjct: 32 ELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEF-LNEASVMKEFNCHHV 90
Query: 64 VNLLEVFRRKKKLHLVFEFCDHTVLNE--------LENHPHGLPWDLIK--QITWQVLRG 113
V LL V + + ++ E L + N+P P L K Q+ ++ G
Sbjct: 91 VRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADG 150
Query: 114 VSYCHRHACIHRDIKPENILLTANGVVKLCDFGFARLIRD 153
++Y + + +HRD+ N ++ + VK+ DFG R I +
Sbjct: 151 MAYLNANKFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYE 190
|
| >1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A* Length = 278 | Back alignment and structure |
|---|
Score = 97.3 bits (243), Expect = 6e-24
Identities = 39/146 (26%), Positives = 65/146 (44%), Gaps = 13/146 (8%)
Query: 9 KLGEGSYGVVFKCRNRDTGQVVAIK--KFLESEEDPLIRKIALREIRLLKSLKHPNLVNL 66
+G+G +G V R G VA+K K + + L E ++ L+H NLV L
Sbjct: 28 TIGKGEFGDVMLGDYR--GNKVAVKCIKNDATAQA------FLAEASVMTQLRHSNLVQL 79
Query: 67 LEV-FRRKKKLHLVFEFCDHTVLNEL--ENHPHGLPWDLIKQITWQVLRGVSYCHRHACI 123
L V K L++V E+ L + L D + + + V + Y + +
Sbjct: 80 LGVIVEEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEGNNFV 139
Query: 124 HRDIKPENILLTANGVVKLCDFGFAR 149
HRD+ N+L++ + V K+ DFG +
Sbjct: 140 HRDLAARNVLVSEDNVAKVSDFGLTK 165
|
| >1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 333 | Back alignment and structure |
|---|
Score = 98.2 bits (245), Expect = 6e-24
Identities = 36/150 (24%), Positives = 67/150 (44%), Gaps = 6/150 (4%)
Query: 9 KLGEGSYGVVFK-CRNRDTGQV---VAIKKFLESEEDPLIRKIALREIRLLKSLKHPNLV 64
+G G +G V+K +G+ VAIK + L E ++ H N++
Sbjct: 51 VIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDF-LGEAGIMGQFSHHNII 109
Query: 65 NLLEVFRRKKKLHLVFEFCDHTVLNE-LENHPHGLPWDLIKQITWQVLRGVSYCHRHACI 123
L V + K + ++ E+ ++ L++ L + + + G+ Y +
Sbjct: 110 RLEGVISKYKPMMIITEYMENGALDKFLREKDGEFSVLQLVGMLRGIAAGMKYLANMNYV 169
Query: 124 HRDIKPENILLTANGVVKLCDFGFARLIRD 153
HRD+ NIL+ +N V K+ DFG +R++ D
Sbjct: 170 HRDLAARNILVNSNLVCKVSDFGLSRVLED 199
|
| >1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ... Length = 350 | Back alignment and structure |
|---|
Score = 98.5 bits (246), Expect = 6e-24
Identities = 64/277 (23%), Positives = 118/277 (42%), Gaps = 69/277 (24%)
Query: 1 MERYEKIGKLGEGSYGVVFKCRNRDTGQVVAIKKFLESEEDPLIRK---IALREI----- 52
++++++I LG GS+G V +++++G A+K ++ K + L++I
Sbjct: 40 LDQFDRIKTLGTGSFGRVMLVKHKESGNHYAMK---------ILDKQKVVKLKQIEHTLN 90
Query: 53 --RLLKSLKHPNLVNLLEVFRRKKKLHLVFEFCDHTVLN--ELENH---PHGLPWDLIKQ 105
R+L+++ P LV L F+ L++V E+ E+ +H +
Sbjct: 91 EKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYV-----AGGEMFSHLRRIGRFSEPHARF 145
Query: 106 ITWQVLRGVSYCHRHACIHRDIKPENILLTANGVVKLCDFGFARLIRD-----------L 154
Q++ Y H I+RD+KPEN+L+ G +++ DFGFA+ ++ L
Sbjct: 146 YAAQIVLTFEYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWTLCGTPEAL 205
Query: 155 IPRHLHIFQTNEYFKGV---SL------------P-HAENVVPLEIKI--GK---PAATN 193
P I + Y K V +L P A+ + + KI GK P+ +
Sbjct: 206 APE---IILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVRFPSHFS 262
Query: 194 IYLIDFLKRCLDKDPLRRWSC-----DQLLRHPYFNG 225
L D L+ L D +R+ + + H +F
Sbjct: 263 SDLKDLLRNLLQVDLTKRFGNLKNGVNDIKNHKWFAT 299
|
| >1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A* Length = 281 | Back alignment and structure |
|---|
Score = 96.9 bits (242), Expect = 7e-24
Identities = 40/149 (26%), Positives = 71/149 (47%), Gaps = 6/149 (4%)
Query: 9 KLGEGSYGVVFK--CRNRDTGQV-VAIKKFLESEEDPLIRKIALREIRLLKSLKHPNLVN 65
+GEG +G V + + + + VAIK D + K L+E ++ HP++V
Sbjct: 22 CIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKF-LQEALTMRQFDHPHIVK 80
Query: 66 LLEVFRRKKKLHLVFEFCDHTVLNE-LENHPHGLPWDLIKQITWQVLRGVSYCHRHACIH 124
L+ V + + ++ E C L L+ + L + +Q+ ++Y +H
Sbjct: 81 LIGVIT-ENPVWIIMELCTLGELRSFLQVRKYSLDLASLILYAYQLSTALAYLESKRFVH 139
Query: 125 RDIKPENILLTANGVVKLCDFGFARLIRD 153
RDI N+L+++N VKL DFG +R + D
Sbjct: 140 RDIAARNVLVSSNDCVKLGDFGLSRYMED 168
|
| >1z57_A Dual specificity protein kinase CLK1; protein tyrosine kinase, splicing, human, 10Z-hymendialdisine, structural genomics; HET: DBQ; 1.70A {Homo sapiens} PDB: 2vag_A* Length = 339 | Back alignment and structure |
|---|
Score = 98.1 bits (245), Expect = 7e-24
Identities = 45/179 (25%), Positives = 77/179 (43%), Gaps = 44/179 (24%)
Query: 2 ERYEKIGKLGEGSYGVVFKCRNRDTG-QVVAIKKFLESEEDPLIRKI------ALREIRL 54
RYE + LGEG++G V +C + G + VA+K +++ + A EI++
Sbjct: 14 ARYEIVDTLGEGAFGKVVECIDHKAGGRHVAVK---------IVKNVDRYCEAARSEIQV 64
Query: 55 LKSLKHP------NLVNLLEVFRRKKKLHLVFEFCDHTVLNEL--ENHPHGLPWDLIKQI 106
L+ L V +LE F + +VFE + + EN D I+++
Sbjct: 65 LEHLNTTDPNSTFRCVQMLEWFEHHGHICIVFELLGLS-TYDFIKENGFLPFRLDHIRKM 123
Query: 107 TWQVLRGVSYCHRHACIHRDIKPENILLTANGV-------------------VKLCDFG 146
+Q+ + V++ H + H D+KPENIL + +K+ DFG
Sbjct: 124 AYQICKSVNFLHSNKLTHTDLKPENILFVQSDYTEAYNPKIKRDERTLINPDIKVVDFG 182
|
| >1z57_A Dual specificity protein kinase CLK1; protein tyrosine kinase, splicing, human, 10Z-hymendialdisine, structural genomics; HET: DBQ; 1.70A {Homo sapiens} PDB: 2vag_A* Length = 339 | Back alignment and structure |
|---|
Score = 45.7 bits (109), Expect = 8e-06
Identities = 12/47 (25%), Positives = 25/47 (53%)
Query: 181 PLEIKIGKPAATNIYLIDFLKRCLDKDPLRRWSCDQLLRHPYFNGYY 227
PL+ + + L D +++ L+ DP +R + + L+HP+F+
Sbjct: 290 PLKEFMLSQDVEHERLFDLIQKMLEYDPAKRITLREALKHPFFDLLK 336
|
| >3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus} Length = 323 | Back alignment and structure |
|---|
Score = 97.8 bits (244), Expect = 9e-24
Identities = 37/160 (23%), Positives = 62/160 (38%), Gaps = 15/160 (9%)
Query: 9 KLGEGSYGVVFKCRNRDTGQ---VVAIKKFLESEEDPLIRKIALREIRLLKSLKHPNLVN 65
LG+G +G V + + + VA+K + LRE +K HP++
Sbjct: 30 MLGKGEFGSVREAQLKQEDGSFVKVAVKMLKADIIASSDIEEFLREAACMKEFDHPHVAK 89
Query: 66 LLEV------FRRKKKLHLVFEFCDHTVLNE------LENHPHGLPWDLIKQITWQVLRG 113
L+ V R ++ F H L+ + +P LP + + + G
Sbjct: 90 LVGVSLRSRAKGRLPIPMVILPFMKHGDLHAFLLASRIGENPFNLPLQTLVRFMVDIACG 149
Query: 114 VSYCHRHACIHRDIKPENILLTANGVVKLCDFGFARLIRD 153
+ Y IHRD+ N +L + V + DFG +R I
Sbjct: 150 MEYLSSRNFIHRDLAARNCMLAEDMTVCVADFGLSRKIYS 189
|
| >2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A* Length = 333 | Back alignment and structure |
|---|
Score = 97.7 bits (244), Expect = 9e-24
Identities = 46/164 (28%), Positives = 74/164 (45%), Gaps = 23/164 (14%)
Query: 9 KLGEGSYGVVFKC-----RNRDTGQVVAIKKFLESEEDPLIRKIALREIRLLKSL-KHPN 62
LG G++G V + D VA+K L+S ++ + E++++ L +H N
Sbjct: 53 TLGAGAFGKVVEATAFGLGKEDAVLKVAVKM-LKSTAHADEKEALMSELKIMSHLGQHEN 111
Query: 63 LVNLLEVFRRKKKLHLVFEFCDHTVLNE-LENHPHGL--------------PWDLIKQIT 107
+VNLL + ++ E+C + L L L DL+ +
Sbjct: 112 IVNLLGACTHGGPVLVITEYCCYGDLLNFLRRKSRVLETDPAFAIANSTASTRDLL-HFS 170
Query: 108 WQVLRGVSYCHRHACIHRDIKPENILLTANGVVKLCDFGFARLI 151
QV +G+++ CIHRD+ N+LLT V K+ DFG AR I
Sbjct: 171 SQVAQGMAFLASKNCIHRDVAARNVLLTNGHVAKIGDFGLARDI 214
|
| >2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 Length = 535 | Back alignment and structure |
|---|
Score = 99.6 bits (248), Expect = 1e-23
Identities = 45/147 (30%), Positives = 72/147 (48%), Gaps = 7/147 (4%)
Query: 9 KLGEGSYGVVFKCRNRDTGQVVAIKKFLESEEDPLIRKIALREIRLLKSLKHPNLVNLLE 68
KLG+G +G V+ T +V AIK + L+E +++K L+H LV L
Sbjct: 274 KLGQGCFGEVWMGTWNGTTRV-AIKTLKPGTMS---PEAFLQEAQVMKKLRHEKLVQLYA 329
Query: 69 VFRRKKKLHLVFEFCDHTVLNEL--ENHPHGLPWDLIKQITWQVLRGVSYCHRHACIHRD 126
V ++ +++V E+ L + L + + Q+ G++Y R +HRD
Sbjct: 330 VVS-EEPIYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERMNYVHRD 388
Query: 127 IKPENILLTANGVVKLCDFGFARLIRD 153
++ NIL+ N V K+ DFG ARLI D
Sbjct: 389 LRAANILVGENLVCKVADFGLARLIED 415
|
| >3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* 2jiu_A* ... Length = 327 | Back alignment and structure |
|---|
Score = 97.4 bits (243), Expect = 1e-23
Identities = 39/154 (25%), Positives = 73/154 (47%), Gaps = 7/154 (4%)
Query: 5 EKIGKLGEGSYGVVFKCRNRDTGQ----VVAIKKFLESEEDPLIRKIALREIRLLKSLKH 60
+KI LG G++G V+K G+ VAIK+ E+ ++I L E ++ S+ +
Sbjct: 18 KKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEI-LDEAYVMASVDN 76
Query: 61 PNLVNLLEVFRRKKKLHLVFEFCDHTVLNE-LENHPHGLPWDLIKQITWQVLRGVSYCHR 119
P++ LL + + L+ + L + + H + + Q+ +G++Y
Sbjct: 77 PHVCRLLGICL-TSTVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLED 135
Query: 120 HACIHRDIKPENILLTANGVVKLCDFGFARLIRD 153
+HRD+ N+L+ VK+ DFG A+L+
Sbjct: 136 RRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGA 169
|
| >1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A Length = 450 | Back alignment and structure |
|---|
Score = 98.6 bits (246), Expect = 2e-23
Identities = 39/146 (26%), Positives = 65/146 (44%), Gaps = 13/146 (8%)
Query: 9 KLGEGSYGVVFKCRNRDTGQVVAIK--KFLESEEDPLIRKIALREIRLLKSLKHPNLVNL 66
+G+G +G V R G VA+K K + + L E ++ L+H NLV L
Sbjct: 200 TIGKGEFGDVMLGDYR--GNKVAVKCIKNDATAQA------FLAEASVMTQLRHSNLVQL 251
Query: 67 LEV-FRRKKKLHLVFEFCDHTVLNEL--ENHPHGLPWDLIKQITWQVLRGVSYCHRHACI 123
L V K L++V E+ L + L D + + + V + Y + +
Sbjct: 252 LGVIVEEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEGNNFV 311
Query: 124 HRDIKPENILLTANGVVKLCDFGFAR 149
HRD+ N+L++ + V K+ DFG +
Sbjct: 312 HRDLAARNVLVSEDNVAKVSDFGLTK 337
|
| >1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B Length = 454 | Back alignment and structure |
|---|
Score = 98.6 bits (246), Expect = 2e-23
Identities = 42/147 (28%), Positives = 72/147 (48%), Gaps = 7/147 (4%)
Query: 9 KLGEGSYGVVFKCRNRDTGQVVAIKKFLESEEDPLIRKIALREIRLLKSLKHPNLVNLLE 68
KLG G +G V+ +V A+K + L E ++K+L+H LV L
Sbjct: 195 KLGAGQFGEVWMATYNKHTKV-AVKTMKPGSMS---VEAFLAEANVMKTLQHDKLVKLHA 250
Query: 69 VFRRKKKLHLVFEFCDHTVLNEL--ENHPHGLPWDLIKQITWQVLRGVSYCHRHACIHRD 126
V K+ ++++ EF L + + P + + Q+ G+++ + IHRD
Sbjct: 251 VVT-KEPIYIITEFMAKGSLLDFLKSDEGSKQPLPKLIDFSAQIAEGMAFIEQRNYIHRD 309
Query: 127 IKPENILLTANGVVKLCDFGFARLIRD 153
++ NIL++A+ V K+ DFG AR+I D
Sbjct: 310 LRAANILVSASLVCKIADFGLARVIED 336
|
| >4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens} Length = 329 | Back alignment and structure |
|---|
Score = 97.0 bits (242), Expect = 2e-23
Identities = 47/166 (28%), Positives = 70/166 (42%), Gaps = 24/166 (14%)
Query: 9 KLGEGSYGVVFKCRNRDTG-----QVVAIKKFLESEEDPLIRKIALREIRLLKSLKHPNL 63
+LGEG++G VF + +VA+K E+ E R+ RE LL L+H ++
Sbjct: 48 ELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESA--RQDFQREAELLTMLQHQHI 105
Query: 64 VNLLEVFRRKKKLHLVFEFCDHTVLNEL--ENHPHGLPW--------------DLIKQIT 107
V V + L +VFE+ H LN + P L+ +
Sbjct: 106 VRFFGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLL-AVA 164
Query: 108 WQVLRGVSYCHRHACIHRDIKPENILLTANGVVKLCDFGFARLIRD 153
QV G+ Y +HRD+ N L+ VVK+ DFG +R I
Sbjct: 165 SQVAAGMVYLAGLHFVHRDLATRNCLVGQGLVVKIGDFGMSRDIYS 210
|
| >1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A* Length = 291 | Back alignment and structure |
|---|
Score = 96.2 bits (240), Expect = 2e-23
Identities = 39/148 (26%), Positives = 73/148 (49%), Gaps = 5/148 (3%)
Query: 9 KLGEGSYGVVFK--CRNRDTGQVVAIKKFLESEEDPLIRKIALREIRLLKSLKHPNLVNL 66
+LG G++G V K + + + VA+K DP ++ L E +++ L +P +V +
Sbjct: 24 ELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRM 83
Query: 67 LEVFRRKKKLHLVFEFCDHTVLNE-LENHPHGLPWDLIKQITWQVLRGVSYCHRHACIHR 125
+ + + LV E + LN+ L+ + H ++I ++ QV G+ Y +HR
Sbjct: 84 IGICE-AESWMLVMEMAELGPLNKYLQQNRHVKDKNII-ELVHQVSMGMKYLEESNFVHR 141
Query: 126 DIKPENILLTANGVVKLCDFGFARLIRD 153
D+ N+LL K+ DFG ++ +R
Sbjct: 142 DLAARNVLLVTQHYAKISDFGLSKALRA 169
|
| >3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A* Length = 325 | Back alignment and structure |
|---|
Score = 96.6 bits (241), Expect = 2e-23
Identities = 37/150 (24%), Positives = 62/150 (41%), Gaps = 7/150 (4%)
Query: 9 KLGEGSYGVVFKCR----NRDTGQVVAIKKFLESEEDPLIRKIALREIRLLKSLKHPNLV 64
LG G +G V K V IK + + + + + SL H ++V
Sbjct: 20 VLGSGVFGTVHKGVWIPEGESIKIPVCIKVIEDKSGRQSFQAV-TDHMLAIGSLDHAHIV 78
Query: 65 NLLEVFRRKKKLHLVFEFCDHTVLNE-LENHPHGLPWDLIKQITWQVLRGVSYCHRHACI 123
LL + L LV ++ L + + H L L+ Q+ +G+ Y H +
Sbjct: 79 RLLGLCP-GSSLQLVTQYLPLGSLLDHVRQHRGALGPQLLLNWGVQIAKGMYYLEEHGMV 137
Query: 124 HRDIKPENILLTANGVVKLCDFGFARLIRD 153
HR++ N+LL + V++ DFG A L+
Sbjct: 138 HRNLAARNVLLKSPSQVQVADFGVADLLPP 167
|
| >1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ... Length = 452 | Back alignment and structure |
|---|
Score = 97.9 bits (244), Expect = 2e-23
Identities = 45/147 (30%), Positives = 72/147 (48%), Gaps = 7/147 (4%)
Query: 9 KLGEGSYGVVFKCRNRDTGQVVAIKKFLESEEDPLIRKIALREIRLLKSLKHPNLVNLLE 68
KLG+G +G V+ T +V AIK + L+E +++K L+H LV L
Sbjct: 191 KLGQGCFGEVWMGTWNGTTRV-AIKTLKPGTMS---PEAFLQEAQVMKKLRHEKLVQLYA 246
Query: 69 VFRRKKKLHLVFEFCDHTVLNEL--ENHPHGLPWDLIKQITWQVLRGVSYCHRHACIHRD 126
V ++ +++V E+ L + L + + Q+ G++Y R +HRD
Sbjct: 247 VVS-EEPIYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERMNYVHRD 305
Query: 127 IKPENILLTANGVVKLCDFGFARLIRD 153
++ NIL+ N V K+ DFG ARLI D
Sbjct: 306 LRAANILVGENLVCKVADFGLARLIED 332
|
| >3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7 Length = 373 | Back alignment and structure |
|---|
Score = 97.1 bits (242), Expect = 2e-23
Identities = 37/150 (24%), Positives = 63/150 (42%), Gaps = 6/150 (4%)
Query: 9 KLGEGSYGVVFKCRNRDTGQV---VAIKKFLESEEDPLIRKIALREIRLLKSLKHPNLVN 65
+G G +G V+ D A+K + + + L E ++K HPN+++
Sbjct: 96 VIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQF-LTEGIIMKDFSHPNVLS 154
Query: 66 LLEV-FRRKKKLHLVFEFCDHTVLNE-LENHPHGLPWDLIKQITWQVLRGVSYCHRHACI 123
LL + R + +V + H L + N H + QV +G+ + +
Sbjct: 155 LLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKFLASKKFV 214
Query: 124 HRDIKPENILLTANGVVKLCDFGFARLIRD 153
HRD+ N +L VK+ DFG AR + D
Sbjct: 215 HRDLAARNCMLDEKFTVKVADFGLARDMYD 244
|
| >1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7 Length = 344 | Back alignment and structure |
|---|
Score = 96.6 bits (241), Expect = 2e-23
Identities = 46/175 (26%), Positives = 74/175 (42%), Gaps = 32/175 (18%)
Query: 9 KLGEGSYGVVFKCR-----NRDTGQVVAIKKFLESEEDPLIRKIALREIRLLKSL-KHPN 62
LG G++G V VA+K E + + + E++++ L H N
Sbjct: 52 VLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREAL-MSELKMMTQLGSHEN 110
Query: 63 LVNLLEVFRRKKKLHLVFEFCDH------------------------TVLNELENHPHGL 98
+VNLL ++L+FE+C + L E E+
Sbjct: 111 IVNLLGACTLSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLT 170
Query: 99 PWDLIKQITWQVLRGVSYCHRHACIHRDIKPENILLTANGVVKLCDFGFARLIRD 153
DL+ +QV +G+ + +C+HRD+ N+L+T VVK+CDFG AR I
Sbjct: 171 FEDLL-CFAYQVAKGMEFLEFKSCVHRDLAARNVLVTHGKVVKICDFGLARDIMS 224
|
| >1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7 Length = 318 | Back alignment and structure |
|---|
Score = 96.4 bits (241), Expect = 2e-23
Identities = 61/268 (22%), Positives = 108/268 (40%), Gaps = 69/268 (25%)
Query: 10 LGEGSYGVVFKCRNRDTGQVVAIKKFLESEEDPLIRK---IALREI-------RLLKSLK 59
LG GS+G V R+R G+ A+K +++K + L+++ +L +
Sbjct: 14 LGTGSFGRVHLIRSRHNGRYYAMK---------VLKKEIVVRLKQVEHTNDERLMLSIVT 64
Query: 60 HPNLVNLLEVFRRKKKLHLVFEFCDHTVLN--ELENH---PHGLPWDLIKQITWQVLRGV 114
HP ++ + F+ +++ ++ ++ EL + P + K +V +
Sbjct: 65 HPFIIRMWGTFQDAQQIFMIMDYI-----EGGELFSLLRKSQRFPNPVAKFYAAEVCLAL 119
Query: 115 SYCHRHACIHRDIKPENILLTANGVVKLCDFGFARLIRD-----------LIPRHLHIFQ 163
Y H I+RD+KPENILL NG +K+ DFGFA+ + D + P +
Sbjct: 120 EYLHSKDIIYRDLKPENILLDKNGHIKITDFGFAKYVPDVTYTLCGTPDYIAP---EVVS 176
Query: 164 TNEYFKGV---------------SLP-HAENVVPLEIKI--GK---PAATNIYLIDFLKR 202
T Y K + P + N + KI + P N + D L R
Sbjct: 177 TKPYNKSIDWWSFGILIYEMLAGYTPFYDSNTMKTYEKILNAELRFPPFFNEDVKDLLSR 236
Query: 203 CLDKDPLRRWSC-----DQLLRHPYFNG 225
+ +D +R + + HP+F
Sbjct: 237 LITRDLSQRLGNLQNGTEDVKNHPWFKE 264
|
| >2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A* Length = 314 | Back alignment and structure |
|---|
Score = 96.2 bits (240), Expect = 3e-23
Identities = 43/173 (24%), Positives = 70/173 (40%), Gaps = 32/173 (18%)
Query: 9 KLGEGSYGVVFKCR-----NRDTGQVVAIKKFLESEEDPLIRKIALREIRLLKSLKHPNL 63
LGEG +G V K R VA+K E+ +R + L E +LK + HP++
Sbjct: 30 TLGEGEFGKVVKATAFHLKGRAGYTTVAVKMLKENASPSELRDL-LSEFNVLKQVNHPHV 88
Query: 64 VNLLEVFRRKKKLHLVFEFCDH----------------------TVLNELENHPHGLP-- 99
+ L + L L+ E+ + + + +HP
Sbjct: 89 IKLYGACSQDGPLLLIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRNSSSLDHPDERALT 148
Query: 100 -WDLIKQITWQVLRGVSYCHRHACIHRDIKPENILLTANGVVKLCDFGFARLI 151
DLI WQ+ +G+ Y +HRD+ NIL+ +K+ DFG +R +
Sbjct: 149 MGDLI-SFAWQISQGMQYLAEMKLVHRDLAARNILVAEGRKMKISDFGLSRDV 200
|
| >2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ... Length = 316 | Back alignment and structure |
|---|
Score = 96.2 bits (240), Expect = 3e-23
Identities = 47/167 (28%), Positives = 71/167 (42%), Gaps = 26/167 (15%)
Query: 9 KLGEGSYGVVFKCR-----NRDTGQVVAIKKFLESEEDPLIRKIALREIRLLKSL-KHPN 62
LG G++G V + T + VA+K E R + + E+++L + H N
Sbjct: 34 PLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRAL-MSELKILIHIGHHLN 92
Query: 63 LVNLLEV-FRRKKKLHLVFEFCDH--------------TVLNELENHPHGLPW---DLIK 104
+VNLL + L ++ EFC + LI
Sbjct: 93 VVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLI- 151
Query: 105 QITWQVLRGVSYCHRHACIHRDIKPENILLTANGVVKLCDFGFARLI 151
++QV +G+ + CIHRD+ NILL+ VVK+CDFG AR I
Sbjct: 152 CYSFQVAKGMEFLASRKCIHRDLAARNILLSEKNVVKICDFGLARDI 198
|
| >3zzw_A Tyrosine-protein kinase transmembrane receptor RO; transferase, neurotrophic tyrosine kinase, receptor-related NTRKR2; 2.90A {Homo sapiens} Length = 289 | Back alignment and structure |
|---|
Score = 95.4 bits (238), Expect = 4e-23
Identities = 46/167 (27%), Positives = 70/167 (41%), Gaps = 24/167 (14%)
Query: 9 KLGEGSYGVVFKCRNRDTG-----QVVAIKKFLESEEDPLIRKIALREIRLLKSLKHPNL 63
+LGE +G V+K Q VAIK + E PL + E L L+HPN+
Sbjct: 16 ELGEDRFGKVYKGHLFGPAPGEQTQAVAIKTLKDKAEGPLREEF-RHEAMLRARLQHPNV 74
Query: 64 VNLLEVFRRKKKLHLVFEFCDHTVLNEL--ENHPHGLPW---------------DLIKQI 106
V LL V + + L ++F +C H L+E PH D + +
Sbjct: 75 VCLLGVVTKDQPLSMIFSYCSHGDLHEFLVMRSPHSDVGSTDDDRTVKSALEPPDFV-HL 133
Query: 107 TWQVLRGVSYCHRHACIHRDIKPENILLTANGVVKLCDFGFARLIRD 153
Q+ G+ Y H +H+D+ N+L+ VK+ D G R +
Sbjct: 134 VAQIAAGMEYLSSHHVVHKDLATRNVLVYDKLNVKISDLGLFREVYA 180
|
| >2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A Length = 370 | Back alignment and structure |
|---|
Score = 96.7 bits (241), Expect = 4e-23
Identities = 44/170 (25%), Positives = 73/170 (42%), Gaps = 27/170 (15%)
Query: 9 KLGEGSYGVVFKCR-------NRDTGQVVAIKKFLESEEDPLIRKIALREIRLLKSL-KH 60
LGEG +G V VA+K + + + + + E+ ++K + KH
Sbjct: 88 PLGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDL-VSEMEMMKMIGKH 146
Query: 61 PNLVNLLEVFRRKKKLHLVFEFCDH--------------TVLNELENHPHGLP---WDLI 103
N++NLL + L+++ E+ + N DL+
Sbjct: 147 KNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLV 206
Query: 104 KQITWQVLRGVSYCHRHACIHRDIKPENILLTANGVVKLCDFGFARLIRD 153
T+Q+ RG+ Y CIHRD+ N+L+T N V+K+ DFG AR I +
Sbjct: 207 -SCTYQLARGMEYLASQKCIHRDLAARNVLVTENNVMKIADFGLARDINN 255
|
| >2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ... Length = 334 | Back alignment and structure |
|---|
Score = 95.8 bits (239), Expect = 4e-23
Identities = 44/170 (25%), Positives = 74/170 (43%), Gaps = 27/170 (15%)
Query: 9 KLGEGSYGVVFKCR-------NRDTGQVVAIKKFLESEEDPLIRKIALREIRLLKSL-KH 60
LGEG++G V VA+K + + + + + E+ ++K + KH
Sbjct: 42 PLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDL-VSEMEMMKMIGKH 100
Query: 61 PNLVNLLEVFRRKKKLHLVFEFCDH--------------TVLNELENHPHGLP---WDLI 103
N++NLL + L+++ E+ + N DL+
Sbjct: 101 KNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLV 160
Query: 104 KQITWQVLRGVSYCHRHACIHRDIKPENILLTANGVVKLCDFGFARLIRD 153
T+Q+ RG+ Y CIHRD+ N+L+T N V+K+ DFG AR I +
Sbjct: 161 -SCTYQLARGMEYLASQKCIHRDLAARNVLVTENNVMKIADFGLARDINN 209
|
| >2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A* Length = 321 | Back alignment and structure |
|---|
Score = 95.7 bits (239), Expect = 5e-23
Identities = 66/285 (23%), Positives = 109/285 (38%), Gaps = 72/285 (25%)
Query: 9 KLGEGSYGVVFKCRNRDTGQVVAIKKFLES-----EEDPLIRKIALREIRLLKSLKHPNL 63
+G G +G V+K RD G VA+K+ EE EI L +HP+L
Sbjct: 46 LIGHGVFGKVYKGVLRD-GAKVALKRRTPESSQGIEE-------FETEIETLSFCRHPHL 97
Query: 64 VNLLEVFRRKKKLHLVFEFCDHTVLNELENHPHG-------LPWDLIKQITWQVLRGVSY 116
V+L+ + ++ L++++ ++ L+ H +G + W+ +I RG+ Y
Sbjct: 98 VSLIGFCDERNEMILIYKYMEN---GNLKRHLYGSDLPTMSMSWEQRLEICIGAARGLHY 154
Query: 117 CHRHACIHRDIKPENILLTANGVVKLCDFGFARLIRDLIPRHLHIFQTN----------E 166
H A IHRD+K NILL N V K+ DFG ++ +L HL T E
Sbjct: 155 LHTRAIIHRDVKSINILLDENFVPKITDFGISKKGTELDQTHL---STVVKGTLGYIDPE 211
Query: 167 YFK-------------GVSLPHAENVVPLEIKIGKPA------ATNIYLIDFLKRCLDKD 207
YF G VV E+ + A + L ++ +
Sbjct: 212 YFIKGRLTEKSDVYSFG--------VVLFEVLCARSAIVQSLPREMVNLAEWAVESHNNG 263
Query: 208 PLRRWSCDQLLRHPYFNGYYFEVPDEM-QYEEITQRCLDKDPLRR 251
L + + P P+ + ++ + +CL R
Sbjct: 264 QLEQ------IVDPNLADKI--RPESLRKFGDTAVKCLALSSEDR 300
|
| >1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ... Length = 279 | Back alignment and structure |
|---|
Score = 94.6 bits (236), Expect = 5e-23
Identities = 41/149 (27%), Positives = 70/149 (46%), Gaps = 11/149 (7%)
Query: 9 KLGEGSYGVVFKCRNRDTGQVVAIK--KFLESEEDPLIRKIALREIRLLKSLKHPNLVNL 66
+LG G +G V+ +V A+K K D L E L+K L+H LV L
Sbjct: 20 RLGAGQFGEVWMGYYNGHTKV-AVKSLKQGSMSPDAF-----LAEANLMKQLQHQRLVRL 73
Query: 67 LEVFRRKKKLHLVFEFCDHTVLNEL--ENHPHGLPWDLIKQITWQVLRGVSYCHRHACIH 124
V ++ ++++ E+ ++ L + L + + + Q+ G+++ IH
Sbjct: 74 YAVVT-QEPIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEERNYIH 132
Query: 125 RDIKPENILLTANGVVKLCDFGFARLIRD 153
RD++ NIL++ K+ DFG ARLI D
Sbjct: 133 RDLRAANILVSDTLSCKIADFGLARLIED 161
|
| >3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A* Length = 281 | Back alignment and structure |
|---|
Score = 94.6 bits (236), Expect = 6e-23
Identities = 42/149 (28%), Positives = 74/149 (49%), Gaps = 6/149 (4%)
Query: 9 KLGEGSYGVVFK--CRNRDTGQV-VAIKKFLESEEDPLIRKIALREIRLLKSLKHPNLVN 65
LGEG +G V++ N ++ VA+K + K + E ++K+L HP++V
Sbjct: 19 ILGEGFFGEVYEGVYTNHKGEKINVAVKTCKKDCTLDNKEKF-MSEAVIMKNLDHPHIVK 77
Query: 66 LLEVFRRKKKLHLVFEFCDHTVLNE-LENHPHGLPWDLIKQITWQVLRGVSYCHRHACIH 124
L+ + ++ ++ E + L LE + + L + + Q+ + ++Y C+H
Sbjct: 78 LIGIIE-EEPTWIIMELYPYGELGHYLERNKNSLKVLTLVLYSLQICKAMAYLESINCVH 136
Query: 125 RDIKPENILLTANGVVKLCDFGFARLIRD 153
RDI NIL+ + VKL DFG +R I D
Sbjct: 137 RDIAVRNILVASPECVKLGDFGLSRYIED 165
|
| >3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A* Length = 313 | Back alignment and structure |
|---|
Score = 95.0 bits (237), Expect = 7e-23
Identities = 37/159 (23%), Positives = 62/159 (38%), Gaps = 14/159 (8%)
Query: 9 KLGEGSYGVVFKCRNRDTGQV---VAIKKFLESEEDPLIRKIALREIRLLKSLKHPNLVN 65
LGEG +G V + + VA+K + L E +K HPN++
Sbjct: 41 ILGEGEFGSVMEGNLKQEDGTSLKVAVKTMKLDNSSQREIEEFLSEAACMKDFSHPNVIR 100
Query: 66 LLEV-----FRRKKKLHLVFEFCDHTVLNE------LENHPHGLPWDLIKQITWQVLRGV 114
LL V + K ++ F + L+ LE P +P + + + G+
Sbjct: 101 LLGVCIEMSSQGIPKPMVILPFMKYGDLHTYLLYSRLETGPKHIPLQTLLKFMVDIALGM 160
Query: 115 SYCHRHACIHRDIKPENILLTANGVVKLCDFGFARLIRD 153
Y +HRD+ N +L + V + DFG ++ I
Sbjct: 161 EYLSNRNFLHRDLAARNCMLRDDMTVCVADFGLSKKIYS 199
|
| >2eu9_A Dual specificity protein kinase CLK3; kinase domain, transferase; 1.53A {Homo sapiens} PDB: 2wu6_A* 2wu7_A* 3raw_A* 2exe_A 3nr9_A* Length = 355 | Back alignment and structure |
|---|
Score = 95.5 bits (238), Expect = 7e-23
Identities = 45/179 (25%), Positives = 74/179 (41%), Gaps = 44/179 (24%)
Query: 2 ERYEKIGKLGEGSYGVVFKCRNRDTGQ-VVAIKKFLESEEDPLIRKI------ALREIRL 54
ERYE +G LGEG++G V +C + G+ VA+K +IR + A EI +
Sbjct: 19 ERYEIVGNLGEGTFGKVVECLDHARGKSQVALK---------IIRNVGKYREAARLEINV 69
Query: 55 LKSLKHP------NLVNLLEVFRRKKKLHLVFEFCDHTVLNEL--ENHPHGLPWDLIKQI 106
LK +K V + + F + + FE E EN+ P ++ +
Sbjct: 70 LKKIKEKDKENKFLCVLMSDWFNFHGHMCIAFELLGKN-TFEFLKENNFQPYPLPHVRHM 128
Query: 107 TWQVLRGVSYCHRHACIHRDIKPENILLTANGV-------------------VKLCDFG 146
+Q+ + + H + H D+KPENIL + +++ DFG
Sbjct: 129 AYQLCHALRFLHENQLTHTDLKPENILFVNSEFETLYNEHKSCEEKSVKNTSIRVADFG 187
|
| >2eu9_A Dual specificity protein kinase CLK3; kinase domain, transferase; 1.53A {Homo sapiens} PDB: 2wu6_A* 2wu7_A* 3raw_A* 2exe_A 3nr9_A* Length = 355 | Back alignment and structure |
|---|
Score = 46.6 bits (111), Expect = 5e-06
Identities = 17/57 (29%), Positives = 30/57 (52%)
Query: 175 HAENVVPLEIKIGKPAATNIYLIDFLKRCLDKDPLRRWSCDQLLRHPYFNGYYFEVP 231
EN PL+ + + + ++ L D ++R L+ DP +R + + L HP+F G E
Sbjct: 289 VKENCKPLKSYMLQDSLEHVQLFDLMRRMLEFDPAQRITLAEALLHPFFAGLTPEER 345
|
| >2eu9_A Dual specificity protein kinase CLK3; kinase domain, transferase; 1.53A {Homo sapiens} PDB: 2wu6_A* 2wu7_A* 3raw_A* 2exe_A 3nr9_A* Length = 355 | Back alignment and structure |
|---|
Score = 40.0 bits (94), Expect = 6e-04
Identities = 12/43 (27%), Positives = 23/43 (53%)
Query: 229 EVPDEMQYEEITQRCLDKDPLRRWSCDQLLRHPYFNGYYFEVP 271
+ + +Q ++ +R L+ DP +R + + L HP+F G E
Sbjct: 303 DSLEHVQLFDLMRRMLEFDPAQRITLAEALLHPFFAGLTPEER 345
|
| >2nru_A Interleukin-1 receptor-associated kinase 4; inhibitor, IRAK, transferase; HET: TPO SEP T12; 2.00A {Homo sapiens} PDB: 2nry_A* 2oib_A* 2oic_A* 2oid_A* 2o8y_A* Length = 307 | Back alignment and structure |
|---|
Score = 94.5 bits (236), Expect = 8e-23
Identities = 48/157 (30%), Positives = 72/157 (45%), Gaps = 27/157 (17%)
Query: 9 KLGEGSYGVVFK-CRNRDTGQVVAIKKFLESEEDPLIRKIA---LREIRLLKSLKHPNLV 64
K+GEG +GVV+K N VA+KK L + D ++ +EI+++ +H NLV
Sbjct: 38 KMGEGGFGVVYKGYVN---NTTVAVKK-LAAMVDITTEELKQQFDQEIKVMAKCQHENLV 93
Query: 65 NLL----EVFRRKKKLHLVFEFCDHTVLNE-LENHPHG------LPWDLIKQITWQVLRG 113
LL + LV+ + + N L + L W + +I G
Sbjct: 94 ELLGFSSD---GDDLC-LVYVY----MPNGSLLDRLSCLDGTPPLSWHMRCKIAQGAANG 145
Query: 114 VSYCHRHACIHRDIKPENILLTANGVVKLCDFGFARL 150
+++ H + IHRDIK NILL K+ DFG AR
Sbjct: 146 INFLHENHHIHRDIKSANILLDEAFTAKISDFGLARA 182
|
| >1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 287 | Back alignment and structure |
|---|
Score = 94.2 bits (235), Expect = 9e-23
Identities = 40/148 (27%), Positives = 70/148 (47%), Gaps = 5/148 (3%)
Query: 9 KLGEGSYGVVFK--CRNRDTGQVVAIKKFLESEEDPLIRKIALREIRLLKSLKHPNLVNL 66
+LG G++G V + R R VAIK L+ + + +RE +++ L +P +V L
Sbjct: 17 ELGCGNFGSVRQGVYRMRKKQIDVAIKV-LKQGTEKADTEEMMREAQIMHQLDNPYIVRL 75
Query: 67 LEVFRRKKKLHLVFEFCDHTVLNE-LENHPHGLPWDLIKQITWQVLRGVSYCHRHACIHR 125
+ V + + L LV E L++ L +P + ++ QV G+ Y +HR
Sbjct: 76 IGVCQ-AEALMLVMEMAGGGPLHKFLVGKREEIPVSNVAELLHQVSMGMKYLEEKNFVHR 134
Query: 126 DIKPENILLTANGVVKLCDFGFARLIRD 153
D+ N+LL K+ DFG ++ +
Sbjct: 135 DLAARNVLLVNRHYAKISDFGLSKALGA 162
|
| >1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7 Length = 343 | Back alignment and structure |
|---|
Score = 95.1 bits (237), Expect = 9e-23
Identities = 48/173 (27%), Positives = 73/173 (42%), Gaps = 32/173 (18%)
Query: 9 KLGEGSYGVVFKCR-----NRDTGQVVAIKKFLESEEDPLIRKIALREIRLLKSLKHPNL 63
+GEG++G VF+ R + +VA+K E + RE L+ +PN+
Sbjct: 54 DIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADF-QREAALMAEFDNPNI 112
Query: 64 VNLLEVFRRKKKLHLVFEFCDHTVLNE--LENHPHGLPW--------------------- 100
V LL V K + L+FE+ + LNE PH +
Sbjct: 113 VKLLGVCAVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLS 172
Query: 101 --DLIKQITWQVLRGVSYCHRHACIHRDIKPENILLTANGVVKLCDFGFARLI 151
+ + I QV G++Y +HRD+ N L+ N VVK+ DFG +R I
Sbjct: 173 CAEQL-CIARQVAAGMAYLSERKFVHRDLATRNCLVGENMVVKIADFGLSRNI 224
|
| >2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A* Length = 656 | Back alignment and structure |
|---|
Score = 96.8 bits (241), Expect = 1e-22
Identities = 40/149 (26%), Positives = 70/149 (46%), Gaps = 6/149 (4%)
Query: 9 KLGEGSYGVVFK--CRNRDTGQV-VAIKKFLESEEDPLIRKIALREIRLLKSLKHPNLVN 65
+GEG +G V + + + + VAIK D + K L+E ++ HP++V
Sbjct: 397 CIGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTSDSVREKF-LQEALTMRQFDHPHIVK 455
Query: 66 LLEVFRRKKKLHLVFEFCDHTVLNE-LENHPHGLPWDLIKQITWQVLRGVSYCHRHACIH 124
L+ V + + ++ E C L L+ L + +Q+ ++Y +H
Sbjct: 456 LIGVIT-ENPVWIIMELCTLGELRSFLQVRKFSLDLASLILYAYQLSTALAYLESKRFVH 514
Query: 125 RDIKPENILLTANGVVKLCDFGFARLIRD 153
RDI N+L+++N VKL DFG +R + D
Sbjct: 515 RDIAARNVLVSSNDCVKLGDFGLSRYMED 543
|
| >3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens} Length = 382 | Back alignment and structure |
|---|
Score = 95.1 bits (237), Expect = 1e-22
Identities = 45/170 (26%), Positives = 73/170 (42%), Gaps = 27/170 (15%)
Query: 9 KLGEGSYGVVFKCR-------NRDTGQVVAIKKFLESEEDPLIRKIALREIRLLKSL-KH 60
LGEG++G V + VA+K + + + + E+ ++K + KH
Sbjct: 76 PLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDL-ISEMEMMKMIGKH 134
Query: 61 PNLVNLLEVFRRKKKLHLVFEFCDH------------TVLNELENHPHGLPW-----DLI 103
N++NLL + L+++ E+ L N H DL+
Sbjct: 135 KNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLV 194
Query: 104 KQITWQVLRGVSYCHRHACIHRDIKPENILLTANGVVKLCDFGFARLIRD 153
+QV RG+ Y CIHRD+ N+L+T + V+K+ DFG AR I
Sbjct: 195 -SCAYQVARGMEYLASKKCIHRDLAARNVLVTEDNVMKIADFGLARDIHH 243
|
| >3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus} Length = 332 | Back alignment and structure |
|---|
Score = 94.2 bits (234), Expect = 2e-22
Identities = 39/213 (18%), Positives = 69/213 (32%), Gaps = 61/213 (28%)
Query: 1 MERYEKIGKLGEGSYGVVFKCRNRDTGQVVAIKKFLESEEDPLIRKIALREIRLLKSLKH 60
+ +E I +G G +GVVF+ +N+ AIK+ + K+ +RE++ L L+H
Sbjct: 5 LTDFEPIQCMGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKV-MREVKALAKLEH 63
Query: 61 PNLVNLLEVF---------RRKKKLHLVFEFCDHTVLNELENHPHGLPWDLIKQITWQVL 111
P +V + ++ L E D + + + + + +
Sbjct: 64 PGIVRYFNAWLETPPEKWQEEMDEIWLKDESTDWPLSSPSPMDAPSVKIRRMDPFSTKNT 123
Query: 112 RGVS--------------YCHRH-------------------------------ACIH-- 124
G C + +H
Sbjct: 124 VGQLQPSSPKVYLYIQMQLCRKENLKDWMNRRCSLEDREHGVCLHIFIQIAEAVEFLHSK 183
Query: 125 ----RDIKPENILLTANGVVKLCDFGFARLIRD 153
RD+KP NI T + VVK+ DFG +
Sbjct: 184 GLMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQ 216
|
| >3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A* Length = 410 | Back alignment and structure |
|---|
Score = 94.8 bits (236), Expect = 3e-22
Identities = 42/153 (27%), Positives = 74/153 (48%), Gaps = 16/153 (10%)
Query: 4 YEKIGKLGEGSYGVVFKCRNRDTGQVVAIKKFLESEEDPLIRKI----ALREIRLLKSLK 59
YE + +G G++G V R++ T +V A+K + E +I++ E ++
Sbjct: 71 YEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFE---MIKRSDSAFFWEERDIMAFAN 127
Query: 60 HPNLVNLLEVFRRKKKLHLVFEFCDHTVLN--ELENH--PHGLPWDLIKQITWQVLRGVS 115
P +V L F+ + L++V E+ +L N + +P + T +V+ +
Sbjct: 128 SPWVVQLFYAFQDDRYLYMVMEYM-----PGGDLVNLMSNYDVPEKWARFYTAEVVLALD 182
Query: 116 YCHRHACIHRDIKPENILLTANGVVKLCDFGFA 148
H IHRD+KP+N+LL +G +KL DFG
Sbjct: 183 AIHSMGFIHRDVKPDNMLLDKSGHLKLADFGTC 215
|
| >1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B* Length = 291 | Back alignment and structure |
|---|
Score = 93.1 bits (232), Expect = 3e-22
Identities = 43/150 (28%), Positives = 62/150 (41%), Gaps = 6/150 (4%)
Query: 9 KLGEGSYGVVFK--CRNRDTGQV-VAIKKFLESEEDPLIRKIA-LREIRLLKSLKHPNLV 64
KLG+GS+GVV + V VA+K +RE+ + SL H NL+
Sbjct: 25 KLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLI 84
Query: 65 NLLEVFRRKKKLHLVFEFCDHTVLNE-LENHPHGLPWDLIKQITWQVLRGVSYCHRHACI 123
L V + +V E L + L H + + QV G+ Y I
Sbjct: 85 RLYGVVL-TPPMKMVTELAPLGSLLDRLRKHQGHFLLGTLSRYAVQVAEGMGYLESKRFI 143
Query: 124 HRDIKPENILLTANGVVKLCDFGFARLIRD 153
HRD+ N+LL +VK+ DFG R +
Sbjct: 144 HRDLAARNLLLATRDLVKIGDFGLMRALPQ 173
|
| >1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A* Length = 327 | Back alignment and structure |
|---|
Score = 93.1 bits (232), Expect = 3e-22
Identities = 44/161 (27%), Positives = 64/161 (39%), Gaps = 22/161 (13%)
Query: 9 KLGEGSYGVVFKCR--NRDTGQVVAIKKFLESEEDPLIRKIALREIRLLKSL-KHPNLVN 65
+GEG++G V K R AIK+ E R E+ +L L HPN++N
Sbjct: 32 VIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDF-AGELEVLCKLGHHPNIIN 90
Query: 66 LLEVFRRKKKLHLVFEFCDH------------TVLNELENHPHGL-----PWDLIKQITW 108
LL + L+L E+ H + + L+
Sbjct: 91 LLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLL-HFAA 149
Query: 109 QVLRGVSYCHRHACIHRDIKPENILLTANGVVKLCDFGFAR 149
V RG+ Y + IHRD+ NIL+ N V K+ DFG +R
Sbjct: 150 DVARGMDYLSQKQFIHRDLAARNILVGENYVAKIADFGLSR 190
|
| >4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A* Length = 437 | Back alignment and structure |
|---|
Score = 94.4 bits (235), Expect = 3e-22
Identities = 36/152 (23%), Positives = 68/152 (44%), Gaps = 24/152 (15%)
Query: 10 LGEGSYGVVFKCRNRDTGQVVAIKKFLESEEDPLIRK---IALREI-------RLLKSLK 59
+G G++G V + ++ +V A+K ++ K + E +L +
Sbjct: 82 IGRGAFGEVAVVKLKNADKVFAMK---------ILNKWEMLKRAETACFREERDVLVNGD 132
Query: 60 HPNLVNLLEVFRRKKKLHLVFEFC---DHTVLNELENHPHGLPWDLIKQITWQVLRGVSY 116
+ L F+ L+LV ++ D +L L LP ++ + +++ +
Sbjct: 133 SKWITTLHYAFQDDNNLYLVMDYYVGGD--LLTLLSKFEDRLPEEMARFYLAEMVIAIDS 190
Query: 117 CHRHACIHRDIKPENILLTANGVVKLCDFGFA 148
H+ +HRDIKP+NIL+ NG ++L DFG
Sbjct: 191 VHQLHYVHRDIKPDNILMDMNGHIRLADFGSC 222
|
| >2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A* Length = 327 | Back alignment and structure |
|---|
Score = 92.8 bits (231), Expect = 5e-22
Identities = 42/162 (25%), Positives = 64/162 (39%), Gaps = 20/162 (12%)
Query: 9 KLGEGSYGVVFKCR-----NRDTGQVVAIK--KFLESEEDPLIRKIALREIRLLKSLKHP 61
LG G++G V++ + N + VA+K + SE+D L E ++ H
Sbjct: 37 GLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQD---ELDFLMEALIISKFNHQ 93
Query: 62 NLVNLLEVFRRKKKLHLVFEFCDHTVLNE-------LENHPHGLPWDLIKQITWQVLRGV 114
N+V + V + ++ E L + P L + + + G
Sbjct: 94 NIVRCIGVSLQSLPRFILMELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGC 153
Query: 115 SYCHRHACIHRDIKPENILLTANG---VVKLCDFGFARLIRD 153
Y + IHRDI N LLT G V K+ DFG AR I
Sbjct: 154 QYLEENHFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYR 195
|
| >2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens} Length = 412 | Back alignment and structure |
|---|
Score = 93.2 bits (232), Expect = 8e-22
Identities = 39/152 (25%), Positives = 73/152 (48%), Gaps = 12/152 (7%)
Query: 4 YEKIGKLGEGSYGVVFKCRNRDTGQVVAIKKFLESEEDPLIRKI----ALREIRLLKSLK 59
+E + +G G++ V + + TGQV A+K + + ++++ E +L +
Sbjct: 63 FEILKVIGRGAFSEVAVVKMKQTGQVYAMKIMNKWD---MLKRGEVSCFREERDVLVNGD 119
Query: 60 HPNLVNLLEVFRRKKKLHLVFEFC---DHTVLNELENHPHGLPWDLIKQITWQVLRGVSY 116
+ L F+ + L+LV E+ D +L L +P ++ + +++ +
Sbjct: 120 RRWITQLHFAFQDENYLYLVMEYYVGGD--LLTLLSKFGERIPAEMARFYLAEIVMAIDS 177
Query: 117 CHRHACIHRDIKPENILLTANGVVKLCDFGFA 148
HR +HRDIKP+NILL G ++L DFG
Sbjct: 178 VHRLGYVHRDIKPDNILLDRCGHIRLADFGSC 209
|
| >3uim_A Brassinosteroid insensitive 1-associated receptor; kinase, protein kinase, transferase; HET: SEP TPO ANP; 2.20A {Arabidopsis thaliana} PDB: 3tl8_A* Length = 326 | Back alignment and structure |
|---|
Score = 91.5 bits (228), Expect = 1e-21
Identities = 43/155 (27%), Positives = 67/155 (43%), Gaps = 15/155 (9%)
Query: 9 KLGEGSYGVVFKCRNRDTGQVVAIKKFLESEEDPLIRKIALREIRLLKSLKHPNLVNLLE 68
LG G +G V+K R D G +VA+K+ L+ E E+ ++ H NL+ L
Sbjct: 37 ILGRGGFGKVYKGRLAD-GTLVAVKR-LKEERTQGGELQFQTEVEMISMAVHRNLLRLRG 94
Query: 69 VFRRKKKLHLVFEFCDHTVLNELENHPHG-------LPWDLIKQITWQVLRGVSYCHRHA 121
+ LV+ + + + + L W ++I RG++Y H H
Sbjct: 95 FCMTPTERLLVYPYMAN---GSVASCLRERPESQPPLDWPKRQRIALGSARGLAYLHDHC 151
Query: 122 C---IHRDIKPENILLTANGVVKLCDFGFARLIRD 153
IHRD+K NILL + DFG A+L+
Sbjct: 152 DPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDY 186
|
| >3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B Length = 543 | Back alignment and structure |
|---|
Score = 92.9 bits (231), Expect = 2e-21
Identities = 43/149 (28%), Positives = 72/149 (48%), Gaps = 15/149 (10%)
Query: 10 LGEGSYGVVFKCRNRDTGQVVAIKKFLESEEDPLIRK----IALREIRLLKSLKHPNLVN 65
LG G +G VF C+ + TG++ A KK + L ++ A+ E ++L + +V+
Sbjct: 193 LGRGGFGEVFACQMKATGKLYACKKL---NKKRLKKRKGYQGAMVEKKILAKVHSRFIVS 249
Query: 66 LLEVFRRKKKLHLVFEFCD------HTVLNELENHPHGLPWDLIKQITWQVLRGVSYCHR 119
L F K L LV + H + ++ G T Q++ G+ + H+
Sbjct: 250 LAYAFETKTDLCLVMTIMNGGDIRYH--IYNVDEDNPGFQEPRAIFYTAQIVSGLEHLHQ 307
Query: 120 HACIHRDIKPENILLTANGVVKLCDFGFA 148
I+RD+KPEN+LL +G V++ D G A
Sbjct: 308 RNIIYRDLKPENVLLDDDGNVRISDLGLA 336
|
| >3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens} Length = 367 | Back alignment and structure |
|---|
Score = 91.7 bits (228), Expect = 2e-21
Identities = 42/162 (25%), Positives = 64/162 (39%), Gaps = 20/162 (12%)
Query: 9 KLGEGSYGVVFKCR-----NRDTGQVVAIK--KFLESEEDPLIRKIALREIRLLKSLKHP 61
LG G++G V++ + N + VA+K + SE+D L E ++ H
Sbjct: 78 GLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQD---ELDFLMEALIISKFNHQ 134
Query: 62 NLVNLLEVFRRKKKLHLVFEFCDHTVLNE-------LENHPHGLPWDLIKQITWQVLRGV 114
N+V + V + ++ E L + P L + + + G
Sbjct: 135 NIVRCIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGC 194
Query: 115 SYCHRHACIHRDIKPENILLTANG---VVKLCDFGFARLIRD 153
Y + IHRDI N LLT G V K+ DFG AR I
Sbjct: 195 QYLEENHFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYR 236
|
| >2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens} Length = 613 | Back alignment and structure |
|---|
Score = 92.7 bits (230), Expect = 2e-21
Identities = 39/148 (26%), Positives = 70/148 (47%), Gaps = 5/148 (3%)
Query: 9 KLGEGSYGVVFK--CRNRDTGQVVAIKKFLESEEDPLIRKIALREIRLLKSLKHPNLVNL 66
+LG G++G V + R R VAIK L+ + + +RE +++ L +P +V L
Sbjct: 343 ELGCGNFGSVRQGVYRMRKKQIDVAIKV-LKQGTEKADTEEMMREAQIMHQLDNPYIVRL 401
Query: 67 LEVFRRKKKLHLVFEFCDHTVLNE-LENHPHGLPWDLIKQITWQVLRGVSYCHRHACIHR 125
+ V + + L LV E L++ L +P + ++ QV G+ Y +HR
Sbjct: 402 IGVCQ-AEALMLVMEMAGGGPLHKFLVGKREEIPVSNVAELLHQVSMGMKYLEEKNFVHR 460
Query: 126 DIKPENILLTANGVVKLCDFGFARLIRD 153
++ N+LL K+ DFG ++ +
Sbjct: 461 NLAARNVLLVNRHYAKISDFGLSKALGA 488
|
| >2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A* Length = 576 | Back alignment and structure |
|---|
Score = 92.5 bits (230), Expect = 3e-21
Identities = 44/155 (28%), Positives = 75/155 (48%), Gaps = 19/155 (12%)
Query: 10 LGEGSYGVVFKCRNRDTGQVVAIKKFLESEEDPLIRK----IALREIRLLKSLKHPNLVN 65
LG+G +G V C+ R TG++ A KK E+ + ++ +AL E ++L+ + +V+
Sbjct: 192 LGKGGFGEVCACQVRATGKMYACKKL---EKKRIKKRKGEAMALNEKQILEKVNSRFVVS 248
Query: 66 LLEVFRRKKKLHLVFEFCDHTVLN--ELENH-----PHGLPWDLIKQITWQVLRGVSYCH 118
L + K L LV N +L+ H G P ++ G+ H
Sbjct: 249 LAYAYETKDALCLVLTLM-----NGGDLKFHIYHMGQAGFPEARAVFYAAEICCGLEDLH 303
Query: 119 RHACIHRDIKPENILLTANGVVKLCDFGFARLIRD 153
R ++RD+KPENILL +G +++ D G A + +
Sbjct: 304 RERIVYRDLKPENILLDDHGHIRISDLGLAVHVPE 338
|
| >4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A* Length = 289 | Back alignment and structure |
|---|
Score = 89.7 bits (223), Expect = 4e-21
Identities = 31/161 (19%), Positives = 62/161 (38%), Gaps = 18/161 (11%)
Query: 9 KLGEGSYGVVFKCRNRDTGQV-------VAIKKFLESEEDPLIRKIALREIRLLKSLKHP 61
LG+G++ +FK R+ G V +K ++ + + ++ L H
Sbjct: 15 SLGQGTFTKIFKGVRREVGDYGQLHETEVLLKVLDKAHRNY--SESFFEAASMMSKLSHK 72
Query: 62 NLVNLLEVFRRKKKLHLVFEFCDHTVLNE-LENHPHGLPWDLIKQITWQVLRGVSYCHRH 120
+LV V + LV EF L+ L+ + + + ++ Q+ + + +
Sbjct: 73 HLVLNYGVCVCGDENILVQEFVKFGSLDTYLKKNKNCINILWKLEVAKQLAAAMHFLEEN 132
Query: 121 ACIHRDIKPENILLTA--------NGVVKLCDFGFARLIRD 153
IH ++ +NILL +KL D G + +
Sbjct: 133 TLIHGNVCAKNILLIREEDRKTGNPPFIKLSDPGISITVLP 173
|
| >1wak_A Serine/threonine-protein kinase SPRK1; SRPK, transferase, alternative splicing, ATP-binding, chromosome partition, differentiation, mRNA processing; 1.73A {Homo sapiens} PDB: 1wbp_A* 3beg_A* 2x7g_A* Length = 397 | Back alignment and structure |
|---|
Score = 88.8 bits (220), Expect = 3e-20
Identities = 57/150 (38%), Positives = 79/150 (52%), Gaps = 17/150 (11%)
Query: 2 ERYEKIGKLGEGSYGVVFKCRNRDTGQVVAIKKFLESEEDPLIRKIALREIRLLKSLK-- 59
RY I KLG G + V+ + + VA+ K ++S E + AL EIRLLKS++
Sbjct: 37 GRYHVIRKLGWGHFSTVWLSWDIQGKKFVAM-KVVKSAEHY--TETALDEIRLLKSVRNS 93
Query: 60 ---HPN---LVNLLEVF--RRKKKLH--LVFEFCDHTVLNELE-NHPHGLPWDLIKQITW 108
PN +V LL+ F H +VFE H +L + ++ GLP +K+I
Sbjct: 94 DPNDPNREMVVQLLDDFKISGVNGTHICMVFEVLGHHLLKWIIKSNYQGLPLPCVKKIIQ 153
Query: 109 QVLRGVSYCHRHA-CIHRDIKPENILLTAN 137
QVL+G+ Y H IH DIKPENILL+ N
Sbjct: 154 QVLQGLDYLHTKCRIIHTDIKPENILLSVN 183
|
| >3pvu_A Beta-adrenergic receptor kinase 1; transferase, serine/threonine-protein kinase, ATP-binding, I membrane; HET: QRW; 2.48A {Bos taurus} PDB: 3psc_A* 3pvw_A* 1omw_A 1ym7_A 2bcj_A* 3cik_A 3krw_A* 3krx_A* 1bak_A Length = 695 | Back alignment and structure |
|---|
Score = 89.6 bits (222), Expect = 3e-20
Identities = 39/151 (25%), Positives = 69/151 (45%), Gaps = 20/151 (13%)
Query: 10 LGEGSYGVVFKCRNRDTGQVVAIKKFLESEEDPLIRK----IALREIRLL---KSLKHPN 62
+G G +G V+ CR DTG++ A+K ++ + K +AL E +L + P
Sbjct: 197 IGRGGFGEVYGCRKADTGKMYAMKCL---DKKRIKMKQGETLALNERIMLSLVSTGDCPF 253
Query: 63 LVNLLEVFRRKKKLHLVFEFCDHTVLN--ELENH---PHGLPWDLIKQITWQVLRGVSYC 117
+V + F KL + + N +L H ++ +++ G+ +
Sbjct: 254 IVCMSYAFHTPDKLSFILDLM-----NGGDLHYHLSQHGVFSEADMRFYAAEIILGLEHM 308
Query: 118 HRHACIHRDIKPENILLTANGVVKLCDFGFA 148
H ++RD+KP NILL +G V++ D G A
Sbjct: 309 HNRFVVYRDLKPANILLDEHGHVRISDLGLA 339
|
| >2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A* Length = 353 | Back alignment and structure |
|---|
Score = 85.4 bits (212), Expect = 3e-19
Identities = 34/143 (23%), Positives = 65/143 (45%), Gaps = 10/143 (6%)
Query: 10 LGEGSYGVVFKCRNRDTGQVVAIK---KFLESEEDPLIRKIALREIRLLKSLKHPNLVNL 66
LG+GS+G V + T ++ A+K K + ++D + + + + L K P L L
Sbjct: 28 LGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRV-LALPGKPPFLTQL 86
Query: 67 LEVFRRKKKLHLVFEFCDHTVLNELENHPHG---LPWDLIKQITWQVLRGVSYCHRHACI 123
F+ +L+ V E+ + +L H ++ G+ + I
Sbjct: 87 HSCFQTMDRLYFVMEYVNG---GDLMYHIQQVGRFKEPHAVFYAAEIAIGLFFLQSKGII 143
Query: 124 HRDIKPENILLTANGVVKLCDFG 146
+RD+K +N++L + G +K+ DFG
Sbjct: 144 YRDLKLDNVMLDSEGHIKIADFG 166
|
| >3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A Length = 674 | Back alignment and structure |
|---|
Score = 86.6 bits (214), Expect = 3e-19
Identities = 34/143 (23%), Positives = 65/143 (45%), Gaps = 10/143 (6%)
Query: 10 LGEGSYGVVFKCRNRDTGQVVAIK---KFLESEEDPLIRKIALREIRLLKSLKHPNLVNL 66
LG+GS+G V + T ++ A+K K + ++D + + + + L K P L L
Sbjct: 349 LGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRV-LALPGKPPFLTQL 407
Query: 67 LEVFRRKKKLHLVFEFCDHTVLNELENHPHG---LPWDLIKQITWQVLRGVSYCHRHACI 123
F+ +L+ V E+ + +L H ++ G+ + I
Sbjct: 408 HSCFQTMDRLYFVMEYVNG---GDLMYHIQQVGRFKEPHAVFYAAEIAIGLFFLQSKGII 464
Query: 124 HRDIKPENILLTANGVVKLCDFG 146
+RD+K +N++L + G +K+ DFG
Sbjct: 465 YRDLKLDNVMLDSEGHIKIADFG 487
|
| >1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A* Length = 345 | Back alignment and structure |
|---|
Score = 85.0 bits (211), Expect = 4e-19
Identities = 40/145 (27%), Positives = 69/145 (47%), Gaps = 14/145 (9%)
Query: 10 LGEGSYGVVFKCRNRDTGQVVAIK---KFLESEEDPLIRKIALREIRLLKSLKHPNLVNL 66
LG+GS+G VF + T Q AIK K + +D + + + + L + +HP L ++
Sbjct: 25 LGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRV-LSLAWEHPFLTHM 83
Query: 67 LEVFRRKKKLHLVFEFCDHTVLN--ELENHPH---GLPWDLIKQITWQVLRGVSYCHRHA 121
F+ K+ L V E+ N +L H +++ G+ + H
Sbjct: 84 FCTFQTKENLFFVMEYL-----NGGDLMYHIQSCHKFDLSRATFYAAEIILGLQFLHSKG 138
Query: 122 CIHRDIKPENILLTANGVVKLCDFG 146
++RD+K +NILL +G +K+ DFG
Sbjct: 139 IVYRDLKLDNILLDKDGHIKIADFG 163
|
| >2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A* Length = 373 | Back alignment and structure |
|---|
Score = 85.0 bits (211), Expect = 4e-19
Identities = 43/147 (29%), Positives = 69/147 (46%), Gaps = 14/147 (9%)
Query: 10 LGEGSYGVVFKCRNRDTGQVVAIK---KFLESEEDPLIRKIALREIRLLKSLKHPNLVNL 66
+G+GS+G V R++ A+K K ++ ++ R + LLK++KHP LV L
Sbjct: 46 IGKGSFGKVLLARHKAEEVFYAVKVLQKKAILKKKEEKHIMSERNV-LLKNVKHPFLVGL 104
Query: 67 LEVFRRKKKLHLVFEFCDHTVLN--ELENH---PHGLPWDLIKQITWQVLRGVSYCHRHA 121
F+ KL+ V ++ N EL H + ++ + Y H
Sbjct: 105 HFSFQTADKLYFVLDYI-----NGGELFYHLQRERCFLEPRARFYAAEIASALGYLHSLN 159
Query: 122 CIHRDIKPENILLTANGVVKLCDFGFA 148
++RD+KPENILL + G + L DFG
Sbjct: 160 IVYRDLKPENILLDSQGHIVLTDFGLC 186
|
| >3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 84.6 bits (210), Expect = 6e-19
Identities = 41/145 (28%), Positives = 67/145 (46%), Gaps = 14/145 (9%)
Query: 10 LGEGSYGVVFKCRNRDTGQVVAIK---KFLESEEDPLIRKIALREIRLLKSLKHPNLVNL 66
LG+GS+G V R ++TG + A+K K + ++D + + + I L + HP L L
Sbjct: 31 LGKGSFGKVMLARVKETGDLYAVKVLKKDVILQDDDVECTMTEKRI-LSLARNHPFLTQL 89
Query: 67 LEVFRRKKKLHLVFEFCDHTVLN--ELENHPH---GLPWDLIKQITWQVLRGVSYCHRHA 121
F+ +L V EF N +L H + +++ + + H
Sbjct: 90 FCCFQTPDRLFFVMEFV-----NGGDLMFHIQKSRRFDEARARFYAAEIISALMFLHDKG 144
Query: 122 CIHRDIKPENILLTANGVVKLCDFG 146
I+RD+K +N+LL G KL DFG
Sbjct: 145 IIYRDLKLDNVLLDHEGHCKLADFG 169
|
| >1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ... Length = 337 | Back alignment and structure |
|---|
Score = 84.6 bits (210), Expect = 6e-19
Identities = 40/143 (27%), Positives = 71/143 (49%), Gaps = 11/143 (7%)
Query: 10 LGEGSYGVVFKCRNRDTGQVVAIK---KFLESEEDPLIRKIALREIRLLKSLKHPNLVNL 66
LG+G++G V R + TG+ A+K K + +D + + E R+L++ +HP L L
Sbjct: 13 LGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVT--ESRVLQNTRHPFLTAL 70
Query: 67 LEVFRRKKKLHLVFEFCDHTVLNELENHPH---GLPWDLIKQITWQVLRGVSYCHRHACI 123
F+ +L V E+ + EL H + + +++ + Y H +
Sbjct: 71 KYAFQTHDRLCFVMEYANG---GELFFHLSRERVFTEERARFYGAEIVSALEYLHSRDVV 127
Query: 124 HRDIKPENILLTANGVVKLCDFG 146
+RDIK EN++L +G +K+ DFG
Sbjct: 128 YRDIKLENLMLDKDGHIKITDFG 150
|
| >3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A* Length = 345 | Back alignment and structure |
|---|
Score = 83.4 bits (207), Expect = 1e-18
Identities = 39/145 (26%), Positives = 72/145 (49%), Gaps = 14/145 (9%)
Query: 10 LGEGSYGVVFKCRNRDTGQVVAIK---KFLESEEDPLIRKIALREIRLLKSLKHPNLVNL 66
+G GSY V R + T ++ A+K K L ++++ + + + ++ HP LV L
Sbjct: 17 IGRGSYAKVLLVRLKKTDRIYAMKVVKKELVNDDEDIDWVQTEKHV-FEQASNHPFLVGL 75
Query: 67 LEVFRRKKKLHLVFEFCDHTVLN--ELENHPH---GLPWDLIKQITWQVLRGVSYCHRHA 121
F+ + +L V E+ N +L H LP + + + ++ ++Y H
Sbjct: 76 HSCFQTESRLFFVIEYV-----NGGDLMFHMQRQRKLPEEHARFYSAEISLALNYLHERG 130
Query: 122 CIHRDIKPENILLTANGVVKLCDFG 146
I+RD+K +N+LL + G +KL D+G
Sbjct: 131 IIYRDLKLDNVLLDSEGHIKLTDYG 155
|
| >4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus} Length = 396 | Back alignment and structure |
|---|
Score = 83.9 bits (208), Expect = 2e-18
Identities = 38/145 (26%), Positives = 72/145 (49%), Gaps = 14/145 (9%)
Query: 10 LGEGSYGVVFKCRNRDTGQVVAIK---KFLESEEDPLIRKIALREIRLLKSLKHPNLVNL 66
+G GSY V R + T ++ A++ K L ++++ + + + ++ HP LV L
Sbjct: 60 IGRGSYAKVLLVRLKKTDRIYAMRVVKKELVNDDEDIDWVQTEKHV-FEQASNHPFLVGL 118
Query: 67 LEVFRRKKKLHLVFEFCDHTVLN--ELENHPH---GLPWDLIKQITWQVLRGVSYCHRHA 121
F+ + +L V E+ N +L H LP + + + ++ ++Y H
Sbjct: 119 HSCFQTESRLFFVIEYV-----NGGDLMFHMQRQRKLPEEHARFYSAEISLALNYLHERG 173
Query: 122 CIHRDIKPENILLTANGVVKLCDFG 146
I+RD+K +N+LL + G +KL D+G
Sbjct: 174 IIYRDLKLDNVLLDSEGHIKLTDYG 198
|
| >3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A* Length = 327 | Back alignment and structure |
|---|
Score = 81.8 bits (203), Expect = 4e-18
Identities = 45/149 (30%), Positives = 70/149 (46%), Gaps = 19/149 (12%)
Query: 10 LGEGSYGVVF---KCRNRDTGQVVAIK----KFLESEEDPLIRKIALREIRLLKSLKHPN 62
LG+G YG VF K +TG++ A+K + A E +L+ +KHP
Sbjct: 25 LGKGGYGKVFQVRKVTGANTGKIFAMKVLKKAMIVRNAKDTAHTKA--ERNILEEVKHPF 82
Query: 63 LVNLLEVFRRKKKLHLVFEFCDHTVLN--ELENH---PHGLPWDLIKQITWQVLRGVSYC 117
+V+L+ F+ KL+L+ E+ + EL D ++ + +
Sbjct: 83 IVDLIYAFQTGGKLYLILEYL-----SGGELFMQLEREGIFMEDTACFYLAEISMALGHL 137
Query: 118 HRHACIHRDIKPENILLTANGVVKLCDFG 146
H+ I+RD+KPENI+L G VKL DFG
Sbjct: 138 HQKGIIYRDLKPENIMLNHQGHVKLTDFG 166
|
| >2vuw_A Serine/threonine-protein kinase haspin; cell cycle, transferase, CAsp8, nucleotide binding; HET: MSE 5ID MPD; 1.80A {Homo sapiens} PDB: 3f2n_A* 3e7v_A* 3dlz_A* 3fmd_A* 3iq7_A* 2wb8_A Length = 336 | Back alignment and structure |
|---|
Score = 81.5 bits (200), Expect = 8e-18
Identities = 39/212 (18%), Positives = 63/212 (29%), Gaps = 51/212 (24%)
Query: 2 ERYEKIGKLGEGSYGVVFKCRNRDTGQVVAIKK------FLESEEDPLIRKIALREIRLL 55
E+ ++ K+GEG +G VF+ VAIK L + + L EI +
Sbjct: 20 EKLQRCEKIGEGVFGEVFQTIA--DHTPVAIKIIAIEGPDLVNGSHQKTFEEILPEIIIS 77
Query: 56 KSL---------KHPNLVNLLEVF------------------------------RRKKKL 76
K L + + L V + +L
Sbjct: 78 KELSLLSGEVCNRTEGFIGLNSVHCVQGSYPPLLLKAWDHYNSTKGSANDRPDFFKDDQL 137
Query: 77 HLVFEFCDHTVLNELENHPHGLPWDLIKQITWQVLRGVSYCH-RHACIHRDIKPENILLT 135
+V EF + E + K I Q+ ++ HRD+ N+LL
Sbjct: 138 FIVLEFEFGGIDLE-QMRTKLSSLATAKSILHQLTASLAVAEASLRFEHRDLHWGNVLLK 196
Query: 136 ANGVVKLCDFGFARLIRDLIPRHLHIFQTNEY 167
+ KL + IP +Y
Sbjct: 197 KTSLKKLHYTLNGKSST--IPSCGLQVSIIDY 226
|
| >3g51_A Ribosomal protein S6 kinase alpha-3; N-terminal kinase domain of P90 ribosomal S6 kinase 2, ATP- binding, nucleotide-binding, phosphoprotein; HET: ANP; 1.80A {Mus musculus} PDB: 2z7q_A* 2z7r_A* 2z7s_A* Length = 325 | Back alignment and structure |
|---|
Score = 79.5 bits (197), Expect = 3e-17
Identities = 45/161 (27%), Positives = 72/161 (44%), Gaps = 45/161 (27%)
Query: 10 LGEGSYGVVF---KCRNRDTGQVVAIKKFLESEEDPLIRKIALR---------EIRLLKS 57
LG+GS+G VF K D Q+ A+K +++K L+ E +L
Sbjct: 32 LGQGSFGKVFLVKKISGSDARQLYAMK---------VLKKATLKVRDRVRTKMERDILVE 82
Query: 58 LKHPNLVNLLEVFRRKKKLHLVFEFCDHTVLN--ELENHPHGLPWDLIKQITW------- 108
+ HP +V L F+ + KL+L+ +F +L L K++ +
Sbjct: 83 VNHPFIVKLHYAFQTEGKLYLILDFL-----RGGDLFTR-------LSKEVMFTEEDVKF 130
Query: 109 ---QVLRGVSYCHRHACIHRDIKPENILLTANGVVKLCDFG 146
++ + + H I+RD+KPENILL G +KL DFG
Sbjct: 131 YLAELALALDHLHSLGIIYRDLKPENILLDEEGHIKLTDFG 171
|
| >1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7 Length = 355 | Back alignment and structure |
|---|
Score = 79.6 bits (197), Expect = 3e-17
Identities = 46/151 (30%), Positives = 71/151 (47%), Gaps = 18/151 (11%)
Query: 10 LGEGSYGVVF---KCRNRDTGQVVAI----KKFLESEEDPLIRKIALREIRLLKSLKHPN 62
LG G+YG VF K DTG++ A+ K + + R++ L + P
Sbjct: 62 LGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQV-LEHIRQSPF 120
Query: 63 LVNLLEVFRRKKKLHLVFEFCDHTVLN--ELENH---PHGLPWDLIKQITWQVLRGVSYC 117
LV L F+ + KLHL+ ++ N EL H ++ +++ + +
Sbjct: 121 LVTLHYAFQTETKLHLILDYI-----NGGELFTHLSQRERFTEHEVQIYVGEIVLALEHL 175
Query: 118 HRHACIHRDIKPENILLTANGVVKLCDFGFA 148
H+ I+RDIK ENILL +NG V L DFG +
Sbjct: 176 HKLGIIYRDIKLENILLDSNGHVVLTDFGLS 206
|
| >4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A* Length = 446 | Back alignment and structure |
|---|
Score = 79.8 bits (197), Expect = 4e-17
Identities = 40/147 (27%), Positives = 72/147 (48%), Gaps = 18/147 (12%)
Query: 10 LGEGSYGVVFKCRNRDTGQVVAIKKFLESEEDPLIRK----IALREIRLLKSLKHPNLVN 65
LG+G++G V + + TG+ A+K +++ ++ K L E R+L++ +HP L
Sbjct: 156 LGKGTFGKVILVKEKATGRYYAMKIL---KKEVIVAKDEVAHTLTENRVLQNSRHPFLTA 212
Query: 66 LLEVFRRKKKLHLVFEFCDHTVLN--ELENHPH---GLPWDLIKQITWQVLRGVSYCH-R 119
L F+ +L V E+ N EL H D + +++ + Y H
Sbjct: 213 LKYSFQTHDRLCFVMEYA-----NGGELFFHLSRERVFSEDRARFYGAEIVSALDYLHSE 267
Query: 120 HACIHRDIKPENILLTANGVVKLCDFG 146
++RD+K EN++L +G +K+ DFG
Sbjct: 268 KNVVYRDLKLENLMLDKDGHIKITDFG 294
|
| >3sv0_A Casein kinase I-like; typical kinase domain fold, cytosol, transferase; 2.00A {Oryza sativa japonica group} Length = 483 | Back alignment and structure |
|---|
Score = 79.3 bits (195), Expect = 8e-17
Identities = 43/175 (24%), Positives = 76/175 (43%), Gaps = 12/175 (6%)
Query: 2 ERYEKIGKLGEGSYGVVFKCRNRDTGQVVAIKKFLESEEDPLIRKIALREIRLLKSLK-H 60
++ K+G GS+G ++ N T + VAIK + P + E ++ + L+
Sbjct: 7 NKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKHPQLL----YESKIYRILQGG 62
Query: 61 PNLVNLLEVFRRKKKLHLVFEFCDHTVLNELENHPHGLPWDLIKQITWQVLRGVSYCHRH 120
+ N+ LV + ++ + L + + Q++ V + H
Sbjct: 63 TGIPNVRWFGVEGDYNVLVMDLLGPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSK 122
Query: 121 ACIHRDIKPENILL----TANGVVKLCDFGFARLIRDLIPRHLHI-FQTNEYFKG 170
+ +HRDIKP+N L+ AN V + DFG A+ RD H HI ++ N+ G
Sbjct: 123 SFLHRDIKPDNFLMGLGRRANQVY-IIDFGLAKKYRDTST-HQHIPYRENKNLTG 175
|
| >1csn_A Casein kinase-1; phosphotransferase; HET: ATP; 2.00A {Schizosaccharomyces pombe} SCOP: d.144.1.7 PDB: 1eh4_A* 2csn_A* Length = 298 | Back alignment and structure |
|---|
Score = 76.2 bits (188), Expect = 3e-16
Identities = 48/200 (24%), Positives = 74/200 (37%), Gaps = 60/200 (30%)
Query: 2 ERYEKIGKLGEGSYGVVFKCRNRDTGQVVAIKKFLESEEDPLIRKIALREIRLLKSLKH- 60
Y+ ++GEGS+GV+F+ N Q VAIK + P +R E R K L
Sbjct: 10 VHYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRSDAPQLR----DEYRTYKLLAGC 65
Query: 61 ------------------------PNLVNLLEVFRRKKKLHLVFEFCDHTVLNELENHPH 96
P+L +LL++ RK F TV
Sbjct: 66 TGIPNVYYFGQEGLHNVLVIDLLGPSLEDLLDLCGRK--------FSVKTVA-------- 109
Query: 97 GLPWDLIKQITWQVLRGVSYCHRHACIHRDIKPENILLTANG-----VVKLCDFGFARLI 151
Q+L V H + ++RDIKP+N L+ ++ + DFG +
Sbjct: 110 --------MAAKQMLARVQSIHEKSLVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFY 161
Query: 152 RDLIPRHLHI-FQTNEYFKG 170
RD + HI ++ + G
Sbjct: 162 RDPVT-KQHIPYREKKNLSG 180
|
| >2izr_A Casein kinase I isoform gamma-3; serine/threonine-protein kinase, transferase, ATP- binding, phosphorylation, nucleotide-binding; HET: BRK; 1.3A {Homo sapiens} PDB: 2izs_A* 2izt_A* 2izu_A* 2chl_A* 2c47_A* 2cmw_A* Length = 330 | Back alignment and structure |
|---|
Score = 75.9 bits (187), Expect = 5e-16
Identities = 44/199 (22%), Positives = 69/199 (34%), Gaps = 60/199 (30%)
Query: 3 RYEKIGKLGEGSYGVVFKCRNRDTGQVVAIKKFLESEEDPLIRKIALREIRLLKSLKH-- 60
+ K+G G++G + +N T + VAIK LE + E R K L
Sbjct: 10 NFRVGKKIGCGNFGELRLGKNLYTNEYVAIK--LEPMKSR--APQLHLEYRFYKQLGSGD 65
Query: 61 -----------------------PNLVNLLEVFRRKKKLHLVFEFCDHTVLNELENHPHG 97
P+L +L ++ R F TVL
Sbjct: 66 GIPQVYYFGPCGKYNAMVLELLGPSLEDLFDLCDRT--------FSLKTVL--------- 108
Query: 98 LPWDLIKQITWQVLRGVSYCHRHACIHRDIKPENILL-----TANGVVKLCDFGFARLIR 152
I Q++ + Y H I+RD+KPEN L+ V+ + DF A+
Sbjct: 109 -------MIAIQLISRMEYVHSKNLIYRDVKPENFLIGRPGNKTQQVIHIIDFALAKEYI 161
Query: 153 DLIPRHLHI-FQTNEYFKG 170
D HI ++ ++ G
Sbjct: 162 DPE-TKKHIPYREHKSLTG 179
|
| >3uzp_A CKI-delta, CKID, casein kinase I isoform delta; CK1D, inhibitor, PF670462, transferase-transferase I complex; HET: 0CK; 1.94A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 1cki_A 1ckj_A Length = 296 | Back alignment and structure |
|---|
Score = 74.7 bits (184), Expect = 9e-16
Identities = 41/175 (23%), Positives = 72/175 (41%), Gaps = 12/175 (6%)
Query: 2 ERYEKIGKLGEGSYGVVFKCRNRDTGQVVAIKKFLESEEDPLIRKIALREIRLLKSLKH- 60
RY K+G GS+G ++ + G+ VAIK + P + E ++ K ++
Sbjct: 9 NRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTKHPQLH----IESKIYKMMQGG 64
Query: 61 PNLVNLLEVFRRKKKLHLVFEFCDHTVLNELENHPHGLPWDLIKQITWQVLRGVSYCHRH 120
+ + +V E ++ + + + Q++ + Y H
Sbjct: 65 VGIPTIRWCGAEGDYNVMVMELLGPSLEDLFNFCSRKFSLKTVLLLADQMISRIEYIHSK 124
Query: 121 ACIHRDIKPENILL----TANGVVKLCDFGFARLIRDLIPRHLHI-FQTNEYFKG 170
IHRD+KP+N L+ N V + DFG A+ RD H HI ++ N+ G
Sbjct: 125 NFIHRDVKPDNFLMGLGKKGNLVY-IIDFGLAKKYRDAR-THQHIPYRENKNLTG 177
|
| >2v62_A Serine/threonine-protein kinase VRK2; transferase, ATP-binding, membrane, nucleotide-binding, TRAN; 1.7A {Homo sapiens} Length = 345 | Back alignment and structure |
|---|
Score = 69.8 bits (171), Expect = 7e-14
Identities = 27/180 (15%), Positives = 62/180 (34%), Gaps = 26/180 (14%)
Query: 3 RYEKIGKLGEGSYGVVFKCRNRDTGQVVAIKKF-LESEEDPLIRKIALREIRLLKSLKHP 61
++ K+G G +G+++ + + A +E +E+ + E++ + +
Sbjct: 38 QWVLGKKIGSGGFGLIYLAFPTNKPEKDARHVVKVEYQENGPL----FSELKFYQRVAKK 93
Query: 62 NLVNLLEVFRRKKKL---------HLVFEFCDHTV---------LNELENHPHGLPWDLI 103
+ + ++ L F+ + L ++ +
Sbjct: 94 DCIKKWIERKQLDYLGIPLFYGSGLTEFKGRSYRFMVMERLGIDLQKISGQNGTFKKSTV 153
Query: 104 KQITWQVLRGVSYCHRHACIHRDIKPENILL--TANGVVKLCDFGFARLIRDLIPRHLHI 161
Q+ ++L + Y H + +H DIK N+LL V L D+G + H
Sbjct: 154 LQLGIRMLDVLEYIHENEYVHGDIKAANLLLGYKNPDQVYLADYGLSYRYCPN-GNHKQY 212
|
| >3op5_A Serine/threonine-protein kinase VRK1; adenosine triphosphate, amino acid sequence, binding sites, domain, models, molecular; HET: REB; 2.40A {Homo sapiens} PDB: 2lav_A 2kty_A 2kul_A Length = 364 | Back alignment and structure |
|---|
Score = 62.9 bits (153), Expect = 2e-11
Identities = 32/185 (17%), Positives = 63/185 (34%), Gaps = 33/185 (17%)
Query: 3 RYEKIGKLGEGSYGVVFKCRNRDTGQVVAIK-----KFLESEEDPLIRKIALREIRLLKS 57
++ +G+G +G ++ + ++ + V K S+ PL E++ +
Sbjct: 36 AWKVGLPIGQGGFGCIYLA-DMNSSESVGSDAPCVVKVEPSDNGPL-----FTELKFYQR 89
Query: 58 LKHPNLVNLLEVFRRKKKL-------------------HLVFEFCDHTVLNELENHPHGL 98
P + R+ K L ++ + + E +
Sbjct: 90 AAKPEQIQKWIRTRKLKYLGVPKYWGSGLHDKNGKSYRFMIMDRFGSDLQKIYEANAKRF 149
Query: 99 PWDLIKQITWQVLRGVSYCHRHACIHRDIKPENILL--TANGVVKLCDFGFARLIRDLIP 156
+ Q++ ++L + Y H H +H DIK N+LL V L D+G A
Sbjct: 150 SRKTVLQLSLRILDILEYIHEHEYVHGDIKASNLLLNYKNPDQVYLVDYGLAYRYCPE-G 208
Query: 157 RHLHI 161
H
Sbjct: 209 VHKAY 213
|
| >2jii_A Serine/threonine-protein kinase VRK3 molecule: VA related kinase 3; transferase, pseudo kinase domain, vaccinia related kinase, ATP-binding; 2.00A {Homo sapiens} Length = 352 | Back alignment and structure |
|---|
Score = 62.1 bits (151), Expect = 3e-11
Identities = 27/175 (15%), Positives = 61/175 (34%), Gaps = 26/175 (14%)
Query: 2 ERYEKIGKLGEGSYGVVFKCRNRDTGQV--------VAIKKFLESEEDPL-------IRK 46
+++ + G++++ T ++K L++++ L R
Sbjct: 42 RQWKLKSFQTRDNQGILYEAAPTSTLTCDSGPQKQKFSLK--LDAKDGRLFNEQNFFQRA 99
Query: 47 IALREIRLLKSLKHPNLVNLLEV--FRRKKKLH--LVFEFCDHTVLNEL--ENHPHGLPW 100
++ K L L+ + F + + LV + L + H L
Sbjct: 100 AKPLQVNKWKKLYSTPLLAIPTCMGFGVHQDKYRFLVLPSLGRS-LQSALDVSPKHVLSE 158
Query: 101 DLIKQITWQVLRGVSYCHRHACIHRDIKPENILL--TANGVVKLCDFGFARLIRD 153
+ Q+ ++L + + H + +H ++ ENI + V L +GFA
Sbjct: 159 RSVLQVACRLLDALEFLHENEYVHGNVTAENIFVDPEDQSQVTLAGYGFAFRYCP 213
|
| >3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vid_A* 3hng_A* Length = 359 | Back alignment and structure |
|---|
Score = 59.9 bits (145), Expect = 1e-10
Identities = 40/218 (18%), Positives = 64/218 (29%), Gaps = 74/218 (33%)
Query: 9 KLGEGSYGVVFKCR----NRDTGQVVAIKKFLESEEDPLIRKIALREIRLLKSL------ 58
LG G++G V + ++ K L+ + + E+++L +
Sbjct: 29 PLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNV 88
Query: 59 ---------------------KHPNLVNLLEVFRRKKKLHLVFEFCDHTVLNELENHPHG 97
K NL L R + + + + P
Sbjct: 89 VNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKTKGARFRQGKDYVGAIPVD 148
Query: 98 L------------------------------------------PWDLIKQITWQVLRGVS 115
L LI ++QV +G+
Sbjct: 149 LKRRLDSITSSQSSASSGFVEEKSLSDVEEEEAPEDLYKDFLTLEHLI-CYSFQVAKGME 207
Query: 116 YCHRHACIHRDIKPENILLTANGVVKLCDFGFARLIRD 153
+ CIHRD+ NILL+ VVK+CDFG AR I
Sbjct: 208 FLASRKCIHRDLAARNILLSEKNVVKICDFGLARDIYK 245
|
| >1vt4_I APAF-1 related killer DARK; drosophila apoptosome, apoptosis, programmed cell death; HET: DTP; 6.90A {Drosophila melanogaster} PDB: 3iz8_A* Length = 1221 | Back alignment and structure |
|---|
Score = 41.8 bits (97), Expect = 2e-04
Identities = 50/290 (17%), Positives = 92/290 (31%), Gaps = 77/290 (26%)
Query: 32 IKKFLESEEDPLIR--------KIALREIRLLKSLKHPN-LVNLLEVFRRKKKLHLVFEF 82
I S D + LR RLLKS + N L+ LL V + K F
Sbjct: 209 IDPNWTSRSDHSSNIKLRIHSIQAELR--RLLKSKPYENCLLVLLNV--QNAKAWNAFNL 264
Query: 83 -C-------DHTVLN----------ELENHPHGLPWDLIKQITWQVLRGVSYCHRHACIH 124
C V + L++H L D +K + + L C
Sbjct: 265 SCKILLTTRFKQVTDFLSAATTTHISLDHHSMTLTPDEVKSLLLKYLD---------CRP 315
Query: 125 RDIKPENILLTANGVVKLCDFGFARLIRDLIPR-----HLHIFQTNEYFKGVSLPHAEN- 178
+D+ P +L T + + A IRD + H++ + + SL E
Sbjct: 316 QDL-PREVLTTNPRRLSI----IAESIRDGLATWDNWKHVNCDKLTTIIE-SSLNVLEPA 369
Query: 179 ----------VVPLEIKIGKPAAT-NIY--------LIDFLKRCLDKDPLRRWSCDQLLR 219
V P I P ++ ++ + + + + + +
Sbjct: 370 EYRKMFDRLSVFPPSAHI--PTILLSLIWFDVIKSDVMVVVNKLHKYSLVEKQPKESTI- 426
Query: 220 HPYFNGYYFEVPDEMQYE-EITQRCLDKDPLRRWSCDQLLRHPYFNGYYF 268
Y E+ +++ E + + +D + + L PY + Y++
Sbjct: 427 --SIPSIYLELKVKLENEYALHRSIVDHYNIPKTFDSDDLIPPYLDQYFY 474
|
Structure Templates Detected by HHsearch
Original result of HHsearch against PDB70 database
| ID | Alignment Graph | Length |
Definition |
Probability |
| Query | 292 | |||
| 4aw0_A | 311 | HPDK1, 3-phosphoinositide-dependent protein kinase | 100.0 | |
| 4b9d_A | 350 | Serine/threonine-protein kinase NEK1; transferase, | 100.0 | |
| 3hyh_A | 275 | Carbon catabolite-derepressing protein kinase; kin | 100.0 | |
| 4fih_A | 346 | Serine/threonine-protein kinase PAK 4; kinase doma | 100.0 | |
| 3ubd_A | 304 | Ribosomal protein S6 kinase alpha-3; kinase-inhibi | 100.0 | |
| 4fie_A | 423 | Serine/threonine-protein kinase PAK 4; kinase doma | 100.0 | |
| 3fpq_A | 290 | Serine/threonine-protein kinase WNK1; protein seri | 100.0 | |
| 4b99_A | 398 | Mitogen-activated protein kinase 7; transferase, i | 100.0 | |
| 4g3f_A | 336 | NF-kappa-beta-inducing kinase; non-RD kinase, prot | 100.0 | |
| 4g31_A | 299 | Eukaryotic translation initiation factor 2-alpha; | 100.0 | |
| 3v5w_A | 689 | G-protein coupled receptor kinase 2; inhibitor com | 100.0 | |
| 4f9c_A | 361 | Cell division cycle 7-related protein kinase; Ser/ | 100.0 | |
| 4asz_A | 299 | BDNF/NT-3 growth factors receptor; transferase, TR | 100.0 | |
| 3uto_A | 573 | Twitchin; kinase, muscle sarcomere, transferase; H | 100.0 | |
| 3fe3_A | 328 | MAP/microtubule affinity-regulating kinase 3; seri | 100.0 | |
| 4aoj_A | 329 | High affinity nerve growth factor receptor; transf | 100.0 | |
| 3omv_A | 307 | RAF proto-oncogene serine/threonine-protein kinas; | 100.0 | |
| 4gt4_A | 308 | Tyrosine-protein kinase transmembrane receptor RO; | 100.0 | |
| 1o6l_A | 337 | RAC-beta serine/threonine protein kinase; protein | 100.0 | |
| 3o0g_A | 292 | Cell division protein kinase 5; kinase activator c | 100.0 | |
| 3txo_A | 353 | PKC-L, NPKC-ETA, protein kinase C ETA type; phosph | 100.0 | |
| 3zgw_A | 347 | Maternal embryonic leucine zipper kinase; transfer | 100.0 | |
| 1fot_A | 318 | TPK1 delta, CAMP-dependent protein kinase type 1; | 100.0 | |
| 3niz_A | 311 | Rhodanese family protein; structural genomics, str | 100.0 | |
| 2yab_A | 361 | Death-associated protein kinase 2; apoptosis, tran | 100.0 | |
| 1xjd_A | 345 | Protein kinase C, theta type; PKC-theta, ATP, AMP, | 100.0 | |
| 3a8x_A | 345 | Protein kinase C IOTA type; transferase; HET: TPO; | 100.0 | |
| 4dc2_A | 396 | Protein kinase C IOTA type; kinase, substrate, cel | 100.0 | |
| 4ase_A | 353 | Vascular endothelial growth factor receptor 2; tra | 100.0 | |
| 1rdq_E | 350 | PKA C-alpha, CAMP-dependent protein kinase, alpha- | 100.0 | |
| 4agu_A | 311 | Cyclin-dependent kinase-like 1; transferase, phosp | 100.0 | |
| 3fxz_A | 297 | Serine/threonine-protein kinase PAK 1; transferase | 100.0 | |
| 3soa_A | 444 | Calcium/calmodulin-dependent protein kinase type a | 100.0 | |
| 3gni_B | 389 | Strad alpha; kinase fold, pseudokinase, alpha heli | 100.0 | |
| 4fr4_A | 384 | YANK1, serine/threonine-protein kinase 32A; struct | 100.0 | |
| 2i0e_A | 353 | Protein kinase C-beta II; serine/threonine protein | 100.0 | |
| 3gbz_A | 329 | Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide- | 100.0 | |
| 2bdw_A | 362 | Hypothetical protein K11E8.1D; kinase, calmodulin | 100.0 | |
| 3fdn_A | 279 | Serine/threonine-protein kinase 6; aurora kinase i | 100.0 | |
| 1ob3_A | 288 | PFPK5, cell division control protein 2 homolog; tr | 100.0 | |
| 3h4j_B | 336 | AMPK kdaid, SNF1-like protein kinase SSP2; ATP-bin | 100.0 | |
| 2eue_A | 275 | Carbon catabolite derepressing protein kinase; kin | 100.0 | |
| 4ejn_A | 446 | RAC-alpha serine/threonine-protein kinase; AKT1, a | 100.0 | |
| 2r5t_A | 373 | Serine/threonine-protein kinase SGK1; AGC protein | 100.0 | |
| 3a62_A | 327 | Ribosomal protein S6 kinase beta-1; kinase domain, | 100.0 | |
| 1tki_A | 321 | Titin; serine kinase, muscle, autoinhibition; 2.00 | 100.0 | |
| 3cok_A | 278 | Serine/threonine-protein kinase PLK4; POLO-like ki | 100.0 | |
| 4aaa_A | 331 | Cyclin-dependent kinase-like 2; transferase, phosp | 100.0 | |
| 2y0a_A | 326 | Death-associated protein kinase 1; transferase, ca | 100.0 | |
| 3tki_A | 323 | Serine/threonine-protein kinase CHK1; cell checkpo | 100.0 | |
| 3mtl_A | 324 | Cell division protein kinase 16; pctaire1, indirub | 100.0 | |
| 3kk8_A | 284 | Calcium/calmodulin dependent protein kinase II; AT | 100.0 | |
| 2y94_A | 476 | 5'-AMP-activated protein kinase catalytic subunit; | 100.0 | |
| 2rku_A | 294 | Serine/threonine-protein kinase PLK1; structure of | 100.0 | |
| 3v8s_A | 410 | RHO-associated protein kinase 1; dimerization, myo | 100.0 | |
| 2a2a_A | 321 | Death-associated protein kinase 2; autoinhibition, | 100.0 | |
| 2zv2_A | 298 | Calcium/calmodulin-dependent protein kinase kinas; | 100.0 | |
| 3ttj_A | 464 | Mitogen-activated protein kinase 10; JNK3, protein | 100.0 | |
| 3n9x_A | 432 | Phosphotransferase; malaria kinase, structural gen | 100.0 | |
| 3rp9_A | 458 | Mitogen-activated protein kinase; structural genom | 100.0 | |
| 3hmm_A | 303 | TGF-beta receptor type-1; ALK5, kinase, inhibitor, | 100.0 | |
| 2vgo_A | 284 | Serine/threonine-protein kinase 12-A; nucleotide-b | 100.0 | |
| 2pmi_A | 317 | Negative RE, cyclin-dependent protein kinase PHO85 | 100.0 | |
| 3uc3_A | 361 | Serine/threonine-protein kinase SRK2I; SNRK2, ABA | 100.0 | |
| 2owb_A | 335 | Serine/threonine-protein kinase PLK1; catalytic do | 100.0 | |
| 1kob_A | 387 | Twitchin; kinase, intrasteric regulation; 2.30A {A | 100.0 | |
| 3mi9_A | 351 | Cell division protein kinase 9; P-TEFB, HIV-1, pro | 100.0 | |
| 2r3i_A | 299 | Cell division protein kinase 2; serine/threonine-p | 100.0 | |
| 4aw2_A | 437 | Serine/threonine-protein kinase MRCK alpha; transf | 100.0 | |
| 3mwu_A | 486 | Calmodulin-domain protein kinase 1; serine/threoni | 100.0 | |
| 3oz6_A | 388 | Mitogen-activated protein kinase 1, serine/threon | 100.0 | |
| 2w4o_A | 349 | Calcium/calmodulin-dependent protein kinase type I | 100.0 | |
| 3pfq_A | 674 | PKC-B, PKC-beta, protein kinase C beta type; phosp | 100.0 | |
| 3f3z_A | 277 | Calcium/calmodulin-dependent protein kinase with d | 100.0 | |
| 1ua2_A | 346 | CAK, cell division protein kinase 7; cell cycle, p | 100.0 | |
| 3c0i_A | 351 | Peripheral plasma membrane protein CASK; neurexin, | 100.0 | |
| 2acx_A | 576 | G protein-coupled receptor kinase 6; GRK, G transf | 100.0 | |
| 2vd5_A | 412 | DMPK protein; serine/threonine-protein kinase, kin | 100.0 | |
| 3qd2_B | 332 | Eukaryotic translation initiation factor 2-alpha; | 100.0 | |
| 3dls_A | 335 | PAS domain-containing serine/threonine-protein KI; | 100.0 | |
| 3p1a_A | 311 | MYT1 kinase, membrane-associated tyrosine- and thr | 100.0 | |
| 3is5_A | 285 | Calcium-dependent protein kinase; CDPK, structural | 100.0 | |
| 3eqc_A | 360 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 1cm8_A | 367 | Phosphorylated MAP kinase P38-gamma; phosphorylati | 100.0 | |
| 2c30_A | 321 | Serine/threonine-protein kinase PAK 6; CRIB domain | 100.0 | |
| 2h6d_A | 276 | 5'-AMP-activated protein kinase catalytic subunit | 100.0 | |
| 1x8b_A | 289 | WEE1HU, WEE1-like protein kinase; cell cycle, tran | 100.0 | |
| 3lij_A | 494 | Calcium/calmodulin dependent protein kinase with A | 100.0 | |
| 3g33_A | 308 | Cell division protein kinase 4; Ser/Thr protein ki | 100.0 | |
| 3q5i_A | 504 | Protein kinase; CDPK, malaria, phosphotransferase, | 100.0 | |
| 3lm5_A | 327 | Serine/threonine-protein kinase 17B; STK17B, serin | 100.0 | |
| 3nyv_A | 484 | Calmodulin-domain protein kinase 1; serine/threoni | 100.0 | |
| 3hko_A | 345 | Calcium/calmodulin-dependent protein kinase with d | 100.0 | |
| 1t4h_A | 290 | Serine/threonine-protein kinase WNK1; protein seri | 100.0 | |
| 3c4z_A | 543 | Rhodopsin kinase; Ser/Thr kinase, RGS homology dom | 100.0 | |
| 2yex_A | 276 | Serine/threonine-protein kinase CHK1; transferase, | 100.0 | |
| 3kn6_A | 325 | Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1 | 100.0 | |
| 2fst_X | 367 | Mitogen-activated protein kinase 14; active mutant | 100.0 | |
| 2xrw_A | 371 | Mitogen-activated protein kinase 8; transcription, | 100.0 | |
| 2j7t_A | 302 | Serine/threonine-protein kinase 10; transferase, A | 100.0 | |
| 1u5q_A | 348 | Serine/threonine protein kinase TAO2; transferase; | 100.0 | |
| 2qr7_A | 342 | Ribosomal protein S6 kinase alpha-3; kinase domain | 100.0 | |
| 3bhy_A | 283 | Death-associated protein kinase 3; death associate | 100.0 | |
| 4exu_A | 371 | Mitogen-activated protein kinase 13; P38 kinase, t | 100.0 | |
| 3i6u_A | 419 | CDS1, serine/threonine-protein kinase CHK2; Ser/Th | 100.0 | |
| 2jam_A | 304 | Calcium/calmodulin-dependent protein kinase type 1 | 100.0 | |
| 1phk_A | 298 | Phosphorylase kinase; glycogen metabolism, transfe | 100.0 | |
| 3nsz_A | 330 | CK II alpha, casein kinase II subunit alpha; inhib | 100.0 | |
| 2pml_X | 348 | PFPK7, Ser/Thr protein kinase; phosphorylati trans | 100.0 | |
| 3dbq_A | 343 | Dual specificity protein kinase TTK; MPS1 structur | 100.0 | |
| 3qyz_A | 364 | Mitogen-activated protein kinase 1; transferase, s | 100.0 | |
| 2wei_A | 287 | Calmodulin-domain protein kinase 1, putative; nucl | 100.0 | |
| 2x4f_A | 373 | Myosin light chain kinase family member 4; LUNG, b | 100.0 | |
| 3llt_A | 360 | Serine/threonine kinase-1, pflammer; lammer kinase | 100.0 | |
| 3eb0_A | 383 | Putative uncharacterized protein; kinase cryptospo | 100.0 | |
| 2ac3_A | 316 | MAP kinase-interacting serine/threonine kinase 2; | 100.0 | |
| 3fme_A | 290 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 2y7j_A | 365 | Phosphorylase B kinase gamma catalytic chain, test | 100.0 | |
| 2w5a_A | 279 | Serine/threonine-protein kinase NEK2; Ser/Thr prot | 100.0 | |
| 3coi_A | 353 | Mitogen-activated protein kinase 13; P38D, P38delt | 100.0 | |
| 2zmd_A | 390 | Dual specificity protein kinase TTK; MPS1, T686A, | 100.0 | |
| 2ycf_A | 322 | Serine/threonine-protein kinase CHK2; transferase, | 100.0 | |
| 1nxk_A | 400 | MAP kinase-activated protein kinase 2; MK2, phosph | 100.0 | |
| 3byv_A | 377 | Rhoptry kinase; malaria, transferase, structural g | 100.0 | |
| 3com_A | 314 | Serine/threonine-protein kinase 4; MST1, STE20-lik | 100.0 | |
| 3p86_A | 309 | Serine/threonine-protein kinase CTR1; ETR1, ERS1, | 100.0 | |
| 4euu_A | 319 | Serine/threonine-protein kinase TBK1; ATP binding, | 100.0 | |
| 2i6l_A | 320 | Mitogen-activated protein kinase 6; MAPK6, ERK3, e | 100.0 | |
| 3ork_A | 311 | Serine/threonine protein kinase; structural genomi | 100.0 | |
| 2wtk_C | 305 | Serine/threonine-protein kinase 11; transferase-me | 100.0 | |
| 3pg1_A | 362 | Mitogen-activated protein kinase, putative (MAP K | 100.0 | |
| 2x7f_A | 326 | TRAF2 and NCK-interacting protein kinase; serine/t | 100.0 | |
| 4eqm_A | 294 | Protein kinase; transferase; HET: ANP; 3.00A {Stap | 100.0 | |
| 2vwi_A | 303 | Serine/threonine-protein kinase OSR1; STE kinase, | 100.0 | |
| 3s95_A | 310 | LIMK-1, LIM domain kinase 1; structural genomics, | 100.0 | |
| 3kvw_A | 429 | DYRK2, dual specificity tyrosine-phosphorylation-r | 100.0 | |
| 1vzo_A | 355 | Ribosomal protein S6 kinase alpha 5; protein kinas | 100.0 | |
| 3an0_A | 340 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 1zy4_A | 303 | Serine/threonine-protein kinase GCN2; translation | 100.0 | |
| 3a7i_A | 303 | MST3 kinase, serine/threonine kinase 24 (STE20 hom | 100.0 | |
| 3q60_A | 371 | ROP5B; pseudokinase, transferase; HET: ATP; 1.72A | 100.0 | |
| 1wak_A | 397 | Serine/threonine-protein kinase SPRK1; SRPK, trans | 100.0 | |
| 1blx_A | 326 | Cyclin-dependent kinase 6; inhibitor protein, cycl | 100.0 | |
| 3qup_A | 323 | Tyrosine-protein kinase receptor TYRO3; protein ki | 100.0 | |
| 3a99_A | 320 | Proto-oncogene serine/threonine-protein kinase PI; | 100.0 | |
| 2b9h_A | 353 | MAP kinase FUS3, mitogen-activated protein kinase | 100.0 | |
| 3e3p_A | 360 | Protein kinase, putative glycogen synthase kinase; | 100.0 | |
| 3m2w_A | 299 | MAP kinase-activated protein kinase 2; small molec | 100.0 | |
| 4e7w_A | 394 | Glycogen synthase kinase 3; GSK3, PTyr195, transfe | 100.0 | |
| 3aln_A | 327 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 2iwi_A | 312 | Serine/threonine-protein kinase PIM-2; nucleotide- | 100.0 | |
| 2dyl_A | 318 | Dual specificity mitogen-activated protein kinase | 100.0 | |
| 3kul_A | 325 | Ephrin type-A receptor 8; ATP-binding, kinase, nuc | 100.0 | |
| 3rgf_A | 405 | Cyclin-dependent kinase 8; protein kinase complex, | 100.0 | |
| 1j1b_A | 420 | Glycogen synthase kinase-3 beta; complex, TAU, AMP | 100.0 | |
| 4hcu_A | 269 | Tyrosine-protein kinase ITK/TSK; transferase-trans | 100.0 | |
| 3cek_A | 313 | Dual specificity protein kinase TTK; HMPS1, PYT, E | 100.0 | |
| 1z57_A | 339 | Dual specificity protein kinase CLK1; protein tyro | 100.0 | |
| 2clq_A | 295 | Mitogen-activated protein kinase kinase kinase 5; | 100.0 | |
| 2psq_A | 370 | Fibroblast growth factor receptor 2; kinase domain | 100.0 | |
| 2vx3_A | 382 | Dual specificity tyrosine-phosphorylation- regula | 100.0 | |
| 3l9p_A | 367 | Anaplastic lymphoma kinase; kinase domain, ATP-bin | 100.0 | |
| 2eu9_A | 355 | Dual specificity protein kinase CLK3; kinase domai | 100.0 | |
| 2h34_A | 309 | Serine/threonine-protein kinase PKNE; apoenzyme, t | 100.0 | |
| 3kmu_A | 271 | ILK, integrin-linked kinase; cell adhesion, ANK re | 100.0 | |
| 3vhe_A | 359 | Vascular endothelial growth factor receptor 2; kin | 100.0 | |
| 4fvq_A | 289 | Tyrosine-protein kinase JAK2; janus protein kinase | 100.0 | |
| 3gen_A | 283 | Tyrosine-protein kinase BTK; bruton'S tyrosine kin | 100.0 | |
| 3ugc_A | 295 | Tyrosine-protein kinase JAK2; small molecule inhib | 100.0 | |
| 3sxs_A | 268 | Cytoplasmic tyrosine-protein kinase BMX; transfera | 100.0 | |
| 1luf_A | 343 | Muscle-specific tyrosine kinase receptor MUSK; pho | 100.0 | |
| 3qa8_A | 676 | MGC80376 protein; kinase ubiquitin-like domain, ph | 100.0 | |
| 3cbl_A | 377 | C-FES, proto-oncogene tyrosine-protein kinase FES/ | 100.0 | |
| 2ivs_A | 314 | Proto-oncogene tyrosine-protein kinase receptor RE | 100.0 | |
| 3fhr_A | 336 | MAP kinase-activated protein kinase 3; kinase-inhi | 100.0 | |
| 3tt0_A | 382 | Basic fibroblast growth factor receptor 1; kinase | 100.0 | |
| 1p4o_A | 322 | Insulin-like growth factor I receptor protein; IGF | 100.0 | |
| 1q8y_A | 373 | SR protein kinase; transferase; HET: ADP ADE; 2.05 | 100.0 | |
| 4e5w_A | 302 | Tyrosine-protein kinase JAK1; kinase domain, trans | 100.0 | |
| 3brb_A | 313 | Proto-oncogene tyrosine-protein kinase MER; ATP-bi | 100.0 | |
| 3lb7_A | 307 | RAF proto-oncogene serine/threonine-protein kinas; | 100.0 | |
| 1xbb_A | 291 | Tyrosine-protein kinase SYK; gleevec, STI-571, ima | 100.0 | |
| 2vuw_A | 336 | Serine/threonine-protein kinase haspin; cell cycle | 100.0 | |
| 3dtc_A | 271 | Mitogen-activated protein kinase kinase kinase 9; | 100.0 | |
| 1rjb_A | 344 | FL cytokine receptor; kinase, structure, autoinhib | 100.0 | |
| 2qol_A | 373 | Ephrin receptor; receptor tyrosine kinase, juxtame | 100.0 | |
| 4eut_A | 396 | Serine/threonine-protein kinase TBK1; ATP binding, | 100.0 | |
| 1mp8_A | 281 | Focal adhesion kinase 1; tyrosine protein kinase, | 100.0 | |
| 1fvr_A | 327 | Tyrosine-protein kinase TIE-2; tyrosine kinase, tr | 100.0 | |
| 3kfa_A | 288 | Tyrosine-protein kinase ABL1; CML, drug resistance | 100.0 | |
| 3t9t_A | 267 | Tyrosine-protein kinase ITK/TSK; kinase domain, al | 100.0 | |
| 1t46_A | 313 | HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcom | 100.0 | |
| 1mqb_A | 333 | Ephrin type-A receptor 2; tyrosine protein kinase, | 100.0 | |
| 2yfx_A | 327 | Tyrosine-protein kinase receptor; nucleotide-bindi | 100.0 | |
| 2pvf_A | 334 | Fibroblast growth factor receptor 2; kinase domain | 100.0 | |
| 2wqm_A | 310 | Serine/threonine-protein kinase NEK7; ATP-binding, | 100.0 | |
| 2buj_A | 317 | Serine/threonine-protein kinase 16; transferase, A | 100.0 | |
| 3lxl_A | 327 | Tyrosine-protein kinase JAK3; TYK2, inflammation, | 100.0 | |
| 3poz_A | 327 | Epidermal growth factor receptor; kinase domain, a | 100.0 | |
| 1u59_A | 287 | Tyrosine-protein kinase ZAP-70; transferase; HET: | 100.0 | |
| 4f0f_A | 287 | Serine/threonine-protein kinase ROCO4; LRRK2, ATP- | 100.0 | |
| 2xir_A | 316 | Vascular endothelial growth factor receptor 2; ang | 100.0 | |
| 3kex_A | 325 | Receptor tyrosine-protein kinase ERBB-3; kinase do | 100.0 | |
| 3og7_A | 289 | AKAP9-BRAF fusion protein; proto-oncogene, V600E, | 100.0 | |
| 2i1m_A | 333 | Macrophage colony-stimulating factor 1 receptor; k | 100.0 | |
| 3soc_A | 322 | Activin receptor type-2A; structural genomics cons | 100.0 | |
| 2qkw_B | 321 | Protein kinase; three-helix bundle motif, AVRPTO-P | 100.0 | |
| 3uim_A | 326 | Brassinosteroid insensitive 1-associated receptor; | 100.0 | |
| 2a19_B | 284 | Interferon-induced, double-stranded RNA-activated | 100.0 | |
| 1opk_A | 495 | P150, C-ABL, proto-oncogene tyrosine-protein kinas | 100.0 | |
| 3lzb_A | 327 | Epidermal growth factor receptor; epidermal growth | 100.0 | |
| 1k9a_A | 450 | Carboxyl-terminal SRC kinase; COOH-terminal SRC ki | 100.0 | |
| 3pls_A | 298 | Macrophage-stimulating protein receptor; protein k | 100.0 | |
| 3p23_A | 432 | Serine/threonine-protein kinase/endoribonuclease; | 100.0 | |
| 3f66_A | 298 | Hepatocyte growth factor receptor; C-Met, protein | 100.0 | |
| 1byg_A | 278 | CSK, protein (C-terminal SRC kinase); protein kina | 100.0 | |
| 3cc6_A | 281 | Protein tyrosine kinase 2 beta; focal adhesion kin | 100.0 | |
| 3q4u_A | 301 | Activin receptor type-1; structural genomics conso | 100.0 | |
| 2izr_A | 330 | Casein kinase I isoform gamma-3; serine/threonine- | 100.0 | |
| 1csn_A | 298 | Casein kinase-1; phosphotransferase; HET: ATP; 2.0 | 100.0 | |
| 3lxp_A | 318 | Non-receptor tyrosine-protein kinase TYK2; JAK3, i | 100.0 | |
| 2rio_A | 434 | Serine/threonine-protein kinase/endoribonuclease I | 100.0 | |
| 1qcf_A | 454 | Haematopoetic cell kinase (HCK); tyrosine kinase-i | 100.0 | |
| 3ll6_A | 337 | Cyclin G-associated kinase; transferase, protein k | 100.0 | |
| 1qpc_A | 279 | LCK kinase; alpha beta fold, transferase; HET: PTR | 100.0 | |
| 2nru_A | 307 | Interleukin-1 receptor-associated kinase 4; inhibi | 100.0 | |
| 2w1i_A | 326 | JAK2; chromosomal rearrangement, nucleotide-bindin | 100.0 | |
| 2jii_A | 352 | Serine/threonine-protein kinase VRK3 molecule: VA | 100.0 | |
| 2v62_A | 345 | Serine/threonine-protein kinase VRK2; transferase, | 100.0 | |
| 2eva_A | 307 | TAK1 kinase - TAB1 chimera fusion protein; transfe | 100.0 | |
| 4fl3_A | 635 | Tyrosine-protein kinase SYK; transferase; HET: ANP | 100.0 | |
| 3uzp_A | 296 | CKI-delta, CKID, casein kinase I isoform delta; CK | 100.0 | |
| 4hgt_A | 296 | Casein kinase I isoform delta; CK1D, inhibitor, tr | 100.0 | |
| 1fmk_A | 452 | C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyros | 100.0 | |
| 3c1x_A | 373 | Hepatocyte growth factor receptor; receptor tyrosi | 100.0 | |
| 1u46_A | 291 | ACK-1, activated CDC42 kinase 1; tyrosine kinase, | 100.0 | |
| 3g2f_A | 336 | Bone morphogenetic protein receptor type-2; kinase | 100.0 | |
| 3gxj_A | 303 | TGF-beta receptor type-1; ALK5, kinase, inhibitor, | 100.0 | |
| 3op5_A | 364 | Serine/threonine-protein kinase VRK1; adenosine tr | 100.0 | |
| 2y4i_B | 319 | KSR2, HKSR2, kinase suppressor of RAS 2; transfera | 100.0 | |
| 3mdy_A | 337 | Bone morphogenetic protein receptor type-1B; compl | 100.0 | |
| 3uqc_A | 286 | Probable conserved transmembrane protein; structur | 100.0 | |
| 2ozo_A | 613 | Tyrosine-protein kinase ZAP-70; inactive ZAP-70, t | 100.0 | |
| 2h8h_A | 535 | Proto-oncogene tyrosine-protein kinase SRC; SRC ki | 100.0 | |
| 1b6c_B | 342 | TGF-B superfamily receptor type I; complex (isomer | 100.0 | |
| 2j0j_A | 656 | Focal adhesion kinase 1; cell migration, FERM, tra | 100.0 | |
| 3e7e_A | 365 | HBUB1, BUB1A, mitotic checkpoint serine/threonine- | 100.0 | |
| 3sv0_A | 483 | Casein kinase I-like; typical kinase domain fold, | 100.0 | |
| 3dzo_A | 413 | Rhoptry kinase domain; parasitic disease, transfer | 100.0 | |
| 2pzi_A | 681 | Probable serine/threonine-protein kinase PKNG; ATP | 100.0 | |
| 4azs_A | 569 | Methyltransferase WBDD; kinase; HET: AMP SAM; 2.15 | 99.97 | |
| 1zar_A | 282 | RIO2 kinase; serine kinase, winged-helix, RIO doma | 99.93 | |
| 3en9_A | 540 | Glycoprotease, O-sialoglycoprotein endopeptidase/p | 99.92 | |
| 1zth_A | 258 | RIO1 serine protein kinase; ribosome biogenesis, r | 99.89 | |
| 4gyi_A | 397 | RIO2 kinase; protein kinase, ADP complex, phosphoa | 99.83 | |
| 3tm0_A | 263 | Aminoglycoside 3'-phosphotransferase; protein kina | 99.57 | |
| 1nd4_A | 264 | Aminoglycoside 3'-phosphotransferase; protein kina | 99.44 | |
| 3dxp_A | 359 | Putative acyl-COA dehydrogenase; protein kinase-li | 99.36 | |
| 3r70_A | 320 | Aminoglycoside phosphotransferase; structural geno | 99.06 | |
| 3sg8_A | 304 | APH(2'')-ID; antibiotic resistance enzyme, transfe | 98.93 | |
| 4gkh_A | 272 | Aminoglycoside 3'-phosphotransferase APHA1-IAB; py | 98.9 | |
| 3tdw_A | 306 | Gentamicin resistance protein; kinase, phosphoryl | 98.89 | |
| 3ovc_A | 362 | Hygromycin-B 4-O-kinase; aminoglycoside phosphotra | 98.75 | |
| 2olc_A | 397 | MTR kinase, methylthioribose kinase; kinase ADP-2H | 98.56 | |
| 3d1u_A | 288 | Putative fructosamine-3-kinase; YP_290396.1, struc | 98.51 | |
| 2q83_A | 346 | YTAA protein; 2635576, structural genomics, joint | 98.41 | |
| 3ats_A | 357 | Putative uncharacterized protein; hypothetical pro | 98.33 | |
| 3jr1_A | 312 | Putative fructosamine-3-kinase; YP_719053.1, struc | 98.18 | |
| 2pyw_A | 420 | Uncharacterized protein; 5-methylthioribose kinase | 98.17 | |
| 3dxq_A | 301 | Choline/ethanolamine kinase family protein; NP_106 | 98.11 | |
| 3feg_A | 379 | Choline/ethanolamine kinase; non-protein kinase, c | 97.86 | |
| 2ppq_A | 322 | HSK, HK, homoserine kinase; structural genomics, M | 97.86 | |
| 1nw1_A | 429 | Choline kinase (49.2 KD); phospholipid synthesis, | 97.85 | |
| 3csv_A | 333 | Aminoglycoside phosphotransferase; YP_614837.1, ph | 97.75 | |
| 1zyl_A | 328 | Hypothetical protein YIHE; putative protein kinase | 97.67 | |
| 3f7w_A | 288 | Putative fructosamine-3-kinase; YP_290396.1, struc | 97.6 | |
| 3i1a_A | 339 | Spectinomycin phosphotransferase; protein kinase, | 97.54 | |
| 3c5i_A | 369 | Choline kinase; choline, kinase, malaria, transfer | 97.46 | |
| 2qg7_A | 458 | Ethanolamine kinase PV091845; malaria, SGC, struct | 97.38 | |
| 3f2s_A | 401 | CK, chetk-alpha, choline kinase alpha; non-protein | 97.29 | |
| 4aw0_A | 311 | HPDK1, 3-phosphoinositide-dependent protein kinase | 97.11 | |
| 3ubd_A | 304 | Ribosomal protein S6 kinase alpha-3; kinase-inhibi | 96.99 | |
| 4b9d_A | 350 | Serine/threonine-protein kinase NEK1; transferase, | 96.77 | |
| 3mes_A | 424 | Choline kinase; malaria, structural genomics, stru | 96.7 | |
| 3g15_A | 401 | CK, chetk-alpha, choline kinase alpha; non-protein | 96.4 | |
| 2ac3_A | 316 | MAP kinase-interacting serine/threonine kinase 2; | 96.35 | |
| 2yle_A | 229 | Protein spire homolog 1; actin-binding protein, ac | 96.08 | |
| 3gni_B | 389 | Strad alpha; kinase fold, pseudokinase, alpha heli | 96.03 | |
| 3kn6_A | 325 | Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1 | 95.96 | |
| 1o6l_A | 337 | RAC-beta serine/threonine protein kinase; protein | 95.85 | |
| 4ejn_A | 446 | RAC-alpha serine/threonine-protein kinase; AKT1, a | 95.83 | |
| 2zv2_A | 298 | Calcium/calmodulin-dependent protein kinase kinas; | 95.81 | |
| 4dc2_A | 396 | Protein kinase C IOTA type; kinase, substrate, cel | 95.77 | |
| 3hyh_A | 275 | Carbon catabolite-derepressing protein kinase; kin | 95.63 | |
| 3soa_A | 444 | Calcium/calmodulin-dependent protein kinase type a | 95.42 | |
| 3h4j_B | 336 | AMPK kdaid, SNF1-like protein kinase SSP2; ATP-bin | 95.38 | |
| 1xjd_A | 345 | Protein kinase C, theta type; PKC-theta, ATP, AMP, | 95.29 | |
| 3a8x_A | 345 | Protein kinase C IOTA type; transferase; HET: TPO; | 95.26 | |
| 3txo_A | 353 | PKC-L, NPKC-ETA, protein kinase C ETA type; phosph | 95.14 | |
| 2x7f_A | 326 | TRAF2 and NCK-interacting protein kinase; serine/t | 94.99 | |
| 3com_A | 314 | Serine/threonine-protein kinase 4; MST1, STE20-lik | 94.89 | |
| 3cok_A | 278 | Serine/threonine-protein kinase PLK4; POLO-like ki | 94.87 | |
| 2pml_X | 348 | PFPK7, Ser/Thr protein kinase; phosphorylati trans | 94.79 | |
| 3c0i_A | 351 | Peripheral plasma membrane protein CASK; neurexin, | 94.73 | |
| 3uto_A | 573 | Twitchin; kinase, muscle sarcomere, transferase; H | 94.68 | |
| 3a62_A | 327 | Ribosomal protein S6 kinase beta-1; kinase domain, | 94.64 | |
| 3fe3_A | 328 | MAP/microtubule affinity-regulating kinase 3; seri | 94.53 | |
| 3pfq_A | 674 | PKC-B, PKC-beta, protein kinase C beta type; phosp | 94.45 | |
| 2i0e_A | 353 | Protein kinase C-beta II; serine/threonine protein | 94.44 | |
| 4ano_A | 219 | ESSB; membrane protein, membrane secretion, ESS ty | 94.42 | |
| 3tki_A | 323 | Serine/threonine-protein kinase CHK1; cell checkpo | 93.98 | |
| 2qr7_A | 342 | Ribosomal protein S6 kinase alpha-3; kinase domain | 93.97 | |
| 4ann_A | 215 | ESSB; membrane protein, membrane secretion, ESS ty | 93.86 | |
| 1kob_A | 387 | Twitchin; kinase, intrasteric regulation; 2.30A {A | 93.78 | |
| 4f9c_A | 361 | Cell division cycle 7-related protein kinase; Ser/ | 93.77 | |
| 3lm5_A | 327 | Serine/threonine-protein kinase 17B; STK17B, serin | 93.74 | |
| 2rku_A | 294 | Serine/threonine-protein kinase PLK1; structure of | 93.73 | |
| 4g3f_A | 336 | NF-kappa-beta-inducing kinase; non-RD kinase, prot | 93.73 | |
| 2owb_A | 335 | Serine/threonine-protein kinase PLK1; catalytic do | 93.69 | |
| 4b99_A | 398 | Mitogen-activated protein kinase 7; transferase, i | 93.61 | |
| 3hko_A | 345 | Calcium/calmodulin-dependent protein kinase with d | 93.57 | |
| 3c4z_A | 543 | Rhodopsin kinase; Ser/Thr kinase, RGS homology dom | 93.49 | |
| 3zgw_A | 347 | Maternal embryonic leucine zipper kinase; transfer | 93.37 | |
| 3mi9_A | 351 | Cell division protein kinase 9; P-TEFB, HIV-1, pro | 93.27 | |
| 2yab_A | 361 | Death-associated protein kinase 2; apoptosis, tran | 93.23 | |
| 3a7i_A | 303 | MST3 kinase, serine/threonine kinase 24 (STE20 hom | 93.21 | |
| 2jam_A | 304 | Calcium/calmodulin-dependent protein kinase type 1 | 93.16 | |
| 1t4h_A | 290 | Serine/threonine-protein kinase WNK1; protein seri | 93.11 | |
| 2r5t_A | 373 | Serine/threonine-protein kinase SGK1; AGC protein | 92.97 | |
| 3v5w_A | 689 | G-protein coupled receptor kinase 2; inhibitor com | 92.8 | |
| 3fhr_A | 336 | MAP kinase-activated protein kinase 3; kinase-inhi | 92.74 | |
| 2eu9_A | 355 | Dual specificity protein kinase CLK3; kinase domai | 92.56 | |
| 4agu_A | 311 | Cyclin-dependent kinase-like 1; transferase, phosp | 92.5 | |
| 3n9x_A | 432 | Phosphotransferase; malaria kinase, structural gen | 92.26 | |
| 3fme_A | 290 | Dual specificity mitogen-activated protein kinase; | 92.25 | |
| 2yex_A | 276 | Serine/threonine-protein kinase CHK1; transferase, | 92.24 | |
| 1z57_A | 339 | Dual specificity protein kinase CLK1; protein tyro | 92.22 | |
| 4fih_A | 346 | Serine/threonine-protein kinase PAK 4; kinase doma | 92.21 | |
| 3q5i_A | 504 | Protein kinase; CDPK, malaria, phosphotransferase, | 92.17 | |
| 2y0a_A | 326 | Death-associated protein kinase 1; transferase, ca | 92.12 | |
| 2w4o_A | 349 | Calcium/calmodulin-dependent protein kinase type I | 92.09 | |
| 3dls_A | 335 | PAS domain-containing serine/threonine-protein KI; | 92.05 | |
| 3o0g_A | 292 | Cell division protein kinase 5; kinase activator c | 91.92 | |
| 2a2a_A | 321 | Death-associated protein kinase 2; autoinhibition, | 91.92 | |
| 1nxk_A | 400 | MAP kinase-activated protein kinase 2; MK2, phosph | 91.87 | |
| 3e3p_A | 360 | Protein kinase, putative glycogen synthase kinase; | 91.84 | |
| 3niz_A | 311 | Rhodanese family protein; structural genomics, str | 91.79 | |
| 3p1a_A | 311 | MYT1 kinase, membrane-associated tyrosine- and thr | 91.72 | |
| 2w5a_A | 279 | Serine/threonine-protein kinase NEK2; Ser/Thr prot | 91.65 | |
| 3an0_A | 340 | Dual specificity mitogen-activated protein kinase; | 91.62 | |
| 3kk8_A | 284 | Calcium/calmodulin dependent protein kinase II; AT | 91.48 | |
| 1x8b_A | 289 | WEE1HU, WEE1-like protein kinase; cell cycle, tran | 91.41 | |
| 4fie_A | 423 | Serine/threonine-protein kinase PAK 4; kinase doma | 91.37 | |
| 2r3i_A | 299 | Cell division protein kinase 2; serine/threonine-p | 91.04 | |
| 2eue_A | 275 | Carbon catabolite derepressing protein kinase; kin | 90.97 | |
| 3q60_A | 371 | ROP5B; pseudokinase, transferase; HET: ATP; 1.72A | 90.96 | |
| 3fpq_A | 290 | Serine/threonine-protein kinase WNK1; protein seri | 90.87 | |
| 1cja_A | 342 | Protein (actin-fragmin kinase); transferase; HET: | 90.86 | |
| 1fot_A | 318 | TPK1 delta, CAMP-dependent protein kinase type 1; | 90.83 | |
| 3gbz_A | 329 | Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide- | 90.77 | |
| 2y7j_A | 365 | Phosphorylase B kinase gamma catalytic chain, test | 90.76 | |
| 2i6l_A | 320 | Mitogen-activated protein kinase 6; MAPK6, ERK3, e | 90.62 | |
| 3rp9_A | 458 | Mitogen-activated protein kinase; structural genom | 90.49 | |
| 1tki_A | 321 | Titin; serine kinase, muscle, autoinhibition; 2.00 | 90.4 | |
| 2ycf_A | 322 | Serine/threonine-protein kinase CHK2; transferase, | 90.37 | |
| 3f3z_A | 277 | Calcium/calmodulin-dependent protein kinase with d | 90.04 | |
| 4g31_A | 299 | Eukaryotic translation initiation factor 2-alpha; | 89.96 | |
| 1rdq_E | 350 | PKA C-alpha, CAMP-dependent protein kinase, alpha- | 89.83 | |
| 1ob3_A | 288 | PFPK5, cell division control protein 2 homolog; tr | 89.72 | |
| 4exu_A | 371 | Mitogen-activated protein kinase 13; P38 kinase, t | 89.42 | |
| 3oz6_A | 388 | Mitogen-activated protein kinase 1, serine/threon | 89.37 | |
| 3mtl_A | 324 | Cell division protein kinase 16; pctaire1, indirub | 89.33 | |
| 1cm8_A | 367 | Phosphorylated MAP kinase P38-gamma; phosphorylati | 89.21 | |
| 2b9h_A | 353 | MAP kinase FUS3, mitogen-activated protein kinase | 89.14 | |
| 3qyz_A | 364 | Mitogen-activated protein kinase 1; transferase, s | 88.91 | |
| 3fdn_A | 279 | Serine/threonine-protein kinase 6; aurora kinase i | 88.87 | |
| 2pmi_A | 317 | Negative RE, cyclin-dependent protein kinase PHO85 | 88.83 | |
| 2vx3_A | 382 | Dual specificity tyrosine-phosphorylation- regula | 88.81 | |
| 3g33_A | 308 | Cell division protein kinase 4; Ser/Thr protein ki | 88.75 | |
| 2y94_A | 476 | 5'-AMP-activated protein kinase catalytic subunit; | 88.69 | |
| 3lij_A | 494 | Calcium/calmodulin dependent protein kinase with A | 88.67 | |
| 4fr4_A | 384 | YANK1, serine/threonine-protein kinase 32A; struct | 88.63 | |
| 3byv_A | 377 | Rhoptry kinase; malaria, transferase, structural g | 88.61 | |
| 1ua2_A | 346 | CAK, cell division protein kinase 7; cell cycle, p | 88.58 | |
| 2h6d_A | 276 | 5'-AMP-activated protein kinase catalytic subunit | 88.36 | |
| 2fst_X | 367 | Mitogen-activated protein kinase 14; active mutant | 88.33 | |
| 3coi_A | 353 | Mitogen-activated protein kinase 13; P38D, P38delt | 88.32 | |
| 3nsz_A | 330 | CK II alpha, casein kinase II subunit alpha; inhib | 88.12 | |
| 3nyv_A | 484 | Calmodulin-domain protein kinase 1; serine/threoni | 88.05 | |
| 3m2w_A | 299 | MAP kinase-activated protein kinase 2; small molec | 88.02 | |
| 3rgf_A | 405 | Cyclin-dependent kinase 8; protein kinase complex, | 88.01 | |
| 2x4f_A | 373 | Myosin light chain kinase family member 4; LUNG, b | 88.0 | |
| 2wtk_C | 305 | Serine/threonine-protein kinase 11; transferase-me | 87.89 | |
| 3kvw_A | 429 | DYRK2, dual specificity tyrosine-phosphorylation-r | 87.87 | |
| 2vgo_A | 284 | Serine/threonine-protein kinase 12-A; nucleotide-b | 87.84 | |
| 3aln_A | 327 | Dual specificity mitogen-activated protein kinase; | 87.58 | |
| 3pg1_A | 362 | Mitogen-activated protein kinase, putative (MAP K | 87.58 | |
| 2bdw_A | 362 | Hypothetical protein K11E8.1D; kinase, calmodulin | 87.56 | |
| 3is5_A | 285 | Calcium-dependent protein kinase; CDPK, structural | 87.46 | |
| 3a99_A | 320 | Proto-oncogene serine/threonine-protein kinase PI; | 87.31 | |
| 4e7w_A | 394 | Glycogen synthase kinase 3; GSK3, PTyr195, transfe | 87.19 | |
| 2dyl_A | 318 | Dual specificity mitogen-activated protein kinase | 87.02 | |
| 2j7t_A | 302 | Serine/threonine-protein kinase 10; transferase, A | 86.91 | |
| 3p23_A | 432 | Serine/threonine-protein kinase/endoribonuclease; | 86.83 | |
| 1vzo_A | 355 | Ribosomal protein S6 kinase alpha 5; protein kinas | 86.79 | |
| 1blx_A | 326 | Cyclin-dependent kinase 6; inhibitor protein, cycl | 86.33 | |
| 1q8y_A | 373 | SR protein kinase; transferase; HET: ADP ADE; 2.05 | 86.29 | |
| 4aw2_A | 437 | Serine/threonine-protein kinase MRCK alpha; transf | 86.24 | |
| 1zy4_A | 303 | Serine/threonine-protein kinase GCN2; translation | 86.21 | |
| 3v8s_A | 410 | RHO-associated protein kinase 1; dimerization, myo | 86.04 | |
| 2acx_A | 576 | G protein-coupled receptor kinase 6; GRK, G transf | 85.76 | |
| 3dbq_A | 343 | Dual specificity protein kinase TTK; MPS1 structur | 85.73 | |
| 3cxl_A | 463 | N-chimerin; SH2, RHO-GAP, structural genomics cons | 85.73 | |
| 3llt_A | 360 | Serine/threonine kinase-1, pflammer; lammer kinase | 85.32 | |
| 2clq_A | 295 | Mitogen-activated protein kinase kinase kinase 5; | 85.31 | |
| 3p86_A | 309 | Serine/threonine-protein kinase CTR1; ETR1, ERS1, | 84.88 | |
| 1wak_A | 397 | Serine/threonine-protein kinase SPRK1; SRPK, trans | 84.78 | |
| 1phk_A | 298 | Phosphorylase kinase; glycogen metabolism, transfe | 84.74 | |
| 2c30_A | 321 | Serine/threonine-protein kinase PAK 6; CRIB domain | 84.69 | |
| 3ttj_A | 464 | Mitogen-activated protein kinase 10; JNK3, protein | 84.53 | |
| 2iwi_A | 312 | Serine/threonine-protein kinase PIM-2; nucleotide- | 84.31 | |
| 3fxz_A | 297 | Serine/threonine-protein kinase PAK 1; transferase | 84.06 | |
| 4aaa_A | 331 | Cyclin-dependent kinase-like 2; transferase, phosp | 83.53 | |
| 3omv_A | 307 | RAF proto-oncogene serine/threonine-protein kinas; | 83.44 | |
| 4aoj_A | 329 | High affinity nerve growth factor receptor; transf | 83.2 | |
| 3qd2_B | 332 | Eukaryotic translation initiation factor 2-alpha; | 83.18 | |
| 3kex_A | 325 | Receptor tyrosine-protein kinase ERBB-3; kinase do | 82.87 | |
| 3i6u_A | 419 | CDS1, serine/threonine-protein kinase CHK2; Ser/Th | 82.71 | |
| 3mwu_A | 486 | Calmodulin-domain protein kinase 1; serine/threoni | 82.66 | |
| 2vwi_A | 303 | Serine/threonine-protein kinase OSR1; STE kinase, | 82.64 | |
| 4ase_A | 353 | Vascular endothelial growth factor receptor 2; tra | 82.52 | |
| 2vd5_A | 412 | DMPK protein; serine/threonine-protein kinase, kin | 82.3 | |
| 3eps_A | 578 | Isocitrate dehydrogenase kinase/phosphatase; ATP-b | 82.15 | |
| 3dzo_A | 413 | Rhoptry kinase domain; parasitic disease, transfer | 82.09 | |
| 1j1b_A | 420 | Glycogen synthase kinase-3 beta; complex, TAU, AMP | 82.01 | |
| 2zmd_A | 390 | Dual specificity protein kinase TTK; MPS1, T686A, | 81.39 | |
| 4gt4_A | 308 | Tyrosine-protein kinase transmembrane receptor RO; | 80.91 | |
| 3eb0_A | 383 | Putative uncharacterized protein; kinase cryptospo | 80.72 | |
| 3uc3_A | 361 | Serine/threonine-protein kinase SRK2I; SNRK2, ABA | 80.47 | |
| 3cek_A | 313 | Dual specificity protein kinase TTK; HMPS1, PYT, E | 80.38 | |
| 3eqc_A | 360 | Dual specificity mitogen-activated protein kinase; | 80.04 |
| >4aw0_A HPDK1, 3-phosphoinositide-dependent protein kinase 1; transferase, allosteric regulation, allosteric site, phosphorylation, AGC protein kinase; HET: SEP ATP MJF; 1.43A {Homo sapiens} PDB: 3hrc_A* 3hrf_A* 4a06_A* 4a07_A* 3rcj_A* 4aw1_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* 1uu3_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=3.7e-59 Score=376.97 Aligned_cols=253 Identities=23% Similarity=0.292 Sum_probs=203.9
Q ss_pred cccceeeeecccCceEEEEEEEcCCCcEEEEEEeccCCC-ChHHHHHHHHHHHHHHhCCCCCcchhhhhhhcCCeEEEEE
Q psy758 2 ERYEKIGKLGEGSYGVVFKCRNRDTGQVVAIKKFLESEE-DPLIRKIALREIRLLKSLKHPNLVNLLEVFRRKKKLHLVF 80 (292)
Q Consensus 2 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~v~iK~~~~~~~-~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~iv~ 80 (292)
++|++++.||+|+||.||+|++..+|+.||+|++.+... .....+.+.+|+++++.++||||++++++|++++.+|+||
T Consensus 32 ~dy~i~~~lG~G~fg~V~~a~~~~~~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~yivm 111 (311)
T 4aw0_A 32 EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYFTFQDDEKLYFGL 111 (311)
T ss_dssp GGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred cccEEEEEEecccCeEEEEEEECCCCCEEEEEEEEHHHCCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEEEE
Confidence 579999999999999999999999999999999975431 2223567889999999999999999999999999999999
Q ss_pred ecCCCccHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEEccCCcEEEeecCchhhhhcccc----
Q psy758 81 EFCDHTVLNELENHPHGLPWDLIKQITWQVLRGVSYCHRHACIHRDIKPENILLTANGVVKLCDFGFARLIRDLIP---- 156 (292)
Q Consensus 81 e~~~~~~L~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~givH~dl~p~Nilv~~~~~~kl~dfg~~~~~~~~~~---- 156 (292)
|||+||+|.+++...+.+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||+++.+.....
T Consensus 112 Ey~~gG~L~~~i~~~~~l~e~~~~~~~~qi~~al~ylH~~~IiHRDlKPeNILl~~~g~vKl~DFGla~~~~~~~~~~~~ 191 (311)
T 4aw0_A 112 SYAKNGELLKYIRKIGSFDETCTRFYTAEIVSALEYLHGKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARA 191 (311)
T ss_dssp CCCTTEEHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTSCEEECCCTTCEECCTTTTCCCB
T ss_pred ecCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCCccCCCCHHHeEEcCCCCEEEEEcCCceecCCCCCcccc
Confidence 9999999999998878899999999999999999999999999999999999999999999999999987643211
Q ss_pred ---ccccccccccccccCCC-----CCCCcccceeeecCCCCCCchHHHHHHHhhcccCCCCCCChhhhhhccCcCCCCC
Q psy758 157 ---RHLHIFQTNEYFKGVSL-----PHAENVVPLEIKIGKPAATNIYLIDFLKRCLDKDPLRRWSCDQLLRHPYFNGYYF 228 (292)
Q Consensus 157 ---~~~~~~~~~~~~~~~~~-----~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~ 228 (292)
.++..|.+||...+... .|+.|+..+++++|.+++.......++...+ -....+
T Consensus 192 ~~~~GTp~YmAPEvl~~~~y~~~~DiWSlGvilyeml~G~~PF~~~~~~~~~~~i~------------------~~~~~~ 253 (311)
T 4aw0_A 192 NSFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPPFRAGNEGLIFAKII------------------KLEYDF 253 (311)
T ss_dssp CCCCSCGGGCCHHHHHHSCBCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHH------------------HTCCCC
T ss_pred cCcccCcccCCHHHHcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHH------------------cCCCCC
Confidence 23445555655544433 2445555555555555544333333333332 223344
Q ss_pred CCCCccchHHHHhcccCcCCCCCCChhh------hhhCCcccceeccCCC
Q psy758 229 EVPDEMQYEEITQRCLDKDPLRRWSCDQ------LLRHPYFNGYYFEVPD 272 (292)
Q Consensus 229 ~~~~~~~l~~li~~~l~~dP~~Rpt~~~------il~h~w~~~~~~~~~~ 272 (292)
+...++++++||.+||+.||++|||++| |++||||+++.|+..-
T Consensus 254 p~~~s~~~~dli~~lL~~dp~~R~t~~e~~~~~~i~~Hp~F~~idw~~l~ 303 (311)
T 4aw0_A 254 PEKFFPKARDLVEKLLVLDATKRLGCEEMEGYGPLKAHPFFESVTWENLH 303 (311)
T ss_dssp CTTCCHHHHHHHHHHSCSSGGGSTTSGGGTCHHHHHTSGGGTTCCCTTGG
T ss_pred CcccCHHHHHHHHHHccCCHhHCcChHHHcCCHHHHCCCCcCCCCHHHhc
Confidence 5566889999999999999999999998 5899999999998653
|
| >4b9d_A Serine/threonine-protein kinase NEK1; transferase, inhibitor; HET: CK7; 1.90A {Homo sapiens} PDB: 4apc_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.6e-57 Score=371.18 Aligned_cols=249 Identities=24% Similarity=0.343 Sum_probs=198.4
Q ss_pred CcccceeeeecccCceEEEEEEEcCCCcEEEEEEeccCCCChHHHHHHHHHHHHHHhCCCCCcchhhhhhhcCCeEEEEE
Q psy758 1 MERYEKIGKLGEGSYGVVFKCRNRDTGQVVAIKKFLESEEDPLIRKIALREIRLLKSLKHPNLVNLLEVFRRKKKLHLVF 80 (292)
Q Consensus 1 ~~~y~~~~~l~~g~~~~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~iv~ 80 (292)
|++|++++.||+|+||.||+|++..+|+.||||++..........+.+.+|+.+++.++||||+++++++.+++.+|+||
T Consensus 23 me~Y~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~yiVm 102 (350)
T 4b9d_A 23 MEKYVRLQKIGEGSFGKAILVKSTEDGRQYVIKEINISRMSSKEREESRREVAVLANMKHPNIVQYRESFEENGSLYIVM 102 (350)
T ss_dssp CCCEEEEEEC------CEEEEEETTTCCEEEEEEEECTTSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEE
T ss_pred ccceEEeEEEecCCCeEEEEEEECCCCCEEEEEEEehHHCCHHHHHHHHHHHHHHHHCCCCCCCcEEEEEEECCEEEEEE
Confidence 57999999999999999999999999999999999887777777888999999999999999999999999999999999
Q ss_pred ecCCCccHHHHhcC--CCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEEccCCcEEEeecCchhhhhccc---
Q psy758 81 EFCDHTVLNELENH--PHGLPWDLIKQITWQVLRGVSYCHRHACIHRDIKPENILLTANGVVKLCDFGFARLIRDLI--- 155 (292)
Q Consensus 81 e~~~~~~L~~~~~~--~~~~~~~~~~~i~~qi~~aL~~LH~~givH~dl~p~Nilv~~~~~~kl~dfg~~~~~~~~~--- 155 (292)
|||+||+|.+++.. ...+++..++.++.||+.||+|||++||+||||||+|||++.+|.+||+|||+++......
T Consensus 103 Ey~~gg~L~~~i~~~~~~~~~e~~~~~~~~qi~~aL~ylH~~~IiHRDlKp~NILl~~~g~vKl~DFGla~~~~~~~~~~ 182 (350)
T 4b9d_A 103 DYCEGGDLFKRINAQKGVLFQEDQILDWFVQICLALKHVHDRKILHRDIKSQNIFLTKDGTVQLGDFGIARVLNSTVELA 182 (350)
T ss_dssp ECCTTCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHTTCEETTCCGGGEEECTTCCEEECSTTEESCCCHHHHHH
T ss_pred eCCCCCcHHHHHHHcCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeeccCCHHHEEECCCCCEEEcccccceeecCCcccc
Confidence 99999999999853 3457999999999999999999999999999999999999999999999999998765422
Q ss_pred --cccccccccccccccCCC-----CCCCcccceeeecCCCCCCchHHHHHHHhhcccCCCCCCChhhhhhccCcCCCCC
Q psy758 156 --PRHLHIFQTNEYFKGVSL-----PHAENVVPLEIKIGKPAATNIYLIDFLKRCLDKDPLRRWSCDQLLRHPYFNGYYF 228 (292)
Q Consensus 156 --~~~~~~~~~~~~~~~~~~-----~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~ 228 (292)
..++..|.+||...+... .|+.|+..+++++|..++.......++........ ...
T Consensus 183 ~~~~GT~~YmAPE~l~~~~y~~~~DiwSlGvilyemltG~~PF~~~~~~~~~~~i~~~~~-----------------~~~ 245 (350)
T 4b9d_A 183 RACIGTPYYLSPEICENKPYNNKSDIWALGCVLYELCTLKHAFEAGSMKNLVLKIISGSF-----------------PPV 245 (350)
T ss_dssp HHHHSCCTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHTCC-----------------CCC
T ss_pred cccCCCccccCHHHHCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcCHHHHHHHHHcCCC-----------------CCC
Confidence 124556777776665443 35555555555566555544444444333332211 012
Q ss_pred CCCCccchHHHHhcccCcCCCCCCChhhhhhCCcccce
Q psy758 229 EVPDEMQYEEITQRCLDKDPLRRWSCDQLLRHPYFNGY 266 (292)
Q Consensus 229 ~~~~~~~l~~li~~~l~~dP~~Rpt~~~il~h~w~~~~ 266 (292)
+...+.++++||.+||+.||++|||++|+|+||||+.-
T Consensus 246 ~~~~s~~~~~li~~~L~~dP~~R~s~~e~l~hp~~~~~ 283 (350)
T 4b9d_A 246 SLHYSYDLRSLVSQLFKRNPRDRPSVNSILEKGFIAKR 283 (350)
T ss_dssp CTTSCHHHHHHHHHHTCSSGGGSCCHHHHHTSHHHHTT
T ss_pred CccCCHHHHHHHHHHccCChhHCcCHHHHhcCHHhhcC
Confidence 33457899999999999999999999999999999863
|
| >3hyh_A Carbon catabolite-derepressing protein kinase; kinase domain, transferase, ATP-binding, carbohydrate metabo kinase, membrane; 2.20A {Saccharomyces cerevisiae} PDB: 3dae_A 2fh9_A 3mn3_A | Back alignment and structure |
|---|
Probab=100.00 E-value=4e-57 Score=360.42 Aligned_cols=246 Identities=26% Similarity=0.388 Sum_probs=186.3
Q ss_pred CcccceeeeecccCceEEEEEEEcCCCcEEEEEEeccCCC-ChHHHHHHHHHHHHHHhCCCCCcchhhhhhhcCCeEEEE
Q psy758 1 MERYEKIGKLGEGSYGVVFKCRNRDTGQVVAIKKFLESEE-DPLIRKIALREIRLLKSLKHPNLVNLLEVFRRKKKLHLV 79 (292)
Q Consensus 1 ~~~y~~~~~l~~g~~~~v~~~~~~~~~~~v~iK~~~~~~~-~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~iv 79 (292)
|++|++.+.||+|+||.||+|++..+|+.||+|++..... .......+.+|+.+++.++||||+++++++.+++.+|+|
T Consensus 12 ig~Y~i~~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~iv 91 (275)
T 3hyh_A 12 IGNYQIVKTLGEGSFGKVKLAYHTTTGQKVALKIINKKVLAKSDMQGRIEREISYLRLLRHPHIIKLYDVIKSKDEIIMV 91 (275)
T ss_dssp --CCEEEEEEEC---CCEEEEECTTTCCEEEEEEEECC------CHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEE
T ss_pred eeCeEEEEEEecCcCeEEEEEEECCCCCEEEEEEEeHHHcCCHHHHHHHHHHHHHHHHCCCCCCCeEEEEEEECCEEEEE
Confidence 5799999999999999999999999999999999976543 233456788999999999999999999999999999999
Q ss_pred EecCCCccHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEEccCCcEEEeecCchhhhhccc----
Q psy758 80 FEFCDHTVLNELENHPHGLPWDLIKQITWQVLRGVSYCHRHACIHRDIKPENILLTANGVVKLCDFGFARLIRDLI---- 155 (292)
Q Consensus 80 ~e~~~~~~L~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~givH~dl~p~Nilv~~~~~~kl~dfg~~~~~~~~~---- 155 (292)
|||++ |+|.+++...+.+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||+++......
T Consensus 92 mEy~~-g~L~~~l~~~~~l~e~~~~~~~~qi~~al~ylH~~~IiHRDiKP~NILl~~~~~vkl~DFGla~~~~~~~~~~~ 170 (275)
T 3hyh_A 92 IEYAG-NELFDYIVQRDKMSEQEARRFFQQIISAVEYCHRHKIVHRDLKPENLLLDEHLNVKIADFGLSNIMTDGNFLKT 170 (275)
T ss_dssp EECCC-EEHHHHHHHSCSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCTTTEEECTTCCEEECCSSCC-----------
T ss_pred EeCCC-CCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCChHHeEECCCCCEEEeecCCCeecCCCCccCC
Confidence 99995 6777777767789999999999999999999999999999999999999999999999999998765422
Q ss_pred cccccccccccccccCCC------CCCCcccceeeecCCCCCCchHHHHHHHhhcccCCCCCCChhhhhhccCcCCCCCC
Q psy758 156 PRHLHIFQTNEYFKGVSL------PHAENVVPLEIKIGKPAATNIYLIDFLKRCLDKDPLRRWSCDQLLRHPYFNGYYFE 229 (292)
Q Consensus 156 ~~~~~~~~~~~~~~~~~~------~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~ 229 (292)
..++..|.+||...+... .|+.|+..+++.+|.. |+...+..+++....-....++
T Consensus 171 ~~GT~~Y~APE~~~~~~y~~~~~DiwSlGvily~lltg~~------------------PF~~~~~~~~~~~i~~~~~~~p 232 (275)
T 3hyh_A 171 SCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYVMLCRRL------------------PFDDESIPVLFKNISNGVYTLP 232 (275)
T ss_dssp ----CTTSCHHHHSSSSCCCTHHHHHHHHHHHHHHHHSSC------------------SSCCSSHHHHHHHHHHTCCCCC
T ss_pred eeECcccCChhhhcCCCCCCChhhhHHHHHHHHHHHHCCC------------------CCCCCCHHHHHHHHHcCCCCCC
Confidence 233455667766655432 2344444444444444 4444444443333222233445
Q ss_pred CCCccchHHHHhcccCcCCCCCCChhhhhhCCcccc
Q psy758 230 VPDEMQYEEITQRCLDKDPLRRWSCDQLLRHPYFNG 265 (292)
Q Consensus 230 ~~~~~~l~~li~~~l~~dP~~Rpt~~~il~h~w~~~ 265 (292)
...++++++||.+||+.||++|||++|+++||||+.
T Consensus 233 ~~~s~~~~~li~~~L~~dP~~R~s~~eil~hpw~k~ 268 (275)
T 3hyh_A 233 KFLSPGAAGLIKRMLIVNPLNRISIHEIMQDDWFKV 268 (275)
T ss_dssp TTSCHHHHHHHHHHSCSSGGGSCCHHHHHHCHHHHT
T ss_pred CCCCHHHHHHHHHHccCChhHCcCHHHHHcCccccc
Confidence 566889999999999999999999999999999974
|
| >4fih_A Serine/threonine-protein kinase PAK 4; kinase domain, protein ATP binding, phosphorylation, transferase; HET: SEP; 1.97A {Homo sapiens} PDB: 4fig_A* 4fif_A* 4fii_A* 4fij_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.5e-57 Score=368.16 Aligned_cols=248 Identities=27% Similarity=0.424 Sum_probs=196.8
Q ss_pred cccceeeeecccCceEEEEEEEcCCCcEEEEEEeccCCCChHHHHHHHHHHHHHHhCCCCCcchhhhhhhcCCeEEEEEe
Q psy758 2 ERYEKIGKLGEGSYGVVFKCRNRDTGQVVAIKKFLESEEDPLIRKIALREIRLLKSLKHPNLVNLLEVFRRKKKLHLVFE 81 (292)
Q Consensus 2 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~iv~e 81 (292)
+.|++.+.||+|+||.||+|++..+|+.||||++....... .+.+.+|+.+++.++||||++++++|.+++.+|+|||
T Consensus 74 ~~y~~~~~iG~G~fG~V~~a~~~~tg~~vAiK~i~~~~~~~--~~~~~~Ei~il~~l~HpnIV~l~~~~~~~~~~~ivmE 151 (346)
T 4fih_A 74 SYLDNFIKIGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQR--RELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVME 151 (346)
T ss_dssp GTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEGGGCSS--GGGGHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEC
T ss_pred HhcEEeEEeecCcCeEEEEEEECCCCCEEEEEEEecCchhH--HHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEe
Confidence 46999999999999999999999999999999997554322 3567899999999999999999999999999999999
Q ss_pred cCCCccHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEEccCCcEEEeecCchhhhhccccc----
Q psy758 82 FCDHTVLNELENHPHGLPWDLIKQITWQVLRGVSYCHRHACIHRDIKPENILLTANGVVKLCDFGFARLIRDLIPR---- 157 (292)
Q Consensus 82 ~~~~~~L~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~givH~dl~p~Nilv~~~~~~kl~dfg~~~~~~~~~~~---- 157 (292)
||+||+|.+++.. +.+++..++.++.||+.||+|||++||+||||||+|||++.+|.+||+|||+++.+......
T Consensus 152 y~~gg~L~~~l~~-~~l~e~~~~~~~~qi~~aL~ylH~~~IiHRDlKp~NILl~~~g~vKl~DFGla~~~~~~~~~~~~~ 230 (346)
T 4fih_A 152 FLEGGALTDIVTH-TRMNEEQIAAVCLAVLQALSVLHAQGVIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEVPRRKSL 230 (346)
T ss_dssp CCTTEEHHHHHHH-SCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTCCEEECCCTTCEECCSSSCCBCCC
T ss_pred CCCCCcHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCHHHEEECCCCCEEEecCcCceecCCCCCccccc
Confidence 9999999999876 47999999999999999999999999999999999999999999999999999876543322
Q ss_pred -cccccccccccccCCC-----CCCCcccceeeecCCCCCCchHHHHHHHhhcccCCCCCCChhhhhhccCcCCCCCCCC
Q psy758 158 -HLHIFQTNEYFKGVSL-----PHAENVVPLEIKIGKPAATNIYLIDFLKRCLDKDPLRRWSCDQLLRHPYFNGYYFEVP 231 (292)
Q Consensus 158 -~~~~~~~~~~~~~~~~-----~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~ 231 (292)
++..|.+||...+..+ .|+.|++.+++++|.+++.......++..+....+ ........
T Consensus 231 ~GTp~YmAPEvl~~~~y~~~~DiWSlGvilyeml~G~~PF~~~~~~~~~~~i~~~~~---------------~~~~~~~~ 295 (346)
T 4fih_A 231 VGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNEPPLKAMKMIRDNLP---------------PRLKNLHK 295 (346)
T ss_dssp CSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHSSC---------------CCCSCGGG
T ss_pred ccCcCcCCHHHHCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcCHHHHHHHHHcCCC---------------CCCCcccc
Confidence 3444555555544333 35555555555556555544333333333322111 11112234
Q ss_pred CccchHHHHhcccCcCCCCCCChhhhhhCCccccee
Q psy758 232 DEMQYEEITQRCLDKDPLRRWSCDQLLRHPYFNGYY 267 (292)
Q Consensus 232 ~~~~l~~li~~~l~~dP~~Rpt~~~il~h~w~~~~~ 267 (292)
.++++++||.+||+.||++|||++|+|+||||+...
T Consensus 296 ~s~~~~dli~~~L~~dP~~R~ta~e~l~Hp~~~~~~ 331 (346)
T 4fih_A 296 VSPSLKGFLDRLLVRDPAQRATAAELLKHPFLAKAG 331 (346)
T ss_dssp SCHHHHHHHHHHSCSSTTTSCCHHHHTTCGGGGGCC
T ss_pred CCHHHHHHHHHHcCCChhHCcCHHHHhcCHhhcCCC
Confidence 577899999999999999999999999999999743
|
| >3ubd_A Ribosomal protein S6 kinase alpha-3; kinase-inhibitor complex, induced FIT, transferase-transfera inhibitor complex; HET: SL0; 1.53A {Mus musculus} PDB: 4el9_A* 3g51_A* 2z7q_A* 2z7r_A* 2z7s_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-57 Score=367.44 Aligned_cols=251 Identities=22% Similarity=0.271 Sum_probs=191.9
Q ss_pred cccceeeeecccCceEEEEEEEc---CCCcEEEEEEeccCCCChHHHHHHHHHHHHHHhCCCCCcchhhhhhhcCCeEEE
Q psy758 2 ERYEKIGKLGEGSYGVVFKCRNR---DTGQVVAIKKFLESEEDPLIRKIALREIRLLKSLKHPNLVNLLEVFRRKKKLHL 78 (292)
Q Consensus 2 ~~y~~~~~l~~g~~~~v~~~~~~---~~~~~v~iK~~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~i 78 (292)
++|++++.||+|+||.||+|++. .+++.||+|++............+.+|+.+++.++||||+++++++.+++.+|+
T Consensus 24 ~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~i 103 (304)
T 3ubd_A 24 SQFELLKVLGQGSFGKVFLVKKISGSDARQLYAMKVLKKATLKVRDRVRTKMERDILVEVNHPFIVKLHYAFQTEGKLYL 103 (304)
T ss_dssp GGEEEEEEEECGGGCEEEEEEECSSTTTTCEEEEEEEESEEEEEEECC------CCCCCCCCTTEECEEEEEEETTEEEE
T ss_pred cccEEEEEEecCCCeEEEEEEEccCCCCCEEEEEEEEehHHcChHHHHHHHHHHHHHHHCCCCCCCeEEEEEEECCEEEE
Confidence 57999999999999999999874 467899999997554222223356789999999999999999999999999999
Q ss_pred EEecCCCccHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEEccCCcEEEeecCchhhhhcccc--
Q psy758 79 VFEFCDHTVLNELENHPHGLPWDLIKQITWQVLRGVSYCHRHACIHRDIKPENILLTANGVVKLCDFGFARLIRDLIP-- 156 (292)
Q Consensus 79 v~e~~~~~~L~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~givH~dl~p~Nilv~~~~~~kl~dfg~~~~~~~~~~-- 156 (292)
|||||+||+|.+++...+.+++..++.++.||+.||+|||++||+||||||+|||++.+|.+||+|||+++.......
T Consensus 104 vmEy~~gg~L~~~l~~~~~l~e~~~~~~~~qi~~aL~ylH~~~IiHRDlKp~NILl~~~g~vKl~DFGla~~~~~~~~~~ 183 (304)
T 3ubd_A 104 ILDFLRGGDLFTRLSKEVMFTEEDVKFYLAELALALDHLHSLGIIYRDLKPENILLDEEGHIKLTDFGLSKESIDHEKKA 183 (304)
T ss_dssp EECCCTTCEEHHHHHHHCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSSCCGGGEEECTTSCEEEESSEEEEC-----CCC
T ss_pred EEEcCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCcCCCCCHHHeEEcCCCCEEecccccceeccCCCccc
Confidence 999999999999998888899999999999999999999999999999999999999999999999999986543322
Q ss_pred ---ccccccccccccccCCCC-----CCCcccceeeecCCCCCCchHHHHHHHhhcccCCCCCCChhhhhhccCcCCCCC
Q psy758 157 ---RHLHIFQTNEYFKGVSLP-----HAENVVPLEIKIGKPAATNIYLIDFLKRCLDKDPLRRWSCDQLLRHPYFNGYYF 228 (292)
Q Consensus 157 ---~~~~~~~~~~~~~~~~~~-----~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~ 228 (292)
.++..|.+||...+.... |+.|+..+++++|.. |+...+..+++....-.....
T Consensus 184 ~~~~GT~~YmAPE~~~~~~y~~~~DiwSlGvilyemltG~~------------------PF~~~~~~~~~~~i~~~~~~~ 245 (304)
T 3ubd_A 184 YSFCGTVEYMAPEVVNRRGHTQSADWWSFGVLMFEMLTGTL------------------PFQGKDRKETMTMILKAKLGM 245 (304)
T ss_dssp CSCCCCGGGCCHHHHHTSCCCTHHHHHHHHHHHHHHHHSSC------------------SSCCSSHHHHHHHHHHCCCCC
T ss_pred cccccCcccCCHHHhccCCCCCCCcccchHHHHHHHHhCCC------------------CCCCcCHHHHHHHHHcCCCCC
Confidence 234455566555444332 344444444444444 444444444433322223344
Q ss_pred CCCCccchHHHHhcccCcCCCCCCCh-----hhhhhCCcccceeccC
Q psy758 229 EVPDEMQYEEITQRCLDKDPLRRWSC-----DQLLRHPYFNGYYFEV 270 (292)
Q Consensus 229 ~~~~~~~l~~li~~~l~~dP~~Rpt~-----~~il~h~w~~~~~~~~ 270 (292)
+...++++++||.+||+.||++|||+ +|+++||||+++.|+.
T Consensus 246 p~~~s~~~~~li~~~L~~dP~~R~ta~~~~~~eil~Hp~f~~idw~~ 292 (304)
T 3ubd_A 246 PQFLSPEAQSLLRMLFKRNPANRLGAGPDGVEEIKRHSFFSTIDWNK 292 (304)
T ss_dssp CTTSCHHHHHHHHHHTCSSGGGSTTCSTTTHHHHHTSGGGTTCCHHH
T ss_pred CCcCCHHHHHHHHHHcccCHHHCCCCCcCCHHHHHcCccccCCCHHH
Confidence 55678899999999999999999995 6999999999988763
|
| >4fie_A Serine/threonine-protein kinase PAK 4; kinase domain, protein ATP binding, phosphorylation, transferase; HET: SEP ANP; 3.11A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-55 Score=370.25 Aligned_cols=248 Identities=27% Similarity=0.427 Sum_probs=197.6
Q ss_pred cccceeeeecccCceEEEEEEEcCCCcEEEEEEeccCCCChHHHHHHHHHHHHHHhCCCCCcchhhhhhhcCCeEEEEEe
Q psy758 2 ERYEKIGKLGEGSYGVVFKCRNRDTGQVVAIKKFLESEEDPLIRKIALREIRLLKSLKHPNLVNLLEVFRRKKKLHLVFE 81 (292)
Q Consensus 2 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~iv~e 81 (292)
+.|++.+.||+|+||.||+|++..+|+.||||++....... .+.+.+|+.+++.++||||++++++|.+++.+|+|||
T Consensus 151 ~~y~~~~~iG~G~fG~V~~a~~~~tg~~vAiK~i~~~~~~~--~~~~~~Ei~il~~l~HpnIV~l~~~~~~~~~~~iVmE 228 (423)
T 4fie_A 151 SYLDNFIKIGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQR--RELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVME 228 (423)
T ss_dssp GTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEESTTCSS--GGGHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred HhcEeeeEeccCcCcEEEEEEECCCCCEEEEEEEeccchhH--HHHHHHHHHHHHhCCCCCCCceEEEEEECCEEEEEEe
Confidence 46999999999999999999999999999999997654332 3567899999999999999999999999999999999
Q ss_pred cCCCccHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEEccCCcEEEeecCchhhhhcccccc---
Q psy758 82 FCDHTVLNELENHPHGLPWDLIKQITWQVLRGVSYCHRHACIHRDIKPENILLTANGVVKLCDFGFARLIRDLIPRH--- 158 (292)
Q Consensus 82 ~~~~~~L~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~givH~dl~p~Nilv~~~~~~kl~dfg~~~~~~~~~~~~--- 158 (292)
||+||+|.+++... .+++..++.++.||+.||+|||++||+||||||+|||++.+|.+||+|||+++.+.......
T Consensus 229 y~~gG~L~~~i~~~-~l~e~~~~~~~~qil~aL~ylH~~~IiHRDiKp~NILl~~~g~vKl~DFGla~~~~~~~~~~~~~ 307 (423)
T 4fie_A 229 FLEGGALTDIVTHT-RMNEEQIAAVCLAVLQALSVLHAQGVIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEVPRRKSL 307 (423)
T ss_dssp CCTTEEHHHHHHHS-CCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSTTTEEECTTCCEEECCCTTCEECCSSCCCBCCC
T ss_pred CCCCCcHHHHHhcc-CCCHHHHHHHHHHHHHHHHHHHHCCeecccCCHHHEEEcCCCCEEEecCccceECCCCCcccccc
Confidence 99999999999764 69999999999999999999999999999999999999999999999999998765433322
Q ss_pred --ccccccccccccCCC-----CCCCcccceeeecCCCCCCchHHHHHHHhhcccCCCCCCChhhhhhccCcCCCCCCCC
Q psy758 159 --LHIFQTNEYFKGVSL-----PHAENVVPLEIKIGKPAATNIYLIDFLKRCLDKDPLRRWSCDQLLRHPYFNGYYFEVP 231 (292)
Q Consensus 159 --~~~~~~~~~~~~~~~-----~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~ 231 (292)
+..|.+||...+..+ .|+.|++.+++++|.+++.......++..+....+ ........
T Consensus 308 ~GTp~YmAPEvl~~~~y~~~~DiWSlGvilyeml~G~~PF~~~~~~~~~~~i~~~~~---------------~~~~~~~~ 372 (423)
T 4fie_A 308 VGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNEPPLKAMKMIRDNLP---------------PRLKNLHK 372 (423)
T ss_dssp EECTTTCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHSCC---------------CCCSCTTS
T ss_pred ccCcCcCCHHHHCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcCHHHHHHHHHcCCC---------------CCCccccc
Confidence 344555555444333 35555555556666655544433333333322111 11122334
Q ss_pred CccchHHHHhcccCcCCCCCCChhhhhhCCccccee
Q psy758 232 DEMQYEEITQRCLDKDPLRRWSCDQLLRHPYFNGYY 267 (292)
Q Consensus 232 ~~~~l~~li~~~l~~dP~~Rpt~~~il~h~w~~~~~ 267 (292)
.+..+++||.+||+.||++|||++|+|+||||+...
T Consensus 373 ~s~~~~dli~~~L~~dP~~R~ta~ell~Hp~~~~~~ 408 (423)
T 4fie_A 373 VSPSLKGFLDRLLVRDPAQRATAAELLKHPFLAKAG 408 (423)
T ss_dssp SCHHHHHHHHHHSCSSTTTSCCHHHHTTCGGGGGCC
T ss_pred CCHHHHHHHHHHcCCChhHCcCHHHHhcCHHhcCCC
Confidence 578999999999999999999999999999999743
|
| >3fpq_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase, ATP-BIND kinase, nucleotide-binding, phosphoprotein; 1.80A {Rattus norvegicus} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.9e-55 Score=350.45 Aligned_cols=252 Identities=24% Similarity=0.375 Sum_probs=189.6
Q ss_pred cc-ceeeeecccCceEEEEEEEcCCCcEEEEEEeccCCCChHHHHHHHHHHHHHHhCCCCCcchhhhhhhc----CCeEE
Q psy758 3 RY-EKIGKLGEGSYGVVFKCRNRDTGQVVAIKKFLESEEDPLIRKIALREIRLLKSLKHPNLVNLLEVFRR----KKKLH 77 (292)
Q Consensus 3 ~y-~~~~~l~~g~~~~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~----~~~~~ 77 (292)
|| .+.+.||+|+||.||+|.+..++..||+|.+..........+.+.+|+.+++.++||||+++++++.+ ++.+|
T Consensus 26 r~~~~~~~iG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~~~~~~ 105 (290)
T 3fpq_A 26 RFLKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKCIV 105 (290)
T ss_dssp SEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEEEETTEEEEE
T ss_pred ceEEeeeEEecCcCcEEEEEEECCCCeEEEEEEEchhhCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEeeccCCCcEEE
Confidence 55 67788999999999999999999999999998777677777889999999999999999999999864 45689
Q ss_pred EEEecCCCccHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCC--ccccCCCCCceEEcc-CCcEEEeecCchhhhhcc
Q psy758 78 LVFEFCDHTVLNELENHPHGLPWDLIKQITWQVLRGVSYCHRHA--CIHRDIKPENILLTA-NGVVKLCDFGFARLIRDL 154 (292)
Q Consensus 78 iv~e~~~~~~L~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~g--ivH~dl~p~Nilv~~-~~~~kl~dfg~~~~~~~~ 154 (292)
+|||||+||+|.+++...+.+++..+..++.||+.||+|||++| |+||||||+|||++. +|.+||+|||+++.....
T Consensus 106 lvmEy~~gg~L~~~l~~~~~l~~~~~~~~~~qi~~aL~ylH~~~~~IiHRDlKp~NILl~~~~g~vKl~DFGla~~~~~~ 185 (290)
T 3fpq_A 106 LVTELMTSGTLKTYLKRFKVMKIKVLRSWCRQILKGLQFLHTRTPPIIHRDLKCDNIFITGPTGSVKIGDLGLATLKRAS 185 (290)
T ss_dssp EEEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHTSSSCCCCCCCCGGGEEESSTTSCEEECCTTGGGGCCTT
T ss_pred EEEeCCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCCEEecccChhheeEECCCCCEEEEeCcCCEeCCCC
Confidence 99999999999999988788999999999999999999999999 999999999999985 789999999999764332
Q ss_pred ccccccccccccccccCCCCCCCcccceeeecCCCCCCchHHHHHHHhhcccCCCCCCC-hhhhhhccCcC--CCCCCCC
Q psy758 155 IPRHLHIFQTNEYFKGVSLPHAENVVPLEIKIGKPAATNIYLIDFLKRCLDKDPLRRWS-CDQLLRHPYFN--GYYFEVP 231 (292)
Q Consensus 155 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~-~~~~~~~~~~~--~~~~~~~ 231 (292)
. .....++|.|.+|+.+.. .++...++++.+.-+++.+.+..|+...+ ..++....... ....+..
T Consensus 186 ~--~~~~~GTp~YmAPE~~~~---------~y~~~~DiwSlGvilyelltg~~Pf~~~~~~~~~~~~i~~~~~~~~~~~~ 254 (290)
T 3fpq_A 186 F--AKAVIGTPEFMAPEMYEE---------KYDESVDVYAFGMCMLEMATSEYPYSECQNAAQIYRRVTSGVKPASFDKV 254 (290)
T ss_dssp S--BEESCSSCCCCCGGGGGT---------CCCTHHHHHHHHHHHHHHHHSSCTTTTCSSHHHHHHHHTTTCCCGGGGGC
T ss_pred c--cCCcccCccccCHHHcCC---------CCCcHHHHHHHHHHHHHHHHCCCCCCCCCcHHHHHHHHHcCCCCCCCCcc
Confidence 1 112234444444433210 01111222333333444444555543322 22222211110 1112334
Q ss_pred CccchHHHHhcccCcCCCCCCChhhhhhCCcccc
Q psy758 232 DEMQYEEITQRCLDKDPLRRWSCDQLLRHPYFNG 265 (292)
Q Consensus 232 ~~~~l~~li~~~l~~dP~~Rpt~~~il~h~w~~~ 265 (292)
.++++++||.+||+.||++|||++|+|+||||++
T Consensus 255 ~~~~~~~li~~~L~~dP~~R~s~~e~l~Hp~~~~ 288 (290)
T 3fpq_A 255 AIPEVKEIIEGCIRQNKDERYSIKDLLNHAFFQE 288 (290)
T ss_dssp CCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGC-
T ss_pred CCHHHHHHHHHHccCChhHCcCHHHHhcCccccC
Confidence 4678999999999999999999999999999986
|
| >4b99_A Mitogen-activated protein kinase 7; transferase, inhibitor; HET: R4L; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-52 Score=350.94 Aligned_cols=265 Identities=26% Similarity=0.378 Sum_probs=205.2
Q ss_pred cccceeeeecccCceEEEEEEEcCCCcEEEEEEeccCCCChHHHHHHHHHHHHHHhCCCCCcchhhhhhh------cCCe
Q psy758 2 ERYEKIGKLGEGSYGVVFKCRNRDTGQVVAIKKFLESEEDPLIRKIALREIRLLKSLKHPNLVNLLEVFR------RKKK 75 (292)
Q Consensus 2 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~------~~~~ 75 (292)
++|++++.||+|+||.||+|++..+|+.||||++..........+.+.+|+.+++.++||||+++++++. +.+.
T Consensus 54 ~~Y~~~~~lG~G~fG~V~~a~~~~t~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~~~~~ 133 (398)
T 4b99_A 54 DEYEIIETIGNGAYGVVSSARRRLTGQQVAIKKIPNAFDVVTNAKRTLRELKILKHFKHDNIIAIKDILRPTVPYGEFKS 133 (398)
T ss_dssp SSEEEEEEEEECSSCEEEEEEETTTCCEEEEEEETTTTSSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSSCTTTCCC
T ss_pred CCeEEEEEEecccCeEEEEEEECCCCCEEEEEEECccccchHHHHHHHHHHHHHHhcCCCCcceEeeeeecccccccCCE
Confidence 4799999999999999999999999999999999877777777788899999999999999999999864 4468
Q ss_pred EEEEEecCCCccHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEEccCCcEEEeecCchhhhhcc-
Q psy758 76 LHLVFEFCDHTVLNELENHPHGLPWDLIKQITWQVLRGVSYCHRHACIHRDIKPENILLTANGVVKLCDFGFARLIRDL- 154 (292)
Q Consensus 76 ~~iv~e~~~~~~L~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~givH~dl~p~Nilv~~~~~~kl~dfg~~~~~~~~- 154 (292)
+|+|||||+| +|..++...+.+++..++.++.||+.||+|||++||+||||||+|||++.+|.+||+|||+++.+...
T Consensus 134 ~~ivmE~~~g-~L~~~i~~~~~l~~~~~~~~~~qil~al~ylH~~~iiHRDlKP~NIl~~~~~~~Ki~DFGla~~~~~~~ 212 (398)
T 4b99_A 134 VYVVLDLMES-DLHQIIHSSQPLTLEHVRYFLYQLLRGLKYMHSAQVIHRDLKPSNLLVNENCELKIGDFGMARGLCTSP 212 (398)
T ss_dssp EEEEEECCSE-EHHHHHTSSSCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTCCEEECCCTTCBCC----
T ss_pred EEEEEeCCCC-CHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCcCcCCCcCccccccCCCCCEEEeecceeeecccCc
Confidence 9999999974 58888887788999999999999999999999999999999999999999999999999999765321
Q ss_pred --------ccccccccccccccccCC------CCCCCcccceeeecCCCCCCchHHHHHHHhhc---ccCCCCCCC----
Q psy758 155 --------IPRHLHIFQTNEYFKGVS------LPHAENVVPLEIKIGKPAATNIYLIDFLKRCL---DKDPLRRWS---- 213 (292)
Q Consensus 155 --------~~~~~~~~~~~~~~~~~~------~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~---~~~p~~~~~---- 213 (292)
...++..|.+||...+.. ..|+.|++.+++++|.+++.+....+.+..++ +..+.....
T Consensus 213 ~~~~~~~~~~~GT~~Y~APEv~~~~~~~~~~~DiWSlG~il~ell~G~~pF~g~~~~~~l~~I~~~~g~p~~~~~~~~~~ 292 (398)
T 4b99_A 213 AEHQYFMTEYVATRWYRAPELMLSLHEYTQAIDLWSVGCIFGEMLARRQLFPGKNYVHQLQLIMMVLGTPSPAVIQAVGA 292 (398)
T ss_dssp ---CCCCCSSCCCCTTCCHHHHTTCSCCCTHHHHHHHHHHHHHHHHTSCSSCCSSHHHHHHHHHHHHCCCCGGGTC----
T ss_pred cccccccccceeChHhcCHHHhcCCCCCCChhheehhHHHHHHHHHCCCCCCCCCHHHHHHHHHHhcCCCChHHhhhhhh
Confidence 123456677887765533 34778888888889988876555444443332 222211110
Q ss_pred --hhhhhh-ccCcCCCC---CCCCCccchHHHHhcccCcCCCCCCChhhhhhCCccccee
Q psy758 214 --CDQLLR-HPYFNGYY---FEVPDEMQYEEITQRCLDKDPLRRWSCDQLLRHPYFNGYY 267 (292)
Q Consensus 214 --~~~~~~-~~~~~~~~---~~~~~~~~l~~li~~~l~~dP~~Rpt~~~il~h~w~~~~~ 267 (292)
...... .+...... .....+.++.+||.+||++||++|||++|+|+||||++..
T Consensus 293 ~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~Hp~f~~~~ 352 (398)
T 4b99_A 293 ERVRAYIQSLPPRQPVPWETVYPGADRQALSLLGRMLRFEPSARISAAAALRHPFLAKYH 352 (398)
T ss_dssp -CHHHHHHSSCCCCCCCHHHHSTTCCHHHHHHHHHHSCSSTTTSCCHHHHTTSGGGTTTC
T ss_pred hhhhhhhhcCCCcCCCCHHHhCCCCCHHHHHHHHHHCcCChhHCcCHHHHhcCHhhCcCC
Confidence 000000 00000000 0113467889999999999999999999999999999754
|
| >4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-52 Score=342.95 Aligned_cols=246 Identities=22% Similarity=0.274 Sum_probs=188.4
Q ss_pred cccceeeeecccCceEEEEEEEcCCCcEEEEEEeccCCCChHHHHHHHHHHHHHHhCCCCCcchhhhhhhcCCeEEEEEe
Q psy758 2 ERYEKIGKLGEGSYGVVFKCRNRDTGQVVAIKKFLESEEDPLIRKIALREIRLLKSLKHPNLVNLLEVFRRKKKLHLVFE 81 (292)
Q Consensus 2 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~iv~e 81 (292)
+.|++.+.||+|+||.||+|++..+|+.||+|++..... ..+|+.+++.++||||+++++++.+++.+|+|||
T Consensus 58 ~~~~~~~~lG~G~fG~Vy~a~~~~~g~~vAiK~i~~~~~-------~~~E~~il~~l~HpnIV~l~~~~~~~~~~~ivmE 130 (336)
T 4g3f_A 58 HWMTHQPRVGRGSFGEVHRMKDKQTGFQCAVKKVRLEVF-------RVEELVACAGLSSPRIVPLYGAVREGPWVNIFME 130 (336)
T ss_dssp TEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTC-------CTHHHHTTTTCCCTTBCCEEEEEEETTEEEEEEC
T ss_pred hheEeCcEeccCCCeEEEEEEECCCCCEEEEEEECHHHh-------HHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEe
Confidence 468889999999999999999999999999999976543 2469999999999999999999999999999999
Q ss_pred cCCCccHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEEccCC-cEEEeecCchhhhhcccc----
Q psy758 82 FCDHTVLNELENHPHGLPWDLIKQITWQVLRGVSYCHRHACIHRDIKPENILLTANG-VVKLCDFGFARLIRDLIP---- 156 (292)
Q Consensus 82 ~~~~~~L~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~givH~dl~p~Nilv~~~~-~~kl~dfg~~~~~~~~~~---- 156 (292)
||+||+|.++++..+.+++..+..++.||+.||+|||++||+||||||+|||++.+| .+||+|||+++.......
T Consensus 131 y~~gg~L~~~l~~~~~l~e~~~~~~~~qi~~aL~ylH~~~IiHRDlKp~NILl~~~g~~vKl~DFGla~~~~~~~~~~~~ 210 (336)
T 4g3f_A 131 LLEGGSLGQLIKQMGCLPEDRALYYLGQALEGLEYLHTRRILHGDVKADNVLLSSDGSRAALCDFGHALCLQPDGLGKSL 210 (336)
T ss_dssp CCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHTTTEECSCCCGGGEEECTTSCCEEECCCTTCEEC---------
T ss_pred ccCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCceecccCHHHEEEeCCCCEEEEeeCCCCeEccCCCcccce
Confidence 999999999998878899999999999999999999999999999999999999987 699999999987643211
Q ss_pred ------ccccccccccccccCCCCCCCcccceeeecCCCCCCchHHHHHHHhhcccCCCCCCChhhhhhccCcCC---CC
Q psy758 157 ------RHLHIFQTNEYFKGVSLPHAENVVPLEIKIGKPAATNIYLIDFLKRCLDKDPLRRWSCDQLLRHPYFNG---YY 227 (292)
Q Consensus 157 ------~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~---~~ 227 (292)
.++..|.+||...+.......|+| +.++.+++.+.+..|+...+..+++....... ..
T Consensus 211 ~~~~~~~GT~~YmAPE~~~~~~y~~~~Diw-------------SlGvilyemltG~~Pf~~~~~~~~~~~i~~~~~~~~~ 277 (336)
T 4g3f_A 211 LTGDYIPGTETHMAPEVVMGKPCDAKVDIW-------------SSCCMMLHMLNGCHPWTQYFRGPLCLKIASEPPPIRE 277 (336)
T ss_dssp ---CCCCCCGGGCCHHHHTTCCCCTHHHHH-------------HHHHHHHHHHHSSCSSTTTCCSCCHHHHHHSCCGGGG
T ss_pred ecCCccccCccccCHHHHCCCCCCcHHHHH-------------HHHHHHHHHHHCcCCCCCCCHHHHHHHHHcCCCCchh
Confidence 234556666666554432222222 22223333334444443332222221111011 12
Q ss_pred CCCCCccchHHHHhcccCcCCCCCCChhhh-------------hhCCccccee
Q psy758 228 FEVPDEMQYEEITQRCLDKDPLRRWSCDQL-------------LRHPYFNGYY 267 (292)
Q Consensus 228 ~~~~~~~~l~~li~~~l~~dP~~Rpt~~~i-------------l~h~w~~~~~ 267 (292)
.+...++.+.+||.+||+.||.+|||+.|+ ++|||+....
T Consensus 278 ~~~~~s~~~~~li~~~L~~dP~~R~sa~el~~~l~~~l~~~~~l~hPw~~~~~ 330 (336)
T 4g3f_A 278 IPPSCAPLTAQAIQEGLRKEPVHRASAMELRRKVGKALQEVGGLKSPWKGEYK 330 (336)
T ss_dssp SCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHTTSSCSCSSSSCC
T ss_pred cCccCCHHHHHHHHHHccCCHhHCcCHHHHHHHHHHHHhhhhhccCCCcCCCC
Confidence 344568899999999999999999999997 6799998743
|
| >4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-53 Score=345.41 Aligned_cols=247 Identities=24% Similarity=0.392 Sum_probs=179.0
Q ss_pred cccceeeeecccCceEEEEEEEcCCCcEEEEEEeccCCCChHHHHHHHHHHHHHHhCCCCCcchhhhhhhcCC-------
Q psy758 2 ERYEKIGKLGEGSYGVVFKCRNRDTGQVVAIKKFLESEEDPLIRKIALREIRLLKSLKHPNLVNLLEVFRRKK------- 74 (292)
Q Consensus 2 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~------- 74 (292)
++|++++.||+|+||.||+|++..+|+.||+|++.... .....+.+.+|+.+++.++||||+++++++.+.+
T Consensus 5 ~dy~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~-~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~~~~~~ 83 (299)
T 4g31_A 5 TDFEPIQCLGRGGFGVVFEAKNKVDDCNYAIKRIRLPN-RELAREKVMREVKALAKLEHPGIVRYFNAWLEKNTTEKLQP 83 (299)
T ss_dssp HHEEEEEEEEECC--EEEEEEETTTCCEEEEEEEEECS-SHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEEC-------
T ss_pred hhCEEeeEEecCCCeEEEEEEECCCCCEEEEEEEeccC-CHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEecCccccccc
Confidence 57899999999999999999999999999999997654 3445677899999999999999999999986533
Q ss_pred -----eEEEEEecCCCccHHHHhcCCCCC---CHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEEccCCcEEEeecC
Q psy758 75 -----KLHLVFEFCDHTVLNELENHPHGL---PWDLIKQITWQVLRGVSYCHRHACIHRDIKPENILLTANGVVKLCDFG 146 (292)
Q Consensus 75 -----~~~iv~e~~~~~~L~~~~~~~~~~---~~~~~~~i~~qi~~aL~~LH~~givH~dl~p~Nilv~~~~~~kl~dfg 146 (292)
.+|+|||||+||+|.+++.....+ ++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||
T Consensus 84 ~~~~~~l~ivmE~~~gg~L~~~l~~~~~~~~~~~~~~~~i~~qi~~al~ylH~~~IiHRDlKp~NILl~~~~~vKl~DFG 163 (299)
T 4g31_A 84 SSPKVYLYIQMQLCRKENLKDWMNGRCTIEERERSVCLHIFLQIAEAVEFLHSKGLMHRDLKPSNIFFTMDDVVKVGDFG 163 (299)
T ss_dssp ---CEEEEEEEECCCSCCHHHHHHTCCSGGGSCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTCCEEECCCC
T ss_pred cCCCcEEEEEEecCCCCcHHHHHHhcCCCChhHHHHHHHHHHHHHHHHHHHHHCcCccccCcHHHeEECCCCcEEEccCc
Confidence 479999999999999999876543 456688999999999999999999999999999999999999999999
Q ss_pred chhhhhcccc-----------------ccccccccccccccCCCCCCCcccce-----eeecCCCCCCchHHHHHHHhhc
Q psy758 147 FARLIRDLIP-----------------RHLHIFQTNEYFKGVSLPHAENVVPL-----EIKIGKPAATNIYLIDFLKRCL 204 (292)
Q Consensus 147 ~~~~~~~~~~-----------------~~~~~~~~~~~~~~~~~~~~~~~~~~-----~~~~~~~~~~~~~~~~~~~~~~ 204 (292)
+++....... .++..|.+||...+.......|+|++ +++++ +.........+....
T Consensus 164 la~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~YmAPE~~~~~~y~~~~DiwSlGvilyell~P--f~~~~~~~~~~~~~~ 241 (299)
T 4g31_A 164 LVTAMDQDEEEQTVLTPMPAYARHTGQVGTKLYMSPEQIHGNSYSHKVDIFSLGLILFELLYP--FSTQMERVRTLTDVR 241 (299)
T ss_dssp CC--------------------------CCCTTSCHHHHTTCCCCTHHHHHHHHHHHHHHHSC--CSSHHHHHHHHHHHH
T ss_pred cceecCCCccccccccccccccccCCcccCccccCHHHHcCCCCCCHHHHHHHHHHHHHHccC--CCCccHHHHHHHHHh
Confidence 9987653211 24555777776666554433444443 33321 111111111111111
Q ss_pred ccCCCCCCChhhhhhccCcCCCCCCCCCccchHHHHhcccCcCCCCCCChhhhhhCCcccceec
Q psy758 205 DKDPLRRWSCDQLLRHPYFNGYYFEVPDEMQYEEITQRCLDKDPLRRWSCDQLLRHPYFNGYYF 268 (292)
Q Consensus 205 ~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~~il~h~w~~~~~~ 268 (292)
... +. ......++.+.+||.+||+.||++|||+.|+++||||+++.|
T Consensus 242 ~~~---------------~p--~~~~~~~~~~~~li~~~L~~dP~~Rps~~eil~h~~~~~~~~ 288 (299)
T 4g31_A 242 NLK---------------FP--PLFTQKYPCEYVMVQDMLSPSPMERPEAINIIENAVFEDLDF 288 (299)
T ss_dssp TTC---------------CC--HHHHHHCHHHHHHHHHHTCSSGGGSCCHHHHHTSGGGCCC--
T ss_pred cCC---------------CC--CCCcccCHHHHHHHHHHcCCChhHCcCHHHHhcCHhhCCCCC
Confidence 000 00 000112446789999999999999999999999999999754
|
| >3v5w_A G-protein coupled receptor kinase 2; inhibitor complex, protein kinase, beta propeller, RGS homol domain; HET: 8PR; 2.07A {Homo sapiens} PDB: 3cik_A* 3krw_A* 3krx_A* 1omw_A 1ym7_A 2bcj_A* 3uzs_A 3uzt_A 3pvu_A* 3psc_A* 3pvw_A* 1bak_A | Back alignment and structure |
|---|
Probab=100.00 E-value=8.3e-51 Score=355.65 Aligned_cols=255 Identities=18% Similarity=0.273 Sum_probs=198.0
Q ss_pred CcccceeeeecccCceEEEEEEEcCCCcEEEEEEeccCC----CChHHHHHHHHHHHHHHhCCCCCcchhhhhhhcCCeE
Q psy758 1 MERYEKIGKLGEGSYGVVFKCRNRDTGQVVAIKKFLESE----EDPLIRKIALREIRLLKSLKHPNLVNLLEVFRRKKKL 76 (292)
Q Consensus 1 ~~~y~~~~~l~~g~~~~v~~~~~~~~~~~v~iK~~~~~~----~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~ 76 (292)
|++|++++.||+|+||.||+|++..+|+.||+|++.+.. ...........++.+++.++||||++++++|++++.+
T Consensus 188 lddf~i~k~LG~G~fG~V~la~~~~tg~~~AiK~i~K~~i~~~~~~~~~~~E~~~l~ll~~~~HP~IV~l~~~f~~~~~l 267 (689)
T 3v5w_A 188 MNDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDKL 267 (689)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHSSSCCTTBCCEEEEEECSSEE
T ss_pred hHHeEEEEEEecccCeEEEEEEECCCCCEEEEEEEeHHHcchhhhHHHHHHHHHHHHHHhhCCCCCEeEEEEEEEECCEE
Confidence 578999999999999999999999999999999996542 2222333334556777888999999999999999999
Q ss_pred EEEEecCCCccHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEEccCCcEEEeecCchhhhhccc-
Q psy758 77 HLVFEFCDHTVLNELENHPHGLPWDLIKQITWQVLRGVSYCHRHACIHRDIKPENILLTANGVVKLCDFGFARLIRDLI- 155 (292)
Q Consensus 77 ~iv~e~~~~~~L~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~givH~dl~p~Nilv~~~~~~kl~dfg~~~~~~~~~- 155 (292)
|+|||||+||+|..++...+.+++..++.++.||+.||.|||++||+||||||+|||++.+|++||+|||+++......
T Consensus 268 ylVmEy~~GGdL~~~l~~~~~l~E~~a~~y~~qIl~aL~yLH~~gIiHRDLKPeNILld~~G~vKL~DFGlA~~~~~~~~ 347 (689)
T 3v5w_A 268 SFILDLMNGGDLHYHLSQHGVFSEADMRFYAAEIILGLEHMHNRFVVYRDLKPANILLDEHGHVRISDLGLACDFSKKKP 347 (689)
T ss_dssp EEEECCCCSCBHHHHHHHHCCCCHHHHHHHHHHHHHHHHHHHTTTEECCCCSGGGEEECTTSCEEECCCTTCEECSSCCC
T ss_pred EEEEecCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCchHHeEEeCCCCEEecccceeeecCCCCC
Confidence 9999999999999999888889999999999999999999999999999999999999999999999999998765422
Q ss_pred --cccccccccccccc-cCCC-----CCCCcccceeeecCCCCCCchHHHHHHHhhcccCCCCCCChhhhhhccCcCCCC
Q psy758 156 --PRHLHIFQTNEYFK-GVSL-----PHAENVVPLEIKIGKPAATNIYLIDFLKRCLDKDPLRRWSCDQLLRHPYFNGYY 227 (292)
Q Consensus 156 --~~~~~~~~~~~~~~-~~~~-----~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~ 227 (292)
..++..|.+||... +... .|+.|++.|++++|.+++..... ....++..........
T Consensus 348 ~t~~GTp~YmAPEvl~~~~~y~~~vDiWSLGvilYEmLtG~~PF~~~~~---------------~~~~~i~~~i~~~~~~ 412 (689)
T 3v5w_A 348 HASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKT---------------KDKHEIDRMTLTMAVE 412 (689)
T ss_dssp CSCCSCGGGCCHHHHSTTCCCCTHHHHHHHHHHHHHHHHSSCTTCGGGC---------------CCHHHHHHHHHHCCCC
T ss_pred CCccCCcCccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCh---------------HHHHHHHHhhcCCCCC
Confidence 22344455555543 2222 24445555555555554432110 1111222222222334
Q ss_pred CCCCCccchHHHHhcccCcCCCCCCC-----hhhhhhCCcccceeccC
Q psy758 228 FEVPDEMQYEEITQRCLDKDPLRRWS-----CDQLLRHPYFNGYYFEV 270 (292)
Q Consensus 228 ~~~~~~~~l~~li~~~l~~dP~~Rpt-----~~~il~h~w~~~~~~~~ 270 (292)
.+...++++++||.+||+.||.+|++ ++||++||||+++.|+.
T Consensus 413 ~p~~~S~~a~dLI~~lL~~dP~~Rl~~~~~ga~ei~~HpfF~~idW~~ 460 (689)
T 3v5w_A 413 LPDSFSPELRSLLEGLLQRDVNRRLGCLGRGAQEVKESPFFRSLDWQM 460 (689)
T ss_dssp CCTTSCHHHHHHHHHHTCSCGGGCTTCSSSTHHHHTTSGGGTTCCHHH
T ss_pred CCccCCHHHHHHHHHHccCCHhHCCCCCCCCHHHHhcCccccCCCHHH
Confidence 45567889999999999999999998 79999999999999873
|
| >4f9c_A Cell division cycle 7-related protein kinase; Ser/Thr protein kinase, transferase, phosphorylation, cell C cell division, mitosis, S phase; HET: 0SX; 2.08A {Homo sapiens} PDB: 4f99_A* 4f9b_A* 4f9a_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3e-50 Score=334.62 Aligned_cols=259 Identities=17% Similarity=0.280 Sum_probs=191.9
Q ss_pred cccceeeeecccCceEEEEEEEc---CCCcEEEEEEeccCCCChHHHHHHHHHHHHHHhC-CCCCcchhhhhhhcCCeEE
Q psy758 2 ERYEKIGKLGEGSYGVVFKCRNR---DTGQVVAIKKFLESEEDPLIRKIALREIRLLKSL-KHPNLVNLLEVFRRKKKLH 77 (292)
Q Consensus 2 ~~y~~~~~l~~g~~~~v~~~~~~---~~~~~v~iK~~~~~~~~~~~~~~~~~e~~~~~~l-~~~~i~~~~~~~~~~~~~~ 77 (292)
++|++.+.||+|+||.||+|++. .+++.||+|.+..... ...+.+|+.+++.+ +||||++++++|.+++++|
T Consensus 21 ~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~~~~vAiK~i~~~~~----~~~~~~E~~~l~~~~~h~nIv~l~~~~~~~~~~~ 96 (361)
T 4f9c_A 21 NVFKIEDKIGEGTFSSVYLATAQLQVGPEEKIALKHLIPTSH----PIRIAAELQCLTVAGGQDNVMGVKYCFRKNDHVV 96 (361)
T ss_dssp GTCEEEEEEEECSSEEEEEEEEEBTTSCEEEEEEEEECTTSC----HHHHHHHHHHHHHTCSBTTBCCCSEEEEETTEEE
T ss_pred CcEEEEEEEecccCcEEEEEEEcccCCCCCEEEEEEEccccC----HHHHHHHHHHHHHhcCCCCCceEEEEEEECCEEE
Confidence 57999999999999999999875 4678999999865433 24567899999998 6999999999999999999
Q ss_pred EEEecCCCccHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEEccC-CcEEEeecCchhhhhccc-
Q psy758 78 LVFEFCDHTVLNELENHPHGLPWDLIKQITWQVLRGVSYCHRHACIHRDIKPENILLTAN-GVVKLCDFGFARLIRDLI- 155 (292)
Q Consensus 78 iv~e~~~~~~L~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~givH~dl~p~Nilv~~~-~~~kl~dfg~~~~~~~~~- 155 (292)
+||||++|++|.++++ .+++..++.++.||+.||+|||++||+||||||+|||++.+ +.+||+|||+++......
T Consensus 97 lvmE~~~g~~L~~~~~---~l~~~~~~~~~~qll~al~ylH~~gIiHRDiKPeNiLl~~~~~~~kl~DFGla~~~~~~~~ 173 (361)
T 4f9c_A 97 IAMPYLEHESFLDILN---SLSFQEVREYMLNLFKALKRIHQFGIVHRDVKPSNFLYNRRLKKYALVDFGLAQGTHDTKI 173 (361)
T ss_dssp EEEECCCCCCHHHHHT---TCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEETTTTEEEECCCTTCEECTTCSC
T ss_pred EEEeCCCcccHHHHHc---CCCHHHHHHHHHHHHHHHHHHHHCCeEeCcCCHHHeEEeCCCCeEEECcCCCCcccCCccc
Confidence 9999999999999985 59999999999999999999999999999999999999977 799999999997543211
Q ss_pred --------------------------------cccccccccccccccCC------CCCCCcccceeeecCCCCCC-chHH
Q psy758 156 --------------------------------PRHLHIFQTNEYFKGVS------LPHAENVVPLEIKIGKPAAT-NIYL 196 (292)
Q Consensus 156 --------------------------------~~~~~~~~~~~~~~~~~------~~~~~~~~~~~~~~~~~~~~-~~~~ 196 (292)
..++..|.+||...+.. +.|+.|+..+++++|..++. ...-
T Consensus 174 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~y~~~~DiWSlG~il~ell~G~~Pf~~~~~~ 253 (361)
T 4f9c_A 174 ELLKFVQSEAQQERCSQNKCSICLSRRQQVAPRAGTPGFRAPEVLTKCPNQTTAIDMWSAGVIFLSLLSGRYPFYKASDD 253 (361)
T ss_dssp GGGGGC--------------------------CCCCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHHHTCSSSSCCSSH
T ss_pred cccccccccccccccccccccccccccccccccccCccccCHHHHcCCCCCCCccchhhhHHHHHHHHHCCCCCCCCCCH
Confidence 12456688888766543 34777777788888886652 1111
Q ss_pred HHHH---Hhhccc-----------------CCCCCCChhhhhhc--------c--------CcCCCCCCCCCccchHHHH
Q psy758 197 IDFL---KRCLDK-----------------DPLRRWSCDQLLRH--------P--------YFNGYYFEVPDEMQYEEIT 240 (292)
Q Consensus 197 ~~~~---~~~~~~-----------------~p~~~~~~~~~~~~--------~--------~~~~~~~~~~~~~~l~~li 240 (292)
.+.+ ...++. .............. + ...........++++.+||
T Consensus 254 ~~~l~~I~~~~G~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~is~~a~DLl 333 (361)
T 4f9c_A 254 LTALAQIMTIRGSRETIQAAKTFGKSILCSKEVPAQDLRKLCERLRGMDSSTPKLTSDIQGHATNLEGWNEVPDEAYDLL 333 (361)
T ss_dssp HHHHHHHHHHHCHHHHHHHHHHTTEEEEESSCCCCCCHHHHHHHHC----------------------CTTCCHHHHHHH
T ss_pred HHHHHHHHHhcCCccchhhhhhccccccccccCcchhhhHHHHhhccccccccccccccccccccccccccCCHHHHHHH
Confidence 1111 111110 00000000110000 0 0000111234577899999
Q ss_pred hcccCcCCCCCCChhhhhhCCccccee
Q psy758 241 QRCLDKDPLRRWSCDQLLRHPYFNGYY 267 (292)
Q Consensus 241 ~~~l~~dP~~Rpt~~~il~h~w~~~~~ 267 (292)
.+||++||++||||+|+|+||||+++.
T Consensus 334 ~~lL~~dP~~R~ta~eaL~Hp~f~~i~ 360 (361)
T 4f9c_A 334 DKLLDLNPASRITAEEALLHPFFKDMS 360 (361)
T ss_dssp HHHTCSCTTTSCCHHHHHTSGGGTTC-
T ss_pred HHHCcCChhHCcCHHHHhcCcccCCCC
Confidence 999999999999999999999999864
|
| >4asz_A BDNF/NT-3 growth factors receptor; transferase, TRKA, TRKB; 1.70A {Homo sapiens} PDB: 4at3_A* 4at4_A* 4at5_A* 3v5q_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-50 Score=327.08 Aligned_cols=249 Identities=22% Similarity=0.265 Sum_probs=187.1
Q ss_pred cccceeeeecccCceEEEEEEEc-----CCCcEEEEEEeccCCCChHHHHHHHHHHHHHHhCCCCCcchhhhhhhcCCeE
Q psy758 2 ERYEKIGKLGEGSYGVVFKCRNR-----DTGQVVAIKKFLESEEDPLIRKIALREIRLLKSLKHPNLVNLLEVFRRKKKL 76 (292)
Q Consensus 2 ~~y~~~~~l~~g~~~~v~~~~~~-----~~~~~v~iK~~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~ 76 (292)
++|++.+.||+|+||.||+|++. .++..||+|++... .....+.+.+|+.+++.++||||+++++++.+++.+
T Consensus 13 ~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~--~~~~~~~f~~E~~il~~l~HpnIV~l~g~~~~~~~~ 90 (299)
T 4asz_A 13 HNIVLKRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDA--SDNARKDFHREAELLTNLQHEHIVKFYGVCVEGDPL 90 (299)
T ss_dssp GGEEEEEEEEC--CCCEEEEEECSCC----CEEEEEEEECSC--CHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSE
T ss_pred HHeEEeeEEeeCCCcEEEEEEECCcccCCCCEEEEEEEeCCC--ChHHHHHHHHHHHHHHhCCCCCCccEEEEEeeCCEE
Confidence 46889999999999999999875 35778999999643 345567899999999999999999999999999999
Q ss_pred EEEEecCCCccHHHHhcCC-------------CCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEEccCCcEEEe
Q psy758 77 HLVFEFCDHTVLNELENHP-------------HGLPWDLIKQITWQVLRGVSYCHRHACIHRDIKPENILLTANGVVKLC 143 (292)
Q Consensus 77 ~iv~e~~~~~~L~~~~~~~-------------~~~~~~~~~~i~~qi~~aL~~LH~~givH~dl~p~Nilv~~~~~~kl~ 143 (292)
|+|||||++|+|.+++... ..+++..+..++.||+.||+|||+++|+||||||+|||+++++.+||+
T Consensus 91 ~lV~Ey~~~G~L~~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~~iiHRDlKp~NILl~~~~~~Ki~ 170 (299)
T 4asz_A 91 IMVFEYMKHGDLNKFLRAHGPDAVLMAEGNPPTELTQSQMLHIAQQIAAGMVYLASQHFVHRDLATRNCLVGENLLVKIG 170 (299)
T ss_dssp EEEEECCTTCBHHHHHHHTSHHHHHC----CCCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECGGGCEEEC
T ss_pred EEEEEcCCCCcHHHHHHhcCcccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCccCHhhEEECCCCcEEEC
Confidence 9999999999999998642 369999999999999999999999999999999999999999999999
Q ss_pred ecCchhhhhcccc-------ccccccccccccccCCCCCCCcccceeeecCCCCCCchHHHHHHHhhc-ccCCCCCCChh
Q psy758 144 DFGFARLIRDLIP-------RHLHIFQTNEYFKGVSLPHAENVVPLEIKIGKPAATNIYLIDFLKRCL-DKDPLRRWSCD 215 (292)
Q Consensus 144 dfg~~~~~~~~~~-------~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~p~~~~~~~ 215 (292)
|||+++....... ..+..|.+||...+..+....|+|++ +.-+++.+. +..|+...+..
T Consensus 171 DFGla~~~~~~~~~~~~~~~~gt~~ymAPE~~~~~~~~~k~DVwS~-------------Gvvl~Ellt~G~~Pf~~~~~~ 237 (299)
T 4asz_A 171 DFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSL-------------GVVLWEIFTYGKQPWYQLSNN 237 (299)
T ss_dssp CCSCHHHHTGGGCEEETTTEEECGGGCCHHHHHHCCCCHHHHHHHH-------------HHHHHHHHTTTCCTTTTSCHH
T ss_pred CcccceecCCCCceeecCceecChhhcCHHHHcCCCCCchhhHHHH-------------HHHHHHHHcCCCCCCCCCCHH
Confidence 9999987643221 12334666666655444333333322 222233332 34455444444
Q ss_pred hhhhccCcCC-CCCCCCCccchHHHHhcccCcCCCCCCChhhhhhCCccccee
Q psy758 216 QLLRHPYFNG-YYFEVPDEMQYEEITQRCLDKDPLRRWSCDQLLRHPYFNGYY 267 (292)
Q Consensus 216 ~~~~~~~~~~-~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~~il~h~w~~~~~ 267 (292)
+++....... ...+...+.++.+||.+||+.||++|||+++|+ +||+++.
T Consensus 238 ~~~~~i~~~~~~~~p~~~~~~~~~li~~cl~~dP~~RPs~~~i~--~~L~~~~ 288 (299)
T 4asz_A 238 EVIECITQGRVLQRPRTCPQEVYELMLGCWQREPHMRKNIKGIH--TLLQNLA 288 (299)
T ss_dssp HHHHHHHHTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHH--HHHHHHH
T ss_pred HHHHHHHcCCCCCCCccchHHHHHHHHHHcCCChhHCcCHHHHH--HHHHHHH
Confidence 4433221111 123445678999999999999999999999995 4887643
|
| >3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.7e-49 Score=346.53 Aligned_cols=253 Identities=23% Similarity=0.312 Sum_probs=198.5
Q ss_pred CcccceeeeecccCceEEEEEEEcCCCcEEEEEEeccCCCChHHHHHHHHHHHHHHhCCCCCcchhhhhhhcCCeEEEEE
Q psy758 1 MERYEKIGKLGEGSYGVVFKCRNRDTGQVVAIKKFLESEEDPLIRKIALREIRLLKSLKHPNLVNLLEVFRRKKKLHLVF 80 (292)
Q Consensus 1 ~~~y~~~~~l~~g~~~~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~iv~ 80 (292)
+++|++.+.||+|+||.||+|++..+|+.||+|++.... ....+.+.+|+.+++.++||||++++++|.+++.+|+||
T Consensus 156 l~~Y~i~~~lG~G~fg~V~~~~~~~tg~~~AiK~i~~~~--~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~iv~ 233 (573)
T 3uto_A 156 LDHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPH--ESDKETVRKEIQTMSVLRHPTLVNLHDAFEDDNEMVMIY 233 (573)
T ss_dssp GGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCS--HHHHHHHHHHHHHHHHTCCTTBCCEEEEEECSSEEEEEE
T ss_pred ccccEEEEEEeeccCeEEEEEEECCCCCEEEEEEEeccc--hhhHHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEEEEE
Confidence 478999999999999999999999999999999987643 334567889999999999999999999999999999999
Q ss_pred ecCCCccHHHHhcC-CCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEEccC--CcEEEeecCchhhhhcccc-
Q psy758 81 EFCDHTVLNELENH-PHGLPWDLIKQITWQVLRGVSYCHRHACIHRDIKPENILLTAN--GVVKLCDFGFARLIRDLIP- 156 (292)
Q Consensus 81 e~~~~~~L~~~~~~-~~~~~~~~~~~i~~qi~~aL~~LH~~givH~dl~p~Nilv~~~--~~~kl~dfg~~~~~~~~~~- 156 (292)
|||.||+|.+++.. .+.+++..+..++.||+.||+|||++||+||||||+|||++.+ +.+||+|||+++.+.....
T Consensus 234 E~~~gg~L~~~i~~~~~~l~e~~~~~~~~qi~~al~ylH~~~iiHRDlKp~Nill~~~~~~~vKl~DFG~a~~~~~~~~~ 313 (573)
T 3uto_A 234 EFMSGGELFEKVADEHNKMSEDEAVEYMRQVCKGLCHMHENNYVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPKQSV 313 (573)
T ss_dssp ECCCCCBHHHHHTCTTSCEEHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESSSSCCCEEECCCSSCEECCTTSEE
T ss_pred eecCCCcHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCeeeccCChhhccccCCCCCCEEEeeccceeEccCCCce
Confidence 99999999998854 4579999999999999999999999999999999999999865 8999999999987654221
Q ss_pred ---ccccccccccccccCCCC-----CCCcccceeeecCCCCCCchHHHHHHHhhcccCCCCCCChhhhhhccCcCCCCC
Q psy758 157 ---RHLHIFQTNEYFKGVSLP-----HAENVVPLEIKIGKPAATNIYLIDFLKRCLDKDPLRRWSCDQLLRHPYFNGYYF 228 (292)
Q Consensus 157 ---~~~~~~~~~~~~~~~~~~-----~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~ 228 (292)
.++..|.+||...+.... |+.|+..+++++|.+++.......++..+...... -....
T Consensus 314 ~~~~GT~~y~APEv~~~~~y~~~~DiWSlGvilyeml~G~~Pf~~~~~~~~~~~i~~~~~~--------------~~~~~ 379 (573)
T 3uto_A 314 KVTTGTAEFAAPEVAEGKPVGYYTDMWSVGVLSYILLSGLSPFGGENDDETLRNVKSCDWN--------------MDDSA 379 (573)
T ss_dssp EEECSSGGGCCHHHHTTCCBCHHHHHHHHHHHHHHHHHSCCSSCCSSHHHHHHHHHTTCCC--------------CCSGG
T ss_pred eeeEECccccCHHHhCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcCHHHHHHHHHhCCCC--------------CCccc
Confidence 234456666666554433 44444455555555554433333333333221110 00111
Q ss_pred CCCCccchHHHHhcccCcCCCCCCChhhhhhCCcccceecc
Q psy758 229 EVPDEMQYEEITQRCLDKDPLRRWSCDQLLRHPYFNGYYFE 269 (292)
Q Consensus 229 ~~~~~~~l~~li~~~l~~dP~~Rpt~~~il~h~w~~~~~~~ 269 (292)
....+..+++||.+||+.||.+|||++|+|+||||+...+.
T Consensus 380 ~~~~s~~~~dli~~~L~~dp~~R~t~~e~l~Hpw~~~~~~~ 420 (573)
T 3uto_A 380 FSGISEDGKDFIRKLLLADPNTRMTIHQALEHPWLTPGNAP 420 (573)
T ss_dssp GTTSCHHHHHHHHTTSCSSGGGSCCHHHHHHSTTTSCCCCT
T ss_pred ccCCCHHHHHHHHHHccCChhHCcCHHHHhcCcCcCCCCCC
Confidence 12357789999999999999999999999999999987654
|
| >3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A | Back alignment and structure |
|---|
Probab=100.00 E-value=9.3e-49 Score=323.32 Aligned_cols=254 Identities=24% Similarity=0.352 Sum_probs=204.1
Q ss_pred CcccceeeeecccCceEEEEEEEcCCCcEEEEEEeccCCCChHHHHHHHHHHHHHHhCCCCCcchhhhhhhcCCeEEEEE
Q psy758 1 MERYEKIGKLGEGSYGVVFKCRNRDTGQVVAIKKFLESEEDPLIRKIALREIRLLKSLKHPNLVNLLEVFRRKKKLHLVF 80 (292)
Q Consensus 1 ~~~y~~~~~l~~g~~~~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~iv~ 80 (292)
+++|++.+.||+|+||.||+|.+..+|+.||+|++..........+.+.+|+.+++.++||||+++++++.+++..|+||
T Consensus 14 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv~ 93 (328)
T 3fe3_A 14 IGNYRLLKTIGKGNFAKVKLARHILTGREVAIKIIDKTQLNPTSLQKLFREVRIMKILNHPNIVKLFEVIETEKTLYLIM 93 (328)
T ss_dssp ETTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEE
T ss_pred cCCEEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEhhcCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCEEEEEE
Confidence 47899999999999999999999999999999999877766677788899999999999999999999999999999999
Q ss_pred ecCCCccHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEEccCCcEEEeecCchhhhhccc----c
Q psy758 81 EFCDHTVLNELENHPHGLPWDLIKQITWQVLRGVSYCHRHACIHRDIKPENILLTANGVVKLCDFGFARLIRDLI----P 156 (292)
Q Consensus 81 e~~~~~~L~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~givH~dl~p~Nilv~~~~~~kl~dfg~~~~~~~~~----~ 156 (292)
||+++++|.+++...+.+++..++.++.||+.||+|||++||+||||||+||+++.++.+||+|||++....... .
T Consensus 94 e~~~~~~L~~~l~~~~~l~~~~~~~~~~qi~~al~~lH~~~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~~~~~~~ 173 (328)
T 3fe3_A 94 EYASGGEVFDYLVAHGRMKEKEARSKFRQIVSAVQYCHQKRIVHRDLKAENLLLDADMNIKIADFGFSNEFTVGGKLDAF 173 (328)
T ss_dssp CCCTTCBHHHHHHHHCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTSCEEECSTTCCGGGSSSCGGGTT
T ss_pred ECCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCEeccCCCHHHEEEcCCCCEEEeeccCceecCCCCccccc
Confidence 999999999998777789999999999999999999999999999999999999999999999999997654321 2
Q ss_pred ccccccccccccccCCCC-CCCcccceeeecCCCCCCchHHHHHHHhhcccCCCCCCChhhhhhccCcCCCCCCCCCccc
Q psy758 157 RHLHIFQTNEYFKGVSLP-HAENVVPLEIKIGKPAATNIYLIDFLKRCLDKDPLRRWSCDQLLRHPYFNGYYFEVPDEMQ 235 (292)
Q Consensus 157 ~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 235 (292)
.++..|.+||...+.... ...++ ++.+.-++..+.+..|+...+..++...........+...+..
T Consensus 174 ~gt~~y~aPE~~~~~~~~~~~~Di-------------wslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~p~~~s~~ 240 (328)
T 3fe3_A 174 CGAPPYAAPELFQGKKYDGPEVDV-------------WSLGVILYTLVSGSLPFDGQNLKELRERVLRGKYRIPFYMSTD 240 (328)
T ss_dssp SSSGGGCCHHHHHTCCCCSHHHHH-------------HHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCCTTSCHH
T ss_pred cCCcceeCcccccCCCcCCchhhh-------------hhhHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCCCCCCHH
Confidence 234456666665543321 11222 2222233333444455544444444433333334455566889
Q ss_pred hHHHHhcccCcCCCCCCChhhhhhCCccccee
Q psy758 236 YEEITQRCLDKDPLRRWSCDQLLRHPYFNGYY 267 (292)
Q Consensus 236 l~~li~~~l~~dP~~Rpt~~~il~h~w~~~~~ 267 (292)
+.+||.+||+.||.+|||++|+++||||+...
T Consensus 241 ~~~li~~~L~~dP~~R~t~~eil~h~~~~~~~ 272 (328)
T 3fe3_A 241 CENLLKRFLVLNPIKRGTLEQIMKDRWINAGH 272 (328)
T ss_dssp HHHHHHHHCCSSTTTSCCHHHHTTCTTTTTTC
T ss_pred HHHHHHHHCCCChhHCcCHHHHhcCHhhcCCC
Confidence 99999999999999999999999999998754
|
| >4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-48 Score=320.33 Aligned_cols=244 Identities=23% Similarity=0.267 Sum_probs=180.2
Q ss_pred cccceeeeecccCceEEEEEEEc-----CCCcEEEEEEeccCCCChHHHHHHHHHHHHHHhCCCCCcchhhhhhhcCCeE
Q psy758 2 ERYEKIGKLGEGSYGVVFKCRNR-----DTGQVVAIKKFLESEEDPLIRKIALREIRLLKSLKHPNLVNLLEVFRRKKKL 76 (292)
Q Consensus 2 ~~y~~~~~l~~g~~~~v~~~~~~-----~~~~~v~iK~~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~ 76 (292)
++|++.+.||+|+||.||+|+.. .++..||||++... .....+.|.+|+.+++.++||||+++++++.+++.+
T Consensus 41 ~d~~l~~~LG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~--~~~~~~~f~~E~~il~~l~HpnIV~l~g~~~~~~~~ 118 (329)
T 4aoj_A 41 RDIVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEA--SESARQDFQREAELLTMLQHQHIVRFFGVCTEGRPL 118 (329)
T ss_dssp GGEEEEEEEEECSSEEEEEEEESSSCC---CEEEEEEEESCC--SHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSE
T ss_pred HHeEEEEEEccCCCcEEEEEEECCcccCCCCeEEEEEEECcC--CHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEE
Confidence 36788899999999999999865 36789999999643 445567899999999999999999999999999999
Q ss_pred EEEEecCCCccHHHHhcCC---------------CCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEEccCCcEE
Q psy758 77 HLVFEFCDHTVLNELENHP---------------HGLPWDLIKQITWQVLRGVSYCHRHACIHRDIKPENILLTANGVVK 141 (292)
Q Consensus 77 ~iv~e~~~~~~L~~~~~~~---------------~~~~~~~~~~i~~qi~~aL~~LH~~givH~dl~p~Nilv~~~~~~k 141 (292)
|+|||||++|+|.+++... +.+++.++..++.||+.||+|||+++|+||||||+|||+++++.+|
T Consensus 119 ~lV~Ey~~~G~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~~iiHRDLKp~NILl~~~~~~K 198 (329)
T 4aoj_A 119 LMVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVASQVAAGMVYLAGLHFVHRDLATRNCLVGQGLVVK 198 (329)
T ss_dssp EEEEECCTTCBHHHHHHTSSCC-----------CCSCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEETTTEEE
T ss_pred EEEEEcCCCCcHHHHHHhcCcccccccccccccCCCCCHHHHHHHHHHHHHHHHHHhcCCeecccccHhhEEECCCCcEE
Confidence 9999999999999998653 3589999999999999999999999999999999999999999999
Q ss_pred EeecCchhhhhccc-------cccccccccccccccCCCCCCCcccceeeecCCCCCCchHHHHHHHhhc-ccCCCCCCC
Q psy758 142 LCDFGFARLIRDLI-------PRHLHIFQTNEYFKGVSLPHAENVVPLEIKIGKPAATNIYLIDFLKRCL-DKDPLRRWS 213 (292)
Q Consensus 142 l~dfg~~~~~~~~~-------~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~p~~~~~ 213 (292)
|+|||+++...... ...+..|.+||...+.......|+|+++ .-+++.+. +..|+...+
T Consensus 199 i~DFGla~~~~~~~~~~~~~~~~gt~~ymAPE~~~~~~~~~~sDvwS~G-------------vvl~Ellt~G~~Pf~~~~ 265 (329)
T 4aoj_A 199 IGDFGMSRDIYSTDYYRVGGRTMLPIRWMPPESILYRKFTTESDVWSFG-------------VVLWEIFTYGKQPWYQLS 265 (329)
T ss_dssp ECCCC----------------CCCCGGGCCHHHHTTCCCCHHHHHHHHH-------------HHHHHHHTTSCCTTCSSC
T ss_pred EcccccceeccCCCcceecCcccccccccChhhhcCCCCCccccccchH-------------HHHHHHHcCCCCCCCCCC
Confidence 99999998654321 1223446677766555443333333322 22222232 344444444
Q ss_pred hhhhhhccCcC-CCCCCCCCccchHHHHhcccCcCCCCCCChhhhhhC
Q psy758 214 CDQLLRHPYFN-GYYFEVPDEMQYEEITQRCLDKDPLRRWSCDQLLRH 260 (292)
Q Consensus 214 ~~~~~~~~~~~-~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~~il~h 260 (292)
..+++...... ....+...++.+.+||.+||+.||++|||++||+++
T Consensus 266 ~~~~~~~i~~g~~~~~p~~~~~~~~~li~~cl~~dP~~RPs~~ei~~~ 313 (329)
T 4aoj_A 266 NTEAIDCITQGRELERPRACPPEVYAIMRGCWQREPQQRHSIKDVHAR 313 (329)
T ss_dssp HHHHHHHHHHTCCCCCCTTCCHHHHHHHHHHCCSSTTTSCCHHHHHHH
T ss_pred HHHHHHHHHcCCCCCCcccccHHHHHHHHHHcCcChhHCcCHHHHHHH
Confidence 44433221110 112344557899999999999999999999999873
|
| >3omv_A RAF proto-oncogene serine/threonine-protein kinas; serine/threonine-protein kinase, transferase; HET: SM5; 4.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-48 Score=316.31 Aligned_cols=242 Identities=21% Similarity=0.275 Sum_probs=181.6
Q ss_pred cccceeeeecccCceEEEEEEEcCCCcEEEEEEeccCCCChHHHHHHHHHHHHHHhCCCCCcchhhhhhhcCCeEEEEEe
Q psy758 2 ERYEKIGKLGEGSYGVVFKCRNRDTGQVVAIKKFLESEEDPLIRKIALREIRLLKSLKHPNLVNLLEVFRRKKKLHLVFE 81 (292)
Q Consensus 2 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~iv~e 81 (292)
+++++.+.||+|+||.||+|+.. ..||||+++.........+.+.+|+.+++.++||||+++++++.+ +.+|+|||
T Consensus 36 ~~l~l~~~iG~G~fG~Vy~~~~~---~~vAvK~~~~~~~~~~~~~~f~~E~~il~~l~HpNIV~l~g~~~~-~~~~iVmE 111 (307)
T 3omv_A 36 SEVMLSTRIGSGSFGTVYKGKWH---GDVAVKILKVVDPTPEQFQAFRNEVAVLRKTRHVNILLFMGYMTK-DNLAIVTQ 111 (307)
T ss_dssp TSCCEEEECCCCSSSEEEEEESS---SEEEEEECCCSSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECS-SSCEEEEE
T ss_pred HHeEEeeEEeeCCCcEEEEEEEC---CcEEEEEEEecCCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEC-CeEEEEEE
Confidence 57889999999999999999864 369999998777777778889999999999999999999998754 56899999
Q ss_pred cCCCccHHHHhcC-CCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEEccCCcEEEeecCchhhhhccc-----
Q psy758 82 FCDHTVLNELENH-PHGLPWDLIKQITWQVLRGVSYCHRHACIHRDIKPENILLTANGVVKLCDFGFARLIRDLI----- 155 (292)
Q Consensus 82 ~~~~~~L~~~~~~-~~~~~~~~~~~i~~qi~~aL~~LH~~givH~dl~p~Nilv~~~~~~kl~dfg~~~~~~~~~----- 155 (292)
||+||+|.+++.. ...+++..+..++.||+.||+|||++||+||||||+|||+++++.+||+|||+++......
T Consensus 112 y~~gGsL~~~l~~~~~~l~~~~~~~i~~qia~gL~yLH~~~IiHRDlKp~NILl~~~~~~Ki~DFGla~~~~~~~~~~~~ 191 (307)
T 3omv_A 112 WCEGSSLYKHLHVQETKFQMFQLIDIARQTAQGMDYLHAKNIIHRDMKSNNIFLHEGLTVKIGDFGLATVKSRWSGSQQV 191 (307)
T ss_dssp CCSSCBHHHHHHTSCCCCCHHHHHHHHHHHHHHHHHHHHTTCBCSCCCSSSEEEETTEEEEECCCSSCBC----------
T ss_pred cCCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHHCCccCCccCHHHEEECCCCcEEEeeccCceecccCCcceee
Confidence 9999999998854 4579999999999999999999999999999999999999999999999999997654321
Q ss_pred --cccccccccccccccC--------CCCCCCcccceeeecCCCCCCchHHHHHHHhhcccCCCCCCChhhhhhccCcCC
Q psy758 156 --PRHLHIFQTNEYFKGV--------SLPHAENVVPLEIKIGKPAATNIYLIDFLKRCLDKDPLRRWSCDQLLRHPYFNG 225 (292)
Q Consensus 156 --~~~~~~~~~~~~~~~~--------~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~ 225 (292)
..++..|.+||...+. .+.|++|+..+++.+|..++........+.... .......
T Consensus 192 ~~~~GT~~ymAPE~l~~~~~~~y~~ksDVwS~Gvvl~Elltg~~Pf~~~~~~~~~~~~~--------------~~~~~~p 257 (307)
T 3omv_A 192 EQPTGSVLWMAPEVIRMQDNNPFSFQSDVYSYGIVLYELMTGELPYSHINNRDQIIFMV--------------GRGYASP 257 (307)
T ss_dssp --CCCCTTSCCHHHHHCCSSCCCCHHHHHHHHHHHHHHHHHSSCTTTTCCCHHHHHHHH--------------HTTCCCC
T ss_pred cccccCCCccCHHHhhccCCCCCCcHHHhHhHHHHHHHHHHCCCCCCCCChHHHHHHHH--------------hcCCCCC
Confidence 2234556666665432 123555555555555555543211111111111 0000000
Q ss_pred --CCCCCCCccchHHHHhcccCcCCCCCCChhhhhhCC
Q psy758 226 --YYFEVPDEMQYEEITQRCLDKDPLRRWSCDQLLRHP 261 (292)
Q Consensus 226 --~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~~il~h~ 261 (292)
...+...+..+.+||.+||+.||++|||+.||+++.
T Consensus 258 ~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ei~~~L 295 (307)
T 3omv_A 258 DLSKLYKNCPKAMKRLVADCVKKVKEERPLFPQILSSI 295 (307)
T ss_dssp CSTTSCTTSCHHHHHHHHHHTCSSSTTSCCHHHHHHHH
T ss_pred CcccccccchHHHHHHHHHHcCCCHhHCcCHHHHHHHH
Confidence 112334577899999999999999999999987653
|
| >4gt4_A Tyrosine-protein kinase transmembrane receptor RO; ATP binding, phosphorylation, transferase; 2.41A {Homo sapiens} PDB: 3zzw_A | Back alignment and structure |
|---|
Probab=100.00 E-value=9.1e-49 Score=318.36 Aligned_cols=245 Identities=20% Similarity=0.250 Sum_probs=183.6
Q ss_pred cccceeeeecccCceEEEEEEEc-----CCCcEEEEEEeccCCCChHHHHHHHHHHHHHHhCCCCCcchhhhhhhcCCeE
Q psy758 2 ERYEKIGKLGEGSYGVVFKCRNR-----DTGQVVAIKKFLESEEDPLIRKIALREIRLLKSLKHPNLVNLLEVFRRKKKL 76 (292)
Q Consensus 2 ~~y~~~~~l~~g~~~~v~~~~~~-----~~~~~v~iK~~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~ 76 (292)
+++++.+.||+|+||.||+|... .+++.||||++..... ....+.|.+|+.+++.++||||++++|++.+++.+
T Consensus 26 ~~~~~~~~lG~G~fG~Vykg~~~~~~~~~~~~~VAvK~l~~~~~-~~~~~~f~~E~~il~~l~HpNIV~l~g~~~~~~~~ 104 (308)
T 4gt4_A 26 SAVRFMEELGEDRFGKVYKGHLFGPAPGEQTQAVAIKTLKDKAE-GPLREEFRHEAMLRARLQHPNVVCLLGVVTKDQPL 104 (308)
T ss_dssp GGEEEEEEEEECSSCEEEEEEEC-------CEEEEEEECCC-CC-C-CHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSC
T ss_pred HHCeEeeEeccCCCcEEEEEEEcCCccCCCCeEEEEEEECcccC-hHHHHHHHHHHHHHHhCCCCCCCCcceEEEECCEE
Confidence 56788999999999999999853 4578899999965432 33456789999999999999999999999999999
Q ss_pred EEEEecCCCccHHHHhcCC----------------CCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEEccCCcE
Q psy758 77 HLVFEFCDHTVLNELENHP----------------HGLPWDLIKQITWQVLRGVSYCHRHACIHRDIKPENILLTANGVV 140 (292)
Q Consensus 77 ~iv~e~~~~~~L~~~~~~~----------------~~~~~~~~~~i~~qi~~aL~~LH~~givH~dl~p~Nilv~~~~~~ 140 (292)
++|||||++|+|.+++... ..+++..+..++.||+.||+|||+++|+||||||+|||+++++.+
T Consensus 105 ~lV~Ey~~~G~L~~~L~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~~iiHRDLK~~NILl~~~~~~ 184 (308)
T 4gt4_A 105 SMIFSYCSHGDLHEFLVMRSPHSDVGSTDDDRTVKSALEPPDFVHLVAQIAAGMEYLSSHHVVHKDLATRNVLVYDKLNV 184 (308)
T ss_dssp EEEEECCSSCBHHHHHHTTCSSCCCC-----CCEECCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECGGGCE
T ss_pred EEEEEcCCCCcHHHHHHhhCccccccccccccccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCCCccccceEECCCCCE
Confidence 9999999999999998542 358999999999999999999999999999999999999999999
Q ss_pred EEeecCchhhhhcccc-------ccccccccccccccCCCCCCCcccceeeecCCCCCCchHHHHHHHhhc-ccCCCCCC
Q psy758 141 KLCDFGFARLIRDLIP-------RHLHIFQTNEYFKGVSLPHAENVVPLEIKIGKPAATNIYLIDFLKRCL-DKDPLRRW 212 (292)
Q Consensus 141 kl~dfg~~~~~~~~~~-------~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~p~~~~ 212 (292)
||+|||+++....... ..+..|.+||...+..+....|+|+++ .-+++.+. +..|+...
T Consensus 185 Ki~DFGlar~~~~~~~~~~~~~~~gt~~ymAPE~l~~~~~s~ksDVwSfG-------------vvl~El~t~g~~Pf~~~ 251 (308)
T 4gt4_A 185 KISDLGLFREVYAADYYKLLGNSLLPIRWMAPEAIMYGKFSIDSDIWSYG-------------VVLWEVFSYGLQPYCGY 251 (308)
T ss_dssp EECCSCCBCGGGGGGCBCSSSSSCBCGGGCCHHHHHHCCCCHHHHHHHHH-------------HHHHHHHTTTCCTTTTC
T ss_pred EECCcccceeccCCCceeEecccccCCcccCHHHHhCCCCCccchhhhHH-------------HHHHHHHhCCCCCCCCC
Confidence 9999999986643221 223346666665554443333333332 22222222 34454444
Q ss_pred ChhhhhhccCcCC-CCCCCCCccchHHHHhcccCcCCCCCCChhhhhhC
Q psy758 213 SCDQLLRHPYFNG-YYFEVPDEMQYEEITQRCLDKDPLRRWSCDQLLRH 260 (292)
Q Consensus 213 ~~~~~~~~~~~~~-~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~~il~h 260 (292)
+..+++....-.. ...+...+..+.+|+.+||+.||++|||+.||+++
T Consensus 252 ~~~~~~~~i~~~~~~~~p~~~~~~~~~li~~C~~~dP~~RPs~~ei~~~ 300 (308)
T 4gt4_A 252 SNQDVVEMIRNRQVLPCPDDCPAWVYALMIECWNEFPSRRPRFKDIHSR 300 (308)
T ss_dssp CHHHHHHHHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred CHHHHHHHHHcCCCCCCcccchHHHHHHHHHHcCCChhHCcCHHHHHHH
Confidence 4444433211111 12344557889999999999999999999999885
|
| >1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=8e-48 Score=318.59 Aligned_cols=256 Identities=19% Similarity=0.272 Sum_probs=201.6
Q ss_pred CcccceeeeecccCceEEEEEEEcCCCcEEEEEEeccCCC-ChHHHHHHHHHHHHHHhCCCCCcchhhhhhhcCCeEEEE
Q psy758 1 MERYEKIGKLGEGSYGVVFKCRNRDTGQVVAIKKFLESEE-DPLIRKIALREIRLLKSLKHPNLVNLLEVFRRKKKLHLV 79 (292)
Q Consensus 1 ~~~y~~~~~l~~g~~~~v~~~~~~~~~~~v~iK~~~~~~~-~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~iv 79 (292)
+++|++.+.||+|+||.||+|++..+|+.||+|++..... .......+.+|..+++.++||||+++++++.+.+.+|+|
T Consensus 4 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~~~~~~~lv 83 (337)
T 1o6l_A 4 MNDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLCFV 83 (337)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCCTTBCCEEEEEECSSEEEEE
T ss_pred hHHeEEEEEEecCCCeEEEEEEECCCCCEEEEEEEeHHHhhhhhHHHHHHHHHHHHHhCCCCcCcceEEEEEeCCEEEEE
Confidence 4789999999999999999999999999999999965421 112245678899999999999999999999999999999
Q ss_pred EecCCCccHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEEccCCcEEEeecCchhhhhcccc---
Q psy758 80 FEFCDHTVLNELENHPHGLPWDLIKQITWQVLRGVSYCHRHACIHRDIKPENILLTANGVVKLCDFGFARLIRDLIP--- 156 (292)
Q Consensus 80 ~e~~~~~~L~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~givH~dl~p~Nilv~~~~~~kl~dfg~~~~~~~~~~--- 156 (292)
|||++||+|..++...+.+++..++.++.||+.||.|||++||+||||||+||+++.+|.+||+|||+++.......
T Consensus 84 ~E~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~g~vkL~DFG~a~~~~~~~~~~~ 163 (337)
T 1o6l_A 84 MEYANGGELFFHLSRERVFTEERARFYGAEIVSALEYLHSRDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGATMK 163 (337)
T ss_dssp EECCTTCBHHHHHHHHSCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTSCEEECCCTTCBCSCCTTCCBC
T ss_pred EeCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeecCcCCHHHEEECCCCCEEEeeccchhhcccCCCccc
Confidence 99999999999998777899999999999999999999999999999999999999999999999999875432221
Q ss_pred --ccccccccccccccCCCCCCCcccceeeecCCCCCCchHHHHHHHhhcccCCCCCCChhhhhhccCcCCCCCCCCCcc
Q psy758 157 --RHLHIFQTNEYFKGVSLPHAENVVPLEIKIGKPAATNIYLIDFLKRCLDKDPLRRWSCDQLLRHPYFNGYYFEVPDEM 234 (292)
Q Consensus 157 --~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 234 (292)
.++..|.+||...+.......++ ++.+.-++..+.+..|+...+..++..........++...+.
T Consensus 164 ~~~gt~~y~aPE~~~~~~~~~~~Di-------------wslG~il~ell~g~~Pf~~~~~~~~~~~i~~~~~~~p~~~s~ 230 (337)
T 1o6l_A 164 TFCGTPEYLAPEVLEDNDYGRAVDW-------------WGLGVVMYEMMCGRLPFYNQDHERLFELILMEEIRFPRTLSP 230 (337)
T ss_dssp CCEECGGGCCGGGGSSSCBCTTHHH-------------HHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCCTTSCH
T ss_pred ccccChhhCChhhhcCCCCCchhhc-------------ccchhHHHHHhcCCCCCCCCCHHHHHHHHHcCCCCCCCCCCH
Confidence 22334555555544333222222 223333444444555555444444443333333445566788
Q ss_pred chHHHHhcccCcCCCCCC-----ChhhhhhCCcccceecc
Q psy758 235 QYEEITQRCLDKDPLRRW-----SCDQLLRHPYFNGYYFE 269 (292)
Q Consensus 235 ~l~~li~~~l~~dP~~Rp-----t~~~il~h~w~~~~~~~ 269 (292)
.+.+||.+||+.||.+|| +++++++||||.++.|+
T Consensus 231 ~~~~li~~lL~~dP~~R~g~~~~~~~ei~~h~~f~~~~~~ 270 (337)
T 1o6l_A 231 EAKSLLAGLLKKDPKQRLGGGPSDAKEVMEHRFFLSINWQ 270 (337)
T ss_dssp HHHHHHHHHTCSSTTTSTTCSTTTHHHHHTSGGGTTCCHH
T ss_pred HHHHHHHHHhhcCHHHhcCCCCCCHHHHHcCCCcCCCCHH
Confidence 999999999999999999 99999999999998776
|
| >3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} SCOP: d.144.1.7 PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-47 Score=310.64 Aligned_cols=267 Identities=31% Similarity=0.506 Sum_probs=204.0
Q ss_pred CcccceeeeecccCceEEEEEEEcCCCcEEEEEEeccCCCChHHHHHHHHHHHHHHhCCCCCcchhhhhhhcCCeEEEEE
Q psy758 1 MERYEKIGKLGEGSYGVVFKCRNRDTGQVVAIKKFLESEEDPLIRKIALREIRLLKSLKHPNLVNLLEVFRRKKKLHLVF 80 (292)
Q Consensus 1 ~~~y~~~~~l~~g~~~~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~iv~ 80 (292)
|++|++++.||+|+||.||+|.+..+++.||+|++............+.+|+.+++.++||||+++++++.+++..++||
T Consensus 1 l~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ 80 (292)
T 3o0g_A 1 MQKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLHSDKKLTLVF 80 (292)
T ss_dssp CCSEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEESSCSSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEE
T ss_pred CCCceeeeEecCCCCeEEEEEEECCCCceEEEEeeeccCCcCCcchHHHHHHHHHhcCCCCCEeeEEeEEEeCCEEEEEE
Confidence 68999999999999999999999999999999999877666666778889999999999999999999999999999999
Q ss_pred ecCCCccHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEEccCCcEEEeecCchhhhhccc-----
Q psy758 81 EFCDHTVLNELENHPHGLPWDLIKQITWQVLRGVSYCHRHACIHRDIKPENILLTANGVVKLCDFGFARLIRDLI----- 155 (292)
Q Consensus 81 e~~~~~~L~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~givH~dl~p~Nilv~~~~~~kl~dfg~~~~~~~~~----- 155 (292)
||++++.+..+....+.+++..++.++.||+.||+|||++||+||||||+||+++.++.++|+|||++.......
T Consensus 81 e~~~~~l~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lH~~~ivH~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~ 160 (292)
T 3o0g_A 81 EFCDQDLKKYFDSCNGDLDPEIVKSFLFQLLKGLGFCHSRNVLHRDLKPQNLLINRNGELKLANFGLARAFGIPVRCYSA 160 (292)
T ss_dssp ECCSEEHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTCEECCSCCSCCCS
T ss_pred ecCCCCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCCEEEeecccceecCCccccccC
Confidence 999998888888777789999999999999999999999999999999999999999999999999997654321
Q ss_pred cccccccccccccccCC-C-----CCCCcccceeeecCCCC-CCchHHHHH----HHhhcccCCCCCCChhhhhhccCcC
Q psy758 156 PRHLHIFQTNEYFKGVS-L-----PHAENVVPLEIKIGKPA-ATNIYLIDF----LKRCLDKDPLRRWSCDQLLRHPYFN 224 (292)
Q Consensus 156 ~~~~~~~~~~~~~~~~~-~-----~~~~~~~~~~~~~~~~~-~~~~~~~~~----~~~~~~~~p~~~~~~~~~~~~~~~~ 224 (292)
...+..|.+||...+.. . .|+.|+..+++.++..+ +......+. ...+-...+.............-+.
T Consensus 161 ~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~~~~p~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~ 240 (292)
T 3o0g_A 161 EVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEEQWPSMTKLPDYKPYP 240 (292)
T ss_dssp CCSCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHTTTSCCSCCCSSHHHHHHHHHHHHCCCCTTTCTTGGGSTTCCCCC
T ss_pred CccccCCcChHHHcCCCCcCchHHHHHHHHHHHHHHHcCCCCcCCCCHHHHHHHHHHHhCCCChhhhhhhcccccccccc
Confidence 22345577887765543 2 35566666666655433 222222222 2222222222222222211110000
Q ss_pred -------CCCCCCCCccchHHHHhcccCcCCCCCCChhhhhhCCccccee
Q psy758 225 -------GYYFEVPDEMQYEEITQRCLDKDPLRRWSCDQLLRHPYFNGYY 267 (292)
Q Consensus 225 -------~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~~il~h~w~~~~~ 267 (292)
........+..+++||.+||+.||++|||++|+++||||++..
T Consensus 241 ~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~hp~f~~~~ 290 (292)
T 3o0g_A 241 MYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEALQHPYFSDFC 290 (292)
T ss_dssp CCCTTCCCTTTSTTCCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGTTC-
T ss_pred cccCCcchhhcccccChHHHHHHHHHhccChhhCCCHHHHhcCcccccCC
Confidence 0111223577889999999999999999999999999999854
|
| >3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.8e-48 Score=321.41 Aligned_cols=251 Identities=23% Similarity=0.309 Sum_probs=197.0
Q ss_pred CcccceeeeecccCceEEEEEEEcCCCcEEEEEEeccCC-CChHHHHHHHHHHHHHHhC-CCCCcchhhhhhhcCCeEEE
Q psy758 1 MERYEKIGKLGEGSYGVVFKCRNRDTGQVVAIKKFLESE-EDPLIRKIALREIRLLKSL-KHPNLVNLLEVFRRKKKLHL 78 (292)
Q Consensus 1 ~~~y~~~~~l~~g~~~~v~~~~~~~~~~~v~iK~~~~~~-~~~~~~~~~~~e~~~~~~l-~~~~i~~~~~~~~~~~~~~i 78 (292)
+++|++.+.||+|+||.||+|++..+++.||+|++.... ........+.+|..+++.+ +||||+++++++.+.+.+|+
T Consensus 22 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AvK~~~~~~~~~~~~~~~~~~E~~il~~~~~hp~Iv~l~~~~~~~~~~~l 101 (353)
T 3txo_A 22 IDNFEFIRVLGKGSFGKVMLARVKETGDLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQLFCCFQTPDRLFF 101 (353)
T ss_dssp -CCEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHHTTHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEE
T ss_pred hhheEEEEEEeeCCCEEEEEEEEcCCCCEEEEEEEEHHHhcchhHHHHHHHHHHHHHhccCCCceeeEEEEEEeCCEEEE
Confidence 478999999999999999999999999999999997542 1222345677899999988 69999999999999999999
Q ss_pred EEecCCCccHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEEccCCcEEEeecCchhhhhcccc--
Q psy758 79 VFEFCDHTVLNELENHPHGLPWDLIKQITWQVLRGVSYCHRHACIHRDIKPENILLTANGVVKLCDFGFARLIRDLIP-- 156 (292)
Q Consensus 79 v~e~~~~~~L~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~givH~dl~p~Nilv~~~~~~kl~dfg~~~~~~~~~~-- 156 (292)
||||++|++|..++...+.+++..++.++.||+.||+|||++||+||||||+||+++.++++||+|||+++.......
T Consensus 102 v~E~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NILl~~~g~ikL~DFG~a~~~~~~~~~~ 181 (353)
T 3txo_A 102 VMEFVNGGDLMFHIQKSRRFDEARARFYAAEIISALMFLHDKGIIYRDLKLDNVLLDHEGHCKLADFGMCKEGICNGVTT 181 (353)
T ss_dssp EEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTSCEEECCCTTCBCSCC-----
T ss_pred EEeCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCHHHEEECCCCCEEEccccceeecccCCccc
Confidence 999999999999998777899999999999999999999999999999999999999999999999999875432222
Q ss_pred ---ccccccccccccccCCC-----CCCCcccceeeecCCCCCCchHHHHHHHhhcccCCCCCCChhhhhhccCcCCCCC
Q psy758 157 ---RHLHIFQTNEYFKGVSL-----PHAENVVPLEIKIGKPAATNIYLIDFLKRCLDKDPLRRWSCDQLLRHPYFNGYYF 228 (292)
Q Consensus 157 ---~~~~~~~~~~~~~~~~~-----~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~ 228 (292)
.++..|.+||...+... .|+.|+..+++++| ..|+...+..++.....-.....
T Consensus 182 ~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G------------------~~Pf~~~~~~~~~~~i~~~~~~~ 243 (353)
T 3txo_A 182 ATFCGTPDYIAPEILQEMLYGPAVDWWAMGVLLYEMLCG------------------HAPFEAENEDDLFEAILNDEVVY 243 (353)
T ss_dssp ----CCGGGCCHHHHHHHHCTTHHHHHHHHHHHHHHHHS------------------SCSSCCSSHHHHHHHHHHCCCCC
T ss_pred cccCCCcCeEChhhcCCCCcCCccCCCcchHHHHHHHhC------------------CCCCCCCCHHHHHHHHHcCCCCC
Confidence 22344555555443322 23334444444444 44444444444333332233344
Q ss_pred CCCCccchHHHHhcccCcCCCCCCCh------hhhhhCCcccceecc
Q psy758 229 EVPDEMQYEEITQRCLDKDPLRRWSC------DQLLRHPYFNGYYFE 269 (292)
Q Consensus 229 ~~~~~~~l~~li~~~l~~dP~~Rpt~------~~il~h~w~~~~~~~ 269 (292)
+...+..+.+||.+||+.||.+||++ +++++||||+++.|+
T Consensus 244 p~~~~~~~~~li~~lL~~dP~~R~~~~~~~~~~~il~hp~f~~~~w~ 290 (353)
T 3txo_A 244 PTWLHEDATGILKSFMTKNPTMRLGSLTQGGEHAILRHPFFKEIDWA 290 (353)
T ss_dssp CTTSCHHHHHHHHHHTCSSGGGSTTSGGGTCTHHHHTSGGGTTCCHH
T ss_pred CCCCCHHHHHHHHHHhhhCHHHccCCcccCCHHHHhhCCcccCCCHH
Confidence 55568899999999999999999999 899999999998876
|
| >1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-47 Score=313.28 Aligned_cols=256 Identities=21% Similarity=0.318 Sum_probs=200.7
Q ss_pred CcccceeeeecccCceEEEEEEEcCCCcEEEEEEeccCCC-ChHHHHHHHHHHHHHHhCCCCCcchhhhhhhcCCeEEEE
Q psy758 1 MERYEKIGKLGEGSYGVVFKCRNRDTGQVVAIKKFLESEE-DPLIRKIALREIRLLKSLKHPNLVNLLEVFRRKKKLHLV 79 (292)
Q Consensus 1 ~~~y~~~~~l~~g~~~~v~~~~~~~~~~~v~iK~~~~~~~-~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~iv 79 (292)
+++|++.+.||+|+||.||+|++..+|+.||+|++..... .....+.+.+|..+++.++||||+++++++.+.+.+|+|
T Consensus 5 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~~~~lv 84 (318)
T 1fot_A 5 LQDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPFIIRMWGTFQDAQQIFMI 84 (318)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCBTTBCCEEEEEECSSEEEEE
T ss_pred hHHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHhhCCCCCCceEeEEEEeCCEEEEE
Confidence 4789999999999999999999999999999999865421 112245677899999999999999999999999999999
Q ss_pred EecCCCccHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEEccCCcEEEeecCchhhhhccc--cc
Q psy758 80 FEFCDHTVLNELENHPHGLPWDLIKQITWQVLRGVSYCHRHACIHRDIKPENILLTANGVVKLCDFGFARLIRDLI--PR 157 (292)
Q Consensus 80 ~e~~~~~~L~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~givH~dl~p~Nilv~~~~~~kl~dfg~~~~~~~~~--~~ 157 (292)
|||++|++|.+++.....+++..++.++.||+.||.|||++||+||||||+||+++.+|.+||+|||++....... ..
T Consensus 85 ~e~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~g~~kL~Dfg~a~~~~~~~~~~~ 164 (318)
T 1fot_A 85 MDYIEGGELFSLLRKSQRFPNPVAKFYAAEVCLALEYLHSKDIIYRDLKPENILLDKNGHIKITDFGFAKYVPDVTYTLC 164 (318)
T ss_dssp ECCCCSCBHHHHHHHTSSCCHHHHHHHHHHHHHHHHHHHTTTEECCCCCGGGEEECTTSCEEECCCSSCEECSSCBCCCC
T ss_pred EeCCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCChheEEEcCCCCEEEeecCcceecCCcccccc
Confidence 9999999999999887789999999999999999999999999999999999999999999999999997654321 22
Q ss_pred cccccccccccccCCCCCCCcccceeeecCCCCCCchHHHHHHHhhcccCCCCCCChhhhhhccCcCCCCCCCCCccchH
Q psy758 158 HLHIFQTNEYFKGVSLPHAENVVPLEIKIGKPAATNIYLIDFLKRCLDKDPLRRWSCDQLLRHPYFNGYYFEVPDEMQYE 237 (292)
Q Consensus 158 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~l~ 237 (292)
++..|.+||...+.......++| +.+.-++..+.+..|+...+..+......-....++...+..+.
T Consensus 165 gt~~y~aPE~~~~~~~~~~~Diw-------------slG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~p~~~~~~~~ 231 (318)
T 1fot_A 165 GTPDYIAPEVVSTKPYNKSIDWW-------------SFGILIYEMLAGYTPFYDSNTMKTYEKILNAELRFPPFFNEDVK 231 (318)
T ss_dssp SCTTTCCHHHHTTCCBCTTHHHH-------------HHHHHHHHHHHSSCTTCCSSHHHHHHHHHHCCCCCCTTSCHHHH
T ss_pred CCccccCHhHhcCCCCCcccchh-------------hhHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCCCCCCHHHH
Confidence 33446666655444332222222 22233344444455554444433333222223344555688999
Q ss_pred HHHhcccCcCCCCCC-----ChhhhhhCCcccceecc
Q psy758 238 EITQRCLDKDPLRRW-----SCDQLLRHPYFNGYYFE 269 (292)
Q Consensus 238 ~li~~~l~~dP~~Rp-----t~~~il~h~w~~~~~~~ 269 (292)
+||.+||+.||++|| +++++++||||+++.|+
T Consensus 232 ~li~~lL~~dp~~R~~~~~~~~~~i~~hp~f~~~~~~ 268 (318)
T 1fot_A 232 DLLSRLITRDLSQRLGNLQNGTEDVKNHPWFKEVVWE 268 (318)
T ss_dssp HHHHHHTCSCTTTCTTSSTTTTHHHHTSGGGSSCCHH
T ss_pred HHHHHHhccCHHHcCCCcCCCHHHHhcCccccCCCHH
Confidence 999999999999999 99999999999998876
|
| >3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} SCOP: d.144.1.7 PDB: 2qkr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-46 Score=309.14 Aligned_cols=268 Identities=32% Similarity=0.518 Sum_probs=197.0
Q ss_pred CcccceeeeecccCceEEEEEEEcCCCcEEEEEEeccCCCChHHHHHHHHHHHHHHhCCCCCcchhhhhhhcCCeEEEEE
Q psy758 1 MERYEKIGKLGEGSYGVVFKCRNRDTGQVVAIKKFLESEEDPLIRKIALREIRLLKSLKHPNLVNLLEVFRRKKKLHLVF 80 (292)
Q Consensus 1 ~~~y~~~~~l~~g~~~~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~iv~ 80 (292)
+++|++++.||+|+||.||+|.+. +++.||+|++............+.+|+.+++.++||||+++++++.+++..++||
T Consensus 20 ~~~y~~~~~lG~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~ 98 (311)
T 3niz_A 20 MEKYQKLEKVGEGTYGVVYKAKDS-QGRIVALKRIRLDAEDEGIPSTAIREISLLKELHHPNIVSLIDVIHSERCLTLVF 98 (311)
T ss_dssp SCEEEEEEEEEECSSCEEEEEEET-TSCEEEEEEEC------CHHHHHHHHHHHHHHCCCTTBCCEEEEECCSSCEEEEE
T ss_pred HhhhHhhhhccCCCCeEEEEEEEC-CCCEEEEEEEecccccchhhHHHHHHHHHHHHcCCCCEeeeeeEEccCCEEEEEE
Confidence 479999999999999999999985 4899999999766555555677889999999999999999999999999999999
Q ss_pred ecCCCccHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEEccCCcEEEeecCchhhhhccc-----
Q psy758 81 EFCDHTVLNELENHPHGLPWDLIKQITWQVLRGVSYCHRHACIHRDIKPENILLTANGVVKLCDFGFARLIRDLI----- 155 (292)
Q Consensus 81 e~~~~~~L~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~givH~dl~p~Nilv~~~~~~kl~dfg~~~~~~~~~----- 155 (292)
||++++.+..+......+++..++.++.||+.||.|||++||+||||||+||+++.++.+||+|||++.......
T Consensus 99 e~~~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivH~Dikp~NIl~~~~~~~kl~Dfg~a~~~~~~~~~~~~ 178 (311)
T 3niz_A 99 EFMEKDLKKVLDENKTGLQDSQIKIYLYQLLRGVAHCHQHRILHRDLKPQNLLINSDGALKLADFGLARAFGIPVRSYTH 178 (311)
T ss_dssp ECCSEEHHHHHHTCTTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCEEECCCTTCEETTSCCC---C
T ss_pred cCCCCCHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCchHhEEECCCCCEEEccCcCceecCCCcccccC
Confidence 999986555555555679999999999999999999999999999999999999999999999999997654322
Q ss_pred cccccccccccccccCC------CCCCCcccceeeecCCCCCCch----HHHHHHHhhcccCCCCCCChhhhhh--ccCc
Q psy758 156 PRHLHIFQTNEYFKGVS------LPHAENVVPLEIKIGKPAATNI----YLIDFLKRCLDKDPLRRWSCDQLLR--HPYF 223 (292)
Q Consensus 156 ~~~~~~~~~~~~~~~~~------~~~~~~~~~~~~~~~~~~~~~~----~~~~~~~~~~~~~p~~~~~~~~~~~--~~~~ 223 (292)
...+..|.+||...+.. ..|+.|+..+++.+|..++... ....+...+-...+.......+... ...+
T Consensus 179 ~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~ 258 (311)
T 3niz_A 179 EVVTLWYRAPDVLMGSKKYSTSVDIWSIGCIFAEMITGKPLFPGVTDDDQLPKIFSILGTPNPREWPQVQELPLWKQRTF 258 (311)
T ss_dssp CCCCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSTTTHHHHHHHHHCCCCTTTSGGGTTSHHHHSCCC
T ss_pred CcccCCcCCHHHhcCCCCCCchHHhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHHCCCChHHhhhhhccchhhhccc
Confidence 22345577777765422 2356666666677776654322 2222333332233322222111110 0000
Q ss_pred CCC------CCCCCCccchHHHHhcccCcCCCCCCChhhhhhCCcccceecc
Q psy758 224 NGY------YFEVPDEMQYEEITQRCLDKDPLRRWSCDQLLRHPYFNGYYFE 269 (292)
Q Consensus 224 ~~~------~~~~~~~~~l~~li~~~l~~dP~~Rpt~~~il~h~w~~~~~~~ 269 (292)
... ......+.++.+||.+||++||++|||++|+++||||+++.++
T Consensus 259 ~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~f~~~~~~ 310 (311)
T 3niz_A 259 QVFEKKPWSSIIPGFCQEGIDLLSNMLCFDPNKRISARDAMNHPYFKDLDPQ 310 (311)
T ss_dssp CCCCCCCHHHHSTTCCHHHHHHHHHHSCSCTTTSCCHHHHHTSGGGTTSCTT
T ss_pred ccccCCcHHHhCcccCHHHHHHHHHHcCCChhHCCCHHHHhcCcccccCCcc
Confidence 000 0112246688999999999999999999999999999987654
|
| >2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-46 Score=313.61 Aligned_cols=253 Identities=24% Similarity=0.331 Sum_probs=194.6
Q ss_pred cccceeeeecccCceEEEEEEEcCCCcEEEEEEeccCCCCh----HHHHHHHHHHHHHHhCCCCCcchhhhhhhcCCeEE
Q psy758 2 ERYEKIGKLGEGSYGVVFKCRNRDTGQVVAIKKFLESEEDP----LIRKIALREIRLLKSLKHPNLVNLLEVFRRKKKLH 77 (292)
Q Consensus 2 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~v~iK~~~~~~~~~----~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~ 77 (292)
++|++.+.||+|+||.||+|.+..+|+.||+|++....... ...+.+.+|+.+++.++||||+++++++.+.+.++
T Consensus 12 ~~y~~~~~LG~G~fg~V~~~~~~~~~~~~avK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~ 91 (361)
T 2yab_A 12 DFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVCREEIEREVSILRQVLHPNIITLHDVYENRTDVV 91 (361)
T ss_dssp GTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEE
T ss_pred hceEEeeEEeeCcCEEEEEEEECCCCCEEEEEEEEccccccccchhHHHHHHHHHHHHHhCCCcCCCcEEEEEEeCCEEE
Confidence 57999999999999999999999999999999997654321 12456889999999999999999999999999999
Q ss_pred EEEecCCCccHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEEccCC----cEEEeecCchhhhhc
Q psy758 78 LVFEFCDHTVLNELENHPHGLPWDLIKQITWQVLRGVSYCHRHACIHRDIKPENILLTANG----VVKLCDFGFARLIRD 153 (292)
Q Consensus 78 iv~e~~~~~~L~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~givH~dl~p~Nilv~~~~----~~kl~dfg~~~~~~~ 153 (292)
+||||++|++|.+++...+.+++..++.++.||+.||.|||++||+|+||||+||++++++ .++|+|||++.....
T Consensus 92 lv~e~~~gg~L~~~l~~~~~l~~~~~~~i~~qi~~aL~~LH~~givHrDlkp~NIll~~~~~~~~~vkl~DFG~a~~~~~ 171 (361)
T 2yab_A 92 LILELVSGGELFDFLAQKESLSEEEATSFIKQILDGVNYLHTKKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIED 171 (361)
T ss_dssp EEEECCCSCBHHHHHTTCSCCBHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESCTTSSSCCEEECCCSSCEECCT
T ss_pred EEEEcCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEEeCCCCCccCEEEEecCCceEcCC
Confidence 9999999999999998888899999999999999999999999999999999999998877 799999999976543
Q ss_pred cc----cccccccccccccccCCCC-----CCCcccceeeecCCCCCCchHHHHHHHhhcccCCCCCCChhhhhhccCcC
Q psy758 154 LI----PRHLHIFQTNEYFKGVSLP-----HAENVVPLEIKIGKPAATNIYLIDFLKRCLDKDPLRRWSCDQLLRHPYFN 224 (292)
Q Consensus 154 ~~----~~~~~~~~~~~~~~~~~~~-----~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~ 224 (292)
.. ..++..|.+||...+.... |+.|+..+++.+|..++.......++..+.......
T Consensus 172 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~~ll~g~~Pf~~~~~~~~~~~i~~~~~~~-------------- 237 (361)
T 2yab_A 172 GVEFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANITAVSYDF-------------- 237 (361)
T ss_dssp TCCCCCCCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSCCSSCCSSHHHHHHHHHTTCCCC--------------
T ss_pred CCccccCCCCccEECchHHcCCCCCccccHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCCC--------------
Confidence 21 1233446666655543332 333334444444444443322222222222111000
Q ss_pred CCCCCCCCccchHHHHhcccCcCCCCCCChhhhhhCCcccceec
Q psy758 225 GYYFEVPDEMQYEEITQRCLDKDPLRRWSCDQLLRHPYFNGYYF 268 (292)
Q Consensus 225 ~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~~il~h~w~~~~~~ 268 (292)
........+..+++||.+||..||.+|||+.|+++||||++..+
T Consensus 238 ~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~e~l~hp~~~~~~~ 281 (361)
T 2yab_A 238 DEEFFSQTSELAKDFIRKLLVKETRKRLTIQEALRHPWITPVDT 281 (361)
T ss_dssp CHHHHTTSCHHHHHHHHHHSCSSTTTSCCHHHHHTSTTTSCSSH
T ss_pred CchhccCCCHHHHHHHHHHCCCChhHCcCHHHHhcCcCcCCCch
Confidence 00011245778999999999999999999999999999997654
|
| >1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-47 Score=316.75 Aligned_cols=256 Identities=20% Similarity=0.297 Sum_probs=197.4
Q ss_pred CcccceeeeecccCceEEEEEEEcCCCcEEEEEEeccCCC-ChHHHHHHHHHHHHHHhC-CCCCcchhhhhhhcCCeEEE
Q psy758 1 MERYEKIGKLGEGSYGVVFKCRNRDTGQVVAIKKFLESEE-DPLIRKIALREIRLLKSL-KHPNLVNLLEVFRRKKKLHL 78 (292)
Q Consensus 1 ~~~y~~~~~l~~g~~~~v~~~~~~~~~~~v~iK~~~~~~~-~~~~~~~~~~e~~~~~~l-~~~~i~~~~~~~~~~~~~~i 78 (292)
+++|++.+.||+|+||.||+|++..+++.||+|++..... .......+..|..+++.+ +||||+++++++.+.+.+|+
T Consensus 16 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~il~~~~~hp~iv~l~~~~~~~~~~~l 95 (345)
T 1xjd_A 16 IEDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHMFCTFQTKENLFF 95 (345)
T ss_dssp CTTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHTTCTTBCCEEEEEECSSEEEE
T ss_pred hHHeEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhHHhhhhhhHHHHHHHHHHHHhcCCCCCCCcEEEEEEeCCEEEE
Confidence 4789999999999999999999999999999999975421 111234567788888876 89999999999999999999
Q ss_pred EEecCCCccHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEEccCCcEEEeecCchhhhhccc---
Q psy758 79 VFEFCDHTVLNELENHPHGLPWDLIKQITWQVLRGVSYCHRHACIHRDIKPENILLTANGVVKLCDFGFARLIRDLI--- 155 (292)
Q Consensus 79 v~e~~~~~~L~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~givH~dl~p~Nilv~~~~~~kl~dfg~~~~~~~~~--- 155 (292)
||||++||+|..++...+.+++..++.++.||+.||.|||++||+||||||+||+++.+|.++|+|||+++......
T Consensus 96 v~E~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~g~vkL~DFG~a~~~~~~~~~~ 175 (345)
T 1xjd_A 96 VMEYLNGGDLMYHIQSCHKFDLSRATFYAAEIILGLQFLHSKGIVYRDLKLDNILLDKDGHIKIADFGMCKENMLGDAKT 175 (345)
T ss_dssp EEECCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTSCEEECCCTTCBCCCCTTCCB
T ss_pred EEeCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEeCCCChhhEEECCCCCEEEeEChhhhhcccCCCcc
Confidence 99999999999999877789999999999999999999999999999999999999999999999999987543211
Q ss_pred --cccccccccccccccCCCCCCCcccceeeecCCCCCCchHHHHHHHhhcccCCCCCCChhhhhhccCcCCCCCCCCCc
Q psy758 156 --PRHLHIFQTNEYFKGVSLPHAENVVPLEIKIGKPAATNIYLIDFLKRCLDKDPLRRWSCDQLLRHPYFNGYYFEVPDE 233 (292)
Q Consensus 156 --~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 233 (292)
..++..|.+||...+.......++|+ .+.-++..+.+..|+...+..++...........+...+
T Consensus 176 ~~~~gt~~y~aPE~~~~~~~~~~~Diws-------------lG~il~ell~g~~Pf~~~~~~~~~~~i~~~~~~~p~~~s 242 (345)
T 1xjd_A 176 NTFCGTPDYIAPEILLGQKYNHSVDWWS-------------FGVLLYEMLIGQSPFHGQDEEELFHSIRMDNPFYPRWLE 242 (345)
T ss_dssp CCCCSCGGGCCHHHHTTCCBCTHHHHHH-------------HHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCCTTSC
T ss_pred cCCCCCcccCChhhhcCCCCCChhhhHH-------------HHHHHHHHhcCCCCCCCCCHHHHHHHHHhCCCCCCcccC
Confidence 12334466666655443322222222 222233334444444444444333322222233444567
Q ss_pred cchHHHHhcccCcCCCCCCChh-hhhhCCcccceecc
Q psy758 234 MQYEEITQRCLDKDPLRRWSCD-QLLRHPYFNGYYFE 269 (292)
Q Consensus 234 ~~l~~li~~~l~~dP~~Rpt~~-~il~h~w~~~~~~~ 269 (292)
..+.+||.+||+.||++||++. ++++||||+++.|+
T Consensus 243 ~~~~~li~~lL~~dp~~R~~~~~~i~~hp~f~~~~w~ 279 (345)
T 1xjd_A 243 KEAKDLLVKLFVREPEKRLGVRGDIRQHPLFREINWE 279 (345)
T ss_dssp HHHHHHHHHHSCSSGGGSBTTBSCGGGSGGGTTCCHH
T ss_pred HHHHHHHHHHhcCCHhHcCCChHHHHcCccccCCCHH
Confidence 8999999999999999999998 99999999998876
|
| >3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-46 Score=311.98 Aligned_cols=260 Identities=21% Similarity=0.324 Sum_probs=197.8
Q ss_pred CcccceeeeecccCceEEEEEEEcCCCcEEEEEEeccCC-CChHHHHHHHHHHHHHHhC-CCCCcchhhhhhhcCCeEEE
Q psy758 1 MERYEKIGKLGEGSYGVVFKCRNRDTGQVVAIKKFLESE-EDPLIRKIALREIRLLKSL-KHPNLVNLLEVFRRKKKLHL 78 (292)
Q Consensus 1 ~~~y~~~~~l~~g~~~~v~~~~~~~~~~~v~iK~~~~~~-~~~~~~~~~~~e~~~~~~l-~~~~i~~~~~~~~~~~~~~i 78 (292)
+++|++.+.||+|+||.||+|++..+++.||+|++.... ......+.+.+|..+++.+ +||||+++++++.+.+.+|+
T Consensus 8 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~l~~~~~~~~~~~l 87 (345)
T 3a8x_A 8 LQDFDLLRVIGRGSYAKVLLVRLKKTDRIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRLFF 87 (345)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEGGGSCSHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEE
T ss_pred hhheEEEEEEEecCCeEEEEEEECCCCCEEEEEEEEhHHhcchHHHHHHHHHHHHHHhcCCCCccCeEEEEEEeCCEEEE
Confidence 478999999999999999999999999999999997654 3445567788999999988 89999999999999999999
Q ss_pred EEecCCCccHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEEccCCcEEEeecCchhhhhccc---
Q psy758 79 VFEFCDHTVLNELENHPHGLPWDLIKQITWQVLRGVSYCHRHACIHRDIKPENILLTANGVVKLCDFGFARLIRDLI--- 155 (292)
Q Consensus 79 v~e~~~~~~L~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~givH~dl~p~Nilv~~~~~~kl~dfg~~~~~~~~~--- 155 (292)
||||++|++|..++...+.+++..++.++.||+.||.|||++||+||||||+||+++.++.+||+|||+++......
T Consensus 88 v~e~~~gg~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~g~~kL~DFG~a~~~~~~~~~~ 167 (345)
T 3a8x_A 88 VIEYVNGGDLMFHMQRQRKLPEEHARFYSAEISLALNYLHERGIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGDTT 167 (345)
T ss_dssp EECCCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTSCEEECCGGGCBCSCCTTCCB
T ss_pred EEeCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCHHHEEECCCCCEEEEeccccccccCCCCcc
Confidence 99999999999998877789999999999999999999999999999999999999999999999999987532211
Q ss_pred --cccccccccccccccCCCC-----CCCcccceeeecCCCCCCchHHHHHHHhhcccCCCCCCChhhhhhccCcCCCCC
Q psy758 156 --PRHLHIFQTNEYFKGVSLP-----HAENVVPLEIKIGKPAATNIYLIDFLKRCLDKDPLRRWSCDQLLRHPYFNGYYF 228 (292)
Q Consensus 156 --~~~~~~~~~~~~~~~~~~~-----~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~ 228 (292)
..++..|.+||...+.... |+.|+..+++.+|..++..... ...+ .......+.....-.....
T Consensus 168 ~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~--------~~~~-~~~~~~~~~~~i~~~~~~~ 238 (345)
T 3a8x_A 168 STFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGS--------SDNP-DQNTEDYLFQVILEKQIRI 238 (345)
T ss_dssp CCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTTTC----------------CHHHHHHHHHHCCCCC
T ss_pred cccCCCccccCccccCCCCCChHHhHHHHHHHHHHHHhCCCCcCCccc--------cccc-ccccHHHHHHHHHcCCCCC
Confidence 1234456666665554332 3333333344444433211000 0000 0011111111111122344
Q ss_pred CCCCccchHHHHhcccCcCCCCCCCh------hhhhhCCcccceecc
Q psy758 229 EVPDEMQYEEITQRCLDKDPLRRWSC------DQLLRHPYFNGYYFE 269 (292)
Q Consensus 229 ~~~~~~~l~~li~~~l~~dP~~Rpt~------~~il~h~w~~~~~~~ 269 (292)
+...+..+.+||.+||+.||.+||++ +++++||||+++.|+
T Consensus 239 p~~~s~~~~~li~~lL~~dP~~R~~~~~~~~~~~i~~hp~f~~~~w~ 285 (345)
T 3a8x_A 239 PRSLSVKAASVLKSFLNKDPKERLGCHPQTGFADIQGHPFFRNVDWD 285 (345)
T ss_dssp CTTSCHHHHHHHHHHTCSSTTTSTTCCTTTHHHHHHTSGGGTTCCHH
T ss_pred CCCCCHHHHHHHHHHhcCCHhHCCCCCCcCCHHHHhcCCccCCCCHH
Confidence 55668899999999999999999996 799999999998876
|
| >4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus} | Back alignment and structure |
|---|
Probab=100.00 E-value=6e-47 Score=318.78 Aligned_cols=260 Identities=21% Similarity=0.317 Sum_probs=195.2
Q ss_pred CcccceeeeecccCceEEEEEEEcCCCcEEEEEEeccCCC-ChHHHHHHHHHHHHHHhC-CCCCcchhhhhhhcCCeEEE
Q psy758 1 MERYEKIGKLGEGSYGVVFKCRNRDTGQVVAIKKFLESEE-DPLIRKIALREIRLLKSL-KHPNLVNLLEVFRRKKKLHL 78 (292)
Q Consensus 1 ~~~y~~~~~l~~g~~~~v~~~~~~~~~~~v~iK~~~~~~~-~~~~~~~~~~e~~~~~~l-~~~~i~~~~~~~~~~~~~~i 78 (292)
+++|++++.||+|+||.||+|++..+++.||+|++.+... .....+.+..|..++..+ +||||+++++++.+++.+|+
T Consensus 51 ~~~y~~~~~LG~G~fG~V~~~~~~~~~~~~AvK~~~k~~~~~~~~~~~~~~E~~il~~~~~hp~Iv~l~~~~~~~~~~~l 130 (396)
T 4dc2_A 51 LQDFDLLRVIGRGSYAKVLLVRLKKTDRIYAMRVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRLFF 130 (396)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEGGGTC----CCHHHHHHHHHHHHTTCTTBCCEEEEEECSSEEEE
T ss_pred hhHcEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhhhccCHHHHHHHHHHHHHHHhcCCCCCcCeeEEEEEECCEEEE
Confidence 4689999999999999999999999999999999976542 233345577899998877 89999999999999999999
Q ss_pred EEecCCCccHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEEccCCcEEEeecCchhhhhccc---
Q psy758 79 VFEFCDHTVLNELENHPHGLPWDLIKQITWQVLRGVSYCHRHACIHRDIKPENILLTANGVVKLCDFGFARLIRDLI--- 155 (292)
Q Consensus 79 v~e~~~~~~L~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~givH~dl~p~Nilv~~~~~~kl~dfg~~~~~~~~~--- 155 (292)
||||++||+|..++...+.+++..++.++.||+.||.|||++||+||||||+|||++.+|.+||+|||+++......
T Consensus 131 V~E~~~gg~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~LH~~givHrDLKp~NILl~~~g~ikL~DFGla~~~~~~~~~~ 210 (396)
T 4dc2_A 131 VIEYVNGGDLMFHMQRQRKLPEEHARFYSAEISLALNYLHERGIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGDTT 210 (396)
T ss_dssp EEECCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTSCEEECCCTTCBCCCCTTCCB
T ss_pred EEEcCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCEEeccCCHHHEEECCCCCEEEeecceeeecccCCCcc
Confidence 99999999999999877789999999999999999999999999999999999999999999999999997532221
Q ss_pred --cccccccccccccccCCCC-----CCCcccceeeecCCCCCCchHHHHHHHhhcccCCCCCCChhhhhhccCcCCCCC
Q psy758 156 --PRHLHIFQTNEYFKGVSLP-----HAENVVPLEIKIGKPAATNIYLIDFLKRCLDKDPLRRWSCDQLLRHPYFNGYYF 228 (292)
Q Consensus 156 --~~~~~~~~~~~~~~~~~~~-----~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~ 228 (292)
..++..|.+||...+.... |+.|+..+++++|..++...... .++ .......+.....-.....
T Consensus 211 ~~~~gt~~Y~aPE~l~~~~~~~~~DiwslGvllyell~G~~Pf~~~~~~--------~~~-~~~~~~~~~~~i~~~~~~~ 281 (396)
T 4dc2_A 211 STFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSS--------DNP-DQNTEDYLFQVILEKQIRI 281 (396)
T ss_dssp CCCCBCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSTTTTC---------------CCHHHHHHHHHHCCCCC
T ss_pred ccccCCcccCCchhhcCCCCChHHHHHHHHHHHHHHHhCCCCCcccccc--------ccc-chhhHHHHHHHHhccccCC
Confidence 1233446666665554433 33333334444444433110000 000 0001111222222223345
Q ss_pred CCCCccchHHHHhcccCcCCCCCCCh------hhhhhCCcccceecc
Q psy758 229 EVPDEMQYEEITQRCLDKDPLRRWSC------DQLLRHPYFNGYYFE 269 (292)
Q Consensus 229 ~~~~~~~l~~li~~~l~~dP~~Rpt~------~~il~h~w~~~~~~~ 269 (292)
+...+..+.+||++||+.||.+||++ +|+++||||+++.|+
T Consensus 282 p~~~s~~~~~li~~lL~~dP~~R~~~~~~~~~~ei~~Hpff~~i~w~ 328 (396)
T 4dc2_A 282 PRSLSVKAASVLKSFLNKDPKERLGCHPQTGFADIQGHPFFRNVDWD 328 (396)
T ss_dssp CTTSCHHHHHHHHHHTCSCTTTSTTCSTTTHHHHHHHSTTTTTCCHH
T ss_pred CCcCCHHHHHHHHHHhcCCHhHcCCCCCCCCHHHHhcCccccCCCHH
Confidence 55678899999999999999999996 799999999999886
|
| >4ase_A Vascular endothelial growth factor receptor 2; transferase, angiogenesis, signaling protein, phosphorylatio receptor, inhibitor; HET: AV9; 1.83A {Homo sapiens} PDB: 4agd_A* 4asd_A* 4agc_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.2e-47 Score=314.47 Aligned_cols=245 Identities=23% Similarity=0.339 Sum_probs=182.3
Q ss_pred cccceeeeecccCceEEEEEEEcCC-----CcEEEEEEeccCCCChHHHHHHHHHHHHHHhCCC-CCcchhhhhhhc-CC
Q psy758 2 ERYEKIGKLGEGSYGVVFKCRNRDT-----GQVVAIKKFLESEEDPLIRKIALREIRLLKSLKH-PNLVNLLEVFRR-KK 74 (292)
Q Consensus 2 ~~y~~~~~l~~g~~~~v~~~~~~~~-----~~~v~iK~~~~~~~~~~~~~~~~~e~~~~~~l~~-~~i~~~~~~~~~-~~ 74 (292)
++|++.+.||+|+||.||+|.+..+ ++.||+|.+..... ....+.+.+|+.+++.++| |||+++++++.+ ++
T Consensus 64 ~~~~l~~~LG~G~fG~Vy~a~~~~~~~~~~~k~VAvK~l~~~~~-~~~~~~~~~E~~il~~l~hhpnIV~l~g~~~~~~~ 142 (353)
T 4ase_A 64 DRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGAT-HSEHRALMSELKILIHIGHHLNVVNLLGACTKPGG 142 (353)
T ss_dssp GGEEEEEEEEECSSEEEEEEEEETSSSTTCEEEEEEEEECTTCC-HHHHHHHHHHHHHHHHHCCCTTBCCEEEEECCTTS
T ss_pred HHeEEeeEEecCCCeEEEEEEEcCCCcccCCeEEEEEEEccccC-hHHHHHHHHHHHHHHHcCCCCcEEEEEEEEEecCC
Confidence 5799999999999999999987654 35799999875543 3446778999999999976 899999999865 56
Q ss_pred eEEEEEecCCCccHHHHhcCC----------------CCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEEccCC
Q psy758 75 KLHLVFEFCDHTVLNELENHP----------------HGLPWDLIKQITWQVLRGVSYCHRHACIHRDIKPENILLTANG 138 (292)
Q Consensus 75 ~~~iv~e~~~~~~L~~~~~~~----------------~~~~~~~~~~i~~qi~~aL~~LH~~givH~dl~p~Nilv~~~~ 138 (292)
.+|+|||||++|+|.++++.. ..+++..+..++.||+.||+|||+++|+||||||+|||+++++
T Consensus 143 ~~~iV~Ey~~~G~L~~~L~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qia~gl~yLH~~~iiHRDLK~~NILl~~~~ 222 (353)
T 4ase_A 143 PLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRKCIHRDLAARNILLSEKN 222 (353)
T ss_dssp CCEEEEECCTTEEHHHHHHHTGGGBCCC-------CTTCBCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECGGG
T ss_pred EEEEEEEcCCCCCHHHHHHhcccccccccccchhhccccCCHHHHHHHHHHHHHHHHhHhhCCeecCccCccceeeCCCC
Confidence 789999999999999998642 3489999999999999999999999999999999999999999
Q ss_pred cEEEeecCchhhhhcccc-------ccccccccccccccCCCCCCCcccceeeecCCCCCCchHHHHHHHhhc-ccCCCC
Q psy758 139 VVKLCDFGFARLIRDLIP-------RHLHIFQTNEYFKGVSLPHAENVVPLEIKIGKPAATNIYLIDFLKRCL-DKDPLR 210 (292)
Q Consensus 139 ~~kl~dfg~~~~~~~~~~-------~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~p~~ 210 (292)
.+||+|||+++....... ..+..|.+||...+..+....|+|++++ -+++.+. +..|+.
T Consensus 223 ~vKi~DFGlar~~~~~~~~~~~~~~~gt~~ymAPE~l~~~~y~~ksDVwS~Gv-------------~l~El~t~G~~Pf~ 289 (353)
T 4ase_A 223 VVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGV-------------LLWEIFSLGASPYP 289 (353)
T ss_dssp CEEECCCGGGSCTTTCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHH-------------HHHHHTTTSCCSST
T ss_pred CEEECcchhhhhcccCCCceeeccccccccccCHHHHhcCCCCCcccEeehHH-------------HHHHHHhCCCCCCC
Confidence 999999999986543211 1233466666665554443333333322 2222221 344443
Q ss_pred CCChhhhhhccCcCC--CCCCCCCccchHHHHhcccCcCCCCCCChhhhhhC
Q psy758 211 RWSCDQLLRHPYFNG--YYFEVPDEMQYEEITQRCLDKDPLRRWSCDQLLRH 260 (292)
Q Consensus 211 ~~~~~~~~~~~~~~~--~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~~il~h 260 (292)
..+..+.+......+ ...+...++++.+||.+||+.||++|||+.||++|
T Consensus 290 ~~~~~~~~~~~i~~g~~~~~p~~~~~~~~~li~~c~~~dP~~RPt~~eil~~ 341 (353)
T 4ase_A 290 GVKIDEEFCRRLKEGTRMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEH 341 (353)
T ss_dssp TCCCSHHHHHHHHHTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred CCCHHHHHHHHHHcCCCCCCCccCCHHHHHHHHHHcCcChhHCcCHHHHHHH
Confidence 333222221111111 12334457899999999999999999999999997
|
| >1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=5.8e-47 Score=315.17 Aligned_cols=256 Identities=19% Similarity=0.264 Sum_probs=200.2
Q ss_pred CcccceeeeecccCceEEEEEEEcCCCcEEEEEEeccCCC-ChHHHHHHHHHHHHHHhCCCCCcchhhhhhhcCCeEEEE
Q psy758 1 MERYEKIGKLGEGSYGVVFKCRNRDTGQVVAIKKFLESEE-DPLIRKIALREIRLLKSLKHPNLVNLLEVFRRKKKLHLV 79 (292)
Q Consensus 1 ~~~y~~~~~l~~g~~~~v~~~~~~~~~~~v~iK~~~~~~~-~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~iv 79 (292)
+++|++.+.||+|+||.||+|++..+|+.||+|++..... .....+.+.+|+.+++.++||||+++++++.+.+.+|+|
T Consensus 40 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv 119 (350)
T 1rdq_E 40 LDQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMV 119 (350)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEE
T ss_pred HHHCEEEEEeecCcCcEEEEEEECCCCCEEEEEEEEhHHhccHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEcCCEEEEE
Confidence 4789999999999999999999999999999999865431 112345678899999999999999999999999999999
Q ss_pred EecCCCccHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEEccCCcEEEeecCchhhhhccc--cc
Q psy758 80 FEFCDHTVLNELENHPHGLPWDLIKQITWQVLRGVSYCHRHACIHRDIKPENILLTANGVVKLCDFGFARLIRDLI--PR 157 (292)
Q Consensus 80 ~e~~~~~~L~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~givH~dl~p~Nilv~~~~~~kl~dfg~~~~~~~~~--~~ 157 (292)
|||++|++|..++...+.+++..++.++.||+.||.|||++||+||||||+||+++.+|.++|+|||++....... ..
T Consensus 120 ~e~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~g~~kL~DFg~a~~~~~~~~~~~ 199 (350)
T 1rdq_E 120 MEYVAGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWTLC 199 (350)
T ss_dssp EECCTTCBHHHHHHHHCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTCEECSSCBCCCE
T ss_pred EcCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCccceEEECCCCCEEEcccccceeccCCccccc
Confidence 9999999999999877789999999999999999999999999999999999999999999999999997654321 22
Q ss_pred cccccccccccccCCCCCCCcccceeeecCCCCCCchHHHHHHHhhcccCCCCCCChhhhhhccCcCCCCCCCCCccchH
Q psy758 158 HLHIFQTNEYFKGVSLPHAENVVPLEIKIGKPAATNIYLIDFLKRCLDKDPLRRWSCDQLLRHPYFNGYYFEVPDEMQYE 237 (292)
Q Consensus 158 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~l~ 237 (292)
++..|.+||...+.......++|+ .+.-++..+.+..|+...+..++..........++...+..+.
T Consensus 200 gt~~y~aPE~~~~~~~~~~~Diws-------------lG~il~ell~g~~Pf~~~~~~~~~~~i~~~~~~~p~~~~~~~~ 266 (350)
T 1rdq_E 200 GTPEALAPEIILSKGYNKAVDWWA-------------LGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVRFPSHFSSDLK 266 (350)
T ss_dssp ECGGGCCHHHHTTCCBCTHHHHHH-------------HHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCCTTCCHHHH
T ss_pred CCccccCHHHhcCCCCCCcCCEec-------------ccHhHhHHhhCCCCCCCCCHHHHHHHHHcCCCCCCCCCCHHHH
Confidence 344566666655443322222222 2222333344444444444433333222223344455688999
Q ss_pred HHHhcccCcCCCCCCC-----hhhhhhCCcccceecc
Q psy758 238 EITQRCLDKDPLRRWS-----CDQLLRHPYFNGYYFE 269 (292)
Q Consensus 238 ~li~~~l~~dP~~Rpt-----~~~il~h~w~~~~~~~ 269 (292)
+||.+||+.||.+||+ ++++++||||++..|+
T Consensus 267 ~li~~lL~~dp~~R~~~~~~~~~ei~~h~~f~~~~w~ 303 (350)
T 1rdq_E 267 DLLRNLLQVDLTKRFGNLKNGVNDIKNHKWFATTDWI 303 (350)
T ss_dssp HHHHHHSCSCTTTCTTSSTTTTHHHHTSGGGTTCCHH
T ss_pred HHHHHHhhcCHHhccCCccCCHHHHHhCcCcCCCCHH
Confidence 9999999999999998 9999999999998875
|
| >4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-46 Score=307.48 Aligned_cols=266 Identities=53% Similarity=0.868 Sum_probs=202.3
Q ss_pred CcccceeeeecccCceEEEEEEEcCCCcEEEEEEeccCCCChHHHHHHHHHHHHHHhCCCCCcchhhhhhhcCCeEEEEE
Q psy758 1 MERYEKIGKLGEGSYGVVFKCRNRDTGQVVAIKKFLESEEDPLIRKIALREIRLLKSLKHPNLVNLLEVFRRKKKLHLVF 80 (292)
Q Consensus 1 ~~~y~~~~~l~~g~~~~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~iv~ 80 (292)
+++|++++.||+|++|.||+|.+..+|+.||+|++..........+.+.+|+.+++.++||||+++++++.+.+..++||
T Consensus 2 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 81 (311)
T 4agu_A 2 MEKYEKIGKIGEGSYGVVFKCRNRDTGQIVAIKKFLESEDDPVIKKIALREIRMLKQLKHPNLVNLLEVFRRKRRLHLVF 81 (311)
T ss_dssp -CCEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECCCCC-HHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEE
T ss_pred cccceEeeEEeecCCeEEEEEEeCCCCcEEEEEEeeccccchHHHHHHHHHHHHHHhCCCCCccchhheeecCCeEEEEE
Confidence 58999999999999999999999999999999999877777777788899999999999999999999999999999999
Q ss_pred ecCCCccHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEEccCCcEEEeecCchhhhhccc-----
Q psy758 81 EFCDHTVLNELENHPHGLPWDLIKQITWQVLRGVSYCHRHACIHRDIKPENILLTANGVVKLCDFGFARLIRDLI----- 155 (292)
Q Consensus 81 e~~~~~~L~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~givH~dl~p~Nilv~~~~~~kl~dfg~~~~~~~~~----- 155 (292)
||+++++|..++.....+++..++.++.|++.||.|||++|++||||+|+||+++.++.++|+|||++.......
T Consensus 82 e~~~~~~l~~~~~~~~~~~~~~~~~i~~~l~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~ 161 (311)
T 4agu_A 82 EYCDHTVLHELDRYQRGVPEHLVKSITWQTLQAVNFCHKHNCIHRDVKPENILITKHSVIKLCDFGFARLLTGPSDYYDD 161 (311)
T ss_dssp ECCSEEHHHHHHHTSSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTCEECC--------
T ss_pred EeCCCchHHHHHhhhcCCCHHHHHHHHHHHHHHHHHHHHCCCcCCCCChhhEEEcCCCCEEEeeCCCchhccCcccccCC
Confidence 999999999999888889999999999999999999999999999999999999999999999999987654221
Q ss_pred cccccccccccccccC-C-----CCCCCcccceeeecCCCCCCchHHHHHHHh---hcccCCCCCCChhhh-hhccCcCC
Q psy758 156 PRHLHIFQTNEYFKGV-S-----LPHAENVVPLEIKIGKPAATNIYLIDFLKR---CLDKDPLRRWSCDQL-LRHPYFNG 225 (292)
Q Consensus 156 ~~~~~~~~~~~~~~~~-~-----~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~---~~~~~p~~~~~~~~~-~~~~~~~~ 225 (292)
...+..|.+||...+. . ..|+.|+..+++.+|..++......+.+.. .+...+ +..... ....++..
T Consensus 162 ~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~---~~~~~~~~~~~~~~~ 238 (311)
T 4agu_A 162 EVATRWYRSPELLVGDTQYGPPVDVWAIGCVFAELLSGVPLWPGKSDVDQLYLIRKTLGDLI---PRHQQVFSTNQYFSG 238 (311)
T ss_dssp ----GGGCCHHHHHTCSCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCC---HHHHHHHHTCGGGTT
T ss_pred CcCCccccChHHHhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhcccc---ccccccccccccccc
Confidence 2334557777766542 2 235566666666777666543332222211 111100 000000 01111111
Q ss_pred CCCC------------CCCccchHHHHhcccCcCCCCCCChhhhhhCCcccceecc
Q psy758 226 YYFE------------VPDEMQYEEITQRCLDKDPLRRWSCDQLLRHPYFNGYYFE 269 (292)
Q Consensus 226 ~~~~------------~~~~~~l~~li~~~l~~dP~~Rpt~~~il~h~w~~~~~~~ 269 (292)
...+ ...+..+.+||.+||+.||.+|||++|+++||||++..+.
T Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~f~~~~~~ 294 (311)
T 4agu_A 239 VKIPDPEDMEPLELKFPNISYPALGLLKGCLHMDPTERLTCEQLLHHPYFENIREI 294 (311)
T ss_dssp CCCCCCSSCCCHHHHCTTCCHHHHHHHHHHCCSSTTTSCCHHHHHTSGGGTTCC--
T ss_pred CcCCCccccchhhhhcccccHHHHHHHHHHccCChhhcCCHHHHhcChHHHhccCH
Confidence 1111 1346678999999999999999999999999999996643
|
| >3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} SCOP: d.144.1.7 PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.1e-46 Score=304.02 Aligned_cols=250 Identities=24% Similarity=0.352 Sum_probs=192.0
Q ss_pred cccceeeeecccCceEEEEEEEcCCCcEEEEEEeccCCCChHHHHHHHHHHHHHHhCCCCCcchhhhhhhcCCeEEEEEe
Q psy758 2 ERYEKIGKLGEGSYGVVFKCRNRDTGQVVAIKKFLESEEDPLIRKIALREIRLLKSLKHPNLVNLLEVFRRKKKLHLVFE 81 (292)
Q Consensus 2 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~iv~e 81 (292)
++|++.+.||+|+||.||+|.+..+++.||+|.+....... .+.+.+|+.+++.++||||+++++++.+++..++|||
T Consensus 20 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~--~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e 97 (297)
T 3fxz_A 20 KKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPK--KELIINEILVMRENKNPNIVNYLDSYLVGDELWVVME 97 (297)
T ss_dssp GTBCCCEEEEEETTEEEEEEEBTTTCCEEEEEEEEGGGCSC--HHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred hceeeeeeeccCCCeEEEEEEECCCCcEEEEEEeecccccH--HHHHHHHHHHHhcCCCCCCCeEeEEEEECCEEEEEEE
Confidence 68999999999999999999999999999999986554333 3567889999999999999999999999999999999
Q ss_pred cCCCccHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEEccCCcEEEeecCchhhhhcccc-----
Q psy758 82 FCDHTVLNELENHPHGLPWDLIKQITWQVLRGVSYCHRHACIHRDIKPENILLTANGVVKLCDFGFARLIRDLIP----- 156 (292)
Q Consensus 82 ~~~~~~L~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~givH~dl~p~Nilv~~~~~~kl~dfg~~~~~~~~~~----- 156 (292)
|+.|++|.+++... .+++..++.++.|++.||.|||++|++||||||+||+++.++.++|+|||++........
T Consensus 98 ~~~~~~L~~~~~~~-~~~~~~~~~~~~qi~~~l~~lH~~~i~H~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~ 176 (297)
T 3fxz_A 98 YLAGGSLTDVVTET-CMDEGQIAAVCRECLQALEFLHSNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSTM 176 (297)
T ss_dssp CCTTCBHHHHHHHS-CCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTCCEEECCCTTCEECCSTTCCBCCC
T ss_pred CCCCCCHHHHHhhc-CCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCHHHEEECCCCCEEEeeCCCceecCCcccccCCc
Confidence 99999999998764 699999999999999999999999999999999999999999999999999876543222
Q ss_pred ccccccccccccccCCCCCCCcccceeeecCCCCCCchHHHHHHHhhcccCCCCCCChhhhhhcc---CcCCCCCCCCCc
Q psy758 157 RHLHIFQTNEYFKGVSLPHAENVVPLEIKIGKPAATNIYLIDFLKRCLDKDPLRRWSCDQLLRHP---YFNGYYFEVPDE 233 (292)
Q Consensus 157 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~---~~~~~~~~~~~~ 233 (292)
.++..|.+||...+.......|+|++ +.-++..+.+..|+......+..... .......+...+
T Consensus 177 ~gt~~y~aPE~~~~~~~~~~~Diwsl-------------G~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 243 (297)
T 3fxz_A 177 VGTPYWMAPEVVTRKAYGPKVDIWSL-------------GIMAIEMIEGEPPYLNENPLRALYLIATNGTPELQNPEKLS 243 (297)
T ss_dssp CSCGGGCCHHHHHCSCBCTHHHHHHH-------------HHHHHHHHHSSCTTTTSCHHHHHHHHHHHCSCCCSCGGGSC
T ss_pred cCCcCccChhhhcCCCCCcHHHHHHH-------------HHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCCCCccccC
Confidence 23445666666554443322222222 22233333344443333322221110 011112233457
Q ss_pred cchHHHHhcccCcCCCCCCChhhhhhCCccccee
Q psy758 234 MQYEEITQRCLDKDPLRRWSCDQLLRHPYFNGYY 267 (292)
Q Consensus 234 ~~l~~li~~~l~~dP~~Rpt~~~il~h~w~~~~~ 267 (292)
..+.+||.+||+.||.+|||++|+++||||+...
T Consensus 244 ~~~~~li~~~l~~dp~~Rps~~ell~h~~~~~~~ 277 (297)
T 3fxz_A 244 AIFRDFLNRCLEMDVEKRGSAKELLQHQFLKIAK 277 (297)
T ss_dssp HHHHHHHHHHSCSSTTTSCCHHHHTTCGGGGGCC
T ss_pred HHHHHHHHHHccCChhHCcCHHHHhhChhhcccC
Confidence 7899999999999999999999999999999754
|
| >3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-46 Score=321.25 Aligned_cols=252 Identities=22% Similarity=0.283 Sum_probs=194.9
Q ss_pred cccceeeeecccCceEEEEEEEcCCCcEEEEEEeccCCCChHHHHHHHHHHHHHHhCCCCCcchhhhhhhcCCeEEEEEe
Q psy758 2 ERYEKIGKLGEGSYGVVFKCRNRDTGQVVAIKKFLESEEDPLIRKIALREIRLLKSLKHPNLVNLLEVFRRKKKLHLVFE 81 (292)
Q Consensus 2 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~iv~e 81 (292)
++|++.+.||+|+||.||+|.+..+|+.||+|++..........+.+.+|+.+++.++||||+++++++.+++..|+|||
T Consensus 11 ~~Y~i~~~LG~G~fg~V~~~~~~~~~~~~a~K~i~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~lv~E 90 (444)
T 3soa_A 11 EEYQLFEELGKGAFSVVRRCVKVLAGQEYAAMIINTKKLSARDHQKLEREARICRLLKHPNIVRLHDSISEEGHHYLIFD 90 (444)
T ss_dssp HHEEEEEEEEEC--CEEEEEEETTTTEEEEEEEEESCSCHHHHHHHHHHHHHHHHHCCBTTBCCEEEEEECSSEEEEEEC
T ss_pred CCeEEEEEeccCCCeEEEEEEECCCCcEEEEEEEEcccCCHHHHHHHHHHHHHHHhCCCcCCCeEEEEEEECCEEEEEEE
Confidence 57999999999999999999999999999999998777666677889999999999999999999999999999999999
Q ss_pred cCCCccHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEEc---cCCcEEEeecCchhhhhcccc--
Q psy758 82 FCDHTVLNELENHPHGLPWDLIKQITWQVLRGVSYCHRHACIHRDIKPENILLT---ANGVVKLCDFGFARLIRDLIP-- 156 (292)
Q Consensus 82 ~~~~~~L~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~givH~dl~p~Nilv~---~~~~~kl~dfg~~~~~~~~~~-- 156 (292)
|+.|++|.+.+...+.+++..++.++.||+.||.|||++||+||||||+||+++ .++.+||+|||++........
T Consensus 91 ~~~gg~L~~~i~~~~~~~e~~~~~i~~qil~aL~~lH~~givHrDlKp~NIll~~~~~~~~vkL~DFG~a~~~~~~~~~~ 170 (444)
T 3soa_A 91 LVTGGELFEDIVAREYYSEADASHCIQQILEAVLHCHQMGVVHRNLKPENLLLASKLKGAAVKLADFGLAIEVEGEQQAW 170 (444)
T ss_dssp CCBCCBHHHHHHHCSCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCSSTTEEESBSSTTCCEEECCCSSCBCCCTTCCBC
T ss_pred eCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEEeccCCCCcEEEccCceeEEecCCCcee
Confidence 999999999888777899999999999999999999999999999999999998 457899999999976654322
Q ss_pred ---ccccccccccccccCCCCCCCcccceeeecCCCCCCchHHHHHHHhhcccCCCCCCChhhhhhccCcCCCC----CC
Q psy758 157 ---RHLHIFQTNEYFKGVSLPHAENVVPLEIKIGKPAATNIYLIDFLKRCLDKDPLRRWSCDQLLRHPYFNGYY----FE 229 (292)
Q Consensus 157 ---~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~----~~ 229 (292)
.++..|.+||...+.......|+|+ .+.-++..+.+..|+...+..++.......... ..
T Consensus 171 ~~~~gt~~Y~APE~l~~~~~~~~~DIwS-------------lGvilyell~G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~ 237 (444)
T 3soa_A 171 FGFAGTPGYLSPEVLRKDPYGKPVDLWA-------------CGVILYILLVGYPPFWDEDQHRLYQQIKAGAYDFPSPEW 237 (444)
T ss_dssp CCSCSCGGGCCHHHHTTCCBCTHHHHHH-------------HHHHHHHHHHSSCSCCCSSHHHHHHHHHHTCCCCCTTTT
T ss_pred ecccCCcccCCHHHhcCCCCCCccccHH-------------HHHHHHHHHhCCCCCCCccHHHHHHHHHhCCCCCCcccc
Confidence 2344566666655443322222222 222233333344444333333332221111111 11
Q ss_pred CCCccchHHHHhcccCcCCCCCCChhhhhhCCcccce
Q psy758 230 VPDEMQYEEITQRCLDKDPLRRWSCDQLLRHPYFNGY 266 (292)
Q Consensus 230 ~~~~~~l~~li~~~l~~dP~~Rpt~~~il~h~w~~~~ 266 (292)
...+..+.+||.+||+.||.+|||+.|+|+||||++.
T Consensus 238 ~~~s~~~~~li~~~L~~dP~~Rpta~e~L~hp~~~~~ 274 (444)
T 3soa_A 238 DTVTPEAKDLINKMLTINPSKRITAAEALKHPWISHR 274 (444)
T ss_dssp TTSCHHHHHHHHHHSCSSTTTSCCHHHHHHSCTTHHH
T ss_pred ccCCHHHHHHHHHHcCCChhHCCCHHHHhcCccccCC
Confidence 2457889999999999999999999999999999864
|
| >3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-45 Score=312.05 Aligned_cols=271 Identities=18% Similarity=0.241 Sum_probs=198.3
Q ss_pred cccceeeeeccc--CceEEEEEEEcCCCcEEEEEEeccCCCChHHHHHHHHHHHHHHhCCCCCcchhhhhhhcCCeEEEE
Q psy758 2 ERYEKIGKLGEG--SYGVVFKCRNRDTGQVVAIKKFLESEEDPLIRKIALREIRLLKSLKHPNLVNLLEVFRRKKKLHLV 79 (292)
Q Consensus 2 ~~y~~~~~l~~g--~~~~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~iv 79 (292)
++|++++.||+| ++|.||+|++..+++.||+|++..........+.+.+|+.+++.++||||+++++++.+++.+|+|
T Consensus 25 ~~y~~~~~lG~G~~~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv 104 (389)
T 3gni_B 25 GCYELLTVIGKGFEDLMTVNLARYKPTGEYVTVRRINLEACSNEMVTFLQGELHVSKLFNHPNIVPYRATFIADNELWVV 104 (389)
T ss_dssp GGEEEEEEEEEETTTTEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEE
T ss_pred CcEEEEecccCCcCCceEEEEEEEcCCCCEEEEEEecccccChHHHHHHHHHHHHHHhCCCCCCCcEeEEEEECCEEEEE
Confidence 689999999999 999999999999999999999987777777788899999999999999999999999999999999
Q ss_pred EecCCCccHHHHhcCC--CCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEEccCCcEEEeecCchhhhhccc--
Q psy758 80 FEFCDHTVLNELENHP--HGLPWDLIKQITWQVLRGVSYCHRHACIHRDIKPENILLTANGVVKLCDFGFARLIRDLI-- 155 (292)
Q Consensus 80 ~e~~~~~~L~~~~~~~--~~~~~~~~~~i~~qi~~aL~~LH~~givH~dl~p~Nilv~~~~~~kl~dfg~~~~~~~~~-- 155 (292)
|||+.+++|.+++... ..+++..++.++.||+.||+|||++||+||||||+||+++.++.++|+|||.+.......
T Consensus 105 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivHrDlkp~NIll~~~~~~kl~dfg~~~~~~~~~~~ 184 (389)
T 3gni_B 105 TSFMAYGSAKDLICTHFMDGMNELAIAYILQGVLKALDYIHHMGYVHRSVKASHILISVDGKVYLSGLRSNLSMISHGQR 184 (389)
T ss_dssp EECCTTCBHHHHHHHTCTTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTCCEEECCGGGCEECEETTEE
T ss_pred EEccCCCCHHHHHhhhcccCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCCEEEcccccceeecccccc
Confidence 9999999999998654 579999999999999999999999999999999999999999999999999875432211
Q ss_pred ----------cccccccccccccccC--C-----CCCCCcccceeeecCCCCCCchHHHHHHHhhcccCCCCCCC-----
Q psy758 156 ----------PRHLHIFQTNEYFKGV--S-----LPHAENVVPLEIKIGKPAATNIYLIDFLKRCLDKDPLRRWS----- 213 (292)
Q Consensus 156 ----------~~~~~~~~~~~~~~~~--~-----~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~----- 213 (292)
..++..|.+||...+. . ..|+.|+..+++.+|..++........+...+.........
T Consensus 185 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 264 (389)
T 3gni_B 185 QRVVHDFPKYSVKVLPWLSPEVLQQNLQGYDAKSDIYSVGITACELANGHVPFKDMPATQMLLEKLNGTVPCLLDTSTIP 264 (389)
T ss_dssp CSCBCCCCTTCTTTGGGSCHHHHSTTSSCBCTHHHHHHHHHHHHHHHHSSCTTTTCCSTTHHHHC---------------
T ss_pred ccccccccccccccccccCHHHHhccCCCCCcHhHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHhcCCCCccccccccc
Confidence 1223446777776552 2 23555555666666666543222111111111100000000
Q ss_pred hhhhh-----------------------hccCcCCCCCCCCCccchHHHHhcccCcCCCCCCChhhhhhCCcccceeccC
Q psy758 214 CDQLL-----------------------RHPYFNGYYFEVPDEMQYEEITQRCLDKDPLRRWSCDQLLRHPYFNGYYFEV 270 (292)
Q Consensus 214 ~~~~~-----------------------~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~~il~h~w~~~~~~~~ 270 (292)
..+.. ..........+...+..+.+||.+||+.||++|||++|+|+||||++..+..
T Consensus 265 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpta~ell~hp~f~~~~~~~ 344 (389)
T 3gni_B 265 AEELTMSPSRSVANSGLSDSLTTSTPRPSNGDSPSHPYHRTFSPHFHHFVEQCLQRNPDARPSASTLLNHSFFKQIKRRA 344 (389)
T ss_dssp -----------------------------------------CCHHHHHHHHHHTCSCTTTSCCHHHHTTSGGGGGC---C
T ss_pred cccccccccccccccccccccccCccccccCCCCCCccccccCHHHHHHHHHHhhcCcccCCCHHHHhcCHHHHHHhhcc
Confidence 00000 0000001112334577899999999999999999999999999999987654
Q ss_pred CC
Q psy758 271 PD 272 (292)
Q Consensus 271 ~~ 272 (292)
..
T Consensus 345 ~~ 346 (389)
T 3gni_B 345 SE 346 (389)
T ss_dssp CS
T ss_pred hh
Confidence 43
|
| >4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.1e-46 Score=312.68 Aligned_cols=256 Identities=20% Similarity=0.322 Sum_probs=198.0
Q ss_pred CcccceeeeecccCceEEEEEEEcCCCcEEEEEEeccCC-CChHHHHHHHHHHHHHHhCCCCCcchhhhhhhcCCeEEEE
Q psy758 1 MERYEKIGKLGEGSYGVVFKCRNRDTGQVVAIKKFLESE-EDPLIRKIALREIRLLKSLKHPNLVNLLEVFRRKKKLHLV 79 (292)
Q Consensus 1 ~~~y~~~~~l~~g~~~~v~~~~~~~~~~~v~iK~~~~~~-~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~iv 79 (292)
+++|++.+.||+|+||.||+|.+..+++.||+|++.... ........+.+|+.+++.++||||+++++++.+.+.+|+|
T Consensus 14 ~~~y~i~~~LG~G~fG~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~~lv 93 (384)
T 4fr4_A 14 FDHFEILRAIGKGSFGKVCIVQKNDTKKMYAMKYMNKQKCVERNEVRNVFKELQIMQGLEHPFLVNLWYSFQDEEDMFMV 93 (384)
T ss_dssp GGGEEEEEEEECCTTCCEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEE
T ss_pred hHHeEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEehhhcccHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEEEEE
Confidence 478999999999999999999999999999999986543 1112346678999999999999999999999999999999
Q ss_pred EecCCCccHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEEccCCcEEEeecCchhhhhccc----
Q psy758 80 FEFCDHTVLNELENHPHGLPWDLIKQITWQVLRGVSYCHRHACIHRDIKPENILLTANGVVKLCDFGFARLIRDLI---- 155 (292)
Q Consensus 80 ~e~~~~~~L~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~givH~dl~p~Nilv~~~~~~kl~dfg~~~~~~~~~---- 155 (292)
|||+.||+|..++.....+++..++.++.||+.||.|||++||+||||||+||+++.+|.++|+|||++.......
T Consensus 94 ~e~~~gg~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NIll~~~g~vkL~DFG~a~~~~~~~~~~~ 173 (384)
T 4fr4_A 94 VDLLLGGDLRYHLQQNVHFKEETVKLFICELVMALDYLQNQRIIHRDMKPDNILLDEHGHVHITDFNIAAMLPRETQITT 173 (384)
T ss_dssp ECCCTTEEHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTCEECCTTCCBCC
T ss_pred EecCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCcHHHeEECCCCCEEEeccceeeeccCCCceec
Confidence 9999999999999988889999999999999999999999999999999999999999999999999997654321
Q ss_pred cccccccccccccccC---CCCCCCcccceeeecCCCCCCchHHHHHHHhhcccCCCCC---CChhhhhhccCcCCCCCC
Q psy758 156 PRHLHIFQTNEYFKGV---SLPHAENVVPLEIKIGKPAATNIYLIDFLKRCLDKDPLRR---WSCDQLLRHPYFNGYYFE 229 (292)
Q Consensus 156 ~~~~~~~~~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~p~~~---~~~~~~~~~~~~~~~~~~ 229 (292)
..++..|.+||...+. ......++ ++.+.-++..+.+..|+.. ....++...........+
T Consensus 174 ~~gt~~Y~aPE~~~~~~~~~~~~~~Di-------------wSlG~il~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~p 240 (384)
T 4fr4_A 174 MAGTKPYMAPEMFSSRKGAGYSFAVDW-------------WSLGVTAYELLRGRRPYHIRSSTSSKEIVHTFETTVVTYP 240 (384)
T ss_dssp CCSCGGGCCGGGTCCCSSCCBCTTHHH-------------HHHHHHHHHHHHSSCSSCCCTTSCHHHHHHHHHHCCCCCC
T ss_pred cCCCccccCCeeeccCCCCCCCcccee-------------echHHHHHHHHhCCCCCCCCCCccHHHHHHHHhhcccCCC
Confidence 2233445666655321 11112222 2223333344444444432 122222222112223345
Q ss_pred CCCccchHHHHhcccCcCCCCCCC-hhhhhhCCcccceecc
Q psy758 230 VPDEMQYEEITQRCLDKDPLRRWS-CDQLLRHPYFNGYYFE 269 (292)
Q Consensus 230 ~~~~~~l~~li~~~l~~dP~~Rpt-~~~il~h~w~~~~~~~ 269 (292)
...+..+.+||.+||+.||.+||+ ++++++||||+++.|+
T Consensus 241 ~~~s~~~~~li~~lL~~dP~~R~s~~~~l~~hp~f~~~~w~ 281 (384)
T 4fr4_A 241 SAWSQEMVSLLKKLLEPNPDQRFSQLSDVQNFPYMNDINWD 281 (384)
T ss_dssp TTSCHHHHHHHHHHSCSSGGGSCCSHHHHHTSGGGTTCCHH
T ss_pred CcCCHHHHHHHHHHhcCCHhHhcccHHHHHcChhhhcCCHH
Confidence 556889999999999999999998 8999999999998886
|
| >2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-46 Score=313.13 Aligned_cols=256 Identities=17% Similarity=0.193 Sum_probs=198.5
Q ss_pred CcccceeeeecccCceEEEEEEEcCCCcEEEEEEeccCCC-ChHHHHHHHHHHHHHHhC-CCCCcchhhhhhhcCCeEEE
Q psy758 1 MERYEKIGKLGEGSYGVVFKCRNRDTGQVVAIKKFLESEE-DPLIRKIALREIRLLKSL-KHPNLVNLLEVFRRKKKLHL 78 (292)
Q Consensus 1 ~~~y~~~~~l~~g~~~~v~~~~~~~~~~~v~iK~~~~~~~-~~~~~~~~~~e~~~~~~l-~~~~i~~~~~~~~~~~~~~i 78 (292)
+++|++.+.||+|+||.||+|++..+++.||+|++..... .......+..|..++..+ .||+|+++++++.+.+.+|+
T Consensus 19 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~l~~~~~~~~~~~l 98 (353)
T 2i0e_A 19 LTDFNFLMVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDRLYF 98 (353)
T ss_dssp CTTEEEEEEEEEETTEEEEEEEETTEEEEEEEEEEEHHHHHHTTCHHHHHHHHHHHTCTTCCTTBCCEEEEEECSSEEEE
T ss_pred hHHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhcchHHHHHHHHHHHHHhcCCCCEEeeEEEEEEcCCEEEE
Confidence 5789999999999999999999999999999999975421 112245677899999888 79999999999999999999
Q ss_pred EEecCCCccHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEEccCCcEEEeecCchhhhhccc---
Q psy758 79 VFEFCDHTVLNELENHPHGLPWDLIKQITWQVLRGVSYCHRHACIHRDIKPENILLTANGVVKLCDFGFARLIRDLI--- 155 (292)
Q Consensus 79 v~e~~~~~~L~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~givH~dl~p~Nilv~~~~~~kl~dfg~~~~~~~~~--- 155 (292)
||||++||+|..++...+.+++..++.++.||+.||.|||++||+||||||+||+++.+|+++|+|||++.......
T Consensus 99 v~E~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NIll~~~g~vkL~DFG~a~~~~~~~~~~ 178 (353)
T 2i0e_A 99 VMEYVNGGDLMYHIQQVGRFKEPHAVFYAAEIAIGLFFLQSKGIIYRDLKLDNVMLDSEGHIKIADFGMCKENIWDGVTT 178 (353)
T ss_dssp EEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTSCEEECCCTTCBCCCCTTCCB
T ss_pred EEeCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCEEeccCCHHHEEEcCCCcEEEEeCCcccccccCCccc
Confidence 99999999999999877789999999999999999999999999999999999999999999999999987533221
Q ss_pred --cccccccccccccccCCCCCCCcccceeeecCCCCCCchHHHHHHHhhcccCCCCCCChhhhhhccCcCCCCCCCCCc
Q psy758 156 --PRHLHIFQTNEYFKGVSLPHAENVVPLEIKIGKPAATNIYLIDFLKRCLDKDPLRRWSCDQLLRHPYFNGYYFEVPDE 233 (292)
Q Consensus 156 --~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 233 (292)
..++..|.+||...+.....+.++| +.+.-+++.+.+..|+...+..++.....-....++...+
T Consensus 179 ~~~~gt~~y~aPE~~~~~~~~~~~Diw-------------slG~il~ell~G~~Pf~~~~~~~~~~~i~~~~~~~p~~~s 245 (353)
T 2i0e_A 179 KTFCGTPDYIAPEIIAYQPYGKSVDWW-------------AFGVLLYEMLAGQAPFEGEDEDELFQSIMEHNVAYPKSMS 245 (353)
T ss_dssp CCCCSCGGGCCHHHHTTCCBSTHHHHH-------------HHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCCTTSC
T ss_pred ccccCCccccChhhhcCCCcCCccccc-------------chHHHHHHHHcCCCCCCCCCHHHHHHHHHhCCCCCCCCCC
Confidence 1223445566555443332222222 2223333444445555444444444332223334455678
Q ss_pred cchHHHHhcccCcCCCCCCC-----hhhhhhCCcccceecc
Q psy758 234 MQYEEITQRCLDKDPLRRWS-----CDQLLRHPYFNGYYFE 269 (292)
Q Consensus 234 ~~l~~li~~~l~~dP~~Rpt-----~~~il~h~w~~~~~~~ 269 (292)
..+.+||.+||+.||.+||+ ++++++||||+++.|+
T Consensus 246 ~~~~~li~~lL~~dP~~R~~~~~~~~~~i~~h~~f~~~~w~ 286 (353)
T 2i0e_A 246 KEAVAICKGLMTKHPGKRLGCGPEGERDIKEHAFFRYIDWE 286 (353)
T ss_dssp HHHHHHHHHHTCSCTTSCTTCSTTHHHHHHTSGGGTTCCHH
T ss_pred HHHHHHHHHHhhcCHHHcCCCCCCCHHHHhcCccccCCCHH
Confidence 89999999999999999995 6999999999998876
|
| >3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-46 Score=309.80 Aligned_cols=266 Identities=30% Similarity=0.518 Sum_probs=196.8
Q ss_pred CcccceeeeecccCceEEEEEEEcCCCcEEEEEEeccCCCChHHHHHHHHHHHHHHhCCCCCcchhhhhhhcCCeEEEEE
Q psy758 1 MERYEKIGKLGEGSYGVVFKCRNRDTGQVVAIKKFLESEEDPLIRKIALREIRLLKSLKHPNLVNLLEVFRRKKKLHLVF 80 (292)
Q Consensus 1 ~~~y~~~~~l~~g~~~~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~iv~ 80 (292)
+++|++.+.||+|+||.||+|.+..+++.||+|++............+.+|+.+++.++||||+++++++.+++..++||
T Consensus 33 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ 112 (329)
T 3gbz_A 33 IDRYRRITKLGEGTYGEVYKAIDTVTNETVAIKRIRLEHEEEGVPGTAIREVSLLKELQHRNIIELKSVIHHNHRLHLIF 112 (329)
T ss_dssp GGGEEEEEEEEECSSSEEEEEEETTTTEEEEEEECCCCC--------CHHHHHHGGGCCCTTBCCEEEEEEETTEEEEEE
T ss_pred hhhEEEEEEEEecCCeEEEEEEECCCCceEEEEEEcccccccccchhHHHHHHHHHHcCCCCcceEEEEEecCCEEEEEE
Confidence 47999999999999999999999999999999999776655556677889999999999999999999999999999999
Q ss_pred ecCCCccHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEEc-----cCCcEEEeecCchhhhhccc
Q psy758 81 EFCDHTVLNELENHPHGLPWDLIKQITWQVLRGVSYCHRHACIHRDIKPENILLT-----ANGVVKLCDFGFARLIRDLI 155 (292)
Q Consensus 81 e~~~~~~L~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~givH~dl~p~Nilv~-----~~~~~kl~dfg~~~~~~~~~ 155 (292)
||+++ +|.+++.....+++..++.++.||+.||.|||++||+|+||||+||+++ .++.++|+|||++.......
T Consensus 113 e~~~~-~L~~~~~~~~~~~~~~~~~i~~ql~~~l~~LH~~~ivH~Dlkp~NIll~~~~~~~~~~~kl~Dfg~a~~~~~~~ 191 (329)
T 3gbz_A 113 EYAEN-DLKKYMDKNPDVSMRVIKSFLYQLINGVNFCHSRRCLHRDLKPQNLLLSVSDASETPVLKIGDFGLARAFGIPI 191 (329)
T ss_dssp ECCSE-EHHHHHHHCTTCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEEC-----CCEEEECCTTHHHHHC---
T ss_pred ecCCC-CHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhCCEECCCCCHHHEEEecCCCCccceEEECcCCCccccCCcc
Confidence 99996 7888887777899999999999999999999999999999999999994 45569999999998764322
Q ss_pred c-----ccccccccccccccCC------CCCCCcccceeeecCCCCCCchHHHHHHHhh---cccCCCCCC-Chhhhhhc
Q psy758 156 P-----RHLHIFQTNEYFKGVS------LPHAENVVPLEIKIGKPAATNIYLIDFLKRC---LDKDPLRRW-SCDQLLRH 220 (292)
Q Consensus 156 ~-----~~~~~~~~~~~~~~~~------~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~---~~~~p~~~~-~~~~~~~~ 220 (292)
. ..+..|.+||...+.. ..|+.|+..+++.++..++......+.+... +...+...+ ..... .
T Consensus 192 ~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~ 269 (329)
T 3gbz_A 192 RQFTHEIITLWYRPPEILLGSRHYSTSVDIWSIACIWAEMLMKTPLFPGDSEIDQLFKIFEVLGLPDDTTWPGVTAL--P 269 (329)
T ss_dssp --------CCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCTTTSTTGGGS--T
T ss_pred cccCCCcCCccccCHHHhcCCCCCCcHHHHHHHHHHHHHHHHCCCCcCCCCHHHHHHHHHHHhCCCchhhhhhhhhh--h
Confidence 1 2245578888765533 2466666667777777766544333322222 122221111 11110 0
Q ss_pred cCcCCCC----------CCCCCccchHHHHhcccCcCCCCCCChhhhhhCCcccceecc
Q psy758 221 PYFNGYY----------FEVPDEMQYEEITQRCLDKDPLRRWSCDQLLRHPYFNGYYFE 269 (292)
Q Consensus 221 ~~~~~~~----------~~~~~~~~l~~li~~~l~~dP~~Rpt~~~il~h~w~~~~~~~ 269 (292)
.|..... .+...+..+.+||.+||+.||.+|||++|+++||||++..|+
T Consensus 270 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~hp~f~~~~~~ 328 (329)
T 3gbz_A 270 DWKQSFPKFRGKTLKRVLGALLDDEGLDLLTAMLEMDPVKRISAKNALEHPYFSHNDFD 328 (329)
T ss_dssp TCCTTCCCCCCCCHHHHHGGGSCHHHHHHHHHHTCSSGGGSCCHHHHHTSGGGSSSCSC
T ss_pred hhhhhhhhhccccHhhhcccccCHHHHHHHHHHccCChhhCCCHHHHhCCcccCCCCCC
Confidence 0111100 011146788999999999999999999999999999998775
|
| >2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-45 Score=308.55 Aligned_cols=247 Identities=25% Similarity=0.348 Sum_probs=195.5
Q ss_pred cccceeeeecccCceEEEEEEEcCCCcEEEEEEeccCCCChHHHHHHHHHHHHHHhCCCCCcchhhhhhhcCCeEEEEEe
Q psy758 2 ERYEKIGKLGEGSYGVVFKCRNRDTGQVVAIKKFLESEEDPLIRKIALREIRLLKSLKHPNLVNLLEVFRRKKKLHLVFE 81 (292)
Q Consensus 2 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~iv~e 81 (292)
++|++.+.||+|+||.||+|.+..+++.||+|++..........+.+.+|+.+++.++||||+++++++.+++..|+|||
T Consensus 29 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~lv~e 108 (362)
T 2bdw_A 29 DNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEESFHYLVFD 108 (362)
T ss_dssp HHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEEC
T ss_pred cCeEEeeEEecCCCeEEEEEEECCCCCEEEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEEEEe
Confidence 47999999999999999999999999999999998777666677889999999999999999999999999999999999
Q ss_pred cCCCccHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEEccCC---cEEEeecCchhhhhccc---
Q psy758 82 FCDHTVLNELENHPHGLPWDLIKQITWQVLRGVSYCHRHACIHRDIKPENILLTANG---VVKLCDFGFARLIRDLI--- 155 (292)
Q Consensus 82 ~~~~~~L~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~givH~dl~p~Nilv~~~~---~~kl~dfg~~~~~~~~~--- 155 (292)
|+.|++|.+.+.....+++..++.++.||+.||.|||++||+|+||||+||+++.++ .+||+|||++.......
T Consensus 109 ~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~al~~lH~~~ivH~Dlkp~NIll~~~~~~~~~kl~DfG~a~~~~~~~~~~ 188 (362)
T 2bdw_A 109 LVTGGELFEDIVAREFYSEADASHCIQQILESIAYCHSNGIVHRNLKPENLLLASKAKGAAVKLADFGLAIEVNDSEAWH 188 (362)
T ss_dssp CCCSCBHHHHHTTCSCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCSGGGEEESCSSTTCCEEECCCTTCBCCTTCCSCC
T ss_pred cCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEeccCchHHEEEecCCCCCCEEEeecCcceEecCCcccc
Confidence 999999999988877899999999999999999999999999999999999998654 59999999997665322
Q ss_pred -cccccccccccccccCCCC-----CCCcccceeeecCCCCCCchHHHHHHHhhcccCCCCCCChhhhhhccCcCCCCCC
Q psy758 156 -PRHLHIFQTNEYFKGVSLP-----HAENVVPLEIKIGKPAATNIYLIDFLKRCLDKDPLRRWSCDQLLRHPYFNGYYFE 229 (292)
Q Consensus 156 -~~~~~~~~~~~~~~~~~~~-----~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~ 229 (292)
..++..|.+||...+.... |+.|+..+++.+|.++ +...+..++...........+
T Consensus 189 ~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~P------------------f~~~~~~~~~~~i~~~~~~~~ 250 (362)
T 2bdw_A 189 GFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPP------------------FWDEDQHRLYAQIKAGAYDYP 250 (362)
T ss_dssp CSCSCTTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCS------------------SCCSSHHHHHHHHHHTCCCCC
T ss_pred cCCCCccccCHHHHccCCCCchhhHHHHHHHHHHHHHCCCC------------------CCCCCHHHHHHHHHhCCCCCC
Confidence 1234456677666554332 3333444444444444 333332222221111111111
Q ss_pred ----CCCccchHHHHhcccCcCCCCCCChhhhhhCCcccce
Q psy758 230 ----VPDEMQYEEITQRCLDKDPLRRWSCDQLLRHPYFNGY 266 (292)
Q Consensus 230 ----~~~~~~l~~li~~~l~~dP~~Rpt~~~il~h~w~~~~ 266 (292)
...+..+.+||.+||+.||.+|||+.++++||||.+.
T Consensus 251 ~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~hp~~~~~ 291 (362)
T 2bdw_A 251 SPEWDTVTPEAKSLIDSMLTVNPKKRITADQALKVPWICNR 291 (362)
T ss_dssp TTGGGGSCHHHHHHHHHHSCSSGGGSCCHHHHTTSHHHHTH
T ss_pred cccccCCCHHHHHHHHHHcCCChhhCcCHHHHhcCcccCCC
Confidence 2347789999999999999999999999999999863
|
| >3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 4dea_A* 4deb_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-46 Score=303.16 Aligned_cols=256 Identities=20% Similarity=0.327 Sum_probs=200.0
Q ss_pred CcccceeeeecccCceEEEEEEEcCCCcEEEEEEeccCCCC-hHHHHHHHHHHHHHHhCCCCCcchhhhhhhcCCeEEEE
Q psy758 1 MERYEKIGKLGEGSYGVVFKCRNRDTGQVVAIKKFLESEED-PLIRKIALREIRLLKSLKHPNLVNLLEVFRRKKKLHLV 79 (292)
Q Consensus 1 ~~~y~~~~~l~~g~~~~v~~~~~~~~~~~v~iK~~~~~~~~-~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~iv 79 (292)
+++|++.+.||+|++|.||+|.+..++..||+|++...... ......+.+|+.+++.++||||+++++++.+.+..++|
T Consensus 8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 87 (279)
T 3fdn_A 8 LEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYFHDATRVYLI 87 (279)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHHTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEE
T ss_pred cccEEEeeEEecCCCeEEEEEEEccCCcEEEEEEEeccccchhhHHHHHHHHHHHHHcCCCCCCcchhheEecCCEEEEE
Confidence 47899999999999999999999999999999998654321 12246688999999999999999999999999999999
Q ss_pred EecCCCccHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEEccCCcEEEeecCchhhhhccc---c
Q psy758 80 FEFCDHTVLNELENHPHGLPWDLIKQITWQVLRGVSYCHRHACIHRDIKPENILLTANGVVKLCDFGFARLIRDLI---P 156 (292)
Q Consensus 80 ~e~~~~~~L~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~givH~dl~p~Nilv~~~~~~kl~dfg~~~~~~~~~---~ 156 (292)
|||+++++|..++.....+++..++.++.||+.||.|||++|++|+||+|+||+++.++.++|+|||++....... .
T Consensus 88 ~e~~~~~~l~~~l~~~~~~~~~~~~~~~~qi~~~l~~LH~~~i~H~dlkp~Nili~~~~~~~l~Dfg~~~~~~~~~~~~~ 167 (279)
T 3fdn_A 88 LEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCHSKRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRRTDL 167 (279)
T ss_dssp ECCCTTEEHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHTTTCEECCCCGGGEEECTTSCEEECSCCEESCC--------
T ss_pred EecCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCEecccCChHhEEEcCCCCEEEEeccccccCCccccccc
Confidence 9999999999998877789999999999999999999999999999999999999999999999999886543321 2
Q ss_pred ccccccccccccccCCCCCCCcccceeeecCCCCCCchHHHHHHHhhcccCCCCCCChhhhhhccCcCCCCCCCCCccch
Q psy758 157 RHLHIFQTNEYFKGVSLPHAENVVPLEIKIGKPAATNIYLIDFLKRCLDKDPLRRWSCDQLLRHPYFNGYYFEVPDEMQY 236 (292)
Q Consensus 157 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~l 236 (292)
..+..|.+||...+.......++| +.+.-++..+.+..|+...+..+............+...+..+
T Consensus 168 ~~~~~y~aPE~~~~~~~~~~~Di~-------------slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 234 (279)
T 3fdn_A 168 CGTLDYLPPEMIEGRMHDEKVDLW-------------SLGVLCYEFLVGKPPFEANTYQETYKRISRVEFTFPDFVTEGA 234 (279)
T ss_dssp CCCCTTCCHHHHTTCCCCTTHHHH-------------HHHHHHHHHHHSSCTTCCSSHHHHHHHHHHTCCCCCTTSCHHH
T ss_pred CCCCCccCHhHhccCCCCccchhH-------------hHHHHHHHHHHCCCCCCCCcHHHHHHHHHhCCCCCCCcCCHHH
Confidence 233456666665544333222222 2233344444555565555554444332222334455568899
Q ss_pred HHHHhcccCcCCCCCCChhhhhhCCcccceecc
Q psy758 237 EEITQRCLDKDPLRRWSCDQLLRHPYFNGYYFE 269 (292)
Q Consensus 237 ~~li~~~l~~dP~~Rpt~~~il~h~w~~~~~~~ 269 (292)
.+||.+||+.||.+|||++|+++||||++...+
T Consensus 235 ~~li~~~l~~~p~~Rps~~e~l~h~~~~~~~~~ 267 (279)
T 3fdn_A 235 RDLISRLLKHNPSQRPMLREVLEHPWITANSSK 267 (279)
T ss_dssp HHHHHHHCCSSGGGSCCHHHHHHCHHHHHHCSS
T ss_pred HHHHHHHhccChhhCCCHHHHhhCccccCCccC
Confidence 999999999999999999999999999986543
|
| >1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-45 Score=299.32 Aligned_cols=264 Identities=33% Similarity=0.506 Sum_probs=196.6
Q ss_pred CcccceeeeecccCceEEEEEEEcCCCcEEEEEEeccCCCChHHHHHHHHHHHHHHhCCCCCcchhhhhhhcCCeEEEEE
Q psy758 1 MERYEKIGKLGEGSYGVVFKCRNRDTGQVVAIKKFLESEEDPLIRKIALREIRLLKSLKHPNLVNLLEVFRRKKKLHLVF 80 (292)
Q Consensus 1 ~~~y~~~~~l~~g~~~~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~iv~ 80 (292)
|++|++.+.||+|+||.||+|.+ .+++.||+|.+..........+.+.+|+.+++.++||||+++++++.+++..++||
T Consensus 1 ~~~y~~~~~lg~G~~g~V~~~~~-~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ 79 (288)
T 1ob3_A 1 MEKYHGLEKIGEGTYGVVYKAQN-NYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKLYDVIHTKKRLVLVF 79 (288)
T ss_dssp CCSEEEEEEEEEETTEEEEEEEE-TTSCEEEEEEECCSSGGGCCCHHHHHHHHGGGGCCCTTBCCEEEEEECSSCEEEEE
T ss_pred CccchhhhhcccCCCEEEEEEEc-CCCCEEEEEEEeccccccccchhHHHHHHHHHhcCCCCEeeeeeEEccCCeEEEEE
Confidence 68999999999999999999998 67899999999765544334466789999999999999999999999999999999
Q ss_pred ecCCCccHHHHhcC-CCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEEccCCcEEEeecCchhhhhccc----
Q psy758 81 EFCDHTVLNELENH-PHGLPWDLIKQITWQVLRGVSYCHRHACIHRDIKPENILLTANGVVKLCDFGFARLIRDLI---- 155 (292)
Q Consensus 81 e~~~~~~L~~~~~~-~~~~~~~~~~~i~~qi~~aL~~LH~~givH~dl~p~Nilv~~~~~~kl~dfg~~~~~~~~~---- 155 (292)
||+++ +|..++.. .+.+++..++.++.||+.||.|||++|++||||||+||+++.++.+||+|||++.......
T Consensus 80 e~~~~-~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~ 158 (288)
T 1ob3_A 80 EHLDQ-DLKKLLDVCEGGLESVTAKSFLLQLLNGIAYCHDRRVLHRDLKPQNLLINREGELKIADFGLARAFGIPVRKYT 158 (288)
T ss_dssp ECCSE-EHHHHHHTSTTCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTSCEEECCTTHHHHHCC------
T ss_pred EecCC-CHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEEcCCCCEEEeECccccccCccccccc
Confidence 99997 56665544 4679999999999999999999999999999999999999999999999999998754321
Q ss_pred -cccccccccccccccCC------CCCCCcccceeeecCCCCCCchHHHHHHHhh---ccc-CCCCCCChhhhhhc-cCc
Q psy758 156 -PRHLHIFQTNEYFKGVS------LPHAENVVPLEIKIGKPAATNIYLIDFLKRC---LDK-DPLRRWSCDQLLRH-PYF 223 (292)
Q Consensus 156 -~~~~~~~~~~~~~~~~~------~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~---~~~-~p~~~~~~~~~~~~-~~~ 223 (292)
...+..|.+||...+.. ..|+.|+..+++.+|..++......+.+... +.. .+...+...+.... +.+
T Consensus 159 ~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (288)
T 1ob3_A 159 HEIVTLWYRAPDVLMGSKKYSTTIDIWSVGCIFAEMVNGTPLFPGVSEADQLMRIFRILGTPNSKNWPNVTELPKYDPNF 238 (288)
T ss_dssp ---CCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTTTSTTGGGSTTCCTTC
T ss_pred cccccccccCchheeCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHHCCCChhhchhhhccccccccc
Confidence 22345577887765432 2466666777777777765443332222222 122 11111121111100 000
Q ss_pred CC---C---CCCCCCccchHHHHhcccCcCCCCCCChhhhhhCCcccce
Q psy758 224 NG---Y---YFEVPDEMQYEEITQRCLDKDPLRRWSCDQLLRHPYFNGY 266 (292)
Q Consensus 224 ~~---~---~~~~~~~~~l~~li~~~l~~dP~~Rpt~~~il~h~w~~~~ 266 (292)
.. . ......+..+.+||.+||+.||++|||++|+++||||++.
T Consensus 239 ~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~hp~f~~~ 287 (288)
T 1ob3_A 239 TVYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQALEHAYFKEN 287 (288)
T ss_dssp CCCCCCCGGGTCCSCCHHHHHHHHHHTCSSTTTSCCHHHHHTSGGGGC-
T ss_pred ccccCccHHHHhhhcCHHHHHHHHHHcCCCcccCCCHHHHhcCcchhhc
Confidence 00 0 1112357788999999999999999999999999999863
|
| >3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.1e-46 Score=307.48 Aligned_cols=252 Identities=25% Similarity=0.332 Sum_probs=194.4
Q ss_pred CcccceeeeecccCceEEEEEEEcCCCcEEEEEEeccCCCC-hHHHHHHHHHHHHHHhCCCCCcchhhhhhhcCCeEEEE
Q psy758 1 MERYEKIGKLGEGSYGVVFKCRNRDTGQVVAIKKFLESEED-PLIRKIALREIRLLKSLKHPNLVNLLEVFRRKKKLHLV 79 (292)
Q Consensus 1 ~~~y~~~~~l~~g~~~~v~~~~~~~~~~~v~iK~~~~~~~~-~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~iv 79 (292)
+++|++.+.||+|+||.||+|.+..+++.||+|++...... ......+.+|+.+++.++||||+++++++.+++..++|
T Consensus 8 i~~Y~i~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv 87 (336)
T 3h4j_B 8 IGPYIIRETLGEGSFGKVKLATHYKTQQKVALKFISRQLLKKSDMHMRVEREISYLKLLRHPHIIKLYDVITTPTDIVMV 87 (336)
T ss_dssp ETTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCSHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEE
T ss_pred cCCEEEEEEEecCCCeEEEEEEECCCCCEEEEEEEehHHccchhHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEEE
Confidence 47999999999999999999999999999999998643211 11234678999999999999999999999999999999
Q ss_pred EecCCCccHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEEccCCcEEEeecCchhhhhcccc---
Q psy758 80 FEFCDHTVLNELENHPHGLPWDLIKQITWQVLRGVSYCHRHACIHRDIKPENILLTANGVVKLCDFGFARLIRDLIP--- 156 (292)
Q Consensus 80 ~e~~~~~~L~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~givH~dl~p~Nilv~~~~~~kl~dfg~~~~~~~~~~--- 156 (292)
|||+ +|+|.+++...+.+++..++.++.||+.||.|||++|++||||||+||++++++.+||+|||++........
T Consensus 88 ~E~~-~g~l~~~l~~~~~l~~~~~~~i~~qi~~aL~~LH~~givH~Dlkp~NIll~~~~~~kl~DFG~s~~~~~~~~~~~ 166 (336)
T 3h4j_B 88 IEYA-GGELFDYIVEKKRMTEDEGRRFFQQIICAIEYCHRHKIVHRDLKPENLLLDDNLNVKIADFGLSNIMTDGNFLKT 166 (336)
T ss_dssp ECCC-CEEHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHHTCCCCCCSTTTEEECTTCCEEECCSSCTBTTTTSBTTCC
T ss_pred EECC-CCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCchhhEEEcCCCCEEEEEeccceeccCCccccc
Confidence 9999 456666665556899999999999999999999999999999999999999999999999999976543221
Q ss_pred -ccccccccccccccCCC-CCCCcccceeeecCCCCCCchHHHHHHHhhcccCCCCCCChhhhhhccCcCCCCCCCCCcc
Q psy758 157 -RHLHIFQTNEYFKGVSL-PHAENVVPLEIKIGKPAATNIYLIDFLKRCLDKDPLRRWSCDQLLRHPYFNGYYFEVPDEM 234 (292)
Q Consensus 157 -~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 234 (292)
.++..|.+||...+... ....+ +++.+.-++..+.+..|+......++...........+...+.
T Consensus 167 ~~gt~~y~aPE~~~~~~~~~~~~D-------------iwslG~il~~ll~g~~Pf~~~~~~~~~~~i~~~~~~~p~~~s~ 233 (336)
T 3h4j_B 167 SCGSPNYAAPEVINGKLYAGPEVD-------------VWSCGIVLYVMLVGRLPFDDEFIPNLFKKVNSCVYVMPDFLSP 233 (336)
T ss_dssp CTTSTTTSCGGGSCCSGGGCHHHH-------------HHHHHHHHHHHHHSSCSSBCSSSTTCBCCCCSSCCCCCTTSCH
T ss_pred ccCCcCcCCHHHHcCCCCCCCccc-------------hhHHHHHHHHHHhCCCCCCCccHHHHHHHHHcCCCCCcccCCH
Confidence 22334555555443322 11112 2333333444455555655544444444433333445556788
Q ss_pred chHHHHhcccCcCCCCCCChhhhhhCCcccce
Q psy758 235 QYEEITQRCLDKDPLRRWSCDQLLRHPYFNGY 266 (292)
Q Consensus 235 ~l~~li~~~l~~dP~~Rpt~~~il~h~w~~~~ 266 (292)
.+.+||.+||+.||.+|||++|+++||||+..
T Consensus 234 ~~~~li~~~L~~dP~~Rpt~~eil~hp~~~~~ 265 (336)
T 3h4j_B 234 GAQSLIRRMIVADPMQRITIQEIRRDPWFNVN 265 (336)
T ss_dssp HHHHHHHTTSCSSGGGSCCHHHHTTCHHHHTT
T ss_pred HHHHHHHHHcCCChhHCcCHHHHHhChhhccC
Confidence 99999999999999999999999999999864
|
| >4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.2e-46 Score=321.05 Aligned_cols=256 Identities=20% Similarity=0.283 Sum_probs=193.9
Q ss_pred CcccceeeeecccCceEEEEEEEcCCCcEEEEEEeccCC-CChHHHHHHHHHHHHHHhCCCCCcchhhhhhhcCCeEEEE
Q psy758 1 MERYEKIGKLGEGSYGVVFKCRNRDTGQVVAIKKFLESE-EDPLIRKIALREIRLLKSLKHPNLVNLLEVFRRKKKLHLV 79 (292)
Q Consensus 1 ~~~y~~~~~l~~g~~~~v~~~~~~~~~~~v~iK~~~~~~-~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~iv 79 (292)
+++|++.+.||+|+||.||+|.+..+++.||+|++.... ........+.+|+.+++.++||||+++++++.+.+.+++|
T Consensus 147 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~l~~~~~~~~~~~lv 226 (446)
T 4ejn_A 147 MNEFEYLKLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALKYSFQTHDRLCFV 226 (446)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHC-------------CCCCCSCTTSCCEEEEEEETTEEEEE
T ss_pred hHHcEEeEEEeeCcCEEEEEEEEcCCCCEEEEEEEEhhhhhhhHHHHHHHHHHHHHHhCCCCeEeeEEEEEeeCCEEEEE
Confidence 368999999999999999999999999999999997542 2233445677899999999999999999999999999999
Q ss_pred EecCCCccHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHh-CCccccCCCCCceEEccCCcEEEeecCchhhhhccc---
Q psy758 80 FEFCDHTVLNELENHPHGLPWDLIKQITWQVLRGVSYCHR-HACIHRDIKPENILLTANGVVKLCDFGFARLIRDLI--- 155 (292)
Q Consensus 80 ~e~~~~~~L~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~-~givH~dl~p~Nilv~~~~~~kl~dfg~~~~~~~~~--- 155 (292)
|||+++++|..++.....+++..++.++.||+.||+|||+ +||+||||||+|||++.++.+||+|||++.......
T Consensus 227 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~giiHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~~~~~ 306 (446)
T 4ejn_A 227 MEYANGGELFFHLSRERVFSEDRARFYGAEIVSALDYLHSEKNVVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDGATM 306 (446)
T ss_dssp ECCCSSCBHHHHHHHHSCCCHHHHHHHHHHHHHHHHHHHHHTCCCCCCCCGGGEEECSSSCEEECCCCCCCTTCC-----
T ss_pred EeeCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhcCCEEECCCCHHHEEECCCCCEEEccCCCceeccCCCccc
Confidence 9999999999999877789999999999999999999998 999999999999999999999999999987643222
Q ss_pred --cccccccccccccccCCCCCCCcccceeeecCCCCCCchHHHHHHHhhcccCCCCCCChhhhhhccCcCCCCCCCCCc
Q psy758 156 --PRHLHIFQTNEYFKGVSLPHAENVVPLEIKIGKPAATNIYLIDFLKRCLDKDPLRRWSCDQLLRHPYFNGYYFEVPDE 233 (292)
Q Consensus 156 --~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 233 (292)
..++..|.+||...+.......|+| +.+.-++..+.+..|+...+..++...........+...+
T Consensus 307 ~~~~gt~~y~aPE~~~~~~~~~~~Diw-------------slG~il~ell~g~~Pf~~~~~~~~~~~i~~~~~~~p~~~~ 373 (446)
T 4ejn_A 307 KTFCGTPEYLAPEVLEDNDYGRAVDWW-------------GLGVVMYEMMCGRLPFYNQDHEKLFELILMEEIRFPRTLG 373 (446)
T ss_dssp CCSSSCGGGCCHHHHHTSCCCTHHHHH-------------HHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCCTTSC
T ss_pred ccccCCccccCHhhcCCCCCCCccchh-------------hhHHHHHHHhhCCCCCCCCCHHHHHHHHHhCCCCCCccCC
Confidence 2234456666665444333222222 2223333444455555544444444433333444556678
Q ss_pred cchHHHHhcccCcCCCCCC-----ChhhhhhCCcccceecc
Q psy758 234 MQYEEITQRCLDKDPLRRW-----SCDQLLRHPYFNGYYFE 269 (292)
Q Consensus 234 ~~l~~li~~~l~~dP~~Rp-----t~~~il~h~w~~~~~~~ 269 (292)
..+.+||.+||+.||.+|| |++|+++||||+++.|+
T Consensus 374 ~~~~~li~~~L~~dP~~R~~~~~~t~~ell~hp~f~~~~~~ 414 (446)
T 4ejn_A 374 PEAKSLLSGLLKKDPKQRLGGGSEDAKEIMQHRFFAGIVWQ 414 (446)
T ss_dssp HHHHHHHHHHTCSSTTTSTTCSTTTHHHHHTSGGGTTCCHH
T ss_pred HHHHHHHHHHcccCHHHhCCCCCCCHHHHHhCccccCCCHH
Confidence 8999999999999999999 99999999999998776
|
| >2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.7e-46 Score=310.84 Aligned_cols=256 Identities=18% Similarity=0.234 Sum_probs=190.0
Q ss_pred CcccceeeeecccCceEEEEEEEcCCCcEEEEEEeccCCC-ChHHHHHHHHHHHH-HHhCCCCCcchhhhhhhcCCeEEE
Q psy758 1 MERYEKIGKLGEGSYGVVFKCRNRDTGQVVAIKKFLESEE-DPLIRKIALREIRL-LKSLKHPNLVNLLEVFRRKKKLHL 78 (292)
Q Consensus 1 ~~~y~~~~~l~~g~~~~v~~~~~~~~~~~v~iK~~~~~~~-~~~~~~~~~~e~~~-~~~l~~~~i~~~~~~~~~~~~~~i 78 (292)
+++|++.+.||+|+||.||+|++..+++.||+|++..... .......+..|..+ ++.++||||+++++++.+.+.+|+
T Consensus 37 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~e~~~ll~~~~hp~Iv~l~~~~~~~~~~~l 116 (373)
T 2r5t_A 37 PSDFHFLKVIGKGSFGKVLLARHKAEEVFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGLHFSFQTADKLYF 116 (373)
T ss_dssp GGGEEEEEEEECCTTCEEEEEEETTTCCEEEEEEEEGGGBC-------------CCBCCCCCTTBCCEEEEEECSSEEEE
T ss_pred hhheEEEEEEeeCCCeEEEEEEEcCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHHhCCCCCCCCEEEEEEeCCEEEE
Confidence 3689999999999999999999999999999999976543 22334556667766 567899999999999999999999
Q ss_pred EEecCCCccHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEEccCCcEEEeecCchhhhhccccc-
Q psy758 79 VFEFCDHTVLNELENHPHGLPWDLIKQITWQVLRGVSYCHRHACIHRDIKPENILLTANGVVKLCDFGFARLIRDLIPR- 157 (292)
Q Consensus 79 v~e~~~~~~L~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~givH~dl~p~Nilv~~~~~~kl~dfg~~~~~~~~~~~- 157 (292)
||||++||+|..++...+.+++..++.++.||+.||.|||++||+||||||+||+++.+|++||+|||+++........
T Consensus 117 v~E~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NIll~~~g~ikL~DFG~a~~~~~~~~~~ 196 (373)
T 2r5t_A 117 VLDYINGGELFYHLQRERCFLEPRARFYAAEIASALGYLHSLNIVYRDLKPENILLDSQGHIVLTDFGLCKENIEHNSTT 196 (373)
T ss_dssp EEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTSCEEECCCCBCGGGBCCCCCC
T ss_pred EEeCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCHHHEEECCCCCEEEeeCccccccccCCCcc
Confidence 9999999999999987778999999999999999999999999999999999999999999999999999764332222
Q ss_pred ----cccccccccccccCCCCCCCcccceeeecCCCCCCchHHHHHHHhhcccCCCCCCChhhhhhccCcCCCCCCCCCc
Q psy758 158 ----HLHIFQTNEYFKGVSLPHAENVVPLEIKIGKPAATNIYLIDFLKRCLDKDPLRRWSCDQLLRHPYFNGYYFEVPDE 233 (292)
Q Consensus 158 ----~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 233 (292)
++..|.+||...+.......++| +.+.-+++.+.+..|+...+..++...........+...+
T Consensus 197 ~~~~gt~~y~aPE~~~~~~~~~~~Diw-------------slG~il~ell~G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~ 263 (373)
T 2r5t_A 197 STFCGTPEYLAPEVLHKQPYDRTVDWW-------------CLGAVLYEMLYGLPPFYSRNTAEMYDNILNKPLQLKPNIT 263 (373)
T ss_dssp CSBSCCCCCCCHHHHTTCCCCTHHHHH-------------HHHHHHHHHHHSSCTTCCSBHHHHHHHHHHSCCCCCSSSC
T ss_pred ccccCCccccCHHHhCCCCCCchhhhH-------------HHHHHHHHHHcCCCCCCCCCHHHHHHHHHhcccCCCCCCC
Confidence 23345555555443332222222 2222333444444555444444433332222333445567
Q ss_pred cchHHHHhcccCcCCCCCCCh----hhhhhCCcccceecc
Q psy758 234 MQYEEITQRCLDKDPLRRWSC----DQLLRHPYFNGYYFE 269 (292)
Q Consensus 234 ~~l~~li~~~l~~dP~~Rpt~----~~il~h~w~~~~~~~ 269 (292)
..+++||.+||+.||.+||++ .++++||||+++.|+
T Consensus 264 ~~~~~li~~lL~~dp~~R~~~~~~~~~i~~h~~f~~~~w~ 303 (373)
T 2r5t_A 264 NSARHLLEGLLQKDRTKRLGAKDDFMEIKSHVFFSLINWD 303 (373)
T ss_dssp HHHHHHHHHHTCSSGGGSTTTTTTHHHHHTSGGGTTCCHH
T ss_pred HHHHHHHHHHcccCHHhCCCCCCCHHHHhCCccccCCCHH
Confidence 899999999999999999997 589999999998886
|
| >3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-45 Score=302.96 Aligned_cols=255 Identities=21% Similarity=0.254 Sum_probs=188.9
Q ss_pred cccceeeeecccCceEEEEEEEc---CCCcEEEEEEeccCCC--ChHHHHHHHHHHHHHHhCCCCCcchhhhhhhcCCeE
Q psy758 2 ERYEKIGKLGEGSYGVVFKCRNR---DTGQVVAIKKFLESEE--DPLIRKIALREIRLLKSLKHPNLVNLLEVFRRKKKL 76 (292)
Q Consensus 2 ~~y~~~~~l~~g~~~~v~~~~~~---~~~~~v~iK~~~~~~~--~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~ 76 (292)
++|++.+.||+|+||.||+|++. .+++.||+|++..... .......+.+|+.+++.++||||+++++++.+++.+
T Consensus 17 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~ 96 (327)
T 3a62_A 17 ECFELLRVLGKGGYGKVFQVRKVTGANTGKIFAMKVLKKAMIVRNAKDTAHTKAERNILEEVKHPFIVDLIYAFQTGGKL 96 (327)
T ss_dssp GGEEEEEEEEEETTEEEEEEEECSSTTTTCEEEEEEECCC--------------HHHHHHHCCCTTBCCEEEEEECSSCE
T ss_pred HHeEEEEEEEeCCCEEEEEEEEeccCCCCcEEEEEEEEHHHhhhhhhHHHHHHHHHHHHHhCCCCCccceeEEEEcCCEE
Confidence 68999999999999999999985 6799999999976532 223445677899999999999999999999999999
Q ss_pred EEEEecCCCccHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEEccCCcEEEeecCchhhhhccc-
Q psy758 77 HLVFEFCDHTVLNELENHPHGLPWDLIKQITWQVLRGVSYCHRHACIHRDIKPENILLTANGVVKLCDFGFARLIRDLI- 155 (292)
Q Consensus 77 ~iv~e~~~~~~L~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~givH~dl~p~Nilv~~~~~~kl~dfg~~~~~~~~~- 155 (292)
|+||||++|++|..++...+.+++..++.++.||+.||.|||++||+||||||+||+++.++.+||+|||++.......
T Consensus 97 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~al~~lH~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~ 176 (327)
T 3a62_A 97 YLILEYLSGGELFMQLEREGIFMEDTACFYLAEISMALGHLHQKGIIYRDLKPENIMLNHQGHVKLTDFGLCKESIHDGT 176 (327)
T ss_dssp EEEEECCTTEEHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCTTTEEECTTSCEEECCCSCC--------
T ss_pred EEEEeCCCCCcHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCEEcccCCHHHeEECCCCcEEEEeCCcccccccCCc
Confidence 9999999999999999877789999999999999999999999999999999999999999999999999987543221
Q ss_pred ----cccccccccccccccCCCCCCCcccceeeecCCCCCCchHHHHHHHhhcccCCCCCCChhhhhhccCcCCCCCCCC
Q psy758 156 ----PRHLHIFQTNEYFKGVSLPHAENVVPLEIKIGKPAATNIYLIDFLKRCLDKDPLRRWSCDQLLRHPYFNGYYFEVP 231 (292)
Q Consensus 156 ----~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~ 231 (292)
..++..|.+||...+.......++|+ .+.-++..+.+..|+...+..+............+..
T Consensus 177 ~~~~~~gt~~y~aPE~~~~~~~~~~~Diws-------------lG~il~el~~g~~pf~~~~~~~~~~~i~~~~~~~p~~ 243 (327)
T 3a62_A 177 VTHTFCGTIEYMAPEILMRSGHNRAVDWWS-------------LGALMYDMLTGAPPFTGENRKKTIDKILKCKLNLPPY 243 (327)
T ss_dssp --CTTSSCCTTSCHHHHTTSCCCTHHHHHH-------------HHHHHHHHHHSSCSCCCSSHHHHHHHHHHTCCCCCTT
T ss_pred cccccCCCcCccCHhhCcCCCCCCcccchh-------------HHHHHHHHHHCCCCCCCCCHHHHHHHHHhCCCCCCCC
Confidence 12334466666654443322222222 2222333344444544444433333222222334455
Q ss_pred CccchHHHHhcccCcCCCCCC-----ChhhhhhCCcccceecc
Q psy758 232 DEMQYEEITQRCLDKDPLRRW-----SCDQLLRHPYFNGYYFE 269 (292)
Q Consensus 232 ~~~~l~~li~~~l~~dP~~Rp-----t~~~il~h~w~~~~~~~ 269 (292)
.+..+.+||.+||+.||.+|| +++++++||||+++.|+
T Consensus 244 ~~~~~~~li~~~L~~dp~~R~~~~~~~~~e~l~hp~f~~~~~~ 286 (327)
T 3a62_A 244 LTQEARDLLKKLLKRNAASRLGAGPGDAGEVQAHPFFRHINWE 286 (327)
T ss_dssp SCHHHHHHHHHHSCSCGGGSTTSSTTTHHHHHHSGGGSSCCHH
T ss_pred CCHHHHHHHHHHHhcCHhhccCCCCCCHHHHHcCCcccCCCHH
Confidence 678999999999999999999 88899999999998775
|
| >1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-45 Score=302.26 Aligned_cols=247 Identities=22% Similarity=0.317 Sum_probs=191.3
Q ss_pred CcccceeeeecccCceEEEEEEEcCCCcEEEEEEeccCCCChHHHHHHHHHHHHHHhCCCCCcchhhhhhhcCCeEEEEE
Q psy758 1 MERYEKIGKLGEGSYGVVFKCRNRDTGQVVAIKKFLESEEDPLIRKIALREIRLLKSLKHPNLVNLLEVFRRKKKLHLVF 80 (292)
Q Consensus 1 ~~~y~~~~~l~~g~~~~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~iv~ 80 (292)
.++|++.+.||+|+||.||+|.+..+++.||+|.+.... .....+.+|+.+++.++||||+++++++.+.+.+++||
T Consensus 4 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~a~K~~~~~~---~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~ 80 (321)
T 1tki_A 4 YEKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVKG---TDQVLVKKEISILNIARHRNILHLHESFESMEELVMIF 80 (321)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCCT---HHHHHHHHHHHHHHHSCCTTBCCEEEEEEETTEEEEEE
T ss_pred hhceEeeeEEecCCCeEEEEEEECCCCcEEEEEEEecCc---ccHHHHHHHHHHHHhCCCCCCCeEeEEEecCCEEEEEE
Confidence 368999999999999999999999999999999986443 33456789999999999999999999999999999999
Q ss_pred ecCCCccHHHHhcCC-CCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEEcc--CCcEEEeecCchhhhhccc--
Q psy758 81 EFCDHTVLNELENHP-HGLPWDLIKQITWQVLRGVSYCHRHACIHRDIKPENILLTA--NGVVKLCDFGFARLIRDLI-- 155 (292)
Q Consensus 81 e~~~~~~L~~~~~~~-~~~~~~~~~~i~~qi~~aL~~LH~~givH~dl~p~Nilv~~--~~~~kl~dfg~~~~~~~~~-- 155 (292)
||++|++|.+++... ..+++..++.++.||+.||.|||++|++|+||||+||+++. ++.++|+|||++.......
T Consensus 81 e~~~g~~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~~givH~Dlkp~NIl~~~~~~~~~kl~Dfg~a~~~~~~~~~ 160 (321)
T 1tki_A 81 EFISGLDIFERINTSAFELNEREIVSYVHQVCEALQFLHSHNIGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPGDNF 160 (321)
T ss_dssp CCCCCCBHHHHHTSSSCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESSSSCCCEEECCCTTCEECCTTCEE
T ss_pred EeCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCCCcCCCCHHHEEEccCCCCCEEEEECCCCeECCCCCcc
Confidence 999999999998764 36999999999999999999999999999999999999997 7899999999997654321
Q ss_pred --cccccccccccccccCCC-----CCCCcccceeeecCCCCCCchHHHHHHHhhcccCCCCCCChhhhhhccCcCCCCC
Q psy758 156 --PRHLHIFQTNEYFKGVSL-----PHAENVVPLEIKIGKPAATNIYLIDFLKRCLDKDPLRRWSCDQLLRHPYFNGYYF 228 (292)
Q Consensus 156 --~~~~~~~~~~~~~~~~~~-----~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~ 228 (292)
...+..|.+||...+... .|+.|+..+++.+|. .|+...+..+.+....-.....
T Consensus 161 ~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~------------------~pf~~~~~~~~~~~i~~~~~~~ 222 (321)
T 1tki_A 161 RLLFTAPEYYAPEVHQHDVVSTATDMWSLGTLVYVLLSGI------------------NPFLAETNQQIIENIMNAEYTF 222 (321)
T ss_dssp EEEESCGGGSCHHHHTTCEECHHHHHHHHHHHHHHHHHSS------------------CTTCCSSHHHHHHHHHHTCCCC
T ss_pred ccccCChhhcCcHHhcCCCCCchhhHHHHHHHHHHHHhCC------------------CCCcCCCHHHHHHHHHcCCCCC
Confidence 112334555555444322 233333444444444 4444333333322211111111
Q ss_pred C----CCCccchHHHHhcccCcCCCCCCChhhhhhCCcccceec
Q psy758 229 E----VPDEMQYEEITQRCLDKDPLRRWSCDQLLRHPYFNGYYF 268 (292)
Q Consensus 229 ~----~~~~~~l~~li~~~l~~dP~~Rpt~~~il~h~w~~~~~~ 268 (292)
+ ...+..+.+||.+||+.||.+|||+.|+++||||++...
T Consensus 223 ~~~~~~~~s~~~~~li~~~L~~dp~~Rpt~~e~l~hp~~~~~~~ 266 (321)
T 1tki_A 223 DEEAFKEISIEAMDFVDRLLVKERKSRMTASEALQHPWLKQKIE 266 (321)
T ss_dssp CHHHHTTSCHHHHHHHHTTSCSSGGGSCCHHHHHHSHHHHSCGG
T ss_pred ChhhhccCCHHHHHHHHHHcCCChhHCcCHHHHhcChhhccCcc
Confidence 1 244778999999999999999999999999999987543
|
| >3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.5e-45 Score=295.96 Aligned_cols=253 Identities=22% Similarity=0.348 Sum_probs=186.9
Q ss_pred CcccceeeeecccCceEEEEEEEcCCCcEEEEEEeccCCC-ChHHHHHHHHHHHHHHhCCCCCcchhhhhhhcCCeEEEE
Q psy758 1 MERYEKIGKLGEGSYGVVFKCRNRDTGQVVAIKKFLESEE-DPLIRKIALREIRLLKSLKHPNLVNLLEVFRRKKKLHLV 79 (292)
Q Consensus 1 ~~~y~~~~~l~~g~~~~v~~~~~~~~~~~v~iK~~~~~~~-~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~iv 79 (292)
+++|++.+.||+|++|.||+|.+..+++.||+|++..... .....+.+.+|+.+++.++||||+++++++.+.+..++|
T Consensus 10 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 89 (278)
T 3cok_A 10 IEDFKVGNLLGKGSFAGVYRAESIHTGLEVAIKMIDKKAMYKAGMVQRVQNEVKIHCQLKHPSILELYNYFEDSNYVYLV 89 (278)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTBCCTTBCCEEEEEECSSEEEEE
T ss_pred cccceeeeeecCCCceEEEEEEEccCCceEEEEEeehhhhhhhhHHHHHHHHHHHHHhCCCCCeEeEEEEEccCCeEEEE
Confidence 4789999999999999999999999999999999864321 112246688999999999999999999999999999999
Q ss_pred EecCCCccHHHHhcCC-CCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEEccCCcEEEeecCchhhhhcccc--
Q psy758 80 FEFCDHTVLNELENHP-HGLPWDLIKQITWQVLRGVSYCHRHACIHRDIKPENILLTANGVVKLCDFGFARLIRDLIP-- 156 (292)
Q Consensus 80 ~e~~~~~~L~~~~~~~-~~~~~~~~~~i~~qi~~aL~~LH~~givH~dl~p~Nilv~~~~~~kl~dfg~~~~~~~~~~-- 156 (292)
+||+++++|..++... ..+++..++.++.||+.||.|||++|++|+||+|+||+++.++.++|+|||++........
T Consensus 90 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~Nili~~~~~~kl~dfg~~~~~~~~~~~~ 169 (278)
T 3cok_A 90 LEMCHNGEMNRYLKNRVKPFSENEARHFMHQIITGMLYLHSHGILHRDLTLSNLLLTRNMNIKIADFGLATQLKMPHEKH 169 (278)
T ss_dssp EECCTTEEHHHHHHTCSSCCCHHHHHHHHHHHHHHHHHHHHTTEECSSCCGGGEEECTTCCEEECCCTTCEECC------
T ss_pred EecCCCCcHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEEcCCCCEEEEeecceeeccCCCCcc
Confidence 9999999999998764 5699999999999999999999999999999999999999999999999999876543221
Q ss_pred ---ccccccccccccccCCCCCCCcccceeeecCCCCCCchHHHHHHHhhcccCCCCCCChhhhhhccCcCCCCCCCCCc
Q psy758 157 ---RHLHIFQTNEYFKGVSLPHAENVVPLEIKIGKPAATNIYLIDFLKRCLDKDPLRRWSCDQLLRHPYFNGYYFEVPDE 233 (292)
Q Consensus 157 ---~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 233 (292)
..+..|.+||...+.......++ ++.+.-++..+.+..|.......+.+..........+...+
T Consensus 170 ~~~~~~~~y~aPE~~~~~~~~~~~Di-------------~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (278)
T 3cok_A 170 YTLCGTPNYISPEIATRSAHGLESDV-------------WSLGCMFYTLLIGRPPFDTDTVKNTLNKVVLADYEMPSFLS 236 (278)
T ss_dssp ----------------------CTHH-------------HHHHHHHHHHHHSSCSSCCCSCC-----CCSSCCCCCTTSC
T ss_pred eeccCCCCcCCcchhcCCCCCchhhH-------------HHHHHHHHHHHhCCCCCCChhHHHHHHHHhhcccCCccccC
Confidence 22334555555443332222222 33333445555566665554444444443334444555668
Q ss_pred cchHHHHhcccCcCCCCCCChhhhhhCCcccce
Q psy758 234 MQYEEITQRCLDKDPLRRWSCDQLLRHPYFNGY 266 (292)
Q Consensus 234 ~~l~~li~~~l~~dP~~Rpt~~~il~h~w~~~~ 266 (292)
..+.+||.+||+.||++|||++++++||||.+.
T Consensus 237 ~~~~~li~~~l~~dp~~Rps~~~~l~h~~~~~~ 269 (278)
T 3cok_A 237 IEAKDLIHQLLRRNPADRLSLSSVLDHPFMSRN 269 (278)
T ss_dssp HHHHHHHHHHSCSSGGGSCCHHHHTTSTTTC--
T ss_pred HHHHHHHHHHcccCHhhCCCHHHHhcCccccCC
Confidence 899999999999999999999999999999873
|
| >4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} PDB: 4bbm_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-45 Score=305.99 Aligned_cols=267 Identities=43% Similarity=0.712 Sum_probs=202.1
Q ss_pred CcccceeeeecccCceEEEEEEEcCCCcEEEEEEeccCCCChHHHHHHHHHHHHHHhCCCCCcchhhhhhhcCCeEEEEE
Q psy758 1 MERYEKIGKLGEGSYGVVFKCRNRDTGQVVAIKKFLESEEDPLIRKIALREIRLLKSLKHPNLVNLLEVFRRKKKLHLVF 80 (292)
Q Consensus 1 ~~~y~~~~~l~~g~~~~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~iv~ 80 (292)
+++|++.+.||+|++|.||+|.+..+++.||+|++..........+.+.+|+.+++.++||||+++++++.+.+..++||
T Consensus 24 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ 103 (331)
T 4aaa_A 24 MEKYENLGLVGEGSYGMVMKCRNKDTGRIVAIKKFLESDDDKMVKKIAMREIKLLKQLRHENLVNLLEVCKKKKRWYLVF 103 (331)
T ss_dssp GGGEEEEEEGGGGTTSSEEEEEETTTCCEEEEEEEESCSSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEE
T ss_pred hhhheeeeEEeecCCEEEEEEEECCCCceEEEEEEecCCCchHHHHHHHHHHHHHhhCCCCCEeeEEEEeecCCEEEEEE
Confidence 57999999999999999999999999999999999877777777788899999999999999999999999999999999
Q ss_pred ecCCCccHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEEccCCcEEEeecCchhhhhcc-----c
Q psy758 81 EFCDHTVLNELENHPHGLPWDLIKQITWQVLRGVSYCHRHACIHRDIKPENILLTANGVVKLCDFGFARLIRDL-----I 155 (292)
Q Consensus 81 e~~~~~~L~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~givH~dl~p~Nilv~~~~~~kl~dfg~~~~~~~~-----~ 155 (292)
||+++++|..+......+++..++.++.||+.||.|||++|++|+||+|+||+++.++.++|+|||++...... .
T Consensus 104 e~~~~~~l~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~ 183 (331)
T 4aaa_A 104 EFVDHTILDDLELFPNGLDYQVVQKYLFQIINGIGFCHSHNIIHRDIKPENILVSQSGVVKLCDFGFARTLAAPGEVYDD 183 (331)
T ss_dssp ECCSEEHHHHHHHSTTCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTSCEEECCCTTC------------
T ss_pred ecCCcchHHHHHhhccCCCHHHHHHHHHHHHHHHHHHHHCCEEccCcChheEEEcCCCcEEEEeCCCceeecCCccccCC
Confidence 99999999999887778999999999999999999999999999999999999999999999999999765432 1
Q ss_pred cccccccccccccccC-C-----CCCCCcccceeeecCCCCCCchHHHHHHHhhcccCCCCCCChhh-hhhccCcCCCCC
Q psy758 156 PRHLHIFQTNEYFKGV-S-----LPHAENVVPLEIKIGKPAATNIYLIDFLKRCLDKDPLRRWSCDQ-LLRHPYFNGYYF 228 (292)
Q Consensus 156 ~~~~~~~~~~~~~~~~-~-----~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~-~~~~~~~~~~~~ 228 (292)
...+..|.+||...+. . ..|+.|+..+++.+|..++........+...........+.... .-..+.+.+...
T Consensus 184 ~~~t~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 263 (331)
T 4aaa_A 184 EVATRWYRAPELLVGDVKYGKAVDVWAIGCLVTEMFMGEPLFPGDSDIDQLYHIMMCLGNLIPRHQELFNKNPVFAGVRL 263 (331)
T ss_dssp CCCCCTTCCHHHHTTCTTCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCHHHHHHHHHCGGGTTCCC
T ss_pred CcCCccccCcccccCCCCcchHHHHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCChhhhhHhhhccccccccC
Confidence 2334557777766543 2 24566666666677766554332222221111000000000000 001111111111
Q ss_pred C------------CCCccchHHHHhcccCcCCCCCCChhhhhhCCccccee
Q psy758 229 E------------VPDEMQYEEITQRCLDKDPLRRWSCDQLLRHPYFNGYY 267 (292)
Q Consensus 229 ~------------~~~~~~l~~li~~~l~~dP~~Rpt~~~il~h~w~~~~~ 267 (292)
+ ...+..+.+||.+||+.||.+|||++|+|+||||+...
T Consensus 264 ~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpt~~ell~hp~f~~~~ 314 (331)
T 4aaa_A 264 PEIKEREPLERRYPKLSEVVIDLAKKCLHIDPDKRPFCAELLHHDFFQMDG 314 (331)
T ss_dssp CCCSSCCCHHHHSTTSCHHHHHHHHHHTCSSGGGSCCGGGGGGSHHHHGGG
T ss_pred ccccccchhhhcccchhHHHHHHHHHHhccCcccCCCHHHHhcCchhccCC
Confidence 1 13477899999999999999999999999999999754
|
| >2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.6e-45 Score=302.17 Aligned_cols=254 Identities=26% Similarity=0.327 Sum_probs=193.0
Q ss_pred cccceeeeecccCceEEEEEEEcCCCcEEEEEEeccCCCCh----HHHHHHHHHHHHHHhCCCCCcchhhhhhhcCCeEE
Q psy758 2 ERYEKIGKLGEGSYGVVFKCRNRDTGQVVAIKKFLESEEDP----LIRKIALREIRLLKSLKHPNLVNLLEVFRRKKKLH 77 (292)
Q Consensus 2 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~v~iK~~~~~~~~~----~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~ 77 (292)
++|++.+.||+|+||.||+|.+..+++.||+|++....... ...+.+.+|+.+++.++||||+++++++.+.+..+
T Consensus 11 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~ 90 (326)
T 2y0a_A 11 DYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVITLHEVYENKTDVI 90 (326)
T ss_dssp HHEEEEEEEECCSSEEEEEEEETTTCCEEEEEEEEBCCSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEE
T ss_pred cceEeceEEeeCCCeEEEEEEECCCCcEEEEEEEEccccccccchhhHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEEE
Confidence 47999999999999999999999999999999997654221 13466889999999999999999999999999999
Q ss_pred EEEecCCCccHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEEccCC----cEEEeecCchhhhhc
Q psy758 78 LVFEFCDHTVLNELENHPHGLPWDLIKQITWQVLRGVSYCHRHACIHRDIKPENILLTANG----VVKLCDFGFARLIRD 153 (292)
Q Consensus 78 iv~e~~~~~~L~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~givH~dl~p~Nilv~~~~----~~kl~dfg~~~~~~~ 153 (292)
+||||+++++|.+++.....+++..++.++.||+.||.|||++|++|+||||+||+++.++ .++|+|||++.....
T Consensus 91 lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dlkp~NIll~~~~~~~~~~kl~Dfg~a~~~~~ 170 (326)
T 2y0a_A 91 LILELVAGGELFDFLAEKESLTEEEATEFLKQILNGVYYLHSLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDF 170 (326)
T ss_dssp EEEECCCSCBHHHHHTTSSCCBHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESCSSSSSCCEEECCCTTCEECCT
T ss_pred EEEEcCCCCCHHHHHHhcCCcCHHHHHHHHHHHHHHHHHHHHCCeEcCCCCHHHEEEecCCCCCCCEEEEECCCCeECCC
Confidence 9999999999999998888899999999999999999999999999999999999999887 799999999976542
Q ss_pred cc----cccccccccccccccCCCCCCCcccceeeecCCCCCCchHHHHHHHhhcccCCCCCCChhhhhhccCcCCCCC-
Q psy758 154 LI----PRHLHIFQTNEYFKGVSLPHAENVVPLEIKIGKPAATNIYLIDFLKRCLDKDPLRRWSCDQLLRHPYFNGYYF- 228 (292)
Q Consensus 154 ~~----~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~- 228 (292)
.. ..++..|.+||...+.......++|+ .+.-++..+.+..|+...+..+.+..........
T Consensus 171 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~Diws-------------lG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~ 237 (326)
T 2y0a_A 171 GNEFKNIFGTPEFVAPEIVNYEPLGLEADMWS-------------IGVITYILLSGASPFLGDTKQETLANVSAVNYEFE 237 (326)
T ss_dssp TSCCCCCCSCTTTCCHHHHTTCCCCTHHHHHH-------------HHHHHHHHHHSCCSSCCSSHHHHHHHHHHTCCCCC
T ss_pred CCccccccCCcCcCCceeecCCCCCcHHHHHH-------------HHHHHHHHHHCcCCCCCCCHHHHHHHHHhcCCCcC
Confidence 21 12344566666654443322222222 2222233333444443333332222111011111
Q ss_pred ---CCCCccchHHHHhcccCcCCCCCCChhhhhhCCcccceec
Q psy758 229 ---EVPDEMQYEEITQRCLDKDPLRRWSCDQLLRHPYFNGYYF 268 (292)
Q Consensus 229 ---~~~~~~~l~~li~~~l~~dP~~Rpt~~~il~h~w~~~~~~ 268 (292)
....+..+.+||.+||+.||.+|||+.++++||||++..+
T Consensus 238 ~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~hp~~~~~~~ 280 (326)
T 2y0a_A 238 DEYFSNTSALAKDFIRRLLVKDPKKRMTIQDSLQHPWIKPKDT 280 (326)
T ss_dssp HHHHTTSCHHHHHHHHHHSCSSGGGSCCHHHHHHSTTTSCCSH
T ss_pred ccccccCCHHHHHHHHHHccCChhhCCCHHHHhcCCCccCCcc
Confidence 1234678999999999999999999999999999997543
|
| >3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6e-45 Score=300.42 Aligned_cols=253 Identities=23% Similarity=0.240 Sum_probs=189.8
Q ss_pred CcccceeeeecccCceEEEEEEEcCCCcEEEEEEeccCCCChHHHHHHHHHHHHHHhCCCCCcchhhhhhhcCCeEEEEE
Q psy758 1 MERYEKIGKLGEGSYGVVFKCRNRDTGQVVAIKKFLESEEDPLIRKIALREIRLLKSLKHPNLVNLLEVFRRKKKLHLVF 80 (292)
Q Consensus 1 ~~~y~~~~~l~~g~~~~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~iv~ 80 (292)
+++|++++.||+|+||.||+|.+..+++.||+|++...... ...+.+.+|+.+++.++||||+++++++.+++..|+||
T Consensus 6 ~~~y~i~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~-~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~ 84 (323)
T 3tki_A 6 VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAV-DCPENIKKEICINKMLNHENVVKFYGHRREGNIQYLFL 84 (323)
T ss_dssp TTCEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECC--------CHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEE
T ss_pred hhhceeeeEEecCCCEEEEEEEECCCCcEEEEEEEEccccc-chHHHHHHHHHHHHhCCCCCCCeEEEEEecCCeEEEEE
Confidence 57999999999999999999999999999999998654432 23466789999999999999999999999999999999
Q ss_pred ecCCCccHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEEccCCcEEEeecCchhhhhccc-----
Q psy758 81 EFCDHTVLNELENHPHGLPWDLIKQITWQVLRGVSYCHRHACIHRDIKPENILLTANGVVKLCDFGFARLIRDLI----- 155 (292)
Q Consensus 81 e~~~~~~L~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~givH~dl~p~Nilv~~~~~~kl~dfg~~~~~~~~~----- 155 (292)
||+++++|.+++.....+++..++.++.||+.||+|||++||+||||||+||+++.++.++|+|||++.......
T Consensus 85 e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~givH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~~ 164 (323)
T 3tki_A 85 EYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHGIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLL 164 (323)
T ss_dssp ECCTTEEGGGGSBTTTBCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTCCEEECCCTTCEECEETTEECCB
T ss_pred EcCCCCcHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHCCccccccchHHEEEeCCCCEEEEEeeccceeccCCccccc
Confidence 999999999999988889999999999999999999999999999999999999999999999999997653211
Q ss_pred --cccccccccccccccCCC-CCCCcccceeeecCCCCCCchHHHHHHHhhcccCCCCCCChhhhhhccCc---CCCCCC
Q psy758 156 --PRHLHIFQTNEYFKGVSL-PHAENVVPLEIKIGKPAATNIYLIDFLKRCLDKDPLRRWSCDQLLRHPYF---NGYYFE 229 (292)
Q Consensus 156 --~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~---~~~~~~ 229 (292)
..++..|.+||...+... ....|+ ++.+.-++..+.+..|+............+. ......
T Consensus 165 ~~~~gt~~y~aPE~~~~~~~~~~~~Di-------------wslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~ 231 (323)
T 3tki_A 165 NKMCGTLPYVAPELLKRREFHAEPVDV-------------WSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKKTYLNPW 231 (323)
T ss_dssp CSCCSCGGGSCHHHHHCSSBCHHHHHH-------------HHHHHHHHHHHHSSCSCSSSCTTSHHHHHHHTTCTTSTTG
T ss_pred CCCccCcCccCcHHhccCCCCCCcccH-------------HHHHHHHHHHHhCCCCCCCCchHHHHHHHHhcccccCCcc
Confidence 223445666666544332 111222 2222223333334444433222111100000 011112
Q ss_pred CCCccchHHHHhcccCcCCCCCCChhhhhhCCccccee
Q psy758 230 VPDEMQYEEITQRCLDKDPLRRWSCDQLLRHPYFNGYY 267 (292)
Q Consensus 230 ~~~~~~l~~li~~~l~~dP~~Rpt~~~il~h~w~~~~~ 267 (292)
...+..+.+||.+||+.||.+|||++|+++||||++..
T Consensus 232 ~~~~~~~~~li~~~L~~dP~~R~t~~eil~h~~~~~~~ 269 (323)
T 3tki_A 232 KKIDSAPLALLHKILVENPSARITIPDIKKDRWYNKPL 269 (323)
T ss_dssp GGSCHHHHHHHHHHSCSSTTTSCCHHHHTTCTTTTCCC
T ss_pred ccCCHHHHHHHHHHccCChhhCcCHHHHhhChhhcccc
Confidence 34577899999999999999999999999999998743
|
| >3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.3e-46 Score=307.62 Aligned_cols=271 Identities=28% Similarity=0.460 Sum_probs=196.6
Q ss_pred CcccceeeeecccCceEEEEEEEcCCCcEEEEEEeccCCCChHHHHHHHHHHHHHHhCCCCCcchhhhhhhcCCeEEEEE
Q psy758 1 MERYEKIGKLGEGSYGVVFKCRNRDTGQVVAIKKFLESEEDPLIRKIALREIRLLKSLKHPNLVNLLEVFRRKKKLHLVF 80 (292)
Q Consensus 1 ~~~y~~~~~l~~g~~~~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~iv~ 80 (292)
|++|++++.||+|+||.||+|.+..+++.||+|++...... .....+.+|+.+++.++||||+++++++.+++..++||
T Consensus 1 l~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~-~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ 79 (324)
T 3mtl_A 1 METYIKLDKLGEGTYATVYKGKSKLTDNLVALKEIRLEHEE-GAPCTAIREVSLLKDLKHANIVTLHDIIHTEKSLTLVF 79 (324)
T ss_dssp CCSEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECC-------CCCCCCCHHHHSCCCCTTBCCEEEEEECSSCEEEEE
T ss_pred CCceEEEEEEcCCCCEEEEEEEECCCCcEEEEEEEeccccc-ccchhHHHHHHHHHhcCCCCCCeeeeEEeeCCEEEEEe
Confidence 68999999999999999999999999999999998654322 11223457999999999999999999999999999999
Q ss_pred ecCCCccHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEEccCCcEEEeecCchhhhhccc-----
Q psy758 81 EFCDHTVLNELENHPHGLPWDLIKQITWQVLRGVSYCHRHACIHRDIKPENILLTANGVVKLCDFGFARLIRDLI----- 155 (292)
Q Consensus 81 e~~~~~~L~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~givH~dl~p~Nilv~~~~~~kl~dfg~~~~~~~~~----- 155 (292)
||++++.+..+......+++..++.++.||+.||.|||++||+||||||+||+++.++.++|+|||++.......
T Consensus 80 e~~~~~l~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivH~Dikp~NIl~~~~~~~kl~Dfg~a~~~~~~~~~~~~ 159 (324)
T 3mtl_A 80 EYLDKDLKQYLDDCGNIINMHNVKLFLFQLLRGLAYCHRQKVLHRDLKPQNLLINERGELKLADFGLARAKSIPTKTYDN 159 (324)
T ss_dssp ECCSEEHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTTEEESSCCGGGEEECTTCCEEECSSSEEECC---------
T ss_pred cccccCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCccCCCcCHHHEEECCCCCEEEccCcccccccCCcccccc
Confidence 999975444444455569999999999999999999999999999999999999999999999999987554221
Q ss_pred cccccccccccccccCC------CCCCCcccceeeecCCCCCCchHHHHHH---HhhcccCCCCCC-Chhhh--hhccCc
Q psy758 156 PRHLHIFQTNEYFKGVS------LPHAENVVPLEIKIGKPAATNIYLIDFL---KRCLDKDPLRRW-SCDQL--LRHPYF 223 (292)
Q Consensus 156 ~~~~~~~~~~~~~~~~~------~~~~~~~~~~~~~~~~~~~~~~~~~~~~---~~~~~~~p~~~~-~~~~~--~~~~~~ 223 (292)
...+..|.+||...+.. ..|+.|+..+++.+|..++......+.+ ...++..+...+ ..... .....+
T Consensus 160 ~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~ 239 (324)
T 3mtl_A 160 EVVTLWYRPPDILLGSTDYSTQIDMWGVGCIFYEMATGRPLFPGSTVEEQLHFIFRILGTPTEETWPGILSNEEFKTYNY 239 (324)
T ss_dssp ---CGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTTTSTTGGGCHHHHHTCC
T ss_pred ccCcccccChhhhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChHhchhhhcchhhccccc
Confidence 12345678888765522 3466677777777887766544333322 222222222111 11000 000000
Q ss_pred CCC------CCCCCCccchHHHHhcccCcCCCCCCChhhhhhCCcccceeccCCC
Q psy758 224 NGY------YFEVPDEMQYEEITQRCLDKDPLRRWSCDQLLRHPYFNGYYFEVPD 272 (292)
Q Consensus 224 ~~~------~~~~~~~~~l~~li~~~l~~dP~~Rpt~~~il~h~w~~~~~~~~~~ 272 (292)
... ......+..+.+||.+||+.||.+|||++|+++||||.+.......
T Consensus 240 ~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~hp~f~~~~~~~~~ 294 (324)
T 3mtl_A 240 PKYRAEALLSHAPRLDSDGADLLTKLLQFEGRNRISAEDAMKHPFFLSLGERIHK 294 (324)
T ss_dssp CCCCCCCHHHHCTTSCHHHHHHHHHHSCSSGGGSCCHHHHTTSGGGGGGCSTTSS
T ss_pred ccccchhhhhhcCCCCHHHHHHHHHHcCcCcccCCCHHHHhcChhhhhccccccc
Confidence 000 0112346788999999999999999999999999999998765433
|
| >3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.5e-45 Score=295.74 Aligned_cols=253 Identities=23% Similarity=0.300 Sum_probs=197.6
Q ss_pred cccceeeeecccCceEEEEEEEcCCCcEEEEEEeccCCCChHHHHHHHHHHHHHHhCCCCCcchhhhhhhcCCeEEEEEe
Q psy758 2 ERYEKIGKLGEGSYGVVFKCRNRDTGQVVAIKKFLESEEDPLIRKIALREIRLLKSLKHPNLVNLLEVFRRKKKLHLVFE 81 (292)
Q Consensus 2 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~iv~e 81 (292)
++|++.+.||+|++|.||+|.+..+++.||+|++..........+.+.+|+.+++.++||||+++++++.+++..++|||
T Consensus 6 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e 85 (284)
T 3kk8_A 6 DNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEESFHYLVFD 85 (284)
T ss_dssp TTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEEC
T ss_pred hhhhhhhhhcCcCCeEEEEEEEcCCCceEEEEEeecccCCHHHHHHHHHHHHHHHHcCCCCcCeEEEEEEcCCEEEEEEe
Confidence 68999999999999999999999999999999998777677777888999999999999999999999999999999999
Q ss_pred cCCCccHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEEccCCc---EEEeecCchhhhhcccc--
Q psy758 82 FCDHTVLNELENHPHGLPWDLIKQITWQVLRGVSYCHRHACIHRDIKPENILLTANGV---VKLCDFGFARLIRDLIP-- 156 (292)
Q Consensus 82 ~~~~~~L~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~givH~dl~p~Nilv~~~~~---~kl~dfg~~~~~~~~~~-- 156 (292)
|+.+++|...+.....+++..++.++.||+.||.|||++|++|+||+|+||+++.++. ++|+|||++........
T Consensus 86 ~~~~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dikp~Nil~~~~~~~~~~kl~Dfg~~~~~~~~~~~~ 165 (284)
T 3kk8_A 86 LVTGGELFEDIVAREFYSEADASHCIQQILESIAYCHSNGIVHRNLKPENLLLASKAKGAAVKLADFGLAIEVNDSEAWH 165 (284)
T ss_dssp CCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEESSSSTTCCEEECCCTTCEECCSSCBCC
T ss_pred cCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCcCcCCCCHHHEEEecCCCCCcEEEeeceeeEEcccCcccc
Confidence 9999999888877778999999999999999999999999999999999999987655 99999999876543222
Q ss_pred --ccccccccccccccCCCCCCCcccceeeecCCCCCCchHHHHHHHhhcccCCCCCCChhhhhhccCcCCC----CCCC
Q psy758 157 --RHLHIFQTNEYFKGVSLPHAENVVPLEIKIGKPAATNIYLIDFLKRCLDKDPLRRWSCDQLLRHPYFNGY----YFEV 230 (292)
Q Consensus 157 --~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~----~~~~ 230 (292)
..+..|.+||...+.......++|+ .+.-++..+.+..|+......+.......... ....
T Consensus 166 ~~~~~~~y~aPE~~~~~~~~~~~Di~s-------------lG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~ 232 (284)
T 3kk8_A 166 GFAGTPGYLSPEVLKKDPYSKPVDIWA-------------CGVILYILLVGYPPFWDEDQHRLYAQIKAGAYDYPSPEWD 232 (284)
T ss_dssp CSCSCGGGCCHHHHTTCCBCTHHHHHH-------------HHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCCCTTTTT
T ss_pred CCCCCcCCcCchhhcCCCCCcccchHH-------------HHHHHHHHHHCCCCCCCCchhHHHHHHHhccccCCchhhc
Confidence 2344566666655543332222222 22223333444444444333333222111111 1113
Q ss_pred CCccchHHHHhcccCcCCCCCCChhhhhhCCccccee
Q psy758 231 PDEMQYEEITQRCLDKDPLRRWSCDQLLRHPYFNGYY 267 (292)
Q Consensus 231 ~~~~~l~~li~~~l~~dP~~Rpt~~~il~h~w~~~~~ 267 (292)
..+..+.+||.+||+.||.+|||++|+++||||++..
T Consensus 233 ~~~~~~~~li~~~l~~dp~~Rps~~~~l~h~~~~~~~ 269 (284)
T 3kk8_A 233 TVTPEAKSLIDSMLTVNPKKRITADQALKVPWICNRE 269 (284)
T ss_dssp TSCHHHHHHHHHHSCSSTTTSCCHHHHTTSHHHHSCC
T ss_pred ccCHHHHHHHHHHcccChhhCCCHHHHhcCccccCCh
Confidence 4577899999999999999999999999999998743
|
| >2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-45 Score=317.69 Aligned_cols=253 Identities=23% Similarity=0.325 Sum_probs=196.4
Q ss_pred CcccceeeeecccCceEEEEEEEcCCCcEEEEEEeccCCCC-hHHHHHHHHHHHHHHhCCCCCcchhhhhhhcCCeEEEE
Q psy758 1 MERYEKIGKLGEGSYGVVFKCRNRDTGQVVAIKKFLESEED-PLIRKIALREIRLLKSLKHPNLVNLLEVFRRKKKLHLV 79 (292)
Q Consensus 1 ~~~y~~~~~l~~g~~~~v~~~~~~~~~~~v~iK~~~~~~~~-~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~iv 79 (292)
+++|++.+.||+|+||.||+|.+..+|+.||+|++...... ......+.+|+.+++.++||||+++++++.+.+..|+|
T Consensus 15 ~~~Y~l~~~LG~G~fg~V~~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~~~~~~lv 94 (476)
T 2y94_A 15 IGHYILGDTLGVGTFGKVKVGKHELTGHKVAVKILNRQKIRSLDVVGKIRREIQNLKLFRHPHIIKLYQVISTPSDIFMV 94 (476)
T ss_dssp ETTEEEEEEEECCSSSCEEEEEETTTCCEEEEEEEEHHHHHHTTTHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEE
T ss_pred ecCEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhhhccCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEE
Confidence 47899999999999999999999999999999999654311 12345688999999999999999999999999999999
Q ss_pred EecCCCccHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEEccCCcEEEeecCchhhhhccc----
Q psy758 80 FEFCDHTVLNELENHPHGLPWDLIKQITWQVLRGVSYCHRHACIHRDIKPENILLTANGVVKLCDFGFARLIRDLI---- 155 (292)
Q Consensus 80 ~e~~~~~~L~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~givH~dl~p~Nilv~~~~~~kl~dfg~~~~~~~~~---- 155 (292)
|||++|++|.+++...+.+++..++.++.||+.||.|||++||+||||||+||+++.++.+||+|||++.......
T Consensus 95 ~E~~~gg~L~~~l~~~~~l~~~~~~~i~~qi~~aL~~LH~~givHrDLkp~NIll~~~~~vkL~DFG~a~~~~~~~~~~~ 174 (476)
T 2y94_A 95 MEYVSGGELFDYICKNGRLDEKESRRLFQQILSGVDYCHRHMVVHRDLKPENVLLDAHMNAKIADFGLSNMMSDGEFLRT 174 (476)
T ss_dssp EECCSSEEHHHHTTSSSSCCHHHHHHHHHHHHHHHHHHHTTTEECSCCSGGGEEECTTCCEEECCCSSCEECCTTCCBCC
T ss_pred EeCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCCcccccHHHEEEecCCCeEEEeccchhhccccccccc
Confidence 9999999999999888889999999999999999999999999999999999999999999999999997654321
Q ss_pred cccccccccccccccCCC-CCCCcccceeeecCCCCCCchHHHHHHHhhcccCCCCCCChhhhhhccCcCCCCCCCCCcc
Q psy758 156 PRHLHIFQTNEYFKGVSL-PHAENVVPLEIKIGKPAATNIYLIDFLKRCLDKDPLRRWSCDQLLRHPYFNGYYFEVPDEM 234 (292)
Q Consensus 156 ~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 234 (292)
..++..|.+||...+... ....|+ ++.+.-++..+.+..|+......++.....-.....+...+.
T Consensus 175 ~~gt~~y~aPE~~~~~~~~~~~~Di-------------wSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~~~p~~~s~ 241 (476)
T 2y94_A 175 SCGSPNYAAPEVISGRLYAGPEVDI-------------WSSGVILYALLCGTLPFDDDHVPTLFKKICDGIFYTPQYLNP 241 (476)
T ss_dssp CCSCSTTCCHHHHTTCCBCSHHHHH-------------HHHHHHHHHHHHSSCSSCCSSSHHHHHHHHTTCCCCCTTCCH
T ss_pred cCCCcCeEChhhccCCCCCCCccee-------------hhhHHHHHHHhhCCCCCCCCCHHHHHHHHhcCCcCCCccCCH
Confidence 123344666665544322 111122 222222333344444444444333333222222233445678
Q ss_pred chHHHHhcccCcCCCCCCChhhhhhCCcccce
Q psy758 235 QYEEITQRCLDKDPLRRWSCDQLLRHPYFNGY 266 (292)
Q Consensus 235 ~l~~li~~~l~~dP~~Rpt~~~il~h~w~~~~ 266 (292)
.+.+||.+||+.||.+|||++++++||||++.
T Consensus 242 ~~~~Li~~~L~~dP~~Rpt~~eil~hp~~~~~ 273 (476)
T 2y94_A 242 SVISLLKHMLQVDPMKRATIKDIREHEWFKQD 273 (476)
T ss_dssp HHHHHHHHHTCSSTTTSCCHHHHHTCHHHHTT
T ss_pred HHHHHHHHHcCCCchhCcCHHHHHhCHHhhhc
Confidence 89999999999999999999999999999874
|
| >2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-44 Score=294.70 Aligned_cols=255 Identities=24% Similarity=0.290 Sum_probs=201.2
Q ss_pred cccceeeeecccCceEEEEEEEcCCCcEEEEEEeccCC-CChHHHHHHHHHHHHHHhCCCCCcchhhhhhhcCCeEEEEE
Q psy758 2 ERYEKIGKLGEGSYGVVFKCRNRDTGQVVAIKKFLESE-EDPLIRKIALREIRLLKSLKHPNLVNLLEVFRRKKKLHLVF 80 (292)
Q Consensus 2 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~v~iK~~~~~~-~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~iv~ 80 (292)
++|++.+.||+|+||.||+|.+..+++.||+|++.... ......+.+.+|+.+++.++||||+++++++.+++..++|+
T Consensus 15 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ 94 (294)
T 2rku_A 15 RRYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHGFFEDNDFVFVVL 94 (294)
T ss_dssp EEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred cceEEEEEEeecCCEEEEEEEECCCCceEEEEEechhhccCHHHHHHHHHHHHHHHhCCCCCEeeeeeeeccCCEEEEEE
Confidence 68999999999999999999999999999999987654 34456677889999999999999999999999999999999
Q ss_pred ecCCCccHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEEccCCcEEEeecCchhhhhcccc----
Q psy758 81 EFCDHTVLNELENHPHGLPWDLIKQITWQVLRGVSYCHRHACIHRDIKPENILLTANGVVKLCDFGFARLIRDLIP---- 156 (292)
Q Consensus 81 e~~~~~~L~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~givH~dl~p~Nilv~~~~~~kl~dfg~~~~~~~~~~---- 156 (292)
||+++++|.+++.....+++..++.++.||+.||.|||++|++|+||+|+||+++.++.++|+|||++........
T Consensus 95 e~~~~~~L~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~~ 174 (294)
T 2rku_A 95 ELCRRRSLLELHKRRKALTEPEARYYLRQIVLGCQYLHRNRVIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGERKKV 174 (294)
T ss_dssp ECCTTCBHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCEEECCCTTCEECCSTTCCBCC
T ss_pred ecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCChHhEEEcCCCCEEEEeccCceecccCcccccc
Confidence 9999999999988777899999999999999999999999999999999999999999999999999876542221
Q ss_pred -ccccccccccccccCCCCCCCcccceeeecCCCCCCchHHHHHHHhhcccCCCCCCChhhhhhccCcCCCCCCCCCccc
Q psy758 157 -RHLHIFQTNEYFKGVSLPHAENVVPLEIKIGKPAATNIYLIDFLKRCLDKDPLRRWSCDQLLRHPYFNGYYFEVPDEMQ 235 (292)
Q Consensus 157 -~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 235 (292)
..+..|.+||...+.......|+| +.+.-++..+.+..|.......+............+...+..
T Consensus 175 ~~~~~~y~aPE~~~~~~~~~~~Di~-------------slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 241 (294)
T 2rku_A 175 LCGTPNYIAPEVLSKKGHSFEVDVW-------------SIGCIMYTLLVGKPPFETSCLKETYLRIKKNEYSIPKHINPV 241 (294)
T ss_dssp CCSCCSSCCHHHHTTSCBCTHHHHH-------------HHHHHHHHHHHSSCTTCCSSHHHHHHHHHTTCCCCCTTSCHH
T ss_pred ccCCCCcCCcchhccCCCCchhhHH-------------HHHHHHHHHHhCCCCCCCCCHHHHHHHHhhccCCCccccCHH
Confidence 223345666655443332222222 222333444445555555444443332222233444556788
Q ss_pred hHHHHhcccCcCCCCCCChhhhhhCCcccceecc
Q psy758 236 YEEITQRCLDKDPLRRWSCDQLLRHPYFNGYYFE 269 (292)
Q Consensus 236 l~~li~~~l~~dP~~Rpt~~~il~h~w~~~~~~~ 269 (292)
+.++|.+||+.||++|||++++++||||++....
T Consensus 242 ~~~li~~~l~~~p~~Rps~~~ll~~~~~~~~~~~ 275 (294)
T 2rku_A 242 AASLIQKMLQTDPTARPTINELLNDEFFTSGYIP 275 (294)
T ss_dssp HHHHHHHHTCSSGGGSCCGGGGGGSHHHHTSCCC
T ss_pred HHHHHHHHcccChhhCcCHHHHhhChheecCCcC
Confidence 9999999999999999999999999999986643
|
| >3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3twj_A* 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-45 Score=312.64 Aligned_cols=257 Identities=21% Similarity=0.261 Sum_probs=196.7
Q ss_pred cccceeeeecccCceEEEEEEEcCCCcEEEEEEeccCCC-ChHHHHHHHHHHHHHHhCCCCCcchhhhhhhcCCeEEEEE
Q psy758 2 ERYEKIGKLGEGSYGVVFKCRNRDTGQVVAIKKFLESEE-DPLIRKIALREIRLLKSLKHPNLVNLLEVFRRKKKLHLVF 80 (292)
Q Consensus 2 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~v~iK~~~~~~~-~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~iv~ 80 (292)
++|++.+.||+|+||.||+|++..+++.||+|++..... .......+.+|..+++.++||||+++++++.+++.+|+||
T Consensus 69 ~~y~~~~~LG~G~fG~V~~~~~~~~~~~~AiK~~~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~~lV~ 148 (410)
T 3v8s_A 69 EDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFYAFQDDRYLYMVM 148 (410)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTCCCSTHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEE
T ss_pred cccEEEEEEEcCCCEEEEEEEECCCCcEEEEEEEehhhhhhhHHHHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEEEEE
Confidence 689999999999999999999999999999999865321 0111234678999999999999999999999999999999
Q ss_pred ecCCCccHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEEccCCcEEEeecCchhhhhccc-----
Q psy758 81 EFCDHTVLNELENHPHGLPWDLIKQITWQVLRGVSYCHRHACIHRDIKPENILLTANGVVKLCDFGFARLIRDLI----- 155 (292)
Q Consensus 81 e~~~~~~L~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~givH~dl~p~Nilv~~~~~~kl~dfg~~~~~~~~~----- 155 (292)
||++||+|..++... .+++..++.++.||+.||.|||++||+||||||+||+++.++++||+|||++.......
T Consensus 149 E~~~gg~L~~~l~~~-~~~e~~~~~~~~qi~~aL~~LH~~givHrDLKp~NILl~~~g~ikL~DFG~a~~~~~~~~~~~~ 227 (410)
T 3v8s_A 149 EYMPGGDLVNLMSNY-DVPEKWARFYTAEVVLALDAIHSMGFIHRDVKPDNMLLDKSGHLKLADFGTCMKMNKEGMVRCD 227 (410)
T ss_dssp CCCTTEEHHHHHHHC-CCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTCEECCTTSEEECC
T ss_pred eCCCCCcHHHHHHcC-CCCHHHHHHHHHHHHHHHHHHHHCCeEeccCCHHHeeECCCCCEEEeccceeEeeccCCccccc
Confidence 999999999998764 69999999999999999999999999999999999999999999999999997654321
Q ss_pred -cccccccccccccccCC---------CCCCCcccceeeecCCCCCCchHHHHHHHhhcccCCCCCCChhhhhhccCcCC
Q psy758 156 -PRHLHIFQTNEYFKGVS---------LPHAENVVPLEIKIGKPAATNIYLIDFLKRCLDKDPLRRWSCDQLLRHPYFNG 225 (292)
Q Consensus 156 -~~~~~~~~~~~~~~~~~---------~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~ 225 (292)
..++..|.+||...+.. ..|+.|+..+++++|..++.......++..++.. ...-.
T Consensus 228 ~~~gt~~Y~APE~l~~~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~~~~~~i~~~--------------~~~~~ 293 (410)
T 3v8s_A 228 TAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLVGTYSKIMNH--------------KNSLT 293 (410)
T ss_dssp SCCSCGGGCCHHHHHTTTTTCEEETHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHTH--------------HHHCC
T ss_pred CCcCCccccCHHHhhccCCCcCCCCcceEecchHHHHHHHhCCCCCCCCChhhHHHHHHhc--------------ccccc
Confidence 22344566666554322 2344444445555555544333333322222211 00001
Q ss_pred CCCCCCCccchHHHHhcccCcCCCC--CCChhhhhhCCcccceeccCCCh
Q psy758 226 YYFEVPDEMQYEEITQRCLDKDPLR--RWSCDQLLRHPYFNGYYFEVPDE 273 (292)
Q Consensus 226 ~~~~~~~~~~l~~li~~~l~~dP~~--Rpt~~~il~h~w~~~~~~~~~~~ 273 (292)
++.....+..+++||.+||+.+|.+ ||+++||++||||+++.|+....
T Consensus 294 ~p~~~~~s~~~~~li~~lL~~~~~rlgR~~~~ei~~Hp~f~~~~w~~~~~ 343 (410)
T 3v8s_A 294 FPDDNDISKEAKNLICAFLTDREVRLGRNGVEEIKRHLFFKNDQWAWETL 343 (410)
T ss_dssp CCTTCCCCHHHHHHHHHHSSCGGGCTTSSCHHHHHTSGGGCCSSCCSTTG
T ss_pred CCCcccccHHHHHHHHHHccChhhhCCCCCHHHHhcCccccCCCHHHHhh
Confidence 1222345789999999999999988 99999999999999998875443
|
| >2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-44 Score=298.76 Aligned_cols=255 Identities=24% Similarity=0.327 Sum_probs=194.8
Q ss_pred cccceeeeecccCceEEEEEEEcCCCcEEEEEEeccCCCCh----HHHHHHHHHHHHHHhCCCCCcchhhhhhhcCCeEE
Q psy758 2 ERYEKIGKLGEGSYGVVFKCRNRDTGQVVAIKKFLESEEDP----LIRKIALREIRLLKSLKHPNLVNLLEVFRRKKKLH 77 (292)
Q Consensus 2 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~v~iK~~~~~~~~~----~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~ 77 (292)
++|++.+.||+|+||.||+|.+..+|+.||+|++....... ...+.+.+|+.+++.++||||+++++++.+.+..+
T Consensus 12 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~ 91 (321)
T 2a2a_A 12 DFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVSILRQVLHHNVITLHDVYENRTDVV 91 (321)
T ss_dssp HHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSSSCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEE
T ss_pred ccEEEeeEeeecCCEEEEEEEECCCCeEEEEEEEecccccccccchhHHHHHHHHHHHHhCCCCCcceEEEEEecCCEEE
Confidence 57999999999999999999999999999999997654221 13466889999999999999999999999999999
Q ss_pred EEEecCCCccHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEEccCC----cEEEeecCchhhhhc
Q psy758 78 LVFEFCDHTVLNELENHPHGLPWDLIKQITWQVLRGVSYCHRHACIHRDIKPENILLTANG----VVKLCDFGFARLIRD 153 (292)
Q Consensus 78 iv~e~~~~~~L~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~givH~dl~p~Nilv~~~~----~~kl~dfg~~~~~~~ 153 (292)
+||||+++++|.+++.....+++..++.++.||+.||.|||++|++|+||+|+||+++.++ .++|+|||++.....
T Consensus 92 lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~lH~~~ivH~dikp~NIl~~~~~~~~~~~kl~Dfg~~~~~~~ 171 (321)
T 2a2a_A 92 LILELVSGGELFDFLAQKESLSEEEATSFIKQILDGVNYLHTKKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIED 171 (321)
T ss_dssp EEECCCCSCBHHHHHHTCSCEEHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESCTTSSSCCEEECCCTTCEECCT
T ss_pred EEEEcCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCChHHEEEecCCCCcCCEEEccCccceecCc
Confidence 9999999999999998888899999999999999999999999999999999999999888 799999999876543
Q ss_pred cc----cccccccccccccccCCCCCCCcccceeeecCCCCCCchHHHHHHHhhcccCCCCCCChhhhhhccCcCCCCC-
Q psy758 154 LI----PRHLHIFQTNEYFKGVSLPHAENVVPLEIKIGKPAATNIYLIDFLKRCLDKDPLRRWSCDQLLRHPYFNGYYF- 228 (292)
Q Consensus 154 ~~----~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~- 228 (292)
.. ..++..|.+||...+.......|+|++ +.-++..+.+..|+...+..+.+..........
T Consensus 172 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~sl-------------G~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~ 238 (321)
T 2a2a_A 172 GVEFKNIFGTPEFVAPEIVNYEPLGLEADMWSI-------------GVITYILLSGASPFLGDTKQETLANITSVSYDFD 238 (321)
T ss_dssp TCCCCCCCSCGGGCCHHHHTTCCCCTHHHHHHH-------------HHHHHHHHHSCCSSCCSSHHHHHHHHHTTCCCCC
T ss_pred cccccccCCCCCccCcccccCCCCCCccccHHH-------------HHHHHHHHHCCCCCCCCCHHHHHHHHHhcccccC
Confidence 21 123445666766654433222222222 222333333444443333333222111111111
Q ss_pred ---CCCCccchHHHHhcccCcCCCCCCChhhhhhCCcccceecc
Q psy758 229 ---EVPDEMQYEEITQRCLDKDPLRRWSCDQLLRHPYFNGYYFE 269 (292)
Q Consensus 229 ---~~~~~~~l~~li~~~l~~dP~~Rpt~~~il~h~w~~~~~~~ 269 (292)
....+..+.+||.+||+.||.+|||++++++||||++..+.
T Consensus 239 ~~~~~~~~~~~~~li~~~l~~dp~~Rps~~e~l~hp~~~~~~~~ 282 (321)
T 2a2a_A 239 EEFFSHTSELAKDFIRKLLVKETRKRLTIQEALRHPWITPVDNQ 282 (321)
T ss_dssp HHHHTTCCHHHHHHHHTTSCSSTTTSCCHHHHHHSTTTSCSSHH
T ss_pred hhhhcccCHHHHHHHHHHcCCChhhCcCHHHHhcCccccCCCcc
Confidence 12346789999999999999999999999999999976543
|
| >2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-44 Score=296.02 Aligned_cols=245 Identities=25% Similarity=0.354 Sum_probs=184.0
Q ss_pred CcccceeeeecccCceEEEEEEEcCCCcEEEEEEeccCCCCh------------------------HHHHHHHHHHHHHH
Q psy758 1 MERYEKIGKLGEGSYGVVFKCRNRDTGQVVAIKKFLESEEDP------------------------LIRKIALREIRLLK 56 (292)
Q Consensus 1 ~~~y~~~~~l~~g~~~~v~~~~~~~~~~~v~iK~~~~~~~~~------------------------~~~~~~~~e~~~~~ 56 (292)
+++|++.+.||+|+||.||+|.+..+++.||+|++....... ...+.+.+|+.+++
T Consensus 12 ~~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~ 91 (298)
T 2zv2_A 12 LNQYTLKDEIGKGSYGVVKLAYNENDNTYYAMKVLSKKKLIRQAGFPRRPPPRGTRPAPGGCIQPRGPIEQVYQEIAILK 91 (298)
T ss_dssp ETTEEEEEEEEC--CCEEEEEEETTTTEEEEEEEEECC-------------------------------CHHHHHHHHHH
T ss_pred ecceEEEeEEeecCCEEEEEEEECCCCcEEEEEEeehhhhhhhcccccccccccccccccccccccchHHHHHHHHHHHH
Confidence 478999999999999999999999999999999986553211 12356789999999
Q ss_pred hCCCCCcchhhhhhhc--CCeEEEEEecCCCccHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEE
Q psy758 57 SLKHPNLVNLLEVFRR--KKKLHLVFEFCDHTVLNELENHPHGLPWDLIKQITWQVLRGVSYCHRHACIHRDIKPENILL 134 (292)
Q Consensus 57 ~l~~~~i~~~~~~~~~--~~~~~iv~e~~~~~~L~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~givH~dl~p~Nilv 134 (292)
.++||||+++++++.+ .+..++||||+++++|.++... ..+++..++.++.||+.||.|||++|++|+||||+||++
T Consensus 92 ~l~h~~iv~~~~~~~~~~~~~~~lv~e~~~~~~l~~~~~~-~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dlkp~Nil~ 170 (298)
T 2zv2_A 92 KLDHPNVVKLVEVLDDPNEDHLYMVFELVNQGPVMEVPTL-KPLSEDQARFYFQDLIKGIEYLHYQKIIHRDIKPSNLLV 170 (298)
T ss_dssp TCCCTTBCCEEEEEECSSSSEEEEEEECCTTCBSCCSSCS-SCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEE
T ss_pred hCCCCCCCeEEEEEEcCCCCEEEEEEecCCCCcHHHHhhc-CCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHEEE
Confidence 9999999999999876 6789999999999999887654 479999999999999999999999999999999999999
Q ss_pred ccCCcEEEeecCchhhhhccc-----cccccccccccccccCC--------CCCCCcccceeeecCCCCCCchHHHHHHH
Q psy758 135 TANGVVKLCDFGFARLIRDLI-----PRHLHIFQTNEYFKGVS--------LPHAENVVPLEIKIGKPAATNIYLIDFLK 201 (292)
Q Consensus 135 ~~~~~~kl~dfg~~~~~~~~~-----~~~~~~~~~~~~~~~~~--------~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 201 (292)
+.++.++|+|||++....... ...+..|.+||...+.. ..|+.|+..+++.+|..
T Consensus 171 ~~~~~~kl~Dfg~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~------------ 238 (298)
T 2zv2_A 171 GEDGHIKIADFGVSNEFKGSDALLSNTVGTPAFMAPESLSETRKIFSGKALDVWAMGVTLYCFVFGQC------------ 238 (298)
T ss_dssp CTTSCEEECCCTTCEECSSSSCEECCCCSCGGGCCGGGCCTTCCCEESHHHHHHHHHHHHHHHHHSSC------------
T ss_pred CCCCCEEEecCCCccccccccccccCCcCCccccChhhhccCCCCCCCchhhhHhHHHHHHHHHHCCC------------
Confidence 999999999999987654322 22344566666654432 22334444444444444
Q ss_pred hhcccCCCCCCChhhhhhccCcC--CCCCCCCCccchHHHHhcccCcCCCCCCChhhhhhCCccc
Q psy758 202 RCLDKDPLRRWSCDQLLRHPYFN--GYYFEVPDEMQYEEITQRCLDKDPLRRWSCDQLLRHPYFN 264 (292)
Q Consensus 202 ~~~~~~p~~~~~~~~~~~~~~~~--~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~~il~h~w~~ 264 (292)
|+.......+....... ........+..+.+||.+||+.||++|||+.|+++||||+
T Consensus 239 ------pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~R~s~~e~l~hp~~~ 297 (298)
T 2zv2_A 239 ------PFMDERIMCLHSKIKSQALEFPDQPDIAEDLKDLITRMLDKNPESRIVVPEIKLHPWVT 297 (298)
T ss_dssp ------SSCCSSHHHHHHHHHHCCCCCCSSSCCCHHHHHHHHHHTCSCTTTSCCHHHHTTCHHHH
T ss_pred ------CCCCccHHHHHHHHhcccCCCCCccccCHHHHHHHHHHhhcChhhCCCHHHHhcCcccc
Confidence 43333222221111000 1111234577899999999999999999999999999996
|
| >3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.4e-45 Score=312.77 Aligned_cols=262 Identities=26% Similarity=0.415 Sum_probs=192.7
Q ss_pred cccceeeeecccCceEEEEEEEcCCCcEEEEEEeccCCCChHHHHHHHHHHHHHHhCCCCCcchhhhhhhcC------Ce
Q psy758 2 ERYEKIGKLGEGSYGVVFKCRNRDTGQVVAIKKFLESEEDPLIRKIALREIRLLKSLKHPNLVNLLEVFRRK------KK 75 (292)
Q Consensus 2 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~------~~ 75 (292)
++|++++.||+|+||.||+|.+..+++.||+|++..........+.+.+|+.+++.++||||+++++++... ..
T Consensus 62 ~~y~~~~~lG~G~~g~V~~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~~~~~ 141 (464)
T 3ttj_A 62 KRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKTLEEFQD 141 (464)
T ss_dssp TTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEESGGGSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCCSTTTCCE
T ss_pred CCeEEEEEeecCCCeEEEEEEECCCCCEEEEEEECccccChHHHHHHHHHHHHHHhCCCCCCCcEEEEEccCCccccCCe
Confidence 689999999999999999999999999999999987766666778889999999999999999999998643 46
Q ss_pred EEEEEecCCCccHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEEccCCcEEEeecCchhhhhccc
Q psy758 76 LHLVFEFCDHTVLNELENHPHGLPWDLIKQITWQVLRGVSYCHRHACIHRDIKPENILLTANGVVKLCDFGFARLIRDLI 155 (292)
Q Consensus 76 ~~iv~e~~~~~~L~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~givH~dl~p~Nilv~~~~~~kl~dfg~~~~~~~~~ 155 (292)
+|+||||++++.+..+ .. .+++..++.++.||+.||+|||++||+||||||+||+++.++.+||+|||++.......
T Consensus 142 ~~lv~E~~~~~l~~~~-~~--~l~~~~~~~~~~qil~aL~~lH~~~iiHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~~ 218 (464)
T 3ttj_A 142 VYLVMELMDANLCQVI-QM--ELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSF 218 (464)
T ss_dssp EEEEEECCSEEHHHHH-TS--CCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTSCEEECCCCCC-----CC
T ss_pred EEEEEeCCCCCHHHHH-hh--cCCHHHHHHHHHHHHHHHHHHHHCCcccCCCChHhEEEeCCCCEEEEEEEeeeecCCCc
Confidence 8999999998755544 32 49999999999999999999999999999999999999999999999999998765421
Q ss_pred ----cccccccccccccccCCCC-----CCCcccceeeecCCCCCCchHHHHHHHhhc---ccCCCC---CC--Chhhhh
Q psy758 156 ----PRHLHIFQTNEYFKGVSLP-----HAENVVPLEIKIGKPAATNIYLIDFLKRCL---DKDPLR---RW--SCDQLL 218 (292)
Q Consensus 156 ----~~~~~~~~~~~~~~~~~~~-----~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~---~~~p~~---~~--~~~~~~ 218 (292)
...+..|.+||...+.... |+.|+..+++.+|.+++.+....+.+..+. +..+.. .. .....+
T Consensus 219 ~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~pF~g~~~~~~~~~i~~~lg~p~~~~~~~~~~~~~~~~ 298 (464)
T 3ttj_A 219 MMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQPTVRNYV 298 (464)
T ss_dssp CC----CCCTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCSCCHHHHTTSCHHHHHHH
T ss_pred ccCCCcccccccCHHHHcCCCCCHHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHHHHHHcchhhhhHh
Confidence 2334567888877665443 556666666777777765544333332222 111000 00 000000
Q ss_pred h-ccCcCCCC---------CCCC------CccchHHHHhcccCcCCCCCCChhhhhhCCcccce
Q psy758 219 R-HPYFNGYY---------FEVP------DEMQYEEITQRCLDKDPLRRWSCDQLLRHPYFNGY 266 (292)
Q Consensus 219 ~-~~~~~~~~---------~~~~------~~~~l~~li~~~l~~dP~~Rpt~~~il~h~w~~~~ 266 (292)
. .+.+.... .+.. .+..+.+||.+||++||++|||++|+|+||||+.+
T Consensus 299 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~Hp~~~~~ 362 (464)
T 3ttj_A 299 ENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDALQHPYINVW 362 (464)
T ss_dssp TTSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSTTTSCCHHHHHTSTTTGGG
T ss_pred hcccccCCCChHHhCcccccccccccccccCHHHHHHHHHHcCCChhhCCCHHHHhcChhhhhc
Confidence 0 00000000 0000 14568999999999999999999999999999964
|
| >3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-44 Score=309.30 Aligned_cols=268 Identities=26% Similarity=0.330 Sum_probs=196.0
Q ss_pred cccceeeeecccCceEEEEEEEcCCCcEEEEEEeccCCCChHHHHHHHHHHHHHHhCCCCCcchhhhhhhcC-----CeE
Q psy758 2 ERYEKIGKLGEGSYGVVFKCRNRDTGQVVAIKKFLESEEDPLIRKIALREIRLLKSLKHPNLVNLLEVFRRK-----KKL 76 (292)
Q Consensus 2 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~-----~~~ 76 (292)
++|++.+.||+|+||.||+|.+..+++.||+|++..........+.+.+|+.+++.++||||+++++++... +.+
T Consensus 26 ~~y~~~~~lG~G~~g~V~~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~~~~~ 105 (432)
T 3n9x_A 26 DNYIIKHLIGRGSYGYVYLAYDKNTEKNVAIKKVNRMFEDLIDCKRILREITILNRLKSDYIIRLYDLIIPDDLLKFDEL 105 (432)
T ss_dssp TTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECSTTTSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCTTTCCCE
T ss_pred CCEEEEEEEeecCCEEEEEEEECCCCcEEEEEEeCchhcChHHHHHHHHHHHHHHHcCCCCcceEEEEEecCCCCcCCeE
Confidence 689999999999999999999999999999999987766667778899999999999999999999998765 579
Q ss_pred EEEEecCCCccHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEEccCCcEEEeecCchhhhhccc-
Q psy758 77 HLVFEFCDHTVLNELENHPHGLPWDLIKQITWQVLRGVSYCHRHACIHRDIKPENILLTANGVVKLCDFGFARLIRDLI- 155 (292)
Q Consensus 77 ~iv~e~~~~~~L~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~givH~dl~p~Nilv~~~~~~kl~dfg~~~~~~~~~- 155 (292)
|+||||+++ +|..++.....+++..++.++.||+.||+|||++||+||||||+||+++.++.+||+|||+++......
T Consensus 106 ~lv~e~~~~-~L~~~~~~~~~l~~~~~~~i~~qil~aL~~LH~~givHrDlkp~NILl~~~~~~kL~DFGla~~~~~~~~ 184 (432)
T 3n9x_A 106 YIVLEIADS-DLKKLFKTPIFLTEEHIKTILYNLLLGENFIHESGIIHRDLKPANCLLNQDCSVKVCDFGLARTINSEKD 184 (432)
T ss_dssp EEEEECCSE-EHHHHHHSSCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCEEECCCTTCEEC-----
T ss_pred EEEEecCCc-CHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCCCCCCCCHHHeEECCCCCEEEccCCCccccccccc
Confidence 999999885 888888887789999999999999999999999999999999999999999999999999997654321
Q ss_pred --------------------------cccccccccccccc-cCCC-----CCCCcccceeeecC-----------CCCCC
Q psy758 156 --------------------------PRHLHIFQTNEYFK-GVSL-----PHAENVVPLEIKIG-----------KPAAT 192 (292)
Q Consensus 156 --------------------------~~~~~~~~~~~~~~-~~~~-----~~~~~~~~~~~~~~-----------~~~~~ 192 (292)
...+..|.+||... +... .|+.|+..++++++ .+.+.
T Consensus 185 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~~~~~~DiwSlG~il~ell~g~~p~~~~~~~~~p~f~ 264 (432)
T 3n9x_A 185 TNIVNDLEENEEPGPHNKNLKKQLTSHVVTRWYRAPELILLQENYTKSIDIWSTGCIFAELLNMLQSHINDPTNRFPLFP 264 (432)
T ss_dssp --------------------------CCCCCTTCCHHHHTTCSCCCTHHHHHHHHHHHHHHHTTCTTTCSSGGGCCCSCC
T ss_pred ccccccccccccccccccchhccccCCCCCccccCHHHHhcCCCCCcccccchHHHHHHHHHhcccccccccccccccCC
Confidence 12244577777542 2222 35555555555542 22211
Q ss_pred c--------------------hHHHHHHHhhcccCCCCC---CChhhhhhc----cCcCCCC---CCCCCccchHHHHhc
Q psy758 193 N--------------------IYLIDFLKRCLDKDPLRR---WSCDQLLRH----PYFNGYY---FEVPDEMQYEEITQR 242 (292)
Q Consensus 193 ~--------------------~~~~~~~~~~~~~~p~~~---~~~~~~~~~----~~~~~~~---~~~~~~~~l~~li~~ 242 (292)
+ ......+...++..+... ......... +...... .....+..+.+||.+
T Consensus 265 g~~~~~~~~~~~~~~~~~~~~~~ql~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~ 344 (432)
T 3n9x_A 265 GSSCFPLSPDRNSKKVHEKSNRDQLNIIFNIIGTPTEDDLKNINKPEVIKYIKLFPHRKPINLKQKYPSISDDGINLLES 344 (432)
T ss_dssp CSCSCC----------CHHHHHHHHHHHHHHHCSCCHHHHHTCCCHHHHHHHHTSCCCCCCCHHHHSTTSCHHHHHHHHH
T ss_pred CccccccCcccccccccccchHHHHHHHHHhcCCCCHHHHHhccCHHHHHHHHhCCCCCCCCHHHHCCCCCHHHHHHHHH
Confidence 1 011112222222221100 000000000 0000000 002357789999999
Q ss_pred ccCcCCCCCCChhhhhhCCcccceeccC
Q psy758 243 CLDKDPLRRWSCDQLLRHPYFNGYYFEV 270 (292)
Q Consensus 243 ~l~~dP~~Rpt~~~il~h~w~~~~~~~~ 270 (292)
||+.||++|||++|+|+||||+++.+..
T Consensus 345 mL~~dP~~R~ta~e~L~Hp~f~~~~~~~ 372 (432)
T 3n9x_A 345 MLKFNPNKRITIDQALDHPYLKDVRKKK 372 (432)
T ss_dssp HSCSSTTTSCCHHHHHTCGGGTTTCCTT
T ss_pred HhcCCcccCCCHHHHhcChhhhhccCcc
Confidence 9999999999999999999999976553
|
| >3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-44 Score=310.75 Aligned_cols=267 Identities=27% Similarity=0.377 Sum_probs=185.4
Q ss_pred cccceeeeecccCceEEEEEEEcCCCcEEEEEEeccCCCChHHHHHHHHHHHHHHhCCCCCcchhhhhhh-----cCCeE
Q psy758 2 ERYEKIGKLGEGSYGVVFKCRNRDTGQVVAIKKFLESEEDPLIRKIALREIRLLKSLKHPNLVNLLEVFR-----RKKKL 76 (292)
Q Consensus 2 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~-----~~~~~ 76 (292)
++|++++.||+|+||.||+|++..+++.||+|++..........+.+.+|+.+++.++||||+++++++. ..+.+
T Consensus 53 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~~ 132 (458)
T 3rp9_A 53 DRYEIRHLIGTGSYGHVCEAYDKLEKRVVAIKKILRVFEDLIDCKRILREIAILNRLNHDHVVKVLDIVIPKDVEKFDEL 132 (458)
T ss_dssp TTEEECCC-------CEEEEEECC--CEEEEEEECSTTSSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCTTTCCCE
T ss_pred CCeEEeeEeeecCCeEEEEEEECCCCcEEEEEEechhhcCHHHHHHHHHHHHHHHhCCCCCCCceEEEEecCCcccCceE
Confidence 6899999999999999999999999999999999776666677788999999999999999999999984 34679
Q ss_pred EEEEecCCCccHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEEccCCcEEEeecCchhhhhccc-
Q psy758 77 HLVFEFCDHTVLNELENHPHGLPWDLIKQITWQVLRGVSYCHRHACIHRDIKPENILLTANGVVKLCDFGFARLIRDLI- 155 (292)
Q Consensus 77 ~iv~e~~~~~~L~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~givH~dl~p~Nilv~~~~~~kl~dfg~~~~~~~~~- 155 (292)
|+||||++ ++|..++.....+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||+++......
T Consensus 133 ~lv~e~~~-~~L~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~iiHrDlKp~NILl~~~~~~kl~DFGla~~~~~~~~ 211 (458)
T 3rp9_A 133 YVVLEIAD-SDFKKLFRTPVYLTELHIKTLLYNLLVGVKYVHSAGILHRDLKPANCLVNQDCSVKVCDFGLARTVDYPEN 211 (458)
T ss_dssp EEEECCCS-EEHHHHHHSSCCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTCCEEECCCTTCBCTTSCTT
T ss_pred EEEEeccc-cchhhhcccCCCCCHHHHHHHHHHHHHHHHHHHhCCcCCCCCChhhEEECCCCCEeecccccchhccCccc
Confidence 99999986 5788888777789999999999999999999999999999999999999999999999999997654211
Q ss_pred -------------------------------cccccccccccccc-cCCC-----CCCCcccceeeec-----------C
Q psy758 156 -------------------------------PRHLHIFQTNEYFK-GVSL-----PHAENVVPLEIKI-----------G 187 (292)
Q Consensus 156 -------------------------------~~~~~~~~~~~~~~-~~~~-----~~~~~~~~~~~~~-----------~ 187 (292)
...+..|.+||... +... .|+.|++.+++++ +
T Consensus 212 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~~DiwSlG~il~elltg~~~~~~~~~~~ 291 (458)
T 3rp9_A 212 GNSQLPISPREDDMNLVTFPHTKNLKRQLTGHVVTRWYRAPELILLQENYTEAIDVWSIGCIFAELLNMIKENVAYHADR 291 (458)
T ss_dssp CCCCCC---------------------------CCCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHTTSTTTCSSGGGC
T ss_pred cccccccCccccccccccccccccccccccCCcccccccChHHhhCCCCCCcHhHHHHHHHHHHHHHHhccccccccccc
Confidence 11234477777542 2222 3555666666665 2
Q ss_pred CCCCCch-----------------------HHHHHHHhhcccCCCCCC---C---hhhhhh-ccCcCCC---CCCCCCcc
Q psy758 188 KPAATNI-----------------------YLIDFLKRCLDKDPLRRW---S---CDQLLR-HPYFNGY---YFEVPDEM 234 (292)
Q Consensus 188 ~~~~~~~-----------------------~~~~~~~~~~~~~p~~~~---~---~~~~~~-~~~~~~~---~~~~~~~~ 234 (292)
.+.+.+. .....+...++..+.... . ...... .+..... ......+.
T Consensus 292 ~p~f~g~~~~~~~~~~~~~~~~~~~~~~~~~~l~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~ 371 (458)
T 3rp9_A 292 GPLFPGSSCFPLSPDQKAGNDFKFHTRGNRDQLNVIFNILGTPSEEDIEALEKEDAKRYIRIFPKREGTDLAERFPASSA 371 (458)
T ss_dssp CCSCC--------------------CHHHHHHHHHHHHHHCCCCHHHHHTSSCHHHHHHHTTSCCCCCCCGGGGSTTSCH
T ss_pred cccCCCCccccccccccccccccccccCCHHHHHHHHHHcCCCCHHHHhhcCCHHHHHHHHhcCCCCCCCHHHHCCCCCH
Confidence 2222111 111112222222211000 0 000000 0000000 00123377
Q ss_pred chHHHHhcccCcCCCCCCChhhhhhCCcccceecc
Q psy758 235 QYEEITQRCLDKDPLRRWSCDQLLRHPYFNGYYFE 269 (292)
Q Consensus 235 ~l~~li~~~l~~dP~~Rpt~~~il~h~w~~~~~~~ 269 (292)
.+.+||.+||++||++|||++|+|+||||+++.+.
T Consensus 372 ~~~dLl~~mL~~dP~~R~t~~e~L~Hp~f~~~~~~ 406 (458)
T 3rp9_A 372 DAIHLLKRMLVFNPNKRITINECLAHPFFKEVRIA 406 (458)
T ss_dssp HHHHHHHHHSCSSTTTSCCHHHHHHSGGGTTTCCG
T ss_pred HHHHHHHHHhccCccccCCHHHHhcCHhhhhcCCC
Confidence 89999999999999999999999999999997654
|
| >3hmm_A TGF-beta receptor type-1; ALK5, kinase, inhibitor, quinazoline, aortic aneurysm, ATP-binding, craniosynostosis, disease mutation, disulfide bond; HET: 855; 1.70A {Homo sapiens} PDB: 1vjy_A* 3gxl_A* 3tzm_A* 2wot_A* 2wou_A* 1py5_A* 1rw8_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.3e-46 Score=301.30 Aligned_cols=245 Identities=19% Similarity=0.211 Sum_probs=175.3
Q ss_pred cccceeeeecccCceEEEEEEEcCCCcEEEEEEeccCCCChHHHHHHHHHHHHHHhCCCCCcchhhhhhhcCC----eEE
Q psy758 2 ERYEKIGKLGEGSYGVVFKCRNRDTGQVVAIKKFLESEEDPLIRKIALREIRLLKSLKHPNLVNLLEVFRRKK----KLH 77 (292)
Q Consensus 2 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~----~~~ 77 (292)
.+|.+.+.||+|+||.||+|++ +|+.||||++..... .......|+..+..++||||+++++++.+++ .+|
T Consensus 3 r~i~L~~~iG~G~fG~Vy~~~~--~g~~VAvK~l~~~~~---~~~~~e~Ei~~~~~l~HpNIv~l~g~~~~~~~~~~~~~ 77 (303)
T 3hmm_A 3 RTIVLQESIGKGRFGEVWRGKW--RGEEVAVKIFSSREE---RSWFREAEIYQTVMLRHENILGFIAADNKDNGTWTQLW 77 (303)
T ss_dssp GGEEEEEEEEECSSSEEEEEEE--TTEEEEEEEECGGGH---HHHHHHHHHHTSTTCCCTTBCCEEEEEEEECSSSEEEE
T ss_pred cEEEEEEEEeeCCCeEEEEEEE--CCEEEEEEEECccch---hhHHHHHHHHHHhcCCCCCCCcEEEEEEecCCCceEEE
Confidence 4788999999999999999987 489999999865432 2223345666777889999999999987643 589
Q ss_pred EEEecCCCccHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhC--------CccccCCCCCceEEccCCcEEEeecCchh
Q psy758 78 LVFEFCDHTVLNELENHPHGLPWDLIKQITWQVLRGVSYCHRH--------ACIHRDIKPENILLTANGVVKLCDFGFAR 149 (292)
Q Consensus 78 iv~e~~~~~~L~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~--------givH~dl~p~Nilv~~~~~~kl~dfg~~~ 149 (292)
+|||||++|+|.++++.. .+++..+..++.|++.||+|||++ ||+||||||+|||++.++.+||+|||+++
T Consensus 78 lV~Ey~~~gsL~~~l~~~-~l~~~~~~~i~~~ia~gl~ylH~~~~~~~~~~~IiHRDlKp~NILl~~~~~~Ki~DFGla~ 156 (303)
T 3hmm_A 78 LVSDYHEHGSLFDYLNRY-TVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAV 156 (303)
T ss_dssp EEEECCTTCBHHHHHHHC-CBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCCEECSCCCGGGEEECTTSCEEECCCTTCE
T ss_pred EEecCCCCCcHHHHHHhC-CCCHHHHHHHHHHHHHHHHHHHHhhhhccCCCCEeeccCCcccEEECCCCCEEEEeCCCCc
Confidence 999999999999999764 699999999999999999999987 99999999999999999999999999987
Q ss_pred hhhccc---------cccccccccccccccC-----------CCCCCCcccceeeecCCCCCCchHHHHHHHhhcccCCC
Q psy758 150 LIRDLI---------PRHLHIFQTNEYFKGV-----------SLPHAENVVPLEIKIGKPAATNIYLIDFLKRCLDKDPL 209 (292)
Q Consensus 150 ~~~~~~---------~~~~~~~~~~~~~~~~-----------~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~p~ 209 (292)
...... ..++..|.+||...+. .+.|++|+..+++.++.+++..... ...|.
T Consensus 157 ~~~~~~~~~~~~~~~~~GT~~ymAPE~l~~~~~~~~~~~~~k~DVwS~Gvvl~El~tg~~~~~~~~~--------~~~p~ 228 (303)
T 3hmm_A 157 RHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHED--------YQLPY 228 (303)
T ss_dssp EEETTTTEESCC-----CCGGGCCHHHHTTCSCTTCHHHHHHHHHHHHHHHHHHHHHTBCBTTBCCC--------CCCTT
T ss_pred cccCCCCceeeecccccccccccCHHHhcccccccCCccChhHhhhhHHHHHHHHHHCCCCCCcccc--------ccccc
Confidence 654321 1245567777766543 2346666666666655443210000 00111
Q ss_pred C-----CCChhhhhhccCcCCCCCCC-------CCccchHHHHhcccCcCCCCCCChhhhhhC
Q psy758 210 R-----RWSCDQLLRHPYFNGYYFEV-------PDEMQYEEITQRCLDKDPLRRWSCDQLLRH 260 (292)
Q Consensus 210 ~-----~~~~~~~~~~~~~~~~~~~~-------~~~~~l~~li~~~l~~dP~~Rpt~~~il~h 260 (292)
. .+...++.........+.+. ..+..+.+|+.+||+.||++|||+.||++.
T Consensus 229 ~~~~~~~~~~~~~~~~~~~~~~rp~~p~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ei~~~ 291 (303)
T 3hmm_A 229 YDLVPSDPSVEEMRKVVCEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKT 291 (303)
T ss_dssp TTTSCSSCCHHHHHHHHTTSCCCCCCCGGGGSSHHHHHHHHHHHTTCCSSGGGSCCHHHHHHH
T ss_pred hhcccccchHHHHHHHHhcccCCCCCCccccchHHHHHHHHHHHHHcccCHhHCcCHHHHHHH
Confidence 1 11122221111111111111 113467899999999999999999999874
|
| >2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=3.2e-45 Score=297.10 Aligned_cols=256 Identities=20% Similarity=0.320 Sum_probs=199.4
Q ss_pred CcccceeeeecccCceEEEEEEEcCCCcEEEEEEeccCCCC-hHHHHHHHHHHHHHHhCCCCCcchhhhhhhcCCeEEEE
Q psy758 1 MERYEKIGKLGEGSYGVVFKCRNRDTGQVVAIKKFLESEED-PLIRKIALREIRLLKSLKHPNLVNLLEVFRRKKKLHLV 79 (292)
Q Consensus 1 ~~~y~~~~~l~~g~~~~v~~~~~~~~~~~v~iK~~~~~~~~-~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~iv 79 (292)
+++|++.+.||+|++|.||+|.+..+++.||+|++...... ......+.+|+.+++.++||||+++++++.+++..++|
T Consensus 13 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 92 (284)
T 2vgo_A 13 IDDFDIGRPLGKGKFGNVYLAREKQNKFIMALKVLFKSQLEKEGVEHQLRREIEIQSHLRHPNILRMYNYFHDRKRIYLM 92 (284)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEE
T ss_pred hhhceeeheecCCCCeEEEEEEEcCCCcEEEEEEEcccccchHHHHHHHHHHHHHHhcCCCCCEeeEEEEEEcCCEEEEE
Confidence 47899999999999999999999999999999998654211 11245678999999999999999999999999999999
Q ss_pred EecCCCccHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEEccCCcEEEeecCchhhhhcc---cc
Q psy758 80 FEFCDHTVLNELENHPHGLPWDLIKQITWQVLRGVSYCHRHACIHRDIKPENILLTANGVVKLCDFGFARLIRDL---IP 156 (292)
Q Consensus 80 ~e~~~~~~L~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~givH~dl~p~Nilv~~~~~~kl~dfg~~~~~~~~---~~ 156 (292)
|||+++++|.+++...+.+++..++.++.||+.||.|||++|++|+||+|+||+++.++.++|+|||++...... ..
T Consensus 93 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~ 172 (284)
T 2vgo_A 93 LEFAPRGELYKELQKHGRFDEQRSATFMEELADALHYCHERKVIHRDIKPENLLMGYKGELKIADFGWSVHAPSLRRRTM 172 (284)
T ss_dssp ECCCTTEEHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHTTTEECCCCSGGGEEECTTCCEEECCCTTCEECSSSCBCCC
T ss_pred EEeCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCHHHEEEcCCCCEEEecccccccCcccccccc
Confidence 999999999999887778999999999999999999999999999999999999999999999999988654331 12
Q ss_pred ccccccccccccccCCCCCCCcccceeeecCCCCCCchHHHHHHHhhcccCCCCCCChhhhhhccCcCCCCCCCCCccch
Q psy758 157 RHLHIFQTNEYFKGVSLPHAENVVPLEIKIGKPAATNIYLIDFLKRCLDKDPLRRWSCDQLLRHPYFNGYYFEVPDEMQY 236 (292)
Q Consensus 157 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~l 236 (292)
..+..|.+||...+.......++|+ .+.-++..+.+..|+...+..+............+...+..+
T Consensus 173 ~~~~~y~aPE~~~~~~~~~~~Di~s-------------lG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 239 (284)
T 2vgo_A 173 CGTLDYLPPEMIEGKTHDEKVDLWC-------------AGVLCYEFLVGMPPFDSPSHTETHRRIVNVDLKFPPFLSDGS 239 (284)
T ss_dssp CSCGGGCCHHHHTTCCBCTTHHHHH-------------HHHHHHHHHHSSCTTCCSSHHHHHHHHHTTCCCCCTTSCHHH
T ss_pred cCCCCcCCHHHhccCCCCcccchhh-------------HHHHHHHHHHCCCCCCCCCHhHHHHHHhccccCCCCcCCHHH
Confidence 2344566666665543333333322 233334444455555554444433322222233445567899
Q ss_pred HHHHhcccCcCCCCCCChhhhhhCCcccceecc
Q psy758 237 EEITQRCLDKDPLRRWSCDQLLRHPYFNGYYFE 269 (292)
Q Consensus 237 ~~li~~~l~~dP~~Rpt~~~il~h~w~~~~~~~ 269 (292)
.++|.+||+.||.+|||++++++||||++....
T Consensus 240 ~~li~~~l~~~p~~Rps~~~ll~h~~~~~~~~~ 272 (284)
T 2vgo_A 240 KDLISKLLRYHPPQRLPLKGVMEHPWVKANSRR 272 (284)
T ss_dssp HHHHHHHSCSSGGGSCCHHHHHTCHHHHHHCCC
T ss_pred HHHHHHHhhcCHhhCCCHHHHhhCHHHHhhccc
Confidence 999999999999999999999999999985544
|
| >2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.5e-45 Score=301.26 Aligned_cols=268 Identities=31% Similarity=0.534 Sum_probs=184.4
Q ss_pred CcccceeeeecccCceEEEEEEEcCCCcEEEEEEeccCCCChHHHHHHHHHHHHHHhCCCCCcchhhhhhhcCCeEEEEE
Q psy758 1 MERYEKIGKLGEGSYGVVFKCRNRDTGQVVAIKKFLESEEDPLIRKIALREIRLLKSLKHPNLVNLLEVFRRKKKLHLVF 80 (292)
Q Consensus 1 ~~~y~~~~~l~~g~~~~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~iv~ 80 (292)
.++|++.+.||+|+||.||+|.+..+++.||+|.+...... ...+.+.+|+.+++.++||||+++++++.+++..++||
T Consensus 4 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~-~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~ 82 (317)
T 2pmi_A 4 SSQFKQLEKLGNGTYATVYKGLNKTTGVYVALKEVKLDSEE-GTPSTAIREISLMKELKHENIVRLYDVIHTENKLTLVF 82 (317)
T ss_dssp ---------------CEEEEEECSSSCCEEEEEEEECCSTT-CSCHHHHHHHHHHTTCCBTTBCCEEEEECCTTEEEEEE
T ss_pred ccceeEeeEECCCCCEEEEEEEECCCCcEEEEEEeeccccc-ccHHHHHHHHHHHHhcCCCCcceEEEEEEECCeEEEEE
Confidence 36899999999999999999999999999999998755422 12345778999999999999999999999999999999
Q ss_pred ecCCCccHHHHhcC------CCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEEccCCcEEEeecCchhhhhcc
Q psy758 81 EFCDHTVLNELENH------PHGLPWDLIKQITWQVLRGVSYCHRHACIHRDIKPENILLTANGVVKLCDFGFARLIRDL 154 (292)
Q Consensus 81 e~~~~~~L~~~~~~------~~~~~~~~~~~i~~qi~~aL~~LH~~givH~dl~p~Nilv~~~~~~kl~dfg~~~~~~~~ 154 (292)
||+++ +|.+++.. ...+++..++.++.||+.||.|||++||+||||||+||+++.++.+||+|||++......
T Consensus 83 e~~~~-~L~~~l~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~lH~~~ivH~Dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~ 161 (317)
T 2pmi_A 83 EFMDN-DLKKYMDSRTVGNTPRGLELNLVKYFQWQLLQGLAFCHENKILHRDLKPQNLLINKRGQLKLGDFGLARAFGIP 161 (317)
T ss_dssp ECCCC-BHHHHHHHHHSSSCCCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCEEECCCSSCEETTSC
T ss_pred EecCC-CHHHHHHhccccccccCCCHHHHHHHHHHHHHHHHHHHHCCeeeCCCChHHeEEcCCCCEEECcCccceecCCC
Confidence 99996 66666542 235899999999999999999999999999999999999999999999999999765432
Q ss_pred c-----cccccccccccccccCC------CCCCCcccceeeecCCCCCCchHHHHHHH---hhcccCCCCCCC-hhhhhh
Q psy758 155 I-----PRHLHIFQTNEYFKGVS------LPHAENVVPLEIKIGKPAATNIYLIDFLK---RCLDKDPLRRWS-CDQLLR 219 (292)
Q Consensus 155 ~-----~~~~~~~~~~~~~~~~~------~~~~~~~~~~~~~~~~~~~~~~~~~~~~~---~~~~~~p~~~~~-~~~~~~ 219 (292)
. ...+..|.+||...+.. ..|+.|+..+++.+|..++........+. ..++..+...+. ......
T Consensus 162 ~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~ 241 (317)
T 2pmi_A 162 VNTFSSEVVTLWYRAPDVLMGSRTYSTSIDIWSCGCILAEMITGKPLFPGTNDEEQLKLIFDIMGTPNESLWPSVTKLPK 241 (317)
T ss_dssp CCCCCCCCSCCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCTTTCGGGGGCTT
T ss_pred cccCCCCcccccccCchHhhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChhHhhhhhhhhh
Confidence 1 23345677888765432 24666777777788877664433322222 222222211111 110000
Q ss_pred c-cCcCC-----------CCCCCCCccchHHHHhcccCcCCCCCCChhhhhhCCcccceeccC
Q psy758 220 H-PYFNG-----------YYFEVPDEMQYEEITQRCLDKDPLRRWSCDQLLRHPYFNGYYFEV 270 (292)
Q Consensus 220 ~-~~~~~-----------~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~~il~h~w~~~~~~~~ 270 (292)
. +.+.. .......+..+.+||.+||+.||++|||++|+++||||++..+..
T Consensus 242 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpt~~e~l~hp~f~~~~~~~ 304 (317)
T 2pmi_A 242 YNPNIQQRPPRDLRQVLQPHTKEPLDGNLMDFLHGLLQLNPDMRLSAKQALHHPWFAEYYHHA 304 (317)
T ss_dssp CCTTCCCCCCCCSHHHHGGGCSSCCCHHHHHHHHHHSCSSGGGSCCHHHHTTSGGGGGGCC--
T ss_pred cccccccccchhHHHhhcccccccCCHHHHHHHHHHCCCCcccCCCHHHHhCChhhhcccchh
Confidence 0 00000 011224567899999999999999999999999999999977653
|
| >3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-44 Score=302.92 Aligned_cols=247 Identities=24% Similarity=0.319 Sum_probs=184.8
Q ss_pred cccceeeeecccCceEEEEEEEcCCCcEEEEEEeccCCCChHHHHHHHHHHHHHHhCCCCCcchhhhhhhcCCeEEEEEe
Q psy758 2 ERYEKIGKLGEGSYGVVFKCRNRDTGQVVAIKKFLESEEDPLIRKIALREIRLLKSLKHPNLVNLLEVFRRKKKLHLVFE 81 (292)
Q Consensus 2 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~iv~e 81 (292)
++|++++.||+|+||.||+|++..+++.||+|++....... +.+.+|+.+++.++||||+++++++.+.+..++|||
T Consensus 20 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~---~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e 96 (361)
T 3uc3_A 20 DRYDFVKDIGSGNFGVARLMRDKLTKELVAVKYIERGAAID---ENVQREIINHRSLRHPNIVRFKEVILTPTHLAIIME 96 (361)
T ss_dssp TTEEEEEEESSSTTSSEEEEEETTTCCEEEEEEEESSTTSC---HHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEEE
T ss_pred CcEEEEEEeccCCCEEEEEEEECCCCcEEEEEEEecCcccc---HHHHHHHHHHHhCCCCCCCcEEEEEeeCCEEEEEEE
Confidence 68999999999999999999999999999999997654332 446789999999999999999999999999999999
Q ss_pred cCCCccHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEEccCCc--EEEeecCchhhhhc----cc
Q psy758 82 FCDHTVLNELENHPHGLPWDLIKQITWQVLRGVSYCHRHACIHRDIKPENILLTANGV--VKLCDFGFARLIRD----LI 155 (292)
Q Consensus 82 ~~~~~~L~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~givH~dl~p~Nilv~~~~~--~kl~dfg~~~~~~~----~~ 155 (292)
|+.+++|..++...+.+++..++.++.||+.||+|||++||+||||||+||+++.++. +||+|||++..... ..
T Consensus 97 ~~~~~~L~~~l~~~~~~~~~~~~~i~~ql~~~L~~LH~~~ivH~Dlkp~Nill~~~~~~~~kl~Dfg~a~~~~~~~~~~~ 176 (361)
T 3uc3_A 97 YASGGELYERICNAGRFSEDEARFFFQQLLSGVSYCHSMQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKS 176 (361)
T ss_dssp CCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCCSCCCCGGGEEECSSSSCCEEECCCCCC-----------
T ss_pred eCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEEcCCCCceEEEeecCccccccccCCCCC
Confidence 9999999999877778999999999999999999999999999999999999987765 99999999874322 12
Q ss_pred cccccccccccccccCCC------CCCCcccceeeecCCCCCCchHHHHHHHhhcccCCCCCCChhhhhhccCcCCC--C
Q psy758 156 PRHLHIFQTNEYFKGVSL------PHAENVVPLEIKIGKPAATNIYLIDFLKRCLDKDPLRRWSCDQLLRHPYFNGY--Y 227 (292)
Q Consensus 156 ~~~~~~~~~~~~~~~~~~------~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~--~ 227 (292)
..++..|.+||...+... .|+.|+..+++.+|..++..... .......+........ .
T Consensus 177 ~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~--------------~~~~~~~~~~~~~~~~~~~ 242 (361)
T 3uc3_A 177 TVGTPAYIAPEVLLRQEYDGKIADVWSCGVTLYVMLVGAYPFEDPEE--------------PRDYRKTIQRILSVKYSIP 242 (361)
T ss_dssp ----CTTSCHHHHHCSSCCHHHHHHHHHHHHHHHHHHSSCSCC------------------CCCHHHHHHHHHTTCCCCC
T ss_pred CcCCCCcCChhhhcCCCCCCCeeeeehhHHHHHHHHhCCCCCCCCcc--------------HHHHHHHHHHHhcCCCCCC
Confidence 233455667766544332 24444444444444443321100 0011111111111111 1
Q ss_pred CCCCCccchHHHHhcccCcCCCCCCChhhhhhCCcccc
Q psy758 228 FEVPDEMQYEEITQRCLDKDPLRRWSCDQLLRHPYFNG 265 (292)
Q Consensus 228 ~~~~~~~~l~~li~~~l~~dP~~Rpt~~~il~h~w~~~ 265 (292)
.....+..+.+||.+||+.||.+|||+.|+++||||..
T Consensus 243 ~~~~~s~~~~~li~~~L~~dP~~Rps~~ell~hp~f~~ 280 (361)
T 3uc3_A 243 DDIRISPECCHLISRIFVADPATRISIPEIKTHSWFLK 280 (361)
T ss_dssp TTSCCCHHHHHHHHHHSCSCTTTSCCHHHHHTSHHHHT
T ss_pred CcCCCCHHHHHHHHHHccCChhHCcCHHHHHhCcchhc
Confidence 22245788999999999999999999999999999965
|
| >2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-44 Score=298.10 Aligned_cols=253 Identities=24% Similarity=0.292 Sum_probs=199.8
Q ss_pred cccceeeeecccCceEEEEEEEcCCCcEEEEEEeccCC-CChHHHHHHHHHHHHHHhCCCCCcchhhhhhhcCCeEEEEE
Q psy758 2 ERYEKIGKLGEGSYGVVFKCRNRDTGQVVAIKKFLESE-EDPLIRKIALREIRLLKSLKHPNLVNLLEVFRRKKKLHLVF 80 (292)
Q Consensus 2 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~v~iK~~~~~~-~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~iv~ 80 (292)
++|++.+.||+|+||.||+|.+..+++.|++|++.... ......+.+.+|+.+++.++||||+++++++.+.+..++||
T Consensus 41 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ 120 (335)
T 2owb_A 41 RRYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHGFFEDNDFVFVVL 120 (335)
T ss_dssp EEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred CceEEEEEEeeCCCeEEEEEEECCCCCEEEEEEechhhhcCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEecCCeEEEEE
Confidence 58999999999999999999999999999999987654 34456677889999999999999999999999999999999
Q ss_pred ecCCCccHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEEccCCcEEEeecCchhhhhcccc----
Q psy758 81 EFCDHTVLNELENHPHGLPWDLIKQITWQVLRGVSYCHRHACIHRDIKPENILLTANGVVKLCDFGFARLIRDLIP---- 156 (292)
Q Consensus 81 e~~~~~~L~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~givH~dl~p~Nilv~~~~~~kl~dfg~~~~~~~~~~---- 156 (292)
||+.+++|.+++.....+++..++.++.||+.||.|||++|++|+||+|+||+++.++.++|+|||++........
T Consensus 121 e~~~~~~L~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~~~~~~~ 200 (335)
T 2owb_A 121 ELCRRRSLLELHKRRKALTEPEARYYLRQIVLGCQYLHRNRVIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGERKKV 200 (335)
T ss_dssp CCCTTCBHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECTTCCEEECCCTTCEECCSTTCCBCC
T ss_pred ecCCCCCHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCCEecCCCchhEEEcCCCCEEEeeccCceecccCcccccc
Confidence 9999999999988777899999999999999999999999999999999999999999999999999876542221
Q ss_pred -ccccccccccccccCCCCCCCcccceeeecCCCCCCchHHHHHHHhhcccCCCCCCChhhhhhccCcCCCCCCCCCccc
Q psy758 157 -RHLHIFQTNEYFKGVSLPHAENVVPLEIKIGKPAATNIYLIDFLKRCLDKDPLRRWSCDQLLRHPYFNGYYFEVPDEMQ 235 (292)
Q Consensus 157 -~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 235 (292)
..+..|.+||...+.......|+| +.+.-++..+.+..|+......+............+...+..
T Consensus 201 ~~gt~~y~aPE~~~~~~~~~~~Di~-------------slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 267 (335)
T 2owb_A 201 LCGTPNYIAPEVLSKKGHSFEVDVW-------------SIGCIMYTLLVGKPPFETSCLKETYLRIKKNEYSIPKHINPV 267 (335)
T ss_dssp CCSCCSSCCHHHHHTSCBCTHHHHH-------------HHHHHHHHHHHSSCTTCCSSHHHHHHHHHHTCCCCCTTSCHH
T ss_pred cCCCccccCHHHhccCCCCchhhHH-------------HHHHHHHHHHHCcCCCCCCCHHHHHHHHhcCCCCCCccCCHH
Confidence 223345666655443332222222 222333444445555554444333322222223344556788
Q ss_pred hHHHHhcccCcCCCCCCChhhhhhCCccccee
Q psy758 236 YEEITQRCLDKDPLRRWSCDQLLRHPYFNGYY 267 (292)
Q Consensus 236 l~~li~~~l~~dP~~Rpt~~~il~h~w~~~~~ 267 (292)
+.+||.+||+.||++|||++++++||||.+..
T Consensus 268 ~~~li~~~l~~dp~~Rps~~ell~~~~~~~~~ 299 (335)
T 2owb_A 268 AASLIQKMLQTDPTARPTINELLNDEFFTSGY 299 (335)
T ss_dssp HHHHHHHHTCSSGGGSCCGGGGGGSHHHHTSC
T ss_pred HHHHHHHHccCChhHCcCHHHHhcCccccCCC
Confidence 99999999999999999999999999999865
|
| >1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=3.3e-44 Score=302.06 Aligned_cols=252 Identities=24% Similarity=0.341 Sum_probs=194.4
Q ss_pred cccceeeeecccCceEEEEEEEcCCCcEEEEEEeccCCCChHHHHHHHHHHHHHHhCCCCCcchhhhhhhcCCeEEEEEe
Q psy758 2 ERYEKIGKLGEGSYGVVFKCRNRDTGQVVAIKKFLESEEDPLIRKIALREIRLLKSLKHPNLVNLLEVFRRKKKLHLVFE 81 (292)
Q Consensus 2 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~iv~e 81 (292)
++|++.+.||+|+||.||+|.+..+++.||+|++.... ......+.+|+.+++.++||||+++++++.+.+..++|||
T Consensus 51 ~~y~i~~~LG~G~~g~Vy~~~~~~~~~~~a~K~~~~~~--~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~lv~E 128 (387)
T 1kob_A 51 DYYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPY--PLDKYTVKNEISIMNQLHHPKLINLHDAFEDKYEMVLILE 128 (387)
T ss_dssp GTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCS--HHHHHHHHHHHHHHTTCCSTTBCCEEEEEECSSEEEEEEE
T ss_pred cceEEEEEEecCCCEEEEEEEECCCCCEEEEEEecccc--hhhHHHHHHHHHHHHhCCCcCCCeEEEEEEeCCEEEEEEE
Confidence 57999999999999999999999999999999986543 2334568899999999999999999999999999999999
Q ss_pred cCCCccHHHHhcCC-CCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEEcc--CCcEEEeecCchhhhhccc---
Q psy758 82 FCDHTVLNELENHP-HGLPWDLIKQITWQVLRGVSYCHRHACIHRDIKPENILLTA--NGVVKLCDFGFARLIRDLI--- 155 (292)
Q Consensus 82 ~~~~~~L~~~~~~~-~~~~~~~~~~i~~qi~~aL~~LH~~givH~dl~p~Nilv~~--~~~~kl~dfg~~~~~~~~~--- 155 (292)
|+.|++|.+++... ..+++..++.++.||+.||+|||++||+||||||+||+++. ++.++|+|||++.......
T Consensus 129 ~~~gg~L~~~l~~~~~~l~~~~~~~i~~qi~~aL~~LH~~givHrDlkp~NIll~~~~~~~vkL~DFG~a~~~~~~~~~~ 208 (387)
T 1kob_A 129 FLSGGELFDRIAAEDYKMSEAEVINYMRQACEGLKHMHEHSIVHLDIKPENIMCETKKASSVKIIDFGLATKLNPDEIVK 208 (387)
T ss_dssp CCCCCBHHHHTTCTTCCBCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESSTTCCCEEECCCTTCEECCTTSCEE
T ss_pred cCCCCcHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhCCeeecccchHHeEEecCCCCceEEEecccceecCCCccee
Confidence 99999999988764 36999999999999999999999999999999999999984 4679999999997654321
Q ss_pred -cccccccccccccccCCCC-----CCCcccceeeecCCCCCCchHHHHHHHhhcccCCCCCCChhhhhhccCcCCCCCC
Q psy758 156 -PRHLHIFQTNEYFKGVSLP-----HAENVVPLEIKIGKPAATNIYLIDFLKRCLDKDPLRRWSCDQLLRHPYFNGYYFE 229 (292)
Q Consensus 156 -~~~~~~~~~~~~~~~~~~~-----~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~ 229 (292)
...+..|.+||...+.... |+.|+..+++++|..++........+...... .+.......
T Consensus 209 ~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~Pf~~~~~~~~~~~i~~~--------------~~~~~~~~~ 274 (387)
T 1kob_A 209 VTTATAEFAAPEIVDREPVGFYTDMWAIGVLGYVLLSGLSPFAGEDDLETLQNVKRC--------------DWEFDEDAF 274 (387)
T ss_dssp EECSSGGGCCHHHHTTCCBCHHHHHHHHHHHHHHHHHSCCSSCCSSHHHHHHHHHHC--------------CCCCCSSTT
T ss_pred eeccCCCccCchhccCCCCCCcccEeeHhHHHHHHHhCCCCCCCCCHHHHHHHHHhC--------------CCCCCcccc
Confidence 2334557777766554432 44444444445554444332222222222111 110011112
Q ss_pred CCCccchHHHHhcccCcCCCCCCChhhhhhCCcccceecc
Q psy758 230 VPDEMQYEEITQRCLDKDPLRRWSCDQLLRHPYFNGYYFE 269 (292)
Q Consensus 230 ~~~~~~l~~li~~~l~~dP~~Rpt~~~il~h~w~~~~~~~ 269 (292)
...+..+.+||.+||+.||.+|||+.++++||||++....
T Consensus 275 ~~~s~~~~~li~~~L~~dP~~Rpt~~ell~hp~~~~~~~~ 314 (387)
T 1kob_A 275 SSVSPEAKDFIKNLLQKEPRKRLTVHDALEHPWLKGDHSN 314 (387)
T ss_dssp TTSCHHHHHHHHTTSCSSGGGSCCHHHHHTSTTTSSCCTT
T ss_pred ccCCHHHHHHHHHHcCCChhHCcCHHHHhhCccccCCccc
Confidence 3457789999999999999999999999999999986544
|
| >3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 4ec9_A* 4ec8_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* 4bch_A* 4bci_A* 4bcj_A* 4bcf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-44 Score=301.45 Aligned_cols=266 Identities=30% Similarity=0.453 Sum_probs=199.0
Q ss_pred CcccceeeeecccCceEEEEEEEcCCCcEEEEEEeccCCCChHHHHHHHHHHHHHHhCCCCCcchhhhhhhc--------
Q psy758 1 MERYEKIGKLGEGSYGVVFKCRNRDTGQVVAIKKFLESEEDPLIRKIALREIRLLKSLKHPNLVNLLEVFRR-------- 72 (292)
Q Consensus 1 ~~~y~~~~~l~~g~~~~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~-------- 72 (292)
+++|++++.||+|+||.||+|.+..+|+.||+|++............+.+|+.+++.++||||+++++++.+
T Consensus 16 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 95 (351)
T 3mi9_A 16 VSKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKASPYNRC 95 (351)
T ss_dssp GGGEEEEEECSSCSTTSEEEEEETTTCCEEEEEECCCSSCSSSSCHHHHHHHHHHHHCCCTTBCCEEEEEEEC-------
T ss_pred ccceeEEEEEecCCCcEEEEEEECCCCCEEEEEEEecccccccchHHHHHHHHHHHhccCCCcccHhheeeccccccccC
Confidence 478999999999999999999999999999999987665444444567789999999999999999999876
Q ss_pred CCeEEEEEecCCCccHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEEccCCcEEEeecCchhhhh
Q psy758 73 KKKLHLVFEFCDHTVLNELENHPHGLPWDLIKQITWQVLRGVSYCHRHACIHRDIKPENILLTANGVVKLCDFGFARLIR 152 (292)
Q Consensus 73 ~~~~~iv~e~~~~~~L~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~givH~dl~p~Nilv~~~~~~kl~dfg~~~~~~ 152 (292)
.+.+++||||++++.+..+......+++..++.++.||+.||+|||++||+||||||+||+++.++.++|+|||++....
T Consensus 96 ~~~~~lv~e~~~~~l~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~ivH~Dlkp~NIl~~~~~~~kl~Dfg~a~~~~ 175 (351)
T 3mi9_A 96 KGSIYLVFDFCEHDLAGLLSNVLVKFTLSEIKRVMQMLLNGLYYIHRNKILHRDMKAANVLITRDGVLKLADFGLARAFS 175 (351)
T ss_dssp -CEEEEEEECCSEEHHHHHHCTTSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTCEECC
T ss_pred CceEEEEEeccCCCHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCCeeCCCCCHHHEEEcCCCCEEEccchhccccc
Confidence 45789999999987667676666789999999999999999999999999999999999999999999999999987654
Q ss_pred cc---------ccccccccccccccccCC------CCCCCcccceeeecCCCCCCchHHHH---HHHhhcccCCC-CCCC
Q psy758 153 DL---------IPRHLHIFQTNEYFKGVS------LPHAENVVPLEIKIGKPAATNIYLID---FLKRCLDKDPL-RRWS 213 (292)
Q Consensus 153 ~~---------~~~~~~~~~~~~~~~~~~------~~~~~~~~~~~~~~~~~~~~~~~~~~---~~~~~~~~~p~-~~~~ 213 (292)
.. ....+..|.+||...+.. ..|+.|+..+++.+|.+++....... .+.......+. ..+.
T Consensus 176 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~ 255 (351)
T 3mi9_A 176 LAKNSQPNRYTNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQLALISQLCGSITPEVWPN 255 (351)
T ss_dssp CCSSSSCCCCCSSCSCGGGCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTTTSTT
T ss_pred ccccccccccCCcccccCccCchhhcCCCCCCcHhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChhhccc
Confidence 21 112245577888665432 24666666677777777654433222 22222222222 2222
Q ss_pred hhhhhhccCcCCCCCCCC-------------CccchHHHHhcccCcCCCCCCChhhhhhCCcccceecc
Q psy758 214 CDQLLRHPYFNGYYFEVP-------------DEMQYEEITQRCLDKDPLRRWSCDQLLRHPYFNGYYFE 269 (292)
Q Consensus 214 ~~~~~~~~~~~~~~~~~~-------------~~~~l~~li~~~l~~dP~~Rpt~~~il~h~w~~~~~~~ 269 (292)
.... ..+........ .++.+.+||.+||+.||++|||++|+++||||++....
T Consensus 256 ~~~~---~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~hp~f~~~~~~ 321 (351)
T 3mi9_A 256 VDNY---ELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRIDSDDALNHDFFWSDPMP 321 (351)
T ss_dssp GGGC---GGGTSSCCCSSCCCCHHHHHHHHHCCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGGSSSCC
T ss_pred cccc---hhhcccccccccccCHHHHhhhccCChHHHHHHHHHhcCChhhCCCHHHHhCCCCcCCCCCc
Confidence 1111 11111111100 15568899999999999999999999999999986543
|
| >4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.2e-45 Score=311.36 Aligned_cols=257 Identities=19% Similarity=0.246 Sum_probs=196.3
Q ss_pred cccceeeeecccCceEEEEEEEcCCCcEEEEEEeccCCCC-hHHHHHHHHHHHHHHhCCCCCcchhhhhhhcCCeEEEEE
Q psy758 2 ERYEKIGKLGEGSYGVVFKCRNRDTGQVVAIKKFLESEED-PLIRKIALREIRLLKSLKHPNLVNLLEVFRRKKKLHLVF 80 (292)
Q Consensus 2 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~v~iK~~~~~~~~-~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~iv~ 80 (292)
++|++.+.||+|+||.||+|++..+++.||+|++...... ......+.+|..++..++||||+++++++.+++.+|+||
T Consensus 74 ~~y~~~~~LG~G~fG~V~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~~E~~il~~~~hp~Iv~l~~~~~~~~~~~lV~ 153 (437)
T 4aw2_A 74 EDFEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDSKWITTLHYAFQDDNNLYLVM 153 (437)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEHHHHHHTTTTCCHHHHHHHHHHSCTTTBCCEEEEEECSSEEEEEE
T ss_pred hheEEEEEEEeCCCEEEEEEEEcCCCcEEEEEEEEHHHhhhHHHHHHHHHHHHHHHhCCCCCEEEEEEEEeeCCEEEEEE
Confidence 6899999999999999999999999999999998653211 111234778999999999999999999999999999999
Q ss_pred ecCCCccHHHHhcC-CCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEEccCCcEEEeecCchhhhhccc----
Q psy758 81 EFCDHTVLNELENH-PHGLPWDLIKQITWQVLRGVSYCHRHACIHRDIKPENILLTANGVVKLCDFGFARLIRDLI---- 155 (292)
Q Consensus 81 e~~~~~~L~~~~~~-~~~~~~~~~~~i~~qi~~aL~~LH~~givH~dl~p~Nilv~~~~~~kl~dfg~~~~~~~~~---- 155 (292)
||++||+|..++.. .+.+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++.......
T Consensus 154 Ey~~gg~L~~~l~~~~~~l~e~~~~~~~~qi~~aL~~LH~~giiHrDLKp~NILl~~~g~vkL~DFGla~~~~~~~~~~~ 233 (437)
T 4aw2_A 154 DYYVGGDLLTLLSKFEDRLPEEMARFYLAEMVIAIDSVHQLHYVHRDIKPDNILMDMNGHIRLADFGSCLKLMEDGTVQS 233 (437)
T ss_dssp CCCTTCBHHHHHHTTTTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTCEECCTTSCEEC
T ss_pred ecCCCCcHHHHHHHccCCCCHHHHHHHHHHHHHHHHHHHhCCeEecccCHHHeeEcCCCCEEEcchhhhhhcccCCCccc
Confidence 99999999999976 4679999999999999999999999999999999999999999999999999997654322
Q ss_pred --ccccccccccccccc----------CCCCCCCcccceeeecCCCCCCchHHHHHHHhhcccCCCCCCChhhhhhccCc
Q psy758 156 --PRHLHIFQTNEYFKG----------VSLPHAENVVPLEIKIGKPAATNIYLIDFLKRCLDKDPLRRWSCDQLLRHPYF 223 (292)
Q Consensus 156 --~~~~~~~~~~~~~~~----------~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~ 223 (292)
..++..|.+||...+ ....|+.|+..+++.+|..++........+..++... ..+
T Consensus 234 ~~~~GT~~Y~APE~l~~~~~~~~~~~~~~DvwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~-------------~~~ 300 (437)
T 4aw2_A 234 SVAVGTPDYISPEILQAMEGGKGRYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMNHK-------------ERF 300 (437)
T ss_dssp CSCCSCGGGCCHHHHHHHHTSCCEECTHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHTHH-------------HHC
T ss_pred ccccCCcCeeChHHHhhcccCCCCCCCcCeeHHHHHHHHHHHhCCCCCCCCChhHHHHhhhhcc-------------ccc
Confidence 123445666665541 1223445555555555555443333333322222100 000
Q ss_pred CCCCCCCCCccchHHHHhcccCcCCCC--CCChhhhhhCCcccceeccCC
Q psy758 224 NGYYFEVPDEMQYEEITQRCLDKDPLR--RWSCDQLLRHPYFNGYYFEVP 271 (292)
Q Consensus 224 ~~~~~~~~~~~~l~~li~~~l~~dP~~--Rpt~~~il~h~w~~~~~~~~~ 271 (292)
.-.......+..+++||++||+.+|++ ||+++|+++||||+++.|+..
T Consensus 301 ~~p~~~~~~s~~~~dLi~~lL~~~~~r~~r~~~~eil~Hpff~~i~w~~l 350 (437)
T 4aw2_A 301 QFPTQVTDVSENAKDLIRRLICSREHRLGQNGIEDFKKHPFFSGIDWDNI 350 (437)
T ss_dssp CCCSSCCCSCHHHHHHHHTTSSCGGGCTTTTTTHHHHTSGGGTTCCTTTG
T ss_pred cCCcccccCCHHHHHHHHHHhcccccccCCCCHHHHhCCCccCCCCHHHH
Confidence 000111235789999999999998888 999999999999999998865
|
| >3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-44 Score=314.15 Aligned_cols=253 Identities=27% Similarity=0.400 Sum_probs=195.0
Q ss_pred cccceeeeecccCceEEEEEEEcCCCcEEEEEEeccCCCChHHHHHHHHHHHHHHhCCCCCcchhhhhhhcCCeEEEEEe
Q psy758 2 ERYEKIGKLGEGSYGVVFKCRNRDTGQVVAIKKFLESEEDPLIRKIALREIRLLKSLKHPNLVNLLEVFRRKKKLHLVFE 81 (292)
Q Consensus 2 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~iv~e 81 (292)
++|++++.||+|+||.||+|.+..+++.||+|++............+.+|+.+++.++||||+++++++.+.+.+++|+|
T Consensus 22 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e 101 (486)
T 3mwu_A 22 ERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIMKLFEILEDSSSFYIVGE 101 (486)
T ss_dssp HHEEEEEEEECCSSSEEEEEEETTTCCEEEEEEEEHHHHBCSCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEEC
T ss_pred cceEEeEEEeecCCEEEEEEEECCCCCEEEEEEEecccccchHHHHHHHHHHHHHhCCCCCcCeEEEEEEcCCEEEEEEE
Confidence 58999999999999999999999999999999986543222234668899999999999999999999999999999999
Q ss_pred cCCCccHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEEc---cCCcEEEeecCchhhhhccc---
Q psy758 82 FCDHTVLNELENHPHGLPWDLIKQITWQVLRGVSYCHRHACIHRDIKPENILLT---ANGVVKLCDFGFARLIRDLI--- 155 (292)
Q Consensus 82 ~~~~~~L~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~givH~dl~p~Nilv~---~~~~~kl~dfg~~~~~~~~~--- 155 (292)
|+.+++|.+.+...+.+++..++.++.||+.||.|||++||+||||||+||+++ .++.+||+|||++.......
T Consensus 102 ~~~~~~L~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dlkp~Nil~~~~~~~~~~kl~Dfg~a~~~~~~~~~~ 181 (486)
T 3mwu_A 102 LYTGGELFDEIIKRKRFSEHDAARIIKQVFSGITYMHKHNIVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQNTKMK 181 (486)
T ss_dssp CCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEESSSSTTCCEEECSCSCTTTBCCC----
T ss_pred cCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeEeccCchHHEEEecCCCCCCEEEEECCcCeECCCCCccC
Confidence 999999988887767899999999999999999999999999999999999995 45679999999997654321
Q ss_pred -cccccccccccccccCC----CCCCCcccceeeecCCCCCCchHHHHHHHhhcccCCCCCCChhhhhhccCcCCC----
Q psy758 156 -PRHLHIFQTNEYFKGVS----LPHAENVVPLEIKIGKPAATNIYLIDFLKRCLDKDPLRRWSCDQLLRHPYFNGY---- 226 (292)
Q Consensus 156 -~~~~~~~~~~~~~~~~~----~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~---- 226 (292)
..++..|.+||...+.. ..|+.|+..+++.+| ..|+...+..+++........
T Consensus 182 ~~~gt~~y~aPE~~~~~~~~~~DiwslG~il~~ll~g------------------~~pf~~~~~~~~~~~i~~~~~~~~~ 243 (486)
T 3mwu_A 182 DRIGTAYYIAPEVLRGTYDEKCDVWSAGVILYILLSG------------------TPPFYGKNEYDILKRVETGKYAFDL 243 (486)
T ss_dssp CCTTGGGGCCGGGGGSCCCHHHHHHHHHHHHHHHHHS------------------SCSSCCSSHHHHHHHHHHTCCCSCS
T ss_pred CCcCCCCCCCHHHhCCCCCchhhHHHHHHHHHHHHhC------------------CCCCCCCCHHHHHHHHHhCCCCCCC
Confidence 22345566666655421 123333444444444 444444333333322111111
Q ss_pred CCCCCCccchHHHHhcccCcCCCCCCChhhhhhCCcccceeccCCC
Q psy758 227 YFEVPDEMQYEEITQRCLDKDPLRRWSCDQLLRHPYFNGYYFEVPD 272 (292)
Q Consensus 227 ~~~~~~~~~l~~li~~~l~~dP~~Rpt~~~il~h~w~~~~~~~~~~ 272 (292)
......+..+++||.+||+.||.+|||+.++|+||||++.....+.
T Consensus 244 ~~~~~~s~~~~~li~~~L~~dp~~R~t~~~~l~hp~~~~~~~~~~~ 289 (486)
T 3mwu_A 244 PQWRTISDDAKDLIRKMLTFHPSLRITATQCLEHPWIQKYSSETPT 289 (486)
T ss_dssp GGGGGSCHHHHHHHHHHTCSSTTTSCCHHHHHHCHHHHHTCCCCCC
T ss_pred cccCCCCHHHHHHHHHHcCCChhhCcCHHHHhcCHhhccCcccCcc
Confidence 1112347789999999999999999999999999999987665543
|
| >3oz6_A Mitogen-activated protein kinase 1, serine/threon protein kinase; structural genomics consortium, SGC, transferase; 2.37A {Cryptosporidium parvum iowa II} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.1e-45 Score=307.53 Aligned_cols=264 Identities=28% Similarity=0.437 Sum_probs=190.8
Q ss_pred CcccceeeeecccCceEEEEEEEcCCCcEEEEEEeccCCCChHHHHHHHHHHHHHHhCC-CCCcchhhhhhhcC--CeEE
Q psy758 1 MERYEKIGKLGEGSYGVVFKCRNRDTGQVVAIKKFLESEEDPLIRKIALREIRLLKSLK-HPNLVNLLEVFRRK--KKLH 77 (292)
Q Consensus 1 ~~~y~~~~~l~~g~~~~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~e~~~~~~l~-~~~i~~~~~~~~~~--~~~~ 77 (292)
+++|++++.||+|+||.||+|.+..+++.||+|++............+.+|+.+++.+. ||||+++++++..+ ..+|
T Consensus 8 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~~~ 87 (388)
T 3oz6_A 8 LRKYELVKKLGKGAYGIVWKSIDRRTGEVVAVKKIFDAFQNSTDAQRTFREIMILTELSGHENIVNLLNVLRADNDRDVY 87 (388)
T ss_dssp HTTEEEEEC-------CEEEEEETTTCCEEEEEEECC--CCHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECTTSSCEE
T ss_pred cCceEEEEEeeeCCCeEEEEEEECCCCCEEEEEEecccccChHHHHHHHHHHHHHHhccCCCCCCeeeeEEecCCCCEEE
Confidence 36899999999999999999999999999999999776666677788889999999997 99999999998643 4799
Q ss_pred EEEecCCCccHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEEccCCcEEEeecCchhhhhcc---
Q psy758 78 LVFEFCDHTVLNELENHPHGLPWDLIKQITWQVLRGVSYCHRHACIHRDIKPENILLTANGVVKLCDFGFARLIRDL--- 154 (292)
Q Consensus 78 iv~e~~~~~~L~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~givH~dl~p~Nilv~~~~~~kl~dfg~~~~~~~~--- 154 (292)
+||||+++ +|..++.. ..+++..+..++.||+.||+|||++||+||||||+||+++.++.+||+|||+++.....
T Consensus 88 lv~e~~~~-~L~~~~~~-~~~~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~~~~ 165 (388)
T 3oz6_A 88 LVFDYMET-DLHAVIRA-NILEPVHKQYVVYQLIKVIKYLHSGGLLHRDMKPSNILLNAECHVKVADFGLSRSFVNIRRV 165 (388)
T ss_dssp EEEECCSE-EHHHHHHH-TCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCEEECCCTTCEESSSCCCC
T ss_pred EEecccCc-CHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHhCCEEeCCCCHHHeEEcCCCCEEecCCcccccccccccc
Confidence 99999995 67777765 37999999999999999999999999999999999999999999999999999754320
Q ss_pred -----------------------ccccccccccccccccC-C-----CCCCCcccceeeecCCCCCCchHHHHHHHhhc-
Q psy758 155 -----------------------IPRHLHIFQTNEYFKGV-S-----LPHAENVVPLEIKIGKPAATNIYLIDFLKRCL- 204 (292)
Q Consensus 155 -----------------------~~~~~~~~~~~~~~~~~-~-----~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~- 204 (292)
...++..|.+||...+. . ..|+.|+..+++.+|.+++........+..++
T Consensus 166 ~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~ 245 (388)
T 3oz6_A 166 TNNIPLSINENTENFDDDQPILTDYVATRWYRAPEILLGSTKYTKGIDMWSLGCILGEILCGKPIFPGSSTMNQLERIIG 245 (388)
T ss_dssp CCCGGGCCC---------------CCCGGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHH
T ss_pred cccccccccccccccccccccccCCcccCCcCCHHHhcCCCCCCChhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHH
Confidence 11234557777776552 2 34667777777888887765544443333332
Q ss_pred --ccCCCC------CCChhhhhh----cc------C---c-------CCCCCCCCCccchHHHHhcccCcCCCCCCChhh
Q psy758 205 --DKDPLR------RWSCDQLLR----HP------Y---F-------NGYYFEVPDEMQYEEITQRCLDKDPLRRWSCDQ 256 (292)
Q Consensus 205 --~~~p~~------~~~~~~~~~----~~------~---~-------~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~~ 256 (292)
+..+.. .+....... .. + + .........+..+.+||.+||+.||++|||++|
T Consensus 246 ~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~~L~~dP~~R~t~~e 325 (388)
T 3oz6_A 246 VIDFPSNEDVESIQSPFAKTMIESLKEKVEIRQSNKRDIFTKWKNLLLKINPKADCNEEALDLLDKLLQFNPNKRISAND 325 (388)
T ss_dssp HHCCCCHHHHHTSCCSSHHHHHHHHHHHCC-----CCCCHHHHHHHHHHHCTTCCCCHHHHHHHHHHCCSSGGGSCCHHH
T ss_pred hcCCCCHHHHHhccCHHHHHHHHhCcccccccCCCHHHhCcchhhhcccccccccCCHHHHHHHHHhhccCcccCCCHHH
Confidence 111100 000000000 00 0 0 000112245778999999999999999999999
Q ss_pred hhhCCcccce
Q psy758 257 LLRHPYFNGY 266 (292)
Q Consensus 257 il~h~w~~~~ 266 (292)
+++||||+..
T Consensus 326 ~l~Hp~~~~~ 335 (388)
T 3oz6_A 326 ALKHPFVSIF 335 (388)
T ss_dssp HTTSTTTTTT
T ss_pred HhCCHHHHHh
Confidence 9999999874
|
| >2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=9.6e-44 Score=296.15 Aligned_cols=251 Identities=23% Similarity=0.366 Sum_probs=181.5
Q ss_pred cccceeeeecccCceEEEEEEEcCCCcEEEEEEeccCCCChHHHHHHHHHHHHHHhCCCCCcchhhhhhhcCCeEEEEEe
Q psy758 2 ERYEKIGKLGEGSYGVVFKCRNRDTGQVVAIKKFLESEEDPLIRKIALREIRLLKSLKHPNLVNLLEVFRRKKKLHLVFE 81 (292)
Q Consensus 2 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~iv~e 81 (292)
++|++.+.||+|+||.||+|.+..+++.||+|++.... ..+.+.+|+.+++.++||||+++++++.+.+..++|||
T Consensus 53 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~----~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e 128 (349)
T 2w4o_A 53 DFFEVESELGRGATSIVYRCKQKGTQKPYALKVLKKTV----DKKIVRTEIGVLLRLSHPNIIKLKEIFETPTEISLVLE 128 (349)
T ss_dssp GTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEC--------------CHHHHHCCCTTBCCEEEEEECSSEEEEEEC
T ss_pred CcEEEeeEEeeCCCEEEEEEEECCCCcEEEEEEeccch----hHHHHHHHHHHHHhCCCCCCcceeeeEecCCeEEEEEE
Confidence 46999999999999999999999999999999997543 23557789999999999999999999999999999999
Q ss_pred cCCCccHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEEcc---CCcEEEeecCchhhhhccc---
Q psy758 82 FCDHTVLNELENHPHGLPWDLIKQITWQVLRGVSYCHRHACIHRDIKPENILLTA---NGVVKLCDFGFARLIRDLI--- 155 (292)
Q Consensus 82 ~~~~~~L~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~givH~dl~p~Nilv~~---~~~~kl~dfg~~~~~~~~~--- 155 (292)
|+++++|.+++...+.+++..++.++.||+.||.|||++|++||||||+||+++. ++.++|+|||++.......
T Consensus 129 ~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivH~Dikp~NIll~~~~~~~~~kl~Dfg~a~~~~~~~~~~ 208 (349)
T 2w4o_A 129 LVTGGELFDRIVEKGYYSERDAADAVKQILEAVAYLHENGIVHRDLKPENLLYATPAPDAPLKIADFGLSKIVEHQVLMK 208 (349)
T ss_dssp CCCSCBHHHHHTTCSSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEESSSSTTCCEEECCCC------------
T ss_pred eCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCcccEEEecCCCCCCEEEccCccccccCcccccc
Confidence 9999999999988888999999999999999999999999999999999999975 7899999999987654321
Q ss_pred -cccccccccccccccCCCCCCCcccceeeecCCCCCCchHHHHHHHhhcccCCCCCCChhh-h----hhccCcCCCCCC
Q psy758 156 -PRHLHIFQTNEYFKGVSLPHAENVVPLEIKIGKPAATNIYLIDFLKRCLDKDPLRRWSCDQ-L----LRHPYFNGYYFE 229 (292)
Q Consensus 156 -~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~-~----~~~~~~~~~~~~ 229 (292)
..++..|.+||...+.......|+|++ +.-++..+.+..|+......+ . ............
T Consensus 209 ~~~gt~~y~aPE~~~~~~~~~~~Diwsl-------------G~il~ell~g~~pf~~~~~~~~~~~~i~~~~~~~~~~~~ 275 (349)
T 2w4o_A 209 TVCGTPGYCAPEILRGCAYGPEVDMWSV-------------GIITYILLCGFEPFYDERGDQFMFRRILNCEYYFISPWW 275 (349)
T ss_dssp ----CGGGSCHHHHTTCCCCTHHHHHHH-------------HHHHHHHHHSSCTTCCTTCHHHHHHHHHTTCCCCCTTTT
T ss_pred cccCCCCccCHHHhcCCCCCcccchHHH-------------HHHHHHHHhCCCCCCCCcccHHHHHHHHhCCCccCCchh
Confidence 223455777777665444322333222 222233333333433222211 1 111111111122
Q ss_pred CCCccchHHHHhcccCcCCCCCCChhhhhhCCcccceecc
Q psy758 230 VPDEMQYEEITQRCLDKDPLRRWSCDQLLRHPYFNGYYFE 269 (292)
Q Consensus 230 ~~~~~~l~~li~~~l~~dP~~Rpt~~~il~h~w~~~~~~~ 269 (292)
...+..+.+||.+||+.||++|||+.++++||||++....
T Consensus 276 ~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~hp~~~~~~~~ 315 (349)
T 2w4o_A 276 DEVSLNAKDLVRKLIVLDPKKRLTTFQALQHPWVTGKAAN 315 (349)
T ss_dssp TTSCHHHHHHHHTTSCSSGGGSCCHHHHHHSTTTTSTTCC
T ss_pred hhCCHHHHHHHHHHccCChhhCcCHHHHhcCcccCCCccc
Confidence 3457789999999999999999999999999999986544
|
| >3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-44 Score=323.62 Aligned_cols=257 Identities=18% Similarity=0.211 Sum_probs=201.7
Q ss_pred CcccceeeeecccCceEEEEEEEcCCCcEEEEEEeccCC-CChHHHHHHHHHHHHHHhC-CCCCcchhhhhhhcCCeEEE
Q psy758 1 MERYEKIGKLGEGSYGVVFKCRNRDTGQVVAIKKFLESE-EDPLIRKIALREIRLLKSL-KHPNLVNLLEVFRRKKKLHL 78 (292)
Q Consensus 1 ~~~y~~~~~l~~g~~~~v~~~~~~~~~~~v~iK~~~~~~-~~~~~~~~~~~e~~~~~~l-~~~~i~~~~~~~~~~~~~~i 78 (292)
+++|++.+.||+|+||.||+|++..+++.||+|++.... ........+..|..++..+ .||+|+++++++.+.+.+|+
T Consensus 340 ~~~f~~~~~LG~G~fG~V~~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~l~~~~~~~~~~~l 419 (674)
T 3pfq_A 340 LTDFNFLMVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDRLYF 419 (674)
T ss_dssp CTTEEEEEESSBTTTBCEEEEEESSSCCEEEEEEEEHHHHHHTTTTHHHHHHHHHHTCTTCCTTBCCEEEECBCSSEEEE
T ss_pred ccceEEEEEEccCCCEEEEEEEECCCCcEEEEEEEeccccccHHHHHHHHHHHHHHHhccCCCeEEEEEEEEEeCCEEEE
Confidence 468999999999999999999999999999999987542 1112235567899999887 69999999999999999999
Q ss_pred EEecCCCccHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEEccCCcEEEeecCchhhhhcccc--
Q psy758 79 VFEFCDHTVLNELENHPHGLPWDLIKQITWQVLRGVSYCHRHACIHRDIKPENILLTANGVVKLCDFGFARLIRDLIP-- 156 (292)
Q Consensus 79 v~e~~~~~~L~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~givH~dl~p~Nilv~~~~~~kl~dfg~~~~~~~~~~-- 156 (292)
||||++||+|..++...+.+++..++.++.||+.||.|||++||+||||||+|||++.++++||+|||+++.......
T Consensus 420 V~E~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~gIiHrDLKp~NILl~~~g~ikL~DFGla~~~~~~~~~~ 499 (674)
T 3pfq_A 420 VMEYVNGGDLMYHIQQVGRFKEPHAVFYAAEIAIGLFFLQSKGIIYRDLKLDNVMLDSEGHIKIADFGMCKENIWDGVTT 499 (674)
T ss_dssp EEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTSEECCCCCSTTEEECSSSCEEECCCTTCEECCCTTCCB
T ss_pred EEeCcCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeEeccCChhhEEEcCCCcEEEeecceeeccccCCccc
Confidence 999999999999998877899999999999999999999999999999999999999999999999999875332222
Q ss_pred ---ccccccccccccccCCCCCCCcccceeeecCCCCCCchHHHHHHHhhcccCCCCCCChhhhhhccCcCCCCCCCCCc
Q psy758 157 ---RHLHIFQTNEYFKGVSLPHAENVVPLEIKIGKPAATNIYLIDFLKRCLDKDPLRRWSCDQLLRHPYFNGYYFEVPDE 233 (292)
Q Consensus 157 ---~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 233 (292)
.++..|.+||...+.....+.|+| +.+.-+++.+.+..|+...+..+++.........++...+
T Consensus 500 ~~~~GT~~Y~APE~l~~~~~~~~~Dvw-------------SlGvilyelltG~~Pf~~~~~~~~~~~i~~~~~~~p~~~s 566 (674)
T 3pfq_A 500 KTFCGTPDYIAPEIIAYQPYGKSVDWW-------------AFGVLLYEMLAGQAPFEGEDEDELFQSIMEHNVAYPKSMS 566 (674)
T ss_dssp CCCCSCSSSCCHHHHTCCCBSTHHHHH-------------HHHHHHHHHHHSSCSSCCSSHHHHHHHHHSSCCCCCTTSC
T ss_pred ccccCCCcccCHhhhcCCCCCccceEe-------------chHHHHHHHHcCCCCCCCCCHHHHHHHHHhCCCCCCccCC
Confidence 223445556555444333222222 2223334444455555555555544444434445566678
Q ss_pred cchHHHHhcccCcCCCCCCCh-----hhhhhCCcccceeccC
Q psy758 234 MQYEEITQRCLDKDPLRRWSC-----DQLLRHPYFNGYYFEV 270 (292)
Q Consensus 234 ~~l~~li~~~l~~dP~~Rpt~-----~~il~h~w~~~~~~~~ 270 (292)
..+.+||.+||+.||++||++ +||++||||+++.|+.
T Consensus 567 ~~~~~li~~lL~~dP~~R~~~~~~~~~ei~~h~ff~~i~w~~ 608 (674)
T 3pfq_A 567 KEAVAICKGLMTKHPGKRLGCGPEGERDIKEHAFFRYIDWEK 608 (674)
T ss_dssp HHHHHHHHHHSCSSSTTCTTCSTTHHHHHHSSGGGSSCCHHH
T ss_pred HHHHHHHHHHccCCHHHCCCCCCCcHHHHhcCccccCCCHHH
Confidence 899999999999999999998 9999999999998873
|
| >3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-44 Score=290.72 Aligned_cols=252 Identities=25% Similarity=0.325 Sum_probs=195.4
Q ss_pred cccceeeeecccCceEEEEEEEcCCCcEEEEEEeccCCCChHHHHHHHHHHHHHHhCCCCCcchhhhhhhcCCeEEEEEe
Q psy758 2 ERYEKIGKLGEGSYGVVFKCRNRDTGQVVAIKKFLESEEDPLIRKIALREIRLLKSLKHPNLVNLLEVFRRKKKLHLVFE 81 (292)
Q Consensus 2 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~iv~e 81 (292)
++|++.+.||+|+||.||+|.+..++..|++|.+....... .+.+.+|+.+++.++||||+++++++.+++..++|||
T Consensus 9 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~a~k~~~~~~~~~--~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 86 (277)
T 3f3z_A 9 QYYTLENTIGRGSWGEVKIAVQKGTRIRRAAKKIPKYFVED--VDRFKQEIEIMKSLDHPNIIRLYETFEDNTDIYLVME 86 (277)
T ss_dssp HHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCSC--HHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEEE
T ss_pred hhEEeeeEEeecCCEEEEEEEeCCCCcEEEEEeehhhccch--HHHHHHHHHHHHhCCCCCEeeEEEEEecCCeEEEEEe
Confidence 57999999999999999999999999999999987654332 4567899999999999999999999999999999999
Q ss_pred cCCCccHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEE---ccCCcEEEeecCchhhhhccc---
Q psy758 82 FCDHTVLNELENHPHGLPWDLIKQITWQVLRGVSYCHRHACIHRDIKPENILL---TANGVVKLCDFGFARLIRDLI--- 155 (292)
Q Consensus 82 ~~~~~~L~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~givH~dl~p~Nilv---~~~~~~kl~dfg~~~~~~~~~--- 155 (292)
|+++++|.+++.....+++..++.++.|++.||.|||++|++|+||+|+||++ +.++.++|+|||++.......
T Consensus 87 ~~~~~~L~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~~~~~l~Dfg~~~~~~~~~~~~ 166 (277)
T 3f3z_A 87 LCTGGELFERVVHKRVFRESDAARIMKDVLSAVAYCHKLNVAHRDLKPENFLFLTDSPDSPLKLIDFGLAARFKPGKMMR 166 (277)
T ss_dssp CCCSCBHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESSSSTTCCEEECCCTTCEECCTTSCBC
T ss_pred ccCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCccCCCCCHHHEEEecCCCCCcEEEEecccceeccCccchh
Confidence 99999999988777789999999999999999999999999999999999999 778899999999987654321
Q ss_pred -cccccccccccccccCCCCCCCcccceeeecCCCCCCchHHHHHHHhhcccCCCCCCChhhhhhccCcCCCCCC----C
Q psy758 156 -PRHLHIFQTNEYFKGVSLPHAENVVPLEIKIGKPAATNIYLIDFLKRCLDKDPLRRWSCDQLLRHPYFNGYYFE----V 230 (292)
Q Consensus 156 -~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~----~ 230 (292)
...+..|.+||...+. ... ..+.++.+.-++..+.+..|+......+............+ .
T Consensus 167 ~~~~t~~y~aPE~~~~~-~~~-------------~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 232 (277)
T 3f3z_A 167 TKVGTPYYVSPQVLEGL-YGP-------------ECDEWSAGVMMYVLLCGYPPFSAPTDSEVMLKIREGTFTFPEKDWL 232 (277)
T ss_dssp CCCSCTTTCCHHHHTTC-BCT-------------THHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCCHHHHT
T ss_pred ccCCCCCccChHHhccc-CCc-------------hhhehhHHHHHHHHHHCCCCCCCCCHHHHHHHHHhCCCCCCchhhh
Confidence 2233445666654332 111 12223333334444455555555544444332211111222 1
Q ss_pred CCccchHHHHhcccCcCCCCCCChhhhhhCCcccceecc
Q psy758 231 PDEMQYEEITQRCLDKDPLRRWSCDQLLRHPYFNGYYFE 269 (292)
Q Consensus 231 ~~~~~l~~li~~~l~~dP~~Rpt~~~il~h~w~~~~~~~ 269 (292)
..+..+.+||.+||+.||.+|||+.++++||||++....
T Consensus 233 ~~~~~~~~li~~~l~~dp~~R~s~~~~l~h~~~~~~~~~ 271 (277)
T 3f3z_A 233 NVSPQAESLIRRLLTKSPKQRITSLQALEHEWFEKQLSS 271 (277)
T ss_dssp TSCHHHHHHHHHHTCSSTTTSCCHHHHTTSHHHHHHHCC
T ss_pred cCCHHHHHHHHHHccCChhhCcCHHHHhcCHHHhccccc
Confidence 347789999999999999999999999999999975543
|
| >1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-44 Score=299.84 Aligned_cols=270 Identities=30% Similarity=0.434 Sum_probs=194.4
Q ss_pred CcccceeeeecccCceEEEEEEEcCCCcEEEEEEeccCCCC---hHHHHHHHHHHHHHHhCCCCCcchhhhhhhcCCeEE
Q psy758 1 MERYEKIGKLGEGSYGVVFKCRNRDTGQVVAIKKFLESEED---PLIRKIALREIRLLKSLKHPNLVNLLEVFRRKKKLH 77 (292)
Q Consensus 1 ~~~y~~~~~l~~g~~~~v~~~~~~~~~~~v~iK~~~~~~~~---~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~ 77 (292)
.++|++.+.||+|+||.||+|.+..+|+.||+|++...... ......+.+|+.+++.++||||+++++++.+.+..+
T Consensus 9 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~ 88 (346)
T 1ua2_A 9 AKRYEKLDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIGLLDAFGHKSNIS 88 (346)
T ss_dssp ----CEEEEEEEETTEEEEEEECSSCCSEEEEEEC------------CTHHHHHHHHHHHCCCTTBCCEEEEECCTTCCE
T ss_pred hcccEEEeEEeecCCEEEEEEEECCCCcEEEEEEEecCCcchhhhhhhHHHHHHHHHHhhCCCCCCCeEEEEEeeCCceE
Confidence 36899999999999999999999999999999998754322 122346778999999999999999999999999999
Q ss_pred EEEecCCCccHHHHhcC-CCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEEccCCcEEEeecCchhhhhccc-
Q psy758 78 LVFEFCDHTVLNELENH-PHGLPWDLIKQITWQVLRGVSYCHRHACIHRDIKPENILLTANGVVKLCDFGFARLIRDLI- 155 (292)
Q Consensus 78 iv~e~~~~~~L~~~~~~-~~~~~~~~~~~i~~qi~~aL~~LH~~givH~dl~p~Nilv~~~~~~kl~dfg~~~~~~~~~- 155 (292)
+|+||+++ +|..++.. ...+++..++.++.|++.||.|||++|++||||||+||+++.++.++|+|||++.......
T Consensus 89 lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dlkp~Nil~~~~~~~kl~Dfg~a~~~~~~~~ 167 (346)
T 1ua2_A 89 LVFDFMET-DLEVIIKDNSLVLTPSHIKAYMLMTLQGLEYLHQHWILHRDLKPNNLLLDENGVLKLADFGLAKSFGSPNR 167 (346)
T ss_dssp EEEECCSE-EHHHHHTTCCSSCCSSHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTCCEEECCCGGGSTTTSCCC
T ss_pred EEEEcCCC-CHHHHHHhcCcCCCHHHHHHHHHHHHHHHHHHHHCCEECCCCCHHHEEEcCCCCEEEEecccceeccCCcc
Confidence 99999998 55555544 4568999999999999999999999999999999999999999999999999998764322
Q ss_pred ----cccccccccccccccCC------CCCCCcccceeeecCCCCCCchHHHHHHHhhc----ccCCCCCCChhhhhhcc
Q psy758 156 ----PRHLHIFQTNEYFKGVS------LPHAENVVPLEIKIGKPAATNIYLIDFLKRCL----DKDPLRRWSCDQLLRHP 221 (292)
Q Consensus 156 ----~~~~~~~~~~~~~~~~~------~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~----~~~p~~~~~~~~~~~~~ 221 (292)
...+..|.+||...+.. ..|+.|+..+++.++.+++......+.+...+ ...+...+.........
T Consensus 168 ~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~ 247 (346)
T 1ua2_A 168 AYTHQVVTRWYRAPELLFGARMYGVGVDMWAVGCILAELLLRVPFLPGDSDLDQLTRIFETLGTPTEEQWPDMCSLPDYV 247 (346)
T ss_dssp CCCCSCCCCTTCCHHHHTTCSCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCTTTSSSTTSSTTCC
T ss_pred cCCcccccccccCchHhhCCCCCCchhhhHhHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHcCCCChhhhhhhccCcccc
Confidence 22344577777665432 34666667777777776655443333322222 22222222111111111
Q ss_pred CcCCCC------CCCCCccchHHHHhcccCcCCCCCCChhhhhhCCcccceeccCC
Q psy758 222 YFNGYY------FEVPDEMQYEEITQRCLDKDPLRRWSCDQLLRHPYFNGYYFEVP 271 (292)
Q Consensus 222 ~~~~~~------~~~~~~~~l~~li~~~l~~dP~~Rpt~~~il~h~w~~~~~~~~~ 271 (292)
.+.... .....+..+.+||.+||+.||.+|||++|+++||||++..+..+
T Consensus 248 ~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h~~f~~~~~~~~ 303 (346)
T 1ua2_A 248 TFKSFPGIPLHHIFSAAGDDLLDLIQGLFLFNPCARITATQALKMKYFSNRPGPTP 303 (346)
T ss_dssp CCCCCCCCCHHHHCTTCCHHHHHHHHHHHCSSTTTSCCHHHHHTSGGGTSSSCCCC
T ss_pred cccccCCCChHHhhccCCHHHHHHHHHHhccChhhCCCHHHHhcChhhhcCCCCCC
Confidence 111100 01234678999999999999999999999999999998765543
|
| >3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A | Back alignment and structure |
|---|
Probab=100.00 E-value=6.3e-45 Score=303.64 Aligned_cols=251 Identities=26% Similarity=0.319 Sum_probs=187.8
Q ss_pred cccceeeeecccCceEEEEEEEcCCCcEEEEEEeccCC---CChHHHHHHHHHHHHHHhCCCCCcchhhhhhhcCCeEEE
Q psy758 2 ERYEKIGKLGEGSYGVVFKCRNRDTGQVVAIKKFLESE---EDPLIRKIALREIRLLKSLKHPNLVNLLEVFRRKKKLHL 78 (292)
Q Consensus 2 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~v~iK~~~~~~---~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~i 78 (292)
++|++.+.||+|+||.||+|.+..+++.||+|++.... ......+.+.+|+.+++.++||||+++++++.+++.+|+
T Consensus 24 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~l 103 (351)
T 3c0i_A 24 DVYELCEVIGKGPFSVVRRCINRETGQQFAVKIVDVAKFTSSPGLSTEDLKREASICHMLKHPHIVELLETYSSDGMLYM 103 (351)
T ss_dssp HHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHTSSSCCHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEE
T ss_pred cceEEeeEEeeCCCEEEEEEEECCCCCEEEEEEEEhhhccccccchHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEEEE
Confidence 47999999999999999999999999999999985432 111124668899999999999999999999999999999
Q ss_pred EEecCCCccHHHHhcC----CCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEEccCCc---EEEeecCchhhh
Q psy758 79 VFEFCDHTVLNELENH----PHGLPWDLIKQITWQVLRGVSYCHRHACIHRDIKPENILLTANGV---VKLCDFGFARLI 151 (292)
Q Consensus 79 v~e~~~~~~L~~~~~~----~~~~~~~~~~~i~~qi~~aL~~LH~~givH~dl~p~Nilv~~~~~---~kl~dfg~~~~~ 151 (292)
||||++|++|...+.. ...+++..++.++.||+.||.|||++||+|+||||+||+++.++. +||+|||++...
T Consensus 104 v~e~~~g~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~ivHrDlkp~NIl~~~~~~~~~vkl~Dfg~a~~~ 183 (351)
T 3c0i_A 104 VFEFMDGADLCFEIVKRADAGFVYSEAVASHYMRQILEALRYCHDNNIIHRDVKPHCVLLASKENSAPVKLGGFGVAIQL 183 (351)
T ss_dssp EEECCSSCBHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECSSSTTCCEEECCCTTCEEC
T ss_pred EEeCCCCCCHHHHHHHhcccCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCChHHeEEecCCCCCcEEEecCcceeEe
Confidence 9999999999776542 335899999999999999999999999999999999999987654 999999999766
Q ss_pred hcccc-----ccccccccccccccCCCC-----CCCcccceeeecCCCCCCchHHHHHHHhhcccCCCCCCChhhhhhcc
Q psy758 152 RDLIP-----RHLHIFQTNEYFKGVSLP-----HAENVVPLEIKIGKPAATNIYLIDFLKRCLDKDPLRRWSCDQLLRHP 221 (292)
Q Consensus 152 ~~~~~-----~~~~~~~~~~~~~~~~~~-----~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~ 221 (292)
..... ..+..|.+||...+.... |+.|++.+++.+|..++..... .++...... .
T Consensus 184 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~-~~~~~i~~~--------------~ 248 (351)
T 3c0i_A 184 GESGLVAGGRVGTPHFMAPEVVKREPYGKPVDVWGCGVILFILLSGCLPFYGTKE-RLFEGIIKG--------------K 248 (351)
T ss_dssp CTTSCBCCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCSSHH-HHHHHHHHT--------------C
T ss_pred cCCCeeecCCcCCcCccCHHHHcCCCCCchHhhHHHHHHHHHHHHCCCCCCCcHH-HHHHHHHcC--------------C
Confidence 54222 234556677766554332 3444444444455444332211 111111110 0
Q ss_pred CcCCCCCCCCCccchHHHHhcccCcCCCCCCChhhhhhCCccccee
Q psy758 222 YFNGYYFEVPDEMQYEEITQRCLDKDPLRRWSCDQLLRHPYFNGYY 267 (292)
Q Consensus 222 ~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~~il~h~w~~~~~ 267 (292)
+..........+..+.+||.+||+.||++|||+.++++||||++..
T Consensus 249 ~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~e~l~hp~~~~~~ 294 (351)
T 3c0i_A 249 YKMNPRQWSHISESAKDLVRRMLMLDPAERITVYEALNHPWLKERD 294 (351)
T ss_dssp CCCCHHHHTTSCHHHHHHHHHHTCSSTTTSCCHHHHHTSHHHHTHH
T ss_pred CCCCccccccCCHHHHHHHHHHCCCChhHCcCHHHHhcChhhcCCc
Confidence 0000000123477899999999999999999999999999999754
|
| >2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-44 Score=315.89 Aligned_cols=255 Identities=22% Similarity=0.289 Sum_probs=193.7
Q ss_pred cccceeeeecccCceEEEEEEEcCCCcEEEEEEeccCCC-ChHHHHHHHHHHHHHHhCCCCCcchhhhhhhcCCeEEEEE
Q psy758 2 ERYEKIGKLGEGSYGVVFKCRNRDTGQVVAIKKFLESEE-DPLIRKIALREIRLLKSLKHPNLVNLLEVFRRKKKLHLVF 80 (292)
Q Consensus 2 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~v~iK~~~~~~~-~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~iv~ 80 (292)
++|++.+.||+|+||.||+|++..+|+.||+|++..... .......+.+|+.+++.++||||+++++++.+.+.+|+||
T Consensus 184 ~~f~~~~~LG~G~fG~Vy~a~~~~tg~~vAvK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~~l~lVm 263 (576)
T 2acx_A 184 NTFRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRFVVSLAYAYETKDALCLVL 263 (576)
T ss_dssp GGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEE
T ss_pred cceEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEhHhhhhhHHHHHHHHHHHHHHHcCCCCEeeEEEEEeeCCEEEEEE
Confidence 579999999999999999999999999999999865421 1112355788999999999999999999999999999999
Q ss_pred ecCCCccHHHHhcCCC--CCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEEccCCcEEEeecCchhhhhccc---
Q psy758 81 EFCDHTVLNELENHPH--GLPWDLIKQITWQVLRGVSYCHRHACIHRDIKPENILLTANGVVKLCDFGFARLIRDLI--- 155 (292)
Q Consensus 81 e~~~~~~L~~~~~~~~--~~~~~~~~~i~~qi~~aL~~LH~~givH~dl~p~Nilv~~~~~~kl~dfg~~~~~~~~~--- 155 (292)
||++||+|..++...+ .+++..++.++.||+.||.|||++||+||||||+||+++.+|.+||+|||++.......
T Consensus 264 Ey~~gg~L~~~l~~~~~~~l~e~~~~~i~~qIl~aL~yLH~~gIvHrDLKPeNILld~~g~vKL~DFGla~~~~~~~~~~ 343 (576)
T 2acx_A 264 TLMNGGDLKFHIYHMGQAGFPEARAVFYAAEICCGLEDLHRERIVYRDLKPENILLDDHGHIRISDLGLAVHVPEGQTIK 343 (576)
T ss_dssp CCCCSCBHHHHHHSSSSCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTSCEEECCCTTCEECCTTCCEE
T ss_pred EcCCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCEeccCCchheEEEeCCCCeEEEecccceecccCcccc
Confidence 9999999999887644 39999999999999999999999999999999999999999999999999997654321
Q ss_pred -cccccccccccccccCCCCCCCcccceeeecCCCCCCchHHHHHHHhhcccCCCCCCC----hhhhhhccCcCCCCCCC
Q psy758 156 -PRHLHIFQTNEYFKGVSLPHAENVVPLEIKIGKPAATNIYLIDFLKRCLDKDPLRRWS----CDQLLRHPYFNGYYFEV 230 (292)
Q Consensus 156 -~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~----~~~~~~~~~~~~~~~~~ 230 (292)
..++..|.+||...+.......++|+ .+.-++..+.+..|+.... ..++.....-....++.
T Consensus 344 ~~~GT~~Y~APEvl~~~~~~~~~DiwS-------------LGvilyeLltG~~PF~~~~~~~~~~~i~~~i~~~~~~~p~ 410 (576)
T 2acx_A 344 GRVGTVGYMAPEVVKNERYTFSPDWWA-------------LGCLLYEMIAGQSPFQQRKKKIKREEVERLVKEVPEEYSE 410 (576)
T ss_dssp CCCSCGGGCCHHHHTTCEESSHHHHHH-------------HHHHHHHHHHSSCSSSCSSSCCCHHHHHHHHHHCCCCCCT
T ss_pred ccCCCccccCHHHHcCCCCCccchHHH-------------HHHHHHHHHhCCCCCcccccchhHHHHHHHhhcccccCCc
Confidence 22344566666655433322222222 2222333333333433221 12222111111223344
Q ss_pred CCccchHHHHhcccCcCCCCCC-----ChhhhhhCCcccceecc
Q psy758 231 PDEMQYEEITQRCLDKDPLRRW-----SCDQLLRHPYFNGYYFE 269 (292)
Q Consensus 231 ~~~~~l~~li~~~l~~dP~~Rp-----t~~~il~h~w~~~~~~~ 269 (292)
..+..+.+||.+||+.||.+|| +++|+++||||+++.|+
T Consensus 411 ~~s~~~~dLI~~lL~~dP~~R~g~~~~sa~eil~HpfF~~i~w~ 454 (576)
T 2acx_A 411 RFSPQARSLCSQLLCKDPAERLGCRGGSAREVKEHPLFKKLNFK 454 (576)
T ss_dssp TSCHHHHHHHHHHTCSSGGGSTTCSSSHHHHHHTSGGGTTCCHH
T ss_pred cCCHHHHHHHHHhccCCHHHcCCCCCCCHHHHHhChhhccCCHH
Confidence 5688999999999999999999 88999999999998875
|
| >2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.2e-45 Score=309.31 Aligned_cols=257 Identities=21% Similarity=0.237 Sum_probs=193.0
Q ss_pred cccceeeeecccCceEEEEEEEcCCCcEEEEEEeccCCC-ChHHHHHHHHHHHHHHhCCCCCcchhhhhhhcCCeEEEEE
Q psy758 2 ERYEKIGKLGEGSYGVVFKCRNRDTGQVVAIKKFLESEE-DPLIRKIALREIRLLKSLKHPNLVNLLEVFRRKKKLHLVF 80 (292)
Q Consensus 2 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~v~iK~~~~~~~-~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~iv~ 80 (292)
++|++.+.||+|+||.||+|++..+++.||+|++.+... .......+.+|..++..++||||+++++++.+.+.+|+||
T Consensus 61 ~~f~~~~~lG~G~fG~V~~~~~~~~~~~vAiK~l~k~~~~~~~~~~~~~~E~~il~~~~hp~Iv~l~~~~~~~~~~~lVm 140 (412)
T 2vd5_A 61 DDFEILKVIGRGAFSEVAVVKMKQTGQVYAMKIMNKWDMLKRGEVSCFREERDVLVNGDRRWITQLHFAFQDENYLYLVM 140 (412)
T ss_dssp GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHHGGGCCHHHHHHHHHHSCTTTBCCEEEEEECSSEEEEEE
T ss_pred hhEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEeHHHhhhHHHHHHHHHHHHHHHhcCCCCeeeEEEEEeeCCEEEEEE
Confidence 689999999999999999999999999999999965321 1112345778999999999999999999999999999999
Q ss_pred ecCCCccHHHHhcCC-CCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEEccCCcEEEeecCchhhhhccc----
Q psy758 81 EFCDHTVLNELENHP-HGLPWDLIKQITWQVLRGVSYCHRHACIHRDIKPENILLTANGVVKLCDFGFARLIRDLI---- 155 (292)
Q Consensus 81 e~~~~~~L~~~~~~~-~~~~~~~~~~i~~qi~~aL~~LH~~givH~dl~p~Nilv~~~~~~kl~dfg~~~~~~~~~---- 155 (292)
||++||+|..++... ..+++..++.++.||+.||.|||++||+||||||+||+++.++++||+|||++.......
T Consensus 141 E~~~gg~L~~~l~~~~~~l~~~~~~~~~~qi~~aL~~LH~~giiHrDLKp~NILld~~g~vkL~DFGla~~~~~~~~~~~ 220 (412)
T 2vd5_A 141 EYYVGGDLLTLLSKFGERIPAEMARFYLAEIVMAIDSVHRLGYVHRDIKPDNILLDRCGHIRLADFGSCLKLRADGTVRS 220 (412)
T ss_dssp CCCCSCBHHHHHHHHSSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTCEECCTTSCEEC
T ss_pred cCCCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeeecccCHHHeeecCCCCEEEeechhheeccCCCcccc
Confidence 999999999998753 479999999999999999999999999999999999999999999999999997654322
Q ss_pred --ccccccccccccccc-------C-----CCCCCCcccceeeecCCCCCCchHHHHHHHhhcccCCCCCCChhhhhhcc
Q psy758 156 --PRHLHIFQTNEYFKG-------V-----SLPHAENVVPLEIKIGKPAATNIYLIDFLKRCLDKDPLRRWSCDQLLRHP 221 (292)
Q Consensus 156 --~~~~~~~~~~~~~~~-------~-----~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~ 221 (292)
..++..|.+||...+ . ...|+.|+..+++.+|..++.......++..++... ..
T Consensus 221 ~~~~Gt~~Y~APE~l~~~~~~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~~~~~~i~~~~-----------~~- 288 (412)
T 2vd5_A 221 LVAVGTPDYLSPEILQAVGGGPGTGSYGPECDWWALGVFAYEMFYGQTPFYADSTAETYGKIVHYK-----------EH- 288 (412)
T ss_dssp SSCCSCGGGCCHHHHHHHHTCTTCSEECTHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHTHH-----------HH-
T ss_pred ceeccccCcCCHHHHhhcccCcCCCCCChHHhhhHHhHHHHHHHhCCCCCCCCCHHHHHHHHHhcc-----------cC-
Confidence 123445666665542 1 122444444444444444433322222222221100 00
Q ss_pred CcCCCCCCCCCccchHHHHhcccCcCCCCC---CChhhhhhCCcccceeccCCC
Q psy758 222 YFNGYYFEVPDEMQYEEITQRCLDKDPLRR---WSCDQLLRHPYFNGYYFEVPD 272 (292)
Q Consensus 222 ~~~~~~~~~~~~~~l~~li~~~l~~dP~~R---pt~~~il~h~w~~~~~~~~~~ 272 (292)
..-.......+..+++||++||+ +|.+| |+++|+++||||+++.|+...
T Consensus 289 -~~~p~~~~~~s~~~~dli~~lL~-~p~~Rlgr~~~~ei~~Hpff~~i~w~~l~ 340 (412)
T 2vd5_A 289 -LSLPLVDEGVPEEARDFIQRLLC-PPETRLGRGGAGDFRTHPFFFGLDWDGLR 340 (412)
T ss_dssp -CCCC----CCCHHHHHHHHTTSS-CGGGCTTTTTHHHHHTSGGGTTCCSTTST
T ss_pred -cCCCccccCCCHHHHHHHHHHcC-ChhhcCCCCCHHHHhcCCCcCCCCHHHHh
Confidence 00001123457899999999999 99998 599999999999999988543
|
| >3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus} | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-44 Score=300.45 Aligned_cols=246 Identities=21% Similarity=0.362 Sum_probs=182.0
Q ss_pred CcccceeeeecccCceEEEEEEEcCCCcEEEEEEeccCCCChHHHHHHHHHHHHHHhCCCCCcchhhhhhhcCC------
Q psy758 1 MERYEKIGKLGEGSYGVVFKCRNRDTGQVVAIKKFLESEEDPLIRKIALREIRLLKSLKHPNLVNLLEVFRRKK------ 74 (292)
Q Consensus 1 ~~~y~~~~~l~~g~~~~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~------ 74 (292)
+++|++++.||+|+||.||+|++..+++.||+|++..... ....+.+.+|+.+++.++||||+++++++.+..
T Consensus 5 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~~~-~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~ 83 (332)
T 3qd2_B 5 LTDFEPIQCMGRGGFGVVFEAKNKVDDCNYAIKRIRLPNR-ELAREKVMREVKALAKLEHPGIVRYFNAWLETPPEKWQE 83 (332)
T ss_dssp HHHEEEEEEEECC-CSEEEEEEETTTCCEEEEEEEECCST-TTHHHHHHHHHHHHTSCCCTTBCCEEEEEEECCSCHHHH
T ss_pred hhcCceeeEecCCCCeEEEEEEEcCCCcEEEEEEeecCCc-hhHHHHHHHHHHHHHhCCCCCEeeEEEEEEEeccchhhh
Confidence 3689999999999999999999999999999999976543 334577889999999999999999999875432
Q ss_pred ---------------------------------------------------eEEEEEecCCCccHHHHhcCCCC---CCH
Q psy758 75 ---------------------------------------------------KLHLVFEFCDHTVLNELENHPHG---LPW 100 (292)
Q Consensus 75 ---------------------------------------------------~~~iv~e~~~~~~L~~~~~~~~~---~~~ 100 (292)
..++||||+++++|.+++..... .++
T Consensus 84 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~ 163 (332)
T 3qd2_B 84 EMDEIWLKDESTDWPLSSPSPMDAPSVKIRRMDPFSTKNTVGQLQPSSPKVYLYIQMQLCRKENLKDWMNRRCSLEDREH 163 (332)
T ss_dssp HHHC--------------------------------------------CCCEEEEEEECCCSSCHHHHHHTCCSGGGSCH
T ss_pred hhhhhhhccccccccccCCCcccccccceeeccccCcccccccccCCCCCceEEEEEEecCCCCHHHHHhcccCccchhh
Confidence 38999999999999999987543 455
Q ss_pred HHHHHHHHHHHHHHHHHHhCCccccCCCCCceEEccCCcEEEeecCchhhhhccc-----------------cccccccc
Q psy758 101 DLIKQITWQVLRGVSYCHRHACIHRDIKPENILLTANGVVKLCDFGFARLIRDLI-----------------PRHLHIFQ 163 (292)
Q Consensus 101 ~~~~~i~~qi~~aL~~LH~~givH~dl~p~Nilv~~~~~~kl~dfg~~~~~~~~~-----------------~~~~~~~~ 163 (292)
..++.++.||+.||.|||++|++||||||+||+++.++.++|+|||++....... ...+..|.
T Consensus 164 ~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~kL~DfG~a~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~ 243 (332)
T 3qd2_B 164 GVCLHIFIQIAEAVEFLHSKGLMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTPMPAYATHTGQVGTKLYM 243 (332)
T ss_dssp HHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCEEECCCTTCEECSCC--------------CCCSCC-CGGGS
T ss_pred HHHHHHHHHHHHHHHHHHhCCeeecCCCcccEEEeCCCCEEEeecCcccccccchhhccccccccccccccccCCCcCcc
Confidence 6789999999999999999999999999999999999999999999987664321 12344566
Q ss_pred cccccccCCCC-----CCCcccceeeecCCCCCCchHHHHHHHhhcccCCCCCCChhhhhhccCcCCCCCCCCCccchHH
Q psy758 164 TNEYFKGVSLP-----HAENVVPLEIKIGKPAATNIYLIDFLKRCLDKDPLRRWSCDQLLRHPYFNGYYFEVPDEMQYEE 238 (292)
Q Consensus 164 ~~~~~~~~~~~-----~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ 238 (292)
+||...+.... |+.|+..+++.++..+. ......+....... .+ ......++.+.+
T Consensus 244 aPE~~~~~~~~~~~Di~slG~il~el~~~~~~~--~~~~~~~~~~~~~~---~~--------------~~~~~~~~~~~~ 304 (332)
T 3qd2_B 244 SPEQIHGNNYSHKVDIFSLGLILFELLYSFSTQ--MERVRIITDVRNLK---FP--------------LLFTQKYPQEHM 304 (332)
T ss_dssp CHHHHHCCCCCTHHHHHHHHHHHHHHHSCCCCH--HHHHHHHHHHHTTC---CC--------------HHHHHHCHHHHH
T ss_pred ChHHhcCCCCcchhhHHHHHHHHHHHHHcCCCh--hHHHHHHHHhhccC---CC--------------cccccCChhHHH
Confidence 77666554433 33333333333333221 11111111111000 00 000112457789
Q ss_pred HHhcccCcCCCCCCChhhhhhCCcccce
Q psy758 239 ITQRCLDKDPLRRWSCDQLLRHPYFNGY 266 (292)
Q Consensus 239 li~~~l~~dP~~Rpt~~~il~h~w~~~~ 266 (292)
||.+||+.||.+|||++|+++||||+++
T Consensus 305 li~~~l~~~p~~Rps~~~~l~~~~f~~~ 332 (332)
T 3qd2_B 305 MVQDMLSPSPTERPEATDIIENAIFENL 332 (332)
T ss_dssp HHHHHHCSSGGGSCCHHHHHHSTTCCCC
T ss_pred HHHHHccCCCCcCCCHHHHhhchhhhcC
Confidence 9999999999999999999999999874
|
| >3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-44 Score=298.53 Aligned_cols=245 Identities=20% Similarity=0.286 Sum_probs=191.2
Q ss_pred cccceeeeecccCceEEEEEEEcCCCcEEEEEEeccCCCCh------HHHHHHHHHHHHHHhCCCCCcchhhhhhhcCCe
Q psy758 2 ERYEKIGKLGEGSYGVVFKCRNRDTGQVVAIKKFLESEEDP------LIRKIALREIRLLKSLKHPNLVNLLEVFRRKKK 75 (292)
Q Consensus 2 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~v~iK~~~~~~~~~------~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~ 75 (292)
++|++.+.||+|+||.||+|.+..+++.||+|++....... .....+.+|+.+++.++||||+++++++.+.+.
T Consensus 24 ~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~~~~~~~~~~~ 103 (335)
T 3dls_A 24 QKYSTMSPLGSGAFGFVWTAVDKEKNKEVVVKFIKKEKVLEDCWIEDPKLGKVTLEIAILSRVEHANIIKVLDIFENQGF 103 (335)
T ss_dssp HHEEEEEECSSSSSCSEEEEEETTTTEEEEEEEEESTTSCTTSEEEETTTEEEEHHHHHHTTCCCTTBCCEEEEEECSSE
T ss_pred cceEEEeEEEecCCEEEEEEEECCCCcEEEEEEEehhhcccccccchHHHHHHHHHHHHHHhCCCCCEeeEEEEEeeCCE
Confidence 57999999999999999999999999999999997654221 133456789999999999999999999999999
Q ss_pred EEEEEecCCCc-cHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEEccCCcEEEeecCchhhhhcc
Q psy758 76 LHLVFEFCDHT-VLNELENHPHGLPWDLIKQITWQVLRGVSYCHRHACIHRDIKPENILLTANGVVKLCDFGFARLIRDL 154 (292)
Q Consensus 76 ~~iv~e~~~~~-~L~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~givH~dl~p~Nilv~~~~~~kl~dfg~~~~~~~~ 154 (292)
.++||||+.+| +|..++.....+++..++.++.||+.||.|||++||+||||||+||+++.++.++|+|||++......
T Consensus 104 ~~lv~e~~~~g~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~ivH~Dlkp~NIll~~~~~~kL~Dfg~a~~~~~~ 183 (335)
T 3dls_A 104 FQLVMEKHGSGLDLFAFIDRHPRLDEPLASYIFRQLVSAVGYLRLKDIIHRDIKDENIVIAEDFTIKLIDFGSAAYLERG 183 (335)
T ss_dssp EEEEEECCTTSCBHHHHHHTCCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTSCEEECCCTTCEECCTT
T ss_pred EEEEEEeCCCCccHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeEEeccCHHHEEEcCCCcEEEeecccceECCCC
Confidence 99999999766 99999988888999999999999999999999999999999999999999999999999999765432
Q ss_pred cc----ccccccccccccccCCC-CCCCcccceeeecCCCCCCchHHHHHHHhhcccCCCCCCChhhhhhccCcCCCCCC
Q psy758 155 IP----RHLHIFQTNEYFKGVSL-PHAENVVPLEIKIGKPAATNIYLIDFLKRCLDKDPLRRWSCDQLLRHPYFNGYYFE 229 (292)
Q Consensus 155 ~~----~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~ 229 (292)
.. .++..|.+||...+... ....++ ++.+.-++..+.+..|+... .+... .....+
T Consensus 184 ~~~~~~~gt~~y~aPE~~~~~~~~~~~~Di-------------wslG~il~el~~g~~pf~~~--~~~~~----~~~~~~ 244 (335)
T 3dls_A 184 KLFYTFCGTIEYCAPEVLMGNPYRGPELEM-------------WSLGVTLYTLVFEENPFCEL--EETVE----AAIHPP 244 (335)
T ss_dssp CCBCEECSCGGGCCHHHHTTCCBCSHHHHH-------------HHHHHHHHHHHHSSCSCSSG--GGGTT----TCCCCS
T ss_pred CceeccCCCccccChhhhcCCCCCCCcccc-------------hhHHHHHHHHHhCCCchhhH--HHHHh----hccCCC
Confidence 21 23445666666544332 111222 22223333444444444321 11111 122334
Q ss_pred CCCccchHHHHhcccCcCCCCCCChhhhhhCCcccc
Q psy758 230 VPDEMQYEEITQRCLDKDPLRRWSCDQLLRHPYFNG 265 (292)
Q Consensus 230 ~~~~~~l~~li~~~l~~dP~~Rpt~~~il~h~w~~~ 265 (292)
...+..+.+||.+||+.||.+|||++++++||||++
T Consensus 245 ~~~~~~l~~li~~~L~~dP~~Rps~~ell~hp~~~~ 280 (335)
T 3dls_A 245 YLVSKELMSLVSGLLQPVPERRTTLEKLVTDPWVTQ 280 (335)
T ss_dssp SCCCHHHHHHHHHHTCSSGGGSCCHHHHHHCTTTTC
T ss_pred cccCHHHHHHHHHHccCChhhCcCHHHHhcCccccC
Confidence 446789999999999999999999999999999986
|
| >3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.6e-44 Score=292.52 Aligned_cols=244 Identities=24% Similarity=0.345 Sum_probs=180.9
Q ss_pred cccceeeeecccCceEEEEEEEcCCCcEEEEEEeccCCCChHHHHHHHHHHHHHHhC-CCCCcchhhhhhhcCCeEEEEE
Q psy758 2 ERYEKIGKLGEGSYGVVFKCRNRDTGQVVAIKKFLESEEDPLIRKIALREIRLLKSL-KHPNLVNLLEVFRRKKKLHLVF 80 (292)
Q Consensus 2 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~e~~~~~~l-~~~~i~~~~~~~~~~~~~~iv~ 80 (292)
++|++.+.||+|+||.||+|.+..+++.||+|++...............|+..+..+ +||||+++++++.+++..++||
T Consensus 57 ~~y~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~~~~~~~h~~iv~l~~~~~~~~~~~lv~ 136 (311)
T 3p1a_A 57 QSFQRLSRLGHGSYGEVFKVRSKEDGRLYAVKRSMSPFRGPKDRARKLAEVGSHEKVGQHPCCVRLEQAWEEGGILYLQT 136 (311)
T ss_dssp HHEEEEEEEEEETTEEEEEEEETTTSCEEEEEEESSSCCSHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEE
T ss_pred hheeeeheeccCCCeEEEEEEECCCCeEEEEEEecccccChHHHHHHHHHHHHHHHhcCCCcEEEEEEEEEeCCEEEEEE
Confidence 579999999999999999999999999999999876655555555555666665555 8999999999999999999999
Q ss_pred ecCCCccHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEEccCCcEEEeecCchhhhhccc----c
Q psy758 81 EFCDHTVLNELENHPHGLPWDLIKQITWQVLRGVSYCHRHACIHRDIKPENILLTANGVVKLCDFGFARLIRDLI----P 156 (292)
Q Consensus 81 e~~~~~~L~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~givH~dl~p~Nilv~~~~~~kl~dfg~~~~~~~~~----~ 156 (292)
||++++.+..+......+++..++.++.||+.||+|||++||+|+||||+||+++.++.+||+|||++....... .
T Consensus 137 e~~~~~L~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dikp~NIll~~~~~~kl~DFG~a~~~~~~~~~~~~ 216 (311)
T 3p1a_A 137 ELCGPSLQQHCEAWGASLPEAQVWGYLRDTLLALAHLHSQGLVHLDVKPANIFLGPRGRCKLGDFGLLVELGTAGAGEVQ 216 (311)
T ss_dssp ECCCCBHHHHHHHHCSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECGGGCEEECCCTTCEECC------CC
T ss_pred eccCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCEecCCCCHHHEEECCCCCEEEccceeeeecccCCCCccc
Confidence 999665444444445569999999999999999999999999999999999999999999999999987654322 2
Q ss_pred ccccccccccccccCCCC-----CCCcccceeeecCCCCCCchHHHHHHHhhcccCCCCCCChhhhhhccCcCCCCCCCC
Q psy758 157 RHLHIFQTNEYFKGVSLP-----HAENVVPLEIKIGKPAATNIYLIDFLKRCLDKDPLRRWSCDQLLRHPYFNGYYFEVP 231 (292)
Q Consensus 157 ~~~~~~~~~~~~~~~~~~-----~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~ 231 (292)
.++..|.+||...+. .. |+.|+..+++.++..+....... +.+..... ....+..
T Consensus 217 ~gt~~y~aPE~~~~~-~~~~~DiwslG~il~el~~g~~~~~~~~~~------------------~~~~~~~~-~~~~~~~ 276 (311)
T 3p1a_A 217 EGDPRYMAPELLQGS-YGTAADVFSLGLTILEVACNMELPHGGEGW------------------QQLRQGYL-PPEFTAG 276 (311)
T ss_dssp CCCGGGCCGGGGGTC-CSTHHHHHHHHHHHHHHHHTCCCCSSHHHH------------------HHHTTTCC-CHHHHTT
T ss_pred CCCccccCHhHhcCC-CCchhhHHHHHHHHHHHHhCCCCCCCccHH------------------HHHhccCC-CcccccC
Confidence 234567777766552 22 33333333333432221111111 11111100 0011234
Q ss_pred CccchHHHHhcccCcCCCCCCChhhhhhCCcccc
Q psy758 232 DEMQYEEITQRCLDKDPLRRWSCDQLLRHPYFNG 265 (292)
Q Consensus 232 ~~~~l~~li~~~l~~dP~~Rpt~~~il~h~w~~~ 265 (292)
.+..+.+||.+||+.||++|||++|+++||||++
T Consensus 277 ~~~~l~~li~~~L~~dP~~Rpt~~ell~hp~~~~ 310 (311)
T 3p1a_A 277 LSSELRSVLVMMLEPDPKLRATAEALLALPVLRQ 310 (311)
T ss_dssp SCHHHHHHHHHHSCSSTTTSCCHHHHHTSGGGSC
T ss_pred CCHHHHHHHHHHcCCChhhCcCHHHHHhCccccC
Confidence 5778999999999999999999999999999975
|
| >3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.5e-44 Score=290.39 Aligned_cols=249 Identities=25% Similarity=0.362 Sum_probs=187.5
Q ss_pred cccceeeeecccCceEEEEEEEcCCCcEEEEEEeccCCCChHHHHHHHHHHHHHHhCCCCCcchhhhhhhcCCeEEEEEe
Q psy758 2 ERYEKIGKLGEGSYGVVFKCRNRDTGQVVAIKKFLESEEDPLIRKIALREIRLLKSLKHPNLVNLLEVFRRKKKLHLVFE 81 (292)
Q Consensus 2 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~iv~e 81 (292)
++|++.+.||+|+||.||+|.+..++..||+|.+...... ...+.+.+|+.+++.++||||+++++++.+.+..++|||
T Consensus 22 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~-~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e 100 (285)
T 3is5_A 22 DLFIFKRKLGSGAFGDVHLVEERSSGLERVIKTINKDRSQ-VPMEQIEAEIEVLKSLDHPNIIKIFEVFEDYHNMYIVME 100 (285)
T ss_dssp HHEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEGGGCC-SCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEEC
T ss_pred hheeecceeccCCCeEEEEEEEccCCceEEEEEeeccccc-hhHHHHHHHHHHHHhCCCchHHhHHHheecCCeEEEEEE
Confidence 5799999999999999999999999999999998765432 124667899999999999999999999999999999999
Q ss_pred cCCCccHHHHhcC----CCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEEc---cCCcEEEeecCchhhhhcc
Q psy758 82 FCDHTVLNELENH----PHGLPWDLIKQITWQVLRGVSYCHRHACIHRDIKPENILLT---ANGVVKLCDFGFARLIRDL 154 (292)
Q Consensus 82 ~~~~~~L~~~~~~----~~~~~~~~~~~i~~qi~~aL~~LH~~givH~dl~p~Nilv~---~~~~~kl~dfg~~~~~~~~ 154 (292)
|+++++|.+.+.. ...+++..++.++.||+.||.|||++|++|+||+|+||+++ .++.++|+|||++......
T Consensus 101 ~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivH~dikp~NIl~~~~~~~~~~kl~Dfg~a~~~~~~ 180 (285)
T 3is5_A 101 TCEGGELLERIVSAQARGKALSEGYVAELMKQMMNALAYFHSQHVVHKDLKPENILFQDTSPHSPIKIIDFGLAELFKSD 180 (285)
T ss_dssp CCSCCBHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCSGGGEEESSSSTTCCEEECCCCCCCC----
T ss_pred eCCCCcHHHHHHhhhhcccCCCHHHHHHHHHHHHHHHHHHHhCCEEECCCCHHHEEEecCCCCCCEEEEeeecceecCCc
Confidence 9999999887743 35799999999999999999999999999999999999994 5578999999999765432
Q ss_pred c----cccccccccccccccCCCCCCCcccceeeecCCCCCCchHHHHHHHhhcccCCCCCCChhhhhhccCcCCCC---
Q psy758 155 I----PRHLHIFQTNEYFKGVSLPHAENVVPLEIKIGKPAATNIYLIDFLKRCLDKDPLRRWSCDQLLRHPYFNGYY--- 227 (292)
Q Consensus 155 ~----~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~--- 227 (292)
. ...+..|.+||...+. ..... ++++.+.-++..+.+..|+...+..+...........
T Consensus 181 ~~~~~~~~t~~y~aPE~~~~~-~~~~~-------------Di~slG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~ 246 (285)
T 3is5_A 181 EHSTNAAGTALYMAPEVFKRD-VTFKC-------------DIWSAGVVMYFLLTGCLPFTGTSLEEVQQKATYKEPNYAV 246 (285)
T ss_dssp ------CTTGGGCCHHHHTTC-CCHHH-------------HHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCCC
T ss_pred ccCcCcccccCcCChHHhccC-CCccc-------------CeehHHHHHHHHHhCCCCCCCCCHHHHHhhhccCCccccc
Confidence 1 2233446666654321 11111 1223333344444455555555444443322111111
Q ss_pred CCCCCccchHHHHhcccCcCCCCCCChhhhhhCCcccc
Q psy758 228 FEVPDEMQYEEITQRCLDKDPLRRWSCDQLLRHPYFNG 265 (292)
Q Consensus 228 ~~~~~~~~l~~li~~~l~~dP~~Rpt~~~il~h~w~~~ 265 (292)
...+.++.+.+||.+||+.||++|||+.|+++||||++
T Consensus 247 ~~~~~~~~~~~li~~~L~~dP~~Rps~~e~l~hp~f~~ 284 (285)
T 3is5_A 247 ECRPLTPQAVDLLKQMLTKDPERRPSAAQVLHHEWFKQ 284 (285)
T ss_dssp --CCCCHHHHHHHHHHTCSCTTTSCCHHHHHTSGGGGC
T ss_pred ccCcCCHHHHHHHHHHccCChhhCcCHHHHhcCHHhhc
Confidence 12235778999999999999999999999999999986
|
| >3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3v01_A* 3v04_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=6.3e-44 Score=298.95 Aligned_cols=273 Identities=23% Similarity=0.377 Sum_probs=206.7
Q ss_pred cccceeeeecccCceEEEEEEEcCCCcEEEEEEeccCCCChHHHHHHHHHHHHHHhCCCCCcchhhhhhhcCCeEEEEEe
Q psy758 2 ERYEKIGKLGEGSYGVVFKCRNRDTGQVVAIKKFLESEEDPLIRKIALREIRLLKSLKHPNLVNLLEVFRRKKKLHLVFE 81 (292)
Q Consensus 2 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~iv~e 81 (292)
++|++.+.||+|+||.||+|.+..+++.||+|++.... .....+.+.+|+.+++.++||||+++++++.+++..++|||
T Consensus 33 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~va~K~~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 111 (360)
T 3eqc_A 33 DDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEI-KPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICME 111 (360)
T ss_dssp GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEECCC-CHHHHHHHHHHHGGGGGCCCTTBCCEEEEEEETTEEEEEEC
T ss_pred ccceeeeeecCCCCeEEEEEEECCCCcEEEEEEecccc-CHHHHHHHHHHHHHHHHCCCCCEEEEeEEEEECCEEEEEEE
Confidence 58999999999999999999999999999999987653 44556778999999999999999999999999999999999
Q ss_pred cCCCccHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhC-CccccCCCCCceEEccCCcEEEeecCchhhhhcc---ccc
Q psy758 82 FCDHTVLNELENHPHGLPWDLIKQITWQVLRGVSYCHRH-ACIHRDIKPENILLTANGVVKLCDFGFARLIRDL---IPR 157 (292)
Q Consensus 82 ~~~~~~L~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~-givH~dl~p~Nilv~~~~~~kl~dfg~~~~~~~~---~~~ 157 (292)
|+++++|.+++...+.+++..++.++.|++.||.|||++ |++|+||||+||+++.++.++|+|||++...... ...
T Consensus 112 ~~~~~~L~~~l~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~ 191 (360)
T 3eqc_A 112 HMDGGSLDQVLKKAGRIPEQILGKVSIAVIKGLTYLREKHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSMANSFV 191 (360)
T ss_dssp CCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHHHCCCCSCCSGGGEEECTTCCEEECCCCCCHHHHHHC----C
T ss_pred CCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHhCCEEcCCccHHHEEECCCCCEEEEECCCCcccccccccCCC
Confidence 999999999998777899999999999999999999996 9999999999999999999999999998765432 223
Q ss_pred cccccccccccccCCC-----CCCCcccceeeecCCCCCCchHHHHHHHhhc---ccCCC--------------------
Q psy758 158 HLHIFQTNEYFKGVSL-----PHAENVVPLEIKIGKPAATNIYLIDFLKRCL---DKDPL-------------------- 209 (292)
Q Consensus 158 ~~~~~~~~~~~~~~~~-----~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~---~~~p~-------------------- 209 (292)
.+..|.+||...+... .|+.|+..+++.+|..++.......+..... ...+.
T Consensus 192 gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 271 (360)
T 3eqc_A 192 GTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAETPPRPRTPGRPLNKFGMDS 271 (360)
T ss_dssp CCCTTCCHHHHTTCCCSHHHHHHHHHHHHHHHHHTSCCSSCCCHHHHHHHHC----------------------------
T ss_pred CCCCeECHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHhcccccccCCCCCCCcccCCCcccccccCC
Confidence 3556778877766543 3556666666777766654333222211110 00000
Q ss_pred -CCCChhhhhhccCc--CCCCCCCCCccchHHHHhcccCcCCCCCCChhhhhhCCcccceeccCCChhH
Q psy758 210 -RRWSCDQLLRHPYF--NGYYFEVPDEMQYEEITQRCLDKDPLRRWSCDQLLRHPYFNGYYFEVPDEMQ 275 (292)
Q Consensus 210 -~~~~~~~~~~~~~~--~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~~il~h~w~~~~~~~~~~~~~ 275 (292)
......+.+....- .........+..+.+||.+||+.||.+|||++|+++||||++..++..+-..
T Consensus 272 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~~~~~~~~~~~~~~ 340 (360)
T 3eqc_A 272 RPPMAIFELLDYIVNEPPPKLPSGVFSLEFQDFVNKCLIKNPAERADLKQLMVHAFIKRSDAEEVDFAG 340 (360)
T ss_dssp --CCCHHHHHHHHHHSCCCCCCTTTSCHHHHHHHHHHHCSSTTTSCCHHHHHTSHHHHHHHHSCCCHHH
T ss_pred CCcccchhhhhHHhccCCCCCCcccccHHHHHHHHHHhhcChhhCCCHHHHhhChHhhcchHhhhhHHH
Confidence 00000111110000 0001122347789999999999999999999999999999998877666544
|
| >1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=4.2e-44 Score=300.21 Aligned_cols=264 Identities=28% Similarity=0.428 Sum_probs=195.2
Q ss_pred cccceeeeecccCceEEEEEEEcCCCcEEEEEEeccCCCChHHHHHHHHHHHHHHhCCCCCcchhhhhhhcC------Ce
Q psy758 2 ERYEKIGKLGEGSYGVVFKCRNRDTGQVVAIKKFLESEEDPLIRKIALREIRLLKSLKHPNLVNLLEVFRRK------KK 75 (292)
Q Consensus 2 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~------~~ 75 (292)
++|++.+.||+|+||.||+|.+..+|+.||+|.+..........+.+.+|+.+++.++||||+++++++... ..
T Consensus 25 ~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~~~~~ 104 (367)
T 1cm8_A 25 AVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMRHENVIGLLDVFTPDETLDDFTD 104 (367)
T ss_dssp SSEEEEEEC------CEEEEEETTTCCEEEEEECSSTTSSHHHHHHHHHHHHHHHHCCBTTBCCCSEEECSCSSTTTCCC
T ss_pred ceEEEeEEeeecCCeEEEEEEECCCCCEEEEEEeCccccCHHHHHHHHHHHHHHHhCCCcCCCCceeeEecCCccccCce
Confidence 579999999999999999999999999999999977666666778899999999999999999999998765 34
Q ss_pred EEEEEecCCCccHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEEccCCcEEEeecCchhhhhccc
Q psy758 76 LHLVFEFCDHTVLNELENHPHGLPWDLIKQITWQVLRGVSYCHRHACIHRDIKPENILLTANGVVKLCDFGFARLIRDLI 155 (292)
Q Consensus 76 ~~iv~e~~~~~~L~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~givH~dl~p~Nilv~~~~~~kl~dfg~~~~~~~~~ 155 (292)
+|+||||+ +++|..++.. ..+++..++.++.||+.||+|||++||+||||||+||+++.++.+||+|||++.......
T Consensus 105 ~~lv~e~~-~~~L~~~~~~-~~l~~~~~~~~~~qi~~~L~~LH~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~ 182 (367)
T 1cm8_A 105 FYLVMPFM-GTDLGKLMKH-EKLGEDRIQFLVYQMLKGLRYIHAAGIIHRDLKPGNLAVNEDCELKILDFGLARQADSEM 182 (367)
T ss_dssp CEEEEECC-SEEHHHHHHH-CCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCEEECCCTTCEECCSSC
T ss_pred EEEEEecC-CCCHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCccccCcCHHHEEEcCCCCEEEEeeeccccccccc
Confidence 69999999 7889888876 479999999999999999999999999999999999999999999999999997654322
Q ss_pred --ccccccccccccccc-CC-----CCCCCcccceeeecCCCCCCchHHHHHHHhhc---ccCCCC---CCC---hhhhh
Q psy758 156 --PRHLHIFQTNEYFKG-VS-----LPHAENVVPLEIKIGKPAATNIYLIDFLKRCL---DKDPLR---RWS---CDQLL 218 (292)
Q Consensus 156 --~~~~~~~~~~~~~~~-~~-----~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~---~~~p~~---~~~---~~~~~ 218 (292)
...+..|.+||...+ .. ..|+.|+..+++.+|..++......+.+..+. +..|.. +.. ....+
T Consensus 183 ~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~l~~i~~~~g~~~~~~~~~~~~~~~~~~~ 262 (367)
T 1cm8_A 183 TGYVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTLFKGSDHLDQLKEIMKVTGTPPAEFVQRLQSDEAKNYM 262 (367)
T ss_dssp CSSCSCGGGCCTHHHHTTTCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHHHTCSCHHHHHHH
T ss_pred CcCcCCCCcCCHHHHhCCCCCChhhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHHHHHHhhhHHHHHHH
Confidence 233456788887655 22 24666666677777877765544433333222 221100 000 00000
Q ss_pred h-ccCcCCC---CCCCCCccchHHHHhcccCcCCCCCCChhhhhhCCccccee
Q psy758 219 R-HPYFNGY---YFEVPDEMQYEEITQRCLDKDPLRRWSCDQLLRHPYFNGYY 267 (292)
Q Consensus 219 ~-~~~~~~~---~~~~~~~~~l~~li~~~l~~dP~~Rpt~~~il~h~w~~~~~ 267 (292)
. .+..... ......++.+.+||.+||+.||.+|||++++++||||++..
T Consensus 263 ~~~~~~~~~~~~~~~~~~~~~~~~ll~~mL~~dP~~R~t~~e~l~hp~f~~~~ 315 (367)
T 1cm8_A 263 KGLPELEKKDFASILTNASPLAVNLLEKMLVLDAEQRVTAGEALAHPYFESLH 315 (367)
T ss_dssp HHSCCCCCCCGGGTCTTCCHHHHHHHHHHSCSSTTTSCCHHHHHHSGGGTTTC
T ss_pred HhCCCCCCCCHHHHCCCCCHHHHHHHHHHccCChhHCCCHHHHhcChHHHhhc
Confidence 0 0000000 11123477899999999999999999999999999999854
|
| >2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-43 Score=292.13 Aligned_cols=246 Identities=26% Similarity=0.410 Sum_probs=188.5
Q ss_pred cceeeeecccCceEEEEEEEcCCCcEEEEEEeccCCCChHHHHHHHHHHHHHHhCCCCCcchhhhhhhcCCeEEEEEecC
Q psy758 4 YEKIGKLGEGSYGVVFKCRNRDTGQVVAIKKFLESEEDPLIRKIALREIRLLKSLKHPNLVNLLEVFRRKKKLHLVFEFC 83 (292)
Q Consensus 4 y~~~~~l~~g~~~~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~iv~e~~ 83 (292)
|...+.||+|+||.||+|.+..+|+.||+|++....... .+.+.+|+.+++.++||||+++++++...+..++||||+
T Consensus 47 ~~~~~~lg~G~~g~V~~a~~~~~g~~vavK~~~~~~~~~--~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~ 124 (321)
T 2c30_A 47 LDSYVKIGEGSTGIVCLAREKHSGRQVAVKMMDLRKQQR--RELLFNEVVIMRDYQHFNVVEMYKSYLVGEELWVLMEFL 124 (321)
T ss_dssp EEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCCS--HHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEECCC
T ss_pred hhccEEeccCCCeEEEEEEECCCCcEEEEEEEeccchhH--HHHHHHHHHHHHhCCCCCcceEEEEEEECCEEEEEEecC
Confidence 677889999999999999999999999999987554332 456789999999999999999999999999999999999
Q ss_pred CCccHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEEccCCcEEEeecCchhhhhcccc-----cc
Q psy758 84 DHTVLNELENHPHGLPWDLIKQITWQVLRGVSYCHRHACIHRDIKPENILLTANGVVKLCDFGFARLIRDLIP-----RH 158 (292)
Q Consensus 84 ~~~~L~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~givH~dl~p~Nilv~~~~~~kl~dfg~~~~~~~~~~-----~~ 158 (292)
++++|.+++... .+++..++.++.||+.||.|||++|++||||||+||+++.++.++|+|||++........ .+
T Consensus 125 ~~~~L~~~l~~~-~l~~~~~~~i~~qi~~~L~~LH~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~~~~~~~~g 203 (321)
T 2c30_A 125 QGGALTDIVSQV-RLNEEQIATVCEAVLQALAYLHAQGVIHRDIKSDSILLTLDGRVKLSDFGFCAQISKDVPKRKSLVG 203 (321)
T ss_dssp CSCBHHHHHTTC-CCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTCCEEECCCTTCEECCSSSCCBCCCCS
T ss_pred CCCCHHHHHHhc-CCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEECCCCcEEEeeeeeeeecccCccccccccC
Confidence 999999998764 799999999999999999999999999999999999999999999999999876543222 23
Q ss_pred ccccccccccccCCCC-----CCCcccceeeecCCCCCCchHHHHHHHhhcccCCCCCCChhhhhhccCcCCCCCCCCCc
Q psy758 159 LHIFQTNEYFKGVSLP-----HAENVVPLEIKIGKPAATNIYLIDFLKRCLDKDPLRRWSCDQLLRHPYFNGYYFEVPDE 233 (292)
Q Consensus 159 ~~~~~~~~~~~~~~~~-----~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 233 (292)
+..|.+||...+.... |+.|+..+++.+|..++........+..+....+ .........+
T Consensus 204 t~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~g~~pf~~~~~~~~~~~~~~~~~---------------~~~~~~~~~~ 268 (321)
T 2c30_A 204 TPYWMAPEVISRSLYATEVDIWSLGIMVIEMVDGEPPYFSDSPVQAMKRLRDSPP---------------PKLKNSHKVS 268 (321)
T ss_dssp CGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHSSC---------------CCCTTGGGSC
T ss_pred CccccCHhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcCCC---------------CCcCccccCC
Confidence 4456666666544332 3333333344444443322222222111111100 0111122346
Q ss_pred cchHHHHhcccCcCCCCCCChhhhhhCCccccee
Q psy758 234 MQYEEITQRCLDKDPLRRWSCDQLLRHPYFNGYY 267 (292)
Q Consensus 234 ~~l~~li~~~l~~dP~~Rpt~~~il~h~w~~~~~ 267 (292)
..+.++|.+||+.||++|||++++++||||.+..
T Consensus 269 ~~l~~li~~~l~~dp~~Rps~~ell~hp~~~~~~ 302 (321)
T 2c30_A 269 PVLRDFLERMLVRDPQERATAQELLDHPFLLQTG 302 (321)
T ss_dssp HHHHHHHHHHSCSSTTTSCCHHHHHTSGGGGGCC
T ss_pred HHHHHHHHHHccCChhhCcCHHHHhcChhhccCC
Confidence 7899999999999999999999999999998744
|
| >2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-44 Score=291.53 Aligned_cols=253 Identities=23% Similarity=0.318 Sum_probs=191.7
Q ss_pred CcccceeeeecccCceEEEEEEEcCCCcEEEEEEeccCCC-ChHHHHHHHHHHHHHHhCCCCCcchhhhhhhcCCeEEEE
Q psy758 1 MERYEKIGKLGEGSYGVVFKCRNRDTGQVVAIKKFLESEE-DPLIRKIALREIRLLKSLKHPNLVNLLEVFRRKKKLHLV 79 (292)
Q Consensus 1 ~~~y~~~~~l~~g~~~~v~~~~~~~~~~~v~iK~~~~~~~-~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~iv 79 (292)
+++|++.+.||+|++|.||+|.+..+++.||+|++..... .....+.+.+|+.+++.++||||+++++++.+.+..++|
T Consensus 10 ~~~y~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 89 (276)
T 2h6d_A 10 IGHYVLGDTLGVGTFGKVKIGEHQLTGHKVAVKILNRQKIRSLDVVGKIKREIQNLKLFRHPHIIKLYQVISTPTDFFMV 89 (276)
T ss_dssp ETTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEE
T ss_pred eccEEEEeeecCCCCeEEEEEEECCCCceEEEEEeccccccchhHHHHHHHHHHHHhcCCCCCEeEEEEEEecCCeEEEE
Confidence 3789999999999999999999999999999999865421 112345678999999999999999999999999999999
Q ss_pred EecCCCccHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEEccCCcEEEeecCchhhhhccc----
Q psy758 80 FEFCDHTVLNELENHPHGLPWDLIKQITWQVLRGVSYCHRHACIHRDIKPENILLTANGVVKLCDFGFARLIRDLI---- 155 (292)
Q Consensus 80 ~e~~~~~~L~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~givH~dl~p~Nilv~~~~~~kl~dfg~~~~~~~~~---- 155 (292)
+||+++++|.+++.....+++..++.++.||+.||.|||++|++|+||+|+||+++.++.++|+|||++.......
T Consensus 90 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~~l~dfg~~~~~~~~~~~~~ 169 (276)
T 2h6d_A 90 MEYVSGGELFDYICKHGRVEEMEARRLFQQILSAVDYCHRHMVVHRDLKPENVLLDAHMNAKIADFGLSNMMSDGEFLRT 169 (276)
T ss_dssp EECCCSCBHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHHCSSCCCCCGGGEEECTTSCEEECCCCGGGCCCC------
T ss_pred EeccCCCcHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCCccCCCChhhEEECCCCCEEEeecccccccCCCcceec
Confidence 9999999999998777789999999999999999999999999999999999999999999999999987654321
Q ss_pred cccccccccccccccCCC-CCCCcccceeeecCCCCCCchHHHHHHHhhcccCCCCCCChhhhhhccCcCCCCCCCCCcc
Q psy758 156 PRHLHIFQTNEYFKGVSL-PHAENVVPLEIKIGKPAATNIYLIDFLKRCLDKDPLRRWSCDQLLRHPYFNGYYFEVPDEM 234 (292)
Q Consensus 156 ~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 234 (292)
...+..|.+||...+... ....++ ++.+.-++..+.+..|.......+......-.....+...+.
T Consensus 170 ~~~~~~y~aPE~~~~~~~~~~~~Di-------------~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (276)
T 2h6d_A 170 SCGSPNYAAPEVISGRLYAGPEVDI-------------WSCGVILYALLCGTLPFDDEHVPTLFKKIRGGVFYIPEYLNR 236 (276)
T ss_dssp -------CCTGGGTTSCCCHHHHHH-------------HHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCCTTSCH
T ss_pred ccCCccccCHHHHcCCCCCCccchH-------------HHHHHHHHHHHhCCCCCCCCcHHHHHHHhhcCcccCchhcCH
Confidence 122344666666544322 111222 222223333444444544444333332211112233445578
Q ss_pred chHHHHhcccCcCCCCCCChhhhhhCCcccce
Q psy758 235 QYEEITQRCLDKDPLRRWSCDQLLRHPYFNGY 266 (292)
Q Consensus 235 ~l~~li~~~l~~dP~~Rpt~~~il~h~w~~~~ 266 (292)
.+.++|.+||+.||.+|||++++++||||++.
T Consensus 237 ~l~~li~~~l~~~p~~Rps~~~~l~h~~~~~~ 268 (276)
T 2h6d_A 237 SVATLLMHMLQVDPLKRATIKDIREHEWFKQD 268 (276)
T ss_dssp HHHHHHHHHTCSSGGGSCCHHHHHHSHHHHTT
T ss_pred HHHHHHHHHccCChhhCCCHHHHHhChhhccC
Confidence 89999999999999999999999999999864
|
| >1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-43 Score=288.02 Aligned_cols=246 Identities=23% Similarity=0.311 Sum_probs=187.7
Q ss_pred cccceeeeecccCceEEEEEEEcCCCcEEEEEEeccCCCChHHHHHHHHHHHHHHhC-CCCCcchhhhhhhcCCeEEEEE
Q psy758 2 ERYEKIGKLGEGSYGVVFKCRNRDTGQVVAIKKFLESEEDPLIRKIALREIRLLKSL-KHPNLVNLLEVFRRKKKLHLVF 80 (292)
Q Consensus 2 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~e~~~~~~l-~~~~i~~~~~~~~~~~~~~iv~ 80 (292)
++|++.+.||+|++|.||+|.+..+++.||+|++............+.+|+..+..+ +||||+++++++.+++..++||
T Consensus 11 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~~~~l~~h~~iv~~~~~~~~~~~~~lv~ 90 (289)
T 1x8b_A 11 TEFHELEKIGSGEFGSVFKCVKRLDGCIYAIKRSKKPLAGSVDEQNALREVYAHAVLGQHSHVVRYFSAWAEDDHMLIQN 90 (289)
T ss_dssp HHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCCTTSHHHHHHHHHHHHHHHSCSCTTBCCEEEEEEETTEEEEEE
T ss_pred chhhhhhhhcCCCceEEEEEEEcCCCceEEEEEecccccccHHHHHHHHHHHHHHHhCCCCCeeeeeeeeecCCeEEEEE
Confidence 579999999999999999999999999999999987766556677788999999999 8999999999999999999999
Q ss_pred ecCCCccHHHHhcCC----CCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEEccC-------------------
Q psy758 81 EFCDHTVLNELENHP----HGLPWDLIKQITWQVLRGVSYCHRHACIHRDIKPENILLTAN------------------- 137 (292)
Q Consensus 81 e~~~~~~L~~~~~~~----~~~~~~~~~~i~~qi~~aL~~LH~~givH~dl~p~Nilv~~~------------------- 137 (292)
||+++++|.+++... ..+++..++.++.||+.||.|||++||+|+||||+||+++.+
T Consensus 91 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dikp~NIl~~~~~~~~~~~~~~~~~~~~~~~ 170 (289)
T 1x8b_A 91 EYCNGGSLADAISENYRIMSYFKEAELKDLLLQVGRGLRYIHSMSLVHMDIKPSNIFISRTSIPNAASEEGDEDDWASNK 170 (289)
T ss_dssp ECCTTCBHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEC--------------------C
T ss_pred EecCCCcHHHHHHhhcccccCCCHHHHHHHHHHHHHHHHHHHhCCEeecCCCHHHEEEcCCCCCcccccccccccccCCc
Confidence 999999999988653 569999999999999999999999999999999999999844
Q ss_pred CcEEEeecCchhhhhccc-cccccccccccccccCC-C-----CCCCcccceeeecCCCCCCchHHHHHHHhhcccCCCC
Q psy758 138 GVVKLCDFGFARLIRDLI-PRHLHIFQTNEYFKGVS-L-----PHAENVVPLEIKIGKPAATNIYLIDFLKRCLDKDPLR 210 (292)
Q Consensus 138 ~~~kl~dfg~~~~~~~~~-~~~~~~~~~~~~~~~~~-~-----~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~p~~ 210 (292)
..++|+|||.+....... ...+..|.+||...+.. . .|+.|+..+++.++.++ ..
T Consensus 171 ~~~kl~Dfg~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~~~~~------------------~~ 232 (289)
T 1x8b_A 171 VMFKIGDLGHVTRISSPQVEEGDSRFLANEVLQENYTHLPKADIFALALTVVCAAGAEPL------------------PR 232 (289)
T ss_dssp CCEEECCCTTCEETTCSCCCCCCGGGCCHHHHTTCCTTHHHHHHHHHHHHHHHHTTCCCC------------------CS
T ss_pred eEEEEcccccccccCCccccCCCccccChhHhcCCCCCCchhhHHHHHHHHHHHhcCCCC------------------Cc
Confidence 479999999987665322 23445577777665431 1 23333333333333322 11
Q ss_pred CCChhhhhhccCcCCCCCCCCCccchHHHHhcccCcCCCCCCChhhhhhCCccccee
Q psy758 211 RWSCDQLLRHPYFNGYYFEVPDEMQYEEITQRCLDKDPLRRWSCDQLLRHPYFNGYY 267 (292)
Q Consensus 211 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~~il~h~w~~~~~ 267 (292)
.......+..... ...+...+..+.+||.+||+.||.+|||+.++++||||++..
T Consensus 233 ~~~~~~~~~~~~~--~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~h~~~~~~~ 287 (289)
T 1x8b_A 233 NGDQWHEIRQGRL--PRIPQVLSQEFTELLKVMIHPDPERRPSAMALVKHSVLLSAS 287 (289)
T ss_dssp SSHHHHHHHTTCC--CCCSSCCCHHHHHHHHHHTCSSGGGSCCHHHHHTCTTC----
T ss_pred chhHHHHHHcCCC--CCCCcccCHHHHHHHHHHhCCCcccCCCHHHHhhChHhhhhc
Confidence 1111111111111 122344578999999999999999999999999999999743
|
| >3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-44 Score=313.97 Aligned_cols=252 Identities=27% Similarity=0.385 Sum_probs=187.7
Q ss_pred cccceeeeecccCceEEEEEEEcCCCcEEEEEEeccCCCChHHHHHHHHHHHHHHhCCCCCcchhhhhhhcCCeEEEEEe
Q psy758 2 ERYEKIGKLGEGSYGVVFKCRNRDTGQVVAIKKFLESEEDPLIRKIALREIRLLKSLKHPNLVNLLEVFRRKKKLHLVFE 81 (292)
Q Consensus 2 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~iv~e 81 (292)
++|++++.||+|+||.||+|.+..++..||+|++............+.+|+.+++.++||||+++++++.+.+.+|+|||
T Consensus 37 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e 116 (494)
T 3lij_A 37 EMYQRVKKLGSGAYGEVLLCRDKVTHVERAIKIIRKTSVSTSSNSKLLEEVAVLKLLDHPNIMKLYDFFEDKRNYYLVME 116 (494)
T ss_dssp HHEEEEEEEECC---EEEEEEETTTCCEEEEEEEEC-----CTTHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEEE
T ss_pred cCeEEeeEEecCCCEEEEEEEECCCCcEEEEEEEeccccCchHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEEEEe
Confidence 47999999999999999999999999999999997665333335678899999999999999999999999999999999
Q ss_pred cCCCccHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEEccC---CcEEEeecCchhhhhcccc--
Q psy758 82 FCDHTVLNELENHPHGLPWDLIKQITWQVLRGVSYCHRHACIHRDIKPENILLTAN---GVVKLCDFGFARLIRDLIP-- 156 (292)
Q Consensus 82 ~~~~~~L~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~givH~dl~p~Nilv~~~---~~~kl~dfg~~~~~~~~~~-- 156 (292)
|+.+++|.+.+.....+++..++.++.||+.||.|||++||+||||||+||+++.+ +.+||+|||++........
T Consensus 117 ~~~~g~L~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~Dlkp~Nil~~~~~~~~~~kl~DfG~a~~~~~~~~~~ 196 (494)
T 3lij_A 117 CYKGGELFDEIIHRMKFNEVDAAVIIKQVLSGVTYLHKHNIVHRDLKPENLLLESKEKDALIKIVDFGLSAVFENQKKMK 196 (494)
T ss_dssp CCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEESCSSTTCCEEECCCTTCEECBTTBCBC
T ss_pred cCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCChhhEEEeCCCCCCcEEEEECCCCeECCCCcccc
Confidence 99999998888776789999999999999999999999999999999999999864 4599999999876543221
Q ss_pred --ccccccccccccccCCCCCCCcccceeeecCCCCCCchHHHHHHHhhcccCCCCCCChhhhhhccCcCCCCC----CC
Q psy758 157 --RHLHIFQTNEYFKGVSLPHAENVVPLEIKIGKPAATNIYLIDFLKRCLDKDPLRRWSCDQLLRHPYFNGYYF----EV 230 (292)
Q Consensus 157 --~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~----~~ 230 (292)
.++..|.+||...+. .... .++++.+.-++..+.+..|+...+..+++.......... ..
T Consensus 197 ~~~gt~~y~aPE~l~~~-~~~~-------------~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~ 262 (494)
T 3lij_A 197 ERLGTAYYIAPEVLRKK-YDEK-------------CDVWSIGVILFILLAGYPPFGGQTDQEILRKVEKGKYTFDSPEWK 262 (494)
T ss_dssp CCCSCTTTCCHHHHTTC-BCTH-------------HHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCCCSGGGT
T ss_pred ccCCCcCeeCHHHHccc-CCCc-------------hhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCCchhcc
Confidence 233445555554321 1111 122223333344444455554444444433221111111 12
Q ss_pred CCccchHHHHhcccCcCCCCCCChhhhhhCCccccee
Q psy758 231 PDEMQYEEITQRCLDKDPLRRWSCDQLLRHPYFNGYY 267 (292)
Q Consensus 231 ~~~~~l~~li~~~l~~dP~~Rpt~~~il~h~w~~~~~ 267 (292)
..+..+.+||.+||+.||.+|||+.++|+||||++..
T Consensus 263 ~~s~~~~~li~~~L~~dp~~R~s~~e~l~hp~~~~~~ 299 (494)
T 3lij_A 263 NVSEGAKDLIKQMLQFDSQRRISAQQALEHPWIKEMC 299 (494)
T ss_dssp TSCHHHHHHHHHHTCSSTTTSCCHHHHHTCHHHHHHH
T ss_pred cCCHHHHHHHHHHCCCChhhCccHHHHhcCcccccCc
Confidence 4577899999999999999999999999999999753
|
| >3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-43 Score=289.69 Aligned_cols=264 Identities=30% Similarity=0.451 Sum_probs=188.1
Q ss_pred cccceeeeecccCceEEEEEEEcCCCcEEEEEEeccCCCC---hHHHHHHHHHHHHHHhC---CCCCcchhhhhhhcCC-
Q psy758 2 ERYEKIGKLGEGSYGVVFKCRNRDTGQVVAIKKFLESEED---PLIRKIALREIRLLKSL---KHPNLVNLLEVFRRKK- 74 (292)
Q Consensus 2 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~v~iK~~~~~~~~---~~~~~~~~~e~~~~~~l---~~~~i~~~~~~~~~~~- 74 (292)
++|++.+.||+|+||.||+|++..+++.||+|++...... ......+.+|+.+++.+ +||||+++++++.+..
T Consensus 9 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~niv~~~~~~~~~~~ 88 (308)
T 3g33_A 9 SRYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVPNGGGGGGGLPISTVREVALLRRLEAFEHPNVVRLMDVCATSRT 88 (308)
T ss_dssp -CCEEEEEECCSSSCCEEEEECTTTCCEEEEEEEEEECCCTTSSCCCHHHHHHHHHHHHHHHHCCTTBCCEEEEEEECCS
T ss_pred cceEEEEEEecCCCeEEEEEEECCCCcEEEEEEEecccccccccccchhHHHHHHHHHHHhhcCCCCeEEeeeeeeccCC
Confidence 6899999999999999999999999999999998643311 11123345667666666 4999999999987654
Q ss_pred ----eEEEEEecCCCccHHHHhcCCCC--CCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEEccCCcEEEeecCch
Q psy758 75 ----KLHLVFEFCDHTVLNELENHPHG--LPWDLIKQITWQVLRGVSYCHRHACIHRDIKPENILLTANGVVKLCDFGFA 148 (292)
Q Consensus 75 ----~~~iv~e~~~~~~L~~~~~~~~~--~~~~~~~~i~~qi~~aL~~LH~~givH~dl~p~Nilv~~~~~~kl~dfg~~ 148 (292)
.+++++||+++ +|.+++..... +++..++.++.||+.||+|||++|++|+||||+||+++.++.++|+|||++
T Consensus 89 ~~~~~~~lv~e~~~~-~L~~~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dlkp~Nil~~~~~~~kl~Dfg~a 167 (308)
T 3g33_A 89 DREIKVTLVFEHVDQ-DLRTYLDKAPPPGLPAETIKDLMRQFLRGLDFLHANCIVHRDLKPENILVTSGGTVKLADFGLA 167 (308)
T ss_dssp SSEEEEEEEEECCCC-BHHHHHHTCCTTCSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCTTTEEECTTSCEEECSCSCT
T ss_pred CCceeEEEEehhhhc-CHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEEcCCCCEEEeeCccc
Confidence 58999999985 77777766543 999999999999999999999999999999999999999999999999999
Q ss_pred hhhhccc----cccccccccccccccCCC-----CCCCcccceeeecCCCCCCchHHHHHHHh---hcccCCCCCCChhh
Q psy758 149 RLIRDLI----PRHLHIFQTNEYFKGVSL-----PHAENVVPLEIKIGKPAATNIYLIDFLKR---CLDKDPLRRWSCDQ 216 (292)
Q Consensus 149 ~~~~~~~----~~~~~~~~~~~~~~~~~~-----~~~~~~~~~~~~~~~~~~~~~~~~~~~~~---~~~~~p~~~~~~~~ 216 (292)
....... ...+..|.+||...+... .|+.|+..+++.++.+++........+.. .+...+...+....
T Consensus 168 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~ 247 (308)
T 3g33_A 168 RIYSYQMALTPVVVTLWYRAPEVLLQSTYATPVDMWSVGCIFAEMFRRKPLFCGNSEADQLGKIFDLIGLPPEDDWPRDV 247 (308)
T ss_dssp TTSTTCCCSGGGGCCCSSCCHHHHHTSCCCSTHHHHHHHHHHHHTTTSSCSCCCSSHHHHHHHHHHHHCCCCTTTSCSSC
T ss_pred cccCCCcccCCccccccccCchHHcCCCCCchHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChhhccchh
Confidence 7654322 223455777777655444 35556666667777776654433333222 22222222211110
Q ss_pred hhhccCcCCC------CCCCCCccchHHHHhcccCcCCCCCCChhhhhhCCcccce
Q psy758 217 LLRHPYFNGY------YFEVPDEMQYEEITQRCLDKDPLRRWSCDQLLRHPYFNGY 266 (292)
Q Consensus 217 ~~~~~~~~~~------~~~~~~~~~l~~li~~~l~~dP~~Rpt~~~il~h~w~~~~ 266 (292)
.+....+... ......+..+.+||.+||+.||.+|||+.|+|+||||++.
T Consensus 248 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~h~~~~~~ 303 (308)
T 3g33_A 248 SLPRGAFPPRGPRPVQSVVPEMEESGAQLLLEMLTFNPHKRISAFRALQHSYLHKD 303 (308)
T ss_dssp SSCGGGSCCCCCCCHHHHSCSCCHHHHHHHHHHTCSSTTTSCCHHHHHTSTTC---
T ss_pred hccccccCCCCCCcHHHhCccccHHHHHHHHHHhcCCCccCCCHHHHhcCccccCC
Confidence 0000000000 0112346788999999999999999999999999999974
|
| >3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei} | Back alignment and structure |
|---|
Probab=100.00 E-value=6e-44 Score=311.32 Aligned_cols=255 Identities=28% Similarity=0.394 Sum_probs=191.7
Q ss_pred cccceeeeecccCceEEEEEEEcCCCcEEEEEEeccCCCCh-----------HHHHHHHHHHHHHHhCCCCCcchhhhhh
Q psy758 2 ERYEKIGKLGEGSYGVVFKCRNRDTGQVVAIKKFLESEEDP-----------LIRKIALREIRLLKSLKHPNLVNLLEVF 70 (292)
Q Consensus 2 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~v~iK~~~~~~~~~-----------~~~~~~~~e~~~~~~l~~~~i~~~~~~~ 70 (292)
++|++++.||+|+||.||+|.+..+++.||+|++....... ...+.+.+|+.+++.++||||+++++++
T Consensus 36 ~~Y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~ 115 (504)
T 3q5i_A 36 ESYFKVRKLGSGAYGEVLLCKEKNGHSEKAIKVIKKSQFDKGRYSDDNKNIEKFHEEIYNEISLLKSLDHPNIIKLFDVF 115 (504)
T ss_dssp GTEEEEEEEEC--CEEEEEEEETTTCCEEEEEEEEC----------------CTHHHHHHHHHHHHTCCCTTBCCEEEEE
T ss_pred cceEEEeEecccCCeEEEEEEECCCCcEEEEEEEEhhhcccccccccchhhHHHHHHHHHHHHHHHhCCCCCCCeEEEEE
Confidence 58999999999999999999999999999999997654221 2346788999999999999999999999
Q ss_pred hcCCeEEEEEecCCCccHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEEccCC---cEEEeecCc
Q psy758 71 RRKKKLHLVFEFCDHTVLNELENHPHGLPWDLIKQITWQVLRGVSYCHRHACIHRDIKPENILLTANG---VVKLCDFGF 147 (292)
Q Consensus 71 ~~~~~~~iv~e~~~~~~L~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~givH~dl~p~Nilv~~~~---~~kl~dfg~ 147 (292)
.+++.+|+||||++|++|.+.+.....+++..++.++.||+.||.|||++||+||||||+||+++.++ .++|+|||+
T Consensus 116 ~~~~~~~lv~e~~~gg~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~Dlkp~Nil~~~~~~~~~~kl~Dfg~ 195 (504)
T 3q5i_A 116 EDKKYFYLVTEFYEGGELFEQIINRHKFDECDAANIMKQILSGICYLHKHNIVHRDIKPENILLENKNSLLNIKIVDFGL 195 (504)
T ss_dssp ECSSEEEEEEECCTTCBHHHHHHHHSCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEESSTTCCSSEEECCCTT
T ss_pred EcCCEEEEEEecCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEeCCCcHHHEEEecCCCCccEEEEECCC
Confidence 99999999999999999998887777899999999999999999999999999999999999999876 699999999
Q ss_pred hhhhhccc----cccccccccccccccCCCCCCCcccceeeecCCCCCCchHHHHHHHhhcccCCCCCCChhhhhhccCc
Q psy758 148 ARLIRDLI----PRHLHIFQTNEYFKGVSLPHAENVVPLEIKIGKPAATNIYLIDFLKRCLDKDPLRRWSCDQLLRHPYF 223 (292)
Q Consensus 148 ~~~~~~~~----~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~ 223 (292)
+....... ..++..|.+||...+. ..... ++++.+.-++..+.+..|+...+..+++.....
T Consensus 196 a~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~-------------DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~ 261 (504)
T 3q5i_A 196 SSFFSKDYKLRDRLGTAYYIAPEVLKKK-YNEKC-------------DVWSCGVIMYILLCGYPPFGGQNDQDIIKKVEK 261 (504)
T ss_dssp CEECCTTSCBCCCCSCTTTCCHHHHTTC-BCTHH-------------HHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHH
T ss_pred CEEcCCCCccccccCCcCCCCHHHhccC-CCchH-------------HHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHc
Confidence 97654321 2233445556554321 11111 122223333344444455544444444332211
Q ss_pred CCCCCC----CCCccchHHHHhcccCcCCCCCCChhhhhhCCcccceeccC
Q psy758 224 NGYYFE----VPDEMQYEEITQRCLDKDPLRRWSCDQLLRHPYFNGYYFEV 270 (292)
Q Consensus 224 ~~~~~~----~~~~~~l~~li~~~l~~dP~~Rpt~~~il~h~w~~~~~~~~ 270 (292)
.....+ ...+..+.+||.+||++||.+|||++|+|+||||++.....
T Consensus 262 ~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~R~t~~e~l~h~~~~~~~~~~ 312 (504)
T 3q5i_A 262 GKYYFDFNDWKNISDEAKELIKLMLTYDYNKRCTAEEALNSRWIKKYANNI 312 (504)
T ss_dssp CCCCCCHHHHTTSCHHHHHHHHHHTCSSTTTSCCHHHHHTSHHHHHTCCCC
T ss_pred CCCCCCccccCCCCHHHHHHHHHHcCCChhHCCCHHHHhcCHhhhhchhcc
Confidence 111111 34578899999999999999999999999999999866543
|
| >3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.1e-44 Score=294.72 Aligned_cols=257 Identities=23% Similarity=0.286 Sum_probs=193.5
Q ss_pred ccccee-eeecccCceEEEEEEEcCCCcEEEEEEeccCCCChHHHHHHHHHHHHHHhCC-CCCcchhhhhhhcCCeEEEE
Q psy758 2 ERYEKI-GKLGEGSYGVVFKCRNRDTGQVVAIKKFLESEEDPLIRKIALREIRLLKSLK-HPNLVNLLEVFRRKKKLHLV 79 (292)
Q Consensus 2 ~~y~~~-~~l~~g~~~~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~e~~~~~~l~-~~~i~~~~~~~~~~~~~~iv 79 (292)
++|.+. +.||+|+||.||+|.+..+++.||+|++............+.+|+.+++.+. ||||+++++++.+.+..++|
T Consensus 28 ~~y~~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~iv~~~~~~~~~~~~~lv 107 (327)
T 3lm5_A 28 NFYILTSKELGRGKFAVVRQCISKSTGQEYAAKFLKKRRRGQDCRAEILHEIAVLELAKSCPRVINLHEVYENTSEIILI 107 (327)
T ss_dssp HHEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEESEETTEECHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEE
T ss_pred hEEeeccceeCCCCCeEEEEEEECCCCCEEEEEEEehhhcchHHHHHHHHHHHHHHhccCCCCEEEEEEEEEeCCeEEEE
Confidence 467887 8899999999999999999999999999766544444567889999999995 69999999999999999999
Q ss_pred EecCCCccHHHHhcC--CCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEEcc---CCcEEEeecCchhhhhcc
Q psy758 80 FEFCDHTVLNELENH--PHGLPWDLIKQITWQVLRGVSYCHRHACIHRDIKPENILLTA---NGVVKLCDFGFARLIRDL 154 (292)
Q Consensus 80 ~e~~~~~~L~~~~~~--~~~~~~~~~~~i~~qi~~aL~~LH~~givH~dl~p~Nilv~~---~~~~kl~dfg~~~~~~~~ 154 (292)
|||+.+++|.+++.. ...+++..++.++.||+.||+|||++|++||||||+||+++. ++.++|+|||++......
T Consensus 108 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~ql~~~L~~LH~~givH~Dikp~NIl~~~~~~~~~~kL~Dfg~a~~~~~~ 187 (327)
T 3lm5_A 108 LEYAAGGEIFSLCLPELAEMVSENDVIRLIKQILEGVYYLHQNNIVHLDLKPQNILLSSIYPLGDIKIVDFGMSRKIGHA 187 (327)
T ss_dssp EECCTTEEGGGGGSSCC-CCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEESCBTTBCCEEECCGGGCEEC---
T ss_pred EEecCCCcHHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCCeecCcCChHHEEEecCCCCCcEEEeeCccccccCCc
Confidence 999999999999854 357999999999999999999999999999999999999998 789999999999765432
Q ss_pred c----cccccccccccccccCCCCCCCcccceeeecCCCCCCchHHHHHHHhhcccCCCCCCChhhhhhcc----CcCCC
Q psy758 155 I----PRHLHIFQTNEYFKGVSLPHAENVVPLEIKIGKPAATNIYLIDFLKRCLDKDPLRRWSCDQLLRHP----YFNGY 226 (292)
Q Consensus 155 ~----~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~----~~~~~ 226 (292)
. ...+..|.+||...+.......++|++ +.-++..+.+..|+......+..... .-...
T Consensus 188 ~~~~~~~gt~~y~aPE~~~~~~~~~~~Diwsl-------------G~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~ 254 (327)
T 3lm5_A 188 CELREIMGTPEYLAPEILNYDPITTATDMWNI-------------GIIAYMLLTHTSPFVGEDNQETYLNISQVNVDYSE 254 (327)
T ss_dssp ------CCCGGGCCHHHHTTCCCCTHHHHHHH-------------HHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCCCT
T ss_pred cccccccCCcCccCCeeecCCCCCchhhHHHH-------------HHHHHHHHhCCCCCCCCCchHHHHHHHhcccccCc
Confidence 2 223445667766654443322222222 22223333344444333333222111 00011
Q ss_pred CCCCCCccchHHHHhcccCcCCCCCCChhhhhhCCcccceeccCC
Q psy758 227 YFEVPDEMQYEEITQRCLDKDPLRRWSCDQLLRHPYFNGYYFEVP 271 (292)
Q Consensus 227 ~~~~~~~~~l~~li~~~l~~dP~~Rpt~~~il~h~w~~~~~~~~~ 271 (292)
......+..+.+||.+||+.||.+|||++++++||||++..|+..
T Consensus 255 ~~~~~~~~~~~~li~~~L~~dP~~Rpt~~~ll~h~~~~~~~~~~~ 299 (327)
T 3lm5_A 255 ETFSSVSQLATDFIQSLLVKNPEKRPTAEICLSHSWLQQWDFENL 299 (327)
T ss_dssp TTTTTSCHHHHHHHHHHSCSSGGGSCCHHHHTTCGGGCCCCTTCC
T ss_pred hhhcccCHHHHHHHHHHcCCChhhCcCHHHHhCCHhhcccccccc
Confidence 112345778999999999999999999999999999999887744
|
| >3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.9e-44 Score=311.36 Aligned_cols=249 Identities=26% Similarity=0.354 Sum_probs=194.6
Q ss_pred cccceeeeecccCceEEEEEEEcCCCcEEEEEEeccCCCC-hHHHHHHHHHHHHHHhCCCCCcchhhhhhhcCCeEEEEE
Q psy758 2 ERYEKIGKLGEGSYGVVFKCRNRDTGQVVAIKKFLESEED-PLIRKIALREIRLLKSLKHPNLVNLLEVFRRKKKLHLVF 80 (292)
Q Consensus 2 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~v~iK~~~~~~~~-~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~iv~ 80 (292)
++|++.+.||+|+||.||+|.+..+++.||+|++...... ......+.+|+.+++.++||||+++++++.+.+..++|+
T Consensus 26 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~ 105 (484)
T 3nyv_A 26 DRYKGQRVLGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTDKESLLREVQLLKQLDHPNIMKLYEFFEDKGYFYLVG 105 (484)
T ss_dssp HHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCCBSSCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred CceEEeeEEecCCCEEEEEEEECCCCCEEEEEEEEhhhcccchHHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEEEEEE
Confidence 5799999999999999999999999999999999755422 234567889999999999999999999999999999999
Q ss_pred ecCCCccHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEE---ccCCcEEEeecCchhhhhccc--
Q psy758 81 EFCDHTVLNELENHPHGLPWDLIKQITWQVLRGVSYCHRHACIHRDIKPENILL---TANGVVKLCDFGFARLIRDLI-- 155 (292)
Q Consensus 81 e~~~~~~L~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~givH~dl~p~Nilv---~~~~~~kl~dfg~~~~~~~~~-- 155 (292)
||+.+++|.+.+...+.+++..++.++.||+.||.|||++||+||||||+||++ +.++.++|+|||++.......
T Consensus 106 e~~~~~~L~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~Dlkp~Nil~~~~~~~~~~kl~Dfg~a~~~~~~~~~ 185 (484)
T 3nyv_A 106 EVYTGGELFDEIISRKRFSEVDAARIIRQVLSGITYMHKNKIVHRDLKPENLLLESKSKDANIRIIDFGLSTHFEASKKM 185 (484)
T ss_dssp CCCCSCBHHHHHHTCSCCBHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEESSSSTTCCEEECCTTHHHHBCCCCSH
T ss_pred ecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeeeCCCCHHHEEEecCCCCCcEEEEeeeeeEEccccccc
Confidence 999999999998888889999999999999999999999999999999999999 467899999999997654322
Q ss_pred --cccccccccccccccCC----CCCCCcccceeeecCCCCCCchHHHHHHHhhcccCCCCCCChhhhhhccCcCCC---
Q psy758 156 --PRHLHIFQTNEYFKGVS----LPHAENVVPLEIKIGKPAATNIYLIDFLKRCLDKDPLRRWSCDQLLRHPYFNGY--- 226 (292)
Q Consensus 156 --~~~~~~~~~~~~~~~~~----~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~--- 226 (292)
..++..|.+||...+.. ..|+.|+..+++.+ +..|+...+..+++........
T Consensus 186 ~~~~gt~~y~aPE~~~~~~~~~~DiwslG~il~~ll~------------------g~~pf~~~~~~~~~~~i~~~~~~~~ 247 (484)
T 3nyv_A 186 KDKIGTAYYIAPEVLHGTYDEKCDVWSTGVILYILLS------------------GCPPFNGANEYDILKKVEKGKYTFE 247 (484)
T ss_dssp HHHTTGGGTCCHHHHHTCCCTHHHHHHHHHHHHHHHH------------------SSCSSCCSSHHHHHHHHHHCCCCCC
T ss_pred ccCCCCccccCceeecCCCCCcceeHHHHHHHHHHHH------------------CCCCCCCCCHHHHHHHHHcCCCCCC
Confidence 12344566666654421 12333333334444 4444444443333322111111
Q ss_pred -CCCCCCccchHHHHhcccCcCCCCCCChhhhhhCCcccceec
Q psy758 227 -YFEVPDEMQYEEITQRCLDKDPLRRWSCDQLLRHPYFNGYYF 268 (292)
Q Consensus 227 -~~~~~~~~~l~~li~~~l~~dP~~Rpt~~~il~h~w~~~~~~ 268 (292)
......+..+++||.+||+.||.+|||+.|+++||||++...
T Consensus 248 ~~~~~~~s~~~~~li~~~L~~dp~~R~s~~e~l~h~~~~~~~~ 290 (484)
T 3nyv_A 248 LPQWKKVSESAKDLIRKMLTYVPSMRISARDALDHEWIQTYTK 290 (484)
T ss_dssp SGGGGGSCHHHHHHHHHHTCSSGGGSCCHHHHHTSHHHHHHTC
T ss_pred CcccccCCHHHHHHHHHHCCCChhHCcCHHHHhhChhhccccc
Confidence 111235778999999999999999999999999999998654
|
| >3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-44 Score=299.86 Aligned_cols=251 Identities=26% Similarity=0.389 Sum_probs=188.8
Q ss_pred cccceeeeecccCceEEEEEEEcCCCcEEEEEEeccCC---CChHHHHHHHHHHHHHHhCCCCCcchhhhhhhcCCeEEE
Q psy758 2 ERYEKIGKLGEGSYGVVFKCRNRDTGQVVAIKKFLESE---EDPLIRKIALREIRLLKSLKHPNLVNLLEVFRRKKKLHL 78 (292)
Q Consensus 2 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~v~iK~~~~~~---~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~i 78 (292)
++|++.+.||+|+||.||+|.+..+++.||+|++.... ......+.+.+|+.+++.++||||+++++++.+.+..++
T Consensus 26 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~l 105 (345)
T 3hko_A 26 KKYHLKGAIGQGSYGVVRVAIENQTRAIRAIKIMNKNKIRQINPKDVERIKTEVRLMKKLHHPNIARLYEVYEDEQYICL 105 (345)
T ss_dssp HHEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHC---CHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEE
T ss_pred hheeecceeeecCCeEEEEEEECCCCceEEEeehhhhhhcccCHHHHHHHHHHHHHHHhCCCCCcceeehhhccCCeEEE
Confidence 57999999999999999999999999999999986542 223445778899999999999999999999999999999
Q ss_pred EEecCCCccHHHHhcC----------------------------------------CCCCCHHHHHHHHHHHHHHHHHHH
Q psy758 79 VFEFCDHTVLNELENH----------------------------------------PHGLPWDLIKQITWQVLRGVSYCH 118 (292)
Q Consensus 79 v~e~~~~~~L~~~~~~----------------------------------------~~~~~~~~~~~i~~qi~~aL~~LH 118 (292)
||||++|++|.+++.. ...+++..++.++.||+.||+|||
T Consensus 106 v~e~~~gg~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH 185 (345)
T 3hko_A 106 VMELCHGGHLLDKLNVFIDDSTGKCAMDVVKTQICPCPECNEEAINGSIHGFRESLDFVQREKLISNIMRQIFSALHYLH 185 (345)
T ss_dssp EEECCCSCBHHHHEEEEEETTTTEEEEEEECCCCCCSHHHHHHHHHSCC--CEEECCHHHHHHHHHHHHHHHHHHHHHHH
T ss_pred EEeCCCCCcHHHHHHHhhcccccccccccccccccccccccccccccccccccccccccccHHHHHHHHHHHHHHHHHHH
Confidence 9999999999998852 112467889999999999999999
Q ss_pred hCCccccCCCCCceEEccCC--cEEEeecCchhhhhcc---------cccccccccccccccc--CCC-----CCCCccc
Q psy758 119 RHACIHRDIKPENILLTANG--VVKLCDFGFARLIRDL---------IPRHLHIFQTNEYFKG--VSL-----PHAENVV 180 (292)
Q Consensus 119 ~~givH~dl~p~Nilv~~~~--~~kl~dfg~~~~~~~~---------~~~~~~~~~~~~~~~~--~~~-----~~~~~~~ 180 (292)
++|++|+||||+||+++.++ .++|+|||++...... ....+..|.+||...+ ... .|+.|+.
T Consensus 186 ~~~ivH~Dlkp~NIll~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwslG~i 265 (345)
T 3hko_A 186 NQGICHRDIKPENFLFSTNKSFEIKLVDFGLSKEFYKLNNGEYYGMTTKAGTPYFVAPEVLNTTNESYGPKCDAWSAGVL 265 (345)
T ss_dssp HTTEECCCCCGGGEEESCSSSCCEEECCCTTCEEGGGTTCC--------CCCGGGCCHHHHTCSSSCCCTHHHHHHHHHH
T ss_pred HCCccccCCChhhEEEecCCCceEEEeeccccccccccCccccccccccCCCccccCchhhccCCCCCCcHHHHHHHHHH
Confidence 99999999999999998776 8999999999765331 1223445666666543 121 2333333
Q ss_pred ceeeecCCCCCCchHHHHHHHhhcccCCCCCCChhhhhhccCcCCCCC----CCCCccchHHHHhcccCcCCCCCCChhh
Q psy758 181 PLEIKIGKPAATNIYLIDFLKRCLDKDPLRRWSCDQLLRHPYFNGYYF----EVPDEMQYEEITQRCLDKDPLRRWSCDQ 256 (292)
Q Consensus 181 ~~~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~----~~~~~~~l~~li~~~l~~dP~~Rpt~~~ 256 (292)
.+++.+| ..|+...+..+......-..... ....+..+.+||.+||+.||.+|||+.+
T Consensus 266 l~el~~g------------------~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~ 327 (345)
T 3hko_A 266 LHLLLMG------------------AVPFPGVNDADTISQVLNKKLCFENPNYNVLSPLARDLLSNLLNRNVDERFDAMR 327 (345)
T ss_dssp HHHHHHS------------------SCSSCCSSHHHHHHHHHHCCCCTTSGGGGGSCHHHHHHHHHHSCSCTTTSCCHHH
T ss_pred HHHHHHC------------------CCCCCCCChHHHHHHHHhcccccCCcccccCCHHHHHHHHHHcCCChhHCCCHHH
Confidence 3344444 44444333333222211111111 1124678999999999999999999999
Q ss_pred hhhCCcccceeccC
Q psy758 257 LLRHPYFNGYYFEV 270 (292)
Q Consensus 257 il~h~w~~~~~~~~ 270 (292)
+++||||++..+.+
T Consensus 328 ~l~hp~~~~~~~~~ 341 (345)
T 3hko_A 328 ALQHPWISQFSDKI 341 (345)
T ss_dssp HHHSHHHHTTSSCS
T ss_pred HhcChhhccChHhh
Confidence 99999999876543
|
| >1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} PDB: 3fpq_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.8e-43 Score=285.71 Aligned_cols=249 Identities=24% Similarity=0.354 Sum_probs=190.3
Q ss_pred ccceeeeecccCceEEEEEEEcCCCcEEEEEEeccCCCChHHHHHHHHHHHHHHhCCCCCcchhhhhhhc----CCeEEE
Q psy758 3 RYEKIGKLGEGSYGVVFKCRNRDTGQVVAIKKFLESEEDPLIRKIALREIRLLKSLKHPNLVNLLEVFRR----KKKLHL 78 (292)
Q Consensus 3 ~y~~~~~l~~g~~~~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~----~~~~~i 78 (292)
.|++.+.||+|+||.||+|.+..++..|++|.+..........+.+.+|+.+++.++||||+++++++.+ ...+++
T Consensus 27 ~~~~~~~lg~G~~g~Vy~~~~~~~~~~va~k~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~l 106 (290)
T 1t4h_A 27 FLKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKCIVL 106 (290)
T ss_dssp EEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEESSSCEEEEE
T ss_pred eEEeeeeccCCCCeEEEEeEecCCceEEEEEEecchhhCHHHHHHHHHHHHHHHhCCCCCeeeeeeeeccccCCCceEEE
Confidence 5889999999999999999999999999999998777777778889999999999999999999998764 456899
Q ss_pred EEecCCCccHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCC--ccccCCCCCceEEc-cCCcEEEeecCchhhhhccc
Q psy758 79 VFEFCDHTVLNELENHPHGLPWDLIKQITWQVLRGVSYCHRHA--CIHRDIKPENILLT-ANGVVKLCDFGFARLIRDLI 155 (292)
Q Consensus 79 v~e~~~~~~L~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~g--ivH~dl~p~Nilv~-~~~~~kl~dfg~~~~~~~~~ 155 (292)
||||+++++|.+++.....+++..++.++.||+.||.|||++| ++|+||+|+||+++ .++.++|+|||++.......
T Consensus 107 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~~~i~H~dikp~Nil~~~~~~~~kl~Dfg~~~~~~~~~ 186 (290)
T 1t4h_A 107 VTELMTSGTLKTYLKRFKVMKIKVLRSWCRQILKGLQFLHTRTPPIIHRDLKCDNIFITGPTGSVKIGDLGLATLKRASF 186 (290)
T ss_dssp EEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHTSSSCCCCSCCCGGGEEESSTTSCEEECCTTGGGGCCTTS
T ss_pred EEEecCCCCHHHHHHHccCCCHHHHHHHHHHHHHHHHHHHcCCCCEEECCCCHHHEEEECCCCCEEEeeCCCcccccccc
Confidence 9999999999999987778999999999999999999999999 99999999999998 78899999999997544322
Q ss_pred ---cccccccccccccccCCCCCCCcccceeeecCCCCCCchHHHHHHHhhcccCCCCCCCh-hhhhhccC--cCCCCCC
Q psy758 156 ---PRHLHIFQTNEYFKGVSLPHAENVVPLEIKIGKPAATNIYLIDFLKRCLDKDPLRRWSC-DQLLRHPY--FNGYYFE 229 (292)
Q Consensus 156 ---~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~-~~~~~~~~--~~~~~~~ 229 (292)
...+..|.+||...+. .... .+.++.+.-++..+.+..|+..... .+...... ......+
T Consensus 187 ~~~~~~t~~y~aPE~~~~~-~~~~-------------~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~ 252 (290)
T 1t4h_A 187 AKAVIGTPEFMAPEMYEEK-YDES-------------VDVYAFGMCMLEMATSEYPYSECQNAAQIYRRVTSGVKPASFD 252 (290)
T ss_dssp BEESCSSCCCCCGGGGGTC-CCTH-------------HHHHHHHHHHHHHHHSSCTTTTCSSHHHHHHHHTTTCCCGGGG
T ss_pred cccccCCcCcCCHHHHhcc-CCCc-------------chHHHHHHHHHHHHhCCCCCCCcCcHHHHHHHHhccCCccccC
Confidence 1223445555544322 1111 1222333334444445555443222 22211110 0111222
Q ss_pred CCCccchHHHHhcccCcCCCCCCChhhhhhCCcccc
Q psy758 230 VPDEMQYEEITQRCLDKDPLRRWSCDQLLRHPYFNG 265 (292)
Q Consensus 230 ~~~~~~l~~li~~~l~~dP~~Rpt~~~il~h~w~~~ 265 (292)
...++.+.+||.+||+.||.+|||++++++||||++
T Consensus 253 ~~~~~~l~~li~~~l~~dp~~Rps~~ell~h~~f~~ 288 (290)
T 1t4h_A 253 KVAIPEVKEIIEGCIRQNKDERYSIKDLLNHAFFQE 288 (290)
T ss_dssp GCCCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGC-
T ss_pred CCCCHHHHHHHHHHccCChhhCCCHHHHhhCccccc
Confidence 334678999999999999999999999999999986
|
| >3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B | Back alignment and structure |
|---|
Probab=100.00 E-value=5.8e-44 Score=310.64 Aligned_cols=255 Identities=23% Similarity=0.331 Sum_probs=194.9
Q ss_pred cccceeeeecccCceEEEEEEEcCCCcEEEEEEeccCCCC-hHHHHHHHHHHHHHHhCCCCCcchhhhhhhcCCeEEEEE
Q psy758 2 ERYEKIGKLGEGSYGVVFKCRNRDTGQVVAIKKFLESEED-PLIRKIALREIRLLKSLKHPNLVNLLEVFRRKKKLHLVF 80 (292)
Q Consensus 2 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~v~iK~~~~~~~~-~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~iv~ 80 (292)
++|++.+.||+|+||.||+|++..+|+.||+|++...... ......+.+|..+++.++||||+++++++.+.+.+|+||
T Consensus 185 ~~f~~~~~LG~G~fG~Vy~a~~~~tg~~vAiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~~l~lVm 264 (543)
T 3c4z_A 185 DWFLDFRVLGRGGFGEVFACQMKATGKLYACKKLNKKRLKKRKGYQGAMVEKKILAKVHSRFIVSLAYAFETKTDLCLVM 264 (543)
T ss_dssp GGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEE
T ss_pred hheEEEEEEeeCCCeEEEEEEECCCCcEEEEEEEEhHHhhhhHHHHHHHHHHHHHHhcCCCCEeeEEEEEeeCCEEEEEE
Confidence 6899999999999999999999999999999999654311 122456788999999999999999999999999999999
Q ss_pred ecCCCccHHHHhcCC----CCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEEccCCcEEEeecCchhhhhcccc
Q psy758 81 EFCDHTVLNELENHP----HGLPWDLIKQITWQVLRGVSYCHRHACIHRDIKPENILLTANGVVKLCDFGFARLIRDLIP 156 (292)
Q Consensus 81 e~~~~~~L~~~~~~~----~~~~~~~~~~i~~qi~~aL~~LH~~givH~dl~p~Nilv~~~~~~kl~dfg~~~~~~~~~~ 156 (292)
||++|++|..++... ..+++..++.++.||+.||.|||++||+||||||+||+++.+|++||+|||++........
T Consensus 265 E~~~gg~L~~~l~~~~~~~~~l~e~~~~~~~~qi~~aL~~LH~~gIvHrDLKP~NILl~~~g~vkL~DFGla~~~~~~~~ 344 (543)
T 3c4z_A 265 TIMNGGDIRYHIYNVDEDNPGFQEPRAIFYTAQIVSGLEHLHQRNIIYRDLKPENVLLDDDGNVRISDLGLAVELKAGQT 344 (543)
T ss_dssp CCCTTCBHHHHHHTSSTTSCSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTSCEEECCCTTCEECCTTCC
T ss_pred EeccCCCHHHHHHHhhcccccccHHHHHHHHHHHHHHHHHHHHcCCcccCCChHHEEEeCCCCEEEeecceeeeccCCCc
Confidence 999999999988653 3699999999999999999999999999999999999999999999999999976543222
Q ss_pred -----ccccccccccccccCCCCCCCcccceeeecCCCCCCchHHHHHHHhhcccCCCCCC----ChhhhhhccCcCCCC
Q psy758 157 -----RHLHIFQTNEYFKGVSLPHAENVVPLEIKIGKPAATNIYLIDFLKRCLDKDPLRRW----SCDQLLRHPYFNGYY 227 (292)
Q Consensus 157 -----~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~----~~~~~~~~~~~~~~~ 227 (292)
.++..|.+||...+.......++|++ +.-++..+.+..|+... ...++.....-....
T Consensus 345 ~~~~~~GT~~Y~APE~l~~~~~~~~~DiwSl-------------GvilyelltG~~PF~~~~~~~~~~~~~~~i~~~~~~ 411 (543)
T 3c4z_A 345 KTKGYAGTPGFMAPELLLGEEYDFSVDYFAL-------------GVTLYEMIAARGPFRARGEKVENKELKQRVLEQAVT 411 (543)
T ss_dssp CBCCCCSCTTTSCHHHHTTCCBCTHHHHHHH-------------HHHHHHHHHSSCSSCCTTCCCCHHHHHHHHHHCCCC
T ss_pred ccccccCCccccChhhhcCCCCChHHhcCcc-------------hHHHHHHHhCCCCCCCCccchhHHHHHHHHhhcccC
Confidence 33445666666555433322222222 22233333333343322 122222222222233
Q ss_pred CCCCCccchHHHHhcccCcCCCCCCC-----hhhhhhCCcccceecc
Q psy758 228 FEVPDEMQYEEITQRCLDKDPLRRWS-----CDQLLRHPYFNGYYFE 269 (292)
Q Consensus 228 ~~~~~~~~l~~li~~~l~~dP~~Rpt-----~~~il~h~w~~~~~~~ 269 (292)
.+...+..+.+||.+||+.||.+||+ ++++++||||+++.|+
T Consensus 412 ~p~~~s~~~~~li~~lL~~dP~~R~~~~~~~a~ei~~Hpff~~i~w~ 458 (543)
T 3c4z_A 412 YPDKFSPASKDFCEALLQKDPEKRLGFRDGSCDGLRTHPLFRDISWR 458 (543)
T ss_dssp CCTTSCHHHHHHHHHHSCSSGGGSCCCBTTBSHHHHTSGGGTTCCHH
T ss_pred CCcccCHHHHHHHHHhccCCHhHCCCCcccCHHHHHcCccccCCCHH
Confidence 44566889999999999999999995 5899999999998876
|
| >2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=5.2e-43 Score=282.92 Aligned_cols=252 Identities=23% Similarity=0.240 Sum_probs=192.3
Q ss_pred cccceeeeecccCceEEEEEEEcCCCcEEEEEEeccCCCChHHHHHHHHHHHHHHhCCCCCcchhhhhhhcCCeEEEEEe
Q psy758 2 ERYEKIGKLGEGSYGVVFKCRNRDTGQVVAIKKFLESEEDPLIRKIALREIRLLKSLKHPNLVNLLEVFRRKKKLHLVFE 81 (292)
Q Consensus 2 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~iv~e 81 (292)
++|++.+.||+|++|.||+|.+..+++.||+|++...... ...+.+.+|+.+++.++||||+++++++.+++..++|+|
T Consensus 7 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 85 (276)
T 2yex_A 7 EDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAV-DCPENIKKEICINKMLNHENVVKFYGHRREGNIQYLFLE 85 (276)
T ss_dssp HHEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEGGGCT-THHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred cceEEEEEeecCCCcEEEEEEECCCCcEEEEEEeeeccch-hhhHHHHHHHHHHHhcCCCCceeeeeEEEcCCEEEEEEE
Confidence 6899999999999999999999999999999998755432 235678899999999999999999999999999999999
Q ss_pred cCCCccHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEEccCCcEEEeecCchhhhhccc------
Q psy758 82 FCDHTVLNELENHPHGLPWDLIKQITWQVLRGVSYCHRHACIHRDIKPENILLTANGVVKLCDFGFARLIRDLI------ 155 (292)
Q Consensus 82 ~~~~~~L~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~givH~dl~p~Nilv~~~~~~kl~dfg~~~~~~~~~------ 155 (292)
|+++++|.+++.....+++..++.++.||+.||.|||++|++|+||+|+||+++.++.++|+|||.+.......
T Consensus 86 ~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~ 165 (276)
T 2yex_A 86 YCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHGIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLN 165 (276)
T ss_dssp CCTTEEGGGGSBTTTBCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTCCEEECCCTTCEECEETTEECCBC
T ss_pred ecCCCcHHHHHhhccCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCChHHEEEccCCCEEEeeCCCccccCCCcchhccc
Confidence 99999999999887789999999999999999999999999999999999999999999999999987653211
Q ss_pred -cccccccccccccccCCC-CCCCcccceeeecCCCCCCchHHHHHHHhhcccCCCCCCChhhhhhccCcC---CCCCCC
Q psy758 156 -PRHLHIFQTNEYFKGVSL-PHAENVVPLEIKIGKPAATNIYLIDFLKRCLDKDPLRRWSCDQLLRHPYFN---GYYFEV 230 (292)
Q Consensus 156 -~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~---~~~~~~ 230 (292)
...+..|.+||...+... ....++ ++.+.-++..+.+..|+............+.. ......
T Consensus 166 ~~~~~~~y~aPE~~~~~~~~~~~~Di-------------~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 232 (276)
T 2yex_A 166 KMCGTLPYVAPELLKRREFHAEPVDV-------------WSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKKTYLNPWK 232 (276)
T ss_dssp CCCSCGGGCCGGGGTCSSBCHHHHHH-------------HHHHHHHHHHHHSSCCCSCSCTTSHHHHHHHTTCTTSTTGG
T ss_pred CCccccCccChHHHhcCCCCCCcchH-------------HHHHHHHHHHHhCCCCCCCCchHHHHHHHhhhcccccCchh
Confidence 122344666666544322 111222 22222333344444444433221110000000 011122
Q ss_pred CCccchHHHHhcccCcCCCCCCChhhhhhCCccccee
Q psy758 231 PDEMQYEEITQRCLDKDPLRRWSCDQLLRHPYFNGYY 267 (292)
Q Consensus 231 ~~~~~l~~li~~~l~~dP~~Rpt~~~il~h~w~~~~~ 267 (292)
..+..+.+||.+||+.||.+|||++++++||||++..
T Consensus 233 ~~~~~~~~li~~~l~~~p~~Rps~~~il~~~~~~~~~ 269 (276)
T 2yex_A 233 KIDSAPLALLHKILVENPSARITIPDIKKDRWYNKPL 269 (276)
T ss_dssp GSCHHHHHHHHHHSCSSTTTSCCHHHHTTCTTTTCCC
T ss_pred hcCHHHHHHHHHHCCCCchhCCCHHHHhcCccccChh
Confidence 4577899999999999999999999999999999753
|
| >3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.7e-43 Score=289.97 Aligned_cols=250 Identities=25% Similarity=0.327 Sum_probs=177.6
Q ss_pred ccccee---eeecccCceEEEEEEEcCCCcEEEEEEeccCCCChHHHHHHHHHHHHHHhCC-CCCcchhhhhhhcCCeEE
Q psy758 2 ERYEKI---GKLGEGSYGVVFKCRNRDTGQVVAIKKFLESEEDPLIRKIALREIRLLKSLK-HPNLVNLLEVFRRKKKLH 77 (292)
Q Consensus 2 ~~y~~~---~~l~~g~~~~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~e~~~~~~l~-~~~i~~~~~~~~~~~~~~ 77 (292)
++|.+. +.||+|+||.||+|.+..+++.||+|++... ....+.+|+.+++.+. ||||+++++++.+++..|
T Consensus 8 ~~y~~~~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~-----~~~~~~~e~~~l~~l~~h~niv~~~~~~~~~~~~~ 82 (325)
T 3kn6_A 8 QHYDLDLKDKPLGEGSFSICRKCVHKKSNQAFAVKIISKR-----MEANTQKEITALKLCEGHPNIVKLHEVFHDQLHTF 82 (325)
T ss_dssp HHEEECTTSCCSEEETTEEEEEEEETTTCCEEEEEEEEGG-----GHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEE
T ss_pred hccccccCCCccccCCCeEEEEEEECCCCCEEEEEEEChh-----hhhhHHHHHHHHHHhcCCCCeeEEEEEEEcCCEEE
Confidence 457765 7899999999999999999999999998653 2355678999999997 999999999999999999
Q ss_pred EEEecCCCccHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEEccCC---cEEEeecCchhhhhcc
Q psy758 78 LVFEFCDHTVLNELENHPHGLPWDLIKQITWQVLRGVSYCHRHACIHRDIKPENILLTANG---VVKLCDFGFARLIRDL 154 (292)
Q Consensus 78 iv~e~~~~~~L~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~givH~dl~p~Nilv~~~~---~~kl~dfg~~~~~~~~ 154 (292)
+||||+++++|.+++...+.+++..++.++.||+.||.|||++||+||||||+||+++.++ .++|+|||++......
T Consensus 83 lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~~ivH~Dlkp~NIll~~~~~~~~~kl~Dfg~a~~~~~~ 162 (325)
T 3kn6_A 83 LVMELLNGGELFERIKKKKHFSETEASYIMRKLVSAVSHMHDVGVVHRDLKPENLLFTDENDNLEIKIIDFGFARLKPPD 162 (325)
T ss_dssp EEECCCCSCBHHHHHHHCSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEEEC----CEEEECCCTTCEECCC-
T ss_pred EEEEccCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCHHHEEEecCCCcccEEEeccccceecCCC
Confidence 9999999999999998888899999999999999999999999999999999999998766 8999999999755432
Q ss_pred cc-----ccccccccccccccCCCC-----CCCcccceeeecCCCCCCchHHHHHHHhhcccCCCCCCChhhhhhccCcC
Q psy758 155 IP-----RHLHIFQTNEYFKGVSLP-----HAENVVPLEIKIGKPAATNIYLIDFLKRCLDKDPLRRWSCDQLLRHPYFN 224 (292)
Q Consensus 155 ~~-----~~~~~~~~~~~~~~~~~~-----~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~ 224 (292)
.. ..+..|.+||...+.... |+.|+..+++.+|..++...... .......+++......
T Consensus 163 ~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~-----------~~~~~~~~~~~~i~~~ 231 (325)
T 3kn6_A 163 NQPLKTPCFTLHYAAPELLNQNGYDESCDLWSLGVILYTMLSGQVPFQSHDRS-----------LTCTSAVEIMKKIKKG 231 (325)
T ss_dssp ---------------------CCCCHHHHHHHHHHHHHHHHHSSCTTC------------------CCCHHHHHHHHTTT
T ss_pred CCcccccCCCcCccCHHHhcCCCCCCccchHHHHHHHHHHHhCCCCCCCCccc-----------cccccHHHHHHHHHcC
Confidence 21 223456666665544332 33444444444444443211100 0001112222211111
Q ss_pred CCCCC----CCCccchHHHHhcccCcCCCCCCChhhhhhCCccccee
Q psy758 225 GYYFE----VPDEMQYEEITQRCLDKDPLRRWSCDQLLRHPYFNGYY 267 (292)
Q Consensus 225 ~~~~~----~~~~~~l~~li~~~l~~dP~~Rpt~~~il~h~w~~~~~ 267 (292)
....+ ...+..+.+||.+||+.||.+|||++++++||||++..
T Consensus 232 ~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~ell~h~w~~~~~ 278 (325)
T 3kn6_A 232 DFSFEGEAWKNVSQEAKDLIQGLLTVDPNKRLKMSGLRYNEWLQDGS 278 (325)
T ss_dssp CCCCCSHHHHTSCHHHHHHHHHHHCCCTTTCCCTTTSTTCGGGCTTC
T ss_pred CCCCCcccccCCCHHHHHHHHHHCCCChhHCCCHHHHhcChhhccCc
Confidence 11111 13477899999999999999999999999999999743
|
| >2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=8.3e-44 Score=298.16 Aligned_cols=264 Identities=27% Similarity=0.400 Sum_probs=184.0
Q ss_pred cccceeeeecccCceEEEEEEEcCCCcEEEEEEeccCCCChHHHHHHHHHHHHHHhCCCCCcchhhhhhhcC------Ce
Q psy758 2 ERYEKIGKLGEGSYGVVFKCRNRDTGQVVAIKKFLESEEDPLIRKIALREIRLLKSLKHPNLVNLLEVFRRK------KK 75 (292)
Q Consensus 2 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~------~~ 75 (292)
++|++.+.||+|+||.||+|.+..+|+.||+|++..........+.+.+|+.+++.++||||+++++++... ..
T Consensus 29 ~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~~~~~ 108 (367)
T 2fst_X 29 ERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFND 108 (367)
T ss_dssp TTEEEEEECC----CCEEEEEETTTTEEEEEEECSSTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSGGGCCC
T ss_pred CceEEeeEEeecCCeEEEEEEECCCCCEEEEEEeCccccCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEecCCccccCCe
Confidence 589999999999999999999999999999999977666666778889999999999999999999998643 56
Q ss_pred EEEEEecCCCccHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEEccCCcEEEeecCchhhhhccc
Q psy758 76 LHLVFEFCDHTVLNELENHPHGLPWDLIKQITWQVLRGVSYCHRHACIHRDIKPENILLTANGVVKLCDFGFARLIRDLI 155 (292)
Q Consensus 76 ~~iv~e~~~~~~L~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~givH~dl~p~Nilv~~~~~~kl~dfg~~~~~~~~~ 155 (292)
+|+++|++ +++|..++.. ..+++..++.++.||+.||+|||++||+||||||+||+++.++.+||+|||++.......
T Consensus 109 ~~lv~e~~-~~~L~~~~~~-~~l~~~~~~~i~~qi~~aL~~LH~~givH~Dlkp~NIll~~~~~~kL~DFG~a~~~~~~~ 186 (367)
T 2fst_X 109 VYLVTHLM-GADLNNIVKC-QKLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTADEM 186 (367)
T ss_dssp CEEEEECC-CEECC------CCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTCCEEECC-----------
T ss_pred EEEEeccc-CCCHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCeeeCCCCHhhEEECCCCCEEEeeccccccccccC
Confidence 89999999 5788888775 479999999999999999999999999999999999999999999999999997654321
Q ss_pred --ccccccccccccccc-C-----CCCCCCcccceeeecCCCCCCchHHHHHHHhh---cccCCCC---CCC---hhhhh
Q psy758 156 --PRHLHIFQTNEYFKG-V-----SLPHAENVVPLEIKIGKPAATNIYLIDFLKRC---LDKDPLR---RWS---CDQLL 218 (292)
Q Consensus 156 --~~~~~~~~~~~~~~~-~-----~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~---~~~~p~~---~~~---~~~~~ 218 (292)
...+..|.+||...+ . ...|+.|+..+++.+|..++......+.+..+ ++..+.. ... ....+
T Consensus 187 ~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~l~~i~~~~g~p~~~~~~~~~~~~~~~~~ 266 (367)
T 2fst_X 187 TGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARNYI 266 (367)
T ss_dssp ----CCCTTCCHHHHTTCCSCCTTHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCHHHHTTCCCHHHHHHH
T ss_pred CCcCcCcCccChHHHcCCcCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHHhhhHHHHHHH
Confidence 233456788887655 2 23466666667777777766544433333222 2221100 000 00000
Q ss_pred hc-cCcCCCC---CCCCCccchHHHHhcccCcCCCCCCChhhhhhCCccccee
Q psy758 219 RH-PYFNGYY---FEVPDEMQYEEITQRCLDKDPLRRWSCDQLLRHPYFNGYY 267 (292)
Q Consensus 219 ~~-~~~~~~~---~~~~~~~~l~~li~~~l~~dP~~Rpt~~~il~h~w~~~~~ 267 (292)
.. +...... .....++.+.+||.+||+.||.+|||++|+|+||||++..
T Consensus 267 ~~~~~~~~~~~~~~~~~~~~~~~dLl~~mL~~dP~~R~t~~e~L~hp~~~~~~ 319 (367)
T 2fst_X 267 QSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQYH 319 (367)
T ss_dssp HTSCCCCCCCHHHHTTTCCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGTTTC
T ss_pred hccCCCCCCCHHHHCCCCCHHHHHHHHHhCCCCcccCcCHHHHhcChhhhhcc
Confidence 00 0000000 0113467899999999999999999999999999999754
|
| >2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-43 Score=297.95 Aligned_cols=262 Identities=26% Similarity=0.392 Sum_probs=190.8
Q ss_pred cccceeeeecccCceEEEEEEEcCCCcEEEEEEeccCCCChHHHHHHHHHHHHHHhCCCCCcchhhhhhhcCC------e
Q psy758 2 ERYEKIGKLGEGSYGVVFKCRNRDTGQVVAIKKFLESEEDPLIRKIALREIRLLKSLKHPNLVNLLEVFRRKK------K 75 (292)
Q Consensus 2 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~------~ 75 (292)
++|++++.||+|+||.||+|.+..+++.||+|++..........+.+.+|+.+++.++||||+++++++...+ .
T Consensus 25 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~ 104 (371)
T 2xrw_A 25 KRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLLNVFTPQKSLEEFQD 104 (371)
T ss_dssp TTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEECTTSSHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSCCSTTTCCE
T ss_pred hheeEeeeeEecCCEEEEEEEECCCCceEEEEEeccccCChHHHHHHHHHHHHHHhcCCCCccceEEeeccccccccccc
Confidence 6899999999999999999999999999999999876666667788899999999999999999999987554 7
Q ss_pred EEEEEecCCCccHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEEccCCcEEEeecCchhhhhcc-
Q psy758 76 LHLVFEFCDHTVLNELENHPHGLPWDLIKQITWQVLRGVSYCHRHACIHRDIKPENILLTANGVVKLCDFGFARLIRDL- 154 (292)
Q Consensus 76 ~~iv~e~~~~~~L~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~givH~dl~p~Nilv~~~~~~kl~dfg~~~~~~~~- 154 (292)
.|+||||++++ |.+.+.. .+++..++.++.||+.||.|||++||+||||||+||+++.++.+||+|||++......
T Consensus 105 ~~lv~e~~~~~-l~~~~~~--~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dlkp~NIl~~~~~~~kl~Dfg~a~~~~~~~ 181 (371)
T 2xrw_A 105 VYIVMELMDAN-LCQVIQM--ELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSF 181 (371)
T ss_dssp EEEEEECCSEE-HHHHHHS--CCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTSCEEECCCCC--------
T ss_pred eEEEEEcCCCC-HHHHHhh--ccCHHHHHHHHHHHHHHHHHHHHCCeecccCCHHHEEEcCCCCEEEEEeeccccccccc
Confidence 89999999975 5555553 5999999999999999999999999999999999999999999999999999766432
Q ss_pred ---ccccccccccccccccCCC-----CCCCcccceeeecCCCCCCchHHHHHHHhhcccCCCCCCC--------hhhhh
Q psy758 155 ---IPRHLHIFQTNEYFKGVSL-----PHAENVVPLEIKIGKPAATNIYLIDFLKRCLDKDPLRRWS--------CDQLL 218 (292)
Q Consensus 155 ---~~~~~~~~~~~~~~~~~~~-----~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~--------~~~~~ 218 (292)
....+..|.+||...+... .|+.|+..+++.+|..++......+.+..+........+. .....
T Consensus 182 ~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~ 261 (371)
T 2xrw_A 182 MMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKGGVLFPGTDHIDQWNKVIEQLGTPCPEFMKKLQPTVRTYV 261 (371)
T ss_dssp --------CTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHC-CCCCCHHHHTTSCHHHHHHH
T ss_pred ccCCceecCCccCHHHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHHhhhHHHHHH
Confidence 1233456788887766544 3555666666777776665444333333332211100000 00000
Q ss_pred -hccCcCC---------CCCCCC------CccchHHHHhcccCcCCCCCCChhhhhhCCcccce
Q psy758 219 -RHPYFNG---------YYFEVP------DEMQYEEITQRCLDKDPLRRWSCDQLLRHPYFNGY 266 (292)
Q Consensus 219 -~~~~~~~---------~~~~~~------~~~~l~~li~~~l~~dP~~Rpt~~~il~h~w~~~~ 266 (292)
..+.+.. ...+.. .+..+.+||.+||+.||++|||++|+++||||+..
T Consensus 262 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R~t~~e~l~hp~~~~~ 325 (371)
T 2xrw_A 262 ENRPKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKRISVDEALQHPYINVW 325 (371)
T ss_dssp HSSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSGGGSCCHHHHHHSHHHHTT
T ss_pred hhCccccccchhhhcccccCcccccccccccHHHHHHHHHHCcCChhhCCCHHHHhCCcchhhh
Confidence 0000000 001111 15578999999999999999999999999999864
|
| >2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-43 Score=290.36 Aligned_cols=248 Identities=25% Similarity=0.392 Sum_probs=187.1
Q ss_pred cccceeeeecccCceEEEEEEEcCCCcEEEEEEeccCCCChHHHHHHHHHHHHHHhCCCCCcchhhhhhhcCCeEEEEEe
Q psy758 2 ERYEKIGKLGEGSYGVVFKCRNRDTGQVVAIKKFLESEEDPLIRKIALREIRLLKSLKHPNLVNLLEVFRRKKKLHLVFE 81 (292)
Q Consensus 2 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~iv~e 81 (292)
++|++++.||+|++|.||+|.+..+++.|++|++...... ..+.+.+|+.+++.++||||+++++++.+++..++|+|
T Consensus 19 ~~y~i~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~--~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 96 (302)
T 2j7t_A 19 EVWEIVGELGDGAFGKVYKAKNKETGALAAAKVIETKSEE--ELEDYIVEIEILATCDHPYIVKLLGAYYHDGKLWIMIE 96 (302)
T ss_dssp GTEEEEEEEECSTTCCEEEEEETTTCCEEEEEEEC----C--CHHHHHHHHHHHHHCCCTTBCCEEEEEECC-CEEEEEE
T ss_pred cceeecceeccCCCeEEEEEEEcCCCcEEEEEEecCCCHH--HHHHHHHHHHHHhcCCCCCEeeeeeeeeeCCeEEEEEE
Confidence 5799999999999999999999999999999998655322 24567889999999999999999999999999999999
Q ss_pred cCCCccHHHHhcC-CCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEEccCCcEEEeecCchhhhhcc-----c
Q psy758 82 FCDHTVLNELENH-PHGLPWDLIKQITWQVLRGVSYCHRHACIHRDIKPENILLTANGVVKLCDFGFARLIRDL-----I 155 (292)
Q Consensus 82 ~~~~~~L~~~~~~-~~~~~~~~~~~i~~qi~~aL~~LH~~givH~dl~p~Nilv~~~~~~kl~dfg~~~~~~~~-----~ 155 (292)
|+++++|..++.. ...+++..++.++.||+.||.|||++|++|+||+|+||+++.++.++|+|||++...... .
T Consensus 97 ~~~~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~ 176 (302)
T 2j7t_A 97 FCPGGAVDAIMLELDRGLTEPQIQVVCRQMLEALNFLHSKRIIHRDLKAGNVLMTLEGDIRLADFGVSAKNLKTLQKRDS 176 (302)
T ss_dssp CCTTEEHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCSGGGEEECTTSCEEECCCHHHHHHHHHHHC---
T ss_pred eCCCCcHHHHHHhhccCCCHHHHHHHHHHHHHHHHHHhcCCcccCCCCHHHEEECCCCCEEEEECCCCcccccccccccc
Confidence 9999999988754 456999999999999999999999999999999999999999999999999987654321 1
Q ss_pred cccccccccccccc-----cCCC-----CCCCcccceeeecCCCCCCchHHHHHHHhhcccCCCCCCChhhhhhccC---
Q psy758 156 PRHLHIFQTNEYFK-----GVSL-----PHAENVVPLEIKIGKPAATNIYLIDFLKRCLDKDPLRRWSCDQLLRHPY--- 222 (292)
Q Consensus 156 ~~~~~~~~~~~~~~-----~~~~-----~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~--- 222 (292)
...+..|.+||... +... .|+.|+..+++.++. .|.......+......
T Consensus 177 ~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~------------------~p~~~~~~~~~~~~~~~~~ 238 (302)
T 2j7t_A 177 FIGTPYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQIE------------------PPHHELNPMRVLLKIAKSD 238 (302)
T ss_dssp --CCGGGCCHHHHHHHHTTSTTTTTHHHHHHHHHHHHHHHHSS------------------CTTTTSCHHHHHHHHHHSC
T ss_pred ccCChhhcCCeeeccccCCCCCCchhhhHHHHHHHHHHHhcCC------------------CCCccCCHHHHHHHHhccC
Confidence 23345567777653 2222 233333333444443 3433333222221110
Q ss_pred cCCCCCCCCCccchHHHHhcccCcCCCCCCChhhhhhCCcccceecc
Q psy758 223 FNGYYFEVPDEMQYEEITQRCLDKDPLRRWSCDQLLRHPYFNGYYFE 269 (292)
Q Consensus 223 ~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~~il~h~w~~~~~~~ 269 (292)
......+...+..+.+||.+||+.||.+|||+.++++||||++..+.
T Consensus 239 ~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~h~~~~~~~~~ 285 (302)
T 2j7t_A 239 PPTLLTPSKWSVEFRDFLKIALDKNPETRPSAAQLLEHPFVSSITSN 285 (302)
T ss_dssp CCCCSSGGGSCHHHHHHHHHHSCSCTTTSCCHHHHTTSTTTTTCCCC
T ss_pred CcccCCccccCHHHHHHHHHHcccChhhCCCHHHHhcChHHhhhccc
Confidence 00111223346789999999999999999999999999999986654
|
| >1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.5e-44 Score=295.87 Aligned_cols=250 Identities=27% Similarity=0.386 Sum_probs=189.3
Q ss_pred cccceeeeecccCceEEEEEEEcCCCcEEEEEEeccCCC-ChHHHHHHHHHHHHHHhCCCCCcchhhhhhhcCCeEEEEE
Q psy758 2 ERYEKIGKLGEGSYGVVFKCRNRDTGQVVAIKKFLESEE-DPLIRKIALREIRLLKSLKHPNLVNLLEVFRRKKKLHLVF 80 (292)
Q Consensus 2 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~v~iK~~~~~~~-~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~iv~ 80 (292)
++|++.+.||+|+||.||+|.+..+++.||+|++..... .....+.+.+|+.+++.++||||+++++++.+++..++||
T Consensus 54 ~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~ 133 (348)
T 1u5q_A 54 KLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLVM 133 (348)
T ss_dssp HHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEESCSSCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEE
T ss_pred hheeeeeEEccCCCEEEEEEEEccCCeEEEEEEEccccccchHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCeEEEEE
Confidence 358999999999999999999999999999999976543 3445577889999999999999999999999999999999
Q ss_pred ecCCCccHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEEccCCcEEEeecCchhhhhccc-cccc
Q psy758 81 EFCDHTVLNELENHPHGLPWDLIKQITWQVLRGVSYCHRHACIHRDIKPENILLTANGVVKLCDFGFARLIRDLI-PRHL 159 (292)
Q Consensus 81 e~~~~~~L~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~givH~dl~p~Nilv~~~~~~kl~dfg~~~~~~~~~-~~~~ 159 (292)
||+.|+.+..+......+++..++.++.|++.||.|||++|++||||||+||+++.++.+||+|||++....... ..++
T Consensus 134 e~~~g~l~~~l~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~kL~DfG~a~~~~~~~~~~gt 213 (348)
T 1u5q_A 134 EYCLGSASDLLEVHKKPLQEVEIAAVTHGALQGLAYLHSHNMIHRDVKAGNILLSEPGLVKLGDFGSASIMAPANSFVGT 213 (348)
T ss_dssp ECCSEEHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCSGGGEEEETTTEEEECCCTTCBSSSSBCCCCSC
T ss_pred ecCCCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeeeCCCCHHHEEECCCCCEEEeeccCceecCCCCcccCC
Confidence 999965544444445679999999999999999999999999999999999999999999999999987654322 2334
Q ss_pred ccccccccccc---CC-----CCCCCcccceeeecCCCCCCchHHHHHHHhhcccCCCCCCChhhhhhccCcCCCCCCCC
Q psy758 160 HIFQTNEYFKG---VS-----LPHAENVVPLEIKIGKPAATNIYLIDFLKRCLDKDPLRRWSCDQLLRHPYFNGYYFEVP 231 (292)
Q Consensus 160 ~~~~~~~~~~~---~~-----~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~ 231 (292)
..|.+||...+ .. ..|+.|+..+++.++..++........+....... ........
T Consensus 214 ~~y~aPE~~~~~~~~~~~~~~DiwslG~il~ell~g~~p~~~~~~~~~~~~~~~~~----------------~~~~~~~~ 277 (348)
T 1u5q_A 214 PYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNE----------------SPALQSGH 277 (348)
T ss_dssp GGGCCHHHHHTTSSCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHSC----------------CCCCCCTT
T ss_pred cceeCHhhhccccCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhcC----------------CCCCCCCC
Confidence 55777776532 11 22444444444444444432222111111111100 00011223
Q ss_pred CccchHHHHhcccCcCCCCCCChhhhhhCCccccee
Q psy758 232 DEMQYEEITQRCLDKDPLRRWSCDQLLRHPYFNGYY 267 (292)
Q Consensus 232 ~~~~l~~li~~~l~~dP~~Rpt~~~il~h~w~~~~~ 267 (292)
.+..+.+||.+||+.||++|||++++++||||....
T Consensus 278 ~~~~l~~li~~~l~~dP~~Rps~~~ll~h~~~~~~~ 313 (348)
T 1u5q_A 278 WSEYFRNFVDSCLQKIPQDRPTSEVLLKHRFVLRER 313 (348)
T ss_dssp SCHHHHHHHHHHTCSSGGGSCCHHHHTTCHHHHSCC
T ss_pred CCHHHHHHHHHHcccChhhCcCHHHHhhChhhhccC
Confidence 477899999999999999999999999999998744
|
| >2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A | Back alignment and structure |
|---|
Probab=100.00 E-value=8.7e-44 Score=295.28 Aligned_cols=243 Identities=23% Similarity=0.348 Sum_probs=185.4
Q ss_pred cccceeeeecccCceEEEEEEEcCCCcEEEEEEeccCCCChHHHHHHHHHHHHHHhC-CCCCcchhhhhhhcCCeEEEEE
Q psy758 2 ERYEKIGKLGEGSYGVVFKCRNRDTGQVVAIKKFLESEEDPLIRKIALREIRLLKSL-KHPNLVNLLEVFRRKKKLHLVF 80 (292)
Q Consensus 2 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~e~~~~~~l-~~~~i~~~~~~~~~~~~~~iv~ 80 (292)
++|++.+.||+|+||.||+|.+..+++.||+|++...... ..+|++++..+ +||||+++++++.+++.+|+||
T Consensus 22 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~------~~~E~~~l~~~~~hp~iv~~~~~~~~~~~~~lv~ 95 (342)
T 2qr7_A 22 DGYEVKEDIGVGSYSVCKRCIHKATNMEFAVKIIDKSKRD------PTEEIEILLRYGQHPNIITLKDVYDDGKYVYVVT 95 (342)
T ss_dssp HHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTTCC------CHHHHHHHHHHTTSTTBCCEEEEEECSSEEEEEE
T ss_pred ccEEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEcccCC------hHHHHHHHHHhcCCCCcCeEEEEEEcCCEEEEEE
Confidence 5799999999999999999999999999999999765432 34577888777 7999999999999999999999
Q ss_pred ecCCCccHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEEccC----CcEEEeecCchhhhhcccc
Q psy758 81 EFCDHTVLNELENHPHGLPWDLIKQITWQVLRGVSYCHRHACIHRDIKPENILLTAN----GVVKLCDFGFARLIRDLIP 156 (292)
Q Consensus 81 e~~~~~~L~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~givH~dl~p~Nilv~~~----~~~kl~dfg~~~~~~~~~~ 156 (292)
||+.|++|.+.+...+.+++..++.++.||+.||.|||++||+||||||+||++.++ +.+||+|||++........
T Consensus 96 E~~~gg~L~~~i~~~~~~~~~~~~~~~~qi~~al~~lH~~givHrDlkp~NIl~~~~~~~~~~~kl~Dfg~a~~~~~~~~ 175 (342)
T 2qr7_A 96 ELMKGGELLDKILRQKFFSEREASAVLFTITKTVEYLHAQGVVHRDLKPSNILYVDESGNPESIRICDFGFAKQLRAENG 175 (342)
T ss_dssp CCCCSCBHHHHHHTCTTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEESSSSCSGGGEEECCCTTCEECBCTTC
T ss_pred eCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCcEeccCCHHHEEEecCCCCcCeEEEEECCCcccCcCCCC
Confidence 999999999999888889999999999999999999999999999999999998543 3599999999976543222
Q ss_pred -----ccccccccccccccC-----CCCCCCcccceeeecCCCCCCchHHHHHHHhhcccCCCCCCChhhhhhc----cC
Q psy758 157 -----RHLHIFQTNEYFKGV-----SLPHAENVVPLEIKIGKPAATNIYLIDFLKRCLDKDPLRRWSCDQLLRH----PY 222 (292)
Q Consensus 157 -----~~~~~~~~~~~~~~~-----~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~----~~ 222 (292)
..+..|.+||...+. ...|+.|+..+++.+|..++... ...+..+++.. .+
T Consensus 176 ~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~---------------~~~~~~~~~~~i~~~~~ 240 (342)
T 2qr7_A 176 LLMTPCYTANFVAPEVLERQGYDAACDIWSLGVLLYTMLTGYTPFANG---------------PDDTPEEILARIGSGKF 240 (342)
T ss_dssp CBCCSSCCSSCCCHHHHHHHHHHHHHHHHHHHHHHHHHHHSSCSSCSS---------------TTSCHHHHHHHHHHCCC
T ss_pred ceeccCCCccccCHHHhcCCCCCCccCeeeHhHHHHHHhcCCCCCCCC---------------CcCCHHHHHHHHccCCc
Confidence 223345555554332 22355555555555555443210 00122222211 11
Q ss_pred cCCCCCCCCCccchHHHHhcccCcCCCCCCChhhhhhCCcccc
Q psy758 223 FNGYYFEVPDEMQYEEITQRCLDKDPLRRWSCDQLLRHPYFNG 265 (292)
Q Consensus 223 ~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~~il~h~w~~~ 265 (292)
..........+..+.+||.+||+.||.+|||+.++++||||.+
T Consensus 241 ~~~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~~il~hp~~~~ 283 (342)
T 2qr7_A 241 SLSGGYWNSVSDTAKDLVSKMLHVDPHQRLTAALVLRHPWIVH 283 (342)
T ss_dssp CCCSTTTTTSCHHHHHHHHHHTCSSTTTSCCHHHHTTSHHHHT
T ss_pred ccCccccccCCHHHHHHHHHHCCCChhHCcCHHHHhcCCeecC
Confidence 1111122346789999999999999999999999999999976
|
| >3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-43 Score=287.48 Aligned_cols=255 Identities=26% Similarity=0.348 Sum_probs=193.1
Q ss_pred cccceeeeecccCceEEEEEEEcCCCcEEEEEEeccCCCCh----HHHHHHHHHHHHHHhCCCCCcchhhhhhhcCCeEE
Q psy758 2 ERYEKIGKLGEGSYGVVFKCRNRDTGQVVAIKKFLESEEDP----LIRKIALREIRLLKSLKHPNLVNLLEVFRRKKKLH 77 (292)
Q Consensus 2 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~v~iK~~~~~~~~~----~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~ 77 (292)
++|++.+.||+|++|.||+|.+..+++.||+|++....... ...+.+.+|+.+++.++||||+++++++.+.+..+
T Consensus 5 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~ 84 (283)
T 3bhy_A 5 DHYEMGEELGSGQFAIVRKCRQKGTGKEYAAKFIKKRRLSSSRRGVSREEIEREVNILREIRHPNIITLHDIFENKTDVV 84 (283)
T ss_dssp HHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEE
T ss_pred hhhhhHHhhcccCceEEEEEEEcCCCCeeehHHhhhccccccccchHHHHHHHHHHHHHhCCCCCeeehhheecCCCeEE
Confidence 57999999999999999999999999999999987554221 13566889999999999999999999999999999
Q ss_pred EEEecCCCccHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEEccCC----cEEEeecCchhhhhc
Q psy758 78 LVFEFCDHTVLNELENHPHGLPWDLIKQITWQVLRGVSYCHRHACIHRDIKPENILLTANG----VVKLCDFGFARLIRD 153 (292)
Q Consensus 78 iv~e~~~~~~L~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~givH~dl~p~Nilv~~~~----~~kl~dfg~~~~~~~ 153 (292)
+||||+++++|.+++.....+++..++.++.||+.||.|||++|++|+||+|+||+++.++ .++|+|||++.....
T Consensus 85 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~~~~~kl~dfg~~~~~~~ 164 (283)
T 3bhy_A 85 LILELVSGGELFDFLAEKESLTEDEATQFLKQILDGVHYLHSKRIAHFDLKPENIMLLDKNVPNPRIKLIDFGIAHKIEA 164 (283)
T ss_dssp EEEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEESCSSSSSCCEEECCCTTCEECC-
T ss_pred EEEeecCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCccCCCCChHHEEEecCCCCCCceEEEecccceeccC
Confidence 9999999999999997767899999999999999999999999999999999999999877 899999999876543
Q ss_pred cc----cccccccccccccccCCCCCCCcccceeeecCCCCCCchHHHHHHHhhcccCCCCCCChhhhhhccCcCCCC--
Q psy758 154 LI----PRHLHIFQTNEYFKGVSLPHAENVVPLEIKIGKPAATNIYLIDFLKRCLDKDPLRRWSCDQLLRHPYFNGYY-- 227 (292)
Q Consensus 154 ~~----~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~-- 227 (292)
.. ...+..|.+||...+.......++|++ +.-++..+.+..|....+..+.+.........
T Consensus 165 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~sl-------------G~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~ 231 (283)
T 3bhy_A 165 GNEFKNIFGTPEFVAPEIVNYEPLGLEADMWSI-------------GVITYILLSGASPFLGETKQETLTNISAVNYDFD 231 (283)
T ss_dssp -------CCCGGGCCHHHHTTCCCCTHHHHHHH-------------HHHHHHHHHSSCTTCCSSHHHHHHHHHTTCCCCC
T ss_pred CCcccccCCCcCccCcceecCCCCCcchhhhhH-------------HHHHHHHHHCCCCCCCcchHHHHHHhHhcccCCc
Confidence 21 123345666666554433222222222 22233333344444433333322211101111
Q ss_pred --CCCCCccchHHHHhcccCcCCCCCCChhhhhhCCcccceecc
Q psy758 228 --FEVPDEMQYEEITQRCLDKDPLRRWSCDQLLRHPYFNGYYFE 269 (292)
Q Consensus 228 --~~~~~~~~l~~li~~~l~~dP~~Rpt~~~il~h~w~~~~~~~ 269 (292)
.....+..+.+||.+||+.||.+|||+.++++||||++..+.
T Consensus 232 ~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~~l~h~~~~~~~~~ 275 (283)
T 3bhy_A 232 EEYFSNTSELAKDFIRRLLVKDPKRRMTIAQSLEHSWIKAIRRR 275 (283)
T ss_dssp HHHHTTCCHHHHHHHHTTSCSSGGGSCCHHHHHHCHHHHHHHHC
T ss_pred chhcccCCHHHHHHHHHHccCCHhHCcCHHHHHhCHHHHHHHHH
Confidence 112346789999999999999999999999999999987544
|
| >4exu_A Mitogen-activated protein kinase 13; P38 kinase, transferase; 1.70A {Homo sapiens} PDB: 4eyj_A* 4eym_A* 3coi_A | Back alignment and structure |
|---|
Probab=100.00 E-value=6.5e-43 Score=293.67 Aligned_cols=263 Identities=24% Similarity=0.379 Sum_probs=194.6
Q ss_pred cccceeeeecccCceEEEEEEEcCCCcEEEEEEeccCCCChHHHHHHHHHHHHHHhCCCCCcchhhhhhhcCCeE-----
Q psy758 2 ERYEKIGKLGEGSYGVVFKCRNRDTGQVVAIKKFLESEEDPLIRKIALREIRLLKSLKHPNLVNLLEVFRRKKKL----- 76 (292)
Q Consensus 2 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~----- 76 (292)
++|.+.+.||+|+||.||+|.+..+|+.||+|++..........+.+.+|+.+++.++||||+++++++...+..
T Consensus 42 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~ 121 (371)
T 4exu_A 42 KTYVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQSEIFAKRAYRELLLLKHMQHENVIGLLDVFTPASSLRNFYD 121 (371)
T ss_dssp TTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSSTTCCC
T ss_pred ccEEEEeEEecCCCeEEEEEEECCCCCEEEEEEecccccchhHHHHHHHHHHHHHhcCCCCchhhhhheeccCCccccee
Confidence 589999999999999999999999999999999987776777778899999999999999999999999876654
Q ss_pred -EEEEecCCCccHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEEccCCcEEEeecCchhhhhccc
Q psy758 77 -HLVFEFCDHTVLNELENHPHGLPWDLIKQITWQVLRGVSYCHRHACIHRDIKPENILLTANGVVKLCDFGFARLIRDLI 155 (292)
Q Consensus 77 -~iv~e~~~~~~L~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~givH~dl~p~Nilv~~~~~~kl~dfg~~~~~~~~~ 155 (292)
++||||+.+ +|...+.. .+++..++.++.||+.||+|||++||+||||||+||+++.++.++|+|||++.......
T Consensus 122 ~~lv~e~~~~-~l~~~~~~--~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dikp~NIll~~~~~~kL~Dfg~a~~~~~~~ 198 (371)
T 4exu_A 122 FYLVMPFMQT-DLQKIMGM--EFSEEKIQYLVYQMLKGLKYIHSAGVVHRDLKPGNLAVNEDCELKILDFGLARHADAEM 198 (371)
T ss_dssp CEEEEECCCE-EHHHHTTS--CCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTCCEEECSTTCC-------
T ss_pred EEEEEccccc-cHHHHhhc--CCCHHHHHHHHHHHHHHHHHHHHCCCcCCCcCHHHeEECCCCCEEEEecCcccccccCc
Confidence 999999995 67777653 59999999999999999999999999999999999999999999999999997664322
Q ss_pred --ccccccccccccccc-CC-----CCCCCcccceeeecCCCCCCchHHHHHHHhhcc---cCCCCC---C---Chhhhh
Q psy758 156 --PRHLHIFQTNEYFKG-VS-----LPHAENVVPLEIKIGKPAATNIYLIDFLKRCLD---KDPLRR---W---SCDQLL 218 (292)
Q Consensus 156 --~~~~~~~~~~~~~~~-~~-----~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~---~~p~~~---~---~~~~~~ 218 (292)
...+..|.+||...+ .. ..|+.|+..+++.+|..++......+.+..++. ..+... . ......
T Consensus 199 ~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~ 278 (371)
T 4exu_A 199 TGYVVTRWYRAPEVILSWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQLTQILKVTGVPGTEFVQKLNDKAAKSYI 278 (371)
T ss_dssp -CTTCCCTTSCHHHHSCCSCCCTTHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCHHHHTTCSCHHHHHHH
T ss_pred CCcccCccccCHHHhcCCCCCCcHHhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCcHHHHHHhhhhhhhhhh
Confidence 233456778877655 22 235566666667777766654443333333221 111000 0 000000
Q ss_pred hcc-CcCC---CCCCCCCccchHHHHhcccCcCCCCCCChhhhhhCCccccee
Q psy758 219 RHP-YFNG---YYFEVPDEMQYEEITQRCLDKDPLRRWSCDQLLRHPYFNGYY 267 (292)
Q Consensus 219 ~~~-~~~~---~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~~il~h~w~~~~~ 267 (292)
... .... .......+..+.+||.+||+.||.+|||++|+++||||++..
T Consensus 279 ~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~f~~~~ 331 (371)
T 4exu_A 279 QSLPQTPRKDFTQLFPRASPQAADLLEKMLELDVDKRLTAAQALTHPFFEPFR 331 (371)
T ss_dssp HHSCCCCCCCHHHHSTTSCHHHHHHHHHHSCSCTTTSCCHHHHHTSGGGTTTC
T ss_pred hccCCCcchhHHHhccccChHHHHHHHHHCCCChhhcCCHHHHhcCcccccCC
Confidence 000 0000 001123477899999999999999999999999999999754
|
| >3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-43 Score=302.58 Aligned_cols=247 Identities=22% Similarity=0.303 Sum_probs=181.6
Q ss_pred cccceeeeecccCceEEEEEEEcCCCcEEEEEEeccCCC------ChHHHHHHHHHHHHHHhCCCCCcchhhhhhhcCCe
Q psy758 2 ERYEKIGKLGEGSYGVVFKCRNRDTGQVVAIKKFLESEE------DPLIRKIALREIRLLKSLKHPNLVNLLEVFRRKKK 75 (292)
Q Consensus 2 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~v~iK~~~~~~~------~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~ 75 (292)
++|.+.+.||+|+||.||+|.+..+++.||+|++..... .......+.+|+.+++.++||||+++++++. .+.
T Consensus 135 ~~y~~~~~LG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~-~~~ 213 (419)
T 3i6u_A 135 DEYIMSKTLGSGACGEVKLAFERKTCKKVAIRIISKRKFAIGSAREADPALNVETEIEILKKLNHPCIIKIKNFFD-AED 213 (419)
T ss_dssp TTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEGGGGTTC--------CCHHHHHHHHHHCCCTTBCCCCEEEE-SSE
T ss_pred ccEEEEeEEeeCCCeEEEEEEECCCCcEEEEEEEEechhcccccccchhHHHHHHHHHHHHhCCCCCEeeEEEEEe-cCc
Confidence 579999999999999999999999999999999875431 1222345788999999999999999999875 456
Q ss_pred EEEEEecCCCccHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEEccCC---cEEEeecCchhhhh
Q psy758 76 LHLVFEFCDHTVLNELENHPHGLPWDLIKQITWQVLRGVSYCHRHACIHRDIKPENILLTANG---VVKLCDFGFARLIR 152 (292)
Q Consensus 76 ~~iv~e~~~~~~L~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~givH~dl~p~Nilv~~~~---~~kl~dfg~~~~~~ 152 (292)
.++||||+++++|.+++...+.+++..++.++.||+.||+|||++||+||||||+||+++.++ .+||+|||++....
T Consensus 214 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~~ivHrDlkp~NIll~~~~~~~~~kl~DFG~a~~~~ 293 (419)
T 3i6u_A 214 YYIVLELMEGGELFDKVVGNKRLKEATCKLYFYQMLLAVQYLHENGIIHRDLKPENVLLSSQEEDCLIKITDFGHSKILG 293 (419)
T ss_dssp EEEEEECCTTCBGGGGTSSSCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEESSSSSSCCEEECCSSTTTSCC
T ss_pred eEEEEEcCCCCcHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCChHhEEEecCCCcceEEEeecccceecC
Confidence 899999999999999998888899999999999999999999999999999999999997654 59999999998764
Q ss_pred ccc----ccccccccccccccc---CC-----CCCCCcccceeeecCCCCCCchHHHHHHHhhcccCCCCCCC----hhh
Q psy758 153 DLI----PRHLHIFQTNEYFKG---VS-----LPHAENVVPLEIKIGKPAATNIYLIDFLKRCLDKDPLRRWS----CDQ 216 (292)
Q Consensus 153 ~~~----~~~~~~~~~~~~~~~---~~-----~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~----~~~ 216 (292)
... ..++..|.+||...+ .. ..|+.|+..+++.+ +..|+.... ..+
T Consensus 294 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~DiwslG~il~~llt------------------g~~pf~~~~~~~~~~~ 355 (419)
T 3i6u_A 294 ETSLMRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLS------------------GYPPFSEHRTQVSLKD 355 (419)
T ss_dssp -----------CTTCCTTTTC----CTTHHHHHHHHHHHHHHHHHH------------------SSCSSCCCSSSCCHHH
T ss_pred CCccccccCCCCCccCceeeecCCCCCCCchhhhHhHHHHHHHHHH------------------CCCCCCCCcchHHHHH
Confidence 322 122344666665432 11 12333333333333 444433221 111
Q ss_pred hhhccCcCCC-CCCCCCccchHHHHhcccCcCCCCCCChhhhhhCCccccee
Q psy758 217 LLRHPYFNGY-YFEVPDEMQYEEITQRCLDKDPLRRWSCDQLLRHPYFNGYY 267 (292)
Q Consensus 217 ~~~~~~~~~~-~~~~~~~~~l~~li~~~l~~dP~~Rpt~~~il~h~w~~~~~ 267 (292)
.+....+... ......+..+.+||.+||+.||.+|||++|+++||||++..
T Consensus 356 ~i~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~e~l~hp~~~~~~ 407 (419)
T 3i6u_A 356 QITSGKYNFIPEVWAEVSEKALDLVKKLLVVDPKARFTTEEALRHPWLQDED 407 (419)
T ss_dssp HHHTTCCCCCHHHHTTSCHHHHHHHHHHSCSSTTTSCCHHHHHHSGGGCCHH
T ss_pred HHhcCCCCCCchhhcccCHHHHHHHHHHccCChhHCcCHHHHhCCcccCChh
Confidence 2111111100 01123577899999999999999999999999999999744
|
| >2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.5e-43 Score=287.83 Aligned_cols=251 Identities=23% Similarity=0.318 Sum_probs=189.8
Q ss_pred cccceeeeecccCceEEEEEEEcCCCcEEEEEEeccCCCChHHHHHHHHHHHHHHhCCCCCcchhhhhhhcCCeEEEEEe
Q psy758 2 ERYEKIGKLGEGSYGVVFKCRNRDTGQVVAIKKFLESEEDPLIRKIALREIRLLKSLKHPNLVNLLEVFRRKKKLHLVFE 81 (292)
Q Consensus 2 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~iv~e 81 (292)
++|++.+.||+|++|.||+|.+..+|+.||+|++...... ....+.+|+.+++.++||||+++++++.+.+..++|||
T Consensus 9 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~--~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 86 (304)
T 2jam_A 9 KTFIFMEVLGSGAFSEVFLVKQRLTGKLFALKCIKKSPAF--RDSSLENEIAVLKKIKHENIVTLEDIYESTTHYYLVMQ 86 (304)
T ss_dssp HHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEECC--------HHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEEC
T ss_pred ccceeeeeccCCCCceEEEEEECCCCCEEEEEEEeccccc--chHHHHHHHHHHHhCCCCCeeehhhhcccCCEEEEEEE
Confidence 5799999999999999999999999999999999754322 23567899999999999999999999999999999999
Q ss_pred cCCCccHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEE---ccCCcEEEeecCchhhhhccc---
Q psy758 82 FCDHTVLNELENHPHGLPWDLIKQITWQVLRGVSYCHRHACIHRDIKPENILL---TANGVVKLCDFGFARLIRDLI--- 155 (292)
Q Consensus 82 ~~~~~~L~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~givH~dl~p~Nilv---~~~~~~kl~dfg~~~~~~~~~--- 155 (292)
|+++++|.+++...+.+++..++.++.||+.||.|||++|++|+||+|+||++ +.++.++|+|||++.......
T Consensus 87 ~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dikp~NIl~~~~~~~~~~kl~Dfg~~~~~~~~~~~~ 166 (304)
T 2jam_A 87 LVSGGELFDRILERGVYTEKDASLVIQQVLSAVKYLHENGIVHRDLKPENLLYLTPEENSKIMITDFGLSKMEQNGIMST 166 (304)
T ss_dssp CCCSCBHHHHHHHHSCCCHHHHHHHHHHHHHHHHHHHHTTCCCCSCCGGGCEESSSSTTCCEEBCSCSTTCCCCCBTTHH
T ss_pred cCCCccHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEEecCCCCCCEEEccCCcceecCCCcccc
Confidence 99999999988766789999999999999999999999999999999999999 778899999999987543321
Q ss_pred cccccccccccccccCCCCCCCcccceeeecCCCCCCchHHHHHHHhhcccCCCCCCChhhhhhcc----CcCCCCCCCC
Q psy758 156 PRHLHIFQTNEYFKGVSLPHAENVVPLEIKIGKPAATNIYLIDFLKRCLDKDPLRRWSCDQLLRHP----YFNGYYFEVP 231 (292)
Q Consensus 156 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~----~~~~~~~~~~ 231 (292)
...+..|.+||...+.......|+|++ +.-++..+.+..|+...+..++.... +.........
T Consensus 167 ~~~~~~y~aPE~~~~~~~~~~~Di~sl-------------G~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~ 233 (304)
T 2jam_A 167 ACGTPGYVAPEVLAQKPYSKAVDCWSI-------------GVITYILLCGYPPFYEETESKLFEKIKEGYYEFESPFWDD 233 (304)
T ss_dssp HHSCCCBCCTTTBSSCSCCHHHHHHHH-------------HHHHHHHHHSSCTTTTSCHHHHHHHHHHCCCCCCTTTTTT
T ss_pred ccCCCCccChHHhccCCCCchhhHHHH-------------HHHHHHHHHCCCCCCCCCHHHHHHHHHcCCCCCCcccccc
Confidence 123445667776655433222222222 22233333344444333333222111 0001112234
Q ss_pred CccchHHHHhcccCcCCCCCCChhhhhhCCccccee
Q psy758 232 DEMQYEEITQRCLDKDPLRRWSCDQLLRHPYFNGYY 267 (292)
Q Consensus 232 ~~~~l~~li~~~l~~dP~~Rpt~~~il~h~w~~~~~ 267 (292)
.+..+.+||.+||+.||.+|||++++++||||++..
T Consensus 234 ~~~~~~~li~~~l~~dp~~Rps~~~~l~h~~~~~~~ 269 (304)
T 2jam_A 234 ISESAKDFICHLLEKDPNERYTCEKALSHPWIDGNT 269 (304)
T ss_dssp SCHHHHHHHHHHHCSSTTTSCCHHHHHTSHHHHSSC
T ss_pred CCHHHHHHHHHHcCCChhHCcCHHHHhcCccccCCC
Confidence 578899999999999999999999999999998754
|
| >1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-43 Score=288.62 Aligned_cols=255 Identities=24% Similarity=0.354 Sum_probs=191.7
Q ss_pred CcccceeeeecccCceEEEEEEEcCCCcEEEEEEeccCCC---C----hHHHHHHHHHHHHHHhCC-CCCcchhhhhhhc
Q psy758 1 MERYEKIGKLGEGSYGVVFKCRNRDTGQVVAIKKFLESEE---D----PLIRKIALREIRLLKSLK-HPNLVNLLEVFRR 72 (292)
Q Consensus 1 ~~~y~~~~~l~~g~~~~v~~~~~~~~~~~v~iK~~~~~~~---~----~~~~~~~~~e~~~~~~l~-~~~i~~~~~~~~~ 72 (292)
.++|++.+.||+|++|.||+|.+..+++.||+|++..... . ....+.+.+|+.+++.+. ||||+++++++.+
T Consensus 16 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~ 95 (298)
T 1phk_A 16 YENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHPNIIQLKDTYET 95 (298)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTCSTTCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEEEC
T ss_pred hhccceeeeecCCCceEEEEEEEcCcCceEEEEEEecccccccCHHHHHHHHHHHHHHHHHHHHhcCCCCEeeeeeeecc
Confidence 4789999999999999999999999999999999975531 1 234567789999999996 9999999999999
Q ss_pred CCeEEEEEecCCCccHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEEccCCcEEEeecCchhhhh
Q psy758 73 KKKLHLVFEFCDHTVLNELENHPHGLPWDLIKQITWQVLRGVSYCHRHACIHRDIKPENILLTANGVVKLCDFGFARLIR 152 (292)
Q Consensus 73 ~~~~~iv~e~~~~~~L~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~givH~dl~p~Nilv~~~~~~kl~dfg~~~~~~ 152 (292)
++..++||||+++++|.+++.....+++..++.++.||+.||.|||++|++|+||+|+||+++.++.++|+|||++....
T Consensus 96 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~ 175 (298)
T 1phk_A 96 NTFFFLVFDLMKKGELFDYLTEKVTLSEKETRKIMRALLEVICALHKLNIVHRDLKPENILLDDDMNIKLTDFGFSCQLD 175 (298)
T ss_dssp SSEEEEEEECCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTCCEEECCCTTCEECC
T ss_pred CCeEEEEEeccCCCcHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCcceEEEcCCCcEEEecccchhhcC
Confidence 99999999999999999999877789999999999999999999999999999999999999999999999999987654
Q ss_pred ccc----ccccccccccccccc-----------CCCCCCCcccceeeecCCCCCCchHHHHHHHhhcccCCCCCCChhhh
Q psy758 153 DLI----PRHLHIFQTNEYFKG-----------VSLPHAENVVPLEIKIGKPAATNIYLIDFLKRCLDKDPLRRWSCDQL 217 (292)
Q Consensus 153 ~~~----~~~~~~~~~~~~~~~-----------~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~ 217 (292)
... ...+..|.+||...+ ....|+.|+..+++.++..++...........+....
T Consensus 176 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~---------- 245 (298)
T 1phk_A 176 PGEKLREVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQMLMLRMIMSGN---------- 245 (298)
T ss_dssp TTCCBCCCCSCGGGCCHHHHHHHHCTTSCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTC----------
T ss_pred CCcccccccCCccccCHHHhccccccccccCCcccccHhHHHHHHHHHHCCCCCcCccHHHHHHHHhcCC----------
Confidence 321 123344666665431 1122333444444444443332222211111111110
Q ss_pred hhccCcCCCCCCCCCccchHHHHhcccCcCCCCCCChhhhhhCCcccceecc
Q psy758 218 LRHPYFNGYYFEVPDEMQYEEITQRCLDKDPLRRWSCDQLLRHPYFNGYYFE 269 (292)
Q Consensus 218 ~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~~il~h~w~~~~~~~ 269 (292)
+..........+..+.+||.+||+.||.+|||+.++++||||++..++
T Consensus 246 ----~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~h~~~~~~~~~ 293 (298)
T 1phk_A 246 ----YQFGSPEWDDYSDTVKDLVSRFLVVQPQKRYTAEEALAHPFFQQYVVE 293 (298)
T ss_dssp ----CCCCTTTGGGSCHHHHHHHHHHCCSSGGGSCCHHHHTTSGGGCTTC--
T ss_pred ----cccCcccccccCHHHHHHHHHHccCCcccCCCHHHHHhChHhhhccch
Confidence 000001112346789999999999999999999999999999986543
|
| >3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} SCOP: d.144.1.7 PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3u9c_A* 4fbx_A* 3mb7_A* 3mb6_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=6.7e-43 Score=289.40 Aligned_cols=260 Identities=21% Similarity=0.303 Sum_probs=192.2
Q ss_pred cccceeeeecccCceEEEEEEEcCCCcEEEEEEeccCCCChHHHHHHHHHHHHHHhCC-CCCcchhhhhhhc--CCeEEE
Q psy758 2 ERYEKIGKLGEGSYGVVFKCRNRDTGQVVAIKKFLESEEDPLIRKIALREIRLLKSLK-HPNLVNLLEVFRR--KKKLHL 78 (292)
Q Consensus 2 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~e~~~~~~l~-~~~i~~~~~~~~~--~~~~~i 78 (292)
++|++++.||+|+||.||+|.+..+++.||+|++.... .+.+.+|+.+++.++ ||||+++++++.+ ....++
T Consensus 36 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~-----~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~~~l 110 (330)
T 3nsz_A 36 DDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPVK-----KKKIKREIKILENLRGGPNIITLADIVKDPVSRTPAL 110 (330)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECSCC-----HHHHHHHHHHHHHHTTSTTBCCEEEEEECTTTCCEEE
T ss_pred CceEEEEEecccCCeEEEEEEECCCCcEEEEEEecccc-----hHHHHHHHHHHHHcCCCCCEEEeeeeeccCCCCceEE
Confidence 68999999999999999999999999999999986432 356789999999997 9999999999887 677999
Q ss_pred EEecCCCccHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEEccCC-cEEEeecCchhhhhccc--
Q psy758 79 VFEFCDHTVLNELENHPHGLPWDLIKQITWQVLRGVSYCHRHACIHRDIKPENILLTANG-VVKLCDFGFARLIRDLI-- 155 (292)
Q Consensus 79 v~e~~~~~~L~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~givH~dl~p~Nilv~~~~-~~kl~dfg~~~~~~~~~-- 155 (292)
||||+.+++|..++. .+++..++.++.||+.||+|||++|++||||||+||+++.++ .++|+|||++.......
T Consensus 111 v~e~~~~~~l~~~~~---~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dikp~Nil~~~~~~~~kl~Dfg~a~~~~~~~~~ 187 (330)
T 3nsz_A 111 VFEHVNNTDFKQLYQ---TLTDYDIRFYMYEILKALDYCHSMGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQEY 187 (330)
T ss_dssp EEECCCCCCHHHHGG---GCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEETTTTEEEECCCTTCEECCTTCCC
T ss_pred EEeccCchhHHHHHH---hCCHHHHHHHHHHHHHHHHHHHhCCeeeCCCCHHHEEEcCCCCEEEEEeCCCceEcCCCCcc
Confidence 999999999999986 489999999999999999999999999999999999999777 89999999997654321
Q ss_pred --ccccccccccccccc-CC-----CCCCCcccceeeecCCCCCCch-HHHHHH-------------HhhcccCCCCCCC
Q psy758 156 --PRHLHIFQTNEYFKG-VS-----LPHAENVVPLEIKIGKPAATNI-YLIDFL-------------KRCLDKDPLRRWS 213 (292)
Q Consensus 156 --~~~~~~~~~~~~~~~-~~-----~~~~~~~~~~~~~~~~~~~~~~-~~~~~~-------------~~~~~~~p~~~~~ 213 (292)
...+..|.+||...+ .. ..|+.|+..+++.+|..++... .....+ ..+........+.
T Consensus 188 ~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~ 267 (330)
T 3nsz_A 188 NVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEDLYDYIDKYNIELDPR 267 (330)
T ss_dssp CSCCSCGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHTCSSSSCCSSHHHHHHHHHHHHCHHHHHHHHHHTTCCCCTH
T ss_pred ccccccccccChhhhcCCCcCCchhhHHHHHHHHHHHHhCCCCcccCCchHHHHHHHHHhcCCchhhhHHHHhccccccc
Confidence 233445777777655 22 2466666666777776554211 000000 0000111111111
Q ss_pred hhhhhhccCcC------CCCCCCCCccchHHHHhcccCcCCCCCCChhhhhhCCcccceecc
Q psy758 214 CDQLLRHPYFN------GYYFEVPDEMQYEEITQRCLDKDPLRRWSCDQLLRHPYFNGYYFE 269 (292)
Q Consensus 214 ~~~~~~~~~~~------~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~~il~h~w~~~~~~~ 269 (292)
..+........ ........+..+.+||.+||++||.+|||++|+|+||||+++.++
T Consensus 268 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpta~e~l~hp~f~~~~~~ 329 (330)
T 3nsz_A 268 FNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAMEHPYFYTVVKD 329 (330)
T ss_dssp HHHHHCCCCCCCGGGGCCTTTGGGCCHHHHHHHHTTSCSSGGGSCCHHHHHTSGGGTTCC--
T ss_pred hhhhhhhccccchhhhccccccccCCHHHHHHHHHHhcCCcccCCCHHHHhcCccHhhhccC
Confidence 12221111000 001112257789999999999999999999999999999997754
|
| >2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-43 Score=295.05 Aligned_cols=279 Identities=20% Similarity=0.280 Sum_probs=201.1
Q ss_pred CcccceeeeecccCceEEEEEEEcCCCcEEEEEEeccCCCCh---------------HHHHHHHHHHHHHHhCCCCCcch
Q psy758 1 MERYEKIGKLGEGSYGVVFKCRNRDTGQVVAIKKFLESEEDP---------------LIRKIALREIRLLKSLKHPNLVN 65 (292)
Q Consensus 1 ~~~y~~~~~l~~g~~~~v~~~~~~~~~~~v~iK~~~~~~~~~---------------~~~~~~~~e~~~~~~l~~~~i~~ 65 (292)
+++|++.+.||+|++|.||+|.+ +++.||+|.+....... ...+.+.+|+.+++.++||||++
T Consensus 30 ~~~y~~~~~lg~G~~g~V~~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~ 107 (348)
T 2pml_X 30 INDYRIIRTLNQGKFNKIILCEK--DNKFYALKKYEKSLLEKKRDFTKSNNDKISIKSKYDDFKNELQIITDIKNEYCLT 107 (348)
T ss_dssp ETTEEEEEEEECCSSCCEEEEEE--TTEEEEEEEEEHHHHSSCEEECCCSSSSCCEEEHHHHHHHHHHHHTTCCCTTBCC
T ss_pred cCceEEEEEEcCCCCeEEEEEEc--CCceEEEEEeecccccchhhhccccchhhhHHhHHHHHHHHHHHHHhCCCCCcce
Confidence 36899999999999999999999 79999999986442111 11266889999999999999999
Q ss_pred hhhhhhcCCeEEEEEecCCCccHHHH------hcC--CCCCCHHHHHHHHHHHHHHHHHHHh-CCccccCCCCCceEEcc
Q psy758 66 LLEVFRRKKKLHLVFEFCDHTVLNEL------ENH--PHGLPWDLIKQITWQVLRGVSYCHR-HACIHRDIKPENILLTA 136 (292)
Q Consensus 66 ~~~~~~~~~~~~iv~e~~~~~~L~~~------~~~--~~~~~~~~~~~i~~qi~~aL~~LH~-~givH~dl~p~Nilv~~ 136 (292)
+++++.+++..++||||+++++|.++ +.. ...+++..++.++.||+.||.|||+ +|++|+||+|+||+++.
T Consensus 108 ~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~i~H~dl~p~Nil~~~ 187 (348)
T 2pml_X 108 CEGIITNYDEVYIIYEYMENDSILKFDEYFFVLDKNYTCFIPIQVIKCIIKSVLNSFSYIHNEKNICHRDVKPSNILMDK 187 (348)
T ss_dssp CSEEEESSSEEEEEEECCTTCBSSEESSSEESSCSSSCCCCCHHHHHHHHHHHHHHHHHHHHTSCEECCCCCGGGEEECT
T ss_pred EEEEEeeCCeEEEEEeccCCCcHHHHHHHhhhhhhccccCCCHHHHHHHHHHHHHHHHHHhccCCEeecCCChHhEEEcC
Confidence 99999999999999999999999998 665 5679999999999999999999999 99999999999999999
Q ss_pred CCcEEEeecCchhhhhcc---ccccccccccccccccC-C------CCCCCcccceeeecCCCCCCchHH-HHHHHhhcc
Q psy758 137 NGVVKLCDFGFARLIRDL---IPRHLHIFQTNEYFKGV-S------LPHAENVVPLEIKIGKPAATNIYL-IDFLKRCLD 205 (292)
Q Consensus 137 ~~~~kl~dfg~~~~~~~~---~~~~~~~~~~~~~~~~~-~------~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~ 205 (292)
++.++|+|||++...... ....+..|.+||...+. . ..|+.|+..+++.++..++..... ..++..+..
T Consensus 188 ~~~~kl~dfg~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~i~~ 267 (348)
T 2pml_X 188 NGRVKLSDFGESEYMVDKKIKGSRGTYEFMPPEFFSNESSYNGAKVDIWSLGICLYVMFYNVVPFSLKISLVELFNNIRT 267 (348)
T ss_dssp TSCEEECCCTTCEECBTTEECSSCSCGGGCCGGGGSSCCCEEHHHHHHHHHHHHHHHHHHSSCSSCCSSCSHHHHHHHTS
T ss_pred CCcEEEeccccccccccccccCCCCCcCccCchhhcCCCCCCcchhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHhc
Confidence 999999999998765332 22334557777776554 1 234455555555555554432211 222222222
Q ss_pred cCCCCCCChhhhhhccCcC--CCCCCCCCccchHHHHhcccCcCCCCCCChhhhhhCCcccceeccCCChhHHHHHhhh
Q psy758 206 KDPLRRWSCDQLLRHPYFN--GYYFEVPDEMQYEEITQRCLDKDPLRRWSCDQLLRHPYFNGYYFEVPDEMQYEEITQV 282 (292)
Q Consensus 206 ~~p~~~~~~~~~~~~~~~~--~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~~il~h~w~~~~~~~~~~~~~~~~~~~~ 282 (292)
..+.......... .++.. ........+..+.+||.+||+.||.+|||++|+++||||++..++...+...+-++..
T Consensus 268 ~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rps~~e~l~hp~f~~~~~~~~~~~~~~~~~~~ 345 (348)
T 2pml_X 268 KNIEYPLDRNHFL-YPLTNKKSTCSNNFLSNEDIDFLKLFLRKNPAERITSEDALKHEWLADTNIEDLREFSKELYKKR 345 (348)
T ss_dssp CCCCCCCSSSSST-TTTCC--------CCCHHHHHHHHHHCCSSGGGSCCHHHHHTSGGGTTCCHHHHHHHHHHHHHHT
T ss_pred cCcCCccchhhhh-ccccccccccchhhcCHHHHHHHHHHccCChhhCCCHHHHhcCccccCCCHHHHHHHHHHHHHHh
Confidence 1111000000000 00000 0001134578899999999999999999999999999999977665555544444443
|
| >3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-43 Score=293.23 Aligned_cols=261 Identities=23% Similarity=0.291 Sum_probs=187.0
Q ss_pred cccceeeeecccCceEEEEEEEcCCCcEEEEEEeccCCCChHHHHHHHHHHHHHHhCCC--CCcchhhhhhhcCCeEEEE
Q psy758 2 ERYEKIGKLGEGSYGVVFKCRNRDTGQVVAIKKFLESEEDPLIRKIALREIRLLKSLKH--PNLVNLLEVFRRKKKLHLV 79 (292)
Q Consensus 2 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~e~~~~~~l~~--~~i~~~~~~~~~~~~~~iv 79 (292)
++|++.+.||+|+||.||+|.+. +++.||+|++..........+.+.+|+.+++.++| |||+++++++.+++..++|
T Consensus 9 ~~y~i~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~iv~~~~~~~~~~~~~lv 87 (343)
T 3dbq_A 9 RIYSILKQIGSGGSSKVFQVLNE-KKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQYIYMV 87 (343)
T ss_dssp CEEEEEEEESCCSSEEEEEEECT-TSCEEEEEEEECTTCCHHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEE
T ss_pred CEEEEEEEEecCCCeEEEEEEeC-CCCEEEEEEeeccccchHHHHHHHHHHHHHHhhhhcCCceEEEeeeEeeCCEEEEE
Confidence 47999999999999999999884 58899999998777777777889999999999986 9999999999999999999
Q ss_pred EecCCCccHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEEccCCcEEEeecCchhhhhccc----
Q psy758 80 FEFCDHTVLNELENHPHGLPWDLIKQITWQVLRGVSYCHRHACIHRDIKPENILLTANGVVKLCDFGFARLIRDLI---- 155 (292)
Q Consensus 80 ~e~~~~~~L~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~givH~dl~p~Nilv~~~~~~kl~dfg~~~~~~~~~---- 155 (292)
|| +.+++|.+++.....+++..++.++.||+.||.|||++||+||||||+||+++ ++.+||+|||++.......
T Consensus 88 ~e-~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~al~~lH~~~iiHrDikp~NIll~-~~~~kl~DFG~a~~~~~~~~~~~ 165 (343)
T 3dbq_A 88 ME-CGNIDLNSWLKKKKSIDPWERKSYWKNMLEAVHTIHQHGIVHSDLKPANFLIV-DGMLKLIDFGIANQMQPDTTSVV 165 (343)
T ss_dssp EC-CCSEEHHHHHHHSCCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEEE-TTEEEECCCSSSCCC--------
T ss_pred Ee-CCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCcceEEEE-CCcEEEeecccccccCccccccc
Confidence 99 56778999888777899999999999999999999999999999999999997 6789999999997654322
Q ss_pred ---cccccccccccccccCCCCCCCcccceeeecCCCCCCchHHHHHHHhhcccCCCCCCChh-hhhhccC--cCCCCCC
Q psy758 156 ---PRHLHIFQTNEYFKGVSLPHAENVVPLEIKIGKPAATNIYLIDFLKRCLDKDPLRRWSCD-QLLRHPY--FNGYYFE 229 (292)
Q Consensus 156 ---~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~-~~~~~~~--~~~~~~~ 229 (292)
..++..|.+||...+.......+. -........++++.+.-++..+.+..|+...... ..+.... ......+
T Consensus 166 ~~~~~gt~~y~aPE~~~~~~~~~~~~~--~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~ 243 (343)
T 3dbq_A 166 KDSQVGTVNYMPPEAIKDMSSSRENGK--SKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQISKLHAIIDPNHEIEFP 243 (343)
T ss_dssp ----CCCCSSCCHHHHHHCC-------------CCHHHHHHHHHHHHHHHHHSSCTTTTCCSHHHHHHHHHCTTSCCCCC
T ss_pred CCCCcCCcCcCCHHHHhhccccccccc--cccCCCchhhHHHHHHHHHHHHhCCCcchhhhhHHHHHHHHhcCCcccCCc
Confidence 123455667766543110000000 0000000011122222233333444444332111 1110000 0112233
Q ss_pred CCCccchHHHHhcccCcCCCCCCChhhhhhCCccccee
Q psy758 230 VPDEMQYEEITQRCLDKDPLRRWSCDQLLRHPYFNGYY 267 (292)
Q Consensus 230 ~~~~~~l~~li~~~l~~dP~~Rpt~~~il~h~w~~~~~ 267 (292)
...+..+.+||.+||+.||.+|||+.|+++||||+...
T Consensus 244 ~~~~~~l~~li~~~L~~dp~~Rpt~~e~l~hp~~~~~~ 281 (343)
T 3dbq_A 244 DIPEKDLQDVLKCCLKRDPKQRISIPELLAHPYVQIQT 281 (343)
T ss_dssp CCSCHHHHHHHHHHTCSSTTTSCCHHHHHTSHHHHSCC
T ss_pred ccCCHHHHHHHHHHcCCChhHCCCHHHHHhCccccccC
Confidence 44467899999999999999999999999999998643
|
| >3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 4gsb_A* 4gt3_A* 4gva_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3zu7_A 3zuv_A* 3o71_A 3r63_A 3c9w_A* 2y9q_A* 4fmq_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-43 Score=296.52 Aligned_cols=263 Identities=26% Similarity=0.414 Sum_probs=191.2
Q ss_pred cccceeeeecccCceEEEEEEEcCCCcEEEEEEeccCCCChHHHHHHHHHHHHHHhCCCCCcchhhhhhhcC-----CeE
Q psy758 2 ERYEKIGKLGEGSYGVVFKCRNRDTGQVVAIKKFLESEEDPLIRKIALREIRLLKSLKHPNLVNLLEVFRRK-----KKL 76 (292)
Q Consensus 2 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~-----~~~ 76 (292)
++|++++.||+|+||.||+|.+..+++.||+|++.... .....+.+.+|+.+++.++||||+++++++... ...
T Consensus 27 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~ 105 (364)
T 3qyz_A 27 PRYTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKISPFE-HQTYCQRTLREIKILLRFRHENIIGINDIIRAPTIEQMKDV 105 (364)
T ss_dssp TTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCTT-CHHHHHHHHHHHHHHHHCCCTTBCCCCEEECCSSTTTCCCE
T ss_pred ccEEEEEEeecCCCeEEEEEEECCCCeEEEEEEecccc-CcHHHHHHHHHHHHHHhcCCCCCccceeEEecCCccccceE
Confidence 48999999999999999999999999999999987533 344567788999999999999999999988643 478
Q ss_pred EEEEecCCCccHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEEccCCcEEEeecCchhhhhcccc
Q psy758 77 HLVFEFCDHTVLNELENHPHGLPWDLIKQITWQVLRGVSYCHRHACIHRDIKPENILLTANGVVKLCDFGFARLIRDLIP 156 (292)
Q Consensus 77 ~iv~e~~~~~~L~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~givH~dl~p~Nilv~~~~~~kl~dfg~~~~~~~~~~ 156 (292)
|+|+||+++ +|..++... .+++..++.++.||+.||+|||++||+||||||+||+++.++.++|+|||++........
T Consensus 106 ~iv~e~~~~-~L~~~l~~~-~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dikp~NIl~~~~~~~kl~Dfg~a~~~~~~~~ 183 (364)
T 3qyz_A 106 YIVQDLMET-DLYKLLKTQ-HLSNDHICYFLYQILRGLKYIHSANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHD 183 (364)
T ss_dssp EEEEECCSE-EHHHHHHHC-CCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCEEECCCTTCEECCGGGC
T ss_pred EEEEcccCc-CHHHHHHhC-CCCHHHHHHHHHHHHHHHHHHHHCCeecCCCChHhEEECCCCCEEEEeCcceEecCCCCC
Confidence 999999996 677777653 699999999999999999999999999999999999999999999999999976543221
Q ss_pred --------ccccccccccccccCC------CCCCCcccceeeecCCCCCCchHHHHHHH---hhcccCCCCCC----C--
Q psy758 157 --------RHLHIFQTNEYFKGVS------LPHAENVVPLEIKIGKPAATNIYLIDFLK---RCLDKDPLRRW----S-- 213 (292)
Q Consensus 157 --------~~~~~~~~~~~~~~~~------~~~~~~~~~~~~~~~~~~~~~~~~~~~~~---~~~~~~p~~~~----~-- 213 (292)
.++..|.+||...+.. ..|+.|+..+++.+|..++......+.+. ..++..+.... .
T Consensus 184 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~ 263 (364)
T 3qyz_A 184 HTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNCIINLK 263 (364)
T ss_dssp BCCTTCCCCSCGGGCCHHHHHTBCSCSTHHHHHHHHHHHHHHHHSSCSSCCSSGGGHHHHHHHHHCSCCHHHHHTCCCHH
T ss_pred ccccccccccccCCCCCHHhcCCCCCCcchhHHHHHHHHHHHHHCCCCCCCCChHHHHHHHHHHhCCCCHHHHHHhhhhh
Confidence 2344567777543322 23555566666666666553322221111 11111110000 0
Q ss_pred hhhhh-hccCcCCC---CCCCCCccchHHHHhcccCcCCCCCCChhhhhhCCccccee
Q psy758 214 CDQLL-RHPYFNGY---YFEVPDEMQYEEITQRCLDKDPLRRWSCDQLLRHPYFNGYY 267 (292)
Q Consensus 214 ~~~~~-~~~~~~~~---~~~~~~~~~l~~li~~~l~~dP~~Rpt~~~il~h~w~~~~~ 267 (292)
..... ..+.-... ......+..+.+||.+||++||.+|||++|+++||||++..
T Consensus 264 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~hp~~~~~~ 321 (364)
T 3qyz_A 264 ARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALAHPYLEQYY 321 (364)
T ss_dssp HHHHHHTSCCCCCCCHHHHCTTSCHHHHHHHHHHTCSSTTTSCCHHHHHTSGGGTTTC
T ss_pred HHHHHHhcCCccCCCHHHhCCCCCHHHHHHHHHHcCCChhhCCCHHHHhcCcchhhcc
Confidence 00000 00000000 01123467899999999999999999999999999999864
|
| >2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-43 Score=286.58 Aligned_cols=253 Identities=26% Similarity=0.354 Sum_probs=192.2
Q ss_pred cccceeeeecccCceEEEEEEEcCCCcEEEEEEeccCCCChHHHHHHHHHHHHHHhCCCCCcchhhhhhhcCCeEEEEEe
Q psy758 2 ERYEKIGKLGEGSYGVVFKCRNRDTGQVVAIKKFLESEEDPLIRKIALREIRLLKSLKHPNLVNLLEVFRRKKKLHLVFE 81 (292)
Q Consensus 2 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~iv~e 81 (292)
++|++.+.||+|++|.||+|.+..+++.||+|++............+.+|+.+++.++||||+++++++.+.+..++|+|
T Consensus 22 ~~y~i~~~lg~G~~g~V~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 101 (287)
T 2wei_A 22 ERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIMKLFEILEDSSSFYIVGE 101 (287)
T ss_dssp HHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGBSSSCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEEC
T ss_pred hcceeeEEEcCCCCEEEEEEEEcCCCcEEEEEEecccccchHHHHHHHHHHHHHHhccCCCccEEEEEEeCCCeEEEEEE
Confidence 58999999999999999999999999999999997655444445678899999999999999999999999999999999
Q ss_pred cCCCccHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEEccC---CcEEEeecCchhhhhcccc--
Q psy758 82 FCDHTVLNELENHPHGLPWDLIKQITWQVLRGVSYCHRHACIHRDIKPENILLTAN---GVVKLCDFGFARLIRDLIP-- 156 (292)
Q Consensus 82 ~~~~~~L~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~givH~dl~p~Nilv~~~---~~~kl~dfg~~~~~~~~~~-- 156 (292)
|+.+++|.+.+.....+++..++.++.||+.||.|||++|++|+||+|+||+++.+ +.++|+|||++........
T Consensus 102 ~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dl~p~NIlv~~~~~~~~~kL~Dfg~~~~~~~~~~~~ 181 (287)
T 2wei_A 102 LYTGGELFDEIIKRKRFSEHDAARIIKQVFSGITYMHKHNIVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQNTKMK 181 (287)
T ss_dssp CCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEESCSSTTCCEEECSTTGGGTBCCCSSCS
T ss_pred ccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCChhhEEEecCCCcccEEEeccCcceeecCCCccc
Confidence 99999998887766689999999999999999999999999999999999999764 4699999999876543221
Q ss_pred --ccccccccccccccCCCCCCCcccceeeecCCCCCCchHHHHHHHhhcccCCCCCCChhhhhhccCcCC----CCCCC
Q psy758 157 --RHLHIFQTNEYFKGVSLPHAENVVPLEIKIGKPAATNIYLIDFLKRCLDKDPLRRWSCDQLLRHPYFNG----YYFEV 230 (292)
Q Consensus 157 --~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~----~~~~~ 230 (292)
..+..|.+||...+. .....++ ++.+..++..+.+..|....+..++.....-.. .....
T Consensus 182 ~~~~~~~y~aPE~~~~~-~~~~~Di-------------~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 247 (287)
T 2wei_A 182 DRIGTAYYIAPEVLRGT-YDEKCDV-------------WSAGVILYILLSGTPPFYGKNEYDILKRVETGKYAFDLPQWR 247 (287)
T ss_dssp CHHHHHTTCCHHHHTTC-CCTHHHH-------------HHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCCSGGGT
T ss_pred cccCcccccChHHhcCC-CCCchhh-------------HhHHHHHHHHHhCCCCCCCCCHHHHHHHHHcCCCCCCchhhh
Confidence 123346666665442 1111111 222223333344444444433333322111111 11113
Q ss_pred CCccchHHHHhcccCcCCCCCCChhhhhhCCcccceec
Q psy758 231 PDEMQYEEITQRCLDKDPLRRWSCDQLLRHPYFNGYYF 268 (292)
Q Consensus 231 ~~~~~l~~li~~~l~~dP~~Rpt~~~il~h~w~~~~~~ 268 (292)
..+..+.++|.+||+.||.+|||+.++++||||++..+
T Consensus 248 ~~~~~~~~li~~~l~~dp~~Rps~~ell~hp~~~~~~~ 285 (287)
T 2wei_A 248 TISDDAKDLIRKMLTFHPSLRITATQCLEHPWIQKYSS 285 (287)
T ss_dssp TSCHHHHHHHHHHTCSSGGGSCCHHHHHHSHHHHHHCC
T ss_pred hcCHHHHHHHHHHcccChhhCcCHHHHhcCHHHhcccc
Confidence 45778999999999999999999999999999998654
|
| >2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.1e-43 Score=294.60 Aligned_cols=241 Identities=24% Similarity=0.265 Sum_probs=179.6
Q ss_pred eeeecccCceEEEEEEEcCCCcEEEEEEeccCCCChHHHHHHHHHHHHHHhCCCCCcchhhhhhhcCCeEEEEEecCCCc
Q psy758 7 IGKLGEGSYGVVFKCRNRDTGQVVAIKKFLESEEDPLIRKIALREIRLLKSLKHPNLVNLLEVFRRKKKLHLVFEFCDHT 86 (292)
Q Consensus 7 ~~~l~~g~~~~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~iv~e~~~~~ 86 (292)
.+.||+|+||.||+|.+..+|+.||+|++..... ...+.+.+|+.+++.++||||+++++++.+.+..++||||++++
T Consensus 94 ~~~lG~G~~g~Vy~a~~~~~g~~vavK~~~~~~~--~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~E~~~~~ 171 (373)
T 2x4f_A 94 TEILGGGRFGQVHKCEETATGLKLAAKIIKTRGM--KDKEEVKNEISVMNQLDHANLIQLYDAFESKNDIVLVMEYVDGG 171 (373)
T ss_dssp EEECC-----CEEEEEETTTCCEEEEEEEECCSH--HHHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEEECCTTC
T ss_pred ceEEecCcCEEEEEEEEcCCCcEEEEEEEccccc--ccHHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEEEEEeCCCCC
Confidence 6789999999999999999999999999976432 34567889999999999999999999999999999999999999
Q ss_pred cHHHHhcC-CCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEE--ccCCcEEEeecCchhhhhcccc----ccc
Q psy758 87 VLNELENH-PHGLPWDLIKQITWQVLRGVSYCHRHACIHRDIKPENILL--TANGVVKLCDFGFARLIRDLIP----RHL 159 (292)
Q Consensus 87 ~L~~~~~~-~~~~~~~~~~~i~~qi~~aL~~LH~~givH~dl~p~Nilv--~~~~~~kl~dfg~~~~~~~~~~----~~~ 159 (292)
+|.+++.. ...+++..++.++.||+.||.|||++||+||||||+||++ +.++.++|+|||++........ .++
T Consensus 172 ~L~~~l~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~~~kl~DFG~a~~~~~~~~~~~~~gt 251 (373)
T 2x4f_A 172 ELFDRIIDESYNLTELDTILFMKQICEGIRHMHQMYILHLDLKPENILCVNRDAKQIKIIDFGLARRYKPREKLKVNFGT 251 (373)
T ss_dssp EEHHHHHHTGGGCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEEEETTTTEEEECCCSSCEECCTTCBCCCCCSS
T ss_pred cHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCHHHEEEecCCCCcEEEEeCCCceecCCccccccccCC
Confidence 98877643 3469999999999999999999999999999999999999 5667899999999976543221 233
Q ss_pred cccccccccccCCCC-----CCCcccceeeecCCCCCCchHHHHHHHhhcccCCCCCCChhhhhhccCcCCC----CCCC
Q psy758 160 HIFQTNEYFKGVSLP-----HAENVVPLEIKIGKPAATNIYLIDFLKRCLDKDPLRRWSCDQLLRHPYFNGY----YFEV 230 (292)
Q Consensus 160 ~~~~~~~~~~~~~~~-----~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~----~~~~ 230 (292)
..|.+||...+.... |+.|+..+++.++.. |+...+..+.+........ ....
T Consensus 252 ~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~------------------pf~~~~~~~~~~~i~~~~~~~~~~~~~ 313 (373)
T 2x4f_A 252 PEFLAPEVVNYDFVSFPTDMWSVGVIAYMLLSGLS------------------PFLGDNDAETLNNILACRWDLEDEEFQ 313 (373)
T ss_dssp CTTCCHHHHTTCBCCHHHHHHHHHHHHHHHHHSSC------------------TTCCSSHHHHHHHHHHTCCCSCSGGGT
T ss_pred CcEeChhhccCCCCCcHHhHHHHHHHHHHHHhCCC------------------CCCCCCHHHHHHHHHhccCCCChhhhc
Confidence 446666655443332 333344444444444 4333333222221111111 1112
Q ss_pred CCccchHHHHhcccCcCCCCCCChhhhhhCCccccee
Q psy758 231 PDEMQYEEITQRCLDKDPLRRWSCDQLLRHPYFNGYY 267 (292)
Q Consensus 231 ~~~~~l~~li~~~l~~dP~~Rpt~~~il~h~w~~~~~ 267 (292)
..+..+.+||.+||+.||.+|||++|+++||||++..
T Consensus 314 ~~~~~~~~li~~~L~~dp~~Rps~~e~l~hp~~~~~~ 350 (373)
T 2x4f_A 314 DISEEAKEFISKLLIKEKSWRISASEALKHPWLSDHK 350 (373)
T ss_dssp TSCHHHHHHHHTTSCSSGGGSCCHHHHHHSHHHHCHH
T ss_pred cCCHHHHHHHHHHcCCChhhCCCHHHHhcCcCcCCCc
Confidence 3577899999999999999999999999999999854
|
| >3llt_A Serine/threonine kinase-1, pflammer; lammer kinase, malaria, structural GE structural genomics consortium, SGC, transferase; HET: ANP; 2.50A {Plasmodium falciparum 3D7} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.4e-43 Score=292.51 Aligned_cols=259 Identities=22% Similarity=0.314 Sum_probs=190.6
Q ss_pred cccceeeeecccCceEEEEEEEcCCCcEEEEEEeccCCCChHHHHHHHHHHHHHHhCC-----CCCcchhhhhhhcCCeE
Q psy758 2 ERYEKIGKLGEGSYGVVFKCRNRDTGQVVAIKKFLESEEDPLIRKIALREIRLLKSLK-----HPNLVNLLEVFRRKKKL 76 (292)
Q Consensus 2 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~e~~~~~~l~-----~~~i~~~~~~~~~~~~~ 76 (292)
++|++.+.||+|+||.||+|.+..+++.||+|++... ......+..|..+++.++ ||||+++++++...+..
T Consensus 35 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~---~~~~~~~~~e~~~l~~l~~~~~~h~~iv~~~~~~~~~~~~ 111 (360)
T 3llt_A 35 NAFLVIRKMGDGTFGRVLLCQHIDNKKYYAVKVVRNI---KKYTRSAKIEADILKKIQNDDINNNNIVKYHGKFMYYDHM 111 (360)
T ss_dssp TTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECSC---HHHHHHHHHHHHHHHHTCCCSTTGGGBCCEEEEEEETTEE
T ss_pred CEEEEEEEEcccCCeEEEEEEECCCCeEEEEEEeccc---hhhhhhhHHHHHHHHHhcccCCCCCCeecccceeeECCee
Confidence 6899999999999999999999999999999998642 344566778999999996 99999999999999999
Q ss_pred EEEEecCCCccHHHHhcCCC--CCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEEcc------------------
Q psy758 77 HLVFEFCDHTVLNELENHPH--GLPWDLIKQITWQVLRGVSYCHRHACIHRDIKPENILLTA------------------ 136 (292)
Q Consensus 77 ~iv~e~~~~~~L~~~~~~~~--~~~~~~~~~i~~qi~~aL~~LH~~givH~dl~p~Nilv~~------------------ 136 (292)
++||||+ +++|.+++.... .+++..++.++.||+.||+|||++||+||||||+||+++.
T Consensus 112 ~lv~e~~-~~~L~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~~~~~~~~~~~~~~~~~~ 190 (360)
T 3llt_A 112 CLIFEPL-GPSLYEIITRNNYNGFHIEDIKLYCIEILKALNYLRKMSLTHTDLKPENILLDDPYFEKSLITVRRVTDGKK 190 (360)
T ss_dssp EEEECCC-CCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEESCTTCCEEEEEEECTTTCCE
T ss_pred EEEEcCC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeeCCCCcccEEEccccccccccchhccccccc
Confidence 9999999 788888876543 5999999999999999999999999999999999999975
Q ss_pred -------CCcEEEeecCchhhhhcc--ccccccccccccccccCCCC-----CCCcccceeeecCCCCCCchHHHHH---
Q psy758 137 -------NGVVKLCDFGFARLIRDL--IPRHLHIFQTNEYFKGVSLP-----HAENVVPLEIKIGKPAATNIYLIDF--- 199 (292)
Q Consensus 137 -------~~~~kl~dfg~~~~~~~~--~~~~~~~~~~~~~~~~~~~~-----~~~~~~~~~~~~~~~~~~~~~~~~~--- 199 (292)
++.++|+|||++...... ...++..|.+||...+.... |+.|+..+++.+|..++......+.
T Consensus 191 ~~~~~~~~~~~kl~DFG~a~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~ 270 (360)
T 3llt_A 191 IQIYRTKSTGIKLIDFGCATFKSDYHGSIINTRQYRAPEVILNLGWDVSSDMWSFGCVLAELYTGSLLFRTHEHMEHLAM 270 (360)
T ss_dssp EEEEEESCCCEEECCCTTCEETTSCCCSCCSCGGGCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHH
T ss_pred ccccccCCCCEEEEeccCceecCCCCcCccCcccccCcHHHcCCCCCCccchHHHHHHHHHHHHCCCCCCCCcHHHHHHH
Confidence 788999999999765432 22335567888877665443 5555555666777766543332222
Q ss_pred HHhhcccCCCCCCChhhh-hhccCcCC----CCCC--------------------CCCccchHHHHhcccCcCCCCCCCh
Q psy758 200 LKRCLDKDPLRRWSCDQL-LRHPYFNG----YYFE--------------------VPDEMQYEEITQRCLDKDPLRRWSC 254 (292)
Q Consensus 200 ~~~~~~~~p~~~~~~~~~-~~~~~~~~----~~~~--------------------~~~~~~l~~li~~~l~~dP~~Rpt~ 254 (292)
+.......|......... ....+... ..++ ...+..+.+||.+||+.||.+|||+
T Consensus 271 ~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpta 350 (360)
T 3llt_A 271 MESIIQPIPKNMLYEATKTNGSKYVNKDELKLAWPENASSINSIKHVKKCLPLYKIIKHELFCDFLYSILQIDPTLRPSP 350 (360)
T ss_dssp HHHHTCCCCHHHHHHHTTSGGGGGEETTTTEECTTTTCSCHHHHHHHHTCCCHHHHCCCHHHHHHHHHHCCSSGGGSCCH
T ss_pred HHHhcCCCCHHHHhhhhhccCccccCcccceecCcccccchhhhhhhhhcccccccchHHHHHHHHHHHhcCChhhCCCH
Confidence 222222222100000000 00000000 0000 0113567799999999999999999
Q ss_pred hhhhhCCccc
Q psy758 255 DQLLRHPYFN 264 (292)
Q Consensus 255 ~~il~h~w~~ 264 (292)
+|+|+||||+
T Consensus 351 ~elL~hp~f~ 360 (360)
T 3llt_A 351 AELLKHKFLE 360 (360)
T ss_dssp HHHTTSGGGC
T ss_pred HHHhcCcccC
Confidence 9999999996
|
| >3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.4e-43 Score=296.66 Aligned_cols=259 Identities=26% Similarity=0.429 Sum_probs=189.8
Q ss_pred cccceeeeecccCceEEEEEEEcCCCcEEEEEEeccCCCChHHHHHHHHHHHHHHhCCCCCcchhhhhhh----------
Q psy758 2 ERYEKIGKLGEGSYGVVFKCRNRDTGQVVAIKKFLESEEDPLIRKIALREIRLLKSLKHPNLVNLLEVFR---------- 71 (292)
Q Consensus 2 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~---------- 71 (292)
++|++++.||+|+||.||+|.+..+|+.||+|++...... ..+|+.+++.++||||+++++++.
T Consensus 7 ~~y~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~~~~~~~~------~~~E~~il~~l~hpnIv~l~~~~~~~~~~~~~~~ 80 (383)
T 3eb0_A 7 KKYSLGKTLGTGSFGIVCEVFDIESGKRFALKKVLQDPRY------KNRELDIMKVLDHVNIIKLVDYFYTTGDEEPKPP 80 (383)
T ss_dssp TTEEEEEEEECC-CEEEEEEEETTTCCEEEEEEEECCTTS------CCHHHHHHTTCCCTTBCCEEEEEEEC--------
T ss_pred ceEEEEEEEEeccCEEEEEEEECCCCCEEEEEEEecCcch------HHHHHHHHHHcCCCCccchhheeeecCccccccc
Confidence 6899999999999999999999999999999998654322 236999999999999999999883
Q ss_pred ----------------------------cCCeEEEEEecCCCc---cHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhC
Q psy758 72 ----------------------------RKKKLHLVFEFCDHT---VLNELENHPHGLPWDLIKQITWQVLRGVSYCHRH 120 (292)
Q Consensus 72 ----------------------------~~~~~~iv~e~~~~~---~L~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~ 120 (292)
++...++||||++++ .+..+......+++..++.++.||+.||+|||++
T Consensus 81 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~ 160 (383)
T 3eb0_A 81 QPPDDHNKLGGKNNGVNNHHKSVIVNPSQNKYLNVIMEYVPDTLHKVLKSFIRSGRSIPMNLISIYIYQLFRAVGFIHSL 160 (383)
T ss_dssp -----------------------------CCEEEEEECCCSEEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHTT
T ss_pred ccccccccccccccccccccccccccCCCceEEEEEEecCCccHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHC
Confidence 344589999999974 3344445567899999999999999999999999
Q ss_pred CccccCCCCCceEEc-cCCcEEEeecCchhhhhccc----cccccccccccccccCC------CCCCCcccceeeecCCC
Q psy758 121 ACIHRDIKPENILLT-ANGVVKLCDFGFARLIRDLI----PRHLHIFQTNEYFKGVS------LPHAENVVPLEIKIGKP 189 (292)
Q Consensus 121 givH~dl~p~Nilv~-~~~~~kl~dfg~~~~~~~~~----~~~~~~~~~~~~~~~~~------~~~~~~~~~~~~~~~~~ 189 (292)
||+||||||+||+++ .++.++|+|||++....... ...+..|.+||...+.. ..|+.|+..+++.+|..
T Consensus 161 gi~H~Dikp~Nil~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~ 240 (383)
T 3eb0_A 161 GICHRDIKPQNLLVNSKDNTLKLCDFGSAKKLIPSEPSVAYICSRFYRAPELMLGATEYTPSIDLWSIGCVFGELILGKP 240 (383)
T ss_dssp TEECSCCCGGGEEEETTTTEEEECCCTTCEECCTTSCCCCCCCCSSCCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSC
T ss_pred cCccCccCHHHEEEcCCCCcEEEEECCCCcccCCCCCCcCcccCCCccCHHHhcCCCCCCcchhhhhHHHHHHHHHhCCC
Confidence 999999999999998 68899999999997653322 22344577888765533 24666666677777777
Q ss_pred CCCchHHHHHHHhhcccCCCCCCChhhhhh-ccCcCCC------------CCCCCCccchHHHHhcccCcCCCCCCChhh
Q psy758 190 AATNIYLIDFLKRCLDKDPLRRWSCDQLLR-HPYFNGY------------YFEVPDEMQYEEITQRCLDKDPLRRWSCDQ 256 (292)
Q Consensus 190 ~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~-~~~~~~~------------~~~~~~~~~l~~li~~~l~~dP~~Rpt~~~ 256 (292)
++......+.+..+..... .++..+... .+.+... ..+...+..+.+||.+||+.||.+|||+.|
T Consensus 241 pf~~~~~~~~~~~i~~~~g--~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e 318 (383)
T 3eb0_A 241 LFSGETSIDQLVRIIQIMG--TPTKEQMIRMNPHYTEVRFPTLKAKDWRKILPEGTPSLAIDLLEQILRYEPDLRINPYE 318 (383)
T ss_dssp SSCCSSHHHHHHHHHHHHC--CCCHHHHHHHCTTC--CCCCCCCCCCHHHHSCTTCCHHHHHHHHHHCCSSGGGSCCHHH
T ss_pred CCCCCChHHHHHHHHHHhC--CCCHHHHHHhCcccccccCCccCcccHHhhCCCCCCHHHHHHHHHHccCChhhCCCHHH
Confidence 6654443333322221100 011111110 0001110 022345778999999999999999999999
Q ss_pred hhhCCcccceec
Q psy758 257 LLRHPYFNGYYF 268 (292)
Q Consensus 257 il~h~w~~~~~~ 268 (292)
+++||||++...
T Consensus 319 ~l~hp~f~~~~~ 330 (383)
T 3eb0_A 319 AMAHPFFDHLRN 330 (383)
T ss_dssp HHTSGGGHHHHH
T ss_pred HhcCHHHHHHHh
Confidence 999999998653
|
| >2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-42 Score=285.15 Aligned_cols=262 Identities=24% Similarity=0.284 Sum_probs=184.2
Q ss_pred ccccee-eeecccCceEEEEEEEcCCCcEEEEEEeccCCCChHHHHHHHHHHHHHHhC-CCCCcchhhhhhhcCCeEEEE
Q psy758 2 ERYEKI-GKLGEGSYGVVFKCRNRDTGQVVAIKKFLESEEDPLIRKIALREIRLLKSL-KHPNLVNLLEVFRRKKKLHLV 79 (292)
Q Consensus 2 ~~y~~~-~~l~~g~~~~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~e~~~~~~l-~~~~i~~~~~~~~~~~~~~iv 79 (292)
++|++. +.||+|+||.||+|.+..+++.||+|++...... ....+.+|+.++..+ +||||+++++++.+++..++|
T Consensus 12 ~~y~i~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~--~~~~~~~E~~~l~~~~~h~~i~~~~~~~~~~~~~~lv 89 (316)
T 2ac3_A 12 DVYQLQEDVLGEGAHARVQTCINLITSQEYAVKIIEKQPGH--IRSRVFREVEMLYQCQGHRNVLELIEFFEEEDRFYLV 89 (316)
T ss_dssp TSCEECCCCCCCCSSEEEEEEECSSSCCEEEEEEEECCSSC--CHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEE
T ss_pred eeEEecCceecCCceEEEEEEEEcCCCcEEEEEEEeeCcch--hHHHHHHHHHHHHHhcCCCCeeeEEEEEeeCCEEEEE
Confidence 578885 7899999999999999999999999999765432 245678899999885 799999999999999999999
Q ss_pred EecCCCccHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEEccCCc---EEEeecCchhhhhcc--
Q psy758 80 FEFCDHTVLNELENHPHGLPWDLIKQITWQVLRGVSYCHRHACIHRDIKPENILLTANGV---VKLCDFGFARLIRDL-- 154 (292)
Q Consensus 80 ~e~~~~~~L~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~givH~dl~p~Nilv~~~~~---~kl~dfg~~~~~~~~-- 154 (292)
|||+++++|.+++.....+++..++.++.||+.||+|||++|++||||||+||+++.++. ++|+|||++......
T Consensus 90 ~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~~~~kl~Dfg~~~~~~~~~~ 169 (316)
T 2ac3_A 90 FEKMRGGSILSHIHKRRHFNELEASVVVQDVASALDFLHNKGIAHRDLKPENILCEHPNQVSPVKICDFDLGSGIKLNGD 169 (316)
T ss_dssp EECCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEESCSSSSCSEEECCTTCCC-------
T ss_pred EEcCCCCcHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCHHHEEEccCCCcCceEEEEccCccccccCCc
Confidence 999999999999987778999999999999999999999999999999999999998775 999999998654321
Q ss_pred ----------cccccccccccccccc----------CCCCCCCcccceeeecCCCCCCchHHHHHHHhhcccCCCCCCC-
Q psy758 155 ----------IPRHLHIFQTNEYFKG----------VSLPHAENVVPLEIKIGKPAATNIYLIDFLKRCLDKDPLRRWS- 213 (292)
Q Consensus 155 ----------~~~~~~~~~~~~~~~~----------~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~- 213 (292)
....+..|.+||...+ ....|+.|+..+++.+|..++......+. .+. .......
T Consensus 170 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~---~~~-~~~~~~~~ 245 (316)
T 2ac3_A 170 CSPISTPELLTPCGSAEYMAPEVVEAFSEEASIYDKRCDLWSLGVILYILLSGYPPFVGRCGSDC---GWD-RGEACPAC 245 (316)
T ss_dssp ------------CCSGGGCCHHHHHHTSHHHHHHTTTHHHHHHHHHHHHHHHSSCSCCCCCCSCS---CC-----CCHHH
T ss_pred cccccccccccccCCcCccChHHhhcccccccCCCcccccHhHHHHHHHHHHCCCCCcccccccc---ccc-ccccchhH
Confidence 1113445667766543 12334555555555555544321100000 000 0000000
Q ss_pred hhhhhhccCcCCCCCC----CCCccchHHHHhcccCcCCCCCCChhhhhhCCcccceecc
Q psy758 214 CDQLLRHPYFNGYYFE----VPDEMQYEEITQRCLDKDPLRRWSCDQLLRHPYFNGYYFE 269 (292)
Q Consensus 214 ~~~~~~~~~~~~~~~~----~~~~~~l~~li~~~l~~dP~~Rpt~~~il~h~w~~~~~~~ 269 (292)
...+.....-.....+ ...+..+.+||.+||+.||.+|||++|+++||||++..++
T Consensus 246 ~~~~~~~i~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~e~l~hp~~~~~~~~ 305 (316)
T 2ac3_A 246 QNMLFESIQEGKYEFPDKDWAHISCAAKDLISKLLVRDAKQRLSAAQVLQHPWVQGCAPE 305 (316)
T ss_dssp HHHHHHHHHHCCCCCCHHHHTTSCHHHHHHHHHHSCSSTTTSCCHHHHHHSTTCC-----
T ss_pred HHHHHHHHhccCcccCchhcccCCHHHHHHHHHHhhCChhhCCCHHHHhcChhhcCCCCc
Confidence 0000000000001111 2346789999999999999999999999999999986544
|
| >3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A | Back alignment and structure |
|---|
Probab=100.00 E-value=9.8e-43 Score=283.29 Aligned_cols=249 Identities=23% Similarity=0.406 Sum_probs=177.6
Q ss_pred cccceeeeecccCceEEEEEEEcCCCcEEEEEEeccCCCChHHHHHHHHHHHHHHhCCCCCcchhhhhhhcCCeEEEEEe
Q psy758 2 ERYEKIGKLGEGSYGVVFKCRNRDTGQVVAIKKFLESEEDPLIRKIALREIRLLKSLKHPNLVNLLEVFRRKKKLHLVFE 81 (292)
Q Consensus 2 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~iv~e 81 (292)
++|++++.||+|+||.||+|.+..+++.||+|++..........+.+..+...++.++||||+++++++.+++..++|||
T Consensus 7 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~h~~iv~~~~~~~~~~~~~lv~e 86 (290)
T 3fme_A 7 DDLEPIMELGRGAYGVVEKMRHVPSGQIMAVKRIRATVNSQEQKRLLMDLDISMRTVDCPFTVTFYGALFREGDVWICME 86 (290)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEC---CHHHHHHHHHHHHHHHTTCCCTTBCCEEEEEECSSSEEEEEE
T ss_pred HhhhhHHhcCCCCCeEEEEEEecCCCeEEEEEEeecccCcHHHHHHHHHHHHHHHhCCCCeEEEEeeeeeccCCEEEEEe
Confidence 68999999999999999999999999999999997765555555666666777888999999999999999999999999
Q ss_pred cCCCccHHHHh----cCCCCCCHHHHHHHHHHHHHHHHHHHhC-CccccCCCCCceEEccCCcEEEeecCchhhhhccc-
Q psy758 82 FCDHTVLNELE----NHPHGLPWDLIKQITWQVLRGVSYCHRH-ACIHRDIKPENILLTANGVVKLCDFGFARLIRDLI- 155 (292)
Q Consensus 82 ~~~~~~L~~~~----~~~~~~~~~~~~~i~~qi~~aL~~LH~~-givH~dl~p~Nilv~~~~~~kl~dfg~~~~~~~~~- 155 (292)
|+++ +|.+++ .....+++..++.++.||+.||.|||++ |++|+||||+||+++.++.++|+|||++.......
T Consensus 87 ~~~~-~l~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~ 165 (290)
T 3fme_A 87 LMDT-SLDKFYKQVIDKGQTIPEDILGKIAVSIVKALEHLHSKLSVIHRDVKPSNVLINALGQVKMCDFGISGYLVDDVA 165 (290)
T ss_dssp CCSE-EHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHHSCCCCCCCSGGGCEECTTCCEEBCCC-----------
T ss_pred hhcc-chHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhhcCCeecCCCCHHHEEECCCCCEEEeecCCccccccccc
Confidence 9996 544443 3456799999999999999999999998 99999999999999999999999999987654322
Q ss_pred ---cccccccccccccc----cCCC-----CCCCcccceeeecCCCCCCchHHHHHHHhhcccCCCCCCC-hhhhhhccC
Q psy758 156 ---PRHLHIFQTNEYFK----GVSL-----PHAENVVPLEIKIGKPAATNIYLIDFLKRCLDKDPLRRWS-CDQLLRHPY 222 (292)
Q Consensus 156 ---~~~~~~~~~~~~~~----~~~~-----~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~-~~~~~~~~~ 222 (292)
...+..|.+||... +... .|+.|+..+++.++. .|..... ....+....
T Consensus 166 ~~~~~~t~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~~l~~g~------------------~p~~~~~~~~~~~~~~~ 227 (290)
T 3fme_A 166 KDIDAGCKPYMAPERINPELNQKGYSVKSDIWSLGITMIELAILR------------------FPYDSWGTPFQQLKQVV 227 (290)
T ss_dssp ----CCCCCCSCHHHHSCCTTC--CCHHHHHHHHHHHHHHHHHTS------------------CSSCCCSCHHHHHHHHH
T ss_pred ccccCCCccccChhhcChhhcCcCCCcHHHHHHHHHHHHHHHHCC------------------CCccccCchHHHHHHHh
Confidence 12344566676642 1111 233333333344443 3333211 111111100
Q ss_pred cC--CCCCCCCCccchHHHHhcccCcCCCCCCChhhhhhCCcccceecc
Q psy758 223 FN--GYYFEVPDEMQYEEITQRCLDKDPLRRWSCDQLLRHPYFNGYYFE 269 (292)
Q Consensus 223 ~~--~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~~il~h~w~~~~~~~ 269 (292)
.. ........+..+.+||.+||+.||++|||++|+++||||+.....
T Consensus 228 ~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~e~l~hp~f~~~~~~ 276 (290)
T 3fme_A 228 EEPSPQLPADKFSAEFVDFTSQCLKKNSKERPTYPELMQHPFFTLHESK 276 (290)
T ss_dssp HSCCCCCCTTTSCHHHHHHHHHHTCSSGGGSCCHHHHTTSHHHHHHHHS
T ss_pred ccCCCCcccccCCHHHHHHHHHHhhcChhhCcCHHHHHhCcccccCccc
Confidence 00 011122457789999999999999999999999999999975443
|
| >2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A | Back alignment and structure |
|---|
Probab=100.00 E-value=4.1e-42 Score=288.06 Aligned_cols=249 Identities=26% Similarity=0.390 Sum_probs=189.7
Q ss_pred cccceeeeecccCceEEEEEEEcCCCcEEEEEEeccCCCC------hHHHHHHHHHHHHHHhC-CCCCcchhhhhhhcCC
Q psy758 2 ERYEKIGKLGEGSYGVVFKCRNRDTGQVVAIKKFLESEED------PLIRKIALREIRLLKSL-KHPNLVNLLEVFRRKK 74 (292)
Q Consensus 2 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~v~iK~~~~~~~~------~~~~~~~~~e~~~~~~l-~~~~i~~~~~~~~~~~ 74 (292)
++|++.+.||+|++|.||+|.+..+|+.||+|++...... ....+.+.+|+.+++.+ +||||+++++++...+
T Consensus 94 ~~y~~~~~lg~G~~g~Vy~a~~~~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~ 173 (365)
T 2y7j_A 94 QKYDPKDVIGRGVSSVVRRCVHRATGHEFAVKIMEVTAERLSPEQLEEVREATRRETHILRQVAGHPHIITLIDSYESSS 173 (365)
T ss_dssp HHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEETTSSCCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEEEBSS
T ss_pred hhcccceEEecCCCEEEEEEEECCCCcEEEEEEEEccccccCHHHHHHHHHHHHHHHHHHHHhcCCCCEeEEEEEEeeCC
Confidence 4799999999999999999999999999999998655321 23356778999999999 7999999999999999
Q ss_pred eEEEEEecCCCccHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEEccCCcEEEeecCchhhhhcc
Q psy758 75 KLHLVFEFCDHTVLNELENHPHGLPWDLIKQITWQVLRGVSYCHRHACIHRDIKPENILLTANGVVKLCDFGFARLIRDL 154 (292)
Q Consensus 75 ~~~iv~e~~~~~~L~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~givH~dl~p~Nilv~~~~~~kl~dfg~~~~~~~~ 154 (292)
..++||||+.|++|.+++.....+++..++.++.||+.||.|||+.|++|+||+|+||+++.++.++|+|||++......
T Consensus 174 ~~~lv~e~~~g~~L~~~l~~~~~l~~~~~~~i~~qi~~~L~~LH~~gi~H~Dlkp~NIl~~~~~~ikl~DfG~~~~~~~~ 253 (365)
T 2y7j_A 174 FMFLVFDLMRKGELFDYLTEKVALSEKETRSIMRSLLEAVSFLHANNIVHRDLKPENILLDDNMQIRLSDFGFSCHLEPG 253 (365)
T ss_dssp EEEEEECCCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTCCEEECCCTTCEECCTT
T ss_pred EEEEEEEeCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEECCCCCEEEEecCcccccCCC
Confidence 99999999999999999887778999999999999999999999999999999999999999999999999998765432
Q ss_pred c----cccccccccccccccC-----------CCCCCCcccceeeecCCCCCCchHHHHHHHhhcccCCCCCCChhhhhh
Q psy758 155 I----PRHLHIFQTNEYFKGV-----------SLPHAENVVPLEIKIGKPAATNIYLIDFLKRCLDKDPLRRWSCDQLLR 219 (292)
Q Consensus 155 ~----~~~~~~~~~~~~~~~~-----------~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~ 219 (292)
. ..++..|.+||...+. ...|+.|+..+++.+|..++........+.......
T Consensus 254 ~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~il~ell~g~~pf~~~~~~~~~~~i~~~~------------ 321 (365)
T 2y7j_A 254 EKLRELCGTPGYLAPEILKCSMDETHPGYGKEVDLWACGVILFTLLAGSPPFWHRRQILMLRMIMEGQ------------ 321 (365)
T ss_dssp CCBCCCCSCGGGCCHHHHHHTTCTTSCCBCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTC------------
T ss_pred cccccCCCCCCccChhhccccccccCcCCCchhhHHhHHHHHHHHHHCCCCCCCCCHHHHHHHHHhCC------------
Confidence 1 2234456677765432 122344444444444444432222222211111110
Q ss_pred ccCcCCCCCCCCCccchHHHHhcccCcCCCCCCChhhhhhCCccc
Q psy758 220 HPYFNGYYFEVPDEMQYEEITQRCLDKDPLRRWSCDQLLRHPYFN 264 (292)
Q Consensus 220 ~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~~il~h~w~~ 264 (292)
+..........+..+.+||.+||+.||.+|||++++++||||+
T Consensus 322 --~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~ell~hp~f~ 364 (365)
T 2y7j_A 322 --YQFSSPEWDDRSSTVKDLISRLLQVDPEARLTAEQALQHPFFE 364 (365)
T ss_dssp --CCCCHHHHSSSCHHHHHHHHHHSCSSTTTSCCHHHHHHSGGGC
T ss_pred --CCCCCcccccCCHHHHHHHHHHcCCChhHCcCHHHHhcCcccC
Confidence 0000000123467899999999999999999999999999997
|
| >2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9e-43 Score=281.99 Aligned_cols=252 Identities=24% Similarity=0.385 Sum_probs=192.2
Q ss_pred CcccceeeeecccCceEEEEEEEcCCCcEEEEEEeccCCCChHHHHHHHHHHHHHHhCCCCCcchhhhhh--hcCCeEEE
Q psy758 1 MERYEKIGKLGEGSYGVVFKCRNRDTGQVVAIKKFLESEEDPLIRKIALREIRLLKSLKHPNLVNLLEVF--RRKKKLHL 78 (292)
Q Consensus 1 ~~~y~~~~~l~~g~~~~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~--~~~~~~~i 78 (292)
+++|++.+.||+|++|.||+|.+..+++.||+|.+..........+.+.+|+.+++.++||||+++++++ ..++..++
T Consensus 5 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~l 84 (279)
T 2w5a_A 5 AEDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVRYYDRIIDRTNTTLYI 84 (279)
T ss_dssp GGGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEECTTCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEEGGGTEEEE
T ss_pred hhheeeehhccCCCCcEEEEEEECCCCcEEEEEEEEcccCCHHHHHHHHHHHHHHHhcCCCCCCeEEEEEecCCCceEEE
Confidence 3789999999999999999999999999999999987776677788899999999999999999999987 45678999
Q ss_pred EEecCCCccHHHHhcC----CCCCCHHHHHHHHHHHHHHHHHHHhCC-----ccccCCCCCceEEccCCcEEEeecCchh
Q psy758 79 VFEFCDHTVLNELENH----PHGLPWDLIKQITWQVLRGVSYCHRHA-----CIHRDIKPENILLTANGVVKLCDFGFAR 149 (292)
Q Consensus 79 v~e~~~~~~L~~~~~~----~~~~~~~~~~~i~~qi~~aL~~LH~~g-----ivH~dl~p~Nilv~~~~~~kl~dfg~~~ 149 (292)
||||+++++|.+++.. ...+++..++.++.||+.||.|||++| ++|+||+|+||+++.++.++|+|||++.
T Consensus 85 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~ivH~dl~p~NIl~~~~~~~kl~dfg~~~ 164 (279)
T 2w5a_A 85 VMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLAR 164 (279)
T ss_dssp EEECCTTEEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHHC------CCCCCSGGGEEECSSSCEEECCCCHHH
T ss_pred EEeCCCCCCHHHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHhcccCCCCeeEEeccchhhEEEcCCCCEEEecCchhe
Confidence 9999999999998864 234999999999999999999999999 9999999999999999999999999997
Q ss_pred hhhccc-----cccccccccccccccCCCCCCCcccceeeecCCCCCCchHHHHHHHhhcccCCCCCCChhhhhhccCcC
Q psy758 150 LIRDLI-----PRHLHIFQTNEYFKGVSLPHAENVVPLEIKIGKPAATNIYLIDFLKRCLDKDPLRRWSCDQLLRHPYFN 224 (292)
Q Consensus 150 ~~~~~~-----~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~ 224 (292)
...... ...+..|.+||...+.......++|+ .+.-++..+.+..|+...+..++.....-.
T Consensus 165 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~s-------------lG~il~~l~~g~~p~~~~~~~~~~~~i~~~ 231 (279)
T 2w5a_A 165 ILNHDTSFAKTFVGTPYYMSPEQMNRMSYNEKSDIWS-------------LGCLLYELCALMPPFTAFSQKELAGKIREG 231 (279)
T ss_dssp HC---CHHHHHHHSCCTTCCHHHHHCC-CCHHHHHHH-------------HHHHHHHHHHSSCSSCCSSHHHHHHHHHHT
T ss_pred eeccccccccccCCCccccChHHhccCCCCchhhHHH-------------HHHHHHHHHHCCCCCcccCHHHHHHHHhhc
Confidence 654322 12334566777665543322222222 222233333344444433333222111000
Q ss_pred C-CCCCCCCccchHHHHhcccCcCCCCCCChhhhhhCCcccc
Q psy758 225 G-YYFEVPDEMQYEEITQRCLDKDPLRRWSCDQLLRHPYFNG 265 (292)
Q Consensus 225 ~-~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~~il~h~w~~~ 265 (292)
. ...+...+..+.++|.+||+.||.+|||+.++++|+|+++
T Consensus 232 ~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~~~~~~ 273 (279)
T 2w5a_A 232 KFRRIPYRYSDELNEIITRMLNLKDYHRPSVEEILENPLILE 273 (279)
T ss_dssp CCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHTSTTCCG
T ss_pred ccccCCcccCHHHHHHHHHHcCCCcccCCCHHHHHhChhhhh
Confidence 0 1223345789999999999999999999999999999986
|
| >3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-42 Score=290.78 Aligned_cols=263 Identities=24% Similarity=0.398 Sum_probs=195.3
Q ss_pred cccceeeeecccCceEEEEEEEcCCCcEEEEEEeccCCCChHHHHHHHHHHHHHHhCCCCCcchhhhhhhcCCe------
Q psy758 2 ERYEKIGKLGEGSYGVVFKCRNRDTGQVVAIKKFLESEEDPLIRKIALREIRLLKSLKHPNLVNLLEVFRRKKK------ 75 (292)
Q Consensus 2 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~------ 75 (292)
++|++.+.||+|+||.||+|.+..+|+.||+|.+..........+.+.+|+.+++.++||||+++++++...+.
T Consensus 24 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~ 103 (353)
T 3coi_A 24 KTYVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQSEIFAKRAYRELLLLKHMQHENVIGLLDVFTPASSLRNFYD 103 (353)
T ss_dssp TTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEESSTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSGGGCCC
T ss_pred ceEEEeeeEecCCCeEEEEEEECCCCCEEEEEEecccccchHHHHHHHHHHHHHHhcCCCCcccHhheEeccccccccee
Confidence 57999999999999999999999999999999998776666677888999999999999999999999876543
Q ss_pred EEEEEecCCCccHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEEccCCcEEEeecCchhhhhccc
Q psy758 76 LHLVFEFCDHTVLNELENHPHGLPWDLIKQITWQVLRGVSYCHRHACIHRDIKPENILLTANGVVKLCDFGFARLIRDLI 155 (292)
Q Consensus 76 ~~iv~e~~~~~~L~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~givH~dl~p~Nilv~~~~~~kl~dfg~~~~~~~~~ 155 (292)
.|+||||+.+ +|..++.. .+++..++.++.||+.||.|||++|++|+||+|+||+++.++.++|+|||++.......
T Consensus 104 ~~lv~e~~~~-~l~~~~~~--~~~~~~~~~i~~qi~~al~~LH~~~ivH~dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~~ 180 (353)
T 3coi_A 104 FYLVMPFMQT-DLQKIMGL--KFSEEKIQYLVYQMLKGLKYIHSAGVVHRDLKPGNLAVNEDCELKILDFGLARHADAEM 180 (353)
T ss_dssp CEEEEECCSE-EGGGTTTS--CCCHHHHHHHHHHHHHHHHHHHHTTCCCSSCCGGGEEECTTCCEEECSTTCTTC-----
T ss_pred EEEEeccccC-CHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEeECCCCcEEEeecccccCCCCCc
Confidence 5999999985 77777654 59999999999999999999999999999999999999999999999999997654322
Q ss_pred --ccccccccccccccc-CC-----CCCCCcccceeeecCCCCCCchHHHHHHHhhc---ccCCCC---CCC---hhhhh
Q psy758 156 --PRHLHIFQTNEYFKG-VS-----LPHAENVVPLEIKIGKPAATNIYLIDFLKRCL---DKDPLR---RWS---CDQLL 218 (292)
Q Consensus 156 --~~~~~~~~~~~~~~~-~~-----~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~---~~~p~~---~~~---~~~~~ 218 (292)
...+..|.+||...+ .. ..|+.|+..+++.+|..++......+.+..+. +..+.. ... ....+
T Consensus 181 ~~~~~t~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~ 260 (353)
T 3coi_A 181 TGYVVTRWYRAPEVILSWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQLTQILKVTGVPGTEFVQKLNDKAAKSYI 260 (353)
T ss_dssp ---CCSBCCSCHHHHSCCSCCCTTHHHHHHHHHHHHHHHSSCSSBSSCHHHHHHHHHHHHCBCCHHHHTTCSCHHHHHHH
T ss_pred cccccCcCcCCHHHHhCcCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHHHhhHHHHHHH
Confidence 233456777876654 22 24566666666777776655443333322221 111100 000 00000
Q ss_pred hc-cCc--CC-CCCCCCCccchHHHHhcccCcCCCCCCChhhhhhCCccccee
Q psy758 219 RH-PYF--NG-YYFEVPDEMQYEEITQRCLDKDPLRRWSCDQLLRHPYFNGYY 267 (292)
Q Consensus 219 ~~-~~~--~~-~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~~il~h~w~~~~~ 267 (292)
.. +.. .. .......+..+.+||.+||+.||.+|||++++++||||+...
T Consensus 261 ~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~e~l~hp~f~~~~ 313 (353)
T 3coi_A 261 QSLPQTPRKDFTQLFPRASPQAADLLEKMLELDVDKRLTAAQALTHPFFEPFR 313 (353)
T ss_dssp HTSCBCSSCCTTTTCTTSCHHHHHHHHHHSCSCTTTSCCHHHHHTSGGGTTTC
T ss_pred HhCcCCCCccHHHhcCCcCHHHHHHHHHHcCCCcccCCCHHHHhcCcchhhcc
Confidence 00 000 00 011224577899999999999999999999999999999754
|
| >2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9e-43 Score=294.30 Aligned_cols=245 Identities=24% Similarity=0.318 Sum_probs=187.6
Q ss_pred cccceeeeecccCceEEEEEEEcCCCcEEEEEEeccCCCChHHHHHHHHHHHHHHhCC--CCCcchhhhhhhcCCeEEEE
Q psy758 2 ERYEKIGKLGEGSYGVVFKCRNRDTGQVVAIKKFLESEEDPLIRKIALREIRLLKSLK--HPNLVNLLEVFRRKKKLHLV 79 (292)
Q Consensus 2 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~e~~~~~~l~--~~~i~~~~~~~~~~~~~~iv 79 (292)
++|++.+.||+|+||.||+|.+.. ++.||+|++..........+.+.+|+.+++.++ ||||+++++++..++.+|+|
T Consensus 56 ~~y~~~~~LG~G~fg~Vy~~~~~~-~~~vaiK~~~~~~~~~~~~~~~~~Ei~~l~~l~~~~~~iv~~~~~~~~~~~~~lv 134 (390)
T 2zmd_A 56 RIYSILKQIGSGGSSKVFQVLNEK-KQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQYIYMV 134 (390)
T ss_dssp EEEEEEEEEECCSSEEEEEEECTT-CCEEEEEEEECTTCCHHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEE
T ss_pred CceEEEEEEccCCCeEEEEEEcCC-CCEEEEEEEecccccHHHHHHHHHHHHHHHHcccCCCeEEEEEEEEecCCEEEEE
Confidence 359999999999999999999875 899999999877767777788999999999997 59999999999999999999
Q ss_pred EecCCCccHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEEccCCcEEEeecCchhhhhccc----
Q psy758 80 FEFCDHTVLNELENHPHGLPWDLIKQITWQVLRGVSYCHRHACIHRDIKPENILLTANGVVKLCDFGFARLIRDLI---- 155 (292)
Q Consensus 80 ~e~~~~~~L~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~givH~dl~p~Nilv~~~~~~kl~dfg~~~~~~~~~---- 155 (292)
|| +.+++|.+++.....+++..++.++.||+.||.|||++||+||||||+|||++ ++.+||+|||++.......
T Consensus 135 ~E-~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~lH~~~ivHrDlkp~NIll~-~~~~kl~DFG~a~~~~~~~~~~~ 212 (390)
T 2zmd_A 135 ME-CGNIDLNSWLKKKKSIDPWERKSYWKNMLEAVHTIHQHGIVHSDLKPANFLIV-DGMLKLIDFGIANQMQPDTTSVV 212 (390)
T ss_dssp EE-CCSEEHHHHHHHCSSCCHHHHHHHHHHHHHHHHHHHTTTCCCCCCCGGGEEES-SSCEEECCCSSSCCC--------
T ss_pred Ee-cCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCHHHEEEE-CCeEEEEecCccccccCCCcccc
Confidence 99 67788999888777899999999999999999999999999999999999995 5799999999997654321
Q ss_pred ---cccccccccccccccC----------------CCCCCCcccceeeecCCCCCCchHHHHHHHhhcccCCCCCCCh-h
Q psy758 156 ---PRHLHIFQTNEYFKGV----------------SLPHAENVVPLEIKIGKPAATNIYLIDFLKRCLDKDPLRRWSC-D 215 (292)
Q Consensus 156 ---~~~~~~~~~~~~~~~~----------------~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~-~ 215 (292)
..++..|.+||...+. ...|+.|+..+++.+|.. |+..... .
T Consensus 213 ~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DiwSlGvil~ell~G~~------------------Pf~~~~~~~ 274 (390)
T 2zmd_A 213 KDSQVGAVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKT------------------PFQQIINQI 274 (390)
T ss_dssp -CCSCCCGGGCCHHHHHCC------------CCHHHHHHHHHHHHHHHHHSSC------------------TTTTCCCHH
T ss_pred CCCCCcCCCccChHHhhhccccccccccccCCCChhhHHHHHHHHHHHHHCCC------------------cchhhhHHH
Confidence 2234556677765441 123444444444444444 3332211 0
Q ss_pred hhhhccCc--CCCCCCCCCccchHHHHhcccCcCCCCCCChhhhhhCCccccee
Q psy758 216 QLLRHPYF--NGYYFEVPDEMQYEEITQRCLDKDPLRRWSCDQLLRHPYFNGYY 267 (292)
Q Consensus 216 ~~~~~~~~--~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~~il~h~w~~~~~ 267 (292)
..+....- .....+...+..+.+||.+||+.||.+|||+.|+++||||+...
T Consensus 275 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~ell~hp~~~~~~ 328 (390)
T 2zmd_A 275 SKLHAIIDPNHEIEFPDIPEKDLQDVLKCCLKRDPKQRISIPELLAHPYVQIQT 328 (390)
T ss_dssp HHHHHHHCTTSCCCCCCCSCHHHHHHHHHHTCSSTTTSCCHHHHHTSHHHHSCC
T ss_pred HHHHHHhCccccCCCCccchHHHHHHHHHHcccChhhCCCHHHHhhCcCccccC
Confidence 11110000 01122333467899999999999999999999999999998643
|
| >2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.2e-43 Score=288.60 Aligned_cols=253 Identities=22% Similarity=0.296 Sum_probs=183.4
Q ss_pred cccceeeeecccCceEEEEEEEcCCCcEEEEEEeccCCC------ChHHHHHHHHHHHHHHhCCCCCcchhhhhhhcCCe
Q psy758 2 ERYEKIGKLGEGSYGVVFKCRNRDTGQVVAIKKFLESEE------DPLIRKIALREIRLLKSLKHPNLVNLLEVFRRKKK 75 (292)
Q Consensus 2 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~v~iK~~~~~~~------~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~ 75 (292)
++|++.+.||+|+||.||+|.+..+++.||+|++..... .......+.+|+.+++.++||||+++++++..++
T Consensus 10 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~- 88 (322)
T 2ycf_A 10 DEYIMSKTLGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVETEIEILKKLNHPCIIKIKNFFDAED- 88 (322)
T ss_dssp HHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECC---------------CHHHHHHHHHHCCCTTBCCEEEEEESSS-
T ss_pred hceeEeeEEecCCCEEEEEEEEcCCCcEEEEEEeehhhhhhcccccchhhhhHHHHHHHHHhCCCCCCceEeeEEcCCc-
Confidence 579999999999999999999999999999999865432 1223456789999999999999999999987655
Q ss_pred EEEEEecCCCccHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEEccCCc---EEEeecCchhhhh
Q psy758 76 LHLVFEFCDHTVLNELENHPHGLPWDLIKQITWQVLRGVSYCHRHACIHRDIKPENILLTANGV---VKLCDFGFARLIR 152 (292)
Q Consensus 76 ~~iv~e~~~~~~L~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~givH~dl~p~Nilv~~~~~---~kl~dfg~~~~~~ 152 (292)
.++||||+++++|.+++.....+++..++.++.||+.||.|||++|++|+||+|+||+++.++. ++|+|||++....
T Consensus 89 ~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~NIl~~~~~~~~~~kl~Dfg~~~~~~ 168 (322)
T 2ycf_A 89 YYIVLELMEGGELFDKVVGNKRLKEATCKLYFYQMLLAVQYLHENGIIHRDLKPENVLLSSQEEDCLIKITDFGHSKILG 168 (322)
T ss_dssp EEEEEECCTTEETHHHHSTTCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESSSSSSCCEEECCCTTCEECC
T ss_pred eEEEEecCCCCcHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHEEEecCCCCCeEEEccCccceecc
Confidence 8999999999999999988888999999999999999999999999999999999999987664 9999999987654
Q ss_pred ccc----ccccccccccccccc---CCCCCCCcccceeeecCCCCCCchHHHHHHHhhcccCCCCCCC----hhhhhhcc
Q psy758 153 DLI----PRHLHIFQTNEYFKG---VSLPHAENVVPLEIKIGKPAATNIYLIDFLKRCLDKDPLRRWS----CDQLLRHP 221 (292)
Q Consensus 153 ~~~----~~~~~~~~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~----~~~~~~~~ 221 (292)
... ...+..|.+||...+ .......++|+ .+.-++..+.+..|+.... ....+...
T Consensus 169 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~s-------------lG~il~~l~~g~~pf~~~~~~~~~~~~~~~~ 235 (322)
T 2ycf_A 169 ETSLMRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWS-------------LGVILFICLSGYPPFSEHRTQVSLKDQITSG 235 (322)
T ss_dssp CCHHHHHHHSCCTTCCHHHHHHTTTTTCTTHHHHHH-------------HHHHHHHHHHSSCSSCSTTCSSCHHHHHHHT
T ss_pred cccccccccCCcCccCchhhccCCCCCCCchhhHHH-------------HHHHHHHHHhCCCCCcccchHHHHHHHHHhC
Confidence 321 123445677776431 11111222222 2222233333333332211 11111111
Q ss_pred CcCCC-CCCCCCccchHHHHhcccCcCCCCCCChhhhhhCCcccceec
Q psy758 222 YFNGY-YFEVPDEMQYEEITQRCLDKDPLRRWSCDQLLRHPYFNGYYF 268 (292)
Q Consensus 222 ~~~~~-~~~~~~~~~l~~li~~~l~~dP~~Rpt~~~il~h~w~~~~~~ 268 (292)
..... ......+..+.+||.+||+.||.+|||++++++||||++..+
T Consensus 236 ~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rps~~~~l~h~~~~~~~~ 283 (322)
T 2ycf_A 236 KYNFIPEVWAEVSEKALDLVKKLLVVDPKARFTTEEALRHPWLQDEDM 283 (322)
T ss_dssp CCCCCHHHHTTSCHHHHHHHHHHSCSSTTTSCCHHHHHTSGGGCCHHH
T ss_pred ccccCchhhhhcCHHHHHHHHHHcccCHhhCCCHHHHhhCcCcCCHHH
Confidence 00000 011234778999999999999999999999999999998553
|
| >1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-42 Score=292.12 Aligned_cols=245 Identities=22% Similarity=0.283 Sum_probs=178.1
Q ss_pred ccccee-eeecccCceEEEEEEEcCCCcEEEEEEeccCCCChHHHHHHHHHHHHH-HhCCCCCcchhhhhhhc----CCe
Q psy758 2 ERYEKI-GKLGEGSYGVVFKCRNRDTGQVVAIKKFLESEEDPLIRKIALREIRLL-KSLKHPNLVNLLEVFRR----KKK 75 (292)
Q Consensus 2 ~~y~~~-~~l~~g~~~~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~e~~~~-~~l~~~~i~~~~~~~~~----~~~ 75 (292)
++|.+. +.||+|+||.||+|.+..+++.||+|++... ..+.+|+.++ +..+||||+++++++.. .+.
T Consensus 61 ~~y~~~~~~LG~G~~g~V~~~~~~~~~~~vAiK~~~~~-------~~~~~E~~~~~~~~~hp~iv~l~~~~~~~~~~~~~ 133 (400)
T 1nxk_A 61 DDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDC-------PKARREVELHWRASQCPHIVRIVDVYENLYAGRKC 133 (400)
T ss_dssp GTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECS-------HHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEE
T ss_pred ccceeccceeeeccCeEEEEEEECCCCCEEEEEEeCcc-------hhHHHHHHHHHHhcCCCCcceEeEEEeecccCCcE
Confidence 567776 6899999999999999999999999998642 3456788876 45589999999998865 567
Q ss_pred EEEEEecCCCccHHHHhcCCC--CCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEEcc---CCcEEEeecCchhh
Q psy758 76 LHLVFEFCDHTVLNELENHPH--GLPWDLIKQITWQVLRGVSYCHRHACIHRDIKPENILLTA---NGVVKLCDFGFARL 150 (292)
Q Consensus 76 ~~iv~e~~~~~~L~~~~~~~~--~~~~~~~~~i~~qi~~aL~~LH~~givH~dl~p~Nilv~~---~~~~kl~dfg~~~~ 150 (292)
+|+||||+.||+|.+++.... .+++..++.++.||+.||.|||++||+||||||+|||++. ++.+||+|||++..
T Consensus 134 ~~lv~E~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~Nill~~~~~~~~~kl~DFG~a~~ 213 (400)
T 1nxk_A 134 LLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSINIAHRDVKPENLLYTSKRPNAILKLTDFGFAKE 213 (400)
T ss_dssp EEEEEECCCSEEHHHHHHCC---CCBHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESSSSTTCCEEECCCTTCEE
T ss_pred EEEEEEeCCCCcHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCcCcceEEEecCCCCccEEEEecccccc
Confidence 999999999999999987643 5999999999999999999999999999999999999998 78999999999976
Q ss_pred hhccc----cccccccccccccccCCCCCCCcccceeeecCCCCCCchHHHHHHHhhcccCCCCCCCh--------hhhh
Q psy758 151 IRDLI----PRHLHIFQTNEYFKGVSLPHAENVVPLEIKIGKPAATNIYLIDFLKRCLDKDPLRRWSC--------DQLL 218 (292)
Q Consensus 151 ~~~~~----~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~--------~~~~ 218 (292)
..... ...+..|.+||...+.......|+|++ +.-++..+.+..|+..... ..+.
T Consensus 214 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Diwsl-------------G~il~ell~g~~pf~~~~~~~~~~~~~~~i~ 280 (400)
T 1nxk_A 214 TTSHNSLTTPCYTPYYVAPEVLGPEKYDKSCDMWSL-------------GVIMYILLCGYPPFYSNHGLAISPGMKTRIR 280 (400)
T ss_dssp CC-----------CTTCCGGGSCCCCSSSHHHHHHH-------------HHHHHHHHHSSCSCCCCTTCSSCCSHHHHHH
T ss_pred cCCCCccccCCCCCCccCHhhcCCCCCCCcccHHHH-------------HHHHHHHHhCCCCCCCCccccccHHHHHHHH
Confidence 54321 122345667776654443322222222 2223333333333322111 1111
Q ss_pred hccCcCCCCCCCCCccchHHHHhcccCcCCCCCCChhhhhhCCcccce
Q psy758 219 RHPYFNGYYFEVPDEMQYEEITQRCLDKDPLRRWSCDQLLRHPYFNGY 266 (292)
Q Consensus 219 ~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~~il~h~w~~~~ 266 (292)
...+..........+..+.+||.+||+.||.+|||+.++++||||.+.
T Consensus 281 ~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~eil~hp~~~~~ 328 (400)
T 1nxk_A 281 MGQYEFPNPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMNHPWIMQS 328 (400)
T ss_dssp HTCCCCCTTTTTTSCHHHHHHHHTTSCSSGGGSCCHHHHHHSHHHHTT
T ss_pred cCcccCCCcccccCCHHHHHHHHHHCCCChhHCcCHHHHhcCccccCC
Confidence 111110111113457889999999999999999999999999999863
|
| >3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A | Back alignment and structure |
|---|
Probab=100.00 E-value=6.1e-44 Score=300.66 Aligned_cols=247 Identities=13% Similarity=0.060 Sum_probs=178.9
Q ss_pred cccceeeeecccCceEEEEEEEcCCCcEEEEEEeccCC-CChHHHHHHHHHHH---HHHhCCCCCcchhhh-------hh
Q psy758 2 ERYEKIGKLGEGSYGVVFKCRNRDTGQVVAIKKFLESE-EDPLIRKIALREIR---LLKSLKHPNLVNLLE-------VF 70 (292)
Q Consensus 2 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~v~iK~~~~~~-~~~~~~~~~~~e~~---~~~~l~~~~i~~~~~-------~~ 70 (292)
++|++.+.||+|+||.||+|.+..+|+.||+|++.... ......+.+.+|+. .++.++||||+++++ ++
T Consensus 73 ~~y~~~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~l~hpniv~~~~~~~~~~~~~ 152 (377)
T 3byv_A 73 RTLVRGTVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAKVHLRFIFPFDLV 152 (377)
T ss_dssp EEEEEEEEEEEETTEEEEEEEC-CCCCEEEEEEEEECC-CCTTHHHHHHHHHHGGGGSTTCCSHHHHHHHHCBCCCSEEE
T ss_pred ceEEEcceeecCCCEEEEEEEECCCCcEEEEEEEeeccccchHHHHHHHHHHHHHHhccccCCHHHHHHHhhhhhhhhhh
Confidence 57999999999999999999999999999999997553 33345677889994 555557999999994 43
Q ss_pred hcCC-----------------eEEEEEecCCCccHHHHhcCCCCCCH-------HHHHHHHHHHHHHHHHHHhCCccccC
Q psy758 71 RRKK-----------------KLHLVFEFCDHTVLNELENHPHGLPW-------DLIKQITWQVLRGVSYCHRHACIHRD 126 (292)
Q Consensus 71 ~~~~-----------------~~~iv~e~~~~~~L~~~~~~~~~~~~-------~~~~~i~~qi~~aL~~LH~~givH~d 126 (292)
.+++ ..|++|||+ +|+|.+++...+.+++ ..++.++.||+.||+|||++||+|||
T Consensus 153 ~~~~~~~~~~~~~~~~~~~i~~~~lv~E~~-~g~L~~~l~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrD 231 (377)
T 3byv_A 153 KDPQKKKMIRVRLDERDMWVLSRFFLYPRM-QSNLQTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLASLHHYGLVHTY 231 (377)
T ss_dssp ECTTSCSEEEC------CEEESEEEEEECC-SEEHHHHHHHHHHTTTTTHHHHHHHHHHHHHHHHHHHHHHHHTTEECSC
T ss_pred hccCCccccccccCCCceEEEEEEEEEecc-CCCHHHHHHhccccccccccccHHHHHHHHHHHHHHHHHHHhCCeecCC
Confidence 3332 388999999 5789988875444555 88889999999999999999999999
Q ss_pred CCCCceEEccCCcEEEeecCchhhhhcc--ccccccccccccccccC-----------CCCCCCcccceeeecCCCCCCc
Q psy758 127 IKPENILLTANGVVKLCDFGFARLIRDL--IPRHLHIFQTNEYFKGV-----------SLPHAENVVPLEIKIGKPAATN 193 (292)
Q Consensus 127 l~p~Nilv~~~~~~kl~dfg~~~~~~~~--~~~~~~~~~~~~~~~~~-----------~~~~~~~~~~~~~~~~~~~~~~ 193 (292)
|||+|||++.++.+||+|||++...... ...+ ..|.+||...+. ......|+ +
T Consensus 232 ikp~NIll~~~~~~kL~DFG~a~~~~~~~~~~~g-~~y~aPE~~~~~~~~~~~~~~~~~~~~~~Dv-------------w 297 (377)
T 3byv_A 232 LRPVDIVLDQRGGVFLTGFEHLVRDGARVVSSVS-RGFEPPELEARRATISYHRDRRTLMTFSFDA-------------W 297 (377)
T ss_dssp CCGGGEEECTTCCEEECCGGGCEETTCEEECCCC-TTCCCHHHHHHHTSTHHHHCCEEECCHHHHH-------------H
T ss_pred CCHHHEEEcCCCCEEEEechhheecCCcccCCCC-cCccChhhhcccccccccccccccCChhhhH-------------H
Confidence 9999999999999999999999764431 1122 556777766554 22222222 2
Q ss_pred hHHHHHHHhhcccCCCCCCChhhhhhccCcCCCCCCCCCccchHHHHhcccCcCCCCCCChhhhhhCCccccee
Q psy758 194 IYLIDFLKRCLDKDPLRRWSCDQLLRHPYFNGYYFEVPDEMQYEEITQRCLDKDPLRRWSCDQLLRHPYFNGYY 267 (292)
Q Consensus 194 ~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~~il~h~w~~~~~ 267 (292)
+.+..++..+.+..|+......+...... ......+..+.+||.+||+.||.+|||+.++++||||+++.
T Consensus 298 SlG~il~elltg~~Pf~~~~~~~~~~~~~----~~~~~~~~~~~~li~~~L~~dp~~Rpt~~e~l~hp~f~~~~ 367 (377)
T 3byv_A 298 ALGLVIYWIWCADLPITKDAALGGSEWIF----RSCKNIPQPVRALLEGFLRYPKEDRLLPLQAMETPEYEQLR 367 (377)
T ss_dssp HHHHHHHHHHHSSCCC------CCSGGGG----SSCCCCCHHHHHHHHHHTCSSGGGCCCHHHHHTSHHHHHHH
T ss_pred HHHHHHHHHHHCCCCCcccccccchhhhh----hhccCCCHHHHHHHHHHcCCCchhCCCHHHHhhChHHHHHH
Confidence 22233334444444543333222222111 11235578999999999999999999999999999999754
|
| >3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.4e-42 Score=281.60 Aligned_cols=251 Identities=27% Similarity=0.414 Sum_probs=186.8
Q ss_pred cccceeeeecccCceEEEEEEEcCCCcEEEEEEeccCCCChHHHHHHHHHHHHHHhCCCCCcchhhhhhhcCCeEEEEEe
Q psy758 2 ERYEKIGKLGEGSYGVVFKCRNRDTGQVVAIKKFLESEEDPLIRKIALREIRLLKSLKHPNLVNLLEVFRRKKKLHLVFE 81 (292)
Q Consensus 2 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~iv~e 81 (292)
++|++.+.||+|++|.||+|.+..+|+.||+|.+...... +.+.+|+.+++.++||||+++++++.+.+..++|||
T Consensus 29 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~----~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 104 (314)
T 3com_A 29 EVFDVLEKLGEGSYGSVYKAIHKETGQIVAIKQVPVESDL----QEIIKEISIMQQCDSPHVVKYYGSYFKNTDLWIVME 104 (314)
T ss_dssp -CEEEEEECC----CEEEEEEETTTCCEEEEEEEETTSCC----HHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred hhhhhheeeccCCCeEEEEEEECCCCCEEEEEecCchHHH----HHHHHHHHHHHhCCCCCCccEEEEEEeCCEEEEEee
Confidence 5799999999999999999999999999999999765432 457789999999999999999999999999999999
Q ss_pred cCCCccHHHHhc-CCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEEccCCcEEEeecCchhhhhcccc----
Q psy758 82 FCDHTVLNELEN-HPHGLPWDLIKQITWQVLRGVSYCHRHACIHRDIKPENILLTANGVVKLCDFGFARLIRDLIP---- 156 (292)
Q Consensus 82 ~~~~~~L~~~~~-~~~~~~~~~~~~i~~qi~~aL~~LH~~givH~dl~p~Nilv~~~~~~kl~dfg~~~~~~~~~~---- 156 (292)
|+++++|.+++. ....+++..++.++.||+.||.|||++|++|+||+|+||+++.++.++|+|||++........
T Consensus 105 ~~~~~~L~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~~ 184 (314)
T 3com_A 105 YCGAGSVSDIIRLRNKTLTEDEIATILQSTLKGLEYLHFMRKIHRDIKAGNILLNTEGHAKLADFGVAGQLTDTMAKRNT 184 (314)
T ss_dssp CCTTEEHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTCCEEECCCTTCEECBTTBSCBCC
T ss_pred cCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCcCCCcCHHHEEECCCCCEEEeecccchhhhhhccccCc
Confidence 999999999886 345799999999999999999999999999999999999999999999999999876543221
Q ss_pred -ccccccccccccccCCCCCCCcccceeeecCCCCCCchHHHHHHHhhcccCCCCCCChhhhhhc---cCcCCCCCCCCC
Q psy758 157 -RHLHIFQTNEYFKGVSLPHAENVVPLEIKIGKPAATNIYLIDFLKRCLDKDPLRRWSCDQLLRH---PYFNGYYFEVPD 232 (292)
Q Consensus 157 -~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~---~~~~~~~~~~~~ 232 (292)
..+..|.+||...+.......++|++ +.-++..+.+..|+........... ........+...
T Consensus 185 ~~~~~~y~aPE~~~~~~~~~~~Di~sl-------------G~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 251 (314)
T 3com_A 185 VIGTPFWMAPEVIQEIGYNCVADIWSL-------------GITAIEMAEGKPPYADIHPMRAIFMIPTNPPPTFRKPELW 251 (314)
T ss_dssp CCSCGGGCCHHHHSSSCBCTTHHHHHH-------------HHHHHHHHHSSCTTTTSCHHHHHHHHHHSCCCCCSSGGGS
T ss_pred cCCCCCccChhhcCCCCCCccccHHHH-------------HHHHHHHHhCCCCCCCCChHHHHHHHhcCCCcccCCcccC
Confidence 23344666666554433222222222 2223333334444433322221110 000111122334
Q ss_pred ccchHHHHhcccCcCCCCCCChhhhhhCCcccceecc
Q psy758 233 EMQYEEITQRCLDKDPLRRWSCDQLLRHPYFNGYYFE 269 (292)
Q Consensus 233 ~~~l~~li~~~l~~dP~~Rpt~~~il~h~w~~~~~~~ 269 (292)
+..+.+||.+||+.||.+|||+.++++||||++....
T Consensus 252 ~~~l~~li~~~l~~dp~~Rpt~~~ll~~~~~~~~~~~ 288 (314)
T 3com_A 252 SDNFTDFVKQCLVKSPEQRATATQLLQHPFVRSAKGV 288 (314)
T ss_dssp CHHHHHHHHHHTCSCTTTSCCHHHHTTSHHHHTCCCG
T ss_pred CHHHHHHHHHHccCChhhCcCHHHHHhCHHHhcCCcc
Confidence 6789999999999999999999999999999986543
|
| >3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.6e-42 Score=280.96 Aligned_cols=249 Identities=22% Similarity=0.342 Sum_probs=191.1
Q ss_pred cccceeeeecccCceEEEEEEEcCCCcEEEEEEeccCCCChHHHHHHHHHHHHHHhCCCCCcchhhhhhhcCCeEEEEEe
Q psy758 2 ERYEKIGKLGEGSYGVVFKCRNRDTGQVVAIKKFLESEEDPLIRKIALREIRLLKSLKHPNLVNLLEVFRRKKKLHLVFE 81 (292)
Q Consensus 2 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~iv~e 81 (292)
++|++.+.||+|+||.||+|.+ ++..||+|++..........+.+.+|+.+++.++||||+++++++.+.+..++|||
T Consensus 37 ~~y~i~~~lG~G~~g~V~~~~~--~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e 114 (309)
T 3p86_A 37 CDLNIKEKIGAGSFGTVHRAEW--HGSDVAVKILMEQDFHAERVNEFLREVAIMKRLRHPNIVLFMGAVTQPPNLSIVTE 114 (309)
T ss_dssp GGEEEEEEEEECSSEEEEEEEE--TTEEEEEEEECCCCCSHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSTTCCEEEEE
T ss_pred hHceeeeEeecCCCeEEEEEEE--CCCcEEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCceEEEEe
Confidence 6899999999999999999987 48899999998777777777889999999999999999999999999999999999
Q ss_pred cCCCccHHHHhcCCCC---CCHHHHHHHHHHHHHHHHHHHhCC--ccccCCCCCceEEccCCcEEEeecCchhhhhccc-
Q psy758 82 FCDHTVLNELENHPHG---LPWDLIKQITWQVLRGVSYCHRHA--CIHRDIKPENILLTANGVVKLCDFGFARLIRDLI- 155 (292)
Q Consensus 82 ~~~~~~L~~~~~~~~~---~~~~~~~~i~~qi~~aL~~LH~~g--ivH~dl~p~Nilv~~~~~~kl~dfg~~~~~~~~~- 155 (292)
|+.+++|.+++..... +++..++.++.||+.||+|||++| ++||||||+||+++.++.++|+|||++.......
T Consensus 115 ~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~~~ivH~Dikp~NIll~~~~~~kL~Dfg~a~~~~~~~~ 194 (309)
T 3p86_A 115 YLSRGSLYRLLHKSGAREQLDERRRLSMAYDVAKGMNYLHNRNPPIVHRNLKSPNLLVDKKYTVKVCDFGLSRLKASTFL 194 (309)
T ss_dssp CCTTCBHHHHHHSTTHHHHSCHHHHHHHHHHHHHHHHHHHTSSSCCCCTTCCGGGEEECTTCCEEECCCC----------
T ss_pred cCCCCcHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCEECCCCChhhEEEeCCCcEEECCCCCCcccccccc
Confidence 9999999999987543 999999999999999999999999 9999999999999999999999999987554322
Q ss_pred ----cccccccccccccccCCCCCCCcccceeeecCCCCCCchHHHHHHHhhcccCCCCCCChhhhhhccC--cCCCCCC
Q psy758 156 ----PRHLHIFQTNEYFKGVSLPHAENVVPLEIKIGKPAATNIYLIDFLKRCLDKDPLRRWSCDQLLRHPY--FNGYYFE 229 (292)
Q Consensus 156 ----~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~--~~~~~~~ 229 (292)
..++..|.+||...+.......++ ++.+..++..+.+..|+...+..+...... ......+
T Consensus 195 ~~~~~~gt~~y~aPE~~~~~~~~~~~Di-------------wslG~il~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~ 261 (309)
T 3p86_A 195 SSKSAAGTPEWMAPEVLRDEPSNEKSDV-------------YSFGVILWELATLQQPWGNLNPAQVVAAVGFKCKRLEIP 261 (309)
T ss_dssp -------CCTTSCHHHHTTCCCCTTHHH-------------HHHHHHHHHHHHCCCTTTTSCHHHHHHHHHHSCCCCCCC
T ss_pred ccccCCCCccccChhhhcCCCCCchhhH-------------HHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCCCCCC
Confidence 223445666666555433322233 233333444455555665555554443321 1223344
Q ss_pred CCCccchHHHHhcccCcCCCCCCChhhhhh--CCcccc
Q psy758 230 VPDEMQYEEITQRCLDKDPLRRWSCDQLLR--HPYFNG 265 (292)
Q Consensus 230 ~~~~~~l~~li~~~l~~dP~~Rpt~~~il~--h~w~~~ 265 (292)
...+..+.+||.+||+.||.+|||++++++ .+++++
T Consensus 262 ~~~~~~l~~li~~~l~~dP~~Rps~~~ll~~L~~~~~~ 299 (309)
T 3p86_A 262 RNLNPQVAAIIEGCWTNEPWKRPSFATIMDLLRPLIKS 299 (309)
T ss_dssp TTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHC-
T ss_pred ccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHh
Confidence 566889999999999999999999999998 455554
|
| >4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-43 Score=290.91 Aligned_cols=259 Identities=22% Similarity=0.295 Sum_probs=195.2
Q ss_pred cccceeeeecccCceEEEEEEEcCCCcEEEEEEeccCCCChHHHHHHHHHHHHHHhCCCCCcchhhhhhhcCC--eEEEE
Q psy758 2 ERYEKIGKLGEGSYGVVFKCRNRDTGQVVAIKKFLESEEDPLIRKIALREIRLLKSLKHPNLVNLLEVFRRKK--KLHLV 79 (292)
Q Consensus 2 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~--~~~iv 79 (292)
++|++.+.||+|+||.||+|.+..+++.||+|++....... ..+.+.+|+.+++.++||||+++++++.+.+ ..++|
T Consensus 9 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~-~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~lv 87 (319)
T 4euu_A 9 HLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLR-PVDVQMREFEVLKKLNHKNIVKLFAIEEETTTRHKVLI 87 (319)
T ss_dssp EEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECGGGGGS-CHHHHHHHHHHHHHCCCTTBCCEEEEEECTTTCCEEEE
T ss_pred CCEEEEEEecCCCCeEEEEEEECCCCcEEEEEEeccccccc-hHHHHHHHHHHHHhcCCCCcceEEEEeecCCCceEEEE
Confidence 58999999999999999999999999999999997544222 2455678999999999999999999987544 78999
Q ss_pred EecCCCccHHHHhcCCCC---CCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEE----ccCCcEEEeecCchhhhh
Q psy758 80 FEFCDHTVLNELENHPHG---LPWDLIKQITWQVLRGVSYCHRHACIHRDIKPENILL----TANGVVKLCDFGFARLIR 152 (292)
Q Consensus 80 ~e~~~~~~L~~~~~~~~~---~~~~~~~~i~~qi~~aL~~LH~~givH~dl~p~Nilv----~~~~~~kl~dfg~~~~~~ 152 (292)
|||+++++|.+++..... +++..++.++.||+.||.|||++||+|+||||+||++ +.++.+||+|||++....
T Consensus 88 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivH~Dlkp~NIll~~~~~~~~~~kL~Dfg~a~~~~ 167 (319)
T 4euu_A 88 MEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHLRENGIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARELE 167 (319)
T ss_dssp EECCTTCBHHHHHHSGGGTTCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEEECTTSCEEEEECCCTTCEECC
T ss_pred EeCCCCCCHHHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHHCCEecCCCCHHHEEEeccCCCCceEEEccCCCceecC
Confidence 999999999999876433 9999999999999999999999999999999999999 777889999999997654
Q ss_pred ccc----ccccccccccccccc-------------CCCCCCCcccceeeecCCCCCC----chHHHHHHHhhcccCCCCC
Q psy758 153 DLI----PRHLHIFQTNEYFKG-------------VSLPHAENVVPLEIKIGKPAAT----NIYLIDFLKRCLDKDPLRR 211 (292)
Q Consensus 153 ~~~----~~~~~~~~~~~~~~~-------------~~~~~~~~~~~~~~~~~~~~~~----~~~~~~~~~~~~~~~p~~~ 211 (292)
... ...+..|.+||...+ ....|+.|+..+++.+|..++. ......++..++...|..+
T Consensus 168 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~p~~~ 247 (319)
T 4euu_A 168 DDEQFVSLYGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPRRNKEVMYKIITGKPSGA 247 (319)
T ss_dssp TTCCBCCCCSCGGGCCHHHHHHHTSCCCCCCCBCTTHHHHHHHHHHHHHHHSSCSEECTTCGGGCHHHHHHHHHHCCTTC
T ss_pred CCCceeecccCCCccCHHHhhhccccccccCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCccchhHHHHHHHhcCCCccc
Confidence 322 223455777776541 2234666666677777776653 2333445555555555444
Q ss_pred CChhhhhhc---cCcCCCC----CCCCCccchHHHHhcccCcCCCCCCChhhhhhCC
Q psy758 212 WSCDQLLRH---PYFNGYY----FEVPDEMQYEEITQRCLDKDPLRRWSCDQLLRHP 261 (292)
Q Consensus 212 ~~~~~~~~~---~~~~~~~----~~~~~~~~l~~li~~~l~~dP~~Rpt~~~il~h~ 261 (292)
+........ .|....+ .....+..+.+||.+||+.||++|||++|+++||
T Consensus 248 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ll~~~L~~dP~~R~s~~ell~h~ 304 (319)
T 4euu_A 248 ISGVQKAENGPIDWSGDMPVSCSLSRGLQVLLTPVLANILEADQEKCWGFDQFFAET 304 (319)
T ss_dssp CEEEECSTTCCEEEESSCCTTCSSCHHHHHHHHHHHHHHSCCCTTTSCCHHHHHHHH
T ss_pred chhhhcccCCccccCccCCcccccchhHHHHhHHHHHHhccCChhhhccHHHhhhcc
Confidence 322111111 0111111 1122355788999999999999999999999997
|
| >2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-42 Score=286.46 Aligned_cols=264 Identities=26% Similarity=0.396 Sum_probs=189.7
Q ss_pred cccceeeeecccCceEEEEEEEcCCCcEEEEEEeccCCCChHHHHHHHHHHHHHHhCCCCCcchhhhhhh----------
Q psy758 2 ERYEKIGKLGEGSYGVVFKCRNRDTGQVVAIKKFLESEEDPLIRKIALREIRLLKSLKHPNLVNLLEVFR---------- 71 (292)
Q Consensus 2 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~---------- 71 (292)
++|++++.||+|++|.||+|.+..+++.||+|.+... .....+.+.+|+.+++.++||||+++++++.
T Consensus 11 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~--~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~ 88 (320)
T 2i6l_A 11 SRYMDLKPLGCGGNGLVFSAVDNDCDKRVAIKKIVLT--DPQSVKHALREIKIIRRLDHDNIVKVFEILGPSGSQLTDDV 88 (320)
T ss_dssp TTEEEEEECC-----CEEEEEETTTTEEEEEEEEECC--SHHHHHHHHHHHHHHHTCCCTTBCCEEEEECTTSCBCCC--
T ss_pred CceeEEEEeccCCCeEEEEEEECCCCeEEEEEEEecC--ChHHHHHHHHHHHHHHhcCCCCeeEEEEecccccccccccc
Confidence 6899999999999999999999999999999998654 3445677889999999999999999998763
Q ss_pred ----cCCeEEEEEecCCCccHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEEc-cCCcEEEeecC
Q psy758 72 ----RKKKLHLVFEFCDHTVLNELENHPHGLPWDLIKQITWQVLRGVSYCHRHACIHRDIKPENILLT-ANGVVKLCDFG 146 (292)
Q Consensus 72 ----~~~~~~iv~e~~~~~~L~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~givH~dl~p~Nilv~-~~~~~kl~dfg 146 (292)
+.+..++||||+++ +|.+++.. +.+++..++.++.||+.||+|||++|++|+||||+||+++ .++.++|+|||
T Consensus 89 ~~~~~~~~~~lv~e~~~~-~L~~~~~~-~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~~kl~Dfg 166 (320)
T 2i6l_A 89 GSLTELNSVYIVQEYMET-DLANVLEQ-GPLLEEHARLFMYQLLRGLKYIHSANVLHRDLKPANLFINTEDLVLKIGDFG 166 (320)
T ss_dssp --CCSCSEEEEEEECCSE-EHHHHHTT-CCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCSGGGEEEETTTTEEEECCCT
T ss_pred ccccccCceeEEeeccCC-CHHHHhhc-CCccHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEEcCCCCeEEEccCc
Confidence 44689999999984 78888865 4799999999999999999999999999999999999997 56799999999
Q ss_pred chhhhhccc--------ccccccccccccccc-CC-----CCCCCcccceeeecCCCCCCchHHHHHHHhhcccCCCCCC
Q psy758 147 FARLIRDLI--------PRHLHIFQTNEYFKG-VS-----LPHAENVVPLEIKIGKPAATNIYLIDFLKRCLDKDPLRRW 212 (292)
Q Consensus 147 ~~~~~~~~~--------~~~~~~~~~~~~~~~-~~-----~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~ 212 (292)
++....... ...+..|.+||...+ .. ..|+.|+..+++.+|..++........+..+....|....
T Consensus 167 ~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~ 246 (320)
T 2i6l_A 167 LARIMDPHYSHKGHLSEGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKTLFAGAHELEQMQLILESIPVVHE 246 (320)
T ss_dssp TCBCC--------CCCGGGSCCTTCCHHHHHCTTCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHSCCCCH
T ss_pred cccccCCCcccccccccccccccccCcHHhcCcccCCchhhhHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCch
Confidence 987654211 112344677776543 22 3466666667777777666544444444333332222111
Q ss_pred Chhhhhhc------------cCcCCCCCCCCCccchHHHHhcccCcCCCCCCChhhhhhCCcccceecc
Q psy758 213 SCDQLLRH------------PYFNGYYFEVPDEMQYEEITQRCLDKDPLRRWSCDQLLRHPYFNGYYFE 269 (292)
Q Consensus 213 ~~~~~~~~------------~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~~il~h~w~~~~~~~ 269 (292)
...+-+.. +...-.......+..+.+||.+||+.||.+|||++++++||||++..+.
T Consensus 247 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~~~~~~~p 315 (320)
T 2i6l_A 247 EDRQELLSVIPVYIRNDMTEPHKPLTQLLPGISREAVDFLEQILTFSPMDRLTAEEALSHPYMSIYSFP 315 (320)
T ss_dssp HHHHHHHTTSCHHHHHHTTSCCCCHHHHSTTCCHHHHHHHHTTSCSSGGGSCCHHHHHTSHHHHTTCC-
T ss_pred hhhhhhhhcCcccccccccCCCCChhHhcchhhHHHHHHHHHHcCCCccccCCHHHHhCCcccccccCc
Confidence 11000000 0000000112357789999999999999999999999999999986544
|
| >3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-43 Score=291.22 Aligned_cols=253 Identities=21% Similarity=0.244 Sum_probs=188.7
Q ss_pred cccceeeeecccCceEEEEEEEcCCCcEEEEEEeccCC-CChHHHHHHHHHHHHHHhCCCCCcchhhhhhhcCC----eE
Q psy758 2 ERYEKIGKLGEGSYGVVFKCRNRDTGQVVAIKKFLESE-EDPLIRKIALREIRLLKSLKHPNLVNLLEVFRRKK----KL 76 (292)
Q Consensus 2 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~v~iK~~~~~~-~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~----~~ 76 (292)
++|++.+.||+|+||.||+|.+..+++.||+|++.... ........+.+|+.+++.++||||+++++++.... ..
T Consensus 12 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~~~~ 91 (311)
T 3ork_A 12 DRYELGEILGFGGMSEVHLARDLRDHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVYDTGEAETPAGPLP 91 (311)
T ss_dssp TTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECTTTTTSHHHHHHHHHHHTTCCCCCCTTBCCEEEEEEEEETTEEEE
T ss_pred CcEEEEEEEccCCCEEEEEEEECCCCceEEEEEeCccccCCHHHHHHHHHHHHHHHcCCCCCcceEEEeeeccCCCCccc
Confidence 68999999999999999999999999999999997654 34455677899999999999999999999987543 35
Q ss_pred EEEEecCCCccHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEEccCCcEEEeecCchhhhhcccc
Q psy758 77 HLVFEFCDHTVLNELENHPHGLPWDLIKQITWQVLRGVSYCHRHACIHRDIKPENILLTANGVVKLCDFGFARLIRDLIP 156 (292)
Q Consensus 77 ~iv~e~~~~~~L~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~givH~dl~p~Nilv~~~~~~kl~dfg~~~~~~~~~~ 156 (292)
|+||||++|++|.+++...+.+++..++.++.||+.||.|||++|++|+||||+||+++.++.++|+|||++........
T Consensus 92 ~lv~e~~~g~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~a~~~~~~~~ 171 (311)
T 3ork_A 92 YIVMEYVDGVTLRDIVHTEGPMTPKRAIEVIADACQALNFSHQNGIIHRDVKPANIMISATNAVKVMDFGIARAIADSGN 171 (311)
T ss_dssp EEEEECCCEEEHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEEETTSCEEECCCSCC--------
T ss_pred EEEEecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCCcCCCCHHHEEEcCCCCEEEeeccCccccccccc
Confidence 99999999999999998777899999999999999999999999999999999999999999999999999976543211
Q ss_pred --------ccccccccccccccCCCCCCCcccceeeecCCCCCCchHHHHHHHhhcccCCCCCCChhhhhhccCcCCC--
Q psy758 157 --------RHLHIFQTNEYFKGVSLPHAENVVPLEIKIGKPAATNIYLIDFLKRCLDKDPLRRWSCDQLLRHPYFNGY-- 226 (292)
Q Consensus 157 --------~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~-- 226 (292)
.++..|.+||...+.......|+|+ .+.-++..+.+..|+......+..........
T Consensus 172 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~s-------------lG~~l~~ll~g~~pf~~~~~~~~~~~~~~~~~~~ 238 (311)
T 3ork_A 172 SVTQTAAVIGTAQYLSPEQARGDSVDARSDVYS-------------LGCVLYEVLTGEPPFTGDSPVSVAYQHVREDPIP 238 (311)
T ss_dssp ----------CCTTCCHHHHHTCCCCHHHHHHH-------------HHHHHHHHHHSSCSCCCSSHHHHHHHHHHCCCCC
T ss_pred ccccccccCcCcccCCHHHhcCCCCCchHhHHH-------------HHHHHHHHHhCCCCCCCCChHHHHHHHhcCCCCC
Confidence 1244566776665543322222222 22223333334444443333222211111110
Q ss_pred --CCCCCCccchHHHHhcccCcCCCCCCChhhhhhCCccccee
Q psy758 227 --YFEVPDEMQYEEITQRCLDKDPLRRWSCDQLLRHPYFNGYY 267 (292)
Q Consensus 227 --~~~~~~~~~l~~li~~~l~~dP~~Rpt~~~il~h~w~~~~~ 267 (292)
......+..+.++|.+||+.||.+||++.+++.|+|+....
T Consensus 239 ~~~~~~~~~~~l~~li~~~l~~dP~~R~~~~~~l~~~l~~~~~ 281 (311)
T 3ork_A 239 PSARHEGLSADLDAVVLKALAKNPENRYQTAAEMRADLVRVHN 281 (311)
T ss_dssp HHHHSTTCCHHHHHHHHHHTCSSGGGSCSSHHHHHHHHHHHHT
T ss_pred cccccCCCCHHHHHHHHHHHhcCHhhChhhHHHHHHHHHHHhc
Confidence 11223577899999999999999999999999999998643
|
| >2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-42 Score=284.82 Aligned_cols=256 Identities=23% Similarity=0.348 Sum_probs=187.3
Q ss_pred CcccceeeeecccCceEEEEEEEcCCCcEEEEEEeccCCC--ChHHHHHHHHHHHHHHhCCCCCcchhhhhh--hcCCeE
Q psy758 1 MERYEKIGKLGEGSYGVVFKCRNRDTGQVVAIKKFLESEE--DPLIRKIALREIRLLKSLKHPNLVNLLEVF--RRKKKL 76 (292)
Q Consensus 1 ~~~y~~~~~l~~g~~~~v~~~~~~~~~~~v~iK~~~~~~~--~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~--~~~~~~ 76 (292)
+++|++.+.||+|+||.||+|.+..+++.||+|++..... .......+.+|+.+++.++||||+++++++ .+.+..
T Consensus 4 ~~~y~i~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~ 83 (305)
T 2wtk_C 4 IGKYLMGDLLGEGSYGKVKEVLDSETLCRRAVKILKKKKLRRIPNGEANVKKEIQLLRRLRHKNVIQLVDVLYNEEKQKM 83 (305)
T ss_dssp -CCBCCCCEEEECSSCEEEEEEBTTTCCEEEEEEECHHHHHHSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEECC---CE
T ss_pred ccceeEeeEEecCCCeEEEEEEECCCCcEEEEEEeccccccccchhHHHHHHHHHHHHhcCCCCeeEEEEEEEcCCCCeE
Confidence 4799999999999999999999999999999999865431 123456788999999999999999999998 455689
Q ss_pred EEEEecCCCccHHHHhc-CCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEEccCCcEEEeecCchhhhhcc-
Q psy758 77 HLVFEFCDHTVLNELEN-HPHGLPWDLIKQITWQVLRGVSYCHRHACIHRDIKPENILLTANGVVKLCDFGFARLIRDL- 154 (292)
Q Consensus 77 ~iv~e~~~~~~L~~~~~-~~~~~~~~~~~~i~~qi~~aL~~LH~~givH~dl~p~Nilv~~~~~~kl~dfg~~~~~~~~- 154 (292)
++||||+.++....+.. ....+++..++.++.||+.||.|||++|++|+||+|+||+++.++.++|+|||++......
T Consensus 84 ~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~i~H~dlkp~NIl~~~~~~~kl~dfg~~~~~~~~~ 163 (305)
T 2wtk_C 84 YMVMEYCVCGMQEMLDSVPEKRFPVCQAHGYFCQLIDGLEYLHSQGIVHKDIKPGNLLLTTGGTLKISALGVAEALHPFA 163 (305)
T ss_dssp EEEEECCSEEHHHHHHHSTTCSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTCCEEECCCTTCEECCTTC
T ss_pred EEEehhccCCHHHHHHhCcccccCHHHHHHHHHHHHHHHHHHHHCCeeecCCCcccEEEcCCCcEEeeccccccccCccc
Confidence 99999999884333332 2356999999999999999999999999999999999999999999999999998765321
Q ss_pred ------ccccccccccccccccCCC--CCCCcccceeeecCCCCCCchHHHHHHHhhcccCCCCCCChhhhhhccCcCCC
Q psy758 155 ------IPRHLHIFQTNEYFKGVSL--PHAENVVPLEIKIGKPAATNIYLIDFLKRCLDKDPLRRWSCDQLLRHPYFNGY 226 (292)
Q Consensus 155 ------~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~ 226 (292)
....+..|.+||...+... ....++ ++.+.-++..+.+..|+......+......-...
T Consensus 164 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di-------------~slG~il~~l~~g~~p~~~~~~~~~~~~i~~~~~ 230 (305)
T 2wtk_C 164 ADDTCRTSQGSPAFQPPEIANGLDTFSGFKVDI-------------WSAGVTLYNITTGLYPFEGDNIYKLFENIGKGSY 230 (305)
T ss_dssp SSCEECCCCSCGGGCCHHHHTCCSCEESHHHHH-------------HHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHCCC
T ss_pred cccccccCCCCCCCcChhhccCcccCCcchhhH-------------HHHHHHHHHHHhCCCCCCCchHHHHHHHHhcCCC
Confidence 1123345666665543211 111111 2222233334444445444443333322111222
Q ss_pred CCCCCCccchHHHHhcccCcCCCCCCChhhhhhCCcccceecc
Q psy758 227 YFEVPDEMQYEEITQRCLDKDPLRRWSCDQLLRHPYFNGYYFE 269 (292)
Q Consensus 227 ~~~~~~~~~l~~li~~~l~~dP~~Rpt~~~il~h~w~~~~~~~ 269 (292)
..+...+..+.+||.+||+.||.+|||++++++||||++....
T Consensus 231 ~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~~~~~~~~~~ 273 (305)
T 2wtk_C 231 AIPGDCGPPLSDLLKGMLEYEPAKRFSIRQIRQHSWFRKKHPP 273 (305)
T ss_dssp CCCSSSCHHHHHHHHHHTCSSTTTSCCHHHHHHSHHHHSCCCC
T ss_pred CCCCccCHHHHHHHHHHccCChhhCCCHHHHhcCcccccCCCC
Confidence 3344567889999999999999999999999999999985543
|
| >3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} PDB: 3uib_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9e-42 Score=286.11 Aligned_cols=265 Identities=26% Similarity=0.380 Sum_probs=189.0
Q ss_pred cccceeeeecccCceEEEEEEEcCCCcEEEEEEeccCCC---------ChHHHHHHHHHHHHHHhCCCCCcchhhhhhh-
Q psy758 2 ERYEKIGKLGEGSYGVVFKCRNRDTGQVVAIKKFLESEE---------DPLIRKIALREIRLLKSLKHPNLVNLLEVFR- 71 (292)
Q Consensus 2 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~v~iK~~~~~~~---------~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~- 71 (292)
++|++.+.||+|+||.||+|.+.. ++.||+|.+..... .....+.+.+|+.+++.++||||+++++++.
T Consensus 22 ~~y~~~~~lg~G~~g~V~~~~~~~-~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~ 100 (362)
T 3pg1_A 22 SPYTVQRFISSGSYGAVCAGVDSE-GIPVAIKRVFNTVSDGRTVNILSDSFLCKRVLREIRLLNHFHHPNILGLRDIFVH 100 (362)
T ss_dssp CSCEEEEEEEEETTEEEEEEECTT-SCEEEEEEECEECCTTSCEEGGGSHHHHHHHHHHHHHHHHCCCTTBCCCSEEEEE
T ss_pred cceEEeEEeccCCCEEEEEEECCC-CCeEEEEeccccCCccchhhhhhhhhHHHHHHHHHHHHHhCCCcCccceeeeEEe
Confidence 689999999999999999999865 89999999864332 2334577899999999999999999999983
Q ss_pred ----cCCeEEEEEecCCCccHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEEccCCcEEEeecCc
Q psy758 72 ----RKKKLHLVFEFCDHTVLNELENHPHGLPWDLIKQITWQVLRGVSYCHRHACIHRDIKPENILLTANGVVKLCDFGF 147 (292)
Q Consensus 72 ----~~~~~~iv~e~~~~~~L~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~givH~dl~p~Nilv~~~~~~kl~dfg~ 147 (292)
.....|+||||++++.+..+......+++..++.++.||+.||.|||++|++|+||||+||+++.++.++|+|||+
T Consensus 101 ~~~~~~~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dlkp~NIl~~~~~~~kl~Dfg~ 180 (362)
T 3pg1_A 101 FEEPAMHKLYLVTELMRTDLAQVIHDQRIVISPQHIQYFMYHILLGLHVLHEAGVVHRDLHPGNILLADNNDITICDFNL 180 (362)
T ss_dssp CCTTTCCEEEEEEECCSEEHHHHHHCTTSCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTCCEEECCTTC
T ss_pred ccCCCcceEEEEEccCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCcCEecCCChHHEEEcCCCCEEEEecCc
Confidence 3457899999999766666666556799999999999999999999999999999999999999999999999999
Q ss_pred hhhhhccc----ccccccccccccccc-CC-----CCCCCcccceeeecCCCCCCchHHHHHHHhhccc---CCCC----
Q psy758 148 ARLIRDLI----PRHLHIFQTNEYFKG-VS-----LPHAENVVPLEIKIGKPAATNIYLIDFLKRCLDK---DPLR---- 210 (292)
Q Consensus 148 ~~~~~~~~----~~~~~~~~~~~~~~~-~~-----~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~---~p~~---- 210 (292)
+....... ...+..|.+||...+ .. ..|+.|+..+++.++..++........+..+... .+..
T Consensus 181 ~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~ 260 (362)
T 3pg1_A 181 AREDTADANKTHYVTHRWYRAPELVMQFKGFTKLVDMWSAGCVMAEMFNRKALFRGSTFYNQLNKIVEVVGTPKIEDVVM 260 (362)
T ss_dssp ---------------CGGGCCHHHHTTCTTCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCHHHHHH
T ss_pred ccccccccccceecccceecCcHHhcCCCCCCcHhHHHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCChHHhhh
Confidence 97543321 223445777876654 22 2456666666777777665544333333222211 0000
Q ss_pred --CCChhhhhhccCcCC-----CCCCCCCccchHHHHhcccCcCCCCCCChhhhhhCCccccee
Q psy758 211 --RWSCDQLLRHPYFNG-----YYFEVPDEMQYEEITQRCLDKDPLRRWSCDQLLRHPYFNGYY 267 (292)
Q Consensus 211 --~~~~~~~~~~~~~~~-----~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~~il~h~w~~~~~ 267 (292)
.....+.+....... .......+..+.+||.+||+.||.+|||+.|+++||||+++.
T Consensus 261 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~f~~~~ 324 (362)
T 3pg1_A 261 FSSPSARDYLRNSLSNVPARAWTAVVPTADPVALDLIAKMLEFNPQRRISTEQALRHPYFESLF 324 (362)
T ss_dssp TSCHHHHHHTTTCCCCCCCCCHHHHSTTSCHHHHHHHHHHTCSSGGGSCCHHHHHTSGGGTTTC
T ss_pred ccchhhhHHHHhhcccCChhhHHhhCCCCCHHHHHHHHHHhcCChhhCCCHHHHHcCchhhhcc
Confidence 000001110000000 001123467799999999999999999999999999999865
|
| >2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-42 Score=285.78 Aligned_cols=252 Identities=27% Similarity=0.388 Sum_probs=185.1
Q ss_pred cccceeeeecccCceEEEEEEEcCCCcEEEEEEeccCCCChHHHHHHHHHHHHHHhC-CCCCcchhhhhhhc------CC
Q psy758 2 ERYEKIGKLGEGSYGVVFKCRNRDTGQVVAIKKFLESEEDPLIRKIALREIRLLKSL-KHPNLVNLLEVFRR------KK 74 (292)
Q Consensus 2 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~e~~~~~~l-~~~~i~~~~~~~~~------~~ 74 (292)
++|++.+.||+|++|.||+|.+..+++.||+|++...... ...+.+|+.+++.+ +||||+++++++.. .+
T Consensus 24 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~---~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~~~~ 100 (326)
T 2x7f_A 24 GIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTGDE---EEEIKQEINMLKKYSHHRNIATYYGAFIKKNPPGMDD 100 (326)
T ss_dssp TTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSST---THHHHHHHHHHHHHCCSTTBCCEEEEEEECC--CCCC
T ss_pred CcEEEEEEeccCCCEEEEEEEECCCCCeEEEEEEecCccc---HHHHHHHHHHHHhccCCCCeeeeeeEEeeccCccccc
Confidence 6899999999999999999999999999999998765433 24577899999998 79999999999876 56
Q ss_pred eEEEEEecCCCccHHHHhcCC--CCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEEccCCcEEEeecCchhhhh
Q psy758 75 KLHLVFEFCDHTVLNELENHP--HGLPWDLIKQITWQVLRGVSYCHRHACIHRDIKPENILLTANGVVKLCDFGFARLIR 152 (292)
Q Consensus 75 ~~~iv~e~~~~~~L~~~~~~~--~~~~~~~~~~i~~qi~~aL~~LH~~givH~dl~p~Nilv~~~~~~kl~dfg~~~~~~ 152 (292)
..++||||+++++|.+++... ..+++..++.++.||+.||.|||++|++|+||+|+||+++.++.++|+|||++....
T Consensus 101 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~dlkp~NIl~~~~~~~kl~Dfg~~~~~~ 180 (326)
T 2x7f_A 101 QLWLVMEFCGAGSVTDLIKNTKGNTLKEEWIAYICREILRGLSHLHQHKVIHRDIKGQNVLLTENAEVKLVDFGVSAQLD 180 (326)
T ss_dssp EEEEEEECCTTEEHHHHHHHSGGGCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCSGGGEEECTTCCEEECCCTTTC---
T ss_pred eEEEEEEcCCCCcHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCcHHHEEEcCCCCEEEeeCcCceecC
Confidence 899999999999999998653 469999999999999999999999999999999999999999999999999987654
Q ss_pred ccc-----ccccccccccccccc-----CCCCCCCcccceeeecCCCCCCchHHHHHHHhhcccCCCCCCChhhhhhccC
Q psy758 153 DLI-----PRHLHIFQTNEYFKG-----VSLPHAENVVPLEIKIGKPAATNIYLIDFLKRCLDKDPLRRWSCDQLLRHPY 222 (292)
Q Consensus 153 ~~~-----~~~~~~~~~~~~~~~-----~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~ 222 (292)
... ...+..|.+||...+ .......++ ++.+.-++..+.+..|.......+.+....
T Consensus 181 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di-------------~slG~il~~l~~g~~p~~~~~~~~~~~~~~ 247 (326)
T 2x7f_A 181 RTVGRRNTFIGTPYWMAPEVIACDENPDATYDFKSDL-------------WSLGITAIEMAEGAPPLCDMHPMRALFLIP 247 (326)
T ss_dssp ----------CCGGGCCHHHHC--------CCTTHHH-------------HHHHHHHHHHHHSSCTTTTSCHHHHHHHHH
T ss_pred cCccccccccCCccccChhhhccccccCcCCCccchH-------------HHHHHHHHHHHhCCCCCCCCcHHHHHHHhh
Confidence 322 123445666666542 111111122 222222333333444443333222211100
Q ss_pred cC--CCCCCCCCccchHHHHhcccCcCCCCCCChhhhhhCCcccceecc
Q psy758 223 FN--GYYFEVPDEMQYEEITQRCLDKDPLRRWSCDQLLRHPYFNGYYFE 269 (292)
Q Consensus 223 ~~--~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~~il~h~w~~~~~~~ 269 (292)
.. ........+..+.+||.+||+.||.+|||++++++||||++...+
T Consensus 248 ~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~hp~~~~~~~~ 296 (326)
T 2x7f_A 248 RNPAPRLKSKKWSKKFQSFIESCLVKNHSQRPATEQLMKHPFIRDQPNE 296 (326)
T ss_dssp HSCCCCCSCSCSCHHHHHHHHHHCCSSGGGSCCHHHHHTSHHHHCCTTH
T ss_pred cCccccCCccccCHHHHHHHHHHhccChhhCCCHHHHhhChHHhhCccc
Confidence 00 011123447789999999999999999999999999999986544
|
| >4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.1e-42 Score=279.99 Aligned_cols=250 Identities=23% Similarity=0.299 Sum_probs=189.8
Q ss_pred cccceeeeecccCceEEEEEEEcCCCcEEEEEEeccCC-CChHHHHHHHHHHHHHHhCCCCCcchhhhhhhcCCeEEEEE
Q psy758 2 ERYEKIGKLGEGSYGVVFKCRNRDTGQVVAIKKFLESE-EDPLIRKIALREIRLLKSLKHPNLVNLLEVFRRKKKLHLVF 80 (292)
Q Consensus 2 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~v~iK~~~~~~-~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~iv~ 80 (292)
++|++.+.||+|+||.||+|.+..+++.||+|.+.... ......+.+.+|+.+++.++||||+++++++.+++..++||
T Consensus 11 ~~y~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~lv~ 90 (294)
T 4eqm_A 11 ERYKIVDKLGGGGMSTVYLAEDTILNIKVAIKAIFIPPREKEETLKRFEREVHNSSQLSHQNIVSMIDVDEEDDCYYLVM 90 (294)
T ss_dssp TTEEEEEEEEEETTEEEEEEEETTTCSEEEEEEEECCSSCCHHHHHHHHHHHHHHTTCCBTTBCCEEEEEECSSEEEEEE
T ss_pred ccEEEEEEEccCCCEEEEEEEECCCCCeEEEEEeccCccccHHHHHHHHHHHHHHhcCCCCCCceEEEeeeeCCeEEEEE
Confidence 58999999999999999999999999999999986554 44556778899999999999999999999999999999999
Q ss_pred ecCCCccHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEEccCCcEEEeecCchhhhhccc-----
Q psy758 81 EFCDHTVLNELENHPHGLPWDLIKQITWQVLRGVSYCHRHACIHRDIKPENILLTANGVVKLCDFGFARLIRDLI----- 155 (292)
Q Consensus 81 e~~~~~~L~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~givH~dl~p~Nilv~~~~~~kl~dfg~~~~~~~~~----- 155 (292)
||++|++|.+++...+.+++..++.++.||+.||.|||++|++||||||+||+++.++.++|+|||++.......
T Consensus 91 e~~~g~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~ 170 (294)
T 4eqm_A 91 EYIEGPTLSEYIESHGPLSVDTAINFTNQILDGIKHAHDMRIVHRDIKPQNILIDSNKTLKIFDFGIAKALSETSLTQTN 170 (294)
T ss_dssp ECCCSCBHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTSCEEECCCSSSTTC---------
T ss_pred eCCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCCEEEEeCCCccccccccccccC
Confidence 999999999999877789999999999999999999999999999999999999999999999999997654322
Q ss_pred -cccccccccccccccCCCCCCCcccceeeecCCCCCCchHHHHHHHhhcccCCCCCCChhhhhhccCcCC-----CCCC
Q psy758 156 -PRHLHIFQTNEYFKGVSLPHAENVVPLEIKIGKPAATNIYLIDFLKRCLDKDPLRRWSCDQLLRHPYFNG-----YYFE 229 (292)
Q Consensus 156 -~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~-----~~~~ 229 (292)
..++..|.+||...+.......++|+ .+..++..+.+..|+...+..+......... ....
T Consensus 171 ~~~gt~~y~aPE~~~~~~~~~~~Di~s-------------lG~~l~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (294)
T 4eqm_A 171 HVLGTVQYFSPEQAKGEATDECTDIYS-------------IGIVLYEMLVGEPPFNGETAVSIAIKHIQDSVPNVTTDVR 237 (294)
T ss_dssp ----CCSSCCHHHHHTCCCCTTHHHHH-------------HHHHHHHHHHSSCSSCSSCHHHHHHHHHSSCCCCHHHHSC
T ss_pred ccccCccccCHhHhcCCCCCchHhHHH-------------HHHHHHHHHhCCCCCCCCChHHHHHHHhhccCCCcchhcc
Confidence 12344566666655543332222222 2223334444444544444332221111111 0122
Q ss_pred CCCccchHHHHhcccCcCCCCCCChhhhhhCCccc
Q psy758 230 VPDEMQYEEITQRCLDKDPLRRWSCDQLLRHPYFN 264 (292)
Q Consensus 230 ~~~~~~l~~li~~~l~~dP~~Rpt~~~il~h~w~~ 264 (292)
...+..+.++|.+||+.||.+||+..+.+.+.|..
T Consensus 238 ~~~~~~l~~li~~~l~~dp~~R~~~~~~l~~~l~~ 272 (294)
T 4eqm_A 238 KDIPQSLSNVILRATEKDKANRYKTIQEMKDDLSS 272 (294)
T ss_dssp TTSCHHHHHHHHHHSCSSGGGSCSSHHHHHHHHHT
T ss_pred cCCCHHHHHHHHHHhcCCHhHccccHHHHHHHHHH
Confidence 34578899999999999999999666666665543
|
| >2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-43 Score=288.31 Aligned_cols=258 Identities=24% Similarity=0.328 Sum_probs=168.0
Q ss_pred cccceeeeecccCceEEEEEEEcCCCcEEEEEEeccCCCChHHHHHHHHHHHHHHhCCCCCcchhhhhhhcCCeEEEEEe
Q psy758 2 ERYEKIGKLGEGSYGVVFKCRNRDTGQVVAIKKFLESEEDPLIRKIALREIRLLKSLKHPNLVNLLEVFRRKKKLHLVFE 81 (292)
Q Consensus 2 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~iv~e 81 (292)
++|++.+.||+|++|.||+|.+..+++.||+|.+..... ....+.+.+|+.+++.++||||+++++++.+.+..++|||
T Consensus 15 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 93 (303)
T 2vwi_A 15 DDYELQEVIGSGATAVVQAAYCAPKKEKVAIKRINLEKC-QTSMDELLKEIQAMSQCHHPNIVSYYTSFVVKDELWLVMK 93 (303)
T ss_dssp CCCEEEEECC---CCCEEEEEC----CEEEEECCC-----------------CCCCCCCTTBCCEEEEEESSSCEEEEEE
T ss_pred hhhhhhheeccccceEEEEEEECCCCcEEEEEEEEhhhc-chhHHHHHHHHHHHhhcCCCCEeeEEEEEeecCCcEEEeh
Confidence 689999999999999999999998999999999865432 2334567889999999999999999999999999999999
Q ss_pred cCCCccHHHHhcC--------CCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEEccCCcEEEeecCchhhhhc
Q psy758 82 FCDHTVLNELENH--------PHGLPWDLIKQITWQVLRGVSYCHRHACIHRDIKPENILLTANGVVKLCDFGFARLIRD 153 (292)
Q Consensus 82 ~~~~~~L~~~~~~--------~~~~~~~~~~~i~~qi~~aL~~LH~~givH~dl~p~Nilv~~~~~~kl~dfg~~~~~~~ 153 (292)
|+++++|.+++.. ...+++..++.++.||+.||.|||++|++|+||+|+||+++.++.++|+|||++.....
T Consensus 94 ~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~~ 173 (303)
T 2vwi_A 94 LLSGGSVLDIIKHIVAKGEHKSGVLDESTIATILREVLEGLEYLHKNGQIHRDVKAGNILLGEDGSVQIADFGVSAFLAT 173 (303)
T ss_dssp CCTTCBHHHHHHHHHHTTTTTTCSSCHHHHHHHHHHHHHHHHHHHHTTCCCCCCSGGGEEECTTCCEEECCCHHHHHCC-
T ss_pred hccCCchHHHHHHHhhccccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCCCCChhhEEEcCCCCEEEEeccchheecc
Confidence 9999999998862 45699999999999999999999999999999999999999999999999999876542
Q ss_pred cc----------ccccccccccccccc-CC-----CCCCCcccceeeecCCCCCCchHHHHHHHhhcccCCCCCCChhhh
Q psy758 154 LI----------PRHLHIFQTNEYFKG-VS-----LPHAENVVPLEIKIGKPAATNIYLIDFLKRCLDKDPLRRWSCDQL 217 (292)
Q Consensus 154 ~~----------~~~~~~~~~~~~~~~-~~-----~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~ 217 (292)
.. ...+..|.+||...+ .. ..|+.|+..+++.+|..++........+.......+... ..
T Consensus 174 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~---~~- 249 (303)
T 2vwi_A 174 GGDITRNKVRKTFVGTPCWMAPEVMEQVRGYDFKADIWSFGITAIELATGAAPYHKYPPMKVLMLTLQNDPPSL---ET- 249 (303)
T ss_dssp --------------CCCTTCCHHHHHHHHCCCTHHHHHHHHHHHHHHHHSSCTTTTSCGGGHHHHHHTSSCCCT---TC-
T ss_pred CCCccchhhhcccCCCccccCHHHhccccCCCchhhHHHHHHHHHHHHhCCCCCccCchhhHHHHHhccCCCcc---cc-
Confidence 11 122334666665432 11 123344444444444443321111111111111111000 00
Q ss_pred hhccCcCCCCCCCCCccchHHHHhcccCcCCCCCCChhhhhhCCcccceec
Q psy758 218 LRHPYFNGYYFEVPDEMQYEEITQRCLDKDPLRRWSCDQLLRHPYFNGYYF 268 (292)
Q Consensus 218 ~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~~il~h~w~~~~~~ 268 (292)
...........+..+.+||.+||+.||.+|||+.++++||||++...
T Consensus 250 ----~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~h~~~~~~~~ 296 (303)
T 2vwi_A 250 ----GVQDKEMLKKYGKSFRKMISLCLQKDPEKRPTAAELLRHKFFQKAKN 296 (303)
T ss_dssp ---------CCCCCCCHHHHHHHHHHCCSSGGGSCCHHHHHTSTTC-----
T ss_pred ----ccccchhhhhhhHHHHHHHHHHccCChhhCcCHHHHhhChhhhcCCC
Confidence 00001112344678999999999999999999999999999998553
|
| >3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.8e-42 Score=280.59 Aligned_cols=249 Identities=24% Similarity=0.372 Sum_probs=188.1
Q ss_pred cccceeeeecccCceEEEEEEEcCCCcEEEEEEeccCCCChHHHHHHHHHHHHHHhCCCCCcchhhhhhhcCCeEEEEEe
Q psy758 2 ERYEKIGKLGEGSYGVVFKCRNRDTGQVVAIKKFLESEEDPLIRKIALREIRLLKSLKHPNLVNLLEVFRRKKKLHLVFE 81 (292)
Q Consensus 2 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~iv~e 81 (292)
++|++.+.||+|+||.||+|.+..+++.||+|.+.. ......+.+.+|+.+++.++||||+++++++.+++..++|||
T Consensus 10 ~~~~~~~~lG~G~~g~V~~~~~~~~~~~va~K~~~~--~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e 87 (310)
T 3s95_A 10 SDLIHGEVLGKGCFGQAIKVTHRETGEVMVMKELIR--FDEETQRTFLKEVKVMRCLEHPNVLKFIGVLYKDKRLNFITE 87 (310)
T ss_dssp GGEEEEEEEECCSSEEEEEEEETTTCCEEEEEEESC--CCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred hHeeccceecCCCCEEEEEEEECCCCcEEEEEEecc--CCHHHHHHHHHHHHHHHhCCCcCcccEEEEEecCCeeEEEEE
Confidence 689999999999999999999999999999998844 345567788999999999999999999999999999999999
Q ss_pred cCCCccHHHHhcC-CCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEEccCCcEEEeecCchhhhhcccc----
Q psy758 82 FCDHTVLNELENH-PHGLPWDLIKQITWQVLRGVSYCHRHACIHRDIKPENILLTANGVVKLCDFGFARLIRDLIP---- 156 (292)
Q Consensus 82 ~~~~~~L~~~~~~-~~~~~~~~~~~i~~qi~~aL~~LH~~givH~dl~p~Nilv~~~~~~kl~dfg~~~~~~~~~~---- 156 (292)
|+.+++|.+++.. ...+++..++.++.||+.||+|||++|++|+||||+||+++.++.++|+|||++........
T Consensus 88 ~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~ 167 (310)
T 3s95_A 88 YIKGGTLRGIIKSMDSQYPWSQRVSFAKDIASGMAYLHSMNIIHRDLNSHNCLVRENKNVVVADFGLARLMVDEKTQPEG 167 (310)
T ss_dssp CCTTCBHHHHHHHCCTTSCHHHHHHHHHHHHHHHHHHHHTTEECSCCSTTSEEECTTSCEEECCCTTCEECC--------
T ss_pred ecCCCcHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCCccCCCCCcCeEEECCCCCEEEeecccceecccccccccc
Confidence 9999999999875 56799999999999999999999999999999999999999999999999999976533211
Q ss_pred ---------------ccccccccccccccCCCCCCCcccceeeecCCCCCCchHHHHHHHhhcccCCCCCCChhhhhhcc
Q psy758 157 ---------------RHLHIFQTNEYFKGVSLPHAENVVPLEIKIGKPAATNIYLIDFLKRCLDKDPLRRWSCDQLLRHP 221 (292)
Q Consensus 157 ---------------~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~ 221 (292)
.++..|.+||...+.......|+|++++ .++..+.+..|.............
T Consensus 168 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~-------------~l~el~~g~~~~~~~~~~~~~~~~ 234 (310)
T 3s95_A 168 LRSLKKPDRKKRYTVVGNPYWMAPEMINGRSYDEKVDVFSFGI-------------VLCEIIGRVNADPDYLPRTMDFGL 234 (310)
T ss_dssp ------------CCCCSCGGGCCHHHHTTCCCCTHHHHHHHHH-------------HHHHHHHTCCSSTTTSCBCTTSSB
T ss_pred cccccccccccccccCCCcceeCHHHhcCCCCCcHHHHHHHHH-------------HHHHHhcCCCCCcchhhhHHHHhh
Confidence 2334466666665544433333333322 222222232222211110000000
Q ss_pred C---cCCCCCCCCCccchHHHHhcccCcCCCCCCChhhhhhCCccccee
Q psy758 222 Y---FNGYYFEVPDEMQYEEITQRCLDKDPLRRWSCDQLLRHPYFNGYY 267 (292)
Q Consensus 222 ~---~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~~il~h~w~~~~~ 267 (292)
. ......+...+..+.++|.+||+.||.+|||+.++++ ||+.+.
T Consensus 235 ~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~~l~~--~L~~l~ 281 (310)
T 3s95_A 235 NVRGFLDRYCPPNCPPSFFPITVRCCDLDPEKRPSFVKLEH--WLETLR 281 (310)
T ss_dssp CHHHHHHHTCCTTCCTTHHHHHHHHTCSSGGGSCCHHHHHH--HHHHHH
T ss_pred hhhccccccCCCCCCHHHHHHHHHHccCChhhCcCHHHHHH--HHHHHH
Confidence 0 0001123455779999999999999999999999998 777654
|
| >3kvw_A DYRK2, dual specificity tyrosine-phosphorylation-regulat 2; KI-(Y)-phosphorylation REG kinase 2, PSK-H2, kinase, structural genomics consortium; HET: SEP PTR IRB; 2.28A {Homo sapiens} PDB: 3k2l_A* 4azf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.6e-42 Score=291.68 Aligned_cols=262 Identities=26% Similarity=0.391 Sum_probs=190.4
Q ss_pred cccceeeeecccCceEEEEEEEcCCCcEEEEEEeccCCCChHHHHHHHHHHHHHHhC------CCCCcchhhhhhhcCCe
Q psy758 2 ERYEKIGKLGEGSYGVVFKCRNRDTGQVVAIKKFLESEEDPLIRKIALREIRLLKSL------KHPNLVNLLEVFRRKKK 75 (292)
Q Consensus 2 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~e~~~~~~l------~~~~i~~~~~~~~~~~~ 75 (292)
++|++.+.||+|+||.||+|.+..+++.||+|++... ......+.+|+.+++.+ +|+||+++++++...+.
T Consensus 97 ~ry~~~~~LG~G~fg~V~~a~~~~~~~~vAvK~~~~~---~~~~~~~~~E~~~l~~l~~~~~~~~~~iv~~~~~~~~~~~ 173 (429)
T 3kvw_A 97 YRYEVLKVIGKGSFGQVVKAYDHKVHQHVALKMVRNE---KRFHRQAAEEIRILEHLRKQDKDNTMNVIHMLENFTFRNH 173 (429)
T ss_dssp TTEEEEEEEEESSSEEEEEEEETTTTEEEEEEEECSC---HHHHHHHHHHHHHHHHHHTTCTTSCSCBCCEEEEEEETTE
T ss_pred CcEEEEEEcccCccEEEEEEEECCCCcEEEEEEECCc---cchHHHHHHHHHHHHHHhhccccCCcCEEEEEeecccCCe
Confidence 5799999999999999999999999999999998653 33445667788888777 57799999999999999
Q ss_pred EEEEEecCCCccHHHHhcCC--CCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEEccCCc--EEEeecCchhhh
Q psy758 76 LHLVFEFCDHTVLNELENHP--HGLPWDLIKQITWQVLRGVSYCHRHACIHRDIKPENILLTANGV--VKLCDFGFARLI 151 (292)
Q Consensus 76 ~~iv~e~~~~~~L~~~~~~~--~~~~~~~~~~i~~qi~~aL~~LH~~givH~dl~p~Nilv~~~~~--~kl~dfg~~~~~ 151 (292)
+++||||+++ +|.+++... ..+++..++.++.||+.||+|||++||+||||||+|||++.++. +||+|||++...
T Consensus 174 ~~lv~e~~~~-~L~~~l~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlKp~NILl~~~~~~~vkL~DFG~a~~~ 252 (429)
T 3kvw_A 174 ICMTFELLSM-NLYELIKKNKFQGFSLPLVRKFAHSILQCLDALHKNRIIHCDLKPENILLKQQGRSGIKVIDFGSSCYE 252 (429)
T ss_dssp EEEEECCCCC-BHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHHTEECSCCSGGGEEESSTTSCCEEECCCTTCEET
T ss_pred EEEEEeccCC-CHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEEccCCCcceEEeecccceec
Confidence 9999999986 555555433 34999999999999999999999999999999999999999987 999999998665
Q ss_pred hcc--ccccccccccccccccCCC-----CCCCcccceeeecCCCCCCchHHHHHHHhh---cccCCCCCC----Chhhh
Q psy758 152 RDL--IPRHLHIFQTNEYFKGVSL-----PHAENVVPLEIKIGKPAATNIYLIDFLKRC---LDKDPLRRW----SCDQL 217 (292)
Q Consensus 152 ~~~--~~~~~~~~~~~~~~~~~~~-----~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~---~~~~p~~~~----~~~~~ 217 (292)
... ....+..|.+||...+... .|+.|+..+++.+|.+++......+.+..+ ++..+.... .....
T Consensus 253 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltG~~pf~~~~~~~~l~~i~~~~~~p~~~~~~~~~~~~~~ 332 (429)
T 3kvw_A 253 HQRVYTYIQSRFYRAPEVILGARYGMPIDMWSLGCILAELLTGYPLLPGEDEGDQLACMIELLGMPSQKLLDASKRAKNF 332 (429)
T ss_dssp TCCCCSSCSCGGGCCHHHHHTBCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHHHTBTTHHHH
T ss_pred CCcccccCCCCCccChHHHhCCCCCchHHHHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCCHHHHHhhhhhhhc
Confidence 432 2234556888888766544 466666667778887766544333322222 221110000 00000
Q ss_pred hhccCcC--------------------------CC--------CCCCCCccchHHHHhcccCcCCCCCCChhhhhhCCcc
Q psy758 218 LRHPYFN--------------------------GY--------YFEVPDEMQYEEITQRCLDKDPLRRWSCDQLLRHPYF 263 (292)
Q Consensus 218 ~~~~~~~--------------------------~~--------~~~~~~~~~l~~li~~~l~~dP~~Rpt~~~il~h~w~ 263 (292)
+....+. .. ..+...++.+.+||.+||++||++|||++|+|+||||
T Consensus 333 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~dli~~~L~~dP~~Rpta~e~L~Hpw~ 412 (429)
T 3kvw_A 333 VSSKGYPRYCTVTTLSDGSVVLNGGRSRRGKLRGPPESREWGNALKGCDDPLFLDFLKQCLEWDPAVRMTPGQALRHPWL 412 (429)
T ss_dssp BCTTSCBTTSCEECCCC--CEECCEECTTCCEECSTTCSCHHHHTTTCCCHHHHHHHHHHTCSSTTTSCCHHHHHTSTTT
T ss_pred cCCCCCcccccccccccccccccccccchhhccCCccchhhHhhccccchHHHHHHHHHHCCCChhhCCCHHHHhCChhh
Confidence 0000000 00 0111235678999999999999999999999999999
Q ss_pred ccee
Q psy758 264 NGYY 267 (292)
Q Consensus 264 ~~~~ 267 (292)
++..
T Consensus 413 ~~~~ 416 (429)
T 3kvw_A 413 RRRL 416 (429)
T ss_dssp C---
T ss_pred ccCC
Confidence 9854
|
| >1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-42 Score=289.85 Aligned_cols=251 Identities=25% Similarity=0.336 Sum_probs=190.6
Q ss_pred CcccceeeeecccCceEEEEEEEc---CCCcEEEEEEeccCCC--ChHHHHHHHHHHHHHHhC-CCCCcchhhhhhhcCC
Q psy758 1 MERYEKIGKLGEGSYGVVFKCRNR---DTGQVVAIKKFLESEE--DPLIRKIALREIRLLKSL-KHPNLVNLLEVFRRKK 74 (292)
Q Consensus 1 ~~~y~~~~~l~~g~~~~v~~~~~~---~~~~~v~iK~~~~~~~--~~~~~~~~~~e~~~~~~l-~~~~i~~~~~~~~~~~ 74 (292)
+++|++.+.||+|+||.||+|++. .+++.||+|++..... .......+.+|+.+++.+ .||||+++++++.+++
T Consensus 53 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~ 132 (355)
T 1vzo_A 53 IENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTET 132 (355)
T ss_dssp GGGEEEEEEEEETTTEEEEEEEECSSTTTTCEEEEEEESEEEEEEEESSGGGCCCHHHHHHHHHTCTTBCCEEEEEEETT
T ss_pred ccceEEEEEeccCCCEEEEEEEEcccCCCCeEEEEEEEeHHHhhhhhhHHHHHHHHHHHHHHccCCCceeEEEEEEeeCc
Confidence 368999999999999999999984 4789999999864321 111234466799999999 6999999999999999
Q ss_pred eEEEEEecCCCccHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEEccCCcEEEeecCchhhhhcc
Q psy758 75 KLHLVFEFCDHTVLNELENHPHGLPWDLIKQITWQVLRGVSYCHRHACIHRDIKPENILLTANGVVKLCDFGFARLIRDL 154 (292)
Q Consensus 75 ~~~iv~e~~~~~~L~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~givH~dl~p~Nilv~~~~~~kl~dfg~~~~~~~~ 154 (292)
..++||||+++++|.+++.....+++..++.++.||+.||.|||++||+|+||||+||+++.++.++|+|||++......
T Consensus 133 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~kl~DfG~a~~~~~~ 212 (355)
T 1vzo_A 133 KLHLILDYINGGELFTHLSQRERFTEHEVQIYVGEIVLALEHLHKLGIIYRDIKLENILLDSNGHVVLTDFGLSKEFVAD 212 (355)
T ss_dssp EEEEEECCCCSCBHHHHHHHHSCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTSCEEESCSSEEEECCGG
T ss_pred eEEEEeecCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCcEEEeeCCCCeecccC
Confidence 99999999999999999987778999999999999999999999999999999999999999999999999998754321
Q ss_pred c------cccccccccccccccCC-------CCCCCcccceeeecCCCCCCchHHHHHHHhhcccCCCCCC----Chhhh
Q psy758 155 I------PRHLHIFQTNEYFKGVS-------LPHAENVVPLEIKIGKPAATNIYLIDFLKRCLDKDPLRRW----SCDQL 217 (292)
Q Consensus 155 ~------~~~~~~~~~~~~~~~~~-------~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~----~~~~~ 217 (292)
. ...+..|.+||...+.. ..|+.|+..+++.+| ..|+... ...++
T Consensus 213 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DvwslG~il~ell~g------------------~~pf~~~~~~~~~~~~ 274 (355)
T 1vzo_A 213 ETERAYDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTG------------------ASPFTVDGEKNSQAEI 274 (355)
T ss_dssp GGGGGCGGGSCCTTCCHHHHTTCC---CTHHHHHHHHHHHHHHHHS------------------SCTTSCTTSCCCHHHH
T ss_pred CCCcccCcccCcCccChhhhcCCCCCCCchhhHHHHHHHHHHHHHC------------------CCCCccCCccchHHHH
Confidence 1 12344566666655321 123333333333333 3333211 11222
Q ss_pred hhccCcCCCCCCCCCccchHHHHhcccCcCCCCCC-----ChhhhhhCCcccceecc
Q psy758 218 LRHPYFNGYYFEVPDEMQYEEITQRCLDKDPLRRW-----SCDQLLRHPYFNGYYFE 269 (292)
Q Consensus 218 ~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rp-----t~~~il~h~w~~~~~~~ 269 (292)
...........+...+..+.+||.+||+.||.+|| |++++++||||++..|+
T Consensus 275 ~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~~~~~~s~~ell~h~~f~~~~~~ 331 (355)
T 1vzo_A 275 SRRILKSEPPYPQEMSALAKDLIQRLLMKDPKKRLGCGPRDADEIKEHLFFQKINWD 331 (355)
T ss_dssp HHHHHHCCCCCCTTSCHHHHHHHHHHTCSSGGGSTTSSTTTHHHHHTSGGGTTCCHH
T ss_pred HHHHhccCCCCCcccCHHHHHHHHHHhhhCHHHhcCCCCCCHHHHHcCcchhcCChh
Confidence 22111112233445677899999999999999999 99999999999997765
|
| >1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-41 Score=278.73 Aligned_cols=246 Identities=25% Similarity=0.368 Sum_probs=181.8
Q ss_pred cccceeeeecccCceEEEEEEEcCCCcEEEEEEeccCCCChHHHHHHHHHHHHHHhCCCCCcchhhhhhhc---------
Q psy758 2 ERYEKIGKLGEGSYGVVFKCRNRDTGQVVAIKKFLESEEDPLIRKIALREIRLLKSLKHPNLVNLLEVFRR--------- 72 (292)
Q Consensus 2 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~--------- 72 (292)
++|++.+.||+|+||.||+|.+..+++.||+|.+... ....+.+.+|+.+++.++||||+++++++.+
T Consensus 6 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~---~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~ 82 (303)
T 1zy4_A 6 SDFEEIAVLGQGAFGQVVKARNALDSRYYAIKKIRHT---EEKLSTILSEVMLLASLNHQYVVRYYAAWLERRNFVKPMT 82 (303)
T ss_dssp HHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEEE---HHHHHHHHHHHHHHTTCCCTTBCCEEEEEEECCCCCC---
T ss_pred ccchhhheeccCCcEEEEEEEEcCCCeEEEEEEEecc---HHHHHHHHHHHHHHHhcCchHHHHHHHHHHhhcchhhhhc
Confidence 5799999999999999999999999999999998543 3445778899999999999999999988754
Q ss_pred ----CCeEEEEEecCCCccHHHHhcC-CCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEEccCCcEEEeecCc
Q psy758 73 ----KKKLHLVFEFCDHTVLNELENH-PHGLPWDLIKQITWQVLRGVSYCHRHACIHRDIKPENILLTANGVVKLCDFGF 147 (292)
Q Consensus 73 ----~~~~~iv~e~~~~~~L~~~~~~-~~~~~~~~~~~i~~qi~~aL~~LH~~givH~dl~p~Nilv~~~~~~kl~dfg~ 147 (292)
.+..++||||+++++|.+++.. ...+++..++.++.||+.||.|||++|++|+||+|+||+++.++.++|+|||+
T Consensus 83 ~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dlkp~Nil~~~~~~~kl~dfg~ 162 (303)
T 1zy4_A 83 AVKKKSTLFIQMEYCENGTLYDLIHSENLNQQRDEYWRLFRQILEALSYIHSQGIIHRDLKPMNIFIDESRNVKIGDFGL 162 (303)
T ss_dssp ---CEEEEEEEEECCCSCBHHHHHHHSCGGGCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTSCEEECCCCC
T ss_pred ccccCCceEEEEecCCCCCHHHhhhccccccchHHHHHHHHHHHHHHHHHHhCCeecccCCHHhEEEcCCCCEEEeeCcc
Confidence 4578999999999999999874 34578899999999999999999999999999999999999999999999999
Q ss_pred hhhhhcc-------------------ccccccccccccccccC-CCC-----CCCcccceeeecCCCCCCchHHHHHHHh
Q psy758 148 ARLIRDL-------------------IPRHLHIFQTNEYFKGV-SLP-----HAENVVPLEIKIGKPAATNIYLIDFLKR 202 (292)
Q Consensus 148 ~~~~~~~-------------------~~~~~~~~~~~~~~~~~-~~~-----~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 202 (292)
+...... ....+..|.+||...+. ... |+.|+..+++.++.. .......++..
T Consensus 163 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~p~~--~~~~~~~~~~~ 240 (303)
T 1zy4_A 163 AKNVHRSLDILKLDSQNLPGSSDNLTSAIGTAMYVATEVLDGTGHYNEKIDMYSLGIIFFEMIYPFS--TGMERVNILKK 240 (303)
T ss_dssp CSCTTC-------------------------CTTSCHHHHTSCSCCCTHHHHHHHHHHHHHHHSCCS--SHHHHHHHHHH
T ss_pred hhhcccccchhccccccccccccccccCCCcccccCcccccCCCCCcchhhHHHHHHHHHHHHhccC--CchhHHHHHHh
Confidence 8765321 11223446666665443 222 333333333333111 11111112222
Q ss_pred hcccCCCCCCChhhhhhccCcCCCCCCCCCccchHHHHhcccCcCCCCCCChhhhhhCCcccce
Q psy758 203 CLDKDPLRRWSCDQLLRHPYFNGYYFEVPDEMQYEEITQRCLDKDPLRRWSCDQLLRHPYFNGY 266 (292)
Q Consensus 203 ~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~~il~h~w~~~~ 266 (292)
+...... + ........+..+.++|.+||+.||.+|||++++++||||+..
T Consensus 241 ~~~~~~~------------~--~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~h~~~~~~ 290 (303)
T 1zy4_A 241 LRSVSIE------------F--PPDFDDNKMKVEKKIIRLLIDHDPNKRPGARTLLNSGWLPVK 290 (303)
T ss_dssp HHSTTCC------------C--CTTCCTTTSHHHHHHHHHHTCSSGGGSCCHHHHHHSSCSCCC
T ss_pred ccccccc------------c--CccccccchHHHHHHHHHHHhcCcccCcCHHHHhCCCCcCCC
Confidence 1111100 0 011223445678999999999999999999999999999864
|
| >3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-41 Score=276.92 Aligned_cols=251 Identities=26% Similarity=0.341 Sum_probs=193.2
Q ss_pred cccceeeeecccCceEEEEEEEcCCCcEEEEEEeccCCCChHHHHHHHHHHHHHHhCCCCCcchhhhhhhcCCeEEEEEe
Q psy758 2 ERYEKIGKLGEGSYGVVFKCRNRDTGQVVAIKKFLESEEDPLIRKIALREIRLLKSLKHPNLVNLLEVFRRKKKLHLVFE 81 (292)
Q Consensus 2 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~iv~e 81 (292)
++|++.+.||+|++|.||+|.+..+++.||+|++....... ..+.+.+|+.+++.++||||+++++++.+.+..++|||
T Consensus 22 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~-~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 100 (303)
T 3a7i_A 22 ELFTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAED-EIEDIQQEITVLSQCDSPYVTKYYGSYLKDTKLWIIME 100 (303)
T ss_dssp GTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEETTTCST-THHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred HHHHHhhhhcccCCeEEEEEEECCCCcEEEEEEecccccHH-HHHHHHHHHHHHHhCCCCCEeEEEEEEecCCeEEEEEE
Confidence 46999999999999999999999999999999997654332 35668899999999999999999999999999999999
Q ss_pred cCCCccHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEEccCCcEEEeecCchhhhhccc-----c
Q psy758 82 FCDHTVLNELENHPHGLPWDLIKQITWQVLRGVSYCHRHACIHRDIKPENILLTANGVVKLCDFGFARLIRDLI-----P 156 (292)
Q Consensus 82 ~~~~~~L~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~givH~dl~p~Nilv~~~~~~kl~dfg~~~~~~~~~-----~ 156 (292)
|+++++|.+++.. +.+++..++.++.||+.||.|||++|++|+||+|+||+++.++.++|+|||++....... .
T Consensus 101 ~~~~~~L~~~~~~-~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~ 179 (303)
T 3a7i_A 101 YLGGGSALDLLEP-GPLDETQIATILREILKGLDYLHSEKKIHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQIKRNTF 179 (303)
T ss_dssp CCTTEEHHHHHTT-SCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTCEECBTTBCCBCCC
T ss_pred eCCCCcHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCCccCCCChheEEECCCCCEEEeecccceecCccccccCcc
Confidence 9999999999876 479999999999999999999999999999999999999999999999999987654322 1
Q ss_pred ccccccccccccccCCCCCCCcccceeeecCCCCCCchHHHHHHHhhcccCCCCCCChhhhhhccC-cCCCCCCCCCccc
Q psy758 157 RHLHIFQTNEYFKGVSLPHAENVVPLEIKIGKPAATNIYLIDFLKRCLDKDPLRRWSCDQLLRHPY-FNGYYFEVPDEMQ 235 (292)
Q Consensus 157 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~-~~~~~~~~~~~~~ 235 (292)
..+..|.+||...+.......++|+ .+.-++..+.+..|.......+...... ......+...+..
T Consensus 180 ~~~~~y~aPE~~~~~~~~~~~Di~s-------------lG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 246 (303)
T 3a7i_A 180 VGTPFWMAPEVIKQSAYDSKADIWS-------------LGITAIELARGEPPHSELHPMKVLFLIPKNNPPTLEGNYSKP 246 (303)
T ss_dssp CSCGGGCCHHHHTTCCBCTHHHHHH-------------HHHHHHHHHHSSCTTTTSCHHHHHHHHHHSCCCCCCSSCCHH
T ss_pred CCCcCccCHHHHhcCCCCchhhhHH-------------HHHHHHHHccCCCCCCCcCHHHHHHHhhcCCCCCCccccCHH
Confidence 2334466666665443322222222 2222333344444444333332221100 0011223345778
Q ss_pred hHHHHhcccCcCCCCCCChhhhhhCCccccee
Q psy758 236 YEEITQRCLDKDPLRRWSCDQLLRHPYFNGYY 267 (292)
Q Consensus 236 l~~li~~~l~~dP~~Rpt~~~il~h~w~~~~~ 267 (292)
+.+||.+||+.||.+|||+.++++||||....
T Consensus 247 l~~li~~~l~~dp~~Rps~~~ll~~~~~~~~~ 278 (303)
T 3a7i_A 247 LKEFVEACLNKEPSFRPTAKELLKHKFILRNA 278 (303)
T ss_dssp HHHHHHHHCCSSGGGSCCHHHHTTCHHHHHHC
T ss_pred HHHHHHHHcCCChhhCcCHHHHhhChhhhcCC
Confidence 99999999999999999999999999998743
|
| >3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-42 Score=292.14 Aligned_cols=248 Identities=15% Similarity=0.091 Sum_probs=170.7
Q ss_pred ccceeeeecccCceEEEEEEEcCCCcEEEEEEeccCCC-ChHHHHHHHHHHHHHHhC--CCCCcchhhhhh-------hc
Q psy758 3 RYEKIGKLGEGSYGVVFKCRNRDTGQVVAIKKFLESEE-DPLIRKIALREIRLLKSL--KHPNLVNLLEVF-------RR 72 (292)
Q Consensus 3 ~y~~~~~l~~g~~~~v~~~~~~~~~~~v~iK~~~~~~~-~~~~~~~~~~e~~~~~~l--~~~~i~~~~~~~-------~~ 72 (292)
+|++.+.||+|+||.||+|.+..+++.||+|++..... .....+.+.+|+.+++.+ +||||++++..+ ..
T Consensus 63 ~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~~~~l~~~hp~iv~~~~~~~~p~d~~~~ 142 (371)
T 3q60_A 63 KLKLVEPLRVGDRSVVFLVRDVERLEDFALKVFTMGAENSRSELERLHEATFAAARLLGESPEEARDRRRLLLPSDAVAV 142 (371)
T ss_dssp EEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEECCSTTHHHHHHHHHHHHHHHHHHHC----------CBCCCCEEEEE
T ss_pred eeeeeeeccCCCCEEEEEEEECCCCceeEEEEEEecccccccHHHHHHHHHHHHHHhcccChhhhhhceeEEeeehheec
Confidence 58999999999999999999999999999999987664 344566677785544444 699988866333 22
Q ss_pred C-----------------CeEEEEEecCCCccHHHHhcCC-CCCCHHHH------HHHHHHHHHHHHHHHhCCccccCCC
Q psy758 73 K-----------------KKLHLVFEFCDHTVLNELENHP-HGLPWDLI------KQITWQVLRGVSYCHRHACIHRDIK 128 (292)
Q Consensus 73 ~-----------------~~~~iv~e~~~~~~L~~~~~~~-~~~~~~~~------~~i~~qi~~aL~~LH~~givH~dl~ 128 (292)
. ..+|+||||++ ++|.+++... ..+++..+ ..++.||+.||+|||++||+|||||
T Consensus 143 ~~~~~~~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~~~~~~~~~~~~~~vk~~i~~qi~~aL~~LH~~~ivHrDik 221 (371)
T 3q60_A 143 QSQPPFAQLSPGQDDYAVANYLLLMPAAS-VDLELLFSTLDFVYVFRGDEGILALHILTAQLIRLAANLQSKGLVHGHFT 221 (371)
T ss_dssp TTSCSSSBCSCC---CCEEEEEEEECCCS-EEHHHHHHHHHHSCCCCHHHHHHHHHHHHHHHHHHHHHHHHTTEEETTCS
T ss_pred CCCCCeeeccCCcccceeeeEEEEecCCC-CCHHHHHHHhccccchhhhhhhhhHHHHHHHHHHHHHHHHHCCCccCcCC
Confidence 1 34899999999 7888887652 23455555 6788999999999999999999999
Q ss_pred CCceEEccCCcEEEeecCchhhhhccc--ccccccccccccccc--CCCC-----CCCcccceeeecCCCCCCchHHHHH
Q psy758 129 PENILLTANGVVKLCDFGFARLIRDLI--PRHLHIFQTNEYFKG--VSLP-----HAENVVPLEIKIGKPAATNIYLIDF 199 (292)
Q Consensus 129 p~Nilv~~~~~~kl~dfg~~~~~~~~~--~~~~~~~~~~~~~~~--~~~~-----~~~~~~~~~~~~~~~~~~~~~~~~~ 199 (292)
|+|||++.++.+||+|||++....... ...+..|.+||...+ .... |+.|+..+++++|..
T Consensus 222 p~NIll~~~~~~kL~DFG~a~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~DiwSlG~il~elltg~~---------- 291 (371)
T 3q60_A 222 PDNLFIMPDGRLMLGDVSALWKVGTRGPASSVPVTYAPREFLNASTATFTHALNAWQLGLSIYRVWCLFL---------- 291 (371)
T ss_dssp GGGEEECTTSCEEECCGGGEEETTCEEEGGGSCGGGCCHHHHTCSEEECCHHHHHHHHHHHHHHHHHSSC----------
T ss_pred HHHEEECCCCCEEEEecceeeecCCCccCccCCcCCcChhhccCCCCCcCccccHHHHHHHHHHHHhCCC----------
Confidence 999999999999999999998765432 233356777777654 2222 334444444444443
Q ss_pred HHhhcccCCCCCCChhh--hhhc-----cCcCCC--CCCCCCccchHHHHhcccCcCCCCCCChhhhhhCCcccceecc
Q psy758 200 LKRCLDKDPLRRWSCDQ--LLRH-----PYFNGY--YFEVPDEMQYEEITQRCLDKDPLRRWSCDQLLRHPYFNGYYFE 269 (292)
Q Consensus 200 ~~~~~~~~p~~~~~~~~--~~~~-----~~~~~~--~~~~~~~~~l~~li~~~l~~dP~~Rpt~~~il~h~w~~~~~~~ 269 (292)
|+....... .... ...... ......+..+.+||.+||+.||++|||+.++++||||++..+.
T Consensus 292 --------Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~hp~f~~~~~~ 362 (371)
T 3q60_A 292 --------PFGLVTPGIKGSWKRPSLRVPGTDSLAFGSCTPLPDFVKTLIGRFLNFDRRRRLLPLEAMETPEFLQLQNE 362 (371)
T ss_dssp --------STTBCCTTCTTCCCBCCTTSCCCCSCCCTTSSCCCHHHHHHHHHHTCSSTTTCCCHHHHTTSHHHHHHHHH
T ss_pred --------CCCCcCcccccchhhhhhhhccccccchhhccCCCHHHHHHHHHHcCCChhhCCCHHHHhcCHHHHHHHHH
Confidence 332221110 0000 000011 1123558899999999999999999999999999999987644
|
| >1wak_A Serine/threonine-protein kinase SPRK1; SRPK, transferase, alternative splicing, ATP-binding, chromosome partition, differentiation, mRNA processing; 1.73A {Homo sapiens} PDB: 1wbp_A* 3beg_A* 2x7g_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.1e-42 Score=291.65 Aligned_cols=260 Identities=29% Similarity=0.440 Sum_probs=191.3
Q ss_pred cccceeeeecccCceEEEEEEEcCCCcEEEEEEeccCCCChHHHHHHHHHHHHHHhCC--------CCCcchhhhhhh--
Q psy758 2 ERYEKIGKLGEGSYGVVFKCRNRDTGQVVAIKKFLESEEDPLIRKIALREIRLLKSLK--------HPNLVNLLEVFR-- 71 (292)
Q Consensus 2 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~e~~~~~~l~--------~~~i~~~~~~~~-- 71 (292)
++|++.+.||+|+||.||+|++..+++.||+|++... ....+.+.+|+.+++.++ |+||+++++++.
T Consensus 37 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~---~~~~~~~~~E~~~l~~l~~~~~~~~~~~~iv~~~~~~~~~ 113 (397)
T 1wak_A 37 GRYHVIRKLGWGHFSTVWLSWDIQGKKFVAMKVVKSA---EHYTETALDEIRLLKSVRNSDPNDPNREMVVQLLDDFKIS 113 (397)
T ss_dssp TTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSC---HHHHHHHHHHHHHHHHHHHSCTTCGGGGGBCCEEEEEEEE
T ss_pred CeEEEEEEeeecCCeeEEEEEecCCCeEEEEEEEecC---CcchHHHHHHHHHHHHHhhcCCCCCCcceeeeeecceeec
Confidence 6899999999999999999999999999999998643 344567889999999986 778999999987
Q ss_pred --cCCeEEEEEecCCCccHHHHhcCC-CCCCHHHHHHHHHHHHHHHHHHHhC-CccccCCCCCceEEccCC---------
Q psy758 72 --RKKKLHLVFEFCDHTVLNELENHP-HGLPWDLIKQITWQVLRGVSYCHRH-ACIHRDIKPENILLTANG--------- 138 (292)
Q Consensus 72 --~~~~~~iv~e~~~~~~L~~~~~~~-~~~~~~~~~~i~~qi~~aL~~LH~~-givH~dl~p~Nilv~~~~--------- 138 (292)
+...+++||||++++++..+.... ..+++..++.++.||+.||+|||++ ||+||||||+|||++.++
T Consensus 114 ~~~~~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~lH~~~givHrDikp~NIll~~~~~~~~~~~~~ 193 (397)
T 1wak_A 114 GVNGTHICMVFEVLGHHLLKWIIKSNYQGLPLPCVKKIIQQVLQGLDYLHTKCRIIHTDIKPENILLSVNEQYIRRLAAE 193 (397)
T ss_dssp ETTEEEEEEEECCCCCBHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHHHTTCEECCCCSGGGEEECCCHHHHHHHHHH
T ss_pred CCCCceEEEEEeccCccHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHeeEeccchhhhhhhhh
Confidence 556899999999887777777653 5699999999999999999999998 999999999999999775
Q ss_pred ----------------------------------------cEEEeecCchhhhhccc--cccccccccccccccCCC---
Q psy758 139 ----------------------------------------VVKLCDFGFARLIRDLI--PRHLHIFQTNEYFKGVSL--- 173 (292)
Q Consensus 139 ----------------------------------------~~kl~dfg~~~~~~~~~--~~~~~~~~~~~~~~~~~~--- 173 (292)
.++|+|||++....... ..++..|.+||...+...
T Consensus 194 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~kl~DfG~a~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~ 273 (397)
T 1wak_A 194 ATEWQRSGAPPPSGSAVSTAPATAGNFLVNPLEPKNAEKLKVKIADLGNACWVHKHFTEDIQTRQYRSLEVLIGSGYNTP 273 (397)
T ss_dssp HC---------------------CCTTSCCTTSGGGGGGCCEEECCGGGCEETTBCSCSCCSCGGGCCHHHHHTSCCCTH
T ss_pred hHHHhhcCCCCCCCCccccCCcccccccccccccccccccceEeccccccccccccCccCCCCCcccCChhhcCCCCCcH
Confidence 79999999997654322 233566788887766544
Q ss_pred --CCCCcccceeeecCCCCCCc---------hHHHHHHHhhcccCCCCCCChhhhhhccCcC------------------
Q psy758 174 --PHAENVVPLEIKIGKPAATN---------IYLIDFLKRCLDKDPLRRWSCDQLLRHPYFN------------------ 224 (292)
Q Consensus 174 --~~~~~~~~~~~~~~~~~~~~---------~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~------------------ 224 (292)
.|+.|+..+++++|..++.. ......+...++..|..... .......++.
T Consensus 274 ~DiwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 352 (397)
T 1wak_A 274 ADIWSTACMAFELATGDYLFEPHSGEEYTRDEDHIALIIELLGKVPRKLIV-AGKYSKEFFTKKGDLKHITKLKPWGLFE 352 (397)
T ss_dssp HHHHHHHHHHHHHHHSSCSCCCCCCSSSCHHHHHHHHHHHHHCSCCHHHHH-HCTTGGGTBCTTSSBSSCCCCCCCCHHH
T ss_pred HHHHHHHHHHHHHhhCCCCCCCCcccccCchHHHHHHHHHhcCCCChHHhh-cccccccccCCccccccccccCCcchhH
Confidence 35566666666777665431 11222222222222210000 0000000000
Q ss_pred ----CCCCCCCCccchHHHHhcccCcCCCCCCChhhhhhCCcccc
Q psy758 225 ----GYYFEVPDEMQYEEITQRCLDKDPLRRWSCDQLLRHPYFNG 265 (292)
Q Consensus 225 ----~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~~il~h~w~~~ 265 (292)
....+...+..+.+||.+||+.||++|||++|+|+||||++
T Consensus 353 ~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~hp~~~~ 397 (397)
T 1wak_A 353 VLVEKYEWSQEEAAGFTDFLLPMLELIPEKRATAAECLRHPWLNS 397 (397)
T ss_dssp HHHHTSCCCHHHHHHHHHHHGGGGCSSGGGSCCHHHHHTSGGGGC
T ss_pred hhhhhcccchhhHHHHHHHHHHHhccChhhcCCHHHHhhCccccC
Confidence 01112223556889999999999999999999999999974
|
| >1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B | Back alignment and structure |
|---|
Probab=100.00 E-value=8.5e-42 Score=282.31 Aligned_cols=267 Identities=31% Similarity=0.503 Sum_probs=190.3
Q ss_pred cccceeeeecccCceEEEEEEEc-CCCcEEEEEEeccCCCChHHHHHHHHHHHHHHhC---CCCCcchhhhhhh-----c
Q psy758 2 ERYEKIGKLGEGSYGVVFKCRNR-DTGQVVAIKKFLESEEDPLIRKIALREIRLLKSL---KHPNLVNLLEVFR-----R 72 (292)
Q Consensus 2 ~~y~~~~~l~~g~~~~v~~~~~~-~~~~~v~iK~~~~~~~~~~~~~~~~~e~~~~~~l---~~~~i~~~~~~~~-----~ 72 (292)
++|++.+.||+|+||.||+|.+. .+++.||+|++............+.+|+.+++.+ +||||+++++++. .
T Consensus 11 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~~i~~~~~~~~~~~~~~ 90 (326)
T 1blx_A 11 QQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRTDR 90 (326)
T ss_dssp GTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEEEEEBCTTSCBCTHHHHHHHHHHHHHTCCTTBCCEEEEEEEEECSS
T ss_pred hceeeeeeecccccEEEEEEEecCCCCEEEEEEEeccCcccccCCchhhHHHHHHHhhhccCCCCeEeeeeeeeecccCC
Confidence 68999999999999999999995 6788999999865443222223345666666655 8999999999986 5
Q ss_pred CCeEEEEEecCCCccHHHHhcCC--CCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEEccCCcEEEeecCchhh
Q psy758 73 KKKLHLVFEFCDHTVLNELENHP--HGLPWDLIKQITWQVLRGVSYCHRHACIHRDIKPENILLTANGVVKLCDFGFARL 150 (292)
Q Consensus 73 ~~~~~iv~e~~~~~~L~~~~~~~--~~~~~~~~~~i~~qi~~aL~~LH~~givH~dl~p~Nilv~~~~~~kl~dfg~~~~ 150 (292)
....++|+||+++ +|.+++... ..+++..++.++.||+.||.|||++|++|+||+|+||+++.++.++|+|||++..
T Consensus 91 ~~~~~lv~e~~~~-~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~gi~H~dlkp~Nili~~~~~~kl~Dfg~~~~ 169 (326)
T 1blx_A 91 ETKLTLVFEHVDQ-DLTTYLDKVPEPGVPTETIKDMMFQLLRGLDFLHSHRVVHRDLKPQNILVTSSGQIKLADFGLARI 169 (326)
T ss_dssp EEEEEEEEECCSC-BHHHHHHHSCTTCSCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTCCEEECSCCSCCC
T ss_pred CceEEEEEecCCC-CHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCHHHeEEcCCCCEEEecCccccc
Confidence 5679999999995 777776543 3499999999999999999999999999999999999999999999999999876
Q ss_pred hhccc----cccccccccccccccCCC-----CCCCcccceeeecCCCCCCchHHHHHHHhhc---ccCCCCCCCh-hhh
Q psy758 151 IRDLI----PRHLHIFQTNEYFKGVSL-----PHAENVVPLEIKIGKPAATNIYLIDFLKRCL---DKDPLRRWSC-DQL 217 (292)
Q Consensus 151 ~~~~~----~~~~~~~~~~~~~~~~~~-----~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~---~~~p~~~~~~-~~~ 217 (292)
..... ...+..|.+||...+... .|+.|+..+++.++..++........+..++ ...+...+.. ...
T Consensus 170 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~ 249 (326)
T 1blx_A 170 YSFQMALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLPGEEDWPRDVAL 249 (326)
T ss_dssp CCGGGGGCCCCCCCTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCGGGSCTTCSS
T ss_pred ccCCCCccccccccceeCHHHHhcCCCCcchhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHHHcCCCCcccCcccccc
Confidence 54321 223455777777655443 3555556666677766654433333222221 1111110000 000
Q ss_pred hhccCcC-----CCCCCCCCccchHHHHhcccCcCCCCCCChhhhhhCCcccceecc
Q psy758 218 LRHPYFN-----GYYFEVPDEMQYEEITQRCLDKDPLRRWSCDQLLRHPYFNGYYFE 269 (292)
Q Consensus 218 ~~~~~~~-----~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~~il~h~w~~~~~~~ 269 (292)
....+.. ........+..+.+||.+||+.||.+|||+.++++||||++..+.
T Consensus 250 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~hp~~~~~~~~ 306 (326)
T 1blx_A 250 PRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALSHPYFQDLERC 306 (326)
T ss_dssp CGGGSCCCCCCCGGGTCCSCCHHHHHHHHHHSCSSTTTSCCHHHHHTSGGGTTCCCC
T ss_pred chhhhcccCcchhhhccccCCHHHHHHHHHHcCCCcccCCCHHHHhcCccccccchh
Confidence 0000000 001223457788999999999999999999999999999997654
|
| >3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.2e-42 Score=282.76 Aligned_cols=254 Identities=18% Similarity=0.216 Sum_probs=171.8
Q ss_pred cccceeeeecccCceEEEEEEEcCCCc---EEEEEEeccCCCChHHHHHHHHHHHHHHhCCCCCcchhhhhhhcCCeE--
Q psy758 2 ERYEKIGKLGEGSYGVVFKCRNRDTGQ---VVAIKKFLESEEDPLIRKIALREIRLLKSLKHPNLVNLLEVFRRKKKL-- 76 (292)
Q Consensus 2 ~~y~~~~~l~~g~~~~v~~~~~~~~~~---~v~iK~~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~-- 76 (292)
++|++.+.||+|+||.||+|.+..++. .||+|++..........+.+.+|+.+++.++||||+++++++.+....
T Consensus 23 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~ 102 (323)
T 3qup_A 23 QQFTLGRMLGKGEFGSVREAQLKQEDGSFVKVAVKMLKADIIASSDIEEFLREAACMKEFDHPHVAKLVGVSLRSRAKGR 102 (323)
T ss_dssp --CEEEEEEEEETTEEEEEEEC-------CEEEEEEC------CHHHHHHHHHHHHHTTCCCTTBCCCCEEEECC-----
T ss_pred hHeEEeceecccCCeEEEEEEEcccCCcceeEEEEEecccccCHHHHHHHHHHHHHHHHCCCCceehhhceeeccccccC
Confidence 579999999999999999999887765 899999977665556678899999999999999999999998776554
Q ss_pred ----EEEEecCCCccHHHHhcCC------CCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEEccCCcEEEeecC
Q psy758 77 ----HLVFEFCDHTVLNELENHP------HGLPWDLIKQITWQVLRGVSYCHRHACIHRDIKPENILLTANGVVKLCDFG 146 (292)
Q Consensus 77 ----~iv~e~~~~~~L~~~~~~~------~~~~~~~~~~i~~qi~~aL~~LH~~givH~dl~p~Nilv~~~~~~kl~dfg 146 (292)
++|+||+.+++|..++... ..+++..++.++.||+.||.|||++|++||||||+||+++.++.++|+|||
T Consensus 103 ~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~ivH~Dikp~NIli~~~~~~kl~Dfg 182 (323)
T 3qup_A 103 LPIPMVILPFMKHGDLHAFLLASRIGENPFNLPLQTLVRFMVDIACGMEYLSSRNFIHRDLAARNCMLAEDMTVCVADFG 182 (323)
T ss_dssp --CEEEEEECCTTCBHHHHHHHHHC---CCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECTTSCEEECCCC
T ss_pred CCccEEEEEeccCCcHHHHHHhhhccccccccCHHHHHHHHHHHHHHHHHHHcCCcccCCCCcceEEEcCCCCEEEeecc
Confidence 9999999999999987532 258999999999999999999999999999999999999999999999999
Q ss_pred chhhhhcccc-------ccccccccccccccCCCCCCCcccceeeecCCCCCCchHHHHHHHhhc-ccCCCCCCChhhhh
Q psy758 147 FARLIRDLIP-------RHLHIFQTNEYFKGVSLPHAENVVPLEIKIGKPAATNIYLIDFLKRCL-DKDPLRRWSCDQLL 218 (292)
Q Consensus 147 ~~~~~~~~~~-------~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~p~~~~~~~~~~ 218 (292)
++........ ..+..|.+||...+.......|+|+ .+.-++..+. +..|+......++.
T Consensus 183 ~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~s-------------lG~il~ell~~g~~p~~~~~~~~~~ 249 (323)
T 3qup_A 183 LSRKIYSGDYYRQGCASKLPVKWLALESLADNLYTVHSDVWA-------------FGVTMWEIMTRGQTPYAGIENAEIY 249 (323)
T ss_dssp C-----------------CCGGGCCHHHHHHCCCCHHHHHHH-------------HHHHHHHHHTTSCCTTTTCCGGGHH
T ss_pred ccccccccccccccccccCcccccCchhhcCCCCCCccchhh-------------HHHHHHHHHhCCCCCccccChHHHH
Confidence 9976543211 1122356666554443332222222 2222333344 44455444444433
Q ss_pred hccCcC-CCCCCCCCccchHHHHhcccCcCCCCCCC-------hhhhhhCCcccceec
Q psy758 219 RHPYFN-GYYFEVPDEMQYEEITQRCLDKDPLRRWS-------CDQLLRHPYFNGYYF 268 (292)
Q Consensus 219 ~~~~~~-~~~~~~~~~~~l~~li~~~l~~dP~~Rpt-------~~~il~h~w~~~~~~ 268 (292)
...... ....+...+..+.+||.+||+.||.+||| ++++++|||+.+...
T Consensus 250 ~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~l~~~l~~~~~~~~~~ 307 (323)
T 3qup_A 250 NYLIGGNRLKQPPECMEEVYDLMYQCWSADPKQRPSFTCLRMELENILGHLSVLSTSQ 307 (323)
T ss_dssp HHHHTTCCCCCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHHHC--------
T ss_pred HHHhcCCCCCCCCccCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHHhhhcCCCC
Confidence 321111 12233455788999999999999999999 888899999997543
|
| >3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-42 Score=285.57 Aligned_cols=242 Identities=24% Similarity=0.413 Sum_probs=188.2
Q ss_pred cccceeeeecccCceEEEEEEEcCCCcEEEEEEeccCCCCh----HHHHHHHHHHHHHHhCC--CCCcchhhhhhhcCCe
Q psy758 2 ERYEKIGKLGEGSYGVVFKCRNRDTGQVVAIKKFLESEEDP----LIRKIALREIRLLKSLK--HPNLVNLLEVFRRKKK 75 (292)
Q Consensus 2 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~v~iK~~~~~~~~~----~~~~~~~~e~~~~~~l~--~~~i~~~~~~~~~~~~ 75 (292)
++|++.+.||+|+||.||+|.+..+++.||+|.+....... .....+.+|+.+++.++ ||||+++++++.+++.
T Consensus 43 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~i~~~~~~~~~~~~ 122 (320)
T 3a99_A 43 SQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDWFERPDS 122 (320)
T ss_dssp TTEEEEEECSSSSSCEEEEEEETTTTEEEEEEEEEGGGCCCEEECTTCCEEEHHHHHHHHHCSSSCSBCCEEEEEECSSE
T ss_pred CceEEEEEEeeCCCeEEEEEEECCCCcEEEEEEEecccchhhhhhhhhhHHHHHHHHHHhhccCCCCceEEEEEEecCCc
Confidence 68999999999999999999999999999999986553221 12245667999999996 5999999999999999
Q ss_pred EEEEEecCCC-ccHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEEc-cCCcEEEeecCchhhhhc
Q psy758 76 LHLVFEFCDH-TVLNELENHPHGLPWDLIKQITWQVLRGVSYCHRHACIHRDIKPENILLT-ANGVVKLCDFGFARLIRD 153 (292)
Q Consensus 76 ~~iv~e~~~~-~~L~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~givH~dl~p~Nilv~-~~~~~kl~dfg~~~~~~~ 153 (292)
.++|+|++.+ ++|.+++...+.+++..++.++.||+.||.|||++||+||||||+||+++ +++.+||+|||++.....
T Consensus 123 ~~lv~e~~~~~~~L~~~l~~~~~l~~~~~~~i~~qi~~~L~~LH~~~ivH~Dlkp~NIll~~~~~~~kL~Dfg~~~~~~~ 202 (320)
T 3a99_A 123 FVLILERPEPVQDLFDFITERGALQEELARSFFWQVLEAVRHCHNCGVLHRDIKDENILIDLNRGELKLIDFGSGALLKD 202 (320)
T ss_dssp EEEEEECCSSEEEHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEETTTTEEEECCCTTCEECCS
T ss_pred EEEEEEcCCCCccHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCcEeCCCCHHHEEEeCCCCCEEEeeCcccccccc
Confidence 9999999986 89999988777899999999999999999999999999999999999999 778999999999876543
Q ss_pred cc---cccccccccccccccCCC------CCCCcccceeeecCCCCCCchHHHHHHHhhcccCCCCCCChhhhhhccCcC
Q psy758 154 LI---PRHLHIFQTNEYFKGVSL------PHAENVVPLEIKIGKPAATNIYLIDFLKRCLDKDPLRRWSCDQLLRHPYFN 224 (292)
Q Consensus 154 ~~---~~~~~~~~~~~~~~~~~~------~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~ 224 (292)
.. ...+..|.+||...+... .|+.|+..+++.++. .|+... .+.....
T Consensus 203 ~~~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~------------------~pf~~~--~~~~~~~--- 259 (320)
T 3a99_A 203 TVYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGD------------------IPFEHD--EEIIRGQ--- 259 (320)
T ss_dssp SCBCCCCSCGGGSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSS------------------CSCCSH--HHHHHCC---
T ss_pred ccccCCCCCccCCChHHhccCCCCCccchHHhHHHHHHHHHHCC------------------CCCCCh--hhhhccc---
Confidence 22 223445667766543322 233333333333333 333221 1122111
Q ss_pred CCCCCCCCccchHHHHhcccCcCCCCCCChhhhhhCCccccee
Q psy758 225 GYYFEVPDEMQYEEITQRCLDKDPLRRWSCDQLLRHPYFNGYY 267 (292)
Q Consensus 225 ~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~~il~h~w~~~~~ 267 (292)
...+...+..+.+||.+||+.||.+|||++++++||||++..
T Consensus 260 -~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~hp~~~~~~ 301 (320)
T 3a99_A 260 -VFFRQRVSSECQHLIRWCLALRPSDRPTFEEIQNHPWMQDVL 301 (320)
T ss_dssp -CCCSSCCCHHHHHHHHHHTCSSGGGSCCHHHHHTSGGGSSCC
T ss_pred -ccccccCCHHHHHHHHHHccCChhhCcCHHHHhcCHhhcCcc
Confidence 123345578999999999999999999999999999999855
|
| >2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-41 Score=282.23 Aligned_cols=265 Identities=26% Similarity=0.411 Sum_probs=194.3
Q ss_pred cccceeeeecccCceEEEEEEEcCCCcEEEEEEeccCCCChHHHHHHHHHHHHHHhCCCCCcchhhhhhhcC-----CeE
Q psy758 2 ERYEKIGKLGEGSYGVVFKCRNRDTGQVVAIKKFLESEEDPLIRKIALREIRLLKSLKHPNLVNLLEVFRRK-----KKL 76 (292)
Q Consensus 2 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~-----~~~ 76 (292)
++|++.+.||+|++|.||+|.+..+|+.||+|.+... ........+.+|+.+++.++||||+++++++... ...
T Consensus 11 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~-~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~ 89 (353)
T 2b9h_A 11 SDFQLKSLLGEGAYGVVCSATHKPTGEIVAIKKIEPF-DKPLFALRTLREIKILKHFKHENIITIFNIQRPDSFENFNEV 89 (353)
T ss_dssp TTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCC-SSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCSTTCCCE
T ss_pred cceEEeeEEcCCCCeEEEEEEECCCCcEEEEEeeccc-ccchHHHHHHHHHHHHHhCcCCCcCCeeeeecccccCccceE
Confidence 6899999999999999999999999999999998643 3344566788999999999999999999886543 679
Q ss_pred EEEEecCCCccHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEEccCCcEEEeecCchhhhhccc-
Q psy758 77 HLVFEFCDHTVLNELENHPHGLPWDLIKQITWQVLRGVSYCHRHACIHRDIKPENILLTANGVVKLCDFGFARLIRDLI- 155 (292)
Q Consensus 77 ~iv~e~~~~~~L~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~givH~dl~p~Nilv~~~~~~kl~dfg~~~~~~~~~- 155 (292)
++|+||+.+ +|..++.. +.+++..++.++.||+.||.|||++|++||||||+||+++.++.++|+|||++.......
T Consensus 90 ~lv~e~~~~-~L~~~~~~-~~~~~~~~~~~~~qi~~~L~~LH~~~ivH~Dlkp~Nil~~~~~~~kl~Dfg~a~~~~~~~~ 167 (353)
T 2b9h_A 90 YIIQELMQT-DLHRVIST-QMLSDDHIQYFIYQTLRAVKVLHGSNVIHRDLKPSNLLINSNCDLKVCDFGLARIIDESAA 167 (353)
T ss_dssp EEEECCCSE-EHHHHHHH-CCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECTTCCEEECCCTTCEECC----
T ss_pred EEEEeccCc-cHHHHHhh-cCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEEcCCCcEEEEecccccccccccc
Confidence 999999985 67777765 469999999999999999999999999999999999999999999999999987654211
Q ss_pred --------------ccccccccccccccc-CC-----CCCCCcccceeeecCCCCCCchHHHHHHHh---hcccCCCCC-
Q psy758 156 --------------PRHLHIFQTNEYFKG-VS-----LPHAENVVPLEIKIGKPAATNIYLIDFLKR---CLDKDPLRR- 211 (292)
Q Consensus 156 --------------~~~~~~~~~~~~~~~-~~-----~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~---~~~~~p~~~- 211 (292)
..++..|.+||...+ .. ..|+.|+..+++.+|..++........+.. ..+..+...
T Consensus 168 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~ 247 (353)
T 2b9h_A 168 DNSEPTGQQSGMVEFVATRWYRAPEVMLTSAKYSRAMDVWSCGCILAELFLRRPIFPGRDYRHQLLLIFGIIGTPHSDND 247 (353)
T ss_dssp ------------CCCCCCGGGCCHHHHHSCCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCSTTT
T ss_pred cccCccccccchhhccccccccCCeeeccCCCccchhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCchhcc
Confidence 122445777775433 22 346666666677777766654433322222 222111000
Q ss_pred C------Chhhhhhc-cCcCCC---CCCCCCccchHHHHhcccCcCCCCCCChhhhhhCCcccceecc
Q psy758 212 W------SCDQLLRH-PYFNGY---YFEVPDEMQYEEITQRCLDKDPLRRWSCDQLLRHPYFNGYYFE 269 (292)
Q Consensus 212 ~------~~~~~~~~-~~~~~~---~~~~~~~~~l~~li~~~l~~dP~~Rpt~~~il~h~w~~~~~~~ 269 (292)
. ...+.... +..... ......+..+.+||.+||+.||++|||++++++||||++..+.
T Consensus 248 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~~~~~~~~ 315 (353)
T 2b9h_A 248 LRCIESPRAREYIKSLPMYPAAPLEKMFPRVNPKGIDLLQRMLVFDPAKRITAKEALEHPYLQTYHDP 315 (353)
T ss_dssp TTTCCCHHHHHHHHTSCCCCCCCHHHHSTTSCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGTTTCCT
T ss_pred ccccccchhhHHhhcccCCCCcchhhhcccCCHHHHHHHHHhcCcCcccCCCHHHHhcCccccccCCc
Confidence 0 00111100 000000 0112457789999999999999999999999999999986644
|
| >3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major} | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-42 Score=289.95 Aligned_cols=266 Identities=25% Similarity=0.332 Sum_probs=181.5
Q ss_pred CcccceeeeecccCceEEEEEEEcCCCcEEEEEEeccCCCChHHHHHHHHHHHHHHhCCCCCcchhhhhhhcCC------
Q psy758 1 MERYEKIGKLGEGSYGVVFKCRNRDTGQVVAIKKFLESEEDPLIRKIALREIRLLKSLKHPNLVNLLEVFRRKK------ 74 (292)
Q Consensus 1 ~~~y~~~~~l~~g~~~~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~------ 74 (292)
+++|++.+.||+|+||.||+|.+..+++.||+|++....... ....+++..+..++||||+++++++...+
T Consensus 22 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~---~~~~~~~~~l~~l~h~niv~~~~~~~~~~~~~~~~ 98 (360)
T 3e3p_A 22 MDRFQVERMAGQGTFGTVQLGKEKSTGMSVAIKKVIQDPRFR---NRELQIMQDLAVLHHPNIVQLQSYFYTLGERDRRD 98 (360)
T ss_dssp HTTEEEC----------CEEEEETTTCCEEEEEEEECCTTCC---CHHHHHHHHHHHHCCTTBCCEEEEEEEECSSCTTC
T ss_pred ccceEEEEEEecCCCeEEEEEEECCCCCEEEEEEEecCcccc---HHHHHHHHHHHhcCCCCcccHHHhhhccccccccc
Confidence 478999999999999999999999999999999886543222 23456778888899999999999986432
Q ss_pred -eEEEEEecCCCccHHH---HhcCCCCCCHHHHHHHHHHHHHHHHHHH--hCCccccCCCCCceEEcc-CCcEEEeecCc
Q psy758 75 -KLHLVFEFCDHTVLNE---LENHPHGLPWDLIKQITWQVLRGVSYCH--RHACIHRDIKPENILLTA-NGVVKLCDFGF 147 (292)
Q Consensus 75 -~~~iv~e~~~~~~L~~---~~~~~~~~~~~~~~~i~~qi~~aL~~LH--~~givH~dl~p~Nilv~~-~~~~kl~dfg~ 147 (292)
..++||||++++.+.. .......+++..++.++.||+.||.||| ++||+||||||+||+++. ++.++|+|||+
T Consensus 99 ~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~~~ivH~Dlkp~NIll~~~~~~~kl~Dfg~ 178 (360)
T 3e3p_A 99 IYLNVVMEYVPDTLHRCCRNYYRRQVAPPPILIKVFLFQLIRSIGCLHLPSVNVCHRDIKPHNVLVNEADGTLKLCDFGS 178 (360)
T ss_dssp EEEEEEEECCSCBHHHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHTSTTTCCBCSCCCGGGEEEETTTTEEEECCCTT
T ss_pred eeEEEEeecccccHHHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHhCCCCCeecCcCCHHHEEEeCCCCcEEEeeCCC
Confidence 3889999999875543 3446667999999999999999999999 999999999999999997 89999999999
Q ss_pred hhhhhccc----cccccccccccccccCC------CCCCCcccceeeecCCCCCCchHHHHHHHhhcc---cCCCCC---
Q psy758 148 ARLIRDLI----PRHLHIFQTNEYFKGVS------LPHAENVVPLEIKIGKPAATNIYLIDFLKRCLD---KDPLRR--- 211 (292)
Q Consensus 148 ~~~~~~~~----~~~~~~~~~~~~~~~~~------~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~---~~p~~~--- 211 (292)
+....... ...+..|.+||...+.. ..|+.|+..+++.+|..++........+..+.. ..+...
T Consensus 179 a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 258 (360)
T 3e3p_A 179 AKKLSPSEPNVAYICSRYYRAPELIFGNQHYTTAVDIWSVGCIFAEMMLGEPIFRGDNSAGQLHEIVRVLGCPSREVLRK 258 (360)
T ss_dssp CBCCCTTSCCCSTTSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHHHH
T ss_pred ceecCCCCCcccccCCcceeCHHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCcCCCChHHHHHHHHHHcCCCCHHHHHh
Confidence 97654322 22345577887764433 246666666777777776654433333322221 111000
Q ss_pred ----CChhhhhh---ccCcCC-CCCCCCCccchHHHHhcccCcCCCCCCChhhhhhCCcccceecc
Q psy758 212 ----WSCDQLLR---HPYFNG-YYFEVPDEMQYEEITQRCLDKDPLRRWSCDQLLRHPYFNGYYFE 269 (292)
Q Consensus 212 ----~~~~~~~~---~~~~~~-~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~~il~h~w~~~~~~~ 269 (292)
........ .++... .......+..+.+||.+||+.||.+|||+.|+++||||++....
T Consensus 259 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~hp~f~~~~~~ 324 (360)
T 3e3p_A 259 LNPSHTDVDLYNSKGIPWSNVFSDHSLKDAKEAYDLLSALLQYLPEERMKPYEALCHPYFDELHDP 324 (360)
T ss_dssp HCTTCCCGGGGCCCCCCHHHHTTTCCCTTHHHHHHHHHHHTCSSGGGSCCHHHHTTSGGGGGGGCT
T ss_pred cccchhhccccccccCCcccccchhhccccHHHHHHHHHHhccCccccCCHHHHhcCccccccCCc
Confidence 00000000 000000 01112246789999999999999999999999999999997643
|
| >3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6e-42 Score=279.78 Aligned_cols=234 Identities=23% Similarity=0.325 Sum_probs=176.9
Q ss_pred Cccccee-eeecccCceEEEEEEEcCCCcEEEEEEeccCCCChHHHHHHHHHHHHH-HhCCCCCcchhhhhhhc----CC
Q psy758 1 MERYEKI-GKLGEGSYGVVFKCRNRDTGQVVAIKKFLESEEDPLIRKIALREIRLL-KSLKHPNLVNLLEVFRR----KK 74 (292)
Q Consensus 1 ~~~y~~~-~~l~~g~~~~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~e~~~~-~~l~~~~i~~~~~~~~~----~~ 74 (292)
+++|.+. +.||+|++|.||+|.+..+++.||+|++... ..+.+|+.++ +.++||||+++++++.+ .+
T Consensus 16 ~~~y~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~-------~~~~~e~~~~~~~~~h~~i~~~~~~~~~~~~~~~ 88 (299)
T 3m2w_A 16 IDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDC-------PKARREVELHWRASQCPHIVRIVDVYENLYAGRK 88 (299)
T ss_dssp GGTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECS-------HHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEE
T ss_pred ccchhhcCcccccCCCeEEEEEEEcCCCcEEEEEEeccc-------HHHHHHHHHHHHhccCCCchhHHhhhhhhcCCCc
Confidence 4678887 7899999999999999999999999998643 3456788887 66689999999999876 67
Q ss_pred eEEEEEecCCCccHHHHhcCCC--CCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEEcc---CCcEEEeecCchh
Q psy758 75 KLHLVFEFCDHTVLNELENHPH--GLPWDLIKQITWQVLRGVSYCHRHACIHRDIKPENILLTA---NGVVKLCDFGFAR 149 (292)
Q Consensus 75 ~~~iv~e~~~~~~L~~~~~~~~--~~~~~~~~~i~~qi~~aL~~LH~~givH~dl~p~Nilv~~---~~~~kl~dfg~~~ 149 (292)
..++||||+++++|.+++.... .+++..++.++.||+.||.|||++|++|+||||+||+++. ++.++|+|||++.
T Consensus 89 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~~~~kl~Dfg~a~ 168 (299)
T 3m2w_A 89 CLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSINIAHRDVKPENLLYTSKRPNAILKLTDFGFAK 168 (299)
T ss_dssp EEEEEECCCCSCBHHHHHHHCTTCCCBHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESSSSTTCCEEECCCTTCE
T ss_pred eEEEEEeecCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEEecCCCCCcEEEecccccc
Confidence 8999999999999999886543 6999999999999999999999999999999999999998 7889999999986
Q ss_pred hhhccccccccccccccccccCCCCCCCcccceeeecCCCCCCchHHHHHHHhhcccCCCCCCChhhhhhccCcCCCCCC
Q psy758 150 LIRDLIPRHLHIFQTNEYFKGVSLPHAENVVPLEIKIGKPAATNIYLIDFLKRCLDKDPLRRWSCDQLLRHPYFNGYYFE 229 (292)
Q Consensus 150 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~ 229 (292)
...... .......|+.|+..+++.+|..++............. ..........+
T Consensus 169 ~~~~~~------------~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~~~~~--------------~~~~~~~~~~~ 222 (299)
T 3m2w_A 169 ETTGEK------------YDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMK--------------TRIRMGQYEFP 222 (299)
T ss_dssp ECTTCG------------GGGHHHHHHHHHHHHHHHHSSCSCCC-------CCSC--------------CSSCTTCCSSC
T ss_pred cccccc------------CCchhhHHHHHHHHHHHHHCCCCCCCCcchhhhHHHH--------------HHHhhccccCC
Confidence 543211 1112334455555566666655543222211111100 00000111111
Q ss_pred ----CCCccchHHHHhcccCcCCCCCCChhhhhhCCccccee
Q psy758 230 ----VPDEMQYEEITQRCLDKDPLRRWSCDQLLRHPYFNGYY 267 (292)
Q Consensus 230 ----~~~~~~l~~li~~~l~~dP~~Rpt~~~il~h~w~~~~~ 267 (292)
...+..+.+||.+||+.||.+|||+.|+++||||++..
T Consensus 223 ~~~~~~~~~~~~~li~~~l~~dP~~Rps~~e~l~hp~~~~~~ 264 (299)
T 3m2w_A 223 NPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMNHPWIMQST 264 (299)
T ss_dssp HHHHTTSCHHHHHHHHHHTCSSTTTSCCHHHHHTSHHHHTGG
T ss_pred chhcccCCHHHHHHHHHHcccChhhCCCHHHHhcChhhcccc
Confidence 33577899999999999999999999999999998854
|
| >4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis} | Back alignment and structure |
|---|
Probab=100.00 E-value=3e-42 Score=291.60 Aligned_cols=259 Identities=29% Similarity=0.434 Sum_probs=188.0
Q ss_pred cccceeeeecccCceEEEEEEEcCCCcEEEEEEeccCCCChHHHHHHHHHHHHHHhCCCCCcchhhhhhhcC------Ce
Q psy758 2 ERYEKIGKLGEGSYGVVFKCRNRDTGQVVAIKKFLESEEDPLIRKIALREIRLLKSLKHPNLVNLLEVFRRK------KK 75 (292)
Q Consensus 2 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~------~~ 75 (292)
.+|++.+.||+|+||.||+|.+..+++ ||+|.+..... ...+|+.+++.++||||+++++++... ..
T Consensus 40 ~~Y~~~~~lG~G~~g~V~~a~~~~~~~-~aikk~~~~~~------~~~~E~~il~~l~h~niv~l~~~~~~~~~~~~~~~ 112 (394)
T 4e7w_A 40 IAYTNCKVIGNGSFGVVFQAKLVESDE-VAIKKVLQDKR------FKNRELQIMRIVKHPNVVDLKAFFYSNGDKKDEVF 112 (394)
T ss_dssp EEEEEEEEEEEETTEEEEEEEETTTEE-EEEEEEECCTT------SCCHHHHHHHTCCCTTBCCEEEEEEEESSSSSCEE
T ss_pred ceEEEeEEEeeCCCeEEEEEEECCCCe-EEEEEEecCcc------hHHHHHHHHHhCCCCCcceEEEEEEecCCCCCceE
Confidence 479999999999999999999987665 88887754332 123699999999999999999998533 34
Q ss_pred EEEEEecCCCccHHHHh---cCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEEc-cCCcEEEeecCchhhh
Q psy758 76 LHLVFEFCDHTVLNELE---NHPHGLPWDLIKQITWQVLRGVSYCHRHACIHRDIKPENILLT-ANGVVKLCDFGFARLI 151 (292)
Q Consensus 76 ~~iv~e~~~~~~L~~~~---~~~~~~~~~~~~~i~~qi~~aL~~LH~~givH~dl~p~Nilv~-~~~~~kl~dfg~~~~~ 151 (292)
+++||||++++.+.... .....+++..++.++.||+.||+|||++||+||||||+||+++ .++.+||+|||+++..
T Consensus 113 ~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~Nill~~~~~~~kL~DFG~a~~~ 192 (394)
T 4e7w_A 113 LNLVLEYVPETVYRASRHYAKLKQTMPMLLIKLYMYQLLRSLAYIHSIGICHRDIKPQNLLLDPPSGVLKLIDFGSAKIL 192 (394)
T ss_dssp EEEEEECCSEEHHHHHHHHHHTTSCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEETTTTEEEECCCTTCEEC
T ss_pred EEEEeeccCccHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHCCccCCCCCHHHEEEcCCCCcEEEeeCCCcccc
Confidence 88999999998665543 3456799999999999999999999999999999999999999 7899999999999765
Q ss_pred hccc----cccccccccccccccCC------CCCCCcccceeeecCCCCCCchHHHHHHHhhcccCCCCCCChhhhhh-c
Q psy758 152 RDLI----PRHLHIFQTNEYFKGVS------LPHAENVVPLEIKIGKPAATNIYLIDFLKRCLDKDPLRRWSCDQLLR-H 220 (292)
Q Consensus 152 ~~~~----~~~~~~~~~~~~~~~~~------~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~-~ 220 (292)
.... ...+..|.+||...+.. ..|+.|+..+++.+|..++......+.+..+...-. .++...+.. .
T Consensus 193 ~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~l~~i~~~~g--~p~~~~~~~~~ 270 (394)
T 4e7w_A 193 IAGEPNVSYICSRYYRAPELIFGATNYTTNIDIWSTGCVMAELMQGQPLFPGESGIDQLVEIIKVLG--TPSREQIKTMN 270 (394)
T ss_dssp CTTCCCCSSCSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHC--CCCHHHHHHHC
T ss_pred cCCCCCcccccCcCccCHHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhC--CCCHHHHHhhC
Confidence 3222 23345577888765533 246667777777888777655443333222211000 001111000 0
Q ss_pred cCcCCC------------CCCCCCccchHHHHhcccCcCCCCCCChhhhhhCCcccceecc
Q psy758 221 PYFNGY------------YFEVPDEMQYEEITQRCLDKDPLRRWSCDQLLRHPYFNGYYFE 269 (292)
Q Consensus 221 ~~~~~~------------~~~~~~~~~l~~li~~~l~~dP~~Rpt~~~il~h~w~~~~~~~ 269 (292)
+.+... .++...+..+.+||.+||++||.+|||+.|+++||||+++.+.
T Consensus 271 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~hp~f~~~~~~ 331 (394)
T 4e7w_A 271 PNYMEHKFPQIRPHPFSKVFRPRTPPDAIDLISRLLEYTPSARLTAIEALCHPFFDELRTG 331 (394)
T ss_dssp GGGSSSCCCCCCCCCHHHHSCTTCCHHHHHHHHHHCCSSGGGSCCHHHHHTSGGGSTTTSS
T ss_pred hhhhhhccccccCCcHHHhccccCCHHHHHHHHHHhCCChhhCCCHHHHhcChhhhhhccc
Confidence 000000 0122357789999999999999999999999999999986553
|
| >3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-41 Score=280.66 Aligned_cols=271 Identities=23% Similarity=0.381 Sum_probs=177.2
Q ss_pred cccceeeeecccCceEEEEEEEcCCCcEEEEEEeccCCCChHHHHHHHHHHH-HHHhCCCCCcchhhhhhhcCCeEEEEE
Q psy758 2 ERYEKIGKLGEGSYGVVFKCRNRDTGQVVAIKKFLESEEDPLIRKIALREIR-LLKSLKHPNLVNLLEVFRRKKKLHLVF 80 (292)
Q Consensus 2 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~e~~-~~~~l~~~~i~~~~~~~~~~~~~~iv~ 80 (292)
++|++.+.||+|+||.||+|.+..+++.||+|++........ ...+..|.. +++.++||||+++++++.+++..++||
T Consensus 22 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~-~~~~~~e~~~~~~~~~h~niv~~~~~~~~~~~~~lv~ 100 (327)
T 3aln_A 22 EDLKDLGEIGRGAYGSVNKMVHKPSGQIMAVKRIRSTVDEKE-QKQLLMDLDVVMRSSDCPYIVQFYGALFREGDCWICM 100 (327)
T ss_dssp CSEEC-CEEEECSSEEEEEEEETTTTEEEEEEEEECCCCHHH-HHHHHHHHHHHHSSCCCTTBCCEEEEEECSSEEEEEE
T ss_pred HHhhehheeccCCCEEEEEEEEcCCCCEEEEEEeecccCchH-HHHHHHHHHHHHHcCCCCcEeeeeeEEEeCCceEEEE
Confidence 689999999999999999999999999999999976544333 334445555 777889999999999999999999999
Q ss_pred ecCCCccHHHHhc-----CCCCCCHHHHHHHHHHHHHHHHHHHhC-CccccCCCCCceEEccCCcEEEeecCchhhhhcc
Q psy758 81 EFCDHTVLNELEN-----HPHGLPWDLIKQITWQVLRGVSYCHRH-ACIHRDIKPENILLTANGVVKLCDFGFARLIRDL 154 (292)
Q Consensus 81 e~~~~~~L~~~~~-----~~~~~~~~~~~~i~~qi~~aL~~LH~~-givH~dl~p~Nilv~~~~~~kl~dfg~~~~~~~~ 154 (292)
||+++ +|..++. ....+++..++.++.|++.||.|||++ |++|+||+|+||+++.++.+||+|||++......
T Consensus 101 e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~ivH~dlkp~NIll~~~~~~kl~Dfg~~~~~~~~ 179 (327)
T 3aln_A 101 ELMST-SFDKFYKYVYSVLDDVIPEEILGKITLATVKALNHLKENLKIIHRDIKPSNILLDRSGNIKLCDFGISGQLVDS 179 (327)
T ss_dssp CCCSE-EHHHHHHHHHHTTCCCCCHHHHHHHHHHHHHHHHHHHHHHSCCCSCCCGGGEEEETTTEEEECCCSSSCC----
T ss_pred eecCC-ChHHHHHHHHhhhcccCcHHHHHHHHHHHHHHHHHHhccCCEeECCCCHHHEEEcCCCCEEEccCCCceecccc
Confidence 99997 5555443 245799999999999999999999999 9999999999999999999999999998765432
Q ss_pred cc----ccccccccccccc----cCCCCCCCcccceeeecCCCCCCchHHHHHHHhhcccCCCCCCCh-hhhhhccCcCC
Q psy758 155 IP----RHLHIFQTNEYFK----GVSLPHAENVVPLEIKIGKPAATNIYLIDFLKRCLDKDPLRRWSC-DQLLRHPYFNG 225 (292)
Q Consensus 155 ~~----~~~~~~~~~~~~~----~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~-~~~~~~~~~~~ 225 (292)
.. ..+..|.+||... +.......++ ++.+.-++..+.+..|+..... .+.+.......
T Consensus 180 ~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~Di-------------~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~ 246 (327)
T 3aln_A 180 IAKTRDAGCRPYMAPERIDPSASRQGYDVRSDV-------------WSLGITLYELATGRFPYPKWNSVFDQLTQVVKGD 246 (327)
T ss_dssp --------------------------CCSHHHH-------------HHHHHHHHHHHHSCCCSSCC-------CCCCCSC
T ss_pred cccccCCCCccccCceeeccccCcCCCCchhhH-------------HHHHHHHHHHHHCCCCCCCcchHHHHHHHHhcCC
Confidence 21 2334466666552 1111111111 2222333333444444333211 11111111000
Q ss_pred -----CCCCCCCccchHHHHhcccCcCCCCCCChhhhhhCCcccceeccCCChh--HHHHHhhhcCCCC
Q psy758 226 -----YYFEVPDEMQYEEITQRCLDKDPLRRWSCDQLLRHPYFNGYYFEVPDEM--QYEEITQVSRLPT 287 (292)
Q Consensus 226 -----~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~~il~h~w~~~~~~~~~~~~--~~~~~~~~~~~~~ 287 (292)
.......+..+.+||.+||+.||.+|||+.++++||||.+...+..... ..+.+.+.+.+|+
T Consensus 247 ~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~hp~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 315 (327)
T 3aln_A 247 PPQLSNSEEREFSPSFINFVNLCLTKDESKRPKYKELLKHPFILMYEERAVEVACYVCKILDQMPATPS 315 (327)
T ss_dssp CCCCCCCSSCCCCHHHHHHHHHHTCSSGGGSCCHHHHTTSHHHHHHHHSCCCHHHHHHHHHHHC-----
T ss_pred CCCCCCcccccCCHHHHHHHHHHhhCChhhCcCHHHHHhChHHHHhHhhHHHHHHHHHHHHhcCCCCCC
Confidence 0111235778999999999999999999999999999998665433322 2233444444443
|
| >2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5e-42 Score=281.99 Aligned_cols=252 Identities=24% Similarity=0.320 Sum_probs=180.7
Q ss_pred cccceeeeecccCceEEEEEEEcCCCcEEEEEEeccCCCCh----HHHHHHHHHHHHHHhC----CCCCcchhhhhhhcC
Q psy758 2 ERYEKIGKLGEGSYGVVFKCRNRDTGQVVAIKKFLESEEDP----LIRKIALREIRLLKSL----KHPNLVNLLEVFRRK 73 (292)
Q Consensus 2 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~v~iK~~~~~~~~~----~~~~~~~~e~~~~~~l----~~~~i~~~~~~~~~~ 73 (292)
++|++.+.||+|+||.||+|.+..+++.||+|++....... .....+.+|+.+++.+ +||||+++++++.+.
T Consensus 31 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~h~~i~~~~~~~~~~ 110 (312)
T 2iwi_A 31 AEYRLGPLLGKGGFGTVFAGHRLTDRLQVAIKVIPRNRVLGWSPLSDSVTCPLEVALLWKVGAGGGHPGVIRLLDWFETQ 110 (312)
T ss_dssp --CEEEEEEEEETTEEEEEEECTTTCCEEEEEECCSTTTC--------CCCCHHHHHHHHHHSSCCCSSBCCEEEEC---
T ss_pred hceEEeeEEEcCCCEEEEEEEEccCCeEEEEEEEecccccccccchhhHHHHHHHHHHHhhcccCCCCCeeeEEEEEecC
Confidence 58999999999999999999999999999999997554322 2334566799999888 899999999999999
Q ss_pred CeEEEEEec-CCCccHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEEc-cCCcEEEeecCchhhh
Q psy758 74 KKLHLVFEF-CDHTVLNELENHPHGLPWDLIKQITWQVLRGVSYCHRHACIHRDIKPENILLT-ANGVVKLCDFGFARLI 151 (292)
Q Consensus 74 ~~~~iv~e~-~~~~~L~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~givH~dl~p~Nilv~-~~~~~kl~dfg~~~~~ 151 (292)
+..++|+|+ +.+++|.+++...+.+++..++.++.||+.||.|||++|++|+||+|+||+++ .++.++|+|||++...
T Consensus 111 ~~~~~v~e~~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~~kl~dfg~~~~~ 190 (312)
T 2iwi_A 111 EGFMLVLERPLPAQDLFDYITEKGPLGEGPSRCFFGQVVAAIQHCHSRGVVHRDIKDENILIDLRRGCAKLIDFGSGALL 190 (312)
T ss_dssp --CEEEEECCSSEEEHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHHTEECCCCSGGGEEEETTTTEEEECCCSSCEEC
T ss_pred CeEEEEEEecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCChhhEEEeCCCCeEEEEEcchhhhc
Confidence 999999999 78999999998777899999999999999999999999999999999999999 7899999999998765
Q ss_pred hccc---cccccccccccccccCCC------CCCCcccceeeecCCCCCCchHHHHHHHhhcccCCCCCCChhhhhhccC
Q psy758 152 RDLI---PRHLHIFQTNEYFKGVSL------PHAENVVPLEIKIGKPAATNIYLIDFLKRCLDKDPLRRWSCDQLLRHPY 222 (292)
Q Consensus 152 ~~~~---~~~~~~~~~~~~~~~~~~------~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~ 222 (292)
.... ...+..|.+||...+... .|+.|+..+++.+| ..|+... .++...
T Consensus 191 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g------------------~~pf~~~--~~~~~~-- 248 (312)
T 2iwi_A 191 HDEPYTDFDGTRVYSPPEWISRHQYHALPATVWSLGILLYDMVCG------------------DIPFERD--QEILEA-- 248 (312)
T ss_dssp CSSCBCCCCSCTTTSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHS------------------SCSCCSH--HHHHHT--
T ss_pred ccCcccccCCcccccCceeeecCCCCCccchHHHHHHHHHHHHHC------------------CCCCCCh--HHHhhh--
Confidence 4321 122344666665543222 23333333333333 3333221 122211
Q ss_pred cCCCCCCCCCccchHHHHhcccCcCCCCCCChhhhhhCCcccceeccCCChhHHH
Q psy758 223 FNGYYFEVPDEMQYEEITQRCLDKDPLRRWSCDQLLRHPYFNGYYFEVPDEMQYE 277 (292)
Q Consensus 223 ~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~~il~h~w~~~~~~~~~~~~~~~ 277 (292)
....+...+..+.+||.+||+.||++|||++++++||||++...+.|......
T Consensus 249 --~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~~~~~~~~~~~~~~~~~~ 301 (312)
T 2iwi_A 249 --ELHFPAHVSPDCCALIRRCLAPKPSSRPSLEEILLDPWMQTPAEDVPLNPSKG 301 (312)
T ss_dssp --CCCCCTTSCHHHHHHHHHHTCSSTTTSCCHHHHHHSTTTCC------------
T ss_pred --ccCCcccCCHHHHHHHHHHccCChhhCcCHHHHhcChhhcCchhccccccccC
Confidence 11233456788999999999999999999999999999999777766555443
|
| >2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=8.3e-42 Score=281.40 Aligned_cols=250 Identities=24% Similarity=0.391 Sum_probs=176.1
Q ss_pred CcccceeeeecccCceEEEEEEEcCCCcEEEEEEeccCCCChHHHHHHHHHHHHHHhCCCCCcchhhhhhhcCCeEEEEE
Q psy758 1 MERYEKIGKLGEGSYGVVFKCRNRDTGQVVAIKKFLESEEDPLIRKIALREIRLLKSLKHPNLVNLLEVFRRKKKLHLVF 80 (292)
Q Consensus 1 ~~~y~~~~~l~~g~~~~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~iv~ 80 (292)
+++|++.+.||+|+||.||+|.+..+++.||+|++..........+.+..+..+++.++||||+++++++.+++..++||
T Consensus 24 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~h~~i~~~~~~~~~~~~~~lv~ 103 (318)
T 2dyl_A 24 INDLENLGEMGSGTCGQVWKMRFRKTGHVIAVKQMRRSGNKEENKRILMDLDVVLKSHDCPYIVQCFGTFITNTDVFIAM 103 (318)
T ss_dssp GGGEEEEEEC------CEEEEEETTTCCEEEEEEEETTSCHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEEE
T ss_pred hccccccceeeecCCeeEEEEEEecCCeEEEEEEecccccchHHHHHHHHHHHHHHhcCCCceeeEEEEEecCCcEEEEE
Confidence 47899999999999999999999999999999999876655555566666667788889999999999999999999999
Q ss_pred ecCCCccHHHHhcC-CCCCCHHHHHHHHHHHHHHHHHHHhC-CccccCCCCCceEEccCCcEEEeecCchhhhhccc---
Q psy758 81 EFCDHTVLNELENH-PHGLPWDLIKQITWQVLRGVSYCHRH-ACIHRDIKPENILLTANGVVKLCDFGFARLIRDLI--- 155 (292)
Q Consensus 81 e~~~~~~L~~~~~~-~~~~~~~~~~~i~~qi~~aL~~LH~~-givH~dl~p~Nilv~~~~~~kl~dfg~~~~~~~~~--- 155 (292)
||+ ++.+..+... ...+++..++.++.||+.||.|||++ |++|+||+|+||+++.++.++|+|||++.......
T Consensus 104 e~~-~~~~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~~~~~~~ 182 (318)
T 2dyl_A 104 ELM-GTCAEKLKKRMQGPIPERILGKMTVAIVKALYYLKEKHGVIHRDVKPSNILLDERGQIKLCDFGISGRLVDDKAKD 182 (318)
T ss_dssp CCC-SEEHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHHHHHCCCCCCCCGGGEEECTTSCEEECCCTTC----------
T ss_pred ecc-CCcHHHHHHHhccCCCHHHHHHHHHHHHHHHHHHHhhCCEEeCCCCHHHEEECCCCCEEEEECCCchhccCCcccc
Confidence 999 5555555432 45799999999999999999999996 99999999999999999999999999987654321
Q ss_pred -ccccccccccccccc-----CC-----CCCCCcccceeeecCCCCCCchHHHHHHHhhcccCCCCCC-ChhhhhhccC-
Q psy758 156 -PRHLHIFQTNEYFKG-----VS-----LPHAENVVPLEIKIGKPAATNIYLIDFLKRCLDKDPLRRW-SCDQLLRHPY- 222 (292)
Q Consensus 156 -~~~~~~~~~~~~~~~-----~~-----~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~-~~~~~~~~~~- 222 (292)
...+..|.+||...+ .. ..|+.|+..+++.++. .|+... ...+.+....
T Consensus 183 ~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~------------------~pf~~~~~~~~~~~~~~~ 244 (318)
T 2dyl_A 183 RSAGCAAYMAPERIDPPDPTKPDYDIRADVWSLGISLVELATGQ------------------FPYKNCKTDFEVLTKVLQ 244 (318)
T ss_dssp ----CCTTCCHHHHC--------CCTHHHHHHHHHHHHHHHHSS------------------CTTTTCCSHHHHHHHHHH
T ss_pred ccCCCccccChhhcccccccccCCccccchhhHHHHHHHHHhCC------------------CCCCCCCccHHHHHHHhc
Confidence 223445667776532 11 1233333333444443 333321 1111111100
Q ss_pred --cCCCCCCCCCccchHHHHhcccCcCCCCCCChhhhhhCCcccceecc
Q psy758 223 --FNGYYFEVPDEMQYEEITQRCLDKDPLRRWSCDQLLRHPYFNGYYFE 269 (292)
Q Consensus 223 --~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~~il~h~w~~~~~~~ 269 (292)
..........+..+.+||.+||+.||.+|||++++++||||++....
T Consensus 245 ~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~h~~~~~~~~~ 293 (318)
T 2dyl_A 245 EEPPLLPGHMGFSGDFQSFVKDCLTKDHRKRPKYNKLLEHSFIKRYETL 293 (318)
T ss_dssp SCCCCCCSSSCCCHHHHHHHHHHTCSCTTTSCCHHHHTTSHHHHHHHHS
T ss_pred cCCCCCCccCCCCHHHHHHHHHHccCChhHCcCHHHHhhCHHHHhcccc
Confidence 00111122357789999999999999999999999999999986543
|
| >3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.2e-41 Score=278.41 Aligned_cols=248 Identities=20% Similarity=0.250 Sum_probs=186.7
Q ss_pred cccceeeeecccCceEEEEEEEcCCCc---EEEEEEeccCCCChHHHHHHHHHHHHHHhCCCCCcchhhhhhhcCCeEEE
Q psy758 2 ERYEKIGKLGEGSYGVVFKCRNRDTGQ---VVAIKKFLESEEDPLIRKIALREIRLLKSLKHPNLVNLLEVFRRKKKLHL 78 (292)
Q Consensus 2 ~~y~~~~~l~~g~~~~v~~~~~~~~~~---~v~iK~~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~i 78 (292)
++|++.+.||+|+||.||+|.+..+++ .||+|++.... .....+.+.+|+.+++.++||||+++++++.+++..++
T Consensus 49 ~~y~i~~~lG~G~~g~V~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~l 127 (325)
T 3kul_A 49 SRIHIEKIIGSGDSGEVCYGRLRVPGQRDVPVAIKALKAGY-TERQRRDFLSEASIMGQFDHPNIIRLEGVVTRGRLAMI 127 (325)
T ss_dssp GGEEEEEEEEETTTEEEEEEEECCTTSCCEEEEEEEECTTC-CHHHHHHHHHHHHHHTTCCCTTBCCEEEEECGGGCCEE
T ss_pred hHeEEeeEEEeCCCcEEEEEEEecCCCCCceEEEEecCCCC-CHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCccEE
Confidence 589999999999999999999986655 49999986543 34456778999999999999999999999999999999
Q ss_pred EEecCCCccHHHHhcCC-CCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEEccCCcEEEeecCchhhhhccccc
Q psy758 79 VFEFCDHTVLNELENHP-HGLPWDLIKQITWQVLRGVSYCHRHACIHRDIKPENILLTANGVVKLCDFGFARLIRDLIPR 157 (292)
Q Consensus 79 v~e~~~~~~L~~~~~~~-~~~~~~~~~~i~~qi~~aL~~LH~~givH~dl~p~Nilv~~~~~~kl~dfg~~~~~~~~~~~ 157 (292)
||||+++++|.+++... ..+++..++.++.||+.||.|||++||+||||||+||+++.++.++|+|||++.........
T Consensus 128 v~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~~ 207 (325)
T 3kul_A 128 VTEYMENGSLDTFLRTHDGQFTIMQLVGMLRGVGAGMRYLSDLGYVHRDLAARNVLVDSNLVCKVSDFGLSRVLEDDPDA 207 (325)
T ss_dssp EEECCTTCBHHHHHHTTTTCSCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTCCEEECCCSSCEECC----C
T ss_pred EeeCCCCCcHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCCeeCCCCCcceEEECCCCCEEECCCCcccccccCccc
Confidence 99999999999998643 57999999999999999999999999999999999999999999999999999765432111
Q ss_pred --------cccccccccccccCCCCCCCcccceeeecCCCCCCchHHHHHHHhhc-ccCCCCCCChhhhhhccCcC-CCC
Q psy758 158 --------HLHIFQTNEYFKGVSLPHAENVVPLEIKIGKPAATNIYLIDFLKRCL-DKDPLRRWSCDQLLRHPYFN-GYY 227 (292)
Q Consensus 158 --------~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~p~~~~~~~~~~~~~~~~-~~~ 227 (292)
.+..|.+||...+.......|+|+ .+.-++..+. +..|+......++....... ...
T Consensus 208 ~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~s-------------lG~il~ell~~g~~p~~~~~~~~~~~~~~~~~~~~ 274 (325)
T 3kul_A 208 AYTTTGGKIPIRWTAPEAIAFRTFSSASDVWS-------------FGVVMWEVLAYGERPYWNMTNRDVISSVEEGYRLP 274 (325)
T ss_dssp CEECC---CCGGGSCHHHHHHCEECHHHHHHH-------------HHHHHHHHHTTSCCTTTTSCHHHHHHHHHTTCCCC
T ss_pred eeeccCCCCcccccCHhHhcCCCCCcHHHHHH-------------HHHHHHHHHcCCCCCcccCCHHHHHHHHHcCCCCC
Confidence 112366666655433322222222 2222333333 44454444444433221111 122
Q ss_pred CCCCCccchHHHHhcccCcCCCCCCChhhhhhCCcccc
Q psy758 228 FEVPDEMQYEEITQRCLDKDPLRRWSCDQLLRHPYFNG 265 (292)
Q Consensus 228 ~~~~~~~~l~~li~~~l~~dP~~Rpt~~~il~h~w~~~ 265 (292)
.+...+..+.+||.+||+.||.+|||+.++++ .|..
T Consensus 275 ~~~~~~~~l~~li~~~l~~dp~~Rps~~eil~--~L~~ 310 (325)
T 3kul_A 275 APMGCPHALHQLMLDCWHKDRAQRPRFSQIVS--VLDA 310 (325)
T ss_dssp CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH--HHHH
T ss_pred CCCCcCHHHHHHHHHHccCChhhCcCHHHHHH--HHHH
Confidence 33455788999999999999999999999998 4444
|
| >3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-41 Score=288.20 Aligned_cols=263 Identities=27% Similarity=0.481 Sum_probs=179.4
Q ss_pred ccce-eeeecccCceEEEEEEEc--CCCcEEEEEEeccCCCChHHHHHHHHHHHHHHhCCCCCcchhhhhh--hcCCeEE
Q psy758 3 RYEK-IGKLGEGSYGVVFKCRNR--DTGQVVAIKKFLESEEDPLIRKIALREIRLLKSLKHPNLVNLLEVF--RRKKKLH 77 (292)
Q Consensus 3 ~y~~-~~~l~~g~~~~v~~~~~~--~~~~~v~iK~~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~--~~~~~~~ 77 (292)
.|.+ ++.||+|+||.||+|.+. .+++.||+|++...... ..+.+|+.+++.++||||+++++++ ..+..++
T Consensus 21 ~y~~~g~~lG~G~~g~Vy~~~~~~~~~~~~vaiK~~~~~~~~----~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~ 96 (405)
T 3rgf_A 21 LFEYEGCKVGRGTYGHVYKAKRKDGKDDKDYALKQIEGTGIS----MSACREIALLRELKHPNVISLQKVFLSHADRKVW 96 (405)
T ss_dssp HEECSSCCCC-----EEEEEEESSSSCCCCEEEEECSSSSCC----HHHHHHHHHHHHCCCTTBCCCCEEEEETTTTEEE
T ss_pred hhhhcCcEeeecCCeEEEEEEEccCCCCeEEEEEEECCCCCC----HHHHHHHHHHHhcCCCCeeeEeeEEecCCCCeEE
Confidence 5666 557999999999999965 57889999999765544 3467899999999999999999999 4578899
Q ss_pred EEEecCCCccHHHHhc--------CCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEE----ccCCcEEEeec
Q psy758 78 LVFEFCDHTVLNELEN--------HPHGLPWDLIKQITWQVLRGVSYCHRHACIHRDIKPENILL----TANGVVKLCDF 145 (292)
Q Consensus 78 iv~e~~~~~~L~~~~~--------~~~~~~~~~~~~i~~qi~~aL~~LH~~givH~dl~p~Nilv----~~~~~~kl~df 145 (292)
+||||+.++.+..+.. ....+++..++.++.||+.||+|||++||+||||||+||++ +.++.+||+||
T Consensus 97 lv~e~~~~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~ivH~Dlkp~NIll~~~~~~~~~~kl~Df 176 (405)
T 3rgf_A 97 LLFDYAEHDLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLHANWVLHRDLKPANILVMGEGPERGRVKIADM 176 (405)
T ss_dssp EEEECCSEEHHHHHHHHHHHC-------CCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECCSSTTTTCEEECCT
T ss_pred EEEeCCCCCHHHHHHHhccccccccccCCCHHHHHHHHHHHHHHHHHHHhCCEeCCCcCHHHeEEecCCCCCCcEEEEEC
Confidence 9999998754433321 12249999999999999999999999999999999999999 67789999999
Q ss_pred Cchhhhhccc--------cccccccccccccccCC------CCCCCcccceeeecCCCCCCch------------HHHHH
Q psy758 146 GFARLIRDLI--------PRHLHIFQTNEYFKGVS------LPHAENVVPLEIKIGKPAATNI------------YLIDF 199 (292)
Q Consensus 146 g~~~~~~~~~--------~~~~~~~~~~~~~~~~~------~~~~~~~~~~~~~~~~~~~~~~------------~~~~~ 199 (292)
|++....... ...+..|.+||...+.. ..|+.|+..+++++|.+++... .....
T Consensus 177 g~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~~~~~~~l~~ 256 (405)
T 3rgf_A 177 GFARLFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIKTSNPYHHDQLDR 256 (405)
T ss_dssp TCCC----------------CCCTTCCHHHHTTCCSCCHHHHHHHHHHHHHHHHHSSCTTCCCC------CCCCHHHHHH
T ss_pred CCceecCCCCcccccCCCceecCcccCchhhcCCCcccchhhhHHHHHHHHHHHhCCCCCCCccccccccccchHHHHHH
Confidence 9997654321 22345578888776532 2467777777778887765321 12222
Q ss_pred HHhhcccCCCCCCChh-------hhhhc---cCcCCC-------CCCCCCccchHHHHhcccCcCCCCCCChhhhhhCCc
Q psy758 200 LKRCLDKDPLRRWSCD-------QLLRH---PYFNGY-------YFEVPDEMQYEEITQRCLDKDPLRRWSCDQLLRHPY 262 (292)
Q Consensus 200 ~~~~~~~~p~~~~~~~-------~~~~~---~~~~~~-------~~~~~~~~~l~~li~~~l~~dP~~Rpt~~~il~h~w 262 (292)
+...++..+...+... ..... ..+... ......+..+.+||.+||++||.+|||++|+|+|||
T Consensus 257 i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Ll~~~L~~dP~~R~ta~e~L~hp~ 336 (405)
T 3rgf_A 257 IFNVMGFPADKDWEDIKKMPEHSTLMKDFRRNTYTNCSLIKYMEKHKVKPDSKAFHLLQKLLTMDPIKRITSEQAMQDPY 336 (405)
T ss_dssp HHHHHCCCCTTTCGGGGGSTTHHHHHHHCCGGGGTTCCHHHHHHTTTCCTTSHHHHHHHHHSCSSGGGSCCHHHHHTSGG
T ss_pred HHHhhCCCChhhcchhhcCcchhhhhhhccccCCCcchhhhhHhhcCCCCCHHHHHHHHHHccCCcccCCCHHHHhcChh
Confidence 2223333322221110 00000 000000 011123668899999999999999999999999999
Q ss_pred ccceecc
Q psy758 263 FNGYYFE 269 (292)
Q Consensus 263 ~~~~~~~ 269 (292)
|++..+.
T Consensus 337 f~~~~~~ 343 (405)
T 3rgf_A 337 FLEDPLP 343 (405)
T ss_dssp GTSSSCC
T ss_pred hccCCCC
Confidence 9986544
|
| >1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-41 Score=290.15 Aligned_cols=258 Identities=27% Similarity=0.425 Sum_probs=188.3
Q ss_pred ccceeeeecccCceEEEEEEEcCCCcEEEEEEeccCCCChHHHHHHHHHHHHHHhCCCCCcchhhhhhhc------CCeE
Q psy758 3 RYEKIGKLGEGSYGVVFKCRNRDTGQVVAIKKFLESEEDPLIRKIALREIRLLKSLKHPNLVNLLEVFRR------KKKL 76 (292)
Q Consensus 3 ~y~~~~~l~~g~~~~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~------~~~~ 76 (292)
+|++.+.||+|+||.||+|.+..+++.||+|.+..... ...+|+.+++.++||||+++++++.. ...+
T Consensus 55 ~y~~~~~lG~G~fg~Vy~~~~~~~~~~vaiK~~~~~~~------~~~~E~~il~~l~hpniv~l~~~~~~~~~~~~~~~~ 128 (420)
T 1j1b_A 55 SYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKR------FKNRELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYL 128 (420)
T ss_dssp EEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEECCTT------SCCHHHHHHHTCCCTTBCCEEEEEEEEETTTTEEEE
T ss_pred eEEeeeEEeeCCCEEEEEEEECCCCcEEEEEEecccch------hHHHHHHHHHHcCCCCccceeeEEeccCCCCcceeE
Confidence 69999999999999999999999999999999865432 23469999999999999999998742 2347
Q ss_pred EEEEecCCCccHHHH---hcCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEEccC-CcEEEeecCchhhhh
Q psy758 77 HLVFEFCDHTVLNEL---ENHPHGLPWDLIKQITWQVLRGVSYCHRHACIHRDIKPENILLTAN-GVVKLCDFGFARLIR 152 (292)
Q Consensus 77 ~iv~e~~~~~~L~~~---~~~~~~~~~~~~~~i~~qi~~aL~~LH~~givH~dl~p~Nilv~~~-~~~kl~dfg~~~~~~ 152 (292)
++||||++++.+... ......+++..++.++.||+.||+|||++||+||||||+|||++.+ +.+||+|||+++...
T Consensus 129 ~lv~e~~~~~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~NILl~~~~~~~kl~DFG~a~~~~ 208 (420)
T 1j1b_A 129 NLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLV 208 (420)
T ss_dssp EEEEECCCEEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHTTTEECSCCSGGGEEEETTTTEEEECCCTTCEECC
T ss_pred EeehhcccccHHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCChhhEEEeCCCCeEEeccchhhhhcc
Confidence 799999998644332 2345679999999999999999999999999999999999999965 578999999997653
Q ss_pred ccc----cccccccccccccccCC------CCCCCcccceeeecCCCCCCchHHHHHHHhhcccCCCCCCChhhhhh-cc
Q psy758 153 DLI----PRHLHIFQTNEYFKGVS------LPHAENVVPLEIKIGKPAATNIYLIDFLKRCLDKDPLRRWSCDQLLR-HP 221 (292)
Q Consensus 153 ~~~----~~~~~~~~~~~~~~~~~------~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~-~~ 221 (292)
... ...+..|.+||...+.. +.|+.|+..+++++|..++......+.+..++..-. .+....+.. .+
T Consensus 209 ~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~G~~pf~~~~~~~~l~~i~~~lg--~p~~~~~~~~~~ 286 (420)
T 1j1b_A 209 RGEPNVSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLG--TPTREQIREMNP 286 (420)
T ss_dssp TTCCCCSCCSCTTSCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHC--SCCHHHHHHHCS
T ss_pred cCCCceeeeeCCCcCCHHHHcCCCCCCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhC--CCCHHHHHhhCh
Confidence 321 23345577888765532 346777777778888877654433333222221100 001111100 01
Q ss_pred CcCCCC------------CCCCCccchHHHHhcccCcCCCCCCChhhhhhCCcccceec
Q psy758 222 YFNGYY------------FEVPDEMQYEEITQRCLDKDPLRRWSCDQLLRHPYFNGYYF 268 (292)
Q Consensus 222 ~~~~~~------------~~~~~~~~l~~li~~~l~~dP~~Rpt~~~il~h~w~~~~~~ 268 (292)
.+..+. +....+..+.+||.+||+.||.+|||+.|+++||||++...
T Consensus 287 ~~~~~~~p~~~~~~~~~~~~~~~~~~~~~Li~~~L~~dP~~R~t~~e~l~hp~f~~~~~ 345 (420)
T 1j1b_A 287 NYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACAHSFFDELRD 345 (420)
T ss_dssp CCCCCCCCCCCCCCHHHHSCTTSCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGGGGGC
T ss_pred hhhhhccCccCCCCHHHhcCCCCCHHHHHHHHHhccCChhHCCCHHHHhCCHhhccccc
Confidence 111111 12234678999999999999999999999999999988653
|
| >4hcu_A Tyrosine-protein kinase ITK/TSK; transferase-transferase inhibitor complex; HET: 13L; 1.43A {Homo sapiens} PDB: 4hct_A* 4hcv_A* 3t9t_A* 1sm2_A* 1snu_A* 1snx_A 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.2e-41 Score=268.77 Aligned_cols=242 Identities=23% Similarity=0.327 Sum_probs=185.0
Q ss_pred cccceeeeecccCceEEEEEEEcCCCcEEEEEEeccCCCChHHHHHHHHHHHHHHhCCCCCcchhhhhhhcCCeEEEEEe
Q psy758 2 ERYEKIGKLGEGSYGVVFKCRNRDTGQVVAIKKFLESEEDPLIRKIALREIRLLKSLKHPNLVNLLEVFRRKKKLHLVFE 81 (292)
Q Consensus 2 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~iv~e 81 (292)
++|++.+.||+|+||.||+|.+.. ++.||+|++....... +.+.+|+.+++.++||||+++++++.+++..++|||
T Consensus 10 ~~y~~~~~lg~G~~g~V~~~~~~~-~~~vavK~~~~~~~~~---~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 85 (269)
T 4hcu_A 10 SELTFVQEIGSGQFGLVHLGYWLN-KDKVAIKTIREGAMSE---EDFIEEAEVMMKLSHPKLVQLYGVCLEQAPICLVFE 85 (269)
T ss_dssp GGEEEEEEEEECSSCEEEEEEETT-TEEEEEEEECTTSBCH---HHHHHHHHHHHTCCCTTBCCEEEEECSSSSEEEEEE
T ss_pred hhceeeheecCCCccEEEEEEecC-CCeEEEEEecccccCH---HHHHHHHHHHHhCCCCCEeeEEEEEecCCceEEEEE
Confidence 589999999999999999999874 7789999997665443 457899999999999999999999999999999999
Q ss_pred cCCCccHHHHhcC-CCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEEccCCcEEEeecCchhhhhccc-----
Q psy758 82 FCDHTVLNELENH-PHGLPWDLIKQITWQVLRGVSYCHRHACIHRDIKPENILLTANGVVKLCDFGFARLIRDLI----- 155 (292)
Q Consensus 82 ~~~~~~L~~~~~~-~~~~~~~~~~~i~~qi~~aL~~LH~~givH~dl~p~Nilv~~~~~~kl~dfg~~~~~~~~~----- 155 (292)
|+++++|.+++.. ...+++..++.++.|++.||.|||++|++|+||||+||+++.++.++|+|||++.......
T Consensus 86 ~~~~~~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~ 165 (269)
T 4hcu_A 86 FMEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLEEACVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYTSST 165 (269)
T ss_dssp CCTTCBHHHHHHTTTTCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECGGGCEEECCTTGGGGBCCHHHHSTT
T ss_pred eCCCCcHHHHHHhcCcccCHHHHHHHHHHHHHHHHHHHhCCeecCCcchheEEEcCCCCEEecccccccccccccccccc
Confidence 9999999999865 3458999999999999999999999999999999999999999999999999997653221
Q ss_pred -cccccccccccccccCCCCCCCcccceeeecCCCCCCchHHHHHHHhhc-ccCCCCCCChhhhhhccCcC-CCCCCCCC
Q psy758 156 -PRHLHIFQTNEYFKGVSLPHAENVVPLEIKIGKPAATNIYLIDFLKRCL-DKDPLRRWSCDQLLRHPYFN-GYYFEVPD 232 (292)
Q Consensus 156 -~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~p~~~~~~~~~~~~~~~~-~~~~~~~~ 232 (292)
...+..|.+||...+.......++|++ +..++..+. +..|+...+..+........ ....+...
T Consensus 166 ~~~~~~~y~aPE~~~~~~~~~~~Di~sl-------------G~~l~~ll~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 232 (269)
T 4hcu_A 166 GTKFPVKWASPEVFSFSRYSSKSDVWSF-------------GVLMWEVFSEGKIPYENRSNSEVVEDISTGFRLYKPRLA 232 (269)
T ss_dssp STTCCGGGCCHHHHHHCCCCHHHHHHHH-------------HHHHHHHHTTSCCTTTTCCHHHHHHHHHTTCCCCCCTTS
T ss_pred CcccccccCCHHHhcCCCCCchhhhHHH-------------HHHHHHHhcCCCCCCCCCCHHHHHHHHhcCccCCCCCcC
Confidence 112234667776654443322233222 222333333 44454444444433221111 11223445
Q ss_pred ccchHHHHhcccCcCCCCCCChhhhhhC
Q psy758 233 EMQYEEITQRCLDKDPLRRWSCDQLLRH 260 (292)
Q Consensus 233 ~~~l~~li~~~l~~dP~~Rpt~~~il~h 260 (292)
+..+.++|.+||+.||.+|||+.++++|
T Consensus 233 ~~~~~~li~~~l~~~p~~Rps~~~ll~~ 260 (269)
T 4hcu_A 233 STHVYQIMNHCWRERPEDRPAFSRLLRQ 260 (269)
T ss_dssp CHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred CHHHHHHHHHHccCCcccCcCHHHHHHH
Confidence 7889999999999999999999999985
|
| >3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-41 Score=277.54 Aligned_cols=261 Identities=23% Similarity=0.285 Sum_probs=185.2
Q ss_pred cccceeeeecccCceEEEEEEEcCCCcEEEEEEeccCCCChHHHHHHHHHHHHHHhCC--CCCcchhhhhhhcCCeEEEE
Q psy758 2 ERYEKIGKLGEGSYGVVFKCRNRDTGQVVAIKKFLESEEDPLIRKIALREIRLLKSLK--HPNLVNLLEVFRRKKKLHLV 79 (292)
Q Consensus 2 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~e~~~~~~l~--~~~i~~~~~~~~~~~~~~iv 79 (292)
++|++.+.||+|+||.||+|.+.. ++.||+|++..........+.+.+|+.+++.++ ||||+++++++.+++..++|
T Consensus 28 ~~y~~~~~lg~G~~g~Vy~~~~~~-~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~iv~~~~~~~~~~~~~lv 106 (313)
T 3cek_A 28 RIYSILKQIGSGGSSKVFQVLNEK-KQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQYIYMV 106 (313)
T ss_dssp EEEEEEEEEECCSSEEEEEEECTT-CCEEEEEEEECSSCCHHHHHHHHHHHHHHHHHGGGCTTBCCEEEEEECSSEEEEE
T ss_pred ceEEEEEEecCCCCEEEEEEEcCC-CcEEEEEEeccccccccchHHHHHHHHHHHhccccCCceEEEEEEeecCCEEEEE
Confidence 479999999999999999999864 889999999877767777788999999999997 59999999999999999999
Q ss_pred EecCCCccHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEEccCCcEEEeecCchhhhhccc----
Q psy758 80 FEFCDHTVLNELENHPHGLPWDLIKQITWQVLRGVSYCHRHACIHRDIKPENILLTANGVVKLCDFGFARLIRDLI---- 155 (292)
Q Consensus 80 ~e~~~~~~L~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~givH~dl~p~Nilv~~~~~~kl~dfg~~~~~~~~~---- 155 (292)
|| +.+++|.+++.....+++..++.++.||+.||.|||++|++|+||+|+||++++ +.++|+|||++.......
T Consensus 107 ~e-~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~dlkp~NIl~~~-~~~kL~Dfg~~~~~~~~~~~~~ 184 (313)
T 3cek_A 107 ME-CGNIDLNSWLKKKKSIDPWERKSYWKNMLEAVHTIHQHGIVHSDLKPANFLIVD-GMLKLIDFGIANQMQPDTTSVV 184 (313)
T ss_dssp EC-CCSEEHHHHHHHCSSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEEET-TEEEECCCSSSCC---------
T ss_pred Ee-cCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCcccEEEEC-CeEEEeeccccccccCcccccc
Confidence 99 677889998887778999999999999999999999999999999999999964 899999999997654321
Q ss_pred ---cccccccccccccccCCCCCCCcccceeeecCCCCCCchHHHHHHHhhcccCCCCCCChh-hhhhccCc--CCCCCC
Q psy758 156 ---PRHLHIFQTNEYFKGVSLPHAENVVPLEIKIGKPAATNIYLIDFLKRCLDKDPLRRWSCD-QLLRHPYF--NGYYFE 229 (292)
Q Consensus 156 ---~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~-~~~~~~~~--~~~~~~ 229 (292)
...+..|.+||...+.......+. .........++++.+..++..+.+..|+...... ..+..... .....+
T Consensus 185 ~~~~~gt~~y~aPE~~~~~~~~~~~~~--~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~ 262 (313)
T 3cek_A 185 KDSQVGTVNYMPPEAIKDMSSSRENGK--SKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQISKLHAIIDPNHEIEFP 262 (313)
T ss_dssp -----CCGGGCCHHHHTTCC------------CCCHHHHHHHHHHHHHHHHHSSCTTTTCCSHHHHHHHHHCTTSCCCCC
T ss_pred ccCCCCCCCcCCHHHHhhccccccccc--ccccCCchHHHHHHHHHHHHHHhCCCchhhHHHHHHHHHHHHhcccccCCc
Confidence 123455667776544110000000 0000000111122222233333444443332111 11110000 011223
Q ss_pred CCCccchHHHHhcccCcCCCCCCChhhhhhCCccccee
Q psy758 230 VPDEMQYEEITQRCLDKDPLRRWSCDQLLRHPYFNGYY 267 (292)
Q Consensus 230 ~~~~~~l~~li~~~l~~dP~~Rpt~~~il~h~w~~~~~ 267 (292)
...+..+.++|.+||+.||.+|||++++++||||+...
T Consensus 263 ~~~~~~l~~li~~~l~~dp~~Rps~~ell~h~~~~~~~ 300 (313)
T 3cek_A 263 DIPEKDLQDVLKCCLKRDPKQRISIPELLAHPYVQIQT 300 (313)
T ss_dssp CCSCHHHHHHHHHHTCSSTTTSCCHHHHHTSHHHHCC-
T ss_pred ccchHHHHHHHHHHccCCcccCcCHHHHhcCccccCCC
Confidence 34467899999999999999999999999999999743
|
| >1z57_A Dual specificity protein kinase CLK1; protein tyrosine kinase, splicing, human, 10Z-hymendialdisine, structural genomics; HET: DBQ; 1.70A {Homo sapiens} PDB: 2vag_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.7e-41 Score=278.25 Aligned_cols=262 Identities=23% Similarity=0.376 Sum_probs=189.3
Q ss_pred cccceeeeecccCceEEEEEEE-cCCCcEEEEEEeccCCCChHHHHHHHHHHHHHHhCCCC------CcchhhhhhhcCC
Q psy758 2 ERYEKIGKLGEGSYGVVFKCRN-RDTGQVVAIKKFLESEEDPLIRKIALREIRLLKSLKHP------NLVNLLEVFRRKK 74 (292)
Q Consensus 2 ~~y~~~~~l~~g~~~~v~~~~~-~~~~~~v~iK~~~~~~~~~~~~~~~~~e~~~~~~l~~~------~i~~~~~~~~~~~ 74 (292)
++|++.+.||+|+||.||+|.+ ..+++.||+|++... ....+.+.+|+.+++.++|+ +++++++++.+.+
T Consensus 14 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~---~~~~~~~~~e~~~l~~l~~~~~~~~~~i~~~~~~~~~~~ 90 (339)
T 1z57_A 14 ARYEIVDTLGEGAFGKVVECIDHKAGGRHVAVKIVKNV---DRYCEAARSEIQVLEHLNTTDPNSTFRCVQMLEWFEHHG 90 (339)
T ss_dssp TTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEECSS---HHHHHHHHHHHHHHHHHHHHCTTCTTCBCCEEEEEEETT
T ss_pred CceEEEEEEecCCCeEEEEEEecCCCCcEEEEEEEecC---CchhHHHHHHHHHHHHhhhcCCCCceeeEeeecccccCC
Confidence 6899999999999999999998 557889999998643 34456778899999988765 4899999999999
Q ss_pred eEEEEEecCCCccHHHHhcCCC--CCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEEcc----------------
Q psy758 75 KLHLVFEFCDHTVLNELENHPH--GLPWDLIKQITWQVLRGVSYCHRHACIHRDIKPENILLTA---------------- 136 (292)
Q Consensus 75 ~~~iv~e~~~~~~L~~~~~~~~--~~~~~~~~~i~~qi~~aL~~LH~~givH~dl~p~Nilv~~---------------- 136 (292)
..++||||+ +++|.+++...+ .+++..++.++.||+.||+|||++|++||||||+||+++.
T Consensus 91 ~~~lv~e~~-~~~l~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dlkp~Nil~~~~~~~~~~~~~~~~~~~ 169 (339)
T 1z57_A 91 HICIVFELL-GLSTYDFIKENGFLPFRLDHIRKMAYQICKSVNFLHSNKLTHTDLKPENILFVQSDYTEAYNPKIKRDER 169 (339)
T ss_dssp EEEEEEECC-CCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESCCCEEEEEC----CEEE
T ss_pred cEEEEEcCC-CCCHHHHHHhcCCCCCcHHHHHHHHHHHHHHHHHHHHCCCcCCCCCHHHEEEeccccccccCCccccccc
Confidence 999999999 666777665443 5899999999999999999999999999999999999987
Q ss_pred ---CCcEEEeecCchhhhhccc--cccccccccccccccCCCC-----CCCcccceeeecCCCCCCchHH---HHHHHhh
Q psy758 137 ---NGVVKLCDFGFARLIRDLI--PRHLHIFQTNEYFKGVSLP-----HAENVVPLEIKIGKPAATNIYL---IDFLKRC 203 (292)
Q Consensus 137 ---~~~~kl~dfg~~~~~~~~~--~~~~~~~~~~~~~~~~~~~-----~~~~~~~~~~~~~~~~~~~~~~---~~~~~~~ 203 (292)
++.++|+|||++....... ...+..|.+||...+.... |+.|+..+++.+|..++..... ...+...
T Consensus 170 ~~~~~~~kl~Dfg~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~~~~~ 249 (339)
T 1z57_A 170 TLINPDIKVVDFGSATYDDEHHSTLVSTRHYRAPEVILALGWSQPCDVWSIGCILIEYYLGFTVFPTHDSKEHLAMMERI 249 (339)
T ss_dssp EESCCCEEECCCSSCEETTSCCCSSCSCGGGCCHHHHTTSCCCTHHHHHHHHHHHHHHHHSSCSCCCSCHHHHHHHHHHH
T ss_pred cccCCCceEeeCcccccCccccccccCCccccChHHhhCCCCCcchhhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHH
Confidence 6689999999987654322 2335567788877665443 5555555566666655433222 2222222
Q ss_pred cccCCCCC-----------------CC---hhhhhh---ccCcCCCCCCCCCccchHHHHhcccCcCCCCCCChhhhhhC
Q psy758 204 LDKDPLRR-----------------WS---CDQLLR---HPYFNGYYFEVPDEMQYEEITQRCLDKDPLRRWSCDQLLRH 260 (292)
Q Consensus 204 ~~~~p~~~-----------------~~---~~~~~~---~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~~il~h 260 (292)
....|... .. ...... .+...........+..+.+||.+||+.||.+|||++|+++|
T Consensus 250 ~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpt~~ell~h 329 (339)
T 1z57_A 250 LGPLPKHMIQKTRKRKYFHHDRLDWDEHSSAGRYVSRACKPLKEFMLSQDVEHERLFDLIQKMLEYDPAKRITLREALKH 329 (339)
T ss_dssp HCSCCHHHHHHCSCGGGEETTEECCCTTSHHHHHHHHHCCCGGGGCSCCSHHHHHHHHHHHHHTCSSTTTSCCHHHHTTS
T ss_pred hCCCCHHHHhhccchhHHhhccccccccccccchhhhcCcchhhhcccchhhHHHHHHHHHHHhCcCcccccCHHHHhcC
Confidence 22222100 00 000000 00000011112235678899999999999999999999999
Q ss_pred Cccccee
Q psy758 261 PYFNGYY 267 (292)
Q Consensus 261 ~w~~~~~ 267 (292)
|||++..
T Consensus 330 p~f~~~~ 336 (339)
T 1z57_A 330 PFFDLLK 336 (339)
T ss_dssp GGGGGGG
T ss_pred HHHHHHh
Confidence 9999754
|
| >2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.7e-41 Score=274.04 Aligned_cols=246 Identities=23% Similarity=0.312 Sum_probs=183.6
Q ss_pred cccceeeeecccCceEEEEEEEcCCCcEEEEEEeccCCCChHHHHHHHHHHHHHHhCCCCCcchhhhhhhcCCeEEEEEe
Q psy758 2 ERYEKIGKLGEGSYGVVFKCRNRDTGQVVAIKKFLESEEDPLIRKIALREIRLLKSLKHPNLVNLLEVFRRKKKLHLVFE 81 (292)
Q Consensus 2 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~iv~e 81 (292)
++|.....||+|++|.||+|.+..+++.||+|.+..... ...+.+.+|+.+++.++||||+++++++.+.+..++|+|
T Consensus 22 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~--~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 99 (295)
T 2clq_A 22 DENGDRVVLGKGTYGIVYAGRDLSNQVRIAIKEIPERDS--RYSQPLHEEIALHKHLKHKNIVQYLGSFSENGFIKIFME 99 (295)
T ss_dssp CTTSSBCEEEECSSSEEEEEEETTTCCEEEEEEEECCCC-----HHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred cCCCCcEEEeecCcEEEEEEEECCCCeEEEEEEccCCch--HHHHHHHHHHHHHHhCCCCCEeeEeeEEEeCCcEEEEEE
Confidence 345556699999999999999999999999999876532 345668899999999999999999999999999999999
Q ss_pred cCCCccHHHHhcCC---CCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEEcc-CCcEEEeecCchhhhhccc--
Q psy758 82 FCDHTVLNELENHP---HGLPWDLIKQITWQVLRGVSYCHRHACIHRDIKPENILLTA-NGVVKLCDFGFARLIRDLI-- 155 (292)
Q Consensus 82 ~~~~~~L~~~~~~~---~~~~~~~~~~i~~qi~~aL~~LH~~givH~dl~p~Nilv~~-~~~~kl~dfg~~~~~~~~~-- 155 (292)
|+++++|.+++... ..+++..++.++.||+.||.|||++|++|+||+|+||+++. ++.++|+|||++.......
T Consensus 100 ~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~~kl~Dfg~~~~~~~~~~~ 179 (295)
T 2clq_A 100 QVPGGSLSALLRSKWGPLKDNEQTIGFYTKQILEGLKYLHDNQIVHRDIKGDNVLINTYSGVLKISDFGTSKRLAGINPC 179 (295)
T ss_dssp CCSEEEHHHHHHHTTCCCTTCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEETTTCCEEECCTTTCEESCC----
T ss_pred eCCCCCHHHHHHhhccCCCccHHHHHHHHHHHHHHHHHHHhCCEEccCCChhhEEEECCCCCEEEeecccccccCCCCCc
Confidence 99999999988653 24678999999999999999999999999999999999998 8999999999987654322
Q ss_pred ---cccccccccccccccCC-------CCCCCcccceeeecCCCCCCchHHHHHHHhhcccCCCCCCChhh-h-hhc-cC
Q psy758 156 ---PRHLHIFQTNEYFKGVS-------LPHAENVVPLEIKIGKPAATNIYLIDFLKRCLDKDPLRRWSCDQ-L-LRH-PY 222 (292)
Q Consensus 156 ---~~~~~~~~~~~~~~~~~-------~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~-~-~~~-~~ 222 (292)
...+..|.+||...+.. ..|+.|+..+++.+|..++ ....... . ... ..
T Consensus 180 ~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf------------------~~~~~~~~~~~~~~~~ 241 (295)
T 2clq_A 180 TETFTGTLQYMAPEIIDKGPRGYGKAADIWSLGCTIIEMATGKPPF------------------YELGEPQAAMFKVGMF 241 (295)
T ss_dssp -CCCCCCGGGCCHHHHHHGGGGCSHHHHHHHHHHHHHHHHHTSCTT------------------GGGSSHHHHHHHHHHH
T ss_pred ccccCCCccccChhhhcCCCCCCCcHHHHHHHHHHHHHHHHCCCCc------------------cCCCchhHHHHhhccc
Confidence 22334566666654321 2244444444444444432 2111100 0 000 00
Q ss_pred cCCCCCCCCCccchHHHHhcccCcCCCCCCChhhhhhCCccccee
Q psy758 223 FNGYYFEVPDEMQYEEITQRCLDKDPLRRWSCDQLLRHPYFNGYY 267 (292)
Q Consensus 223 ~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~~il~h~w~~~~~ 267 (292)
......+...+..+.+||.+||+.||.+|||++++++||||+...
T Consensus 242 ~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~~~~~~~~~ 286 (295)
T 2clq_A 242 KVHPEIPESMSAEAKAFILKCFEPDPDKRACANDLLVDEFLKVSS 286 (295)
T ss_dssp CCCCCCCTTSCHHHHHHHHHTTCSSTTTSCCHHHHHTSGGGCC--
T ss_pred cccccccccCCHHHHHHHHHHccCChhhCCCHHHHhcChhhhhcc
Confidence 011123345578899999999999999999999999999998643
|
| >2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A | Back alignment and structure |
|---|
Probab=100.00 E-value=9.4e-41 Score=280.17 Aligned_cols=245 Identities=22% Similarity=0.319 Sum_probs=184.8
Q ss_pred cccceeeeecccCceEEEEEEEc-------CCCcEEEEEEeccCCCChHHHHHHHHHHHHHHhC-CCCCcchhhhhhhcC
Q psy758 2 ERYEKIGKLGEGSYGVVFKCRNR-------DTGQVVAIKKFLESEEDPLIRKIALREIRLLKSL-KHPNLVNLLEVFRRK 73 (292)
Q Consensus 2 ~~y~~~~~l~~g~~~~v~~~~~~-------~~~~~v~iK~~~~~~~~~~~~~~~~~e~~~~~~l-~~~~i~~~~~~~~~~ 73 (292)
++|++.+.||+|+||.||+|.+. .++..||+|++.... .....+.+.+|+.+++.+ +||||+++++++.+.
T Consensus 81 ~~~~~~~~LG~G~fg~Vy~a~~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~~ 159 (370)
T 2psq_A 81 DKLTLGKPLGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDA-TEKDLSDLVSEMEMMKMIGKHKNIINLLGACTQD 159 (370)
T ss_dssp GGEEEEEEESCCSSSEEEEEEEETCSTTCTTCEEEEEEEECCTTC-BHHHHHHHHHHHHHHHHSCCCTTBCCEEEEECSS
T ss_pred HHCEeeeEEeeCCCeeEEEEEEecccCcCcCcceeEEEEEecCCc-CHHHHHHHHHHHHHHHHhcCCCCEeeEEEEEccC
Confidence 57999999999999999999874 345579999986553 444567789999999999 899999999999999
Q ss_pred CeEEEEEecCCCccHHHHhcCCC----------------CCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEEccC
Q psy758 74 KKLHLVFEFCDHTVLNELENHPH----------------GLPWDLIKQITWQVLRGVSYCHRHACIHRDIKPENILLTAN 137 (292)
Q Consensus 74 ~~~~iv~e~~~~~~L~~~~~~~~----------------~~~~~~~~~i~~qi~~aL~~LH~~givH~dl~p~Nilv~~~ 137 (292)
+.+|+||||+++++|.+++.... .+++..++.++.||+.||.|||++||+||||||+||+++.+
T Consensus 160 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~ 239 (370)
T 2psq_A 160 GPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQKCIHRDLAARNVLVTEN 239 (370)
T ss_dssp SSCEEEEECCTTCBHHHHHHHTCCC-----------CCCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECTT
T ss_pred CCEEEEEEcCCCCCHHHHHHhhCCccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhCCeeccccchhhEEECCC
Confidence 99999999999999999986532 47899999999999999999999999999999999999999
Q ss_pred CcEEEeecCchhhhhcccc-------ccccccccccccccCCCCCCCcccceeeecCCCCCCchHHHHHHHhhc-ccCCC
Q psy758 138 GVVKLCDFGFARLIRDLIP-------RHLHIFQTNEYFKGVSLPHAENVVPLEIKIGKPAATNIYLIDFLKRCL-DKDPL 209 (292)
Q Consensus 138 ~~~kl~dfg~~~~~~~~~~-------~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~p~ 209 (292)
+.+||+|||++........ ..+..|.+||...+.......|+|++ +.-+++.+. +..|+
T Consensus 240 ~~~kl~DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Dvwsl-------------G~il~ellt~g~~p~ 306 (370)
T 2psq_A 240 NVMKIADFGLARDINNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSF-------------GVLMWEIFTLGGSPY 306 (370)
T ss_dssp CCEEECCCSSCEETTCCCTTCTTTTTTSCGGGCCHHHHHTCCCCHHHHHHHH-------------HHHHHHHHTTSCCSS
T ss_pred CCEEEccccCCcccCcccceecccCCCcccceECHhHhcCCCCCcHHHHHHH-------------HHHHHHHHcCCCCCC
Confidence 9999999999976543211 11234667766655443322222222 222333333 44454
Q ss_pred CCCChhhhhhccCcC-CCCCCCCCccchHHHHhcccCcCCCCCCChhhhhhC
Q psy758 210 RRWSCDQLLRHPYFN-GYYFEVPDEMQYEEITQRCLDKDPLRRWSCDQLLRH 260 (292)
Q Consensus 210 ~~~~~~~~~~~~~~~-~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~~il~h 260 (292)
......++....... ....+...+..+.++|.+||+.||.+|||+.|++++
T Consensus 307 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~ell~~ 358 (370)
T 2psq_A 307 PGIPVEELFKLLKEGHRMDKPANCTNELYMMMRDCWHAVPSQRPTFKQLVED 358 (370)
T ss_dssp TTCCGGGHHHHHHTTCCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred CCCCHHHHHHHHhcCCCCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence 444444433221111 112334557789999999999999999999999984
|
| >2vx3_A Dual specificity tyrosine-phosphorylation- regula kinase 1A; serine/threonine-protein kinase, minibrain homolog, nucleotide-binding, transferase; HET: PTR D15 P6G; 2.40A {Homo sapiens} PDB: 2wo6_A* 3anq_A* 3anr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-40 Score=279.16 Aligned_cols=263 Identities=25% Similarity=0.394 Sum_probs=189.8
Q ss_pred CcccceeeeecccCceEEEEEEEcCCCcEEEEEEeccCCCChHHHHHHHHHHHHHHhCC-CC-----CcchhhhhhhcCC
Q psy758 1 MERYEKIGKLGEGSYGVVFKCRNRDTGQVVAIKKFLESEEDPLIRKIALREIRLLKSLK-HP-----NLVNLLEVFRRKK 74 (292)
Q Consensus 1 ~~~y~~~~~l~~g~~~~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~e~~~~~~l~-~~-----~i~~~~~~~~~~~ 74 (292)
+++|++.+.||+|+||.||+|.+..+++.||+|++... ......+..|+.+++.++ |+ +|+++++++...+
T Consensus 53 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~---~~~~~~~~~e~~~l~~l~~~~~~~~~~iv~~~~~~~~~~ 129 (382)
T 2vx3_A 53 MDRYEIDSLIGKGSFGQVVKAYDRVEQEWVAIKIIKNK---KAFLNQAQIEVRLLELMNKHDTEMKYYIVHLKRHFMFRN 129 (382)
T ss_dssp TTTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECSS---HHHHHHHHHHHHHHHHHHHCSSGGGGGBCCEEEEEEETT
T ss_pred eeeEEEEEEEeecCCEEEEEEEEcCCCcEEEEEEEecc---HHHHHHHHHHHHHHHHHHhcccccceeEEEeeeeeccCC
Confidence 37899999999999999999999999999999999643 334566777888888885 44 4888899999999
Q ss_pred eEEEEEecCCCccHHHHhcCC--CCCCHHHHHHHHHHHHHHHHHHH--hCCccccCCCCCceEEc--cCCcEEEeecCch
Q psy758 75 KLHLVFEFCDHTVLNELENHP--HGLPWDLIKQITWQVLRGVSYCH--RHACIHRDIKPENILLT--ANGVVKLCDFGFA 148 (292)
Q Consensus 75 ~~~iv~e~~~~~~L~~~~~~~--~~~~~~~~~~i~~qi~~aL~~LH--~~givH~dl~p~Nilv~--~~~~~kl~dfg~~ 148 (292)
..++||||+++ +|.+++... ..+++..++.++.||+.||.||| +.||+||||||+||+++ .++.+||+|||++
T Consensus 130 ~~~lv~e~~~~-~L~~~l~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~~~ivHrDlkp~NIll~~~~~~~~kL~DFG~a 208 (382)
T 2vx3_A 130 HLCLVFEMLSY-NLYDLLRNTNFRGVSLNLTRKFAQQMCTALLFLATPELSIIHCDLKPENILLCNPKRSAIKIVDFGSS 208 (382)
T ss_dssp EEEEEEECCCC-BHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHTSTTTCEECCCCSGGGEEESSTTSCCEEECCCTTC
T ss_pred ceEEEEecCCC-CHHHHHhhcCcCCCCHHHHHHHHHHHHHHHHHhccCCCCEEcCCCCcccEEEecCCCCcEEEEeccCc
Confidence 99999999986 666666543 45899999999999999999999 57999999999999995 4678999999999
Q ss_pred hhhhcc--ccccccccccccccccCCC-----CCCCcccceeeecCCCCCCchHHHHHHHhhc---ccCCCC----CCCh
Q psy758 149 RLIRDL--IPRHLHIFQTNEYFKGVSL-----PHAENVVPLEIKIGKPAATNIYLIDFLKRCL---DKDPLR----RWSC 214 (292)
Q Consensus 149 ~~~~~~--~~~~~~~~~~~~~~~~~~~-----~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~---~~~p~~----~~~~ 214 (292)
...... ....+..|.+||...+... .|+.|+..+++.+|..++......+.+..+. +..|.. .+..
T Consensus 209 ~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~ 288 (382)
T 2vx3_A 209 CQLGQRIYQYIQSRFYRSPEVLLGMPYDLAIDMWSLGCILVEMHTGEPLFSGANEVDQMNKIVEVLGIPPAHILDQAPKA 288 (382)
T ss_dssp EETTCCCCSSCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCSCCHHHHTTCTTH
T ss_pred eecccccccccCCccccChHHHcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHhhHHH
Confidence 776532 2234556888888776544 3666666777888887765544333332222 111100 0000
Q ss_pred hhhhhc----cCc--------CCCCCC---------------------------CCCccchHHHHhcccCcCCCCCCChh
Q psy758 215 DQLLRH----PYF--------NGYYFE---------------------------VPDEMQYEEITQRCLDKDPLRRWSCD 255 (292)
Q Consensus 215 ~~~~~~----~~~--------~~~~~~---------------------------~~~~~~l~~li~~~l~~dP~~Rpt~~ 255 (292)
...+.. .|. ..+..+ ......+.+||.+||++||++|||++
T Consensus 289 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~dP~~Rpta~ 368 (382)
T 2vx3_A 289 RKFFEKLPDGTWNLKKTKDGKREYKPPGTRKLHNILGVETGGPGGRRAGESGHTVADYLKFKDLILRMLDYDPKTRIQPY 368 (382)
T ss_dssp HHHEEECTTSCEEECCCCTTCCCSCCTTCSCHHHHHTTTTTSGGGTTTTCTTCCHHHHHHHHHHHHHHTCSCTTTSCCHH
T ss_pred HHHHHhccccccccccccccccccCCcchhhHHHHhhccccCCCccccccccccchhhHHHHHHHHHhcCCChhhCCCHH
Confidence 110000 000 000000 00113688999999999999999999
Q ss_pred hhhhCCccccee
Q psy758 256 QLLRHPYFNGYY 267 (292)
Q Consensus 256 ~il~h~w~~~~~ 267 (292)
|+|+||||++..
T Consensus 369 e~L~hp~f~~~~ 380 (382)
T 2vx3_A 369 YALQHSFFKKTA 380 (382)
T ss_dssp HHTTSGGGCC--
T ss_pred HHhcCcccccCC
Confidence 999999999754
|
| >3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.5e-41 Score=282.56 Aligned_cols=251 Identities=20% Similarity=0.194 Sum_probs=185.1
Q ss_pred cccceeeeecccCceEEEEEE-----EcCCCcEEEEEEeccCCCChHHHHHHHHHHHHHHhCCCCCcchhhhhhhcCCeE
Q psy758 2 ERYEKIGKLGEGSYGVVFKCR-----NRDTGQVVAIKKFLESEEDPLIRKIALREIRLLKSLKHPNLVNLLEVFRRKKKL 76 (292)
Q Consensus 2 ~~y~~~~~l~~g~~~~v~~~~-----~~~~~~~v~iK~~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~ 76 (292)
++|++.+.||+|+||.||+|. +..++..||+|.+.... .......+.+|+.+++.++||||+++++++.+.+..
T Consensus 71 ~~~~~~~~LG~G~fg~Vy~~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~ 149 (367)
T 3l9p_A 71 KNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVC-SEQDELDFLMEALIISKFNHQNIVRCIGVSLQSLPR 149 (367)
T ss_dssp GGEEEEEECCCCSSSCEEEEEECC-----CCEEEEEEECCSSC-CHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSC
T ss_pred hHeEEeeEeeeCCCEEEEEEEEccCCCCCcceeEEEEeccccc-ChhhHHHHHHHHHHHHhCCCCCCCeEEEEEecCCCC
Confidence 579999999999999999999 45567899999986443 334456688999999999999999999999999999
Q ss_pred EEEEecCCCccHHHHhcCC-------CCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEEccCC---cEEEeecC
Q psy758 77 HLVFEFCDHTVLNELENHP-------HGLPWDLIKQITWQVLRGVSYCHRHACIHRDIKPENILLTANG---VVKLCDFG 146 (292)
Q Consensus 77 ~iv~e~~~~~~L~~~~~~~-------~~~~~~~~~~i~~qi~~aL~~LH~~givH~dl~p~Nilv~~~~---~~kl~dfg 146 (292)
++||||+.+++|.+++... ..+++..++.++.||+.||+|||++||+||||||+||+++.++ .+||+|||
T Consensus 150 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~~~~~~~kL~DFG 229 (367)
T 3l9p_A 150 FILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEENHFIHRDIAARNCLLTCPGPGRVAKIGDFG 229 (367)
T ss_dssp EEEEECCTTEEHHHHHHHHSCCSSSCCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEESCSSTTCCEEECCCH
T ss_pred EEEEEeCCCCCHHHHHHhhccccCccccccHHHHHHHHHHHHHHHHHHHhCCeeCCCCChhhEEEecCCCCceEEECCCc
Confidence 9999999999999988643 3589999999999999999999999999999999999999555 59999999
Q ss_pred chhhhhcccc-------ccccccccccccccCCCCCCCcccceeeecCCCCCCchHHHHHHHhhc-ccCCCCCCChhhhh
Q psy758 147 FARLIRDLIP-------RHLHIFQTNEYFKGVSLPHAENVVPLEIKIGKPAATNIYLIDFLKRCL-DKDPLRRWSCDQLL 218 (292)
Q Consensus 147 ~~~~~~~~~~-------~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~p~~~~~~~~~~ 218 (292)
+++....... ..+..|.+||...+.......++|+++ .-++..+. +..|+......++.
T Consensus 230 ~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DvwslG-------------~il~ellt~g~~pf~~~~~~~~~ 296 (367)
T 3l9p_A 230 MARDIYRAGYYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFG-------------VLLWEIFSLGYMPYPSKSNQEVL 296 (367)
T ss_dssp HHHHHHHHSSCTTCCGGGSCGGGCCHHHHHHCCCCHHHHHHHHH-------------HHHHHHHTTSCCSSTTCCHHHHH
T ss_pred cccccccccccccCCCcCCcccEECHHHhcCCCCCcHHHHHHHH-------------HHHHHHHhCCCCCCCCCCHHHHH
Confidence 9986543211 112346666665444333222222222 22222222 33444444433333
Q ss_pred hccCcC-CCCCCCCCccchHHHHhcccCcCCCCCCChhhhhhCCcccce
Q psy758 219 RHPYFN-GYYFEVPDEMQYEEITQRCLDKDPLRRWSCDQLLRHPYFNGY 266 (292)
Q Consensus 219 ~~~~~~-~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~~il~h~w~~~~ 266 (292)
...... ....+...+..+.+||.+||+.||.+|||+.+|+++.|....
T Consensus 297 ~~i~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~eil~~l~~~~~ 345 (367)
T 3l9p_A 297 EFVTSGGRMDPPKNCPGPVYRIMTQCWQHQPEDRPNFAIILERIEYCTQ 345 (367)
T ss_dssp HHHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred HHHHcCCCCCCCccCCHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHhh
Confidence 221111 112234457789999999999999999999999999887653
|
| >2eu9_A Dual specificity protein kinase CLK3; kinase domain, transferase; 1.53A {Homo sapiens} PDB: 2wu6_A* 2wu7_A* 3raw_A* 2exe_A 3nr9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-40 Score=278.29 Aligned_cols=265 Identities=23% Similarity=0.376 Sum_probs=191.3
Q ss_pred cccceeeeecccCceEEEEEEEcCCC-cEEEEEEeccCCCChHHHHHHHHHHHHHHhCCCCC------cchhhhhhhcCC
Q psy758 2 ERYEKIGKLGEGSYGVVFKCRNRDTG-QVVAIKKFLESEEDPLIRKIALREIRLLKSLKHPN------LVNLLEVFRRKK 74 (292)
Q Consensus 2 ~~y~~~~~l~~g~~~~v~~~~~~~~~-~~v~iK~~~~~~~~~~~~~~~~~e~~~~~~l~~~~------i~~~~~~~~~~~ 74 (292)
++|++.+.||+|+||.||+|.+..++ ..||+|++... ....+.+.+|+.+++.++|++ ++.+++++...+
T Consensus 19 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~---~~~~~~~~~E~~~l~~l~~~~~~~~~~~~~~~~~~~~~~ 95 (355)
T 2eu9_A 19 ERYEIVGNLGEGTFGKVVECLDHARGKSQVALKIIRNV---GKYREAARLEINVLKKIKEKDKENKFLCVLMSDWFNFHG 95 (355)
T ss_dssp TTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEECSC---HHHHHHHHHHHHHHHHHHHHCTTSCSCBCCEEEEEEETT
T ss_pred ccEEEEEEeeccCCeEEEEEEecCCCceEEEEEEEccc---ccchhHHHHHHHHHHHHhhcCCCCceeEEEeeeeeeeCC
Confidence 68999999999999999999998777 68999998643 344567788999999997655 888899999999
Q ss_pred eEEEEEecCCCccHHHHhcCC-CCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEE-------------------
Q psy758 75 KLHLVFEFCDHTVLNELENHP-HGLPWDLIKQITWQVLRGVSYCHRHACIHRDIKPENILL------------------- 134 (292)
Q Consensus 75 ~~~iv~e~~~~~~L~~~~~~~-~~~~~~~~~~i~~qi~~aL~~LH~~givH~dl~p~Nilv------------------- 134 (292)
..++||||++++++..+.... ..+++..++.++.||+.||+|||++||+|+||||+||++
T Consensus 96 ~~~lv~e~~~~~l~~~l~~~~~~~~~~~~~~~i~~qi~~~L~~lH~~~ivH~Dlkp~NIll~~~~~~~~~~~~~~~~~~~ 175 (355)
T 2eu9_A 96 HMCIAFELLGKNTFEFLKENNFQPYPLPHVRHMAYQLCHALRFLHENQLTHTDLKPENILFVNSEFETLYNEHKSCEEKS 175 (355)
T ss_dssp EEEEEEECCCCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHTTTEECCCCCGGGEEESCCCEEEEECCC-CCCEEE
T ss_pred eEEEEEeccCCChHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEEecccccccccccccccccc
Confidence 999999999777766665543 469999999999999999999999999999999999999
Q ss_pred ccCCcEEEeecCchhhhhccc--cccccccccccccccCCC-----CCCCcccceeeecCCCCCCchHHH---HHHHhhc
Q psy758 135 TANGVVKLCDFGFARLIRDLI--PRHLHIFQTNEYFKGVSL-----PHAENVVPLEIKIGKPAATNIYLI---DFLKRCL 204 (292)
Q Consensus 135 ~~~~~~kl~dfg~~~~~~~~~--~~~~~~~~~~~~~~~~~~-----~~~~~~~~~~~~~~~~~~~~~~~~---~~~~~~~ 204 (292)
+.++.++|+|||++....... ...+..|.+||...+... .|+.|+..+++.+|..++...... ..+...+
T Consensus 176 ~~~~~~kl~Dfg~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~~~~~~ 255 (355)
T 2eu9_A 176 VKNTSIRVADFGSATFDHEHHTTIVATRHYRPPEVILELGWAQPCDVWSIGCILFEYYRGFTLFQTHENREHLVMMEKIL 255 (355)
T ss_dssp ESCCCEEECCCTTCEETTSCCCSSCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHH
T ss_pred cCCCcEEEeecCccccccccccCCcCCCcccCCeeeecCCCCCccchHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHc
Confidence 567899999999997654322 233456778877665544 355555556666676665433222 2222222
Q ss_pred ccCCCCCCC--------------------hhhhhh---ccCcCCCCCCCCCccchHHHHhcccCcCCCCCCChhhhhhCC
Q psy758 205 DKDPLRRWS--------------------CDQLLR---HPYFNGYYFEVPDEMQYEEITQRCLDKDPLRRWSCDQLLRHP 261 (292)
Q Consensus 205 ~~~p~~~~~--------------------~~~~~~---~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~~il~h~ 261 (292)
...|..... ...... .++..........+..+.+||.+||+.||++|||++|+++||
T Consensus 256 ~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpt~~e~l~hp 335 (355)
T 2eu9_A 256 GPIPSHMIHRTRKQKYFYKGGLVWDENSSDGRYVKENCKPLKSYMLQDSLEHVQLFDLMRRMLEFDPAQRITLAEALLHP 335 (355)
T ss_dssp CCCCHHHHHHCSCGGGEETTEECCCTTSHHHHHHHHHCCCGGGGCSCCSHHHHHHHHHHHHHTCSSTTTSCCHHHHTTSG
T ss_pred CCCcHHHhhhccchhhhcccccccccccchhccccccCCcccccccccchhHHHHHHHHHHHhcCChhhCcCHHHHhcCh
Confidence 222210000 000000 000000011112245788999999999999999999999999
Q ss_pred cccceecc
Q psy758 262 YFNGYYFE 269 (292)
Q Consensus 262 w~~~~~~~ 269 (292)
||++..++
T Consensus 336 ~f~~~~~~ 343 (355)
T 2eu9_A 336 FFAGLTPE 343 (355)
T ss_dssp GGGGCCHH
T ss_pred hhcCCChh
Confidence 99987643
|
| >2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-40 Score=271.85 Aligned_cols=246 Identities=20% Similarity=0.273 Sum_probs=181.8
Q ss_pred CcccceeeeecccCceEEEEEEEcCCCcEEEEEEeccCC-CChHHHHHHHHHHHHHHhCCCCCcchhhhhhhcCCeEEEE
Q psy758 1 MERYEKIGKLGEGSYGVVFKCRNRDTGQVVAIKKFLESE-EDPLIRKIALREIRLLKSLKHPNLVNLLEVFRRKKKLHLV 79 (292)
Q Consensus 1 ~~~y~~~~~l~~g~~~~v~~~~~~~~~~~v~iK~~~~~~-~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~iv 79 (292)
+++|++.+.||+|++|.||+|.+..+++.||+|++.... ......+.+.+|+.+++.++||||+++++++.+++..++|
T Consensus 33 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~lv 112 (309)
T 2h34_A 33 FGPYRLRRLVGRGGMGDVYEAEDTVRERIVALKLMSETLSSDPVFRTRMQREARTAGRLQEPHVVPIHDFGEIDGQLYVD 112 (309)
T ss_dssp -CCEEEEEEEEECSSSEEEEEEETTTTEEEEEEECGGGGGGSHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEE
T ss_pred eccEEEEEEEcCCCCeeEEEEEEcCCCeEEEEEecCcccccCHHHHHHHHHHHHHHhhcCCCCeeEEEEEEeeCCeEEEE
Confidence 578999999999999999999999999999999997654 3445567889999999999999999999999999999999
Q ss_pred EecCCCccHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEEccCCcEEEeecCchhhhhccc----
Q psy758 80 FEFCDHTVLNELENHPHGLPWDLIKQITWQVLRGVSYCHRHACIHRDIKPENILLTANGVVKLCDFGFARLIRDLI---- 155 (292)
Q Consensus 80 ~e~~~~~~L~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~givH~dl~p~Nilv~~~~~~kl~dfg~~~~~~~~~---- 155 (292)
+||+++++|.+++...+.+++..++.++.||+.||.|||++|++|+||+|+||+++.++.++|+|||++.......
T Consensus 113 ~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~~~~~~ 192 (309)
T 2h34_A 113 MRLINGVDLAAMLRRQGPLAPPRAVAIVRQIGSALDAAHAAGATHRDVKPENILVSADDFAYLVDFGIASATTDEKLTQL 192 (309)
T ss_dssp EECCCCEEHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTSCEEECSCCC------------
T ss_pred EEecCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCcCCcCCCChHHEEEcCCCCEEEecCccCccccccccccc
Confidence 9999999999999877789999999999999999999999999999999999999999999999999987654321
Q ss_pred --cccccccccccccccCCCCCCCcccceeeecCCCCCCchHHHHHHHhhcccCCCCCCChhhhh---hccCcCCCCCCC
Q psy758 156 --PRHLHIFQTNEYFKGVSLPHAENVVPLEIKIGKPAATNIYLIDFLKRCLDKDPLRRWSCDQLL---RHPYFNGYYFEV 230 (292)
Q Consensus 156 --~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~---~~~~~~~~~~~~ 230 (292)
...+..|.+||...+.......++|++ +.-++..+.+..|+......... ..........+.
T Consensus 193 ~~~~~~~~y~aPE~~~~~~~~~~~Di~sl-------------G~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~ 259 (309)
T 2h34_A 193 GNTVGTLYYMAPERFSESHATYRADIYAL-------------TCVLYECLTGSPPYQGDQLSVMGAHINQAIPRPSTVRP 259 (309)
T ss_dssp ----CCGGGCCGGGTCC----CCCHHHHH-------------HHHHHHHHHSSCSSCSCHHHHHHHHHHSCCCCGGGTST
T ss_pred cccCCCcCccCHHHHcCCCCCchHhHHHH-------------HHHHHHHHHCCCCCCCchHHHHHHHhccCCCCccccCC
Confidence 123345667776654433323333222 22233333333343332221111 111111112234
Q ss_pred CCccchHHHHhcccCcCCCCCC-Chhhhhh
Q psy758 231 PDEMQYEEITQRCLDKDPLRRW-SCDQLLR 259 (292)
Q Consensus 231 ~~~~~l~~li~~~l~~dP~~Rp-t~~~il~ 259 (292)
..+..+.++|.+||+.||.+|| |++++++
T Consensus 260 ~~~~~l~~li~~~l~~dP~~Rp~s~~~l~~ 289 (309)
T 2h34_A 260 GIPVAFDAVIARGMAKNPEDRYVTCGDLSA 289 (309)
T ss_dssp TCCTHHHHHHHHHTCSSGGGSCSSHHHHHH
T ss_pred CCCHHHHHHHHHhccCCHHHHHHhHHHHHH
Confidence 4577899999999999999999 7888876
|
| >3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} SCOP: d.144.1.0 PDB: 3kmw_A* 3rep_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-40 Score=268.33 Aligned_cols=239 Identities=13% Similarity=0.148 Sum_probs=190.6
Q ss_pred CcccceeeeecccCceEEEEEEEcCCCcEEEEEEeccCCCChHHHHHHHHHHHHHHhCCCCCcchhhhhhhcC--CeEEE
Q psy758 1 MERYEKIGKLGEGSYGVVFKCRNRDTGQVVAIKKFLESEEDPLIRKIALREIRLLKSLKHPNLVNLLEVFRRK--KKLHL 78 (292)
Q Consensus 1 ~~~y~~~~~l~~g~~~~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~--~~~~i 78 (292)
+++|++.+.||+|++|.||+|.+. ++.||+|++..........+.+.+|+.+++.++||||+++++++.+. +..++
T Consensus 9 ~~~y~~~~~lg~G~~g~V~~~~~~--~~~~avK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~l 86 (271)
T 3kmu_A 9 FKQLNFLTKLNENHSGELWKGRWQ--GNDIVVKVLKVRDWSTRKSRDFNEECPRLRIFSHPNVLPVLGACQSPPAPHPTL 86 (271)
T ss_dssp GGGCEEEEEEEEETTEEEEEEEET--TEEEEEEEECCTTCCHHHHHHHHHHGGGGCCCSCTTEECEEEEECTTTSSSCEE
T ss_pred HHHhHHHHHhcCCCcceEEEEEEC--CeeEEEEEecccccCHHHHHHHHHHHHHHHhcCCCchhheEEEEccCCCCCeEe
Confidence 478999999999999999999985 88999999988777777778899999999999999999999998876 78999
Q ss_pred EEecCCCccHHHHhcCCC--CCCHHHHHHHHHHHHHHHHHHHhCC--ccccCCCCCceEEccCCcEEEeecCchhhhhcc
Q psy758 79 VFEFCDHTVLNELENHPH--GLPWDLIKQITWQVLRGVSYCHRHA--CIHRDIKPENILLTANGVVKLCDFGFARLIRDL 154 (292)
Q Consensus 79 v~e~~~~~~L~~~~~~~~--~~~~~~~~~i~~qi~~aL~~LH~~g--ivH~dl~p~Nilv~~~~~~kl~dfg~~~~~~~~ 154 (292)
||||+++++|.+++.... .+++..++.++.||+.||.|||++| ++|+||+|+||+++.++.++|+||++.......
T Consensus 87 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~~i~H~dikp~Nil~~~~~~~~l~~~~~~~~~~~~ 166 (271)
T 3kmu_A 87 ITHWMPYGSLYNVLHEGTNFVVDQSQAVKFALDMARGMAFLHTLEPLIPRHALNSRSVMIDEDMTARISMADVKFSFQSP 166 (271)
T ss_dssp EEECCTTCBHHHHHHSCSSCCCCHHHHHHHHHHHHHHHHHHTTSSSCCTTCCCSGGGEEECTTSCEEEEGGGSCCTTSCT
T ss_pred eecccCCCcHHHHHhhcccCCCCHHHHHHHHHHHHHHHHHHhcCCCceecCCCccceEEEcCCcceeEEeccceeeeccc
Confidence 999999999999998755 4899999999999999999999999 999999999999999999999998887665554
Q ss_pred ccccccccccccccccCC--------CCCCCcccceeeecCCCCCCchHHHHHHHhhcccCCCCCCChhhhhhccCcCC-
Q psy758 155 IPRHLHIFQTNEYFKGVS--------LPHAENVVPLEIKIGKPAATNIYLIDFLKRCLDKDPLRRWSCDQLLRHPYFNG- 225 (292)
Q Consensus 155 ~~~~~~~~~~~~~~~~~~--------~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~- 225 (292)
....+..|.+||...+.. ..|+.|+..+++.+ +..|+...+..+.........
T Consensus 167 ~~~~t~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~------------------g~~p~~~~~~~~~~~~~~~~~~ 228 (271)
T 3kmu_A 167 GRMYAPAWVAPEALQKKPEDTNRRSADMWSFAVLLWELVT------------------REVPFADLSNMEIGMKVALEGL 228 (271)
T ss_dssp TCBSCGGGSCHHHHHSCGGGSCHHHHHHHHHHHHHHHHHH------------------CSCTTTTSCHHHHHHHHHHSCC
T ss_pred CccCCccccChhhhccCCCCCCCchhhHHHHHHHHHHHHh------------------CCCCccccChHHHHHHHHhcCC
Confidence 555566677887765432 22333333333333 444444444333322211111
Q ss_pred -CCCCCCCccchHHHHhcccCcCCCCCCChhhhhh
Q psy758 226 -YYFEVPDEMQYEEITQRCLDKDPLRRWSCDQLLR 259 (292)
Q Consensus 226 -~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~~il~ 259 (292)
...+...+..+.++|.+||+.||.+|||++++++
T Consensus 229 ~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~ 263 (271)
T 3kmu_A 229 RPTIPPGISPHVSKLMKICMNEDPAKRPKFDMIVP 263 (271)
T ss_dssp CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred CCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHH
Confidence 1233455789999999999999999999999987
|
| >3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vhk_A* 3vid_A* 3hng_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.4e-41 Score=281.08 Aligned_cols=245 Identities=23% Similarity=0.346 Sum_probs=181.9
Q ss_pred cccceeeeecccCceEEEEEE-----EcCCCcEEEEEEeccCCCChHHHHHHHHHHHHHHhC-CCCCcchhhhhhhcCC-
Q psy758 2 ERYEKIGKLGEGSYGVVFKCR-----NRDTGQVVAIKKFLESEEDPLIRKIALREIRLLKSL-KHPNLVNLLEVFRRKK- 74 (292)
Q Consensus 2 ~~y~~~~~l~~g~~~~v~~~~-----~~~~~~~v~iK~~~~~~~~~~~~~~~~~e~~~~~~l-~~~~i~~~~~~~~~~~- 74 (292)
++|++.+.||+|+||.||+|. +..+++.||+|++.... .....+.+.+|+.+++.+ +||||+++++++.+.+
T Consensus 22 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~~hpniv~~~~~~~~~~~ 100 (359)
T 3vhe_A 22 DRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGA-THSEHRALMSELKILIHIGHHLNVVNLLGACTKPGG 100 (359)
T ss_dssp GGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTC-CHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSTTS
T ss_pred cceeeceeecCCCCceEEEEEeccccccccceEEEEEEecCcC-CHHHHHHHHHHHHHHHhhcCCcceeeeeeeeecCCC
Confidence 689999999999999999998 55667899999997543 334456789999999999 7899999999987654
Q ss_pred eEEEEEecCCCccHHHHhcCCCC---------------------------------------------------------
Q psy758 75 KLHLVFEFCDHTVLNELENHPHG--------------------------------------------------------- 97 (292)
Q Consensus 75 ~~~iv~e~~~~~~L~~~~~~~~~--------------------------------------------------------- 97 (292)
..++||||+++|+|.+++.....
T Consensus 101 ~~~iv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 180 (359)
T 3vhe_A 101 PLMVIVEFCKFGNLSTYLRSKRNEFVPYKTKGARFRQGKDYVGAIPVDLKRRLDSITSSQSSASSGFVEEKSLSDVEEEE 180 (359)
T ss_dssp CCEEEEECCTTEEHHHHHHTTTTSBCSCC---------------------------------------------------
T ss_pred ceEEEEEecCCCcHHHHHHhccccccccccccchhhcccccccccchhhhccccccCccccccccccccccccchhhhcc
Confidence 59999999999999999876433
Q ss_pred ---------CCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEEccCCcEEEeecCchhhhhccc-------cccccc
Q psy758 98 ---------LPWDLIKQITWQVLRGVSYCHRHACIHRDIKPENILLTANGVVKLCDFGFARLIRDLI-------PRHLHI 161 (292)
Q Consensus 98 ---------~~~~~~~~i~~qi~~aL~~LH~~givH~dl~p~Nilv~~~~~~kl~dfg~~~~~~~~~-------~~~~~~ 161 (292)
+++..++.++.||+.||+|||++||+||||||+||+++.++.++|+|||++....... ...+..
T Consensus 181 ~~~~~~~~~l~~~~~~~~~~ql~~aL~~LH~~~ivH~Dikp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~t~~ 260 (359)
T 3vhe_A 181 APEDLYKDFLTLEHLICYSFQVAKGMEFLASRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLK 260 (359)
T ss_dssp ---CTTTTCBCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECGGGCEEECCCGGGSCTTSCTTCEEC--CEECGG
T ss_pred cccchhccccCHHHHHHHHHHHHHHHHHHHHCCcccCCCChhhEEEcCCCcEEEEeccceeeecccccchhccccCCCce
Confidence 8999999999999999999999999999999999999999999999999997653211 112234
Q ss_pred cccccccccCCCCCCCcccceeeecCCCCCCchHHHHHHHhhc-ccCCCCCCChhhhhhccCcC--CCCCCCCCccchHH
Q psy758 162 FQTNEYFKGVSLPHAENVVPLEIKIGKPAATNIYLIDFLKRCL-DKDPLRRWSCDQLLRHPYFN--GYYFEVPDEMQYEE 238 (292)
Q Consensus 162 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~p~~~~~~~~~~~~~~~~--~~~~~~~~~~~l~~ 238 (292)
|.+||...+.......|+|++ +..++..+. +..|+......+.+...... ....+...+..+.+
T Consensus 261 y~aPE~~~~~~~~~~~Di~sl-------------G~il~ellt~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ 327 (359)
T 3vhe_A 261 WMAPETIFDRVYTIQSDVWSF-------------GVLLWEIFSLGASPYPGVKIDEEFCRRLKEGTRMRAPDYTTPEMYQ 327 (359)
T ss_dssp GCCHHHHHHCCCCHHHHHHHH-------------HHHHHHHTTTSCCSSTTCCCSHHHHHHHHHTCCCCCCTTCCHHHHH
T ss_pred eEChhhhcCCCCCchhhhhhH-------------HHHHHHHHhcCCCCCCccchhHHHHHHHHcCCCCCCCCCCCHHHHH
Confidence 667776654443322222222 222223332 34444333222211111111 12233445778999
Q ss_pred HHhcccCcCCCCCCChhhhhhC
Q psy758 239 ITQRCLDKDPLRRWSCDQLLRH 260 (292)
Q Consensus 239 li~~~l~~dP~~Rpt~~~il~h 260 (292)
+|.+||+.||.+|||+.++++|
T Consensus 328 li~~~l~~dP~~Rps~~ell~~ 349 (359)
T 3vhe_A 328 TMLDCWHGEPSQRPTFSELVEH 349 (359)
T ss_dssp HHHHHTCSSGGGSCCHHHHHHH
T ss_pred HHHHHccCChhhCCCHHHHHHH
Confidence 9999999999999999999985
|
| >4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.3e-41 Score=272.95 Aligned_cols=243 Identities=19% Similarity=0.257 Sum_probs=182.7
Q ss_pred cccceeeeecccCceEEEEEEEcCCC-------cEEEEEEeccCCCChHHHHHHHHHHHHHHhCCCCCcchhhhhhhcCC
Q psy758 2 ERYEKIGKLGEGSYGVVFKCRNRDTG-------QVVAIKKFLESEEDPLIRKIALREIRLLKSLKHPNLVNLLEVFRRKK 74 (292)
Q Consensus 2 ~~y~~~~~l~~g~~~~v~~~~~~~~~-------~~v~iK~~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~ 74 (292)
++|++.+.||+|+||.||+|.+..++ ..|++|++..... ...+.+.+|+.+++.++||||+++++++.+++
T Consensus 8 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~va~K~~~~~~~--~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~ 85 (289)
T 4fvq_A 8 EDLIFNESLGQGTFTKIFKGVRREVGDYGQLHETEVLLKVLDKAHR--NYSESFFEAASMMSKLSHKHLVLNYGVCVCGD 85 (289)
T ss_dssp GGEEEEEEEEEETTEEEEEEEEEEECGGGCEEEEEEEEEEECGGGG--GGHHHHHHHHHHHHTSCCTTBCCEEEEECCTT
T ss_pred hHeeeeeeeccCCCceEEEEEEecccccccccchhhhhhhcccccH--HHHHHHHHHHHHHHhCCCCCEeEEEEEEEeCC
Confidence 68999999999999999999998877 4699999865432 23466889999999999999999999999999
Q ss_pred eEEEEEecCCCccHHHHhcCCCC-CCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEEccCCc--------EEEeec
Q psy758 75 KLHLVFEFCDHTVLNELENHPHG-LPWDLIKQITWQVLRGVSYCHRHACIHRDIKPENILLTANGV--------VKLCDF 145 (292)
Q Consensus 75 ~~~iv~e~~~~~~L~~~~~~~~~-~~~~~~~~i~~qi~~aL~~LH~~givH~dl~p~Nilv~~~~~--------~kl~df 145 (292)
..++||||+.+++|.+++..... +++..++.++.||+.||.|||++|++||||||+||+++.++. ++|+||
T Consensus 86 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivH~Dlkp~NIll~~~~~~~~~~~~~~kl~Df 165 (289)
T 4fvq_A 86 ENILVQEFVKFGSLDTYLKKNKNCINILWKLEVAKQLAAAMHFLEENTLIHGNVCAKNILLIREEDRKTGNPPFIKLSDP 165 (289)
T ss_dssp CCEEEEECCTTCBHHHHHHHTGGGCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEEEECCBGGGTBCCEEEECCC
T ss_pred CCEEEEECCCCCCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHhhCCeECCCcCcceEEEecCCcccccccceeeeccC
Confidence 99999999999999999876544 999999999999999999999999999999999999998887 999999
Q ss_pred Cchhhhhcc-cccccccccccccccc-CCCCCCCcccceeeecCCCCCCchHHHHHHHhhccc-CCCCCCChhhhhhccC
Q psy758 146 GFARLIRDL-IPRHLHIFQTNEYFKG-VSLPHAENVVPLEIKIGKPAATNIYLIDFLKRCLDK-DPLRRWSCDQLLRHPY 222 (292)
Q Consensus 146 g~~~~~~~~-~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~p~~~~~~~~~~~~~~ 222 (292)
|++...... ....+..|.+||...+ .......|+|++ +.-++..+.+. .|........... ..
T Consensus 166 g~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Diwsl-------------G~il~el~~g~~~~~~~~~~~~~~~-~~ 231 (289)
T 4fvq_A 166 GISITVLPKDILQERIPWVPPECIENPKNLNLATDKWSF-------------GTTLWEICSGGDKPLSALDSQRKLQ-FY 231 (289)
T ss_dssp CSCTTTSCHHHHHHTTTTSCHHHHHCGGGCCHHHHHHHH-------------HHHHHHHHTTTCCTTTTSCHHHHHH-HH
T ss_pred cccccccCccccCCcCcccCHHHhCCCCCCCchhHHHHH-------------HHHHHHHHcCCCCCccccchHHHHH-Hh
Confidence 998665332 1223445777776654 222222222222 22222223312 2222222222111 11
Q ss_pred cCCCCCCCCCccchHHHHhcccCcCCCCCCChhhhhhC
Q psy758 223 FNGYYFEVPDEMQYEEITQRCLDKDPLRRWSCDQLLRH 260 (292)
Q Consensus 223 ~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~~il~h 260 (292)
......+...+..+.+||.+||+.||.+|||+.+++++
T Consensus 232 ~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~ 269 (289)
T 4fvq_A 232 EDRHQLPAPKAAELANLINNCMDYEPDHRPSFRAIIRD 269 (289)
T ss_dssp HTTCCCCCCSSCTTHHHHHHHSCSSGGGSCCHHHHHHH
T ss_pred hccCCCCCCCCHHHHHHHHHHcCCChhHCcCHHHHHHH
Confidence 11223344557789999999999999999999999994
|
| >3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.5e-40 Score=267.29 Aligned_cols=242 Identities=20% Similarity=0.288 Sum_probs=182.0
Q ss_pred cccceeeeecccCceEEEEEEEcCCCcEEEEEEeccCCCChHHHHHHHHHHHHHHhCCCCCcchhhhhhhcCCeEEEEEe
Q psy758 2 ERYEKIGKLGEGSYGVVFKCRNRDTGQVVAIKKFLESEEDPLIRKIALREIRLLKSLKHPNLVNLLEVFRRKKKLHLVFE 81 (292)
Q Consensus 2 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~iv~e 81 (292)
++|++++.||+|+||.||++.+. ++..||+|++....... +.+.+|+.+++.++||||+++++++.+.+..++|||
T Consensus 24 ~~y~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~---~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 99 (283)
T 3gen_A 24 KDLTFLKELGTGQFGVVKYGKWR-GQYDVAIKMIKEGSMSE---DEFIEEAKVMMNLSHEKLVQLYGVCTKQRPIFIITE 99 (283)
T ss_dssp GGEEEEEECC---CEEEEEEEET-TTEEEEEEEECTTSBCH---HHHHHHHHHHHTCCCTTBCCEEEEECSSSSEEEEEC
T ss_pred HHHHhHhhcCCCCCceEEEEEEc-CCCeEEEEEecCCCCCH---HHHHHHHHHHhcCCCCCEeeEEEEEecCCCeEEEEe
Confidence 58999999999999999999876 57789999997665443 457899999999999999999999999999999999
Q ss_pred cCCCccHHHHhcC-CCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEEccCCcEEEeecCchhhhhccc-----
Q psy758 82 FCDHTVLNELENH-PHGLPWDLIKQITWQVLRGVSYCHRHACIHRDIKPENILLTANGVVKLCDFGFARLIRDLI----- 155 (292)
Q Consensus 82 ~~~~~~L~~~~~~-~~~~~~~~~~~i~~qi~~aL~~LH~~givH~dl~p~Nilv~~~~~~kl~dfg~~~~~~~~~----- 155 (292)
|+.+++|.+++.. ...+++..++.++.||+.||.|||++|++|+||||+||+++.++.++|+|||++.......
T Consensus 100 ~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dikp~Nili~~~~~~kl~Dfg~~~~~~~~~~~~~~ 179 (283)
T 3gen_A 100 YMANGCLLNYLREMRHRFQTQQLLEMCKDVCEAMEYLESKQFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEYTSSV 179 (283)
T ss_dssp CCTTCBHHHHHHCGGGCCCHHHHHHHHHHHHHHHHHHHHTTCCCSSCSGGGEEECTTSCEEECSTTGGGGBCCHHHHSTT
T ss_pred ccCCCcHHHHHHHhccCCCHHHHHHHHHHHHHHHHHHHHCCccCCCCccceEEEcCCCCEEEcccccccccccccccccc
Confidence 9999999999876 4579999999999999999999999999999999999999999999999999997653221
Q ss_pred -cccccccccccccccCCCCCCCcccceeeecCCCCCCchHHHHHHHhhc-ccCCCCCCChhhhhhccCcC-CCCCCCCC
Q psy758 156 -PRHLHIFQTNEYFKGVSLPHAENVVPLEIKIGKPAATNIYLIDFLKRCL-DKDPLRRWSCDQLLRHPYFN-GYYFEVPD 232 (292)
Q Consensus 156 -~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~p~~~~~~~~~~~~~~~~-~~~~~~~~ 232 (292)
...+..|.+||...+.......++|+ .+..++..+. +..|+...+..+........ ....+...
T Consensus 180 ~~~~~~~y~aPE~~~~~~~~~~~Dv~s-------------lG~~l~~l~t~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 246 (283)
T 3gen_A 180 GSKFPVRWSPPEVLMYSKFSSKSDIWA-------------FGVLMWEIYSLGKMPYERFTNSETAEHIAQGLRLYRPHLA 246 (283)
T ss_dssp STTSCGGGCCHHHHHHCCCSHHHHHHH-------------HHHHHHHHHTTTCCTTTTSCHHHHHHHHHTTCCCCCCTTC
T ss_pred CCccCcccCCHHHhccCCCCchhhHHH-------------HHHHHHHHHhCCCCCccccChhHHHHHHhcccCCCCCCcC
Confidence 11123466666655443322222222 2222333332 44555544443333221111 11223345
Q ss_pred ccchHHHHhcccCcCCCCCCChhhhhhC
Q psy758 233 EMQYEEITQRCLDKDPLRRWSCDQLLRH 260 (292)
Q Consensus 233 ~~~l~~li~~~l~~dP~~Rpt~~~il~h 260 (292)
+..+.++|.+||+.||.+|||++++++|
T Consensus 247 ~~~l~~li~~~l~~~p~~Rps~~~ll~~ 274 (283)
T 3gen_A 247 SEKVYTIMYSCWHEKADERPTFKILLSN 274 (283)
T ss_dssp CHHHHHHHHHTTCSSGGGSCCHHHHHHH
T ss_pred CHHHHHHHHHHccCChhHCcCHHHHHHH
Confidence 7789999999999999999999999986
|
| >3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 4e4m_A* 4f08_A* 4f09_A* 3q32_A* 3rvg_A* 4hge_A* 3tjc_A* 3tjd_A* 4bbe_A* 4bbf_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-40 Score=272.06 Aligned_cols=254 Identities=24% Similarity=0.295 Sum_probs=184.2
Q ss_pred cccceeeeecccCceEEEEEE----EcCCCcEEEEEEeccCCCChHHHHHHHHHHHHHHhCCCCCcchhhhhhhc--CCe
Q psy758 2 ERYEKIGKLGEGSYGVVFKCR----NRDTGQVVAIKKFLESEEDPLIRKIALREIRLLKSLKHPNLVNLLEVFRR--KKK 75 (292)
Q Consensus 2 ~~y~~~~~l~~g~~~~v~~~~----~~~~~~~v~iK~~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~--~~~ 75 (292)
++|++.+.||+|+||.||+|. +..+++.||+|++... .....+.+.+|+.+++.++||||+++++++.. ...
T Consensus 10 ~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~ 87 (295)
T 3ugc_A 10 RHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHS--TEEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRN 87 (295)
T ss_dssp GGEEEEEEEEECSSEEEEEEEECTTCSSCCEEEEEEEESCC--CHHHHHHHHHHHHHHHTCCCTTBCCEEEEECHHHHTS
T ss_pred HHhhhhheeeccCCEEEEEEEEecccCCCCcEEEEEEcccC--CHHHHHHHHHHHHHHHhCCCCCEeeEEEEEecCCCCc
Confidence 689999999999999999998 5678999999998644 34556778899999999999999999998753 466
Q ss_pred EEEEEecCCCccHHHHhcCCC-CCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEEccCCcEEEeecCchhhhhcc
Q psy758 76 LHLVFEFCDHTVLNELENHPH-GLPWDLIKQITWQVLRGVSYCHRHACIHRDIKPENILLTANGVVKLCDFGFARLIRDL 154 (292)
Q Consensus 76 ~~iv~e~~~~~~L~~~~~~~~-~~~~~~~~~i~~qi~~aL~~LH~~givH~dl~p~Nilv~~~~~~kl~dfg~~~~~~~~ 154 (292)
.++||||+++++|.+++.... .+++..++.++.||+.||.|||++|++|+||||+||+++.++.++|+|||++......
T Consensus 88 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dikp~Nil~~~~~~~kl~Dfg~~~~~~~~ 167 (295)
T 3ugc_A 88 LKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKGMEYLGTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQD 167 (295)
T ss_dssp CEEEEECCTTCBHHHHHHHCGGGCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEEETTEEEECCCCSCC-----
T ss_pred eEEEEEeCCCCCHHHHHHhcccccCHHHHHHHHHHHHHHHHHHhcCCcccCCCCHhhEEEcCCCeEEEccCcccccccCC
Confidence 899999999999999886543 4999999999999999999999999999999999999999999999999999765432
Q ss_pred c--------cccccccccccccccCCCC-----CCCcccceeeecCCCCCCchHHHHHHHhhcccCCCCCCChhhhhhcc
Q psy758 155 I--------PRHLHIFQTNEYFKGVSLP-----HAENVVPLEIKIGKPAATNIYLIDFLKRCLDKDPLRRWSCDQLLRHP 221 (292)
Q Consensus 155 ~--------~~~~~~~~~~~~~~~~~~~-----~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~ 221 (292)
. ...+..|.+||...+.... |+.++..+++.++..++..... ... ......+........+....
T Consensus 168 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~~~~~~~~-~~~-~~~~~~~~~~~~~~~~~~~~ 245 (295)
T 3ugc_A 168 KEFFKVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYIEKSKSPPA-EFM-RMIGNDKQGQMIVFHLIELL 245 (295)
T ss_dssp --------CTTCGGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHHTTCTTCSHHH-HHH-HHHCTTCCTHHHHHHHHHHH
T ss_pred cceeeeccCCCCccceeCcHHhcCCCCChHHHHHHHHHHHHHHHhcccccCCChH-HHH-hhhcCccccchhHHHHHHHH
Confidence 1 1122347777776655443 4455555555555544332211 111 11111111111111111100
Q ss_pred -CcCCCCCCCCCccchHHHHhcccCcCCCCCCChhhhhh
Q psy758 222 -YFNGYYFEVPDEMQYEEITQRCLDKDPLRRWSCDQLLR 259 (292)
Q Consensus 222 -~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~~il~ 259 (292)
.......+...+..+.+||.+||+.||++|||+.++++
T Consensus 246 ~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~el~~ 284 (295)
T 3ugc_A 246 KNNGRLPRPDGCPDEIYMIMTECWNNNVNQRPSFRDLAL 284 (295)
T ss_dssp HTTCCCCCCTTCCHHHHHHHHHHSCSSGGGSCCHHHHHH
T ss_pred hccCcCCCCcCcCHHHHHHHHHHcCCChhhCCCHHHHHH
Confidence 00112234455788999999999999999999999987
|
| >3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} SCOP: d.144.1.7 PDB: 3sxr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-40 Score=267.03 Aligned_cols=242 Identities=22% Similarity=0.299 Sum_probs=183.4
Q ss_pred cccceeeeecccCceEEEEEEEcCCCcEEEEEEeccCCCChHHHHHHHHHHHHHHhCCCCCcchhhhhhhcCCeEEEEEe
Q psy758 2 ERYEKIGKLGEGSYGVVFKCRNRDTGQVVAIKKFLESEEDPLIRKIALREIRLLKSLKHPNLVNLLEVFRRKKKLHLVFE 81 (292)
Q Consensus 2 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~iv~e 81 (292)
++|++.+.||+|+||.||+|.+. ++..||+|++....... +.+.+|+.+++.++||||+++++++.+++..++|||
T Consensus 8 ~~y~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~---~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 83 (268)
T 3sxs_A 8 EEITLLKELGSGQFGVVKLGKWK-GQYDVAVKMIKEGSMSE---DEFFQEAQTMMKLSHPKLVKFYGVCSKEYPIYIVTE 83 (268)
T ss_dssp GGEEEEEEEEEETTEEEEEEEET-TTEEEEEEEECBTTBCH---HHHHHHHHHHHHCCCTTBCCEEEEECSSSSEEEEEE
T ss_pred hheeeeeeeccCCCceEEEEEec-CceeEEEEEeccCCCcH---HHHHHHHHHHHhCCCCCEeeEEEEEccCCceEEEEE
Confidence 68999999999999999999776 46789999997665443 457899999999999999999999999999999999
Q ss_pred cCCCccHHHHhcCC-CCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEEccCCcEEEeecCchhhhhcccc----
Q psy758 82 FCDHTVLNELENHP-HGLPWDLIKQITWQVLRGVSYCHRHACIHRDIKPENILLTANGVVKLCDFGFARLIRDLIP---- 156 (292)
Q Consensus 82 ~~~~~~L~~~~~~~-~~~~~~~~~~i~~qi~~aL~~LH~~givH~dl~p~Nilv~~~~~~kl~dfg~~~~~~~~~~---- 156 (292)
|+++++|.+++... ..+++..++.++.|++.||.|||++|++|+||||+||+++.++.++|+|||++........
T Consensus 84 ~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dikp~Nil~~~~~~~~l~Dfg~~~~~~~~~~~~~~ 163 (268)
T 3sxs_A 84 YISNGCLLNYLRSHGKGLEPSQLLEMCYDVCEGMAFLESHQFIHRDLAARNCLVDRDLCVKVSDFGMTRYVLDDQYVSSV 163 (268)
T ss_dssp CCTTCBHHHHHHHHGGGCCHHHHHHHHHHHHHHHHHHHHTTEEESSCSGGGEEECTTCCEEECCTTCEEECCTTCEEECC
T ss_pred ccCCCcHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCcCcceEEECCCCCEEEccCccceecchhhhhccc
Confidence 99999999988654 3499999999999999999999999999999999999999999999999999876543211
Q ss_pred --ccccccccccccccCCCCCCCcccceeeecCCCCCCchHHHHHHHhhc-ccCCCCCCChhhhhhccCcC-CCCCCCCC
Q psy758 157 --RHLHIFQTNEYFKGVSLPHAENVVPLEIKIGKPAATNIYLIDFLKRCL-DKDPLRRWSCDQLLRHPYFN-GYYFEVPD 232 (292)
Q Consensus 157 --~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~p~~~~~~~~~~~~~~~~-~~~~~~~~ 232 (292)
..+..|.+||...+.......++|+ .+.-++..+. +..|+......+........ ....+...
T Consensus 164 ~~~~~~~y~aPE~~~~~~~~~~~Di~s-------------lG~il~~l~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 230 (268)
T 3sxs_A 164 GTKFPVKWSAPEVFHYFKYSSKSDVWA-------------FGILMWEVFSLGKMPYDLYTNSEVVLKVSQGHRLYRPHLA 230 (268)
T ss_dssp SCCCCGGGCCHHHHHHSEEETTHHHHH-------------HHHHHHHHHTTTCCTTTTSCHHHHHHHHHTTCCCCCCTTS
T ss_pred CCCcCcccCCHHHHhccCCchhhhhHH-------------HHHHHHHHHcCCCCCccccChHHHHHHHHcCCCCCCCCcC
Confidence 1122366666654433322222222 2222333333 44455444444333221111 11223345
Q ss_pred ccchHHHHhcccCcCCCCCCChhhhhhC
Q psy758 233 EMQYEEITQRCLDKDPLRRWSCDQLLRH 260 (292)
Q Consensus 233 ~~~l~~li~~~l~~dP~~Rpt~~~il~h 260 (292)
+..+.++|.+||+.||.+|||+.+++++
T Consensus 231 ~~~l~~li~~~l~~~p~~Rps~~~ll~~ 258 (268)
T 3sxs_A 231 SDTIYQIMYSCWHELPEKRPTFQQLLSS 258 (268)
T ss_dssp CHHHHHHHHHTTCSSGGGSCCHHHHHHH
T ss_pred hHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence 7789999999999999999999999985
|
| >1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-40 Score=275.73 Aligned_cols=248 Identities=23% Similarity=0.269 Sum_probs=186.9
Q ss_pred cccceeeeecccCceEEEEEEEc-----CCCcEEEEEEeccCCCChHHHHHHHHHHHHHHhCCCCCcchhhhhhhcCCeE
Q psy758 2 ERYEKIGKLGEGSYGVVFKCRNR-----DTGQVVAIKKFLESEEDPLIRKIALREIRLLKSLKHPNLVNLLEVFRRKKKL 76 (292)
Q Consensus 2 ~~y~~~~~l~~g~~~~v~~~~~~-----~~~~~v~iK~~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~ 76 (292)
++|++.+.||+|+||.||+|.+. .+++.||+|++.... .....+.+.+|+.+++.++||||+++++++.+++..
T Consensus 47 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~ 125 (343)
T 1luf_A 47 NNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEA-SADMQADFQREAALMAEFDNPNIVKLLGVCAVGKPM 125 (343)
T ss_dssp GGCEEEEEEEECSSCEEEEEEEETSSTTSSEEEEEEEECCTTC-CHHHHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSC
T ss_pred HHCeeeeeeeecCCeeEEEEEecCcCCCCCceeEEEEEecccc-CHHHHHHHHHHHHHHHhCCCCCEEEEEEEEccCCce
Confidence 68999999999999999999987 345889999987543 345567789999999999999999999999999999
Q ss_pred EEEEecCCCccHHHHhcCC------------------------CCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCce
Q psy758 77 HLVFEFCDHTVLNELENHP------------------------HGLPWDLIKQITWQVLRGVSYCHRHACIHRDIKPENI 132 (292)
Q Consensus 77 ~iv~e~~~~~~L~~~~~~~------------------------~~~~~~~~~~i~~qi~~aL~~LH~~givH~dl~p~Ni 132 (292)
++||||+++++|.+++... ..+++..++.++.||+.||.|||++|++|+||||+||
T Consensus 126 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~ivH~Dlkp~NI 205 (343)
T 1luf_A 126 CLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSERKFVHRDLATRNC 205 (343)
T ss_dssp EEEEECCTTCBHHHHHHHTCC----------------------CCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGE
T ss_pred EEEEecCCCCcHHHHHHHhCcccccccccccccccccccccCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCcceE
Confidence 9999999999999998652 4689999999999999999999999999999999999
Q ss_pred EEccCCcEEEeecCchhhhhccc-------cccccccccccccccCCCCCCCcccceeeecCCCCCCchHHHHHHHhhc-
Q psy758 133 LLTANGVVKLCDFGFARLIRDLI-------PRHLHIFQTNEYFKGVSLPHAENVVPLEIKIGKPAATNIYLIDFLKRCL- 204 (292)
Q Consensus 133 lv~~~~~~kl~dfg~~~~~~~~~-------~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~- 204 (292)
+++.++.++|+|||++....... ...+..|.+||...+.......|+|++ +.-++..+.
T Consensus 206 l~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~sl-------------G~il~el~t~ 272 (343)
T 1luf_A 206 LVGENMVVKIADFGLSRNIYSADYYKADGNDAIPIRWMPPESIFYNRYTTESDVWAY-------------GVVLWEIFSY 272 (343)
T ss_dssp EECGGGCEEECCCSCHHHHTGGGCBC----CCBCGGGCCHHHHHHCCCCHHHHHHHH-------------HHHHHHHHTT
T ss_pred EECCCCeEEEeecCCCcccccCccccccCCCcccceecChhhhccCCcCcccccHHH-------------HHHHHHHHhc
Confidence 99999999999999997664321 112234666666554433222222222 222223332
Q ss_pred ccCCCCCCChhhhhhccCcCC-CCCCCCCccchHHHHhcccCcCCCCCCChhhhhhCCcccc
Q psy758 205 DKDPLRRWSCDQLLRHPYFNG-YYFEVPDEMQYEEITQRCLDKDPLRRWSCDQLLRHPYFNG 265 (292)
Q Consensus 205 ~~~p~~~~~~~~~~~~~~~~~-~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~~il~h~w~~~ 265 (292)
+..|+...+..++.....-.. ...+...+..+.+||.+||+.||.+|||+.++++ .|++
T Consensus 273 g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~~~~--~L~~ 332 (343)
T 1luf_A 273 GLQPYYGMAHEEVIYYVRDGNILACPENCPLELYNLMRLCWSKLPADRPSFCSIHR--ILQR 332 (343)
T ss_dssp TCCTTTTSCHHHHHHHHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH--HHHH
T ss_pred CCCcCCCCChHHHHHHHhCCCcCCCCCCCCHHHHHHHHHHcccCcccCCCHHHHHH--HHHH
Confidence 334444444333332111000 1223445778999999999999999999999988 4444
|
| >3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.5e-41 Score=296.91 Aligned_cols=265 Identities=23% Similarity=0.266 Sum_probs=183.0
Q ss_pred CcccceeeeecccCceEEEEEEEcCCCcEEEEEEeccCCCChHHHHHHHHHHHHHHhCCCCCcchhhhhhhc------CC
Q psy758 1 MERYEKIGKLGEGSYGVVFKCRNRDTGQVVAIKKFLESEEDPLIRKIALREIRLLKSLKHPNLVNLLEVFRR------KK 74 (292)
Q Consensus 1 ~~~y~~~~~l~~g~~~~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~------~~ 74 (292)
+++|++.+.||+|+||.||+|.+..+|+.||+|++... ......+.+.+|+.+++.++||||+++++++.. ++
T Consensus 13 ~grY~i~~~LG~G~fG~Vyla~~~~tg~~VAVKvi~~~-~~~~~~~~~~~Ei~iL~~L~HpnIV~l~~v~~~~~~~~~~~ 91 (676)
T 3qa8_A 13 CGPWEMKERLGTGGFGYVLRWIHQDTGEQVAIKQCRQE-LSPKNRERWCLEIQIMKKLNHPNVVSAREVPDGLQKLAPND 91 (676)
T ss_dssp ----CCCCCCCBCSSSBCCCCCCTTTTCCEEECCCCSC-CCHHHHHHHHHHHHHHHHCCBTTBCCEEECCTTTCCCCTTS
T ss_pred CCCeEEEEEEeeCCCeEEEEEEECCCCcEEEEEEeccc-CCHHHHHHHHHHHHHHHhCCCCCCCceeeeecccccccCCC
Confidence 47899999999999999999999999999999998654 344556778999999999999999999998765 67
Q ss_pred eEEEEEecCCCccHHHHhcCCC---CCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEEccCCc---EEEeecCch
Q psy758 75 KLHLVFEFCDHTVLNELENHPH---GLPWDLIKQITWQVLRGVSYCHRHACIHRDIKPENILLTANGV---VKLCDFGFA 148 (292)
Q Consensus 75 ~~~iv~e~~~~~~L~~~~~~~~---~~~~~~~~~i~~qi~~aL~~LH~~givH~dl~p~Nilv~~~~~---~kl~dfg~~ 148 (292)
..++||||++|++|.+++.... .+++..++.++.||+.||+|||++|++||||+|+||+++.++. ++|+|||++
T Consensus 92 ~~~LVmEy~~ggsL~~~L~~~~~~~~lse~~i~~I~~QLl~aL~yLHs~gIVHrDLKP~NILl~~~g~~~~vKL~DFG~a 171 (676)
T 3qa8_A 92 LPLLAMEYCEGGDLRKYLNQFENCCGLKEGPIRTLLSDISSALRYLHENRIIHRDLKPENIVLQPGPQRLIHKIIDLGYA 171 (676)
T ss_dssp SCCCEEECCSSCBHHHHHHSSSCTTCCCSSHHHHHHHHHHHHHHHHHHTTBCCCCCCSTTEEEECCSSSCEEEECSCCCC
T ss_pred eEEEEEEeCCCCCHHHHHHhcccCCCCCHHHHHHHHHHHHHHHHHHHHCCCccCCCCHHHeEeecCCCceeEEEcccccc
Confidence 7899999999999999987643 5899999999999999999999999999999999999997764 999999999
Q ss_pred hhhhccc----cccccccccccccccCCCC-----CCCcccceeeecCCCCCCchHH-HHHHHhhcccCCCCCCChhhhh
Q psy758 149 RLIRDLI----PRHLHIFQTNEYFKGVSLP-----HAENVVPLEIKIGKPAATNIYL-IDFLKRCLDKDPLRRWSCDQLL 218 (292)
Q Consensus 149 ~~~~~~~----~~~~~~~~~~~~~~~~~~~-----~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~p~~~~~~~~~~ 218 (292)
....... ...+..|.+||...+.... |+.|+..+++.+|..++..... ..+...................
T Consensus 172 ~~~~~~~~~~~~~gt~~Y~APE~l~~~~~s~ksDIwSLGviLyeLltG~~Pf~~~~~~~~~~~~i~~~~~~~~~~~~~l~ 251 (676)
T 3qa8_A 172 KELDQGELCTEFVGTLQYLAPELLEQKKYTVTVDYWSFGTLAFECITGFRPFLPNWQPVQWHGKVREKSNEHIVVYDDLT 251 (676)
T ss_dssp CBTTSCCCCCCCCSCCTTCSSCSSCCSCCSTTHHHHHHHHHHHHHHSSCSSCCSSCHHHHSSTTCC------CCSCCCCS
T ss_pred cccccccccccccCCcccCChHHhccCCCCchhHHHHHHHHHHHHHHCCCCCCcccchhhhhhhhhcccchhhhhhhhhc
Confidence 8764322 1233456666666544433 3333334444444444322111 0000000000000000000000
Q ss_pred hccCc-CCCC----CCCCCccchHHHHhcccCcCCCCCCChhhhhhCCcccce
Q psy758 219 RHPYF-NGYY----FEVPDEMQYEEITQRCLDKDPLRRWSCDQLLRHPYFNGY 266 (292)
Q Consensus 219 ~~~~~-~~~~----~~~~~~~~l~~li~~~l~~dP~~Rpt~~~il~h~w~~~~ 266 (292)
....+ .... .....+..+.+||.+||++||++|||+.++++||||+.+
T Consensus 252 g~~~~~~~lp~p~~l~~~ls~~L~dLI~~mL~~DP~kRPTa~elL~hp~F~~l 304 (676)
T 3qa8_A 252 GAVKFSSVLPTPNHLSGILAGKLERWLQCMLMWHQRQRGTDPQNPNVGCFQAL 304 (676)
T ss_dssp SSCCCCSSSCCSCCCCGGGHHHHHHHHHHHSCSSCC---CCTTCCCCTTHHHH
T ss_pred cccccccccCCchhhchhhhHHHHHHHHHHccCCHhhCcCHHHHhcCHHHHHH
Confidence 00000 0111 112246778999999999999999999999999999873
|
| >3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.2e-41 Score=281.77 Aligned_cols=244 Identities=23% Similarity=0.295 Sum_probs=184.4
Q ss_pred cccceeeeecccCceEEEEEEEcCCCcEEEEEEeccCCCChHHHHHHHHHHHHHHhCCCCCcchhhhhhhcCCeEEEEEe
Q psy758 2 ERYEKIGKLGEGSYGVVFKCRNRDTGQVVAIKKFLESEEDPLIRKIALREIRLLKSLKHPNLVNLLEVFRRKKKLHLVFE 81 (292)
Q Consensus 2 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~iv~e 81 (292)
++|++.+.||+|+||.||+|.+..+++.||+|.+... ........+.+|+.+++.++||||+++++++.+++..++|||
T Consensus 114 ~~~~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~-~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e 192 (377)
T 3cbl_A 114 EDLVLGEQIGRGNFGEVFSGRLRADNTLVAVKSCRET-LPPDLKAKFLQEARILKQYSHPNIVRLIGVCTQKQPIYIVME 192 (377)
T ss_dssp GGEEEEEEEEEETTEEEEEEEETTTCCEEEEEECCTT-SCHHHHTTTTHHHHHHTTCCCTTBCCEEEEECSSSSCEEEEE
T ss_pred HHeEEeeEeccCCCCeEEEEEEecCCeEEEEEEcccc-CCHHHHHHHHHHHHHHHhCCCCCEEEEEEEEecCCCcEEEEE
Confidence 5799999999999999999999989999999998754 334456678899999999999999999999999999999999
Q ss_pred cCCCccHHHHhcCC-CCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEEccCCcEEEeecCchhhhhcccc----
Q psy758 82 FCDHTVLNELENHP-HGLPWDLIKQITWQVLRGVSYCHRHACIHRDIKPENILLTANGVVKLCDFGFARLIRDLIP---- 156 (292)
Q Consensus 82 ~~~~~~L~~~~~~~-~~~~~~~~~~i~~qi~~aL~~LH~~givH~dl~p~Nilv~~~~~~kl~dfg~~~~~~~~~~---- 156 (292)
|+++++|.+++... ..+++..++.++.||+.||+|||++|++||||||+||+++.++.+||+|||++........
T Consensus 193 ~~~~g~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivHrDlkp~Nil~~~~~~~kl~DfG~s~~~~~~~~~~~~ 272 (377)
T 3cbl_A 193 LVQGGDFLTFLRTEGARLRVKTLLQMVGDAAAGMEYLESKCCIHRDLAARNCLVTEKNVLKISDFGMSREEADGVYAASG 272 (377)
T ss_dssp CCTTCBHHHHHHHHGGGCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTCCEEECCGGGCEECTTSEEECCS
T ss_pred cCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcCCcccCHHHEEEcCCCcEEECcCCCceecCCCceeecC
Confidence 99999999988653 3599999999999999999999999999999999999999999999999999875432111
Q ss_pred ---ccccccccccccccCCCCCCCcccceeeecCCCCCCchHHHHHHHhhc-ccCCCCCCChhhhhhccCc-CCCCCCCC
Q psy758 157 ---RHLHIFQTNEYFKGVSLPHAENVVPLEIKIGKPAATNIYLIDFLKRCL-DKDPLRRWSCDQLLRHPYF-NGYYFEVP 231 (292)
Q Consensus 157 ---~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~p~~~~~~~~~~~~~~~-~~~~~~~~ 231 (292)
..+..|.+||...+.......|+|++ +.-+++.+. +..|....+..++.....- .....+..
T Consensus 273 ~~~~~~~~y~aPE~~~~~~~~~~~Dvwsl-------------G~il~el~t~g~~p~~~~~~~~~~~~~~~~~~~~~~~~ 339 (377)
T 3cbl_A 273 GLRQVPVKWTAPEALNYGRYSSESDVWSF-------------GILLWETFSLGASPYPNLSNQQTREFVEKGGRLPCPEL 339 (377)
T ss_dssp SCCEEEGGGSCHHHHHHCEEEHHHHHHHH-------------HHHHHHHHTTSCCSSTTSCHHHHHHHHHTTCCCCCCTT
T ss_pred CCCCCCcCcCCHhHhccCCCCchhhHHHH-------------HHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCCCCCCC
Confidence 11223666665543332222222222 222223332 4444444443333221110 01123344
Q ss_pred CccchHHHHhcccCcCCCCCCChhhhhh
Q psy758 232 DEMQYEEITQRCLDKDPLRRWSCDQLLR 259 (292)
Q Consensus 232 ~~~~l~~li~~~l~~dP~~Rpt~~~il~ 259 (292)
.+..+.+||.+||+.||.+|||++++++
T Consensus 340 ~~~~l~~li~~cl~~dP~~Rps~~~i~~ 367 (377)
T 3cbl_A 340 CPDAVFRLMEQCWAYEPGQRPSFSTIYQ 367 (377)
T ss_dssp CCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred CCHHHHHHHHHHcCCCchhCcCHHHHHH
Confidence 5778999999999999999999999987
|
| >2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-40 Score=272.92 Aligned_cols=245 Identities=19% Similarity=0.271 Sum_probs=183.8
Q ss_pred cccceeeeecccCceEEEEEEEc-----CCCcEEEEEEeccCCCChHHHHHHHHHHHHHHhCCCCCcchhhhhhhcCCeE
Q psy758 2 ERYEKIGKLGEGSYGVVFKCRNR-----DTGQVVAIKKFLESEEDPLIRKIALREIRLLKSLKHPNLVNLLEVFRRKKKL 76 (292)
Q Consensus 2 ~~y~~~~~l~~g~~~~v~~~~~~-----~~~~~v~iK~~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~ 76 (292)
++|++.+.||+|+||.||+|.+. .++..||+|++.... .....+.+.+|+.+++.++||||+++++++.+++..
T Consensus 23 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~ 101 (314)
T 2ivs_A 23 KNLVLGKTLGEGEFGKVVKATAFHLKGRAGYTTVAVKMLKENA-SPSELRDLLSEFNVLKQVNHPHVIKLYGACSQDGPL 101 (314)
T ss_dssp GGEEEEEEEEECSSSEEEEEEEETGGGCSSEEEEEEEECCTTC-CHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSC
T ss_pred hheeeeeeecccCCeeEEEEEEeccCcccCcceEEEEeccCCC-CHHHHHHHHHHHHHHhhCCCCceeeEEEEEecCCce
Confidence 58999999999999999999883 445789999987543 445567789999999999999999999999999999
Q ss_pred EEEEecCCCccHHHHhcCCC------------------------CCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCce
Q psy758 77 HLVFEFCDHTVLNELENHPH------------------------GLPWDLIKQITWQVLRGVSYCHRHACIHRDIKPENI 132 (292)
Q Consensus 77 ~iv~e~~~~~~L~~~~~~~~------------------------~~~~~~~~~i~~qi~~aL~~LH~~givH~dl~p~Ni 132 (292)
++||||+++++|.+++.... .+++..++.++.||+.||.|||++|++|+||||+||
T Consensus 102 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~dikp~NI 181 (314)
T 2ivs_A 102 LLIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRNSSSLDHPDERALTMGDLISFAWQISQGMQYLAEMKLVHRDLAARNI 181 (314)
T ss_dssp EEEEECCTTCBHHHHHHHTTTSTTEEC----------------CEECHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGE
T ss_pred EEEEeecCCCCHHHHHHHHhhccCCcccccccccccccccccccCcCHHHHHHHHHHHHHHHHHHHHCCCcccccchheE
Confidence 99999999999999987543 389999999999999999999999999999999999
Q ss_pred EEccCCcEEEeecCchhhhhcccc-------ccccccccccccccCCCCCCCcccceeeecCCCCCCchHHHHHHHhhc-
Q psy758 133 LLTANGVVKLCDFGFARLIRDLIP-------RHLHIFQTNEYFKGVSLPHAENVVPLEIKIGKPAATNIYLIDFLKRCL- 204 (292)
Q Consensus 133 lv~~~~~~kl~dfg~~~~~~~~~~-------~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~- 204 (292)
+++.++.++|+|||++........ ..+..|.+||...+.......|+| +.+..++..+.
T Consensus 182 li~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~-------------slG~il~el~t~ 248 (314)
T 2ivs_A 182 LVAEGRKMKISDFGLSRDVYEEDSYVKRSQGRIPVKWMAIESLFDHIYTTQSDVW-------------SFGVLLWEIVTL 248 (314)
T ss_dssp EEETTTEEEECCCTTCEECTTTSCEECSSCCCSCGGGCCHHHHHHCEECHHHHHH-------------HHHHHHHHHHTT
T ss_pred EEcCCCCEEEccccccccccccccceeccCCCCcccccChhhhcCCCcCchhhHH-------------HHHHHHHHHHhC
Confidence 999999999999999876533211 112235566655433222222222 22222333333
Q ss_pred ccCCCCCCChhhhhhccCcC-CCCCCCCCccchHHHHhcccCcCCCCCCChhhhhhC
Q psy758 205 DKDPLRRWSCDQLLRHPYFN-GYYFEVPDEMQYEEITQRCLDKDPLRRWSCDQLLRH 260 (292)
Q Consensus 205 ~~~p~~~~~~~~~~~~~~~~-~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~~il~h 260 (292)
+..|.......++....... ....+...+..+.++|.+||+.||.+|||+.+++++
T Consensus 249 g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~l~~~ 305 (314)
T 2ivs_A 249 GGNPYPGIPPERLFNLLKTGHRMERPDNCSEEMYRLMLQCWKQEPDKRPVFADISKD 305 (314)
T ss_dssp SCCSSTTCCGGGHHHHHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred CCCCCCCCCHHHHHHHhhcCCcCCCCccCCHHHHHHHHHHccCChhhCcCHHHHHHH
Confidence 44454444433333211110 112334557889999999999999999999999985
|
| >3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-40 Score=276.33 Aligned_cols=250 Identities=22% Similarity=0.276 Sum_probs=166.4
Q ss_pred cccceee-eecccCceEEEEEEEcCCCcEEEEEEeccCCCChHHHHHHHHHHHHHHhCCCCCcchhhhhhhc----CCeE
Q psy758 2 ERYEKIG-KLGEGSYGVVFKCRNRDTGQVVAIKKFLESEEDPLIRKIALREIRLLKSLKHPNLVNLLEVFRR----KKKL 76 (292)
Q Consensus 2 ~~y~~~~-~l~~g~~~~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~----~~~~ 76 (292)
++|.+.+ .||+|+||.||+|.+..+++.||+|++.... . ........++.++||||+++++++.. ....
T Consensus 28 ~~y~i~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~---~---~~~e~~~~~~~~~h~~i~~~~~~~~~~~~~~~~~ 101 (336)
T 3fhr_A 28 DDYQLSKQVLGLGVNGKVLECFHRRTGQKCALKLLYDSP---K---ARQEVDHHWQASGGPHIVCILDVYENMHHGKRCL 101 (336)
T ss_dssp GTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEESSH---H---HHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEEE
T ss_pred ceeEecceeeeeCCCeEEEEEEECCCCCEEEEEEecCcH---H---HHHHHHHHHHhcCCCChHHHHHHHhhccCCCceE
Confidence 6899855 6999999999999999999999999986531 1 12223344667799999999999875 4568
Q ss_pred EEEEecCCCccHHHHhcCCC--CCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEEccC---CcEEEeecCchhhh
Q psy758 77 HLVFEFCDHTVLNELENHPH--GLPWDLIKQITWQVLRGVSYCHRHACIHRDIKPENILLTAN---GVVKLCDFGFARLI 151 (292)
Q Consensus 77 ~iv~e~~~~~~L~~~~~~~~--~~~~~~~~~i~~qi~~aL~~LH~~givH~dl~p~Nilv~~~---~~~kl~dfg~~~~~ 151 (292)
++||||+.|++|.+++.... .+++..++.++.||+.||.|||++|++||||||+||+++.+ +.++|+|||++...
T Consensus 102 ~lv~e~~~gg~L~~~l~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~ivH~dlkp~NIll~~~~~~~~~kl~Dfg~~~~~ 181 (336)
T 3fhr_A 102 LIIMECMEGGELFSRIQERGDQAFTEREAAEIMRDIGTAIQFLHSHNIAHRDVKPENLLYTSKEKDAVLKLTDFGFAKET 181 (336)
T ss_dssp EEEEECCTTEEHHHHHHTC-CCCCBHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEESCSSTTCCEEECCCTTCEEC
T ss_pred EEEEeccCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEEecCCCceEEEeccccceec
Confidence 99999999999999987653 69999999999999999999999999999999999999864 45999999998755
Q ss_pred hccc---cccccccccccccccCCC-----CCCCcccceeeecCCCCCCchHHHHHHHhhcccCCCCCCChhhhhhccCc
Q psy758 152 RDLI---PRHLHIFQTNEYFKGVSL-----PHAENVVPLEIKIGKPAATNIYLIDFLKRCLDKDPLRRWSCDQLLRHPYF 223 (292)
Q Consensus 152 ~~~~---~~~~~~~~~~~~~~~~~~-----~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~ 223 (292)
.... ...+..|.+||...+... .|+.|+..+++.+|..++............. ..+....+.
T Consensus 182 ~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~----------~~~~~~~~~ 251 (336)
T 3fhr_A 182 TQNALQTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGFPPFYSNTGQAISPGMK----------RRIRLGQYG 251 (336)
T ss_dssp ----------------------CHHHHHHHHHHHHHHHHHHHHSSCCC-------------------------------C
T ss_pred cccccccCCCCcCccChhhhCCCCCCchhhHHHHHHHHHHHHHCCCCCCCccchhhhhhHH----------Hhhhccccc
Confidence 4321 122344666665543322 3444444444444444432211111000000 000000000
Q ss_pred CCCCCCCCCccchHHHHhcccCcCCCCCCChhhhhhCCccccee
Q psy758 224 NGYYFEVPDEMQYEEITQRCLDKDPLRRWSCDQLLRHPYFNGYY 267 (292)
Q Consensus 224 ~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~~il~h~w~~~~~ 267 (292)
.........+..+.+||.+||+.||.+|||++|+++||||++..
T Consensus 252 ~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~~~~~~ 295 (336)
T 3fhr_A 252 FPNPEWSEVSEDAKQLIRLLLKTDPTERLTITQFMNHPWINQSM 295 (336)
T ss_dssp CCTTTSTTCCHHHHHHHHHHSCSSGGGSCCHHHHHHSHHHHTGG
T ss_pred cCchhhccCCHHHHHHHHHHCCCChhHCcCHHHHhcCccccccc
Confidence 00111134577899999999999999999999999999999743
|
| >3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.2e-40 Score=277.63 Aligned_cols=245 Identities=22% Similarity=0.301 Sum_probs=184.9
Q ss_pred cccceeeeecccCceEEEEEEEcCC-------CcEEEEEEeccCCCChHHHHHHHHHHHHHHhC-CCCCcchhhhhhhcC
Q psy758 2 ERYEKIGKLGEGSYGVVFKCRNRDT-------GQVVAIKKFLESEEDPLIRKIALREIRLLKSL-KHPNLVNLLEVFRRK 73 (292)
Q Consensus 2 ~~y~~~~~l~~g~~~~v~~~~~~~~-------~~~v~iK~~~~~~~~~~~~~~~~~e~~~~~~l-~~~~i~~~~~~~~~~ 73 (292)
++|++.+.||+|+||.||+|.+..+ +..||+|++.... .......+.+|+.+++.+ +||||+++++++.++
T Consensus 69 ~~y~i~~~LG~G~~g~Vy~a~~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~~ 147 (382)
T 3tt0_A 69 DRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDA-TEKDLSDLISEMEMMKMIGKHKNIINLLGACTQD 147 (382)
T ss_dssp GGEEEEEEEEECSSEEEEEEEEETSSTTCTTCEEEEEEEEECTTC-CHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSS
T ss_pred hheEeeeEEecCCCeEEEEEEEccccccccccceEEEEEeecccc-CHHHHHHHHHHHHHHHHhcCCchhhhheeeeccC
Confidence 5899999999999999999997543 3579999986553 445567788999999999 899999999999999
Q ss_pred CeEEEEEecCCCccHHHHhcCCC----------------CCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEEccC
Q psy758 74 KKLHLVFEFCDHTVLNELENHPH----------------GLPWDLIKQITWQVLRGVSYCHRHACIHRDIKPENILLTAN 137 (292)
Q Consensus 74 ~~~~iv~e~~~~~~L~~~~~~~~----------------~~~~~~~~~i~~qi~~aL~~LH~~givH~dl~p~Nilv~~~ 137 (292)
+..++||||+.+++|.+++.... .+++..++.++.||+.||.|||++||+||||||+||+++.+
T Consensus 148 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~ 227 (382)
T 3tt0_A 148 GPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLASKKCIHRDLAARNVLVTED 227 (382)
T ss_dssp SSCEEEEECCTTCBHHHHHHHTCCSSSSSCCCCCSSCCCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTT
T ss_pred CceEEEEEecCCCcHHHHHHHhcccccccccccccccccccCHHHHHHHHHHHHHHHHHHHhCCEecCCCCcceEEEcCC
Confidence 99999999999999999986532 49999999999999999999999999999999999999999
Q ss_pred CcEEEeecCchhhhhccc-------cccccccccccccccCCCCCCCcccceeeecCCCCCCchHHHHHHHhhc-ccCCC
Q psy758 138 GVVKLCDFGFARLIRDLI-------PRHLHIFQTNEYFKGVSLPHAENVVPLEIKIGKPAATNIYLIDFLKRCL-DKDPL 209 (292)
Q Consensus 138 ~~~kl~dfg~~~~~~~~~-------~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~p~ 209 (292)
+.+||+|||++....... ...+..|.+||...+.......++|+++ .-++..+. +..|.
T Consensus 228 ~~~kL~DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG-------------~il~ellt~g~~p~ 294 (382)
T 3tt0_A 228 NVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFG-------------VLLWEIFTLGGSPY 294 (382)
T ss_dssp CCEEECSCSCCCCSSCCCTTCCCTTCCCGGGGSCHHHHHSCCCCHHHHHHHHH-------------HHHHHHHTTSCCSS
T ss_pred CcEEEcccCcccccccccccccccCCCCCcceeCHHHhcCCCCCchhHHHHHH-------------HHHHHHHhCCCCCC
Confidence 999999999997654321 1122346777766554433223333222 22222232 34444
Q ss_pred CCCChhhhhhccCcC-CCCCCCCCccchHHHHhcccCcCCCCCCChhhhhhC
Q psy758 210 RRWSCDQLLRHPYFN-GYYFEVPDEMQYEEITQRCLDKDPLRRWSCDQLLRH 260 (292)
Q Consensus 210 ~~~~~~~~~~~~~~~-~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~~il~h 260 (292)
......++.....-. ....+...+..+.+||.+||+.||.+|||+++++++
T Consensus 295 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~ 346 (382)
T 3tt0_A 295 PGVPVEELFKLLKEGHRMDKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVED 346 (382)
T ss_dssp TTCCHHHHHHHHHTTCCCCCCSSCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred CCCCHHHHHHHHHcCCCCCCCccCCHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence 444433333211100 112234457789999999999999999999999985
|
| >1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-40 Score=273.33 Aligned_cols=259 Identities=21% Similarity=0.254 Sum_probs=193.3
Q ss_pred cccceeeeecccCceEEEEEEEc-----CCCcEEEEEEeccCCCChHHHHHHHHHHHHHHhCCCCCcchhhhhhhcCCeE
Q psy758 2 ERYEKIGKLGEGSYGVVFKCRNR-----DTGQVVAIKKFLESEEDPLIRKIALREIRLLKSLKHPNLVNLLEVFRRKKKL 76 (292)
Q Consensus 2 ~~y~~~~~l~~g~~~~v~~~~~~-----~~~~~v~iK~~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~ 76 (292)
++|++.+.||+|+||.||+|.+. .+++.||+|.+.... .......+.+|+.+++.++||||+++++++.+++..
T Consensus 25 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~ 103 (322)
T 1p4o_A 25 EKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAA-SMRERIEFLNEASVMKEFNCHHVVRLLGVVSQGQPT 103 (322)
T ss_dssp GGEEEEEEEEECSSSEEEEEEEEEEETTEEEEEEEEEECCTTS-CHHHHHHHHHHHHHGGGCCCTTBCCEEEEECSSSSC
T ss_pred hheeeeeEeccCCceEEEeeeecCccCCCCceEEEEEeccccc-CHHHHHHHHHHHHHHHhcCCCCEeeeEEEEccCCcc
Confidence 58999999999999999999876 357789999987543 334456788999999999999999999999999999
Q ss_pred EEEEecCCCccHHHHhcCC----------CCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEEccCCcEEEeecC
Q psy758 77 HLVFEFCDHTVLNELENHP----------HGLPWDLIKQITWQVLRGVSYCHRHACIHRDIKPENILLTANGVVKLCDFG 146 (292)
Q Consensus 77 ~iv~e~~~~~~L~~~~~~~----------~~~~~~~~~~i~~qi~~aL~~LH~~givH~dl~p~Nilv~~~~~~kl~dfg 146 (292)
++||||+++++|.+++... ..+++..++.++.||+.||.|||++|++||||||+||+++.++.++|+|||
T Consensus 104 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dikp~NIli~~~~~~kl~Dfg 183 (322)
T 1p4o_A 104 LVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLNANKFVHRDLAARNCMVAEDFTVKIGDFG 183 (322)
T ss_dssp EEEEECCTTCBHHHHHHHHHHHHHHCTTCCCCCHHHHHHHHHHHHHHHHHHHHTTCBCSCCSGGGEEECTTCCEEECCTT
T ss_pred EEEEEeCCCCcHHHHHHHhchhhccCCCCCCcCHHHHHHHHHHHHHHHHHHHHCCCccCCCccceEEEcCCCeEEECcCc
Confidence 9999999999999988642 357999999999999999999999999999999999999999999999999
Q ss_pred chhhhhcccc-------ccccccccccccccCCCCCCCcccceeeecCCCCCCchHHHHHHHhhc-ccCCCCCCChhhhh
Q psy758 147 FARLIRDLIP-------RHLHIFQTNEYFKGVSLPHAENVVPLEIKIGKPAATNIYLIDFLKRCL-DKDPLRRWSCDQLL 218 (292)
Q Consensus 147 ~~~~~~~~~~-------~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~p~~~~~~~~~~ 218 (292)
++........ ..+..|.+||...+.......++|++ +..++..+. +..|....+..+..
T Consensus 184 ~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~sl-------------G~il~el~~~g~~p~~~~~~~~~~ 250 (322)
T 1p4o_A 184 MTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSF-------------GVVLWEIATLAEQPYQGLSNEQVL 250 (322)
T ss_dssp CCCGGGGGGCEEGGGSSEECGGGCCHHHHHHCCCCHHHHHHHH-------------HHHHHHHHHTSCCTTTTSCHHHHH
T ss_pred cccccccccccccccCCCCCCCccChhhhccCCCCchhhHHHH-------------HHHHHHHHhcCCCccccCCHHHHH
Confidence 9876543221 11233666666554433222222222 222233333 34444444443333
Q ss_pred hccCcCC-CCCCCCCccchHHHHhcccCcCCCCCCChhhhhhC------CcccceeccCCChh
Q psy758 219 RHPYFNG-YYFEVPDEMQYEEITQRCLDKDPLRRWSCDQLLRH------PYFNGYYFEVPDEM 274 (292)
Q Consensus 219 ~~~~~~~-~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~~il~h------~w~~~~~~~~~~~~ 274 (292)
....-.. ...+...+..+.+||.+||+.||.+|||+.+++++ +|+.+..+....+.
T Consensus 251 ~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~e~l~~L~~~~~~~~~~~~~~~~~~~ 313 (322)
T 1p4o_A 251 RFVMEGGLLDKPDNCPDMLFELMRMCWQYNPKMRPSFLEIISSIKEEMEPGFREVSFYYSEEN 313 (322)
T ss_dssp HHHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHGGGSCTTHHHHCSTTSTTC
T ss_pred HHHHcCCcCCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHHhhccCCccccccccccc
Confidence 2211111 12234557789999999999999999999999997 88887666554433
|
| >1q8y_A SR protein kinase; transferase; HET: ADP ADE; 2.05A {Saccharomyces cerevisiae} SCOP: d.144.1.7 PDB: 1q8z_A 1q97_A* 1q99_A* 1how_A 2jd5_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-40 Score=280.68 Aligned_cols=258 Identities=26% Similarity=0.387 Sum_probs=189.2
Q ss_pred cccceeeeecccCceEEEEEEEcCCCcEEEEEEeccCCCChHHHHHHHHHHHHHHhCC-----------CCCcchhhhhh
Q psy758 2 ERYEKIGKLGEGSYGVVFKCRNRDTGQVVAIKKFLESEEDPLIRKIALREIRLLKSLK-----------HPNLVNLLEVF 70 (292)
Q Consensus 2 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~e~~~~~~l~-----------~~~i~~~~~~~ 70 (292)
++|++.+.||+|+||.||+|.+..+++.||+|++... ......+.+|+.+++.++ ||||+++++++
T Consensus 19 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~---~~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~i~~~~~~~ 95 (373)
T 1q8y_A 19 ARYILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGD---KVYTEAAEDEIKLLQRVNDADNTKEDSMGANHILKLLDHF 95 (373)
T ss_dssp TTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSC---HHHHHHHHHHHHHHHHHHHTCCSHHHHHHHTTBCCCCEEE
T ss_pred CeEEEEEeeeecCCeEEEEEEecCCCcEEEEEEecCC---ccchhhhhHHHHHHHHhhcccccchhccccchHHHHHHHh
Confidence 6899999999999999999999999999999998643 334566778999988886 78999999998
Q ss_pred hcCC----eEEEEEecCCCccHHHHhcC--CCCCCHHHHHHHHHHHHHHHHHHHhC-CccccCCCCCceEEcc------C
Q psy758 71 RRKK----KLHLVFEFCDHTVLNELENH--PHGLPWDLIKQITWQVLRGVSYCHRH-ACIHRDIKPENILLTA------N 137 (292)
Q Consensus 71 ~~~~----~~~iv~e~~~~~~L~~~~~~--~~~~~~~~~~~i~~qi~~aL~~LH~~-givH~dl~p~Nilv~~------~ 137 (292)
...+ .+++++|++ +++|.+++.. ...+++..++.++.||+.||.|||++ ||+|+||||+||+++. .
T Consensus 96 ~~~~~~~~~~~lv~e~~-~~~L~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~lH~~~~ivH~Dikp~NIll~~~~~~~~~ 174 (373)
T 1q8y_A 96 NHKGPNGVHVVMVFEVL-GENLLALIKKYEHRGIPLIYVKQISKQLLLGLDYMHRRCGIIHTDIKPENVLMEIVDSPENL 174 (373)
T ss_dssp EEEETTEEEEEEEECCC-CEEHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHHHTTCEECSCCSGGGEEEEEEETTTTE
T ss_pred hccCCCCceEEEEEecC-CCCHHHHHHHhhccCCcHHHHHHHHHHHHHHHHHHHhcCCEEecCCChHHeEEeccCCCcCc
Confidence 7543 789999999 7788877754 34599999999999999999999998 9999999999999953 3
Q ss_pred CcEEEeecCchhhhhcc--ccccccccccccccccCCC-----CCCCcccceeeecCCCCCCchH---------HHHHHH
Q psy758 138 GVVKLCDFGFARLIRDL--IPRHLHIFQTNEYFKGVSL-----PHAENVVPLEIKIGKPAATNIY---------LIDFLK 201 (292)
Q Consensus 138 ~~~kl~dfg~~~~~~~~--~~~~~~~~~~~~~~~~~~~-----~~~~~~~~~~~~~~~~~~~~~~---------~~~~~~ 201 (292)
+.++|+|||++...... ....+..|.+||...+... .|+.|+..+++.+|..++.... ....+.
T Consensus 175 ~~~kl~Dfg~a~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~ 254 (373)
T 1q8y_A 175 IQIKIADLGNACWYDEHYTNSIQTREYRSPEVLLGAPWGCGADIWSTACLIFELITGDFLFEPDEGHSYTKDDDHIAQII 254 (373)
T ss_dssp EEEEECCCTTCEETTBCCCSCCSCGGGCCHHHHHTCCCCTHHHHHHHHHHHHHHHHSSCCC---------CHHHHHHHHH
T ss_pred ceEEEcccccccccCCCCCCCCCCccccCcHHHhCCCCCchHhHHHHHHHHHHHHhCCCCCCCCcccccCChHHHHHHHH
Confidence 47999999999766542 2234556788887766544 3566666667777776654221 111112
Q ss_pred hhcccCCCCC-------------------------CChhhhhhccCcCCCCCCCCCccchHHHHhcccCcCCCCCCChhh
Q psy758 202 RCLDKDPLRR-------------------------WSCDQLLRHPYFNGYYFEVPDEMQYEEITQRCLDKDPLRRWSCDQ 256 (292)
Q Consensus 202 ~~~~~~p~~~-------------------------~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~~ 256 (292)
..++..|... +...+.+. .....+...+..+.+||.+||+.||.+|||++|
T Consensus 255 ~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~----~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e 330 (373)
T 1q8y_A 255 ELLGELPSYLLRNGKYTRTFFNSRGLLRNISKLKFWPLEDVLT----EKYKFSKDEAKEISDFLSPMLQLDPRKRADAGG 330 (373)
T ss_dssp HHHCSCCHHHHHHCTTHHHHBCC--CBSSCCCCCBCCHHHHHH----HTTCCCHHHHHHHHHHHGGGGCSSTTTCBCHHH
T ss_pred HhcCCCCHHHHhccchhhhhcCCcchhcccccccccchhhhhh----hcccCCcchHHHHHHHHHHHhccCccccCCHHH
Confidence 2222221100 00011110 011122334667899999999999999999999
Q ss_pred hhhCCccccee
Q psy758 257 LLRHPYFNGYY 267 (292)
Q Consensus 257 il~h~w~~~~~ 267 (292)
+++||||++..
T Consensus 331 ll~hp~f~~~~ 341 (373)
T 1q8y_A 331 LVNHPWLKDTL 341 (373)
T ss_dssp HHTCGGGTTCT
T ss_pred HhhChhhhccc
Confidence 99999999854
|
| >4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 4ehz_A* 4ei4_A* 4fk6_A* 3eyg_A* 3eyh_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-40 Score=272.45 Aligned_cols=254 Identities=19% Similarity=0.268 Sum_probs=184.5
Q ss_pred cccceeeeecccCceEEEEEE----EcCCCcEEEEEEeccCCCChHHHHHHHHHHHHHHhCCCCCcchhhhhhhcC--Ce
Q psy758 2 ERYEKIGKLGEGSYGVVFKCR----NRDTGQVVAIKKFLESEEDPLIRKIALREIRLLKSLKHPNLVNLLEVFRRK--KK 75 (292)
Q Consensus 2 ~~y~~~~~l~~g~~~~v~~~~----~~~~~~~v~iK~~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~--~~ 75 (292)
++|++.+.||+|+||.||+|. +..+++.||+|++...... ...+.+.+|+.+++.++||||+++++++.+. +.
T Consensus 21 ~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~-~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~ 99 (302)
T 4e5w_A 21 RFLKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGG-NHIADLKKEIEILRNLYHENIVKYKGICTEDGGNG 99 (302)
T ss_dssp GGEEEEEEEEECSSEEEEEEEECTTSSSCSEEEEEEEEC------CCHHHHHHHHHHHHTCCCTTBCCEEEEEEC---CC
T ss_pred hhhhhhhccCCCCceEEEEEEEccccCccCeEEEEEEecccccc-hhHHHHHHHHHHHHhCCCCCeeeeeeEEecCCCce
Confidence 468999999999999999998 5678999999998754322 2346678999999999999999999998765 67
Q ss_pred EEEEEecCCCccHHHHhc-CCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEEccCCcEEEeecCchhhhhcc
Q psy758 76 LHLVFEFCDHTVLNELEN-HPHGLPWDLIKQITWQVLRGVSYCHRHACIHRDIKPENILLTANGVVKLCDFGFARLIRDL 154 (292)
Q Consensus 76 ~~iv~e~~~~~~L~~~~~-~~~~~~~~~~~~i~~qi~~aL~~LH~~givH~dl~p~Nilv~~~~~~kl~dfg~~~~~~~~ 154 (292)
+++||||+++++|.+++. ....+++..++.++.||+.||+|||++|++|+||||+||+++.++.++|+|||++......
T Consensus 100 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~ 179 (302)
T 4e5w_A 100 IKLIMEFLPSGSLKEYLPKNKNKINLKQQLKYAVQICKGMDYLGSRQYVHRDLAARNVLVESEHQVKIGDFGLTKAIETD 179 (302)
T ss_dssp EEEEEECCTTCBHHHHHHHHTTTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEEETTEEEECCCTTCEECCTT
T ss_pred EEEEEEeCCCCcHHHHHHhccccCCHHHHHHHHHHHHHHHHHhhcCCcccCCCchheEEEcCCCCEEECcccccccccCC
Confidence 899999999999999983 3456999999999999999999999999999999999999999999999999998765432
Q ss_pred c--------cccccccccccccccCC-----CCCCCcccceeeecCCCCCCchHHHHHHHhhcccCCCCCCChhhhhhcc
Q psy758 155 I--------PRHLHIFQTNEYFKGVS-----LPHAENVVPLEIKIGKPAATNIYLIDFLKRCLDKDPLRRWSCDQLLRHP 221 (292)
Q Consensus 155 ~--------~~~~~~~~~~~~~~~~~-----~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~ 221 (292)
. ...+..|.+||...+.. ..|+.|+..+++.+|..+...... ......... ........+....
T Consensus 180 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~--~~~~~~~~~-~~~~~~~~~~~~~ 256 (302)
T 4e5w_A 180 KEYYTVKDDRDSPVFWYAPECLMQSKFYIASDVWSFGVTLHELLTYCDSDSSPMA--LFLKMIGPT-HGQMTVTRLVNTL 256 (302)
T ss_dssp CCEEECCCCTTCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCGGGSHHH--HHHHHHCSC-CGGGHHHHHHHHH
T ss_pred CcceeccCCCCCCccccCCeeecCCCCCcchhHHHHHHHHHHHHHccCCCcchhh--HHhhccCCc-ccccCHHHHHHHH
Confidence 1 12223367777655443 345566666666666654322211 111111111 1111111111110
Q ss_pred -CcCCCCCCCCCccchHHHHhcccCcCCCCCCChhhhhh
Q psy758 222 -YFNGYYFEVPDEMQYEEITQRCLDKDPLRRWSCDQLLR 259 (292)
Q Consensus 222 -~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~~il~ 259 (292)
.......+...+..+.+||.+||+.||.+|||+.++++
T Consensus 257 ~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~ 295 (302)
T 4e5w_A 257 KEGKRLPCPPNCPDEVYQLMRKCWEFQPSNRTSFQNLIE 295 (302)
T ss_dssp HTTCCCCCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHH
T ss_pred hccCCCCCCCCCCHHHHHHHHHHcCCCCCCCCCHHHHHH
Confidence 00112234456789999999999999999999999987
|
| >3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.5e-40 Score=269.12 Aligned_cols=246 Identities=19% Similarity=0.227 Sum_probs=177.2
Q ss_pred cccceeeeecccCceEEEEEEEcC---CCcEEEEEEeccCCCChHHHHHHHHHHHHHHhCCCCCcchhhhhhhcCC----
Q psy758 2 ERYEKIGKLGEGSYGVVFKCRNRD---TGQVVAIKKFLESEEDPLIRKIALREIRLLKSLKHPNLVNLLEVFRRKK---- 74 (292)
Q Consensus 2 ~~y~~~~~l~~g~~~~v~~~~~~~---~~~~v~iK~~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~---- 74 (292)
++|++.+.||+|+||.||+|.... ++..||+|.+..........+.+.+|+.+++.++||||+++++++.+.+
T Consensus 34 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~ 113 (313)
T 3brb_A 34 NLLILGKILGEGEFGSVMEGNLKQEDGTSLKVAVKTMKLDNSSQREIEEFLSEAACMKDFSHPNVIRLLGVCIEMSSQGI 113 (313)
T ss_dssp GGEEEEEEEEC-CCCCEEEEEEECTTSCEEEEEEEEC---CCCHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEC------
T ss_pred HHeeeccceeecCCeEEEEEEEeccCCceeEEEEEEEeccccchhHHHHHHHHHHHHhcCCCCCeeeeeEEEeeccccCC
Confidence 589999999999999999998765 4558999999877666677788999999999999999999999987644
Q ss_pred -eEEEEEecCCCccHHHHh------cCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEEccCCcEEEeecCc
Q psy758 75 -KLHLVFEFCDHTVLNELE------NHPHGLPWDLIKQITWQVLRGVSYCHRHACIHRDIKPENILLTANGVVKLCDFGF 147 (292)
Q Consensus 75 -~~~iv~e~~~~~~L~~~~------~~~~~~~~~~~~~i~~qi~~aL~~LH~~givH~dl~p~Nilv~~~~~~kl~dfg~ 147 (292)
..++|+||+.+++|..++ .....+++..++.++.||+.||.|||++|++||||||+||+++.++.++|+|||+
T Consensus 114 ~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~dikp~NIli~~~~~~kl~Dfg~ 193 (313)
T 3brb_A 114 PKPMVILPFMKYGDLHTYLLYSRLETGPKHIPLQTLLKFMVDIALGMEYLSNRNFLHRDLAARNCMLRDDMTVCVADFGL 193 (313)
T ss_dssp -CEEEEEECCTTCBHHHHHHHTTBTTSCCCCCHHHHHHHHHHHHHHHHHHHTTTCCCCCCSGGGEEECTTSCEEECSCSC
T ss_pred cccEEEEecccCCCHHHHHHHhhhhcCCccCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCcceEEEcCCCcEEEeecCc
Confidence 469999999999999988 3345699999999999999999999999999999999999999999999999999
Q ss_pred hhhhhccc-------cccccccccccccccCCCCCCCcccceeeecCCCCCCchHHHHHHHhhc-ccCCCCCCChhhhhh
Q psy758 148 ARLIRDLI-------PRHLHIFQTNEYFKGVSLPHAENVVPLEIKIGKPAATNIYLIDFLKRCL-DKDPLRRWSCDQLLR 219 (292)
Q Consensus 148 ~~~~~~~~-------~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~p~~~~~~~~~~~ 219 (292)
+....... ...+..|.+||...+.......++|+ .+.-++..+. +..|.......+...
T Consensus 194 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~s-------------lG~il~el~~~g~~p~~~~~~~~~~~ 260 (313)
T 3brb_A 194 SKKIYSGDYYRQGRIAKMPVKWIAIESLADRVYTSKSDVWA-------------FGVTMWEIATRGMTPYPGVQNHEMYD 260 (313)
T ss_dssp C----------------CCGGGSCHHHHHSSCCCHHHHHHH-------------HHHHHHHHHTTSCCSSTTCCGGGHHH
T ss_pred ceecccccccCcccccCCCccccCchhhcCCCccchhhhHH-------------HHHHHHHHHhcCCCCCccCCHHHHHH
Confidence 87654321 11123455666554433322222222 2222333333 344444433333322
Q ss_pred ccCcC-CCCCCCCCccchHHHHhcccCcCCCCCCChhhhhhC
Q psy758 220 HPYFN-GYYFEVPDEMQYEEITQRCLDKDPLRRWSCDQLLRH 260 (292)
Q Consensus 220 ~~~~~-~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~~il~h 260 (292)
..... ....+...+..+.++|.+||+.||.+|||+.+++++
T Consensus 261 ~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~ 302 (313)
T 3brb_A 261 YLLHGHRLKQPEDCLDELYEIMYSCWRTDPLDRPTFSVLRLQ 302 (313)
T ss_dssp HHHTTCCCCCBTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHH
T ss_pred HHHcCCCCCCCccccHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence 11111 122334557789999999999999999999999984
|
| >1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4e-40 Score=268.00 Aligned_cols=250 Identities=18% Similarity=0.264 Sum_probs=183.9
Q ss_pred cccceee-eecccCceEEEEEE--EcCCCcEEEEEEeccCCCChHHHHHHHHHHHHHHhCCCCCcchhhhhhhcCCeEEE
Q psy758 2 ERYEKIG-KLGEGSYGVVFKCR--NRDTGQVVAIKKFLESEEDPLIRKIALREIRLLKSLKHPNLVNLLEVFRRKKKLHL 78 (292)
Q Consensus 2 ~~y~~~~-~l~~g~~~~v~~~~--~~~~~~~v~iK~~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~i 78 (292)
++|++.+ .||+|+||.||+|. ...+++.||+|++..........+.+.+|+.+++.++||||+++++++ ..+..++
T Consensus 16 ~~y~~~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~-~~~~~~l 94 (291)
T 1xbb_A 16 KLLTLEDKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGIC-EAESWML 94 (291)
T ss_dssp GGEEEEEEEEEECSSEEEEEEEEECSSSEEEEEEEEEC-----CHHHHHHHHHHHHHHTCCCTTBCCEEEEE-ESSSEEE
T ss_pred hhhhhccCccccccCeeeEeeeecCCCceeeEEEEeecccccCHHHHHHHHHHHHHHHhCCCCCEEEEEEEE-CCCCcEE
Confidence 5789988 99999999999995 456678999999987665556678899999999999999999999998 5677899
Q ss_pred EEecCCCccHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEEccCCcEEEeecCchhhhhcccc--
Q psy758 79 VFEFCDHTVLNELENHPHGLPWDLIKQITWQVLRGVSYCHRHACIHRDIKPENILLTANGVVKLCDFGFARLIRDLIP-- 156 (292)
Q Consensus 79 v~e~~~~~~L~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~givH~dl~p~Nilv~~~~~~kl~dfg~~~~~~~~~~-- 156 (292)
|+||+++++|.+++.....+++..++.++.||+.||.|||++|++|+||+|+||+++.++.++|+|||++........
T Consensus 95 v~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~ 174 (291)
T 1xbb_A 95 VMEMAELGPLNKYLQQNRHVKDKNIIELVHQVSMGMKYLEESNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYY 174 (291)
T ss_dssp EEECCTTEEHHHHHHHCTTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEEETTEEEECCCTTCEECCTTCSEE
T ss_pred EEEeCCCCCHHHHHHhCcCCCHHHHHHHHHHHHHHHHHHHhCCeEcCCCCcceEEEeCCCcEEEccCCcceeeccCCCcc
Confidence 999999999999998877899999999999999999999999999999999999999999999999999876543211
Q ss_pred ------ccccccccccccccCCCCCCCcccceeeecCCCCCCchHHHHHHHhhc-ccCCCCCCChhhhhhccCc-CCCCC
Q psy758 157 ------RHLHIFQTNEYFKGVSLPHAENVVPLEIKIGKPAATNIYLIDFLKRCL-DKDPLRRWSCDQLLRHPYF-NGYYF 228 (292)
Q Consensus 157 ------~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~p~~~~~~~~~~~~~~~-~~~~~ 228 (292)
..+..|.+||...+.......++ ++.+.-++..+. +..|+......++...... .....
T Consensus 175 ~~~~~~~~~~~y~aPE~~~~~~~~~~~Di-------------~slG~il~~l~~~g~~p~~~~~~~~~~~~~~~~~~~~~ 241 (291)
T 1xbb_A 175 KAQTHGKWPVKWYAPECINYYKFSSKSDV-------------WSFGVLMWEAFSYGQKPYRGMKGSEVTAMLEKGERMGC 241 (291)
T ss_dssp EC----CCCGGGCCHHHHHHCEEEHHHHH-------------HHHHHHHHHHHTTTCCSSTTCCHHHHHHHHHTTCCCCC
T ss_pred cccccCCCCceeeChHHhccCCCChhhhH-------------HHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHcCCCCCC
Confidence 11133666665544322211222 222222333333 3444444333332221110 01122
Q ss_pred CCCCccchHHHHhcccCcCCCCCCChhhhhhCCccccee
Q psy758 229 EVPDEMQYEEITQRCLDKDPLRRWSCDQLLRHPYFNGYY 267 (292)
Q Consensus 229 ~~~~~~~l~~li~~~l~~dP~~Rpt~~~il~h~w~~~~~ 267 (292)
+...+..+.++|.+||+.||.+|||+.++++ .|++++
T Consensus 242 ~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~--~L~~~~ 278 (291)
T 1xbb_A 242 PAGCPREMYDLMNLCWTYDVENRPGFAAVEL--RLRNYY 278 (291)
T ss_dssp CTTCCHHHHHHHHHHTCSSTTTSCCHHHHHH--HHHHHH
T ss_pred CCCCCHHHHHHHHHHcCCChhhCcCHHHHHH--HHHHHH
Confidence 3455789999999999999999999999998 555544
|
| >2vuw_A Serine/threonine-protein kinase haspin; cell cycle, transferase, CAsp8, nucleotide binding; HET: MSE 5ID MPD; 1.80A {Homo sapiens} PDB: 3f2n_A* 3e7v_A* 3dlz_A* 3fmd_A* 3iq7_A* 2wb8_A | Back alignment and structure |
|---|
Probab=100.00 E-value=5.9e-41 Score=278.31 Aligned_cols=240 Identities=23% Similarity=0.255 Sum_probs=175.2
Q ss_pred cccceeeeecccCceEEEEEEEcCCCcEEEEEEeccCCC------ChHHHHHHHHHHHHHHhCC----------------
Q psy758 2 ERYEKIGKLGEGSYGVVFKCRNRDTGQVVAIKKFLESEE------DPLIRKIALREIRLLKSLK---------------- 59 (292)
Q Consensus 2 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~v~iK~~~~~~~------~~~~~~~~~~e~~~~~~l~---------------- 59 (292)
++|++.+.||+|+||.||+|++ +|+.||+|++..... .....+.+.+|+.+++.++
T Consensus 20 ~~y~~~~~lG~G~~g~V~~~~~--~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~l~~~~~~~h~niv~l 97 (336)
T 2vuw_A 20 EKLQRCEKIGEGVFGEVFQTIA--DHTPVAIKIIAIEGPDLVNGSHQKTFEEILPEIIISKELSLLSGEVCNRTEGFIGL 97 (336)
T ss_dssp HHHHTCEEEEEETTEEEEEEEE--TTEEEEEEEEEESCSSCBTTBCCBCHHHHHHHHHHHHHHHHGGGCSSSBCCCBCCE
T ss_pred ccchheeeecccCceEEEEEEe--CCceEEEEEEecCCccccccccchhHHHHHHHHHHHHHHHHhhccccccCCchhhh
Confidence 5799999999999999999998 589999999976532 2223356778999888886
Q ss_pred ----------CCCcchhhhhhhc-------------CCeEEEEEecCCCccHHHHhcCCCCCCHHHHHHHHHHHHHHHHH
Q psy758 60 ----------HPNLVNLLEVFRR-------------KKKLHLVFEFCDHTVLNELENHPHGLPWDLIKQITWQVLRGVSY 116 (292)
Q Consensus 60 ----------~~~i~~~~~~~~~-------------~~~~~iv~e~~~~~~L~~~~~~~~~~~~~~~~~i~~qi~~aL~~ 116 (292)
||||+++++++.+ .+.+|+||||+.+|++...+.. +.+++..++.++.||+.||.|
T Consensus 98 ~~~~~~~~~~hp~iv~~~~~~~~~~~~~~~~~~~~~~~~~~lv~E~~~~g~ll~~~~~-~~~~~~~~~~i~~qi~~aL~~ 176 (336)
T 2vuw_A 98 NSVHCVQGSYPPLLLKAWDHYNSTKGSANDRPDFFKDDQLFIVLEFEFGGIDLEQMRT-KLSSLATAKSILHQLTASLAV 176 (336)
T ss_dssp EEEEEEESSCCHHHHHHHHHHHHHTCCSSCCSCCCCTTCEEEEEEEECCCEETGGGTT-TCCCHHHHHHHHHHHHHHHHH
T ss_pred cceeEecCCCcHHHHHHHHHHhhhccccccCccccccCeEEEEEEecCCCccHHHHHh-cCCCHHHHHHHHHHHHHHHHH
Confidence 7889999999886 7899999999998855444433 468999999999999999999
Q ss_pred HH-hCCccccCCCCCceEEccCC--------------------cEEEeecCchhhhhccccccccccccccccccCCCCC
Q psy758 117 CH-RHACIHRDIKPENILLTANG--------------------VVKLCDFGFARLIRDLIPRHLHIFQTNEYFKGVSLPH 175 (292)
Q Consensus 117 LH-~~givH~dl~p~Nilv~~~~--------------------~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 175 (292)
|| ++||+||||||+|||++.++ .+||+|||+++........++..|.+||...|.. ..
T Consensus 177 lH~~~~ivHrDlKp~NILl~~~~~~~~~~~~~~~~~~~~~~~~~vkL~DFG~a~~~~~~~~~gt~~y~aPE~~~g~~-~~ 255 (336)
T 2vuw_A 177 AEASLRFEHRDLHWGNVLLKKTSLKKLHYTLNGKSSTIPSCGLQVSIIDYTLSRLERDGIVVFCDVSMDEDLFTGDG-DY 255 (336)
T ss_dssp HHHHHCCBCSCCCGGGEEEEECSCSEEEEEETTEEEEEECTTEEEEECCCTTCBEEETTEEECCCCTTCSGGGCCCS-SH
T ss_pred HHHhCCEeECCCCHHHEEEeccCCcceeeeccCccccccCCCceEEEeeccccEecCCCcEEEeecccChhhhcCCC-cc
Confidence 99 99999999999999999987 8999999999877655555566778888776655 33
Q ss_pred CCccccee------eecCCCCCCch-HHHHHHHhhcccCCCCCCChhhhhhccCcCCCC---CCCCCccchHHHHhcccC
Q psy758 176 AENVVPLE------IKIGKPAATNI-YLIDFLKRCLDKDPLRRWSCDQLLRHPYFNGYY---FEVPDEMQYEEITQRCLD 245 (292)
Q Consensus 176 ~~~~~~~~------~~~~~~~~~~~-~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~---~~~~~~~~l~~li~~~l~ 245 (292)
..++|++. ++.+..++... +...+...+. ....+.... .....+..+.+||.+||+
T Consensus 256 ~~Diwsl~~~~~~~~~~g~~p~~~~~~~~~~~~~~~--------------~~~~~~~~~~~~~~~~~s~~~~dli~~~L~ 321 (336)
T 2vuw_A 256 QFDIYRLMKKENNNRWGEYHPYSNVLWLHYLTDKML--------------KQMTFKTKCNTPAMKQIKRKIQEFHRTMLN 321 (336)
T ss_dssp HHHHHHHHHHHHTTCTTSCCTHHHHHHHHHHHHHHH--------------HTCCCSSCCCSHHHHHHHHHHHHHHHHGGG
T ss_pred ceehhhhhCCCCcccccccCCCcchhhhhHHHHhhh--------------hhhccCcccchhhhhhcCHHHHHHHHHHhc
Confidence 44454431 11122221110 0011111111 010011000 011236789999999999
Q ss_pred cCCCCCCChhhhh-hCCccc
Q psy758 246 KDPLRRWSCDQLL-RHPYFN 264 (292)
Q Consensus 246 ~dP~~Rpt~~~il-~h~w~~ 264 (292)
.| |++|+| +||||+
T Consensus 322 ~d-----sa~e~l~~Hp~f~ 336 (336)
T 2vuw_A 322 FS-----SATDLLCQHSLFK 336 (336)
T ss_dssp SS-----SHHHHHHHCGGGC
T ss_pred cC-----CHHHHHhcCCCcC
Confidence 87 999999 999995
|
| >3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} SCOP: d.144.1.0 | Back alignment and structure |
|---|
Probab=100.00 E-value=5.1e-40 Score=264.69 Aligned_cols=244 Identities=24% Similarity=0.358 Sum_probs=175.5
Q ss_pred CcccceeeeecccCceEEEEEEEcCCCcEEEEEEeccCCCC--hHHHHHHHHHHHHHHhCCCCCcchhhhhhhcCCeEEE
Q psy758 1 MERYEKIGKLGEGSYGVVFKCRNRDTGQVVAIKKFLESEED--PLIRKIALREIRLLKSLKHPNLVNLLEVFRRKKKLHL 78 (292)
Q Consensus 1 ~~~y~~~~~l~~g~~~~v~~~~~~~~~~~v~iK~~~~~~~~--~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~i 78 (292)
+++|++.+.||+|++|.||+|.+. +..||+|++...... ....+.+.+|+.+++.++||||+++++++.+++..++
T Consensus 6 ~~~~~~~~~lg~G~~g~V~~~~~~--~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l 83 (271)
T 3dtc_A 6 FAELTLEEIIGIGGFGKVYRAFWI--GDEVAVKAARHDPDEDISQTIENVRQEAKLFAMLKHPNIIALRGVCLKEPNLCL 83 (271)
T ss_dssp TTSEEEEEEEEEETTEEEEEEEET--TEEEEEEEC----------CHHHHHHHHHHHHHCCCTTBCCEEEEECCC--CEE
T ss_pred hhheeeeeeeccCCCeEEEEEEEc--CCeEEEEEEecCCcccHHHHHHHHHHHHHHHHhcCCCCEeeEEEEEecCCceEE
Confidence 478999999999999999999975 889999998655422 2335678899999999999999999999999999999
Q ss_pred EEecCCCccHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCC---ccccCCCCCceEEcc--------CCcEEEeecCc
Q psy758 79 VFEFCDHTVLNELENHPHGLPWDLIKQITWQVLRGVSYCHRHA---CIHRDIKPENILLTA--------NGVVKLCDFGF 147 (292)
Q Consensus 79 v~e~~~~~~L~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~g---ivH~dl~p~Nilv~~--------~~~~kl~dfg~ 147 (292)
||||+++++|..++.. ..+++..++.++.|++.||.|||++| ++||||||+||+++. ++.++|+|||+
T Consensus 84 v~e~~~~~~L~~~~~~-~~~~~~~~~~i~~~l~~~l~~lH~~~~~~i~H~dikp~Nil~~~~~~~~~~~~~~~kl~Dfg~ 162 (271)
T 3dtc_A 84 VMEFARGGPLNRVLSG-KRIPPDILVNWAVQIARGMNYLHDEAIVPIIHRDLKSSNILILQKVENGDLSNKILKITDFGL 162 (271)
T ss_dssp EEECCTTEEHHHHHTS-SCCCHHHHHHHHHHHHHHHHHHHHSSSSCCCCSCCSGGGEEESSCCSSSCCSSCCEEECCCCC
T ss_pred EEEcCCCCCHHHHhhc-CCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCchHHEEEecccccccccCcceEEccCCc
Confidence 9999999999999875 47999999999999999999999999 889999999999986 67899999999
Q ss_pred hhhhhccc---cccccccccccccccCCCCCCCcccceeeecCCCCCCchHHHHHHHhhcccCCCCCCChhhhhhccCcC
Q psy758 148 ARLIRDLI---PRHLHIFQTNEYFKGVSLPHAENVVPLEIKIGKPAATNIYLIDFLKRCLDKDPLRRWSCDQLLRHPYFN 224 (292)
Q Consensus 148 ~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~ 224 (292)
+....... ...+..|.+||...+.......++|+ .+.-++..+.+..|+...............
T Consensus 163 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~s-------------lG~~l~~l~~g~~p~~~~~~~~~~~~~~~~ 229 (271)
T 3dtc_A 163 AREWHRTTKMSAAGAYAWMAPEVIRASMFSKGSDVWS-------------YGVLLWELLTGEVPFRGIDGLAVAYGVAMN 229 (271)
T ss_dssp -------------CCGGGSCHHHHHHCCCSHHHHHHH-------------HHHHHHHHHHCCCTTTTSCHHHHHHHHHTS
T ss_pred ccccccccccCCCCccceeCHHHhccCCCCchhhHHH-------------HHHHHHHHHhCCCCCCCCCHHHHHHhhhcC
Confidence 97654322 23344566776655443322222222 222233334444454444433332221111
Q ss_pred C--CCCCCCCccchHHHHhcccCcCCCCCCChhhhhhC
Q psy758 225 G--YYFEVPDEMQYEEITQRCLDKDPLRRWSCDQLLRH 260 (292)
Q Consensus 225 ~--~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~~il~h 260 (292)
. ...+...+..+.++|.+||+.||.+|||+.|++++
T Consensus 230 ~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~ 267 (271)
T 3dtc_A 230 KLALPIPSTCPEPFAKLMEDCWNPDPHSRPSFTNILDQ 267 (271)
T ss_dssp CCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred CCCCCCCcccCHHHHHHHHHHhcCCcccCcCHHHHHHH
Confidence 1 22334557889999999999999999999999985
|
| >1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=3.1e-40 Score=274.96 Aligned_cols=246 Identities=25% Similarity=0.316 Sum_probs=180.0
Q ss_pred cccceeeeecccCceEEEEEEEc-----CCCcEEEEEEeccCCCChHHHHHHHHHHHHHHhC-CCCCcchhhhhhhcCCe
Q psy758 2 ERYEKIGKLGEGSYGVVFKCRNR-----DTGQVVAIKKFLESEEDPLIRKIALREIRLLKSL-KHPNLVNLLEVFRRKKK 75 (292)
Q Consensus 2 ~~y~~~~~l~~g~~~~v~~~~~~-----~~~~~v~iK~~~~~~~~~~~~~~~~~e~~~~~~l-~~~~i~~~~~~~~~~~~ 75 (292)
++|++.+.||+|+||.||+|.+. .++..||+|++.... .....+.+.+|+.+++.+ +||||+++++++.+.+.
T Consensus 45 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~ 123 (344)
T 1rjb_A 45 ENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKA-DSSEREALMSELKMMTQLGSHENIVNLLGACTLSGP 123 (344)
T ss_dssp GGEEEEEEEEECSSEEEEEEEEESCSSSSCEEEEEEEEECC-------CHHHHHHHHHHHHHCCCTTBCCEEEEECSSSS
T ss_pred HHceeeeeecCCCCceeEEeeeeccccCCcceEEEEEeccccc-CHHHHHHHHHHHHHHHhhcCCCCeeeEEEEEeeCCc
Confidence 57999999999999999999973 356689999997543 233456788999999999 89999999999999999
Q ss_pred EEEEEecCCCccHHHHhcCCC-----------------------CCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCce
Q psy758 76 LHLVFEFCDHTVLNELENHPH-----------------------GLPWDLIKQITWQVLRGVSYCHRHACIHRDIKPENI 132 (292)
Q Consensus 76 ~~iv~e~~~~~~L~~~~~~~~-----------------------~~~~~~~~~i~~qi~~aL~~LH~~givH~dl~p~Ni 132 (292)
.++||||+++++|.+++.... .+++..++.++.||+.||.|||++||+||||||+||
T Consensus 124 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dikp~NI 203 (344)
T 1rjb_A 124 IYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEFKSCVHRDLAARNV 203 (344)
T ss_dssp CEEEEECCTTCBHHHHHHTTTTCC---------------------CCHHHHHHHHHHHHHHHHHHHHTTEEETTCSGGGE
T ss_pred cEEEEecCCCCcHHHHHhhccccccccccchhhhcccccccccccCCHHHHHHHHHHHHHHHHHHHhCCcccCCCChhhE
Confidence 999999999999999987643 279999999999999999999999999999999999
Q ss_pred EEccCCcEEEeecCchhhhhcccc-------ccccccccccccccCCCCCCCcccceeeecCCCCCCchHHHHHHHhhc-
Q psy758 133 LLTANGVVKLCDFGFARLIRDLIP-------RHLHIFQTNEYFKGVSLPHAENVVPLEIKIGKPAATNIYLIDFLKRCL- 204 (292)
Q Consensus 133 lv~~~~~~kl~dfg~~~~~~~~~~-------~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~- 204 (292)
+++.++.++|+|||++........ ..+..|.+||...+.......++|++ +..++..+.
T Consensus 204 ll~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~sl-------------G~il~el~t~ 270 (344)
T 1rjb_A 204 LVTHGKVVKICDFGLARDIMSDSNYVVRGNARLPVKWMAPESLFEGIYTIKSDVWSY-------------GILLWEIFSL 270 (344)
T ss_dssp EEETTTEEEECCCGGGSCGGGCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHH-------------HHHHHHHTTT
T ss_pred EEcCCCcEEeCCCccCcccccCccceeccCccCccCccCHHHhccCCCChhHhHHHH-------------HHHHHHHHcC
Confidence 999999999999999976543221 11224666766544433222222222 222333332
Q ss_pred ccCCCCCCChhhhhhccCcCC--CCCCCCCccchHHHHhcccCcCCCCCCChhhhhhCC
Q psy758 205 DKDPLRRWSCDQLLRHPYFNG--YYFEVPDEMQYEEITQRCLDKDPLRRWSCDQLLRHP 261 (292)
Q Consensus 205 ~~~p~~~~~~~~~~~~~~~~~--~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~~il~h~ 261 (292)
+..|+......+.+......+ ...+...+..+.+||.+||+.||.+|||+.+++++.
T Consensus 271 g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~l 329 (344)
T 1rjb_A 271 GVNPYPGIPVDANFYKLIQNGFKMDQPFYATEEIYIIMQSCWAFDSRKRPSFPNLTSFL 329 (344)
T ss_dssp SCCSSTTCCCSHHHHHHHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHH
T ss_pred CCCCcccCCcHHHHHHHHhcCCCCCCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHH
Confidence 444443332222111111111 122334578999999999999999999999999953
|
| >2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=3.8e-40 Score=276.66 Aligned_cols=244 Identities=20% Similarity=0.247 Sum_probs=177.3
Q ss_pred cccceeeeecccCceEEEEEEEc---CCCcEEEEEEeccCCCChHHHHHHHHHHHHHHhCCCCCcchhhhhhhcCCeEEE
Q psy758 2 ERYEKIGKLGEGSYGVVFKCRNR---DTGQVVAIKKFLESEEDPLIRKIALREIRLLKSLKHPNLVNLLEVFRRKKKLHL 78 (292)
Q Consensus 2 ~~y~~~~~l~~g~~~~v~~~~~~---~~~~~v~iK~~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~i 78 (292)
++|++.+.||+|+||.||+|.+. .++..||+|.+.... .....+.+.+|+.+++.++||||+++++++.+.+..++
T Consensus 45 ~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~l 123 (373)
T 2qol_A 45 TNISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGY-TEKQRRDFLGEASIMGQFDHPNIIRLEGVVTKSKPVMI 123 (373)
T ss_dssp GGCCCCEEEEECSSSEEEEC-CBCTTSCBCCEEEEECCTTC-CHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSCEE
T ss_pred hhceeeeEEeeCCCeEEEEEEEecCCCCceeEEEEEecCcc-CHHHHHHHHHHHHHHHhCCCCCCCeEEEEEeeCCceEE
Confidence 57999999999999999999886 457789999986543 44556778999999999999999999999999999999
Q ss_pred EEecCCCccHHHHhcCC-CCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEEccCCcEEEeecCchhhhhccccc
Q psy758 79 VFEFCDHTVLNELENHP-HGLPWDLIKQITWQVLRGVSYCHRHACIHRDIKPENILLTANGVVKLCDFGFARLIRDLIPR 157 (292)
Q Consensus 79 v~e~~~~~~L~~~~~~~-~~~~~~~~~~i~~qi~~aL~~LH~~givH~dl~p~Nilv~~~~~~kl~dfg~~~~~~~~~~~ 157 (292)
||||+++++|.+++... ..+++..++.++.||+.||+|||++||+||||||+||+++.++.+||+|||++.........
T Consensus 124 v~e~~~~~sL~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~~ 203 (373)
T 2qol_A 124 VTEYMENGSLDSFLRKHDAQFTVIQLVGMLRGIASGMKYLSDMGYVHRDLAARNILINSNLVCKVSDFGLGRVLEDDPEA 203 (373)
T ss_dssp EEECCTTCBHHHHHHTTTTCSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTCCEEECCC------------
T ss_pred EEeCCCCCcHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeCCCCCcceEEEcCCCCEEECcCccccccccCCcc
Confidence 99999999999998764 36999999999999999999999999999999999999999999999999999776432111
Q ss_pred --------cccccccccccccCCCCCCCcccceeeecCCCCCCchHHHHHHHhhc-ccCCCCCCChhhhhhccCcC-CCC
Q psy758 158 --------HLHIFQTNEYFKGVSLPHAENVVPLEIKIGKPAATNIYLIDFLKRCL-DKDPLRRWSCDQLLRHPYFN-GYY 227 (292)
Q Consensus 158 --------~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~p~~~~~~~~~~~~~~~~-~~~ 227 (292)
.+..|.+||...+.......++|++ +.-+++.+. +..|....+..++.....-. ...
T Consensus 204 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~Sl-------------G~il~ellt~g~~P~~~~~~~~~~~~i~~~~~~~ 270 (373)
T 2qol_A 204 AYTTRGGKIPIRWTSPEAIAYRKFTSASDVWSY-------------GIVLWEVMSYGERPYWEMSNQDVIKAVDEGYRLP 270 (373)
T ss_dssp ----------CTTSCHHHHHHCCCCHHHHHHHH-------------HHHHHHHHTTC-CTTTTCCHHHHHHHHHTTEECC
T ss_pred ceeccCCCcCCCccChhhhccCCcCchhcHHHH-------------HHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCCC
Confidence 1123666766654433322222222 222233332 44454444443333221100 112
Q ss_pred CCCCCccchHHHHhcccCcCCCCCCChhhhhh
Q psy758 228 FEVPDEMQYEEITQRCLDKDPLRRWSCDQLLR 259 (292)
Q Consensus 228 ~~~~~~~~l~~li~~~l~~dP~~Rpt~~~il~ 259 (292)
.+...+..+.+||.+||+.||.+|||+.++++
T Consensus 271 ~~~~~~~~l~~li~~cl~~dp~~RPs~~~i~~ 302 (373)
T 2qol_A 271 PPMDCPAALYQLMLDCWQKDRNNRPKFEQIVS 302 (373)
T ss_dssp CCTTCBHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred CCccccHHHHHHHHHHhCcChhhCcCHHHHHH
Confidence 23345778999999999999999999999987
|
| >4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.9e-41 Score=284.07 Aligned_cols=258 Identities=22% Similarity=0.296 Sum_probs=193.9
Q ss_pred cccceeeeecccCceEEEEEEEcCCCcEEEEEEeccCCCChHHHHHHHHHHHHHHhCCCCCcchhhhhhhcCC--eEEEE
Q psy758 2 ERYEKIGKLGEGSYGVVFKCRNRDTGQVVAIKKFLESEEDPLIRKIALREIRLLKSLKHPNLVNLLEVFRRKK--KLHLV 79 (292)
Q Consensus 2 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~--~~~iv 79 (292)
++|++.+.||+|+||.||+|.+..+++.||+|++....... ..+.+.+|+.+++.++||||+++++++.+.+ ..++|
T Consensus 9 ~~y~i~~~LG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~-~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~~~lv 87 (396)
T 4eut_A 9 HLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLR-PVDVQMREFEVLKKLNHKNIVKLFAIEEETTTRHKVLI 87 (396)
T ss_dssp EEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECGGGGGS-CHHHHHHHHHHHHHCCCTTBCCEEEEEECTTTCCEEEE
T ss_pred CceEEEEEEEcCCCeEEEEEEECCCCcEEEEEEeccccccc-hHHHHHHHHHHHHhcCCCCCCeEEEeeccCCCCeeEEE
Confidence 58999999999999999999999999999999997543221 2455678999999999999999999987644 78999
Q ss_pred EecCCCccHHHHhcCCCC---CCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEE----ccCCcEEEeecCchhhhh
Q psy758 80 FEFCDHTVLNELENHPHG---LPWDLIKQITWQVLRGVSYCHRHACIHRDIKPENILL----TANGVVKLCDFGFARLIR 152 (292)
Q Consensus 80 ~e~~~~~~L~~~~~~~~~---~~~~~~~~i~~qi~~aL~~LH~~givH~dl~p~Nilv----~~~~~~kl~dfg~~~~~~ 152 (292)
|||+++++|.+++..... +++..++.++.||+.||+|||++||+||||||+||++ +.++.+||+|||++....
T Consensus 88 ~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~~~~~kL~DFG~a~~~~ 167 (396)
T 4eut_A 88 MEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHLRENGIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARELE 167 (396)
T ss_dssp ECCCTTEEHHHHTTSGGGTTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEEEECTTSCEEEEECCGGGCEECC
T ss_pred EecCCCCCHHHHHHhhhcccCCCHHHHHHHHHHHHHHHHHHHHCCEEECCcCHHHEEEeecCCCceeEEEecCCCceEcc
Confidence 999999999999876433 9999999999999999999999999999999999999 777889999999997654
Q ss_pred ccc----ccccccccccccccc-------------CCCCCCCcccceeeecCCCCCCc----hHHHHHHHhhcccCCCCC
Q psy758 153 DLI----PRHLHIFQTNEYFKG-------------VSLPHAENVVPLEIKIGKPAATN----IYLIDFLKRCLDKDPLRR 211 (292)
Q Consensus 153 ~~~----~~~~~~~~~~~~~~~-------------~~~~~~~~~~~~~~~~~~~~~~~----~~~~~~~~~~~~~~p~~~ 211 (292)
... ..++..|.+||...+ ....|+.|+..+++.+|..++.. .....++..++...|...
T Consensus 168 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwSlG~il~el~tg~~Pf~~~~~~~~~~~~~~~~~~~~p~~~ 247 (396)
T 4eut_A 168 DDEQFVSLYGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPRRNKEVMYKIITGKPSGA 247 (396)
T ss_dssp CGGGSSCSSSCCTTCCHHHHHHHCC--CHHHHHHHHHHHHHHHHHHHHHHHSSCSEECTTCTTTCHHHHHHHHHSCCTTC
T ss_pred CCCccccccCCccccCHHHhhccccccccccCCCcHHHHHHHHHHHHHHHHCCCCCCCCCcccchHHHHHHHhcCCCccc
Confidence 322 223445677776543 23457778888888888776532 223344555555555443
Q ss_pred CChhhhhhc---cCcCCCC----CCCCCccchHHHHhcccCcCCCCCCChhhhhhC
Q psy758 212 WSCDQLLRH---PYFNGYY----FEVPDEMQYEEITQRCLDKDPLRRWSCDQLLRH 260 (292)
Q Consensus 212 ~~~~~~~~~---~~~~~~~----~~~~~~~~l~~li~~~l~~dP~~Rpt~~~il~h 260 (292)
+........ .|....+ .....+..+.++|.+||+.||++|||+++++++
T Consensus 248 ~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~l~~ll~~~L~~dP~~R~s~~e~l~~ 303 (396)
T 4eut_A 248 ISGVQKAENGPIDWSGDMPVSCSLSRGLQVLLTPVLANILEADQEKCWGFDQFFAE 303 (396)
T ss_dssp CEEEECSTTCCEEEESSCCTTCSSCHHHHHHHHHHHHHHSCCCTTTSCCHHHHHHH
T ss_pred chhheeccCCCcccCccCCcccccchHHHhhchHHHHHhhccChhhhccHHHHHHH
Confidence 321111111 1111111 112235678899999999999999999998553
|
| >1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.2e-40 Score=265.57 Aligned_cols=244 Identities=21% Similarity=0.298 Sum_probs=174.5
Q ss_pred cccceeeeecccCceEEEEEEEcCC---CcEEEEEEeccCCCChHHHHHHHHHHHHHHhCCCCCcchhhhhhhcCCeEEE
Q psy758 2 ERYEKIGKLGEGSYGVVFKCRNRDT---GQVVAIKKFLESEEDPLIRKIALREIRLLKSLKHPNLVNLLEVFRRKKKLHL 78 (292)
Q Consensus 2 ~~y~~~~~l~~g~~~~v~~~~~~~~---~~~v~iK~~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~i 78 (292)
++|++.+.||+|+||.||+|.+..+ +..|++|.+.... .....+.+.+|+.+++.++||||+++++++. ++..++
T Consensus 15 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~-~~~~~l 92 (281)
T 1mp8_A 15 ERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCT-SDSVREKFLQEALTMRQFDHPHIVKLIGVIT-ENPVWI 92 (281)
T ss_dssp GGEEEEEEEEECSSSEEEEEEECCC--CCEEEEEEECTTTT-SHHHHHHHHHHHHHHHTCCCTTBCCEEEEEC-SSSCEE
T ss_pred HHeEEEeEeeecCCeeEEEEEEecCCCCceEEEEEeccccC-CHHHHHHHHHHHHHHHhCCCCccceEEEEEc-cCccEE
Confidence 6899999999999999999998654 4569999886543 3455677899999999999999999999874 567899
Q ss_pred EEecCCCccHHHHhcCC-CCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEEccCCcEEEeecCchhhhhcccc-
Q psy758 79 VFEFCDHTVLNELENHP-HGLPWDLIKQITWQVLRGVSYCHRHACIHRDIKPENILLTANGVVKLCDFGFARLIRDLIP- 156 (292)
Q Consensus 79 v~e~~~~~~L~~~~~~~-~~~~~~~~~~i~~qi~~aL~~LH~~givH~dl~p~Nilv~~~~~~kl~dfg~~~~~~~~~~- 156 (292)
||||+++++|.+++... ..+++..++.++.|++.||.|||++|++|+||||+||+++.++.++|+|||++........
T Consensus 93 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~ 172 (281)
T 1mp8_A 93 IMELCTLGELRSFLQVRKYSLDLASLILYAYQLSTALAYLESKRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYY 172 (281)
T ss_dssp EEECCTTEEHHHHHHHTTTTSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEEETTEEEECC-------------
T ss_pred EEecCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCeecccccHHHEEECCCCCEEECccccccccCccccc
Confidence 99999999999988654 3699999999999999999999999999999999999999999999999999976643221
Q ss_pred -----ccccccccccccccCCCCCCCcccceeeecCCCCCCchHHHHHHHhhc-ccCCCCCCChhhhhhccCc-CCCCCC
Q psy758 157 -----RHLHIFQTNEYFKGVSLPHAENVVPLEIKIGKPAATNIYLIDFLKRCL-DKDPLRRWSCDQLLRHPYF-NGYYFE 229 (292)
Q Consensus 157 -----~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~p~~~~~~~~~~~~~~~-~~~~~~ 229 (292)
..+..|.+||...+.......++|++ +..++..+. +..|+......+....... .....+
T Consensus 173 ~~~~~~~~~~y~aPE~~~~~~~~~~~Di~sl-------------G~~l~ell~~g~~pf~~~~~~~~~~~i~~~~~~~~~ 239 (281)
T 1mp8_A 173 KASKGKLPIKWMAPESINFRRFTSASDVWMF-------------GVCMWEILMHGVKPFQGVKNNDVIGRIENGERLPMP 239 (281)
T ss_dssp ------CCGGGCCHHHHHHCCCSHHHHHHHH-------------HHHHHHHHTTSCCTTTTCCGGGHHHHHHTTCCCCCC
T ss_pred ccccCCCcccccChhhcccCCCCCccCchHH-------------HHHHHHHHhcCCCCCCcCCHHHHHHHHHcCCCCCCC
Confidence 11234666666544333222222222 222333332 4445444433333221110 112234
Q ss_pred CCCccchHHHHhcccCcCCCCCCChhhhhhC
Q psy758 230 VPDEMQYEEITQRCLDKDPLRRWSCDQLLRH 260 (292)
Q Consensus 230 ~~~~~~l~~li~~~l~~dP~~Rpt~~~il~h 260 (292)
...+..+.++|.+||+.||.+|||+.+++++
T Consensus 240 ~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~ 270 (281)
T 1mp8_A 240 PNCPPTLYSLMTKCWAYDPSRRPRFTELKAQ 270 (281)
T ss_dssp TTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred CCCCHHHHHHHHHHccCChhhCcCHHHHHHH
Confidence 4567889999999999999999999999873
|
| >1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.7e-40 Score=271.94 Aligned_cols=246 Identities=24% Similarity=0.321 Sum_probs=181.6
Q ss_pred CcccceeeeecccCceEEEEEEEcCCCcEE--EEEEeccCCCChHHHHHHHHHHHHHHhC-CCCCcchhhhhhhcCCeEE
Q psy758 1 MERYEKIGKLGEGSYGVVFKCRNRDTGQVV--AIKKFLESEEDPLIRKIALREIRLLKSL-KHPNLVNLLEVFRRKKKLH 77 (292)
Q Consensus 1 ~~~y~~~~~l~~g~~~~v~~~~~~~~~~~v--~iK~~~~~~~~~~~~~~~~~e~~~~~~l-~~~~i~~~~~~~~~~~~~~ 77 (292)
+++|++.+.||+|+||.||+|.+..++..+ ++|.+.... .....+.+.+|+.+++.+ +||||+++++++.+.+..+
T Consensus 24 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~v~iK~~~~~~-~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~~~ 102 (327)
T 1fvr_A 24 WNDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYA-SKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLY 102 (327)
T ss_dssp GGGCEEEEEEECGGGCEEEEEEEEETTEEEEEEEEEEECC-------CHHHHHHHHHTTCCCCTTBCCEEEEEEETTEEE
T ss_pred HHHccceeeeecCCCceEEEEEEccCCcccceeeeeecccc-chHHHHHHHHHHHHHHhccCCCchhhhceeeeeCCceE
Confidence 368999999999999999999999888865 999886433 223456688999999999 8999999999999999999
Q ss_pred EEEecCCCccHHHHhcCCC----------------CCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEEccCCcEE
Q psy758 78 LVFEFCDHTVLNELENHPH----------------GLPWDLIKQITWQVLRGVSYCHRHACIHRDIKPENILLTANGVVK 141 (292)
Q Consensus 78 iv~e~~~~~~L~~~~~~~~----------------~~~~~~~~~i~~qi~~aL~~LH~~givH~dl~p~Nilv~~~~~~k 141 (292)
+||||+++++|.+++.... .+++..++.++.||+.||.|||++|++||||||+||+++.++.++
T Consensus 103 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~dlkp~NIl~~~~~~~k 182 (327)
T 1fvr_A 103 LAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQFIHRDLAARNILVGENYVAK 182 (327)
T ss_dssp EEECCCTTCBHHHHHHTTCHHHHCHHHHHHTTBSCSSCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECGGGCEE
T ss_pred EEEecCCCCCHHHHHHhcccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhCCccCCCCccceEEEcCCCeEE
Confidence 9999999999999987653 699999999999999999999999999999999999999999999
Q ss_pred EeecCchhhhhccc----cccccccccccccccCCCCCCCcccceeeecCCCCCCchHHHHHHHhhc-ccCCCCCCChhh
Q psy758 142 LCDFGFARLIRDLI----PRHLHIFQTNEYFKGVSLPHAENVVPLEIKIGKPAATNIYLIDFLKRCL-DKDPLRRWSCDQ 216 (292)
Q Consensus 142 l~dfg~~~~~~~~~----~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~p~~~~~~~~ 216 (292)
|+|||++....... ...+..|.+||...+.......++| +.+.-++..+. +..|+...+..+
T Consensus 183 L~Dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~-------------slG~il~ellt~g~~pf~~~~~~~ 249 (327)
T 1fvr_A 183 IADFGLSRGQEVYVKKTMGRLPVRWMAIESLNYSVYTTNSDVW-------------SYGVLLWEIVSLGGTPYCGMTCAE 249 (327)
T ss_dssp ECCTTCEESSCEECCC----CCTTTCCHHHHHHCEECHHHHHH-------------HHHHHHHHHHTTSCCTTTTCCHHH
T ss_pred EcccCcCccccccccccCCCCCccccChhhhccccCCchhcch-------------HHHHHHHHHHcCCCCCCCCCcHHH
Confidence 99999986433211 1112346666655433222222222 22222333332 444444444333
Q ss_pred hhhccCcC-CCCCCCCCccchHHHHhcccCcCCCCCCChhhhhhC
Q psy758 217 LLRHPYFN-GYYFEVPDEMQYEEITQRCLDKDPLRRWSCDQLLRH 260 (292)
Q Consensus 217 ~~~~~~~~-~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~~il~h 260 (292)
+....... ....+...+..+.+||.+||+.||.+|||+++++++
T Consensus 250 ~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~ 294 (327)
T 1fvr_A 250 LYEKLPQGYRLEKPLNCDDEVYDLMRQCWREKPYERPSFAQILVS 294 (327)
T ss_dssp HHHHGGGTCCCCCCTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred HHHHhhcCCCCCCCCCCCHHHHHHHHHHccCChhhCcCHHHHHHH
Confidence 33221110 112233457889999999999999999999999985
|
| >3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} SCOP: d.144.1.7 PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=7.8e-40 Score=265.93 Aligned_cols=248 Identities=21% Similarity=0.262 Sum_probs=188.2
Q ss_pred cccceeeeecccCceEEEEEEEcCCCcEEEEEEeccCCCChHHHHHHHHHHHHHHhCCCCCcchhhhhhhcCCeEEEEEe
Q psy758 2 ERYEKIGKLGEGSYGVVFKCRNRDTGQVVAIKKFLESEEDPLIRKIALREIRLLKSLKHPNLVNLLEVFRRKKKLHLVFE 81 (292)
Q Consensus 2 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~iv~e 81 (292)
++|++.+.||+|++|.||+|.+..++..||+|.+..... ..+.+.+|+.+++.++||||+++++++.+++..++|||
T Consensus 13 ~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~---~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e 89 (288)
T 3kfa_A 13 TDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTM---EVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITE 89 (288)
T ss_dssp GGEEEEEESGGGTTCSEEEEEEGGGTEEEEEEEECSCST---HHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSEEEEEE
T ss_pred cceeEEeecCCCCceeEEEeEecCCCEEEEEEecCcCHH---HHHHHHHHHHHHHhCCCCCEeeEEEEEccCCCEEEEEE
Confidence 579999999999999999999999999999999865432 34668899999999999999999999999999999999
Q ss_pred cCCCccHHHHhcC--CCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEEccCCcEEEeecCchhhhhcccc---
Q psy758 82 FCDHTVLNELENH--PHGLPWDLIKQITWQVLRGVSYCHRHACIHRDIKPENILLTANGVVKLCDFGFARLIRDLIP--- 156 (292)
Q Consensus 82 ~~~~~~L~~~~~~--~~~~~~~~~~~i~~qi~~aL~~LH~~givH~dl~p~Nilv~~~~~~kl~dfg~~~~~~~~~~--- 156 (292)
|+.+++|.+++.. ...+++..++.++.||+.||.|||++|++|+||+|+||+++.++.++|+|||++........
T Consensus 90 ~~~~~~L~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~i~H~dikp~Nil~~~~~~~~l~Dfg~~~~~~~~~~~~~ 169 (288)
T 3kfa_A 90 FMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAH 169 (288)
T ss_dssp CCTTEEHHHHHHHCCTTTSCHHHHHHHHHHHHHHHHHHHHHTCCCSCCSGGGEEECGGGCEEECCCCGGGTSCSSSSEEE
T ss_pred cCCCCcHHHHHHhcccCCccHhHHHHHHHHHHHHHHHHHHCCccCCCCCcceEEEcCCCCEEEccCccceeccCCccccc
Confidence 9999999999864 34599999999999999999999999999999999999999999999999999976543221
Q ss_pred ---ccccccccccccccCCCCCCCcccceeeecCCCCCCchHHHHHHHhhc-ccCCCCCCChhhhhhccCc-CCCCCCCC
Q psy758 157 ---RHLHIFQTNEYFKGVSLPHAENVVPLEIKIGKPAATNIYLIDFLKRCL-DKDPLRRWSCDQLLRHPYF-NGYYFEVP 231 (292)
Q Consensus 157 ---~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~p~~~~~~~~~~~~~~~-~~~~~~~~ 231 (292)
..+..|.+||...+.......++|++ +.-++..+. +..|.......++...... .....+..
T Consensus 170 ~~~~~~~~y~aPE~~~~~~~~~~~Di~sl-------------G~il~~ll~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~ 236 (288)
T 3kfa_A 170 AGAKFPIKWTAPESLAYNKFSIKSDVWAF-------------GVLLWEIATYGMSPYPGIDLSQVYELLEKDYRMERPEG 236 (288)
T ss_dssp TTEEECGGGCCHHHHHHCCCCHHHHHHHH-------------HHHHHHHHTTSCCSSTTCCGGGHHHHHHTTCCCCCCTT
T ss_pred cCCccccCcCChhhhccCCCCchhhHHHH-------------HHHHHHHHhCCCCCCCCCCHHHHHHHHhccCCCCCCCC
Confidence 11224667776654443322233222 222333333 4444444333333221100 01123345
Q ss_pred CccchHHHHhcccCcCCCCCCChhhhhhCCccccee
Q psy758 232 DEMQYEEITQRCLDKDPLRRWSCDQLLRHPYFNGYY 267 (292)
Q Consensus 232 ~~~~l~~li~~~l~~dP~~Rpt~~~il~h~w~~~~~ 267 (292)
.+..+.+||.+||+.||.+|||++++++ .|+...
T Consensus 237 ~~~~l~~li~~~l~~dp~~Rps~~~~~~--~l~~~~ 270 (288)
T 3kfa_A 237 CPEKVYELMRACWQWNPSDRPSFAEIHQ--AFETMF 270 (288)
T ss_dssp CCHHHHHHHHHHTCSSGGGSCCHHHHHH--HHHHHH
T ss_pred CCHHHHHHHHHHhCCChhhCcCHHHHHH--HHHHHH
Confidence 5788999999999999999999999988 455433
|
| >3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-39 Score=261.00 Aligned_cols=242 Identities=22% Similarity=0.309 Sum_probs=182.8
Q ss_pred cccceeeeecccCceEEEEEEEcCCCcEEEEEEeccCCCChHHHHHHHHHHHHHHhCCCCCcchhhhhhhcCCeEEEEEe
Q psy758 2 ERYEKIGKLGEGSYGVVFKCRNRDTGQVVAIKKFLESEEDPLIRKIALREIRLLKSLKHPNLVNLLEVFRRKKKLHLVFE 81 (292)
Q Consensus 2 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~iv~e 81 (292)
++|++.+.||+|++|.||+|.+. +++.||+|.+....... +.+.+|+.+++.++||||+++++++.+++..++|||
T Consensus 8 ~~y~~~~~lg~G~~g~V~~~~~~-~~~~vaiK~~~~~~~~~---~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 83 (267)
T 3t9t_A 8 SELTFVQEIGSGQFGLVHLGYWL-NKDKVAIKTIREGAMSE---EDFIEEAEVMMKLSHPKLVQLYGVCLEQAPICLVTE 83 (267)
T ss_dssp GGEEEEEEEEEETTEEEEEEEET-TTEEEEEEEECTTTBCH---HHHHHHHHHHHTCCCTTBCCEEEEECSSSSCEEEEC
T ss_pred hheeeeeEecCCCceeEEEEEec-CCCeEEEEEccccCCCH---HHHHHHHHHHHhCCCCCEeeEEEEEccCCCeEEEEe
Confidence 68999999999999999999986 57789999997665443 567899999999999999999999999999999999
Q ss_pred cCCCccHHHHhcCC-CCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEEccCCcEEEeecCchhhhhcc------
Q psy758 82 FCDHTVLNELENHP-HGLPWDLIKQITWQVLRGVSYCHRHACIHRDIKPENILLTANGVVKLCDFGFARLIRDL------ 154 (292)
Q Consensus 82 ~~~~~~L~~~~~~~-~~~~~~~~~~i~~qi~~aL~~LH~~givH~dl~p~Nilv~~~~~~kl~dfg~~~~~~~~------ 154 (292)
|+++++|.+++... ..+++..++.++.|++.||.|||++|++|+||+|+||+++.++.++|+|||++......
T Consensus 84 ~~~~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~Nili~~~~~~kl~dfg~~~~~~~~~~~~~~ 163 (267)
T 3t9t_A 84 FMEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLEEACVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYTSST 163 (267)
T ss_dssp CCTTCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTTCCCSSCCGGGEEECGGGCEEECCTTGGGGBCCHHHHSTT
T ss_pred CCCCCcHHHHHhhCcccCCHHHHHHHHHHHHHHHHHHHhCCcccCCCchheEEECCCCCEEEcccccccccccccccccc
Confidence 99999999988653 46899999999999999999999999999999999999999999999999998765321
Q ss_pred ccccccccccccccccCCCCCCCcccceeeecCCCCCCchHHHHHHHhhc-ccCCCCCCChhhhhhccCcC-CCCCCCCC
Q psy758 155 IPRHLHIFQTNEYFKGVSLPHAENVVPLEIKIGKPAATNIYLIDFLKRCL-DKDPLRRWSCDQLLRHPYFN-GYYFEVPD 232 (292)
Q Consensus 155 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~p~~~~~~~~~~~~~~~~-~~~~~~~~ 232 (292)
....+..|.+||...+.......++|++ +.-++..+. +..|.......+........ ....+...
T Consensus 164 ~~~~~~~y~aPE~~~~~~~~~~~Di~sl-------------G~il~~l~~~g~~p~~~~~~~~~~~~i~~~~~~~~~~~~ 230 (267)
T 3t9t_A 164 GTKFPVKWASPEVFSFSRYSSKSDVWSF-------------GVLMWEVFSEGKIPYENRSNSEVVEDISTGFRLYKPRLA 230 (267)
T ss_dssp STTCCGGGCCHHHHHHCCCCHHHHHHHH-------------HHHHHHHHTTSCCTTTTCCHHHHHHHHHTTCCCCCCTTS
T ss_pred cccccccccChhhhcCCCccchhchhhh-------------HHHHHHHhccCCCCCCCCCHHHHHHHHhcCCcCCCCccC
Confidence 1122234667766654433222222222 222233333 34444443333332211100 11223345
Q ss_pred ccchHHHHhcccCcCCCCCCChhhhhhC
Q psy758 233 EMQYEEITQRCLDKDPLRRWSCDQLLRH 260 (292)
Q Consensus 233 ~~~l~~li~~~l~~dP~~Rpt~~~il~h 260 (292)
+..+.++|.+||+.||.+|||+.+++++
T Consensus 231 ~~~l~~li~~~l~~~p~~Rps~~~ll~~ 258 (267)
T 3t9t_A 231 STHVYQIMNHCWRERPEDRPAFSRLLRQ 258 (267)
T ss_dssp CHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred cHHHHHHHHHHccCChhhCcCHHHHHHH
Confidence 7789999999999999999999999974
|
| >1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6e-40 Score=269.71 Aligned_cols=245 Identities=25% Similarity=0.364 Sum_probs=182.9
Q ss_pred cccceeeeecccCceEEEEEEE-----cCCCcEEEEEEeccCCCChHHHHHHHHHHHHHHhC-CCCCcchhhhhhhcCCe
Q psy758 2 ERYEKIGKLGEGSYGVVFKCRN-----RDTGQVVAIKKFLESEEDPLIRKIALREIRLLKSL-KHPNLVNLLEVFRRKKK 75 (292)
Q Consensus 2 ~~y~~~~~l~~g~~~~v~~~~~-----~~~~~~v~iK~~~~~~~~~~~~~~~~~e~~~~~~l-~~~~i~~~~~~~~~~~~ 75 (292)
++|++.+.||+|+||.||+|.+ ..+++.||+|++.... .....+.+.+|+.+++.+ +||||+++++++.+++.
T Consensus 23 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~~ 101 (313)
T 1t46_A 23 NRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSA-HLTEREALMSELKVLSYLGNHMNIVNLLGACTIGGP 101 (313)
T ss_dssp GGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTC-CHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSS
T ss_pred hhhhHHHhhCccCCcceEEEEEeeccccchhhhhHHHhcCcch-hHHHHHHHHHHHHHHhhcccCCCeeeEEEEEecCCC
Confidence 5899999999999999999985 4567899999987554 334567789999999999 89999999999999999
Q ss_pred EEEEEecCCCccHHHHhcCCC------------------CCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEEccC
Q psy758 76 LHLVFEFCDHTVLNELENHPH------------------GLPWDLIKQITWQVLRGVSYCHRHACIHRDIKPENILLTAN 137 (292)
Q Consensus 76 ~~iv~e~~~~~~L~~~~~~~~------------------~~~~~~~~~i~~qi~~aL~~LH~~givH~dl~p~Nilv~~~ 137 (292)
.++||||+++++|.+++.... .+++..++.++.||+.||.|||++|++|+||||+||+++.+
T Consensus 102 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nil~~~~ 181 (313)
T 1t46_A 102 TLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLASKNCIHRDLAARNILLTHG 181 (313)
T ss_dssp CEEEEECCTTEEHHHHHHHTTTTC--------------CCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEETT
T ss_pred cEEEEecCCCCCHHHHHHhcccccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHHCCeecCCCccceEEEcCC
Confidence 999999999999999886543 48999999999999999999999999999999999999999
Q ss_pred CcEEEeecCchhhhhcccc-------ccccccccccccccCCCCCCCcccceeeecCCCCCCchHHHHHHHhhc-ccCCC
Q psy758 138 GVVKLCDFGFARLIRDLIP-------RHLHIFQTNEYFKGVSLPHAENVVPLEIKIGKPAATNIYLIDFLKRCL-DKDPL 209 (292)
Q Consensus 138 ~~~kl~dfg~~~~~~~~~~-------~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~p~ 209 (292)
+.++|+|||++........ ..+..|.+||...+.......++|++ +.-++..+. +..|.
T Consensus 182 ~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~sl-------------G~il~ellt~g~~p~ 248 (313)
T 1t46_A 182 RITKICDFGLARDIKNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSY-------------GIFLWELFSLGSSPY 248 (313)
T ss_dssp TEEEECCCGGGSCTTSCTTSEECSSSEECGGGCCHHHHHHCCCCHHHHHHHH-------------HHHHHHHHTTTCCSS
T ss_pred CCEEEccccccccccccccceeccCCCCcceeeChHHhcCCCCChHHHHHHH-------------HHHHHHHHhCCCCCC
Confidence 9999999999976643221 11224666766544433322222222 222233332 34443
Q ss_pred CCCChhhhhhccCcCC--CCCCCCCccchHHHHhcccCcCCCCCCChhhhhhC
Q psy758 210 RRWSCDQLLRHPYFNG--YYFEVPDEMQYEEITQRCLDKDPLRRWSCDQLLRH 260 (292)
Q Consensus 210 ~~~~~~~~~~~~~~~~--~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~~il~h 260 (292)
................ ...+...+..+.++|.+||+.||.+|||+.+++++
T Consensus 249 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~ 301 (313)
T 1t46_A 249 PGMPVDSKFYKMIKEGFRMLSPEHAPAEMYDIMKTCWDADPLKRPTFKQIVQL 301 (313)
T ss_dssp TTCCSSHHHHHHHHHTCCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred CcccchhHHHHHhccCCCCCCcccCCHHHHHHHHHHcCCCchhCcCHHHHHHH
Confidence 3332221111110001 11233457789999999999999999999999984
|
| >1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-39 Score=268.23 Aligned_cols=245 Identities=18% Similarity=0.247 Sum_probs=178.9
Q ss_pred cccceeeeecccCceEEEEEEEcCCC----cEEEEEEeccCCCChHHHHHHHHHHHHHHhCCCCCcchhhhhhhcCCeEE
Q psy758 2 ERYEKIGKLGEGSYGVVFKCRNRDTG----QVVAIKKFLESEEDPLIRKIALREIRLLKSLKHPNLVNLLEVFRRKKKLH 77 (292)
Q Consensus 2 ~~y~~~~~l~~g~~~~v~~~~~~~~~----~~v~iK~~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~ 77 (292)
++|++.+.||+|+||.||+|.+..++ ..||+|.+.... .......+.+|+.+++.++||||+++++++.+.+..+
T Consensus 44 ~~~~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~ 122 (333)
T 1mqb_A 44 SCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGY-TEKQRVDFLGEAGIMGQFSHHNIIRLEGVISKYKPMM 122 (333)
T ss_dssp TTEEEEEEEEECSSSEEEEEEEEC---CCEEEEEEEEECTTC-CHHHHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSEE
T ss_pred HHhhcccEEecCCCeEEEEEEEecCCCCccccEEEEEcCCCC-CHHHHHHHHHHHHHHHhCCCCCCCcEEEEEecCCCcE
Confidence 57899999999999999999887553 359999987543 3445667889999999999999999999999999999
Q ss_pred EEEecCCCccHHHHhcCC-CCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEEccCCcEEEeecCchhhhhcccc
Q psy758 78 LVFEFCDHTVLNELENHP-HGLPWDLIKQITWQVLRGVSYCHRHACIHRDIKPENILLTANGVVKLCDFGFARLIRDLIP 156 (292)
Q Consensus 78 iv~e~~~~~~L~~~~~~~-~~~~~~~~~~i~~qi~~aL~~LH~~givH~dl~p~Nilv~~~~~~kl~dfg~~~~~~~~~~ 156 (292)
+||||+++++|.+++... ..+++..++.++.||+.||.|||++|++|+||||+||+++.++.++|+|||++........
T Consensus 123 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dikp~NIl~~~~~~~kl~Dfg~~~~~~~~~~ 202 (333)
T 1mqb_A 123 IITEYMENGALDKFLREKDGEFSVLQLVGMLRGIAAGMKYLANMNYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPE 202 (333)
T ss_dssp EEEECCTTEEHHHHHHHTTTCSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTCCEEECCCCC---------
T ss_pred EEEeCCCCCcHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCChheEEECCCCcEEECCCCcchhhccccc
Confidence 999999999999988643 5799999999999999999999999999999999999999999999999999977643211
Q ss_pred --------ccccccccccccccCCCCCCCcccceeeecCCCCCCchHHHHHHHhhc-ccCCCCCCChhhhhhccCcC-CC
Q psy758 157 --------RHLHIFQTNEYFKGVSLPHAENVVPLEIKIGKPAATNIYLIDFLKRCL-DKDPLRRWSCDQLLRHPYFN-GY 226 (292)
Q Consensus 157 --------~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~p~~~~~~~~~~~~~~~~-~~ 226 (292)
..+..|.+||...+.......++|++ +.-++..+. +..|+...+..++.....-. ..
T Consensus 203 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~sl-------------G~il~ellt~g~~pf~~~~~~~~~~~~~~~~~~ 269 (333)
T 1mqb_A 203 ATYTTSGGKIPIRWTAPEAISYRKFTSASDVWSF-------------GIVMWEVMTYGERPYWELSNHEVMKAINDGFRL 269 (333)
T ss_dssp --------CCCGGGSCHHHHHSCCCCHHHHHHHH-------------HHHHHHHHTTSCCTTTTCCHHHHHHHHHTTCCC
T ss_pred cccccCCCCccccccCchhcccCCCCchhhhHHH-------------HHHHHHHHcCCCCCcccCCHHHHHHHHHCCCcC
Confidence 11224666666544433222222222 222333333 44454444443333221100 11
Q ss_pred CCCCCCccchHHHHhcccCcCCCCCCChhhhhhC
Q psy758 227 YFEVPDEMQYEEITQRCLDKDPLRRWSCDQLLRH 260 (292)
Q Consensus 227 ~~~~~~~~~l~~li~~~l~~dP~~Rpt~~~il~h 260 (292)
..+...+..+.++|.+||+.||.+|||+.+++++
T Consensus 270 ~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~ 303 (333)
T 1mqb_A 270 PTPMDCPSAIYQLMMQCWQQERARRPKFADIVSI 303 (333)
T ss_dssp CCCTTCBHHHHHHHHHHTCSSTTTSCCHHHHHHH
T ss_pred CCcccCCHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence 2233457889999999999999999999999884
|
| >2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.3e-40 Score=270.80 Aligned_cols=250 Identities=20% Similarity=0.191 Sum_probs=181.8
Q ss_pred cccceeeeecccCceEEEEEE-----EcCCCcEEEEEEeccCCCChHHHHHHHHHHHHHHhCCCCCcchhhhhhhcCCeE
Q psy758 2 ERYEKIGKLGEGSYGVVFKCR-----NRDTGQVVAIKKFLESEEDPLIRKIALREIRLLKSLKHPNLVNLLEVFRRKKKL 76 (292)
Q Consensus 2 ~~y~~~~~l~~g~~~~v~~~~-----~~~~~~~v~iK~~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~ 76 (292)
++|++.+.||+|+||.||+|. +..++..||+|.+.... .......+.+|+.+++.++||||+++++++.+.+..
T Consensus 30 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~ 108 (327)
T 2yfx_A 30 KNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVC-SEQDELDFLMEALIISKFNHQNIVRCIGVSLQSLPR 108 (327)
T ss_dssp GGCEEEEECC--CSSCEEEEEC--------CCEEEEEECCSSC-CHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSC
T ss_pred hheEEEEEEcCCCCeeEEEEEEcCCCCCCccceEEEEEecccc-chhhHHHHHHHHHHHhhCCCCCCCeEEEEEcCCCCc
Confidence 689999999999999999999 55678899999996443 344556788999999999999999999999999999
Q ss_pred EEEEecCCCccHHHHhcCC-------CCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEEcc---CCcEEEeecC
Q psy758 77 HLVFEFCDHTVLNELENHP-------HGLPWDLIKQITWQVLRGVSYCHRHACIHRDIKPENILLTA---NGVVKLCDFG 146 (292)
Q Consensus 77 ~iv~e~~~~~~L~~~~~~~-------~~~~~~~~~~i~~qi~~aL~~LH~~givH~dl~p~Nilv~~---~~~~kl~dfg 146 (292)
++||||+++++|.+++... ..+++..++.++.||+.||.|||++|++||||+|+||+++. +..++|+|||
T Consensus 109 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~i~H~dlkp~NIli~~~~~~~~~kl~Dfg 188 (327)
T 2yfx_A 109 FILMELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEENHFIHRDIAARNCLLTCPGPGRVAKIGDFG 188 (327)
T ss_dssp EEEEECCTTEEHHHHHHHTSCCSSSTTSCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEESCSSTTCCEEECCCH
T ss_pred EEEEecCCCCcHHHHHHhhcccccccccccHHHHHHHHHHHHHHHHHHhhCCeecCcCCHhHEEEecCCCcceEEECccc
Confidence 9999999999999998754 34899999999999999999999999999999999999994 4469999999
Q ss_pred chhhhhccc-------cccccccccccccccCCCCCCCcccceeeecCCCCCCchHHHHHHHhhc-ccCCCCCCChhhhh
Q psy758 147 FARLIRDLI-------PRHLHIFQTNEYFKGVSLPHAENVVPLEIKIGKPAATNIYLIDFLKRCL-DKDPLRRWSCDQLL 218 (292)
Q Consensus 147 ~~~~~~~~~-------~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~p~~~~~~~~~~ 218 (292)
++....... ...+..|.+||...+.......++|++ +.-++..+. +..|+......++.
T Consensus 189 ~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~sl-------------G~il~ellt~g~~p~~~~~~~~~~ 255 (327)
T 2yfx_A 189 MARDIYRASYYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSF-------------GVLLWEIFSLGYMPYPSKSNQEVL 255 (327)
T ss_dssp HHHHHHC------CCGGGSCGGGCCHHHHHHCCCCHHHHHHHH-------------HHHHHHHHTTSCCSSTTCCHHHHH
T ss_pred cccccccccccccCCCcCCCcceeCHhHhcCCCCCchhhHHHH-------------HHHHHHHHcCCCCCCCCcCHHHHH
Confidence 987654321 112234667766544433222222222 222222232 33444433333332
Q ss_pred hccCcC-CCCCCCCCccchHHHHhcccCcCCCCCCChhhhhhCCcccc
Q psy758 219 RHPYFN-GYYFEVPDEMQYEEITQRCLDKDPLRRWSCDQLLRHPYFNG 265 (292)
Q Consensus 219 ~~~~~~-~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~~il~h~w~~~ 265 (292)
...... ....+...+..+.+||.+||+.||.+|||+.+++++.|...
T Consensus 256 ~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~l~~~~ 303 (327)
T 2yfx_A 256 EFVTSGGRMDPPKNCPGPVYRIMTQCWQHQPEDRPNFAIILERIEYCT 303 (327)
T ss_dssp HHHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred HHHhcCCCCCCCCCCCHHHHHHHHHHhcCChhhCcCHHHHHHHHHHHh
Confidence 211111 11223445778999999999999999999999999988764
|
| >2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-39 Score=270.40 Aligned_cols=245 Identities=22% Similarity=0.325 Sum_probs=182.4
Q ss_pred cccceeeeecccCceEEEEEEEc-------CCCcEEEEEEeccCCCChHHHHHHHHHHHHHHhC-CCCCcchhhhhhhcC
Q psy758 2 ERYEKIGKLGEGSYGVVFKCRNR-------DTGQVVAIKKFLESEEDPLIRKIALREIRLLKSL-KHPNLVNLLEVFRRK 73 (292)
Q Consensus 2 ~~y~~~~~l~~g~~~~v~~~~~~-------~~~~~v~iK~~~~~~~~~~~~~~~~~e~~~~~~l-~~~~i~~~~~~~~~~ 73 (292)
++|++.+.||+|+||.||+|.+. .++..||+|++.... .....+.+.+|+.+++.+ +||||+++++++.+.
T Consensus 35 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~ 113 (334)
T 2pvf_A 35 DKLTLGKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDA-TEKDLSDLVSEMEMMKMIGKHKNIINLLGACTQD 113 (334)
T ss_dssp GGEEEEEEEEECSSCEEEEEEETTCSTTCC---CEEEEEECCTTC-CHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSS
T ss_pred hHeEEeeEEeecCceeEEEeEeccccccccccceEEEEeeeccCC-cHHHHHHHHHHHHHHHHhhcCCCEeeEEEEEccC
Confidence 68999999999999999999975 456789999987543 344567788999999999 899999999999999
Q ss_pred CeEEEEEecCCCccHHHHhcCCC----------------CCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEEccC
Q psy758 74 KKLHLVFEFCDHTVLNELENHPH----------------GLPWDLIKQITWQVLRGVSYCHRHACIHRDIKPENILLTAN 137 (292)
Q Consensus 74 ~~~~iv~e~~~~~~L~~~~~~~~----------------~~~~~~~~~i~~qi~~aL~~LH~~givH~dl~p~Nilv~~~ 137 (292)
+..++||||+.+++|.+++.... .+++..++.++.||+.||.|||++|++|+||||+||+++.+
T Consensus 114 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~ 193 (334)
T 2pvf_A 114 GPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQKCIHRDLAARNVLVTEN 193 (334)
T ss_dssp SCCEEEEECCTTCBHHHHHHTTSCTTCCSCC--------CCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTT
T ss_pred CceEEEEECCCCCcHHHHHHHhccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCccceEEEcCC
Confidence 99999999999999999987643 38999999999999999999999999999999999999999
Q ss_pred CcEEEeecCchhhhhcccc-------ccccccccccccccCCCCCCCcccceeeecCCCCCCchHHHHHHHhhc-ccCCC
Q psy758 138 GVVKLCDFGFARLIRDLIP-------RHLHIFQTNEYFKGVSLPHAENVVPLEIKIGKPAATNIYLIDFLKRCL-DKDPL 209 (292)
Q Consensus 138 ~~~kl~dfg~~~~~~~~~~-------~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~p~ 209 (292)
+.++|+|||++........ ..+..|.+||...+.......++|+ .+..++..+. +..|.
T Consensus 194 ~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~s-------------lG~il~ellt~g~~p~ 260 (334)
T 2pvf_A 194 NVMKIADFGLARDINNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWS-------------FGVLMWEIFTLGGSPY 260 (334)
T ss_dssp CCEEECCCTTCEECTTTSSEECCSCCCCCGGGCCHHHHHHCEECHHHHHHH-------------HHHHHHHHHTTSCCSS
T ss_pred CCEEEccccccccccccccccccCCCCcccceeChHHhcCCCcChHHHHHH-------------HHHHHHHHHhCCCCCc
Confidence 9999999999876543211 1123366666554433222222222 2222333333 44444
Q ss_pred CCCChhhhhhccCcC-CCCCCCCCccchHHHHhcccCcCCCCCCChhhhhhC
Q psy758 210 RRWSCDQLLRHPYFN-GYYFEVPDEMQYEEITQRCLDKDPLRRWSCDQLLRH 260 (292)
Q Consensus 210 ~~~~~~~~~~~~~~~-~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~~il~h 260 (292)
...+..++....... ....+...+..+.++|.+||+.||.+|||+.+++++
T Consensus 261 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~ 312 (334)
T 2pvf_A 261 PGIPVEELFKLLKEGHRMDKPANCTNELYMMMRDCWHAVPSQRPTFKQLVED 312 (334)
T ss_dssp TTCCHHHHHHHHHHTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred CcCCHHHHHHHHhcCCCCCCCccCCHHHHHHHHHHccCChhhCcCHHHHHHH
Confidence 444433332211000 112234457789999999999999999999999984
|
| >2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.1e-39 Score=264.39 Aligned_cols=245 Identities=22% Similarity=0.335 Sum_probs=176.0
Q ss_pred CcccceeeeecccCceEEEEEEEcCCCcEEEEEEeccCC-CChHHHHHHHHHHHHHHhCCCCCcchhhhhhhcCCeEEEE
Q psy758 1 MERYEKIGKLGEGSYGVVFKCRNRDTGQVVAIKKFLESE-EDPLIRKIALREIRLLKSLKHPNLVNLLEVFRRKKKLHLV 79 (292)
Q Consensus 1 ~~~y~~~~~l~~g~~~~v~~~~~~~~~~~v~iK~~~~~~-~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~iv 79 (292)
+++|++.+.||+|++|.||+|.+..+++.||+|++.... ........+.+|+.+++.++||||+++++++.+.+..++|
T Consensus 31 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv 110 (310)
T 2wqm_A 31 LANFRIEKKIGRGQFSEVYRAACLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPNVIKYYASFIEDNELNIV 110 (310)
T ss_dssp GGGEEEEEEEECC--CEEEEEEETTTCCEEEEEEECTTSSCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEE
T ss_pred ccceEEEEeecCCCCceEEEEEEcCCCceEEEEeeehhhccCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCcEEEE
Confidence 468999999999999999999999999999999997643 4455677889999999999999999999999999999999
Q ss_pred EecCCCccHHHHhcC----CCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEEccCCcEEEeecCchhhhhccc
Q psy758 80 FEFCDHTVLNELENH----PHGLPWDLIKQITWQVLRGVSYCHRHACIHRDIKPENILLTANGVVKLCDFGFARLIRDLI 155 (292)
Q Consensus 80 ~e~~~~~~L~~~~~~----~~~~~~~~~~~i~~qi~~aL~~LH~~givH~dl~p~Nilv~~~~~~kl~dfg~~~~~~~~~ 155 (292)
|||+.+++|.+++.. ...+++..++.++.||+.||.|||++|++|+||+|+||+++.++.++|+|||++.......
T Consensus 111 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dl~p~NIl~~~~~~~kl~Dfg~~~~~~~~~ 190 (310)
T 2wqm_A 111 LELADAGDLSRMIKHFKKQKRLIPERTVWKYFVQLCSALEHMHSRRVMHRDIKPANVFITATGVVKLGDLGLGRFFSSKT 190 (310)
T ss_dssp EECCCSCBHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTSCEEECCC----------
T ss_pred EecCCCCCHHHHHHHhcccccCCCHHHHHHHHHHHHHHHHHHhhCCeeCCCCcHHHEEEcCCCCEEEEeccceeeecCCC
Confidence 999999999988753 4569999999999999999999999999999999999999999999999999987654322
Q ss_pred c-----ccccccccccccccCCCCCCCcccceeeecCCCCCCchHHHHHHHhhcccCCCCCC--Chhhhhh---ccCcCC
Q psy758 156 P-----RHLHIFQTNEYFKGVSLPHAENVVPLEIKIGKPAATNIYLIDFLKRCLDKDPLRRW--SCDQLLR---HPYFNG 225 (292)
Q Consensus 156 ~-----~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~--~~~~~~~---~~~~~~ 225 (292)
. ..+..|.+||...+.......++|++ +.-++..+.+..|.... ...++.. ...+..
T Consensus 191 ~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~sl-------------G~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~ 257 (310)
T 2wqm_A 191 TAAHSLVGTPYYMSPERIHENGYNFKSDIWSL-------------GCLLYEMAALQSPFYGDKMNLYSLCKKIEQCDYPP 257 (310)
T ss_dssp --------CCSSCCHHHHTTCCCCHHHHHHHH-------------HHHHHHHHHSSCTTC---CCHHHHHHHHHTTCSCC
T ss_pred ccccccCCCeeEeChHHhCCCCCCchhhHHHH-------------HHHHHHHHhCCCCCcccchhHHHHHHHhhcccCCC
Confidence 1 23344666666554433222222222 22222333333332211 1111111 110000
Q ss_pred CCCCCCCccchHHHHhcccCcCCCCCCChhhhhh
Q psy758 226 YYFEVPDEMQYEEITQRCLDKDPLRRWSCDQLLR 259 (292)
Q Consensus 226 ~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~~il~ 259 (292)
......+..+.+||.+||+.||.+|||+.++++
T Consensus 258 -~~~~~~~~~l~~li~~~l~~dp~~Rps~~~il~ 290 (310)
T 2wqm_A 258 -LPSDHYSEELRQLVNMCINPDPEKRPDVTYVYD 290 (310)
T ss_dssp -CCTTTSCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred -CcccccCHHHHHHHHHHcCCChhhCCCHHHHHH
Confidence 111345778999999999999999999999998
|
| >2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.2e-39 Score=264.14 Aligned_cols=252 Identities=22% Similarity=0.258 Sum_probs=183.5
Q ss_pred cccceeeeecccCceEEEEEEEcCCCcEEEEEEeccCCCChHHHHHHHHHHHHHHhCCCCCcchhhhhhh----cCCeEE
Q psy758 2 ERYEKIGKLGEGSYGVVFKCRNRDTGQVVAIKKFLESEEDPLIRKIALREIRLLKSLKHPNLVNLLEVFR----RKKKLH 77 (292)
Q Consensus 2 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~----~~~~~~ 77 (292)
++|++.+.||+|++|.||+|.+..+++.||+|++... .....+.+.+|+.+++.++||||+++++++. .....+
T Consensus 29 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~ 106 (317)
T 2buj_A 29 KHYLFIQKLGEGGFSYVDLVEGLHDGHFYALKRILCH--EQQDREEAQREADMHRLFNHPNILRLVAYCLRERGAKHEAW 106 (317)
T ss_dssp EEEEEEEEEEC--CEEEEEEEETTTCCEEEEEEEEES--SHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEEEETTEEEEE
T ss_pred eEEEEEEEecCCCCeEEEEEEecCCCcEEEEEEEecC--CHHHHHHHHHHHHHHhhcCCCCeeeEEEEEEeccCCCceeE
Confidence 5799999999999999999999999999999998653 3445677889999999999999999999986 345789
Q ss_pred EEEecCCCccHHHHhcC----CCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEEccCCcEEEeecCchhhhhc
Q psy758 78 LVFEFCDHTVLNELENH----PHGLPWDLIKQITWQVLRGVSYCHRHACIHRDIKPENILLTANGVVKLCDFGFARLIRD 153 (292)
Q Consensus 78 iv~e~~~~~~L~~~~~~----~~~~~~~~~~~i~~qi~~aL~~LH~~givH~dl~p~Nilv~~~~~~kl~dfg~~~~~~~ 153 (292)
+|+||+.+++|.+++.. ...+++..++.++.||+.||.|||++|++|+||+|+||+++.++.++|+|||++.....
T Consensus 107 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivH~dlkp~NIl~~~~~~~kl~dfg~~~~~~~ 186 (317)
T 2buj_A 107 LLLPFFKRGTLWNEIERLKDKGNFLTEDQILWLLLGICRGLEAIHAKGYAHRDLKPTNILLGDEGQPVLMDLGSMNQACI 186 (317)
T ss_dssp EEEECCTTCBHHHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTSCEEECCCSSCEESCE
T ss_pred EEEEeCCCCcHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEEcCCCCEEEEecCcchhccc
Confidence 99999999999888764 46799999999999999999999999999999999999999999999999998765432
Q ss_pred cc--------------cccccccccccccccCC--------CCCCCcccceeeecCCCCCCchHHHHHHHhhcccCCCCC
Q psy758 154 LI--------------PRHLHIFQTNEYFKGVS--------LPHAENVVPLEIKIGKPAATNIYLIDFLKRCLDKDPLRR 211 (292)
Q Consensus 154 ~~--------------~~~~~~~~~~~~~~~~~--------~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~p~~~ 211 (292)
.. ...+..|.+||...+.. ..|+.|+..+++.++..++..... ..
T Consensus 187 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~-------------~~ 253 (317)
T 2buj_A 187 HVEGSRQALTLQDWAAQRCTISYRAPELFSVQSHCVIDERTDVWSLGCVLYAMMFGEGPYDMVFQ-------------KG 253 (317)
T ss_dssp EEESHHHHHHHHHHHHHHSCGGGCCGGGSSCCSEEEECTHHHHHHHHHHHHHHHHSSCTTHHHHH-------------TT
T ss_pred ccccccccccccccccccCCcccCCHhHhccCCCcCCCchhhHHHHHHHHHHHHhCCCChhhhhc-------------cc
Confidence 11 11244577777654322 223344444444444433211000 00
Q ss_pred CChhhhhhccCcCCCCCCCCCccchHHHHhcccCcCCCCCCChhhhhhCCcccceeccCCC
Q psy758 212 WSCDQLLRHPYFNGYYFEVPDEMQYEEITQRCLDKDPLRRWSCDQLLRHPYFNGYYFEVPD 272 (292)
Q Consensus 212 ~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~~il~h~w~~~~~~~~~~ 272 (292)
........... ........+..+.+||.+||+.||.+|||+.+++++ |..+....|.
T Consensus 254 ~~~~~~~~~~~--~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~--L~~~~~~~~~ 310 (317)
T 2buj_A 254 DSVALAVQNQL--SIPQSPRHSSALWQLLNSMMTVDPHQRPHIPLLLSQ--LEALQPPAPG 310 (317)
T ss_dssp SCHHHHHHCC----CCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHH--HHHTCCCCCC
T ss_pred chhhHHhhccC--CCCccccCCHHHHHHHHHHhhcChhhCCCHHHHHHH--hhhcCCCCCC
Confidence 11111111111 112223457789999999999999999999999995 4554433333
|
| >3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 4hvd_A* 4hvg_A* 4hvh_A* 4hvi_A* 3pjc_A* 1yvj_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7e-40 Score=270.90 Aligned_cols=254 Identities=23% Similarity=0.275 Sum_probs=187.2
Q ss_pred cccceeeeecccCceEEEEEE----EcCCCcEEEEEEeccCCCChHHHHHHHHHHHHHHhCCCCCcchhhhhhh--cCCe
Q psy758 2 ERYEKIGKLGEGSYGVVFKCR----NRDTGQVVAIKKFLESEEDPLIRKIALREIRLLKSLKHPNLVNLLEVFR--RKKK 75 (292)
Q Consensus 2 ~~y~~~~~l~~g~~~~v~~~~----~~~~~~~v~iK~~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~--~~~~ 75 (292)
++|++.+.||+|+||.||+|. +..+++.||+|++... .....+.+.+|+.+++.++||||+++++++. +.+.
T Consensus 23 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~ 100 (327)
T 3lxl_A 23 RHLKYISQLGKGNFGSVELCRYDPLGDNTGALVAVKQLQHS--GPDQQRDFQREIQILKALHSDFIVKYRGVSYGPGRQS 100 (327)
T ss_dssp GGEEEEEEEEEETTEEEEEEEECTTSSSCSEEEEEEEESSC--CHHHHHHHHHHHHHHHTCCCTTBCCEEEEEECSSSCE
T ss_pred hhhhhhhhccCCCCeEEEEEEeccCCCCcceEEEEEEeccC--CHHHHHHHHHHHHHHHhcCCCceeEEEEEEecCCCce
Confidence 589999999999999999998 5678999999998654 3445677899999999999999999999875 5667
Q ss_pred EEEEEecCCCccHHHHhcC-CCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEEccCCcEEEeecCchhhhhcc
Q psy758 76 LHLVFEFCDHTVLNELENH-PHGLPWDLIKQITWQVLRGVSYCHRHACIHRDIKPENILLTANGVVKLCDFGFARLIRDL 154 (292)
Q Consensus 76 ~~iv~e~~~~~~L~~~~~~-~~~~~~~~~~~i~~qi~~aL~~LH~~givH~dl~p~Nilv~~~~~~kl~dfg~~~~~~~~ 154 (292)
.++||||+++++|.+++.. ...+++..++.++.||+.||+|||++|++|+||||+||+++.++.++|+|||++......
T Consensus 101 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dikp~NIl~~~~~~~kl~Dfg~~~~~~~~ 180 (327)
T 3lxl_A 101 LRLVMEYLPSGCLRDFLQRHRARLDASRLLLYSSQICKGMEYLGSRRCVHRDLAARNILVESEAHVKIADFGLAKLLPLD 180 (327)
T ss_dssp EEEEEECCTTCBHHHHHHHHGGGCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEEETTEEEECCGGGCEECCTT
T ss_pred EEEEEeecCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCCccCCCCChhhEEECCCCCEEEcccccceecccC
Confidence 9999999999999998865 346999999999999999999999999999999999999999999999999999765422
Q ss_pred c--------cccccccccccccccCCC-----CCCCcccceeeecCCCCCCchHHHHHHHhhcccCCCCCCChhhhhhcc
Q psy758 155 I--------PRHLHIFQTNEYFKGVSL-----PHAENVVPLEIKIGKPAATNIYLIDFLKRCLDKDPLRRWSCDQLLRHP 221 (292)
Q Consensus 155 ~--------~~~~~~~~~~~~~~~~~~-----~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~ 221 (292)
. ...+..|.+||...+... .|+.++..+++.++..++............... .......+....
T Consensus 181 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~ll~g~~p~~~~~~~~~~~~~~~~---~~~~~~~~~~~~ 257 (327)
T 3lxl_A 181 KDYYVVREPGQSPIFWYAPESLSDNIFSRQSDVWSFGVVLYELFTYCDKSCSPSAEFLRMMGCER---DVPALSRLLELL 257 (327)
T ss_dssp CSEEECSSCCCSCGGGSCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCGGGSHHHHHHHHCC-------CCHHHHHHHHH
T ss_pred CccceeeccCCccccccCHHHhccCCCChHHhHHHHHHHHHHHHhCCCCCccccchhhhhccccc---ccccHHHHHHHh
Confidence 1 112233677776654433 455666666666666554333221111110000 011111111100
Q ss_pred -CcCCCCCCCCCccchHHHHhcccCcCCCCCCChhhhhhC
Q psy758 222 -YFNGYYFEVPDEMQYEEITQRCLDKDPLRRWSCDQLLRH 260 (292)
Q Consensus 222 -~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~~il~h 260 (292)
.-.....+...+..+.+||.+||+.||.+|||+++++++
T Consensus 258 ~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~ 297 (327)
T 3lxl_A 258 EEGQRLPAPPACPAEVHELMKLCWAPSPQDRPSFSALGPQ 297 (327)
T ss_dssp HTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred hcccCCCCCCcccHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence 001112344557889999999999999999999999663
|
| >3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 4g5j_A* 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-39 Score=268.98 Aligned_cols=244 Identities=20% Similarity=0.262 Sum_probs=177.2
Q ss_pred cccceeeeecccCceEEEEEEEcCCCcEE----EEEEeccCCCChHHHHHHHHHHHHHHhCCCCCcchhhhhhhcCCeEE
Q psy758 2 ERYEKIGKLGEGSYGVVFKCRNRDTGQVV----AIKKFLESEEDPLIRKIALREIRLLKSLKHPNLVNLLEVFRRKKKLH 77 (292)
Q Consensus 2 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~v----~iK~~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~ 77 (292)
++|++.+.||+|+||.||+|.+..+++.+ ++|.+.... .....+.+.+|+.+++.++||||+++++++.+++ .+
T Consensus 15 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~-~~ 92 (327)
T 3poz_A 15 TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREAT-SPKANKEILDEAYVMASVDNPHVCRLLGICLTST-VQ 92 (327)
T ss_dssp GGEEEEEEEEEETTEEEEEEEECC----CCEEEEEEEC--------CHHHHHHHHHHHHHCCBTTBCCEEEEEESSS-EE
T ss_pred HHcccceEEeeCCCeEEEEEEEcCCCceEEEEEEEeeccccc-CHHHHHHHHHHHHHHHhCCCCCEeEEEEEEecCC-eE
Confidence 58999999999999999999998877754 777765332 2234567889999999999999999999988654 78
Q ss_pred EEEecCCCccHHHHhcC-CCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEEccCCcEEEeecCchhhhhcccc
Q psy758 78 LVFEFCDHTVLNELENH-PHGLPWDLIKQITWQVLRGVSYCHRHACIHRDIKPENILLTANGVVKLCDFGFARLIRDLIP 156 (292)
Q Consensus 78 iv~e~~~~~~L~~~~~~-~~~~~~~~~~~i~~qi~~aL~~LH~~givH~dl~p~Nilv~~~~~~kl~dfg~~~~~~~~~~ 156 (292)
++++++.+++|.+++.. ...+++..++.++.||+.||.|||++||+||||||+||+++.++.+||+|||+++.......
T Consensus 93 ~v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivH~Dikp~NIll~~~~~~kl~Dfg~a~~~~~~~~ 172 (327)
T 3poz_A 93 LITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEK 172 (327)
T ss_dssp EEEECCTTCBHHHHHHHSTTSCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEEETTEEEECCTTHHHHHTTTCC
T ss_pred EEEEecCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhhCCeeCCCCChheEEECCCCCEEEccCcceeEccCCcc
Confidence 89999999999988765 45799999999999999999999999999999999999999999999999999987643221
Q ss_pred -------ccccccccccccccCCCCCCCcccceeeecCCCCCCchHHHHHHHhhc-ccCCCCCCChhhhhhccCc-CCCC
Q psy758 157 -------RHLHIFQTNEYFKGVSLPHAENVVPLEIKIGKPAATNIYLIDFLKRCL-DKDPLRRWSCDQLLRHPYF-NGYY 227 (292)
Q Consensus 157 -------~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~p~~~~~~~~~~~~~~~-~~~~ 227 (292)
..+..|.+||...+.......++|++ +.-++..+. +..|+...+..++...... ....
T Consensus 173 ~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~sl-------------G~il~ellt~g~~p~~~~~~~~~~~~~~~~~~~~ 239 (327)
T 3poz_A 173 EYHAEGGKVPIKWMALESILHRIYTHQSDVWSY-------------GVTVWELMTFGSKPYDGIPASEISSILEKGERLP 239 (327)
T ss_dssp -------CCCGGGSCHHHHHHCCCCHHHHHHHH-------------HHHHHHHHTTSCCTTTTCCGGGHHHHHHTTCCCC
T ss_pred cccccCCCccccccChHHhccCCCCchhhhhhh-------------HHHHHHHHhcCCCCccCCCHHHHHHHHHcCCCCC
Confidence 11234667776655443323333322 222333343 4555544444333221111 1122
Q ss_pred CCCCCccchHHHHhcccCcCCCCCCChhhhhhC
Q psy758 228 FEVPDEMQYEEITQRCLDKDPLRRWSCDQLLRH 260 (292)
Q Consensus 228 ~~~~~~~~l~~li~~~l~~dP~~Rpt~~~il~h 260 (292)
.+...+..+.+++.+||+.||.+|||+.+++++
T Consensus 240 ~~~~~~~~~~~li~~~l~~~p~~Rps~~ell~~ 272 (327)
T 3poz_A 240 QPPICTIDVYMIMVKCWMIDADSRPKFRELIIE 272 (327)
T ss_dssp CCTTBCHHHHHHHHHHTCSCGGGSCCHHHHHHH
T ss_pred CCccCCHHHHHHHHHHcCCChhhCCCHHHHHHH
Confidence 334457789999999999999999999999986
|
| >1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=3.9e-39 Score=261.68 Aligned_cols=245 Identities=18% Similarity=0.225 Sum_probs=181.2
Q ss_pred cccceee-eecccCceEEEEEEEc--CCCcEEEEEEeccCCCChHHHHHHHHHHHHHHhCCCCCcchhhhhhhcCCeEEE
Q psy758 2 ERYEKIG-KLGEGSYGVVFKCRNR--DTGQVVAIKKFLESEEDPLIRKIALREIRLLKSLKHPNLVNLLEVFRRKKKLHL 78 (292)
Q Consensus 2 ~~y~~~~-~l~~g~~~~v~~~~~~--~~~~~v~iK~~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~i 78 (292)
++|.+.+ .||+|++|.||+|.+. .++..||+|++.... .....+.+.+|+.+++.++||||+++++++ ..+..++
T Consensus 9 ~~~~i~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~-~~~~~~l 86 (287)
T 1u59_A 9 DNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGT-EKADTEEMMREAQIMHQLDNPYIVRLIGVC-QAEALML 86 (287)
T ss_dssp GGEEEEEEEEECCTTEEEEEEEEC---CCEEEEEEEECSSC-CHHHHHHHHHHHHHHHHCCCTTBCCEEEEE-ESSSEEE
T ss_pred HHhhhhhccccccCceeEEEeEeccCCCcceEEEEecCCcc-chhHHHHHHHHHHHHHhCCCCCEeEEEEEe-cCCCcEE
Confidence 4677777 9999999999999864 457789999997653 345567788999999999999999999998 5567999
Q ss_pred EEecCCCccHHHHhcC-CCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEEccCCcEEEeecCchhhhhcccc-
Q psy758 79 VFEFCDHTVLNELENH-PHGLPWDLIKQITWQVLRGVSYCHRHACIHRDIKPENILLTANGVVKLCDFGFARLIRDLIP- 156 (292)
Q Consensus 79 v~e~~~~~~L~~~~~~-~~~~~~~~~~~i~~qi~~aL~~LH~~givH~dl~p~Nilv~~~~~~kl~dfg~~~~~~~~~~- 156 (292)
||||+++++|.+++.. ...+++..++.++.||+.||.|||++|++|+||+|+||+++.++.++|+|||++........
T Consensus 87 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nili~~~~~~kl~Dfg~~~~~~~~~~~ 166 (287)
T 1u59_A 87 VMEMAGGGPLHKFLVGKREEIPVSNVAELLHQVSMGMKYLEEKNFVHRDLAARNVLLVNRHYAKISDFGLSKALGADDSY 166 (287)
T ss_dssp EEECCTTEEHHHHHTTCTTTSCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEEETTEEEECCCTTCEECTTCSCE
T ss_pred EEEeCCCCCHHHHHHhCCccCCHHHHHHHHHHHHHHHHHHHHCCEeeCCCchheEEEcCCCCEEECcccceeeeccCcce
Confidence 9999999999998864 34699999999999999999999999999999999999999999999999999876542211
Q ss_pred -------ccccccccccccccCCCCCCCcccceeeecCCCCCCchHHHHHHHhhc-ccCCCCCCChhhhhhccCcC-CCC
Q psy758 157 -------RHLHIFQTNEYFKGVSLPHAENVVPLEIKIGKPAATNIYLIDFLKRCL-DKDPLRRWSCDQLLRHPYFN-GYY 227 (292)
Q Consensus 157 -------~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~p~~~~~~~~~~~~~~~~-~~~ 227 (292)
..+..|.+||...+.......++ ++.+.-++..+. +..|+......++....... ...
T Consensus 167 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di-------------~slG~il~ellt~g~~p~~~~~~~~~~~~i~~~~~~~ 233 (287)
T 1u59_A 167 YTARSAGKWPLKWYAPECINFRKFSSRSDV-------------WSYGVTMWEALSYGQKPYKKMKGPEVMAFIEQGKRME 233 (287)
T ss_dssp ECCCCSSCCCGGGCCHHHHHHCEECHHHHH-------------HHHHHHHHHHHTTSCCTTTTCCTHHHHHHHHTTCCCC
T ss_pred eeccccccccccccCHHHhccCCCCchhhH-------------HHHHHHHHHHHcCCCCCcccCCHHHHHHHHhcCCcCC
Confidence 11234566665543322222222 222222333333 44454444433333211110 112
Q ss_pred CCCCCccchHHHHhcccCcCCCCCCChhhhhhCC
Q psy758 228 FEVPDEMQYEEITQRCLDKDPLRRWSCDQLLRHP 261 (292)
Q Consensus 228 ~~~~~~~~l~~li~~~l~~dP~~Rpt~~~il~h~ 261 (292)
.+...+..+.++|.+||+.||.+|||+.+++++.
T Consensus 234 ~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~l 267 (287)
T 1u59_A 234 CPPECPPELYALMSDCWIYKWEDRPDFLTVEQRM 267 (287)
T ss_dssp CCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHH
T ss_pred CCCCcCHHHHHHHHHHcCCChhhCcCHHHHHHHH
Confidence 3345678999999999999999999999999863
|
| >4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.8e-39 Score=259.60 Aligned_cols=241 Identities=19% Similarity=0.323 Sum_probs=177.9
Q ss_pred cccceeeeecccCceEEEEEEEcCCCcEEEEEEeccCCCChHH--H---HHHHHHHHHHHhCCCCCcchhhhhhhcCCeE
Q psy758 2 ERYEKIGKLGEGSYGVVFKCRNRDTGQVVAIKKFLESEEDPLI--R---KIALREIRLLKSLKHPNLVNLLEVFRRKKKL 76 (292)
Q Consensus 2 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~v~iK~~~~~~~~~~~--~---~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~ 76 (292)
++|++.+.||+|+||.||+|.+..+++.||+|++......... . +.+.+|+.+++.++||||+++++++.+..
T Consensus 19 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~-- 96 (287)
T 4f0f_A 19 NEIEYEKQIGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKFQEFQREVFIMSNLNHPNIVKLYGLMHNPP-- 96 (287)
T ss_dssp TTEEEEEECCCCSSSCEEEEEETTTCCEEEEEECCCCTTTCCHHHHCCSHHHHHHHHHHTTCCCTTBCCEEEEETTTT--
T ss_pred ccceehhccccCCceeEEEEEEcCCceEEEEEEeeccccccchhHHHHHHHHHHHHHHHHhCCCCCchhhheeecCCC--
Confidence 6899999999999999999999999999999998655432211 1 67889999999999999999999987665
Q ss_pred EEEEecCCCccHHHHhc-CCCCCCHHHHHHHHHHHHHHHHHHHhCC--ccccCCCCCceEEccCCc-----EEEeecCch
Q psy758 77 HLVFEFCDHTVLNELEN-HPHGLPWDLIKQITWQVLRGVSYCHRHA--CIHRDIKPENILLTANGV-----VKLCDFGFA 148 (292)
Q Consensus 77 ~iv~e~~~~~~L~~~~~-~~~~~~~~~~~~i~~qi~~aL~~LH~~g--ivH~dl~p~Nilv~~~~~-----~kl~dfg~~ 148 (292)
++||||+++++|.+.+. ....+++..++.++.|++.||+|||++| ++|+||||+||+++.++. ++|+|||++
T Consensus 97 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~~ivH~dikp~Nil~~~~~~~~~~~~kl~Dfg~~ 176 (287)
T 4f0f_A 97 RMVMEFVPCGDLYHRLLDKAHPIKWSVKLRLMLDIALGIEYMQNQNPPIVHRDLRSPNIFLQSLDENAPVCAKVADFGLS 176 (287)
T ss_dssp EEEEECCTTCBHHHHHHCTTSCCCHHHHHHHHHHHHHHHHHHHTSSSCCBCSCCSGGGEEESCCCTTCSCCEEECCCTTC
T ss_pred eEEEEecCCCCHHHHHhcccCCccHHHHHHHHHHHHHHHHHHHhCCCCeecCCCCcceEEEeccCCCCceeEEeCCCCcc
Confidence 69999999999977664 4457999999999999999999999999 999999999999988776 999999998
Q ss_pred hhhhccc--cccccccccccccccCC--CCCCCcccceeeecCCCCCCchHHHHHHHhhcccCCCCCCChhhh------h
Q psy758 149 RLIRDLI--PRHLHIFQTNEYFKGVS--LPHAENVVPLEIKIGKPAATNIYLIDFLKRCLDKDPLRRWSCDQL------L 218 (292)
Q Consensus 149 ~~~~~~~--~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~------~ 218 (292)
....... ...+..|.+||...+.. .....++ ++.+..++..+.+..|+...+..+. .
T Consensus 177 ~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~Di-------------~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~ 243 (287)
T 4f0f_A 177 QQSVHSVSGLLGNFQWMAPETIGAEEESYTEKADT-------------YSFAMILYTILTGEGPFDEYSYGKIKFINMIR 243 (287)
T ss_dssp BCCSSCEECCCCCCTTSCGGGSSCSSCEECHHHHH-------------HHHHHHHHHHHHSSCTTTTCCCCHHHHHHHHH
T ss_pred ccccccccccCCCccccCchhhccCCCCcCchhhH-------------HHHHHHHHHHHcCCCCCccccccHHHHHHHHh
Confidence 7543321 22334455666542211 1111111 2233333444444445443332221 1
Q ss_pred hccCcCCCCCCCCCccchHHHHhcccCcCCCCCCChhhhhh
Q psy758 219 RHPYFNGYYFEVPDEMQYEEITQRCLDKDPLRRWSCDQLLR 259 (292)
Q Consensus 219 ~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~~il~ 259 (292)
.... ....+...+..+.+||.+||+.||.+|||++++++
T Consensus 244 ~~~~--~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~ 282 (287)
T 4f0f_A 244 EEGL--RPTIPEDCPPRLRNVIELCWSGDPKKRPHFSYIVK 282 (287)
T ss_dssp HSCC--CCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred ccCC--CCCCCcccCHHHHHHHHHHhcCChhhCcCHHHHHH
Confidence 1111 11233455788999999999999999999999987
|
| >2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-39 Score=268.24 Aligned_cols=245 Identities=23% Similarity=0.343 Sum_probs=181.9
Q ss_pred cccceeeeecccCceEEEEEEE-----cCCCcEEEEEEeccCCCChHHHHHHHHHHHHHHhC-CCCCcchhhhhhhcC-C
Q psy758 2 ERYEKIGKLGEGSYGVVFKCRN-----RDTGQVVAIKKFLESEEDPLIRKIALREIRLLKSL-KHPNLVNLLEVFRRK-K 74 (292)
Q Consensus 2 ~~y~~~~~l~~g~~~~v~~~~~-----~~~~~~v~iK~~~~~~~~~~~~~~~~~e~~~~~~l-~~~~i~~~~~~~~~~-~ 74 (292)
++|++.+.||+|+||.||+|.+ ..+++.||+|++.... .....+.+.+|+.+++.+ +||||+++++++... +
T Consensus 27 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~ 105 (316)
T 2xir_A 27 DRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGA-THSEHRALMSELKILIHIGHHLNVVNLLGACTKPGG 105 (316)
T ss_dssp GGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTC-CHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECCTTS
T ss_pred hheeeeeEEcCCCceeEEEEEEecCCccccceEEEEEecccCC-CcHHHHHHHHHHHHHHhcccCCCeeeEEEEEecCCC
Confidence 6899999999999999999985 4567899999987554 334556788999999999 689999999998764 4
Q ss_pred eEEEEEecCCCccHHHHhcCCCC----------------CCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEEccCC
Q psy758 75 KLHLVFEFCDHTVLNELENHPHG----------------LPWDLIKQITWQVLRGVSYCHRHACIHRDIKPENILLTANG 138 (292)
Q Consensus 75 ~~~iv~e~~~~~~L~~~~~~~~~----------------~~~~~~~~i~~qi~~aL~~LH~~givH~dl~p~Nilv~~~~ 138 (292)
.+++|+||+++++|.+++..... +++..++.++.||+.||.|||++|++|+||||+||+++.++
T Consensus 106 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~i~H~dikp~Nil~~~~~ 185 (316)
T 2xir_A 106 PLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRKCIHRDLAARNILLSEKN 185 (316)
T ss_dssp CCEEEEECCTTEEHHHHHHTCTTSEECC-------CTTCEEHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECGGG
T ss_pred ceEEEEEcCCCCcHHHHHHhcccccccccccchhhhccccCHHHHHHHHHHHHHHHHHHHhCCcccccCccceEEECCCC
Confidence 59999999999999999976543 89999999999999999999999999999999999999999
Q ss_pred cEEEeecCchhhhhcccc-------ccccccccccccccCCCCCCCcccceeeecCCCCCCchHHHHHHHhhc-ccCCCC
Q psy758 139 VVKLCDFGFARLIRDLIP-------RHLHIFQTNEYFKGVSLPHAENVVPLEIKIGKPAATNIYLIDFLKRCL-DKDPLR 210 (292)
Q Consensus 139 ~~kl~dfg~~~~~~~~~~-------~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~p~~ 210 (292)
.++|+|||++........ ..+..|.+||...+.......++|++ +..++..+. +..|+.
T Consensus 186 ~~kl~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~sl-------------G~il~~l~t~g~~p~~ 252 (316)
T 2xir_A 186 VVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSF-------------GVLLWEIFSLGASPYP 252 (316)
T ss_dssp CEEECCCGGGSCTTTCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHH-------------HHHHHHHHTTSCCSST
T ss_pred CEEECCCccccccccCccceeccCCCcceeecCchhhccccccchhHHHHH-------------HHHHHHHHhCCCCCCc
Confidence 999999999976543211 11234667776654443322333222 222233332 444443
Q ss_pred CCChhhhhhccCcC--CCCCCCCCccchHHHHhcccCcCCCCCCChhhhhhC
Q psy758 211 RWSCDQLLRHPYFN--GYYFEVPDEMQYEEITQRCLDKDPLRRWSCDQLLRH 260 (292)
Q Consensus 211 ~~~~~~~~~~~~~~--~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~~il~h 260 (292)
.....+.+...... ....+...+..+.++|.+||+.||.+|||+.++++|
T Consensus 253 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~ 304 (316)
T 2xir_A 253 GVKIDEEFCRRLKEGTRMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEH 304 (316)
T ss_dssp TCCCSHHHHHHHHHTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred ccchhHHHHHHhccCccCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence 33322211111111 112234457789999999999999999999999986
|
| >3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9e-40 Score=269.94 Aligned_cols=244 Identities=19% Similarity=0.216 Sum_probs=179.8
Q ss_pred cccceeeeecccCceEEEEEEEcCCCcE----EEEEEeccCCCChHHHHHHHHHHHHHHhCCCCCcchhhhhhhcCCeEE
Q psy758 2 ERYEKIGKLGEGSYGVVFKCRNRDTGQV----VAIKKFLESEEDPLIRKIALREIRLLKSLKHPNLVNLLEVFRRKKKLH 77 (292)
Q Consensus 2 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~----v~iK~~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~ 77 (292)
++|++.+.||+|+||.||+|.+..+++. |++|.+...... .....+.+|+.+++.++||||+++++++. ++..+
T Consensus 13 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~kv~~K~~~~~~~~-~~~~~~~~e~~~l~~l~h~~iv~~~~~~~-~~~~~ 90 (325)
T 3kex_A 13 TELRKLKVLGSGVFGTVHKGVWIPEGESIKIPVCIKVIEDKSGR-QSFQAVTDHMLAIGSLDHAHIVRLLGLCP-GSSLQ 90 (325)
T ss_dssp TTEEEEEEEECCSSCEEEEEEECCTTCSCCEEEEEEEECCTTSC-SCBCSCCHHHHHHHTCCCTTBCCEEEEEC-BSSEE
T ss_pred hHceeeeeeeecCCceEEEEEEcCCCceEEEEEEEEeccccccH-HHHHHHHHHHHHHhcCCCCCcCeEEEEEc-CCccE
Confidence 6899999999999999999999888776 777776433211 12345668999999999999999999886 45689
Q ss_pred EEEecCCCccHHHHhcCC-CCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEEccCCcEEEeecCchhhhhcccc
Q psy758 78 LVFEFCDHTVLNELENHP-HGLPWDLIKQITWQVLRGVSYCHRHACIHRDIKPENILLTANGVVKLCDFGFARLIRDLIP 156 (292)
Q Consensus 78 iv~e~~~~~~L~~~~~~~-~~~~~~~~~~i~~qi~~aL~~LH~~givH~dl~p~Nilv~~~~~~kl~dfg~~~~~~~~~~ 156 (292)
+|+||+.+++|.+++... +.+++..++.++.||+.||.|||++||+||||||+||+++.++.++|+|||++........
T Consensus 91 ~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dikp~Nil~~~~~~~kl~Dfg~a~~~~~~~~ 170 (325)
T 3kex_A 91 LVTQYLPLGSLLDHVRQHRGALGPQLLLNWGVQIAKGMYYLEEHGMVHRNLAARNVLLKSPSQVQVADFGVADLLPPDDK 170 (325)
T ss_dssp EEEECCTTCBSHHHHHSSGGGSCTTHHHHHHHHHHHHHHHHHHTTCCCSCCSSTTEEESSSSCEEECSCSGGGGSCCCTT
T ss_pred EEEEeCCCCCHHHHHHHccccCCHHHHHHHHHHHHHHHHHHHhCCCCCCccchheEEECCCCeEEECCCCcccccCcccc
Confidence 999999999999988764 5799999999999999999999999999999999999999999999999999987643221
Q ss_pred -------ccccccccccccccCCCCCCCcccceeeecCCCCCCchHHHHHHHhhc-ccCCCCCCChhhhhhccCc-CCCC
Q psy758 157 -------RHLHIFQTNEYFKGVSLPHAENVVPLEIKIGKPAATNIYLIDFLKRCL-DKDPLRRWSCDQLLRHPYF-NGYY 227 (292)
Q Consensus 157 -------~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~p~~~~~~~~~~~~~~~-~~~~ 227 (292)
..+..|.+||...+.......++|+ .+..++..+. +..|+......++...... ....
T Consensus 171 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~s-------------lG~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~~~ 237 (325)
T 3kex_A 171 QLLYSEAKTPIKWMALESIHFGKYTHQSDVWS-------------YGVTVWELMTFGAEPYAGLRLAEVPDLLEKGERLA 237 (325)
T ss_dssp CCC-----CCTTTSCHHHHHHCCCCHHHHHHH-------------HHHHHHHHHTTSCCTTTTSCTTHHHHHHHTTCBCC
T ss_pred cccccCCCCcccccChHHhccCCCChhhHhHH-------------hHHHHHHHHhCCCCCccccCHHHHHHHHHcCCCCC
Confidence 1122456666554433322222222 2222333343 4555544443333221111 1122
Q ss_pred CCCCCccchHHHHhcccCcCCCCCCChhhhhhC
Q psy758 228 FEVPDEMQYEEITQRCLDKDPLRRWSCDQLLRH 260 (292)
Q Consensus 228 ~~~~~~~~l~~li~~~l~~dP~~Rpt~~~il~h 260 (292)
.+...+..+.++|.+||+.||.+|||+.+++++
T Consensus 238 ~~~~~~~~~~~li~~~l~~dp~~Rps~~el~~~ 270 (325)
T 3kex_A 238 QPQICTIDVYMVMVKCWMIDENIRPTFKELANE 270 (325)
T ss_dssp CCTTBCTTTTHHHHHHTCSCTTTSCCHHHHHHH
T ss_pred CCCcCcHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence 333457789999999999999999999999986
|
| >3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} SCOP: d.144.1.7 PDB: 4fk3_A* 3c4c_A* 3c4d_A* 3idp_A* 4g9r_A* 3ii5_A* 4e26_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 3d4q_A* 4e4x_A* 4g9c_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=4.1e-39 Score=261.79 Aligned_cols=241 Identities=20% Similarity=0.283 Sum_probs=171.4
Q ss_pred cccceeeeecccCceEEEEEEEcCCCcEEEEEEeccCCCChHHHHHHHHHHHHHHhCCCCCcchhhhhhhcCCeEEEEEe
Q psy758 2 ERYEKIGKLGEGSYGVVFKCRNRDTGQVVAIKKFLESEEDPLIRKIALREIRLLKSLKHPNLVNLLEVFRRKKKLHLVFE 81 (292)
Q Consensus 2 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~iv~e 81 (292)
++|++.+.||+|+||.||+|.+. ..||+|++..........+.+.+|+.+++.++||||++++++. ..+..++|||
T Consensus 24 ~~y~~~~~lG~G~~g~Vy~~~~~---~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~-~~~~~~lv~e 99 (289)
T 3og7_A 24 GQITVGQRIGSGSFGTVYKGKWH---GDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYS-TAPQLAIVTQ 99 (289)
T ss_dssp TSCEEEEEEEECSSEEEEEEESS---SEEEEEEESCSSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEE-CSSSCEEEEE
T ss_pred cceeeeeEecCCCCeEEEEEEEc---CceEEEEEeccCCCHHHHHHHHHHHHHHHhCCCCcEEEEEeec-cCCccEEEEE
Confidence 58999999999999999999864 3599999987777777788899999999999999999999954 5567899999
Q ss_pred cCCCccHHHHhcC-CCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEEccCCcEEEeecCchhhhhccc-----
Q psy758 82 FCDHTVLNELENH-PHGLPWDLIKQITWQVLRGVSYCHRHACIHRDIKPENILLTANGVVKLCDFGFARLIRDLI----- 155 (292)
Q Consensus 82 ~~~~~~L~~~~~~-~~~~~~~~~~~i~~qi~~aL~~LH~~givH~dl~p~Nilv~~~~~~kl~dfg~~~~~~~~~----- 155 (292)
|+.+++|.+++.. ...+++..++.++.||+.||.|||++|++|+||||+||+++.++.++|+|||++.......
T Consensus 100 ~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~L~~lH~~~i~H~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~ 179 (289)
T 3og7_A 100 WCEGSSLYHHLHASETKFEMKKLIDIARQTARGMDYLHAKSIIHRDLKSNNIFLHEDNTVKIGDFGLATEKSRWSGSHQF 179 (289)
T ss_dssp CCCEEEHHHHHTTC---CCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEETTTEEEECCCC--------------
T ss_pred ecCCCcHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhCCcccccCccceEEECCCCCEEEccceeccccccccccccc
Confidence 9999999998853 4569999999999999999999999999999999999999999999999999987554211
Q ss_pred --cccccccccccccc---cCCCCCCCcccceeeecCCCCCCchHHHHHHHhhcccCCCCCCChhhhhh----cc-CcCC
Q psy758 156 --PRHLHIFQTNEYFK---GVSLPHAENVVPLEIKIGKPAATNIYLIDFLKRCLDKDPLRRWSCDQLLR----HP-YFNG 225 (292)
Q Consensus 156 --~~~~~~~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~----~~-~~~~ 225 (292)
...+..|.+||... +.......++ ++.+..++..+.+..|+......+.+. .. ....
T Consensus 180 ~~~~gt~~y~aPE~~~~~~~~~~~~~~Di-------------~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~ 246 (289)
T 3og7_A 180 EQLSGSILWMAPEVIRMQDSNPYSFQSDV-------------YAFGIVLYELMTGQLPYSNINNRDQIIEMVGRGSLSPD 246 (289)
T ss_dssp ----CCCTTCCHHHHC----CCSCHHHHH-------------HHHHHHHHHHHHSSCTTSSCCCHHHHHHHHHHTSCCCC
T ss_pred cccCCCccccCchhhcccCCCCCCcccch-------------HHHHHHHHHHHHCCCCccccchHHHHHHHhcccccCcc
Confidence 12234466666543 1111111112 222222333333444443322211111 10 0000
Q ss_pred -CCCCCCCccchHHHHhcccCcCCCCCCChhhhhh
Q psy758 226 -YYFEVPDEMQYEEITQRCLDKDPLRRWSCDQLLR 259 (292)
Q Consensus 226 -~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~~il~ 259 (292)
.......+..+.+||.+||+.||.+|||++++++
T Consensus 247 ~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~ell~ 281 (289)
T 3og7_A 247 LSKVRSNCPKRMKRLMAECLKKKRDERPSFPRILA 281 (289)
T ss_dssp TTSSCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred hhhccccCCHHHHHHHHHHccCChhhCCCHHHHHH
Confidence 1122345778999999999999999999999987
|
| >2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-39 Score=268.88 Aligned_cols=244 Identities=21% Similarity=0.262 Sum_probs=181.0
Q ss_pred cccceeeeecccCceEEEEEEEcCCCc-----EEEEEEeccCCCChHHHHHHHHHHHHHHhC-CCCCcchhhhhhhcCCe
Q psy758 2 ERYEKIGKLGEGSYGVVFKCRNRDTGQ-----VVAIKKFLESEEDPLIRKIALREIRLLKSL-KHPNLVNLLEVFRRKKK 75 (292)
Q Consensus 2 ~~y~~~~~l~~g~~~~v~~~~~~~~~~-----~v~iK~~~~~~~~~~~~~~~~~e~~~~~~l-~~~~i~~~~~~~~~~~~ 75 (292)
++|++.+.||+|+||.||+|.+..+++ .||+|.+.... .....+.+.+|+.+++.+ +||||+++++++.+++.
T Consensus 46 ~~~~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~ 124 (333)
T 2i1m_A 46 NNLQFGKTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTA-HADEKEALMSELKIMSHLGQHENIVNLLGACTHGGP 124 (333)
T ss_dssp TSEEEEEEEEECSSEEEEEEEETTCSSSCCCCEEEEEEECTTC-CHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSS
T ss_pred HHceeeeEeccCCCcceEEEEecCCCcccchhHHHHHhccccc-ChHHHHHHHHHHHHHHhhcCCCCeeeEEEEEecCCc
Confidence 579999999999999999999877664 79999986554 334567788999999999 89999999999999999
Q ss_pred EEEEEecCCCccHHHHhcC--------------CCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEEccCCcEE
Q psy758 76 LHLVFEFCDHTVLNELENH--------------PHGLPWDLIKQITWQVLRGVSYCHRHACIHRDIKPENILLTANGVVK 141 (292)
Q Consensus 76 ~~iv~e~~~~~~L~~~~~~--------------~~~~~~~~~~~i~~qi~~aL~~LH~~givH~dl~p~Nilv~~~~~~k 141 (292)
.++||||+++++|.+++.. ...+++..++.++.||+.||.|||++|++|+||||+||+++.++.++
T Consensus 125 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dlkp~NIl~~~~~~~k 204 (333)
T 2i1m_A 125 VLVITEYCCYGDLLNFLRRKSRVLETDPAFAIANSTASTRDLLHFSSQVAQGMAFLASKNCIHRDVAARNVLLTNGHVAK 204 (333)
T ss_dssp CEEEEECCTTEEHHHHHHHHHHHHSCC-------CCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGCEEEGGGEEE
T ss_pred eEEEEecCCCCcHHHHHHHhcccccccccccccccccCHHHHHHHHHHHHHHHHHHhcCCcccCCcccceEEECCCCeEE
Confidence 9999999999999998753 23589999999999999999999999999999999999999999999
Q ss_pred EeecCchhhhhcccc-------ccccccccccccccCCCCCCCcccceeeecCCCCCCchHHHHHHHhhc-ccCCCCCCC
Q psy758 142 LCDFGFARLIRDLIP-------RHLHIFQTNEYFKGVSLPHAENVVPLEIKIGKPAATNIYLIDFLKRCL-DKDPLRRWS 213 (292)
Q Consensus 142 l~dfg~~~~~~~~~~-------~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~p~~~~~ 213 (292)
|+|||++........ ..+..|.+||...+.......|+|++ +.-++..+. +..|.....
T Consensus 205 l~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~sl-------------G~il~el~t~g~~p~~~~~ 271 (333)
T 2i1m_A 205 IGDFGLARDIMNDSNYIVKGNARLPVKWMAPESIFDCVYTVQSDVWSY-------------GILLWEIFSLGLNPYPGIL 271 (333)
T ss_dssp BCCCGGGCCGGGCTTSEECSSCEECGGGSCHHHHHHCCCCHHHHHHHH-------------HHHHHHHTTTSCCSSTTCC
T ss_pred ECccccccccccccceeecCCCCCCccccCHHHhccCCCChHHHHHHH-------------HHHHHHHHcCCCCCCcccc
Confidence 999999976543211 11234667766554433322222222 222222222 333433322
Q ss_pred hhhhhhccCcC--CCCCCCCCccchHHHHhcccCcCCCCCCChhhhhh
Q psy758 214 CDQLLRHPYFN--GYYFEVPDEMQYEEITQRCLDKDPLRRWSCDQLLR 259 (292)
Q Consensus 214 ~~~~~~~~~~~--~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~~il~ 259 (292)
........... ....+...+..+.+||.+||+.||.+|||+.++++
T Consensus 272 ~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~ 319 (333)
T 2i1m_A 272 VNSKFYKLVKDGYQMAQPAFAPKNIYSIMQACWALEPTHRPTFQQICS 319 (333)
T ss_dssp SSHHHHHHHHHTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred hhHHHHHHHhcCCCCCCCCCCCHHHHHHHHHHhccChhhCcCHHHHHH
Confidence 21111110000 11123344778999999999999999999999998
|
| >3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 4asx_A* 2qlu_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-39 Score=269.26 Aligned_cols=247 Identities=21% Similarity=0.250 Sum_probs=177.3
Q ss_pred cccceeeeecccCceEEEEEEEcCCCcEEEEEEeccCCCChHHHHHHHHHHHHHHhCCCCCcchhhhhhhcCC----eEE
Q psy758 2 ERYEKIGKLGEGSYGVVFKCRNRDTGQVVAIKKFLESEEDPLIRKIALREIRLLKSLKHPNLVNLLEVFRRKK----KLH 77 (292)
Q Consensus 2 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~----~~~ 77 (292)
++|++.+.||+|+||.||+|.+. ++.||+|++.... ........|+.+++.++||||+++++++.+.. .++
T Consensus 24 ~~y~~~~~lg~G~~g~Vy~~~~~--~~~vavK~~~~~~---~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~ 98 (322)
T 3soc_A 24 MPLQLLEVKARGRFGCVWKAQLL--NEYVAVKIFPIQD---KQSWQNEYEVYSLPGMKHENILQFIGAEKRGTSVDVDLW 98 (322)
T ss_dssp EEEEEEEEEECSTTCEEEEEEET--TEEEEEEEECGGG---HHHHHHHHHHHTSTTCCCTTBCCEEEEEEEECSSSEEEE
T ss_pred hhchhhheecccCceEEEEEEEC--CCEEEEEEeecCc---hHHHHHHHHHHHHhcCCCCCchhhcceeccCCCCCceEE
Confidence 68999999999999999999876 7899999986543 23344566999999999999999999988643 479
Q ss_pred EEEecCCCccHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhC----------CccccCCCCCceEEccCCcEEEeecCc
Q psy758 78 LVFEFCDHTVLNELENHPHGLPWDLIKQITWQVLRGVSYCHRH----------ACIHRDIKPENILLTANGVVKLCDFGF 147 (292)
Q Consensus 78 iv~e~~~~~~L~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~----------givH~dl~p~Nilv~~~~~~kl~dfg~ 147 (292)
+||||+++++|.+++... .+++..++.++.||+.||+|||+. ||+|+||||+||+++.++.+||+|||+
T Consensus 99 lv~e~~~~g~L~~~l~~~-~~~~~~~~~i~~qi~~al~~LH~~~~~l~~~~~~~ivH~Dlkp~Nill~~~~~~kL~DFg~ 177 (322)
T 3soc_A 99 LITAFHEKGSLSDFLKAN-VVSWNELCHIAETMARGLAYLHEDIPGLKDGHKPAISHRDIKSKNVLLKNNLTACIADFGL 177 (322)
T ss_dssp EEEECCTTCBHHHHHHHC-CBCHHHHHHHHHHHHHHHHHHTCCEEEETTEEECEEECSCCSGGGEEECTTCCEEECCCTT
T ss_pred EEEecCCCCCHHHHHHhc-CCCHHHHHHHHHHHHHHHHHHHhhccccccccCCCEEeCCCChHhEEECCCCeEEEccCCc
Confidence 999999999999999764 699999999999999999999999 999999999999999999999999999
Q ss_pred hhhhhccc-------cccccccccccccccCC----------CCCCCcccceeeecCCCCCCchHH---HHHHHhhcccC
Q psy758 148 ARLIRDLI-------PRHLHIFQTNEYFKGVS----------LPHAENVVPLEIKIGKPAATNIYL---IDFLKRCLDKD 207 (292)
Q Consensus 148 ~~~~~~~~-------~~~~~~~~~~~~~~~~~----------~~~~~~~~~~~~~~~~~~~~~~~~---~~~~~~~~~~~ 207 (292)
+....... ...+..|.+||...+.. ..|+.|+..+++.+|..++..... ..+... .
T Consensus 178 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~~~~~~-~--- 253 (322)
T 3soc_A 178 ALKFEAGKSAGDTHGQVGTRRYMAPEVLEGAINFQRDAFLRIDMYAMGLVLWELASRCTAADGPVDEYMLPFEEE-I--- 253 (322)
T ss_dssp CEEECTTSCCCCCTTCCCCGGGCCHHHHTTCCCCCHHHHHHHHHHHHHHHHHHHHTTBTTSSSCCCCCCCTTHHH-H---
T ss_pred ccccccccCccccccCccCccccCHhhcccccccCcCCCccchhHHHHHHHHHHHhCCCCCCCCcchhccchhhh-h---
Confidence 97654322 12345577777665421 345555555556555444321000 000000 0
Q ss_pred CCCCCChhhhhhccCcCCCCC-------CCCCccchHHHHhcccCcCCCCCCChhhhhh
Q psy758 208 PLRRWSCDQLLRHPYFNGYYF-------EVPDEMQYEEITQRCLDKDPLRRWSCDQLLR 259 (292)
Q Consensus 208 p~~~~~~~~~~~~~~~~~~~~-------~~~~~~~l~~li~~~l~~dP~~Rpt~~~il~ 259 (292)
...+...+............ ....+..+.+||.+||+.||++|||+.++++
T Consensus 254 -~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ell~ 311 (322)
T 3soc_A 254 -GQHPSLEDMQEVVVHKKKRPVLRDYWQKHAGMAMLCETIEECWDHDAEARLSAGCVGE 311 (322)
T ss_dssp -CSSCCHHHHHHHHTTSCCCCCCCGGGGSSHHHHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred -ccCCchhhhhhhhhcccCCCCccccccccchHHHHHHHHHHHccCChhhCcCHHHHHH
Confidence 00111111111111011100 1112345899999999999999999999987
|
| >2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-39 Score=268.06 Aligned_cols=245 Identities=23% Similarity=0.323 Sum_probs=179.0
Q ss_pred cccceeeeecccCceEEEEEEEcCCCcEEEEEEeccCCCChHHHHHHHHHHHHHHhCCCCCcchhhhhhhcCCeEEEEEe
Q psy758 2 ERYEKIGKLGEGSYGVVFKCRNRDTGQVVAIKKFLESEEDPLIRKIALREIRLLKSLKHPNLVNLLEVFRRKKKLHLVFE 81 (292)
Q Consensus 2 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~iv~e 81 (292)
++|++.+.||+|+||.||+|.+. +++.||+|.+...... ..+.+.+|+.+++.++||||+++++++.+.+..++|||
T Consensus 39 ~~y~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~--~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 115 (321)
T 2qkw_B 39 NNFDHKFLIGHGVFGKVYKGVLR-DGAKVALKRRTPESSQ--GIEEFETEIETLSFCRHPHLVSLIGFCDERNEMILIYK 115 (321)
T ss_dssp CCCSCCCCSCBCSSSEEEEEECT-TCCEEEEEECCSCCSS--HHHHHHHHHHGGGSCCCTTBCCEEEECCCTTCCEEEEE
T ss_pred hccCccceeecCCCeeEEEEEEC-CCCEEEEEEecccChH--HHHHHHHHHHHHHhCCCCCEeeEEEEEcCCCeEEEEEE
Confidence 68999999999999999999964 6899999988655433 35668899999999999999999999999999999999
Q ss_pred cCCCccHHHHhcCCC----CCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEEccCCcEEEeecCchhhhhccc--
Q psy758 82 FCDHTVLNELENHPH----GLPWDLIKQITWQVLRGVSYCHRHACIHRDIKPENILLTANGVVKLCDFGFARLIRDLI-- 155 (292)
Q Consensus 82 ~~~~~~L~~~~~~~~----~~~~~~~~~i~~qi~~aL~~LH~~givH~dl~p~Nilv~~~~~~kl~dfg~~~~~~~~~-- 155 (292)
|+++++|.+++.... .+++..++.++.||+.||.|||++|++||||||+||+++.++.++|+|||++.......
T Consensus 116 ~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~ 195 (321)
T 2qkw_B 116 YMENGNLKRHLYGSDLPTMSMSWEQRLEICIGAARGLHYLHTRAIIHRDVKSINILLDENFVPKITDFGISKKGTELDQT 195 (321)
T ss_dssp CCTTCBTGGGSSSSCCCSCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCSTTEEECTTCCEEECCCTTCEECSSSSCC
T ss_pred cCCCCcHHHHHhccCCCccccCHHHHHHHHHHHHHHHHHhcCCCeecCCCCHHHEEECCCCCEEEeeccccccccccccc
Confidence 999999999986543 48999999999999999999999999999999999999999999999999987543211
Q ss_pred -----cccccccccccccccCCCC-----CCCcccceeeecCCCCCCchHHHHHHHhhcccCCCCCCChhhh----hhcc
Q psy758 156 -----PRHLHIFQTNEYFKGVSLP-----HAENVVPLEIKIGKPAATNIYLIDFLKRCLDKDPLRRWSCDQL----LRHP 221 (292)
Q Consensus 156 -----~~~~~~~~~~~~~~~~~~~-----~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~----~~~~ 221 (292)
..++..|.+||...+.... |+.|+..+++.++..++... .+.......+. ....
T Consensus 196 ~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~ell~g~~p~~~~------------~~~~~~~~~~~~~~~~~~~ 263 (321)
T 2qkw_B 196 HLSTVVKGTLGYIDPEYFIKGRLTEKSDVYSFGVVLFEVLCARSAIVQS------------LPREMVNLAEWAVESHNNG 263 (321)
T ss_dssp CCBCCCEEETTTCCHHHHHHCBCCTHHHHHHHHHHHHHHHHCCTTCSCS------------SSSSCCCHHHHTHHHHTTT
T ss_pred ccccccCCCccccCHHHhcCCCCCcccchHhHHHHHHHHHhCCCccccc------------CcHHHHHHHHHhhhccccc
Confidence 1124456777765544333 33333333334443322110 00000000000 0000
Q ss_pred CcCCC-------CCCCCCccchHHHHhcccCcCCCCCCChhhhhhCC
Q psy758 222 YFNGY-------YFEVPDEMQYEEITQRCLDKDPLRRWSCDQLLRHP 261 (292)
Q Consensus 222 ~~~~~-------~~~~~~~~~l~~li~~~l~~dP~~Rpt~~~il~h~ 261 (292)
.+... ......+..+.+++.+||+.||++|||+.+++++.
T Consensus 264 ~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L 310 (321)
T 2qkw_B 264 QLEQIVDPNLADKIRPESLRKFGDTAVKCLALSSEDRPSMGDVLWKL 310 (321)
T ss_dssp CCCSSSSSSCTTCSCHHHHHHHHHHHHHHTCSSGGGSCCHHHHHHHH
T ss_pred cHHHhcChhhccccCHHHHHHHHHHHHHHcCCCcccCcCHHHHHHHH
Confidence 00000 01112256788999999999999999999999864
|
| >3uim_A Brassinosteroid insensitive 1-associated receptor; kinase, protein kinase, transferase; HET: SEP TPO ANP; 2.20A {Arabidopsis thaliana} PDB: 3ulz_A* 3tl8_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.5e-40 Score=271.47 Aligned_cols=258 Identities=24% Similarity=0.326 Sum_probs=184.3
Q ss_pred cccceeeeecccCceEEEEEEEcCCCcEEEEEEeccCCCChHHHHHHHHHHHHHHhCCCCCcchhhhhhhcCCeEEEEEe
Q psy758 2 ERYEKIGKLGEGSYGVVFKCRNRDTGQVVAIKKFLESEEDPLIRKIALREIRLLKSLKHPNLVNLLEVFRRKKKLHLVFE 81 (292)
Q Consensus 2 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~iv~e 81 (292)
++|++.+.||+|+||.||+|.+. +++.||+|++....... ....+.+|+.+++.++||||+++++++.+++..++|||
T Consensus 30 ~~y~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~-~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 107 (326)
T 3uim_A 30 DNFSNKNILGRGGFGKVYKGRLA-DGTLVAVKRLKEERTQG-GELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLLVYP 107 (326)
T ss_dssp TSSCSTTEEECCSSSEEEEECCS-SSCCEEEEECCC------CCCHHHHHHHGGGTCCCTTBCCCCEEECCSSCCEEEEE
T ss_pred hccccceeEecCCCcEEEEEEec-CCCEEEEEEeccccCch-HHHHHHHHHHHHHhccCCCccceEEEEecCCceEEEEE
Confidence 68999999999999999999854 58899999986543221 12257889999999999999999999999999999999
Q ss_pred cCCCccHHHHhcCCC----CCCHHHHHHHHHHHHHHHHHHHhC---CccccCCCCCceEEccCCcEEEeecCchhhhhcc
Q psy758 82 FCDHTVLNELENHPH----GLPWDLIKQITWQVLRGVSYCHRH---ACIHRDIKPENILLTANGVVKLCDFGFARLIRDL 154 (292)
Q Consensus 82 ~~~~~~L~~~~~~~~----~~~~~~~~~i~~qi~~aL~~LH~~---givH~dl~p~Nilv~~~~~~kl~dfg~~~~~~~~ 154 (292)
|+.+++|.+++.... .+++..++.++.|++.||.|||++ |++|+||||+||+++.++.++|+|||++......
T Consensus 108 ~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~ivH~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~ 187 (326)
T 3uim_A 108 YMANGSVASCLRERPESQPPLDWPKRQRIALGSARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYK 187 (326)
T ss_dssp CCTTCBHHHHHHCCSTTCCCCCHHHHHHHHHHHHHHHHHHHHSSSSCEECCCCSGGGEEECTTCCEEECCCSSCEECCSS
T ss_pred eccCCCHHHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCchhhEEECCCCCEEeccCccccccCcc
Confidence 999999999987543 389999999999999999999999 9999999999999999999999999999765422
Q ss_pred cc------ccccccccccccccCCC-----CCCCcccceeeecCCCCCCchH--------HHHHHHhhcccCCCCCCChh
Q psy758 155 IP------RHLHIFQTNEYFKGVSL-----PHAENVVPLEIKIGKPAATNIY--------LIDFLKRCLDKDPLRRWSCD 215 (292)
Q Consensus 155 ~~------~~~~~~~~~~~~~~~~~-----~~~~~~~~~~~~~~~~~~~~~~--------~~~~~~~~~~~~p~~~~~~~ 215 (292)
.. .++..|.+||...+... .|+.|+..+++.+|..++.... ....+...+..... .
T Consensus 188 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~-----~ 262 (326)
T 3uim_A 188 DTHVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWVKGLLKEKKL-----E 262 (326)
T ss_dssp SSCEECCCCSCGGGCCHHHHHHSEECHHHHHHHHHHHHHHHHHCCCSBCHHHHTTTSCSBHHHHHTTTTSSCCS-----T
T ss_pred cccccccccCCcCccCHHHhccCCCCccccchhHHHHHHHHHhCCCcccccccccccchhHHHHHHHHhhchhh-----h
Confidence 11 13445666666544332 3555555555566655542111 11111111111000 0
Q ss_pred hhhhccCcCCCCCCCCCccchHHHHhcccCcCCCCCCChhhhhhCCcccceec
Q psy758 216 QLLRHPYFNGYYFEVPDEMQYEEITQRCLDKDPLRRWSCDQLLRHPYFNGYYF 268 (292)
Q Consensus 216 ~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~~il~h~w~~~~~~ 268 (292)
....... ........+..+.+++.+||+.||.+|||+.++++|.+-.+...
T Consensus 263 ~~~~~~~--~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ell~~L~~~~~~~ 313 (326)
T 3uim_A 263 ALVDVDL--QGNYKDEEVEQLIQVALLCTQSSPMERPKMSEVVRMLEGDGLAE 313 (326)
T ss_dssp TSSCTTC--TTSCCHHHHHHHHHHHHHHTCSCGGGSCCHHHHHHHHHTSSCSS
T ss_pred hhcChhh--ccccCHHHHHHHHHHHHHHhCcCCccCCCHHHHHHHhcCcchhh
Confidence 0000000 00111122467899999999999999999999999866544433
|
| >2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-39 Score=262.81 Aligned_cols=236 Identities=25% Similarity=0.353 Sum_probs=181.1
Q ss_pred cccceeeeecccCceEEEEEEEcCCCcEEEEEEeccCCCChHHHHHHHHHHHHHHhCCCCCcchhhhhhhc---------
Q psy758 2 ERYEKIGKLGEGSYGVVFKCRNRDTGQVVAIKKFLESEEDPLIRKIALREIRLLKSLKHPNLVNLLEVFRR--------- 72 (292)
Q Consensus 2 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~--------- 72 (292)
++|++++.||+|++|.||+|.+..+++.||+|.+.... ..+.+|+.+++.++||||+++++++..
T Consensus 11 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~------~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~ 84 (284)
T 2a19_B 11 MDFKEIELIGSGGFGQVFKAKHRIDGKTYVIKRVKYNN------EKAEREVKALAKLDHVNIVHYNGCWDGFDYDPETSS 84 (284)
T ss_dssp HHEEEEEEEECSSSCCEEEEEETTTCCEEEEEEEECCS------GGGHHHHHHHHHCCCTTBCCEEEEEEEEEEC-----
T ss_pred cccceeeeeccCCceEEEEEEEcCCCeEEEEEEecccc------HHHHHHHHHHHhCCCCCEEEEeeeEeccccCccccc
Confidence 57999999999999999999999999999999987543 346689999999999999999998754
Q ss_pred -------CCeEEEEEecCCCccHHHHhcCC--CCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEEccCCcEEEe
Q psy758 73 -------KKKLHLVFEFCDHTVLNELENHP--HGLPWDLIKQITWQVLRGVSYCHRHACIHRDIKPENILLTANGVVKLC 143 (292)
Q Consensus 73 -------~~~~~iv~e~~~~~~L~~~~~~~--~~~~~~~~~~i~~qi~~aL~~LH~~givH~dl~p~Nilv~~~~~~kl~ 143 (292)
....++||||+++++|.+++... ..+++..++.++.||+.||.|||++|++|+||+|+||++++++.++|+
T Consensus 85 ~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~kl~ 164 (284)
T 2a19_B 85 KNSSRSKTKCLFIQMEFCDKGTLEQWIEKRRGEKLDKVLALELFEQITKGVDYIHSKKLINRDLKPSNIFLVDTKQVKIG 164 (284)
T ss_dssp ----CCEEEEEEEEECCCCSCBHHHHHHHGGGSCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEEETTEEEEC
T ss_pred ccccccCcceEEEEEeccCCCCHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCCHHHEEEcCCCCEEEC
Confidence 44589999999999999998542 579999999999999999999999999999999999999999999999
Q ss_pred ecCchhhhhccc----cccccccccccccccCCCCCCCcc-----cceeeecCCCCCCchHHHHHHHhhcccCCCCCCCh
Q psy758 144 DFGFARLIRDLI----PRHLHIFQTNEYFKGVSLPHAENV-----VPLEIKIGKPAATNIYLIDFLKRCLDKDPLRRWSC 214 (292)
Q Consensus 144 dfg~~~~~~~~~----~~~~~~~~~~~~~~~~~~~~~~~~-----~~~~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~ 214 (292)
|||++....... ...+..|.+||...+.......++ ..+++.++..+.. ........
T Consensus 165 Dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~~~~~~--~~~~~~~~------------ 230 (284)
T 2a19_B 165 DFGLVTSLKNDGKRTRSKGTLRYMSPEQISSQDYGKEVDLYALGLILAELLHVCDTAF--ETSKFFTD------------ 230 (284)
T ss_dssp CCTTCEESSCCSCCCCCCSCCTTSCHHHHHCSCCCTHHHHHHHHHHHHHHHSCCSSHH--HHHHHHHH------------
T ss_pred cchhheeccccccccccCCcccccChhhhccCCCcchhhhHHHHHHHHHHHhcCCcch--hHHHHHHH------------
Confidence 999987654321 223445677776655444333333 3333333333211 00011110
Q ss_pred hhhhhccCcCCCCCCCCCccchHHHHhcccCcCCCCCCChhhhhhCCcccc
Q psy758 215 DQLLRHPYFNGYYFEVPDEMQYEEITQRCLDKDPLRRWSCDQLLRHPYFNG 265 (292)
Q Consensus 215 ~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~~il~h~w~~~ 265 (292)
+.. ...+...+..+.++|.+||+.||.+|||+.++++++|.-.
T Consensus 231 ---~~~-----~~~~~~~~~~~~~li~~~l~~dp~~Rps~~e~l~~l~~~~ 273 (284)
T 2a19_B 231 ---LRD-----GIISDIFDKKEKTLLQKLLSKKPEDRPNTSEILRTLTVWK 273 (284)
T ss_dssp ---HHT-----TCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHT
T ss_pred ---hhc-----ccccccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHh
Confidence 011 1123345778999999999999999999999999987654
|
| >1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.7e-39 Score=280.06 Aligned_cols=247 Identities=21% Similarity=0.269 Sum_probs=186.1
Q ss_pred cccceeeeecccCceEEEEEEEcCCCcEEEEEEeccCCCChHHHHHHHHHHHHHHhCCCCCcchhhhhhhcCCeEEEEEe
Q psy758 2 ERYEKIGKLGEGSYGVVFKCRNRDTGQVVAIKKFLESEEDPLIRKIALREIRLLKSLKHPNLVNLLEVFRRKKKLHLVFE 81 (292)
Q Consensus 2 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~iv~e 81 (292)
++|++.+.||+|+||.||+|.+..++..||+|.+...... .+.+.+|+.+++.++||||+++++++.+.+..++|||
T Consensus 220 ~~~~~~~~lG~G~fg~Vy~~~~~~~~~~vavK~~~~~~~~---~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lv~E 296 (495)
T 1opk_A 220 TDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTME---VEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITE 296 (495)
T ss_dssp GGEEEEEESGGGTTSSEEEEEEGGGTEEEEEEECCSSSSC---HHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEEE
T ss_pred HHceeeeEecCCCCeEEEEEEEcCCCeEEEEEEecCcccc---hHHHHHHHHHHHhcCCCCEeeEEEEEecCCcEEEEEE
Confidence 4688999999999999999999998999999999765433 4568899999999999999999999999999999999
Q ss_pred cCCCccHHHHhcC--CCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEEccCCcEEEeecCchhhhhcccc---
Q psy758 82 FCDHTVLNELENH--PHGLPWDLIKQITWQVLRGVSYCHRHACIHRDIKPENILLTANGVVKLCDFGFARLIRDLIP--- 156 (292)
Q Consensus 82 ~~~~~~L~~~~~~--~~~~~~~~~~~i~~qi~~aL~~LH~~givH~dl~p~Nilv~~~~~~kl~dfg~~~~~~~~~~--- 156 (292)
|+.+++|.+++.. ...+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||++........
T Consensus 297 ~~~~g~L~~~l~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~~~~~~ 376 (495)
T 1opk_A 297 FMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKKNFIHRNLAARNCLVGENHLVKVADFGLSRLMTGDTYTAH 376 (495)
T ss_dssp CCTTCBHHHHHHHSCTTTSCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECGGGCEEECCTTCEECCTTCCEECC
T ss_pred ccCCCCHHHHHHhcCcCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCChhhEEECCCCcEEEeecccceeccCCceeec
Confidence 9999999999864 34589999999999999999999999999999999999999999999999999976543211
Q ss_pred ---ccccccccccccccCCCCCCCcccceeeecCCCCCCchHHHHHHHhhc-ccCCCCCCChhhhhhccCcC-CCCCCCC
Q psy758 157 ---RHLHIFQTNEYFKGVSLPHAENVVPLEIKIGKPAATNIYLIDFLKRCL-DKDPLRRWSCDQLLRHPYFN-GYYFEVP 231 (292)
Q Consensus 157 ---~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~p~~~~~~~~~~~~~~~~-~~~~~~~ 231 (292)
..+..|.+||...+.......++|+ .+.-+++.+. +..|.......++.....-. ....+..
T Consensus 377 ~~~~~~~~y~aPE~~~~~~~~~~sDvwS-------------lG~~l~el~t~g~~p~~~~~~~~~~~~~~~~~~~~~~~~ 443 (495)
T 1opk_A 377 AGAKFPIKWTAPESLAYNKFSIKSDVWA-------------FGVLLWEIATYGMSPYPGIDLSQVYELLEKDYRMERPEG 443 (495)
T ss_dssp TTCCCCGGGCCHHHHHHCEECHHHHHHH-------------HHHHHHHHHTTSCCSSTTCCGGGHHHHHHTTCCCCCCTT
T ss_pred CCCcCCcceeCHhHHhcCCCCcHHhHHh-------------HHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCCCCCCC
Confidence 1122356666554433222222222 2222333333 44444444433333211000 1122344
Q ss_pred CccchHHHHhcccCcCCCCCCChhhhhhCCcccce
Q psy758 232 DEMQYEEITQRCLDKDPLRRWSCDQLLRHPYFNGY 266 (292)
Q Consensus 232 ~~~~l~~li~~~l~~dP~~Rpt~~~il~h~w~~~~ 266 (292)
.+..+.+||.+||+.||.+|||+.+|++ .|+++
T Consensus 444 ~~~~l~~li~~cl~~dP~~RPs~~el~~--~L~~~ 476 (495)
T 1opk_A 444 CPEKVYELMRACWQWNPSDRPSFAEIHQ--AFETM 476 (495)
T ss_dssp CCHHHHHHHHHHTCSSGGGSCCHHHHHH--HHHTS
T ss_pred CCHHHHHHHHHHcCcChhHCcCHHHHHH--HHHHH
Confidence 5788999999999999999999999988 44443
|
| >3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.4e-39 Score=266.51 Aligned_cols=243 Identities=20% Similarity=0.266 Sum_probs=176.7
Q ss_pred cccceeeeecccCceEEEEEEEcCCCcEE----EEEEeccCCCChHHHHHHHHHHHHHHhCCCCCcchhhhhhhcCCeEE
Q psy758 2 ERYEKIGKLGEGSYGVVFKCRNRDTGQVV----AIKKFLESEEDPLIRKIALREIRLLKSLKHPNLVNLLEVFRRKKKLH 77 (292)
Q Consensus 2 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~v----~iK~~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~ 77 (292)
++|++.+.||+|+||.||+|.+..+++.+ ++|.+.... .....+.+.+|+.+++.++||||+++++++.++. .+
T Consensus 15 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~kv~iK~~~~~~-~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~-~~ 92 (327)
T 3lzb_A 15 TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREAT-SPKANKEILDEAYVMASVDNPHVCRLLGICLTST-VQ 92 (327)
T ss_dssp TTEEEEEEEEECSSEEEEEEEECCTTCSCCEEEEEEEECCCS-SCCCHHHHHHHHHHHTTCCBTTBCCCCEEEESSS-EE
T ss_pred hHceEEEEeeeCCCeEEEEEEEcCCCceEEEEEEEEeecccc-CHHHHHHHHHHHHHHHhCCCCCeeEEEEEEecCC-ce
Confidence 68999999999999999999998888765 666664332 2223566889999999999999999999987655 88
Q ss_pred EEEecCCCccHHHHhcC-CCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEEccCCcEEEeecCchhhhhcccc
Q psy758 78 LVFEFCDHTVLNELENH-PHGLPWDLIKQITWQVLRGVSYCHRHACIHRDIKPENILLTANGVVKLCDFGFARLIRDLIP 156 (292)
Q Consensus 78 iv~e~~~~~~L~~~~~~-~~~~~~~~~~~i~~qi~~aL~~LH~~givH~dl~p~Nilv~~~~~~kl~dfg~~~~~~~~~~ 156 (292)
++++++.+++|.+++.. ...+++..++.++.||+.||.|||++||+||||||+||+++.++.++|+|||++........
T Consensus 93 ~v~~~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dikp~NIl~~~~~~~kL~DfG~a~~~~~~~~ 172 (327)
T 3lzb_A 93 LITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEK 172 (327)
T ss_dssp EEECCCSSCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEEETTEEEECCTTC---------
T ss_pred EEEEecCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhhCCCcCCCCCHHHEEEcCCCCEEEccCcceeEccCccc
Confidence 99999999999988764 45699999999999999999999999999999999999999999999999999977543211
Q ss_pred -------ccccccccccccccCCCCCCCcccceeeecCCCCCCchHHHHHHHhhc-ccCCCCCCChhhhhhccCcC-CCC
Q psy758 157 -------RHLHIFQTNEYFKGVSLPHAENVVPLEIKIGKPAATNIYLIDFLKRCL-DKDPLRRWSCDQLLRHPYFN-GYY 227 (292)
Q Consensus 157 -------~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~p~~~~~~~~~~~~~~~~-~~~ 227 (292)
..+..|.+||...+.......++|++ +.-++..+. +..|+......++....... ...
T Consensus 173 ~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~sl-------------G~il~ell~~g~~p~~~~~~~~~~~~~~~~~~~~ 239 (327)
T 3lzb_A 173 EYHAEGGKVPIKWMALESILHRIYTHQSDVWSY-------------GVTVWELMTFGSKPYDGIPASEISSILEKGERLP 239 (327)
T ss_dssp -------CCCGGGSCHHHHHHCCCCHHHHHHHH-------------HHHHHHHHTTSCCTTTTCCGGGHHHHHHTTCCCC
T ss_pred cccccCCCccccccCHHHHcCCCCChHHHHHHH-------------HHHHHHHHHCCCCCCCCCCHHHHHHHHHcCCCCC
Confidence 11224666666554443322233222 222333343 45555444443333221111 122
Q ss_pred CCCCCccchHHHHhcccCcCCCCCCChhhhhh
Q psy758 228 FEVPDEMQYEEITQRCLDKDPLRRWSCDQLLR 259 (292)
Q Consensus 228 ~~~~~~~~l~~li~~~l~~dP~~Rpt~~~il~ 259 (292)
.+...+..+.+||.+||+.||.+|||+.++++
T Consensus 240 ~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~ 271 (327)
T 3lzb_A 240 QPPICTIDVYMIMRKCWMIDADSRPKFRELII 271 (327)
T ss_dssp CCTTBCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred CCccCCHHHHHHHHHHcCCChhHCcCHHHHHH
Confidence 33445778999999999999999999999998
|
| >1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A | Back alignment and structure |
|---|
Probab=100.00 E-value=4.4e-39 Score=276.68 Aligned_cols=239 Identities=20% Similarity=0.260 Sum_probs=180.3
Q ss_pred cccceeeeecccCceEEEEEEEcCCCcEEEEEEeccCCCChHHHHHHHHHHHHHHhCCCCCcchhhhhhhcC-CeEEEEE
Q psy758 2 ERYEKIGKLGEGSYGVVFKCRNRDTGQVVAIKKFLESEEDPLIRKIALREIRLLKSLKHPNLVNLLEVFRRK-KKLHLVF 80 (292)
Q Consensus 2 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~-~~~~iv~ 80 (292)
++|++.+.||+|+||.||+|... ++.||+|++..... .+.+.+|+.+++.++||||+++++++.+. +..++||
T Consensus 193 ~~~~~~~~lG~G~fg~V~~~~~~--~~~vavK~~~~~~~----~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~iv~ 266 (450)
T 1k9a_A 193 KELKLLQTIGKGEFGDVMLGDYR--GNKVAVKCIKNDAT----AQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVT 266 (450)
T ss_dssp GGEEEEEEEEECSSEEEEEEEET--TEEEEEEEESSCTT----SHHHHHHHHHHHTCCCTTBCCEEEEEECTTSCEEEEE
T ss_pred HHeEEEeeecCcCCeeEEEEEec--CCeEEEEEeCCchH----HHHHHHHHHHHHhccCCCEEEEEEEEEcCCCceEEEE
Confidence 67999999999999999999875 77999999976542 35678999999999999999999997654 4799999
Q ss_pred ecCCCccHHHHhcCCC--CCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEEccCCcEEEeecCchhhhhccc--c
Q psy758 81 EFCDHTVLNELENHPH--GLPWDLIKQITWQVLRGVSYCHRHACIHRDIKPENILLTANGVVKLCDFGFARLIRDLI--P 156 (292)
Q Consensus 81 e~~~~~~L~~~~~~~~--~~~~~~~~~i~~qi~~aL~~LH~~givH~dl~p~Nilv~~~~~~kl~dfg~~~~~~~~~--~ 156 (292)
||+++++|.+++...+ .+++..++.++.||+.||+|||++|++||||||+||+++.++.+||+|||+++...... .
T Consensus 267 e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~~~~~ 346 (450)
T 1k9a_A 267 EYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEGNNFVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQDTG 346 (450)
T ss_dssp ECCTTCBHHHHHHHHCTTTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECTTSCEEECCCTTCEECC------
T ss_pred EecCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCCHhhEEECCCCCEEEeeCCCcccccccccCC
Confidence 9999999999987543 37999999999999999999999999999999999999999999999999987543221 1
Q ss_pred ccccccccccccccCCCCCCCcccceeeecCCCCCCchHHHHHHHhhc-ccCCCCCCChhhhhhccCcC-CCCCCCCCcc
Q psy758 157 RHLHIFQTNEYFKGVSLPHAENVVPLEIKIGKPAATNIYLIDFLKRCL-DKDPLRRWSCDQLLRHPYFN-GYYFEVPDEM 234 (292)
Q Consensus 157 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~p~~~~~~~~~~~~~~~~-~~~~~~~~~~ 234 (292)
..+..|.+||...+.......|+|++ +.-+++.+. +..|....+..++....... ....+...+.
T Consensus 347 ~~~~~y~aPE~~~~~~~~~~sDvwsl-------------G~~l~el~t~g~~P~~~~~~~~~~~~i~~~~~~~~p~~~~~ 413 (450)
T 1k9a_A 347 KLPVKWTAPEALREKKFSTKSDVWSF-------------GILLWEIYSFGRVPYPRIPLKDVVPRVEKGYKMDAPDGCPP 413 (450)
T ss_dssp CCCTTTSCHHHHHSSCCCHHHHHHHH-------------HHHHHHHHTTTCCSSTTSCTTTHHHHHHTTCCCCCCTTCCH
T ss_pred CCCcceeCHHHhcCCCCCcHHHHHHH-------------HHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCCCCCCcCCH
Confidence 22234666666654443333333332 222333332 45555554444433221100 1223445578
Q ss_pred chHHHHhcccCcCCCCCCChhhhhh
Q psy758 235 QYEEITQRCLDKDPLRRWSCDQLLR 259 (292)
Q Consensus 235 ~l~~li~~~l~~dP~~Rpt~~~il~ 259 (292)
.+.+||.+||+.||.+|||+.++++
T Consensus 414 ~l~~li~~cl~~dp~~Rpt~~~l~~ 438 (450)
T 1k9a_A 414 AVYDVMKNCWHLDAATRPTFLQLRE 438 (450)
T ss_dssp HHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred HHHHHHHHHcCCChhHCcCHHHHHH
Confidence 9999999999999999999999987
|
| >3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-38 Score=259.26 Aligned_cols=243 Identities=22% Similarity=0.251 Sum_probs=177.3
Q ss_pred ccceeeeecccCceEEEEEEEcCCCc---EEEEEEeccCCCChHHHHHHHHHHHHHHhCCCCCcchhhhhhhcCCe-EEE
Q psy758 3 RYEKIGKLGEGSYGVVFKCRNRDTGQ---VVAIKKFLESEEDPLIRKIALREIRLLKSLKHPNLVNLLEVFRRKKK-LHL 78 (292)
Q Consensus 3 ~y~~~~~l~~g~~~~v~~~~~~~~~~---~v~iK~~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~-~~i 78 (292)
+|.+.+.||+|+||.||+|.+..++. .||+|.+.... .....+.+.+|+.+++.++||||+++++++.+.+. .++
T Consensus 22 ~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~ 100 (298)
T 3pls_A 22 VTHSDRVIGKGHFGVVYHGEYIDQAQNRIQCAIKSLSRIT-EMQQVEAFLREGLLMRGLNHPNVLALIGIMLPPEGLPHV 100 (298)
T ss_dssp EEEEEEEEEEETTEEEEEEEEECSSSCEEEEEEEEETTCC-SHHHHHHHHHHHHHHHTCCCTTBCCCCEEECCSSSCCEE
T ss_pred EEccCceeccCCCceEEEEEEecCCCceeeeeeeeccccc-cHHHHHHHHHHHHHHHhCCCCCeeeEEEEEecCCCCcEE
Confidence 46677999999999999999765544 79999986533 34456778899999999999999999999986555 499
Q ss_pred EEecCCCccHHHHhcC-CCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEEccCCcEEEeecCchhhhhccc--
Q psy758 79 VFEFCDHTVLNELENH-PHGLPWDLIKQITWQVLRGVSYCHRHACIHRDIKPENILLTANGVVKLCDFGFARLIRDLI-- 155 (292)
Q Consensus 79 v~e~~~~~~L~~~~~~-~~~~~~~~~~~i~~qi~~aL~~LH~~givH~dl~p~Nilv~~~~~~kl~dfg~~~~~~~~~-- 155 (292)
++||+.+++|.+++.. ...+++..++.++.|++.||+|||++|++||||||+||+++.++.++|+|||++.......
T Consensus 101 v~e~~~~~~L~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dikp~Nili~~~~~~kl~Dfg~~~~~~~~~~~ 180 (298)
T 3pls_A 101 LLPYMCHGDLLQFIRSPQRNPTVKDLISFGLQVARGMEYLAEQKFVHRDLAARNCMLDESFTVKVADFGLARDILDREYY 180 (298)
T ss_dssp EECCCTTCBHHHHHHCTTCCCBHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECTTCCEEECCTTSSCTTTTGGGG
T ss_pred EEecccCCCHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCcceEEEcCCCcEEeCcCCCcccccCCccc
Confidence 9999999999998876 4568999999999999999999999999999999999999999999999999997553321
Q ss_pred -------cccccccccccccccCCCCCCCcccceeeecCCCCCCchHHHHHHHhhcccC-CCCCCChhhhhhccC-cCCC
Q psy758 156 -------PRHLHIFQTNEYFKGVSLPHAENVVPLEIKIGKPAATNIYLIDFLKRCLDKD-PLRRWSCDQLLRHPY-FNGY 226 (292)
Q Consensus 156 -------~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-p~~~~~~~~~~~~~~-~~~~ 226 (292)
...+..|.+||...+.......++|++ +..++..+.+.. |.......++..... ....
T Consensus 181 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~sl-------------G~il~~l~~g~~~~~~~~~~~~~~~~~~~~~~~ 247 (298)
T 3pls_A 181 SVQQHRHARLPVKWTALESLQTYRFTTKSDVWSF-------------GVLLWELLTRGAPPYRHIDPFDLTHFLAQGRRL 247 (298)
T ss_dssp CSCCSSCTTCGGGGSCHHHHTTCCCCHHHHHHHH-------------HHHHHHHHHTSCCTTTTSCGGGHHHHHHTTCCC
T ss_pred ccccCcCCCCCccccChhhhccCCCChhhchhhH-------------HHHHHHHhhCCCCCCccCCHHHHHHHhhcCCCC
Confidence 111234555555544433222222222 222333333222 222222222221110 0112
Q ss_pred CCCCCCccchHHHHhcccCcCCCCCCChhhhhh
Q psy758 227 YFEVPDEMQYEEITQRCLDKDPLRRWSCDQLLR 259 (292)
Q Consensus 227 ~~~~~~~~~l~~li~~~l~~dP~~Rpt~~~il~ 259 (292)
..+...+..+.++|.+||+.||.+|||++++++
T Consensus 248 ~~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~ 280 (298)
T 3pls_A 248 PQPEYCPDSLYQVMQQCWEADPAVRPTFRVLVG 280 (298)
T ss_dssp CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred CCCccchHHHHHHHHHHccCChhhCcCHHHHHH
Confidence 233445778999999999999999999999988
|
| >3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.4e-39 Score=275.48 Aligned_cols=246 Identities=20% Similarity=0.244 Sum_probs=169.2
Q ss_pred ccceeeeecccCceEEEEEEEcCCCcEEEEEEeccCCCChHHHHHHHHHHHHHHhC-CCCCcchhhhhhhcCCeEEEEEe
Q psy758 3 RYEKIGKLGEGSYGVVFKCRNRDTGQVVAIKKFLESEEDPLIRKIALREIRLLKSL-KHPNLVNLLEVFRRKKKLHLVFE 81 (292)
Q Consensus 3 ~y~~~~~l~~g~~~~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~e~~~~~~l-~~~~i~~~~~~~~~~~~~~iv~e 81 (292)
+|.+.+.||+|+||.|+. ....+++.||+|++..... ..+.+|+.+++.+ +||||+++++++.+.+..|+|||
T Consensus 25 ~y~~~~~LG~G~~G~V~~-~~~~~~~~vAvK~~~~~~~-----~~~~~E~~~l~~l~~HpnIv~l~~~~~~~~~~~lv~E 98 (432)
T 3p23_A 25 SFCPKDVLGHGAEGTIVY-RGMFDNRDVAVKRILPECF-----SFADREVQLLRESDEHPNVIRYFCTEKDRQFQYIAIE 98 (432)
T ss_dssp EEEEEEEEEECGGGCEEE-EEESSSSEEEEEEECTTTE-----EECHHHHHHHHHSCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred EEecCCeeecCcCEEEEE-EEEeCCeEEEEEEECHHHH-----HHHHHHHHHHHhccCCCCcCeEEEEEecCCEEEEEEE
Confidence 588999999999999763 4456799999999865432 2245799999999 79999999999999999999999
Q ss_pred cCCCccHHHHhcCC-CCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEEcc---C--CcEEEeecCchhhhhccc
Q psy758 82 FCDHTVLNELENHP-HGLPWDLIKQITWQVLRGVSYCHRHACIHRDIKPENILLTA---N--GVVKLCDFGFARLIRDLI 155 (292)
Q Consensus 82 ~~~~~~L~~~~~~~-~~~~~~~~~~i~~qi~~aL~~LH~~givH~dl~p~Nilv~~---~--~~~kl~dfg~~~~~~~~~ 155 (292)
|++| +|.+++... ...++..++.++.||+.||.|||++||+||||||+||+++. + ..++|+|||++.......
T Consensus 99 ~~~g-~L~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlKp~NIll~~~~~~~~~~~kL~DFG~a~~~~~~~ 177 (432)
T 3p23_A 99 LCAA-TLQEYVEQKDFAHLGLEPITLLQQTTSGLAHLHSLNIVHRDLKPHNILISMPNAHGKIKAMISDFGLCKKLAVGR 177 (432)
T ss_dssp CCSE-EHHHHHHSSSCCCCSSCHHHHHHHHHHHHHHHHHTTCCCCCCSTTSEEECCCBTTTBCCEEECCTTEEECC----
T ss_pred CCCC-CHHHHHHhcCCCccchhHHHHHHHHHHHHHHHHHCcCEeCCCCHHHEEEecCCCCCceeEEEecccceeeccCCC
Confidence 9986 677766543 34666678899999999999999999999999999999953 2 358899999997654321
Q ss_pred --------cccccccccccccccC---CCCCCCcccceeeecCCCCCCchHHHHHHHhhc-ccCCCCCCChhhhh---hc
Q psy758 156 --------PRHLHIFQTNEYFKGV---SLPHAENVVPLEIKIGKPAATNIYLIDFLKRCL-DKDPLRRWSCDQLL---RH 220 (292)
Q Consensus 156 --------~~~~~~~~~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~p~~~~~~~~~~---~~ 220 (292)
..++..|.+||...+. ....+.++|+ .+.-++..+. +..|.......... ..
T Consensus 178 ~~~~~~~~~~gt~~y~APE~l~~~~~~~~t~~~DiwS-------------lG~il~ellt~g~~pf~~~~~~~~~~~~~~ 244 (432)
T 3p23_A 178 HSFSRRSGVPGTEGWIAPEMLSEDCKENPTYTVDIFS-------------AGCVFYYVISEGSHPFGKSLQRQANILLGA 244 (432)
T ss_dssp --------CCSCTTSCCGGGTSCC---CCCTHHHHHH-------------HHHHHHHHHTTSCBTTBSTTTHHHHHHTTC
T ss_pred cceeeccccCCCcCccChhhhhcccccCCCcHHHHHH-------------HHHHHHHHHcCCCCCcchhhHHHHHHHhcc
Confidence 1234445666655421 1111122222 2222233333 33333222111111 11
Q ss_pred cCcCCCCCCCCCccchHHHHhcccCcCCCCCCChhhhhhCCcccceec
Q psy758 221 PYFNGYYFEVPDEMQYEEITQRCLDKDPLRRWSCDQLLRHPYFNGYYF 268 (292)
Q Consensus 221 ~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~~il~h~w~~~~~~ 268 (292)
........+...+..+.+||.+||+.||.+|||++++++||||.+..+
T Consensus 245 ~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~evl~hp~f~~~~~ 292 (432)
T 3p23_A 245 CSLDCLHPEKHEDVIARELIEKMIAMDPQKRPSAKHVLKHPFFWSLEK 292 (432)
T ss_dssp CCCTTSCTTCHHHHHHHHHHHHHSCSSGGGSCCHHHHHTSTTTCCHHH
T ss_pred CCccccCccccccHHHHHHHHHHHhCCHhhCCCHHHHHhCccccChHH
Confidence 111111112223456889999999999999999999999999987554
|
| >3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 4deg_A* 4deh_A* 4dei_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 4aoi_A* 4ap7_A* 3q6w_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-38 Score=258.71 Aligned_cols=244 Identities=19% Similarity=0.197 Sum_probs=175.7
Q ss_pred cccceeeeecccCceEEEEEEEcCCC---cEEEEEEeccCCCChHHHHHHHHHHHHHHhCCCCCcchhhhhh-hcCCeEE
Q psy758 2 ERYEKIGKLGEGSYGVVFKCRNRDTG---QVVAIKKFLESEEDPLIRKIALREIRLLKSLKHPNLVNLLEVF-RRKKKLH 77 (292)
Q Consensus 2 ~~y~~~~~l~~g~~~~v~~~~~~~~~---~~v~iK~~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~-~~~~~~~ 77 (292)
.+|++.+.||+|+||.||+|.+..++ ..+++|.+.... .....+.+.+|+.+++.++||||+++++++ ..++..+
T Consensus 25 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~avk~~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~ 103 (298)
T 3f66_A 25 LIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRIT-DIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPL 103 (298)
T ss_dssp EEEEEEEEEEEETTEEEEEEEEC-----CEEEEEEEETTCC-SHHHHHHHHHHHHHHHTCCCTTBCCCCEEECCSSSCCE
T ss_pred eehhhcceeeecCCceEEEEEEecCCCceeEEEEEecccCC-CHHHHHHHHHHHHHHHhCCCCCEeeeeeEEEcCCCceE
Confidence 36899999999999999999875433 358999886533 344567788999999999999999999984 5567889
Q ss_pred EEEecCCCccHHHHhcC-CCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEEccCCcEEEeecCchhhhhcccc
Q psy758 78 LVFEFCDHTVLNELENH-PHGLPWDLIKQITWQVLRGVSYCHRHACIHRDIKPENILLTANGVVKLCDFGFARLIRDLIP 156 (292)
Q Consensus 78 iv~e~~~~~~L~~~~~~-~~~~~~~~~~~i~~qi~~aL~~LH~~givH~dl~p~Nilv~~~~~~kl~dfg~~~~~~~~~~ 156 (292)
+||||+++++|.+++.. ...+++..++.++.|++.||.|||++|++||||||+||+++.++.++|+|||++........
T Consensus 104 ~v~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~ql~~~l~~lH~~~i~H~dikp~Nil~~~~~~~kl~Dfg~a~~~~~~~~ 183 (298)
T 3f66_A 104 VVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKYLASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEY 183 (298)
T ss_dssp EEEECCTTCBHHHHHHCTTCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECTTCCEEECSCGGGCCCSCGGG
T ss_pred EEEeCCCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCCccCCCCchheEEECCCCCEEECcccccccccccch
Confidence 99999999999999865 44689999999999999999999999999999999999999999999999999976533211
Q ss_pred ---------ccccccccccccccCCCCCCCcccceeeecCCCCCCchHHHHHHHhhc-ccCCCCCCChhhhhhccCc-CC
Q psy758 157 ---------RHLHIFQTNEYFKGVSLPHAENVVPLEIKIGKPAATNIYLIDFLKRCL-DKDPLRRWSCDQLLRHPYF-NG 225 (292)
Q Consensus 157 ---------~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~p~~~~~~~~~~~~~~~-~~ 225 (292)
..+..|.+||...+.......++|++ +.-++..+. +..|.......+....... ..
T Consensus 184 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~sl-------------G~il~~l~~~~~~~~~~~~~~~~~~~~~~~~~ 250 (298)
T 3f66_A 184 YSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSF-------------GVLLWELMTRGAPPYPDVNTFDITVYLLQGRR 250 (298)
T ss_dssp CBC-----CCBCGGGSCHHHHHHCCCCHHHHHHHH-------------HHHHHHHHTTSCCSSTTSCTTTHHHHHHTTCC
T ss_pred hccccccCCCCCccccChHHhcCCCCChHHHHHHH-------------HHHHHHHHhCCCCCCccCCHHHHHHHHhcCCC
Confidence 11123556665544333222222222 222333333 2222222222222111100 11
Q ss_pred CCCCCCCccchHHHHhcccCcCCCCCCChhhhhh
Q psy758 226 YYFEVPDEMQYEEITQRCLDKDPLRRWSCDQLLR 259 (292)
Q Consensus 226 ~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~~il~ 259 (292)
...+...+..+.++|.+||+.||.+|||+.++++
T Consensus 251 ~~~~~~~~~~l~~li~~~l~~~p~~Rps~~ell~ 284 (298)
T 3f66_A 251 LLQPEYCPDPLYEVMLKCWHPKAEMRPSFSELVS 284 (298)
T ss_dssp CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred CCCCccCCHHHHHHHHHHcCCChhhCcCHHHHHH
Confidence 1223345778999999999999999999999998
|
| >1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.5e-39 Score=260.13 Aligned_cols=240 Identities=21% Similarity=0.274 Sum_probs=175.2
Q ss_pred CcccceeeeecccCceEEEEEEEcCCCcEEEEEEeccCCCChHHHHHHHHHHHHHHhCCCCCcchhhhhhhc-CCeEEEE
Q psy758 1 MERYEKIGKLGEGSYGVVFKCRNRDTGQVVAIKKFLESEEDPLIRKIALREIRLLKSLKHPNLVNLLEVFRR-KKKLHLV 79 (292)
Q Consensus 1 ~~~y~~~~~l~~g~~~~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~-~~~~~iv 79 (292)
+++|++.+.||+|++|.||+|.+. ++.||+|.+.... ..+.+.+|+.+++.++||||+++++++.+ .+..++|
T Consensus 20 ~~~y~~~~~lg~G~~g~V~~~~~~--~~~vavK~~~~~~----~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~lv 93 (278)
T 1byg_A 20 MKELKLLQTIGKGEFGDVMLGDYR--GNKVAVKCIKNDA----TAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIV 93 (278)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEET--TEEEEEEECCCCC------HHHHHTHHHHTTCCCTTBCCEEEEECCC--CCEEE
T ss_pred hhhceEEeEEecCCCceEEEEEEc--CCEEEEEEecchh----HHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCCceEEE
Confidence 368999999999999999999875 8899999987543 34567899999999999999999998654 4579999
Q ss_pred EecCCCccHHHHhcCCCC--CCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEEccCCcEEEeecCchhhhhccc--
Q psy758 80 FEFCDHTVLNELENHPHG--LPWDLIKQITWQVLRGVSYCHRHACIHRDIKPENILLTANGVVKLCDFGFARLIRDLI-- 155 (292)
Q Consensus 80 ~e~~~~~~L~~~~~~~~~--~~~~~~~~i~~qi~~aL~~LH~~givH~dl~p~Nilv~~~~~~kl~dfg~~~~~~~~~-- 155 (292)
+||+++++|.+++..... +++..++.++.|++.||.|||++|++|+||+|+||+++.++.++|+|||++.......
T Consensus 94 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~~l~Dfg~~~~~~~~~~~ 173 (278)
T 1byg_A 94 TEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEGNNFVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQDT 173 (278)
T ss_dssp ECCCTTEEHHHHHHHHHHHHCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECTTSCEEECCCCC----------
T ss_pred EecCCCCCHHHHHHhcccccCCHHHHHHHHHHHHHHHHHHHhCCccccCCCcceEEEeCCCcEEEeeccccccccccccC
Confidence 999999999998875433 8999999999999999999999999999999999999999999999999987654322
Q ss_pred cccccccccccccccCCCCCCCcccceeeecCCCCCCchHHHHHHHhhc-ccCCCCCCChhhhhhccCcC-CCCCCCCCc
Q psy758 156 PRHLHIFQTNEYFKGVSLPHAENVVPLEIKIGKPAATNIYLIDFLKRCL-DKDPLRRWSCDQLLRHPYFN-GYYFEVPDE 233 (292)
Q Consensus 156 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~p~~~~~~~~~~~~~~~~-~~~~~~~~~ 233 (292)
...+..|.+||...+.......++|+ .+.-++..+. +..|.......++....... ....+...+
T Consensus 174 ~~~~~~y~aPE~~~~~~~~~~~Di~s-------------lG~il~~l~t~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 240 (278)
T 1byg_A 174 GKLPVKWTAPEALREKKFSTKSDVWS-------------FGILLWEIYSFGRVPYPRIPLKDVVPRVEKGYKMDAPDGCP 240 (278)
T ss_dssp --CCTTTSCHHHHHHCCCCHHHHHHH-------------HHHHHHHHHTTSCCSCTTSCGGGHHHHHTTTCCCCCCTTCC
T ss_pred CCccccccCHHHhCCCCCCchhcHHH-------------HHHHHHHHHhCCCCCCCCCCHHHHHHHHhcCCCCCCcccCC
Confidence 12233466666654433322222222 2222333333 55555554444443221111 122334557
Q ss_pred cchHHHHhcccCcCCCCCCChhhhhh
Q psy758 234 MQYEEITQRCLDKDPLRRWSCDQLLR 259 (292)
Q Consensus 234 ~~l~~li~~~l~~dP~~Rpt~~~il~ 259 (292)
..+.++|.+||+.||.+|||+.++++
T Consensus 241 ~~l~~li~~~l~~~p~~Rps~~~l~~ 266 (278)
T 1byg_A 241 PAVYEVMKNCWHLDAAMRPSFLQLRE 266 (278)
T ss_dssp HHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred HHHHHHHHHHhcCChhhCCCHHHHHH
Confidence 89999999999999999999999987
|
| >3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.7e-39 Score=258.57 Aligned_cols=244 Identities=21% Similarity=0.251 Sum_probs=178.9
Q ss_pred cccceeeeecccCceEEEEEEEcCC---CcEEEEEEeccCCCChHHHHHHHHHHHHHHhCCCCCcchhhhhhhcCCeEEE
Q psy758 2 ERYEKIGKLGEGSYGVVFKCRNRDT---GQVVAIKKFLESEEDPLIRKIALREIRLLKSLKHPNLVNLLEVFRRKKKLHL 78 (292)
Q Consensus 2 ~~y~~~~~l~~g~~~~v~~~~~~~~---~~~v~iK~~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~i 78 (292)
++|++.+.||+|++|.||+|.+... +..||+|.+.... .....+.+.+|+.+++.++||||+++++++.+ +..++
T Consensus 12 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~-~~~~~ 89 (281)
T 3cc6_A 12 EDVVLNRILGEGFFGEVYEGVYTNHKGEKINVAVKTCKKDC-TLDNKEKFMSEAVIMKNLDHPHIVKLIGIIEE-EPTWI 89 (281)
T ss_dssp GGEEEEEEEEECSSSEEEEEEEECTTCCEEEEEEEECCTTS-CHHHHHHHHHHHHHHHHHCCTTBCCEEEEECS-SSCEE
T ss_pred cceEEEEEEEecCCeeEEEeEEcCCCCCcceEEEEeccccc-CchHHHHHHHHHHHHHhCCCCCcceEEEEEcC-CCCEE
Confidence 6899999999999999999986543 3469999987553 34456778999999999999999999999865 45689
Q ss_pred EEecCCCccHHHHhcCC-CCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEEccCCcEEEeecCchhhhhccc--
Q psy758 79 VFEFCDHTVLNELENHP-HGLPWDLIKQITWQVLRGVSYCHRHACIHRDIKPENILLTANGVVKLCDFGFARLIRDLI-- 155 (292)
Q Consensus 79 v~e~~~~~~L~~~~~~~-~~~~~~~~~~i~~qi~~aL~~LH~~givH~dl~p~Nilv~~~~~~kl~dfg~~~~~~~~~-- 155 (292)
|+||+++++|.+++... ..+++..++.++.||+.||.|||++|++|+||+|+||+++.++.++|+|||++.......
T Consensus 90 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~ 169 (281)
T 3cc6_A 90 IMELYPYGELGHYLERNKNSLKVLTLVLYSLQICKAMAYLESINCVHRDIAVRNILVASPECVKLGDFGLSRYIEDEDYY 169 (281)
T ss_dssp EEECCTTCBHHHHHHHHTTTCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCSGGGEEEEETTEEEECCCCGGGCC------
T ss_pred EEecCCCCCHHHHHHhccccCCHHHHHHHHHHHHHHHHHHHHCCcccCCCccceEEECCCCcEEeCccCCCccccccccc
Confidence 99999999999988653 459999999999999999999999999999999999999999999999999987654321
Q ss_pred ----cccccccccccccccCCCCCCCcccceeeecCCCCCCchHHHHHHHhhc-ccCCCCCCChhhhhhccCc-CCCCCC
Q psy758 156 ----PRHLHIFQTNEYFKGVSLPHAENVVPLEIKIGKPAATNIYLIDFLKRCL-DKDPLRRWSCDQLLRHPYF-NGYYFE 229 (292)
Q Consensus 156 ----~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~p~~~~~~~~~~~~~~~-~~~~~~ 229 (292)
...+..|.+||...+.......++|++ +.-++..+. +..|.......+....... .....+
T Consensus 170 ~~~~~~~~~~y~aPE~~~~~~~~~~~Di~sl-------------G~il~~llt~g~~p~~~~~~~~~~~~~~~~~~~~~~ 236 (281)
T 3cc6_A 170 KASVTRLPIKWMSPESINFRRFTTASDVWMF-------------AVCMWEILSFGKQPFFWLENKDVIGVLEKGDRLPKP 236 (281)
T ss_dssp ---CCCCCGGGCCHHHHHHCCCCHHHHHHHH-------------HHHHHHHHTTTCCTTTTSCGGGHHHHHHHTCCCCCC
T ss_pred ccccCCCCcceeCchhhccCCCCchhccHHH-------------HHHHHHHHhCCCCCcccCChHHHHHHHhcCCCCCCC
Confidence 112234666666544333222222222 222233332 4444443333322211100 111233
Q ss_pred CCCccchHHHHhcccCcCCCCCCChhhhhhC
Q psy758 230 VPDEMQYEEITQRCLDKDPLRRWSCDQLLRH 260 (292)
Q Consensus 230 ~~~~~~l~~li~~~l~~dP~~Rpt~~~il~h 260 (292)
...+..+.++|.+||+.||.+|||+.+++++
T Consensus 237 ~~~~~~l~~li~~~l~~~p~~Rps~~ell~~ 267 (281)
T 3cc6_A 237 DLCPPVLYTLMTRCWDYDPSDRPRFTELVCS 267 (281)
T ss_dssp TTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred CCCCHHHHHHHHHHccCCchhCcCHHHHHHH
Confidence 4457789999999999999999999999984
|
| >3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-38 Score=260.78 Aligned_cols=242 Identities=20% Similarity=0.277 Sum_probs=170.1
Q ss_pred cccceeeeecccCceEEEEEEEcCCCcEEEEEEeccCCCChHHHHHHHHHHHHHHh--CCCCCcchhhhhhhc----CCe
Q psy758 2 ERYEKIGKLGEGSYGVVFKCRNRDTGQVVAIKKFLESEEDPLIRKIALREIRLLKS--LKHPNLVNLLEVFRR----KKK 75 (292)
Q Consensus 2 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~e~~~~~~--l~~~~i~~~~~~~~~----~~~ 75 (292)
++|++.+.||+|+||.||+|.+ +++.||+|++.... ...+..|.+++.. ++||||+++++++.+ ...
T Consensus 8 ~~y~~~~~lg~G~~g~V~~~~~--~~~~vavK~~~~~~-----~~~~~~e~~~~~~~~l~h~niv~~~~~~~~~~~~~~~ 80 (301)
T 3q4u_A 8 RDITLLECVGKGRYGEVWRGSW--QGENVAVKIFSSRD-----EKSWFRETELYNTVMLRHENILGFIASDMTSRHSSTQ 80 (301)
T ss_dssp GGCEEEEEEEECSSEEEEEEEE--TTEEEEEEEECGGG-----HHHHHHHHHHHHHTCCCCTTBCCEEEEEEEEETTEEE
T ss_pred CcEEEEEeeccCCCcEEEEEEE--CCEEEEEEEecccc-----chhhHHHHHHHHHhhccCcCeeeEEEeeccccCCCce
Confidence 6899999999999999999987 58899999986542 2334556666666 789999999998543 456
Q ss_pred EEEEEecCCCccHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHH--------hCCccccCCCCCceEEccCCcEEEeecCc
Q psy758 76 LHLVFEFCDHTVLNELENHPHGLPWDLIKQITWQVLRGVSYCH--------RHACIHRDIKPENILLTANGVVKLCDFGF 147 (292)
Q Consensus 76 ~~iv~e~~~~~~L~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH--------~~givH~dl~p~Nilv~~~~~~kl~dfg~ 147 (292)
.++||||+++++|.++++. ..+++..++.++.||+.||+||| ++|++||||||+||+++.++.+||+|||+
T Consensus 81 ~~lv~e~~~~g~L~~~l~~-~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~ 159 (301)
T 3q4u_A 81 LWLITHYHEMGSLYDYLQL-TTLDTVSCLRIVLSIASGLAHLHIEIFGTQGKPAIAHRDLKSKNILVKKNGQCCIADLGL 159 (301)
T ss_dssp EEEEECCCTTCBHHHHHTT-CCBCHHHHHHHHHHHHHHHHHHHSCBCSTTCBCEEECSCCCGGGEEECTTSCEEECCCTT
T ss_pred eEEehhhccCCCHHHHHhh-cccCHHHHHHHHHHHHHHHHHHHHhhhhccCCCCeecCCCChHhEEEcCCCCEEEeeCCC
Confidence 8999999999999999975 47999999999999999999999 99999999999999999999999999999
Q ss_pred hhhhhcccc---------ccccccccccccccCC-----------CCCCCcccceeeecCCCCCCchHHHHHHHhhcccC
Q psy758 148 ARLIRDLIP---------RHLHIFQTNEYFKGVS-----------LPHAENVVPLEIKIGKPAATNIYLIDFLKRCLDKD 207 (292)
Q Consensus 148 ~~~~~~~~~---------~~~~~~~~~~~~~~~~-----------~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 207 (292)
+........ .++..|.+||...+.. ..|+.|+..+++.++..+.... .....
T Consensus 160 a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DvwslG~il~el~tg~~~~~~~--------~~~~~ 231 (301)
T 3q4u_A 160 AVMHSQSTNQLDVGNNPRVGTKRYMAPEVLDETIQVDCFDSYKRVDIWAFGLVLWEVARRMVSNGIV--------EDYKP 231 (301)
T ss_dssp CEEEETTTTEEECCCCCCCCCGGGCCHHHHTTCCCTTCHHHHHHHHHHHHHHHHHHHHTTBCBTTBC--------CCCCC
T ss_pred eeecccccccccccccccccccceeChhhhcCcCCCCcccCCchhhHHHHHHHHHHHHhhhcCcccc--------ccccc
Confidence 865432211 3345567777665431 2344444444444441100000 00012
Q ss_pred CCCCC-----ChhhhhhccCcCCCC-------CCCCCccchHHHHhcccCcCCCCCCChhhhhh
Q psy758 208 PLRRW-----SCDQLLRHPYFNGYY-------FEVPDEMQYEEITQRCLDKDPLRRWSCDQLLR 259 (292)
Q Consensus 208 p~~~~-----~~~~~~~~~~~~~~~-------~~~~~~~~l~~li~~~l~~dP~~Rpt~~~il~ 259 (292)
|+... ............... .....+..+.+||.+||+.||.+|||+.++++
T Consensus 232 pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~~i~~ 295 (301)
T 3q4u_A 232 PFYDVVPNDPSFEDMRKVVCVDQQRPNIPNRWFSDPTLTSLAKLMKECWYQNPSARLTALRIKK 295 (301)
T ss_dssp TTTTTSCSSCCHHHHHHHHTTSCCCCCCCGGGGGSHHHHHHHHHHHHHCCSSGGGSCCHHHHHH
T ss_pred cccccCCCCcchhhhhHHHhccCCCCCCChhhccCccHHHHHHHHHHHhhcChhhCCCHHHHHH
Confidence 22111 111111100000101 11123467899999999999999999999987
|
| >2izr_A Casein kinase I isoform gamma-3; serine/threonine-protein kinase, transferase, ATP- binding, phosphorylation, nucleotide-binding; HET: BRK; 1.3A {Homo sapiens} PDB: 2izs_A* 2izt_A* 2izu_A* 2chl_A* 2c47_A* 2cmw_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.2e-39 Score=267.28 Aligned_cols=239 Identities=18% Similarity=0.159 Sum_probs=176.6
Q ss_pred cccceeeeecccCceEEEEEEEcCCCcEEEEEEeccCCCChHHHHHHHHHHHHHHhC-CCCCcchhhhhhhcCCeEEEEE
Q psy758 2 ERYEKIGKLGEGSYGVVFKCRNRDTGQVVAIKKFLESEEDPLIRKIALREIRLLKSL-KHPNLVNLLEVFRRKKKLHLVF 80 (292)
Q Consensus 2 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~e~~~~~~l-~~~~i~~~~~~~~~~~~~~iv~ 80 (292)
++|++.+.||+|+||.||+|.+..+++.||+|++...... +.+.+|+.+++.+ +||||+++++++.+++..++||
T Consensus 9 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~----~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~~~~lv~ 84 (330)
T 2izr_A 9 PNFRVGKKIGCGNFGELRLGKNLYTNEYVAIKLEPMKSRA----PQLHLEYRFYKQLGSGDGIPQVYYFGPCGKYNAMVL 84 (330)
T ss_dssp TTEEEEEECCC-CTTSEEEEEETTTTEEEEEEEEETTCSS----CCHHHHHHHHHHHCSCTTSCCEEEEEEETTEEEEEE
T ss_pred CCeEEEEEeeccCCceEEEEEECCCCcEEEEEEeccccch----HHHHHHHHHHHHhhCCCCCCEEEEEEecCCccEEEE
Confidence 5799999999999999999999999999999998765433 3467899999999 8999999999999999999999
Q ss_pred ecCCCccHHHHhcC-CCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEEccCCc-----EEEeecCchhhhhcc
Q psy758 81 EFCDHTVLNELENH-PHGLPWDLIKQITWQVLRGVSYCHRHACIHRDIKPENILLTANGV-----VKLCDFGFARLIRDL 154 (292)
Q Consensus 81 e~~~~~~L~~~~~~-~~~~~~~~~~~i~~qi~~aL~~LH~~givH~dl~p~Nilv~~~~~-----~kl~dfg~~~~~~~~ 154 (292)
||+ +++|.+++.. ...+++..++.++.||+.||+|||++||+||||||+||+++.++. ++|+|||++......
T Consensus 85 e~~-~~~L~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~iiHrDlkp~Nill~~~~~~~~~~~kl~DFg~a~~~~~~ 163 (330)
T 2izr_A 85 ELL-GPSLEDLFDLCDRTFSLKTVLMIAIQLISRMEYVHSKNLIYRDVKPENFLIGRPGNKTQQVIHIIDFALAKEYIDP 163 (330)
T ss_dssp ECC-CCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECCGGGTCTTSEEECCCTTCEESBCT
T ss_pred EeC-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHeeeccCCCCCCceEEEEEcccceeeecC
Confidence 999 8899988864 357999999999999999999999999999999999999998887 999999999865432
Q ss_pred cc------------ccccccccccccccCCCCCCCcccceeeecCCCCCCchHHHHHHHhhcccCCCCCCChh---hhhh
Q psy758 155 IP------------RHLHIFQTNEYFKGVSLPHAENVVPLEIKIGKPAATNIYLIDFLKRCLDKDPLRRWSCD---QLLR 219 (292)
Q Consensus 155 ~~------------~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~---~~~~ 219 (292)
.. .++..|.+||...+.......|+| +.+.-++..+.+..|+...+.. +.+.
T Consensus 164 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~-------------slG~il~ell~g~~Pf~~~~~~~~~~~~~ 230 (330)
T 2izr_A 164 ETKKHIPYREHKSLTGTARYMSINTHLGKEQSRRDDLE-------------ALGHMFMYFLRGSLPWQGLKADTLKERYQ 230 (330)
T ss_dssp TTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHH-------------HHHHHHHHHHHSSCTTTTCCCSSHHHHHH
T ss_pred CCCccccccccCCcCCCccccChHHHcCCCCCchhHHH-------------HHHHHHHHHhcCCCCccccccccHHHHHH
Confidence 21 223445566655544332222222 2222233333444444332211 1111
Q ss_pred cc----CcCCC-CCCCCCccchHHHHhcccCcCCCCCCChhhhhh
Q psy758 220 HP----YFNGY-YFEVPDEMQYEEITQRCLDKDPLRRWSCDQLLR 259 (292)
Q Consensus 220 ~~----~~~~~-~~~~~~~~~l~~li~~~l~~dP~~Rpt~~~il~ 259 (292)
.. ..... ......+ .+.++|.+||+.||.+||++++|++
T Consensus 231 ~i~~~~~~~~~~~~~~~~p-~~~~li~~~l~~~p~~RP~~~~l~~ 274 (330)
T 2izr_A 231 KIGDTKRATPIEVLCENFP-EMATYLRYVRRLDFFEKPDYDYLRK 274 (330)
T ss_dssp HHHHHHHHSCHHHHTTTCH-HHHHHHHHHHHCCTTCCCCHHHHHH
T ss_pred HHHhhhccCCHHHHhccCh-HHHHHHHHHHhCCCCCCCCHHHHHH
Confidence 10 00000 0011124 8999999999999999999999977
|
| >1csn_A Casein kinase-1; phosphotransferase; HET: ATP; 2.00A {Schizosaccharomyces pombe} SCOP: d.144.1.7 PDB: 1eh4_A* 2csn_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-38 Score=260.36 Aligned_cols=240 Identities=19% Similarity=0.157 Sum_probs=177.9
Q ss_pred cccceeeeecccCceEEEEEEEcCCCcEEEEEEeccCCCChHHHHHHHHHHHHHHhC-CCCCcchhhhhhhcCCeEEEEE
Q psy758 2 ERYEKIGKLGEGSYGVVFKCRNRDTGQVVAIKKFLESEEDPLIRKIALREIRLLKSL-KHPNLVNLLEVFRRKKKLHLVF 80 (292)
Q Consensus 2 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~e~~~~~~l-~~~~i~~~~~~~~~~~~~~iv~ 80 (292)
++|++.+.||+|++|.||+|.+..+++.||+|++...... ..+.+|+.+++.+ +|++++++++++.++...++|+
T Consensus 10 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~----~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~~~lv~ 85 (298)
T 1csn_A 10 VHYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRSDA----PQLRDEYRTYKLLAGCTGIPNVYYFGQEGLHNVLVI 85 (298)
T ss_dssp TTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEECCTTS----CCHHHHHHHHHHTTTCTTCCCEEEEEEETTEEEEEE
T ss_pred cceEEEEEEeecCCEEEEEEEECCCCcEEEEEEeccCCcc----HHHHHHHHHHHHHhcCCCCCeEEeecCCCceeEEEE
Confidence 5799999999999999999999999999999998755433 3466799999999 7999999999999999999999
Q ss_pred ecCCCccHHHHhcCC-CCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEEccCCc-----EEEeecCchhhhhcc
Q psy758 81 EFCDHTVLNELENHP-HGLPWDLIKQITWQVLRGVSYCHRHACIHRDIKPENILLTANGV-----VKLCDFGFARLIRDL 154 (292)
Q Consensus 81 e~~~~~~L~~~~~~~-~~~~~~~~~~i~~qi~~aL~~LH~~givH~dl~p~Nilv~~~~~-----~kl~dfg~~~~~~~~ 154 (292)
||+ +++|.+++... ..+++..++.++.||+.||.|||++|++||||||+||+++.++. ++|+|||++......
T Consensus 86 e~~-~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~Dlkp~NIl~~~~~~~~~~~~kl~Dfg~~~~~~~~ 164 (298)
T 1csn_A 86 DLL-GPSLEDLLDLCGRKFSVKTVAMAAKQMLARVQSIHEKSLVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFYRDP 164 (298)
T ss_dssp ECC-CCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHTTTEECCCCCGGGEEECCSSSTTTTCEEECCCTTCEESBCT
T ss_pred Eec-CCCHHHHHHHhccCCCHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEeccCCCCCCCeEEEEECccccccccc
Confidence 999 88999988753 35999999999999999999999999999999999999987765 999999999765432
Q ss_pred cc------------ccccccccccccccCCCCCCCcccceeeecCCCCCCchHHHHHHHhhcccCCCCCCC---hhhhhh
Q psy758 155 IP------------RHLHIFQTNEYFKGVSLPHAENVVPLEIKIGKPAATNIYLIDFLKRCLDKDPLRRWS---CDQLLR 219 (292)
Q Consensus 155 ~~------------~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~---~~~~~~ 219 (292)
.. .++..|.+||...+.......++|+ .+.-++..+.+..|+.... ..+.+.
T Consensus 165 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~s-------------lG~il~el~~g~~pf~~~~~~~~~~~~~ 231 (298)
T 1csn_A 165 VTKQHIPYREKKNLSGTARYMSINTHLGREQSRRDDLEA-------------LGHVFMYFLRGSLPWQGLKAATNKQKYE 231 (298)
T ss_dssp TTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHH-------------HHHHHHHHHHSSCTTSSCCSCCHHHHHH
T ss_pred cccccccccCccCCCCCcccCCchhhcCCCCChHHHHHH-------------HHHHHHHHHcCCCCcchhhccccHHHHH
Confidence 21 2234466666655443322222222 2222333333444433321 111111
Q ss_pred ccC-----cCCCCCCCCCccchHHHHhcccCcCCCCCCChhhhhh
Q psy758 220 HPY-----FNGYYFEVPDEMQYEEITQRCLDKDPLRRWSCDQLLR 259 (292)
Q Consensus 220 ~~~-----~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~~il~ 259 (292)
... ..........+..+.+||.+||+.||.+|||+++|++
T Consensus 232 ~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~RP~~~~l~~ 276 (298)
T 1csn_A 232 RIGEKKQSTPLRELCAGFPEEFYKYMHYARNLAFDATPDYDYLQG 276 (298)
T ss_dssp HHHHHHHHSCHHHHTTTSCHHHHHHHHHHHHCCTTCCCCHHHHHH
T ss_pred HHHhhccCccHHHHHhhCcHHHHHHHHHHhcCCcccCCCHHHHHH
Confidence 000 0000011244778999999999999999999999987
|
| >3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* 4e20_A* 4e1z_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-39 Score=267.01 Aligned_cols=258 Identities=21% Similarity=0.280 Sum_probs=185.6
Q ss_pred ccc-ceeeeecccCceEEEEEE----EcCCCcEEEEEEeccCCCChHHHHHHHHHHHHHHhCCCCCcchhhhhhhc--CC
Q psy758 2 ERY-EKIGKLGEGSYGVVFKCR----NRDTGQVVAIKKFLESEEDPLIRKIALREIRLLKSLKHPNLVNLLEVFRR--KK 74 (292)
Q Consensus 2 ~~y-~~~~~l~~g~~~~v~~~~----~~~~~~~v~iK~~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~--~~ 74 (292)
++| ++++.||+|+||.||++. +..+++.||+|++... ......+.+.+|+.+++.++||||+++++++.+ ..
T Consensus 30 ~r~~~~~~~lG~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~-~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~ 108 (318)
T 3lxp_A 30 KRYLKKIRDLGEGHFGKVSLYCYDPTNDGTGEMVAVKALKAD-AGPQHRSGWKQEIDILRTLYHEHIIKYKGCCEDAGAA 108 (318)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEECSCC--CCEEEEEEEECTT-CCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTTT
T ss_pred HHHHhhhheecCCCCeEEEEEEEccCCCCCCcEEEEEEeccc-cChHHHHHHHHHHHHHHhCCCcchhhEEEEEecCCCc
Confidence 355 999999999999998775 3457889999999755 344556778999999999999999999999986 46
Q ss_pred eEEEEEecCCCccHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEEccCCcEEEeecCchhhhhcc
Q psy758 75 KLHLVFEFCDHTVLNELENHPHGLPWDLIKQITWQVLRGVSYCHRHACIHRDIKPENILLTANGVVKLCDFGFARLIRDL 154 (292)
Q Consensus 75 ~~~iv~e~~~~~~L~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~givH~dl~p~Nilv~~~~~~kl~dfg~~~~~~~~ 154 (292)
.+++||||+++++|.+++... .+++..++.++.||+.||.|||++|++|+||||+||+++.++.++|+|||++......
T Consensus 109 ~~~lv~e~~~~~~L~~~l~~~-~~~~~~~~~i~~~l~~~l~~LH~~~ivH~Dikp~Nil~~~~~~~kl~Dfg~a~~~~~~ 187 (318)
T 3lxp_A 109 SLQLVMEYVPLGSLRDYLPRH-SIGLAQLLLFAQQICEGMAYLHAQHYIHRDLAARNVLLDNDRLVKIGDFGLAKAVPEG 187 (318)
T ss_dssp EEEEEECCCTTCBHHHHGGGS-CCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTCCEEECCGGGCEECCTT
T ss_pred eEEEEEecccCCcHHHHHhhC-CCCHHHHHHHHHHHHHHHHHHHhCCccCCCCchheEEEcCCCCEEECCcccccccccc
Confidence 799999999999999999765 5999999999999999999999999999999999999999999999999999765432
Q ss_pred c--------cccccccccccccccCC-----CCCCCcccceeeecCCCCCCchHHHHHHHhhcccCCCCCCChhhhhhcc
Q psy758 155 I--------PRHLHIFQTNEYFKGVS-----LPHAENVVPLEIKIGKPAATNIYLIDFLKRCLDKDPLRRWSCDQLLRHP 221 (292)
Q Consensus 155 ~--------~~~~~~~~~~~~~~~~~-----~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~ 221 (292)
. ...+..|.+||...+.. ..|+.++..+++.++..++........................+.+...
T Consensus 188 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 267 (318)
T 3lxp_A 188 HEYYRVREDGDSPVFWYAPECLKEYKFYYASDVWSFGVTLYELLTHCDSSQSPPTKFLELIGIAQGQMTVLRLTELLERG 267 (318)
T ss_dssp CSEEEC---CCCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCGGGSHHHHHHHHHCSCCHHHHHHHHHHHHHTT
T ss_pred ccccccccCCCCCceeeChHHhcCCCCCcHHHHHHHHHHHHHHHhCCCcccccchhhhhhhcccccchhHHHHHHHHhcc
Confidence 1 11223366777665433 3455555556666665544322211100000000000000001111111
Q ss_pred CcCCCCCCCCCccchHHHHhcccCcCCCCCCChhhhhhCCcccc
Q psy758 222 YFNGYYFEVPDEMQYEEITQRCLDKDPLRRWSCDQLLRHPYFNG 265 (292)
Q Consensus 222 ~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~~il~h~w~~~ 265 (292)
.....+...+..+.+||.+||+.||.+|||++++++ +|+.
T Consensus 268 --~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~--~L~~ 307 (318)
T 3lxp_A 268 --ERLPRPDKCPAEVYHLMKNCWETEASFRPTFENLIP--ILKT 307 (318)
T ss_dssp --CCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH--HHHH
T ss_pred --cCCCCCccccHHHHHHHHHHcCCCcccCcCHHHHHH--HHHH
Confidence 112233455788999999999999999999999997 5554
|
| >2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.9e-39 Score=275.77 Aligned_cols=243 Identities=24% Similarity=0.312 Sum_probs=166.6
Q ss_pred ccceeeeecccCceEEEEEEEcCCCcEEEEEEeccCCCChHHHHHHHHHHHHHHhC-CCCCcchhhhhhhcCCeEEEEEe
Q psy758 3 RYEKIGKLGEGSYGVVFKCRNRDTGQVVAIKKFLESEEDPLIRKIALREIRLLKSL-KHPNLVNLLEVFRRKKKLHLVFE 81 (292)
Q Consensus 3 ~y~~~~~l~~g~~~~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~e~~~~~~l-~~~~i~~~~~~~~~~~~~~iv~e 81 (292)
.|.+.+.||+|+||+||.+ ...+|+.||+|.+.... .+.+.+|+.+++.+ +||||+++++++.+++..|+|||
T Consensus 16 ~~~~~~~LG~G~~g~V~~~-~~~~g~~vAvK~~~~~~-----~~~~~~E~~~l~~l~~HpnIv~~~~~~~~~~~~~lv~E 89 (434)
T 2rio_A 16 LVVSEKILGYGSSGTVVFQ-GSFQGRPVAVKRMLIDF-----CDIALMEIKLLTESDDHPNVIRYYCSETTDRFLYIALE 89 (434)
T ss_dssp CEEEEEEEEECSTTCEEEE-EESSSSEEEEEEEEGGG-----HHHHHHHHHHHHHHTTSTTBCCEEEEEECSSEEEEEEC
T ss_pred eeeccCeEeeCCCeEEEEE-EEECCeEEEEEEEcHHH-----HHHHHHHHHHHHhccCCCCcCeEEEEEecCCeEEEEEe
Confidence 4566788999999999865 44569999999986532 24567899999876 89999999999999999999999
Q ss_pred cCCCccHHHHhcCCCCC-------CHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEEccC-------------CcEE
Q psy758 82 FCDHTVLNELENHPHGL-------PWDLIKQITWQVLRGVSYCHRHACIHRDIKPENILLTAN-------------GVVK 141 (292)
Q Consensus 82 ~~~~~~L~~~~~~~~~~-------~~~~~~~i~~qi~~aL~~LH~~givH~dl~p~Nilv~~~-------------~~~k 141 (292)
|++ ++|.+++...... ++..++.++.||+.||+|||++||+||||||+||+++.+ +.++
T Consensus 90 ~~~-gsL~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDLkp~NILl~~~~~~~~~~~~~~~~~~~k 168 (434)
T 2rio_A 90 LCN-LNLQDLVESKNVSDENLKLQKEYNPISLLRQIASGVAHLHSLKIIHRDLKPQNILVSTSSRFTADQQTGAENLRIL 168 (434)
T ss_dssp CCS-EEHHHHHHTC------------CCHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEECCHHHHSCCTTCCCSCEEE
T ss_pred cCC-CCHHHHHhccCCCchhhhhccchhHHHHHHHHHHHHHHHHHCCccccCCChHhEEEecCcccccccccCCCceEEE
Confidence 997 5899988765433 223457899999999999999999999999999999754 4899
Q ss_pred EeecCchhhhhccc---------cccccccccccccccC-------CCCCCCcccceeeecCCCCCCchHHHHHHHhhc-
Q psy758 142 LCDFGFARLIRDLI---------PRHLHIFQTNEYFKGV-------SLPHAENVVPLEIKIGKPAATNIYLIDFLKRCL- 204 (292)
Q Consensus 142 l~dfg~~~~~~~~~---------~~~~~~~~~~~~~~~~-------~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~- 204 (292)
|+|||++....... ..++..|.+||...+. ....+.|+ ++.+.-++..+.
T Consensus 169 L~DFG~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~Di-------------wSlG~il~ellt~ 235 (434)
T 2rio_A 169 ISDFGLCKKLDSGQSSFRTNLNNPSGTSGWRAPELLEESNNLQTKRRLTRSIDI-------------FSMGCVFYYILSK 235 (434)
T ss_dssp ECCCTTCEECCC--------------CCTTSCHHHHSCCCTTSCCCCCCTHHHH-------------HHHHHHHHHHHTT
T ss_pred EcccccceecCCCCccceeeecCCCCCCCccCHHHhccccccccccCcchhhhh-------------HhHHHHHHHHHhC
Confidence 99999997654321 1234456666665441 11111222 222222333333
Q ss_pred ccCCCCCCChh--hhhhccCc-CCCC--CCCCCccchHHHHhcccCcCCCCCCChhhhhhCCcccc
Q psy758 205 DKDPLRRWSCD--QLLRHPYF-NGYY--FEVPDEMQYEEITQRCLDKDPLRRWSCDQLLRHPYFNG 265 (292)
Q Consensus 205 ~~~p~~~~~~~--~~~~~~~~-~~~~--~~~~~~~~l~~li~~~l~~dP~~Rpt~~~il~h~w~~~ 265 (292)
+..|....... .++...+. .... .....+..+.+||.+||+.||.+|||+.++++||||.+
T Consensus 236 g~~Pf~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~eil~hp~f~~ 301 (434)
T 2rio_A 236 GKHPFGDKYSRESNIIRGIFSLDEMKCLHDRSLIAEATDLISQMIDHDPLKRPTAMKVLRHPLFWP 301 (434)
T ss_dssp SCCTTCSTTTHHHHHHHTCCCCCCCTTCCCHHHHHHHHHHHHHHTCSSGGGSCCHHHHHTSGGGSC
T ss_pred CCCCCCCchhhHHHHhcCCCCcccccccccccchHHHHHHHHHHhhCChhhCCCHHHHHhCCccCC
Confidence 33343222111 11111110 0000 01122467899999999999999999999999999975
|
| >1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-38 Score=272.97 Aligned_cols=240 Identities=23% Similarity=0.302 Sum_probs=180.0
Q ss_pred cccceeeeecccCceEEEEEEEcCCCcEEEEEEeccCCCChHHHHHHHHHHHHHHhCCCCCcchhhhhhhcCCeEEEEEe
Q psy758 2 ERYEKIGKLGEGSYGVVFKCRNRDTGQVVAIKKFLESEEDPLIRKIALREIRLLKSLKHPNLVNLLEVFRRKKKLHLVFE 81 (292)
Q Consensus 2 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~iv~e 81 (292)
++|++.+.||+|+||.||+|.+.. +..||+|.+...... .+.+.+|+.+++.++||||+++++++. .+..++|||
T Consensus 188 ~~~~~~~~lG~G~fg~V~~~~~~~-~~~vavK~~~~~~~~---~~~~~~E~~~l~~l~h~~iv~l~~~~~-~~~~~lv~e 262 (454)
T 1qcf_A 188 ESLKLEKKLGAGQFGEVWMATYNK-HTKVAVKTMKPGSMS---VEAFLAEANVMKTLQHDKLVKLHAVVT-KEPIYIITE 262 (454)
T ss_dssp GGEEEEEEEECCSSEEEEEEEETT-TEEEEEEEECTTSBC---HHHHHHHHHHHTTCCCTTBCCEEEEEC-SSSCEEEEC
T ss_pred HHeEEEEEcccCCceEEEEEEECC-ccEEEEEEecCCCcc---HHHHHHHHHHHhhCCCCCEeeEEEEEe-CCccEEEEe
Confidence 578999999999999999999864 678999999765432 466889999999999999999999886 567899999
Q ss_pred cCCCccHHHHhcCC--CCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEEccCCcEEEeecCchhhhhccc----
Q psy758 82 FCDHTVLNELENHP--HGLPWDLIKQITWQVLRGVSYCHRHACIHRDIKPENILLTANGVVKLCDFGFARLIRDLI---- 155 (292)
Q Consensus 82 ~~~~~~L~~~~~~~--~~~~~~~~~~i~~qi~~aL~~LH~~givH~dl~p~Nilv~~~~~~kl~dfg~~~~~~~~~---- 155 (292)
|+.+|+|.+++... ..+++..++.++.||+.||+|||++|++||||||+|||++.++.+||+|||+++......
T Consensus 263 ~~~~g~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivHrDlkp~Nill~~~~~~kl~DFG~a~~~~~~~~~~~ 342 (454)
T 1qcf_A 263 FMAKGSLLDFLKSDEGSKQPLPKLIDFSAQIAEGMAFIEQRNYIHRDLRAANILVSASLVCKIADFGLARVIEDNEYTAR 342 (454)
T ss_dssp CCTTCBHHHHHHSHHHHTCCHHHHHHHHHHHHHHHHHHHHTTCCCSSCSGGGEEECTTCCEEECSTTGGGGBCCHHHHTT
T ss_pred ecCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCCccCCCCCHHHEEECCCCcEEEeeCCCceEcCCCceecc
Confidence 99999999998754 258999999999999999999999999999999999999999999999999998654211
Q ss_pred --cccccccccccccccCCCCCCCcccceeeecCCCCCCchHHHHHHHhhc-ccCCCCCCChhhhhhccCcC-CCCCCCC
Q psy758 156 --PRHLHIFQTNEYFKGVSLPHAENVVPLEIKIGKPAATNIYLIDFLKRCL-DKDPLRRWSCDQLLRHPYFN-GYYFEVP 231 (292)
Q Consensus 156 --~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~p~~~~~~~~~~~~~~~~-~~~~~~~ 231 (292)
...+..|.+||...+.......|+|++ +.-+++.+. +..|....+..++....... ....+..
T Consensus 343 ~~~~~~~~y~aPE~~~~~~~~~~~Dvwsl-------------G~~l~el~t~g~~P~~~~~~~~~~~~i~~~~~~~~~~~ 409 (454)
T 1qcf_A 343 EGAKFPIKWTAPEAINFGSFTIKSDVWSF-------------GILLMEIVTYGRIPYPGMSNPEVIRALERGYRMPRPEN 409 (454)
T ss_dssp CSSSSCGGGSCHHHHHHCCCCHHHHHHHH-------------HHHHHHHHTTSCCSSTTCCHHHHHHHHHHTCCCCCCTT
T ss_pred CCCcccccccCHHHhccCCCCcHHHHHhH-------------HHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCCCCCCC
Confidence 111234667766654433322222222 222233333 44444444443333221100 1122334
Q ss_pred CccchHHHHhcccCcCCCCCCChhhhhh
Q psy758 232 DEMQYEEITQRCLDKDPLRRWSCDQLLR 259 (292)
Q Consensus 232 ~~~~l~~li~~~l~~dP~~Rpt~~~il~ 259 (292)
.+..+.+||.+||+.||.+|||+++|++
T Consensus 410 ~~~~l~~li~~cl~~dp~~RPt~~~i~~ 437 (454)
T 1qcf_A 410 CPEELYNIMMRCWKNRPEERPTFEYIQS 437 (454)
T ss_dssp SCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred CCHHHHHHHHHHccCChhHCcCHHHHHH
Confidence 5788999999999999999999999987
|
| >3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-38 Score=262.19 Aligned_cols=244 Identities=23% Similarity=0.384 Sum_probs=169.1
Q ss_pred cccceeeeecccCceEEEEEEEcCCCcEEEEEEeccCCCChHHHHHHHHHHHHHHhCC-CCCcchhhhhh--------hc
Q psy758 2 ERYEKIGKLGEGSYGVVFKCRNRDTGQVVAIKKFLESEEDPLIRKIALREIRLLKSLK-HPNLVNLLEVF--------RR 72 (292)
Q Consensus 2 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~e~~~~~~l~-~~~i~~~~~~~--------~~ 72 (292)
.+|++.+.||+|+||.||+|.+..+++.||+|++... .....+.+.+|+.+++.+. ||||+++++++ ..
T Consensus 28 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~--~~~~~~~~~~e~~~l~~l~~h~~iv~~~~~~~~~~~~~~~~ 105 (337)
T 3ll6_A 28 LRLRVRRVLAEGGFAFVYEAQDVGSGREYALKRLLSN--EEEKNRAIIQEVCFMKKLSGHPNIVQFCSAASIGKEESDTG 105 (337)
T ss_dssp EEEEEEEEEECCSSEEEEEEEETTTCCEEEEEEEEES--SHHHHHHHHHHHHHHHHHTTSTTBCCEEEEEEECTTTSTTS
T ss_pred ceEEEEEEEccCCceEEEEEEECCCCcEEEEEEecCC--chHHHHHHHHHHHHHHHhccCCChhhccccccccccccccC
Confidence 3799999999999999999999999999999998544 3445667889999999996 99999999887 34
Q ss_pred CCeEEEEEecCCCccHHHHhc---CCCCCCHHHHHHHHHHHHHHHHHHHhCC--ccccCCCCCceEEccCCcEEEeecCc
Q psy758 73 KKKLHLVFEFCDHTVLNELEN---HPHGLPWDLIKQITWQVLRGVSYCHRHA--CIHRDIKPENILLTANGVVKLCDFGF 147 (292)
Q Consensus 73 ~~~~~iv~e~~~~~~L~~~~~---~~~~~~~~~~~~i~~qi~~aL~~LH~~g--ivH~dl~p~Nilv~~~~~~kl~dfg~ 147 (292)
...+++++||+.| +|.+++. ..+.+++..++.++.||+.||.|||++| ++|+||||+||+++.++.++|+|||+
T Consensus 106 ~~~~~lv~e~~~g-~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~ivH~Dikp~NIl~~~~~~~kl~Dfg~ 184 (337)
T 3ll6_A 106 QAEFLLLTELCKG-QLVEFLKKMESRGPLSCDTVLKIFYQTCRAVQHMHRQKPPIIHRDLKVENLLLSNQGTIKLCDFGS 184 (337)
T ss_dssp SEEEEEEEECCSE-EHHHHHHHHHTTCSCCHHHHHHHHHHHHHHHHHHHTSSSCCBCCCCCGGGCEECTTSCEEBCCCTT
T ss_pred CceEEEEEEecCC-CHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhCCCCEEEccCCcccEEECCCCCEEEecCcc
Confidence 5568999999985 5555543 3457999999999999999999999999 99999999999999999999999999
Q ss_pred hhhhhcccc-----------------cccccccccccc---ccCCCCCCCcccceeeecCCCCCCchHHHHHHHhhcccC
Q psy758 148 ARLIRDLIP-----------------RHLHIFQTNEYF---KGVSLPHAENVVPLEIKIGKPAATNIYLIDFLKRCLDKD 207 (292)
Q Consensus 148 ~~~~~~~~~-----------------~~~~~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 207 (292)
+........ ..+..|.+||.. .+.......++ ++.+.-++..+.+..
T Consensus 185 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~~Dv-------------~slG~il~el~~g~~ 251 (337)
T 3ll6_A 185 ATTISHYPDYSWSAQRRALVEEEITRNTTPMYRTPEIIDLYSNFPIGEKQDI-------------WALGCILYLLCFRQH 251 (337)
T ss_dssp CBCCSSCC-------------------------------CCTTSCSSHHHHH-------------HHHHHHHHHHHHSSC
T ss_pred ceeccccCcccccccccccchhhccccCCCCcCChhhhhccccCCCChHHhH-------------HHHHHHHHHHHhCCC
Confidence 976543211 123345556554 12111111122 222223333344444
Q ss_pred CCCCCChhhhhhccCcCCCCCCCCCccchHHHHhcccCcCCCCCCChhhhhhCCcc
Q psy758 208 PLRRWSCDQLLRHPYFNGYYFEVPDEMQYEEITQRCLDKDPLRRWSCDQLLRHPYF 263 (292)
Q Consensus 208 p~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~~il~h~w~ 263 (292)
|+.......+....+ ........+..+.+||.+||+.||.+|||+.+++++.+-
T Consensus 252 p~~~~~~~~~~~~~~--~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~l~~ 305 (337)
T 3ll6_A 252 PFEDGAKLRIVNGKY--SIPPHDTQYTVFHSLIRAMLQVNPEERLSIAEVVHQLQE 305 (337)
T ss_dssp CC------------C--CCCTTCCSSGGGHHHHHHHSCSSGGGSCCHHHHHHHHHH
T ss_pred CCcchhHHHhhcCcc--cCCcccccchHHHHHHHHHccCChhhCcCHHHHHHHHHH
Confidence 443333222222211 112233446789999999999999999999999997543
|
| >1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-38 Score=255.71 Aligned_cols=240 Identities=21% Similarity=0.303 Sum_probs=177.4
Q ss_pred cccceeeeecccCceEEEEEEEcCCCcEEEEEEeccCCCChHHHHHHHHHHHHHHhCCCCCcchhhhhhhcCCeEEEEEe
Q psy758 2 ERYEKIGKLGEGSYGVVFKCRNRDTGQVVAIKKFLESEEDPLIRKIALREIRLLKSLKHPNLVNLLEVFRRKKKLHLVFE 81 (292)
Q Consensus 2 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~iv~e 81 (292)
++|++.+.||+|++|.||+|.+. ++..||+|.+...... .+.+.+|+.+++.++||||+++++++. .+..++|||
T Consensus 13 ~~y~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~---~~~~~~E~~~l~~l~h~~i~~~~~~~~-~~~~~~v~e 87 (279)
T 1qpc_A 13 ETLKLVERLGAGQFGEVWMGYYN-GHTKVAVKSLKQGSMS---PDAFLAEANLMKQLQHQRLVRLYAVVT-QEPIYIITE 87 (279)
T ss_dssp GGEEEEEEEEEETTEEEEEEEET-TTEEEEEEEECTTSSC---HHHHHHHHHHHHHCCCTTBCCEEEEEC-SSSCEEEEE
T ss_pred HhhhheeeecCCCCeEEEEEEEc-CCcEEEEEEecCCccc---HHHHHHHHHHHHhCCCcCcceEEEEEc-CCCcEEEEe
Confidence 68999999999999999999975 4678999998765443 356789999999999999999999876 455899999
Q ss_pred cCCCccHHHHhcCCC--CCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEEccCCcEEEeecCchhhhhcccc---
Q psy758 82 FCDHTVLNELENHPH--GLPWDLIKQITWQVLRGVSYCHRHACIHRDIKPENILLTANGVVKLCDFGFARLIRDLIP--- 156 (292)
Q Consensus 82 ~~~~~~L~~~~~~~~--~~~~~~~~~i~~qi~~aL~~LH~~givH~dl~p~Nilv~~~~~~kl~dfg~~~~~~~~~~--- 156 (292)
|+++++|.+++.... .+++..++.++.|++.||.|||++|++|+||+|+||+++.++.++|+|||++........
T Consensus 88 ~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~ 167 (279)
T 1qpc_A 88 YMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEERNYIHRDLRAANILVSDTLSCKIADFGLARLIEDNEYTAR 167 (279)
T ss_dssp CCTTCBHHHHTTSHHHHTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTSCEEECCCTTCEECSSSCEECC
T ss_pred cCCCCCHHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHhhEEEcCCCCEEECCCcccccccCcccccc
Confidence 999999999987643 699999999999999999999999999999999999999999999999999876543211
Q ss_pred ---ccccccccccccccCCCCCCCcccceeeecCCCCCCchHHHHHHHhhc-ccCCCCCCChhhhhhccCcC-CCCCCCC
Q psy758 157 ---RHLHIFQTNEYFKGVSLPHAENVVPLEIKIGKPAATNIYLIDFLKRCL-DKDPLRRWSCDQLLRHPYFN-GYYFEVP 231 (292)
Q Consensus 157 ---~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~p~~~~~~~~~~~~~~~~-~~~~~~~ 231 (292)
..+..|.+||...+.......++|+ .+..++..+. +..|....+..++....... ....+..
T Consensus 168 ~~~~~~~~y~aPE~~~~~~~~~~~Di~s-------------lG~il~el~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~ 234 (279)
T 1qpc_A 168 EGAKFPIKWTAPEAINYGTFTIKSDVWS-------------FGILLTEIVTHGRIPYPGMTNPEVIQNLERGYRMVRPDN 234 (279)
T ss_dssp TTCCCCTTTSCHHHHHHCEECHHHHHHH-------------HHHHHHHHHTTTCCSSTTCCHHHHHHHHHTTCCCCCCTT
T ss_pred cCCCCccCccChhhhccCCCCchhhhHH-------------HHHHHHHHHhCCCCCCcccCHHHHHHHHhcccCCCCccc
Confidence 1122366666554332222222222 2222233333 33344333333322211000 1122334
Q ss_pred CccchHHHHhcccCcCCCCCCChhhhhh
Q psy758 232 DEMQYEEITQRCLDKDPLRRWSCDQLLR 259 (292)
Q Consensus 232 ~~~~l~~li~~~l~~dP~~Rpt~~~il~ 259 (292)
.+..+.++|.+||+.||++|||++++++
T Consensus 235 ~~~~l~~li~~~l~~~p~~Rps~~~l~~ 262 (279)
T 1qpc_A 235 CPEELYQLMRLCWKERPEDRPTFDYLRS 262 (279)
T ss_dssp CCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred ccHHHHHHHHHHhccChhhCCCHHHHHH
Confidence 5789999999999999999999999988
|
| >2nru_A Interleukin-1 receptor-associated kinase 4; inhibitor, IRAK, transferase; HET: TPO SEP T12; 2.00A {Homo sapiens} PDB: 2nry_A* 2oib_A* 2oic_A* 2oid_A* 2o8y_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.6e-39 Score=263.76 Aligned_cols=248 Identities=25% Similarity=0.340 Sum_probs=174.4
Q ss_pred cceeeeecccCceEEEEEEEcCCCcEEEEEEeccCC--CChHHHHHHHHHHHHHHhCCCCCcchhhhhhhcCCeEEEEEe
Q psy758 4 YEKIGKLGEGSYGVVFKCRNRDTGQVVAIKKFLESE--EDPLIRKIALREIRLLKSLKHPNLVNLLEVFRRKKKLHLVFE 81 (292)
Q Consensus 4 y~~~~~l~~g~~~~v~~~~~~~~~~~v~iK~~~~~~--~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~iv~e 81 (292)
|...+.||+|++|.||+|.+ +++.||+|.+.... ......+.+.+|+.+++.++||||+++++++.+.+..++|||
T Consensus 33 ~~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 110 (307)
T 2nru_A 33 SVGGNKMGEGGFGVVYKGYV--NNTTVAVKKLAAMVDITTEELKQQFDQEIKVMAKCQHENLVELLGFSSDGDDLCLVYV 110 (307)
T ss_dssp TTTCCEEEECSSEEEEEEES--SSCEEEEEEECCCTTSCTTTHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEEE
T ss_pred cccCCccccCCCeEEEEEEE--CCceEEEEEEecccCcchHHHHHHHHHHHHHHHhcCCCCeEEEEEEEecCCceEEEEE
Confidence 45568999999999999986 48899999986543 334456778999999999999999999999999999999999
Q ss_pred cCCCccHHHHhcC---CCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEEccCCcEEEeecCchhhhhccc---
Q psy758 82 FCDHTVLNELENH---PHGLPWDLIKQITWQVLRGVSYCHRHACIHRDIKPENILLTANGVVKLCDFGFARLIRDLI--- 155 (292)
Q Consensus 82 ~~~~~~L~~~~~~---~~~~~~~~~~~i~~qi~~aL~~LH~~givH~dl~p~Nilv~~~~~~kl~dfg~~~~~~~~~--- 155 (292)
|+++++|.+++.. ...+++..++.++.||+.||.|||++|++|+||+|+||+++.++.++|+|||++.......
T Consensus 111 ~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~i~H~dlkp~Nili~~~~~~kl~Dfg~~~~~~~~~~~~ 190 (307)
T 2nru_A 111 YMPNGSLLDRLSCLDGTPPLSWHMRCKIAQGAANGINFLHENHHIHRDIKSANILLDEAFTAKISDFGLARASEKFAQTV 190 (307)
T ss_dssp CCTTCBHHHHHHTGGGCCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECTTCCEEECCCTTCEECCSCSSCE
T ss_pred ecCCCcHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhcCCeecCCCCHHHEEEcCCCcEEEeecccccccccccccc
Confidence 9999999998863 3458999999999999999999999999999999999999999999999999987654321
Q ss_pred ----cccccccccccccccC----CCCCCCcccceeeecCCCCCCchH----HHHHHHhhcccCCCCCCChhhhhhccCc
Q psy758 156 ----PRHLHIFQTNEYFKGV----SLPHAENVVPLEIKIGKPAATNIY----LIDFLKRCLDKDPLRRWSCDQLLRHPYF 223 (292)
Q Consensus 156 ----~~~~~~~~~~~~~~~~----~~~~~~~~~~~~~~~~~~~~~~~~----~~~~~~~~~~~~p~~~~~~~~~~~~~~~ 223 (292)
..++..|.+||...+. ...|+.|+..+++.+|..++.... ...+...... ......+.+....
T Consensus 191 ~~~~~~g~~~y~aPE~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~----~~~~~~~~~~~~~- 265 (307)
T 2nru_A 191 MTSRIVGTTAYMAPEALRGEITPKSDIYSFGVVLLEIITGLPAVDEHREPQLLLDIKEEIED----EEKTIEDYIDKKM- 265 (307)
T ss_dssp ECSSCCSCGGGCCHHHHTTEECTHHHHHHHHHHHHHHHHCCCSBCTTBSSSBTTHHHHHHHT----TSCCHHHHSCSSC-
T ss_pred cccccCCCcCcCChHHhcCCCCccchhHHHHHHHHHHHHCCCCcccCcchHHHHHHHHHhhh----hhhhhhhhccccc-
Confidence 1233456666654432 112333333333333333221100 0000000000 0000111110000
Q ss_pred CCCCCCCCCccchHHHHhcccCcCCCCCCChhhhhhC
Q psy758 224 NGYYFEVPDEMQYEEITQRCLDKDPLRRWSCDQLLRH 260 (292)
Q Consensus 224 ~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~~il~h 260 (292)
...+...+..+.+++.+||+.||.+|||+++++++
T Consensus 266 --~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~l~~~ 300 (307)
T 2nru_A 266 --NDADSTSVEAMYSVASQCLHEKKNKRPDIKKVQQL 300 (307)
T ss_dssp --SCCCHHHHHHHHHHHHHHTCSSTTTSCCHHHHHHH
T ss_pred --cccchHHHHHHHHHHHHHcCCCcccCcCHHHHHHH
Confidence 01112235678899999999999999999999974
|
| >2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-38 Score=262.26 Aligned_cols=252 Identities=24% Similarity=0.301 Sum_probs=184.5
Q ss_pred cccceeeeecccCceEEEEEE----EcCCCcEEEEEEeccCCCChHHHHHHHHHHHHHHhCCCCCcchhhhhhhcC--Ce
Q psy758 2 ERYEKIGKLGEGSYGVVFKCR----NRDTGQVVAIKKFLESEEDPLIRKIALREIRLLKSLKHPNLVNLLEVFRRK--KK 75 (292)
Q Consensus 2 ~~y~~~~~l~~g~~~~v~~~~----~~~~~~~v~iK~~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~--~~ 75 (292)
++|++++.||+|++|.||+|. +..+++.||+|.+... .....+.+.+|+.+++.++||||+++++++... ..
T Consensus 41 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~ 118 (326)
T 2w1i_A 41 RHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHS--TEEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRN 118 (326)
T ss_dssp GGEEEEEEEECCSSEEEEEEEECTTSSSCCEEEEEEEESSC--CSHHHHHHHHHHHHHHTCCCTTBCCEEEEECC----C
T ss_pred HHceeeeeeccCCCeEEEEEEeccccCCCceEEEEEEeccC--CHHHHHHHHHHHHHHHhCCCCCeeeEEEEEEecCCCc
Confidence 479999999999999999998 4668999999998654 334567788999999999999999999987654 37
Q ss_pred EEEEEecCCCccHHHHhcCC-CCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEEccCCcEEEeecCchhhhhcc
Q psy758 76 LHLVFEFCDHTVLNELENHP-HGLPWDLIKQITWQVLRGVSYCHRHACIHRDIKPENILLTANGVVKLCDFGFARLIRDL 154 (292)
Q Consensus 76 ~~iv~e~~~~~~L~~~~~~~-~~~~~~~~~~i~~qi~~aL~~LH~~givH~dl~p~Nilv~~~~~~kl~dfg~~~~~~~~ 154 (292)
.++|+||+++++|.+++... ..+++..++.++.||+.||.+||++|++|+||||+||+++.++.++|+|||++......
T Consensus 119 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~dikp~NIli~~~~~~kL~Dfg~~~~~~~~ 198 (326)
T 2w1i_A 119 LKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKGMEYLGTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQD 198 (326)
T ss_dssp CEEEECCCTTCBHHHHHHHSTTSSCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEEEETTEEEECCCTTCEECCSS
T ss_pred eEEEEECCCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCCEeccCCCcceEEEcCCCcEEEecCcchhhcccc
Confidence 89999999999999988654 45999999999999999999999999999999999999999999999999998765432
Q ss_pred c--------cccccccccccccccCCC-----CCCCcccceeeecCCCCCCchHHHHHHHhhcccCCCCCCCh---hhhh
Q psy758 155 I--------PRHLHIFQTNEYFKGVSL-----PHAENVVPLEIKIGKPAATNIYLIDFLKRCLDKDPLRRWSC---DQLL 218 (292)
Q Consensus 155 ~--------~~~~~~~~~~~~~~~~~~-----~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~---~~~~ 218 (292)
. ...+..|.+||...+... .|+.|+..+++.++..++.... ..+.. .....+...... .+.+
T Consensus 199 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~tg~~~~~~~~-~~~~~-~~~~~~~~~~~~~~~~~~~ 276 (326)
T 2w1i_A 199 KEYYKVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYIEKSKSPP-AEFMR-MIGNDKQGQMIVFHLIELL 276 (326)
T ss_dssp CSEEECSSCCSCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHHTTCGGGSHH-HHHHH-HHCTTCCTHHHHHHHHHHH
T ss_pred ccccccccCCCCceeEECchhhcCCCCCchhhHHHHHHHHHHHHhcCCCCCCCH-HHHHH-hhccccchhhhHHHHHHHh
Confidence 1 112234677776554433 4555555566666655432221 11111 111111111000 1111
Q ss_pred hccCcCCCCCCCCCccchHHHHhcccCcCCCCCCChhhhhh
Q psy758 219 RHPYFNGYYFEVPDEMQYEEITQRCLDKDPLRRWSCDQLLR 259 (292)
Q Consensus 219 ~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~~il~ 259 (292)
.... ....+...+..+.+||.+||+.||.+|||+.++++
T Consensus 277 ~~~~--~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~el~~ 315 (326)
T 2w1i_A 277 KNNG--RLPRPDGCPDEIYMIMTECWNNNVNQRPSFRDLAL 315 (326)
T ss_dssp HTTC--CCCCCTTCCHHHHHHHHHHSCSSGGGSCCHHHHHH
T ss_pred hcCC--CCCCCCcccHHHHHHHHHHcCCChhhCcCHHHHHH
Confidence 1110 11233455789999999999999999999999987
|
| >2jii_A Serine/threonine-protein kinase VRK3 molecule: VA related kinase 3; transferase, pseudo kinase domain, vaccinia related kinase, ATP-binding; 2.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-38 Score=264.80 Aligned_cols=238 Identities=16% Similarity=0.174 Sum_probs=172.7
Q ss_pred cccceeeeecccCceEEEEEEEcCC--------CcEEEEEEeccCCCChHHHHHHHHHHHHHHhCCCCCcchhhhhh---
Q psy758 2 ERYEKIGKLGEGSYGVVFKCRNRDT--------GQVVAIKKFLESEEDPLIRKIALREIRLLKSLKHPNLVNLLEVF--- 70 (292)
Q Consensus 2 ~~y~~~~~l~~g~~~~v~~~~~~~~--------~~~v~iK~~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~--- 70 (292)
++|++.+.||+|+||.||+|.+..+ ++.||+|.+... +.+.+|+.+++.++||||+++++.+
T Consensus 42 ~~y~~~~~lg~G~~g~Vy~~~~~~t~~~~~~~~~~~vavK~~~~~-------~~~~~E~~~l~~l~h~niv~~~~~~~~~ 114 (352)
T 2jii_A 42 RQWKLKSFQTRDNQGILYEAAPTSTLTCDSGPQKQKFSLKLDAKD-------GRLFNEQNFFQRAAKPLQVNKWKKLYST 114 (352)
T ss_dssp CEEEEEEEEEEETTEEEEEEEECC-----------CEEEEEEETT-------STHHHHHHHHHHHCCHHHHHHHHHHTTC
T ss_pred CeEEEEEEecCCCCeEEEEEeecCCccccccccCceEEEEEeccc-------chHHHHHHHHHHhcccchhhhhhhhccC
Confidence 6899999999999999999999874 889999998754 3467899999999999999965543
Q ss_pred ------------hc-CCeEEEEEecCCCccHHHHhcCC--CCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEEc
Q psy758 71 ------------RR-KKKLHLVFEFCDHTVLNELENHP--HGLPWDLIKQITWQVLRGVSYCHRHACIHRDIKPENILLT 135 (292)
Q Consensus 71 ------------~~-~~~~~iv~e~~~~~~L~~~~~~~--~~~~~~~~~~i~~qi~~aL~~LH~~givH~dl~p~Nilv~ 135 (292)
.. ++..++||||+ +++|.+++... ..+++..++.++.||+.||.|||++|++||||||+||+++
T Consensus 115 ~~~~i~~~~~~~~~~~~~~~lv~e~~-~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~ivH~Dikp~NIl~~ 193 (352)
T 2jii_A 115 PLLAIPTCMGFGVHQDKYRFLVLPSL-GRSLQSALDVSPKHVLSERSVLQVACRLLDALEFLHENEYVHGNVTAENIFVD 193 (352)
T ss_dssp TTCSCCCCCEEEEETTTEEEEEEECC-CEEHHHHHHHSGGGCCCHHHHHHHHHHHHHHHHHHHHTTCBCSCCCGGGEEEE
T ss_pred CccCccchhhccccCCcEEEEEecCC-CcCHHHHHHhCCcCCCCHHHHHHHHHHHHHHHHHHHhCCccCCCCCHHHEEEc
Confidence 22 67899999999 99999998765 6799999999999999999999999999999999999999
Q ss_pred cCC--cEEEeecCchhhhhcccc------------ccccccccccccccCCCC-----CCCcccceeeecCCCCCCchH-
Q psy758 136 ANG--VVKLCDFGFARLIRDLIP------------RHLHIFQTNEYFKGVSLP-----HAENVVPLEIKIGKPAATNIY- 195 (292)
Q Consensus 136 ~~~--~~kl~dfg~~~~~~~~~~------------~~~~~~~~~~~~~~~~~~-----~~~~~~~~~~~~~~~~~~~~~- 195 (292)
.++ .++|+|||++........ ..+..|.+||...+.... |+.|+..+++.+|..++....
T Consensus 194 ~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~ 273 (352)
T 2jii_A 194 PEDQSQVTLAGYGFAFRYCPSGKHVAYVEGSRSPHEGDLEFISMDLHKGCGPSRRSDLQSLGYCMLKWLYGFLPWTNCLP 273 (352)
T ss_dssp TTEEEEEEECCGGGCBCSSGGGCCCCCCTTSSCTTCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSCCTTGGGTT
T ss_pred CCCCceEEEecCcceeeccCCCccccccccccccccCCccccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCcccCCc
Confidence 998 899999999976543221 233456666655554332 444444444445544432210
Q ss_pred ----HHHHHHhhcccCCCCCCChhhhhhccCcCCCCCCCCCccchHHHHhcccCcCCCCCCChhhhhh
Q psy758 196 ----LIDFLKRCLDKDPLRRWSCDQLLRHPYFNGYYFEVPDEMQYEEITQRCLDKDPLRRWSCDQLLR 259 (292)
Q Consensus 196 ----~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~~il~ 259 (292)
........... + ..+..........+..+.+||.+||+.||.+|||++++++
T Consensus 274 ~~~~~~~~~~~~~~~-~-----------~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~ 329 (352)
T 2jii_A 274 NTEDIMKQKQKFVDK-P-----------GPFVGPCGHWIRPSETLQKYLKVVMALTYEEKPPYAMLRN 329 (352)
T ss_dssp CHHHHHHHHHHHHHS-C-----------CCEECTTSCEECCCHHHHHHHHHHHTCCTTCCCCHHHHHH
T ss_pred CHHHHHHHHHhccCC-h-----------hhhhhhccccCCCcHHHHHHHHHHHhCChhhCCCHHHHHH
Confidence 00010000000 0 0000111111234778999999999999999999999987
|
| >2v62_A Serine/threonine-protein kinase VRK2; transferase, ATP-binding, membrane, nucleotide-binding, TRAN; 1.7A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.5e-39 Score=266.89 Aligned_cols=245 Identities=16% Similarity=0.132 Sum_probs=174.6
Q ss_pred cccceeeeecccCceEEEEEEEcC---CCcEEEEEEeccCCCChH---------HHHHHHHHHHHHHhCCCCCcchhhhh
Q psy758 2 ERYEKIGKLGEGSYGVVFKCRNRD---TGQVVAIKKFLESEEDPL---------IRKIALREIRLLKSLKHPNLVNLLEV 69 (292)
Q Consensus 2 ~~y~~~~~l~~g~~~~v~~~~~~~---~~~~v~iK~~~~~~~~~~---------~~~~~~~e~~~~~~l~~~~i~~~~~~ 69 (292)
++|++.+.||+|+||.||+|.+.. ++..||+|++........ ....+.+|+..++.++||||++++++
T Consensus 37 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~e~~~~~~~~~~~~~~e~~~~~~l~h~ni~~~~~~ 116 (345)
T 2v62_A 37 NQWVLGKKIGSGGFGLIYLAFPTNKPEKDARHVVKVEYQENGPLFSELKFYQRVAKKDCIKKWIERKQLDYLGIPLFYGS 116 (345)
T ss_dssp CEEEEEEEC------CEEEEEESSSCGGGCCEEEEEEECC-CHHHHHHHHHHHHCCHHHHHHHHHHHTCSCCCCCCEEEE
T ss_pred ceEEEEeeEeecCCeEEEEEEecCCCCccceEEEEeeecCCcchHHHHHHHHHHhhhHHHHHHHhhccccccCcceeecc
Confidence 579999999999999999999987 788999999876543211 11235678889999999999999999
Q ss_pred hhc----CCeEEEEEecCCCccHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEEccCC--cEEEe
Q psy758 70 FRR----KKKLHLVFEFCDHTVLNELENHPHGLPWDLIKQITWQVLRGVSYCHRHACIHRDIKPENILLTANG--VVKLC 143 (292)
Q Consensus 70 ~~~----~~~~~iv~e~~~~~~L~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~givH~dl~p~Nilv~~~~--~~kl~ 143 (292)
+.+ ....|+||||+ +++|.+++...+.+++..++.++.||+.||+|||++||+||||||+||+++.++ .++|+
T Consensus 117 ~~~~~~~~~~~~lv~e~~-~~~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~~~kL~ 195 (345)
T 2v62_A 117 GLTEFKGRSYRFMVMERL-GIDLQKISGQNGTFKKSTVLQLGIRMLDVLEYIHENEYVHGDIKAANLLLGYKNPDQVYLA 195 (345)
T ss_dssp EEEESSSCEEEEEEEECE-EEEHHHHCBGGGBCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEESSSTTSEEEC
T ss_pred cccccCCCcEEEEEEecc-CCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCcCHHHEEEccCCCCcEEEE
Confidence 877 77899999999 999999998777899999999999999999999999999999999999999887 99999
Q ss_pred ecCchhhhhcc------------ccccccccccccccccCCCC-----CCCcccceeeecCCCCCCch----H-HHHHHH
Q psy758 144 DFGFARLIRDL------------IPRHLHIFQTNEYFKGVSLP-----HAENVVPLEIKIGKPAATNI----Y-LIDFLK 201 (292)
Q Consensus 144 dfg~~~~~~~~------------~~~~~~~~~~~~~~~~~~~~-----~~~~~~~~~~~~~~~~~~~~----~-~~~~~~ 201 (292)
|||++...... ....+..|.+||...+.... |+.|+..+++++|..++... . ......
T Consensus 196 Dfg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~ell~g~~pf~~~~~~~~~~~~~~~ 275 (345)
T 2v62_A 196 DYGLSYRYCPNGNHKQYQENPRKGHNGTIEFTSLDAHKGVALSRRSDVEILGYCMLRWLCGKLPWEQNLKDPVAVQTAKT 275 (345)
T ss_dssp CCTTCEESSGGGCCCCCCCCGGGCSCSCTTTCCHHHHHTCCCCHHHHHHHHHHHHHHHHHSSCTTGGGTTCHHHHHHHHH
T ss_pred eCCCceecccccccccchhccccccCCCccccCHHHhcCCCCCchhhHHHHHHHHHHHHhCCCCccccccccHHHHHHHH
Confidence 99999765321 11234456677766554432 44444445555555544210 0 000111
Q ss_pred hhcccCCCCCCChhhhhhccCcCCCCCCCCCccchHHHHhcccCcCCCCCCChhhhhh
Q psy758 202 RCLDKDPLRRWSCDQLLRHPYFNGYYFEVPDEMQYEEITQRCLDKDPLRRWSCDQLLR 259 (292)
Q Consensus 202 ~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~~il~ 259 (292)
......| ..+ .........+..+.++|.+||+.||++|||+++|++
T Consensus 276 ~~~~~~~-------~~~-----~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~ 321 (345)
T 2v62_A 276 NLLDELP-------QSV-----LKWAPSGSSCCEIAQFLVCAHSLAYDEKPNYQALKK 321 (345)
T ss_dssp HHHHTTT-------HHH-----HHHSCTTSCCHHHHHHHHHHHTCCTTCCCCHHHHHH
T ss_pred hhccccc-------HHH-----HhhccccccHHHHHHHHHHHhhcCcccCCCHHHHHH
Confidence 1100000 000 000111245779999999999999999999999988
|
| >2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-37 Score=255.61 Aligned_cols=238 Identities=27% Similarity=0.369 Sum_probs=172.2
Q ss_pred cccceeeeecccCceEEEEEEEcCCCcEEEEEEeccCCCChHHHHHHHHHHHHHHhCCCCCcchhhhhhhcCCeEEEEEe
Q psy758 2 ERYEKIGKLGEGSYGVVFKCRNRDTGQVVAIKKFLESEEDPLIRKIALREIRLLKSLKHPNLVNLLEVFRRKKKLHLVFE 81 (292)
Q Consensus 2 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~iv~e 81 (292)
++|++.+.||+|+||.||+|.+. ++.||+|.+... ...+.+.+|+.+++.++||||+++++++.+ ..++|||
T Consensus 8 ~~~~~~~~lg~G~~g~V~~~~~~--~~~vavK~~~~~----~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~--~~~lv~e 79 (307)
T 2eva_A 8 KEIEVEEVVGRGAFGVVCKAKWR--AKDVAIKQIESE----SERKAFIVELRQLSRVNHPNIVKLYGACLN--PVCLVME 79 (307)
T ss_dssp GGEEEEEEEECCSSSEEEEEEET--TEEEEEEECSST----THHHHHHHHHHHHHHCCCTTBCCEEEBCTT--TTEEEEE
T ss_pred hHeeeeeEeecCCCceEEEEEEC--CeeEEEEEecCh----hHHHHHHHHHHHHhcCCCCCcCeEEEEEcC--CcEEEEE
Confidence 68999999999999999999875 788999998543 234678899999999999999999998874 4789999
Q ss_pred cCCCccHHHHhcCCC---CCCHHHHHHHHHHHHHHHHHHHh---CCccccCCCCCceEEccCCc-EEEeecCchhhhhcc
Q psy758 82 FCDHTVLNELENHPH---GLPWDLIKQITWQVLRGVSYCHR---HACIHRDIKPENILLTANGV-VKLCDFGFARLIRDL 154 (292)
Q Consensus 82 ~~~~~~L~~~~~~~~---~~~~~~~~~i~~qi~~aL~~LH~---~givH~dl~p~Nilv~~~~~-~kl~dfg~~~~~~~~ 154 (292)
|+++++|.+++.... .++...++.++.|++.||.|||+ +|++||||||+||+++.++. +||+|||++......
T Consensus 80 ~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~~~~ivH~dlkp~NIll~~~~~~~kl~Dfg~~~~~~~~ 159 (307)
T 2eva_A 80 YAEGGSLYNVLHGAEPLPYYTAAHAMSWCLQCSQGVAYLHSMQPKALIHRDLKPPNLLLVAGGTVLKICDFGTACDIQTH 159 (307)
T ss_dssp CCTTCBHHHHHHCSSSEECCCHHHHHHHHHHHHHHHHHHHTCSSSCCCCCCCSGGGEEEETTTTEEEECCCCC-------
T ss_pred cCCCCCHHHHHhccCCCCccCHHHHHHHHHHHHHHHHHHHhCCCCCeecCCCChhHEEEeCCCCEEEEcccccccccccc
Confidence 999999999998654 37899999999999999999999 89999999999999998886 799999998765432
Q ss_pred --ccccccccccccccccCCCCCCCcccceeeecCCCCCCchHHHHHHHhhcccCCCCCCChh--hhhhcc-CcCCCCCC
Q psy758 155 --IPRHLHIFQTNEYFKGVSLPHAENVVPLEIKIGKPAATNIYLIDFLKRCLDKDPLRRWSCD--QLLRHP-YFNGYYFE 229 (292)
Q Consensus 155 --~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~--~~~~~~-~~~~~~~~ 229 (292)
....+..|.+||...+.......++|++ +..++..+.+..|+...... .+.... .-......
T Consensus 160 ~~~~~gt~~y~aPE~~~~~~~~~~~Di~sl-------------G~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~ 226 (307)
T 2eva_A 160 MTNNKGSAAWMAPEVFEGSNYSEKCDVFSW-------------GIILWEVITRRKPFDEIGGPAFRIMWAVHNGTRPPLI 226 (307)
T ss_dssp -----CCTTSSCHHHHTCCCCCTHHHHHHH-------------HHHHHHHHHTCCTTTTTCSSHHHHHHHHHTTCCCCCB
T ss_pred cccCCCCCceEChhhhCCCCCCcHHHHHHH-------------HHHHHHHHHCCCCchhhCccHHHHHHHHhcCCCCCcc
Confidence 2233455777777665443333333222 22233333344443322111 111000 00011223
Q ss_pred CCCccchHHHHhcccCcCCCCCCChhhhhhC
Q psy758 230 VPDEMQYEEITQRCLDKDPLRRWSCDQLLRH 260 (292)
Q Consensus 230 ~~~~~~l~~li~~~l~~dP~~Rpt~~~il~h 260 (292)
...+..+.++|.+||+.||.+|||+++++++
T Consensus 227 ~~~~~~l~~li~~~l~~dp~~Rps~~ell~~ 257 (307)
T 2eva_A 227 KNLPKPIESLMTRCWSKDPSQRPSMEEIVKI 257 (307)
T ss_dssp TTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred cccCHHHHHHHHHHhcCChhhCcCHHHHHHH
Confidence 3457789999999999999999999999983
|
| >4fl3_A Tyrosine-protein kinase SYK; transferase; HET: ANP; 1.90A {Homo sapiens} PDB: 4fl2_A* 1a81_A* 1csy_A* 1csz_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.7e-38 Score=280.55 Aligned_cols=234 Identities=19% Similarity=0.263 Sum_probs=178.3
Q ss_pred eeecccCceEEEEEEE--cCCCcEEEEEEeccCCCChHHHHHHHHHHHHHHhCCCCCcchhhhhhhcCCeEEEEEecCCC
Q psy758 8 GKLGEGSYGVVFKCRN--RDTGQVVAIKKFLESEEDPLIRKIALREIRLLKSLKHPNLVNLLEVFRRKKKLHLVFEFCDH 85 (292)
Q Consensus 8 ~~l~~g~~~~v~~~~~--~~~~~~v~iK~~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~iv~e~~~~ 85 (292)
+.||+|+||.||+|.+ ..+++.||+|++..........+.+.+|+.+++.++||||+++++++.+ +..++||||+.+
T Consensus 375 ~~LG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~-~~~~lv~E~~~~ 453 (635)
T 4fl3_A 375 KELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGICEA-ESWMLVMEMAEL 453 (635)
T ss_dssp EEEEECSSEEEEEEEEECSSCEEEEEEEEECGGGGCGGGHHHHHHHHHHHHHCCCTTBCCEEEEEES-SSEEEEEECCTT
T ss_pred CEeccCCCEEEEEEEEcCCCcceEEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEec-CCEEEEEEccCC
Confidence 4799999999999954 4567889999998766555556789999999999999999999998864 558899999999
Q ss_pred ccHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEEccCCcEEEeecCchhhhhcccc--------c
Q psy758 86 TVLNELENHPHGLPWDLIKQITWQVLRGVSYCHRHACIHRDIKPENILLTANGVVKLCDFGFARLIRDLIP--------R 157 (292)
Q Consensus 86 ~~L~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~givH~dl~p~Nilv~~~~~~kl~dfg~~~~~~~~~~--------~ 157 (292)
++|.+++.....+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||+++....... .
T Consensus 454 g~L~~~l~~~~~l~~~~~~~i~~qi~~~L~yLH~~~iiHrDLkp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~~~~~ 533 (635)
T 4fl3_A 454 GPLNKYLQQNRHVKDKNIIELVHQVSMGMKYLEESNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGK 533 (635)
T ss_dssp EEHHHHHHHCTTCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEEETTEEEECCTTHHHHTTC------------
T ss_pred CCHHHHHhhCCCCCHHHHHHHHHHHHHHHHHHHHCCEeCCCCChHhEEEeCCCCEEEEEcCCccccccCccccccccCCC
Confidence 99999998877899999999999999999999999999999999999999999999999999987643211 1
Q ss_pred cccccccccccccCCCC-----CCCcccceeeecCCCCCCchHHHHHHHhhcccCCCCCCChhhhhhccCcC-CCCCCCC
Q psy758 158 HLHIFQTNEYFKGVSLP-----HAENVVPLEIKIGKPAATNIYLIDFLKRCLDKDPLRRWSCDQLLRHPYFN-GYYFEVP 231 (292)
Q Consensus 158 ~~~~~~~~~~~~~~~~~-----~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~-~~~~~~~ 231 (292)
.+..|.+||...+.... |+.|+..+++.+ .+..|+......++....... ....+..
T Consensus 534 ~t~~y~APE~~~~~~~~~~sDvwSlGv~l~ellt-----------------~G~~Pf~~~~~~~~~~~i~~~~~~~~p~~ 596 (635)
T 4fl3_A 534 WPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFS-----------------YGQKPYRGMKGSEVTAMLEKGERMGCPAG 596 (635)
T ss_dssp -CGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHT-----------------TTCCSSTTCCHHHHHHHHHTTCCCCCCTT
T ss_pred CceeeeChhhhcCCCCCcHHHHHHHHHHHHHHHh-----------------CCCCCCCCCCHHHHHHHHHcCCCCCCCCC
Confidence 11236667666544333 333333333333 134444444333332211100 1123345
Q ss_pred CccchHHHHhcccCcCCCCCCChhhhhh
Q psy758 232 DEMQYEEITQRCLDKDPLRRWSCDQLLR 259 (292)
Q Consensus 232 ~~~~l~~li~~~l~~dP~~Rpt~~~il~ 259 (292)
.+..+.+||.+||+.||++|||+++|++
T Consensus 597 ~~~~l~~li~~cl~~dP~~RPs~~~l~~ 624 (635)
T 4fl3_A 597 CPREMYDLMNLCWTYDVENRPGFAAVEL 624 (635)
T ss_dssp CCHHHHHHHHHHTCSSTTTSCCHHHHHH
T ss_pred CCHHHHHHHHHHcCCCHhHCcCHHHHHH
Confidence 5789999999999999999999999987
|
| >3uzp_A CKI-delta, CKID, casein kinase I isoform delta; CK1D, inhibitor, PF670462, transferase-transferase I complex; HET: 0CK; 1.94A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 1cki_A 1ckj_A | Back alignment and structure |
|---|
Probab=100.00 E-value=7.2e-38 Score=255.30 Aligned_cols=240 Identities=18% Similarity=0.219 Sum_probs=175.3
Q ss_pred cccceeeeecccCceEEEEEEEcCCCcEEEEEEeccCCCChHHHHHHHHHHHHHHhCCCCCcchhhhhh-hcCCeEEEEE
Q psy758 2 ERYEKIGKLGEGSYGVVFKCRNRDTGQVVAIKKFLESEEDPLIRKIALREIRLLKSLKHPNLVNLLEVF-RRKKKLHLVF 80 (292)
Q Consensus 2 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~-~~~~~~~iv~ 80 (292)
++|++.+.||+|++|.||+|.+..+++.||+|++...... +.+.+|+.+++.++|++++..+..+ .+++..++||
T Consensus 9 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~----~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~~lv~ 84 (296)
T 3uzp_A 9 NRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTKH----PQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVMVM 84 (296)
T ss_dssp TTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEEESCSSC----CHHHHHHHHHHHHTTSTTCCCEEEEEEETTEEEEEE
T ss_pred cEEEEEEEEccCCCeEEEEEEEcCCCcEEEEEEecCCcch----hHHHHHHHHHHHhhcCCCCCccccccCCCCceEEEE
Confidence 6899999999999999999999999999999998765543 2467899999999998877766655 4677899999
Q ss_pred ecCCCccHHHHhc-CCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEE---ccCCcEEEeecCchhhhhcccc
Q psy758 81 EFCDHTVLNELEN-HPHGLPWDLIKQITWQVLRGVSYCHRHACIHRDIKPENILL---TANGVVKLCDFGFARLIRDLIP 156 (292)
Q Consensus 81 e~~~~~~L~~~~~-~~~~~~~~~~~~i~~qi~~aL~~LH~~givH~dl~p~Nilv---~~~~~~kl~dfg~~~~~~~~~~ 156 (292)
||+ +++|.+++. ....+++..++.++.||+.||.|||++|++|+||||+||++ ++++.++|+|||++........
T Consensus 85 e~~-~~~L~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~dlkp~NIl~~~~~~~~~~kl~Dfg~~~~~~~~~~ 163 (296)
T 3uzp_A 85 ELL-GPSLEDLFNFCSRKFSLKTVLLLADQMISRIEYIHSKNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDART 163 (296)
T ss_dssp ECC-CCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECCGGGTTCEEECCCTTCEECBCTTT
T ss_pred Eec-CCCHHHHHHhhccCCCHHHHHHHHHHHHHHHHHHHhCCeeeCCCCHHHeEEecCCCCCeEEEeeCCCccccccccc
Confidence 999 888888886 44579999999999999999999999999999999999999 4888999999999976543221
Q ss_pred ------------ccccccccccccccCCCCCCCcccceeeecCCCCCCchHHHHHHHhhcccCCCCCCCh-------hhh
Q psy758 157 ------------RHLHIFQTNEYFKGVSLPHAENVVPLEIKIGKPAATNIYLIDFLKRCLDKDPLRRWSC-------DQL 217 (292)
Q Consensus 157 ------------~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~-------~~~ 217 (292)
..+..|.+||...+.......++|+ .+.-++..+.+..|+..... ..+
T Consensus 164 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~s-------------lG~il~~l~~g~~pf~~~~~~~~~~~~~~~ 230 (296)
T 3uzp_A 164 HQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLES-------------LGYVLMYFNLGSLPWQGLKAATKRQKYERI 230 (296)
T ss_dssp CCBCCCCCSCCCCSCTTTCCHHHHTTCCCCHHHHHHH-------------HHHHHHHHHHSSCTTSSCCCSSSSSHHHHH
T ss_pred ccccccccccccccccccCChhhhcCCCCCcchhhHH-------------HHHHHHHHHhCCCCCCCcCchhhhhhhhhh
Confidence 2233455666555443322222222 22223333444444433211 011
Q ss_pred hhccCcCC-CCCCCCCccchHHHHhcccCcCCCCCCChhhhhh
Q psy758 218 LRHPYFNG-YYFEVPDEMQYEEITQRCLDKDPLRRWSCDQLLR 259 (292)
Q Consensus 218 ~~~~~~~~-~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~~il~ 259 (292)
........ .......+..+.+||.+||+.||.+|||++++++
T Consensus 231 ~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~ 273 (296)
T 3uzp_A 231 SEKKMSTPIEVLCKGYPSEFATYLNFCRSLRFDDKPDYSYLRQ 273 (296)
T ss_dssp HHHHHHSCHHHHTTTSCHHHHHHHHHHHTSCTTCCCCHHHHHH
T ss_pred cccccCCchHHHHhhCCHHHHHHHHHHHhcCcCcCCCHHHHHH
Confidence 11000000 0011345778999999999999999999999988
|
| >4hgt_A Casein kinase I isoform delta; CK1D, inhibitor, transferase-transferase inhibitor C; HET: 15G; 1.80A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 3uzp_A* 4hnf_A* 1cki_A 1ckj_A 4hni_A* 4hok_A | Back alignment and structure |
|---|
Probab=100.00 E-value=4.5e-38 Score=256.48 Aligned_cols=240 Identities=18% Similarity=0.217 Sum_probs=172.2
Q ss_pred cccceeeeecccCceEEEEEEEcCCCcEEEEEEeccCCCChHHHHHHHHHHHHHHhCCCCCcchhhhhh-hcCCeEEEEE
Q psy758 2 ERYEKIGKLGEGSYGVVFKCRNRDTGQVVAIKKFLESEEDPLIRKIALREIRLLKSLKHPNLVNLLEVF-RRKKKLHLVF 80 (292)
Q Consensus 2 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~-~~~~~~~iv~ 80 (292)
++|++.+.||+|++|.||+|.+..+++.||+|++...... ..+.+|+.+++.++|++++..+..+ .+++..++||
T Consensus 9 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~----~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~~lv~ 84 (296)
T 4hgt_A 9 NRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTKH----PQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVMVM 84 (296)
T ss_dssp --CEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEC---C----CCHHHHHHHHHHHTTSTTCCCEEEEEEETTEEEEEE
T ss_pred CceEEeeeecCCCCeEEEEEEEcCCCceEEEEeecccccc----hHHHHHHHHHHHhcCCCCCCeeeeecCCCCceEEEE
Confidence 5899999999999999999999999999999987655432 3467899999999988877776665 5678899999
Q ss_pred ecCCCccHHHHhc-CCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEE---ccCCcEEEeecCchhhhhcccc
Q psy758 81 EFCDHTVLNELEN-HPHGLPWDLIKQITWQVLRGVSYCHRHACIHRDIKPENILL---TANGVVKLCDFGFARLIRDLIP 156 (292)
Q Consensus 81 e~~~~~~L~~~~~-~~~~~~~~~~~~i~~qi~~aL~~LH~~givH~dl~p~Nilv---~~~~~~kl~dfg~~~~~~~~~~ 156 (292)
||+ +++|.+++. ....+++..++.++.||+.||.|||++|++|+||||+||++ +.++.++|+|||++........
T Consensus 85 e~~-~~~L~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~ivH~Dlkp~NIl~~~~~~~~~~kL~Dfg~a~~~~~~~~ 163 (296)
T 4hgt_A 85 ELL-GPSLEDLFNFCSRKFSLKTVLLLADQMISRIEYIHSKNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDART 163 (296)
T ss_dssp ECC-CCBHHHHHHHTTSCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECCGGGTTCEEECCCTTCEECBCTTT
T ss_pred Ecc-CCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeeeeccCCCCeEEEecCccceeccCccc
Confidence 999 888888876 34579999999999999999999999999999999999999 7889999999999976543221
Q ss_pred ------------ccccccccccccccCCCCCCCcccceeeecCCCCCCchHHHHHHHhhcccCCCCCCChh---h----h
Q psy758 157 ------------RHLHIFQTNEYFKGVSLPHAENVVPLEIKIGKPAATNIYLIDFLKRCLDKDPLRRWSCD---Q----L 217 (292)
Q Consensus 157 ------------~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~---~----~ 217 (292)
..+..|.+||...+.......++|+ .+.-++..+.+..|+...... + +
T Consensus 164 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~s-------------lG~il~~l~~g~~pf~~~~~~~~~~~~~~~ 230 (296)
T 4hgt_A 164 HQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLES-------------LGYVLMYFNLGSLPWQGLKAATKRQKYERI 230 (296)
T ss_dssp CCBCCCCCSCCCCSCGGGCCHHHHTTCCCCHHHHHHH-------------HHHHHHHHHHSSCTTSSCCCSSSSSHHHHH
T ss_pred CccCCCCcccccCCCccccchHHhcCCCCCchhHHHH-------------HHHHHHHHhcCCCCCcccchhhhhhhhhhh
Confidence 2334455666555443322222222 222233333444444322111 1 1
Q ss_pred hhccCcCC-CCCCCCCccchHHHHhcccCcCCCCCCChhhhhh
Q psy758 218 LRHPYFNG-YYFEVPDEMQYEEITQRCLDKDPLRRWSCDQLLR 259 (292)
Q Consensus 218 ~~~~~~~~-~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~~il~ 259 (292)
........ .......+..+.+||.+||+.||++|||++++++
T Consensus 231 ~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~l~~ 273 (296)
T 4hgt_A 231 SEKKMSTPIEVLCKGYPSEFATYLNFCRSLRFDDKPDYSYLRQ 273 (296)
T ss_dssp HHHHHHSCHHHHTTTSCHHHHHHHHHHHTSCTTCCCCHHHHHH
T ss_pred hcccccchhhhhhccCCHHHHHHHHHHHhcCCCCCCCHHHHHH
Confidence 00000000 0011234778999999999999999999999988
|
| >1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=4.6e-38 Score=270.47 Aligned_cols=240 Identities=23% Similarity=0.281 Sum_probs=176.8
Q ss_pred cccceeeeecccCceEEEEEEEcCCCcEEEEEEeccCCCChHHHHHHHHHHHHHHhCCCCCcchhhhhhhcCCeEEEEEe
Q psy758 2 ERYEKIGKLGEGSYGVVFKCRNRDTGQVVAIKKFLESEEDPLIRKIALREIRLLKSLKHPNLVNLLEVFRRKKKLHLVFE 81 (292)
Q Consensus 2 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~iv~e 81 (292)
++|++.+.||+|+||.||+|.+.. +..||+|++...... .+.+.+|+.+++.++||||+++++++.+ +..++|||
T Consensus 184 ~~~~~~~~lG~G~fg~Vy~~~~~~-~~~vavK~~~~~~~~---~~~~~~E~~~l~~l~hp~iv~~~~~~~~-~~~~iv~e 258 (452)
T 1fmk_A 184 ESLRLEVKLGQGCFGEVWMGTWNG-TTRVAIKTLKPGTMS---PEAFLQEAQVMKKLRHEKLVQLYAVVSE-EPIYIVTE 258 (452)
T ss_dssp GGEEEEEEEEECSSCEEEEEEETT-TEEEEEEECCTTSSC---HHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCEEEEC
T ss_pred hHceeeeeecCCCCeEEEEEEECC-CceEEEEEeccCCCC---HHHHHHHHHHHHhCCCCCEeeEEEEEcC-CceEEEeh
Confidence 578999999999999999999875 467999999765433 3567899999999999999999999866 67899999
Q ss_pred cCCCccHHHHhcC--CCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEEccCCcEEEeecCchhhhhccc----
Q psy758 82 FCDHTVLNELENH--PHGLPWDLIKQITWQVLRGVSYCHRHACIHRDIKPENILLTANGVVKLCDFGFARLIRDLI---- 155 (292)
Q Consensus 82 ~~~~~~L~~~~~~--~~~~~~~~~~~i~~qi~~aL~~LH~~givH~dl~p~Nilv~~~~~~kl~dfg~~~~~~~~~---- 155 (292)
|+++++|.+++.. ...+++..++.++.||+.||+|||++|++||||||+||+++.++.+||+|||++.......
T Consensus 259 ~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~~~~~~ 338 (452)
T 1fmk_A 259 YMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERMNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTAR 338 (452)
T ss_dssp CCTTCBHHHHHSHHHHTTCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECGGGCEEECCCCTTC----------
T ss_pred hhcCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCChhhEEECCCCCEEECCCccceecCCCceecc
Confidence 9999999999874 2458999999999999999999999999999999999999999999999999997654321
Q ss_pred --cccccccccccccccCCCCCCCcccceeeecCCCCCCchHHHHHHHhhc-ccCCCCCCChhhhhhccCcC-CCCCCCC
Q psy758 156 --PRHLHIFQTNEYFKGVSLPHAENVVPLEIKIGKPAATNIYLIDFLKRCL-DKDPLRRWSCDQLLRHPYFN-GYYFEVP 231 (292)
Q Consensus 156 --~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~p~~~~~~~~~~~~~~~~-~~~~~~~ 231 (292)
...+..|.+||...+.......|+|++ +..++..+. +..|.......++....... ....+..
T Consensus 339 ~~~~~~~~y~aPE~~~~~~~~~~sDvwsl-------------G~~l~el~t~g~~P~~~~~~~~~~~~i~~~~~~~~~~~ 405 (452)
T 1fmk_A 339 QGAKFPIKWTAPEAALYGRFTIKSDVWSF-------------GILLTELTTKGRVPYPGMVNREVLDQVERGYRMPCPPE 405 (452)
T ss_dssp ----CCGGGSCHHHHHHCCCCHHHHHHHH-------------HHHHHHHHTTTCCSSTTCCHHHHHHHHHTTCCCCCCTT
T ss_pred cCCcccccccCHhHHhcCCCCccccHHhH-------------HHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCCCCCCC
Confidence 111234666666544433222222222 222233333 34444444433333221100 1122344
Q ss_pred CccchHHHHhcccCcCCCCCCChhhhhh
Q psy758 232 DEMQYEEITQRCLDKDPLRRWSCDQLLR 259 (292)
Q Consensus 232 ~~~~l~~li~~~l~~dP~~Rpt~~~il~ 259 (292)
.+..+.+||.+||+.||++|||++++++
T Consensus 406 ~~~~l~~li~~cl~~dP~~Rpt~~~l~~ 433 (452)
T 1fmk_A 406 CPESLHDLMCQCWRKEPEERPTFEYLQA 433 (452)
T ss_dssp SCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred CCHHHHHHHHHHccCChhhCcCHHHHHH
Confidence 5778999999999999999999999998
|
| >3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=4.1e-38 Score=264.11 Aligned_cols=244 Identities=18% Similarity=0.192 Sum_probs=170.5
Q ss_pred ccceeeeecccCceEEEEEEEcCCC---cEEEEEEeccCCCChHHHHHHHHHHHHHHhCCCCCcchhhhhhh-cCCeEEE
Q psy758 3 RYEKIGKLGEGSYGVVFKCRNRDTG---QVVAIKKFLESEEDPLIRKIALREIRLLKSLKHPNLVNLLEVFR-RKKKLHL 78 (292)
Q Consensus 3 ~y~~~~~l~~g~~~~v~~~~~~~~~---~~v~iK~~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~-~~~~~~i 78 (292)
+|++.+.||+|+||.||+|....++ ..||+|.+.... .....+.+.+|+.+++.++||||+++++++. .++..++
T Consensus 90 ~~~~~~~LG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~~l 168 (373)
T 3c1x_A 90 IVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRIT-DIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLV 168 (373)
T ss_dssp EEEEEEEEECCSSSEEEEEEEEETTTEEEEEEEEECCSCS-CSHHHHHHHHHHTTSTTCCCTTBCCCCEEECCCSSCCEE
T ss_pred eeecCcEeeeCCCeEEEEEEEECCCCcEEEEEEEEcCCCC-CHHHHHHHHHHHHHHHhCCCCCcceEEEEEEcCCCCeEE
Confidence 4788899999999999999875433 358999886543 3345677889999999999999999999854 5668899
Q ss_pred EEecCCCccHHHHhcCC-CCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEEccCCcEEEeecCchhhhhccc--
Q psy758 79 VFEFCDHTVLNELENHP-HGLPWDLIKQITWQVLRGVSYCHRHACIHRDIKPENILLTANGVVKLCDFGFARLIRDLI-- 155 (292)
Q Consensus 79 v~e~~~~~~L~~~~~~~-~~~~~~~~~~i~~qi~~aL~~LH~~givH~dl~p~Nilv~~~~~~kl~dfg~~~~~~~~~-- 155 (292)
||||+++++|.+++... ..+++..++.++.||+.||.|||++||+||||||+||+++.++.+||+|||++.......
T Consensus 169 v~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~~~~kL~DFG~a~~~~~~~~~ 248 (373)
T 3c1x_A 169 VLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKFLASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFD 248 (373)
T ss_dssp EEECCTTCBHHHHHHCTTCCCBHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTCCEEECCC------------
T ss_pred EEECCCCCCHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHHHCCEecCccchheEEECCCCCEEEeeccccccccccccc
Confidence 99999999999998764 458999999999999999999999999999999999999999999999999997653221
Q ss_pred -------cccccccccccccccCCCCCCCcccceeeecCCCCCCchHHHHHHHhhc-ccCCCCCCChhhhhhccCc-CCC
Q psy758 156 -------PRHLHIFQTNEYFKGVSLPHAENVVPLEIKIGKPAATNIYLIDFLKRCL-DKDPLRRWSCDQLLRHPYF-NGY 226 (292)
Q Consensus 156 -------~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~p~~~~~~~~~~~~~~~-~~~ 226 (292)
...+..|.+||...+.......|+|++ +.-++..+. +..|+...+..++...... ...
T Consensus 249 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSl-------------G~il~ellt~~~~p~~~~~~~~~~~~~~~~~~~ 315 (373)
T 3c1x_A 249 SVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSF-------------GVLLWELMTRGAPPYPDVNTFDITVYLLQGRRL 315 (373)
T ss_dssp ---------CCGGGSCHHHHHHCCCCHHHHHHHH-------------HHHHHHHHTTSCCSCTTSCSSCHHHHHHTTCCC
T ss_pred cccccCCCCCcccccChHHhcCCCCCcHHHHHHH-------------HHHHHHHHhCcCCCCCCCCHHHHHHHHHcCCCC
Confidence 111223666666554433322222222 222233333 2233332222222111000 011
Q ss_pred CCCCCCccchHHHHhcccCcCCCCCCChhhhhhC
Q psy758 227 YFEVPDEMQYEEITQRCLDKDPLRRWSCDQLLRH 260 (292)
Q Consensus 227 ~~~~~~~~~l~~li~~~l~~dP~~Rpt~~~il~h 260 (292)
..+...+..+.++|.+||+.||.+|||+.+++++
T Consensus 316 ~~p~~~~~~l~~li~~cl~~dp~~RPs~~ell~~ 349 (373)
T 3c1x_A 316 LQPEYCPDPLYEVMLKCWHPKAEMRPSFSELVSR 349 (373)
T ss_dssp CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred CCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence 2233457789999999999999999999999984
|
| >1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-38 Score=259.22 Aligned_cols=248 Identities=22% Similarity=0.304 Sum_probs=174.4
Q ss_pred cccceeeeecccCceEEEEEEEcC-CCc--EEEEEEeccCC-CChHHHHHHHHHHHHHHhCCCCCcchhhhhhhcCCeEE
Q psy758 2 ERYEKIGKLGEGSYGVVFKCRNRD-TGQ--VVAIKKFLESE-EDPLIRKIALREIRLLKSLKHPNLVNLLEVFRRKKKLH 77 (292)
Q Consensus 2 ~~y~~~~~l~~g~~~~v~~~~~~~-~~~--~v~iK~~~~~~-~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~ 77 (292)
++|++.+.||+|++|.||+|.+.. +++ .||+|++.... ......+.+.+|+.+++.++||||+++++++.++. .+
T Consensus 18 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~-~~ 96 (291)
T 1u46_A 18 KDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIRLYGVVLTPP-MK 96 (291)
T ss_dssp GGEEEEEECC----CCCEEEEEECTTSCEEEEEEEC--------CHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSS-CE
T ss_pred hHeeeeeeecCCCceeEEEEEeccCCCceeEEEEEEEccCccCCHHHHHHHHHHHHHHHhCCCCCcccEEEEEccCC-ce
Confidence 589999999999999999998643 333 68999986553 23455678899999999999999999999988765 88
Q ss_pred EEEecCCCccHHHHhcCC-CCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEEccCCcEEEeecCchhhhhcccc
Q psy758 78 LVFEFCDHTVLNELENHP-HGLPWDLIKQITWQVLRGVSYCHRHACIHRDIKPENILLTANGVVKLCDFGFARLIRDLIP 156 (292)
Q Consensus 78 iv~e~~~~~~L~~~~~~~-~~~~~~~~~~i~~qi~~aL~~LH~~givH~dl~p~Nilv~~~~~~kl~dfg~~~~~~~~~~ 156 (292)
+|+||+.+++|.+++... ..+++..++.++.||+.||.|||++|++|+||+|+||+++.++.++|+|||++........
T Consensus 97 ~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dikp~Nili~~~~~~kl~Dfg~~~~~~~~~~ 176 (291)
T 1u46_A 97 MVTELAPLGSLLDRLRKHQGHFLLGTLSRYAVQVAEGMGYLESKRFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDD 176 (291)
T ss_dssp EEEECCTTCBHHHHHHHHGGGSCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEEEETTEEEECCCTTCEECCC-CC
T ss_pred eeEecccCCCHHHHHHhccCCcCHHHHHHHHHHHHHHHHHHHhCCcccCCCchheEEEcCCCCEEEcccccccccccccc
Confidence 999999999999887653 4699999999999999999999999999999999999999999999999999876543211
Q ss_pred --------ccccccccccccccCCCCCCCcccceeeecCCCCCCchHHHHHHHhhc-ccCCCCCCChhhhhhccCcCC--
Q psy758 157 --------RHLHIFQTNEYFKGVSLPHAENVVPLEIKIGKPAATNIYLIDFLKRCL-DKDPLRRWSCDQLLRHPYFNG-- 225 (292)
Q Consensus 157 --------~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~p~~~~~~~~~~~~~~~~~-- 225 (292)
..+..|.+||...+.......++| +.+.-++..+. +..|.......++........
T Consensus 177 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~-------------slG~il~~l~~~g~~p~~~~~~~~~~~~~~~~~~~ 243 (291)
T 1u46_A 177 HYVMQEHRKVPFAWCAPESLKTRTFSHASDTW-------------MFGVTLWEMFTYGQEPWIGLNGSQILHKIDKEGER 243 (291)
T ss_dssp EEEC-----CCGGGCCHHHHHHCEEEHHHHHH-------------HHHHHHHHHHTTSCCTTTTCCHHHHHHHHHTSCCC
T ss_pred chhhhccCCCCceeeCchhhcCCCCCchhhHH-------------HHHHHHHHHHhCCCCCcccCCHHHHHHHHHccCCC
Confidence 112246677665443322222222 22222333333 444444444333332211111
Q ss_pred CCCCCCCccchHHHHhcccCcCCCCCCChhhhhhCCcccc
Q psy758 226 YYFEVPDEMQYEEITQRCLDKDPLRRWSCDQLLRHPYFNG 265 (292)
Q Consensus 226 ~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~~il~h~w~~~ 265 (292)
...+...+..+.++|.+||+.||.+|||+.++++ +|++
T Consensus 244 ~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~--~l~~ 281 (291)
T 1u46_A 244 LPRPEDCPQDIYNVMVQCWAHKPEDRPTFVALRD--FLLE 281 (291)
T ss_dssp CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH--HHHH
T ss_pred CCCCcCcCHHHHHHHHHHccCCcccCcCHHHHHH--HHHH
Confidence 1223345788999999999999999999999998 5554
|
| >3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4e-39 Score=267.37 Aligned_cols=259 Identities=17% Similarity=0.217 Sum_probs=170.4
Q ss_pred CcccceeeeecccCceEEEEEEEcCCCcEEEEEEeccCCCChHHHHHHHHHHHHHHhCCCCCcchhhhhh-----hcCCe
Q psy758 1 MERYEKIGKLGEGSYGVVFKCRNRDTGQVVAIKKFLESEEDPLIRKIALREIRLLKSLKHPNLVNLLEVF-----RRKKK 75 (292)
Q Consensus 1 ~~~y~~~~~l~~g~~~~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~-----~~~~~ 75 (292)
+++|++.+.||+|+||.||+|.. +++.||+|++...... ......++..+..++||||+++++.+ .....
T Consensus 12 ~~~y~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~~~~---~~~~e~~~~~~~~~~h~~i~~~~~~~~~~~~~~~~~ 86 (336)
T 3g2f_A 12 LDNLKLLELIGRGRYGAVYKGSL--DERPVAVKVFSFANRQ---NFINEKNIYRVPLMEHDNIARFIVGDERVTADGRME 86 (336)
T ss_dssp TTSEEEEEEEEECSSEEEEEEEE--TTEEEEEEEEEGGGHH---HHHHHHHHHTSTTCCCTTBCCEEEEEEEECTTSCEE
T ss_pred hHHhheeeecccCCCeEEEEEEE--CCeEEEEEEeeccchh---hHHHHHHHHHHHhccCcchhhheecccccccCCCce
Confidence 57899999999999999999976 5899999998654321 11222344445568999999998743 33456
Q ss_pred EEEEEecCCCccHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhC---------CccccCCCCCceEEccCCcEEEeecC
Q psy758 76 LHLVFEFCDHTVLNELENHPHGLPWDLIKQITWQVLRGVSYCHRH---------ACIHRDIKPENILLTANGVVKLCDFG 146 (292)
Q Consensus 76 ~~iv~e~~~~~~L~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~---------givH~dl~p~Nilv~~~~~~kl~dfg 146 (292)
+++||||+++++|.+++... ..++..++.++.||+.||.|||++ ||+||||||+||+++.++.+||+|||
T Consensus 87 ~~lv~e~~~~g~L~~~l~~~-~~~~~~~~~i~~qi~~~L~~LH~~~~~~~~~~~~ivH~Dikp~Nill~~~~~~kL~DFG 165 (336)
T 3g2f_A 87 YLLVMEYYPNGSLXKYLSLH-TSDWVSSCRLAHSVTRGLAYLHTELPRGDHYKPAISHRDLNSRNVLVKNDGTCVISDFG 165 (336)
T ss_dssp EEEEECCCTTCBHHHHHHHC-CBCHHHHHHHHHHHHHHHHHHHCCBCCGGGCBCCEECSSCSGGGEEECTTSCEEECCCT
T ss_pred EEEEEecCCCCcHHHHHhhc-ccchhHHHHHHHHHHHHHHHHHhhhccccccccceeecccccceEEEcCCCcEEEeecc
Confidence 89999999999999999764 469999999999999999999999 99999999999999999999999999
Q ss_pred chhhhhcc-------------ccccccccccccccccC------------CCCCCCcccceeeecCCCCCCchHHHHHHH
Q psy758 147 FARLIRDL-------------IPRHLHIFQTNEYFKGV------------SLPHAENVVPLEIKIGKPAATNIYLIDFLK 201 (292)
Q Consensus 147 ~~~~~~~~-------------~~~~~~~~~~~~~~~~~------------~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 201 (292)
++...... ...++..|.+||...+. ...|+.|+..+++.++..+...........
T Consensus 166 ~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~il~ell~g~~p~~~~~~~~~~~ 245 (336)
T 3g2f_A 166 LSMRLTGNRLVRPGEEDNAAISEVGTIRYMAPEVLEGAVNLRDXESALKQVDMYALGLIYWEIFMRCTDLFPGESVPEYQ 245 (336)
T ss_dssp TCEECSSSSCC---------CCTTSCGGGCCHHHHTTCCCGGGHHHHHHHHHHHHHHHHHHHHHTTBGGGSTTSCCCCCC
T ss_pred ceeecccccccCccccccccccCCCccceeCchhhcCCcccccccccccccchHHHHHHHHHHHhcCCcCCCccchhHHH
Confidence 99765321 11234567777776552 233455555555554432211000000000
Q ss_pred hhcccCCCCCCChhhhhh---cc-CcCC----CCCCCCCccchHHHHhcccCcCCCCCCChhhhhh------CCcccc
Q psy758 202 RCLDKDPLRRWSCDQLLR---HP-YFNG----YYFEVPDEMQYEEITQRCLDKDPLRRWSCDQLLR------HPYFNG 265 (292)
Q Consensus 202 ~~~~~~p~~~~~~~~~~~---~~-~~~~----~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~~il~------h~w~~~ 265 (292)
..+.......+...+... .. .... .......+..+.+||.+||+.||++|||++|+++ ++|-.+
T Consensus 246 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~e~l~~L~~ll~~~~~~ 323 (336)
T 3g2f_A 246 MAFQTEVGNHPTFEDMQVLVSREKQRPKFPEAWKENSLAVRSLKETIEDCWDQDAEARLTAQXAEERMAELMMIWERN 323 (336)
T ss_dssp CTTHHHHCSSCCHHHHHHHHTTSCCCCCCCTTCCCCSHHHHHHHHHHHHHSCSSGGGSCCHHHHHHHHHHHHHCCCC-
T ss_pred HhhhcccCCCchHHHHHhhhcccccCCCCCcccccccchHHHHHHHHHHHhcCChhhCcchHHHHHHHHHHHHHHHhc
Confidence 000000000011111100 00 0000 0001112446999999999999999999999954 566665
|
| >3op5_A Serine/threonine-protein kinase VRK1; adenosine triphosphate, amino acid sequence, binding sites, domain, models, molecular; HET: REB; 2.40A {Homo sapiens} PDB: 2lav_A 2kty_A 2kul_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-38 Score=267.30 Aligned_cols=249 Identities=13% Similarity=0.125 Sum_probs=174.7
Q ss_pred cccceeeeecccCceEEEEEEEcCC-----CcEEEEEEeccCCCChHH---------HHHHHHHHHHHHhCCCCCcchhh
Q psy758 2 ERYEKIGKLGEGSYGVVFKCRNRDT-----GQVVAIKKFLESEEDPLI---------RKIALREIRLLKSLKHPNLVNLL 67 (292)
Q Consensus 2 ~~y~~~~~l~~g~~~~v~~~~~~~~-----~~~v~iK~~~~~~~~~~~---------~~~~~~e~~~~~~l~~~~i~~~~ 67 (292)
++|++.+.||+|+||.||+|.+..+ ++.||+|++......... ......|+..++.++||||++++
T Consensus 35 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~e~~~~~~~~~~~~~~e~~~~~~l~h~~iv~~~ 114 (364)
T 3op5_A 35 AAWKVGLPIGQGGFGCIYLADMNSSESVGSDAPCVVKVEPSDNGPLFTELKFYQRAAKPEQIQKWIRTRKLKYLGVPKYW 114 (364)
T ss_dssp CEEEEEEECCCC-CCEEEEEEECCSSCCCTTCSEEEEEEETTCHHHHHHHHHHHHHCCHHHHHHHHHHTTCSCCCSCCEE
T ss_pred CeEEEEEEEecCCCeEEEEeeecCccccccccceEEEEeeccchhHHHHHHHHHhhhhhHHHHHHHHHhhccCCCCCeEE
Confidence 4899999999999999999998764 578999998655421111 12233456677788999999999
Q ss_pred hhhhcC----CeEEEEEecCCCccHHHHhcCC-CCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEEc--cCCcE
Q psy758 68 EVFRRK----KKLHLVFEFCDHTVLNELENHP-HGLPWDLIKQITWQVLRGVSYCHRHACIHRDIKPENILLT--ANGVV 140 (292)
Q Consensus 68 ~~~~~~----~~~~iv~e~~~~~~L~~~~~~~-~~~~~~~~~~i~~qi~~aL~~LH~~givH~dl~p~Nilv~--~~~~~ 140 (292)
+++.+. ...++||||+ |++|.+++... ..+++..++.++.||+.||+|||++||+||||||+|||++ .++.+
T Consensus 115 ~~~~~~~~~~~~~~lv~e~~-g~~L~~~~~~~~~~l~~~~~~~i~~qi~~~l~~lH~~~iiHrDlkp~Nill~~~~~~~~ 193 (364)
T 3op5_A 115 GSGLHDKNGKSYRFMIMDRF-GSDLQKIYEANAKRFSRKTVLQLSLRILDILEYIHEHEYVHGDIKASNLLLNYKNPDQV 193 (364)
T ss_dssp EEEEEEETTEEEEEEEEECE-EEEHHHHHHHTTSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEEESSCTTCE
T ss_pred eeeeeccCCcceEEEEEeCC-CCCHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCeEEecCCHHHEEEecCCCCeE
Confidence 998753 5689999999 99999988654 5799999999999999999999999999999999999999 88999
Q ss_pred EEeecCchhhhhcccc------------ccccccccccccccCCC-----CCCCcccceeeecCCCCCCchH-HHHHHHh
Q psy758 141 KLCDFGFARLIRDLIP------------RHLHIFQTNEYFKGVSL-----PHAENVVPLEIKIGKPAATNIY-LIDFLKR 202 (292)
Q Consensus 141 kl~dfg~~~~~~~~~~------------~~~~~~~~~~~~~~~~~-----~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~ 202 (292)
||+|||++........ .++..|.+||...+... .|+.|+..+++.+|..++.... .......
T Consensus 194 kl~DFG~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~Pf~~~~~~~~~~~~ 273 (364)
T 3op5_A 194 YLVDYGLAYRYCPEGVHKAYAADPKRCHDGTIEFTSIDAHNGVAPSRRGDLEILGYCMIQWLTGHLPWEDNLKDPKYVRD 273 (364)
T ss_dssp EECCCTTCEESSGGGCCCCSSCCSSCCCCCCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSCCTTGGGTTCHHHHHH
T ss_pred EEEECCcceecccCCcccccccCcccccCCCCCccCHHHhCCCCCCchhhHHHHHHHHHHHHhCCCCccccccCHHHHHH
Confidence 9999999976543211 13445667776655543 3444555555555555443210 0000000
Q ss_pred hcccCCCCCCChhhhhhccCcCCCCCCCCCccchHHHHhcccCcCCCCCCChhhhhh
Q psy758 203 CLDKDPLRRWSCDQLLRHPYFNGYYFEVPDEMQYEEITQRCLDKDPLRRWSCDQLLR 259 (292)
Q Consensus 203 ~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~~il~ 259 (292)
.... .+....+++...+ .....+..+.++|..||+.||.+|||+++|++
T Consensus 274 ~~~~---~~~~~~~~~~~~~-----~~~~~~~~~~~li~~cl~~~p~~RP~~~~l~~ 322 (364)
T 3op5_A 274 SKIR---YRENIASLMDKCF-----PAANAPGEIAKYMETVKLLDYTEKPLYENLRD 322 (364)
T ss_dssp HHHH---HHHCHHHHHHHHS-----CTTCCCHHHHHHHHHHHTCCTTCCCCHHHHHH
T ss_pred HHHH---hhhhHHHHHHHhc-----ccccCHHHHHHHHHHHhcCCCCCCCCHHHHHH
Confidence 0000 0001111111111 11344778999999999999999999999976
|
| >2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=9.7e-39 Score=263.19 Aligned_cols=257 Identities=18% Similarity=0.257 Sum_probs=180.3
Q ss_pred CcccceeeeecccCceEEEEEEEcCCCcEEEEEEeccCCCChHHHHHHHHHHHHHHhCCCCCcchhhhhhhcCCeEEEEE
Q psy758 1 MERYEKIGKLGEGSYGVVFKCRNRDTGQVVAIKKFLESEEDPLIRKIALREIRLLKSLKHPNLVNLLEVFRRKKKLHLVF 80 (292)
Q Consensus 1 ~~~y~~~~~l~~g~~~~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~iv~ 80 (292)
.++|++.+.||+|++|.||+|.+.. .|++|++..........+.+.+|+.+++.++||||+++++++.+++..++|+
T Consensus 32 ~~~~~~~~~lg~G~~g~V~~~~~~~---~~avk~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~iv~ 108 (319)
T 2y4i_B 32 FEQLEIGELIGKGRFGQVYHGRWHG---EVAIRLIDIERDNEDQLKAFKREVMAYRQTRHENVVLFMGACMSPPHLAIIT 108 (319)
T ss_dssp CSCEECCCBCCCSSSSEEEEEEESS---SEEEEECCCCSCCCCCCCCCCTTGGGGTTCCCTTBCCCCEEEECSSCEEEEC
T ss_pred HHHeEEeeEeccCCceEEEEEEEcC---eEEEEEeecCCCCHHHHHHHHHHHHHHhcCCCCCEeEEEEEEecCCceEEEe
Confidence 3689999999999999999998854 4999998765444334455778999999999999999999999999999999
Q ss_pred ecCCCccHHHHhcCCC-CCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEEccCCcEEEeecCchhhhhcc-----
Q psy758 81 EFCDHTVLNELENHPH-GLPWDLIKQITWQVLRGVSYCHRHACIHRDIKPENILLTANGVVKLCDFGFARLIRDL----- 154 (292)
Q Consensus 81 e~~~~~~L~~~~~~~~-~~~~~~~~~i~~qi~~aL~~LH~~givH~dl~p~Nilv~~~~~~kl~dfg~~~~~~~~----- 154 (292)
||+.+++|.+++...+ .+++..++.++.||+.||.|||++|++|+||+|+||+++ ++.++|+|||++......
T Consensus 109 e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~~~i~H~dlkp~NIl~~-~~~~~l~Dfg~~~~~~~~~~~~~ 187 (319)
T 2y4i_B 109 SLCKGRTLYSVVRDAKIVLDVNKTRQIAQEIVKGMGYLHAKGILHKDLKSKNVFYD-NGKVVITDFGLFSISGVLQAGRR 187 (319)
T ss_dssp BCCCSEEHHHHTTSSCCCCCSHHHHHHHHHHHHHHHHHHHTTCCCCCCCSTTEEEC---CCEECCCSCCC----------
T ss_pred ecccCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCChhhEEEe-CCCEEEeecCCcccccccccccc
Confidence 9999999999997654 699999999999999999999999999999999999998 679999999987654311
Q ss_pred -----ccccccccccccccccCCCCCCCcccceeeecCCCCCCchHHHHHHHhhcccCCCCCCChhhhhhccCcC--CCC
Q psy758 155 -----IPRHLHIFQTNEYFKGVSLPHAENVVPLEIKIGKPAATNIYLIDFLKRCLDKDPLRRWSCDQLLRHPYFN--GYY 227 (292)
Q Consensus 155 -----~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~--~~~ 227 (292)
....+..|.+||...+.......+. ...+...++++.+.-++..+.+..|+......+........ ...
T Consensus 188 ~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~----~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~ 263 (319)
T 2y4i_B 188 EDKLRIQNGWLCHLAPEIIRQLSPDTEEDK----LPFSKHSDVFALGTIWYELHAREWPFKTQPAEAIIWQMGTGMKPNL 263 (319)
T ss_dssp CCSCBCCSGGGGTSCHHHHSCBSCC--CCC----SCCCHHHHHHHHHHHHHHHHHSSCSSSSCCHHHHHHHHHTTCCCCC
T ss_pred ccccccCCCcccccChHHhhhccccccccc----cCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHhccCCCCCC
Confidence 1123344666665543211000000 00001111223333344444455555544444333221111 111
Q ss_pred CCCCCccchHHHHhcccCcCCCCCCChhhhhhCCccccee
Q psy758 228 FEVPDEMQYEEITQRCLDKDPLRRWSCDQLLRHPYFNGYY 267 (292)
Q Consensus 228 ~~~~~~~~l~~li~~~l~~dP~~Rpt~~~il~h~w~~~~~ 267 (292)
.....+..+.++|.+||+.||.+|||+.++++ .|+.+.
T Consensus 264 ~~~~~~~~l~~li~~~l~~~p~~Rpt~~~l~~--~l~~l~ 301 (319)
T 2y4i_B 264 SQIGMGKEISDILLFCWAFEQEERPTFTKLMD--MLEKLP 301 (319)
T ss_dssp CCSSCCTTHHHHHHHHHCSSTTTSCCHHHHHH--HHTTC-
T ss_pred CcCCCCHHHHHHHHHHhcCChhhCcCHHHHHH--HHHHHH
Confidence 12235778999999999999999999999998 555544
|
| >3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=5.3e-38 Score=260.70 Aligned_cols=243 Identities=18% Similarity=0.272 Sum_probs=169.6
Q ss_pred cccceeeeecccCceEEEEEEEcCCCcEEEEEEeccCCCChHHHHHHHHHHHHHHh--CCCCCcchhhhhhhcC----Ce
Q psy758 2 ERYEKIGKLGEGSYGVVFKCRNRDTGQVVAIKKFLESEEDPLIRKIALREIRLLKS--LKHPNLVNLLEVFRRK----KK 75 (292)
Q Consensus 2 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~e~~~~~~--l~~~~i~~~~~~~~~~----~~ 75 (292)
++|++.+.||+|+||.||+|.+. ++.||+|++.... ......|.+++.. ++||||+++++++.+. ..
T Consensus 37 ~~y~~~~~lg~G~~g~V~~~~~~--~~~vavK~~~~~~-----~~~~~~e~~~~~~~~~~h~~i~~~~~~~~~~~~~~~~ 109 (337)
T 3mdy_A 37 KQIQMVKQIGKGRYGEVWMGKWR--GEKVAVKVFFTTE-----EASWFRETEIYQTVLMRHENILGFIAADIKGTGSWTQ 109 (337)
T ss_dssp HHCEEEEEEEEETTEEEEEEEET--TEEEEEEEEEGGG-----HHHHHHHHHHHTSTTCCCTTBCCEEEEEEESCGGGCE
T ss_pred cceEEEeEeecCCCeEEEEEEEC--CceEEEEEEeccc-----cchhhhHHHHHHHHhhcCCCeeeEEEEEccCCCCCCc
Confidence 58999999999999999999886 8899999985432 1233445555554 4899999999998776 78
Q ss_pred EEEEEecCCCccHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhC--------CccccCCCCCceEEccCCcEEEeecCc
Q psy758 76 LHLVFEFCDHTVLNELENHPHGLPWDLIKQITWQVLRGVSYCHRH--------ACIHRDIKPENILLTANGVVKLCDFGF 147 (292)
Q Consensus 76 ~~iv~e~~~~~~L~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~--------givH~dl~p~Nilv~~~~~~kl~dfg~ 147 (292)
.++||||+++++|.++++.. .+++..++.++.|++.||.|||++ |++|+||||+||+++.++.+||+|||+
T Consensus 110 ~~lv~e~~~~g~L~~~l~~~-~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~ivH~Dikp~Nill~~~~~~kl~Dfg~ 188 (337)
T 3mdy_A 110 LYLITDYHENGSLYDYLKST-TLDAKSMLKLAYSSVSGLCHLHTEIFSTQGKPAIAHRDLKSKNILVKKNGTCCIADLGL 188 (337)
T ss_dssp EEEEECCCTTCBHHHHHHHC-CBCHHHHHHHHHHHHHHHHHHHSCBCSTTCBCCEECSCCCGGGEEECTTSCEEECCCTT
T ss_pred eEEEEeccCCCcHHHHhhcc-CCCHHHHHHHHHHHHHHHHHHHHhhhhhccCCCEEecccchHHEEECCCCCEEEEeCCC
Confidence 99999999999999999764 699999999999999999999999 999999999999999999999999999
Q ss_pred hhhhhccc---------cccccccccccccccCC-----------CCCCCcccceeeecCCCCCCchHHHHHHHhhcccC
Q psy758 148 ARLIRDLI---------PRHLHIFQTNEYFKGVS-----------LPHAENVVPLEIKIGKPAATNIYLIDFLKRCLDKD 207 (292)
Q Consensus 148 ~~~~~~~~---------~~~~~~~~~~~~~~~~~-----------~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 207 (292)
+....... ..++..|.+||...+.. ..|+.|+..+++.++..+..... ....
T Consensus 189 a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~el~tg~~~~~~~~--------~~~~ 260 (337)
T 3mdy_A 189 AVKFISDTNEVDIPPNTRVGTKRYMPPEVLDESLNRNHFQSYIMADMYSFGLILWEVARRCVSGGIVE--------EYQL 260 (337)
T ss_dssp CEECC---------CCSSCSCGGGCCHHHHTTCCCTTCTHHHHHHHHHHHHHHHHHHHTTBCBTTBCC--------CCCC
T ss_pred ceeeccccccccCCCCCCccCcceeChhhcccccCCccccCccccchHHHHHHHHHHHhccCcccccc--------cccc
Confidence 86543221 12345577777665432 23344444444444311100000 0011
Q ss_pred CCCCC-----ChhhhhhccCcCCCCC-------CCCCccchHHHHhcccCcCCCCCCChhhhhhC
Q psy758 208 PLRRW-----SCDQLLRHPYFNGYYF-------EVPDEMQYEEITQRCLDKDPLRRWSCDQLLRH 260 (292)
Q Consensus 208 p~~~~-----~~~~~~~~~~~~~~~~-------~~~~~~~l~~li~~~l~~dP~~Rpt~~~il~h 260 (292)
|.... ................ ....+..+.+||.+||+.||.+|||+.+++++
T Consensus 261 p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~ 325 (337)
T 3mdy_A 261 PYHDLVPSDPSYEDMREIVCIKKLRPSFPNRWSSDECLRQMGKLMTECWAHNPASRLTALRVKKT 325 (337)
T ss_dssp TTTTTSCSSCCHHHHHHHHTTSCCCCCCCGGGGGSHHHHHHHHHHHHHSCSSGGGSCCHHHHHHH
T ss_pred cHhhhcCCCCchhhhHHHHhhhccCccccccchhhHHHHHHHHHHHHhhhhChhhCCCHHHHHHH
Confidence 11111 1111111000111110 11224568999999999999999999999985
|
| >3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-37 Score=250.26 Aligned_cols=226 Identities=14% Similarity=0.052 Sum_probs=172.5
Q ss_pred cccceeeeecccCceEEEEEEEcCCCcEEEEEEeccCCC-ChHHHHHHHHHHHHHHhCCCCCcchhhhhhhcCCeEEEEE
Q psy758 2 ERYEKIGKLGEGSYGVVFKCRNRDTGQVVAIKKFLESEE-DPLIRKIALREIRLLKSLKHPNLVNLLEVFRRKKKLHLVF 80 (292)
Q Consensus 2 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~v~iK~~~~~~~-~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~iv~ 80 (292)
++|++.+.||+|+||.||+|.+..+++.||+|++..... .....+.+.+|+..+..++||||+++++++.+++..|+||
T Consensus 31 ~~y~i~~~lg~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~lv~ 110 (286)
T 3uqc_A 31 GRYRLLIFHGGVPPLQFWQALDTALDRQVALTFVDPQGVLPDDVLQETLSRTLRLSRIDKPGVARVLDVVHTRAGGLVVA 110 (286)
T ss_dssp TTEEEEEEEEBSTTCEEEEEEETTTTEEEEEEESCTTCCSCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEE
T ss_pred CcEEEEEEEcccCCeEEEEEEecCCCceEEEEEECcccccCHHHHHHHHHHHHHHhcCCCCCcceeeEEEEECCcEEEEE
Confidence 689999999999999999999999999999999976653 3556678899999999999999999999999999999999
Q ss_pred ecCCCccHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEEccCCcEEEeecCchhhhhcccccccc
Q psy758 81 EFCDHTVLNELENHPHGLPWDLIKQITWQVLRGVSYCHRHACIHRDIKPENILLTANGVVKLCDFGFARLIRDLIPRHLH 160 (292)
Q Consensus 81 e~~~~~~L~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~givH~dl~p~Nilv~~~~~~kl~dfg~~~~~~~~~~~~~~ 160 (292)
||++|++|.++++.. .....+..++.||+.||+|||++||+||||||+||+++.+|.++|++++....
T Consensus 111 e~~~g~~L~~~l~~~--~~~~~~~~i~~ql~~aL~~lH~~givH~Dikp~NIll~~~g~~kl~~~~~~~~---------- 178 (286)
T 3uqc_A 111 EWIRGGSLQEVADTS--PSPVGAIRAMQSLAAAADAAHRAGVALSIDHPSRVRVSIDGDVVLAYPATMPD---------- 178 (286)
T ss_dssp ECCCEEEHHHHHTTC--CCHHHHHHHHHHHHHHHHHHHHTTCCCCCCSGGGEEEETTSCEEECSCCCCTT----------
T ss_pred EecCCCCHHHHHhcC--CChHHHHHHHHHHHHHHHHHHHCCCccCCCCcccEEEcCCCCEEEEeccccCC----------
Confidence 999999999999753 46677899999999999999999999999999999999999999986544310
Q ss_pred ccccccccccCCCCCCCcccceeeecCCCCCCchHHHHHHHhhcccCCCCCCChhhhhhc--cCcCC-C----CCCCCCc
Q psy758 161 IFQTNEYFKGVSLPHAENVVPLEIKIGKPAATNIYLIDFLKRCLDKDPLRRWSCDQLLRH--PYFNG-Y----YFEVPDE 233 (292)
Q Consensus 161 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~--~~~~~-~----~~~~~~~ 233 (292)
.......|+.|+..+++.+|. .|+...+..+.+.. ..... . ......+
T Consensus 179 -------~~~~~Di~slG~il~elltg~------------------~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 233 (286)
T 3uqc_A 179 -------ANPQDDIRGIGASLYALLVNR------------------WPLPEAGVRSGLAPAERDTAGQPIEPADIDRDIP 233 (286)
T ss_dssp -------CCHHHHHHHHHHHHHHHHHSE------------------ECSCCCSBCCCSEECCBCTTSCBCCHHHHCTTSC
T ss_pred -------CCchhHHHHHHHHHHHHHHCC------------------CCCCcCCcchhhHHHHHHhccCCCChhhcccCCC
Confidence 111112233333334444443 33333222211100 00000 0 1123457
Q ss_pred cchHHHHhcccCcCCCCCCChhhhhhCCccccee
Q psy758 234 MQYEEITQRCLDKDPLRRWSCDQLLRHPYFNGYY 267 (292)
Q Consensus 234 ~~l~~li~~~l~~dP~~Rpt~~~il~h~w~~~~~ 267 (292)
..+.+||.+||+.||.+| |+.|+++ .|....
T Consensus 234 ~~l~~li~~~l~~dP~~R-s~~el~~--~L~~~~ 264 (286)
T 3uqc_A 234 FQISAVAARSVQGDGGIR-SASTLLN--LMQQAT 264 (286)
T ss_dssp HHHHHHHHHHHCTTSSCC-CHHHHHH--HHHHHH
T ss_pred HHHHHHHHHHcccCCccC-CHHHHHH--HHHHHh
Confidence 789999999999999999 9999999 555533
|
| >2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-37 Score=274.97 Aligned_cols=241 Identities=17% Similarity=0.213 Sum_probs=176.5
Q ss_pred cceee-eecccCceEEEEEEEcC--CCcEEEEEEeccCCCChHHHHHHHHHHHHHHhCCCCCcchhhhhhhcCCeEEEEE
Q psy758 4 YEKIG-KLGEGSYGVVFKCRNRD--TGQVVAIKKFLESEEDPLIRKIALREIRLLKSLKHPNLVNLLEVFRRKKKLHLVF 80 (292)
Q Consensus 4 y~~~~-~l~~g~~~~v~~~~~~~--~~~~v~iK~~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~iv~ 80 (292)
+.+.+ .||+|+||.||+|.+.. ++..||+|++..... ....+.+.+|+.+++.++||||+++++++.+ +..++||
T Consensus 337 ~~~~~~~LG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~-~~~~~~~~~E~~il~~l~hpniv~l~~~~~~-~~~~lv~ 414 (613)
T 2ozo_A 337 LLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTE-KADTEEMMREAQIMHQLDNPYIVRLIGVCQA-EALMLVM 414 (613)
T ss_dssp EEEEEEEEEECSSSEEEEEEEECSSCEEEEEEEECCCCCS-STTHHHHHHHHHHHTTCCCTTBCCEEEEEES-SSEEEEE
T ss_pred eeEcCcEEecCCCcEEEEEEEecCCCcEEEEEEEcCCCCC-hHHHHHHHHHHHHHHhCCCCCEeeEEEEecc-CCeEEEE
Confidence 34444 79999999999998753 456799999976532 2235678899999999999999999999875 5699999
Q ss_pred ecCCCccHHHHhcCC-CCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEEccCCcEEEeecCchhhhhcccc---
Q psy758 81 EFCDHTVLNELENHP-HGLPWDLIKQITWQVLRGVSYCHRHACIHRDIKPENILLTANGVVKLCDFGFARLIRDLIP--- 156 (292)
Q Consensus 81 e~~~~~~L~~~~~~~-~~~~~~~~~~i~~qi~~aL~~LH~~givH~dl~p~Nilv~~~~~~kl~dfg~~~~~~~~~~--- 156 (292)
||+.+|+|.+++... ..+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||+++.......
T Consensus 415 E~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~iiHrDlkp~NILl~~~~~vkL~DFGla~~~~~~~~~~~ 494 (613)
T 2ozo_A 415 EMAGGGPLHKFLVGKREEIPVSNVAELLHQVSMGMKYLEEKNFVHRNLAARNVLLVNRHYAKISDFGLSKALGADDSYYT 494 (613)
T ss_dssp ECCTTCBHHHHHTTCTTTSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEEETTEEEECCCSTTTTCC-------
T ss_pred EeCCCCcHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCCEEcCcCCHHHEEEcCCCcEEEeeccCcccccCCCceee
Confidence 999999999988643 4599999999999999999999999999999999999999999999999999986542211
Q ss_pred -----ccccccccccccccCCCCCCCcccceeeecCCCCCCchHHHHHHHhhc-ccCCCCCCChhhhhhccCcC-CCCCC
Q psy758 157 -----RHLHIFQTNEYFKGVSLPHAENVVPLEIKIGKPAATNIYLIDFLKRCL-DKDPLRRWSCDQLLRHPYFN-GYYFE 229 (292)
Q Consensus 157 -----~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~p~~~~~~~~~~~~~~~~-~~~~~ 229 (292)
..+..|.+||...+.......|+|++ +.-+++.+. +..|+...+..++....... ....+
T Consensus 495 ~~~~~~~~~~y~APE~~~~~~~~~~sDvwSl-------------Gv~l~ellt~G~~Pf~~~~~~~~~~~i~~~~~~~~p 561 (613)
T 2ozo_A 495 ARSAGKWPLKWYAPECINFRKFSSRSDVWSY-------------GVTMWEALSYGQKPYKKMKGPEVMAFIEQGKRMECP 561 (613)
T ss_dssp -------CCTTSCHHHHHHCCCCHHHHHHHH-------------HHHHHHHHTTSCCTTTTCCSHHHHHHHHTTCCCCCC
T ss_pred eccCCCCccceeCHhhhcCCCCCcHHHHHHH-------------HHHHHHHHHCCCCCCCCCCHHHHHHHHHcCCCCCCC
Confidence 11124666666544433322222222 222333332 45555544444433221111 11233
Q ss_pred CCCccchHHHHhcccCcCCCCCCChhhhhh
Q psy758 230 VPDEMQYEEITQRCLDKDPLRRWSCDQLLR 259 (292)
Q Consensus 230 ~~~~~~l~~li~~~l~~dP~~Rpt~~~il~ 259 (292)
...+..+.+||.+||+.||.+|||+.+|++
T Consensus 562 ~~~~~~l~~li~~cl~~dP~~RPs~~~l~~ 591 (613)
T 2ozo_A 562 PECPPELYALMSDCWIYKWEDRPDFLTVEQ 591 (613)
T ss_dssp TTCCHHHHHHHHHTTCSSTTTSCCHHHHHH
T ss_pred CcCCHHHHHHHHHHcCCChhHCcCHHHHHH
Confidence 456789999999999999999999999976
|
| >2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-37 Score=271.79 Aligned_cols=240 Identities=23% Similarity=0.283 Sum_probs=178.8
Q ss_pred cccceeeeecccCceEEEEEEEcCCCcEEEEEEeccCCCChHHHHHHHHHHHHHHhCCCCCcchhhhhhhcCCeEEEEEe
Q psy758 2 ERYEKIGKLGEGSYGVVFKCRNRDTGQVVAIKKFLESEEDPLIRKIALREIRLLKSLKHPNLVNLLEVFRRKKKLHLVFE 81 (292)
Q Consensus 2 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~iv~e 81 (292)
++|++.+.||+|+||.||+|.+.. +..||+|++...... .+.+.+|+.+++.++||||+++++++.+ +..++|||
T Consensus 267 ~~~~~~~~lG~G~fg~Vy~~~~~~-~~~vavK~~~~~~~~---~~~~~~E~~~l~~l~hpniv~~~~~~~~-~~~~lv~e 341 (535)
T 2h8h_A 267 ESLRLEVKLGQGCFGEVWMGTWNG-TTRVAIKTLKPGTMS---PEAFLQEAQVMKKLRHEKLVQLYAVVSE-EPIYIVTE 341 (535)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETT-TEEEEEEEECTTSSC---HHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCEEEEC
T ss_pred hhhhhheecccCCCeEEEEEEECC-CceEEEEEeCCCCCC---HHHHHHHHHHHHhCCCCCEeeEEEEEee-ccceEeee
Confidence 578999999999999999999875 467999999765433 3568899999999999999999999866 67899999
Q ss_pred cCCCccHHHHhcCC--CCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEEccCCcEEEeecCchhhhhccc----
Q psy758 82 FCDHTVLNELENHP--HGLPWDLIKQITWQVLRGVSYCHRHACIHRDIKPENILLTANGVVKLCDFGFARLIRDLI---- 155 (292)
Q Consensus 82 ~~~~~~L~~~~~~~--~~~~~~~~~~i~~qi~~aL~~LH~~givH~dl~p~Nilv~~~~~~kl~dfg~~~~~~~~~---- 155 (292)
|+.+++|.+++... ..+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||++.......
T Consensus 342 ~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~~~~~~ 421 (535)
T 2h8h_A 342 YMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERMNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTAR 421 (535)
T ss_dssp CCTTEEHHHHHSHHHHTTCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECGGGCEEECCTTSTTTCCCHHHHTT
T ss_pred hhcCCcHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCCHhhEEEcCCCcEEEcccccceecCCCceecc
Confidence 99999999998742 458999999999999999999999999999999999999999999999999997654211
Q ss_pred --cccccccccccccccCCCCCCCcccceeeecCCCCCCchHHHHHHHhhc-ccCCCCCCChhhhhhccCcC-CCCCCCC
Q psy758 156 --PRHLHIFQTNEYFKGVSLPHAENVVPLEIKIGKPAATNIYLIDFLKRCL-DKDPLRRWSCDQLLRHPYFN-GYYFEVP 231 (292)
Q Consensus 156 --~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~p~~~~~~~~~~~~~~~~-~~~~~~~ 231 (292)
...+..|.+||...+.......|+|++ +..+++.+. +..|+......+++...... ....+..
T Consensus 422 ~~~~~~~~y~aPE~~~~~~~~~~sDvwSl-------------Gv~l~el~t~g~~P~~~~~~~~~~~~i~~~~~~~~~~~ 488 (535)
T 2h8h_A 422 QGAKFPIKWTAPEAALYGRFTIKSDVWSF-------------GILLTELTTKGRVPYPGMVNREVLDQVERGYRMPCPPE 488 (535)
T ss_dssp CSTTSCGGGSCHHHHHHCCCCHHHHHHHH-------------HHHHHHHTTTTCCSSTTCCHHHHHHHHHTTCCCCCCTT
T ss_pred cCCcCcccccCHHHhccCCCCchhhHHHH-------------HHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCCCCCCC
Confidence 111234666766544433222222222 222222232 33344433333333221100 1122334
Q ss_pred CccchHHHHhcccCcCCCCCCChhhhhh
Q psy758 232 DEMQYEEITQRCLDKDPLRRWSCDQLLR 259 (292)
Q Consensus 232 ~~~~l~~li~~~l~~dP~~Rpt~~~il~ 259 (292)
.+..+.+||.+||+.||++|||+++|++
T Consensus 489 ~~~~l~~li~~cl~~dP~~RPt~~~l~~ 516 (535)
T 2h8h_A 489 CPESLHDLMCQCWRKEPEERPTFEYLQA 516 (535)
T ss_dssp CCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred CCHHHHHHHHHHcCCChhHCcCHHHHHH
Confidence 5778999999999999999999999998
|
| >1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-37 Score=257.64 Aligned_cols=243 Identities=19% Similarity=0.249 Sum_probs=174.4
Q ss_pred cccceeeeecccCceEEEEEEEcCCCcEEEEEEeccCCCChHHHHHHHHHHHHHHh--CCCCCcchhhhhhhcCC----e
Q psy758 2 ERYEKIGKLGEGSYGVVFKCRNRDTGQVVAIKKFLESEEDPLIRKIALREIRLLKS--LKHPNLVNLLEVFRRKK----K 75 (292)
Q Consensus 2 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~e~~~~~~--l~~~~i~~~~~~~~~~~----~ 75 (292)
++|++.+.||+|+||.||+|.+. ++.||+|++.... ...+.+|.+++.. ++||||+++++++...+ .
T Consensus 42 ~~y~~~~~lg~G~~g~Vy~~~~~--~~~vavK~~~~~~-----~~~~~~e~~~~~~~~l~h~ni~~~~~~~~~~~~~~~~ 114 (342)
T 1b6c_B 42 RTIVLQESIGKGRFGEVWRGKWR--GEEVAVKIFSSRE-----ERSWFREAEIYQTVMLRHENILGFIAADNKDNGTWTQ 114 (342)
T ss_dssp HHCEEEEEEEEETTEEEEEEEET--TEEEEEEEECGGG-----HHHHHHHHHHHHHSCCCCTTBCCEEEEEECCCSSCCC
T ss_pred ccEEEEeeecCCCCcEEEEEEEc--CccEEEEEeCchh-----HHHHHHHHHHHHHhhcCCCcEEEEEeeecccCCccce
Confidence 57999999999999999999884 8999999986432 3456678888887 78999999999988765 7
Q ss_pred EEEEEecCCCccHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHH--------hCCccccCCCCCceEEccCCcEEEeecCc
Q psy758 76 LHLVFEFCDHTVLNELENHPHGLPWDLIKQITWQVLRGVSYCH--------RHACIHRDIKPENILLTANGVVKLCDFGF 147 (292)
Q Consensus 76 ~~iv~e~~~~~~L~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH--------~~givH~dl~p~Nilv~~~~~~kl~dfg~ 147 (292)
.++||||+++++|.+++... .+++..++.++.||+.||.||| ++|++|+||||+||+++.++.++|+|||+
T Consensus 115 ~~lv~e~~~~g~L~~~l~~~-~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~ivH~Dlkp~NIll~~~~~~kL~Dfg~ 193 (342)
T 1b6c_B 115 LWLVSDYHEHGSLFDYLNRY-TVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGL 193 (342)
T ss_dssp EEEEECCCTTCBHHHHHHHC-CBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCEEECSCCSGGGEEECTTSCEEECCCTT
T ss_pred eEEEEeecCCCcHHHHHhcc-CccHHHHHHHHHHHHHHHHHHHHHHhhhcccCCeeeCCCCHHHEEECCCCCEEEEECCC
Confidence 99999999999999999764 6999999999999999999999 89999999999999999999999999999
Q ss_pred hhhhhccc---------cccccccccccccccC-----------CCCCCCcccceeeecCCCCCCchHHHHHHHhhcccC
Q psy758 148 ARLIRDLI---------PRHLHIFQTNEYFKGV-----------SLPHAENVVPLEIKIGKPAATNIYLIDFLKRCLDKD 207 (292)
Q Consensus 148 ~~~~~~~~---------~~~~~~~~~~~~~~~~-----------~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 207 (292)
+....... ...+..|.+||...+. ...|+.|+..+++.++....... -....
T Consensus 194 ~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~il~el~tg~~~~~~~--------~~~~~ 265 (342)
T 1b6c_B 194 AVRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIH--------EDYQL 265 (342)
T ss_dssp CEEEETTTTEEEECCCSCCCCGGGCCHHHHTSCCCTTCHHHHHHHHHHHHHHHHHHHHTTBCBTTBC--------CCCCC
T ss_pred ceeccccccccccccccCCcCcccCCHhhhcccccccccccCCcccHHHHHHHHHHHHhccCcCCcc--------ccccc
Confidence 87654322 1234456777766543 22344444444444441100000 00011
Q ss_pred CCCCC-----ChhhhhhccCcCCCCC-------CCCCccchHHHHhcccCcCCCCCCChhhhhhC
Q psy758 208 PLRRW-----SCDQLLRHPYFNGYYF-------EVPDEMQYEEITQRCLDKDPLRRWSCDQLLRH 260 (292)
Q Consensus 208 p~~~~-----~~~~~~~~~~~~~~~~-------~~~~~~~l~~li~~~l~~dP~~Rpt~~~il~h 260 (292)
|+... ....+........... ....+..+.+||.+||+.||++|||+.++++|
T Consensus 266 p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~i~~~ 330 (342)
T 1b6c_B 266 PYYDLVPSDPSVEEMRKVVCEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKT 330 (342)
T ss_dssp TTTTTSCSSCCHHHHHHHHTTSCCCCCCCGGGGTSHHHHHHHHHHHHHCCSSGGGSCCHHHHHHH
T ss_pred CccccCcCcccHHHHHHHHHHHHhCCCCcccccchhHHHHHHHHHHHHhccChhhCCCHHHHHHH
Confidence 22111 1111111111011111 11223578899999999999999999999985
|
| >2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.1e-37 Score=273.71 Aligned_cols=243 Identities=21% Similarity=0.306 Sum_probs=179.6
Q ss_pred cccceeeeecccCceEEEEEEEcCC---CcEEEEEEeccCCCChHHHHHHHHHHHHHHhCCCCCcchhhhhhhcCCeEEE
Q psy758 2 ERYEKIGKLGEGSYGVVFKCRNRDT---GQVVAIKKFLESEEDPLIRKIALREIRLLKSLKHPNLVNLLEVFRRKKKLHL 78 (292)
Q Consensus 2 ~~y~~~~~l~~g~~~~v~~~~~~~~---~~~v~iK~~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~i 78 (292)
++|++.+.||+|+||.||+|.+..+ +..||+|.+.... .....+.+.+|+.+++.++||||+++++++. ++..++
T Consensus 390 ~~y~i~~~LG~G~fG~Vy~a~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~-~~~~~l 467 (656)
T 2j0j_A 390 ERIELGRCIGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCT-SDSVREKFLQEALTMRQFDHPHIVKLIGVIT-ENPVWI 467 (656)
T ss_dssp GGEEEEEEEECCSSCCEEEEEECCSSSCCEEEEEEECSSTT-CHHHHHHHHHHHHHHHHCCCTTBCCEEEEEC-SSSCEE
T ss_pred ccEEEeeEEeeCCCEEEEEEEEecCCCccEEEEEEEecccC-CHHHHHHHHHHHHHHHhCCCCCCCeEEEEEe-cCceEE
Confidence 5799999999999999999998654 4579999886543 3455677899999999999999999999985 456899
Q ss_pred EEecCCCccHHHHhcCC-CCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEEccCCcEEEeecCchhhhhcccc-
Q psy758 79 VFEFCDHTVLNELENHP-HGLPWDLIKQITWQVLRGVSYCHRHACIHRDIKPENILLTANGVVKLCDFGFARLIRDLIP- 156 (292)
Q Consensus 79 v~e~~~~~~L~~~~~~~-~~~~~~~~~~i~~qi~~aL~~LH~~givH~dl~p~Nilv~~~~~~kl~dfg~~~~~~~~~~- 156 (292)
||||+++++|.+++... ..+++..++.++.||+.||.|||++||+||||||+||+++.++.+||+|||++........
T Consensus 468 v~E~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~aL~~LH~~givHrDikp~NILl~~~~~vkL~DFG~a~~~~~~~~~ 547 (656)
T 2j0j_A 468 IMELCTLGELRSFLQVRKFSLDLASLILYAYQLSTALAYLESKRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYY 547 (656)
T ss_dssp EEECCTTCBHHHHHHHTTTTCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEEETTEEEECCCCCCCSCCC----
T ss_pred EEEcCCCCcHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCCccccccchHhEEEeCCCCEEEEecCCCeecCCCcce
Confidence 99999999999998743 3689999999999999999999999999999999999999999999999999976543211
Q ss_pred -----ccccccccccccccCCCCCCCcccceeeecCCCCCCchHHHHHHHhhc-ccCCCCCCChhhhhhccCc-CCCCCC
Q psy758 157 -----RHLHIFQTNEYFKGVSLPHAENVVPLEIKIGKPAATNIYLIDFLKRCL-DKDPLRRWSCDQLLRHPYF-NGYYFE 229 (292)
Q Consensus 157 -----~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~p~~~~~~~~~~~~~~~-~~~~~~ 229 (292)
..+..|.+||...+.......|+|+++ .-++..+. +..|+......+....... .....+
T Consensus 548 ~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG-------------~il~ellt~g~~Pf~~~~~~~~~~~i~~~~~~~~~ 614 (656)
T 2j0j_A 548 KASKGKLPIKWMAPESINFRRFTSASDVWMFG-------------VCMWEILMHGVKPFQGVKNNDVIGRIENGERLPMP 614 (656)
T ss_dssp ------CCGGGCCHHHHHHCCCCHHHHHHHHH-------------HHHHHHHTTSCCTTTTCCHHHHHHHHHHTCCCCCC
T ss_pred eccCCCCCcceeCHHHhcCCCCCchhhHHHHH-------------HHHHHHHHcCCCCCCCCCHHHHHHHHHcCCCCCCC
Confidence 112346677665544333222332222 22222232 3344443333333221110 011233
Q ss_pred CCCccchHHHHhcccCcCCCCCCChhhhhh
Q psy758 230 VPDEMQYEEITQRCLDKDPLRRWSCDQLLR 259 (292)
Q Consensus 230 ~~~~~~l~~li~~~l~~dP~~Rpt~~~il~ 259 (292)
...+..+.+||.+||+.||.+|||+.++++
T Consensus 615 ~~~~~~l~~li~~~l~~dP~~RPs~~el~~ 644 (656)
T 2j0j_A 615 PNCPPTLYSLMTKCWAYDPSRRPRFTELKA 644 (656)
T ss_dssp TTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred ccccHHHHHHHHHHcCCChhHCcCHHHHHH
Confidence 455789999999999999999999999987
|
| >3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.7e-37 Score=257.14 Aligned_cols=242 Identities=17% Similarity=0.152 Sum_probs=174.1
Q ss_pred cccceeeeecccCceEEEEE-----EEcCCCcEEEEEEeccCCCChHHHHHHHHHHHHHHhCC---CCCcchhhhhhhcC
Q psy758 2 ERYEKIGKLGEGSYGVVFKC-----RNRDTGQVVAIKKFLESEEDPLIRKIALREIRLLKSLK---HPNLVNLLEVFRRK 73 (292)
Q Consensus 2 ~~y~~~~~l~~g~~~~v~~~-----~~~~~~~~v~iK~~~~~~~~~~~~~~~~~e~~~~~~l~---~~~i~~~~~~~~~~ 73 (292)
++|++.+.||+|+||.||+| .+..+++.||+|++.... ...+..|..+++.++ |+||+++++++...
T Consensus 65 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~-----~~~~~~e~~~~~~l~~~~~~~iv~~~~~~~~~ 139 (365)
T 3e7e_A 65 KLVYVHHLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKPAN-----PWEFYIGTQLMERLKPSMQHMFMKFYSAHLFQ 139 (365)
T ss_dssp SEEEEEEEEEECSSEEEEEEEC-------CCCCEEEEEESSCC-----HHHHHHHHHHHHHSCGGGGGGBCCEEEEEECS
T ss_pred EEEEEEEEeeccCCEEEEEEEecCCcccccCcEEEEEEeCCCC-----hhHHHHHHHHHHHhhhhhhhhhhhhheeeecC
Confidence 47999999999999999999 467789999999986543 234667777777776 89999999999999
Q ss_pred CeEEEEEecCCCccHHHHhc-----CCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEEcc-----------C
Q psy758 74 KKLHLVFEFCDHTVLNELEN-----HPHGLPWDLIKQITWQVLRGVSYCHRHACIHRDIKPENILLTA-----------N 137 (292)
Q Consensus 74 ~~~~iv~e~~~~~~L~~~~~-----~~~~~~~~~~~~i~~qi~~aL~~LH~~givH~dl~p~Nilv~~-----------~ 137 (292)
+..++||||+++|+|.+++. ....+++..++.++.||+.||+|||++||+||||||+|||++. +
T Consensus 140 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~L~~lH~~~ivHrDiKp~NIll~~~~~~~~~~~~~~ 219 (365)
T 3e7e_A 140 NGSVLVGELYSYGTLLNAINLYKNTPEKVMPQGLVISFAMRMLYMIEQVHDCEIIHGDIKPDNFILGNGFLEQDDEDDLS 219 (365)
T ss_dssp SCEEEEECCCCSCBHHHHHHHHHTSTTCSCCHHHHHHHHHHHHHHHHHHHTTTEECCCCSGGGEEECGGGTCC------C
T ss_pred CCcEEEEeccCCCcHHHHHHHhhcccccCCCHHHHHHHHHHHHHHHHHHhhCCeecCCCCHHHEEecccccCcccccccc
Confidence 99999999999999999986 3557999999999999999999999999999999999999998 8
Q ss_pred CcEEEeecCchhhhhcc-------ccccccccccccccccCCCCCCCcccceeeecCCCCCCchHHHHHHHhhcccCCCC
Q psy758 138 GVVKLCDFGFARLIRDL-------IPRHLHIFQTNEYFKGVSLPHAENVVPLEIKIGKPAATNIYLIDFLKRCLDKDPLR 210 (292)
Q Consensus 138 ~~~kl~dfg~~~~~~~~-------~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~p~~ 210 (292)
+.+||+|||++...... ...++..|.+||...+.......|+|++ +..++..+.+..|+.
T Consensus 220 ~~~kl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Diwsl-------------G~il~elltg~~pf~ 286 (365)
T 3e7e_A 220 AGLALIDLGQSIDMKLFPKGTIFTAKCETSGFQCVEMLSNKPWNYQIDYFGV-------------AATVYCMLFGTYMKV 286 (365)
T ss_dssp TTEEECCCTTCEEGGGSCTTEEECCSSCTTSCCCHHHHTTCCBSTHHHHHHH-------------HHHHHHHHHSSCCCE
T ss_pred CCEEEeeCchhhhhhccCCCceeeeecCCCCCCChHHhcCCCCCccccHHHH-------------HHHHHHHHhCCCccc
Confidence 99999999999654311 1223455667776655543333333322 223334444444432
Q ss_pred CCChhhhhhccCcCCCCCCCCCccchHHHHhcccCcCCCCCCChhhhhhC---Ccccc
Q psy758 211 RWSCDQLLRHPYFNGYYFEVPDEMQYEEITQRCLDKDPLRRWSCDQLLRH---PYFNG 265 (292)
Q Consensus 211 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~~il~h---~w~~~ 265 (292)
............+ .....+..+.+++..||+.+|.+|++..+.+.+ .|+..
T Consensus 287 ~~~~~~~~~~~~~----~~~~~~~~~~~~~~~~l~~~p~~r~~~~~~l~~~l~~~l~~ 340 (365)
T 3e7e_A 287 KNEGGECKPEGLF----RRLPHLDMWNEFFHVMLNIPDCHHLPSLDLLRQKLKKVFQQ 340 (365)
T ss_dssp EEETTEEEECSCC----TTCSSHHHHHHHHHHHHCCCCTTCCCCHHHHHHHHHHHHHH
T ss_pred cCCCCceeechhc----cccCcHHHHHHHHHHHcCCCCCCcchHHHHHHHHHHHHHHH
Confidence 2111111111111 112346688999999999999999765555443 44444
|
| >3sv0_A Casein kinase I-like; typical kinase domain fold, cytosol, transferase; 2.00A {Oryza sativa japonica group} | Back alignment and structure |
|---|
Probab=100.00 E-value=9e-37 Score=263.04 Aligned_cols=251 Identities=18% Similarity=0.209 Sum_probs=178.6
Q ss_pred cccceeeeecccCceEEEEEEEcCCCcEEEEEEeccCCCChHHHHHHHHHHHHHHhCCCC-CcchhhhhhhcCCeEEEEE
Q psy758 2 ERYEKIGKLGEGSYGVVFKCRNRDTGQVVAIKKFLESEEDPLIRKIALREIRLLKSLKHP-NLVNLLEVFRRKKKLHLVF 80 (292)
Q Consensus 2 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~e~~~~~~l~~~-~i~~~~~~~~~~~~~~iv~ 80 (292)
++|++.+.||+|+||.||+|.+..+++.||||++...... ..+.+|+.+++.++|+ ++..+..+..+.+..++||
T Consensus 7 ~~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~~----~~~~~E~~il~~L~~~~~i~~i~~~~~~~~~~~lvm 82 (483)
T 3sv0_A 7 NKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKH----PQLLYESKIYRILQGGTGIPNVRWFGVEGDYNVLVM 82 (483)
T ss_dssp TTEECCCCCEECSSCEEEEEEETTTCCEEEEEEEETTCSS----CCHHHHHHHHHHTTTSTTCCCEEEEEEETTEEEEEE
T ss_pred CcEEEEEEEeeCCCEEEEEEEECCCCcEEEEEEecccccc----HHHHHHHHHHHHhcCCCCCCeEEEEEeeCCEEEEEE
Confidence 6899999999999999999999999999999988755433 2367899999999875 4555555556788899999
Q ss_pred ecCCCccHHHHhcC-CCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEE---ccCCcEEEeecCchhhhhcccc
Q psy758 81 EFCDHTVLNELENH-PHGLPWDLIKQITWQVLRGVSYCHRHACIHRDIKPENILL---TANGVVKLCDFGFARLIRDLIP 156 (292)
Q Consensus 81 e~~~~~~L~~~~~~-~~~~~~~~~~~i~~qi~~aL~~LH~~givH~dl~p~Nilv---~~~~~~kl~dfg~~~~~~~~~~ 156 (292)
||+ +++|.+++.. ...+++..++.++.||+.||.|||++||+||||||+|||+ +.++.+||+|||++........
T Consensus 83 e~~-g~sL~~ll~~~~~~l~~~~~~~i~~qi~~aL~yLH~~gIvHrDIKP~NILl~~~~~~~~vkL~DFGla~~~~~~~~ 161 (483)
T 3sv0_A 83 DLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDTST 161 (483)
T ss_dssp ECC-CCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECCGGGTTCEEECCCTTCEECBCTTT
T ss_pred ECC-CCCHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHCCEeecccCcceEEEecCCCCCeEEEEeCCcceeccCCcc
Confidence 999 8888888863 4579999999999999999999999999999999999999 6889999999999976643221
Q ss_pred ------------ccccccccccccccCCCCCCCcccceeeecCCCCCCchHHHHHHHhhcccCCCCCCCh---hhhh---
Q psy758 157 ------------RHLHIFQTNEYFKGVSLPHAENVVPLEIKIGKPAATNIYLIDFLKRCLDKDPLRRWSC---DQLL--- 218 (292)
Q Consensus 157 ------------~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~---~~~~--- 218 (292)
..+..|.+||...+.......|+| +.++.++..+.+..|+..... .+.+
T Consensus 162 ~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~~sDvw-------------SlGvil~elltG~~Pf~~~~~~~~~~~~~~i 228 (483)
T 3sv0_A 162 HQHIPYRENKNLTGTARYASVNTHLGIEQSRRDDLE-------------SLGYVLMYFLRGSLPWQGLKAGTKKQKYEKI 228 (483)
T ss_dssp CCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHH-------------HHHHHHHHHHHSSCTTSSCCCSSHHHHHHHH
T ss_pred ccccccccccccCCCccccCHHHhcCCCCChHHHHH-------------HHHHHHHHHHhCCCCCccccchhHHHHHHHH
Confidence 223345566555544332222222 222223333334444333221 1110
Q ss_pred -hccCcCC-CCCCCCCccchHHHHhcccCcCCCCCCChhhhhh----------CCcccceeccC
Q psy758 219 -RHPYFNG-YYFEVPDEMQYEEITQRCLDKDPLRRWSCDQLLR----------HPYFNGYYFEV 270 (292)
Q Consensus 219 -~~~~~~~-~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~~il~----------h~w~~~~~~~~ 270 (292)
....... .......+..+.+||.+||+.||.+||++++|++ ++|+..+.|+.
T Consensus 229 ~~~~~~~~~~~l~~~~p~~l~~li~~cl~~dP~~RPs~~el~~~L~~l~~~~~~~~~~~~dW~~ 292 (483)
T 3sv0_A 229 SEKKVATSIEALCRGYPTEFASYFHYCRSLRFDDKPDYSYLKRLFRDLFIREGFQFDYVFDWTI 292 (483)
T ss_dssp HHHHHHSCHHHHHTTSCHHHHHHHHHHHTCCTTCCCCHHHHHHHHHHHHHHTTCCCSSCCHHHH
T ss_pred hhccccccHHHHhcCCcHHHHHHHHHHhcCChhhCcCHHHHHHHHHHHHHHcCCCccCCcCchh
Confidence 0000000 0011234678999999999999999999998865 56666666663
|
| >3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.6e-37 Score=261.30 Aligned_cols=256 Identities=14% Similarity=0.038 Sum_probs=171.9
Q ss_pred ccceeeeecccCceEEEEEEEcCCCcEEEEEEeccCC-CChHHHHHHHHHHHHHHhCCC-CCcchhhhh-----------
Q psy758 3 RYEKIGKLGEGSYGVVFKCRNRDTGQVVAIKKFLESE-EDPLIRKIALREIRLLKSLKH-PNLVNLLEV----------- 69 (292)
Q Consensus 3 ~y~~~~~l~~g~~~~v~~~~~~~~~~~v~iK~~~~~~-~~~~~~~~~~~e~~~~~~l~~-~~i~~~~~~----------- 69 (292)
.|.+.+.||+|+||.||+|.+..+|+.||+|++.... ......+.+.+|+.+++.++| ++...+...
T Consensus 79 ~~~~~~~LG~G~fG~Vy~a~~~~~g~~vAvK~~~~~~~~~~~~~~~~~~E~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~ 158 (413)
T 3dzo_A 79 TLVRGTVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAKVHLRFIFPFDLVK 158 (413)
T ss_dssp EEEEEEEEEEETTEEEEEEEETTTCCEEEEEEECCSCC----CCHHHHHHHHGGGGSTTCCSHHHHHHHTCBCCCCEEEE
T ss_pred eEEEecccccCCCEEEEEEEecCCCCceEEEEEecCCCccHHHHHHHHHHHHHHHhhccCCCHHHHHHhcccccchhhcc
Confidence 4778899999999999999999999999999987443 222335678899999999987 433333222
Q ss_pred ----------hhc-----CCeEEEEEecCCCccHHHHhc-------CCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCC
Q psy758 70 ----------FRR-----KKKLHLVFEFCDHTVLNELEN-------HPHGLPWDLIKQITWQVLRGVSYCHRHACIHRDI 127 (292)
Q Consensus 70 ----------~~~-----~~~~~iv~e~~~~~~L~~~~~-------~~~~~~~~~~~~i~~qi~~aL~~LH~~givH~dl 127 (292)
+.. ...++++|+++. ++|.+++. ....+++..++.++.||+.||+|||++||+||||
T Consensus 159 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~L~~ll~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~iiHrDi 237 (413)
T 3dzo_A 159 DPQKKKMIRVRLDERDMWVLSRFFLYPRMQ-SNLQTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLASLHHYGLVHTYL 237 (413)
T ss_dssp CCC---------------CCSEEEEEECCS-EEHHHHHHHHHHHTTTSHHHHHHHHHHHHHHHHHHHHHHHHTTEECSCC
T ss_pred cCCCCccccccCCCccccccceEEEeehhc-CCHHHHHHHhhcccccCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCc
Confidence 111 224677777665 66777663 1334788899999999999999999999999999
Q ss_pred CCCceEEccCCcEEEeecCchhhhhccc--cccccccccccccccCCCCCCCcccceeeecCCCCCCchHHHHHHHhhcc
Q psy758 128 KPENILLTANGVVKLCDFGFARLIRDLI--PRHLHIFQTNEYFKGVSLPHAENVVPLEIKIGKPAATNIYLIDFLKRCLD 205 (292)
Q Consensus 128 ~p~Nilv~~~~~~kl~dfg~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 205 (292)
||+|||++.++.+||+|||+++...... ..+ ..|.+||...+....... ..........++++.+..++..+.+
T Consensus 238 Kp~NILl~~~~~~kL~DFG~a~~~~~~~~~~~g-~~y~aPE~~~~~~~~~~~---~~~~~~~~~~DvwSlGvil~elltg 313 (413)
T 3dzo_A 238 RPVDIVLDQRGGVFLTGFEHLVRDGASAVSPIG-RGFAPPETTAERMLPFGQ---HHPTLMTFAFDTWTLGLAIYWIWCA 313 (413)
T ss_dssp CGGGEEECTTCCEEECCGGGCEETTEEECCCCC-TTTCCHHHHHHHTSTTGG---GCCEEECHHHHHHHHHHHHHHHHHS
T ss_pred ccceEEEecCCeEEEEeccceeecCCccccCCC-CceeCchhhhcccccccc---ccCcCCCchhhHHHHHHHHHHHHHC
Confidence 9999999999999999999987655421 122 456666665221100000 0000011111223333334444445
Q ss_pred cCCCCCCChhhhhhccCcCCCCCCCCCccchHHHHhcccCcCCCCCCChhhhhhCCccccee
Q psy758 206 KDPLRRWSCDQLLRHPYFNGYYFEVPDEMQYEEITQRCLDKDPLRRWSCDQLLRHPYFNGYY 267 (292)
Q Consensus 206 ~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~~il~h~w~~~~~ 267 (292)
..|+......+.....+ ......+..+.+||.+||+.||.+|||+.++++||||+++.
T Consensus 314 ~~Pf~~~~~~~~~~~~~----~~~~~~~~~~~~li~~~l~~dP~~Rpt~~~~l~~~~~~~~~ 371 (413)
T 3dzo_A 314 DLPNTDDAALGGSEWIF----RSCKNIPQPVRALLEGFLRYPKEDRLLPLQAMETPEYEQLR 371 (413)
T ss_dssp SCCCCTTGGGSCSGGGG----SSCCCCCHHHHHHHHHHTCSSGGGSCCHHHHTTSHHHHHHH
T ss_pred CCCCCCcchhhhHHHHH----hhcccCCHHHHHHHHHHccCChhhCcCHHHHHhCHHHHHHH
Confidence 55554433333322221 11234578999999999999999999999999999999854
|
| >2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.1e-37 Score=277.84 Aligned_cols=240 Identities=22% Similarity=0.314 Sum_probs=175.1
Q ss_pred cccceeeeecccCceEEEEEEEcC-CCcEEEEEEeccCCCChHHHHHHHHHHHHHHhCCCCCcchhhhhhhcCCe-----
Q psy758 2 ERYEKIGKLGEGSYGVVFKCRNRD-TGQVVAIKKFLESEEDPLIRKIALREIRLLKSLKHPNLVNLLEVFRRKKK----- 75 (292)
Q Consensus 2 ~~y~~~~~l~~g~~~~v~~~~~~~-~~~~v~iK~~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~----- 75 (292)
++|++.+.||+|+||.||+|.+.. +++.||+|++.... .......+.+|+.+++.++||||+++++++.+.+.
T Consensus 80 ~~y~i~~~lg~G~~g~Vy~a~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~~~~ 158 (681)
T 2pzi_A 80 GQYEVKGCIAHGGLGWIYLALDRNVNGRPVVLKGLVHSG-DAEAQAMAMAERQFLAEVVHPSIVQIFNFVEHTDRHGDPV 158 (681)
T ss_dssp TTEEEEEEEEEETTEEEEEEEEGGGTTEEEEEEESCSSC-CHHHHHHHHHHHGGGGGCCCTTBCCEEEEEEEECTTSCEE
T ss_pred CceEEEEEEeeCCCeEEEEEEEcCCCCcEEEEEEeCccC-CHHHHHHHHHHHHHHHhcCCCCcCeEeeeEeecCCCCCce
Confidence 689999999999999999999976 78999999886543 34556678899999999999999999999886554
Q ss_pred EEEEEecCCCccHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEEccCCcEEEeecCchhhhhccc
Q psy758 76 LHLVFEFCDHTVLNELENHPHGLPWDLIKQITWQVLRGVSYCHRHACIHRDIKPENILLTANGVVKLCDFGFARLIRDLI 155 (292)
Q Consensus 76 ~~iv~e~~~~~~L~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~givH~dl~p~Nilv~~~~~~kl~dfg~~~~~~~~~ 155 (292)
.|+||||++|++|.+++.. .+++..++.++.||+.||.|||++||+|+||||+||+++.+ .+||+|||++.......
T Consensus 159 ~~lv~E~~~g~~L~~~~~~--~l~~~~~~~~~~qi~~aL~~lH~~giiHrDlkp~NIll~~~-~~kl~DFG~a~~~~~~~ 235 (681)
T 2pzi_A 159 GYIVMEYVGGQSLKRSKGQ--KLPVAEAIAYLLEILPALSYLHSIGLVYNDLKPENIMLTEE-QLKLIDLGAVSRINSFG 235 (681)
T ss_dssp EEEEEECCCCEECC----C--CCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECSS-CEEECCCTTCEETTCCS
T ss_pred eEEEEEeCCCCcHHHHHhC--CCCHHHHHHHHHHHHHHHHHHHHCCCeecccChHHeEEeCC-cEEEEecccchhcccCC
Confidence 7999999999999998765 69999999999999999999999999999999999999986 89999999997665432
Q ss_pred -cccccccccccccccCCCCCCCcccceeeecCCCCCCchHHHHHHHhhcccCCCCCCChhhhhhccCcCCCCCCCCCcc
Q psy758 156 -PRHLHIFQTNEYFKGVSLPHAENVVPLEIKIGKPAATNIYLIDFLKRCLDKDPLRRWSCDQLLRHPYFNGYYFEVPDEM 234 (292)
Q Consensus 156 -~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 234 (292)
..++..|.+||...+.. ....++|+ .+..++..+.+..|........+ .........+.
T Consensus 236 ~~~gt~~y~aPE~~~~~~-~~~sDi~s-------------lG~~l~~l~~g~~~~~~~~~~~~------~~~~~~~~~~~ 295 (681)
T 2pzi_A 236 YLYGTPGFQAPEIVRTGP-TVATDIYT-------------VGRTLAALTLDLPTRNGRYVDGL------PEDDPVLKTYD 295 (681)
T ss_dssp CCCCCTTTSCTTHHHHCS-CHHHHHHH-------------HHHHHHHHHSCCCEETTEECSSC------CTTCHHHHHCH
T ss_pred ccCCCccccCHHHHcCCC-CCceehhh-------------hHHHHHHHHhCCCCCcccccccc------cccccccccCH
Confidence 22334455665543321 11222222 22223333333222221100000 00000011246
Q ss_pred chHHHHhcccCcCCCCCCChhhhhhCCcccc
Q psy758 235 QYEEITQRCLDKDPLRRWSCDQLLRHPYFNG 265 (292)
Q Consensus 235 ~l~~li~~~l~~dP~~Rpt~~~il~h~w~~~ 265 (292)
.+.+||.+||+.||.+||++.+.+.|+|+.-
T Consensus 296 ~l~~li~~~l~~dP~~R~~~~~~l~~~l~~~ 326 (681)
T 2pzi_A 296 SYGRLLRRAIDPDPRQRFTTAEEMSAQLTGV 326 (681)
T ss_dssp HHHHHHHHHTCSSGGGSCSSHHHHHHHHHHH
T ss_pred HHHHHHhhhccCChhhCCCHHHHHHHHHHHH
Confidence 7899999999999999999999999998754
|
| >4azs_A Methyltransferase WBDD; kinase; HET: AMP SAM; 2.15A {Escherichia coli} PDB: 4azt_A* 4azv_A* 4azw_A* | Back alignment and structure |
|---|
Probab=99.97 E-value=2.9e-32 Score=239.50 Aligned_cols=173 Identities=16% Similarity=0.109 Sum_probs=123.4
Q ss_pred eecccCceEEEEEEEcCCCcEEEEEEeccCCC--------ChHHHHHHHHHHHHHHhC-CCCCcchhhhhhhcCCeEEEE
Q psy758 9 KLGEGSYGVVFKCRNRDTGQVVAIKKFLESEE--------DPLIRKIALREIRLLKSL-KHPNLVNLLEVFRRKKKLHLV 79 (292)
Q Consensus 9 ~l~~g~~~~v~~~~~~~~~~~v~iK~~~~~~~--------~~~~~~~~~~e~~~~~~l-~~~~i~~~~~~~~~~~~~~iv 79 (292)
....|+.|....++....|+.|++|++..... .....+.+.+|+++++++ .|+||+++++++++++..|+|
T Consensus 241 ~~~~~~~~~h~~~rr~~fg~~~~~K~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~~~~~~ed~~~~yLV 320 (569)
T 4azs_A 241 QPYAGAGLAHKRSRRYFFGEDYVCKFFYYDMPHGILTAEESQRNKYELHNEIKFLTQPPAGFDAPAVLAHGENAQSGWLV 320 (569)
T ss_dssp C-C--------CCEEEEECSSEEEEEEESSCSTTCSCHHHHHHHHHHHHHHHHHHHSCCTTCCCCCEEEEEECSSEEEEE
T ss_pred ccccCCcccccccccccccceeEEEEEecccccccchhhhhHHHHHHHHHHHHHHHhcCCCCCeeEEEEEEEECCEEEEE
Confidence 35567777777777777899999999975531 123456789999999999 699999999999999999999
Q ss_pred EecCCCccHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEEccCCcEEEeecCchhhhhcccccc-
Q psy758 80 FEFCDHTVLNELENHPHGLPWDLIKQITWQVLRGVSYCHRHACIHRDIKPENILLTANGVVKLCDFGFARLIRDLIPRH- 158 (292)
Q Consensus 80 ~e~~~~~~L~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~givH~dl~p~Nilv~~~~~~kl~dfg~~~~~~~~~~~~- 158 (292)
|||++|++|.+++...+.+++. .|+.||+.||+|+|++||+||||||+|||++++|.+||+|||+++.........
T Consensus 321 MEyv~G~~L~d~i~~~~~l~~~---~I~~QIl~AL~ylH~~GIIHRDIKPeNILL~~dg~vKL~DFGlAr~~~~~~~~~~ 397 (569)
T 4azs_A 321 MEKLPGRLLSDMLAAGEEIDRE---KILGSLLRSLAALEKQGFWHDDVRPWNVMVDARQHARLIDFGSIVTTPQDCSWPT 397 (569)
T ss_dssp EECCCSEEHHHHHHTTCCCCHH---HHHHHHHHHHHHHHHTTCEESCCCGGGEEECTTSCEEECCCTTEESCC---CCSH
T ss_pred EecCCCCcHHHHHHhCCCCCHH---HHHHHHHHHHHHHHHCCceeccCchHhEEECCCCCEEEeecccCeeCCCCCcccc
Confidence 9999999999999988888765 488999999999999999999999999999999999999999998765433222
Q ss_pred ----ccccccccccccCCCCCCCcccceeee
Q psy758 159 ----LHIFQTNEYFKGVSLPHAENVVPLEIK 185 (292)
Q Consensus 159 ----~~~~~~~~~~~~~~~~~~~~~~~~~~~ 185 (292)
+..|.+||...|.. .+..++++..+.
T Consensus 398 t~vGTp~YmAPE~l~g~~-~~~~d~~s~g~~ 427 (569)
T 4azs_A 398 NLVQSFFVFVNELFAENK-SWNGFWRSAPVH 427 (569)
T ss_dssp HHHHHHHHHHHHHC-----------------
T ss_pred CceechhhccHHHhCCCC-CCcccccccccc
Confidence 33455566555432 233444444433
|
| >1zar_A RIO2 kinase; serine kinase, winged-helix, RIO domain, ADP-Mn complex, rRNA processing, transferase; HET: ADP; 1.75A {Archaeoglobus fulgidus} SCOP: a.4.5.56 d.144.1.9 PDB: 1tqi_A* 1tqp_A* 1tqm_A* 1zao_A* | Back alignment and structure |
|---|
Probab=99.93 E-value=3.7e-26 Score=184.02 Aligned_cols=135 Identities=19% Similarity=0.222 Sum_probs=110.9
Q ss_pred cceeeeecccCceEEEEEEEcCCCcEEEEEEeccCCCCh----------------HHHHHHHHHHHHHHhCCCCCcchhh
Q psy758 4 YEKIGKLGEGSYGVVFKCRNRDTGQVVAIKKFLESEEDP----------------LIRKIALREIRLLKSLKHPNLVNLL 67 (292)
Q Consensus 4 y~~~~~l~~g~~~~v~~~~~~~~~~~v~iK~~~~~~~~~----------------~~~~~~~~e~~~~~~l~~~~i~~~~ 67 (292)
|.+.+.||+|++|.||+|.+ .+|+.||+|.+....... .....+.+|+.+++.++ | +++.
T Consensus 92 ~~~~~~iG~G~~g~Vy~~~~-~~g~~valK~~~~~~~~~~~~~~~~~~~~~~w~~~~~~~~~~E~~~l~~l~--~-~~v~ 167 (282)
T 1zar_A 92 DAIGKLMGEGKESAVFNCYS-EKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEFRALQKLQ--G-LAVP 167 (282)
T ss_dssp SEEEEEEEECSSEEEEEEEE-TTTEEEEEEEECC------CCCC-------CHHHHHHHHHHHHHHHHHHTT--T-SSSC
T ss_pred EEecCEeccCCCceEEEEEe-CCCCEEEEEEEECCCCchhhhhhhhhhcchhhHHHHHHHHHHHHHHHHhcc--C-CCcC
Confidence 44569999999999999999 789999999986433211 24567889999999999 5 6666
Q ss_pred hhhhcCCeEEEEEecCCCccHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEEccCCcEEEeecCc
Q psy758 68 EVFRRKKKLHLVFEFCDHTVLNELENHPHGLPWDLIKQITWQVLRGVSYCHRHACIHRDIKPENILLTANGVVKLCDFGF 147 (292)
Q Consensus 68 ~~~~~~~~~~iv~e~~~~~~L~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~givH~dl~p~Nilv~~~~~~kl~dfg~ 147 (292)
+++.. +..|+||||++|++|.+ +.. .....++.||+.||.+||++||+||||||+||+++ ++.++|+|||+
T Consensus 168 ~~~~~-~~~~lvmE~~~g~~L~~-l~~------~~~~~i~~qi~~~l~~lH~~giiHrDlkp~NILl~-~~~vkl~DFG~ 238 (282)
T 1zar_A 168 KVYAW-EGNAVLMELIDAKELYR-VRV------ENPDEVLDMILEEVAKFYHRGIVHGDLSQYNVLVS-EEGIWIIDFPQ 238 (282)
T ss_dssp CEEEE-ETTEEEEECCCCEEGGG-CCC------SCHHHHHHHHHHHHHHHHHTTEECSCCSTTSEEEE-TTEEEECCCTT
T ss_pred eEEec-cceEEEEEecCCCcHHH-cch------hhHHHHHHHHHHHHHHHHHCCCEeCCCCHHHEEEE-CCcEEEEECCC
Confidence 65543 55799999999999988 432 23457999999999999999999999999999999 99999999999
Q ss_pred hhhh
Q psy758 148 ARLI 151 (292)
Q Consensus 148 ~~~~ 151 (292)
+...
T Consensus 239 a~~~ 242 (282)
T 1zar_A 239 SVEV 242 (282)
T ss_dssp CEET
T ss_pred CeEC
Confidence 8744
|
| >3en9_A Glycoprotease, O-sialoglycoprotein endopeptidase/protein kinase; endopeptidase activity, protein kinase activity; HET: TBR; 2.67A {Methanocaldococcus jannaschii} PDB: 3enh_A* 2vwb_A* | Back alignment and structure |
|---|
Probab=99.92 E-value=7.6e-26 Score=197.75 Aligned_cols=136 Identities=15% Similarity=0.193 Sum_probs=108.2
Q ss_pred eeeeecccCceEEEEEEEcCCCcEEEEEEeccCCCCh------HHHHHHHHHHHHHHhCCCCCcchhhhhhhcCCeEEEE
Q psy758 6 KIGKLGEGSYGVVFKCRNRDTGQVVAIKKFLESEEDP------LIRKIALREIRLLKSLKHPNLVNLLEVFRRKKKLHLV 79 (292)
Q Consensus 6 ~~~~l~~g~~~~v~~~~~~~~~~~v~iK~~~~~~~~~------~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~iv 79 (292)
..+.||+|+||.||++. ..+..+++|......... ...+.+.+|+.+++.++||||+++..+..+.+..|+|
T Consensus 340 ~~~~LG~G~fg~Vy~~~--~~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~~~~~~~~~~~~~lV 417 (540)
T 3en9_A 340 PEHLIGKGAEADIKRDS--YLDFDVIIKERVKKGYRDERLDENIRKSRTAREARYLALVKDFGIPAPYIFDVDLDNKRIM 417 (540)
T ss_dssp --------CCEEEEEEE--CSSCEEEEEEECCCTTSCHHHHHHHHHHHHHHHHHHHHHGGGGTCCCCCEEEEETTTTEEE
T ss_pred CCCEEeeCCCEEEEEEE--ECCCeEEEEEEecccccchhhhhHHHHHHHHHHHHHHHhcCCCCcCceEEEEEeCCccEEE
Confidence 35689999999999994 347889999875443221 1245678999999999999999555555566777999
Q ss_pred EecCCCccHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEEccCCcEEEeecCchhhhhc
Q psy758 80 FEFCDHTVLNELENHPHGLPWDLIKQITWQVLRGVSYCHRHACIHRDIKPENILLTANGVVKLCDFGFARLIRD 153 (292)
Q Consensus 80 ~e~~~~~~L~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~givH~dl~p~Nilv~~~~~~kl~dfg~~~~~~~ 153 (292)
|||++|++|.+++.. +..++.||+.||.|||++||+||||||+||+++. .+||+|||+++....
T Consensus 418 mE~~~ggsL~~~l~~--------~~~i~~qi~~aL~~LH~~gIiHrDiKp~NILl~~--~~kL~DFGla~~~~~ 481 (540)
T 3en9_A 418 MSYINGKLAKDVIED--------NLDIAYKIGEIVGKLHKNDVIHNDLTTSNFIFDK--DLYIIDFGLGKISNL 481 (540)
T ss_dssp EECCCSEEHHHHSTT--------CTHHHHHHHHHHHHHHHTTEECTTCCTTSEEESS--SEEECCCTTCEECCC
T ss_pred EECCCCCCHHHHHHH--------HHHHHHHHHHHHHHHHHCcCccCCCCHHHEEECC--eEEEEECccCEECCC
Confidence 999999999999875 6799999999999999999999999999999999 999999999987654
|
| >1zth_A RIO1 serine protein kinase; ribosome biogenesis, rRNA, ADP, manganese, transferase; HET: ADP; 1.89A {Archaeoglobus fulgidus} PDB: 1zp9_A* 1ztf_A* | Back alignment and structure |
|---|
Probab=99.89 E-value=2.2e-23 Score=165.95 Aligned_cols=139 Identities=22% Similarity=0.199 Sum_probs=109.0
Q ss_pred cceeeeecccCceEEEEEEEcCCCcE--EEEEEeccCCCC----------------------hHHHHHHHHHHHHHHhCC
Q psy758 4 YEKIGKLGEGSYGVVFKCRNRDTGQV--VAIKKFLESEED----------------------PLIRKIALREIRLLKSLK 59 (292)
Q Consensus 4 y~~~~~l~~g~~~~v~~~~~~~~~~~--v~iK~~~~~~~~----------------------~~~~~~~~~e~~~~~~l~ 59 (292)
|.+.+.||+|++|.||+|.+..+|+. ||+|++...... ......+.+|+..++.+.
T Consensus 49 ~~i~~~ig~G~~g~Vy~a~~~~~g~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~ 128 (258)
T 1zth_A 49 TAMGGVISTGKEANVFYADGVFDGKPVAMAVKIYRIETSEFDKMDEYLYGDERFDMRRISPKEKVFIWTEKEFRNLERAK 128 (258)
T ss_dssp EEEEEEEEECSSEEEEEEEEEETTEEEEEEEEEECCC-------GGGTTTCTTSCC----CHHHHHHHHHHHHHHHHHHH
T ss_pred hhhCCEEeecceEEEEEEEEcCCCcEeeEEEEEEECCccchhhHHHhhcccchhhhhccChHHHHHHHHHHHHHHHHHHH
Confidence 67889999999999999999777989 999987543211 112246788999999998
Q ss_pred CCCc--chhhhhhhcCCeEEEEEecCCC-c----cHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHH-hCCccccCCCCCc
Q psy758 60 HPNL--VNLLEVFRRKKKLHLVFEFCDH-T----VLNELENHPHGLPWDLIKQITWQVLRGVSYCH-RHACIHRDIKPEN 131 (292)
Q Consensus 60 ~~~i--~~~~~~~~~~~~~~iv~e~~~~-~----~L~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH-~~givH~dl~p~N 131 (292)
|+++ +.+++. +..++||||+++ | .|.+.... .++..+..++.|++.||.+|| +.||+||||||+|
T Consensus 129 ~~~i~~p~~~~~----~~~~lVmE~~g~~g~~~~~L~~~~~~---~~~~~~~~i~~qi~~~l~~lH~~~givHrDlkp~N 201 (258)
T 1zth_A 129 EAGVSVPQPYTY----MKNVLLMEFIGEDELPAPTLVELGRE---LKELDVEGIFNDVVENVKRLYQEAELVHADLSEYN 201 (258)
T ss_dssp HTTCCCCCEEEE----ETTEEEEECCEETTEECCBHHHHGGG---GGGSCHHHHHHHHHHHHHHHHHTSCEECSSCSTTS
T ss_pred hCCCCCCeEEEc----CCCEEEEEecCCCCCccccHHHHhhc---cChHHHHHHHHHHHHHHHHHHHHCCEEeCCCCHHH
Confidence 7754 333332 356899999943 3 66665432 345678899999999999999 9999999999999
Q ss_pred eEEccCCcEEEeecCchhhh
Q psy758 132 ILLTANGVVKLCDFGFARLI 151 (292)
Q Consensus 132 ilv~~~~~~kl~dfg~~~~~ 151 (292)
||+++ .++|+|||++...
T Consensus 202 ILl~~--~~~liDFG~a~~~ 219 (258)
T 1zth_A 202 IMYID--KVYFIDMGQAVTL 219 (258)
T ss_dssp EEESS--SEEECCCTTCEET
T ss_pred EEEcC--cEEEEECcccccC
Confidence 99998 8999999999654
|
| >4gyi_A RIO2 kinase; protein kinase, ADP complex, phosphoaspartate, acyl-phosphat ribosome biogenesis, Ser/Thr protein kinase; HET: PHD ADP; 2.20A {Chaetomium thermophilum} PDB: 4gyg_A | Back alignment and structure |
|---|
Probab=99.83 E-value=5.1e-21 Score=158.09 Aligned_cols=140 Identities=14% Similarity=0.089 Sum_probs=100.6
Q ss_pred cceeeeecccCceEEEEEEEcCCCcEEEEEEeccCCCC------------hHHHHHHHHHHHHHHhCCCCCcchhhhhhh
Q psy758 4 YEKIGKLGEGSYGVVFKCRNRDTGQVVAIKKFLESEED------------PLIRKIALREIRLLKSLKHPNLVNLLEVFR 71 (292)
Q Consensus 4 y~~~~~l~~g~~~~v~~~~~~~~~~~v~iK~~~~~~~~------------~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~ 71 (292)
|.+.+.||+|++|.||.|.+. +|+.||+|+++..... .........+.+++....|+|+.+++....
T Consensus 97 Y~I~~~IG~Gk~a~VY~a~d~-~G~~vAvKi~r~~~~sfr~v~~~r~~~~~~~~~~~~~~~rl~A~kE~~nL~rL~~~gv 175 (397)
T 4gyi_A 97 YSVGSRIGVGKESDIMIVADE-KGKQKVLKIHRLGRISFRTVKANRDYLRNRSTGSWMYLSRLAAIKEFAFMKALYEEGF 175 (397)
T ss_dssp SEEEEEEEECSSEEEEEEECT-TCCEEEEEEECTTEECCCCCC--CEECTTSCHHHHHHHHHHHHHHHHHHHHHHHHTTC
T ss_pred EEecCEeeeCCceEEEEEECC-CCCEEEEEEEecccccHHHHHHHHHHHHhhccccHHHHHHHHHHHHHHHHHHHHhcCC
Confidence 889999999999999999985 5999999987532110 001112233334444444555555554432
Q ss_pred cC------CeEEEEEecCCCccHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEEccCC-------
Q psy758 72 RK------KKLHLVFEFCDHTVLNELENHPHGLPWDLIKQITWQVLRGVSYCHRHACIHRDIKPENILLTANG------- 138 (292)
Q Consensus 72 ~~------~~~~iv~e~~~~~~L~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~givH~dl~p~Nilv~~~~------- 138 (292)
.. ...++||||++|+.|..+... ..+..++.||+.+|.+||++|||||||||.|||+++++
T Consensus 176 ~vp~p~~~~~~~LVME~i~G~~L~~l~~~------~~~~~l~~qll~~l~~lH~~gIVHrDLKp~NILl~~dgd~~d~~~ 249 (397)
T 4gyi_A 176 PVPEPIAQSRHTIVMSLVDALPMRQVSSV------PDPASLYADLIALILRLAKHGLIHGDFNEFNILIREEKDAEDPSS 249 (397)
T ss_dssp SCCCEEEEETTEEEEECCSCEEGGGCCCC------SCHHHHHHHHHHHHHHHHHTTEECSCCSTTSEEEEEEECSSCTTS
T ss_pred CCCeeeeccCceEEEEecCCccHhhhccc------HHHHHHHHHHHHHHHHHHHCCCcCCCCCHHHEEEeCCCCcccccc
Confidence 21 123699999999988765432 23467889999999999999999999999999999876
Q ss_pred ---cEEEeecCchhh
Q psy758 139 ---VVKLCDFGFARL 150 (292)
Q Consensus 139 ---~~kl~dfg~~~~ 150 (292)
.+.|+||+-+..
T Consensus 250 ~~~~~~iID~~Q~V~ 264 (397)
T 4gyi_A 250 ITLTPIIIXFPQMVS 264 (397)
T ss_dssp EEEEEEECCCTTCEE
T ss_pred cccceEEEEeCCccc
Confidence 389999987654
|
| >3tm0_A Aminoglycoside 3'-phosphotransferase; protein kinase, phosphorylation, transferase-antibiotic COMP; HET: ANP B31; 2.10A {Enterococcus faecalis} SCOP: d.144.1.6 PDB: 2b0q_A* 1l8t_A* 3q2j_A* 1j7i_A* 1j7u_A* 3h8p_A* 1j7l_A* 2bkk_A* | Back alignment and structure |
|---|
Probab=99.57 E-value=1.5e-14 Score=115.29 Aligned_cols=140 Identities=16% Similarity=0.110 Sum_probs=111.1
Q ss_pred cccceeeeecccCceEEEEEEEcCCCcEEEEEEeccCCCChHHHHHHHHHHHHHHhCC-CCCcchhhhhhhcCCeEEEEE
Q psy758 2 ERYEKIGKLGEGSYGVVFKCRNRDTGQVVAIKKFLESEEDPLIRKIALREIRLLKSLK-HPNLVNLLEVFRRKKKLHLVF 80 (292)
Q Consensus 2 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~e~~~~~~l~-~~~i~~~~~~~~~~~~~~iv~ 80 (292)
+.|++...++.|+.+.||++... +..+++|..+...... ...+.+|..+++.+. +..+.+++++..+.+..|+||
T Consensus 14 ~~~~~~~~~~g~s~~~v~~~~~~--~~~~vlK~~~~~~~~~--~~~~~~E~~~l~~l~~~~~vP~v~~~~~~~~~~~lv~ 89 (263)
T 3tm0_A 14 EKYRCVKDTEGMSPAKVYKLVGE--NENLYLKMTDSRYKGT--TYDVEREKDMMLWLEGKLPVPKVLHFERHDGWSNLLM 89 (263)
T ss_dssp TTSEEEECCSCCSSSEEEEEECS--SCEEEEEEECGGGTTS--TTCHHHHHHHHHHHTTTSCCCCEEEEEEETTEEEEEE
T ss_pred ccceeEeeccCCCCCeEEEEECC--CCcEEEEeCCcccCCC--HHHHHHHHHHHHHHhcCCCCCeEEEEEecCCceEEEE
Confidence 57888999999999999999754 6789999986421111 124678899998885 567888898888888999999
Q ss_pred ecCCCccHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHh-----------------------------------------
Q psy758 81 EFCDHTVLNELENHPHGLPWDLIKQITWQVLRGVSYCHR----------------------------------------- 119 (292)
Q Consensus 81 e~~~~~~L~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~----------------------------------------- 119 (292)
|+++|..+..... +......++.+++.+|..||+
T Consensus 90 e~i~G~~l~~~~~-----~~~~~~~~~~~l~~~l~~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 164 (263)
T 3tm0_A 90 SEADGVLCSEEYE-----DEQSPEKIIELYAECIRLFHSIDISDCPYTNSLDSRLAELDYLLNNDLADVDCENWEEDTPF 164 (263)
T ss_dssp ECCSSEEHHHHCC-----TTTCHHHHHHHHHHHHHHHHHSCCTTCSCBCCHHHHHHHHHHHHHTTCSCCSGGGGSTTCSS
T ss_pred EecCCeehhhccC-----CcccHHHHHHHHHHHHHHHhCCCcccCCCcchHHHHHHHHHHHHhccccccccccccccccC
Confidence 9999999987632 122345788999999999998
Q ss_pred ------------------CCccccCCCCCceEEccCCcEEEeecCchhh
Q psy758 120 ------------------HACIHRDIKPENILLTANGVVKLCDFGFARL 150 (292)
Q Consensus 120 ------------------~givH~dl~p~Nilv~~~~~~kl~dfg~~~~ 150 (292)
.+++|||++|.||++++++.+.|+||+.+..
T Consensus 165 ~~~~~l~~~l~~~~~~~~~~l~HgDl~~~Nil~~~~~~~~lIDwe~a~~ 213 (263)
T 3tm0_A 165 KDPRELYDFLKTEKPEEELVFSHGDLGDSNIFVKDGKVSGFIDLGRSGR 213 (263)
T ss_dssp SSHHHHHHHHHHCCCCCCEEEECSSCCTTSEEEETTEEEEECCCTTCEE
T ss_pred CCHHHHHHHHHhcCCCCCceEECCCCCcCcEEEECCcEEEEEEchhccc
Confidence 4489999999999998765667999998753
|
| >1nd4_A Aminoglycoside 3'-phosphotransferase; protein kinase, ATPase, kanamycin; HET: KAN; 2.10A {Klebsiella pneumoniae} SCOP: d.144.1.6 | Back alignment and structure |
|---|
Probab=99.44 E-value=1.9e-13 Score=108.74 Aligned_cols=134 Identities=16% Similarity=0.095 Sum_probs=98.9
Q ss_pred ccceeeeecccCceEEEEEEEcCCCcEEEEEEeccCCCChHHHHHHHHHHHHHHhCCCCC--cchhhhhhhcCCeEEEEE
Q psy758 3 RYEKIGKLGEGSYGVVFKCRNRDTGQVVAIKKFLESEEDPLIRKIALREIRLLKSLKHPN--LVNLLEVFRRKKKLHLVF 80 (292)
Q Consensus 3 ~y~~~~~l~~g~~~~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~e~~~~~~l~~~~--i~~~~~~~~~~~~~~iv~ 80 (292)
.|.+....+.|..+.||++.. .+|..+++|...... ...+.+|..+++.+.+.+ +.+++++..+++..++||
T Consensus 21 ~~~~~~~~~gg~~~~v~~~~~-~~g~~~vlK~~~~~~-----~~~~~~E~~~l~~l~~~~~~vP~~~~~~~~~~~~~~v~ 94 (264)
T 1nd4_A 21 GYDWAQQTIGCSDAAVFRLSA-QGRPVLFVKTDLSGA-----LNELQDEAARLSWLATTGVPCAAVLDVVTEAGRDWLLL 94 (264)
T ss_dssp TCEEEECSCTTSSCEEEEEEC-TTSCCEEEEEECSCT-----TSCHHHHHHHHHHHHTTTCCBCCEEEEEECSSCEEEEE
T ss_pred CCceEecccCCCCceEEEEec-CCCCeEEEEeCCccc-----chhhhHHHHHHHHHHhCCCCCCeEEEeccCCCCCEEEE
Confidence 455544444666799999864 457789999875442 134567888888886444 556788777777899999
Q ss_pred ecCCCccHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCC---------------------------------------
Q psy758 81 EFCDHTVLNELENHPHGLPWDLIKQITWQVLRGVSYCHRHA--------------------------------------- 121 (292)
Q Consensus 81 e~~~~~~L~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~g--------------------------------------- 121 (292)
|+++|..+. .. ..+ ...++.+++.+|..||+..
T Consensus 95 e~i~G~~l~--~~---~~~---~~~~~~~l~~~l~~lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 166 (264)
T 1nd4_A 95 GEVPGQDLL--SS---HLA---PAEKVSIMADAMRRLHTLDPATCPFDHQAKHRIERARTRMEAGLVDQDDLDEEHQGLA 166 (264)
T ss_dssp ECCSSEETT--TS---CCC---HHHHHHHHHHHHHHHTTSCGGGCCCBCCHHHHHHHHHHHHHTTCCCTTSCCGGGTTCC
T ss_pred EecCCcccC--cC---cCC---HhHHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHHHHHhcCCccchhhhhhccCcc
Confidence 999999884 22 122 2367788888888888753
Q ss_pred -------------------ccccCCCCCceEEccCCcEEEeecCchhh
Q psy758 122 -------------------CIHRDIKPENILLTANGVVKLCDFGFARL 150 (292)
Q Consensus 122 -------------------ivH~dl~p~Nilv~~~~~~kl~dfg~~~~ 150 (292)
++|||++|.||++++++.+.|+||+.+..
T Consensus 167 ~~~~~~~l~~~~~~~~~~~l~HgDl~~~Nil~~~~~~~~liD~~~a~~ 214 (264)
T 1nd4_A 167 PAELFARLKARMPDGEDLVVTHGDACLPNIMVENGRFSGFIDCGRLGV 214 (264)
T ss_dssp HHHHHHHHHHTCCSSCCEEEECSSCCGGGEEEETTEEEEECCCTTCEE
T ss_pred HHHHHHHHHHhcCCCCCeEEECCCCCCCcEEEECCcEEEEEcchhccc
Confidence 89999999999998776677999999754
|
| >3dxp_A Putative acyl-COA dehydrogenase; protein kinase-like fold, structural genomics, joint center structural genomics, JCSG; 2.32A {Ralstonia eutropha JMP134} | Back alignment and structure |
|---|
Probab=99.36 E-value=2.7e-12 Score=106.95 Aligned_cols=141 Identities=16% Similarity=0.224 Sum_probs=105.6
Q ss_pred eeeeecccCceEEEEEEEcCCCcEEEEEEec--cCCCChHHHHHHHHHHHHHHhCC--CCCcchhhhhhhcC---CeEEE
Q psy758 6 KIGKLGEGSYGVVFKCRNRDTGQVVAIKKFL--ESEEDPLIRKIALREIRLLKSLK--HPNLVNLLEVFRRK---KKLHL 78 (292)
Q Consensus 6 ~~~~l~~g~~~~v~~~~~~~~~~~v~iK~~~--~~~~~~~~~~~~~~e~~~~~~l~--~~~i~~~~~~~~~~---~~~~i 78 (292)
.++.|+.|.++.+|++... +..+++|..+ ..... .....+.+|..+++.+. +..+++++.++.+. +..|+
T Consensus 42 ~~~~l~~G~sn~~y~v~~~--~~~~vlr~~~~p~~~~~-~~~~~~~~E~~~l~~L~~~~vpvP~~~~~~~~~~~~g~~~~ 118 (359)
T 3dxp_A 42 SVEQFKGGQSNPTFKLVTP--GQTYVMRAKPGPKSKLL-PSAHAIEREYRVMDALAGTDVPVAKMYALCEDESVIGRAFY 118 (359)
T ss_dssp EEEECCC-CCSCEEEEECS--SCEEEEECCCC-----------CHHHHHHHHHHHTTSSSCCCCEEEEECCTTTTSSCEE
T ss_pred eEEEcCCcccceEEEEEEC--CceEEEEeCCCCCCCCC-CcHHHHHHHHHHHHHhhcCCCCCCcEEEECCCCCccCCeEE
Confidence 4677899999999998764 5688899876 32211 12346778999999987 34577788777655 55899
Q ss_pred EEecCCCccHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHh---------------------------------------
Q psy758 79 VFEFCDHTVLNELENHPHGLPWDLIKQITWQVLRGVSYCHR--------------------------------------- 119 (292)
Q Consensus 79 v~e~~~~~~L~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~--------------------------------------- 119 (292)
|||+++|..+.+... ..++......++.+++.+|..||+
T Consensus 119 vme~v~G~~l~~~~~--~~l~~~~~~~~~~~l~~~La~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 196 (359)
T 3dxp_A 119 IMEFVSGRVLWDQSL--PGMSPAERTAIYDEMNRVIAAMHTVDYQAIGLGDYGKPGNYFQRQIERWTKQYKLSETESIPA 196 (359)
T ss_dssp EEECCCCBCCCCTTC--TTCCHHHHHHHHHHHHHHHHHHHHSCTTTTTCTTSSCCSCHHHHHHHHHHHHHHHHCCSCCHH
T ss_pred EEEecCCeecCCCcc--ccCCHHHHHHHHHHHHHHHHHHhCCCchhccccccCCCCCchHHHHHHHHHHHHhcCCcCChH
Confidence 999999987754221 247888899999999999999997
Q ss_pred -------------------CCccccCCCCCceEEccCCc--EEEeecCchhhh
Q psy758 120 -------------------HACIHRDIKPENILLTANGV--VKLCDFGFARLI 151 (292)
Q Consensus 120 -------------------~givH~dl~p~Nilv~~~~~--~kl~dfg~~~~~ 151 (292)
.+++|||++|.||++++++. +.|+||+.+...
T Consensus 197 ~~~~~~~l~~~~~~~~~~~~~lvHgD~~~~Nil~~~~~~~v~~viDwe~a~~g 249 (359)
T 3dxp_A 197 MDSLMDWLPQHIPQEDADLTSIVHGDYRLDNLMFHPTEPRVLAVLDWELSTLG 249 (359)
T ss_dssp HHHHHHHGGGCCCSTTSSCCEEECSSCSGGGEEECSSSSCEEEECCCTTCEEE
T ss_pred HHHHHHHHHhcCCCccCCCceEEeCCCCCCcEEEeCCCCcEEEEECccccccC
Confidence 35899999999999998753 689999988643
|
| >3sg8_A APH(2'')-ID; antibiotic resistance enzyme, transferase, aminoglycoside, phosphorylation, transferase-antibiotic complex; HET: TOY; 1.80A {Enterococcus casseliflavus} PDB: 3sg9_A* 3n4v_A 3n4t_A 3n4u_A 3r81_A* 3r80_A* 3r7z_A* 3r82_A* 3vcq_A* 4dbx_A 4de4_A* 4dfb_A* 4dfu_A* 4dt9_A* 4dt8_A* 4dtb_A* 3sgc_A 4dta_A* 3lzh_A | Back alignment and structure |
|---|
Probab=98.93 E-value=1.8e-09 Score=87.63 Aligned_cols=133 Identities=21% Similarity=0.205 Sum_probs=97.9
Q ss_pred eeeecccCceEEEEEEEcCCCcEEEEEEeccCCCChHHHHHHHHHHHHHHhCC-CCC--cchhhhhhhcCC---eEEEEE
Q psy758 7 IGKLGEGSYGVVFKCRNRDTGQVVAIKKFLESEEDPLIRKIALREIRLLKSLK-HPN--LVNLLEVFRRKK---KLHLVF 80 (292)
Q Consensus 7 ~~~l~~g~~~~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~e~~~~~~l~-~~~--i~~~~~~~~~~~---~~~iv~ 80 (292)
++.++.|..+.||++. ..+++|..... .....+.+|...++.+. +.. +.+++......+ ..|+||
T Consensus 25 i~~~~~G~~n~v~~v~-----~~~vlR~~~~~----~~~~~~~~E~~~l~~l~~~~~v~vP~~~~~~~~~~~~~~~~~vm 95 (304)
T 3sg8_A 25 IEISGEGNDCIAYEIN-----RDFIFKFPKHS----RGSTNLFNEVNILKRIHNKLPLPIPEVVFTGMPSETYQMSFAGF 95 (304)
T ss_dssp CCEEEECSSEEEEEST-----TSEEEEEESSH----HHHHHHHHHHHHHHHHTTSSSSCCCCEEEECCCCSSCSCSCEEE
T ss_pred eEecCCCCcceEEEEC-----CEEEEEecCCc----chHHHHHHHHHHHHHHHhcCCCCCCceEeecCCCCCCCcceEEE
Confidence 4558899999999863 46889985432 34566888999998873 322 344444433322 458999
Q ss_pred ecCCCccHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHh-----------------------------------------
Q psy758 81 EFCDHTVLNELENHPHGLPWDLIKQITWQVLRGVSYCHR----------------------------------------- 119 (292)
Q Consensus 81 e~~~~~~L~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~----------------------------------------- 119 (292)
++++|..+..... ..++..+...++.+++..|+.||+
T Consensus 96 ~~i~G~~l~~~~~--~~l~~~~~~~~~~~l~~~la~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 173 (304)
T 3sg8_A 96 TKIKGVPLTPLLL--NNLPKQSQNQAAKDLARFLSELHSINISGFKSNLVLDFREKINEDNKKIKKLLSRELKGPQMKKV 173 (304)
T ss_dssp ECCCCEECCHHHH--HTSCHHHHHHHHHHHHHHHHHHHHSCCTTSCGGGBCCHHHHHHHHHHHHHHHHTTTSCHHHHHHH
T ss_pred cccCCeECCcccc--ccCCHHHHHHHHHHHHHHHHHHHcCCCCCCCccchhhHHHHHHHHHHHHHHHhcccCCcccHHHH
Confidence 9999988875332 247888889999999999999996
Q ss_pred -----------------CCccccCCCCCceEEcc--CCcEEEeecCchhh
Q psy758 120 -----------------HACIHRDIKPENILLTA--NGVVKLCDFGFARL 150 (292)
Q Consensus 120 -----------------~givH~dl~p~Nilv~~--~~~~kl~dfg~~~~ 150 (292)
..++|||++|.||++++ ++.+.|+||+.+..
T Consensus 174 ~~~~~~~l~~~~~~~~~~~~~HgD~~~~N~l~~~~~~~~~~~iD~~~~~~ 223 (304)
T 3sg8_A 174 DDFYRDILENEIYFKYYPCLIHNDFSSDHILFDTEKNTICGIIDFGDAAI 223 (304)
T ss_dssp HHHHHHHHTCGGGTCCCCEEECSCCCGGGEEEETTTTEEEEECCCTTCEE
T ss_pred HHHHHHHHhccccccCCceeEeCCCCcccEEEeCCCCCEEEEEeCCCCcc
Confidence 13699999999999998 45678999998754
|
| >4gkh_A Aminoglycoside 3'-phosphotransferase APHA1-IAB; pyrazolopyrimidine, 1-Na-PP1, bumped kinase inhibitor, BKI, kinase inhibitor; HET: KAN 0J9; 1.86A {Acinetobacter baumannii} PDB: 4feu_A* 4few_A* 4fex_A* 4fev_A* 4gki_A* 4ej7_A* 3r78_A* | Back alignment and structure |
|---|
Probab=98.90 E-value=1.1e-08 Score=81.58 Aligned_cols=132 Identities=14% Similarity=0.101 Sum_probs=97.5
Q ss_pred ecccCce-EEEEEEEcCCCcEEEEEEeccCCCChHHHHHHHHHHHHHHhCC-CCCcchhhhhhhcCCeEEEEEecCCCcc
Q psy758 10 LGEGSYG-VVFKCRNRDTGQVVAIKKFLESEEDPLIRKIALREIRLLKSLK-HPNLVNLLEVFRRKKKLHLVFEFCDHTV 87 (292)
Q Consensus 10 l~~g~~~-~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~e~~~~~~l~-~~~i~~~~~~~~~~~~~~iv~e~~~~~~ 87 (292)
+..|..+ .||+......+..+++|+-+.. ....+.+|...++.+. +-.+.+++++..+++..++|||+++|..
T Consensus 32 ~~~G~S~~~v~rl~~~~~~~~~~lk~~~~~-----~~~~~~~E~~~l~~l~~~vPVP~v~~~~~~~~~~~lvme~l~G~~ 106 (272)
T 4gkh_A 32 DNVGQSGATIYRLYGKPNAPELFLKHGKGS-----VANDVTDEMVRLNWLTAFMPLPTIKHFIRTPDDAWLLTTAIPGKT 106 (272)
T ss_dssp EECSSSSCEEEEEECCTTCCCEEEEEEETH-----HHHHHHHHHHHHHHHTTTSCCCCEEEEEEETTEEEEEEECCCSEE
T ss_pred ccCCCcCCeEEEEEecCCCeEEEEEECCCC-----CHhHHHHHHHHHHHhccCCCcCeEEEEEEECCeEEEEEEeeCCcc
Confidence 4445444 6899888777788999986533 2345677888888875 3346777888888899999999999988
Q ss_pred HHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhC-----------------------------------------------
Q psy758 88 LNELENHPHGLPWDLIKQITWQVLRGVSYCHRH----------------------------------------------- 120 (292)
Q Consensus 88 L~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~----------------------------------------------- 120 (292)
+...... .......+..++...|..||+.
T Consensus 107 ~~~~~~~----~~~~~~~~~~~l~~~L~~Lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 182 (272)
T 4gkh_A 107 AFQVLEE----YPDSGENIVDALAVFLRRLHSIPVCNCPFNSDRVFRLAQAQSRMNNGLVDASDFDDERNGWPVEQVWKE 182 (272)
T ss_dssp HHHHHHH----CGGGHHHHHHHHHHHHHHHHTSCGGGCCBBCCHHHHHHHHHHHHHTTCCCGGGCCGGGTTCCHHHHHHH
T ss_pred ccccccC----CHHHHHHHHHHHHHHHHHhcCCCcccCCcCcccccchhhHHHHHHHhhhhhhhccccccchHHHHHHHH
Confidence 8776542 1223345667777777777740
Q ss_pred -----------CccccCCCCCceEEccCCcEEEeecCchhh
Q psy758 121 -----------ACIHRDIKPENILLTANGVVKLCDFGFARL 150 (292)
Q Consensus 121 -----------givH~dl~p~Nilv~~~~~~kl~dfg~~~~ 150 (292)
.++|||++|.||++++++.+-|+||+.+..
T Consensus 183 l~~~~~~~~~~~l~HGDl~~~Nil~~~~~~~~viDwe~a~~ 223 (272)
T 4gkh_A 183 MHKLLPFSPDSVVTHGDFSLDNLIFDEGKLIGCIDVGRVGI 223 (272)
T ss_dssp HHTTCCCCCCEEEECSCCCTTSEEEETTEEEEECCCTTCEE
T ss_pred HHhcccccCCcEEEcCCCCCCeEEEECCeEEEEEECccccc
Confidence 268999999999999887777999998864
|
| >3tdw_A Gentamicin resistance protein; kinase, phosphoryl transfer, antibiotic resistance, transfer; HET: GDP; 1.70A {Enterococcus gallinarum} PDB: 3tdv_A* | Back alignment and structure |
|---|
Probab=98.89 E-value=3e-08 Score=80.47 Aligned_cols=133 Identities=19% Similarity=0.163 Sum_probs=96.1
Q ss_pred eeeecccCceEEEEEEEcCCCcEEEEEEeccCCCChHHHHHHHHHHHHHHhCCCC---Ccchhhhhhh-cCCeEEEEEec
Q psy758 7 IGKLGEGSYGVVFKCRNRDTGQVVAIKKFLESEEDPLIRKIALREIRLLKSLKHP---NLVNLLEVFR-RKKKLHLVFEF 82 (292)
Q Consensus 7 ~~~l~~g~~~~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~e~~~~~~l~~~---~i~~~~~~~~-~~~~~~iv~e~ 82 (292)
++.++.|....||++ +..+++|+-.. ......+.+|..+++.+.+. .+.+++.+.. ..+..++|||+
T Consensus 24 v~~l~~G~~n~v~~v-----g~~~VlR~~~~----~~~~~~~~~E~~~L~~L~~~~~v~VP~~~~~~~~~~g~~~~v~e~ 94 (306)
T 3tdw_A 24 VESLGEGFRNYAILV-----NGDWVFRFPKS----QQGADELNKEIQLLPLLVGCVKVNIPQYVYIGKRSDGNPFVGYRK 94 (306)
T ss_dssp EEEEEECSSEEEEEE-----TTTEEEEEESS----HHHHHHHHHHHHHHHHHTTTCSSBCCCEEEEEECTTSCEEEEEEC
T ss_pred eeecCCCcceeEEEE-----CCEEEEEecCC----chHHHHHHHHHHHHHHHHhcCCCCCCCeEeecccCCCceEEEEec
Confidence 456788888899988 56788887421 23456788999999998742 2445555442 45668899999
Q ss_pred CCCccHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhC------------------------------------------
Q psy758 83 CDHTVLNELENHPHGLPWDLIKQITWQVLRGVSYCHRH------------------------------------------ 120 (292)
Q Consensus 83 ~~~~~L~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~------------------------------------------ 120 (292)
++|..+....-. .++......++.++...|+.||+.
T Consensus 95 i~G~~l~~~~~~--~l~~~~~~~~~~~lg~~La~LH~~~~~~~~~~g~p~~~w~~~~~~~~~~~~~~~~~~l~~~~~~~l 172 (306)
T 3tdw_A 95 VQGQILGEDGMA--VLPDDAKDRLALQLAEFMNELSAFPVETAISAGVPVTNLKNKILLLSEAVEDQVFPLLDESLRDYL 172 (306)
T ss_dssp CCSEECHHHHHT--TSCHHHHHHHHHHHHHHHHHHHHSCHHHHHHTTCCBCCHHHHHHHHHHHHHHHTGGGSCHHHHHHH
T ss_pred cCCeECchhhhh--hCCHHHHHHHHHHHHHHHHHHhcCCcccccccCCChHHHHHHHHHHHHHHHHhcccccchhhHHHH
Confidence 999888764322 356666777777777777777753
Q ss_pred ------------------CccccCCCCCceEEcc---CCc-EEEeecCchhh
Q psy758 121 ------------------ACIHRDIKPENILLTA---NGV-VKLCDFGFARL 150 (292)
Q Consensus 121 ------------------givH~dl~p~Nilv~~---~~~-~kl~dfg~~~~ 150 (292)
.++|||++|.||++++ ++. ..|+||+.+..
T Consensus 173 ~~~~~~~l~~~~~~~~~~~~~HgD~~~~N~l~~~~~~~~~~~~~iD~~~a~~ 224 (306)
T 3tdw_A 173 TLRFQSYMTHPVYTRYTPRLIHGDLSPDHFLTNLNSRQTPLTGIIDFGDAAI 224 (306)
T ss_dssp HHHHHHHHHCHHHHCCCCEEECSCCSGGGEEECTTCSSCCEEEECCCTTCEE
T ss_pred HHHHHHHHhCcccccCCCeeEeCCCCcccEEEecCCCCCceEEEEehhhcCC
Confidence 2489999999999998 455 58999998754
|
| >2olc_A MTR kinase, methylthioribose kinase; kinase ADP-2HO complex, transferase; HET: CPS ADP; 2.00A {Bacillus subtilis} SCOP: d.144.1.6 PDB: 2pu8_A* 2pui_A* 2pul_A* 2pun_A* 2pup_A* | Back alignment and structure |
|---|
Probab=98.56 E-value=2.4e-07 Score=78.04 Aligned_cols=78 Identities=18% Similarity=0.199 Sum_probs=47.8
Q ss_pred eeeecccCceEEEEEEEcCCCcEEEEEEeccCCC--Ch---HHHHHHHHHHHHHHhCCC--C-CcchhhhhhhcCCeEEE
Q psy758 7 IGKLGEGSYGVVFKCRNRDTGQVVAIKKFLESEE--DP---LIRKIALREIRLLKSLKH--P-NLVNLLEVFRRKKKLHL 78 (292)
Q Consensus 7 ~~~l~~g~~~~v~~~~~~~~~~~v~iK~~~~~~~--~~---~~~~~~~~e~~~~~~l~~--~-~i~~~~~~~~~~~~~~i 78 (292)
.+.||.|..+.||++....+++.+++|....... .. .....+..|.++++.+.. | .+.+++.+ +.+..++
T Consensus 35 ~~~lg~G~~n~vyrv~~~~~~~~~vvK~~~~~~r~~~~~~~~~~~r~~~E~~~L~~l~~~~~~~vP~~~~~--d~~~~~l 112 (397)
T 2olc_A 35 CQEIGDGNLNYVFHIYDQEHDRALIIKQAVPYAKVVGESWPLTIDRARIESSALIRQGEHVPHLVPRVFYS--DTEMAVT 112 (397)
T ss_dssp EEECCSSSSEEEEEEEC----CEEEEEEECCC-------CCCCTTHHHHHHHHHHHHHTTCGGGSCCEEEE--ETTTTEE
T ss_pred EEECCCCceEEEEEEEECCCCcEEEEEecchhhcccCCCCcCcHHHHHHHHHHHHHhhhhCCCCcCeEEEE--cCCccEE
Confidence 5679999999999997766678899997643211 00 012345668888877642 3 33445543 3445689
Q ss_pred EEecCCCc
Q psy758 79 VFEFCDHT 86 (292)
Q Consensus 79 v~e~~~~~ 86 (292)
|||+++|.
T Consensus 113 vmE~l~g~ 120 (397)
T 2olc_A 113 VMEDLSHL 120 (397)
T ss_dssp EECCCTTS
T ss_pred EEEeCCCc
Confidence 99999873
|
| >2q83_A YTAA protein; 2635576, structural genomics, joint center for structu genomics, JCSG, protein structure initiative, PSI-2, transf; HET: ADN CIT UNL; 2.50A {Bacillus subtilis} | Back alignment and structure |
|---|
Probab=98.41 E-value=3.4e-06 Score=69.35 Aligned_cols=30 Identities=23% Similarity=0.247 Sum_probs=27.3
Q ss_pred CCccccCCCCCceEEccCCcEEEeecCchh
Q psy758 120 HACIHRDIKPENILLTANGVVKLCDFGFAR 149 (292)
Q Consensus 120 ~givH~dl~p~Nilv~~~~~~kl~dfg~~~ 149 (292)
.+++|||+++.||+++.++.+.|+||+.+.
T Consensus 222 ~~l~HgD~~~~Nil~~~~~~~~lIDfe~a~ 251 (346)
T 2q83_A 222 PNLCHQDYGTGNTLLGENEQIWVIDLDTVS 251 (346)
T ss_dssp CCEECSSCSTTSEEECGGGCEEECCCTTCE
T ss_pred CceecCCCCcccEEEeCCCcEEEEehhhcc
Confidence 579999999999999888889999999874
|
| >3ats_A Putative uncharacterized protein; hypothetical protein, putative aminoglycoside phosphortransf transferase; 1.67A {Mycobacterium tuberculosis} PDB: 3att_A* | Back alignment and structure |
|---|
Probab=98.33 E-value=2.6e-06 Score=70.58 Aligned_cols=83 Identities=6% Similarity=0.027 Sum_probs=51.7
Q ss_pred eeee-cccCceEEEEEEEc--C----CCcEEEEEEeccCCC-ChHHHHHHHHHHHHHHhCCC---CCcchhhhhhhcC--
Q psy758 7 IGKL-GEGSYGVVFKCRNR--D----TGQVVAIKKFLESEE-DPLIRKIALREIRLLKSLKH---PNLVNLLEVFRRK-- 73 (292)
Q Consensus 7 ~~~l-~~g~~~~v~~~~~~--~----~~~~v~iK~~~~~~~-~~~~~~~~~~e~~~~~~l~~---~~i~~~~~~~~~~-- 73 (292)
.+.| +.|..+.+|++... . ++..+++|....... .......+.+|..+++.+.. -.+.+++.+..+.
T Consensus 25 ~~~l~~~G~~n~~y~v~~~~~~~~~~~~~~~vlR~~~~~~~~~~~~~~~~~~E~~~l~~L~~~~~vpvP~v~~~~~~~~~ 104 (357)
T 3ats_A 25 ESGVDSTGMSSETIILTARWQQDGRSIQQKLVARVAPAAEDVPVFPTYRLDHQFEVIRLVGELTDVPVPRVRWIETTGDV 104 (357)
T ss_dssp EEEECTTSSEEEEEEEEEEEEETTEEEEEEEEEEECCCGGGCCSSSCCCHHHHHHHHHHHHHHCCSCCCCEEEEECSSTT
T ss_pred EEECCCCCccceEEEEEEecccCCCCCCceEEEEeCCCCCccccCchhHHHHHHHHHHHHhhcCCCCCCcEEEEccCCCc
Confidence 4567 88888999988653 1 156789998654320 00001234567777777642 3466677665544
Q ss_pred -CeEEEEEecCCCccHH
Q psy758 74 -KKLHLVFEFCDHTVLN 89 (292)
Q Consensus 74 -~~~~iv~e~~~~~~L~ 89 (292)
+..++|||+++|..+.
T Consensus 105 ~g~~~~v~e~l~G~~l~ 121 (357)
T 3ats_A 105 LGTPFFLMDYVEGVVPP 121 (357)
T ss_dssp TSSCEEEEECCCCBCCC
T ss_pred cCCceEEEEecCCCChh
Confidence 4578999999986654
|
| >3jr1_A Putative fructosamine-3-kinase; YP_719053.1, structural genomics, joint center for structural genomics, JCSG; HET: MSE UNL; 2.32A {Haemophilus somnus 129PT} | Back alignment and structure |
|---|
Probab=98.18 E-value=1.1e-05 Score=65.19 Aligned_cols=75 Identities=19% Similarity=0.106 Sum_probs=57.0
Q ss_pred eeeecccCceEEEEEEEcCCCcEEEEEEeccCCCChHHHHHHHHHHHHHHhCC---CCCcchhhhhhhcCCeEEEEEecC
Q psy758 7 IGKLGEGSYGVVFKCRNRDTGQVVAIKKFLESEEDPLIRKIALREIRLLKSLK---HPNLVNLLEVFRRKKKLHLVFEFC 83 (292)
Q Consensus 7 ~~~l~~g~~~~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~e~~~~~~l~---~~~i~~~~~~~~~~~~~~iv~e~~ 83 (292)
.+.|+.|....+|++.. ++..+++|+.+.. ....+..|...++.|. ...+++++.+....+..++|||++
T Consensus 41 ~~~l~gG~~n~~y~v~~--~~~~~vlK~~~~~-----~~~~~~~E~~~L~~L~~~~~v~VP~vl~~~~~~g~~~lvme~l 113 (312)
T 3jr1_A 41 KEKLYSGEMNEIWLIND--EVQTVFVKINERS-----YRSMFRAEADQLALLAKTNSINVPLVYGIGNSQGHSFLLLEAL 113 (312)
T ss_dssp EEEECCSSSSEEEEEES--SSCEEEEEEEEGG-----GHHHHHHHHHHHHHHHHTTSSBCCCEEEEEECSSEEEEEEECC
T ss_pred eEEeCCccceeeeEEEE--CCCeEEEEeCCcc-----cHHHHHHHHHHHHHHHhhCCCCcceEEEEeecCCceEEEEEec
Confidence 46688999999999875 3678999987643 1455778888888874 345777777766678899999999
Q ss_pred CCccH
Q psy758 84 DHTVL 88 (292)
Q Consensus 84 ~~~~L 88 (292)
+|..+
T Consensus 114 ~G~~~ 118 (312)
T 3jr1_A 114 NKSKN 118 (312)
T ss_dssp CCCCC
T ss_pred cCCCC
Confidence 98653
|
| >2pyw_A Uncharacterized protein; 5-methylthioribose kinase, plant methionine recycling, refol transferase; HET: SR1 ADP; 1.90A {Arabidopsis thaliana} | Back alignment and structure |
|---|
Probab=98.17 E-value=6.7e-06 Score=69.70 Aligned_cols=33 Identities=21% Similarity=0.352 Sum_probs=28.3
Q ss_pred HhCCccccCCCCCceEEccCCcEEEeecCchhhh
Q psy758 118 HRHACIHRDIKPENILLTANGVVKLCDFGFARLI 151 (292)
Q Consensus 118 H~~givH~dl~p~Nilv~~~~~~kl~dfg~~~~~ 151 (292)
+...++|||++|.||++++++ +.++||+.+...
T Consensus 230 ~~~~liHGDl~~~Nil~~~~~-~~lID~e~a~~G 262 (420)
T 2pyw_A 230 RAQALIHGDLHTGSVMVTQDS-TQVIDPEFSFYG 262 (420)
T ss_dssp BCCEEECSCCSGGGEEECSSC-EEECCCTTCEEE
T ss_pred CCCeEEecCCCCCcEEEeCCC-CEEEeCcccccC
Confidence 456799999999999999877 999999887643
|
| >3dxq_A Choline/ethanolamine kinase family protein; NP_106042.1, STR genomics, joint center for structural genomics, JCSG, prote structure initiative; HET: MSE; 2.55A {Mesorhizobium loti} | Back alignment and structure |
|---|
Probab=98.11 E-value=2e-05 Score=63.57 Aligned_cols=74 Identities=12% Similarity=0.071 Sum_probs=43.5
Q ss_pred cceeeeecccCceEEEEEEEcCCCcEEEEEEeccCCCChHHHHHHHHHHHHHHhCCCCCc-chhhhhhhcCCeEEEEEec
Q psy758 4 YEKIGKLGEGSYGVVFKCRNRDTGQVVAIKKFLESEEDPLIRKIALREIRLLKSLKHPNL-VNLLEVFRRKKKLHLVFEF 82 (292)
Q Consensus 4 y~~~~~l~~g~~~~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~e~~~~~~l~~~~i-~~~~~~~~~~~~~~iv~e~ 82 (292)
+.-++.|+.|....+|++ ..+++|+....... .-...+|...++.+...++ .++++.. .+.-++++|+
T Consensus 20 ~~~i~~l~gG~tN~~~~~------~~~vlR~~~~~~~~---~~~r~~E~~~l~~l~~~g~~P~~~~~~--~~~~~~v~e~ 88 (301)
T 3dxq_A 20 YTGPLERLGGLTNLVFRA------GDLCLRIPGKGTEE---YINRANEAVAAREAAKAGVSPEVLHVD--PATGVMVTRY 88 (301)
T ss_dssp CCSCEEEESCSSEEEEEE------TTEEEEEECC-------CCCHHHHHHHHHHHHHTTSSCCEEEEC--TTTCCEEEEC
T ss_pred ccceeEcCCcccccccee------eeEEEECCCCCccc---eeCHHHHHHHHHHHHHcCCCCceEEEE--CCCCEEEEee
Confidence 334677889999999998 45889987543211 0112346666666642222 4555443 3234689999
Q ss_pred C-CCccH
Q psy758 83 C-DHTVL 88 (292)
Q Consensus 83 ~-~~~~L 88 (292)
+ +|..+
T Consensus 89 i~~g~~l 95 (301)
T 3dxq_A 89 IAGAQTM 95 (301)
T ss_dssp CTTCEEC
T ss_pred cCCCccC
Confidence 9 76544
|
| >3feg_A Choline/ethanolamine kinase; non-protein kinase, choline kinase, structural genomics CONS SGC, hemicholinium-3, phosphorylation; HET: HC7 ADP AMP; 1.30A {Homo sapiens} PDB: 3lq3_A* 2ig7_A* | Back alignment and structure |
|---|
Probab=97.86 E-value=5.3e-05 Score=62.99 Aligned_cols=137 Identities=16% Similarity=0.205 Sum_probs=78.9
Q ss_pred eeeecccCceEEEEEEEcC-------CCcEEEEEEeccCCCChHHHHHHHHHHHHHHhCC-CCCcchhhhhhhcCCeEEE
Q psy758 7 IGKLGEGSYGVVFKCRNRD-------TGQVVAIKKFLESEEDPLIRKIALREIRLLKSLK-HPNLVNLLEVFRRKKKLHL 78 (292)
Q Consensus 7 ~~~l~~g~~~~v~~~~~~~-------~~~~v~iK~~~~~~~~~~~~~~~~~e~~~~~~l~-~~~i~~~~~~~~~~~~~~i 78 (292)
++.|..|-...+|++.... +++.+++|+....... ...+.+|..+++.|. +.-..++++.+.+ .+
T Consensus 55 v~~lsGG~TN~~y~v~~~~~~~~~~~~~~~~vlR~~g~~~~~---~~~~~rE~~vl~~L~~~gv~P~ll~~~~~----g~ 127 (379)
T 3feg_A 55 VYPVSGGLSNLLFRCSLPDHLPSVGEEPREVLLRLYGAILQG---VDSLVLESVMFAILAERSLGPQLYGVFPE----GR 127 (379)
T ss_dssp CEEC-----CCEEEEECCTTSCCCSSCCSEEEEEECC---CC---HHHHHHHHHHHHHHHHTTSSCCEEEEETT----EE
T ss_pred EEEcCCcccccEEEEEeCCCccccCCCCCeEEEEECCCccch---HHHHHHHHHHHHHHHhcCCCCeEEEEcCC----cc
Confidence 3557778888899987642 3578999986332111 233457888888775 2223556665543 28
Q ss_pred EEecCCCccHHHH--------------h---cC-----CCCCC--HHHHHHHHHHHHH-------------------HHH
Q psy758 79 VFEFCDHTVLNEL--------------E---NH-----PHGLP--WDLIKQITWQVLR-------------------GVS 115 (292)
Q Consensus 79 v~e~~~~~~L~~~--------------~---~~-----~~~~~--~~~~~~i~~qi~~-------------------aL~ 115 (292)
|+|+++|..+..- + .. .+... ..++..+..++-. .+.
T Consensus 128 v~e~i~G~~l~~~~l~~p~~~~~ia~~La~LH~~~~~~~~~~~~l~~~i~~w~~~~~~~~~~~~~~~~~~~~~~l~~~~~ 207 (379)
T 3feg_A 128 LEQYIPSRPLKTQELREPVLSAAIATKMAQFHGMEMPFTKEPHWLFGTMERYLKQIQDLPPTGLPEMNLLEMYSLKDEMG 207 (379)
T ss_dssp EEECCSEEECCGGGGGCHHHHHHHHHHHHHHHTCCCSSCCSCCHHHHHHHHHHHHHHHCCCCSCCSCCHHHHTTHHHHHH
T ss_pred EEEEecCccCChhHhCCHHHHHHHHHHHHHHhCCCCCCCCCcccHHHHHHHHHHHHHhccCcccchhhhhhhHHHHHHHH
Confidence 9999998554311 0 00 01111 2444445444322 122
Q ss_pred HH----Hh----CCccccCCCCCceEEccC----CcEEEeecCchhh
Q psy758 116 YC----HR----HACIHRDIKPENILLTAN----GVVKLCDFGFARL 150 (292)
Q Consensus 116 ~L----H~----~givH~dl~p~Nilv~~~----~~~kl~dfg~~~~ 150 (292)
.| .+ ..++|+|+.+.||+++++ +.+.++||..+..
T Consensus 208 ~L~~~L~~~~~~~~~~H~D~~~~Nil~~~~~~~~~~~~~IDwE~a~~ 254 (379)
T 3feg_A 208 NLRKLLESTPSPVVFCHNDIQEGNILLLSEPENADSLMLVDFEYSSY 254 (379)
T ss_dssp HHHHHHHTSCCCEEEECSCCCGGGEEEESCC---CCEEECCCTTCEE
T ss_pred HHHHHHhhcCCCcEEEcCCCCCCeEEEcCCCCccCcEEEEecccCCc
Confidence 22 22 248999999999999876 7899999998864
|
| >2ppq_A HSK, HK, homoserine kinase; structural genomics, MCSG, PSI-2, protein structure initiative; 2.00A {Agrobacterium tumefaciens str} SCOP: d.144.1.6 | Back alignment and structure |
|---|
Probab=97.86 E-value=3.2e-05 Score=62.96 Aligned_cols=138 Identities=16% Similarity=0.139 Sum_probs=74.4
Q ss_pred eeeecccCceEEEEEEEcCCCcEEEEEEeccCCCChHHHHHHHHHHHHHHhCCCCC--cchhhhhh------hcCCeEEE
Q psy758 7 IGKLGEGSYGVVFKCRNRDTGQVVAIKKFLESEEDPLIRKIALREIRLLKSLKHPN--LVNLLEVF------RRKKKLHL 78 (292)
Q Consensus 7 ~~~l~~g~~~~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~e~~~~~~l~~~~--i~~~~~~~------~~~~~~~i 78 (292)
.+.|+.|....+|++... +..+++|........ ..+..|..+++.+...+ +.+++... ...+..++
T Consensus 27 ~~~i~~G~~n~~~~v~~~--~g~~vlk~~~~~~~~----~~l~~e~~~l~~L~~~g~~vP~~~~~~~g~~~~~~~g~~~~ 100 (322)
T 2ppq_A 27 YKGIAEGVENSNFLLHTT--KDPLILTLYEKRVEK----NDLPFFLGLMQHLAAKGLSCPLPLPRKDGELLGELSGRPAA 100 (322)
T ss_dssp EEEECC---EEEEEEEES--SCCEEEEEECC---C----CHHHHHHHHHHHHHHTTCCCCCBCCBTTCCSCEEETTEEEE
T ss_pred eeccCCCcccceEEEEeC--CccEEEEEeCCCCCH----HHHHHHHHHHHHHHHCCCCCCcccCCCCCCEEEEECCEEEE
Confidence 445677888889998764 336889988653211 22334666666553211 23333221 12466799
Q ss_pred EEecCCCccHHH---------------H---hcCC-CC----CCHHHHHH---------------HHHHHHHHHHHHHh-
Q psy758 79 VFEFCDHTVLNE---------------L---ENHP-HG----LPWDLIKQ---------------ITWQVLRGVSYCHR- 119 (292)
Q Consensus 79 v~e~~~~~~L~~---------------~---~~~~-~~----~~~~~~~~---------------i~~qi~~aL~~LH~- 119 (292)
++++++|..+.. + .... .. ........ +...+...+..+.+
T Consensus 101 l~~~l~G~~~~~~~~~~~~~~g~~La~lH~~~~~~~~~~~~~~~~~~w~~~~~~~~~~~~~~~~~l~~~l~~~~~~l~~~ 180 (322)
T 2ppq_A 101 LISFLEGMWLRKPEAKHCREVGKALAAMHLASEGFEIKRPNALSVDGWKVLWDKSEERADEVEKGLREEIRPEIDYLAAH 180 (322)
T ss_dssp EEECCCCBCCSSCCHHHHHHHHHHHHHHHHHTTTCCCCCBCTTSHHHHHHHHHHHGGGGGGTSTTHHHHHHHHHHHHHHH
T ss_pred EEEeCCCcCCCCCCHHHHHHHHHHHHHHHHHhccCCCcccCccChHHHHHHHHHHHHHHHhhhhhhHHHHHHHHHHHHhh
Confidence 999999854311 0 0000 00 11110000 00113334455542
Q ss_pred ------CCccccCCCCCceEEccCCcEEEeecCchhh
Q psy758 120 ------HACIHRDIKPENILLTANGVVKLCDFGFARL 150 (292)
Q Consensus 120 ------~givH~dl~p~Nilv~~~~~~kl~dfg~~~~ 150 (292)
.+++|||+.+.||++++++.+.|+||+.+..
T Consensus 181 ~~~~~~~~liHgDl~~~Nil~~~~~~~~lIDf~~a~~ 217 (322)
T 2ppq_A 181 WPKDLPAGVIHADLFQDNVFFLGDELSGLIDFYFACN 217 (322)
T ss_dssp CCCSSCEEEECSCCCGGGEEEETTEEEEECCCTTCEE
T ss_pred CcccCCcccCCCCCCccCEEEeCCceEEEecchhccC
Confidence 3689999999999999876668999988753
|
| >1nw1_A Choline kinase (49.2 KD); phospholipid synthesis, protein kinase fold, transferase; 2.02A {Caenorhabditis elegans} SCOP: d.144.1.8 | Back alignment and structure |
|---|
Probab=97.85 E-value=6.7e-05 Score=63.66 Aligned_cols=74 Identities=19% Similarity=0.338 Sum_probs=47.8
Q ss_pred eeeecccCceEEEEEEEcC-------CCcEEEEEEeccCCCChHHHHHHHHHHHHHHhCCCCCc-chhhhhhhcCCeEEE
Q psy758 7 IGKLGEGSYGVVFKCRNRD-------TGQVVAIKKFLESEEDPLIRKIALREIRLLKSLKHPNL-VNLLEVFRRKKKLHL 78 (292)
Q Consensus 7 ~~~l~~g~~~~v~~~~~~~-------~~~~v~iK~~~~~~~~~~~~~~~~~e~~~~~~l~~~~i-~~~~~~~~~~~~~~i 78 (292)
++.|+.|-...+|++.... ++..+++|+.... .. ...+.+|..+++.|...++ .++++.+.+ .+
T Consensus 78 v~~l~gG~tN~~y~v~~~~~~~~~~~~~~~~vlRi~~~~-~~---~~~li~E~~~l~~L~~~g~~P~l~~~~~~----g~ 149 (429)
T 1nw1_A 78 ISRIKGGMSNMLFLCRLSEVYPPIRNEPNKVLLRVYFNP-ET---ESHLVAESVIFTLLSERHLGPKLYGIFSG----GR 149 (429)
T ss_dssp EEEECCCTTEEEEEEEECTTSCCSSSCCSEEEEEEECSC-CC---HHHHHHHHHHHHHHHHTTSSSCEEEEETT----EE
T ss_pred EEEeCCCcccceEEEEeCCCccccCCCCceEEEEEeCCC-Cc---HHHHHHHHHHHHHHHhCCCCCcEEEEeCC----CE
Confidence 4567888889999997643 2578999988432 11 1233468888887753333 556655432 28
Q ss_pred EEecCCCccH
Q psy758 79 VFEFCDHTVL 88 (292)
Q Consensus 79 v~e~~~~~~L 88 (292)
|+||++|..+
T Consensus 150 v~e~l~G~~l 159 (429)
T 1nw1_A 150 LEEYIPSRPL 159 (429)
T ss_dssp EECCCCEEEC
T ss_pred EEEEeCCccc
Confidence 9999987443
|
| >3csv_A Aminoglycoside phosphotransferase; YP_614837.1, phosphotransferase enzyme family, structural genomics, JOIN for structural genomics, JCSG; HET: MSE; 2.15A {Silicibacter SP} | Back alignment and structure |
|---|
Probab=97.75 E-value=5.3e-05 Score=62.03 Aligned_cols=31 Identities=32% Similarity=0.503 Sum_probs=26.9
Q ss_pred CCccccCCCCCceEEccC----CcEEEeecCchhh
Q psy758 120 HACIHRDIKPENILLTAN----GVVKLCDFGFARL 150 (292)
Q Consensus 120 ~givH~dl~p~Nilv~~~----~~~kl~dfg~~~~ 150 (292)
..++|||+.+.||+++++ +.+.|+||+.+..
T Consensus 183 ~~lvHgD~~~~Nil~~~~~~~~~~~~lIDf~~a~~ 217 (333)
T 3csv_A 183 MVFVHRDFHAQNLLWLPEREGLARVGVIDFQDAKL 217 (333)
T ss_dssp CEEECSCCSGGGEEECTTSCGGGGEEECCCTTCEE
T ss_pred CeeEeCCcCcccEEeccCcCCCCCeEEEeCCCcCc
Confidence 469999999999999875 6799999998764
|
| >1zyl_A Hypothetical protein YIHE; putative protein kinase, structural genomics, PSI, protein structure initiative; 2.80A {Escherichia coli} SCOP: d.144.1.6 | Back alignment and structure |
|---|
Probab=97.67 E-value=0.00059 Score=55.57 Aligned_cols=135 Identities=13% Similarity=0.136 Sum_probs=75.5
Q ss_pred eeecccCceEEEEEEEcCCCcEEEEEEeccCCCChHHHHHHHHHHHHHHhCCCCC--cchhhhh-----hhcCCeEEEEE
Q psy758 8 GKLGEGSYGVVFKCRNRDTGQVVAIKKFLESEEDPLIRKIALREIRLLKSLKHPN--LVNLLEV-----FRRKKKLHLVF 80 (292)
Q Consensus 8 ~~l~~g~~~~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~e~~~~~~l~~~~--i~~~~~~-----~~~~~~~~iv~ 80 (292)
..++ |....+|++... +|+.+++|......... ..+..|..+++.+...+ +++++.. ...++..++++
T Consensus 32 ~~l~-g~~n~~y~v~~~-~g~~~vlK~~~~~~~~~---~~~~~E~~~~~~L~~~g~~vp~~~~~~g~~~~~~~g~~~~l~ 106 (328)
T 1zyl_A 32 TPLN-SYENRVYQFQDE-DRRRFVVKFYRPERWTA---DQILEEHQFALQLVNDEVPVAAPVAFNGQTLLNHQGFYFAVF 106 (328)
T ss_dssp EEEC-CSSSEEEEECCT-TCCCEEEEEECTTTSCH---HHHHHHHHHHHHHHHTTCSBCCCCCBTTBSCEEETTEEEEEE
T ss_pred Eeec-CcccceEEEEcC-CCCEEEEEEcCCCCCCH---HHHHHHHHHHHHHHHcCCeecceeecCCcEEEEECCEEEEEE
Confidence 3455 777889987543 36679999986432222 33445777776664211 3334432 11245678999
Q ss_pred ecCCCccHH-----HH-------------hcCC-----CCCCHHHH----------------------HHHHHHHHHHHH
Q psy758 81 EFCDHTVLN-----EL-------------ENHP-----HGLPWDLI----------------------KQITWQVLRGVS 115 (292)
Q Consensus 81 e~~~~~~L~-----~~-------------~~~~-----~~~~~~~~----------------------~~i~~qi~~aL~ 115 (292)
++++|..+. .. .... ...+.... ...+.+++..+.
T Consensus 107 ~~i~G~~~~~~~~~~~~~~g~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~ 186 (328)
T 1zyl_A 107 PSVGGRQFEADNIDQMEAVGRYLGRMHQTGRKQLFIHRPTIGLNEYLIEPRKLFEDATLIPSGLKAAFLKATDELIAAVT 186 (328)
T ss_dssp ECCCCEECCSSCHHHHHHHHHHHHHHHHHHTSSCCSSSCBCSHHHHTHHHHHHHHTCSSSCTTTHHHHHHHHHHHHHHHH
T ss_pred EecCCCCCCCCCHHHHHHHHHHHHHHHHhhccCCCccCCCCCHHHHHhhHHHHHhhcCcCCHHHHHHHHHHHHHHHHHHH
Confidence 999985432 10 0100 01111110 111222222222
Q ss_pred HH----HhCCccccCCCCCceEEccCCcEEEeecCchh
Q psy758 116 YC----HRHACIHRDIKPENILLTANGVVKLCDFGFAR 149 (292)
Q Consensus 116 ~L----H~~givH~dl~p~Nilv~~~~~~kl~dfg~~~ 149 (292)
.+ ....++|||+++.||+++ + .+.|+||+.+.
T Consensus 187 ~~~~~~~~~~l~HgD~~~~Nil~~-~-~~~lIDfe~a~ 222 (328)
T 1zyl_A 187 AHWREDFTVLRLHGDCHAGNILWR-D-GPMFVDLDDAR 222 (328)
T ss_dssp HHCCSCSCCEECCSSCSGGGEEES-S-SEEECCCTTCC
T ss_pred HHhhhcCCeeeeeCCCCcccEeEc-C-CCEEEECCCCC
Confidence 22 234589999999999999 4 89999998775
|
| >3f7w_A Putative fructosamine-3-kinase; YP_290396.1, structural GENO joint center for structural genomics, JCSG, protein structu initiative, PSI-2; 1.85A {Thermobifida fusca YX} | Back alignment and structure |
|---|
Probab=97.60 E-value=0.00026 Score=56.63 Aligned_cols=76 Identities=12% Similarity=0.121 Sum_probs=50.4
Q ss_pred ceeeeecccCceEEEEEEEcCCCcEEEEEEeccCCCChHHHHHHHHHHHHHHhCCC---CCcchhhhhhhcCCeEEEEEe
Q psy758 5 EKIGKLGEGSYGVVFKCRNRDTGQVVAIKKFLESEEDPLIRKIALREIRLLKSLKH---PNLVNLLEVFRRKKKLHLVFE 81 (292)
Q Consensus 5 ~~~~~l~~g~~~~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~e~~~~~~l~~---~~i~~~~~~~~~~~~~~iv~e 81 (292)
.-++.+|.|..+.||++... +|+.|++|+.+...... ...+..|...++.|.. -.+++++++ +.-++|||
T Consensus 18 ~~v~~~g~G~~~~vyrv~l~-DG~~~~vK~~~~~~~~~--~~~~~~Ea~~L~~L~~~~~vpvP~v~~~----~~~~lv~e 90 (288)
T 3f7w_A 18 AAVAERGHSHRWHLYRVELA-DGTPLFVKALPDDAPAL--DGLFRAEALGLDWLGRSFGSPVPQVAGW----DDRTLAME 90 (288)
T ss_dssp EEEEEEEEETTEEEEEEEET-TSCEEEEEECCTTCCCC--TTHHHHHHHHHHHHTCSTTCCSCCEEEE----ETTEEEEE
T ss_pred EEEEecCCCCCeEEEEEEEC-CCCEEEEEEeCCCCcch--hhHHHHHHHHHHHHHhhCCCCcceEEec----cCceEEEE
Confidence 34677899999999998764 58899999865443221 2346678888888742 234444443 22368899
Q ss_pred cCCCcc
Q psy758 82 FCDHTV 87 (292)
Q Consensus 82 ~~~~~~ 87 (292)
+..++.
T Consensus 91 ~l~~~~ 96 (288)
T 3f7w_A 91 WVDERP 96 (288)
T ss_dssp CCCCCC
T ss_pred eecccC
Confidence 987643
|
| >3i1a_A Spectinomycin phosphotransferase; protein kinase, aminoglycoside phosphotransferase, antibiotic resistance; HET: MES PG4; 1.70A {Legionella pneumophila} PDB: 3i0q_A* 3i0o_A* 3q2m_A* | Back alignment and structure |
|---|
Probab=97.54 E-value=0.0014 Score=53.61 Aligned_cols=31 Identities=23% Similarity=0.325 Sum_probs=27.2
Q ss_pred CCccccCCCCCceEEccCCcEEEeecCchhh
Q psy758 120 HACIHRDIKPENILLTANGVVKLCDFGFARL 150 (292)
Q Consensus 120 ~givH~dl~p~Nilv~~~~~~kl~dfg~~~~ 150 (292)
.+++|||+.+.||++++++.+.|+||+.+..
T Consensus 206 ~~~~HgD~~~~N~l~~~~~~~~~iD~e~~~~ 236 (339)
T 3i1a_A 206 YVLCHSDIHAGNVLVGNEESIYIIDWDEPML 236 (339)
T ss_dssp CEEECSCCCGGGEEECGGGCEEECCCSSCEE
T ss_pred ceeEeCCCCcCCEEEeCCCeEEEEECCCCee
Confidence 3689999999999999888899999987753
|
| >3c5i_A Choline kinase; choline, kinase, malaria, transferase, structural genomics, structural genomics consortium; 2.20A {Plasmodium knowlesi} PDB: 3fi8_A* | Back alignment and structure |
|---|
Probab=97.46 E-value=0.00053 Score=56.90 Aligned_cols=75 Identities=13% Similarity=0.210 Sum_probs=42.0
Q ss_pred eeeecccCceEEEEEEEcC--------CCcEEEEEEeccCCCChHHHHHHHHHHHHHHhCCCCC-cchhhhhhhcCCeEE
Q psy758 7 IGKLGEGSYGVVFKCRNRD--------TGQVVAIKKFLESEEDPLIRKIALREIRLLKSLKHPN-LVNLLEVFRRKKKLH 77 (292)
Q Consensus 7 ~~~l~~g~~~~v~~~~~~~--------~~~~v~iK~~~~~~~~~~~~~~~~~e~~~~~~l~~~~-i~~~~~~~~~~~~~~ 77 (292)
.+.|+.|....+|++.... .+..+++|+....... . .....|..+++.+...+ ..++++.. .+ +
T Consensus 38 ~~~l~~G~~N~~y~v~~~~~~~~~~~~~~~~~vlRi~~~~~~~--~-~~~~~E~~~l~~L~~~g~~P~~~~~~--~~--~ 110 (369)
T 3c5i_A 38 VKQILSGLTNQLFEVGLKEETANNYNSIRTRVLFRIYGKHVDE--L-YNTISEFEVYKTMSKYKIAPQLLNTF--NG--G 110 (369)
T ss_dssp EEEC----CCEEEEEEECHHHHTTCTTSCCEEEEEECCTTGGG--T-SCHHHHHHHHHHHHHTTSSCCEEEEE--TT--E
T ss_pred EEEeCCcccceEEEEEeCCCCcccccCCCceEEEEecCCCccc--e-ecHHHHHHHHHHHHhcCCCCceEEec--CC--c
Confidence 4567788888999987653 1368899987543211 0 01245777777764323 34555443 22 6
Q ss_pred EEEecCCCccH
Q psy758 78 LVFEFCDHTVL 88 (292)
Q Consensus 78 iv~e~~~~~~L 88 (292)
+|+|+++|..+
T Consensus 111 ~v~e~i~G~~l 121 (369)
T 3c5i_A 111 RIEEWLYGDPL 121 (369)
T ss_dssp EEEECCCSEEC
T ss_pred EEEEEecCCcC
Confidence 89999998543
|
| >2qg7_A Ethanolamine kinase PV091845; malaria, SGC, structural genomics consortium, transferase; 2.41A {Plasmodium vivax} | Back alignment and structure |
|---|
Probab=97.38 E-value=0.001 Score=56.83 Aligned_cols=75 Identities=16% Similarity=0.193 Sum_probs=46.7
Q ss_pred eeeecccCceEEEEEEEcCCCcEEEEEEeccCCCChHHHHHHHHHHHHHHhCCCCCc-chhhhhhhcCCeEEEEEecCCC
Q psy758 7 IGKLGEGSYGVVFKCRNRDTGQVVAIKKFLESEEDPLIRKIALREIRLLKSLKHPNL-VNLLEVFRRKKKLHLVFEFCDH 85 (292)
Q Consensus 7 ~~~l~~g~~~~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~e~~~~~~l~~~~i-~~~~~~~~~~~~~~iv~e~~~~ 85 (292)
++.|+.|-...+|++.....+..+++|+........ . ...+|..+++.|...++ .++++.+. + ..|+||++|
T Consensus 113 i~~lsgG~tN~~y~v~~~~~~~~~vLRi~g~~~~~~--i-dR~~E~~vl~~L~~~gl~P~ll~~~~--~--G~v~e~I~G 185 (458)
T 2qg7_A 113 FQIINGGITNILIKVKDMSKQAKYLIRLYGPKTDEI--I-NREREKKISCILYNKNIAKKIYVFFT--N--GRIEEFMDG 185 (458)
T ss_dssp EEEECC--CEEEEEEEETTTTEEEEEEEECC-CCSC--S-CHHHHHHHHHHHTTSSSBCCEEEEET--T--EEEEECCCS
T ss_pred EEEcCCCeEeEEEEEEECCCCceEEEEECCCChhhh--c-CHHHHHHHHHHHHhcCCCCCEEEEeC--C--eEEEEeeCC
Confidence 456788888999999876445789999874322110 0 01468888888864444 45666653 2 259999988
Q ss_pred ccH
Q psy758 86 TVL 88 (292)
Q Consensus 86 ~~L 88 (292)
..+
T Consensus 186 ~~l 188 (458)
T 2qg7_A 186 YAL 188 (458)
T ss_dssp EEC
T ss_pred ccC
Confidence 444
|
| >4aw0_A HPDK1, 3-phosphoinositide-dependent protein kinase 1; transferase, allosteric regulation, allosteric site, phosphorylation, AGC protein kinase; HET: SEP ATP MJF; 1.43A {Homo sapiens} PDB: 3hrc_A* 3hrf_A* 4a06_A* 4a07_A* 3rcj_A* 4aw1_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* 1uu3_A* ... | Back alignment and structure |
|---|
Probab=97.11 E-value=9.8e-05 Score=59.54 Aligned_cols=41 Identities=27% Similarity=0.511 Sum_probs=35.0
Q ss_pred CCCCchHHHHHHHhhcccCCCCCCChhh------hhhccCcCCCCCC
Q psy758 189 PAATNIYLIDFLKRCLDKDPLRRWSCDQ------LLRHPYFNGYYFE 229 (292)
Q Consensus 189 ~~~~~~~~~~~~~~~~~~~p~~~~~~~~------~~~~~~~~~~~~~ 229 (292)
+...+..+.+++..|+..+|.+|++..+ +++|+||.+..+.
T Consensus 254 p~~~s~~~~dli~~lL~~dp~~R~t~~e~~~~~~i~~Hp~F~~idw~ 300 (311)
T 4aw0_A 254 PEKFFPKARDLVEKLLVLDATKRLGCEEMEGYGPLKAHPFFESVTWE 300 (311)
T ss_dssp CTTCCHHHHHHHHHHSCSSGGGSTTSGGGTCHHHHHTSGGGTTCCCT
T ss_pred CcccCHHHHHHHHHHccCCHhHCcChHHHcCCHHHHCCCCcCCCCHH
Confidence 3456888999999999999999999887 5789999987665
|
| >3ubd_A Ribosomal protein S6 kinase alpha-3; kinase-inhibitor complex, induced FIT, transferase-transfera inhibitor complex; HET: SL0; 1.53A {Mus musculus} PDB: 4el9_A* 3g51_A* 2z7q_A* 2z7r_A* 2z7s_A* | Back alignment and structure |
|---|
Probab=96.99 E-value=0.00013 Score=58.68 Aligned_cols=40 Identities=18% Similarity=0.368 Sum_probs=34.4
Q ss_pred CCCCCchHHHHHHHhhcccCCCCCCC-----hhhhhhccCcCCCC
Q psy758 188 KPAATNIYLIDFLKRCLDKDPLRRWS-----CDQLLRHPYFNGYY 227 (292)
Q Consensus 188 ~~~~~~~~~~~~~~~~~~~~p~~~~~-----~~~~~~~~~~~~~~ 227 (292)
.+...+..+.+++..|+..+|.+|++ .+++++|+||.+..
T Consensus 245 ~p~~~s~~~~~li~~~L~~dP~~R~ta~~~~~~eil~Hp~f~~id 289 (304)
T 3ubd_A 245 MPQFLSPEAQSLLRMLFKRNPANRLGAGPDGVEEIKRHSFFSTID 289 (304)
T ss_dssp CCTTSCHHHHHHHHHHTCSSGGGSTTCSTTTHHHHHTSGGGTTCC
T ss_pred CCCcCCHHHHHHHHHHcccCHHHCCCCCcCCHHHHHcCccccCCC
Confidence 34556889999999999999999998 47999999998764
|
| >4b9d_A Serine/threonine-protein kinase NEK1; transferase, inhibitor; HET: CK7; 1.90A {Homo sapiens} PDB: 4apc_A* | Back alignment and structure |
|---|
Probab=96.77 E-value=0.0003 Score=57.69 Aligned_cols=37 Identities=14% Similarity=0.230 Sum_probs=33.0
Q ss_pred CCCchHHHHHHHhhcccCCCCCCChhhhhhccCcCCC
Q psy758 190 AATNIYLIDFLKRCLDKDPLRRWSCDQLLRHPYFNGY 226 (292)
Q Consensus 190 ~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~ 226 (292)
...+..+.+++..|+..+|.+|+++.+++.|+|+...
T Consensus 247 ~~~s~~~~~li~~~L~~dP~~R~s~~e~l~hp~~~~~ 283 (350)
T 4b9d_A 247 LHYSYDLRSLVSQLFKRNPRDRPSVNSILEKGFIAKR 283 (350)
T ss_dssp TTSCHHHHHHHHHHTCSSGGGSCCHHHHHTSHHHHTT
T ss_pred ccCCHHHHHHHHHHccCChhHCcCHHHHhcCHHhhcC
Confidence 3457889999999999999999999999999998753
|
| >3mes_A Choline kinase; malaria, structural genomics, structural genomics consortium, SGC, transferase; HET: ADP DME PT3; 2.35A {Cryptosporidium parvum} | Back alignment and structure |
|---|
Probab=96.70 E-value=0.0077 Score=50.77 Aligned_cols=75 Identities=13% Similarity=0.125 Sum_probs=45.9
Q ss_pred eeeecccCceEEEEEEEcCC-------CcEEEEEEeccCCCChHHHHHHHHHHHHHHhCCC-CCcchhhhhhhcCCeEEE
Q psy758 7 IGKLGEGSYGVVFKCRNRDT-------GQVVAIKKFLESEEDPLIRKIALREIRLLKSLKH-PNLVNLLEVFRRKKKLHL 78 (292)
Q Consensus 7 ~~~l~~g~~~~v~~~~~~~~-------~~~v~iK~~~~~~~~~~~~~~~~~e~~~~~~l~~-~~i~~~~~~~~~~~~~~i 78 (292)
++.+..|-...+|++..... +..+++|+........ -...+|..+++.+.. .-..++++.+ .+ +.
T Consensus 75 v~~lsGG~TN~~y~v~~~~~~~~~~~~~~~~vlRi~g~~t~~~---idR~~E~~~l~~L~~~gi~P~l~~~~--~~--~~ 147 (424)
T 3mes_A 75 VKQIFSGLTNQLFVVSIVNESMSLSLKHPRILFRIYGKHVGKF---YDSKVELDVFRYLSNINIAPNIIADF--PE--GR 147 (424)
T ss_dssp EEEECCCSSSEEEEEEECCC-----CCCSEEEEEECCCCC-CC---CCHHHHHHHHHHHHHTTSSCCEEEEE--TT--EE
T ss_pred EEEcCCCcccceEEEEeCCCcccccCCCCeEEEEECCCCcchh---cCHHHHHHHHHHHHhcCCCCCEEEEc--CC--CE
Confidence 45677788888999887521 5789999875432110 112357777777642 2234445433 22 68
Q ss_pred EEecCCCccH
Q psy758 79 VFEFCDHTVL 88 (292)
Q Consensus 79 v~e~~~~~~L 88 (292)
|++|++|..+
T Consensus 148 I~efI~G~~l 157 (424)
T 3mes_A 148 IEEFIDGEPL 157 (424)
T ss_dssp EEECCCSEEC
T ss_pred EEEEeCCccC
Confidence 9999998653
|
| >3g15_A CK, chetk-alpha, choline kinase alpha; non-protein kinase, structural genomics CONS SGC, hemicholinium-3, transferase; HET: ADP HC6; 1.70A {Homo sapiens} PDB: 3f2r_A* 2i7q_A 2cko_A 2ckp_A* 2ckq_A* | Back alignment and structure |
|---|
Probab=96.40 E-value=0.015 Score=48.79 Aligned_cols=30 Identities=30% Similarity=0.425 Sum_probs=25.1
Q ss_pred ccccCCCCCceEEc------cCCcEEEeecCchhhh
Q psy758 122 CIHRDIKPENILLT------ANGVVKLCDFGFARLI 151 (292)
Q Consensus 122 ivH~dl~p~Nilv~------~~~~~kl~dfg~~~~~ 151 (292)
++|+|+.+.||++. +++.+.++||..+...
T Consensus 246 fcHnDl~~gNil~~~~~~~~~~~~l~vIDwEya~~n 281 (401)
T 3g15_A 246 FCHNDCQEGNILLLEGRENSEKQKLMLIDFEYSSYN 281 (401)
T ss_dssp EECSCCCGGGEEEETTGGGCSSCCEEECCCTTCEEE
T ss_pred eEEecCCCCeEEEecCcccCcCCeEEEechHhccCC
Confidence 67999999999993 4567999999988643
|
| >2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A | Back alignment and structure |
|---|
Probab=96.35 E-value=0.00054 Score=55.37 Aligned_cols=38 Identities=29% Similarity=0.451 Sum_probs=31.0
Q ss_pred CchHHHHHHHhhcccCCCCCCChhhhhhccCcCCCCCC
Q psy758 192 TNIYLIDFLKRCLDKDPLRRWSCDQLLRHPYFNGYYFE 229 (292)
Q Consensus 192 ~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~ 229 (292)
.+..+.+++..|+..+|..|++..+++.|+|+.+...+
T Consensus 268 ~~~~~~~li~~~L~~dP~~Rps~~e~l~hp~~~~~~~~ 305 (316)
T 2ac3_A 268 ISCAAKDLISKLLVRDAKQRLSAAQVLQHPWVQGCAPE 305 (316)
T ss_dssp SCHHHHHHHHHHSCSSTTTSCCHHHHHHSTTCC-----
T ss_pred CCHHHHHHHHHHhhCChhhCCCHHHHhcChhhcCCCCc
Confidence 46778999999999999999999999999999875443
|
| >2yle_A Protein spire homolog 1; actin-binding protein, actin polymerization; 1.80A {Homo sapiens} PDB: 2ylf_A 3r7g_A 3rbw_A | Back alignment and structure |
|---|
Probab=96.08 E-value=0.0059 Score=45.99 Aligned_cols=59 Identities=17% Similarity=0.147 Sum_probs=43.3
Q ss_pred ccHHHHhcC-CCCCCHHHHHHHHHHHHHHHHHHHh-CCccccCCCCCceEEccCCcEEEee
Q psy758 86 TVLNELENH-PHGLPWDLIKQITWQVLRGVSYCHR-HACIHRDIKPENILLTANGVVKLCD 144 (292)
Q Consensus 86 ~~L~~~~~~-~~~~~~~~~~~i~~qi~~aL~~LH~-~givH~dl~p~Nilv~~~~~~kl~d 144 (292)
-+|.++++. +.+++|+++|.++.|.+.+|.-+-. +.-...=+.|..|++..+|.+.+.+
T Consensus 33 vSL~eIL~~~~~PlsEEqaWALc~Qc~~~L~~~~~~~~~~~~i~~~~~i~l~~dG~V~f~~ 93 (229)
T 2yle_A 33 LSLEEILRLYNQPINEEQAWAVCYQCCGSLRAAARRRQPRHRVRSAAQIRVWRDGAVTLAP 93 (229)
T ss_dssp EEHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCSGGGEEEETTSCEEECC
T ss_pred ccHHHHHHHcCCCcCHHHHHHHHHHHHHHHHhhhhcccCCceecCCcceEEecCCceeccc
Confidence 356676653 4579999999999999999888732 1212333567899999999988764
|
| >3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B* | Back alignment and structure |
|---|
Probab=96.03 E-value=0.0011 Score=55.31 Aligned_cols=38 Identities=26% Similarity=0.473 Sum_probs=32.2
Q ss_pred CchHHHHHHHhhcccCCCCCCChhhhhhccCcCCCCCC
Q psy758 192 TNIYLIDFLKRCLDKDPLRRWSCDQLLRHPYFNGYYFE 229 (292)
Q Consensus 192 ~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~ 229 (292)
.+..+.+++..|+..+|.+|+++.+++.|+||......
T Consensus 306 ~s~~~~~li~~~L~~dP~~Rpta~ell~hp~f~~~~~~ 343 (389)
T 3gni_B 306 FSPHFHHFVEQCLQRNPDARPSASTLLNHSFFKQIKRR 343 (389)
T ss_dssp CCHHHHHHHHHHTCSCTTTSCCHHHHTTSGGGGGC---
T ss_pred cCHHHHHHHHHHhhcCcccCCCHHHHhcCHHHHHHhhc
Confidence 46678899999999999999999999999999876543
|
| >3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A | Back alignment and structure |
|---|
Probab=95.96 E-value=0.0036 Score=50.89 Aligned_cols=36 Identities=17% Similarity=0.189 Sum_probs=32.5
Q ss_pred CchHHHHHHHhhcccCCCCCCChhhhhhccCcCCCC
Q psy758 192 TNIYLIDFLKRCLDKDPLRRWSCDQLLRHPYFNGYY 227 (292)
Q Consensus 192 ~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~ 227 (292)
.+..+.+++..|+..+|.+|++..+++.|+|+....
T Consensus 243 ~s~~~~~li~~~L~~dP~~Rpt~~ell~h~w~~~~~ 278 (325)
T 3kn6_A 243 VSQEAKDLIQGLLTVDPNKRLKMSGLRYNEWLQDGS 278 (325)
T ss_dssp SCHHHHHHHHHHHCCCTTTCCCTTTSTTCGGGCTTC
T ss_pred CCHHHHHHHHHHCCCChhHCCCHHHHhcChhhccCc
Confidence 467889999999999999999999999999998653
|
| >1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ... | Back alignment and structure |
|---|
Probab=95.85 E-value=0.0089 Score=48.85 Aligned_cols=36 Identities=22% Similarity=0.360 Sum_probs=32.1
Q ss_pred CchHHHHHHHhhcccCCCCCC-----ChhhhhhccCcCCCC
Q psy758 192 TNIYLIDFLKRCLDKDPLRRW-----SCDQLLRHPYFNGYY 227 (292)
Q Consensus 192 ~~~~~~~~~~~~~~~~p~~~~-----~~~~~~~~~~~~~~~ 227 (292)
.+..+.+++..|+..+|..|+ +..+++.|+||.+..
T Consensus 228 ~s~~~~~li~~lL~~dP~~R~g~~~~~~~ei~~h~~f~~~~ 268 (337)
T 1o6l_A 228 LSPEAKSLLAGLLKKDPKQRLGGGPSDAKEVMEHRFFLSIN 268 (337)
T ss_dssp SCHHHHHHHHHHTCSSTTTSTTCSTTTHHHHHTSGGGTTCC
T ss_pred CCHHHHHHHHHHhhcCHHHhcCCCCCCHHHHHcCCCcCCCC
Confidence 467788999999999999998 899999999998763
|
| >4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A* | Back alignment and structure |
|---|
Probab=95.83 E-value=0.0064 Score=51.76 Aligned_cols=36 Identities=25% Similarity=0.480 Sum_probs=32.5
Q ss_pred CCchHHHHHHHhhcccCCCCCC-----ChhhhhhccCcCCC
Q psy758 191 ATNIYLIDFLKRCLDKDPLRRW-----SCDQLLRHPYFNGY 226 (292)
Q Consensus 191 ~~~~~~~~~~~~~~~~~p~~~~-----~~~~~~~~~~~~~~ 226 (292)
..+..+.+++..|+..+|..|+ ++.+++.|+||.+.
T Consensus 371 ~~~~~~~~li~~~L~~dP~~R~~~~~~t~~ell~hp~f~~~ 411 (446)
T 4ejn_A 371 TLGPEAKSLLSGLLKKDPKQRLGGGSEDAKEIMQHRFFAGI 411 (446)
T ss_dssp TSCHHHHHHHHHHTCSSTTTSTTCSTTTHHHHHTSGGGTTC
T ss_pred cCCHHHHHHHHHHcccCHHHhCCCCCCCHHHHHhCccccCC
Confidence 3467788999999999999999 99999999999976
|
| >2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens} | Back alignment and structure |
|---|
Probab=95.81 E-value=0.0019 Score=51.72 Aligned_cols=35 Identities=29% Similarity=0.451 Sum_probs=31.5
Q ss_pred CCCchHHHHHHHhhcccCCCCCCChhhhhhccCcC
Q psy758 190 AATNIYLIDFLKRCLDKDPLRRWSCDQLLRHPYFN 224 (292)
Q Consensus 190 ~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~ 224 (292)
...+..+.+++..|+..+|.+|++..+++.|+|+.
T Consensus 263 ~~~~~~l~~li~~~l~~dp~~R~s~~e~l~hp~~~ 297 (298)
T 2zv2_A 263 PDIAEDLKDLITRMLDKNPESRIVVPEIKLHPWVT 297 (298)
T ss_dssp SCCCHHHHHHHHHHTCSCTTTSCCHHHHTTCHHHH
T ss_pred cccCHHHHHHHHHHhhcChhhCCCHHHHhcCcccc
Confidence 34578899999999999999999999999999874
|
| >4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus} | Back alignment and structure |
|---|
Probab=95.77 E-value=0.003 Score=52.91 Aligned_cols=40 Identities=30% Similarity=0.636 Sum_probs=34.2
Q ss_pred CCCCchHHHHHHHhhcccCCCCCCCh------hhhhhccCcCCCCC
Q psy758 189 PAATNIYLIDFLKRCLDKDPLRRWSC------DQLLRHPYFNGYYF 228 (292)
Q Consensus 189 ~~~~~~~~~~~~~~~~~~~p~~~~~~------~~~~~~~~~~~~~~ 228 (292)
+...+..+.+++..|+..+|.+|++. .+++.|+||.+..+
T Consensus 282 p~~~s~~~~~li~~lL~~dP~~R~~~~~~~~~~ei~~Hpff~~i~w 327 (396)
T 4dc2_A 282 PRSLSVKAASVLKSFLNKDPKERLGCHPQTGFADIQGHPFFRNVDW 327 (396)
T ss_dssp CTTSCHHHHHHHHHHTCSCTTTSTTCSTTTHHHHHHHSTTTTTCCH
T ss_pred CCcCCHHHHHHHHHHhcCCHhHcCCCCCCCCHHHHhcCccccCCCH
Confidence 44568889999999999999999985 79999999987643
|
| >3hyh_A Carbon catabolite-derepressing protein kinase; kinase domain, transferase, ATP-binding, carbohydrate metabo kinase, membrane; 2.20A {Saccharomyces cerevisiae} PDB: 3dae_A 2fh9_A 3mn3_A | Back alignment and structure |
|---|
Probab=95.63 E-value=0.00084 Score=53.17 Aligned_cols=37 Identities=24% Similarity=0.379 Sum_probs=33.1
Q ss_pred CCCCchHHHHHHHhhcccCCCCCCChhhhhhccCcCC
Q psy758 189 PAATNIYLIDFLKRCLDKDPLRRWSCDQLLRHPYFNG 225 (292)
Q Consensus 189 ~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~ 225 (292)
+...+..+.+++..|+..+|.+|++..++++|+|+..
T Consensus 232 p~~~s~~~~~li~~~L~~dP~~R~s~~eil~hpw~k~ 268 (275)
T 3hyh_A 232 PKFLSPGAAGLIKRMLIVNPLNRISIHEIMQDDWFKV 268 (275)
T ss_dssp CTTSCHHHHHHHHHHSCSSGGGSCCHHHHHHCHHHHT
T ss_pred CCCCCHHHHHHHHHHccCChhHCcCHHHHHcCccccc
Confidence 3456788999999999999999999999999999864
|
| >3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens} | Back alignment and structure |
|---|
Probab=95.42 E-value=0.0051 Score=52.35 Aligned_cols=35 Identities=20% Similarity=0.448 Sum_probs=31.6
Q ss_pred CCchHHHHHHHhhcccCCCCCCChhhhhhccCcCC
Q psy758 191 ATNIYLIDFLKRCLDKDPLRRWSCDQLLRHPYFNG 225 (292)
Q Consensus 191 ~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~ 225 (292)
..+..+.+++..|+..+|.+|++..+++.|+|+..
T Consensus 239 ~~s~~~~~li~~~L~~dP~~Rpta~e~L~hp~~~~ 273 (444)
T 3soa_A 239 TVTPEAKDLINKMLTINPSKRITAAEALKHPWISH 273 (444)
T ss_dssp TSCHHHHHHHHHHSCSSTTTSCCHHHHHHSCTTHH
T ss_pred cCCHHHHHHHHHHcCCChhHCCCHHHHhcCccccC
Confidence 34677899999999999999999999999999864
|
| >3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe} | Back alignment and structure |
|---|
Probab=95.38 E-value=0.0028 Score=51.84 Aligned_cols=36 Identities=22% Similarity=0.417 Sum_probs=32.3
Q ss_pred CCchHHHHHHHhhcccCCCCCCChhhhhhccCcCCC
Q psy758 191 ATNIYLIDFLKRCLDKDPLRRWSCDQLLRHPYFNGY 226 (292)
Q Consensus 191 ~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~ 226 (292)
..+..+.+++..|+..+|.+|++..++++|+|+...
T Consensus 230 ~~s~~~~~li~~~L~~dP~~Rpt~~eil~hp~~~~~ 265 (336)
T 3h4j_B 230 FLSPGAQSLIRRMIVADPMQRITIQEIRRDPWFNVN 265 (336)
T ss_dssp TSCHHHHHHHHTTSCSSGGGSCCHHHHTTCHHHHTT
T ss_pred cCCHHHHHHHHHHcCCChhHCcCHHHHHhChhhccC
Confidence 357788999999999999999999999999998753
|
| >1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A* | Back alignment and structure |
|---|
Probab=95.29 E-value=0.0033 Score=51.60 Aligned_cols=37 Identities=19% Similarity=0.383 Sum_probs=32.8
Q ss_pred CchHHHHHHHhhcccCCCCCCChh-hhhhccCcCCCCC
Q psy758 192 TNIYLIDFLKRCLDKDPLRRWSCD-QLLRHPYFNGYYF 228 (292)
Q Consensus 192 ~~~~~~~~~~~~~~~~p~~~~~~~-~~~~~~~~~~~~~ 228 (292)
.+..+.+++..|+..+|..|++.. ++..|+||.+..+
T Consensus 241 ~s~~~~~li~~lL~~dp~~R~~~~~~i~~hp~f~~~~w 278 (345)
T 1xjd_A 241 LEKEAKDLLVKLFVREPEKRLGVRGDIRQHPLFREINW 278 (345)
T ss_dssp SCHHHHHHHHHHSCSSGGGSBTTBSCGGGSGGGTTCCH
T ss_pred cCHHHHHHHHHHhcCCHhHcCCChHHHHcCccccCCCH
Confidence 467789999999999999999998 9999999987643
|
| >3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A* | Back alignment and structure |
|---|
Probab=95.26 E-value=0.0052 Score=50.40 Aligned_cols=40 Identities=30% Similarity=0.636 Sum_probs=34.0
Q ss_pred CCCCchHHHHHHHhhcccCCCCCCCh------hhhhhccCcCCCCC
Q psy758 189 PAATNIYLIDFLKRCLDKDPLRRWSC------DQLLRHPYFNGYYF 228 (292)
Q Consensus 189 ~~~~~~~~~~~~~~~~~~~p~~~~~~------~~~~~~~~~~~~~~ 228 (292)
+...+..+.+++..|+..+|..|++. .+++.|+||.+..+
T Consensus 239 p~~~s~~~~~li~~lL~~dP~~R~~~~~~~~~~~i~~hp~f~~~~w 284 (345)
T 3a8x_A 239 PRSLSVKAASVLKSFLNKDPKERLGCHPQTGFADIQGHPFFRNVDW 284 (345)
T ss_dssp CTTSCHHHHHHHHHHTCSSTTTSTTCCTTTHHHHHHTSGGGTTCCH
T ss_pred CCCCCHHHHHHHHHHhcCCHhHCCCCCCcCCHHHHhcCCccCCCCH
Confidence 34557889999999999999999985 79999999987643
|
| >3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens} | Back alignment and structure |
|---|
Probab=95.14 E-value=0.0022 Score=52.79 Aligned_cols=39 Identities=28% Similarity=0.477 Sum_probs=34.2
Q ss_pred CCCCchHHHHHHHhhcccCCCCCCCh------hhhhhccCcCCCC
Q psy758 189 PAATNIYLIDFLKRCLDKDPLRRWSC------DQLLRHPYFNGYY 227 (292)
Q Consensus 189 ~~~~~~~~~~~~~~~~~~~p~~~~~~------~~~~~~~~~~~~~ 227 (292)
+...+..+.+++..|+..+|..|++. .+++.|+||.+..
T Consensus 244 p~~~~~~~~~li~~lL~~dP~~R~~~~~~~~~~~il~hp~f~~~~ 288 (353)
T 3txo_A 244 PTWLHEDATGILKSFMTKNPTMRLGSLTQGGEHAILRHPFFKEID 288 (353)
T ss_dssp CTTSCHHHHHHHHHHTCSSGGGSTTSGGGTCTHHHHTSGGGTTCC
T ss_pred CCCCCHHHHHHHHHHhhhCHHHccCCcccCCHHHHhhCCcccCCC
Confidence 44467889999999999999999998 8899999998764
|
| >2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=94.99 E-value=0.0011 Score=53.81 Aligned_cols=38 Identities=26% Similarity=0.456 Sum_probs=33.1
Q ss_pred CchHHHHHHHhhcccCCCCCCChhhhhhccCcCCCCCC
Q psy758 192 TNIYLIDFLKRCLDKDPLRRWSCDQLLRHPYFNGYYFE 229 (292)
Q Consensus 192 ~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~ 229 (292)
.+..+.+++..|+..+|..|++..+++.|+|+......
T Consensus 259 ~~~~l~~li~~~l~~dp~~Rps~~~ll~hp~~~~~~~~ 296 (326)
T 2x7f_A 259 WSKKFQSFIESCLVKNHSQRPATEQLMKHPFIRDQPNE 296 (326)
T ss_dssp SCHHHHHHHHHHCCSSGGGSCCHHHHHTSHHHHCCTTH
T ss_pred cCHHHHHHHHHHhccChhhCCCHHHHhhChHHhhCccc
Confidence 35678899999999999999999999999999875443
|
| >3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens} | Back alignment and structure |
|---|
Probab=94.89 E-value=0.009 Score=48.04 Aligned_cols=51 Identities=27% Similarity=0.466 Sum_probs=37.8
Q ss_pred chHHHHHHHhhcccCCCCCCChhhhhhccCcCCCCCCCCCccchHHHHhcccCcC
Q psy758 193 NIYLIDFLKRCLDKDPLRRWSCDQLLRHPYFNGYYFEVPDEMQYEEITQRCLDKD 247 (292)
Q Consensus 193 ~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~d 247 (292)
+..+.+++..|+..+|..|++..+++.|+|+..... ...+++++.......
T Consensus 252 ~~~l~~li~~~l~~dp~~Rpt~~~ll~~~~~~~~~~----~~~~~~~~~~~~~~~ 302 (314)
T 3com_A 252 SDNFTDFVKQCLVKSPEQRATATQLLQHPFVRSAKG----VSILRDLINEAMDVK 302 (314)
T ss_dssp CHHHHHHHHHHTCSCTTTSCCHHHHTTSHHHHTCCC----GGGGHHHHHHHC---
T ss_pred CHHHHHHHHHHccCChhhCcCHHHHHhCHHHhcCCc----chHHHHHhhhhhhhh
Confidence 567889999999999999999999999999986532 234455555555443
|
| >3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens} | Back alignment and structure |
|---|
Probab=94.87 E-value=0.0049 Score=48.64 Aligned_cols=37 Identities=24% Similarity=0.432 Sum_probs=31.4
Q ss_pred CCchHHHHHHHhhcccCCCCCCChhhhhhccCcCCCC
Q psy758 191 ATNIYLIDFLKRCLDKDPLRRWSCDQLLRHPYFNGYY 227 (292)
Q Consensus 191 ~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~ 227 (292)
..+..+.+++..|+..+|..|++..+++.|+|+....
T Consensus 234 ~~~~~~~~li~~~l~~dp~~Rps~~~~l~h~~~~~~~ 270 (278)
T 3cok_A 234 FLSIEAKDLIHQLLRRNPADRLSLSSVLDHPFMSRNS 270 (278)
T ss_dssp TSCHHHHHHHHHHSCSSGGGSCCHHHHTTSTTTC---
T ss_pred ccCHHHHHHHHHHcccCHhhCCCHHHHhcCccccCCC
Confidence 3567889999999999999999999999999987643
|
| >2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X* | Back alignment and structure |
|---|
Probab=94.79 E-value=0.0044 Score=50.72 Aligned_cols=38 Identities=29% Similarity=0.407 Sum_probs=33.9
Q ss_pred CCchHHHHHHHhhcccCCCCCCChhhhhhccCcCCCCC
Q psy758 191 ATNIYLIDFLKRCLDKDPLRRWSCDQLLRHPYFNGYYF 228 (292)
Q Consensus 191 ~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~ 228 (292)
..+..+.+++..|+..+|..|++..+++.|+|+.....
T Consensus 294 ~~~~~l~~li~~~L~~dP~~Rps~~e~l~hp~f~~~~~ 331 (348)
T 2pml_X 294 FLSNEDIDFLKLFLRKNPAERITSEDALKHEWLADTNI 331 (348)
T ss_dssp CCCHHHHHHHHHHCCSSGGGSCCHHHHHTSGGGTTCCH
T ss_pred hcCHHHHHHHHHHccCChhhCCCHHHHhcCccccCCCH
Confidence 45778899999999999999999999999999987643
|
| >3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A | Back alignment and structure |
|---|
Probab=94.73 E-value=0.0063 Score=50.00 Aligned_cols=36 Identities=25% Similarity=0.384 Sum_probs=32.3
Q ss_pred CCchHHHHHHHhhcccCCCCCCChhhhhhccCcCCC
Q psy758 191 ATNIYLIDFLKRCLDKDPLRRWSCDQLLRHPYFNGY 226 (292)
Q Consensus 191 ~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~ 226 (292)
..+..+.+++..|+..+|.+|++..+++.|+|+...
T Consensus 258 ~~s~~~~~li~~~L~~dP~~R~s~~e~l~hp~~~~~ 293 (351)
T 3c0i_A 258 HISESAKDLVRRMLMLDPAERITVYEALNHPWLKER 293 (351)
T ss_dssp TSCHHHHHHHHHHTCSSTTTSCCHHHHHTSHHHHTH
T ss_pred cCCHHHHHHHHHHCCCChhHCcCHHHHhcChhhcCC
Confidence 346788999999999999999999999999998763
|
| >3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A | Back alignment and structure |
|---|
Probab=94.68 E-value=0.0094 Score=52.46 Aligned_cols=40 Identities=25% Similarity=0.280 Sum_probs=35.7
Q ss_pred CCchHHHHHHHhhcccCCCCCCChhhhhhccCcCCCCCCC
Q psy758 191 ATNIYLIDFLKRCLDKDPLRRWSCDQLLRHPYFNGYYFEV 230 (292)
Q Consensus 191 ~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~ 230 (292)
..+..+.+++..||..+|.+|+++.++++|+|+.....+.
T Consensus 382 ~~s~~~~dli~~~L~~dp~~R~t~~e~l~Hpw~~~~~~~~ 421 (573)
T 3uto_A 382 GISEDGKDFIRKLLLADPNTRMTIHQALEHPWLTPGNAPG 421 (573)
T ss_dssp TSCHHHHHHHHTTSCSSGGGSCCHHHHHHSTTTSCCCCTT
T ss_pred CCCHHHHHHHHHHccCChhHCcCHHHHhcCcCcCCCCCCC
Confidence 4577899999999999999999999999999999876654
|
| >3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A* | Back alignment and structure |
|---|
Probab=94.64 E-value=0.018 Score=46.68 Aligned_cols=37 Identities=22% Similarity=0.371 Sum_probs=32.2
Q ss_pred CCchHHHHHHHhhcccCCCCCC-----ChhhhhhccCcCCCC
Q psy758 191 ATNIYLIDFLKRCLDKDPLRRW-----SCDQLLRHPYFNGYY 227 (292)
Q Consensus 191 ~~~~~~~~~~~~~~~~~p~~~~-----~~~~~~~~~~~~~~~ 227 (292)
..+..+.+++..|+..+|..|+ +..+++.|+||....
T Consensus 243 ~~~~~~~~li~~~L~~dp~~R~~~~~~~~~e~l~hp~f~~~~ 284 (327)
T 3a62_A 243 YLTQEARDLLKKLLKRNAASRLGAGPGDAGEVQAHPFFRHIN 284 (327)
T ss_dssp TSCHHHHHHHHHHSCSCGGGSTTSSTTTHHHHHHSGGGSSCC
T ss_pred CCCHHHHHHHHHHHhcCHhhccCCCCCCHHHHHcCCcccCCC
Confidence 3467788999999999999998 788999999998653
|
| >3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A | Back alignment and structure |
|---|
Probab=94.53 E-value=0.017 Score=46.89 Aligned_cols=38 Identities=21% Similarity=0.294 Sum_probs=33.4
Q ss_pred CCchHHHHHHHhhcccCCCCCCChhhhhhccCcCCCCC
Q psy758 191 ATNIYLIDFLKRCLDKDPLRRWSCDQLLRHPYFNGYYF 228 (292)
Q Consensus 191 ~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~ 228 (292)
..+..+.+++..|+..+|.+|++..+++.|+|+.....
T Consensus 236 ~~s~~~~~li~~~L~~dP~~R~t~~eil~h~~~~~~~~ 273 (328)
T 3fe3_A 236 YMSTDCENLLKRFLVLNPIKRGTLEQIMKDRWINAGHE 273 (328)
T ss_dssp TSCHHHHHHHHHHCCSSTTTSCCHHHHTTCTTTTTTCT
T ss_pred CCCHHHHHHHHHHCCCChhHCcCHHHHhcCHhhcCCCc
Confidence 34677889999999999999999999999999986543
|
| >3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A | Back alignment and structure |
|---|
Probab=94.45 E-value=0.011 Score=53.16 Aligned_cols=38 Identities=18% Similarity=0.379 Sum_probs=33.2
Q ss_pred CCchHHHHHHHhhcccCCCCCCCh-----hhhhhccCcCCCCC
Q psy758 191 ATNIYLIDFLKRCLDKDPLRRWSC-----DQLLRHPYFNGYYF 228 (292)
Q Consensus 191 ~~~~~~~~~~~~~~~~~p~~~~~~-----~~~~~~~~~~~~~~ 228 (292)
..+..+.+++..|+..+|.+|++. .+++.|+||....+
T Consensus 564 ~~s~~~~~li~~lL~~dP~~R~~~~~~~~~ei~~h~ff~~i~w 606 (674)
T 3pfq_A 564 SMSKEAVAICKGLMTKHPGKRLGCGPEGERDIKEHAFFRYIDW 606 (674)
T ss_dssp TSCHHHHHHHHHHSCSSSTTCTTCSTTHHHHHHSSGGGSSCCH
T ss_pred cCCHHHHHHHHHHccCCHHHCCCCCCCcHHHHhcCccccCCCH
Confidence 356778999999999999999987 89999999987643
|
| >2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A* | Back alignment and structure |
|---|
Probab=94.44 E-value=0.01 Score=48.87 Aligned_cols=37 Identities=16% Similarity=0.227 Sum_probs=31.7
Q ss_pred CCchHHHHHHHhhcccCCCCCCC-----hhhhhhccCcCCCC
Q psy758 191 ATNIYLIDFLKRCLDKDPLRRWS-----CDQLLRHPYFNGYY 227 (292)
Q Consensus 191 ~~~~~~~~~~~~~~~~~p~~~~~-----~~~~~~~~~~~~~~ 227 (292)
..+..+.+++..|+..+|..|++ ..+++.|+||....
T Consensus 243 ~~s~~~~~li~~lL~~dP~~R~~~~~~~~~~i~~h~~f~~~~ 284 (353)
T 2i0e_A 243 SMSKEAVAICKGLMTKHPGKRLGCGPEGERDIKEHAFFRYID 284 (353)
T ss_dssp TSCHHHHHHHHHHTCSCTTSCTTCSTTHHHHHHTSGGGTTCC
T ss_pred CCCHHHHHHHHHHhhcCHHHcCCCCCCCHHHHhcCccccCCC
Confidence 34677889999999999999995 58999999998754
|
| >4ano_A ESSB; membrane protein, membrane secretion, ESS type V secretion S; HET: MSE; 1.70A {Geobacillus thermodenitrificans ng80-2organism_taxid} | Back alignment and structure |
|---|
Probab=94.42 E-value=0.061 Score=40.55 Aligned_cols=86 Identities=8% Similarity=0.018 Sum_probs=62.5
Q ss_pred CCCCcchhhhhhhcCCeEEEEEecCCCccHHHHhcCCCCCCHHHHHHHHHHHHHHHH-HHHhCCccccCCCCCceEEccC
Q psy758 59 KHPNLVNLLEVFRRKKKLHLVFEFCDHTVLNELENHPHGLPWDLIKQITWQVLRGVS-YCHRHACIHRDIKPENILLTAN 137 (292)
Q Consensus 59 ~~~~i~~~~~~~~~~~~~~iv~e~~~~~~L~~~~~~~~~~~~~~~~~i~~qi~~aL~-~LH~~givH~dl~p~Nilv~~~ 137 (292)
.||++ --.+-.+++.+.+.++.-++..-..-++ ..+....++++.+|+.... ++ ..-+|--|+|+||+++.+
T Consensus 48 ~~~~f--~~~I~~~eD~~~i~y~~~~~~~~f~~i~---~~~~~eKlrll~nl~~L~~~~~--~~r~tf~l~P~NL~f~~~ 120 (219)
T 4ano_A 48 VDPCI--VRDIDVSEDEVKVVIKPPSSFLTFAAIR---KTTLLSRIRAAIHLVSKVKHHS--ARRLIFIVCPENLMFNRA 120 (219)
T ss_dssp SCSSS--EEEEEECSSEEEEEEECCTTCEEHHHHH---TSCHHHHHHHHHHHHHHHSSCC--SSSEECCCCGGGEEECTT
T ss_pred cCCCC--CeEEEEeCCEEEEEEEcCcccCcHHHHH---hcCHHHHHHHHHHHHHHHHHhh--hCceeEEEeCceEEEeCC
Confidence 46777 3333456788888888875443333443 4889999999999887665 44 445788999999999999
Q ss_pred CcEEEeecCchhhh
Q psy758 138 GVVKLCDFGFARLI 151 (292)
Q Consensus 138 ~~~kl~dfg~~~~~ 151 (292)
+.+++.-.|+-..+
T Consensus 121 ~~p~i~hRGi~~~l 134 (219)
T 4ano_A 121 LEPFFLHVGVKESL 134 (219)
T ss_dssp CCEEESCCEETTTB
T ss_pred CcEEEEEcCCcccC
Confidence 99999877775443
|
| >3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A* | Back alignment and structure |
|---|
Probab=93.98 E-value=0.027 Score=45.55 Aligned_cols=35 Identities=14% Similarity=0.293 Sum_probs=31.3
Q ss_pred CchHHHHHHHhhcccCCCCCCChhhhhhccCcCCC
Q psy758 192 TNIYLIDFLKRCLDKDPLRRWSCDQLLRHPYFNGY 226 (292)
Q Consensus 192 ~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~ 226 (292)
.+..+.+++..|+..+|.+|++..+++.++|+...
T Consensus 234 ~~~~~~~li~~~L~~dP~~R~t~~eil~h~~~~~~ 268 (323)
T 3tki_A 234 IDSAPLALLHKILVENPSARITIPDIKKDRWYNKP 268 (323)
T ss_dssp SCHHHHHHHHHHSCSSTTTSCCHHHHTTCTTTTCC
T ss_pred CCHHHHHHHHHHccCChhhCcCHHHHhhChhhccc
Confidence 45677899999999999999999999999999754
|
| >2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A | Back alignment and structure |
|---|
Probab=93.97 E-value=0.0048 Score=50.54 Aligned_cols=37 Identities=24% Similarity=0.465 Sum_probs=32.8
Q ss_pred CCCchHHHHHHHhhcccCCCCCCChhhhhhccCcCCC
Q psy758 190 AATNIYLIDFLKRCLDKDPLRRWSCDQLLRHPYFNGY 226 (292)
Q Consensus 190 ~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~ 226 (292)
...+..+.+++..|+..+|.+|++..+++.|+|+...
T Consensus 248 ~~~s~~~~~li~~~L~~dP~~R~t~~~il~hp~~~~~ 284 (342)
T 2qr7_A 248 NSVSDTAKDLVSKMLHVDPHQRLTAALVLRHPWIVHW 284 (342)
T ss_dssp TTSCHHHHHHHHHHTCSSTTTSCCHHHHTTSHHHHTG
T ss_pred ccCCHHHHHHHHHHCCCChhHCcCHHHHhcCCeecCc
Confidence 3457889999999999999999999999999998653
|
| >4ann_A ESSB; membrane protein, membrane secretion, ESS type VII secretion virulence; 1.05A {Staphylococcus aureus subsp} | Back alignment and structure |
|---|
Probab=93.86 E-value=0.077 Score=39.86 Aligned_cols=86 Identities=10% Similarity=0.220 Sum_probs=63.5
Q ss_pred CCCCcchhhhhhhcCCeEEEEEecCC-CccHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEEccC
Q psy758 59 KHPNLVNLLEVFRRKKKLHLVFEFCD-HTVLNELENHPHGLPWDLIKQITWQVLRGVSYCHRHACIHRDIKPENILLTAN 137 (292)
Q Consensus 59 ~~~~i~~~~~~~~~~~~~~iv~e~~~-~~~L~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~givH~dl~p~Nilv~~~ 137 (292)
.+|++++. .+-.+++.+.+.++.-+ +-++.. ++ ..+....+.++.+|+....++ ..-+|--|+|+||+++.+
T Consensus 43 ~~~~Fl~~-~I~e~eD~v~~~y~~~~~~~~f~~-ik---~~~~~eKlr~l~ni~~l~~~~--~~r~tf~L~P~NL~f~~~ 115 (215)
T 4ann_A 43 HSPYFIDA-ELTELRDSFQIHYDINDNHTPFDN-IK---SFTKNEKLRYLLNIKNLEEVN--RTRYTFVLAPDELFFTRD 115 (215)
T ss_dssp CCTTBCCE-EEEECSSEEEEEECCCTTSEEGGG-GG---GSCHHHHHHHHHHGGGGGGGG--GSSEECCCSGGGEEECTT
T ss_pred cCCcccce-EEEEcccEEEEEEEcCcccCCHHH-HH---hcCHHHHHHHHHHHHHHHHHh--cCceEEEEecceEEEcCC
Confidence 46777765 45556677777777766 344444 33 478899999999999887444 344788999999999999
Q ss_pred CcEEEeecCchhhh
Q psy758 138 GVVKLCDFGFARLI 151 (292)
Q Consensus 138 ~~~kl~dfg~~~~~ 151 (292)
+.+++.-.|+...+
T Consensus 116 ~~p~i~~RGik~~l 129 (215)
T 4ann_A 116 GLPIAKTRGLQNVV 129 (215)
T ss_dssp SCEEESCCEETTTB
T ss_pred CCEEEEEccCccCC
Confidence 99999877765433
|
| >1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=93.78 E-value=0.049 Score=45.35 Aligned_cols=37 Identities=30% Similarity=0.549 Sum_probs=33.4
Q ss_pred CCchHHHHHHHhhcccCCCCCCChhhhhhccCcCCCC
Q psy758 191 ATNIYLIDFLKRCLDKDPLRRWSCDQLLRHPYFNGYY 227 (292)
Q Consensus 191 ~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~ 227 (292)
..+..+.+++..|+..+|..|++..+++.|+|+.+..
T Consensus 276 ~~s~~~~~li~~~L~~dP~~Rpt~~ell~hp~~~~~~ 312 (387)
T 1kob_A 276 SVSPEAKDFIKNLLQKEPRKRLTVHDALEHPWLKGDH 312 (387)
T ss_dssp TSCHHHHHHHHTTSCSSGGGSCCHHHHHTSTTTSSCC
T ss_pred cCCHHHHHHHHHHcCCChhHCcCHHHHhhCccccCCc
Confidence 4577899999999999999999999999999998654
|
| >4f9c_A Cell division cycle 7-related protein kinase; Ser/Thr protein kinase, transferase, phosphorylation, cell C cell division, mitosis, S phase; HET: 0SX; 2.08A {Homo sapiens} PDB: 4f99_A* 4f9b_A* 4f9a_A* | Back alignment and structure |
|---|
Probab=93.77 E-value=0.054 Score=44.66 Aligned_cols=37 Identities=27% Similarity=0.474 Sum_probs=33.0
Q ss_pred CCchHHHHHHHhhcccCCCCCCChhhhhhccCcCCCC
Q psy758 191 ATNIYLIDFLKRCLDKDPLRRWSCDQLLRHPYFNGYY 227 (292)
Q Consensus 191 ~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~ 227 (292)
..+..+.+++..|+..+|.+|+++.++++|+||.+.+
T Consensus 324 ~is~~a~DLl~~lL~~dP~~R~ta~eaL~Hp~f~~i~ 360 (361)
T 4f9c_A 324 EVPDEAYDLLDKLLDLNPASRITAEEALLHPFFKDMS 360 (361)
T ss_dssp TCCHHHHHHHHHHTCSCTTTSCCHHHHHTSGGGTTC-
T ss_pred cCCHHHHHHHHHHCcCChhHCcCHHHHhcCcccCCCC
Confidence 3477899999999999999999999999999998653
|
| >3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A* | Back alignment and structure |
|---|
Probab=93.74 E-value=0.018 Score=46.62 Aligned_cols=38 Identities=26% Similarity=0.478 Sum_probs=33.9
Q ss_pred CchHHHHHHHhhcccCCCCCCChhhhhhccCcCCCCCC
Q psy758 192 TNIYLIDFLKRCLDKDPLRRWSCDQLLRHPYFNGYYFE 229 (292)
Q Consensus 192 ~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~ 229 (292)
....+.+++..|+..+|..|++..+++.|+|+....+.
T Consensus 260 ~~~~~~~li~~~L~~dP~~Rpt~~~ll~h~~~~~~~~~ 297 (327)
T 3lm5_A 260 VSQLATDFIQSLLVKNPEKRPTAEICLSHSWLQQWDFE 297 (327)
T ss_dssp SCHHHHHHHHHHSCSSGGGSCCHHHHTTCGGGCCCCTT
T ss_pred cCHHHHHHHHHHcCCChhhCcCHHHHhCCHhhcccccc
Confidence 46678899999999999999999999999999887654
|
| >2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A* | Back alignment and structure |
|---|
Probab=93.73 E-value=0.011 Score=46.92 Aligned_cols=40 Identities=23% Similarity=0.420 Sum_probs=34.2
Q ss_pred CCchHHHHHHHhhcccCCCCCCChhhhhhccCcCCCCCCC
Q psy758 191 ATNIYLIDFLKRCLDKDPLRRWSCDQLLRHPYFNGYYFEV 230 (292)
Q Consensus 191 ~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~ 230 (292)
..+..+.+++..|+..+|..|++..+++.++|+.....+.
T Consensus 237 ~~~~~~~~li~~~l~~~p~~Rps~~~ll~~~~~~~~~~~~ 276 (294)
T 2rku_A 237 HINPVAASLIQKMLQTDPTARPTINELLNDEFFTSGYIPA 276 (294)
T ss_dssp TSCHHHHHHHHHHTCSSGGGSCCGGGGGGSHHHHTSCCCS
T ss_pred ccCHHHHHHHHHHcccChhhCcCHHHHhhChheecCCcCC
Confidence 3466788999999999999999999999999998765443
|
| >4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A* | Back alignment and structure |
|---|
Probab=93.73 E-value=0.02 Score=46.66 Aligned_cols=40 Identities=20% Similarity=0.276 Sum_probs=31.5
Q ss_pred CCCchHHHHHHHhhcccCCCCCCChhhhh-------------hccCcCCCCCC
Q psy758 190 AATNIYLIDFLKRCLDKDPLRRWSCDQLL-------------RHPYFNGYYFE 229 (292)
Q Consensus 190 ~~~~~~~~~~~~~~~~~~p~~~~~~~~~~-------------~~~~~~~~~~~ 229 (292)
...+..+.+++..|+..+|.+|+++.+++ .|||+..+..|
T Consensus 280 ~~~s~~~~~li~~~L~~dP~~R~sa~el~~~l~~~l~~~~~l~hPw~~~~~~P 332 (336)
T 4g3f_A 280 PSCAPLTAQAIQEGLRKEPVHRASAMELRRKVGKALQEVGGLKSPWKGEYKEP 332 (336)
T ss_dssp TTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHTTSSCSCSSSSCCCC
T ss_pred ccCCHHHHHHHHHHccCCHhHCcCHHHHHHHHHHHHhhhhhccCCCcCCCCCC
Confidence 34567889999999999999999999874 56776655443
|
| >2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A* | Back alignment and structure |
|---|
Probab=93.69 E-value=0.011 Score=48.23 Aligned_cols=40 Identities=23% Similarity=0.420 Sum_probs=34.1
Q ss_pred CCchHHHHHHHhhcccCCCCCCChhhhhhccCcCCCCCCC
Q psy758 191 ATNIYLIDFLKRCLDKDPLRRWSCDQLLRHPYFNGYYFEV 230 (292)
Q Consensus 191 ~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~ 230 (292)
..+..+.+++..|+..+|..|++..+++.++|+.....+.
T Consensus 263 ~~~~~~~~li~~~l~~dp~~Rps~~ell~~~~~~~~~~~~ 302 (335)
T 2owb_A 263 HINPVAASLIQKMLQTDPTARPTINELLNDEFFTSGYIPA 302 (335)
T ss_dssp TSCHHHHHHHHHHTCSSGGGSCCGGGGGGSHHHHTSCCCS
T ss_pred cCCHHHHHHHHHHccCChhHCcCHHHHhcCccccCCCccc
Confidence 3466788999999999999999999999999998765443
|
| >4b99_A Mitogen-activated protein kinase 7; transferase, inhibitor; HET: R4L; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=93.61 E-value=0.063 Score=44.85 Aligned_cols=38 Identities=29% Similarity=0.439 Sum_probs=34.2
Q ss_pred CchHHHHHHHhhcccCCCCCCChhhhhhccCcCCCCCC
Q psy758 192 TNIYLIDFLKRCLDKDPLRRWSCDQLLRHPYFNGYYFE 229 (292)
Q Consensus 192 ~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~ 229 (292)
.+..+.+++..||..+|.+|+++.++++|+|+.....+
T Consensus 317 ~s~~~~dLl~~mL~~dP~~R~ta~e~L~Hp~f~~~~~p 354 (398)
T 4b99_A 317 ADRQALSLLGRMLRFEPSARISAAAALRHPFLAKYHDP 354 (398)
T ss_dssp CCHHHHHHHHHHSCSSTTTSCCHHHHTTSGGGTTTCCG
T ss_pred CCHHHHHHHHHHCcCChhHCcCHHHHhcCHhhCcCCCC
Confidence 47789999999999999999999999999999876543
|
| >3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II} | Back alignment and structure |
|---|
Probab=93.57 E-value=0.016 Score=47.26 Aligned_cols=37 Identities=19% Similarity=0.344 Sum_probs=33.2
Q ss_pred CchHHHHHHHhhcccCCCCCCChhhhhhccCcCCCCC
Q psy758 192 TNIYLIDFLKRCLDKDPLRRWSCDQLLRHPYFNGYYF 228 (292)
Q Consensus 192 ~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~ 228 (292)
.+..+.+++..|+..+|.+|++..+++.|+|+.....
T Consensus 303 ~~~~~~~li~~~l~~~p~~Rps~~~~l~hp~~~~~~~ 339 (345)
T 3hko_A 303 LSPLARDLLSNLLNRNVDERFDAMRALQHPWISQFSD 339 (345)
T ss_dssp SCHHHHHHHHHHSCSCTTTSCCHHHHHHSHHHHTTSS
T ss_pred CCHHHHHHHHHHcCCChhHCCCHHHHhcChhhccChH
Confidence 4678899999999999999999999999999987643
|
| >3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B | Back alignment and structure |
|---|
Probab=93.49 E-value=0.079 Score=46.24 Aligned_cols=38 Identities=34% Similarity=0.511 Sum_probs=32.1
Q ss_pred CCCchHHHHHHHhhcccCCCCCCC-----hhhhhhccCcCCCC
Q psy758 190 AATNIYLIDFLKRCLDKDPLRRWS-----CDQLLRHPYFNGYY 227 (292)
Q Consensus 190 ~~~~~~~~~~~~~~~~~~p~~~~~-----~~~~~~~~~~~~~~ 227 (292)
...+..+.+++..|+..+|..|++ ..+++.|+||....
T Consensus 414 ~~~s~~~~~li~~lL~~dP~~R~~~~~~~a~ei~~Hpff~~i~ 456 (543)
T 3c4z_A 414 DKFSPASKDFCEALLQKDPEKRLGFRDGSCDGLRTHPLFRDIS 456 (543)
T ss_dssp TTSCHHHHHHHHHHSCSSGGGSCCCBTTBSHHHHTSGGGTTCC
T ss_pred cccCHHHHHHHHHhccCCHhHCCCCcccCHHHHHcCccccCCC
Confidence 345678899999999999999996 47899999998764
|
| >3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 4ec9_A* 4ec8_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* 4bch_A* 4bci_A* 4bcj_A* 4bcf_A* | Back alignment and structure |
|---|
Probab=93.27 E-value=0.023 Score=46.45 Aligned_cols=40 Identities=25% Similarity=0.399 Sum_probs=34.8
Q ss_pred chHHHHHHHhhcccCCCCCCChhhhhhccCcCCCCCCCCC
Q psy758 193 NIYLIDFLKRCLDKDPLRRWSCDQLLRHPYFNGYYFEVPD 232 (292)
Q Consensus 193 ~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~ 232 (292)
+..+.+++..|+..+|.+|+++.+++.|+||.....+...
T Consensus 285 ~~~~~~li~~~L~~dP~~R~t~~e~l~hp~f~~~~~~~~~ 324 (351)
T 3mi9_A 285 DPYALDLIDKLLVLDPAQRIDSDDALNHDFFWSDPMPSDL 324 (351)
T ss_dssp CHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGGSSSCCCCS
T ss_pred ChHHHHHHHHHhcCChhhCCCHHHHhCCCCcCCCCCcccc
Confidence 4568899999999999999999999999999877666544
|
| >2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A* | Back alignment and structure |
|---|
Probab=93.23 E-value=0.034 Score=45.86 Aligned_cols=37 Identities=27% Similarity=0.464 Sum_probs=32.9
Q ss_pred CCchHHHHHHHhhcccCCCCCCChhhhhhccCcCCCC
Q psy758 191 ATNIYLIDFLKRCLDKDPLRRWSCDQLLRHPYFNGYY 227 (292)
Q Consensus 191 ~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~ 227 (292)
..+..+.+++..|+..+|..|++..+++.|+|+....
T Consensus 244 ~~s~~~~~li~~~L~~dP~~R~t~~e~l~hp~~~~~~ 280 (361)
T 2yab_A 244 QTSELAKDFIRKLLVKETRKRLTIQEALRHPWITPVD 280 (361)
T ss_dssp TSCHHHHHHHHHHSCSSTTTSCCHHHHHTSTTTSCSS
T ss_pred CCCHHHHHHHHHHCCCChhHCcCHHHHhcCcCcCCCc
Confidence 3467789999999999999999999999999998653
|
| >3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A* | Back alignment and structure |
|---|
Probab=93.21 E-value=0.011 Score=47.33 Aligned_cols=49 Identities=24% Similarity=0.394 Sum_probs=37.0
Q ss_pred CchHHHHHHHhhcccCCCCCCChhhhhhccCcCCCCCCCCCccchHHHHhcc
Q psy758 192 TNIYLIDFLKRCLDKDPLRRWSCDQLLRHPYFNGYYFEVPDEMQYEEITQRC 243 (292)
Q Consensus 192 ~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~ 243 (292)
.+..+.+++..|+..+|..|++..+++.++|+...... ...+.+++.+.
T Consensus 243 ~~~~l~~li~~~l~~dp~~Rps~~~ll~~~~~~~~~~~---~~~~~~~~~~~ 291 (303)
T 3a7i_A 243 YSKPLKEFVEACLNKEPSFRPTAKELLKHKFILRNAKK---TSYLTELIDRY 291 (303)
T ss_dssp CCHHHHHHHHHHCCSSGGGSCCHHHHTTCHHHHHHCCC---GGGGHHHHHHH
T ss_pred cCHHHHHHHHHHcCCChhhCcCHHHHhhChhhhcCCCc---cHHHHHHHHHH
Confidence 45678899999999999999999999999998654332 33445555443
|
| >2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A | Back alignment and structure |
|---|
Probab=93.16 E-value=0.027 Score=45.02 Aligned_cols=37 Identities=32% Similarity=0.679 Sum_probs=32.8
Q ss_pred CCchHHHHHHHhhcccCCCCCCChhhhhhccCcCCCC
Q psy758 191 ATNIYLIDFLKRCLDKDPLRRWSCDQLLRHPYFNGYY 227 (292)
Q Consensus 191 ~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~ 227 (292)
..+..+.+++..|+..+|.+|++..+++.|+|+.+..
T Consensus 233 ~~~~~~~~li~~~l~~dp~~Rps~~~~l~h~~~~~~~ 269 (304)
T 2jam_A 233 DISESAKDFICHLLEKDPNERYTCEKALSHPWIDGNT 269 (304)
T ss_dssp TSCHHHHHHHHHHHCSSTTTSCCHHHHHTSHHHHSSC
T ss_pred cCCHHHHHHHHHHcCCChhHCcCHHHHhcCccccCCC
Confidence 3467789999999999999999999999999998654
|
| >1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} PDB: 3fpq_A | Back alignment and structure |
|---|
Probab=93.11 E-value=0.019 Score=45.56 Aligned_cols=33 Identities=21% Similarity=0.503 Sum_probs=29.7
Q ss_pred chHHHHHHHhhcccCCCCCCChhhhhhccCcCC
Q psy758 193 NIYLIDFLKRCLDKDPLRRWSCDQLLRHPYFNG 225 (292)
Q Consensus 193 ~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~ 225 (292)
...+.+++..|+..+|..|++..+++.|+||.+
T Consensus 256 ~~~l~~li~~~l~~dp~~Rps~~ell~h~~f~~ 288 (290)
T 1t4h_A 256 IPEVKEIIEGCIRQNKDERYSIKDLLNHAFFQE 288 (290)
T ss_dssp CHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGC-
T ss_pred CHHHHHHHHHHccCChhhCCCHHHHhhCccccc
Confidence 356889999999999999999999999999875
|
| >2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A* | Back alignment and structure |
|---|
Probab=92.97 E-value=0.022 Score=47.23 Aligned_cols=37 Identities=19% Similarity=0.222 Sum_probs=31.7
Q ss_pred CCchHHHHHHHhhcccCCCCCCCh----hhhhhccCcCCCC
Q psy758 191 ATNIYLIDFLKRCLDKDPLRRWSC----DQLLRHPYFNGYY 227 (292)
Q Consensus 191 ~~~~~~~~~~~~~~~~~p~~~~~~----~~~~~~~~~~~~~ 227 (292)
..+..+.+++..|+..+|..|++. .++..|+||.+..
T Consensus 261 ~~~~~~~~li~~lL~~dp~~R~~~~~~~~~i~~h~~f~~~~ 301 (373)
T 2r5t_A 261 NITNSARHLLEGLLQKDRTKRLGAKDDFMEIKSHVFFSLIN 301 (373)
T ss_dssp SSCHHHHHHHHHHTCSSGGGSTTTTTTHHHHHTSGGGTTCC
T ss_pred CCCHHHHHHHHHHcccCHHhCCCCCCCHHHHhCCccccCCC
Confidence 456778999999999999999986 5899999998764
|
| >3v5w_A G-protein coupled receptor kinase 2; inhibitor complex, protein kinase, beta propeller, RGS homol domain; HET: 8PR; 2.07A {Homo sapiens} PDB: 3cik_A* 3krw_A* 3krx_A* 1omw_A 1ym7_A 2bcj_A* 3uzs_A 3uzt_A 3pvu_A* 3psc_A* 3pvw_A* 1bak_A | Back alignment and structure |
|---|
Probab=92.80 E-value=0.022 Score=50.83 Aligned_cols=40 Identities=23% Similarity=0.413 Sum_probs=35.1
Q ss_pred CCCCchHHHHHHHhhcccCCCCCCC-----hhhhhhccCcCCCCC
Q psy758 189 PAATNIYLIDFLKRCLDKDPLRRWS-----CDQLLRHPYFNGYYF 228 (292)
Q Consensus 189 ~~~~~~~~~~~~~~~~~~~p~~~~~-----~~~~~~~~~~~~~~~ 228 (292)
+...+..+.+++..|+..+|..|++ +.+++.|+||.+..|
T Consensus 414 p~~~S~~a~dLI~~lL~~dP~~Rl~~~~~ga~ei~~HpfF~~idW 458 (689)
T 3v5w_A 414 PDSFSPELRSLLEGLLQRDVNRRLGCLGRGAQEVKESPFFRSLDW 458 (689)
T ss_dssp CTTSCHHHHHHHHHHTCSCGGGCTTCSSSTHHHHTTSGGGTTCCH
T ss_pred CccCCHHHHHHHHHHccCCHhHCCCCCCCCHHHHhcCccccCCCH
Confidence 4456889999999999999999997 689999999998754
|
| >3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A* | Back alignment and structure |
|---|
Probab=92.74 E-value=0.022 Score=46.39 Aligned_cols=37 Identities=22% Similarity=0.401 Sum_probs=33.0
Q ss_pred CCchHHHHHHHhhcccCCCCCCChhhhhhccCcCCCC
Q psy758 191 ATNIYLIDFLKRCLDKDPLRRWSCDQLLRHPYFNGYY 227 (292)
Q Consensus 191 ~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~ 227 (292)
..+..+.+++..|+..+|.+|++..+++.|+|+....
T Consensus 259 ~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~~~~~~ 295 (336)
T 3fhr_A 259 EVSEDAKQLIRLLLKTDPTERLTITQFMNHPWINQSM 295 (336)
T ss_dssp TCCHHHHHHHHHHSCSSGGGSCCHHHHHHSHHHHTGG
T ss_pred cCCHHHHHHHHHHCCCChhHCcCHHHHhcCccccccc
Confidence 4577899999999999999999999999999987643
|
| >2eu9_A Dual specificity protein kinase CLK3; kinase domain, transferase; 1.53A {Homo sapiens} PDB: 2wu6_A* 2wu7_A* 3raw_A* 2exe_A 3nr9_A* | Back alignment and structure |
|---|
Probab=92.56 E-value=0.032 Score=45.47 Aligned_cols=34 Identities=35% Similarity=0.720 Sum_probs=30.7
Q ss_pred hHHHHHHHhhcccCCCCCCChhhhhhccCcCCCC
Q psy758 194 IYLIDFLKRCLDKDPLRRWSCDQLLRHPYFNGYY 227 (292)
Q Consensus 194 ~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~ 227 (292)
..+.+++..|+..+|.+|++..+++.|+|+.+..
T Consensus 308 ~~l~~li~~~L~~dP~~Rpt~~e~l~hp~f~~~~ 341 (355)
T 2eu9_A 308 VQLFDLMRRMLEFDPAQRITLAEALLHPFFAGLT 341 (355)
T ss_dssp HHHHHHHHHHTCSSTTTSCCHHHHTTSGGGGGCC
T ss_pred HHHHHHHHHHhcCChhhCcCHHHHhcChhhcCCC
Confidence 3677999999999999999999999999998753
|
| >4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens} | Back alignment and structure |
|---|
Probab=92.50 E-value=0.13 Score=40.95 Aligned_cols=39 Identities=38% Similarity=0.715 Sum_probs=33.5
Q ss_pred CCchHHHHHHHhhcccCCCCCCChhhhhhccCcCCCCCC
Q psy758 191 ATNIYLIDFLKRCLDKDPLRRWSCDQLLRHPYFNGYYFE 229 (292)
Q Consensus 191 ~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~ 229 (292)
..+..+.+++..|+..+|.+|+++.+++.|+|+......
T Consensus 256 ~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~f~~~~~~ 294 (311)
T 4agu_A 256 NISYPALGLLKGCLHMDPTERLTCEQLLHHPYFENIREI 294 (311)
T ss_dssp TCCHHHHHHHHHHCCSSTTTSCCHHHHHTSGGGTTCC--
T ss_pred cccHHHHHHHHHHccCChhhcCCHHHHhcChHHHhccCH
Confidence 347788999999999999999999999999999976433
|
| >3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A* | Back alignment and structure |
|---|
Probab=92.26 E-value=0.095 Score=44.27 Aligned_cols=40 Identities=28% Similarity=0.370 Sum_probs=35.7
Q ss_pred CCchHHHHHHHhhcccCCCCCCChhhhhhccCcCCCCCCC
Q psy758 191 ATNIYLIDFLKRCLDKDPLRRWSCDQLLRHPYFNGYYFEV 230 (292)
Q Consensus 191 ~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~ 230 (292)
..+..+.+++..|+..+|.+|+++.+++.|+|+.....+.
T Consensus 333 ~~s~~~~dLl~~mL~~dP~~R~ta~e~L~Hp~f~~~~~~~ 372 (432)
T 3n9x_A 333 SISDDGINLLESMLKFNPNKRITIDQALDHPYLKDVRKKK 372 (432)
T ss_dssp TSCHHHHHHHHHHSCSSTTTSCCHHHHHTCGGGTTTCCTT
T ss_pred CCCHHHHHHHHHHhcCCcccCCCHHHHhcChhhhhccCcc
Confidence 3578899999999999999999999999999999876553
|
| >3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A | Back alignment and structure |
|---|
Probab=92.25 E-value=0.012 Score=46.69 Aligned_cols=51 Identities=22% Similarity=0.387 Sum_probs=38.7
Q ss_pred CCchHHHHHHHhhcccCCCCCCChhhhhhccCcCCCCCCCCCccchHHHHhccc
Q psy758 191 ATNIYLIDFLKRCLDKDPLRRWSCDQLLRHPYFNGYYFEVPDEMQYEEITQRCL 244 (292)
Q Consensus 191 ~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l 244 (292)
..+..+.+++..|+..+|.+|++..+++.|+|+...... .....++++.+|
T Consensus 238 ~~~~~~~~li~~~l~~~p~~Rpt~~e~l~hp~f~~~~~~---~~~~~~~~~~~l 288 (290)
T 3fme_A 238 KFSAEFVDFTSQCLKKNSKERPTYPELMQHPFFTLHESK---GTDVASFVKLIL 288 (290)
T ss_dssp TSCHHHHHHHHHHTCSSGGGSCCHHHHTTSHHHHHHHHS---CCCHHHHHHHHH
T ss_pred cCCHHHHHHHHHHhhcChhhCcCHHHHHhCcccccCccc---ccCHHHHHHHhh
Confidence 346788999999999999999999999999998764333 234445555444
|
| >2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ... | Back alignment and structure |
|---|
Probab=92.24 E-value=0.055 Score=42.36 Aligned_cols=35 Identities=14% Similarity=0.293 Sum_probs=31.7
Q ss_pred CchHHHHHHHhhcccCCCCCCChhhhhhccCcCCC
Q psy758 192 TNIYLIDFLKRCLDKDPLRRWSCDQLLRHPYFNGY 226 (292)
Q Consensus 192 ~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~ 226 (292)
.+..+.+++..|+..+|..|++..+++.|+|+...
T Consensus 234 ~~~~~~~li~~~l~~~p~~Rps~~~il~~~~~~~~ 268 (276)
T 2yex_A 234 IDSAPLALLHKILVENPSARITIPDIKKDRWYNKP 268 (276)
T ss_dssp SCHHHHHHHHHHSCSSTTTSCCHHHHTTCTTTTCC
T ss_pred cCHHHHHHHHHHCCCCchhCCCHHHHhcCccccCh
Confidence 46678899999999999999999999999998864
|
| >1z57_A Dual specificity protein kinase CLK1; protein tyrosine kinase, splicing, human, 10Z-hymendialdisine, structural genomics; HET: DBQ; 1.70A {Homo sapiens} PDB: 2vag_A* | Back alignment and structure |
|---|
Probab=92.22 E-value=0.037 Score=44.75 Aligned_cols=34 Identities=29% Similarity=0.649 Sum_probs=30.4
Q ss_pred chHHHHHHHhhcccCCCCCCChhhhhhccCcCCC
Q psy758 193 NIYLIDFLKRCLDKDPLRRWSCDQLLRHPYFNGY 226 (292)
Q Consensus 193 ~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~ 226 (292)
+..+.+++..|+..+|.+|+++.+++.|+|+...
T Consensus 302 ~~~l~~li~~~L~~dP~~Rpt~~ell~hp~f~~~ 335 (339)
T 1z57_A 302 HERLFDLIQKMLEYDPAKRITLREALKHPFFDLL 335 (339)
T ss_dssp HHHHHHHHHHHTCSSTTTSCCHHHHTTSGGGGGG
T ss_pred HHHHHHHHHHHhCcCcccccCHHHHhcCHHHHHH
Confidence 3457799999999999999999999999999864
|
| >4fih_A Serine/threonine-protein kinase PAK 4; kinase domain, protein ATP binding, phosphorylation, transferase; HET: SEP; 1.97A {Homo sapiens} PDB: 4fig_A* 4fif_A* 4fii_A* 4fij_A* | Back alignment and structure |
|---|
Probab=92.21 E-value=0.091 Score=42.93 Aligned_cols=37 Identities=32% Similarity=0.518 Sum_probs=33.4
Q ss_pred CCchHHHHHHHhhcccCCCCCCChhhhhhccCcCCCC
Q psy758 191 ATNIYLIDFLKRCLDKDPLRRWSCDQLLRHPYFNGYY 227 (292)
Q Consensus 191 ~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~ 227 (292)
..+..+.+++..|+..+|.+|+++.++++|+|+....
T Consensus 295 ~~s~~~~dli~~~L~~dP~~R~ta~e~l~Hp~~~~~~ 331 (346)
T 4fih_A 295 KVSPSLKGFLDRLLVRDPAQRATAAELLKHPFLAKAG 331 (346)
T ss_dssp GSCHHHHHHHHHHSCSSTTTSCCHHHHTTCGGGGGCC
T ss_pred cCCHHHHHHHHHHcCCChhHCcCHHHHhcCHhhcCCC
Confidence 3577899999999999999999999999999998654
|
| >3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei} | Back alignment and structure |
|---|
Probab=92.17 E-value=0.019 Score=49.74 Aligned_cols=37 Identities=16% Similarity=0.188 Sum_probs=32.5
Q ss_pred CchHHHHHHHhhcccCCCCCCChhhhhhccCcCCCCC
Q psy758 192 TNIYLIDFLKRCLDKDPLRRWSCDQLLRHPYFNGYYF 228 (292)
Q Consensus 192 ~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~ 228 (292)
.+..+.+++..|+..+|..|++..+++.|+|+.....
T Consensus 274 ~s~~~~~li~~~L~~dp~~R~t~~e~l~h~~~~~~~~ 310 (504)
T 3q5i_A 274 ISDEAKELIKLMLTYDYNKRCTAEEALNSRWIKKYAN 310 (504)
T ss_dssp SCHHHHHHHHHHTCSSTTTSCCHHHHHTSHHHHHTCC
T ss_pred CCHHHHHHHHHHcCCChhHCCCHHHHhcCHhhhhchh
Confidence 3567889999999999999999999999999976543
|
| >2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=92.12 E-value=0.04 Score=44.59 Aligned_cols=34 Identities=32% Similarity=0.584 Sum_probs=30.8
Q ss_pred chHHHHHHHhhcccCCCCCCChhhhhhccCcCCC
Q psy758 193 NIYLIDFLKRCLDKDPLRRWSCDQLLRHPYFNGY 226 (292)
Q Consensus 193 ~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~ 226 (292)
+..+.+++..|+..+|..|++..+++.|+|+...
T Consensus 245 ~~~~~~li~~~L~~dP~~Rpt~~e~l~hp~~~~~ 278 (326)
T 2y0a_A 245 SALAKDFIRRLLVKDPKKRMTIQDSLQHPWIKPK 278 (326)
T ss_dssp CHHHHHHHHHHSCSSGGGSCCHHHHHHSTTTSCC
T ss_pred CHHHHHHHHHHccCChhhCCCHHHHhcCCCccCC
Confidence 5567889999999999999999999999999864
|
| >2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens} | Back alignment and structure |
|---|
Probab=92.09 E-value=0.056 Score=44.25 Aligned_cols=38 Identities=24% Similarity=0.429 Sum_probs=33.6
Q ss_pred CchHHHHHHHhhcccCCCCCCChhhhhhccCcCCCCCC
Q psy758 192 TNIYLIDFLKRCLDKDPLRRWSCDQLLRHPYFNGYYFE 229 (292)
Q Consensus 192 ~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~ 229 (292)
.+..+.+++..|+..+|.+|++..+++.|+|+.+....
T Consensus 278 ~~~~~~~li~~~L~~dP~~Rpt~~e~l~hp~~~~~~~~ 315 (349)
T 2w4o_A 278 VSLNAKDLVRKLIVLDPKKRLTTFQALQHPWVTGKAAN 315 (349)
T ss_dssp SCHHHHHHHHTTSCSSGGGSCCHHHHHHSTTTTSTTCC
T ss_pred CCHHHHHHHHHHccCChhhCcCHHHHhcCcccCCCccc
Confidence 46678899999999999999999999999999876544
|
| >3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens} | Back alignment and structure |
|---|
Probab=92.05 E-value=0.036 Score=45.14 Aligned_cols=35 Identities=20% Similarity=0.335 Sum_probs=32.0
Q ss_pred CchHHHHHHHhhcccCCCCCCChhhhhhccCcCCC
Q psy758 192 TNIYLIDFLKRCLDKDPLRRWSCDQLLRHPYFNGY 226 (292)
Q Consensus 192 ~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~ 226 (292)
.+..+.+++..|+..+|..|++..+++.++|+...
T Consensus 247 ~~~~l~~li~~~L~~dP~~Rps~~ell~hp~~~~~ 281 (335)
T 3dls_A 247 VSKELMSLVSGLLQPVPERRTTLEKLVTDPWVTQP 281 (335)
T ss_dssp CCHHHHHHHHHHTCSSGGGSCCHHHHHHCTTTTCC
T ss_pred cCHHHHHHHHHHccCChhhCcCHHHHhcCccccCC
Confidence 46788999999999999999999999999998763
|
| >3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} SCOP: d.144.1.7 PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A | Back alignment and structure |
|---|
Probab=91.92 E-value=0.1 Score=41.29 Aligned_cols=37 Identities=32% Similarity=0.601 Sum_probs=33.1
Q ss_pred CCchHHHHHHHhhcccCCCCCCChhhhhhccCcCCCC
Q psy758 191 ATNIYLIDFLKRCLDKDPLRRWSCDQLLRHPYFNGYY 227 (292)
Q Consensus 191 ~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~ 227 (292)
..+..+.+++..|+..+|.+|+++.++++|+||....
T Consensus 254 ~~~~~~~~li~~~L~~dP~~R~t~~e~l~hp~f~~~~ 290 (292)
T 3o0g_A 254 KLNATGRDLLQNLLKCNPVQRISAEEALQHPYFSDFC 290 (292)
T ss_dssp TCCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGTTC-
T ss_pred ccChHHHHHHHHHhccChhhCCCHHHHhcCcccccCC
Confidence 4578889999999999999999999999999998754
|
| >2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A | Back alignment and structure |
|---|
Probab=91.92 E-value=0.058 Score=43.47 Aligned_cols=36 Identities=28% Similarity=0.479 Sum_probs=31.6
Q ss_pred CchHHHHHHHhhcccCCCCCCChhhhhhccCcCCCC
Q psy758 192 TNIYLIDFLKRCLDKDPLRRWSCDQLLRHPYFNGYY 227 (292)
Q Consensus 192 ~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~ 227 (292)
.+..+.+++..|+..+|..|++..+++.|+|+....
T Consensus 245 ~~~~~~~li~~~l~~dp~~Rps~~e~l~hp~~~~~~ 280 (321)
T 2a2a_A 245 TSELAKDFIRKLLVKETRKRLTIQEALRHPWITPVD 280 (321)
T ss_dssp CCHHHHHHHHTTSCSSTTTSCCHHHHHHSTTTSCSS
T ss_pred cCHHHHHHHHHHcCCChhhCcCHHHHhcCccccCCC
Confidence 355678999999999999999999999999998653
|
| >1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C | Back alignment and structure |
|---|
Probab=91.87 E-value=0.037 Score=46.27 Aligned_cols=38 Identities=13% Similarity=0.290 Sum_probs=33.3
Q ss_pred CCchHHHHHHHhhcccCCCCCCChhhhhhccCcCCCCC
Q psy758 191 ATNIYLIDFLKRCLDKDPLRRWSCDQLLRHPYFNGYYF 228 (292)
Q Consensus 191 ~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~ 228 (292)
..+..+.+++..|+..+|..|++..+++.|+|+.....
T Consensus 293 ~~s~~~~~li~~~L~~dP~~Rpt~~eil~hp~~~~~~~ 330 (400)
T 1nxk_A 293 EVSEEVKMLIRNLLKTEPTQRMTITEFMNHPWIMQSTK 330 (400)
T ss_dssp TSCHHHHHHHHTTSCSSGGGSCCHHHHHHSHHHHTTTT
T ss_pred cCCHHHHHHHHHHCCCChhHCcCHHHHhcCccccCCCC
Confidence 34677899999999999999999999999999976543
|
| >3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major} | Back alignment and structure |
|---|
Probab=91.84 E-value=0.018 Score=47.20 Aligned_cols=38 Identities=26% Similarity=0.252 Sum_probs=33.9
Q ss_pred CchHHHHHHHhhcccCCCCCCChhhhhhccCcCCCCCC
Q psy758 192 TNIYLIDFLKRCLDKDPLRRWSCDQLLRHPYFNGYYFE 229 (292)
Q Consensus 192 ~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~ 229 (292)
.+..+.+++..|+..+|.+|++..+++.|+||.....+
T Consensus 287 ~~~~~~~li~~~L~~dP~~Rpt~~e~l~hp~f~~~~~~ 324 (360)
T 3e3p_A 287 DAKEAYDLLSALLQYLPEERMKPYEALCHPYFDELHDP 324 (360)
T ss_dssp THHHHHHHHHHHTCSSGGGSCCHHHHTTSGGGGGGGCT
T ss_pred ccHHHHHHHHHHhccCccccCCHHHHhcCccccccCCc
Confidence 46788999999999999999999999999999876544
|
| >3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} SCOP: d.144.1.7 PDB: 2qkr_A* | Back alignment and structure |
|---|
Probab=91.79 E-value=0.18 Score=40.35 Aligned_cols=36 Identities=33% Similarity=0.420 Sum_probs=32.7
Q ss_pred CchHHHHHHHhhcccCCCCCCChhhhhhccCcCCCC
Q psy758 192 TNIYLIDFLKRCLDKDPLRRWSCDQLLRHPYFNGYY 227 (292)
Q Consensus 192 ~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~ 227 (292)
.+..+.+++..|+..+|.+|+++.+++.|+||....
T Consensus 273 ~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~f~~~~ 308 (311)
T 3niz_A 273 FCQEGIDLLSNMLCFDPNKRISARDAMNHPYFKDLD 308 (311)
T ss_dssp CCHHHHHHHHHHSCSCTTTSCCHHHHHTSGGGTTSC
T ss_pred cCHHHHHHHHHHcCCChhHCCCHHHHhcCcccccCC
Confidence 467789999999999999999999999999998764
|
| >3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=91.72 E-value=0.056 Score=43.39 Aligned_cols=34 Identities=26% Similarity=0.296 Sum_probs=31.3
Q ss_pred CchHHHHHHHhhcccCCCCCCChhhhhhccCcCC
Q psy758 192 TNIYLIDFLKRCLDKDPLRRWSCDQLLRHPYFNG 225 (292)
Q Consensus 192 ~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~ 225 (292)
.+..+.+++..|+..+|.+|+++.+++.++|+..
T Consensus 277 ~~~~l~~li~~~L~~dP~~Rpt~~ell~hp~~~~ 310 (311)
T 3p1a_A 277 LSSELRSVLVMMLEPDPKLRATAEALLALPVLRQ 310 (311)
T ss_dssp SCHHHHHHHHHHSCSSTTTSCCHHHHHTSGGGSC
T ss_pred CCHHHHHHHHHHcCCChhhCcCHHHHHhCccccC
Confidence 4778899999999999999999999999999864
|
| >2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A* | Back alignment and structure |
|---|
Probab=91.65 E-value=0.04 Score=43.26 Aligned_cols=36 Identities=19% Similarity=0.236 Sum_probs=31.6
Q ss_pred CCchHHHHHHHhhcccCCCCCCChhhhhhccCcCCC
Q psy758 191 ATNIYLIDFLKRCLDKDPLRRWSCDQLLRHPYFNGY 226 (292)
Q Consensus 191 ~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~ 226 (292)
..+..+.+++..|+..+|..|++..+++.++++.+.
T Consensus 239 ~~~~~l~~li~~~l~~~p~~Rps~~~ll~~~~~~~~ 274 (279)
T 2w5a_A 239 RYSDELNEIITRMLNLKDYHRPSVEEILENPLILEH 274 (279)
T ss_dssp TSCHHHHHHHHHHTCSSGGGSCCHHHHHTSTTCCGG
T ss_pred ccCHHHHHHHHHHcCCCcccCCCHHHHHhChhhhhh
Confidence 346778999999999999999999999999987653
|
| >3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A* | Back alignment and structure |
|---|
Probab=91.48 E-value=0.038 Score=43.51 Aligned_cols=37 Identities=19% Similarity=0.294 Sum_probs=32.6
Q ss_pred CCchHHHHHHHhhcccCCCCCCChhhhhhccCcCCCC
Q psy758 191 ATNIYLIDFLKRCLDKDPLRRWSCDQLLRHPYFNGYY 227 (292)
Q Consensus 191 ~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~ 227 (292)
..+..+.+++..|+..+|.+|++..+++.|+|+....
T Consensus 233 ~~~~~~~~li~~~l~~dp~~Rps~~~~l~h~~~~~~~ 269 (284)
T 3kk8_A 233 TVTPEAKSLIDSMLTVNPKKRITADQALKVPWICNRE 269 (284)
T ss_dssp TSCHHHHHHHHHHSCSSTTTSCCHHHHTTSHHHHSCC
T ss_pred ccCHHHHHHHHHHcccChhhCCCHHHHhcCccccCCh
Confidence 3467789999999999999999999999999987643
|
| >1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A* | Back alignment and structure |
|---|
Probab=91.41 E-value=0.049 Score=42.87 Aligned_cols=37 Identities=24% Similarity=0.292 Sum_probs=31.4
Q ss_pred CCCchHHHHHHHhhcccCCCCCCChhhhhhccCcCCC
Q psy758 190 AATNIYLIDFLKRCLDKDPLRRWSCDQLLRHPYFNGY 226 (292)
Q Consensus 190 ~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~ 226 (292)
...+..+.+++..|+..+|.+|++..+++.|+|+...
T Consensus 250 ~~~~~~~~~li~~~l~~dp~~Rps~~~ll~h~~~~~~ 286 (289)
T 1x8b_A 250 QVLSQEFTELLKVMIHPDPERRPSAMALVKHSVLLSA 286 (289)
T ss_dssp SCCCHHHHHHHHHHTCSSGGGSCCHHHHHTCTTC---
T ss_pred cccCHHHHHHHHHHhCCCcccCCCHHHHhhChHhhhh
Confidence 3457889999999999999999999999999998754
|
| >4fie_A Serine/threonine-protein kinase PAK 4; kinase domain, protein ATP binding, phosphorylation, transferase; HET: SEP ANP; 3.11A {Homo sapiens} | Back alignment and structure |
|---|
Probab=91.37 E-value=0.18 Score=42.34 Aligned_cols=38 Identities=32% Similarity=0.497 Sum_probs=34.0
Q ss_pred CCCchHHHHHHHhhcccCCCCCCChhhhhhccCcCCCC
Q psy758 190 AATNIYLIDFLKRCLDKDPLRRWSCDQLLRHPYFNGYY 227 (292)
Q Consensus 190 ~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~ 227 (292)
...+..+.+++..||..+|.+|+++.+++.|+|+....
T Consensus 371 ~~~s~~~~dli~~~L~~dP~~R~ta~ell~Hp~~~~~~ 408 (423)
T 4fie_A 371 HKVSPSLKGFLDRLLVRDPAQRATAAELLKHPFLAKAG 408 (423)
T ss_dssp TSSCHHHHHHHHHHSCSSTTTSCCHHHHTTCGGGGGCC
T ss_pred ccCCHHHHHHHHHHcCCChhHCcCHHHHhcCHHhcCCC
Confidence 34578899999999999999999999999999998654
|
| >2r3i_A Cell division protein kinase 2; serine/threonine-protein kinase, cell cycle, inhibition, cyclin-dependent kinase, cancer, ATP-binding; HET: SCF; 1.28A {Homo sapiens} PDB: 2r3j_A* 2r3k_A* 2r3l_A* 2r3m_A* 2r3n_A* 2r3o_A* 2r3p_A* 2r3q_A* 1jvp_P* 1buh_A 1ckp_A* 1di8_A* 1dm2_A* 1f5q_A 1fin_A* 1fq1_B* 1fvt_A* 1fvv_A* 1g5s_A* 1gih_A* ... | Back alignment and structure |
|---|
Probab=91.04 E-value=0.26 Score=38.96 Aligned_cols=39 Identities=28% Similarity=0.354 Sum_probs=34.5
Q ss_pred CchHHHHHHHhhcccCCCCCCChhhhhhccCcCCCCCCC
Q psy758 192 TNIYLIDFLKRCLDKDPLRRWSCDQLLRHPYFNGYYFEV 230 (292)
Q Consensus 192 ~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~ 230 (292)
.+..+.+++..|+..+|..|++..+++.|+|+.....+.
T Consensus 256 ~~~~~~~li~~~L~~dP~~Rpt~~~~l~hp~~~~~~~~~ 294 (299)
T 2r3i_A 256 LDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQDVTKPV 294 (299)
T ss_dssp CCHHHHHHHHHHTCSSTTTSCCHHHHHTSGGGTTCCCCC
T ss_pred CCHHHHHHHHHhcCcCcccCCCHHHHhcChhhhcCCCCC
Confidence 467889999999999999999999999999998765543
|
| >3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A* | Back alignment and structure |
|---|
Probab=90.96 E-value=0.041 Score=45.42 Aligned_cols=37 Identities=19% Similarity=0.205 Sum_probs=33.1
Q ss_pred CCCchHHHHHHHhhcccCCCCCCChhhhhhccCcCCC
Q psy758 190 AATNIYLIDFLKRCLDKDPLRRWSCDQLLRHPYFNGY 226 (292)
Q Consensus 190 ~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~ 226 (292)
...+..+.+++..|+..+|.+|+++.+++.|+||...
T Consensus 323 ~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~hp~f~~~ 359 (371)
T 3q60_A 323 TPLPDFVKTLIGRFLNFDRRRRLLPLEAMETPEFLQL 359 (371)
T ss_dssp SCCCHHHHHHHHHHTCSSTTTCCCHHHHTTSHHHHHH
T ss_pred cCCCHHHHHHHHHHcCCChhhCCCHHHHhcCHHHHHH
Confidence 3557889999999999999999999999999998753
|
| >3fpq_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase, ATP-BIND kinase, nucleotide-binding, phosphoprotein; 1.80A {Rattus norvegicus} | Back alignment and structure |
|---|
Probab=90.87 E-value=0.12 Score=41.02 Aligned_cols=69 Identities=17% Similarity=0.239 Sum_probs=50.4
Q ss_pred ccccccccccccccC----CCCCCCcccceeeecCCCCC-------------------------CchHHHHHHHhhcccC
Q psy758 157 RHLHIFQTNEYFKGV----SLPHAENVVPLEIKIGKPAA-------------------------TNIYLIDFLKRCLDKD 207 (292)
Q Consensus 157 ~~~~~~~~~~~~~~~----~~~~~~~~~~~~~~~~~~~~-------------------------~~~~~~~~~~~~~~~~ 207 (292)
.++..|.+||...+. .+.|+.|+..+++.+|..++ .+..+.+++..|+..+
T Consensus 191 ~GTp~YmAPE~~~~~y~~~~DiwSlGvilyelltg~~Pf~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~li~~~L~~d 270 (290)
T 3fpq_A 191 IGTPEFMAPEMYEEKYDESVDVYAFGMCMLEMATSEYPYSECQNAAQIYRRVTSGVKPASFDKVAIPEVKEIIEGCIRQN 270 (290)
T ss_dssp CSSCCCCCGGGGGTCCCTHHHHHHHHHHHHHHHHSSCTTTTCSSHHHHHHHHTTTCCCGGGGGCCCHHHHHHHHHHSCSS
T ss_pred ccCccccCHHHcCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCcHHHHHHHHHcCCCCCCCCccCCHHHHHHHHHHccCC
Confidence 345667777776543 22466666666777766554 2345778999999999
Q ss_pred CCCCCChhhhhhccCcCC
Q psy758 208 PLRRWSCDQLLRHPYFNG 225 (292)
Q Consensus 208 p~~~~~~~~~~~~~~~~~ 225 (292)
|.+|+++.+++.|+|+..
T Consensus 271 P~~R~s~~e~l~Hp~~~~ 288 (290)
T 3fpq_A 271 KDERYSIKDLLNHAFFQE 288 (290)
T ss_dssp GGGSCCHHHHHTSGGGC-
T ss_pred hhHCcCHHHHhcCccccC
Confidence 999999999999999875
|
| >1cja_A Protein (actin-fragmin kinase); transferase; HET: AMP; 2.90A {Physarum polycephalum} SCOP: d.144.1.3 | Back alignment and structure |
|---|
Probab=90.86 E-value=3 Score=33.58 Aligned_cols=135 Identities=17% Similarity=0.200 Sum_probs=73.1
Q ss_pred cceeeeecccCceEEEEEEEcCCCcEEEEEEeccCCCChHHHHHHHHHHHHHHhCCCCCcchh--h------------hh
Q psy758 4 YEKIGKLGEGSYGVVFKCRNRDTGQVVAIKKFLESEEDPLIRKIALREIRLLKSLKHPNLVNL--L------------EV 69 (292)
Q Consensus 4 y~~~~~l~~g~~~~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~--~------------~~ 69 (292)
...++....|..| ||.+.. ++..|++|... ....+.+-.++...-.+..|+..-+ - ..
T Consensus 71 v~~I~~s~~Gstg-vff~~t--d~~~~VVK~s~-----~l~~E~l~s~LA~~LGlpiP~~Riv~~~~~E~~e~~~~L~~~ 142 (342)
T 1cja_A 71 FKGIERSEKGTEG-LFFVET--ESGVFIVKRST-----NIESETFCSLLCMRLGLHAPKVRVVSSNSEEGTNMLECLAAI 142 (342)
T ss_dssp EEEEEECCSTTSC-EEEEEE--SSCEEEEECCT-----THHHHHHHHHHHHHHTCCCCCEEEEESSSHHHHHHHHHHHHH
T ss_pred eeEEEeccCCCCC-eEEEEe--CCCEEEEeCcH-----HHHHHHHHHHHHHHhCCCCCCeeEEeeCcHHHHHHHHHHHHh
Confidence 3444555666554 555554 47789999441 2244555555655556666652111 0 00
Q ss_pred --------hhcCCeEEEEEecCCCccHHHHhcCC--CCCCHHHHHHHHHHH--HHHHHHHHhCC-----ccccCCCCCce
Q psy758 70 --------FRRKKKLHLVFEFCDHTVLNELENHP--HGLPWDLIKQITWQV--LRGVSYCHRHA-----CIHRDIKPENI 132 (292)
Q Consensus 70 --------~~~~~~~~iv~e~~~~~~L~~~~~~~--~~~~~~~~~~i~~qi--~~aL~~LH~~g-----ivH~dl~p~Ni 132 (292)
....+.+.++|+|.+|..|...-... ..+.++ .+.++ +-++..+..++ +-+..-.++||
T Consensus 143 ~~~~~~l~~l~~~~~~l~meyv~G~~L~e~~~~~~~~~f~~~----~~k~LG~Ii~FDi~InN~DR~Pl~W~n~GN~~NI 218 (342)
T 1cja_A 143 DKSFRVITTLANQANILLMELVRGITLNKLTTTSAPEVLTKS----TMQQLGSLMALDVIVNNSDRLPIAWTNEGNLDNI 218 (342)
T ss_dssp CSSSCHHHHHTTCSEEEEEECCCEEESTTCCSSSHHHHSCHH----HHHHHHHHHHHHHHHTCCSSSCSSSCSCCCGGGE
T ss_pred hhhhHHHHHhhcccceehhhhcCCCccccchhhhhhhhcCHH----HHHhhchhheehhhhcCCccCcccccCCCChhhe
Confidence 01133577999999987665432210 012222 23332 23445555543 12224589999
Q ss_pred EEccCC-cEEEeecCchhh
Q psy758 133 LLTANG-VVKLCDFGFARL 150 (292)
Q Consensus 133 lv~~~~-~~kl~dfg~~~~ 150 (292)
+++.++ .+.++|.+.+..
T Consensus 219 L~~~~n~~~~~IDhn~af~ 237 (342)
T 1cja_A 219 MLSERGATVVPIDSKIIPL 237 (342)
T ss_dssp EEESBTTCEEECSCCCCCC
T ss_pred EEeCCCCeEEEEcCCcccc
Confidence 998765 488899888743
|
| >1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=90.83 E-value=0.071 Score=43.03 Aligned_cols=37 Identities=24% Similarity=0.405 Sum_probs=32.5
Q ss_pred CCchHHHHHHHhhcccCCCCCC-----ChhhhhhccCcCCCC
Q psy758 191 ATNIYLIDFLKRCLDKDPLRRW-----SCDQLLRHPYFNGYY 227 (292)
Q Consensus 191 ~~~~~~~~~~~~~~~~~p~~~~-----~~~~~~~~~~~~~~~ 227 (292)
..+..+.+++..|+..+|.+|+ +..+++.|+||.+..
T Consensus 225 ~~~~~~~~li~~lL~~dp~~R~~~~~~~~~~i~~hp~f~~~~ 266 (318)
T 1fot_A 225 FFNEDVKDLLSRLITRDLSQRLGNLQNGTEDVKNHPWFKEVV 266 (318)
T ss_dssp TSCHHHHHHHHHHTCSCTTTCTTSSTTTTHHHHTSGGGSSCC
T ss_pred CCCHHHHHHHHHHhccCHHHcCCCcCCCHHHHhcCccccCCC
Confidence 3467789999999999999999 889999999998753
|
| >3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A* | Back alignment and structure |
|---|
Probab=90.77 E-value=0.16 Score=40.99 Aligned_cols=38 Identities=34% Similarity=0.593 Sum_probs=34.0
Q ss_pred CchHHHHHHHhhcccCCCCCCChhhhhhccCcCCCCCC
Q psy758 192 TNIYLIDFLKRCLDKDPLRRWSCDQLLRHPYFNGYYFE 229 (292)
Q Consensus 192 ~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~ 229 (292)
.+..+.+++..|+..+|.+|+++.+++.|+||.+..+.
T Consensus 291 ~~~~~~~li~~~L~~dP~~R~t~~e~l~hp~f~~~~~~ 328 (329)
T 3gbz_A 291 LDDEGLDLLTAMLEMDPVKRISAKNALEHPYFSHNDFD 328 (329)
T ss_dssp SCHHHHHHHHHHTCSSGGGSCCHHHHHTSGGGSSSCSC
T ss_pred cCHHHHHHHHHHccCChhhCCCHHHHhCCcccCCCCCC
Confidence 36788999999999999999999999999999986543
|
| >2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A | Back alignment and structure |
|---|
Probab=90.76 E-value=0.078 Score=43.69 Aligned_cols=33 Identities=33% Similarity=0.646 Sum_probs=30.2
Q ss_pred CchHHHHHHHhhcccCCCCCCChhhhhhccCcC
Q psy758 192 TNIYLIDFLKRCLDKDPLRRWSCDQLLRHPYFN 224 (292)
Q Consensus 192 ~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~ 224 (292)
.+..+.+++..|+..+|..|++..+++.|+||.
T Consensus 332 ~~~~~~~li~~~L~~dP~~Rps~~ell~hp~f~ 364 (365)
T 2y7j_A 332 RSSTVKDLISRLLQVDPEARLTAEQALQHPFFE 364 (365)
T ss_dssp SCHHHHHHHHHHSCSSTTTSCCHHHHHHSGGGC
T ss_pred CCHHHHHHHHHHcCCChhHCcCHHHHhcCcccC
Confidence 456789999999999999999999999999986
|
| >2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens} | Back alignment and structure |
|---|
Probab=90.62 E-value=0.094 Score=41.95 Aligned_cols=41 Identities=29% Similarity=0.585 Sum_probs=34.8
Q ss_pred CCchHHHHHHHhhcccCCCCCCChhhhhhccCcCCCCCCCC
Q psy758 191 ATNIYLIDFLKRCLDKDPLRRWSCDQLLRHPYFNGYYFEVP 231 (292)
Q Consensus 191 ~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~ 231 (292)
..+..+.+++..|+..+|.+|++..+++.|+|+....++..
T Consensus 277 ~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~~~~~~~p~~ 317 (320)
T 2i6l_A 277 GISREAVDFLEQILTFSPMDRLTAEEALSHPYMSIYSFPMD 317 (320)
T ss_dssp TCCHHHHHHHHTTSCSSGGGSCCHHHHHTSHHHHTTCC---
T ss_pred hhhHHHHHHHHHHcCCCccccCCHHHHhCCcccccccCccC
Confidence 34778999999999999999999999999999998776644
|
| >3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii} | Back alignment and structure |
|---|
Probab=90.49 E-value=0.23 Score=42.23 Aligned_cols=39 Identities=31% Similarity=0.493 Sum_probs=35.1
Q ss_pred CCchHHHHHHHhhcccCCCCCCChhhhhhccCcCCCCCC
Q psy758 191 ATNIYLIDFLKRCLDKDPLRRWSCDQLLRHPYFNGYYFE 229 (292)
Q Consensus 191 ~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~ 229 (292)
..+..+.+++..|+..+|.+|+++.+++.|+||.....+
T Consensus 368 ~~s~~~~dLl~~mL~~dP~~R~t~~e~L~Hp~f~~~~~~ 406 (458)
T 3rp9_A 368 ASSADAIHLLKRMLVFNPNKRITINECLAHPFFKEVRIA 406 (458)
T ss_dssp TSCHHHHHHHHHHSCSSTTTSCCHHHHHHSGGGTTTCCG
T ss_pred CCCHHHHHHHHHHhccCccccCCHHHHhcCHhhhhcCCC
Confidence 347889999999999999999999999999999987654
|
| >1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=90.40 E-value=0.032 Score=45.10 Aligned_cols=36 Identities=28% Similarity=0.496 Sum_probs=32.4
Q ss_pred CCchHHHHHHHhhcccCCCCCCChhhhhhccCcCCC
Q psy758 191 ATNIYLIDFLKRCLDKDPLRRWSCDQLLRHPYFNGY 226 (292)
Q Consensus 191 ~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~ 226 (292)
..+..+.+++..|+..+|..|++..+++.|+|+...
T Consensus 229 ~~s~~~~~li~~~L~~dp~~Rpt~~e~l~hp~~~~~ 264 (321)
T 1tki_A 229 EISIEAMDFVDRLLVKERKSRMTASEALQHPWLKQK 264 (321)
T ss_dssp TSCHHHHHHHHTTSCSSGGGSCCHHHHHHSHHHHSC
T ss_pred cCCHHHHHHHHHHcCCChhHCcCHHHHhcChhhccC
Confidence 347788999999999999999999999999998764
|
| >2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A* | Back alignment and structure |
|---|
Probab=90.37 E-value=0.089 Score=42.33 Aligned_cols=35 Identities=29% Similarity=0.559 Sum_probs=31.4
Q ss_pred CchHHHHHHHhhcccCCCCCCChhhhhhccCcCCC
Q psy758 192 TNIYLIDFLKRCLDKDPLRRWSCDQLLRHPYFNGY 226 (292)
Q Consensus 192 ~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~ 226 (292)
.+..+.+++..|+..+|.+|++..+++.|+|+...
T Consensus 247 ~~~~~~~li~~~l~~dP~~Rps~~~~l~h~~~~~~ 281 (322)
T 2ycf_A 247 VSEKALDLVKKLLVVDPKARFTTEEALRHPWLQDE 281 (322)
T ss_dssp SCHHHHHHHHHHSCSSTTTSCCHHHHHTSGGGCCH
T ss_pred cCHHHHHHHHHHcccCHhhCCCHHHHhhCcCcCCH
Confidence 35678899999999999999999999999999753
|
| >3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A* | Back alignment and structure |
|---|
Probab=90.04 E-value=0.062 Score=42.15 Aligned_cols=34 Identities=26% Similarity=0.407 Sum_probs=30.6
Q ss_pred CchHHHHHHHhhcccCCCCCCChhhhhhccCcCC
Q psy758 192 TNIYLIDFLKRCLDKDPLRRWSCDQLLRHPYFNG 225 (292)
Q Consensus 192 ~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~ 225 (292)
.+..+.+++..|+..+|.+|++..+++.|+|+..
T Consensus 234 ~~~~~~~li~~~l~~dp~~R~s~~~~l~h~~~~~ 267 (277)
T 3f3z_A 234 VSPQAESLIRRLLTKSPKQRITSLQALEHEWFEK 267 (277)
T ss_dssp SCHHHHHHHHHHTCSSTTTSCCHHHHTTSHHHHH
T ss_pred CCHHHHHHHHHHccCChhhCcCHHHHhcCHHHhc
Confidence 3667889999999999999999999999999864
|
| >4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A* | Back alignment and structure |
|---|
Probab=89.96 E-value=0.17 Score=40.41 Aligned_cols=37 Identities=14% Similarity=0.213 Sum_probs=30.5
Q ss_pred chHHHHHHHhhcccCCCCCCChhhhhhccCcCCCCCC
Q psy758 193 NIYLIDFLKRCLDKDPLRRWSCDQLLRHPYFNGYYFE 229 (292)
Q Consensus 193 ~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~ 229 (292)
.....+++..|+..+|.+|+++.++++|+|+.+..++
T Consensus 253 ~~~~~~li~~~L~~dP~~Rps~~eil~h~~~~~~~~p 289 (299)
T 4g31_A 253 YPCEYVMVQDMLSPSPMERPEAINIIENAVFEDLDFP 289 (299)
T ss_dssp CHHHHHHHHHHTCSSGGGSCCHHHHHTSGGGCCC---
T ss_pred CHHHHHHHHHHcCCChhHCcCHHHHhcCHhhCCCCCC
Confidence 3456789999999999999999999999999877654
|
| >1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ... | Back alignment and structure |
|---|
Probab=89.83 E-value=0.095 Score=42.92 Aligned_cols=37 Identities=22% Similarity=0.340 Sum_probs=32.6
Q ss_pred CCchHHHHHHHhhcccCCCCCCC-----hhhhhhccCcCCCC
Q psy758 191 ATNIYLIDFLKRCLDKDPLRRWS-----CDQLLRHPYFNGYY 227 (292)
Q Consensus 191 ~~~~~~~~~~~~~~~~~p~~~~~-----~~~~~~~~~~~~~~ 227 (292)
..+..+.+++..|+..+|..|++ ..+++.|+||.+..
T Consensus 260 ~~~~~~~~li~~lL~~dp~~R~~~~~~~~~ei~~h~~f~~~~ 301 (350)
T 1rdq_E 260 HFSSDLKDLLRNLLQVDLTKRFGNLKNGVNDIKNHKWFATTD 301 (350)
T ss_dssp TCCHHHHHHHHHHSCSCTTTCTTSSTTTTHHHHTSGGGTTCC
T ss_pred CCCHHHHHHHHHHhhcCHHhccCCccCCHHHHHhCcCcCCCC
Confidence 34677899999999999999998 89999999998754
|
| >1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A | Back alignment and structure |
|---|
Probab=89.72 E-value=0.3 Score=38.51 Aligned_cols=35 Identities=34% Similarity=0.503 Sum_probs=31.5
Q ss_pred CchHHHHHHHhhcccCCCCCCChhhhhhccCcCCC
Q psy758 192 TNIYLIDFLKRCLDKDPLRRWSCDQLLRHPYFNGY 226 (292)
Q Consensus 192 ~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~ 226 (292)
.+..+.+++..|+..+|.+|++..+++.|+||...
T Consensus 253 ~~~~~~~li~~~L~~dP~~Rpt~~e~l~hp~f~~~ 287 (288)
T 1ob3_A 253 LDESGIDLLSKMLKLDPNQRITAKQALEHAYFKEN 287 (288)
T ss_dssp CCHHHHHHHHHHTCSSTTTSCCHHHHHTSGGGGC-
T ss_pred cCHHHHHHHHHHcCCCcccCCCHHHHhcCcchhhc
Confidence 47788999999999999999999999999998753
|
| >4exu_A Mitogen-activated protein kinase 13; P38 kinase, transferase; 1.70A {Homo sapiens} PDB: 4eyj_A* 4eym_A* 3coi_A | Back alignment and structure |
|---|
Probab=89.42 E-value=0.35 Score=39.75 Aligned_cols=39 Identities=26% Similarity=0.418 Sum_probs=34.4
Q ss_pred CCchHHHHHHHhhcccCCCCCCChhhhhhccCcCCCCCC
Q psy758 191 ATNIYLIDFLKRCLDKDPLRRWSCDQLLRHPYFNGYYFE 229 (292)
Q Consensus 191 ~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~ 229 (292)
..+..+.+++..|+..+|..|+++.+++.|+||.....+
T Consensus 295 ~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~f~~~~~~ 333 (371)
T 4exu_A 295 RASPQAADLLEKMLELDVDKRLTAAQALTHPFFEPFRDP 333 (371)
T ss_dssp TSCHHHHHHHHHHSCSCTTTSCCHHHHHTSGGGTTTCCG
T ss_pred ccChHHHHHHHHHCCCChhhcCCHHHHhcCcccccCCCc
Confidence 347789999999999999999999999999999876543
|
| >3oz6_A Mitogen-activated protein kinase 1, serine/threon protein kinase; structural genomics consortium, SGC, transferase; 2.37A {Cryptosporidium parvum iowa II} | Back alignment and structure |
|---|
Probab=89.37 E-value=0.26 Score=40.81 Aligned_cols=38 Identities=26% Similarity=0.456 Sum_probs=33.9
Q ss_pred CCchHHHHHHHhhcccCCCCCCChhhhhhccCcCCCCC
Q psy758 191 ATNIYLIDFLKRCLDKDPLRRWSCDQLLRHPYFNGYYF 228 (292)
Q Consensus 191 ~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~ 228 (292)
..+..+.+++..|+..+|.+|+++.++++|+|+..+..
T Consensus 300 ~~~~~~~dll~~~L~~dP~~R~t~~e~l~Hp~~~~~~~ 337 (388)
T 3oz6_A 300 DCNEEALDLLDKLLQFNPNKRISANDALKHPFVSIFHN 337 (388)
T ss_dssp CCCHHHHHHHHHHCCSSGGGSCCHHHHTTSTTTTTTCC
T ss_pred cCCHHHHHHHHHhhccCcccCCCHHHHhCCHHHHHhcC
Confidence 44778999999999999999999999999999987643
|
| >3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens} | Back alignment and structure |
|---|
Probab=89.33 E-value=0.29 Score=39.38 Aligned_cols=38 Identities=21% Similarity=0.282 Sum_probs=33.7
Q ss_pred CCchHHHHHHHhhcccCCCCCCChhhhhhccCcCCCCC
Q psy758 191 ATNIYLIDFLKRCLDKDPLRRWSCDQLLRHPYFNGYYF 228 (292)
Q Consensus 191 ~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~ 228 (292)
..+..+.+++..|+..+|.+|+++.++++|+||.....
T Consensus 253 ~~~~~~~~li~~~L~~dP~~R~t~~e~l~hp~f~~~~~ 290 (324)
T 3mtl_A 253 RLDSDGADLLTKLLQFEGRNRISAEDAMKHPFFLSLGE 290 (324)
T ss_dssp TSCHHHHHHHHHHSCSSGGGSCCHHHHTTSGGGGGGCS
T ss_pred CCCHHHHHHHHHHcCcCcccCCCHHHHhcChhhhhccc
Confidence 44778899999999999999999999999999987543
|
| >1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=89.21 E-value=0.37 Score=39.60 Aligned_cols=39 Identities=23% Similarity=0.389 Sum_probs=33.7
Q ss_pred CCchHHHHHHHhhcccCCCCCCChhhhhhccCcCCCCCC
Q psy758 191 ATNIYLIDFLKRCLDKDPLRRWSCDQLLRHPYFNGYYFE 229 (292)
Q Consensus 191 ~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~ 229 (292)
..+..+.+++..|+..+|..|++..+++.|+|+.....+
T Consensus 279 ~~~~~~~~ll~~mL~~dP~~R~t~~e~l~hp~f~~~~~~ 317 (367)
T 1cm8_A 279 NASPLAVNLLEKMLVLDAEQRVTAGEALAHPYFESLHDT 317 (367)
T ss_dssp TCCHHHHHHHHHHSCSSTTTSCCHHHHHHSGGGTTTC--
T ss_pred CCCHHHHHHHHHHccCChhHCCCHHHHhcChHHHhhcCC
Confidence 347789999999999999999999999999999876543
|
| >2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A* | Back alignment and structure |
|---|
Probab=89.14 E-value=0.35 Score=39.30 Aligned_cols=39 Identities=36% Similarity=0.510 Sum_probs=34.4
Q ss_pred CCchHHHHHHHhhcccCCCCCCChhhhhhccCcCCCCCC
Q psy758 191 ATNIYLIDFLKRCLDKDPLRRWSCDQLLRHPYFNGYYFE 229 (292)
Q Consensus 191 ~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~ 229 (292)
..+..+.+++..|+..+|..|++..+++.|+|+.....+
T Consensus 277 ~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~~~~~~~~ 315 (353)
T 2b9h_A 277 RVNPKGIDLLQRMLVFDPAKRITAKEALEHPYLQTYHDP 315 (353)
T ss_dssp TSCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGTTTCCT
T ss_pred cCCHHHHHHHHHhcCcCcccCCCHHHHhcCccccccCCc
Confidence 347788999999999999999999999999999876544
|
| >3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 4gsb_A* 4gt3_A* 4gva_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3zu7_A 3zuv_A* 3o71_A 3r63_A 3c9w_A* 2y9q_A* 4fmq_A* ... | Back alignment and structure |
|---|
Probab=88.91 E-value=0.41 Score=39.22 Aligned_cols=36 Identities=33% Similarity=0.689 Sum_probs=32.7
Q ss_pred CchHHHHHHHhhcccCCCCCCChhhhhhccCcCCCC
Q psy758 192 TNIYLIDFLKRCLDKDPLRRWSCDQLLRHPYFNGYY 227 (292)
Q Consensus 192 ~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~ 227 (292)
.+..+.+++..|+..+|.+|++..+++.|+|+....
T Consensus 286 ~~~~~~~li~~~L~~dP~~R~t~~e~l~hp~~~~~~ 321 (364)
T 3qyz_A 286 ADSKALDLLDKMLTFNPHKRIEVEQALAHPYLEQYY 321 (364)
T ss_dssp SCHHHHHHHHHHTCSSTTTSCCHHHHHTSGGGTTTC
T ss_pred CCHHHHHHHHHHcCCChhhCCCHHHHhcCcchhhcc
Confidence 467889999999999999999999999999998753
|
| >3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 4dea_A* 4deb_A* ... | Back alignment and structure |
|---|
Probab=88.87 E-value=0.049 Score=42.82 Aligned_cols=36 Identities=22% Similarity=0.354 Sum_probs=31.9
Q ss_pred CchHHHHHHHhhcccCCCCCCChhhhhhccCcCCCC
Q psy758 192 TNIYLIDFLKRCLDKDPLRRWSCDQLLRHPYFNGYY 227 (292)
Q Consensus 192 ~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~ 227 (292)
....+.+++..|+..+|.+|++..+++.|+|+....
T Consensus 230 ~~~~~~~li~~~l~~~p~~Rps~~e~l~h~~~~~~~ 265 (279)
T 3fdn_A 230 VTEGARDLISRLLKHNPSQRPMLREVLEHPWITANS 265 (279)
T ss_dssp SCHHHHHHHHHHCCSSGGGSCCHHHHHHCHHHHHHC
T ss_pred CCHHHHHHHHHHhccChhhCCCHHHHhhCccccCCc
Confidence 466788999999999999999999999999987643
|
| >2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A* | Back alignment and structure |
|---|
Probab=88.83 E-value=0.22 Score=39.98 Aligned_cols=38 Identities=39% Similarity=0.658 Sum_probs=33.7
Q ss_pred CchHHHHHHHhhcccCCCCCCChhhhhhccCcCCCCCC
Q psy758 192 TNIYLIDFLKRCLDKDPLRRWSCDQLLRHPYFNGYYFE 229 (292)
Q Consensus 192 ~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~ 229 (292)
.+..+.+++..|+..+|..|++..+++.|+|+.....+
T Consensus 266 ~~~~l~~li~~~L~~dP~~Rpt~~e~l~hp~f~~~~~~ 303 (317)
T 2pmi_A 266 LDGNLMDFLHGLLQLNPDMRLSAKQALHHPWFAEYYHH 303 (317)
T ss_dssp CCHHHHHHHHHHSCSSGGGSCCHHHHTTSGGGGGGCC-
T ss_pred CCHHHHHHHHHHCCCCcccCCCHHHHhCChhhhcccch
Confidence 46789999999999999999999999999999876554
|
| >2vx3_A Dual specificity tyrosine-phosphorylation- regula kinase 1A; serine/threonine-protein kinase, minibrain homolog, nucleotide-binding, transferase; HET: PTR D15 P6G; 2.40A {Homo sapiens} PDB: 2wo6_A* 3anq_A* 3anr_A* | Back alignment and structure |
|---|
Probab=88.81 E-value=0.3 Score=40.35 Aligned_cols=33 Identities=30% Similarity=0.450 Sum_probs=29.8
Q ss_pred hHHHHHHHhhcccCCCCCCChhhhhhccCcCCC
Q psy758 194 IYLIDFLKRCLDKDPLRRWSCDQLLRHPYFNGY 226 (292)
Q Consensus 194 ~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~ 226 (292)
..+.+++..|+..+|..|+++.+++.|+||...
T Consensus 347 ~~~~dli~~mL~~dP~~Rpta~e~L~hp~f~~~ 379 (382)
T 2vx3_A 347 LKFKDLILRMLDYDPKTRIQPYYALQHSFFKKT 379 (382)
T ss_dssp HHHHHHHHHHTCSCTTTSCCHHHHTTSGGGCC-
T ss_pred HHHHHHHHHhcCCChhhCCCHHHHhcCcccccC
Confidence 367899999999999999999999999999864
|
| >3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=88.75 E-value=0.39 Score=38.21 Aligned_cols=36 Identities=22% Similarity=0.247 Sum_probs=30.7
Q ss_pred CCchHHHHHHHhhcccCCCCCCChhhhhhccCcCCC
Q psy758 191 ATNIYLIDFLKRCLDKDPLRRWSCDQLLRHPYFNGY 226 (292)
Q Consensus 191 ~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~ 226 (292)
..+..+.+++..|+..+|.+|+++.++++|+|+...
T Consensus 268 ~~~~~~~~li~~~L~~dP~~R~t~~e~l~h~~~~~~ 303 (308)
T 3g33_A 268 EMEESGAQLLLEMLTFNPHKRISAFRALQHSYLHKD 303 (308)
T ss_dssp SCCHHHHHHHHHHTCSSTTTSCCHHHHHTSTTC---
T ss_pred cccHHHHHHHHHHhcCCCccCCCHHHHhcCccccCC
Confidence 347788999999999999999999999999999864
|
| >2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus} | Back alignment and structure |
|---|
Probab=88.69 E-value=0.11 Score=44.43 Aligned_cols=36 Identities=28% Similarity=0.459 Sum_probs=31.9
Q ss_pred CCchHHHHHHHhhcccCCCCCCChhhhhhccCcCCC
Q psy758 191 ATNIYLIDFLKRCLDKDPLRRWSCDQLLRHPYFNGY 226 (292)
Q Consensus 191 ~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~ 226 (292)
..+..+.+++..|+..+|..|++..+++.|+|+...
T Consensus 238 ~~s~~~~~Li~~~L~~dP~~Rpt~~eil~hp~~~~~ 273 (476)
T 2y94_A 238 YLNPSVISLLKHMLQVDPMKRATIKDIREHEWFKQD 273 (476)
T ss_dssp TCCHHHHHHHHHHTCSSTTTSCCHHHHHTCHHHHTT
T ss_pred cCCHHHHHHHHHHcCCCchhCcCHHHHHhCHHhhhc
Confidence 346788999999999999999999999999998653
|
| >3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A* | Back alignment and structure |
|---|
Probab=88.67 E-value=0.09 Score=45.29 Aligned_cols=34 Identities=32% Similarity=0.443 Sum_probs=30.8
Q ss_pred CchHHHHHHHhhcccCCCCCCChhhhhhccCcCC
Q psy758 192 TNIYLIDFLKRCLDKDPLRRWSCDQLLRHPYFNG 225 (292)
Q Consensus 192 ~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~ 225 (292)
.+..+.+++..|+..+|..|++..+++.|+|+..
T Consensus 264 ~s~~~~~li~~~L~~dp~~R~s~~e~l~hp~~~~ 297 (494)
T 3lij_A 264 VSEGAKDLIKQMLQFDSQRRISAQQALEHPWIKE 297 (494)
T ss_dssp SCHHHHHHHHHHTCSSTTTSCCHHHHHTCHHHHH
T ss_pred CCHHHHHHHHHHCCCChhhCccHHHHhcCccccc
Confidence 4667889999999999999999999999999864
|
| >4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens} | Back alignment and structure |
|---|
Probab=88.63 E-value=0.091 Score=43.68 Aligned_cols=37 Identities=24% Similarity=0.507 Sum_probs=32.2
Q ss_pred CchHHHHHHHhhcccCCCCCCC-hhhhhhccCcCCCCC
Q psy758 192 TNIYLIDFLKRCLDKDPLRRWS-CDQLLRHPYFNGYYF 228 (292)
Q Consensus 192 ~~~~~~~~~~~~~~~~p~~~~~-~~~~~~~~~~~~~~~ 228 (292)
.+..+.+++..|+..+|..|++ ..++..|+||.+..+
T Consensus 243 ~s~~~~~li~~lL~~dP~~R~s~~~~l~~hp~f~~~~w 280 (384)
T 4fr4_A 243 WSQEMVSLLKKLLEPNPDQRFSQLSDVQNFPYMNDINW 280 (384)
T ss_dssp SCHHHHHHHHHHSCSSGGGSCCSHHHHHTSGGGTTCCH
T ss_pred CCHHHHHHHHHHhcCCHhHhcccHHHHHcChhhhcCCH
Confidence 4567889999999999999998 899999999987643
|
| >3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A | Back alignment and structure |
|---|
Probab=88.61 E-value=0.064 Score=44.38 Aligned_cols=35 Identities=14% Similarity=0.040 Sum_probs=31.5
Q ss_pred CCchHHHHHHHhhcccCCCCCCChhhhhhccCcCC
Q psy758 191 ATNIYLIDFLKRCLDKDPLRRWSCDQLLRHPYFNG 225 (292)
Q Consensus 191 ~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~ 225 (292)
..+..+.+++..|+..+|..|++..+++.|+|+..
T Consensus 331 ~~~~~~~~li~~~L~~dp~~Rpt~~e~l~hp~f~~ 365 (377)
T 3byv_A 331 NIPQPVRALLEGFLRYPKEDRLLPLQAMETPEYEQ 365 (377)
T ss_dssp CCCHHHHHHHHHHTCSSGGGCCCHHHHHTSHHHHH
T ss_pred CCCHHHHHHHHHHcCCCchhCCCHHHHhhChHHHH
Confidence 44678899999999999999999999999999873
|
| >1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=88.58 E-value=0.49 Score=38.44 Aligned_cols=38 Identities=21% Similarity=0.254 Sum_probs=34.0
Q ss_pred CchHHHHHHHhhcccCCCCCCChhhhhhccCcCCCCCC
Q psy758 192 TNIYLIDFLKRCLDKDPLRRWSCDQLLRHPYFNGYYFE 229 (292)
Q Consensus 192 ~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~ 229 (292)
.+..+.+++..|+..+|..|++..+++.|+|+.....+
T Consensus 264 ~~~~~~~li~~~L~~dP~~Rpt~~ell~h~~f~~~~~~ 301 (346)
T 1ua2_A 264 AGDDLLDLIQGLFLFNPCARITATQALKMKYFSNRPGP 301 (346)
T ss_dssp CCHHHHHHHHHHHCSSTTTSCCHHHHHTSGGGTSSSCC
T ss_pred CCHHHHHHHHHHhccChhhCCCHHHHhcChhhhcCCCC
Confidence 46789999999999999999999999999999876544
|
| >2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A* | Back alignment and structure |
|---|
Probab=88.36 E-value=0.067 Score=41.90 Aligned_cols=35 Identities=26% Similarity=0.412 Sum_probs=31.4
Q ss_pred CchHHHHHHHhhcccCCCCCCChhhhhhccCcCCC
Q psy758 192 TNIYLIDFLKRCLDKDPLRRWSCDQLLRHPYFNGY 226 (292)
Q Consensus 192 ~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~ 226 (292)
.+..+.+++..|+..+|..|++..+++.|+|+...
T Consensus 234 ~~~~l~~li~~~l~~~p~~Rps~~~~l~h~~~~~~ 268 (276)
T 2h6d_A 234 LNRSVATLLMHMLQVDPLKRATIKDIREHEWFKQD 268 (276)
T ss_dssp SCHHHHHHHHHHTCSSGGGSCCHHHHHHSHHHHTT
T ss_pred cCHHHHHHHHHHccCChhhCCCHHHHHhChhhccC
Confidence 46778899999999999999999999999998653
|
| >2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ... | Back alignment and structure |
|---|
Probab=88.33 E-value=0.3 Score=40.18 Aligned_cols=38 Identities=32% Similarity=0.440 Sum_probs=33.9
Q ss_pred CchHHHHHHHhhcccCCCCCCChhhhhhccCcCCCCCC
Q psy758 192 TNIYLIDFLKRCLDKDPLRRWSCDQLLRHPYFNGYYFE 229 (292)
Q Consensus 192 ~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~ 229 (292)
.+..+.+++..|+..+|..|++..+++.|+|+.....+
T Consensus 284 ~~~~~~dLl~~mL~~dP~~R~t~~e~L~hp~~~~~~~~ 321 (367)
T 2fst_X 284 ANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQYHDP 321 (367)
T ss_dssp CCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGTTTCCG
T ss_pred CCHHHHHHHHHhCCCCcccCcCHHHHhcChhhhhccCC
Confidence 36788999999999999999999999999999876544
|
| >3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens} | Back alignment and structure |
|---|
Probab=88.32 E-value=0.48 Score=38.55 Aligned_cols=39 Identities=26% Similarity=0.418 Sum_probs=34.5
Q ss_pred CCchHHHHHHHhhcccCCCCCCChhhhhhccCcCCCCCC
Q psy758 191 ATNIYLIDFLKRCLDKDPLRRWSCDQLLRHPYFNGYYFE 229 (292)
Q Consensus 191 ~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~ 229 (292)
..+..+.+++..|+..+|..|++..+++.|+|+.....+
T Consensus 277 ~~~~~~~~li~~~L~~dp~~Rpt~~e~l~hp~f~~~~~~ 315 (353)
T 3coi_A 277 RASPQAADLLEKMLELDVDKRLTAAQALTHPFFEPFRDP 315 (353)
T ss_dssp TSCHHHHHHHHHHSCSCTTTSCCHHHHHTSGGGTTTCCG
T ss_pred CcCHHHHHHHHHHcCCCcccCCCHHHHhcCcchhhccCc
Confidence 447889999999999999999999999999999876543
|
| >3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} SCOP: d.144.1.7 PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3u9c_A* 4fbx_A* 3mb7_A* 3mb6_A* ... | Back alignment and structure |
|---|
Probab=88.12 E-value=0.27 Score=39.54 Aligned_cols=36 Identities=28% Similarity=0.474 Sum_probs=32.9
Q ss_pred CchHHHHHHHhhcccCCCCCCChhhhhhccCcCCCC
Q psy758 192 TNIYLIDFLKRCLDKDPLRRWSCDQLLRHPYFNGYY 227 (292)
Q Consensus 192 ~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~ 227 (292)
.+..+.+++..|+..+|..|+++.++++|+||....
T Consensus 292 ~~~~~~~li~~~L~~dP~~Rpta~e~l~hp~f~~~~ 327 (330)
T 3nsz_A 292 VSPEALDFLDKLLRYDHQSRLTAREAMEHPYFYTVV 327 (330)
T ss_dssp CCHHHHHHHHTTSCSSGGGSCCHHHHHTSGGGTTCC
T ss_pred CCHHHHHHHHHHhcCCcccCCCHHHHhcCccHhhhc
Confidence 477899999999999999999999999999998754
|
| >3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A* | Back alignment and structure |
|---|
Probab=88.05 E-value=0.074 Score=45.64 Aligned_cols=36 Identities=22% Similarity=0.322 Sum_probs=32.5
Q ss_pred CchHHHHHHHhhcccCCCCCCChhhhhhccCcCCCC
Q psy758 192 TNIYLIDFLKRCLDKDPLRRWSCDQLLRHPYFNGYY 227 (292)
Q Consensus 192 ~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~ 227 (292)
.+..+.+++..|+..+|..|++..+++.|+|+....
T Consensus 254 ~s~~~~~li~~~L~~dp~~R~s~~e~l~h~~~~~~~ 289 (484)
T 3nyv_A 254 VSESAKDLIRKMLTYVPSMRISARDALDHEWIQTYT 289 (484)
T ss_dssp SCHHHHHHHHHHTCSSGGGSCCHHHHHTSHHHHHHT
T ss_pred CCHHHHHHHHHHCCCChhHCcCHHHHhhChhhcccc
Confidence 467889999999999999999999999999987643
|
| >3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A* | Back alignment and structure |
|---|
Probab=88.02 E-value=0.4 Score=37.97 Aligned_cols=36 Identities=14% Similarity=0.337 Sum_probs=32.4
Q ss_pred CchHHHHHHHhhcccCCCCCCChhhhhhccCcCCCC
Q psy758 192 TNIYLIDFLKRCLDKDPLRRWSCDQLLRHPYFNGYY 227 (292)
Q Consensus 192 ~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~ 227 (292)
.+..+.+++..|+..+|..|++..+++.|+|+....
T Consensus 229 ~~~~~~~li~~~l~~dP~~Rps~~e~l~hp~~~~~~ 264 (299)
T 3m2w_A 229 VSEEVKMLIRNLLKTEPTQRMTITEFMNHPWIMQST 264 (299)
T ss_dssp SCHHHHHHHHHHTCSSTTTSCCHHHHHTSHHHHTGG
T ss_pred CCHHHHHHHHHHcccChhhCCCHHHHhcChhhcccc
Confidence 477889999999999999999999999999987654
|
| >3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens} | Back alignment and structure |
|---|
Probab=88.01 E-value=0.35 Score=40.35 Aligned_cols=38 Identities=24% Similarity=0.485 Sum_probs=33.8
Q ss_pred chHHHHHHHhhcccCCCCCCChhhhhhccCcCCCCCCC
Q psy758 193 NIYLIDFLKRCLDKDPLRRWSCDQLLRHPYFNGYYFEV 230 (292)
Q Consensus 193 ~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~ 230 (292)
+..+.+++..|+..+|.+|+++.+++.|+||.....+.
T Consensus 307 ~~~~~~Ll~~~L~~dP~~R~ta~e~L~hp~f~~~~~~~ 344 (405)
T 3rgf_A 307 DSKAFHLLQKLLTMDPIKRITSEQAMQDPYFLEDPLPT 344 (405)
T ss_dssp TSHHHHHHHHHSCSSGGGSCCHHHHHTSGGGTSSSCCC
T ss_pred CHHHHHHHHHHccCCcccCCCHHHHhcChhhccCCCCc
Confidence 56788999999999999999999999999998765543
|
| >2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens} | Back alignment and structure |
|---|
Probab=88.00 E-value=0.061 Score=44.50 Aligned_cols=36 Identities=22% Similarity=0.360 Sum_probs=32.7
Q ss_pred CCchHHHHHHHhhcccCCCCCCChhhhhhccCcCCC
Q psy758 191 ATNIYLIDFLKRCLDKDPLRRWSCDQLLRHPYFNGY 226 (292)
Q Consensus 191 ~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~ 226 (292)
..+..+.+++..|+..+|..|++..+++.|+|+...
T Consensus 314 ~~~~~~~~li~~~L~~dp~~Rps~~e~l~hp~~~~~ 349 (373)
T 2x4f_A 314 DISEEAKEFISKLLIKEKSWRISASEALKHPWLSDH 349 (373)
T ss_dssp TSCHHHHHHHHTTSCSSGGGSCCHHHHHHSHHHHCH
T ss_pred cCCHHHHHHHHHHcCCChhhCCCHHHHhcCcCcCCC
Confidence 357889999999999999999999999999998864
|
| >2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens} | Back alignment and structure |
|---|
Probab=87.89 E-value=0.55 Score=37.18 Aligned_cols=38 Identities=29% Similarity=0.413 Sum_probs=33.1
Q ss_pred CCchHHHHHHHhhcccCCCCCCChhhhhhccCcCCCCC
Q psy758 191 ATNIYLIDFLKRCLDKDPLRRWSCDQLLRHPYFNGYYF 228 (292)
Q Consensus 191 ~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~ 228 (292)
..+..+.+++..|+..+|..|++..+++.|+|+.....
T Consensus 235 ~~~~~l~~li~~~l~~dp~~Rps~~~ll~~~~~~~~~~ 272 (305)
T 2wtk_C 235 DCGPPLSDLLKGMLEYEPAKRFSIRQIRQHSWFRKKHP 272 (305)
T ss_dssp SSCHHHHHHHHHHTCSSTTTSCCHHHHHHSHHHHSCCC
T ss_pred ccCHHHHHHHHHHccCChhhCCCHHHHhcCcccccCCC
Confidence 34677889999999999999999999999999876544
|
| >3kvw_A DYRK2, dual specificity tyrosine-phosphorylation-regulat 2; KI-(Y)-phosphorylation REG kinase 2, PSK-H2, kinase, structural genomics consortium; HET: SEP PTR IRB; 2.28A {Homo sapiens} PDB: 3k2l_A* 4azf_A* | Back alignment and structure |
|---|
Probab=87.87 E-value=0.43 Score=40.22 Aligned_cols=35 Identities=40% Similarity=0.745 Sum_probs=30.4
Q ss_pred chHHHHHHHhhcccCCCCCCChhhhhhccCcCCCC
Q psy758 193 NIYLIDFLKRCLDKDPLRRWSCDQLLRHPYFNGYY 227 (292)
Q Consensus 193 ~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~ 227 (292)
+..+.+++..|+..+|..|+++.++++|+|+....
T Consensus 382 ~~~~~dli~~~L~~dP~~Rpta~e~L~Hpw~~~~~ 416 (429)
T 3kvw_A 382 DPLFLDFLKQCLEWDPAVRMTPGQALRHPWLRRRL 416 (429)
T ss_dssp CHHHHHHHHHHTCSSTTTSCCHHHHHTSTTTC---
T ss_pred hHHHHHHHHHHCCCChhhCCCHHHHhCChhhccCC
Confidence 67789999999999999999999999999998653
|
| >2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ... | Back alignment and structure |
|---|
Probab=87.84 E-value=0.062 Score=42.35 Aligned_cols=36 Identities=17% Similarity=0.279 Sum_probs=31.9
Q ss_pred CCchHHHHHHHhhcccCCCCCCChhhhhhccCcCCC
Q psy758 191 ATNIYLIDFLKRCLDKDPLRRWSCDQLLRHPYFNGY 226 (292)
Q Consensus 191 ~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~ 226 (292)
..+..+.+++..|+..+|..|++..+++.|+|+...
T Consensus 234 ~~~~~~~~li~~~l~~~p~~Rps~~~ll~h~~~~~~ 269 (284)
T 2vgo_A 234 FLSDGSKDLISKLLRYHPPQRLPLKGVMEHPWVKAN 269 (284)
T ss_dssp TSCHHHHHHHHHHSCSSGGGSCCHHHHHTCHHHHHH
T ss_pred cCCHHHHHHHHHHhhcCHhhCCCHHHHhhCHHHHhh
Confidence 346778899999999999999999999999998754
|
| >3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A* | Back alignment and structure |
|---|
Probab=87.58 E-value=0.047 Score=44.10 Aligned_cols=36 Identities=33% Similarity=0.591 Sum_probs=32.4
Q ss_pred CchHHHHHHHhhcccCCCCCCChhhhhhccCcCCCC
Q psy758 192 TNIYLIDFLKRCLDKDPLRRWSCDQLLRHPYFNGYY 227 (292)
Q Consensus 192 ~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~ 227 (292)
.+..+.+++..|+..+|..|++..+++.++|+....
T Consensus 258 ~~~~l~~li~~~l~~dp~~Rps~~ell~hp~~~~~~ 293 (327)
T 3aln_A 258 FSPSFINFVNLCLTKDESKRPKYKELLKHPFILMYE 293 (327)
T ss_dssp CCHHHHHHHHHHTCSSGGGSCCHHHHTTSHHHHHHH
T ss_pred CCHHHHHHHHHHhhCChhhCcCHHHHHhChHHHHhH
Confidence 467889999999999999999999999999987653
|
| >3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} PDB: 3uib_A* | Back alignment and structure |
|---|
Probab=87.58 E-value=0.33 Score=39.63 Aligned_cols=38 Identities=34% Similarity=0.669 Sum_probs=33.7
Q ss_pred CCchHHHHHHHhhcccCCCCCCChhhhhhccCcCCCCC
Q psy758 191 ATNIYLIDFLKRCLDKDPLRRWSCDQLLRHPYFNGYYF 228 (292)
Q Consensus 191 ~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~ 228 (292)
..+..+.+++..|+..+|..|++..+++.|+|+.....
T Consensus 288 ~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~f~~~~~ 325 (362)
T 3pg1_A 288 TADPVALDLIAKMLEFNPQRRISTEQALRHPYFESLFD 325 (362)
T ss_dssp TSCHHHHHHHHHHTCSSGGGSCCHHHHHTSGGGTTTCC
T ss_pred CCCHHHHHHHHHHhcCChhhCCCHHHHHcCchhhhccC
Confidence 34677899999999999999999999999999987643
|
| >2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B | Back alignment and structure |
|---|
Probab=87.56 E-value=0.082 Score=43.52 Aligned_cols=34 Identities=21% Similarity=0.358 Sum_probs=31.2
Q ss_pred CchHHHHHHHhhcccCCCCCCChhhhhhccCcCC
Q psy758 192 TNIYLIDFLKRCLDKDPLRRWSCDQLLRHPYFNG 225 (292)
Q Consensus 192 ~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~ 225 (292)
.+..+.+++..|+..+|..|++..+++.|+|+..
T Consensus 257 ~~~~~~~li~~~L~~dP~~R~t~~e~l~hp~~~~ 290 (362)
T 2bdw_A 257 VTPEAKSLIDSMLTVNPKKRITADQALKVPWICN 290 (362)
T ss_dssp SCHHHHHHHHHHSCSSGGGSCCHHHHTTSHHHHT
T ss_pred CCHHHHHHHHHHcCCChhhCcCHHHHhcCcccCC
Confidence 4678899999999999999999999999999864
|
| >3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii} | Back alignment and structure |
|---|
Probab=87.46 E-value=0.45 Score=37.39 Aligned_cols=34 Identities=41% Similarity=0.592 Sum_probs=30.9
Q ss_pred CchHHHHHHHhhcccCCCCCCChhhhhhccCcCC
Q psy758 192 TNIYLIDFLKRCLDKDPLRRWSCDQLLRHPYFNG 225 (292)
Q Consensus 192 ~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~ 225 (292)
....+.+++..|+..+|.+|++..+++.|+|+..
T Consensus 251 ~~~~~~~li~~~L~~dP~~Rps~~e~l~hp~f~~ 284 (285)
T 3is5_A 251 LTPQAVDLLKQMLTKDPERRPSAAQVLHHEWFKQ 284 (285)
T ss_dssp CCHHHHHHHHHHTCSCTTTSCCHHHHHTSGGGGC
T ss_pred CCHHHHHHHHHHccCChhhCcCHHHHhcCHHhhc
Confidence 3677889999999999999999999999999874
|
| >3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ... | Back alignment and structure |
|---|
Probab=87.31 E-value=0.53 Score=37.76 Aligned_cols=55 Identities=18% Similarity=0.354 Sum_probs=37.7
Q ss_pred CCchHHHHHHHhhcccCCCCCCChhhhhhccCcCCCCCCCCCccchHHHHhcccCcCCC
Q psy758 191 ATNIYLIDFLKRCLDKDPLRRWSCDQLLRHPYFNGYYFEVPDEMQYEEITQRCLDKDPL 249 (292)
Q Consensus 191 ~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~ 249 (292)
..+..+.+++..|+..+|..|++..+++.++|+..... +....++...-+.+.|.
T Consensus 265 ~~~~~~~~li~~~l~~dp~~Rps~~~ll~hp~~~~~~~----~~~~~~~~~~~~~p~~s 319 (320)
T 3a99_A 265 RVSSECQHLIRWCLALRPSDRPTFEEIQNHPWMQDVLL----PQETAEIHLHSLSPGPS 319 (320)
T ss_dssp CCCHHHHHHHHHHTCSSGGGSCCHHHHHTSGGGSSCCC----HHHHHHHHTC-------
T ss_pred cCCHHHHHHHHHHccCChhhCcCHHHHhcCHhhcCccC----ccccccccccccCCCCC
Confidence 34778899999999999999999999999999987533 23334444444444443
|
| >4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis} | Back alignment and structure |
|---|
Probab=87.19 E-value=0.56 Score=38.96 Aligned_cols=38 Identities=29% Similarity=0.423 Sum_probs=34.3
Q ss_pred CchHHHHHHHhhcccCCCCCCChhhhhhccCcCCCCCC
Q psy758 192 TNIYLIDFLKRCLDKDPLRRWSCDQLLRHPYFNGYYFE 229 (292)
Q Consensus 192 ~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~ 229 (292)
.+..+.+++..|+..+|..|+++.+++.|+||......
T Consensus 294 ~~~~~~~li~~~L~~dP~~R~t~~e~l~hp~f~~~~~~ 331 (394)
T 4e7w_A 294 TPPDAIDLISRLLEYTPSARLTAIEALCHPFFDELRTG 331 (394)
T ss_dssp CCHHHHHHHHHHCCSSGGGSCCHHHHHTSGGGSTTTSS
T ss_pred CCHHHHHHHHHHhCCChhhCCCHHHHhcChhhhhhccc
Confidence 47789999999999999999999999999999876544
|
| >2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens} | Back alignment and structure |
|---|
Probab=87.02 E-value=0.21 Score=39.86 Aligned_cols=57 Identities=25% Similarity=0.350 Sum_probs=39.9
Q ss_pred CchHHHHHHHhhcccCCCCCCChhhhhhccCcCCCCCCCCCccchHHHHhcccCcCCCCC
Q psy758 192 TNIYLIDFLKRCLDKDPLRRWSCDQLLRHPYFNGYYFEVPDEMQYEEITQRCLDKDPLRR 251 (292)
Q Consensus 192 ~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~R 251 (292)
.+..+.+++..|+..+|..|++..+++.|+|+...... ...+.+++...+...+..|
T Consensus 256 ~~~~l~~li~~~l~~dp~~Rps~~~ll~h~~~~~~~~~---~~~~~~~~~~~~~~~~~~~ 312 (318)
T 2dyl_A 256 FSGDFQSFVKDCLTKDHRKRPKYNKLLEHSFIKRYETL---EVDVASWFKDVMAKTESPR 312 (318)
T ss_dssp CCHHHHHHHHHHTCSCTTTSCCHHHHTTSHHHHHHHHS---CCCHHHHHHHHHHTTC---
T ss_pred CCHHHHHHHHHHccCChhHCcCHHHHhhCHHHHhcccc---cchhHHHhhcccCCCCCCC
Confidence 47789999999999999999999999999998764332 2244445555444434333
|
| >2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A* | Back alignment and structure |
|---|
Probab=86.91 E-value=0.44 Score=37.69 Aligned_cols=47 Identities=34% Similarity=0.478 Sum_probs=37.2
Q ss_pred CchHHHHHHHhhcccCCCCCCChhhhhhccCcCCCCCCCCCccchHHHHhc
Q psy758 192 TNIYLIDFLKRCLDKDPLRRWSCDQLLRHPYFNGYYFEVPDEMQYEEITQR 242 (292)
Q Consensus 192 ~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~ 242 (292)
.+..+.+++..|+..+|..|++..+++.|+|+...... ..+++++..
T Consensus 248 ~~~~l~~li~~~l~~dp~~Rps~~~ll~h~~~~~~~~~----~~~~~~~~~ 294 (302)
T 2j7t_A 248 WSVEFRDFLKIALDKNPETRPSAAQLLEHPFVSSITSN----KALRELVAE 294 (302)
T ss_dssp SCHHHHHHHHHHSCSCTTTSCCHHHHTTSTTTTTCCCC----HHHHHHHHH
T ss_pred cCHHHHHHHHHHcccChhhCCCHHHHhcChHHhhhccc----hhHHHHHHH
Confidence 35678899999999999999999999999999876432 345555443
|
| >3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=86.83 E-value=0.14 Score=43.33 Aligned_cols=33 Identities=24% Similarity=0.595 Sum_probs=29.4
Q ss_pred hHHHHHHHhhcccCCCCCCChhhhhhccCcCCC
Q psy758 194 IYLIDFLKRCLDKDPLRRWSCDQLLRHPYFNGY 226 (292)
Q Consensus 194 ~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~ 226 (292)
..+.+++..|+..+|..|+++.+++.|+||...
T Consensus 258 ~~~~~li~~~L~~dP~~Rps~~evl~hp~f~~~ 290 (432)
T 3p23_A 258 VIARELIEKMIAMDPQKRPSAKHVLKHPFFWSL 290 (432)
T ss_dssp HHHHHHHHHHSCSSGGGSCCHHHHHTSTTTCCH
T ss_pred HHHHHHHHHHHhCCHhhCCCHHHHHhCccccCh
Confidence 346789999999999999999999999999753
|
| >1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=86.79 E-value=0.13 Score=42.04 Aligned_cols=38 Identities=29% Similarity=0.545 Sum_probs=33.4
Q ss_pred CCCCchHHHHHHHhhcccCCCCCC-----ChhhhhhccCcCCC
Q psy758 189 PAATNIYLIDFLKRCLDKDPLRRW-----SCDQLLRHPYFNGY 226 (292)
Q Consensus 189 ~~~~~~~~~~~~~~~~~~~p~~~~-----~~~~~~~~~~~~~~ 226 (292)
+...+..+.+++..|+..+|..|+ +..+++.|+|+...
T Consensus 286 ~~~~~~~~~~li~~~L~~dP~~R~~~~~~s~~ell~h~~f~~~ 328 (355)
T 1vzo_A 286 PQEMSALAKDLIQRLLMKDPKKRLGCGPRDADEIKEHLFFQKI 328 (355)
T ss_dssp CTTSCHHHHHHHHHHTCSSGGGSTTSSTTTHHHHHTSGGGTTC
T ss_pred CcccCHHHHHHHHHHhhhCHHHhcCCCCCCHHHHHcCcchhcC
Confidence 344577889999999999999999 99999999999865
|
| >1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B | Back alignment and structure |
|---|
Probab=86.33 E-value=0.87 Score=36.37 Aligned_cols=38 Identities=32% Similarity=0.523 Sum_probs=33.7
Q ss_pred CCCchHHHHHHHhhcccCCCCCCChhhhhhccCcCCCC
Q psy758 190 AATNIYLIDFLKRCLDKDPLRRWSCDQLLRHPYFNGYY 227 (292)
Q Consensus 190 ~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~ 227 (292)
...+..+.+++..|+..+|..|++..+++.|+|+....
T Consensus 267 ~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~hp~~~~~~ 304 (326)
T 1blx_A 267 TDIDELGKDLLLKCLTFNPAKRISAYSALSHPYFQDLE 304 (326)
T ss_dssp CSCCHHHHHHHHHHSCSSTTTSCCHHHHHTSGGGTTCC
T ss_pred ccCCHHHHHHHHHHcCCCcccCCCHHHHhcCccccccc
Confidence 34477889999999999999999999999999998754
|
| >1q8y_A SR protein kinase; transferase; HET: ADP ADE; 2.05A {Saccharomyces cerevisiae} SCOP: d.144.1.7 PDB: 1q8z_A 1q97_A* 1q99_A* 1how_A 2jd5_A | Back alignment and structure |
|---|
Probab=86.29 E-value=0.66 Score=37.94 Aligned_cols=35 Identities=29% Similarity=0.491 Sum_probs=31.4
Q ss_pred chHHHHHHHhhcccCCCCCCChhhhhhccCcCCCC
Q psy758 193 NIYLIDFLKRCLDKDPLRRWSCDQLLRHPYFNGYY 227 (292)
Q Consensus 193 ~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~ 227 (292)
+..+.+++..|+..+|..|+++.+++.|+|+....
T Consensus 307 ~~~~~~li~~~L~~dP~~Rpt~~ell~hp~f~~~~ 341 (373)
T 1q8y_A 307 AKEISDFLSPMLQLDPRKRADAGGLVNHPWLKDTL 341 (373)
T ss_dssp HHHHHHHHGGGGCSSTTTCBCHHHHHTCGGGTTCT
T ss_pred HHHHHHHHHHHhccCccccCCHHHHhhChhhhccc
Confidence 55678999999999999999999999999998753
|
| >4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A* | Back alignment and structure |
|---|
Probab=86.24 E-value=0.19 Score=42.57 Aligned_cols=39 Identities=18% Similarity=0.426 Sum_probs=33.2
Q ss_pred CCchHHHHHHHhhcccCCCC--CCChhhhhhccCcCCCCCC
Q psy758 191 ATNIYLIDFLKRCLDKDPLR--RWSCDQLLRHPYFNGYYFE 229 (292)
Q Consensus 191 ~~~~~~~~~~~~~~~~~p~~--~~~~~~~~~~~~~~~~~~~ 229 (292)
..+..+.+++..|+..+|.. |++..+++.|+||.+..+.
T Consensus 308 ~~s~~~~dLi~~lL~~~~~r~~r~~~~eil~Hpff~~i~w~ 348 (437)
T 4aw2_A 308 DVSENAKDLIRRLICSREHRLGQNGIEDFKKHPFFSGIDWD 348 (437)
T ss_dssp CSCHHHHHHHHTTSSCGGGCTTTTTTHHHHTSGGGTTCCTT
T ss_pred cCCHHHHHHHHHHhcccccccCCCCHHHHhCCCccCCCCHH
Confidence 35888999999999776665 8999999999999987665
|
| >1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A | Back alignment and structure |
|---|
Probab=86.21 E-value=0.17 Score=39.99 Aligned_cols=34 Identities=18% Similarity=0.195 Sum_probs=30.9
Q ss_pred chHHHHHHHhhcccCCCCCCChhhhhhccCcCCC
Q psy758 193 NIYLIDFLKRCLDKDPLRRWSCDQLLRHPYFNGY 226 (292)
Q Consensus 193 ~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~ 226 (292)
...+.+++..|+..+|..|++..+++.|+|+...
T Consensus 257 ~~~~~~li~~~l~~dp~~Rps~~~ll~h~~~~~~ 290 (303)
T 1zy4_A 257 MKVEKKIIRLLIDHDPNKRPGARTLLNSGWLPVK 290 (303)
T ss_dssp SHHHHHHHHHHTCSSGGGSCCHHHHHHSSCSCCC
T ss_pred hHHHHHHHHHHHhcCcccCcCHHHHhCCCCcCCC
Confidence 5568899999999999999999999999999754
|
| >3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3twj_A* 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A* | Back alignment and structure |
|---|
Probab=86.04 E-value=0.26 Score=41.34 Aligned_cols=40 Identities=15% Similarity=0.268 Sum_probs=34.6
Q ss_pred CCCchHHHHHHHhhcccCCCC--CCChhhhhhccCcCCCCCC
Q psy758 190 AATNIYLIDFLKRCLDKDPLR--RWSCDQLLRHPYFNGYYFE 229 (292)
Q Consensus 190 ~~~~~~~~~~~~~~~~~~p~~--~~~~~~~~~~~~~~~~~~~ 229 (292)
...+..+.+++..|+..+|.. |++..+++.|+||.+..+.
T Consensus 298 ~~~s~~~~~li~~lL~~~~~rlgR~~~~ei~~Hp~f~~~~w~ 339 (410)
T 3v8s_A 298 NDISKEAKNLICAFLTDREVRLGRNGVEEIKRHLFFKNDQWA 339 (410)
T ss_dssp CCCCHHHHHHHHHHSSCGGGCTTSSCHHHHHTSGGGCCSSCC
T ss_pred ccccHHHHHHHHHHccChhhhCCCCCHHHHhcCccccCCCHH
Confidence 356888999999999988877 8999999999999987654
|
| >2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A* | Back alignment and structure |
|---|
Probab=85.76 E-value=0.54 Score=41.28 Aligned_cols=37 Identities=24% Similarity=0.307 Sum_probs=32.4
Q ss_pred CCchHHHHHHHhhcccCCCCCC-----ChhhhhhccCcCCCC
Q psy758 191 ATNIYLIDFLKRCLDKDPLRRW-----SCDQLLRHPYFNGYY 227 (292)
Q Consensus 191 ~~~~~~~~~~~~~~~~~p~~~~-----~~~~~~~~~~~~~~~ 227 (292)
..+..+.+++..|+..+|..|+ +..+++.|+||....
T Consensus 411 ~~s~~~~dLI~~lL~~dP~~R~g~~~~sa~eil~HpfF~~i~ 452 (576)
T 2acx_A 411 RFSPQARSLCSQLLCKDPAERLGCRGGSAREVKEHPLFKKLN 452 (576)
T ss_dssp TSCHHHHHHHHHHTCSSGGGSTTCSSSHHHHHHTSGGGTTCC
T ss_pred cCCHHHHHHHHHhccCCHHHcCCCCCCCHHHHHhChhhccCC
Confidence 3467789999999999999999 689999999998763
|
| >3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=85.73 E-value=0.52 Score=38.23 Aligned_cols=35 Identities=43% Similarity=0.618 Sum_probs=31.3
Q ss_pred chHHHHHHHhhcccCCCCCCChhhhhhccCcCCCC
Q psy758 193 NIYLIDFLKRCLDKDPLRRWSCDQLLRHPYFNGYY 227 (292)
Q Consensus 193 ~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~ 227 (292)
...+.+++..|+..+|..|++..+++.|+|+....
T Consensus 247 ~~~l~~li~~~L~~dp~~Rpt~~e~l~hp~~~~~~ 281 (343)
T 3dbq_A 247 EKDLQDVLKCCLKRDPKQRISIPELLAHPYVQIQT 281 (343)
T ss_dssp CHHHHHHHHHHTCSSTTTSCCHHHHHTSHHHHSCC
T ss_pred CHHHHHHHHHHcCCChhHCCCHHHHHhCccccccC
Confidence 45788999999999999999999999999987543
|
| >3cxl_A N-chimerin; SH2, RHO-GAP, structural genomics consortium, SGC, gtpas activation, metal-binding, phorbol-ester binding, SH2 domai finger; 2.60A {Homo sapiens} PDB: 1xa6_A | Back alignment and structure |
|---|
Probab=85.73 E-value=0.049 Score=46.55 Aligned_cols=61 Identities=10% Similarity=0.015 Sum_probs=15.3
Q ss_pred eeeecccCceEEEEEEEcCCCcEEEE------EEeccCCCChHHHHHHHHHHHHHHhCCCCCcchhhhhh
Q psy758 7 IGKLGEGSYGVVFKCRNRDTGQVVAI------KKFLESEEDPLIRKIALREIRLLKSLKHPNLVNLLEVF 70 (292)
Q Consensus 7 ~~~l~~g~~~~v~~~~~~~~~~~v~i------K~~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~ 70 (292)
.+.|| ||.||.+........||+ |.........+....+.++..+++.++|||+++.+++.
T Consensus 147 ~~~lG---fG~v~~g~~~~~~~~Vav~~~~~~K~~~~~~~~~e~~~~~~rea~l~~~~~H~niv~~h~f~ 213 (463)
T 3cxl_A 147 YEHVG---YTTLNREPAYKKHMPVLKETHDERDSTGQDGVSEKRLTSLVRRATLKENEQIPKYEKIHNFK 213 (463)
T ss_dssp TTTSS---BCCC---------CCBGGGC-----------------------------------CBCCCEE
T ss_pred cccCC---chhhhcccccccCCchhhhhccCccccccccccccccccccccccccccccccccCCCcceE
Confidence 34455 999999988655557888 65544344444455677888888999999999987764
|
| >3llt_A Serine/threonine kinase-1, pflammer; lammer kinase, malaria, structural GE structural genomics consortium, SGC, transferase; HET: ANP; 2.50A {Plasmodium falciparum 3D7} | Back alignment and structure |
|---|
Probab=85.32 E-value=0.43 Score=38.94 Aligned_cols=32 Identities=34% Similarity=0.497 Sum_probs=29.1
Q ss_pred chHHHHHHHhhcccCCCCCCChhhhhhccCcC
Q psy758 193 NIYLIDFLKRCLDKDPLRRWSCDQLLRHPYFN 224 (292)
Q Consensus 193 ~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~ 224 (292)
...+.+++..|+..+|..|+++.+++.|+|++
T Consensus 329 ~~~l~~li~~~L~~dP~~Rpta~elL~hp~f~ 360 (360)
T 3llt_A 329 HELFCDFLYSILQIDPTLRPSPAELLKHKFLE 360 (360)
T ss_dssp CHHHHHHHHHHCCSSGGGSCCHHHHTTSGGGC
T ss_pred HHHHHHHHHHHhcCChhhCCCHHHHhcCcccC
Confidence 46677999999999999999999999999974
|
| >2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens} | Back alignment and structure |
|---|
Probab=85.31 E-value=0.79 Score=35.99 Aligned_cols=37 Identities=19% Similarity=0.387 Sum_probs=32.0
Q ss_pred CCchHHHHHHHhhcccCCCCCCChhhhhhccCcCCCC
Q psy758 191 ATNIYLIDFLKRCLDKDPLRRWSCDQLLRHPYFNGYY 227 (292)
Q Consensus 191 ~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~ 227 (292)
..+..+.+++..|+..+|..|++..+++.++|+....
T Consensus 250 ~~~~~~~~li~~~l~~dp~~Rps~~~ll~~~~~~~~~ 286 (295)
T 2clq_A 250 SMSAEAKAFILKCFEPDPDKRACANDLLVDEFLKVSS 286 (295)
T ss_dssp TSCHHHHHHHHHTTCSSTTTSCCHHHHHTSGGGCC--
T ss_pred cCCHHHHHHHHHHccCChhhCCCHHHHhcChhhhhcc
Confidence 4477889999999999999999999999999987643
|
| >3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A* | Back alignment and structure |
|---|
Probab=84.88 E-value=0.2 Score=40.04 Aligned_cols=29 Identities=17% Similarity=0.376 Sum_probs=25.1
Q ss_pred CCchHHHHHHHhhcccCCCCCCChhhhhh
Q psy758 191 ATNIYLIDFLKRCLDKDPLRRWSCDQLLR 219 (292)
Q Consensus 191 ~~~~~~~~~~~~~~~~~p~~~~~~~~~~~ 219 (292)
..+..+.+++..|+..+|.+|++..+++.
T Consensus 263 ~~~~~l~~li~~~l~~dP~~Rps~~~ll~ 291 (309)
T 3p86_A 263 NLNPQVAAIIEGCWTNEPWKRPSFATIMD 291 (309)
T ss_dssp TSCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred cCCHHHHHHHHHHccCChhhCcCHHHHHH
Confidence 34667889999999999999999998875
|
| >1wak_A Serine/threonine-protein kinase SPRK1; SRPK, transferase, alternative splicing, ATP-binding, chromosome partition, differentiation, mRNA processing; 1.73A {Homo sapiens} PDB: 1wbp_A* 3beg_A* 2x7g_A* | Back alignment and structure |
|---|
Probab=84.78 E-value=0.4 Score=39.56 Aligned_cols=32 Identities=34% Similarity=0.538 Sum_probs=29.0
Q ss_pred chHHHHHHHhhcccCCCCCCChhhhhhccCcC
Q psy758 193 NIYLIDFLKRCLDKDPLRRWSCDQLLRHPYFN 224 (292)
Q Consensus 193 ~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~ 224 (292)
...+.+++..|+..+|.+|+++.+++.|+|+.
T Consensus 365 ~~~~~~li~~~L~~dP~~Rpt~~e~l~hp~~~ 396 (397)
T 1wak_A 365 AAGFTDFLLPMLELIPEKRATAAECLRHPWLN 396 (397)
T ss_dssp HHHHHHHHGGGGCSSGGGSCCHHHHHTSGGGG
T ss_pred HHHHHHHHHHHhccChhhcCCHHHHhhCcccc
Confidence 34577999999999999999999999999986
|
| >1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A* | Back alignment and structure |
|---|
Probab=84.74 E-value=0.59 Score=36.85 Aligned_cols=38 Identities=29% Similarity=0.594 Sum_probs=32.7
Q ss_pred CchHHHHHHHhhcccCCCCCCChhhhhhccCcCCCCCC
Q psy758 192 TNIYLIDFLKRCLDKDPLRRWSCDQLLRHPYFNGYYFE 229 (292)
Q Consensus 192 ~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~ 229 (292)
.+..+.+++..|+..+|..|++..+++.|+|+.....+
T Consensus 256 ~~~~l~~li~~~l~~dp~~Rps~~~ll~h~~~~~~~~~ 293 (298)
T 1phk_A 256 YSDTVKDLVSRFLVVQPQKRYTAEEALAHPFFQQYVVE 293 (298)
T ss_dssp SCHHHHHHHHHHCCSSGGGSCCHHHHTTSGGGCTTC--
T ss_pred cCHHHHHHHHHHccCCcccCCCHHHHHhChHhhhccch
Confidence 46778999999999999999999999999999876443
|
| >2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A* | Back alignment and structure |
|---|
Probab=84.69 E-value=0.7 Score=37.07 Aligned_cols=37 Identities=35% Similarity=0.547 Sum_probs=32.7
Q ss_pred CchHHHHHHHhhcccCCCCCCChhhhhhccCcCCCCC
Q psy758 192 TNIYLIDFLKRCLDKDPLRRWSCDQLLRHPYFNGYYF 228 (292)
Q Consensus 192 ~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~ 228 (292)
.+..+.+++..|+..+|..|++..+++.|+|+.....
T Consensus 267 ~~~~l~~li~~~l~~dp~~Rps~~ell~hp~~~~~~~ 303 (321)
T 2c30_A 267 VSPVLRDFLERMLVRDPQERATAQELLDHPFLLQTGL 303 (321)
T ss_dssp SCHHHHHHHHHHSCSSTTTSCCHHHHHTSGGGGGCCC
T ss_pred CCHHHHHHHHHHccCChhhCcCHHHHhcChhhccCCC
Confidence 3667899999999999999999999999999986543
|
| >3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A* | Back alignment and structure |
|---|
Probab=84.53 E-value=0.54 Score=40.06 Aligned_cols=35 Identities=40% Similarity=0.646 Sum_probs=31.2
Q ss_pred chHHHHHHHhhcccCCCCCCChhhhhhccCcCCCC
Q psy758 193 NIYLIDFLKRCLDKDPLRRWSCDQLLRHPYFNGYY 227 (292)
Q Consensus 193 ~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~ 227 (292)
+..+.+++..|+..+|.+|+++.++++|+|+....
T Consensus 329 s~~~~dLl~~mL~~dP~~R~ta~e~L~Hp~~~~~~ 363 (464)
T 3ttj_A 329 ASQARDLLSKMLVIDPAKRISVDDALQHPYINVWY 363 (464)
T ss_dssp HHHHHHHHHHHSCSSTTTSCCHHHHHTSTTTGGGC
T ss_pred CHHHHHHHHHHcCCChhhCCCHHHHhcChhhhhcc
Confidence 34678999999999999999999999999998643
|
| >2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=84.31 E-value=1 Score=35.74 Aligned_cols=38 Identities=24% Similarity=0.389 Sum_probs=32.6
Q ss_pred CCCchHHHHHHHhhcccCCCCCCChhhhhhccCcCCCC
Q psy758 190 AATNIYLIDFLKRCLDKDPLRRWSCDQLLRHPYFNGYY 227 (292)
Q Consensus 190 ~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~ 227 (292)
...+..+.+++..|+..+|..|++..+++.++|+....
T Consensus 254 ~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~~~~~~~~ 291 (312)
T 2iwi_A 254 AHVSPDCCALIRRCLAPKPSSRPSLEEILLDPWMQTPA 291 (312)
T ss_dssp TTSCHHHHHHHHHHTCSSTTTSCCHHHHHHSTTTCC--
T ss_pred ccCCHHHHHHHHHHccCChhhCcCHHHHhcChhhcCch
Confidence 34577889999999999999999999999999998654
|
| >3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} SCOP: d.144.1.7 PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A* | Back alignment and structure |
|---|
Probab=84.06 E-value=0.78 Score=36.30 Aligned_cols=35 Identities=34% Similarity=0.578 Sum_probs=31.4
Q ss_pred CchHHHHHHHhhcccCCCCCCChhhhhhccCcCCC
Q psy758 192 TNIYLIDFLKRCLDKDPLRRWSCDQLLRHPYFNGY 226 (292)
Q Consensus 192 ~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~ 226 (292)
.+..+.+++..|+..+|.+|++..+++.|+|+...
T Consensus 242 ~~~~~~~li~~~l~~dp~~Rps~~ell~h~~~~~~ 276 (297)
T 3fxz_A 242 LSAIFRDFLNRCLEMDVEKRGSAKELLQHQFLKIA 276 (297)
T ss_dssp SCHHHHHHHHHHSCSSTTTSCCHHHHTTCGGGGGC
T ss_pred cCHHHHHHHHHHccCChhHCcCHHHHhhChhhccc
Confidence 35668899999999999999999999999999864
|
| >4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} PDB: 4bbm_A* | Back alignment and structure |
|---|
Probab=83.53 E-value=0.43 Score=38.43 Aligned_cols=36 Identities=36% Similarity=0.626 Sum_probs=32.4
Q ss_pred CCchHHHHHHHhhcccCCCCCCChhhhhhccCcCCC
Q psy758 191 ATNIYLIDFLKRCLDKDPLRRWSCDQLLRHPYFNGY 226 (292)
Q Consensus 191 ~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~ 226 (292)
..+..+.+++..|+..+|.+|+++.+++.|+||...
T Consensus 278 ~~~~~l~~li~~~L~~dP~~Rpt~~ell~hp~f~~~ 313 (331)
T 4aaa_A 278 KLSEVVIDLAKKCLHIDPDKRPFCAELLHHDFFQMD 313 (331)
T ss_dssp TSCHHHHHHHHHHTCSSGGGSCCGGGGGGSHHHHGG
T ss_pred chhHHHHHHHHHHhccCcccCCCHHHHhcCchhccC
Confidence 347789999999999999999999999999998754
|
| >3omv_A RAF proto-oncogene serine/threonine-protein kinas; serine/threonine-protein kinase, transferase; HET: SM5; 4.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=83.44 E-value=0.3 Score=39.18 Aligned_cols=30 Identities=17% Similarity=0.155 Sum_probs=26.0
Q ss_pred CCchHHHHHHHhhcccCCCCCCChhhhhhc
Q psy758 191 ATNIYLIDFLKRCLDKDPLRRWSCDQLLRH 220 (292)
Q Consensus 191 ~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~ 220 (292)
..+..+.+++..|+..+|.+||++.+++..
T Consensus 265 ~~~~~l~~li~~cl~~dP~~RPs~~ei~~~ 294 (307)
T 3omv_A 265 NCPKAMKRLVADCVKKVKEERPLFPQILSS 294 (307)
T ss_dssp TSCHHHHHHHHHHTCSSSTTSCCHHHHHHH
T ss_pred cchHHHHHHHHHHcCCCHhHCcCHHHHHHH
Confidence 456788999999999999999999988653
|
| >4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens} | Back alignment and structure |
|---|
Probab=83.20 E-value=0.34 Score=39.25 Aligned_cols=32 Identities=19% Similarity=0.417 Sum_probs=26.7
Q ss_pred CCCCchHHHHHHHhhcccCCCCCCChhhhhhc
Q psy758 189 PAATNIYLIDFLKRCLDKDPLRRWSCDQLLRH 220 (292)
Q Consensus 189 ~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~ 220 (292)
+...+..+.+++..|+..+|.+|+++.+++.+
T Consensus 282 p~~~~~~~~~li~~cl~~dP~~RPs~~ei~~~ 313 (329)
T 4aoj_A 282 PRACPPEVYAIMRGCWQREPQQRHSIKDVHAR 313 (329)
T ss_dssp CTTCCHHHHHHHHHHCCSSTTTSCCHHHHHHH
T ss_pred cccccHHHHHHHHHHcCcChhHCcCHHHHHHH
Confidence 34457788999999999999999999988653
|
| >3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus} | Back alignment and structure |
|---|
Probab=83.18 E-value=0.65 Score=37.16 Aligned_cols=33 Identities=12% Similarity=0.179 Sum_probs=29.7
Q ss_pred chHHHHHHHhhcccCCCCCCChhhhhhccCcCC
Q psy758 193 NIYLIDFLKRCLDKDPLRRWSCDQLLRHPYFNG 225 (292)
Q Consensus 193 ~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~ 225 (292)
.....+++..|+..+|.+|++..++++|+||.+
T Consensus 299 ~~~~~~li~~~l~~~p~~Rps~~~~l~~~~f~~ 331 (332)
T 3qd2_B 299 YPQEHMMVQDMLSPSPTERPEATDIIENAIFEN 331 (332)
T ss_dssp CHHHHHHHHHHHCSSGGGSCCHHHHHHSTTCCC
T ss_pred ChhHHHHHHHHccCCCCcCCCHHHHhhchhhhc
Confidence 455688999999999999999999999999875
|
| >3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A* | Back alignment and structure |
|---|
Probab=82.87 E-value=0.23 Score=39.97 Aligned_cols=68 Identities=15% Similarity=0.069 Sum_probs=36.6
Q ss_pred CchHHHHHHHhhcccCCCCCCChhhhhhccCcCCCCCCCCCccchHHHHhcccCcCCCCCCChhhhhhCCcccceeccCC
Q psy758 192 TNIYLIDFLKRCLDKDPLRRWSCDQLLRHPYFNGYYFEVPDEMQYEEITQRCLDKDPLRRWSCDQLLRHPYFNGYYFEVP 271 (292)
Q Consensus 192 ~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~~il~h~w~~~~~~~~~ 271 (292)
....+.+++..|+..+|..|++..+++.+. ..+...--..-...|.+......+|.+.+..++..
T Consensus 242 ~~~~~~~li~~~l~~dp~~Rps~~el~~~l---------------~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~ 306 (325)
T 3kex_A 242 CTIDVYMVMVKCWMIDENIRPTFKELANEF---------------TRMARDPPRYLVIKRESGPGIAPGPEPHGLTNKKL 306 (325)
T ss_dssp BCTTTTHHHHHHTCSCTTTSCCHHHHHHHH---------------HHHTTSHHHHBCCCSSSSCCCBCCCCCCC------
T ss_pred CcHHHHHHHHHHcCCChhhCcCHHHHHHHH---------------HHHHhcchhhhccccCCCCCCCCCCccccchhhcc
Confidence 355677899999999999999999987642 22222111111223334444556777777666654
Q ss_pred Chh
Q psy758 272 DEM 274 (292)
Q Consensus 272 ~~~ 274 (292)
.+.
T Consensus 307 ~~~ 309 (325)
T 3kex_A 307 EEV 309 (325)
T ss_dssp ---
T ss_pred ccc
Confidence 444
|
| >3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A | Back alignment and structure |
|---|
Probab=82.71 E-value=1.1 Score=37.59 Aligned_cols=35 Identities=29% Similarity=0.559 Sum_probs=31.8
Q ss_pred CchHHHHHHHhhcccCCCCCCChhhhhhccCcCCC
Q psy758 192 TNIYLIDFLKRCLDKDPLRRWSCDQLLRHPYFNGY 226 (292)
Q Consensus 192 ~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~ 226 (292)
.+..+.+++..|+..+|..|++..+++.|+|+...
T Consensus 372 ~~~~~~~li~~~L~~dP~~Rps~~e~l~hp~~~~~ 406 (419)
T 3i6u_A 372 VSEKALDLVKKLLVVDPKARFTTEEALRHPWLQDE 406 (419)
T ss_dssp SCHHHHHHHHHHSCSSTTTSCCHHHHHHSGGGCCH
T ss_pred cCHHHHHHHHHHccCChhHCcCHHHHhCCcccCCh
Confidence 46788999999999999999999999999999753
|
| >3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A* | Back alignment and structure |
|---|
Probab=82.66 E-value=0.85 Score=39.05 Aligned_cols=38 Identities=26% Similarity=0.390 Sum_probs=33.7
Q ss_pred CchHHHHHHHhhcccCCCCCCChhhhhhccCcCCCCCC
Q psy758 192 TNIYLIDFLKRCLDKDPLRRWSCDQLLRHPYFNGYYFE 229 (292)
Q Consensus 192 ~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~ 229 (292)
.+..+.+++..|+..+|..|+++.+++.|+|+......
T Consensus 249 ~s~~~~~li~~~L~~dp~~R~t~~~~l~hp~~~~~~~~ 286 (486)
T 3mwu_A 249 ISDDAKDLIRKMLTFHPSLRITATQCLEHPWIQKYSSE 286 (486)
T ss_dssp SCHHHHHHHHHHTCSSTTTSCCHHHHHHCHHHHHTCCC
T ss_pred CCHHHHHHHHHHcCCChhhCcCHHHHhcCHhhccCccc
Confidence 46788999999999999999999999999999876544
|
| >2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A* | Back alignment and structure |
|---|
Probab=82.64 E-value=0.85 Score=35.94 Aligned_cols=36 Identities=31% Similarity=0.531 Sum_probs=29.8
Q ss_pred CchHHHHHHHhhcccCCCCCCChhhhhhccCcCCCC
Q psy758 192 TNIYLIDFLKRCLDKDPLRRWSCDQLLRHPYFNGYY 227 (292)
Q Consensus 192 ~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~ 227 (292)
.+..+.+++..|+..+|..|++..+++.|+|+....
T Consensus 260 ~~~~~~~li~~~l~~dp~~Rps~~~ll~h~~~~~~~ 295 (303)
T 2vwi_A 260 YGKSFRKMISLCLQKDPEKRPTAAELLRHKFFQKAK 295 (303)
T ss_dssp CCHHHHHHHHHHCCSSGGGSCCHHHHHTSTTC----
T ss_pred hhHHHHHHHHHHccCChhhCcCHHHHhhChhhhcCC
Confidence 367788999999999999999999999999998653
|
| >4ase_A Vascular endothelial growth factor receptor 2; transferase, angiogenesis, signaling protein, phosphorylatio receptor, inhibitor; HET: AV9; 1.83A {Homo sapiens} PDB: 4agd_A* 4asd_A* 4agc_A* | Back alignment and structure |
|---|
Probab=82.52 E-value=0.28 Score=40.23 Aligned_cols=32 Identities=22% Similarity=0.403 Sum_probs=27.4
Q ss_pred CCCCchHHHHHHHhhcccCCCCCCChhhhhhc
Q psy758 189 PAATNIYLIDFLKRCLDKDPLRRWSCDQLLRH 220 (292)
Q Consensus 189 ~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~ 220 (292)
+...+..+.+++..|+..+|.+||++.+++.+
T Consensus 310 p~~~~~~~~~li~~c~~~dP~~RPt~~eil~~ 341 (353)
T 4ase_A 310 PDYTTPEMYQTMLDCWHGEPSQRPTFSELVEH 341 (353)
T ss_dssp CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred CccCCHHHHHHHHHHcCcChhHCcCHHHHHHH
Confidence 34457788999999999999999999999864
|
| >2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=82.30 E-value=0.36 Score=40.52 Aligned_cols=38 Identities=26% Similarity=0.463 Sum_probs=32.8
Q ss_pred CCchHHHHHHHhhcccCCCCCC---ChhhhhhccCcCCCCCC
Q psy758 191 ATNIYLIDFLKRCLDKDPLRRW---SCDQLLRHPYFNGYYFE 229 (292)
Q Consensus 191 ~~~~~~~~~~~~~~~~~p~~~~---~~~~~~~~~~~~~~~~~ 229 (292)
..+..+.+++..|+. +|..|+ +..+++.|+||.+..+.
T Consensus 297 ~~s~~~~dli~~lL~-~p~~Rlgr~~~~ei~~Hpff~~i~w~ 337 (412)
T 2vd5_A 297 GVPEEARDFIQRLLC-PPETRLGRGGAGDFRTHPFFFGLDWD 337 (412)
T ss_dssp CCCHHHHHHHHTTSS-CGGGCTTTTTHHHHHTSGGGTTCCST
T ss_pred CCCHHHHHHHHHHcC-ChhhcCCCCCHHHHhcCCCcCCCCHH
Confidence 457889999999998 888874 89999999999987665
|
| >3eps_A Isocitrate dehydrogenase kinase/phosphatase; ATP-binding, glyoxylate bypass, nucleotide-binding, protein phosphatase; HET: AMP ATP; 2.80A {Escherichia coli O157} PDB: 3lcb_A* 3lc6_A* | Back alignment and structure |
|---|
Probab=82.15 E-value=4.4 Score=34.78 Aligned_cols=65 Identities=12% Similarity=0.078 Sum_probs=55.6
Q ss_pred ccHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEEccCCcEEEeecCchhhhhc
Q psy758 86 TVLNELENHPHGLPWDLIKQITWQVLRGVSYCHRHACIHRDIKPENILLTANGVVKLCDFGFARLIRD 153 (292)
Q Consensus 86 ~~L~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~givH~dl~p~Nilv~~~~~~kl~dfg~~~~~~~ 153 (292)
..|.-+++. -+++++...+.+--.|++.|-..+|.-||+-..|+-|+..|.+..-|+.-...+.+
T Consensus 420 tPLNLYL~~---a~~~~~~~av~eYG~AIKqLAaANIFPGDML~KNFGVTRhgRVVFYDYDEI~ylTd 484 (578)
T 3eps_A 420 VPLNIWLEQ---VEGQQLRDAIEEYGNAIRQLAAANIFPGDMLFKNFGVTRHGRVVFYDYDEICYMTE 484 (578)
T ss_dssp EEHHHHHHH---CCTHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECTTCCEEECCGGGCEESTT
T ss_pred cchhHHHhh---CCHHHHHHHHHHHHHHHHHHHHhcCCCcccccccCCccccceEEEecccceeeecc
Confidence 456667764 57788899999999999999999999999999999999999999999876655544
|
| >3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} | Back alignment and structure |
|---|
Probab=82.09 E-value=0.2 Score=41.98 Aligned_cols=34 Identities=15% Similarity=0.051 Sum_probs=30.8
Q ss_pred CCchHHHHHHHhhcccCCCCCCChhhhhhccCcC
Q psy758 191 ATNIYLIDFLKRCLDKDPLRRWSCDQLLRHPYFN 224 (292)
Q Consensus 191 ~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~ 224 (292)
..+..+.+++..|+..+|.+|++..+++.++|+.
T Consensus 335 ~~~~~~~~li~~~l~~dP~~Rpt~~~~l~~~~~~ 368 (413)
T 3dzo_A 335 NIPQPVRALLEGFLRYPKEDRLLPLQAMETPEYE 368 (413)
T ss_dssp CCCHHHHHHHHHHTCSSGGGSCCHHHHTTSHHHH
T ss_pred cCCHHHHHHHHHHccCChhhCcCHHHHHhCHHHH
Confidence 3467889999999999999999999999999876
|
| >1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ... | Back alignment and structure |
|---|
Probab=82.01 E-value=0.83 Score=38.30 Aligned_cols=37 Identities=22% Similarity=0.212 Sum_probs=33.2
Q ss_pred CchHHHHHHHhhcccCCCCCCChhhhhhccCcCCCCC
Q psy758 192 TNIYLIDFLKRCLDKDPLRRWSCDQLLRHPYFNGYYF 228 (292)
Q Consensus 192 ~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~ 228 (292)
....+.+++..|+..+|..|++..+++.|+||.....
T Consensus 309 ~~~~~~~Li~~~L~~dP~~R~t~~e~l~hp~f~~~~~ 345 (420)
T 1j1b_A 309 TPPEAIALCSRLLEYTPTARLTPLEACAHSFFDELRD 345 (420)
T ss_dssp SCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGGGGGC
T ss_pred CCHHHHHHHHHhccCChhHCCCHHHHhCCHhhccccc
Confidence 4678999999999999999999999999999976543
|
| >2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A* | Back alignment and structure |
|---|
Probab=81.39 E-value=1 Score=37.35 Aligned_cols=35 Identities=43% Similarity=0.618 Sum_probs=31.7
Q ss_pred chHHHHHHHhhcccCCCCCCChhhhhhccCcCCCC
Q psy758 193 NIYLIDFLKRCLDKDPLRRWSCDQLLRHPYFNGYY 227 (292)
Q Consensus 193 ~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~ 227 (292)
...+.+++..|+..+|..|++..+++.|+|+....
T Consensus 294 ~~~~~~li~~~L~~dP~~Rps~~ell~hp~~~~~~ 328 (390)
T 2zmd_A 294 EKDLQDVLKCCLKRDPKQRISIPELLAHPYVQIQT 328 (390)
T ss_dssp CHHHHHHHHHHTCSSTTTSCCHHHHHTSHHHHSCC
T ss_pred hHHHHHHHHHHcccChhhCCCHHHHhhCcCccccC
Confidence 56789999999999999999999999999987654
|
| >4gt4_A Tyrosine-protein kinase transmembrane receptor RO; ATP binding, phosphorylation, transferase; 2.41A {Homo sapiens} PDB: 3zzw_A | Back alignment and structure |
|---|
Probab=80.91 E-value=0.32 Score=39.00 Aligned_cols=32 Identities=16% Similarity=0.356 Sum_probs=27.1
Q ss_pred CCCCchHHHHHHHhhcccCCCCCCChhhhhhc
Q psy758 189 PAATNIYLIDFLKRCLDKDPLRRWSCDQLLRH 220 (292)
Q Consensus 189 ~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~ 220 (292)
+......+.+++..|+..+|.+||++.+++..
T Consensus 269 p~~~~~~~~~li~~C~~~dP~~RPs~~ei~~~ 300 (308)
T 4gt4_A 269 PDDCPAWVYALMIECWNEFPSRRPRFKDIHSR 300 (308)
T ss_dssp CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred cccchHHHHHHHHHHcCCChhHCcCHHHHHHH
Confidence 44557788999999999999999999998764
|
| >3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II} | Back alignment and structure |
|---|
Probab=80.72 E-value=0.97 Score=37.27 Aligned_cols=35 Identities=29% Similarity=0.455 Sum_probs=31.9
Q ss_pred CchHHHHHHHhhcccCCCCCCChhhhhhccCcCCC
Q psy758 192 TNIYLIDFLKRCLDKDPLRRWSCDQLLRHPYFNGY 226 (292)
Q Consensus 192 ~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~ 226 (292)
.+..+.+++..|+..+|..|+++.+++.|+||...
T Consensus 294 ~~~~~~~li~~~L~~dP~~R~t~~e~l~hp~f~~~ 328 (383)
T 3eb0_A 294 TPSLAIDLLEQILRYEPDLRINPYEAMAHPFFDHL 328 (383)
T ss_dssp CCHHHHHHHHHHCCSSGGGSCCHHHHHTSGGGHHH
T ss_pred CCHHHHHHHHHHccCChhhCCCHHHHhcCHHHHHH
Confidence 47789999999999999999999999999998753
|
| >3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A | Back alignment and structure |
|---|
Probab=80.47 E-value=1.1 Score=36.56 Aligned_cols=35 Identities=20% Similarity=0.272 Sum_probs=31.7
Q ss_pred CchHHHHHHHhhcccCCCCCCChhhhhhccCcCCC
Q psy758 192 TNIYLIDFLKRCLDKDPLRRWSCDQLLRHPYFNGY 226 (292)
Q Consensus 192 ~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~ 226 (292)
.+..+.+++..|+..+|..|++..+++.|+|+...
T Consensus 247 ~s~~~~~li~~~L~~dP~~Rps~~ell~hp~f~~~ 281 (361)
T 3uc3_A 247 ISPECCHLISRIFVADPATRISIPEIKTHSWFLKN 281 (361)
T ss_dssp CCHHHHHHHHHHSCSCTTTSCCHHHHHTSHHHHTT
T ss_pred CCHHHHHHHHHHccCChhHCcCHHHHHhCcchhcC
Confidence 47788999999999999999999999999998543
|
| >3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A* | Back alignment and structure |
|---|
Probab=80.38 E-value=0.98 Score=35.90 Aligned_cols=35 Identities=43% Similarity=0.618 Sum_probs=31.1
Q ss_pred chHHHHHHHhhcccCCCCCCChhhhhhccCcCCCC
Q psy758 193 NIYLIDFLKRCLDKDPLRRWSCDQLLRHPYFNGYY 227 (292)
Q Consensus 193 ~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~ 227 (292)
...+.+++..|+..+|..|++..+++.++|+....
T Consensus 266 ~~~l~~li~~~l~~dp~~Rps~~ell~h~~~~~~~ 300 (313)
T 3cek_A 266 EKDLQDVLKCCLKRDPKQRISIPELLAHPYVQIQT 300 (313)
T ss_dssp CHHHHHHHHHHTCSSTTTSCCHHHHHTSHHHHCC-
T ss_pred hHHHHHHHHHHccCCcccCcCHHHHhcCccccCCC
Confidence 56788999999999999999999999999987653
|
| >3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3v01_A* 3v04_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* ... | Back alignment and structure |
|---|
Probab=80.04 E-value=0.82 Score=37.25 Aligned_cols=38 Identities=29% Similarity=0.498 Sum_probs=33.2
Q ss_pred CchHHHHHHHhhcccCCCCCCChhhhhhccCcCCCCCC
Q psy758 192 TNIYLIDFLKRCLDKDPLRRWSCDQLLRHPYFNGYYFE 229 (292)
Q Consensus 192 ~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~ 229 (292)
.+..+.+++..|+..+|.+|+++.+++.|+|+.....+
T Consensus 297 ~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~~~~~~~~ 334 (360)
T 3eqc_A 297 FSLEFQDFVNKCLIKNPAERADLKQLMVHAFIKRSDAE 334 (360)
T ss_dssp SCHHHHHHHHHHHCSSTTTSCCHHHHHTSHHHHHHHHS
T ss_pred ccHHHHHHHHHHhhcChhhCCCHHHHhhChHhhcchHh
Confidence 36778999999999999999999999999998865433
|
Homologous Structure Domains
Structure Domains Detected by RPS-BLAST
Original result of RPS-BLAST against SCOP70(version1.75) database
| ID | Alignment Graph | Length |
Definition |
E-value |
| 292 | ||||
| d1s9ja_ | 322 | d.144.1.7 (A:) Dual specificity mitogen-activated | 2e-60 | |
| d1u5ra_ | 309 | d.144.1.7 (A:) Serine/threonine protein kinase TAO | 9e-60 | |
| d2jfla1 | 288 | d.144.1.7 (A:21-308) STE20-like serine/threonine-p | 2e-59 | |
| d2j4za1 | 263 | d.144.1.7 (A:126-388) Aurora-related kinase 1 (aur | 1e-58 | |
| d1nvra_ | 271 | d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 { | 2e-57 | |
| d2java1 | 269 | d.144.1.7 (A:3-271) Serine/threonine-protein kinas | 4e-56 | |
| d1koaa2 | 350 | d.144.1.7 (A:5915-6264) Twitchin, kinase domain {C | 5e-56 | |
| d1yhwa1 | 293 | d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [ | 3e-55 | |
| d1koba_ | 352 | d.144.1.7 (A:) Twitchin, kinase domain {California | 1e-54 | |
| d1ua2a_ | 299 | d.144.1.7 (A:) Cell division protein kinase 7, CDK | 3e-54 | |
| d1tkia_ | 321 | d.144.1.7 (A:) Titin, kinase domain {Human (Homo s | 1e-52 | |
| d1uu3a_ | 288 | d.144.1.7 (A:) 3-phosphoinositide dependent protei | 2e-52 | |
| d1ob3a_ | 286 | d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmod | 2e-52 | |
| d1t4ha_ | 270 | d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sa | 7e-52 | |
| d1phka_ | 277 | d.144.1.7 (A:) gamma-subunit of glycogen phosphory | 8e-52 | |
| d3blha1 | 318 | d.144.1.7 (A:8-325) Cell division protein kinase 9 | 1e-51 | |
| d1unla_ | 292 | d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (H | 2e-51 | |
| d1gz8a_ | 298 | d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (H | 5e-50 | |
| d1jksa_ | 293 | d.144.1.7 (A:) Death-associated protein kinase, Da | 2e-49 | |
| d1a06a_ | 307 | d.144.1.7 (A:) Calmodulin-dependent protein kinase | 2e-49 | |
| d1fota_ | 316 | d.144.1.7 (A:) cAMP-dependent PK, catalytic subuni | 2e-49 | |
| d1omwa3 | 364 | d.144.1.7 (A:186-549) G-protein coupled receptor k | 3e-49 | |
| d1o6la_ | 337 | d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sap | 3e-49 | |
| d1q5ka_ | 350 | d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gs | 5e-49 | |
| d1pmea_ | 345 | d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapien | 1e-48 | |
| d1xjda_ | 320 | d.144.1.7 (A:) Protein kinase C, theta type {Human | 3e-47 | |
| d1uwha_ | 276 | d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) | 6e-47 | |
| d1cm8a_ | 346 | d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo s | 3e-46 | |
| d2ozaa1 | 335 | d.144.1.7 (A:51-385) MAP kinase activated protein | 8e-46 | |
| d1blxa_ | 305 | d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (H | 2e-45 | |
| d1xbba_ | 277 | d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human | 3e-45 | |
| d1xwsa_ | 273 | d.144.1.7 (A:) Proto-oncogene serine/threonine-pro | 4e-45 | |
| d1rdqe_ | 350 | d.144.1.7 (E:) cAMP-dependent PK, catalytic subuni | 9e-45 | |
| d1opja_ | 287 | d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mou | 1e-44 | |
| d1qpca_ | 272 | d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Hom | 2e-44 | |
| d1u59a_ | 285 | d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Hum | 5e-44 | |
| d1byga_ | 262 | d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) | 6e-44 | |
| d1jpaa_ | 299 | d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mou | 6e-44 | |
| d1rjba_ | 325 | d.144.1.7 (A:) Fl cytokine receptor {Human (Homo s | 6e-44 | |
| d1xkka_ | 317 | d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb- | 2e-43 | |
| d1sm2a_ | 263 | d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Hu | 3e-43 | |
| d2b1pa1 | 355 | d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3 | 4e-43 | |
| d2b1pa1 | 355 | d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3 | 7e-09 | |
| d3bqca1 | 328 | d.144.1.7 (A:3-330) Protein kinase CK2, alpha subu | 5e-43 | |
| d1k2pa_ | 258 | d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Hum | 1e-42 | |
| d2gfsa1 | 348 | d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sa | 3e-42 | |
| d1o6ya_ | 277 | d.144.1.7 (A:) Mycobacterial protein kinase PknB, | 5e-42 | |
| d1mp8a_ | 273 | d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Huma | 7e-42 | |
| d1t46a_ | 311 | d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens | 5e-41 | |
| d1u46a_ | 273 | d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Hum | 6e-41 | |
| d1fmka3 | 285 | d.144.1.7 (A:249-533) c-src tyrosine kinase {Human | 3e-40 | |
| d1fvra_ | 309 | d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [ | 1e-39 | |
| d1lufa_ | 301 | d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus n | 3e-39 | |
| d1vzoa_ | 322 | d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5 | 4e-39 | |
| d1mqba_ | 283 | d.144.1.7 (A:) epha2 receptor tyrosine kinase {Hum | 2e-38 | |
| d1vjya_ | 303 | d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human | 5e-38 | |
| d1ckia_ | 299 | d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus n | 9e-38 | |
| d1ywna1 | 299 | d.144.1.7 (A:818-1166) Vascular endothelial growth | 7e-37 | |
| d1p4oa_ | 308 | d.144.1.7 (A:) Insulin-like growth factor 1 recept | 8e-36 | |
| d1csna_ | 293 | d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast | 9e-36 | |
| d1r0pa_ | 311 | d.144.1.7 (A:) Hepatocyte growth factor receptor, | 2e-34 | |
| d1fgka_ | 299 | d.144.1.7 (A:) Fibroblast growth factor receptor 1 | 2e-33 | |
| d1q8ya_ | 362 | d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces | 2e-30 | |
| d1zara2 | 191 | d.144.1.9 (A:91-281) Rio2 serine protein kinase C- | 8e-21 |
| >d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 192 bits (490), Expect = 2e-60
Identities = 67/310 (21%), Positives = 118/310 (38%), Gaps = 36/310 (11%)
Query: 2 ERYEKIGKLGEGSYGVVFKCRNRDTGQVVAIKKFLESEEDPLIRKIALREIRLLKSLKHP 61
+ +EKI +LG G+ GVVFK ++ +G V+A K + E P IR +RE+++L P
Sbjct: 6 DDFEKISELGAGNGGVVFKVSHKPSGLVMARKL-IHLEIKPAIRNQIIRELQVLHECNSP 64
Query: 62 NLVNLLEVFRRKKKLHLVFEFCDHTVLNELENHPHGLPWDLIKQITWQVLRGVSYCH-RH 120
+V F ++ + E D L+++ +P ++ +++ V++G++Y +H
Sbjct: 65 YIVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGRIPEQILGKVSIAVIKGLTYLREKH 124
Query: 121 ACIHRDIKPENILLTANGVVKLCDFGFARLIRDLIPRHL---------HIFQTNEY---- 167
+HRD+KP NIL+ + G +KLCDFG + + D + Q Y
Sbjct: 125 KIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSMANSFVGTRSYMSPERLQGTHYSVQS 184
Query: 168 ------------------FKGVSLPHAENVVPLEIKIGKPAATNIYLIDFLKRCLDKDPL 209
E + +++
Sbjct: 185 DIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAETPPRPRTPGRPLSSYGMDS 244
Query: 210 RRWSCDQLLRHPYFNGYYFEVPDEMQYEE---ITQRCLDKDPLRRWSCDQLLRHPYFNGY 266
R L N ++P + E +CL K+P R QL+ H +
Sbjct: 245 RPPMAIFELLDYIVNEPPPKLPSGVFSLEFQDFVNKCLIKNPAERADLKQLMVHAFIKRS 304
Query: 267 YFEVPDEMQY 276
E D +
Sbjct: 305 DAEEVDFAGW 314
|
| >d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 309 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine protein kinase TAO2 species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 190 bits (484), Expect = 9e-60
Identities = 69/273 (25%), Positives = 116/273 (42%), Gaps = 28/273 (10%)
Query: 2 ERYEKIGKLGEGSYGVVFKCRNRDTGQVVAIKKF-LESEEDPLIRKIALREIRLLKSLKH 60
+ + + ++G GS+G V+ R+ +VVAIKK ++ + ++E+R L+ L+H
Sbjct: 15 KLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRH 74
Query: 61 PNLVNLLEVFRRKKKLHLVFEFCDHTVLNELENHPHGLPWDLIKQITWQVLRGVSYCHRH 120
PN + + R+ LV E+C + + LE H L I +T L+G++Y H H
Sbjct: 75 PNTIQYRGCYLREHTAWLVMEYCLGSASDLLEVHKKPLQEVEIAAVTHGALQGLAYLHSH 134
Query: 121 ACIHRDIKPENILLTANGVVKLCDFGFARLIRDLI----------PRHLHIFQTNEYFKG 170
IHRD+K NILL+ G+VKL DFG A ++ P + +Y
Sbjct: 135 NMIHRDVKAGNILLSEPGLVKLGDFGSASIMAPANSFVGTPYWMAPEVILAMDEGQYDGK 194
Query: 171 VSLPHAENVVPLEIKIGKPAATNIYLIDFLKRCLDKDPLRRWSCDQLLRHPYFNGYYFEV 230
V + + +E+ KP N+ + L + S
Sbjct: 195 VDVWSLG-ITCIELAERKPPLFNMNAMSALYHIAQNESPALQSGH--------------W 239
Query: 231 PDEMQYEEITQRCLDKDPLRRWSCDQLLRHPYF 263
+ + CL K P R + + LL+H +
Sbjct: 240 SEYFR--NFVDSCLQKIPQDRPTSEVLLKHRFV 270
|
| >d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]} Length = 288 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: STE20-like serine/threonine-protein kinase, SLK species: Human (Homo sapiens) [TaxId: 9606]
Score = 189 bits (481), Expect = 2e-59
Identities = 72/293 (24%), Positives = 125/293 (42%), Gaps = 33/293 (11%)
Query: 2 ERYEKIGKLGEGSYGVVFKCRNRDTGQVVAIKKFLESEEDPLIRKIALREIRLLKSLKHP 61
+ +E IG+LG+G++G V+K +N++T + A K E+ L + EI +L S HP
Sbjct: 12 DFWEIIGELGDGAFGKVYKAQNKETSVLAAAKVIDTKSEEELED--YMVEIDILASCDHP 69
Query: 62 NLVNLLEVFRRKKKLHLVFEFCDHTVLNELENHPHG-LPWDLIKQITWQVLRGVSYCHRH 120
N+V LL+ F + L ++ EFC ++ + L I+ + Q L ++Y H +
Sbjct: 70 NIVKLLDAFYYENNLWILIEFCAGGAVDAVMLELERPLTESQIQVVCKQTLDALNYLHDN 129
Query: 121 ACIHRDIKPENILLTANGVVKLCDFGFARLIRDLIPRHLHIFQTNEYFKGVSLPHAEN-- 178
IHRD+K NIL T +G +KL DFG + I R T + + +
Sbjct: 130 KIIHRDLKAGNILFTLDGDIKLADFGVSAKNTRTIQRRDSFIGTPYWMAPEVVMCETSKD 189
Query: 179 -------------VVPLEIKIGKPAATNIYLIDFLKRCLDKDPLRRWSCDQLLRHPYFNG 225
+ +E+ +P + + L + +P L P
Sbjct: 190 RPYDYKADVWSLGITLIEMAEIEPPHHELNPMRVLLKIAKSEPPT-------LAQPS--- 239
Query: 226 YYFEVPDEMQYEEITQRCLDKDPLRRWSCDQLLRHPYFNGYYFEVPDEMQYEE 278
+ + ++CL+K+ RW+ QLL+HP+ + E+ E
Sbjct: 240 ---RWSSNFK--DFLKKCLEKNVDARWTTSQLLQHPFVTVDSNKPIRELIAEA 287
|
| >d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 263 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Aurora-related kinase 1 (aurora-2) species: Human (Homo sapiens) [TaxId: 9606]
Score = 186 bits (473), Expect = 1e-58
Identities = 54/256 (21%), Positives = 99/256 (38%), Gaps = 31/256 (12%)
Query: 1 MERYEKIGKLGEGSYGVVFKCRNRDTGQVVAIKKFLESE-EDPLIRKIALREIRLLKSLK 59
+E +E LG+G +G V+ R + + ++A+K +++ E + RE+ + L+
Sbjct: 5 LEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLR 64
Query: 60 HPNLVNLLEVFRRKKKLHLVFEFCDHTVLNELENHPHGLPWDLIKQITWQVLRGVSYCHR 119
HPN++ L F +++L+ E+ + ++ +SYCH
Sbjct: 65 HPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCHS 124
Query: 120 HACIHRDIKPENILLTANGVVKLCDFGFARLIRDLIPRHLH---------IFQTNEY--- 167
IHRDIKPEN+LL + G +K+ DFG++ L + + +
Sbjct: 125 KRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRRTTLCGTLDYLPPEMIEGRMHDEK 184
Query: 168 -------------FKGVSLPHAENVVPLEIKIGK-----PAATNIYLIDFLKRCLDKDPL 209
G A +I + P D + R L +P
Sbjct: 185 VDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFTFPDFVTEGARDLISRLLKHNPS 244
Query: 210 RRWSCDQLLRHPYFNG 225
+R ++L HP+
Sbjct: 245 QRPMLREVLEHPWITA 260
|
| >d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 271 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell cycle checkpoint kinase chk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 183 bits (465), Expect = 2e-57
Identities = 59/275 (21%), Positives = 104/275 (37%), Gaps = 27/275 (9%)
Query: 2 ERYEKIGKLGEGSYGVVFKCRNRDTGQVVAIKKFLESEEDPLIRKIALREIRLLKSLKHP 61
E ++ + LGEG+YG V NR T + VA+K ++ + + +EI + K L H
Sbjct: 5 EDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKI-VDMKRAVDCPENIKKEICINKMLNHE 63
Query: 62 NLVNLLEVFRRKKKLHLVFEFCDHTVLNELENHPHGLPWDLIKQITWQVLRGVSYCHRHA 121
N+V R +L E+C L + G+P ++ Q++ GV Y H
Sbjct: 64 NVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHGIG 123
Query: 122 CIHRDIKPENILLTANGVVKLCDFGFARLIRDLIPRHL--HIFQTNEYFKGVSLPHAENV 179
HRDIKPEN+LL +K+ DFG A + R L + T Y
Sbjct: 124 ITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPY------------ 171
Query: 180 VPLEIKIGKPAATN----------IYLIDFLKRCLDKDPLRRWSCDQLLRHPYFNGYYFE 229
V E+ + + + + D+ + + +
Sbjct: 172 VAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKKTYLNPWKK 231
Query: 230 VPDEMQYEEITQRCLDKDPLRRWSCDQLLRHPYFN 264
+ + + L ++P R + + + ++N
Sbjct: 232 IDSAPL--ALLHKILVENPSARITIPDIKKDRWYN 264
|
| >d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]} Length = 269 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine-protein kinase Nek2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 180 bits (457), Expect = 4e-56
Identities = 64/282 (22%), Positives = 111/282 (39%), Gaps = 38/282 (13%)
Query: 2 ERYEKIGKLGEGSYGVVFKCRNRDTGQVVAIKKFLESEEDPLIRKIALREIRLLKSLKHP 61
E YE + +G GSYG K R + G+++ K+ +++ + E+ LL+ LKHP
Sbjct: 4 EDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHP 63
Query: 62 NLVNLLEVF--RRKKKLHLVFEFCD----HTVLNELENHPHGLPWDLIKQITWQVLRGVS 115
N+V + R L++V E+C+ +V+ + L + + ++ Q+ +
Sbjct: 64 NIVRYYDRIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALK 123
Query: 116 YCHRHAC-----IHRDIKPENILLTANGVVKLCDFGFARLIRDLIPRHLHIFQT-----N 165
CHR + +HRD+KP N+ L VKL DFG AR++ T
Sbjct: 124 ECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARILNHDTSFAKAFVGTPYYMSP 183
Query: 166 EYFKGVSLPHAEN-----VVPLEIKIGKPAATNIYLIDFLKRCLDKDPLRRWSCDQLLRH 220
E +S + + E+ P T + + + R
Sbjct: 184 EQMNRMSYNEKSDIWSLGCLLYELCALMPPFTAFSQKELAGKIREGKFRRIPY------- 236
Query: 221 PYFNGYYFEVPDEMQYEEITQRCLDKDPLRRWSCDQLLRHPY 262
DE+ EI R L+ R S +++L +P
Sbjct: 237 --------RYSDELN--EIITRMLNLKDYHRPSVEEILENPL 268
|
| >d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: Caenorhabditis elegans, pjk4 [TaxId: 6239]
Score = 182 bits (462), Expect = 5e-56
Identities = 60/288 (20%), Positives = 116/288 (40%), Gaps = 34/288 (11%)
Query: 1 MERYEKIGKLGEGSYGVVFKCRNRDTGQVVAIKKFLESEEDPLIRKIALREIRLLKSLKH 60
++ Y+ +LG G++GVV + R TG A K + E ++ +EI+ + L+H
Sbjct: 25 LDHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHESD--KETVRKEIQTMSVLRH 82
Query: 61 PNLVNLLEVFRRKKKLHLVFEFCDHTVLNE-LENHPHGLPWDLIKQITWQVLRGVSYCHR 119
P LVNL + F ++ +++EF L E + + + + D + QV +G+ + H
Sbjct: 83 PTLVNLHDAFEDDNEMVMIYEFMSGGELFEKVADEHNKMSEDEAVEYMRQVCKGLCHMHE 142
Query: 120 HACIHRDIKPENILLTA--NGVVKLCDFGFARLIRDLIPRHLHIFQTN----EYFKGVSL 173
+ +H D+KPENI+ T + +KL DFG + + E +G +
Sbjct: 143 NNYVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPKQSVKVTTGTAEFAAPEVAEGKPV 202
Query: 174 PHAENVVPL-----EIKIGKP---AATNIYLIDFLKRCLDKDPLRRWSCDQLLRHPYFNG 225
+ ++ + + G + + +K C +S
Sbjct: 203 GYYTDMWSVGVLSYILLSGLSPFGGENDDETLRNVKSCDWNMDDSAFS------------ 250
Query: 226 YYFEVPDEMQYEEITQRCLDKDPLRRWSCDQLLRHPYFNGYYFEVPDE 273
+ ++ + + ++ L DP R + Q L HP+ D
Sbjct: 251 ---GISEDGK--DFIRKLLLADPNTRMTIHQALEHPWLTPGNAPGRDS 293
|
| >d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: pak1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 178 bits (453), Expect = 3e-55
Identities = 65/257 (25%), Positives = 112/257 (43%), Gaps = 38/257 (14%)
Query: 2 ERYEKIGKLGEGSYGVVFKCRNRDTGQVVAIKKFLESEEDPLIRKIALREIRLLKSLKHP 61
++Y + K+G+G+ G V+ + TGQ VAI++ + + +++ + EI +++ K+P
Sbjct: 20 KKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQM--NLQQQPKKELIINEILVMRENKNP 77
Query: 62 NLVNLLEVFRRKKKLHLVFEFCDHTVLNELENHPHGLPWDLIKQITWQVLRGVSYCHRHA 121
N+VN L+ + +L +V E+ L ++ + I + + L+ + + H +
Sbjct: 78 NIVNYLDSYLVGDELWVVMEYLAGGSLTDVVTE-TCMDEGQIAAVCRECLQALEFLHSNQ 136
Query: 122 CIHRDIKPENILLTANGVVKLCDFGFARLIRDLIPRHLHIFQTNEY-------------- 167
IHRDIK +NILL +G VKL DFGF I + + T +
Sbjct: 137 VIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSTMVGTPYWMAPEVVTRKAYGPK 196
Query: 168 -------------FKGVSLPHAENVVPLEIKIGK--------PAATNIYLIDFLKRCLDK 206
+G EN + I P + DFL RCLD
Sbjct: 197 VDIWSLGIMAIEMIEGEPPYLNENPLRALYLIATNGTPELQNPEKLSAIFRDFLNRCLDM 256
Query: 207 DPLRRWSCDQLLRHPYF 223
D +R S +LL+H +
Sbjct: 257 DVEKRGSAKELLQHQFL 273
|
| >d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]} Length = 352 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]
Score = 178 bits (453), Expect = 1e-54
Identities = 64/306 (20%), Positives = 119/306 (38%), Gaps = 31/306 (10%)
Query: 2 ERYEKIGKLGEGSYGVVFKCRNRDTGQVVAIKKFLESEEDPLIRKIALREIRLLKSLKHP 61
+ Y+ + +LG G++GVV +C + TG+V K + PL + EI ++ L HP
Sbjct: 29 DYYDILEELGSGAFGVVHRCVEKATGRVFVAKFI--NTPYPLDKYTVKNEISIMNQLHHP 86
Query: 62 NLVNLLEVFRRKKKLHLVFEFCDH-TVLNELENHPHGLPWDLIKQITWQVLRGVSYCHRH 120
L+NL + F K ++ L+ EF + + + + + + Q G+ + H H
Sbjct: 87 KLINLHDAFEDKYEMVLILEFLSGGELFDRIAAEDYKMSEAEVINYMRQACEGLKHMHEH 146
Query: 121 ACIHRDIKPENILLTA--NGVVKLCDFGFARLIRDLIPRHLHI----FQTNEYFKGVSLP 174
+ +H DIKPENI+ VK+ DFG A + + F E +
Sbjct: 147 SIVHLDIKPENIMCETKKASSVKIIDFGLATKLNPDEIVKVTTATAEFAAPEIVDREPVG 206
Query: 175 HAENVVPL-----EIKIGKPAATNIYLIDFLKRCLDKDPLRRWSCDQLLRHPYFNGYYFE 229
++ + + G ++ L+ D + +
Sbjct: 207 FYTDMWAIGVLGYVLLSGLSPFAGEDDLETLQNVKRCDW------------EFDEDAFSS 254
Query: 230 VPDEMQYEEITQRCLDKDPLRRWSCDQLLRHPYFNGYYFEVPDEM---QYEEITQVSRLP 286
V E + + + L K+P +R + L HP+ G + + + +Y +I Q +
Sbjct: 255 VSPEAK--DFIKNLLQKEPRKRLTVHDALEHPWLKGDHSNLTSRIPSSRYNKIRQKIKEK 312
Query: 287 TKDKNK 292
D
Sbjct: 313 YADWPA 318
|
| >d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 7, CDK7 species: Human (Homo sapiens) [TaxId: 9606]
Score = 176 bits (446), Expect = 3e-54
Identities = 82/294 (27%), Positives = 128/294 (43%), Gaps = 24/294 (8%)
Query: 5 EKIGKLGEGSYGVVFKCRNRDTGQVVAIKKF---LESEEDPLIRKIALREIRLLKSLKHP 61
EK+ LGEG + V+K R+++T Q+VAIKK SE I + ALREI+LL+ L HP
Sbjct: 1 EKLDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHP 60
Query: 62 NLVNLLEVFRRKKKLHLVFEFCDHTVLNELENHPHGLPWDLIKQITWQVLRGVSYCHRHA 121
N++ LL+ F K + LVF+F + + ++++ L IK L+G+ Y H+H
Sbjct: 61 NIIGLLDAFGHKSNISLVFDFMETDLEVIIKDNSLVLTPSHIKAYMLMTLQGLEYLHQHW 120
Query: 122 CIHRDIKPENILLTANGVVKLCDFGFARLIRDLIPRHLHIFQTNEYFKGVSLPHAEN--- 178
+HRD+KP N+LL NGV+KL DFG A+ + H T Y L A
Sbjct: 121 ILHRDLKPNNLLLDENGVLKLADFGLAKSFGSPNRAYTHQVVTRWYRAPELLFGARMYGV 180
Query: 179 --------VVPLEIKIGKP---AATNIYLIDFLKRCLDKDPLRRWSCDQLLRHPYFNGYY 227
+ E+ + P +++ + + L +W L +
Sbjct: 181 GVDMWAVGCILAELLLRVPFLPGDSDLDQLTRIFETLGTPTEEQWPDMCSLPDYVTFKSF 240
Query: 228 FEVPDEMQYEEIT-------QRCLDKDPLRRWSCDQLLRHPYFNGYYFEVPDEM 274
+P + Q +P R + Q L+ YF+ P
Sbjct: 241 PGIPLHHIFSAAGDDLLDLIQGLFLFNPCARITATQALKMKYFSNRPGPTPGCQ 294
|
| >d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]} Length = 321 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Titin, kinase domain species: Human (Homo sapiens) [TaxId: 9606]
Score = 172 bits (438), Expect = 1e-52
Identities = 58/260 (22%), Positives = 99/260 (38%), Gaps = 41/260 (15%)
Query: 2 ERYEKIGKLGEGSYGVVFKCRNRDTGQVVAIKKFLESEEDPLIRKIALREIRLLKSLKHP 61
E+Y LG G +G+V +C + + K D + + +EI +L +H
Sbjct: 5 EKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVKGTD---QVLVKKEISILNIARHR 61
Query: 62 NLVNLLEVFRRKKKLHLVFEFCDHTVLNE-LENHPHGLPWDLIKQITWQVLRGVSYCHRH 120
N+++L E F ++L ++FEF + E + L I QV + + H H
Sbjct: 62 NILHLHESFESMEELVMIFEFISGLDIFERINTSAFELNEREIVSYVHQVCEALQFLHSH 121
Query: 121 ACIHRDIKPENILLTA--NGVVKLCDFGFARLIRDLIPRHLHIFQTNEY----------- 167
H DI+PENI+ + +K+ +FG AR ++ L Y
Sbjct: 122 NIGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPGDNFRLLFTAPEYYAPEVHQHDVVS 181
Query: 168 ---------------------FKGVSLPHA-ENVVPLEIKIGKPAATNI--YLIDFLKRC 203
F + EN++ E + A I +DF+ R
Sbjct: 182 TATDMWSLGTLVYVLLSGINPFLAETNQQIIENIMNAEYTFDEEAFKEISIEAMDFVDRL 241
Query: 204 LDKDPLRRWSCDQLLRHPYF 223
L K+ R + + L+HP+
Sbjct: 242 LVKERKSRMTASEALQHPWL 261
|
| >d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 288 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: 3-phosphoinositide dependent protein kinase-1 Pdk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 171 bits (434), Expect = 2e-52
Identities = 58/269 (21%), Positives = 95/269 (35%), Gaps = 41/269 (15%)
Query: 2 ERYEKIGKLGEGSYGVVFKCRNRDTGQVVAIKKF-LESEEDPLIRKIALREIRLLKSLKH 60
E ++ LGEGS+ V R T + AIK RE ++ L H
Sbjct: 8 EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDH 67
Query: 61 PNLVNLLEVFRRKKKLHLVFEFCDHTVLNELENHPHGLPWDLIKQITWQVLRGVSYCHRH 120
P V L F+ +KL+ + + L + + T +++ + Y H
Sbjct: 68 PFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEIVSALEYLHGK 127
Query: 121 ACIHRDIKPENILLTANGVVKLCDFGFARLIRDLIPRHLH-------------IFQTNEY 167
IHRD+KPENILL + +++ DFG A+++ + +
Sbjct: 128 GIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANSFVGTAQYVSPELLTEKSA 187
Query: 168 ----------------FKGVSLPHAENVVPLEIKIGK-----PAATNIYLIDFLKRCLDK 206
G+ A N + KI K P D +++ L
Sbjct: 188 CKSSDLWALGCIIYQLVAGLPPFRAGNEYLIFQKIIKLEYDFPEKFFPKARDLVEKLLVL 247
Query: 207 DPLRRWSCDQ------LLRHPYFNGYYFE 229
D +R C++ L HP+F +E
Sbjct: 248 DATKRLGCEEMEGYGPLKAHPFFESVTWE 276
|
| >d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]} Length = 286 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: (Plasmodium falciparum) [TaxId: 5833]
Score = 170 bits (432), Expect = 2e-52
Identities = 86/285 (30%), Positives = 130/285 (45%), Gaps = 23/285 (8%)
Query: 1 MERYEKIGKLGEGSYGVVFKCRNRDTGQVVAIKKFLESEEDPLIRKIALREIRLLKSLKH 60
ME+Y + K+GEG+YGVV+K +N G+ A+KK +ED I +REI +LK LKH
Sbjct: 1 MEKYHGLEKIGEGTYGVVYKAQNN-YGETFALKKIRLEKEDEGIPSTTIREISILKELKH 59
Query: 61 PNLVNLLEVFRRKKKLHLVFEFCDHTVLNELENHPHGLPWDLIKQITWQVLRGVSYCHRH 120
N+V L +V KK+L LVFE D + L+ GL K Q+L G++YCH
Sbjct: 60 SNIVKLYDVIHTKKRLVLVFEHLDQDLKKLLDVCEGGLESVTAKSFLLQLLNGIAYCHDR 119
Query: 121 ACIHRDIKPENILLTANGVVKLCDFGFARLIRDLIPRHLHIFQTNEYFKGVSLPHAEN-- 178
+HRD+KP+N+L+ G +K+ DFG AR + ++ H T Y L ++
Sbjct: 120 RVLHRDLKPQNLLINREGELKIADFGLARAFGIPVRKYTHEIVTLWYRAPDVLMGSKKYS 179
Query: 179 ---------VVPLEIKIGKP---AATNIYLIDFLKRCLDKDPLRRWSCDQLLRHPYFNGY 226
+ E+ G P + + + R L + W L N
Sbjct: 180 TTIDIWSVGCIFAEMVNGTPLFPGVSEADQLMRIFRILGTPNSKNWPNVTELPKYDPNFT 239
Query: 227 YFEVPDEMQYE--------EITQRCLDKDPLRRWSCDQLLRHPYF 263
+E + ++ + L DP +R + Q L H YF
Sbjct: 240 VYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQALEHAYF 284
|
| >d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 270 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase wnk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 169 bits (429), Expect = 7e-52
Identities = 61/275 (22%), Positives = 112/275 (40%), Gaps = 28/275 (10%)
Query: 3 RYEKIG-KLGEGSYGVVFKCRNRDTGQVVAIKKFLESEEDPLIRKIALREIRLLKSLKHP 61
R+ K ++G GS+ V+K + +T VA + + + R+ E +LK L+HP
Sbjct: 9 RFLKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHP 68
Query: 62 NLVNLLEVF----RRKKKLHLVFEFCDHTVLNELENHPHGLPWDLIKQITWQVLRGVSYC 117
N+V + + + KK + LV E L + +++ Q+L+G+ +
Sbjct: 69 NIVRFYDSWESTVKGKKCIVLVTELMTSGTLKTYLKRFKVMKIKVLRSWCRQILKGLQFL 128
Query: 118 HRH--ACIHRDIKPENILLTA-NGVVKLCDFGFARLIRDLIPRHLH---IFQTNEYFKGV 171
H IHRD+K +NI +T G VK+ D G A L R + + F E ++
Sbjct: 129 HTRTPPIIHRDLKCDNIFITGPTGSVKIGDLGLATLKRASFAKAVIGTPEFMAPEMYEE- 187
Query: 172 SLPHAENVVPLEIKIGKPAATNIYLIDFLKRCLDKDPLRRWSCDQLLRHPYFNGYYFEVP 231
K + + + L+ + P + +G
Sbjct: 188 -------------KYDESVDVYAFGMCMLEMATSEYPYSECQNAAQIYRRVTSGVKPASF 234
Query: 232 DEM---QYEEITQRCLDKDPLRRWSCDQLLRHPYF 263
D++ + +EI + C+ ++ R+S LL H +F
Sbjct: 235 DKVAIPEVKEIIEGCIRQNKDERYSIKDLLNHAFF 269
|
| >d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: gamma-subunit of glycogen phosphorylase kinase (Phk) species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]
Score = 169 bits (429), Expect = 8e-52
Identities = 64/279 (22%), Positives = 111/279 (39%), Gaps = 19/279 (6%)
Query: 2 ERYEKIGKLGEGSYGVVFKCRNRDTGQVVAIKKF-------LESEEDPLIRKIALREIRL 54
E YE LG G VV +C ++ T + A+K +EE +R+ L+E+ +
Sbjct: 3 ENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDI 62
Query: 55 LKSLK-HPNLVNLLEVFRRKKKLHLVFEFCDHTVLNELENHPHGLPWDLIKQITWQVLRG 113
L+ + HPN++ L + + LVF+ L + L ++I +L
Sbjct: 63 LRKVSGHPNIIQLKDTYETNTFFFLVFDLMKKGELFDYLTEKVTLSEKETRKIMRALLEV 122
Query: 114 VSYCHRHACIHRDIKPENILLTANGVVKLCDFGFARLIRDLIPRHLHIFQTNEYFKGVSL 173
+ H+ +HRD+KPENILL + +KL DFGF+ + +
Sbjct: 123 ICALHKLNIVHRDLKPENILLDDDMNIKLTDFGFSCQLDP-----GEKLREVCGTPSYLA 177
Query: 174 PHAENVVPLEIKIGKPAATNIY--LIDFLKRCLDKDPLRRWSCDQLLRHPYFNGYYFEVP 231
P + G +++ + P +LR Y F P
Sbjct: 178 PEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQMLMLRMIMSGNYQFGSP 237
Query: 232 DEMQY----EEITQRCLDKDPLRRWSCDQLLRHPYFNGY 266
+ Y +++ R L P +R++ ++ L HP+F Y
Sbjct: 238 EWDDYSDTVKDLVSRFLVVQPQKRYTAEEALAHPFFQQY 276
|
| >d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]} Length = 318 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 9, CDK9 species: Human (Homo sapiens) [TaxId: 9606]
Score = 170 bits (430), Expect = 1e-51
Identities = 84/300 (28%), Positives = 132/300 (44%), Gaps = 37/300 (12%)
Query: 1 MERYEKIGKLGEGSYGVVFKCRNRDTGQVVAIKKFLESEEDPLIRKIALREIRLLKSLKH 60
+ +YEK+ K+G+G++G VFK R+R TGQ VA+KK L E ALREI++L+ LKH
Sbjct: 9 VSKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKH 68
Query: 61 PNLVNLLEVF--------RRKKKLHLVFEFCDHTVLNELENHPHGLPWDLIKQITWQVLR 112
N+VNL+E+ R K ++LVF+FC+H + L N IK++ +L
Sbjct: 69 ENVVNLIEICRTKASPYNRCKGSIYLVFDFCEHDLAGLLSNVLVKFTLSEIKRVMQMLLN 128
Query: 113 GVSYCHRHACIHRDIKPENILLTANGVVKLCDFGFARLIRDLIP---------------R 157
G+ Y HR+ +HRD+K N+L+T +GV+KL DFG AR R
Sbjct: 129 GLYYIHRNKILHRDMKAANVLITRDGVLKLADFGLARAFSLAKNSQPNRYTNRVVTLWYR 188
Query: 158 HLHIFQTNEYFKGVSLPHAENVVPLEIKIGKP---AATNIYLIDFLKRCLDKDPLRRW-- 212
+ + + E+ P T + + + + W
Sbjct: 189 PPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQLALISQLCGSITPEVWPN 248
Query: 213 --SCDQLLRHPYFNGYYFEVPDEMQYEEIT-------QRCLDKDPLRRWSCDQLLRHPYF 263
+ + + G +V D ++ + L DP +R D L H +F
Sbjct: 249 VDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRIDSDDALNHDFF 308
|
| >d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]} Length = 292 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK5 species: Human (Homo sapiens) [TaxId: 9606]
Score = 168 bits (427), Expect = 2e-51
Identities = 88/290 (30%), Positives = 141/290 (48%), Gaps = 23/290 (7%)
Query: 1 MERYEKIGKLGEGSYGVVFKCRNRDTGQVVAIKKFLESEEDPLIRKIALREIRLLKSLKH 60
M++YEK+ K+GEG+YG VFK +NR+T ++VA+K+ ++D + ALREI LLK LKH
Sbjct: 1 MQKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKH 60
Query: 61 PNLVNLLEVFRRKKKLHLVFEFCDHTVLNELENHPHGLPWDLIKQITWQVLRGVSYCHRH 120
N+V L +V KKL LVFEFCD + ++ L +++K +Q+L+G+ +CH
Sbjct: 61 KNIVRLHDVLHSDKKLTLVFEFCDQDLKKYFDSCNGDLDPEIVKSFLFQLLKGLGFCHSR 120
Query: 121 ACIHRDIKPENILLTANGVVKLCDFGFARLIRDLIPRHLHIFQTNEYFKGVSLPHAEN-- 178
+HRD+KP+N+L+ NG +KL +FG AR + + T Y L A+
Sbjct: 121 NVLHRDLKPQNLLINRNGELKLANFGLARAFGIPVRCYSAEVVTLWYRPPDVLFGAKLYS 180
Query: 179 ---------VVPLEIKIGK----PAATNIYLIDFLKRCLDKDPLRRWSCDQLLRHPYFNG 225
+ E+ P + + R L +W L
Sbjct: 181 TSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEEQWPSMTKLPDYKPYP 240
Query: 226 YYFEVPDEMQYE--------EITQRCLDKDPLRRWSCDQLLRHPYFNGYY 267
Y + ++ Q L +P++R S ++ L+HPYF+ +
Sbjct: 241 MYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEALQHPYFSDFC 290
|
| >d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]} Length = 298 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 165 bits (418), Expect = 5e-50
Identities = 90/294 (30%), Positives = 141/294 (47%), Gaps = 23/294 (7%)
Query: 1 MERYEKIGKLGEGSYGVVFKCRNRDTGQVVAIKKFLESEEDPLIRKIALREIRLLKSLKH 60
ME ++K+ K+GEG+YGVV+K RN+ TG+VVA+KK E + A+REI LLK L H
Sbjct: 1 MENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNH 60
Query: 61 PNLVNLLEVFRRKKKLHLVFEFCDHTVLNELE-NHPHGLPWDLIKQITWQVLRGVSYCHR 119
PN+V LL+V + KL+LVFEF + ++ + G+P LIK +Q+L+G+++CH
Sbjct: 61 PNIVKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHS 120
Query: 120 HACIHRDIKPENILLTANGVVKLCDFGFARLIRDLIPRHLH-----------IFQTNEYF 168
H +HRD+KP+N+L+ G +KL DFG AR + + H I +Y+
Sbjct: 121 HRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVVTLWYRAPEILLGCKYY 180
Query: 169 KGVSLPHAENVVPLEIKIGKP---AATNIYLIDFLKRCLDKDPLRRWSCDQLLRHPYFNG 225
+ + E+ + + I + + R L W + +
Sbjct: 181 STAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKPSF 240
Query: 226 YYFEVPDEMQY--------EEITQRCLDKDPLRRWSCDQLLRHPYFNGYYFEVP 271
+ D + + + L DP +R S L HP+F VP
Sbjct: 241 PKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQDVTKPVP 294
|
| >d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Death-associated protein kinase, Dap species: Human (Homo sapiens) [TaxId: 9606]
Score = 163 bits (414), Expect = 2e-49
Identities = 70/269 (26%), Positives = 107/269 (39%), Gaps = 45/269 (16%)
Query: 2 ERYEKIGKLGEGSYGVVFKCRNRDTGQVVAIKKF----LESEEDPLIRKIALREIRLLKS 57
+ Y+ +LG G + VV KCR + TG A K +S + R+ RE+ +LK
Sbjct: 10 DYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKE 69
Query: 58 LKHPNLVNLLEVFRRKKKLHLVFEFCDHTVLNELENHPHGLPWDLIKQITWQVLRGVSYC 117
++HPN++ L EV+ K + L+ E L + L + + Q+L GV Y
Sbjct: 70 IQHPNVITLHEVYENKTDVILILELVAGGELFDFLAEKESLTEEEATEFLKQILNGVYYL 129
Query: 118 HRHACIHRDIKPENILLTANGV----VKLCDFGFARLIRDLIPRHLHIFQTNEY------ 167
H H D+KPENI+L V +K+ DFG A I D +IF T E+
Sbjct: 130 HSLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKI-DFGNEFKNIFGTPEFVAPEIV 188
Query: 168 ---------------------FKGVSLPHAENVVPLEIKIGK---------PAATNIYLI 197
G S + + + T+
Sbjct: 189 NYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANVSAVNYEFEDEYFSNTSALAK 248
Query: 198 DFLKRCLDKDPLRRWSCDQLLRHPYFNGY 226
DF++R L KDP +R + L+HP+
Sbjct: 249 DFIRRLLVKDPKKRMTIQDSLQHPWIKPK 277
|
| >d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 307 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Calmodulin-dependent protein kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 164 bits (415), Expect = 2e-49
Identities = 58/262 (22%), Positives = 105/262 (40%), Gaps = 39/262 (14%)
Query: 2 ERYEKIGKLGEGSYGVVFKCRNRDTGQVVAIKKFLESEEDPLIRKIALREIRLLKSLKHP 61
+ Y+ LG G++ V ++ T ++VAIK + + EI +L +KHP
Sbjct: 9 DIYDFRDVLGTGAFSEVILAEDKRTQKLVAIKC-IAKKALEGKEGSMENEIAVLHKIKHP 67
Query: 62 NLVNLLEVFRRKKKLHLVFEFCDHTVLNELENHPHGLPWDLIKQITWQVLRGVSYCHRHA 121
N+V L +++ L+L+ + L + ++ +QVL V Y H
Sbjct: 68 NIVALDDIYESGGHLYLIMQLVSGGELFDRIVEKGFYTERDASRLIFQVLDAVKYLHDLG 127
Query: 122 CIHRDIKPENILLT---ANGVVKLCDFGFARLIRDLIPRHL----------HIFQTNEYF 168
+HRD+KPEN+L + + + DFG +++ + Y
Sbjct: 128 IVHRDLKPENLLYYSLDEDSKIMISDFGLSKMEDPGSVLSTACGTPGYVAPEVLAQKPYS 187
Query: 169 KGV-----------------------SLPHAENVVPLEIKIGKPAATNI--YLIDFLKRC 203
K V E ++ E + P +I DF++
Sbjct: 188 KAVDCWSIGVIAYILLCGYPPFYDENDAKLFEQILKAEYEFDSPYWDDISDSAKDFIRHL 247
Query: 204 LDKDPLRRWSCDQLLRHPYFNG 225
++KDP +R++C+Q L+HP+ G
Sbjct: 248 MEKDPEKRFTCEQALQHPWIAG 269
|
| >d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 316 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Score = 164 bits (415), Expect = 2e-49
Identities = 60/264 (22%), Positives = 106/264 (40%), Gaps = 35/264 (13%)
Query: 1 MERYEKIGKLGEGSYGVVFKCRNRDTGQVVAIKKF-LESEEDPLIRKIALREIRLLKSLK 59
++ ++ + LG GS+G V R+R G+ A+K E + E +L +
Sbjct: 3 LQDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVT 62
Query: 60 HPNLVNLLEVFRRKKKLHLVFEFCDHTVLNELENHPHGLPWDLIKQITWQVLRGVSYCHR 119
HP ++ + F+ +++ ++ ++ + L L P + K +V + Y H
Sbjct: 63 HPFIIRMWGTFQDAQQIFMIMDYIEGGELFSLLRKSQRFPNPVAKFYAAEVCLALEYLHS 122
Query: 120 HACIHRDIKPENILLTANGVVKLCDFGFARLIRDLIPR--------HLHIFQTNEY---- 167
I+RD+KPENILL NG +K+ DFGFA+ + D+ + T Y
Sbjct: 123 KDIIYRDLKPENILLDKNGHIKITDFGFAKYVPDVTYTLCGTPDYIAPEVVSTKPYNKSI 182
Query: 168 ------------FKGVSLPHAENVVPLEIKIGK-----PAATNIYLIDFLKRCLDKDPLR 210
G + + N + KI P N + D L R + +D +
Sbjct: 183 DWWSFGILIYEMLAGYTPFYDSNTMKTYEKILNAELRFPPFFNEDVKDLLSRLITRDLSQ 242
Query: 211 RW-----SCDQLLRHPYFNGYYFE 229
R + + HP+F +E
Sbjct: 243 RLGNLQNGTEDVKNHPWFKEVVWE 266
|
| >d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]} Length = 364 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: G-protein coupled receptor kinase 2 species: Cow (Bos taurus) [TaxId: 9913]
Score = 165 bits (418), Expect = 3e-49
Identities = 49/280 (17%), Positives = 102/280 (36%), Gaps = 43/280 (15%)
Query: 1 MERYEKIGKLGEGSYGVVFKCRNRDTGQVVAIK----KFLESEEDPLIRKIALREIRLLK 56
M + +G G +G V+ CR DTG++ A+K K ++ ++ + + L+
Sbjct: 3 MNDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVS 62
Query: 57 SLKHPNLVNLLEVFRRKKKLHLVFEFCDHTVLNELENHPHGLPWDLIKQITWQVLRGVSY 116
+ P +V + F KL + + + L+ + ++ +++ G+ +
Sbjct: 63 TGDCPFIVCMSYAFHTPDKLSFILDLMNGGDLHYHLSQHGVFSEADMRFYAAEIILGLEH 122
Query: 117 CHRHACIHRDIKPENILLTANGVVKLCDFGFARLIRDLIPRHLH---------IFQTNEY 167
H ++RD+KP NILL +G V++ D G A P + Q
Sbjct: 123 MHNRFVVYRDLKPANILLDEHGHVRISDLGLACDFSKKKPHASVGTHGYMAPEVLQKGVA 182
Query: 168 FKGVSLPHAENVVPLEIKIGK-------------------------PAATNIYLIDFLKR 202
+ + + + ++ G P + + L L+
Sbjct: 183 YDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTLTMAVELPDSFSPELRSLLEG 242
Query: 203 CLDKDPLRRWSC-----DQLLRHPYFNGYYFEVPDEMQYE 237
L +D RR C ++ P+F +++ +Y
Sbjct: 243 LLQRDVNRRLGCLGRGAQEVKESPFFRSLDWQMVFLQKYP 282
|
| >d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 337 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Pkb kinase (Akt-2) species: Human (Homo sapiens) [TaxId: 9606]
Score = 164 bits (415), Expect = 3e-49
Identities = 54/277 (19%), Positives = 103/277 (37%), Gaps = 18/277 (6%)
Query: 1 MERYEKIGKLGEGSYGVVFKCRNRDTGQVVAIKKF-LESEEDPLIRKIALREIRLLKSLK 59
M ++ + LG+G++G V R + TG+ A+K E + E R+L++ +
Sbjct: 4 MNDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTR 63
Query: 60 HPNLVNLLEVFRRKKKLHLVFEFCDHTVLNELENHPHGLPWDLIKQITWQVLRGVSYCHR 119
HP L L F+ +L V E+ + L + + + +++ + Y H
Sbjct: 64 HPFLTALKYAFQTHDRLCFVMEYANGGELFFHLSRERVFTEERARFYGAEIVSALEYLHS 123
Query: 120 HACIHRDIKPENILLTANGVVKLCDFGFARLIRDLIPRHLHIFQTNEYFKGVSLPHAENV 179
++RDIK EN++L +G +K+ DFG + T EY L
Sbjct: 124 RDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGATMKTFCGTPEYLAPEVLEDN--- 180
Query: 180 VPLEIKIGKPAATNIYLIDFLKRCLDKDPLRRWSCDQLLRHPYFNGYYF--EVPDEMQYE 237
G+ + + + P ++L F + E +
Sbjct: 181 -----DYGRAVDWWGLGVVMYEMMCGRLPFYNQDHERLFELILMEEIRFPRTLSPEAK-- 233
Query: 238 EITQRCLDKDPLRRWSC-----DQLLRHPYFNGYYFE 269
+ L KDP +R +++ H +F ++
Sbjct: 234 SLLAGLLKKDPKQRLGGGPSDAKEVMEHRFFLSINWQ 270
|
| >d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Glycogen synthase kinase-3 beta (Gsk3b) species: Human (Homo sapiens) [TaxId: 9606]
Score = 164 bits (415), Expect = 5e-49
Identities = 71/298 (23%), Positives = 127/298 (42%), Gaps = 41/298 (13%)
Query: 3 RYEKIGKLGEGSYGVVFKCRNRDTGQVVAIKKFLESEEDPLIRKIALREIRLLKSLKHPN 62
Y +G GS+GVV++ + D+G++VAIKK L+ + + RE+++++ L H N
Sbjct: 21 SYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDK------RFKNRELQIMRKLDHCN 74
Query: 63 LVNLLEVF------RRKKKLHLVFEFCDHTVLNELENHPHG---LPWDLIKQITWQVLRG 113
+V L F + + L+LV ++ TV ++ LP +K +Q+ R
Sbjct: 75 IVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRS 134
Query: 114 VSYCHRHACIHRDIKPENILLTANG-VVKLCDFGFARLIRDLIPRHLHIFQT-----NEY 167
++Y H HRDIKP+N+LL + V+KLCDFG A+ + P +I
Sbjct: 135 LAYIHSFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSYICSRYYRAPELI 194
Query: 168 FKGVSLPHAENVVPL-----EIKIGKP---AATNIYLIDFLKRCLDKDPLRRWSC----- 214
F + +V E+ +G+P + + + + + L +
Sbjct: 195 FGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPTREQIREMNPNY 254
Query: 215 -----DQLLRHPYFNGYYFEVPDEMQYEEITQRCLDKDPLRRWSCDQLLRHPYFNGYY 267
Q+ HP+ + P E + R L+ P R + + H +F+
Sbjct: 255 TEFKFPQIKAHPWTKVFRPRTPPEAI--ALCSRLLEYTPTARLTPLEACAHSFFDELR 310
|
| >d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]} Length = 345 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase Erk2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 163 bits (412), Expect = 1e-48
Identities = 69/300 (23%), Positives = 118/300 (39%), Gaps = 39/300 (13%)
Query: 2 ERYEKIGKLGEGSYGVVFKCRNRDTGQVVAIKKFLESEEDPLIRKIALREIRLLKSLKHP 61
RY + +GEG+YG+V + VAIKK + E + LREI++L +H
Sbjct: 8 PRYTNLSYIGEGAYGMVCSAYDNVNKVRVAIKK-ISPFEHQTYCQRTLREIKILLRFRHE 66
Query: 62 NLVNLLEVFR-----RKKKLHLVFEFCDHTVLNELENHPHGLPWDLIKQITWQVLRGVSY 116
N++ + ++ R + K ++LV + L+ L D I +Q+LRG+ Y
Sbjct: 67 NIIGINDIIRAPTIEQMKDVYLVTHLMGADLYKLLKTQH--LSNDHICYFLYQILRGLKY 124
Query: 117 CHRHACIHRDIKPENILLTANGVVKLCDFGFARLIRD----------------------L 154
H +HRD+KP N+LL +K+CDFG AR+ +
Sbjct: 125 IHSANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIM 184
Query: 155 IPRHLHIFQTNEYFKGVSLPHAENVVPLEIKIGKPAATNIYLIDFLKRCLDKDPLRRWSC 214
+ + + + G L + P+ GK + I + ++ L
Sbjct: 185 LNSKGYTKSIDIWSVGCILAEMLSNRPI--FPGKHYLDQLNHILGILGSPSQEDLNCIIN 242
Query: 215 DQLLRHPYFNGYYFEVPDEMQYEEIT-------QRCLDKDPLRRWSCDQLLRHPYFNGYY 267
+ + + +VP + + L +P +R +Q L HPY YY
Sbjct: 243 LKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALAHPYLEQYY 302
|
| >d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]} Length = 320 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase C, theta type species: Human (Homo sapiens) [TaxId: 9606]
Score = 158 bits (401), Expect = 3e-47
Identities = 55/264 (20%), Positives = 98/264 (37%), Gaps = 35/264 (13%)
Query: 1 MERYEKIGKLGEGSYGVVFKCRNRDTGQVVAIKKFLES--EEDPLIRKIALREIRLLKSL 58
+E + LG+GS+G VF + T Q AIK + D + + + L +
Sbjct: 1 IEDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAW 60
Query: 59 KHPNLVNLLEVFRRKKKLHLVFEFCDHTVLNELENHPHGLPWDLIKQITWQVLRGVSYCH 118
+HP L ++ F+ K+ L V E+ + L H +++ G+ + H
Sbjct: 61 EHPFLTHMFCTFQTKENLFFVMEYLNGGDLMYHIQSCHKFDLSRATFYAAEIILGLQFLH 120
Query: 119 RHACIHRDIKPENILLTANGVVKLCDFGFARLIRDLIPRHLHIFQTNEY----------- 167
++RD+K +NILL +G +K+ DFG + + T +Y
Sbjct: 121 SKGIVYRDLKLDNILLDKDGHIKIADFGMCKENMLGDAKTNTFCGTPDYIAPEILLGQKY 180
Query: 168 ----------------FKGVSLPHAENVVPL--EIKIGKPAATNIY---LIDFLKRCLDK 206
G S H ++ L I++ P D L + +
Sbjct: 181 NHSVDWWSFGVLLYEMLIGQSPFHGQDEEELFHSIRMDNPFYPRWLEKEAKDLLVKLFVR 240
Query: 207 DPLRRWSC-DQLLRHPYFNGYYFE 229
+P +R + +HP F +E
Sbjct: 241 EPEKRLGVRGDIRQHPLFREINWE 264
|
| >d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 276 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: B-Raf kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 156 bits (396), Expect = 6e-47
Identities = 57/275 (20%), Positives = 101/275 (36%), Gaps = 32/275 (11%)
Query: 2 ERYEKIGKLGEGSYGVVFKCRNRDTGQVVAIKKFLESEEDPLIRKIALREIRLLKSLKHP 61
+ ++G GS+G V+K + VA+K + P + E+ +L+ +H
Sbjct: 8 GQITVGQRIGSGSFGTVYKGKWHGD---VAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHV 64
Query: 62 NLVNLLEVFRRKKKLHLVFEFCDHTVLNE-LENHPHGLPWDLIKQITWQVLRGVSYCHRH 120
N++ L + +L +V ++C+ + L L + I Q +G+ Y H
Sbjct: 65 NIL-LFMGYSTAPQLAIVTQWCEGSSLYHHLHIIETKFEMIKLIDIARQTAQGMDYLHAK 123
Query: 121 ACIHRDIKPENILLTANGVVKLCDFGFARLIRDLIPRHLH-------IFQTNEYFKGVSL 173
+ IHRD+K NI L + VK+ DFG A + H ++ E +
Sbjct: 124 SIIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAPEVIRMQDK 183
Query: 174 PHAEN--------VVPLEIKIGKPAATNIYLIDFLKRCLDKDPLRRWSCDQLLRHPYFNG 225
+V E+ G+ +NI D + + + L P +
Sbjct: 184 NPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIFMVGRGYLS----------PDLSK 233
Query: 226 YYFEVPDEMQYEEITQRCLDKDPLRRWSCDQLLRH 260
P M+ + CL K R Q+L
Sbjct: 234 VRSNCPKAMK--RLMAECLKKKRDERPLFPQILAS 266
|
| >d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]} Length = 346 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38-gamma species: Human (Homo sapiens) [TaxId: 9606]
Score = 156 bits (396), Expect = 3e-46
Identities = 71/307 (23%), Positives = 127/307 (41%), Gaps = 30/307 (9%)
Query: 2 ERYEKIGKLGEGSYGVVFKCRNRDTGQVVAIKKFLESEEDPLIRKIALREIRLLKSLKHP 61
Y + +G G+YG V + TG VAIKK + L K A RE+RLLK ++H
Sbjct: 18 AVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMRHE 77
Query: 62 NLVNLLEVFRRKKKL------HLVFEFCDHTVLNELENHPHGLPWDLIKQITWQVLRGVS 115
N++ LL+VF + L +LV F + +++ L D I+ + +Q+L+G+
Sbjct: 78 NVIGLLDVFTPDETLDDFTDFYLVMPFMGTDLGKLMKHEK--LGEDRIQFLVYQMLKGLR 135
Query: 116 YCHRHACIHRDIKPENILLTANGVVKLCDFGFARLIRDLIPRHLH--------IFQTNEY 167
Y H IHRD+KP N+ + + +K+ DFG AR + ++ +
Sbjct: 136 YIHAAGIIHRDLKPGNLAVNEDCELKILDFGLARQADSEMTGYVVTRWYRAPEVILNWMR 195
Query: 168 FKGVSLPHAENVVPLEIKIGKP---AATNIYLIDFLKRCLDKDPLRRWSCDQLLRHPYFN 224
+ + + E+ GK + ++ + + + P Q +
Sbjct: 196 YTQTVDIWSVGCIMAEMITGKTLFKGSDHLDQLKEIMKVTGTPPAEFVQRLQSDEAKNYM 255
Query: 225 GYYFEVPDEMQYEEIT----------QRCLDKDPLRRWSCDQLLRHPYFNGYYFEVPDEM 274
E+ + +T ++ L D +R + + L HPYF + + DE
Sbjct: 256 KGLPELEKKDFASILTNASPLAVNLLEKMLVLDAEQRVTAGEALAHPYFESLH-DTEDEP 314
Query: 275 QYEEITQ 281
Q ++
Sbjct: 315 QVQKYDD 321
|
| >d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]} Length = 335 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase activated protein kinase 2, mapkap2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 155 bits (392), Expect = 8e-46
Identities = 55/283 (19%), Positives = 113/283 (39%), Gaps = 37/283 (13%)
Query: 1 MERYEKIGK-LGEGSYGVVFKCRNRDTGQVVAIKKFLESEEDPLIRKIALREIR-LLKSL 58
++ Y+ + LG G G V + N+ T + A+K + + A RE+ ++
Sbjct: 10 IDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDCPK-------ARREVELHWRAS 62
Query: 59 KHPNLVNLLEVFR----RKKKLHLVFEFCDHTVLNEL--ENHPHGLPWDLIKQITWQVLR 112
+ P++V +++V+ +K L +V E D L + +I +
Sbjct: 63 QCPHIVRIVDVYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGE 122
Query: 113 GVSYCHRHACIHRDIKPENILLTA---NGVVKLCDFGFARLIRDLIPRHLHIFQTN---- 165
+ Y H HRD+KPEN+L T+ N ++KL DFGFA+ +
Sbjct: 123 AIQYLHSINIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNSLTTPCYTPYYVAP 182
Query: 166 EYFKGVSLPHAENVVPL-----EIKIGKPAATNIYLIDFLKRCLDKDPLRRWSCDQLLRH 220
E + ++ L + G P + + + + ++ ++
Sbjct: 183 EVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTR--------IRMGQY 234
Query: 221 PYFNGYYFEVPDEMQYEEITQRCLDKDPLRRWSCDQLLRHPYF 263
+ N + EV +E++ + + L +P +R + + + HP+
Sbjct: 235 EFPNPEWSEVSEEVK--MLIRNLLKTEPTQRMTITEFMNHPWI 275
|
| >d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]} Length = 305 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK6 species: Human (Homo sapiens) [TaxId: 9606]
Score = 153 bits (388), Expect = 2e-45
Identities = 83/293 (28%), Positives = 145/293 (49%), Gaps = 30/293 (10%)
Query: 2 ERYEKIGKLGEGSYGVVFKCRN-RDTGQVVAIKKFLESEEDPLIRKIALREIRLLKSLK- 59
++YE + ++GEG+YG VFK R+ ++ G+ VA+K+ + + +RE+ +L+ L+
Sbjct: 7 QQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLET 66
Query: 60 --HPNLVNLLEVF-----RRKKKLHLVFEFCDHTVLNELENHPH-GLPWDLIKQITWQVL 111
HPN+V L +V R+ KL LVFE D + L+ P G+P + IK + +Q+L
Sbjct: 67 FEHPNVVRLFDVCTVSRTDRETKLTLVFEHVDQDLTTYLDKVPEPGVPTETIKDMMFQLL 126
Query: 112 RGVSYCHRHACIHRDIKPENILLTANGVVKLCDFGFARLIRDLIP----------RHLHI 161
RG+ + H H +HRD+KP+NIL+T++G +KL DFG AR+ + R +
Sbjct: 127 RGLDFLHSHRVVHRDLKPQNILVTSSGQIKLADFGLARIYSFQMALTSVVVTLWYRAPEV 186
Query: 162 FQTNEYFKGVSLPHAENVVPLEIKIGKP---AATNIYLIDFLKRCLDKDPLRRWSCDQLL 218
+ Y V L + + E+ KP ++++ + + + W D L
Sbjct: 187 LLQSSYATPVDL-WSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLPGEEDWPRDVAL 245
Query: 219 RHPYFNGYYFEVPDEMQYE------EITQRCLDKDPLRRWSCDQLLRHPYFNG 265
F+ + ++ + ++ +CL +P +R S L HPYF
Sbjct: 246 PRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALSHPYFQD 298
|
| >d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase SYK species: Human (Homo sapiens) [TaxId: 9606]
Score = 152 bits (385), Expect = 3e-45
Identities = 51/272 (18%), Positives = 101/272 (37%), Gaps = 12/272 (4%)
Query: 9 KLGEGSYGVVFKCRNRD--TGQVVAIKKFLESEEDPLIRKIALREIRLLKSLKHPNLVNL 66
+LG G++G V K + + VA+K DP ++ L E +++ L +P +V +
Sbjct: 14 ELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRM 73
Query: 67 LEVFRRKKKLHLVFEFCDHTVLNELENHPHGLPWDLIKQITWQVLRGVSYCHRHACIHRD 126
+ + + LV E + LN+ + I ++ QV G+ Y +HRD
Sbjct: 74 IGICEAES-WMLVMEMAELGPLNKYLQQNRHVKDKNIIELVHQVSMGMKYLEESNFVHRD 132
Query: 127 IKPENILLTANGVVKLCDFGFARLIRDLIPRHLHIFQTNEYFKGVSLPHAENVVPLEIKI 186
+ N+LL K+ DFG ++ +R + + + K +A +
Sbjct: 133 LAARNVLLVTQHYAKISDFGLSKALRADENYY----KAQTHGKWPVKWYAPECINYYKFS 188
Query: 187 GKPAATNIYLIDFLKRCLDKDPLRRWSCDQLLRHPYFNGYYFEVPDEM--QYEEITQRCL 244
K + ++ + + P R ++ G P + ++ C
Sbjct: 189 SKSDVWSFGVLMWEAFSYGQKPYRGMKGSEVTAM-LEKGERMGCPAGCPREMYDLMNLCW 247
Query: 245 DKDPLRRWSCDQLLRHPYFNGYYFEVPDEMQY 276
D R + YY++V +E +
Sbjct: 248 TYDVENRPGFAAVELR--LRNYYYDVVNEGHH 277
|
| >d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Proto-oncogene serine/threonine-protein kinase Pim-1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 152 bits (384), Expect = 4e-45
Identities = 57/259 (22%), Positives = 96/259 (37%), Gaps = 33/259 (12%)
Query: 3 RYEKIGKLGEGSYGVVFKCRNRDTGQVVAIKKF----LESEEDPLIRKIALREIRLLKSL 58
+Y+ LG G +G V+ VAIK + + E+ LLK +
Sbjct: 5 QYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKV 64
Query: 59 K--HPNLVNLLEVFRRKKKLHLVFEFCD-HTVLNELENHPHGLPWDLIKQITWQVLRGVS 115
++ LL+ F R L+ E + L + L +L + WQVL V
Sbjct: 65 SSGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELARSFFWQVLEAVR 124
Query: 116 YCHRHACIHRDIKPENILLTAN-GVVKLCDFGFARLIRDLIPRHL---HIFQTNEYFKGV 171
+CH +HRDIK ENIL+ N G +KL DFG L++D + ++ E+ +
Sbjct: 125 HCHNCGVLHRDIKDENILIDLNRGELKLIDFGSGALLKDTVYTDFDGTRVYSPPEWIRYH 184
Query: 172 SLP------HAENVVPLEIKIGKP---AATNIY-------------LIDFLKRCLDKDPL 209
+ ++ ++ G I ++ CL P
Sbjct: 185 RYHGRSAAVWSLGILLYDMVCGDIPFEHDEEIIRGQVFFRQRVSSECQHLIRWCLALRPS 244
Query: 210 RRWSCDQLLRHPYFNGYYF 228
R + +++ HP+
Sbjct: 245 DRPTFEEIQNHPWMQDVLL 263
|
| >d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Mouse (Mus musculus) [TaxId: 10090]
Score = 153 bits (386), Expect = 9e-45
Identities = 56/285 (19%), Positives = 109/285 (38%), Gaps = 37/285 (12%)
Query: 1 MERYEKIGKLGEGSYGVVFKCRNRDTGQVVAIKKF-LESEEDPLIRKIALREIRLLKSLK 59
++++++I LG GS+G V +++++G A+K + + L E R+L+++
Sbjct: 40 LDQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVN 99
Query: 60 HPNLVNLLEVFRRKKKLHLVFEFCDHTVLNELENHPHGLPWDLIKQITWQVLRGVSYCHR 119
P LV L F+ L++V E+ + + Q++ Y H
Sbjct: 100 FPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHS 159
Query: 120 HACIHRDIKPENILLTANGVVKLCDFGFARLIRDLIP--------RHLHIFQTNEYFKGV 171
I+RD+KPEN+L+ G +++ DFGFA+ ++ I + Y K V
Sbjct: 160 LDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWTLCGTPEALAPEIILSKGYNKAV 219
Query: 172 SLPHAENVVPLEIKIGKPAATNIYLIDFLKRCLDKDPLRRWSCDQLLRHPYFNGYYF--E 229
A V+ E+ G P P Q+ F
Sbjct: 220 DW-WALGVLIYEMAAGYP------------------PFFADQPIQIYEKIVSGKVRFPSH 260
Query: 230 VPDEMQYEEITQRCLDKDPLRRW-----SCDQLLRHPYFNGYYFE 269
+++ ++ + L D +R+ + + H +F +
Sbjct: 261 FSSDLK--DLLRNLLQVDLTKRFGNLKNGVNDIKNHKWFATTDWI 303
|
| >d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]} Length = 287 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Abelsone tyrosine kinase (abl) species: Mouse (Mus musculus) [TaxId: 10090]
Score = 151 bits (381), Expect = 1e-44
Identities = 53/255 (20%), Positives = 103/255 (40%), Gaps = 40/255 (15%)
Query: 2 ERYEKIGKLGEGSYGVVFKCRNRDTGQVVAIKKFLESEEDPLIRKIALREIRLLKSLKHP 61
KLG G YG V++ + VA+K +ED + + L+E ++K +KHP
Sbjct: 17 TDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTL---KEDTMEVEEFLKEAAVMKEIKHP 73
Query: 62 NLVNLLEVFRRKKKLHLVFEFCDHTVLNEL--ENHPHGLPWDLIKQITWQVLRGVSYCHR 119
NLV LL V R+ +++ EF + L + E + + ++ + Q+ + Y +
Sbjct: 74 NLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEK 133
Query: 120 HACIHRDIKPENILLTANGVVKLCDFGFARLIRD------------LIPRHLHIFQTNEY 167
IHRD+ N L+ N +VK+ DFG +RL+ + N++
Sbjct: 134 KNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPESLAYNKF 193
Query: 168 -----------------------FKGVSLPHAENVVPLEIKIGKPAATNIYLIDFLKRCL 204
+ G+ L ++ + ++ +P + + ++ C
Sbjct: 194 SIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEKDYRMERPEGCPEKVYELMRACW 253
Query: 205 DKDPLRRWSCDQLLR 219
+P R S ++ +
Sbjct: 254 QWNPSDRPSFAEIHQ 268
|
| >d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]} Length = 272 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Lymphocyte kinase (lck) species: Human (Homo sapiens) [TaxId: 9606]
Score = 150 bits (379), Expect = 2e-44
Identities = 58/272 (21%), Positives = 110/272 (40%), Gaps = 26/272 (9%)
Query: 2 ERYEKIGKLGEGSYGVVFKCRNRDTGQVVAIKKFLESEEDPLIRKIALREIRLLKSLKHP 61
E + + +LG G +G V+ VA+K + P L E L+K L+H
Sbjct: 13 ETLKLVERLGAGQFGEVWMGYYNG-HTKVAVKSLKQGSMSP---DAFLAEANLMKQLQHQ 68
Query: 62 NLVNLLEVFRRKKKLHLVFEFCDHTVLNELENHPHG--LPWDLIKQITWQVLRGVSYCHR 119
LV L V ++ ++++ E+ ++ L + P G L + + + Q+ G+++
Sbjct: 69 RLVRLYAVVT-QEPIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEE 127
Query: 120 HACIHRDIKPENILLTANGVVKLCDFGFARLIRDLIPRHLHIFQTNEYFKGVSLPHAENV 179
IHRD++ NIL++ K+ DFG ARLI D + +
Sbjct: 128 RNYIHRDLRAANILVSDTLSCKIADFGLARLIEDNEYTAREGAKFPIKW----------T 177
Query: 180 VPLEIKIGKP-AATNIY---LIDFLKRCLDKDPLRRWSCDQLLRHPYFNGYYFEVPDEMQ 235
P I G ++++ ++ + P + +++++ GY PD
Sbjct: 178 APEAINYGTFTIKSDVWSFGILLTEIVTHGRIPYPGMTNPEVIQN-LERGYRMVRPDNCP 236
Query: 236 YE--EITQRCLDKDPLRRWSCDQLLR--HPYF 263
E ++ + C + P R + D L +F
Sbjct: 237 EELYQLMRLCWKERPEDRPTFDYLRSVLEDFF 268
|
| >d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]} Length = 285 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase ZAP-70 species: Human (Homo sapiens) [TaxId: 9606]
Score = 149 bits (376), Expect = 5e-44
Identities = 50/264 (18%), Positives = 99/264 (37%), Gaps = 15/264 (5%)
Query: 9 KLGEGSYGVVFKCRNRDT--GQVVAIKKFLESEEDPLIRKIALREIRLLKSLKHPNLVNL 66
+LG G++G V + R VAIK L+ + + +RE +++ L +P +V L
Sbjct: 16 ELGCGNFGSVRQGVYRMRKKQIDVAIKV-LKQGTEKADTEEMMREAQIMHQLDNPYIVRL 74
Query: 67 LEVFRRKKKLHLVFEFCDHTVLNE-LENHPHGLPWDLIKQITWQVLRGVSYCHRHACIHR 125
+ V + + L LV E L++ L +P + ++ QV G+ Y +HR
Sbjct: 75 IGVCQ-AEALMLVMEMAGGGPLHKFLVGKREEIPVSNVAELLHQVSMGMKYLEEKNFVHR 133
Query: 126 DIKPENILLTANGVVKLCDFGFARLIRDLIPRHLHIFQTNEYFKGVSLPHAENVVPLEIK 185
D+ N+LL K+ DFG ++ + + K +A +
Sbjct: 134 DLAARNVLLVNRHYAKISDFGLSKALGADDSYY----TARSAGKWPLKWYAPECINFRKF 189
Query: 186 IGKPAATNIYLIDFLKRCLDKDPLRRWSCDQLLRHPYFNGYYFEVPDEM--QYEEITQRC 243
+ + + + + P ++ +++ G E P E + + C
Sbjct: 190 SSRSDVWSYGVTMWEALSYGQKPYKKMKGPEVMAF-IEQGKRMECPPECPPELYALMSDC 248
Query: 244 LDKDPLRRWSCDQL---LRHPYFN 264
R + +R Y++
Sbjct: 249 WIYKWEDRPDFLTVEQRMRACYYS 272
|
| >d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]} Length = 262 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Carboxyl-terminal src kinase (csk) species: Human (Homo sapiens) [TaxId: 9606]
Score = 148 bits (375), Expect = 6e-44
Identities = 54/269 (20%), Positives = 101/269 (37%), Gaps = 30/269 (11%)
Query: 1 MERYEKIGKLGEGSYGVVFKCRNRDTGQVVAIKKFLESEEDPLIRKIALREIRLLKSLKH 60
M+ + + +G+G +G V R G VA+K ++ + L E ++ L+H
Sbjct: 6 MKELKLLQTIGKGEFGDVMLGDYR--GNKVAVKCI----KNDATAQAFLAEASVMTQLRH 59
Query: 61 PNLVNLLEVF-RRKKKLHLVFEFCDHTVLNEL--ENHPHGLPWDLIKQITWQVLRGVSYC 117
NLV LL V K L++V E+ L + L D + + + V + Y
Sbjct: 60 SNLVQLLGVIVEEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYL 119
Query: 118 HRHACIHRDIKPENILLTANGVVKLCDFGFARLIRDLIPRHLHIFQTNEYFKGVSLPHAE 177
+ +HRD+ N+L++ + V K+ DFG + ++
Sbjct: 120 EGNNFVHRDLAARNVLVSEDNVAKVSDFGLTKEASS---TQDTGKLPVKW---------- 166
Query: 178 NVVPLEIKIGKP-AATNIY---LIDFLKRCLDKDPLRRWSCDQLLRHPYFNGYYFEVPDE 233
P ++ K ++++ ++ + + P R ++ GY + PD
Sbjct: 167 -TAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPR-VEKGYKMDAPDG 224
Query: 234 M--QYEEITQRCLDKDPLRRWSCDQLLRH 260
E+ + C D R S QL
Sbjct: 225 CPPAVYEVMKNCWHLDAAMRPSFLQLREQ 253
|
| >d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: ephb2 receptor tyrosine kinase species: Mouse (Mus musculus) [TaxId: 10090]
Score = 149 bits (377), Expect = 6e-44
Identities = 49/266 (18%), Positives = 96/266 (36%), Gaps = 10/266 (3%)
Query: 1 MERYEKIGKLGEGSYGVVFKCRNRDTGQ---VVAIKKFLESEEDPLIRKIALREIRLLKS 57
+ + +G G +G V + G+ VAIK L+S R+ L E ++
Sbjct: 25 ISCVKIEQVIGAGEFGEVCSGHLKLPGKREIFVAIKT-LKSGYTEKQRRDFLSEASIMGQ 83
Query: 58 LKHPNLVNLLEVFRRKKKLHLVFEFCDHTVLNELENHPHG-LPWDLIKQITWQVLRGVSY 116
HPN+++L V + + ++ EF ++ L+ G + + + G+ Y
Sbjct: 84 FDHPNVIHLEGVVTKSTPVMIITEFMENGSLDSFLRQNDGQFTVIQLVGMLRGIAAGMKY 143
Query: 117 CHRHACIHRDIKPENILLTANGVVKLCDFGFARLIRDLIPRHLHIFQTNEYFKGVSLPHA 176
+HRD+ NIL+ +N V K+ DFG +R + D + + K A
Sbjct: 144 LADMNYVHRDLAARNILVNSNLVCKVSDFGLSRFLED--DTSDPTYTSALGGKIPIRWTA 201
Query: 177 ENVVPLEIKIGKPAATNIYLIDFLKRCLDKDPLRRWSCDQLLRHPYFNGYYFEVPDEM-- 234
+ + ++ + + P + ++ Y P +
Sbjct: 202 PEAIQYRKFTSASDVWSYGIVMWEVMSYGERPYWDMTNQDVINA-IEQDYRLPPPMDCPS 260
Query: 235 QYEEITQRCLDKDPLRRWSCDQLLRH 260
++ C KD R Q++
Sbjct: 261 ALHQLMLDCWQKDRNHRPKFGQIVNT 286
|
| >d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 325 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fl cytokine receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 150 bits (379), Expect = 6e-44
Identities = 64/290 (22%), Positives = 108/290 (37%), Gaps = 37/290 (12%)
Query: 2 ERYEKIGKLGEGSYGVVFKCRNRDTGQ-----VVAIKKFLESEEDPLIRKIALREIRLLK 56
E E LG G++G V + VA+K L+ + D R+ + E++++
Sbjct: 37 ENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKM-LKEKADSSEREALMSELKMMT 95
Query: 57 SL-KHPNLVNLLEVFRRKKKLHLVFEFCDHTVLNEL-----------------------E 92
L H N+VNLL ++L+FE+C + L E
Sbjct: 96 QLGSHENIVNLLGACTLSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEE 155
Query: 93 NHPHGLPWDLIKQITWQVLRGVSYCHRHACIHRDIKPENILLTANGVVKLCDFGFARLIR 152
+ L ++ + +QV +G+ + +C+HRD+ N+L+T VVK+CDFG AR I
Sbjct: 156 EDLNVLTFEDLLCFAYQVAKGMEFLEFKSCVHRDLAARNVLVTHGKVVKICDFGLARDIM 215
Query: 153 DLIPRHLHIFQTNEYFKGVSLPHAENVVPLEIKIGKPAATNIYLIDFLKRCLDKDPLRRW 212
+ + A + I K + ++ + L +P
Sbjct: 216 SDSNYVVR-----GNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFSLGVNPYPGI 270
Query: 213 SCDQLLRHPYFNGYYFEVPDEM--QYEEITQRCLDKDPLRRWSCDQLLRH 260
D NG+ + P + I Q C D +R S L
Sbjct: 271 PVDANFYKLIQNGFKMDQPFYATEEIYIIMQSCWAFDSRKRPSFPNLTSF 320
|
| >d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 317 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: EGF receptor tyrosine kinase, Erbb-1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 148 bits (375), Expect = 2e-43
Identities = 50/262 (19%), Positives = 91/262 (34%), Gaps = 11/262 (4%)
Query: 4 YEKIGKLGEGSYGVVFKCRNRDTGQVVAIK---KFLESEEDPLIRKIALREIRLLKSLKH 60
++KI LG G++G V+K G+ V I K L P K L E ++ S+ +
Sbjct: 11 FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDN 70
Query: 61 PNLVNLLEVFRRKKKLHLVFEFCDHTVLNELENHPHGLPWDLIKQITWQVLRGVSYCHRH 120
P++ LL + + +L+ + H + + Q+ +G++Y
Sbjct: 71 PHVCRLLGICLTSTVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDR 130
Query: 121 ACIHRDIKPENILLTANGVVKLCDFGFARLIRDLIPRHLHIFQTNEYFKGVSLPHAENVV 180
+HRD+ N+L+ VK+ DFG A+L+ + E K A +
Sbjct: 131 RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEY-----HAEGGKVPIKWMALESI 185
Query: 181 PLEIKIGKPAATNIYLIDFLKRCLDKDPLRRWSCDQLLRHPYFNGYYFEVPDEM--QYEE 238
I + + + + P ++ G P
Sbjct: 186 LHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSI-LEKGERLPQPPICTIDVYM 244
Query: 239 ITQRCLDKDPLRRWSCDQLLRH 260
I +C D R +L+
Sbjct: 245 IMVKCWMIDADSRPKFRELIIE 266
|
| >d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]} Length = 263 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase Itk/Tsk species: Human (Homo sapiens) [TaxId: 9606]
Score = 146 bits (370), Expect = 3e-43
Identities = 56/262 (21%), Positives = 98/262 (37%), Gaps = 14/262 (5%)
Query: 2 ERYEKIGKLGEGSYGVVFKCRNRDTGQVVAIKKFLESEEDPLIRKIALREIRLLKSLKHP 61
+ ++G G +G+V + VAIK E + + + E ++ L HP
Sbjct: 5 SELTFVQEIGSGQFGLVHLGYWLN-KDKVAIKTI---REGAMSEEDFIEEAEVMMKLSHP 60
Query: 62 NLVNLLEVFRRKKKLHLVFEFCDHTVLNEL-ENHPHGLPWDLIKQITWQVLRGVSYCHRH 120
LV L V + + LVFEF +H L++ + + + V G++Y
Sbjct: 61 KLVQLYGVCLEQAPICLVFEFMEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLEEA 120
Query: 121 ACIHRDIKPENILLTANGVVKLCDFGFARLIRDLIPRHLHIFQTNEYFKGVSLPHAENVV 180
IHRD+ N L+ N V+K+ DFG R + D + ++ K + V
Sbjct: 121 CVIHRDLAARNCLVGENQVIKVSDFGMTRFVLD------DQYTSSTGTKFPVKWASPEVF 174
Query: 181 PLEIKIGKPAATNIYLIDFLKRCLDKDPLRRWSCDQLLRHPYFNGYYFEVPDEM--QYEE 238
K + ++ + K P S +++ G+ P +
Sbjct: 175 SFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSNSEVVEDIS-TGFRLYKPRLASTHVYQ 233
Query: 239 ITQRCLDKDPLRRWSCDQLLRH 260
I C + P R + +LLR
Sbjct: 234 IMNHCWKERPEDRPAFSRLLRQ 255
|
| >d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]} Length = 355 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-jun N-terminal kinase (jnk3s) species: Human (Homo sapiens) [TaxId: 9606]
Score = 148 bits (375), Expect = 4e-43
Identities = 72/318 (22%), Positives = 132/318 (41%), Gaps = 42/318 (13%)
Query: 1 MERYEKIGKLGEGSYGVVFKCRNRDTGQVVAIKKFLESEEDPLIRKIALREIRLLKSLKH 60
++RY+ + +G G+ G+V + + VAIKK ++ K A RE+ L+K + H
Sbjct: 16 LKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNH 75
Query: 61 PNLVNLLEVFRRKKK------LHLVFEFCDHTVLNELENHPHGLPWDLIKQITWQVLRGV 114
N+++LL VF +K ++LV E D + ++ + + + +Q+L G+
Sbjct: 76 KNIISLLNVFTPQKTLEEFQDVYLVMELMDANLCQVIQMEL---DHERMSYLLYQMLCGI 132
Query: 115 SYCHRHACIHRDIKPENILLTANGVVKLCDFGFARLIRDLIPRHLHI----FQTNEYFKG 170
+ H IHRD+KP NI++ ++ +K+ DFG AR ++ ++ E G
Sbjct: 133 KHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMTPYVVTRYYRAPEVILG 192
Query: 171 VSLPHAEN-----VVPLEIKIGKPAATNIYLIDFLKRCLDKDP---------LRRWSCDQ 216
+ + + E+ K ID + +++ L+ +
Sbjct: 193 MGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQPTVRNY 252
Query: 217 LLRHPYFNGYYFE--VPDEMQYEEIT-------------QRCLDKDPLRRWSCDQLLRHP 261
+ P + G F PD + + + L DP +R S D L+HP
Sbjct: 253 VENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDALQHP 312
Query: 262 YFNGYYFEVPDEMQYEEI 279
Y N +Y E +I
Sbjct: 313 YINVWYDPAEVEAPPPQI 330
|
| >d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]} Length = 355 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-jun N-terminal kinase (jnk3s) species: Human (Homo sapiens) [TaxId: 9606]
Score = 53.8 bits (128), Expect = 7e-09
Identities = 24/117 (20%), Positives = 42/117 (35%)
Query: 130 ENILLTANGVVKLCDFGFARLIRDLIPRHLHIFQTNEYFKGVSLPHAENVVPLEIKIGKP 189
+ + N V++ ++ L P + + + G++ P
Sbjct: 221 RDYIDQWNKVIEQLGTPCPEFMKKLQPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHN 280
Query: 190 AATNIYLIDFLKRCLDKDPLRRWSCDQLLRHPYFNGYYFEVPDEMQYEEITQRCLDK 246
D L + L DP +R S D L+HPY N +Y E +I + LD+
Sbjct: 281 KLKASQARDLLSKMLVIDPAKRISVDDALQHPYINVWYDPAEVEAPPPQIYDKQLDE 337
|
| >d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]} Length = 328 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase CK2, alpha subunit species: Rattus norvegicus [TaxId: 10116]
Score = 148 bits (373), Expect = 5e-43
Identities = 61/299 (20%), Positives = 117/299 (39%), Gaps = 42/299 (14%)
Query: 1 MERYEKIGKLGEGSYGVVFKCRNRDTGQVVAIKKFLESEEDPLIRKIALREIRLLKSLK- 59
+ Y+ + KLG G Y VF+ N + V +K P+ +K REI++L++L+
Sbjct: 34 QDDYQLVRKLGRGKYSEVFEAINITNNEKVVVKIL-----KPVKKKKIKREIKILENLRG 88
Query: 60 HPNLVNLLEVFRR--KKKLHLVFEFCDHTVLNELENHPHGLPWDLIKQITWQVLRGVSYC 117
PN++ L ++ + + LVFE ++T + + L I+ +++L+ + YC
Sbjct: 89 GPNIITLADIVKDPVSRTPALVFEHVNNT---DFKQLYQTLTDYDIRFYMYEILKALDYC 145
Query: 118 HRHACIHRDIKPENILLTA-NGVVKLCDFGFARLIRDLIPRHLHI----FQTNEYFKGVS 172
H +HRD+KP N+++ + ++L D+G A ++ + F+ E
Sbjct: 146 HSMGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQEYNVRVASRYFKGPELLVDYQ 205
Query: 173 ------------------------LPHAENVVPLEIKIGKPAATNIYLIDFLKRCLDKDP 208
H + ++I K T K ++ DP
Sbjct: 206 MYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEDLYDYIDKYNIELDP 265
Query: 209 LRRWSCDQLLRHPYFNGYYFEVPDEMQYE--EITQRCLDKDPLRRWSCDQLLRHPYFNG 265
+ R + + E + E + + L D R + + + HPYF
Sbjct: 266 RFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAMEHPYFYT 324
|
| >d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]} Length = 258 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Bruton's tyrosine kinase (Btk) species: Human (Homo sapiens) [TaxId: 9606]
Score = 145 bits (366), Expect = 1e-42
Identities = 58/269 (21%), Positives = 102/269 (37%), Gaps = 28/269 (10%)
Query: 2 ERYEKIGKLGEGSYGVVFKCRNRDTGQVVAIKKFLESEEDPLIRKIALREIRLLKSLKHP 61
+ + +LG G +GVV + R VAIK +E + + E +++ +L H
Sbjct: 4 KDLTFLKELGTGQFGVVKYGKWRG-QYDVAIKMI---KEGSMSEDEFIEEAKVMMNLSHE 59
Query: 62 NLVNLLEVFRRKKKLHLVFEFCDH-TVLNELENHPHGLPWDLIKQITWQVLRGVSYCHRH 120
LV L V +++ + ++ E+ + +LN L H + ++ V + Y
Sbjct: 60 KLVQLYGVCTKQRPIFIITEYMANGCLLNYLREMRHRFQTQQLLEMCKDVCEAMEYLESK 119
Query: 121 ACIHRDIKPENILLTANGVVKLCDFGFARLIRDLIPRHLHIFQTNEYFKGVSLPHAENVV 180
+HRD+ N L+ GVVK+ DFG +R + D +EY V
Sbjct: 120 QFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLD-----------DEYTSSVGSKFPVRWS 168
Query: 181 PLEIKIGKPA-------ATNIYLIDFLKRCLDKDPLRRWSCDQLLRHPYFNGYYFEVPDE 233
P E+ + A + + + L K P R++ + H G P
Sbjct: 169 PPEVLMYSKFSSKSDIWAFGVLMWEIY--SLGKMPYERFTNSETAEH-IAQGLRLYRPHL 225
Query: 234 M--QYEEITQRCLDKDPLRRWSCDQLLRH 260
+ I C + R + LL +
Sbjct: 226 ASEKVYTIMYSCWHEKADERPTFKILLSN 254
|
| >d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]} Length = 348 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38 species: Human (Homo sapiens) [TaxId: 9606]
Score = 146 bits (368), Expect = 3e-42
Identities = 68/292 (23%), Positives = 117/292 (40%), Gaps = 27/292 (9%)
Query: 2 ERYEKIGKLGEGSYGVVFKCRNRDTGQVVAIKKFLESEEDPLIRKIALREIRLLKSLKHP 61
ERY+ + +G G+YG V + TG VA+KK + + K RE+RLLK +KH
Sbjct: 18 ERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHE 77
Query: 62 NLVNLLEVFRRKKKLH-----LVFEFCDHTVLNELENHPHGLPWDLIKQITWQVLRGVSY 116
N++ LL+VF + L + LN + L D ++ + +Q+LRG+ Y
Sbjct: 78 NVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKC-QKLTDDHVQFLIYQILRGLKY 136
Query: 117 CHRHACIHRDIKPENILLTANGVVKLCDFGFARLIRDLIPRHLH--------IFQTNEYF 168
H IHRD+KP N+ + + +K+ DFG AR D + ++ I ++
Sbjct: 137 IHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGYVATRWYRAPEIMLNWMHY 196
Query: 169 KGVSLPHAENVVPLEIKIGKP---AATNIYLIDFLKRCLDKDPLRRWSCDQLLRHPYFNG 225
+ + E+ G+ +I + + R + +
Sbjct: 197 NQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARNYIQ 256
Query: 226 YYFEVPDEMQYEEIT----------QRCLDKDPLRRWSCDQLLRHPYFNGYY 267
++P ++ L D +R + Q L H YF Y+
Sbjct: 257 SLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQYH 308
|
| >d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Mycobacterial protein kinase PknB, catalytic domain species: Mycobacterium tuberculosis [TaxId: 1773]
Score = 143 bits (362), Expect = 5e-42
Identities = 58/278 (20%), Positives = 111/278 (39%), Gaps = 32/278 (11%)
Query: 2 ERYEKIGKLGEGSYGVVFKCRNRDTGQVVAIKKF-LESEEDPLIRKIALREIRLLKSLKH 60
+RYE LG G V R+ + VA+K + DP RE + +L H
Sbjct: 7 DRYELGEILGFGGMSEVHLARDLRLHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNH 66
Query: 61 PNLVNLLEVFRRKKK----LHLVFEFCDHTVLNELENHPHGLPWDLIKQITWQVLRGVSY 116
P +V + + + ++V E+ D L ++ + + ++ + +++
Sbjct: 67 PAIVAVYDTGEAETPAGPLPYIVMEYVDGVTLRDIVHTEGPMTPKRAIEVIADACQALNF 126
Query: 117 CHRHACIHRDIKPENILLTANGVVKLCDFGFARLIRDLIPRHLHI--------FQTNEYF 168
H++ IHRD+KP NI+++A VK+ DFG AR I D + + E
Sbjct: 127 SHQNGIIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQTAAVIGTAQYLSPEQA 186
Query: 169 KGVSLPHAENV-----VPLEIKIGKPAATNIYLIDFLKRCLDKDPLRRWSCDQLLRHPYF 223
+G S+ +V V E+ G+P T + + + +DP+ + +
Sbjct: 187 RGDSVDARSDVYSLGCVLYEVLTGEPPFTGDSPVSVAYQHVREDPIPPSARHE------- 239
Query: 224 NGYYFEVPDEMQYEEITQRCLDKDPLRRWSCDQLLRHP 261
+ ++ + + L K+P R+ +R
Sbjct: 240 -----GLSADLD--AVVLKALAKNPENRYQTAAEMRAD 270
|
| >d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Focal adhesion kinase 1 (fak) species: Human (Homo sapiens) [TaxId: 9606]
Score = 143 bits (361), Expect = 7e-42
Identities = 55/271 (20%), Positives = 98/271 (36%), Gaps = 27/271 (9%)
Query: 2 ERYEKIGKLGEGSYGVVFKCRNRDT---GQVVAIKKFLESEEDPLIRKIALREIRLLKSL 58
ER E +GEG +G V + VAIK ++ +R+ L+E ++
Sbjct: 7 ERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKT-CKNCTSDSVREKFLQEALTMRQF 65
Query: 59 KHPNLVNLLEVFRRKKKLHLVFEFCDHTVLNELE-NHPHGLPWDLIKQITWQVLRGVSYC 117
HP++V L+ V + + ++ E C L + L + +Q+ ++Y
Sbjct: 66 DHPHIVKLIGVIT-ENPVWIIMELCTLGELRSFLQVRKYSLDLASLILYAYQLSTALAYL 124
Query: 118 HRHACIHRDIKPENILLTANGVVKLCDFGFARLIRDLIPRHLHIFQT------NEYFKGV 171
+HRDI N+L+++N VKL DFG +R + D + E
Sbjct: 125 ESKRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASKGKLPIKWMAPESINFR 184
Query: 172 SLPHAENVVPLEIKIGKPAATNIYLIDFLKRCLDKDPLRRWSCDQLLRHPYFNGYYFEVP 231
A +V + + + L P + + ++ NG +P
Sbjct: 185 RFTSASDVWMF----------GVCMWEIL--MHGVKPFQGVKNNDVIGR-IENGERLPMP 231
Query: 232 DEM--QYEEITQRCLDKDPLRRWSCDQLLRH 260
+ +C DP RR +L
Sbjct: 232 PNCPPTLYSLMTKCWAYDPSRRPRFTELKAQ 262
|
| >d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 311 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-KIT receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 142 bits (358), Expect = 5e-41
Identities = 61/284 (21%), Positives = 107/284 (37%), Gaps = 32/284 (11%)
Query: 2 ERYEKIGKLGEGSYGVVFKCR-----NRDTGQVVAIKKFLESEEDPLIRKIALREIRLLK 56
R LG G++G V + D VA+K L+ R+ + E+++L
Sbjct: 23 NRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKM-LKPSAHLTEREALMSELKVLS 81
Query: 57 SLK-HPNLVNLLEVFRRKKKLHLVFEFCDHTVLNEL------------------ENHPHG 97
L H N+VNLL ++ E+C + L E+
Sbjct: 82 YLGNHMNIVNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELA 141
Query: 98 LPWDLIKQITWQVLRGVSYCHRHACIHRDIKPENILLTANGVVKLCDFGFARLIRDLIPR 157
L + + ++QV +G+++ CIHRD+ NILLT + K+CDFG AR I++
Sbjct: 142 LDLEDLLSFSYQVAKGMAFLASKNCIHRDLAARNILLTHGRITKICDFGLARDIKNDSNY 201
Query: 158 HLHIFQTNEYFKGVSLPHAENVVPLEIKIGKPAATNIYLIDFLKRCLDKDPLRRWSCDQL 217
+ A + + + + + + L P D
Sbjct: 202 V-----VKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPYPGMPVDSK 256
Query: 218 LRHPYFNGYYFEVPDEM--QYEEITQRCLDKDPLRRWSCDQLLR 259
G+ P+ + +I + C D DPL+R + Q+++
Sbjct: 257 FYKMIKEGFRMLSPEHAPAEMYDIMKTCWDADPLKRPTFKQIVQ 300
|
| >d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Activated CDC42 kinase 1, ACK1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 141 bits (355), Expect = 6e-41
Identities = 57/266 (21%), Positives = 94/266 (35%), Gaps = 16/266 (6%)
Query: 2 ERYEKIGKLGEGSYGVVFKCRNRDT---GQVVAIKKF-LESEEDPLIRKIALREIRLLKS 57
+ + KLG+GS+GVV + VA+K + P +RE+ + S
Sbjct: 8 KDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHS 67
Query: 58 LKHPNLVNLLEVFRRKKKLHLVFEFCDHTVLNELENHPHG-LPWDLIKQITWQVLRGVSY 116
L H NL+ L V + +V E L + G + + QV G+ Y
Sbjct: 68 LDHRNLIRLYGVVL-TPPMKMVTELAPLGSLLDRLRKHQGHFLLGTLSRYAVQVAEGMGY 126
Query: 117 CHRHACIHRDIKPENILLTANGVVKLCDFGFARLIRDLIPRHLHIFQTNEYFKGVSLPHA 176
IHRD+ N+LL +VK+ DFG R + ++ E+ K A
Sbjct: 127 LESKRFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYV----MQEHRKVPFAWCA 182
Query: 177 ENVVPLEIKIGKPAATNIYLIDFLKRCL--DKDPLRRWSCDQLLRHPYFNGYYFEVPDEM 234
L+ + A+ L ++P + Q+L G P++
Sbjct: 183 PES--LKTRTFSHASDTWMFGVTLWEMFTYGQEPWIGLNGSQILHKIDKEGERLPRPEDC 240
Query: 235 --QYEEITQRCLDKDPLRRWSCDQLL 258
+ +C P R + L
Sbjct: 241 PQDIYNVMVQCWAHKPEDRPTFVALR 266
|
| >d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 285 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-src tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 139 bits (352), Expect = 3e-40
Identities = 62/272 (22%), Positives = 106/272 (38%), Gaps = 24/272 (8%)
Query: 2 ERYEKIGKLGEGSYGVVFKCRNRDTGQVVAIKKFLESEEDPLIRKIALREIRLLKSLKHP 61
E KLG+G +G V+ T +V AIK P + L+E +++K L+H
Sbjct: 17 ESLRLEVKLGQGCFGEVWMGTWNGTTRV-AIKTLKPGTMSP---EAFLQEAQVMKKLRHE 72
Query: 62 NLVNLLEVFRRKKKLHLVFEFCDHTVLNELENHPHGLP--WDLIKQITWQVLRGVSYCHR 119
LV L V + +++V E+ L + G + + Q+ G++Y R
Sbjct: 73 KLVQLYAVVSEEP-IYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVER 131
Query: 120 HACIHRDIKPENILLTANGVVKLCDFGFARLIRDLIPRHLHIFQTNEYFKGVSLPHAENV 179
+HRD++ NIL+ N V K+ DFG ARLI D + + + K A
Sbjct: 132 MNYVHRDLRAANILVGENLVCKVADFGLARLIED------NEYTARQGAKFPIKWTAPEA 185
Query: 180 VPLEIKIGKPAATNIY---LIDFLKRCLDKDPLRRWSCDQLLRHPYFNGYYFEVPDEM-- 234
++++ ++ + P ++L GY P E
Sbjct: 186 ALYG---RFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQ-VERGYRMPCPPECPE 241
Query: 235 QYEEITQRCLDKDPLRRWSCDQLLR--HPYFN 264
++ +C K+P R + + L YF
Sbjct: 242 SLHDLMCQCWRKEPEERPTFEYLQAFLEDYFT 273
|
| >d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 309 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tie2 kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 138 bits (349), Expect = 1e-39
Identities = 58/280 (20%), Positives = 100/280 (35%), Gaps = 29/280 (10%)
Query: 1 MERYEKIGKLGEGSYGVVFKCRNRDTGQVVAIK-KFLESEEDPLIRKIALREIRLLKSL- 58
+ +GEG++G V K R + G + K ++ + E+ +L L
Sbjct: 9 WNDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLG 68
Query: 59 KHPNLVNLLEVFRRKKKLHLVFEFCDHTVLNEL----------------ENHPHGLPWDL 102
HPN++NLL + L+L E+ H L + + L
Sbjct: 69 HHPNIINLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQ 128
Query: 103 IKQITWQVLRGVSYCHRHACIHRDIKPENILLTANGVVKLCDFGFARLIRDLIPRHLHIF 162
+ V RG+ Y + IHRD+ NIL+ N V K+ DFG +R ++
Sbjct: 129 LLHFAADVARGMDYLSQKQFIHRDLAARNILVGENYVAKIADFGLSRGQ--------EVY 180
Query: 163 QTNEYFKGVSLPHAENVVPLEIKIGKPAATNIYLIDFLKRCLDKDPLRRWSCDQLLRHPY 222
+ A + + + ++ + L P +C +L
Sbjct: 181 VKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAELYEK-L 239
Query: 223 FNGYYFEVPDEMQYE--EITQRCLDKDPLRRWSCDQLLRH 260
GY E P E ++ ++C + P R S Q+L
Sbjct: 240 PQGYRLEKPLNCDDEVYDLMRQCWREKPYERPSFAQILVS 279
|
| >d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 301 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Musk tyrosine kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 137 bits (345), Expect = 3e-39
Identities = 59/289 (20%), Positives = 102/289 (35%), Gaps = 38/289 (13%)
Query: 2 ERYEKIGKLGEGSYGVVFKCRNR-----DTGQVVAIKKFLESEEDPLIRKIALREIRLLK 56
E + +GEG++G VF+ R + +VA+K L+ E ++ RE L+
Sbjct: 13 NNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKM-LKEEASADMQADFQREAALMA 71
Query: 57 SLKHPNLVNLLEVFRRKKKLHLVFEFCDHTVLNEL------------------------E 92
+PN+V LL V K + L+FE+ + LNE
Sbjct: 72 EFDNPNIVKLLGVCAVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSS 131
Query: 93 NHPHGLPWDLIKQITWQVLRGVSYCHRHACIHRDIKPENILLTANGVVKLCDFGFARLIR 152
P L I QV G++Y +HRD+ N L+ N VVK+ DFG +R I
Sbjct: 132 PGPPPLSCAEQLCIARQVAAGMAYLSERKFVHRDLATRNCLVGENMVVKIADFGLSRNIY 191
Query: 153 DLIPRHLHIFQTNEYFKGVSLPHAENVVPLEIKIGKPAATNIYLIDFLKRCLDKDPLRRW 212
+ + + ++ + P
Sbjct: 192 SADYYK-----ADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGLQPYYGM 246
Query: 213 SCDQLLRHPYFNGYYFEVPDEM--QYEEITQRCLDKDPLRRWSCDQLLR 259
+ ++++ + +G P+ + + + C K P R S + R
Sbjct: 247 AHEEVIYY-VRDGNILACPENCPLELYNLMRLCWSKLPADRPSFCSIHR 294
|
| >d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Ribosomal protein S6 kinase alpha 5, Msk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 137 bits (345), Expect = 4e-39
Identities = 62/284 (21%), Positives = 113/284 (39%), Gaps = 20/284 (7%)
Query: 1 MERYEKIGKLGEGSYGVVFKCR---NRDTGQVVAIKKFLESE--EDPLIRKIALREIRLL 55
+E +E + LG G+YG VF R DTG++ A+K ++ + + E ++L
Sbjct: 23 IENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVL 82
Query: 56 KSLKH-PNLVNLLEVFRRKKKLHLVFEFCDHTVLNELENHPHGLPWDLIKQITWQVLRGV 114
+ ++ P LV L F+ + KLHL+ ++ + L + ++ +++ +
Sbjct: 83 EHIRQSPFLVTLHYAFQTETKLHLILDYINGGELFTHLSQRERFTEHEVQIYVGEIVLAL 142
Query: 115 SYCHRHACIHRDIKPENILLTANGVVKLCDFGFARLIRDLIPRHLHIFQTNEYFKGVSLP 174
+ H+ I+RDIK ENILL +NG V L DFG ++ + F +
Sbjct: 143 EHLHKLGIIYRDIKLENILLDSNGHVVLTDFGLSKEFVADETERAYDFCGTIEY-----M 197
Query: 175 HAENVVPLEIKIGKPAATNIYLIDFLKRCLDKDPLRRWSCDQLLRHPYFNGYYFEVPDEM 234
+ V + K + + P E P
Sbjct: 198 APDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKNSQAEISRRILKSEPPYPQ 257
Query: 235 QY----EEITQRCLDKDPLRRWSC-----DQLLRHPYFNGYYFE 269
+ +++ QR L KDP +R C D++ H +F ++
Sbjct: 258 EMSALAKDLIQRLLMKDPKKRLGCGPRDADEIKEHLFFQKINWD 301
|
| >d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 283 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: epha2 receptor tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 134 bits (338), Expect = 2e-38
Identities = 45/263 (17%), Positives = 96/263 (36%), Gaps = 9/263 (3%)
Query: 2 ERYEKIGKLGEGSYGVVFKCRNRDTGQ----VVAIKKFLESEEDPLIRKIALREIRLLKS 57
+ +G G +G V+K + + VAIK L++ R L E ++
Sbjct: 7 SCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKT-LKAGYTEKQRVDFLGEAGIMGQ 65
Query: 58 LKHPNLVNLLEVFRRKKKLHLVFEFCDHTVLNELENHPHG-LPWDLIKQITWQVLRGVSY 116
H N++ L V + K + ++ E+ ++ L++ G + + + G+ Y
Sbjct: 66 FSHHNIIRLEGVISKYKPMMIITEYMENGALDKFLREKDGEFSVLQLVGMLRGIAAGMKY 125
Query: 117 CHRHACIHRDIKPENILLTANGVVKLCDFGFARLIRDLIPRHLHIFQTNEYFKGVSLPHA 176
+HRD+ NIL+ +N V K+ DFG +R++ D P + + + P A
Sbjct: 126 LANMNYVHRDLAARNILVNSNLVCKVSDFGLSRVLED-DPEATYTTSGGKIPIRWTAPEA 184
Query: 177 ENVVPLEIKIGKPAATNIYLIDFLKRCLDKDPLRRWSCDQLLRHPYFNGYYFEVPDEMQY 236
+ + + L + + + + P +
Sbjct: 185 ISYRKFTSASDVWSFGIVMWEVMTYGERPYWELSNHEVMKAINDGFRLPTPMDCPSAIY- 243
Query: 237 EEITQRCLDKDPLRRWSCDQLLR 259
++ +C ++ RR ++
Sbjct: 244 -QLMMQCWQQERARRPKFADIVS 265
|
| >d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]} Length = 303 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Type I TGF-beta receptor R4 species: Human (Homo sapiens) [TaxId: 9606]
Score = 134 bits (337), Expect = 5e-38
Identities = 52/295 (17%), Positives = 101/295 (34%), Gaps = 44/295 (14%)
Query: 2 ERYEKIGKLGEGSYGVVFKCRNRDTGQVVAIKKFLESEEDPLIRKIALREIRLLKSLKHP 61
+G+G +G V++ + G+ VA+K F EE R+ EI L+H
Sbjct: 3 RTIVLQESIGKGRFGEVWRGK--WRGEEVAVKIFSSREERSWFRE---AEIYQTVMLRHE 57
Query: 62 NLVNLLEVFRRK----KKLHLVFEFCDHTVLNELENHPHGLPWDLIKQITWQVLRGVSYC 117
N++ + + +L LV ++ +H L + N + + + + ++ G+++
Sbjct: 58 NILGFIAADNKDNGTWTQLWLVSDYHEHGSLFDYLNR-YTVTVEGMIKLALSTASGLAHL 116
Query: 118 HRHAC--------IHRDIKPENILLTANGVVKLCDFGFARLIRDLIPRHLHIFQTN---- 165
H HRD+K +NIL+ NG + D G A
Sbjct: 117 HMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTK 176
Query: 166 -----EYFKGV-----------SLPHAENVVPLEIKIGKP-----AATNIYLIDFLKRCL 204
E + +A +V EI + D +
Sbjct: 177 RYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVPSDP 236
Query: 205 DKDPLRRWSCDQLLRHPYFNGYYFEVPDEMQYEEITQRCLDKDPLRRWSCDQLLR 259
+ +R+ C+Q LR P + +I + C + R + ++ +
Sbjct: 237 SVEEMRKVVCEQKLR-PNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKK 290
|
| >d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 133 bits (335), Expect = 9e-38
Identities = 48/284 (16%), Positives = 92/284 (32%), Gaps = 28/284 (9%)
Query: 3 RYEKIGKLGEGSYGVVFKCRNRDTGQVVAIKKFLESEEDPLIRKIALREIRLLKSLKHPN 62
RY K+G GS+G ++ + G+ VAIK + P + E ++ K ++
Sbjct: 8 RYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTKHPQLH----IESKIYKMMQGGV 63
Query: 63 LVNLLE-VFRRKKKLHLVFEFCDHTVLNELENHPHGLPWDLIKQITWQVLRGVSYCHRHA 121
+ + +V E ++ + + + Q++ + Y H
Sbjct: 64 GIPTIRWCGAEGDYNVMVMELLGPSLEDLFNFCSRKFSLKTVLLLADQMISRIEYIHSKN 123
Query: 122 CIHRDIKPENILLTANG---VVKLCDFGFARLIRDLIPRHLHIFQTNEYFKGVSLPHAEN 178
IHRD+KP+N L+ +V + DFG A+ RD Q Y + +L
Sbjct: 124 FIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRD-----ARTHQHIPYRENKNLTGTAR 178
Query: 179 VVPLEIKIGKPAATN-------IYLIDFLKRCLDKDPLRRWSCDQLLRHPYFNGYYFEVP 231
+ +G + L+ F L L+ + Q +
Sbjct: 179 YASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKMSTPIE 238
Query: 232 DEM-----QYEEITQRCLDKDPLRRWSCD---QLLRHPYFNGYY 267
++ C + QL R+ + +
Sbjct: 239 VLCKGYPSEFATYLNFCRSLRFDDKPDYSYLRQLFRNLFHRQGF 282
|
| >d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Vascular endothelial growth factor receptor 2 (kdr) species: Human (Homo sapiens) [TaxId: 9606]
Score = 131 bits (329), Expect = 7e-37
Identities = 60/283 (21%), Positives = 101/283 (35%), Gaps = 29/283 (10%)
Query: 2 ERYEKIGKLGEGSYGVVFKCRNRD-----TGQVVAIKKFLESEEDPLIRKIALREIRLLK 56
+R + LG G++G V + T + VA+K E R + L+
Sbjct: 13 DRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIH 72
Query: 57 SLKHPNLVNLLEV-FRRKKKLHLVFEFCDHTVLNEL----------------ENHPHGLP 99
H N+VNLL + L ++ EFC L+ + + L
Sbjct: 73 IGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLT 132
Query: 100 WDLIKQITWQVLRGVSYCHRHACIHRDIKPENILLTANGVVKLCDFGFARLIRDLIPRHL 159
+ + ++QV +G+ + CIHRD+ NILL+ VVK+CDFG AR I
Sbjct: 133 LEHLICYSFQVAKGMEFLASRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVR 192
Query: 160 HIFQTNEYFKGVSLPHAENVVPLEIKIGKPAATNIYLIDFLKRCLDKDPLRRWSCDQLLR 219
+ A + + + + ++ + L P D+
Sbjct: 193 K-----GDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFC 247
Query: 220 HPYFNGYYFEVPDEMQYE--EITQRCLDKDPLRRWSCDQLLRH 260
G PD E + C +P +R + +L+ H
Sbjct: 248 RRLKEGTRMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEH 290
|
| >d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 308 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Insulin-like growth factor 1 receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 128 bits (322), Expect = 8e-36
Identities = 60/300 (20%), Positives = 108/300 (36%), Gaps = 40/300 (13%)
Query: 2 ERYEKIGKLGEGSYGVVFKCRNR-----DTGQVVAIKKFLESEEDPLIRKIALREIRLLK 56
E+ +LG+GS+G+V++ + + VAIK + R L E ++K
Sbjct: 20 EKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKT-VNEAASMRERIEFLNEASVMK 78
Query: 57 SLKHPNLVNLLEVFRRKKKLHLVFEFCDHTVLNELENHPHG----------LPWDLIKQI 106
++V LL V + + ++ E L + Q+
Sbjct: 79 EFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQM 138
Query: 107 TWQVLRGVSYCHRHACIHRDIKPENILLTANGVVKLCDFGFARLIRDLIPRHLHIFQTNE 166
++ G++Y + + +HRD+ N ++ + VK+ DFG R I + T+
Sbjct: 139 AGEIADGMAYLNANKFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYE----------TDY 188
Query: 167 YFKGVSLPHAENVVPLEIKIGKPAATNIYLIDFLK-----RCLDKDPLRRWSCDQLLRHP 221
Y KG + E T + F L + P + S +Q+LR
Sbjct: 189 YRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLSNEQVLRF- 247
Query: 222 YFNGYYFEVPDEM--QYEEITQRCLDKDPLRRWSCDQLLR------HPYFNGYYFEVPDE 273
G + PD E+ + C +P R S +++ P F F +E
Sbjct: 248 VMEGGLLDKPDNCPDMLFELMRMCWQYNPKMRPSFLEIISSIKEEMEPGFREVSFYYSEE 307
|
| >d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Score = 128 bits (321), Expect = 9e-36
Identities = 41/175 (23%), Positives = 73/175 (41%), Gaps = 10/175 (5%)
Query: 2 ERYEKIGKLGEGSYGVVFKCRNRDTGQVVAIKKFLESEEDPLIRKIALREIRLLKSLKH- 60
Y+ ++GEGS+GV+F+ N Q VAIK + P +R E R K L
Sbjct: 5 VHYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRSDAPQLR----DEYRTYKLLAGC 60
Query: 61 PNLVNLLEVFRRKKKLHLVFEFCDHTVLNELENHPHGLPWDLIKQITWQVLRGVSYCHRH 120
+ N+ + LV + ++ + L+ + Q+L V H
Sbjct: 61 TGIPNVYYFGQEGLHNVLVIDLLGPSLEDLLDLCGRKFSVKTVAMAAKQMLARVQSIHEK 120
Query: 121 ACIHRDIKPENILLTA-----NGVVKLCDFGFARLIRDLIPRHLHIFQTNEYFKG 170
+ ++RDIKP+N L+ ++ + DFG + RD + + ++ + G
Sbjct: 121 SLVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFYRDPVTKQHIPYREKKNLSG 175
|
| >d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]} Length = 311 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Hepatocyte growth factor receptor, c-MET species: Human (Homo sapiens) [TaxId: 9606]
Score = 124 bits (313), Expect = 2e-34
Identities = 50/262 (19%), Positives = 89/262 (33%), Gaps = 18/262 (6%)
Query: 9 KLGEGSYGVVFKCRNRD---TGQVVAIKKFLESEEDPLIRKIALREIRLLKSLKHPNLVN 65
+G G +G V+ D A+K L D L E ++K HPN+++
Sbjct: 34 VIGRGHFGCVYHGTLLDNDGKKIHCAVKS-LNRITDIGEVSQFLTEGIIMKDFSHPNVLS 92
Query: 66 LLEV-FRRKKKLHLVFEFCDHTVLNELEN-HPHGLPWDLIKQITWQVLRGVSYCHRHACI 123
LL + R + +V + H L H + QV +G+ + +
Sbjct: 93 LLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKFLASKKFV 152
Query: 124 HRDIKPENILLTANGVVKLCDFGFARLIRDLIPRHLHIFQTNEYFKGVSLPHAENVVPLE 183
HRD+ N +L VK+ DFG AR + D F + G LP +
Sbjct: 153 HRDLAARNCMLDEKFTVKVADFGLARDMYD------KEFDSVHNKTGAKLPVKWMALESL 206
Query: 184 IKIGKPAATNIY---LIDFLKRCLDKDPLRRWSCDQLLRHPYFNGYYFEVPDEM--QYEE 238
++++ ++ + P + + + G P+ E
Sbjct: 207 QTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVY-LLQGRRLLQPEYCPDPLYE 265
Query: 239 ITQRCLDKDPLRRWSCDQLLRH 260
+ +C R S +L+
Sbjct: 266 VMLKCWHPKAEMRPSFSELVSR 287
|
| >d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fibroblast growth factor receptor 1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 121 bits (305), Expect = 2e-33
Identities = 58/285 (20%), Positives = 101/285 (35%), Gaps = 33/285 (11%)
Query: 2 ERYEKIGKLGEGSYGVVFKCRNRDT-------GQVVAIKKFLESEEDPLIRKIALREIRL 54
+R LGEG++G V VA+K L+S+ + E+ +
Sbjct: 13 DRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKM-LKSDATEKDLSDLISEMEM 71
Query: 55 LKSL-KHPNLVNLLEVFRRKKKLHLVFEFCDHTVLNEL----------------ENHPHG 97
+K + KH N++NLL + L+++ E+ L E N
Sbjct: 72 MKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQ 131
Query: 98 LPWDLIKQITWQVLRGVSYCHRHACIHRDIKPENILLTANGVVKLCDFGFARLIRDLIPR 157
L + +QV RG+ Y CIHRD+ N+L+T + V+K+ DFG AR I +
Sbjct: 132 LSSKDLVSCAYQVARGMEYLASKKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYY 191
Query: 158 HLHIFQTNEYFKGVSLPHAENVVPLEIKIGKPAATNIYLIDFLKRCLDKDPLRRWSCDQL 217
+ + + + + L P ++L
Sbjct: 192 KKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIF-----TLGGSPYPGVPVEEL 246
Query: 218 LRHPYFNGYYFEVPDEMQYE--EITQRCLDKDPLRRWSCDQLLRH 260
+ G+ + P E + + C P +R + QL+
Sbjct: 247 FKL-LKEGHRMDKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVED 290
|
| >d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 362 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Sky1p species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Score = 115 bits (288), Expect = 2e-30
Identities = 63/347 (18%), Positives = 112/347 (32%), Gaps = 67/347 (19%)
Query: 3 RYEKIGKLGEGSYGVVFKCRNRDTGQVVAIKKFLESEEDPLIRKIALREIRLLKSLKHPN 62
RY + KLG G + V+ ++ VA+K D + + A EI+LL+ + +
Sbjct: 14 RYILVRKLGWGHFSTVWLAKDMVNNTHVAMKIV---RGDKVYTEAAEDEIKLLQRVNDAD 70
Query: 63 LVNLLEV---------------FRRKKKLHLVFEFCDHTVLNELENHPHGL-PWDLIKQI 106
+ + +VFE +L ++ + H P +KQI
Sbjct: 71 NTKEDSMGANHILKLLDHFNHKGPNGVHVVMVFEVLGENLLALIKKYEHRGIPLIYVKQI 130
Query: 107 TWQVLRGVSYCHRHACI-HRDIKPENILLTANGV------VKLCDFGFARLIRDLIP--- 156
+ Q+L G+ Y HR I H DIKPEN+L+ +K+ D G A +
Sbjct: 131 SKQLLLGLDYMHRRCGIIHTDIKPENVLMEIVDSPENLIQIKIADLGNACWYDEHYTNSI 190
Query: 157 -----RHLHIFQTNEYFKGVSLPHAENVV--------PLEIKIGKPAATNIYLIDFLKRC 203
R + + G + ++ E G + I +
Sbjct: 191 QTREYRSPEVLLGAPWGCGADIWSTACLIFELITGDFLFEPDEGHSYTKDDDHIAQIIEL 250
Query: 204 LDKDPLRRWSCDQLLRHPYFNGYYFEVPDEMQYEEIT---------------------QR 242
L + P + R + + ++++ +
Sbjct: 251 LGELPSYLLRNGKYTRTFFNSRGLLRNISKLKFWPLEDVLTEKYKFSKDEAKEISDFLSP 310
Query: 243 CLDKDPLRRWSCDQLLRHPYFNGYY----FEVPDEMQYEEITQVSRL 285
L DP +R L+ HP+ VPD Y + +
Sbjct: 311 MLQLDPRKRADAGGLVNHPWLKDTLGMEEIRVPDRELYGSGSDIPGW 357
|
| >d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]} Length = 191 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: RIO1-like kinases domain: Rio2 serine protein kinase C-terminal domain species: Archaeoglobus fulgidus [TaxId: 2234]
Score = 85.6 bits (211), Expect = 8e-21
Identities = 24/157 (15%), Positives = 51/157 (32%), Gaps = 29/157 (18%)
Query: 9 KLGEGSYGVVFKCRNRDTGQVVAIKKF----------------LESEEDPLIRKIALREI 52
+GEG VF C + +K + L + A E
Sbjct: 7 LMGEGKESAVFNCYSEK-FGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEF 65
Query: 53 RLLKSLKHPNLVNLLEVFRRKKKLHLVFEFCDHTVLNELENHPHGLPWDLIKQITWQVLR 112
R L+ L+ + + ++ E D + + + ++ +L
Sbjct: 66 RALQKLQGLAVPKVYAWEGN----AVLMELIDA-------KELYRVRVENPDEVLDMILE 114
Query: 113 GVSYCHRHACIHRDIKPENILLTANGVVKLCDFGFAR 149
V+ + +H D+ N+L++ G + + DF +
Sbjct: 115 EVAKFYHRGIVHGDLSQYNVLVSEEG-IWIIDFPQSV 150
|
Homologous Domains Detected by HHsearch
Original result of HHsearch against SCOP70(version1.75) database
| ID | Alignment Graph | Length |
Definition |
Probability |
| Query | 292 | |||
| d2j4za1 | 263 | Aurora-related kinase 1 (aurora-2) {Human (Homo sa | 100.0 | |
| d1nvra_ | 271 | Cell cycle checkpoint kinase chk1 {Human (Homo sap | 100.0 | |
| d1uu3a_ | 288 | 3-phosphoinositide dependent protein kinase-1 Pdk1 | 100.0 | |
| d1o6la_ | 337 | Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9 | 100.0 | |
| d1yhwa1 | 293 | pak1 {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d2jfla1 | 288 | STE20-like serine/threonine-protein kinase, SLK {H | 100.0 | |
| d1fota_ | 316 | cAMP-dependent PK, catalytic subunit {Baker's yeas | 100.0 | |
| d1a06a_ | 307 | Calmodulin-dependent protein kinase {Rat (Rattus n | 100.0 | |
| d1u5ra_ | 309 | Serine/threonine protein kinase TAO2 {Rat (Rattus | 100.0 | |
| d1jksa_ | 293 | Death-associated protein kinase, Dap {Human (Homo | 100.0 | |
| d2java1 | 269 | Serine/threonine-protein kinase Nek2 {Human (Homo | 100.0 | |
| d1koaa2 | 350 | Twitchin, kinase domain {Caenorhabditis elegans, p | 100.0 | |
| d1koba_ | 352 | Twitchin, kinase domain {California sea hare (Aply | 100.0 | |
| d1rdqe_ | 350 | cAMP-dependent PK, catalytic subunit {Mouse (Mus m | 100.0 | |
| d1gz8a_ | 298 | Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [T | 100.0 | |
| d1t4ha_ | 270 | Protein kinase wnk1 {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1s9ja_ | 322 | Dual specificity mitogen-activated protein kinase | 100.0 | |
| d1phka_ | 277 | gamma-subunit of glycogen phosphorylase kinase (Ph | 100.0 | |
| d1xjda_ | 320 | Protein kinase C, theta type {Human (Homo sapiens) | 100.0 | |
| d1omwa3 | 364 | G-protein coupled receptor kinase 2 {Cow (Bos taur | 100.0 | |
| d1ob3a_ | 286 | Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) | 100.0 | |
| d1ua2a_ | 299 | Cell division protein kinase 7, CDK7 {Human (Homo | 100.0 | |
| d1tkia_ | 321 | Titin, kinase domain {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1unla_ | 292 | Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [T | 100.0 | |
| d1xwsa_ | 273 | Proto-oncogene serine/threonine-protein kinase Pim | 100.0 | |
| d1cm8a_ | 346 | MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: | 100.0 | |
| d2ozaa1 | 335 | MAP kinase activated protein kinase 2, mapkap2 {Hu | 100.0 | |
| d1blxa_ | 305 | Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [T | 100.0 | |
| d3blha1 | 318 | Cell division protein kinase 9, CDK9 {Human (Homo | 100.0 | |
| d3bqca1 | 328 | Protein kinase CK2, alpha subunit {Rattus norvegic | 100.0 | |
| d1opja_ | 287 | Abelsone tyrosine kinase (abl) {Mouse (Mus musculu | 100.0 | |
| d2b1pa1 | 355 | c-jun N-terminal kinase (jnk3s) {Human (Homo sapie | 100.0 | |
| d1pmea_ | 345 | MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606 | 100.0 | |
| d1q5ka_ | 350 | Glycogen synthase kinase-3 beta (Gsk3b) {Human (Ho | 100.0 | |
| d1jpaa_ | 299 | ephb2 receptor tyrosine kinase {Mouse (Mus musculu | 100.0 | |
| d2gfsa1 | 348 | MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606] | 100.0 | |
| d1xbba_ | 277 | Tyrosine-protein kinase SYK {Human (Homo sapiens) | 100.0 | |
| d1uwha_ | 276 | B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d1sm2a_ | 263 | Tyrosine-protein kinase Itk/Tsk {Human (Homo sapie | 100.0 | |
| d1k2pa_ | 258 | Bruton's tyrosine kinase (Btk) {Human (Homo sapien | 100.0 | |
| d1o6ya_ | 277 | Mycobacterial protein kinase PknB, catalytic domai | 100.0 | |
| d1qpca_ | 272 | Lymphocyte kinase (lck) {Human (Homo sapiens) [Tax | 100.0 | |
| d1vzoa_ | 322 | Ribosomal protein S6 kinase alpha 5, Msk1 {Human ( | 100.0 | |
| d1rjba_ | 325 | Fl cytokine receptor {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1u59a_ | 285 | Tyrosine-protein kinase ZAP-70 {Human (Homo sapien | 100.0 | |
| d1fmka3 | 285 | c-src tyrosine kinase {Human (Homo sapiens) [TaxId | 100.0 | |
| d1mqba_ | 283 | epha2 receptor tyrosine kinase {Human (Homo sapien | 100.0 | |
| d1mp8a_ | 273 | Focal adhesion kinase 1 (fak) {Human (Homo sapiens | 100.0 | |
| d1byga_ | 262 | Carboxyl-terminal src kinase (csk) {Human (Homo sa | 100.0 | |
| d1lufa_ | 301 | Musk tyrosine kinase {Rat (Rattus norvegicus) [Tax | 100.0 | |
| d1xkka_ | 317 | EGF receptor tyrosine kinase, Erbb-1 {Human (Homo | 100.0 | |
| d1fvra_ | 309 | Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d1u46a_ | 273 | Activated CDC42 kinase 1, ACK1 {Human (Homo sapien | 100.0 | |
| d1p4oa_ | 308 | Insulin-like growth factor 1 receptor {Human (Homo | 100.0 | |
| d1fgka_ | 299 | Fibroblast growth factor receptor 1 {Human (Homo s | 100.0 | |
| d1ywna1 | 299 | Vascular endothelial growth factor receptor 2 (kdr | 100.0 | |
| d1r0pa_ | 311 | Hepatocyte growth factor receptor, c-MET {Human (H | 100.0 | |
| d1t46a_ | 311 | c-KIT receptor {Human (Homo sapiens) [TaxId: 9606] | 100.0 | |
| d1vjya_ | 303 | Type I TGF-beta receptor R4 {Human (Homo sapiens) | 100.0 | |
| d1ckia_ | 299 | Casein kinase-1, CK1 {Rat (Rattus norvegicus) [Tax | 100.0 | |
| d1q8ya_ | 362 | Sky1p {Baker's yeast (Saccharomyces cerevisiae) [T | 100.0 | |
| d1csna_ | 293 | Casein kinase-1, CK1 {Fission yeast (Schizosacchar | 100.0 | |
| d1zara2 | 191 | Rio2 serine protein kinase C-terminal domain {Arch | 99.93 | |
| d1j7la_ | 263 | Type IIIa 3',5"-aminoglycoside phosphotransferase | 98.9 | |
| d1nd4a_ | 255 | Aminoglycoside 3'-phosphotransferase IIa (Kanamyci | 98.48 | |
| d2pula1 | 392 | Methylthioribose kinase MtnK {Bacillus subtilis [T | 98.31 | |
| d1nw1a_ | 395 | Choline kinase {Caenorhabditis elegans [TaxId: 623 | 97.62 | |
| d1zyla1 | 325 | RdoA {Escherichia coli [TaxId: 562]} | 97.45 | |
| d2ppqa1 | 316 | Homoserine kinase ThrB {Agrobacterium tumefaciens | 97.38 | |
| d1o6la_ | 337 | Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9 | 97.34 | |
| d1yhwa1 | 293 | pak1 {Human (Homo sapiens) [TaxId: 9606]} | 97.03 | |
| d2java1 | 269 | Serine/threonine-protein kinase Nek2 {Human (Homo | 96.77 | |
| d1xjda_ | 320 | Protein kinase C, theta type {Human (Homo sapiens) | 96.56 | |
| d1a06a_ | 307 | Calmodulin-dependent protein kinase {Rat (Rattus n | 96.24 | |
| d1s9ja_ | 322 | Dual specificity mitogen-activated protein kinase | 95.84 | |
| d1koba_ | 352 | Twitchin, kinase domain {California sea hare (Aply | 95.79 | |
| d1jksa_ | 293 | Death-associated protein kinase, Dap {Human (Homo | 95.51 | |
| d1phka_ | 277 | gamma-subunit of glycogen phosphorylase kinase (Ph | 95.45 | |
| d1t4ha_ | 270 | Protein kinase wnk1 {Human (Homo sapiens) [TaxId: | 95.44 | |
| d1tkia_ | 321 | Titin, kinase domain {Human (Homo sapiens) [TaxId: | 95.39 | |
| d1koaa2 | 350 | Twitchin, kinase domain {Caenorhabditis elegans, p | 95.38 | |
| d2j4za1 | 263 | Aurora-related kinase 1 (aurora-2) {Human (Homo sa | 95.38 | |
| d1vzoa_ | 322 | Ribosomal protein S6 kinase alpha 5, Msk1 {Human ( | 95.34 | |
| d1omwa3 | 364 | G-protein coupled receptor kinase 2 {Cow (Bos taur | 95.33 | |
| d1fota_ | 316 | cAMP-dependent PK, catalytic subunit {Baker's yeas | 94.69 | |
| d1uu3a_ | 288 | 3-phosphoinositide dependent protein kinase-1 Pdk1 | 94.64 | |
| d1rdqe_ | 350 | cAMP-dependent PK, catalytic subunit {Mouse (Mus m | 94.64 | |
| d1ua2a_ | 299 | Cell division protein kinase 7, CDK7 {Human (Homo | 94.62 | |
| d1unla_ | 292 | Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [T | 94.48 | |
| d1gz8a_ | 298 | Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [T | 94.33 | |
| d3blha1 | 318 | Cell division protein kinase 9, CDK9 {Human (Homo | 94.01 | |
| d2jfla1 | 288 | STE20-like serine/threonine-protein kinase, SLK {H | 93.7 | |
| d2gfsa1 | 348 | MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606] | 93.28 | |
| d3bqca1 | 328 | Protein kinase CK2, alpha subunit {Rattus norvegic | 93.1 | |
| d1blxa_ | 305 | Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [T | 93.03 | |
| d1ob3a_ | 286 | Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) | 92.94 | |
| d1cm8a_ | 346 | MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: | 92.86 | |
| d1nvra_ | 271 | Cell cycle checkpoint kinase chk1 {Human (Homo sap | 92.25 | |
| d1q8ya_ | 362 | Sky1p {Baker's yeast (Saccharomyces cerevisiae) [T | 92.2 | |
| d1xwsa_ | 273 | Proto-oncogene serine/threonine-protein kinase Pim | 91.96 | |
| d1pmea_ | 345 | MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606 | 91.12 | |
| d2b1pa1 | 355 | c-jun N-terminal kinase (jnk3s) {Human (Homo sapie | 91.09 | |
| d1u5ra_ | 309 | Serine/threonine protein kinase TAO2 {Rat (Rattus | 90.74 | |
| d1q5ka_ | 350 | Glycogen synthase kinase-3 beta (Gsk3b) {Human (Ho | 90.52 | |
| d2ozaa1 | 335 | MAP kinase activated protein kinase 2, mapkap2 {Hu | 87.9 | |
| d1ckia_ | 299 | Casein kinase-1, CK1 {Rat (Rattus norvegicus) [Tax | 86.41 | |
| d1t46a_ | 311 | c-KIT receptor {Human (Homo sapiens) [TaxId: 9606] | 84.61 | |
| d1cjaa_ | 342 | Actin-fragmin kinase, catalytic domain {Physarum p | 82.59 | |
| d1rjba_ | 325 | Fl cytokine receptor {Human (Homo sapiens) [TaxId: | 82.1 | |
| d1mp8a_ | 273 | Focal adhesion kinase 1 (fak) {Human (Homo sapiens | 81.85 |
| >d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Aurora-related kinase 1 (aurora-2) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.1e-56 Score=356.14 Aligned_cols=252 Identities=21% Similarity=0.335 Sum_probs=203.9
Q ss_pred CcccceeeeecccCceEEEEEEEcCCCcEEEEEEeccCCC-ChHHHHHHHHHHHHHHhCCCCCcchhhhhhhcCCeEEEE
Q psy758 1 MERYEKIGKLGEGSYGVVFKCRNRDTGQVVAIKKFLESEE-DPLIRKIALREIRLLKSLKHPNLVNLLEVFRRKKKLHLV 79 (292)
Q Consensus 1 ~~~y~~~~~l~~g~~~~v~~~~~~~~~~~v~iK~~~~~~~-~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~iv 79 (292)
|++|++++.||+|+||.||+|++..+++.||+|++..... .....+.+.+|+.+++.++||||+++++++.+++.+|+|
T Consensus 5 l~dy~i~~~iG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~iv 84 (263)
T d2j4za1 5 LEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYFHDATRVYLI 84 (263)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEE
T ss_pred hhHeEEEEEEecCCCcEEEEEEECCCCcEEEEEEEchHHccChHHHHHHHHHHHHHHhcCCCCCCeEEEEEEECCEEEEE
Confidence 5799999999999999999999999999999999865431 122356678999999999999999999999999999999
Q ss_pred EecCCCccHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEEccCCcEEEeecCchhhhhccc---c
Q psy758 80 FEFCDHTVLNELENHPHGLPWDLIKQITWQVLRGVSYCHRHACIHRDIKPENILLTANGVVKLCDFGFARLIRDLI---P 156 (292)
Q Consensus 80 ~e~~~~~~L~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~givH~dl~p~Nilv~~~~~~kl~dfg~~~~~~~~~---~ 156 (292)
||||++|+|..++...+.+++..++.++.||+.||+|||++||+||||||+||+++.++.+||+|||++....... .
T Consensus 85 mEy~~~g~L~~~l~~~~~l~e~~~~~i~~qi~~al~~lH~~~ivHrDiKp~Nill~~~~~~kl~DFG~a~~~~~~~~~~~ 164 (263)
T d2j4za1 85 LEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCHSKRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRRTTL 164 (263)
T ss_dssp EECCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTSCEEECCCCSCSCCCCCCCEET
T ss_pred EeecCCCcHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHCCeeeeeeccccceecCCCCEeecccceeeecCCCccccc
Confidence 9999999999999877789999999999999999999999999999999999999999999999999997654322 2
Q ss_pred ccccccccccccccCCCCCCCcccceeeecCCCCCCchHHHHHHHhhcccCCCCCCChhhhhhccCcCCCCCCCCCccch
Q psy758 157 RHLHIFQTNEYFKGVSLPHAENVVPLEIKIGKPAATNIYLIDFLKRCLDKDPLRRWSCDQLLRHPYFNGYYFEVPDEMQY 236 (292)
Q Consensus 157 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~l 236 (292)
.++..|.+||...+.......|+ ++.+..++..+.+..|+...+..+++..........+...++++
T Consensus 165 ~Gt~~Y~APE~~~~~~~~~~~Di-------------wSlGvilyell~G~~Pf~~~~~~~~~~~i~~~~~~~p~~~s~~~ 231 (263)
T d2j4za1 165 CGTLDYLPPEMIEGRMHDEKVDL-------------WSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFTFPDFVTEGA 231 (263)
T ss_dssp TEEGGGCCHHHHTTCCCCTTHHH-------------HHHHHHHHHHHHSSCTTCCSSHHHHHHHHHTTCCCCCTTSCHHH
T ss_pred CCCCcccCHHHHcCCCCCchhhh-------------hhHhHHHHHHhcCCCCCCCCCHHHHHHHHHcCCCCCCccCCHHH
Confidence 33455677776655443333333 33333344445555566555555555443333444556678899
Q ss_pred HHHHhcccCcCCCCCCChhhhhhCCcccc
Q psy758 237 EEITQRCLDKDPLRRWSCDQLLRHPYFNG 265 (292)
Q Consensus 237 ~~li~~~l~~dP~~Rpt~~~il~h~w~~~ 265 (292)
++||.+||+.||++|||++|+|+||||++
T Consensus 232 ~~li~~~L~~dp~~R~t~~eil~hp~~~~ 260 (263)
T d2j4za1 232 RDLISRLLKHNPSQRPMLREVLEHPWITA 260 (263)
T ss_dssp HHHHHHHTCSSGGGSCCHHHHHTCHHHHH
T ss_pred HHHHHHHccCCHhHCcCHHHHHcCcCcCC
Confidence 99999999999999999999999999975
|
| >d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell cycle checkpoint kinase chk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=9.9e-56 Score=351.85 Aligned_cols=246 Identities=24% Similarity=0.273 Sum_probs=190.6
Q ss_pred CcccceeeeecccCceEEEEEEEcCCCcEEEEEEeccCCCChHHHHHHHHHHHHHHhCCCCCcchhhhhhhcCCeEEEEE
Q psy758 1 MERYEKIGKLGEGSYGVVFKCRNRDTGQVVAIKKFLESEEDPLIRKIALREIRLLKSLKHPNLVNLLEVFRRKKKLHLVF 80 (292)
Q Consensus 1 ~~~y~~~~~l~~g~~~~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~iv~ 80 (292)
+++|++++.||+|+||.||+|++..+|+.||+|++...... ...+.+.+|+.+++.++||||+++++++.+++.+|+||
T Consensus 4 ~~dy~~~~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~-~~~~~~~~Ei~~l~~l~HpnIv~~~~~~~~~~~~~ivm 82 (271)
T d1nvra_ 4 VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAV-DCPENIKKEICINKMLNHENVVKFYGHRREGNIQYLFL 82 (271)
T ss_dssp TTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECC--------CHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEE
T ss_pred CcceEEEEEEecCcCeEEEEEEECCCCCEEEEEEEehhhcc-hHHHHHHHHHHHHHhCCCCCEeeEeeeeccCceeEEEE
Confidence 57899999999999999999999999999999999765432 23456889999999999999999999999999999999
Q ss_pred ecCCCccHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEEccCCcEEEeecCchhhhhccc-----
Q psy758 81 EFCDHTVLNELENHPHGLPWDLIKQITWQVLRGVSYCHRHACIHRDIKPENILLTANGVVKLCDFGFARLIRDLI----- 155 (292)
Q Consensus 81 e~~~~~~L~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~givH~dl~p~Nilv~~~~~~kl~dfg~~~~~~~~~----- 155 (292)
|||+||+|.+++...+.+++..++.++.||+.||+|||++||+||||||+|||+++++.+||+|||+++......
T Consensus 83 Ey~~gg~L~~~l~~~~~l~e~~~~~i~~qi~~al~ylH~~~IiHrDiKp~NILl~~~~~~KL~DFG~a~~~~~~~~~~~~ 162 (271)
T d1nvra_ 83 EYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHGIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLL 162 (271)
T ss_dssp ECCTTEEGGGGSBTTTBCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECTTCCEEECCCTTCEECEETTEECCB
T ss_pred eccCCCcHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcCCccCcccHHHEEECCCCCEEEccchhheeeccCCccccc
Confidence 999999999999888889999999999999999999999999999999999999999999999999998754321
Q ss_pred --cccccccccccccccCCC------CCCCcccceeeecCCCCCCchHHHHHHHhhcccCCCCCCChhhhhhccCcC---
Q psy758 156 --PRHLHIFQTNEYFKGVSL------PHAENVVPLEIKIGKPAATNIYLIDFLKRCLDKDPLRRWSCDQLLRHPYFN--- 224 (292)
Q Consensus 156 --~~~~~~~~~~~~~~~~~~------~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~--- 224 (292)
..++..|.+||...+... .|+.|+..+++.+|.+ |+...+...........
T Consensus 163 ~~~~GT~~Y~APE~~~~~~~~~~~~DiwSlGvilyeml~G~~------------------pf~~~~~~~~~~~~~~~~~~ 224 (271)
T d1nvra_ 163 NKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGEL------------------PWDQPSDSCQEYSDWKEKKT 224 (271)
T ss_dssp CCCCSCGGGSCTHHHHCSSBCHHHHHHHHHHHHHHHHHHSSC------------------SCSSSSTTSHHHHHHHTTCT
T ss_pred cceeeCcCccCHhHhcCCCCCCCceeeeHhHHHHHHHHhCCC------------------CCCCCChHHHHHHHHhcCCC
Confidence 123455667766544332 2334444444444444 43322211111000000
Q ss_pred CCCCCCCCccchHHHHhcccCcCCCCCCChhhhhhCCcccc
Q psy758 225 GYYFEVPDEMQYEEITQRCLDKDPLRRWSCDQLLRHPYFNG 265 (292)
Q Consensus 225 ~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~~il~h~w~~~ 265 (292)
........+.++.+||.+||+.||++|||++|+++||||+.
T Consensus 225 ~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~eil~hpwf~~ 265 (271)
T d1nvra_ 225 YLNPWKKIDSAPLALLHKILVENPSARITIPDIKKDRWYNK 265 (271)
T ss_dssp TSTTGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTTCTTTTC
T ss_pred CCCccccCCHHHHHHHHHHcCCChhHCcCHHHHhcCHhhCc
Confidence 01112244778999999999999999999999999999974
|
| >d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: 3-phosphoinositide dependent protein kinase-1 Pdk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.8e-56 Score=358.07 Aligned_cols=255 Identities=23% Similarity=0.295 Sum_probs=204.1
Q ss_pred cccceeeeecccCceEEEEEEEcCCCcEEEEEEeccCC-CChHHHHHHHHHHHHHHhCCCCCcchhhhhhhcCCeEEEEE
Q psy758 2 ERYEKIGKLGEGSYGVVFKCRNRDTGQVVAIKKFLESE-EDPLIRKIALREIRLLKSLKHPNLVNLLEVFRRKKKLHLVF 80 (292)
Q Consensus 2 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~v~iK~~~~~~-~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~iv~ 80 (292)
++|++++.||+|+||.||+|++..+|+.||+|++.... ......+.+.+|+.+++.++||||+++++++.+++.+|+||
T Consensus 8 ~dy~i~~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~ivm 87 (288)
T d1uu3a_ 8 EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYFTFQDDEKLYFGL 87 (288)
T ss_dssp GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCSTTBCCEEEEEECSSEEEEEE
T ss_pred CCCEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEehHHccCHHHHHHHHHHHHHHHHcCCCCeeEEEEEEEECCEEEEEE
Confidence 57999999999999999999999999999999986543 12223467889999999999999999999999999999999
Q ss_pred ecCCCccHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEEccCCcEEEeecCchhhhhccc-----
Q psy758 81 EFCDHTVLNELENHPHGLPWDLIKQITWQVLRGVSYCHRHACIHRDIKPENILLTANGVVKLCDFGFARLIRDLI----- 155 (292)
Q Consensus 81 e~~~~~~L~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~givH~dl~p~Nilv~~~~~~kl~dfg~~~~~~~~~----- 155 (292)
||++||+|.+++...+.+++..++.++.||+.||+|||++||+||||||+||++++++.+||+|||+++......
T Consensus 88 Ey~~gg~L~~~~~~~~~l~e~~~~~~~~qi~~al~ylH~~~iiHrDiKp~NIll~~~~~vkl~DFG~a~~~~~~~~~~~~ 167 (288)
T d1uu3a_ 88 SYAKNGELLKYIRKIGSFDETCTRFYTAEIVSALEYLHGKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARA 167 (288)
T ss_dssp CCCTTEEHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTSCEEECCCTTCEECC--------
T ss_pred EccCCCCHHHhhhccCCCCHHHHHHHHHHHHHHHHhhccccEEcCcCCccccccCCCceEEecccccceecccCCccccc
Confidence 999999999998887889999999999999999999999999999999999999999999999999998654221
Q ss_pred --cccccccccccccccCCCC-----CCCcccceeeecCCCCCCchHHHHHHHhhcccCCCCCCChhhhhhccCcCCCCC
Q psy758 156 --PRHLHIFQTNEYFKGVSLP-----HAENVVPLEIKIGKPAATNIYLIDFLKRCLDKDPLRRWSCDQLLRHPYFNGYYF 228 (292)
Q Consensus 156 --~~~~~~~~~~~~~~~~~~~-----~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~ 228 (292)
..++..|.+||...+.... |+.|+..+++.+|..++ ...+..+++....-....+
T Consensus 168 ~~~~GT~~Y~APE~~~~~~~~~~~DiwSlGvilyell~g~~Pf------------------~~~~~~~~~~~i~~~~~~~ 229 (288)
T d1uu3a_ 168 NSFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPPF------------------RAGNEYLIFQKIIKLEYDF 229 (288)
T ss_dssp --CCCCGGGCCHHHHHTCCCCHHHHHHHHHHHHHHHHHSSCSS------------------CCSSHHHHHHHHHTTCCCC
T ss_pred ccccCCccccCceeeccCCCCcccceehhhHHHHHHhhCCCCC------------------CCcCHHHHHHHHHcCCCCC
Confidence 2245567777776655443 44444444455555444 3333333332222222334
Q ss_pred CCCCccchHHHHhcccCcCCCCCCChhh------hhhCCcccceeccCCChh
Q psy758 229 EVPDEMQYEEITQRCLDKDPLRRWSCDQ------LLRHPYFNGYYFEVPDEM 274 (292)
Q Consensus 229 ~~~~~~~l~~li~~~l~~dP~~Rpt~~~------il~h~w~~~~~~~~~~~~ 274 (292)
+...++.+++||.+||+.||++|||++| +++||||+++.|+...++
T Consensus 230 p~~~s~~~~~li~~~L~~dP~~R~t~~e~~~~~~i~~Hpff~~i~w~~l~~~ 281 (288)
T d1uu3a_ 230 PEKFFPKARDLVEKLLVLDATKRLGCEEMEGYGPLKAHPFFESVTWENLHQQ 281 (288)
T ss_dssp CTTCCHHHHHHHHTTSCSSGGGSTTSGGGTCHHHHHTSGGGTTCCCTTGGGS
T ss_pred CccCCHHHHHHHHHHccCCHhHCcCHHHHcCCHHHHcCCccCCCCHHHhhcC
Confidence 4566889999999999999999999998 588999999988865543
|
| >d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Pkb kinase (Akt-2) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.7e-54 Score=354.65 Aligned_cols=256 Identities=19% Similarity=0.279 Sum_probs=205.4
Q ss_pred CcccceeeeecccCceEEEEEEEcCCCcEEEEEEeccCCC-ChHHHHHHHHHHHHHHhCCCCCcchhhhhhhcCCeEEEE
Q psy758 1 MERYEKIGKLGEGSYGVVFKCRNRDTGQVVAIKKFLESEE-DPLIRKIALREIRLLKSLKHPNLVNLLEVFRRKKKLHLV 79 (292)
Q Consensus 1 ~~~y~~~~~l~~g~~~~v~~~~~~~~~~~v~iK~~~~~~~-~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~iv 79 (292)
|++|++++.||+|+||.||+|++..+|+.||+|++.+... .....+.+.+|+.+++.++||||+++++++.+++.+|+|
T Consensus 4 l~dy~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~~iv 83 (337)
T d1o6la_ 4 MNDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLCFV 83 (337)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCCTTBCCEEEEEECSSEEEEE
T ss_pred hHhcEEEEEEecCcCeEEEEEEECCCCCEEEEEEEchhhccCHHHHHHHHHHHHHHHhCCCCCEEEEEeeeccccccccc
Confidence 6899999999999999999999999999999999975431 122356678999999999999999999999999999999
Q ss_pred EecCCCccHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEEccCCcEEEeecCchhhhhccccc--
Q psy758 80 FEFCDHTVLNELENHPHGLPWDLIKQITWQVLRGVSYCHRHACIHRDIKPENILLTANGVVKLCDFGFARLIRDLIPR-- 157 (292)
Q Consensus 80 ~e~~~~~~L~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~givH~dl~p~Nilv~~~~~~kl~dfg~~~~~~~~~~~-- 157 (292)
|||++||+|..++...+.+++..++.++.||+.||+|||++||+||||||+|||++.+|.+||+|||+++........
T Consensus 84 ~ey~~gg~L~~~~~~~~~~~e~~~~~~~~qil~al~ylH~~~iiHRDlKP~NILl~~~g~vkl~DFG~a~~~~~~~~~~~ 163 (337)
T d1o6la_ 84 MEYANGGELFFHLSRERVFTEERARFYGAEIVSALEYLHSRDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGATMK 163 (337)
T ss_dssp EECCTTCBHHHHHHHHSCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTSCEEECCCTTCBCSCCTTCCBC
T ss_pred eeccCCCchhhhhhcccCCcHHHHHHHHHHHhhhhhhhhhcCccccccCHHHeEecCCCCEEEeecccccccccCCcccc
Confidence 999999999999988888999999999999999999999999999999999999999999999999999865433222
Q ss_pred ---cccccccccccccCCCCCCCcccceeeecCCCCCCchHHHHHHHhhcccCCCCCCChhhhhhccCcCCCCCCCCCcc
Q psy758 158 ---HLHIFQTNEYFKGVSLPHAENVVPLEIKIGKPAATNIYLIDFLKRCLDKDPLRRWSCDQLLRHPYFNGYYFEVPDEM 234 (292)
Q Consensus 158 ---~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 234 (292)
++..|.+||...+.....+.++|+ .++-+++.+.+..|+...+..++..........++...++
T Consensus 164 ~~~GT~~Y~aPE~~~~~~y~~~~DiwS-------------lGvilyeml~G~~pf~~~~~~~~~~~i~~~~~~~p~~~s~ 230 (337)
T d1o6la_ 164 TFCGTPEYLAPEVLEDNDYGRAVDWWG-------------LGVVMYEMMCGRLPFYNQDHERLFELILMEEIRFPRTLSP 230 (337)
T ss_dssp CCEECGGGCCGGGGSSSCBCTTHHHHH-------------HHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCCTTSCH
T ss_pred cceeCHHHhhhhhccCCCCChhhcccc-------------hhhHHHHHHHCCCCCCCcCHHHHHHHHhcCCCCCCccCCH
Confidence 234456666555544432333322 2333344444455555555555544444444455667788
Q ss_pred chHHHHhcccCcCCCCCCC-----hhhhhhCCcccceecc
Q psy758 235 QYEEITQRCLDKDPLRRWS-----CDQLLRHPYFNGYYFE 269 (292)
Q Consensus 235 ~l~~li~~~l~~dP~~Rpt-----~~~il~h~w~~~~~~~ 269 (292)
++++||++||++||.+||+ ++|+++||||+++.|+
T Consensus 231 ~~~dli~~~L~~dP~~R~~~~~~~~~eil~Hp~f~~i~~~ 270 (337)
T d1o6la_ 231 EAKSLLAGLLKKDPKQRLGGGPSDAKEVMEHRFFLSINWQ 270 (337)
T ss_dssp HHHHHHHHHTCSSTTTSTTCSTTTHHHHHTSGGGTTCCHH
T ss_pred HHHHHHHhhccCCchhhcccccccHHHHHcCcccccCCHH
Confidence 9999999999999999994 8999999999997764
|
| >d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: pak1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.4e-54 Score=346.46 Aligned_cols=243 Identities=26% Similarity=0.408 Sum_probs=192.7
Q ss_pred cccceeeeecccCceEEEEEEEcCCCcEEEEEEeccCCCChHHHHHHHHHHHHHHhCCCCCcchhhhhhhcCCeEEEEEe
Q psy758 2 ERYEKIGKLGEGSYGVVFKCRNRDTGQVVAIKKFLESEEDPLIRKIALREIRLLKSLKHPNLVNLLEVFRRKKKLHLVFE 81 (292)
Q Consensus 2 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~iv~e 81 (292)
++|++.+.||+|+||.||+|++..+|+.||+|++....... .+.+.+|+.+++.++||||+++++++.+++.+|+|||
T Consensus 20 ~~Y~~~~~iG~G~fg~Vy~a~~~~~~~~vAvK~~~~~~~~~--~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~ivmE 97 (293)
T d1yhwa1 20 KKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPK--KELIINEILVMRENKNPNIVNYLDSYLVGDELWVVME 97 (293)
T ss_dssp TTBCSCEECCCSSSCEEEEEEBTTTCCEEEEEEEEGGGCSC--HHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred cccEEEEEEecCcCcEEEEEEECCCCCEEEEEEEecccChH--HHHHHHHHHHHHhCCCCCEeeEeEEEEECCEEEEEEE
Confidence 47999999999999999999999999999999987654332 3568899999999999999999999999999999999
Q ss_pred cCCCccHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEEccCCcEEEeecCchhhhhcccc-----
Q psy758 82 FCDHTVLNELENHPHGLPWDLIKQITWQVLRGVSYCHRHACIHRDIKPENILLTANGVVKLCDFGFARLIRDLIP----- 156 (292)
Q Consensus 82 ~~~~~~L~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~givH~dl~p~Nilv~~~~~~kl~dfg~~~~~~~~~~----- 156 (292)
||+||+|..++... .+++..++.++.||+.||+|||++||+||||||+|||++.+|.+||+|||+++.......
T Consensus 98 y~~gg~L~~~~~~~-~l~~~~~~~i~~qi~~aL~yLH~~~iiHrDiKp~NILl~~~~~vkl~DFG~a~~~~~~~~~~~~~ 176 (293)
T d1yhwa1 98 YLAGGSLTDVVTET-CMDEGQIAAVCRECLQALEFLHSNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSTM 176 (293)
T ss_dssp CCTTCBHHHHHHHS-CCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTCCEEECCCTTCEECCSTTCCBCCC
T ss_pred ecCCCcHHHHhhcc-CCCHHHHHHHHHHHHHHHHHHHHCCCcccCCcHHHeEECCCCcEeeccchhheeecccccccccc
Confidence 99999999988754 699999999999999999999999999999999999999999999999999987643222
Q ss_pred ccccccccccccccCCCC-----CCCcccceeeecCCCCCCchHHHHHHHhhcccCCCCCCChhhhhhccCc---CCCCC
Q psy758 157 RHLHIFQTNEYFKGVSLP-----HAENVVPLEIKIGKPAATNIYLIDFLKRCLDKDPLRRWSCDQLLRHPYF---NGYYF 228 (292)
Q Consensus 157 ~~~~~~~~~~~~~~~~~~-----~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~---~~~~~ 228 (292)
.++..|.+||...+.... |+.|+..+++.+|.. |+...+..+.+..... .....
T Consensus 177 ~gt~~Y~aPE~~~~~~~~~~~DiwSlGvilyemltG~~------------------Pf~~~~~~~~~~~~~~~~~~~~~~ 238 (293)
T d1yhwa1 177 VGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEP------------------PYLNENPLRALYLIATNGTPELQN 238 (293)
T ss_dssp CSCGGGCCHHHHSSSCBCTHHHHHHHHHHHHHHHHSSC------------------TTTTSCHHHHHHHHHHHCSCCCSS
T ss_pred ccCCCccChhhhcCCCCCchhceehHhHHHHHHhhCCC------------------CCCCCCHHHHHHHHHhCCCCCCCC
Confidence 234456666666554432 334444444444444 4433333222211110 01122
Q ss_pred CCCCccchHHHHhcccCcCCCCCCChhhhhhCCcccc
Q psy758 229 EVPDEMQYEEITQRCLDKDPLRRWSCDQLLRHPYFNG 265 (292)
Q Consensus 229 ~~~~~~~l~~li~~~l~~dP~~Rpt~~~il~h~w~~~ 265 (292)
+...+..+++||.+||+.||.+|||++|+|+||||+.
T Consensus 239 ~~~~s~~~~~li~~~L~~dP~~R~s~~eil~Hp~~~~ 275 (293)
T d1yhwa1 239 PEKLSAIFRDFLNRCLDMDVEKRGSAKELLQHQFLKI 275 (293)
T ss_dssp GGGSCHHHHHHHHHHTCSSTTTSCCHHHHTTCGGGGG
T ss_pred cccCCHHHHHHHHHHccCChhHCcCHHHHhcCHhhCC
Confidence 3345778999999999999999999999999999985
|
| >d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: STE20-like serine/threonine-protein kinase, SLK species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2e-54 Score=347.51 Aligned_cols=254 Identities=26% Similarity=0.380 Sum_probs=193.7
Q ss_pred cccceeeeecccCceEEEEEEEcCCCcEEEEEEeccCCCChHHHHHHHHHHHHHHhCCCCCcchhhhhhhcCCeEEEEEe
Q psy758 2 ERYEKIGKLGEGSYGVVFKCRNRDTGQVVAIKKFLESEEDPLIRKIALREIRLLKSLKHPNLVNLLEVFRRKKKLHLVFE 81 (292)
Q Consensus 2 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~iv~e 81 (292)
+.|++++.||+|+||.||+|++..+++.||+|++...... ..+.+.+|+.+++.++||||+++++++.+++.+|+|||
T Consensus 12 d~Y~i~~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~--~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~lvmE 89 (288)
T d2jfla1 12 DFWEIIGELGDGAFGKVYKAQNKETSVLAAAKVIDTKSEE--ELEDYMVEIDILASCDHPNIVKLLDAFYYENNLWILIE 89 (288)
T ss_dssp GTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECSSSG--GGGGTHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred cCeEEeEEEeeCCCcEEEEEEECCCCeEEEEEEECcCCHH--HHHHHHHHHHHHHhCCCCCCCeEEEEEeeCCeEEEEEe
Confidence 3599999999999999999999999999999999765332 34678899999999999999999999999999999999
Q ss_pred cCCCccHHHHhcC-CCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEEccCCcEEEeecCchhhhhcc-----c
Q psy758 82 FCDHTVLNELENH-PHGLPWDLIKQITWQVLRGVSYCHRHACIHRDIKPENILLTANGVVKLCDFGFARLIRDL-----I 155 (292)
Q Consensus 82 ~~~~~~L~~~~~~-~~~~~~~~~~~i~~qi~~aL~~LH~~givH~dl~p~Nilv~~~~~~kl~dfg~~~~~~~~-----~ 155 (292)
||+||+|..++.. .+.+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||++...... .
T Consensus 90 y~~~g~L~~~~~~~~~~l~e~~~~~i~~qi~~gL~ylH~~~ivHrDiKp~NIll~~~~~~Kl~DFG~a~~~~~~~~~~~~ 169 (288)
T d2jfla1 90 FCAGGAVDAVMLELERPLTESQIQVVCKQTLDALNYLHDNKIIHRDLKAGNILFTLDGDIKLADFGVSAKNTRTIQRRDS 169 (288)
T ss_dssp CCTTEEHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTCEECHHHHHHHTC
T ss_pred cCCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCEEEeecChhheeECCCCCEEEEechhhhccCCCcccccc
Confidence 9999999998653 456999999999999999999999999999999999999999999999999998765432 2
Q ss_pred cccccccccccccccCCCCCCCcccceeeecCCCCCCchHHHHHHHhhcccCCCCCCChhhhhhccCcC---CCCCCCCC
Q psy758 156 PRHLHIFQTNEYFKGVSLPHAENVVPLEIKIGKPAATNIYLIDFLKRCLDKDPLRRWSCDQLLRHPYFN---GYYFEVPD 232 (292)
Q Consensus 156 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~---~~~~~~~~ 232 (292)
..++..|.+||...+...... .++...++++.+..+++.+.+..|+...+..+++...... ....+...
T Consensus 170 ~~Gt~~y~APE~l~~~~~~~~--------~y~~k~DiwSlGvilyemltg~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~ 241 (288)
T d2jfla1 170 FIGTPYWMAPEVVMCETSKDR--------PYDYKADVWSLGITLIEMAEIEPPHHELNPMRVLLKIAKSEPPTLAQPSRW 241 (288)
T ss_dssp CCSCCTTCCHHHHTTCSTTTS--------STTTHHHHHHHHHHHHHHHHSSCTTTTSCGGGHHHHHHHSCCCCCSSGGGS
T ss_pred cccccccCCHHHHhhcccCCC--------CCChhhhHHHHHHHHHHHhhCCCCCCCCCHHHHHHHHHcCCCCCCCccccC
Confidence 334455677776532211000 0001112233333344444455555544444443321111 11223345
Q ss_pred ccchHHHHhcccCcCCCCCCChhhhhhCCcccc
Q psy758 233 EMQYEEITQRCLDKDPLRRWSCDQLLRHPYFNG 265 (292)
Q Consensus 233 ~~~l~~li~~~l~~dP~~Rpt~~~il~h~w~~~ 265 (292)
+.++.+||.+||+.||++|||++|+++||||+.
T Consensus 242 s~~~~~li~~~L~~dp~~R~t~~ell~hp~~~~ 274 (288)
T d2jfla1 242 SSNFKDFLKKCLEKNVDARWTTSQLLQHPFVTV 274 (288)
T ss_dssp CHHHHHHHHHHSCSSTTTSCCHHHHTTSGGGCC
T ss_pred CHHHHHHHHHHccCChhHCcCHHHHhcCcccCC
Confidence 788999999999999999999999999999985
|
| >d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Probab=100.00 E-value=5.8e-54 Score=349.26 Aligned_cols=256 Identities=21% Similarity=0.316 Sum_probs=206.5
Q ss_pred CcccceeeeecccCceEEEEEEEcCCCcEEEEEEeccCCC-ChHHHHHHHHHHHHHHhCCCCCcchhhhhhhcCCeEEEE
Q psy758 1 MERYEKIGKLGEGSYGVVFKCRNRDTGQVVAIKKFLESEE-DPLIRKIALREIRLLKSLKHPNLVNLLEVFRRKKKLHLV 79 (292)
Q Consensus 1 ~~~y~~~~~l~~g~~~~v~~~~~~~~~~~v~iK~~~~~~~-~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~iv 79 (292)
|++|++++.||+|+||.||+|++..+|+.||+|++..... .....+.+.+|+.+++.++||||+++++++.+++.+|+|
T Consensus 3 l~dy~i~~~lG~G~fg~Vy~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~iv 82 (316)
T d1fota_ 3 LQDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPFIIRMWGTFQDAQQIFMI 82 (316)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCBTTBCCEEEEEECSSEEEEE
T ss_pred hhHeEEEEEEecCcCcEEEEEEECCCCCEEEEEEEchHHccCHHHHHHHHHHHHHHHhccCcChhheeeeEeeCCeeeeE
Confidence 5789999999999999999999999999999999965431 122356788999999999999999999999999999999
Q ss_pred EecCCCccHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEEccCCcEEEeecCchhhhhccc--cc
Q psy758 80 FEFCDHTVLNELENHPHGLPWDLIKQITWQVLRGVSYCHRHACIHRDIKPENILLTANGVVKLCDFGFARLIRDLI--PR 157 (292)
Q Consensus 80 ~e~~~~~~L~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~givH~dl~p~Nilv~~~~~~kl~dfg~~~~~~~~~--~~ 157 (292)
|||+.||++..++.....+++..++.++.||+.||+|||++||+||||||+|||++.+|.+||+|||+++...... ..
T Consensus 83 mE~~~gg~l~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~iiHrDiKp~NILl~~~g~vkL~DFG~a~~~~~~~~~~~ 162 (316)
T d1fota_ 83 MDYIEGGELFSLLRKSQRFPNPVAKFYAAEVCLALEYLHSKDIIYRDLKPENILLDKNGHIKITDFGFAKYVPDVTYTLC 162 (316)
T ss_dssp ECCCCSCBHHHHHHHTSSCCHHHHHHHHHHHHHHHHHHHTTTEECCCCCGGGEEECTTSCEEECCCSSCEECSSCBCCCC
T ss_pred eeecCCccccccccccccccccHHHHHHHHHHHhhhhhccCcEEccccCchheeEcCCCCEEEecCccceEecccccccc
Confidence 9999999999999888889999999999999999999999999999999999999999999999999998765422 23
Q ss_pred cccccccccccccCCCCCCCcccceeeecCCCCCCchHHHHHHHhhcccCCCCCCChhhhhhccCcCCCCCCCCCccchH
Q psy758 158 HLHIFQTNEYFKGVSLPHAENVVPLEIKIGKPAATNIYLIDFLKRCLDKDPLRRWSCDQLLRHPYFNGYYFEVPDEMQYE 237 (292)
Q Consensus 158 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~l~ 237 (292)
++..|.+||...+.....+.++ ++.+..++..+.+..|+...+..++...........+...+.++.
T Consensus 163 Gt~~Y~APE~l~~~~y~~~~Di-------------wSlGvilyemltG~~Pf~~~~~~~~~~~i~~~~~~~p~~~s~~~~ 229 (316)
T d1fota_ 163 GTPDYIAPEVVSTKPYNKSIDW-------------WSFGILIYEMLAGYTPFYDSNTMKTYEKILNAELRFPPFFNEDVK 229 (316)
T ss_dssp SCTTTCCHHHHTTCCBCTTHHH-------------HHHHHHHHHHHHSSCTTCCSSHHHHHHHHHHCCCCCCTTSCHHHH
T ss_pred CcccccCHHHHcCCCCCchhhc-------------cccchhHHHHHhCCCCCCCcCHHHHHHHHHcCCCCCCCCCCHHHH
Confidence 3455667776655443322222 333333444455555555555554444333333445556688999
Q ss_pred HHHhcccCcCCCCCC-----ChhhhhhCCcccceecc
Q psy758 238 EITQRCLDKDPLRRW-----SCDQLLRHPYFNGYYFE 269 (292)
Q Consensus 238 ~li~~~l~~dP~~Rp-----t~~~il~h~w~~~~~~~ 269 (292)
++|.+||..||.+|+ |++++++||||+++.|+
T Consensus 230 ~li~~~L~~dp~~R~~~~r~t~~~il~Hp~f~~i~~~ 266 (316)
T d1fota_ 230 DLLSRLITRDLSQRLGNLQNGTEDVKNHPWFKEVVWE 266 (316)
T ss_dssp HHHHHHTCSCTTTCTTSSTTTTHHHHTSGGGSSCCHH
T ss_pred HHHHHHhhhCHHhccccchhhHHHHHcCcccccCCHH
Confidence 999999999999996 99999999999998876
|
| >d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Calmodulin-dependent protein kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=4e-53 Score=342.93 Aligned_cols=250 Identities=22% Similarity=0.327 Sum_probs=184.7
Q ss_pred cccceeeeecccCceEEEEEEEcCCCcEEEEEEeccCCCChHHHHHHHHHHHHHHhCCCCCcchhhhhhhcCCeEEEEEe
Q psy758 2 ERYEKIGKLGEGSYGVVFKCRNRDTGQVVAIKKFLESEEDPLIRKIALREIRLLKSLKHPNLVNLLEVFRRKKKLHLVFE 81 (292)
Q Consensus 2 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~iv~e 81 (292)
++|++.+.||+|+||.||+|++..+++.||+|++....... ....+.+|+.+++.++||||+++++++.+++.+|+|||
T Consensus 9 d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~-~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lvmE 87 (307)
T d1a06a_ 9 DIYDFRDVLGTGAFSEVILAEDKRTQKLVAIKCIAKKALEG-KEGSMENEIAVLHKIKHPNIVALDDIYESGGHLYLIMQ 87 (307)
T ss_dssp GTEEEEEESBSGGGGGEEEEEETTTCCEEEEEEEEC-----------CHHHHHHHTCCCTTBCCEEEEEECSSEEEEEEC
T ss_pred cceEEEEEEeeccCeEEEEEEECCCCCEEEEEEEchHHhhh-HHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEe
Confidence 46999999999999999999999999999999997655332 23567899999999999999999999999999999999
Q ss_pred cCCCccHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEEc---cCCcEEEeecCchhhhhccc---
Q psy758 82 FCDHTVLNELENHPHGLPWDLIKQITWQVLRGVSYCHRHACIHRDIKPENILLT---ANGVVKLCDFGFARLIRDLI--- 155 (292)
Q Consensus 82 ~~~~~~L~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~givH~dl~p~Nilv~---~~~~~kl~dfg~~~~~~~~~--- 155 (292)
||+||+|.+++...+.+++..+..++.||+.||+|||++||+||||||+||+++ +++.+||+|||+++......
T Consensus 88 ~~~gg~L~~~l~~~~~l~e~~~~~~~~qi~~al~ylH~~~iiHrDiKp~Nil~~~~~~~~~vkl~DFG~a~~~~~~~~~~ 167 (307)
T d1a06a_ 88 LVSGGELFDRIVEKGFYTERDASRLIFQVLDAVKYLHDLGIVHRDLKPENLLYYSLDEDSKIMISDFGLSKMEDPGSVLS 167 (307)
T ss_dssp CCCSCBHHHHHHTCSCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEESSSSTTCCEEECCC-------------
T ss_pred ccCCCcHHHhhhcccCCCHHHHHHHHHHHHHHHHhhhhceeeeEEecccceeecccCCCceEEEeccceeEEccCCCeee
Confidence 999999999998888899999999999999999999999999999999999995 47899999999998664322
Q ss_pred -cccccccccccccccCCCC-----CCCcccceeeecCCCCCCchHHHHHHHhhcccCCCCCCChhhhhhccCcCCCCCC
Q psy758 156 -PRHLHIFQTNEYFKGVSLP-----HAENVVPLEIKIGKPAATNIYLIDFLKRCLDKDPLRRWSCDQLLRHPYFNGYYFE 229 (292)
Q Consensus 156 -~~~~~~~~~~~~~~~~~~~-----~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~ 229 (292)
..++..|.+||...+.... |+.|+..+++.+|..++.......+....+.... .......
T Consensus 168 ~~~GT~~y~APE~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~~~~~~~~i~~~~~--------------~~~~~~~ 233 (307)
T d1a06a_ 168 TACGTPGYVAPEVLAQKPYSKAVDCWSIGVIAYILLCGYPPFYDENDAKLFEQILKAEY--------------EFDSPYW 233 (307)
T ss_dssp -----CTTSCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHTTCC--------------CCCTTTT
T ss_pred eeeeCccccCcHHHcCCCCCcHHHhhhhhHHHHHHHhCCCCCCCCCHHHHHHHHhccCC--------------CCCCccc
Confidence 2234567777766554443 4444444445555554433333333333222111 1111222
Q ss_pred CCCccchHHHHhcccCcCCCCCCChhhhhhCCcccce
Q psy758 230 VPDEMQYEEITQRCLDKDPLRRWSCDQLLRHPYFNGY 266 (292)
Q Consensus 230 ~~~~~~l~~li~~~l~~dP~~Rpt~~~il~h~w~~~~ 266 (292)
...++.+.+||.+||+.||++|||++|+++||||++.
T Consensus 234 ~~~s~~~~~li~~~L~~dP~~R~s~~eil~hp~~~~~ 270 (307)
T d1a06a_ 234 DDISDSAKDFIRHLMEKDPEKRFTCEQALQHPWIAGD 270 (307)
T ss_dssp TTSCHHHHHHHHHHSCSSGGGSCCHHHHHHSTTTTSS
T ss_pred cCCCHHHHHHHHHHccCCHhHCcCHHHHhcCHhhCCC
Confidence 3457889999999999999999999999999999863
|
| >d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine protein kinase TAO2 species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=6.3e-54 Score=347.71 Aligned_cols=246 Identities=28% Similarity=0.395 Sum_probs=196.4
Q ss_pred ccceeeeecccCceEEEEEEEcCCCcEEEEEEeccCCC-ChHHHHHHHHHHHHHHhCCCCCcchhhhhhhcCCeEEEEEe
Q psy758 3 RYEKIGKLGEGSYGVVFKCRNRDTGQVVAIKKFLESEE-DPLIRKIALREIRLLKSLKHPNLVNLLEVFRRKKKLHLVFE 81 (292)
Q Consensus 3 ~y~~~~~l~~g~~~~v~~~~~~~~~~~v~iK~~~~~~~-~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~iv~e 81 (292)
+|++.+.||+|+||.||+|++..+|+.||+|++..... .....+.+.+|+.+++.++||||+++++++.+++.+|+|||
T Consensus 16 ~y~~l~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~iv~E 95 (309)
T d1u5ra_ 16 LFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLVME 95 (309)
T ss_dssp HEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEECCSSCHHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred hcEeeEEEecCCCeEEEEEEECCCCcEEEEEEEchhhccCHHHHHHHHHHHHHHHHCCCCCEeeEEEEEEECCEEEEEEE
Confidence 59999999999999999999999999999999976653 34456778999999999999999999999999999999999
Q ss_pred cCCCccHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEEccCCcEEEeecCchhhhhcc-cccccc
Q psy758 82 FCDHTVLNELENHPHGLPWDLIKQITWQVLRGVSYCHRHACIHRDIKPENILLTANGVVKLCDFGFARLIRDL-IPRHLH 160 (292)
Q Consensus 82 ~~~~~~L~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~givH~dl~p~Nilv~~~~~~kl~dfg~~~~~~~~-~~~~~~ 160 (292)
||.+|++..++...+.+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++...... ...++.
T Consensus 96 ~~~~g~l~~~~~~~~~l~e~~~~~i~~qi~~aL~yLH~~~iiHrDiKp~NILl~~~~~~Kl~DFG~a~~~~~~~~~~GT~ 175 (309)
T d1u5ra_ 96 YCLGSASDLLEVHKKPLQEVEIAAVTHGALQGLAYLHSHNMIHRDVKAGNILLSEPGLVKLGDFGSASIMAPANSFVGTP 175 (309)
T ss_dssp CCSEEHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCSGGGEEEETTTEEEECCCTTCBSSSSBCCCCSCG
T ss_pred ecCCCchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCEeccCCCcceEEECCCCCEEEeecccccccCCCCccccCc
Confidence 9999999888777778999999999999999999999999999999999999999999999999999866432 234455
Q ss_pred ccccccccccC--------CCCCCCcccceeeecCCCCCCchHHHHHHHhhcccCCCCCCChhhhhhccCcCCC--CCCC
Q psy758 161 IFQTNEYFKGV--------SLPHAENVVPLEIKIGKPAATNIYLIDFLKRCLDKDPLRRWSCDQLLRHPYFNGY--YFEV 230 (292)
Q Consensus 161 ~~~~~~~~~~~--------~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~--~~~~ 230 (292)
.|.+||...+. ...|+.|+..+++.+|..+ +...+..+.+........ ..+.
T Consensus 176 ~Y~APE~~~~~~~~~y~~~~DiwSlGvilyel~~g~~P------------------f~~~~~~~~~~~i~~~~~~~~~~~ 237 (309)
T d1u5ra_ 176 YWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPP------------------LFNMNAMSALYHIAQNESPALQSG 237 (309)
T ss_dssp GGCCHHHHTTTTSCCBCTHHHHHHHHHHHHHHHHSSCT------------------TTTSCHHHHHHHHHHSCCCCCSCT
T ss_pred cccCHHHHhccCCCCcCchhhhhhHHHHHHHHHHCCCC------------------CCCCCHHHHHHHHHhCCCCCCCCC
Confidence 67777765432 1234444444445555444 333333332221111111 1123
Q ss_pred CCccchHHHHhcccCcCCCCCCChhhhhhCCcccce
Q psy758 231 PDEMQYEEITQRCLDKDPLRRWSCDQLLRHPYFNGY 266 (292)
Q Consensus 231 ~~~~~l~~li~~~l~~dP~~Rpt~~~il~h~w~~~~ 266 (292)
..++.+.+||.+||+.||.+|||++|+|+||||...
T Consensus 238 ~~s~~~~~li~~~L~~dP~~Rpt~~ell~Hp~~~~~ 273 (309)
T d1u5ra_ 238 HWSEYFRNFVDSCLQKIPQDRPTSEVLLKHRFVLRE 273 (309)
T ss_dssp TSCHHHHHHHHHHTCSSGGGSCCHHHHTTCHHHHSC
T ss_pred CCCHHHHHHHHHHCcCChhHCcCHHHHHhCHHhcCC
Confidence 347789999999999999999999999999999863
|
| >d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Death-associated protein kinase, Dap species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4e-53 Score=341.94 Aligned_cols=256 Identities=25% Similarity=0.313 Sum_probs=194.6
Q ss_pred cccceeeeecccCceEEEEEEEcCCCcEEEEEEeccCCCC----hHHHHHHHHHHHHHHhCCCCCcchhhhhhhcCCeEE
Q psy758 2 ERYEKIGKLGEGSYGVVFKCRNRDTGQVVAIKKFLESEED----PLIRKIALREIRLLKSLKHPNLVNLLEVFRRKKKLH 77 (292)
Q Consensus 2 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~v~iK~~~~~~~~----~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~ 77 (292)
++|++++.||+|+||.||+|++..+|+.||+|++...... ....+.+.+|+.+++.++||||+++++++.+++.+|
T Consensus 10 d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~~AvK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~ 89 (293)
T d1jksa_ 10 DYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVITLHEVYENKTDVI 89 (293)
T ss_dssp GTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEE
T ss_pred cCEEEeEEEecCCCeEEEEEEECCCCCEEEEEEEEhhhcchhhhhHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEE
Confidence 4799999999999999999999999999999999755322 123567889999999999999999999999999999
Q ss_pred EEEecCCCccHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEEccCC----cEEEeecCchhhhhc
Q psy758 78 LVFEFCDHTVLNELENHPHGLPWDLIKQITWQVLRGVSYCHRHACIHRDIKPENILLTANG----VVKLCDFGFARLIRD 153 (292)
Q Consensus 78 iv~e~~~~~~L~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~givH~dl~p~Nilv~~~~----~~kl~dfg~~~~~~~ 153 (292)
+|||||+||+|.+++...+.+++..++.++.||+.||+|||++||+||||||+||+++.++ .+||+|||++.....
T Consensus 90 iv~E~~~gg~L~~~i~~~~~l~~~~~~~~~~qi~~al~yLH~~~ivHrDiKp~Nill~~~~~~~~~vkl~DfG~a~~~~~ 169 (293)
T d1jksa_ 90 LILELVAGGELFDFLAEKESLTEEEATEFLKQILNGVYYLHSLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDF 169 (293)
T ss_dssp EEEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESCSSSSSCCEEECCCTTCEECTT
T ss_pred EEEEcCCCccccchhccccccchhHHHHHHHHHHHHHHhhhhcceeecccccceEEEecCCCcccceEecchhhhhhcCC
Confidence 9999999999999998777899999999999999999999999999999999999999776 599999999977643
Q ss_pred cc----cccccccccccccccCCCC-----CCCcccceeeecCCCCCCchHHHHHHHhhcccCCCCCCChhhhhhccCcC
Q psy758 154 LI----PRHLHIFQTNEYFKGVSLP-----HAENVVPLEIKIGKPAATNIYLIDFLKRCLDKDPLRRWSCDQLLRHPYFN 224 (292)
Q Consensus 154 ~~----~~~~~~~~~~~~~~~~~~~-----~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~ 224 (292)
.. ...+..|.+||...+.... |+.|+..+++.+|..++........+..........
T Consensus 170 ~~~~~~~~~t~~y~APE~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~~~~~~~~i~~~~~~~-------------- 235 (293)
T d1jksa_ 170 GNEFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANVSAVNYEF-------------- 235 (293)
T ss_dssp SCBCSCCCCCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHTTCCCC--------------
T ss_pred CccccccCCCCcccCHHHHcCCCCCCcccchhhhHHHHHHHcCCCCCCCCCHHHHHHHHHhcCCCC--------------
Confidence 22 2233456777766554443 334444444444544443333333222222211100
Q ss_pred CCCCCCCCccchHHHHhcccCcCCCCCCChhhhhhCCcccceeccCC
Q psy758 225 GYYFEVPDEMQYEEITQRCLDKDPLRRWSCDQLLRHPYFNGYYFEVP 271 (292)
Q Consensus 225 ~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~~il~h~w~~~~~~~~~ 271 (292)
........+..+++||++||+.||++|||++|+++||||++..+...
T Consensus 236 ~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~hp~~~~~~~~~~ 282 (293)
T d1jksa_ 236 EDEYFSNTSALAKDFIRRLLVKDPKKRMTIQDSLQHPWIKPKDTQQA 282 (293)
T ss_dssp CHHHHTTSCHHHHHHHHTTSCSSGGGSCCHHHHHHSTTTCC------
T ss_pred CchhcCCCCHHHHHHHHHHccCChhHCcCHHHHhcCcccCCCChhHh
Confidence 00111235778999999999999999999999999999998665543
|
| >d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine-protein kinase Nek2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.2e-53 Score=338.38 Aligned_cols=249 Identities=24% Similarity=0.387 Sum_probs=186.7
Q ss_pred cccceeeeecccCceEEEEEEEcCCCcEEEEEEeccCCCChHHHHHHHHHHHHHHhCCCCCcchhhhhhhc--CCeEEEE
Q psy758 2 ERYEKIGKLGEGSYGVVFKCRNRDTGQVVAIKKFLESEEDPLIRKIALREIRLLKSLKHPNLVNLLEVFRR--KKKLHLV 79 (292)
Q Consensus 2 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~--~~~~~iv 79 (292)
++|++.+.||+|+||.||+|++..+|+.||+|.+......+...+.+.+|+.+++.++||||+++++++.+ ++.+|+|
T Consensus 4 edy~~~~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~~~iv 83 (269)
T d2java1 4 EDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVRYYDRIIDRTNTTLYIV 83 (269)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECCTTSCHHHHHHHHHHHHHTTSCCCTTBCCEEEEEEC----CEEEE
T ss_pred hhCEEeEEEecCCCeEEEEEEECCCCCEEEEEEEChhhCCHHHHHHHHHHHHHHHHCCCCCEeeEEEEEEeCCCCEEEEE
Confidence 68999999999999999999999999999999998877777777889999999999999999999998854 5678999
Q ss_pred EecCCCccHHHHhcC----CCCCCHHHHHHHHHHHHHHHHHHHhCC-----ccccCCCCCceEEccCCcEEEeecCchhh
Q psy758 80 FEFCDHTVLNELENH----PHGLPWDLIKQITWQVLRGVSYCHRHA-----CIHRDIKPENILLTANGVVKLCDFGFARL 150 (292)
Q Consensus 80 ~e~~~~~~L~~~~~~----~~~~~~~~~~~i~~qi~~aL~~LH~~g-----ivH~dl~p~Nilv~~~~~~kl~dfg~~~~ 150 (292)
||||+||+|.+++.. ...+++..++.++.||+.||+|||++| |+||||||+|||++.++.+||+|||+++.
T Consensus 84 mEy~~~g~L~~~i~~~~~~~~~l~e~~~~~i~~qi~~al~ylH~~~~~~~~IiHrDiKp~NIll~~~~~vkl~DFG~a~~ 163 (269)
T d2java1 84 MEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARI 163 (269)
T ss_dssp EECCTTEEHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHHCC---------CCGGGEEECTTSCEEECCHHHHHH
T ss_pred EecCCCCcHHHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHHhcCCCCCEEeCcCchhhcCcCCCCcEEEeeccceee
Confidence 999999999998753 457999999999999999999999976 99999999999999999999999999987
Q ss_pred hhcccc-----ccccccccccccccCCCCCCCcccceeeecCCCCCCchHHHHHHHhhcccCCCCCCChhhhhhccCcCC
Q psy758 151 IRDLIP-----RHLHIFQTNEYFKGVSLPHAENVVPLEIKIGKPAATNIYLIDFLKRCLDKDPLRRWSCDQLLRHPYFNG 225 (292)
Q Consensus 151 ~~~~~~-----~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~ 225 (292)
...... .++..|.+||...+.......|+ ++.+..+++.+.+..|+...+..++.....-..
T Consensus 164 ~~~~~~~~~~~~gt~~Y~APE~l~~~~~~~~~DI-------------wSlGvilyel~tg~~Pf~~~~~~~~~~~i~~~~ 230 (269)
T d2java1 164 LNHDTSFAKAFVGTPYYMSPEQMNRMSYNEKSDI-------------WSLGCLLYELCALMPPFTAFSQKELAGKIREGK 230 (269)
T ss_dssp C-----------CCCSCCCHHHHTTCCCCHHHHH-------------HHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHTC
T ss_pred cccCCCccccCCCCcccCCHHHHcCCCCChHHHH-------------HhhCHHHHHHhhCCCCCCCCCHHHHHHHHHcCC
Confidence 654322 23445666666655443322222 222233334444444444444443332211111
Q ss_pred -CCCCCCCccchHHHHhcccCcCCCCCCChhhhhhCCcc
Q psy758 226 -YYFEVPDEMQYEEITQRCLDKDPLRRWSCDQLLRHPYF 263 (292)
Q Consensus 226 -~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~~il~h~w~ 263 (292)
...+...+.++.+||.+||+.||++|||++|+++|||+
T Consensus 231 ~~~~~~~~s~~l~~li~~~L~~dp~~Rps~~ell~hp~i 269 (269)
T d2java1 231 FRRIPYRYSDELNEIITRMLNLKDYHRPSVEEILENPLI 269 (269)
T ss_dssp CCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHTSTTC
T ss_pred CCCCCcccCHHHHHHHHHHcCCChhHCcCHHHHHhCCcC
Confidence 12334557899999999999999999999999999996
|
| >d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: Caenorhabditis elegans, pjk4 [TaxId: 6239]
Probab=100.00 E-value=5.2e-53 Score=347.85 Aligned_cols=252 Identities=23% Similarity=0.314 Sum_probs=196.4
Q ss_pred CcccceeeeecccCceEEEEEEEcCCCcEEEEEEeccCCCChHHHHHHHHHHHHHHhCCCCCcchhhhhhhcCCeEEEEE
Q psy758 1 MERYEKIGKLGEGSYGVVFKCRNRDTGQVVAIKKFLESEEDPLIRKIALREIRLLKSLKHPNLVNLLEVFRRKKKLHLVF 80 (292)
Q Consensus 1 ~~~y~~~~~l~~g~~~~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~iv~ 80 (292)
|++|++++.||+|+||.||+|++..+|+.||+|++.... ....+.+.+|+.+++.++||||+++++++.+++.+|+||
T Consensus 25 l~~Y~i~~~lG~G~fg~Vy~~~~~~~g~~vAvK~i~~~~--~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~ivm 102 (350)
T d1koaa2 25 LDHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPH--ESDKETVRKEIQTMSVLRHPTLVNLHDAFEDDNEMVMIY 102 (350)
T ss_dssp GGTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECCCS--HHHHHHHHHHHHHHHHTCCTTBCCEEEEEEETTEEEEEE
T ss_pred ccCeEEEEEEecCcCeEEEEEEECCCCCEEEEEEEcccc--hhhHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEE
Confidence 578999999999999999999999999999999996543 334577889999999999999999999999999999999
Q ss_pred ecCCCccHHHHhc-CCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEEcc--CCcEEEeecCchhhhhccc--
Q psy758 81 EFCDHTVLNELEN-HPHGLPWDLIKQITWQVLRGVSYCHRHACIHRDIKPENILLTA--NGVVKLCDFGFARLIRDLI-- 155 (292)
Q Consensus 81 e~~~~~~L~~~~~-~~~~~~~~~~~~i~~qi~~aL~~LH~~givH~dl~p~Nilv~~--~~~~kl~dfg~~~~~~~~~-- 155 (292)
|||+||+|.+++. ..+.+++..++.++.||+.||+|||++||+||||||+|||++. ++.+||+|||+++......
T Consensus 103 E~~~gg~L~~~l~~~~~~l~e~~~~~i~~qi~~aL~ylH~~~iiHrDiKp~NIll~~~~~~~vkL~DFG~a~~~~~~~~~ 182 (350)
T d1koaa2 103 EFMSGGELFEKVADEHNKMSEDEAVEYMRQVCKGLCHMHENNYVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPKQSV 182 (350)
T ss_dssp CCCCSCBHHHHHTCTTSCBCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESSTTSCCEEECCCTTCEECCTTSCE
T ss_pred EcCCCCCHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhcCCeeeeechhHeeeccCCCCeEEEeecchheeccccccc
Confidence 9999999999884 4457999999999999999999999999999999999999964 5789999999998765432
Q ss_pred --cccccccccccccccCCCC-----CCCcccceeeecCCCCCCchHHHHHHHhhcccCCCCCCChhhhhhccCcCCCCC
Q psy758 156 --PRHLHIFQTNEYFKGVSLP-----HAENVVPLEIKIGKPAATNIYLIDFLKRCLDKDPLRRWSCDQLLRHPYFNGYYF 228 (292)
Q Consensus 156 --~~~~~~~~~~~~~~~~~~~-----~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~ 228 (292)
..++..|.+||...+.... |+.|+..+++++|..++.......++......... .....
T Consensus 183 ~~~~gT~~Y~aPEv~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~~~~~~i~~~~~~--------------~~~~~ 248 (350)
T d1koaa2 183 KVTTGTAEFAAPEVAEGKPVGYYTDMWSVGVLSYILLSGLSPFGGENDDETLRNVKSCDWN--------------MDDSA 248 (350)
T ss_dssp EEECSCTTTCCHHHHHTCCBCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCC--------------SCCGG
T ss_pred ceecCcccccCHHHHcCCCCChhHhhhhhhHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCC--------------CCccc
Confidence 2334567777776654432 44444444445555444333322322222211110 00011
Q ss_pred CCCCccchHHHHhcccCcCCCCCCChhhhhhCCcccceec
Q psy758 229 EVPDEMQYEEITQRCLDKDPLRRWSCDQLLRHPYFNGYYF 268 (292)
Q Consensus 229 ~~~~~~~l~~li~~~l~~dP~~Rpt~~~il~h~w~~~~~~ 268 (292)
....+..+++||.+||+.||++|||++|+|+||||++..+
T Consensus 249 ~~~~s~~~~~li~~~L~~dP~~R~t~~eil~hp~~~~~~~ 288 (350)
T d1koaa2 249 FSGISEDGKDFIRKLLLADPNTRMTIHQALEHPWLTPGNA 288 (350)
T ss_dssp GGGCCHHHHHHHHHHCCSSGGGSCCHHHHHHSTTTSCTTC
T ss_pred ccCCCHHHHHHHHHHccCChhHCcCHHHHhcCcccCCCCC
Confidence 1234678999999999999999999999999999998654
|
| >d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]
Probab=100.00 E-value=1.3e-52 Score=345.74 Aligned_cols=252 Identities=24% Similarity=0.335 Sum_probs=197.7
Q ss_pred cccceeeeecccCceEEEEEEEcCCCcEEEEEEeccCCCChHHHHHHHHHHHHHHhCCCCCcchhhhhhhcCCeEEEEEe
Q psy758 2 ERYEKIGKLGEGSYGVVFKCRNRDTGQVVAIKKFLESEEDPLIRKIALREIRLLKSLKHPNLVNLLEVFRRKKKLHLVFE 81 (292)
Q Consensus 2 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~iv~e 81 (292)
++|++++.||+|+||.||+|++..+|+.||+|++.... ......+.+|+.+++.++||||+++++++.+++.+|+|||
T Consensus 29 d~Y~i~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~--~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~ivmE 106 (352)
T d1koba_ 29 DYYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPY--PLDKYTVKNEISIMNQLHHPKLINLHDAFEDKYEMVLILE 106 (352)
T ss_dssp GTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCS--HHHHHHHHHHHHHHTTCCSTTBCCEEEEEECSSEEEEEEE
T ss_pred cceEEEEEEecCCCeEEEEEEECCCCCEEEEEEECCcc--hhHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEE
Confidence 57999999999999999999999999999999987654 2345678899999999999999999999999999999999
Q ss_pred cCCCccHHHHhcCC-CCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEEc--cCCcEEEeecCchhhhhccc---
Q psy758 82 FCDHTVLNELENHP-HGLPWDLIKQITWQVLRGVSYCHRHACIHRDIKPENILLT--ANGVVKLCDFGFARLIRDLI--- 155 (292)
Q Consensus 82 ~~~~~~L~~~~~~~-~~~~~~~~~~i~~qi~~aL~~LH~~givH~dl~p~Nilv~--~~~~~kl~dfg~~~~~~~~~--- 155 (292)
||+||+|.+.+... ..+++..++.++.||+.||+|||++||+||||||+|||++ .++.+||+|||++.......
T Consensus 107 ~~~gg~L~~~~~~~~~~l~e~~~~~i~~qi~~aL~ylH~~~iiHRDiKp~NILl~~~~~~~vkL~DFGla~~~~~~~~~~ 186 (352)
T d1koba_ 107 FLSGGELFDRIAAEDYKMSEAEVINYMRQACEGLKHMHEHSIVHLDIKPENIMCETKKASSVKIIDFGLATKLNPDEIVK 186 (352)
T ss_dssp CCCCCBHHHHTTCTTCCBCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESSTTCCCEEECCCTTCEECCTTSCEE
T ss_pred cCCCChHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeeecccccccccccccCCCeEEEeecccceecCCCCcee
Confidence 99999998876554 4699999999999999999999999999999999999998 56899999999998765322
Q ss_pred -cccccccccccccccCCC-----CCCCcccceeeecCCCCCCchHHHHHHHhhcccCCCCCCChhhhhhccCcCCCCCC
Q psy758 156 -PRHLHIFQTNEYFKGVSL-----PHAENVVPLEIKIGKPAATNIYLIDFLKRCLDKDPLRRWSCDQLLRHPYFNGYYFE 229 (292)
Q Consensus 156 -~~~~~~~~~~~~~~~~~~-----~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~ 229 (292)
..++..|.+||...+... .|+.|++.+++++|..++.+.....++.......+. -.....
T Consensus 187 ~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~~~~~~i~~~~~~--------------~~~~~~ 252 (352)
T d1koba_ 187 VTTATAEFAAPEIVDREPVGFYTDMWAIGVLGYVLLSGLSPFAGEDDLETLQNVKRCDWE--------------FDEDAF 252 (352)
T ss_dssp EECSSGGGCCHHHHTTCCBCHHHHHHHHHHHHHHHHHSCCSSCCSSHHHHHHHHHHCCCC--------------CCSSTT
T ss_pred eccCcccccCHHHHcCCCCCCccchHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCC--------------CCcccc
Confidence 233455667776665543 345555555555555554443333333332221110 001112
Q ss_pred CCCccchHHHHhcccCcCCCCCCChhhhhhCCcccceecc
Q psy758 230 VPDEMQYEEITQRCLDKDPLRRWSCDQLLRHPYFNGYYFE 269 (292)
Q Consensus 230 ~~~~~~l~~li~~~l~~dP~~Rpt~~~il~h~w~~~~~~~ 269 (292)
...+.++.+||.+||+.||.+|||++|+|+||||++....
T Consensus 253 ~~~s~~~~~li~~~L~~dp~~R~s~~eil~Hp~~~~~~~~ 292 (352)
T d1koba_ 253 SSVSPEAKDFIKNLLQKEPRKRLTVHDALEHPWLKGDHSN 292 (352)
T ss_dssp TTSCHHHHHHHHTTSCSSGGGSCCHHHHHTSTTTSSCCTT
T ss_pred cCCCHHHHHHHHHHccCChhHCcCHHHHhcCHhhCCCcch
Confidence 3457889999999999999999999999999999875444
|
| >d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=2.5e-53 Score=350.01 Aligned_cols=256 Identities=19% Similarity=0.264 Sum_probs=203.2
Q ss_pred CcccceeeeecccCceEEEEEEEcCCCcEEEEEEeccCC-CChHHHHHHHHHHHHHHhCCCCCcchhhhhhhcCCeEEEE
Q psy758 1 MERYEKIGKLGEGSYGVVFKCRNRDTGQVVAIKKFLESE-EDPLIRKIALREIRLLKSLKHPNLVNLLEVFRRKKKLHLV 79 (292)
Q Consensus 1 ~~~y~~~~~l~~g~~~~v~~~~~~~~~~~v~iK~~~~~~-~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~iv 79 (292)
|++|++++.||+|+||.||+|++..+|+.||+|++.... ......+.+.+|+.+++.++||||+++++++.+.+.+++|
T Consensus 40 ld~y~i~~~lG~G~fg~Vy~a~~~~~g~~~AvK~i~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~~v 119 (350)
T d1rdqe_ 40 LDQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMV 119 (350)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEE
T ss_pred ccCeEEEEEeecCcCcEEEEEEECCCCCEEEEEEEchHHccCHHHHHHHHHHHHHHHHcCCCcEeecccccccccccccc
Confidence 578999999999999999999999999999999986543 1122345688999999999999999999999999999999
Q ss_pred EecCCCccHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEEccCCcEEEeecCchhhhhccc--cc
Q psy758 80 FEFCDHTVLNELENHPHGLPWDLIKQITWQVLRGVSYCHRHACIHRDIKPENILLTANGVVKLCDFGFARLIRDLI--PR 157 (292)
Q Consensus 80 ~e~~~~~~L~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~givH~dl~p~Nilv~~~~~~kl~dfg~~~~~~~~~--~~ 157 (292)
+||+.||+|..++...+.+++..++.++.||+.||.|||++||+||||||+|||++.+|.+||+|||+++...... ..
T Consensus 120 ~e~~~~g~l~~~l~~~~~l~e~~~~~i~~qi~~aL~yLH~~~iiHRDIKP~NILl~~~g~ikL~DFG~a~~~~~~~~~~~ 199 (350)
T d1rdqe_ 120 MEYVAGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWTLC 199 (350)
T ss_dssp EECCTTCBHHHHHHHHCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTCEECSSCBCCCE
T ss_pred cccccccchhhhHhhcCCCCHHHHHHHHHHHHHHHHHHHhCCEecCcCCHHHcccCCCCCEEeeeceeeeeccccccccc
Confidence 9999999999998877789999999999999999999999999999999999999999999999999998765322 23
Q ss_pred cccccccccccccCCCCCCCcccceeeecCCCCCCchHHHHHHHhhcccCCCCCCChhhhhhccCcCCCCCCCCCccchH
Q psy758 158 HLHIFQTNEYFKGVSLPHAENVVPLEIKIGKPAATNIYLIDFLKRCLDKDPLRRWSCDQLLRHPYFNGYYFEVPDEMQYE 237 (292)
Q Consensus 158 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~l~ 237 (292)
++..|.+||...+.......|+|+ .++.++..+.+..|+...+..+++..........+...++.+.
T Consensus 200 Gt~~Y~APE~~~~~~~~~~~DiwS-------------lGvilyemltG~~Pf~~~~~~~~~~~i~~~~~~~p~~~s~~~~ 266 (350)
T d1rdqe_ 200 GTPEALAPEIILSKGYNKAVDWWA-------------LGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVRFPSHFSSDLK 266 (350)
T ss_dssp ECGGGCCHHHHTTCCBCTHHHHHH-------------HHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCCTTCCHHHH
T ss_pred CccccCCHHHHcCCCCCccccccc-------------hhHHHHHHHhCCCCCCCcCHHHHHHHHhcCCCCCCccCCHHHH
Confidence 345577777666554332222222 2222333344444444444444433332233344556688999
Q ss_pred HHHhcccCcCCCCCC-----ChhhhhhCCcccceecc
Q psy758 238 EITQRCLDKDPLRRW-----SCDQLLRHPYFNGYYFE 269 (292)
Q Consensus 238 ~li~~~l~~dP~~Rp-----t~~~il~h~w~~~~~~~ 269 (292)
+||++||+.||.+|+ |++++++||||+++.|+
T Consensus 267 ~li~~~L~~dP~kR~~~~r~t~~ell~Hp~f~~~~~~ 303 (350)
T d1rdqe_ 267 DLLRNLLQVDLTKRFGNLKNGVNDIKNHKWFATTDWI 303 (350)
T ss_dssp HHHHHHSCSCTTTCTTSSTTTTHHHHTSGGGTTCCHH
T ss_pred HHHHHHhhhCHHhccccccccHHHHHcCccccCCCHH
Confidence 999999999999995 99999999999998876
|
| >d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=8.7e-53 Score=340.92 Aligned_cols=270 Identities=34% Similarity=0.541 Sum_probs=201.3
Q ss_pred CcccceeeeecccCceEEEEEEEcCCCcEEEEEEeccCCCChHHHHHHHHHHHHHHhCCCCCcchhhhhhhcCCeEEEEE
Q psy758 1 MERYEKIGKLGEGSYGVVFKCRNRDTGQVVAIKKFLESEEDPLIRKIALREIRLLKSLKHPNLVNLLEVFRRKKKLHLVF 80 (292)
Q Consensus 1 ~~~y~~~~~l~~g~~~~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~iv~ 80 (292)
|++|++++.||+|+||.||+|.+..+|+.||+|++..........+.+.+|+++++.++||||+++++++.+++.+|+||
T Consensus 1 ~d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~Hp~Iv~~~~~~~~~~~~~iv~ 80 (298)
T d1gz8a_ 1 MENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVF 80 (298)
T ss_dssp CTTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEC-------CCHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEE
T ss_pred CCCCEeccEEecCcCeEEEEEEECCCCCEEEEEEEehhhcChHHHHHHHHHHHHHHhCCCCcEEEeccccccccceeEEE
Confidence 68999999999999999999999999999999999765544444577889999999999999999999999999999999
Q ss_pred ecCCCccHHHHhc-CCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEEccCCcEEEeecCchhhhhcccc---
Q psy758 81 EFCDHTVLNELEN-HPHGLPWDLIKQITWQVLRGVSYCHRHACIHRDIKPENILLTANGVVKLCDFGFARLIRDLIP--- 156 (292)
Q Consensus 81 e~~~~~~L~~~~~-~~~~~~~~~~~~i~~qi~~aL~~LH~~givH~dl~p~Nilv~~~~~~kl~dfg~~~~~~~~~~--- 156 (292)
||+.++.+..... ....+++..++.++.||+.||+|||++||+||||||+||+++.++.+||+|||+++.......
T Consensus 81 e~~~~~~~~~~~~~~~~~l~e~~~~~~~~qil~~L~yLH~~~IiHrDiKpeNIl~~~~~~~kl~DFG~a~~~~~~~~~~~ 160 (298)
T d1gz8a_ 81 EFLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYT 160 (298)
T ss_dssp ECCSEEHHHHHHHTTTTCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTSCEEECSTTHHHHHCCCSBCTT
T ss_pred eecCCchhhhhhhhcccCCCHHHHHHHHHHHHHHHHHhhcCCEEccccCchheeecccCcceeccCCcceeccCCcccce
Confidence 9999887776644 345699999999999999999999999999999999999999999999999999987654322
Q ss_pred --ccccccccccccccCC------CCCCCcccceeeecCCCCCCchHHHHHHHhhcc--cCCCCCCChhhhhhccCc-CC
Q psy758 157 --RHLHIFQTNEYFKGVS------LPHAENVVPLEIKIGKPAATNIYLIDFLKRCLD--KDPLRRWSCDQLLRHPYF-NG 225 (292)
Q Consensus 157 --~~~~~~~~~~~~~~~~------~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~p~~~~~~~~~~~~~~~-~~ 225 (292)
.++..|.+||...... +.|+.|+..+++.+|..++......+.+..... ..|..... ......+.. ..
T Consensus 161 ~~~gt~~y~apE~~~~~~~~~~~~DiwSlGvily~m~~G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~-~~~~~~~~~~~~ 239 (298)
T d1gz8a_ 161 HEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVW-PGVTSMPDYKPS 239 (298)
T ss_dssp CCBCCCTTCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTTTS-TTGGGSTTCCTT
T ss_pred eecccceeeehhhhccccCCCccccccccchhhhHHhhCCCCCCCCCHHHHHHHHHHhcCCCchhhc-cccccccccccc
Confidence 2334566666543322 247777777888888877654433333222211 11111111 111111100 00
Q ss_pred CC---------CCCCCccchHHHHhcccCcCCCCCCChhhhhhCCcccceeccCC
Q psy758 226 YY---------FEVPDEMQYEEITQRCLDKDPLRRWSCDQLLRHPYFNGYYFEVP 271 (292)
Q Consensus 226 ~~---------~~~~~~~~l~~li~~~l~~dP~~Rpt~~~il~h~w~~~~~~~~~ 271 (292)
.. .....+.++.+||.+||++||++|||++|+++||||+++.-.+|
T Consensus 240 ~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~t~~ell~H~ff~~~~~p~p 294 (298)
T d1gz8a_ 240 FPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQDVTKPVP 294 (298)
T ss_dssp SCCCCCCCHHHHSTTCCHHHHHHHHHHTCSSTTTSCCHHHHHTSGGGTTCCCCCC
T ss_pred cccccccchhhhccCCCHHHHHHHHHHccCChhHCcCHHHHhCCHhhccCCCCCC
Confidence 00 01234678899999999999999999999999999998765554
|
| >d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase wnk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.7e-52 Score=333.12 Aligned_cols=249 Identities=24% Similarity=0.373 Sum_probs=190.1
Q ss_pred ccc-ceeeeecccCceEEEEEEEcCCCcEEEEEEeccCCCChHHHHHHHHHHHHHHhCCCCCcchhhhhhhc----CCeE
Q psy758 2 ERY-EKIGKLGEGSYGVVFKCRNRDTGQVVAIKKFLESEEDPLIRKIALREIRLLKSLKHPNLVNLLEVFRR----KKKL 76 (292)
Q Consensus 2 ~~y-~~~~~l~~g~~~~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~----~~~~ 76 (292)
+|| ++.+.||+|+||.||+|.+..+++.||+|.+..........+.+.+|+++++.++||||+++++++.+ ++.+
T Consensus 8 gry~~~~~~iG~G~fg~Vy~~~~~~~~~~va~K~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~~~~ 87 (270)
T d1t4ha_ 8 GRFLKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKCI 87 (270)
T ss_dssp SCEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEESSSCEEE
T ss_pred CCEEEeeeEEecCcCcEEEEEEECCCCeEEEEEEEchhhCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEeeccccCCEE
Confidence 355 67778999999999999999999999999998776666677889999999999999999999999864 4568
Q ss_pred EEEEecCCCccHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCC--ccccCCCCCceEEc-cCCcEEEeecCchhhhhc
Q psy758 77 HLVFEFCDHTVLNELENHPHGLPWDLIKQITWQVLRGVSYCHRHA--CIHRDIKPENILLT-ANGVVKLCDFGFARLIRD 153 (292)
Q Consensus 77 ~iv~e~~~~~~L~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~g--ivH~dl~p~Nilv~-~~~~~kl~dfg~~~~~~~ 153 (292)
|+||||+++|+|.+++.....+++..++.++.||+.||+|||++| |+||||||+|||++ +++.+||+|||+++....
T Consensus 88 ~ivmE~~~~g~L~~~l~~~~~~~~~~~~~~~~qi~~gl~yLH~~~~~IiHrDiKp~NILl~~~~~~~Kl~DFGla~~~~~ 167 (270)
T d1t4ha_ 88 VLVTELMTSGTLKTYLKRFKVMKIKVLRSWCRQILKGLQFLHTRTPPIIHRDLKCDNIFITGPTGSVKIGDLGLATLKRA 167 (270)
T ss_dssp EEEEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHTSSSCCCCSCCCGGGEEESSTTSCEEECCTTGGGGCCT
T ss_pred EEEEeCCCCCcHHHHHhccccccHHHHHHHHHHHHHHHHHHHHCCCCEEeCCcChhhceeeCCCCCEEEeecCcceeccC
Confidence 999999999999999987778999999999999999999999999 99999999999997 478999999999976443
Q ss_pred ccc---ccccccccccccccCCCCCCCcccceeeecCCCCCCchHHHHHHHhhcccCCCCCCC-hhhhhhccCcC--CCC
Q psy758 154 LIP---RHLHIFQTNEYFKGVSLPHAENVVPLEIKIGKPAATNIYLIDFLKRCLDKDPLRRWS-CDQLLRHPYFN--GYY 227 (292)
Q Consensus 154 ~~~---~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~-~~~~~~~~~~~--~~~ 227 (292)
... .++..|.+||...+. .. ...++++.+..+++.+.+..|+.... ..++....... ...
T Consensus 168 ~~~~~~~GT~~Y~aPE~~~~~-~~-------------~~~DIwSlGvilyel~~g~~Pf~~~~~~~~~~~~i~~~~~~~~ 233 (270)
T d1t4ha_ 168 SFAKAVIGTPEFMAPEMYEEK-YD-------------ESVDVYAFGMCMLEMATSEYPYSECQNAAQIYRRVTSGVKPAS 233 (270)
T ss_dssp TSBEESCSSCCCCCGGGGGTC-CC-------------THHHHHHHHHHHHHHHHSSCTTTTCSSHHHHHHHHTTTCCCGG
T ss_pred CccCCcccCccccCHHHhCCC-CC-------------CcCchhhHHHHHHHHHHCCCCCCCcccHHHHHHHHHcCCCCcc
Confidence 221 223445555544332 11 11222333344444455555544332 22222211110 112
Q ss_pred CCCCCccchHHHHhcccCcCCCCCCChhhhhhCCccc
Q psy758 228 FEVPDEMQYEEITQRCLDKDPLRRWSCDQLLRHPYFN 264 (292)
Q Consensus 228 ~~~~~~~~l~~li~~~l~~dP~~Rpt~~~il~h~w~~ 264 (292)
.+...++++.+||.+||+.||++|||++|+++||||+
T Consensus 234 ~~~~~~~~~~~li~~~l~~dp~~R~s~~ell~Hp~fk 270 (270)
T d1t4ha_ 234 FDKVAIPEVKEIIEGCIRQNKDERYSIKDLLNHAFFQ 270 (270)
T ss_dssp GGGCCCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGC
T ss_pred cCccCCHHHHHHHHHHccCCHhHCcCHHHHhCCcccC
Confidence 2334567899999999999999999999999999996
|
| >d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.3e-53 Score=346.54 Aligned_cols=270 Identities=24% Similarity=0.421 Sum_probs=204.1
Q ss_pred cccceeeeecccCceEEEEEEEcCCCcEEEEEEeccCCCChHHHHHHHHHHHHHHhCCCCCcchhhhhhhcCCeEEEEEe
Q psy758 2 ERYEKIGKLGEGSYGVVFKCRNRDTGQVVAIKKFLESEEDPLIRKIALREIRLLKSLKHPNLVNLLEVFRRKKKLHLVFE 81 (292)
Q Consensus 2 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~iv~e 81 (292)
++|++++.||+|+||.||+|++..+|+.||+|++..... ......+.+|+.+++.++||||++++++|.+++.+|+|||
T Consensus 6 d~y~~~~~iG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~-~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~iVmE 84 (322)
T d1s9ja_ 6 DDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIK-PAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICME 84 (322)
T ss_dssp GGEEEEEEEECCSSCCEEEEEETTTTEEEEEEEEECCCC-TTHHHHHHHHGGGGGGCCCTTBCCEEEEEECSSEEEEEEE
T ss_pred cCCEEEEEEecCCCeEEEEEEECCCCcEEEEEEEChhhC-HHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEE
Confidence 689999999999999999999999999999999976543 3345678899999999999999999999999999999999
Q ss_pred cCCCccHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHh-CCccccCCCCCceEEccCCcEEEeecCchhhhhccc---cc
Q psy758 82 FCDHTVLNELENHPHGLPWDLIKQITWQVLRGVSYCHR-HACIHRDIKPENILLTANGVVKLCDFGFARLIRDLI---PR 157 (292)
Q Consensus 82 ~~~~~~L~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~-~givH~dl~p~Nilv~~~~~~kl~dfg~~~~~~~~~---~~ 157 (292)
|++||+|..++.+.+.+++..++.++.||+.||.|||+ +||+||||||+|||+++++.+||+|||++....+.. ..
T Consensus 85 y~~gg~L~~~l~~~~~l~~~~~~~~~~qil~aL~yLH~~~~IiHRDiKP~NILl~~~~~vkl~DFGla~~~~~~~~~~~~ 164 (322)
T d1s9ja_ 85 HMDGGSLDQVLKKAGRIPEQILGKVSIAVIKGLTYLREKHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSMANSFV 164 (322)
T ss_dssp CCTTEEHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHHHCCCCSCCSGGGEEECTTCCEEECCCCCCHHHHHHTC---C
T ss_pred cCCCCcHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHhCCEEccccCHHHeeECCCCCEEEeeCCCccccCCCcccccc
Confidence 99999999999877789999999999999999999997 499999999999999999999999999998765432 23
Q ss_pred cccccccccccccCCCC-----CCCcccceeeecCCCCCCchHHHH---HHHhhcccCCCCC------------------
Q psy758 158 HLHIFQTNEYFKGVSLP-----HAENVVPLEIKIGKPAATNIYLID---FLKRCLDKDPLRR------------------ 211 (292)
Q Consensus 158 ~~~~~~~~~~~~~~~~~-----~~~~~~~~~~~~~~~~~~~~~~~~---~~~~~~~~~p~~~------------------ 211 (292)
++..|.+||...+.... |+.|+..+++.+|..++....... .........+...
T Consensus 165 GT~~Y~APEvl~~~~y~~~~DiWSlGvil~ell~G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 244 (322)
T d1s9ja_ 165 GTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAETPPRPRTPGRPLSSYGMDS 244 (322)
T ss_dssp CSSCCCCHHHHHCSCCCTTHHHHHHHHHHHHHHHSSCCSSCCCTTHHHHHC-----------------------------
T ss_pred CCccccCchHHcCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHhcCCcccCCccccccccccccccccc
Confidence 45668888887765554 566666666777776653321110 0000000000000
Q ss_pred ---CChhhhhhccCcC--CCCCCCCCccchHHHHhcccCcCCCCCCChhhhhhCCcccceeccCCC
Q psy758 212 ---WSCDQLLRHPYFN--GYYFEVPDEMQYEEITQRCLDKDPLRRWSCDQLLRHPYFNGYYFEVPD 272 (292)
Q Consensus 212 ---~~~~~~~~~~~~~--~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~~il~h~w~~~~~~~~~~ 272 (292)
....+........ ........+.++.+||.+||+.||.+|||++|+|+||||++..++.-+
T Consensus 245 ~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~R~ta~e~L~Hpf~~~~~~~~~d 310 (322)
T d1s9ja_ 245 RPPMAIFELLDYIVNEPPPKLPSGVFSLEFQDFVNKCLIKNPAERADLKQLMVHAFIKRSDAEEVD 310 (322)
T ss_dssp -CCCCHHHHHHHHHTSCCCCCCBTTBCHHHHHHHHHHTCSSTTTSCCHHHHHTSHHHHHHHHSCCC
T ss_pred ccchhHHHHHhhhhccCCccCccccCCHHHHHHHHHHcCCChhHCcCHHHHhhCHhhCcCCccccc
Confidence 0001111100000 001112246789999999999999999999999999999987765544
|
| >d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: gamma-subunit of glycogen phosphorylase kinase (Phk) species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]
Probab=100.00 E-value=1.7e-52 Score=334.44 Aligned_cols=251 Identities=24% Similarity=0.344 Sum_probs=198.4
Q ss_pred cccceeeeecccCceEEEEEEEcCCCcEEEEEEeccCCCC-------hHHHHHHHHHHHHHHhCC-CCCcchhhhhhhcC
Q psy758 2 ERYEKIGKLGEGSYGVVFKCRNRDTGQVVAIKKFLESEED-------PLIRKIALREIRLLKSLK-HPNLVNLLEVFRRK 73 (292)
Q Consensus 2 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~v~iK~~~~~~~~-------~~~~~~~~~e~~~~~~l~-~~~i~~~~~~~~~~ 73 (292)
++|++.+.||+|+||+||+|++..+|+.||+|++...... ....+.+.+|+.+++.++ ||||+++++++.++
T Consensus 3 ~~y~~~~~iG~G~~g~V~~~~~~~~~~~~AvK~i~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~~ 82 (277)
T d1phka_ 3 ENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHPNIIQLKDTYETN 82 (277)
T ss_dssp TTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTCSTTCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEEECS
T ss_pred ccCEEceEEecCcCeEEEEEEECCCCCEEEEEEEecccccchhHHHHHHHHHHHHHHHHHHHHhcCCCCeEEEEeecccC
Confidence 7899999999999999999999999999999999765422 223456889999999997 99999999999999
Q ss_pred CeEEEEEecCCCccHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEEccCCcEEEeecCchhhhhc
Q psy758 74 KKLHLVFEFCDHTVLNELENHPHGLPWDLIKQITWQVLRGVSYCHRHACIHRDIKPENILLTANGVVKLCDFGFARLIRD 153 (292)
Q Consensus 74 ~~~~iv~e~~~~~~L~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~givH~dl~p~Nilv~~~~~~kl~dfg~~~~~~~ 153 (292)
+..|+||||++||+|.+++...+.+++..++.++.||+.||+|||++||+||||||+||+++.++.+||+|||+++....
T Consensus 83 ~~~~ivmE~~~~g~L~~~l~~~~~l~e~~~~~~~~qi~~al~~lH~~~ivHrDlkp~Nill~~~~~~kl~DFG~a~~~~~ 162 (277)
T d1phka_ 83 TFFFLVFDLMKKGELFDYLTEKVTLSEKETRKIMRALLEVICALHKLNIVHRDLKPENILLDDDMNIKLTDFGFSCQLDP 162 (277)
T ss_dssp SEEEEEEECCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTCCEEECCCTTCEECCT
T ss_pred cceEEEEEcCCCchHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCcccccccceEEEcCCCCeEEccchheeEccC
Confidence 99999999999999999998888899999999999999999999999999999999999999999999999999987654
Q ss_pred cc----cccccccccccccccC-----------CCCCCCcccceeeecCCCCCCchHHHHHHHhhcccCCCCCCChhhhh
Q psy758 154 LI----PRHLHIFQTNEYFKGV-----------SLPHAENVVPLEIKIGKPAATNIYLIDFLKRCLDKDPLRRWSCDQLL 218 (292)
Q Consensus 154 ~~----~~~~~~~~~~~~~~~~-----------~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~ 218 (292)
.. ..++..|.+||+..+. .+.|+.|+..+++.+|..++........+...+.....
T Consensus 163 ~~~~~~~~gt~~y~~PE~~~~~~~~~~~~~~~~~DiwslGvilyeml~g~~Pf~~~~~~~~~~~i~~~~~~--------- 233 (277)
T d1phka_ 163 GEKLREVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQMLMLRMIMSGNYQ--------- 233 (277)
T ss_dssp TCCBCCCCSCGGGCCHHHHHHHHCTTSCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCC---------
T ss_pred CCceeeeeccCCCCCHHHhhccccccCCCCCchheEcccchhhhhhccCCCCCCCCCHHHHHHHHHhCCCC---------
Confidence 22 2223456677766532 12355555555555555544433333333222221110
Q ss_pred hccCcCCCCCCCCCccchHHHHhcccCcCCCCCCChhhhhhCCcccce
Q psy758 219 RHPYFNGYYFEVPDEMQYEEITQRCLDKDPLRRWSCDQLLRHPYFNGY 266 (292)
Q Consensus 219 ~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~~il~h~w~~~~ 266 (292)
-........++++++||.+||++||++|||++|+++||||+..
T Consensus 234 -----~~~~~~~~~s~~~~~li~~~L~~~p~~R~s~~eil~h~~~~~~ 276 (277)
T d1phka_ 234 -----FGSPEWDDYSDTVKDLVSRFLVVQPQKRYTAEEALAHPFFQQY 276 (277)
T ss_dssp -----CCTTTGGGSCHHHHHHHHHHCCSSGGGSCCHHHHTTSGGGCTT
T ss_pred -----CCCcccccCCHHHHHHHHHHccCChhHCcCHHHHHcCHHHHHh
Confidence 0111122457789999999999999999999999999999863
|
| >d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase C, theta type species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.2e-52 Score=342.01 Aligned_cols=256 Identities=20% Similarity=0.311 Sum_probs=198.5
Q ss_pred CcccceeeeecccCceEEEEEEEcCCCcEEEEEEeccCCC-ChHHHHHHHHHHHHH-HhCCCCCcchhhhhhhcCCeEEE
Q psy758 1 MERYEKIGKLGEGSYGVVFKCRNRDTGQVVAIKKFLESEE-DPLIRKIALREIRLL-KSLKHPNLVNLLEVFRRKKKLHL 78 (292)
Q Consensus 1 ~~~y~~~~~l~~g~~~~v~~~~~~~~~~~v~iK~~~~~~~-~~~~~~~~~~e~~~~-~~l~~~~i~~~~~~~~~~~~~~i 78 (292)
|++|++++.||+|+||.||+|.+..+|+.||+|++.+... .....+.+..|..++ +.++||||+++++++.+++.+|+
T Consensus 1 iddy~i~~~iG~G~fg~Vy~~~~~~t~~~vAvK~i~k~~~~~~~~~~~~~~e~~~l~~~~~hp~Iv~~~~~~~~~~~~yi 80 (320)
T d1xjda_ 1 IEDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHMFCTFQTKENLFF 80 (320)
T ss_dssp CTTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHTTCTTBCCEEEEEECSSEEEE
T ss_pred CCCeEEeeEEecCCCcEEEEEEECCCCCEEEEEEEchhhccChHHHHHHHHHHHHHHHhCCCCcEEEEEEEEccCCceeE
Confidence 6899999999999999999999999999999999965421 111234455666665 47899999999999999999999
Q ss_pred EEecCCCccHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEEccCCcEEEeecCchhhhhccccc-
Q psy758 79 VFEFCDHTVLNELENHPHGLPWDLIKQITWQVLRGVSYCHRHACIHRDIKPENILLTANGVVKLCDFGFARLIRDLIPR- 157 (292)
Q Consensus 79 v~e~~~~~~L~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~givH~dl~p~Nilv~~~~~~kl~dfg~~~~~~~~~~~- 157 (292)
||||++||+|..++.....+++..++.++.||+.||+|||++||+||||||+|||+++++.+||+|||+++........
T Consensus 81 vmEy~~~g~L~~~i~~~~~~~e~~~~~~~~qi~~al~ylH~~~iiHrDikp~NiL~~~~~~~kl~DFG~a~~~~~~~~~~ 160 (320)
T d1xjda_ 81 VMEYLNGGDLMYHIQSCHKFDLSRATFYAAEIILGLQFLHSKGIVYRDLKLDNILLDKDGHIKIADFGMCKENMLGDAKT 160 (320)
T ss_dssp EEECCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTSCEEECCCTTCBCCCCTTCCB
T ss_pred EEeecCCCcHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCcccceeecCCCceeccccchhhhcccccccc
Confidence 9999999999999988888999999999999999999999999999999999999999999999999999865433222
Q ss_pred ----cccccccccccccCCCCCCCcccceeeecCCCCCCchHHHHHHHhhcccCCCCCCChhhhhhccCcCCCCCCCCCc
Q psy758 158 ----HLHIFQTNEYFKGVSLPHAENVVPLEIKIGKPAATNIYLIDFLKRCLDKDPLRRWSCDQLLRHPYFNGYYFEVPDE 233 (292)
Q Consensus 158 ----~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 233 (292)
++..|.+||...+.......|+|+ .++.++..+.+..|+...+..++...........+...+
T Consensus 161 ~~~~gt~~y~aPE~~~~~~~~~~~DiwS-------------lGvilyemltG~~PF~~~~~~~~~~~i~~~~~~~p~~~s 227 (320)
T d1xjda_ 161 NTFCGTPDYIAPEILLGQKYNHSVDWWS-------------FGVLLYEMLIGQSPFHGQDEEELFHSIRMDNPFYPRWLE 227 (320)
T ss_dssp CCCCSCGGGCCHHHHTTCCBCTHHHHHH-------------HHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCCTTSC
T ss_pred cccCCCCCcCCHHHHcCCCCCchhhhhh-------------hhHHHHHHHhCCCCCCCCCHHHHHHHHHcCCCCCCccCC
Confidence 234455666555544332222222 222333444444555544544444333333334455568
Q ss_pred cchHHHHhcccCcCCCCCCChh-hhhhCCcccceecc
Q psy758 234 MQYEEITQRCLDKDPLRRWSCD-QLLRHPYFNGYYFE 269 (292)
Q Consensus 234 ~~l~~li~~~l~~dP~~Rpt~~-~il~h~w~~~~~~~ 269 (292)
..+.+||.+||+.||++|||+. ++++||||+++.|+
T Consensus 228 ~~~~dli~~~L~~dP~~R~s~~~~l~~hpff~~~~~~ 264 (320)
T d1xjda_ 228 KEAKDLLVKLFVREPEKRLGVRGDIRQHPLFREINWE 264 (320)
T ss_dssp HHHHHHHHHHSCSSGGGSBTTBSCGGGSGGGTTCCHH
T ss_pred HHHHHHHHHhcccCCCCCcCHHHHHHhCchhccCCHH
Confidence 8999999999999999999996 89999999998765
|
| >d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: G-protein coupled receptor kinase 2 species: Cow (Bos taurus) [TaxId: 9913]
Probab=100.00 E-value=9.8e-52 Score=342.21 Aligned_cols=256 Identities=18% Similarity=0.276 Sum_probs=197.6
Q ss_pred CcccceeeeecccCceEEEEEEEcCCCcEEEEEEeccCC----CChHHHHHHHHHHHHHHhCCCCCcchhhhhhhcCCeE
Q psy758 1 MERYEKIGKLGEGSYGVVFKCRNRDTGQVVAIKKFLESE----EDPLIRKIALREIRLLKSLKHPNLVNLLEVFRRKKKL 76 (292)
Q Consensus 1 ~~~y~~~~~l~~g~~~~v~~~~~~~~~~~v~iK~~~~~~----~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~ 76 (292)
|++|++.+.||+|+||.||+|++..+|+.||+|++.... ...........++.+++.++||||+++++++.+++.+
T Consensus 3 lddy~i~~~lG~G~fg~Vy~~~~~~t~~~vAiK~i~~~~~~~~~~~~~~~~e~~~~~~l~~~~hpnIv~l~~~~~~~~~~ 82 (364)
T d1omwa3 3 MNDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDKL 82 (364)
T ss_dssp STTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHHTCHHHHHHHHHHHHHHSSSCCTTBCCEEEEEECSSEE
T ss_pred HHhCeeeeEEecCCCeEEEEEEECCCCCEEEEEEEchHHcchhhHHHHHHHHHHHHHHHhcCCCCcEEEEEEEEEECCEE
Confidence 689999999999999999999999999999999986432 1222223334457778888999999999999999999
Q ss_pred EEEEecCCCccHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEEccCCcEEEeecCchhhhhccc-
Q psy758 77 HLVFEFCDHTVLNELENHPHGLPWDLIKQITWQVLRGVSYCHRHACIHRDIKPENILLTANGVVKLCDFGFARLIRDLI- 155 (292)
Q Consensus 77 ~iv~e~~~~~~L~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~givH~dl~p~Nilv~~~~~~kl~dfg~~~~~~~~~- 155 (292)
|+||||++||+|..++.....+++..++.++.||+.||.|||++||+||||||+|||++.+|.+||+|||+++......
T Consensus 83 ~ivmE~~~gg~L~~~l~~~~~~~e~~~~~~~~qi~~aL~ylH~~~iiHrDlKP~NILl~~~g~iKl~DFGla~~~~~~~~ 162 (364)
T d1omwa3 83 SFILDLMNGGDLHYHLSQHGVFSEADMRFYAAEIILGLEHMHNRFVVYRDLKPANILLDEHGHVRISDLGLACDFSKKKP 162 (364)
T ss_dssp EEEECCCCSCBHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECSSSCEEECCCTTCEECSSSCC
T ss_pred EEEEEecCCCcHHHHHHhcccccHHHHHHHHHHHHHHHHHHHHCCccceeeccceeEEcCCCcEEEeeeceeeecCCCcc
Confidence 9999999999999999887889999999999999999999999999999999999999999999999999998665322
Q ss_pred --ccccccccccccccc-CCCCCCCcccceeeecCCCCCCchHHHHHHHhhcccCCCCCCC---hhhhhhccCcCCCCCC
Q psy758 156 --PRHLHIFQTNEYFKG-VSLPHAENVVPLEIKIGKPAATNIYLIDFLKRCLDKDPLRRWS---CDQLLRHPYFNGYYFE 229 (292)
Q Consensus 156 --~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~---~~~~~~~~~~~~~~~~ 229 (292)
..++..|.+||...+ .......|+ ++.++.++..+.+..|+...+ ..++...........+
T Consensus 163 ~~~~GT~~y~APE~~~~~~~~~~~~Di-------------wSlGvilyemltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~ 229 (364)
T d1omwa3 163 HASVGTHGYMAPEVLQKGVAYDSSADW-------------FSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTLTMAVELP 229 (364)
T ss_dssp CSCCSCGGGCCHHHHSTTCCCCTHHHH-------------HHHHHHHHHHHHSSCSSCSSCSSCHHHHHHHSSSCCCCCC
T ss_pred cccccccccchhHHhhcCCCCCcccch-------------hHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcccCCCCCC
Confidence 234455666666542 222222222 233333444444455543322 2223333333334445
Q ss_pred CCCccchHHHHhcccCcCCCCCCC-----hhhhhhCCcccceecc
Q psy758 230 VPDEMQYEEITQRCLDKDPLRRWS-----CDQLLRHPYFNGYYFE 269 (292)
Q Consensus 230 ~~~~~~l~~li~~~l~~dP~~Rpt-----~~~il~h~w~~~~~~~ 269 (292)
...++.+++||.+||+.||++||| |+|+++||||+++.|+
T Consensus 230 ~~~s~~~~~li~~~L~~dP~~R~t~~~~~a~eil~Hp~f~~i~~~ 274 (364)
T d1omwa3 230 DSFSPELRSLLEGLLQRDVNRRLGCLGRGAQEVKESPFFRSLDWQ 274 (364)
T ss_dssp SSSCHHHHHHHHHHTCSSTTTSTTTSSSTHHHHHTSGGGTTCCHH
T ss_pred CCCCHHHHHHHHHHcccCHHHhCCCcccCHHHHHcCccccCCCHH
Confidence 567889999999999999999999 7999999999998775
|
| >d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: (Plasmodium falciparum) [TaxId: 5833]
Probab=100.00 E-value=1.4e-51 Score=332.26 Aligned_cols=264 Identities=32% Similarity=0.486 Sum_probs=203.9
Q ss_pred CcccceeeeecccCceEEEEEEEcCCCcEEEEEEeccCCCChHHHHHHHHHHHHHHhCCCCCcchhhhhhhcCCeEEEEE
Q psy758 1 MERYEKIGKLGEGSYGVVFKCRNRDTGQVVAIKKFLESEEDPLIRKIALREIRLLKSLKHPNLVNLLEVFRRKKKLHLVF 80 (292)
Q Consensus 1 ~~~y~~~~~l~~g~~~~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~iv~ 80 (292)
|+||++.+.||+|+||+||+|++. +|+.||+|++..........+.+.+|+.+++.++||||+++++++.+++..++++
T Consensus 1 ~~~Y~~~~~iG~G~fg~Vy~~~~~-~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~i~~ 79 (286)
T d1ob3a_ 1 MEKYHGLEKIGEGTYGVVYKAQNN-YGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKLYDVIHTKKRLVLVF 79 (286)
T ss_dssp CCSEEEEEEEEEETTEEEEEEEET-TSCEEEEEEECCSSGGGCCCHHHHHHHHGGGGCCCTTBCCEEEEEECSSCEEEEE
T ss_pred CCCceeccEEecCCCcEEEEEEeC-CCCEEEEEEEehhhcChHHHHHHHHHHHHHHhCCCCcEEeeeeecccCCceeEEE
Confidence 689999999999999999999985 6899999999766544444577889999999999999999999999999999999
Q ss_pred ecCCCccHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEEccCCcEEEeecCchhhhhcccc----
Q psy758 81 EFCDHTVLNELENHPHGLPWDLIKQITWQVLRGVSYCHRHACIHRDIKPENILLTANGVVKLCDFGFARLIRDLIP---- 156 (292)
Q Consensus 81 e~~~~~~L~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~givH~dl~p~Nilv~~~~~~kl~dfg~~~~~~~~~~---- 156 (292)
|++.++++..+....+.+++..++.++.||+.||+|||+.||+||||||+||+++.++.+||+|||.+........
T Consensus 80 e~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~IvHrDiKp~NIll~~~~~~kl~DfG~a~~~~~~~~~~~~ 159 (286)
T d1ob3a_ 80 EHLDQDLKKLLDVCEGGLESVTAKSFLLQLLNGIAYCHDRRVLHRDLKPQNLLINREGELKIADFGLARAFGIPVRKYTH 159 (286)
T ss_dssp ECCSEEHHHHHHTSTTCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTSCEEECCTTHHHHHCC-------
T ss_pred EeehhhhHHHHHhhcCCcchhhhHHHHHHHHHHHHHhccCcEEecCCCCceeeEcCCCCEEecccccceecccCccccce
Confidence 9999999999988888999999999999999999999999999999999999999999999999999987654322
Q ss_pred -ccccccccccccccCC------CCCCCcccceeeecCCCCCCchHHHHHHHhh---ccc-CCCCCCChhhhhhccC-cC
Q psy758 157 -RHLHIFQTNEYFKGVS------LPHAENVVPLEIKIGKPAATNIYLIDFLKRC---LDK-DPLRRWSCDQLLRHPY-FN 224 (292)
Q Consensus 157 -~~~~~~~~~~~~~~~~------~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~---~~~-~p~~~~~~~~~~~~~~-~~ 224 (292)
..+..|.+||...+.. +.|+.|+..+++.+|..++....-.+.+... +.. ................ +.
T Consensus 160 ~~~~~~y~~pE~~~~~~~~~~~~DiwslGv~l~el~~G~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~ 239 (286)
T d1ob3a_ 160 EIVTLWYRAPDVLMGSKKYSTTIDIWSVGCIFAEMVNGTPLFPGVSEADQLMRIFRILGTPNSKNWPNVTELPKYDPNFT 239 (286)
T ss_dssp --CCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTTTSTTGGGSTTCCTTCC
T ss_pred ecccchhhhHHHHhCCCCCCcceeehhcCcHHHHHHHCCCCCCCCCHHHHHHHHHHhhCCCChhhccchhhhhhcccccc
Confidence 2334466666554332 3477777788888888877544333322221 111 1111112111111100 00
Q ss_pred ---C---CCCCCCCccchHHHHhcccCcCCCCCCChhhhhhCCcccc
Q psy758 225 ---G---YYFEVPDEMQYEEITQRCLDKDPLRRWSCDQLLRHPYFNG 265 (292)
Q Consensus 225 ---~---~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~~il~h~w~~~ 265 (292)
. .......+..+.+||++||++||++|||++|+++||||++
T Consensus 240 ~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~R~s~~ell~Hp~f~~ 286 (286)
T d1ob3a_ 240 VYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQALEHAYFKE 286 (286)
T ss_dssp CCCCCCGGGTCCSCCHHHHHHHHHHTCSSTTTSCCHHHHHTSGGGGC
T ss_pred cccCcchhhhcccCCHHHHHHHHHHccCChhHCcCHHHHhcCcccCc
Confidence 0 0112334678899999999999999999999999999984
|
| >d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 7, CDK7 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=6.9e-52 Score=336.07 Aligned_cols=267 Identities=29% Similarity=0.418 Sum_probs=201.4
Q ss_pred eeeeecccCceEEEEEEEcCCCcEEEEEEeccCCCC---hHHHHHHHHHHHHHHhCCCCCcchhhhhhhcCCeEEEEEec
Q psy758 6 KIGKLGEGSYGVVFKCRNRDTGQVVAIKKFLESEED---PLIRKIALREIRLLKSLKHPNLVNLLEVFRRKKKLHLVFEF 82 (292)
Q Consensus 6 ~~~~l~~g~~~~v~~~~~~~~~~~v~iK~~~~~~~~---~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~iv~e~ 82 (292)
.++.||+|+||+||+|++..+|+.||+|++...... ....+.+.+|+.+++.++||||+++++++.+++.+|+||||
T Consensus 2 ~l~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~~~~~~~~~~~~~ivmE~ 81 (299)
T d1ua2a_ 2 KLDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIGLLDAFGHKSNISLVFDF 81 (299)
T ss_dssp EEEEEEEETTEEEEEEECSSCCSEEEEEEC------------CTHHHHHHHHHHHCCCTTBCCEEEEECCTTCCEEEEEC
T ss_pred cceEeccCcCeEEEEEEECCCCcEEEEEEEehhhhhhhhHHHHHHHHHHHHHHHhCCCCCEeEEEeeeccCCceeehhhh
Confidence 468899999999999999999999999998655422 22345688999999999999999999999999999999999
Q ss_pred CCCccHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEEccCCcEEEeecCchhhhhcccc-----c
Q psy758 83 CDHTVLNELENHPHGLPWDLIKQITWQVLRGVSYCHRHACIHRDIKPENILLTANGVVKLCDFGFARLIRDLIP-----R 157 (292)
Q Consensus 83 ~~~~~L~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~givH~dl~p~Nilv~~~~~~kl~dfg~~~~~~~~~~-----~ 157 (292)
+.++++..+......+++..++.++.||+.||+|||++||+||||||+||+++.++.+||+|||++........ .
T Consensus 82 ~~~~~~~~~~~~~~~l~~~~~~~~~~qil~aL~~lH~~~iiHrDiKp~NIli~~~~~~KL~DFG~a~~~~~~~~~~~~~~ 161 (299)
T d1ua2a_ 82 METDLEVIIKDNSLVLTPSHIKAYMLMTLQGLEYLHQHWILHRDLKPNNLLLDENGVLKLADFGLAKSFGSPNRAYTHQV 161 (299)
T ss_dssp CSEEHHHHHTTCCSSCCSSHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTCCEEECCCGGGSTTTSCCCCCCCSC
T ss_pred hcchHHhhhhhcccCCCHHHHHHHHHHHHHHHHHhhccceecccCCcceEEecCCCccccccCccccccCCCccccccee
Confidence 99999999888888899999999999999999999999999999999999999999999999999987654322 2
Q ss_pred cccccccccccccCC------CCCCCcccceeeecCCCCCCchHHHHHHHhhc---ccCCC-CCCChhhhhhccCcCCCC
Q psy758 158 HLHIFQTNEYFKGVS------LPHAENVVPLEIKIGKPAATNIYLIDFLKRCL---DKDPL-RRWSCDQLLRHPYFNGYY 227 (292)
Q Consensus 158 ~~~~~~~~~~~~~~~------~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~---~~~p~-~~~~~~~~~~~~~~~~~~ 227 (292)
++..|.+||...+.. +.|+.|+..+++.+|.+++....-.+.+..+. +..+. ..+..........+....
T Consensus 162 gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~~g~~pf~~~~~~~~l~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 241 (299)
T d1ua2a_ 162 VTRWYRAPELLFGARMYGVGVDMWAVGCILAELLLRVPFLPGDSDLDQLTRIFETLGTPTEEQWPDMCSLPDYVTFKSFP 241 (299)
T ss_dssp CCCTTCCHHHHTTCSCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCTTTSSSTTSSTTCCCCCCCC
T ss_pred cChhhccHHHHccCCCCChhhhhhhcchHHHHHHhCcCCCCCCCHHHHHHHHHHhcCCCChhhccchhccchhhhhccCC
Confidence 345677777654332 35778888888888887765444333333222 22111 111111111111111110
Q ss_pred ------CCCCCccchHHHHhcccCcCCCCCCChhhhhhCCcccceeccCCC
Q psy758 228 ------FEVPDEMQYEEITQRCLDKDPLRRWSCDQLLRHPYFNGYYFEVPD 272 (292)
Q Consensus 228 ------~~~~~~~~l~~li~~~l~~dP~~Rpt~~~il~h~w~~~~~~~~~~ 272 (292)
.....+..+.+||.+||+.||++||||+|+|+||||++.....|.
T Consensus 242 ~~~~~~~~~~~s~~~~dll~~~L~~dP~~R~sa~e~L~Hp~f~~~p~p~~~ 292 (299)
T d1ua2a_ 242 GIPLHHIFSAAGDDLLDLIQGLFLFNPCARITATQALKMKYFSNRPGPTPG 292 (299)
T ss_dssp CCCHHHHCTTCCHHHHHHHHHHHCSSTTTSCCHHHHHTSGGGTSSSCCCCS
T ss_pred CCChHHhcccCCHHHHHHHHHHccCChhhCcCHHHHhCCHhhCCCCCCCCC
Confidence 012346789999999999999999999999999999987655444
|
| >d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Titin, kinase domain species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.3e-51 Score=334.85 Aligned_cols=244 Identities=21% Similarity=0.305 Sum_probs=189.2
Q ss_pred CcccceeeeecccCceEEEEEEEcCCCcEEEEEEeccCCCChHHHHHHHHHHHHHHhCCCCCcchhhhhhhcCCeEEEEE
Q psy758 1 MERYEKIGKLGEGSYGVVFKCRNRDTGQVVAIKKFLESEEDPLIRKIALREIRLLKSLKHPNLVNLLEVFRRKKKLHLVF 80 (292)
Q Consensus 1 ~~~y~~~~~l~~g~~~~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~iv~ 80 (292)
+++|++.+.||+|+||.||+|++..+|+.||+|++..... ....+.+|+.+++.++||||+++++++.+++.+|+||
T Consensus 4 ~~rY~i~~~lG~G~fg~Vy~~~~~~~~~~~AiK~i~~~~~---~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~lvm 80 (321)
T d1tkia_ 4 YEKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVKGT---DQVLVKKEISILNIARHRNILHLHESFESMEELVMIF 80 (321)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCCTH---HHHHHHHHHHHHHHSCCTTBCCEEEEEEETTEEEEEE
T ss_pred ccceEEEEEEecCCCeEEEEEEECCCCcEEEEEEEcCCcc---cHHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEEEEE
Confidence 4799999999999999999999999999999999976542 2355789999999999999999999999999999999
Q ss_pred ecCCCccHHHHhcCCC-CCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEEccC--CcEEEeecCchhhhhcccc-
Q psy758 81 EFCDHTVLNELENHPH-GLPWDLIKQITWQVLRGVSYCHRHACIHRDIKPENILLTAN--GVVKLCDFGFARLIRDLIP- 156 (292)
Q Consensus 81 e~~~~~~L~~~~~~~~-~~~~~~~~~i~~qi~~aL~~LH~~givH~dl~p~Nilv~~~--~~~kl~dfg~~~~~~~~~~- 156 (292)
|||+|++|.+++...+ .+++..++.++.||+.||+|||++||+||||||+||+++.+ +.++|+|||++........
T Consensus 81 E~~~gg~L~~~i~~~~~~l~e~~~~~i~~qi~~al~yLH~~~iiHrDlKp~NIll~~~~~~~ikl~DFG~~~~~~~~~~~ 160 (321)
T d1tkia_ 81 EFISGLDIFERINTSAFELNEREIVSYVHQVCEALQFLHSHNIGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPGDNF 160 (321)
T ss_dssp CCCCCCBHHHHHTSSSCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESSSSCCCEEECCCTTCEECCTTCEE
T ss_pred ecCCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcCCCcccccccceeecCCCceEEEEcccchhhccccCCcc
Confidence 9999999999987654 69999999999999999999999999999999999999854 4799999999876543221
Q ss_pred ---ccccccccccccccCC-----CCCCCcccceeeecCCCCCCchHHHHHHHhhcccCCCCCCChhhhhhccCcCCCCC
Q psy758 157 ---RHLHIFQTNEYFKGVS-----LPHAENVVPLEIKIGKPAATNIYLIDFLKRCLDKDPLRRWSCDQLLRHPYFNGYYF 228 (292)
Q Consensus 157 ---~~~~~~~~~~~~~~~~-----~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~ 228 (292)
..+..|.+|+...+.. +.|+.|+..+++.+|..++......+++...+.. ...+
T Consensus 161 ~~~~~t~~y~ape~~~~~~~~~~~DiWSlGvily~ll~G~~Pf~~~~~~~~~~~i~~~------------------~~~~ 222 (321)
T d1tkia_ 161 RLLFTAPEYYAPEVHQHDVVSTATDMWSLGTLVYVLLSGINPFLAETNQQIIENIMNA------------------EYTF 222 (321)
T ss_dssp EEEESCGGGSCHHHHTTCEECHHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHHT------------------CCCC
T ss_pred cccccccccccchhccCCCCCchhhcccHHHHHHHHHhCCCCCCCCCHHHHHHHHHhC------------------CCCC
Confidence 1122333333332222 2344455555555555544333333333332221 1111
Q ss_pred C----CCCccchHHHHhcccCcCCCCCCChhhhhhCCcccc
Q psy758 229 E----VPDEMQYEEITQRCLDKDPLRRWSCDQLLRHPYFNG 265 (292)
Q Consensus 229 ~----~~~~~~l~~li~~~l~~dP~~Rpt~~~il~h~w~~~ 265 (292)
+ ...+..+++||.+||+.||++|||++|+++||||++
T Consensus 223 ~~~~~~~~s~~~~~li~~~L~~dp~~R~s~~eil~hp~~~~ 263 (321)
T d1tkia_ 223 DEEAFKEISIEAMDFVDRLLVKERKSRMTASEALQHPWLKQ 263 (321)
T ss_dssp CHHHHTTSCHHHHHHHHTTSCSSGGGSCCHHHHHHSHHHHS
T ss_pred ChhhccCCCHHHHHHHHHHccCChhHCcCHHHHhcCHhhcc
Confidence 1 234778999999999999999999999999999975
|
| >d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK5 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.4e-50 Score=325.58 Aligned_cols=267 Identities=31% Similarity=0.517 Sum_probs=204.7
Q ss_pred CcccceeeeecccCceEEEEEEEcCCCcEEEEEEeccCCCChHHHHHHHHHHHHHHhCCCCCcchhhhhhhcCCeEEEEE
Q psy758 1 MERYEKIGKLGEGSYGVVFKCRNRDTGQVVAIKKFLESEEDPLIRKIALREIRLLKSLKHPNLVNLLEVFRRKKKLHLVF 80 (292)
Q Consensus 1 ~~~y~~~~~l~~g~~~~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~iv~ 80 (292)
|+||++++.||+|+||+||+|++..+++.||+|++............+.+|+.+++.++||||+++++++.+....++++
T Consensus 1 ~~ry~~i~~LG~G~fg~V~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~h~niv~~~~~~~~~~~~~iv~ 80 (292)
T d1unla_ 1 MQKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLHSDKKLTLVF 80 (292)
T ss_dssp CCSEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEESSCSSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred CCCCEeeeEEecCcCeEEEEEEECCCCcEEEEEEEehhhCChHHHHHHHHHHHHHHhcCcCCEEeeccccccccceeEEe
Confidence 68999999999999999999999999999999999877666667788999999999999999999999999999999999
Q ss_pred ecCCCccHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEEccCCcEEEeecCchhhhhcccc----
Q psy758 81 EFCDHTVLNELENHPHGLPWDLIKQITWQVLRGVSYCHRHACIHRDIKPENILLTANGVVKLCDFGFARLIRDLIP---- 156 (292)
Q Consensus 81 e~~~~~~L~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~givH~dl~p~Nilv~~~~~~kl~dfg~~~~~~~~~~---- 156 (292)
+++.++++..++...+.+++..++.++.|++.||+|||++||+||||||+||+++.++.+||+|||.+........
T Consensus 81 ~~~~~~~l~~~~~~~~~~~~~~~~~~~~q~~~aL~~lH~~~IvHrDiKP~NIli~~~~~~kl~DFG~a~~~~~~~~~~~~ 160 (292)
T d1unla_ 81 EFCDQDLKKYFDSCNGDLDPEIVKSFLFQLLKGLGFCHSRNVLHRDLKPQNLLINRNGELKLANFGLARAFGIPVRCYSA 160 (292)
T ss_dssp ECCSEEHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTCCEEECCCTTCEECCSCCSCCCS
T ss_pred eeccccccccccccccccchhHHHHHHHHHHHHHHHhhcCCEeeecccCcccccccCCceeeeecchhhcccCCCcccee
Confidence 9999999999998888999999999999999999999999999999999999999999999999999987653222
Q ss_pred -ccccccccccccccCC------CCCCCcccceeeecCCCCC-CchHHHH---HHHhhccc-CCCCCCChhhhhhccC--
Q psy758 157 -RHLHIFQTNEYFKGVS------LPHAENVVPLEIKIGKPAA-TNIYLID---FLKRCLDK-DPLRRWSCDQLLRHPY-- 222 (292)
Q Consensus 157 -~~~~~~~~~~~~~~~~------~~~~~~~~~~~~~~~~~~~-~~~~~~~---~~~~~~~~-~p~~~~~~~~~~~~~~-- 222 (292)
..+..+.+|+...+.. +.|+.|+..+++.+|..++ ......+ .+...... .+.............-
T Consensus 161 ~~~~~~~~~pe~~~~~~~~~~~~DiwSlG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 240 (292)
T d1unla_ 161 EVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEEQWPSMTKLPDYKPYP 240 (292)
T ss_dssp CCSCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHTTTSCCSCCCSSHHHHHHHHHHHHCCCCTTTCTTGGGSTTCCCCC
T ss_pred eccccchhhhhHhccCCCCCchhhccccchHHHHHhhCCCCCCCCCCHHHHHHHHHhhcCCCChhhhhhhhhcccccccc
Confidence 2233455555444332 3466666666777766542 2222222 22222222 2222222211111100
Q ss_pred -c----CCCCCCCCCccchHHHHhcccCcCCCCCCChhhhhhCCccccee
Q psy758 223 -F----NGYYFEVPDEMQYEEITQRCLDKDPLRRWSCDQLLRHPYFNGYY 267 (292)
Q Consensus 223 -~----~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~~il~h~w~~~~~ 267 (292)
. .........++.+.+||.+||++||++||||+|+|+||||++..
T Consensus 241 ~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~sa~e~L~Hp~f~~~~ 290 (292)
T d1unla_ 241 MYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEALQHPYFSDFC 290 (292)
T ss_dssp CCCTTCCCTTTSTTCCHHHHHHHHHHSCSSGGGSCCHHHHTTSGGGSSCS
T ss_pred cccccchhhhccccCCHHHHHHHHHHccCChhHCcCHHHHhcChhhcCCC
Confidence 0 01112233467889999999999999999999999999999743
|
| >d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Proto-oncogene serine/threonine-protein kinase Pim-1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1e-51 Score=330.24 Aligned_cols=249 Identities=24% Similarity=0.412 Sum_probs=193.6
Q ss_pred cccceeeeecccCceEEEEEEEcCCCcEEEEEEeccCCCCh----HHHHHHHHHHHHHHhCC--CCCcchhhhhhhcCCe
Q psy758 2 ERYEKIGKLGEGSYGVVFKCRNRDTGQVVAIKKFLESEEDP----LIRKIALREIRLLKSLK--HPNLVNLLEVFRRKKK 75 (292)
Q Consensus 2 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~v~iK~~~~~~~~~----~~~~~~~~e~~~~~~l~--~~~i~~~~~~~~~~~~ 75 (292)
++|++.+.||+|+||.||+|++..+|+.||+|++....... .....+.+|+.+++.++ ||||+++++++.+++.
T Consensus 4 ~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~~~h~nIv~~~~~~~~~~~ 83 (273)
T d1xwsa_ 4 SQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDWFERPDS 83 (273)
T ss_dssp TTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCCEEECTTCCEEEHHHHHHHHHCSSSCSBCCEEEEEECSSE
T ss_pred CeEEEeEEEeeCCCeEEEEEEECCCCCEEEEEEEehHHccchhhhhHHHHHHHHHHHHHHhccCCCCccEEEEEEeeCCe
Confidence 68999999999999999999999999999999986543211 12234668999999986 8999999999999999
Q ss_pred EEEEEecCCC-ccHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEEccC-CcEEEeecCchhhhhc
Q psy758 76 LHLVFEFCDH-TVLNELENHPHGLPWDLIKQITWQVLRGVSYCHRHACIHRDIKPENILLTAN-GVVKLCDFGFARLIRD 153 (292)
Q Consensus 76 ~~iv~e~~~~-~~L~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~givH~dl~p~Nilv~~~-~~~kl~dfg~~~~~~~ 153 (292)
.++||||+.+ +++..++.....+++..++.++.||+.||+|||++||+||||||+||+++.+ +.+||+|||++.....
T Consensus 84 ~~lv~e~~~~~~~l~~~~~~~~~l~e~~~~~~~~qi~~al~~lH~~~iiHrDiKp~NIll~~~~~~vkl~DFG~a~~~~~ 163 (273)
T d1xwsa_ 84 FVLILERPEPVQDLFDFITERGALQEELARSFFWQVLEAVRHCHNCGVLHRDIKDENILIDLNRGELKLIDFGSGALLKD 163 (273)
T ss_dssp EEEEEECCSSEEEHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEETTTTEEEECCCTTCEECCS
T ss_pred EEEEEEeccCcchHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCCccccCcccceEEecCCCeEEECccccceeccc
Confidence 9999999976 6788888777789999999999999999999999999999999999999854 7999999999976543
Q ss_pred cc---cccccccccccccccCCC------CCCCcccceeeecCCCCCCchHHHHHHHhhcccCCCCCCChhhhhhccCcC
Q psy758 154 LI---PRHLHIFQTNEYFKGVSL------PHAENVVPLEIKIGKPAATNIYLIDFLKRCLDKDPLRRWSCDQLLRHPYFN 224 (292)
Q Consensus 154 ~~---~~~~~~~~~~~~~~~~~~------~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~ 224 (292)
.. ..++..|.+||+..+... .|+.|+..+++.+|..+ +.. ..++...
T Consensus 164 ~~~~~~~GT~~y~aPE~~~~~~~~~~~~DiwSlGvilyell~g~~P------------------f~~--~~~i~~~---- 219 (273)
T d1xwsa_ 164 TVYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIP------------------FEH--DEEIIRG---- 219 (273)
T ss_dssp SCBCCCCSCGGGSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCS------------------CCS--HHHHHHC----
T ss_pred ccccccccCCCcCCHHHHcCCCCCCcccccccceeeehhHhhCCCC------------------CCC--chHHhhc----
Confidence 22 233556777777654432 24444444444444444 322 1222222
Q ss_pred CCCCCCCCccchHHHHhcccCcCCCCCCChhhhhhCCcccceeccCCChhHH
Q psy758 225 GYYFEVPDEMQYEEITQRCLDKDPLRRWSCDQLLRHPYFNGYYFEVPDEMQY 276 (292)
Q Consensus 225 ~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~~il~h~w~~~~~~~~~~~~~~ 276 (292)
....+...+.++++||.+||+.||++|||++|+++||||++.. .|.+...
T Consensus 220 ~~~~~~~~s~~~~~li~~~L~~dp~~R~s~~eil~hp~~~~~~--~p~e~~~ 269 (273)
T d1xwsa_ 220 QVFFRQRVSSECQHLIRWCLALRPSDRPTFEEIQNHPWMQDVL--LPQETAE 269 (273)
T ss_dssp CCCCSSCCCHHHHHHHHHHTCSSGGGSCCHHHHHTSGGGSSCC--CHHHHHH
T ss_pred ccCCCCCCCHHHHHHHHHHccCCHhHCcCHHHHhcCHhhCCCC--CCCCccc
Confidence 1233445688999999999999999999999999999999854 3444433
|
| >d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38-gamma species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.7e-49 Score=326.37 Aligned_cols=264 Identities=28% Similarity=0.414 Sum_probs=195.0
Q ss_pred cccceeeeecccCceEEEEEEEcCCCcEEEEEEeccCCCChHHHHHHHHHHHHHHhCCCCCcchhhhhhhcCC------e
Q psy758 2 ERYEKIGKLGEGSYGVVFKCRNRDTGQVVAIKKFLESEEDPLIRKIALREIRLLKSLKHPNLVNLLEVFRRKK------K 75 (292)
Q Consensus 2 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~------~ 75 (292)
++|++++.||+|+||.||+|.+..+|+.||+|++..........+.+.+|+.+++.++||||++++++|...+ .
T Consensus 18 ~~Y~~i~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~hpniv~l~~~~~~~~~~~~~~~ 97 (346)
T d1cm8a_ 18 AVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMRHENVIGLLDVFTPDETLDDFTD 97 (346)
T ss_dssp SSEEEEEEC------CEEEEEETTTCCEEEEEECSSTTSSHHHHHHHHHHHHHHHHCCBTTBCCCSEEECSCSSTTTCCC
T ss_pred CcEEEEEEEecCCCeEEEEEEECCCCCEEEEEEEchhhcChHHHHHHHHHHHHHHhcCCCCeeEEEEEeccCccccccce
Confidence 5899999999999999999999999999999999877777777888999999999999999999999987544 5
Q ss_pred EEEEEecCCCccHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEEccCCcEEEeecCchhhhhccc
Q psy758 76 LHLVFEFCDHTVLNELENHPHGLPWDLIKQITWQVLRGVSYCHRHACIHRDIKPENILLTANGVVKLCDFGFARLIRDLI 155 (292)
Q Consensus 76 ~~iv~e~~~~~~L~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~givH~dl~p~Nilv~~~~~~kl~dfg~~~~~~~~~ 155 (292)
+|+||||+ +++|..+.+. +.+++..++.++.||+.||+|||++||+||||||+|||++.++.++|+|||++.......
T Consensus 98 ~~lv~e~~-~~~l~~~~~~-~~l~~~~~~~~~~qi~~aL~~LH~~~IiHrDiKp~NIL~~~~~~~kl~Dfg~a~~~~~~~ 175 (346)
T d1cm8a_ 98 FYLVMPFM-GTDLGKLMKH-EKLGEDRIQFLVYQMLKGLRYIHAAGIIHRDLKPGNLAVNEDCELKILDFGLARQADSEM 175 (346)
T ss_dssp CEEEEECC-SEEHHHHHHH-CCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCEEECCCTTCEECCSSC
T ss_pred EEEEEecc-cccHHHHHHh-ccccHHHHHHHHHHHHHHHHHHHhCCCcccccCcchhhcccccccccccccceeccCCcc
Confidence 79999999 5667777654 479999999999999999999999999999999999999999999999999998765422
Q ss_pred --cccccccccccccccC------CCCCCCcccceeeecCCCCCCchHHHHHHHhhc---ccCCCCC---CChhh---hh
Q psy758 156 --PRHLHIFQTNEYFKGV------SLPHAENVVPLEIKIGKPAATNIYLIDFLKRCL---DKDPLRR---WSCDQ---LL 218 (292)
Q Consensus 156 --~~~~~~~~~~~~~~~~------~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~---~~~p~~~---~~~~~---~~ 218 (292)
...+..|.+||...+. ...|+.|+..+++.+|.+++......+.+..+. ...|... ..... ..
T Consensus 176 ~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 255 (346)
T d1cm8a_ 176 TGYVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTLFKGSDHLDQLKEIMKVTGTPPAEFVQRLQSDEAKNYM 255 (346)
T ss_dssp CSSCSCGGGCCTHHHHTTTCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHHHTCSCHHHHHHH
T ss_pred ccccccccccCHHHHcCCCCCCccchhhcchHHHHHHHHCcCCCCCCChHHHHHHHHhccCCCcHHHHhhhcchhhhhhh
Confidence 3345567788766442 234667777777788877765544333332222 1111000 00000 00
Q ss_pred -hccCcCCC---CCCCCCccchHHHHhcccCcCCCCCCChhhhhhCCccccee
Q psy758 219 -RHPYFNGY---YFEVPDEMQYEEITQRCLDKDPLRRWSCDQLLRHPYFNGYY 267 (292)
Q Consensus 219 -~~~~~~~~---~~~~~~~~~l~~li~~~l~~dP~~Rpt~~~il~h~w~~~~~ 267 (292)
..+-.... ......++.+.+||.+||.+||++|||++|+|+||||++..
T Consensus 256 ~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~ta~eiL~Hp~f~~~~ 308 (346)
T d1cm8a_ 256 KGLPELEKKDFASILTNASPLAVNLLEKMLVLDAEQRVTAGEALAHPYFESLH 308 (346)
T ss_dssp HHSCCCCCCCGGGTCTTCCHHHHHHHHHHSCSSTTTSCCHHHHHHSGGGTTTC
T ss_pred ccCCcccccchHHhccCCCHHHHHHHHHHCcCChhHCcCHHHHhcChhhCcCC
Confidence 00000000 11123467889999999999999999999999999999854
|
| >d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase activated protein kinase 2, mapkap2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=6.6e-50 Score=327.82 Aligned_cols=244 Identities=23% Similarity=0.325 Sum_probs=179.6
Q ss_pred Ccccceee-eecccCceEEEEEEEcCCCcEEEEEEeccCCCChHHHHHHHHHHHHHHh-CCCCCcchhhhhhhc----CC
Q psy758 1 MERYEKIG-KLGEGSYGVVFKCRNRDTGQVVAIKKFLESEEDPLIRKIALREIRLLKS-LKHPNLVNLLEVFRR----KK 74 (292)
Q Consensus 1 ~~~y~~~~-~l~~g~~~~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~e~~~~~~-l~~~~i~~~~~~~~~----~~ 74 (292)
+++|.+.+ .||+|+||.||+|++..+++.||+|++... ..+.+|+.++.+ .+||||++++++|.+ +.
T Consensus 10 ~~~y~i~~~~lG~G~fg~Vy~a~~~~~~~~vAiK~i~~~-------~~~~~E~~~~~~~~~hpnIv~l~~~~~~~~~~~~ 82 (335)
T d2ozaa1 10 IDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDC-------PKARREVELHWRASQCPHIVRIVDVYENLYAGRK 82 (335)
T ss_dssp GGTEEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEECS-------HHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEE
T ss_pred ccCEEEeeEEeeeccCeEEEEEEECCCCCEEEEEEECCc-------HHHHHHHHHHHHhcCCCCCCeEEEEEeecccCCC
Confidence 47899875 699999999999999999999999998643 346689988654 589999999999865 46
Q ss_pred eEEEEEecCCCccHHHHhcCC--CCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEEcc---CCcEEEeecCchh
Q psy758 75 KLHLVFEFCDHTVLNELENHP--HGLPWDLIKQITWQVLRGVSYCHRHACIHRDIKPENILLTA---NGVVKLCDFGFAR 149 (292)
Q Consensus 75 ~~~iv~e~~~~~~L~~~~~~~--~~~~~~~~~~i~~qi~~aL~~LH~~givH~dl~p~Nilv~~---~~~~kl~dfg~~~ 149 (292)
.+|+|||||+||+|.+++... ..+++..++.++.||+.||+|||++||+||||||+|||++. ++.+||+|||+++
T Consensus 83 ~~~ivmEy~~gg~L~~~i~~~~~~~l~e~~~~~i~~qi~~al~ylH~~~iiHRDiKp~NIll~~~~~~~~~Kl~DFG~a~ 162 (335)
T d2ozaa1 83 CLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSINIAHRDVKPENLLYTSKRPNAILKLTDFGFAK 162 (335)
T ss_dssp EEEEEEECCCSEEHHHHHHSCSCCCEEHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESCSSTTCCEEECCCTTCE
T ss_pred EEEEEEECCCCCcHHHHHHhcCCCCcCHHHHHHHHHHHHHHHHHHHHcCCccccccccccccccccccccccccccceee
Confidence 799999999999999998763 46999999999999999999999999999999999999986 4579999999997
Q ss_pred hhhccc----cccccccccccccccCCC-----CCCCcccceeeecCCCCCCchHHHHHHHhhcccCCCCCCChhhhhhc
Q psy758 150 LIRDLI----PRHLHIFQTNEYFKGVSL-----PHAENVVPLEIKIGKPAATNIYLIDFLKRCLDKDPLRRWSCDQLLRH 220 (292)
Q Consensus 150 ~~~~~~----~~~~~~~~~~~~~~~~~~-----~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~ 220 (292)
...... ..++..|.+||...+... .|+.|+..+++.+|.+++........ ...+...
T Consensus 163 ~~~~~~~~~~~~gt~~y~aPE~~~~~~y~~~~DiwSlGvily~lltg~~Pf~~~~~~~~--------------~~~~~~~ 228 (335)
T d2ozaa1 163 ETTSHNSLTTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAI--------------SPGMKTR 228 (335)
T ss_dssp ECCCCCCCCCCSCCCSSCCCCCCCGGGGSHHHHHHHHHHHHHHHTTSSCSCEETTCC----------------------C
T ss_pred eccCCCccccccCCcccCCcHHHcCCCCCHHHHHHhhchhHHHHhhCCCCCCCCCHHHH--------------HHHHHHH
Confidence 654322 223344555555444333 24444444444444444322111000 0111111
Q ss_pred cCcCCCCCCC----CCccchHHHHhcccCcCCCCCCChhhhhhCCcccc
Q psy758 221 PYFNGYYFEV----PDEMQYEEITQRCLDKDPLRRWSCDQLLRHPYFNG 265 (292)
Q Consensus 221 ~~~~~~~~~~----~~~~~l~~li~~~l~~dP~~Rpt~~~il~h~w~~~ 265 (292)
.......++. ..++.+.+||++||+.||++|||+.|+++||||.+
T Consensus 229 i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~hp~~~~ 277 (335)
T d2ozaa1 229 IRMGQYEFPNPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMNHPWIMQ 277 (335)
T ss_dssp CCSCSSSCCTTHHHHSCHHHHHHHHHHSCSSTTTSCCHHHHHHSHHHHT
T ss_pred HhcCCCCCCCcccccCCHHHHHHHHHHccCChhHCcCHHHHHcCHHhhC
Confidence 1112222222 24678999999999999999999999999999975
|
| >d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK6 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=7e-49 Score=319.52 Aligned_cols=267 Identities=31% Similarity=0.517 Sum_probs=194.4
Q ss_pred cccceeeeecccCceEEEEEEEcCC-CcEEEEEEeccCCCChHHHHHHHHHHHHHHhC---CCCCcchhhhhhh-----c
Q psy758 2 ERYEKIGKLGEGSYGVVFKCRNRDT-GQVVAIKKFLESEEDPLIRKIALREIRLLKSL---KHPNLVNLLEVFR-----R 72 (292)
Q Consensus 2 ~~y~~~~~l~~g~~~~v~~~~~~~~-~~~v~iK~~~~~~~~~~~~~~~~~e~~~~~~l---~~~~i~~~~~~~~-----~ 72 (292)
++|++++.||+|+||.||+|++..+ ++.||+|++............+.+|+.+++.| +||||+++++++. .
T Consensus 7 ~~Y~i~~~LG~G~fg~V~~a~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~~l~~l~~~~HpnIv~~~~~~~~~~~~~ 86 (305)
T d1blxa_ 7 QQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRTDR 86 (305)
T ss_dssp GTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEEEEEBCTTSCBCTHHHHHHHHHHHHHTCCTTBCCEEEEEEEEECSS
T ss_pred CCEEEEEEEecccCeEEEEEEEECCCCEEEEEEEEehhhccchHHHHHHHHHHHHHHHhhcCCCCcceeeeeeccccccc
Confidence 6899999999999999999999765 56799999865543332233455677776665 7999999999985 3
Q ss_pred CCeEEEEEecCCCccHHHHh-cCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEEccCCcEEEeecCchhhh
Q psy758 73 KKKLHLVFEFCDHTVLNELE-NHPHGLPWDLIKQITWQVLRGVSYCHRHACIHRDIKPENILLTANGVVKLCDFGFARLI 151 (292)
Q Consensus 73 ~~~~~iv~e~~~~~~L~~~~-~~~~~~~~~~~~~i~~qi~~aL~~LH~~givH~dl~p~Nilv~~~~~~kl~dfg~~~~~ 151 (292)
....++++||+.++.+.... .....+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||++...
T Consensus 87 ~~~~~~~~e~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~yLH~~~ivHrDiKp~NILi~~~~~~kl~dfg~~~~~ 166 (305)
T d1blxa_ 87 ETKLTLVFEHVDQDLTTYLDKVPEPGVPTETIKDMMFQLLRGLDFLHSHRVVHRDLKPQNILVTSSGQIKLADFGLARIY 166 (305)
T ss_dssp EEEEEEEEECCSCBHHHHHHHSCTTCSCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTCCEEECSCCSCCCC
T ss_pred CceEEEEEEeccCCchhhhhhccCCCCCHHHHHHHHHHHHHHHHHHHhCCEEecCCCccEEEEcCCCCeeecchhhhhhh
Confidence 45789999999999876554 34456999999999999999999999999999999999999999999999999998765
Q ss_pred hcc----ccccccccccccccccCCC-----CCCCcccceeeecCCCCCCchHHHHHHHhhc---ccCCCCCCChh-hhh
Q psy758 152 RDL----IPRHLHIFQTNEYFKGVSL-----PHAENVVPLEIKIGKPAATNIYLIDFLKRCL---DKDPLRRWSCD-QLL 218 (292)
Q Consensus 152 ~~~----~~~~~~~~~~~~~~~~~~~-----~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~---~~~p~~~~~~~-~~~ 218 (292)
... ...++..|.+||...+... .|+.|+..+++.+|.+++......+.+..++ ...+...+... ...
T Consensus 167 ~~~~~~~~~~gT~~Y~APE~~~~~~y~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~ 246 (305)
T d1blxa_ 167 SFQMALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLPGEEDWPRDVALP 246 (305)
T ss_dssp CGGGGGCCCCCCCTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCGGGSCTTCSSC
T ss_pred cccccCCCcccChhhcCcchhcCCCCChhehhhchHHHHHHHHHCCCCCCCCCHHHHHHHHHHhhCCCchhcccccccch
Confidence 322 2334566788887766554 3666666777788887765544333333222 21111111100 000
Q ss_pred hccCcCC-----CCCCCCCccchHHHHhcccCcCCCCCCChhhhhhCCcccceec
Q psy758 219 RHPYFNG-----YYFEVPDEMQYEEITQRCLDKDPLRRWSCDQLLRHPYFNGYYF 268 (292)
Q Consensus 219 ~~~~~~~-----~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~~il~h~w~~~~~~ 268 (292)
...+... .......++.+.+||.+||++||++|||++|+|+||||+++..
T Consensus 247 ~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~sa~e~L~Hpff~~i~~ 301 (305)
T d1blxa_ 247 RQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALSHPYFQDLER 301 (305)
T ss_dssp GGGSCCCCCCCGGGTCCSCCHHHHHHHHHHSCSSTTTSCCHHHHHTSGGGTTCCC
T ss_pred hhhhccccccchhhccccCCHHHHHHHHHHCcCChhHCcCHHHHhcChhhcCchh
Confidence 0001000 1123345778899999999999999999999999999998643
|
| >d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 9, CDK9 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.6e-48 Score=319.15 Aligned_cols=266 Identities=30% Similarity=0.435 Sum_probs=196.1
Q ss_pred CcccceeeeecccCceEEEEEEEcCCCcEEEEEEeccCCCChHHHHHHHHHHHHHHhCCCCCcchhhhhhhc--------
Q psy758 1 MERYEKIGKLGEGSYGVVFKCRNRDTGQVVAIKKFLESEEDPLIRKIALREIRLLKSLKHPNLVNLLEVFRR-------- 72 (292)
Q Consensus 1 ~~~y~~~~~l~~g~~~~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~-------- 72 (292)
+++|++++.||+|+||+||+|++..+|+.||||++............+.+|+.+++.++||||+++++++..
T Consensus 9 ~~rY~i~~~LG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~h~nii~~~~~~~~~~~~~~~~ 88 (318)
T d3blha1 9 VSKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKASPYNRC 88 (318)
T ss_dssp GGGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEC----CTTSSCHHHHHHHHHHHHCCCTTBCCEEEEEEC--------
T ss_pred cCCEEEEEEEecCcCeEEEEEEECCCCCEEEEEEEehhhcchHHHHHHHHHHHHHHHhcCCCccceEeeeeccccccccc
Confidence 589999999999999999999999999999999987665554455667899999999999999999988743
Q ss_pred CCeEEEEEecCCCccHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEEccCCcEEEeecCchhhhh
Q psy758 73 KKKLHLVFEFCDHTVLNELENHPHGLPWDLIKQITWQVLRGVSYCHRHACIHRDIKPENILLTANGVVKLCDFGFARLIR 152 (292)
Q Consensus 73 ~~~~~iv~e~~~~~~L~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~givH~dl~p~Nilv~~~~~~kl~dfg~~~~~~ 152 (292)
++..|+||||+.++.+.........+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++....
T Consensus 89 ~~~~~iv~e~~~~~~~~~~~~~~~~~~~~~~~~i~~qil~~l~~lH~~~ivHrDlKp~NILl~~~~~~kl~dfg~~~~~~ 168 (318)
T d3blha1 89 KGSIYLVFDFCEHDLAGLLSNVLVKFTLSEIKRVMQMLLNGLYYIHRNKILHRDMKAANVLITRDGVLKLADFGLARAFS 168 (318)
T ss_dssp --CEEEEEECCCEEHHHHHTCTTCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTSCEEECCCTTCEECC
T ss_pred CceEEEEEeccCCCccchhhhcccccccHHHHHHHHHHHHHHHHhccCCEEecCcCchheeecCCCcEEeeecceeeecc
Confidence 45689999999999998888888889999999999999999999999999999999999999999999999999997554
Q ss_pred ccc---------cccccccccccccccCC------CCCCCcccceeeecCCCCCCchHHHH---HHHhhcccCCCCC-CC
Q psy758 153 DLI---------PRHLHIFQTNEYFKGVS------LPHAENVVPLEIKIGKPAATNIYLID---FLKRCLDKDPLRR-WS 213 (292)
Q Consensus 153 ~~~---------~~~~~~~~~~~~~~~~~------~~~~~~~~~~~~~~~~~~~~~~~~~~---~~~~~~~~~p~~~-~~ 213 (292)
... ..++..|.+||...+.. ..|+.|+..+++.+|.+++....... .+.......+... ..
T Consensus 169 ~~~~~~~~~~~~~~gT~~Y~aPE~~~~~~~~~~k~DiwSlGvil~el~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~ 248 (318)
T d3blha1 169 LAKNSQPNRYTNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQLALISQLCGSITPEVWPN 248 (318)
T ss_dssp C-----CCCCCSCCSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTTTSTT
T ss_pred cccccccccccceecCHHHhhHHHHcCCCCCCcHHHcccCCceeeeHhhCCCCCCCCCHHHHHHHHHHhcCCCChhhccc
Confidence 211 12345677777654432 35777777788888887765433222 2223322222111 11
Q ss_pred hhhhhhccCcCCCCCC----------CCCccchHHHHhcccCcCCCCCCChhhhhhCCcccce
Q psy758 214 CDQLLRHPYFNGYYFE----------VPDEMQYEEITQRCLDKDPLRRWSCDQLLRHPYFNGY 266 (292)
Q Consensus 214 ~~~~~~~~~~~~~~~~----------~~~~~~l~~li~~~l~~dP~~Rpt~~~il~h~w~~~~ 266 (292)
.........+...... ...++.+.+||.+||++||++||||+|+|+||||++.
T Consensus 249 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLl~~mL~~dP~~R~sa~elL~Hpff~~~ 311 (318)
T d3blha1 249 VDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRIDSDDALNHDFFWSD 311 (318)
T ss_dssp CCCC-------CCSSCCBCHHHHHHHHHCCHHHHHHHHHHSCSSTTTSCCHHHHHHSGGGSSS
T ss_pred cchhhhhhhhcccccccccchhhhccccCCHHHHHHHHHHCcCChhHCcCHHHHHcChhhccC
Confidence 1000000000000000 0124567899999999999999999999999999864
|
| >d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase CK2, alpha subunit species: Rattus norvegicus [TaxId: 10116]
Probab=100.00 E-value=2.9e-48 Score=318.83 Aligned_cols=260 Identities=21% Similarity=0.313 Sum_probs=190.9
Q ss_pred cccceeeeecccCceEEEEEEEcCCCcEEEEEEeccCCCChHHHHHHHHHHHHHHhCC-CCCcchhhhhhhc--CCeEEE
Q psy758 2 ERYEKIGKLGEGSYGVVFKCRNRDTGQVVAIKKFLESEEDPLIRKIALREIRLLKSLK-HPNLVNLLEVFRR--KKKLHL 78 (292)
Q Consensus 2 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~e~~~~~~l~-~~~i~~~~~~~~~--~~~~~i 78 (292)
++|++++.||+|+||+||+|++..+|+.||+|++.... .+.+.+|+.+++.++ ||||+++++++.. ...+++
T Consensus 35 d~y~i~~~LG~G~fg~V~~a~~~~~~~~vAiK~i~~~~-----~~~~~~Ei~il~~l~~hpnIv~~~~~~~~~~~~~~~~ 109 (328)
T d3bqca1 35 DDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPVK-----KKKIKREIKILENLRGGPNIITLADIVKDPVSRTPAL 109 (328)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSSC-----HHHHHHHHHHHHHHTTSTTBCCEEEEEECTTTCSEEE
T ss_pred cCeEEEEEEecCcCeEEEEEEECCCCCEEEEEEECHHH-----HHHHHHHHHHHHhccCCCCCcEEEEEEEecCCCceeE
Confidence 68999999999999999999999999999999986543 355788999999996 9999999999863 467999
Q ss_pred EEecCCCccHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEEccCC-cEEEeecCchhhhhccc--
Q psy758 79 VFEFCDHTVLNELENHPHGLPWDLIKQITWQVLRGVSYCHRHACIHRDIKPENILLTANG-VVKLCDFGFARLIRDLI-- 155 (292)
Q Consensus 79 v~e~~~~~~L~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~givH~dl~p~Nilv~~~~-~~kl~dfg~~~~~~~~~-- 155 (292)
||||+.+++|..+.+ .+++..++.++.||+.||+|||++||+||||||+|||++.++ .++|+|||++.......
T Consensus 110 v~e~~~~~~L~~~~~---~l~e~~i~~i~~qil~aL~~LH~~gIvHrDiKp~NILi~~~~~~vkl~DFG~a~~~~~~~~~ 186 (328)
T d3bqca1 110 VFEHVNNTDFKQLYQ---TLTDYDIRFYMYEILKALDYCHSMGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQEY 186 (328)
T ss_dssp EEECCCSCBGGGTTT---SCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEETTTTEEEECCGGGCEECCTTCCC
T ss_pred EEeecCCCcHHHHhc---CCCHHHHHHHHHHHHHHHHHHhhcccccccccccceEEcCCCCeeeecccccceeccCCCcc
Confidence 999999999987653 699999999999999999999999999999999999999765 69999999997664322
Q ss_pred --cccccccccccccccCC------CCCCCcccceeeecCCCCCCch--H--HHHHHHhhcc----------cCCCCCCC
Q psy758 156 --PRHLHIFQTNEYFKGVS------LPHAENVVPLEIKIGKPAATNI--Y--LIDFLKRCLD----------KDPLRRWS 213 (292)
Q Consensus 156 --~~~~~~~~~~~~~~~~~------~~~~~~~~~~~~~~~~~~~~~~--~--~~~~~~~~~~----------~~p~~~~~ 213 (292)
...+..|.+||...+.. ..|+.|+..+++.++..++... . ....+...++ ......+.
T Consensus 187 ~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~~l~e~~~g~~pf~~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~~~~~~ 266 (328)
T d3bqca1 187 NVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEDLYDYIDKYNIELDPR 266 (328)
T ss_dssp CSCCSCGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHTCSSSSCCSSHHHHHHHHHHHHCHHHHHHHHHHTTCCCCGG
T ss_pred cccccCccccCcccccCCCCCCcccchhhhhhhhHHhccCCCCCCCCchhHHHHHHHHHHHCCchhhhhhhhcccccCcc
Confidence 22345577777765543 2356666666667776554211 0 1111111111 00111111
Q ss_pred hhhhhhccCc------CCCCCCCCCccchHHHHhcccCcCCCCCCChhhhhhCCcccceecc
Q psy758 214 CDQLLRHPYF------NGYYFEVPDEMQYEEITQRCLDKDPLRRWSCDQLLRHPYFNGYYFE 269 (292)
Q Consensus 214 ~~~~~~~~~~------~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~~il~h~w~~~~~~~ 269 (292)
.......... .........++++.+||++||++||++|||++|+|+||||+++.||
T Consensus 267 ~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~ta~e~L~Hp~F~~v~~~ 328 (328)
T d3bqca1 267 FNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAMEHPYFYTVVKD 328 (328)
T ss_dssp GGGTCCCCCCCCGGGGCCTTTGGGCCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGTTSCCC
T ss_pred cchhcccccccchhhcccccccccCCHHHHHHHHHHccCChhHCcCHHHHhcCcccCCCCCC
Confidence 1111110000 0001122346788999999999999999999999999999998875
|
| >d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Abelsone tyrosine kinase (abl) species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=2.4e-48 Score=312.25 Aligned_cols=243 Identities=23% Similarity=0.272 Sum_probs=185.9
Q ss_pred cccceeeeecccCceEEEEEEEcCCCcEEEEEEeccCCCChHHHHHHHHHHHHHHhCCCCCcchhhhhhhcCCeEEEEEe
Q psy758 2 ERYEKIGKLGEGSYGVVFKCRNRDTGQVVAIKKFLESEEDPLIRKIALREIRLLKSLKHPNLVNLLEVFRRKKKLHLVFE 81 (292)
Q Consensus 2 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~iv~e 81 (292)
++|++.+.||+|+||.||+|.+..+++.||+|++...... .+.+.+|+.+++.++||||+++++++.+++..++|||
T Consensus 17 ~~~~~~~~iG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~---~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~iv~E 93 (287)
T d1opja_ 17 TDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTME---VEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITE 93 (287)
T ss_dssp GGEEEEEETTTTTTSSEEEEEEGGGTEEEEEEECCTTCSC---HHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEEE
T ss_pred HHeEEeeEEeeCCCeEEEEEEECCCCeEEEEEEECCccch---HHHHHHHHHHHHhCCCCCEecCCccEeeCCeeEEEee
Confidence 5789999999999999999999999999999998765443 3568899999999999999999999999999999999
Q ss_pred cCCCccHHHHhcC--CCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEEccCCcEEEeecCchhhhhcccc---
Q psy758 82 FCDHTVLNELENH--PHGLPWDLIKQITWQVLRGVSYCHRHACIHRDIKPENILLTANGVVKLCDFGFARLIRDLIP--- 156 (292)
Q Consensus 82 ~~~~~~L~~~~~~--~~~~~~~~~~~i~~qi~~aL~~LH~~givH~dl~p~Nilv~~~~~~kl~dfg~~~~~~~~~~--- 156 (292)
|+++|+|..++.. ...+++..+..++.||+.||+|||++||+||||||+|||++.++.+||+|||+++.......
T Consensus 94 ~~~~g~l~~~l~~~~~~~~~~~~~~~i~~qi~~gL~yLH~~~iiHrDlKp~NILl~~~~~~Kl~DFG~a~~~~~~~~~~~ 173 (287)
T d1opja_ 94 FMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAH 173 (287)
T ss_dssp CCTTCBHHHHHHHSCTTTSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECGGGCEEECCCCCTTTCCSSSSEEE
T ss_pred cccCcchHHHhhhccccchHHHHHHHHHHHHHHHHHHHHHCCcccCccccCeEEECCCCcEEEccccceeecCCCCceee
Confidence 9999999998753 35789999999999999999999999999999999999999999999999999987643211
Q ss_pred ---ccccccccccccccCCCC-----CCCcccceeeecCCCCCCchHHHHHHHhhcccCCCCCCChhhhhhccCc-CCCC
Q psy758 157 ---RHLHIFQTNEYFKGVSLP-----HAENVVPLEIKIGKPAATNIYLIDFLKRCLDKDPLRRWSCDQLLRHPYF-NGYY 227 (292)
Q Consensus 157 ---~~~~~~~~~~~~~~~~~~-----~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~-~~~~ 227 (292)
..+..|.+||...+.... |+.|+..+++.++.. .+....+..++.....- ....
T Consensus 174 ~~~~g~~~y~aPE~~~~~~~~~k~DiwS~Gv~l~ell~~~~-----------------p~~~~~~~~~~~~~i~~~~~~~ 236 (287)
T d1opja_ 174 AGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGM-----------------SPYPGIDLSQVYELLEKDYRME 236 (287)
T ss_dssp TTEEECGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTSC-----------------CSSTTCCHHHHHHHHHTTCCCC
T ss_pred ccccccccccChHHHcCCCCCchhhhhhHHHHHHHHHhCCC-----------------CCCCcchHHHHHHHHhcCCCCC
Confidence 123346677766554443 333333333333221 12222222222211000 0112
Q ss_pred CCCCCccchHHHHhcccCcCCCCCCChhhhhhCCcccce
Q psy758 228 FEVPDEMQYEEITQRCLDKDPLRRWSCDQLLRHPYFNGY 266 (292)
Q Consensus 228 ~~~~~~~~l~~li~~~l~~dP~~Rpt~~~il~h~w~~~~ 266 (292)
.+...+..+.+||.+||+.||++|||++||++ +|+.+
T Consensus 237 ~~~~~~~~l~~li~~cl~~dP~~Rps~~ei~~--~L~~~ 273 (287)
T d1opja_ 237 RPEGCPEKVYELMRACWQWNPSDRPSFAEIHQ--AFETM 273 (287)
T ss_dssp CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH--HHHHT
T ss_pred CCccchHHHHHHHHHHcCCCHhHCcCHHHHHH--HHHHH
Confidence 33445789999999999999999999999977 55543
|
| >d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-jun N-terminal kinase (jnk3s) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.9e-48 Score=320.24 Aligned_cols=264 Identities=25% Similarity=0.379 Sum_probs=192.0
Q ss_pred CcccceeeeecccCceEEEEEEEcCCCcEEEEEEeccCCCChHHHHHHHHHHHHHHhCCCCCcchhhhhhh------cCC
Q psy758 1 MERYEKIGKLGEGSYGVVFKCRNRDTGQVVAIKKFLESEEDPLIRKIALREIRLLKSLKHPNLVNLLEVFR------RKK 74 (292)
Q Consensus 1 ~~~y~~~~~l~~g~~~~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~------~~~ 74 (292)
+++|++++.||+|+||+||+|++..+|+.||+|++..........+.+.+|+.+++.++||||++++++|. +..
T Consensus 16 ~~~Y~i~~~LG~G~fg~V~~~~d~~t~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~~~~~f~~~~~~~~~~ 95 (355)
T d2b1pa1 16 LKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKTLEEFQ 95 (355)
T ss_dssp ETTEEEEEECSCC--CEEEEEEETTTTEEEEEEEEESTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCCSTTTCC
T ss_pred cCCeEEEEEeecCcCeEEEEEEECCCCCEEEEEEEChhhcCHHHHHHHHHHHHHHHhcCCCCeeEEEEEEecccccccCc
Confidence 36899999999999999999999999999999999887777777788999999999999999999999985 346
Q ss_pred eEEEEEecCCCccHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEEccCCcEEEeecCchhhhhcc
Q psy758 75 KLHLVFEFCDHTVLNELENHPHGLPWDLIKQITWQVLRGVSYCHRHACIHRDIKPENILLTANGVVKLCDFGFARLIRDL 154 (292)
Q Consensus 75 ~~~iv~e~~~~~~L~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~givH~dl~p~Nilv~~~~~~kl~dfg~~~~~~~~ 154 (292)
.+|+||||+.++++..+. ..+++..++.++.||+.||.|||++||+||||||+||+++.++.++++|||+++.....
T Consensus 96 ~~~iv~Ey~~~~l~~~~~---~~~~~~~i~~~~~qil~gl~~LH~~giiHrDlKP~Nil~~~~~~~kl~df~~~~~~~~~ 172 (355)
T d2b1pa1 96 DVYLVMELMDANLCQVIQ---MELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTS 172 (355)
T ss_dssp EEEEEEECCSEEHHHHHT---SCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTCCEEECCCCC-------
T ss_pred eeEEEEeccchHHHHhhh---cCCCHHHHHHHHHHHHHHHHHhhhcccccccCCccccccccccceeeechhhhhccccc
Confidence 899999999988777664 36999999999999999999999999999999999999999999999999998765532
Q ss_pred c----cccccccccccccccCCC-----CCCCcccceeeecCCCCCCchHHHHHHHh----hcccC--------------
Q psy758 155 I----PRHLHIFQTNEYFKGVSL-----PHAENVVPLEIKIGKPAATNIYLIDFLKR----CLDKD-------------- 207 (292)
Q Consensus 155 ~----~~~~~~~~~~~~~~~~~~-----~~~~~~~~~~~~~~~~~~~~~~~~~~~~~----~~~~~-------------- 207 (292)
. ...+..|.+||...+... .|+.|+..+++.+|.+++........+.. .....
T Consensus 173 ~~~~~~~~t~~y~aPE~l~~~~~~~~~DiwSlG~~l~ell~g~~pF~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~ 252 (355)
T d2b1pa1 173 FMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQPTVRNY 252 (355)
T ss_dssp --------CCTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHHTTSCHHHHHH
T ss_pred cccccccccccccChhhhcCCCCCCCcccccccchHHHHhhCCCCCCCCCHHHHHHHHHHhccCCCHHHHHHhhhhHHHH
Confidence 2 233456778888766544 36666666777788777643322222211 11110
Q ss_pred -----CCCCCChhhhhhccCcCCC-CCCCCCccchHHHHhcccCcCCCCCCChhhhhhCCccccee
Q psy758 208 -----PLRRWSCDQLLRHPYFNGY-YFEVPDEMQYEEITQRCLDKDPLRRWSCDQLLRHPYFNGYY 267 (292)
Q Consensus 208 -----p~~~~~~~~~~~~~~~~~~-~~~~~~~~~l~~li~~~l~~dP~~Rpt~~~il~h~w~~~~~ 267 (292)
+.................. ......+..+.+||++||++||++||||+|+|+||||+...
T Consensus 253 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~ta~elL~Hpw~~~~~ 318 (355)
T d2b1pa1 253 VENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDALQHPYINVWY 318 (355)
T ss_dssp HHTSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSTTTSCCHHHHHTSTTTGGGC
T ss_pred hhcCccccccccccccccccccccccccccCCHHHHHHHHHHCcCChhHCcCHHHHhcCcccCCCC
Confidence 1111111111110000000 00011256788999999999999999999999999999743
|
| >d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase Erk2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2e-47 Score=315.39 Aligned_cols=264 Identities=27% Similarity=0.404 Sum_probs=186.1
Q ss_pred cccceeeeecccCceEEEEEEEcCCCcEEEEEEeccCCCChHHHHHHHHHHHHHHhCCCCCcchhhhhhhcCC----eEE
Q psy758 2 ERYEKIGKLGEGSYGVVFKCRNRDTGQVVAIKKFLESEEDPLIRKIALREIRLLKSLKHPNLVNLLEVFRRKK----KLH 77 (292)
Q Consensus 2 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~----~~~ 77 (292)
+||++++.||+|+||+||+|.+..+|+.||||++.... .....+.+.+|+.+++.++||||+++++++.... ..+
T Consensus 8 ~rY~~~~~LG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~-~~~~~~~~~~Ei~il~~l~hp~iv~~~~~~~~~~~~~~~~~ 86 (345)
T d1pmea_ 8 PRYTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFE-HQTYCQRTLREIKILLRFRHENIIGINDIIRAPTIEQMKDV 86 (345)
T ss_dssp TTEEEEEECC---CCCEEEEEETTTCSEEEEEEECCTT-CHHHHHHHHHHHHHHHHCCCTTBCCCCEEECCSSTTTCCCE
T ss_pred CCeEEEEEEeeccCeEEEEEEECCCCcEEEEEEEehhc-ChHHHHHHHHHHHHHHHcCCCCCCcEEEEEeeccccccceE
Confidence 57999999999999999999999999999999997544 3455677889999999999999999999986532 234
Q ss_pred EEEecCCCccHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEEccCCcEEEeecCchhhhhcccc-
Q psy758 78 LVFEFCDHTVLNELENHPHGLPWDLIKQITWQVLRGVSYCHRHACIHRDIKPENILLTANGVVKLCDFGFARLIRDLIP- 156 (292)
Q Consensus 78 iv~e~~~~~~L~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~givH~dl~p~Nilv~~~~~~kl~dfg~~~~~~~~~~- 156 (292)
++++++.+++|.+++... .+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||++........
T Consensus 87 ~l~~~~~~g~L~~~l~~~-~l~~~~i~~i~~qil~al~yLH~~~iiHRDIKp~NILl~~~~~~kl~DfG~a~~~~~~~~~ 165 (345)
T d1pmea_ 87 YLVTHLMGADLYKLLKTQ-HLSNDHICYFLYQILRGLKYIHSANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDH 165 (345)
T ss_dssp EEEEECCCEEHHHHHHHC-CCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCEEECCCTTCEECCGGGCB
T ss_pred EEEEeecCCchhhhhhcC-CCCHHHHHHHHHHHHHHHHHHHHCCCcCCCCCcceEEECCCCCEEEcccCceeeccCCCcc
Confidence 444556688999988754 699999999999999999999999999999999999999999999999999876543221
Q ss_pred -------ccccccccccccccC-C-----CCCCCcccceeeecCCCCCCchHHHHHHHhhccc--CCCCC-----CC--h
Q psy758 157 -------RHLHIFQTNEYFKGV-S-----LPHAENVVPLEIKIGKPAATNIYLIDFLKRCLDK--DPLRR-----WS--C 214 (292)
Q Consensus 157 -------~~~~~~~~~~~~~~~-~-----~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~p~~~-----~~--~ 214 (292)
.++..|.+||..... . ..|+.|+..+++.+|..++......+........ .|... .. .
T Consensus 166 ~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~eml~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 245 (345)
T d1pmea_ 166 TGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNCIINLKA 245 (345)
T ss_dssp CCTTCCCCSCGGGCCGGGTTTBCSCSTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCHHHHHTCCCHHH
T ss_pred ceeeccccccceechHHHhhcCCCCCchhhhhccCceehHHhhCCCCCCCCCHHHHHHHHhhhccCCChhhhhhhhhhhh
Confidence 223456666654222 1 2356666666677776665443332222221110 00000 00 0
Q ss_pred -hhhhhccCcCCCC---CCCCCccchHHHHhcccCcCCCCCCChhhhhhCCccccee
Q psy758 215 -DQLLRHPYFNGYY---FEVPDEMQYEEITQRCLDKDPLRRWSCDQLLRHPYFNGYY 267 (292)
Q Consensus 215 -~~~~~~~~~~~~~---~~~~~~~~l~~li~~~l~~dP~~Rpt~~~il~h~w~~~~~ 267 (292)
......+...... .....+..+.+||.+||+.||.+|||++|+|+||||+...
T Consensus 246 ~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~ta~e~L~hpf~~~~~ 302 (345)
T d1pmea_ 246 RNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALAHPYLEQYY 302 (345)
T ss_dssp HHHHHTSCCCCCCCHHHHCTTSCHHHHHHHHHHSCSSTTTSCCHHHHHTSGGGTTTC
T ss_pred hcccccCCccCCCCHHHhCCCCCHHHHHHHHHHccCChhHCcCHHHHhcCHhhccCC
Confidence 0000000000000 0123356789999999999999999999999999999644
|
| >d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Glycogen synthase kinase-3 beta (Gsk3b) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4e-48 Score=320.17 Aligned_cols=257 Identities=27% Similarity=0.437 Sum_probs=188.6
Q ss_pred ccceeeeecccCceEEEEEEEcCCCcEEEEEEeccCCCChHHHHHHHHHHHHHHhCCCCCcchhhhhhhc------CCeE
Q psy758 3 RYEKIGKLGEGSYGVVFKCRNRDTGQVVAIKKFLESEEDPLIRKIALREIRLLKSLKHPNLVNLLEVFRR------KKKL 76 (292)
Q Consensus 3 ~y~~~~~l~~g~~~~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~------~~~~ 76 (292)
+|+.+++||+|+||+||+|++..+|+.||+|++...... ..+|+.+++.++||||++++++|.. ..++
T Consensus 21 ~Y~~~k~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~------~~~Ei~il~~l~h~niv~~~~~~~~~~~~~~~~~~ 94 (350)
T d1q5ka_ 21 SYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRF------KNRELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYL 94 (350)
T ss_dssp EEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSSS------CCHHHHHHHHCCCTTBCCEEEEEEEC--CCSCCEE
T ss_pred CcEeeeEEeeCcCeEEEEEEECCCCCEEEEEEECccchH------HHHHHHHHHhcCCCCCCcEEEEEEecCccCCceEE
Confidence 699999999999999999999999999999999765422 3479999999999999999999843 3468
Q ss_pred EEEEecCCCccHHHH---hcCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEEccCC-cEEEeecCchhhhh
Q psy758 77 HLVFEFCDHTVLNEL---ENHPHGLPWDLIKQITWQVLRGVSYCHRHACIHRDIKPENILLTANG-VVKLCDFGFARLIR 152 (292)
Q Consensus 77 ~iv~e~~~~~~L~~~---~~~~~~~~~~~~~~i~~qi~~aL~~LH~~givH~dl~p~Nilv~~~~-~~kl~dfg~~~~~~ 152 (292)
|+||||++++++..+ ......+++..++.++.||+.||+|||++||+||||||+|||++.++ .+||+|||++....
T Consensus 95 ~lv~Ey~~~~~~~~l~~~~~~~~~l~~~~~~~i~~qil~aL~yLH~~~IiHrDiKp~NILl~~~~~~~kl~DFG~a~~~~ 174 (350)
T d1q5ka_ 95 NLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLV 174 (350)
T ss_dssp EEEEECCSEEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHTTTEECCCCCGGGEEECTTTCCEEECCCTTCEECC
T ss_pred EEEEeccCCccHHHHHhhhhccCCCCHHHHHHHHHHHHHHHHHHHhcCCcccCCCcceEEEecCCCceeEecccchhhcc
Confidence 999999998865544 34556799999999999999999999999999999999999999775 89999999987654
Q ss_pred ccc----cccccccccccccccCC------CCCCCcccceeeecCCCCCCchHHHHHHHhhc---ccCCCCC--------
Q psy758 153 DLI----PRHLHIFQTNEYFKGVS------LPHAENVVPLEIKIGKPAATNIYLIDFLKRCL---DKDPLRR-------- 211 (292)
Q Consensus 153 ~~~----~~~~~~~~~~~~~~~~~------~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~---~~~p~~~-------- 211 (292)
... ..++..|.+||...+.. ..|+.|+..+++.+|.+++......+.+..++ +..+...
T Consensus 175 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DIwSlG~il~el~~g~~pf~~~~~~~~l~~i~~~~g~~~~~~~~~~~~~~ 254 (350)
T d1q5ka_ 175 RGEPNVSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPTREQIREMNPNY 254 (350)
T ss_dssp TTSCCCSCCSCTTSCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHTSCSSCCSSHHHHHHHHHHHHCCCCHHHHHHHCC--
T ss_pred CCcccccccccccccChHHhhcccCCCcceeecccceEEEehhhCCCCCCCCCHHHHHHHHHHHhCCChHHhhhhhccch
Confidence 322 22334566666544322 24677777777888877765443333333222 1111000
Q ss_pred --CChhhhhhccCcCCCCCCCCCccchHHHHhcccCcCCCCCCChhhhhhCCccccee
Q psy758 212 --WSCDQLLRHPYFNGYYFEVPDEMQYEEITQRCLDKDPLRRWSCDQLLRHPYFNGYY 267 (292)
Q Consensus 212 --~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~~il~h~w~~~~~ 267 (292)
.........++.. ......++.+.+||.+||++||++||||+|+|+||||+++.
T Consensus 255 ~~~~~~~~~~~~~~~--~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~Hp~f~~~~ 310 (350)
T d1q5ka_ 255 TEFKFPQIKAHPWTK--VFRPRTPPEAIALCSRLLEYTPTARLTPLEACAHSFFDELR 310 (350)
T ss_dssp -CCCCCCCCCCCGGG--TSCTTSCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGGGGG
T ss_pred hhccccccccCchhh--hcccCCCHHHHHHHHHHccCChhHCcCHHHHhcCHhhcccc
Confidence 0000000001100 01123467899999999999999999999999999999864
|
| >d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: ephb2 receptor tyrosine kinase species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=2.1e-47 Score=308.45 Aligned_cols=245 Identities=19% Similarity=0.259 Sum_probs=176.3
Q ss_pred cccceeeeecccCceEEEEEEEcCCCc---EEEEEEeccCCCChHHHHHHHHHHHHHHhCCCCCcchhhhhhhcCCeEEE
Q psy758 2 ERYEKIGKLGEGSYGVVFKCRNRDTGQ---VVAIKKFLESEEDPLIRKIALREIRLLKSLKHPNLVNLLEVFRRKKKLHL 78 (292)
Q Consensus 2 ~~y~~~~~l~~g~~~~v~~~~~~~~~~---~v~iK~~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~i 78 (292)
++|++.+.||+|+||.||+|.+..+++ .||+|.+.... .....+.+.+|+.+++.++||||+++++++.+++.+++
T Consensus 26 ~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~HpnIv~l~g~~~~~~~~~i 104 (299)
T d1jpaa_ 26 SCVKIEQVIGAGEFGEVCSGHLKLPGKREIFVAIKTLKSGY-TEKQRRDFLSEASIMGQFDHPNVIHLEGVVTKSTPVMI 104 (299)
T ss_dssp GGEEEEEEEEECSSSEEEEEEECC---CCEEEEEEECCSSC-CHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSCEE
T ss_pred hhcEEeeEEeeCCCeEEEEEEEeCCCCEEEEEEEEEECccc-CHHHHHHHHHHHHHHHhCCCCCCccEEEEEeeCCEEEE
Confidence 578999999999999999999887665 58888875443 34456778999999999999999999999999999999
Q ss_pred EEecCCCccHHHHhcC-CCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEEccCCcEEEeecCchhhhhcccc-
Q psy758 79 VFEFCDHTVLNELENH-PHGLPWDLIKQITWQVLRGVSYCHRHACIHRDIKPENILLTANGVVKLCDFGFARLIRDLIP- 156 (292)
Q Consensus 79 v~e~~~~~~L~~~~~~-~~~~~~~~~~~i~~qi~~aL~~LH~~givH~dl~p~Nilv~~~~~~kl~dfg~~~~~~~~~~- 156 (292)
|||||++|+|..++.. .+.+++..+..++.||+.||+|||++||+||||||+|||++.++.+||+|||+++.......
T Consensus 105 v~Ey~~~g~L~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~~iiHrDlKp~NILl~~~~~~Kl~DFGla~~~~~~~~~ 184 (299)
T d1jpaa_ 105 ITEFMENGSLDSFLRQNDGQFTVIQLVGMLRGIAAGMKYLADMNYVHRDLAARNILVNSNLVCKVSDFGLSRFLEDDTSD 184 (299)
T ss_dssp EEECCTTEEHHHHHHTTTTCSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTCCEEECCC------------
T ss_pred EEEecCCCcceeeeccccCCCCHHHHHHHHHHHHHHHHHHhhCCCccCccccceEEECCCCcEEECCcccceEccCCCCc
Confidence 9999999999997766 44699999999999999999999999999999999999999999999999999987643221
Q ss_pred ---------ccccccccccccccCCCCCCCcccceeeecCCCCCCchHHHHHHHhhc-ccCCCCCCChhhhhhccCcC-C
Q psy758 157 ---------RHLHIFQTNEYFKGVSLPHAENVVPLEIKIGKPAATNIYLIDFLKRCL-DKDPLRRWSCDQLLRHPYFN-G 225 (292)
Q Consensus 157 ---------~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~p~~~~~~~~~~~~~~~~-~ 225 (292)
..+..|.+||...+.......|+|++ +..+++.+. +..|+...+..+++...... .
T Consensus 185 ~~~~~~~~~~~t~~y~aPE~~~~~~~~~~sDvwS~-------------Gvvl~el~t~g~~Pf~~~~~~~~~~~i~~~~~ 251 (299)
T d1jpaa_ 185 PTYTSALGGKIPIRWTAPEAIQYRKFTSASDVWSY-------------GIVMWEVMSYGERPYWDMTNQDVINAIEQDYR 251 (299)
T ss_dssp -----------CGGGSCHHHHHSCCCCHHHHHHHH-------------HHHHHHHHTTSCCTTTTCCHHHHHHHHHTTCC
T ss_pred ceeeecccccCCccccCHHHHhcCCCCcccccccc-------------hHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCC
Confidence 11234556665544433222222222 222233332 34444444444443221111 1
Q ss_pred CCCCCCCccchHHHHhcccCcCCCCCCChhhhhhC
Q psy758 226 YYFEVPDEMQYEEITQRCLDKDPLRRWSCDQLLRH 260 (292)
Q Consensus 226 ~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~~il~h 260 (292)
...+...+..+.+||.+||+.||++|||++||+++
T Consensus 252 ~~~~~~~~~~l~~li~~cl~~~P~~RPs~~ei~~~ 286 (299)
T d1jpaa_ 252 LPPPMDCPSALHQLMLDCWQKDRNHRPKFGQIVNT 286 (299)
T ss_dssp CCCCTTCCHHHHHHHHHHTCSSTTTSCCHHHHHHH
T ss_pred CCCCccchHHHHHHHHHHcCCCHhHCcCHHHHHHH
Confidence 12334557889999999999999999999999885
|
| >d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.4e-47 Score=317.47 Aligned_cols=265 Identities=26% Similarity=0.348 Sum_probs=194.9
Q ss_pred cccceeeeecccCceEEEEEEEcCCCcEEEEEEeccCCCChHHHHHHHHHHHHHHhCCCCCcchhhhhhhc-----CCeE
Q psy758 2 ERYEKIGKLGEGSYGVVFKCRNRDTGQVVAIKKFLESEEDPLIRKIALREIRLLKSLKHPNLVNLLEVFRR-----KKKL 76 (292)
Q Consensus 2 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~-----~~~~ 76 (292)
+||++++.||+|+||+||+|++..+|+.||||++.....+....+.+.+|+.+++.++||||+++++++.. ....
T Consensus 18 ~rY~i~~~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~h~~iv~~~~~~~~~~~~~~~~~ 97 (348)
T d2gfsa1 18 ERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFND 97 (348)
T ss_dssp TTEEEEEECGGGTTSSEEEEEETTTTEEEEEEECSCTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSTTTCCC
T ss_pred CCeEEEEEEecCCCeEEEEEEECCCCCEEEEEEECchhcChHHHHHHHHHHHHHHhcCCCCeeeEEEEEeeccccccCce
Confidence 58999999999999999999999999999999998777777777889999999999999999999999853 2344
Q ss_pred EEEEecCCCccHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEEccCCcEEEeecCchhhhhccc-
Q psy758 77 HLVFEFCDHTVLNELENHPHGLPWDLIKQITWQVLRGVSYCHRHACIHRDIKPENILLTANGVVKLCDFGFARLIRDLI- 155 (292)
Q Consensus 77 ~iv~e~~~~~~L~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~givH~dl~p~Nilv~~~~~~kl~dfg~~~~~~~~~- 155 (292)
+++++++.|++|.+++... .+++..++.++.||+.||+|||++||+||||||+||+++.++.++++|||.+.......
T Consensus 98 ~~i~~~~~gg~L~~~~~~~-~l~e~~~~~i~~qil~aL~~LH~~giiHrDiKp~NILi~~~~~~kl~dfg~a~~~~~~~~ 176 (348)
T d2gfsa1 98 VYLVTHLMGADLNNIVKCQ-KLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMT 176 (348)
T ss_dssp CEEEEECCSEEHHHHHTTC-CCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTCCEEECCC----CCTGGGS
T ss_pred EEEEEeecCCchhhhcccc-cccHHHHHHHHHHHHHHHHHHHhCCCcccccCCccccccccccccccccchhcccCcccc
Confidence 6667778899999998654 79999999999999999999999999999999999999999999999999987654322
Q ss_pred -cccccccccccccccCC------CCCCCcccceeeecCCCCCCchHHHHHHHhhccc---CCC----CCCCh-hhhhhc
Q psy758 156 -PRHLHIFQTNEYFKGVS------LPHAENVVPLEIKIGKPAATNIYLIDFLKRCLDK---DPL----RRWSC-DQLLRH 220 (292)
Q Consensus 156 -~~~~~~~~~~~~~~~~~------~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~---~p~----~~~~~-~~~~~~ 220 (292)
..++..|.+||...+.. ..|+.|+..+++.+|.+++.+.........++.. .+. ..... ......
T Consensus 177 ~~~g~~~y~apE~~~~~~~~~~~~DiwSlGv~l~~ll~g~~pF~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~ 256 (348)
T d2gfsa1 177 GYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARNYIQ 256 (348)
T ss_dssp SSCHHHHTSCHHHHTTCSCCCTTHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCHHHHTTCCCHHHHHHHT
T ss_pred cccccccccCchhhcCCccCCcccchhhhhHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCChHHhhhccchhhhhhhh
Confidence 23345566777654432 3466677777778887776544333322222211 110 00000 000000
Q ss_pred cCc--CCC---CCCCCCccchHHHHhcccCcCCCCCCChhhhhhCCccccee
Q psy758 221 PYF--NGY---YFEVPDEMQYEEITQRCLDKDPLRRWSCDQLLRHPYFNGYY 267 (292)
Q Consensus 221 ~~~--~~~---~~~~~~~~~l~~li~~~l~~dP~~Rpt~~~il~h~w~~~~~ 267 (292)
... ... ......++.+.+||.+||+.||++||||+|+|+||||++..
T Consensus 257 ~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~ta~elL~Hp~f~~~~ 308 (348)
T d2gfsa1 257 SLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQYH 308 (348)
T ss_dssp TSCCCCCCCHHHHSTTCCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGTTTC
T ss_pred hcccCCCcchhhhcCCCCHHHHHHHHHHCcCChhhCcCHHHHhcCHhhCCCC
Confidence 000 000 00123477899999999999999999999999999999753
|
| >d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase SYK species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=7e-48 Score=307.98 Aligned_cols=239 Identities=20% Similarity=0.281 Sum_probs=176.8
Q ss_pred eeecccCceEEEEEEEc--CCCcEEEEEEeccCCCChHHHHHHHHHHHHHHhCCCCCcchhhhhhhcCCeEEEEEecCCC
Q psy758 8 GKLGEGSYGVVFKCRNR--DTGQVVAIKKFLESEEDPLIRKIALREIRLLKSLKHPNLVNLLEVFRRKKKLHLVFEFCDH 85 (292)
Q Consensus 8 ~~l~~g~~~~v~~~~~~--~~~~~v~iK~~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~iv~e~~~~ 85 (292)
+.||+|+||.||+|... .+++.||+|++.....+....+.+.+|+.+++.++||||+++++++.+ +..++||||+++
T Consensus 13 k~iG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~g~~~~-~~~~lvmE~~~~ 91 (277)
T d1xbba_ 13 KELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGICEA-ESWMLVMEMAEL 91 (277)
T ss_dssp EEEEECSSEEEEEEEEECSSSEEEEEEEEEC-----CHHHHHHHHHHHHHHTCCCTTBCCEEEEEES-SSEEEEEECCTT
T ss_pred CCcccCCCeEEEEEEEccCCcCeEEEEEEEChhhCCHHHHHHHHHHHHHHHhCCCCCCceEEEEecc-CCEEEEEEcCCC
Confidence 46999999999999764 355789999997766666677889999999999999999999999865 457899999999
Q ss_pred ccHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEEccCCcEEEeecCchhhhhcccc--------c
Q psy758 86 TVLNELENHPHGLPWDLIKQITWQVLRGVSYCHRHACIHRDIKPENILLTANGVVKLCDFGFARLIRDLIP--------R 157 (292)
Q Consensus 86 ~~L~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~givH~dl~p~Nilv~~~~~~kl~dfg~~~~~~~~~~--------~ 157 (292)
|+|.+++.....+++..+..++.||+.||+|||++||+||||||+||+++.++.+||+|||+++....... .
T Consensus 92 g~L~~~l~~~~~l~~~~~~~i~~qi~~gl~ylH~~~iiHrDlKp~Nill~~~~~~kl~DFGla~~~~~~~~~~~~~~~~~ 171 (277)
T d1xbba_ 92 GPLNKYLQQNRHVKDKNIIELVHQVSMGMKYLEESNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGK 171 (277)
T ss_dssp EEHHHHHHHCTTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEEETTEEEECCCTTCEECCTTCSEEEC----C
T ss_pred CcHHHHHhhccCCCHHHHHHHHHHHHHHHhhHHhCCcccCCCcchhhcccccCcccccchhhhhhccccccccccccccC
Confidence 99999998888899999999999999999999999999999999999999999999999999976543211 1
Q ss_pred cccccccccccccCCC-----CCCCcccceeeecCCCCCCchHHHHHHHhhcccCCCCCCChhhhhhccCcC-CCCCCCC
Q psy758 158 HLHIFQTNEYFKGVSL-----PHAENVVPLEIKIGKPAATNIYLIDFLKRCLDKDPLRRWSCDQLLRHPYFN-GYYFEVP 231 (292)
Q Consensus 158 ~~~~~~~~~~~~~~~~-----~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~-~~~~~~~ 231 (292)
.+..|.+||...+... .|+.|+..+++.+ .+..|+...+..++.....-. ....+..
T Consensus 172 gt~~y~APE~l~~~~~~~~sDiwS~Gv~l~ellt-----------------~g~~Pf~~~~~~~~~~~i~~~~~~~~p~~ 234 (277)
T d1xbba_ 172 WPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFS-----------------YGQKPYRGMKGSEVTAMLEKGERMGCPAG 234 (277)
T ss_dssp CCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHT-----------------TTCCSSTTCCHHHHHHHHHTTCCCCCCTT
T ss_pred CCceecCchhhcCCCCCchhhhccchhhhhHHhh-----------------CCCCCCCCCCHHHHHHHHHcCCCCCCCcc
Confidence 2233555555443332 2333443444332 133444444433332211100 1123344
Q ss_pred CccchHHHHhcccCcCCCCCCChhhhh---hCCccc
Q psy758 232 DEMQYEEITQRCLDKDPLRRWSCDQLL---RHPYFN 264 (292)
Q Consensus 232 ~~~~l~~li~~~l~~dP~~Rpt~~~il---~h~w~~ 264 (292)
.+..+.+||.+||+.||++|||+++|+ +|+|++
T Consensus 235 ~~~~~~~li~~cl~~dp~~RPs~~~i~~~L~~~~~~ 270 (277)
T d1xbba_ 235 CPREMYDLMNLCWTYDVENRPGFAAVELRLRNYYYD 270 (277)
T ss_dssp CCHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHHHH
T ss_pred cCHHHHHHHHHHcCCCHhHCcCHHHHHHHhhCHHhh
Confidence 578999999999999999999999995 555543
|
| >d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: B-Raf kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.3e-48 Score=308.82 Aligned_cols=237 Identities=21% Similarity=0.275 Sum_probs=180.4
Q ss_pred cccceeeeecccCceEEEEEEEcCCCcEEEEEEeccCCCChHHHHHHHHHHHHHHhCCCCCcchhhhhhhcCCeEEEEEe
Q psy758 2 ERYEKIGKLGEGSYGVVFKCRNRDTGQVVAIKKFLESEEDPLIRKIALREIRLLKSLKHPNLVNLLEVFRRKKKLHLVFE 81 (292)
Q Consensus 2 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~iv~e 81 (292)
++|++.+.||+|+||.||+|+.. ..||||++..........+.+.+|+.+++.++||||+++++++. ++.+++|||
T Consensus 8 ~~~~~~~~lG~G~fg~Vy~~~~~---~~vAvK~~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~~~~~~~-~~~~~lv~E 83 (276)
T d1uwha_ 8 GQITVGQRIGSGSFGTVYKGKWH---GDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYST-APQLAIVTQ 83 (276)
T ss_dssp TCCCCCSEEEECSSCEEEEEESS---SEEEEEECCCSSCCTTHHHHHHHHHHHHTTCCCTTBCCEEEEEC-SSSCEEEEE
T ss_pred ccEEEEEEEeeCCCcEEEEEEEC---CEEEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCEeeeeEEEe-ccEEEEEEe
Confidence 57999999999999999999754 36999999877666666788999999999999999999999864 456899999
Q ss_pred cCCCccHHHHhcC-CCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEEccCCcEEEeecCchhhhhccc-----
Q psy758 82 FCDHTVLNELENH-PHGLPWDLIKQITWQVLRGVSYCHRHACIHRDIKPENILLTANGVVKLCDFGFARLIRDLI----- 155 (292)
Q Consensus 82 ~~~~~~L~~~~~~-~~~~~~~~~~~i~~qi~~aL~~LH~~givH~dl~p~Nilv~~~~~~kl~dfg~~~~~~~~~----- 155 (292)
|+++|+|.+++.. ...+++..+..++.||+.||+|||++||+||||||+|||++.++.+||+|||+++......
T Consensus 84 y~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~gl~yLH~~~ivHrDlKp~NiLl~~~~~~Kl~DFGla~~~~~~~~~~~~ 163 (276)
T d1uwha_ 84 WCEGSSLYHHLHIIETKFEMIKLIDIARQTAQGMDYLHAKSIIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQF 163 (276)
T ss_dssp CCCEEEHHHHHHTSCCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEETTSSEEECCCCCSCC----------
T ss_pred cCCCCCHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHhcCCEeccccCHHHEEEcCCCCEEEccccceeeccccCCcccc
Confidence 9999999998854 4569999999999999999999999999999999999999999999999999987654311
Q ss_pred --cccccccccccccccCC--------CCCCCcccceeeecCCCCCCchHHHHHHHhhcccCCCCCCChhhhh----hcc
Q psy758 156 --PRHLHIFQTNEYFKGVS--------LPHAENVVPLEIKIGKPAATNIYLIDFLKRCLDKDPLRRWSCDQLL----RHP 221 (292)
Q Consensus 156 --~~~~~~~~~~~~~~~~~--------~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~----~~~ 221 (292)
..++..|.+||...+.. ..|+.|+..+++.+|..++ ...+..+.+ ...
T Consensus 164 ~~~~gt~~y~APE~l~~~~~~~~~~~sDiwS~Gv~l~el~tg~~Pf------------------~~~~~~~~~~~~~~~~ 225 (276)
T d1uwha_ 164 EQLSGSILWMAPEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQLPY------------------SNINNRDQIIFMVGRG 225 (276)
T ss_dssp --CCCCGGGCCHHHHTTCSSCCCCHHHHHHHHHHHHHHHHHSSCTT------------------TTCCCHHHHHHHHHHT
T ss_pred cccccCcccCCHHHHhcccCCCCCchhhhhhhHHHHHHHHHCCCCC------------------CCCChHHHHHHHHhcC
Confidence 12344567777654321 2344455555555555443 332221111 111
Q ss_pred CcCC--CCCCCCCccchHHHHhcccCcCCCCCCChhhhhhC
Q psy758 222 YFNG--YYFEVPDEMQYEEITQRCLDKDPLRRWSCDQLLRH 260 (292)
Q Consensus 222 ~~~~--~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~~il~h 260 (292)
.... ...+...+..+.+||.+||+.||++|||++||+++
T Consensus 226 ~~~p~~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~~il~~ 266 (276)
T d1uwha_ 226 YLSPDLSKVRSNCPKAMKRLMAECLKKKRDERPLFPQILAS 266 (276)
T ss_dssp SCCCCGGGSCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred CCCCcchhccccchHHHHHHHHHHcCCCHhHCcCHHHHHHH
Confidence 1000 11233457789999999999999999999999986
|
| >d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase Itk/Tsk species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.5e-47 Score=303.06 Aligned_cols=242 Identities=23% Similarity=0.321 Sum_probs=177.4
Q ss_pred cccceeeeecccCceEEEEEEEcCCCcEEEEEEeccCCCChHHHHHHHHHHHHHHhCCCCCcchhhhhhhcCCeEEEEEe
Q psy758 2 ERYEKIGKLGEGSYGVVFKCRNRDTGQVVAIKKFLESEEDPLIRKIALREIRLLKSLKHPNLVNLLEVFRRKKKLHLVFE 81 (292)
Q Consensus 2 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~iv~e 81 (292)
++|++.+.||+|+||.||+|.+. +++.||||++....... +.+.+|+.+++.++||||+++++++.+++..++|||
T Consensus 5 ~~~~~~~~iG~G~fg~Vy~~~~~-~~~~vAvK~i~~~~~~~---~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~lv~E 80 (263)
T d1sm2a_ 5 SELTFVQEIGSGQFGLVHLGYWL-NKDKVAIKTIREGAMSE---EDFIEEAEVMMKLSHPKLVQLYGVCLEQAPICLVFE 80 (263)
T ss_dssp SCEEEEEEEECCSSCCEEEEEET-TTEEEEEEECCSSSSCH---HHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEEE
T ss_pred HHcEEEEEEeeCCCeEEEEEEEC-CCCEEEEEEECCCcCcH---HHHHHHHHHHHhcCCCCcccccceeccCCceEEEEE
Confidence 58999999999999999999986 46789999997655443 468899999999999999999999999999999999
Q ss_pred cCCCccHHHHhcC-CCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEEccCCcEEEeecCchhhhhcccc----
Q psy758 82 FCDHTVLNELENH-PHGLPWDLIKQITWQVLRGVSYCHRHACIHRDIKPENILLTANGVVKLCDFGFARLIRDLIP---- 156 (292)
Q Consensus 82 ~~~~~~L~~~~~~-~~~~~~~~~~~i~~qi~~aL~~LH~~givH~dl~p~Nilv~~~~~~kl~dfg~~~~~~~~~~---- 156 (292)
|+++|+|.+++.. ...+++..+..++.||+.||+|||++||+||||||+||++++++.+||+|||+++.......
T Consensus 81 ~~~~g~L~~~l~~~~~~~~~~~~~~i~~qia~gl~~lH~~~iiHrDlKp~Nill~~~~~~Kl~DFGla~~~~~~~~~~~~ 160 (263)
T d1sm2a_ 81 FMEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLEEACVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYTSST 160 (263)
T ss_dssp CCTTCBHHHHHHTTTTCCCHHHHHHHHHHHHHHHHHHHHTTCCCTTCSGGGEEECGGGCEEECSCC--------------
T ss_pred ecCCCcHHHHhhccccCCCHHHHHHHHHHHHHHHHhhhccceeecccchhheeecCCCCeEecccchheeccCCCceeec
Confidence 9999999998754 35689999999999999999999999999999999999999999999999999976643221
Q ss_pred --ccccccccccccccCCCCCCCcccceeeecCCCCCCchHHHHHHHhhc-ccCCCCCCChhhhhhccCc-CCCCCCCCC
Q psy758 157 --RHLHIFQTNEYFKGVSLPHAENVVPLEIKIGKPAATNIYLIDFLKRCL-DKDPLRRWSCDQLLRHPYF-NGYYFEVPD 232 (292)
Q Consensus 157 --~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~p~~~~~~~~~~~~~~~-~~~~~~~~~ 232 (292)
..+..|.+||...+.......|+|++++ .+++.+. +..|....+..+++..... .....+...
T Consensus 161 ~~~gt~~y~aPE~l~~~~~~~k~DVwS~Gv-------------il~el~t~~~~~~~~~~~~~~~~~i~~~~~~~~p~~~ 227 (263)
T d1sm2a_ 161 GTKFPVKWASPEVFSFSRYSSKSDVWSFGV-------------LMWEVFSEGKIPYENRSNSEVVEDISTGFRLYKPRLA 227 (263)
T ss_dssp ----CTTSCCHHHHTTCCCCHHHHHHHHHH-------------HHHHHHTTSCCTTCSCCHHHHHHHHHHTCCCCCCTTS
T ss_pred ceecCcccCChHHhcCCCCCchhhhcchHH-------------HHHHHHHCCCCCCCCCCHHHHHHHHHhcCCCCCcccc
Confidence 2234467777666554433333333322 2222222 2223333333333321110 011223445
Q ss_pred ccchHHHHhcccCcCCCCCCChhhhhhC
Q psy758 233 EMQYEEITQRCLDKDPLRRWSCDQLLRH 260 (292)
Q Consensus 233 ~~~l~~li~~~l~~dP~~Rpt~~~il~h 260 (292)
+..+.+||.+||+.||++|||++||++|
T Consensus 228 ~~~l~~li~~cl~~~p~~Rps~~~il~~ 255 (263)
T d1sm2a_ 228 STHVYQIMNHCWKERPEDRPAFSRLLRQ 255 (263)
T ss_dssp CHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred CHHHHHHHHHHccCCHhHCcCHHHHHHH
Confidence 7789999999999999999999999986
|
| >d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Bruton's tyrosine kinase (Btk) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.6e-47 Score=299.92 Aligned_cols=242 Identities=20% Similarity=0.283 Sum_probs=187.3
Q ss_pred cccceeeeecccCceEEEEEEEcCCCcEEEEEEeccCCCChHHHHHHHHHHHHHHhCCCCCcchhhhhhhcCCeEEEEEe
Q psy758 2 ERYEKIGKLGEGSYGVVFKCRNRDTGQVVAIKKFLESEEDPLIRKIALREIRLLKSLKHPNLVNLLEVFRRKKKLHLVFE 81 (292)
Q Consensus 2 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~iv~e 81 (292)
++|++++.||+|+||.||+|+.. ++..||+|+++...... +.+.+|+.+++.++||||+++++++.+++.+++|||
T Consensus 4 ~~~~~~~~iG~G~fg~Vy~~~~~-~~~~vAvK~l~~~~~~~---~~~~~Ev~~~~~l~HpnIv~~~g~~~~~~~~~iv~E 79 (258)
T d1k2pa_ 4 KDLTFLKELGTGQFGVVKYGKWR-GQYDVAIKMIKEGSMSE---DEFIEEAKVMMNLSHEKLVQLYGVCTKQRPIFIITE 79 (258)
T ss_dssp CCCCCCCCCCEETTEEEEEEEET-TTEEEEEEEEESSSSCH---HHHHHHHHHHHTCCCTTBCCEEEEECCSSSEEEEEE
T ss_pred HHCEEeEEEecCCCeEEEEEEEC-CCCEEEEEEECcCcCCH---HHHHHHHHHHHhcCCCceeeEEEEEeeCCceEEEEE
Confidence 68999999999999999999985 67899999998765543 468899999999999999999999999999999999
Q ss_pred cCCCccHHHHhcC-CCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEEccCCcEEEeecCchhhhhcccc----
Q psy758 82 FCDHTVLNELENH-PHGLPWDLIKQITWQVLRGVSYCHRHACIHRDIKPENILLTANGVVKLCDFGFARLIRDLIP---- 156 (292)
Q Consensus 82 ~~~~~~L~~~~~~-~~~~~~~~~~~i~~qi~~aL~~LH~~givH~dl~p~Nilv~~~~~~kl~dfg~~~~~~~~~~---- 156 (292)
|+++|++..++.. ...+++..++.++.||++||+|||++||+||||||+||+++.++.+||+|||+++.......
T Consensus 80 y~~~g~l~~~~~~~~~~~~~~~~~~i~~qi~~gl~~LH~~~iiH~dlk~~Nill~~~~~~kl~DfG~a~~~~~~~~~~~~ 159 (258)
T d1k2pa_ 80 YMANGCLLNYLREMRHRFQTQQLLEMCKDVCEAMEYLESKQFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEYTSSV 159 (258)
T ss_dssp CCTTEEHHHHHHSGGGCCCHHHHHHHHHHHHHHHHHHHHTTBCCSCCSGGGEEECTTCCEEECCCSSCCBCSSSSCCCCC
T ss_pred ccCCCcHHHhhhccccCCcHHHHHHHHHHHHHHHHHHhhcCcccccccceeEEEcCCCcEEECcchhheeccCCCceeec
Confidence 9999998888544 45689999999999999999999999999999999999999999999999999976543222
Q ss_pred --ccccccccccccccCCCCCCCcccceeeecCCCCCCchHHHHHHHhhc-ccCCCCCCChhhhhhccCcC-CCCCCCCC
Q psy758 157 --RHLHIFQTNEYFKGVSLPHAENVVPLEIKIGKPAATNIYLIDFLKRCL-DKDPLRRWSCDQLLRHPYFN-GYYFEVPD 232 (292)
Q Consensus 157 --~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~p~~~~~~~~~~~~~~~~-~~~~~~~~ 232 (292)
..+..|.+||...+.......|+|+ .+..+++.+. +..|+...+..++.....-. ....+...
T Consensus 160 ~~~~t~~y~aPE~~~~~~~~~ksDiwS-------------~G~~l~el~t~g~~Pf~~~~~~~~~~~i~~~~~~~~p~~~ 226 (258)
T d1k2pa_ 160 GSKFPVRWSPPEVLMYSKFSSKSDIWA-------------FGVLMWEIYSLGKMPYERFTNSETAEHIAQGLRLYRPHLA 226 (258)
T ss_dssp CSCCCGGGCCHHHHHHCCCCHHHHHHH-------------HHHHHHHHHTTSCCTTTTSCHHHHHHHHHTTCCCCCCTTC
T ss_pred ccCCCCCcCCcHHhcCCCCCcceeecc-------------cchhhHhHHhcCCCCCCCCCHHHHHHHHHhCCCCCCcccc
Confidence 1223355555554433322222222 2223334333 45566666655555432211 11233445
Q ss_pred ccchHHHHhcccCcCCCCCCChhhhhhC
Q psy758 233 EMQYEEITQRCLDKDPLRRWSCDQLLRH 260 (292)
Q Consensus 233 ~~~l~~li~~~l~~dP~~Rpt~~~il~h 260 (292)
++.+.+||.+||+.||++|||+++|++|
T Consensus 227 ~~~l~~li~~cl~~dP~~RPt~~eil~~ 254 (258)
T d1k2pa_ 227 SEKVYTIMYSCWHEKADERPTFKILLSN 254 (258)
T ss_dssp CHHHHHHHHHTTCSSGGGSCCHHHHHHH
T ss_pred cHHHHHHHHHHccCCHhHCcCHHHHHHH
Confidence 7789999999999999999999999997
|
| >d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Mycobacterial protein kinase PknB, catalytic domain species: Mycobacterium tuberculosis [TaxId: 1773]
Probab=100.00 E-value=2.3e-47 Score=305.88 Aligned_cols=249 Identities=23% Similarity=0.307 Sum_probs=188.1
Q ss_pred cccceeeeecccCceEEEEEEEcCCCcEEEEEEeccCC-CChHHHHHHHHHHHHHHhCCCCCcchhhhhhhcCC----eE
Q psy758 2 ERYEKIGKLGEGSYGVVFKCRNRDTGQVVAIKKFLESE-EDPLIRKIALREIRLLKSLKHPNLVNLLEVFRRKK----KL 76 (292)
Q Consensus 2 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~v~iK~~~~~~-~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~----~~ 76 (292)
++|++.+.||+|+||.||+|.+..+|+.||+|++.... .+......+.+|+.+++.++||||+++++++.+.+ .+
T Consensus 7 drY~i~~~lG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~~l~~~~hpniv~~~~~~~~~~~~~~~~ 86 (277)
T d1o6ya_ 7 DRYELGEILGFGGMSEVHLARDLRLHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVYDTGEAETPAGPLP 86 (277)
T ss_dssp TTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSTTTTCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEEECSSSEEE
T ss_pred ceeEEeEEEeeCCCeEEEEEEECCCCCEEEEEEEchhhccCHHHHHHHHHHHHHHHhcCCCCCCcccceeeeccCCCceE
Confidence 57999999999999999999999999999999997665 34556678999999999999999999999987543 48
Q ss_pred EEEEecCCCccHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEEccCCcEEEeecCchhhhhcc--
Q psy758 77 HLVFEFCDHTVLNELENHPHGLPWDLIKQITWQVLRGVSYCHRHACIHRDIKPENILLTANGVVKLCDFGFARLIRDL-- 154 (292)
Q Consensus 77 ~iv~e~~~~~~L~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~givH~dl~p~Nilv~~~~~~kl~dfg~~~~~~~~-- 154 (292)
|+||||++|++|..++...+.+++..++.++.||+.||+|||++||+||||||+||+++.++..+|+|||.+......
T Consensus 87 ~lvmE~~~g~~L~~~~~~~~~l~~~~~~~i~~qi~~al~~lH~~~iiHrDiKP~NIll~~~~~~~l~d~~~~~~~~~~~~ 166 (277)
T d1o6ya_ 87 YIVMEYVDGVTLRDIVHTEGPMTPKRAIEVIADACQALNFSHQNGIIHRDVKPANIMISATNAVKVMDFGIARAIADSGN 166 (277)
T ss_dssp EEEEECCCEEEHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEETTSCEEECCCTTCEECC----
T ss_pred EEEEECCCCCEehhhhcccCCCCHHHHHHHHHHHHHHHHHHHhCCccCccccCcccccCccccceeehhhhhhhhccccc
Confidence 999999999999999888788999999999999999999999999999999999999999999999999987654321
Q ss_pred ------ccccccccccccccccCCCC-----CCCcccceeeecCCCCCCchHHHHHHHhhcccCCCCCCChhhhhhccCc
Q psy758 155 ------IPRHLHIFQTNEYFKGVSLP-----HAENVVPLEIKIGKPAATNIYLIDFLKRCLDKDPLRRWSCDQLLRHPYF 223 (292)
Q Consensus 155 ------~~~~~~~~~~~~~~~~~~~~-----~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~ 223 (292)
...++..|.+||...+.... |+.|+..+++.+|.+++.......++...+...+ .
T Consensus 167 ~~~~~~~~~Gt~~Y~aPE~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~~~~~~~~~~~~--------------~ 232 (277)
T d1o6ya_ 167 SVTQTAAVIGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPPFTGDSPVSVAYQHVREDP--------------I 232 (277)
T ss_dssp ------------TTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHCCC--------------C
T ss_pred cccccccccCcccccCHHHHcCCCCCcceecccchHHHHHHHhCCCCCCCcCHHHHHHHHHhcCC--------------C
Confidence 12234567777776655442 4444444455555554433322222222222111 1
Q ss_pred CCCCCCCCCccchHHHHhcccCcCCCCCCChhhhhhCCccc
Q psy758 224 NGYYFEVPDEMQYEEITQRCLDKDPLRRWSCDQLLRHPYFN 264 (292)
Q Consensus 224 ~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~~il~h~w~~ 264 (292)
.........+..+.+||.+||+.||.+||+..+.+.|+|++
T Consensus 233 ~~~~~~~~~s~~l~~li~~~L~~dp~~R~~sa~~l~~~l~r 273 (277)
T d1o6ya_ 233 PPSARHEGLSADLDAVVLKALAKNPENRYQTAAEMRADLVR 273 (277)
T ss_dssp CGGGTSSSCCHHHHHHHHHHTCSSGGGSCSSHHHHHHHHHH
T ss_pred CCchhccCCCHHHHHHHHHHccCCHhHCHhHHHHHHHHHHH
Confidence 11112234578999999999999999999555555566653
|
| >d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Lymphocyte kinase (lck) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.5e-47 Score=305.64 Aligned_cols=242 Identities=21% Similarity=0.319 Sum_probs=181.9
Q ss_pred cccceeeeecccCceEEEEEEEcCCCcEEEEEEeccCCCChHHHHHHHHHHHHHHhCCCCCcchhhhhhhcCCeEEEEEe
Q psy758 2 ERYEKIGKLGEGSYGVVFKCRNRDTGQVVAIKKFLESEEDPLIRKIALREIRLLKSLKHPNLVNLLEVFRRKKKLHLVFE 81 (292)
Q Consensus 2 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~iv~e 81 (292)
++|++.+.||+|+||.||+|.+. ++..||||++...... .+.+.+|+.+++.++||||+++++++.+ +..++|||
T Consensus 13 ~~~~~~~~iG~G~fg~Vy~~~~~-~~~~vAvK~~~~~~~~---~~~~~~E~~~l~~l~HpnIv~~~g~~~~-~~~~iv~E 87 (272)
T d1qpca_ 13 ETLKLVERLGAGQFGEVWMGYYN-GHTKVAVKSLKQGSMS---PDAFLAEANLMKQLQHQRLVRLYAVVTQ-EPIYIITE 87 (272)
T ss_dssp GGEEEEEEEEEETTEEEEEEEET-TTEEEEEEEECTTSSC---HHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCEEEEE
T ss_pred HHeEEeEEEecCCCcEEEEEEEC-CCCEEEEEEEccCcCC---HHHHHHHHHHHHhCCCCCEeEEEeeecc-CCeEEEEE
Confidence 57999999999999999999975 4778999999765443 3568899999999999999999998754 56799999
Q ss_pred cCCCccHHHHhcCCC--CCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEEccCCcEEEeecCchhhhhccc----
Q psy758 82 FCDHTVLNELENHPH--GLPWDLIKQITWQVLRGVSYCHRHACIHRDIKPENILLTANGVVKLCDFGFARLIRDLI---- 155 (292)
Q Consensus 82 ~~~~~~L~~~~~~~~--~~~~~~~~~i~~qi~~aL~~LH~~givH~dl~p~Nilv~~~~~~kl~dfg~~~~~~~~~---- 155 (292)
|+++|+|.+++.... .+++..+..++.||+.||.|||++||+||||||+||++++++.+||+|||+++......
T Consensus 88 y~~~g~L~~~~~~~~~~~l~~~~~~~i~~qi~~gl~~lH~~~ivHrDiKp~NIll~~~~~~Kl~DFGla~~~~~~~~~~~ 167 (272)
T d1qpca_ 88 YMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEERNYIHRDLRAANILVSDTLSCKIADFGLARLIEDNEYTAR 167 (272)
T ss_dssp CCTTCBHHHHTTSHHHHTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTSCEEECCCTTCEECSSSCEECC
T ss_pred eCCCCcHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCccchhheeeecccceeeccccceEEccCCccccc
Confidence 999999998775432 58999999999999999999999999999999999999999999999999998764321
Q ss_pred --cccccccccccccccCCC-----CCCCcccceeeecCCCCCCchHHHHHHHhhcccCCCCCCChhhhhhccCc-CCCC
Q psy758 156 --PRHLHIFQTNEYFKGVSL-----PHAENVVPLEIKIGKPAATNIYLIDFLKRCLDKDPLRRWSCDQLLRHPYF-NGYY 227 (292)
Q Consensus 156 --~~~~~~~~~~~~~~~~~~-----~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~-~~~~ 227 (292)
...+..|.+||...+... .|+.|+..+++.++. ..|....+..+++....- ....
T Consensus 168 ~~~~gt~~y~APE~~~~~~~~~~sDvwS~Gvvl~ellt~~-----------------~~~~~~~~~~~~~~~i~~~~~~~ 230 (272)
T d1qpca_ 168 EGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTHG-----------------RIPYPGMTNPEVIQNLERGYRMV 230 (272)
T ss_dssp TTCCCCTTTSCHHHHHHCEECHHHHHHHHHHHHHHHHTTT-----------------CCSSTTCCHHHHHHHHHTTCCCC
T ss_pred cccCCcccccChHHHhCCCCCchhhhhhhHHHHHHHHhCC-----------------CCCCCCCCHHHHHHHHHhcCCCC
Confidence 122234666665544332 234444444444321 122222222222221100 0112
Q ss_pred CCCCCccchHHHHhcccCcCCCCCCChhhhhh--CCcccc
Q psy758 228 FEVPDEMQYEEITQRCLDKDPLRRWSCDQLLR--HPYFNG 265 (292)
Q Consensus 228 ~~~~~~~~l~~li~~~l~~dP~~Rpt~~~il~--h~w~~~ 265 (292)
.+...+..+.+||.+||+.||++|||+++|++ ++||+.
T Consensus 231 ~p~~~~~~l~~li~~cl~~~P~~Rpt~~ei~~~L~~~fts 270 (272)
T d1qpca_ 231 RPDNCPEELYQLMRLCWKERPEDRPTFDYLRSVLEDFFTA 270 (272)
T ss_dssp CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred CcccChHHHHHHHHHHcCCCHhHCcCHHHHHHHhhhhhhc
Confidence 23445778999999999999999999999998 788864
|
| >d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Ribosomal protein S6 kinase alpha 5, Msk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=9.4e-48 Score=313.53 Aligned_cols=258 Identities=23% Similarity=0.305 Sum_probs=192.9
Q ss_pred CcccceeeeecccCceEEEEEEEc---CCCcEEEEEEeccCCC--ChHHHHHHHHHHHHHHhCCC-CCcchhhhhhhcCC
Q psy758 1 MERYEKIGKLGEGSYGVVFKCRNR---DTGQVVAIKKFLESEE--DPLIRKIALREIRLLKSLKH-PNLVNLLEVFRRKK 74 (292)
Q Consensus 1 ~~~y~~~~~l~~g~~~~v~~~~~~---~~~~~v~iK~~~~~~~--~~~~~~~~~~e~~~~~~l~~-~~i~~~~~~~~~~~ 74 (292)
|++|++++.||+|+||.||+|.+. .+|+.||+|++..... .....+.+.+|+.++++++| |||+++++++.+..
T Consensus 23 l~~y~~~~~IG~G~fg~Vy~~~~~~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~~E~~il~~l~h~pnIv~~~~~~~~~~ 102 (322)
T d1vzoa_ 23 IENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTET 102 (322)
T ss_dssp GGGEEEEEEEEETTTEEEEEEEECSSTTTTCEEEEEEESEEEEEEEESSGGGCCCHHHHHHHHHTCTTBCCEEEEEEETT
T ss_pred hhceEEEEEEecCCCeEEEEEEECccCCCCcEEEEEEEehHHhccchHHHHHHHHHHHHHHhccCCCeEEEeeeeeccCC
Confidence 578999999999999999999874 4688999999865431 12234567889999999977 89999999999999
Q ss_pred eEEEEEecCCCccHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEEccCCcEEEeecCchhhhhcc
Q psy758 75 KLHLVFEFCDHTVLNELENHPHGLPWDLIKQITWQVLRGVSYCHRHACIHRDIKPENILLTANGVVKLCDFGFARLIRDL 154 (292)
Q Consensus 75 ~~~iv~e~~~~~~L~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~givH~dl~p~Nilv~~~~~~kl~dfg~~~~~~~~ 154 (292)
.+++++||+.+++|..++...+.+++..++.++.||+.||+|||++|++||||||+||+++.++.++|+|||+++.....
T Consensus 103 ~~~~v~e~~~~~~L~~~i~~~~~~~e~~~~~~~~Qi~~al~~lH~~~ivHrDiKp~Nill~~~~~vkL~DFG~a~~~~~~ 182 (322)
T d1vzoa_ 103 KLHLILDYINGGELFTHLSQRERFTEHEVQIYVGEIVLALEHLHKLGIIYRDIKLENILLDSNGHVVLTDFGLSKEFVAD 182 (322)
T ss_dssp EEEEEECCCCSCBHHHHHHHHSCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTSCEEESCSSEEEECCGG
T ss_pred ceeeeeecccccHHHHHHHhcccccHHHHHHHHHHHHHHHHHhhcCCEEeccCCccceeecCCCCEEEeeccchhhhccc
Confidence 99999999999999999988888999999999999999999999999999999999999999999999999998765322
Q ss_pred cc------ccccccccccccccCCCCCCCcccceeeecCCCCCCchHHHHHHHhhcccCCCCCCCh----hhhhhccCcC
Q psy758 155 IP------RHLHIFQTNEYFKGVSLPHAENVVPLEIKIGKPAATNIYLIDFLKRCLDKDPLRRWSC----DQLLRHPYFN 224 (292)
Q Consensus 155 ~~------~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~----~~~~~~~~~~ 224 (292)
.. ..+..|.+|+...+.... .....++++.++.++..+.+..|+...+. ..+.......
T Consensus 183 ~~~~~~~~~g~~~~~~pe~~~~~~~~-----------~~~ksDIWSlG~iLyelltG~~PF~~~~~~~~~~~i~~~~~~~ 251 (322)
T d1vzoa_ 183 ETERAYDFCGTIEYMAPDIVRGGDSG-----------HDKAVDWWSLGVLMYELLTGASPFTVDGEKNSQAEISRRILKS 251 (322)
T ss_dssp GGGGGCGGGSCCTTCCHHHHTTCC--------------CTHHHHHHHHHHHHHHHHSSCTTSCTTSCCCHHHHHHHHHHC
T ss_pred ccccccccccccccchhHHhhcCCcC-----------CCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcccC
Confidence 11 122233344333221110 01111223333344444445555443322 2222222222
Q ss_pred CCCCCCCCccchHHHHhcccCcCCCCCC-----ChhhhhhCCcccceecc
Q psy758 225 GYYFEVPDEMQYEEITQRCLDKDPLRRW-----SCDQLLRHPYFNGYYFE 269 (292)
Q Consensus 225 ~~~~~~~~~~~l~~li~~~l~~dP~~Rp-----t~~~il~h~w~~~~~~~ 269 (292)
....+...+..+.+||.+||++||.+|| |++|+++||||+++.|+
T Consensus 252 ~~~~~~~~s~~~~~li~~~l~~dP~~R~s~~~~t~~eil~Hpff~~i~~~ 301 (322)
T d1vzoa_ 252 EPPYPQEMSALAKDLIQRLLMKDPKKRLGCGPRDADEIKEHLFFQKINWD 301 (322)
T ss_dssp CCCCCTTSCHHHHHHHHHHTCSSGGGSTTSSTTTHHHHHTSGGGTTCCHH
T ss_pred CCCCcccCCHHHHHHHHHHcccCHHHcCCCCcccHHHHHcCHhhcCCCHH
Confidence 2334456688999999999999999999 58999999999998775
|
| >d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fl cytokine receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5e-47 Score=310.15 Aligned_cols=241 Identities=26% Similarity=0.345 Sum_probs=179.5
Q ss_pred cccceeeeecccCceEEEEEEEcCCCc-----EEEEEEeccCCCChHHHHHHHHHHHHHHhC-CCCCcchhhhhhhcCCe
Q psy758 2 ERYEKIGKLGEGSYGVVFKCRNRDTGQ-----VVAIKKFLESEEDPLIRKIALREIRLLKSL-KHPNLVNLLEVFRRKKK 75 (292)
Q Consensus 2 ~~y~~~~~l~~g~~~~v~~~~~~~~~~-----~v~iK~~~~~~~~~~~~~~~~~e~~~~~~l-~~~~i~~~~~~~~~~~~ 75 (292)
++|++.+.||+|+||.||+|++..+++ .||+|.+..... ......+.+|+.+++.+ +||||+++++++.+.+.
T Consensus 37 ~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~~E~~~l~~l~~HpnIv~l~~~~~~~~~ 115 (325)
T d1rjba_ 37 ENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKAD-SSEREALMSELKMMTQLGSHENIVNLLGACTLSGP 115 (325)
T ss_dssp GGEEEEEEEEECSSEEEEEEEEESCSSSSCEEEEEEEEECC-------CHHHHHHHHHHHHHCCCTTBCCEEEEECSSSS
T ss_pred HHeEEeeEEeeCCCeEEEEEEEcCCCcccceeEEEEEEeccccC-HHHHHHHHHHHHHHHHhcCCCcEeEEEEEEeeCCe
Confidence 578999999999999999999876544 689998865432 23446688999999998 89999999999999999
Q ss_pred EEEEEecCCCccHHHHhcCCC-----------------------CCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCce
Q psy758 76 LHLVFEFCDHTVLNELENHPH-----------------------GLPWDLIKQITWQVLRGVSYCHRHACIHRDIKPENI 132 (292)
Q Consensus 76 ~~iv~e~~~~~~L~~~~~~~~-----------------------~~~~~~~~~i~~qi~~aL~~LH~~givH~dl~p~Ni 132 (292)
+|+|||||++|+|.+++.... .+++..++.++.||+.||+|||++||+||||||+||
T Consensus 116 ~~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gl~yLH~~~IiHRDlKp~Ni 195 (325)
T d1rjba_ 116 IYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEFKSCVHRDLAARNV 195 (325)
T ss_dssp CEEEEECCTTCBHHHHHHTTTTCC---------------------CCHHHHHHHHHHHHHHHHHHHHTTEEETTCSGGGE
T ss_pred EEEEEEcCCCCcHHHHHHhccCCCcchhhhhccccccccccccCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCchhcc
Confidence 999999999999999986542 489999999999999999999999999999999999
Q ss_pred EEccCCcEEEeecCchhhhhcccc-------ccccccccccccccCCCC-----CCCcccceeeecCCCCCCchHHHHHH
Q psy758 133 LLTANGVVKLCDFGFARLIRDLIP-------RHLHIFQTNEYFKGVSLP-----HAENVVPLEIKIGKPAATNIYLIDFL 200 (292)
Q Consensus 133 lv~~~~~~kl~dfg~~~~~~~~~~-------~~~~~~~~~~~~~~~~~~-----~~~~~~~~~~~~~~~~~~~~~~~~~~ 200 (292)
+++.++.+||+|||+++....... ..+..|.+||...+.... |+.|+..+++.+
T Consensus 196 ll~~~~~~Kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~DiwS~Gvil~emlt-------------- 261 (325)
T d1rjba_ 196 LVTHGKVVKICDFGLARDIMSDSNYVVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFS-------------- 261 (325)
T ss_dssp EEETTTEEEECCCGGGSCGGGCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTT--------------
T ss_pred ccccCCeEEEeeccccccccCCCceeeeccccCCCccCChHHHcCCCCCcceeccchhHHHHHHHh--------------
Confidence 999999999999999976554221 113346666655444333 333444444432
Q ss_pred HhhcccCCCCCCChhhhhhccCcCC--CCCCCCCccchHHHHhcccCcCCCCCCChhhhhhC
Q psy758 201 KRCLDKDPLRRWSCDQLLRHPYFNG--YYFEVPDEMQYEEITQRCLDKDPLRRWSCDQLLRH 260 (292)
Q Consensus 201 ~~~~~~~p~~~~~~~~~~~~~~~~~--~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~~il~h 260 (292)
.+..|+...+..+.+......+ ...+...+..+.+||.+||+.||++|||++||++|
T Consensus 262 ---~g~~Pf~~~~~~~~~~~~~~~~~~~~~p~~~~~~l~~li~~cl~~dP~~RPt~~ei~~~ 320 (325)
T d1rjba_ 262 ---LGVNPYPGIPVDANFYKLIQNGFKMDQPFYATEEIYIIMQSCWAFDSRKRPSFPNLTSF 320 (325)
T ss_dssp ---TSCCSSTTCCCSHHHHHHHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred ---CCCCCCCCCCHHHHHHHHHhcCCCCCCCCcCCHHHHHHHHHHcCCChhHCcCHHHHHHH
Confidence 1333433332222221111111 12334457889999999999999999999999986
|
| >d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase ZAP-70 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.2e-46 Score=301.67 Aligned_cols=248 Identities=18% Similarity=0.244 Sum_probs=180.2
Q ss_pred cccceeee-ecccCceEEEEEEEcC--CCcEEEEEEeccCCCChHHHHHHHHHHHHHHhCCCCCcchhhhhhhcCCeEEE
Q psy758 2 ERYEKIGK-LGEGSYGVVFKCRNRD--TGQVVAIKKFLESEEDPLIRKIALREIRLLKSLKHPNLVNLLEVFRRKKKLHL 78 (292)
Q Consensus 2 ~~y~~~~~-l~~g~~~~v~~~~~~~--~~~~v~iK~~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~i 78 (292)
++|.+.+. ||+|+||.||+|.+.. ++..||||++.... .....+.+.+|+++++.++||||+++++++.+ +.+|+
T Consensus 8 ~~~~~~~~~iG~G~fg~Vy~~~~~~~~~~~~vAvK~l~~~~-~~~~~~~~~~E~~il~~l~HpnIv~l~g~~~~-~~~~l 85 (285)
T d1u59a_ 8 DNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGT-EKADTEEMMREAQIMHQLDNPYIVRLIGVCQA-EALML 85 (285)
T ss_dssp GGEEEEEEEEECCTTEEEEEEEEC---CCEEEEEEEECSSC-CHHHHHHHHHHHHHHHHCCCTTBCCEEEEEES-SSEEE
T ss_pred cCeEECCcEEecccCeEEEEEEEecCCCcEEEEEEEEChhc-CHHHHHHHHHHHHHHHhCCCCCEeeEeeeecc-CeEEE
Confidence 35777775 9999999999998754 34479999987543 44556778999999999999999999998865 45899
Q ss_pred EEecCCCccHHHHhcC-CCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEEccCCcEEEeecCchhhhhcccc-
Q psy758 79 VFEFCDHTVLNELENH-PHGLPWDLIKQITWQVLRGVSYCHRHACIHRDIKPENILLTANGVVKLCDFGFARLIRDLIP- 156 (292)
Q Consensus 79 v~e~~~~~~L~~~~~~-~~~~~~~~~~~i~~qi~~aL~~LH~~givH~dl~p~Nilv~~~~~~kl~dfg~~~~~~~~~~- 156 (292)
||||+++|+|.+++.. ...+++..+..++.||+.||+|||++||+||||||+||+++.++.+||+|||+++.......
T Consensus 86 vmE~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~gL~ylH~~~iiHrDlKp~Nill~~~~~~Kl~DFGla~~~~~~~~~ 165 (285)
T d1u59a_ 86 VMEMAGGGPLHKFLVGKREEIPVSNVAELLHQVSMGMKYLEEKNFVHRDLAARNVLLVNRHYAKISDFGLSKALGADDSY 165 (285)
T ss_dssp EEECCTTEEHHHHHTTCTTTSCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEEETTEEEECCCTTCEECTTCSCE
T ss_pred EEEeCCCCcHHHHhhccccCCCHHHHHHHHHHHHHHHHHHHhCCeecCcCchhheeeccCCceeeccchhhhcccccccc
Confidence 9999999999998754 45799999999999999999999999999999999999999999999999999986643211
Q ss_pred -------ccccccccccccccCCCCCCCcccceeeecCCCCCCchHHHHHHHhhc-ccCCCCCCChhhhhhccCcC-CCC
Q psy758 157 -------RHLHIFQTNEYFKGVSLPHAENVVPLEIKIGKPAATNIYLIDFLKRCL-DKDPLRRWSCDQLLRHPYFN-GYY 227 (292)
Q Consensus 157 -------~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~p~~~~~~~~~~~~~~~~-~~~ 227 (292)
..+..|.+||...+.......|+|+ .+..+++.+. +..|+...+..++.....-. ...
T Consensus 166 ~~~~~~~~gt~~y~aPE~~~~~~~~~ksDVwS-------------~Gv~l~E~lt~G~~Pf~~~~~~~~~~~i~~~~~~~ 232 (285)
T d1u59a_ 166 YTARSAGKWPLKWYAPECINFRKFSSRSDVWS-------------YGVTMWEALSYGQKPYKKMKGPEVMAFIEQGKRME 232 (285)
T ss_dssp ECCCCSSCCCGGGCCHHHHHHCEECHHHHHHH-------------HHHHHHHHHTTSCCTTTTCCTHHHHHHHHTTCCCC
T ss_pred cccccccccCccccChHHHhCCCCCccchhhc-------------chHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCCC
Confidence 1123345555543333222222222 2222333232 34454444444333221100 112
Q ss_pred CCCCCccchHHHHhcccCcCCCCCCChhhh---hhCCccc
Q psy758 228 FEVPDEMQYEEITQRCLDKDPLRRWSCDQL---LRHPYFN 264 (292)
Q Consensus 228 ~~~~~~~~l~~li~~~l~~dP~~Rpt~~~i---l~h~w~~ 264 (292)
.+...+.++.+||.+||+.||++|||+.+| |+|+|++
T Consensus 233 ~p~~~~~~l~~li~~cl~~~p~~RPs~~~i~~~L~~~~~~ 272 (285)
T d1u59a_ 233 CPPECPPELYALMSDCWIYKWEDRPDFLTVEQRMRACYYS 272 (285)
T ss_dssp CCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred CCCcCCHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHHHH
Confidence 344567899999999999999999999998 5566654
|
| >d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-src tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.6e-46 Score=300.64 Aligned_cols=244 Identities=23% Similarity=0.303 Sum_probs=181.5
Q ss_pred cccceeeeecccCceEEEEEEEcCCCcEEEEEEeccCCCChHHHHHHHHHHHHHHhCCCCCcchhhhhhhcCCeEEEEEe
Q psy758 2 ERYEKIGKLGEGSYGVVFKCRNRDTGQVVAIKKFLESEEDPLIRKIALREIRLLKSLKHPNLVNLLEVFRRKKKLHLVFE 81 (292)
Q Consensus 2 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~iv~e 81 (292)
++|++.+.||+|+||.||+|.+..+ +.||+|++...... .+.+.+|+.+++.++||||+++++++.+ +..++|||
T Consensus 17 ~~~~i~~~iG~G~fg~Vy~~~~~~~-~~vAiK~l~~~~~~---~~~~~~E~~~l~~l~h~nIv~~~g~~~~-~~~~lv~E 91 (285)
T d1fmka3 17 ESLRLEVKLGQGCFGEVWMGTWNGT-TRVAIKTLKPGTMS---PEAFLQEAQVMKKLRHEKLVQLYAVVSE-EPIYIVTE 91 (285)
T ss_dssp GGEEEEEEEEECSSCEEEEEEETTT-EEEEEEECCTTSSC---HHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCEEEEC
T ss_pred HHEEEeeEEeeCCCeEEEEEEECCC-CEEEEEEECcccCC---HHHHHHHHHHHHhcccCCEeEEEEEEec-CCeEEEEE
Confidence 6899999999999999999998764 57999999765544 3568899999999999999999999854 56899999
Q ss_pred cCCCccHHHHhcC--CCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEEccCCcEEEeecCchhhhhccc----
Q psy758 82 FCDHTVLNELENH--PHGLPWDLIKQITWQVLRGVSYCHRHACIHRDIKPENILLTANGVVKLCDFGFARLIRDLI---- 155 (292)
Q Consensus 82 ~~~~~~L~~~~~~--~~~~~~~~~~~i~~qi~~aL~~LH~~givH~dl~p~Nilv~~~~~~kl~dfg~~~~~~~~~---- 155 (292)
|+.+|+|..++.. ...+++..+..++.||+.||+|||++|++||||||+|||++.++.+||+|||+++...+..
T Consensus 92 y~~~g~l~~~~~~~~~~~l~~~~~~~i~~~i~~gl~~LH~~~ivH~DlKp~NIll~~~~~~kl~DfGla~~~~~~~~~~~ 171 (285)
T d1fmka3 92 YMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERMNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTAR 171 (285)
T ss_dssp CCTTCBHHHHHSHHHHTTCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECGGGCEEECCCCTTC----------
T ss_pred ecCCCchhhhhhhcccccchHHHHHHHHHHHHHHHHHHhhhheecccccceEEEECCCCcEEEcccchhhhccCCCceee
Confidence 9999999888754 2469999999999999999999999999999999999999999999999999997654221
Q ss_pred --cccccccccccccccCCCC-----CCCcccceeeecCCCCCCchHHHHHHHhhcccCCCCCCChhhhhhccCcC-CCC
Q psy758 156 --PRHLHIFQTNEYFKGVSLP-----HAENVVPLEIKIGKPAATNIYLIDFLKRCLDKDPLRRWSCDQLLRHPYFN-GYY 227 (292)
Q Consensus 156 --~~~~~~~~~~~~~~~~~~~-----~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~-~~~ 227 (292)
...+..|.+||...+.... |+.|+..+++.++. ..+.......+++...... ...
T Consensus 172 ~~~~gt~~y~aPE~~~~~~~~~ksDI~S~Giil~el~t~~-----------------~p~~~~~~~~~~~~~i~~~~~~~ 234 (285)
T d1fmka3 172 QGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKG-----------------RVPYPGMVNREVLDQVERGYRMP 234 (285)
T ss_dssp ----CCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTT-----------------CCSSTTCCHHHHHHHHHTTCCCC
T ss_pred ccccccccccChHHHhCCCCCcHHhhhcchHHHHHHHhCC-----------------CCCCCCCCHHHHHHHHHhcCCCC
Confidence 2233446666666554443 33334444443321 1122222222222211100 112
Q ss_pred CCCCCccchHHHHhcccCcCCCCCCChhhhhh--CCccccee
Q psy758 228 FEVPDEMQYEEITQRCLDKDPLRRWSCDQLLR--HPYFNGYY 267 (292)
Q Consensus 228 ~~~~~~~~l~~li~~~l~~dP~~Rpt~~~il~--h~w~~~~~ 267 (292)
.+...+.++.+||.+||+.||++|||+++|++ ++||++..
T Consensus 235 ~~~~~~~~l~~li~~cl~~dP~~Rps~~~i~~~L~~~~~~~~ 276 (285)
T d1fmka3 235 CPPECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDYFTSTE 276 (285)
T ss_dssp CCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTTTSCSC
T ss_pred CCcccCHHHHHHHHHHcccCHhHCcCHHHHHHHHhhhhcCCC
Confidence 33455788999999999999999999999998 88888743
|
| >d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: epha2 receptor tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.7e-45 Score=295.54 Aligned_cols=243 Identities=19% Similarity=0.268 Sum_probs=178.0
Q ss_pred cccceeeeecccCceEEEEEEEcCCC----cEEEEEEeccCCCChHHHHHHHHHHHHHHhCCCCCcchhhhhhhcCCeEE
Q psy758 2 ERYEKIGKLGEGSYGVVFKCRNRDTG----QVVAIKKFLESEEDPLIRKIALREIRLLKSLKHPNLVNLLEVFRRKKKLH 77 (292)
Q Consensus 2 ~~y~~~~~l~~g~~~~v~~~~~~~~~----~~v~iK~~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~ 77 (292)
++|++.+.||+|+||.||+|....++ ..||+|.+..... ......+.+|+.+++.++||||++++|++.+.+..+
T Consensus 7 ~~~~~~~~iG~G~fG~Vy~~~~~~~~~~~~~~vAvK~~~~~~~-~~~~~~~~~E~~il~~l~H~nIv~~~g~~~~~~~~~ 85 (283)
T d1mqba_ 7 SCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYT-EKQRVDFLGEAGIMGQFSHHNIIRLEGVISKYKPMM 85 (283)
T ss_dssp TTEEEEEEEEECSSSEEEEEEEEC---CCEEEEEEEEECTTCC-HHHHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSEE
T ss_pred HHeEeeeEEeeCCCeEEEEEEEeCCCCEEEEEEEEEEECcccC-hHHHHHHHHHHHHHHhcCCCCEeeeeEEEecCCceE
Confidence 57899999999999999999887654 3699999865443 344567889999999999999999999999999999
Q ss_pred EEEecCCCccHHHHhc-CCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEEccCCcEEEeecCchhhhhccc-
Q psy758 78 LVFEFCDHTVLNELEN-HPHGLPWDLIKQITWQVLRGVSYCHRHACIHRDIKPENILLTANGVVKLCDFGFARLIRDLI- 155 (292)
Q Consensus 78 iv~e~~~~~~L~~~~~-~~~~~~~~~~~~i~~qi~~aL~~LH~~givH~dl~p~Nilv~~~~~~kl~dfg~~~~~~~~~- 155 (292)
+|+||+.++++..++. ....+++..+..++.||+.||+|||++||+||||||+|||++.++.+||+|||+++......
T Consensus 86 ~v~e~~~~~~l~~~~~~~~~~~~~~~~~~i~~~i~~gl~~lH~~~iiHrDlKp~NILl~~~~~~Kl~DFGla~~~~~~~~ 165 (283)
T d1mqba_ 86 IITEYMENGALDKFLREKDGEFSVLQLVGMLRGIAAGMKYLANMNYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPE 165 (283)
T ss_dssp EEEECCTTEEHHHHHHHTTTCSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTCCEEECCCCC---------
T ss_pred EEEEecccCcchhhhhcccccccHHHHHHHHHHHHHhhhhccccccccCccccceEEECCCCeEEEcccchhhcccCCCc
Confidence 9999999999988765 44579999999999999999999999999999999999999999999999999998754321
Q ss_pred -------cccccccccccccccCCCCCCCcccceeeecCCCCCCchHHHHHHHhhcc-cCCCCCCChhhhhhccCcCC--
Q psy758 156 -------PRHLHIFQTNEYFKGVSLPHAENVVPLEIKIGKPAATNIYLIDFLKRCLD-KDPLRRWSCDQLLRHPYFNG-- 225 (292)
Q Consensus 156 -------~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~p~~~~~~~~~~~~~~~~~-- 225 (292)
..++..|.+||...+.......|+|++++ .+++.+.. ..+....+..+++... ..+
T Consensus 166 ~~~~~~~~~gt~~Y~APE~l~~~~~~~~sDI~S~Gv-------------il~el~t~~~~~~~~~~~~~~~~~i-~~~~~ 231 (283)
T d1mqba_ 166 ATYTTSGGKIPIRWTAPEAISYRKFTSASDVWSFGI-------------VMWEVMTYGERPYWELSNHEVMKAI-NDGFR 231 (283)
T ss_dssp --------CCCGGGSCHHHHHSCCCCHHHHHHHHHH-------------HHHHHHTTSCCTTTTCCHHHHHHHH-HTTCC
T ss_pred cceEeccCCCCccccCHHHHccCCCCCcccccccHH-------------HHHHHHhCCCCccccCCHHHHHHHH-hccCC
Confidence 12234577777766554443333333322 22222221 2222223333332211 111
Q ss_pred CCCCCCCccchHHHHhcccCcCCCCCCChhhhhh
Q psy758 226 YYFEVPDEMQYEEITQRCLDKDPLRRWSCDQLLR 259 (292)
Q Consensus 226 ~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~~il~ 259 (292)
...+...+..+.+||.+||+.||++|||+.||++
T Consensus 232 ~~~~~~~~~~l~~li~~cl~~~p~~RPt~~eil~ 265 (283)
T d1mqba_ 232 LPTPMDCPSAIYQLMMQCWQQERARRPKFADIVS 265 (283)
T ss_dssp CCCCTTCBHHHHHHHHHHTCSSTTTSCCHHHHHH
T ss_pred CCCchhhHHHHHHHHHHHCcCCHhHCcCHHHHHH
Confidence 1223345788999999999999999999999988
|
| >d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Focal adhesion kinase 1 (fak) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.4e-45 Score=294.75 Aligned_cols=244 Identities=21% Similarity=0.300 Sum_probs=175.9
Q ss_pred cccceeeeecccCceEEEEEEEcCCC---cEEEEEEeccCCCChHHHHHHHHHHHHHHhCCCCCcchhhhhhhcCCeEEE
Q psy758 2 ERYEKIGKLGEGSYGVVFKCRNRDTG---QVVAIKKFLESEEDPLIRKIALREIRLLKSLKHPNLVNLLEVFRRKKKLHL 78 (292)
Q Consensus 2 ~~y~~~~~l~~g~~~~v~~~~~~~~~---~~v~iK~~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~i 78 (292)
++|++++.||+|+||.||+|.+..++ ..||+|.+.... .....+.+.+|+.+++.++||||+++++++. ++.+|+
T Consensus 7 ~~~~l~~~iG~G~fg~Vy~a~~~~~~~~~~~vaik~~~~~~-~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~-~~~~~i 84 (273)
T d1mp8a_ 7 ERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCT-SDSVREKFLQEALTMRQFDHPHIVKLIGVIT-ENPVWI 84 (273)
T ss_dssp GGEEEEEEEEECSSSEEEEEEECCC--CCEEEEEEECTTTT-SHHHHHHHHHHHHHHHTCCCTTBCCEEEEEC-SSSCEE
T ss_pred HHeEEEEEEeeCCCcEEEEEEEecCCceeEEEEEEEecccc-CHHHHHHHHHHHHHHHhCCCCCEeeEEEEEe-cCeEEE
Confidence 68999999999999999999886543 468888875443 4455677899999999999999999999985 467899
Q ss_pred EEecCCCccHHHHhc-CCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEEccCCcEEEeecCchhhhhcccc-
Q psy758 79 VFEFCDHTVLNELEN-HPHGLPWDLIKQITWQVLRGVSYCHRHACIHRDIKPENILLTANGVVKLCDFGFARLIRDLIP- 156 (292)
Q Consensus 79 v~e~~~~~~L~~~~~-~~~~~~~~~~~~i~~qi~~aL~~LH~~givH~dl~p~Nilv~~~~~~kl~dfg~~~~~~~~~~- 156 (292)
||||+++|++..++. ....+++..++.++.||+.||.|||++|++||||||+||++++++.+||+|||+++.......
T Consensus 85 v~E~~~~g~l~~~~~~~~~~l~~~~~~~~~~qi~~gl~ylH~~~iiHrDlKp~NIll~~~~~~Kl~DfG~a~~~~~~~~~ 164 (273)
T d1mp8a_ 85 IMELCTLGELRSFLQVRKYSLDLASLILYAYQLSTALAYLESKRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYY 164 (273)
T ss_dssp EEECCTTEEHHHHHHHTTTTSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEEETTEEEECC-------------
T ss_pred EEEeccCCcHHhhhhccCCCCCHHHHHHHHHHHHHHhhhhcccCeeccccchhheeecCCCcEEEccchhheeccCCcce
Confidence 999999999988754 455799999999999999999999999999999999999999999999999999987543221
Q ss_pred -----ccccccccccccccCCCCCCCcccceeeecCCCCCCchHHHHHHHhhc-ccCCCCCCChhhhhhccCcC-CCCCC
Q psy758 157 -----RHLHIFQTNEYFKGVSLPHAENVVPLEIKIGKPAATNIYLIDFLKRCL-DKDPLRRWSCDQLLRHPYFN-GYYFE 229 (292)
Q Consensus 157 -----~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~p~~~~~~~~~~~~~~~~-~~~~~ 229 (292)
..+..|.+||...+.......|+|++ +..+++.+. +..|....+..++....... ....+
T Consensus 165 ~~~~~~gt~~y~apE~l~~~~~~~~~DiwSl-------------Gvil~e~lt~g~~P~~~~~~~~~~~~i~~~~~~~~~ 231 (273)
T d1mp8a_ 165 KASKGKLPIKWMAPESINFRRFTSASDVWMF-------------GVCMWEILMHGVKPFQGVKNNDVIGRIENGERLPMP 231 (273)
T ss_dssp ------CCGGGCCHHHHHHCCCSHHHHHHHH-------------HHHHHHHHTTSCCTTTTCCGGGHHHHHHTTCCCCCC
T ss_pred eccceecCcccchhhHhccCCCCCccccccc-------------hHHHHHHHhcCCCCCCCCCHHHHHHHHHcCCCCCCC
Confidence 12234555555544333322233222 222333333 44555555555444321111 12334
Q ss_pred CCCccchHHHHhcccCcCCCCCCChhhhhhC
Q psy758 230 VPDEMQYEEITQRCLDKDPLRRWSCDQLLRH 260 (292)
Q Consensus 230 ~~~~~~l~~li~~~l~~dP~~Rpt~~~il~h 260 (292)
...+..+.+||.+||+.||++|||++||++|
T Consensus 232 ~~~~~~~~~li~~cl~~dp~~Rps~~ei~~~ 262 (273)
T d1mp8a_ 232 PNCPPTLYSLMTKCWAYDPSRRPRFTELKAQ 262 (273)
T ss_dssp TTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred CCCCHHHHHHHHHHcCCCHhHCcCHHHHHHH
Confidence 4568899999999999999999999999986
|
| >d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Carboxyl-terminal src kinase (csk) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2e-45 Score=291.02 Aligned_cols=241 Identities=21% Similarity=0.265 Sum_probs=179.0
Q ss_pred CcccceeeeecccCceEEEEEEEcCCCcEEEEEEeccCCCChHHHHHHHHHHHHHHhCCCCCcchhhhhhhc-CCeEEEE
Q psy758 1 MERYEKIGKLGEGSYGVVFKCRNRDTGQVVAIKKFLESEEDPLIRKIALREIRLLKSLKHPNLVNLLEVFRR-KKKLHLV 79 (292)
Q Consensus 1 ~~~y~~~~~l~~g~~~~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~-~~~~~iv 79 (292)
+++|++.+.||+|+||.||+|... |..||+|+++.... .+.+.+|+.+++.++||||+++++++.+ .+.+++|
T Consensus 6 ~~~~~~~~~lG~G~fg~Vy~~~~~--~~~vAvK~i~~~~~----~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~~lv 79 (262)
T d1byga_ 6 MKELKLLQTIGKGEFGDVMLGDYR--GNKVAVKCIKNDAT----AQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIV 79 (262)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEET--TEEEEEEECCCCC------HHHHHTHHHHTTCCCTTBCCEEEEECCC--CCEEE
T ss_pred HHHeEEeEEEecCCCeEEEEEEEC--CeEEEEEEECcHHH----HHHHHHHHHHHHhCCCCCEeeEEEEEEecCCcEEEE
Confidence 478999999999999999999985 78899999965442 3567899999999999999999998754 5678999
Q ss_pred EecCCCccHHHHhcCCC--CCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEEccCCcEEEeecCchhhhhccc--
Q psy758 80 FEFCDHTVLNELENHPH--GLPWDLIKQITWQVLRGVSYCHRHACIHRDIKPENILLTANGVVKLCDFGFARLIRDLI-- 155 (292)
Q Consensus 80 ~e~~~~~~L~~~~~~~~--~~~~~~~~~i~~qi~~aL~~LH~~givH~dl~p~Nilv~~~~~~kl~dfg~~~~~~~~~-- 155 (292)
|||+++|+|.+++.... .+++..++.++.||+.||.|||+++++||||+|+||+++.++.++|+|||+++......
T Consensus 80 ~ey~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~al~ylH~~~ivH~dlkp~Nil~~~~~~~kl~dfg~s~~~~~~~~~ 159 (262)
T d1byga_ 80 TEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEGNNFVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQDT 159 (262)
T ss_dssp ECCCTTEEHHHHHHHHHHHHCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECTTSCEEECCCCC----------
T ss_pred EeccCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHhhccccccCceeccccchHhheecCCCCEeecccccceecCCCCcc
Confidence 99999999999985432 48999999999999999999999999999999999999999999999999998754322
Q ss_pred cccccccccccccccCCCCCCCcccceeeecCCCCCCchHHHHHHHhhc-ccCCCCCCChhhhhhccCc-CCCCCCCCCc
Q psy758 156 PRHLHIFQTNEYFKGVSLPHAENVVPLEIKIGKPAATNIYLIDFLKRCL-DKDPLRRWSCDQLLRHPYF-NGYYFEVPDE 233 (292)
Q Consensus 156 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~p~~~~~~~~~~~~~~~-~~~~~~~~~~ 233 (292)
...+..|.+||+..+.......|+|++ +..+++.+. +..|....+..++.....- .....+...+
T Consensus 160 ~~~~~~y~aPE~l~~~~~t~~sDIwSf-------------G~il~el~t~~~~p~~~~~~~~~~~~i~~~~~~~~~~~~~ 226 (262)
T d1byga_ 160 GKLPVKWTAPEALREKKFSTKSDVWSF-------------GILLWEIYSFGRVPYPRIPLKDVVPRVEKGYKMDAPDGCP 226 (262)
T ss_dssp --CCTTTSCHHHHHHCCCCHHHHHHHH-------------HHHHHHHHTTSCCSCTTSCGGGHHHHHTTTCCCCCCTTCC
T ss_pred ccccccCCChHHHhCCCCChHHHHHhH-------------HHHHHHHHHCCCCCCCCCCHHHHHHHHHcCCCCCCCccCC
Confidence 233445777777655444333333333 222333332 4445555555554433211 1123344557
Q ss_pred cchHHHHhcccCcCCCCCCChhhhhhC
Q psy758 234 MQYEEITQRCLDKDPLRRWSCDQLLRH 260 (292)
Q Consensus 234 ~~l~~li~~~l~~dP~~Rpt~~~il~h 260 (292)
+.+.+||.+||+.||.+|||+.+++++
T Consensus 227 ~~~~~li~~cl~~dP~~Rps~~~l~~~ 253 (262)
T d1byga_ 227 PAVYEVMKNCWHLDAAMRPSFLQLREQ 253 (262)
T ss_dssp HHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred HHHHHHHHHHcccCHhHCcCHHHHHHH
Confidence 899999999999999999999999883
|
| >d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Musk tyrosine kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=2.2e-44 Score=291.64 Aligned_cols=244 Identities=23% Similarity=0.273 Sum_probs=184.0
Q ss_pred cccceeeeecccCceEEEEEEEc-----CCCcEEEEEEeccCCCChHHHHHHHHHHHHHHhCCCCCcchhhhhhhcCCeE
Q psy758 2 ERYEKIGKLGEGSYGVVFKCRNR-----DTGQVVAIKKFLESEEDPLIRKIALREIRLLKSLKHPNLVNLLEVFRRKKKL 76 (292)
Q Consensus 2 ~~y~~~~~l~~g~~~~v~~~~~~-----~~~~~v~iK~~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~ 76 (292)
++|++.+.||+|+||.||+|+.. .+++.||||++.... .....+.+.+|+.+++.++||||+++++++.+.+..
T Consensus 13 ~~~~~~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~i~~~~-~~~~~~~~~~E~~il~~l~h~niv~~~~~~~~~~~~ 91 (301)
T d1lufa_ 13 NNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEA-SADMQADFQREAALMAEFDNPNIVKLLGVCAVGKPM 91 (301)
T ss_dssp GGCEEEEEEEECSSCEEEEEEEETSSTTSSEEEEEEEECCTTC-CHHHHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSC
T ss_pred HHcEEeEEEeeCCCeEEEEEEECCCccCCCCeEEEEEEEChhc-ChHHHHHHHHHHHHHHhcCCCCcccceeeeccCCce
Confidence 57999999999999999999875 356789999986543 445567789999999999999999999999999999
Q ss_pred EEEEecCCCccHHHHhcCC------------------------CCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCce
Q psy758 77 HLVFEFCDHTVLNELENHP------------------------HGLPWDLIKQITWQVLRGVSYCHRHACIHRDIKPENI 132 (292)
Q Consensus 77 ~iv~e~~~~~~L~~~~~~~------------------------~~~~~~~~~~i~~qi~~aL~~LH~~givH~dl~p~Ni 132 (292)
++++||+++|+|.+++... ..+++..+..++.||+.||+|||++|++||||||+||
T Consensus 92 ~~v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gl~ylH~~~ivHrDlKp~NI 171 (301)
T d1lufa_ 92 CLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSERKFVHRDLATRNC 171 (301)
T ss_dssp EEEEECCTTCBHHHHHHHTCC----------------------CCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGE
T ss_pred EEEEEecCCCcHHHHHHhcCccccccccccccchhhhccccCCCCCCHHHHHHHHHHHHHHhhhcccCCeEeeEEcccce
Confidence 9999999999999988532 1388999999999999999999999999999999999
Q ss_pred EEccCCcEEEeecCchhhhhccc-------cccccccccccccccCCCCCCCcccceeeecCCCCCCchHHHHHHHhhcc
Q psy758 133 LLTANGVVKLCDFGFARLIRDLI-------PRHLHIFQTNEYFKGVSLPHAENVVPLEIKIGKPAATNIYLIDFLKRCLD 205 (292)
Q Consensus 133 lv~~~~~~kl~dfg~~~~~~~~~-------~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 205 (292)
|++.++.+||+|||+++...+.. ...+..|.+||...+.......|+|+++ .-+++.+..
T Consensus 172 Lld~~~~~Kl~DFGls~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~t~ksDVwS~G-------------vvl~ell~~ 238 (301)
T d1lufa_ 172 LVGENMVVKIADFGLSRNIYSADYYKADGNDAIPIRWMPPESIFYNRYTTESDVWAYG-------------VVLWEIFSY 238 (301)
T ss_dssp EECGGGCEEECCCSCHHHHTGGGCBC----CCBCGGGCCHHHHHHCCCCHHHHHHHHH-------------HHHHHHHTT
T ss_pred EECCCCcEEEccchhheeccCCccccccCCCCcCcCcCCHHHHccCCCChhhhhccch-------------hhHHHHHcc
Confidence 99999999999999998664322 1222346666666554443233333222 222222222
Q ss_pred -cCCCCCCChhhhhhccCcCC-CCCCCCCccchHHHHhcccCcCCCCCCChhhhhh
Q psy758 206 -KDPLRRWSCDQLLRHPYFNG-YYFEVPDEMQYEEITQRCLDKDPLRRWSCDQLLR 259 (292)
Q Consensus 206 -~~p~~~~~~~~~~~~~~~~~-~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~~il~ 259 (292)
..|+...+..+++....-.. ...+...++++.+||.+||+.||++|||+.||++
T Consensus 239 ~~~p~~~~~~~e~~~~v~~~~~~~~p~~~~~~~~~li~~cl~~~P~~RPt~~ev~~ 294 (301)
T d1lufa_ 239 GLQPYYGMAHEEVIYYVRDGNILACPENCPLELYNLMRLCWSKLPADRPSFCSIHR 294 (301)
T ss_dssp TCCTTTTSCHHHHHHHHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred CCCCCCCCCHHHHHHHHHcCCCCCCCccchHHHHHHHHHHcCCChhHCcCHHHHHH
Confidence 23444444444433211111 1223455789999999999999999999999976
|
| >d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: EGF receptor tyrosine kinase, Erbb-1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.1e-44 Score=295.48 Aligned_cols=243 Identities=21% Similarity=0.285 Sum_probs=176.4
Q ss_pred cccceeeeecccCceEEEEEEEcCCCc----EEEEEEeccCCCChHHHHHHHHHHHHHHhCCCCCcchhhhhhhcCCeEE
Q psy758 2 ERYEKIGKLGEGSYGVVFKCRNRDTGQ----VVAIKKFLESEEDPLIRKIALREIRLLKSLKHPNLVNLLEVFRRKKKLH 77 (292)
Q Consensus 2 ~~y~~~~~l~~g~~~~v~~~~~~~~~~----~v~iK~~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~ 77 (292)
++|++++.||+|+||.||+|.+..+|+ .||+|.+..... ....+.+.+|+.+++.++||||+++++++.+++ .+
T Consensus 9 ~dy~~~~~lG~G~fG~Vy~~~~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~~E~~~l~~l~HpnIv~l~g~~~~~~-~~ 86 (317)
T d1xkka_ 9 TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATS-PKANKEILDEAYVMASVDNPHVCRLLGICLTST-VQ 86 (317)
T ss_dssp TTEEEEEEEEECSSEEEEEEEECC----CCEEEEEEEECC-----CTHHHHHHHHHHHHHCCCTTBCCEEEEEESSS-EE
T ss_pred HHCEEeeEEecCCCeEEEEEEEcCCCCEEEEEEEEEEeccccC-HHHHHHHHHHHHHHHhCCCCCEeeEEEEEecCC-ee
Confidence 469999999999999999999988776 478887754332 223567889999999999999999999987654 66
Q ss_pred EEEecCCCccHHHHh-cCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEEccCCcEEEeecCchhhhhcccc
Q psy758 78 LVFEFCDHTVLNELE-NHPHGLPWDLIKQITWQVLRGVSYCHRHACIHRDIKPENILLTANGVVKLCDFGFARLIRDLIP 156 (292)
Q Consensus 78 iv~e~~~~~~L~~~~-~~~~~~~~~~~~~i~~qi~~aL~~LH~~givH~dl~p~Nilv~~~~~~kl~dfg~~~~~~~~~~ 156 (292)
+++|++.+++|.+.+ .....+++..++.++.||+.||+|||++||+||||||+||+++.++.+||+|||+++.......
T Consensus 87 ~v~e~~~~~~l~~~~~~~~~~~~~~~~~~i~~qi~~gl~yLH~~~iiHrDlKp~NIll~~~~~~kl~DFGla~~~~~~~~ 166 (317)
T d1xkka_ 87 LITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEK 166 (317)
T ss_dssp EEEECCTTCBHHHHHHHTSSSCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEEETTEEEECCCSHHHHTTTTCC
T ss_pred EEEEeccCCcccccccccccCCCHHHHHHHHHHHHHHHHHHHHcCcccCcchhhcceeCCCCCeEeeccccceecccccc
Confidence 777888777776654 4456799999999999999999999999999999999999999999999999999987643221
Q ss_pred -------ccccccccccccccCCCCCCCcccceeeecCCCCCCchHHHHHHHhhc-ccCCCCCCChhhhhhccCcCCC--
Q psy758 157 -------RHLHIFQTNEYFKGVSLPHAENVVPLEIKIGKPAATNIYLIDFLKRCL-DKDPLRRWSCDQLLRHPYFNGY-- 226 (292)
Q Consensus 157 -------~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~p~~~~~~~~~~~~~~~~~~-- 226 (292)
.++..|.+||...+.......++|+++ ..+++.+. +..|....+..++.... ..+.
T Consensus 167 ~~~~~~~~gt~~y~APE~l~~~~~~~~sDvwS~G-------------vil~el~t~g~~p~~~~~~~~~~~~i-~~~~~~ 232 (317)
T d1xkka_ 167 EYHAEGGKVPIKWMALESILHRIYTHQSDVWSYG-------------VTVWELMTFGSKPYDGIPASEISSIL-EKGERL 232 (317)
T ss_dssp --------CCTTTSCHHHHHHCCCCHHHHHHHHH-------------HHHHHHHTTSCCTTTTSCGGGHHHHH-HHTCCC
T ss_pred cccccccccCccccChHHHhcCCCChhhhhhhHH-------------HHHHHHHHCCCCCCCCCCHHHHHHHH-HcCCCC
Confidence 123456667666554443333333332 22233332 34444444444333221 1111
Q ss_pred CCCCCCccchHHHHhcccCcCCCCCCChhhhhhC
Q psy758 227 YFEVPDEMQYEEITQRCLDKDPLRRWSCDQLLRH 260 (292)
Q Consensus 227 ~~~~~~~~~l~~li~~~l~~dP~~Rpt~~~il~h 260 (292)
..+...+..+.+||.+||+.||.+|||+.||++|
T Consensus 233 ~~p~~~~~~~~~li~~cl~~dP~~RPs~~eil~~ 266 (317)
T d1xkka_ 233 PQPPICTIDVYMIMVKCWMIDADSRPKFRELIIE 266 (317)
T ss_dssp CCCTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred CCCcccCHHHHHHHHHhCCCChhhCcCHHHHHHH
Confidence 2334457889999999999999999999999987
|
| >d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tie2 kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.1e-44 Score=294.43 Aligned_cols=245 Identities=23% Similarity=0.310 Sum_probs=182.8
Q ss_pred cccceeeeecccCceEEEEEEEcCCCcE--EEEEEeccCCCChHHHHHHHHHHHHHHhC-CCCCcchhhhhhhcCCeEEE
Q psy758 2 ERYEKIGKLGEGSYGVVFKCRNRDTGQV--VAIKKFLESEEDPLIRKIALREIRLLKSL-KHPNLVNLLEVFRRKKKLHL 78 (292)
Q Consensus 2 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~--v~iK~~~~~~~~~~~~~~~~~e~~~~~~l-~~~~i~~~~~~~~~~~~~~i 78 (292)
++|++.+.||+|+||.||+|.+..+|.. ||||.+...... ...+.+.+|+.+++.+ +||||+++++++.+++..++
T Consensus 10 ~~~~~~~~iG~G~fg~Vy~~~~~~~~~~~~vaiK~~~~~~~~-~~~~~~~~E~~~l~~l~~HpnIv~~~~~~~~~~~~~i 88 (309)
T d1fvra_ 10 NDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASK-DDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYL 88 (309)
T ss_dssp GGCEEEEEEECGGGCEEEEEEEEETTEEEEEEEEEEECC-------CHHHHHHHHHTTCCCCTTBCCEEEEEEETTEEEE
T ss_pred HHcEEEEEEeeCCCcEEEEEEECCCCeEEEEEEEEECcccCh-HHHHHHHHHHHHHHhccCCCCEeeEEEEEecCCeeEE
Confidence 6899999999999999999999888875 667776543322 3456688999999999 69999999999999999999
Q ss_pred EEecCCCccHHHHhcCC----------------CCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEEccCCcEEE
Q psy758 79 VFEFCDHTVLNELENHP----------------HGLPWDLIKQITWQVLRGVSYCHRHACIHRDIKPENILLTANGVVKL 142 (292)
Q Consensus 79 v~e~~~~~~L~~~~~~~----------------~~~~~~~~~~i~~qi~~aL~~LH~~givH~dl~p~Nilv~~~~~~kl 142 (292)
||||+++|+|.+++... ..+++..++.++.||+.||.|||++|++||||||+|||++.++.+||
T Consensus 89 V~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qia~gl~~lH~~~iiHrDlkp~NIL~~~~~~~kl 168 (309)
T d1fvra_ 89 AIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQFIHRDLAARNILVGENYVAKI 168 (309)
T ss_dssp EECCCTTCBHHHHHHTTCHHHHCHHHHHHTTBSCSSCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECGGGCEEE
T ss_pred EEEecCCCcHHHHHhhccccccchhhhccccccCCCCHHHHHHHHHHHHHHHHhhhcCCccccccccceEEEcCCCceEE
Confidence 99999999999998643 46899999999999999999999999999999999999999999999
Q ss_pred eecCchhhhhcccc----ccccccccccccccCCCCCCCcccceeeecCCCCCCchHHHHHHHhhccc-CCCCCCChhhh
Q psy758 143 CDFGFARLIRDLIP----RHLHIFQTNEYFKGVSLPHAENVVPLEIKIGKPAATNIYLIDFLKRCLDK-DPLRRWSCDQL 217 (292)
Q Consensus 143 ~dfg~~~~~~~~~~----~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~p~~~~~~~~~ 217 (292)
+|||+++....... ..+..|.+||...+.......|+|++ +..+++.+.+. .|+...+..++
T Consensus 169 ~DfG~a~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~sDvwSf-------------Gvil~ell~~~~~p~~~~~~~~~ 235 (309)
T d1fvra_ 169 ADFGLSRGQEVYVKKTMGRLPVRWMAIESLNYSVYTTNSDVWSY-------------GVLLWEIVSLGGTPYCGMTCAEL 235 (309)
T ss_dssp CCTTCEESSCEECCC----CCTTTCCHHHHHHCEECHHHHHHHH-------------HHHHHHHHTTSCCTTTTCCHHHH
T ss_pred ccccccccccccccccceecCCcccchHHhccCCCCccceeehh-------------HHHHHHHHhcCCCCCCCCCHHHH
Confidence 99999876543222 22344566665544333322233322 22233333322 24444444444
Q ss_pred hhccCcC-CCCCCCCCccchHHHHhcccCcCCCCCCChhhhhhC
Q psy758 218 LRHPYFN-GYYFEVPDEMQYEEITQRCLDKDPLRRWSCDQLLRH 260 (292)
Q Consensus 218 ~~~~~~~-~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~~il~h 260 (292)
+....-. ....+...++.+.+||.+||+.||++|||+++|+++
T Consensus 236 ~~~i~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPs~~eil~~ 279 (309)
T d1fvra_ 236 YEKLPQGYRLEKPLNCDDEVYDLMRQCWREKPYERPSFAQILVS 279 (309)
T ss_dssp HHHGGGTCCCCCCTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred HHHHHhcCCCCCCccCCHHHHHHHHHHcCCChhHCcCHHHHHHH
Confidence 3322110 122334557899999999999999999999999997
|
| >d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Activated CDC42 kinase 1, ACK1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=6.3e-45 Score=290.19 Aligned_cols=244 Identities=22% Similarity=0.293 Sum_probs=173.0
Q ss_pred cccceeeeecccCceEEEEEEEcCC-Cc--EEEEEEeccCC-CChHHHHHHHHHHHHHHhCCCCCcchhhhhhhcCCeEE
Q psy758 2 ERYEKIGKLGEGSYGVVFKCRNRDT-GQ--VVAIKKFLESE-EDPLIRKIALREIRLLKSLKHPNLVNLLEVFRRKKKLH 77 (292)
Q Consensus 2 ~~y~~~~~l~~g~~~~v~~~~~~~~-~~--~v~iK~~~~~~-~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~ 77 (292)
++|++.+.||+|+||.||+|....+ ++ .||+|++.... ......+.+.+|+.+++.++||||+++++++.+ +..+
T Consensus 8 ~d~~~~~~iG~G~fg~Vy~~~~~~~~~~~~~vAiK~l~~~~~~~~~~~~~~~~Ei~~l~~l~H~nIv~~~g~~~~-~~~~ 86 (273)
T d1u46a_ 8 KDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIRLYGVVLT-PPMK 86 (273)
T ss_dssp GGEEEEEECC----CCCEEEEEECTTSCEEEEEEEC--------CHHHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCE
T ss_pred HHeEEEEEEecCCCeEEEEEEEECCCCcEEEEEEEEEChhhcCCHHHHHHHHHHHHHHHhCCCCCEEEEEEEEee-cchh
Confidence 5799999999999999999986533 33 68999987654 334556778999999999999999999999975 4678
Q ss_pred EEEecCCCccHHHHhcC-CCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEEccCCcEEEeecCchhhhhcccc
Q psy758 78 LVFEFCDHTVLNELENH-PHGLPWDLIKQITWQVLRGVSYCHRHACIHRDIKPENILLTANGVVKLCDFGFARLIRDLIP 156 (292)
Q Consensus 78 iv~e~~~~~~L~~~~~~-~~~~~~~~~~~i~~qi~~aL~~LH~~givH~dl~p~Nilv~~~~~~kl~dfg~~~~~~~~~~ 156 (292)
+|+||++++++.+.+.. .+.+++..+..++.||+.||.|||++||+||||||+||+++.++.+||+|||+++.......
T Consensus 87 lv~e~~~~~~l~~~~~~~~~~l~~~~~~~~~~qi~~gl~ylH~~~iiHrDikp~NIll~~~~~vkl~DfGl~~~~~~~~~ 166 (273)
T d1u46a_ 87 MVTELAPLGSLLDRLRKHQGHFLLGTLSRYAVQVAEGMGYLESKRFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDD 166 (273)
T ss_dssp EEEECCTTCBHHHHHHHHGGGSCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEEEETTEEEECCCTTCEECCC-CC
T ss_pred eeeeeecCcchhhhhhcccCCCCHHHHHHHHHHHHHHHHHhhhCCEeeeeecHHHhccccccceeeccchhhhhcccCCC
Confidence 99999999998876543 34699999999999999999999999999999999999999999999999999987643221
Q ss_pred c--------cccccccccccccCCCCCCCcccceeeecCCCCCCchHHHHHHHhhc-ccCCCCCCChhhhhhccCcCCCC
Q psy758 157 R--------HLHIFQTNEYFKGVSLPHAENVVPLEIKIGKPAATNIYLIDFLKRCL-DKDPLRRWSCDQLLRHPYFNGYY 227 (292)
Q Consensus 157 ~--------~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~p~~~~~~~~~~~~~~~~~~~ 227 (292)
. .+..|.+||...+.......|+|+ .+.-+++.+. +..|+...+..+++......+..
T Consensus 167 ~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Di~S-------------~Gvil~emlt~G~~Pf~~~~~~~~~~~i~~~~~~ 233 (273)
T d1u46a_ 167 HYVMQEHRKVPFAWCAPESLKTRTFSHASDTWM-------------FGVTLWEMFTYGQEPWIGLNGSQILHKIDKEGER 233 (273)
T ss_dssp EEEC-----CCGGGCCHHHHHHCEEEHHHHHHH-------------HHHHHHHHHTTSCCTTTTCCHHHHHHHHHTSCCC
T ss_pred cceecCccccCcccCCHHHHhCCCCCcchhhhh-------------hHHHHHHHHhCCCCCCCCcCHHHHHHHHHhCCCC
Confidence 1 122344555444333222222222 2222333332 45566555555554433222222
Q ss_pred --CCCCCccchHHHHhcccCcCCCCCCChhhhhh
Q psy758 228 --FEVPDEMQYEEITQRCLDKDPLRRWSCDQLLR 259 (292)
Q Consensus 228 --~~~~~~~~l~~li~~~l~~dP~~Rpt~~~il~ 259 (292)
.+...+..+.+||.+||+.||++|||+++|++
T Consensus 234 ~~~~~~~~~~l~~li~~cl~~dp~~RPt~~ei~~ 267 (273)
T d1u46a_ 234 LPRPEDCPQDIYNVMVQCWAHKPEDRPTFVALRD 267 (273)
T ss_dssp CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred CCCcccccHHHHHHHHHHcCCChhHCcCHHHHHH
Confidence 23445789999999999999999999999975
|
| >d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Insulin-like growth factor 1 receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=6.8e-44 Score=289.38 Aligned_cols=254 Identities=21% Similarity=0.251 Sum_probs=189.0
Q ss_pred cccceeeeecccCceEEEEEEEcC-----CCcEEEEEEeccCCCChHHHHHHHHHHHHHHhCCCCCcchhhhhhhcCCeE
Q psy758 2 ERYEKIGKLGEGSYGVVFKCRNRD-----TGQVVAIKKFLESEEDPLIRKIALREIRLLKSLKHPNLVNLLEVFRRKKKL 76 (292)
Q Consensus 2 ~~y~~~~~l~~g~~~~v~~~~~~~-----~~~~v~iK~~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~ 76 (292)
++|++.+.||+|+||.||+|.+.. ++..||||++.... .......+.+|+.+++.++||||+++++++..++..
T Consensus 20 ~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~VAvK~~~~~~-~~~~~~~~~~E~~il~~l~h~nIv~~~~~~~~~~~~ 98 (308)
T d1p4oa_ 20 EKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAA-SMRERIEFLNEASVMKEFNCHHVVRLLGVVSQGQPT 98 (308)
T ss_dssp GGEEEEEEEEECSSSEEEEEEEEEEETTEEEEEEEEEECCTTS-CHHHHHHHHHHHHHGGGCCCTTBCCEEEEECSSSSC
T ss_pred HHeEEeeEEeeCCCeEEEEEEECCcccCCCCcEEEEEEECccc-ChHHHHHHHHHHHHHHHcCCCCEeeeeeEEecCCce
Confidence 689999999999999999998753 35689999997544 444566789999999999999999999999999999
Q ss_pred EEEEecCCCccHHHHhcCC----------CCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEEccCCcEEEeecC
Q psy758 77 HLVFEFCDHTVLNELENHP----------HGLPWDLIKQITWQVLRGVSYCHRHACIHRDIKPENILLTANGVVKLCDFG 146 (292)
Q Consensus 77 ~iv~e~~~~~~L~~~~~~~----------~~~~~~~~~~i~~qi~~aL~~LH~~givH~dl~p~Nilv~~~~~~kl~dfg 146 (292)
++||||+++|+|..++... ..++...+..++.|++.||.|||+++|+||||||+|||++.++++||+|||
T Consensus 99 ~lv~e~~~~g~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~ia~gl~~LH~~~ivHrDlk~~NiLld~~~~~Kl~DFG 178 (308)
T d1p4oa_ 99 LVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLNANKFVHRDLAARNCMVAEDFTVKIGDFG 178 (308)
T ss_dssp EEEEECCTTCBHHHHHHHHHHHHHHCTTCCCCCHHHHHHHHHHHHHHHHHHHHTTCBCSCCSGGGEEECTTCCEEECCTT
T ss_pred eEEEeecCCCCHHHHHHhcccccccccccCCCCHHHHHHHHHHHHHHHHHHhhCCeeeceEcCCceeecCCceEEEeecc
Confidence 9999999999999986431 247889999999999999999999999999999999999999999999999
Q ss_pred chhhhhcccc--ccccccccccccccCCC-----CCCCcccceeeecCCCCCCchHHHHHHHhhcc-cCCCCCCChhhhh
Q psy758 147 FARLIRDLIP--RHLHIFQTNEYFKGVSL-----PHAENVVPLEIKIGKPAATNIYLIDFLKRCLD-KDPLRRWSCDQLL 218 (292)
Q Consensus 147 ~~~~~~~~~~--~~~~~~~~~~~~~~~~~-----~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~p~~~~~~~~~~ 218 (292)
+++....... .....+++++|..++.. ....++ ++.+..+++.+.. ..|....+..+++
T Consensus 179 la~~~~~~~~~~~~~~~~~t~~y~aPe~l~~~~~~~~~Dv-------------~S~G~il~El~t~~~~p~~~~~~~~~~ 245 (308)
T d1p4oa_ 179 MTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDV-------------WSFGVVLWEIATLAEQPYQGLSNEQVL 245 (308)
T ss_dssp CCCGGGGGGCEEGGGSSEECGGGCCHHHHHHCCCCHHHHH-------------HHHHHHHHHHHHTSCCTTTTSCHHHHH
T ss_pred cceeccCCcceeeccceecccccCCHHHHccCCCCccccc-------------ccHHHHHHHHHhCCCCCCCCCCHHHHH
Confidence 9987654322 11222344555444322 211222 2222333333333 3455555555544
Q ss_pred hccCcCC-CCCCCCCccchHHHHhcccCcCCCCCCChhhhhh------CCcccceecc
Q psy758 219 RHPYFNG-YYFEVPDEMQYEEITQRCLDKDPLRRWSCDQLLR------HPYFNGYYFE 269 (292)
Q Consensus 219 ~~~~~~~-~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~~il~------h~w~~~~~~~ 269 (292)
....-.. ...+...+..+.+||.+||+.||++|||+++|++ +|+|++..+.
T Consensus 246 ~~i~~~~~~~~p~~~~~~l~~li~~cl~~~P~~RPs~~~il~~L~~~~~~~~~~~~~~ 303 (308)
T d1p4oa_ 246 RFVMEGGLLDKPDNCPDMLFELMRMCWQYNPKMRPSFLEIISSIKEEMEPGFREVSFY 303 (308)
T ss_dssp HHHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHGGGSCTTHHHHCST
T ss_pred HHHHhCCCCCCcccchHHHHHHHHHHcCCChhHCcCHHHHHHHHHHhcCCCCcCCCCC
Confidence 3211111 1223445788999999999999999999999998 6777665443
|
| >d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fibroblast growth factor receptor 1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=9.9e-44 Score=287.38 Aligned_cols=244 Identities=23% Similarity=0.300 Sum_probs=176.1
Q ss_pred cccceeeeecccCceEEEEEEEcCCC-------cEEEEEEeccCCCChHHHHHHHHHHHHHHhC-CCCCcchhhhhhhcC
Q psy758 2 ERYEKIGKLGEGSYGVVFKCRNRDTG-------QVVAIKKFLESEEDPLIRKIALREIRLLKSL-KHPNLVNLLEVFRRK 73 (292)
Q Consensus 2 ~~y~~~~~l~~g~~~~v~~~~~~~~~-------~~v~iK~~~~~~~~~~~~~~~~~e~~~~~~l-~~~~i~~~~~~~~~~ 73 (292)
++|++++.||+|+||.||+|+...++ ..||+|++..... ......+.+|...+..+ +||||+++++++.++
T Consensus 13 ~~~~l~~~iG~G~fg~Vy~~~~~~~~~~~~~~~~~vAvK~~~~~~~-~~~~~~~~~e~~~l~~~~~HpnIv~~~~~~~~~ 91 (299)
T d1fgka_ 13 DRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDAT-EKDLSDLISEMEMMKMIGKHKNIINLLGACTQD 91 (299)
T ss_dssp GGEEEEEECC-----CEEEEEEECC----CCCEEEEEEECCCTTCC-HHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSS
T ss_pred HHeEEeeEEeecCCcEEEEEEEcCCCcccccCceEEEEEEECcccC-hHHHHHHHHHHHHHHHhcCCCeEEecccccccC
Confidence 68999999999999999999876554 3699999875543 34456677888888887 799999999999999
Q ss_pred CeEEEEEecCCCccHHHHhcCC----------------CCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEEccC
Q psy758 74 KKLHLVFEFCDHTVLNELENHP----------------HGLPWDLIKQITWQVLRGVSYCHRHACIHRDIKPENILLTAN 137 (292)
Q Consensus 74 ~~~~iv~e~~~~~~L~~~~~~~----------------~~~~~~~~~~i~~qi~~aL~~LH~~givH~dl~p~Nilv~~~ 137 (292)
+..++||||+.+|+|.+++... ..+++.+++.++.||+.||+|||++||+||||||+|||++.+
T Consensus 92 ~~~~~v~e~~~~g~l~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~ylH~~~ivHrDiKp~NiLl~~~ 171 (299)
T d1fgka_ 92 GPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLASKKCIHRDLAARNVLVTED 171 (299)
T ss_dssp SSCEEEECCCTTCBHHHHHHTTSCC------------CCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECTT
T ss_pred CeEEEEEEccCCCcHHHHHHhhcCCccccccccccCccccCCHHHHHHHHHHHHHHHHHhhhCCEEeeeecccceeecCC
Confidence 9999999999999999998644 248999999999999999999999999999999999999999
Q ss_pred CcEEEeecCchhhhhcccc-------ccccccccccccccCCCCCCCcccceeeecCCCCCCchHHHHHHHhhc-ccCCC
Q psy758 138 GVVKLCDFGFARLIRDLIP-------RHLHIFQTNEYFKGVSLPHAENVVPLEIKIGKPAATNIYLIDFLKRCL-DKDPL 209 (292)
Q Consensus 138 ~~~kl~dfg~~~~~~~~~~-------~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~p~ 209 (292)
+.+||+|||++........ ..+..|.+||...+.......|+|++ +..+++.+. +..|+
T Consensus 172 ~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~l~~~~y~~k~DiwS~-------------Gvvl~ell~~g~~p~ 238 (299)
T d1fgka_ 172 NVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSF-------------GVLLWEIFTLGGSPY 238 (299)
T ss_dssp CCEEECSTTCCCCGGGCCTTCCCTTSCCGGGGSCHHHHHHCCCCHHHHHHHH-------------HHHHHHHHTTSCCSS
T ss_pred CCeEeccchhhccccccccccccccCCCChhhhhhhHhcCCCCCchhhhHHh-------------HHHHHHhccCCCCCC
Confidence 9999999999987654321 22234555555544333222222222 222223222 33344
Q ss_pred CCCChhhhhhccCc-CCCCCCCCCccchHHHHhcccCcCCCCCCChhhhhh
Q psy758 210 RRWSCDQLLRHPYF-NGYYFEVPDEMQYEEITQRCLDKDPLRRWSCDQLLR 259 (292)
Q Consensus 210 ~~~~~~~~~~~~~~-~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~~il~ 259 (292)
...+..++.....- .....+...+..+.+||.+||+.||++|||+.||++
T Consensus 239 ~~~~~~~~~~~i~~~~~~~~p~~~~~~l~~li~~cl~~dP~~Rps~~eil~ 289 (299)
T d1fgka_ 239 PGVPVEELFKLLKEGHRMDKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVE 289 (299)
T ss_dssp TTCCHHHHHHHHHTTCCCCCCSSCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred CCCCHHHHHHHHHcCCCCCCCccchHHHHHHHHHHccCCHhHCcCHHHHHH
Confidence 44444433321100 011233455788999999999999999999999987
|
| >d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Vascular endothelial growth factor receptor 2 (kdr) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=7e-44 Score=288.78 Aligned_cols=245 Identities=24% Similarity=0.344 Sum_probs=169.7
Q ss_pred cccceeeeecccCceEEEEEEEcC-----CCcEEEEEEeccCCCChHHHHHHHHHHHHHHhC-CCCCcchhhhhhhc-CC
Q psy758 2 ERYEKIGKLGEGSYGVVFKCRNRD-----TGQVVAIKKFLESEEDPLIRKIALREIRLLKSL-KHPNLVNLLEVFRR-KK 74 (292)
Q Consensus 2 ~~y~~~~~l~~g~~~~v~~~~~~~-----~~~~v~iK~~~~~~~~~~~~~~~~~e~~~~~~l-~~~~i~~~~~~~~~-~~ 74 (292)
++|++.+.||+|+||.||+|.+.. +++.||+|++...... ...+.+.+|...+.++ .|+||+.+++++.+ ++
T Consensus 13 ~~y~~~~~iG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~~~-~~~~~~~~e~~~l~~~~~h~~iv~~~~~~~~~~~ 91 (299)
T d1ywna1 13 DRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATH-SEHRALMSELKILIHIGHHLNVVNLLGACTKPGG 91 (299)
T ss_dssp GGEEEEEEEEECSSCEEEEEEEESTTSSSCEEEEEEEEC----CH-HHHHHHHHHHHHHHHHCCCTTBCCEEEEECSTTS
T ss_pred HHEEEeeEEeecCCeEEEEEEEcCCCcccCCeEEEEEEEccccCc-HHHHHHHHHHHHHHhhcCCCeEEEeeeeeccCCC
Confidence 579999999999999999999754 3468999998654433 3445667777777776 68899999998764 55
Q ss_pred eEEEEEecCCCccHHHHhcCC----------------CCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEEccCC
Q psy758 75 KLHLVFEFCDHTVLNELENHP----------------HGLPWDLIKQITWQVLRGVSYCHRHACIHRDIKPENILLTANG 138 (292)
Q Consensus 75 ~~~iv~e~~~~~~L~~~~~~~----------------~~~~~~~~~~i~~qi~~aL~~LH~~givH~dl~p~Nilv~~~~ 138 (292)
.+++|||||++|+|.+++... ..+++..+..++.||+.||+|||++||+||||||+|||+++++
T Consensus 92 ~~~iv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~gl~ylH~~~ivHrDlKp~NILl~~~~ 171 (299)
T d1ywna1 92 PLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRKCIHRDLAARNILLSEKN 171 (299)
T ss_dssp CCEEEEECCTTCBHHHHHHHTGGGBCC-----------CBCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECGGG
T ss_pred eEEEEEEecCCCcHHHHHHhccccccccccchhhhhcccCCHHHHHHHHHHHHHHHHHHHhCCCcCCcCCccceeECCCC
Confidence 789999999999999998532 2489999999999999999999999999999999999999999
Q ss_pred cEEEeecCchhhhhccc-------cccccccccccccccCCCCCCCcccceeeecCCCCCCchHHHHHHHhhcc-cCCCC
Q psy758 139 VVKLCDFGFARLIRDLI-------PRHLHIFQTNEYFKGVSLPHAENVVPLEIKIGKPAATNIYLIDFLKRCLD-KDPLR 210 (292)
Q Consensus 139 ~~kl~dfg~~~~~~~~~-------~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~p~~ 210 (292)
.+||+|||+++...... ..++..|.+||...+.......++|+++ ..+++.+.. ..|+.
T Consensus 172 ~~Kl~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~sDiwS~G-------------vil~ellt~~~~p~~ 238 (299)
T d1ywna1 172 VVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFG-------------VLLWEIFSLGASPYP 238 (299)
T ss_dssp CEEECC------CCSCTTSCCTTSCCCGGGGCCHHHHHHCCCCHHHHHHHHH-------------HHHHHHHTTSCCSST
T ss_pred cEEEccCcchhhccccccccccCceeeCccccchhHhhcCCCCcccceeehH-------------HHHHHHHhCCCCCCC
Confidence 99999999997654321 1233456666665554443333333332 222222222 23333
Q ss_pred CCChhhhhhccCcCC--CCCCCCCccchHHHHhcccCcCCCCCCChhhhhhC
Q psy758 211 RWSCDQLLRHPYFNG--YYFEVPDEMQYEEITQRCLDKDPLRRWSCDQLLRH 260 (292)
Q Consensus 211 ~~~~~~~~~~~~~~~--~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~~il~h 260 (292)
.....+.+......+ ...+...++.+.+||.+||+.||++|||++||++|
T Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~eil~~ 290 (299)
T d1ywna1 239 GVKIDEEFCRRLKEGTRMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEH 290 (299)
T ss_dssp TCCCSHHHHHHHHHTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred CCCHHHHHHHHHhcCCCCCCCccCCHHHHHHHHHHcCCChhHCcCHHHHHHH
Confidence 332222211111111 12334457889999999999999999999999997
|
| >d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Hepatocyte growth factor receptor, c-MET species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=6.7e-43 Score=283.39 Aligned_cols=241 Identities=19% Similarity=0.195 Sum_probs=171.5
Q ss_pred eeeeecccCceEEEEEEEcCCC---cEEEEEEeccCCCChHHHHHHHHHHHHHHhCCCCCcchhhhhhhc-CCeEEEEEe
Q psy758 6 KIGKLGEGSYGVVFKCRNRDTG---QVVAIKKFLESEEDPLIRKIALREIRLLKSLKHPNLVNLLEVFRR-KKKLHLVFE 81 (292)
Q Consensus 6 ~~~~l~~g~~~~v~~~~~~~~~---~~v~iK~~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~-~~~~~iv~e 81 (292)
+.+.||+|+||+||+|.+..++ ..||+|.++.. ......+.+.+|++++++++||||++++|++.+ ++..++|||
T Consensus 31 ~~~~iG~G~fg~Vyk~~~~~~~~~~~~vAvK~~~~~-~~~~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~~lv~E 109 (311)
T d1r0pa_ 31 FNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRI-TDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVVLP 109 (311)
T ss_dssp EEEEEEEETTEEEEEEEECC----CEEEEEEEECCC-CCHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEETTTEEEEEEE
T ss_pred cceEEeecCCeEEEEEEEECCCCEEEEEEEEEECcc-cCHHHHHHHHHHHHHHHhCCCCCEeEEeEEEEecCCceEEEEE
Confidence 3578999999999999986643 35899998643 345556789999999999999999999999764 678999999
Q ss_pred cCCCccHHHHhcCC-CCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEEccCCcEEEeecCchhhhhcccc----
Q psy758 82 FCDHTVLNELENHP-HGLPWDLIKQITWQVLRGVSYCHRHACIHRDIKPENILLTANGVVKLCDFGFARLIRDLIP---- 156 (292)
Q Consensus 82 ~~~~~~L~~~~~~~-~~~~~~~~~~i~~qi~~aL~~LH~~givH~dl~p~Nilv~~~~~~kl~dfg~~~~~~~~~~---- 156 (292)
||++++|.+++... ...++..+..++.|++.||.|||+.||+||||||+|||+++++.+||+|||+++.......
T Consensus 110 ~~~~g~l~~~~~~~~~~~~~~~~~~i~~qia~gL~~lH~~~iiHrDLK~~NILl~~~~~~kL~DFG~~~~~~~~~~~~~~ 189 (311)
T d1r0pa_ 110 YMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKFLASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVH 189 (311)
T ss_dssp CCTTCBHHHHHHCTTCCCBHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECTTCCEEECSSGGGCCTTTTTCCCTT
T ss_pred EeecCchhhhhccccccchHHHHHHHHHHHHHhhhhhcccCcccCCccHHhEeECCCCCEEEecccchhhccccccccce
Confidence 99999999987654 4577889999999999999999999999999999999999999999999999987543211
Q ss_pred -----ccccccccccccccCCCCCCCcccceeeecCCCCCCchHHHHHHHhhcccCCCC-CCChhhhhhccCcC-CCCCC
Q psy758 157 -----RHLHIFQTNEYFKGVSLPHAENVVPLEIKIGKPAATNIYLIDFLKRCLDKDPLR-RWSCDQLLRHPYFN-GYYFE 229 (292)
Q Consensus 157 -----~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~p~~-~~~~~~~~~~~~~~-~~~~~ 229 (292)
..+..|.+||...+.......|+|++ +..+++.+.+..|.. ..+..++.....-. ....+
T Consensus 190 ~~~~~~gt~~y~aPE~~~~~~~~~ksDI~Sf-------------Givl~El~t~~~p~~~~~~~~~~~~~i~~g~~~~~p 256 (311)
T d1r0pa_ 190 NKTGAKLPVKWMALESLQTQKFTTKSDVWSF-------------GVLLWELMTRGAPPYPDVNTFDITVYLLQGRRLLQP 256 (311)
T ss_dssp CTTCSSCCGGGSCHHHHHHCCCCHHHHHHHH-------------HHHHHHHHTTSCCSCC------CHHHHHTTCCCCCC
T ss_pred ecccccccccccChHHHhcCCCCChhHhhhh-------------HHHHHHHHHCCCCCCCCCCHHHHHHHHHcCCCCCCc
Confidence 12234555555443333222222222 222233333222221 11111111110000 11123
Q ss_pred CCCccchHHHHhcccCcCCCCCCChhhhhhC
Q psy758 230 VPDEMQYEEITQRCLDKDPLRRWSCDQLLRH 260 (292)
Q Consensus 230 ~~~~~~l~~li~~~l~~dP~~Rpt~~~il~h 260 (292)
...+..+.+||.+||+.||++|||+.||++|
T Consensus 257 ~~~~~~l~~li~~cl~~dP~~RPs~~ei~~~ 287 (311)
T d1r0pa_ 257 EYCPDPLYEVMLKCWHPKAEMRPSFSELVSR 287 (311)
T ss_dssp TTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred ccCcHHHHHHHHHHcCCCHhHCcCHHHHHHH
Confidence 3457789999999999999999999999998
|
| >d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-KIT receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5.7e-43 Score=284.46 Aligned_cols=244 Identities=25% Similarity=0.368 Sum_probs=177.6
Q ss_pred cccceeeeecccCceEEEEEEEc-----CCCcEEEEEEeccCCCChHHHHHHHHHHHHHHhC-CCCCcchhhhhhhcCCe
Q psy758 2 ERYEKIGKLGEGSYGVVFKCRNR-----DTGQVVAIKKFLESEEDPLIRKIALREIRLLKSL-KHPNLVNLLEVFRRKKK 75 (292)
Q Consensus 2 ~~y~~~~~l~~g~~~~v~~~~~~-----~~~~~v~iK~~~~~~~~~~~~~~~~~e~~~~~~l-~~~~i~~~~~~~~~~~~ 75 (292)
++|++++.||+|+||.||+|... .+++.||+|++.... .......+.+|+.+++.+ +||||+++++++.+++.
T Consensus 23 ~~~~l~~~iG~G~fg~Vy~a~~~~~~~~~~~~~vAvK~i~~~~-~~~~~~~~~~E~~~~~~l~~HpnIv~~~g~~~~~~~ 101 (311)
T d1t46a_ 23 NRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSA-HLTEREALMSELKVLSYLGNHMNIVNLLGACTIGGP 101 (311)
T ss_dssp GGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTC-CHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSS
T ss_pred HHeEEeeEEeecCCeEEEEEEEeccccCCCCeEEEEEEECccc-CHHHHHHHHHHHHHHHhccCCCCEEEEEEEEeeCCE
Confidence 67899999999999999999863 456789999987554 344556788999999999 69999999999999999
Q ss_pred EEEEEecCCCccHHHHhcCCC------------------CCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEEccC
Q psy758 76 LHLVFEFCDHTVLNELENHPH------------------GLPWDLIKQITWQVLRGVSYCHRHACIHRDIKPENILLTAN 137 (292)
Q Consensus 76 ~~iv~e~~~~~~L~~~~~~~~------------------~~~~~~~~~i~~qi~~aL~~LH~~givH~dl~p~Nilv~~~ 137 (292)
.++|||||++|+|..++.... .+++..+..++.||+.||+|||++|++||||||+||+++.+
T Consensus 102 ~~lvmE~~~~g~l~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~gl~~LH~~~ivHrDLKp~NIl~~~~ 181 (311)
T d1t46a_ 102 TLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLASKNCIHRDLAARNILLTHG 181 (311)
T ss_dssp CEEEEECCTTEEHHHHHHHTTTTC--------------CCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEETT
T ss_pred EEEEEEcCCCCCHHHHHHhccccccccccccccccccccCCCHHHHHHHHHHHHHHHHHHHhCCeeeccccccccccccc
Confidence 999999999999999875432 58999999999999999999999999999999999999999
Q ss_pred CcEEEeecCchhhhhccccc--c-----ccccccccccccCCCCCCCcccceeeecCCCCCCchHHHHHHHhhc-ccCCC
Q psy758 138 GVVKLCDFGFARLIRDLIPR--H-----LHIFQTNEYFKGVSLPHAENVVPLEIKIGKPAATNIYLIDFLKRCL-DKDPL 209 (292)
Q Consensus 138 ~~~kl~dfg~~~~~~~~~~~--~-----~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~p~ 209 (292)
+.++|+|||.++........ . +..|.+||...+.......++|++ +..+++.+. +..+.
T Consensus 182 ~~~ki~DfG~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DIwS~-------------G~~l~ellt~g~p~~ 248 (311)
T d1t46a_ 182 RITKICDFGLARDIKNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSY-------------GIFLWELFSLGSSPY 248 (311)
T ss_dssp TEEEECCCGGGSCTTSCTTSEECSSSEECGGGCCHHHHHHCCCCHHHHHHHH-------------HHHHHHHHTTTCCSS
T ss_pred CcccccccchheeccCCCcceEeeecccChHHcCHHHhcCCCCCCcccccch-------------HHHHHHHHhCCCCCC
Confidence 99999999999876542211 1 222344444333322222222222 222233332 22222
Q ss_pred CCCChhhhhhccCcCCC--CCCCCCccchHHHHhcccCcCCCCCCChhhhhh
Q psy758 210 RRWSCDQLLRHPYFNGY--YFEVPDEMQYEEITQRCLDKDPLRRWSCDQLLR 259 (292)
Q Consensus 210 ~~~~~~~~~~~~~~~~~--~~~~~~~~~l~~li~~~l~~dP~~Rpt~~~il~ 259 (292)
......+.+....-.+. ..+...+..+.+||.+||+.||.+|||+++|++
T Consensus 249 ~~~~~~~~~~~~i~~~~~~~~~~~~~~~l~~Li~~cl~~dP~~RPs~~~il~ 300 (311)
T d1t46a_ 249 PGMPVDSKFYKMIKEGFRMLSPEHAPAEMYDIMKTCWDADPLKRPTFKQIVQ 300 (311)
T ss_dssp TTCCSSHHHHHHHHHTCCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred CCCCHHHHHHHHHhcCCCCCCcccccHHHHHHHHHHcCCChhHCcCHHHHHH
Confidence 22222111111111111 122345788999999999999999999999997
|
| >d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Type I TGF-beta receptor R4 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.7e-42 Score=278.32 Aligned_cols=250 Identities=18% Similarity=0.179 Sum_probs=170.6
Q ss_pred cccceeeeecccCceEEEEEEEcCCCcEEEEEEeccCCCChHHHHHHHHHHHHHHhCCCCCcchhhhhhhcCC----eEE
Q psy758 2 ERYEKIGKLGEGSYGVVFKCRNRDTGQVVAIKKFLESEEDPLIRKIALREIRLLKSLKHPNLVNLLEVFRRKK----KLH 77 (292)
Q Consensus 2 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~----~~~ 77 (292)
.+|.+.+.||+|+||.||+|+. +|+.||+|++..... .......|+..+..++||||+++++++.+.+ .+|
T Consensus 3 ~~~~l~~~iG~G~fg~Vy~~~~--~g~~vAvK~~~~~~~---~~~~~e~ei~~~~~~~HpnIv~~~~~~~~~~~~~~~~~ 77 (303)
T d1vjya_ 3 RTIVLQESIGKGRFGEVWRGKW--RGEEVAVKIFSSREE---RSWFREAEIYQTVMLRHENILGFIAADNKDNGTWTQLW 77 (303)
T ss_dssp GGEEEEEEEECCSSSEEEEEEE--TTEEEEEEEECGGGH---HHHHHHHHHHTSTTCCCTTBCCEEEEEEEECSSSEEEE
T ss_pred cEEEEEEEEeeCCCeEEEEEEE--CCEEEEEEEECccch---hHHHHHHHHHHHhhCCCCcCcceEEEEEeCCCcceEEE
Confidence 4789999999999999999986 488999999865432 2222334666667789999999999987543 689
Q ss_pred EEEecCCCccHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHh--------CCccccCCCCCceEEccCCcEEEeecCchh
Q psy758 78 LVFEFCDHTVLNELENHPHGLPWDLIKQITWQVLRGVSYCHR--------HACIHRDIKPENILLTANGVVKLCDFGFAR 149 (292)
Q Consensus 78 iv~e~~~~~~L~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~--------~givH~dl~p~Nilv~~~~~~kl~dfg~~~ 149 (292)
+||||+++|+|..++++. .+++..++.++.|++.||.|||+ +||+||||||+|||++.++.+||+|||+++
T Consensus 78 lv~Ey~~~g~L~~~l~~~-~l~~~~~~~~~~~ia~gl~~lH~~~~~~~~~~~IvHrDlKp~NILl~~~~~~Kl~DFGl~~ 156 (303)
T d1vjya_ 78 LVSDYHEHGSLFDYLNRY-TVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAV 156 (303)
T ss_dssp EEEECCTTCBHHHHHHHC-CBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCEEECSCCCGGGEEECTTSCEEECCCTTCE
T ss_pred EEEecccCCCHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHHhhhhhccCCCeeccccCccceEEcCCCCeEEEecCccc
Confidence 999999999999999865 69999999999999999999996 599999999999999999999999999987
Q ss_pred hhhccc---------cccccccccccccccCC-----------CCCCCcccceeeecCCCCCCchHHHHHHHhhcccCCC
Q psy758 150 LIRDLI---------PRHLHIFQTNEYFKGVS-----------LPHAENVVPLEIKIGKPAATNIYLIDFLKRCLDKDPL 209 (292)
Q Consensus 150 ~~~~~~---------~~~~~~~~~~~~~~~~~-----------~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~p~ 209 (292)
...... ..++..|.+||...+.. +.|++|+..+++.++..++....... ........
T Consensus 157 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~k~Di~S~Gvvl~el~tg~~~~~~~~~~~---~~~~~~~~ 233 (303)
T d1vjya_ 157 RHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQ---LPYYDLVP 233 (303)
T ss_dssp EEETTTTEECC----CCSCGGGCCHHHHTTCSCTTCHHHHHHHHHHHHHHHHHHHHHTBCBTTBCCCCC---CTTTTTSC
T ss_pred cccCCCcceeccccceecccCcCChhhccccccccCCCcCcchhhhhhHHHHHHHhhCCCCCCcccccc---cchhhccc
Confidence 654321 22345566666654432 23445555555544433221000000 00000000
Q ss_pred CCCChhhhhhccCcCCCCCCC-------CCccchHHHHhcccCcCCCCCCChhhhhhC
Q psy758 210 RRWSCDQLLRHPYFNGYYFEV-------PDEMQYEEITQRCLDKDPLRRWSCDQLLRH 260 (292)
Q Consensus 210 ~~~~~~~~~~~~~~~~~~~~~-------~~~~~l~~li~~~l~~dP~~Rpt~~~il~h 260 (292)
..++...+...........+. .....+.+|+.+||+.||++|||+.||+++
T Consensus 234 ~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~ei~~~ 291 (303)
T d1vjya_ 234 SDPSVEEMRKVVCEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKT 291 (303)
T ss_dssp SSCCHHHHHHHHTTSCCCCCCCGGGGGCHHHHHHHHHHHTTCCSSGGGSCCHHHHHHH
T ss_pred ccchHHHHHHHHhccccCCCCCcccCChHHHHHHHHHHHHHcccCHhHCcCHHHHHHH
Confidence 011111111111111111111 112348899999999999999999999883
|
| >d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=1.2e-40 Score=269.78 Aligned_cols=247 Identities=16% Similarity=0.180 Sum_probs=174.9
Q ss_pred cccceeeeecccCceEEEEEEEcCCCcEEEEEEeccCCCChHHHHHHHHHHHHHHhCCCCCcchh-hhhhhcCCeEEEEE
Q psy758 2 ERYEKIGKLGEGSYGVVFKCRNRDTGQVVAIKKFLESEEDPLIRKIALREIRLLKSLKHPNLVNL-LEVFRRKKKLHLVF 80 (292)
Q Consensus 2 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~-~~~~~~~~~~~iv~ 80 (292)
++|++++.||+|+||.||+|++..+|+.||+|++...... ..+..|+++++.++|++++.. .+++.+++..++||
T Consensus 7 ~rY~l~~~iG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~~----~~~~~E~~i~~~l~~~~~i~~~~~~~~~~~~~~ivm 82 (299)
T d1ckia_ 7 NRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTKH----PQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVMVM 82 (299)
T ss_dssp TTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEESCTTS----CCHHHHHHHHHHSTTSTTCCCEEEEEEETTEEEEEE
T ss_pred CEEEEeEEEeeCCCcEEEEEEECCCCCEEEEEEEchhccC----HHHHHHHHHHHHccCCCcccEEEEEEecCCEEEEEE
Confidence 5799999999999999999999999999999998765433 236789999999987765555 45556788999999
Q ss_pred ecCCCccHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEEcc---CCcEEEeecCchhhhhcccc-
Q psy758 81 EFCDHTVLNELENHPHGLPWDLIKQITWQVLRGVSYCHRHACIHRDIKPENILLTA---NGVVKLCDFGFARLIRDLIP- 156 (292)
Q Consensus 81 e~~~~~~L~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~givH~dl~p~Nilv~~---~~~~kl~dfg~~~~~~~~~~- 156 (292)
||++++.+..+....+.+++..+..++.|++.||+|||++||+||||||+||+++. +..++|+|||+++.......
T Consensus 83 e~~~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~iiHrDiKp~NIl~~~~~~~~~vkl~DFG~a~~~~~~~~~ 162 (299)
T d1ckia_ 83 ELLGPSLEDLFNFCSRKFSLKTVLLLADQMISRIEYIHSKNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTH 162 (299)
T ss_dssp ECCCCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECCGGGTTCEEECCCSSCEECBCTTTC
T ss_pred EEcCCchhhhhhhccCCCcHHHHHHHHHHHHHHHHHHHHCCeeeccCCHhhccccccCCCceeeeeccCcceeccccccc
Confidence 99988877777777778999999999999999999999999999999999999863 45799999999987653221
Q ss_pred -----------ccccccccccccccCCCCCCCcccceeeecCCCCCCchHHHHHHHhhcccCCCCCCChhhhhhc-----
Q psy758 157 -----------RHLHIFQTNEYFKGVSLPHAENVVPLEIKIGKPAATNIYLIDFLKRCLDKDPLRRWSCDQLLRH----- 220 (292)
Q Consensus 157 -----------~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~----- 220 (292)
.++..|.+||...+.......|+ ++.+..+++.+.+..|+......+....
T Consensus 163 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di-------------wSlG~~l~el~tg~~P~~~~~~~~~~~~~~~~~ 229 (299)
T d1ckia_ 163 QHIPYRENKNLTGTARYASINTHLGIEQSRRDDL-------------ESLGYVLMYFNLGSLPWQGLKAATKRQKYERIS 229 (299)
T ss_dssp CBCCCCBCCSCCCCSSSCCHHHHTTBCCCHHHHH-------------HHHHHHHHHHHHSSCTTCCCC-------HHHHH
T ss_pred cceeccccCCcCCCccccCHHHHhCCCCCChhhE-------------EecCHHHHHHHhCCCcccccchHHHHHHHHHhh
Confidence 12334455554444333222222 2233333444444444433322211110
Q ss_pred --cC-cCCCCCCCCCccchHHHHhcccCcCCCCCCChhh---hhhCCcccc
Q psy758 221 --PY-FNGYYFEVPDEMQYEEITQRCLDKDPLRRWSCDQ---LLRHPYFNG 265 (292)
Q Consensus 221 --~~-~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~~---il~h~w~~~ 265 (292)
.. ..........|.++.+||.+||+.||++||++++ +|+|+|.+.
T Consensus 230 ~~~~~~~~~~~~~~~p~~~~~li~~cl~~~p~~RP~~~~i~~~l~~~~~~~ 280 (299)
T d1ckia_ 230 EKKMSTPIEVLCKGYPSEFATYLNFCRSLRFDDKPDYSYLRQLFRNLFHRQ 280 (299)
T ss_dssp HHHHHSCHHHHTTTSCHHHHHHHHHHHHSCTTCCCCHHHHHHHHHHHHHHH
T ss_pred cccCCCChhHhccCCCHHHHHHHHHHccCChhHCcCHHHHHHHHHHHHHHc
Confidence 00 0000112245778999999999999999999875 467777654
|
| >d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Sky1p species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Probab=100.00 E-value=1.3e-39 Score=270.85 Aligned_cols=261 Identities=25% Similarity=0.366 Sum_probs=179.5
Q ss_pred cccceeeeecccCceEEEEEEEcCCCcEEEEEEeccCCCChHHHHHHHHHHHHHHhCC-----------CCCcchhhhhh
Q psy758 2 ERYEKIGKLGEGSYGVVFKCRNRDTGQVVAIKKFLESEEDPLIRKIALREIRLLKSLK-----------HPNLVNLLEVF 70 (292)
Q Consensus 2 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~e~~~~~~l~-----------~~~i~~~~~~~ 70 (292)
+||++++.||+|+||+||+|++..+|+.||||++.... ...+.+.+|+.+++.++ |+||+++++++
T Consensus 13 ~rY~i~~~LG~G~fg~Vy~~~~~~~g~~vAvKvi~~~~---~~~~~~~~Ei~~l~~l~~~~~~~~~~~~~~~iv~~~~~~ 89 (362)
T d1q8ya_ 13 ARYILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGDK---VYTEAAEDEIKLLQRVNDADNTKEDSMGANHILKLLDHF 89 (362)
T ss_dssp TTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSCH---HHHHHHHHHHHHHHHHHHTCCSHHHHHHHTTBCCCCEEE
T ss_pred CcEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEeccc---cchHHHHHHHHHHHHhcchhhhhhhhcCcCceEEEEEEe
Confidence 37999999999999999999999999999999996542 33456778888888775 47788888887
Q ss_pred hc--CCeEEEEEecCCCcc--HH-HHhcCCCCCCHHHHHHHHHHHHHHHHHHHh-CCccccCCCCCceEEccCC------
Q psy758 71 RR--KKKLHLVFEFCDHTV--LN-ELENHPHGLPWDLIKQITWQVLRGVSYCHR-HACIHRDIKPENILLTANG------ 138 (292)
Q Consensus 71 ~~--~~~~~iv~e~~~~~~--L~-~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~-~givH~dl~p~Nilv~~~~------ 138 (292)
.. ....+.+++++..+. .. ........+++..++.++.||+.||.|||+ .||+||||||+||+++.++
T Consensus 90 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~i~~qil~al~~lh~~~~IvHrDlKp~NIll~~~~~~~~~~ 169 (362)
T d1q8ya_ 90 NHKGPNGVHVVMVFEVLGENLLALIKKYEHRGIPLIYVKQISKQLLLGLDYMHRRCGIIHTDIKPENVLMEIVDSPENLI 169 (362)
T ss_dssp EEEETTEEEEEEEECCCCEEHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHHHTTCEECSCCSGGGEEEEEEETTTTEE
T ss_pred eeccccceeeeeeecccccccccccccccccCCcHHHHHHHHHHHHHHHHHHhhhcCcccccCChhHeeeeccCcccccc
Confidence 53 455666666554432 22 223344578999999999999999999998 8999999999999998765
Q ss_pred cEEEeecCchhhhhccc--cccccccccccccccCCC-----CCCCcccceeeecCCCCCCchHH---------HHHHHh
Q psy758 139 VVKLCDFGFARLIRDLI--PRHLHIFQTNEYFKGVSL-----PHAENVVPLEIKIGKPAATNIYL---------IDFLKR 202 (292)
Q Consensus 139 ~~kl~dfg~~~~~~~~~--~~~~~~~~~~~~~~~~~~-----~~~~~~~~~~~~~~~~~~~~~~~---------~~~~~~ 202 (292)
.++++|||.+....... ..++..|.+||...+... .|+.|+..+++.+|..++..... ......
T Consensus 170 ~~kl~dfg~s~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~~g~~pF~~~~~~~~~~~~~~~~~~~~ 249 (362)
T d1q8ya_ 170 QIKIADLGNACWYDEHYTNSIQTREYRSPEVLLGAPWGCGADIWSTACLIFELITGDFLFEPDEGHSYTKDDDHIAQIIE 249 (362)
T ss_dssp EEEECCCTTCEETTBCCCSCCSCGGGCCHHHHHTCCCCTHHHHHHHHHHHHHHHHSSCCC---------CHHHHHHHHHH
T ss_pred eeeEeecccccccccccccccccccccChhhccccCCCccccccchHHHHHHHHHCCCCCCCCccccccchhHHHHHHHH
Confidence 39999999987654322 223455777776665444 46666666666777765432211 111112
Q ss_pred hcccCCCCC-------------------------CChhhhhhccCcCCCCCCCCCccchHHHHhcccCcCCCCCCChhhh
Q psy758 203 CLDKDPLRR-------------------------WSCDQLLRHPYFNGYYFEVPDEMQYEEITQRCLDKDPLRRWSCDQL 257 (292)
Q Consensus 203 ~~~~~p~~~-------------------------~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~~i 257 (292)
+++..|... ........ .........++.+.+||.+||++||.+||||+|+
T Consensus 250 ~lg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~----~~~~~~~~~~~~~~dll~~mL~~dP~~Rpta~e~ 325 (362)
T d1q8ya_ 250 LLGELPSYLLRNGKYTRTFFNSRGLLRNISKLKFWPLEDVLT----EKYKFSKDEAKEISDFLSPMLQLDPRKRADAGGL 325 (362)
T ss_dssp HHCSCCHHHHHHCTTHHHHBCC--CBSSCCCCCBCCHHHHHH----HTTCCCHHHHHHHHHHHGGGGCSSTTTCBCHHHH
T ss_pred HhCCCCHHHhhcccccccccccchhhhccccccCCchhhhcc----cccccCcccCHHHHHHHHHHCCCChhHCcCHHHH
Confidence 222211100 00000000 0011112235678999999999999999999999
Q ss_pred hhCCcccceecc
Q psy758 258 LRHPYFNGYYFE 269 (292)
Q Consensus 258 l~h~w~~~~~~~ 269 (292)
|+||||++....
T Consensus 326 L~Hp~f~~~~~~ 337 (362)
T d1q8ya_ 326 VNHPWLKDTLGM 337 (362)
T ss_dssp HTCGGGTTCTTC
T ss_pred hcCcccCCCCCc
Confidence 999999987544
|
| >d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Probab=100.00 E-value=2.5e-39 Score=260.69 Aligned_cols=240 Identities=19% Similarity=0.169 Sum_probs=171.8
Q ss_pred cccceeeeecccCceEEEEEEEcCCCcEEEEEEeccCCCChHHHHHHHHHHHHHHhCCC-CCcchhhhhhhcCCeEEEEE
Q psy758 2 ERYEKIGKLGEGSYGVVFKCRNRDTGQVVAIKKFLESEEDPLIRKIALREIRLLKSLKH-PNLVNLLEVFRRKKKLHLVF 80 (292)
Q Consensus 2 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~e~~~~~~l~~-~~i~~~~~~~~~~~~~~iv~ 80 (292)
++|++++.||+|+||.||+|++..+|+.||+|+++..... ..+.+|++.++.++| +|++.+++++.++...++||
T Consensus 5 ~~Y~i~~~iG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~~----~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~~~~vm 80 (293)
T d1csna_ 5 VHYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRSDA----PQLRDEYRTYKLLAGCTGIPNVYYFGQEGLHNVLVI 80 (293)
T ss_dssp TTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEECCTTS----CCHHHHHHHHHHTTTCTTCCCEEEEEEETTEEEEEE
T ss_pred CceEEEEEEecCCCeEEEEEEECCCCCEEEEEEEccccCc----HHHHHHHHHHHHhcCCCCCCEEEEEeecCCccEEEE
Confidence 5899999999999999999999999999999998665433 235678899999975 89999999999999999999
Q ss_pred ecCCCccHHHHh-cCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEEcc-----CCcEEEeecCchhhhhcc
Q psy758 81 EFCDHTVLNELE-NHPHGLPWDLIKQITWQVLRGVSYCHRHACIHRDIKPENILLTA-----NGVVKLCDFGFARLIRDL 154 (292)
Q Consensus 81 e~~~~~~L~~~~-~~~~~~~~~~~~~i~~qi~~aL~~LH~~givH~dl~p~Nilv~~-----~~~~kl~dfg~~~~~~~~ 154 (292)
||++ ++|..++ .....++...+..++.|++.||+|||++||+||||||+||+++. ++.++|+|||+++.....
T Consensus 81 e~~~-~~l~~~~~~~~~~~~~~~~~~i~~q~~~~l~~lH~~giiHrDiKp~Nili~~~~~~~~~~vkl~DFG~a~~~~~~ 159 (293)
T d1csna_ 81 DLLG-PSLEDLLDLCGRKFSVKTVAMAAKQMLARVQSIHEKSLVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFYRDP 159 (293)
T ss_dssp ECCC-CBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHTTTEECCCCCGGGEEECCSSSTTTTCEEECCCTTCEESBCT
T ss_pred EecC-CCHHHHHHhhccchhhHHHHHHHHHHHHHHHHHHHCCceeccCCccceeecCcccccCCceEEcccceeEEcccC
Confidence 9996 5555555 44457999999999999999999999999999999999999974 578999999999875432
Q ss_pred cc------------ccccccccccccccCCCCCCCcccceeeecCCCCCCchHHHHHHHhhcccCCCCCCC---hhhhhh
Q psy758 155 IP------------RHLHIFQTNEYFKGVSLPHAENVVPLEIKIGKPAATNIYLIDFLKRCLDKDPLRRWS---CDQLLR 219 (292)
Q Consensus 155 ~~------------~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~---~~~~~~ 219 (292)
.. .++..|.+||...+.......|+ ++.+..+++.+.+..|+.... ..+...
T Consensus 160 ~~~~~~~~~~~~~~~GT~~y~aPE~~~~~~~~~~~Di-------------wSlG~~l~elltg~~Pf~~~~~~~~~~~~~ 226 (293)
T d1csna_ 160 VTKQHIPYREKKNLSGTARYMSINTHLGREQSRRDDL-------------EALGHVFMYFLRGSLPWQGLKAATNKQKYE 226 (293)
T ss_dssp TTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHH-------------HHHHHHHHHHHHSSCTTSSCCSCCHHHHHH
T ss_pred ccccceeecccCceEEchhhcCHHHhcCCCCChHHHH-------------HHhhHHHHHHHhCCCcCCCccchhHHHHHH
Confidence 11 12344555555544433222222 222223333333444433221 111110
Q ss_pred c----cCcC-CCCCCCCCccchHHHHhcccCcCCCCCCChhhhhh
Q psy758 220 H----PYFN-GYYFEVPDEMQYEEITQRCLDKDPLRRWSCDQLLR 259 (292)
Q Consensus 220 ~----~~~~-~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~~il~ 259 (292)
. .... ........|+++.+++..|++.+|++||+++.+.+
T Consensus 227 ~i~~~~~~~~~~~l~~~~p~~l~~ii~~~~~~~~~~rP~y~~l~~ 271 (293)
T d1csna_ 227 RIGEKKQSTPLRELCAGFPEEFYKYMHYARNLAFDATPDYDYLQG 271 (293)
T ss_dssp HHHHHHHHSCHHHHTTTSCHHHHHHHHHHHHCCTTCCCCHHHHHH
T ss_pred HHHhccCCCChHHhcCCCCHHHHHHHHHHhcCCcccCcCHHHHHH
Confidence 0 0000 00011234678999999999999999999887765
|
| >d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: RIO1-like kinases domain: Rio2 serine protein kinase C-terminal domain species: Archaeoglobus fulgidus [TaxId: 2234]
Probab=99.93 E-value=5.3e-26 Score=171.06 Aligned_cols=136 Identities=18% Similarity=0.180 Sum_probs=107.6
Q ss_pred cceeeeecccCceEEEEEEEcCCCcEEEEEEeccCCCC----------------hHHHHHHHHHHHHHHhCCCCCcchhh
Q psy758 4 YEKIGKLGEGSYGVVFKCRNRDTGQVVAIKKFLESEED----------------PLIRKIALREIRLLKSLKHPNLVNLL 67 (292)
Q Consensus 4 y~~~~~l~~g~~~~v~~~~~~~~~~~v~iK~~~~~~~~----------------~~~~~~~~~e~~~~~~l~~~~i~~~~ 67 (292)
|.+++.||+|+||.||+|.+. +|+.||+|++...... .........|...+..+.|++++..+
T Consensus 2 ~~vg~~IG~G~~g~Vy~a~~~-~g~~vAvKi~r~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~v~~~~ 80 (191)
T d1zara2 2 DAIGKLMGEGKESAVFNCYSE-KFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEFRALQKLQGLAVPKVY 80 (191)
T ss_dssp SEEEEEEEECSSEEEEEEEET-TTEEEEEEEECC------CCCC-------CHHHHHHHHHHHHHHHHHHTTTSSSCCEE
T ss_pred chhCCEeeeCcceEEEEEECC-CCCEEEEEEEecccchhhhhhhhhhhccHHHHHHHHHHHHHHHHHHHHccCCCcceEE
Confidence 568899999999999999985 5899999987532110 11234455688899999999988877
Q ss_pred hhhhcCCeEEEEEecCCCccHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCceEEccCCcEEEeecCc
Q psy758 68 EVFRRKKKLHLVFEFCDHTVLNELENHPHGLPWDLIKQITWQVLRGVSYCHRHACIHRDIKPENILLTANGVVKLCDFGF 147 (292)
Q Consensus 68 ~~~~~~~~~~iv~e~~~~~~L~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~givH~dl~p~Nilv~~~~~~kl~dfg~ 147 (292)
++.. .+++||+++++.+.. ++...+..++.|++.+|++||++||+||||||+|||++++ .++|+|||.
T Consensus 81 ~~~~----~~lvme~~~~~~~~~-------l~~~~~~~i~~ql~~~l~~lH~~giiHrDiKP~NILv~~~-~~~liDFG~ 148 (191)
T d1zara2 81 AWEG----NAVLMELIDAKELYR-------VRVENPDEVLDMILEEVAKFYHRGIVHGDLSQYNVLVSEE-GIWIIDFPQ 148 (191)
T ss_dssp EEET----TEEEEECCCCEEGGG-------CCCSCHHHHHHHHHHHHHHHHHTTEECSCCSTTSEEEETT-EEEECCCTT
T ss_pred EecC----CEEEEEeeccccccc-------hhhHHHHHHHHHHHHHHHHHhhCCEEEccCChhheeeeCC-CEEEEECCC
Confidence 5532 379999999876643 4455577899999999999999999999999999999965 589999999
Q ss_pred hhhhh
Q psy758 148 ARLIR 152 (292)
Q Consensus 148 ~~~~~ 152 (292)
+....
T Consensus 149 a~~~~ 153 (191)
T d1zara2 149 SVEVG 153 (191)
T ss_dssp CEETT
T ss_pred cccCC
Confidence 86543
|
| >d1j7la_ d.144.1.6 (A:) Type IIIa 3',5"-aminoglycoside phosphotransferase {Enterococcus faecalis [TaxId: 1351]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Type IIIa 3',5"-aminoglycoside phosphotransferase species: Enterococcus faecalis [TaxId: 1351]
Probab=98.90 E-value=2.7e-09 Score=82.80 Aligned_cols=140 Identities=16% Similarity=0.120 Sum_probs=95.2
Q ss_pred cccceeeeecccCceEEEEEEEcCCCcEEEEEEeccCCCChHHHHHHHHHHHHHHhCC-CCCcchhhhhhhcCCeEEEEE
Q psy758 2 ERYEKIGKLGEGSYGVVFKCRNRDTGQVVAIKKFLESEEDPLIRKIALREIRLLKSLK-HPNLVNLLEVFRRKKKLHLVF 80 (292)
Q Consensus 2 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~e~~~~~~l~-~~~i~~~~~~~~~~~~~~iv~ 80 (292)
+.|+.++..+.++.+.||++.. .++.+++|......... ...+.+|...++.+. +-.+.+++.+..+++..++||
T Consensus 14 ~~~~~~~~~~G~s~~~v~rv~~--~~~~~vlk~~~~~~~~~--~~~~~~E~~~l~~l~~~vpvP~vl~~~~~~~~~~lv~ 89 (263)
T d1j7la_ 14 EKYRCVKDTEGMSPAKVYKLVG--ENENLYLKMTDSRYKGT--TYDVEREKDMMLWLEGKLPVPKVLHFERHDGWSNLLM 89 (263)
T ss_dssp TTSEEEECSCCCSSSEEEEEEC--SSCEEEEEEECGGGTTS--TTCHHHHHHHHHHHTTTSCCCCEEEEEEETTEEEEEE
T ss_pred hceEEEEcCCCCCCCcEEEEEe--CCCeEEEEEcCCCcccc--hhhHHHHHHHHHHHhccCCCCcEEEEEecCCceEEEE
Confidence 4677777666666678998753 46678889875443211 123456777777664 333566777777788999999
Q ss_pred ecCCCccHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHh-----------------------------------------
Q psy758 81 EFCDHTVLNELENHPHGLPWDLIKQITWQVLRGVSYCHR----------------------------------------- 119 (292)
Q Consensus 81 e~~~~~~L~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~----------------------------------------- 119 (292)
++.+|..+....... .....++.++...+..||+
T Consensus 90 ~~l~G~~~~~~~~~~-----~~~~~~~~~l~~~l~~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 164 (263)
T d1j7la_ 90 SEADGVLCSEEYEDE-----QSPEKIIELYAECIRLFHSIDISDCPYTNSLDSRLAELDYLLNNDLADVDCENWEEDTPF 164 (263)
T ss_dssp ECCSSEEHHHHTTTC-----SCHHHHHHHHHHHHHHHHTSCCTTCSCBCCHHHHHHHHHHHHHTTCSCCCGGGGSTTCSC
T ss_pred Eeccccccccccccc-----ccHHHHHHHHHHHHHHHhccCccccccCcchhhhhhhHHHHHHHHhhhhhhhcccccccc
Confidence 999998887654321 1223345555555666552
Q ss_pred ------------------CCccccCCCCCceEEccCCcEEEeecCchhh
Q psy758 120 ------------------HACIHRDIKPENILLTANGVVKLCDFGFARL 150 (292)
Q Consensus 120 ------------------~givH~dl~p~Nilv~~~~~~kl~dfg~~~~ 150 (292)
..++|||+.|.||++++++..-|+||+.+..
T Consensus 165 ~~~~~~~~~l~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~lIDwe~a~~ 213 (263)
T d1j7la_ 165 KDPRELYDFLKTEKPEEELVFSHGDLGDSNIFVKDGKVSGFIDLGRSGR 213 (263)
T ss_dssp SSHHHHHHHHHHSCCCCCEEEECSCCCTTSEEEETTEEEEECCCTTCEE
T ss_pred hHHHHHHHHHHhcCCcCCcEEEEeeccCcceeecCCceEEEeechhccc
Confidence 1278999999999999876677999988764
|
| >d1nd4a_ d.144.1.6 (A:) Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase) {Bacteria (Klebsiella pneumoniae) [TaxId: 573]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase) species: Bacteria (Klebsiella pneumoniae) [TaxId: 573]
Probab=98.48 E-value=2.6e-07 Score=70.87 Aligned_cols=127 Identities=17% Similarity=0.092 Sum_probs=81.4
Q ss_pred ecccC-ceEEEEEEEcCCCcEEEEEEeccCCCChHHHHHHHHHHHHHHhCCC--CCcchhhhhhhcCCeEEEEEecCCCc
Q psy758 10 LGEGS-YGVVFKCRNRDTGQVVAIKKFLESEEDPLIRKIALREIRLLKSLKH--PNLVNLLEVFRRKKKLHLVFEFCDHT 86 (292)
Q Consensus 10 l~~g~-~~~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~e~~~~~~l~~--~~i~~~~~~~~~~~~~~iv~e~~~~~ 86 (292)
+..|. .+.||++... .+..+++|..+..... .+..|...++.+.. -.+.+++.+..+++..++||++++|.
T Consensus 18 ~~~G~s~~~v~r~~~~-~~~~~vlK~~~~~~~~-----~l~~E~~~l~~L~~~gvpvP~v~~~~~~~~~~~~v~~~i~G~ 91 (255)
T d1nd4a_ 18 QTIGCSDAAVFRLSAQ-GRPVLFVKTDLSGALN-----ELQDEAARLSWLATTGVPCAAVLDVVTEAGRDWLLLGEVPGQ 91 (255)
T ss_dssp CSCTTSSCEEEEEECT-TSCCEEEEEECSCTTS-----CHHHHHHHHHHHHTTTCCBCCEEEEEECSSCEEEEEECCSSE
T ss_pred cCCcccCCeEEEEEeC-CCCEEEEEeCCccCHh-----HHHHHHHHHHHHHhcCCCCCceeeecccccceEEEEEeeecc
Confidence 34444 4678988754 4667889986544322 24556666666642 23566777777788899999999987
Q ss_pred cHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHh-----------------------------------------------
Q psy758 87 VLNELENHPHGLPWDLIKQITWQVLRGVSYCHR----------------------------------------------- 119 (292)
Q Consensus 87 ~L~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~----------------------------------------------- 119 (292)
.+.... .+.. ..+.++...|+.||+
T Consensus 92 ~~~~~~-----~~~~---~~~~~l~~~la~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 163 (255)
T d1nd4a_ 92 DLLSSH-----LAPA---EKVSIMADAMRRLHTLDPATCPFDHQAKHRIERARTRMEAGLVDQDDLDEEHQGLAPAELFA 163 (255)
T ss_dssp ETTTSC-----CCHH---HHHHHHHHHHHHHTTSCGGGCCCBCCHHHHHHHHHHHHHTTCCCTTSCCGGGTTCCHHHHHH
T ss_pred cccccc-----ccHH---HHHHHHHHHHHHHccCChhhCCCcccchhhHHHHHHHHHHhhhccccccchhhhhHHHHHHH
Confidence 653311 1111 112233333344331
Q ss_pred -----------CCccccCCCCCceEEccCCcEEEeecCchhh
Q psy758 120 -----------HACIHRDIKPENILLTANGVVKLCDFGFARL 150 (292)
Q Consensus 120 -----------~givH~dl~p~Nilv~~~~~~kl~dfg~~~~ 150 (292)
..++|||+.|.||+++++..+-|+||+.+..
T Consensus 164 ~l~~~~~~~~~~~liHgD~~~~Nvl~~~~~~~~iID~~~~~~ 205 (255)
T d1nd4a_ 164 RLKARMPDGEDLVVTHGDACLPNIMVENGRFSGFIDCGRLGV 205 (255)
T ss_dssp HHHHTCCSSCCEEEECSSCCGGGEEEETTEEEEECCCTTCEE
T ss_pred HHHHhCCccCCceEEeCCCCCcceEEeCCceEEEEEchhccc
Confidence 1379999999999999876678999988753
|
| >d2pula1 d.144.1.6 (A:5-396) Methylthioribose kinase MtnK {Bacillus subtilis [TaxId: 1423]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Methylthioribose kinase MtnK species: Bacillus subtilis [TaxId: 1423]
Probab=98.31 E-value=6e-07 Score=73.36 Aligned_cols=79 Identities=19% Similarity=0.165 Sum_probs=47.0
Q ss_pred eeeecccCceEEEEEEEcCCCcEEEEEEeccC-----CCChHHHHHHHHHHHHHHhCC--C-CCcchhhhhhhcCCeEEE
Q psy758 7 IGKLGEGSYGVVFKCRNRDTGQVVAIKKFLES-----EEDPLIRKIALREIRLLKSLK--H-PNLVNLLEVFRRKKKLHL 78 (292)
Q Consensus 7 ~~~l~~g~~~~v~~~~~~~~~~~v~iK~~~~~-----~~~~~~~~~~~~e~~~~~~l~--~-~~i~~~~~~~~~~~~~~i 78 (292)
.+.||.|....||++.+..+++.|++|.-... ..-.........|...++.+. . ..+++++.+ ++...++
T Consensus 31 ~~eig~G~~N~vfrV~~~~~~~svivKqa~p~~r~~g~~~~~~~~R~~~E~~~L~~~~~~~p~~vP~v~~~--d~~~~~l 108 (392)
T d2pula1 31 CQEIGDGNLNYVFHIYDQEHDRALIIKQAVPYAKVVGESWPLTIDRARIESSALIRQGEHVPHLVPRVFYS--DTEMAVT 108 (392)
T ss_dssp EEECCSSSSEEEEEEEC----CEEEEEEECCGGGC--CCCCCCTTHHHHHHHHHHHHHTTCGGGSCCEEEE--ETTTTEE
T ss_pred EEEeCCCceEeEEEEEeCCCCeEEEEecCCchhcccCCCCCCCHHHHHHHHHHHHHhhhhCCCCcceEEEE--cCCCCEE
Confidence 45789999999999998887889999964311 110111223445777776663 2 234555543 4445678
Q ss_pred EEecCCCcc
Q psy758 79 VFEFCDHTV 87 (292)
Q Consensus 79 v~e~~~~~~ 87 (292)
|||++++..
T Consensus 109 vmE~L~~~~ 117 (392)
T d2pula1 109 VMEDLSHLK 117 (392)
T ss_dssp EECCCTTSE
T ss_pred EEeccCCcc
Confidence 999998743
|
| >d1nw1a_ d.144.1.8 (A:) Choline kinase {Caenorhabditis elegans [TaxId: 6239]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Choline kinase domain: Choline kinase species: Caenorhabditis elegans [TaxId: 6239]
Probab=97.62 E-value=0.00018 Score=58.36 Aligned_cols=74 Identities=18% Similarity=0.297 Sum_probs=49.0
Q ss_pred eeeecccCceEEEEEEEcC-------CCcEEEEEEeccCCCChHHHHHHHHHHHHHHhCCCCC-cchhhhhhhcCCeEEE
Q psy758 7 IGKLGEGSYGVVFKCRNRD-------TGQVVAIKKFLESEEDPLIRKIALREIRLLKSLKHPN-LVNLLEVFRRKKKLHL 78 (292)
Q Consensus 7 ~~~l~~g~~~~v~~~~~~~-------~~~~v~iK~~~~~~~~~~~~~~~~~e~~~~~~l~~~~-i~~~~~~~~~~~~~~i 78 (292)
++.|+.|-.-.+|++.... .++.|++++..... .. -...+|..+++.+.-.+ ..++++++.+ ..
T Consensus 47 v~~l~GGltN~~y~v~~~~~~~~~~~~~~~vllRi~g~~~-~~---idr~~E~~i~~~ls~~gl~Pkll~~~~~----g~ 118 (395)
T d1nw1a_ 47 ISRIKGGMSNMLFLCRLSEVYPPIRNEPNKVLLRVYFNPE-TE---SHLVAESVIFTLLSERHLGPKLYGIFSG----GR 118 (395)
T ss_dssp EEEECCCTTEEEEEEEECTTSCCSSSCCSEEEEEEECSCC-CH---HHHHHHHHHHHHHHHTTSSSCEEEEETT----EE
T ss_pred EEEcCCccccceEEEEeCCCCccccCCCCcEEEEecCCcc-hh---hHHHHHHHHHHHHHhCCCCCeEEEEcCC----ce
Confidence 4678888889999987653 34578888875322 21 12447888888885333 4566766543 57
Q ss_pred EEecCCCccH
Q psy758 79 VFEFCDHTVL 88 (292)
Q Consensus 79 v~e~~~~~~L 88 (292)
|+||.+|..+
T Consensus 119 I~efi~g~~l 128 (395)
T d1nw1a_ 119 LEEYIPSRPL 128 (395)
T ss_dssp EECCCCEEEC
T ss_pred EEEEeccccC
Confidence 8999988544
|
| >d1zyla1 d.144.1.6 (A:4-328) RdoA {Escherichia coli [TaxId: 562]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: RdoA species: Escherichia coli [TaxId: 562]
Probab=97.45 E-value=0.00082 Score=52.79 Aligned_cols=128 Identities=14% Similarity=0.169 Sum_probs=71.5
Q ss_pred eEEEEEEEcCCCcEEEEEEeccCCCChHHHHHHHHHHHHHHhCCCCCc--chhhh-----hhhcCCeEEEEEecCCCccH
Q psy758 16 GVVFKCRNRDTGQVVAIKKFLESEEDPLIRKIALREIRLLKSLKHPNL--VNLLE-----VFRRKKKLHLVFEFCDHTVL 88 (292)
Q Consensus 16 ~~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~e~~~~~~l~~~~i--~~~~~-----~~~~~~~~~iv~e~~~~~~L 88 (292)
..||++.. .+|..|++|+......+. +.+..|...+..|...++ +..+. .+...+..+.++++.+|..+
T Consensus 36 N~vy~v~~-~dg~~~VlK~~rp~~~s~---~~i~~E~~~l~~L~~~gipv~~p~~~~g~~~~~~~~~~~~l~~~~~G~~~ 111 (325)
T d1zyla1 36 NRVYQFQD-EDRRRFVVKFYRPERWTA---DQILEEHQFALQLVNDEVPVAAPVAFNGQTLLNHQGFYFAVFPSVGGRQF 111 (325)
T ss_dssp SEEEEECC-TTCCCEEEEEECTTTSCH---HHHHHHHHHHHHHHHTTCSBCCCCCBTTBSCEEETTEEEEEEECCCCEEC
T ss_pred ceeEEEEc-CCCCEEEEEEeCCCCCCH---HHHHHHHHHHHHHHhcCCCCCCceecCCCeeeeeeeEEEEEEeecCCcCC
Confidence 46898876 458889999986543332 335567777777642211 11111 12345678899999887443
Q ss_pred HH-----H------h-------cCC-----CC-------------------CCHH---HHHHHHHHHHHHHHHHH----h
Q psy758 89 NE-----L------E-------NHP-----HG-------------------LPWD---LIKQITWQVLRGVSYCH----R 119 (292)
Q Consensus 89 ~~-----~------~-------~~~-----~~-------------------~~~~---~~~~i~~qi~~aL~~LH----~ 119 (292)
.. . + ... .. ++.. .....+.++...+...- .
T Consensus 112 ~~~~~~~~~~lG~~LA~lH~~~~~~~~~~r~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~~~~~~~p 191 (325)
T d1zyla1 112 EADNIDQMEAVGRYLGRMHQTGRKQLFIHRPTIGLNEYLIEPRKLFEDATLIPSGLKAAFLKATDELIAAVTAHWREDFT 191 (325)
T ss_dssp CSSCHHHHHHHHHHHHHHHHHHTSSCCSSSCBCSHHHHTHHHHHHHHTCSSSCTTTHHHHHHHHHHHHHHHHHHCCSCSC
T ss_pred CCCCHHHHHHHHHHHHHHHhhcccCCccccCCCCHHHHhhhhHHHHHHcCcCCHHHHHHHHHHHHHHHHHHHHhccccCC
Confidence 11 0 0 000 00 1111 11222333333333221 1
Q ss_pred CCccccCCCCCceEEccCCcEEEeecCchh
Q psy758 120 HACIHRDIKPENILLTANGVVKLCDFGFAR 149 (292)
Q Consensus 120 ~givH~dl~p~Nilv~~~~~~kl~dfg~~~ 149 (292)
.+++|||+.|.||+++++ ..++||+-+.
T Consensus 192 ~~liHgDlh~~NvL~~~~--~~~IDFdd~~ 219 (325)
T d1zyla1 192 VLRLHGDCHAGNILWRDG--PMFVDLDDAR 219 (325)
T ss_dssp CEECCSSCSGGGEEESSS--EEECCCTTCC
T ss_pred ceeecCCCCcccEEEeCC--ceEEechhcc
Confidence 368999999999999754 4578998875
|
| >d2ppqa1 d.144.1.6 (A:5-320) Homoserine kinase ThrB {Agrobacterium tumefaciens [TaxId: 358]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Homoserine kinase ThrB species: Agrobacterium tumefaciens [TaxId: 358]
Probab=97.38 E-value=0.00011 Score=57.76 Aligned_cols=31 Identities=29% Similarity=0.450 Sum_probs=27.3
Q ss_pred CCccccCCCCCceEEccCCcEEEeecCchhh
Q psy758 120 HACIHRDIKPENILLTANGVVKLCDFGFARL 150 (292)
Q Consensus 120 ~givH~dl~p~Nilv~~~~~~kl~dfg~~~~ 150 (292)
.|++|||+.++||+++++...-++||+.+..
T Consensus 183 ~giIHgDl~~dNvl~~~~~v~gvIDF~~~~~ 213 (316)
T d2ppqa1 183 AGVIHADLFQDNVFFLGDELSGLIDFYFACN 213 (316)
T ss_dssp EEEECSCCCGGGEEEETTEEEEECCCTTCEE
T ss_pred cccccCCcchhhhhcccccceeEeccccccc
Confidence 4799999999999999887778999998853
|
| >d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Pkb kinase (Akt-2) species: Human (Homo sapiens) [TaxId: 9606]
Probab=97.34 E-value=8.7e-05 Score=58.84 Aligned_cols=46 Identities=22% Similarity=0.399 Sum_probs=36.8
Q ss_pred CchHHHHHHHhhcccCCCCCCC-----hhhhhhccCcCCCCCCCCCccchHHHHhcccC
Q psy758 192 TNIYLIDFLKRCLDKDPLRRWS-----CDQLLRHPYFNGYYFEVPDEMQYEEITQRCLD 245 (292)
Q Consensus 192 ~~~~~~~~~~~~~~~~p~~~~~-----~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~ 245 (292)
.+..+.+++..|+..+|.+|++ ..+++.|+||.+. ...++..+.+.
T Consensus 228 ~s~~~~dli~~~L~~dP~~R~~~~~~~~~eil~Hp~f~~i--------~~~~l~~~~~~ 278 (337)
T d1o6la_ 228 LSPEAKSLLAGLLKKDPKQRLGGGPSDAKEVMEHRFFLSI--------NWQDVVQKKLL 278 (337)
T ss_dssp SCHHHHHHHHHHTCSSTTTSTTCSTTTHHHHHTSGGGTTC--------CHHHHHTTCSC
T ss_pred CCHHHHHHHHhhccCCchhhcccccccHHHHHcCcccccC--------CHHHHHhCCCC
Confidence 5777899999999999999995 7899999999875 34455555543
|
| >d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: pak1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=97.03 E-value=8.5e-05 Score=57.68 Aligned_cols=36 Identities=36% Similarity=0.597 Sum_probs=32.4
Q ss_pred CCCchHHHHHHHhhcccCCCCCCChhhhhhccCcCC
Q psy758 190 AATNIYLIDFLKRCLDKDPLRRWSCDQLLRHPYFNG 225 (292)
Q Consensus 190 ~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~ 225 (292)
...+..+.+++..|+..+|.+|+++.+++.|+|+..
T Consensus 240 ~~~s~~~~~li~~~L~~dP~~R~s~~eil~Hp~~~~ 275 (293)
T d1yhwa1 240 EKLSAIFRDFLNRCLDMDVEKRGSAKELLQHQFLKI 275 (293)
T ss_dssp GGSCHHHHHHHHHHTCSSTTTSCCHHHHTTCGGGGG
T ss_pred ccCCHHHHHHHHHHccCChhHCcCHHHHhcCHhhCC
Confidence 345778999999999999999999999999999964
|
| >d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine-protein kinase Nek2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=96.77 E-value=0.00014 Score=55.65 Aligned_cols=33 Identities=21% Similarity=0.318 Sum_probs=29.8
Q ss_pred CCchHHHHHHHhhcccCCCCCCChhhhhhccCc
Q psy758 191 ATNIYLIDFLKRCLDKDPLRRWSCDQLLRHPYF 223 (292)
Q Consensus 191 ~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~ 223 (292)
..+..+.+++..|+..+|..|+++.++++|||.
T Consensus 237 ~~s~~l~~li~~~L~~dp~~Rps~~ell~hp~i 269 (269)
T d2java1 237 RYSDELNEIITRMLNLKDYHRPSVEEILENPLI 269 (269)
T ss_dssp TSCHHHHHHHHHHTCSSGGGSCCHHHHHTSTTC
T ss_pred ccCHHHHHHHHHHcCCChhHCcCHHHHHhCCcC
Confidence 346788999999999999999999999999984
|
| >d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase C, theta type species: Human (Homo sapiens) [TaxId: 9606]
Probab=96.56 E-value=0.00044 Score=54.24 Aligned_cols=35 Identities=20% Similarity=0.384 Sum_probs=31.4
Q ss_pred CchHHHHHHHhhcccCCCCCCChh-hhhhccCcCCC
Q psy758 192 TNIYLIDFLKRCLDKDPLRRWSCD-QLLRHPYFNGY 226 (292)
Q Consensus 192 ~~~~~~~~~~~~~~~~p~~~~~~~-~~~~~~~~~~~ 226 (292)
.+..+.+++..|+..+|.+|++.. +++.|+|+.+.
T Consensus 226 ~s~~~~dli~~~L~~dP~~R~s~~~~l~~hpff~~~ 261 (320)
T d1xjda_ 226 LEKEAKDLLVKLFVREPEKRLGVRGDIRQHPLFREI 261 (320)
T ss_dssp SCHHHHHHHHHHSCSSGGGSBTTBSCGGGSGGGTTC
T ss_pred CCHHHHHHHHHhcccCCCCCcCHHHHHHhCchhccC
Confidence 467889999999999999999985 79999999875
|
| >d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Calmodulin-dependent protein kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=96.24 E-value=0.0011 Score=51.62 Aligned_cols=38 Identities=32% Similarity=0.695 Sum_probs=33.8
Q ss_pred CCCchHHHHHHHhhcccCCCCCCChhhhhhccCcCCCC
Q psy758 190 AATNIYLIDFLKRCLDKDPLRRWSCDQLLRHPYFNGYY 227 (292)
Q Consensus 190 ~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~ 227 (292)
...+..+.+++..|+..+|.+|+++.+++.|+|+.+..
T Consensus 234 ~~~s~~~~~li~~~L~~dP~~R~s~~eil~hp~~~~~~ 271 (307)
T d1a06a_ 234 DDISDSAKDFIRHLMEKDPEKRFTCEQALQHPWIAGDT 271 (307)
T ss_dssp TTSCHHHHHHHHHHSCSSGGGSCCHHHHHHSTTTTSSC
T ss_pred cCCCHHHHHHHHHHccCCHhHCcCHHHHhcCHhhCCCC
Confidence 34578899999999999999999999999999998643
|
| >d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=95.84 E-value=0.0003 Score=55.30 Aligned_cols=35 Identities=29% Similarity=0.549 Sum_probs=31.7
Q ss_pred chHHHHHHHhhcccCCCCCCChhhhhhccCcCCCC
Q psy758 193 NIYLIDFLKRCLDKDPLRRWSCDQLLRHPYFNGYY 227 (292)
Q Consensus 193 ~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~ 227 (292)
+..+.+++..|+..+|.+|+++.++++|+|+....
T Consensus 271 s~~~~dli~~~L~~dP~~R~ta~e~L~Hpf~~~~~ 305 (322)
T d1s9ja_ 271 SLEFQDFVNKCLIKNPAERADLKQLMVHAFIKRSD 305 (322)
T ss_dssp CHHHHHHHHHHTCSSTTTSCCHHHHHTSHHHHHHH
T ss_pred CHHHHHHHHHHcCCChhHCcCHHHHhhCHhhCcCC
Confidence 56789999999999999999999999999997643
|
| >d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]
Probab=95.79 E-value=0.002 Score=51.12 Aligned_cols=37 Identities=30% Similarity=0.579 Sum_probs=33.4
Q ss_pred CCCchHHHHHHHhhcccCCCCCCChhhhhhccCcCCC
Q psy758 190 AATNIYLIDFLKRCLDKDPLRRWSCDQLLRHPYFNGY 226 (292)
Q Consensus 190 ~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~ 226 (292)
...+..+.+++..|+..+|..|++..+++.|+|+.+.
T Consensus 253 ~~~s~~~~~li~~~L~~dp~~R~s~~eil~Hp~~~~~ 289 (352)
T d1koba_ 253 SSVSPEAKDFIKNLLQKEPRKRLTVHDALEHPWLKGD 289 (352)
T ss_dssp TTSCHHHHHHHHTTSCSSGGGSCCHHHHHTSTTTSSC
T ss_pred cCCCHHHHHHHHHHccCChhHCcCHHHHhcCHhhCCC
Confidence 3457889999999999999999999999999999864
|
| >d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Death-associated protein kinase, Dap species: Human (Homo sapiens) [TaxId: 9606]
Probab=95.51 E-value=0.0013 Score=50.75 Aligned_cols=37 Identities=32% Similarity=0.531 Sum_probs=32.1
Q ss_pred CCchHHHHHHHhhcccCCCCCCChhhhhhccCcCCCC
Q psy758 191 ATNIYLIDFLKRCLDKDPLRRWSCDQLLRHPYFNGYY 227 (292)
Q Consensus 191 ~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~ 227 (292)
..+..+.+++..|+..+|.+|+++.+++.|+|+....
T Consensus 242 ~~s~~~~~li~~~L~~dP~~R~s~~eil~hp~~~~~~ 278 (293)
T d1jksa_ 242 NTSALAKDFIRRLLVKDPKKRMTIQDSLQHPWIKPKD 278 (293)
T ss_dssp TSCHHHHHHHHTTSCSSGGGSCCHHHHHHSTTTCC--
T ss_pred CCCHHHHHHHHHHccCChhHCcCHHHHhcCcccCCCC
Confidence 3567889999999999999999999999999998653
|
| >d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: gamma-subunit of glycogen phosphorylase kinase (Phk) species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]
Probab=95.45 E-value=0.0015 Score=49.97 Aligned_cols=36 Identities=28% Similarity=0.600 Sum_probs=33.1
Q ss_pred CCchHHHHHHHhhcccCCCCCCChhhhhhccCcCCC
Q psy758 191 ATNIYLIDFLKRCLDKDPLRRWSCDQLLRHPYFNGY 226 (292)
Q Consensus 191 ~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~ 226 (292)
..+..+.+++..|+..+|.+|+++.+++.|+|++.+
T Consensus 241 ~~s~~~~~li~~~L~~~p~~R~s~~eil~h~~~~~~ 276 (277)
T d1phka_ 241 DYSDTVKDLVSRFLVVQPQKRYTAEEALAHPFFQQY 276 (277)
T ss_dssp GSCHHHHHHHHHHCCSSGGGSCCHHHHTTSGGGCTT
T ss_pred cCCHHHHHHHHHHccCChhHCcCHHHHHcCHHHHHh
Confidence 467889999999999999999999999999999764
|
| >d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase wnk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=95.44 E-value=0.0013 Score=50.05 Aligned_cols=32 Identities=22% Similarity=0.527 Sum_probs=29.3
Q ss_pred chHHHHHHHhhcccCCCCCCChhhhhhccCcC
Q psy758 193 NIYLIDFLKRCLDKDPLRRWSCDQLLRHPYFN 224 (292)
Q Consensus 193 ~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~ 224 (292)
+..+.+++..|+..+|.+|+++.++++|+||+
T Consensus 239 ~~~~~~li~~~l~~dp~~R~s~~ell~Hp~fk 270 (270)
T d1t4ha_ 239 IPEVKEIIEGCIRQNKDERYSIKDLLNHAFFQ 270 (270)
T ss_dssp CHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGC
T ss_pred CHHHHHHHHHHccCCHhHCcCHHHHhCCcccC
Confidence 55688999999999999999999999999974
|
| >d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Titin, kinase domain species: Human (Homo sapiens) [TaxId: 9606]
Probab=95.39 E-value=0.00073 Score=52.98 Aligned_cols=34 Identities=29% Similarity=0.546 Sum_probs=31.3
Q ss_pred CchHHHHHHHhhcccCCCCCCChhhhhhccCcCC
Q psy758 192 TNIYLIDFLKRCLDKDPLRRWSCDQLLRHPYFNG 225 (292)
Q Consensus 192 ~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~ 225 (292)
.+..+.+++..|+..+|.+|+++.+++.|+|+..
T Consensus 230 ~s~~~~~li~~~L~~dp~~R~s~~eil~hp~~~~ 263 (321)
T d1tkia_ 230 ISIEAMDFVDRLLVKERKSRMTASEALQHPWLKQ 263 (321)
T ss_dssp SCHHHHHHHHTTSCSSGGGSCCHHHHHHSHHHHS
T ss_pred CCHHHHHHHHHHccCChhHCcCHHHHhcCHhhcc
Confidence 4677899999999999999999999999999865
|
| >d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: Caenorhabditis elegans, pjk4 [TaxId: 6239]
Probab=95.38 E-value=0.0023 Score=50.61 Aligned_cols=39 Identities=26% Similarity=0.315 Sum_probs=34.4
Q ss_pred CCchHHHHHHHhhcccCCCCCCChhhhhhccCcCCCCCC
Q psy758 191 ATNIYLIDFLKRCLDKDPLRRWSCDQLLRHPYFNGYYFE 229 (292)
Q Consensus 191 ~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~ 229 (292)
..+..+.+++..|+..+|..|+++.+++.|+|+.....+
T Consensus 251 ~~s~~~~~li~~~L~~dP~~R~t~~eil~hp~~~~~~~~ 289 (350)
T d1koaa2 251 GISEDGKDFIRKLLLADPNTRMTIHQALEHPWLTPGNAP 289 (350)
T ss_dssp GCCHHHHHHHHHHCCSSGGGSCCHHHHHHSTTTSCTTCC
T ss_pred CCCHHHHHHHHHHccCChhHCcCHHHHhcCcccCCCCCC
Confidence 346788999999999999999999999999999876543
|
| >d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Aurora-related kinase 1 (aurora-2) species: Human (Homo sapiens) [TaxId: 9606]
Probab=95.38 E-value=0.00048 Score=52.37 Aligned_cols=34 Identities=24% Similarity=0.407 Sum_probs=30.9
Q ss_pred CchHHHHHHHhhcccCCCCCCChhhhhhccCcCC
Q psy758 192 TNIYLIDFLKRCLDKDPLRRWSCDQLLRHPYFNG 225 (292)
Q Consensus 192 ~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~ 225 (292)
.+..+.+++..|+..+|.+|+++.++++|+|+.+
T Consensus 227 ~s~~~~~li~~~L~~dp~~R~t~~eil~hp~~~~ 260 (263)
T d2j4za1 227 VTEGARDLISRLLKHNPSQRPMLREVLEHPWITA 260 (263)
T ss_dssp SCHHHHHHHHHHTCSSGGGSCCHHHHHTCHHHHH
T ss_pred CCHHHHHHHHHHccCCHhHCcCHHHHHcCcCcCC
Confidence 5677889999999999999999999999999864
|
| >d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Ribosomal protein S6 kinase alpha 5, Msk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=95.34 E-value=0.0025 Score=49.81 Aligned_cols=36 Identities=28% Similarity=0.493 Sum_probs=31.3
Q ss_pred CchHHHHHHHhhcccCCCCCCC-----hhhhhhccCcCCCC
Q psy758 192 TNIYLIDFLKRCLDKDPLRRWS-----CDQLLRHPYFNGYY 227 (292)
Q Consensus 192 ~~~~~~~~~~~~~~~~p~~~~~-----~~~~~~~~~~~~~~ 227 (292)
.+..+.+++..|+..+|.+|++ .++++.|+||.+.+
T Consensus 259 ~s~~~~~li~~~l~~dP~~R~s~~~~t~~eil~Hpff~~i~ 299 (322)
T d1vzoa_ 259 MSALAKDLIQRLLMKDPKKRLGCGPRDADEIKEHLFFQKIN 299 (322)
T ss_dssp SCHHHHHHHHHHTCSSGGGSTTSSTTTHHHHHTSGGGTTCC
T ss_pred CCHHHHHHHHHHcccCHHHcCCCCcccHHHHHcCHhhcCCC
Confidence 4667889999999999999984 78999999998753
|
| >d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: G-protein coupled receptor kinase 2 species: Cow (Bos taurus) [TaxId: 9913]
Probab=95.33 E-value=0.0014 Score=52.29 Aligned_cols=37 Identities=22% Similarity=0.348 Sum_probs=32.7
Q ss_pred CCchHHHHHHHhhcccCCCCCCC-----hhhhhhccCcCCCC
Q psy758 191 ATNIYLIDFLKRCLDKDPLRRWS-----CDQLLRHPYFNGYY 227 (292)
Q Consensus 191 ~~~~~~~~~~~~~~~~~p~~~~~-----~~~~~~~~~~~~~~ 227 (292)
..+..+.+++..|+..+|.+|++ +++++.|+||.+..
T Consensus 231 ~~s~~~~~li~~~L~~dP~~R~t~~~~~a~eil~Hp~f~~i~ 272 (364)
T d1omwa3 231 SFSPELRSLLEGLLQRDVNRRLGCLGRGAQEVKESPFFRSLD 272 (364)
T ss_dssp SSCHHHHHHHHHHTCSSTTTSTTTSSSTHHHHHTSGGGTTCC
T ss_pred CCCHHHHHHHHHHcccCHHHhCCCcccCHHHHHcCccccCCC
Confidence 35678899999999999999998 69999999998764
|
| >d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Probab=94.69 E-value=0.0053 Score=47.76 Aligned_cols=37 Identities=24% Similarity=0.405 Sum_probs=32.3
Q ss_pred CCchHHHHHHHhhcccCCCCCC-----ChhhhhhccCcCCCC
Q psy758 191 ATNIYLIDFLKRCLDKDPLRRW-----SCDQLLRHPYFNGYY 227 (292)
Q Consensus 191 ~~~~~~~~~~~~~~~~~p~~~~-----~~~~~~~~~~~~~~~ 227 (292)
..+..+.+++..|+..+|.+|+ +.+++++|+|+.+..
T Consensus 223 ~~s~~~~~li~~~L~~dp~~R~~~~r~t~~~il~Hp~f~~i~ 264 (316)
T d1fota_ 223 FFNEDVKDLLSRLITRDLSQRLGNLQNGTEDVKNHPWFKEVV 264 (316)
T ss_dssp TSCHHHHHHHHHHTCSCTTTCTTSSTTTTHHHHTSGGGSSCC
T ss_pred CCCHHHHHHHHHHhhhCHHhccccchhhHHHHHcCcccccCC
Confidence 3567788999999999999996 899999999998764
|
| >d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: 3-phosphoinositide dependent protein kinase-1 Pdk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=94.64 E-value=0.0035 Score=48.09 Aligned_cols=40 Identities=25% Similarity=0.460 Sum_probs=33.5
Q ss_pred CCCchHHHHHHHhhcccCCCCCCChhh------hhhccCcCCCCCC
Q psy758 190 AATNIYLIDFLKRCLDKDPLRRWSCDQ------LLRHPYFNGYYFE 229 (292)
Q Consensus 190 ~~~~~~~~~~~~~~~~~~p~~~~~~~~------~~~~~~~~~~~~~ 229 (292)
...+..+.+++..|+..+|.+|+++++ ++.|+||.+..+.
T Consensus 231 ~~~s~~~~~li~~~L~~dP~~R~t~~e~~~~~~i~~Hpff~~i~w~ 276 (288)
T d1uu3a_ 231 EKFFPKARDLVEKLLVLDATKRLGCEEMEGYGPLKAHPFFESVTWE 276 (288)
T ss_dssp TTCCHHHHHHHHTTSCSSGGGSTTSGGGTCHHHHHTSGGGTTCCCT
T ss_pred ccCCHHHHHHHHHHccCCHhHCcCHHHHcCCHHHHcCCccCCCCHH
Confidence 446888999999999999999999887 4678998876543
|
| >d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Mouse (Mus musculus) [TaxId: 10090]
Probab=94.64 E-value=0.0044 Score=48.96 Aligned_cols=36 Identities=22% Similarity=0.357 Sum_probs=31.7
Q ss_pred CchHHHHHHHhhcccCCCCCC-----ChhhhhhccCcCCCC
Q psy758 192 TNIYLIDFLKRCLDKDPLRRW-----SCDQLLRHPYFNGYY 227 (292)
Q Consensus 192 ~~~~~~~~~~~~~~~~p~~~~-----~~~~~~~~~~~~~~~ 227 (292)
.+..+.+++..|+..+|.+|+ +..++++|+||.+..
T Consensus 261 ~s~~~~~li~~~L~~dP~kR~~~~r~t~~ell~Hp~f~~~~ 301 (350)
T d1rdqe_ 261 FSSDLKDLLRNLLQVDLTKRFGNLKNGVNDIKNHKWFATTD 301 (350)
T ss_dssp CCHHHHHHHHHHSCSCTTTCTTSSTTTTHHHHTSGGGTTCC
T ss_pred CCHHHHHHHHHHhhhCHHhccccccccHHHHHcCccccCCC
Confidence 567789999999999999995 899999999998763
|
| >d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 7, CDK7 species: Human (Homo sapiens) [TaxId: 9606]
Probab=94.62 E-value=0.018 Score=44.13 Aligned_cols=41 Identities=24% Similarity=0.317 Sum_probs=35.4
Q ss_pred CCchHHHHHHHhhcccCCCCCCChhhhhhccCcCCCCCCCC
Q psy758 191 ATNIYLIDFLKRCLDKDPLRRWSCDQLLRHPYFNGYYFEVP 231 (292)
Q Consensus 191 ~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~ 231 (292)
..+..+.+++..|+..+|.+|+++.++++|+||...+.+.+
T Consensus 251 ~~s~~~~dll~~~L~~dP~~R~sa~e~L~Hp~f~~~p~p~~ 291 (299)
T d1ua2a_ 251 AAGDDLLDLIQGLFLFNPCARITATQALKMKYFSNRPGPTP 291 (299)
T ss_dssp TCCHHHHHHHHHHHCSSTTTSCCHHHHHTSGGGTSSSCCCC
T ss_pred cCCHHHHHHHHHHccCChhhCcCHHHHhCCHhhCCCCCCCC
Confidence 34778999999999999999999999999999987655433
|
| >d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK5 species: Human (Homo sapiens) [TaxId: 9606]
Probab=94.48 E-value=0.013 Score=44.75 Aligned_cols=38 Identities=32% Similarity=0.552 Sum_probs=33.7
Q ss_pred CCchHHHHHHHhhcccCCCCCCChhhhhhccCcCCCCC
Q psy758 191 ATNIYLIDFLKRCLDKDPLRRWSCDQLLRHPYFNGYYF 228 (292)
Q Consensus 191 ~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~ 228 (292)
..+..+.+++..|+..+|.+|+++++++.|+||+++..
T Consensus 254 ~~s~~~~dll~~mL~~dP~~R~sa~e~L~Hp~f~~~~~ 291 (292)
T d1unla_ 254 KLNATGRDLLQNLLKCNPVQRISAEEALQHPYFSDFCP 291 (292)
T ss_dssp TCCHHHHHHHHHHSCSSGGGSCCHHHHTTSGGGSSCSC
T ss_pred cCCHHHHHHHHHHccCChhHCcCHHHHhcChhhcCCCC
Confidence 34778899999999999999999999999999987643
|
| >d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=94.33 E-value=0.022 Score=43.69 Aligned_cols=39 Identities=28% Similarity=0.354 Sum_probs=34.6
Q ss_pred CchHHHHHHHhhcccCCCCCCChhhhhhccCcCCCCCCC
Q psy758 192 TNIYLIDFLKRCLDKDPLRRWSCDQLLRHPYFNGYYFEV 230 (292)
Q Consensus 192 ~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~ 230 (292)
.+..+.+++..|+..+|.+|+++.+++.|+||...+.|.
T Consensus 255 ~s~~~~dll~~mL~~dP~~R~t~~ell~H~ff~~~~~p~ 293 (298)
T d1gz8a_ 255 LDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQDVTKPV 293 (298)
T ss_dssp CCHHHHHHHHHHTCSSTTTSCCHHHHHTSGGGTTCCCCC
T ss_pred CCHHHHHHHHHHccCChhHCcCHHHHhCCHhhccCCCCC
Confidence 467889999999999999999999999999998776553
|
| >d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 9, CDK9 species: Human (Homo sapiens) [TaxId: 9606]
Probab=94.01 E-value=0.025 Score=43.66 Aligned_cols=37 Identities=27% Similarity=0.482 Sum_probs=32.4
Q ss_pred chHHHHHHHhhcccCCCCCCChhhhhhccCcCCCCCC
Q psy758 193 NIYLIDFLKRCLDKDPLRRWSCDQLLRHPYFNGYYFE 229 (292)
Q Consensus 193 ~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~ 229 (292)
+..+.+++..|+..+|..|+++.+++.|+||...+.|
T Consensus 278 ~~~~~dLl~~mL~~dP~~R~sa~elL~Hpff~~~p~p 314 (318)
T d3blha1 278 DPYALDLIDKLLVLDPAQRIDSDDALNHDFFWSDPMP 314 (318)
T ss_dssp CHHHHHHHHHHSCSSTTTSCCHHHHHHSGGGSSSSCC
T ss_pred CHHHHHHHHHHCcCChhHCcCHHHHHcChhhccCCCC
Confidence 5567889999999999999999999999999865443
|
| >d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: STE20-like serine/threonine-protein kinase, SLK species: Human (Homo sapiens) [TaxId: 9606]
Probab=93.70 E-value=0.029 Score=42.78 Aligned_cols=45 Identities=33% Similarity=0.621 Sum_probs=36.7
Q ss_pred CchHHHHHHHhhcccCCCCCCChhhhhhccCcCCCCCCCCCccchHHHHh
Q psy758 192 TNIYLIDFLKRCLDKDPLRRWSCDQLLRHPYFNGYYFEVPDEMQYEEITQ 241 (292)
Q Consensus 192 ~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~ 241 (292)
.+..+.+++..|+..+|..|+++.+++.|+|+... .+..++++|.
T Consensus 241 ~s~~~~~li~~~L~~dp~~R~t~~ell~hp~~~~~-----~~~p~~~li~ 285 (288)
T d2jfla1 241 WSSNFKDFLKKCLEKNVDARWTTSQLLQHPFVTVD-----SNKPIRELIA 285 (288)
T ss_dssp SCHHHHHHHHHHSCSSTTTSCCHHHHTTSGGGCCC-----CCHHHHHHHH
T ss_pred CCHHHHHHHHHHccCChhHCcCHHHHhcCcccCCC-----CCCCcHHHHh
Confidence 46788999999999999999999999999998742 2335666664
|
| >d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38 species: Human (Homo sapiens) [TaxId: 9606]
Probab=93.28 E-value=0.032 Score=43.71 Aligned_cols=39 Identities=31% Similarity=0.433 Sum_probs=34.3
Q ss_pred CCchHHHHHHHhhcccCCCCCCChhhhhhccCcCCCCCC
Q psy758 191 ATNIYLIDFLKRCLDKDPLRRWSCDQLLRHPYFNGYYFE 229 (292)
Q Consensus 191 ~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~ 229 (292)
..+..+.+++..|+..+|.+|+++.++++|+||.+...+
T Consensus 272 ~~s~~~~dli~~mL~~dP~~R~ta~elL~Hp~f~~~~~~ 310 (348)
T d2gfsa1 272 GANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQYHDP 310 (348)
T ss_dssp TCCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGTTTCCT
T ss_pred CCCHHHHHHHHHHCcCChhhCcCHHHHhcCHhhCCCCCC
Confidence 347788999999999999999999999999999876543
|
| >d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase CK2, alpha subunit species: Rattus norvegicus [TaxId: 10116]
Probab=93.10 E-value=0.027 Score=43.71 Aligned_cols=36 Identities=28% Similarity=0.474 Sum_probs=32.7
Q ss_pred CchHHHHHHHhhcccCCCCCCChhhhhhccCcCCCC
Q psy758 192 TNIYLIDFLKRCLDKDPLRRWSCDQLLRHPYFNGYY 227 (292)
Q Consensus 192 ~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~ 227 (292)
.+..+.+++..|+..+|.+|++++++++|+||....
T Consensus 291 ~s~~~~dli~~mL~~dP~~R~ta~e~L~Hp~F~~v~ 326 (328)
T d3bqca1 291 VSPEALDFLDKLLRYDHQSRLTAREAMEHPYFYTVV 326 (328)
T ss_dssp CCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGTTSC
T ss_pred CCHHHHHHHHHHccCChhHCcCHHHHhcCcccCCCC
Confidence 467889999999999999999999999999998654
|
| >d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK6 species: Human (Homo sapiens) [TaxId: 9606]
Probab=93.03 E-value=0.042 Score=42.07 Aligned_cols=36 Identities=33% Similarity=0.572 Sum_probs=32.6
Q ss_pred CCchHHHHHHHhhcccCCCCCCChhhhhhccCcCCC
Q psy758 191 ATNIYLIDFLKRCLDKDPLRRWSCDQLLRHPYFNGY 226 (292)
Q Consensus 191 ~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~ 226 (292)
..+..+.+++..|+..+|.+|+++.+++.|+|+...
T Consensus 264 ~~s~~~~dli~~mL~~dP~~R~sa~e~L~Hpff~~i 299 (305)
T d1blxa_ 264 DIDELGKDLLLKCLTFNPAKRISAYSALSHPYFQDL 299 (305)
T ss_dssp SCCHHHHHHHHHHSCSSTTTSCCHHHHHTSGGGTTC
T ss_pred cCCHHHHHHHHHHCcCChhHCcCHHHHhcChhhcCc
Confidence 347788999999999999999999999999999864
|
| >d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: (Plasmodium falciparum) [TaxId: 5833]
Probab=92.94 E-value=0.041 Score=41.74 Aligned_cols=35 Identities=34% Similarity=0.521 Sum_probs=31.5
Q ss_pred CCchHHHHHHHhhcccCCCCCCChhhhhhccCcCC
Q psy758 191 ATNIYLIDFLKRCLDKDPLRRWSCDQLLRHPYFNG 225 (292)
Q Consensus 191 ~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~ 225 (292)
..+..+.+++..|+..+|..|+++.+++.|+||++
T Consensus 252 ~~s~~~~dli~~~L~~dP~~R~s~~ell~Hp~f~~ 286 (286)
T d1ob3a_ 252 GLDESGIDLLSKMLKLDPNQRITAKQALEHAYFKE 286 (286)
T ss_dssp SCCHHHHHHHHHHTCSSTTTSCCHHHHHTSGGGGC
T ss_pred cCCHHHHHHHHHHccCChhHCcCHHHHhcCcccCc
Confidence 34778899999999999999999999999999863
|
| >d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38-gamma species: Human (Homo sapiens) [TaxId: 9606]
Probab=92.86 E-value=0.047 Score=42.68 Aligned_cols=37 Identities=24% Similarity=0.451 Sum_probs=33.3
Q ss_pred CCchHHHHHHHhhcccCCCCCCChhhhhhccCcCCCC
Q psy758 191 ATNIYLIDFLKRCLDKDPLRRWSCDQLLRHPYFNGYY 227 (292)
Q Consensus 191 ~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~ 227 (292)
..+..+.+++..|+..+|..|+++.+++.|+||....
T Consensus 272 ~~s~~~~dli~~mL~~dP~~R~ta~eiL~Hp~f~~~~ 308 (346)
T d1cm8a_ 272 NASPLAVNLLEKMLVLDAEQRVTAGEALAHPYFESLH 308 (346)
T ss_dssp TCCHHHHHHHHHHSCSSTTTSCCHHHHHHSGGGTTTC
T ss_pred CCCHHHHHHHHHHCcCChhHCcCHHHHhcChhhCcCC
Confidence 3477889999999999999999999999999998754
|
| >d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell cycle checkpoint kinase chk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=92.25 E-value=0.057 Score=40.63 Aligned_cols=35 Identities=14% Similarity=0.319 Sum_probs=31.7
Q ss_pred CCchHHHHHHHhhcccCCCCCCChhhhhhccCcCC
Q psy758 191 ATNIYLIDFLKRCLDKDPLRRWSCDQLLRHPYFNG 225 (292)
Q Consensus 191 ~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~ 225 (292)
..+..+.+++..|+..+|.+|+++.++++|+||..
T Consensus 231 ~~s~~~~~li~~~L~~dP~~R~t~~eil~hpwf~~ 265 (271)
T d1nvra_ 231 KIDSAPLALLHKILVENPSARITIPDIKKDRWYNK 265 (271)
T ss_dssp GSCHHHHHHHHHHSCSSTTTSCCHHHHTTCTTTTC
T ss_pred cCCHHHHHHHHHHcCCChhHCcCHHHHhcCHhhCc
Confidence 34678899999999999999999999999999874
|
| >d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Sky1p species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Probab=92.20 E-value=0.036 Score=43.56 Aligned_cols=34 Identities=29% Similarity=0.506 Sum_probs=31.1
Q ss_pred chHHHHHHHhhcccCCCCCCChhhhhhccCcCCC
Q psy758 193 NIYLIDFLKRCLDKDPLRRWSCDQLLRHPYFNGY 226 (292)
Q Consensus 193 ~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~ 226 (292)
+..+.+++..|+..+|.+|+++.+++.|+||...
T Consensus 301 ~~~~~dll~~mL~~dP~~Rpta~e~L~Hp~f~~~ 334 (362)
T d1q8ya_ 301 AKEISDFLSPMLQLDPRKRADAGGLVNHPWLKDT 334 (362)
T ss_dssp HHHHHHHHGGGGCSSTTTCBCHHHHHTCGGGTTC
T ss_pred CHHHHHHHHHHCCCChhHCcCHHHHhcCcccCCC
Confidence 5678899999999999999999999999999854
|
| >d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Proto-oncogene serine/threonine-protein kinase Pim-1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=91.96 E-value=0.045 Score=41.23 Aligned_cols=39 Identities=15% Similarity=0.351 Sum_probs=34.5
Q ss_pred CCCCchHHHHHHHhhcccCCCCCCChhhhhhccCcCCCC
Q psy758 189 PAATNIYLIDFLKRCLDKDPLRRWSCDQLLRHPYFNGYY 227 (292)
Q Consensus 189 ~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~ 227 (292)
+...+..+.+++..|+..+|.+|+++.+++.|+|+....
T Consensus 224 ~~~~s~~~~~li~~~L~~dp~~R~s~~eil~hp~~~~~~ 262 (273)
T d1xwsa_ 224 RQRVSSECQHLIRWCLALRPSDRPTFEEIQNHPWMQDVL 262 (273)
T ss_dssp SSCCCHHHHHHHHHHTCSSGGGSCCHHHHHTSGGGSSCC
T ss_pred CCCCCHHHHHHHHHHccCCHhHCcCHHHHhcCHhhCCCC
Confidence 344588999999999999999999999999999998653
|
| >d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase Erk2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=91.12 E-value=0.099 Score=40.75 Aligned_cols=37 Identities=32% Similarity=0.668 Sum_probs=32.7
Q ss_pred CCchHHHHHHHhhcccCCCCCCChhhhhhccCcCCCC
Q psy758 191 ATNIYLIDFLKRCLDKDPLRRWSCDQLLRHPYFNGYY 227 (292)
Q Consensus 191 ~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~ 227 (292)
..+..+.+++..|+..+|..|+++.+++.|+|+....
T Consensus 266 ~~s~~~~~li~~~L~~dP~~R~ta~e~L~hpf~~~~~ 302 (345)
T d1pmea_ 266 NADSKALDLLDKMLTFNPHKRIEVEQALAHPYLEQYY 302 (345)
T ss_dssp TSCHHHHHHHHHHSCSSTTTSCCHHHHHTSGGGTTTC
T ss_pred CCCHHHHHHHHHHccCChhHCcCHHHHhcCHhhccCC
Confidence 3467889999999999999999999999999988553
|
| >d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-jun N-terminal kinase (jnk3s) species: Human (Homo sapiens) [TaxId: 9606]
Probab=91.09 E-value=0.057 Score=42.39 Aligned_cols=34 Identities=38% Similarity=0.589 Sum_probs=30.9
Q ss_pred chHHHHHHHhhcccCCCCCCChhhhhhccCcCCC
Q psy758 193 NIYLIDFLKRCLDKDPLRRWSCDQLLRHPYFNGY 226 (292)
Q Consensus 193 ~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~ 226 (292)
+..+.+++..|+..+|..|++++++++|+|+...
T Consensus 284 s~~~~dll~~mL~~dP~~R~ta~elL~Hpw~~~~ 317 (355)
T d2b1pa1 284 ASQARDLLSKMLVIDPAKRISVDDALQHPYINVW 317 (355)
T ss_dssp HHHHHHHHHHHSCSSTTTSCCHHHHHTSTTTGGG
T ss_pred CHHHHHHHHHHCcCChhHCcCHHHHhcCcccCCC
Confidence 4567889999999999999999999999999864
|
| >d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine protein kinase TAO2 species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=90.74 E-value=0.055 Score=41.57 Aligned_cols=35 Identities=29% Similarity=0.493 Sum_probs=31.9
Q ss_pred CchHHHHHHHhhcccCCCCCCChhhhhhccCcCCC
Q psy758 192 TNIYLIDFLKRCLDKDPLRRWSCDQLLRHPYFNGY 226 (292)
Q Consensus 192 ~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~ 226 (292)
.+..+.+++..|+..+|..|+++.+++.|+|+...
T Consensus 239 ~s~~~~~li~~~L~~dP~~Rpt~~ell~Hp~~~~~ 273 (309)
T d1u5ra_ 239 WSEYFRNFVDSCLQKIPQDRPTSEVLLKHRFVLRE 273 (309)
T ss_dssp SCHHHHHHHHHHTCSSGGGSCCHHHHTTCHHHHSC
T ss_pred CCHHHHHHHHHHCcCChhHCcCHHHHHhCHHhcCC
Confidence 46789999999999999999999999999998754
|
| >d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Glycogen synthase kinase-3 beta (Gsk3b) species: Human (Homo sapiens) [TaxId: 9606]
Probab=90.52 E-value=0.071 Score=41.69 Aligned_cols=37 Identities=22% Similarity=0.247 Sum_probs=33.2
Q ss_pred CCchHHHHHHHhhcccCCCCCCChhhhhhccCcCCCC
Q psy758 191 ATNIYLIDFLKRCLDKDPLRRWSCDQLLRHPYFNGYY 227 (292)
Q Consensus 191 ~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~ 227 (292)
..+..+.+++..|+..+|.+|+++.++++|+||....
T Consensus 274 ~~s~~~~dLl~~mL~~dP~~R~ta~e~L~Hp~f~~~~ 310 (350)
T d1q5ka_ 274 RTPPEAIALCSRLLEYTPTARLTPLEACAHSFFDELR 310 (350)
T ss_dssp TSCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGGGGG
T ss_pred CCCHHHHHHHHHHccCChhHCcCHHHHhcCHhhcccc
Confidence 3477899999999999999999999999999998653
|
| >d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase activated protein kinase 2, mapkap2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=87.90 E-value=0.22 Score=38.57 Aligned_cols=35 Identities=14% Similarity=0.364 Sum_probs=31.3
Q ss_pred CchHHHHHHHhhcccCCCCCCChhhhhhccCcCCC
Q psy758 192 TNIYLIDFLKRCLDKDPLRRWSCDQLLRHPYFNGY 226 (292)
Q Consensus 192 ~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~ 226 (292)
.+..+.+++..|+..+|.+|++..+++.|+|+...
T Consensus 244 ~s~~~~~li~~~L~~dP~~R~s~~eil~hp~~~~~ 278 (335)
T d2ozaa1 244 VSEEVKMLIRNLLKTEPTQRMTITEFMNHPWIMQS 278 (335)
T ss_dssp SCHHHHHHHHHHSCSSTTTSCCHHHHHHSHHHHTT
T ss_pred CCHHHHHHHHHHccCChhHCcCHHHHHcCHHhhCC
Confidence 46678999999999999999999999999998643
|
| >d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=86.41 E-value=0.089 Score=40.05 Aligned_cols=26 Identities=12% Similarity=0.008 Sum_probs=21.3
Q ss_pred CchHHHHHHHhhcccCCCCCCChhhh
Q psy758 192 TNIYLIDFLKRCLDKDPLRRWSCDQL 217 (292)
Q Consensus 192 ~~~~~~~~~~~~~~~~p~~~~~~~~~ 217 (292)
.+..+.+++..|+..+|.+||+..++
T Consensus 244 ~p~~~~~li~~cl~~~p~~RP~~~~i 269 (299)
T d1ckia_ 244 YPSEFATYLNFCRSLRFDDKPDYSYL 269 (299)
T ss_dssp SCHHHHHHHHHHHHSCTTCCCCHHHH
T ss_pred CCHHHHHHHHHHccCChhHCcCHHHH
Confidence 34667889999999999999987654
|
| >d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-KIT receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=84.61 E-value=0.087 Score=40.41 Aligned_cols=30 Identities=30% Similarity=0.587 Sum_probs=25.9
Q ss_pred CCCchHHHHHHHhhcccCCCCCCChhhhhh
Q psy758 190 AATNIYLIDFLKRCLDKDPLRRWSCDQLLR 219 (292)
Q Consensus 190 ~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~ 219 (292)
...+..+.+++..|+..+|.+||++.+++.
T Consensus 271 ~~~~~~l~~Li~~cl~~dP~~RPs~~~il~ 300 (311)
T d1t46a_ 271 EHAPAEMYDIMKTCWDADPLKRPTFKQIVQ 300 (311)
T ss_dssp TTSCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred ccccHHHHHHHHHHcCCChhHCcCHHHHHH
Confidence 345678899999999999999999998875
|
| >d1cjaa_ d.144.1.3 (A:) Actin-fragmin kinase, catalytic domain {Physarum polycephalum [TaxId: 5791]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Actin-fragmin kinase, catalytic domain domain: Actin-fragmin kinase, catalytic domain species: Physarum polycephalum [TaxId: 5791]
Probab=82.59 E-value=5.7 Score=29.80 Aligned_cols=128 Identities=18% Similarity=0.198 Sum_probs=68.8
Q ss_pred cccCceEEEEEEEcCCCcEEEEEEeccCCCChHHHHHHHHHHHHHHhCCCCCcchhh--------------------hhh
Q psy758 11 GEGSYGVVFKCRNRDTGQVVAIKKFLESEEDPLIRKIALREIRLLKSLKHPNLVNLL--------------------EVF 70 (292)
Q Consensus 11 ~~g~~~~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~--------------------~~~ 70 (292)
-+|+.|..| +.. ++..+++|.-. ....+.+-.++...-.+..|...-+. +..
T Consensus 78 ~~Gs~Gv~F-V~~--e~gaiVlK~s~-----tta~E~y~~eLAr~LGvpvPqmRvI~~~~~E~~~~~~~~l~~~e~d~~I 149 (342)
T d1cjaa_ 78 EKGTEGLFF-VET--ESGVFIVKRST-----NIESETFCSLLCMRLGLHAPKVRVVSSNSEEGTNMLECLAAIDKSFRVI 149 (342)
T ss_dssp CSTTSCEEE-EEE--SSCEEEEECCT-----THHHHHHHHHHHHHHTCCCCCEEEEESSSHHHHHHHHHHHHHCSSSCHH
T ss_pred ecCCceEEE-EEc--CCceEEEecCC-----chHHHHHHHHHHHHhCCCCCceEEecCCCHHHHHHHHHHhcCCChhHHH
Confidence 345555555 432 25578888532 23446666677766777777643321 000
Q ss_pred h--cCCeEEEEEecCCCccHHHHhcCCCCCCHHHHHHHHHHH---HHHHHHHHhC---CccccC-CCCCceEEccCC-cE
Q psy758 71 R--RKKKLHLVFEFCDHTVLNELENHPHGLPWDLIKQITWQV---LRGVSYCHRH---ACIHRD-IKPENILLTANG-VV 140 (292)
Q Consensus 71 ~--~~~~~~iv~e~~~~~~L~~~~~~~~~~~~~~~~~i~~qi---~~aL~~LH~~---givH~d-l~p~Nilv~~~~-~~ 140 (292)
. -....+++|||.+|..+.+.-.. ..++......+.++ +..=.++++. .+.+++ =.+.||+++.++ .+
T Consensus 150 ~sel~~A~~liMeYvpG~~l~e~~~~--~a~~~fs~~~l~~LGkIiaFDifInN~DR~PL~Wrn~GN~~Niml~~n~~~~ 227 (342)
T d1cjaa_ 150 TTLANQANILLMELVRGITLNKLTTT--SAPEVLTKSTMQQLGSLMALDVIVNNSDRLPIAWTNEGNLDNIMLSERGATV 227 (342)
T ss_dssp HHHTTCSEEEEEECCCEEESTTCCSS--SHHHHSCHHHHHHHHHHHHHHHHHTCCSSSCSSSCSCCCGGGEEEESBTTCE
T ss_pred HHHHhcccceeeeccCCccccccccc--cchhhhcHHHHHHhhhHHHHHHHHcCCccccccccCCCCccceEEecCCcEE
Confidence 1 12457899999999877554321 22222223334443 2222334543 234431 289999998876 67
Q ss_pred EEeecCch
Q psy758 141 KLCDFGFA 148 (292)
Q Consensus 141 kl~dfg~~ 148 (292)
..+|=+..
T Consensus 228 ~~IDs~i~ 235 (342)
T d1cjaa_ 228 VPIDSKII 235 (342)
T ss_dssp EECSCCCC
T ss_pred EEecCCcc
Confidence 77774443
|
| >d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fl cytokine receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=82.10 E-value=0.14 Score=39.53 Aligned_cols=32 Identities=19% Similarity=0.195 Sum_probs=28.1
Q ss_pred CCCCchHHHHHHHhhcccCCCCCCChhhhhhc
Q psy758 189 PAATNIYLIDFLKRCLDKDPLRRWSCDQLLRH 220 (292)
Q Consensus 189 ~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~ 220 (292)
+...+..+.+++..|+..+|.+||++.+++.+
T Consensus 289 p~~~~~~l~~li~~cl~~dP~~RPt~~ei~~~ 320 (325)
T d1rjba_ 289 PFYATEEIYIIMQSCWAFDSRKRPSFPNLTSF 320 (325)
T ss_dssp CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred CCcCCHHHHHHHHHHcCCChhHCcCHHHHHHH
Confidence 44567889999999999999999999998865
|
| >d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Focal adhesion kinase 1 (fak) species: Human (Homo sapiens) [TaxId: 9606]
Probab=81.85 E-value=0.13 Score=38.43 Aligned_cols=32 Identities=25% Similarity=0.410 Sum_probs=27.3
Q ss_pred CCCCchHHHHHHHhhcccCCCCCCChhhhhhc
Q psy758 189 PAATNIYLIDFLKRCLDKDPLRRWSCDQLLRH 220 (292)
Q Consensus 189 ~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~ 220 (292)
+...+..+.+++..|+..+|.+|+++.+++.+
T Consensus 231 ~~~~~~~~~~li~~cl~~dp~~Rps~~ei~~~ 262 (273)
T d1mp8a_ 231 PPNCPPTLYSLMTKCWAYDPSRRPRFTELKAQ 262 (273)
T ss_dssp CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred CCCCCHHHHHHHHHHcCCCHhHCcCHHHHHHH
Confidence 34457789999999999999999999998764
|